id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
170399431|NCT03302299|615801751|FG000|Overall Study|Protocol Violation|1|||
170399432|NCT01458132|615801752|FG000|Overall Study|Other|15|||
170399433|NCT01458132|615801753|FG001|Overall Study|Other|3|||
170399434|NCT00297492|615801754|FG000|Set Quit Date|Lost to Follow-up|7|||
170399435|NCT00297492|615801755|FG001|Set Quit Date|Lost to Follow-up|13|||
170399436|NCT00297492|615801756|FG002|Set Quit Date|Lost to Follow-up|5|||
170399437|NCT00297492|615801754|FG000|6 Month Follow-up|Lost to Follow-up|63|||
170399438|NCT00297492|615801755|FG001|6 Month Follow-up|Lost to Follow-up|49|||
170399439|NCT00297492|615801756|FG002|6 Month Follow-up|Lost to Follow-up|27|||
170399440|NCT00080288|615801757|FG000|Overall Study|Adverse Event|7|||
170399441|NCT00080288|615801758|FG001|Overall Study|Adverse Event|4|||
170399442|NCT00080288|615801757|FG000|Overall Study|Lost to Follow-up|3|||
170399443|NCT00080288|615801758|FG001|Overall Study|Lost to Follow-up|5|||
170399444|NCT00080288|615801757|FG000|Overall Study|Physician Decision|6|||
170399445|NCT00080288|615801758|FG001|Overall Study|Physician Decision|2|||
170399446|NCT00080288|615801757|FG000|Overall Study|Withdrawal by Subject|3|||
170399447|NCT00080288|615801758|FG001|Overall Study|Withdrawal by Subject|16|||
170399448|NCT00080288|615801757|FG000|Overall Study|Miscellaneous|11|||
170399449|NCT00080288|615801758|FG001|Overall Study|Miscellaneous|11|||
170399450|NCT03044431|615801761|FG000|Overall Study|Lost to Follow-up|59|||
170399451|NCT00569231|615801762|FG000|Overall Study|Study unrelated surgery|1|||
170399452|NCT00569231|615801762|FG000|Overall Study|Airfare expense|2|||
170399453|NCT00569231|615801762|FG000|Overall Study|Withdrawal by Subject|1|||
170399454|NCT00569231|615801762|FG000|Overall Study|Car accident injury|1|||
170399455|NCT00569231|615801762|FG000|Overall Study|Non-compliance|2|||
170399456|NCT03456726|615801763|FG000|Overall Study|Disease Progression|6|||
170399457|NCT03456726|615801764|FG001|Overall Study|Disease Progression|1|||
170399458|NCT03456726|615801763|FG000|Overall Study|Adverse Event|4|||
170399459|NCT03456726|615801764|FG001|Overall Study|Adverse Event|2|||
170399460|NCT03456726|615801763|FG000|Overall Study|Withdrawal by Subject|1|||
170399461|NCT03456726|615801764|FG001|Overall Study|Withdrawal by Subject|0|||
170399462|NCT03456726|615801763|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
170399463|NCT03456726|615801764|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
170399464|NCT04470622|615801765|FG000|Overall Study|Withdrawal by Subject|0|||
170399465|NCT04470622|615801766|FG001|Overall Study|Withdrawal by Subject|1|||
170399466|NCT04470622|615801765|FG000|Overall Study|Screen Failure|0|||
170399467|NCT04470622|615801766|FG001|Overall Study|Screen Failure|1|||
170399468|NCT04470622|615801765|FG000|Overall Study|Death|0|||
170399469|NCT04470622|615801766|FG001|Overall Study|Death|1|||
170399470|NCT00399490|615801769|FG000|Overall Study|Adverse Event|19|||
170399471|NCT00399490|615801769|FG000|Overall Study|Lack of Efficacy|31|||
170399472|NCT00399490|615801769|FG000|Overall Study|Lost to Follow-up|5|||
170399473|NCT00399490|615801769|FG000|Overall Study|Withdrawal by Subject|18|||
170399474|NCT00399490|615801769|FG000|Overall Study|Other|25|||
170399475|NCT02437890|615801770|FG000|Overall Study|Non-compliance to study drug|0|||
170399476|NCT02437890|615801771|FG001|Overall Study|Non-compliance to study drug|1|||
170399477|NCT02437890|615801772|FG002|Overall Study|Non-compliance to study drug|0|||
170399478|NCT02437890|615801773|FG003|Overall Study|Non-compliance to study drug|0|||
170399479|NCT02437890|615801774|FG004|Overall Study|Non-compliance to study drug|1|||
170399480|NCT02437890|615801770|FG000|Overall Study|Sponsor's decision|1|||
170399481|NCT02437890|615801771|FG001|Overall Study|Sponsor's decision|1|||
170399482|NCT02437890|615801772|FG002|Overall Study|Sponsor's decision|4|||
170399483|NCT02437890|615801773|FG003|Overall Study|Sponsor's decision|0|||
170399484|NCT02437890|615801774|FG004|Overall Study|Sponsor's decision|2|||
170399485|NCT02437890|615801770|FG000|Overall Study|Physician Decision|0|||
170399486|NCT02437890|615801771|FG001|Overall Study|Physician Decision|0|||
170399487|NCT02437890|615801772|FG002|Overall Study|Physician Decision|0|||
170399488|NCT02437890|615801773|FG003|Overall Study|Physician Decision|1|||
170399489|NCT02437890|615801774|FG004|Overall Study|Physician Decision|0|||
170399490|NCT02437890|615801770|FG000|Overall Study|Unable to attend visit(s)|1|||
170399491|NCT02437890|615801771|FG001|Overall Study|Unable to attend visit(s)|0|||
170399492|NCT02437890|615801772|FG002|Overall Study|Unable to attend visit(s)|0|||
170399493|NCT02437890|615801773|FG003|Overall Study|Unable to attend visit(s)|0|||
170399494|NCT02437890|615801774|FG004|Overall Study|Unable to attend visit(s)|0|||
170399495|NCT02437890|615801770|FG000|Overall Study|Lack of Efficacy|1|||
170399496|NCT02437890|615801771|FG001|Overall Study|Lack of Efficacy|3|||
170399497|NCT02437890|615801772|FG002|Overall Study|Lack of Efficacy|0|||
170399498|NCT02437890|615801773|FG003|Overall Study|Lack of Efficacy|3|||
170399499|NCT02437890|615801774|FG004|Overall Study|Lack of Efficacy|1|||
170399500|NCT02437890|615801770|FG000|Overall Study|Adverse Event|4|||
170399501|NCT02437890|615801771|FG001|Overall Study|Adverse Event|9|||
170399502|NCT02437890|615801772|FG002|Overall Study|Adverse Event|5|||
170399503|NCT02437890|615801773|FG003|Overall Study|Adverse Event|11|||
170399504|NCT02437890|615801774|FG004|Overall Study|Adverse Event|7|||
170399505|NCT02437890|615801770|FG000|Overall Study|Withdrawal by Subject|1|||
170399506|NCT02437890|615801771|FG001|Overall Study|Withdrawal by Subject|2|||
170399507|NCT02437890|615801772|FG002|Overall Study|Withdrawal by Subject|6|||
170399508|NCT02437890|615801773|FG003|Overall Study|Withdrawal by Subject|5|||
170399509|NCT02437890|615801774|FG004|Overall Study|Withdrawal by Subject|5|||
170399510|NCT02437890|615801770|FG000|Overall Study|Death|0|||
170399511|NCT02437890|615801771|FG001|Overall Study|Death|0|||
170399512|NCT02437890|615801772|FG002|Overall Study|Death|0|||
170399513|NCT02437890|615801773|FG003|Overall Study|Death|2|||
170399514|NCT02437890|615801774|FG004|Overall Study|Death|0|||
170399515|NCT02328547|615801775|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
170399516|NCT02328547|615801776|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
170399517|NCT02328547|615801775|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
170399518|NCT02328547|615801776|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
170399519|NCT00344305|615801777|FG000|Overall Study|Lost to Follow-up|2|||
170399520|NCT00344305|615801778|FG001|Overall Study|Lost to Follow-up|0|||
170399521|NCT00344305|615801777|FG000|Overall Study|Participant was not contacted in window|0|||
170399522|NCT00344305|615801778|FG001|Overall Study|Participant was not contacted in window|1|||
170399523|NCT01190098|615801779|FG000|Overall Study|Adverse Event|2|||
170399524|NCT01190098|615801780|FG001|Overall Study|Adverse Event|0|||
170399525|NCT01190098|615801779|FG000|Overall Study|Patient coomorbidity|0|||
170399526|NCT01190098|615801780|FG001|Overall Study|Patient coomorbidity|1|||
170399527|NCT01190098|615801779|FG000|Overall Study|Lack of transportation|1|||
170399528|NCT01190098|615801780|FG001|Overall Study|Lack of transportation|0|||
170399529|NCT01190098|615801779|FG000|Overall Study|Other|0|||
170399530|NCT01190098|615801780|FG001|Overall Study|Other|1|||
170399531|NCT03978117|615801781|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
170399532|NCT03978117|615801782|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
170399533|NCT03978117|615801781|FG000|Overall Study|Lost to Follow-up|4|||
170399534|NCT03978117|615801782|FG001|Overall Study|Lost to Follow-up|4|||
170399535|NCT01422720|615801783|FG000|Overall Study|Adverse Event|16|||
170399536|NCT01422720|615801783|FG000|Overall Study|Lack of Efficacy|1|||
170399537|NCT01422720|615801783|FG000|Overall Study|Withdrawal by Subject|4|||
170399538|NCT01422720|615801783|FG000|Overall Study|Ineligibility|1|||
170399539|NCT00606801|615801784|FG000|Intervention|Protocol Violation|3|||
170399540|NCT00606801|615801785|FG001|Intervention|Protocol Violation|3|||
170399541|NCT00817778|615801790|FG000|Overall Study|Adverse Event|1|||
170399542|NCT00817778|615801791|FG001|Overall Study|Adverse Event|0|||
170399543|NCT00817778|615801790|FG000|Overall Study|Withdrawal by Subject|1|||
170399544|NCT00817778|615801791|FG001|Overall Study|Withdrawal by Subject|1|||
170399545|NCT00817778|615801790|FG000|Overall Study|Protocol Violation|0|||
170399546|NCT00817778|615801791|FG001|Overall Study|Protocol Violation|1|||
170399547|NCT00817778|615801790|FG000|Overall Study|Study-specific discontinuation criteria|0|||
170399548|NCT00817778|615801791|FG001|Overall Study|Study-specific discontinuation criteria|1|||
170399549|NCT00817778|615801790|FG000|Overall Study|Poor venous access|1|||
170399550|NCT00817778|615801791|FG001|Overall Study|Poor venous access|0|||
170399551|NCT01286207|615801799|FG000|Overall Study|Adverse Event|27|||
170399552|NCT01286207|615801800|FG001|Overall Study|Adverse Event|41|||
170399553|NCT01286207|615801801|FG002|Overall Study|Adverse Event|8|||
170399554|NCT01286207|615801799|FG000|Overall Study|Lost to Follow-up|49|||
170399555|NCT01286207|615801800|FG001|Overall Study|Lost to Follow-up|43|||
170399556|NCT01286207|615801801|FG002|Overall Study|Lost to Follow-up|20|||
170399557|NCT01286207|615801799|FG000|Overall Study|Withdrawal by Subject|93|||
170399558|NCT01286207|615801800|FG001|Overall Study|Withdrawal by Subject|79|||
170399559|NCT01286207|615801801|FG002|Overall Study|Withdrawal by Subject|41|||
170399560|NCT01286207|615801799|FG000|Overall Study|Lack of Response|92|||
170399561|NCT01286207|615801800|FG001|Overall Study|Lack of Response|38|||
170399562|NCT01286207|615801801|FG002|Overall Study|Lack of Response|8|||
170399563|NCT01286207|615801799|FG000|Overall Study|Other|37|||
170399564|NCT01286207|615801800|FG001|Overall Study|Other|47|||
170399565|NCT01286207|615801801|FG002|Overall Study|Other|13|||
170399566|NCT00068406|615801813|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
170399567|NCT00068406|615801813|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
170399568|NCT03231709|615801814|FG000|Treatment Period 1|Reason not Specified|0|||
170399569|NCT03231709|615801815|FG001|Treatment Period 1|Reason not Specified|1|||
170399570|NCT03231709|615801814|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
170399571|NCT03231709|615801815|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
170399572|NCT01785875|615801816|FG000|Overall Study|Withdrawal by Subject|41|||
170399573|NCT01785875|615801817|FG001|Overall Study|Withdrawal by Subject|34|||
170399574|NCT01785875|615801818|FG002|Overall Study|Withdrawal by Subject|36|||
170399575|NCT01785875|615801816|FG000|Overall Study|Lost to Follow-up|19|||
170399576|NCT01785875|615801817|FG001|Overall Study|Lost to Follow-up|22|||
170399577|NCT01785875|615801818|FG002|Overall Study|Lost to Follow-up|6|||
170399578|NCT01785875|615801816|FG000|Overall Study|Death|27|||
170399579|NCT01785875|615801817|FG001|Overall Study|Death|16|||
170399580|NCT01785875|615801818|FG002|Overall Study|Death|7|||
170399581|NCT01785875|615801816|FG000|Overall Study|Sponsor Decision|0|||
170399582|NCT01785875|615801817|FG001|Overall Study|Sponsor Decision|2|||
170399583|NCT01785875|615801818|FG002|Overall Study|Sponsor Decision|0|||
170399584|NCT01785875|615801816|FG000|Overall Study|Protocol Specified Criteria|207|||
170399585|NCT01785875|615801817|FG001|Overall Study|Protocol Specified Criteria|214|||
170514347|NCT02542397|616230255|FG000|Overall Study|Death|2|||
170399586|NCT01785875|615801818|FG002|Overall Study|Protocol Specified Criteria|55|||
170399587|NCT01785875|615801816|FG000|Overall Study|Missing|0|||
170399588|NCT01785875|615801817|FG001|Overall Study|Missing|1|||
170399589|NCT01785875|615801818|FG002|Overall Study|Missing|3|||
170399590|NCT01988493|615801819|FG000|Overall Study|Randomized but not treated|0|||
170399591|NCT01988493|615801820|FG001|Overall Study|Randomized but not treated|0|||
170399592|NCT01988493|615801821|FG002|Overall Study|Randomized but not treated|0|||
170399593|NCT01988493|615801822|FG003|Overall Study|Randomized but not treated|0|||
170399594|NCT01988493|615801823|FG004|Overall Study|Randomized but not treated|1|||
170399595|NCT00185731|615801826|FG000|Overall Study|Withdrawal by Subject|1|||
170399596|NCT00185731|615801826|FG000|Overall Study|Not Eligible|1|||
170399597|NCT03891875|615801833|FG000|Overall Study|Withdrawal by Subject|20|||
170399598|NCT03891875|615801834|FG001|Overall Study|Withdrawal by Subject|3|||
170399599|NCT03891875|615801833|FG000|Overall Study|Adverse Event|10|||
170399600|NCT03891875|615801834|FG001|Overall Study|Adverse Event|4|||
170399601|NCT03891875|615801833|FG000|Overall Study|Physician Decision|1|||
170399602|NCT03891875|615801834|FG001|Overall Study|Physician Decision|1|||
170399603|NCT03891875|615801833|FG000|Overall Study|Protocol Violation|1|||
170399604|NCT03891875|615801834|FG001|Overall Study|Protocol Violation|0|||
170399605|NCT03891875|615801833|FG000|Overall Study|Lost to Follow-up|1|||
170399606|NCT03891875|615801834|FG001|Overall Study|Lost to Follow-up|0|||
170399607|NCT03891875|615801833|FG000|Overall Study|COVID-19 infection|1|||
170399608|NCT03891875|615801834|FG001|Overall Study|COVID-19 infection|0|||
170399609|NCT01787188|615801835|FG000|Overall Study|Adverse Event|2|||
170399610|NCT01787188|615801836|FG001|Overall Study|Adverse Event|4|||
170399611|NCT01787188|615801837|FG002|Overall Study|Adverse Event|6|||
170399612|NCT01787188|615801835|FG000|Overall Study|Lack of Efficacy|7|||
170399613|NCT01787188|615801836|FG001|Overall Study|Lack of Efficacy|3|||
170399614|NCT01787188|615801837|FG002|Overall Study|Lack of Efficacy|5|||
170399615|NCT01787188|615801835|FG000|Overall Study|Non-compliance with Study Drug|0|||
170399616|NCT01787188|615801836|FG001|Overall Study|Non-compliance with Study Drug|1|||
170399617|NCT01787188|615801837|FG002|Overall Study|Non-compliance with Study Drug|0|||
170399618|NCT01787188|615801835|FG000|Overall Study|Withdrawal by Subject|4|||
170399619|NCT01787188|615801836|FG001|Overall Study|Withdrawal by Subject|3|||
170399620|NCT01787188|615801837|FG002|Overall Study|Withdrawal by Subject|2|||
170399621|NCT01787188|615801835|FG000|Overall Study|Protocol Violation|3|||
170399622|NCT01787188|615801836|FG001|Overall Study|Protocol Violation|2|||
170399623|NCT01787188|615801837|FG002|Overall Study|Protocol Violation|3|||
170399624|NCT01787188|615801835|FG000|Overall Study|Lost to Follow-up|1|||
170399625|NCT01787188|615801836|FG001|Overall Study|Lost to Follow-up|2|||
170399626|NCT01787188|615801837|FG002|Overall Study|Lost to Follow-up|2|||
170399627|NCT01787188|615801835|FG000|Overall Study|Other, including patient moved|0|||
170399628|NCT01787188|615801836|FG001|Overall Study|Other, including patient moved|3|||
170399629|NCT01787188|615801837|FG002|Overall Study|Other, including patient moved|0|||
170399630|NCT03151707|615801845|FG000|Overall Study|Lost to Follow-up|6|||
170399631|NCT05631093|615801848|FG000|Overall Study|Death|0|||
170399632|NCT05631093|615801849|FG001|Overall Study|Death|1|||
170399633|NCT05631093|615801848|FG000|Overall Study|Lost to Follow-up|1|||
170399634|NCT05631093|615801849|FG001|Overall Study|Lost to Follow-up|2|||
170399635|NCT05631093|615801848|FG000|Overall Study|Physician Decision|1|||
170399636|NCT05631093|615801849|FG001|Overall Study|Physician Decision|0|||
170399637|NCT05631093|615801848|FG000|Overall Study|Withdrawal by Subject|4|||
170399638|NCT05631093|615801849|FG001|Overall Study|Withdrawal by Subject|1|||
170399639|NCT05631093|615801848|FG000|Overall Study|Ongoing|353|||
170399640|NCT05631093|615801849|FG001|Overall Study|Ongoing|177|||
170399641|NCT05631093|615801848|FG000|Overall Study|Adverse Event|0|||
170399642|NCT05631093|615801849|FG001|Overall Study|Adverse Event|1|||
170399643|NCT03107715|615801854|FG000|Overall Study|did not deliver at the home hospital|4|||
170399644|NCT03107715|615801855|FG001|Overall Study|did not deliver at the home hospital|6|||
170399645|NCT03107715|615801854|FG000|Overall Study|infant stillborn|0|||
170399646|NCT03107715|615801855|FG001|Overall Study|infant stillborn|1|||
170399647|NCT03252756|615801859|FG000|Overall Study|Protocol Violation|2|||
170399648|NCT03252756|615801860|FG001|Overall Study|Protocol Violation|4|||
170399649|NCT03252756|615801859|FG000|Overall Study|COVID-19 Pandemic|1|||
170399650|NCT03252756|615801860|FG001|Overall Study|COVID-19 Pandemic|1|||
170399651|NCT03252756|615801859|FG000|Overall Study|Study Drug Expiration|0|||
170399652|NCT03252756|615801860|FG001|Overall Study|Study Drug Expiration|1|||
170399653|NCT04223193|615801861|FG000|Overall Study|Adverse Event|6|||
170399654|NCT04223193|615801862|FG001|Overall Study|Adverse Event|36|||
170399655|NCT04223193|615801861|FG000|Overall Study|Lack of Efficacy|2|||
170399656|NCT04223193|615801862|FG001|Overall Study|Lack of Efficacy|2|||
170399657|NCT04223193|615801861|FG000|Overall Study|Lost to Follow-up|1|||
170399658|NCT04223193|615801862|FG001|Overall Study|Lost to Follow-up|1|||
170399659|NCT04223193|615801861|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
170399660|NCT04223193|615801862|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
170399661|NCT04223193|615801861|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
170399662|NCT04223193|615801862|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
170399663|NCT04223193|615801861|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170399664|NCT04223193|615801862|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170399665|NCT04223193|615801861|FG000|Overall Study|Physician Decision|0|||
170399666|NCT04223193|615801862|FG001|Overall Study|Physician Decision|1|||
170399667|NCT04223193|615801861|FG000|Overall Study|Protocol Violation|1|||
170399668|NCT04223193|615801862|FG001|Overall Study|Protocol Violation|1|||
170399669|NCT04223193|615801861|FG000|Overall Study|Site Terminated by Sponsor|1|||
170399670|NCT04223193|615801862|FG001|Overall Study|Site Terminated by Sponsor|3|||
170399671|NCT04223193|615801861|FG000|Overall Study|Withdrawal by Subject|5|||
170399672|NCT04223193|615801862|FG001|Overall Study|Withdrawal by Subject|6|||
170399673|NCT04223193|615801861|FG000|Overall Study|Other|3|||
170399674|NCT04223193|615801862|FG001|Overall Study|Other|6|||
170399675|NCT03594175|615801863|FG000|Overall Study|Not treated|8|||
170399676|NCT03594175|615801864|FG001|Overall Study|Not treated|1|||
170399677|NCT03594175|615801865|FG002|Overall Study|Not treated|5|||
170399678|NCT03594175|615801863|FG000|Overall Study|Adverse Event|3|||
170399679|NCT03594175|615801864|FG001|Overall Study|Adverse Event|0|||
170399680|NCT03594175|615801865|FG002|Overall Study|Adverse Event|0|||
170399681|NCT03594175|615801863|FG000|Overall Study|Withdrawal by Subject|3|||
170399682|NCT03594175|615801864|FG001|Overall Study|Withdrawal by Subject|0|||
170399683|NCT03594175|615801865|FG002|Overall Study|Withdrawal by Subject|0|||
170399684|NCT03594175|615801863|FG000|Overall Study|Protocol Violation|2|||
170399685|NCT03594175|615801864|FG001|Overall Study|Protocol Violation|2|||
170399686|NCT03594175|615801865|FG002|Overall Study|Protocol Violation|2|||
170399687|NCT02061293|615801866|FG000|Overall Study|Elevated Blood Pressure|1|||
170399688|NCT02061293|615801867|FG001|Overall Study|Elevated Blood Pressure|1|||
170399689|NCT00604175|615801876|FG000|Entry Through Week 28|Death|2|||
170399690|NCT00604175|615801877|FG001|Entry Through Week 28|Death|0|||
170399691|NCT00604175|615801878|FG002|Entry Through Week 28|Death|0|||
170399692|NCT00604175|615801876|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
170399693|NCT00604175|615801877|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
170399694|NCT00604175|615801878|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
170399695|NCT00604175|615801876|FG000|Entry Through Week 28|Lost to Follow-up|4|||
170399696|NCT00604175|615801877|FG001|Entry Through Week 28|Lost to Follow-up|3|||
170399697|NCT00604175|615801878|FG002|Entry Through Week 28|Lost to Follow-up|0|||
170399698|NCT00604175|615801876|FG000|Entry Through Week 28|Ineligible|1|||
170399699|NCT00604175|615801877|FG001|Entry Through Week 28|Ineligible|0|||
170399700|NCT00604175|615801878|FG002|Entry Through Week 28|Ineligible|0|||
170399701|NCT00604175|615801876|FG000|Entry Through Week 28|Did not start intervention|2|||
170399702|NCT00604175|615801877|FG001|Entry Through Week 28|Did not start intervention|0|||
170399703|NCT00604175|615801878|FG002|Entry Through Week 28|Did not start intervention|1|||
170399704|NCT00604175|615801876|FG000|Week 29 Through Week 72|Death|0|||
170399705|NCT00604175|615801877|FG001|Week 29 Through Week 72|Death|0|||
170399706|NCT00604175|615801878|FG002|Week 29 Through Week 72|Death|1|||
170399707|NCT00604175|615801876|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
170399708|NCT00604175|615801877|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
170399709|NCT00604175|615801878|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
170399710|NCT00604175|615801876|FG000|Week 29 Through Week 72|Site closure|0|||
170399711|NCT00604175|615801877|FG001|Week 29 Through Week 72|Site closure|1|||
170399712|NCT00604175|615801878|FG002|Week 29 Through Week 72|Site closure|0|||
170399713|NCT00604175|615801876|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
170399714|NCT00604175|615801877|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
170399715|NCT00604175|615801878|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
170399716|NCT02044094|615801879|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
170399717|NCT02044094|615801879|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
170399718|NCT02044094|615801879|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
170399719|NCT02044094|615801879|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
170399720|NCT02044094|615801879|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
170399721|NCT02044094|615801879|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
170399722|NCT02044094|615801879|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
170399723|NCT02044094|615801879|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
170399724|NCT02392377|615801880|FG000|Overall Study|Withdrawal by Subject|0|||
170399725|NCT02392377|615801881|FG001|Overall Study|Withdrawal by Subject|1|||
170399726|NCT03205163|615801882|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
170399727|NCT03205163|615801883|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
170399728|NCT00005879|615801884|FG000|Overall Study|Withdrawal by Subject|8|||
170399729|NCT00005879|615801885|FG001|Overall Study|Withdrawal by Subject|10|||
170399730|NCT01238172|615801886|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
170399731|NCT01238172|615801887|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
170399732|NCT01238172|615801886|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
170399733|NCT01238172|615801887|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
170399734|NCT05022121|615801888|FG000|Overall Study|Lack of Efficacy|1|||
170399735|NCT05022121|615801889|FG001|Overall Study|Lack of Efficacy|0|||
170399736|NCT05022121|615801888|FG000|Overall Study|Lost to Follow-up|0|||
170399737|NCT05022121|615801889|FG001|Overall Study|Lost to Follow-up|2|||
170399738|NCT02038959|615803581|FG000|Overall Study|Withdrawal by Subject|6|||
170399739|NCT02038959|615803582|FG001|Overall Study|Withdrawal by Subject|8|||
170399740|NCT03911960|615803589|FG000|Overall Study|Lost to Follow-up|5|||
170399741|NCT03911960|615803590|FG001|Overall Study|Lost to Follow-up|3|||
170399742|NCT00265239|615803591|FG000|Overall Study|Adverse Event|2|||
170399743|NCT00265239|615803592|FG001|Overall Study|Adverse Event|1|||
170399744|NCT02803138|615803595|FG000|Overall Study|Failure to return|38|||
170399745|NCT02803138|615803595|FG000|Overall Study|Insufficient virological response|2|||
170399746|NCT02803138|615803595|FG000|Overall Study|Withdrawn consent|1|||
170399747|NCT02803138|615803595|FG000|Overall Study|Death|1|||
170399748|NCT02803138|615803595|FG000|Overall Study|Other, not specified|28|||
170399749|NCT01858558|615803596|FG000|Overall Study|Death|1|||
170399750|NCT01858558|615803597|FG001|Overall Study|Death|1|||
170399751|NCT01858558|615803596|FG000|Overall Study|Lost to Follow-up|1|||
170399752|NCT01858558|615803597|FG001|Overall Study|Lost to Follow-up|0|||
170399753|NCT01858558|615803596|FG000|Overall Study|Disease progression|3|||
170399754|NCT01858558|615803597|FG001|Overall Study|Disease progression|1|||
170399755|NCT01858558|615803596|FG000|Overall Study|Product contamination|2|||
170399756|NCT01858558|615803597|FG001|Overall Study|Product contamination|0|||
170399757|NCT01858558|615803596|FG000|Overall Study|Failed expansion of cell product|2|||
170399758|NCT01858558|615803597|FG001|Overall Study|Failed expansion of cell product|0|||
170399759|NCT01726335|615803602|FG000|Overall Study|Lost to Follow-up|2|||
170399760|NCT01726335|615803602|FG000|Overall Study|Withdrawal by Subject|15|||
170399761|NCT01726335|615803602|FG000|Overall Study|Adverse Event|4|||
170399762|NCT01726335|615803602|FG000|Overall Study|Lost to Follow-up|2|||
170399763|NCT01726335|615803602|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
170399764|NCT01586624|615803603|FG000|Overall Study|Adverse Event|3|||
170399765|NCT01586624|615803604|FG001|Overall Study|Adverse Event|0|||
170399766|NCT01586624|615803605|FG002|Overall Study|Adverse Event|2|||
170399767|NCT01586624|615803606|FG003|Overall Study|Adverse Event|1|||
170399768|NCT01586624|615803607|FG004|Overall Study|Adverse Event|3|||
170399769|NCT01586624|615803608|FG005|Overall Study|Adverse Event|3|||
170399770|NCT01586624|615803609|FG006|Overall Study|Adverse Event|2|||
170399771|NCT01586624|615803610|FG007|Overall Study|Adverse Event|3|||
170399772|NCT01586624|615803603|FG000|Overall Study|Physician Decision|0|||
170399773|NCT01586624|615803604|FG001|Overall Study|Physician Decision|1|||
170399774|NCT01586624|615803605|FG002|Overall Study|Physician Decision|1|||
170399775|NCT01586624|615803606|FG003|Overall Study|Physician Decision|0|||
170399776|NCT01586624|615803607|FG004|Overall Study|Physician Decision|2|||
170399777|NCT01586624|615803608|FG005|Overall Study|Physician Decision|0|||
170399778|NCT01586624|615803609|FG006|Overall Study|Physician Decision|1|||
170399779|NCT01586624|615803610|FG007|Overall Study|Physician Decision|1|||
170399780|NCT01586624|615803603|FG000|Overall Study|Withdrawal by Subject|0|||
170399781|NCT01586624|615803604|FG001|Overall Study|Withdrawal by Subject|0|||
170399782|NCT01586624|615803605|FG002|Overall Study|Withdrawal by Subject|0|||
170399783|NCT01586624|615803606|FG003|Overall Study|Withdrawal by Subject|1|||
170399784|NCT01586624|615803607|FG004|Overall Study|Withdrawal by Subject|0|||
170399785|NCT01586624|615803608|FG005|Overall Study|Withdrawal by Subject|0|||
170399786|NCT01586624|615803609|FG006|Overall Study|Withdrawal by Subject|0|||
170399787|NCT01586624|615803610|FG007|Overall Study|Withdrawal by Subject|0|||
170399788|NCT01586624|615803603|FG000|Overall Study|Evidence of disease progression|1|||
170399789|NCT01586624|615803604|FG001|Overall Study|Evidence of disease progression|3|||
170399790|NCT01586624|615803605|FG002|Overall Study|Evidence of disease progression|2|||
170399791|NCT01586624|615803606|FG003|Overall Study|Evidence of disease progression|5|||
170399792|NCT01586624|615803607|FG004|Overall Study|Evidence of disease progression|3|||
170399793|NCT01586624|615803608|FG005|Overall Study|Evidence of disease progression|5|||
170399794|NCT01586624|615803609|FG006|Overall Study|Evidence of disease progression|4|||
170399795|NCT01586624|615803610|FG007|Overall Study|Evidence of disease progression|6|||
170399796|NCT01586624|615803603|FG000|Overall Study|Screen failure (no treatment received)|0|||
170399797|NCT01586624|615803604|FG001|Overall Study|Screen failure (no treatment received)|0|||
170399798|NCT01586624|615803605|FG002|Overall Study|Screen failure (no treatment received)|0|||
170399799|NCT01586624|615803606|FG003|Overall Study|Screen failure (no treatment received)|0|||
170399800|NCT01586624|615803607|FG004|Overall Study|Screen failure (no treatment received)|0|||
170399801|NCT01586624|615803608|FG005|Overall Study|Screen failure (no treatment received)|0|||
170399802|NCT01586624|615803609|FG006|Overall Study|Screen failure (no treatment received)|1|||
170399803|NCT01586624|615803610|FG007|Overall Study|Screen failure (no treatment received)|0|||
170399804|NCT02284373|615803614|FG000|Overall Study|Withdrawal by Subject|0|||
170399805|NCT02284373|615803615|FG001|Overall Study|Withdrawal by Subject|1|||
170399806|NCT02284373|615803616|FG002|Overall Study|Withdrawal by Subject|0|||
170399807|NCT02284373|615803614|FG000|Overall Study|Other|0|||
170399808|NCT02284373|615803615|FG001|Overall Study|Other|1|||
170399809|NCT02284373|615803616|FG002|Overall Study|Other|0|||
170399810|NCT02284373|615803614|FG000|Overall Study|Lost to Follow-up|0|||
170399811|NCT02284373|615803615|FG001|Overall Study|Lost to Follow-up|1|||
170399812|NCT02284373|615803616|FG002|Overall Study|Lost to Follow-up|0|||
170399813|NCT00468312|615803617|FG000|Overall Study|Adverse Event|2|||
170399814|NCT00468312|615803618|FG001|Overall Study|Adverse Event|1|||
170399815|NCT00468312|615803617|FG000|Overall Study|Lack of Efficacy|0|||
170399816|NCT00468312|615803618|FG001|Overall Study|Lack of Efficacy|1|||
170399817|NCT00468312|615803617|FG000|Overall Study|Withdrawal by Subject|0|||
170399818|NCT00468312|615803618|FG001|Overall Study|Withdrawal by Subject|1|||
170399819|NCT00468312|615803617|FG000|Overall Study|Protocol Violation|2|||
170399820|NCT00468312|615803618|FG001|Overall Study|Protocol Violation|1|||
170399821|NCT00468312|615803617|FG000|Overall Study|Did not meet protocol eligibility|0|||
170399822|NCT00468312|615803618|FG001|Overall Study|Did not meet protocol eligibility|1|||
170399823|NCT02016755|615803619|FG000|Overall Study|Major amputation of index limb|2|||
170399824|NCT02016755|615803619|FG000|Overall Study|Adverse Event|2|||
170399825|NCT02016755|615803619|FG000|Overall Study|Physician Decision|1|||
170399826|NCT02016755|615803619|FG000|Overall Study|Death|2|||
170399827|NCT02476851|615803624|FG000|Overall Study|Protocol Violation|1|||
170399828|NCT02476851|615803625|FG001|Overall Study|Protocol Violation|1|||
170399829|NCT01537549|615803637|FG000|Overall Study|Lost to Follow-up|1|||
170399830|NCT01537549|615803637|FG000|Overall Study|Withdrawal by Subject|2|||
170399831|NCT02748616|615803640|FG000|Overall Study|Lost to Follow-up|1|||
170399832|NCT02748616|615803640|FG000|Overall Study|Withdrawal by Subject|2|||
170399833|NCT02748616|615803640|FG000|Overall Study|Physician Decision|2|||
170399834|NCT02748616|615803640|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
170399835|NCT01682512|615803641|FG000|Overall Study|Adverse Event|6|||
170399836|NCT01682512|615803642|FG001|Overall Study|Adverse Event|5|||
170399837|NCT01682512|615803643|FG002|Overall Study|Adverse Event|2|||
170399838|NCT01682512|615803641|FG000|Overall Study|Withdrawal by Subject|2|||
170399839|NCT01682512|615803642|FG001|Overall Study|Withdrawal by Subject|6|||
170399840|NCT01682512|615803643|FG002|Overall Study|Withdrawal by Subject|3|||
170399841|NCT01682512|615803641|FG000|Overall Study|Physician Decision|0|||
170399842|NCT01682512|615803642|FG001|Overall Study|Physician Decision|2|||
170399843|NCT01682512|615803643|FG002|Overall Study|Physician Decision|0|||
170399844|NCT01682512|615803641|FG000|Overall Study|Study terminated by sponsor|46|||
170399845|NCT01682512|615803642|FG001|Overall Study|Study terminated by sponsor|43|||
170399846|NCT01682512|615803643|FG002|Overall Study|Study terminated by sponsor|0|||
170399847|NCT01682512|615803641|FG000|Overall Study|Lost to Follow-up|3|||
170399848|NCT01682512|615803642|FG001|Overall Study|Lost to Follow-up|0|||
170399849|NCT01682512|615803643|FG002|Overall Study|Lost to Follow-up|2|||
170399850|NCT01682512|615803641|FG000|Overall Study|Protocol Violation|2|||
170399851|NCT01682512|615803642|FG001|Overall Study|Protocol Violation|3|||
170399852|NCT01682512|615803643|FG002|Overall Study|Protocol Violation|2|||
170399853|NCT01682512|615803641|FG000|Overall Study|Primary lack of efficacy|10|||
170399854|NCT01682512|615803642|FG001|Overall Study|Primary lack of efficacy|7|||
170399855|NCT01682512|615803643|FG002|Overall Study|Primary lack of efficacy|7|||
170399856|NCT01682512|615803641|FG000|Overall Study|Secondary lack of efficacy|1|||
170399857|NCT01682512|615803642|FG001|Overall Study|Secondary lack of efficacy|1|||
170399858|NCT01682512|615803643|FG002|Overall Study|Secondary lack of efficacy|0|||
170399859|NCT01682512|615803641|FG000|Overall Study|Other than stated above|2|||
170399860|NCT01682512|615803642|FG001|Overall Study|Other than stated above|4|||
170399861|NCT01682512|615803643|FG002|Overall Study|Other than stated above|2|||
170399862|NCT00965263|615803648|FG000|Overall Study|Physician Decision|2|||
170399863|NCT00965263|615803649|FG001|Overall Study|Physician Decision|0|||
170399864|NCT00965263|615803648|FG000|Overall Study|Family emergency|0|||
170399865|NCT00965263|615803649|FG001|Overall Study|Family emergency|1|||
170399866|NCT00965263|615803648|FG000|Overall Study|Protocol Violation|0|||
170514348|NCT02542397|616230255|FG000|Overall Study|Physician Decision|6|||
170514349|NCT02542397|616230255|FG000|Overall Study|Withdrawal by Subject|6|||
170514350|NCT02542397|616230255|FG000|Overall Study|Lost to Follow-up|2|||
170514351|NCT00534248|616230258|FG000|Overall Study|Adverse Event|19|||
170514352|NCT00534248|616230259|FG001|Overall Study|Adverse Event|29|||
170514353|NCT00534248|616230258|FG000|Overall Study|Lost to Follow-up|353|||
170514354|NCT00534248|616230259|FG001|Overall Study|Lost to Follow-up|375|||
170514355|NCT00534248|616230258|FG000|Overall Study|Other protocol specified criteria|13|||
170514356|NCT00534248|616230259|FG001|Overall Study|Other protocol specified criteria|3|||
170514357|NCT00534248|616230258|FG000|Overall Study|Physician Decision|10|||
170514358|NCT00534248|616230259|FG001|Overall Study|Physician Decision|7|||
170514359|NCT00534248|616230258|FG000|Overall Study|Protocol Violation|3|||
170514360|NCT00534248|616230259|FG001|Overall Study|Protocol Violation|4|||
170514361|NCT00534248|616230258|FG000|Overall Study|Withdrawal by Subject|263|||
170514362|NCT00534248|616230259|FG001|Overall Study|Withdrawal by Subject|255|||
170514363|NCT02532257|616230262|FG000|Overall Study|Adverse Event|2|||
170514364|NCT02532257|616230262|FG000|Overall Study|Physician Decision|4|||
170399867|NCT00965263|615803649|FG001|Overall Study|Protocol Violation|2|||
170399868|NCT03496207|615803650|FG000|Base Study|Adverse Event|0|||
170399869|NCT03496207|615803651|FG001|Base Study|Adverse Event|0|||
170399870|NCT03496207|615803652|FG002|Base Study|Adverse Event|1|||
170399871|NCT03496207|615803653|FG003|Base Study|Adverse Event|1|||
170399872|NCT03496207|615803654|FG004|Base Study|Adverse Event|4|||
170399873|NCT03496207|615803650|FG000|Base Study|Death|0|||
170399874|NCT03496207|615803651|FG001|Base Study|Death|0|||
170399875|NCT03496207|615803652|FG002|Base Study|Death|0|||
170399876|NCT03496207|615803653|FG003|Base Study|Death|0|||
170399877|NCT03496207|615803654|FG004|Base Study|Death|1|||
170399878|NCT03496207|615803650|FG000|Base Study|Withdrawal by Subject|0|||
170399879|NCT03496207|615803651|FG001|Base Study|Withdrawal by Subject|0|||
170399880|NCT03496207|615803652|FG002|Base Study|Withdrawal by Subject|1|||
170399881|NCT03496207|615803653|FG003|Base Study|Withdrawal by Subject|0|||
170399882|NCT03496207|615803654|FG004|Base Study|Withdrawal by Subject|1|||
170399883|NCT03496207|615803650|FG000|Extension Period|Adverse Event|0|||
170399884|NCT03496207|615803651|FG001|Extension Period|Adverse Event|0|||
170399885|NCT03496207|615803652|FG002|Extension Period|Adverse Event|0|||
170399886|NCT03496207|615803653|FG003|Extension Period|Adverse Event|1|||
170399887|NCT03496207|615803654|FG004|Extension Period|Adverse Event|1|||
170399888|NCT03496207|615803650|FG000|Extension Period|Death|1|||
170399889|NCT03496207|615803651|FG001|Extension Period|Death|0|||
170399890|NCT03496207|615803652|FG002|Extension Period|Death|0|||
170399891|NCT03496207|615803653|FG003|Extension Period|Death|1|||
170399892|NCT03496207|615803654|FG004|Extension Period|Death|2|||
170399893|NCT03496207|615803650|FG000|Extension Period|Withdrawal by Subject|1|||
170514365|NCT02532257|616230262|FG000|Overall Study|Withdrawal by Subject|3|||
170399894|NCT03496207|615803651|FG001|Extension Period|Withdrawal by Subject|0|||
170399895|NCT03496207|615803652|FG002|Extension Period|Withdrawal by Subject|0|||
170399896|NCT03496207|615803653|FG003|Extension Period|Withdrawal by Subject|1|||
170399897|NCT03496207|615803654|FG004|Extension Period|Withdrawal by Subject|1|||
170514366|NCT02532257|616230262|FG000|Overall Study|Progressive Disease|10|||
170514367|NCT02259400|616230263|FG000|Overall Study|Death|0|||
170399898|NCT03496207|615803650|FG000|Extension Period|Elevated hemoglobin levels|0|||
170514368|NCT02259400|616230264|FG001|Overall Study|Death|2|||
170514369|NCT00697593|616230266|FG000|Overall Study|Adverse Event|3|||
170514370|NCT00697593|616230266|FG000|Overall Study|Protocol Violation|1|||
170514371|NCT00697593|616230266|FG000|Overall Study|Lack of Efficacy|3|||
170514372|NCT00697593|616230266|FG000|Overall Study|Suspension of the study by sponsor|12|||
170399899|NCT03496207|615803651|FG001|Extension Period|Elevated hemoglobin levels|0|||
170399900|NCT03496207|615803652|FG002|Extension Period|Elevated hemoglobin levels|0|||
170399901|NCT03496207|615803653|FG003|Extension Period|Elevated hemoglobin levels|0|||
170399902|NCT03496207|615803654|FG004|Extension Period|Elevated hemoglobin levels|1|||
170399903|NCT01783483|615803655|FG000|Overall Study|Death|3|||
170399904|NCT01783483|615803656|FG001|Overall Study|Death|3|||
170399905|NCT01783483|615803655|FG000|Overall Study|Lost to Follow-up|14|||
170399906|NCT01783483|615803656|FG001|Overall Study|Lost to Follow-up|10|||
170399907|NCT01783483|615803655|FG000|Overall Study|Withdrawal by Subject|2|||
170399908|NCT01783483|615803656|FG001|Overall Study|Withdrawal by Subject|1|||
170399909|NCT01783483|615803655|FG000|Overall Study|Physician Decision|1|||
170399910|NCT01783483|615803656|FG001|Overall Study|Physician Decision|1|||
170399911|NCT01766310|615803657|FG000|Overall Study|Lost to Follow-up|1|||
170399912|NCT01766310|615803658|FG001|Overall Study|Lost to Follow-up|3|||
170399913|NCT00835068|615803659|FG000|Overall Study|Death|1|||
170399914|NCT00835068|615803660|FG001|Overall Study|Death|0|||
170399915|NCT00835068|615803659|FG000|Overall Study|Adverse Event|0|||
170399916|NCT00835068|615803660|FG001|Overall Study|Adverse Event|1|||
170399917|NCT00835068|615803659|FG000|Overall Study|Other|8|||
170399918|NCT00835068|615803660|FG001|Overall Study|Other|0|||
170399919|NCT00835068|615803659|FG000|Overall Study|Withdrawal by Subject|1|||
170399920|NCT00835068|615803660|FG001|Overall Study|Withdrawal by Subject|0|||
170399921|NCT01591499|615803661|FG000|Baseline Visit|Withdrawal by Subject|0|||
170399922|NCT01591499|615803662|FG001|Baseline Visit|Withdrawal by Subject|2|||
170399923|NCT01591499|615803663|FG002|Baseline Visit|Withdrawal by Subject|0|||
170399924|NCT01591499|615803664|FG003|Baseline Visit|Withdrawal by Subject|2|||
170399925|NCT01591499|615803661|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
170399926|NCT01591499|615803662|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
170399927|NCT01591499|615803663|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
170399928|NCT01591499|615803664|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
170399929|NCT01591499|615803661|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
170399930|NCT01591499|615803662|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
170399931|NCT01591499|615803663|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
170399932|NCT01591499|615803664|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
170399933|NCT02125734|615803665|FG000|Period 2|Adverse Event|0|||
170399934|NCT02125734|615803666|FG001|Period 2|Adverse Event|1|||
170399935|NCT01308762|615803667|FG000|Overall Study|Protocol Violation|0|||
170399936|NCT01308762|615803668|FG001|Overall Study|Protocol Violation|1|||
170399937|NCT01308762|615803669|FG002|Overall Study|Protocol Violation|0|||
170399938|NCT00530088|615803670|FG000|Overall Study|Disease Progression|4|||
170514373|NCT03084302|616230267|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
170514374|NCT03084302|616230267|FG000|Overall Study|No valid objective monitor data|6|||
170399939|NCT00530088|615803670|FG000|Overall Study|Physician Decision|4|||
170399940|NCT00530088|615803670|FG000|Overall Study|Other Not Specified|2|||
170399941|NCT00758706|615803675|FG000|Overall Study|Adverse Event|4|||
170399942|NCT00758706|615803676|FG001|Overall Study|Adverse Event|4|||
170399943|NCT02441179|615803677|FG000|Overall Study|Withdrawal by Subject|1|||
170399944|NCT02441179|615803678|FG001|Overall Study|Withdrawal by Subject|1|||
170399945|NCT04083378|615803682|FG000|Overall Study|Death|18|||
170399946|NCT04083378|615803683|FG001|Overall Study|Death|4|||
170399947|NCT04083378|615803682|FG000|Overall Study|Lost to Follow-up|4|||
170399948|NCT04083378|615803683|FG001|Overall Study|Lost to Follow-up|0|||
170399949|NCT06078124|615803684|FG000|Overall Study|Lost to Follow-up|14|||
170399950|NCT06078124|615803685|FG001|Overall Study|Lost to Follow-up|14|||
170399951|NCT05824273|615803686|FG000|Overall Study|Lost to Follow-up|16|||
170399952|NCT05824273|615803687|FG001|Overall Study|Lost to Follow-up|13|||
170399953|NCT03732677|615803689|FG000|Overall Study|Terminated the study|154|||
170399954|NCT03732677|615803690|FG001|Overall Study|Terminated the study|197|||
170399955|NCT03732677|615803689|FG000|Overall Study|Continuing study off treatment|379|||
170399956|NCT03732677|615803690|FG001|Overall Study|Continuing study off treatment|333|||
170399957|NCT01500434|615803691|FG000|Overall Study|Death|1|||
170399958|NCT01500434|615803691|FG000|Overall Study|Withdrawal by Subject|1|||
170399959|NCT01500434|615803691|FG000|Overall Study|Missed 12-month follow-up|5|||
170399960|NCT05838755|615803702|FG000|Overall Study|Adverse Event|1|||
170399961|NCT05838755|615803703|FG001|Overall Study|Adverse Event|0|||
170399962|NCT05838755|615803704|FG002|Overall Study|Adverse Event|0|||
170399963|NCT05838755|615803702|FG000|Overall Study|Lack of Efficacy|1|||
170399964|NCT05838755|615803703|FG001|Overall Study|Lack of Efficacy|0|||
170399965|NCT05838755|615803704|FG002|Overall Study|Lack of Efficacy|1|||
170399966|NCT05838755|615803702|FG000|Overall Study|Lost to Follow-up|0|||
170399967|NCT05838755|615803703|FG001|Overall Study|Lost to Follow-up|1|||
170399968|NCT05838755|615803704|FG002|Overall Study|Lost to Follow-up|4|||
170399969|NCT05838755|615803702|FG000|Overall Study|Withdrawal by Subject|0|||
170399970|NCT05838755|615803703|FG001|Overall Study|Withdrawal by Subject|2|||
170399971|NCT05838755|615803704|FG002|Overall Study|Withdrawal by Subject|0|||
170399972|NCT05838755|615803702|FG000|Overall Study|Study terminated by sponsor|26|||
170399973|NCT05838755|615803703|FG001|Overall Study|Study terminated by sponsor|27|||
170399974|NCT05838755|615803704|FG002|Overall Study|Study terminated by sponsor|26|||
170399975|NCT05838755|615803702|FG000|Overall Study|Randomized, not treated|2|||
170399976|NCT05838755|615803703|FG001|Overall Study|Randomized, not treated|0|||
170399977|NCT05838755|615803704|FG002|Overall Study|Randomized, not treated|1|||
170399978|NCT05838755|615803702|FG000|Overall Study|Pregnancy|0|||
170399979|NCT05838755|615803703|FG001|Overall Study|Pregnancy|1|||
170399980|NCT05838755|615803704|FG002|Overall Study|Pregnancy|0|||
170399981|NCT01283282|615803705|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
170399982|NCT01283282|615803706|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
170399983|NCT01283282|615803705|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
170399984|NCT01283282|615803706|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
170399985|NCT01283282|615803705|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
170399986|NCT01283282|615803706|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
170399987|NCT00083226|615803707|FG000|Overall Study|Lack of Efficacy|19|||
170399988|NCT00083226|615803707|FG000|Overall Study|Adverse Event|9|||
170399989|NCT00083226|615803707|FG000|Overall Study|Death|4|||
170399990|NCT00083226|615803707|FG000|Overall Study|Withdrawal by Subject|4|||
170399991|NCT00083226|615803707|FG000|Overall Study|Other|2|||
170399992|NCT00083226|615803707|FG000|Overall Study|ineligible or not receiving treatment|4|||
170399993|NCT00909857|615803708|FG000|Overall Study|Withdrawal by Subject|6|||
170399994|NCT00909857|615803709|FG001|Overall Study|Withdrawal by Subject|10|||
170399995|NCT00909857|615803708|FG000|Overall Study|Adverse Event|5|||
170399996|NCT00909857|615803709|FG001|Overall Study|Adverse Event|5|||
170399997|NCT00909857|615803708|FG000|Overall Study|Lost to Follow-up|2|||
170399998|NCT00909857|615803709|FG001|Overall Study|Lost to Follow-up|5|||
170399999|NCT00909857|615803708|FG000|Overall Study|Protocol Violation|2|||
170400000|NCT00909857|615803709|FG001|Overall Study|Protocol Violation|1|||
170400001|NCT00909857|615803708|FG000|Overall Study|Pregnancy|1|||
170400002|NCT00909857|615803709|FG001|Overall Study|Pregnancy|0|||
170400003|NCT00909857|615803708|FG000|Overall Study|Other|1|||
170400004|NCT00909857|615803709|FG001|Overall Study|Other|0|||
170400005|NCT00909857|615803708|FG000|Overall Study|Did not receive study medication|19|||
170400006|NCT00909857|615803709|FG001|Overall Study|Did not receive study medication|24|||
170400007|NCT00131937|615803712|FG000|Overall Study|Adverse Event|3|||
170400008|NCT00131937|615803712|FG000|Overall Study|Withdrawal by Subject|2|||
170400009|NCT00131937|615803712|FG000|Overall Study|Physician Decision|1|||
170400010|NCT00131937|615803712|FG000|Overall Study|Disease Progression|7|||
170400011|NCT00131937|615803712|FG000|Overall Study|Alternative therapy|1|||
170400012|NCT04822701|615803713|FG000|Overall Study|Not treated|2|||
170400013|NCT04822701|615803714|FG001|Overall Study|Not treated|0|||
170514375|NCT00169104|616230273|FG000|Overall Study|Withdrawal by Subject|2|||
170514376|NCT00169104|616230274|FG001|Overall Study|Withdrawal by Subject|0|||
170400014|NCT04822701|615803713|FG000|Overall Study|Lost to Follow-up|1|||
170400015|NCT04822701|615803714|FG001|Overall Study|Lost to Follow-up|0|||
170400016|NCT04822701|615803713|FG000|Overall Study|Withdrawal by Subject|1|||
170514377|NCT00169104|616230273|FG000|Overall Study|Protocol Violation|0|||
170400017|NCT04822701|615803714|FG001|Overall Study|Withdrawal by Subject|0|||
170400018|NCT04502862|615803715|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
170400019|NCT04502862|615803716|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
170400020|NCT04502862|615803715|FG000|Overall Study|Withdrawal by Subject|1|||
170400021|NCT04502862|615803716|FG001|Overall Study|Withdrawal by Subject|0|||
170400022|NCT04502862|615803715|FG000|Overall Study|Adverse Event|1|||
170400023|NCT04502862|615803716|FG001|Overall Study|Adverse Event|1|||
170400024|NCT02706353|615803717|FG000|Dose Level 1|Disease Progression|1|||
170400025|NCT02706353|615803718|FG001|Dose Level 1|Disease Progression|0|||
170744593|NCT01625910|617073192|FG000|Overall Study|Lost to Follow-up|3|||
170744594|NCT01625910|617073193|FG001|Overall Study|Lost to Follow-up|4|||
170744595|NCT02959138|617073194|FG000|Overall Study|Enrolled but Never Treated|0|||
170744596|NCT02959138|617073195|FG001|Overall Study|Enrolled but Never Treated|1|||
170744597|NCT02959138|617073196|FG002|Overall Study|Enrolled but Never Treated|0|||
170744598|NCT02391038|617073197|FG000|Overall Study|Progressive disease|3|||
170400026|NCT02706353|615803719|FG002|Dose Level 1|Disease Progression|0|||
170400027|NCT02706353|615803720|FG003|Dose Level 1|Disease Progression|0|||
170400028|NCT02706353|615803721|FG004|Dose Level 1|Disease Progression|0|||
170400029|NCT02706353|615803722|FG005|Dose Level 1|Disease Progression|0|||
170400030|NCT02706353|615803717|FG000|Dose Level 3|Disease Progression|0|||
170400031|NCT02706353|615803718|FG001|Dose Level 3|Disease Progression|0|||
170400032|NCT02706353|615803719|FG002|Dose Level 3|Disease Progression|2|||
170400033|NCT02706353|615803720|FG003|Dose Level 3|Disease Progression|0|||
170744599|NCT02391038|617073198|FG001|Overall Study|Progressive disease|3|||
170744600|NCT02391038|617073199|FG002|Overall Study|Progressive disease|6|||
170744601|NCT01984424|617073205|FG000|Overall Study|Withdrawal by Subject|3|||
170744602|NCT01984424|617073206|FG001|Overall Study|Withdrawal by Subject|5|||
170744603|NCT01984424|617073205|FG000|Overall Study|Sponsor Decision|0|||
170744604|NCT01984424|617073206|FG001|Overall Study|Sponsor Decision|1|||
170744605|NCT01984424|617073205|FG000|Overall Study|Lost to Follow-up|0|||
170744606|NCT01984424|617073206|FG001|Overall Study|Lost to Follow-up|1|||
170744607|NCT00365378|617073210|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
170400034|NCT02706353|615803721|FG004|Dose Level 3|Disease Progression|0|||
170400035|NCT02706353|615803722|FG005|Dose Level 3|Disease Progression|0|||
170400036|NCT02706353|615803717|FG000|Dose Level 4|Disease Progression|0|||
170400037|NCT02706353|615803718|FG001|Dose Level 4|Disease Progression|0|||
170400038|NCT02706353|615803719|FG002|Dose Level 4|Disease Progression|0|||
170400039|NCT02706353|615803720|FG003|Dose Level 4|Disease Progression|1|||
170400040|NCT02706353|615803721|FG004|Dose Level 4|Disease Progression|0|||
170400041|NCT02706353|615803722|FG005|Dose Level 4|Disease Progression|0|||
170400042|NCT02706353|615803717|FG000|Dose Level 4|Toxicity|0|||
170400043|NCT02706353|615803718|FG001|Dose Level 4|Toxicity|0|||
170400044|NCT02706353|615803719|FG002|Dose Level 4|Toxicity|0|||
170400045|NCT02706353|615803720|FG003|Dose Level 4|Toxicity|1|||
170400046|NCT02706353|615803721|FG004|Dose Level 4|Toxicity|0|||
170400047|NCT02706353|615803722|FG005|Dose Level 4|Toxicity|0|||
170514378|NCT00169104|616230274|FG001|Overall Study|Protocol Violation|1|||
170514379|NCT00169104|616230273|FG000|Overall Study|Physician Decision|0|||
170514380|NCT00169104|616230274|FG001|Overall Study|Physician Decision|1|||
170514381|NCT01540981|616230280|FG000|Overall Study|Withdrawal by Subject|1|||
170514382|NCT01540981|616230281|FG001|Overall Study|Withdrawal by Subject|0|||
170514383|NCT02959918|616230282|FG000|Overall Study|Adverse Event|1|||
170514384|NCT02959918|616230283|FG001|Overall Study|Adverse Event|1|||
170514385|NCT02959918|616230284|FG002|Overall Study|Adverse Event|2|||
170514386|NCT02959918|616230285|FG003|Overall Study|Adverse Event|0|||
170514387|NCT02959918|616230286|FG004|Overall Study|Adverse Event|0|||
170514388|NCT02959918|616230287|FG005|Overall Study|Adverse Event|2|||
170744608|NCT00365378|617073211|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
170744609|NCT00365378|617073212|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
170859632|NCT05677893|617495956|FG000|Overall Study|Withdrawal by Subject|0|||
170400048|NCT02706353|615803717|FG000|Dose Level 4|Death|0|||
170400049|NCT02706353|615803718|FG001|Dose Level 4|Death|0|||
170400050|NCT02706353|615803719|FG002|Dose Level 4|Death|0|||
170400051|NCT02706353|615803720|FG003|Dose Level 4|Death|1|||
170400052|NCT02706353|615803721|FG004|Dose Level 4|Death|0|||
170400053|NCT02706353|615803722|FG005|Dose Level 4|Death|0|||
170400054|NCT02706353|615803717|FG000|Dose Level 5|Toxicity|0|||
170400055|NCT02706353|615803718|FG001|Dose Level 5|Toxicity|0|||
170400056|NCT02706353|615803719|FG002|Dose Level 5|Toxicity|0|||
170400057|NCT02706353|615803720|FG003|Dose Level 5|Toxicity|0|||
170400058|NCT02706353|615803721|FG004|Dose Level 5|Toxicity|1|||
170859633|NCT05677893|617495957|FG001|Overall Study|Withdrawal by Subject|0|||
170400059|NCT02706353|615803722|FG005|Dose Level 5|Toxicity|0|||
170400060|NCT02706353|615803717|FG000|Dose Level 5|Disease Progression|0|||
170859634|NCT05677893|617495958|FG002|Overall Study|Withdrawal by Subject|0|||
170400061|NCT02706353|615803718|FG001|Dose Level 5|Disease Progression|0|||
170400062|NCT02706353|615803719|FG002|Dose Level 5|Disease Progression|0|||
170400063|NCT02706353|615803720|FG003|Dose Level 5|Disease Progression|0|||
170514389|NCT02959918|616230288|FG006|Overall Study|Adverse Event|2|||
170514390|NCT02959918|616230289|FG007|Overall Study|Adverse Event|1|||
170400064|NCT02706353|615803721|FG004|Dose Level 5|Disease Progression|3|||
170400065|NCT02706353|615803722|FG005|Dose Level 5|Disease Progression|2|||
170514391|NCT02959918|616230290|FG008|Overall Study|Adverse Event|2|||
170400066|NCT02706353|615803717|FG000|Dose Level 5|Death|0|||
170400067|NCT02706353|615803718|FG001|Dose Level 5|Death|0|||
170400068|NCT02706353|615803719|FG002|Dose Level 5|Death|0|||
170400069|NCT02706353|615803720|FG003|Dose Level 5|Death|0|||
170400070|NCT02706353|615803721|FG004|Dose Level 5|Death|1|||
170400071|NCT02706353|615803722|FG005|Dose Level 5|Death|6|||
170400072|NCT02706353|615803717|FG000|Dose Level 5|Withdrawal by Subject|0|||
170400073|NCT02706353|615803718|FG001|Dose Level 5|Withdrawal by Subject|0|||
170400074|NCT02706353|615803719|FG002|Dose Level 5|Withdrawal by Subject|0|||
170400075|NCT02706353|615803720|FG003|Dose Level 5|Withdrawal by Subject|0|||
170859635|NCT05677893|617495959|FG003|Overall Study|Withdrawal by Subject|0|||
170859636|NCT05677893|617495960|FG004|Overall Study|Withdrawal by Subject|1|||
170859637|NCT05677893|617495961|FG005|Overall Study|Withdrawal by Subject|1|||
170859638|NCT05677893|617495962|FG006|Overall Study|Withdrawal by Subject|0|||
170859639|NCT05677893|617495956|FG000|Overall Study|Others|1|||
170859640|NCT05677893|617495957|FG001|Overall Study|Others|0|||
170859641|NCT05677893|617495958|FG002|Overall Study|Others|0|||
170859642|NCT05677893|617495959|FG003|Overall Study|Others|0|||
170859643|NCT05677893|617495960|FG004|Overall Study|Others|0|||
170859644|NCT05677893|617495961|FG005|Overall Study|Others|0|||
170744610|NCT00365378|617073210|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
170859645|NCT05677893|617495962|FG006|Overall Study|Others|0|||
170744611|NCT00365378|617073211|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
170859646|NCT01390181|617495963|FG000|Overall Study|Lost to Follow-up|1|||
170859647|NCT01390181|617495963|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
170859648|NCT01101477|617495965|FG000|Overall Study|Protocol Violation|5|||
170859649|NCT01101477|617495966|FG001|Overall Study|Protocol Violation|3|||
170859650|NCT01101477|617495967|FG002|Overall Study|Protocol Violation|1|||
170859651|NCT00720941|617495968|FG000|Overall Study|Protocol Violation|1|||
170859652|NCT00720941|617495969|FG001|Overall Study|Protocol Violation|2|||
170859653|NCT00720941|617495968|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
170859654|NCT00720941|617495969|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
170859655|NCT00720941|617495968|FG000|Overall Study|Lost to Follow-up|20|||
170859656|NCT00720941|617495969|FG001|Overall Study|Lost to Follow-up|15|||
170859657|NCT00720941|617495968|FG000|Overall Study|Physician Decision|14|||
170859658|NCT00720941|617495969|FG001|Overall Study|Physician Decision|12|||
170859659|NCT00720941|617495968|FG000|Overall Study|Withdrawal by Subject|29|||
170859660|NCT00720941|617495969|FG001|Overall Study|Withdrawal by Subject|36|||
170859661|NCT01072877|617495973|FG000|Overall Study|Lost to Follow-up|1|||
170859662|NCT01072877|617495974|FG001|Overall Study|Lost to Follow-up|1|||
170859663|NCT01072877|617495975|FG002|Overall Study|Lost to Follow-up|0|||
170859664|NCT01072877|617495976|FG003|Overall Study|Lost to Follow-up|2|||
170859665|NCT01072877|617495977|FG004|Overall Study|Lost to Follow-up|0|||
170859666|NCT01614197|617495978|FG000|Overall Study|Withdrawal by Subject|0|||
170859667|NCT01614197|617495979|FG001|Overall Study|Withdrawal by Subject|1|||
170859668|NCT01614197|617495980|FG002|Overall Study|Withdrawal by Subject|0|||
170859669|NCT01614197|617495981|FG003|Overall Study|Withdrawal by Subject|0|||
170859670|NCT03628898|617495983|FG000|Overall Study|Device deficiency|1|||
170859671|NCT00971932|617495984|FG000|Overall Study|Withdrawal by Subject|1|||
170859672|NCT00971932|617495984|FG000|Overall Study|Investigator's decision|2|||
170859673|NCT00971932|617495984|FG000|Overall Study|Ongoing|4|||
170859674|NCT02864381|617495985|FG000|Overall Study|Death|58|||
170859675|NCT02864381|617495986|FG001|Overall Study|Death|61|||
170859676|NCT02864381|617495985|FG000|Overall Study|Withdrew Consent|5|||
170859677|NCT02864381|617495986|FG001|Overall Study|Withdrew Consent|6|||
170859678|NCT02864381|617495985|FG000|Overall Study|Reason Unknown|7|||
170859679|NCT02864381|617495986|FG001|Overall Study|Reason Unknown|3|||
170859680|NCT02864381|617495985|FG000|Overall Study|Lost to Follow-up|1|||
170859681|NCT02864381|617495986|FG001|Overall Study|Lost to Follow-up|1|||
170859682|NCT02864381|617495985|FG000|Overall Study|Investigator's Discretion|1|||
170859683|NCT02864381|617495986|FG001|Overall Study|Investigator's Discretion|0|||
170859684|NCT02864381|617495985|FG000|Overall Study|Protocol Violation|0|||
170859685|NCT02864381|617495986|FG001|Overall Study|Protocol Violation|1|||
170859686|NCT04142450|617495987|FG000|Overall Study|Screen Failure|1|||
170859687|NCT04142450|617495987|FG000|Overall Study|Lost to Follow-up|1|||
170744612|NCT00365378|617073212|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
170744613|NCT00365378|617073210|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
170859688|NCT02525861|617495988|FG000|Overall Study|Adverse Event|1|||
170859689|NCT02525861|617495989|FG001|Overall Study|Adverse Event|0|||
170859690|NCT02525861|617495988|FG000|Overall Study|Withdrawal by Subject|0|||
170859691|NCT02525861|617495989|FG001|Overall Study|Withdrawal by Subject|1|||
170400076|NCT02706353|615803721|FG004|Dose Level 5|Withdrawal by Subject|0|||
170859692|NCT02525861|617495988|FG000|Overall Study|Physician Decision|0|||
170859693|NCT02525861|617495989|FG001|Overall Study|Physician Decision|1|||
170859694|NCT00975507|617495995|FG000|Overall Study|Adverse Event|1|||
170859695|NCT00975507|617495996|FG001|Overall Study|Adverse Event|0|||
170859696|NCT00975507|617495995|FG000|Overall Study|Lost to Follow-up|7|||
170400077|NCT02706353|615803722|FG005|Dose Level 5|Withdrawal by Subject|2|||
170400078|NCT03560466|615803723|FG000|Overall Study|Adverse Event|1|||
170859697|NCT00975507|617495996|FG001|Overall Study|Lost to Follow-up|1|||
170859698|NCT00975507|617495995|FG000|Overall Study|Protocol Violation|2|||
170859699|NCT00975507|617495996|FG001|Overall Study|Protocol Violation|0|||
170859700|NCT00975507|617495995|FG000|Overall Study|Withdrawal by Subject|10|||
170859701|NCT00975507|617495996|FG001|Overall Study|Withdrawal by Subject|3|||
170859702|NCT01295034|617495997|FG000|Overall Study|Lost to Follow-up|5|||
170859703|NCT01295034|617495998|FG001|Overall Study|Lost to Follow-up|5|||
170400079|NCT03560466|615803724|FG001|Overall Study|Adverse Event|2|||
170400080|NCT03560466|615803725|FG002|Overall Study|Adverse Event|0|||
170859704|NCT00887250|617496000|FG000|Overall Study|Adverse Event|3|||
170859705|NCT00887250|617496001|FG001|Overall Study|Adverse Event|0|||
170859706|NCT00887250|617496002|FG002|Overall Study|Adverse Event|7|||
170859707|NCT00887250|617496000|FG000|Overall Study|Lack of Efficacy|9|||
170859708|NCT00887250|617496001|FG001|Overall Study|Lack of Efficacy|6|||
170859709|NCT00887250|617496002|FG002|Overall Study|Lack of Efficacy|1|||
170859710|NCT00887250|617496000|FG000|Overall Study|Lost to Follow-up|2|||
170859711|NCT00887250|617496001|FG001|Overall Study|Lost to Follow-up|3|||
170859712|NCT00887250|617496002|FG002|Overall Study|Lost to Follow-up|1|||
170859713|NCT00887250|617496000|FG000|Overall Study|Protocol Violation|2|||
170859714|NCT00887250|617496001|FG001|Overall Study|Protocol Violation|2|||
170859715|NCT00887250|617496002|FG002|Overall Study|Protocol Violation|1|||
170859716|NCT00887250|617496000|FG000|Overall Study|Withdrawal by Subject|2|||
170859717|NCT00887250|617496001|FG001|Overall Study|Withdrawal by Subject|1|||
170400081|NCT03560466|615803723|FG000|Overall Study|Poor Compliance to Protocol|0|||
170400082|NCT03560466|615803724|FG001|Overall Study|Poor Compliance to Protocol|2|||
170400083|NCT03560466|615803725|FG002|Overall Study|Poor Compliance to Protocol|0|||
170400084|NCT03560466|615803723|FG000|Overall Study|Other|6|||
170400085|NCT03560466|615803724|FG001|Overall Study|Other|8|||
170400086|NCT03560466|615803725|FG002|Overall Study|Other|1|||
170400087|NCT01074307|615805510|FG000|Overall Study|No primary endpoint evaluation|14|||
170400088|NCT01074307|615805511|FG001|Overall Study|No primary endpoint evaluation|6|||
170400089|NCT01074307|615805510|FG000|Overall Study|Exclusion criterion|0|||
170400090|NCT01074307|615805511|FG001|Overall Study|Exclusion criterion|1|||
170400091|NCT01074307|615805510|FG000|Overall Study|Protocol Violation|8|||
170400092|NCT01074307|615805511|FG001|Overall Study|Protocol Violation|5|||
170400093|NCT02703454|615805517|FG000|Overall Study|Not treated|1|||
170400094|NCT02703454|615805518|FG001|Overall Study|Not treated|3|||
170400095|NCT02703454|615805517|FG000|Overall Study|Withdrawal by Subject|4|||
170400096|NCT02703454|615805518|FG001|Overall Study|Withdrawal by Subject|3|||
170400097|NCT02703454|615805517|FG000|Overall Study|Lost to Follow-up|1|||
170400098|NCT02703454|615805518|FG001|Overall Study|Lost to Follow-up|2|||
170400099|NCT02703454|615805517|FG000|Overall Study|Study discontinuation|5|||
170400100|NCT02703454|615805518|FG001|Overall Study|Study discontinuation|8|||
170400101|NCT01399125|615805520|FG000|Overall Study|Adverse Event|32|||
170400102|NCT01399125|615805521|FG001|Overall Study|Adverse Event|30|||
170400103|NCT01399125|615805520|FG000|Overall Study|Abnormal Lab values|0|||
170400104|NCT01399125|615805521|FG001|Overall Study|Abnormal Lab values|1|||
170400105|NCT01399125|615805520|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170400106|NCT01399125|615805521|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
170400107|NCT01399125|615805520|FG000|Overall Study|Withdrawal by Subject|5|||
170400108|NCT01399125|615805521|FG001|Overall Study|Withdrawal by Subject|8|||
170400109|NCT01399125|615805520|FG000|Overall Study|Lost to Follow-up|2|||
170400110|NCT01399125|615805521|FG001|Overall Study|Lost to Follow-up|3|||
170400111|NCT01399125|615805520|FG000|Overall Study|Administrative Problems|7|||
170400112|NCT01399125|615805521|FG001|Overall Study|Administrative Problems|11|||
170400113|NCT01399125|615805520|FG000|Overall Study|Death|0|||
170400114|NCT01399125|615805521|FG001|Overall Study|Death|1|||
170400115|NCT01399125|615805520|FG000|Overall Study|Protocol Deviation|5|||
170400116|NCT01399125|615805521|FG001|Overall Study|Protocol Deviation|2|||
170400117|NCT01467570|615805525|FG000|Overall Study|Lost to Follow-up|8|||
170400118|NCT01467570|615805526|FG001|Overall Study|Lost to Follow-up|9|||
170400119|NCT02626182|615805527|FG000|Overall Study|Adverse Event|2|||
170400120|NCT02626182|615805528|FG001|Overall Study|Adverse Event|0|||
170400121|NCT03174925|615805531|FG000|Overall Study|Elastographic images not retrievable|2|||
170400122|NCT03174925|615805531|FG000|Overall Study|Elastography image not interpretable|1|||
170400123|NCT04247594|615805532|FG000|Overall Study|Withdrawal by Subject|4|||
170400124|NCT00589693|615805534|FG000|Overall Study|randomized in error|12|||
170400125|NCT00589693|615805535|FG001|Overall Study|randomized in error|6|||
170400126|NCT00589693|615805534|FG000|Overall Study|Adverse Event|4|||
170859718|NCT00887250|617496002|FG002|Overall Study|Withdrawal by Subject|2|||
170859719|NCT00887250|617496000|FG000|Overall Study|Patient uncooperative|0|||
170400127|NCT00589693|615805535|FG001|Overall Study|Adverse Event|4|||
170400128|NCT00589693|615805534|FG000|Overall Study|Death|26|||
170400129|NCT00589693|615805535|FG001|Overall Study|Death|16|||
170400130|NCT00589693|615805534|FG000|Overall Study|Lack of Efficacy|0|||
170400131|NCT00589693|615805535|FG001|Overall Study|Lack of Efficacy|1|||
170400132|NCT00589693|615805534|FG000|Overall Study|Lost to Follow-up|1|||
170859720|NCT00887250|617496001|FG001|Overall Study|Patient uncooperative|0|||
170400133|NCT00589693|615805535|FG001|Overall Study|Lost to Follow-up|0|||
170400134|NCT00589693|615805534|FG000|Overall Study|Physician Decision|0|||
170400135|NCT00589693|615805535|FG001|Overall Study|Physician Decision|1|||
170400136|NCT00589693|615805534|FG000|Overall Study|Protocol Violation|1|||
170400137|NCT00589693|615805535|FG001|Overall Study|Protocol Violation|1|||
170514392|NCT02959918|616230291|FG009|Overall Study|Adverse Event|1|||
170400138|NCT04840901|615805536|FG000|Overall Study|Lost to Follow-up|3|||
170400139|NCT04840901|615805537|FG001|Overall Study|Lost to Follow-up|1|||
170400140|NCT04840901|615805536|FG000|Overall Study|Moved|1|||
170400141|NCT04840901|615805537|FG001|Overall Study|Moved|0|||
170400142|NCT04840901|615805536|FG000|Overall Study|Unable to comply with study schedule|0|||
170400143|NCT04840901|615805537|FG001|Overall Study|Unable to comply with study schedule|1|||
170400144|NCT04840901|615805536|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
170400145|NCT04840901|615805537|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
170400146|NCT01414062|615805538|FG000|Overall Study|Lost to Follow-up|3|||
170400147|NCT01414062|615805539|FG001|Overall Study|Lost to Follow-up|2|||
170400148|NCT01414062|615805538|FG000|Overall Study|Left Country|1|||
170400149|NCT01414062|615805539|FG001|Overall Study|Left Country|1|||
170400150|NCT01414062|615805538|FG000|Overall Study|Family Disapproval|1|||
170400151|NCT01414062|615805539|FG001|Overall Study|Family Disapproval|0|||
170400152|NCT01414062|615805538|FG000|Overall Study|Withdrawal by Subject|0|||
170400153|NCT01414062|615805539|FG001|Overall Study|Withdrawal by Subject|1|||
170400154|NCT04075292|615805540|FG000|Overall Study|Withdrawal by Subject|1|||
170400155|NCT04075292|615805541|FG001|Overall Study|Withdrawal by Subject|9|||
170400156|NCT04075292|615805540|FG000|Overall Study|Death|2|||
170400157|NCT04075292|615805541|FG001|Overall Study|Death|5|||
170400158|NCT04075292|615805540|FG000|Overall Study|Remained on study at time of DCO|74|||
170400159|NCT04075292|615805541|FG001|Overall Study|Remained on study at time of DCO|64|||
170400160|NCT04285983|615805542|FG000|Overall Study|Protocol Violation|6|||
170400161|NCT04936334|615805543|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
170400162|NCT00902265|615805548|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
170400163|NCT00902265|615805548|FG000|Overall Study|Adverse Event|2|||
170400164|NCT00902265|615805548|FG000|Overall Study|Lack of Efficacy|2|||
170400165|NCT00902265|615805548|FG000|Overall Study|Protocol Violation|1|||
170400166|NCT02030834|615805549|FG000|Overall Study|Death|4|||
170400167|NCT02030834|615805550|FG001|Overall Study|Death|0|||
170400168|NCT02030834|615805551|FG002|Overall Study|Death|0|||
170400169|NCT02030834|615805549|FG000|Overall Study|Manufacturing failure|2|||
170400170|NCT02030834|615805550|FG001|Overall Study|Manufacturing failure|0|||
170400171|NCT02030834|615805551|FG002|Overall Study|Manufacturing failure|1|||
170400172|NCT02030834|615805549|FG000|Overall Study|Disease progression|2|||
170400173|NCT02030834|615805550|FG001|Overall Study|Disease progression|0|||
170400174|NCT02030834|615805551|FG002|Overall Study|Disease progression|2|||
170400175|NCT02030834|615805549|FG000|Overall Study|Lost to Follow-up|1|||
170400176|NCT02030834|615805550|FG001|Overall Study|Lost to Follow-up|0|||
170400177|NCT02030834|615805551|FG002|Overall Study|Lost to Follow-up|0|||
170400178|NCT02030834|615805549|FG000|Overall Study|Withdrawal by Subject|1|||
170514393|NCT02959918|616230292|FG010|Overall Study|Adverse Event|1|||
170400179|NCT02030834|615805550|FG001|Overall Study|Withdrawal by Subject|0|||
170400180|NCT02030834|615805551|FG002|Overall Study|Withdrawal by Subject|0|||
170400181|NCT02030834|615805549|FG000|Overall Study|Lack of funding|1|||
170400182|NCT02030834|615805550|FG001|Overall Study|Lack of funding|0|||
170400183|NCT02030834|615805551|FG002|Overall Study|Lack of funding|0|||
170400184|NCT05016765|615805552|FG000|Overall Study|Lost to Follow-up|4|||
170400185|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
170400186|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
170400187|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
170400188|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
170400189|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
170400190|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
170400191|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
170400192|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
170514394|NCT02959918|616230293|FG011|Overall Study|Adverse Event|3|||
170514395|NCT02959918|616230294|FG012|Overall Study|Adverse Event|2|||
170514396|NCT02959918|616230295|FG013|Overall Study|Adverse Event|4|||
170514397|NCT02959918|616230282|FG000|Overall Study|Lost to Follow-up|0|||
170514398|NCT02959918|616230283|FG001|Overall Study|Lost to Follow-up|0|||
170400193|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
170514399|NCT02959918|616230284|FG002|Overall Study|Lost to Follow-up|0|||
170514400|NCT02959918|616230285|FG003|Overall Study|Lost to Follow-up|0|||
170514401|NCT02959918|616230286|FG004|Overall Study|Lost to Follow-up|0|||
170514402|NCT02959918|616230287|FG005|Overall Study|Lost to Follow-up|0|||
170514403|NCT02959918|616230288|FG006|Overall Study|Lost to Follow-up|0|||
170514404|NCT02959918|616230289|FG007|Overall Study|Lost to Follow-up|0|||
170400194|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
170400195|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
170514405|NCT02959918|616230290|FG008|Overall Study|Lost to Follow-up|0|||
170514406|NCT02959918|616230291|FG009|Overall Study|Lost to Follow-up|1|||
170514407|NCT02959918|616230292|FG010|Overall Study|Lost to Follow-up|0|||
170514408|NCT02959918|616230293|FG011|Overall Study|Lost to Follow-up|0|||
170514409|NCT02959918|616230294|FG012|Overall Study|Lost to Follow-up|1|||
170514410|NCT02959918|616230295|FG013|Overall Study|Lost to Follow-up|0|||
170514411|NCT02959918|616230282|FG000|Overall Study|Withdrawal by Subject|0|||
170514412|NCT02959918|616230283|FG001|Overall Study|Withdrawal by Subject|0|||
170514413|NCT02959918|616230284|FG002|Overall Study|Withdrawal by Subject|1|||
170514414|NCT02959918|616230285|FG003|Overall Study|Withdrawal by Subject|2|||
170514415|NCT02959918|616230286|FG004|Overall Study|Withdrawal by Subject|0|||
170514416|NCT02959918|616230287|FG005|Overall Study|Withdrawal by Subject|0|||
170514417|NCT02959918|616230288|FG006|Overall Study|Withdrawal by Subject|1|||
170514418|NCT02959918|616230289|FG007|Overall Study|Withdrawal by Subject|0|||
170514419|NCT02959918|616230290|FG008|Overall Study|Withdrawal by Subject|1|||
170514420|NCT02959918|616230291|FG009|Overall Study|Withdrawal by Subject|1|||
170514421|NCT02959918|616230292|FG010|Overall Study|Withdrawal by Subject|2|||
170514422|NCT02959918|616230293|FG011|Overall Study|Withdrawal by Subject|3|||
170514423|NCT02959918|616230294|FG012|Overall Study|Withdrawal by Subject|1|||
170514424|NCT02959918|616230295|FG013|Overall Study|Withdrawal by Subject|1|||
170514425|NCT02959918|616230282|FG000|Overall Study|Protocol Violation|0|||
170514426|NCT02959918|616230283|FG001|Overall Study|Protocol Violation|0|||
170514427|NCT02959918|616230284|FG002|Overall Study|Protocol Violation|1|||
170514428|NCT02959918|616230285|FG003|Overall Study|Protocol Violation|0|||
170514429|NCT02959918|616230286|FG004|Overall Study|Protocol Violation|0|||
170514430|NCT02959918|616230287|FG005|Overall Study|Protocol Violation|1|||
170514431|NCT02959918|616230288|FG006|Overall Study|Protocol Violation|0|||
170514432|NCT02959918|616230289|FG007|Overall Study|Protocol Violation|0|||
170859721|NCT00887250|617496002|FG002|Overall Study|Patient uncooperative|1|||
170859722|NCT00824161|617496003|FG000|Overall Study|Withdrawal by Subject|1|||
170859723|NCT00824161|617496003|FG000|Overall Study|Screen Failure|1|||
170859724|NCT01607554|617496004|FG000|Overall Study|Disease progression|2|||
170859725|NCT00655863|617496006|FG000|Overall Study|Lost to Follow-up|0|||
170859726|NCT00655863|617496007|FG001|Overall Study|Lost to Follow-up|0|||
170859727|NCT00655863|617496008|FG002|Overall Study|Lost to Follow-up|1|||
170859728|NCT03548987|617496009|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
170859729|NCT03548987|617496010|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
170859730|NCT03548987|617496009|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
170859731|NCT03548987|617496010|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
170859732|NCT03548987|617496009|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
170859733|NCT03548987|617496010|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
170859734|NCT03548987|617496009|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
170859735|NCT03548987|617496010|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
170859736|NCT03548987|617496009|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
170859737|NCT03548987|617496010|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
170859738|NCT03548987|617496009|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
170859739|NCT03548987|617496010|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
170859740|NCT03548987|617496009|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
170514433|NCT02959918|616230290|FG008|Overall Study|Protocol Violation|2|||
170514434|NCT02959918|616230291|FG009|Overall Study|Protocol Violation|1|||
170514435|NCT02959918|616230292|FG010|Overall Study|Protocol Violation|0|||
170514436|NCT02959918|616230293|FG011|Overall Study|Protocol Violation|1|||
170514437|NCT02959918|616230294|FG012|Overall Study|Protocol Violation|1|||
170514438|NCT02959918|616230295|FG013|Overall Study|Protocol Violation|0|||
170514439|NCT02959918|616230282|FG000|Overall Study|Stopping Rule Met|1|||
170514440|NCT02959918|616230283|FG001|Overall Study|Stopping Rule Met|0|||
170514441|NCT02959918|616230284|FG002|Overall Study|Stopping Rule Met|3|||
170859741|NCT03548987|617496010|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
170859742|NCT03548987|617496009|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
170859743|NCT03548987|617496010|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
170859744|NCT03548987|617496009|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
170859745|NCT03548987|617496010|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
170859746|NCT03548987|617496009|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
170859747|NCT03548987|617496010|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
170859748|NCT03548987|617496009|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
170859749|NCT03548987|617496010|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
170859750|NCT03548987|617496009|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
170859751|NCT03548987|617496010|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
170514442|NCT02959918|616230285|FG003|Overall Study|Stopping Rule Met|4|||
170859752|NCT03548987|617496009|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
170859753|NCT03548987|617496010|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
170859754|NCT03548987|617496009|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
170514443|NCT02959918|616230286|FG004|Overall Study|Stopping Rule Met|5|||
170514444|NCT02959918|616230287|FG005|Overall Study|Stopping Rule Met|3|||
170859755|NCT03548987|617496010|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
170859756|NCT04572841|617496011|FG000|Overall Study|Adverse Event|1|||
170859757|NCT04572841|617496012|FG001|Overall Study|Adverse Event|1|||
170859758|NCT04572841|617496011|FG000|Overall Study|Withdrawal by Subject|2|||
170859759|NCT04572841|617496012|FG001|Overall Study|Withdrawal by Subject|1|||
170514445|NCT02959918|616230288|FG006|Overall Study|Stopping Rule Met|2|||
170514446|NCT02959918|616230289|FG007|Overall Study|Stopping Rule Met|4|||
170514447|NCT02959918|616230290|FG008|Overall Study|Stopping Rule Met|1|||
170514448|NCT02959918|616230291|FG009|Overall Study|Stopping Rule Met|1|||
170514449|NCT02959918|616230292|FG010|Overall Study|Stopping Rule Met|3|||
170514450|NCT02959918|616230293|FG011|Overall Study|Stopping Rule Met|5|||
170514451|NCT02959918|616230294|FG012|Overall Study|Stopping Rule Met|2|||
170514452|NCT02959918|616230295|FG013|Overall Study|Stopping Rule Met|1|||
170514453|NCT02959918|616230282|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
170514454|NCT02959918|616230283|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
170514455|NCT02959918|616230284|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
170859760|NCT00712673|617496015|FG000|Overall Study|Adverse Event|3|||
170859761|NCT00712673|617496016|FG001|Overall Study|Adverse Event|3|||
170859762|NCT00712673|617496017|FG002|Overall Study|Adverse Event|21|||
170859763|NCT00712673|617496018|FG003|Overall Study|Adverse Event|26|||
170859764|NCT00712673|617496015|FG000|Overall Study|Lack of Efficacy|2|||
170859765|NCT00712673|617496016|FG001|Overall Study|Lack of Efficacy|8|||
170859766|NCT00712673|617496017|FG002|Overall Study|Lack of Efficacy|8|||
170859767|NCT00712673|617496018|FG003|Overall Study|Lack of Efficacy|6|||
170859768|NCT00712673|617496015|FG000|Overall Study|Poor Compliance to Protocol|3|||
170859769|NCT00712673|617496016|FG001|Overall Study|Poor Compliance to Protocol|3|||
170859770|NCT00712673|617496017|FG002|Overall Study|Poor Compliance to Protocol|4|||
170859771|NCT00712673|617496018|FG003|Overall Study|Poor Compliance to Protocol|16|||
170859772|NCT00712673|617496015|FG000|Overall Study|Lost to Follow-up|1|||
170859773|NCT00712673|617496016|FG001|Overall Study|Lost to Follow-up|0|||
170859774|NCT00712673|617496017|FG002|Overall Study|Lost to Follow-up|2|||
170859775|NCT00712673|617496018|FG003|Overall Study|Lost to Follow-up|0|||
170859776|NCT00712673|617496015|FG000|Overall Study|Withdrawal by Subject|6|||
170859777|NCT00712673|617496016|FG001|Overall Study|Withdrawal by Subject|7|||
170859778|NCT00712673|617496017|FG002|Overall Study|Withdrawal by Subject|15|||
170859779|NCT00712673|617496018|FG003|Overall Study|Withdrawal by Subject|20|||
170859780|NCT00712673|617496015|FG000|Overall Study|Familial and Personal Reasons|5|||
170859781|NCT00712673|617496016|FG001|Overall Study|Familial and Personal Reasons|0|||
170859782|NCT00712673|617496017|FG002|Overall Study|Familial and Personal Reasons|5|||
170859783|NCT00712673|617496018|FG003|Overall Study|Familial and Personal Reasons|2|||
170859784|NCT00712673|617496015|FG000|Overall Study|Investigator's Decision|1|||
170859785|NCT00712673|617496016|FG001|Overall Study|Investigator's Decision|0|||
170859786|NCT00712673|617496017|FG002|Overall Study|Investigator's Decision|0|||
170859787|NCT00712673|617496018|FG003|Overall Study|Investigator's Decision|0|||
170859788|NCT00712673|617496015|FG000|Overall Study|Protocol Violation|0|||
170859789|NCT00712673|617496016|FG001|Overall Study|Protocol Violation|0|||
170859790|NCT00712673|617496017|FG002|Overall Study|Protocol Violation|2|||
170859791|NCT00712673|617496018|FG003|Overall Study|Protocol Violation|0|||
170859792|NCT01323647|617496019|FG000|Overall Study|Migrated/moved from study area|2|||
170859793|NCT01323647|617496020|FG001|Overall Study|Migrated/moved from study area|0|||
170859794|NCT01323647|617496019|FG000|Overall Study|Withdrawal by Subject|5|||
170859795|NCT01323647|617496020|FG001|Overall Study|Withdrawal by Subject|0|||
170859796|NCT01323647|617496019|FG000|Overall Study|Lost to Follow-up|2|||
170859797|NCT01323647|617496020|FG001|Overall Study|Lost to Follow-up|0|||
170859798|NCT05333224|617496021|FG000|Overall Study - Infants|Lost to Follow-up|1|||
170744614|NCT00365378|617073211|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
170744615|NCT00365378|617073212|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
170744616|NCT00365378|617073210|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
170859799|NCT05333224|617496022|FG001|Overall Study - Infants|Lost to Follow-up|1|||
170859800|NCT00063154|617496023|FG000|Overall Study|Disease progression|27|||
170859801|NCT00063154|617496023|FG000|Overall Study|Adverse Event|2|||
170859802|NCT00063154|617496023|FG000|Overall Study|Physician Decision|10|||
170859803|NCT00063154|617496023|FG000|Overall Study|Death|3|||
170859804|NCT00063154|617496023|FG000|Overall Study|Reason unspecified|1|||
170859805|NCT00063154|617496023|FG000|Overall Study|Did not receive treatment|8|||
170859806|NCT00966277|617496024|FG000|Overall Study|Withdrawal by Subject|3|||
170859807|NCT00966277|617496025|FG001|Overall Study|Withdrawal by Subject|0|||
170859808|NCT00966277|617496024|FG000|Overall Study|Ineligible|1|||
170859809|NCT00966277|617496025|FG001|Overall Study|Ineligible|3|||
170514456|NCT02959918|616230285|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
170859810|NCT00966277|617496024|FG000|Overall Study|Treatment Plan Changed|0|||
170859811|NCT00966277|617496025|FG001|Overall Study|Treatment Plan Changed|1|||
170859812|NCT01211197|617496027|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170859813|NCT01211197|617496028|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170859814|NCT01211197|617496029|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
170514457|NCT02959918|616230286|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170744617|NCT00365378|617073211|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
170744618|NCT00365378|617073212|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
170744619|NCT00365378|617073210|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
170744620|NCT00365378|617073211|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
170744621|NCT00365378|617073212|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
170744622|NCT00365378|617073210|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
170744623|NCT00365378|617073211|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
170744624|NCT00365378|617073212|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
170744625|NCT00365378|617073210|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
170744626|NCT00365378|617073211|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
170744627|NCT00365378|617073212|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
170744628|NCT00365378|617073210|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
170744629|NCT00365378|617073211|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
170744630|NCT00365378|617073212|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
170744631|NCT00365378|617073210|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
170744632|NCT00365378|617073211|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
170744633|NCT00365378|617073212|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
170744634|NCT00365378|617073210|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
170744635|NCT00365378|617073211|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
170744636|NCT00365378|617073212|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
170744637|NCT00365378|617073210|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
170744638|NCT00365378|617073211|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
170514458|NCT02959918|616230287|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170514459|NCT02959918|616230288|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170514460|NCT02959918|616230289|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170514461|NCT02959918|616230290|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170514462|NCT02959918|616230291|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170744639|NCT00365378|617073212|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
170744640|NCT00365378|617073210|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
170744641|NCT00365378|617073211|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
170744642|NCT00365378|617073212|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
170744643|NCT00365378|617073210|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
170744644|NCT00365378|617073211|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
170744645|NCT00365378|617073212|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
170744646|NCT00365378|617073210|FG000|Extension|Adverse Event|0|||
170744647|NCT00365378|617073211|FG001|Extension|Adverse Event|0|||
170514463|NCT02959918|616230292|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170514464|NCT02959918|616230293|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170514465|NCT02959918|616230294|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170514466|NCT02959918|616230295|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
170514467|NCT02959918|616230282|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514468|NCT02959918|616230283|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514469|NCT02959918|616230284|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514470|NCT02959918|616230285|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514471|NCT02959918|616230286|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514472|NCT02959918|616230287|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514473|NCT02959918|616230288|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514474|NCT02959918|616230289|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
170514475|NCT02959918|616230290|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514476|NCT02959918|616230291|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514477|NCT02959918|616230292|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514478|NCT02959918|616230293|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514479|NCT02959918|616230294|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514480|NCT02959918|616230295|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
170514481|NCT02959918|616230282|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514482|NCT02959918|616230283|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514483|NCT02959918|616230284|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514484|NCT02959918|616230285|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514485|NCT02959918|616230286|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514486|NCT02959918|616230287|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514487|NCT02959918|616230288|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514488|NCT02959918|616230289|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514489|NCT02959918|616230290|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
170514490|NCT02959918|616230291|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514491|NCT02959918|616230292|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170565415|NCT01405196|616417150|FG002|Overall Study|Adverse Event|0|||
170859815|NCT01211197|617496030|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170859816|NCT01211197|617496031|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170859817|NCT01211197|617496032|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170859818|NCT01211197|617496027|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
170859819|NCT01211197|617496028|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
170859820|NCT01211197|617496029|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
170859821|NCT01211197|617496030|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
170859822|NCT01211197|617496031|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
170859823|NCT01211197|617496032|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
170859824|NCT00325039|617496033|FG000|Overall Study|Lost to Follow-up|18|||
170859825|NCT00325039|617496034|FG001|Overall Study|Lost to Follow-up|14|||
170859826|NCT01009203|617496035|FG000|Overall Study|Withdrawal by Subject|1|||
170859827|NCT01009203|617496035|FG000|Overall Study|Adverse Event|5|||
170859828|NCT01009203|617496035|FG000|Overall Study|Treatment-unrelated death|1|||
170859829|NCT00940108|617496040|FG000|Overall Study|Adverse Event|2|||
170859830|NCT00940108|617496041|FG001|Overall Study|Adverse Event|4|||
170859831|NCT00940108|617496042|FG002|Overall Study|Adverse Event|0|||
170859832|NCT00940108|617496043|FG003|Overall Study|Adverse Event|2|||
170859833|NCT00940108|617496040|FG000|Overall Study|Withdrew Consent|2|||
170859834|NCT00940108|617496041|FG001|Overall Study|Withdrew Consent|1|||
170859835|NCT00940108|617496042|FG002|Overall Study|Withdrew Consent|0|||
170859836|NCT00940108|617496043|FG003|Overall Study|Withdrew Consent|1|||
170859837|NCT00940108|617496040|FG000|Overall Study|Dose 2 contraindicated|1|||
170859838|NCT00940108|617496041|FG001|Overall Study|Dose 2 contraindicated|1|||
170859839|NCT00940108|617496042|FG002|Overall Study|Dose 2 contraindicated|0|||
170859840|NCT00940108|617496043|FG003|Overall Study|Dose 2 contraindicated|1|||
170859841|NCT00940108|617496040|FG000|Overall Study|Declined further vaccination|0|||
170859842|NCT00940108|617496041|FG001|Overall Study|Declined further vaccination|1|||
170859843|NCT00940108|617496042|FG002|Overall Study|Declined further vaccination|3|||
170859844|NCT00940108|617496043|FG003|Overall Study|Declined further vaccination|0|||
170859845|NCT00940108|617496040|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
170859846|NCT00940108|617496041|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
170859847|NCT00940108|617496042|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
170859848|NCT00940108|617496043|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
170859849|NCT00940108|617496040|FG000|Overall Study|Viral illness after Dose 1|0|||
170859850|NCT00940108|617496041|FG001|Overall Study|Viral illness after Dose 1|1|||
170859851|NCT00940108|617496042|FG002|Overall Study|Viral illness after Dose 1|0|||
170859852|NCT00940108|617496043|FG003|Overall Study|Viral illness after Dose 1|0|||
170859853|NCT00940108|617496040|FG000|Overall Study|Diagnosed with H1N1|0|||
170859854|NCT00940108|617496041|FG001|Overall Study|Diagnosed with H1N1|0|||
170859855|NCT00940108|617496042|FG002|Overall Study|Diagnosed with H1N1|0|||
170514492|NCT02959918|616230293|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514493|NCT02959918|616230294|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514494|NCT02959918|616230295|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
170514495|NCT02959918|616230282|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514496|NCT02959918|616230283|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514497|NCT02959918|616230284|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514498|NCT02959918|616230285|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514499|NCT02959918|616230286|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514500|NCT02959918|616230287|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514501|NCT02959918|616230288|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514502|NCT02959918|616230289|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514503|NCT02959918|616230290|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514504|NCT02959918|616230291|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
170514505|NCT02959918|616230292|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514506|NCT02959918|616230293|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170565416|NCT01405196|616417151|FG003|Overall Study|Adverse Event|2|||
170744648|NCT00365378|617073212|FG002|Extension|Adverse Event|1|||
170859856|NCT00940108|617496043|FG003|Overall Study|Diagnosed with H1N1|1|||
170859857|NCT00926211|617496044|FG000|Overall Study|Lost to Follow-up|1|||
170859858|NCT01242800|617496045|FG000|Overall Study|Patient refusal|0|||
170400196|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
170400197|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
170400198|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
170400199|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
170400200|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
170400201|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
170400202|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
170400203|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
170859859|NCT01242800|617496046|FG001|Overall Study|Patient refusal|10|||
170859860|NCT01242800|617496045|FG000|Overall Study|Physician Decision|0|||
170859861|NCT01242800|617496046|FG001|Overall Study|Physician Decision|1|||
170859862|NCT01242800|617496045|FG000|Overall Study|Disease progression|0|||
170859863|NCT01242800|617496046|FG001|Overall Study|Disease progression|3|||
170859864|NCT01242800|617496045|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
170859865|NCT01242800|617496046|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
170859866|NCT01242800|617496045|FG000|Overall Study|Reasons not reported|0|||
170859867|NCT01242800|617496046|FG001|Overall Study|Reasons not reported|4|||
170859868|NCT02409368|617496050|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
170859869|NCT02409368|617496051|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
170859870|NCT02409368|617496052|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
170859871|NCT02409368|617496053|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
170859872|NCT02409368|617496050|FG000|ECOG Reclassification|Death|1|||
170859873|NCT02409368|617496051|FG001|ECOG Reclassification|Death|5|||
170859874|NCT02409368|617496052|FG002|ECOG Reclassification|Death|0|||
170859875|NCT02409368|617496053|FG003|ECOG Reclassification|Death|0|||
170859876|NCT02409368|617496050|FG000|ECOG Reclassification|Disease Progression|113|||
170859877|NCT02409368|617496051|FG001|ECOG Reclassification|Disease Progression|382|||
170859878|NCT02409368|617496052|FG002|ECOG Reclassification|Disease Progression|70|||
170859879|NCT02409368|617496053|FG003|ECOG Reclassification|Disease Progression|1|||
170859880|NCT02409368|617496050|FG000|ECOG Reclassification|Lost to Follow-up|1|||
170859881|NCT02409368|617496051|FG001|ECOG Reclassification|Lost to Follow-up|5|||
170859882|NCT02409368|617496052|FG002|ECOG Reclassification|Lost to Follow-up|0|||
170859883|NCT02409368|617496053|FG003|ECOG Reclassification|Lost to Follow-up|0|||
170859884|NCT02409368|617496050|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
170859885|NCT02409368|617496051|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
170859886|NCT02409368|617496052|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
170744649|NCT00365378|617073210|FG000|Extension|Moved|0|||
170744650|NCT00365378|617073211|FG001|Extension|Moved|0|||
170744651|NCT00365378|617073212|FG002|Extension|Moved|8|||
170744652|NCT00365378|617073210|FG000|Extension|Lost to Follow-up|0|||
170744653|NCT00365378|617073211|FG001|Extension|Lost to Follow-up|0|||
170744654|NCT00365378|617073212|FG002|Extension|Lost to Follow-up|57|||
170744655|NCT00365378|617073210|FG000|Extension|Protocol Violation|0|||
170744656|NCT00365378|617073211|FG001|Extension|Protocol Violation|0|||
170744657|NCT00365378|617073212|FG002|Extension|Protocol Violation|2|||
170744658|NCT00365378|617073210|FG000|Extension|Withdrawal by Subject|0|||
170744659|NCT00365378|617073211|FG001|Extension|Withdrawal by Subject|0|||
170744660|NCT00365378|617073212|FG002|Extension|Withdrawal by Subject|98|||
170744661|NCT00365378|617073210|FG000|Extension|Other|0|||
170744662|NCT00365378|617073211|FG001|Extension|Other|0|||
170744663|NCT00365378|617073212|FG002|Extension|Other|31|||
170400204|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
170400205|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
170400206|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
170400207|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
170400208|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
170400209|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
170400210|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
170400211|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
170400212|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
170400213|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
170400214|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
170400215|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
170400216|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
170400217|NCT03747939|615805555|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
170400218|NCT03747939|615805556|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
170400219|NCT03747939|615805557|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
170400220|NCT03747939|615805558|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
170400221|NCT03747939|615805555|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
170400222|NCT03747939|615805556|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
170400223|NCT03747939|615805557|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
170400224|NCT03747939|615805558|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
170400225|NCT03747939|615805555|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
170400226|NCT03747939|615805556|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
170400227|NCT03747939|615805557|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
170400228|NCT03747939|615805558|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
170400229|NCT03747939|615805555|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
170400230|NCT03747939|615805556|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
170400231|NCT03747939|615805557|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
170514507|NCT02959918|616230294|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514508|NCT02959918|616230295|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
170514509|NCT04676724|616230298|FG000|Overall Study|Adverse Event|2|||
170514510|NCT04676724|616230299|FG001|Overall Study|Adverse Event|0|||
170400232|NCT03747939|615805558|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
170400233|NCT03747939|615805555|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
170400234|NCT03747939|615805556|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
170400235|NCT03747939|615805557|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
170400236|NCT03747939|615805558|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
170400237|NCT03747939|615805555|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
170400238|NCT03747939|615805556|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
170400239|NCT03747939|615805557|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
170400240|NCT03747939|615805558|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
170400241|NCT01850108|615805559|FG000|Overall Study|Lost to Follow-up|4|||
170400242|NCT01850108|615805559|FG000|Overall Study|Not eligible|1|||
170400243|NCT01850108|615805559|FG000|Overall Study|Failed engraftment|2|||
170400244|NCT01850108|615805559|FG000|Overall Study|Physician Decision|1|||
170400245|NCT01447628|615805562|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
170400246|NCT01447628|615805563|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
170514511|NCT04676724|616230298|FG000|Overall Study|Lost to Follow-up|1|||
170514512|NCT04676724|616230299|FG001|Overall Study|Lost to Follow-up|0|||
170514513|NCT04676724|616230298|FG000|Overall Study|Physician Decision|0|||
170514514|NCT04676724|616230299|FG001|Overall Study|Physician Decision|1|||
170514515|NCT04676724|616230298|FG000|Overall Study|Withdrawal by Subject|3|||
170514516|NCT04676724|616230299|FG001|Overall Study|Withdrawal by Subject|2|||
170514517|NCT03173456|616230302|FG000|Baseline|Medication dispensing system malfunction'|0|||
170514518|NCT03173456|616230303|FG001|Baseline|Medication dispensing system malfunction'|1|||
170514519|NCT03173456|616230304|FG002|Baseline|Medication dispensing system malfunction'|0|||
170514520|NCT03173456|616230305|FG003|Baseline|Medication dispensing system malfunction'|0|||
170514521|NCT03173456|616230306|FG004|Baseline|Medication dispensing system malfunction'|2|||
170514522|NCT03173456|616230302|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
170514523|NCT03173456|616230303|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
170514524|NCT03173456|616230304|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
170514525|NCT03173456|616230305|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
170514526|NCT03173456|616230306|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
170514527|NCT01733121|616230307|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
170514528|NCT01733121|616230308|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
170514529|NCT01733121|616230307|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
170514530|NCT01733121|616230308|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
170514531|NCT01733121|616230307|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
170514532|NCT01733121|616230308|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
170514533|NCT01733121|616230307|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
170514534|NCT01733121|616230308|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
170514535|NCT03061188|616230309|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
170514536|NCT03061188|616230310|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
170514537|NCT03061188|616230311|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
170514538|NCT03061188|616230312|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
170514539|NCT03061188|616230309|FG000|On Follow-up for 3 Years|Death|0|||
170514540|NCT03061188|616230310|FG001|On Follow-up for 3 Years|Death|3|||
170514541|NCT03061188|616230311|FG002|On Follow-up for 3 Years|Death|5|||
170514542|NCT03061188|616230312|FG003|On Follow-up for 3 Years|Death|4|||
170514543|NCT03061188|616230309|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
170514544|NCT03061188|616230310|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
170514545|NCT03061188|616230311|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
170514546|NCT03061188|616230312|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
170514547|NCT04074330|616230315|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
170514548|NCT04074330|616230316|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
170514549|NCT04074330|616230317|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
170514550|NCT04074330|616230318|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
170514551|NCT04074330|616230319|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
170514552|NCT04074330|616230320|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
170514553|NCT04074330|616230321|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
170514554|NCT04074330|616230322|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
170514555|NCT04074330|616230323|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
170514556|NCT04074330|616230324|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
170514557|NCT04074330|616230315|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
170514558|NCT04074330|616230316|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
170514559|NCT04074330|616230317|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
170514560|NCT04074330|616230318|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
170859887|NCT02409368|617496053|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
170514561|NCT04074330|616230319|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
170514562|NCT04074330|616230320|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
170514563|NCT04074330|616230321|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
170514564|NCT04074330|616230322|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
170514565|NCT04074330|616230323|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
170514566|NCT04074330|616230324|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
170514567|NCT04074330|616230315|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514568|NCT04074330|616230316|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514569|NCT04074330|616230317|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
170514570|NCT04074330|616230318|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514571|NCT04074330|616230319|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514572|NCT04074330|616230320|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514573|NCT04074330|616230321|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514574|NCT04074330|616230322|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514575|NCT04074330|616230323|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514576|NCT04074330|616230324|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
170514577|NCT04074330|616230315|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
170514578|NCT04074330|616230316|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
170514579|NCT04074330|616230317|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
170514580|NCT04074330|616230318|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
170514581|NCT04074330|616230319|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
170514582|NCT04074330|616230320|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
170514583|NCT04074330|616230321|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
170514584|NCT04074330|616230322|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
170514585|NCT04074330|616230323|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
170514586|NCT04074330|616230324|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
170514587|NCT04074330|616230315|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
170514588|NCT04074330|616230316|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
170514589|NCT04074330|616230317|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
170514590|NCT04074330|616230318|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
170514591|NCT04074330|616230319|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
170514592|NCT04074330|616230320|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
170514593|NCT04074330|616230321|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
170514594|NCT04074330|616230322|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
170514595|NCT04074330|616230323|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
170514596|NCT04074330|616230324|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
170514597|NCT04074330|616230315|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
170514598|NCT04074330|616230316|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
170514599|NCT04074330|616230317|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
170514600|NCT04074330|616230318|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
170514601|NCT04074330|616230319|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
170514602|NCT04074330|616230320|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
170514603|NCT04074330|616230321|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
170514604|NCT04074330|616230322|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
170514605|NCT04074330|616230323|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
170514606|NCT04074330|616230324|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
170514607|NCT04074330|616230315|FG000|Dose Expansion (up to 42 Months)|Death|0|||
170514608|NCT04074330|616230316|FG001|Dose Expansion (up to 42 Months)|Death|0|||
170514609|NCT04074330|616230317|FG002|Dose Expansion (up to 42 Months)|Death|0|||
170514610|NCT04074330|616230318|FG003|Dose Expansion (up to 42 Months)|Death|0|||
170514611|NCT04074330|616230319|FG004|Dose Expansion (up to 42 Months)|Death|0|||
170514612|NCT04074330|616230320|FG005|Dose Expansion (up to 42 Months)|Death|0|||
170514613|NCT04074330|616230321|FG006|Dose Expansion (up to 42 Months)|Death|0|||
170514614|NCT04074330|616230322|FG007|Dose Expansion (up to 42 Months)|Death|0|||
170514615|NCT04074330|616230323|FG008|Dose Expansion (up to 42 Months)|Death|1|||
170514616|NCT04074330|616230324|FG009|Dose Expansion (up to 42 Months)|Death|0|||
170514617|NCT04074330|616230315|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
170514618|NCT04074330|616230316|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
170514619|NCT04074330|616230317|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
170514620|NCT04074330|616230318|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
170514621|NCT04074330|616230319|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
170514622|NCT04074330|616230320|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
170514623|NCT04074330|616230321|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
170514624|NCT04074330|616230322|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
170514625|NCT04074330|616230323|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
170514626|NCT04074330|616230324|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
170514627|NCT00524680|616230325|FG000|Overall Study|progression|0|||
170514628|NCT00524680|616230326|FG001|Overall Study|progression|0|||
170514629|NCT00524680|616230327|FG002|Overall Study|progression|0|||
170514630|NCT00524680|616230328|FG003|Overall Study|progression|1|||
170514631|NCT00524680|616230325|FG000|Overall Study|Adverse Event|2|||
170514632|NCT00524680|616230326|FG001|Overall Study|Adverse Event|0|||
170514633|NCT00524680|616230327|FG002|Overall Study|Adverse Event|0|||
170514634|NCT00524680|616230328|FG003|Overall Study|Adverse Event|1|||
170514635|NCT00524680|616230325|FG000|Overall Study|Other|0|||
170514636|NCT00524680|616230326|FG001|Overall Study|Other|1|||
170514637|NCT00524680|616230327|FG002|Overall Study|Other|2|||
170514638|NCT00524680|616230328|FG003|Overall Study|Other|3|||
170514639|NCT00524680|616230325|FG000|Overall Study|Withdrawal by Subject|1|||
170514640|NCT00524680|616230326|FG001|Overall Study|Withdrawal by Subject|0|||
170514641|NCT00524680|616230327|FG002|Overall Study|Withdrawal by Subject|1|||
170514642|NCT00524680|616230328|FG003|Overall Study|Withdrawal by Subject|1|||
170514643|NCT01146561|616230330|FG000|Overall Study|Withdrawal by Subject|1|||
170514644|NCT01146561|616230330|FG000|Overall Study|Lost to Follow-up|1|||
170514645|NCT03124537|616230331|FG000|Overall Study|Lost to Follow-up|3|||
170514646|NCT03124537|616230332|FG001|Overall Study|Lost to Follow-up|5|||
170514647|NCT03124537|616230331|FG000|Overall Study|App Crash, Incomplete Data|7|||
170514648|NCT03124537|616230332|FG001|Overall Study|App Crash, Incomplete Data|8|||
170514649|NCT02903420|616230340|FG000|Overall Study|Death|3|||
170514650|NCT00181883|616230343|FG000|Overall Study|Lack of Efficacy|2|||
170514651|NCT00181883|616230343|FG000|Overall Study|Treatment Limiting AEs|3|||
170514652|NCT00181883|616230343|FG000|Overall Study|Withdrawal by Subject|4|||
170514653|NCT00181883|616230343|FG000|Overall Study|Lost to Follow-up|1|||
170514654|NCT05305989|616230344|FG000|Overall Study|Other|3|||
170514655|NCT05305989|616230345|FG001|Overall Study|Other|2|||
170514656|NCT05305989|616230346|FG002|Overall Study|Other|0|||
170514657|NCT05305989|616230344|FG000|Overall Study|Sponsor decision|2|||
170514658|NCT05305989|616230345|FG001|Overall Study|Sponsor decision|1|||
170514659|NCT05305989|616230346|FG002|Overall Study|Sponsor decision|0|||
170514660|NCT05305989|616230344|FG000|Overall Study|Protocol Violation|0|||
170514661|NCT05305989|616230345|FG001|Overall Study|Protocol Violation|1|||
170514662|NCT05305989|616230346|FG002|Overall Study|Protocol Violation|0|||
170514663|NCT05305989|616230344|FG000|Overall Study|Investigator decision|1|||
170514664|NCT05305989|616230345|FG001|Overall Study|Investigator decision|2|||
170514665|NCT05305989|616230346|FG002|Overall Study|Investigator decision|0|||
170514666|NCT05305989|616230344|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
170514667|NCT05305989|616230345|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
170514668|NCT05305989|616230346|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
170514669|NCT05305989|616230344|FG000|Overall Study|Adverse Event|1|||
170514670|NCT05305989|616230345|FG001|Overall Study|Adverse Event|1|||
170514671|NCT05305989|616230346|FG002|Overall Study|Adverse Event|0|||
170514672|NCT05305989|616230344|FG000|Overall Study|Enrolled but never dosed|3|||
170514673|NCT05305989|616230345|FG001|Overall Study|Enrolled but never dosed|2|||
170514674|NCT05305989|616230346|FG002|Overall Study|Enrolled but never dosed|1|||
170514675|NCT03162328|616230347|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
170514676|NCT03162328|616230348|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
170514677|NCT03162328|616230349|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
170514678|NCT03162328|616230347|FG000|Screening Period|Withdrawal by Subject|1|||
170514679|NCT03162328|616230348|FG001|Screening Period|Withdrawal by Subject|0|||
170514680|NCT03162328|616230349|FG002|Screening Period|Withdrawal by Subject|0|||
170514681|NCT03162328|616230347|FG000|Study Period|Withdrawal by Subject|0|||
170514682|NCT03162328|616230348|FG001|Study Period|Withdrawal by Subject|0|||
170514683|NCT03162328|616230349|FG002|Study Period|Withdrawal by Subject|1|||
170514684|NCT00830518|616230350|FG000|Overall Study|Progressive Disease|18|||
170514685|NCT00830518|616230351|FG001|Overall Study|Progressive Disease|8|||
170514686|NCT00830518|616230350|FG000|Overall Study|Symptomatic Deterioration|4|||
170514687|NCT00830518|616230351|FG001|Overall Study|Symptomatic Deterioration|1|||
170514688|NCT00830518|616230350|FG000|Overall Study|Adverse Event|14|||
170514689|NCT00830518|616230351|FG001|Overall Study|Adverse Event|1|||
170514690|NCT00830518|616230350|FG000|Overall Study|Withdrawal by Patient|2|||
170514691|NCT00830518|616230351|FG001|Overall Study|Withdrawal by Patient|0|||
170514692|NCT00830518|616230350|FG000|Overall Study|Reason not Specified|8|||
170514693|NCT00830518|616230351|FG001|Overall Study|Reason not Specified|1|||
170514694|NCT03092791|616230352|FG000|Overall Study|Lost to Follow-up|0|||
170514695|NCT03092791|616230353|FG001|Overall Study|Lost to Follow-up|0|||
170514696|NCT03092791|616230354|FG002|Overall Study|Lost to Follow-up|0|||
170514697|NCT03092791|616230355|FG003|Overall Study|Lost to Follow-up|0|||
170514698|NCT03092791|616230356|FG004|Overall Study|Lost to Follow-up|0|||
170514699|NCT03092791|616230357|FG005|Overall Study|Lost to Follow-up|0|||
170514700|NCT03092791|616230358|FG006|Overall Study|Lost to Follow-up|1|||
170514701|NCT03092791|616230359|FG007|Overall Study|Lost to Follow-up|0|||
170514702|NCT03092791|616230352|FG000|Overall Study|Withdrawal of Consent|0|||
170514703|NCT03092791|616230353|FG001|Overall Study|Withdrawal of Consent|0|||
170514704|NCT03092791|616230354|FG002|Overall Study|Withdrawal of Consent|0|||
170514705|NCT03092791|616230355|FG003|Overall Study|Withdrawal of Consent|0|||
170514706|NCT03092791|616230356|FG004|Overall Study|Withdrawal of Consent|4|||
170514707|NCT03092791|616230357|FG005|Overall Study|Withdrawal of Consent|12|||
170514708|NCT03092791|616230358|FG006|Overall Study|Withdrawal of Consent|6|||
170514709|NCT03092791|616230359|FG007|Overall Study|Withdrawal of Consent|4|||
170514710|NCT03092791|616230352|FG000|Overall Study|Study Termination|0|||
170514711|NCT03092791|616230353|FG001|Overall Study|Study Termination|0|||
170514712|NCT03092791|616230354|FG002|Overall Study|Study Termination|0|||
170514713|NCT03092791|616230355|FG003|Overall Study|Study Termination|0|||
170514714|NCT03092791|616230356|FG004|Overall Study|Study Termination|55|||
170514715|NCT03092791|616230357|FG005|Overall Study|Study Termination|46|||
170514716|NCT03092791|616230358|FG006|Overall Study|Study Termination|53|||
170514717|NCT03092791|616230359|FG007|Overall Study|Study Termination|55|||
170514718|NCT03092791|616230352|FG000|Overall Study|Death|0|||
170514719|NCT03092791|616230353|FG001|Overall Study|Death|0|||
170514720|NCT03092791|616230354|FG002|Overall Study|Death|0|||
170514721|NCT03092791|616230355|FG003|Overall Study|Death|0|||
170514722|NCT03092791|616230356|FG004|Overall Study|Death|0|||
170514723|NCT03092791|616230357|FG005|Overall Study|Death|1|||
170514724|NCT03092791|616230358|FG006|Overall Study|Death|0|||
170514725|NCT03092791|616230359|FG007|Overall Study|Death|1|||
170514726|NCT03092791|616230352|FG000|Overall Study|Reason Not Specified|0|||
170514727|NCT03092791|616230353|FG001|Overall Study|Reason Not Specified|0|||
170514728|NCT03092791|616230354|FG002|Overall Study|Reason Not Specified|0|||
170514729|NCT03092791|616230355|FG003|Overall Study|Reason Not Specified|0|||
170514730|NCT03092791|616230356|FG004|Overall Study|Reason Not Specified|1|||
170514731|NCT03092791|616230357|FG005|Overall Study|Reason Not Specified|1|||
170514732|NCT03092791|616230358|FG006|Overall Study|Reason Not Specified|0|||
170514733|NCT03092791|616230359|FG007|Overall Study|Reason Not Specified|0|||
170514734|NCT02182830|616230363|FG000|Overall Study|Not Treated|1|||
170514735|NCT02182830|616230364|FG001|Overall Study|Not Treated|1|||
170514736|NCT02182830|616230363|FG000|Overall Study|Trial stopped, reason missing|3|||
170514737|NCT02182830|616230364|FG001|Overall Study|Trial stopped, reason missing|3|||
170514738|NCT02182830|616230363|FG000|Overall Study|Consent withdrawn|8|||
170514739|NCT02182830|616230364|FG001|Overall Study|Consent withdrawn|8|||
170514740|NCT02182830|616230363|FG000|Overall Study|Lost to Follow-up|3|||
170514741|NCT02182830|616230364|FG001|Overall Study|Lost to Follow-up|3|||
170514742|NCT02348008|616230365|FG000|Overall Study|Adverse Event|2|||
170514743|NCT02348008|616230366|FG001|Overall Study|Adverse Event|3|||
170514744|NCT02348008|616230367|FG002|Overall Study|Adverse Event|3|||
170514745|NCT02348008|616230365|FG000|Overall Study|Disease Progression|1|||
170514746|NCT02348008|616230366|FG001|Overall Study|Disease Progression|5|||
170514747|NCT02348008|616230367|FG002|Overall Study|Disease Progression|16|||
170514748|NCT02348008|616230365|FG000|Overall Study|Withdrawal by Subject|0|||
170514749|NCT02348008|616230366|FG001|Overall Study|Withdrawal by Subject|1|||
170514750|NCT02348008|616230367|FG002|Overall Study|Withdrawal by Subject|0|||
170514751|NCT02348008|616230365|FG000|Overall Study|Symptomatic Deterioration|0|||
170514752|NCT02348008|616230366|FG001|Overall Study|Symptomatic Deterioration|1|||
170514753|NCT02348008|616230367|FG002|Overall Study|Symptomatic Deterioration|0|||
170514754|NCT00586898|616230368|FG000|Overall Study|Adverse Event|1|||
170514755|NCT00586898|616230368|FG000|Overall Study|Patiemt Non-compliance|1|||
170514756|NCT00586898|616230368|FG000|Overall Study|Evaluable for Toxicity Only|5|||
170514757|NCT00893971|616230369|FG000|Overall Study|Physician Decision|3|||
170514758|NCT03268005|616230370|FG000|Overall Study|Death|2|||
170514759|NCT03268005|616230371|FG001|Overall Study|Death|1|||
170514760|NCT03268005|616230370|FG000|Overall Study|Lost to Follow-up|2|||
170514761|NCT03268005|616230371|FG001|Overall Study|Lost to Follow-up|2|||
170514762|NCT03268005|616230370|FG000|Overall Study|Withdrawal by Subject|11|||
170514763|NCT03268005|616230371|FG001|Overall Study|Withdrawal by Subject|11|||
170514764|NCT01926197|616230373|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
170514765|NCT01926197|616230374|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
170514766|NCT01926197|616230373|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
170514767|NCT01926197|616230374|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
170514768|NCT00980655|616230376|FG000|Overall Study|Adverse Event|13|||
170514769|NCT00980655|616230377|FG001|Overall Study|Adverse Event|31|||
170514770|NCT00980655|616230376|FG000|Overall Study|Death|0|||
170514771|NCT00980655|616230377|FG001|Overall Study|Death|7|||
170514772|NCT00980655|616230376|FG000|Overall Study|Protocol Violation|2|||
170514773|NCT00980655|616230377|FG001|Overall Study|Protocol Violation|7|||
170514774|NCT00980655|616230376|FG000|Overall Study|Withdrawal by Subject|0|||
170514775|NCT00980655|616230377|FG001|Overall Study|Withdrawal by Subject|4|||
170514776|NCT00980655|616230376|FG000|Overall Study|Lost to Follow-up|0|||
170514777|NCT00980655|616230377|FG001|Overall Study|Lost to Follow-up|1|||
170514778|NCT00980655|616230376|FG000|Overall Study|Parent/legal guardian request|1|||
170514779|NCT00980655|616230377|FG001|Overall Study|Parent/legal guardian request|0|||
170514780|NCT00980655|616230376|FG000|Overall Study|Other|0|||
170514781|NCT00980655|616230377|FG001|Overall Study|Other|1|||
170514782|NCT01066871|616230381|FG000|Overall Study|Lost to Follow-up|0|||
170514783|NCT01066871|616230382|FG001|Overall Study|Lost to Follow-up|2|||
170514784|NCT01066871|616230383|FG002|Overall Study|Lost to Follow-up|2|||
170514785|NCT01066871|616230384|FG003|Overall Study|Lost to Follow-up|0|||
170514786|NCT01066871|616230381|FG000|Overall Study|Protocol Violation|1|||
170514787|NCT01066871|616230382|FG001|Overall Study|Protocol Violation|0|||
170514788|NCT01066871|616230383|FG002|Overall Study|Protocol Violation|3|||
170514789|NCT01066871|616230384|FG003|Overall Study|Protocol Violation|2|||
170514790|NCT01066871|616230381|FG000|Overall Study|Lack of Efficacy|0|||
170514791|NCT01066871|616230382|FG001|Overall Study|Lack of Efficacy|0|||
170514792|NCT01066871|616230383|FG002|Overall Study|Lack of Efficacy|0|||
170514793|NCT01066871|616230384|FG003|Overall Study|Lack of Efficacy|1|||
170514794|NCT01066871|616230381|FG000|Overall Study|Withdrawal by Subject|3|||
170514795|NCT01066871|616230382|FG001|Overall Study|Withdrawal by Subject|1|||
170514796|NCT01066871|616230383|FG002|Overall Study|Withdrawal by Subject|0|||
170514797|NCT01066871|616230384|FG003|Overall Study|Withdrawal by Subject|0|||
170514798|NCT01066871|616230381|FG000|Overall Study|Other|0|||
170514799|NCT01066871|616230382|FG001|Overall Study|Other|2|||
170514800|NCT01066871|616230383|FG002|Overall Study|Other|1|||
170514801|NCT01066871|616230384|FG003|Overall Study|Other|2|||
170514802|NCT04162795|616230388|FG000|Overall Study|Other|16|||
170514803|NCT04162795|616230388|FG000|Overall Study|Screen failures|10|||
170514804|NCT02029274|616230389|FG000|Overall Study|Adverse Event|1|||
170514805|NCT02029274|616230390|FG001|Overall Study|Adverse Event|0|||
170514806|NCT02029274|616230391|FG002|Overall Study|Adverse Event|2|||
170514807|NCT02029274|616230392|FG003|Overall Study|Adverse Event|2|||
170514808|NCT02756364|616230395|FG000|Overall Study|Site Terminated by Sponsor|24|||
170514809|NCT02756364|616230396|FG001|Overall Study|Site Terminated by Sponsor|30|||
170514810|NCT02756364|616230397|FG002|Overall Study|Site Terminated by Sponsor|21|||
170514811|NCT02756364|616230395|FG000|Overall Study|Death|20|||
170514812|NCT02756364|616230396|FG001|Overall Study|Death|15|||
170514813|NCT02756364|616230397|FG002|Overall Study|Death|18|||
170514814|NCT02756364|616230395|FG000|Overall Study|Withdrawal by Patient|2|||
170514815|NCT02756364|616230396|FG001|Overall Study|Withdrawal by Patient|1|||
170514816|NCT02756364|616230397|FG002|Overall Study|Withdrawal by Patient|8|||
170514817|NCT02756364|616230395|FG000|Overall Study|Lost to Follow-up|0|||
170514818|NCT02756364|616230396|FG001|Overall Study|Lost to Follow-up|1|||
170514819|NCT02756364|616230397|FG002|Overall Study|Lost to Follow-up|1|||
170514820|NCT02223364|616230398|FG000|Overall Study|Protocol Violation|3|||
170514821|NCT02223364|616230399|FG001|Overall Study|Protocol Violation|0|||
170514822|NCT02223364|616230400|FG002|Overall Study|Protocol Violation|3|||
170514823|NCT02223364|616230398|FG000|Overall Study|subject expired before surgery|1|||
170514824|NCT02223364|616230399|FG001|Overall Study|subject expired before surgery|0|||
170514825|NCT02223364|616230400|FG002|Overall Study|subject expired before surgery|0|||
170514826|NCT02223364|616230398|FG000|Overall Study|Physician Decision|1|||
170514827|NCT02223364|616230399|FG001|Overall Study|Physician Decision|0|||
170514828|NCT02223364|616230400|FG002|Overall Study|Physician Decision|0|||
170514829|NCT02984267|616230402|FG000|Overall Study|Protocol Violation|1|||
170514830|NCT02984267|616230403|FG001|Overall Study|Protocol Violation|0|||
170514831|NCT02984267|616230402|FG000|Overall Study|Withdrawal by Subject|0|||
170514832|NCT02984267|616230403|FG001|Overall Study|Withdrawal by Subject|1|||
170514833|NCT01994902|616230404|FG000|Test Period 1|Withdrawal by Subject|3|||
170514834|NCT01994902|616230405|FG001|Test Period 1|Withdrawal by Subject|0|||
170514835|NCT01994902|616230404|FG000|Test Period 1|device deficiency with adverse event|0|||
170514836|NCT01994902|616230405|FG001|Test Period 1|device deficiency with adverse event|1|||
170514837|NCT01994902|616230404|FG000|Test Period 1|Adverse Event|2|||
170514838|NCT01994902|616230405|FG001|Test Period 1|Adverse Event|1|||
170514839|NCT01994902|616230404|FG000|Test Period 1|Lack of Efficacy|0|||
170514840|NCT01994902|616230405|FG001|Test Period 1|Lack of Efficacy|1|||
170514841|NCT01994902|616230404|FG000|Test Period 1|bag too small|1|||
170514842|NCT01994902|616230405|FG001|Test Period 1|bag too small|0|||
170514843|NCT01994902|616230404|FG000|Test Period 2|Withdrawal by Subject|0|||
170514844|NCT01994902|616230405|FG001|Test Period 2|Withdrawal by Subject|2|||
170514845|NCT01994902|616230404|FG000|Test Period 2|Lack of Efficacy|0|||
170514846|NCT01994902|616230405|FG001|Test Period 2|Lack of Efficacy|1|||
170514847|NCT01994902|616230404|FG000|Test Period 2|Other|0|||
170514848|NCT01994902|616230405|FG001|Test Period 2|Other|3|||
170514849|NCT03597139|616230406|FG000|Overall Study|Adverse Event|3|||
170514850|NCT03597139|616230407|FG001|Overall Study|Adverse Event|0|||
170514851|NCT03597139|616230406|FG000|Overall Study|Protocol Non-compliance|1|||
170514852|NCT03597139|616230407|FG001|Overall Study|Protocol Non-compliance|0|||
170514853|NCT01249833|616230409|FG000|Overall Study|Lost to Follow-up|0|||
170514854|NCT01249833|616230410|FG001|Overall Study|Lost to Follow-up|1|||
170514855|NCT00467558|616230418|FG000|Overall Study|Lost to Follow-up|2|||
170514856|NCT00467558|616230419|FG001|Overall Study|Lost to Follow-up|0|||
170514857|NCT02636439|616230421|FG000|Overall Study|Adverse Event|2|||
170514858|NCT02636439|616230422|FG001|Overall Study|Adverse Event|2|||
170514859|NCT02636439|616230421|FG000|Overall Study|Lost to Follow-up|1|||
170514860|NCT02636439|616230422|FG001|Overall Study|Lost to Follow-up|0|||
170514861|NCT02636439|616230421|FG000|Overall Study|Non-compliance|1|||
170514862|NCT02636439|616230422|FG001|Overall Study|Non-compliance|1|||
170514863|NCT02636439|616230421|FG000|Overall Study|Personal reasons|2|||
170514864|NCT02636439|616230422|FG001|Overall Study|Personal reasons|0|||
170514865|NCT02494401|616230423|FG000|Overall Study|Lost to Follow-up|22|||
170514866|NCT02494401|616230424|FG001|Overall Study|Lost to Follow-up|25|||
170514867|NCT02494401|616230423|FG000|Overall Study|Withdrawal by Subject|3|||
170514868|NCT02494401|616230424|FG001|Overall Study|Withdrawal by Subject|2|||
170514869|NCT05188729|616230425|FG000|Overall Study|Withdrawal by Subject|0|||
170514870|NCT05188729|616230426|FG001|Overall Study|Withdrawal by Subject|0|||
170514871|NCT05188729|616230427|FG002|Overall Study|Withdrawal by Subject|0|||
170514872|NCT05188729|616230428|FG003|Overall Study|Withdrawal by Subject|0|||
170514873|NCT05188729|616230429|FG004|Overall Study|Withdrawal by Subject|0|||
170514874|NCT05188729|616230430|FG005|Overall Study|Withdrawal by Subject|0|||
170514875|NCT05188729|616230431|FG006|Overall Study|Withdrawal by Subject|0|||
170514876|NCT05188729|616230432|FG007|Overall Study|Withdrawal by Subject|0|||
170514877|NCT05188729|616230433|FG008|Overall Study|Withdrawal by Subject|0|||
170514878|NCT05188729|616230434|FG009|Overall Study|Withdrawal by Subject|1|||
170514879|NCT05188729|616230435|FG010|Overall Study|Withdrawal by Subject|0|||
170514880|NCT05188729|616230436|FG011|Overall Study|Withdrawal by Subject|0|||
170514881|NCT05188729|616230437|FG012|Overall Study|Withdrawal by Subject|0|||
170514882|NCT05188729|616230425|FG000|Overall Study|Lost to Follow-up|0|||
170514883|NCT05188729|616230426|FG001|Overall Study|Lost to Follow-up|0|||
170514884|NCT05188729|616230427|FG002|Overall Study|Lost to Follow-up|0|||
170514885|NCT05188729|616230428|FG003|Overall Study|Lost to Follow-up|0|||
170514886|NCT05188729|616230429|FG004|Overall Study|Lost to Follow-up|0|||
170514887|NCT05188729|616230430|FG005|Overall Study|Lost to Follow-up|0|||
170514888|NCT05188729|616230431|FG006|Overall Study|Lost to Follow-up|0|||
170514889|NCT05188729|616230432|FG007|Overall Study|Lost to Follow-up|0|||
170514890|NCT05188729|616230433|FG008|Overall Study|Lost to Follow-up|0|||
170514891|NCT05188729|616230434|FG009|Overall Study|Lost to Follow-up|0|||
170514892|NCT05188729|616230435|FG010|Overall Study|Lost to Follow-up|1|||
170514893|NCT05188729|616230436|FG011|Overall Study|Lost to Follow-up|1|||
170514894|NCT05188729|616230437|FG012|Overall Study|Lost to Follow-up|0|||
170514895|NCT00520767|616230438|FG000|Overall Study|Death|2|||
170565417|NCT01405196|616417148|FG000|Overall Study|Death|1|||
170565418|NCT01405196|616417149|FG001|Overall Study|Death|0|||
170565419|NCT01405196|616417150|FG002|Overall Study|Death|3|||
170565420|NCT01405196|616417151|FG003|Overall Study|Death|0|||
170565421|NCT01405196|616417148|FG000|Overall Study|Lost to Follow-up|2|||
170565422|NCT01405196|616417149|FG001|Overall Study|Lost to Follow-up|2|||
170565423|NCT01405196|616417150|FG002|Overall Study|Lost to Follow-up|3|||
170565424|NCT01405196|616417151|FG003|Overall Study|Lost to Follow-up|1|||
170565425|NCT04756531|616417152|FG000|Overall Study|Adverse Event|0|||
170565426|NCT04756531|616417153|FG001|Overall Study|Adverse Event|0|||
170565427|NCT04756531|616417154|FG002|Overall Study|Adverse Event|0|||
170565428|NCT04756531|616417155|FG003|Overall Study|Adverse Event|0|||
170565429|NCT04756531|616417156|FG004|Overall Study|Adverse Event|1|||
170565430|NCT04756531|616417157|FG005|Overall Study|Adverse Event|0|||
170565431|NCT04756531|616417158|FG006|Overall Study|Adverse Event|0|||
170565432|NCT04756531|616417159|FG007|Overall Study|Adverse Event|0|||
170565433|NCT04756531|616417160|FG008|Overall Study|Adverse Event|0|||
170565434|NCT04756531|616417161|FG009|Overall Study|Adverse Event|0|||
170565435|NCT04756531|616417162|FG010|Overall Study|Adverse Event|0|||
170565436|NCT04756531|616417163|FG011|Overall Study|Adverse Event|0|||
170565437|NCT04756531|616417164|FG012|Overall Study|Adverse Event|0|||
170565438|NCT04756531|616417165|FG013|Overall Study|Adverse Event|0|||
170565439|NCT04756531|616417166|FG014|Overall Study|Adverse Event|0|||
170565440|NCT04756531|616417167|FG015|Overall Study|Adverse Event|0|||
170565441|NCT04756531|616417168|FG016|Overall Study|Adverse Event|0|||
170565442|NCT04756531|616417169|FG017|Overall Study|Adverse Event|0|||
170565443|NCT04756531|616417152|FG000|Overall Study|Withdrawal by Subject|0|||
170565444|NCT04756531|616417153|FG001|Overall Study|Withdrawal by Subject|0|||
170565445|NCT04756531|616417154|FG002|Overall Study|Withdrawal by Subject|0|||
170565446|NCT04756531|616417155|FG003|Overall Study|Withdrawal by Subject|0|||
170565447|NCT04756531|616417156|FG004|Overall Study|Withdrawal by Subject|0|||
170565448|NCT04756531|616417157|FG005|Overall Study|Withdrawal by Subject|0|||
170565449|NCT04756531|616417158|FG006|Overall Study|Withdrawal by Subject|1|||
170565450|NCT04756531|616417159|FG007|Overall Study|Withdrawal by Subject|0|||
170565451|NCT04756531|616417160|FG008|Overall Study|Withdrawal by Subject|0|||
170565452|NCT04756531|616417161|FG009|Overall Study|Withdrawal by Subject|0|||
170565453|NCT04756531|616417162|FG010|Overall Study|Withdrawal by Subject|0|||
170565454|NCT04756531|616417163|FG011|Overall Study|Withdrawal by Subject|0|||
170565455|NCT04756531|616417164|FG012|Overall Study|Withdrawal by Subject|0|||
170565456|NCT04756531|616417165|FG013|Overall Study|Withdrawal by Subject|0|||
170565457|NCT04756531|616417166|FG014|Overall Study|Withdrawal by Subject|0|||
170565458|NCT04756531|616417167|FG015|Overall Study|Withdrawal by Subject|0|||
170565459|NCT04756531|616417168|FG016|Overall Study|Withdrawal by Subject|0|||
170565460|NCT04756531|616417169|FG017|Overall Study|Withdrawal by Subject|0|||
170514896|NCT00802672|616232698|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
170514897|NCT00802672|616232699|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
170514898|NCT00802672|616232700|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
170514899|NCT00802672|616232698|FG000|Overall Study|Adverse Event|1|||
170514900|NCT00802672|616232699|FG001|Overall Study|Adverse Event|1|||
170514901|NCT00802672|616232700|FG002|Overall Study|Adverse Event|1|||
170514902|NCT00802672|616232698|FG000|Overall Study|Protocol Violation|2|||
170514903|NCT00802672|616232699|FG001|Overall Study|Protocol Violation|1|||
170514904|NCT00802672|616232700|FG002|Overall Study|Protocol Violation|1|||
170514905|NCT00802672|616232698|FG000|Overall Study|Lost to Follow-up|5|||
170514906|NCT00802672|616232699|FG001|Overall Study|Lost to Follow-up|5|||
170514907|NCT00802672|616232700|FG002|Overall Study|Lost to Follow-up|3|||
170514908|NCT00802672|616232698|FG000|Overall Study|Withdrawal by Subject|1|||
170514909|NCT00802672|616232699|FG001|Overall Study|Withdrawal by Subject|1|||
170514910|NCT00802672|616232700|FG002|Overall Study|Withdrawal by Subject|2|||
170514911|NCT00802672|616232698|FG000|Overall Study|other|3|||
170514912|NCT00802672|616232699|FG001|Overall Study|other|1|||
170514913|NCT00802672|616232700|FG002|Overall Study|other|2|||
170514914|NCT00703677|616232702|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
170514915|NCT04441788|616232705|FG000|Overall Study|Voluntary Withdrawl|0|||
170514916|NCT04441788|616232706|FG001|Overall Study|Voluntary Withdrawl|1|||
170514917|NCT04441788|616232707|FG002|Overall Study|Voluntary Withdrawl|0|||
170514918|NCT04441788|616232705|FG000|Overall Study|Ineligibility|1|||
170514919|NCT04441788|616232706|FG001|Overall Study|Ineligibility|0|||
170514920|NCT04441788|616232707|FG002|Overall Study|Ineligibility|0|||
170514921|NCT04441788|616232705|FG000|Overall Study|Adverse Event|0|||
170514922|NCT04441788|616232706|FG001|Overall Study|Adverse Event|0|||
170514923|NCT04441788|616232707|FG002|Overall Study|Adverse Event|4|||
170514924|NCT04441788|616232705|FG000|Overall Study|Study Terminated by Sponsor|16|||
170514925|NCT04441788|616232706|FG001|Overall Study|Study Terminated by Sponsor|16|||
170514926|NCT04441788|616232707|FG002|Overall Study|Study Terminated by Sponsor|12|||
170514927|NCT03859648|616232714|FG000|Overall Study|Lost to Follow-up|1|||
170514928|NCT03859648|616232714|FG000|Overall Study|Adverse Event|1|||
170514929|NCT01677182|616232715|FG000|Overall Study|Adverse Event|2|||
170514930|NCT01677182|616232716|FG001|Overall Study|Adverse Event|1|||
170514931|NCT01677182|616232717|FG002|Overall Study|Adverse Event|8|||
170514932|NCT01677182|616232715|FG000|Overall Study|Protocol Violation|5|||
170514933|NCT01677182|616232716|FG001|Overall Study|Protocol Violation|1|||
170514934|NCT01677182|616232717|FG002|Overall Study|Protocol Violation|4|||
170514935|NCT01677182|616232715|FG000|Overall Study|Lost to Follow-up|4|||
170514936|NCT01677182|616232716|FG001|Overall Study|Lost to Follow-up|0|||
170514937|NCT01677182|616232717|FG002|Overall Study|Lost to Follow-up|3|||
170514938|NCT01677182|616232715|FG000|Overall Study|Withdrawal by Subject|7|||
170514939|NCT01677182|616232716|FG001|Overall Study|Withdrawal by Subject|12|||
170514940|NCT01677182|616232717|FG002|Overall Study|Withdrawal by Subject|10|||
170514941|NCT01677182|616232715|FG000|Overall Study|Study termination|12|||
170514942|NCT01677182|616232716|FG001|Overall Study|Study termination|9|||
170514943|NCT01677182|616232717|FG002|Overall Study|Study termination|11|||
170514944|NCT01677182|616232715|FG000|Overall Study|Lack of Efficacy|3|||
170514945|NCT01677182|616232716|FG001|Overall Study|Lack of Efficacy|0|||
170514946|NCT01677182|616232717|FG002|Overall Study|Lack of Efficacy|1|||
170514947|NCT01677182|616232715|FG000|Overall Study|Other reasons|1|||
170514948|NCT01677182|616232716|FG001|Overall Study|Other reasons|5|||
170514949|NCT01677182|616232717|FG002|Overall Study|Other reasons|2|||
170514950|NCT00667992|616232722|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
170514951|NCT00667992|616232723|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
170514952|NCT00667992|616232722|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
170514953|NCT00667992|616232723|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
170514954|NCT00667992|616232722|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
170514955|NCT00667992|616232723|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
170514956|NCT00667992|616232722|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
170514957|NCT00667992|616232723|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
170514958|NCT00667992|616232722|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
170514959|NCT00667992|616232723|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
170514960|NCT00667992|616232722|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
170514961|NCT00667992|616232723|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
170514962|NCT00667992|616232722|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
170514963|NCT00667992|616232723|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
170514964|NCT00667992|616232722|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
170514965|NCT00667992|616232723|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
170514966|NCT00667992|616232722|FG000|Wash-out|Not within one doubling dilution|4|||
170514967|NCT00667992|616232723|FG001|Wash-out|Not within one doubling dilution|3|||
170514968|NCT00667992|616232722|FG000|Wash-out|Failure to wash-out|2|||
170514969|NCT00667992|616232723|FG001|Wash-out|Failure to wash-out|2|||
170514970|NCT00667992|616232722|FG000|Wash-out|Withdrawal by Subject|1|||
170514971|NCT00667992|616232723|FG001|Wash-out|Withdrawal by Subject|0|||
170514972|NCT00667992|616232722|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
170514973|NCT00667992|616232723|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
170514974|NCT00667992|616232722|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
170514975|NCT00667992|616232723|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
170514976|NCT01990573|616232727|FG000|Overall Study|Physician Decision|0|||
170514977|NCT01990573|616232728|FG001|Overall Study|Physician Decision|0|||
170514978|NCT01990573|616232729|FG002|Overall Study|Physician Decision|1|||
170514979|NCT03512353|616232735|FG000|Overall Study|Sponsor Decision|3|||
170514980|NCT03512353|616232735|FG000|Overall Study|Death|1|||
170514981|NCT00493012|616232737|FG000|Overall Study|Lost to Follow-up|18|||
170514982|NCT00493012|616232738|FG001|Overall Study|Lost to Follow-up|17|||
170514983|NCT02915159|616232741|FG000|Overall Study|Participant no longer meets criteria|2|||
170514984|NCT02915159|616232742|FG001|Overall Study|Participant no longer meets criteria|0|||
170514985|NCT02915159|616232741|FG000|Overall Study|poor/non-compliance|1|||
170514986|NCT02915159|616232742|FG001|Overall Study|poor/non-compliance|0|||
170514987|NCT02915159|616232741|FG000|Overall Study|Participant withdrew consent|5|||
170514988|NCT02915159|616232742|FG001|Overall Study|Participant withdrew consent|1|||
170514989|NCT02915159|616232741|FG000|Overall Study|Request to discontinue treatment|1|||
170514990|NCT02915159|616232742|FG001|Overall Study|Request to discontinue treatment|2|||
170514991|NCT02915159|616232741|FG000|Overall Study|Adverse Event|2|||
170514992|NCT02915159|616232742|FG001|Overall Study|Adverse Event|2|||
170514993|NCT02915159|616232741|FG000|Overall Study|Lack of Efficacy|0|||
170514994|NCT02915159|616232742|FG001|Overall Study|Lack of Efficacy|3|||
170514995|NCT04534517|616232743|FG000|Overall Study|Adverse Event|1|||
170514996|NCT04534517|616232743|FG000|Overall Study|Withdrawal by Subject|1|||
170514997|NCT04534517|616232743|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
170514998|NCT04534517|616232743|FG000|Overall Study|COVID-19 Related|1|||
170514999|NCT02121795|616232744|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
170515000|NCT02121795|616232745|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
170515001|NCT02121795|616232744|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
170515002|NCT02121795|616232745|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
170515003|NCT02121795|616232744|FG000|Double-Blind Phase|Lost to Follow-up|7|||
170515004|NCT02121795|616232745|FG001|Double-Blind Phase|Lost to Follow-up|4|||
170515005|NCT02121795|616232744|FG000|Double-Blind Phase|Physician Decision|2|||
170515006|NCT02121795|616232745|FG001|Double-Blind Phase|Physician Decision|5|||
170515007|NCT02121795|616232744|FG000|Double-Blind Phase|Adverse Event|5|||
170515008|NCT02121795|616232745|FG001|Double-Blind Phase|Adverse Event|0|||
170515009|NCT02121795|616232744|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
170515010|NCT02121795|616232745|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
170515011|NCT02121795|616232744|FG000|Double-Blind Phase|Protocol Violation|0|||
170515012|NCT02121795|616232745|FG001|Double-Blind Phase|Protocol Violation|3|||
170515013|NCT02121795|616232744|FG000|Double-Blind Phase|Death|1|||
170515014|NCT02121795|616232745|FG001|Double-Blind Phase|Death|1|||
170515015|NCT02121795|616232744|FG000|Open-Label Phase|Physician Decision|8|||
170515016|NCT02121795|616232745|FG001|Open-Label Phase|Physician Decision|8|||
170515017|NCT02121795|616232744|FG000|Open-Label Phase|Withdrawal by Subject|3|||
170515018|NCT02121795|616232745|FG001|Open-Label Phase|Withdrawal by Subject|2|||
170515019|NCT02121795|616232744|FG000|Open-Label Phase|Lost to Follow-up|1|||
170515020|NCT02121795|616232745|FG001|Open-Label Phase|Lost to Follow-up|0|||
170515021|NCT00281697|616232746|FG000|Overall Study|> 60 days since last dose of study drug|4|||
170515022|NCT00281697|616232747|FG001|Overall Study|> 60 days since last dose of study drug|4|||
170515023|NCT00281697|616232746|FG000|Overall Study|Adverse Event|54|||
170515024|NCT00281697|616232747|FG001|Overall Study|Adverse Event|15|||
170515025|NCT00281697|616232746|FG000|Overall Study|Death|8|||
170744664|NCT02310126|617073217|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
170515026|NCT00281697|616232747|FG001|Overall Study|Death|3|||
170515027|NCT00281697|616232746|FG000|Overall Study|Disease progression|279|||
170515028|NCT00281697|616232747|FG001|Overall Study|Disease progression|149|||
170515029|NCT00281697|616232746|FG000|Overall Study|Other|5|||
170515030|NCT00281697|616232747|FG001|Overall Study|Other|6|||
170515031|NCT00281697|616232746|FG000|Overall Study|Physician's decision to withdraw|15|||
170515032|NCT00281697|616232747|FG001|Overall Study|Physician's decision to withdraw|12|||
170515033|NCT00281697|616232746|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
170515034|NCT00281697|616232747|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
170515035|NCT00281697|616232746|FG000|Overall Study|Did not receive study drug|3|||
170515036|NCT00281697|616232747|FG001|Overall Study|Did not receive study drug|2|||
170515037|NCT00632125|616232748|FG000|Overall Study|Death|82|||
170515038|NCT00632125|616232748|FG000|Overall Study|Withdrawal by Subject|44|||
170515039|NCT00632125|616232748|FG000|Overall Study|Adverse Event|36|||
170515040|NCT00632125|616232748|FG000|Overall Study|Renal transplantation|17|||
170515041|NCT00632125|616232748|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
170515042|NCT00632125|616232748|FG000|Overall Study|Non-compliance|8|||
170515043|NCT00632125|616232748|FG000|Overall Study|Development of uncontrolled hypertension|5|||
170515044|NCT00632125|616232748|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
170515045|NCT01914393|616232749|FG000|Overall Study|Protocol Violation|11|||
170515046|NCT01914393|616232750|FG001|Overall Study|Protocol Violation|3|||
170515047|NCT01914393|616232751|FG002|Overall Study|Protocol Violation|19|||
170515048|NCT01914393|616232749|FG000|Overall Study|Lack of Efficacy|11|||
170515049|NCT01914393|616232750|FG001|Overall Study|Lack of Efficacy|16|||
170515050|NCT01914393|616232751|FG002|Overall Study|Lack of Efficacy|5|||
170515051|NCT01914393|616232749|FG000|Overall Study|no reason given|14|||
170515052|NCT01914393|616232750|FG001|Overall Study|no reason given|8|||
170515053|NCT01914393|616232751|FG002|Overall Study|no reason given|16|||
170515054|NCT01914393|616232749|FG000|Overall Study|Adverse Event|29|||
170515055|NCT01914393|616232750|FG001|Overall Study|Adverse Event|18|||
170515056|NCT01914393|616232751|FG002|Overall Study|Adverse Event|31|||
170515057|NCT01914393|616232749|FG000|Overall Study|Withdrawal by Subject|38|||
170515058|NCT01914393|616232750|FG001|Overall Study|Withdrawal by Subject|20|||
170515059|NCT01914393|616232751|FG002|Overall Study|Withdrawal by Subject|47|||
170515060|NCT01914393|616232749|FG000|Overall Study|Lost to Follow-up|12|||
170515061|NCT01914393|616232750|FG001|Overall Study|Lost to Follow-up|6|||
170515062|NCT01914393|616232751|FG002|Overall Study|Lost to Follow-up|19|||
170515063|NCT01914393|616232749|FG000|Overall Study|subject never dosed|0|||
170515064|NCT01914393|616232750|FG001|Overall Study|subject never dosed|0|||
170515065|NCT01914393|616232751|FG002|Overall Study|subject never dosed|1|||
170515066|NCT00540644|616232757|FG000|Overall Study|Adverse Event|3|||
170515067|NCT00540644|616232758|FG001|Overall Study|Adverse Event|1|||
170515068|NCT00540644|616232757|FG000|Overall Study|Disease Progression|3|||
170515069|NCT00540644|616232758|FG001|Overall Study|Disease Progression|1|||
170515070|NCT00540644|616232757|FG000|Overall Study|Physician Decision|0|||
170515071|NCT00540644|616232758|FG001|Overall Study|Physician Decision|5|||
170515072|NCT00540644|616232757|FG000|Overall Study|Withdrawal by Subject|2|||
170515073|NCT00540644|616232758|FG001|Overall Study|Withdrawal by Subject|2|||
170515074|NCT00540644|616232757|FG000|Overall Study|Noncomplilance|1|||
170515075|NCT00540644|616232758|FG001|Overall Study|Noncomplilance|0|||
170515076|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
170515077|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
170515078|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
170515079|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
170515080|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
170515081|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
170515082|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
170515083|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
170515084|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
170515085|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
170515086|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
170515087|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
170515088|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
170515089|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
170515090|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Death|1|||
170515091|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Death|0|||
170515092|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
170515093|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
170515094|NCT00105989|616232759|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
170515095|NCT00105989|616232760|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
170515096|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
170515097|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
170515098|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
170515099|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
170515100|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
170515101|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
170515102|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
170515103|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
170515104|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
170515105|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
170515106|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
170859888|NCT02409368|617496050|FG000|ECOG Reclassification|Poor/non-compliance|0|||
170859889|NCT02409368|617496051|FG001|ECOG Reclassification|Poor/non-compliance|3|||
170515107|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
170515108|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
170515109|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
170515110|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Death|0|||
170515111|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Death|0|||
170515112|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
170515113|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
170565461|NCT05643495|616417170|FG000|Overall Study|Adverse Event|0|||
170515114|NCT00105989|616232759|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
170515115|NCT00105989|616232760|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
170515116|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
170515117|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
170515118|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
170515119|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
170515120|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
170515121|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
170515122|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
170515123|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
170515124|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
170515125|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
170515126|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
170515127|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
170515128|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
170515129|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
170515130|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
170515131|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
170515132|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
170515133|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
170515134|NCT00105989|616232759|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
170515135|NCT00105989|616232760|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
170515136|NCT00610168|616232761|FG000|Overall Study|Withdrawal by Subject|2|||
170515137|NCT00610168|616232762|FG001|Overall Study|Withdrawal by Subject|0|||
170515138|NCT01716663|616232763|FG000|Overall Study|Withdrawn prior to procedure|4|||
170515139|NCT01716663|616232763|FG000|Overall Study|Treated with non-study catheter|2|||
170515140|NCT01059773|616232764|FG000|Overall Study|Adverse Event|2|||
170515141|NCT01059773|616232765|FG001|Overall Study|Adverse Event|2|||
170515142|NCT01059773|616232764|FG000|Overall Study|Withdrawal by Subject|1|||
170515143|NCT01059773|616232765|FG001|Overall Study|Withdrawal by Subject|5|||
170515144|NCT01059773|616232764|FG000|Overall Study|Lost to Follow-up|1|||
170515145|NCT01059773|616232765|FG001|Overall Study|Lost to Follow-up|1|||
170515146|NCT01059773|616232764|FG000|Overall Study|Pregnancy|1|||
170515147|NCT01059773|616232765|FG001|Overall Study|Pregnancy|1|||
170515148|NCT01059773|616232764|FG000|Overall Study|Protocol Violation|6|||
170515149|NCT01059773|616232765|FG001|Overall Study|Protocol Violation|2|||
170515150|NCT01059773|616232764|FG000|Overall Study|Physician Decision|5|||
170515151|NCT01059773|616232765|FG001|Overall Study|Physician Decision|4|||
170515152|NCT01059773|616232764|FG000|Overall Study|Lack of Efficacy|3|||
170515153|NCT01059773|616232765|FG001|Overall Study|Lack of Efficacy|3|||
170515154|NCT01059773|616232764|FG000|Overall Study|Death|0|||
170515155|NCT01059773|616232765|FG001|Overall Study|Death|1|||
170515156|NCT01059773|616232764|FG000|Overall Study|Malignancy including squamous cell skin|0|||
170515157|NCT01059773|616232765|FG001|Overall Study|Malignancy including squamous cell skin|1|||
170515158|NCT01059773|616232764|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
170515159|NCT01059773|616232765|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
170515160|NCT01059773|616232764|FG000|Overall Study|Other|1|||
170515161|NCT01059773|616232765|FG001|Overall Study|Other|3|||
170515162|NCT02620787|616232766|FG000|Overall Study|Adverse Event|1|||
170515163|NCT02620787|616232767|FG001|Overall Study|Adverse Event|0|||
170515164|NCT02620787|616232766|FG000|Overall Study|Eligibility Criteria Not Met|1|||
170515165|NCT02620787|616232767|FG001|Overall Study|Eligibility Criteria Not Met|0|||
170515166|NCT01151345|616232769|FG000|First Intervention Period|Protocol Violation|0|||
170515167|NCT01151345|616232770|FG001|First Intervention Period|Protocol Violation|1|||
170515168|NCT03853291|616232773|FG000|Overall Study|Lost to Follow-up|1|||
170515169|NCT03853291|616232774|FG001|Overall Study|Lost to Follow-up|2|||
170515170|NCT03853291|616232775|FG002|Overall Study|Lost to Follow-up|0|||
170515171|NCT03853291|616232776|FG003|Overall Study|Lost to Follow-up|0|||
170515172|NCT03853291|616232777|FG004|Overall Study|Lost to Follow-up|0|||
170515173|NCT03853291|616232778|FG005|Overall Study|Lost to Follow-up|0|||
170515174|NCT03853291|616232773|FG000|Overall Study|Determined to be ineligible|1|||
170515175|NCT03853291|616232774|FG001|Overall Study|Determined to be ineligible|1|||
170515176|NCT03853291|616232775|FG002|Overall Study|Determined to be ineligible|0|||
170515177|NCT03853291|616232776|FG003|Overall Study|Determined to be ineligible|0|||
170515178|NCT03853291|616232777|FG004|Overall Study|Determined to be ineligible|0|||
170515179|NCT03853291|616232778|FG005|Overall Study|Determined to be ineligible|0|||
170515180|NCT03883477|616232779|FG000|Overall Study|Death|1|||
170515181|NCT03883477|616232780|FG001|Overall Study|Death|0|||
170515182|NCT03883477|616232779|FG000|Overall Study|Protocol Violation|0|||
170515183|NCT03883477|616232780|FG001|Overall Study|Protocol Violation|1|||
170515184|NCT04186221|616232782|FG000|Overall Study|Death|1|||
170515185|NCT01904032|616232783|FG000|Overall Study|Adverse Event|3|||
170515186|NCT01904032|616232784|FG001|Overall Study|Adverse Event|1|||
170515187|NCT01904032|616232783|FG000|Overall Study|Lost to Follow-up|4|||
170515188|NCT01904032|616232784|FG001|Overall Study|Lost to Follow-up|2|||
170515189|NCT01658904|616232785|FG000|Overall Study|Principal Investigator discretion|2|||
170515190|NCT01658904|616232786|FG001|Overall Study|Principal Investigator discretion|0|||
170515191|NCT01658904|616232787|FG002|Overall Study|Principal Investigator discretion|0|||
170515192|NCT02998996|616232792|FG000|Overall Study|Lost to Follow-up|0|||
170515193|NCT02998996|616232793|FG001|Overall Study|Lost to Follow-up|0|||
170515194|NCT02998996|616232794|FG002|Overall Study|Lost to Follow-up|1|||
170515195|NCT02998996|616232795|FG003|Overall Study|Lost to Follow-up|0|||
170515196|NCT02998996|616232796|FG004|Overall Study|Lost to Follow-up|0|||
170515197|NCT02998996|616232797|FG005|Overall Study|Lost to Follow-up|0|||
170515198|NCT02998996|616232792|FG000|Overall Study|Pregnancy|0|||
170515199|NCT02998996|616232793|FG001|Overall Study|Pregnancy|1|||
170515200|NCT02998996|616232794|FG002|Overall Study|Pregnancy|0|||
170515201|NCT02998996|616232795|FG003|Overall Study|Pregnancy|0|||
170515202|NCT02998996|616232796|FG004|Overall Study|Pregnancy|0|||
170515203|NCT02998996|616232797|FG005|Overall Study|Pregnancy|0|||
170515204|NCT02998996|616232792|FG000|Overall Study|Family reasons|0|||
170515205|NCT02998996|616232793|FG001|Overall Study|Family reasons|0|||
170515206|NCT02998996|616232794|FG002|Overall Study|Family reasons|0|||
170515207|NCT02998996|616232795|FG003|Overall Study|Family reasons|0|||
170515208|NCT02998996|616232796|FG004|Overall Study|Family reasons|1|||
170515209|NCT02998996|616232797|FG005|Overall Study|Family reasons|0|||
170515210|NCT01398358|616232802|FG000|Overall Study|Lost to Follow-up|11|||
170515211|NCT01398358|616232803|FG001|Overall Study|Lost to Follow-up|21|||
170515212|NCT01398358|616232804|FG002|Overall Study|Lost to Follow-up|18|||
170515213|NCT01398358|616232802|FG000|Overall Study|Withdrawal by Subject|3|||
170515214|NCT01398358|616232803|FG001|Overall Study|Withdrawal by Subject|2|||
170515215|NCT01398358|616232804|FG002|Overall Study|Withdrawal by Subject|2|||
170515216|NCT01398358|616232802|FG000|Overall Study|no longer eligible|1|||
170515217|NCT01398358|616232803|FG001|Overall Study|no longer eligible|0|||
170515218|NCT01398358|616232804|FG002|Overall Study|no longer eligible|1|||
170515219|NCT00003896|616232805|FG000|Overall Study|Adverse Event|16|||
170515220|NCT00003896|616232805|FG000|Overall Study|Withdrawal by Subject|1|||
170515221|NCT00003896|616232805|FG000|Overall Study|Lack of Efficacy|1|||
170515222|NCT00003896|616232805|FG000|Overall Study|Death|3|||
170515223|NCT00003896|616232805|FG000|Overall Study|not protocol specified|3|||
170515224|NCT00003896|616232805|FG000|Overall Study|ineligible|5|||
170515225|NCT01087203|616232808|FG000|Overall Study|Lost to Follow-up|2|||
170515226|NCT01087203|616232809|FG001|Overall Study|Lost to Follow-up|0|||
170515227|NCT01087203|616232808|FG000|Overall Study|Withdrawal by Subject|2|||
170515228|NCT01087203|616232809|FG001|Overall Study|Withdrawal by Subject|6|||
170515229|NCT01087203|616232808|FG000|Overall Study|Lack of Efficacy|1|||
170515230|NCT01087203|616232809|FG001|Overall Study|Lack of Efficacy|2|||
170515231|NCT01087203|616232808|FG000|Overall Study|Study terminated by sponsor|27|||
170515232|NCT01087203|616232809|FG001|Overall Study|Study terminated by sponsor|27|||
170515233|NCT02559570|616232812|FG000|Overall Study|Adverse Event|0|||
170515234|NCT02559570|616232813|FG001|Overall Study|Adverse Event|2|||
170515235|NCT02559570|616232814|FG002|Overall Study|Adverse Event|0|||
170515236|NCT02559570|616232815|FG003|Overall Study|Adverse Event|1|||
170515237|NCT02559570|616232816|FG004|Overall Study|Adverse Event|0|||
170515238|NCT02559570|616232812|FG000|Overall Study|Withdrawal of Consent|0|||
170515239|NCT02559570|616232813|FG001|Overall Study|Withdrawal of Consent|0|||
170515240|NCT02559570|616232814|FG002|Overall Study|Withdrawal of Consent|1|||
170515241|NCT02559570|616232815|FG003|Overall Study|Withdrawal of Consent|2|||
170515242|NCT02559570|616232816|FG004|Overall Study|Withdrawal of Consent|1|||
170515243|NCT02559570|616232812|FG000|Overall Study|Lost to Follow-up|1|||
170515244|NCT02559570|616232813|FG001|Overall Study|Lost to Follow-up|0|||
170515245|NCT02559570|616232814|FG002|Overall Study|Lost to Follow-up|0|||
170515246|NCT02559570|616232815|FG003|Overall Study|Lost to Follow-up|0|||
170515247|NCT02559570|616232816|FG004|Overall Study|Lost to Follow-up|0|||
170515248|NCT02559570|616232812|FG000|Overall Study|Protocol Violation|1|||
170515249|NCT02559570|616232813|FG001|Overall Study|Protocol Violation|0|||
170515250|NCT02559570|616232814|FG002|Overall Study|Protocol Violation|0|||
170515251|NCT02559570|616232815|FG003|Overall Study|Protocol Violation|0|||
170515252|NCT02559570|616232816|FG004|Overall Study|Protocol Violation|1|||
170515253|NCT02559570|616232812|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170515254|NCT02559570|616232813|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170515255|NCT02559570|616232814|FG002|Overall Study|Other Miscellaneous Reasons|1|||
170515256|NCT02559570|616232815|FG003|Overall Study|Other Miscellaneous Reasons|0|||
170515257|NCT02559570|616232816|FG004|Overall Study|Other Miscellaneous Reasons|0|||
170515258|NCT00829829|616232830|FG000|Overall Study|Protocol Violation|0|||
170515259|NCT00829829|616232831|FG001|Overall Study|Protocol Violation|3|||
170515260|NCT00829829|616232832|FG002|Overall Study|Protocol Violation|0|||
170515261|NCT00829829|616232830|FG000|Overall Study|Adverse Event|4|||
170515262|NCT00829829|616232831|FG001|Overall Study|Adverse Event|4|||
170515263|NCT00829829|616232832|FG002|Overall Study|Adverse Event|3|||
170515264|NCT00829829|616232830|FG000|Overall Study|Withdrawal by Subject|8|||
170515265|NCT00829829|616232831|FG001|Overall Study|Withdrawal by Subject|4|||
170515266|NCT00829829|616232832|FG002|Overall Study|Withdrawal by Subject|2|||
170515267|NCT00829829|616232830|FG000|Overall Study|Decision by the Sponsor|1|||
170515268|NCT00829829|616232831|FG001|Overall Study|Decision by the Sponsor|0|||
170515269|NCT00829829|616232832|FG002|Overall Study|Decision by the Sponsor|2|||
170515270|NCT00829829|616232830|FG000|Overall Study|Lost to Follow-up|7|||
170515271|NCT00829829|616232831|FG001|Overall Study|Lost to Follow-up|3|||
170515272|NCT00829829|616232832|FG002|Overall Study|Lost to Follow-up|3|||
170515273|NCT00829829|616232830|FG000|Overall Study|Other than specified above|2|||
170515274|NCT00829829|616232831|FG001|Overall Study|Other than specified above|2|||
170515275|NCT00829829|616232832|FG002|Overall Study|Other than specified above|1|||
170515276|NCT02685072|616232833|FG000|Treatment Period|Lost to Follow-up|12|||
170515277|NCT02685072|616232834|FG001|Treatment Period|Lost to Follow-up|6|||
170515278|NCT02685072|616232833|FG000|Treatment Period|Withdrawal by Subject|1|||
170515279|NCT02685072|616232834|FG001|Treatment Period|Withdrawal by Subject|3|||
170515280|NCT02685072|616232833|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
170515281|NCT02685072|616232834|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
170515282|NCT05052697|616232835|FG000|Substudy A|Lost to Follow-up|0|||
170515283|NCT05052697|616232836|FG001|Substudy A|Lost to Follow-up|0|||
170515284|NCT05052697|616232837|FG002|Substudy A|Lost to Follow-up|0|||
170515285|NCT05052697|616232838|FG003|Substudy A|Lost to Follow-up|0|||
170515286|NCT05052697|616232839|FG004|Substudy A|Lost to Follow-up|0|||
170515287|NCT05052697|616232840|FG005|Substudy A|Lost to Follow-up|1|||
170515288|NCT05052697|616232841|FG006|Substudy A|Lost to Follow-up|0|||
170515289|NCT05052697|616232842|FG007|Substudy A|Lost to Follow-up|0|||
170515290|NCT05052697|616232843|FG008|Substudy A|Lost to Follow-up|0|||
170515291|NCT05052697|616232844|FG009|Substudy A|Lost to Follow-up|0|||
170515292|NCT05052697|616232845|FG010|Substudy A|Lost to Follow-up|0|||
170515293|NCT05052697|616232846|FG011|Substudy A|Lost to Follow-up|0|||
170515294|NCT05052697|616232847|FG012|Substudy A|Lost to Follow-up|0|||
170515295|NCT05052697|616232848|FG013|Substudy A|Lost to Follow-up|0|||
170515296|NCT05052697|616232849|FG014|Substudy A|Lost to Follow-up|0|||
170515297|NCT05052697|616232850|FG015|Substudy A|Lost to Follow-up|2|||
170515298|NCT05052697|616232851|FG016|Substudy A|Lost to Follow-up|0|||
170515299|NCT05052697|616232852|FG017|Substudy A|Lost to Follow-up|0|||
170515300|NCT05052697|616232853|FG018|Substudy A|Lost to Follow-up|0|||
170515301|NCT05052697|616232854|FG019|Substudy A|Lost to Follow-up|0|||
170515302|NCT05052697|616232855|FG020|Substudy A|Lost to Follow-up|0|||
170515303|NCT05052697|616232856|FG021|Substudy A|Lost to Follow-up|0|||
170515304|NCT05052697|616232857|FG022|Substudy A|Lost to Follow-up|0|||
170515305|NCT05052697|616232858|FG023|Substudy A|Lost to Follow-up|0|||
170515306|NCT05052697|616232859|FG024|Substudy A|Lost to Follow-up|0|||
170515307|NCT05052697|616232860|FG025|Substudy A|Lost to Follow-up|0|||
170515308|NCT05052697|616232861|FG026|Substudy A|Lost to Follow-up|0|||
170515309|NCT05052697|616232862|FG027|Substudy A|Lost to Follow-up|0|||
170515310|NCT05052697|616232863|FG028|Substudy A|Lost to Follow-up|0|||
170515311|NCT05052697|616232864|FG029|Substudy A|Lost to Follow-up|0|||
170515312|NCT05052697|616232865|FG030|Substudy A|Lost to Follow-up|0|||
170515313|NCT05052697|616232866|FG031|Substudy A|Lost to Follow-up|0|||
170515314|NCT05052697|616232867|FG032|Substudy A|Lost to Follow-up|0|||
170515315|NCT05052697|616232868|FG033|Substudy A|Lost to Follow-up|0|||
170515316|NCT05052697|616232835|FG000|Substudy A|No longer met eligibility criteria|0|||
170515317|NCT05052697|616232836|FG001|Substudy A|No longer met eligibility criteria|0|||
170515318|NCT05052697|616232837|FG002|Substudy A|No longer met eligibility criteria|0|||
170515319|NCT05052697|616232838|FG003|Substudy A|No longer met eligibility criteria|0|||
170515320|NCT05052697|616232839|FG004|Substudy A|No longer met eligibility criteria|0|||
170515321|NCT05052697|616232840|FG005|Substudy A|No longer met eligibility criteria|0|||
170515322|NCT05052697|616232841|FG006|Substudy A|No longer met eligibility criteria|0|||
170515323|NCT05052697|616232842|FG007|Substudy A|No longer met eligibility criteria|0|||
170515324|NCT05052697|616232843|FG008|Substudy A|No longer met eligibility criteria|0|||
170515325|NCT05052697|616232844|FG009|Substudy A|No longer met eligibility criteria|0|||
170515326|NCT05052697|616232845|FG010|Substudy A|No longer met eligibility criteria|0|||
170515327|NCT05052697|616232846|FG011|Substudy A|No longer met eligibility criteria|0|||
170515328|NCT05052697|616232847|FG012|Substudy A|No longer met eligibility criteria|0|||
170515329|NCT05052697|616232848|FG013|Substudy A|No longer met eligibility criteria|1|||
170515330|NCT05052697|616232849|FG014|Substudy A|No longer met eligibility criteria|0|||
170515331|NCT05052697|616232850|FG015|Substudy A|No longer met eligibility criteria|0|||
170515332|NCT05052697|616232851|FG016|Substudy A|No longer met eligibility criteria|0|||
170515333|NCT05052697|616232852|FG017|Substudy A|No longer met eligibility criteria|0|||
170515334|NCT05052697|616232853|FG018|Substudy A|No longer met eligibility criteria|0|||
170515335|NCT05052697|616232854|FG019|Substudy A|No longer met eligibility criteria|0|||
170515336|NCT05052697|616232855|FG020|Substudy A|No longer met eligibility criteria|0|||
170515337|NCT05052697|616232856|FG021|Substudy A|No longer met eligibility criteria|0|||
170515338|NCT05052697|616232857|FG022|Substudy A|No longer met eligibility criteria|0|||
170515339|NCT05052697|616232858|FG023|Substudy A|No longer met eligibility criteria|0|||
170515340|NCT05052697|616232859|FG024|Substudy A|No longer met eligibility criteria|0|||
170515341|NCT05052697|616232860|FG025|Substudy A|No longer met eligibility criteria|0|||
170515342|NCT05052697|616232861|FG026|Substudy A|No longer met eligibility criteria|0|||
170515343|NCT05052697|616232862|FG027|Substudy A|No longer met eligibility criteria|0|||
170515344|NCT05052697|616232863|FG028|Substudy A|No longer met eligibility criteria|0|||
170515345|NCT05052697|616232864|FG029|Substudy A|No longer met eligibility criteria|0|||
170515346|NCT05052697|616232865|FG030|Substudy A|No longer met eligibility criteria|0|||
170515347|NCT05052697|616232866|FG031|Substudy A|No longer met eligibility criteria|0|||
170515348|NCT05052697|616232867|FG032|Substudy A|No longer met eligibility criteria|0|||
170515349|NCT05052697|616232868|FG033|Substudy A|No longer met eligibility criteria|0|||
170515350|NCT05052697|616232835|FG000|Substudy A|Not vaccinated|0|||
170515351|NCT05052697|616232836|FG001|Substudy A|Not vaccinated|0|||
170515352|NCT05052697|616232837|FG002|Substudy A|Not vaccinated|0|||
170515353|NCT05052697|616232838|FG003|Substudy A|Not vaccinated|1|||
170515354|NCT05052697|616232839|FG004|Substudy A|Not vaccinated|0|||
170515355|NCT05052697|616232840|FG005|Substudy A|Not vaccinated|0|||
170515356|NCT05052697|616232841|FG006|Substudy A|Not vaccinated|0|||
170515357|NCT05052697|616232842|FG007|Substudy A|Not vaccinated|0|||
170515358|NCT05052697|616232843|FG008|Substudy A|Not vaccinated|1|||
170515359|NCT05052697|616232844|FG009|Substudy A|Not vaccinated|0|||
170515360|NCT05052697|616232845|FG010|Substudy A|Not vaccinated|0|||
170515361|NCT05052697|616232846|FG011|Substudy A|Not vaccinated|0|||
170515362|NCT05052697|616232847|FG012|Substudy A|Not vaccinated|0|||
170515363|NCT05052697|616232848|FG013|Substudy A|Not vaccinated|0|||
170859890|NCT02409368|617496052|FG002|ECOG Reclassification|Poor/non-compliance|2|||
170515364|NCT05052697|616232849|FG014|Substudy A|Not vaccinated|0|||
170515365|NCT05052697|616232850|FG015|Substudy A|Not vaccinated|0|||
170515366|NCT05052697|616232851|FG016|Substudy A|Not vaccinated|0|||
170515367|NCT05052697|616232852|FG017|Substudy A|Not vaccinated|0|||
170515368|NCT05052697|616232853|FG018|Substudy A|Not vaccinated|0|||
170515369|NCT05052697|616232854|FG019|Substudy A|Not vaccinated|0|||
170515370|NCT05052697|616232855|FG020|Substudy A|Not vaccinated|0|||
170515371|NCT05052697|616232856|FG021|Substudy A|Not vaccinated|0|||
170515372|NCT05052697|616232857|FG022|Substudy A|Not vaccinated|0|||
170515373|NCT05052697|616232858|FG023|Substudy A|Not vaccinated|0|||
170515374|NCT05052697|616232859|FG024|Substudy A|Not vaccinated|0|||
170515375|NCT05052697|616232860|FG025|Substudy A|Not vaccinated|0|||
170515376|NCT05052697|616232861|FG026|Substudy A|Not vaccinated|0|||
170515377|NCT05052697|616232862|FG027|Substudy A|Not vaccinated|0|||
170515378|NCT05052697|616232863|FG028|Substudy A|Not vaccinated|0|||
170515379|NCT05052697|616232864|FG029|Substudy A|Not vaccinated|0|||
170515380|NCT05052697|616232865|FG030|Substudy A|Not vaccinated|0|||
170515381|NCT05052697|616232866|FG031|Substudy A|Not vaccinated|0|||
170515382|NCT05052697|616232867|FG032|Substudy A|Not vaccinated|0|||
170515383|NCT05052697|616232868|FG033|Substudy A|Not vaccinated|0|||
170515384|NCT05052697|616232835|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515385|NCT05052697|616232836|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515386|NCT05052697|616232837|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515387|NCT05052697|616232838|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515388|NCT05052697|616232839|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515389|NCT05052697|616232840|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515390|NCT05052697|616232841|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515391|NCT05052697|616232842|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515392|NCT05052697|616232843|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515393|NCT05052697|616232844|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515394|NCT05052697|616232845|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515395|NCT05052697|616232846|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515396|NCT05052697|616232847|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515397|NCT05052697|616232848|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515398|NCT05052697|616232849|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515399|NCT05052697|616232850|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515400|NCT05052697|616232851|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515401|NCT05052697|616232852|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515402|NCT05052697|616232853|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
170515403|NCT05052697|616232854|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
170515404|NCT05052697|616232855|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515405|NCT05052697|616232856|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
170515406|NCT05052697|616232857|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
170515407|NCT05052697|616232858|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515408|NCT05052697|616232859|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515409|NCT05052697|616232860|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515410|NCT05052697|616232861|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515411|NCT05052697|616232862|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515412|NCT05052697|616232863|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515413|NCT05052697|616232864|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515414|NCT05052697|616232865|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515415|NCT05052697|616232866|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515416|NCT05052697|616232867|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515417|NCT05052697|616232868|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
170515418|NCT05052697|616232835|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515419|NCT05052697|616232836|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515420|NCT05052697|616232837|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515421|NCT05052697|616232838|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515422|NCT05052697|616232839|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515423|NCT05052697|616232840|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515424|NCT05052697|616232841|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515425|NCT05052697|616232842|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515426|NCT05052697|616232843|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515427|NCT05052697|616232844|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515428|NCT05052697|616232845|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515429|NCT05052697|616232846|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515430|NCT05052697|616232847|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515431|NCT05052697|616232848|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515432|NCT05052697|616232849|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515433|NCT05052697|616232850|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515434|NCT05052697|616232851|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515435|NCT05052697|616232852|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
170515436|NCT05052697|616232853|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515437|NCT05052697|616232854|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515438|NCT05052697|616232855|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515439|NCT05052697|616232856|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515440|NCT05052697|616232857|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515441|NCT05052697|616232858|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515442|NCT05052697|616232859|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515443|NCT05052697|616232860|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515444|NCT05052697|616232861|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515445|NCT05052697|616232862|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515446|NCT05052697|616232863|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515447|NCT05052697|616232864|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515448|NCT05052697|616232865|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515449|NCT05052697|616232866|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515450|NCT05052697|616232867|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515451|NCT05052697|616232868|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
170515452|NCT05052697|616232835|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515453|NCT05052697|616232836|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515454|NCT05052697|616232837|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515455|NCT05052697|616232838|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515456|NCT05052697|616232839|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515457|NCT05052697|616232840|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515458|NCT05052697|616232841|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515459|NCT05052697|616232842|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515460|NCT05052697|616232843|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515461|NCT05052697|616232844|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515462|NCT05052697|616232845|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515463|NCT05052697|616232846|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515464|NCT05052697|616232847|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515465|NCT05052697|616232848|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515466|NCT05052697|616232849|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515467|NCT05052697|616232850|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515468|NCT05052697|616232851|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515469|NCT05052697|616232852|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515470|NCT05052697|616232853|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515471|NCT05052697|616232854|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
170515472|NCT05052697|616232855|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515473|NCT05052697|616232856|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515474|NCT05052697|616232857|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515475|NCT05052697|616232858|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515476|NCT05052697|616232859|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515477|NCT05052697|616232860|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515478|NCT05052697|616232861|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515479|NCT05052697|616232862|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515480|NCT05052697|616232863|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515481|NCT05052697|616232864|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515482|NCT05052697|616232865|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515483|NCT05052697|616232866|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515484|NCT05052697|616232867|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515485|NCT05052697|616232868|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
170515486|NCT05052697|616232835|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515487|NCT05052697|616232836|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515488|NCT05052697|616232837|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515489|NCT05052697|616232838|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515490|NCT05052697|616232839|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515491|NCT05052697|616232840|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515492|NCT05052697|616232841|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515493|NCT05052697|616232842|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515494|NCT05052697|616232843|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515495|NCT05052697|616232844|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515496|NCT05052697|616232845|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515497|NCT05052697|616232846|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515498|NCT05052697|616232847|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515499|NCT05052697|616232848|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515500|NCT05052697|616232849|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515501|NCT05052697|616232850|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515502|NCT05052697|616232851|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515503|NCT05052697|616232852|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
170515504|NCT05052697|616232853|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515505|NCT05052697|616232854|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515506|NCT05052697|616232855|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515507|NCT05052697|616232856|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515508|NCT05052697|616232857|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515509|NCT05052697|616232858|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170630080|NCT00554216|616660390|FG000|Overall Study|Lost to Follow-up|92|||
170630081|NCT00554216|616660391|FG001|Overall Study|Lost to Follow-up|31|||
170630082|NCT00554216|616660392|FG002|Overall Study|Lost to Follow-up|63|||
170630083|NCT00554216|616660390|FG000|Overall Study|Adverse Event|16|||
170630084|NCT00554216|616660391|FG001|Overall Study|Adverse Event|16|||
170630085|NCT00554216|616660392|FG002|Overall Study|Adverse Event|36|||
170630086|NCT00554216|616660390|FG000|Overall Study|Withdrawal by Subject|92|||
170630087|NCT00554216|616660391|FG001|Overall Study|Withdrawal by Subject|31|||
170630088|NCT00554216|616660392|FG002|Overall Study|Withdrawal by Subject|43|||
170630089|NCT00554216|616660390|FG000|Overall Study|Non compliance|10|||
170630090|NCT00554216|616660391|FG001|Overall Study|Non compliance|4|||
170630091|NCT00554216|616660392|FG002|Overall Study|Non compliance|5|||
170630092|NCT00554216|616660390|FG000|Overall Study|Pregnancy|2|||
170630093|NCT00554216|616660391|FG001|Overall Study|Pregnancy|1|||
170630094|NCT00554216|616660392|FG002|Overall Study|Pregnancy|14|||
170630095|NCT00554216|616660390|FG000|Overall Study|Restricted med|3|||
170630096|NCT00554216|616660391|FG001|Overall Study|Restricted med|1|||
170630097|NCT00554216|616660392|FG002|Overall Study|Restricted med|1|||
170630098|NCT00554216|616660390|FG000|Overall Study|Other|12|||
170630099|NCT00554216|616660391|FG001|Overall Study|Other|7|||
170630100|NCT00554216|616660392|FG002|Overall Study|Other|10|||
170630101|NCT00554216|616660390|FG000|Overall Study|Lack of Efficacy|15|||
170630102|NCT00554216|616660391|FG001|Overall Study|Lack of Efficacy|3|||
170630103|NCT00554216|616660392|FG002|Overall Study|Lack of Efficacy|0|||
170630104|NCT05291520|616660393|FG000|Overall Study|Lost to Follow-up|0|||
170630105|NCT05291520|616660394|FG001|Overall Study|Lost to Follow-up|0|||
170630106|NCT05291520|616660395|FG002|Overall Study|Lost to Follow-up|1|||
170630107|NCT01347112|616660396|FG000|Overall Study|Withdrawal by Subject|1|||
170630108|NCT01347112|616660397|FG001|Overall Study|Withdrawal by Subject|7|||
170630109|NCT01347112|616660396|FG000|Overall Study|Lost to Follow-up|3|||
170630110|NCT01347112|616660397|FG001|Overall Study|Lost to Follow-up|5|||
170630111|NCT00463567|616660404|FG000|Overall Study|Adverse Event|29|||
170630112|NCT00463567|616660405|FG001|Overall Study|Adverse Event|26|||
170630113|NCT00463567|616660406|FG002|Overall Study|Adverse Event|17|||
170630114|NCT00463567|616660407|FG003|Overall Study|Adverse Event|46|||
170630115|NCT00463567|616660408|FG004|Overall Study|Adverse Event|10|||
170630116|NCT00463567|616660409|FG005|Overall Study|Adverse Event|10|||
170630117|NCT00463567|616660410|FG006|Overall Study|Adverse Event|4|||
170630118|NCT00463567|616660404|FG000|Overall Study|Withdrawal by Subject|29|||
170630119|NCT00463567|616660405|FG001|Overall Study|Withdrawal by Subject|22|||
170630120|NCT00463567|616660406|FG002|Overall Study|Withdrawal by Subject|20|||
170630121|NCT00463567|616660407|FG003|Overall Study|Withdrawal by Subject|37|||
170630122|NCT00463567|616660408|FG004|Overall Study|Withdrawal by Subject|6|||
170630123|NCT00463567|616660409|FG005|Overall Study|Withdrawal by Subject|5|||
170630124|NCT00463567|616660410|FG006|Overall Study|Withdrawal by Subject|1|||
170630125|NCT00463567|616660404|FG000|Overall Study|Protocol Deviation|13|||
170630126|NCT00463567|616660405|FG001|Overall Study|Protocol Deviation|9|||
170630127|NCT00463567|616660406|FG002|Overall Study|Protocol Deviation|14|||
170630128|NCT00463567|616660407|FG003|Overall Study|Protocol Deviation|11|||
170630129|NCT00463567|616660408|FG004|Overall Study|Protocol Deviation|1|||
170630130|NCT00463567|616660409|FG005|Overall Study|Protocol Deviation|1|||
170630131|NCT00463567|616660410|FG006|Overall Study|Protocol Deviation|2|||
170630132|NCT00463567|616660404|FG000|Overall Study|Lost to Follow-up|12|||
170630133|NCT00463567|616660405|FG001|Overall Study|Lost to Follow-up|6|||
170515510|NCT05052697|616232859|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515511|NCT05052697|616232860|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
170515512|NCT05052697|616232861|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515513|NCT05052697|616232862|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
170515514|NCT05052697|616232863|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515515|NCT05052697|616232864|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515516|NCT05052697|616232865|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515517|NCT05052697|616232866|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515518|NCT05052697|616232867|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515519|NCT05052697|616232868|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
170515520|NCT05052697|616232835|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515521|NCT05052697|616232836|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515522|NCT05052697|616232837|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515523|NCT05052697|616232838|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515524|NCT05052697|616232839|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515525|NCT05052697|616232840|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515526|NCT05052697|616232841|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515527|NCT05052697|616232842|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515528|NCT05052697|616232843|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515529|NCT05052697|616232844|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515530|NCT05052697|616232845|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515531|NCT05052697|616232846|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515532|NCT05052697|616232847|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515533|NCT05052697|616232848|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515534|NCT05052697|616232849|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515535|NCT05052697|616232850|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515536|NCT05052697|616232851|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515537|NCT05052697|616232852|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515538|NCT05052697|616232853|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515539|NCT05052697|616232854|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515540|NCT05052697|616232855|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515541|NCT05052697|616232856|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515542|NCT05052697|616232857|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515543|NCT05052697|616232858|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515544|NCT05052697|616232859|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515545|NCT05052697|616232860|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515546|NCT05052697|616232861|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515547|NCT05052697|616232862|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515548|NCT05052697|616232863|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
170515549|NCT05052697|616232864|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515550|NCT05052697|616232865|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
170515551|NCT05052697|616232866|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
170515552|NCT05052697|616232867|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
170515553|NCT05052697|616232868|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
170515554|NCT05052697|616232835|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515555|NCT05052697|616232836|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515556|NCT05052697|616232837|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515557|NCT05052697|616232838|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515558|NCT05052697|616232839|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515559|NCT05052697|616232840|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515560|NCT05052697|616232841|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515561|NCT05052697|616232842|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515562|NCT05052697|616232843|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515563|NCT05052697|616232844|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515564|NCT05052697|616232845|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515565|NCT05052697|616232846|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515566|NCT05052697|616232847|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515567|NCT05052697|616232848|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515568|NCT05052697|616232849|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515569|NCT05052697|616232850|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515570|NCT05052697|616232851|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515571|NCT05052697|616232852|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515572|NCT05052697|616232853|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515573|NCT05052697|616232854|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515574|NCT05052697|616232855|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515575|NCT05052697|616232856|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170565462|NCT05643495|616417171|FG001|Overall Study|Adverse Event|1|||
170859891|NCT02409368|617496053|FG003|ECOG Reclassification|Poor/non-compliance|0|||
170515576|NCT05052697|616232857|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515577|NCT05052697|616232858|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515578|NCT05052697|616232859|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515579|NCT05052697|616232860|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515580|NCT05052697|616232861|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515581|NCT05052697|616232862|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515582|NCT05052697|616232863|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
170515583|NCT05052697|616232864|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
170515584|NCT05052697|616232865|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
170515585|NCT05052697|616232866|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
170515586|NCT05052697|616232867|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
170515587|NCT05052697|616232868|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
170515588|NCT05052697|616232835|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515589|NCT05052697|616232836|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515590|NCT05052697|616232837|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515591|NCT05052697|616232838|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515592|NCT05052697|616232839|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515593|NCT05052697|616232840|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515594|NCT05052697|616232841|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515595|NCT05052697|616232842|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515596|NCT05052697|616232843|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515597|NCT05052697|616232844|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515598|NCT05052697|616232845|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515599|NCT05052697|616232846|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515600|NCT05052697|616232847|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515601|NCT05052697|616232848|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515602|NCT05052697|616232849|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515603|NCT05052697|616232850|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515604|NCT05052697|616232851|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515605|NCT05052697|616232852|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515606|NCT05052697|616232853|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515607|NCT05052697|616232854|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515608|NCT05052697|616232855|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515609|NCT05052697|616232856|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515610|NCT05052697|616232857|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515611|NCT05052697|616232858|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515612|NCT05052697|616232859|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515613|NCT05052697|616232860|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515614|NCT05052697|616232861|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515615|NCT05052697|616232862|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515616|NCT05052697|616232863|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515617|NCT05052697|616232864|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515618|NCT05052697|616232865|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515619|NCT05052697|616232866|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515620|NCT05052697|616232867|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
170515621|NCT05052697|616232868|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
170515622|NCT05052697|616232835|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515623|NCT05052697|616232836|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515624|NCT05052697|616232837|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515625|NCT05052697|616232838|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515626|NCT05052697|616232839|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515627|NCT05052697|616232840|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515628|NCT05052697|616232841|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515629|NCT05052697|616232842|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515630|NCT05052697|616232843|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515631|NCT05052697|616232844|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515632|NCT05052697|616232845|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515633|NCT05052697|616232846|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515634|NCT05052697|616232847|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515635|NCT05052697|616232848|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515636|NCT05052697|616232849|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515637|NCT05052697|616232850|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515638|NCT05052697|616232851|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515639|NCT05052697|616232852|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515640|NCT05052697|616232853|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515641|NCT05052697|616232854|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515642|NCT05052697|616232855|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515643|NCT05052697|616232856|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515644|NCT05052697|616232857|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515645|NCT05052697|616232858|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515646|NCT05052697|616232859|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515647|NCT05052697|616232860|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515648|NCT05052697|616232861|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515649|NCT05052697|616232862|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515650|NCT05052697|616232863|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
170515651|NCT05052697|616232864|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
170515652|NCT05052697|616232865|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
170515653|NCT05052697|616232866|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515654|NCT05052697|616232867|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170515655|NCT05052697|616232868|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
170744665|NCT02310126|617073218|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
170859892|NCT02409368|617496050|FG000|ECOG Reclassification|Study drug toxicity|17|||
170859893|NCT02409368|617496051|FG001|ECOG Reclassification|Study drug toxicity|42|||
170859894|NCT02409368|617496052|FG002|ECOG Reclassification|Study drug toxicity|7|||
170859895|NCT02409368|617496053|FG003|ECOG Reclassification|Study drug toxicity|0|||
170859896|NCT02409368|617496050|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
170859897|NCT02409368|617496051|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
170859898|NCT02409368|617496052|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
170859899|NCT02409368|617496053|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
170859900|NCT02409368|617496050|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
170859901|NCT02409368|617496051|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
170859902|NCT02409368|617496052|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
170859903|NCT02409368|617496053|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
170859904|NCT02409368|617496050|FG000|ECOG Reclassification|Participant withdrew consent|2|||
170859905|NCT02409368|617496051|FG001|ECOG Reclassification|Participant withdrew consent|3|||
170859906|NCT02409368|617496052|FG002|ECOG Reclassification|Participant withdrew consent|4|||
170859907|NCT02409368|617496053|FG003|ECOG Reclassification|Participant withdrew consent|0|||
170859908|NCT02409368|617496050|FG000|ECOG Reclassification|Other Reasons|5|||
170859909|NCT02409368|617496051|FG001|ECOG Reclassification|Other Reasons|26|||
170859910|NCT02409368|617496052|FG002|ECOG Reclassification|Other Reasons|2|||
170859911|NCT02409368|617496053|FG003|ECOG Reclassification|Other Reasons|0|||
170859912|NCT02409368|617496050|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
170859913|NCT02409368|617496051|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
170859914|NCT02409368|617496052|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
170859915|NCT02409368|617496053|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
170859916|NCT02041520|617496054|FG000|Overall Study|Adverse Event|2|||
170859917|NCT02041520|617496055|FG001|Overall Study|Adverse Event|1|||
170859918|NCT02041520|617496054|FG000|Overall Study|Withdrawal by Subject|3|||
170859919|NCT02041520|617496055|FG001|Overall Study|Withdrawal by Subject|4|||
170859920|NCT02041520|617496054|FG000|Overall Study|Protocol Violation|1|||
170859921|NCT02041520|617496055|FG001|Overall Study|Protocol Violation|0|||
170859922|NCT02041520|617496054|FG000|Overall Study|Lost to Follow-up|0|||
170859923|NCT02041520|617496055|FG001|Overall Study|Lost to Follow-up|1|||
170859924|NCT02041520|617496054|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
170859925|NCT02041520|617496055|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
170859926|NCT00770341|617496057|FG000|Overall Study|Did not meet eligibility criteria|1|||
170859927|NCT00770341|617496058|FG001|Overall Study|Did not meet eligibility criteria|0|||
170859928|NCT00770341|617496059|FG002|Overall Study|Did not meet eligibility criteria|0|||
170859929|NCT00770341|617496057|FG000|Overall Study|Withdrawal by Subject|0|||
170859930|NCT00770341|617496058|FG001|Overall Study|Withdrawal by Subject|1|||
170859931|NCT00770341|617496059|FG002|Overall Study|Withdrawal by Subject|0|||
170859932|NCT00770341|617496057|FG000|Overall Study|Clinical Adverse Event|3|||
170859933|NCT00770341|617496058|FG001|Overall Study|Clinical Adverse Event|1|||
170859934|NCT00770341|617496059|FG002|Overall Study|Clinical Adverse Event|2|||
170859935|NCT00770341|617496057|FG000|Overall Study|Laboratory adverse event|3|||
170859936|NCT00770341|617496058|FG001|Overall Study|Laboratory adverse event|3|||
170859937|NCT00770341|617496059|FG002|Overall Study|Laboratory adverse event|0|||
170859938|NCT00770341|617496057|FG000|Overall Study|Lack of Efficacy|3|||
170859939|NCT00770341|617496058|FG001|Overall Study|Lack of Efficacy|0|||
170859940|NCT00770341|617496059|FG002|Overall Study|Lack of Efficacy|1|||
170515656|NCT03796676|616232869|FG000|Overall Study|Adverse Event|2|||
170859941|NCT00770341|617496057|FG000|Overall Study|Other|1|||
170859942|NCT00770341|617496058|FG001|Overall Study|Other|0|||
170859943|NCT00770341|617496059|FG002|Overall Study|Other|0|||
170515657|NCT03796676|616232870|FG001|Overall Study|Adverse Event|1|||
170515658|NCT03796676|616232871|FG002|Overall Study|Adverse Event|2|||
170859944|NCT00770341|617496057|FG000|Overall Study|Not treated|1|||
170515659|NCT03796676|616232869|FG000|Overall Study|Lost to Follow-up|2|||
170744666|NCT02310126|617073217|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
170859945|NCT00770341|617496058|FG001|Overall Study|Not treated|0|||
170859946|NCT00770341|617496059|FG002|Overall Study|Not treated|0|||
170859947|NCT02796560|617496065|FG000|Overall Study|Adverse Event|2|||
170859948|NCT02796560|617496066|FG001|Overall Study|Adverse Event|0|||
170859949|NCT02796560|617496065|FG000|Overall Study|Withdrawal by Subject|2|||
170859950|NCT02796560|617496066|FG001|Overall Study|Withdrawal by Subject|2|||
170859951|NCT01163916|617496068|FG000|Overall Study|Withdrawal by Subject|2|||
170859952|NCT01163916|617496069|FG001|Overall Study|Withdrawal by Subject|0|||
170515660|NCT03796676|616232870|FG001|Overall Study|Lost to Follow-up|1|||
170515661|NCT03796676|616232871|FG002|Overall Study|Lost to Follow-up|0|||
170859953|NCT01163916|617496070|FG002|Overall Study|Withdrawal by Subject|2|||
170859954|NCT01163916|617496068|FG000|Overall Study|Adverse Event|2|||
170744667|NCT02310126|617073218|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
170744668|NCT01539863|617073219|FG000|Overall Study|Lost to Follow-up|5|||
170744669|NCT01539863|617073220|FG001|Overall Study|Lost to Follow-up|4|||
170744670|NCT02441946|617073221|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
170744671|NCT02441946|617073222|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
170744672|NCT02441946|617073223|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
170744673|NCT02441946|617073221|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
170744674|NCT02441946|617073222|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
170744675|NCT02441946|617073223|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
170744676|NCT02441946|617073221|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
170744677|NCT02441946|617073222|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
170744678|NCT02441946|617073223|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
170744679|NCT02441946|617073221|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
170744680|NCT02441946|617073222|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
170744681|NCT02441946|617073223|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
170744682|NCT02441946|617073221|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
170744683|NCT02441946|617073222|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
170744684|NCT02441946|617073223|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
170744685|NCT02441946|617073221|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
170744686|NCT02441946|617073222|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
170744687|NCT02441946|617073223|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
170744688|NCT02441946|617073221|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
170744689|NCT02441946|617073222|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
170744690|NCT02441946|617073223|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
170744691|NCT02441946|617073221|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
170744692|NCT02441946|617073222|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
170744693|NCT02441946|617073223|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
170744694|NCT02441946|617073221|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
170744695|NCT02441946|617073222|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
170744696|NCT02441946|617073223|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
170744697|NCT02441946|617073221|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
170744698|NCT02441946|617073222|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
170744699|NCT02441946|617073223|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
170859955|NCT01163916|617496069|FG001|Overall Study|Adverse Event|0|||
170859956|NCT01163916|617496070|FG002|Overall Study|Adverse Event|1|||
170859957|NCT01163916|617496068|FG000|Overall Study|Lack of Efficacy|2|||
170859958|NCT01163916|617496069|FG001|Overall Study|Lack of Efficacy|0|||
170859959|NCT01163916|617496070|FG002|Overall Study|Lack of Efficacy|1|||
170859960|NCT01163916|617496068|FG000|Overall Study|Other|24|||
170859961|NCT01163916|617496069|FG001|Overall Study|Other|4|||
170859962|NCT01163916|617496070|FG002|Overall Study|Other|16|||
170859963|NCT05330312|617496072|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
170859964|NCT05330312|617496073|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
170859965|NCT05330312|617496074|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
170859966|NCT05330312|617496072|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
170859967|NCT05330312|617496073|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
170859968|NCT05330312|617496074|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
170859969|NCT05330312|617496072|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
170859970|NCT05330312|617496073|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
170859971|NCT05330312|617496074|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
170859972|NCT05330312|617496072|FG000|Pivotal Investigation - Part 2|Death|1|||
170859973|NCT05330312|617496073|FG001|Pivotal Investigation - Part 2|Death|4|||
170859974|NCT05330312|617496074|FG002|Pivotal Investigation - Part 2|Death|0|||
170859975|NCT03164564|617496076|FG000|Overall Study|Death|3|||
170859976|NCT03164564|617496077|FG001|Overall Study|Death|0|||
170859977|NCT03164564|617496076|FG000|Overall Study|Withdrawal by Subject|20|||
170859978|NCT03164564|617496077|FG001|Overall Study|Withdrawal by Subject|15|||
170859979|NCT03164564|617496076|FG000|Overall Study|Lost to Follow-up|2|||
170859980|NCT03164564|617496077|FG001|Overall Study|Lost to Follow-up|0|||
170859981|NCT03164564|617496076|FG000|Overall Study|Physician Decision|0|||
170859982|NCT03164564|617496077|FG001|Overall Study|Physician Decision|1|||
170515662|NCT03796676|616232869|FG000|Overall Study|Protocol Violation|0|||
170859983|NCT03164564|617496076|FG000|Overall Study|Adverse Event|0|||
170859984|NCT03164564|617496077|FG001|Overall Study|Adverse Event|1|||
170859985|NCT03164564|617496076|FG000|Overall Study|Ongoing|1586|||
170859986|NCT03164564|617496077|FG001|Overall Study|Ongoing|1586|||
170859987|NCT04469270|617496078|FG000|Overall Study|Adverse Event|2|||
170859988|NCT04469270|617496079|FG001|Overall Study|Adverse Event|0|||
170859989|NCT04469270|617496078|FG000|Overall Study|Lost to Follow-up|4|||
170744700|NCT02441946|617073221|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
170744701|NCT02441946|617073222|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
170744702|NCT02441946|617073223|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
170744703|NCT02111213|617073224|FG000|Overall Study|Withdrawal by Subject|3|||
170744704|NCT02111213|617073225|FG001|Overall Study|Withdrawal by Subject|2|||
170744705|NCT02111213|617073224|FG000|Overall Study|Lost to Follow-up|3|||
170744706|NCT02111213|617073225|FG001|Overall Study|Lost to Follow-up|4|||
170744707|NCT02226172|617073228|FG000|Overall Study|Participant refused further follow-up|4|||
170744708|NCT02226172|617073228|FG000|Overall Study|Other|5|||
170744709|NCT02226172|617073228|FG000|Overall Study|Death|1|||
170744710|NCT02226172|617073228|FG000|Overall Study|Study terminated by sponsor|1|||
170744711|NCT02226172|617073228|FG000|Overall Study|Adverse Event|6|||
170744712|NCT00758160|617073229|FG000|Overall Study|No Longer Requires Study Medication|4|||
170744713|NCT00758160|617073229|FG000|Overall Study|Administration Problems|3|||
170744714|NCT00758160|617073229|FG000|Overall Study|Adverse Event|15|||
170744715|NCT00758160|617073229|FG000|Overall Study|Lack of Efficacy|10|||
170744716|NCT00758160|617073229|FG000|Overall Study|Lost to Follow-up|14|||
170744717|NCT00758160|617073229|FG000|Overall Study|Protocol Violation|12|||
170744718|NCT00758160|617073229|FG000|Overall Study|Withdrawal by Subject|8|||
170744719|NCT01108510|617073235|FG000|Overall Study|Randomized but Not Treated|5|||
170744720|NCT01108510|617073236|FG001|Overall Study|Randomized but Not Treated|1|||
170744721|NCT01108510|617073235|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
170744722|NCT01108510|617073236|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
170744723|NCT01108510|617073235|FG000|Overall Study|Adverse Event|26|||
170744724|NCT01108510|617073236|FG001|Overall Study|Adverse Event|19|||
170744725|NCT01108510|617073235|FG000|Overall Study|Lost to Follow-up|20|||
170859990|NCT04469270|617496079|FG001|Overall Study|Lost to Follow-up|3|||
170859991|NCT04469270|617496078|FG000|Overall Study|Withdrawal by Subject|7|||
170859992|NCT04469270|617496079|FG001|Overall Study|Withdrawal by Subject|3|||
170859993|NCT04469270|617496078|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
170859994|NCT04469270|617496079|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
170859995|NCT04469270|617496078|FG000|Overall Study|missing|1|||
170859996|NCT04469270|617496079|FG001|Overall Study|missing|0|||
170859997|NCT02186847|617496083|FG000|Overall Study|Protocol Violation|3|||
170859998|NCT02186847|617496084|FG001|Overall Study|Protocol Violation|0|||
170859999|NCT00345293|617496085|FG000|Overall Study|Unable to access line for sample|1|||
170860000|NCT00345293|617496086|FG001|Overall Study|Unable to access line for sample|0|||
170860001|NCT00345293|617496085|FG000|Overall Study|Withdrawal by Subject|1|||
170860002|NCT00345293|617496086|FG001|Overall Study|Withdrawal by Subject|0|||
170860003|NCT01307579|617496089|FG000|Overall Study|Death|3|||
170860004|NCT01307579|617496090|FG001|Overall Study|Death|6|||
170860005|NCT01307579|617496089|FG000|Overall Study|Physician Decision|26|||
170860006|NCT01307579|617496090|FG001|Overall Study|Physician Decision|29|||
170860007|NCT01307579|617496089|FG000|Overall Study|Withdrawal by Subject|7|||
170860008|NCT01307579|617496090|FG001|Overall Study|Withdrawal by Subject|3|||
170860009|NCT01307579|617496089|FG000|Overall Study|Institutional diagnosis of IFD|21|||
170860010|NCT01307579|617496090|FG001|Overall Study|Institutional diagnosis of IFD|36|||
170860011|NCT01307579|617496089|FG000|Overall Study|Begin conditioning for HSCT|42|||
170860012|NCT01307579|617496090|FG001|Overall Study|Begin conditioning for HSCT|44|||
170860013|NCT01307579|617496089|FG000|Overall Study|Refractory or relapsed AML|38|||
170860014|NCT01307579|617496090|FG001|Overall Study|Refractory or relapsed AML|23|||
170860015|NCT01307579|617496089|FG000|Overall Study|Ineligible|3|||
170860016|NCT01307579|617496090|FG001|Overall Study|Ineligible|4|||
170860017|NCT03727438|617496092|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
170860018|NCT03727438|617496093|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
170860019|NCT03727438|617496092|FG000|Intervention Period|Excluded (health)|1|||
170860020|NCT03727438|617496093|FG001|Intervention Period|Excluded (health)|0|||
170860021|NCT03727438|617496092|FG000|Intervention Period|Withdrawal by Subject|3|||
170860022|NCT03727438|617496093|FG001|Intervention Period|Withdrawal by Subject|1|||
170860023|NCT03727438|617496092|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
170860024|NCT03727438|617496093|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
170515663|NCT03796676|616232870|FG001|Overall Study|Protocol Violation|0|||
170860025|NCT03727438|617496092|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
170860026|NCT03727438|617496093|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
170515664|NCT03796676|616232871|FG002|Overall Study|Protocol Violation|1|||
170744726|NCT01108510|617073236|FG001|Overall Study|Lost to Follow-up|17|||
170744727|NCT01108510|617073235|FG000|Overall Study|Withdrew Consent|21|||
170860027|NCT03727438|617496092|FG000|8 Week Assessment|Withdrawal by Subject|6|||
170860028|NCT03727438|617496093|FG001|8 Week Assessment|Withdrawal by Subject|1|||
170860029|NCT03727438|617496092|FG000|6 mo Assessment|did not complete assessment|10|||
170860030|NCT03727438|617496093|FG001|6 mo Assessment|did not complete assessment|11|||
170860031|NCT06729606|617496094|FG000|Overall Study|Adverse Event|0|||
170860032|NCT06729606|617496095|FG001|Overall Study|Adverse Event|2|||
170860033|NCT06729606|617496094|FG000|Overall Study|Death|1|||
170860034|NCT06729606|617496095|FG001|Overall Study|Death|0|||
170860035|NCT06729606|617496094|FG000|Overall Study|Physician Decision|0|||
170860036|NCT06729606|617496095|FG001|Overall Study|Physician Decision|1|||
170860037|NCT06729606|617496094|FG000|Overall Study|Withdrawal by Subject|2|||
170860038|NCT06729606|617496095|FG001|Overall Study|Withdrawal by Subject|4|||
170860039|NCT04873232|617496096|FG000|Overall Study|Lost to Follow-up|1|||
170860040|NCT04873232|617496097|FG001|Overall Study|Lost to Follow-up|4|||
170860041|NCT04873232|617496096|FG000|Overall Study|Withdrawal by Subject|1|||
170860042|NCT04873232|617496097|FG001|Overall Study|Withdrawal by Subject|0|||
170860043|NCT01511562|617497854|FG000|Induction|Adverse Event|2|||
170860044|NCT01511562|617497855|FG001|Induction|Adverse Event|0|||
170860045|NCT01511562|617497854|FG000|Induction|Disease Progression|3|||
170860046|NCT01511562|617497855|FG001|Induction|Disease Progression|7|||
170860047|NCT01511562|617497854|FG000|Induction|Death|1|||
170860048|NCT01511562|617497855|FG001|Induction|Death|3|||
170860049|NCT01511562|617497854|FG000|Induction|Withdrawal by Subject|0|||
170860050|NCT01511562|617497855|FG001|Induction|Withdrawal by Subject|4|||
170860051|NCT01511562|617497854|FG000|Induction|Other|3|||
170860052|NCT01511562|617497855|FG001|Induction|Other|0|||
170860053|NCT01511562|617497854|FG000|Consolidation|Withdrawal by Subject|1|||
170860054|NCT01511562|617497855|FG001|Consolidation|Withdrawal by Subject|0|||
170860055|NCT01511562|617497854|FG000|Consolidation|Other|1|||
170860056|NCT01511562|617497855|FG001|Consolidation|Other|0|||
170515665|NCT03796676|616232869|FG000|Overall Study|Withdrawal by Subject|1|||
170515666|NCT03796676|616232870|FG001|Overall Study|Withdrawal by Subject|1|||
170515667|NCT03796676|616232871|FG002|Overall Study|Withdrawal by Subject|0|||
170515668|NCT03796676|616232869|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
170515669|NCT03796676|616232870|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
170515670|NCT03796676|616232871|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
170515671|NCT01900899|616232872|FG000|Overall Study|Withdrawal by Subject|7|||
170515672|NCT01900899|616232873|FG001|Overall Study|Withdrawal by Subject|1|||
170515673|NCT01900899|616232872|FG000|Overall Study|Migrated from study area|2|||
170515674|NCT01900899|616232873|FG001|Overall Study|Migrated from study area|0|||
170515675|NCT02772809|616232874|FG000|Overall Study|not completed some tasks|6|||
170515676|NCT00534105|616232875|FG000|Overall Study|Lost to Follow-up|23|||
170515677|NCT00534105|616232876|FG001|Overall Study|Lost to Follow-up|39|||
170515678|NCT02427802|616232877|FG000|Overall Study|Adverse Event|11|||
170515679|NCT02427802|616232878|FG001|Overall Study|Adverse Event|3|||
170515680|NCT02427802|616232879|FG002|Overall Study|Adverse Event|7|||
170515681|NCT02427802|616232877|FG000|Overall Study|Death|0|||
170515682|NCT02427802|616232878|FG001|Overall Study|Death|4|||
170515683|NCT02427802|616232879|FG002|Overall Study|Death|1|||
170860057|NCT04732117|617497856|FG000|Double-Blind period (up to Week 16)|Lost to Follow-up|1|||
170860058|NCT04732117|617497857|FG001|Double-Blind period (up to Week 16)|Lost to Follow-up|0|||
170860059|NCT04732117|617497856|FG000|Double-Blind period (up to Week 16)|Subject Decision|0|||
170515684|NCT02427802|616232877|FG000|Overall Study|Lost to Follow-up|13|||
170515685|NCT02427802|616232878|FG001|Overall Study|Lost to Follow-up|8|||
170515686|NCT02427802|616232879|FG002|Overall Study|Lost to Follow-up|8|||
170515687|NCT02427802|616232877|FG000|Overall Study|Physician Decision|4|||
170515688|NCT02427802|616232878|FG001|Overall Study|Physician Decision|2|||
170515689|NCT02427802|616232879|FG002|Overall Study|Physician Decision|4|||
170515690|NCT02427802|616232877|FG000|Overall Study|Withdrawal by Subject|10|||
170515691|NCT02427802|616232878|FG001|Overall Study|Withdrawal by Subject|5|||
170515692|NCT02427802|616232879|FG002|Overall Study|Withdrawal by Subject|11|||
170515693|NCT02427802|616232877|FG000|Overall Study|Protocol Violation|3|||
170515694|NCT02427802|616232878|FG001|Overall Study|Protocol Violation|1|||
170515695|NCT02427802|616232879|FG002|Overall Study|Protocol Violation|1|||
170515696|NCT02427802|616232877|FG000|Overall Study|protocol specific treatment unrelated|18|||
170515697|NCT02427802|616232878|FG001|Overall Study|protocol specific treatment unrelated|11|||
170515698|NCT02427802|616232879|FG002|Overall Study|protocol specific treatment unrelated|11|||
170515699|NCT03034135|616232881|FG000|Overall Study|Withdrawal by Subject|2|||
170515700|NCT05259163|616234741|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
170515701|NCT05259163|616234742|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
170630134|NCT00463567|616660406|FG002|Overall Study|Lost to Follow-up|13|||
170860060|NCT04732117|617497857|FG001|Double-Blind period (up to Week 16)|Subject Decision|1|||
170860061|NCT04732117|617497856|FG000|Open-label period|Subject discontinuation|3|||
170860062|NCT04732117|617497857|FG001|Open-label period|Subject discontinuation|3|||
170860063|NCT01222507|617497858|FG000|Overall Study|Physician Decision|1|||
170860064|NCT01222507|617497858|FG000|Overall Study|Withdrawal by Subject|1|||
170860065|NCT02425644|617497863|FG000|Overall Study|Lost to Follow-up|2|||
170860066|NCT02425644|617497864|FG001|Overall Study|Lost to Follow-up|3|||
170860067|NCT02425644|617497863|FG000|Overall Study|Withdrawal by Subject|41|||
170860068|NCT02425644|617497864|FG001|Overall Study|Withdrawal by Subject|36|||
170860069|NCT02425644|617497863|FG000|Overall Study|Lack of Efficacy|3|||
170860070|NCT02425644|617497864|FG001|Overall Study|Lack of Efficacy|10|||
170860071|NCT02425644|617497863|FG000|Overall Study|Adverse Event|13|||
170860072|NCT02425644|617497864|FG001|Overall Study|Adverse Event|3|||
170860073|NCT02425644|617497863|FG000|Overall Study|Death|0|||
170860074|NCT02425644|617497864|FG001|Overall Study|Death|2|||
170860075|NCT02425644|617497863|FG000|Overall Study|Other|18|||
170860076|NCT02425644|617497864|FG001|Overall Study|Other|17|||
170860077|NCT01786174|617497865|FG000|Overall Study|Discontinued Study Drug|2|||
170860078|NCT01786174|617497866|FG001|Overall Study|Discontinued Study Drug|0|||
170860079|NCT00300781|617497867|FG000|Overall Study|Disease Progression|55|||
170860080|NCT00300781|617497868|FG001|Overall Study|Disease Progression|52|||
170860081|NCT00300781|617497867|FG000|Overall Study|Adverse Event|5|||
170860082|NCT00300781|617497868|FG001|Overall Study|Adverse Event|6|||
170860083|NCT00300781|617497867|FG000|Overall Study|Withdrawal by Subject|1|||
170860084|NCT00300781|617497868|FG001|Overall Study|Withdrawal by Subject|2|||
170860085|NCT00300781|617497867|FG000|Overall Study|Physician Decision|1|||
170860086|NCT00300781|617497868|FG001|Overall Study|Physician Decision|0|||
170860087|NCT00300781|617497867|FG000|Overall Study|Not Recorded|0|||
170860088|NCT00300781|617497868|FG001|Overall Study|Not Recorded|1|||
170860089|NCT00300781|617497867|FG000|Overall Study|Symptomatic Deterioration|1|||
170860090|NCT00300781|617497868|FG001|Overall Study|Symptomatic Deterioration|0|||
170860091|NCT00300781|617497867|FG000|Overall Study|Lost to Follow-up|0|||
170860092|NCT00300781|617497868|FG001|Overall Study|Lost to Follow-up|1|||
170860093|NCT00294554|617497875|FG000|Overall Study|Lack of Efficacy|0|||
170860094|NCT00294554|617497876|FG001|Overall Study|Lack of Efficacy|1|||
170860095|NCT00294554|617497875|FG000|Overall Study|Physician Decision|0|||
170860096|NCT00294554|617497876|FG001|Overall Study|Physician Decision|1|||
170515702|NCT05251233|616234745|FG000|Overall Study|Disease progression - did not start treatment|0|||
170515703|NCT05251233|616234746|FG001|Overall Study|Disease progression - did not start treatment|0|||
170515704|NCT05251233|616234747|FG002|Overall Study|Disease progression - did not start treatment|5|||
170515705|NCT05251233|616234745|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
170515706|NCT05251233|616234746|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
170515707|NCT05251233|616234747|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
170515708|NCT05251233|616234745|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
170515709|NCT05251233|616234746|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
170515710|NCT05251233|616234747|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
170515711|NCT05251233|616234745|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
170515712|NCT05251233|616234746|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
170515713|NCT05251233|616234747|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
170515714|NCT05251233|616234745|FG000|Overall Study|Death - did not start treatment|3|||
170515715|NCT05251233|616234746|FG001|Overall Study|Death - did not start treatment|0|||
170515716|NCT05251233|616234747|FG002|Overall Study|Death - did not start treatment|0|||
170860097|NCT02598557|617497877|FG000|Overall Study|Withdrawal by Subject|1|||
170860098|NCT02598557|617497878|FG001|Overall Study|Withdrawal by Subject|0|||
170860099|NCT02598557|617497879|FG002|Overall Study|Withdrawal by Subject|1|||
170515717|NCT05251233|616234745|FG000|Overall Study|Withdrawal by Subject|2|||
170515718|NCT05251233|616234746|FG001|Overall Study|Withdrawal by Subject|2|||
170515719|NCT05251233|616234747|FG002|Overall Study|Withdrawal by Subject|0|||
170515720|NCT05251233|616234745|FG000|Overall Study|Other complicating disease|2|||
170515721|NCT05251233|616234746|FG001|Overall Study|Other complicating disease|1|||
170515722|NCT05251233|616234747|FG002|Overall Study|Other complicating disease|0|||
170515723|NCT05251233|616234745|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
170515724|NCT05251233|616234746|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
170515725|NCT05251233|616234747|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
170515726|NCT05251233|616234745|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
170515727|NCT05251233|616234746|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
170515728|NCT05251233|616234747|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
170515729|NCT00103285|616234748|FG000|Induction|Adverse Event|14|||
170515730|NCT00103285|616234749|FG001|Induction|Adverse Event|0|||
170515731|NCT00103285|616234750|FG002|Induction|Adverse Event|0|||
170515732|NCT00103285|616234751|FG003|Induction|Adverse Event|0|||
170515733|NCT00103285|616234752|FG004|Induction|Adverse Event|0|||
170515734|NCT00103285|616234753|FG005|Induction|Adverse Event|0|||
170860100|NCT02598557|617497877|FG000|Overall Study|Participant did not start treatment|2|||
170860101|NCT02598557|617497878|FG001|Overall Study|Participant did not start treatment|1|||
170860102|NCT02598557|617497879|FG002|Overall Study|Participant did not start treatment|1|||
170860103|NCT02598557|617497877|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
170515735|NCT00103285|616234754|FG006|Induction|Adverse Event|0|||
170515736|NCT00103285|616234755|FG007|Induction|Adverse Event|0|||
170515737|NCT00103285|616234748|FG000|Induction|Death|24|||
170515738|NCT00103285|616234749|FG001|Induction|Death|0|||
170515739|NCT00103285|616234750|FG002|Induction|Death|0|||
170515740|NCT00103285|616234751|FG003|Induction|Death|0|||
170515741|NCT00103285|616234752|FG004|Induction|Death|0|||
170515742|NCT00103285|616234753|FG005|Induction|Death|0|||
170515743|NCT00103285|616234754|FG006|Induction|Death|0|||
170515744|NCT00103285|616234755|FG007|Induction|Death|0|||
170515745|NCT00103285|616234748|FG000|Induction|Physician Decision|103|||
170515746|NCT00103285|616234749|FG001|Induction|Physician Decision|0|||
170515747|NCT00103285|616234750|FG002|Induction|Physician Decision|0|||
170515748|NCT00103285|616234751|FG003|Induction|Physician Decision|0|||
170515749|NCT00103285|616234752|FG004|Induction|Physician Decision|0|||
170515750|NCT00103285|616234753|FG005|Induction|Physician Decision|0|||
170515751|NCT00103285|616234754|FG006|Induction|Physician Decision|0|||
170515752|NCT00103285|616234755|FG007|Induction|Physician Decision|0|||
170860104|NCT02598557|617497878|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
170515753|NCT00103285|616234748|FG000|Induction|Withdrawal by Subject|1|||
170515754|NCT00103285|616234749|FG001|Induction|Withdrawal by Subject|0|||
170515755|NCT00103285|616234750|FG002|Induction|Withdrawal by Subject|0|||
170515756|NCT00103285|616234751|FG003|Induction|Withdrawal by Subject|0|||
170515757|NCT00103285|616234752|FG004|Induction|Withdrawal by Subject|0|||
170515758|NCT00103285|616234753|FG005|Induction|Withdrawal by Subject|0|||
170515759|NCT00103285|616234754|FG006|Induction|Withdrawal by Subject|0|||
170515760|NCT00103285|616234755|FG007|Induction|Withdrawal by Subject|0|||
170515761|NCT00103285|616234748|FG000|Induction|Ineligible|43|||
170515762|NCT00103285|616234749|FG001|Induction|Ineligible|0|||
170515763|NCT00103285|616234750|FG002|Induction|Ineligible|0|||
170515764|NCT00103285|616234751|FG003|Induction|Ineligible|0|||
170515765|NCT00103285|616234752|FG004|Induction|Ineligible|0|||
170515766|NCT00103285|616234753|FG005|Induction|Ineligible|0|||
170515767|NCT00103285|616234754|FG006|Induction|Ineligible|0|||
170515768|NCT00103285|616234755|FG007|Induction|Ineligible|0|||
170515769|NCT00103285|616234748|FG000|Induction|Refusal|906|||
170515770|NCT00103285|616234749|FG001|Induction|Refusal|0|||
170515771|NCT00103285|616234750|FG002|Induction|Refusal|0|||
170515772|NCT00103285|616234751|FG003|Induction|Refusal|0|||
170515773|NCT00103285|616234752|FG004|Induction|Refusal|0|||
170515774|NCT00103285|616234753|FG005|Induction|Refusal|0|||
170515775|NCT00103285|616234754|FG006|Induction|Refusal|0|||
170515776|NCT00103285|616234755|FG007|Induction|Refusal|0|||
170515777|NCT00103285|616234748|FG000|Induction|Other|258|||
170515778|NCT00103285|616234749|FG001|Induction|Other|0|||
170515779|NCT00103285|616234750|FG002|Induction|Other|0|||
170860105|NCT02598557|617497879|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
170860106|NCT02598557|617497877|FG000|Overall Study|Adverse Event|1|||
170860107|NCT02598557|617497878|FG001|Overall Study|Adverse Event|1|||
170860108|NCT02598557|617497879|FG002|Overall Study|Adverse Event|0|||
170860109|NCT04391049|617497880|FG000|Overall Study|Protocol Violation|1|||
170744728|NCT01108510|617073236|FG001|Overall Study|Withdrew Consent|15|||
170744729|NCT01108510|617073235|FG000|Overall Study|Investigator's Discretion|12|||
170744730|NCT01108510|617073236|FG001|Overall Study|Investigator's Discretion|10|||
170744731|NCT01108510|617073235|FG000|Overall Study|Participant Noncompliance|5|||
170744732|NCT01108510|617073236|FG001|Overall Study|Participant Noncompliance|7|||
170744733|NCT01108510|617073235|FG000|Overall Study|Lack of Efficacy|3|||
170744734|NCT01108510|617073236|FG001|Overall Study|Lack of Efficacy|0|||
170744735|NCT01108510|617073235|FG000|Overall Study|Pregnancy|0|||
170744736|NCT01108510|617073236|FG001|Overall Study|Pregnancy|3|||
170515780|NCT00103285|616234751|FG003|Induction|Other|0|||
170515781|NCT00103285|616234752|FG004|Induction|Other|0|||
170515782|NCT00103285|616234753|FG005|Induction|Other|0|||
170515783|NCT00103285|616234754|FG006|Induction|Other|0|||
170515784|NCT00103285|616234755|FG007|Induction|Other|0|||
170860110|NCT03752684|617497881|FG000|Overall Study|Lost to Follow-up|4|||
170515785|NCT00103285|616234748|FG000|Response Assignment|Adverse Event|0|||
170515786|NCT00103285|616234749|FG001|Response Assignment|Adverse Event|8|||
170515787|NCT00103285|616234750|FG002|Response Assignment|Adverse Event|3|||
170515788|NCT00103285|616234751|FG003|Response Assignment|Adverse Event|2|||
170515789|NCT00103285|616234752|FG004|Response Assignment|Adverse Event|3|||
170515790|NCT00103285|616234753|FG005|Response Assignment|Adverse Event|1|||
170515791|NCT00103285|616234754|FG006|Response Assignment|Adverse Event|1|||
170744737|NCT01108510|617073235|FG000|Overall Study|Death|1|||
170860111|NCT06472297|617497883|FG000|Overall Study|Withdrawal by Subject|2|||
170515792|NCT00103285|616234755|FG007|Response Assignment|Adverse Event|2|||
170515793|NCT00103285|616234748|FG000|Response Assignment|Death|0|||
170515794|NCT00103285|616234749|FG001|Response Assignment|Death|5|||
170515795|NCT00103285|616234750|FG002|Response Assignment|Death|2|||
170515796|NCT00103285|616234751|FG003|Response Assignment|Death|2|||
170515797|NCT00103285|616234752|FG004|Response Assignment|Death|3|||
170515798|NCT00103285|616234753|FG005|Response Assignment|Death|1|||
170515799|NCT00103285|616234754|FG006|Response Assignment|Death|0|||
170515800|NCT00103285|616234755|FG007|Response Assignment|Death|8|||
170744738|NCT01108510|617073236|FG001|Overall Study|Death|1|||
170744739|NCT00988351|617073238|FG000|Overall Study|Withdrawal by Subject|8|||
170744740|NCT00988351|617073239|FG001|Overall Study|Withdrawal by Subject|0|||
170744741|NCT00988351|617073238|FG000|Overall Study|Lost to Follow-up|6|||
170744742|NCT00988351|617073239|FG001|Overall Study|Lost to Follow-up|9|||
170744743|NCT00988351|617073238|FG000|Overall Study|not using CPAP|5|||
170744744|NCT00988351|617073239|FG001|Overall Study|not using CPAP|3|||
170860112|NCT04097379|617497884|FG000|Overall Study|Adverse Event|1|||
170860113|NCT04097379|617497885|FG001|Overall Study|Adverse Event|0|||
170860114|NCT04097379|617497886|FG002|Overall Study|Adverse Event|0|||
170860115|NCT04097379|617497887|FG003|Overall Study|Adverse Event|0|||
170860116|NCT04097379|617497884|FG000|Overall Study|Physician Decision|0|||
170860117|NCT04097379|617497885|FG001|Overall Study|Physician Decision|1|||
170860118|NCT04097379|617497886|FG002|Overall Study|Physician Decision|0|||
170744745|NCT02038764|617073240|FG000|Overall Study|Adverse Event|0|||
170744746|NCT02038764|617073241|FG001|Overall Study|Adverse Event|0|||
170744747|NCT02038764|617073242|FG002|Overall Study|Adverse Event|1|||
170860119|NCT04097379|617497887|FG003|Overall Study|Physician Decision|0|||
170860120|NCT03064893|617497889|FG000|Overall Study|Change in surgery plan|0|||
170860121|NCT03064893|617497890|FG001|Overall Study|Change in surgery plan|2|||
170860122|NCT03064893|617497889|FG000|Overall Study|Moved away|0|||
170860123|NCT03064893|617497890|FG001|Overall Study|Moved away|1|||
170860124|NCT04903288|617497891|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
170860125|NCT04903288|617497891|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
170860126|NCT04903288|617497891|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
170860127|NCT04903288|617497891|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
170860128|NCT05245617|617497892|FG000|Overall Study|Withdrawal by Subject|1|||
170860129|NCT04963803|617497893|FG000|Overall Study|Withdrawal by Subject|1|||
170860130|NCT04963803|617497894|FG001|Overall Study|Withdrawal by Subject|0|||
170860131|NCT00640016|617497895|FG000|Overall Study|Withdrawal by Subject|0|||
170860132|NCT00640016|617497896|FG001|Overall Study|Withdrawal by Subject|1|||
170860133|NCT00640016|617497897|FG002|Overall Study|Withdrawal by Subject|0|||
170860134|NCT00640016|617497898|FG003|Overall Study|Withdrawal by Subject|0|||
170860135|NCT00640016|617497895|FG000|Overall Study|Study termination|2|||
170860136|NCT00640016|617497896|FG001|Overall Study|Study termination|1|||
170860137|NCT00640016|617497897|FG002|Overall Study|Study termination|3|||
170860138|NCT00640016|617497898|FG003|Overall Study|Study termination|2|||
170860139|NCT00640016|617497895|FG000|Overall Study|Adverse Event|0|||
170860140|NCT00640016|617497896|FG001|Overall Study|Adverse Event|0|||
170860141|NCT00640016|617497897|FG002|Overall Study|Adverse Event|0|||
170860142|NCT00640016|617497898|FG003|Overall Study|Adverse Event|1|||
170860143|NCT04781387|617497902|FG000|Overall Study|Withdrawal by Subject|1|||
170860144|NCT04781387|617497903|FG001|Overall Study|Withdrawal by Subject|0|||
170860145|NCT04781387|617497904|FG002|Overall Study|Withdrawal by Subject|1|||
170860146|NCT04781387|617497902|FG000|Overall Study|Lost to Follow-up|1|||
170860147|NCT04781387|617497903|FG001|Overall Study|Lost to Follow-up|0|||
170860148|NCT04781387|617497904|FG002|Overall Study|Lost to Follow-up|0|||
170860149|NCT01636960|617497905|FG000|Induction Phase|Adverse Event|2|||
170860150|NCT01636960|617497905|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
170860151|NCT01636960|617497905|FG000|Maintenance Phase|Adverse Event|3|||
170860152|NCT01636960|617497905|FG000|Maintenance Phase|Progressive disease|1|||
170860153|NCT01740323|617497907|FG000|Overall Study|Adverse Event|1|||
170860154|NCT01740323|617497908|FG001|Overall Study|Adverse Event|0|||
170860155|NCT01740323|617497907|FG000|Overall Study|Randomized but did not take study drug|1|||
170860156|NCT01740323|617497908|FG001|Overall Study|Randomized but did not take study drug|0|||
170860157|NCT02019927|617497909|FG000|Overall Study|Lost to Follow-up|2|||
170860158|NCT02019927|617497910|FG001|Overall Study|Lost to Follow-up|4|||
170860159|NCT02019927|617497911|FG002|Overall Study|Lost to Follow-up|1|||
170860160|NCT02019927|617497912|FG003|Overall Study|Lost to Follow-up|2|||
170860161|NCT02019927|617497913|FG004|Overall Study|Lost to Follow-up|3|||
170860162|NCT02019927|617497914|FG005|Overall Study|Lost to Follow-up|1|||
170860163|NCT06338462|617497915|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
170515801|NCT00103285|616234748|FG000|Response Assignment|Lost to Follow-up|0|||
170860164|NCT03181451|617497922|FG000|Overall Study|Adverse Event|0|||
170860165|NCT03181451|617497923|FG001|Overall Study|Adverse Event|1|||
170860166|NCT03181451|617497924|FG002|Overall Study|Adverse Event|0|||
170860167|NCT03181451|617497922|FG000|Overall Study|Withdrawal by Subject|0|||
170515802|NCT00103285|616234749|FG001|Response Assignment|Lost to Follow-up|9|||
170515803|NCT00103285|616234750|FG002|Response Assignment|Lost to Follow-up|5|||
170860168|NCT03181451|617497923|FG001|Overall Study|Withdrawal by Subject|1|||
170860169|NCT03181451|617497924|FG002|Overall Study|Withdrawal by Subject|0|||
170860170|NCT00928447|617497925|FG000|Overall Study|Withdrawal by Subject|1|||
170860171|NCT00928447|617497925|FG000|Overall Study|Investigator's decision|1|||
170860172|NCT01259284|617497926|FG000|Overall Study|Study Termination|2|||
170860173|NCT01259284|617497927|FG001|Overall Study|Study Termination|0|||
170860174|NCT01259284|617497928|FG002|Overall Study|Study Termination|0|||
170860175|NCT01326533|617497933|FG000|Overall Study|Lost to Follow-up|2|||
170860176|NCT01326533|617497934|FG001|Overall Study|Lost to Follow-up|0|||
170860177|NCT01326533|617497933|FG000|Overall Study|Withdrawal by Subject|1|||
170860178|NCT01326533|617497934|FG001|Overall Study|Withdrawal by Subject|0|||
170860179|NCT01326533|617497933|FG000|Overall Study|Adverse Event|1|||
170860180|NCT01326533|617497934|FG001|Overall Study|Adverse Event|0|||
170860181|NCT04079803|617497935|FG000|Overall Study|Withdrawal by Subject|0|||
170860182|NCT04079803|617497936|FG001|Overall Study|Withdrawal by Subject|0|||
170860183|NCT04079803|617497937|FG002|Overall Study|Withdrawal by Subject|1|||
170860184|NCT03353350|617497938|FG000|30-week Core Treatment Period|Protocol Violation|1|||
170515804|NCT00103285|616234751|FG003|Response Assignment|Lost to Follow-up|5|||
170860185|NCT03353350|617497939|FG001|30-week Core Treatment Period|Protocol Violation|1|||
170860186|NCT03353350|617497940|FG002|30-week Core Treatment Period|Protocol Violation|1|||
170860187|NCT03353350|617497941|FG003|30-week Core Treatment Period|Protocol Violation|0|||
170860188|NCT03353350|617497938|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
170860189|NCT03353350|617497939|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
170860190|NCT03353350|617497940|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
170860191|NCT03353350|617497941|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
170860192|NCT03353350|617497938|FG000|30-week Core Treatment Period|Adverse Event|0|||
170860193|NCT03353350|617497939|FG001|30-week Core Treatment Period|Adverse Event|4|||
170860194|NCT03353350|617497940|FG002|30-week Core Treatment Period|Adverse Event|2|||
170860195|NCT03353350|617497941|FG003|30-week Core Treatment Period|Adverse Event|3|||
170860196|NCT03353350|617497938|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
170860197|NCT03353350|617497939|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
170515805|NCT00103285|616234752|FG004|Response Assignment|Lost to Follow-up|1|||
170515806|NCT00103285|616234753|FG005|Response Assignment|Lost to Follow-up|2|||
170515807|NCT00103285|616234754|FG006|Response Assignment|Lost to Follow-up|2|||
170860198|NCT03353350|617497940|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
170860199|NCT03353350|617497941|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
170860200|NCT03353350|617497938|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
170860201|NCT03353350|617497939|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
170860202|NCT03353350|617497940|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
170860203|NCT03353350|617497941|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
170860204|NCT03353350|617497938|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
170860205|NCT03353350|617497939|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
170515808|NCT00103285|616234755|FG007|Response Assignment|Lost to Follow-up|5|||
170515809|NCT00103285|616234748|FG000|Response Assignment|Physician Decision|0|||
170515810|NCT00103285|616234749|FG001|Response Assignment|Physician Decision|13|||
170515811|NCT00103285|616234750|FG002|Response Assignment|Physician Decision|14|||
170515812|NCT00103285|616234751|FG003|Response Assignment|Physician Decision|9|||
170515813|NCT00103285|616234752|FG004|Response Assignment|Physician Decision|13|||
170515814|NCT00103285|616234753|FG005|Response Assignment|Physician Decision|7|||
170515815|NCT00103285|616234754|FG006|Response Assignment|Physician Decision|4|||
170515816|NCT00103285|616234755|FG007|Response Assignment|Physician Decision|35|||
170515817|NCT00103285|616234748|FG000|Response Assignment|Protocol Violation|0|||
170515818|NCT00103285|616234749|FG001|Response Assignment|Protocol Violation|2|||
170515819|NCT00103285|616234750|FG002|Response Assignment|Protocol Violation|0|||
170515820|NCT00103285|616234751|FG003|Response Assignment|Protocol Violation|0|||
170515821|NCT00103285|616234752|FG004|Response Assignment|Protocol Violation|0|||
170515822|NCT00103285|616234753|FG005|Response Assignment|Protocol Violation|0|||
170515823|NCT00103285|616234754|FG006|Response Assignment|Protocol Violation|0|||
170515824|NCT00103285|616234755|FG007|Response Assignment|Protocol Violation|0|||
170515825|NCT00103285|616234748|FG000|Response Assignment|Withdrawal by Subject|0|||
170515826|NCT00103285|616234749|FG001|Response Assignment|Withdrawal by Subject|4|||
170515827|NCT00103285|616234750|FG002|Response Assignment|Withdrawal by Subject|1|||
170515828|NCT00103285|616234751|FG003|Response Assignment|Withdrawal by Subject|1|||
170515829|NCT00103285|616234752|FG004|Response Assignment|Withdrawal by Subject|2|||
170515830|NCT00103285|616234753|FG005|Response Assignment|Withdrawal by Subject|2|||
170515831|NCT00103285|616234754|FG006|Response Assignment|Withdrawal by Subject|0|||
170515832|NCT00103285|616234755|FG007|Response Assignment|Withdrawal by Subject|2|||
170515833|NCT00103285|616234748|FG000|Response Assignment|Ineligible|0|||
170515834|NCT00103285|616234749|FG001|Response Assignment|Ineligible|8|||
170515835|NCT00103285|616234750|FG002|Response Assignment|Ineligible|6|||
170515836|NCT00103285|616234751|FG003|Response Assignment|Ineligible|2|||
170515837|NCT00103285|616234752|FG004|Response Assignment|Ineligible|0|||
170515838|NCT00103285|616234753|FG005|Response Assignment|Ineligible|3|||
170515839|NCT00103285|616234754|FG006|Response Assignment|Ineligible|1|||
170515840|NCT00103285|616234755|FG007|Response Assignment|Ineligible|5|||
170515841|NCT00103285|616234748|FG000|Response Assignment|Refusal|0|||
170515842|NCT00103285|616234749|FG001|Response Assignment|Refusal|53|||
170515843|NCT00103285|616234750|FG002|Response Assignment|Refusal|5|||
170515844|NCT00103285|616234751|FG003|Response Assignment|Refusal|3|||
170515845|NCT00103285|616234752|FG004|Response Assignment|Refusal|25|||
170515846|NCT00103285|616234753|FG005|Response Assignment|Refusal|15|||
170860206|NCT03353350|617497940|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
170860207|NCT03353350|617497941|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
170860208|NCT03353350|617497938|FG000|26-week Treatment Extension Period|Adverse Event|1|||
170860209|NCT03353350|617497939|FG001|26-week Treatment Extension Period|Adverse Event|0|||
170860210|NCT03353350|617497940|FG002|26-week Treatment Extension Period|Adverse Event|0|||
170860211|NCT03353350|617497941|FG003|26-week Treatment Extension Period|Adverse Event|1|||
170860212|NCT03353350|617497938|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
170860213|NCT03353350|617497939|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
170860214|NCT03353350|617497940|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
170860215|NCT03353350|617497941|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
170860216|NCT00307125|617497944|FG000|Screening Phase|Adverse Event|1|||
170860217|NCT00307125|617497945|FG001|Screening Phase|Adverse Event|0|||
170860218|NCT00307125|617497946|FG002|Screening Phase|Adverse Event|0|||
170860219|NCT00307125|617497944|FG000|Screening Phase|Protocol Violation|27|||
170860220|NCT00307125|617497945|FG001|Screening Phase|Protocol Violation|0|||
170860221|NCT00307125|617497946|FG002|Screening Phase|Protocol Violation|0|||
170860222|NCT00307125|617497944|FG000|Screening Phase|Lost to Follow-up|87|||
170860223|NCT00307125|617497945|FG001|Screening Phase|Lost to Follow-up|0|||
170860224|NCT00307125|617497946|FG002|Screening Phase|Lost to Follow-up|0|||
170860225|NCT00307125|617497944|FG000|Screening Phase|Death|10|||
170515847|NCT00103285|616234754|FG006|Response Assignment|Refusal|30|||
170515848|NCT00103285|616234755|FG007|Response Assignment|Refusal|10|||
170515849|NCT00103285|616234748|FG000|Response Assignment|Other|0|||
170515850|NCT00103285|616234749|FG001|Response Assignment|Other|30|||
170515851|NCT00103285|616234750|FG002|Response Assignment|Other|48|||
170515852|NCT00103285|616234751|FG003|Response Assignment|Other|38|||
170515853|NCT00103285|616234752|FG004|Response Assignment|Other|37|||
170515854|NCT00103285|616234753|FG005|Response Assignment|Other|17|||
170515855|NCT00103285|616234754|FG006|Response Assignment|Other|11|||
170515856|NCT00103285|616234755|FG007|Response Assignment|Other|53|||
170515857|NCT00452439|616234757|FG000|Overall Study|Lost to Follow-up|1|||
170515858|NCT00452439|616234758|FG001|Overall Study|Lost to Follow-up|1|||
170515859|NCT00452439|616234757|FG000|Overall Study|Refused Treatment|4|||
170515860|NCT00452439|616234758|FG001|Overall Study|Refused Treatment|3|||
170515861|NCT00452439|616234757|FG000|Overall Study|Death|3|||
170515862|NCT00452439|616234758|FG001|Overall Study|Death|1|||
170515863|NCT00452439|616234757|FG000|Overall Study|Bone Marrow Transplant|0|||
170515864|NCT00452439|616234758|FG001|Overall Study|Bone Marrow Transplant|1|||
170515865|NCT00452439|616234757|FG000|Overall Study|Too Ill to Continue|0|||
170515866|NCT00452439|616234758|FG001|Overall Study|Too Ill to Continue|1|||
170515867|NCT00452439|616234757|FG000|Overall Study|Failed to achieve complete response|2|||
170515868|NCT00452439|616234758|FG001|Overall Study|Failed to achieve complete response|0|||
170515869|NCT00452439|616234757|FG000|Overall Study|Relapse|3|||
170515870|NCT00452439|616234758|FG001|Overall Study|Relapse|0|||
170515871|NCT00452439|616234757|FG000|Overall Study|Fracture|1|||
170860226|NCT00307125|617497945|FG001|Screening Phase|Death|0|||
170860227|NCT00307125|617497946|FG002|Screening Phase|Death|0|||
170860228|NCT00307125|617497944|FG000|Screening Phase|Withdrawal by Subject|77|||
170860229|NCT00307125|617497945|FG001|Screening Phase|Withdrawal by Subject|0|||
170860230|NCT00307125|617497946|FG002|Screening Phase|Withdrawal by Subject|0|||
170860231|NCT00307125|617497944|FG000|Screening Phase|Physician Decision|26|||
170860232|NCT00307125|617497945|FG001|Screening Phase|Physician Decision|0|||
170860233|NCT00307125|617497946|FG002|Screening Phase|Physician Decision|0|||
170860234|NCT00307125|617497944|FG000|Screening Phase|Sponsor Decision|4|||
170860235|NCT00307125|617497945|FG001|Screening Phase|Sponsor Decision|0|||
170860236|NCT00307125|617497946|FG002|Screening Phase|Sponsor Decision|0|||
170860237|NCT00307125|617497944|FG000|Screening Phase|Study Terminated|17|||
170860238|NCT00307125|617497945|FG001|Screening Phase|Study Terminated|0|||
170860239|NCT00307125|617497946|FG002|Screening Phase|Study Terminated|0|||
170860240|NCT00307125|617497944|FG000|Screening Phase|Graft Loss|3|||
170860241|NCT00307125|617497945|FG001|Screening Phase|Graft Loss|0|||
170860242|NCT00307125|617497946|FG002|Screening Phase|Graft Loss|0|||
170860243|NCT00307125|617497944|FG000|Screening Phase|Graft Failure|8|||
170860244|NCT00307125|617497945|FG001|Screening Phase|Graft Failure|0|||
170860245|NCT00307125|617497946|FG002|Screening Phase|Graft Failure|0|||
170860246|NCT00307125|617497944|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
170860247|NCT00307125|617497945|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
170860248|NCT00307125|617497946|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
170860249|NCT00307125|617497944|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
170860250|NCT00307125|617497945|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
170860251|NCT00307125|617497946|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
170860252|NCT00307125|617497944|FG000|Screening Phase|Moved or transferred facilities|34|||
170860253|NCT00307125|617497945|FG001|Screening Phase|Moved or transferred facilities|0|||
170515872|NCT00452439|616234758|FG001|Overall Study|Fracture|0|||
170744748|NCT02038764|617073243|FG003|Overall Study|Adverse Event|0|||
170515873|NCT01381926|616234763|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
170515874|NCT01381926|616234764|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
170860254|NCT00307125|617497946|FG002|Screening Phase|Moved or transferred facilities|0|||
170860255|NCT00307125|617497944|FG000|Screening Phase|Received Pancreas Transplant|8|||
170515875|NCT01381926|616234763|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
170515876|NCT01381926|616234764|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
170515877|NCT00463801|616234773|FG000|Overall Study|Protocol Violation|1|||
170515878|NCT00463801|616234773|FG000|Overall Study|Lack of Efficacy|2|||
170515879|NCT00463801|616234773|FG000|Overall Study|Adverse Event|4|||
170515880|NCT00463801|616234773|FG000|Overall Study|Lost to Follow-up|5|||
170515881|NCT00463801|616234773|FG000|Overall Study|No longer require therapy|1|||
170515882|NCT00669318|616234774|FG000|Overall Study|Withdrawal by Subject|2|||
170515883|NCT01073163|616234775|FG000|Overall Study|Adverse Event|1|||
170515884|NCT01073163|616234775|FG000|Overall Study|Disease Progression|1|||
170515885|NCT01073163|616234775|FG000|Overall Study|Early termination|1|||
170515886|NCT02315664|616234776|FG000|Overall Study|Lost to Follow-up|1|||
170515887|NCT02315664|616234777|FG001|Overall Study|Lost to Follow-up|1|||
170515888|NCT02315664|616234776|FG000|Overall Study|Withdrawal by Subject|0|||
170515889|NCT02315664|616234777|FG001|Overall Study|Withdrawal by Subject|3|||
170515890|NCT00762762|616234780|FG000|Overall Study|Did not return for appointments|6|||
170515891|NCT00762762|616234781|FG001|Overall Study|Did not return for appointments|8|||
170515892|NCT02748057|616234782|FG000|Overall Study|Adverse Event|1|||
170515893|NCT02748057|616234783|FG001|Overall Study|Adverse Event|0|||
170515894|NCT02748057|616234782|FG000|Overall Study|Physician Decision|0|||
170515895|NCT02748057|616234783|FG001|Overall Study|Physician Decision|1|||
170515896|NCT02748057|616234782|FG000|Overall Study|Protocol Violation|2|||
170515897|NCT02748057|616234783|FG001|Overall Study|Protocol Violation|1|||
170515898|NCT02748057|616234782|FG000|Overall Study|Participant Moved|1|||
170515899|NCT02748057|616234783|FG001|Overall Study|Participant Moved|0|||
170515900|NCT02748057|616234782|FG000|Overall Study|Withdrawal by Subject|1|||
170515901|NCT02748057|616234783|FG001|Overall Study|Withdrawal by Subject|0|||
170515902|NCT02937740|616234789|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
170515903|NCT02937740|616234790|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
170515904|NCT02937740|616234789|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
170515905|NCT02937740|616234790|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
170515906|NCT02937740|616234789|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
170515907|NCT02937740|616234790|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
170515908|NCT02937740|616234789|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
170860256|NCT00307125|617497945|FG001|Screening Phase|Received Pancreas Transplant|0|||
170860257|NCT00307125|617497946|FG002|Screening Phase|Received Pancreas Transplant|0|||
170744749|NCT02038764|617073244|FG004|Overall Study|Adverse Event|0|||
170744750|NCT02038764|617073240|FG000|Overall Study|Lost to Follow-up|0|||
170744751|NCT02038764|617073241|FG001|Overall Study|Lost to Follow-up|1|||
170744752|NCT02038764|617073242|FG002|Overall Study|Lost to Follow-up|0|||
170744753|NCT02038764|617073243|FG003|Overall Study|Lost to Follow-up|0|||
170744754|NCT02038764|617073244|FG004|Overall Study|Lost to Follow-up|0|||
170744755|NCT02038764|617073240|FG000|Overall Study|Withdrawal by Subject|0|||
170744756|NCT02038764|617073241|FG001|Overall Study|Withdrawal by Subject|0|||
170744757|NCT02038764|617073242|FG002|Overall Study|Withdrawal by Subject|0|||
170744758|NCT02038764|617073243|FG003|Overall Study|Withdrawal by Subject|0|||
170744759|NCT02038764|617073244|FG004|Overall Study|Withdrawal by Subject|1|||
170744760|NCT02038764|617073240|FG000|Overall Study|Other|1|||
170744761|NCT02038764|617073241|FG001|Overall Study|Other|0|||
170744762|NCT02038764|617073242|FG002|Overall Study|Other|1|||
170744763|NCT02038764|617073243|FG003|Overall Study|Other|0|||
170744764|NCT02038764|617073244|FG004|Overall Study|Other|0|||
170744765|NCT04192630|617073247|FG000|Overall Study|Discontinued before surgery|2|||
170744766|NCT04192630|617073248|FG001|Overall Study|Discontinued before surgery|0|||
170744767|NCT04192630|617073247|FG000|Overall Study|Discontinued after surgery|5|||
170744768|NCT04192630|617073248|FG001|Overall Study|Discontinued after surgery|3|||
170744769|NCT01193582|617073249|FG000|Vaccination Series|Withdrawal by Subject|11|||
170744770|NCT01193582|617073250|FG001|Vaccination Series|Withdrawal by Subject|13|||
170744771|NCT01193582|617073251|FG002|Vaccination Series|Withdrawal by Subject|8|||
170744772|NCT01193582|617073252|FG003|Vaccination Series|Withdrawal by Subject|3|||
170744773|NCT01193582|617073249|FG000|12 Month Follow-up|Death|0|||
170744774|NCT01193582|617073250|FG001|12 Month Follow-up|Death|0|||
170744775|NCT01193582|617073251|FG002|12 Month Follow-up|Death|1|||
170744776|NCT01193582|617073252|FG003|12 Month Follow-up|Death|0|||
170744777|NCT01193582|617073249|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
170744778|NCT01193582|617073250|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
170744779|NCT01193582|617073251|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
170744780|NCT01193582|617073252|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
170744781|NCT00779584|617073253|FG000|Overall Study|Protocol Violation|0|||
170515909|NCT02937740|616234790|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
170744782|NCT00779584|617073254|FG001|Overall Study|Protocol Violation|0|||
170744783|NCT00779584|617073255|FG002|Overall Study|Protocol Violation|0|||
170744784|NCT00779584|617073256|FG003|Overall Study|Protocol Violation|0|||
170515910|NCT02937740|616234789|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
170744785|NCT00779584|617073257|FG004|Overall Study|Protocol Violation|0|||
170744786|NCT00779584|617073258|FG005|Overall Study|Protocol Violation|1|||
170744787|NCT00779584|617073259|FG006|Overall Study|Protocol Violation|0|||
170515911|NCT02937740|616234790|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
170515912|NCT02937740|616234789|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
170515913|NCT02937740|616234790|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
170515914|NCT02090283|616234791|FG000|Overall Study|Withdrawal by Subject|6|||
170515915|NCT02090283|616234792|FG001|Overall Study|Withdrawal by Subject|6|||
170515916|NCT02090283|616234793|FG002|Overall Study|Withdrawal by Subject|6|||
170515917|NCT02090283|616234791|FG000|Overall Study|Sponsor Terminated Study|6|||
170515918|NCT02090283|616234792|FG001|Overall Study|Sponsor Terminated Study|6|||
170515919|NCT02090283|616234793|FG002|Overall Study|Sponsor Terminated Study|1|||
170515920|NCT02090283|616234791|FG000|Overall Study|Lost to Follow-up|2|||
170515921|NCT02090283|616234792|FG001|Overall Study|Lost to Follow-up|2|||
170515922|NCT02090283|616234793|FG002|Overall Study|Lost to Follow-up|3|||
170515923|NCT02090283|616234791|FG000|Overall Study|Adverse Event|1|||
170515924|NCT02090283|616234792|FG001|Overall Study|Adverse Event|1|||
170515925|NCT02090283|616234793|FG002|Overall Study|Adverse Event|0|||
170515926|NCT02090283|616234791|FG000|Overall Study|Protocol Violation|2|||
170515927|NCT02090283|616234792|FG001|Overall Study|Protocol Violation|0|||
170515928|NCT02090283|616234793|FG002|Overall Study|Protocol Violation|0|||
170515929|NCT02372383|616234796|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
170515930|NCT02372383|616234797|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
170515931|NCT02372383|616234798|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
170515932|NCT02239640|616234799|FG000|Overall Study|Withdrawal by Subject|3|||
170515933|NCT02239640|616234799|FG000|Overall Study|Lost to Follow-up|72|||
170515934|NCT02239640|616234799|FG000|Overall Study|Death|142|||
170515935|NCT02171429|616234800|FG000|Overall Study|Other|0|||
170515936|NCT02171429|616234801|FG001|Overall Study|Other|1|||
170515937|NCT02171429|616234802|FG002|Overall Study|Other|1|||
170515938|NCT02171429|616234800|FG000|Overall Study|Non-Compliance|0|||
170515939|NCT02171429|616234801|FG001|Overall Study|Non-Compliance|0|||
170515940|NCT02171429|616234802|FG002|Overall Study|Non-Compliance|1|||
170515941|NCT02171429|616234800|FG000|Overall Study|Physician Decision|0|||
170515942|NCT02171429|616234801|FG001|Overall Study|Physician Decision|0|||
170515943|NCT02171429|616234802|FG002|Overall Study|Physician Decision|1|||
170515944|NCT02171429|616234800|FG000|Overall Study|Withdrawal by Subject|1|||
170515945|NCT02171429|616234801|FG001|Overall Study|Withdrawal by Subject|1|||
170515946|NCT02171429|616234802|FG002|Overall Study|Withdrawal by Subject|1|||
170515947|NCT02171429|616234800|FG000|Overall Study|Lost to Follow-up|0|||
170515948|NCT02171429|616234801|FG001|Overall Study|Lost to Follow-up|1|||
170515949|NCT02171429|616234802|FG002|Overall Study|Lost to Follow-up|0|||
170515950|NCT02171429|616234800|FG000|Overall Study|Death|0|||
170515951|NCT02171429|616234801|FG001|Overall Study|Death|0|||
170515952|NCT02171429|616234802|FG002|Overall Study|Death|1|||
170515953|NCT00577772|616234806|FG000|Overall Study|Lost to Follow-up|0|||
170515954|NCT00577772|616234807|FG001|Overall Study|Lost to Follow-up|1|||
170515955|NCT00572455|616234808|FG000|Stage I (14 Days)|Adverse Event|0|||
170515956|NCT00572455|616234809|FG001|Stage I (14 Days)|Adverse Event|0|||
170515957|NCT00572455|616234810|FG002|Stage I (14 Days)|Adverse Event|0|||
170515958|NCT00572455|616234811|FG003|Stage I (14 Days)|Adverse Event|0|||
170515959|NCT00572455|616234812|FG004|Stage I (14 Days)|Adverse Event|0|||
170515960|NCT00572455|616234813|FG005|Stage I (14 Days)|Adverse Event|3|||
170515961|NCT00572455|616234814|FG006|Stage I (14 Days)|Adverse Event|0|||
170515962|NCT00572455|616234815|FG007|Stage I (14 Days)|Adverse Event|0|||
170515963|NCT00572455|616234816|FG008|Stage I (14 Days)|Adverse Event|0|||
170515964|NCT00572455|616234817|FG009|Stage I (14 Days)|Adverse Event|0|||
170515965|NCT00572455|616234818|FG010|Stage I (14 Days)|Adverse Event|0|||
170515966|NCT00572455|616234819|FG011|Stage I (14 Days)|Adverse Event|0|||
170515967|NCT00572455|616234820|FG012|Stage I (14 Days)|Adverse Event|0|||
170515968|NCT00572455|616234821|FG013|Stage I (14 Days)|Adverse Event|0|||
170515969|NCT00572455|616234808|FG000|Stage I (14 Days)|Other|0|||
170515970|NCT00572455|616234809|FG001|Stage I (14 Days)|Other|0|||
170744788|NCT00779584|617073260|FG007|Overall Study|Protocol Violation|0|||
170744789|NCT00779584|617073261|FG008|Overall Study|Protocol Violation|0|||
170744790|NCT00779584|617073253|FG000|Overall Study|Withdrawal by Subject|1|||
170744791|NCT00779584|617073254|FG001|Overall Study|Withdrawal by Subject|1|||
170860258|NCT00307125|617497944|FG000|Screening Phase|Ineligible for pilot|4|||
170744792|NCT00779584|617073255|FG002|Overall Study|Withdrawal by Subject|2|||
170515971|NCT00572455|616234810|FG002|Stage I (14 Days)|Other|0|||
170744793|NCT00779584|617073256|FG003|Overall Study|Withdrawal by Subject|0|||
170515972|NCT00572455|616234811|FG003|Stage I (14 Days)|Other|0|||
170515973|NCT00572455|616234812|FG004|Stage I (14 Days)|Other|1|||
170515974|NCT00572455|616234813|FG005|Stage I (14 Days)|Other|0|||
170515975|NCT00572455|616234814|FG006|Stage I (14 Days)|Other|0|||
170515976|NCT00572455|616234815|FG007|Stage I (14 Days)|Other|0|||
170744794|NCT00779584|617073257|FG004|Overall Study|Withdrawal by Subject|0|||
170744795|NCT00779584|617073258|FG005|Overall Study|Withdrawal by Subject|2|||
170515977|NCT00572455|616234816|FG008|Stage I (14 Days)|Other|0|||
170515978|NCT00572455|616234817|FG009|Stage I (14 Days)|Other|0|||
170515979|NCT00572455|616234818|FG010|Stage I (14 Days)|Other|0|||
170515980|NCT00572455|616234819|FG011|Stage I (14 Days)|Other|0|||
170744796|NCT00779584|617073259|FG006|Overall Study|Withdrawal by Subject|1|||
170515981|NCT00572455|616234820|FG012|Stage I (14 Days)|Other|0|||
170515982|NCT00572455|616234821|FG013|Stage I (14 Days)|Other|0|||
170515983|NCT00572455|616234808|FG000|Stage II (28 Days)|Adverse Event|0|||
170515984|NCT00572455|616234809|FG001|Stage II (28 Days)|Adverse Event|0|||
170515985|NCT00572455|616234810|FG002|Stage II (28 Days)|Adverse Event|0|||
170515986|NCT00572455|616234811|FG003|Stage II (28 Days)|Adverse Event|0|||
170515987|NCT00572455|616234812|FG004|Stage II (28 Days)|Adverse Event|0|||
170515988|NCT00572455|616234813|FG005|Stage II (28 Days)|Adverse Event|0|||
170515989|NCT00572455|616234814|FG006|Stage II (28 Days)|Adverse Event|0|||
170515990|NCT00572455|616234815|FG007|Stage II (28 Days)|Adverse Event|0|||
170515991|NCT00572455|616234816|FG008|Stage II (28 Days)|Adverse Event|1|||
170515992|NCT00572455|616234817|FG009|Stage II (28 Days)|Adverse Event|3|||
170515993|NCT00572455|616234818|FG010|Stage II (28 Days)|Adverse Event|3|||
170515994|NCT00572455|616234819|FG011|Stage II (28 Days)|Adverse Event|4|||
170515995|NCT00572455|616234820|FG012|Stage II (28 Days)|Adverse Event|5|||
170515996|NCT00572455|616234821|FG013|Stage II (28 Days)|Adverse Event|1|||
170515997|NCT00572455|616234808|FG000|Stage II (28 Days)|Death|0|||
170515998|NCT00572455|616234809|FG001|Stage II (28 Days)|Death|0|||
170515999|NCT00572455|616234810|FG002|Stage II (28 Days)|Death|0|||
170516000|NCT00572455|616234811|FG003|Stage II (28 Days)|Death|0|||
170516001|NCT00572455|616234812|FG004|Stage II (28 Days)|Death|0|||
170516002|NCT00572455|616234813|FG005|Stage II (28 Days)|Death|0|||
170744797|NCT00779584|617073260|FG007|Overall Study|Withdrawal by Subject|0|||
170744798|NCT00779584|617073261|FG008|Overall Study|Withdrawal by Subject|0|||
170744799|NCT00779584|617073253|FG000|Overall Study|Lost to Follow-up|0|||
170744800|NCT00779584|617073254|FG001|Overall Study|Lost to Follow-up|0|||
170744801|NCT00779584|617073255|FG002|Overall Study|Lost to Follow-up|0|||
170516003|NCT00572455|616234814|FG006|Stage II (28 Days)|Death|0|||
170516004|NCT00572455|616234815|FG007|Stage II (28 Days)|Death|0|||
170516005|NCT00572455|616234816|FG008|Stage II (28 Days)|Death|1|||
170516006|NCT00572455|616234817|FG009|Stage II (28 Days)|Death|0|||
170516007|NCT00572455|616234818|FG010|Stage II (28 Days)|Death|0|||
170516008|NCT00572455|616234819|FG011|Stage II (28 Days)|Death|0|||
170516009|NCT00572455|616234820|FG012|Stage II (28 Days)|Death|0|||
170516010|NCT00572455|616234821|FG013|Stage II (28 Days)|Death|0|||
170516011|NCT00572455|616234808|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
170516012|NCT00572455|616234809|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
170516013|NCT00572455|616234810|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
170516014|NCT00572455|616234811|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
170516015|NCT00572455|616234812|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
170516016|NCT00572455|616234813|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
170516017|NCT00572455|616234814|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
170516018|NCT00572455|616234815|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
170516019|NCT00572455|616234816|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
170516020|NCT00572455|616234817|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
170516021|NCT00572455|616234818|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
170516022|NCT00572455|616234819|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
170516023|NCT00572455|616234820|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
170516024|NCT00572455|616234821|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
170516025|NCT00572455|616234808|FG000|Stage II (28 Days)|Other|0|||
170516026|NCT00572455|616234809|FG001|Stage II (28 Days)|Other|0|||
170516027|NCT00572455|616234810|FG002|Stage II (28 Days)|Other|0|||
170516028|NCT00572455|616234811|FG003|Stage II (28 Days)|Other|0|||
170516029|NCT00572455|616234812|FG004|Stage II (28 Days)|Other|0|||
170516030|NCT00572455|616234813|FG005|Stage II (28 Days)|Other|0|||
170516031|NCT00572455|616234814|FG006|Stage II (28 Days)|Other|0|||
170516032|NCT00572455|616234815|FG007|Stage II (28 Days)|Other|0|||
170516033|NCT00572455|616234816|FG008|Stage II (28 Days)|Other|1|||
170516034|NCT00572455|616234817|FG009|Stage II (28 Days)|Other|0|||
170516035|NCT00572455|616234818|FG010|Stage II (28 Days)|Other|0|||
170744802|NCT00779584|617073256|FG003|Overall Study|Lost to Follow-up|0|||
170744803|NCT00779584|617073257|FG004|Overall Study|Lost to Follow-up|1|||
170744804|NCT00779584|617073258|FG005|Overall Study|Lost to Follow-up|0|||
170744805|NCT00779584|617073259|FG006|Overall Study|Lost to Follow-up|0|||
170744806|NCT00779584|617073260|FG007|Overall Study|Lost to Follow-up|0|||
170744807|NCT00779584|617073261|FG008|Overall Study|Lost to Follow-up|0|||
170516036|NCT00572455|616234819|FG011|Stage II (28 Days)|Other|0|||
170744808|NCT00779584|617073253|FG000|Overall Study|Progression of Disease|0|||
170516037|NCT00572455|616234820|FG012|Stage II (28 Days)|Other|0|||
170516038|NCT00572455|616234821|FG013|Stage II (28 Days)|Other|0|||
170516039|NCT00572455|616234808|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
170516040|NCT00572455|616234809|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
170516041|NCT00572455|616234810|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
170516042|NCT00572455|616234811|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
170516043|NCT00572455|616234812|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
170516044|NCT00572455|616234813|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
170516045|NCT00572455|616234814|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
170516046|NCT00572455|616234815|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
170516047|NCT00572455|616234816|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
170630135|NCT00463567|616660407|FG003|Overall Study|Lost to Follow-up|8|||
170744809|NCT00779584|617073254|FG001|Overall Study|Progression of Disease|1|||
170744810|NCT00779584|617073255|FG002|Overall Study|Progression of Disease|2|||
170744811|NCT00779584|617073256|FG003|Overall Study|Progression of Disease|6|||
170516048|NCT00572455|616234817|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
170516049|NCT00572455|616234818|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
170516050|NCT00572455|616234819|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
170516051|NCT00572455|616234820|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
170516052|NCT00572455|616234821|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
170516053|NCT00613821|616234822|FG000|Overall Study|Withdrawal by Subject|1|||
170516054|NCT00613821|616234823|FG001|Overall Study|Withdrawal by Subject|0|||
170516055|NCT00613821|616234822|FG000|Overall Study|Physician Decision|1|||
170516056|NCT00613821|616234823|FG001|Overall Study|Physician Decision|1|||
170516057|NCT00141518|616234825|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
170516058|NCT00141518|616234826|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
170516059|NCT00141518|616234827|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
170516060|NCT00141518|616234825|FG000|Overall Study|Adverse Event|7|||
170516061|NCT00141518|616234826|FG001|Overall Study|Adverse Event|5|||
170516062|NCT00141518|616234827|FG002|Overall Study|Adverse Event|2|||
170516063|NCT00141518|616234825|FG000|Overall Study|Withdrawal by Subject|2|||
170516064|NCT00141518|616234826|FG001|Overall Study|Withdrawal by Subject|0|||
170516065|NCT00141518|616234827|FG002|Overall Study|Withdrawal by Subject|2|||
170516066|NCT00141518|616234825|FG000|Overall Study|Protocol Violation|1|||
170516067|NCT00141518|616234826|FG001|Overall Study|Protocol Violation|1|||
170516068|NCT00141518|616234827|FG002|Overall Study|Protocol Violation|2|||
170516069|NCT00141518|616234825|FG000|Overall Study|Lack of Efficacy|5|||
170516070|NCT00141518|616234826|FG001|Overall Study|Lack of Efficacy|0|||
170516071|NCT00141518|616234827|FG002|Overall Study|Lack of Efficacy|0|||
170516072|NCT01806168|616234829|FG000|Overall Study|Adverse Event|1|||
170516073|NCT01806168|616234830|FG001|Overall Study|Adverse Event|0|||
170516074|NCT01806168|616234831|FG002|Overall Study|Adverse Event|0|||
170516075|NCT01806168|616234829|FG000|Overall Study|Withdrawal by Subject|0|||
170516076|NCT01806168|616234830|FG001|Overall Study|Withdrawal by Subject|1|||
170744812|NCT00779584|617073257|FG004|Overall Study|Progression of Disease|5|||
170744813|NCT00779584|617073258|FG005|Overall Study|Progression of Disease|1|||
170744814|NCT00779584|617073259|FG006|Overall Study|Progression of Disease|4|||
170744815|NCT00779584|617073260|FG007|Overall Study|Progression of Disease|2|||
170744816|NCT00779584|617073261|FG008|Overall Study|Progression of Disease|1|||
170744817|NCT00779584|617073253|FG000|Overall Study|Adverse Event|1|||
170744818|NCT00779584|617073254|FG001|Overall Study|Adverse Event|0|||
170744819|NCT00779584|617073255|FG002|Overall Study|Adverse Event|2|||
170744820|NCT00779584|617073256|FG003|Overall Study|Adverse Event|0|||
170744821|NCT00779584|617073257|FG004|Overall Study|Adverse Event|0|||
170516077|NCT01806168|616234831|FG002|Overall Study|Withdrawal by Subject|2|||
170516078|NCT01806168|616234829|FG000|Overall Study|Protocol Violation|0|||
170516079|NCT01806168|616234830|FG001|Overall Study|Protocol Violation|0|||
170516080|NCT01806168|616234831|FG002|Overall Study|Protocol Violation|1|||
170744822|NCT00779584|617073258|FG005|Overall Study|Adverse Event|0|||
170744823|NCT00779584|617073259|FG006|Overall Study|Adverse Event|2|||
170744824|NCT00779584|617073260|FG007|Overall Study|Adverse Event|1|||
170860259|NCT00307125|617497945|FG001|Screening Phase|Ineligible for pilot|0|||
170516081|NCT01029262|616234837|FG000|Overall Study|Adverse Event|9|||
170516082|NCT01029262|616234838|FG001|Overall Study|Adverse Event|52|||
170516083|NCT01029262|616234837|FG000|Overall Study|Lack of therapeutic effect|57|||
170516084|NCT01029262|616234838|FG001|Overall Study|Lack of therapeutic effect|76|||
170516085|NCT01029262|616234837|FG000|Overall Study|Withdrawal by Subject|10|||
170516086|NCT01029262|616234838|FG001|Overall Study|Withdrawal by Subject|17|||
170516087|NCT01029262|616234837|FG000|Overall Study|Protocol Violation|2|||
170516088|NCT01029262|616234838|FG001|Overall Study|Protocol Violation|3|||
170516089|NCT01029262|616234837|FG000|Overall Study|Miscellaneous|1|||
170516090|NCT01029262|616234838|FG001|Overall Study|Miscellaneous|9|||
170516091|NCT01029262|616234837|FG000|Overall Study|Death|0|||
170516092|NCT01029262|616234838|FG001|Overall Study|Death|3|||
170516093|NCT01001910|616234839|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
170516094|NCT01468454|616234840|FG000|Overall Study|Did not have surgery after PET|9|||
170516095|NCT03200548|616234841|FG000|Overall Study|Withdrawal by Subject|5|||
170516096|NCT03200548|616234842|FG001|Overall Study|Withdrawal by Subject|11|||
170516097|NCT03200548|616234843|FG002|Overall Study|Withdrawal by Subject|7|||
170516098|NCT03200548|616234844|FG003|Overall Study|Withdrawal by Subject|6|||
170516099|NCT02896569|616234847|FG000|Overall Study|Lost to Follow-up|2|||
170516100|NCT02896569|616234848|FG001|Overall Study|Lost to Follow-up|1|||
170516101|NCT02896569|616234847|FG000|Overall Study|Physician Decision|1|||
170516102|NCT02896569|616234848|FG001|Overall Study|Physician Decision|3|||
170516103|NCT02896569|616234847|FG000|Overall Study|Adverse Event|0|||
170516104|NCT02896569|616234848|FG001|Overall Study|Adverse Event|1|||
170516105|NCT02896569|616234847|FG000|Overall Study|Withdrawal by Subject|1|||
170516106|NCT02896569|616234848|FG001|Overall Study|Withdrawal by Subject|0|||
170516107|NCT01462630|616234849|FG000|Overall Study|Did not initiate therapy|3|||
170744825|NCT00779584|617073261|FG008|Overall Study|Adverse Event|1|||
170516108|NCT01462630|616234849|FG000|Overall Study|Death|1|||
170516109|NCT01462630|616234849|FG000|Overall Study|Protocol Violation|2|||
170516110|NCT01462630|616234849|FG000|Overall Study|Adverse Event|1|||
170516111|NCT03428100|616234850|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
170516112|NCT03428100|616234851|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516113|NCT03428100|616234852|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
170516114|NCT03428100|616234853|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
170516115|NCT03428100|616234854|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516116|NCT03428100|616234855|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516117|NCT03428100|616234856|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516118|NCT03428100|616234857|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516119|NCT03428100|616234858|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516120|NCT03428100|616234859|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516121|NCT03428100|616234860|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516122|NCT03428100|616234861|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516123|NCT03428100|616234862|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516124|NCT03428100|616234863|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516125|NCT03428100|616234864|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516126|NCT03428100|616234865|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516127|NCT03428100|616234866|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516128|NCT03428100|616234867|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516129|NCT03428100|616234868|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
170516130|NCT03428100|616234850|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
170516131|NCT03428100|616234851|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
170516132|NCT03428100|616234852|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
170516133|NCT03428100|616234853|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
170516134|NCT03428100|616234854|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516135|NCT03428100|616234855|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516136|NCT03428100|616234856|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516137|NCT03428100|616234857|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516138|NCT03428100|616234858|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516139|NCT03428100|616234859|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516140|NCT03428100|616234860|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516141|NCT03428100|616234861|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516142|NCT03428100|616234862|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516143|NCT03428100|616234863|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516144|NCT03428100|616234864|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516145|NCT03428100|616234865|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516146|NCT03428100|616234866|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516147|NCT03428100|616234867|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516148|NCT03428100|616234868|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
170516149|NCT03428100|616234850|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516150|NCT03428100|616234851|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
170516151|NCT03428100|616234852|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
170516152|NCT03428100|616234853|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170744826|NCT00779584|617073253|FG000|Overall Study|Symptomatic Deterioration|1|||
170744827|NCT00779584|617073254|FG001|Overall Study|Symptomatic Deterioration|1|||
170744828|NCT00779584|617073255|FG002|Overall Study|Symptomatic Deterioration|1|||
170744829|NCT00779584|617073256|FG003|Overall Study|Symptomatic Deterioration|0|||
170744830|NCT00779584|617073257|FG004|Overall Study|Symptomatic Deterioration|0|||
170860260|NCT00307125|617497946|FG002|Screening Phase|Ineligible for pilot|0|||
170860261|NCT00307125|617497944|FG000|Screening Phase|Try to get pregnant|1|||
170516153|NCT03428100|616234854|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516154|NCT03428100|616234855|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516155|NCT03428100|616234856|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516156|NCT03428100|616234857|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516157|NCT03428100|616234858|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516158|NCT03428100|616234859|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516159|NCT03428100|616234860|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516160|NCT03428100|616234861|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516161|NCT03428100|616234862|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516162|NCT03428100|616234863|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516163|NCT03428100|616234864|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516164|NCT03428100|616234865|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170744831|NCT00779584|617073258|FG005|Overall Study|Symptomatic Deterioration|1|||
170744832|NCT00779584|617073259|FG006|Overall Study|Symptomatic Deterioration|1|||
170516165|NCT03428100|616234866|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516166|NCT03428100|616234867|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516167|NCT03428100|616234868|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
170516168|NCT03428100|616234850|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
170516169|NCT03428100|616234851|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516170|NCT03428100|616234852|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516171|NCT03428100|616234853|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516172|NCT03428100|616234854|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516173|NCT03428100|616234855|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516174|NCT03428100|616234856|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516175|NCT03428100|616234857|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516176|NCT03428100|616234858|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516177|NCT03428100|616234859|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516178|NCT03428100|616234860|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516179|NCT03428100|616234861|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516180|NCT03428100|616234862|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516181|NCT03428100|616234863|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516182|NCT03428100|616234864|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516183|NCT03428100|616234865|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516184|NCT03428100|616234866|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516185|NCT03428100|616234867|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516186|NCT03428100|616234868|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
170516187|NCT03428100|616234850|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516188|NCT03428100|616234851|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
170516189|NCT03428100|616234852|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516190|NCT03428100|616234853|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516191|NCT03428100|616234854|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516192|NCT03428100|616234855|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516193|NCT03428100|616234856|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516194|NCT03428100|616234857|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516195|NCT03428100|616234858|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516196|NCT03428100|616234859|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516197|NCT03428100|616234860|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516198|NCT03428100|616234861|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516199|NCT03428100|616234862|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516200|NCT03428100|616234863|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516201|NCT03428100|616234864|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516202|NCT03428100|616234865|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516203|NCT03428100|616234866|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516204|NCT03428100|616234867|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516205|NCT03428100|616234868|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
170516206|NCT03428100|616234850|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170516207|NCT03428100|616234851|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170516208|NCT03428100|616234852|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170516209|NCT03428100|616234853|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170516210|NCT03428100|616234854|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170516211|NCT03428100|616234855|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
170516212|NCT03428100|616234856|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
170516213|NCT03428100|616234857|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
170516214|NCT03428100|616234858|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
170516215|NCT03428100|616234859|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170516216|NCT03428100|616234860|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
170516217|NCT03428100|616234861|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170744833|NCT00779584|617073260|FG007|Overall Study|Symptomatic Deterioration|0|||
170744834|NCT00779584|617073261|FG008|Overall Study|Symptomatic Deterioration|0|||
170744835|NCT00779584|617073253|FG000|Overall Study|Ongoing in Study|0|||
170744836|NCT00779584|617073254|FG001|Overall Study|Ongoing in Study|0|||
170744837|NCT00779584|617073255|FG002|Overall Study|Ongoing in Study|0|||
170744838|NCT00779584|617073256|FG003|Overall Study|Ongoing in Study|0|||
170744839|NCT00779584|617073257|FG004|Overall Study|Ongoing in Study|1|||
170744840|NCT00779584|617073258|FG005|Overall Study|Ongoing in Study|1|||
170744841|NCT00779584|617073259|FG006|Overall Study|Ongoing in Study|0|||
170744842|NCT00779584|617073260|FG007|Overall Study|Ongoing in Study|0|||
170744843|NCT00779584|617073261|FG008|Overall Study|Ongoing in Study|0|||
170744844|NCT01775930|617073271|FG000|Overall Study|Futility stopping boundary met|1|||
170744845|NCT01115491|617073274|FG000|Overall Study|Death|22|||
170744846|NCT01115491|617073274|FG000|Overall Study|Adverse Event|3|||
170744847|NCT01115491|617073274|FG000|Overall Study|Lost to Follow-up|3|||
170744848|NCT01115491|617073274|FG000|Overall Study|Withdrawal by Subject|1|||
170744849|NCT01115491|617073274|FG000|Overall Study|Physician Decision|1|||
170744850|NCT02340520|617073275|FG000|Overall Study|Lost to Follow-up|1|||
170744851|NCT02340520|617073275|FG000|Overall Study|Patient did not take drug as specified|1|||
170744852|NCT02340520|617073275|FG000|Overall Study|Withdrawal by Subject|1|||
170744853|NCT01586338|617073278|FG000|Overall Study|Adverse Event|3|||
170744854|NCT01586338|617073278|FG000|Overall Study|Lost to Follow-up|1|||
170744855|NCT01586338|617073278|FG000|Overall Study|Withdrawal by participant|3|||
170744856|NCT01586338|617073278|FG000|Overall Study|Other|1|||
170744857|NCT01234649|617073279|FG000|Overall Study|Withdrawal by Subject|32|||
170744858|NCT01234649|617073280|FG001|Overall Study|Withdrawal by Subject|26|||
170744859|NCT01234649|617073279|FG000|Overall Study|Pregnancy|6|||
170744860|NCT01234649|617073280|FG001|Overall Study|Pregnancy|6|||
170744861|NCT01234649|617073279|FG000|Overall Study|intolerant to side effects|4|||
170744862|NCT01234649|617073280|FG001|Overall Study|intolerant to side effects|3|||
170744863|NCT01234649|617073279|FG000|Overall Study|Allergic reaction|1|||
170744864|NCT01234649|617073280|FG001|Overall Study|Allergic reaction|0|||
170744865|NCT01234649|617073279|FG000|Overall Study|Lack of Efficacy|0|||
170744866|NCT01234649|617073280|FG001|Overall Study|Lack of Efficacy|3|||
170744867|NCT03679767|617073284|FG000|Overall Study|Death|16|||
170744868|NCT03679767|617073285|FG001|Overall Study|Death|11|||
170744869|NCT03679767|617073286|FG002|Overall Study|Death|17|||
170860262|NCT00307125|617497945|FG001|Screening Phase|Try to get pregnant|0|||
170860263|NCT00307125|617497946|FG002|Screening Phase|Try to get pregnant|0|||
170860264|NCT00307125|617497944|FG000|Screening Phase|Developed acute leukemia|1|||
170860265|NCT00307125|617497945|FG001|Screening Phase|Developed acute leukemia|0|||
170860266|NCT00307125|617497946|FG002|Screening Phase|Developed acute leukemia|0|||
170860267|NCT00307125|617497944|FG000|Screening Phase|Metastatic colon cancer|1|||
170860268|NCT00307125|617497945|FG001|Screening Phase|Metastatic colon cancer|0|||
170860269|NCT00307125|617497946|FG002|Screening Phase|Metastatic colon cancer|0|||
170860270|NCT00307125|617497944|FG000|Screening Phase|Malignancy|1|||
170860271|NCT00307125|617497945|FG001|Screening Phase|Malignancy|0|||
170860272|NCT00307125|617497946|FG002|Screening Phase|Malignancy|0|||
170860273|NCT00307125|617497944|FG000|Screening Phase|PAK|1|||
170860274|NCT00307125|617497945|FG001|Screening Phase|PAK|0|||
170860275|NCT00307125|617497946|FG002|Screening Phase|PAK|0|||
170860276|NCT00307125|617497944|FG000|Screening Phase|Ineligible|1|||
170860277|NCT00307125|617497945|FG001|Screening Phase|Ineligible|0|||
170516218|NCT03428100|616234862|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
170516219|NCT03428100|616234863|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
170516220|NCT03428100|616234864|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
170860278|NCT00307125|617497946|FG002|Screening Phase|Ineligible|0|||
170860279|NCT00307125|617497944|FG000|Screening Phase|Screen Error|1|||
170860280|NCT00307125|617497945|FG001|Screening Phase|Screen Error|0|||
170860281|NCT00307125|617497946|FG002|Screening Phase|Screen Error|0|||
170860282|NCT00307125|617497944|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
170860283|NCT00307125|617497945|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
170860284|NCT00307125|617497946|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
170860285|NCT00307125|617497944|FG000|Screening Phase|AMR and treated with rituximab|1|||
170860286|NCT00307125|617497945|FG001|Screening Phase|AMR and treated with rituximab|0|||
170860287|NCT00307125|617497946|FG002|Screening Phase|AMR and treated with rituximab|0|||
170860288|NCT00307125|617497944|FG000|Screening Phase|Coronary artery bypass|1|||
170860289|NCT00307125|617497945|FG001|Screening Phase|Coronary artery bypass|0|||
170860290|NCT00307125|617497946|FG002|Screening Phase|Coronary artery bypass|0|||
170860291|NCT00307125|617497944|FG000|Pilot Phase|Lost to Follow-up|0|||
170860292|NCT00307125|617497945|FG001|Pilot Phase|Lost to Follow-up|1|||
170860293|NCT00307125|617497946|FG002|Pilot Phase|Lost to Follow-up|0|||
170860294|NCT00307125|617497944|FG000|Pilot Phase|Withdrawal by Subject|0|||
170860295|NCT00307125|617497945|FG001|Pilot Phase|Withdrawal by Subject|1|||
170860296|NCT00307125|617497946|FG002|Pilot Phase|Withdrawal by Subject|1|||
170860297|NCT01012713|617497948|FG000|Overall Study|Lack of Efficacy|3|||
170860298|NCT00985153|617497949|FG000|Overall Study|Lost to Follow-up|16|||
170860299|NCT00985153|617497950|FG001|Overall Study|Lost to Follow-up|19|||
170860300|NCT00985153|617497951|FG002|Overall Study|Lost to Follow-up|17|||
170744870|NCT03679767|617073287|FG003|Overall Study|Death|10|||
170744871|NCT03679767|617073284|FG000|Overall Study|Lost to Follow-up|1|||
170744872|NCT03679767|617073285|FG001|Overall Study|Lost to Follow-up|1|||
170744873|NCT03679767|617073286|FG002|Overall Study|Lost to Follow-up|1|||
170744874|NCT03679767|617073287|FG003|Overall Study|Lost to Follow-up|1|||
170744875|NCT03679767|617073284|FG000|Overall Study|Withdrawal by Subject|0|||
170744876|NCT03679767|617073285|FG001|Overall Study|Withdrawal by Subject|0|||
170744877|NCT03679767|617073286|FG002|Overall Study|Withdrawal by Subject|0|||
170860301|NCT00985153|617497952|FG003|Overall Study|Lost to Follow-up|20|||
170860302|NCT00985153|617497949|FG000|Overall Study|Protocol Violation|3|||
170860303|NCT00985153|617497950|FG001|Overall Study|Protocol Violation|2|||
170744878|NCT03679767|617073287|FG003|Overall Study|Withdrawal by Subject|1|||
170744879|NCT03679767|617073284|FG000|Overall Study|Follow-up Completed|18|||
170744880|NCT03679767|617073285|FG001|Overall Study|Follow-up Completed|11|||
170744881|NCT03679767|617073286|FG002|Overall Study|Follow-up Completed|11|||
170744882|NCT03679767|617073287|FG003|Overall Study|Follow-up Completed|20|||
170744883|NCT03679767|617073284|FG000|Overall Study|Entered Hospice Care|0|||
170744884|NCT03679767|617073285|FG001|Overall Study|Entered Hospice Care|0|||
170744885|NCT03679767|617073286|FG002|Overall Study|Entered Hospice Care|0|||
170744886|NCT03679767|617073287|FG003|Overall Study|Entered Hospice Care|1|||
170744887|NCT03679767|617073284|FG000|Overall Study|Progressive Disease|0|||
170744888|NCT03679767|617073285|FG001|Overall Study|Progressive Disease|0|||
170744889|NCT03679767|617073286|FG002|Overall Study|Progressive Disease|0|||
170744890|NCT03679767|617073287|FG003|Overall Study|Progressive Disease|1|||
170744891|NCT05407311|617073288|FG000|Overall Study|Withdrawal by Subject|5|||
170744892|NCT05407311|617073288|FG000|Overall Study|Protocol Violation|3|||
170744893|NCT05407311|617073288|FG000|Overall Study|Physician Decision|1|||
170744894|NCT05407311|617073288|FG000|Overall Study|Non-compliance|1|||
170744895|NCT04844970|617073289|FG000|Overall Study|Adverse Event|0|||
170744896|NCT04844970|617073290|FG001|Overall Study|Adverse Event|1|||
170744897|NCT04844970|617073289|FG000|Overall Study|Withdrawal by Subject|2|||
170744898|NCT04844970|617073290|FG001|Overall Study|Withdrawal by Subject|0|||
170744899|NCT03169881|617073291|FG000|Overall Study|Incomplete Follow-up|10|||
170744900|NCT03169881|617073292|FG001|Overall Study|Incomplete Follow-up|15|||
170744901|NCT03169881|617073291|FG000|Overall Study|Lost to Follow-up|18|||
170744902|NCT03169881|617073292|FG001|Overall Study|Lost to Follow-up|20|||
170744903|NCT03169881|617073291|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
170744904|NCT03169881|617073292|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
170744905|NCT00447954|617073295|FG000|Overall Study|Adverse Event|0|||
170744906|NCT00447954|617073296|FG001|Overall Study|Adverse Event|2|||
170744907|NCT00447954|617073297|FG002|Overall Study|Adverse Event|0|||
170744908|NCT00447954|617073295|FG000|Overall Study|Withdrawal by Subject|0|||
170744909|NCT00447954|617073296|FG001|Overall Study|Withdrawal by Subject|1|||
170744910|NCT00447954|617073297|FG002|Overall Study|Withdrawal by Subject|1|||
170744911|NCT00447954|617073295|FG000|Overall Study|Lost to Follow-up|0|||
170744912|NCT00447954|617073296|FG001|Overall Study|Lost to Follow-up|1|||
170744913|NCT00447954|617073297|FG002|Overall Study|Lost to Follow-up|0|||
170744914|NCT00447954|617073295|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
170744915|NCT00447954|617073296|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
170744916|NCT00447954|617073297|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
170744917|NCT02180438|617073298|FG000|Overall Study|Lost to Follow-up|1|||
170744918|NCT01351025|617073299|FG000|Week 0 - 20|Lost to Follow-up|2|||
170744919|NCT01351025|617073300|FG001|Week 0 - 20|Lost to Follow-up|1|||
170744920|NCT01351025|617073299|FG000|Week 0 - 20|Withdrawal by Subject|1|||
170744921|NCT01351025|617073300|FG001|Week 0 - 20|Withdrawal by Subject|0|||
170744922|NCT01351025|617073299|FG000|Week 24 - 44|Lost to Follow-up|0|||
170744923|NCT01351025|617073300|FG001|Week 24 - 44|Lost to Follow-up|2|||
170744924|NCT01351025|617073299|FG000|Week 24 - 44|Site closed|0|||
170744925|NCT01351025|617073300|FG001|Week 24 - 44|Site closed|1|||
170744926|NCT01351025|617073299|FG000|Week 24 - 44|unable to get to clinic|1|||
170744927|NCT01351025|617073300|FG001|Week 24 - 44|unable to get to clinic|1|||
170744928|NCT03734991|617073301|FG000|Overall Study|Adverse Event|4|||
170744929|NCT03734991|617073302|FG001|Overall Study|Adverse Event|0|||
170744930|NCT03734991|617073301|FG000|Overall Study|Lost to Follow-up|4|||
170744931|NCT03734991|617073302|FG001|Overall Study|Lost to Follow-up|0|||
170744932|NCT03734991|617073301|FG000|Overall Study|Physician Decision|0|||
170744933|NCT03734991|617073302|FG001|Overall Study|Physician Decision|1|||
170744934|NCT03734991|617073301|FG000|Overall Study|Pregnancy|1|||
170744935|NCT03734991|617073302|FG001|Overall Study|Pregnancy|0|||
170744936|NCT03734991|617073301|FG000|Overall Study|Withdrawal by Subject|6|||
170744937|NCT03734991|617073302|FG001|Overall Study|Withdrawal by Subject|3|||
170744938|NCT03734991|617073301|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
170744939|NCT03734991|617073302|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
170744940|NCT03734991|617073301|FG000|Overall Study|Other|2|||
170744941|NCT03734991|617073302|FG001|Overall Study|Other|2|||
170744942|NCT00180713|617073303|FG000|Overall Study|Withdrawal by Subject|2|||
170744943|NCT00180713|617073304|FG001|Overall Study|Withdrawal by Subject|0|||
170744944|NCT00180713|617073303|FG000|Overall Study|Adverse Event|3|||
170744945|NCT00180713|617073304|FG001|Overall Study|Adverse Event|3|||
170744946|NCT01164228|617073310|FG000|Overall Study|Progression|24|||
170744947|NCT01164228|617073311|FG001|Overall Study|Progression|25|||
170744948|NCT01164228|617073310|FG000|Overall Study|Adverse Event|13|||
170744949|NCT01164228|617073311|FG001|Overall Study|Adverse Event|7|||
170744950|NCT01164228|617073310|FG000|Overall Study|Death|1|||
170744951|NCT01164228|617073311|FG001|Overall Study|Death|1|||
170744952|NCT01164228|617073310|FG000|Overall Study|Withdrawal by Subject|2|||
170744953|NCT01164228|617073311|FG001|Overall Study|Withdrawal by Subject|0|||
170744954|NCT01164228|617073310|FG000|Overall Study|Physician Decision|1|||
170744955|NCT01164228|617073311|FG001|Overall Study|Physician Decision|2|||
170744956|NCT01164228|617073310|FG000|Overall Study|Symptomatic deterioration|1|||
170744957|NCT01164228|617073311|FG001|Overall Study|Symptomatic deterioration|0|||
170744958|NCT01164228|617073310|FG000|Overall Study|Never started treatment|1|||
170744959|NCT01164228|617073311|FG001|Overall Study|Never started treatment|3|||
170744960|NCT01164228|617073310|FG000|Overall Study|Ineligible|1|||
170744961|NCT01164228|617073311|FG001|Overall Study|Ineligible|0|||
170744962|NCT02401308|617073312|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
170744963|NCT02401308|617073313|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
170744964|NCT02998021|617073314|FG000|Overall Study|Withdrawal by Subject|3|||
170744965|NCT02998021|617073315|FG001|Overall Study|Withdrawal by Subject|1|||
170744966|NCT02998021|617073314|FG000|Overall Study|unsafe home|0|||
170744967|NCT02998021|617073315|FG001|Overall Study|unsafe home|1|||
170744968|NCT02041923|617073316|FG000|Overall Study|Lost to Follow-up|26|||
170744969|NCT02041923|617073317|FG001|Overall Study|Lost to Follow-up|30|||
170744970|NCT00309608|617073318|FG000|Overall Study|Adverse Event|1|||
170744971|NCT00309608|617073319|FG001|Overall Study|Adverse Event|5|||
170744972|NCT00309608|617073320|FG002|Overall Study|Adverse Event|3|||
170744973|NCT00309608|617073321|FG003|Overall Study|Adverse Event|2|||
170744974|NCT00309608|617073322|FG004|Overall Study|Adverse Event|3|||
170744975|NCT00309608|617073318|FG000|Overall Study|Protocol Violation|2|||
170744976|NCT00309608|617073319|FG001|Overall Study|Protocol Violation|0|||
170744977|NCT00309608|617073320|FG002|Overall Study|Protocol Violation|0|||
170744978|NCT00309608|617073321|FG003|Overall Study|Protocol Violation|0|||
170744979|NCT00309608|617073322|FG004|Overall Study|Protocol Violation|0|||
170744980|NCT00309608|617073318|FG000|Overall Study|Lost to Follow-up|0|||
170744981|NCT00309608|617073319|FG001|Overall Study|Lost to Follow-up|0|||
170744982|NCT00309608|617073320|FG002|Overall Study|Lost to Follow-up|2|||
170744983|NCT00309608|617073321|FG003|Overall Study|Lost to Follow-up|0|||
170744984|NCT00309608|617073322|FG004|Overall Study|Lost to Follow-up|1|||
170744985|NCT00309608|617073318|FG000|Overall Study|Withdrawal by Subject|1|||
170744986|NCT00309608|617073319|FG001|Overall Study|Withdrawal by Subject|4|||
170744987|NCT00309608|617073320|FG002|Overall Study|Withdrawal by Subject|2|||
170744988|NCT00309608|617073321|FG003|Overall Study|Withdrawal by Subject|0|||
170744989|NCT00309608|617073322|FG004|Overall Study|Withdrawal by Subject|0|||
170744990|NCT00309608|617073318|FG000|Overall Study|Other incl. Lack of efficacy|10|||
170744991|NCT00309608|617073319|FG001|Overall Study|Other incl. Lack of efficacy|4|||
170744992|NCT00309608|617073320|FG002|Overall Study|Other incl. Lack of efficacy|3|||
170744993|NCT00309608|617073321|FG003|Overall Study|Other incl. Lack of efficacy|4|||
170744994|NCT00309608|617073322|FG004|Overall Study|Other incl. Lack of efficacy|0|||
170806882|NCT03389802|617301650|FG001|Overall Study|Adverse Event|0|||
170806883|NCT03389802|617301651|FG002|Overall Study|Adverse Event|1|||
170806884|NCT03389802|617301652|FG003|Overall Study|Adverse Event|0|||
170806885|NCT03389802|617301653|FG004|Overall Study|Adverse Event|4|||
170806886|NCT03389802|617301649|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
170806887|NCT03389802|617301650|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
170806888|NCT03389802|617301651|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
170806889|NCT03389802|617301652|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
170806890|NCT03389802|617301653|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
170806891|NCT02426138|617301654|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
170806892|NCT02426138|617301655|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
170806893|NCT03697603|617301663|FG000|Overall Study|Adverse Event|3|||
170806894|NCT03697603|617301664|FG001|Overall Study|Adverse Event|18|||
170806895|NCT03697603|617301665|FG002|Overall Study|Adverse Event|3|||
170860304|NCT00985153|617497951|FG002|Overall Study|Protocol Violation|4|||
170860305|NCT00985153|617497952|FG003|Overall Study|Protocol Violation|3|||
170860306|NCT00985153|617497949|FG000|Overall Study|Withdrawal by Subject|6|||
170860307|NCT00985153|617497950|FG001|Overall Study|Withdrawal by Subject|11|||
170860308|NCT00985153|617497951|FG002|Overall Study|Withdrawal by Subject|11|||
170860309|NCT00985153|617497952|FG003|Overall Study|Withdrawal by Subject|10|||
170860310|NCT00985153|617497949|FG000|Overall Study|Missed One or More Bleeds|7|||
170860311|NCT00985153|617497950|FG001|Overall Study|Missed One or More Bleeds|7|||
170860312|NCT00985153|617497951|FG002|Overall Study|Missed One or More Bleeds|8|||
170860313|NCT00985153|617497952|FG003|Overall Study|Missed One or More Bleeds|10|||
170860314|NCT00985153|617497949|FG000|Overall Study|Incomplete Safety Follow-up|3|||
170860315|NCT00985153|617497950|FG001|Overall Study|Incomplete Safety Follow-up|5|||
170860316|NCT00985153|617497951|FG002|Overall Study|Incomplete Safety Follow-up|4|||
170860317|NCT00985153|617497952|FG003|Overall Study|Incomplete Safety Follow-up|4|||
170860318|NCT01679405|617497954|FG000|Overall Study|Death|2|||
170860319|NCT01679405|617497955|FG001|Overall Study|Death|5|||
170860320|NCT04677179|617497956|FG000|Induction Treatment Period|Adverse Event|1|||
170806896|NCT03697603|617301663|FG000|Overall Study|Physician Decision|1|||
170806897|NCT03697603|617301664|FG001|Overall Study|Physician Decision|0|||
170806898|NCT03697603|617301665|FG002|Overall Study|Physician Decision|2|||
170806899|NCT03697603|617301663|FG000|Overall Study|Protocol Violation|3|||
170806900|NCT03697603|617301664|FG001|Overall Study|Protocol Violation|8|||
170860321|NCT04677179|617497957|FG001|Induction Treatment Period|Adverse Event|0|||
170744995|NCT01681368|617076046|FG000|Overall Study|Refused further treatment|1|||
170744996|NCT01681368|617076046|FG000|Overall Study|Refused further follow up|1|||
170744997|NCT00592319|617076047|FG000|Overall Study|Lost to Follow-up|0|||
170744998|NCT00592319|617076048|FG001|Overall Study|Lost to Follow-up|3|||
170744999|NCT01807221|617076049|FG000|Overall Study|Progressive disease|1|||
170745000|NCT01807221|617076050|FG001|Overall Study|Progressive disease|0|||
170745001|NCT01807221|617076051|FG002|Overall Study|Progressive disease|1|||
170745002|NCT01807221|617076052|FG003|Overall Study|Progressive disease|0|||
170745003|NCT01807221|617076053|FG004|Overall Study|Progressive disease|0|||
170745004|NCT01807221|617076054|FG005|Overall Study|Progressive disease|0|||
170745005|NCT01807221|617076049|FG000|Overall Study|Death|7|||
170745006|NCT01807221|617076050|FG001|Overall Study|Death|9|||
170745007|NCT01807221|617076051|FG002|Overall Study|Death|4|||
170745008|NCT01807221|617076052|FG003|Overall Study|Death|2|||
170745009|NCT01807221|617076053|FG004|Overall Study|Death|1|||
170745010|NCT01807221|617076054|FG005|Overall Study|Death|6|||
170745011|NCT01807221|617076049|FG000|Overall Study|Physician Decision|2|||
170745012|NCT01807221|617076050|FG001|Overall Study|Physician Decision|1|||
170745013|NCT01807221|617076051|FG002|Overall Study|Physician Decision|0|||
170745014|NCT01807221|617076052|FG003|Overall Study|Physician Decision|0|||
170745015|NCT01807221|617076053|FG004|Overall Study|Physician Decision|0|||
170745016|NCT01807221|617076054|FG005|Overall Study|Physician Decision|0|||
170745017|NCT01807221|617076049|FG000|Overall Study|Adverse Event|33|||
170745018|NCT01807221|617076050|FG001|Overall Study|Adverse Event|22|||
170745019|NCT01807221|617076051|FG002|Overall Study|Adverse Event|26|||
170745020|NCT01807221|617076052|FG003|Overall Study|Adverse Event|25|||
170745021|NCT01807221|617076053|FG004|Overall Study|Adverse Event|18|||
170745022|NCT01807221|617076054|FG005|Overall Study|Adverse Event|21|||
170745023|NCT01807221|617076049|FG000|Overall Study|Protocol Violation|0|||
170745024|NCT01807221|617076050|FG001|Overall Study|Protocol Violation|2|||
170745025|NCT01807221|617076051|FG002|Overall Study|Protocol Violation|1|||
170745026|NCT01807221|617076052|FG003|Overall Study|Protocol Violation|2|||
170745027|NCT01807221|617076053|FG004|Overall Study|Protocol Violation|0|||
170745028|NCT01807221|617076054|FG005|Overall Study|Protocol Violation|1|||
170745029|NCT01807221|617076049|FG000|Overall Study|Non-compliance|1|||
170745030|NCT01807221|617076050|FG001|Overall Study|Non-compliance|2|||
170745031|NCT01807221|617076051|FG002|Overall Study|Non-compliance|0|||
170745032|NCT01807221|617076052|FG003|Overall Study|Non-compliance|1|||
170745033|NCT01807221|617076053|FG004|Overall Study|Non-compliance|0|||
170745034|NCT01807221|617076054|FG005|Overall Study|Non-compliance|0|||
170745035|NCT01807221|617076049|FG000|Overall Study|Logistical difficulties|0|||
170745036|NCT01807221|617076050|FG001|Overall Study|Logistical difficulties|1|||
170745037|NCT01807221|617076051|FG002|Overall Study|Logistical difficulties|0|||
170745038|NCT01807221|617076052|FG003|Overall Study|Logistical difficulties|0|||
170745039|NCT01807221|617076053|FG004|Overall Study|Logistical difficulties|1|||
170745040|NCT01807221|617076054|FG005|Overall Study|Logistical difficulties|0|||
170745041|NCT01807221|617076049|FG000|Overall Study|Withdrawal by Subject|33|||
170745042|NCT01807221|617076050|FG001|Overall Study|Withdrawal by Subject|15|||
170745043|NCT01807221|617076051|FG002|Overall Study|Withdrawal by Subject|8|||
170745044|NCT01807221|617076052|FG003|Overall Study|Withdrawal by Subject|14|||
170745045|NCT01807221|617076053|FG004|Overall Study|Withdrawal by Subject|16|||
170745046|NCT01807221|617076054|FG005|Overall Study|Withdrawal by Subject|13|||
170745047|NCT01807221|617076049|FG000|Overall Study|Sponsor decision|2|||
170745048|NCT01807221|617076050|FG001|Overall Study|Sponsor decision|0|||
170745049|NCT01807221|617076051|FG002|Overall Study|Sponsor decision|1|||
170745050|NCT01807221|617076052|FG003|Overall Study|Sponsor decision|1|||
170745051|NCT01807221|617076053|FG004|Overall Study|Sponsor decision|0|||
170745052|NCT01807221|617076054|FG005|Overall Study|Sponsor decision|0|||
170745053|NCT01807221|617076049|FG000|Overall Study|Lost to Follow-up|1|||
170745054|NCT01807221|617076050|FG001|Overall Study|Lost to Follow-up|0|||
170745055|NCT01807221|617076051|FG002|Overall Study|Lost to Follow-up|2|||
170745056|NCT01807221|617076052|FG003|Overall Study|Lost to Follow-up|1|||
170745057|NCT01807221|617076053|FG004|Overall Study|Lost to Follow-up|0|||
170745058|NCT01807221|617076054|FG005|Overall Study|Lost to Follow-up|0|||
170745059|NCT00900627|617076055|FG000|Overall Study|Condition under investigation worsened|4|||
170745060|NCT00900627|617076056|FG001|Overall Study|Condition under investigation worsened|0|||
170745061|NCT00900627|617076057|FG002|Overall Study|Condition under investigation worsened|5|||
170745062|NCT00900627|617076058|FG003|Overall Study|Condition under investigation worsened|3|||
170745063|NCT00900627|617076059|FG004|Overall Study|Condition under investigation worsened|0|||
170745064|NCT00900627|617076060|FG005|Overall Study|Condition under investigation worsened|0|||
170745065|NCT00900627|617076055|FG000|Overall Study|Withdrawal by Subject|1|||
170745066|NCT00900627|617076056|FG001|Overall Study|Withdrawal by Subject|0|||
170745067|NCT00900627|617076057|FG002|Overall Study|Withdrawal by Subject|1|||
170745068|NCT00900627|617076058|FG003|Overall Study|Withdrawal by Subject|0|||
170745069|NCT00900627|617076059|FG004|Overall Study|Withdrawal by Subject|1|||
170745070|NCT00900627|617076060|FG005|Overall Study|Withdrawal by Subject|2|||
170745071|NCT00900627|617076055|FG000|Overall Study|Adverse Event|1|||
170745072|NCT00900627|617076056|FG001|Overall Study|Adverse Event|2|||
170745073|NCT00900627|617076057|FG002|Overall Study|Adverse Event|0|||
170745074|NCT00900627|617076058|FG003|Overall Study|Adverse Event|3|||
170745075|NCT00900627|617076059|FG004|Overall Study|Adverse Event|0|||
170745076|NCT00900627|617076060|FG005|Overall Study|Adverse Event|0|||
170745077|NCT00900627|617076055|FG000|Overall Study|Death|0|||
170745078|NCT00900627|617076056|FG001|Overall Study|Death|0|||
170745079|NCT00900627|617076057|FG002|Overall Study|Death|0|||
170745080|NCT00900627|617076058|FG003|Overall Study|Death|0|||
170745081|NCT00900627|617076059|FG004|Overall Study|Death|28|||
170745082|NCT00900627|617076060|FG005|Overall Study|Death|24|||
170745083|NCT00373295|617076061|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
170745084|NCT00373295|617076062|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
170745085|NCT00373295|617076063|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
170745086|NCT00373295|617076064|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
170745087|NCT00373295|617076065|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
170745088|NCT00373295|617076066|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
170745089|NCT02291289|617076067|FG000|Induction Treatment|Withdrawal by Subject|0|||
170745090|NCT02291289|617076068|FG001|Induction Treatment|Withdrawal by Subject|0|||
170745091|NCT02291289|617076069|FG002|Induction Treatment|Withdrawal by Subject|0|||
170745092|NCT02291289|617076070|FG003|Induction Treatment|Withdrawal by Subject|24|||
170745093|NCT02291289|617076071|FG004|Induction Treatment|Withdrawal by Subject|0|||
170745094|NCT02291289|617076072|FG005|Induction Treatment|Withdrawal by Subject|0|||
170745095|NCT02291289|617076073|FG006|Induction Treatment|Withdrawal by Subject|0|||
170745096|NCT02291289|617076074|FG007|Induction Treatment|Withdrawal by Subject|0|||
170745097|NCT02291289|617076075|FG008|Induction Treatment|Withdrawal by Subject|0|||
170745098|NCT02291289|617076076|FG009|Induction Treatment|Withdrawal by Subject|18|||
170745099|NCT02291289|617076077|FG010|Induction Treatment|Withdrawal by Subject|0|||
170745100|NCT02291289|617076078|FG011|Induction Treatment|Withdrawal by Subject|0|||
170745101|NCT02291289|617076079|FG012|Induction Treatment|Withdrawal by Subject|0|||
170745102|NCT02291289|617076067|FG000|Induction Treatment|Adverse Event|0|||
170745103|NCT02291289|617076068|FG001|Induction Treatment|Adverse Event|0|||
170745104|NCT02291289|617076069|FG002|Induction Treatment|Adverse Event|0|||
170745105|NCT02291289|617076070|FG003|Induction Treatment|Adverse Event|3|||
170745106|NCT02291289|617076071|FG004|Induction Treatment|Adverse Event|0|||
170745107|NCT02291289|617076072|FG005|Induction Treatment|Adverse Event|0|||
170745108|NCT02291289|617076073|FG006|Induction Treatment|Adverse Event|0|||
170745109|NCT02291289|617076074|FG007|Induction Treatment|Adverse Event|0|||
170745110|NCT02291289|617076075|FG008|Induction Treatment|Adverse Event|0|||
170745111|NCT02291289|617076076|FG009|Induction Treatment|Adverse Event|1|||
170745112|NCT02291289|617076077|FG010|Induction Treatment|Adverse Event|0|||
170745113|NCT02291289|617076078|FG011|Induction Treatment|Adverse Event|0|||
170745114|NCT02291289|617076079|FG012|Induction Treatment|Adverse Event|0|||
170745115|NCT02291289|617076067|FG000|Induction Treatment|Death|25|||
170745116|NCT02291289|617076068|FG001|Induction Treatment|Death|0|||
170745117|NCT02291289|617076069|FG002|Induction Treatment|Death|0|||
170745118|NCT02291289|617076070|FG003|Induction Treatment|Death|111|||
170745119|NCT02291289|617076071|FG004|Induction Treatment|Death|0|||
170745120|NCT02291289|617076072|FG005|Induction Treatment|Death|0|||
170745121|NCT02291289|617076073|FG006|Induction Treatment|Death|1|||
170745122|NCT02291289|617076074|FG007|Induction Treatment|Death|0|||
170745123|NCT02291289|617076075|FG008|Induction Treatment|Death|0|||
170745124|NCT02291289|617076076|FG009|Induction Treatment|Death|82|||
170745125|NCT02291289|617076077|FG010|Induction Treatment|Death|0|||
170745126|NCT02291289|617076078|FG011|Induction Treatment|Death|0|||
170745127|NCT02291289|617076079|FG012|Induction Treatment|Death|0|||
170745128|NCT02291289|617076067|FG000|Induction Treatment|Lost to Follow-up|1|||
170745129|NCT02291289|617076068|FG001|Induction Treatment|Lost to Follow-up|0|||
170745130|NCT02291289|617076069|FG002|Induction Treatment|Lost to Follow-up|0|||
170745131|NCT02291289|617076070|FG003|Induction Treatment|Lost to Follow-up|12|||
170745132|NCT02291289|617076071|FG004|Induction Treatment|Lost to Follow-up|0|||
170745133|NCT02291289|617076072|FG005|Induction Treatment|Lost to Follow-up|0|||
170860322|NCT04677179|617497958|FG002|Induction Treatment Period|Adverse Event|0|||
170860323|NCT04677179|617497959|FG003|Induction Treatment Period|Adverse Event|0|||
170860324|NCT04677179|617497960|FG004|Induction Treatment Period|Adverse Event|0|||
170860325|NCT04677179|617497961|FG005|Induction Treatment Period|Adverse Event|0|||
170860326|NCT04677179|617497962|FG006|Induction Treatment Period|Adverse Event|0|||
170860327|NCT04677179|617497963|FG007|Induction Treatment Period|Adverse Event|0|||
170860328|NCT04677179|617497964|FG008|Induction Treatment Period|Adverse Event|0|||
170860329|NCT04677179|617497965|FG009|Induction Treatment Period|Adverse Event|0|||
170860330|NCT04677179|617497956|FG000|Induction Treatment Period|Physician Decision|1|||
170860331|NCT04677179|617497957|FG001|Induction Treatment Period|Physician Decision|0|||
170860332|NCT04677179|617497958|FG002|Induction Treatment Period|Physician Decision|1|||
170860333|NCT04677179|617497959|FG003|Induction Treatment Period|Physician Decision|0|||
170860334|NCT04677179|617497960|FG004|Induction Treatment Period|Physician Decision|0|||
170630136|NCT00463567|616660408|FG004|Overall Study|Lost to Follow-up|1|||
170745134|NCT02291289|617076073|FG006|Induction Treatment|Lost to Follow-up|0|||
170745135|NCT02291289|617076074|FG007|Induction Treatment|Lost to Follow-up|0|||
170745136|NCT02291289|617076075|FG008|Induction Treatment|Lost to Follow-up|0|||
170860335|NCT04677179|617497961|FG005|Induction Treatment Period|Physician Decision|0|||
170860336|NCT04677179|617497962|FG006|Induction Treatment Period|Physician Decision|0|||
170860337|NCT04677179|617497963|FG007|Induction Treatment Period|Physician Decision|0|||
170860338|NCT04677179|617497964|FG008|Induction Treatment Period|Physician Decision|0|||
170860339|NCT04677179|617497965|FG009|Induction Treatment Period|Physician Decision|0|||
170860340|NCT04677179|617497956|FG000|Induction Treatment Period|Protocol Violation|0|||
170860341|NCT04677179|617497957|FG001|Induction Treatment Period|Protocol Violation|1|||
170860342|NCT04677179|617497958|FG002|Induction Treatment Period|Protocol Violation|0|||
170860343|NCT04677179|617497959|FG003|Induction Treatment Period|Protocol Violation|0|||
170860344|NCT04677179|617497960|FG004|Induction Treatment Period|Protocol Violation|0|||
170860345|NCT04677179|617497961|FG005|Induction Treatment Period|Protocol Violation|0|||
170860346|NCT04677179|617497962|FG006|Induction Treatment Period|Protocol Violation|0|||
170860347|NCT04677179|617497963|FG007|Induction Treatment Period|Protocol Violation|0|||
170860348|NCT04677179|617497964|FG008|Induction Treatment Period|Protocol Violation|0|||
170860349|NCT04677179|617497965|FG009|Induction Treatment Period|Protocol Violation|0|||
170860350|NCT04677179|617497956|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
170860351|NCT04677179|617497957|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
170745137|NCT02291289|617076076|FG009|Induction Treatment|Lost to Follow-up|9|||
170745138|NCT02291289|617076077|FG010|Induction Treatment|Lost to Follow-up|0|||
170745139|NCT02291289|617076078|FG011|Induction Treatment|Lost to Follow-up|0|||
170745140|NCT02291289|617076079|FG012|Induction Treatment|Lost to Follow-up|0|||
170745141|NCT02291289|617076067|FG000|Induction Treatment|Non-Compliance|0|||
170745142|NCT02291289|617076068|FG001|Induction Treatment|Non-Compliance|0|||
170860352|NCT04677179|617497958|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
170860353|NCT04677179|617497959|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
170745143|NCT02291289|617076069|FG002|Induction Treatment|Non-Compliance|0|||
170745144|NCT02291289|617076070|FG003|Induction Treatment|Non-Compliance|1|||
170860354|NCT04677179|617497960|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
170860355|NCT04677179|617497961|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
170860356|NCT04677179|617497962|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
170860357|NCT04677179|617497963|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
170860358|NCT04677179|617497964|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
170860359|NCT04677179|617497965|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
170860360|NCT04677179|617497956|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
170860361|NCT04677179|617497957|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
170860362|NCT04677179|617497958|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
170860363|NCT04677179|617497959|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
170860364|NCT04677179|617497960|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
170860365|NCT04677179|617497961|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
170860366|NCT04677179|617497962|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
170860367|NCT04677179|617497963|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
170745145|NCT02291289|617076071|FG004|Induction Treatment|Non-Compliance|0|||
170860368|NCT04677179|617497964|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
170860369|NCT04677179|617497965|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
170860370|NCT04677179|617497956|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
170860371|NCT04677179|617497957|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
170860372|NCT04677179|617497958|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
170860373|NCT04677179|617497959|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
170860374|NCT04677179|617497960|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
170860375|NCT04677179|617497961|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
170745146|NCT02291289|617076072|FG005|Induction Treatment|Non-Compliance|0|||
170745147|NCT02291289|617076073|FG006|Induction Treatment|Non-Compliance|0|||
170745148|NCT02291289|617076074|FG007|Induction Treatment|Non-Compliance|0|||
170745149|NCT02291289|617076075|FG008|Induction Treatment|Non-Compliance|0|||
170860376|NCT04677179|617497962|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
170860377|NCT04677179|617497963|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
170630137|NCT00463567|616660409|FG005|Overall Study|Lost to Follow-up|1|||
170745150|NCT02291289|617076076|FG009|Induction Treatment|Non-Compliance|1|||
170745151|NCT02291289|617076077|FG010|Induction Treatment|Non-Compliance|0|||
170745152|NCT02291289|617076078|FG011|Induction Treatment|Non-Compliance|0|||
170745153|NCT02291289|617076079|FG012|Induction Treatment|Non-Compliance|0|||
170745154|NCT02291289|617076067|FG000|Induction Treatment|Reason Not Specified|0|||
170745155|NCT02291289|617076068|FG001|Induction Treatment|Reason Not Specified|0|||
170745156|NCT02291289|617076069|FG002|Induction Treatment|Reason Not Specified|0|||
170745157|NCT02291289|617076070|FG003|Induction Treatment|Reason Not Specified|4|||
170745158|NCT02291289|617076071|FG004|Induction Treatment|Reason Not Specified|0|||
170745159|NCT02291289|617076072|FG005|Induction Treatment|Reason Not Specified|0|||
170745160|NCT02291289|617076073|FG006|Induction Treatment|Reason Not Specified|0|||
170745161|NCT02291289|617076074|FG007|Induction Treatment|Reason Not Specified|0|||
170745162|NCT02291289|617076075|FG008|Induction Treatment|Reason Not Specified|0|||
170745163|NCT02291289|617076076|FG009|Induction Treatment|Reason Not Specified|7|||
170860378|NCT04677179|617497964|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
170860379|NCT04677179|617497965|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
170860380|NCT04677179|617497956|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860381|NCT04677179|617497957|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860382|NCT04677179|617497958|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860383|NCT04677179|617497959|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
170860384|NCT04677179|617497960|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860385|NCT04677179|617497961|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860386|NCT04677179|617497962|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860387|NCT04677179|617497963|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860388|NCT04677179|617497964|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860389|NCT04677179|617497965|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
170860390|NCT04677179|617497956|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
170860391|NCT04677179|617497957|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
170860392|NCT04677179|617497958|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
170860393|NCT04677179|617497959|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
170860394|NCT04677179|617497960|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
170860395|NCT04677179|617497961|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
170860396|NCT04677179|617497962|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
170860397|NCT04677179|617497963|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
170860398|NCT04677179|617497964|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
170860399|NCT04677179|617497965|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
170860400|NCT04677179|617497956|FG000|Extension Treatment Period|Lack of Efficacy|0|||
170860401|NCT04677179|617497957|FG001|Extension Treatment Period|Lack of Efficacy|0|||
170860402|NCT04677179|617497958|FG002|Extension Treatment Period|Lack of Efficacy|0|||
170860403|NCT04677179|617497959|FG003|Extension Treatment Period|Lack of Efficacy|0|||
170860404|NCT04677179|617497960|FG004|Extension Treatment Period|Lack of Efficacy|0|||
170860405|NCT04677179|617497961|FG005|Extension Treatment Period|Lack of Efficacy|0|||
170860406|NCT04677179|617497962|FG006|Extension Treatment Period|Lack of Efficacy|6|||
170860407|NCT04677179|617497963|FG007|Extension Treatment Period|Lack of Efficacy|0|||
170860408|NCT04677179|617497964|FG008|Extension Treatment Period|Lack of Efficacy|0|||
170860409|NCT04677179|617497965|FG009|Extension Treatment Period|Lack of Efficacy|0|||
170860410|NCT04677179|617497956|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
170860411|NCT04677179|617497957|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
170860412|NCT04677179|617497958|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
170860413|NCT04677179|617497959|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
170860414|NCT04677179|617497960|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
170860415|NCT04677179|617497961|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
170860416|NCT04677179|617497962|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
170860417|NCT04677179|617497963|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
170860418|NCT04677179|617497964|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
170860419|NCT04677179|617497965|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
170860420|NCT04677179|617497956|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
170860421|NCT04677179|617497957|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
170860422|NCT04677179|617497958|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
170860423|NCT04677179|617497959|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
170860424|NCT04677179|617497960|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
170860425|NCT04677179|617497961|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
170860426|NCT04677179|617497962|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
170860427|NCT04677179|617497963|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
170860428|NCT04677179|617497964|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
170860429|NCT04677179|617497965|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
170860430|NCT04677179|617497956|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
170860431|NCT04677179|617497957|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
170860432|NCT04677179|617497958|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
170860433|NCT04677179|617497959|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
170860434|NCT04677179|617497960|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
170860435|NCT04677179|617497961|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
170860436|NCT04677179|617497962|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
170860437|NCT04677179|617497963|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
170860438|NCT04677179|617497964|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
170860439|NCT04677179|617497965|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
170860440|NCT04677179|617497956|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
170860441|NCT04677179|617497957|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
170860442|NCT04677179|617497958|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
170860443|NCT04677179|617497959|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
170860444|NCT04677179|617497960|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
170860445|NCT04677179|617497961|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
170860446|NCT04677179|617497962|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
170860447|NCT04677179|617497963|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
170860448|NCT04677179|617497964|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
170860449|NCT04677179|617497965|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
170860450|NCT04677179|617497956|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860451|NCT04677179|617497957|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860452|NCT04677179|617497958|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860453|NCT04677179|617497959|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860454|NCT04677179|617497960|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860455|NCT04677179|617497961|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860456|NCT04677179|617497962|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860457|NCT04677179|617497963|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
170860458|NCT04677179|617497964|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860459|NCT04677179|617497965|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170860460|NCT04677179|617497956|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170860461|NCT04677179|617497957|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170860462|NCT04677179|617497958|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170860463|NCT04677179|617497959|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170860464|NCT04677179|617497960|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170860465|NCT04677179|617497961|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170860466|NCT04677179|617497962|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170860467|NCT04677179|617497963|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
170860468|NCT04677179|617497964|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
170860469|NCT04677179|617497965|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170860470|NCT04677179|617497956|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
170860471|NCT04677179|617497957|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
170860472|NCT04677179|617497958|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
170860473|NCT04677179|617497959|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
170516221|NCT03428100|616234865|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
170516222|NCT03428100|616234866|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
170745164|NCT02291289|617076077|FG010|Induction Treatment|Reason Not Specified|0|||
170745165|NCT02291289|617076078|FG011|Induction Treatment|Reason Not Specified|0|||
170745166|NCT02291289|617076079|FG012|Induction Treatment|Reason Not Specified|0|||
170745167|NCT02291289|617076067|FG000|Induction Treatment|Physician Decision|0|||
170745168|NCT02291289|617076068|FG001|Induction Treatment|Physician Decision|0|||
170745169|NCT02291289|617076069|FG002|Induction Treatment|Physician Decision|0|||
170745170|NCT02291289|617076070|FG003|Induction Treatment|Physician Decision|3|||
170745171|NCT02291289|617076071|FG004|Induction Treatment|Physician Decision|0|||
170745172|NCT02291289|617076072|FG005|Induction Treatment|Physician Decision|0|||
170745173|NCT02291289|617076073|FG006|Induction Treatment|Physician Decision|0|||
170745174|NCT02291289|617076074|FG007|Induction Treatment|Physician Decision|0|||
170745175|NCT02291289|617076075|FG008|Induction Treatment|Physician Decision|0|||
170745176|NCT02291289|617076076|FG009|Induction Treatment|Physician Decision|1|||
170745177|NCT02291289|617076077|FG010|Induction Treatment|Physician Decision|0|||
170745178|NCT02291289|617076078|FG011|Induction Treatment|Physician Decision|0|||
170745179|NCT02291289|617076079|FG012|Induction Treatment|Physician Decision|0|||
170745180|NCT02291289|617076067|FG000|Induction Treatment|Protocol Violation|0|||
170745181|NCT02291289|617076068|FG001|Induction Treatment|Protocol Violation|0|||
170745182|NCT02291289|617076069|FG002|Induction Treatment|Protocol Violation|0|||
170745183|NCT02291289|617076070|FG003|Induction Treatment|Protocol Violation|3|||
170745184|NCT02291289|617076071|FG004|Induction Treatment|Protocol Violation|0|||
170745185|NCT02291289|617076072|FG005|Induction Treatment|Protocol Violation|0|||
170745186|NCT02291289|617076073|FG006|Induction Treatment|Protocol Violation|0|||
170745187|NCT02291289|617076074|FG007|Induction Treatment|Protocol Violation|0|||
170745188|NCT02291289|617076075|FG008|Induction Treatment|Protocol Violation|0|||
170745189|NCT02291289|617076076|FG009|Induction Treatment|Protocol Violation|2|||
170745190|NCT02291289|617076077|FG010|Induction Treatment|Protocol Violation|0|||
170745191|NCT02291289|617076078|FG011|Induction Treatment|Protocol Violation|0|||
170745192|NCT02291289|617076079|FG012|Induction Treatment|Protocol Violation|0|||
170745193|NCT02291289|617076067|FG000|Induction Treatment|Missing|4|||
170745194|NCT02291289|617076068|FG001|Induction Treatment|Missing|0|||
170745195|NCT02291289|617076069|FG002|Induction Treatment|Missing|0|||
170745196|NCT02291289|617076070|FG003|Induction Treatment|Missing|14|||
170745197|NCT02291289|617076071|FG004|Induction Treatment|Missing|0|||
170745198|NCT02291289|617076072|FG005|Induction Treatment|Missing|0|||
170745199|NCT02291289|617076073|FG006|Induction Treatment|Missing|0|||
170745200|NCT02291289|617076074|FG007|Induction Treatment|Missing|0|||
170745201|NCT02291289|617076075|FG008|Induction Treatment|Missing|0|||
170745202|NCT02291289|617076076|FG009|Induction Treatment|Missing|54|||
170745203|NCT02291289|617076077|FG010|Induction Treatment|Missing|0|||
170745204|NCT02291289|617076078|FG011|Induction Treatment|Missing|0|||
170745205|NCT02291289|617076079|FG012|Induction Treatment|Missing|0|||
170860474|NCT04677179|617497960|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
170860475|NCT04677179|617497961|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
170860476|NCT04677179|617497962|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
170860477|NCT04677179|617497963|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
170860478|NCT04677179|617497964|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
170860479|NCT04677179|617497965|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
170860480|NCT04508023|617497966|FG000|Overall Study|Withdrawal by Subject|1|||
170860481|NCT04508023|617497967|FG001|Overall Study|Withdrawal by Subject|2|||
170860482|NCT01668667|617497974|FG000|Overall Study|Adverse Event|3|||
170860483|NCT01668667|617497975|FG001|Overall Study|Adverse Event|6|||
170860484|NCT01668667|617497976|FG002|Overall Study|Adverse Event|4|||
170860485|NCT01668667|617497977|FG003|Overall Study|Adverse Event|4|||
170860486|NCT01668667|617497974|FG000|Overall Study|Lack of Efficacy|3|||
170860487|NCT01668667|617497975|FG001|Overall Study|Lack of Efficacy|2|||
170860488|NCT01668667|617497976|FG002|Overall Study|Lack of Efficacy|2|||
170860489|NCT01668667|617497977|FG003|Overall Study|Lack of Efficacy|3|||
170860490|NCT01668667|617497974|FG000|Overall Study|Protocol Violation|6|||
170860491|NCT01668667|617497975|FG001|Overall Study|Protocol Violation|10|||
170860492|NCT01668667|617497976|FG002|Overall Study|Protocol Violation|12|||
170860493|NCT01668667|617497977|FG003|Overall Study|Protocol Violation|5|||
170860494|NCT01668667|617497974|FG000|Overall Study|Lost to Follow-up|9|||
170860495|NCT01668667|617497975|FG001|Overall Study|Lost to Follow-up|4|||
170860496|NCT01668667|617497976|FG002|Overall Study|Lost to Follow-up|7|||
170860497|NCT01668667|617497977|FG003|Overall Study|Lost to Follow-up|6|||
170860498|NCT01668667|617497974|FG000|Overall Study|Physician Decision|3|||
170860499|NCT01668667|617497975|FG001|Overall Study|Physician Decision|0|||
170745206|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745207|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745208|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745209|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745210|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
170745211|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
170745212|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745213|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745214|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745215|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745216|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
170745217|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
170745218|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170745219|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Death|0|||
170745220|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Death|29|||
170745221|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Death|16|||
170745222|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Death|0|||
170745223|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Death|188|||
170745224|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Death|107|||
170745225|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Death|0|||
170745226|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Death|1|||
170745227|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Death|1|||
170745228|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Death|0|||
170745229|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Death|46|||
170745230|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Death|19|||
170745231|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Death|0|||
170745232|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Adverse Event|0|||
170745233|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Adverse Event|0|||
170745234|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Adverse Event|0|||
170745235|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Adverse Event|0|||
170745236|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Adverse Event|1|||
170745237|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Adverse Event|1|||
170745238|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Adverse Event|0|||
170745239|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Adverse Event|0|||
170745240|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Adverse Event|0|||
170745241|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Adverse Event|0|||
170745242|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Adverse Event|0|||
170745243|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Adverse Event|0|||
170745244|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Adverse Event|0|||
170745245|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
170745246|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
170745247|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
170745248|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
170745249|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
170745250|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
170745251|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
170745252|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
170745253|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
170745254|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
170745255|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
170745256|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
170745257|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
170745258|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
170745259|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
170745260|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
170745261|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
170745262|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
170745263|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
170745264|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
170745265|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
170745266|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
170745267|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
170745268|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
170745269|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
170745270|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
170745271|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Physician Decision|0|||
170745272|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Physician Decision|2|||
170745273|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Physician Decision|0|||
170745274|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Physician Decision|0|||
170745275|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Physician Decision|3|||
170745276|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Physician Decision|0|||
170745277|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Physician Decision|0|||
170745278|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Physician Decision|0|||
170745279|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Physician Decision|0|||
170745280|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Physician Decision|0|||
170745281|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Physician Decision|1|||
170745282|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Physician Decision|3|||
170745283|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Physician Decision|0|||
170745284|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Not Treated|0|||
170745285|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Not Treated|0|||
170745286|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Not Treated|2|||
170745287|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Not Treated|0|||
170745288|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Not Treated|0|||
170745289|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Not Treated|0|||
170745290|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Not Treated|0|||
170745291|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Not Treated|0|||
170745292|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Not Treated|0|||
170745293|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Not Treated|0|||
170745294|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Not Treated|0|||
170745295|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Not Treated|0|||
170745296|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Not Treated|0|||
170745297|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745298|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
170745299|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745300|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745301|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745302|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745303|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745304|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745305|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745306|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745307|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745308|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745309|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
170745310|NCT02291289|617076067|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
170745311|NCT02291289|617076068|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
170745312|NCT02291289|617076069|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
170745313|NCT02291289|617076070|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
170745314|NCT02291289|617076071|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
170745315|NCT02291289|617076072|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
170745316|NCT02291289|617076073|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
170745317|NCT02291289|617076074|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
170745318|NCT02291289|617076075|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
170745319|NCT02291289|617076076|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
170745320|NCT02291289|617076077|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
170745321|NCT02291289|617076078|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
170745322|NCT02291289|617076079|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
170745323|NCT02291289|617076067|FG000|Early Disease Progression|Death|0|||
170745324|NCT02291289|617076068|FG001|Early Disease Progression|Death|0|||
170745325|NCT02291289|617076069|FG002|Early Disease Progression|Death|0|||
170745326|NCT02291289|617076070|FG003|Early Disease Progression|Death|0|||
170745327|NCT02291289|617076071|FG004|Early Disease Progression|Death|0|||
170745328|NCT02291289|617076072|FG005|Early Disease Progression|Death|0|||
170745329|NCT02291289|617076073|FG006|Early Disease Progression|Death|0|||
170745330|NCT02291289|617076074|FG007|Early Disease Progression|Death|0|||
170745331|NCT02291289|617076075|FG008|Early Disease Progression|Death|0|||
170745332|NCT02291289|617076076|FG009|Early Disease Progression|Death|0|||
170745333|NCT02291289|617076077|FG010|Early Disease Progression|Death|0|||
170745334|NCT02291289|617076078|FG011|Early Disease Progression|Death|0|||
170745335|NCT02291289|617076079|FG012|Early Disease Progression|Death|10|||
170745336|NCT02291289|617076067|FG000|Early Disease Progression|Lost to Follow-up|0|||
170745337|NCT02291289|617076068|FG001|Early Disease Progression|Lost to Follow-up|0|||
170745338|NCT02291289|617076069|FG002|Early Disease Progression|Lost to Follow-up|0|||
170745339|NCT02291289|617076070|FG003|Early Disease Progression|Lost to Follow-up|0|||
170745340|NCT02291289|617076071|FG004|Early Disease Progression|Lost to Follow-up|0|||
170745341|NCT02291289|617076072|FG005|Early Disease Progression|Lost to Follow-up|0|||
170745342|NCT02291289|617076073|FG006|Early Disease Progression|Lost to Follow-up|0|||
170745343|NCT02291289|617076074|FG007|Early Disease Progression|Lost to Follow-up|0|||
170745344|NCT02291289|617076075|FG008|Early Disease Progression|Lost to Follow-up|0|||
170745345|NCT02291289|617076076|FG009|Early Disease Progression|Lost to Follow-up|0|||
170745346|NCT02291289|617076077|FG010|Early Disease Progression|Lost to Follow-up|0|||
170745347|NCT02291289|617076078|FG011|Early Disease Progression|Lost to Follow-up|0|||
170745348|NCT02291289|617076079|FG012|Early Disease Progression|Lost to Follow-up|1|||
170745349|NCT01474512|617076094|FG000|Induction Period|Adverse Event|6|||
170745350|NCT01474512|617076095|FG001|Induction Period|Adverse Event|10|||
170745351|NCT01474512|617076096|FG002|Induction Period|Adverse Event|10|||
170745352|NCT01474512|617076097|FG003|Induction Period|Adverse Event|0|||
170745353|NCT01474512|617076098|FG004|Induction Period|Adverse Event|0|||
170745354|NCT01474512|617076099|FG005|Induction Period|Adverse Event|0|||
170745355|NCT01474512|617076100|FG006|Induction Period|Adverse Event|0|||
170745356|NCT01474512|617076101|FG007|Induction Period|Adverse Event|0|||
170745357|NCT01474512|617076102|FG008|Induction Period|Adverse Event|0|||
170745358|NCT01474512|617076103|FG009|Induction Period|Adverse Event|0|||
170745359|NCT01474512|617076104|FG010|Induction Period|Adverse Event|0|||
170745360|NCT01474512|617076105|FG011|Induction Period|Adverse Event|0|||
170745361|NCT01474512|617076106|FG012|Induction Period|Adverse Event|0|||
170745362|NCT01474512|617076107|FG013|Induction Period|Adverse Event|0|||
170745363|NCT01474512|617076108|FG014|Induction Period|Adverse Event|0|||
170745364|NCT01474512|617076109|FG015|Induction Period|Adverse Event|0|||
170745365|NCT01474512|617076110|FG016|Induction Period|Adverse Event|0|||
170745366|NCT01474512|617076111|FG017|Induction Period|Adverse Event|0|||
170745367|NCT01474512|617076094|FG000|Induction Period|Lack of Efficacy|7|||
170745368|NCT01474512|617076095|FG001|Induction Period|Lack of Efficacy|1|||
170745369|NCT01474512|617076096|FG002|Induction Period|Lack of Efficacy|0|||
170745370|NCT01474512|617076097|FG003|Induction Period|Lack of Efficacy|0|||
170745371|NCT01474512|617076098|FG004|Induction Period|Lack of Efficacy|0|||
170745372|NCT01474512|617076099|FG005|Induction Period|Lack of Efficacy|0|||
170745373|NCT01474512|617076100|FG006|Induction Period|Lack of Efficacy|0|||
170745374|NCT01474512|617076101|FG007|Induction Period|Lack of Efficacy|0|||
170745375|NCT01474512|617076102|FG008|Induction Period|Lack of Efficacy|0|||
170745376|NCT01474512|617076103|FG009|Induction Period|Lack of Efficacy|0|||
170745377|NCT01474512|617076104|FG010|Induction Period|Lack of Efficacy|0|||
170745378|NCT01474512|617076105|FG011|Induction Period|Lack of Efficacy|0|||
170745379|NCT01474512|617076106|FG012|Induction Period|Lack of Efficacy|0|||
170745380|NCT01474512|617076107|FG013|Induction Period|Lack of Efficacy|0|||
170745381|NCT01474512|617076108|FG014|Induction Period|Lack of Efficacy|0|||
170745382|NCT01474512|617076109|FG015|Induction Period|Lack of Efficacy|0|||
170745383|NCT01474512|617076110|FG016|Induction Period|Lack of Efficacy|0|||
170745384|NCT01474512|617076111|FG017|Induction Period|Lack of Efficacy|0|||
170745385|NCT01474512|617076094|FG000|Induction Period|Withdrawal by Subject|6|||
170745386|NCT01474512|617076095|FG001|Induction Period|Withdrawal by Subject|6|||
170745387|NCT01474512|617076096|FG002|Induction Period|Withdrawal by Subject|5|||
170745388|NCT01474512|617076097|FG003|Induction Period|Withdrawal by Subject|0|||
170745389|NCT01474512|617076098|FG004|Induction Period|Withdrawal by Subject|0|||
170745390|NCT01474512|617076099|FG005|Induction Period|Withdrawal by Subject|0|||
170745391|NCT01474512|617076100|FG006|Induction Period|Withdrawal by Subject|0|||
170745392|NCT01474512|617076101|FG007|Induction Period|Withdrawal by Subject|0|||
170745393|NCT01474512|617076102|FG008|Induction Period|Withdrawal by Subject|0|||
170745394|NCT01474512|617076103|FG009|Induction Period|Withdrawal by Subject|0|||
170745395|NCT01474512|617076104|FG010|Induction Period|Withdrawal by Subject|0|||
170745396|NCT01474512|617076105|FG011|Induction Period|Withdrawal by Subject|0|||
170745397|NCT01474512|617076106|FG012|Induction Period|Withdrawal by Subject|0|||
170745398|NCT01474512|617076107|FG013|Induction Period|Withdrawal by Subject|0|||
170745399|NCT01474512|617076108|FG014|Induction Period|Withdrawal by Subject|0|||
170745400|NCT01474512|617076109|FG015|Induction Period|Withdrawal by Subject|0|||
170745401|NCT01474512|617076110|FG016|Induction Period|Withdrawal by Subject|0|||
170745402|NCT01474512|617076111|FG017|Induction Period|Withdrawal by Subject|0|||
170745403|NCT01474512|617076094|FG000|Induction Period|Protocol Violation|3|||
170745404|NCT01474512|617076095|FG001|Induction Period|Protocol Violation|6|||
170745405|NCT01474512|617076096|FG002|Induction Period|Protocol Violation|0|||
170745406|NCT01474512|617076097|FG003|Induction Period|Protocol Violation|0|||
170745407|NCT01474512|617076098|FG004|Induction Period|Protocol Violation|0|||
170745408|NCT01474512|617076099|FG005|Induction Period|Protocol Violation|0|||
170745409|NCT01474512|617076100|FG006|Induction Period|Protocol Violation|0|||
170745410|NCT01474512|617076101|FG007|Induction Period|Protocol Violation|0|||
170745411|NCT01474512|617076102|FG008|Induction Period|Protocol Violation|0|||
170745412|NCT01474512|617076103|FG009|Induction Period|Protocol Violation|0|||
170745413|NCT01474512|617076104|FG010|Induction Period|Protocol Violation|0|||
170745414|NCT01474512|617076105|FG011|Induction Period|Protocol Violation|0|||
170745415|NCT01474512|617076106|FG012|Induction Period|Protocol Violation|0|||
170745416|NCT01474512|617076107|FG013|Induction Period|Protocol Violation|0|||
170745417|NCT01474512|617076108|FG014|Induction Period|Protocol Violation|0|||
170745418|NCT01474512|617076109|FG015|Induction Period|Protocol Violation|0|||
170745419|NCT01474512|617076110|FG016|Induction Period|Protocol Violation|0|||
170745420|NCT01474512|617076111|FG017|Induction Period|Protocol Violation|0|||
170745421|NCT01474512|617076094|FG000|Induction Period|Sponsor Decision|1|||
170745422|NCT01474512|617076095|FG001|Induction Period|Sponsor Decision|1|||
170745423|NCT01474512|617076096|FG002|Induction Period|Sponsor Decision|1|||
170745424|NCT01474512|617076097|FG003|Induction Period|Sponsor Decision|0|||
170745425|NCT01474512|617076098|FG004|Induction Period|Sponsor Decision|0|||
170745426|NCT01474512|617076099|FG005|Induction Period|Sponsor Decision|0|||
170745427|NCT01474512|617076100|FG006|Induction Period|Sponsor Decision|0|||
170745428|NCT01474512|617076101|FG007|Induction Period|Sponsor Decision|0|||
170745429|NCT01474512|617076102|FG008|Induction Period|Sponsor Decision|0|||
170745430|NCT01474512|617076103|FG009|Induction Period|Sponsor Decision|0|||
170745431|NCT01474512|617076104|FG010|Induction Period|Sponsor Decision|0|||
170745432|NCT01474512|617076105|FG011|Induction Period|Sponsor Decision|0|||
170745433|NCT01474512|617076106|FG012|Induction Period|Sponsor Decision|0|||
170745434|NCT01474512|617076107|FG013|Induction Period|Sponsor Decision|0|||
170860500|NCT01668667|617497976|FG002|Overall Study|Physician Decision|1|||
170860501|NCT01668667|617497977|FG003|Overall Study|Physician Decision|0|||
170860502|NCT01668667|617497974|FG000|Overall Study|Withdrawal by Subject|7|||
170860503|NCT01668667|617497975|FG001|Overall Study|Withdrawal by Subject|4|||
170860504|NCT01668667|617497976|FG002|Overall Study|Withdrawal by Subject|5|||
170860505|NCT01668667|617497977|FG003|Overall Study|Withdrawal by Subject|5|||
170860506|NCT02988622|617497978|FG000|Overall Study|Lost to Follow-up|17|||
170860507|NCT02447172|617497979|FG000|Overall Study|Adverse Event|11|||
170860508|NCT02447172|617497980|FG001|Overall Study|Adverse Event|8|||
170860509|NCT02447172|617497981|FG002|Overall Study|Adverse Event|7|||
170860510|NCT02447172|617497979|FG000|Overall Study|Death|3|||
170860511|NCT02447172|617497980|FG001|Overall Study|Death|1|||
170860512|NCT02447172|617497981|FG002|Overall Study|Death|0|||
170860513|NCT02447172|617497979|FG000|Overall Study|Protocol Violation|2|||
170860514|NCT02447172|617497980|FG001|Overall Study|Protocol Violation|1|||
170860515|NCT02447172|617497981|FG002|Overall Study|Protocol Violation|2|||
170860516|NCT02447172|617497979|FG000|Overall Study|Lost to Follow-up|7|||
170860517|NCT02447172|617497980|FG001|Overall Study|Lost to Follow-up|4|||
170860518|NCT02447172|617497981|FG002|Overall Study|Lost to Follow-up|4|||
170860519|NCT02447172|617497979|FG000|Overall Study|Withdrawal by Subject|5|||
170860520|NCT02447172|617497980|FG001|Overall Study|Withdrawal by Subject|1|||
170860521|NCT02447172|617497981|FG002|Overall Study|Withdrawal by Subject|3|||
170860522|NCT02447172|617497979|FG000|Overall Study|protocol specific treatment unrelated|3|||
170860523|NCT02447172|617497980|FG001|Overall Study|protocol specific treatment unrelated|0|||
170860524|NCT02447172|617497981|FG002|Overall Study|protocol specific treatment unrelated|2|||
170860525|NCT00421707|617497982|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
170860526|NCT00421707|617497983|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
170860527|NCT00421707|617497982|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
170860528|NCT00421707|617497983|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
170860529|NCT00421707|617497982|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
170516223|NCT03428100|616234867|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170516224|NCT03428100|616234868|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
170516225|NCT03428100|616234850|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
170745435|NCT01474512|617076108|FG014|Induction Period|Sponsor Decision|0|||
170860530|NCT00421707|617497983|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
170860531|NCT00421707|617497982|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
170860532|NCT00421707|617497983|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
170860533|NCT00421707|617497982|FG000|Period 2: Washout|Adverse Event|1|||
170860534|NCT00421707|617497983|FG001|Period 2: Washout|Adverse Event|1|||
170745436|NCT01474512|617076109|FG015|Induction Period|Sponsor Decision|0|||
170745437|NCT01474512|617076110|FG016|Induction Period|Sponsor Decision|0|||
170860535|NCT00421707|617497982|FG000|Period 2: Washout|Withdrawal by Subject|0|||
170745438|NCT01474512|617076111|FG017|Induction Period|Sponsor Decision|0|||
170860536|NCT00421707|617497983|FG001|Period 2: Washout|Withdrawal by Subject|1|||
170860537|NCT00421707|617497982|FG000|Period 2: Washout|Lost to Follow-up|0|||
170860538|NCT00421707|617497983|FG001|Period 2: Washout|Lost to Follow-up|1|||
170860539|NCT00421707|617497982|FG000|Period 2: Washout|Other: Pregnancy|0|||
170860540|NCT00421707|617497983|FG001|Period 2: Washout|Other: Pregnancy|1|||
170860541|NCT00421707|617497982|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
170860542|NCT00421707|617497983|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
170860543|NCT00421707|617497982|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
170860544|NCT00421707|617497983|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
170860545|NCT00421707|617497982|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
170860546|NCT00421707|617497983|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
170860547|NCT00983931|617497984|FG000|14 Day Washout Period|Physician Decision|1|||
170860548|NCT05590377|617497985|FG000|Overall Study|Death|1|||
170860549|NCT05590377|617497986|FG001|Overall Study|Death|1|||
170860550|NCT05590377|617497987|FG002|Overall Study|Death|2|||
170860551|NCT05590377|617497988|FG003|Overall Study|Death|0|||
170860552|NCT05590377|617497989|FG004|Overall Study|Death|0|||
170860553|NCT05590377|617497985|FG000|Overall Study|Study Terminated by Sponsor|1|||
170860554|NCT05590377|617497986|FG001|Overall Study|Study Terminated by Sponsor|5|||
170860555|NCT05590377|617497987|FG002|Overall Study|Study Terminated by Sponsor|4|||
170745439|NCT01474512|617076094|FG000|Induction Period|Lost to Follow-up|1|||
170745440|NCT01474512|617076095|FG001|Induction Period|Lost to Follow-up|0|||
170745441|NCT01474512|617076096|FG002|Induction Period|Lost to Follow-up|2|||
170745442|NCT01474512|617076097|FG003|Induction Period|Lost to Follow-up|0|||
170860556|NCT05590377|617497988|FG003|Overall Study|Study Terminated by Sponsor|0|||
170860557|NCT05590377|617497989|FG004|Overall Study|Study Terminated by Sponsor|0|||
170860558|NCT05590377|617497985|FG000|Overall Study|Withdrawal by Subject|1|||
170860559|NCT05590377|617497986|FG001|Overall Study|Withdrawal by Subject|0|||
170860560|NCT05590377|617497987|FG002|Overall Study|Withdrawal by Subject|0|||
170860561|NCT05590377|617497988|FG003|Overall Study|Withdrawal by Subject|0|||
170860562|NCT05590377|617497989|FG004|Overall Study|Withdrawal by Subject|0|||
170860563|NCT03343301|617497993|FG000|Overall Study|Withdrawal by Subject|1|||
170860564|NCT03343301|617497994|FG001|Overall Study|Withdrawal by Subject|1|||
170860565|NCT03343301|617497993|FG000|Overall Study|Death|0|||
170745443|NCT01474512|617076098|FG004|Induction Period|Lost to Follow-up|0|||
170860566|NCT03343301|617497994|FG001|Overall Study|Death|2|||
170860567|NCT03343301|617497993|FG000|Overall Study|Other|0|||
170860568|NCT03343301|617497994|FG001|Overall Study|Other|6|||
170860569|NCT03343301|617497993|FG000|Overall Study|Missing|2|||
170860570|NCT03343301|617497994|FG001|Overall Study|Missing|0|||
170860571|NCT00413972|617497995|FG000|Overall Study|Adverse Event|2|||
170860572|NCT00413972|617497996|FG001|Overall Study|Adverse Event|1|||
170860573|NCT00413972|617497997|FG002|Overall Study|Adverse Event|0|||
170860574|NCT00413972|617497998|FG003|Overall Study|Adverse Event|0|||
170860575|NCT00413972|617497995|FG000|Overall Study|Lost to Follow-up|1|||
170860576|NCT00413972|617497996|FG001|Overall Study|Lost to Follow-up|2|||
170860577|NCT00413972|617497997|FG002|Overall Study|Lost to Follow-up|1|||
170860578|NCT00413972|617497998|FG003|Overall Study|Lost to Follow-up|0|||
170860579|NCT00413972|617497995|FG000|Overall Study|Withdrawal by Subject|4|||
170860580|NCT00413972|617497996|FG001|Overall Study|Withdrawal by Subject|5|||
170860581|NCT00413972|617497997|FG002|Overall Study|Withdrawal by Subject|7|||
170860582|NCT00413972|617497998|FG003|Overall Study|Withdrawal by Subject|2|||
170860583|NCT00413972|617497995|FG000|Overall Study|Protocol Violation|0|||
170860584|NCT00413972|617497996|FG001|Overall Study|Protocol Violation|0|||
170860585|NCT00413972|617497997|FG002|Overall Study|Protocol Violation|2|||
170860586|NCT00413972|617497998|FG003|Overall Study|Protocol Violation|0|||
170860587|NCT00413972|617497995|FG000|Overall Study|Other|0|||
170860588|NCT00413972|617497996|FG001|Overall Study|Other|0|||
170860589|NCT00413972|617497997|FG002|Overall Study|Other|0|||
170860590|NCT00413972|617497998|FG003|Overall Study|Other|1|||
170860591|NCT02668185|617498001|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
170860592|NCT02668185|617498002|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
170860593|NCT02668185|617498001|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
170860594|NCT02668185|617498002|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
170860595|NCT02668185|617498001|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
170860596|NCT02668185|617498002|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
170860597|NCT02668185|617498001|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
170860598|NCT02668185|617498002|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
170860599|NCT01013597|617498003|FG000|Overall Study|Withdrawal by Subject|1|||
170860600|NCT02678247|617498004|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
170860601|NCT02678247|617498005|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
170860602|NCT02678247|617498004|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
170860603|NCT02678247|617498005|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
170860604|NCT02678247|617498004|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
170860605|NCT02678247|617498005|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
170860606|NCT02678247|617498004|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
170860607|NCT02678247|617498005|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
170860608|NCT02678247|617498004|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
170860609|NCT02678247|617498005|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
170860610|NCT02678247|617498004|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
170860611|NCT02678247|617498005|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
170860612|NCT02533570|617498008|FG000|Overall Study|Adverse Event|0|||
170860613|NCT02533570|617498009|FG001|Overall Study|Adverse Event|1|||
170860614|NCT02533570|617498010|FG002|Overall Study|Adverse Event|1|||
170860615|NCT03534284|617498011|FG000|Overall Study|Death|2|||
170860616|NCT03534284|617498012|FG001|Overall Study|Death|3|||
170860617|NCT03534284|617498013|FG002|Overall Study|Death|3|||
170860618|NCT03534284|617498011|FG000|Overall Study|Withdrawal by Subject|5|||
170860619|NCT03534284|617498012|FG001|Overall Study|Withdrawal by Subject|0|||
170860620|NCT03534284|617498013|FG002|Overall Study|Withdrawal by Subject|0|||
170860621|NCT03316300|617498014|FG000|Overall Study|Withdrawal by Subject|3|||
170860622|NCT03316300|617498015|FG001|Overall Study|Withdrawal by Subject|2|||
170860623|NCT03316300|617498014|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
170860624|NCT03316300|617498015|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
170860625|NCT03316300|617498014|FG000|Overall Study|Adverse Event|1|||
170860626|NCT03316300|617498015|FG001|Overall Study|Adverse Event|0|||
170860627|NCT03316300|617498014|FG000|Overall Study|COVID-19|0|||
170860628|NCT03316300|617498015|FG001|Overall Study|COVID-19|1|||
170860629|NCT04002401|617498016|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
170860630|NCT04002401|617498016|FG000|Overall Study|Death|10|||
170860631|NCT04002401|617498016|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
170860632|NCT04002401|617498016|FG000|Overall Study|Enrolled but Never Treated|1|||
170860633|NCT04002401|617498016|FG000|Overall Study|Lost to Follow-up|1|||
170860634|NCT01009580|617498017|FG000|Overall Study|Adverse Event|4|||
170860635|NCT01009580|617498018|FG001|Overall Study|Adverse Event|4|||
170860636|NCT01009580|617498017|FG000|Overall Study|Lack of Efficacy|0|||
170860637|NCT01009580|617498018|FG001|Overall Study|Lack of Efficacy|1|||
170860638|NCT01009580|617498017|FG000|Overall Study|Protocol Violation|2|||
170860639|NCT01009580|617498018|FG001|Overall Study|Protocol Violation|3|||
170860640|NCT01009580|617498017|FG000|Overall Study|Withdrawal Criteria|4|||
170860641|NCT01009580|617498018|FG001|Overall Study|Withdrawal Criteria|6|||
170860642|NCT01009580|617498017|FG000|Overall Study|Unclassified|17|||
170860643|NCT01009580|617498018|FG001|Overall Study|Unclassified|21|||
170860644|NCT00112047|617498020|FG000|Randomized Phase|Lost to Follow-up|26|||
170860645|NCT00112047|617498021|FG001|Randomized Phase|Lost to Follow-up|33|||
170860646|NCT00112047|617498020|FG000|Randomized Phase|Adverse Event|10|||
170860647|NCT00112047|617498021|FG001|Randomized Phase|Adverse Event|10|||
170860648|NCT00112047|617498020|FG000|Randomized Phase|Withrawal of consent|10|||
170860649|NCT00112047|617498021|FG001|Randomized Phase|Withrawal of consent|18|||
170860650|NCT00112047|617498020|FG000|Randomized Phase|Sub-optimal virological response|3|||
170860651|NCT00112047|617498021|FG001|Randomized Phase|Sub-optimal virological response|13|||
170860652|NCT00112047|617498020|FG000|Randomized Phase|Noncompliance|8|||
170860653|NCT00112047|617498021|FG001|Randomized Phase|Noncompliance|4|||
170860654|NCT00112047|617498020|FG000|Randomized Phase|Protocol Violation|2|||
170860655|NCT00112047|617498021|FG001|Randomized Phase|Protocol Violation|0|||
170860656|NCT00112047|617498020|FG000|Randomized Phase|Pregnancy|3|||
170860657|NCT00112047|617498021|FG001|Randomized Phase|Pregnancy|1|||
170860658|NCT00112047|617498020|FG000|Randomized Phase|Death|1|||
170860659|NCT00112047|617498021|FG001|Randomized Phase|Death|3|||
170860660|NCT00112047|617498020|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
170860661|NCT00112047|617498021|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
170860662|NCT00112047|617498020|FG000|Randomized Phase|Inability to swallow pills|0|||
170860663|NCT00112047|617498021|FG001|Randomized Phase|Inability to swallow pills|1|||
170860664|NCT00112047|617498020|FG000|Randomized Phase|Incarceration|3|||
170860665|NCT00112047|617498021|FG001|Randomized Phase|Incarceration|2|||
170860666|NCT00112047|617498020|FG000|Randomized Phase|Moved out of State|0|||
170860667|NCT00112047|617498021|FG001|Randomized Phase|Moved out of State|1|||
170860668|NCT00112047|617498020|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
170860669|NCT00112047|617498021|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
170860670|NCT00112047|617498020|FG000|Randomized Phase|High Hepatitis B DNA|0|||
170860671|NCT00112047|617498021|FG001|Randomized Phase|High Hepatitis B DNA|1|||
170860672|NCT00112047|617498020|FG000|Atripla Phase|Adverse Event|2|||
170860673|NCT00112047|617498021|FG001|Atripla Phase|Adverse Event|1|||
170860674|NCT00112047|617498020|FG000|Atripla Phase|Lost to Follow-up|5|||
170860675|NCT00112047|617498021|FG001|Atripla Phase|Lost to Follow-up|7|||
170860676|NCT00112047|617498020|FG000|Atripla Phase|Pregnancy|0|||
170860677|NCT00112047|617498021|FG001|Atripla Phase|Pregnancy|1|||
170860678|NCT00112047|617498020|FG000|Atripla Phase|Death|0|||
170860679|NCT00112047|617498021|FG001|Atripla Phase|Death|2|||
170860680|NCT00112047|617498020|FG000|Atripla Phase|Withdrew consent|7|||
170860681|NCT00112047|617498021|FG001|Atripla Phase|Withdrew consent|7|||
170860682|NCT00112047|617498020|FG000|Atripla Phase|Sub-optimal virological response|0|||
170860683|NCT00112047|617498021|FG001|Atripla Phase|Sub-optimal virological response|1|||
170860684|NCT00112047|617498020|FG000|Atripla Phase|Non-compliance|1|||
170860685|NCT00112047|617498021|FG001|Atripla Phase|Non-compliance|0|||
170860686|NCT00112047|617498020|FG000|Atripla Phase|Other|3|||
170860687|NCT00112047|617498021|FG001|Atripla Phase|Other|1|||
170906036|NCT01731002|617658597|FG001|Overall Study|Test Agent Discontinuation|1|||
170906037|NCT01731002|617658598|FG002|Overall Study|Test Agent Discontinuation|0|||
170906038|NCT01731002|617658596|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
170906039|NCT01731002|617658597|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
170906040|NCT01731002|617658598|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
170906041|NCT01731002|617658596|FG000|Overall Study|Elevated IOP|1|||
170906042|NCT01731002|617658597|FG001|Overall Study|Elevated IOP|0|||
170906043|NCT01731002|617658598|FG002|Overall Study|Elevated IOP|0|||
170906044|NCT01731002|617658596|FG000|Overall Study|Inappropriate use of study medications|0|||
170906045|NCT01731002|617658597|FG001|Overall Study|Inappropriate use of study medications|0|||
170906046|NCT01731002|617658598|FG002|Overall Study|Inappropriate use of study medications|1|||
170906047|NCT00609622|617658599|FG000|Overall Study|Adverse Event|14|||
170906048|NCT00609622|617658600|FG001|Overall Study|Adverse Event|10|||
170906049|NCT00609622|617658599|FG000|Overall Study|Withdrawal by Subject|4|||
170906050|NCT00609622|617658600|FG001|Overall Study|Withdrawal by Subject|20|||
170906051|NCT00609622|617658599|FG000|Overall Study|Death|1|||
170516226|NCT03428100|616234851|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
170906052|NCT00609622|617658600|FG001|Overall Study|Death|4|||
170906053|NCT00609622|617658599|FG000|Overall Study|Protocol Violation|1|||
170906054|NCT00609622|617658600|FG001|Overall Study|Protocol Violation|1|||
170906055|NCT00609622|617658599|FG000|Overall Study|Objective progression or relapse|47|||
170906056|NCT00609622|617658600|FG001|Overall Study|Objective progression or relapse|41|||
170906057|NCT00609622|617658599|FG000|Overall Study|Study terminated by sponsor|16|||
170906058|NCT00609622|617658600|FG001|Overall Study|Study terminated by sponsor|3|||
170906059|NCT00609622|617658599|FG000|Overall Study|Other|7|||
170906060|NCT00609622|617658600|FG001|Overall Study|Other|14|||
170906061|NCT00609622|617658599|FG000|Overall Study|Global deterioration of health status|6|||
170906062|NCT00609622|617658600|FG001|Overall Study|Global deterioration of health status|2|||
170906063|NCT01708057|617658601|FG000|Overall Study|Withdrawal due to study termination.|1|||
170906064|NCT01708057|617658602|FG001|Overall Study|Withdrawal due to study termination.|1|||
170906065|NCT01708057|617658603|FG002|Overall Study|Withdrawal due to study termination.|1|||
170906066|NCT00752986|617658604|FG000|Overall Study|Withdrawal by Subject|2|||
170906067|NCT00752986|617658605|FG001|Overall Study|Withdrawal by Subject|1|||
170906068|NCT00752986|617658606|FG002|Overall Study|Withdrawal by Subject|2|||
170906069|NCT00752986|617658604|FG000|Overall Study|Protocol Violation|3|||
170906070|NCT00752986|617658605|FG001|Overall Study|Protocol Violation|0|||
170906071|NCT00752986|617658606|FG002|Overall Study|Protocol Violation|0|||
170906072|NCT00947349|617658607|FG000|Triple Treatment Combination Period|Adverse Event|0|||
170906073|NCT00947349|617658608|FG001|Triple Treatment Combination Period|Adverse Event|1|||
170906074|NCT00947349|617658609|FG002|Triple Treatment Combination Period|Adverse Event|0|||
170906075|NCT00947349|617658610|FG003|Triple Treatment Combination Period|Adverse Event|0|||
170906076|NCT00947349|617658607|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
170906077|NCT00947349|617658608|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
170906078|NCT00947349|617658609|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
170906079|NCT00947349|617658610|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
170906080|NCT00947349|617658607|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
170906081|NCT00947349|617658608|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
170906082|NCT00947349|617658609|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
170906083|NCT00947349|617658610|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
170906084|NCT00947349|617658607|FG000|Overall Study Standard of Care|Other|0|||
170906085|NCT00947349|617658608|FG001|Overall Study Standard of Care|Other|0|||
170906086|NCT00947349|617658609|FG002|Overall Study Standard of Care|Other|0|||
170906087|NCT00947349|617658610|FG003|Overall Study Standard of Care|Other|1|||
170906088|NCT00924703|617658611|FG000|Overall Study|Withdrawal by Subject|11|||
170906089|NCT00924703|617658611|FG000|Overall Study|Physician Decision|5|||
170906090|NCT00924703|617658611|FG000|Overall Study|Lost to Follow-up|3|||
170906091|NCT00924703|617658611|FG000|Overall Study|Adverse Event|2|||
170906092|NCT00924703|617658611|FG000|Overall Study|Withdrawal by Sponsor|1|||
170906093|NCT04906707|617658612|FG000|Overall Study|Withdrawal by Subject|2|||
170906094|NCT04906707|617658613|FG001|Overall Study|Withdrawal by Subject|0|||
170906095|NCT04906707|617658612|FG000|Overall Study|Withdrawal due to PI decision|1|||
170906096|NCT04906707|617658613|FG001|Overall Study|Withdrawal due to PI decision|0|||
170906097|NCT04906707|617658612|FG000|Overall Study|Lost to Follow-up|0|||
170906098|NCT04906707|617658613|FG001|Overall Study|Lost to Follow-up|1|||
170906099|NCT05369806|617658614|FG000|Overall Study|Lost to Follow-up|1|||
170906100|NCT00628355|617658615|FG000|Overall Study|Withdrawal by Subject|1|||
170906101|NCT00628355|617658616|FG001|Overall Study|Withdrawal by Subject|1|||
170906102|NCT03430310|617658617|FG000|Overall Study|Protocol Violation|2|||
170906103|NCT03430310|617658618|FG001|Overall Study|Protocol Violation|0|||
170906104|NCT03430310|617658617|FG000|Overall Study|Withdrawal by Subject|3|||
170906105|NCT03430310|617658618|FG001|Overall Study|Withdrawal by Subject|2|||
170860688|NCT03274687|617499227|FG000|Overall Study|Protocol Violation|1|||
170860689|NCT03274687|617499228|FG001|Overall Study|Protocol Violation|1|||
170860690|NCT02720536|617499229|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
170860691|NCT02720536|617499229|FG000|Overall Study|PR - pregnancy|2|||
170860692|NCT02720536|617499229|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
170860693|NCT02720536|617499229|FG000|Overall Study|PR - death|1|||
170860694|NCT02720536|617499229|FG000|Overall Study|PR - adverse event|1|||
170860695|NCT02720536|617499229|FG000|Overall Study|PR - abnormal lab value(s)|1|||
170860696|NCT02720536|617499229|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
170860697|NCT03442985|617499230|FG000|Overall Study|Sponsor Request|55|||
170860698|NCT03442985|617499231|FG001|Overall Study|Sponsor Request|60|||
170860699|NCT03442985|617499232|FG002|Overall Study|Sponsor Request|54|||
170860700|NCT03442985|617499230|FG000|Overall Study|Lost to Follow-up|5|||
170860701|NCT03442985|617499231|FG001|Overall Study|Lost to Follow-up|2|||
170860702|NCT03442985|617499232|FG002|Overall Study|Lost to Follow-up|7|||
170860703|NCT03442985|617499230|FG000|Overall Study|Withdrawal by Subject|2|||
170860704|NCT03442985|617499231|FG001|Overall Study|Withdrawal by Subject|3|||
170860705|NCT03442985|617499232|FG002|Overall Study|Withdrawal by Subject|4|||
170860706|NCT03442985|617499230|FG000|Overall Study|Adverse Event|0|||
170860707|NCT03442985|617499231|FG001|Overall Study|Adverse Event|1|||
170860708|NCT03442985|617499232|FG002|Overall Study|Adverse Event|0|||
170860709|NCT01217957|617499233|FG000|Phase 1|Withdrawal by Patient|1|||
170860710|NCT01217957|617499234|FG001|Phase 1|Withdrawal by Patient|0|||
170860711|NCT01217957|617499235|FG002|Phase 1|Withdrawal by Patient|1|||
170860712|NCT01217957|617499236|FG003|Phase 1|Withdrawal by Patient|1|||
170860713|NCT01217957|617499237|FG004|Phase 1|Withdrawal by Patient|0|||
170860714|NCT01217957|617499233|FG000|Phase 2|Withdrawal by Patient|0|||
170860715|NCT01217957|617499234|FG001|Phase 2|Withdrawal by Patient|0|||
170860716|NCT01217957|617499235|FG002|Phase 2|Withdrawal by Patient|0|||
170860717|NCT01217957|617499236|FG003|Phase 2|Withdrawal by Patient|0|||
170860718|NCT01217957|617499237|FG004|Phase 2|Withdrawal by Patient|1|||
170860719|NCT00795951|617499238|FG000|Overall Study|Lost to Follow-up|1|||
170860720|NCT00795951|617499238|FG000|Overall Study|Withdrawal by Subject|1|||
170860721|NCT01138007|617499239|FG000|Overall Study|Adverse Event|4|||
170860722|NCT01138007|617499240|FG001|Overall Study|Adverse Event|12|||
170860723|NCT01138007|617499241|FG002|Overall Study|Adverse Event|9|||
170860724|NCT01138007|617499239|FG000|Overall Study|Lack of Efficacy|2|||
170860725|NCT01138007|617499240|FG001|Overall Study|Lack of Efficacy|0|||
170860726|NCT01138007|617499241|FG002|Overall Study|Lack of Efficacy|6|||
170860727|NCT01138007|617499239|FG000|Overall Study|Protocol Violation|2|||
170860728|NCT01138007|617499240|FG001|Overall Study|Protocol Violation|3|||
170860729|NCT01138007|617499241|FG002|Overall Study|Protocol Violation|2|||
170860730|NCT01138007|617499239|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
170860731|NCT01138007|617499240|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
170860732|NCT01138007|617499241|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
170860733|NCT01138007|617499239|FG000|Overall Study|Lost to Follow-up|3|||
170860734|NCT01138007|617499240|FG001|Overall Study|Lost to Follow-up|3|||
170860735|NCT01138007|617499241|FG002|Overall Study|Lost to Follow-up|5|||
170860736|NCT01138007|617499239|FG000|Overall Study|Physician Decision|0|||
170860737|NCT01138007|617499240|FG001|Overall Study|Physician Decision|5|||
170860738|NCT01138007|617499241|FG002|Overall Study|Physician Decision|3|||
170860739|NCT01138007|617499239|FG000|Overall Study|Withdrawal by Subject|5|||
170860740|NCT01138007|617499240|FG001|Overall Study|Withdrawal by Subject|6|||
170860741|NCT01138007|617499241|FG002|Overall Study|Withdrawal by Subject|15|||
170860742|NCT03964727|617499242|FG000|Overall Study|Death|14|||
170860743|NCT03964727|617499243|FG001|Overall Study|Death|23|||
170860744|NCT03964727|617499244|FG002|Overall Study|Death|25|||
170860745|NCT03964727|617499245|FG003|Overall Study|Death|31|||
170860746|NCT03964727|617499246|FG004|Overall Study|Death|28|||
170860747|NCT03964727|617499247|FG005|Overall Study|Death|32|||
170860748|NCT03964727|617499242|FG000|Overall Study|Still on study|0|||
170860749|NCT03964727|617499243|FG001|Overall Study|Still on study|6|||
170860750|NCT03964727|617499244|FG002|Overall Study|Still on study|2|||
170860751|NCT03964727|617499245|FG003|Overall Study|Still on study|4|||
170860752|NCT03964727|617499246|FG004|Overall Study|Still on study|7|||
170860753|NCT03964727|617499247|FG005|Overall Study|Still on study|8|||
170860754|NCT03964727|617499242|FG000|Overall Study|Reason not specified|16|||
170516227|NCT03428100|616234852|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
170860755|NCT03964727|617499243|FG001|Overall Study|Reason not specified|3|||
170860756|NCT03964727|617499244|FG002|Overall Study|Reason not specified|1|||
170516228|NCT03428100|616234853|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
170860757|NCT03964727|617499245|FG003|Overall Study|Reason not specified|0|||
170860758|NCT03964727|617499246|FG004|Overall Study|Reason not specified|0|||
170860759|NCT03964727|617499247|FG005|Overall Study|Reason not specified|0|||
170860760|NCT03964727|617499242|FG000|Overall Study|Withdrawal by Subject|1|||
170860761|NCT03964727|617499243|FG001|Overall Study|Withdrawal by Subject|2|||
170860762|NCT03964727|617499244|FG002|Overall Study|Withdrawal by Subject|3|||
170860763|NCT03964727|617499245|FG003|Overall Study|Withdrawal by Subject|7|||
170860764|NCT03964727|617499246|FG004|Overall Study|Withdrawal by Subject|4|||
170860765|NCT03964727|617499247|FG005|Overall Study|Withdrawal by Subject|3|||
170860766|NCT03964727|617499242|FG000|Overall Study|Lost to Follow-up|0|||
170860767|NCT03964727|617499243|FG001|Overall Study|Lost to Follow-up|0|||
170860768|NCT03964727|617499244|FG002|Overall Study|Lost to Follow-up|0|||
170860769|NCT03964727|617499245|FG003|Overall Study|Lost to Follow-up|1|||
170860770|NCT03964727|617499246|FG004|Overall Study|Lost to Follow-up|2|||
170860771|NCT03964727|617499247|FG005|Overall Study|Lost to Follow-up|0|||
170860772|NCT02365597|617499248|FG000|Overall Study|Lost to Follow-up|0|||
170860773|NCT02365597|617499249|FG001|Overall Study|Lost to Follow-up|1|||
170860774|NCT02365597|617499250|FG002|Overall Study|Lost to Follow-up|0|||
170860775|NCT02365597|617499251|FG003|Overall Study|Lost to Follow-up|1|||
170860776|NCT02365597|617499248|FG000|Overall Study|Withdrawal by Subject|1|||
170860777|NCT02365597|617499249|FG001|Overall Study|Withdrawal by Subject|8|||
170860778|NCT02365597|617499250|FG002|Overall Study|Withdrawal by Subject|5|||
170516229|NCT03428100|616234854|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
170516230|NCT03428100|616234855|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
170516231|NCT03428100|616234856|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
170516232|NCT03428100|616234857|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
170516233|NCT03428100|616234858|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
170516234|NCT03428100|616234859|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
170516235|NCT03428100|616234860|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
170516236|NCT03428100|616234861|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
170516237|NCT03428100|616234862|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
170860779|NCT02365597|617499251|FG003|Overall Study|Withdrawal by Subject|1|||
170860780|NCT02365597|617499248|FG000|Overall Study|Sponsor's decision|1|||
170860781|NCT02365597|617499249|FG001|Overall Study|Sponsor's decision|3|||
170860782|NCT02365597|617499250|FG002|Overall Study|Sponsor's decision|13|||
170860783|NCT02365597|617499251|FG003|Overall Study|Sponsor's decision|0|||
170860784|NCT02365597|617499248|FG000|Overall Study|Other|0|||
170860785|NCT02365597|617499249|FG001|Overall Study|Other|4|||
170860786|NCT02365597|617499250|FG002|Overall Study|Other|0|||
170860787|NCT02365597|617499251|FG003|Overall Study|Other|0|||
170860788|NCT02365597|617499248|FG000|Overall Study|Enrolled but not treated|0|||
170860789|NCT02365597|617499249|FG001|Overall Study|Enrolled but not treated|1|||
170860790|NCT02365597|617499250|FG002|Overall Study|Enrolled but not treated|1|||
170860791|NCT02365597|617499251|FG003|Overall Study|Enrolled but not treated|0|||
170860792|NCT02365597|617499248|FG000|Overall Study|Ongoing|0|||
170860793|NCT02365597|617499249|FG001|Overall Study|Ongoing|0|||
170860794|NCT02365597|617499250|FG002|Overall Study|Ongoing|0|||
170860795|NCT02365597|617499251|FG003|Overall Study|Ongoing|17|||
170860796|NCT02768870|617499254|FG000|Overall Study|Death|1|||
170860797|NCT02768870|617499254|FG000|Overall Study|Reoperation|6|||
170860798|NCT02768870|617499254|FG000|Overall Study|Lost to Follow-up|1|||
170516238|NCT03428100|616234863|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
170516239|NCT03428100|616234864|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
170516240|NCT03428100|616234865|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
170516241|NCT03428100|616234866|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
170516242|NCT03428100|616234867|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
170516243|NCT03428100|616234868|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
170516244|NCT03428100|616234850|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
170516245|NCT03428100|616234851|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
170516246|NCT03428100|616234852|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
170516247|NCT03428100|616234853|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
170516248|NCT03428100|616234854|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
170516249|NCT03428100|616234855|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
170516250|NCT03428100|616234856|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
170516251|NCT03428100|616234857|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
170516252|NCT03428100|616234858|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
170516253|NCT03428100|616234859|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
170516254|NCT03428100|616234860|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
170516255|NCT03428100|616234861|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
170516256|NCT03428100|616234862|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
170516257|NCT03428100|616234863|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
170516258|NCT03428100|616234864|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
170516259|NCT03428100|616234865|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
170516260|NCT03428100|616234866|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
170860799|NCT02768870|617499254|FG000|Overall Study|Exit|4|||
170516261|NCT03428100|616234867|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
170516262|NCT03428100|616234868|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
170516263|NCT03428100|616234850|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170516264|NCT03428100|616234851|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170860800|NCT01774110|617499255|FG000|Overall Study|Lost to Follow-up|7|||
170860801|NCT02203695|617499256|FG000|Overall Study|Patient withdrew consent|1|||
170860802|NCT02203695|617499257|FG001|Overall Study|Patient withdrew consent|1|||
170860803|NCT02203695|617499256|FG000|Overall Study|Started non-study treatment|1|||
170860804|NCT02203695|617499257|FG001|Overall Study|Started non-study treatment|0|||
170860805|NCT02974088|617499261|FG000|Overall Study|Lost to Follow-up|0|||
170860806|NCT02974088|617499262|FG001|Overall Study|Lost to Follow-up|2|||
170860807|NCT02974088|617499261|FG000|Overall Study|Adverse Event|0|||
170860808|NCT02974088|617499262|FG001|Overall Study|Adverse Event|1|||
170860809|NCT01580969|617499266|FG000|Overall Study|Physician Decision|3|||
170860810|NCT01580969|617499267|FG001|Overall Study|Physician Decision|0|||
170860811|NCT01580969|617499268|FG002|Overall Study|Physician Decision|0|||
170860812|NCT00807235|617499281|FG000|Overall Study|Adverse Event|1|||
170860813|NCT00807235|617499282|FG001|Overall Study|Adverse Event|0|||
170860814|NCT01032382|617499283|FG000|Overall Study|Disease dissemination|1|||
170860815|NCT01032382|617499284|FG001|Overall Study|Disease dissemination|1|||
170860816|NCT01032382|617499283|FG000|Overall Study|Treatment failure|3|||
170860817|NCT01032382|617499284|FG001|Overall Study|Treatment failure|1|||
170860818|NCT01032382|617499283|FG000|Overall Study|Index lesion relapse|1|||
170860819|NCT01032382|617499284|FG001|Overall Study|Index lesion relapse|3|||
170860820|NCT00427895|617499285|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
170860821|NCT00427895|617499286|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
170860822|NCT00427895|617499287|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
170860823|NCT00427895|617499288|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
170860824|NCT00427895|617499289|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
170860825|NCT00427895|617499290|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
170860826|NCT00427895|617499291|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
170860827|NCT00427895|617499292|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
170860828|NCT00427895|617499285|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
170860829|NCT00427895|617499286|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
170860830|NCT00427895|617499287|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
170860831|NCT00427895|617499288|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
170860832|NCT00427895|617499289|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
170860833|NCT00427895|617499290|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
170860834|NCT00427895|617499291|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
170860835|NCT00427895|617499292|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
170860836|NCT00427895|617499285|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
170860837|NCT00427895|617499286|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
170860838|NCT00427895|617499287|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
170860839|NCT00427895|617499288|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
170860840|NCT00427895|617499289|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
170860841|NCT00427895|617499290|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
170860842|NCT00427895|617499291|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
170860843|NCT00427895|617499292|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
170860844|NCT00427895|617499285|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
170860845|NCT00427895|617499286|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
170860846|NCT00427895|617499287|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
170860847|NCT00427895|617499288|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
170860848|NCT00427895|617499289|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
170860849|NCT00427895|617499290|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
170860850|NCT00427895|617499291|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
170860851|NCT00427895|617499292|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
170860852|NCT00427895|617499285|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
170860853|NCT00427895|617499286|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
170860854|NCT00427895|617499287|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
170860855|NCT00427895|617499288|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
170860856|NCT00427895|617499289|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
170860857|NCT00427895|617499290|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
170860858|NCT00427895|617499291|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
170860859|NCT00427895|617499292|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
170860860|NCT00427895|617499285|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
170860861|NCT00427895|617499286|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
170860862|NCT00427895|617499287|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
170860863|NCT00427895|617499288|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
170860864|NCT00427895|617499289|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
170860865|NCT00427895|617499290|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
170860866|NCT00427895|617499291|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
170860867|NCT00427895|617499292|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
170860868|NCT00427895|617499285|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
170860869|NCT00427895|617499286|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
170860870|NCT00427895|617499287|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
170860871|NCT00427895|617499288|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
170516265|NCT03428100|616234852|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170860872|NCT00427895|617499289|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
170860873|NCT00427895|617499290|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
170860874|NCT00427895|617499291|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
170860875|NCT00427895|617499292|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
170860876|NCT00427895|617499285|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
170860877|NCT00427895|617499286|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
170860878|NCT00427895|617499287|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
170860879|NCT00427895|617499288|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
170860880|NCT00427895|617499289|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
170860881|NCT00427895|617499290|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
170860882|NCT00427895|617499291|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
170860883|NCT00427895|617499292|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
170860884|NCT00427895|617499285|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
170860885|NCT00427895|617499286|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
170860886|NCT00427895|617499287|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
170860887|NCT00427895|617499288|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
170860888|NCT00427895|617499289|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
170860889|NCT00427895|617499290|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
170860890|NCT00427895|617499291|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
170860891|NCT00427895|617499292|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
170860892|NCT00427895|617499285|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
170860893|NCT00427895|617499286|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
170860894|NCT00427895|617499287|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
170860895|NCT00427895|617499288|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
170860896|NCT00427895|617499289|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
170860897|NCT00427895|617499290|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
170860898|NCT00427895|617499291|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
170860899|NCT00427895|617499292|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
170860900|NCT00427895|617499285|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
170860901|NCT00427895|617499286|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
170860902|NCT00427895|617499287|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
170860903|NCT00427895|617499288|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
170860904|NCT00427895|617499289|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
170860905|NCT00427895|617499290|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
170860906|NCT00427895|617499291|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
170860907|NCT00427895|617499292|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
170860908|NCT00427895|617499285|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
170860909|NCT00427895|617499286|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
170860910|NCT00427895|617499287|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
170860911|NCT00427895|617499288|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
170860912|NCT00427895|617499289|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
170860913|NCT00427895|617499290|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
170860914|NCT00427895|617499291|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
170860915|NCT00427895|617499292|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
170860916|NCT00427895|617499285|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
170860917|NCT00427895|617499286|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
170860918|NCT00427895|617499287|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
170860919|NCT00427895|617499288|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
170860920|NCT00427895|617499289|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
170860921|NCT00427895|617499290|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
170860922|NCT00427895|617499291|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
170860923|NCT00427895|617499292|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
170860924|NCT00427895|617499285|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
170860925|NCT00427895|617499286|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
170860926|NCT00427895|617499287|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
170860927|NCT00427895|617499288|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
170860928|NCT00427895|617499289|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
170860929|NCT00427895|617499290|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
170860930|NCT00427895|617499291|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
170860931|NCT00427895|617499292|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
170860932|NCT00427895|617499285|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
170860933|NCT00427895|617499286|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
170860934|NCT00427895|617499287|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
170860935|NCT00427895|617499288|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
170860936|NCT00427895|617499289|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
170860937|NCT00427895|617499290|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
170860938|NCT00427895|617499291|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
170860939|NCT00427895|617499292|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
170516266|NCT03428100|616234853|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170630138|NCT00463567|616660410|FG006|Overall Study|Lost to Follow-up|1|||
170860940|NCT00427895|617499285|FG000|Vax 1/Year 1 Follow-up|Death|1|||
170860941|NCT00427895|617499286|FG001|Vax 1/Year 1 Follow-up|Death|0|||
170860942|NCT00427895|617499287|FG002|Vax 1/Year 1 Follow-up|Death|0|||
170860943|NCT00427895|617499288|FG003|Vax 1/Year 1 Follow-up|Death|0|||
170860944|NCT00427895|617499289|FG004|Vax 1/Year 1 Follow-up|Death|0|||
170860945|NCT00427895|617499290|FG005|Vax 1/Year 1 Follow-up|Death|0|||
170860946|NCT00427895|617499291|FG006|Vax 1/Year 1 Follow-up|Death|0|||
170860947|NCT00427895|617499292|FG007|Vax 1/Year 1 Follow-up|Death|0|||
170860948|NCT00427895|617499285|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
170860949|NCT00427895|617499286|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
170860950|NCT00427895|617499287|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
170860951|NCT00427895|617499288|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
170860952|NCT00427895|617499289|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
170860953|NCT00427895|617499290|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
170860954|NCT00427895|617499291|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
170860955|NCT00427895|617499292|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
170860956|NCT00427895|617499285|FG000|Vax 1/Year 1 Follow-up|Other|0|||
170860957|NCT00427895|617499286|FG001|Vax 1/Year 1 Follow-up|Other|0|||
170860958|NCT00427895|617499287|FG002|Vax 1/Year 1 Follow-up|Other|0|||
170860959|NCT00427895|617499288|FG003|Vax 1/Year 1 Follow-up|Other|2|||
170860960|NCT00427895|617499289|FG004|Vax 1/Year 1 Follow-up|Other|0|||
170860961|NCT00427895|617499290|FG005|Vax 1/Year 1 Follow-up|Other|0|||
170860962|NCT00427895|617499291|FG006|Vax 1/Year 1 Follow-up|Other|0|||
170860963|NCT00427895|617499292|FG007|Vax 1/Year 1 Follow-up|Other|0|||
170860964|NCT00427895|617499285|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
170860965|NCT00427895|617499286|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
170860966|NCT00427895|617499287|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
170860967|NCT00427895|617499288|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
170860968|NCT00427895|617499289|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
170860969|NCT00427895|617499290|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
170860970|NCT00427895|617499291|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
170860971|NCT00427895|617499292|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
170860972|NCT03816332|617499293|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
170860973|NCT03816332|617499293|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
170860974|NCT04661150|617499297|FG000|Overall Study|Ongoing in study|19|||
170860975|NCT04661150|617499298|FG001|Overall Study|Ongoing in study|20|||
170860976|NCT04661150|617499297|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
170860977|NCT04661150|617499298|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
170860978|NCT04661150|617499297|FG000|Overall Study|Death|2|||
170860979|NCT04661150|617499298|FG001|Overall Study|Death|0|||
170860980|NCT01651403|617499301|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
170860981|NCT01651403|617499302|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
170860982|NCT01651403|617499301|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
170860983|NCT01651403|617499302|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
170860984|NCT01651403|617499301|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
170860985|NCT01651403|617499302|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
170860986|NCT01651403|617499301|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
170860987|NCT01651403|617499302|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
170860988|NCT01651403|617499301|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
170860989|NCT01651403|617499302|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
170860990|NCT01651403|617499301|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
170860991|NCT01651403|617499302|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
170860992|NCT00423930|617499303|FG000|Overall Study|Withdrawal by Subject|2|||
170860993|NCT02337751|617499306|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
170860994|NCT02337751|617499307|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
170860995|NCT02337751|617499306|FG000|Overall Study|Voluntary Withdrawal|6|||
170860996|NCT02337751|617499307|FG001|Overall Study|Voluntary Withdrawal|8|||
170860997|NCT02337751|617499306|FG000|Overall Study|Lack of Efficacy|2|||
170860998|NCT02337751|617499307|FG001|Overall Study|Lack of Efficacy|5|||
170860999|NCT02337751|617499306|FG000|Overall Study|Investigator's Judgement|1|||
170861000|NCT02337751|617499307|FG001|Overall Study|Investigator's Judgement|0|||
170861001|NCT02881957|617499308|FG000|Overall Study|Comfort care|0|||
170861002|NCT02881957|617499309|FG001|Overall Study|Comfort care|1|||
170861003|NCT02881957|617499308|FG000|Overall Study|Concurrent trial enrollment|0|||
170861004|NCT02881957|617499309|FG001|Overall Study|Concurrent trial enrollment|1|||
170861005|NCT02881957|617499308|FG000|Overall Study|Discharged within 48 hours|0|||
170861006|NCT02881957|617499309|FG001|Overall Study|Discharged within 48 hours|1|||
170861007|NCT02881957|617499308|FG000|Overall Study|Withdrawal by Subject|2|||
170861008|NCT02881957|617499309|FG001|Overall Study|Withdrawal by Subject|1|||
170861009|NCT02881957|617499308|FG000|Overall Study|Protocol Violation|1|||
170861010|NCT02881957|617499309|FG001|Overall Study|Protocol Violation|0|||
170861011|NCT03301220|617499310|FG000|Overall Study|Death|26|||
170861012|NCT03301220|617499311|FG001|Overall Study|Death|15|||
170861013|NCT03301220|617499310|FG000|Overall Study|Withdrawal by Subject|23|||
170861014|NCT03301220|617499311|FG001|Overall Study|Withdrawal by Subject|12|||
170861015|NCT03301220|617499310|FG000|Overall Study|Lost to Follow-up|1|||
170861016|NCT03301220|617499311|FG001|Overall Study|Lost to Follow-up|1|||
170861017|NCT03301220|617499310|FG000|Overall Study|Randomized in error|1|||
170861018|NCT03301220|617499311|FG001|Overall Study|Randomized in error|1|||
170861019|NCT03301220|617499310|FG000|Overall Study|Randomized but not treated|0|||
170861020|NCT03301220|617499311|FG001|Overall Study|Randomized but not treated|1|||
170861021|NCT03301220|617499310|FG000|Overall Study|Ongoing followup|145|||
170861022|NCT03301220|617499311|FG001|Overall Study|Ongoing followup|163|||
170861023|NCT03301220|617499310|FG000|Overall Study|Principal Investigator and participant decision|0|||
170861024|NCT03301220|617499311|FG001|Overall Study|Principal Investigator and participant decision|1|||
170861025|NCT04621929|617499312|FG000|Overall Study|Withdrawal by Subject|3|||
170861026|NCT04621929|617499313|FG001|Overall Study|Withdrawal by Subject|1|||
170861027|NCT05328167|617499314|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
170861028|NCT05328167|617499314|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
170861029|NCT01050790|617499315|FG000|Overall Study|Adverse Event|1|||
170861030|NCT01880528|617499316|FG000|Overall Study|Other|1|||
170861031|NCT01880528|617499317|FG001|Overall Study|Other|1|||
170861032|NCT00081497|617499318|FG000|Overall Study|Adverse Event|2|||
170861033|NCT00081497|617499319|FG001|Overall Study|Adverse Event|0|||
170861034|NCT00081497|617499318|FG000|Overall Study|Death|0|||
170861035|NCT00081497|617499319|FG001|Overall Study|Death|1|||
170861036|NCT00081497|617499318|FG000|Overall Study|Withdrawal by Subject|1|||
170861037|NCT00081497|617499319|FG001|Overall Study|Withdrawal by Subject|0|||
170861038|NCT00081497|617499318|FG000|Overall Study|Non-compliance|0|||
170861039|NCT00081497|617499319|FG001|Overall Study|Non-compliance|1|||
170861040|NCT02390245|617499320|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
170861041|NCT02390245|617499321|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
170861042|NCT02390245|617499322|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
170861043|NCT02390245|617499320|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
170861044|NCT02390245|617499321|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
170861045|NCT02390245|617499322|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
170861046|NCT03815058|617500498|FG000|Safety Run-in Stage|Death|2|||
170861047|NCT03815058|617500499|FG001|Safety Run-in Stage|Death|0|||
170861048|NCT03815058|617500500|FG002|Safety Run-in Stage|Death|0|||
170861049|NCT03815058|617500501|FG003|Safety Run-in Stage|Death|0|||
170861050|NCT03815058|617500498|FG000|Safety Run-in Stage|Study Ended by Sponsor|4|||
170861051|NCT03815058|617500499|FG001|Safety Run-in Stage|Study Ended by Sponsor|0|||
170861052|NCT03815058|617500500|FG002|Safety Run-in Stage|Study Ended by Sponsor|0|||
170861053|NCT03815058|617500501|FG003|Safety Run-in Stage|Study Ended by Sponsor|0|||
170861054|NCT03815058|617500498|FG000|Randomized Stage|Death|0|||
170861055|NCT03815058|617500499|FG001|Randomized Stage|Death|13|||
170861056|NCT03815058|617500500|FG002|Randomized Stage|Death|29|||
170861057|NCT03815058|617500501|FG003|Randomized Stage|Death|0|||
170861058|NCT03815058|617500498|FG000|Randomized Stage|Lost to Follow-up|0|||
170861059|NCT03815058|617500499|FG001|Randomized Stage|Lost to Follow-up|2|||
170861060|NCT03815058|617500500|FG002|Randomized Stage|Lost to Follow-up|4|||
170861061|NCT03815058|617500501|FG003|Randomized Stage|Lost to Follow-up|0|||
170861062|NCT03815058|617500498|FG000|Randomized Stage|Study Ended by Sponsor|0|||
170861063|NCT03815058|617500499|FG001|Randomized Stage|Study Ended by Sponsor|14|||
170861064|NCT03815058|617500500|FG002|Randomized Stage|Study Ended by Sponsor|42|||
170861065|NCT03815058|617500501|FG003|Randomized Stage|Study Ended by Sponsor|0|||
170861066|NCT03815058|617500498|FG000|Randomized Stage|Withdrawal by Subject|0|||
170861067|NCT03815058|617500499|FG001|Randomized Stage|Withdrawal by Subject|2|||
170861068|NCT03815058|617500500|FG002|Randomized Stage|Withdrawal by Subject|9|||
170861069|NCT03815058|617500501|FG003|Randomized Stage|Withdrawal by Subject|0|||
170861070|NCT03815058|617500498|FG000|Randomized Stage|Discontinued due to PD to Receive Cross-over Treatment|0|||
170861071|NCT03815058|617500499|FG001|Randomized Stage|Discontinued due to PD to Receive Cross-over Treatment|10|||
170861072|NCT03815058|617500500|FG002|Randomized Stage|Discontinued due to PD to Receive Cross-over Treatment|0|||
170861073|NCT03815058|617500501|FG003|Randomized Stage|Discontinued due to PD to Receive Cross-over Treatment|0|||
170861074|NCT03815058|617500498|FG000|Cross-over Treatment|Death|0|||
170861075|NCT03815058|617500499|FG001|Cross-over Treatment|Death|0|||
170861076|NCT03815058|617500500|FG002|Cross-over Treatment|Death|0|||
170861077|NCT03815058|617500501|FG003|Cross-over Treatment|Death|2|||
170861078|NCT03815058|617500498|FG000|Cross-over Treatment|Study Ended by Sponsor|0|||
170861079|NCT03815058|617500499|FG001|Cross-over Treatment|Study Ended by Sponsor|0|||
170516267|NCT03428100|616234854|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170516268|NCT03428100|616234855|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170861080|NCT03815058|617500500|FG002|Cross-over Treatment|Study Ended by Sponsor|0|||
170861081|NCT03815058|617500501|FG003|Cross-over Treatment|Study Ended by Sponsor|7|||
170861082|NCT03815058|617500498|FG000|Cross-over Treatment|Withdrawal by Subject|0|||
170861083|NCT03815058|617500499|FG001|Cross-over Treatment|Withdrawal by Subject|0|||
170861084|NCT03815058|617500500|FG002|Cross-over Treatment|Withdrawal by Subject|0|||
170861085|NCT03815058|617500501|FG003|Cross-over Treatment|Withdrawal by Subject|1|||
170861086|NCT01195545|617500502|FG000|Overall Study|Protocol Violation|4|||
170861087|NCT00462865|617500504|FG000|Overall Study|Adverse Event|1|||
170861088|NCT02986334|617500505|FG000|Overall Study|Withdrawal by Subject|0|||
170861089|NCT02986334|617500506|FG001|Overall Study|Withdrawal by Subject|1|||
170861090|NCT02986334|617500507|FG002|Overall Study|Withdrawal by Subject|2|||
170861091|NCT02986334|617500505|FG000|Overall Study|Lost to Follow-up|1|||
170861092|NCT02986334|617500506|FG001|Overall Study|Lost to Follow-up|2|||
170861093|NCT02986334|617500507|FG002|Overall Study|Lost to Follow-up|1|||
170861094|NCT02986334|617500505|FG000|Overall Study|Adverse Event|0|||
170861095|NCT02986334|617500506|FG001|Overall Study|Adverse Event|2|||
170861096|NCT02986334|617500507|FG002|Overall Study|Adverse Event|1|||
170861097|NCT02986334|617500505|FG000|Overall Study|non compliance in phone ratings|2|||
170861098|NCT02986334|617500506|FG001|Overall Study|non compliance in phone ratings|1|||
170861099|NCT02986334|617500507|FG002|Overall Study|non compliance in phone ratings|2|||
170861100|NCT02986334|617500505|FG000|Overall Study|undisclosed comorbidities|0|||
170861101|NCT02986334|617500506|FG001|Overall Study|undisclosed comorbidities|1|||
170861102|NCT02986334|617500507|FG002|Overall Study|undisclosed comorbidities|1|||
170861103|NCT03456076|617500510|FG000|Overall Study|Withdrawal by Subject|5|||
170861104|NCT03456076|617500511|FG001|Overall Study|Withdrawal by Subject|9|||
170861105|NCT03456076|617500510|FG000|Overall Study|Protocol deviation|0|||
170861106|NCT03456076|617500511|FG001|Overall Study|Protocol deviation|1|||
170861107|NCT03456076|617500510|FG000|Overall Study|Lost to Follow-up|0|||
170861108|NCT03456076|617500511|FG001|Overall Study|Lost to Follow-up|1|||
170861109|NCT03456076|617500510|FG000|Overall Study|Death|2|||
170861110|NCT03456076|617500511|FG001|Overall Study|Death|5|||
170861111|NCT03456076|617500510|FG000|Overall Study|Study ongoing|123|||
170861112|NCT03456076|617500511|FG001|Overall Study|Study ongoing|111|||
170861113|NCT06336603|617500512|FG000|Overall Study|Withdrawal by Subject|1|||
170861114|NCT06336603|617500512|FG000|Overall Study|Lost to Follow-up|2|||
170861115|NCT03814746|617500513|FG000|Overall Study|Participant decision|9|||
170861116|NCT03814746|617500514|FG001|Overall Study|Participant decision|6|||
170861117|NCT03814746|617500515|FG002|Overall Study|Participant decision|15|||
170861118|NCT03814746|617500513|FG000|Overall Study|Physician Decision|2|||
170861119|NCT03814746|617500514|FG001|Overall Study|Physician Decision|2|||
170861120|NCT03814746|617500515|FG002|Overall Study|Physician Decision|4|||
170861121|NCT03814746|617500513|FG000|Overall Study|Death|2|||
170861122|NCT03814746|617500514|FG001|Overall Study|Death|2|||
170861123|NCT03814746|617500515|FG002|Overall Study|Death|2|||
170861124|NCT03814746|617500513|FG000|Overall Study|Adverse Event|2|||
170861125|NCT03814746|617500514|FG001|Overall Study|Adverse Event|2|||
170861126|NCT03814746|617500515|FG002|Overall Study|Adverse Event|1|||
170861127|NCT03814746|617500513|FG000|Overall Study|Lost to Follow-up|2|||
170861128|NCT03814746|617500514|FG001|Overall Study|Lost to Follow-up|1|||
170861129|NCT03814746|617500515|FG002|Overall Study|Lost to Follow-up|2|||
170861130|NCT03814746|617500513|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170861131|NCT03814746|617500514|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170861132|NCT03814746|617500515|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
170861133|NCT03814746|617500513|FG000|Overall Study|Pregnancy|0|||
170861134|NCT03814746|617500514|FG001|Overall Study|Pregnancy|1|||
170861135|NCT03814746|617500515|FG002|Overall Study|Pregnancy|1|||
170861136|NCT03814746|617500513|FG000|Overall Study|Protocol Violation|1|||
170861137|NCT03814746|617500514|FG001|Overall Study|Protocol Violation|0|||
170861138|NCT03814746|617500515|FG002|Overall Study|Protocol Violation|0|||
170861139|NCT05580588|617500516|FG000|Overall Study|Lack of Efficacy|12|||
170745444|NCT01474512|617076099|FG005|Induction Period|Lost to Follow-up|0|||
170806901|NCT03697603|617301665|FG002|Overall Study|Protocol Violation|5|||
170861140|NCT00756470|617500522|FG000|Overall Study|Withdrawal by Subject|1|||
170516269|NCT03428100|616234856|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170861141|NCT00756470|617500522|FG000|Overall Study|Adverse Event|4|||
170861142|NCT03019406|617500523|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
170861143|NCT03019406|617500524|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
170861144|NCT03019406|617500525|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
170861145|NCT03019406|617500526|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
170861146|NCT02446886|617500528|FG000|Overall Study|Adverse Event|1|||
170861147|NCT02446886|617500529|FG001|Overall Study|Adverse Event|3|||
170861148|NCT02446886|617500528|FG000|Overall Study|Withdrawal by Subject|1|||
170516270|NCT03428100|616234857|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
170861149|NCT02446886|617500529|FG001|Overall Study|Withdrawal by Subject|1|||
170861150|NCT02196714|617500530|FG000|Overall Study|Protocol Violation|0|||
170861151|NCT02196714|617500531|FG001|Overall Study|Protocol Violation|0|||
170861152|NCT02196714|617500532|FG002|Overall Study|Protocol Violation|1|||
170861153|NCT02196714|617500533|FG003|Overall Study|Protocol Violation|0|||
170861154|NCT01971203|617500535|FG000|Overall Study|Protocol Violation|3|||
170861155|NCT01971203|617500536|FG001|Overall Study|Protocol Violation|2|||
170861156|NCT01971203|617500535|FG000|Overall Study|Withdrawal by Subject|5|||
170861157|NCT01971203|617500536|FG001|Overall Study|Withdrawal by Subject|6|||
170861158|NCT01971203|617500535|FG000|Overall Study|Adverse Event|1|||
170861159|NCT01971203|617500536|FG001|Overall Study|Adverse Event|0|||
170861160|NCT01055262|617500539|FG000|Overall Study|Adverse Event|5|||
170861161|NCT01055262|617500539|FG000|Overall Study|Protocol Violation|3|||
170861162|NCT01055262|617500539|FG000|Overall Study|Uncooperativeness|1|||
170861163|NCT01596621|617500540|FG000|Overall Study|Death|4|||
170861164|NCT01596621|617500540|FG000|Overall Study|Withdrawal by Subject|9|||
170861165|NCT01596621|617500540|FG000|Overall Study|Disease Progression|49|||
170861166|NCT01596621|617500540|FG000|Overall Study|Lost to Follow-up|3|||
170861167|NCT01596621|617500540|FG000|Overall Study|Other than specified|13|||
170861168|NCT01201265|617500541|FG000|Overall Study|Death|14|||
170861169|NCT01201265|617500541|FG000|Overall Study|Insufficient Therapeutic Response|3|||
170861170|NCT01201265|617500541|FG000|Overall Study|Lost to Follow-up|10|||
170861171|NCT01201265|617500541|FG000|Overall Study|Withdrawal by Subject|7|||
170861172|NCT01201265|617500541|FG000|Overall Study|Disease Progression|4|||
170861173|NCT04640077|617500542|FG000|Period 1|Withdrawal by Subject|4|||
170861174|NCT04640077|617500543|FG001|Period 1|Withdrawal by Subject|5|||
170861175|NCT04640077|617500544|FG002|Period 1|Withdrawal by Subject|0|||
170861176|NCT04640077|617500542|FG000|Period 1|Adverse Event|1|||
170861177|NCT04640077|617500543|FG001|Period 1|Adverse Event|1|||
170861178|NCT04640077|617500544|FG002|Period 1|Adverse Event|0|||
170861179|NCT04640077|617500542|FG000|Period 1|Screen Failure|2|||
170861180|NCT04640077|617500543|FG001|Period 1|Screen Failure|0|||
170861181|NCT04640077|617500544|FG002|Period 1|Screen Failure|0|||
170861182|NCT04640077|617500542|FG000|Period 2|Withdrawal by Subject|0|||
170861183|NCT04640077|617500543|FG001|Period 2|Withdrawal by Subject|0|||
170861184|NCT04640077|617500544|FG002|Period 2|Withdrawal by Subject|18|||
170861185|NCT04640077|617500542|FG000|Period 2|Adverse Event|0|||
170861186|NCT04640077|617500543|FG001|Period 2|Adverse Event|0|||
170861187|NCT04640077|617500544|FG002|Period 2|Adverse Event|6|||
170861188|NCT04640077|617500542|FG000|Period 2|Lost to Follow-up|0|||
170861189|NCT04640077|617500543|FG001|Period 2|Lost to Follow-up|0|||
170861190|NCT04640077|617500544|FG002|Period 2|Lost to Follow-up|2|||
170861191|NCT04640077|617500542|FG000|Period 2|Death|0|||
170861192|NCT04640077|617500543|FG001|Period 2|Death|0|||
170861193|NCT04640077|617500544|FG002|Period 2|Death|2|||
170861194|NCT04640077|617500542|FG000|Period 2|Progressive Disease|0|||
170861195|NCT04640077|617500543|FG001|Period 2|Progressive Disease|0|||
170861196|NCT04640077|617500544|FG002|Period 2|Progressive Disease|1|||
170861197|NCT04640077|617500542|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
170861198|NCT04640077|617500543|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
170861199|NCT04640077|617500544|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
170861200|NCT01257425|617500545|FG000|Overall Study|Lack of Efficacy|3|||
170861201|NCT01257425|617500546|FG001|Overall Study|Lack of Efficacy|3|||
170861202|NCT01257425|617500545|FG000|Overall Study|Adverse Event|1|||
170861203|NCT01257425|617500546|FG001|Overall Study|Adverse Event|1|||
170861204|NCT01257425|617500545|FG000|Overall Study|Protocol Violation|1|||
170861205|NCT01257425|617500546|FG001|Overall Study|Protocol Violation|1|||
170861206|NCT01257425|617500545|FG000|Overall Study|Withdrawal by Subject|0|||
170861207|NCT01257425|617500546|FG001|Overall Study|Withdrawal by Subject|1|||
170861208|NCT01257425|617500545|FG000|Overall Study|Death|1|||
170861209|NCT01257425|617500546|FG001|Overall Study|Death|0|||
170861210|NCT01296347|617500547|FG000|Allocation|Withdrawal by Subject|1|||
170861211|NCT01296347|617500548|FG001|Allocation|Withdrawal by Subject|2|||
170861212|NCT01296347|617500547|FG000|Allocation|Lack of Efficacy|1|||
170861213|NCT01296347|617500548|FG001|Allocation|Lack of Efficacy|2|||
170861214|NCT01296347|617500547|FG000|Allocation|not received infusion|1|||
170861215|NCT01296347|617500548|FG001|Allocation|not received infusion|0|||
170861216|NCT01296347|617500547|FG000|6 Week Follow up|Death|0|||
170861217|NCT01296347|617500548|FG001|6 Week Follow up|Death|1|||
170861218|NCT01296347|617500547|FG000|3 Month Follow up|Death|1|||
170861219|NCT01296347|617500548|FG001|3 Month Follow up|Death|0|||
170861220|NCT01296347|617500547|FG000|3 Month Follow up|Lost to Follow-up|0|||
170861221|NCT01296347|617500548|FG001|3 Month Follow up|Lost to Follow-up|1|||
170861222|NCT01296347|617500547|FG000|6 Month Follow up|Death|2|||
170861223|NCT01296347|617500548|FG001|6 Month Follow up|Death|1|||
170861224|NCT01296347|617500547|FG000|6 Month Follow up|Lost to Follow-up|0|||
170861225|NCT01296347|617500548|FG001|6 Month Follow up|Lost to Follow-up|1|||
170861226|NCT01296347|617500547|FG000|12 Month Follow up|Lost to Follow-up|3|||
170861227|NCT01296347|617500548|FG001|12 Month Follow up|Lost to Follow-up|1|||
170861228|NCT01296347|617500547|FG000|12 Month Follow up|Death|1|||
170861229|NCT01296347|617500548|FG001|12 Month Follow up|Death|1|||
170861230|NCT01296347|617500547|FG000|12 Month Follow up|Withdrawal by Subject|0|||
170516271|NCT03428100|616234858|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170516272|NCT03428100|616234859|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170516273|NCT03428100|616234860|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170516274|NCT03428100|616234861|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
170516275|NCT03428100|616234862|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
170516276|NCT03428100|616234863|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170516277|NCT03428100|616234864|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
170516278|NCT03428100|616234865|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170516279|NCT03428100|616234866|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170745445|NCT01474512|617076100|FG006|Induction Period|Lost to Follow-up|0|||
170861231|NCT01296347|617500548|FG001|12 Month Follow up|Withdrawal by Subject|1|||
170861232|NCT03681223|617500549|FG000|Overall Study|Lost to Follow-up|7|||
170861233|NCT03681223|617500550|FG001|Overall Study|Lost to Follow-up|8|||
170861234|NCT05177484|617500551|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
170861235|NCT05177484|617500552|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
170861236|NCT05177484|617500551|FG000|Overall Study|Inadvertently withdrawn|3|||
170861237|NCT05177484|617500552|FG001|Overall Study|Inadvertently withdrawn|1|||
170861238|NCT05177484|617500551|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
170861239|NCT05177484|617500552|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
170861240|NCT05814666|617500553|FG000|Overall Study|Study terminated by Sponsor|11|||
170861241|NCT05814666|617500554|FG001|Overall Study|Study terminated by Sponsor|7|||
170861242|NCT05814666|617500553|FG000|Overall Study|Patients withdrew prior to receiving study treatment|0|||
170861243|NCT05814666|617500554|FG001|Overall Study|Patients withdrew prior to receiving study treatment|3|||
170861244|NCT02441686|617500575|FG000|Induction|Adverse Event|4|||
170861245|NCT02441686|617500575|FG000|Induction|Complicating disease|1|||
170861246|NCT02441686|617500575|FG000|Induction|Physician Decision|1|||
170861247|NCT02441686|617500575|FG000|Induction|Withdrawal by Subject|1|||
170861248|NCT02441686|617500575|FG000|Induction|Did not receive treatment|1|||
170861249|NCT02441686|617500575|FG000|Maintenance|Remaining on Treatment|23|||
170861250|NCT02441686|617500575|FG000|Maintenance|Physician Decision|1|||
170861251|NCT02441686|617500575|FG000|Maintenance|Adverse Event|3|||
170861252|NCT02441686|617500575|FG000|Maintenance|Progressive Disease|10|||
170861253|NCT02441686|617500575|FG000|Maintenance|Withdrawal by Subject|1|||
170861254|NCT01439360|617500580|FG000|Overall Study|Adverse Event|4|||
170861255|NCT01439360|617500581|FG001|Overall Study|Adverse Event|16|||
170861256|NCT01439360|617500580|FG000|Overall Study|Lost to Follow-up|43|||
170861257|NCT01439360|617500581|FG001|Overall Study|Lost to Follow-up|58|||
170861258|NCT01439360|617500580|FG000|Overall Study|Others|10|||
170861259|NCT01439360|617500581|FG001|Overall Study|Others|5|||
170861260|NCT01439360|617500580|FG000|Overall Study|Protocol Violation|1|||
170861261|NCT01439360|617500581|FG001|Overall Study|Protocol Violation|0|||
170861262|NCT01439360|617500580|FG000|Overall Study|Withdrawal by Subject|140|||
170861263|NCT01439360|617500581|FG001|Overall Study|Withdrawal by Subject|129|||
170861264|NCT06229743|617500583|FG000|Overall Study|Screen Failure|45|||
170861265|NCT06229743|617500583|FG000|Overall Study|Sensors worn did not meet the revised device specifications|12|||
170861266|NCT03459846|617500584|FG000|Overall Study|Death|52|||
170861267|NCT03459846|617500585|FG001|Overall Study|Death|46|||
170861268|NCT03459846|617500584|FG000|Overall Study|Study terminated by sponsor|24|||
170861269|NCT03459846|617500585|FG001|Overall Study|Study terminated by sponsor|28|||
170861270|NCT03459846|617500584|FG000|Overall Study|Withdrawal by Subject|2|||
170861271|NCT03459846|617500585|FG001|Overall Study|Withdrawal by Subject|2|||
170861272|NCT00826111|617501797|FG000|Overall Study|Lost to Follow-up|0|||
170861273|NCT00826111|617501798|FG001|Overall Study|Lost to Follow-up|1|||
170861274|NCT00826111|617501797|FG000|Overall Study|Protocol Violation|1|||
170861275|NCT00826111|617501798|FG001|Overall Study|Protocol Violation|0|||
170861276|NCT00826111|617501797|FG000|Overall Study|Withdrawal by Subject|5|||
170861277|NCT00826111|617501798|FG001|Overall Study|Withdrawal by Subject|0|||
170861278|NCT00826111|617501797|FG000|Overall Study|Physician Decision|1|||
170861279|NCT00826111|617501798|FG001|Overall Study|Physician Decision|1|||
170861280|NCT01929980|617501799|FG000|Overall Study|Physician Decision|1|||
170861281|NCT00985166|617501800|FG000|Overall Study|Lost to Follow-up|3|||
170861282|NCT00985166|617501801|FG001|Overall Study|Lost to Follow-up|2|||
170861283|NCT00985166|617501802|FG002|Overall Study|Lost to Follow-up|2|||
170861284|NCT00985166|617501800|FG000|Overall Study|Withdrawal by Subject|3|||
170861285|NCT00985166|617501801|FG001|Overall Study|Withdrawal by Subject|2|||
170861286|NCT00985166|617501802|FG002|Overall Study|Withdrawal by Subject|0|||
170861287|NCT00985166|617501800|FG000|Overall Study|Test not done|2|||
170861288|NCT00985166|617501801|FG001|Overall Study|Test not done|0|||
170861289|NCT00985166|617501802|FG002|Overall Study|Test not done|4|||
170861290|NCT00985166|617501800|FG000|Overall Study|Other|1|||
170861291|NCT00985166|617501801|FG001|Overall Study|Other|0|||
170861292|NCT00985166|617501802|FG002|Overall Study|Other|1|||
170861293|NCT04773834|617501803|FG000|Overall Study|UPID not claimed|29|||
170861294|NCT04773834|617501804|FG001|Overall Study|UPID not claimed|5|||
170861295|NCT04773834|617501803|FG000|Overall Study|Failed criteria for randomization|41|||
170861296|NCT04773834|617501804|FG001|Overall Study|Failed criteria for randomization|41|||
170861297|NCT00567268|617501805|FG000|Overall Study|Protocol Violation|7|||
170861298|NCT00567268|617501805|FG000|Overall Study|Lost to Follow-up|36|||
170861299|NCT00567268|617501805|FG000|Overall Study|No Visit After First Day of Treatment|2|||
170861300|NCT00567268|617501805|FG000|Overall Study|No Drug Administration|4|||
170861301|NCT00567268|617501805|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
170861302|NCT03224325|617501806|FG000|Overall Study|Adverse Event|1|||
170861303|NCT03224325|617501807|FG001|Overall Study|Adverse Event|0|||
170861304|NCT03224325|617501808|FG002|Overall Study|Adverse Event|0|||
170861305|NCT03224325|617501809|FG003|Overall Study|Adverse Event|0|||
170861306|NCT03224325|617501810|FG004|Overall Study|Adverse Event|0|||
170861307|NCT03224325|617501811|FG005|Overall Study|Adverse Event|0|||
170861308|NCT03224325|617501812|FG006|Overall Study|Adverse Event|1|||
170861309|NCT03224325|617501806|FG000|Overall Study|Withdrawal by Subject|0|||
170861310|NCT03224325|617501807|FG001|Overall Study|Withdrawal by Subject|0|||
170861311|NCT03224325|617501808|FG002|Overall Study|Withdrawal by Subject|0|||
170861312|NCT03224325|617501809|FG003|Overall Study|Withdrawal by Subject|1|||
170861313|NCT03224325|617501810|FG004|Overall Study|Withdrawal by Subject|0|||
170861314|NCT03224325|617501811|FG005|Overall Study|Withdrawal by Subject|0|||
170861315|NCT03224325|617501812|FG006|Overall Study|Withdrawal by Subject|0|||
170861316|NCT05541861|617501813|FG000|Overall Study|Withdrawal by Subject|0|||
170861317|NCT05541861|617501814|FG001|Overall Study|Withdrawal by Subject|0|||
170861318|NCT05541861|617501815|FG002|Overall Study|Withdrawal by Subject|0|||
170861319|NCT05541861|617501816|FG003|Overall Study|Withdrawal by Subject|0|||
170861320|NCT05541861|617501817|FG004|Overall Study|Withdrawal by Subject|0|||
170861321|NCT05541861|617501818|FG005|Overall Study|Withdrawal by Subject|0|||
170861322|NCT05541861|617501819|FG006|Overall Study|Withdrawal by Subject|2|||
170861323|NCT05541861|617501820|FG007|Overall Study|Withdrawal by Subject|0|||
170861324|NCT05541861|617501821|FG008|Overall Study|Withdrawal by Subject|0|||
170861325|NCT05541861|617501813|FG000|Overall Study|Randomized but not dosed|0|||
170861326|NCT05541861|617501814|FG001|Overall Study|Randomized but not dosed|1|||
170861327|NCT05541861|617501815|FG002|Overall Study|Randomized but not dosed|1|||
170861328|NCT05541861|617501816|FG003|Overall Study|Randomized but not dosed|0|||
170861329|NCT05541861|617501817|FG004|Overall Study|Randomized but not dosed|0|||
170861330|NCT05541861|617501818|FG005|Overall Study|Randomized but not dosed|0|||
170861331|NCT05541861|617501819|FG006|Overall Study|Randomized but not dosed|1|||
170400247|NCT01447628|615805564|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
170400248|NCT01447628|615805565|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
170400249|NCT03087773|615805566|FG000|Overall Study|Withdrawal by Subject|8|||
170400250|NCT03087773|615805567|FG001|Overall Study|Withdrawal by Subject|4|||
170400251|NCT03087773|615805566|FG000|Overall Study|Lost to Follow-up|12|||
170400252|NCT03087773|615805567|FG001|Overall Study|Lost to Follow-up|8|||
170400253|NCT03273712|615805575|FG000|Overall Study|Death|5|||
170400254|NCT03273712|615805575|FG000|Overall Study|Adverse Event|1|||
170400255|NCT03273712|615805575|FG000|Overall Study|Disease Progression|1|||
170400256|NCT01333475|615805576|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
170400257|NCT01333475|615805577|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
170400258|NCT01333475|615805576|FG000|Overall Study|Toxicity|1|||
170400259|NCT01333475|615805577|FG001|Overall Study|Toxicity|3|||
170400260|NCT02268045|615805578|FG000|Overall Study|Death|4|||
170400261|NCT02268045|615805579|FG001|Overall Study|Death|4|||
170400262|NCT02268045|615805578|FG000|Overall Study|Disease Progression|2|||
170400263|NCT02268045|615805579|FG001|Overall Study|Disease Progression|1|||
170400264|NCT02268045|615805578|FG000|Overall Study|Adverse Event|7|||
170400265|NCT02268045|615805579|FG001|Overall Study|Adverse Event|7|||
170400266|NCT02268045|615805578|FG000|Overall Study|Withdrawal by Subject|2|||
170400267|NCT02268045|615805579|FG001|Overall Study|Withdrawal by Subject|6|||
170400268|NCT02268045|615805578|FG000|Overall Study|Physician Decision|0|||
170400269|NCT02268045|615805579|FG001|Overall Study|Physician Decision|1|||
170400270|NCT02268045|615805578|FG000|Overall Study|Protocol Violation|1|||
170400271|NCT02268045|615805579|FG001|Overall Study|Protocol Violation|1|||
170400272|NCT00646282|615805580|FG000|Overall Study|Protocol terminated|4|||
170400273|NCT00646282|615805581|FG001|Overall Study|Protocol terminated|4|||
170400274|NCT01556490|615805582|FG000|Randomized Patients Summary|Protocol Violation|22|||
170400275|NCT01556490|615805583|FG001|Randomized Patients Summary|Protocol Violation|23|||
170400276|NCT01556490|615805582|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
170400277|NCT01556490|615805583|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
170400278|NCT00902278|615805584|FG000|Overall Study|Physician Decision|1|||
170400279|NCT00902278|615805585|FG001|Overall Study|Physician Decision|0|||
170400280|NCT00902278|615805586|FG002|Overall Study|Physician Decision|2|||
170400281|NCT00902278|615805587|FG003|Overall Study|Physician Decision|0|||
170400282|NCT00902278|615805588|FG004|Overall Study|Physician Decision|1|||
170400283|NCT00902278|615805584|FG000|Overall Study|Lost to Follow-up|3|||
170400284|NCT00902278|615805585|FG001|Overall Study|Lost to Follow-up|2|||
170400285|NCT00902278|615805586|FG002|Overall Study|Lost to Follow-up|3|||
170400286|NCT00902278|615805587|FG003|Overall Study|Lost to Follow-up|0|||
170400287|NCT00902278|615805588|FG004|Overall Study|Lost to Follow-up|1|||
170400288|NCT02181842|615805589|FG000|Overall Study|Case Report Forms Uncollected|2|||
170400289|NCT01652872|615805590|FG000|Overall Study|Death|36|||
170400290|NCT01652872|615805591|FG001|Overall Study|Death|39|||
170400291|NCT01652872|615805590|FG000|Overall Study|Lost to Follow-up|28|||
170400292|NCT01652872|615805591|FG001|Overall Study|Lost to Follow-up|23|||
170400293|NCT01652872|615805590|FG000|Overall Study|Decision by sponsor|5|||
170400294|NCT01652872|615805591|FG001|Overall Study|Decision by sponsor|7|||
170400295|NCT01652872|615805590|FG000|Overall Study|Withdrawal by Subject|76|||
170400296|NCT01652872|615805591|FG001|Overall Study|Withdrawal by Subject|84|||
170400297|NCT03985293|615805608|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
170400298|NCT03985293|615805609|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
170400299|NCT03985293|615805610|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
170400300|NCT03985293|615805611|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
170400301|NCT03985293|615805612|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
170400302|NCT03985293|615805613|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
170400303|NCT03985293|615805608|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
170400304|NCT03985293|615805609|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
170400305|NCT03985293|615805610|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
170400306|NCT03985293|615805611|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
170400307|NCT03985293|615805612|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
170400308|NCT03985293|615805613|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
170400309|NCT03985293|615805608|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
170400310|NCT03985293|615805609|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
170400311|NCT03985293|615805610|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
170400312|NCT03985293|615805611|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
170400313|NCT03985293|615805612|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
170400314|NCT03985293|615805613|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
170400315|NCT03985293|615805608|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
170400316|NCT03985293|615805609|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
170400317|NCT03985293|615805610|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
170400318|NCT03985293|615805611|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
170400319|NCT03985293|615805612|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
170516280|NCT03428100|616234867|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
170516281|NCT03428100|616234868|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
170516282|NCT03428100|616234850|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
170516283|NCT03428100|616234851|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
170516284|NCT03428100|616234852|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
170516285|NCT03428100|616234853|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
170516286|NCT03428100|616234854|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
170516287|NCT03428100|616234855|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
170516288|NCT03428100|616234856|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
170516289|NCT03428100|616234857|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
170516290|NCT03428100|616234858|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
170516291|NCT03428100|616234859|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
170516292|NCT03428100|616234860|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
170516293|NCT03428100|616234861|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
170516294|NCT03428100|616234862|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
170516295|NCT03428100|616234863|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
170516296|NCT03428100|616234864|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
170516297|NCT03428100|616234865|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
170516298|NCT03428100|616234866|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
170516299|NCT03428100|616234867|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
170516300|NCT03428100|616234868|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
170516301|NCT03428100|616234850|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516302|NCT03428100|616234851|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516303|NCT03428100|616234852|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516304|NCT03428100|616234853|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516305|NCT03428100|616234854|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516306|NCT03428100|616234855|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516307|NCT03428100|616234856|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
170861332|NCT05541861|617501820|FG007|Overall Study|Randomized but not dosed|0|||
170400320|NCT03985293|615805613|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
170400321|NCT03985293|615805608|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
170400322|NCT03985293|615805609|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
170400323|NCT03985293|615805610|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
170516308|NCT03428100|616234857|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516309|NCT03428100|616234858|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516310|NCT03428100|616234859|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516311|NCT03428100|616234860|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516312|NCT03428100|616234861|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516313|NCT03428100|616234862|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516314|NCT03428100|616234863|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516315|NCT03428100|616234864|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516316|NCT03428100|616234865|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516317|NCT03428100|616234866|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516318|NCT03428100|616234867|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
170516319|NCT03428100|616234868|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
170516320|NCT03428100|616234850|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
170516321|NCT03428100|616234851|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
170516322|NCT03428100|616234852|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
170516323|NCT03428100|616234853|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
170516324|NCT03428100|616234854|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
170516325|NCT03428100|616234855|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
170516326|NCT03428100|616234856|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
170516327|NCT03428100|616234857|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
170400324|NCT03985293|615805611|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
170400325|NCT03985293|615805612|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
170400326|NCT03985293|615805613|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
170400327|NCT03985293|615805608|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
170400328|NCT03985293|615805609|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
170400329|NCT03985293|615805610|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
170400330|NCT03985293|615805611|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
170400331|NCT03985293|615805612|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
170400332|NCT03985293|615805613|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
170400333|NCT03985293|615805608|FG000|FOLLOW-UP|Lost to Follow-up|0|||
170400334|NCT03985293|615805609|FG001|FOLLOW-UP|Lost to Follow-up|0|||
170400335|NCT03985293|615805610|FG002|FOLLOW-UP|Lost to Follow-up|1|||
170400336|NCT03985293|615805611|FG003|FOLLOW-UP|Lost to Follow-up|0|||
170400337|NCT03985293|615805612|FG004|FOLLOW-UP|Lost to Follow-up|0|||
170400338|NCT03985293|615805613|FG005|FOLLOW-UP|Lost to Follow-up|0|||
170400339|NCT01488071|615805614|FG000|Overall Study|Adverse Event|15|||
170400340|NCT01488071|615805615|FG001|Overall Study|Adverse Event|23|||
170400341|NCT01488071|615805614|FG000|Overall Study|Lack of Efficacy|11|||
170400342|NCT01488071|615805615|FG001|Overall Study|Lack of Efficacy|17|||
170400343|NCT01488071|615805614|FG000|Overall Study|Non-compliance with study drug|2|||
170400344|NCT01488071|615805615|FG001|Overall Study|Non-compliance with study drug|0|||
170400345|NCT01488071|615805614|FG000|Overall Study|Protocol Violation|5|||
170400346|NCT01488071|615805615|FG001|Overall Study|Protocol Violation|7|||
170400347|NCT01488071|615805614|FG000|Overall Study|Withdrawal of Consent|14|||
170400348|NCT01488071|615805615|FG001|Overall Study|Withdrawal of Consent|12|||
170400349|NCT01488071|615805614|FG000|Overall Study|Lost to Follow-up|1|||
170400350|NCT01488071|615805615|FG001|Overall Study|Lost to Follow-up|0|||
170400351|NCT01488071|615805614|FG000|Overall Study|Administrative or Other Reason(s)|5|||
170400352|NCT01488071|615805615|FG001|Overall Study|Administrative or Other Reason(s)|4|||
170400353|NCT04521608|615805616|FG000|Overall Study|Death|8|||
170400354|NCT04521608|615805617|FG001|Overall Study|Death|9|||
170400355|NCT04521608|615805616|FG000|Overall Study|Withdrawal by Subject|25|||
170400356|NCT04521608|615805617|FG001|Overall Study|Withdrawal by Subject|18|||
170400357|NCT04521608|615805616|FG000|Overall Study|Disease Progression|3|||
170400358|NCT04521608|615805617|FG001|Overall Study|Disease Progression|10|||
170400359|NCT04521608|615805616|FG000|Overall Study|Complicating Disease|6|||
170400360|NCT04521608|615805617|FG001|Overall Study|Complicating Disease|3|||
170400361|NCT04521608|615805616|FG000|Overall Study|Lost Contact|25|||
170400362|NCT04521608|615805617|FG001|Overall Study|Lost Contact|27|||
170400363|NCT04521608|615805616|FG000|Overall Study|Ineligible|1|||
170400364|NCT04521608|615805617|FG001|Overall Study|Ineligible|0|||
170400365|NCT04521608|615805616|FG000|Overall Study|Refused Further Study Participation|13|||
170400366|NCT04521608|615805617|FG001|Overall Study|Refused Further Study Participation|7|||
170400367|NCT03889197|615805618|FG000|Overall Study|Withdrawal by Subject|1|||
170400368|NCT03889197|615805619|FG001|Overall Study|Withdrawal by Subject|0|||
170400369|NCT03889197|615805618|FG000|Overall Study|Physician Decision|0|||
170400370|NCT03889197|615805619|FG001|Overall Study|Physician Decision|1|||
170400371|NCT03889197|615805618|FG000|Overall Study|met exclusion criteria|0|||
170400372|NCT03889197|615805619|FG001|Overall Study|met exclusion criteria|1|||
170400373|NCT03889197|615805618|FG000|Overall Study|Protocol Violation|1|||
170400374|NCT03889197|615805619|FG001|Overall Study|Protocol Violation|0|||
170400375|NCT02278952|615805620|FG000|Overall Study|Insufficient Sample|6|||
170400376|NCT02588651|615805621|FG000|Overall Study|Adverse Event|1|||
170400377|NCT02588651|615805621|FG000|Overall Study|Withdrawal by Subject|2|||
170400378|NCT02588651|615805621|FG000|Overall Study|Death|1|||
170400379|NCT02588651|615805621|FG000|Overall Study|Lack of Efficacy|13|||
170400380|NCT02588651|615805621|FG000|Overall Study|Lost to Follow-up|1|||
170400381|NCT02588651|615805621|FG000|Overall Study|Physician Decision|1|||
170400382|NCT02588651|615805621|FG000|Overall Study|Disease progression|2|||
170400383|NCT00644228|615805626|FG000|Randomization & Eligibility|Ineligible|31|||
170400384|NCT00644228|615805627|FG001|Randomization & Eligibility|Ineligible|21|||
170400385|NCT00644228|615805626|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
170400386|NCT00644228|615805627|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
170400387|NCT00644228|615805626|FG000|Randomization & Eligibility|Invalid Consent|0|||
170400388|NCT00644228|615805627|FG001|Randomization & Eligibility|Invalid Consent|1|||
170400389|NCT00644228|615805626|FG000|Induction Therapy|Adverse Event|22|||
170400390|NCT00644228|615805627|FG001|Induction Therapy|Adverse Event|55|||
170400391|NCT00644228|615805626|FG000|Induction Therapy|Withdrawal by Subject|10|||
170400392|NCT00644228|615805627|FG001|Induction Therapy|Withdrawal by Subject|3|||
170400393|NCT00644228|615805626|FG000|Induction Therapy|Progression/Relapse|24|||
170400394|NCT00644228|615805627|FG001|Induction Therapy|Progression/Relapse|12|||
170400395|NCT00644228|615805626|FG000|Induction Therapy|Death|3|||
170400396|NCT00644228|615805627|FG001|Induction Therapy|Death|7|||
170400397|NCT00644228|615805626|FG000|Induction Therapy|Not Protocol-Specified|24|||
170400398|NCT00644228|615805627|FG001|Induction Therapy|Not Protocol-Specified|28|||
170400399|NCT00644228|615805626|FG000|Maintenance|Adverse Event|27|||
170400400|NCT00644228|615805627|FG001|Maintenance|Adverse Event|31|||
170516328|NCT03428100|616234858|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
170516329|NCT03428100|616234859|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
170516330|NCT03428100|616234860|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
170516331|NCT03428100|616234861|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
170516332|NCT03428100|616234862|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
170516333|NCT03428100|616234863|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
170516334|NCT03428100|616234864|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
170516335|NCT03428100|616234865|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
170516336|NCT03428100|616234866|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
170516337|NCT03428100|616234867|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
170516338|NCT03428100|616234868|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
170516339|NCT03428100|616234850|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
170516340|NCT03428100|616234851|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
170516341|NCT03428100|616234852|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
170516342|NCT03428100|616234853|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
170516343|NCT03428100|616234854|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
170516344|NCT03428100|616234855|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
170516345|NCT03428100|616234856|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
170516346|NCT03428100|616234857|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
170516347|NCT03428100|616234858|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
170516348|NCT03428100|616234859|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
170516349|NCT03428100|616234860|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
170516350|NCT03428100|616234861|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
170516351|NCT03428100|616234862|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
170630139|NCT00463567|616660404|FG000|Overall Study|Administrative problems|5|||
170630140|NCT00463567|616660405|FG001|Overall Study|Administrative problems|3|||
170630141|NCT00463567|616660406|FG002|Overall Study|Administrative problems|6|||
170630142|NCT00463567|616660407|FG003|Overall Study|Administrative problems|9|||
170630143|NCT00463567|616660408|FG004|Overall Study|Administrative problems|3|||
170630144|NCT00463567|616660409|FG005|Overall Study|Administrative problems|2|||
170400401|NCT00644228|615805626|FG000|Maintenance|Withdrawal by Subject|6|||
170400402|NCT00644228|615805627|FG001|Maintenance|Withdrawal by Subject|4|||
170400403|NCT00644228|615805626|FG000|Maintenance|Progression/Relapse|67|||
170400404|NCT00644228|615805627|FG001|Maintenance|Progression/Relapse|42|||
170400405|NCT00644228|615805626|FG000|Maintenance|Death|3|||
170400406|NCT00644228|615805627|FG001|Maintenance|Death|3|||
170400407|NCT00644228|615805626|FG000|Maintenance|Not Protocol-Specified|14|||
170400408|NCT00644228|615805627|FG001|Maintenance|Not Protocol-Specified|15|||
170400409|NCT00644228|615805626|FG000|Maintenance|On Treatment|26|||
170400410|NCT00644228|615805627|FG001|Maintenance|On Treatment|40|||
170400411|NCT00390572|615805628|FG000|Overall Study|Lost to Follow-up|8|||
170400412|NCT00390572|615805629|FG001|Overall Study|Lost to Follow-up|4|||
170400413|NCT00390572|615805628|FG000|Overall Study|health condition|0|||
170400414|NCT00390572|615805629|FG001|Overall Study|health condition|1|||
170400415|NCT01220128|615805630|FG000|Overall Study|Progressive disease|0|||
170400416|NCT01220128|615805631|FG001|Overall Study|Progressive disease|0|||
170400417|NCT01220128|615805632|FG002|Overall Study|Progressive disease|2|||
170400418|NCT01220128|615805633|FG003|Overall Study|Progressive disease|0|||
170630145|NCT00463567|616660410|FG006|Overall Study|Administrative problems|2|||
170630146|NCT00463567|616660404|FG000|Overall Study|Lack of Efficacy|4|||
170630147|NCT00463567|616660405|FG001|Overall Study|Lack of Efficacy|9|||
170630148|NCT00463567|616660406|FG002|Overall Study|Lack of Efficacy|9|||
170630149|NCT00463567|616660407|FG003|Overall Study|Lack of Efficacy|17|||
170630150|NCT00463567|616660408|FG004|Overall Study|Lack of Efficacy|1|||
170630151|NCT00463567|616660409|FG005|Overall Study|Lack of Efficacy|0|||
170630152|NCT00463567|616660410|FG006|Overall Study|Lack of Efficacy|1|||
170630153|NCT00463567|616660404|FG000|Overall Study|Abnormal lab value(s)|1|||
170630154|NCT00463567|616660405|FG001|Overall Study|Abnormal lab value(s)|1|||
170630155|NCT00463567|616660406|FG002|Overall Study|Abnormal lab value(s)|2|||
170630156|NCT00463567|616660407|FG003|Overall Study|Abnormal lab value(s)|1|||
170630157|NCT00463567|616660408|FG004|Overall Study|Abnormal lab value(s)|1|||
170630158|NCT00463567|616660409|FG005|Overall Study|Abnormal lab value(s)|0|||
170630159|NCT00463567|616660410|FG006|Overall Study|Abnormal lab value(s)|0|||
170630160|NCT00463567|616660404|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170630161|NCT00463567|616660405|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170630162|NCT00463567|616660406|FG002|Overall Study|Abnormal test procedure result(s)|6|||
170630163|NCT00463567|616660407|FG003|Overall Study|Abnormal test procedure result(s)|2|||
170630164|NCT00463567|616660408|FG004|Overall Study|Abnormal test procedure result(s)|0|||
170630165|NCT00463567|616660409|FG005|Overall Study|Abnormal test procedure result(s)|2|||
170630166|NCT00463567|616660410|FG006|Overall Study|Abnormal test procedure result(s)|0|||
170630167|NCT00463567|616660404|FG000|Overall Study|Death|1|||
170630168|NCT00463567|616660405|FG001|Overall Study|Death|0|||
170630169|NCT00463567|616660406|FG002|Overall Study|Death|2|||
170630170|NCT00463567|616660407|FG003|Overall Study|Death|0|||
170630171|NCT00463567|616660408|FG004|Overall Study|Death|0|||
170630172|NCT00463567|616660409|FG005|Overall Study|Death|0|||
170630173|NCT00463567|616660410|FG006|Overall Study|Death|0|||
170630174|NCT00641667|616660415|FG000|Overall Study|Withdrawal by Subject|1|||
170630175|NCT00641667|616660415|FG000|Overall Study|Adverse Event|1|||
170630176|NCT00641667|616660415|FG000|Overall Study|Physician Decision|1|||
170630177|NCT00641667|616660415|FG000|Overall Study|Worsening of underlying disease|3|||
170630178|NCT01235741|616660416|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
170630179|NCT01235741|616660417|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
170630180|NCT01235741|616660418|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
170630181|NCT01235741|616660416|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
170630182|NCT01235741|616660417|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
170630183|NCT01235741|616660418|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
170630184|NCT01235741|616660416|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
170630185|NCT01235741|616660417|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
170630186|NCT01235741|616660418|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
170630187|NCT01235741|616660416|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
170630188|NCT01235741|616660417|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
170630189|NCT01235741|616660418|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
170630190|NCT01235741|616660416|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
170630191|NCT01235741|616660417|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
170630192|NCT01235741|616660418|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
170630193|NCT01235741|616660416|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
170630194|NCT01235741|616660417|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
170630195|NCT01235741|616660418|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
170630196|NCT01235741|616660416|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
170630197|NCT01235741|616660417|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
170630198|NCT01235741|616660418|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
170630199|NCT01235741|616660416|FG000|Randomized to Treatment|Adverse Event|0|||
170630200|NCT01235741|616660417|FG001|Randomized to Treatment|Adverse Event|1|||
170630201|NCT01235741|616660418|FG002|Randomized to Treatment|Adverse Event|1|||
170630202|NCT01235741|616660416|FG000|Randomized to Treatment|Sponsor terminated study|0|||
170630203|NCT01235741|616660417|FG001|Randomized to Treatment|Sponsor terminated study|35|||
170630204|NCT01235741|616660418|FG002|Randomized to Treatment|Sponsor terminated study|34|||
170630205|NCT01235741|616660416|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
170630206|NCT01235741|616660417|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
170630207|NCT01235741|616660418|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
170630208|NCT01235741|616660416|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
170630209|NCT01235741|616660417|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
170630210|NCT01235741|616660418|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
170745446|NCT01474512|617076101|FG007|Induction Period|Lost to Follow-up|0|||
170745447|NCT01474512|617076102|FG008|Induction Period|Lost to Follow-up|0|||
170630211|NCT01235741|616660416|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
170630212|NCT01235741|616660417|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
170630213|NCT01235741|616660418|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
170630214|NCT01421719|616660419|FG000|Overall Study|Withdrawal by Subject|4|||
170630215|NCT02736890|616660426|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
170630216|NCT02736890|616660427|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
170630217|NCT02736890|616660426|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
170630218|NCT02736890|616660427|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
170745448|NCT01474512|617076103|FG009|Induction Period|Lost to Follow-up|0|||
170516352|NCT03428100|616234863|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
170516353|NCT03428100|616234864|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
170516354|NCT03428100|616234865|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
170516355|NCT03428100|616234866|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
170516356|NCT03428100|616234867|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
170516357|NCT03428100|616234868|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
170745449|NCT01474512|617076104|FG010|Induction Period|Lost to Follow-up|0|||
170745450|NCT01474512|617076105|FG011|Induction Period|Lost to Follow-up|0|||
170745451|NCT01474512|617076106|FG012|Induction Period|Lost to Follow-up|0|||
170745452|NCT01474512|617076107|FG013|Induction Period|Lost to Follow-up|0|||
170745453|NCT01474512|617076108|FG014|Induction Period|Lost to Follow-up|0|||
170745454|NCT01474512|617076109|FG015|Induction Period|Lost to Follow-up|0|||
170745455|NCT01474512|617076110|FG016|Induction Period|Lost to Follow-up|0|||
170745456|NCT01474512|617076111|FG017|Induction Period|Lost to Follow-up|0|||
170745457|NCT01474512|617076094|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745458|NCT01474512|617076095|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745459|NCT01474512|617076096|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745460|NCT01474512|617076097|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
170745461|NCT01474512|617076098|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
170745462|NCT01474512|617076099|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
170745463|NCT01474512|617076100|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
170745464|NCT01474512|617076101|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745465|NCT01474512|617076102|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745466|NCT01474512|617076103|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745467|NCT01474512|617076104|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745468|NCT01474512|617076105|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745469|NCT01474512|617076106|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745470|NCT01474512|617076107|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745471|NCT01474512|617076108|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745472|NCT01474512|617076109|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745473|NCT01474512|617076110|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745474|NCT01474512|617076111|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
170745475|NCT01474512|617076094|FG000|Maintenance Period|Adverse Event|0|||
170745476|NCT01474512|617076095|FG001|Maintenance Period|Adverse Event|0|||
170745477|NCT01474512|617076096|FG002|Maintenance Period|Adverse Event|0|||
170745478|NCT01474512|617076097|FG003|Maintenance Period|Adverse Event|4|||
170745479|NCT01474512|617076098|FG004|Maintenance Period|Adverse Event|2|||
170745480|NCT01474512|617076099|FG005|Maintenance Period|Adverse Event|7|||
170745481|NCT01474512|617076100|FG006|Maintenance Period|Adverse Event|0|||
170400419|NCT01220128|615805634|FG004|Overall Study|Progressive disease|0|||
170400420|NCT01220128|615805635|FG005|Overall Study|Progressive disease|0|||
170400421|NCT01220128|615805636|FG006|Overall Study|Progressive disease|0|||
170400422|NCT01220128|615805630|FG000|Overall Study|Sponsor study termination|0|||
170400423|NCT01220128|615805631|FG001|Overall Study|Sponsor study termination|1|||
170400424|NCT01220128|615805632|FG002|Overall Study|Sponsor study termination|0|||
170400425|NCT01220128|615805633|FG003|Overall Study|Sponsor study termination|0|||
170400426|NCT01220128|615805634|FG004|Overall Study|Sponsor study termination|0|||
170400427|NCT01220128|615805635|FG005|Overall Study|Sponsor study termination|0|||
170400428|NCT01220128|615805636|FG006|Overall Study|Sponsor study termination|1|||
170400429|NCT01220128|615805630|FG000|Overall Study|Adverse event, serious fatal|2|||
170400430|NCT01220128|615805631|FG001|Overall Study|Adverse event, serious fatal|0|||
170400431|NCT01220128|615805632|FG002|Overall Study|Adverse event, serious fatal|0|||
170400432|NCT01220128|615805633|FG003|Overall Study|Adverse event, serious fatal|0|||
170400433|NCT01220128|615805634|FG004|Overall Study|Adverse event, serious fatal|0|||
170400434|NCT01220128|615805635|FG005|Overall Study|Adverse event, serious fatal|0|||
170400435|NCT01220128|615805636|FG006|Overall Study|Adverse event, serious fatal|1|||
170400436|NCT01220128|615805630|FG000|Overall Study|Adverse event, non-fatal|1|||
170400437|NCT01220128|615805631|FG001|Overall Study|Adverse event, non-fatal|0|||
170400438|NCT01220128|615805632|FG002|Overall Study|Adverse event, non-fatal|0|||
170400439|NCT01220128|615805633|FG003|Overall Study|Adverse event, non-fatal|0|||
170400440|NCT01220128|615805634|FG004|Overall Study|Adverse event, non-fatal|0|||
170516358|NCT02504320|616234873|FG000|Treatment Period 1|Positive Drug Screen|0|||
170516359|NCT02504320|616234874|FG001|Treatment Period 1|Positive Drug Screen|0|||
170745482|NCT01474512|617076101|FG007|Maintenance Period|Adverse Event|19|||
170745483|NCT01474512|617076102|FG008|Maintenance Period|Adverse Event|1|||
170400441|NCT01220128|615805635|FG005|Overall Study|Adverse event, non-fatal|0|||
170745484|NCT01474512|617076103|FG009|Maintenance Period|Adverse Event|3|||
170516360|NCT02504320|616234875|FG002|Treatment Period 1|Positive Drug Screen|1|||
170516361|NCT02504320|616234876|FG003|Treatment Period 1|Positive Drug Screen|0|||
170516362|NCT02504320|616234873|FG000|Treatment Period 2|Positive Drug Screen|0|||
170516363|NCT02504320|616234874|FG001|Treatment Period 2|Positive Drug Screen|1|||
170516364|NCT02504320|616234875|FG002|Treatment Period 2|Positive Drug Screen|0|||
170516365|NCT02504320|616234876|FG003|Treatment Period 2|Positive Drug Screen|0|||
170516366|NCT02504320|616234873|FG000|Treatment Period 3|Positive Drug Screen|0|||
170516367|NCT02504320|616234874|FG001|Treatment Period 3|Positive Drug Screen|0|||
170516368|NCT02504320|616234875|FG002|Treatment Period 3|Positive Drug Screen|0|||
170516369|NCT02504320|616234876|FG003|Treatment Period 3|Positive Drug Screen|1|||
170516370|NCT02504320|616234873|FG000|Treatment Period 3|Adverse Event|0|||
170516371|NCT02504320|616234874|FG001|Treatment Period 3|Adverse Event|0|||
170516372|NCT02504320|616234875|FG002|Treatment Period 3|Adverse Event|1|||
170516373|NCT02504320|616234876|FG003|Treatment Period 3|Adverse Event|0|||
170516374|NCT02306850|616234877|FG000|Overall Study|Lack of Efficacy|2|||
170516375|NCT02420262|616234878|FG000|Overall Study|Adverse Event|1|||
170516376|NCT02420262|616234879|FG001|Overall Study|Adverse Event|0|||
170516377|NCT02420262|616234878|FG000|Overall Study|Withdrawal by Subject|1|||
170516378|NCT02420262|616234879|FG001|Overall Study|Withdrawal by Subject|4|||
170516379|NCT02420262|616234878|FG000|Overall Study|Unclassified|0|||
170516380|NCT02420262|616234879|FG001|Overall Study|Unclassified|1|||
170516381|NCT02497404|616234880|FG000|Overall Study|Adverse Event|1|||
170516382|NCT05446142|616234885|FG000|Period 2|Adverse Event|1|||
170516383|NCT05446142|616234886|FG001|Period 2|Adverse Event|0|||
170516384|NCT05446142|616234887|FG002|Period 2|Adverse Event|0|||
170516385|NCT05446142|616234888|FG003|Period 2|Adverse Event|0|||
170516386|NCT05446142|616234889|FG004|Period 2|Adverse Event|0|||
170516387|NCT05446142|616234890|FG005|Period 2|Adverse Event|0|||
170516388|NCT02098395|616234891|FG000|Overall Study|Protocol Violation|2|||
170516389|NCT02098395|616234892|FG001|Overall Study|Protocol Violation|2|||
170516390|NCT02098395|616234893|FG002|Overall Study|Protocol Violation|0|||
170516391|NCT02098395|616234894|FG003|Overall Study|Protocol Violation|7|||
170516392|NCT02098395|616234891|FG000|Overall Study|Withdrawal by Subject|10|||
170516393|NCT02098395|616234892|FG001|Overall Study|Withdrawal by Subject|10|||
170516394|NCT02098395|616234893|FG002|Overall Study|Withdrawal by Subject|5|||
170516395|NCT02098395|616234894|FG003|Overall Study|Withdrawal by Subject|13|||
170516396|NCT02098395|616234891|FG000|Overall Study|Adverse Event|12|||
170516397|NCT02098395|616234892|FG001|Overall Study|Adverse Event|19|||
170516398|NCT02098395|616234893|FG002|Overall Study|Adverse Event|34|||
170516399|NCT02098395|616234894|FG003|Overall Study|Adverse Event|2|||
170516400|NCT02098395|616234891|FG000|Overall Study|Lost to Follow-up|2|||
170516401|NCT02098395|616234892|FG001|Overall Study|Lost to Follow-up|1|||
170516402|NCT02098395|616234893|FG002|Overall Study|Lost to Follow-up|0|||
170516403|NCT02098395|616234894|FG003|Overall Study|Lost to Follow-up|3|||
170516404|NCT02098395|616234891|FG000|Overall Study|Unclassified|0|||
170516405|NCT02098395|616234892|FG001|Overall Study|Unclassified|0|||
170516406|NCT02098395|616234893|FG002|Overall Study|Unclassified|3|||
170516407|NCT02098395|616234894|FG003|Overall Study|Unclassified|2|||
170516408|NCT00547157|616234900|FG000|Overall Study|Other|1|||
170516409|NCT00547157|616234901|FG001|Overall Study|Other|0|||
170516410|NCT00547157|616234900|FG000|Overall Study|Death|38|||
170516411|NCT00547157|616234901|FG001|Overall Study|Death|18|||
170516412|NCT00547157|616234900|FG000|Overall Study|Withdrawal by Subject|3|||
170400442|NCT01220128|615805636|FG006|Overall Study|Adverse event, non-fatal|3|||
170400443|NCT01220128|615805630|FG000|Overall Study|Other|0|||
170400444|NCT01220128|615805631|FG001|Overall Study|Other|0|||
170400445|NCT01220128|615805632|FG002|Overall Study|Other|1|||
170400446|NCT01220128|615805633|FG003|Overall Study|Other|0|||
170400447|NCT01220128|615805634|FG004|Overall Study|Other|0|||
170400448|NCT01220128|615805635|FG005|Overall Study|Other|0|||
170400449|NCT01220128|615805636|FG006|Overall Study|Other|0|||
170400450|NCT01220128|615805630|FG000|Overall Study|Consent withdrawn by subject|1|||
170400451|NCT01220128|615805631|FG001|Overall Study|Consent withdrawn by subject|0|||
170400452|NCT01220128|615805632|FG002|Overall Study|Consent withdrawn by subject|0|||
170400453|NCT01220128|615805633|FG003|Overall Study|Consent withdrawn by subject|0|||
170400454|NCT01220128|615805634|FG004|Overall Study|Consent withdrawn by subject|0|||
170400455|NCT01220128|615805635|FG005|Overall Study|Consent withdrawn by subject|0|||
170516413|NCT00547157|616234901|FG001|Overall Study|Withdrawal by Subject|1|||
170516414|NCT00547157|616234900|FG000|Overall Study|Administrative decision|3|||
170516415|NCT00547157|616234901|FG001|Overall Study|Administrative decision|2|||
170516416|NCT00547157|616234900|FG000|Overall Study|Lost to Follow-up|4|||
170516417|NCT00547157|616234901|FG001|Overall Study|Lost to Follow-up|2|||
170516418|NCT00110357|616234902|FG000|Overall Study|Deterioration without progression|2|||
170516419|NCT00110357|616234903|FG001|Overall Study|Deterioration without progression|0|||
170516420|NCT00110357|616234902|FG000|Overall Study|Disease progression/relapse|20|||
170516421|NCT00110357|616234903|FG001|Overall Study|Disease progression/relapse|15|||
170516422|NCT00110357|616234902|FG000|Overall Study|Study Closure|1|||
170516423|NCT00110357|616234903|FG001|Overall Study|Study Closure|0|||
170516424|NCT00110357|616234902|FG000|Overall Study|Study Drug Toxicity|1|||
170516425|NCT00110357|616234903|FG001|Overall Study|Study Drug Toxicity|3|||
170516426|NCT00110357|616234902|FG000|Overall Study|Withdrawal by Subject|3|||
170516427|NCT00110357|616234903|FG001|Overall Study|Withdrawal by Subject|1|||
170516428|NCT05285787|616234904|FG000|Overall Study|Withdrawal by Subject|1|||
170516429|NCT02360280|616234908|FG000|Overall Study|Withdrawal by Subject|2|||
170516430|NCT02360280|616234909|FG001|Overall Study|Withdrawal by Subject|0|||
170516431|NCT02360280|616234908|FG000|Overall Study|Adverse Event|0|||
170516432|NCT02360280|616234909|FG001|Overall Study|Adverse Event|1|||
170516433|NCT02360280|616234908|FG000|Overall Study|Lost to Follow-up|1|||
170516434|NCT02360280|616234909|FG001|Overall Study|Lost to Follow-up|0|||
170516435|NCT00805129|616234916|FG000|Overall Study|Not treated|1|||
170516436|NCT00571662|616234917|FG000|Overall Study|Withdrawal by Subject|2|||
170516437|NCT00571662|616234917|FG000|Overall Study|psychiatric instability|1|||
170516438|NCT00571662|616234917|FG000|Overall Study|Adverse Event|5|||
170516439|NCT01429298|616234918|FG000|Overall Study|Protocol Violation|4|||
170516440|NCT01429298|616234919|FG001|Overall Study|Protocol Violation|6|||
170516441|NCT01990768|616234922|FG000|Intervention Started|Found to be ineligible|14|||
170400456|NCT01220128|615805636|FG006|Overall Study|Consent withdrawn by subject|0|||
170400457|NCT02913261|615805643|FG000|Overall Study|Technical problems|0|||
170400458|NCT02913261|615805644|FG001|Overall Study|Technical problems|1|||
170400459|NCT02913261|615805643|FG000|Overall Study|Lack of Efficacy|32|||
170400460|NCT02913261|615805644|FG001|Overall Study|Lack of Efficacy|69|||
170400461|NCT02913261|615805643|FG000|Overall Study|Adverse Event|27|||
170400462|NCT02913261|615805644|FG001|Overall Study|Adverse Event|5|||
170400463|NCT02913261|615805643|FG000|Overall Study|Death|25|||
170400464|NCT02913261|615805644|FG001|Overall Study|Death|22|||
170400465|NCT02913261|615805643|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
170400466|NCT02913261|615805644|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
170400467|NCT02913261|615805643|FG000|Overall Study|Disease relapse|8|||
170861333|NCT05541861|617501821|FG008|Overall Study|Randomized but not dosed|1|||
170861334|NCT03437278|617501827|FG000|Overall Study|Adverse Event|0|||
170861335|NCT03437278|617501828|FG001|Overall Study|Adverse Event|0|||
170861336|NCT03437278|617501829|FG002|Overall Study|Adverse Event|1|||
170861337|NCT03437278|617501827|FG000|Overall Study|Progressive disease|1|||
170861338|NCT03437278|617501828|FG001|Overall Study|Progressive disease|0|||
170861339|NCT03437278|617501829|FG002|Overall Study|Progressive disease|0|||
170861340|NCT03437278|617501827|FG000|Overall Study|Physician Decision|1|||
170861341|NCT03437278|617501828|FG001|Overall Study|Physician Decision|0|||
170861342|NCT03437278|617501829|FG002|Overall Study|Physician Decision|1|||
170516442|NCT01990768|616234923|FG001|Intervention Started|Found to be ineligible|13|||
170516443|NCT01990768|616234924|FG002|Intervention Started|Found to be ineligible|11|||
170516444|NCT01990768|616234922|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
170516445|NCT01990768|616234923|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
170516446|NCT01990768|616234924|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
170516447|NCT01990768|616234922|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
170516448|NCT01990768|616234923|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
170516449|NCT01990768|616234924|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
170516450|NCT01990768|616234922|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
170516451|NCT01990768|616234923|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
170516452|NCT01990768|616234924|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
170516453|NCT01990768|616234922|FG000|Intervention Started|Patient care priority|1|||
170516454|NCT01990768|616234923|FG001|Intervention Started|Patient care priority|2|||
170516455|NCT01990768|616234924|FG002|Intervention Started|Patient care priority|3|||
170516456|NCT01990768|616234922|FG000|Intervention Started|IV lost|2|||
170516457|NCT01990768|616234923|FG001|Intervention Started|IV lost|2|||
170516458|NCT01990768|616234924|FG002|Intervention Started|IV lost|2|||
170516459|NCT01990768|616234922|FG000|Intervention Started|Required CPR|1|||
170516460|NCT01990768|616234923|FG001|Intervention Started|Required CPR|1|||
170516461|NCT01990768|616234924|FG002|Intervention Started|Required CPR|0|||
170516462|NCT01990768|616234922|FG000|Intervention Started|Seizure or hx of seizure|0|||
170516463|NCT01990768|616234923|FG001|Intervention Started|Seizure or hx of seizure|0|||
170516464|NCT01990768|616234924|FG002|Intervention Started|Seizure or hx of seizure|2|||
170516465|NCT01990768|616234922|FG000|Intervention Started|Discovered to be pregnant|0|||
170400468|NCT02913261|615805644|FG001|Overall Study|Disease relapse|13|||
170400469|NCT02913261|615805643|FG000|Overall Study|Physician Decision|8|||
170516466|NCT01990768|616234923|FG001|Intervention Started|Discovered to be pregnant|1|||
170516467|NCT01990768|616234924|FG002|Intervention Started|Discovered to be pregnant|0|||
170516468|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
170516469|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
170516470|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
170516471|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
170516472|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
170745485|NCT01474512|617076104|FG010|Maintenance Period|Adverse Event|0|||
170861343|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
170400470|NCT02913261|615805644|FG001|Overall Study|Physician Decision|9|||
170400471|NCT02913261|615805643|FG000|Overall Study|Subject/guardian decision|4|||
170400472|NCT02913261|615805644|FG001|Overall Study|Subject/guardian decision|6|||
170400473|NCT02913261|615805643|FG000|Overall Study|Graft loss|2|||
170400474|NCT02913261|615805644|FG001|Overall Study|Graft loss|0|||
170400475|NCT00285012|615805645|FG000|Assigned to Study Treatment (Tx)|Other|2|||
170400476|NCT00285012|615805646|FG001|Assigned to Study Treatment (Tx)|Other|3|||
170400477|NCT00285012|615805645|FG000|Received Study Tx|Death|2|||
170516473|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
170400478|NCT00285012|615805646|FG001|Received Study Tx|Death|1|||
170400479|NCT00285012|615805645|FG000|Received Study Tx|Adverse Event|5|||
170400480|NCT00285012|615805646|FG001|Received Study Tx|Adverse Event|11|||
170400481|NCT00285012|615805645|FG000|Received Study Tx|Lack of Efficacy|0|||
170400482|NCT00285012|615805646|FG001|Received Study Tx|Lack of Efficacy|3|||
170516474|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
170516475|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
170516476|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
170516477|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
170516478|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
170516479|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
170516480|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Death|3|||
170516481|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Death|1|||
170516482|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Death|1|||
170516483|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Discharged|2|||
170516484|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Discharged|1|||
170516485|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Discharged|0|||
170516486|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
170516487|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
170516488|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
170516489|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
170516490|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
170516491|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
170516492|NCT01990768|616234922|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
170516493|NCT01990768|616234923|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
170516494|NCT01990768|616234924|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
170516495|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
170516496|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
170516497|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
170516498|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
170516499|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
170516500|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
170516501|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
170516502|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
170516503|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
170516504|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
170516505|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
170516506|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
170516507|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
170630219|NCT01198795|616660431|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
170630220|NCT01198795|616660431|FG000|Overall Study|Withdrawal by Subject|17|||
170630221|NCT01198795|616660431|FG000|Overall Study|Lost to Follow-up|15|||
170630222|NCT01198795|616660431|FG000|Overall Study|Adverse Event|9|||
170630223|NCT01198795|616660431|FG000|Overall Study|Lack of Efficacy|5|||
170630224|NCT01198795|616660431|FG000|Overall Study|Protocol Violation|2|||
170630225|NCT01198795|616660431|FG000|Overall Study|Other Reason|4|||
170630226|NCT05097963|616660432|FG000|Overall Study|Protocol Violation|13|||
170630227|NCT05097963|616660432|FG000|Overall Study|Withdrawal by Subject|21|||
170630228|NCT01193244|616660433|FG000|Overall Study|Withdrawal by Subject|79|||
170630229|NCT01193244|616660434|FG001|Overall Study|Withdrawal by Subject|97|||
170630230|NCT01193244|616660433|FG000|Overall Study|Other|303|||
170630231|NCT01193244|616660434|FG001|Overall Study|Other|278|||
170630232|NCT01193244|616660433|FG000|Overall Study|Lost to Follow-up|6|||
170630233|NCT01193244|616660434|FG001|Overall Study|Lost to Follow-up|15|||
170630234|NCT01774721|616660435|FG000|Overall Study|Death|133|||
170516508|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
170516509|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
170516510|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
170516511|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
170516512|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
170630235|NCT01774721|616660436|FG001|Overall Study|Death|152|||
170400483|NCT00285012|615805645|FG000|Received Study Tx|Lost to Follow-up|29|||
170400484|NCT00285012|615805646|FG001|Received Study Tx|Lost to Follow-up|31|||
170861344|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
170861345|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
170861346|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
170861347|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
170861348|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
170861349|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
170861350|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
170861351|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
170861352|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
170861353|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
170861354|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
170861355|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
170861356|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
170861357|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
170861358|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
170861359|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
170861360|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
170861361|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
170861362|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
170861363|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
170861364|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
170861365|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
170861366|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
170861367|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
170861368|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
170861369|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
170861370|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
170861371|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
170861372|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
170861373|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Other|10|||
170861374|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Other|7|||
170861375|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Other|8|||
170861376|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Other|8|||
170861377|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Other|0|||
170861378|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
170861379|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
170861380|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
170861381|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
170861382|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
170861383|NCT00615836|617501830|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
170400485|NCT00285012|615805645|FG000|Received Study Tx|Withdrawal by Subject|31|||
170400486|NCT00285012|615805646|FG001|Received Study Tx|Withdrawal by Subject|43|||
170400487|NCT00285012|615805645|FG000|Received Study Tx|Other|5|||
170400488|NCT00285012|615805646|FG001|Received Study Tx|Other|5|||
170400489|NCT02873195|615805672|FG000|Overall Study|Ineligible|5|||
170400490|NCT02873195|615805673|FG001|Overall Study|Ineligible|0|||
170400491|NCT04066894|615805676|FG000|Overall Study|Lack of Efficacy|1|||
170400492|NCT04066894|615805676|FG000|Overall Study|Screen Failure|1|||
170400493|NCT00633217|615805678|FG000|Overall Study|Adverse Event|5|||
170400494|NCT00633217|615805679|FG001|Overall Study|Adverse Event|9|||
170400495|NCT00633217|615805678|FG000|Overall Study|Lack of Efficacy|0|||
170400496|NCT00633217|615805679|FG001|Overall Study|Lack of Efficacy|2|||
170400497|NCT00633217|615805678|FG000|Overall Study|Protocol Violation|3|||
170400498|NCT00633217|615805679|FG001|Overall Study|Protocol Violation|7|||
170400499|NCT00633217|615805678|FG000|Overall Study|Lost to Follow-up|2|||
170400500|NCT00633217|615805679|FG001|Overall Study|Lost to Follow-up|2|||
170400501|NCT00633217|615805678|FG000|Overall Study|Investigator Discretion|2|||
170400502|NCT00633217|615805679|FG001|Overall Study|Investigator Discretion|0|||
170400503|NCT00633217|615805678|FG000|Overall Study|Withdrew Consent|3|||
170400504|NCT00633217|615805679|FG001|Overall Study|Withdrew Consent|3|||
170400505|NCT00096031|615805680|FG000|Overall Study|Adverse Event|3|||
170400506|NCT00096031|615805680|FG000|Overall Study|Lack of Efficacy|42|||
170400507|NCT00096031|615805680|FG000|Overall Study|Death|4|||
170400508|NCT00096031|615805680|FG000|Overall Study|Withdrawal by Subject|1|||
170400509|NCT00096031|615805680|FG000|Overall Study|Ineligible|8|||
170400510|NCT00096031|615805680|FG000|Overall Study|Not protocol specified|5|||
170400511|NCT03878108|615805681|FG000|Overall Study|Adverse Event|1|||
170400512|NCT03878108|615805682|FG001|Overall Study|Adverse Event|0|||
170400513|NCT01682681|615805683|FG000|Overall Study|Lack of Efficacy|62|||
170400514|NCT01682681|615805683|FG000|Overall Study|Withdrawal by Subject|1|||
170400515|NCT01682681|615805683|FG000|Overall Study|Moved to other hospital|10|||
170400516|NCT01682681|615805683|FG000|Overall Study|Lost to Follow-up|174|||
170400517|NCT01682681|615805683|FG000|Overall Study|Adverse Event|46|||
170400518|NCT01682681|615805683|FG000|Overall Study|tapering of topiramate|5|||
170400519|NCT01682681|615805683|FG000|Overall Study|Other|21|||
170400520|NCT01682681|615805683|FG000|Overall Study|Low compliance|13|||
170400521|NCT03353415|615805684|FG000|Masked CGM Wear|Lost to Follow-up|2|||
170400522|NCT03353415|615805684|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
170400523|NCT01861717|615805685|FG000|Overall Study|Lost to Follow-up|1|||
170400524|NCT01861717|615805685|FG000|Overall Study|Withdrawal by Subject|1|||
170400525|NCT02395536|615805686|FG000|Overall Study|Lost to Follow-up|4|||
170400526|NCT02395536|615805687|FG001|Overall Study|Lost to Follow-up|4|||
170400527|NCT02395536|615805686|FG000|Overall Study|Death|2|||
170400528|NCT02395536|615805687|FG001|Overall Study|Death|0|||
170400529|NCT02395536|615805686|FG000|Overall Study|Physician Decision|4|||
170400530|NCT02395536|615805687|FG001|Overall Study|Physician Decision|6|||
170400531|NCT02395536|615805686|FG000|Overall Study|Withdrawal by Subject|9|||
170400532|NCT02395536|615805687|FG001|Overall Study|Withdrawal by Subject|17|||
170400533|NCT02395536|615805686|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
170400534|NCT02395536|615805687|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
170516513|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
170516514|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
170516515|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
170516516|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
170516517|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
170516518|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
170516519|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
170516520|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
170516521|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
170516522|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
170516523|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
170400535|NCT02395536|615805686|FG000|Overall Study|Insurance issue|0|||
170400536|NCT02395536|615805687|FG001|Overall Study|Insurance issue|1|||
170516524|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
170516525|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
170516526|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
170516527|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
170516528|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
170516529|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
170516530|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
170516531|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
170516532|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
170516533|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
170516534|NCT01990768|616234922|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
170516535|NCT01990768|616234923|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
170516536|NCT01990768|616234924|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
170516537|NCT01990768|616234922|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
170516538|NCT01990768|616234923|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
170516539|NCT01990768|616234924|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
170516540|NCT01990768|616234922|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
170516541|NCT01990768|616234923|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
170516542|NCT01990768|616234924|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
170516543|NCT01990768|616234922|FG000|6-Month Follow-up|No contact information|5|||
170516544|NCT01990768|616234923|FG001|6-Month Follow-up|No contact information|6|||
170516545|NCT01990768|616234924|FG002|6-Month Follow-up|No contact information|5|||
170516546|NCT01990768|616234922|FG000|6-Month Follow-up|Homeless|4|||
170516547|NCT01990768|616234923|FG001|6-Month Follow-up|Homeless|3|||
170516548|NCT01990768|616234924|FG002|6-Month Follow-up|Homeless|6|||
170516549|NCT01990768|616234922|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
170516550|NCT01990768|616234923|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
170516551|NCT01990768|616234924|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
170516552|NCT01990768|616234922|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
170516553|NCT01990768|616234923|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
170516554|NCT01990768|616234924|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
170516555|NCT01990768|616234922|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
170516556|NCT01990768|616234923|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
170516557|NCT01990768|616234924|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
170516558|NCT03373461|616234925|FG000|Part 2|Adverse Event|0|||
170516559|NCT03373461|616234926|FG001|Part 2|Adverse Event|1|||
170516560|NCT03373461|616234927|FG002|Part 2|Adverse Event|0|||
170516561|NCT03373461|616234928|FG003|Part 2|Adverse Event|0|||
170516562|NCT03373461|616234929|FG004|Part 2|Adverse Event|1|||
170516563|NCT02489448|616236376|FG000|Overall Study|Death|3|||
170516564|NCT02489448|616236376|FG000|Overall Study|Withdrawal by Subject|2|||
170400537|NCT00545441|615807201|FG000|Overall Study|Fistula draining at 6 months|2|||
170400538|NCT00545441|615807202|FG001|Overall Study|Fistula draining at 6 months|4|||
170400539|NCT00545441|615807201|FG000|Overall Study|Lost to Follow-up|9|||
170400540|NCT00545441|615807202|FG001|Overall Study|Lost to Follow-up|5|||
170400541|NCT00545441|615807201|FG000|Overall Study|Technical failure|0|||
170400542|NCT00545441|615807202|FG001|Overall Study|Technical failure|1|||
170400543|NCT00545441|615807201|FG000|Overall Study|Withdrawal by Subject|1|||
170400544|NCT00545441|615807202|FG001|Overall Study|Withdrawal by Subject|1|||
170400545|NCT00545441|615807201|FG000|Overall Study|Persistence or recurrence of fistula|5|||
170400546|NCT00545441|615807202|FG001|Overall Study|Persistence or recurrence of fistula|2|||
170400547|NCT00545441|615807201|FG000|Overall Study|Patients were not treated|1|||
170400548|NCT00545441|615807202|FG001|Overall Study|Patients were not treated|3|||
170400549|NCT01142466|615807206|FG000|Overall Study|Adverse Event|2|||
170400550|NCT01142466|615807207|FG001|Overall Study|Adverse Event|1|||
170400551|NCT01142466|615807206|FG000|Overall Study|Withdrawal by Subject|1|||
170400552|NCT01142466|615807207|FG001|Overall Study|Withdrawal by Subject|1|||
170400553|NCT00700310|615807212|FG000|Overall Study|Adverse Event|6|||
170400554|NCT00700310|615807213|FG001|Overall Study|Adverse Event|10|||
170400555|NCT00700310|615807214|FG002|Overall Study|Adverse Event|5|||
170400556|NCT00700310|615807215|FG003|Overall Study|Adverse Event|11|||
170400557|NCT00700310|615807212|FG000|Overall Study|Lost to Follow-up|4|||
170400558|NCT00700310|615807213|FG001|Overall Study|Lost to Follow-up|1|||
170400559|NCT00700310|615807214|FG002|Overall Study|Lost to Follow-up|0|||
170400560|NCT00700310|615807215|FG003|Overall Study|Lost to Follow-up|1|||
170400561|NCT00700310|615807212|FG000|Overall Study|Withdrawal by Subject|8|||
170400562|NCT00700310|615807213|FG001|Overall Study|Withdrawal by Subject|9|||
170400563|NCT00700310|615807214|FG002|Overall Study|Withdrawal by Subject|8|||
170400564|NCT00700310|615807215|FG003|Overall Study|Withdrawal by Subject|8|||
170400565|NCT00700310|615807212|FG000|Overall Study|Lack of Efficacy|0|||
170400566|NCT00700310|615807213|FG001|Overall Study|Lack of Efficacy|3|||
170400567|NCT00700310|615807214|FG002|Overall Study|Lack of Efficacy|0|||
170400568|NCT00700310|615807215|FG003|Overall Study|Lack of Efficacy|1|||
170400569|NCT00700310|615807212|FG000|Overall Study|Administrative/Other|1|||
170400570|NCT00700310|615807213|FG001|Overall Study|Administrative/Other|3|||
170400571|NCT00700310|615807214|FG002|Overall Study|Administrative/Other|1|||
170400572|NCT00700310|615807215|FG003|Overall Study|Administrative/Other|3|||
170400573|NCT00700310|615807212|FG000|Overall Study|Randomized, Not Treated|2|||
170400574|NCT00700310|615807213|FG001|Overall Study|Randomized, Not Treated|0|||
170400575|NCT00700310|615807214|FG002|Overall Study|Randomized, Not Treated|2|||
170400576|NCT00700310|615807215|FG003|Overall Study|Randomized, Not Treated|2|||
170400577|NCT02414854|615807216|FG000|Overall Study|Adverse Event|9|||
170400578|NCT02414854|615807217|FG001|Overall Study|Adverse Event|7|||
170400579|NCT02414854|615807218|FG002|Overall Study|Adverse Event|1|||
170400580|NCT02414854|615807219|FG003|Overall Study|Adverse Event|12|||
170400581|NCT02414854|615807216|FG000|Overall Study|Poor compliance to protocol|1|||
170400582|NCT02414854|615807217|FG001|Overall Study|Poor compliance to protocol|1|||
170400583|NCT02414854|615807218|FG002|Overall Study|Poor compliance to protocol|2|||
170400584|NCT02414854|615807219|FG003|Overall Study|Poor compliance to protocol|2|||
170400585|NCT02414854|615807216|FG000|Overall Study|Other than specified above|12|||
170400586|NCT02414854|615807217|FG001|Overall Study|Other than specified above|37|||
170400587|NCT02414854|615807218|FG002|Overall Study|Other than specified above|17|||
170400588|NCT02414854|615807219|FG003|Overall Study|Other than specified above|37|||
170400589|NCT01355523|615807220|FG000|Overall Study|Withdrawal by Subject|1|||
170400590|NCT01355523|615807221|FG001|Overall Study|Withdrawal by Subject|4|||
170400591|NCT01355523|615807220|FG000|Overall Study|Lost to Follow-up|0|||
170400592|NCT01355523|615807221|FG001|Overall Study|Lost to Follow-up|2|||
170400593|NCT01355523|615807220|FG000|Overall Study|Protocol Violation|0|||
170400594|NCT01355523|615807221|FG001|Overall Study|Protocol Violation|2|||
170400595|NCT01355523|615807220|FG000|Overall Study|Adverse Event|0|||
170400596|NCT01355523|615807221|FG001|Overall Study|Adverse Event|2|||
170400597|NCT00303316|615807222|FG000|Overall Study|Protocol Violation|1|||
170400598|NCT00303316|615807223|FG001|Overall Study|Protocol Violation|0|||
170400599|NCT00303316|615807222|FG000|Overall Study|Lost to Follow-up|0|||
170400600|NCT00303316|615807223|FG001|Overall Study|Lost to Follow-up|1|||
170400601|NCT00303316|615807222|FG000|Overall Study|Withdrawal by Subject|1|||
170400602|NCT00303316|615807223|FG001|Overall Study|Withdrawal by Subject|2|||
170400603|NCT02162511|615807225|FG000|Overall Study|Lack of Efficacy|0|||
170400604|NCT02162511|615807226|FG001|Overall Study|Lack of Efficacy|0|||
170400605|NCT02162511|615807227|FG002|Overall Study|Lack of Efficacy|2|||
170400606|NCT04651218|615807228|FG000|Overall Study|Withdrawal by Subject|0|||
170400607|NCT04651218|615807229|FG001|Overall Study|Withdrawal by Subject|2|||
170400608|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
170400609|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
170400610|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
170400611|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
170400612|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
170516565|NCT00215644|616236377|FG000|Overall Study|Disease Progression|28|||
170400613|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
170400614|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
170400615|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
170400616|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
170400617|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
170400618|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
170400619|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
170400620|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
170400621|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
170400622|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
170400623|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
170400624|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
170400625|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
170400626|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
170400627|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
170400628|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
170400629|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
170400630|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
170400631|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
170400632|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
170400633|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
170400634|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
170400635|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
170400636|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
170400637|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
170400638|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
170400639|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
170400640|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
170400641|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
170400642|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
170400643|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
170400644|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
170400645|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
170400646|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
170400647|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
170400648|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
170400649|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
170400650|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
170400651|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
170400652|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
170400653|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
170400654|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
170400655|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
170400656|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
170400657|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
170400658|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
170400659|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
170400660|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
170400661|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
170400662|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
170400663|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
170400664|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
170400665|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
170400666|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
170400667|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
170400668|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
170400669|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
170400670|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
170400671|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
170400672|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
170400673|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
170400674|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
170516566|NCT00215644|616236378|FG001|Overall Study|Disease Progression|10|||
170861384|NCT00615836|617501831|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
170861385|NCT00615836|617501832|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
170861386|NCT00615836|617501833|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
170861387|NCT00615836|617501834|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
170861388|NCT01630434|617501835|FG000|Overall Study|Donor lungs turned down|1|||
170861389|NCT01630434|617501836|FG001|Overall Study|Donor lungs turned down|0|||
170861390|NCT01630434|617501835|FG000|Overall Study|Protocol Violation|9|||
170861391|NCT01630434|617501836|FG001|Overall Study|Protocol Violation|4|||
170861392|NCT01630434|617501835|FG000|Overall Study|Death|20|||
170861393|NCT01630434|617501836|FG001|Overall Study|Death|26|||
170861394|NCT02893930|617501838|FG000|Overall Study|Adverse Event|3|||
170861395|NCT02893930|617501838|FG000|Overall Study|Death|1|||
170861396|NCT02893930|617501838|FG000|Overall Study|Disease progression|5|||
170861397|NCT02893930|617501838|FG000|Overall Study|Withdrawal by Subject|2|||
170861398|NCT02893930|617501838|FG000|Overall Study|Physician Decision|1|||
170861399|NCT02893930|617501838|FG000|Overall Study|Ineligible|1|||
170861400|NCT02349360|617501839|FG000|Overall Study|Withdrawal by Subject|0|||
170861401|NCT02349360|617501840|FG001|Overall Study|Withdrawal by Subject|1|||
170861402|NCT02434939|617501841|FG000|Overall Study|Lack of Efficacy|34|||
170861403|NCT02434939|617501842|FG001|Overall Study|Lack of Efficacy|48|||
170861404|NCT02434939|617501841|FG000|Overall Study|Withdrawal by Subject|3|||
170861405|NCT02434939|617501842|FG001|Overall Study|Withdrawal by Subject|0|||
170861406|NCT02434939|617501841|FG000|Overall Study|Adverse Event|0|||
170861407|NCT02434939|617501842|FG001|Overall Study|Adverse Event|1|||
170861408|NCT00394953|617501843|FG000|First Treatment Period|Adverse Event|1|||
170861409|NCT00394953|617501844|FG001|First Treatment Period|Adverse Event|2|||
170861410|NCT00394953|617501843|FG000|First Treatment Period|Death|6|||
170861411|NCT00394953|617501844|FG001|First Treatment Period|Death|7|||
170861412|NCT00394953|617501843|FG000|First Treatment Period|Lack of Efficacy|1|||
170861413|NCT00394953|617501844|FG001|First Treatment Period|Lack of Efficacy|1|||
170861414|NCT00394953|617501843|FG000|First Treatment Period|Withdrawal by Subject|6|||
170861415|NCT00394953|617501844|FG001|First Treatment Period|Withdrawal by Subject|3|||
170861416|NCT00394953|617501843|FG000|First Treatment Period|Lost to Follow-up|0|||
170861417|NCT00394953|617501844|FG001|First Treatment Period|Lost to Follow-up|1|||
170861418|NCT00394953|617501843|FG000|First Treatment Period|Renal transplant|11|||
170861419|NCT00394953|617501844|FG001|First Treatment Period|Renal transplant|7|||
170861420|NCT00394953|617501843|FG000|First Treatment Period|Not defined|4|||
170861421|NCT00394953|617501844|FG001|First Treatment Period|Not defined|1|||
170861422|NCT00394953|617501843|FG000|Second Treatment Period|Adverse Event|2|||
170861423|NCT00394953|617501844|FG001|Second Treatment Period|Adverse Event|5|||
170861424|NCT00394953|617501843|FG000|Second Treatment Period|Death|8|||
170861425|NCT00394953|617501844|FG001|Second Treatment Period|Death|4|||
170861426|NCT00394953|617501843|FG000|Second Treatment Period|Lack of Efficacy|9|||
170861427|NCT00394953|617501844|FG001|Second Treatment Period|Lack of Efficacy|47|||
170861428|NCT00394953|617501843|FG000|Second Treatment Period|Withdrawal by Subject|3|||
170861429|NCT00394953|617501844|FG001|Second Treatment Period|Withdrawal by Subject|3|||
170861430|NCT00394953|617501843|FG000|Second Treatment Period|Lost to Follow-up|0|||
170861431|NCT00394953|617501844|FG001|Second Treatment Period|Lost to Follow-up|1|||
170861432|NCT00394953|617501843|FG000|Second Treatment Period|Renal transplant|4|||
170861433|NCT00394953|617501844|FG001|Second Treatment Period|Renal transplant|6|||
170861434|NCT00394953|617501843|FG000|Second Treatment Period|Not defined|3|||
170861435|NCT00394953|617501844|FG001|Second Treatment Period|Not defined|8|||
170861436|NCT02240693|617501849|FG000|Overall Study|Adverse Event|0|||
170861437|NCT02240693|617501850|FG001|Overall Study|Adverse Event|0|||
170861438|NCT02240693|617501851|FG002|Overall Study|Adverse Event|0|||
170861439|NCT02240693|617501852|FG003|Overall Study|Adverse Event|0|||
170861440|NCT02240693|617501853|FG004|Overall Study|Adverse Event|1|||
170861441|NCT02240693|617501849|FG000|Overall Study|Withdrawal by Subject|0|||
170861442|NCT02240693|617501850|FG001|Overall Study|Withdrawal by Subject|0|||
170861443|NCT02240693|617501851|FG002|Overall Study|Withdrawal by Subject|2|||
170861444|NCT02240693|617501852|FG003|Overall Study|Withdrawal by Subject|1|||
170861445|NCT02240693|617501853|FG004|Overall Study|Withdrawal by Subject|0|||
170861446|NCT02240693|617501849|FG000|Overall Study|Other than specified|0|||
170861447|NCT02240693|617501850|FG001|Overall Study|Other than specified|0|||
170861448|NCT02240693|617501851|FG002|Overall Study|Other than specified|2|||
170861449|NCT02240693|617501852|FG003|Overall Study|Other than specified|0|||
170861450|NCT02240693|617501853|FG004|Overall Study|Other than specified|0|||
170861451|NCT01898923|617501854|FG000|Overall Study|Lack of Efficacy|5|||
170861452|NCT01898923|617501855|FG001|Overall Study|Lack of Efficacy|6|||
170861453|NCT01898923|617501854|FG000|Overall Study|Adverse Event|3|||
170861454|NCT01898923|617501855|FG001|Overall Study|Adverse Event|1|||
170861455|NCT01898923|617501854|FG000|Overall Study|Lost to Follow-up|0|||
170861456|NCT01898923|617501855|FG001|Overall Study|Lost to Follow-up|1|||
170861457|NCT01898923|617501854|FG000|Overall Study|Withdrawal by Subject|4|||
170861458|NCT01898923|617501855|FG001|Overall Study|Withdrawal by Subject|7|||
170861459|NCT01898923|617501854|FG000|Overall Study|Physician Decision|3|||
170400675|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
170400676|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
170400677|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
170400678|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
170400679|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
170400680|NCT04440163|615807232|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
170400681|NCT04440163|615807233|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
170400682|NCT04440163|615807234|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
170400683|NCT04440163|615807235|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
170400684|NCT04440163|615807236|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
170400685|NCT04440163|615807237|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
170400686|NCT04440163|615807238|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
170400687|NCT04440163|615807239|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
170400688|NCT04440163|615807232|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
170400689|NCT04440163|615807233|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
170400690|NCT04440163|615807234|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
170516567|NCT00215644|616236377|FG000|Overall Study|Adverse Event|2|||
170516568|NCT00215644|616236378|FG001|Overall Study|Adverse Event|9|||
170516569|NCT00215644|616236377|FG000|Overall Study|Death|1|||
170516570|NCT00215644|616236378|FG001|Overall Study|Death|2|||
170516571|NCT00215644|616236377|FG000|Overall Study|Withdrawal by Subject|1|||
170516572|NCT00215644|616236378|FG001|Overall Study|Withdrawal by Subject|0|||
170516573|NCT00215644|616236377|FG000|Overall Study|Other|3|||
170516574|NCT00215644|616236378|FG001|Overall Study|Other|15|||
170516575|NCT00215644|616236377|FG000|Overall Study|Randomized but Not Treated|1|||
170516576|NCT00215644|616236378|FG001|Overall Study|Randomized but Not Treated|0|||
170516577|NCT02861664|616236381|FG000|Overall Study|Withdrawal of Consent|0|||
170516578|NCT02861664|616236382|FG001|Overall Study|Withdrawal of Consent|1|||
170516579|NCT01000974|616236383|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
170516580|NCT01000974|616236384|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
170516581|NCT01000974|616236385|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
170516582|NCT01000974|616236383|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
170400691|NCT04440163|615807235|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
170400692|NCT04440163|615807236|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
170400693|NCT04440163|615807237|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
170400694|NCT04440163|615807238|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
170400695|NCT04440163|615807239|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
170400696|NCT04440163|615807232|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
170400697|NCT04440163|615807233|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
170400698|NCT04440163|615807234|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
170400699|NCT04440163|615807235|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
170400700|NCT04440163|615807236|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
170400701|NCT04440163|615807237|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
170400702|NCT04440163|615807238|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
170400703|NCT04440163|615807239|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
170400704|NCT02018042|615807245|FG000|Overall Study|Withdrawal by Subject|1|||
170400705|NCT02609178|615807246|FG000|First Crown|Withdrawal by Subject|0|||
170400706|NCT02609178|615807247|FG001|First Crown|Withdrawal by Subject|0|||
170400707|NCT02609178|615807248|FG002|First Crown|Withdrawal by Subject|1|||
170400708|NCT02609178|615807249|FG003|First Crown|Withdrawal by Subject|1|||
170400709|NCT02609178|615807250|FG004|First Crown|Withdrawal by Subject|0|||
170400710|NCT02609178|615807251|FG005|First Crown|Withdrawal by Subject|0|||
170400711|NCT01128153|615807252|FG000|Overall Study|Adverse Event|1|||
170400712|NCT01128153|615807253|FG001|Overall Study|Adverse Event|3|||
170400713|NCT01128153|615807252|FG000|Overall Study|Condition under investigation worsened|8|||
170400714|NCT01128153|615807253|FG001|Overall Study|Condition under investigation worsened|7|||
170400715|NCT01128153|615807252|FG000|Overall Study|Withdrawal by Subject|2|||
170400716|NCT01128153|615807253|FG001|Overall Study|Withdrawal by Subject|3|||
170400717|NCT01128153|615807252|FG000|Overall Study|Incorrect enrolment to study|2|||
170400718|NCT01128153|615807253|FG001|Overall Study|Incorrect enrolment to study|1|||
170400719|NCT01128153|615807252|FG000|Overall Study|Protocol Violation|2|||
170400720|NCT01128153|615807253|FG001|Overall Study|Protocol Violation|0|||
170400721|NCT01128153|615807252|FG000|Overall Study|Developed discontinuation criteria|1|||
170400722|NCT01128153|615807253|FG001|Overall Study|Developed discontinuation criteria|1|||
170400723|NCT01954082|615807254|FG000|Overall Study|Study Suspension|42|||
170400724|NCT01954082|615807255|FG001|Overall Study|Study Suspension|36|||
170400725|NCT01954082|615807254|FG000|Overall Study|Adverse Event|10|||
170400726|NCT01954082|615807255|FG001|Overall Study|Adverse Event|4|||
170400727|NCT01954082|615807254|FG000|Overall Study|Intolerance|0|||
170516583|NCT01000974|616236384|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
170745486|NCT01474512|617076105|FG011|Maintenance Period|Adverse Event|0|||
170400728|NCT01954082|615807255|FG001|Overall Study|Intolerance|1|||
170400729|NCT01954082|615807254|FG000|Overall Study|Non-compliance|6|||
170400730|NCT01954082|615807255|FG001|Overall Study|Non-compliance|4|||
170400731|NCT01954082|615807254|FG000|Overall Study|Physician Decision|2|||
170400732|NCT01954082|615807255|FG001|Overall Study|Physician Decision|0|||
170400733|NCT01954082|615807254|FG000|Overall Study|Parent Decision|1|||
170400734|NCT01954082|615807255|FG001|Overall Study|Parent Decision|0|||
170400735|NCT01954082|615807254|FG000|Overall Study|Withdrawal by Subject|0|||
170400736|NCT01954082|615807255|FG001|Overall Study|Withdrawal by Subject|1|||
170400737|NCT01954082|615807254|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
170400738|NCT01954082|615807255|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
170400739|NCT01954082|615807254|FG000|Overall Study|Redirection of Care|0|||
170400740|NCT01954082|615807255|FG001|Overall Study|Redirection of Care|2|||
170400741|NCT01954082|615807254|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
170400742|NCT01954082|615807255|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
170400743|NCT01954082|615807254|FG000|Overall Study|Comfort Care|0|||
170400744|NCT01954082|615807255|FG001|Overall Study|Comfort Care|1|||
170400745|NCT01954082|615807254|FG000|Overall Study|Infant Moved|0|||
170400746|NCT01954082|615807255|FG001|Overall Study|Infant Moved|1|||
170400747|NCT01954082|615807254|FG000|Overall Study|Randomized not Treated|4|||
170400748|NCT01954082|615807255|FG001|Overall Study|Randomized not Treated|2|||
170400749|NCT02419469|615807256|FG000|Overall Study|Withdrawal by Subject|1|||
170400750|NCT01377233|615807257|FG000|Open-label|Adverse Event|1|||
170400751|NCT01377233|615807258|FG001|Open-label|Adverse Event|0|||
170400752|NCT01377233|615807259|FG002|Open-label|Adverse Event|0|||
170400753|NCT01377233|615807260|FG003|Open-label|Adverse Event|0|||
170400754|NCT01377233|615807261|FG004|Open-label|Adverse Event|0|||
170400755|NCT01377233|615807257|FG000|Open-label|Withdrawal by Subject|3|||
170400756|NCT01377233|615807258|FG001|Open-label|Withdrawal by Subject|0|||
170400757|NCT01377233|615807259|FG002|Open-label|Withdrawal by Subject|0|||
170400758|NCT01377233|615807260|FG003|Open-label|Withdrawal by Subject|0|||
170400759|NCT01377233|615807261|FG004|Open-label|Withdrawal by Subject|0|||
170400760|NCT01377233|615807257|FG000|Double-blind|Adverse Event|0|||
170400761|NCT01377233|615807258|FG001|Double-blind|Adverse Event|1|||
170400762|NCT01377233|615807259|FG002|Double-blind|Adverse Event|2|||
170400763|NCT01377233|615807260|FG003|Double-blind|Adverse Event|2|||
170400764|NCT01377233|615807261|FG004|Double-blind|Adverse Event|0|||
170400765|NCT01377233|615807257|FG000|Double-blind|Protocol Violation|0|||
170400766|NCT01377233|615807258|FG001|Double-blind|Protocol Violation|0|||
170400767|NCT01377233|615807259|FG002|Double-blind|Protocol Violation|0|||
170400768|NCT01377233|615807260|FG003|Double-blind|Protocol Violation|0|||
170400769|NCT01377233|615807261|FG004|Double-blind|Protocol Violation|1|||
170400770|NCT01377233|615807257|FG000|Double-blind|Withdrawal by Subject|0|||
170400771|NCT01377233|615807258|FG001|Double-blind|Withdrawal by Subject|0|||
170400772|NCT01377233|615807259|FG002|Double-blind|Withdrawal by Subject|0|||
170400773|NCT01377233|615807260|FG003|Double-blind|Withdrawal by Subject|1|||
170400774|NCT01377233|615807261|FG004|Double-blind|Withdrawal by Subject|0|||
170400775|NCT01377233|615807257|FG000|Double-blind|Administrative or other|0|||
170400776|NCT01377233|615807258|FG001|Double-blind|Administrative or other|0|||
170400777|NCT01377233|615807259|FG002|Double-blind|Administrative or other|0|||
170400778|NCT01377233|615807260|FG003|Double-blind|Administrative or other|1|||
170400779|NCT01377233|615807261|FG004|Double-blind|Administrative or other|1|||
170400780|NCT03137082|615807264|FG000|Overall Study|Withdrawal by Subject|1|||
170400781|NCT03137082|615807265|FG001|Overall Study|Withdrawal by Subject|1|||
170400782|NCT03137082|615807264|FG000|Overall Study|Lost to Follow-up|1|||
170400783|NCT03137082|615807265|FG001|Overall Study|Lost to Follow-up|0|||
170400784|NCT00417027|615807266|FG000|Overall Study|Protocol Violation|0|||
170400785|NCT00417027|615807267|FG001|Overall Study|Protocol Violation|5|||
170400786|NCT00417027|615807268|FG002|Overall Study|Protocol Violation|5|||
170400787|NCT00707174|615807269|FG000|Overall Study|Adverse Event|1|||
170400788|NCT00707174|615807270|FG001|Overall Study|Adverse Event|6|||
170400789|NCT00707174|615807269|FG000|Overall Study|Withdrawal by Subject|4|||
170400790|NCT00707174|615807270|FG001|Overall Study|Withdrawal by Subject|1|||
170400791|NCT00467818|615807271|FG000|Overall Study|Adverse Event|1|||
170400792|NCT00467818|615807272|FG001|Overall Study|Adverse Event|0|||
170400793|NCT00467818|615807271|FG000|Overall Study|Lost to Follow-up|2|||
170400794|NCT00467818|615807272|FG001|Overall Study|Lost to Follow-up|2|||
170400795|NCT01017029|615807273|FG000|Overall Study|Lost to Follow-up|1|||
170400796|NCT01017029|615807274|FG001|Overall Study|Lost to Follow-up|0|||
170400797|NCT01017029|615807273|FG000|Overall Study|Administrative problem|0|||
170400798|NCT01017029|615807274|FG001|Overall Study|Administrative problem|1|||
170400799|NCT01017029|615807273|FG000|Overall Study|Death|3|||
170400800|NCT01017029|615807274|FG001|Overall Study|Death|1|||
170516584|NCT01000974|616236385|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
170400801|NCT03402126|615807283|FG000|Overall Study|Lost to Follow-up|6|||
170400802|NCT03402126|615807283|FG000|Overall Study|Protocol Violation|10|||
170400803|NCT03402126|615807283|FG000|Overall Study|Sponsor request/Study termination|29|||
170400804|NCT03402126|615807283|FG000|Overall Study|Study product no longer in use|1|||
170400805|NCT03402126|615807283|FG000|Overall Study|Technical problems|1|||
170400806|NCT03402126|615807283|FG000|Overall Study|Withdrawal by Subject|6|||
170400807|NCT03402126|615807283|FG000|Overall Study|Physician Decision|2|||
170400808|NCT03402126|615807283|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
170400809|NCT03402126|615807283|FG000|Overall Study|Death|4|||
170400810|NCT02261974|615807284|FG000|Overall Study|Withdrawal by Subject|3|||
170400811|NCT02261974|615807285|FG001|Overall Study|Withdrawal by Subject|2|||
170400812|NCT02261974|615807284|FG000|Overall Study|Pregnancy|0|||
170400813|NCT02261974|615807285|FG001|Overall Study|Pregnancy|1|||
170400814|NCT02261974|615807284|FG000|Overall Study|Missed treatment cut-off date|6|||
170400815|NCT02261974|615807285|FG001|Overall Study|Missed treatment cut-off date|3|||
170400816|NCT02261974|615807284|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
170400817|NCT02261974|615807285|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
170400818|NCT02261974|615807284|FG000|Overall Study|Lost to Follow-up|2|||
170400819|NCT02261974|615807285|FG001|Overall Study|Lost to Follow-up|0|||
170400820|NCT02261974|615807284|FG000|Overall Study|Adverse Event|1|||
170400821|NCT02261974|615807285|FG001|Overall Study|Adverse Event|0|||
170400822|NCT01440595|615807290|FG000|Overall Study|Lost to Follow-up|0|||
170400823|NCT01440595|615807291|FG001|Overall Study|Lost to Follow-up|1|||
170400824|NCT01440595|615807292|FG002|Overall Study|Lost to Follow-up|0|||
170400825|NCT01440595|615807290|FG000|Overall Study|Study terminated by sponsor.|1|||
170400826|NCT01440595|615807291|FG001|Overall Study|Study terminated by sponsor.|2|||
170400827|NCT01440595|615807292|FG002|Overall Study|Study terminated by sponsor.|1|||
170400828|NCT01347879|615807293|FG000|Overall Study|Adverse Event|0|||
170400829|NCT01347879|615807294|FG001|Overall Study|Adverse Event|12|||
170400830|NCT01347879|615807293|FG000|Overall Study|Lost to Follow-up|2|||
170400831|NCT01347879|615807294|FG001|Overall Study|Lost to Follow-up|0|||
170400832|NCT01347879|615807293|FG000|Overall Study|Withdrawal by Subject|3|||
170400833|NCT01347879|615807294|FG001|Overall Study|Withdrawal by Subject|2|||
170400834|NCT01347879|615807293|FG000|Overall Study|Other|2|||
170400835|NCT01347879|615807294|FG001|Overall Study|Other|3|||
170400836|NCT03216954|615807295|FG000|Overall Study|Adverse Event|0|||
170400837|NCT03216954|615807296|FG001|Overall Study|Adverse Event|0|||
170400838|NCT03216954|615807297|FG002|Overall Study|Adverse Event|1|||
170400839|NCT03216954|615807298|FG003|Overall Study|Adverse Event|0|||
170400840|NCT03216954|615807299|FG004|Overall Study|Adverse Event|1|||
170400841|NCT03216954|615807295|FG000|Overall Study|Withdrawal by Subject|2|||
170400842|NCT03216954|615807296|FG001|Overall Study|Withdrawal by Subject|0|||
170400843|NCT03216954|615807297|FG002|Overall Study|Withdrawal by Subject|0|||
170400844|NCT03216954|615807298|FG003|Overall Study|Withdrawal by Subject|0|||
170400845|NCT03216954|615807299|FG004|Overall Study|Withdrawal by Subject|0|||
170400846|NCT03216954|615807295|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
170400847|NCT03216954|615807296|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
170400848|NCT03216954|615807297|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
170400849|NCT03216954|615807298|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
170400850|NCT03216954|615807299|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
170400851|NCT05144477|615807303|FG000|Overall Study|Withdrawal by Subject|1|||
170400852|NCT05144477|615807304|FG001|Overall Study|Withdrawal by Subject|1|||
170400853|NCT01466673|615807307|FG000|Overall Study|Non-compliance with study treatment|2|||
170400854|NCT01466673|615807308|FG001|Overall Study|Non-compliance with study treatment|0|||
170400855|NCT01466673|615807307|FG000|Overall Study|Lost to Follow-up|3|||
170400856|NCT01466673|615807308|FG001|Overall Study|Lost to Follow-up|5|||
170400857|NCT01466673|615807307|FG000|Overall Study|Adverse Event|2|||
170400858|NCT01466673|615807308|FG001|Overall Study|Adverse Event|1|||
170400859|NCT00854607|615807309|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
170400860|NCT02981602|615807310|FG000|Overall Study|Adverse Event|0|||
170400861|NCT02981602|615807311|FG001|Overall Study|Adverse Event|0|||
170400862|NCT02981602|615807312|FG002|Overall Study|Adverse Event|0|||
170400863|NCT02981602|615807313|FG003|Overall Study|Adverse Event|1|||
170400864|NCT02981602|615807314|FG004|Overall Study|Adverse Event|0|||
170400865|NCT00666718|615807315|FG000|Overall Study|Adverse Event|0|||
170400866|NCT00666718|615807316|FG001|Overall Study|Adverse Event|1|||
170400867|NCT00666718|615807315|FG000|Overall Study|Death|1|||
170400868|NCT00666718|615807316|FG001|Overall Study|Death|0|||
170400869|NCT00666718|615807315|FG000|Overall Study|Lost to Follow-up|1|||
170400870|NCT00666718|615807316|FG001|Overall Study|Lost to Follow-up|0|||
170400871|NCT00666718|615807315|FG000|Overall Study|Entry Criteria Not Met|2|||
170400872|NCT00666718|615807316|FG001|Overall Study|Entry Criteria Not Met|0|||
170400873|NCT00666718|615807315|FG000|Overall Study|Protocol Violation|1|||
170400874|NCT00666718|615807316|FG001|Overall Study|Protocol Violation|3|||
170400875|NCT00666718|615807315|FG000|Overall Study|Withdrawal by Subject|7|||
170400876|NCT00666718|615807316|FG001|Overall Study|Withdrawal by Subject|12|||
170400877|NCT00666718|615807315|FG000|Overall Study|Physician Decision|0|||
170400878|NCT00666718|615807316|FG001|Overall Study|Physician Decision|2|||
170400879|NCT03959137|615807317|FG000|Overall Study|Protocol Violation|6|||
170400880|NCT02756078|615807318|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
170400881|NCT02756078|615807319|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
170400882|NCT02756078|615807318|FG000|Period 1|Lost to Follow-up|0|||
170400883|NCT02756078|615807319|FG001|Period 1|Lost to Follow-up|2|||
170400884|NCT02756078|615807318|FG000|Period 1|Protocol Violation|0|||
170400885|NCT02756078|615807319|FG001|Period 1|Protocol Violation|1|||
170400886|NCT02756078|615807318|FG000|Period 1|Adverse Event|1|||
170400887|NCT02756078|615807319|FG001|Period 1|Adverse Event|10|||
170400888|NCT02756078|615807318|FG000|Period 1|Withdrawal by Subject|6|||
170400889|NCT02756078|615807319|FG001|Period 1|Withdrawal by Subject|6|||
170400890|NCT02756078|615807318|FG000|Period 1|Lens Discomfort|2|||
170400891|NCT02756078|615807319|FG001|Period 1|Lens Discomfort|2|||
170400892|NCT02756078|615807318|FG000|Period 2|Adverse Event|3|||
170400893|NCT02756078|615807319|FG001|Period 2|Adverse Event|5|||
170400894|NCT02756078|615807318|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
170400895|NCT02756078|615807319|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
170400896|NCT02756078|615807318|FG000|Period 2|Withdrawal by Subject|3|||
170400897|NCT02756078|615807319|FG001|Period 2|Withdrawal by Subject|1|||
170400898|NCT00810615|615807320|FG000|Overall Study|Withdrawal by Subject|1|||
170400899|NCT00810615|615807321|FG001|Overall Study|Withdrawal by Subject|1|||
170400900|NCT02983227|615807322|FG000|Overall Study|Adverse Event|21|||
170400901|NCT02983227|615807323|FG001|Overall Study|Adverse Event|3|||
170400902|NCT02983227|615807322|FG000|Overall Study|Death|3|||
170400903|NCT02983227|615807323|FG001|Overall Study|Death|0|||
170400904|NCT02983227|615807322|FG000|Overall Study|Lack of Efficacy|8|||
170400905|NCT02983227|615807323|FG001|Overall Study|Lack of Efficacy|1|||
170400906|NCT02983227|615807322|FG000|Overall Study|Lost to Follow-up|3|||
170400907|NCT02983227|615807323|FG001|Overall Study|Lost to Follow-up|0|||
170400908|NCT02983227|615807322|FG000|Overall Study|Multiple Reasons|2|||
170400909|NCT02983227|615807323|FG001|Overall Study|Multiple Reasons|1|||
170400910|NCT02983227|615807322|FG000|Overall Study|Physician Decision|3|||
170400911|NCT02983227|615807323|FG001|Overall Study|Physician Decision|1|||
170400912|NCT02983227|615807322|FG000|Overall Study|Withdrawal by Subject|19|||
170400913|NCT02983227|615807323|FG001|Overall Study|Withdrawal by Subject|8|||
170400914|NCT01255722|615807324|FG000|Overall Study|Adverse Event|0|||
170400915|NCT01255722|615807325|FG001|Overall Study|Adverse Event|1|||
170400916|NCT01255722|615807326|FG002|Overall Study|Adverse Event|1|||
170400917|NCT01255722|615807324|FG000|Overall Study|asymptomatic patient|1|||
170400918|NCT01255722|615807325|FG001|Overall Study|asymptomatic patient|0|||
170400919|NCT01255722|615807326|FG002|Overall Study|asymptomatic patient|0|||
170400920|NCT01255722|615807324|FG000|Overall Study|beta-blocker contraindicated|2|||
170400921|NCT01255722|615807325|FG001|Overall Study|beta-blocker contraindicated|0|||
170400922|NCT01255722|615807326|FG002|Overall Study|beta-blocker contraindicated|0|||
170400923|NCT02139306|615807329|FG000|Overall Study|Withdrawal by Subject|4|||
170400924|NCT02139306|615807330|FG001|Overall Study|Withdrawal by Subject|6|||
170400925|NCT02139306|615807329|FG000|Overall Study|Adverse Event|3|||
170400926|NCT02139306|615807330|FG001|Overall Study|Adverse Event|4|||
170400927|NCT02139306|615807329|FG000|Overall Study|Physician Decision|0|||
170400928|NCT02139306|615807330|FG001|Overall Study|Physician Decision|1|||
170400929|NCT02139306|615807329|FG000|Overall Study|Other Unspecified|2|||
170400930|NCT02139306|615807330|FG001|Overall Study|Other Unspecified|3|||
170400931|NCT02139306|615807329|FG000|Overall Study|Protocol Violation|4|||
170400932|NCT02139306|615807330|FG001|Overall Study|Protocol Violation|0|||
170400933|NCT04449354|615807331|FG000|Overall Study|Withdrawal by Subject|1|||
170400934|NCT05899218|615807332|FG000|Overall Study|Lost to Follow-up|2|||
170400935|NCT05899218|615807333|FG001|Overall Study|Lost to Follow-up|2|||
170400936|NCT05899218|615807332|FG000|Overall Study|deemed ineligible out of country|1|||
170400937|NCT05899218|615807333|FG001|Overall Study|deemed ineligible out of country|0|||
170400938|NCT02587325|615807334|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
170400939|NCT02587325|615807335|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
170400940|NCT02587325|615807336|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
170400941|NCT02587325|615807337|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
170400942|NCT02587325|615807338|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
170400943|NCT02587325|615807334|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
170400944|NCT02587325|615807335|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
170400945|NCT02587325|615807336|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
170400946|NCT02587325|615807337|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
170400947|NCT02587325|615807338|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
170400948|NCT02587325|615807334|FG000|32-Week Optional Extension Part|Adverse Event|0|||
170400949|NCT02587325|615807335|FG001|32-Week Optional Extension Part|Adverse Event|0|||
170400950|NCT02587325|615807336|FG002|32-Week Optional Extension Part|Adverse Event|1|||
170400951|NCT02587325|615807337|FG003|32-Week Optional Extension Part|Adverse Event|0|||
170400952|NCT02587325|615807338|FG004|32-Week Optional Extension Part|Adverse Event|0|||
170400953|NCT02587325|615807334|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
170400954|NCT02587325|615807335|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
170400955|NCT02587325|615807336|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
170400956|NCT02587325|615807337|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
170400957|NCT02587325|615807338|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
170400958|NCT03078192|615807339|FG000|Overall Study|Withdrawal by Subject|2|||
170400959|NCT03078192|615807340|FG001|Overall Study|Withdrawal by Subject|1|||
170400960|NCT03078192|615807339|FG000|Overall Study|screen failure|0|||
170400961|NCT03078192|615807340|FG001|Overall Study|screen failure|3|||
170400962|NCT02787746|615807341|FG000|Overall Study|Adverse Event|42|||
170400963|NCT02787746|615807341|FG000|Overall Study|Withdrawal by Subject|65|||
170400964|NCT02787746|615807341|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
170400965|NCT01160198|615808990|FG000|Overall Study|Withdrawal by Subject|2|||
170400966|NCT01160198|615808991|FG001|Overall Study|Withdrawal by Subject|1|||
170400967|NCT01160198|615808992|FG002|Overall Study|Withdrawal by Subject|0|||
170400968|NCT01160198|615808990|FG000|Overall Study|Adverse Event|0|||
170400969|NCT01160198|615808991|FG001|Overall Study|Adverse Event|1|||
170400970|NCT01160198|615808992|FG002|Overall Study|Adverse Event|0|||
170400971|NCT01160198|615808990|FG000|Overall Study|Lost to Follow-up|0|||
170400972|NCT01160198|615808991|FG001|Overall Study|Lost to Follow-up|1|||
170400973|NCT01160198|615808992|FG002|Overall Study|Lost to Follow-up|0|||
170400974|NCT01160198|615808990|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
170400975|NCT01160198|615808991|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
170400976|NCT01160198|615808992|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
170400977|NCT01408576|615808993|FG000|Overall Study|Lack of Efficacy|17|||
170400978|NCT01408576|615808994|FG001|Overall Study|Lack of Efficacy|30|||
170400979|NCT01408576|615808995|FG002|Overall Study|Lack of Efficacy|48|||
170400980|NCT01408576|615808993|FG000|Overall Study|Protocol Violation|1|||
170400981|NCT01408576|615808994|FG001|Overall Study|Protocol Violation|2|||
170400982|NCT01408576|615808995|FG002|Overall Study|Protocol Violation|2|||
170400983|NCT01408576|615808993|FG000|Overall Study|Lost to Follow-up|10|||
170400984|NCT01408576|615808994|FG001|Overall Study|Lost to Follow-up|9|||
170400985|NCT01408576|615808995|FG002|Overall Study|Lost to Follow-up|17|||
170400986|NCT01408576|615808993|FG000|Overall Study|Withdrawal by Subject|34|||
170400987|NCT01408576|615808994|FG001|Overall Study|Withdrawal by Subject|60|||
170400988|NCT01408576|615808995|FG002|Overall Study|Withdrawal by Subject|66|||
170400989|NCT01408576|615808993|FG000|Overall Study|Sponsor terminated study|89|||
170400990|NCT01408576|615808994|FG001|Overall Study|Sponsor terminated study|333|||
170400991|NCT01408576|615808995|FG002|Overall Study|Sponsor terminated study|330|||
170400992|NCT01408576|615808993|FG000|Overall Study|AE, serious fatal|4|||
170400993|NCT01408576|615808994|FG001|Overall Study|AE, serious fatal|4|||
170400994|NCT01408576|615808995|FG002|Overall Study|AE, serious fatal|1|||
170400995|NCT01408576|615808993|FG000|Overall Study|SAE, non-fatal|11|||
170400996|NCT01408576|615808994|FG001|Overall Study|SAE, non-fatal|23|||
170400997|NCT01408576|615808995|FG002|Overall Study|SAE, non-fatal|14|||
170400998|NCT01408576|615808993|FG000|Overall Study|AE, non-serious non-fatal|12|||
170400999|NCT01408576|615808994|FG001|Overall Study|AE, non-serious non-fatal|19|||
170401000|NCT01408576|615808995|FG002|Overall Study|AE, non-serious non-fatal|11|||
170401001|NCT01408576|615808993|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
170401002|NCT01408576|615808994|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
170401003|NCT01408576|615808995|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
170401004|NCT01408576|615808993|FG000|Overall Study|AE, unknown type|0|||
170401005|NCT01408576|615808994|FG001|Overall Study|AE, unknown type|1|||
170401006|NCT01408576|615808995|FG002|Overall Study|AE, unknown type|0|||
170401007|NCT01408576|615808993|FG000|Overall Study|Other|10|||
170401008|NCT01408576|615808994|FG001|Overall Study|Other|16|||
170401009|NCT01408576|615808995|FG002|Overall Study|Other|18|||
170401010|NCT00802529|615808996|FG000|Overall Study|Lost to Follow-up|0|||
170401011|NCT00802529|615808997|FG001|Overall Study|Lost to Follow-up|1|||
170401012|NCT00552617|615808999|FG000|Overall Study|Not Treated|0|||
170401013|NCT00552617|615809000|FG001|Overall Study|Not Treated|0|||
170401014|NCT00552617|615809001|FG002|Overall Study|Not Treated|1|||
170401015|NCT00552617|615809002|FG003|Overall Study|Not Treated|0|||
170401016|NCT00552617|615809003|FG004|Overall Study|Not Treated|0|||
170401017|NCT00552617|615809004|FG005|Overall Study|Not Treated|0|||
170401018|NCT00552617|615809005|FG006|Overall Study|Not Treated|0|||
170401019|NCT00552617|615809006|FG007|Overall Study|Not Treated|0|||
170401020|NCT00552617|615809007|FG008|Overall Study|Not Treated|0|||
170401021|NCT00552617|615809008|FG009|Overall Study|Not Treated|1|||
170401022|NCT00552617|615808999|FG000|Overall Study|Lost to Follow-up|0|||
170401023|NCT00552617|615809000|FG001|Overall Study|Lost to Follow-up|0|||
170401024|NCT00552617|615809001|FG002|Overall Study|Lost to Follow-up|0|||
170401025|NCT00552617|615809002|FG003|Overall Study|Lost to Follow-up|1|||
170401026|NCT00552617|615809003|FG004|Overall Study|Lost to Follow-up|0|||
170401027|NCT00552617|615809004|FG005|Overall Study|Lost to Follow-up|2|||
170401028|NCT00552617|615809005|FG006|Overall Study|Lost to Follow-up|0|||
170401029|NCT00552617|615809006|FG007|Overall Study|Lost to Follow-up|0|||
170401030|NCT00552617|615809007|FG008|Overall Study|Lost to Follow-up|2|||
170401031|NCT00552617|615809008|FG009|Overall Study|Lost to Follow-up|0|||
170401032|NCT01902134|615809009|FG000|Overall Study|Adverse Event|3|||
170401033|NCT01902134|615809010|FG001|Overall Study|Adverse Event|1|||
170401034|NCT01902134|615809011|FG002|Overall Study|Adverse Event|2|||
170401035|NCT01902134|615809012|FG003|Overall Study|Adverse Event|1|||
170401036|NCT01902134|615809013|FG004|Overall Study|Adverse Event|1|||
170401037|NCT01902134|615809014|FG005|Overall Study|Adverse Event|3|||
170401038|NCT01902134|615809009|FG000|Overall Study|Lack of Efficacy|0|||
170401039|NCT01902134|615809010|FG001|Overall Study|Lack of Efficacy|0|||
170401040|NCT01902134|615809011|FG002|Overall Study|Lack of Efficacy|2|||
170401041|NCT01902134|615809012|FG003|Overall Study|Lack of Efficacy|0|||
170401042|NCT01902134|615809013|FG004|Overall Study|Lack of Efficacy|0|||
170401043|NCT01902134|615809014|FG005|Overall Study|Lack of Efficacy|1|||
170401044|NCT01902134|615809009|FG000|Overall Study|Physician Decision|0|||
170401045|NCT01902134|615809010|FG001|Overall Study|Physician Decision|1|||
170401046|NCT01902134|615809011|FG002|Overall Study|Physician Decision|0|||
170401047|NCT01902134|615809012|FG003|Overall Study|Physician Decision|0|||
170401048|NCT01902134|615809013|FG004|Overall Study|Physician Decision|0|||
170401049|NCT01902134|615809014|FG005|Overall Study|Physician Decision|0|||
170401050|NCT01902134|615809009|FG000|Overall Study|Protocol Violation|0|||
170401051|NCT01902134|615809010|FG001|Overall Study|Protocol Violation|0|||
170401052|NCT01902134|615809011|FG002|Overall Study|Protocol Violation|0|||
170401053|NCT01902134|615809012|FG003|Overall Study|Protocol Violation|0|||
170401054|NCT01902134|615809013|FG004|Overall Study|Protocol Violation|0|||
170401055|NCT01902134|615809014|FG005|Overall Study|Protocol Violation|1|||
170401056|NCT01902134|615809009|FG000|Overall Study|Withdrawal by Subject|4|||
170401057|NCT01902134|615809010|FG001|Overall Study|Withdrawal by Subject|8|||
170401058|NCT01902134|615809011|FG002|Overall Study|Withdrawal by Subject|9|||
170401059|NCT01902134|615809012|FG003|Overall Study|Withdrawal by Subject|1|||
170401060|NCT01902134|615809013|FG004|Overall Study|Withdrawal by Subject|5|||
170401061|NCT01902134|615809014|FG005|Overall Study|Withdrawal by Subject|4|||
170401062|NCT01902134|615809009|FG000|Overall Study|no compliance|1|||
170401063|NCT01902134|615809010|FG001|Overall Study|no compliance|0|||
170401064|NCT01902134|615809011|FG002|Overall Study|no compliance|0|||
170401065|NCT01902134|615809012|FG003|Overall Study|no compliance|0|||
170401066|NCT01902134|615809013|FG004|Overall Study|no compliance|0|||
170401067|NCT01902134|615809014|FG005|Overall Study|no compliance|0|||
170401068|NCT01902134|615809009|FG000|Overall Study|Other|0|||
170401069|NCT01902134|615809010|FG001|Overall Study|Other|1|||
170401070|NCT01902134|615809011|FG002|Overall Study|Other|2|||
170401071|NCT01902134|615809012|FG003|Overall Study|Other|0|||
170401072|NCT01902134|615809013|FG004|Overall Study|Other|1|||
170401073|NCT01902134|615809014|FG005|Overall Study|Other|0|||
170401074|NCT00305110|615809015|FG000|Overall Study|Missing data|29|||
170401075|NCT00337129|615809016|FG000|Overall Study|Adverse Event|4|||
170401076|NCT00337129|615809016|FG000|Overall Study|Withdrawal by Subject|1|||
170401077|NCT00337129|615809016|FG000|Overall Study|Lack of Efficacy|32|||
170401078|NCT00337129|615809016|FG000|Overall Study|Death|2|||
170401079|NCT00337129|615809016|FG000|Overall Study|not protocol specified|1|||
170401080|NCT00647426|615809017|FG000|Overall Study|Withdrawal by Subject|2|||
170401081|NCT00563524|615809022|FG000|Overall Study|Adverse Event|0|||
170401082|NCT00563524|615809023|FG001|Overall Study|Adverse Event|1|||
170401083|NCT00563524|615809024|FG002|Overall Study|Adverse Event|0|||
170401084|NCT00563524|615809025|FG003|Overall Study|Adverse Event|0|||
170401085|NCT00563524|615809026|FG004|Overall Study|Adverse Event|2|||
170401086|NCT00563524|615809027|FG005|Overall Study|Adverse Event|0|||
170401087|NCT00563524|615809022|FG000|Overall Study|Lost to Follow-up|1|||
170401088|NCT00563524|615809023|FG001|Overall Study|Lost to Follow-up|0|||
170401089|NCT00563524|615809024|FG002|Overall Study|Lost to Follow-up|0|||
170401090|NCT00563524|615809025|FG003|Overall Study|Lost to Follow-up|0|||
170401091|NCT00563524|615809026|FG004|Overall Study|Lost to Follow-up|0|||
170401092|NCT00563524|615809027|FG005|Overall Study|Lost to Follow-up|0|||
170401093|NCT00563524|615809022|FG000|Overall Study|Protocol Violation|0|||
170401094|NCT00563524|615809023|FG001|Overall Study|Protocol Violation|1|||
170401095|NCT00563524|615809024|FG002|Overall Study|Protocol Violation|0|||
170401096|NCT00563524|615809025|FG003|Overall Study|Protocol Violation|0|||
170401097|NCT00563524|615809026|FG004|Overall Study|Protocol Violation|0|||
170401098|NCT00563524|615809027|FG005|Overall Study|Protocol Violation|0|||
170401099|NCT00563524|615809022|FG000|Overall Study|Withdrawal by Subject|1|||
170401100|NCT00563524|615809023|FG001|Overall Study|Withdrawal by Subject|1|||
170401101|NCT00563524|615809024|FG002|Overall Study|Withdrawal by Subject|3|||
170401102|NCT00563524|615809025|FG003|Overall Study|Withdrawal by Subject|0|||
170401103|NCT00563524|615809026|FG004|Overall Study|Withdrawal by Subject|0|||
170401104|NCT00563524|615809027|FG005|Overall Study|Withdrawal by Subject|1|||
170401105|NCT01272193|615809029|FG000|Overall Study|Adverse Event|1|||
170401106|NCT01272193|615809030|FG001|Overall Study|Adverse Event|1|||
170401107|NCT01272193|615809029|FG000|Overall Study|Lack of Efficacy|0|||
170401108|NCT01272193|615809030|FG001|Overall Study|Lack of Efficacy|3|||
170401109|NCT01272193|615809029|FG000|Overall Study|Withdrawal Criteria|1|||
170401110|NCT01272193|615809030|FG001|Overall Study|Withdrawal Criteria|1|||
170401111|NCT01272193|615809029|FG000|Overall Study|Unclassified|8|||
170401112|NCT01272193|615809030|FG001|Overall Study|Unclassified|7|||
170401113|NCT03578276|615809031|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
170401114|NCT03578276|615809032|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
170401115|NCT01084603|615809037|FG000|Baseline|Withdrawal by Subject|2|||
170401116|NCT01084603|615809037|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
170401117|NCT01084603|615809037|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
170401118|NCT01084603|615809037|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
170401119|NCT01084603|615809037|FG000|Washout Period 4|Adverse Event|1|||
170401120|NCT02766088|615809039|FG000|Overall Study|Sponsor study termination|498|||
170401121|NCT02766088|615809039|FG000|Overall Study|Migrated/moved from the study area|1|||
170401122|NCT02766088|615809039|FG000|Overall Study|Lost to Follow-up|5|||
170401123|NCT02766088|615809039|FG000|Overall Study|Other|1|||
170401124|NCT02766088|615809039|FG000|Overall Study|Death|1|||
170401125|NCT02360397|615809040|FG000|Overall Study|Incomplete screening|3|||
170401126|NCT02360397|615809040|FG000|Overall Study|Adverse Event|1|||
170401127|NCT03836729|615809041|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
170401128|NCT01508325|615809044|FG000|Overall Study|Withdrawal by Subject|8|||
170401129|NCT01508325|615809045|FG001|Overall Study|Withdrawal by Subject|9|||
170401130|NCT01508325|615809044|FG000|Overall Study|Protocol Violation|0|||
170401131|NCT01508325|615809045|FG001|Overall Study|Protocol Violation|3|||
170401132|NCT01508325|615809044|FG000|Overall Study|Physician Decision|2|||
170401133|NCT01508325|615809045|FG001|Overall Study|Physician Decision|1|||
170401134|NCT01508325|615809044|FG000|Overall Study|Adverse Event|1|||
170401135|NCT01508325|615809045|FG001|Overall Study|Adverse Event|0|||
170401136|NCT01508325|615809044|FG000|Overall Study|Lost to Follow-up|5|||
170401137|NCT01508325|615809045|FG001|Overall Study|Lost to Follow-up|6|||
170401138|NCT01508325|615809044|FG000|Overall Study|Other|2|||
170401139|NCT01508325|615809045|FG001|Overall Study|Other|2|||
170401140|NCT01392170|615809046|FG000|Overall Study|Withdrawal by Subject|1|||
170401141|NCT01392170|615809046|FG000|Overall Study|Ineligible|1|||
170401142|NCT00763269|615809057|FG000|Overall Study|Lost to Follow-up|12|||
170401143|NCT00763269|615809058|FG001|Overall Study|Lost to Follow-up|13|||
170401144|NCT03543046|615809059|FG000|Overall Study|Adverse Event|1|||
170401145|NCT03543046|615809060|FG001|Overall Study|Adverse Event|1|||
170401146|NCT03543046|615809059|FG000|Overall Study|Physician Decision|1|||
170401147|NCT03543046|615809060|FG001|Overall Study|Physician Decision|1|||
170401148|NCT03543046|615809059|FG000|Overall Study|Protocol Violation|1|||
170401149|NCT03543046|615809060|FG001|Overall Study|Protocol Violation|0|||
170401150|NCT00544557|615809066|FG000|Overall Study|Adverse Event|140|||
170401151|NCT00544557|615809066|FG000|Overall Study|Lack of Efficacy|196|||
170401152|NCT00544557|615809066|FG000|Overall Study|Other|98|||
170401153|NCT01808209|615809069|FG000|Overall Study|Lost to Follow-up|0|||
170401154|NCT01808209|615809070|FG001|Overall Study|Lost to Follow-up|1|||
170401155|NCT01830920|615809071|FG000|Overall Study|Adverse Event|1|||
170401156|NCT01830920|615809072|FG001|Overall Study|Adverse Event|0|||
170401157|NCT01830920|615809073|FG002|Overall Study|Adverse Event|1|||
170401158|NCT01830920|615809074|FG003|Overall Study|Adverse Event|0|||
170401159|NCT01830920|615809075|FG004|Overall Study|Adverse Event|0|||
170401160|NCT01830920|615809071|FG000|Overall Study|Withdrawal by Subject|2|||
170401161|NCT01830920|615809072|FG001|Overall Study|Withdrawal by Subject|2|||
170401162|NCT01830920|615809073|FG002|Overall Study|Withdrawal by Subject|1|||
170401163|NCT01830920|615809074|FG003|Overall Study|Withdrawal by Subject|7|||
170401164|NCT01830920|615809075|FG004|Overall Study|Withdrawal by Subject|1|||
170401165|NCT01830920|615809071|FG000|Overall Study|Death|3|||
170401166|NCT01830920|615809072|FG001|Overall Study|Death|3|||
170401167|NCT01830920|615809073|FG002|Overall Study|Death|5|||
170401168|NCT01830920|615809074|FG003|Overall Study|Death|4|||
170401169|NCT01830920|615809075|FG004|Overall Study|Death|4|||
170401170|NCT01830920|615809071|FG000|Overall Study|Other|15|||
170401171|NCT01830920|615809072|FG001|Overall Study|Other|1|||
170401172|NCT01830920|615809073|FG002|Overall Study|Other|1|||
170401173|NCT01830920|615809074|FG003|Overall Study|Other|5|||
170401174|NCT01830920|615809075|FG004|Overall Study|Other|3|||
170401175|NCT00697112|615809076|FG000|Overall Study|Adverse Event|8|||
170401176|NCT00697112|615809076|FG000|Overall Study|Lost to Follow-up|1|||
170401177|NCT00697112|615809076|FG000|Overall Study|Did not meet inclusion criteria|1|||
170401178|NCT01313728|615809077|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
170401179|NCT02216214|615809082|FG000|Overall Study|Randomized Never Received Study Drug|1|||
170401180|NCT02216214|615809083|FG001|Overall Study|Randomized Never Received Study Drug|0|||
170401181|NCT02216214|615809082|FG000|Overall Study|Adverse Event|10|||
170401182|NCT02216214|615809083|FG001|Overall Study|Adverse Event|8|||
170401183|NCT02216214|615809082|FG000|Overall Study|Lack of Efficacy|2|||
170401184|NCT02216214|615809083|FG001|Overall Study|Lack of Efficacy|2|||
170401185|NCT02216214|615809082|FG000|Overall Study|Lost to Follow-up|3|||
170401186|NCT02216214|615809083|FG001|Overall Study|Lost to Follow-up|2|||
170401187|NCT02216214|615809082|FG000|Overall Study|Protocol Violation|4|||
170401188|NCT02216214|615809083|FG001|Overall Study|Protocol Violation|2|||
170401189|NCT02216214|615809082|FG000|Overall Study|Withdrawal by Subject|22|||
170401190|NCT02216214|615809083|FG001|Overall Study|Withdrawal by Subject|20|||
170401191|NCT02216214|615809082|FG000|Overall Study|Study Terminated By Sponsor|0|||
170401192|NCT02216214|615809083|FG001|Overall Study|Study Terminated By Sponsor|1|||
170401193|NCT02216214|615809082|FG000|Overall Study|Miscellaneous|1|||
170401194|NCT02216214|615809083|FG001|Overall Study|Miscellaneous|1|||
170401195|NCT05354206|615809084|FG000|Overall Study|Withdrawal by Subject|1|||
170401196|NCT05354206|615809085|FG001|Overall Study|Withdrawal by Subject|0|||
170401197|NCT00713830|615809088|FG000|Overall Study|Adverse Event|23|||
170401198|NCT00713830|615809089|FG001|Overall Study|Adverse Event|71|||
170401199|NCT00713830|615809088|FG000|Overall Study|Lack of Efficacy|24|||
170401200|NCT00713830|615809089|FG001|Overall Study|Lack of Efficacy|16|||
170401201|NCT00713830|615809088|FG000|Overall Study|Lost to Follow-up|2|||
170401202|NCT00713830|615809089|FG001|Overall Study|Lost to Follow-up|9|||
170401203|NCT00713830|615809088|FG000|Overall Study|Withdrawal by Subject|13|||
170401204|NCT00713830|615809089|FG001|Overall Study|Withdrawal by Subject|23|||
170401205|NCT00713830|615809088|FG000|Overall Study|Poor Compliance to Protocol|7|||
170401206|NCT00713830|615809089|FG001|Overall Study|Poor Compliance to Protocol|14|||
170401207|NCT00713830|615809088|FG000|Overall Study|Familial and Personal Reasons|9|||
170401208|NCT00713830|615809089|FG001|Overall Study|Familial and Personal Reasons|34|||
170401209|NCT00713830|615809088|FG000|Overall Study|Sponsor Decision|4|||
170401210|NCT00713830|615809089|FG001|Overall Study|Sponsor Decision|10|||
170401211|NCT04057118|615809090|FG000|Overall Study|Adverse Event|1|||
170401212|NCT04057118|615809091|FG001|Overall Study|Adverse Event|0|||
170401213|NCT04057118|615809092|FG002|Overall Study|Adverse Event|1|||
170401214|NCT04057118|615809093|FG003|Overall Study|Adverse Event|1|||
170401215|NCT04057118|615809090|FG000|Overall Study|Physician Decision|0|||
170401216|NCT04057118|615809091|FG001|Overall Study|Physician Decision|0|||
170401217|NCT04057118|615809092|FG002|Overall Study|Physician Decision|1|||
170401218|NCT04057118|615809093|FG003|Overall Study|Physician Decision|1|||
170401219|NCT04057118|615809090|FG000|Overall Study|Withdrawal by Subject|2|||
170401220|NCT04057118|615809091|FG001|Overall Study|Withdrawal by Subject|2|||
170401221|NCT04057118|615809092|FG002|Overall Study|Withdrawal by Subject|0|||
170401222|NCT04057118|615809093|FG003|Overall Study|Withdrawal by Subject|2|||
170401223|NCT04057118|615809090|FG000|Overall Study|Not Specific|0|||
170401224|NCT04057118|615809091|FG001|Overall Study|Not Specific|0|||
170401225|NCT04057118|615809092|FG002|Overall Study|Not Specific|1|||
170401226|NCT04057118|615809093|FG003|Overall Study|Not Specific|1|||
170401227|NCT02787785|615809094|FG000|Overall Study|Death|3|||
170401228|NCT02787785|615809095|FG001|Overall Study|Death|4|||
170401229|NCT02787785|615809094|FG000|Overall Study|Lost to Follow-up|1|||
170401230|NCT02787785|615809095|FG001|Overall Study|Lost to Follow-up|1|||
170401231|NCT02787785|615809094|FG000|Overall Study|Withdrawal by Subject|0|||
170401232|NCT02787785|615809095|FG001|Overall Study|Withdrawal by Subject|5|||
170401233|NCT00572156|615809098|FG000|Overall Study|Adverse Event|3|||
170401234|NCT00572156|615809099|FG001|Overall Study|Adverse Event|1|||
170401235|NCT00572156|615809100|FG002|Overall Study|Adverse Event|5|||
170401236|NCT00572156|615809101|FG003|Overall Study|Adverse Event|1|||
170401237|NCT00572156|615809098|FG000|Overall Study|Lost to Follow-up|1|||
170401238|NCT00572156|615809099|FG001|Overall Study|Lost to Follow-up|1|||
170401239|NCT00572156|615809100|FG002|Overall Study|Lost to Follow-up|1|||
170401240|NCT00572156|615809101|FG003|Overall Study|Lost to Follow-up|0|||
170401241|NCT00572156|615809098|FG000|Overall Study|Protocol Violation|1|||
170401242|NCT00572156|615809099|FG001|Overall Study|Protocol Violation|2|||
170401243|NCT00572156|615809100|FG002|Overall Study|Protocol Violation|0|||
170401244|NCT00572156|615809101|FG003|Overall Study|Protocol Violation|2|||
170401245|NCT00572156|615809098|FG000|Overall Study|Patient/Parent Decision|1|||
170401246|NCT00572156|615809099|FG001|Overall Study|Patient/Parent Decision|6|||
170401247|NCT00572156|615809100|FG002|Overall Study|Patient/Parent Decision|4|||
170401248|NCT00572156|615809101|FG003|Overall Study|Patient/Parent Decision|3|||
170401249|NCT00572156|615809098|FG000|Overall Study|Sponsor Decision|20|||
170401250|NCT00572156|615809099|FG001|Overall Study|Sponsor Decision|16|||
170401251|NCT00572156|615809100|FG002|Overall Study|Sponsor Decision|17|||
170401252|NCT00572156|615809101|FG003|Overall Study|Sponsor Decision|19|||
170401253|NCT00720304|615809102|FG000|Overall Study|Withdrawal by Subject|14|||
170401254|NCT00720304|615809103|FG001|Overall Study|Withdrawal by Subject|1|||
170401255|NCT00720304|615809102|FG000|Overall Study|Death|1|||
170401256|NCT00720304|615809103|FG001|Overall Study|Death|0|||
170401257|NCT00720304|615809102|FG000|Overall Study|Physician Decision|5|||
170401258|NCT00720304|615809103|FG001|Overall Study|Physician Decision|2|||
170401259|NCT00720304|615809102|FG000|Overall Study|Adverse Event|3|||
170401260|NCT00720304|615809103|FG001|Overall Study|Adverse Event|1|||
170401261|NCT00720304|615809102|FG000|Overall Study|Disease progression|6|||
170516585|NCT01000974|616236383|FG000|Primary Vaccination Phase|Protocol Violation|40|||
170401262|NCT00720304|615809103|FG001|Overall Study|Disease progression|1|||
170401263|NCT04330482|615809104|FG000|Overall Study|Lost to Follow-up|2|||
170401264|NCT04330482|615809105|FG001|Overall Study|Lost to Follow-up|1|||
170401265|NCT04330482|615809104|FG000|Overall Study|Withdrawal by Subject|0|||
170401266|NCT04330482|615809105|FG001|Overall Study|Withdrawal by Subject|3|||
170401267|NCT04440007|615809106|FG000|Overall Study|Adverse Event|0|||
170401268|NCT04440007|615809107|FG001|Overall Study|Adverse Event|1|||
170516586|NCT01000974|616236384|FG001|Primary Vaccination Phase|Protocol Violation|3|||
170401269|NCT04440007|615809106|FG000|Overall Study|Lost to Follow-up|1|||
170401270|NCT04440007|615809107|FG001|Overall Study|Lost to Follow-up|3|||
170401271|NCT04440007|615809106|FG000|Overall Study|Death|7|||
170401272|NCT04440007|615809107|FG001|Overall Study|Death|2|||
170401273|NCT04440007|615809106|FG000|Overall Study|Physician Decision|1|||
170401274|NCT04440007|615809107|FG001|Overall Study|Physician Decision|1|||
170401275|NCT04440007|615809106|FG000|Overall Study|Withdrawal by Subject|2|||
170401276|NCT04440007|615809107|FG001|Overall Study|Withdrawal by Subject|1|||
170401277|NCT04440007|615809106|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
170401278|NCT04440007|615809107|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
170401279|NCT04440007|615809106|FG000|Overall Study|Discontinued prior to dosing|0|||
170401280|NCT04440007|615809107|FG001|Overall Study|Discontinued prior to dosing|2|||
170401281|NCT02524665|615809108|FG000|Overall Study|Lost to Follow-up|1|||
170401282|NCT00314262|615809115|FG000|Overall Study|Adverse Event|2|||
170401283|NCT00314262|615809115|FG000|Overall Study|Withdrawal by Subject|2|||
170401284|NCT00314262|615809115|FG000|Overall Study|Physician Decision|1|||
170401285|NCT00483717|615809116|FG000|Overall Study|Protocol Violation|5|||
170401286|NCT00483717|615809117|FG001|Overall Study|Protocol Violation|7|||
170401287|NCT00483717|615809116|FG000|Overall Study|Time of dosing missing|1|||
170401288|NCT00483717|615809117|FG001|Overall Study|Time of dosing missing|1|||
170401289|NCT00483717|615809116|FG000|Overall Study|No treatment for migraine|16|||
170401290|NCT00483717|615809117|FG001|Overall Study|No treatment for migraine|13|||
170401291|NCT00483717|615809116|FG000|Overall Study|Lost to Follow-up|1|||
170401292|NCT00483717|615809117|FG001|Overall Study|Lost to Follow-up|0|||
170401293|NCT00483717|615809116|FG000|Overall Study|Withdrawal by Subject|1|||
170401294|NCT00483717|615809117|FG001|Overall Study|Withdrawal by Subject|0|||
170401295|NCT01185639|615809118|FG000|Overall Study|Progressed and didn't receive therapy|2|||
170401296|NCT01966107|615809119|FG000|Overall Study|excluded from FAS|21|||
170401297|NCT01966107|615809120|FG001|Overall Study|excluded from FAS|20|||
170401298|NCT01966107|615809119|FG000|Overall Study|discontinued treatment|345|||
170401299|NCT01966107|615809120|FG001|Overall Study|discontinued treatment|372|||
170401300|NCT01966107|615809119|FG000|Overall Study|due to study closure|164|||
170401301|NCT01966107|615809120|FG001|Overall Study|due to study closure|186|||
170401302|NCT01966107|615809119|FG000|Overall Study|withdrew from the study|272|||
170401303|NCT01966107|615809120|FG001|Overall Study|withdrew from the study|303|||
170401304|NCT02200614|615809121|FG000|Double Blind Treatment|Adverse Event|86|||
170401305|NCT02200614|615809122|FG001|Double Blind Treatment|Adverse Event|48|||
170401306|NCT02200614|615809121|FG000|Double Blind Treatment|Confirmed metastasis|120|||
170401307|NCT02200614|615809122|FG001|Double Blind Treatment|Confirmed metastasis|140|||
170401308|NCT02200614|615809121|FG000|Double Blind Treatment|Judgment of the investigator|59|||
170401309|NCT02200614|615809122|FG001|Double Blind Treatment|Judgment of the investigator|99|||
170401310|NCT02200614|615809121|FG000|Double Blind Treatment|Metastasis by local reading|1|||
170401311|NCT02200614|615809122|FG001|Double Blind Treatment|Metastasis by local reading|3|||
170401312|NCT02200614|615809121|FG000|Double Blind Treatment|Other reason|6|||
170401313|NCT02200614|615809122|FG001|Double Blind Treatment|Other reason|2|||
170401314|NCT02200614|615809121|FG000|Double Blind Treatment|Personal reason|77|||
170401315|NCT02200614|615809122|FG001|Double Blind Treatment|Personal reason|85|||
170401316|NCT02200614|615809121|FG000|Double Blind Treatment|Protocol deviation|14|||
170401317|NCT02200614|615809122|FG001|Double Blind Treatment|Protocol deviation|7|||
170401318|NCT02200614|615809121|FG000|Double Blind Treatment|Not treated|1|||
170401319|NCT02200614|615809122|FG001|Double Blind Treatment|Not treated|0|||
170401320|NCT02200614|615809121|FG000|Open Label|Adverse Event|41|||
170401321|NCT02200614|615809122|FG001|Open Label|Adverse Event|11|||
170401322|NCT02200614|615809121|FG000|Open Label|Confirmed metastasis|1|||
170401323|NCT02200614|615809122|FG001|Open Label|Confirmed metastasis|0|||
170401324|NCT02200614|615809121|FG000|Open Label|Judgment of the investigator|29|||
170401325|NCT02200614|615809122|FG001|Open Label|Judgment of the investigator|2|||
170401326|NCT02200614|615809121|FG000|Open Label|Metastasis by local reading|138|||
170401327|NCT02200614|615809122|FG001|Open Label|Metastasis by local reading|27|||
170401328|NCT02200614|615809121|FG000|Open Label|Other reason|22|||
170401329|NCT02200614|615809122|FG001|Open Label|Other reason|4|||
170401330|NCT02200614|615809121|FG000|Open Label|Personal reason|60|||
170401331|NCT02200614|615809122|FG001|Open Label|Personal reason|8|||
170401332|NCT02200614|615809121|FG000|Open Label|Protocol deviation|3|||
170401333|NCT02200614|615809122|FG001|Open Label|Protocol deviation|2|||
170401334|NCT02200614|615809121|FG000|Open Label|Missing|2|||
170401335|NCT02200614|615809122|FG001|Open Label|Missing|2|||
170401336|NCT00828516|615809131|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
170401337|NCT00689273|615809132|FG000|Overall Study|Adverse Event|3|||
170401338|NCT00689273|615809133|FG001|Overall Study|Adverse Event|1|||
170401339|NCT00689273|615809132|FG000|Overall Study|Lack of Efficacy|3|||
170401340|NCT00689273|615809133|FG001|Overall Study|Lack of Efficacy|0|||
170401341|NCT00689273|615809132|FG000|Overall Study|Lost to Follow-up|0|||
170401342|NCT00689273|615809133|FG001|Overall Study|Lost to Follow-up|2|||
170401343|NCT00689273|615809132|FG000|Overall Study|Other|6|||
170401344|NCT00689273|615809133|FG001|Overall Study|Other|2|||
170401345|NCT00689273|615809132|FG000|Overall Study|Randomized but not Treated|1|||
170401346|NCT00689273|615809133|FG001|Overall Study|Randomized but not Treated|0|||
170401347|NCT03703297|615809134|FG000|Overall Study|Death|115|||
170401348|NCT03703297|615809135|FG001|Overall Study|Death|0|||
170401349|NCT03703297|615809136|FG002|Overall Study|Death|144|||
170401350|NCT03703297|615809134|FG000|Overall Study|Withdrawal by Subject|9|||
170516587|NCT01000974|616236385|FG002|Primary Vaccination Phase|Protocol Violation|2|||
170516588|NCT01000974|616236383|FG000|Primary Vaccination Phase|Adverse Event|14|||
170516589|NCT01000974|616236384|FG001|Primary Vaccination Phase|Adverse Event|2|||
170516590|NCT01000974|616236385|FG002|Primary Vaccination Phase|Adverse Event|2|||
170516591|NCT01000974|616236383|FG000|Primary Vaccination Phase|Other|4|||
170516592|NCT01000974|616236384|FG001|Primary Vaccination Phase|Other|9|||
170516593|NCT01000974|616236385|FG002|Primary Vaccination Phase|Other|12|||
170516594|NCT01000974|616236383|FG000|Booster Vaccination Phase|Protocol Violation|0|||
170516595|NCT01000974|616236384|FG001|Booster Vaccination Phase|Protocol Violation|0|||
170516596|NCT01000974|616236385|FG002|Booster Vaccination Phase|Protocol Violation|2|||
170516597|NCT01000974|616236383|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
170516598|NCT01000974|616236384|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
170516599|NCT01000974|616236385|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
170401351|NCT03703297|615809135|FG001|Overall Study|Withdrawal by Subject|0|||
170401352|NCT03703297|615809136|FG002|Overall Study|Withdrawal by Subject|11|||
170401353|NCT03703297|615809134|FG000|Overall Study|Ongoing at the time of DCO|140|||
170401354|NCT03703297|615809135|FG001|Overall Study|Ongoing at the time of DCO|200|||
170401355|NCT03703297|615809136|FG002|Overall Study|Ongoing at the time of DCO|111|||
170401356|NCT00833976|615811447|FG000|Overall Study|Withdrawal by Subject|5|||
170401357|NCT00833976|615811447|FG000|Overall Study|Lost to Follow-up|4|||
170401358|NCT00833976|615811447|FG000|Overall Study|Did not meet eligibility criteria|41|||
170401359|NCT00833976|615811447|FG000|Overall Study|Physician Decision|1|||
170401360|NCT04575038|615811448|FG000|Overall Study|Withdrawal by Subject|1|||
170401361|NCT04575038|615811449|FG001|Overall Study|Withdrawal by Subject|1|||
170401362|NCT03555890|615811456|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170401363|NCT03555890|615811457|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170401364|NCT03555890|615811458|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170401365|NCT03555890|615811459|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
170401366|NCT01383954|615811460|FG000|Overall Study|Lack of Efficacy|2|||
170401367|NCT01383954|615811460|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
170401368|NCT01383954|615811460|FG000|Overall Study|Adverse Event|1|||
170401369|NCT01383954|615811460|FG000|Overall Study|Reason Not Specified|9|||
170401370|NCT04228302|615811466|FG000|Overall Study|Adverse Event|0|||
170401371|NCT04228302|615811467|FG001|Overall Study|Adverse Event|0|||
170516600|NCT01000974|616236383|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
170516601|NCT01000974|616236384|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
170516602|NCT01000974|616236385|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
170516603|NCT01000974|616236383|FG000|Booster Vaccination Phase|Other|24|||
170516604|NCT01000974|616236384|FG001|Booster Vaccination Phase|Other|6|||
170516605|NCT01000974|616236385|FG002|Booster Vaccination Phase|Other|4|||
170516606|NCT01639144|616236386|FG000|Overall Study|Withdrawal by Subject|4|||
170516607|NCT01639144|616236387|FG001|Overall Study|Withdrawal by Subject|2|||
170516608|NCT01639144|616236386|FG000|Overall Study|Physician Decision|2|||
170516609|NCT01639144|616236387|FG001|Overall Study|Physician Decision|0|||
170516610|NCT01639144|616236386|FG000|Overall Study|Met postoperative exclusion criteria|4|||
170516611|NCT01639144|616236387|FG001|Overall Study|Met postoperative exclusion criteria|3|||
170516612|NCT01307891|616236388|FG000|Overall Study|Progressive Disease|3|||
170516613|NCT01307891|616236389|FG001|Overall Study|Progressive Disease|1|||
170516614|NCT04194489|616236390|FG000|Overall Study|Withdrawal by Subject|5|||
170516615|NCT04194489|616236390|FG000|Overall Study|Lost to Follow-up|48|||
170516616|NCT02964338|616236393|FG000|Overall Study|Sponsor terminated study for futility|12|||
170630236|NCT01774721|616660435|FG000|Overall Study|Withdrawal by Subject|20|||
170630237|NCT01774721|616660436|FG001|Overall Study|Withdrawal by Subject|14|||
170630238|NCT01774721|616660435|FG000|Overall Study|Lost to Follow-up|6|||
170630239|NCT01774721|616660436|FG001|Overall Study|Lost to Follow-up|7|||
170630240|NCT01774721|616660435|FG000|Overall Study|Did not meet eligibility criteria|0|||
170630241|NCT01774721|616660436|FG001|Overall Study|Did not meet eligibility criteria|3|||
170630242|NCT01774721|616660435|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
170630243|NCT01774721|616660436|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
170630244|NCT01774721|616660435|FG000|Overall Study|Study terminated by sponsor|5|||
170401372|NCT04228302|615811468|FG002|Overall Study|Adverse Event|0|||
170630245|NCT01774721|616660436|FG001|Overall Study|Study terminated by sponsor|0|||
170630246|NCT01774721|616660435|FG000|Overall Study|Disease progression|5|||
170630247|NCT01774721|616660436|FG001|Overall Study|Disease progression|0|||
170630248|NCT00628108|616660437|FG000|Overall Study|Adverse Event|0|||
170630249|NCT00628108|616660438|FG001|Overall Study|Adverse Event|3|||
170401373|NCT04228302|615811469|FG003|Overall Study|Adverse Event|0|||
170630250|NCT00628108|616660437|FG000|Overall Study|Withdrawal by Subject|1|||
170401374|NCT04228302|615811470|FG004|Overall Study|Adverse Event|1|||
170401375|NCT04228302|615811471|FG005|Overall Study|Adverse Event|0|||
170401376|NCT02354976|615811484|FG000|Overall Study|Other - reason not specified|1|||
170401377|NCT02354976|615811485|FG001|Overall Study|Other - reason not specified|0|||
170401378|NCT02354976|615811486|FG002|Overall Study|Other - reason not specified|1|||
170630251|NCT00628108|616660438|FG001|Overall Study|Withdrawal by Subject|0|||
170401379|NCT02354976|615811484|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
170630252|NCT00865566|616660439|FG000|Overall Study|Death|1|||
170630253|NCT00865566|616660440|FG001|Overall Study|Death|11|||
170630254|NCT00865566|616660439|FG000|Overall Study|Lost to Follow-up|314|||
170630255|NCT00865566|616660440|FG001|Overall Study|Lost to Follow-up|315|||
170630256|NCT00865566|616660439|FG000|Overall Study|Withdrawal by Subject|45|||
170630257|NCT00865566|616660440|FG001|Overall Study|Withdrawal by Subject|65|||
170630258|NCT00865566|616660439|FG000|Overall Study|Physician Decision|0|||
170630259|NCT00865566|616660440|FG001|Overall Study|Physician Decision|1|||
170630260|NCT00865566|616660439|FG000|Overall Study|Participant relocated|78|||
170630261|NCT00865566|616660440|FG001|Overall Study|Participant relocated|107|||
170630262|NCT00865566|616660439|FG000|Overall Study|Participant unable to adhere|27|||
170630263|NCT00865566|616660440|FG001|Overall Study|Participant unable to adhere|42|||
170630264|NCT00865566|616660439|FG000|Overall Study|Other; N=245 due to early study closure|154|||
170630265|NCT00865566|616660440|FG001|Overall Study|Other; N=245 due to early study closure|139|||
170630266|NCT00865566|616660439|FG000|Overall Study|HIV infection|5|||
170630267|NCT00865566|616660440|FG001|Overall Study|HIV infection|7|||
170630268|NCT00521404|616660441|FG000|Overall Study|Adverse Event|13|||
170630269|NCT00521404|616660441|FG000|Overall Study|Disease Progression|33|||
170630270|NCT00521404|616660441|FG000|Overall Study|Investigator decision|5|||
170401380|NCT02354976|615811485|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
170401381|NCT02354976|615811486|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
170401382|NCT02354976|615811484|FG000|Overall Study|Adverse Event|1|||
170401383|NCT02354976|615811485|FG001|Overall Study|Adverse Event|0|||
170401384|NCT02354976|615811486|FG002|Overall Study|Adverse Event|2|||
170401385|NCT02164539|615811489|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
170401386|NCT02164539|615811490|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
170401387|NCT02164539|615811491|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
170401388|NCT02164539|615811492|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
170401389|NCT02164539|615811493|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
170401390|NCT02164539|615811494|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
170401391|NCT02164539|615811495|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
170401392|NCT02164539|615811489|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
170401393|NCT02164539|615811490|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
170401394|NCT02164539|615811491|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
170401395|NCT02164539|615811492|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
170401396|NCT02164539|615811493|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
170401397|NCT02164539|615811494|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
170630271|NCT00521404|616660441|FG000|Overall Study|Withdrawal of consent|3|||
170630272|NCT00521404|616660441|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
170630273|NCT00521404|616660441|FG000|Overall Study|Other|7|||
170630274|NCT01383356|616660442|FG000|Period 1|Adverse Event|5|||
170630275|NCT01383356|616660443|FG001|Period 1|Adverse Event|3|||
170630276|NCT01383356|616660442|FG000|Period 1|Non-compliance|3|||
170630277|NCT01383356|616660443|FG001|Period 1|Non-compliance|0|||
170630278|NCT01383356|616660442|FG000|Period 1|Out of Range Mid-study-Test|0|||
170630279|NCT01383356|616660443|FG001|Period 1|Out of Range Mid-study-Test|1|||
170630280|NCT01383356|616660442|FG000|Period 1|Personal|0|||
170630281|NCT01383356|616660443|FG001|Period 1|Personal|2|||
170630282|NCT01524796|616660446|FG000|Overall Study|Adverse Event|13|||
170630283|NCT01524796|616660446|FG000|Overall Study|Lack of Efficacy|3|||
170630284|NCT01524796|616660446|FG000|Overall Study|Lost to Follow-up|1|||
170630285|NCT01524796|616660446|FG000|Overall Study|The price|1|||
170630286|NCT01524796|616660446|FG000|Overall Study|Withdrawal by Subject|4|||
170630287|NCT01524796|616660446|FG000|Overall Study|Move|1|||
170630288|NCT01524796|616660446|FG000|Overall Study|Deterioration of pains|1|||
170630289|NCT01524796|616660446|FG000|Overall Study|Gall stone surgery|1|||
170401398|NCT02164539|615811495|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
170401399|NCT02164539|615811489|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
170630290|NCT01524796|616660446|FG000|Overall Study|Nervous about confidentiality|1|||
170401400|NCT02164539|615811490|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
170401401|NCT02164539|615811491|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
170401402|NCT02164539|615811492|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
170401403|NCT02164539|615811493|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
170401404|NCT02164539|615811494|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
170401405|NCT02164539|615811495|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
170401406|NCT02164539|615811489|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
170401407|NCT02164539|615811490|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
170630291|NCT01524796|616660446|FG000|Overall Study|Switch to carbamazapine|1|||
170630292|NCT01524796|616660446|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
170630293|NCT01213472|616660447|FG000|Overall Study|Recurrence/Progressive disease|25|||
170630294|NCT01213472|616660447|FG000|Overall Study|Withdrawal by Subject|1|||
170630295|NCT01213472|616660447|FG000|Overall Study|Physician Decision|1|||
170630296|NCT00129402|616660448|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
170630297|NCT00129402|616660449|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
170745487|NCT01474512|617076106|FG012|Maintenance Period|Adverse Event|0|||
170401408|NCT02164539|615811491|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
170401409|NCT02164539|615811492|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
170401410|NCT02164539|615811493|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
170401411|NCT02164539|615811494|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
170401412|NCT02164539|615811495|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
170401413|NCT02164539|615811489|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
170630298|NCT00129402|616660450|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
170630299|NCT00129402|616660451|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
170401414|NCT02164539|615811490|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
170401415|NCT02164539|615811491|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
170401416|NCT02164539|615811492|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
170401417|NCT02164539|615811493|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
170401418|NCT02164539|615811494|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
170630300|NCT00129402|616660452|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
170630301|NCT00129402|616660453|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
170630302|NCT00129402|616660454|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
170630303|NCT00129402|616660448|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
170630304|NCT00129402|616660449|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
170630305|NCT00129402|616660450|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
170630306|NCT00129402|616660451|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
170630307|NCT00129402|616660452|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
170630308|NCT00129402|616660453|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
170630309|NCT00129402|616660454|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
170630310|NCT00129402|616660448|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
170630311|NCT00129402|616660449|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
170630312|NCT00129402|616660450|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
170630313|NCT00129402|616660451|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
170630314|NCT00129402|616660452|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
170630315|NCT00129402|616660453|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
170401419|NCT02164539|615811495|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
170401420|NCT02164539|615811489|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
170401421|NCT02164539|615811490|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
170401422|NCT02164539|615811491|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
170401423|NCT02164539|615811492|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
170401424|NCT02164539|615811493|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
170401425|NCT02164539|615811494|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
170401426|NCT02164539|615811495|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
170401427|NCT01542736|615811496|FG000|Overall Study|Death|1|||
170401428|NCT03674827|615811497|FG000|Treatment Phase|Adverse Event|0|||
170401429|NCT03674827|615811498|FG001|Treatment Phase|Adverse Event|0|||
170401430|NCT03674827|615811499|FG002|Treatment Phase|Adverse Event|0|||
170401431|NCT03674827|615811500|FG003|Treatment Phase|Adverse Event|0|||
170401432|NCT03674827|615811501|FG004|Treatment Phase|Adverse Event|0|||
170630316|NCT00129402|616660454|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
170630317|NCT00129402|616660448|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
170630318|NCT00129402|616660449|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
170630319|NCT00129402|616660450|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
170630320|NCT00129402|616660451|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
170630321|NCT00129402|616660452|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
170630322|NCT00129402|616660453|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
170630323|NCT00129402|616660454|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
170630324|NCT00129402|616660448|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
170630325|NCT00129402|616660449|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
170630326|NCT00129402|616660450|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
170401433|NCT03674827|615811502|FG005|Treatment Phase|Adverse Event|2|||
170401434|NCT03674827|615811497|FG000|Treatment Phase|Death|2|||
170401435|NCT03674827|615811498|FG001|Treatment Phase|Death|0|||
170401436|NCT03674827|615811499|FG002|Treatment Phase|Death|0|||
170401437|NCT03674827|615811500|FG003|Treatment Phase|Death|0|||
170401438|NCT03674827|615811501|FG004|Treatment Phase|Death|1|||
170401439|NCT03674827|615811502|FG005|Treatment Phase|Death|0|||
170401440|NCT03674827|615811497|FG000|Treatment Phase|Progressive Disease|0|||
170401441|NCT03674827|615811498|FG001|Treatment Phase|Progressive Disease|4|||
170630327|NCT00129402|616660451|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
170630328|NCT00129402|616660452|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
170745488|NCT01474512|617076107|FG013|Maintenance Period|Adverse Event|0|||
170401442|NCT03674827|615811499|FG002|Treatment Phase|Progressive Disease|3|||
170401443|NCT03674827|615811500|FG003|Treatment Phase|Progressive Disease|4|||
170401444|NCT03674827|615811501|FG004|Treatment Phase|Progressive Disease|4|||
170401445|NCT03674827|615811502|FG005|Treatment Phase|Progressive Disease|9|||
170401446|NCT03674827|615811497|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
170401447|NCT03674827|615811498|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
170401448|NCT03674827|615811499|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
170401449|NCT03674827|615811500|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
170401450|NCT03674827|615811501|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
170401451|NCT03674827|615811502|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
170401452|NCT03674827|615811497|FG000|Treatment Phase|Withdrawal by Subject|0|||
170401453|NCT03674827|615811498|FG001|Treatment Phase|Withdrawal by Subject|0|||
170401454|NCT03674827|615811499|FG002|Treatment Phase|Withdrawal by Subject|0|||
170401455|NCT03674827|615811500|FG003|Treatment Phase|Withdrawal by Subject|0|||
170401456|NCT03674827|615811501|FG004|Treatment Phase|Withdrawal by Subject|0|||
170401457|NCT03674827|615811502|FG005|Treatment Phase|Withdrawal by Subject|1|||
170401458|NCT03674827|615811497|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
170401459|NCT03674827|615811498|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
170401460|NCT03674827|615811499|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
170401461|NCT03674827|615811500|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
170401462|NCT03674827|615811501|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
170401463|NCT03674827|615811502|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
170401464|NCT03674827|615811497|FG000|Treatment Phase|Other|0|||
170401465|NCT03674827|615811498|FG001|Treatment Phase|Other|1|||
170401466|NCT03674827|615811499|FG002|Treatment Phase|Other|0|||
170401467|NCT03674827|615811500|FG003|Treatment Phase|Other|0|||
170401468|NCT03674827|615811501|FG004|Treatment Phase|Other|0|||
170401469|NCT03674827|615811502|FG005|Treatment Phase|Other|1|||
170401470|NCT03674827|615811497|FG000|Long-Term Follow-up Phase|Death|2|||
170401471|NCT03674827|615811498|FG001|Long-Term Follow-up Phase|Death|4|||
170401472|NCT03674827|615811499|FG002|Long-Term Follow-up Phase|Death|2|||
170401473|NCT03674827|615811500|FG003|Long-Term Follow-up Phase|Death|3|||
170401474|NCT03674827|615811501|FG004|Long-Term Follow-up Phase|Death|2|||
170401475|NCT03674827|615811502|FG005|Long-Term Follow-up Phase|Death|6|||
170401476|NCT03674827|615811497|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
170401477|NCT03674827|615811498|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
170401478|NCT03674827|615811499|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
170401479|NCT03674827|615811500|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
170401480|NCT03674827|615811501|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
170401481|NCT03674827|615811502|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
170401482|NCT03674827|615811497|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
170401483|NCT03674827|615811498|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
170401484|NCT03674827|615811499|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
170401485|NCT03674827|615811500|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
170401486|NCT03674827|615811501|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
170401487|NCT03674827|615811502|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
170401488|NCT02058368|615811506|FG000|Overall Study|Adverse Event|15|||
170401489|NCT02058368|615811507|FG001|Overall Study|Adverse Event|20|||
170401490|NCT02058368|615811506|FG000|Overall Study|Lack of Efficacy|0|||
170401491|NCT02058368|615811507|FG001|Overall Study|Lack of Efficacy|1|||
170401492|NCT02058368|615811506|FG000|Overall Study|Protocol Violation|0|||
170401493|NCT02058368|615811507|FG001|Overall Study|Protocol Violation|4|||
170401494|NCT02058368|615811506|FG000|Overall Study|Lost to Follow-up|2|||
170401495|NCT02058368|615811507|FG001|Overall Study|Lost to Follow-up|0|||
170401496|NCT02058368|615811506|FG000|Overall Study|Physician Decision|2|||
170401497|NCT02058368|615811507|FG001|Overall Study|Physician Decision|3|||
170401498|NCT02058368|615811506|FG000|Overall Study|Withdrawal by Subject|22|||
170401499|NCT02058368|615811507|FG001|Overall Study|Withdrawal by Subject|26|||
170401500|NCT04529096|615811508|FG000|Overall Study|Adverse Event|6|||
170401501|NCT04529096|615811509|FG001|Overall Study|Adverse Event|1|||
170401502|NCT04529096|615811508|FG000|Overall Study|Lack of Efficacy|1|||
170401503|NCT04529096|615811509|FG001|Overall Study|Lack of Efficacy|0|||
170401504|NCT04529096|615811508|FG000|Overall Study|Lost to Follow-up|1|||
170401505|NCT04529096|615811509|FG001|Overall Study|Lost to Follow-up|1|||
170401506|NCT04529096|615811508|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170401507|NCT04529096|615811509|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170401508|NCT04529096|615811508|FG000|Overall Study|Physician Decision|1|||
170401509|NCT04529096|615811509|FG001|Overall Study|Physician Decision|3|||
170401510|NCT04529096|615811508|FG000|Overall Study|Withdrawal by Subject|5|||
170401511|NCT04529096|615811509|FG001|Overall Study|Withdrawal by Subject|0|||
170401512|NCT01289990|615811510|FG000|Overall Study|Death|0|||
170630329|NCT00129402|616660453|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
170401513|NCT01289990|615811511|FG001|Overall Study|Death|0|||
170401514|NCT01289990|615811512|FG002|Overall Study|Death|0|||
170401515|NCT01289990|615811513|FG003|Overall Study|Death|1|||
170401516|NCT01289990|615811514|FG004|Overall Study|Death|2|||
170401517|NCT01289990|615811515|FG005|Overall Study|Death|1|||
170401518|NCT01289990|615811516|FG006|Overall Study|Death|0|||
170401519|NCT01289990|615811517|FG007|Overall Study|Death|0|||
170861460|NCT01898923|617501855|FG001|Overall Study|Physician Decision|4|||
170630330|NCT00129402|616660454|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
170630331|NCT00129402|616660448|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
170630332|NCT00129402|616660449|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
170630333|NCT00129402|616660450|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
170630334|NCT00129402|616660451|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
170630335|NCT00129402|616660452|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
170630336|NCT00129402|616660453|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
170630337|NCT00129402|616660454|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
170630338|NCT00129402|616660448|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
170630339|NCT00129402|616660449|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
170630340|NCT00129402|616660450|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
170630341|NCT00129402|616660451|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
170630342|NCT00129402|616660452|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
170630343|NCT00129402|616660453|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
170630344|NCT00129402|616660454|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
170630345|NCT00129402|616660448|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
170401520|NCT01289990|615811518|FG008|Overall Study|Death|0|||
170401521|NCT01289990|615811519|FG009|Overall Study|Death|0|||
170630346|NCT00129402|616660449|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
170630347|NCT00129402|616660450|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
170630348|NCT00129402|616660451|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
170630349|NCT00129402|616660452|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
170630350|NCT00129402|616660453|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
170630351|NCT00129402|616660454|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
170630352|NCT00129402|616660448|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
170630353|NCT00129402|616660449|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
170630354|NCT00129402|616660450|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
170630355|NCT00129402|616660451|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
170630356|NCT00129402|616660452|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
170401522|NCT01289990|615811520|FG010|Overall Study|Death|0|||
170401523|NCT01289990|615811521|FG011|Overall Study|Death|1|||
170401524|NCT01289990|615811522|FG012|Overall Study|Death|0|||
170401525|NCT01289990|615811510|FG000|Overall Study|Lost to Follow-up|3|||
170401526|NCT01289990|615811511|FG001|Overall Study|Lost to Follow-up|2|||
170401527|NCT01289990|615811512|FG002|Overall Study|Lost to Follow-up|5|||
170401528|NCT01289990|615811513|FG003|Overall Study|Lost to Follow-up|5|||
170401529|NCT01289990|615811514|FG004|Overall Study|Lost to Follow-up|3|||
170401530|NCT01289990|615811515|FG005|Overall Study|Lost to Follow-up|4|||
170401531|NCT01289990|615811516|FG006|Overall Study|Lost to Follow-up|2|||
170401532|NCT01289990|615811517|FG007|Overall Study|Lost to Follow-up|2|||
170401533|NCT01289990|615811518|FG008|Overall Study|Lost to Follow-up|1|||
170401534|NCT01289990|615811519|FG009|Overall Study|Lost to Follow-up|4|||
170401535|NCT01289990|615811520|FG010|Overall Study|Lost to Follow-up|2|||
170401536|NCT01289990|615811521|FG011|Overall Study|Lost to Follow-up|1|||
170401537|NCT01289990|615811522|FG012|Overall Study|Lost to Follow-up|2|||
170401538|NCT01289990|615811510|FG000|Overall Study|Withdrawal by Subject|15|||
170401539|NCT01289990|615811511|FG001|Overall Study|Withdrawal by Subject|14|||
170401540|NCT01289990|615811512|FG002|Overall Study|Withdrawal by Subject|12|||
170401541|NCT01289990|615811513|FG003|Overall Study|Withdrawal by Subject|13|||
170401542|NCT01289990|615811514|FG004|Overall Study|Withdrawal by Subject|8|||
170401543|NCT01289990|615811515|FG005|Overall Study|Withdrawal by Subject|7|||
170401544|NCT01289990|615811516|FG006|Overall Study|Withdrawal by Subject|13|||
170401545|NCT01289990|615811517|FG007|Overall Study|Withdrawal by Subject|9|||
170401546|NCT01289990|615811518|FG008|Overall Study|Withdrawal by Subject|12|||
170401547|NCT01289990|615811519|FG009|Overall Study|Withdrawal by Subject|13|||
170401548|NCT01289990|615811520|FG010|Overall Study|Withdrawal by Subject|11|||
170401549|NCT01289990|615811521|FG011|Overall Study|Withdrawal by Subject|13|||
170401550|NCT01289990|615811522|FG012|Overall Study|Withdrawal by Subject|16|||
170401551|NCT01289990|615811510|FG000|Overall Study|discontinued in preceding trial|18|||
170401552|NCT01289990|615811511|FG001|Overall Study|discontinued in preceding trial|20|||
170401553|NCT01289990|615811512|FG002|Overall Study|discontinued in preceding trial|41|||
170401554|NCT01289990|615811513|FG003|Overall Study|discontinued in preceding trial|17|||
170401555|NCT01289990|615811514|FG004|Overall Study|discontinued in preceding trial|11|||
170401556|NCT01289990|615811515|FG005|Overall Study|discontinued in preceding trial|12|||
170401557|NCT01289990|615811516|FG006|Overall Study|discontinued in preceding trial|18|||
170401558|NCT01289990|615811517|FG007|Overall Study|discontinued in preceding trial|8|||
170401559|NCT01289990|615811518|FG008|Overall Study|discontinued in preceding trial|17|||
170401560|NCT01289990|615811519|FG009|Overall Study|discontinued in preceding trial|21|||
170401561|NCT01289990|615811520|FG010|Overall Study|discontinued in preceding trial|17|||
170401562|NCT01289990|615811521|FG011|Overall Study|discontinued in preceding trial|17|||
170630357|NCT00129402|616660453|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
170630358|NCT00129402|616660454|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
170630359|NCT00129402|616660448|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
170630360|NCT00129402|616660449|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
170630361|NCT00129402|616660450|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
170630362|NCT00129402|616660451|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
170630363|NCT00129402|616660452|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
170630364|NCT00129402|616660453|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
170630365|NCT00129402|616660454|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
170630366|NCT00129402|616660448|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
170630367|NCT00129402|616660449|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
170630368|NCT00129402|616660450|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
170630369|NCT00129402|616660451|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
170630370|NCT00129402|616660452|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
170630371|NCT00129402|616660453|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
170630372|NCT00129402|616660454|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
170630373|NCT00129402|616660448|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
170630374|NCT00129402|616660449|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
170630375|NCT00129402|616660450|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
170630376|NCT00129402|616660451|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
170630377|NCT00129402|616660452|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
170630378|NCT00129402|616660453|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
170630379|NCT00129402|616660454|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
170630380|NCT00129402|616660448|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
170630381|NCT00129402|616660449|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
170630382|NCT00129402|616660450|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
170630383|NCT00129402|616660451|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
170630384|NCT00129402|616660452|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
170630385|NCT00129402|616660453|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
170630386|NCT00129402|616660454|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
170630387|NCT04798196|616660457|FG000|Overall Study|Lost to Follow-up|3|||
170630388|NCT04798196|616660458|FG001|Overall Study|Lost to Follow-up|1|||
170630389|NCT04798196|616660459|FG002|Overall Study|Lost to Follow-up|3|||
170630390|NCT01249261|616660467|FG000|Overall Study|Withdrawal by Subject|1|||
170630391|NCT01249261|616660468|FG001|Overall Study|Withdrawal by Subject|0|||
170630392|NCT01550003|616660479|FG000|Overall Study|Adverse Event|0|||
170630393|NCT01550003|616660480|FG001|Overall Study|Adverse Event|9|||
170630394|NCT01550003|616660481|FG002|Overall Study|Adverse Event|15|||
170630395|NCT01550003|616660479|FG000|Overall Study|Lack of Efficacy|4|||
170630396|NCT01550003|616660480|FG001|Overall Study|Lack of Efficacy|11|||
170630397|NCT01550003|616660481|FG002|Overall Study|Lack of Efficacy|15|||
170630398|NCT01550003|616660479|FG000|Overall Study|Protocol Violation|0|||
170401563|NCT01289990|615811522|FG012|Overall Study|discontinued in preceding trial|24|||
170401564|NCT01289990|615811510|FG000|Overall Study|did not continue in extension|41|||
170401565|NCT01289990|615811511|FG001|Overall Study|did not continue in extension|45|||
170401566|NCT01289990|615811512|FG002|Overall Study|did not continue in extension|51|||
170401567|NCT01289990|615811513|FG003|Overall Study|did not continue in extension|51|||
170401568|NCT01289990|615811514|FG004|Overall Study|did not continue in extension|48|||
170401569|NCT01289990|615811515|FG005|Overall Study|did not continue in extension|50|||
170401570|NCT01289990|615811516|FG006|Overall Study|did not continue in extension|54|||
170401571|NCT01289990|615811517|FG007|Overall Study|did not continue in extension|36|||
170401572|NCT01289990|615811518|FG008|Overall Study|did not continue in extension|44|||
170401573|NCT01289990|615811519|FG009|Overall Study|did not continue in extension|48|||
170401574|NCT01289990|615811520|FG010|Overall Study|did not continue in extension|45|||
170401575|NCT01289990|615811521|FG011|Overall Study|did not continue in extension|34|||
170401576|NCT01289990|615811522|FG012|Overall Study|did not continue in extension|56|||
170401577|NCT01289990|615811510|FG000|Overall Study|Not treated|0|||
170401578|NCT01289990|615811511|FG001|Overall Study|Not treated|0|||
170401579|NCT01289990|615811512|FG002|Overall Study|Not treated|0|||
170401580|NCT01289990|615811513|FG003|Overall Study|Not treated|0|||
170401581|NCT01289990|615811514|FG004|Overall Study|Not treated|0|||
170401582|NCT01289990|615811515|FG005|Overall Study|Not treated|0|||
170401583|NCT01289990|615811516|FG006|Overall Study|Not treated|1|||
170401584|NCT01289990|615811517|FG007|Overall Study|Not treated|0|||
170401585|NCT01289990|615811518|FG008|Overall Study|Not treated|1|||
170401586|NCT01289990|615811519|FG009|Overall Study|Not treated|0|||
170401587|NCT01289990|615811520|FG010|Overall Study|Not treated|1|||
170401588|NCT01289990|615811521|FG011|Overall Study|Not treated|2|||
170401589|NCT01289990|615811522|FG012|Overall Study|Not treated|0|||
170401590|NCT04529499|615811523|FG000|Overall Study|Withdrawal by Subject|9|||
170401591|NCT04529499|615811524|FG001|Overall Study|Withdrawal by Subject|11|||
170401592|NCT04529499|615811523|FG000|Overall Study|Physician Decision|1|||
170401593|NCT04529499|615811524|FG001|Overall Study|Physician Decision|2|||
170401594|NCT04529499|615811523|FG000|Overall Study|Adverse Event|4|||
170401595|NCT04529499|615811524|FG001|Overall Study|Adverse Event|4|||
170401596|NCT04529499|615811523|FG000|Overall Study|Death|14|||
170401597|NCT04529499|615811524|FG001|Overall Study|Death|11|||
170401598|NCT04529499|615811523|FG000|Overall Study|Lost to Follow-up|1|||
170401599|NCT04529499|615811524|FG001|Overall Study|Lost to Follow-up|1|||
170401600|NCT04529499|615811523|FG000|Overall Study|Others|7|||
170401601|NCT04529499|615811524|FG001|Overall Study|Others|11|||
170401602|NCT01494649|615811525|FG000|Overall Study|Lost to Follow-up|0|||
170401603|NCT01494649|615811526|FG001|Overall Study|Lost to Follow-up|1|||
170401604|NCT03091400|615811527|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
170401605|NCT03091400|615811528|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
170401606|NCT03454672|615811529|FG000|Overall Study|Adverse Event|1|||
170401607|NCT03454672|615811530|FG001|Overall Study|Adverse Event|1|||
170401608|NCT03454672|615811529|FG000|Overall Study|Lost to Follow-up|1|||
170401609|NCT03454672|615811530|FG001|Overall Study|Lost to Follow-up|3|||
170401610|NCT03454672|615811529|FG000|Overall Study|painful|1|||
170401611|NCT03454672|615811530|FG001|Overall Study|painful|2|||
170401612|NCT03454672|615811529|FG000|Overall Study|Non-compliance|2|||
170401613|NCT03454672|615811530|FG001|Overall Study|Non-compliance|4|||
170401614|NCT03454672|615811529|FG000|Overall Study|personal reasons|3|||
170401615|NCT03454672|615811530|FG001|Overall Study|personal reasons|2|||
170401616|NCT03454672|615811529|FG000|Overall Study|Withdrawal by Subject|1|||
170401617|NCT03454672|615811530|FG001|Overall Study|Withdrawal by Subject|0|||
170401618|NCT00420849|615811531|FG000|Overall Study|Lack of Efficacy|154|||
170401619|NCT00420849|615811531|FG000|Overall Study|Adverse Event|107|||
170401620|NCT00420849|615811531|FG000|Overall Study|Withdrawal by Subject|28|||
170401621|NCT00420849|615811531|FG000|Overall Study|Death|18|||
170401622|NCT00420849|615811531|FG000|Overall Study|Other|14|||
170401623|NCT00420849|615811531|FG000|Overall Study|Transplant|8|||
170401624|NCT00420849|615811531|FG000|Overall Study|Protocol Violation|1|||
170401625|NCT00420849|615811531|FG000|Overall Study|Lost to Follow-up|1|||
170401626|NCT00383019|615811532|FG000|Overall Study|Adverse Event|5|||
170401627|NCT00383019|615811533|FG001|Overall Study|Adverse Event|1|||
170401628|NCT00383019|615811532|FG000|Overall Study|Withdrawal by Subject|0|||
170401629|NCT00383019|615811533|FG001|Overall Study|Withdrawal by Subject|1|||
170401630|NCT05789420|615811534|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
170401631|NCT05789420|615811534|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
170401632|NCT02304302|615811535|FG000|Overall Study|Adverse Event|2|||
170401633|NCT02304302|615811536|FG001|Overall Study|Adverse Event|3|||
170401634|NCT02304302|615811535|FG000|Overall Study|Lost to Follow-up|1|||
170401635|NCT02304302|615811536|FG001|Overall Study|Lost to Follow-up|4|||
170401636|NCT02304302|615811535|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
170401637|NCT02304302|615811536|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
170401638|NCT00391118|615811537|FG000|Overall Study|Adverse Event|3|||
170401639|NCT00391118|615811538|FG001|Overall Study|Adverse Event|10|||
170401640|NCT00391118|615811539|FG002|Overall Study|Adverse Event|7|||
170401641|NCT00391118|615811537|FG000|Overall Study|Lost to Follow-up|0|||
170401642|NCT00391118|615811538|FG001|Overall Study|Lost to Follow-up|2|||
170401643|NCT00391118|615811539|FG002|Overall Study|Lost to Follow-up|3|||
170401644|NCT00391118|615811537|FG000|Overall Study|Withdrawal by Subject|0|||
170401645|NCT00391118|615811538|FG001|Overall Study|Withdrawal by Subject|9|||
170401646|NCT00391118|615811539|FG002|Overall Study|Withdrawal by Subject|1|||
170401647|NCT00391118|615811537|FG000|Overall Study|Death|0|||
170401648|NCT00391118|615811538|FG001|Overall Study|Death|1|||
170401649|NCT00391118|615811539|FG002|Overall Study|Death|0|||
170401650|NCT00391118|615811537|FG000|Overall Study|Physician Decision|0|||
170401651|NCT00391118|615811538|FG001|Overall Study|Physician Decision|3|||
170401652|NCT00391118|615811539|FG002|Overall Study|Physician Decision|0|||
170401653|NCT00391118|615811537|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
170401654|NCT00391118|615811538|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
170401655|NCT00391118|615811539|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
170401656|NCT00391118|615811537|FG000|Overall Study|Progressive Disease|7|||
170401657|NCT00391118|615811538|FG001|Overall Study|Progressive Disease|26|||
170401658|NCT00391118|615811539|FG002|Overall Study|Progressive Disease|43|||
170401659|NCT00391118|615811537|FG000|Overall Study|Sponsor Decision|0|||
170401660|NCT00391118|615811538|FG001|Overall Study|Sponsor Decision|1|||
170401661|NCT00391118|615811539|FG002|Overall Study|Sponsor Decision|3|||
170401662|NCT00391118|615811537|FG000|Overall Study|Protocol Violation|1|||
170401663|NCT00391118|615811538|FG001|Overall Study|Protocol Violation|0|||
170401664|NCT00391118|615811539|FG002|Overall Study|Protocol Violation|0|||
170401665|NCT00659581|615811540|FG000|Overall Study|Adverse Event|1006|||
170401666|NCT00659581|615811540|FG000|Overall Study|Lack of Efficacy|1183|||
170401667|NCT00659581|615811540|FG000|Overall Study|Other|6393|||
170401668|NCT01619085|615811544|FG000|Overall Study|Adverse Event|231|||
170401669|NCT01619085|615811544|FG000|Overall Study|Protocol Violation|4|||
170401670|NCT01619085|615811544|FG000|Overall Study|Lost to Follow-up|3|||
170401671|NCT01619085|615811544|FG000|Overall Study|Withdrawal by Subject|45|||
170401672|NCT01619085|615811544|FG000|Overall Study|Other than specified|96|||
170630399|NCT01550003|616660480|FG001|Overall Study|Protocol Violation|3|||
170630400|NCT01550003|616660481|FG002|Overall Study|Protocol Violation|2|||
170630401|NCT01550003|616660479|FG000|Overall Study|Lost to Follow-up|1|||
170630402|NCT01550003|616660480|FG001|Overall Study|Lost to Follow-up|4|||
170401673|NCT01619085|615811544|FG000|Overall Study|Not treated|1|||
170401674|NCT01619085|615811544|FG000|Overall Study|Death|145|||
170401675|NCT05473247|615811545|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
170401676|NCT01831596|615811550|FG000|Overall Study|Other|8|||
170401677|NCT02508649|615811553|FG000|Overall Study|Withdrawal by Subject|4|||
170401678|NCT02508649|615811554|FG001|Overall Study|Withdrawal by Subject|6|||
170401679|NCT02508649|615811555|FG002|Overall Study|Withdrawal by Subject|5|||
170401680|NCT02508649|615811556|FG003|Overall Study|Withdrawal by Subject|6|||
170401681|NCT02508649|615811553|FG000|Overall Study|Investigator withdrew the subject|1|||
170401682|NCT02508649|615811554|FG001|Overall Study|Investigator withdrew the subject|2|||
170401683|NCT02508649|615811555|FG002|Overall Study|Investigator withdrew the subject|1|||
170401684|NCT02508649|615811556|FG003|Overall Study|Investigator withdrew the subject|0|||
170401685|NCT02508649|615811553|FG000|Overall Study|Post randomization screening failure|12|||
170401686|NCT02508649|615811554|FG001|Overall Study|Post randomization screening failure|4|||
170401687|NCT02508649|615811555|FG002|Overall Study|Post randomization screening failure|9|||
170401688|NCT02508649|615811556|FG003|Overall Study|Post randomization screening failure|3|||
170401689|NCT02508649|615811553|FG000|Overall Study|Lost to Follow-up|1|||
170401690|NCT02508649|615811554|FG001|Overall Study|Lost to Follow-up|1|||
170401691|NCT02508649|615811555|FG002|Overall Study|Lost to Follow-up|0|||
170401692|NCT02508649|615811556|FG003|Overall Study|Lost to Follow-up|1|||
170401693|NCT01311505|615811557|FG000|First Intervention Period|Protocol Violation|0|||
170401694|NCT01311505|615811558|FG001|First Intervention Period|Protocol Violation|1|||
170401695|NCT00446134|615811559|FG000|Overall Study|Adverse Event|7|||
170401696|NCT00446134|615811560|FG001|Overall Study|Adverse Event|17|||
170401697|NCT00446134|615811561|FG002|Overall Study|Adverse Event|13|||
170401698|NCT00446134|615811562|FG003|Overall Study|Adverse Event|18|||
170401699|NCT00446134|615811559|FG000|Overall Study|Lack of Efficacy|19|||
170401700|NCT00446134|615811560|FG001|Overall Study|Lack of Efficacy|19|||
170401701|NCT00446134|615811561|FG002|Overall Study|Lack of Efficacy|24|||
170401702|NCT00446134|615811562|FG003|Overall Study|Lack of Efficacy|19|||
170401703|NCT00446134|615811559|FG000|Overall Study|Protocol Violation|0|||
170401704|NCT00446134|615811560|FG001|Overall Study|Protocol Violation|2|||
170401705|NCT00446134|615811561|FG002|Overall Study|Protocol Violation|1|||
170401706|NCT00446134|615811562|FG003|Overall Study|Protocol Violation|0|||
170401707|NCT00446134|615811559|FG000|Overall Study|Lost to Follow-up|1|||
170401708|NCT00446134|615811560|FG001|Overall Study|Lost to Follow-up|3|||
170401709|NCT00446134|615811561|FG002|Overall Study|Lost to Follow-up|1|||
170401710|NCT00446134|615811562|FG003|Overall Study|Lost to Follow-up|1|||
170401711|NCT00446134|615811559|FG000|Overall Study|Withdrawal by Subject|3|||
170401712|NCT00446134|615811560|FG001|Overall Study|Withdrawal by Subject|3|||
170401713|NCT00446134|615811561|FG002|Overall Study|Withdrawal by Subject|1|||
170401714|NCT00446134|615811562|FG003|Overall Study|Withdrawal by Subject|3|||
170401715|NCT00446134|615811559|FG000|Overall Study|Physician Decision|0|||
170401716|NCT00446134|615811560|FG001|Overall Study|Physician Decision|0|||
170401717|NCT00446134|615811561|FG002|Overall Study|Physician Decision|0|||
170401718|NCT00446134|615811562|FG003|Overall Study|Physician Decision|2|||
170401719|NCT00446134|615811559|FG000|Overall Study|Adverse Event-Diarrhea|1|||
170401720|NCT00446134|615811560|FG001|Overall Study|Adverse Event-Diarrhea|1|||
170401721|NCT00446134|615811561|FG002|Overall Study|Adverse Event-Diarrhea|2|||
170401722|NCT00446134|615811562|FG003|Overall Study|Adverse Event-Diarrhea|0|||
170401723|NCT00446134|615811559|FG000|Overall Study|Reason Not Completed|3|||
170401724|NCT00446134|615811560|FG001|Overall Study|Reason Not Completed|0|||
170401725|NCT00446134|615811561|FG002|Overall Study|Reason Not Completed|1|||
170401726|NCT00446134|615811562|FG003|Overall Study|Reason Not Completed|2|||
170401727|NCT02149199|615811570|FG000|Overall Study|Study specific withdrawal criteria|4|||
170401728|NCT02149199|615811571|FG001|Overall Study|Study specific withdrawal criteria|21|||
170401729|NCT02149199|615811572|FG002|Overall Study|Study specific withdrawal criteria|6|||
170401730|NCT02149199|615811570|FG000|Overall Study|Other|20|||
170401731|NCT02149199|615811571|FG001|Overall Study|Other|25|||
170401732|NCT02149199|615811572|FG002|Overall Study|Other|20|||
170401733|NCT02149199|615811570|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
170401734|NCT02149199|615811571|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
170401735|NCT02149199|615811572|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
170401736|NCT02149199|615811570|FG000|Overall Study|Withdrawal by Subject|75|||
170401737|NCT02149199|615811571|FG001|Overall Study|Withdrawal by Subject|93|||
170630403|NCT01550003|616660481|FG002|Overall Study|Lost to Follow-up|8|||
170401738|NCT02149199|615811572|FG002|Overall Study|Withdrawal by Subject|77|||
170401739|NCT02149199|615811570|FG000|Overall Study|Protocol Violation|16|||
170630404|NCT01550003|616660479|FG000|Overall Study|Consent withdrawn|2|||
170630405|NCT01550003|616660480|FG001|Overall Study|Consent withdrawn|11|||
170630406|NCT01550003|616660481|FG002|Overall Study|Consent withdrawn|23|||
170630407|NCT01550003|616660479|FG000|Overall Study|Missing|1|||
170630408|NCT01550003|616660480|FG001|Overall Study|Missing|0|||
170630409|NCT01550003|616660481|FG002|Overall Study|Missing|2|||
170630410|NCT01550003|616660479|FG000|Overall Study|Study closure as announced by sponsor|7|||
170630411|NCT01550003|616660480|FG001|Overall Study|Study closure as announced by sponsor|6|||
170630412|NCT01550003|616660481|FG002|Overall Study|Study closure as announced by sponsor|24|||
170630413|NCT01550003|616660479|FG000|Overall Study|Protocol Noncompliance|1|||
170630414|NCT01550003|616660480|FG001|Overall Study|Protocol Noncompliance|0|||
170630415|NCT01550003|616660481|FG002|Overall Study|Protocol Noncompliance|0|||
170630416|NCT01550003|616660479|FG000|Overall Study|Study closure|0|||
170630417|NCT01550003|616660480|FG001|Overall Study|Study closure|1|||
170745489|NCT01474512|617076108|FG014|Maintenance Period|Adverse Event|0|||
170745490|NCT01474512|617076109|FG015|Maintenance Period|Adverse Event|0|||
170745491|NCT01474512|617076110|FG016|Maintenance Period|Adverse Event|0|||
170745492|NCT01474512|617076111|FG017|Maintenance Period|Adverse Event|0|||
170745493|NCT01474512|617076094|FG000|Maintenance Period|Withdrawal by Subject|0|||
170745494|NCT01474512|617076095|FG001|Maintenance Period|Withdrawal by Subject|0|||
170745495|NCT01474512|617076096|FG002|Maintenance Period|Withdrawal by Subject|0|||
170745496|NCT01474512|617076097|FG003|Maintenance Period|Withdrawal by Subject|6|||
170745497|NCT01474512|617076098|FG004|Maintenance Period|Withdrawal by Subject|2|||
170745498|NCT01474512|617076099|FG005|Maintenance Period|Withdrawal by Subject|3|||
170745499|NCT01474512|617076100|FG006|Maintenance Period|Withdrawal by Subject|1|||
170745500|NCT01474512|617076101|FG007|Maintenance Period|Withdrawal by Subject|6|||
170745501|NCT01474512|617076102|FG008|Maintenance Period|Withdrawal by Subject|3|||
170745502|NCT01474512|617076103|FG009|Maintenance Period|Withdrawal by Subject|1|||
170745503|NCT01474512|617076104|FG010|Maintenance Period|Withdrawal by Subject|0|||
170745504|NCT01474512|617076105|FG011|Maintenance Period|Withdrawal by Subject|0|||
170745505|NCT01474512|617076106|FG012|Maintenance Period|Withdrawal by Subject|0|||
170745506|NCT01474512|617076107|FG013|Maintenance Period|Withdrawal by Subject|0|||
170745507|NCT01474512|617076108|FG014|Maintenance Period|Withdrawal by Subject|0|||
170745508|NCT01474512|617076109|FG015|Maintenance Period|Withdrawal by Subject|0|||
170745509|NCT01474512|617076110|FG016|Maintenance Period|Withdrawal by Subject|0|||
170745510|NCT01474512|617076111|FG017|Maintenance Period|Withdrawal by Subject|0|||
170745511|NCT01474512|617076094|FG000|Maintenance Period|Lost to Follow-up|0|||
170745512|NCT01474512|617076095|FG001|Maintenance Period|Lost to Follow-up|0|||
170745513|NCT01474512|617076096|FG002|Maintenance Period|Lost to Follow-up|0|||
170745514|NCT01474512|617076097|FG003|Maintenance Period|Lost to Follow-up|3|||
170745515|NCT01474512|617076098|FG004|Maintenance Period|Lost to Follow-up|3|||
170745516|NCT01474512|617076099|FG005|Maintenance Period|Lost to Follow-up|0|||
170745517|NCT01474512|617076100|FG006|Maintenance Period|Lost to Follow-up|0|||
170745518|NCT01474512|617076101|FG007|Maintenance Period|Lost to Follow-up|2|||
170745519|NCT01474512|617076102|FG008|Maintenance Period|Lost to Follow-up|1|||
170745520|NCT01474512|617076103|FG009|Maintenance Period|Lost to Follow-up|1|||
170745521|NCT01474512|617076104|FG010|Maintenance Period|Lost to Follow-up|0|||
170745522|NCT01474512|617076105|FG011|Maintenance Period|Lost to Follow-up|0|||
170745523|NCT01474512|617076106|FG012|Maintenance Period|Lost to Follow-up|0|||
170745524|NCT01474512|617076107|FG013|Maintenance Period|Lost to Follow-up|0|||
170745525|NCT01474512|617076108|FG014|Maintenance Period|Lost to Follow-up|0|||
170745526|NCT01474512|617076109|FG015|Maintenance Period|Lost to Follow-up|0|||
170745527|NCT01474512|617076110|FG016|Maintenance Period|Lost to Follow-up|0|||
170745528|NCT01474512|617076111|FG017|Maintenance Period|Lost to Follow-up|0|||
170745529|NCT01474512|617076094|FG000|Maintenance Period|Death|0|||
170745530|NCT01474512|617076095|FG001|Maintenance Period|Death|0|||
170745531|NCT01474512|617076096|FG002|Maintenance Period|Death|0|||
170745532|NCT01474512|617076097|FG003|Maintenance Period|Death|0|||
170745533|NCT01474512|617076098|FG004|Maintenance Period|Death|0|||
170745534|NCT01474512|617076099|FG005|Maintenance Period|Death|2|||
170745535|NCT01474512|617076100|FG006|Maintenance Period|Death|0|||
170745536|NCT01474512|617076101|FG007|Maintenance Period|Death|0|||
170745537|NCT01474512|617076102|FG008|Maintenance Period|Death|0|||
170745538|NCT01474512|617076103|FG009|Maintenance Period|Death|0|||
170745539|NCT01474512|617076104|FG010|Maintenance Period|Death|0|||
170745540|NCT01474512|617076105|FG011|Maintenance Period|Death|0|||
170745541|NCT01474512|617076106|FG012|Maintenance Period|Death|0|||
170745542|NCT01474512|617076107|FG013|Maintenance Period|Death|0|||
170745543|NCT01474512|617076108|FG014|Maintenance Period|Death|0|||
170745544|NCT01474512|617076109|FG015|Maintenance Period|Death|0|||
170630418|NCT01550003|616660481|FG002|Overall Study|Study closure|1|||
170630419|NCT01550003|616660479|FG000|Overall Study|Patient reached adulthood|0|||
170745545|NCT01474512|617076110|FG016|Maintenance Period|Death|0|||
170745546|NCT01474512|617076111|FG017|Maintenance Period|Death|0|||
170745547|NCT01474512|617076094|FG000|Maintenance Period|Physician Decision|0|||
170745548|NCT01474512|617076095|FG001|Maintenance Period|Physician Decision|0|||
170745549|NCT01474512|617076096|FG002|Maintenance Period|Physician Decision|0|||
170745550|NCT01474512|617076097|FG003|Maintenance Period|Physician Decision|0|||
170745551|NCT01474512|617076098|FG004|Maintenance Period|Physician Decision|0|||
170401740|NCT02149199|615811571|FG001|Overall Study|Protocol Violation|13|||
170401741|NCT02149199|615811572|FG002|Overall Study|Protocol Violation|15|||
170401742|NCT02149199|615811570|FG000|Overall Study|Lost to Follow-up|3|||
170401743|NCT02149199|615811571|FG001|Overall Study|Lost to Follow-up|12|||
170401744|NCT02149199|615811572|FG002|Overall Study|Lost to Follow-up|11|||
170401745|NCT02149199|615811570|FG000|Overall Study|Death|0|||
170401746|NCT02149199|615811571|FG001|Overall Study|Death|0|||
170401747|NCT02149199|615811572|FG002|Overall Study|Death|1|||
170401748|NCT02149199|615811570|FG000|Overall Study|Adverse Event|6|||
170401749|NCT02149199|615811571|FG001|Overall Study|Adverse Event|15|||
170401750|NCT02149199|615811572|FG002|Overall Study|Adverse Event|9|||
170401751|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401752|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401753|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401754|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
170401755|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
170401756|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401757|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401758|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401759|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401760|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
170401761|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401762|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401763|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
170401764|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
170401765|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
170401766|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
170401767|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
170401768|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
170401769|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
170401770|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401771|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401772|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401773|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401774|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401775|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
170401776|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401777|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401778|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401779|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
170401780|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401781|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401782|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401783|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
170401784|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
170401785|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
170401786|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
170401787|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
170401788|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
170401789|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
170401790|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401791|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401792|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401793|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170630420|NCT01550003|616660480|FG001|Overall Study|Patient reached adulthood|1|||
170630421|NCT01550003|616660481|FG002|Overall Study|Patient reached adulthood|0|||
170630422|NCT01550003|616660479|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
170630423|NCT01550003|616660480|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
170630424|NCT01550003|616660481|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
170630425|NCT01550003|616660479|FG000|Overall Study|Sponsor's order|0|||
170630426|NCT01550003|616660480|FG001|Overall Study|Sponsor's order|3|||
170630427|NCT01550003|616660481|FG002|Overall Study|Sponsor's order|3|||
170401794|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
170401795|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401796|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401797|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170630428|NCT01550003|616660479|FG000|Overall Study|Sponsor's decision|1|||
170630429|NCT01550003|616660480|FG001|Overall Study|Sponsor's decision|5|||
170401798|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401799|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401800|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401801|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401802|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401803|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
170401804|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401805|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401806|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
170401807|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
170401808|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401809|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401810|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401811|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401812|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401813|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401814|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401815|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401816|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401817|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401818|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
170401819|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401820|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401821|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
170401822|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401823|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401824|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
170401825|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
170401826|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
170401827|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
170401828|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
170401829|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
170401830|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
170401831|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
170401832|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
170401833|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
170401834|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
170401835|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
170401836|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
170401837|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
170401838|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
170401839|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
170401840|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
170401841|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
170401842|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
170401843|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
170401844|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
170401845|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
170401846|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401847|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
170401848|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
170401849|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401850|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401851|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401852|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401853|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
170401854|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
170401855|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
170401856|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401857|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
170401858|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401859|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
170401860|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401861|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
170401862|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
170401863|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
170401864|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
170401865|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401866|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401867|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401868|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401869|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
170401870|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401871|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401872|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401873|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401874|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
170401875|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401876|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401877|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401878|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401879|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401880|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401881|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401882|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401883|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
170401884|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
170401885|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
170401886|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
170401887|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
170401888|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
170401889|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
170401890|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
170401891|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
170401892|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
170401893|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
170401894|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
170401895|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
170401896|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
170401897|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
170401898|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
170401899|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
170401900|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
170401901|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
170401902|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
170401903|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401904|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401905|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401906|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401907|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401908|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401909|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401910|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401911|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401912|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401913|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
170401914|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401915|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401916|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401917|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401918|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401919|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401920|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401921|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
170401922|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
170401923|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
170401924|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
170401925|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
170401926|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
170745552|NCT01474512|617076099|FG005|Maintenance Period|Physician Decision|1|||
170401927|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
170401928|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
170401929|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
170401930|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
170401931|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
170401932|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
170401933|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
170401934|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
170401935|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
170401936|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
170401937|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
170401938|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
170401939|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
170401940|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
170401941|NCT01915498|615811575|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
170401942|NCT01915498|615811576|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
170401943|NCT01915498|615811577|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
170401944|NCT01915498|615811578|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
170401945|NCT01915498|615811579|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
170401946|NCT01915498|615811580|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
170401947|NCT01915498|615811581|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
170401948|NCT01915498|615811582|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
170401949|NCT01915498|615811583|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
170401950|NCT01915498|615811584|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
170401951|NCT01915498|615811585|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
170401952|NCT01915498|615811586|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
170401953|NCT01915498|615811587|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
170401954|NCT01915498|615811588|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
170401955|NCT01915498|615811589|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
170401956|NCT01915498|615811590|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
170401957|NCT01915498|615811591|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
170401958|NCT01915498|615811592|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
170401959|NCT01915498|615811593|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
170401960|NCT01915498|615811575|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401961|NCT01915498|615811576|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401962|NCT01915498|615811577|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401963|NCT01915498|615811578|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401964|NCT01915498|615811579|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401965|NCT01915498|615811580|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401966|NCT01915498|615811581|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401967|NCT01915498|615811582|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401968|NCT01915498|615811583|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401969|NCT01915498|615811584|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401970|NCT01915498|615811585|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401971|NCT01915498|615811586|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401972|NCT01915498|615811587|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401973|NCT01915498|615811588|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401974|NCT01915498|615811589|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401975|NCT01915498|615811590|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401976|NCT01915498|615811591|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401977|NCT01915498|615811592|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
170401978|NCT01915498|615811593|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
170401979|NCT01915498|615811575|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401980|NCT01915498|615811576|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401981|NCT01915498|615811577|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401982|NCT01915498|615811578|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401983|NCT01915498|615811579|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401984|NCT01915498|615811580|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401985|NCT01915498|615811581|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170745553|NCT01474512|617076100|FG006|Maintenance Period|Physician Decision|0|||
170745554|NCT01474512|617076101|FG007|Maintenance Period|Physician Decision|2|||
170401986|NCT01915498|615811582|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401987|NCT01915498|615811583|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401988|NCT01915498|615811584|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401989|NCT01915498|615811585|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401990|NCT01915498|615811586|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401991|NCT01915498|615811587|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401992|NCT01915498|615811588|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401993|NCT01915498|615811589|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401994|NCT01915498|615811590|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401995|NCT01915498|615811591|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401996|NCT01915498|615811592|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
170401997|NCT01915498|615811593|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
170401998|NCT01915498|615811575|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170401999|NCT01915498|615811576|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402000|NCT01915498|615811577|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402001|NCT01915498|615811578|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402002|NCT01915498|615811579|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402003|NCT01915498|615811580|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402004|NCT01915498|615811581|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402005|NCT01915498|615811582|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402006|NCT01915498|615811583|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402007|NCT01915498|615811584|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402008|NCT01915498|615811585|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402009|NCT01915498|615811586|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402010|NCT01915498|615811587|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402011|NCT01915498|615811588|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402012|NCT01915498|615811589|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402013|NCT01915498|615811590|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402014|NCT01915498|615811591|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402015|NCT01915498|615811592|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
170402016|NCT01915498|615811593|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
170402017|NCT02989610|615811596|FG000|Overall Study|Withdrawal by Subject|20|||
170402018|NCT02989610|615811596|FG000|Overall Study|Departure of PI from Site|8|||
170402019|NCT02989610|615811596|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
170402020|NCT02989610|615811596|FG000|Overall Study|Lost to Follow-up|3|||
170402021|NCT02989610|615811596|FG000|Overall Study|Death|3|||
170402022|NCT02989610|615811596|FG000|Overall Study|System Explant|3|||
170402023|NCT02989610|615811596|FG000|Overall Study|Subject Non-Compliance|2|||
170402024|NCT02989610|615811596|FG000|Overall Study|System Revision|2|||
170402025|NCT02989610|615811596|FG000|Overall Study|PI Left, Study Closing|1|||
170402026|NCT02989610|615811596|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
170402027|NCT02989610|615811596|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
170402028|NCT00532779|615811599|FG000|Overall Study|Adverse Event|122|||
170402029|NCT00532779|615811600|FG001|Overall Study|Adverse Event|112|||
170402030|NCT00532779|615811601|FG002|Overall Study|Adverse Event|56|||
170402031|NCT00532779|615811599|FG000|Overall Study|Lost to Follow-up|76|||
170402032|NCT00532779|615811600|FG001|Overall Study|Lost to Follow-up|65|||
170402033|NCT00532779|615811601|FG002|Overall Study|Lost to Follow-up|66|||
170402034|NCT00532779|615811599|FG000|Overall Study|Withdrawal by Subject|63|||
170402035|NCT00532779|615811600|FG001|Overall Study|Withdrawal by Subject|60|||
170402036|NCT00532779|615811601|FG002|Overall Study|Withdrawal by Subject|90|||
170402037|NCT00532779|615811599|FG000|Overall Study|Lack of Efficacy|12|||
170402038|NCT00532779|615811600|FG001|Overall Study|Lack of Efficacy|12|||
170402039|NCT00532779|615811601|FG002|Overall Study|Lack of Efficacy|40|||
170402040|NCT00532779|615811599|FG000|Overall Study|Protocol Violation|5|||
170402041|NCT00532779|615811600|FG001|Overall Study|Protocol Violation|9|||
170402042|NCT00532779|615811601|FG002|Overall Study|Protocol Violation|7|||
170402043|NCT00532779|615811599|FG000|Overall Study|Pregnancy|2|||
170402044|NCT00532779|615811600|FG001|Overall Study|Pregnancy|5|||
170630430|NCT01550003|616660481|FG002|Overall Study|Sponsor's decision|4|||
170630431|NCT01550003|616660479|FG000|Overall Study|Subject mother passed away|0|||
170630432|NCT01550003|616660480|FG001|Overall Study|Subject mother passed away|1|||
170630433|NCT01550003|616660481|FG002|Overall Study|Subject mother passed away|0|||
170630434|NCT01550003|616660479|FG000|Overall Study|Discontinuation|0|||
170630435|NCT01550003|616660480|FG001|Overall Study|Discontinuation|1|||
170630436|NCT01550003|616660481|FG002|Overall Study|Discontinuation|0|||
170630437|NCT01550003|616660479|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
170630438|NCT01550003|616660480|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
170630439|NCT01550003|616660481|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
170402045|NCT00532779|615811601|FG002|Overall Study|Pregnancy|3|||
170402046|NCT00532779|615811599|FG000|Overall Study|Death|0|||
170402047|NCT00532779|615811600|FG001|Overall Study|Death|1|||
170402048|NCT00532779|615811601|FG002|Overall Study|Death|0|||
170402049|NCT00532779|615811599|FG000|Overall Study|Drug noncompliance, moved, other|14|||
170402050|NCT00532779|615811600|FG001|Overall Study|Drug noncompliance, moved, other|23|||
170402051|NCT00532779|615811601|FG002|Overall Study|Drug noncompliance, moved, other|29|||
170402052|NCT00759759|615811602|FG000|Overall Study|didn't return for period 2|1|||
170402053|NCT00759759|615811603|FG001|Overall Study|didn't return for period 2|0|||
170402054|NCT00759759|615811602|FG000|Overall Study|Didn't receive drug in period 2|1|||
170402055|NCT00759759|615811603|FG001|Overall Study|Didn't receive drug in period 2|0|||
170402056|NCT00759759|615811602|FG000|Overall Study|Withdrawal by Subject|2|||
170402057|NCT00759759|615811603|FG001|Overall Study|Withdrawal by Subject|1|||
170402058|NCT02662556|615811604|FG000|Overall Study|Adverse Event|4|||
170402059|NCT02662556|615811604|FG000|Overall Study|Lack of Efficacy|4|||
170402060|NCT02598622|615813297|FG000|Overall Study|Withdrawal by Subject|3|||
170402061|NCT02598622|615813298|FG001|Overall Study|Withdrawal by Subject|0|||
170402062|NCT02598622|615813297|FG000|Overall Study|Physician Decision|3|||
170402063|NCT02598622|615813298|FG001|Overall Study|Physician Decision|0|||
170402064|NCT00681824|615813302|FG000|Overall Study|withdrawn by investigator|0|||
170402065|NCT00681824|615813303|FG001|Overall Study|withdrawn by investigator|0|||
170402066|NCT00681824|615813304|FG002|Overall Study|withdrawn by investigator|1|||
170402067|NCT00681824|615813302|FG000|Overall Study|scheduling conflict|1|||
170402068|NCT00681824|615813303|FG001|Overall Study|scheduling conflict|0|||
170402069|NCT00681824|615813304|FG002|Overall Study|scheduling conflict|0|||
170402070|NCT00681824|615813302|FG000|Overall Study|Death|0|||
170402071|NCT00681824|615813303|FG001|Overall Study|Death|1|||
170402072|NCT00681824|615813304|FG002|Overall Study|Death|0|||
170402073|NCT03724916|615813305|FG000|Overall Study|Withdrawal by Subject|0|||
170402074|NCT03724916|615813306|FG001|Overall Study|Withdrawal by Subject|1|||
170402075|NCT03724916|615813307|FG002|Overall Study|Withdrawal by Subject|1|||
170402076|NCT03724916|615813308|FG003|Overall Study|Withdrawal by Subject|2|||
170402077|NCT03724916|615813305|FG000|Overall Study|Randomized but not Treated|1|||
170402078|NCT03724916|615813306|FG001|Overall Study|Randomized but not Treated|0|||
170402079|NCT03724916|615813307|FG002|Overall Study|Randomized but not Treated|0|||
170402080|NCT03724916|615813308|FG003|Overall Study|Randomized but not Treated|0|||
170402081|NCT02464059|615813314|FG000|Overall Study|Lost to Follow-up|6|||
170402082|NCT00350519|615813328|FG000|Overall Study|Death|0|||
170402083|NCT00350519|615813329|FG001|Overall Study|Death|1|||
170402084|NCT00350519|615813328|FG000|Overall Study|Physician Decision|0|||
170402085|NCT00350519|615813329|FG001|Overall Study|Physician Decision|1|||
170402086|NCT00350519|615813328|FG000|Overall Study|Protocol Violation|1|||
170402087|NCT00350519|615813329|FG001|Overall Study|Protocol Violation|2|||
170402088|NCT00350519|615813328|FG000|Overall Study|Withdrawal by Subject|3|||
170402089|NCT00350519|615813329|FG001|Overall Study|Withdrawal by Subject|2|||
170402090|NCT00736099|615813330|FG000|Overall Study|Adverse Event|61|||
170402091|NCT00736099|615813331|FG001|Overall Study|Adverse Event|18|||
170402092|NCT00736099|615813330|FG000|Overall Study|Protocol Violation|10|||
170402093|NCT00736099|615813331|FG001|Overall Study|Protocol Violation|4|||
170402094|NCT00736099|615813330|FG000|Overall Study|Lost to Follow-up|12|||
170402095|NCT00736099|615813331|FG001|Overall Study|Lost to Follow-up|5|||
170402096|NCT00736099|615813330|FG000|Overall Study|Withdrawal by Subject|42|||
170402097|NCT00736099|615813331|FG001|Overall Study|Withdrawal by Subject|13|||
170402098|NCT00736099|615813330|FG000|Overall Study|Lack of Efficacy|15|||
170402099|NCT00736099|615813331|FG001|Overall Study|Lack of Efficacy|8|||
170402100|NCT00736099|615813330|FG000|Overall Study|Other reason|43|||
170402101|NCT00736099|615813331|FG001|Overall Study|Other reason|10|||
170402102|NCT00948025|615813332|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
170402103|NCT00948025|615813333|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
170402104|NCT00948025|615813332|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
170402105|NCT00948025|615813333|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
170402106|NCT00948025|615813332|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
170402107|NCT00948025|615813333|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
170402108|NCT01637961|615813334|FG000|Overall Study|Ineligible: wrong primary|1|||
170402109|NCT01637961|615813334|FG000|Overall Study|Ineligible: inadequate pathology|1|||
170402110|NCT04006847|615813335|FG000|Overall Study|Product issue|1|||
170402111|NCT03101293|615813339|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
170402112|NCT03101293|615813340|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
170402113|NCT03372369|615813344|FG000|Qualification Period|Withdrawal by Subject|16|||
170402114|NCT03372369|615813345|FG001|Qualification Period|Withdrawal by Subject|13|||
170402115|NCT03372369|615813344|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
170402116|NCT03372369|615813345|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
170402117|NCT03372369|615813344|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
170402118|NCT03372369|615813345|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
170402119|NCT02239601|615813346|FG000|Overall Study|Withdrawal by Subject|3|||
170402120|NCT02239601|615813347|FG001|Overall Study|Withdrawal by Subject|4|||
170402121|NCT02239601|615813346|FG000|Overall Study|Protocol Violation|4|||
170402122|NCT02239601|615813347|FG001|Overall Study|Protocol Violation|2|||
170402123|NCT04682639|615813348|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
170402124|NCT04682639|615813349|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
170402125|NCT04682639|615813350|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
170402126|NCT04682639|615813351|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
170402127|NCT04682639|615813352|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
170402128|NCT04682639|615813348|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
170402129|NCT04682639|615813349|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
170402130|NCT04682639|615813350|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
170402131|NCT04682639|615813351|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170402132|NCT04682639|615813352|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170402133|NCT04682639|615813348|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
170402134|NCT04682639|615813349|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170402135|NCT04682639|615813350|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170402136|NCT04682639|615813351|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170402137|NCT04682639|615813352|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170402138|NCT04682639|615813348|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
170402139|NCT04682639|615813349|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
170402140|NCT04682639|615813350|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
170402141|NCT04682639|615813351|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
170402142|NCT04682639|615813352|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
170402143|NCT04682639|615813348|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
170402144|NCT04682639|615813349|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
170402145|NCT04682639|615813350|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
170402146|NCT04682639|615813351|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
170402147|NCT04682639|615813352|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
170402148|NCT04682639|615813348|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
170402149|NCT04682639|615813349|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
170402150|NCT04682639|615813350|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
170402151|NCT04682639|615813351|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
170402152|NCT04682639|615813352|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
170402153|NCT04682639|615813348|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
170402154|NCT04682639|615813349|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
170402155|NCT04682639|615813350|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
170402156|NCT04682639|615813351|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
170516617|NCT02964338|616236394|FG001|Overall Study|Sponsor terminated study for futility|15|||
170516618|NCT02964338|616236395|FG002|Overall Study|Sponsor terminated study for futility|14|||
170516619|NCT02964338|616236393|FG000|Overall Study|Lack of Efficacy|0|||
170516620|NCT02964338|616236394|FG001|Overall Study|Lack of Efficacy|3|||
170516621|NCT02964338|616236395|FG002|Overall Study|Lack of Efficacy|0|||
170516622|NCT02964338|616236393|FG000|Overall Study|Lost to Follow-up|1|||
170516623|NCT02964338|616236394|FG001|Overall Study|Lost to Follow-up|0|||
170516624|NCT02964338|616236395|FG002|Overall Study|Lost to Follow-up|3|||
170516625|NCT02964338|616236393|FG000|Overall Study|Protocol Violation|0|||
170516626|NCT02964338|616236394|FG001|Overall Study|Protocol Violation|1|||
170516627|NCT02964338|616236395|FG002|Overall Study|Protocol Violation|0|||
170516628|NCT02964338|616236393|FG000|Overall Study|Withdrawal by Subject|1|||
170516629|NCT02964338|616236394|FG001|Overall Study|Withdrawal by Subject|3|||
170516630|NCT02964338|616236395|FG002|Overall Study|Withdrawal by Subject|1|||
170516631|NCT02964338|616236393|FG000|Overall Study|Adverse Event|2|||
170516632|NCT02964338|616236394|FG001|Overall Study|Adverse Event|1|||
170516633|NCT02964338|616236395|FG002|Overall Study|Adverse Event|1|||
170516634|NCT02964338|616236393|FG000|Overall Study|Non-compliant with e-diary|0|||
170516635|NCT02964338|616236394|FG001|Overall Study|Non-compliant with e-diary|1|||
170516636|NCT02964338|616236395|FG002|Overall Study|Non-compliant with e-diary|0|||
170516637|NCT02964338|616236393|FG000|Overall Study|Did not meet criteria|1|||
170516638|NCT02964338|616236394|FG001|Overall Study|Did not meet criteria|0|||
170516639|NCT02964338|616236395|FG002|Overall Study|Did not meet criteria|0|||
170516640|NCT02291029|616236399|FG000|Overall Study|Withdrawal by Subject|0|||
170516641|NCT02291029|616236400|FG001|Overall Study|Withdrawal by Subject|0|||
170516642|NCT02291029|616236401|FG002|Overall Study|Withdrawal by Subject|1|||
170516643|NCT02291029|616236402|FG003|Overall Study|Withdrawal by Subject|0|||
170516644|NCT02291029|616236403|FG004|Overall Study|Withdrawal by Subject|0|||
170516645|NCT02291029|616236404|FG005|Overall Study|Withdrawal by Subject|0|||
170516646|NCT02291029|616236399|FG000|Overall Study|Adverse Event|0|||
170516647|NCT02291029|616236400|FG001|Overall Study|Adverse Event|1|||
170516648|NCT02291029|616236401|FG002|Overall Study|Adverse Event|0|||
170516649|NCT02291029|616236402|FG003|Overall Study|Adverse Event|0|||
170516650|NCT02291029|616236403|FG004|Overall Study|Adverse Event|0|||
170516651|NCT02291029|616236404|FG005|Overall Study|Adverse Event|0|||
170516652|NCT04147247|616236405|FG000|Overall Study|Progressive disease|3|||
170516653|NCT04147247|616236406|FG001|Overall Study|Progressive disease|3|||
170516654|NCT04147247|616236407|FG002|Overall Study|Progressive disease|4|||
170516655|NCT04147247|616236408|FG003|Overall Study|Progressive disease|4|||
170516656|NCT04147247|616236409|FG004|Overall Study|Progressive disease|3|||
170516657|NCT04147247|616236405|FG000|Overall Study|Physician Decision|0|||
170516658|NCT04147247|616236406|FG001|Overall Study|Physician Decision|1|||
170516659|NCT04147247|616236407|FG002|Overall Study|Physician Decision|0|||
170516660|NCT04147247|616236408|FG003|Overall Study|Physician Decision|0|||
170516661|NCT04147247|616236409|FG004|Overall Study|Physician Decision|0|||
170516662|NCT04147247|616236405|FG000|Overall Study|Clinical Disease Progression|0|||
170516663|NCT04147247|616236406|FG001|Overall Study|Clinical Disease Progression|0|||
170516664|NCT04147247|616236407|FG002|Overall Study|Clinical Disease Progression|0|||
170516665|NCT04147247|616236408|FG003|Overall Study|Clinical Disease Progression|0|||
170516666|NCT04147247|616236409|FG004|Overall Study|Clinical Disease Progression|1|||
170516667|NCT04147247|616236405|FG000|Overall Study|Adverse Event|0|||
170516668|NCT04147247|616236406|FG001|Overall Study|Adverse Event|0|||
170516669|NCT04147247|616236407|FG002|Overall Study|Adverse Event|1|||
170516670|NCT04147247|616236408|FG003|Overall Study|Adverse Event|0|||
170516671|NCT04147247|616236409|FG004|Overall Study|Adverse Event|1|||
170516672|NCT01724177|616236410|FG000|Overall Study|Adverse Event|8|||
170516673|NCT01724177|616236410|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
170516674|NCT01724177|616236410|FG000|Overall Study|Nervous participant|1|||
170516675|NCT01724177|616236410|FG000|Overall Study|Serious Adverse Event Related|1|||
170516676|NCT01048541|616236416|FG000|Overall Study|Withdrawal by Subject|1|||
170516677|NCT01048541|616236417|FG001|Overall Study|Withdrawal by Subject|0|||
170516678|NCT00922116|616236418|FG000|Overall Study|Adverse Event|4|||
170516679|NCT00922116|616236418|FG000|Overall Study|Death|1|||
170516680|NCT00922116|616236418|FG000|Overall Study|Lost to Follow-up|1|||
170516681|NCT00922116|616236418|FG000|Overall Study|Withdrawal by Subject|4|||
170516682|NCT00922116|616236418|FG000|Overall Study|Other|5|||
170516683|NCT03060291|616236419|FG000|3-month Follow-up|Declined to respond|8|||
170516684|NCT03060291|616236420|FG001|3-month Follow-up|Declined to respond|10|||
170516685|NCT03060291|616236421|FG002|3-month Follow-up|Declined to respond|2|||
170516686|NCT03060291|616236419|FG000|6-month Follow-up|Declined to respond|7|||
170516687|NCT03060291|616236420|FG001|6-month Follow-up|Declined to respond|13|||
170516688|NCT03060291|616236421|FG002|6-month Follow-up|Declined to respond|4|||
170516689|NCT03060291|616236419|FG000|12-month Follow-up|Declined to respond|7|||
170516690|NCT03060291|616236420|FG001|12-month Follow-up|Declined to respond|16|||
170516691|NCT03060291|616236421|FG002|12-month Follow-up|Declined to respond|6|||
170516692|NCT03193047|616236422|FG000|Overall Study|Physician Decision|1|||
170516693|NCT03193047|616236423|FG001|Overall Study|Physician Decision|0|||
170516694|NCT03193047|616236422|FG000|Overall Study|Participant Left State|1|||
170516695|NCT03193047|616236423|FG001|Overall Study|Participant Left State|0|||
170516696|NCT01509664|616236424|FG000|Overall Study|Lost to Follow-up|15|||
170516697|NCT01509664|616236425|FG001|Overall Study|Lost to Follow-up|21|||
170516698|NCT03665077|616236428|FG000|Overall Study|Lost to Follow-up|2|||
170516699|NCT03665077|616236428|FG000|Overall Study|Physician Decision|2|||
170516700|NCT00996034|616236429|FG000|Overall Study|Lost to Follow-up|2|||
170516701|NCT00996034|616236429|FG000|Overall Study|withdrawn by PI|1|||
170516702|NCT02364388|616236432|FG000|Overall Study|Protocol Violation|1|||
170516703|NCT02364388|616236432|FG000|Overall Study|Technical Failure|3|||
170516704|NCT02364388|616236432|FG000|Overall Study|No OA/US data|2|||
170516705|NCT02364388|616236432|FG000|Overall Study|No Biopsy|2|||
170516706|NCT00941304|616236436|FG000|Overall Study|Lost to Follow-up|1|||
170516707|NCT00941304|616236437|FG001|Overall Study|Lost to Follow-up|0|||
170516708|NCT00941304|616236438|FG002|Overall Study|Lost to Follow-up|0|||
170516709|NCT00941304|616236439|FG003|Overall Study|Lost to Follow-up|0|||
170516710|NCT00941304|616236440|FG004|Overall Study|Lost to Follow-up|0|||
170516711|NCT04004260|616236441|FG000|Overall Study|Withdrawal by Subject|7|||
170516712|NCT04004260|616236442|FG001|Overall Study|Withdrawal by Subject|3|||
170516713|NCT04004260|616236441|FG000|Overall Study|Lost to Follow-up|22|||
170516714|NCT04004260|616236442|FG001|Overall Study|Lost to Follow-up|12|||
170516715|NCT04004260|616236441|FG000|Overall Study|Did not engage in intervention|13|||
170516716|NCT04004260|616236442|FG001|Overall Study|Did not engage in intervention|17|||
170516717|NCT04633226|616236446|FG000|Overall Study|Withdrawal by parent/guardian|4|||
170516718|NCT04633226|616236446|FG000|Overall Study|Randomized by mistake without study treatment|1|||
170516719|NCT01765569|616236448|FG000|Period B|Withdrawal by Subject|1|||
170516720|NCT01765569|616236448|FG000|Period C|Death|1|||
170516721|NCT05415462|616236452|FG000|Overall Study|Death|18|||
170516722|NCT05415462|616236453|FG001|Overall Study|Death|10|||
170516723|NCT05415462|616236452|FG000|Overall Study|Lost to Follow-up|72|||
170516724|NCT05415462|616236453|FG001|Overall Study|Lost to Follow-up|64|||
170516725|NCT05415462|616236452|FG000|Overall Study|Physician Decision|5|||
170516726|NCT05415462|616236453|FG001|Overall Study|Physician Decision|5|||
170516727|NCT05415462|616236452|FG000|Overall Study|Protocol Deviation|1|||
170516728|NCT05415462|616236453|FG001|Overall Study|Protocol Deviation|0|||
170516729|NCT05415462|616236452|FG000|Overall Study|Withdrawal by Subject|129|||
170516730|NCT05415462|616236453|FG001|Overall Study|Withdrawal by Subject|101|||
170516731|NCT05415462|616236452|FG000|Overall Study|Other Than Specified|8|||
170516732|NCT05415462|616236453|FG001|Overall Study|Other Than Specified|8|||
170516733|NCT01030718|616236454|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
170516734|NCT01030718|616236455|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
170516735|NCT01030718|616236456|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
170516736|NCT01030718|616236454|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
170516737|NCT01030718|616236455|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
170516738|NCT01030718|616236456|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
170516739|NCT01030718|616236454|FG000|Studies CA180-031 and -036 Combined|Death|0|||
170516740|NCT01030718|616236455|FG001|Studies CA180-031 and -036 Combined|Death|1|||
170516741|NCT01030718|616236456|FG002|Studies CA180-031 and -036 Combined|Death|0|||
170516742|NCT01030718|616236454|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
170516743|NCT01030718|616236455|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
170516744|NCT01030718|616236456|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
170516745|NCT01030718|616236454|FG000|Study CA180-036 Only|insufficient effect|1|||
170516746|NCT01030718|616236455|FG001|Study CA180-036 Only|insufficient effect|1|||
170516747|NCT01030718|616236456|FG002|Study CA180-036 Only|insufficient effect|5|||
170516748|NCT01030718|616236454|FG000|Study CA180-036 Only|Adverse Event|2|||
170516749|NCT01030718|616236455|FG001|Study CA180-036 Only|Adverse Event|3|||
170516750|NCT01030718|616236456|FG002|Study CA180-036 Only|Adverse Event|0|||
170516751|NCT01030718|616236454|FG000|Study CA180-036 Only|Death|0|||
170516752|NCT01030718|616236455|FG001|Study CA180-036 Only|Death|1|||
170516753|NCT01030718|616236456|FG002|Study CA180-036 Only|Death|0|||
170516754|NCT01030718|616236454|FG000|Study CA180-036 Only|Other Reasons|0|||
170516755|NCT01030718|616236455|FG001|Study CA180-036 Only|Other Reasons|2|||
170516756|NCT01030718|616236456|FG002|Study CA180-036 Only|Other Reasons|0|||
170516757|NCT00423813|616236457|FG000|Overall Study|Adverse Event|11|||
170516758|NCT00423813|616236458|FG001|Overall Study|Adverse Event|30|||
170516759|NCT00423813|616236459|FG002|Overall Study|Adverse Event|40|||
170516760|NCT00423813|616236457|FG000|Overall Study|Withdrawal by Subject|6|||
170516761|NCT00423813|616236458|FG001|Overall Study|Withdrawal by Subject|8|||
170516762|NCT00423813|616236459|FG002|Overall Study|Withdrawal by Subject|5|||
170516763|NCT00423813|616236457|FG000|Overall Study|Lost to Follow-up|5|||
170516764|NCT00423813|616236458|FG001|Overall Study|Lost to Follow-up|4|||
170516765|NCT00423813|616236459|FG002|Overall Study|Lost to Follow-up|4|||
170516766|NCT00423813|616236457|FG000|Overall Study|Lack of Efficacy|23|||
170516767|NCT00423813|616236458|FG001|Overall Study|Lack of Efficacy|18|||
170516768|NCT00423813|616236459|FG002|Overall Study|Lack of Efficacy|19|||
170516769|NCT00423813|616236457|FG000|Overall Study|Physician Decision|2|||
170516770|NCT00423813|616236458|FG001|Overall Study|Physician Decision|0|||
170516771|NCT00423813|616236459|FG002|Overall Study|Physician Decision|0|||
170516772|NCT00423813|616236457|FG000|Overall Study|Sponsor Decision|0|||
170516773|NCT00423813|616236458|FG001|Overall Study|Sponsor Decision|1|||
170516774|NCT00423813|616236459|FG002|Overall Study|Sponsor Decision|0|||
170516775|NCT00423813|616236457|FG000|Overall Study|Protocol Violation|9|||
170516776|NCT00423813|616236458|FG001|Overall Study|Protocol Violation|4|||
170516777|NCT00423813|616236459|FG002|Overall Study|Protocol Violation|4|||
170516778|NCT00423813|616236457|FG000|Overall Study|Pregnancy|0|||
170516779|NCT00423813|616236458|FG001|Overall Study|Pregnancy|0|||
170516780|NCT00423813|616236459|FG002|Overall Study|Pregnancy|1|||
170516781|NCT00423813|616236457|FG000|Overall Study|Subject started night shift work|1|||
170516782|NCT00423813|616236458|FG001|Overall Study|Subject started night shift work|0|||
170516783|NCT00423813|616236459|FG002|Overall Study|Subject started night shift work|0|||
170516784|NCT00423813|616236457|FG000|Overall Study|Will start exclusionary medications|0|||
170516785|NCT00423813|616236458|FG001|Overall Study|Will start exclusionary medications|1|||
170516786|NCT00423813|616236459|FG002|Overall Study|Will start exclusionary medications|0|||
170516787|NCT00423813|616236457|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
170516788|NCT00423813|616236458|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
170516789|NCT00423813|616236459|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
170516790|NCT00420628|616236460|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
170516791|NCT00420628|616236461|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
170516792|NCT00420628|616236460|FG000|Overall Study|Lost to Follow-up|3|||
170516793|NCT00420628|616236461|FG001|Overall Study|Lost to Follow-up|2|||
170516794|NCT00420628|616236460|FG000|Overall Study|Adverse Event|1|||
170516795|NCT00420628|616236461|FG001|Overall Study|Adverse Event|0|||
170516796|NCT02716584|616236462|FG000|Overall Study|Lost to Follow-up|8|||
170516797|NCT02716584|616236463|FG001|Overall Study|Lost to Follow-up|5|||
170516798|NCT00913770|616236473|FG000|Overall Study|Unable to contact|24|||
170516799|NCT00913770|616236474|FG001|Overall Study|Unable to contact|19|||
170516800|NCT00913770|616236475|FG002|Overall Study|Unable to contact|13|||
170516801|NCT00913770|616236473|FG000|Overall Study|Refused|11|||
170516802|NCT00913770|616236474|FG001|Overall Study|Refused|10|||
170516803|NCT00913770|616236475|FG002|Overall Study|Refused|8|||
170516804|NCT02453256|616236479|FG000|Double Blind Period|Death|1|||
170516805|NCT02453256|616236480|FG001|Double Blind Period|Death|1|||
170516806|NCT02453256|616236479|FG000|Double Blind Period|Adverse Event|3|||
170516807|NCT02453256|616236480|FG001|Double Blind Period|Adverse Event|2|||
170516808|NCT02453256|616236479|FG000|Double Blind Period|Withdrawal by Subject|9|||
170516809|NCT02453256|616236480|FG001|Double Blind Period|Withdrawal by Subject|5|||
170516810|NCT02453256|616236479|FG000|Double Blind Period|Other|0|||
170516811|NCT02453256|616236480|FG001|Double Blind Period|Other|1|||
170516812|NCT02453256|616236479|FG000|Open Label Period|Adverse Event|1|||
170516813|NCT02453256|616236480|FG001|Open Label Period|Adverse Event|3|||
170516814|NCT02453256|616236479|FG000|Open Label Period|Death|0|||
170516815|NCT02453256|616236480|FG001|Open Label Period|Death|1|||
170516816|NCT02453256|616236479|FG000|Open Label Period|Lost to Follow-up|1|||
170516817|NCT02453256|616236480|FG001|Open Label Period|Lost to Follow-up|0|||
170516818|NCT02453256|616236479|FG000|Open Label Period|Other|0|||
170516819|NCT02453256|616236480|FG001|Open Label Period|Other|2|||
170516820|NCT02453256|616236479|FG000|Open Label Period|Withdrawal by Subject|5|||
170516821|NCT02453256|616236480|FG001|Open Label Period|Withdrawal by Subject|1|||
170516822|NCT00845676|616236483|FG000|Overall Study|Virologic breakthrough at week 20|1|||
170745555|NCT01474512|617076102|FG008|Maintenance Period|Physician Decision|0|||
170745556|NCT01474512|617076103|FG009|Maintenance Period|Physician Decision|0|||
170745557|NCT01474512|617076104|FG010|Maintenance Period|Physician Decision|0|||
170745558|NCT01474512|617076105|FG011|Maintenance Period|Physician Decision|0|||
170745559|NCT01474512|617076106|FG012|Maintenance Period|Physician Decision|0|||
170745560|NCT01474512|617076107|FG013|Maintenance Period|Physician Decision|0|||
170745561|NCT01474512|617076108|FG014|Maintenance Period|Physician Decision|0|||
170745562|NCT01474512|617076109|FG015|Maintenance Period|Physician Decision|0|||
170745563|NCT01474512|617076110|FG016|Maintenance Period|Physician Decision|0|||
170745564|NCT01474512|617076111|FG017|Maintenance Period|Physician Decision|0|||
170745565|NCT01474512|617076094|FG000|Maintenance Period|Clinical Relapse|0|||
170745566|NCT01474512|617076095|FG001|Maintenance Period|Clinical Relapse|0|||
170745567|NCT01474512|617076096|FG002|Maintenance Period|Clinical Relapse|0|||
170745568|NCT01474512|617076097|FG003|Maintenance Period|Clinical Relapse|1|||
170745569|NCT01474512|617076098|FG004|Maintenance Period|Clinical Relapse|0|||
170745570|NCT01474512|617076099|FG005|Maintenance Period|Clinical Relapse|0|||
170745571|NCT01474512|617076100|FG006|Maintenance Period|Clinical Relapse|0|||
170745572|NCT01474512|617076101|FG007|Maintenance Period|Clinical Relapse|0|||
170745573|NCT01474512|617076102|FG008|Maintenance Period|Clinical Relapse|0|||
170745574|NCT01474512|617076103|FG009|Maintenance Period|Clinical Relapse|0|||
170745575|NCT01474512|617076104|FG010|Maintenance Period|Clinical Relapse|0|||
170745576|NCT01474512|617076105|FG011|Maintenance Period|Clinical Relapse|0|||
170745577|NCT01474512|617076106|FG012|Maintenance Period|Clinical Relapse|0|||
170745578|NCT01474512|617076107|FG013|Maintenance Period|Clinical Relapse|0|||
170745579|NCT01474512|617076108|FG014|Maintenance Period|Clinical Relapse|0|||
170745580|NCT01474512|617076109|FG015|Maintenance Period|Clinical Relapse|0|||
170745581|NCT01474512|617076110|FG016|Maintenance Period|Clinical Relapse|0|||
170745582|NCT01474512|617076111|FG017|Maintenance Period|Clinical Relapse|0|||
170745583|NCT01474512|617076094|FG000|Maintenance Period|Lack of Efficacy|0|||
170745584|NCT01474512|617076095|FG001|Maintenance Period|Lack of Efficacy|0|||
170745585|NCT01474512|617076096|FG002|Maintenance Period|Lack of Efficacy|0|||
170745586|NCT01474512|617076097|FG003|Maintenance Period|Lack of Efficacy|1|||
170745587|NCT01474512|617076098|FG004|Maintenance Period|Lack of Efficacy|0|||
170745588|NCT01474512|617076099|FG005|Maintenance Period|Lack of Efficacy|0|||
170745589|NCT01474512|617076100|FG006|Maintenance Period|Lack of Efficacy|0|||
170745590|NCT01474512|617076101|FG007|Maintenance Period|Lack of Efficacy|11|||
170745591|NCT01474512|617076102|FG008|Maintenance Period|Lack of Efficacy|11|||
170745592|NCT01474512|617076103|FG009|Maintenance Period|Lack of Efficacy|12|||
170745593|NCT01474512|617076104|FG010|Maintenance Period|Lack of Efficacy|0|||
170745594|NCT01474512|617076105|FG011|Maintenance Period|Lack of Efficacy|0|||
170745595|NCT01474512|617076106|FG012|Maintenance Period|Lack of Efficacy|0|||
170745596|NCT01474512|617076107|FG013|Maintenance Period|Lack of Efficacy|0|||
170745597|NCT01474512|617076108|FG014|Maintenance Period|Lack of Efficacy|0|||
170745598|NCT01474512|617076109|FG015|Maintenance Period|Lack of Efficacy|0|||
170745599|NCT01474512|617076110|FG016|Maintenance Period|Lack of Efficacy|0|||
170745600|NCT01474512|617076111|FG017|Maintenance Period|Lack of Efficacy|0|||
170745601|NCT01474512|617076094|FG000|Maintenance Period|Protocol Violation|0|||
170516823|NCT00845676|616236483|FG000|Overall Study|Adverse Event|1|||
170516824|NCT00481767|616236485|FG000|Overall Study|Withdrawal by Subject|16|||
170745602|NCT01474512|617076095|FG001|Maintenance Period|Protocol Violation|0|||
170745603|NCT01474512|617076096|FG002|Maintenance Period|Protocol Violation|0|||
170745604|NCT01474512|617076097|FG003|Maintenance Period|Protocol Violation|1|||
170745605|NCT01474512|617076098|FG004|Maintenance Period|Protocol Violation|0|||
170516825|NCT00481767|616236486|FG001|Overall Study|Withdrawal by Subject|11|||
170516826|NCT00481767|616236485|FG000|Overall Study|Lost to Follow-up|16|||
170516827|NCT00481767|616236486|FG001|Overall Study|Lost to Follow-up|10|||
170516828|NCT00636636|616236487|FG000|Overall Study|Other reason|4|||
170745606|NCT01474512|617076099|FG005|Maintenance Period|Protocol Violation|0|||
170745607|NCT01474512|617076100|FG006|Maintenance Period|Protocol Violation|0|||
170516829|NCT00636636|616236488|FG001|Overall Study|Other reason|6|||
170745608|NCT01474512|617076101|FG007|Maintenance Period|Protocol Violation|1|||
170516830|NCT00636636|616236487|FG000|Overall Study|Adverse Event|19|||
170516831|NCT00636636|616236488|FG001|Overall Study|Adverse Event|8|||
170516832|NCT00636636|616236487|FG000|Overall Study|Lack of Efficacy|7|||
170516833|NCT00636636|616236488|FG001|Overall Study|Lack of Efficacy|12|||
170516834|NCT00636636|616236487|FG000|Overall Study|Protocol Violation|2|||
170516835|NCT00636636|616236488|FG001|Overall Study|Protocol Violation|2|||
170516836|NCT00636636|616236487|FG000|Overall Study|Lost to Follow-up|0|||
170516837|NCT00636636|616236488|FG001|Overall Study|Lost to Follow-up|1|||
170516838|NCT00636636|616236487|FG000|Overall Study|Death|0|||
170516839|NCT00636636|616236488|FG001|Overall Study|Death|1|||
170516840|NCT00636636|616236487|FG000|Overall Study|Withdrawal by Subject|4|||
170516841|NCT00636636|616236488|FG001|Overall Study|Withdrawal by Subject|9|||
170516842|NCT01366638|616236489|FG000|Overall Study|Withdrawal by Subject|0|||
170516843|NCT01366638|616236490|FG001|Overall Study|Withdrawal by Subject|0|||
170516844|NCT01366638|616236491|FG002|Overall Study|Withdrawal by Subject|6|||
170516845|NCT01366638|616236489|FG000|Overall Study|Other|1|||
170516846|NCT01366638|616236490|FG001|Overall Study|Other|0|||
170516847|NCT01366638|616236491|FG002|Overall Study|Other|0|||
170516848|NCT00524173|616236492|FG000|Overall Study|Lost to Follow-up|0|||
170516849|NCT00524173|616236493|FG001|Overall Study|Lost to Follow-up|1|||
170516850|NCT00524173|616236492|FG000|Overall Study|Death|1|||
170516851|NCT00524173|616236493|FG001|Overall Study|Death|0|||
170516852|NCT00524173|616236492|FG000|Overall Study|Had not reached endpoint at study close|4|||
170516853|NCT00524173|616236493|FG001|Overall Study|Had not reached endpoint at study close|1|||
170516854|NCT03300180|616236494|FG000|Baseline|Withdrawal by Subject|4|||
170516855|NCT03300180|616236495|FG001|Baseline|Withdrawal by Subject|6|||
170516856|NCT03300180|616236496|FG002|Baseline|Withdrawal by Subject|4|||
170516857|NCT03300180|616236494|FG000|6 Month Outcome|Withdrawal by Subject|12|||
170516858|NCT03300180|616236495|FG001|6 Month Outcome|Withdrawal by Subject|12|||
170516859|NCT03300180|616236496|FG002|6 Month Outcome|Withdrawal by Subject|19|||
170516860|NCT03300180|616236494|FG000|6 Month Outcome|Death|2|||
170516861|NCT03300180|616236495|FG001|6 Month Outcome|Death|4|||
170516862|NCT03300180|616236496|FG002|6 Month Outcome|Death|3|||
170516863|NCT03300180|616236494|FG000|6 Month Outcome|Missed Assessment|43|||
170516864|NCT03300180|616236495|FG001|6 Month Outcome|Missed Assessment|52|||
170516865|NCT03300180|616236496|FG002|6 Month Outcome|Missed Assessment|46|||
170516866|NCT03300180|616236494|FG000|12 Month Outcome|Withdrawal by Subject|3|||
170516867|NCT03300180|616236495|FG001|12 Month Outcome|Withdrawal by Subject|6|||
170516868|NCT03300180|616236496|FG002|12 Month Outcome|Withdrawal by Subject|6|||
170516869|NCT03300180|616236494|FG000|12 Month Outcome|Death|9|||
170516870|NCT03300180|616236495|FG001|12 Month Outcome|Death|6|||
170516871|NCT03300180|616236496|FG002|12 Month Outcome|Death|6|||
170516872|NCT03300180|616236494|FG000|12 Month Outcome|Missed Assessment|62|||
170516873|NCT03300180|616236495|FG001|12 Month Outcome|Missed Assessment|59|||
170516874|NCT03300180|616236496|FG002|12 Month Outcome|Missed Assessment|58|||
170516875|NCT03300180|616236494|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
170516876|NCT03300180|616236495|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
170516877|NCT03300180|616236496|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
170516878|NCT03300180|616236494|FG000|18 Month Outcome Assessment|Death|8|||
170516879|NCT03300180|616236495|FG001|18 Month Outcome Assessment|Death|5|||
170516880|NCT03300180|616236496|FG002|18 Month Outcome Assessment|Death|5|||
170516881|NCT03300180|616236494|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
170516882|NCT03300180|616236495|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
170516883|NCT03300180|616236496|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
170516884|NCT03300180|616236494|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
170516885|NCT03300180|616236495|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
170516886|NCT03300180|616236496|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
170516887|NCT03300180|616236494|FG000|24 Month Outcome Assessment|Death|13|||
170516888|NCT03300180|616236495|FG001|24 Month Outcome Assessment|Death|13|||
170516889|NCT03300180|616236496|FG002|24 Month Outcome Assessment|Death|3|||
170516890|NCT03300180|616236494|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
170516891|NCT03300180|616236495|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
170516892|NCT03300180|616236496|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
170516893|NCT00248833|616236502|FG000|Overall Study|Adverse Event|2|||
170516894|NCT00248833|616236503|FG001|Overall Study|Adverse Event|0|||
170516895|NCT00248833|616236504|FG002|Overall Study|Adverse Event|0|||
170516896|NCT00248833|616236502|FG000|Overall Study|Withdrawal by Subject|0|||
170516897|NCT00248833|616236503|FG001|Overall Study|Withdrawal by Subject|1|||
170516898|NCT00248833|616236504|FG002|Overall Study|Withdrawal by Subject|1|||
170516899|NCT00248833|616236502|FG000|Overall Study|Lost to Follow-up|1|||
170516900|NCT00248833|616236503|FG001|Overall Study|Lost to Follow-up|1|||
170516901|NCT00248833|616236504|FG002|Overall Study|Lost to Follow-up|1|||
170516902|NCT00248833|616236502|FG000|Overall Study|Other|0|||
170516903|NCT00248833|616236503|FG001|Overall Study|Other|1|||
170516904|NCT00248833|616236504|FG002|Overall Study|Other|0|||
170516905|NCT01554163|616236505|FG000|Overall Study|Adverse Event|3|||
170516906|NCT01554163|616236506|FG001|Overall Study|Adverse Event|0|||
170516907|NCT01554163|616236505|FG000|Overall Study|Lack of Efficacy|1|||
170516908|NCT01554163|616236506|FG001|Overall Study|Lack of Efficacy|0|||
170516909|NCT01554163|616236505|FG000|Overall Study|Lost to Follow-up|1|||
170516910|NCT01554163|616236506|FG001|Overall Study|Lost to Follow-up|0|||
170516911|NCT01554163|616236505|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170516912|NCT01554163|616236506|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170516913|NCT01554163|616236505|FG000|Overall Study|Protocol Violation|0|||
170516914|NCT01554163|616236506|FG001|Overall Study|Protocol Violation|4|||
170516915|NCT01554163|616236505|FG000|Overall Study|Withdrawal by Subject|1|||
170516916|NCT01554163|616236506|FG001|Overall Study|Withdrawal by Subject|5|||
170516917|NCT01554163|616236505|FG000|Overall Study|Not Treated|1|||
170516918|NCT01554163|616236506|FG001|Overall Study|Not Treated|0|||
170516919|NCT01941537|616236507|FG000|Overall Study|Lack of Efficacy|1|||
170516920|NCT01941537|616236508|FG001|Overall Study|Lack of Efficacy|2|||
170516921|NCT01941537|616236507|FG000|Overall Study|Lost to Follow-up|1|||
170516922|NCT01941537|616236508|FG001|Overall Study|Lost to Follow-up|0|||
170516923|NCT01941537|616236507|FG000|Overall Study|Pregnancy|1|||
170516924|NCT01941537|616236508|FG001|Overall Study|Pregnancy|0|||
170516925|NCT01941537|616236507|FG000|Overall Study|Adverse Event|1|||
170516926|NCT01941537|616236508|FG001|Overall Study|Adverse Event|0|||
170516927|NCT01941537|616236507|FG000|Overall Study|Withdrawal by Subject|0|||
170516928|NCT01941537|616236508|FG001|Overall Study|Withdrawal by Subject|1|||
170516929|NCT02634983|616236510|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
170516930|NCT02634983|616236511|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
170516931|NCT01243177|616236512|FG000|Overall Study|Lack of Efficacy|47|||
170516932|NCT01243177|616236513|FG001|Overall Study|Lack of Efficacy|31|||
170516933|NCT01243177|616236512|FG000|Overall Study|Protocol Violation|11|||
170516934|NCT01243177|616236513|FG001|Overall Study|Protocol Violation|10|||
170516935|NCT01243177|616236512|FG000|Overall Study|Lost to Follow-up|15|||
170516936|NCT01243177|616236513|FG001|Overall Study|Lost to Follow-up|18|||
170516937|NCT01243177|616236512|FG000|Overall Study|Withdrawal by Subject|46|||
170516938|NCT01243177|616236513|FG001|Overall Study|Withdrawal by Subject|38|||
170516939|NCT01243177|616236512|FG000|Overall Study|AE, serious fatal|0|||
170516940|NCT01243177|616236513|FG001|Overall Study|AE, serious fatal|1|||
170516941|NCT01243177|616236512|FG000|Overall Study|SAE, non-fatal|7|||
170516942|NCT01243177|616236513|FG001|Overall Study|SAE, non-fatal|9|||
170516943|NCT01243177|616236512|FG000|Overall Study|AE, non-serious non-fatal|40|||
170516944|NCT01243177|616236513|FG001|Overall Study|AE, non-serious non-fatal|58|||
170516945|NCT01243177|616236512|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
170516946|NCT01243177|616236513|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
170516947|NCT01243177|616236512|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
170516948|NCT01243177|616236513|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
170516949|NCT01243177|616236512|FG000|Overall Study|Other Reason|11|||
170516950|NCT01243177|616236513|FG001|Overall Study|Other Reason|12|||
170516951|NCT02624947|616237985|FG000|Maternal Participants|Adverse Event|5|||
170516952|NCT02624947|616237986|FG001|Maternal Participants|Adverse Event|0|||
170516953|NCT02624947|616237985|FG000|Maternal Participants|Investigator Decision|5|||
170516954|NCT02624947|616237986|FG001|Maternal Participants|Investigator Decision|3|||
170516955|NCT02624947|616237985|FG000|Maternal Participants|Lost to Follow-up|54|||
170516956|NCT02624947|616237986|FG001|Maternal Participants|Lost to Follow-up|24|||
170516957|NCT02624947|616237985|FG000|Maternal Participants|Non Compliance|8|||
170516958|NCT02624947|616237986|FG001|Maternal Participants|Non Compliance|5|||
170516959|NCT02624947|616237985|FG000|Maternal Participants|Sponsor Request|1|||
170516960|NCT02624947|616237986|FG001|Maternal Participants|Sponsor Request|1|||
170516961|NCT02624947|616237985|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
170516962|NCT02624947|616237986|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
170516963|NCT02624947|616237985|FG000|Maternal Participants|Miscellaneous|23|||
170516964|NCT02624947|616237986|FG001|Maternal Participants|Miscellaneous|15|||
170516965|NCT02624947|616237985|FG000|Infant Participants|Adverse Event|18|||
170516966|NCT02624947|616237986|FG001|Infant Participants|Adverse Event|11|||
170516967|NCT02624947|616237985|FG000|Infant Participants|Investigator Decision|5|||
170516968|NCT02624947|616237986|FG001|Infant Participants|Investigator Decision|4|||
170516969|NCT02624947|616237985|FG000|Infant Participants|Lost to Follow-up|93|||
170516970|NCT02624947|616237986|FG001|Infant Participants|Lost to Follow-up|58|||
170516971|NCT02624947|616237985|FG000|Infant Participants|Non Compliance|17|||
170516972|NCT02624947|616237986|FG001|Infant Participants|Non Compliance|7|||
170516973|NCT02624947|616237985|FG000|Infant Participants|Sponsor Request|0|||
170516974|NCT02624947|616237986|FG001|Infant Participants|Sponsor Request|1|||
170516975|NCT02624947|616237985|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
170516976|NCT02624947|616237986|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
170516977|NCT02624947|616237985|FG000|Infant Participants|Miscellaneous|50|||
170516978|NCT02624947|616237986|FG001|Infant Participants|Miscellaneous|26|||
170516979|NCT03654729|616237991|FG000|Overall Study|Death|9|||
170516980|NCT03654729|616237992|FG001|Overall Study|Death|9|||
170516981|NCT03654729|616237993|FG002|Overall Study|Death|16|||
170516982|NCT03654729|616237991|FG000|Overall Study|Withdrawal by Subject|8|||
170516983|NCT03654729|616237992|FG001|Overall Study|Withdrawal by Subject|6|||
170516984|NCT03654729|616237993|FG002|Overall Study|Withdrawal by Subject|4|||
170630440|NCT01550003|616660479|FG000|Overall Study|Site closure|0|||
170516985|NCT03654729|616237991|FG000|Overall Study|Study terminated by Sponsor|3|||
170516986|NCT03654729|616237992|FG001|Overall Study|Study terminated by Sponsor|5|||
170516987|NCT03654729|616237993|FG002|Overall Study|Study terminated by Sponsor|4|||
170516988|NCT03654729|616237991|FG000|Overall Study|Not reported|2|||
170516989|NCT03654729|616237992|FG001|Overall Study|Not reported|4|||
170516990|NCT03654729|616237993|FG002|Overall Study|Not reported|5|||
170516991|NCT03654729|616237991|FG000|Overall Study|Progressive disease|3|||
170516992|NCT03654729|616237992|FG001|Overall Study|Progressive disease|0|||
170516993|NCT03654729|616237993|FG002|Overall Study|Progressive disease|0|||
170516994|NCT03654729|616237991|FG000|Overall Study|Lost to Follow-up|2|||
170516995|NCT03654729|616237992|FG001|Overall Study|Lost to Follow-up|0|||
170516996|NCT03654729|616237993|FG002|Overall Study|Lost to Follow-up|0|||
170516997|NCT03654729|616237991|FG000|Overall Study|Physician Decision|2|||
170516998|NCT03654729|616237992|FG001|Overall Study|Physician Decision|0|||
170516999|NCT03654729|616237993|FG002|Overall Study|Physician Decision|0|||
170517000|NCT03654729|616237991|FG000|Overall Study|Protocol Violation|1|||
170517001|NCT03654729|616237992|FG001|Overall Study|Protocol Violation|1|||
170517002|NCT03654729|616237993|FG002|Overall Study|Protocol Violation|0|||
170517003|NCT03654729|616237991|FG000|Overall Study|Non-compliance with study drug|0|||
170517004|NCT03654729|616237992|FG001|Overall Study|Non-compliance with study drug|1|||
170517005|NCT03654729|616237993|FG002|Overall Study|Non-compliance with study drug|0|||
170517006|NCT03654729|616237991|FG000|Overall Study|Site terminated by Sponsor|1|||
170517007|NCT03654729|616237992|FG001|Overall Study|Site terminated by Sponsor|0|||
170517008|NCT03654729|616237993|FG002|Overall Study|Site terminated by Sponsor|0|||
170517009|NCT00588146|616237994|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
170517010|NCT00588146|616237995|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
170517011|NCT00327340|616237999|FG000|Overall Study|Withdrawal by Subject|1|||
170517012|NCT00327340|616238000|FG001|Overall Study|Withdrawal by Subject|5|||
170517013|NCT00327340|616237999|FG000|Overall Study|Physician Decision|1|||
170517014|NCT00327340|616238000|FG001|Overall Study|Physician Decision|1|||
170517015|NCT00327340|616237999|FG000|Overall Study|Disease Progression|10|||
170517016|NCT00327340|616238000|FG001|Overall Study|Disease Progression|19|||
170517017|NCT00327340|616237999|FG000|Overall Study|Symptomatic Disease|0|||
170517018|NCT00327340|616238000|FG001|Overall Study|Symptomatic Disease|2|||
170517019|NCT00327340|616237999|FG000|Overall Study|Adverse Event|3|||
170517020|NCT00327340|616238000|FG001|Overall Study|Adverse Event|3|||
170517021|NCT04085601|616238003|FG000|Overall Study|Lost to Follow-up|1|||
170517022|NCT04085601|616238004|FG001|Overall Study|Lost to Follow-up|0|||
170517023|NCT04085601|616238003|FG000|Overall Study|Death|1|||
170517024|NCT04085601|616238004|FG001|Overall Study|Death|1|||
170517025|NCT00206427|616238005|FG000|Overall Study|Adverse Event|2|||
170517026|NCT03492437|616238006|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170517027|NCT03492437|616238007|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170517028|NCT03872843|616238009|FG000|Overall Study|Lost to Follow-up|5|||
170517029|NCT03872843|616238010|FG001|Overall Study|Lost to Follow-up|7|||
170517030|NCT00823264|616238011|FG000|Overall Study|Protocol Violation|2|||
170517031|NCT00823264|616238012|FG001|Overall Study|Protocol Violation|0|||
170517032|NCT00856999|616238013|FG000|Overall Study|Withdrawal by Subject|5|||
170517033|NCT00003483|616238017|FG000|Overall Study|Not evaluable|1|||
170517034|NCT02609386|616238018|FG000|Overall Study|Withdrawal by Subject|6|||
170517035|NCT02609386|616238019|FG001|Overall Study|Withdrawal by Subject|1|||
170517036|NCT02609386|616238018|FG000|Overall Study|Lost to Follow-up|3|||
170517037|NCT02609386|616238019|FG001|Overall Study|Lost to Follow-up|5|||
170517038|NCT02609386|616238018|FG000|Overall Study|Death|19|||
170517039|NCT02609386|616238019|FG001|Overall Study|Death|9|||
170517040|NCT02609386|616238018|FG000|Overall Study|Physician Decision|0|||
170517041|NCT02609386|616238019|FG001|Overall Study|Physician Decision|2|||
170517042|NCT02907463|616238027|FG000|Overall Study|Lost to Follow-up|17|||
170517043|NCT02907463|616238027|FG000|Overall Study|Death|10|||
170517044|NCT02907463|616238027|FG000|Overall Study|Withdrawal by Subject|4|||
170517045|NCT02907463|616238027|FG000|Overall Study|MIS Approach was not used|2|||
170517046|NCT02907463|616238027|FG000|Overall Study|Not Implanted with Study Device|2|||
170745609|NCT01474512|617076102|FG008|Maintenance Period|Protocol Violation|0|||
170517047|NCT02907463|616238027|FG000|Overall Study|Device Explanted|1|||
170517048|NCT02907463|616238027|FG000|Overall Study|Missing Exit Form|1|||
170517049|NCT01266824|616238028|FG000|Overall Study|Study terminated prior to completion|2|||
170517050|NCT01266824|616238029|FG001|Overall Study|Study terminated prior to completion|3|||
170517051|NCT00397189|616238030|FG000|3 Weeks Period|Lost to Follow-up|5|||
170517052|NCT00397189|616238031|FG001|3 Weeks Period|Lost to Follow-up|4|||
170517053|NCT00397189|616238030|FG000|3 Weeks Period|Adverse Event|3|||
170745610|NCT01474512|617076103|FG009|Maintenance Period|Protocol Violation|1|||
170517054|NCT00397189|616238031|FG001|3 Weeks Period|Adverse Event|2|||
170517055|NCT00397189|616238030|FG000|3 Weeks Period|Withdrawal by Subject|13|||
170517056|NCT00397189|616238031|FG001|3 Weeks Period|Withdrawal by Subject|9|||
170517057|NCT00397189|616238030|FG000|3 Weeks Period|Physician Decision|0|||
170517058|NCT00397189|616238031|FG001|3 Weeks Period|Physician Decision|2|||
170517059|NCT00397189|616238030|FG000|3 Weeks Period|Protocol Violation|0|||
170517060|NCT00397189|616238031|FG001|3 Weeks Period|Protocol Violation|3|||
170517061|NCT00397189|616238030|FG000|3 Weeks Period|Other|0|||
170517062|NCT00397189|616238031|FG001|3 Weeks Period|Other|2|||
170517063|NCT01447407|616238032|FG000|Overall Study|Withdrawal by Subject|2|||
170517064|NCT01447407|616238033|FG001|Overall Study|Withdrawal by Subject|0|||
170517065|NCT01447407|616238034|FG002|Overall Study|Withdrawal by Subject|0|||
170517066|NCT01447407|616238035|FG003|Overall Study|Withdrawal by Subject|1|||
170517067|NCT01447407|616238032|FG000|Overall Study|Physician Decision|0|||
170517068|NCT01447407|616238033|FG001|Overall Study|Physician Decision|0|||
170517069|NCT01447407|616238034|FG002|Overall Study|Physician Decision|1|||
170517070|NCT01447407|616238035|FG003|Overall Study|Physician Decision|1|||
170517071|NCT00872521|616238038|FG000|Completed PAD Induction|Patient choice|0|||
170517072|NCT00872521|616238039|FG001|Completed PAD Induction|Patient choice|1|||
170517073|NCT00872521|616238040|FG002|Completed PAD Induction|Patient choice|0|||
170517074|NCT00872521|616238038|FG000|Completed PAD Induction|Disease progression|0|||
170517075|NCT00872521|616238039|FG001|Completed PAD Induction|Disease progression|2|||
170517076|NCT00872521|616238040|FG002|Completed PAD Induction|Disease progression|0|||
170517077|NCT00872521|616238038|FG000|Completed PAD Induction|Adverse Event|4|||
170517078|NCT00872521|616238039|FG001|Completed PAD Induction|Adverse Event|0|||
170517079|NCT00872521|616238040|FG002|Completed PAD Induction|Adverse Event|0|||
170517080|NCT00872521|616238038|FG000|Completed PAD Induction|Death|1|||
170517081|NCT00872521|616238039|FG001|Completed PAD Induction|Death|1|||
170517082|NCT00872521|616238040|FG002|Completed PAD Induction|Death|0|||
170517083|NCT00872521|616238038|FG000|Primary Endpoint Analysis|Other|1|||
170517084|NCT00872521|616238039|FG001|Primary Endpoint Analysis|Other|2|||
170517085|NCT00872521|616238040|FG002|Primary Endpoint Analysis|Other|0|||
170517086|NCT00872521|616238038|FG000|Primary Endpoint Analysis|Patient choice|0|||
170517087|NCT00872521|616238039|FG001|Primary Endpoint Analysis|Patient choice|1|||
170517088|NCT00872521|616238040|FG002|Primary Endpoint Analysis|Patient choice|0|||
170517089|NCT00872521|616238038|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
170517090|NCT00872521|616238039|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
170517091|NCT00872521|616238040|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
170517092|NCT00872521|616238038|FG000|Primary Endpoint Analysis|Patient response missing|0|||
170517093|NCT00872521|616238039|FG001|Primary Endpoint Analysis|Patient response missing|0|||
170517094|NCT00872521|616238040|FG002|Primary Endpoint Analysis|Patient response missing|1|||
170517095|NCT00872521|616238038|FG000|Completed 3-month Follow up|Other|0|||
170517096|NCT00872521|616238039|FG001|Completed 3-month Follow up|Other|2|||
170517097|NCT00872521|616238040|FG002|Completed 3-month Follow up|Other|0|||
170517098|NCT00872521|616238038|FG000|Completed 3-month Follow up|Physician Decision|0|||
170517099|NCT00872521|616238039|FG001|Completed 3-month Follow up|Physician Decision|1|||
170517100|NCT00872521|616238040|FG002|Completed 3-month Follow up|Physician Decision|0|||
170517101|NCT00872521|616238038|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
170517102|NCT00872521|616238039|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
170517103|NCT00872521|616238040|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
170517104|NCT03990051|616238044|FG000|Masked Period|Lost to Follow-up|1|||
170517105|NCT03990051|616238045|FG001|Masked Period|Lost to Follow-up|0|||
170517106|NCT03990051|616238044|FG000|Long Term Period|Death|1|||
170517107|NCT03990051|616238045|FG001|Long Term Period|Death|1|||
170517108|NCT03990051|616238044|FG000|Long Term Period|Lost to Follow-up|7|||
170517109|NCT03990051|616238045|FG001|Long Term Period|Lost to Follow-up|2|||
170517110|NCT00837967|616238054|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
170517111|NCT00837967|616238055|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
170517112|NCT01210222|616238056|FG000|Overall Study|Ineligible|2|||
170517113|NCT01210222|616238056|FG000|Overall Study|Never treated|1|||
170517114|NCT03293394|616238057|FG000|Follow-up (6 Months)|Adverse Event|4|||
170517115|NCT03293394|616238058|FG001|Follow-up (6 Months)|Adverse Event|2|||
170517116|NCT00320788|616238059|FG000|Overall Study|Adverse Event|0|||
170517117|NCT00320788|616238060|FG001|Overall Study|Adverse Event|0|||
170517118|NCT00320788|616238061|FG002|Overall Study|Adverse Event|0|||
170517119|NCT00320788|616238062|FG003|Overall Study|Adverse Event|1|||
170517120|NCT00320788|616238063|FG004|Overall Study|Adverse Event|0|||
170517121|NCT00320788|616238059|FG000|Overall Study|Death|0|||
170517122|NCT00320788|616238060|FG001|Overall Study|Death|0|||
170517123|NCT00320788|616238061|FG002|Overall Study|Death|1|||
170517124|NCT00320788|616238062|FG003|Overall Study|Death|0|||
170517125|NCT00320788|616238063|FG004|Overall Study|Death|1|||
170517126|NCT00320788|616238059|FG000|Overall Study|Lost to Follow-up|0|||
170517127|NCT00320788|616238060|FG001|Overall Study|Lost to Follow-up|2|||
170517128|NCT00320788|616238061|FG002|Overall Study|Lost to Follow-up|1|||
170517129|NCT00320788|616238062|FG003|Overall Study|Lost to Follow-up|0|||
170517130|NCT00320788|616238063|FG004|Overall Study|Lost to Follow-up|0|||
170517131|NCT00320788|616238059|FG000|Overall Study|Decision by the Sponsor|1|||
170517132|NCT00320788|616238060|FG001|Overall Study|Decision by the Sponsor|1|||
170517133|NCT00320788|616238061|FG002|Overall Study|Decision by the Sponsor|0|||
170517134|NCT00320788|616238062|FG003|Overall Study|Decision by the Sponsor|0|||
170517135|NCT00320788|616238063|FG004|Overall Study|Decision by the Sponsor|1|||
170517136|NCT00320788|616238059|FG000|Overall Study|Other|1|||
170517137|NCT00320788|616238060|FG001|Overall Study|Other|2|||
170517138|NCT00320788|616238061|FG002|Overall Study|Other|1|||
170517139|NCT00320788|616238062|FG003|Overall Study|Other|1|||
170517140|NCT00320788|616238063|FG004|Overall Study|Other|1|||
170517141|NCT00320788|616238059|FG000|Overall Study|Physician Decision|1|||
170517142|NCT00320788|616238060|FG001|Overall Study|Physician Decision|1|||
170517143|NCT00320788|616238061|FG002|Overall Study|Physician Decision|0|||
170517144|NCT00320788|616238062|FG003|Overall Study|Physician Decision|0|||
170517145|NCT00320788|616238063|FG004|Overall Study|Physician Decision|0|||
170517146|NCT00320788|616238059|FG000|Overall Study|Protocol Violation|0|||
170517147|NCT00320788|616238060|FG001|Overall Study|Protocol Violation|0|||
170517148|NCT00320788|616238061|FG002|Overall Study|Protocol Violation|0|||
170517149|NCT00320788|616238062|FG003|Overall Study|Protocol Violation|0|||
170517150|NCT00320788|616238063|FG004|Overall Study|Protocol Violation|1|||
170517151|NCT00320788|616238059|FG000|Overall Study|Withdrawal by Subject|3|||
170517152|NCT00320788|616238060|FG001|Overall Study|Withdrawal by Subject|0|||
170517153|NCT00320788|616238061|FG002|Overall Study|Withdrawal by Subject|0|||
170517154|NCT00320788|616238062|FG003|Overall Study|Withdrawal by Subject|3|||
170517155|NCT00320788|616238063|FG004|Overall Study|Withdrawal by Subject|1|||
170517156|NCT01189461|616238066|FG000|Overall Study|Lack of Efficacy|13|||
170517157|NCT01189461|616238066|FG000|Overall Study|Lost to Follow-up|1|||
170517158|NCT01189461|616238066|FG000|Overall Study|Withdrawal by Subject|6|||
170517159|NCT01189461|616238066|FG000|Overall Study|Protocol Violation|1|||
170517160|NCT01189461|616238066|FG000|Overall Study|Adverse Event|2|||
170517161|NCT01189461|616238066|FG000|Overall Study|Did not meet entrance criteria|3|||
170517162|NCT01189461|616238066|FG000|Overall Study|Other|8|||
170517163|NCT00184093|616238074|FG000|Overall Study|Adverse Event|3|||
170517164|NCT00184093|616238074|FG000|Overall Study|Lost to Follow-up|3|||
170517165|NCT00184093|616238074|FG000|Overall Study|Physician Decision|1|||
170517166|NCT00184093|616238074|FG000|Overall Study|Withdrawal by Subject|2|||
170517167|NCT01903993|616238075|FG000|Overall Study|Death|118|||
170517168|NCT01903993|616238076|FG001|Overall Study|Death|121|||
170517169|NCT01903993|616238075|FG000|Overall Study|Withdrawal by Subject|15|||
170517170|NCT01903993|616238076|FG001|Overall Study|Withdrawal by Subject|4|||
170517171|NCT01903993|616238075|FG000|Overall Study|Lost to Follow-up|2|||
170517172|NCT01903993|616238076|FG001|Overall Study|Lost to Follow-up|3|||
170517173|NCT01903993|616238075|FG000|Overall Study|Study Terminated by Sponsor|8|||
170517174|NCT01903993|616238076|FG001|Overall Study|Study Terminated by Sponsor|14|||
170517175|NCT01903993|616238075|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
170517176|NCT01903993|616238076|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
170517177|NCT05095311|616238077|FG000|Overall Study|Lost to Follow-up|7|||
170517178|NCT05095311|616238078|FG001|Overall Study|Lost to Follow-up|0|||
170517179|NCT05095311|616238079|FG002|Overall Study|Lost to Follow-up|0|||
170517180|NCT03283930|616238080|FG000|Overall Study|Scheduling conflict|8|||
170517181|NCT03283930|616238081|FG001|Overall Study|Scheduling conflict|10|||
170517182|NCT03283930|616238080|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
170517183|NCT03283930|616238081|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
170517184|NCT03283930|616238080|FG000|Overall Study|Technical software issue|2|||
170517185|NCT03283930|616238081|FG001|Overall Study|Technical software issue|2|||
170517186|NCT03681184|616238082|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
170517187|NCT03681184|616238083|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
170517188|NCT02385110|616238086|FG000|Overall Study|Early Death|1|||
170517189|NCT02385110|616238087|FG001|Overall Study|Early Death|0|||
170517190|NCT00534638|616238088|FG000|Overall Study|Withdrawal by Subject|3|||
170517191|NCT00534638|616238089|FG001|Overall Study|Withdrawal by Subject|4|||
170517192|NCT00534638|616238088|FG000|Overall Study|Migrated/moved from study area|13|||
170517193|NCT00534638|616238089|FG001|Overall Study|Migrated/moved from study area|11|||
170517194|NCT00534638|616238088|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
170517195|NCT00534638|616238089|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
170517196|NCT00534638|616238088|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
170517197|NCT00534638|616238089|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
170517198|NCT00534638|616238088|FG000|Overall Study|Other|1685|||
170630441|NCT01550003|616660480|FG001|Overall Study|Site closure|2|||
170517199|NCT00534638|616238089|FG001|Overall Study|Other|902|||
170517200|NCT02500719|616238090|FG000|Overall Study|Lost to Follow-up|2|||
170517201|NCT02500719|616238091|FG001|Overall Study|Lost to Follow-up|3|||
170517202|NCT02500719|616238090|FG000|Overall Study|Trauma history|1|||
170517203|NCT02500719|616238091|FG001|Overall Study|Trauma history|0|||
170517204|NCT02500719|616238090|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
170517205|NCT02500719|616238091|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
170517206|NCT02500719|616238090|FG000|Overall Study|Did not meet criteria for PTSD|0|||
170517207|NCT02500719|616238091|FG001|Overall Study|Did not meet criteria for PTSD|1|||
170517208|NCT02500719|616238090|FG000|Overall Study|Claustrophobia|0|||
170517209|NCT02500719|616238091|FG001|Overall Study|Claustrophobia|1|||
170517210|NCT02500719|616238090|FG000|Overall Study|History of head trauma|0|||
170517211|NCT02500719|616238091|FG001|Overall Study|History of head trauma|1|||
170517212|NCT02787083|616238092|FG000|Overall Study|Adverse Event|1|||
170517213|NCT02787083|616238093|FG001|Overall Study|Adverse Event|0|||
170517214|NCT02787083|616238092|FG000|Overall Study|Withdrawal by Subject|2|||
170517215|NCT02787083|616238093|FG001|Overall Study|Withdrawal by Subject|2|||
170517216|NCT02710084|616238096|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
170517217|NCT02710084|616238097|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
170517218|NCT00282152|616238098|FG000|Overall Study|Withdrawal by Subject|1|||
170517219|NCT00282152|616238099|FG001|Overall Study|Withdrawal by Subject|0|||
170517220|NCT03301831|616238100|FG000|Overall Study|Lost to Follow-up|5|||
170517221|NCT03301831|616238101|FG001|Overall Study|Lost to Follow-up|3|||
170517222|NCT03301831|616238100|FG000|Overall Study|Protocol Violation|4|||
170517223|NCT03301831|616238101|FG001|Overall Study|Protocol Violation|0|||
170517224|NCT03301831|616238100|FG000|Overall Study|Withdrawal by Subject|11|||
170517225|NCT03301831|616238101|FG001|Overall Study|Withdrawal by Subject|0|||
170517226|NCT00585325|616238102|FG000|Overall Study|Withdrawal by Subject|1|||
170517227|NCT00585325|616238103|FG001|Overall Study|Withdrawal by Subject|1|||
170517228|NCT00154375|616238104|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
170517229|NCT00154375|616238105|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
170517230|NCT00154375|616238104|FG000|Overall Study|Adverse Event|18|||
170517231|NCT00154375|616238105|FG001|Overall Study|Adverse Event|20|||
170517232|NCT00154375|616238104|FG000|Overall Study|Withdrawal by Subject|14|||
170517233|NCT00154375|616238105|FG001|Overall Study|Withdrawal by Subject|10|||
170517234|NCT00154375|616238104|FG000|Overall Study|Death|5|||
170517235|NCT00154375|616238105|FG001|Overall Study|Death|13|||
170517236|NCT00154375|616238104|FG000|Overall Study|Study drug no longer required|5|||
170517237|NCT00154375|616238105|FG001|Overall Study|Study drug no longer required|3|||
170517238|NCT00154375|616238104|FG000|Overall Study|Lost to Follow-up|2|||
170517239|NCT00154375|616238105|FG001|Overall Study|Lost to Follow-up|1|||
170517240|NCT00154375|616238104|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170517241|NCT00154375|616238105|FG001|Overall Study|Abnormal laboratory value(s)|2|||
170517242|NCT00154375|616238104|FG000|Overall Study|Protocol Violation|0|||
170517243|NCT00154375|616238105|FG001|Overall Study|Protocol Violation|1|||
170517244|NCT00154375|616238104|FG000|Overall Study|Suspected progression of disease|44|||
170517245|NCT00154375|616238105|FG001|Overall Study|Suspected progression of disease|30|||
170517246|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
170517247|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
170517248|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
170517249|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
170517250|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
170517251|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
170517252|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
170517253|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
170517254|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
170517255|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
170517256|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
170517257|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
170517258|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
170517259|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
170517260|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
170517261|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
170517262|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
170517263|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
170517264|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
170517265|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
170517266|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
170517267|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
170517268|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
170517269|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
170517270|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
170517271|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
170517272|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
170517273|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
170517274|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
170517275|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
170517276|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
170517277|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
170517278|NCT03538691|616238106|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
170517279|NCT03538691|616238107|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
170630442|NCT01550003|616660481|FG002|Overall Study|Site closure|0|||
170517280|NCT03538691|616238108|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
170517281|NCT03538691|616238109|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
170517282|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
170517283|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
170517284|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
170517285|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
170517286|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
170517287|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
170517288|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
170517289|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
170517290|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
170517291|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
170517292|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
170517293|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
170517294|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
170517295|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
170517296|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
170517297|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
170517298|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
170517299|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
170517300|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
170517301|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
170517302|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
170517303|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
170517304|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
170517305|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
170517306|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
170517307|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
170517308|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
170517309|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
170517310|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
170517311|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
170517312|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
170517313|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
170517314|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
170517315|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
170517316|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
170517317|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
170517318|NCT03538691|616238106|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
170517319|NCT03538691|616238107|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
170517320|NCT03538691|616238108|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
170517321|NCT03538691|616238109|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
170517322|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
170517323|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
170517324|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
170517325|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
170517326|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
170517327|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
170517328|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
170517329|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
170517330|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
170517331|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
170517332|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
170517333|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
170745611|NCT01474512|617076104|FG010|Maintenance Period|Protocol Violation|0|||
170745612|NCT01474512|617076105|FG011|Maintenance Period|Protocol Violation|0|||
170745613|NCT01474512|617076106|FG012|Maintenance Period|Protocol Violation|0|||
170745614|NCT01474512|617076107|FG013|Maintenance Period|Protocol Violation|0|||
170745615|NCT01474512|617076108|FG014|Maintenance Period|Protocol Violation|0|||
170745616|NCT01474512|617076109|FG015|Maintenance Period|Protocol Violation|0|||
170745617|NCT01474512|617076110|FG016|Maintenance Period|Protocol Violation|0|||
170745618|NCT01474512|617076111|FG017|Maintenance Period|Protocol Violation|0|||
170745619|NCT01474512|617076094|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
170517334|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
170517335|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
170517336|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
170517337|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
170517338|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
170517339|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
170745620|NCT01474512|617076095|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
170517340|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
170517341|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
170517342|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
170517343|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
170517344|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
170517345|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
170517346|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
170517347|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
170517348|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
170517349|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
170517350|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
170517351|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
170517352|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
170630443|NCT01550003|616660479|FG000|Overall Study|Pregnancy|0|||
170630444|NCT01550003|616660480|FG001|Overall Study|Pregnancy|1|||
170630445|NCT01550003|616660481|FG002|Overall Study|Pregnancy|0|||
170630446|NCT01550003|616660479|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
170630447|NCT01550003|616660480|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
170630448|NCT01550003|616660481|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
170630449|NCT01550003|616660479|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
170630450|NCT01550003|616660480|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
170630451|NCT01550003|616660481|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
170630452|NCT01550003|616660479|FG000|Overall Study|Switching to adult rheumatologist|0|||
170630453|NCT01550003|616660480|FG001|Overall Study|Switching to adult rheumatologist|0|||
170630454|NCT01550003|616660481|FG002|Overall Study|Switching to adult rheumatologist|1|||
170630455|NCT01550003|616660479|FG000|Overall Study|Patient transition to adult care|0|||
170630456|NCT01550003|616660480|FG001|Overall Study|Patient transition to adult care|0|||
170630457|NCT01550003|616660481|FG002|Overall Study|Patient transition to adult care|1|||
170630458|NCT01550003|616660479|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
170630459|NCT01550003|616660480|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
170630460|NCT01550003|616660481|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
170630461|NCT01550003|616660479|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
170630462|NCT01550003|616660480|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
170630463|NCT01550003|616660481|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
170630464|NCT01550003|616660479|FG000|Overall Study|Per Sponsor request|1|||
170630465|NCT01550003|616660480|FG001|Overall Study|Per Sponsor request|0|||
170630466|NCT01550003|616660481|FG002|Overall Study|Per Sponsor request|1|||
170630467|NCT01550003|616660479|FG000|Overall Study|Patient not compliance|0|||
170630468|NCT01550003|616660480|FG001|Overall Study|Patient not compliance|0|||
170630469|NCT01550003|616660481|FG002|Overall Study|Patient not compliance|1|||
170630470|NCT01550003|616660479|FG000|Overall Study|Non-compliance|0|||
170630471|NCT01550003|616660480|FG001|Overall Study|Non-compliance|0|||
170630472|NCT01550003|616660481|FG002|Overall Study|Non-compliance|1|||
170630473|NCT01550003|616660479|FG000|Overall Study|Study closed|0|||
170630474|NCT01550003|616660480|FG001|Overall Study|Study closed|1|||
170630475|NCT01550003|616660481|FG002|Overall Study|Study closed|0|||
170630476|NCT01550003|616660479|FG000|Overall Study|Transitioned to adult rheumatology|0|||
170630477|NCT01550003|616660480|FG001|Overall Study|Transitioned to adult rheumatology|0|||
170630478|NCT01550003|616660481|FG002|Overall Study|Transitioned to adult rheumatology|1|||
170630479|NCT01436149|616660482|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
170630480|NCT01436149|616660483|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
170630481|NCT01436149|616660484|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
170630482|NCT01436149|616660482|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
170630483|NCT01436149|616660483|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
170630484|NCT01436149|616660484|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
170630485|NCT01436149|616660482|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
170630486|NCT01436149|616660483|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
170630487|NCT01436149|616660484|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
170745621|NCT01474512|617076096|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
170517353|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
170517354|NCT03538691|616238106|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
170517355|NCT03538691|616238107|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
170517356|NCT03538691|616238108|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
170517357|NCT03538691|616238109|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
170517358|NCT00792116|616238112|FG000|Overall Study|Lost to Follow-up|0|||
170517359|NCT00792116|616238113|FG001|Overall Study|Lost to Follow-up|1|||
170517360|NCT00792116|616238112|FG000|Overall Study|Discontnued intervention|1|||
170517361|NCT00792116|616238113|FG001|Overall Study|Discontnued intervention|0|||
170517362|NCT01124292|616238114|FG000|Overall Study|Lost to Follow-up|2|||
170517363|NCT01124292|616238115|FG001|Overall Study|Lost to Follow-up|4|||
170906106|NCT03430310|617658617|FG000|Overall Study|COVID shutdown March 2020|0|||
170517364|NCT01124292|616238116|FG002|Overall Study|Lost to Follow-up|3|||
170517365|NCT01124292|616238114|FG000|Overall Study|Physician Decision|0|||
170630488|NCT01436149|616660482|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
170630489|NCT01436149|616660483|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
170630490|NCT01436149|616660484|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
170630491|NCT01436149|616660482|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
170630492|NCT01436149|616660483|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
170630493|NCT01436149|616660484|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
170630494|NCT01436149|616660482|FG000|Antidepressant Lead-in Phase|Other|119|||
170630495|NCT01436149|616660483|FG001|Antidepressant Lead-in Phase|Other|0|||
170630496|NCT01436149|616660484|FG002|Antidepressant Lead-in Phase|Other|0|||
170630497|NCT01436149|616660482|FG000|Randomized Phase|Adverse Event|9|||
170630498|NCT01436149|616660483|FG001|Randomized Phase|Adverse Event|10|||
170630499|NCT01436149|616660484|FG002|Randomized Phase|Adverse Event|11|||
170630500|NCT01436149|616660482|FG000|Randomized Phase|Protocol Violation|4|||
170630501|NCT01436149|616660483|FG001|Randomized Phase|Protocol Violation|5|||
170630502|NCT01436149|616660484|FG002|Randomized Phase|Protocol Violation|0|||
170517366|NCT01124292|616238115|FG001|Overall Study|Physician Decision|3|||
170517367|NCT01124292|616238116|FG002|Overall Study|Physician Decision|2|||
170517368|NCT01124292|616238114|FG000|Overall Study|Withdrawal by Subject|0|||
170517369|NCT01124292|616238115|FG001|Overall Study|Withdrawal by Subject|6|||
170517370|NCT01124292|616238116|FG002|Overall Study|Withdrawal by Subject|2|||
170517371|NCT01124292|616238114|FG000|Overall Study|medical issue unrelated to the study|0|||
170517372|NCT01124292|616238115|FG001|Overall Study|medical issue unrelated to the study|0|||
170517373|NCT01124292|616238116|FG002|Overall Study|medical issue unrelated to the study|2|||
170517374|NCT01124292|616238114|FG000|Overall Study|piercing track closed|0|||
170517375|NCT01124292|616238115|FG001|Overall Study|piercing track closed|2|||
170517376|NCT01124292|616238116|FG002|Overall Study|piercing track closed|1|||
170517377|NCT02557516|616238117|FG000|Overall Study|Adverse Event|1|||
170517378|NCT02557516|616238118|FG001|Overall Study|Adverse Event|0|||
170517379|NCT02557516|616238119|FG002|Overall Study|Adverse Event|2|||
170517380|NCT02557516|616238120|FG003|Overall Study|Adverse Event|1|||
170517381|NCT02557516|616238117|FG000|Overall Study|Disease progression|0|||
170630503|NCT01436149|616660482|FG000|Randomized Phase|Withdrawal by Subject|16|||
170630504|NCT01436149|616660483|FG001|Randomized Phase|Withdrawal by Subject|10|||
170630505|NCT01436149|616660484|FG002|Randomized Phase|Withdrawal by Subject|10|||
170630506|NCT01436149|616660482|FG000|Randomized Phase|Lost to Follow-up|34|||
170517382|NCT02557516|616238118|FG001|Overall Study|Disease progression|2|||
170517383|NCT02557516|616238119|FG002|Overall Study|Disease progression|0|||
170517384|NCT02557516|616238120|FG003|Overall Study|Disease progression|0|||
170517385|NCT02557516|616238117|FG000|Overall Study|Physician Decision|0|||
170517386|NCT02557516|616238118|FG001|Overall Study|Physician Decision|2|||
170517387|NCT02557516|616238119|FG002|Overall Study|Physician Decision|0|||
170517388|NCT02557516|616238120|FG003|Overall Study|Physician Decision|0|||
170517389|NCT02557516|616238117|FG000|Overall Study|Sponsor decision|0|||
170517390|NCT02557516|616238118|FG001|Overall Study|Sponsor decision|1|||
170517391|NCT02557516|616238119|FG002|Overall Study|Sponsor decision|2|||
170517392|NCT02557516|616238120|FG003|Overall Study|Sponsor decision|8|||
170517393|NCT02100839|616239921|FG000|Multiple Ascending Dose|Adverse Event|2|||
170517394|NCT02100839|616239922|FG001|Multiple Ascending Dose|Adverse Event|0|||
170517395|NCT02100839|616239921|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
170517396|NCT02100839|616239922|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
170517397|NCT03272347|616239924|FG000|Overall Study|Death|0|||
170517398|NCT03272347|616239925|FG001|Overall Study|Death|0|||
170517399|NCT03272347|616239926|FG002|Overall Study|Death|0|||
170517400|NCT03272347|616239927|FG003|Overall Study|Death|1|||
170517401|NCT03272347|616239924|FG000|Overall Study|Lost to Follow-up|1|||
170630507|NCT01436149|616660483|FG001|Randomized Phase|Lost to Follow-up|5|||
170630508|NCT01436149|616660484|FG002|Randomized Phase|Lost to Follow-up|6|||
170630509|NCT01436149|616660482|FG000|Randomized Phase|Lack of Efficacy|0|||
170517402|NCT03272347|616239925|FG001|Overall Study|Lost to Follow-up|3|||
170517403|NCT03272347|616239926|FG002|Overall Study|Lost to Follow-up|5|||
170517404|NCT03272347|616239927|FG003|Overall Study|Lost to Follow-up|1|||
170517405|NCT03272347|616239924|FG000|Overall Study|Physician Decision|4|||
170517406|NCT03272347|616239925|FG001|Overall Study|Physician Decision|2|||
170517407|NCT03272347|616239926|FG002|Overall Study|Physician Decision|5|||
170517408|NCT03272347|616239927|FG003|Overall Study|Physician Decision|4|||
170517409|NCT03272347|616239924|FG000|Overall Study|Screen Failure|1|||
170517410|NCT03272347|616239925|FG001|Overall Study|Screen Failure|0|||
170517411|NCT03272347|616239926|FG002|Overall Study|Screen Failure|0|||
170517412|NCT03272347|616239927|FG003|Overall Study|Screen Failure|0|||
170517413|NCT03272347|616239924|FG000|Overall Study|Withdrawal by Subject|5|||
170517414|NCT03272347|616239925|FG001|Overall Study|Withdrawal by Subject|1|||
170517415|NCT03272347|616239926|FG002|Overall Study|Withdrawal by Subject|2|||
170517416|NCT03272347|616239927|FG003|Overall Study|Withdrawal by Subject|1|||
170517417|NCT01971567|616239929|FG000|Overall Study|Withdrawal by Subject|3|||
170517418|NCT01971567|616239930|FG001|Overall Study|Withdrawal by Subject|2|||
170517419|NCT01971567|616239929|FG000|Overall Study|Lost to Follow-up|1|||
170517420|NCT01971567|616239930|FG001|Overall Study|Lost to Follow-up|0|||
170517421|NCT00391872|616239931|FG000|Overall Study|Protocol Violation|7|||
170517422|NCT00391872|616239932|FG001|Overall Study|Protocol Violation|2|||
170517423|NCT00391872|616239931|FG000|Overall Study|Withdrawal by Subject|296|||
170517424|NCT00391872|616239932|FG001|Overall Study|Withdrawal by Subject|249|||
170517425|NCT00391872|616239931|FG000|Overall Study|Reason unknown|2|||
170517426|NCT00391872|616239932|FG001|Overall Study|Reason unknown|4|||
170517427|NCT00391872|616239931|FG000|Overall Study|Lost to Follow-up|2|||
170517428|NCT00391872|616239932|FG001|Overall Study|Lost to Follow-up|0|||
170517429|NCT04826484|616239933|FG000|Overall Study|Lost to Follow-up|2|||
170517430|NCT04826484|616239934|FG001|Overall Study|Lost to Follow-up|0|||
170517431|NCT00103662|616239939|FG000|Overall Study|Entered Rescue Procedure|0|||
170517432|NCT00103662|616239940|FG001|Overall Study|Entered Rescue Procedure|7|||
170517433|NCT00103662|616239939|FG000|Overall Study|Death|7|||
170517434|NCT00103662|616239940|FG001|Overall Study|Death|7|||
170517435|NCT00103662|616239939|FG000|Overall Study|Elective Withdrawal|5|||
170517436|NCT00103662|616239940|FG001|Overall Study|Elective Withdrawal|5|||
170517437|NCT00103662|616239939|FG000|Overall Study|Lost to Follow-up|0|||
170517438|NCT00103662|616239940|FG001|Overall Study|Lost to Follow-up|1|||
170517439|NCT00103662|616239939|FG000|Overall Study|Other|6|||
170517440|NCT00103662|616239940|FG001|Overall Study|Other|9|||
170517441|NCT00103662|616239939|FG000|Overall Study|Failed mobilization|0|||
170517442|NCT00103662|616239940|FG001|Overall Study|Failed mobilization|4|||
170517443|NCT00103662|616239939|FG000|Overall Study|Intercurrent illness|1|||
170517444|NCT00103662|616239940|FG001|Overall Study|Intercurrent illness|0|||
170517445|NCT00003537|616239941|FG000|Overall Study|Not evalauable|1|||
170517446|NCT01001520|616239942|FG000|Medication Period 1|Withdrawal by Subject|2|||
170517447|NCT01001520|616239943|FG001|Medication Period 1|Withdrawal by Subject|2|||
170517448|NCT01001520|616239942|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
170517449|NCT01001520|616239943|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
170517450|NCT01001520|616239942|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
170517451|NCT01001520|616239943|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
170517452|NCT01001520|616239942|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
170517453|NCT01001520|616239943|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
170517454|NCT01001520|616239942|FG000|Washout Period|Withdrawal by Subject|2|||
170517455|NCT01001520|616239943|FG001|Washout Period|Withdrawal by Subject|1|||
170517456|NCT01001520|616239942|FG000|Medication Period 2|Withdrawal by Subject|0|||
170517457|NCT01001520|616239943|FG001|Medication Period 2|Withdrawal by Subject|3|||
170517458|NCT02302846|616239947|FG000|Overall Study|Withdrawal by Subject|1|||
170517459|NCT00369915|616239948|FG000|Overall Study|expected side effects|2|||
170517460|NCT00369915|616239949|FG001|Overall Study|expected side effects|1|||
170517461|NCT00369915|616239948|FG000|Overall Study|Withdrawal by Subject|4|||
170517462|NCT00369915|616239949|FG001|Overall Study|Withdrawal by Subject|1|||
170517463|NCT00369915|616239948|FG000|Overall Study|W/drawl by investigators|0|||
170517464|NCT00369915|616239949|FG001|Overall Study|W/drawl by investigators|1|||
170517465|NCT05225558|616239955|FG000|Overall Study|Withdrawal by Subject|4|||
170517466|NCT05225558|616239956|FG001|Overall Study|Withdrawal by Subject|3|||
170517467|NCT05225558|616239955|FG000|Overall Study|Adverse Event|1|||
170517468|NCT05225558|616239956|FG001|Overall Study|Adverse Event|0|||
170517469|NCT05225558|616239955|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
170517470|NCT05225558|616239956|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
170517471|NCT05225558|616239955|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
170517472|NCT05225558|616239956|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
170517473|NCT01896193|616239957|FG000|Overall Study|Lack of Efficacy|20|||
170517474|NCT01896193|616239958|FG001|Overall Study|Lack of Efficacy|11|||
170517475|NCT01896193|616239957|FG000|Overall Study|Protocol Violation|0|||
170517476|NCT01896193|616239958|FG001|Overall Study|Protocol Violation|1|||
170517477|NCT01896193|616239957|FG000|Overall Study|Withdrew Consent|1|||
170517478|NCT01896193|616239958|FG001|Overall Study|Withdrew Consent|0|||
170630510|NCT01436149|616660483|FG001|Randomized Phase|Lack of Efficacy|0|||
170630511|NCT01436149|616660484|FG002|Randomized Phase|Lack of Efficacy|1|||
170630512|NCT01436149|616660482|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
170517479|NCT02592447|616239961|FG000|Overall Study|Lost to Follow-up|1|||
170517480|NCT02592447|616239962|FG001|Overall Study|Lost to Follow-up|0|||
170517481|NCT02592447|616239961|FG000|Overall Study|Ineligible after randomization|1|||
170517482|NCT02592447|616239962|FG001|Overall Study|Ineligible after randomization|0|||
170517483|NCT02592447|616239961|FG000|Overall Study|Withdrawal by Subject|0|||
170517484|NCT02592447|616239962|FG001|Overall Study|Withdrawal by Subject|1|||
170517485|NCT02258659|616239963|FG000|Overall Study|Withdrawal by Subject|1|||
170517486|NCT01411852|616239964|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
170517487|NCT01411852|616239965|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
170517488|NCT01411852|616239964|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
170517489|NCT01411852|616239965|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
170517490|NCT01411852|616239964|FG000|Prehospital Intervention Phase|Found to be under age|0|||
170517491|NCT01411852|616239965|FG001|Prehospital Intervention Phase|Found to be under age|1|||
170517492|NCT01411852|616239964|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
170517493|NCT01411852|616239965|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
170517494|NCT01411852|616239964|FG000|Hospital Intervention Phase|Severe head injury|5|||
170517495|NCT01411852|616239965|FG001|Hospital Intervention Phase|Severe head injury|4|||
170517496|NCT01411852|616239964|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
170517497|NCT01411852|616239965|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
170517498|NCT01411852|616239964|FG000|Hospital Intervention Phase|Miscommunication error|1|||
170517499|NCT01411852|616239965|FG001|Hospital Intervention Phase|Miscommunication error|2|||
170517500|NCT01411852|616239964|FG000|Hospital Intervention Phase|CPR administered|3|||
170517501|NCT01411852|616239965|FG001|Hospital Intervention Phase|CPR administered|1|||
170517502|NCT01411852|616239964|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
170517503|NCT01411852|616239965|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
170517504|NCT01411852|616239964|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
170517505|NCT01411852|616239965|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
170517506|NCT01411852|616239964|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
170517507|NCT01411852|616239965|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
170517508|NCT01411852|616239964|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
170517509|NCT01411852|616239965|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
170517510|NCT01411852|616239964|FG000|Hospital Intervention Phase|Other ineligible|2|||
170517511|NCT01411852|616239965|FG001|Hospital Intervention Phase|Other ineligible|2|||
170517512|NCT01411852|616239964|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
170517513|NCT01411852|616239965|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
170517514|NCT01411852|616239964|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
170517515|NCT01411852|616239965|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
170517516|NCT01411852|616239964|FG000|Hospital Intervention Phase|Vascular access failed|1|||
170517517|NCT01411852|616239965|FG001|Hospital Intervention Phase|Vascular access failed|0|||
170517518|NCT00272844|616239966|FG000|Overall Study|Withdrawal by Subject|5|||
170517519|NCT00618826|616239967|FG000|Overall Study|Adverse Event|1|||
170517520|NCT01556932|616239969|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
170517521|NCT01556932|616239970|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
170517522|NCT03743025|616239971|FG000|Overall Study|Surgery was cancelled|2|||
170517523|NCT03743025|616239972|FG001|Overall Study|Surgery was cancelled|1|||
170517524|NCT00791700|616239977|FG000|Overall Study|Insufficient clinical response|1|||
170517525|NCT00791700|616239978|FG001|Overall Study|Insufficient clinical response|4|||
170517526|NCT00791700|616239979|FG002|Overall Study|Insufficient clinical response|1|||
170517527|NCT00791700|616239980|FG003|Overall Study|Insufficient clinical response|8|||
170517528|NCT00791700|616239977|FG000|Overall Study|No longer willing to participate|1|||
170517529|NCT00791700|616239978|FG001|Overall Study|No longer willing to participate|1|||
170517530|NCT00791700|616239979|FG002|Overall Study|No longer willing to participate|0|||
170517531|NCT00791700|616239980|FG003|Overall Study|No longer willing to participate|8|||
170517532|NCT00791700|616239977|FG000|Overall Study|Non-compliance with study treatment|0|||
170517533|NCT00791700|616239978|FG001|Overall Study|Non-compliance with study treatment|2|||
170517534|NCT00791700|616239979|FG002|Overall Study|Non-compliance with study treatment|0|||
170517535|NCT00791700|616239980|FG003|Overall Study|Non-compliance with study treatment|4|||
170517536|NCT00791700|616239977|FG000|Overall Study|Withdrawn due to pregnancy|0|||
170517537|NCT00791700|616239978|FG001|Overall Study|Withdrawn due to pregnancy|0|||
170517538|NCT00791700|616239979|FG002|Overall Study|Withdrawn due to pregnancy|0|||
170517539|NCT00791700|616239980|FG003|Overall Study|Withdrawn due to pregnancy|1|||
170517540|NCT00791700|616239977|FG000|Overall Study|Other|0|||
170630513|NCT01436149|616660483|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
170630514|NCT01436149|616660484|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
170630515|NCT01436149|616660482|FG000|Randomized Phase|Other|12|||
170630516|NCT01436149|616660483|FG001|Randomized Phase|Other|5|||
170630517|NCT01436149|616660484|FG002|Randomized Phase|Other|11|||
170517541|NCT00791700|616239978|FG001|Overall Study|Other|1|||
170517542|NCT00791700|616239979|FG002|Overall Study|Other|0|||
170517543|NCT00791700|616239980|FG003|Overall Study|Other|1|||
170517544|NCT00791700|616239977|FG000|Overall Study|Death|0|||
170517545|NCT00791700|616239978|FG001|Overall Study|Death|0|||
170517546|NCT00791700|616239979|FG002|Overall Study|Death|0|||
170517547|NCT00791700|616239980|FG003|Overall Study|Death|1|||
170517548|NCT00791700|616239977|FG000|Overall Study|Lost to Follow-up|4|||
170517549|NCT00791700|616239978|FG001|Overall Study|Lost to Follow-up|3|||
170517550|NCT00791700|616239979|FG002|Overall Study|Lost to Follow-up|4|||
170517551|NCT00791700|616239980|FG003|Overall Study|Lost to Follow-up|6|||
170517552|NCT00791700|616239977|FG000|Overall Study|Adverse Event|0|||
170517553|NCT00791700|616239978|FG001|Overall Study|Adverse Event|0|||
170517554|NCT00791700|616239979|FG002|Overall Study|Adverse Event|1|||
170517555|NCT00791700|616239980|FG003|Overall Study|Adverse Event|1|||
170517556|NCT01720524|616239981|FG000|Part A|Insufficient Clinical Response|2|||
170517557|NCT01720524|616239982|FG001|Part A|Insufficient Clinical Response|4|||
170517558|NCT01720524|616239981|FG000|Part A|Adverse Event|2|||
170517559|NCT01720524|616239982|FG001|Part A|Adverse Event|2|||
170517560|NCT01720524|616239981|FG000|Part A|Death|2|||
170517561|NCT01720524|616239982|FG001|Part A|Death|1|||
170517562|NCT01720524|616239981|FG000|Part A|Lost to Follow-up|0|||
170517563|NCT01720524|616239982|FG001|Part A|Lost to Follow-up|1|||
170517564|NCT01720524|616239981|FG000|Part A|Missed 28 day follow-up visit|1|||
170517565|NCT01720524|616239982|FG001|Part A|Missed 28 day follow-up visit|1|||
170517566|NCT01720524|616239981|FG000|Part A|Withdrawal by Subject|0|||
170517567|NCT01720524|616239982|FG001|Part A|Withdrawal by Subject|1|||
170517568|NCT01720524|616239981|FG000|Part A|Other|0|||
170517569|NCT01720524|616239982|FG001|Part A|Other|1|||
170517570|NCT01720524|616239981|FG000|Part A|Lost to Follow-up|0|||
170517571|NCT01720524|616239982|FG001|Part A|Lost to Follow-up|1|||
170517572|NCT01720524|616239981|FG000|Part B|No longer willing to participate in study|1|||
170517573|NCT01720524|616239982|FG001|Part B|No longer willing to participate in study|4|||
170517574|NCT01720524|616239981|FG000|Part B|Other|2|||
170517575|NCT01720524|616239982|FG001|Part B|Other|0|||
170517576|NCT01720524|616239981|FG000|Part B|Lost to Follow-up|2|||
170517577|NCT01720524|616239982|FG001|Part B|Lost to Follow-up|3|||
170517578|NCT01720524|616239981|FG000|Part B|Death|0|||
170517579|NCT01720524|616239982|FG001|Part B|Death|2|||
170517580|NCT00158262|616239986|FG000|Overall Study|Lost to Follow-up|1|||
170517581|NCT00158262|616239987|FG001|Overall Study|Lost to Follow-up|1|||
170517582|NCT00527826|616239988|FG000|Overall Study|Adverse Event|10|||
170517583|NCT00527826|616239989|FG001|Overall Study|Adverse Event|10|||
170517584|NCT00527826|616239988|FG000|Overall Study|Lost to Follow-up|3|||
170517585|NCT00527826|616239989|FG001|Overall Study|Lost to Follow-up|2|||
170517586|NCT00527826|616239988|FG000|Overall Study|Withdrawal by Subject|5|||
170517587|NCT00527826|616239989|FG001|Overall Study|Withdrawal by Subject|8|||
170517588|NCT00527826|616239988|FG000|Overall Study|Inclusion Criteria Not Met|3|||
170517589|NCT00527826|616239989|FG001|Overall Study|Inclusion Criteria Not Met|3|||
170517590|NCT00527826|616239988|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
170517591|NCT00527826|616239989|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
170517592|NCT00527826|616239988|FG000|Overall Study|Additional Intake of Viani forte|0|||
170517593|NCT00527826|616239989|FG001|Overall Study|Additional Intake of Viani forte|1|||
170517594|NCT00527826|616239988|FG000|Overall Study|Participant moved away|0|||
170517595|NCT00527826|616239989|FG001|Overall Study|Participant moved away|1|||
170517596|NCT02105285|616239990|FG000|Overall Study|Adverse Event|1|||
170517597|NCT02105285|616239991|FG001|Overall Study|Adverse Event|1|||
170517598|NCT02105285|616239992|FG002|Overall Study|Adverse Event|0|||
170517599|NCT02105285|616239990|FG000|Overall Study|Protocol Violation|0|||
170517600|NCT02105285|616239991|FG001|Overall Study|Protocol Violation|1|||
170517601|NCT02105285|616239992|FG002|Overall Study|Protocol Violation|0|||
170517602|NCT02105285|616239990|FG000|Overall Study|Withdrawal by Subject|1|||
170517603|NCT02105285|616239991|FG001|Overall Study|Withdrawal by Subject|0|||
170517604|NCT02105285|616239992|FG002|Overall Study|Withdrawal by Subject|0|||
170517605|NCT01421641|616239993|FG000|Overall Study|Protocol Violation|2|||
170517606|NCT01421641|616239994|FG001|Overall Study|Protocol Violation|2|||
170517607|NCT02420119|616239996|FG000|Overall Study|insufficient laboratory data|5|||
170630518|NCT01643668|616660485|FG000|Overall Study|Death|1|||
170517608|NCT01502033|616239997|FG000|Overall Study|1 participant had scalp discomfort|1|||
170517609|NCT01502033|616239997|FG000|Overall Study|1 participant had worsening depression|1|||
170517610|NCT01502033|616239997|FG000|Overall Study|1 participant went back to school|1|||
170517611|NCT02983045|616239998|FG000|Overall Study|Withdrawal by Subject|0|||
170517612|NCT02983045|616239999|FG001|Overall Study|Withdrawal by Subject|1|||
170517613|NCT02983045|616240000|FG002|Overall Study|Withdrawal by Subject|0|||
170517614|NCT02983045|616240001|FG003|Overall Study|Withdrawal by Subject|5|||
170517615|NCT02983045|616240002|FG004|Overall Study|Withdrawal by Subject|0|||
170517616|NCT02983045|616240003|FG005|Overall Study|Withdrawal by Subject|72|||
170517617|NCT02983045|616240004|FG006|Overall Study|Withdrawal by Subject|0|||
170517618|NCT02983045|616240005|FG007|Overall Study|Withdrawal by Subject|0|||
170517619|NCT02983045|616240006|FG008|Overall Study|Withdrawal by Subject|0|||
170517620|NCT02983045|616240007|FG009|Overall Study|Withdrawal by Subject|2|||
170517621|NCT02983045|616239998|FG000|Overall Study|Lost to Follow-up|0|||
170517622|NCT02983045|616239999|FG001|Overall Study|Lost to Follow-up|0|||
170517623|NCT02983045|616240000|FG002|Overall Study|Lost to Follow-up|0|||
170517624|NCT02983045|616240001|FG003|Overall Study|Lost to Follow-up|0|||
170517625|NCT02983045|616240002|FG004|Overall Study|Lost to Follow-up|0|||
170517626|NCT02983045|616240003|FG005|Overall Study|Lost to Follow-up|10|||
170517627|NCT02983045|616240004|FG006|Overall Study|Lost to Follow-up|0|||
170517628|NCT02983045|616240005|FG007|Overall Study|Lost to Follow-up|0|||
170517629|NCT02983045|616240006|FG008|Overall Study|Lost to Follow-up|0|||
170517630|NCT02983045|616240007|FG009|Overall Study|Lost to Follow-up|0|||
170517631|NCT01808261|616240008|FG000|Overall Study|Physician Decision|0|||
170517632|NCT01808261|616240009|FG001|Overall Study|Physician Decision|2|||
170517633|NCT01808261|616240008|FG000|Overall Study|Study Closed/Terminated|25|||
170517634|NCT01808261|616240009|FG001|Overall Study|Study Closed/Terminated|23|||
170517635|NCT01808261|616240008|FG000|Overall Study|Adverse event, non-fatal|2|||
170517636|NCT01808261|616240009|FG001|Overall Study|Adverse event, non-fatal|0|||
170517637|NCT01808261|616240008|FG000|Overall Study|Consent withdrawn by subject|6|||
170517638|NCT01808261|616240009|FG001|Overall Study|Consent withdrawn by subject|7|||
170517639|NCT01808261|616240008|FG000|Overall Study|Lost to Follow-up|3|||
170517640|NCT01808261|616240009|FG001|Overall Study|Lost to Follow-up|1|||
170745622|NCT01474512|617076097|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
170745623|NCT01474512|617076098|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
170745624|NCT01474512|617076099|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
170745625|NCT01474512|617076100|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
170745626|NCT01474512|617076101|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
170745627|NCT01474512|617076102|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
170745628|NCT01474512|617076103|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
170745629|NCT01474512|617076104|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
170745630|NCT01474512|617076105|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
170745631|NCT01474512|617076106|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
170745632|NCT01474512|617076107|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
170745633|NCT01474512|617076108|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
170745634|NCT01474512|617076109|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
170745635|NCT01474512|617076110|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
170745636|NCT01474512|617076111|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
170745637|NCT01474512|617076094|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
170745638|NCT01474512|617076095|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
170745639|NCT01474512|617076096|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
170745640|NCT01474512|617076097|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
170745641|NCT01474512|617076098|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
170745642|NCT01474512|617076099|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
170745643|NCT01474512|617076100|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
170745644|NCT01474512|617076101|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
170745645|NCT01474512|617076102|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
170745646|NCT01474512|617076103|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
170745647|NCT01474512|617076104|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
170745648|NCT01474512|617076105|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
170745649|NCT01474512|617076106|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
170745650|NCT01474512|617076107|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
170745651|NCT01474512|617076108|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
170745652|NCT01474512|617076109|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
170745653|NCT01474512|617076110|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
170745654|NCT01474512|617076111|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
170745655|NCT01474512|617076094|FG000|Long-Term Extension Period|Adverse Event|0|||
170745656|NCT01474512|617076095|FG001|Long-Term Extension Period|Adverse Event|0|||
170745657|NCT01474512|617076096|FG002|Long-Term Extension Period|Adverse Event|0|||
170745658|NCT01474512|617076097|FG003|Long-Term Extension Period|Adverse Event|0|||
170745659|NCT01474512|617076098|FG004|Long-Term Extension Period|Adverse Event|0|||
170745660|NCT01474512|617076099|FG005|Long-Term Extension Period|Adverse Event|0|||
170745661|NCT01474512|617076100|FG006|Long-Term Extension Period|Adverse Event|0|||
170745662|NCT01474512|617076101|FG007|Long-Term Extension Period|Adverse Event|0|||
170745663|NCT01474512|617076102|FG008|Long-Term Extension Period|Adverse Event|0|||
170745664|NCT01474512|617076103|FG009|Long-Term Extension Period|Adverse Event|0|||
170745665|NCT01474512|617076104|FG010|Long-Term Extension Period|Adverse Event|0|||
170745666|NCT01474512|617076105|FG011|Long-Term Extension Period|Adverse Event|1|||
170745667|NCT01474512|617076106|FG012|Long-Term Extension Period|Adverse Event|57|||
170745668|NCT01474512|617076107|FG013|Long-Term Extension Period|Adverse Event|58|||
170745669|NCT01474512|617076108|FG014|Long-Term Extension Period|Adverse Event|0|||
170745670|NCT01474512|617076109|FG015|Long-Term Extension Period|Adverse Event|0|||
170517641|NCT02585713|616240010|FG000|Overall Study|Withdrew prior to treatment|2|||
170517642|NCT02585713|616240011|FG001|Overall Study|Withdrew prior to treatment|7|||
170517643|NCT02585713|616240010|FG000|Overall Study|Other|3|||
170517644|NCT02585713|616240011|FG001|Overall Study|Other|1|||
170517645|NCT04501952|616240016|FG000|Overall Study|Adverse Event|0|||
170517646|NCT04501952|616240017|FG001|Overall Study|Adverse Event|3|||
170517647|NCT04501952|616240016|FG000|Overall Study|Investigator's Discretion|0|||
170517648|NCT04501952|616240017|FG001|Overall Study|Investigator's Discretion|1|||
170517649|NCT04501952|616240016|FG000|Overall Study|Protocol Violation|1|||
170517650|NCT04501952|616240017|FG001|Overall Study|Protocol Violation|1|||
170517651|NCT04501952|616240016|FG000|Overall Study|Withdrew Consent|5|||
170517652|NCT04501952|616240017|FG001|Overall Study|Withdrew Consent|4|||
170517653|NCT04501952|616240016|FG000|Overall Study|Lost to Follow-up|7|||
170517654|NCT04501952|616240017|FG001|Overall Study|Lost to Follow-up|2|||
170517655|NCT04501952|616240016|FG000|Overall Study|Randomized and Never Treated|13|||
170517656|NCT04501952|616240017|FG001|Overall Study|Randomized and Never Treated|9|||
170517657|NCT02080364|616240019|FG000|Baseline Period|Protocol Violation|2|||
170517658|NCT02080364|616240020|FG001|Baseline Period|Protocol Violation|1|||
170517659|NCT02080364|616240021|FG002|Baseline Period|Protocol Violation|0|||
170517660|NCT02080364|616240022|FG003|Baseline Period|Protocol Violation|0|||
170517661|NCT02080364|616240019|FG000|Baseline Period|Other|0|||
170517662|NCT02080364|616240020|FG001|Baseline Period|Other|1|||
170517663|NCT02080364|616240021|FG002|Baseline Period|Other|1|||
170517664|NCT02080364|616240022|FG003|Baseline Period|Other|0|||
170517665|NCT02080364|616240019|FG000|Treatment Period|Adverse Event|10|||
170517666|NCT02080364|616240020|FG001|Treatment Period|Adverse Event|15|||
170517667|NCT02080364|616240021|FG002|Treatment Period|Adverse Event|11|||
170517668|NCT02080364|616240022|FG003|Treatment Period|Adverse Event|14|||
170517669|NCT02080364|616240019|FG000|Treatment Period|Lost to Follow-up|2|||
170517670|NCT02080364|616240020|FG001|Treatment Period|Lost to Follow-up|3|||
170517671|NCT02080364|616240021|FG002|Treatment Period|Lost to Follow-up|5|||
170517672|NCT02080364|616240022|FG003|Treatment Period|Lost to Follow-up|0|||
170517673|NCT02080364|616240019|FG000|Treatment Period|Protocol Violation|5|||
170517674|NCT02080364|616240020|FG001|Treatment Period|Protocol Violation|3|||
170517675|NCT02080364|616240021|FG002|Treatment Period|Protocol Violation|5|||
170517676|NCT02080364|616240022|FG003|Treatment Period|Protocol Violation|1|||
170517677|NCT02080364|616240019|FG000|Treatment Period|Withdrawal by Subject|16|||
170517678|NCT02080364|616240020|FG001|Treatment Period|Withdrawal by Subject|16|||
170517679|NCT02080364|616240021|FG002|Treatment Period|Withdrawal by Subject|15|||
170517680|NCT02080364|616240022|FG003|Treatment Period|Withdrawal by Subject|10|||
170517681|NCT02080364|616240019|FG000|Treatment Period|Study Terminated by Sponsor|0|||
170517682|NCT02080364|616240020|FG001|Treatment Period|Study Terminated by Sponsor|0|||
170517683|NCT02080364|616240021|FG002|Treatment Period|Study Terminated by Sponsor|180|||
170517684|NCT02080364|616240022|FG003|Treatment Period|Study Terminated by Sponsor|183|||
170517685|NCT02080364|616240019|FG000|Treatment Period|Other|14|||
170517686|NCT02080364|616240020|FG001|Treatment Period|Other|12|||
170517687|NCT02080364|616240021|FG002|Treatment Period|Other|21|||
170517688|NCT02080364|616240022|FG003|Treatment Period|Other|16|||
170517689|NCT02609984|616240023|FG000|Overall Study|Death|29|||
170517690|NCT02609984|616240024|FG001|Overall Study|Death|26|||
170517691|NCT02609984|616240023|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
170517692|NCT02609984|616240024|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
170517693|NCT02609984|616240023|FG000|Overall Study|Lost to Follow-up|1|||
170517694|NCT02609984|616240024|FG001|Overall Study|Lost to Follow-up|2|||
170517695|NCT02609984|616240023|FG000|Overall Study|Withdrawal by Subject|0|||
170517696|NCT02609984|616240024|FG001|Overall Study|Withdrawal by Subject|1|||
170517697|NCT02609984|616240023|FG000|Overall Study|Disease Progression|2|||
170517698|NCT02609984|616240024|FG001|Overall Study|Disease Progression|0|||
170517699|NCT00991289|616240025|FG000|Overall Study|Adverse Event|1|||
170517700|NCT00991289|616240025|FG000|Overall Study|Physician Decision|2|||
170517701|NCT00991289|616240025|FG000|Overall Study|Withdrawal by Subject|3|||
170517702|NCT00991289|616240025|FG000|Overall Study|Lost to Follow-up|4|||
170517703|NCT00991289|616240025|FG000|Overall Study|Protocol Violation|2|||
170517704|NCT02256839|616240027|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
170517705|NCT02256839|616240028|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
170517706|NCT01843803|616240029|FG000|Overall Study|not a Veteran, did not see provider|1|||
170517707|NCT01843803|616240030|FG001|Overall Study|not a Veteran, did not see provider|3|||
170517708|NCT00436826|616240036|FG000|Double Blind Period (DBP)|Adverse Event|2|||
170517709|NCT00436826|616240037|FG001|Double Blind Period (DBP)|Adverse Event|0|||
170517710|NCT00436826|616240038|FG002|Double Blind Period (DBP)|Adverse Event|0|||
170517711|NCT00436826|616240039|FG003|Double Blind Period (DBP)|Adverse Event|0|||
170517712|NCT00436826|616240040|FG004|Double Blind Period (DBP)|Adverse Event|0|||
170517713|NCT00436826|616240041|FG005|Double Blind Period (DBP)|Adverse Event|0|||
170517714|NCT00436826|616240036|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
170517715|NCT00436826|616240037|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
170517716|NCT00436826|616240038|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
170517717|NCT00436826|616240039|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
170517718|NCT00436826|616240040|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
170517719|NCT00436826|616240041|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
170517720|NCT00436826|616240036|FG000|Double Blind Period (DBP)|Other|10|||
170517721|NCT00436826|616240037|FG001|Double Blind Period (DBP)|Other|11|||
170517722|NCT00436826|616240038|FG002|Double Blind Period (DBP)|Other|0|||
170517723|NCT00436826|616240039|FG003|Double Blind Period (DBP)|Other|0|||
170517724|NCT00436826|616240040|FG004|Double Blind Period (DBP)|Other|0|||
170517725|NCT00436826|616240041|FG005|Double Blind Period (DBP)|Other|0|||
170517726|NCT00436826|616240036|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
170517727|NCT00436826|616240037|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
170517728|NCT00436826|616240038|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
170517729|NCT00436826|616240039|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
170517730|NCT00436826|616240040|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
170517731|NCT00436826|616240041|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
170517732|NCT00436826|616240036|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
170517733|NCT00436826|616240037|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
170517734|NCT00436826|616240038|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
170517735|NCT00436826|616240039|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
170517736|NCT00436826|616240040|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
170517737|NCT00436826|616240041|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
170517738|NCT00436826|616240036|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
170517739|NCT00436826|616240037|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
170517740|NCT00436826|616240038|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
170517741|NCT00436826|616240039|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
170517742|NCT00436826|616240040|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
170517743|NCT00436826|616240041|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
170517744|NCT00784719|616240042|FG000|Overall Study|Adverse Event|0|||
170517745|NCT00784719|616240043|FG001|Overall Study|Adverse Event|2|||
170517746|NCT00784719|616240044|FG002|Overall Study|Adverse Event|0|||
170517747|NCT00784719|616240045|FG003|Overall Study|Adverse Event|0|||
170517748|NCT00784719|616240046|FG004|Overall Study|Adverse Event|1|||
170517749|NCT00784719|616240047|FG005|Overall Study|Adverse Event|1|||
170517750|NCT00784719|616240048|FG006|Overall Study|Adverse Event|1|||
170517751|NCT00784719|616240042|FG000|Overall Study|Lost to Follow-up|0|||
170517752|NCT00784719|616240043|FG001|Overall Study|Lost to Follow-up|0|||
170517753|NCT00784719|616240044|FG002|Overall Study|Lost to Follow-up|0|||
170517754|NCT00784719|616240045|FG003|Overall Study|Lost to Follow-up|0|||
170630519|NCT00894803|616660486|FG000|Overall Study|Death|20|||
170630520|NCT00894803|616660487|FG001|Overall Study|Death|4|||
170630521|NCT00894803|616660486|FG000|Overall Study|Lost to Follow-up|0|||
170630522|NCT00894803|616660487|FG001|Overall Study|Lost to Follow-up|1|||
170517755|NCT00784719|616240046|FG004|Overall Study|Lost to Follow-up|1|||
170517756|NCT00784719|616240047|FG005|Overall Study|Lost to Follow-up|1|||
170517757|NCT00784719|616240048|FG006|Overall Study|Lost to Follow-up|0|||
170517758|NCT00784719|616240042|FG000|Overall Study|Other|2|||
170517759|NCT00784719|616240043|FG001|Overall Study|Other|1|||
170517760|NCT00784719|616240044|FG002|Overall Study|Other|1|||
170517761|NCT00784719|616240045|FG003|Overall Study|Other|0|||
170517762|NCT00784719|616240046|FG004|Overall Study|Other|2|||
170517763|NCT00784719|616240047|FG005|Overall Study|Other|1|||
170517764|NCT00784719|616240048|FG006|Overall Study|Other|3|||
170517765|NCT00784719|616240042|FG000|Overall Study|Withdrawal by Subject|1|||
170517766|NCT00784719|616240043|FG001|Overall Study|Withdrawal by Subject|0|||
170517767|NCT00784719|616240044|FG002|Overall Study|Withdrawal by Subject|0|||
170517768|NCT00784719|616240045|FG003|Overall Study|Withdrawal by Subject|0|||
170517769|NCT00784719|616240046|FG004|Overall Study|Withdrawal by Subject|2|||
170517770|NCT00784719|616240047|FG005|Overall Study|Withdrawal by Subject|0|||
170517771|NCT00784719|616240048|FG006|Overall Study|Withdrawal by Subject|1|||
170517772|NCT03382418|616240052|FG000|Overall Study|Withdrawal by Subject|1|||
170517773|NCT03382418|616240053|FG001|Overall Study|Withdrawal by Subject|0|||
170517774|NCT03382418|616240054|FG002|Overall Study|Withdrawal by Subject|0|||
170517775|NCT03382418|616240052|FG000|Overall Study|Lost to Follow-up|2|||
170517776|NCT03382418|616240053|FG001|Overall Study|Lost to Follow-up|3|||
170517777|NCT03382418|616240054|FG002|Overall Study|Lost to Follow-up|0|||
170517778|NCT02401035|616240064|FG000|Overall Study|Withdrawal by Subject|1|||
170517779|NCT02401035|616240065|FG001|Overall Study|Withdrawal by Subject|0|||
170517780|NCT00869128|616240066|FG000|Overall Study|lack of Compliance|6|||
170517781|NCT00869128|616240067|FG001|Overall Study|lack of Compliance|6|||
170630523|NCT03944577|616660490|FG000|Overall Study|Adverse Event|3|||
170630524|NCT00361296|616660491|FG000|Overall Study|Physician Decision|1|||
170630525|NCT00361296|616660491|FG000|Overall Study|Lack of Efficacy|2|||
170517782|NCT00985686|616240069|FG000|Overall Study|Lost to Follow-up|1|||
170517783|NCT00985686|616240070|FG001|Overall Study|Lost to Follow-up|1|||
170517784|NCT00985686|616240071|FG002|Overall Study|Lost to Follow-up|0|||
170630526|NCT03011099|616660493|FG000|Overall Study|Withdrawal by Subject|0|||
170517785|NCT00985686|616240072|FG003|Overall Study|Lost to Follow-up|2|||
170630527|NCT03011099|616660494|FG001|Overall Study|Withdrawal by Subject|2|||
170630528|NCT00453206|616660495|FG000|Overall Study|Death|1|||
170517786|NCT04039204|616240073|FG000|Overall Study|Withdrawal by Subject|0|||
170517787|NCT04039204|616240074|FG001|Overall Study|Withdrawal by Subject|2|||
170517788|NCT02588664|616240077|FG000|Overall Study|Death|56|||
170517789|NCT02588664|616240078|FG001|Overall Study|Death|55|||
170517790|NCT02588664|616240077|FG000|Overall Study|Lost to Follow-up|1305|||
170517791|NCT02588664|616240078|FG001|Overall Study|Lost to Follow-up|990|||
170517792|NCT00396383|616240079|FG000|Overall Study|Death|2|||
170517793|NCT00396383|616240079|FG000|Overall Study|Lost to Follow-up|1|||
170517794|NCT02358031|616242359|FG000|Overall Study|Death|253|||
170517795|NCT02358031|616242360|FG001|Overall Study|Death|237|||
170517796|NCT02358031|616242361|FG002|Overall Study|Death|266|||
170517797|NCT02358031|616242359|FG000|Overall Study|Lost to Follow-up|1|||
170517798|NCT02358031|616242360|FG001|Overall Study|Lost to Follow-up|1|||
170517799|NCT02358031|616242361|FG002|Overall Study|Lost to Follow-up|0|||
170517800|NCT02358031|616242359|FG000|Overall Study|Withdrawal by Subject|19|||
170517801|NCT02358031|616242360|FG001|Overall Study|Withdrawal by Subject|14|||
170517802|NCT02358031|616242361|FG002|Overall Study|Withdrawal by Subject|18|||
170517803|NCT02358031|616242359|FG000|Overall Study|Sponsor Decision|26|||
170517804|NCT02358031|616242360|FG001|Overall Study|Sponsor Decision|28|||
170517805|NCT02358031|616242361|FG002|Overall Study|Sponsor Decision|16|||
170517806|NCT01409915|616242362|FG000|Overall Study|Adverse Event|0|||
170517807|NCT01409915|616242363|FG001|Overall Study|Adverse Event|2|||
170517808|NCT01409915|616242362|FG000|Overall Study|Withdrawal by Subject|0|||
170517809|NCT01409915|616242363|FG001|Overall Study|Withdrawal by Subject|1|||
170517810|NCT01409915|616242362|FG000|Overall Study|Protocol Violation|1|||
170517811|NCT01409915|616242363|FG001|Overall Study|Protocol Violation|0|||
170517812|NCT02250300|616242365|FG000|Expansion Phase|Death|6|||
170517813|NCT02250300|616242366|FG001|Expansion Phase|Death|7|||
170517814|NCT02250300|616242367|FG002|Expansion Phase|Death|0|||
170517815|NCT02250300|616242368|FG003|Expansion Phase|Death|0|||
170517816|NCT01239394|616242371|FG000|Overall Study|Adverse Event|1|||
170517817|NCT00905632|616242372|FG000|Overall Study|Adverse Event|0|||
170517818|NCT00905632|616242373|FG001|Overall Study|Adverse Event|0|||
170906107|NCT03430310|617658618|FG001|Overall Study|COVID shutdown March 2020|1|||
170517819|NCT00905632|616242374|FG002|Overall Study|Adverse Event|0|||
170517820|NCT00905632|616242375|FG003|Overall Study|Adverse Event|0|||
170517821|NCT00905632|616242376|FG004|Overall Study|Adverse Event|0|||
170517822|NCT00905632|616242377|FG005|Overall Study|Adverse Event|1|||
170517823|NCT00905632|616242378|FG006|Overall Study|Adverse Event|4|||
170517824|NCT03569098|616242379|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
170517825|NCT03569098|616242380|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
170630529|NCT00888134|616660497|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
170630530|NCT00888134|616660497|FG000|Follow-up|being followed for long-term survival|1|||
170630531|NCT03041181|616660498|FG000|Overall Study|Disease Progression|1|||
170630532|NCT03041181|616660499|FG001|Overall Study|Disease Progression|2|||
170630533|NCT02667119|616660500|FG000|Overall Study|Lost to Follow-up|3|||
170630534|NCT02667119|616660501|FG001|Overall Study|Lost to Follow-up|0|||
170630535|NCT01523756|616660502|FG000|Baseline Period|Adverse Event|0|||
170630536|NCT01523756|616660503|FG001|Baseline Period|Adverse Event|1|||
170630537|NCT01523756|616660502|FG000|Test Period 1|Adverse Event|1|||
170630538|NCT01523756|616660503|FG001|Test Period 1|Adverse Event|0|||
170630539|NCT01523756|616660502|FG000|Test Period 2|Withdrawal by Subject|0|||
170630540|NCT01523756|616660503|FG001|Test Period 2|Withdrawal by Subject|1|||
170630541|NCT03224819|616660504|FG000|Overall Study|Withdrawal by Subject|0|||
170630542|NCT03224819|616660505|FG001|Overall Study|Withdrawal by Subject|0|||
170630543|NCT03224819|616660506|FG002|Overall Study|Withdrawal by Subject|0|||
170630544|NCT03224819|616660507|FG003|Overall Study|Withdrawal by Subject|0|||
170630545|NCT03224819|616660508|FG004|Overall Study|Withdrawal by Subject|0|||
170630546|NCT03224819|616660509|FG005|Overall Study|Withdrawal by Subject|0|||
170630547|NCT03224819|616660510|FG006|Overall Study|Withdrawal by Subject|0|||
170630548|NCT03224819|616660511|FG007|Overall Study|Withdrawal by Subject|0|||
170630549|NCT03224819|616660512|FG008|Overall Study|Withdrawal by Subject|0|||
170630550|NCT03224819|616660513|FG009|Overall Study|Withdrawal by Subject|0|||
170630551|NCT03224819|616660514|FG010|Overall Study|Withdrawal by Subject|0|||
170630552|NCT03224819|616660515|FG011|Overall Study|Withdrawal by Subject|0|||
170630553|NCT03224819|616660516|FG012|Overall Study|Withdrawal by Subject|1|||
170630554|NCT03224819|616660517|FG013|Overall Study|Withdrawal by Subject|0|||
170630555|NCT03224819|616660504|FG000|Overall Study|Sponsor Decision|0|||
170630556|NCT03224819|616660505|FG001|Overall Study|Sponsor Decision|0|||
170630557|NCT03224819|616660506|FG002|Overall Study|Sponsor Decision|0|||
170630558|NCT03224819|616660507|FG003|Overall Study|Sponsor Decision|1|||
170630559|NCT03224819|616660508|FG004|Overall Study|Sponsor Decision|1|||
170630560|NCT03224819|616660509|FG005|Overall Study|Sponsor Decision|2|||
170630561|NCT03224819|616660510|FG006|Overall Study|Sponsor Decision|1|||
170630562|NCT03224819|616660511|FG007|Overall Study|Sponsor Decision|1|||
170630563|NCT03224819|616660512|FG008|Overall Study|Sponsor Decision|1|||
170630564|NCT03224819|616660513|FG009|Overall Study|Sponsor Decision|2|||
170630565|NCT03224819|616660514|FG010|Overall Study|Sponsor Decision|1|||
170630566|NCT03224819|616660515|FG011|Overall Study|Sponsor Decision|1|||
170517826|NCT03569098|616242381|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
170517827|NCT03569098|616242379|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
170517828|NCT03569098|616242380|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
170517829|NCT03569098|616242381|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
170517830|NCT03569098|616242379|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
170517831|NCT03569098|616242380|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
170517832|NCT03569098|616242381|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
170517833|NCT03569098|616242379|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
170517834|NCT03569098|616242380|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
170517835|NCT03569098|616242381|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
170517836|NCT03569098|616242379|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
170517837|NCT03569098|616242380|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
170517838|NCT03569098|616242381|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
170517839|NCT03569098|616242379|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
170517840|NCT03569098|616242380|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
170517841|NCT03569098|616242381|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
170517842|NCT03569098|616242379|FG000|Double-Blind Treatment Cycle 1|Other|1|||
170517843|NCT03569098|616242380|FG001|Double-Blind Treatment Cycle 1|Other|0|||
170517844|NCT03569098|616242381|FG002|Double-Blind Treatment Cycle 1|Other|1|||
170517845|NCT03569098|616242379|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
170517846|NCT03569098|616242380|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
170517847|NCT03569098|616242381|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
170517848|NCT03569098|616242379|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
170517849|NCT03569098|616242380|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
170517850|NCT03569098|616242381|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
170517851|NCT03569098|616242379|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
170517852|NCT03569098|616242380|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
170517853|NCT03569098|616242381|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
170517854|NCT03569098|616242379|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
170517855|NCT03569098|616242380|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
170517856|NCT03569098|616242381|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
170517857|NCT03569098|616242379|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
170517858|NCT03569098|616242380|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
170517859|NCT03569098|616242381|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
170517860|NCT03569098|616242379|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
170517861|NCT03569098|616242380|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
170517862|NCT03569098|616242381|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
170517863|NCT01845597|616242382|FG000|Overall Study|Death|8|||
170517864|NCT01845597|616242382|FG000|Overall Study|Lost to Follow-up|22|||
170517865|NCT00758498|616242383|FG000|Overall Study|Adverse Event|2|||
170517866|NCT00758498|616242384|FG001|Overall Study|Adverse Event|2|||
170517867|NCT00758498|616242385|FG002|Overall Study|Adverse Event|3|||
170517868|NCT00758498|616242383|FG000|Overall Study|Subject legally detained out of state|1|||
170517869|NCT00758498|616242384|FG001|Overall Study|Subject legally detained out of state|0|||
170517870|NCT00758498|616242385|FG002|Overall Study|Subject legally detained out of state|0|||
170517871|NCT00758498|616242383|FG000|Overall Study|Withdrawal by Subject|0|||
170517872|NCT00758498|616242384|FG001|Overall Study|Withdrawal by Subject|0|||
170517873|NCT00758498|616242385|FG002|Overall Study|Withdrawal by Subject|1|||
170517874|NCT00758498|616242383|FG000|Overall Study|Noncompliance to study procedures|0|||
170517875|NCT00758498|616242384|FG001|Overall Study|Noncompliance to study procedures|0|||
170517876|NCT00758498|616242385|FG002|Overall Study|Noncompliance to study procedures|1|||
170517877|NCT00715559|616242386|FG000|Overall Study|medication not tolerated - nausea|1|||
170517878|NCT02581488|616242392|FG000|Overall Study|Adverse Event|6|||
170517879|NCT02581488|616242393|FG001|Overall Study|Adverse Event|7|||
170517880|NCT02581488|616242392|FG000|Overall Study|Lost to Follow-up|1|||
170630567|NCT03224819|616660516|FG012|Overall Study|Sponsor Decision|1|||
170630568|NCT03224819|616660517|FG013|Overall Study|Sponsor Decision|0|||
170630569|NCT03224819|616660504|FG000|Overall Study|Lost to Follow-up|0|||
170630570|NCT03224819|616660505|FG001|Overall Study|Lost to Follow-up|0|||
170630571|NCT03224819|616660506|FG002|Overall Study|Lost to Follow-up|0|||
170630572|NCT03224819|616660507|FG003|Overall Study|Lost to Follow-up|0|||
170630573|NCT03224819|616660508|FG004|Overall Study|Lost to Follow-up|0|||
170630574|NCT03224819|616660509|FG005|Overall Study|Lost to Follow-up|0|||
170630575|NCT03224819|616660510|FG006|Overall Study|Lost to Follow-up|0|||
170630576|NCT03224819|616660511|FG007|Overall Study|Lost to Follow-up|0|||
170630577|NCT03224819|616660512|FG008|Overall Study|Lost to Follow-up|1|||
170517881|NCT02581488|616242393|FG001|Overall Study|Lost to Follow-up|0|||
170517882|NCT02581488|616242392|FG000|Overall Study|Withdrawal by Subject|1|||
170630578|NCT03224819|616660513|FG009|Overall Study|Lost to Follow-up|0|||
170630579|NCT03224819|616660514|FG010|Overall Study|Lost to Follow-up|0|||
170630580|NCT03224819|616660515|FG011|Overall Study|Lost to Follow-up|0|||
170630581|NCT03224819|616660516|FG012|Overall Study|Lost to Follow-up|0|||
170745671|NCT01474512|617076110|FG016|Long-Term Extension Period|Adverse Event|0|||
170745672|NCT01474512|617076111|FG017|Long-Term Extension Period|Adverse Event|0|||
170745673|NCT01474512|617076094|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
170745674|NCT01474512|617076095|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
170745675|NCT01474512|617076096|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
170745676|NCT01474512|617076097|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
170745677|NCT01474512|617076098|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
170745678|NCT01474512|617076099|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
170745679|NCT01474512|617076100|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
170745680|NCT01474512|617076101|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
170745681|NCT01474512|617076102|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
170745682|NCT01474512|617076103|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
170745683|NCT01474512|617076104|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
170745684|NCT01474512|617076105|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
170745685|NCT01474512|617076106|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
170745686|NCT01474512|617076107|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
170745687|NCT01474512|617076108|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
170745688|NCT01474512|617076109|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
170745689|NCT01474512|617076110|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
170745690|NCT01474512|617076111|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
170745691|NCT01474512|617076094|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
170745692|NCT01474512|617076095|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
170745693|NCT01474512|617076096|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
170745694|NCT01474512|617076097|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
170745695|NCT01474512|617076098|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
170745696|NCT01474512|617076099|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
170745697|NCT01474512|617076100|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
170745698|NCT01474512|617076101|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
170745699|NCT01474512|617076102|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
170745700|NCT01474512|617076103|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
170745701|NCT01474512|617076104|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
170745702|NCT01474512|617076105|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
170517883|NCT02581488|616242393|FG001|Overall Study|Withdrawal by Subject|0|||
170517884|NCT02581488|616242392|FG000|Overall Study|Non-Compliance|1|||
170517885|NCT02581488|616242393|FG001|Overall Study|Non-Compliance|0|||
170517886|NCT02581488|616242392|FG000|Overall Study|Protocol Violation|0|||
170517887|NCT02581488|616242393|FG001|Overall Study|Protocol Violation|4|||
170517888|NCT02781818|616242394|FG000|Overall Study|Lost to Follow-up|4|||
170517889|NCT02781818|616242395|FG001|Overall Study|Lost to Follow-up|2|||
170517890|NCT02781818|616242396|FG002|Overall Study|Lost to Follow-up|1|||
170517891|NCT01877668|616242397|FG000|Overall Study|Death|0|||
170517892|NCT01877668|616242398|FG001|Overall Study|Death|0|||
170517893|NCT01877668|616242399|FG002|Overall Study|Death|0|||
170517894|NCT01877668|616242400|FG003|Overall Study|Death|1|||
170517895|NCT01877668|616242401|FG004|Overall Study|Death|0|||
170517896|NCT01877668|616242397|FG000|Overall Study|No longer met study criteria|1|||
170517897|NCT01877668|616242398|FG001|Overall Study|No longer met study criteria|0|||
170517898|NCT01877668|616242399|FG002|Overall Study|No longer met study criteria|1|||
170517899|NCT01877668|616242400|FG003|Overall Study|No longer met study criteria|0|||
170517900|NCT01877668|616242401|FG004|Overall Study|No longer met study criteria|0|||
170517901|NCT01877668|616242397|FG000|Overall Study|Insufficient clinical response|0|||
170517902|NCT01877668|616242398|FG001|Overall Study|Insufficient clinical response|1|||
170517903|NCT01877668|616242399|FG002|Overall Study|Insufficient clinical response|2|||
170517904|NCT01877668|616242400|FG003|Overall Study|Insufficient clinical response|2|||
170517905|NCT01877668|616242401|FG004|Overall Study|Insufficient clinical response|0|||
170517906|NCT01877668|616242397|FG000|Overall Study|Lost to Follow-up|0|||
170517907|NCT01877668|616242398|FG001|Overall Study|Lost to Follow-up|2|||
170517908|NCT01877668|616242399|FG002|Overall Study|Lost to Follow-up|1|||
170517909|NCT01877668|616242400|FG003|Overall Study|Lost to Follow-up|0|||
170517910|NCT01877668|616242401|FG004|Overall Study|Lost to Follow-up|0|||
170517911|NCT01877668|616242397|FG000|Overall Study|Withdrawal by Subject|2|||
170517912|NCT01877668|616242398|FG001|Overall Study|Withdrawal by Subject|0|||
170517913|NCT01877668|616242399|FG002|Overall Study|Withdrawal by Subject|3|||
170517914|NCT01877668|616242400|FG003|Overall Study|Withdrawal by Subject|2|||
170517915|NCT01877668|616242401|FG004|Overall Study|Withdrawal by Subject|2|||
170517916|NCT01877668|616242397|FG000|Overall Study|Other|1|||
170517917|NCT01877668|616242398|FG001|Overall Study|Other|1|||
170517918|NCT01877668|616242399|FG002|Overall Study|Other|1|||
170517919|NCT01877668|616242400|FG003|Overall Study|Other|1|||
170517920|NCT01877668|616242401|FG004|Overall Study|Other|3|||
170517921|NCT01877668|616242397|FG000|Overall Study|Protocol Violation|1|||
170517922|NCT01877668|616242398|FG001|Overall Study|Protocol Violation|1|||
170745703|NCT01474512|617076106|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
170745704|NCT01474512|617076107|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
170906108|NCT01446809|617658620|FG000|Overall Study|Adverse Event|0|||
170517923|NCT01877668|616242399|FG002|Overall Study|Protocol Violation|0|||
170517924|NCT01877668|616242400|FG003|Overall Study|Protocol Violation|0|||
170517925|NCT01877668|616242401|FG004|Overall Study|Protocol Violation|3|||
170517926|NCT01877668|616242397|FG000|Overall Study|Adverse event related to study drug|2|||
170517927|NCT01877668|616242398|FG001|Overall Study|Adverse event related to study drug|2|||
170517928|NCT01877668|616242399|FG002|Overall Study|Adverse event related to study drug|2|||
170517929|NCT01877668|616242400|FG003|Overall Study|Adverse event related to study drug|2|||
170517930|NCT01877668|616242401|FG004|Overall Study|Adverse event related to study drug|1|||
170517931|NCT01877668|616242397|FG000|Overall Study|Adverse event unrelated to study drug|4|||
170517932|NCT01877668|616242398|FG001|Overall Study|Adverse event unrelated to study drug|1|||
170517933|NCT01877668|616242399|FG002|Overall Study|Adverse event unrelated to study drug|2|||
170517934|NCT01877668|616242400|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170517935|NCT01877668|616242401|FG004|Overall Study|Adverse event unrelated to study drug|1|||
170517936|NCT03365934|616242402|FG000|Overall Study|Adverse Event|1|||
170517937|NCT03365934|616242402|FG000|Overall Study|Withdrawal by Subject|1|||
170517938|NCT02485483|616242407|FG000|Overall Study|Depression at baseline|15|||
170517939|NCT02485483|616242408|FG001|Overall Study|Depression at baseline|0|||
170517940|NCT02485483|616242407|FG000|Overall Study|Discontinued after baseline|39|||
170517941|NCT02485483|616242408|FG001|Overall Study|Discontinued after baseline|0|||
170517942|NCT01128296|616242409|FG000|Overall Study|Physician Decision|0|||
170517943|NCT01128296|616242410|FG001|Overall Study|Physician Decision|0|||
170517944|NCT01128296|616242411|FG002|Overall Study|Physician Decision|0|||
170517945|NCT01128296|616242412|FG003|Overall Study|Physician Decision|0|||
170517946|NCT01128296|616242413|FG004|Overall Study|Physician Decision|0|||
170517947|NCT01128296|616242414|FG005|Overall Study|Physician Decision|3|||
170517948|NCT01128296|616242409|FG000|Overall Study|Withdrawal by Subject|0|||
170517949|NCT01128296|616242410|FG001|Overall Study|Withdrawal by Subject|0|||
170517950|NCT01128296|616242411|FG002|Overall Study|Withdrawal by Subject|0|||
170517951|NCT01128296|616242412|FG003|Overall Study|Withdrawal by Subject|0|||
170517952|NCT01128296|616242413|FG004|Overall Study|Withdrawal by Subject|0|||
170517953|NCT01128296|616242414|FG005|Overall Study|Withdrawal by Subject|2|||
170517954|NCT03316586|616242415|FG000|Overall Study|Adverse Event|2|||
170517955|NCT03316586|616242415|FG000|Overall Study|Physician Decision|3|||
170517956|NCT03316586|616242415|FG000|Overall Study|Lack of Efficacy|10|||
170517957|NCT03316586|616242415|FG000|Overall Study|still on treatment|1|||
170517958|NCT03316586|616242415|FG000|Overall Study|Patient needed radiation therapy|1|||
170517959|NCT03316586|616242415|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
170517960|NCT01714544|616242418|FG000|Overall Study|Lost to Follow-up|1|||
170517961|NCT01714544|616242418|FG000|Overall Study|Physician Decision|1|||
170517962|NCT01714544|616242418|FG000|Overall Study|Withdrawal by Subject|1|||
170517963|NCT00666211|616242419|FG000|Overall Study|Withdrawal by Subject|10|||
170517964|NCT00666211|616242420|FG001|Overall Study|Withdrawal by Subject|13|||
170517965|NCT00666211|616242419|FG000|Overall Study|went off medication, no more pain|1|||
170517966|NCT00666211|616242420|FG001|Overall Study|went off medication, no more pain|0|||
170517967|NCT00666211|616242419|FG000|Overall Study|patient non-compliant|6|||
170517968|NCT00666211|616242420|FG001|Overall Study|patient non-compliant|6|||
170517969|NCT00666211|616242419|FG000|Overall Study|disease progression|1|||
170517970|NCT00666211|616242420|FG001|Overall Study|disease progression|8|||
170517971|NCT00666211|616242419|FG000|Overall Study|Lost to Follow-up|2|||
170517972|NCT00666211|616242420|FG001|Overall Study|Lost to Follow-up|0|||
170517973|NCT00666211|616242419|FG000|Overall Study|toxicity|0|||
170517974|NCT00666211|616242420|FG001|Overall Study|toxicity|2|||
170517975|NCT00666211|616242419|FG000|Overall Study|hospital admission|0|||
170517976|NCT00666211|616242420|FG001|Overall Study|hospital admission|5|||
170517977|NCT00666211|616242419|FG000|Overall Study|Death|0|||
170517978|NCT00666211|616242420|FG001|Overall Study|Death|2|||
170517979|NCT00666211|616242419|FG000|Overall Study|off tx for other complicating disease|0|||
170517980|NCT00666211|616242420|FG001|Overall Study|off tx for other complicating disease|1|||
170517981|NCT00666211|616242419|FG000|Overall Study|Physician Decision|0|||
170517982|NCT00666211|616242420|FG001|Overall Study|Physician Decision|1|||
170745705|NCT01474512|617076108|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
170745706|NCT01474512|617076109|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
170745707|NCT01474512|617076110|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
170745708|NCT01474512|617076111|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
170745709|NCT01474512|617076094|FG000|Long-Term Extension Period|Physician Decision|0|||
170745710|NCT01474512|617076095|FG001|Long-Term Extension Period|Physician Decision|0|||
170517983|NCT00619827|616242421|FG000|Overall Study|Adverse Event|1|||
170517984|NCT00619827|616242422|FG001|Overall Study|Adverse Event|2|||
170517985|NCT00619827|616242421|FG000|Overall Study|Withdrawal by Subject|2|||
170517986|NCT00619827|616242422|FG001|Overall Study|Withdrawal by Subject|2|||
170745711|NCT01474512|617076096|FG002|Long-Term Extension Period|Physician Decision|0|||
170517987|NCT01063855|616242423|FG000|Overall Study|Adverse Event|4|||
170517988|NCT01063855|616242424|FG001|Overall Study|Adverse Event|4|||
170517989|NCT01063855|616242423|FG000|Overall Study|Death|0|||
170517990|NCT01063855|616242424|FG001|Overall Study|Death|1|||
170745712|NCT01474512|617076097|FG003|Long-Term Extension Period|Physician Decision|0|||
170517991|NCT01063855|616242423|FG000|Overall Study|Lost to Follow-up|8|||
170517992|NCT01063855|616242424|FG001|Overall Study|Lost to Follow-up|4|||
170517993|NCT01063855|616242423|FG000|Overall Study|Pregnancy|1|||
170517994|NCT01063855|616242424|FG001|Overall Study|Pregnancy|0|||
170517995|NCT01063855|616242423|FG000|Overall Study|Lack of Efficacy|0|||
170517996|NCT01063855|616242424|FG001|Overall Study|Lack of Efficacy|1|||
170517997|NCT01063855|616242423|FG000|Overall Study|Withdrawal by Subject|11|||
170517998|NCT01063855|616242424|FG001|Overall Study|Withdrawal by Subject|8|||
170517999|NCT01063855|616242423|FG000|Overall Study|Reason not specified|13|||
170518000|NCT01063855|616242424|FG001|Overall Study|Reason not specified|11|||
170518001|NCT02806713|616242425|FG000|Overall Study|Urethral injury during procedure|1|||
170518002|NCT02806713|616242426|FG001|Overall Study|Urethral injury during procedure|0|||
170518003|NCT02806713|616242425|FG000|Overall Study|cancelled surgery|1|||
170518004|NCT02806713|616242426|FG001|Overall Study|cancelled surgery|2|||
170518005|NCT01165307|616242427|FG000|Overall Study|Lost to Follow-up|11|||
170518006|NCT01165307|616242428|FG001|Overall Study|Lost to Follow-up|3|||
170518007|NCT01165307|616242427|FG000|Overall Study|Withdrawal by Subject|2|||
170518008|NCT01165307|616242428|FG001|Overall Study|Withdrawal by Subject|0|||
170518009|NCT01165307|616242427|FG000|Overall Study|Subject not available for contact|1|||
170518010|NCT01165307|616242428|FG001|Overall Study|Subject not available for contact|0|||
170518011|NCT03234036|616242432|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
170518012|NCT03234036|616242433|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
170518013|NCT03234036|616242434|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
170518014|NCT03234036|616242435|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
170518015|NCT02163395|616242436|FG000|Overall Study|Withdrawal by Subject|1|||
170518016|NCT02163395|616242436|FG000|Overall Study|Lost to Follow-up|3|||
170518017|NCT02163395|616242436|FG000|Overall Study|Adverse Event|1|||
170518018|NCT02999789|616242437|FG000|Overall Study|Withdrawal by Subject|0|||
170518019|NCT02999789|616242438|FG001|Overall Study|Withdrawal by Subject|1|||
170518020|NCT02999789|616242437|FG000|Overall Study|Became ineligible|1|||
170518021|NCT02999789|616242438|FG001|Overall Study|Became ineligible|2|||
170518022|NCT02824224|616242455|FG000|Overall Study|Discontinued, IUS expulsion|0|||
170518023|NCT02824224|616242456|FG001|Overall Study|Discontinued, IUS expulsion|1|||
170518024|NCT02824224|616242455|FG000|Overall Study|Did not show up for allocation visit|2|||
170518025|NCT02824224|616242456|FG001|Overall Study|Did not show up for allocation visit|0|||
170518026|NCT02683239|616242457|FG000|Overall Study|Protocol Violation|35|||
170518027|NCT02683239|616242458|FG001|Overall Study|Protocol Violation|23|||
170518028|NCT02683239|616242459|FG002|Overall Study|Protocol Violation|26|||
170518029|NCT02683239|616242460|FG003|Overall Study|Protocol Violation|4|||
170518030|NCT02683239|616242461|FG004|Overall Study|Protocol Violation|35|||
170518031|NCT02683239|616242462|FG005|Overall Study|Protocol Violation|4|||
170518032|NCT02683239|616242463|FG006|Overall Study|Protocol Violation|5|||
170518033|NCT02683239|616242457|FG000|Overall Study|Adverse Event|64|||
170518034|NCT02683239|616242458|FG001|Overall Study|Adverse Event|39|||
170518035|NCT02683239|616242459|FG002|Overall Study|Adverse Event|42|||
170518036|NCT02683239|616242460|FG003|Overall Study|Adverse Event|16|||
170518037|NCT02683239|616242461|FG004|Overall Study|Adverse Event|189|||
170518038|NCT02683239|616242462|FG005|Overall Study|Adverse Event|9|||
170518039|NCT02683239|616242463|FG006|Overall Study|Adverse Event|9|||
170518040|NCT02683239|616242457|FG000|Overall Study|Physician Decision|38|||
170518041|NCT02683239|616242458|FG001|Overall Study|Physician Decision|19|||
170518042|NCT02683239|616242459|FG002|Overall Study|Physician Decision|14|||
170518043|NCT02683239|616242460|FG003|Overall Study|Physician Decision|73|||
170518044|NCT02683239|616242461|FG004|Overall Study|Physician Decision|143|||
170518045|NCT02683239|616242462|FG005|Overall Study|Physician Decision|14|||
170518046|NCT02683239|616242463|FG006|Overall Study|Physician Decision|15|||
170518047|NCT02683239|616242457|FG000|Overall Study|Withdrawal by Subject|187|||
170518048|NCT02683239|616242458|FG001|Overall Study|Withdrawal by Subject|99|||
170518049|NCT02683239|616242459|FG002|Overall Study|Withdrawal by Subject|91|||
170518050|NCT02683239|616242460|FG003|Overall Study|Withdrawal by Subject|18|||
170518051|NCT02683239|616242461|FG004|Overall Study|Withdrawal by Subject|248|||
170518052|NCT02683239|616242462|FG005|Overall Study|Withdrawal by Subject|22|||
170518053|NCT02683239|616242463|FG006|Overall Study|Withdrawal by Subject|28|||
170518054|NCT02683239|616242457|FG000|Overall Study|Lost to Follow-up|77|||
170518055|NCT02683239|616242458|FG001|Overall Study|Lost to Follow-up|24|||
170518056|NCT02683239|616242459|FG002|Overall Study|Lost to Follow-up|25|||
170518057|NCT02683239|616242460|FG003|Overall Study|Lost to Follow-up|7|||
170518058|NCT02683239|616242461|FG004|Overall Study|Lost to Follow-up|88|||
170518059|NCT02683239|616242462|FG005|Overall Study|Lost to Follow-up|8|||
170518060|NCT02683239|616242463|FG006|Overall Study|Lost to Follow-up|11|||
170518061|NCT02683239|616242457|FG000|Overall Study|Death|9|||
170518062|NCT02683239|616242458|FG001|Overall Study|Death|5|||
170518063|NCT02683239|616242459|FG002|Overall Study|Death|8|||
170518064|NCT02683239|616242460|FG003|Overall Study|Death|0|||
170518065|NCT02683239|616242461|FG004|Overall Study|Death|12|||
170518066|NCT02683239|616242462|FG005|Overall Study|Death|1|||
170518067|NCT02683239|616242463|FG006|Overall Study|Death|0|||
170518068|NCT02683239|616242457|FG000|Overall Study|Lack of Efficacy|50|||
170745713|NCT01474512|617076098|FG004|Long-Term Extension Period|Physician Decision|0|||
170745714|NCT01474512|617076099|FG005|Long-Term Extension Period|Physician Decision|0|||
170745715|NCT01474512|617076100|FG006|Long-Term Extension Period|Physician Decision|0|||
170745716|NCT01474512|617076101|FG007|Long-Term Extension Period|Physician Decision|0|||
170745717|NCT01474512|617076102|FG008|Long-Term Extension Period|Physician Decision|0|||
170518069|NCT02683239|616242458|FG001|Overall Study|Lack of Efficacy|23|||
170518070|NCT02683239|616242459|FG002|Overall Study|Lack of Efficacy|12|||
170518071|NCT02683239|616242460|FG003|Overall Study|Lack of Efficacy|2|||
170518072|NCT02683239|616242461|FG004|Overall Study|Lack of Efficacy|29|||
170518073|NCT02683239|616242462|FG005|Overall Study|Lack of Efficacy|2|||
170518074|NCT02683239|616242463|FG006|Overall Study|Lack of Efficacy|3|||
170518075|NCT02683239|616242457|FG000|Overall Study|Missing data|0|||
170518076|NCT02683239|616242458|FG001|Overall Study|Missing data|1|||
170518077|NCT02683239|616242459|FG002|Overall Study|Missing data|1|||
170518078|NCT02683239|616242460|FG003|Overall Study|Missing data|0|||
170518079|NCT02683239|616242461|FG004|Overall Study|Missing data|1|||
170518080|NCT02683239|616242462|FG005|Overall Study|Missing data|0|||
170518081|NCT02683239|616242463|FG006|Overall Study|Missing data|0|||
170518082|NCT02465437|616242466|FG000|Overall Study|Physician Decision|0|||
170518083|NCT02465437|616242467|FG001|Overall Study|Physician Decision|0|||
170518084|NCT02465437|616242468|FG002|Overall Study|Physician Decision|1|||
170518085|NCT02465437|616242469|FG003|Overall Study|Physician Decision|0|||
170518086|NCT02465437|616242466|FG000|Overall Study|Withdrawal by Subject|1|||
170518087|NCT02465437|616242467|FG001|Overall Study|Withdrawal by Subject|0|||
170518088|NCT02465437|616242468|FG002|Overall Study|Withdrawal by Subject|0|||
170518089|NCT02465437|616242469|FG003|Overall Study|Withdrawal by Subject|1|||
170518090|NCT02465437|616242466|FG000|Overall Study|Adverse Event|0|||
170518091|NCT02465437|616242467|FG001|Overall Study|Adverse Event|1|||
170518092|NCT02465437|616242468|FG002|Overall Study|Adverse Event|0|||
170518093|NCT02465437|616242469|FG003|Overall Study|Adverse Event|0|||
170518094|NCT01308463|616242470|FG000|Overall Study|Study Discontinued|23|||
170518095|NCT01308463|616242470|FG000|Overall Study|Death|4|||
170518096|NCT01308463|616242470|FG000|Overall Study|Revision|2|||
170518097|NCT02299388|616242471|FG000|Overall Study|Withdrawal by Subject|0|||
170518098|NCT02299388|616242472|FG001|Overall Study|Withdrawal by Subject|1|||
170518099|NCT03373760|616242477|FG000|Overall Study|Adverse Event|8|||
170518100|NCT03373760|616242477|FG000|Overall Study|Disease Progression|46|||
170518101|NCT03373760|616242477|FG000|Overall Study|Death|4|||
170518102|NCT03280056|616242478|FG000|Overall Study|Withdrawal by Subject|12|||
170518103|NCT03280056|616242479|FG001|Overall Study|Withdrawal by Subject|14|||
170518104|NCT03280056|616242478|FG000|Overall Study|Death|9|||
170518105|NCT03280056|616242479|FG001|Overall Study|Death|2|||
170518106|NCT03280056|616242478|FG000|Overall Study|Adverse Event|1|||
170518107|NCT03280056|616242479|FG001|Overall Study|Adverse Event|3|||
170518108|NCT03280056|616242478|FG000|Overall Study|Lost to Follow-up|1|||
170518109|NCT03280056|616242479|FG001|Overall Study|Lost to Follow-up|1|||
170518110|NCT03280056|616242478|FG000|Overall Study|Physician Decision|0|||
170518111|NCT03280056|616242479|FG001|Overall Study|Physician Decision|1|||
170518112|NCT03280056|616242478|FG000|Overall Study|Early Discontinuation|1|||
170518113|NCT03280056|616242479|FG001|Overall Study|Early Discontinuation|0|||
170518114|NCT01968811|616242485|FG000|Overall Study|Protocol Violation|4|||
170518115|NCT01968811|616242485|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
170518116|NCT01178125|616242487|FG000|Overall Study|Lost to Follow-up|397|||
170518117|NCT01178125|616242487|FG000|Overall Study|Adverse Event|244|||
170518118|NCT01178125|616242487|FG000|Overall Study|Withdrawal by Subject|209|||
170518119|NCT01178125|616242487|FG000|Overall Study|Noncompliance|184|||
170518120|NCT01178125|616242487|FG000|Overall Study|Pregnancy|55|||
170745718|NCT01474512|617076103|FG009|Long-Term Extension Period|Physician Decision|0|||
170745719|NCT01474512|617076104|FG010|Long-Term Extension Period|Physician Decision|0|||
170745720|NCT01474512|617076105|FG011|Long-Term Extension Period|Physician Decision|0|||
170518121|NCT01178125|616242487|FG000|Overall Study|Other Reason|39|||
170518122|NCT01178125|616242487|FG000|Overall Study|Sponsor Decision|28|||
170518123|NCT01178125|616242487|FG000|Overall Study|Protocol Violation|17|||
170518124|NCT01178125|616242487|FG000|Overall Study|Investigator Decision|5|||
170518125|NCT02948829|616242488|FG000|Overall Study|Lost to Follow-up|2|||
170518126|NCT02948829|616242488|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
170518127|NCT02948829|616242488|FG000|Overall Study|Pregnancy|1|||
170518128|NCT02948829|616242488|FG000|Overall Study|Other: Reason not Specified|8|||
170518129|NCT01004978|616242489|FG000|Overall Study|Disease progression|31|||
170518130|NCT01004978|616242490|FG001|Overall Study|Disease progression|48|||
170518131|NCT01004978|616242489|FG000|Overall Study|Adverse Event|42|||
170518132|NCT01004978|616242490|FG001|Overall Study|Adverse Event|22|||
170518133|NCT01004978|616242489|FG000|Overall Study|Death|3|||
170518134|NCT01004978|616242490|FG001|Overall Study|Death|2|||
170518135|NCT01004978|616242489|FG000|Overall Study|Withdrawal by Subject|16|||
170518136|NCT01004978|616242490|FG001|Overall Study|Withdrawal by Subject|16|||
170518137|NCT01004978|616242489|FG000|Overall Study|Alternative therapy|4|||
170518138|NCT01004978|616242490|FG001|Overall Study|Alternative therapy|8|||
170745721|NCT01474512|617076106|FG012|Long-Term Extension Period|Physician Decision|21|||
170745722|NCT01474512|617076107|FG013|Long-Term Extension Period|Physician Decision|21|||
170745723|NCT01474512|617076108|FG014|Long-Term Extension Period|Physician Decision|0|||
170745724|NCT01474512|617076109|FG015|Long-Term Extension Period|Physician Decision|0|||
170745725|NCT01474512|617076110|FG016|Long-Term Extension Period|Physician Decision|0|||
170745726|NCT01474512|617076111|FG017|Long-Term Extension Period|Physician Decision|0|||
170745727|NCT01474512|617076094|FG000|Long-Term Extension Period|Clinical Relapse|0|||
170745728|NCT01474512|617076095|FG001|Long-Term Extension Period|Clinical Relapse|0|||
170745729|NCT01474512|617076096|FG002|Long-Term Extension Period|Clinical Relapse|0|||
170745730|NCT01474512|617076097|FG003|Long-Term Extension Period|Clinical Relapse|0|||
170745731|NCT01474512|617076098|FG004|Long-Term Extension Period|Clinical Relapse|0|||
170745732|NCT01474512|617076099|FG005|Long-Term Extension Period|Clinical Relapse|0|||
170745733|NCT01474512|617076100|FG006|Long-Term Extension Period|Clinical Relapse|0|||
170745734|NCT01474512|617076101|FG007|Long-Term Extension Period|Clinical Relapse|0|||
170745735|NCT01474512|617076102|FG008|Long-Term Extension Period|Clinical Relapse|0|||
170745736|NCT01474512|617076103|FG009|Long-Term Extension Period|Clinical Relapse|0|||
170745737|NCT01474512|617076104|FG010|Long-Term Extension Period|Clinical Relapse|0|||
170745738|NCT01474512|617076105|FG011|Long-Term Extension Period|Clinical Relapse|0|||
170745739|NCT01474512|617076106|FG012|Long-Term Extension Period|Clinical Relapse|9|||
170745740|NCT01474512|617076107|FG013|Long-Term Extension Period|Clinical Relapse|9|||
170745741|NCT01474512|617076108|FG014|Long-Term Extension Period|Clinical Relapse|0|||
170745742|NCT01474512|617076109|FG015|Long-Term Extension Period|Clinical Relapse|0|||
170745743|NCT01474512|617076110|FG016|Long-Term Extension Period|Clinical Relapse|0|||
170745744|NCT01474512|617076111|FG017|Long-Term Extension Period|Clinical Relapse|0|||
170745745|NCT01474512|617076094|FG000|Long-Term Extension Period|Death|0|||
170745746|NCT01474512|617076095|FG001|Long-Term Extension Period|Death|0|||
170745747|NCT01474512|617076096|FG002|Long-Term Extension Period|Death|0|||
170745748|NCT01474512|617076097|FG003|Long-Term Extension Period|Death|0|||
170745749|NCT01474512|617076098|FG004|Long-Term Extension Period|Death|0|||
170745750|NCT01474512|617076099|FG005|Long-Term Extension Period|Death|0|||
170745751|NCT01474512|617076100|FG006|Long-Term Extension Period|Death|0|||
170745752|NCT01474512|617076101|FG007|Long-Term Extension Period|Death|0|||
170745753|NCT01474512|617076102|FG008|Long-Term Extension Period|Death|0|||
170745754|NCT01474512|617076103|FG009|Long-Term Extension Period|Death|0|||
170745755|NCT01474512|617076104|FG010|Long-Term Extension Period|Death|0|||
170745756|NCT01474512|617076105|FG011|Long-Term Extension Period|Death|0|||
170745757|NCT01474512|617076106|FG012|Long-Term Extension Period|Death|9|||
170745758|NCT01474512|617076107|FG013|Long-Term Extension Period|Death|9|||
170745759|NCT01474512|617076108|FG014|Long-Term Extension Period|Death|0|||
170745760|NCT01474512|617076109|FG015|Long-Term Extension Period|Death|0|||
170745761|NCT01474512|617076110|FG016|Long-Term Extension Period|Death|0|||
170745762|NCT01474512|617076111|FG017|Long-Term Extension Period|Death|0|||
170745763|NCT01474512|617076094|FG000|Long-Term Extension Period|Sponsor Decision|0|||
170745764|NCT01474512|617076095|FG001|Long-Term Extension Period|Sponsor Decision|0|||
170745765|NCT01474512|617076096|FG002|Long-Term Extension Period|Sponsor Decision|0|||
170745766|NCT01474512|617076097|FG003|Long-Term Extension Period|Sponsor Decision|0|||
170745767|NCT01474512|617076098|FG004|Long-Term Extension Period|Sponsor Decision|0|||
170745768|NCT01474512|617076099|FG005|Long-Term Extension Period|Sponsor Decision|0|||
170745769|NCT01474512|617076100|FG006|Long-Term Extension Period|Sponsor Decision|0|||
170745770|NCT01474512|617076101|FG007|Long-Term Extension Period|Sponsor Decision|0|||
170745771|NCT01474512|617076102|FG008|Long-Term Extension Period|Sponsor Decision|0|||
170745772|NCT01474512|617076103|FG009|Long-Term Extension Period|Sponsor Decision|0|||
170745773|NCT01474512|617076104|FG010|Long-Term Extension Period|Sponsor Decision|0|||
170745774|NCT01474512|617076105|FG011|Long-Term Extension Period|Sponsor Decision|0|||
170745775|NCT01474512|617076106|FG012|Long-Term Extension Period|Sponsor Decision|6|||
170745776|NCT01474512|617076107|FG013|Long-Term Extension Period|Sponsor Decision|6|||
170745777|NCT01474512|617076108|FG014|Long-Term Extension Period|Sponsor Decision|0|||
170745778|NCT01474512|617076109|FG015|Long-Term Extension Period|Sponsor Decision|0|||
170745779|NCT01474512|617076110|FG016|Long-Term Extension Period|Sponsor Decision|0|||
170745780|NCT01474512|617076111|FG017|Long-Term Extension Period|Sponsor Decision|0|||
170745781|NCT01474512|617076094|FG000|Long-Term Extension Period|Protocol Violation|0|||
170745782|NCT01474512|617076095|FG001|Long-Term Extension Period|Protocol Violation|0|||
170745783|NCT01474512|617076096|FG002|Long-Term Extension Period|Protocol Violation|0|||
170745784|NCT01474512|617076097|FG003|Long-Term Extension Period|Protocol Violation|0|||
170745785|NCT01474512|617076098|FG004|Long-Term Extension Period|Protocol Violation|0|||
170745786|NCT01474512|617076099|FG005|Long-Term Extension Period|Protocol Violation|0|||
170745787|NCT01474512|617076100|FG006|Long-Term Extension Period|Protocol Violation|0|||
170745788|NCT01474512|617076101|FG007|Long-Term Extension Period|Protocol Violation|0|||
170745789|NCT01474512|617076102|FG008|Long-Term Extension Period|Protocol Violation|0|||
170745790|NCT01474512|617076103|FG009|Long-Term Extension Period|Protocol Violation|0|||
170745791|NCT01474512|617076104|FG010|Long-Term Extension Period|Protocol Violation|0|||
170745792|NCT01474512|617076105|FG011|Long-Term Extension Period|Protocol Violation|0|||
170906109|NCT01446809|617658621|FG001|Overall Study|Adverse Event|0|||
170745793|NCT01474512|617076106|FG012|Long-Term Extension Period|Protocol Violation|5|||
170745794|NCT01474512|617076107|FG013|Long-Term Extension Period|Protocol Violation|5|||
170745795|NCT01474512|617076108|FG014|Long-Term Extension Period|Protocol Violation|0|||
170745796|NCT01474512|617076109|FG015|Long-Term Extension Period|Protocol Violation|0|||
170745797|NCT01474512|617076110|FG016|Long-Term Extension Period|Protocol Violation|0|||
170745798|NCT01474512|617076111|FG017|Long-Term Extension Period|Protocol Violation|0|||
170745799|NCT01474512|617076094|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745800|NCT01474512|617076095|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745801|NCT01474512|617076096|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745802|NCT01474512|617076097|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745803|NCT01474512|617076098|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745804|NCT01474512|617076099|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745805|NCT01474512|617076100|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745806|NCT01474512|617076101|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745807|NCT01474512|617076102|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745808|NCT01474512|617076103|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745809|NCT01474512|617076104|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745810|NCT01474512|617076105|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745811|NCT01474512|617076106|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
170745812|NCT01474512|617076107|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
170745813|NCT01474512|617076108|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745814|NCT01474512|617076109|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745815|NCT01474512|617076110|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745816|NCT01474512|617076111|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
170745817|NCT01474512|617076094|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745818|NCT01474512|617076095|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745819|NCT01474512|617076096|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745820|NCT01474512|617076097|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745821|NCT01474512|617076098|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745822|NCT01474512|617076099|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745823|NCT01474512|617076100|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745824|NCT01474512|617076101|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745825|NCT01474512|617076102|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745826|NCT01474512|617076103|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745827|NCT01474512|617076104|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745828|NCT01474512|617076105|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
170745829|NCT01474512|617076106|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745830|NCT01474512|617076107|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745831|NCT01474512|617076108|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745832|NCT01474512|617076109|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745833|NCT01474512|617076110|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745834|NCT01474512|617076111|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
170745835|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
170745836|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
170745837|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
170745838|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
170745839|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
170745840|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
170745841|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
170745842|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
170745843|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
170745844|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
170745845|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
170745846|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
170745847|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
170745848|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
170745849|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
170745850|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
170745851|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
170745852|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
170745853|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745854|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745855|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745856|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745857|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745858|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745859|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745860|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745861|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745862|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745863|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745864|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745865|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745866|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
170745867|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
170745868|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
170745869|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
170745870|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
170745871|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745872|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745873|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745874|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745875|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745876|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745877|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745878|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745879|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745880|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745881|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745882|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745883|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745884|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
170745885|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
170745886|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
170745887|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
170745888|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
170745889|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745890|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745891|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745892|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745893|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745894|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745895|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745896|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745897|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745898|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745899|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745900|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745901|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745902|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745903|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745904|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
170745905|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
170745906|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
170745907|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
170745908|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
170745909|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
170745910|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
170745911|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
170745912|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
170745913|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
170745914|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
170745915|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
170745916|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
170745917|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
170745918|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
170745919|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
170745920|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
170745921|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
170745922|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
170745923|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
170745924|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
170745925|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745926|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745927|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745928|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745929|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745930|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745931|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745932|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
170518139|NCT01004978|616242489|FG000|Overall Study|Physician Decision|6|||
170745933|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745934|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745935|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745936|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745937|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745938|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745939|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745940|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
170745941|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
170745942|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
170745943|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
170745944|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
170745945|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
170745946|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
170745947|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
170745948|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
170745949|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
170745950|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
170745951|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
170745952|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
170745953|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
170745954|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
170745955|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
170745956|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
170745957|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
170745958|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
170745959|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
170745960|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
170745961|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745962|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745963|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745964|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745965|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745966|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745967|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745968|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745969|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745970|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745971|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745972|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745973|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745974|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745975|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
170745976|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745977|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
170745978|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
170745979|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745980|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745981|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745982|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745983|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745984|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745985|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745986|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745987|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745988|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745989|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745990|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745991|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745992|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745993|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
170745994|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745995|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
170745996|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
170745997|NCT01474512|617076094|FG000|Post-Treatment Follow-Up|Death|0|||
170745998|NCT01474512|617076095|FG001|Post-Treatment Follow-Up|Death|0|||
170745999|NCT01474512|617076096|FG002|Post-Treatment Follow-Up|Death|0|||
170746000|NCT01474512|617076097|FG003|Post-Treatment Follow-Up|Death|0|||
170746001|NCT01474512|617076098|FG004|Post-Treatment Follow-Up|Death|0|||
170746002|NCT01474512|617076099|FG005|Post-Treatment Follow-Up|Death|0|||
170746003|NCT01474512|617076100|FG006|Post-Treatment Follow-Up|Death|0|||
170746004|NCT01474512|617076101|FG007|Post-Treatment Follow-Up|Death|0|||
170746005|NCT01474512|617076102|FG008|Post-Treatment Follow-Up|Death|0|||
170746006|NCT01474512|617076103|FG009|Post-Treatment Follow-Up|Death|0|||
170746007|NCT01474512|617076104|FG010|Post-Treatment Follow-Up|Death|0|||
170746008|NCT01474512|617076105|FG011|Post-Treatment Follow-Up|Death|0|||
170746009|NCT01474512|617076106|FG012|Post-Treatment Follow-Up|Death|0|||
170746010|NCT01474512|617076107|FG013|Post-Treatment Follow-Up|Death|0|||
170746011|NCT01474512|617076108|FG014|Post-Treatment Follow-Up|Death|0|||
170746012|NCT01474512|617076109|FG015|Post-Treatment Follow-Up|Death|0|||
170746013|NCT01474512|617076110|FG016|Post-Treatment Follow-Up|Death|1|||
170746014|NCT01474512|617076111|FG017|Post-Treatment Follow-Up|Death|0|||
170746015|NCT01118962|617076116|FG000|Overall Study|Adverse Event|2|||
170746016|NCT01118962|617076116|FG000|Overall Study|Lack of Efficacy|1|||
170746017|NCT01118962|617076116|FG000|Overall Study|Protocol Violation|1|||
170746018|NCT01118962|617076116|FG000|Overall Study|Withdrawal by Subject|4|||
170746019|NCT01118962|617076116|FG000|Overall Study|Pregnancy|1|||
170746020|NCT01118962|617076116|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
170746021|NCT01089556|617076117|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
170746022|NCT01089556|617076118|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
170746023|NCT01089556|617076119|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
170746024|NCT01089556|617076120|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
170746025|NCT01089556|617076121|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
170746026|NCT01089556|617076122|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
170746027|NCT01089556|617076117|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
170746028|NCT01089556|617076118|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
170746029|NCT01089556|617076119|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
170746030|NCT01089556|617076120|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
170746031|NCT01089556|617076121|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
170746032|NCT01089556|617076122|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
170746033|NCT01089556|617076117|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
170746034|NCT01089556|617076118|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
170746035|NCT01089556|617076119|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
170746036|NCT01089556|617076120|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
170746037|NCT01089556|617076121|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
170746038|NCT01089556|617076122|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
170746039|NCT01089556|617076117|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
170746040|NCT01089556|617076118|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
170746041|NCT01089556|617076119|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
170746042|NCT01089556|617076120|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
170746043|NCT01089556|617076121|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
170746044|NCT01089556|617076122|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
170746045|NCT01089556|617076117|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
170746046|NCT01089556|617076118|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
170746047|NCT01089556|617076119|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
170746048|NCT01089556|617076120|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
170746049|NCT01089556|617076121|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
170746050|NCT01089556|617076122|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
170746051|NCT01089556|617076117|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
170746052|NCT01089556|617076118|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
170746053|NCT01089556|617076119|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
170746054|NCT01089556|617076120|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
170746055|NCT01089556|617076121|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
170746056|NCT01089556|617076122|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
170746057|NCT01089556|617076117|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
170746058|NCT01089556|617076118|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
170746059|NCT01089556|617076119|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
170746060|NCT01089556|617076120|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
170746061|NCT01089556|617076121|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
170746062|NCT01089556|617076122|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
170746063|NCT01089556|617076117|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
170746064|NCT01089556|617076118|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
170746065|NCT01089556|617076119|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
170746066|NCT01089556|617076120|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
170746067|NCT01089556|617076121|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
170746068|NCT01089556|617076122|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
170746069|NCT01089556|617076117|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
170746070|NCT01089556|617076118|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
170746071|NCT01089556|617076119|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
170746072|NCT01089556|617076120|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
170746073|NCT01089556|617076121|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
170746074|NCT01089556|617076122|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
170746075|NCT01089556|617076117|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
170906110|NCT01446809|617658622|FG002|Overall Study|Adverse Event|1|||
170518140|NCT01004978|616242490|FG001|Overall Study|Physician Decision|3|||
170518141|NCT01004978|616242489|FG000|Overall Study|Other complicating disease|2|||
170518142|NCT01004978|616242490|FG001|Overall Study|Other complicating disease|2|||
170518143|NCT01004978|616242489|FG000|Overall Study|Protocol Violation|2|||
170518144|NCT01004978|616242490|FG001|Overall Study|Protocol Violation|3|||
170518145|NCT01004978|616242489|FG000|Overall Study|Non-compliance|3|||
170518146|NCT01004978|616242490|FG001|Overall Study|Non-compliance|2|||
170518147|NCT01004978|616242489|FG000|Overall Study|Ineligible|1|||
170518148|NCT01004978|616242490|FG001|Overall Study|Ineligible|0|||
170518149|NCT01004978|616242489|FG000|Overall Study|Unblinded|0|||
170518150|NCT01004978|616242490|FG001|Overall Study|Unblinded|1|||
170518151|NCT01004978|616242489|FG000|Overall Study|Performance status worsening|0|||
170518152|NCT01004978|616242490|FG001|Overall Study|Performance status worsening|1|||
170518153|NCT01004978|616242489|FG000|Overall Study|Never started treatment|8|||
170518154|NCT01004978|616242490|FG001|Overall Study|Never started treatment|9|||
170518155|NCT01089127|616242497|FG000|Overall Study|Adverse Event|5|||
170518156|NCT01089127|616242498|FG001|Overall Study|Adverse Event|1|||
170518157|NCT01089127|616242499|FG002|Overall Study|Adverse Event|1|||
170518158|NCT01089127|616242500|FG003|Overall Study|Adverse Event|0|||
170518159|NCT01089127|616242501|FG004|Overall Study|Adverse Event|0|||
170518160|NCT01089127|616242502|FG005|Overall Study|Adverse Event|1|||
170518161|NCT01089127|616242497|FG000|Overall Study|Subject withdrew consent|0|||
170518162|NCT01089127|616242498|FG001|Overall Study|Subject withdrew consent|1|||
170518163|NCT01089127|616242499|FG002|Overall Study|Subject withdrew consent|1|||
170518164|NCT01089127|616242500|FG003|Overall Study|Subject withdrew consent|1|||
170518165|NCT01089127|616242501|FG004|Overall Study|Subject withdrew consent|0|||
170518166|NCT01089127|616242502|FG005|Overall Study|Subject withdrew consent|2|||
170518167|NCT01089127|616242497|FG000|Overall Study|Abnormal test procedure result(s)|2|||
170518168|NCT01089127|616242498|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170518169|NCT01089127|616242499|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170518170|NCT01089127|616242500|FG003|Overall Study|Abnormal test procedure result(s)|0|||
170518171|NCT01089127|616242501|FG004|Overall Study|Abnormal test procedure result(s)|0|||
170518172|NCT01089127|616242502|FG005|Overall Study|Abnormal test procedure result(s)|0|||
170518173|NCT01089127|616242497|FG000|Overall Study|Lost to Follow-up|1|||
170518174|NCT01089127|616242498|FG001|Overall Study|Lost to Follow-up|1|||
170518175|NCT01089127|616242499|FG002|Overall Study|Lost to Follow-up|0|||
170518176|NCT01089127|616242500|FG003|Overall Study|Lost to Follow-up|0|||
170518177|NCT01089127|616242501|FG004|Overall Study|Lost to Follow-up|1|||
170518178|NCT01089127|616242502|FG005|Overall Study|Lost to Follow-up|0|||
170518179|NCT01089127|616242497|FG000|Overall Study|Protocol deviation|0|||
170518180|NCT01089127|616242498|FG001|Overall Study|Protocol deviation|1|||
170518181|NCT01089127|616242499|FG002|Overall Study|Protocol deviation|0|||
170518182|NCT01089127|616242500|FG003|Overall Study|Protocol deviation|0|||
170518183|NCT01089127|616242501|FG004|Overall Study|Protocol deviation|1|||
170518184|NCT01089127|616242502|FG005|Overall Study|Protocol deviation|0|||
170518185|NCT00875563|616242504|FG000|Overall Study|Death|4|||
170518186|NCT00875563|616242504|FG000|Overall Study|Withdrawal by Subject|7|||
170518187|NCT00875563|616242504|FG000|Overall Study|No long-term (3-5 year) consent|6|||
170518188|NCT00875563|616242504|FG000|Overall Study|Still be eligible for follow-up|7|||
170518189|NCT00313846|616242507|FG000|Overall Study|Withdrawal by Subject|2|||
170518190|NCT00313846|616242508|FG001|Overall Study|Withdrawal by Subject|0|||
170518191|NCT00313846|616242507|FG000|Overall Study|Adverse Event|1|||
170518192|NCT00313846|616242508|FG001|Overall Study|Adverse Event|8|||
170518193|NCT00313846|616242507|FG000|Overall Study|Administrative|2|||
170518194|NCT00313846|616242508|FG001|Overall Study|Administrative|3|||
170518195|NCT00627497|616242513|FG000|Overall Study|Lost to Follow-up|1|||
170518196|NCT00627497|616242514|FG001|Overall Study|Lost to Follow-up|1|||
170518197|NCT00627497|616242515|FG002|Overall Study|Lost to Follow-up|0|||
170518198|NCT00627497|616242516|FG003|Overall Study|Lost to Follow-up|0|||
170518199|NCT01300247|616242517|FG000|Overall Study|Death|1|||
170518200|NCT01300247|616242518|FG001|Overall Study|Death|1|||
170518201|NCT01300247|616242517|FG000|Overall Study|Lost to Follow-up|2|||
170518202|NCT01300247|616242518|FG001|Overall Study|Lost to Follow-up|0|||
170518203|NCT01300247|616242517|FG000|Overall Study|Withdrawal by Subject|1|||
170518204|NCT01300247|616242518|FG001|Overall Study|Withdrawal by Subject|0|||
170518205|NCT01300247|616242517|FG000|Overall Study|Non-Compliance|0|||
170518206|NCT01300247|616242518|FG001|Overall Study|Non-Compliance|1|||
170518207|NCT03231306|616242519|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
170518208|NCT03231306|616242519|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
170518209|NCT03231306|616242519|FG000|Overall Study|Treatment delay > 21 days|2|||
170518210|NCT03231306|616242519|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
170518211|NCT03231306|616242519|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
170518212|NCT03231306|616242519|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
170518213|NCT03231306|616242519|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
170518214|NCT03231306|616242519|FG000|Overall Study|More than 1 Reason|2|||
170746076|NCT01089556|617076118|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
170746077|NCT01089556|617076119|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
170746078|NCT01089556|617076120|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
170746079|NCT01089556|617076121|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
170746080|NCT01089556|617076122|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
170746081|NCT01089556|617076117|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
170746082|NCT01089556|617076118|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
170746083|NCT01089556|617076119|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
170746084|NCT01089556|617076120|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
170746085|NCT01089556|617076121|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
170746086|NCT01089556|617076122|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
170746087|NCT01089556|617076117|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
170746088|NCT01089556|617076118|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
170746089|NCT01089556|617076119|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
170746090|NCT01089556|617076120|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
170746091|NCT01089556|617076121|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
170746092|NCT01089556|617076122|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
170746093|NCT01089556|617076117|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
170746094|NCT01089556|617076118|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
170746095|NCT01089556|617076119|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
170746096|NCT01089556|617076120|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
170746097|NCT01089556|617076121|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
170746098|NCT01089556|617076122|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
170746099|NCT01089556|617076117|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
170746100|NCT01089556|617076118|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
170746101|NCT01089556|617076119|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
170746102|NCT01089556|617076120|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
170746103|NCT01089556|617076121|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
170746104|NCT01089556|617076122|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
170746105|NCT01089556|617076117|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
170746106|NCT01089556|617076118|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
170746107|NCT01089556|617076119|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
170746108|NCT01089556|617076120|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
170746109|NCT01089556|617076121|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
170746110|NCT01089556|617076122|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
170746111|NCT01087723|617076124|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
170746112|NCT01087723|617076125|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
170746113|NCT01087723|617076124|FG000|Overall Study|Withdrawal by Subject|10|||
170746114|NCT01087723|617076125|FG001|Overall Study|Withdrawal by Subject|13|||
170746115|NCT01087723|617076124|FG000|Overall Study|Physician Decision|2|||
170746116|NCT01087723|617076125|FG001|Overall Study|Physician Decision|0|||
170746117|NCT01087723|617076124|FG000|Overall Study|Lost to Follow-up|1|||
170746118|NCT01087723|617076125|FG001|Overall Study|Lost to Follow-up|4|||
170746119|NCT01087723|617076124|FG000|Overall Study|Reason Not Specified|1|||
170746120|NCT01087723|617076125|FG001|Overall Study|Reason Not Specified|2|||
170746121|NCT01868035|617076126|FG000|Overall Study|Lost to Follow-up|3|||
170746122|NCT01868035|617076126|FG000|Overall Study|Withdrawal by Subject|1|||
170746123|NCT01868035|617076126|FG000|Overall Study|Progressive Disease|2|||
170746124|NCT01868035|617076126|FG000|Overall Study|Non-compliance|1|||
170746125|NCT01757665|617076133|FG000|Overall Study|Still on Study - Visit Completed|240|||
170746126|NCT01757665|617076134|FG001|Overall Study|Still on Study - Visit Completed|30|||
170746127|NCT01757665|617076133|FG000|Overall Study|Still on Study - Visit Pending|398|||
170746128|NCT01757665|617076134|FG001|Overall Study|Still on Study - Visit Pending|40|||
170746129|NCT01757665|617076133|FG000|Overall Study|Still on Study - Missed Visit|14|||
170746130|NCT01757665|617076134|FG001|Overall Study|Still on Study - Missed Visit|1|||
170746131|NCT01757665|617076133|FG000|Overall Study|Death|25|||
170746132|NCT01757665|617076134|FG001|Overall Study|Death|8|||
170746133|NCT01757665|617076133|FG000|Overall Study|Explant|1|||
170746134|NCT01757665|617076134|FG001|Overall Study|Explant|2|||
170746135|NCT01757665|617076133|FG000|Overall Study|Withdrawal by Subject|10|||
170746136|NCT01757665|617076134|FG001|Overall Study|Withdrawal by Subject|0|||
170746137|NCT01757665|617076133|FG000|Overall Study|Lost to Follow-up|1|||
170746138|NCT01757665|617076134|FG001|Overall Study|Lost to Follow-up|1|||
170746139|NCT01757665|617076133|FG000|Overall Study|Not Implanted with Device|5|||
170746140|NCT01757665|617076134|FG001|Overall Study|Not Implanted with Device|1|||
170746141|NCT01912222|617076137|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
170746142|NCT01912222|617076138|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
170746143|NCT01912222|617076139|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
170746144|NCT01912222|617076137|FG000|Part B: Treatment Period|Progressive disease|10|||
170746145|NCT01912222|617076138|FG001|Part B: Treatment Period|Progressive disease|12|||
170746146|NCT01912222|617076139|FG002|Part B: Treatment Period|Progressive disease|15|||
170746147|NCT01912222|617076137|FG000|Part B: Treatment Period|Adverse Event|1|||
170746148|NCT01912222|617076138|FG001|Part B: Treatment Period|Adverse Event|2|||
170746149|NCT01912222|617076139|FG002|Part B: Treatment Period|Adverse Event|3|||
170746150|NCT01912222|617076137|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
170746151|NCT01912222|617076138|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
170746152|NCT01912222|617076139|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
170746153|NCT00154063|617076140|FG000|Overall Study|Adverse Event|4|||
170746154|NCT00154063|617076141|FG001|Overall Study|Adverse Event|8|||
170746155|NCT00154063|617076140|FG000|Overall Study|Protocol Violation|1|||
170746156|NCT00154063|617076141|FG001|Overall Study|Protocol Violation|1|||
170746157|NCT00154063|617076140|FG000|Overall Study|Investigator or Sponsor Request|0|||
170746158|NCT00154063|617076141|FG001|Overall Study|Investigator or Sponsor Request|1|||
170746159|NCT00154063|617076140|FG000|Overall Study|Withdrawal by Subject|4|||
170746160|NCT00154063|617076141|FG001|Overall Study|Withdrawal by Subject|9|||
170746161|NCT00154063|617076140|FG000|Overall Study|Other|3|||
170746162|NCT00154063|617076141|FG001|Overall Study|Other|3|||
170630582|NCT03224819|616660517|FG013|Overall Study|Lost to Follow-up|0|||
170630583|NCT03224819|616660504|FG000|Overall Study|Death|0|||
170630584|NCT03224819|616660505|FG001|Overall Study|Death|1|||
170630585|NCT03224819|616660506|FG002|Overall Study|Death|0|||
170630586|NCT03224819|616660507|FG003|Overall Study|Death|0|||
170630587|NCT03224819|616660508|FG004|Overall Study|Death|0|||
170630588|NCT03224819|616660509|FG005|Overall Study|Death|0|||
170630589|NCT03224819|616660510|FG006|Overall Study|Death|0|||
170630590|NCT03224819|616660511|FG007|Overall Study|Death|1|||
170630591|NCT03224819|616660512|FG008|Overall Study|Death|0|||
170630592|NCT03224819|616660513|FG009|Overall Study|Death|0|||
170630593|NCT03224819|616660514|FG010|Overall Study|Death|0|||
170630594|NCT03224819|616660515|FG011|Overall Study|Death|1|||
170630595|NCT03224819|616660516|FG012|Overall Study|Death|0|||
170630596|NCT03224819|616660517|FG013|Overall Study|Death|0|||
170630597|NCT03783078|616660518|FG000|Overall Study|Death|31|||
170630598|NCT03783078|616660518|FG000|Overall Study|Sponsor Decision|23|||
170630599|NCT03783078|616660518|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170630600|NCT00795535|616660521|FG000|Overall Study|incomplete data and technical problems|20|||
170630601|NCT00521079|616660523|FG000|Overall Study|Adverse Event|7|||
170630602|NCT00521079|616660524|FG001|Overall Study|Adverse Event|1|||
170630603|NCT00521079|616660523|FG000|Overall Study|Lost to Follow-up|2|||
170630604|NCT00521079|616660524|FG001|Overall Study|Lost to Follow-up|1|||
170630605|NCT00521079|616660523|FG000|Overall Study|Withdrawal by Subject|5|||
170630606|NCT00521079|616660524|FG001|Overall Study|Withdrawal by Subject|3|||
170630607|NCT00541658|616660525|FG000|Overall Study|Adverse Event|28|||
170630608|NCT00541658|616660526|FG001|Overall Study|Adverse Event|37|||
170630609|NCT00541658|616660527|FG002|Overall Study|Adverse Event|25|||
170630610|NCT00541658|616660525|FG000|Overall Study|Physician Decision|0|||
170630611|NCT00541658|616660526|FG001|Overall Study|Physician Decision|0|||
170630612|NCT00541658|616660527|FG002|Overall Study|Physician Decision|4|||
170630613|NCT00541658|616660525|FG000|Overall Study|Lost to Follow-up|3|||
170630614|NCT00541658|616660526|FG001|Overall Study|Lost to Follow-up|3|||
170630615|NCT00541658|616660527|FG002|Overall Study|Lost to Follow-up|6|||
170630616|NCT00541658|616660525|FG000|Overall Study|Protocol Violation|0|||
170630617|NCT00541658|616660526|FG001|Overall Study|Protocol Violation|1|||
170630618|NCT00541658|616660527|FG002|Overall Study|Protocol Violation|1|||
170630619|NCT00541658|616660525|FG000|Overall Study|Withdrawal by Subject|28|||
170630620|NCT00541658|616660526|FG001|Overall Study|Withdrawal by Subject|32|||
170630621|NCT00541658|616660527|FG002|Overall Study|Withdrawal by Subject|32|||
170630622|NCT00541658|616660525|FG000|Overall Study|Took No Study Drug|1|||
170630623|NCT00541658|616660526|FG001|Overall Study|Took No Study Drug|0|||
170630624|NCT00541658|616660527|FG002|Overall Study|Took No Study Drug|0|||
170630625|NCT03435211|616660528|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
170630626|NCT03866577|616660529|FG000|Overall Study|Protocol Violation|0|||
170630627|NCT03866577|616660530|FG001|Overall Study|Protocol Violation|0|||
170630628|NCT03866577|616660531|FG002|Overall Study|Protocol Violation|0|||
170630629|NCT03866577|616660532|FG003|Overall Study|Protocol Violation|0|||
170630630|NCT03866577|616660533|FG004|Overall Study|Protocol Violation|0|||
170630631|NCT03866577|616660534|FG005|Overall Study|Protocol Violation|0|||
170630632|NCT03866577|616660535|FG006|Overall Study|Protocol Violation|0|||
170630633|NCT03866577|616660536|FG007|Overall Study|Protocol Violation|0|||
170630634|NCT03866577|616660537|FG008|Overall Study|Protocol Violation|0|||
170630635|NCT03866577|616660538|FG009|Overall Study|Protocol Violation|0|||
170630636|NCT03866577|616660539|FG010|Overall Study|Protocol Violation|0|||
170630637|NCT03866577|616660540|FG011|Overall Study|Protocol Violation|1|||
170630638|NCT03866577|616660541|FG012|Overall Study|Protocol Violation|0|||
170746163|NCT01804673|617076142|FG000|Overall Study|Adverse Event|4|||
170746164|NCT01804673|617076142|FG000|Overall Study|Withdrawal by Subject|1|||
170630639|NCT03866577|616660529|FG000|Overall Study|Withdrawal by Subject|0|||
170630640|NCT03866577|616660530|FG001|Overall Study|Withdrawal by Subject|0|||
170746165|NCT01804673|617076142|FG000|Overall Study|Lack of Efficacy|9|||
170746166|NCT01804673|617076142|FG000|Overall Study|Change to Oral Therapy|37|||
170630641|NCT03866577|616660531|FG002|Overall Study|Withdrawal by Subject|0|||
170518215|NCT04533438|616242520|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
170518216|NCT04533438|616242521|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
170518217|NCT01972464|616242534|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
170518218|NCT01972464|616242535|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
170518219|NCT01972464|616242534|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
170518220|NCT01972464|616242535|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
170518221|NCT01972464|616242534|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
170518222|NCT01972464|616242535|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
170518223|NCT01972464|616242534|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
170518224|NCT01972464|616242535|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
170518225|NCT01919164|616244373|FG000|Overall Study|Adverse Event|6|||
170518226|NCT01919164|616244374|FG001|Overall Study|Adverse Event|4|||
170518227|NCT01919164|616244375|FG002|Overall Study|Adverse Event|9|||
170518228|NCT01919164|616244376|FG003|Overall Study|Adverse Event|3|||
170518229|NCT01919164|616244377|FG004|Overall Study|Adverse Event|2|||
170518230|NCT01919164|616244373|FG000|Overall Study|Lost to Follow-up|2|||
170518231|NCT01919164|616244374|FG001|Overall Study|Lost to Follow-up|2|||
170518232|NCT01919164|616244375|FG002|Overall Study|Lost to Follow-up|2|||
170518233|NCT01919164|616244376|FG003|Overall Study|Lost to Follow-up|0|||
170518234|NCT01919164|616244377|FG004|Overall Study|Lost to Follow-up|4|||
170518235|NCT01919164|616244373|FG000|Overall Study|Death|1|||
170518236|NCT01919164|616244374|FG001|Overall Study|Death|0|||
170518237|NCT01919164|616244375|FG002|Overall Study|Death|0|||
170518238|NCT01919164|616244376|FG003|Overall Study|Death|0|||
170518239|NCT01919164|616244377|FG004|Overall Study|Death|0|||
170518240|NCT01919164|616244373|FG000|Overall Study|Protocol Violation|6|||
170518241|NCT01919164|616244374|FG001|Overall Study|Protocol Violation|0|||
170518242|NCT01919164|616244375|FG002|Overall Study|Protocol Violation|3|||
170518243|NCT01919164|616244376|FG003|Overall Study|Protocol Violation|2|||
170518244|NCT01919164|616244377|FG004|Overall Study|Protocol Violation|2|||
170518245|NCT01919164|616244373|FG000|Overall Study|Disease progression|2|||
170518246|NCT01919164|616244374|FG001|Overall Study|Disease progression|2|||
170518247|NCT01919164|616244375|FG002|Overall Study|Disease progression|1|||
170518248|NCT01919164|616244376|FG003|Overall Study|Disease progression|2|||
170518249|NCT01919164|616244377|FG004|Overall Study|Disease progression|1|||
170518250|NCT01919164|616244373|FG000|Overall Study|Withdrew consent|13|||
170518251|NCT01919164|616244374|FG001|Overall Study|Withdrew consent|13|||
170518252|NCT01919164|616244375|FG002|Overall Study|Withdrew consent|14|||
170518253|NCT01919164|616244376|FG003|Overall Study|Withdrew consent|14|||
170518254|NCT01919164|616244377|FG004|Overall Study|Withdrew consent|9|||
170518255|NCT01919164|616244373|FG000|Overall Study|Other Un-specified|13|||
170518256|NCT01919164|616244374|FG001|Overall Study|Other Un-specified|9|||
170518257|NCT01919164|616244375|FG002|Overall Study|Other Un-specified|8|||
170518258|NCT01919164|616244376|FG003|Overall Study|Other Un-specified|7|||
170518259|NCT01919164|616244377|FG004|Overall Study|Other Un-specified|15|||
170518260|NCT04980014|616244381|FG000|Overall Study|Participants who are Duplicated|1|||
170518261|NCT04980014|616244381|FG000|Overall Study|Follow-up Failure|13|||
170518262|NCT04980014|616244381|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
170518263|NCT04980014|616244381|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
170518264|NCT04980014|616244381|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
170518265|NCT00940888|616244382|FG000|Overall Study|Unsuccessful Implant|4|||
170518266|NCT00940888|616244382|FG000|Overall Study|Death|461|||
170518267|NCT00940888|616244382|FG000|Overall Study|Withdrawn - Non-Death|364|||
170518268|NCT00940888|616244382|FG000|Overall Study|Lost to Follow-up|6|||
170518269|NCT01516736|616244390|FG000|Overall Study|Withdrawal by Subject|10|||
170518270|NCT01516736|616244391|FG001|Overall Study|Withdrawal by Subject|4|||
170518271|NCT01516736|616244390|FG000|Overall Study|Adverse Event|4|||
170518272|NCT01516736|616244391|FG001|Overall Study|Adverse Event|5|||
170518273|NCT01516736|616244390|FG000|Overall Study|Death|3|||
170518274|NCT01516736|616244391|FG001|Overall Study|Death|1|||
170518275|NCT01516736|616244390|FG000|Overall Study|Physician Decision|2|||
170518276|NCT01516736|616244391|FG001|Overall Study|Physician Decision|1|||
170518277|NCT01516736|616244390|FG000|Overall Study|Lack of Efficacy|1|||
170518278|NCT01516736|616244391|FG001|Overall Study|Lack of Efficacy|0|||
170518279|NCT01516736|616244390|FG000|Overall Study|Protocol Violation|0|||
170518280|NCT01516736|616244391|FG001|Overall Study|Protocol Violation|1|||
170518281|NCT01516736|616244390|FG000|Overall Study|Other (not specified)|0|||
170518282|NCT01516736|616244391|FG001|Overall Study|Other (not specified)|1|||
170518283|NCT00524771|616244392|FG000|Overall Study|Protocol Violation|220|||
170518284|NCT00524771|616244393|FG001|Overall Study|Protocol Violation|585|||
170518285|NCT01223404|616244394|FG000|First Intervention (1 Day)|Adverse Event|0|||
170518286|NCT01223404|616244395|FG001|First Intervention (1 Day)|Adverse Event|0|||
170518287|NCT01223404|616244396|FG002|First Intervention (1 Day)|Adverse Event|0|||
170518288|NCT01223404|616244397|FG003|First Intervention (1 Day)|Adverse Event|1|||
170518289|NCT01223404|616244398|FG004|First Intervention (1 Day)|Adverse Event|0|||
170518290|NCT01223404|616244399|FG005|First Intervention (1 Day)|Adverse Event|0|||
170518291|NCT01223404|616244394|FG000|Second Intervention (1 Day)|Adverse Event|1|||
170630642|NCT03866577|616660532|FG003|Overall Study|Withdrawal by Subject|0|||
170630643|NCT03866577|616660533|FG004|Overall Study|Withdrawal by Subject|0|||
170630644|NCT03866577|616660534|FG005|Overall Study|Withdrawal by Subject|0|||
170630645|NCT03866577|616660535|FG006|Overall Study|Withdrawal by Subject|0|||
170630646|NCT03866577|616660536|FG007|Overall Study|Withdrawal by Subject|0|||
170630647|NCT03866577|616660537|FG008|Overall Study|Withdrawal by Subject|1|||
170630648|NCT03866577|616660538|FG009|Overall Study|Withdrawal by Subject|1|||
170630649|NCT03866577|616660539|FG010|Overall Study|Withdrawal by Subject|0|||
170630650|NCT03866577|616660540|FG011|Overall Study|Withdrawal by Subject|0|||
170630651|NCT03866577|616660541|FG012|Overall Study|Withdrawal by Subject|0|||
170630652|NCT03866577|616660529|FG000|Overall Study|Not qualified for IVIg infusion|0|||
170630653|NCT03866577|616660530|FG001|Overall Study|Not qualified for IVIg infusion|0|||
170630654|NCT03866577|616660531|FG002|Overall Study|Not qualified for IVIg infusion|0|||
170630655|NCT03866577|616660532|FG003|Overall Study|Not qualified for IVIg infusion|0|||
170630656|NCT03866577|616660533|FG004|Overall Study|Not qualified for IVIg infusion|0|||
170630657|NCT03866577|616660534|FG005|Overall Study|Not qualified for IVIg infusion|0|||
170630658|NCT03866577|616660535|FG006|Overall Study|Not qualified for IVIg infusion|0|||
170630659|NCT03866577|616660536|FG007|Overall Study|Not qualified for IVIg infusion|0|||
170630660|NCT03866577|616660537|FG008|Overall Study|Not qualified for IVIg infusion|0|||
170630661|NCT03866577|616660538|FG009|Overall Study|Not qualified for IVIg infusion|1|||
170630662|NCT03866577|616660539|FG010|Overall Study|Not qualified for IVIg infusion|0|||
170630663|NCT03866577|616660540|FG011|Overall Study|Not qualified for IVIg infusion|0|||
170630664|NCT03866577|616660541|FG012|Overall Study|Not qualified for IVIg infusion|0|||
170630665|NCT03818256|616660543|FG000|Overall Study|Withdrawal by Subject|2|||
170630666|NCT03818256|616660544|FG001|Overall Study|Withdrawal by Subject|2|||
170630667|NCT03818256|616660543|FG000|Overall Study|Adverse Event|3|||
170630668|NCT03818256|616660544|FG001|Overall Study|Adverse Event|1|||
170630669|NCT03818256|616660543|FG000|Overall Study|Lost to Follow-up|0|||
170630670|NCT03818256|616660544|FG001|Overall Study|Lost to Follow-up|5|||
170630671|NCT03818256|616660543|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
170630672|NCT03818256|616660544|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
170630673|NCT03818256|616660543|FG000|Overall Study|Not reporting for scheduled visits|1|||
170630674|NCT03818256|616660544|FG001|Overall Study|Not reporting for scheduled visits|0|||
170630675|NCT03818256|616660543|FG000|Overall Study|Non-compliant with investigational product|1|||
170630676|NCT03818256|616660544|FG001|Overall Study|Non-compliant with investigational product|0|||
170630677|NCT01342211|616660545|FG000|Overall Study|Lost to Follow-up|0|||
170630678|NCT01342211|616660546|FG001|Overall Study|Lost to Follow-up|0|||
170630679|NCT01342211|616660547|FG002|Overall Study|Lost to Follow-up|0|||
170630680|NCT01342211|616660548|FG003|Overall Study|Lost to Follow-up|1|||
170630681|NCT01342211|616660549|FG004|Overall Study|Lost to Follow-up|0|||
170630682|NCT01342211|616660545|FG000|Overall Study|Adverse Event|0|||
170630683|NCT01342211|616660546|FG001|Overall Study|Adverse Event|0|||
170630684|NCT01342211|616660547|FG002|Overall Study|Adverse Event|0|||
170630685|NCT01342211|616660548|FG003|Overall Study|Adverse Event|0|||
170630686|NCT01342211|616660549|FG004|Overall Study|Adverse Event|1|||
170630687|NCT01342211|616660545|FG000|Overall Study|Withdrawal by Subject|0|||
170630688|NCT01342211|616660546|FG001|Overall Study|Withdrawal by Subject|0|||
170630689|NCT01342211|616660547|FG002|Overall Study|Withdrawal by Subject|0|||
170630690|NCT01342211|616660548|FG003|Overall Study|Withdrawal by Subject|1|||
170630691|NCT01342211|616660549|FG004|Overall Study|Withdrawal by Subject|0|||
170630692|NCT01342211|616660545|FG000|Overall Study|Randomized, but not Treated|0|||
170630693|NCT01342211|616660546|FG001|Overall Study|Randomized, but not Treated|2|||
170630694|NCT01342211|616660547|FG002|Overall Study|Randomized, but not Treated|0|||
170630695|NCT01342211|616660548|FG003|Overall Study|Randomized, but not Treated|0|||
170630696|NCT01342211|616660549|FG004|Overall Study|Randomized, but not Treated|1|||
170630697|NCT00400179|616660550|FG000|Overall Study|Adverse Event|2|||
170630698|NCT00400179|616660551|FG001|Overall Study|Adverse Event|2|||
170630699|NCT00400179|616660550|FG000|Overall Study|Death|1|||
170630700|NCT00400179|616660551|FG001|Overall Study|Death|2|||
170630701|NCT00400179|616660550|FG000|Overall Study|Withdrew Consent|1|||
170630702|NCT00400179|616660551|FG001|Overall Study|Withdrew Consent|5|||
170630703|NCT00400179|616660550|FG000|Overall Study|Disease progression|1|||
170630704|NCT00400179|616660551|FG001|Overall Study|Disease progression|1|||
170630705|NCT00400179|616660550|FG000|Overall Study|Intercurrent illness|0|||
170630706|NCT00400179|616660551|FG001|Overall Study|Intercurrent illness|1|||
170630707|NCT00400179|616660550|FG000|Overall Study|Investigator judgment|0|||
170630708|NCT00400179|616660551|FG001|Overall Study|Investigator judgment|1|||
170906111|NCT01446809|617658620|FG000|Overall Study|Failure to complete study procedures|0|||
170630709|NCT00400179|616660550|FG000|Overall Study|Randomization error/patient ineligible|1|||
170630710|NCT00400179|616660551|FG001|Overall Study|Randomization error/patient ineligible|6|||
170630711|NCT04780061|616660552|FG000|Overall Study|Withdrawal by Subject|5|||
170630712|NCT04780061|616660553|FG001|Overall Study|Withdrawal by Subject|8|||
170630713|NCT04780061|616660552|FG000|Overall Study|Adverse Event|2|||
170630714|NCT04780061|616660553|FG001|Overall Study|Adverse Event|2|||
170630715|NCT04780061|616660552|FG000|Overall Study|Lost to Follow-up|1|||
170518292|NCT01223404|616244395|FG001|Second Intervention (1 Day)|Adverse Event|0|||
170518293|NCT01223404|616244396|FG002|Second Intervention (1 Day)|Adverse Event|0|||
170518294|NCT01223404|616244397|FG003|Second Intervention (1 Day)|Adverse Event|0|||
170518295|NCT01223404|616244398|FG004|Second Intervention (1 Day)|Adverse Event|0|||
170518296|NCT01223404|616244399|FG005|Second Intervention (1 Day)|Adverse Event|0|||
170518297|NCT01223404|616244394|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
170518298|NCT01223404|616244395|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
170518299|NCT01223404|616244396|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
170518300|NCT01223404|616244397|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
170518301|NCT01223404|616244398|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
170518302|NCT01223404|616244399|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
170518303|NCT01697800|616244400|FG000|Overall Study|Death|0|||
170518304|NCT01697800|616244401|FG001|Overall Study|Death|1|||
170518305|NCT01957579|616244406|FG000|Overall Study|Withdrawal of concent|0|||
170518306|NCT01957579|616244407|FG001|Overall Study|Withdrawal of concent|1|||
170518307|NCT01957579|616244408|FG002|Overall Study|Withdrawal of concent|0|||
170518308|NCT01957579|616244409|FG003|Overall Study|Withdrawal of concent|0|||
170518309|NCT01957579|616244406|FG000|Overall Study|Death|0|||
170518310|NCT01957579|616244407|FG001|Overall Study|Death|0|||
170518311|NCT01957579|616244408|FG002|Overall Study|Death|2|||
170518312|NCT01957579|616244409|FG003|Overall Study|Death|0|||
170518313|NCT02019550|616244410|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
170518314|NCT02019550|616244411|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
170518315|NCT02750332|616244413|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170518316|NCT02750332|616244414|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170518317|NCT02922153|616244422|FG000|Overall Study|Death|8|||
170518318|NCT02922153|616244423|FG001|Overall Study|Death|1|||
170518319|NCT02922153|616244422|FG000|Overall Study|Lost to Follow-up|1|||
170518320|NCT02922153|616244423|FG001|Overall Study|Lost to Follow-up|0|||
170518321|NCT02922153|616244422|FG000|Overall Study|Physician Decision|1|||
170518322|NCT02922153|616244423|FG001|Overall Study|Physician Decision|1|||
170518323|NCT01325350|616244424|FG000|Overall Study|Adverse Event|3|||
170518324|NCT01325350|616244425|FG001|Overall Study|Adverse Event|3|||
170518325|NCT01325350|616244426|FG002|Overall Study|Adverse Event|3|||
170518326|NCT01325350|616244427|FG003|Overall Study|Adverse Event|1|||
170518327|NCT01325350|616244428|FG004|Overall Study|Adverse Event|2|||
170518328|NCT01325350|616244424|FG000|Overall Study|Pregnancy|0|||
170518329|NCT01325350|616244425|FG001|Overall Study|Pregnancy|0|||
170518330|NCT01325350|616244426|FG002|Overall Study|Pregnancy|1|||
170518331|NCT01325350|616244427|FG003|Overall Study|Pregnancy|0|||
170518332|NCT01325350|616244428|FG004|Overall Study|Pregnancy|1|||
170518333|NCT01325350|616244424|FG000|Overall Study|Lost to Follow-up|1|||
170518334|NCT01325350|616244425|FG001|Overall Study|Lost to Follow-up|0|||
170518335|NCT01325350|616244426|FG002|Overall Study|Lost to Follow-up|5|||
170518336|NCT01325350|616244427|FG003|Overall Study|Lost to Follow-up|1|||
170518337|NCT01325350|616244428|FG004|Overall Study|Lost to Follow-up|5|||
170518338|NCT01325350|616244424|FG000|Overall Study|Personal Reasons|2|||
170518339|NCT01325350|616244425|FG001|Overall Study|Personal Reasons|1|||
170518340|NCT01325350|616244426|FG002|Overall Study|Personal Reasons|6|||
170518341|NCT01325350|616244427|FG003|Overall Study|Personal Reasons|5|||
170518342|NCT01325350|616244428|FG004|Overall Study|Personal Reasons|3|||
170518343|NCT01325350|616244424|FG000|Overall Study|Protocol Violation|0|||
170518344|NCT01325350|616244425|FG001|Overall Study|Protocol Violation|0|||
170518345|NCT01325350|616244426|FG002|Overall Study|Protocol Violation|0|||
170518346|NCT01325350|616244427|FG003|Overall Study|Protocol Violation|1|||
170518347|NCT01325350|616244428|FG004|Overall Study|Protocol Violation|0|||
170518348|NCT01325350|616244424|FG000|Overall Study|Withdrawal by Subject|0|||
170518349|NCT01325350|616244425|FG001|Overall Study|Withdrawal by Subject|0|||
170518350|NCT01325350|616244426|FG002|Overall Study|Withdrawal by Subject|1|||
170518351|NCT01325350|616244427|FG003|Overall Study|Withdrawal by Subject|1|||
170518352|NCT01325350|616244428|FG004|Overall Study|Withdrawal by Subject|0|||
170518353|NCT01325350|616244424|FG000|Overall Study|Did Not Receive Treatment|0|||
170518354|NCT01325350|616244425|FG001|Overall Study|Did Not Receive Treatment|1|||
170518355|NCT01325350|616244426|FG002|Overall Study|Did Not Receive Treatment|1|||
170518356|NCT01325350|616244427|FG003|Overall Study|Did Not Receive Treatment|0|||
170518357|NCT01325350|616244428|FG004|Overall Study|Did Not Receive Treatment|1|||
170518358|NCT00522548|616244429|FG000|Overall Study|Adverse Event|2|||
170518359|NCT00522548|616244430|FG001|Overall Study|Adverse Event|2|||
170518360|NCT00522548|616244429|FG000|Overall Study|Withdrawal by Subject|0|||
170518361|NCT00522548|616244430|FG001|Overall Study|Withdrawal by Subject|2|||
170518362|NCT00956839|616244431|FG000|Overall Study|Lost to Follow-up|3|||
170518363|NCT00956839|616244432|FG001|Overall Study|Lost to Follow-up|0|||
170518364|NCT00956839|616244433|FG002|Overall Study|Lost to Follow-up|3|||
170518365|NCT03506438|616244437|FG000|Overall Study|Lost to Follow-up|8|||
170518366|NCT03506438|616244438|FG001|Overall Study|Lost to Follow-up|7|||
170518367|NCT03506438|616244439|FG002|Overall Study|Lost to Follow-up|8|||
170518368|NCT03506438|616244440|FG003|Overall Study|Lost to Follow-up|7|||
170518369|NCT03506438|616244441|FG004|Overall Study|Lost to Follow-up|0|||
170518370|NCT03506438|616244442|FG005|Overall Study|Lost to Follow-up|0|||
170630716|NCT04780061|616660553|FG001|Overall Study|Lost to Follow-up|5|||
170630717|NCT04050553|616660555|FG000|Period 1|Physician Decision|2|||
170630718|NCT04050553|616660556|FG001|Period 1|Physician Decision|2|||
170630719|NCT04050553|616660555|FG000|Period 1|Adverse Event|1|||
170630720|NCT04050553|616660556|FG001|Period 1|Adverse Event|1|||
170630721|NCT04050553|616660555|FG000|Period 1|Withdrawal by Subject|0|||
170630722|NCT04050553|616660556|FG001|Period 1|Withdrawal by Subject|1|||
170630723|NCT04050553|616660555|FG000|Wash-out|Adverse Event|0|||
170630724|NCT04050553|616660556|FG001|Wash-out|Adverse Event|1|||
170630725|NCT04050553|616660555|FG000|Wash-out|Withdrawal by Subject|0|||
170630726|NCT04050553|616660556|FG001|Wash-out|Withdrawal by Subject|1|||
170630727|NCT05430854|616660557|FG000|Overall Study|Trial terminated by Sponsor|39|||
170630728|NCT05430854|616660558|FG001|Overall Study|Trial terminated by Sponsor|50|||
170518371|NCT04155463|616244445|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
170518372|NCT04155463|616244446|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
170518373|NCT00113295|616244447|FG000|Overall Study|Adverse Event|4|||
170518374|NCT00113295|616244448|FG001|Overall Study|Adverse Event|1|||
170518375|NCT00113295|616244447|FG000|Overall Study|Unrelated Medical Illness|1|||
170518376|NCT00113295|616244448|FG001|Overall Study|Unrelated Medical Illness|0|||
170518377|NCT01053741|616244449|FG000|2nd Study Intervention|Physician Decision|0|||
170518378|NCT01053741|616244450|FG001|2nd Study Intervention|Physician Decision|1|||
170518379|NCT00994110|616244451|FG000|Overall Study|Withdrawal by Subject|9|||
170518380|NCT00994110|616244452|FG001|Overall Study|Withdrawal by Subject|9|||
170518381|NCT00994110|616244451|FG000|Overall Study|Not Treated|4|||
170518382|NCT00994110|616244452|FG001|Overall Study|Not Treated|8|||
170518383|NCT00994110|616244451|FG000|Overall Study|Adverse Event|1|||
170518384|NCT00994110|616244452|FG001|Overall Study|Adverse Event|0|||
170518385|NCT00994110|616244451|FG000|Overall Study|Patient not resected|41|||
170518386|NCT00994110|616244452|FG001|Overall Study|Patient not resected|52|||
170518387|NCT00994110|616244451|FG000|Overall Study|Pt not eligible|10|||
170518388|NCT00994110|616244452|FG001|Overall Study|Pt not eligible|5|||
170518389|NCT00521365|616244458|FG000|Overall Study|Adverse Event|3|||
170518390|NCT00521365|616244458|FG000|Overall Study|Lost to Follow-up|6|||
170518391|NCT00521365|616244458|FG000|Overall Study|Protocol deviation|2|||
170518392|NCT00521365|616244458|FG000|Overall Study|Drug compliance|3|||
170518393|NCT00521365|616244458|FG000|Overall Study|Usage of not allowed drugs|6|||
170518394|NCT00368108|616244459|FG000|Overall Study|Adverse Event|38|||
170518395|NCT00368108|616244460|FG001|Overall Study|Adverse Event|26|||
170518396|NCT00368108|616244461|FG002|Overall Study|Adverse Event|44|||
170518397|NCT00368108|616244459|FG000|Overall Study|Abnormal Laboratory Value|0|||
170518398|NCT00368108|616244460|FG001|Overall Study|Abnormal Laboratory Value|0|||
170518399|NCT00368108|616244461|FG002|Overall Study|Abnormal Laboratory Value|3|||
170518400|NCT00368108|616244459|FG000|Overall Study|Protocol Violation|5|||
170518401|NCT00368108|616244460|FG001|Overall Study|Protocol Violation|9|||
170518402|NCT00368108|616244461|FG002|Overall Study|Protocol Violation|9|||
170518403|NCT00368108|616244459|FG000|Overall Study|Withdrawal by Subject|9|||
170518404|NCT00368108|616244460|FG001|Overall Study|Withdrawal by Subject|3|||
170518405|NCT00368108|616244461|FG002|Overall Study|Withdrawal by Subject|5|||
170518406|NCT00368108|616244459|FG000|Overall Study|Lack of Efficacy|7|||
170518407|NCT00368108|616244460|FG001|Overall Study|Lack of Efficacy|8|||
170518408|NCT00368108|616244461|FG002|Overall Study|Lack of Efficacy|5|||
170518409|NCT00368108|616244459|FG000|Overall Study|Physician Decision|2|||
170518410|NCT00368108|616244460|FG001|Overall Study|Physician Decision|0|||
170518411|NCT00368108|616244461|FG002|Overall Study|Physician Decision|1|||
170518412|NCT00368108|616244459|FG000|Overall Study|Other|3|||
170518413|NCT00368108|616244460|FG001|Overall Study|Other|7|||
170518414|NCT00368108|616244461|FG002|Overall Study|Other|1|||
170518415|NCT03150082|616244462|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
170518416|NCT03150082|616244463|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
170518417|NCT01718483|616244464|FG000|Overall Study|Withdrawal by Subject|14|||
170518418|NCT01718483|616244465|FG001|Overall Study|Withdrawal by Subject|12|||
170518419|NCT01718483|616244464|FG000|Overall Study|Adverse Event|5|||
170518420|NCT01718483|616244465|FG001|Overall Study|Adverse Event|12|||
170518421|NCT01718483|616244464|FG000|Overall Study|Lost to Follow-up|8|||
170518422|NCT01718483|616244465|FG001|Overall Study|Lost to Follow-up|3|||
170518423|NCT01718483|616244464|FG000|Overall Study|Protocol Violation|4|||
170518424|NCT01718483|616244465|FG001|Overall Study|Protocol Violation|2|||
170518425|NCT01718483|616244464|FG000|Overall Study|Other|1|||
170518426|NCT01718483|616244465|FG001|Overall Study|Other|4|||
170518427|NCT01718483|616244464|FG000|Overall Study|Pregnancy|1|||
170518428|NCT01718483|616244465|FG001|Overall Study|Pregnancy|1|||
170518429|NCT01718483|616244464|FG000|Overall Study|Lack of Efficacy|1|||
170518430|NCT01718483|616244465|FG001|Overall Study|Lack of Efficacy|0|||
170518431|NCT03334188|616244470|FG000|Overall Study|Withdrawal by Subject|0|||
170518432|NCT03334188|616244471|FG001|Overall Study|Withdrawal by Subject|1|||
170518433|NCT03334188|616244470|FG000|Overall Study|Death|1|||
170630729|NCT05430854|616660559|FG002|Overall Study|Trial terminated by Sponsor|46|||
170630730|NCT05430854|616660557|FG000|Overall Study|Withdrawal by Subject|0|||
170630731|NCT05430854|616660558|FG001|Overall Study|Withdrawal by Subject|3|||
170746167|NCT01804673|617076142|FG000|Overall Study|No Further Therapy Required|84|||
170746168|NCT01804673|617076142|FG000|Overall Study|Use of Prohibited Medication|1|||
170746169|NCT01804673|617076142|FG000|Overall Study|Other|4|||
170746170|NCT01857934|617076150|FG000|Overall Study|Relapse or progression|2|||
170746171|NCT01857934|617076150|FG000|Overall Study|Unacceptable toxicity|3|||
170746172|NCT01857934|617076150|FG000|Overall Study|Unwillingness or inability to comply|2|||
170746173|NCT01857934|617076150|FG000|Overall Study|Physician Decision|3|||
170746174|NCT00603265|617076151|FG000|Overall Study|Adverse Event|2|||
170746175|NCT00603265|617076152|FG001|Overall Study|Adverse Event|11|||
170746176|NCT00603265|617076153|FG002|Overall Study|Adverse Event|1|||
170746177|NCT00603265|617076151|FG000|Overall Study|Withdrawal by Subject|1|||
170746178|NCT00603265|617076152|FG001|Overall Study|Withdrawal by Subject|2|||
170746179|NCT00603265|617076153|FG002|Overall Study|Withdrawal by Subject|1|||
170746180|NCT00603265|617076151|FG000|Overall Study|Lack of Efficacy|3|||
170746181|NCT00603265|617076152|FG001|Overall Study|Lack of Efficacy|0|||
170746182|NCT00603265|617076153|FG002|Overall Study|Lack of Efficacy|3|||
170746183|NCT00603265|617076151|FG000|Overall Study|Lost to Follow-up|0|||
170746184|NCT00603265|617076152|FG001|Overall Study|Lost to Follow-up|1|||
170746185|NCT00603265|617076153|FG002|Overall Study|Lost to Follow-up|0|||
170746186|NCT00603265|617076151|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
170746187|NCT00603265|617076152|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
170746188|NCT00603265|617076153|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
170746189|NCT00603265|617076151|FG000|Overall Study|Participant Left Country, No Responses|0|||
170746190|NCT00603265|617076152|FG001|Overall Study|Participant Left Country, No Responses|1|||
170746191|NCT00603265|617076153|FG002|Overall Study|Participant Left Country, No Responses|0|||
170746192|NCT00603265|617076151|FG000|Overall Study|Protocol Violation|1|||
170746193|NCT00603265|617076152|FG001|Overall Study|Protocol Violation|0|||
170746194|NCT00603265|617076153|FG002|Overall Study|Protocol Violation|0|||
170746195|NCT04399551|617076154|FG000|Overall Study|Adverse Event|15|||
170746196|NCT04399551|617076154|FG000|Overall Study|Withdrawal by Subject|6|||
170746197|NCT04399551|617076154|FG000|Overall Study|Physician Decision|3|||
170746198|NCT04399551|617076154|FG000|Overall Study|Lost to Follow-up|2|||
170746199|NCT04399551|617076154|FG000|Overall Study|Protocol Deviation|2|||
170746200|NCT03377790|617076159|FG000|Overall Study|Withdrawal by Subject|1|||
170746201|NCT03377790|617076160|FG001|Overall Study|Withdrawal by Subject|0|||
170746202|NCT03377790|617076159|FG000|Overall Study|Adverse Event|1|||
170746203|NCT03377790|617076160|FG001|Overall Study|Adverse Event|0|||
170746204|NCT03377790|617076159|FG000|Overall Study|Lost to Follow-up|0|||
170746205|NCT03377790|617076160|FG001|Overall Study|Lost to Follow-up|2|||
170746206|NCT03377790|617076159|FG000|Overall Study|Randomized but not treated|1|||
170746207|NCT03377790|617076160|FG001|Overall Study|Randomized but not treated|0|||
170746208|NCT03377790|617076159|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
170746209|NCT03377790|617076160|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
170746210|NCT00594906|617076161|FG000|Overall Study|Physician Decision|1|||
170746211|NCT00594906|617076162|FG001|Overall Study|Physician Decision|0|||
170746212|NCT00594906|617076161|FG000|Overall Study|Physician Decision|0|||
170746213|NCT00594906|617076162|FG001|Overall Study|Physician Decision|1|||
170746214|NCT00594906|617076161|FG000|Overall Study|Death|0|||
170746215|NCT00594906|617076162|FG001|Overall Study|Death|1|||
170746216|NCT01533714|617076164|FG000|Overall Study|Adverse Event|0|||
170746217|NCT01533714|617076165|FG001|Overall Study|Adverse Event|1|||
170746218|NCT01533714|617076166|FG002|Overall Study|Adverse Event|2|||
170746219|NCT01533714|617076167|FG003|Overall Study|Adverse Event|2|||
170746220|NCT01533714|617076168|FG004|Overall Study|Adverse Event|2|||
170746221|NCT01533714|617076169|FG005|Overall Study|Adverse Event|1|||
170746222|NCT01533714|617076164|FG000|Overall Study|Lack of Efficacy|0|||
170746223|NCT01533714|617076165|FG001|Overall Study|Lack of Efficacy|0|||
170746224|NCT01533714|617076166|FG002|Overall Study|Lack of Efficacy|0|||
170746225|NCT01533714|617076167|FG003|Overall Study|Lack of Efficacy|0|||
170746226|NCT01533714|617076168|FG004|Overall Study|Lack of Efficacy|0|||
170746227|NCT01533714|617076169|FG005|Overall Study|Lack of Efficacy|1|||
170746228|NCT01533714|617076164|FG000|Overall Study|Withdrawal by Subject|0|||
170746229|NCT01533714|617076165|FG001|Overall Study|Withdrawal by Subject|1|||
170746230|NCT01533714|617076166|FG002|Overall Study|Withdrawal by Subject|0|||
170746231|NCT01533714|617076167|FG003|Overall Study|Withdrawal by Subject|1|||
170518434|NCT03334188|616244471|FG001|Overall Study|Death|0|||
170746232|NCT01533714|617076168|FG004|Overall Study|Withdrawal by Subject|1|||
170746233|NCT01533714|617076169|FG005|Overall Study|Withdrawal by Subject|0|||
170746234|NCT01533714|617076164|FG000|Overall Study|Exclusion criteria|0|||
170746235|NCT01533714|617076165|FG001|Overall Study|Exclusion criteria|1|||
170746236|NCT01533714|617076166|FG002|Overall Study|Exclusion criteria|0|||
170746237|NCT01533714|617076167|FG003|Overall Study|Exclusion criteria|0|||
170746238|NCT01533714|617076168|FG004|Overall Study|Exclusion criteria|0|||
170518435|NCT03334188|616244470|FG000|Overall Study|Never had qualifying clinic visit|7|||
170746239|NCT01533714|617076169|FG005|Overall Study|Exclusion criteria|0|||
170746240|NCT01533714|617076164|FG000|Overall Study|Positive for purified protein derivative|0|||
170746241|NCT01533714|617076165|FG001|Overall Study|Positive for purified protein derivative|0|||
170518436|NCT03334188|616244471|FG001|Overall Study|Never had qualifying clinic visit|7|||
170518437|NCT04668209|616244472|FG000|Overall Study|Withdrawal by Subject|2|||
170518438|NCT04668209|616244473|FG001|Overall Study|Withdrawal by Subject|2|||
170518439|NCT04668209|616244472|FG000|Overall Study|Lost to Follow-up|3|||
170518440|NCT04668209|616244473|FG001|Overall Study|Lost to Follow-up|4|||
170518441|NCT04668209|616244472|FG000|Overall Study|Subject Expired|2|||
170518442|NCT04668209|616244473|FG001|Overall Study|Subject Expired|0|||
170518443|NCT04668209|616244472|FG000|Overall Study|Withdrawn from study|0|||
170518444|NCT04668209|616244473|FG001|Overall Study|Withdrawn from study|1|||
170518445|NCT04668209|616244472|FG000|Overall Study|Adverse Event|0|||
170518446|NCT04668209|616244473|FG001|Overall Study|Adverse Event|1|||
170518447|NCT00613366|616244483|FG000|Overall Study|Withdrawal by Subject|3|||
170518448|NCT00613366|616244484|FG001|Overall Study|Withdrawal by Subject|2|||
170518449|NCT00943397|616244486|FG000|Overall Study|Adverse Event|0|||
170518450|NCT00943397|616244487|FG001|Overall Study|Adverse Event|6|||
170518451|NCT00943397|616244486|FG000|Overall Study|Lost to Follow-up|0|||
170518452|NCT00943397|616244487|FG001|Overall Study|Lost to Follow-up|4|||
170518453|NCT00943397|616244486|FG000|Overall Study|Protocol Violation|2|||
170518454|NCT00943397|616244487|FG001|Overall Study|Protocol Violation|5|||
170518455|NCT00943397|616244486|FG000|Overall Study|Withdrawal by Subject|1|||
170518456|NCT00943397|616244487|FG001|Overall Study|Withdrawal by Subject|1|||
170518457|NCT00943397|616244486|FG000|Overall Study|Site terminated and other|12|||
170518458|NCT00943397|616244487|FG001|Overall Study|Site terminated and other|56|||
170518459|NCT01135524|616244488|FG000|Overall Study|Withdrawal by Subject|14|||
170518460|NCT01135524|616244488|FG000|Overall Study|Adverse Event|20|||
170518461|NCT01135524|616244488|FG000|Overall Study|Lost to Follow-up|3|||
170518462|NCT01135524|616244488|FG000|Overall Study|Administrative|151|||
170518463|NCT01135524|616244488|FG000|Overall Study|Lack of Efficacy|8|||
170518464|NCT04878055|616244489|FG000|Overall Study|Patient transferred in another department|0|||
170518465|NCT04878055|616244490|FG001|Overall Study|Patient transferred in another department|2|||
170518466|NCT04878055|616244489|FG000|Overall Study|Physician Decision|1|||
170518467|NCT04878055|616244490|FG001|Overall Study|Physician Decision|1|||
170518468|NCT04878055|616244489|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
170518469|NCT04878055|616244490|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
170518470|NCT04878055|616244489|FG000|Overall Study|Adverse Event|12|||
170518471|NCT04878055|616244490|FG001|Overall Study|Adverse Event|7|||
170518472|NCT04878055|616244489|FG000|Overall Study|Other|5|||
170518473|NCT04878055|616244490|FG001|Overall Study|Other|0|||
170518474|NCT04878055|616244489|FG000|Overall Study|Withdrawal by Subject|7|||
170518475|NCT04878055|616244490|FG001|Overall Study|Withdrawal by Subject|3|||
170518476|NCT04878055|616244489|FG000|Overall Study|Lost to Follow-up|10|||
170518477|NCT04878055|616244490|FG001|Overall Study|Lost to Follow-up|1|||
170518478|NCT01719380|616244492|FG000|Overall Study|Adverse Event|0|||
170518479|NCT01719380|616244493|FG001|Overall Study|Adverse Event|0|||
170518480|NCT01719380|616244494|FG002|Overall Study|Adverse Event|1|||
170518481|NCT01719380|616244495|FG003|Overall Study|Adverse Event|2|||
170518482|NCT01719380|616244496|FG004|Overall Study|Adverse Event|0|||
170518483|NCT01719380|616244497|FG005|Overall Study|Adverse Event|1|||
170518484|NCT01719380|616244498|FG006|Overall Study|Adverse Event|0|||
170518485|NCT01719380|616244499|FG007|Overall Study|Adverse Event|1|||
170518486|NCT01719380|616244500|FG008|Overall Study|Adverse Event|4|||
170518487|NCT01719380|616244501|FG009|Overall Study|Adverse Event|3|||
170518488|NCT01719380|616244492|FG000|Overall Study|Death|0|||
170518489|NCT01719380|616244493|FG001|Overall Study|Death|1|||
170518490|NCT01719380|616244494|FG002|Overall Study|Death|0|||
170518491|NCT01719380|616244495|FG003|Overall Study|Death|0|||
170518492|NCT01719380|616244496|FG004|Overall Study|Death|0|||
170518493|NCT01719380|616244497|FG005|Overall Study|Death|0|||
170518494|NCT01719380|616244498|FG006|Overall Study|Death|0|||
170518495|NCT01719380|616244499|FG007|Overall Study|Death|0|||
170518496|NCT01719380|616244500|FG008|Overall Study|Death|3|||
170518497|NCT01719380|616244501|FG009|Overall Study|Death|3|||
170518498|NCT01719380|616244492|FG000|Overall Study|Participant/Guardian Decision|0|||
170518499|NCT01719380|616244493|FG001|Overall Study|Participant/Guardian Decision|0|||
170518500|NCT01719380|616244494|FG002|Overall Study|Participant/Guardian Decision|1|||
170518501|NCT01719380|616244495|FG003|Overall Study|Participant/Guardian Decision|0|||
170518502|NCT01719380|616244496|FG004|Overall Study|Participant/Guardian Decision|0|||
170518503|NCT01719380|616244497|FG005|Overall Study|Participant/Guardian Decision|0|||
170518504|NCT01719380|616244498|FG006|Overall Study|Participant/Guardian Decision|0|||
170518505|NCT01719380|616244499|FG007|Overall Study|Participant/Guardian Decision|0|||
170518506|NCT01719380|616244500|FG008|Overall Study|Participant/Guardian Decision|2|||
170518507|NCT01719380|616244501|FG009|Overall Study|Participant/Guardian Decision|2|||
170518508|NCT01719380|616244492|FG000|Overall Study|Physician Decision|0|||
170518509|NCT01719380|616244493|FG001|Overall Study|Physician Decision|0|||
170518510|NCT01719380|616244494|FG002|Overall Study|Physician Decision|2|||
170518511|NCT01719380|616244495|FG003|Overall Study|Physician Decision|0|||
170518512|NCT01719380|616244496|FG004|Overall Study|Physician Decision|0|||
170518513|NCT01719380|616244497|FG005|Overall Study|Physician Decision|0|||
170518514|NCT01719380|616244498|FG006|Overall Study|Physician Decision|0|||
170518515|NCT01719380|616244499|FG007|Overall Study|Physician Decision|0|||
170518516|NCT01719380|616244500|FG008|Overall Study|Physician Decision|1|||
170518517|NCT01719380|616244501|FG009|Overall Study|Physician Decision|1|||
170518518|NCT01719380|616244492|FG000|Overall Study|Lack of Efficacy|2|||
170518519|NCT01719380|616244493|FG001|Overall Study|Lack of Efficacy|6|||
170518520|NCT01719380|616244494|FG002|Overall Study|Lack of Efficacy|5|||
170518521|NCT01719380|616244495|FG003|Overall Study|Lack of Efficacy|6|||
170518522|NCT01719380|616244496|FG004|Overall Study|Lack of Efficacy|3|||
170518523|NCT01719380|616244497|FG005|Overall Study|Lack of Efficacy|7|||
170518524|NCT01719380|616244498|FG006|Overall Study|Lack of Efficacy|10|||
170518525|NCT01719380|616244499|FG007|Overall Study|Lack of Efficacy|6|||
170518526|NCT01719380|616244500|FG008|Overall Study|Lack of Efficacy|39|||
170518527|NCT01719380|616244501|FG009|Overall Study|Lack of Efficacy|42|||
170518528|NCT01719380|616244492|FG000|Overall Study|Progressive Disease|0|||
170518529|NCT01719380|616244493|FG001|Overall Study|Progressive Disease|0|||
170518530|NCT01719380|616244494|FG002|Overall Study|Progressive Disease|0|||
170518531|NCT01719380|616244495|FG003|Overall Study|Progressive Disease|0|||
170518532|NCT01719380|616244496|FG004|Overall Study|Progressive Disease|0|||
170518533|NCT01719380|616244497|FG005|Overall Study|Progressive Disease|0|||
170518534|NCT01719380|616244498|FG006|Overall Study|Progressive Disease|0|||
170518535|NCT01719380|616244499|FG007|Overall Study|Progressive Disease|0|||
170518536|NCT01719380|616244500|FG008|Overall Study|Progressive Disease|1|||
170518537|NCT01719380|616244501|FG009|Overall Study|Progressive Disease|0|||
170518538|NCT00249873|616244504|FG000|Overall Study|Not treated|7|||
170518539|NCT00249873|616244505|FG001|Overall Study|Not treated|8|||
170518540|NCT00249873|616244504|FG000|Overall Study|Significant thrombocytopenia|9|||
170518541|NCT00249873|616244505|FG001|Overall Study|Significant thrombocytopenia|8|||
170518542|NCT00249873|616244504|FG000|Overall Study|Severe allergic reaction|8|||
170518543|NCT00249873|616244505|FG001|Overall Study|Severe allergic reaction|1|||
170518544|NCT00249873|616244504|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
170518545|NCT00249873|616244505|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
170518546|NCT00249873|616244504|FG000|Overall Study|Other Serious Adverse Event|86|||
170518547|NCT00249873|616244505|FG001|Overall Study|Other Serious Adverse Event|97|||
170518548|NCT00249873|616244504|FG000|Overall Study|Qualifying condition not present|20|||
170518549|NCT00249873|616244505|FG001|Overall Study|Qualifying condition not present|23|||
170518550|NCT00249873|616244504|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
170518551|NCT00249873|616244505|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
170518552|NCT00249873|616244504|FG000|Overall Study|Withdrawal by Subject|504|||
170518553|NCT00249873|616244505|FG001|Overall Study|Withdrawal by Subject|466|||
170630732|NCT05430854|616660559|FG002|Overall Study|Withdrawal by Subject|0|||
170630733|NCT02023086|616660563|FG000|Overall Study|Withdrawal by Subject|2|||
170630734|NCT02023086|616660564|FG001|Overall Study|Withdrawal by Subject|0|||
170630735|NCT04607005|616660565|FG000|Overall Study|Adverse Event|0|||
170630736|NCT04607005|616660566|FG001|Overall Study|Adverse Event|1|||
170630737|NCT04607005|616660565|FG000|Overall Study|Lack of Efficacy|1|||
170630738|NCT04607005|616660566|FG001|Overall Study|Lack of Efficacy|6|||
170630739|NCT04607005|616660565|FG000|Overall Study|Withdrawal by Subject|4|||
170630740|NCT04607005|616660566|FG001|Overall Study|Withdrawal by Subject|9|||
170630741|NCT04607005|616660565|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
170630742|NCT04607005|616660566|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
170630743|NCT03589859|616660567|FG000|Overall Study|Withdrawal by Subject|0|||
170630744|NCT03589859|616660568|FG001|Overall Study|Withdrawal by Subject|6|||
170630745|NCT00626106|616660570|FG000|Overall Study|Withdrawal by Subject|2|||
170630746|NCT00626106|616660571|FG001|Overall Study|Withdrawal by Subject|1|||
170630747|NCT00626106|616660570|FG000|Overall Study|Lost to Follow-up|1|||
170630748|NCT00626106|616660571|FG001|Overall Study|Lost to Follow-up|4|||
170630749|NCT00626106|616660570|FG000|Overall Study|Death|64|||
170630750|NCT00626106|616660571|FG001|Overall Study|Death|19|||
170630751|NCT03253393|616660575|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
170630752|NCT03253393|616660576|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
170630753|NCT03253393|616660577|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
170646056|NCT01628029|616717883|FG004|Overall Study|started different cancer treatment clinical trial|0|||
170646057|NCT01628029|616717884|FG005|Overall Study|started different cancer treatment clinical trial|0|||
170646058|NCT01628029|616717885|FG006|Overall Study|started different cancer treatment clinical trial|0|||
170646059|NCT01628029|616717886|FG007|Overall Study|started different cancer treatment clinical trial|0|||
170518554|NCT00249873|616244504|FG000|Overall Study|Lost to Follow-up|4|||
170518555|NCT00249873|616244505|FG001|Overall Study|Lost to Follow-up|7|||
170518556|NCT00249873|616244504|FG000|Overall Study|Minor bleeding|99|||
170518557|NCT00249873|616244505|FG001|Overall Study|Minor bleeding|37|||
170518558|NCT00249873|616244504|FG000|Overall Study|Non-compliance|41|||
170518559|NCT00249873|616244505|FG001|Overall Study|Non-compliance|46|||
170518560|NCT00249873|616244504|FG000|Overall Study|Other non serious Adverse Event|112|||
170646060|NCT01628029|616717879|FG000|Overall Study|Incomplete primary outcome assessment|0|||
170746242|NCT01533714|617076166|FG002|Overall Study|Positive for purified protein derivative|1|||
170746243|NCT01533714|617076167|FG003|Overall Study|Positive for purified protein derivative|0|||
170746244|NCT01533714|617076168|FG004|Overall Study|Positive for purified protein derivative|1|||
170746245|NCT01533714|617076169|FG005|Overall Study|Positive for purified protein derivative|0|||
170746246|NCT01533714|617076164|FG000|Overall Study|Withdrawal criteria|0|||
170746247|NCT01533714|617076165|FG001|Overall Study|Withdrawal criteria|0|||
170746248|NCT01533714|617076166|FG002|Overall Study|Withdrawal criteria|1|||
170746249|NCT01533714|617076167|FG003|Overall Study|Withdrawal criteria|0|||
170746250|NCT01533714|617076168|FG004|Overall Study|Withdrawal criteria|3|||
170746251|NCT01533714|617076169|FG005|Overall Study|Withdrawal criteria|1|||
170746252|NCT01533714|617076164|FG000|Overall Study|Ineligibility reason|0|||
170746253|NCT01533714|617076165|FG001|Overall Study|Ineligibility reason|0|||
170746254|NCT01533714|617076166|FG002|Overall Study|Ineligibility reason|0|||
170746255|NCT01533714|617076167|FG003|Overall Study|Ineligibility reason|1|||
170746256|NCT01533714|617076168|FG004|Overall Study|Ineligibility reason|0|||
170746257|NCT01533714|617076169|FG005|Overall Study|Ineligibility reason|0|||
170746258|NCT02564055|617076174|FG000|Overall Study|Adverse Event|1|||
170746259|NCT02564055|617076175|FG001|Overall Study|Adverse Event|0|||
170746260|NCT02564055|617076176|FG002|Overall Study|Adverse Event|4|||
170746261|NCT02564055|617076177|FG003|Overall Study|Adverse Event|1|||
170746262|NCT02564055|617076178|FG004|Overall Study|Adverse Event|4|||
170746263|NCT02564055|617076179|FG005|Overall Study|Adverse Event|1|||
170746264|NCT02564055|617076174|FG000|Overall Study|Protocol Violation|1|||
170746265|NCT02564055|617076175|FG001|Overall Study|Protocol Violation|0|||
170746266|NCT02564055|617076176|FG002|Overall Study|Protocol Violation|0|||
170746267|NCT02564055|617076177|FG003|Overall Study|Protocol Violation|0|||
170746268|NCT02564055|617076178|FG004|Overall Study|Protocol Violation|0|||
170746269|NCT02564055|617076179|FG005|Overall Study|Protocol Violation|0|||
170746270|NCT02564055|617076174|FG000|Overall Study|Reached stopping criteria|0|||
170518561|NCT00249873|616244505|FG001|Overall Study|Other non serious Adverse Event|108|||
170518562|NCT00249873|616244504|FG000|Overall Study|Other contraindicated medication|1|||
170518563|NCT00249873|616244505|FG001|Overall Study|Other contraindicated medication|0|||
170518564|NCT00249873|616244504|FG000|Overall Study|Patient not wish to continue after May08|3|||
170518565|NCT00249873|616244505|FG001|Overall Study|Patient not wish to continue after May08|4|||
170518566|NCT00249873|616244504|FG000|Overall Study|Physician withdrew consent|59|||
170518567|NCT00249873|616244505|FG001|Overall Study|Physician withdrew consent|60|||
170518568|NCT00249873|616244504|FG000|Overall Study|Open label clopidogrel required|31|||
170518569|NCT00249873|616244505|FG001|Overall Study|Open label clopidogrel required|42|||
170518570|NCT00249873|616244504|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
170518571|NCT00249873|616244505|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
170518572|NCT00249873|616244504|FG000|Overall Study|Oral anticoagulant required|159|||
170518573|NCT00249873|616244505|FG001|Overall Study|Oral anticoagulant required|157|||
170518574|NCT00249873|616244504|FG000|Overall Study|Study drug intolerance|5|||
170518575|NCT00249873|616244505|FG001|Overall Study|Study drug intolerance|0|||
170518576|NCT00249873|616244504|FG000|Overall Study|Surgery/ procedure|9|||
170518577|NCT00249873|616244505|FG001|Overall Study|Surgery/ procedure|9|||
170518578|NCT00249873|616244504|FG000|Overall Study|Event related to cardiac condition|12|||
170518579|NCT00249873|616244505|FG001|Overall Study|Event related to cardiac condition|21|||
170518580|NCT00249873|616244504|FG000|Overall Study|Thromboembolic/outcome event|82|||
170518581|NCT00249873|616244505|FG001|Overall Study|Thromboembolic/outcome event|122|||
170518582|NCT02532374|616244508|FG000|Overall Study|Withdrawal by Subject|1|||
170518583|NCT02532374|616244508|FG000|Overall Study|Physician Decision|1|||
170518584|NCT02762084|616244509|FG000|Overall Study|Withdrawal by Subject|1|||
170518585|NCT02762084|616244510|FG001|Overall Study|Withdrawal by Subject|0|||
170518586|NCT02762084|616244511|FG002|Overall Study|Withdrawal by Subject|0|||
170518587|NCT02762084|616244509|FG000|Overall Study|Adverse Event|0|||
170746271|NCT02564055|617076175|FG001|Overall Study|Reached stopping criteria|0|||
170746272|NCT02564055|617076176|FG002|Overall Study|Reached stopping criteria|0|||
170746273|NCT02564055|617076177|FG003|Overall Study|Reached stopping criteria|0|||
170746274|NCT02564055|617076178|FG004|Overall Study|Reached stopping criteria|0|||
170746275|NCT02564055|617076179|FG005|Overall Study|Reached stopping criteria|1|||
170518588|NCT02762084|616244510|FG001|Overall Study|Adverse Event|0|||
170518589|NCT02762084|616244511|FG002|Overall Study|Adverse Event|1|||
170746276|NCT02564055|617076174|FG000|Overall Study|Lost to Follow-up|0|||
170746277|NCT02564055|617076175|FG001|Overall Study|Lost to Follow-up|1|||
170746278|NCT02564055|617076176|FG002|Overall Study|Lost to Follow-up|4|||
170518590|NCT00928434|616244512|FG000|Overall Study|Adverse Event|14|||
170518591|NCT00928434|616244513|FG001|Overall Study|Adverse Event|5|||
170518592|NCT00928434|616244514|FG002|Overall Study|Adverse Event|18|||
170518593|NCT00928434|616244512|FG000|Overall Study|Protocol Violation|5|||
170518594|NCT00928434|616244513|FG001|Overall Study|Protocol Violation|0|||
170518595|NCT00928434|616244514|FG002|Overall Study|Protocol Violation|8|||
170518596|NCT00928434|616244512|FG000|Overall Study|Physician Decision|2|||
170518597|NCT00928434|616244513|FG001|Overall Study|Physician Decision|0|||
170746279|NCT02564055|617076177|FG003|Overall Study|Lost to Follow-up|2|||
170746280|NCT02564055|617076178|FG004|Overall Study|Lost to Follow-up|1|||
170630754|NCT05462756|616662162|FG000|Treatment Period|Adverse Event|3|||
170630755|NCT05462756|616662163|FG001|Treatment Period|Adverse Event|0|||
170630756|NCT05462756|616662162|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
170630757|NCT05462756|616662163|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
170630758|NCT05462756|616662162|FG000|Treatment Period|Death|0|||
170630759|NCT05462756|616662163|FG001|Treatment Period|Death|1|||
170630760|NCT05462756|616662162|FG000|Treatment Period|Lost to Follow-up|2|||
170518598|NCT00928434|616244514|FG002|Overall Study|Physician Decision|3|||
170518599|NCT00928434|616244512|FG000|Overall Study|Lost to Follow-up|1|||
170518600|NCT00928434|616244513|FG001|Overall Study|Lost to Follow-up|0|||
170518601|NCT00928434|616244514|FG002|Overall Study|Lost to Follow-up|3|||
170518602|NCT00928434|616244512|FG000|Overall Study|Withdrawal by Subject|5|||
170518603|NCT00928434|616244513|FG001|Overall Study|Withdrawal by Subject|3|||
170518604|NCT00928434|616244514|FG002|Overall Study|Withdrawal by Subject|2|||
170518605|NCT00928434|616244512|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
170518606|NCT00928434|616244513|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
170518607|NCT00928434|616244514|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
170518608|NCT00928434|616244512|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
170518609|NCT00928434|616244513|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
170518610|NCT00928434|616244514|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
170518611|NCT00928434|616244512|FG000|Overall Study|Other (not meeting above criteria)|5|||
170518612|NCT00928434|616244513|FG001|Overall Study|Other (not meeting above criteria)|1|||
170518613|NCT00928434|616244514|FG002|Overall Study|Other (not meeting above criteria)|2|||
170518614|NCT00716456|616244515|FG000|Overall Study|Adverse Event|0|||
170518615|NCT00716456|616244516|FG001|Overall Study|Adverse Event|2|||
170518616|NCT00716456|616244517|FG002|Overall Study|Adverse Event|0|||
170630761|NCT05462756|616662163|FG001|Treatment Period|Lost to Follow-up|1|||
170630762|NCT05462756|616662162|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
170630763|NCT05462756|616662163|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
170630764|NCT05462756|616662162|FG000|Treatment Period|Physician Decision|2|||
170630765|NCT05462756|616662163|FG001|Treatment Period|Physician Decision|0|||
170630766|NCT05462756|616662162|FG000|Treatment Period|Protocol Violation|0|||
170630767|NCT05462756|616662163|FG001|Treatment Period|Protocol Violation|1|||
170630768|NCT05462756|616662162|FG000|Treatment Period|Withdrawal by Subject|5|||
170630769|NCT05462756|616662163|FG001|Treatment Period|Withdrawal by Subject|12|||
170630770|NCT05462756|616662162|FG000|Follow-Up Period|Adverse Event|1|||
170630771|NCT05462756|616662163|FG001|Follow-Up Period|Adverse Event|0|||
170630772|NCT05462756|616662162|FG000|Follow-Up Period|Death|1|||
170630773|NCT05462756|616662163|FG001|Follow-Up Period|Death|0|||
170630774|NCT05462756|616662162|FG000|Follow-Up Period|Lost to Follow-up|3|||
170630775|NCT05462756|616662163|FG001|Follow-Up Period|Lost to Follow-up|1|||
170630776|NCT05462756|616662162|FG000|Follow-Up Period|Withdrawal by Subject|0|||
170630777|NCT05462756|616662163|FG001|Follow-Up Period|Withdrawal by Subject|4|||
170630778|NCT02066181|616662165|FG000|Overall Study|Withdrawal by Subject|1|||
170630779|NCT02066181|616662166|FG001|Overall Study|Withdrawal by Subject|1|||
170630780|NCT02141295|616662167|FG000|Overall Study|Adverse Event|1|||
170630781|NCT02141295|616662168|FG001|Overall Study|Adverse Event|18|||
170630782|NCT02141295|616662169|FG002|Overall Study|Adverse Event|11|||
170630783|NCT02141295|616662167|FG000|Overall Study|Physician Decision|2|||
170630784|NCT02141295|616662168|FG001|Overall Study|Physician Decision|19|||
170630785|NCT02141295|616662169|FG002|Overall Study|Physician Decision|14|||
170630786|NCT02141295|616662167|FG000|Overall Study|Study terminated by sponsor|0|||
170630787|NCT02141295|616662168|FG001|Overall Study|Study terminated by sponsor|6|||
170630788|NCT02141295|616662169|FG002|Overall Study|Study terminated by sponsor|6|||
170630789|NCT02141295|616662167|FG000|Overall Study|Non-compliance|0|||
170630790|NCT02141295|616662168|FG001|Overall Study|Non-compliance|1|||
170630791|NCT02141295|616662169|FG002|Overall Study|Non-compliance|0|||
170630792|NCT02141295|616662167|FG000|Overall Study|Progressive disease|3|||
170630793|NCT02141295|616662168|FG001|Overall Study|Progressive disease|32|||
170630794|NCT02141295|616662169|FG002|Overall Study|Progressive disease|50|||
170630795|NCT02141295|616662167|FG000|Overall Study|Reason not specified|0|||
170630796|NCT02141295|616662168|FG001|Overall Study|Reason not specified|9|||
170630797|NCT02141295|616662169|FG002|Overall Study|Reason not specified|10|||
170630798|NCT02141295|616662167|FG000|Overall Study|Withdrawal by Subject|0|||
170630799|NCT02141295|616662168|FG001|Overall Study|Withdrawal by Subject|9|||
170630800|NCT02141295|616662169|FG002|Overall Study|Withdrawal by Subject|4|||
170630801|NCT01710501|616662170|FG000|Overall Study|Lost to Follow-up|2|||
170630802|NCT01710501|616662171|FG001|Overall Study|Lost to Follow-up|0|||
170630803|NCT01710501|616662172|FG002|Overall Study|Lost to Follow-up|0|||
170630804|NCT01671319|616662175|FG000|Overall Study|Withdrawal by Subject|1|||
170630805|NCT02144610|616662176|FG000|Overall Study|Physician Decision|1|||
170630806|NCT02144610|616662177|FG001|Overall Study|Physician Decision|0|||
170630807|NCT02144610|616662176|FG000|Overall Study|Withdrawal by Subject|1|||
170630808|NCT02144610|616662177|FG001|Overall Study|Withdrawal by Subject|5|||
170630809|NCT02144610|616662176|FG000|Overall Study|Death|2|||
170630810|NCT02144610|616662177|FG001|Overall Study|Death|2|||
170630811|NCT02144610|616662176|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
170630812|NCT02144610|616662177|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
170630813|NCT02144610|616662176|FG000|Overall Study|Other|0|||
170630814|NCT02144610|616662177|FG001|Overall Study|Other|1|||
170630815|NCT01354899|616662178|FG000|Overall Study|discharge from the hospital|2|||
170630816|NCT01354899|616662178|FG000|Overall Study|Protocol Violation|1|||
170630817|NCT01376804|616662179|FG000|Treatment Period|Withdrawal by Subject|1|||
170630818|NCT01376804|616662179|FG000|Treatment Period|Adverse Event|6|||
170630819|NCT01376804|616662179|FG000|Treatment Period|Patient did not receive study drug|1|||
170630820|NCT01357850|616662180|FG000|Overall Study|Lost to Follow-up|1|||
170630821|NCT01357850|616662181|FG001|Overall Study|Lost to Follow-up|0|||
170630822|NCT01357850|616662182|FG002|Overall Study|Lost to Follow-up|0|||
170630823|NCT01357850|616662183|FG003|Overall Study|Lost to Follow-up|0|||
170630824|NCT01803607|616662185|FG000|Overall Study|Adverse Event|5|||
170630825|NCT01803607|616662186|FG001|Overall Study|Adverse Event|3|||
170630826|NCT01803607|616662185|FG000|Overall Study|Lack of Efficacy|0|||
170630827|NCT01803607|616662186|FG001|Overall Study|Lack of Efficacy|1|||
170630828|NCT01803607|616662185|FG000|Overall Study|Protocol Violation|3|||
170630829|NCT01803607|616662186|FG001|Overall Study|Protocol Violation|2|||
170630830|NCT01803607|616662185|FG000|Overall Study|Study terminated by sponsor|54|||
170630831|NCT01803607|616662186|FG001|Overall Study|Study terminated by sponsor|56|||
170630832|NCT01803607|616662185|FG000|Overall Study|Withdrawal by Subject|6|||
170630833|NCT01803607|616662186|FG001|Overall Study|Withdrawal by Subject|5|||
170630834|NCT03077412|616662187|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
170630835|NCT03077412|616662188|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
170630836|NCT03077412|616662189|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
170630837|NCT03077412|616662187|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
170630838|NCT03077412|616662188|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
170630839|NCT03077412|616662189|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
170630840|NCT03077412|616662187|FG000|Overall Study|Adverse Event|1|||
170630841|NCT03077412|616662188|FG001|Overall Study|Adverse Event|2|||
170630842|NCT03077412|616662189|FG002|Overall Study|Adverse Event|2|||
170630843|NCT03077412|616662187|FG000|Overall Study|Investigator's Discretion|0|||
170630844|NCT03077412|616662188|FG001|Overall Study|Investigator's Discretion|1|||
170630845|NCT03077412|616662189|FG002|Overall Study|Investigator's Discretion|1|||
170630846|NCT03077412|616662187|FG000|Overall Study|Withdrew Consent|0|||
170630847|NCT03077412|616662188|FG001|Overall Study|Withdrew Consent|2|||
170630848|NCT03077412|616662189|FG002|Overall Study|Withdrew Consent|0|||
170630849|NCT02904954|616662190|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
170630850|NCT02904954|616662191|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
170630851|NCT02904954|616662190|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
170630852|NCT02904954|616662191|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
170630853|NCT02904954|616662190|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
170630854|NCT02904954|616662191|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
170630855|NCT02904954|616662190|FG000|Adjuvant Durvalumab|Recurrence|2|||
170630856|NCT02904954|616662191|FG001|Adjuvant Durvalumab|Recurrence|0|||
170630857|NCT02904954|616662190|FG000|Adjuvant Durvalumab|Adverse Event|2|||
170630858|NCT02904954|616662191|FG001|Adjuvant Durvalumab|Adverse Event|6|||
170630859|NCT02904954|616662190|FG000|Adjuvant Durvalumab|Participant wishes|12|||
170630860|NCT02904954|616662191|FG001|Adjuvant Durvalumab|Participant wishes|7|||
170630861|NCT02904954|616662190|FG000|Adjuvant Durvalumab|Physician Decision|2|||
170630862|NCT02904954|616662191|FG001|Adjuvant Durvalumab|Physician Decision|1|||
170630863|NCT02904954|616662190|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
170630864|NCT02904954|616662191|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
170630865|NCT02904954|616662190|FG000|Adjuvant Durvalumab|Death|0|||
170630866|NCT02904954|616662191|FG001|Adjuvant Durvalumab|Death|1|||
170630867|NCT02904954|616662190|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
170630868|NCT02904954|616662191|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
170630869|NCT00706238|616662192|FG000|Overall Study|Disease progression|4|||
170630870|NCT00706238|616662192|FG000|Overall Study|Other|1|||
170630871|NCT00753506|616662193|FG000|Overall Study|Withdrawal by Subject|4|||
170630872|NCT00753506|616662194|FG001|Overall Study|Withdrawal by Subject|1|||
170630873|NCT00753506|616662193|FG000|Overall Study|Lost to Follow-up|2|||
170630874|NCT00753506|616662194|FG001|Overall Study|Lost to Follow-up|0|||
170630875|NCT00753506|616662193|FG000|Overall Study|Other reason|1|||
170630876|NCT00753506|616662194|FG001|Overall Study|Other reason|1|||
170630877|NCT02492763|616662197|FG000|Overall Study|Withdrawal by Subject|0|||
170630878|NCT02492763|616662198|FG001|Overall Study|Withdrawal by Subject|2|||
170630879|NCT02492763|616662199|FG002|Overall Study|Withdrawal by Subject|1|||
170630880|NCT02492763|616662200|FG003|Overall Study|Withdrawal by Subject|0|||
170630881|NCT02492763|616662197|FG000|Overall Study|Adverse Event|3|||
170630882|NCT02492763|616662198|FG001|Overall Study|Adverse Event|1|||
170630883|NCT02492763|616662199|FG002|Overall Study|Adverse Event|1|||
170630884|NCT02492763|616662200|FG003|Overall Study|Adverse Event|2|||
170630885|NCT02492763|616662197|FG000|Overall Study|Death|0|||
170630886|NCT02492763|616662198|FG001|Overall Study|Death|0|||
170518617|NCT00447772|616244518|FG000|Overall Study|Lack of Efficacy|3|||
170518618|NCT00447772|616244518|FG000|Overall Study|Insufficient compliance|6|||
170518619|NCT00447772|616244518|FG000|Overall Study|Discontinuation of drug therapy|1|||
170518620|NCT00447772|616244518|FG000|Overall Study|Lost to Follow-up|9|||
170518621|NCT00447772|616244518|FG000|Overall Study|Withdrawal by Subject|1|||
170518622|NCT00447772|616244518|FG000|Overall Study|Unable to attend all study visits|2|||
170518623|NCT00447772|616244518|FG000|Overall Study|Adverse Event|1|||
170518624|NCT00447772|616244518|FG000|Overall Study|Patient relocated|1|||
170518625|NCT00447772|616244518|FG000|Overall Study|Incomplete documentation at visit 1|1|||
170518626|NCT00447772|616244518|FG000|Overall Study|Chemotherapy for lung cancer|1|||
170518627|NCT00447772|616244518|FG000|Overall Study|Premature re-injection required|1|||
170518628|NCT00511810|616244519|FG000|Overall Study|Lost to Follow-up|1|||
170518629|NCT00511810|616244520|FG001|Overall Study|Lost to Follow-up|2|||
170518630|NCT00511810|616244519|FG000|Overall Study|Lack of Efficacy|0|||
170518631|NCT00511810|616244520|FG001|Overall Study|Lack of Efficacy|2|||
170518632|NCT00511810|616244519|FG000|Overall Study|Refused second scn|0|||
170518633|NCT00511810|616244520|FG001|Overall Study|Refused second scn|1|||
170518634|NCT01619852|616244521|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
170518635|NCT01619852|616244522|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
170518636|NCT01619852|616244521|FG000|3 Month Follow up|Lost to Follow-up|31|||
170518637|NCT01619852|616244522|FG001|3 Month Follow up|Lost to Follow-up|34|||
170518638|NCT01096160|616244523|FG000|Overall Study|Adverse Event|0|||
170518639|NCT01096160|616244524|FG001|Overall Study|Adverse Event|0|||
170518640|NCT01096160|616244525|FG002|Overall Study|Adverse Event|1|||
170518641|NCT01096160|616244526|FG003|Overall Study|Adverse Event|0|||
170518642|NCT01096160|616244527|FG004|Overall Study|Adverse Event|0|||
170518643|NCT01096160|616244528|FG005|Overall Study|Adverse Event|0|||
170518644|NCT01096160|616244529|FG006|Overall Study|Adverse Event|0|||
170518645|NCT01096160|616244530|FG007|Overall Study|Adverse Event|0|||
170518646|NCT01096160|616244531|FG008|Overall Study|Adverse Event|0|||
170518647|NCT01096160|616244532|FG009|Overall Study|Adverse Event|1|||
170518648|NCT01096160|616244523|FG000|Overall Study|Met stopping criteria per protocol|0|||
170518649|NCT01096160|616244524|FG001|Overall Study|Met stopping criteria per protocol|0|||
170518650|NCT01096160|616244525|FG002|Overall Study|Met stopping criteria per protocol|0|||
170518651|NCT01096160|616244526|FG003|Overall Study|Met stopping criteria per protocol|0|||
170518652|NCT01096160|616244527|FG004|Overall Study|Met stopping criteria per protocol|1|||
170518653|NCT01096160|616244528|FG005|Overall Study|Met stopping criteria per protocol|0|||
170518654|NCT01096160|616244529|FG006|Overall Study|Met stopping criteria per protocol|2|||
170518655|NCT01096160|616244530|FG007|Overall Study|Met stopping criteria per protocol|0|||
170518656|NCT01096160|616244531|FG008|Overall Study|Met stopping criteria per protocol|2|||
170518657|NCT01096160|616244532|FG009|Overall Study|Met stopping criteria per protocol|0|||
170518658|NCT00838097|616244536|FG000|Overall Study|Ineligibility determined|6|||
170518659|NCT00838097|616244536|FG000|Overall Study|Adverse Event|2|||
170518660|NCT00838097|616244536|FG000|Overall Study|Withdrawal by Subject|3|||
170518661|NCT00838097|616244536|FG000|Overall Study|Requirement for alternative therapy|2|||
170518662|NCT00838097|616244536|FG000|Overall Study|Physician Decision|4|||
170518663|NCT00838097|616244536|FG000|Overall Study|Lost to Follow-up|11|||
170518664|NCT00838097|616244536|FG000|Overall Study|Death|6|||
170518665|NCT00838097|616244536|FG000|Overall Study|Protocol-specified criteria|142|||
170518666|NCT04346199|616244538|FG000|Overall Study|Death|8|||
170518667|NCT04346199|616244539|FG001|Overall Study|Death|9|||
170518668|NCT04346199|616244538|FG000|Overall Study|Lost to Follow-up|0|||
170518669|NCT04346199|616244539|FG001|Overall Study|Lost to Follow-up|1|||
170518670|NCT04346199|616244538|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
170518671|NCT04346199|616244539|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
170518672|NCT04346199|616244538|FG000|Overall Study|Withdrawal by Subject|5|||
170518673|NCT04346199|616244539|FG001|Overall Study|Withdrawal by Subject|1|||
170518674|NCT05568797|616244540|FG000|Overall Study|Adverse Event|0|||
170518675|NCT05568797|616244541|FG001|Overall Study|Adverse Event|8|||
170518676|NCT05568797|616244540|FG000|Overall Study|Lost to Follow-up|2|||
170518677|NCT05568797|616244541|FG001|Overall Study|Lost to Follow-up|3|||
170518678|NCT05568797|616244540|FG000|Overall Study|Withdrawal by Subject|1|||
170518679|NCT05568797|616244541|FG001|Overall Study|Withdrawal by Subject|10|||
170518680|NCT05568797|616244540|FG000|Overall Study|Other|2|||
170518681|NCT05568797|616244541|FG001|Overall Study|Other|2|||
170518682|NCT01216332|616244542|FG000|Overall Study|Withdrawal by Subject|4|||
170518683|NCT01216332|616244543|FG001|Overall Study|Withdrawal by Subject|0|||
170518684|NCT03677869|616244544|FG000|Overall Study|Withdrawal by Subject|1|||
170518685|NCT01237327|616244545|FG000|Overall Study|Protocol Violation: Core Study|1|||
170518686|NCT01237327|616244546|FG001|Overall Study|Protocol Violation: Core Study|0|||
170518687|NCT01237327|616244545|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
170518688|NCT01237327|616244546|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
170518689|NCT01237327|616244545|FG000|Overall Study|Progression of Disease: Core Study|18|||
170518690|NCT01237327|616244546|FG001|Overall Study|Progression of Disease: Core Study|22|||
170518691|NCT01237327|616244545|FG000|Overall Study|Progression of Disease: Extension Study|15|||
170518692|NCT01237327|616244546|FG001|Overall Study|Progression of Disease: Extension Study|13|||
170518693|NCT01237327|616244545|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
170518694|NCT01237327|616244546|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
170518695|NCT01237327|616244545|FG000|Overall Study|Withdrawal by Subject|1|||
170518696|NCT01237327|616244546|FG001|Overall Study|Withdrawal by Subject|3|||
170518697|NCT01237327|616244545|FG000|Overall Study|Lost to Follow-up|3|||
170518698|NCT01237327|616244546|FG001|Overall Study|Lost to Follow-up|0|||
170518699|NCT03877224|616244547|FG000|Overall Study|Death|3|||
170518700|NCT03877224|616244548|FG001|Overall Study|Death|2|||
170518701|NCT03877224|616244547|FG000|Overall Study|Withdrawal by Subject|1|||
170518702|NCT03877224|616244548|FG001|Overall Study|Withdrawal by Subject|6|||
170518703|NCT03877224|616244547|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
170518704|NCT03877224|616244548|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
170518705|NCT03101150|616245985|FG000|Overall Study|Lost to Follow-up|2|||
170630887|NCT02492763|616662199|FG002|Overall Study|Death|1|||
170518706|NCT03101150|616245986|FG001|Overall Study|Lost to Follow-up|4|||
170518707|NCT03101150|616245985|FG000|Overall Study|Miscarriage|3|||
170518708|NCT03101150|616245986|FG001|Overall Study|Miscarriage|6|||
170518709|NCT02317991|616245987|FG000|Overall Study|Adverse Event|12|||
170518710|NCT02317991|616245987|FG000|Overall Study|Death|4|||
170518711|NCT02317991|616245987|FG000|Overall Study|Withdrawal by Subject|8|||
170518712|NCT02317991|616245987|FG000|Overall Study|Progressive Disease|41|||
170518713|NCT00707057|616245988|FG000|Overall Study|Withdrawal by Subject|8|||
170518714|NCT00707057|616245989|FG001|Overall Study|Withdrawal by Subject|3|||
170518715|NCT00707057|616245988|FG000|Overall Study|Dosed incorrectly|0|||
170518716|NCT00707057|616245989|FG001|Overall Study|Dosed incorrectly|1|||
170518717|NCT02492165|616245990|FG000|Overall Study|Withdrawal by Subject|0|||
170518718|NCT02492165|616245991|FG001|Overall Study|Withdrawal by Subject|1|||
170518719|NCT02492165|616245992|FG002|Overall Study|Withdrawal by Subject|0|||
170518720|NCT02492165|616245993|FG003|Overall Study|Withdrawal by Subject|0|||
170518721|NCT01302418|616245994|FG000|Overall Study|Protocol Violation|9|||
170518722|NCT01302418|616245994|FG000|Overall Study|Non-evaluable|9|||
170518723|NCT00954122|616245995|FG000|Overall Study|Withdrawal by Subject|5|||
170518724|NCT00954122|616245995|FG000|Overall Study|Adverse Event|1|||
170518725|NCT00954122|616245995|FG000|Overall Study|Safety Reason|1|||
170518726|NCT00823134|616246001|FG000|Overall Study|Invalid measurement|1|||
170518727|NCT00377637|616246002|FG000|Induction Phase|Adverse Event|12|||
170518728|NCT00377637|616246003|FG001|Induction Phase|Adverse Event|21|||
170518729|NCT00377637|616246004|FG002|Induction Phase|Adverse Event|0|||
170518730|NCT00377637|616246005|FG003|Induction Phase|Adverse Event|0|||
170518731|NCT00377637|616246002|FG000|Induction Phase|Deterioration/serum creatinine|2|||
170518732|NCT00377637|616246003|FG001|Induction Phase|Deterioration/serum creatinine|0|||
170518733|NCT00377637|616246004|FG002|Induction Phase|Deterioration/serum creatinine|0|||
170518734|NCT00377637|616246005|FG003|Induction Phase|Deterioration/serum creatinine|0|||
170518735|NCT00377637|616246002|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
170518736|NCT00377637|616246003|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
170518737|NCT00377637|616246004|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
170518738|NCT00377637|616246005|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
170518739|NCT00377637|616246002|FG000|Induction Phase|Lost to Follow-up|2|||
170518740|NCT00377637|616246003|FG001|Induction Phase|Lost to Follow-up|1|||
170518741|NCT00377637|616246004|FG002|Induction Phase|Lost to Follow-up|0|||
170518742|NCT00377637|616246005|FG003|Induction Phase|Lost to Follow-up|0|||
170518743|NCT00377637|616246002|FG000|Induction Phase|Death|1|||
170518744|NCT00377637|616246003|FG001|Induction Phase|Death|3|||
170518745|NCT00377637|616246004|FG002|Induction Phase|Death|0|||
170518746|NCT00377637|616246005|FG003|Induction Phase|Death|0|||
170518747|NCT00377637|616246002|FG000|Induction Phase|Withdrawal by Subject|5|||
170518748|NCT00377637|616246003|FG001|Induction Phase|Withdrawal by Subject|6|||
170518749|NCT00377637|616246004|FG002|Induction Phase|Withdrawal by Subject|0|||
170518750|NCT00377637|616246005|FG003|Induction Phase|Withdrawal by Subject|0|||
170518751|NCT00377637|616246002|FG000|Induction Phase|Physician Decision|3|||
170518752|NCT00377637|616246003|FG001|Induction Phase|Physician Decision|1|||
170518753|NCT00377637|616246004|FG002|Induction Phase|Physician Decision|0|||
170518754|NCT00377637|616246005|FG003|Induction Phase|Physician Decision|0|||
170518755|NCT00377637|616246002|FG000|Induction Phase|Sponsor decision|1|||
170518756|NCT00377637|616246003|FG001|Induction Phase|Sponsor decision|2|||
170518757|NCT00377637|616246004|FG002|Induction Phase|Sponsor decision|0|||
170518758|NCT00377637|616246005|FG003|Induction Phase|Sponsor decision|0|||
170518759|NCT00377637|616246002|FG000|Induction Phase|Non-Compliance|1|||
170518760|NCT00377637|616246003|FG001|Induction Phase|Non-Compliance|0|||
170518761|NCT00377637|616246004|FG002|Induction Phase|Non-Compliance|0|||
170518762|NCT00377637|616246005|FG003|Induction Phase|Non-Compliance|0|||
170518763|NCT00377637|616246002|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
170518764|NCT00377637|616246003|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
170746281|NCT02564055|617076179|FG005|Overall Study|Lost to Follow-up|0|||
170746282|NCT02564055|617076174|FG000|Overall Study|Physician Decision|0|||
170746283|NCT02564055|617076175|FG001|Overall Study|Physician Decision|0|||
170746284|NCT02564055|617076176|FG002|Overall Study|Physician Decision|1|||
170746285|NCT02564055|617076177|FG003|Overall Study|Physician Decision|0|||
170746286|NCT02564055|617076178|FG004|Overall Study|Physician Decision|0|||
170746287|NCT02564055|617076179|FG005|Overall Study|Physician Decision|0|||
170746288|NCT02564055|617076174|FG000|Overall Study|Withdrawal by Subject|4|||
170746289|NCT02564055|617076175|FG001|Overall Study|Withdrawal by Subject|4|||
170746290|NCT02564055|617076176|FG002|Overall Study|Withdrawal by Subject|3|||
170746291|NCT02564055|617076177|FG003|Overall Study|Withdrawal by Subject|3|||
170746292|NCT02564055|617076178|FG004|Overall Study|Withdrawal by Subject|10|||
170746293|NCT02564055|617076179|FG005|Overall Study|Withdrawal by Subject|10|||
170746294|NCT04161807|617076183|FG000|Overall Study|Withdrawal by Subject|2|||
170746295|NCT04161807|617076183|FG000|Overall Study|Performed only 1 treatment|2|||
170746296|NCT01275196|617076185|FG000|Overall Study|Adverse Event|3|||
170746297|NCT01275196|617076186|FG001|Overall Study|Adverse Event|5|||
170746298|NCT01275196|617076185|FG000|Overall Study|Withdrawal by Subject|4|||
170746299|NCT01275196|617076186|FG001|Overall Study|Withdrawal by Subject|5|||
170746300|NCT01275196|617076185|FG000|Overall Study|Lost to Follow-up|1|||
170746301|NCT01275196|617076186|FG001|Overall Study|Lost to Follow-up|0|||
170746302|NCT01275196|617076185|FG000|Overall Study|Disease Progression|6|||
170746303|NCT01275196|617076186|FG001|Overall Study|Disease Progression|5|||
170746304|NCT01275196|617076185|FG000|Overall Study|Protocol Violation|1|||
170746305|NCT01275196|617076186|FG001|Overall Study|Protocol Violation|0|||
170746306|NCT01275196|617076185|FG000|Overall Study|Suboptimal response/treatment failure|5|||
170746307|NCT01275196|617076186|FG001|Overall Study|Suboptimal response/treatment failure|6|||
170746308|NCT02693834|617076187|FG000|Baseline Measurement|Withdrawal by Subject|1|||
170746309|NCT02693834|617076188|FG001|Baseline Measurement|Withdrawal by Subject|0|||
170746310|NCT02693834|617076187|FG000|Baseline Measurement|Adverse Event|1|||
170746311|NCT02693834|617076188|FG001|Baseline Measurement|Adverse Event|0|||
170746312|NCT02693834|617076187|FG000|Week 2 Practice|Adverse Event|0|||
170746313|NCT02693834|617076188|FG001|Week 2 Practice|Adverse Event|1|||
170746314|NCT02500979|617076193|FG000|Period 1|Hyperglycemia|1|||
170746315|NCT02500979|617076194|FG001|Period 1|Hyperglycemia|0|||
170746316|NCT02500979|617076193|FG000|Period 1|Severe non-compliance to protocol|0|||
170630888|NCT02492763|616662200|FG003|Overall Study|Death|0|||
170630889|NCT02492763|616662197|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
170630890|NCT02492763|616662198|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
170630891|NCT02492763|616662199|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
170630892|NCT02492763|616662200|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
170630893|NCT02492763|616662197|FG000|Overall Study|Lost to Follow-up|0|||
170630894|NCT02492763|616662198|FG001|Overall Study|Lost to Follow-up|0|||
170630895|NCT02492763|616662199|FG002|Overall Study|Lost to Follow-up|1|||
170630896|NCT02492763|616662200|FG003|Overall Study|Lost to Follow-up|0|||
170630897|NCT02492763|616662197|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170630898|NCT02492763|616662198|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170630899|NCT02492763|616662199|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170630900|NCT02492763|616662200|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170630901|NCT02492763|616662197|FG000|Overall Study|Screen Failure|0|||
170630902|NCT02492763|616662198|FG001|Overall Study|Screen Failure|0|||
170630903|NCT02492763|616662199|FG002|Overall Study|Screen Failure|0|||
170630904|NCT02492763|616662200|FG003|Overall Study|Screen Failure|1|||
170630905|NCT02492763|616662197|FG000|Overall Study|Study Terminated by Sponsor|13|||
170630906|NCT02492763|616662198|FG001|Overall Study|Study Terminated by Sponsor|10|||
170630907|NCT02492763|616662199|FG002|Overall Study|Study Terminated by Sponsor|6|||
170630908|NCT02492763|616662200|FG003|Overall Study|Study Terminated by Sponsor|10|||
170630909|NCT03848832|616662201|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
170746317|NCT02500979|617076194|FG001|Period 1|Severe non-compliance to protocol|1|||
170746318|NCT02500979|617076193|FG000|Period 1|Adverse Event|1|||
170746319|NCT02500979|617076194|FG001|Period 1|Adverse Event|0|||
170746320|NCT02500979|617076193|FG000|Period 1|Subject decision|2|||
170746321|NCT02500979|617076194|FG001|Period 1|Subject decision|0|||
170746322|NCT02500979|617076193|FG000|Period 2|Change in risk|1|||
170746323|NCT02500979|617076194|FG001|Period 2|Change in risk|0|||
170746324|NCT01613027|617076198|FG000|Overall Study|Lost to Follow-up|5|||
170746325|NCT01613027|617076198|FG000|Overall Study|Switched Physician|1|||
170746326|NCT01613027|617076198|FG000|Overall Study|Lack of Efficacy|1|||
170746327|NCT01613027|617076198|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
170630910|NCT03848832|616662202|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
170746328|NCT00579982|617076201|FG000|Overall Study|Adverse Event|4|||
170630911|NCT03848832|616662203|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
170630912|NCT03848832|616662201|FG000|Overall Study|Withdrawal by Subject|0|||
170746329|NCT00579982|617076201|FG000|Overall Study|Protocol Violation|4|||
170746330|NCT03632434|617076204|FG000|Overall Study|Withdrawal by Subject|2|||
170630913|NCT03848832|616662202|FG001|Overall Study|Withdrawal by Subject|0|||
170746331|NCT04297241|617076205|FG000|Overall Study|Withdrawal by Subject|1|||
170630914|NCT03848832|616662203|FG002|Overall Study|Withdrawal by Subject|1|||
170630915|NCT03848832|616662201|FG000|Overall Study|Withdrawal (Covid-19)|0|||
170630916|NCT03848832|616662202|FG001|Overall Study|Withdrawal (Covid-19)|2|||
170630917|NCT03848832|616662203|FG002|Overall Study|Withdrawal (Covid-19)|0|||
170630918|NCT03848832|616662201|FG000|Overall Study|Physician Decision|2|||
170630919|NCT03848832|616662202|FG001|Overall Study|Physician Decision|1|||
170630920|NCT03848832|616662203|FG002|Overall Study|Physician Decision|3|||
170630921|NCT03848832|616662201|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
170630922|NCT03848832|616662202|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
170630923|NCT03848832|616662203|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
170630924|NCT03848832|616662201|FG000|Overall Study|Adverse Event|1|||
170630925|NCT03848832|616662202|FG001|Overall Study|Adverse Event|0|||
170630926|NCT03848832|616662203|FG002|Overall Study|Adverse Event|0|||
170630927|NCT02395471|616662204|FG000|Overall Study|Lost to Follow-up|2|||
170630928|NCT02395471|616662205|FG001|Overall Study|Lost to Follow-up|0|||
170630929|NCT02395471|616662204|FG000|Overall Study|Withdrawal by Subject|2|||
170630930|NCT02395471|616662205|FG001|Overall Study|Withdrawal by Subject|1|||
170630931|NCT02395471|616662204|FG000|Overall Study|Physician Decision|1|||
170630932|NCT02395471|616662205|FG001|Overall Study|Physician Decision|0|||
170630933|NCT02395471|616662204|FG000|Overall Study|Protocol Violation|0|||
170630934|NCT02395471|616662205|FG001|Overall Study|Protocol Violation|1|||
170630935|NCT02395471|616662204|FG000|Overall Study|Failure to swollow sponge twice|1|||
170630936|NCT02395471|616662205|FG001|Overall Study|Failure to swollow sponge twice|0|||
170630937|NCT02395471|616662204|FG000|Overall Study|Patient did not return for procedure|0|||
170630938|NCT02395471|616662205|FG001|Overall Study|Patient did not return for procedure|1|||
170630939|NCT02395471|616662204|FG000|Overall Study|Subject not eligible|1|||
170630940|NCT02395471|616662205|FG001|Overall Study|Subject not eligible|0|||
170630941|NCT03847896|616662206|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
170630942|NCT03847896|616662207|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
170630943|NCT03847896|616662208|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
170630944|NCT03847896|616662209|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
170630945|NCT03847896|616662210|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
170630946|NCT03847896|616662206|FG000|Overall Study|Withdrawal by Subject|2|||
170630947|NCT03847896|616662207|FG001|Overall Study|Withdrawal by Subject|10|||
170630948|NCT03847896|616662208|FG002|Overall Study|Withdrawal by Subject|5|||
170630949|NCT03847896|616662209|FG003|Overall Study|Withdrawal by Subject|9|||
170746332|NCT04297241|617076205|FG000|Overall Study|Adverse Event|1|||
170746333|NCT04297241|617076205|FG000|Overall Study|Physician Decision|3|||
170746334|NCT02836613|617076212|FG000|Overall Study|Accidental drowning|1|||
170746335|NCT02836613|617076213|FG001|Overall Study|Accidental drowning|0|||
170746336|NCT02836613|617076212|FG000|Overall Study|Lost to Follow-up|0|||
170746337|NCT02836613|617076213|FG001|Overall Study|Lost to Follow-up|1|||
170746338|NCT02836613|617076212|FG000|Overall Study|Withdrawal by Subject|0|||
170746339|NCT02836613|617076213|FG001|Overall Study|Withdrawal by Subject|2|||
170746340|NCT03881059|617076214|FG000|Treatment Period - Part A|Adverse Event|1|||
170746341|NCT03881059|617076215|FG001|Treatment Period - Part A|Adverse Event|3|||
170746342|NCT03881059|617076216|FG002|Treatment Period - Part A|Adverse Event|4|||
170746343|NCT03881059|617076214|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
170746344|NCT03881059|617076215|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
170630950|NCT03847896|616662210|FG004|Overall Study|Withdrawal by Subject|8|||
170630951|NCT03847896|616662206|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170630952|NCT03847896|616662207|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170630953|NCT03847896|616662208|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170630954|NCT03847896|616662209|FG003|Overall Study|Withdrawal by parent/guardian|0|||
170630955|NCT03847896|616662210|FG004|Overall Study|Withdrawal by parent/guardian|0|||
170630956|NCT03847896|616662206|FG000|Overall Study|Adverse Event|2|||
170630957|NCT03847896|616662207|FG001|Overall Study|Adverse Event|1|||
170630958|NCT03847896|616662208|FG002|Overall Study|Adverse Event|3|||
170630959|NCT03847896|616662209|FG003|Overall Study|Adverse Event|2|||
170630960|NCT03847896|616662210|FG004|Overall Study|Adverse Event|4|||
170630961|NCT03847896|616662206|FG000|Overall Study|A severe exacerbation event|0|||
170746345|NCT03881059|617076216|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
170746346|NCT03881059|617076214|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
170746347|NCT03881059|617076215|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
170630962|NCT03847896|616662207|FG001|Overall Study|A severe exacerbation event|0|||
170630963|NCT03847896|616662208|FG002|Overall Study|A severe exacerbation event|0|||
170630964|NCT03847896|616662209|FG003|Overall Study|A severe exacerbation event|0|||
170630965|NCT03847896|616662210|FG004|Overall Study|A severe exacerbation event|3|||
170630966|NCT03847896|616662206|FG000|Overall Study|Protocol Violation|0|||
170630967|NCT03847896|616662207|FG001|Overall Study|Protocol Violation|2|||
170630968|NCT03847896|616662208|FG002|Overall Study|Protocol Violation|1|||
170630969|NCT03847896|616662209|FG003|Overall Study|Protocol Violation|0|||
170746348|NCT03881059|617076216|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
170746349|NCT03881059|617076214|FG000|Treatment Period - Part A|Other reasons|2|||
170746350|NCT03881059|617076215|FG001|Treatment Period - Part A|Other reasons|1|||
170746351|NCT03881059|617076216|FG002|Treatment Period - Part A|Other reasons|0|||
170746352|NCT03881059|617076214|FG000|Treatment Period - Part B|Adverse Event|0|||
170746353|NCT03881059|617076215|FG001|Treatment Period - Part B|Adverse Event|0|||
170746354|NCT03881059|617076216|FG002|Treatment Period - Part B|Adverse Event|3|||
170746355|NCT03881059|617076214|FG000|Treatment Period - Part B|Death|0|||
170746356|NCT03881059|617076215|FG001|Treatment Period - Part B|Death|1|||
170746357|NCT03881059|617076216|FG002|Treatment Period - Part B|Death|1|||
170746358|NCT03881059|617076214|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
170746359|NCT03881059|617076215|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
170746360|NCT03881059|617076216|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
170746361|NCT03881059|617076214|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
170746362|NCT03881059|617076215|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
170630970|NCT03847896|616662210|FG004|Overall Study|Protocol Violation|2|||
170746363|NCT03881059|617076216|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
170746364|NCT03881059|617076214|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
170746365|NCT03881059|617076215|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
170746366|NCT03881059|617076216|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
170746367|NCT03881059|617076214|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
170746368|NCT03881059|617076215|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
170746369|NCT03881059|617076216|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
170746370|NCT03881059|617076214|FG000|Treatment Period - Part B|Other reasons|4|||
170746371|NCT03881059|617076215|FG001|Treatment Period - Part B|Other reasons|3|||
170746372|NCT03881059|617076216|FG002|Treatment Period - Part B|Other reasons|3|||
170746373|NCT00786474|617076219|FG000|Overall Study|Death|5|||
170746374|NCT00786474|617076220|FG001|Overall Study|Death|4|||
170746375|NCT00786474|617076219|FG000|Overall Study|Withdrawal by Subject|23|||
170746376|NCT00786474|617076220|FG001|Overall Study|Withdrawal by Subject|31|||
170746377|NCT00786474|617076219|FG000|Overall Study|Lost to Follow-up|3|||
170746378|NCT00786474|617076220|FG001|Overall Study|Lost to Follow-up|3|||
170746379|NCT00786474|617076219|FG000|Overall Study|Physician Decision|2|||
170746380|NCT00786474|617076220|FG001|Overall Study|Physician Decision|1|||
170746381|NCT00786474|617076219|FG000|Overall Study|Other|4|||
170746382|NCT00786474|617076220|FG001|Overall Study|Other|4|||
170746383|NCT04276090|617076221|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
170630971|NCT03847896|616662206|FG000|Overall Study|Lost to Follow-up|0|||
170630972|NCT03847896|616662207|FG001|Overall Study|Lost to Follow-up|0|||
170630973|NCT03847896|616662208|FG002|Overall Study|Lost to Follow-up|0|||
170630974|NCT03847896|616662209|FG003|Overall Study|Lost to Follow-up|1|||
170630975|NCT03847896|616662210|FG004|Overall Study|Lost to Follow-up|0|||
170630976|NCT03847896|616662206|FG000|Overall Study|Condition under investigation worsened|0|||
170630977|NCT03847896|616662207|FG001|Overall Study|Condition under investigation worsened|0|||
170630978|NCT03847896|616662208|FG002|Overall Study|Condition under investigation worsened|0|||
170630979|NCT03847896|616662209|FG003|Overall Study|Condition under investigation worsened|1|||
170630980|NCT03847896|616662210|FG004|Overall Study|Condition under investigation worsened|1|||
170630981|NCT03847896|616662206|FG000|Overall Study|Lack of Efficacy|0|||
170630982|NCT03847896|616662207|FG001|Overall Study|Lack of Efficacy|0|||
170630983|NCT03847896|616662208|FG002|Overall Study|Lack of Efficacy|0|||
170630984|NCT03847896|616662209|FG003|Overall Study|Lack of Efficacy|2|||
170630985|NCT03847896|616662210|FG004|Overall Study|Lack of Efficacy|2|||
170630986|NCT03847896|616662206|FG000|Overall Study|Other reasons|3|||
170630987|NCT03847896|616662207|FG001|Overall Study|Other reasons|3|||
170746384|NCT04276090|617076222|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
170746385|NCT02322814|617076241|FG000|Overall Study|Death|7|||
170746386|NCT02322814|617076242|FG001|Overall Study|Death|29|||
170746387|NCT02322814|617076243|FG002|Overall Study|Death|32|||
170746388|NCT02322814|617076244|FG003|Overall Study|Death|23|||
170746389|NCT02322814|617076245|FG004|Overall Study|Death|14|||
170630988|NCT03847896|616662208|FG002|Overall Study|Other reasons|1|||
170630989|NCT03847896|616662209|FG003|Overall Study|Other reasons|2|||
170630990|NCT03847896|616662210|FG004|Overall Study|Other reasons|1|||
170630991|NCT01039376|616662211|FG000|Overall Study|Lost to Follow-up|5|||
170630992|NCT01039376|616662212|FG001|Overall Study|Lost to Follow-up|12|||
170746390|NCT02322814|617076241|FG000|Overall Study|Lost to Follow-up|1|||
170746391|NCT02322814|617076242|FG001|Overall Study|Lost to Follow-up|3|||
170861461|NCT01898923|617501854|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
170630993|NCT01039376|616662211|FG000|Overall Study|Physician Decision|15|||
170630994|NCT01039376|616662212|FG001|Overall Study|Physician Decision|10|||
170746392|NCT02322814|617076243|FG002|Overall Study|Lost to Follow-up|3|||
170746393|NCT02322814|617076244|FG003|Overall Study|Lost to Follow-up|1|||
170630995|NCT01039376|616662211|FG000|Overall Study|Withdrawal by Subject|20|||
170630996|NCT01039376|616662212|FG001|Overall Study|Withdrawal by Subject|32|||
170630997|NCT01039376|616662211|FG000|Overall Study|Study terminated by Sponsor|90|||
170630998|NCT01039376|616662212|FG001|Overall Study|Study terminated by Sponsor|72|||
170746394|NCT02322814|617076245|FG004|Overall Study|Lost to Follow-up|0|||
170746395|NCT02322814|617076241|FG000|Overall Study|Various Reasons|2|||
170746396|NCT02322814|617076242|FG001|Overall Study|Various Reasons|0|||
170746397|NCT02322814|617076243|FG002|Overall Study|Various Reasons|1|||
170746398|NCT02322814|617076244|FG003|Overall Study|Various Reasons|1|||
170746399|NCT02322814|617076245|FG004|Overall Study|Various Reasons|0|||
170746400|NCT02322814|617076241|FG000|Overall Study|Progressive Disease|0|||
170746401|NCT02322814|617076242|FG001|Overall Study|Progressive Disease|0|||
170746402|NCT02322814|617076243|FG002|Overall Study|Progressive Disease|0|||
170746403|NCT02322814|617076244|FG003|Overall Study|Progressive Disease|1|||
170746404|NCT02322814|617076245|FG004|Overall Study|Progressive Disease|1|||
170746405|NCT02322814|617076241|FG000|Overall Study|Protocol Violation|1|||
170630999|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
170631000|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
170631001|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Adverse Event|31|||
170631002|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Adverse Event|21|||
170631003|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
170631004|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
170631005|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
170631006|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
170631007|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
170631008|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
170631009|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
170631010|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
170631011|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Administrative problems|3|||
170631012|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Administrative problems|3|||
170631013|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Death|5|||
170631014|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Death|8|||
170631015|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Disease progression|139|||
170631016|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Disease progression|119|||
170631017|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
170631018|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
170631019|NCT00785785|616662213|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
170631020|NCT00785785|616662214|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
170631021|NCT00785785|616662213|FG000|Optional Extension Phase|Adverse Event|4|||
170631022|NCT00785785|616662214|FG001|Optional Extension Phase|Adverse Event|5|||
170631023|NCT00785785|616662213|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
170631024|NCT00785785|616662214|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
170631025|NCT00785785|616662213|FG000|Optional Extension Phase|Lost to Follow-up|1|||
170631026|NCT00785785|616662214|FG001|Optional Extension Phase|Lost to Follow-up|0|||
170631027|NCT00785785|616662213|FG000|Optional Extension Phase|Administrative problems|2|||
170631028|NCT00785785|616662214|FG001|Optional Extension Phase|Administrative problems|0|||
170631029|NCT00785785|616662213|FG000|Optional Extension Phase|Death|1|||
170631030|NCT00785785|616662214|FG001|Optional Extension Phase|Death|5|||
170631031|NCT00785785|616662213|FG000|Optional Extension Phase|Disease progression|22|||
170631032|NCT00785785|616662214|FG001|Optional Extension Phase|Disease progression|70|||
170631033|NCT00785785|616662213|FG000|Optional Extension Phase|Protocol deviation|0|||
170631034|NCT00785785|616662214|FG001|Optional Extension Phase|Protocol deviation|2|||
170631035|NCT00785785|616662213|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
170631036|NCT00785785|616662214|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
170631037|NCT00357552|616662215|FG000|Screening|Did not meet eligibility criteria|84|||
170631038|NCT00357552|616662215|FG000|Weeks 0 to 24|Death|1|||
170631039|NCT00357552|616662215|FG000|Weeks 24 to 104|Death|3|||
170631040|NCT00357552|616662215|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
170746406|NCT02322814|617076242|FG001|Overall Study|Protocol Violation|0|||
170631041|NCT00882557|616662218|FG000|Overall Study|Withdrawal by Subject|1|||
170631042|NCT00882557|616662219|FG001|Overall Study|Withdrawal by Subject|0|||
170631043|NCT00882557|616662218|FG000|Overall Study|Trouble with Vein Access|1|||
170631044|NCT00882557|616662219|FG001|Overall Study|Trouble with Vein Access|0|||
170631045|NCT00882557|616662218|FG000|Overall Study|Randomized Not Treated|0|||
170631046|NCT00882557|616662219|FG001|Overall Study|Randomized Not Treated|1|||
170631047|NCT02282605|616662220|FG000|Overall Study|negative SA result on Day -1|3|||
170631048|NCT02282605|616662221|FG001|Overall Study|negative SA result on Day -1|0|||
170746407|NCT02322814|617076243|FG002|Overall Study|Protocol Violation|0|||
170631049|NCT02282605|616662222|FG002|Overall Study|negative SA result on Day -1|0|||
170631050|NCT00711191|616662223|FG000|Overall Study|Adverse Event|1|||
170631051|NCT00711191|616662224|FG001|Overall Study|Adverse Event|1|||
170631052|NCT00711191|616662225|FG002|Overall Study|Adverse Event|2|||
170746408|NCT02322814|617076244|FG003|Overall Study|Protocol Violation|0|||
170746409|NCT02322814|617076245|FG004|Overall Study|Protocol Violation|0|||
170631053|NCT00711191|616662223|FG000|Overall Study|Objective progression or relapse|2|||
170631054|NCT00711191|616662224|FG001|Overall Study|Objective progression or relapse|3|||
170746410|NCT02322814|617076241|FG000|Overall Study|Study Terminated by Sponsor|0|||
170631055|NCT00711191|616662225|FG002|Overall Study|Objective progression or relapse|7|||
170631056|NCT00711191|616662223|FG000|Overall Study|Withdrawal by Subject|0|||
170631057|NCT00711191|616662224|FG001|Overall Study|Withdrawal by Subject|1|||
170631058|NCT00711191|616662225|FG002|Overall Study|Withdrawal by Subject|3|||
170631059|NCT02035267|616662226|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
170631060|NCT02035267|616662227|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
170631061|NCT02035267|616662228|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
170631062|NCT02035267|616662229|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
170631063|NCT02035267|616662226|FG000|Overall Study|Adverse Event|0|||
170631064|NCT02035267|616662227|FG001|Overall Study|Adverse Event|0|||
170631065|NCT02035267|616662228|FG002|Overall Study|Adverse Event|1|||
170631066|NCT02035267|616662229|FG003|Overall Study|Adverse Event|0|||
170631067|NCT02035267|616662226|FG000|Overall Study|Lost to Follow-up|0|||
170631068|NCT02035267|616662227|FG001|Overall Study|Lost to Follow-up|0|||
170631069|NCT02035267|616662228|FG002|Overall Study|Lost to Follow-up|0|||
170631070|NCT02035267|616662229|FG003|Overall Study|Lost to Follow-up|1|||
170631071|NCT02035267|616662226|FG000|Overall Study|Other unspecified|0|||
170631072|NCT02035267|616662227|FG001|Overall Study|Other unspecified|1|||
170631073|NCT02035267|616662228|FG002|Overall Study|Other unspecified|0|||
170631074|NCT02035267|616662229|FG003|Overall Study|Other unspecified|0|||
170631075|NCT03038880|616662230|FG000|Overall Study|Death|1|||
170631076|NCT03038880|616662231|FG001|Overall Study|Death|2|||
170631077|NCT03038880|616662232|FG002|Overall Study|Death|0|||
170631078|NCT03038880|616662230|FG000|Overall Study|Physician Decision|2|||
170631079|NCT03038880|616662231|FG001|Overall Study|Physician Decision|1|||
170631080|NCT03038880|616662232|FG002|Overall Study|Physician Decision|0|||
170631081|NCT02054104|616662233|FG000|Overall Study|Did not want to continue due to college classes|1|||
170631082|NCT02054104|616662234|FG001|Overall Study|Did not want to continue due to college classes|0|||
170631083|NCT02054104|616662233|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
170631084|NCT02054104|616662234|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
170631085|NCT02054104|616662233|FG000|Overall Study|No evidence of immunologic response|2|||
170631086|NCT02054104|616662234|FG001|Overall Study|No evidence of immunologic response|2|||
170631087|NCT02054104|616662233|FG000|Overall Study|Disease Progression On Study|4|||
170631088|NCT02054104|616662234|FG001|Overall Study|Disease Progression On Study|5|||
170631089|NCT02054104|616662233|FG000|Overall Study|Diagnosis of lymphoma|0|||
170631090|NCT02054104|616662234|FG001|Overall Study|Diagnosis of lymphoma|1|||
170631091|NCT02054104|616662233|FG000|Overall Study|Inconclusive response|0|||
170631092|NCT02054104|616662234|FG001|Overall Study|Inconclusive response|1|||
170631093|NCT02633306|616662237|FG000|Overall Study|Withdrawal by Subject|3|||
170631094|NCT01657019|616662238|FG000|Overall Study|Withdrawal by Subject|65|||
170631095|NCT01657019|616662238|FG000|Overall Study|Adverse Event|55|||
170631096|NCT01657019|616662238|FG000|Overall Study|Lost to Follow-up|48|||
170631097|NCT01657019|616662238|FG000|Overall Study|Protocol Violation|6|||
170631098|NCT01657019|616662238|FG000|Overall Study|Lack of Efficacy|3|||
170631099|NCT01657019|616662238|FG000|Overall Study|Other|58|||
170631100|NCT00763035|616662255|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
170631101|NCT00763035|616662256|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
170631102|NCT00763035|616662255|FG000|First Intervention|Adverse Event|0|||
170631103|NCT00763035|616662256|FG001|First Intervention|Adverse Event|1|||
170631104|NCT00763035|616662255|FG000|Second Intervention|Adverse Event|1|||
170631105|NCT00763035|616662256|FG001|Second Intervention|Adverse Event|0|||
170631106|NCT00763035|616662255|FG000|Second Intervention|Physician Decision|2|||
170631107|NCT00763035|616662256|FG001|Second Intervention|Physician Decision|0|||
170631108|NCT02131259|616662257|FG000|Overall Study|Progressive disease|751|||
170631109|NCT02131259|616662257|FG000|Overall Study|Adverse Event|341|||
170631110|NCT02131259|616662257|FG000|Overall Study|Lost to Follow-up|7|||
170631111|NCT02131259|616662257|FG000|Overall Study|Relocation|32|||
170631112|NCT02131259|616662257|FG000|Overall Study|Other|63|||
170631113|NCT02131259|616662257|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
170631114|NCT02131259|616662257|FG000|Overall Study|Progressive disease/relocation|1|||
170631115|NCT02131259|616662257|FG000|Overall Study|Progressive disease/other|2|||
170631116|NCT02131259|616662257|FG000|Overall Study|AE/lost to follow-up|1|||
170631117|NCT02131259|616662257|FG000|Overall Study|AE/other|1|||
170631118|NCT02131259|616662257|FG000|Overall Study|Progressive disease/AE/other|1|||
170631119|NCT02131259|616662257|FG000|Overall Study|Missing|3|||
170631120|NCT01472289|616662258|FG000|Overall Study|Death|2|||
170631121|NCT00912808|616662259|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
170631122|NCT00912808|616662260|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
170631123|NCT00912808|616662259|FG000|Washout|Withdrawal by Subject|0|||
170631124|NCT00912808|616662260|FG001|Washout|Withdrawal by Subject|1|||
170631125|NCT00912808|616662259|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
170631126|NCT00912808|616662260|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
170631127|NCT00912808|616662259|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
170631128|NCT00912808|616662260|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
170631129|NCT00702221|616662261|FG000|Overall Study|Adverse Event|4|||
170631130|NCT00702221|616662262|FG001|Overall Study|Adverse Event|3|||
170631131|NCT02900378|616662263|FG000|Randomization (Visit 2)|Adverse Event|14|||
170631132|NCT02900378|616662264|FG001|Randomization (Visit 2)|Adverse Event|11|||
170631133|NCT02900378|616662263|FG000|Randomization (Visit 2)|Death|1|||
170631134|NCT02900378|616662264|FG001|Randomization (Visit 2)|Death|4|||
170631135|NCT02900378|616662263|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
170631136|NCT02900378|616662264|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
170631137|NCT02900378|616662263|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
170631138|NCT02900378|616662264|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
170631139|NCT02900378|616662263|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
170631140|NCT02900378|616662264|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
170631141|NCT02900378|616662263|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
170631142|NCT02900378|616662264|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
170631143|NCT02900378|616662263|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
170631144|NCT02900378|616662264|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
170631145|NCT02504151|616662268|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
170631146|NCT02504151|616662269|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
170631147|NCT02504151|616662268|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
170631148|NCT02504151|616662269|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
170631149|NCT02504151|616662268|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
170631150|NCT02504151|616662269|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
170631151|NCT02504151|616662268|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
170631152|NCT02504151|616662269|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
170631153|NCT01188343|616662272|FG000|Overall Study|Not vaccinated|0|||
170631154|NCT01188343|616662273|FG001|Overall Study|Not vaccinated|2|||
170631155|NCT01188343|616662274|FG002|Overall Study|Not vaccinated|1|||
170631156|NCT01188343|616662272|FG000|Overall Study|Withdrawal by Subject|1|||
170631157|NCT01188343|616662273|FG001|Overall Study|Withdrawal by Subject|24|||
170631158|NCT01188343|616662274|FG002|Overall Study|Withdrawal by Subject|0|||
170631159|NCT04109547|616662275|FG000|Overall Study|Withdrawal by Subject|3|||
170631160|NCT04109547|616662276|FG001|Overall Study|Withdrawal by Subject|2|||
170631161|NCT04109547|616662277|FG002|Overall Study|Withdrawal by Subject|6|||
170631162|NCT04109547|616662278|FG003|Overall Study|Withdrawal by Subject|6|||
170631163|NCT04109547|616662275|FG000|Overall Study|Lost to Follow-up|0|||
170631164|NCT04109547|616662276|FG001|Overall Study|Lost to Follow-up|0|||
170631165|NCT04109547|616662277|FG002|Overall Study|Lost to Follow-up|0|||
170631166|NCT04109547|616662278|FG003|Overall Study|Lost to Follow-up|1|||
170631167|NCT04109547|616662275|FG000|Overall Study|Physician Decision|1|||
170631168|NCT04109547|616662276|FG001|Overall Study|Physician Decision|2|||
170631169|NCT04109547|616662277|FG002|Overall Study|Physician Decision|0|||
170631170|NCT04109547|616662278|FG003|Overall Study|Physician Decision|0|||
170631171|NCT05567783|616662279|FG000|Overall Study|Death|2|||
170631172|NCT05567783|616662280|FG001|Overall Study|Death|3|||
170631173|NCT05567783|616662281|FG002|Overall Study|Death|0|||
170631174|NCT05567783|616662279|FG000|Overall Study|Lost to Follow-up|25|||
170631175|NCT05567783|616662280|FG001|Overall Study|Lost to Follow-up|19|||
170631176|NCT05567783|616662281|FG002|Overall Study|Lost to Follow-up|17|||
170631177|NCT05567783|616662279|FG000|Overall Study|Physician Decision|10|||
170631178|NCT05567783|616662280|FG001|Overall Study|Physician Decision|7|||
170631179|NCT05567783|616662281|FG002|Overall Study|Physician Decision|9|||
170631180|NCT05567783|616662279|FG000|Overall Study|Study Terminated by Sponsor|924|||
170631181|NCT05567783|616662280|FG001|Overall Study|Study Terminated by Sponsor|937|||
170631182|NCT05567783|616662281|FG002|Overall Study|Study Terminated by Sponsor|941|||
170631183|NCT05567783|616662279|FG000|Overall Study|Withdrawal by Subject|23|||
170631184|NCT05567783|616662280|FG001|Overall Study|Withdrawal by Subject|27|||
170631185|NCT05567783|616662281|FG002|Overall Study|Withdrawal by Subject|24|||
170631186|NCT05567783|616662279|FG000|Overall Study|Incarcerated|1|||
170631187|NCT05567783|616662280|FG001|Overall Study|Incarcerated|0|||
170631188|NCT05567783|616662281|FG002|Overall Study|Incarcerated|0|||
170631189|NCT05567783|616662279|FG000|Overall Study|Participant randomized in error|4|||
170631190|NCT05567783|616662280|FG001|Overall Study|Participant randomized in error|2|||
170631191|NCT05567783|616662281|FG002|Overall Study|Participant randomized in error|2|||
170631192|NCT03675126|616662284|FG000|Overall Study|Study Terminated by Sponsor|9|||
170631193|NCT03675126|616662284|FG000|Overall Study|Death|2|||
170631194|NCT03675126|616662284|FG000|Overall Study|Withdrawal by Subject|4|||
170631195|NCT00001959|616662285|FG000|Overall Study|newly diagnosed colon cancer|1|||
170631196|NCT00001959|616662285|FG000|Overall Study|disabling sedation|1|||
170631197|NCT00001959|616662285|FG000|Overall Study|non-compliance|1|||
170631198|NCT03113487|616662289|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
170631199|NCT04189952|616662292|FG000|Follow-up Period|Death|1|||
170631200|NCT04189952|616662292|FG000|Follow-up Period|Withdrawal by Subject|1|||
170631201|NCT04298697|616662293|FG000|Overall Study|Lost to Follow-up|5|||
170631202|NCT04298697|616662294|FG001|Overall Study|Lost to Follow-up|5|||
170631203|NCT04298697|616662295|FG002|Overall Study|Lost to Follow-up|1|||
170631204|NCT04298697|616662296|FG003|Overall Study|Lost to Follow-up|0|||
170631205|NCT04298697|616662293|FG000|Overall Study|Withdrawal by Subject|0|||
170631206|NCT04298697|616662294|FG001|Overall Study|Withdrawal by Subject|3|||
170746411|NCT02322814|617076242|FG001|Overall Study|Study Terminated by Sponsor|7|||
170746412|NCT02322814|617076243|FG002|Overall Study|Study Terminated by Sponsor|9|||
170746413|NCT02322814|617076244|FG003|Overall Study|Study Terminated by Sponsor|5|||
170746414|NCT02322814|617076245|FG004|Overall Study|Study Terminated by Sponsor|13|||
170746415|NCT02322814|617076241|FG000|Overall Study|Withdrawal by Subject|5|||
170746416|NCT02322814|617076242|FG001|Overall Study|Withdrawal by Subject|4|||
170746417|NCT02322814|617076243|FG002|Overall Study|Withdrawal by Subject|2|||
170746418|NCT02322814|617076244|FG003|Overall Study|Withdrawal by Subject|1|||
170746419|NCT02322814|617076245|FG004|Overall Study|Withdrawal by Subject|3|||
170746420|NCT04908449|617076251|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
170746421|NCT04908449|617076252|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
170746422|NCT04908449|617076251|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
170746423|NCT04908449|617076252|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
170746424|NCT02736968|617076253|FG000|Overall Study|Lost to Follow-up|0|||
170746425|NCT02736968|617076254|FG001|Overall Study|Lost to Follow-up|0|||
170746426|NCT02736968|617076255|FG002|Overall Study|Lost to Follow-up|0|||
170746427|NCT02736968|617076256|FG003|Overall Study|Lost to Follow-up|0|||
170746428|NCT02736968|617076257|FG004|Overall Study|Lost to Follow-up|0|||
170746429|NCT02736968|617076258|FG005|Overall Study|Lost to Follow-up|0|||
170746430|NCT02736968|617076259|FG006|Overall Study|Lost to Follow-up|5|||
170746431|NCT02736968|617076260|FG007|Overall Study|Lost to Follow-up|2|||
170746432|NCT02736968|617076253|FG000|Overall Study|COVID-19 Pandemic|0|||
170746433|NCT02736968|617076254|FG001|Overall Study|COVID-19 Pandemic|0|||
170746434|NCT02736968|617076255|FG002|Overall Study|COVID-19 Pandemic|0|||
170746435|NCT02736968|617076256|FG003|Overall Study|COVID-19 Pandemic|0|||
170746436|NCT02736968|617076257|FG004|Overall Study|COVID-19 Pandemic|0|||
170746437|NCT02736968|617076258|FG005|Overall Study|COVID-19 Pandemic|0|||
170746438|NCT02736968|617076259|FG006|Overall Study|COVID-19 Pandemic|2|||
170746439|NCT02736968|617076260|FG007|Overall Study|COVID-19 Pandemic|0|||
170746440|NCT02736968|617076253|FG000|Overall Study|Withdrawal by Subject|0|||
170746441|NCT02736968|617076254|FG001|Overall Study|Withdrawal by Subject|0|||
170746442|NCT02736968|617076255|FG002|Overall Study|Withdrawal by Subject|0|||
170746443|NCT02736968|617076256|FG003|Overall Study|Withdrawal by Subject|0|||
170746444|NCT02736968|617076257|FG004|Overall Study|Withdrawal by Subject|0|||
170746445|NCT02736968|617076258|FG005|Overall Study|Withdrawal by Subject|0|||
170746446|NCT02736968|617076259|FG006|Overall Study|Withdrawal by Subject|1|||
170746447|NCT02736968|617076260|FG007|Overall Study|Withdrawal by Subject|0|||
170746448|NCT01032044|617076261|FG000|Overall Study|Protocol Violation|14|||
170631207|NCT04298697|616662295|FG002|Overall Study|Withdrawal by Subject|2|||
170746449|NCT01032044|617076262|FG001|Overall Study|Protocol Violation|8|||
170746450|NCT01032044|617076261|FG000|Overall Study|Adverse Event|0|||
170746451|NCT01032044|617076262|FG001|Overall Study|Adverse Event|1|||
170746452|NCT01032044|617076261|FG000|Overall Study|Lost to Follow-up|11|||
170631208|NCT04298697|616662296|FG003|Overall Study|Withdrawal by Subject|3|||
170631209|NCT01502293|616662297|FG000|Overall Study|Progressive Disease|20|||
170631210|NCT01502293|616662298|FG001|Overall Study|Progressive Disease|12|||
170631211|NCT01502293|616662299|FG002|Overall Study|Progressive Disease|2|||
170631212|NCT01502293|616662297|FG000|Overall Study|Withdrawal by Subject|3|||
170631213|NCT01502293|616662298|FG001|Overall Study|Withdrawal by Subject|3|||
170631214|NCT01502293|616662299|FG002|Overall Study|Withdrawal by Subject|1|||
170631215|NCT01502293|616662297|FG000|Overall Study|Adverse Event|0|||
170746453|NCT01032044|617076262|FG001|Overall Study|Lost to Follow-up|11|||
170746454|NCT03342053|617076265|FG000|Overall Study|Adverse Event|2|||
170746455|NCT03342053|617076266|FG001|Overall Study|Adverse Event|0|||
170746456|NCT03342053|617076265|FG000|Overall Study|Withdrawal by Subject|0|||
170746457|NCT03342053|617076266|FG001|Overall Study|Withdrawal by Subject|1|||
170746458|NCT00171873|617076271|FG000|Overall Study|Withdrawal by Subject|4|||
170746459|NCT00171873|617076272|FG001|Overall Study|Withdrawal by Subject|2|||
170746460|NCT00171873|617076271|FG000|Overall Study|Adverse Event|5|||
170746461|NCT00171873|617076272|FG001|Overall Study|Adverse Event|0|||
170746462|NCT00171873|617076271|FG000|Overall Study|Switched to Octreotide|0|||
170746463|NCT00171873|617076272|FG001|Overall Study|Switched to Octreotide|1|||
170746464|NCT01051063|617076275|FG000|Overall Study|Death|2|||
170746465|NCT01051063|617076276|FG001|Overall Study|Death|2|||
170746466|NCT01051063|617076275|FG000|Overall Study|Withdrawal by Subject|1|||
170746467|NCT01051063|617076276|FG001|Overall Study|Withdrawal by Subject|1|||
170631216|NCT01502293|616662298|FG001|Overall Study|Adverse Event|2|||
170631217|NCT01502293|616662299|FG002|Overall Study|Adverse Event|0|||
170631218|NCT01502293|616662297|FG000|Overall Study|Reason Not Specified|2|||
170631219|NCT01502293|616662298|FG001|Overall Study|Reason Not Specified|0|||
170746468|NCT01051063|617076275|FG000|Overall Study|Termination of the study|5|||
170746469|NCT01051063|617076276|FG001|Overall Study|Termination of the study|0|||
170746470|NCT01051063|617076275|FG000|Overall Study|Moved from the study site area|1|||
170746471|NCT01051063|617076276|FG001|Overall Study|Moved from the study site area|0|||
170746472|NCT01051063|617076275|FG000|Overall Study|Other|1|||
170746473|NCT01051063|617076276|FG001|Overall Study|Other|0|||
170746474|NCT01051063|617076275|FG000|Overall Study|Lost to Follow-up|0|||
170746475|NCT01051063|617076276|FG001|Overall Study|Lost to Follow-up|1|||
170746476|NCT02023879|617076278|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
170746477|NCT02023879|617076279|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
170746478|NCT02023879|617076280|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
170746479|NCT02023879|617076278|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
170746480|NCT02023879|617076279|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
170746481|NCT02023879|617076280|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
170746482|NCT02023879|617076278|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
170746483|NCT02023879|617076279|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
170746484|NCT02023879|617076280|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
170746485|NCT02023879|617076278|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
170746486|NCT02023879|617076279|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
170746487|NCT02023879|617076280|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
170746488|NCT02023879|617076278|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
170746489|NCT02023879|617076279|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
170746490|NCT02023879|617076280|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
170746491|NCT02023879|617076278|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
170746492|NCT02023879|617076279|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
170746493|NCT02023879|617076280|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
170746494|NCT02023879|617076278|FG000|Extension Open Label Treatment|Adverse Event|1|||
170746495|NCT02023879|617076279|FG001|Extension Open Label Treatment|Adverse Event|7|||
170746496|NCT02023879|617076280|FG002|Extension Open Label Treatment|Adverse Event|3|||
170746497|NCT02023879|617076278|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
170746498|NCT02023879|617076279|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
170746499|NCT02023879|617076280|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
170746500|NCT02023879|617076278|FG000|Extension Open Label Treatment|Participant moved|1|||
170746501|NCT02023879|617076279|FG001|Extension Open Label Treatment|Participant moved|2|||
170746502|NCT02023879|617076280|FG002|Extension Open Label Treatment|Participant moved|0|||
170746503|NCT02023879|617076278|FG000|Extension Open Label Treatment|Other than specified above|2|||
170746504|NCT02023879|617076279|FG001|Extension Open Label Treatment|Other than specified above|7|||
170746505|NCT02023879|617076280|FG002|Extension Open Label Treatment|Other than specified above|2|||
170746506|NCT00874432|617076281|FG000|Overall Study|Withdrawal by Subject|1|||
170746507|NCT00874432|617076282|FG001|Overall Study|Withdrawal by Subject|0|||
170746508|NCT00874432|617076283|FG002|Overall Study|Withdrawal by Subject|0|||
170746509|NCT00874432|617076284|FG003|Overall Study|Withdrawal by Subject|0|||
170746510|NCT00874432|617076281|FG000|Overall Study|Physician Decision|1|||
170746511|NCT00874432|617076282|FG001|Overall Study|Physician Decision|0|||
170746512|NCT00874432|617076283|FG002|Overall Study|Physician Decision|0|||
170746513|NCT00874432|617076284|FG003|Overall Study|Physician Decision|0|||
170746514|NCT00874432|617076281|FG000|Overall Study|Other|1|||
170746515|NCT00874432|617076282|FG001|Overall Study|Other|2|||
170746516|NCT00874432|617076283|FG002|Overall Study|Other|8|||
170746517|NCT00874432|617076284|FG003|Overall Study|Other|3|||
170746518|NCT06385483|617076285|FG000|Overall Study|Withdrawal by Subject|2|||
170746519|NCT06385483|617076285|FG000|Overall Study|Never start protocol therapy|2|||
170746520|NCT06385483|617076285|FG000|Overall Study|Disease progression|15|||
170746521|NCT00381641|617076288|FG000|Overall Study|Withdrawal by Subject|0|||
170746522|NCT00381641|617076289|FG001|Overall Study|Withdrawal by Subject|2|||
170746523|NCT01282476|617077517|FG000|Overall Study|Death|11|||
170746524|NCT01327547|617077520|FG000|Overall Study|Adverse Event|4|||
170746525|NCT01327547|617077521|FG001|Overall Study|Adverse Event|1|||
170746526|NCT01327547|617077520|FG000|Overall Study|Death|1|||
170746527|NCT01327547|617077521|FG001|Overall Study|Death|2|||
170746528|NCT01327547|617077520|FG000|Overall Study|Lost to Follow-up|6|||
170746529|NCT01327547|617077521|FG001|Overall Study|Lost to Follow-up|6|||
170746530|NCT01327547|617077520|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
170746531|NCT01327547|617077521|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
170746532|NCT01327547|617077520|FG000|Overall Study|Withdrawal by Subject|3|||
170746533|NCT01327547|617077521|FG001|Overall Study|Withdrawal by Subject|7|||
170746534|NCT01327547|617077520|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
170746535|NCT01327547|617077521|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
170746536|NCT01327547|617077520|FG000|Overall Study|Protocol Violation|1|||
170746537|NCT01327547|617077521|FG001|Overall Study|Protocol Violation|0|||
170746538|NCT01327547|617077520|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
170746539|NCT01327547|617077521|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
170746540|NCT01327547|617077520|FG000|Overall Study|Required prohibited medication|2|||
170746541|NCT01327547|617077521|FG001|Overall Study|Required prohibited medication|0|||
170746542|NCT01327547|617077520|FG000|Overall Study|Non-compliance with study procedures|1|||
170746543|NCT01327547|617077521|FG001|Overall Study|Non-compliance with study procedures|0|||
170746544|NCT01327547|617077520|FG000|Overall Study|By investigator in subject's interest|0|||
170746545|NCT01327547|617077521|FG001|Overall Study|By investigator in subject's interest|1|||
170746546|NCT03918239|617077522|FG000|Overall Study|Lost to Follow-up|3|||
170746547|NCT03918239|617077523|FG001|Overall Study|Lost to Follow-up|1|||
170746548|NCT03918239|617077522|FG000|Overall Study|Pregnancy|0|||
170746549|NCT03918239|617077523|FG001|Overall Study|Pregnancy|2|||
170746550|NCT03918239|617077522|FG000|Overall Study|Withdrawal by Subject|3|||
170746551|NCT03918239|617077523|FG001|Overall Study|Withdrawal by Subject|3|||
170746552|NCT03918239|617077522|FG000|Overall Study|positive urine drug screening results|4|||
170746553|NCT03918239|617077523|FG001|Overall Study|positive urine drug screening results|1|||
170746554|NCT00830947|617077529|FG000|Overall Study|Lost to Follow-up|4|||
170746555|NCT00830947|617077530|FG001|Overall Study|Lost to Follow-up|4|||
170746556|NCT01702428|617077531|FG000|Overall Study|Adverse Event|2|||
170746557|NCT01702428|617077532|FG001|Overall Study|Adverse Event|0|||
170746558|NCT01702428|617077533|FG002|Overall Study|Adverse Event|0|||
170746559|NCT01702428|617077534|FG003|Overall Study|Adverse Event|0|||
170746560|NCT01702428|617077531|FG000|Overall Study|Lost to Follow-up|33|||
170746561|NCT01702428|617077532|FG001|Overall Study|Lost to Follow-up|41|||
170746562|NCT01702428|617077533|FG002|Overall Study|Lost to Follow-up|37|||
170746563|NCT01702428|617077534|FG003|Overall Study|Lost to Follow-up|44|||
170746564|NCT01702428|617077531|FG000|Overall Study|Parents cannot assist to site|1|||
170746565|NCT01702428|617077532|FG001|Overall Study|Parents cannot assist to site|0|||
170746566|NCT01702428|617077533|FG002|Overall Study|Parents cannot assist to site|1|||
170746567|NCT01702428|617077534|FG003|Overall Study|Parents cannot assist to site|0|||
170746568|NCT01702428|617077531|FG000|Overall Study|Lost Coverage|0|||
170746569|NCT01702428|617077532|FG001|Overall Study|Lost Coverage|0|||
170746570|NCT01702428|617077533|FG002|Overall Study|Lost Coverage|0|||
170746571|NCT01702428|617077534|FG003|Overall Study|Lost Coverage|1|||
170746572|NCT01702428|617077531|FG000|Overall Study|Lost Health Plan|3|||
170746573|NCT01702428|617077532|FG001|Overall Study|Lost Health Plan|5|||
170746574|NCT01702428|617077533|FG002|Overall Study|Lost Health Plan|0|||
170746575|NCT01702428|617077534|FG003|Overall Study|Lost Health Plan|2|||
170746576|NCT01702428|617077531|FG000|Overall Study|Mother transferred care|0|||
170746577|NCT01702428|617077532|FG001|Overall Study|Mother transferred care|1|||
170746578|NCT01702428|617077533|FG002|Overall Study|Mother transferred care|0|||
170746579|NCT01702428|617077534|FG003|Overall Study|Mother transferred care|0|||
170746580|NCT01702428|617077531|FG000|Overall Study|Parents too busy|1|||
170746581|NCT01702428|617077532|FG001|Overall Study|Parents too busy|0|||
170746582|NCT01702428|617077533|FG002|Overall Study|Parents too busy|0|||
170746583|NCT01702428|617077534|FG003|Overall Study|Parents too busy|0|||
170746584|NCT01702428|617077531|FG000|Overall Study|Protocol Violation|3|||
170746585|NCT01702428|617077532|FG001|Overall Study|Protocol Violation|0|||
170746586|NCT01702428|617077533|FG002|Overall Study|Protocol Violation|1|||
170746587|NCT01702428|617077534|FG003|Overall Study|Protocol Violation|0|||
170746588|NCT01702428|617077531|FG000|Overall Study|Withdrawal by Subject|21|||
170746589|NCT01702428|617077532|FG001|Overall Study|Withdrawal by Subject|23|||
170746590|NCT01702428|617077533|FG002|Overall Study|Withdrawal by Subject|14|||
170746591|NCT01702428|617077534|FG003|Overall Study|Withdrawal by Subject|10|||
170746592|NCT03685708|617077535|FG000|Overall Study|Withdrawal by Subject|0|||
170746593|NCT03685708|617077536|FG001|Overall Study|Withdrawal by Subject|0|||
170746594|NCT03685708|617077537|FG002|Overall Study|Withdrawal by Subject|1|||
170746595|NCT03685708|617077535|FG000|Overall Study|Screen Fail|0|||
170746596|NCT03685708|617077536|FG001|Overall Study|Screen Fail|1|||
170746597|NCT03685708|617077537|FG002|Overall Study|Screen Fail|1|||
170746598|NCT03685708|617077535|FG000|Overall Study|COVID 19 Pandemic|1|||
170746599|NCT03685708|617077536|FG001|Overall Study|COVID 19 Pandemic|1|||
170746600|NCT03685708|617077537|FG002|Overall Study|COVID 19 Pandemic|6|||
170746601|NCT03685708|617077535|FG000|Overall Study|Disease Progression|0|||
170746602|NCT03685708|617077536|FG001|Overall Study|Disease Progression|0|||
170746603|NCT03685708|617077537|FG002|Overall Study|Disease Progression|1|||
170746604|NCT02771210|617077541|FG000|Period 1|Adverse Event|5|||
170746605|NCT02771210|617077542|FG001|Period 1|Adverse Event|3|||
170746606|NCT02771210|617077541|FG000|Period 1|Lack of Efficacy|3|||
170746607|NCT02771210|617077542|FG001|Period 1|Lack of Efficacy|6|||
170746608|NCT02771210|617077541|FG000|Period 1|Lost to Follow-up|2|||
170746609|NCT02771210|617077542|FG001|Period 1|Lost to Follow-up|0|||
170746610|NCT02771210|617077541|FG000|Period 1|Physician Decision|0|||
170746611|NCT02771210|617077542|FG001|Period 1|Physician Decision|1|||
170746612|NCT02771210|617077541|FG000|Period 1|Withdrawal by Subject|0|||
170746613|NCT02771210|617077542|FG001|Period 1|Withdrawal by Subject|3|||
170746614|NCT02771210|617077541|FG000|Period 1|Withdrawal of informed consent|1|||
170746615|NCT02771210|617077542|FG001|Period 1|Withdrawal of informed consent|5|||
170746616|NCT02771210|617077541|FG000|Period 2|Adverse Event|1|||
170746617|NCT02771210|617077542|FG001|Period 2|Adverse Event|0|||
170746618|NCT02771210|617077541|FG000|Period 2|Lack of Efficacy|0|||
170746619|NCT02771210|617077542|FG001|Period 2|Lack of Efficacy|1|||
170746620|NCT02771210|617077541|FG000|Period 2|Withdrawal by Subject|1|||
170746621|NCT02771210|617077542|FG001|Period 2|Withdrawal by Subject|0|||
170746622|NCT02771210|617077541|FG000|Period 2|Withdrawal of informed consent|0|||
170746623|NCT02771210|617077542|FG001|Period 2|Withdrawal of informed consent|2|||
170746624|NCT04012814|617077543|FG000|Overall Study|Lost to Follow-up|4|||
170746625|NCT04012814|617077543|FG000|Overall Study|Withdrawal by Subject|2|||
170746626|NCT04012814|617077543|FG000|Overall Study|Protocol Violation|1|||
170746627|NCT04012814|617077543|FG000|Overall Study|Adverse Event|1|||
170746628|NCT01027364|617077544|FG000|Overall Study|Adverse Event|1|||
170746629|NCT01027364|617077545|FG001|Overall Study|Adverse Event|0|||
170746630|NCT01027364|617077546|FG002|Overall Study|Adverse Event|1|||
170746631|NCT01027364|617077547|FG003|Overall Study|Adverse Event|0|||
170746632|NCT01027364|617077544|FG000|Overall Study|Lost to Follow-up|1|||
170746633|NCT01027364|617077545|FG001|Overall Study|Lost to Follow-up|0|||
170746634|NCT01027364|617077546|FG002|Overall Study|Lost to Follow-up|0|||
170746635|NCT01027364|617077547|FG003|Overall Study|Lost to Follow-up|0|||
170746636|NCT01027364|617077544|FG000|Overall Study|Protocol Violation|1|||
170746637|NCT01027364|617077545|FG001|Overall Study|Protocol Violation|0|||
170746638|NCT01027364|617077546|FG002|Overall Study|Protocol Violation|0|||
170746639|NCT01027364|617077547|FG003|Overall Study|Protocol Violation|1|||
170746640|NCT01027364|617077544|FG000|Overall Study|Withdrawal by Subject|1|||
170746641|NCT01027364|617077545|FG001|Overall Study|Withdrawal by Subject|2|||
170746642|NCT01027364|617077546|FG002|Overall Study|Withdrawal by Subject|0|||
170746643|NCT01027364|617077547|FG003|Overall Study|Withdrawal by Subject|0|||
170746644|NCT01394250|617077548|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
170746645|NCT01394250|617077549|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
170746646|NCT01394250|617077548|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
170746647|NCT01394250|617077549|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
170746648|NCT03230864|617077550|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
170746649|NCT03230864|617077551|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
170746650|NCT03230864|617077552|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
170746651|NCT03230864|617077553|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
170746652|NCT03230864|617077550|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
170746653|NCT03230864|617077551|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
170746654|NCT03230864|617077552|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
170746655|NCT03230864|617077553|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
170746656|NCT03230864|617077550|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
170746657|NCT03230864|617077551|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
170746658|NCT03230864|617077552|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
170746659|NCT03230864|617077553|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
170746660|NCT03230864|617077550|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
170746661|NCT03230864|617077551|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
170746662|NCT03230864|617077552|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
170746663|NCT03230864|617077553|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
170746664|NCT03230864|617077550|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
170746665|NCT03230864|617077551|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
170746666|NCT03230864|617077552|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
170746667|NCT03230864|617077553|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
170746668|NCT03230864|617077550|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
170746669|NCT03230864|617077551|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
170746670|NCT03230864|617077552|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
170746671|NCT03230864|617077553|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
170746672|NCT03230864|617077550|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
170746673|NCT03230864|617077551|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
170746674|NCT03230864|617077552|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
170746675|NCT03230864|617077553|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
170746676|NCT03230864|617077550|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
170746677|NCT03230864|617077551|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
170746678|NCT03230864|617077552|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
170746679|NCT03230864|617077553|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
170746680|NCT03230864|617077550|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
170746681|NCT03230864|617077551|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
170746682|NCT03230864|617077552|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
170746683|NCT03230864|617077553|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
170746684|NCT03230864|617077550|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
170746685|NCT03230864|617077551|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
170746686|NCT03230864|617077552|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
170746687|NCT03230864|617077553|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
170746688|NCT02222896|617077556|FG000|Abdomen|Did not qualify|34|||
170746689|NCT02222896|617077557|FG001|Abdomen|Did not qualify|10|||
170746690|NCT02222896|617077558|FG002|Abdomen|Did not qualify|32|||
170746691|NCT02222896|617077556|FG000|Groin|Did not qualify|43|||
170746692|NCT02222896|617077557|FG001|Groin|Did not qualify|9|||
170746693|NCT02222896|617077558|FG002|Groin|Did not qualify|40|||
170746694|NCT01865617|617077560|FG000|Overall Study|Death|27|||
170746695|NCT01865617|617077561|FG001|Overall Study|Death|3|||
170746696|NCT01865617|617077562|FG002|Overall Study|Death|1|||
170746697|NCT01865617|617077563|FG003|Overall Study|Death|1|||
170746698|NCT01865617|617077564|FG004|Overall Study|Death|5|||
170746699|NCT01865617|617077565|FG005|Overall Study|Death|1|||
170746700|NCT01865617|617077566|FG006|Overall Study|Death|11|||
170746701|NCT01865617|617077567|FG007|Overall Study|Death|1|||
170746702|NCT01865617|617077568|FG008|Overall Study|Death|11|||
170746703|NCT01865617|617077569|FG009|Overall Study|Death|3|||
170746704|NCT01865617|617077570|FG010|Overall Study|Death|32|||
170746705|NCT01865617|617077571|FG011|Overall Study|Death|6|||
170746706|NCT01865617|617077572|FG012|Overall Study|Death|13|||
170746707|NCT01865617|617077560|FG000|Overall Study|Lost to Follow-up|2|||
170746708|NCT01865617|617077561|FG001|Overall Study|Lost to Follow-up|0|||
170746709|NCT01865617|617077562|FG002|Overall Study|Lost to Follow-up|0|||
170746710|NCT01865617|617077563|FG003|Overall Study|Lost to Follow-up|0|||
170746711|NCT01865617|617077564|FG004|Overall Study|Lost to Follow-up|0|||
170746712|NCT01865617|617077565|FG005|Overall Study|Lost to Follow-up|0|||
170746713|NCT01865617|617077566|FG006|Overall Study|Lost to Follow-up|0|||
170746714|NCT01865617|617077567|FG007|Overall Study|Lost to Follow-up|0|||
170746715|NCT01865617|617077568|FG008|Overall Study|Lost to Follow-up|0|||
170746716|NCT01865617|617077569|FG009|Overall Study|Lost to Follow-up|0|||
170746717|NCT01865617|617077570|FG010|Overall Study|Lost to Follow-up|0|||
170746718|NCT01865617|617077571|FG011|Overall Study|Lost to Follow-up|0|||
170746719|NCT01865617|617077572|FG012|Overall Study|Lost to Follow-up|0|||
170746720|NCT01865617|617077560|FG000|Overall Study|Withdrawal by Subject|1|||
170746721|NCT01865617|617077561|FG001|Overall Study|Withdrawal by Subject|0|||
170746722|NCT01865617|617077562|FG002|Overall Study|Withdrawal by Subject|0|||
170746723|NCT01865617|617077563|FG003|Overall Study|Withdrawal by Subject|0|||
170746724|NCT01865617|617077564|FG004|Overall Study|Withdrawal by Subject|0|||
170746725|NCT01865617|617077565|FG005|Overall Study|Withdrawal by Subject|0|||
170746726|NCT01865617|617077566|FG006|Overall Study|Withdrawal by Subject|0|||
170746727|NCT01865617|617077567|FG007|Overall Study|Withdrawal by Subject|0|||
170746728|NCT01865617|617077568|FG008|Overall Study|Withdrawal by Subject|0|||
170746729|NCT01865617|617077569|FG009|Overall Study|Withdrawal by Subject|0|||
170746730|NCT01865617|617077570|FG010|Overall Study|Withdrawal by Subject|0|||
170746731|NCT01865617|617077571|FG011|Overall Study|Withdrawal by Subject|0|||
170746732|NCT01865617|617077572|FG012|Overall Study|Withdrawal by Subject|0|||
170746733|NCT01865617|617077560|FG000|Overall Study|Patient proceeded to new therapy|0|||
170746734|NCT01865617|617077561|FG001|Overall Study|Patient proceeded to new therapy|0|||
170746735|NCT01865617|617077562|FG002|Overall Study|Patient proceeded to new therapy|0|||
170746736|NCT01865617|617077563|FG003|Overall Study|Patient proceeded to new therapy|0|||
170746737|NCT01865617|617077564|FG004|Overall Study|Patient proceeded to new therapy|2|||
170746738|NCT01865617|617077565|FG005|Overall Study|Patient proceeded to new therapy|0|||
170746739|NCT01865617|617077566|FG006|Overall Study|Patient proceeded to new therapy|0|||
170746740|NCT01865617|617077567|FG007|Overall Study|Patient proceeded to new therapy|0|||
170746741|NCT01865617|617077568|FG008|Overall Study|Patient proceeded to new therapy|0|||
170746742|NCT01865617|617077569|FG009|Overall Study|Patient proceeded to new therapy|0|||
170746743|NCT01865617|617077570|FG010|Overall Study|Patient proceeded to new therapy|0|||
170746744|NCT01865617|617077571|FG011|Overall Study|Patient proceeded to new therapy|0|||
170746745|NCT01865617|617077572|FG012|Overall Study|Patient proceeded to new therapy|0|||
170746746|NCT01865617|617077560|FG000|Overall Study|Other|0|||
170746747|NCT01865617|617077561|FG001|Overall Study|Other|0|||
170746748|NCT01865617|617077562|FG002|Overall Study|Other|0|||
170746749|NCT01865617|617077563|FG003|Overall Study|Other|0|||
170746750|NCT01865617|617077564|FG004|Overall Study|Other|0|||
170746751|NCT01865617|617077565|FG005|Overall Study|Other|0|||
170746752|NCT01865617|617077566|FG006|Overall Study|Other|1|||
170746753|NCT01865617|617077567|FG007|Overall Study|Other|0|||
170746754|NCT01865617|617077568|FG008|Overall Study|Other|0|||
170746755|NCT01865617|617077569|FG009|Overall Study|Other|0|||
170746756|NCT01865617|617077570|FG010|Overall Study|Other|0|||
170746757|NCT01865617|617077571|FG011|Overall Study|Other|0|||
170746758|NCT01865617|617077572|FG012|Overall Study|Other|0|||
170746759|NCT03772314|617077581|FG000|Overall Study|Adverse Event|7|||
170746760|NCT03772314|617077582|FG001|Overall Study|Adverse Event|2|||
170746761|NCT01258660|617077583|FG000|Overall Study|Adverse Event|2|||
170746762|NCT01258660|617077584|FG001|Overall Study|Adverse Event|4|||
170746763|NCT01258660|617077583|FG000|Overall Study|Withdrawal by Subject|3|||
170746764|NCT01258660|617077584|FG001|Overall Study|Withdrawal by Subject|0|||
170746765|NCT01258660|617077583|FG000|Overall Study|due to relocation|2|||
170746766|NCT01258660|617077584|FG001|Overall Study|due to relocation|0|||
170746767|NCT01258660|617077583|FG000|Overall Study|Protocol Violation|0|||
170746768|NCT01258660|617077584|FG001|Overall Study|Protocol Violation|1|||
170746769|NCT01258660|617077583|FG000|Overall Study|Invalid for primary analysis data set|4|||
170746770|NCT01258660|617077584|FG001|Overall Study|Invalid for primary analysis data set|6|||
170746771|NCT02743793|617077585|FG000|Overall Study|Death|1|||
170746772|NCT02743793|617077586|FG001|Overall Study|Death|1|||
170746773|NCT02743793|617077585|FG000|Overall Study|Withdrawal by Subject|0|||
170746774|NCT02743793|617077586|FG001|Overall Study|Withdrawal by Subject|1|||
170746775|NCT02743793|617077585|FG000|Overall Study|Screen Failure|4|||
170746776|NCT02743793|617077586|FG001|Overall Study|Screen Failure|0|||
170746777|NCT02743793|617077585|FG000|Overall Study|No Primary Care Physician|0|||
170746778|NCT02743793|617077586|FG001|Overall Study|No Primary Care Physician|1|||
170746779|NCT02743793|617077585|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
170746780|NCT02743793|617077586|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
170746781|NCT02743793|617077585|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
170746782|NCT02743793|617077586|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
170746783|NCT01799720|617077589|FG000|Overall Study|Withdrawal by Subject|3|||
170746784|NCT01799720|617077590|FG001|Overall Study|Withdrawal by Subject|0|||
170746785|NCT01799720|617077591|FG002|Overall Study|Withdrawal by Subject|0|||
170746786|NCT01799720|617077589|FG000|Overall Study|Protocol Violation|0|||
170746787|NCT01799720|617077590|FG001|Overall Study|Protocol Violation|1|||
170746788|NCT01799720|617077591|FG002|Overall Study|Protocol Violation|0|||
170746789|NCT01799720|617077589|FG000|Overall Study|Pregnancy|0|||
170746790|NCT01799720|617077590|FG001|Overall Study|Pregnancy|0|||
170746791|NCT01799720|617077591|FG002|Overall Study|Pregnancy|1|||
170746792|NCT04175912|617077598|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
170746793|NCT04175912|617077599|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
170746794|NCT04175912|617077598|FG000|Overall Study|Adverse Event|0|||
170746795|NCT04175912|617077599|FG001|Overall Study|Adverse Event|3|||
170746796|NCT04175912|617077598|FG000|Overall Study|Never started treatment|3|||
170746797|NCT04175912|617077599|FG001|Overall Study|Never started treatment|3|||
170746798|NCT04175912|617077598|FG000|Overall Study|Death|0|||
170746799|NCT04175912|617077599|FG001|Overall Study|Death|1|||
170746800|NCT01155661|617077602|FG000|Overall Study|Adverse Event|101|||
170746801|NCT01155661|617077602|FG000|Overall Study|Death|1|||
170746802|NCT01155661|617077602|FG000|Overall Study|Lack of Efficacy|32|||
170746803|NCT01155661|617077602|FG000|Overall Study|Lost to Follow-up|22|||
170746804|NCT01155661|617077602|FG000|Overall Study|Physician Decision|3|||
170746805|NCT01155661|617077602|FG000|Overall Study|Protocol Violation|35|||
170746806|NCT01155661|617077602|FG000|Overall Study|Withdrawal by Subject|73|||
170746807|NCT01155661|617077602|FG000|Overall Study|Sponsor Decision|13|||
170746808|NCT02058290|617077603|FG000|Overall Study|Protocol Violation|2|||
170746809|NCT02058290|617077604|FG001|Overall Study|Protocol Violation|1|||
170746810|NCT02058290|617077603|FG000|Overall Study|Physician Decision|1|||
170746811|NCT02058290|617077604|FG001|Overall Study|Physician Decision|0|||
170746812|NCT02058290|617077603|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
170746813|NCT02058290|617077604|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
170746814|NCT02058290|617077603|FG000|Overall Study|Withdrawal by Subject|0|||
170746815|NCT02058290|617077604|FG001|Overall Study|Withdrawal by Subject|1|||
170746816|NCT00105586|617077606|FG000|Overall Study|Adverse Event|4|||
170746817|NCT00105586|617077607|FG001|Overall Study|Adverse Event|3|||
170746818|NCT00105586|617077606|FG000|Overall Study|Physician Decision|13|||
170746819|NCT00105586|617077607|FG001|Overall Study|Physician Decision|13|||
170746820|NCT02262260|617077610|FG000|Overall Study|Adverse Event|4|||
170746821|NCT02262260|617077611|FG001|Overall Study|Adverse Event|1|||
170746822|NCT02262260|617077610|FG000|Overall Study|Withdrawal of consent|4|||
170746823|NCT02262260|617077611|FG001|Overall Study|Withdrawal of consent|2|||
170746824|NCT02262260|617077610|FG000|Overall Study|Lost to Follow-up|1|||
170746825|NCT02262260|617077611|FG001|Overall Study|Lost to Follow-up|2|||
170746826|NCT02262260|617077610|FG000|Overall Study|Protocol deviation|2|||
170746827|NCT02262260|617077611|FG001|Overall Study|Protocol deviation|5|||
170746828|NCT02090634|617077612|FG000|Overall Study|Lost to Follow-up|0|||
170746829|NCT02090634|617077613|FG001|Overall Study|Lost to Follow-up|1|||
170746830|NCT02090634|617077612|FG000|Overall Study|Death|0|||
170746831|NCT02090634|617077613|FG001|Overall Study|Death|1|||
170746832|NCT02090634|617077612|FG000|Overall Study|Protocol Violation|3|||
170746833|NCT02090634|617077613|FG001|Overall Study|Protocol Violation|1|||
170746834|NCT02090634|617077612|FG000|Overall Study|Adverse Event|2|||
170746835|NCT02090634|617077613|FG001|Overall Study|Adverse Event|0|||
170746836|NCT03757234|617077614|FG000|Overall Study|Adverse Event|0|||
170746837|NCT03757234|617077615|FG001|Overall Study|Adverse Event|0|||
170746838|NCT03757234|617077616|FG002|Overall Study|Adverse Event|0|||
170746839|NCT03757234|617077617|FG003|Overall Study|Adverse Event|0|||
170746840|NCT03757234|617077618|FG004|Overall Study|Adverse Event|1|||
170746841|NCT03757234|617077614|FG000|Overall Study|Lost to Follow-up|1|||
170746842|NCT03757234|617077615|FG001|Overall Study|Lost to Follow-up|0|||
170746843|NCT03757234|617077616|FG002|Overall Study|Lost to Follow-up|0|||
170746844|NCT03757234|617077617|FG003|Overall Study|Lost to Follow-up|0|||
170746845|NCT03757234|617077618|FG004|Overall Study|Lost to Follow-up|1|||
170746846|NCT03757234|617077614|FG000|Overall Study|Withdrawal by Subject|1|||
170746847|NCT03757234|617077615|FG001|Overall Study|Withdrawal by Subject|1|||
170746848|NCT03757234|617077616|FG002|Overall Study|Withdrawal by Subject|0|||
170746849|NCT03757234|617077617|FG003|Overall Study|Withdrawal by Subject|1|||
170746850|NCT03757234|617077618|FG004|Overall Study|Withdrawal by Subject|2|||
170746851|NCT03757234|617077614|FG000|Overall Study|Other|1|||
170746852|NCT03757234|617077615|FG001|Overall Study|Other|1|||
170746853|NCT03757234|617077616|FG002|Overall Study|Other|0|||
170746854|NCT03757234|617077617|FG003|Overall Study|Other|0|||
170746855|NCT03757234|617077618|FG004|Overall Study|Other|0|||
170746856|NCT00147225|617077624|FG000|Overall Study|Withdrawal by Subject|1|||
170746857|NCT00147225|617077625|FG001|Overall Study|Withdrawal by Subject|0|||
170746858|NCT00147225|617077626|FG002|Overall Study|Withdrawal by Subject|1|||
170631220|NCT01502293|616662299|FG002|Overall Study|Reason Not Specified|0|||
170631221|NCT01502293|616662297|FG000|Overall Study|Physician Decision|0|||
170631222|NCT01502293|616662298|FG001|Overall Study|Physician Decision|0|||
170631223|NCT01502293|616662299|FG002|Overall Study|Physician Decision|1|||
170631224|NCT01498068|616662300|FG000|Overall Study|Withdrawal by Subject|1|||
170631225|NCT01498068|616662301|FG001|Overall Study|Withdrawal by Subject|1|||
170631226|NCT03058146|616662313|FG000|Overall Study|Withdrawal by Subject|4|||
170631227|NCT03058146|616662314|FG001|Overall Study|Withdrawal by Subject|1|||
170631228|NCT03058146|616662313|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
170631229|NCT03058146|616662314|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
170631230|NCT00632229|616662315|FG000|Overall Study|Adverse Event|6|||
170631231|NCT00632229|616662316|FG001|Overall Study|Adverse Event|0|||
170631232|NCT00632229|616662315|FG000|Overall Study|Lost to Follow-up|0|||
170631233|NCT00632229|616662316|FG001|Overall Study|Lost to Follow-up|3|||
170631234|NCT00632229|616662315|FG000|Overall Study|Lack of Efficacy|0|||
170631235|NCT00632229|616662316|FG001|Overall Study|Lack of Efficacy|2|||
170631236|NCT00632229|616662315|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
170631237|NCT00632229|616662316|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
170631238|NCT00577889|616662318|FG000|Overall Study|Withdrawal by Subject|1|||
170631239|NCT00577889|616662319|FG001|Overall Study|Withdrawal by Subject|0|||
170631240|NCT00577889|616662320|FG002|Overall Study|Withdrawal by Subject|0|||
170631241|NCT01716234|616662321|FG000|Overall Study|Protocol Violation|0|||
170631242|NCT01716234|616662322|FG001|Overall Study|Protocol Violation|0|||
170631243|NCT01716234|616662323|FG002|Overall Study|Protocol Violation|0|||
170631244|NCT01716234|616662324|FG003|Overall Study|Protocol Violation|1|||
170631245|NCT01716234|616662325|FG004|Overall Study|Protocol Violation|1|||
170631246|NCT01716234|616662326|FG005|Overall Study|Protocol Violation|1|||
170631247|NCT01716234|616662327|FG006|Overall Study|Protocol Violation|0|||
170631248|NCT01716234|616662321|FG000|Overall Study|Lack of Efficacy|0|||
170631249|NCT01716234|616662322|FG001|Overall Study|Lack of Efficacy|0|||
170631250|NCT01716234|616662323|FG002|Overall Study|Lack of Efficacy|0|||
170631251|NCT01716234|616662324|FG003|Overall Study|Lack of Efficacy|1|||
170631252|NCT01716234|616662325|FG004|Overall Study|Lack of Efficacy|0|||
170631253|NCT01716234|616662326|FG005|Overall Study|Lack of Efficacy|0|||
170631254|NCT01716234|616662327|FG006|Overall Study|Lack of Efficacy|0|||
170631255|NCT01716234|616662321|FG000|Overall Study|Did not meet protocol eligibility|0|||
170631256|NCT01716234|616662322|FG001|Overall Study|Did not meet protocol eligibility|0|||
170631257|NCT01716234|616662323|FG002|Overall Study|Did not meet protocol eligibility|1|||
170631258|NCT01716234|616662324|FG003|Overall Study|Did not meet protocol eligibility|0|||
170631259|NCT01716234|616662325|FG004|Overall Study|Did not meet protocol eligibility|0|||
170631260|NCT01716234|616662326|FG005|Overall Study|Did not meet protocol eligibility|4|||
170631261|NCT01716234|616662327|FG006|Overall Study|Did not meet protocol eligibility|0|||
170631262|NCT01716234|616662321|FG000|Overall Study|Adverse Event|7|||
170631263|NCT01716234|616662322|FG001|Overall Study|Adverse Event|10|||
170631264|NCT01716234|616662323|FG002|Overall Study|Adverse Event|2|||
170631265|NCT01716234|616662324|FG003|Overall Study|Adverse Event|8|||
170631266|NCT01716234|616662325|FG004|Overall Study|Adverse Event|3|||
170631267|NCT01716234|616662326|FG005|Overall Study|Adverse Event|6|||
170631268|NCT01716234|616662327|FG006|Overall Study|Adverse Event|0|||
170631269|NCT01716234|616662321|FG000|Overall Study|Withdrawal by Subject|3|||
170631270|NCT01716234|616662322|FG001|Overall Study|Withdrawal by Subject|0|||
170631271|NCT01716234|616662323|FG002|Overall Study|Withdrawal by Subject|2|||
170631272|NCT01716234|616662324|FG003|Overall Study|Withdrawal by Subject|2|||
170746859|NCT00147225|617077627|FG003|Overall Study|Withdrawal by Subject|0|||
170746860|NCT00147225|617077628|FG004|Overall Study|Withdrawal by Subject|0|||
170746861|NCT00147225|617077629|FG005|Overall Study|Withdrawal by Subject|1|||
170746862|NCT00147225|617077624|FG000|Overall Study|Adverse Event|0|||
170746863|NCT00147225|617077625|FG001|Overall Study|Adverse Event|0|||
170746864|NCT00147225|617077626|FG002|Overall Study|Adverse Event|1|||
170746865|NCT00147225|617077627|FG003|Overall Study|Adverse Event|1|||
170746866|NCT00147225|617077628|FG004|Overall Study|Adverse Event|0|||
170746867|NCT00147225|617077629|FG005|Overall Study|Adverse Event|0|||
170746868|NCT00147225|617077624|FG000|Overall Study|Screen Failure|0|||
170631273|NCT01716234|616662325|FG004|Overall Study|Withdrawal by Subject|1|||
170631274|NCT01716234|616662326|FG005|Overall Study|Withdrawal by Subject|3|||
170631275|NCT01716234|616662327|FG006|Overall Study|Withdrawal by Subject|0|||
170631276|NCT03313037|616662328|FG000|Overall Study|Protocol Violation|4|||
170631277|NCT03313037|616662329|FG001|Overall Study|Protocol Violation|1|||
170631278|NCT03313037|616662328|FG000|Overall Study|Other|1|||
170631279|NCT03313037|616662329|FG001|Overall Study|Other|1|||
170631280|NCT03313037|616662328|FG000|Overall Study|Withdrawal by Subject|4|||
170631281|NCT03313037|616662329|FG001|Overall Study|Withdrawal by Subject|3|||
170631282|NCT03313037|616662328|FG000|Overall Study|No longer meets eligibility criteria|1|||
170631283|NCT03313037|616662329|FG001|Overall Study|No longer meets eligibility criteria|7|||
170631284|NCT03313037|616662328|FG000|Overall Study|Lost to Follow-up|9|||
170631285|NCT03313037|616662329|FG001|Overall Study|Lost to Follow-up|8|||
170631286|NCT03313037|616662328|FG000|Overall Study|Randomized but not treated|1|||
170631287|NCT03313037|616662329|FG001|Overall Study|Randomized but not treated|0|||
170631288|NCT01535040|616662330|FG000|Overall Study|Physician Decision|0|||
170631289|NCT01535040|616662331|FG001|Overall Study|Physician Decision|1|||
170631290|NCT01535040|616662330|FG000|Overall Study|Withdrawal by Subject|13|||
170631291|NCT01535040|616662331|FG001|Overall Study|Withdrawal by Subject|10|||
170631292|NCT01535040|616662330|FG000|Overall Study|Never Started|9|||
170631293|NCT01535040|616662331|FG001|Overall Study|Never Started|4|||
170631294|NCT01535040|616662330|FG000|Overall Study|Toxicity|7|||
170631295|NCT01535040|616662331|FG001|Overall Study|Toxicity|5|||
170631296|NCT01535040|616662330|FG000|Overall Study|Multiple Reasons|1|||
170631297|NCT01535040|616662331|FG001|Overall Study|Multiple Reasons|1|||
170631298|NCT03043794|616662336|FG000|Overall Study|Lost to Follow-up|1|||
170631299|NCT01987453|616664385|FG000|Overall Study|Death|0|||
170631300|NCT01987453|616664386|FG001|Overall Study|Death|0|||
170631301|NCT01987453|616664387|FG002|Overall Study|Death|1|||
170631302|NCT01987453|616664385|FG000|Overall Study|Lack of Efficacy|1|||
170631303|NCT01987453|616664386|FG001|Overall Study|Lack of Efficacy|12|||
170631304|NCT01987453|616664387|FG002|Overall Study|Lack of Efficacy|0|||
170631305|NCT01590888|616664388|FG000|Overall Study|Adverse Event|3|||
170631306|NCT01590888|616664389|FG001|Overall Study|Adverse Event|0|||
170631307|NCT01590888|616664390|FG002|Overall Study|Adverse Event|1|||
170631308|NCT01590888|616664388|FG000|Overall Study|Lost to Follow-up|1|||
170631309|NCT01590888|616664389|FG001|Overall Study|Lost to Follow-up|0|||
170631310|NCT01590888|616664390|FG002|Overall Study|Lost to Follow-up|0|||
170631311|NCT01646125|616664392|FG000|Overall Study|Untreated|2|||
170631312|NCT01646125|616664393|FG001|Overall Study|Untreated|5|||
170631313|NCT01646125|616664392|FG000|Overall Study|Adverse Event|2|||
170631314|NCT01646125|616664393|FG001|Overall Study|Adverse Event|1|||
170631315|NCT01646125|616664392|FG000|Overall Study|Death|1|||
170631316|NCT01646125|616664393|FG001|Overall Study|Death|1|||
170631317|NCT01646125|616664392|FG000|Overall Study|Physician Decision|1|||
170631318|NCT01646125|616664393|FG001|Overall Study|Physician Decision|3|||
170631319|NCT01646125|616664392|FG000|Overall Study|Progressive disease|22|||
170631320|NCT01646125|616664393|FG001|Overall Study|Progressive disease|16|||
170631321|NCT01646125|616664392|FG000|Overall Study|Study terminated by sponsor|2|||
170631322|NCT01646125|616664393|FG001|Overall Study|Study terminated by sponsor|1|||
170631323|NCT01646125|616664392|FG000|Overall Study|Subject/Guardian decision|1|||
170631324|NCT01646125|616664393|FG001|Overall Study|Subject/Guardian decision|1|||
170631325|NCT02105662|616664394|FG000|Overall Study|Lost to Follow-up|5|||
170631326|NCT02105662|616664394|FG000|Overall Study|Withdrawal by Subject|1|||
170631327|NCT00775190|616664402|FG000|Overall Study|Lost to Follow-up|2|||
170631328|NCT00775190|616664403|FG001|Overall Study|Lost to Follow-up|3|||
170631329|NCT00775190|616664402|FG000|Overall Study|Withdrawal by Subject|1|||
170631330|NCT00775190|616664403|FG001|Overall Study|Withdrawal by Subject|2|||
170631331|NCT00775190|616664402|FG000|Overall Study|Protocol Violation|1|||
170631332|NCT00775190|616664403|FG001|Overall Study|Protocol Violation|0|||
170631333|NCT01071798|616664405|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
170631334|NCT01071798|616664405|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
170631335|NCT01071798|616664405|FG000|Participants Who Received One Cycle|Patient requirement|20|||
170631336|NCT01071798|616664405|FG000|Participants Who Received One Cycle|Death|5|||
170631337|NCT01071798|616664405|FG000|Participants Who Received One Cycle|Change of therapy|6|||
170631338|NCT01071798|616664405|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
170631339|NCT01071798|616664405|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
170631340|NCT01071798|616664405|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
170631341|NCT01071798|616664405|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
170631342|NCT01071798|616664405|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
170631343|NCT01417377|616664409|FG000|Overall Study|Lost to Follow-up|12|||
170631344|NCT01417377|616664409|FG000|Overall Study|Enrolled, but not treated|1|||
170631345|NCT02113982|616664410|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
170631346|NCT02113982|616664411|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
170631347|NCT02113982|616664412|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
170631348|NCT02113982|616664413|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
170631349|NCT02113982|616664414|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
170631350|NCT02113982|616664415|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
170631351|NCT02113982|616664416|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
170631352|NCT02113982|616664417|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
170631353|NCT02113982|616664418|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
170631354|NCT02113982|616664419|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
170631355|NCT02113982|616664420|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
170631356|NCT02113982|616664421|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
170631357|NCT02113982|616664422|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
170631358|NCT02113982|616664423|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
170631359|NCT02113982|616664410|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
170631360|NCT02113982|616664411|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
170631361|NCT02113982|616664412|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
170631362|NCT02113982|616664413|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
170631363|NCT02113982|616664414|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
170631364|NCT02113982|616664415|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
170631365|NCT02113982|616664416|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
170631366|NCT02113982|616664417|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
170631367|NCT02113982|616664418|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
170631368|NCT02113982|616664419|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
170631369|NCT02113982|616664420|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
170631370|NCT02113982|616664421|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
170631371|NCT02113982|616664422|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
170631372|NCT02113982|616664423|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
170631373|NCT02113982|616664410|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631374|NCT02113982|616664411|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631375|NCT02113982|616664412|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631376|NCT02113982|616664413|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631377|NCT02113982|616664414|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631378|NCT02113982|616664415|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631379|NCT02113982|616664416|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
170631380|NCT02113982|616664417|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631381|NCT02113982|616664418|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631382|NCT02113982|616664419|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631383|NCT02113982|616664420|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631384|NCT02113982|616664421|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631385|NCT02113982|616664422|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631386|NCT02113982|616664423|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
170631387|NCT02113982|616664410|FG000|Stage 1: Dose Escalation|Transplant|0|||
170631388|NCT02113982|616664411|FG001|Stage 1: Dose Escalation|Transplant|1|||
170631389|NCT02113982|616664412|FG002|Stage 1: Dose Escalation|Transplant|0|||
170631390|NCT02113982|616664413|FG003|Stage 1: Dose Escalation|Transplant|0|||
170631391|NCT02113982|616664414|FG004|Stage 1: Dose Escalation|Transplant|0|||
170631392|NCT02113982|616664415|FG005|Stage 1: Dose Escalation|Transplant|1|||
170631393|NCT02113982|616664416|FG006|Stage 1: Dose Escalation|Transplant|0|||
170631394|NCT02113982|616664417|FG007|Stage 1: Dose Escalation|Transplant|0|||
170631395|NCT02113982|616664418|FG008|Stage 1: Dose Escalation|Transplant|0|||
170631396|NCT02113982|616664419|FG009|Stage 1: Dose Escalation|Transplant|0|||
170631397|NCT02113982|616664420|FG010|Stage 1: Dose Escalation|Transplant|0|||
170631398|NCT02113982|616664421|FG011|Stage 1: Dose Escalation|Transplant|0|||
170631399|NCT02113982|616664422|FG012|Stage 1: Dose Escalation|Transplant|0|||
170631400|NCT02113982|616664423|FG013|Stage 1: Dose Escalation|Transplant|0|||
170631401|NCT02113982|616664410|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
170631402|NCT02113982|616664411|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
170631403|NCT02113982|616664412|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
170631404|NCT02113982|616664413|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
170631405|NCT02113982|616664414|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
170631406|NCT02113982|616664415|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
170631407|NCT02113982|616664416|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
170631408|NCT02113982|616664417|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
170631409|NCT02113982|616664418|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
170631410|NCT02113982|616664419|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
170631411|NCT02113982|616664420|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
170631412|NCT02113982|616664421|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
170631413|NCT02113982|616664422|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
170631414|NCT02113982|616664423|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
170631415|NCT02113982|616664410|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
170631416|NCT02113982|616664411|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
170631417|NCT02113982|616664412|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
170631418|NCT02113982|616664413|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
170631419|NCT02113982|616664414|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
170631420|NCT02113982|616664415|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
170631421|NCT02113982|616664416|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
170631422|NCT02113982|616664417|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
170631423|NCT02113982|616664418|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
170631424|NCT02113982|616664419|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
170631425|NCT02113982|616664420|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
170631426|NCT02113982|616664421|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
170631427|NCT02113982|616664422|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
170631428|NCT02113982|616664423|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
170631429|NCT02113982|616664410|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
170746869|NCT00147225|617077625|FG001|Overall Study|Screen Failure|0|||
170746870|NCT00147225|617077626|FG002|Overall Study|Screen Failure|0|||
170746871|NCT00147225|617077627|FG003|Overall Study|Screen Failure|0|||
170746872|NCT00147225|617077628|FG004|Overall Study|Screen Failure|1|||
170746873|NCT00147225|617077629|FG005|Overall Study|Screen Failure|0|||
170746874|NCT00147225|617077624|FG000|Overall Study|Chemotherapy Changed|0|||
170746875|NCT00147225|617077625|FG001|Overall Study|Chemotherapy Changed|0|||
170746876|NCT00147225|617077626|FG002|Overall Study|Chemotherapy Changed|0|||
170746877|NCT00147225|617077627|FG003|Overall Study|Chemotherapy Changed|0|||
170746878|NCT00147225|617077628|FG004|Overall Study|Chemotherapy Changed|0|||
170746879|NCT00147225|617077629|FG005|Overall Study|Chemotherapy Changed|1|||
170746880|NCT01567865|617077634|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
170746881|NCT01567865|617077635|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
170746882|NCT01567865|617077636|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
170746883|NCT01567865|617077637|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
170746884|NCT01567865|617077634|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
170746885|NCT01567865|617077635|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
170746886|NCT01567865|617077636|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
170746887|NCT01567865|617077637|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
170746888|NCT00383240|617077646|FG000|Overall Study|Adverse Event|4|||
170746889|NCT00383240|617077647|FG001|Overall Study|Adverse Event|6|||
170746890|NCT00383240|617077648|FG002|Overall Study|Adverse Event|9|||
170746891|NCT00383240|617077649|FG003|Overall Study|Adverse Event|7|||
170746892|NCT00383240|617077646|FG000|Overall Study|Treatment Failure|8|||
170746893|NCT00383240|617077647|FG001|Overall Study|Treatment Failure|13|||
170746894|NCT00383240|617077648|FG002|Overall Study|Treatment Failure|47|||
170746895|NCT00383240|617077649|FG003|Overall Study|Treatment Failure|46|||
170746896|NCT00383240|617077646|FG000|Overall Study|Lost to Follow-up|3|||
170746897|NCT00383240|617077647|FG001|Overall Study|Lost to Follow-up|0|||
170746898|NCT00383240|617077648|FG002|Overall Study|Lost to Follow-up|0|||
170746899|NCT00383240|617077649|FG003|Overall Study|Lost to Follow-up|2|||
170746900|NCT00383240|617077646|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
170746901|NCT00383240|617077647|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
170746902|NCT00383240|617077648|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
170746903|NCT00383240|617077649|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
170746904|NCT00383240|617077646|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
170746905|NCT00383240|617077647|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
170746906|NCT00383240|617077648|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
170746907|NCT00383240|617077649|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
170746908|NCT00383240|617077646|FG000|Overall Study|Protocol Violation|4|||
170746909|NCT00383240|617077647|FG001|Overall Study|Protocol Violation|5|||
170746910|NCT00383240|617077648|FG002|Overall Study|Protocol Violation|9|||
170746911|NCT00383240|617077649|FG003|Overall Study|Protocol Violation|6|||
170746912|NCT00383240|617077646|FG000|Overall Study|Did not meet protocol eligibility|9|||
170746913|NCT00383240|617077647|FG001|Overall Study|Did not meet protocol eligibility|4|||
170746914|NCT00383240|617077648|FG002|Overall Study|Did not meet protocol eligibility|9|||
170746915|NCT00383240|617077649|FG003|Overall Study|Did not meet protocol eligibility|3|||
170746916|NCT00383240|617077646|FG000|Overall Study|Administrative|1|||
170746917|NCT00383240|617077647|FG001|Overall Study|Administrative|1|||
170746918|NCT00383240|617077648|FG002|Overall Study|Administrative|0|||
170746919|NCT00383240|617077649|FG003|Overall Study|Administrative|0|||
170746920|NCT01518946|617077661|FG000|Open-label Phase|Other|4|||
170746921|NCT01518946|617077662|FG001|Open-label Phase|Other|0|||
170746922|NCT01518946|617077663|FG002|Open-label Phase|Other|0|||
170746923|NCT01518946|617077661|FG000|Randomized Phase (First Intervention)|Other|0|||
170746924|NCT01518946|617077662|FG001|Randomized Phase (First Intervention)|Other|1|||
170746925|NCT01518946|617077663|FG002|Randomized Phase (First Intervention)|Other|0|||
170746926|NCT03391960|617077664|FG000|Overall Study|Protocol Violation|0|||
170746927|NCT03391960|617077665|FG001|Overall Study|Protocol Violation|0|||
170746928|NCT00581113|617079065|FG000|Overall Study|Withdrawal by Subject|0|||
170746929|NCT00581113|617079066|FG001|Overall Study|Withdrawal by Subject|1|||
170746930|NCT04834362|617079067|FG000|Overall Study|Death|1|||
170746931|NCT04834362|617079068|FG001|Overall Study|Death|2|||
170746932|NCT04781647|617079071|FG000|Overall Study|Study terminated by Sponsor|11|||
170746933|NCT04781647|617079072|FG001|Overall Study|Study terminated by Sponsor|9|||
170746934|NCT04781647|617079073|FG002|Overall Study|Study terminated by Sponsor|9|||
170746935|NCT04781647|617079071|FG000|Overall Study|Withdrawal by Subject|1|||
170746936|NCT04781647|617079072|FG001|Overall Study|Withdrawal by Subject|2|||
170746937|NCT04781647|617079073|FG002|Overall Study|Withdrawal by Subject|0|||
170746938|NCT04781647|617079071|FG000|Overall Study|Adverse Event|0|||
170746939|NCT04781647|617079072|FG001|Overall Study|Adverse Event|1|||
170746940|NCT04781647|617079073|FG002|Overall Study|Adverse Event|1|||
170746941|NCT04781647|617079071|FG000|Overall Study|Protocol Violation|1|||
170746942|NCT04781647|617079072|FG001|Overall Study|Protocol Violation|0|||
170746943|NCT04781647|617079073|FG002|Overall Study|Protocol Violation|0|||
170746944|NCT04781647|617079071|FG000|Overall Study|Pregnancy|0|||
170746945|NCT04781647|617079072|FG001|Overall Study|Pregnancy|0|||
170746946|NCT04781647|617079073|FG002|Overall Study|Pregnancy|1|||
170746947|NCT04781647|617079071|FG000|Overall Study|Virology rebounded|1|||
170746948|NCT04781647|617079072|FG001|Overall Study|Virology rebounded|0|||
170746949|NCT04781647|617079073|FG002|Overall Study|Virology rebounded|0|||
170746950|NCT04213989|617079074|FG000|Overall Study|Withdrawal by Subject|3|||
170746951|NCT04213989|617079075|FG001|Overall Study|Withdrawal by Subject|2|||
170746952|NCT04213989|617079074|FG000|Overall Study|Physician Decision|1|||
170746953|NCT04213989|617079075|FG001|Overall Study|Physician Decision|0|||
170746954|NCT04213989|617079074|FG000|Overall Study|Lost to Follow-up|0|||
170746955|NCT04213989|617079075|FG001|Overall Study|Lost to Follow-up|4|||
170746956|NCT00329719|617079076|FG000|Overall Study|Lost to Follow-up|0|||
170746957|NCT00329719|617079077|FG001|Overall Study|Lost to Follow-up|0|||
170746958|NCT00329719|617079078|FG002|Overall Study|Lost to Follow-up|0|||
170746959|NCT00329719|617079079|FG003|Overall Study|Lost to Follow-up|1|||
170746960|NCT03390036|617079082|FG000|Overall Study|Lost to Follow-up|1|||
170746961|NCT03390036|617079083|FG001|Overall Study|Lost to Follow-up|0|||
170746962|NCT03390036|617079084|FG002|Overall Study|Lost to Follow-up|0|||
170746963|NCT03390036|617079082|FG000|Overall Study|Lack of Efficacy|1|||
170746964|NCT03390036|617079083|FG001|Overall Study|Lack of Efficacy|0|||
170746965|NCT03390036|617079084|FG002|Overall Study|Lack of Efficacy|0|||
170746966|NCT06017999|617079085|FG000|Overall Study|Withdrawal by Subject|0|||
170746967|NCT06017999|617079086|FG001|Overall Study|Withdrawal by Subject|4|||
170746968|NCT06017999|617079087|FG002|Overall Study|Withdrawal by Subject|3|||
170746969|NCT06017999|617079085|FG000|Overall Study|Adverse Event|2|||
170746970|NCT06017999|617079086|FG001|Overall Study|Adverse Event|1|||
170746971|NCT06017999|617079087|FG002|Overall Study|Adverse Event|1|||
170746972|NCT06017999|617079085|FG000|Overall Study|Lost to Follow-up|0|||
170746973|NCT06017999|617079086|FG001|Overall Study|Lost to Follow-up|0|||
170746974|NCT06017999|617079087|FG002|Overall Study|Lost to Follow-up|1|||
170746975|NCT06017999|617079085|FG000|Overall Study|Physician Decision|1|||
170746976|NCT06017999|617079086|FG001|Overall Study|Physician Decision|1|||
170746977|NCT06017999|617079087|FG002|Overall Study|Physician Decision|0|||
170746978|NCT06017999|617079085|FG000|Overall Study|Non-Compliance|0|||
170746979|NCT06017999|617079086|FG001|Overall Study|Non-Compliance|0|||
170746980|NCT06017999|617079087|FG002|Overall Study|Non-Compliance|1|||
170746981|NCT06017999|617079085|FG000|Overall Study|Lack of Efficacy|1|||
170746982|NCT06017999|617079086|FG001|Overall Study|Lack of Efficacy|0|||
170746983|NCT06017999|617079087|FG002|Overall Study|Lack of Efficacy|7|||
170746984|NCT06017999|617079085|FG000|Overall Study|COVID Positive|0|||
170746985|NCT06017999|617079086|FG001|Overall Study|COVID Positive|1|||
170746986|NCT06017999|617079087|FG002|Overall Study|COVID Positive|0|||
170746987|NCT06017999|617079085|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
170746988|NCT06017999|617079086|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
170746989|NCT06017999|617079087|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
170518765|NCT00377637|616246004|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
170746990|NCT01155388|617079088|FG000|Overall Study|Adverse Event|1|||
170746991|NCT01155388|617079089|FG001|Overall Study|Adverse Event|0|||
170746992|NCT04747275|617079090|FG000|Overall Study|Study terminated|0|||
170746993|NCT04747275|617079091|FG001|Overall Study|Study terminated|1|||
170746994|NCT04397523|617079116|FG000|Overall Study|Lost to Follow-up|3|||
170746995|NCT04397523|617079116|FG000|Overall Study|Transfer from/to other hospital|8|||
170746996|NCT01744496|617079129|FG000|Titration Period|Adverse Event|2|||
170746997|NCT01744496|617079130|FG001|Titration Period|Adverse Event|1|||
170746998|NCT01744496|617079129|FG000|Titration Period|Personal reasons|0|||
170746999|NCT01744496|617079130|FG001|Titration Period|Personal reasons|1|||
170747000|NCT01744496|617079129|FG000|Maintenance Period|Adverse Event|1|||
170747001|NCT01744496|617079130|FG001|Maintenance Period|Adverse Event|3|||
170747002|NCT01744496|617079129|FG000|Maintenance Period|Protocol Violation|1|||
170747003|NCT01744496|617079130|FG001|Maintenance Period|Protocol Violation|0|||
170747004|NCT01744496|617079129|FG000|Maintenance Period|Withdrawal by Subject|1|||
170747005|NCT01744496|617079130|FG001|Maintenance Period|Withdrawal by Subject|1|||
170747006|NCT01744496|617079129|FG000|Maintenance Period|Subject left town|1|||
170747007|NCT01744496|617079130|FG001|Maintenance Period|Subject left town|0|||
170747008|NCT01729728|617079133|FG000|Overall Study|Adverse Event|0|||
170747009|NCT01729728|617079134|FG001|Overall Study|Adverse Event|6|||
170747010|NCT01729728|617079135|FG002|Overall Study|Adverse Event|0|||
170747011|NCT01729728|617079133|FG000|Overall Study|Protocol Violation|1|||
170747012|NCT01729728|617079134|FG001|Overall Study|Protocol Violation|0|||
170747013|NCT01729728|617079135|FG002|Overall Study|Protocol Violation|1|||
170747014|NCT04422639|617079136|FG000|Overall Study|Death|1|||
170747015|NCT04422639|617079137|FG001|Overall Study|Death|0|||
170747016|NCT04422639|617079136|FG000|Overall Study|study closed prior to completion of FU visits|0|||
170747017|NCT04422639|617079137|FG001|Overall Study|study closed prior to completion of FU visits|2|||
170747018|NCT04267614|617079138|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
170747019|NCT04267614|617079138|FG000|Overall Study|Lost to Follow-up|115|||
170747020|NCT04844918|617079142|FG000|Overall Study|Adverse Event|7|||
170747021|NCT04844918|617079143|FG001|Overall Study|Adverse Event|8|||
170747022|NCT04844918|617079144|FG002|Overall Study|Adverse Event|5|||
170747023|NCT04844918|617079142|FG000|Overall Study|Physician Decision|0|||
170747024|NCT04844918|617079143|FG001|Overall Study|Physician Decision|1|||
170747025|NCT04844918|617079144|FG002|Overall Study|Physician Decision|0|||
170747026|NCT04844918|617079142|FG000|Overall Study|Withdrawal by Subject|6|||
170747027|NCT04844918|617079143|FG001|Overall Study|Withdrawal by Subject|3|||
170747028|NCT04844918|617079144|FG002|Overall Study|Withdrawal by Subject|3|||
170747029|NCT04844918|617079142|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
170747030|NCT04844918|617079143|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
170747031|NCT04844918|617079144|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
170747032|NCT02141659|617079156|FG000|Overall Study|Major Protocol Deviation|0|||
170747033|NCT02141659|617079157|FG001|Overall Study|Major Protocol Deviation|1|||
170747034|NCT02141659|617079158|FG002|Overall Study|Major Protocol Deviation|0|||
170747035|NCT02141659|617079159|FG003|Overall Study|Major Protocol Deviation|0|||
170747036|NCT02141659|617079160|FG004|Overall Study|Major Protocol Deviation|0|||
170747037|NCT02141659|617079161|FG005|Overall Study|Major Protocol Deviation|0|||
170747038|NCT02141659|617079156|FG000|Overall Study|Lack of Efficacy|0|||
170747039|NCT02141659|617079157|FG001|Overall Study|Lack of Efficacy|0|||
170747040|NCT02141659|617079158|FG002|Overall Study|Lack of Efficacy|0|||
170747041|NCT02141659|617079159|FG003|Overall Study|Lack of Efficacy|0|||
170747042|NCT02141659|617079160|FG004|Overall Study|Lack of Efficacy|0|||
170747043|NCT02141659|617079161|FG005|Overall Study|Lack of Efficacy|1|||
170747044|NCT02141659|617079156|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
170747045|NCT02141659|617079157|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
170747046|NCT02141659|617079158|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
170747047|NCT02141659|617079159|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
170747048|NCT02141659|617079160|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
170747049|NCT02141659|617079161|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
170747050|NCT01927731|617079162|FG000|Overall Study|Graft Failure|1|||
170747051|NCT01927731|617079163|FG001|Overall Study|Graft Failure|2|||
170747052|NCT01927731|617079162|FG000|Overall Study|Physician Decision|2|||
170747053|NCT01927731|617079163|FG001|Overall Study|Physician Decision|3|||
170747054|NCT01927731|617079162|FG000|Overall Study|Withdrawal by Subject|0|||
170747055|NCT01927731|617079163|FG001|Overall Study|Withdrawal by Subject|2|||
170747056|NCT01927731|617079162|FG000|Overall Study|Death|0|||
170747057|NCT01927731|617079163|FG001|Overall Study|Death|3|||
170747058|NCT02065570|617079166|FG000|Induction Study|Adverse Event|5|||
170747059|NCT02065570|617079167|FG001|Induction Study|Adverse Event|12|||
170747060|NCT02065570|617079168|FG002|Induction Study|Adverse Event|0|||
170747061|NCT02065570|617079169|FG003|Induction Study|Adverse Event|0|||
170747062|NCT02065570|617079166|FG000|Induction Study|Withdrawal by Subject|2|||
170747063|NCT02065570|617079167|FG001|Induction Study|Withdrawal by Subject|3|||
170747064|NCT02065570|617079168|FG002|Induction Study|Withdrawal by Subject|0|||
170747065|NCT02065570|617079169|FG003|Induction Study|Withdrawal by Subject|0|||
170747066|NCT02065570|617079166|FG000|Induction Study|Lost to Follow-up|1|||
170747067|NCT02065570|617079167|FG001|Induction Study|Lost to Follow-up|1|||
170747068|NCT02065570|617079168|FG002|Induction Study|Lost to Follow-up|0|||
170747069|NCT02065570|617079169|FG003|Induction Study|Lost to Follow-up|0|||
170747070|NCT02065570|617079166|FG000|Induction Study|Other, Not Specified|6|||
170747071|NCT02065570|617079167|FG001|Induction Study|Other, Not Specified|5|||
170747072|NCT02065570|617079168|FG002|Induction Study|Other, Not Specified|0|||
170747073|NCT02065570|617079169|FG003|Induction Study|Other, Not Specified|0|||
170747074|NCT02065570|617079166|FG000|Maintenance Study|Adverse Event|0|||
170747075|NCT02065570|617079167|FG001|Maintenance Study|Adverse Event|0|||
170747076|NCT02065570|617079168|FG002|Maintenance Study|Adverse Event|8|||
170747077|NCT02065570|617079169|FG003|Maintenance Study|Adverse Event|8|||
170747078|NCT02065570|617079166|FG000|Maintenance Study|Withdrawal by Subject|0|||
170747079|NCT02065570|617079167|FG001|Maintenance Study|Withdrawal by Subject|0|||
170747080|NCT02065570|617079168|FG002|Maintenance Study|Withdrawal by Subject|1|||
170747081|NCT02065570|617079169|FG003|Maintenance Study|Withdrawal by Subject|4|||
170747082|NCT02065570|617079166|FG000|Maintenance Study|Lost to Follow-up|0|||
170747083|NCT02065570|617079167|FG001|Maintenance Study|Lost to Follow-up|0|||
170747084|NCT02065570|617079168|FG002|Maintenance Study|Lost to Follow-up|2|||
170747085|NCT02065570|617079169|FG003|Maintenance Study|Lost to Follow-up|2|||
170747086|NCT02065570|617079166|FG000|Maintenance Study|Other, Not Specified|0|||
170747087|NCT02065570|617079167|FG001|Maintenance Study|Other, Not Specified|0|||
170747088|NCT02065570|617079168|FG002|Maintenance Study|Other, Not Specified|11|||
170747089|NCT02065570|617079169|FG003|Maintenance Study|Other, Not Specified|5|||
170747090|NCT03382600|617079170|FG000|Overall Study|Adverse Event|3|||
170747091|NCT03382600|617079171|FG001|Overall Study|Adverse Event|3|||
170747092|NCT03382600|617079170|FG000|Overall Study|Clinical Disease Progression|2|||
170747093|NCT03382600|617079171|FG001|Overall Study|Clinical Disease Progression|4|||
170747094|NCT03382600|617079170|FG000|Overall Study|Radiological Progression|40|||
170747095|NCT03382600|617079171|FG001|Overall Study|Radiological Progression|31|||
170747096|NCT03382600|617079170|FG000|Overall Study|Withdrawal by Subject|0|||
170747097|NCT03382600|617079171|FG001|Overall Study|Withdrawal by Subject|1|||
170747098|NCT03382600|617079170|FG000|Overall Study|Other|9|||
170747099|NCT03382600|617079171|FG001|Overall Study|Other|7|||
170747100|NCT04642469|617079172|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
170747101|NCT04642469|617079173|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
170747102|NCT04642469|617079172|FG000|Overall Study|Death|1|||
170747103|NCT04642469|617079173|FG001|Overall Study|Death|2|||
170747104|NCT04642469|617079172|FG000|Overall Study|Study/site closed following amendment 1|11|||
170747105|NCT04642469|617079173|FG001|Overall Study|Study/site closed following amendment 1|11|||
170747106|NCT04642469|617079172|FG000|Overall Study|Other|1|||
170747107|NCT04642469|617079173|FG001|Overall Study|Other|1|||
170747108|NCT04642469|617079172|FG000|Overall Study|Withdrawal by Subject|1|||
170747109|NCT04642469|617079173|FG001|Overall Study|Withdrawal by Subject|0|||
170747110|NCT02733042|617079174|FG000|Overall Study|Adverse Event|1|||
170747111|NCT02733042|617079175|FG001|Overall Study|Adverse Event|0|||
170747112|NCT02733042|617079176|FG002|Overall Study|Adverse Event|1|||
170747113|NCT02733042|617079177|FG003|Overall Study|Adverse Event|1|||
170747114|NCT02733042|617079178|FG004|Overall Study|Adverse Event|0|||
170747115|NCT02733042|617079179|FG005|Overall Study|Adverse Event|0|||
170747116|NCT02733042|617079180|FG006|Overall Study|Adverse Event|0|||
170747117|NCT02733042|617079181|FG007|Overall Study|Adverse Event|0|||
170747118|NCT02733042|617079182|FG008|Overall Study|Adverse Event|0|||
170747119|NCT02733042|617079183|FG009|Overall Study|Adverse Event|0|||
170747120|NCT02733042|617079184|FG010|Overall Study|Adverse Event|2|||
170747121|NCT02733042|617079185|FG011|Overall Study|Adverse Event|2|||
170747122|NCT02733042|617079186|FG012|Overall Study|Adverse Event|0|||
170747123|NCT02733042|617079187|FG013|Overall Study|Adverse Event|2|||
170747124|NCT02733042|617079188|FG014|Overall Study|Adverse Event|0|||
170747125|NCT02733042|617079189|FG015|Overall Study|Adverse Event|0|||
170747126|NCT02733042|617079190|FG016|Overall Study|Adverse Event|0|||
170747127|NCT02733042|617079191|FG017|Overall Study|Adverse Event|1|||
170747128|NCT02733042|617079192|FG018|Overall Study|Adverse Event|0|||
170747129|NCT02733042|617079174|FG000|Overall Study|Progressive Disease|2|||
170747130|NCT02733042|617079175|FG001|Overall Study|Progressive Disease|1|||
170747131|NCT02733042|617079176|FG002|Overall Study|Progressive Disease|3|||
170747132|NCT02733042|617079177|FG003|Overall Study|Progressive Disease|1|||
170747133|NCT02733042|617079178|FG004|Overall Study|Progressive Disease|2|||
170747134|NCT02733042|617079179|FG005|Overall Study|Progressive Disease|3|||
170747135|NCT02733042|617079180|FG006|Overall Study|Progressive Disease|0|||
170747136|NCT02733042|617079181|FG007|Overall Study|Progressive Disease|3|||
170747137|NCT02733042|617079182|FG008|Overall Study|Progressive Disease|3|||
170747138|NCT02733042|617079183|FG009|Overall Study|Progressive Disease|2|||
170747139|NCT02733042|617079184|FG010|Overall Study|Progressive Disease|2|||
170747140|NCT02733042|617079185|FG011|Overall Study|Progressive Disease|2|||
170747141|NCT02733042|617079186|FG012|Overall Study|Progressive Disease|8|||
170747142|NCT02733042|617079187|FG013|Overall Study|Progressive Disease|1|||
170747143|NCT02733042|617079188|FG014|Overall Study|Progressive Disease|4|||
170747144|NCT02733042|617079189|FG015|Overall Study|Progressive Disease|7|||
170747145|NCT02733042|617079190|FG016|Overall Study|Progressive Disease|2|||
170747146|NCT02733042|617079191|FG017|Overall Study|Progressive Disease|3|||
170747147|NCT02733042|617079192|FG018|Overall Study|Progressive Disease|4|||
170747148|NCT02733042|617079174|FG000|Overall Study|Withdrawal by Subject|0|||
170747149|NCT02733042|617079175|FG001|Overall Study|Withdrawal by Subject|1|||
170747150|NCT02733042|617079176|FG002|Overall Study|Withdrawal by Subject|2|||
170747151|NCT02733042|617079177|FG003|Overall Study|Withdrawal by Subject|1|||
170747152|NCT02733042|617079178|FG004|Overall Study|Withdrawal by Subject|1|||
170747153|NCT02733042|617079179|FG005|Overall Study|Withdrawal by Subject|0|||
170747154|NCT02733042|617079180|FG006|Overall Study|Withdrawal by Subject|0|||
170747155|NCT02733042|617079181|FG007|Overall Study|Withdrawal by Subject|0|||
170747156|NCT02733042|617079182|FG008|Overall Study|Withdrawal by Subject|1|||
170747157|NCT02733042|617079183|FG009|Overall Study|Withdrawal by Subject|1|||
170747158|NCT02733042|617079184|FG010|Overall Study|Withdrawal by Subject|0|||
170747159|NCT02733042|617079185|FG011|Overall Study|Withdrawal by Subject|2|||
170747160|NCT02733042|617079186|FG012|Overall Study|Withdrawal by Subject|1|||
170747161|NCT02733042|617079187|FG013|Overall Study|Withdrawal by Subject|1|||
170747162|NCT02733042|617079188|FG014|Overall Study|Withdrawal by Subject|0|||
170518766|NCT00377637|616246005|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
170518767|NCT00377637|616246002|FG000|Maintenance Phase|Adverse Event|0|||
170747163|NCT02733042|617079189|FG015|Overall Study|Withdrawal by Subject|0|||
170747164|NCT02733042|617079190|FG016|Overall Study|Withdrawal by Subject|0|||
170747165|NCT02733042|617079191|FG017|Overall Study|Withdrawal by Subject|0|||
170747166|NCT02733042|617079192|FG018|Overall Study|Withdrawal by Subject|0|||
170747167|NCT02733042|617079174|FG000|Overall Study|Other Reasons|0|||
170747168|NCT02733042|617079175|FG001|Overall Study|Other Reasons|0|||
170747169|NCT02733042|617079176|FG002|Overall Study|Other Reasons|1|||
170747170|NCT02733042|617079177|FG003|Overall Study|Other Reasons|0|||
170747171|NCT02733042|617079178|FG004|Overall Study|Other Reasons|0|||
170747172|NCT02733042|617079179|FG005|Overall Study|Other Reasons|0|||
170747173|NCT02733042|617079180|FG006|Overall Study|Other Reasons|0|||
170747174|NCT02733042|617079181|FG007|Overall Study|Other Reasons|0|||
170747175|NCT02733042|617079182|FG008|Overall Study|Other Reasons|0|||
170747176|NCT02733042|617079183|FG009|Overall Study|Other Reasons|1|||
170747177|NCT02733042|617079184|FG010|Overall Study|Other Reasons|1|||
170747178|NCT02733042|617079185|FG011|Overall Study|Other Reasons|0|||
170747179|NCT02733042|617079186|FG012|Overall Study|Other Reasons|0|||
170747180|NCT02733042|617079187|FG013|Overall Study|Other Reasons|0|||
170747181|NCT02733042|617079188|FG014|Overall Study|Other Reasons|0|||
170747182|NCT02733042|617079189|FG015|Overall Study|Other Reasons|1|||
170747183|NCT02733042|617079190|FG016|Overall Study|Other Reasons|0|||
170747184|NCT02733042|617079191|FG017|Overall Study|Other Reasons|1|||
170747185|NCT02733042|617079192|FG018|Overall Study|Other Reasons|0|||
170747186|NCT02733042|617079174|FG000|Overall Study|Death|0|||
170747187|NCT02733042|617079175|FG001|Overall Study|Death|0|||
170747188|NCT02733042|617079176|FG002|Overall Study|Death|0|||
170747189|NCT02733042|617079177|FG003|Overall Study|Death|0|||
170747190|NCT02733042|617079178|FG004|Overall Study|Death|0|||
170747191|NCT02733042|617079179|FG005|Overall Study|Death|0|||
170747192|NCT02733042|617079180|FG006|Overall Study|Death|1|||
170747193|NCT02733042|617079181|FG007|Overall Study|Death|0|||
170747194|NCT02733042|617079182|FG008|Overall Study|Death|1|||
170747195|NCT02733042|617079183|FG009|Overall Study|Death|0|||
170747196|NCT02733042|617079184|FG010|Overall Study|Death|1|||
170747197|NCT02733042|617079185|FG011|Overall Study|Death|0|||
170747198|NCT02733042|617079186|FG012|Overall Study|Death|0|||
170747199|NCT02733042|617079187|FG013|Overall Study|Death|0|||
170747200|NCT02733042|617079188|FG014|Overall Study|Death|1|||
170747201|NCT02733042|617079189|FG015|Overall Study|Death|2|||
170747202|NCT02733042|617079190|FG016|Overall Study|Death|0|||
170747203|NCT02733042|617079191|FG017|Overall Study|Death|0|||
170747204|NCT02733042|617079192|FG018|Overall Study|Death|0|||
170747205|NCT02066532|617079193|FG000|Phase II|Withdrawal by Subject|1|||
170747206|NCT02066532|617079194|FG001|Phase II|Withdrawal by Subject|0|||
170747207|NCT02066532|617079195|FG002|Phase II|Withdrawal by Subject|0|||
170747208|NCT02066532|617079196|FG003|Phase II|Withdrawal by Subject|0|||
170747209|NCT05033080|617079197|FG000|Overall Study|Adverse Event|4|||
170747210|NCT05033080|617079198|FG001|Overall Study|Adverse Event|4|||
170747211|NCT05033080|617079197|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
170747212|NCT05033080|617079198|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
170747213|NCT05033080|617079197|FG000|Overall Study|Lost to Follow-up|1|||
170747214|NCT05033080|617079198|FG001|Overall Study|Lost to Follow-up|0|||
170747215|NCT05033080|617079197|FG000|Overall Study|Other non-compliance|0|||
170747216|NCT05033080|617079198|FG001|Overall Study|Other non-compliance|1|||
170747217|NCT05033080|617079197|FG000|Overall Study|Physician Decision|0|||
170747218|NCT05033080|617079198|FG001|Overall Study|Physician Decision|1|||
170747219|NCT05033080|617079197|FG000|Overall Study|Other|1|||
170747220|NCT05033080|617079198|FG001|Overall Study|Other|1|||
170747221|NCT02303626|617079199|FG000|Overall Study|Lack of Efficacy|1|||
170747222|NCT02303626|617079200|FG001|Overall Study|Lack of Efficacy|0|||
170747223|NCT02303626|617079201|FG002|Overall Study|Lack of Efficacy|1|||
170747224|NCT02303626|617079199|FG000|Overall Study|Adverse Event|0|||
170747225|NCT02303626|617079200|FG001|Overall Study|Adverse Event|2|||
170747226|NCT02303626|617079201|FG002|Overall Study|Adverse Event|0|||
170747227|NCT02303626|617079199|FG000|Overall Study|Protocol Violation|0|||
170747228|NCT02303626|617079200|FG001|Overall Study|Protocol Violation|1|||
170747229|NCT02303626|617079201|FG002|Overall Study|Protocol Violation|0|||
170747230|NCT02303626|617079199|FG000|Overall Study|Pregnancy|0|||
170747231|NCT02303626|617079200|FG001|Overall Study|Pregnancy|0|||
170747232|NCT02303626|617079201|FG002|Overall Study|Pregnancy|1|||
170747233|NCT02303626|617079199|FG000|Overall Study|Subject Non-Compliance|0|||
170747234|NCT02303626|617079200|FG001|Overall Study|Subject Non-Compliance|0|||
170747235|NCT02303626|617079201|FG002|Overall Study|Subject Non-Compliance|1|||
170747236|NCT04159415|617079202|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
170747237|NCT04159415|617079203|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
170747238|NCT04159415|617079204|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
170747239|NCT04159415|617079205|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
170747240|NCT04159415|617079206|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
170518768|NCT00377637|616246003|FG001|Maintenance Phase|Adverse Event|0|||
170747241|NCT04159415|617079207|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
170747242|NCT04159415|617079208|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
170747243|NCT04159415|617079209|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
170747244|NCT04159415|617079210|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
170747245|NCT04159415|617079211|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
170747246|NCT04159415|617079202|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747247|NCT04159415|617079203|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747248|NCT04159415|617079204|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747249|NCT04159415|617079205|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747250|NCT04159415|617079206|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747251|NCT04159415|617079207|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747252|NCT04159415|617079208|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747253|NCT04159415|617079209|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
170747254|NCT04159415|617079210|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747255|NCT04159415|617079211|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
170747256|NCT04159415|617079202|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747257|NCT04159415|617079203|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747258|NCT04159415|617079204|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747259|NCT04159415|617079205|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747260|NCT04159415|617079206|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747261|NCT04159415|617079207|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747262|NCT04159415|617079208|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747263|NCT04159415|617079209|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
170747264|NCT04159415|617079210|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747265|NCT04159415|617079211|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
170747266|NCT04159415|617079202|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747267|NCT04159415|617079203|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747268|NCT04159415|617079204|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747269|NCT04159415|617079205|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747270|NCT04159415|617079206|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747271|NCT04159415|617079207|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747272|NCT04159415|617079208|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747273|NCT04159415|617079209|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747274|NCT04159415|617079210|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
170747275|NCT04159415|617079211|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
170747276|NCT00337662|617079212|FG000|Study Period II|Lost to Follow-up|0|||
170747277|NCT00337662|617079213|FG001|Study Period II|Lost to Follow-up|0|||
170747278|NCT00337662|617079214|FG002|Study Period II|Lost to Follow-up|0|||
170747279|NCT00337662|617079215|FG003|Study Period II|Lost to Follow-up|35|||
170747280|NCT00337662|617079212|FG000|Study Period II|Withdrawal by Subject|0|||
170747281|NCT00337662|617079213|FG001|Study Period II|Withdrawal by Subject|0|||
170747282|NCT00337662|617079214|FG002|Study Period II|Withdrawal by Subject|0|||
170747283|NCT00337662|617079215|FG003|Study Period II|Withdrawal by Subject|20|||
170747284|NCT00337662|617079212|FG000|Study Period II|Adverse Event|0|||
170747285|NCT00337662|617079213|FG001|Study Period II|Adverse Event|0|||
170747286|NCT00337662|617079214|FG002|Study Period II|Adverse Event|0|||
170747287|NCT00337662|617079215|FG003|Study Period II|Adverse Event|16|||
170747288|NCT00337662|617079212|FG000|Study Period II|Physician Decision|0|||
170747289|NCT00337662|617079213|FG001|Study Period II|Physician Decision|0|||
170747290|NCT00337662|617079214|FG002|Study Period II|Physician Decision|0|||
170747291|NCT00337662|617079215|FG003|Study Period II|Physician Decision|13|||
170747292|NCT00337662|617079212|FG000|Study Period II|Entry Criteria Not Met|0|||
170747293|NCT00337662|617079213|FG001|Study Period II|Entry Criteria Not Met|0|||
170747294|NCT00337662|617079214|FG002|Study Period II|Entry Criteria Not Met|0|||
170747295|NCT00337662|617079215|FG003|Study Period II|Entry Criteria Not Met|6|||
170747296|NCT00337662|617079212|FG000|Study Period II|Protocol Violation|0|||
170747297|NCT00337662|617079213|FG001|Study Period II|Protocol Violation|0|||
170747298|NCT00337662|617079214|FG002|Study Period II|Protocol Violation|0|||
170747299|NCT00337662|617079215|FG003|Study Period II|Protocol Violation|6|||
170747300|NCT00337662|617079212|FG000|Study Period II|Lack of Efficacy|0|||
170747301|NCT00337662|617079213|FG001|Study Period II|Lack of Efficacy|0|||
170747302|NCT00337662|617079214|FG002|Study Period II|Lack of Efficacy|0|||
170747303|NCT00337662|617079215|FG003|Study Period II|Lack of Efficacy|7|||
170747304|NCT00337662|617079212|FG000|Study Period II|Sponsor Decision|0|||
170747305|NCT00337662|617079213|FG001|Study Period II|Sponsor Decision|0|||
170747306|NCT00337662|617079214|FG002|Study Period II|Sponsor Decision|0|||
170747307|NCT00337662|617079215|FG003|Study Period II|Sponsor Decision|2|||
170747308|NCT00337662|617079212|FG000|Study Period II|Parent/Caregiver Decision|0|||
170747309|NCT00337662|617079213|FG001|Study Period II|Parent/Caregiver Decision|0|||
170747310|NCT00337662|617079214|FG002|Study Period II|Parent/Caregiver Decision|0|||
170747311|NCT00337662|617079215|FG003|Study Period II|Parent/Caregiver Decision|1|||
170747312|NCT00337662|617079212|FG000|Study Period III|Lost to Follow-up|14|||
170747313|NCT00337662|617079213|FG001|Study Period III|Lost to Follow-up|16|||
170747314|NCT00337662|617079214|FG002|Study Period III|Lost to Follow-up|14|||
170747315|NCT00337662|617079215|FG003|Study Period III|Lost to Follow-up|0|||
170747316|NCT00337662|617079212|FG000|Study Period III|Withdrawal by Subject|18|||
170747317|NCT00337662|617079213|FG001|Study Period III|Withdrawal by Subject|14|||
170747318|NCT00337662|617079214|FG002|Study Period III|Withdrawal by Subject|12|||
170747319|NCT00337662|617079215|FG003|Study Period III|Withdrawal by Subject|0|||
170747320|NCT00337662|617079212|FG000|Study Period III|Adverse Event|9|||
170747321|NCT00337662|617079213|FG001|Study Period III|Adverse Event|10|||
170747322|NCT00337662|617079214|FG002|Study Period III|Adverse Event|8|||
170747323|NCT00337662|617079215|FG003|Study Period III|Adverse Event|0|||
170747324|NCT00337662|617079212|FG000|Study Period III|Protocol Violation|3|||
170747325|NCT00337662|617079213|FG001|Study Period III|Protocol Violation|8|||
170747326|NCT00337662|617079214|FG002|Study Period III|Protocol Violation|2|||
170747327|NCT00337662|617079215|FG003|Study Period III|Protocol Violation|0|||
170747328|NCT00337662|617079212|FG000|Study Period III|Physician Decision|6|||
170747329|NCT00337662|617079213|FG001|Study Period III|Physician Decision|5|||
170747330|NCT00337662|617079214|FG002|Study Period III|Physician Decision|0|||
170747331|NCT00337662|617079215|FG003|Study Period III|Physician Decision|0|||
170747332|NCT00337662|617079212|FG000|Study Period III|Entry Criteria Not Met|4|||
170747333|NCT00337662|617079213|FG001|Study Period III|Entry Criteria Not Met|1|||
170747334|NCT00337662|617079214|FG002|Study Period III|Entry Criteria Not Met|3|||
170747335|NCT00337662|617079215|FG003|Study Period III|Entry Criteria Not Met|0|||
170747336|NCT00337662|617079212|FG000|Study Period III|Lack of Efficacy|4|||
170747337|NCT00337662|617079213|FG001|Study Period III|Lack of Efficacy|4|||
170747338|NCT00337662|617079214|FG002|Study Period III|Lack of Efficacy|2|||
170747339|NCT00337662|617079215|FG003|Study Period III|Lack of Efficacy|0|||
170747340|NCT00337662|617079212|FG000|Study Period III|Parent/Caregiver Decision|0|||
170747341|NCT00337662|617079213|FG001|Study Period III|Parent/Caregiver Decision|0|||
170747342|NCT00337662|617079214|FG002|Study Period III|Parent/Caregiver Decision|2|||
170747343|NCT00337662|617079215|FG003|Study Period III|Parent/Caregiver Decision|0|||
170747344|NCT00337662|617079212|FG000|Study Period III|Sponsor Decision|1|||
170747345|NCT00337662|617079213|FG001|Study Period III|Sponsor Decision|0|||
170747346|NCT00337662|617079214|FG002|Study Period III|Sponsor Decision|1|||
170747347|NCT00337662|617079215|FG003|Study Period III|Sponsor Decision|0|||
170747348|NCT00337662|617079212|FG000|Study Period III|Clinical Relapse|1|||
170747349|NCT00337662|617079213|FG001|Study Period III|Clinical Relapse|0|||
170747350|NCT00337662|617079214|FG002|Study Period III|Clinical Relapse|0|||
170747351|NCT00337662|617079215|FG003|Study Period III|Clinical Relapse|0|||
170747352|NCT01233609|617079228|FG000|Overall Study|Death|1|||
170747353|NCT01233609|617079229|FG001|Overall Study|Death|0|||
170747354|NCT01233609|617079228|FG000|Overall Study|Lost to Follow-up|3|||
170747355|NCT01233609|617079229|FG001|Overall Study|Lost to Follow-up|1|||
170747356|NCT01233609|617079228|FG000|Overall Study|Adverse Event|2|||
170747357|NCT01233609|617079229|FG001|Overall Study|Adverse Event|1|||
170747358|NCT01233609|617079228|FG000|Overall Study|Withdrawal by Subject|3|||
170747359|NCT01233609|617079229|FG001|Overall Study|Withdrawal by Subject|0|||
170747360|NCT02049710|617079230|FG000|Overall Study|Lost to Follow-up|319|||
170747361|NCT02049710|617079231|FG001|Overall Study|Lost to Follow-up|324|||
170747362|NCT03857841|617079232|FG000|Overall Study|Death|1|||
170747363|NCT03857841|617079233|FG001|Overall Study|Death|0|||
170747364|NCT03857841|617079234|FG002|Overall Study|Death|0|||
170747365|NCT03857841|617079235|FG003|Overall Study|Death|0|||
170747366|NCT03857841|617079232|FG000|Overall Study|Study Terminated by Sponsor|1|||
170747367|NCT03857841|617079233|FG001|Overall Study|Study Terminated by Sponsor|0|||
170747368|NCT03857841|617079234|FG002|Overall Study|Study Terminated by Sponsor|0|||
170747369|NCT03857841|617079235|FG003|Overall Study|Study Terminated by Sponsor|0|||
170747370|NCT01040780|617080395|FG000|Overall Study|Protocol Violation|1|||
170747371|NCT01040780|617080396|FG001|Overall Study|Protocol Violation|3|||
170747372|NCT03681639|617080397|FG000|Overall Study|Death|4|||
170747373|NCT03681639|617080397|FG000|Overall Study|Lost to Follow-up|2|||
170747374|NCT03681639|617080397|FG000|Overall Study|Withdrawal by Subject|1|||
170747375|NCT03681639|617080397|FG000|Overall Study|Adverse Event|2|||
170747376|NCT01349829|617080403|FG000|Overall Study|Lost to Follow-up|4|||
170747377|NCT01349829|617080404|FG001|Overall Study|Lost to Follow-up|8|||
170747378|NCT01349829|617080403|FG000|Overall Study|Consent withdrawal|3|||
170747379|NCT01349829|617080404|FG001|Overall Study|Consent withdrawal|8|||
170747380|NCT01349829|617080403|FG000|Overall Study|Migrated/moved|2|||
170747381|NCT01349829|617080404|FG001|Overall Study|Migrated/moved|7|||
170747382|NCT01995357|617080407|FG000|Period 5|Lack of Efficacy|1|||
170747383|NCT01995357|617080408|FG001|Period 5|Lack of Efficacy|0|||
170861462|NCT01898923|617501855|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
170747384|NCT01995357|617080409|FG002|Period 5|Lack of Efficacy|0|||
170747385|NCT01995357|617080410|FG003|Period 5|Lack of Efficacy|0|||
170747386|NCT01995357|617080411|FG004|Period 5|Lack of Efficacy|0|||
170747387|NCT01995357|617080412|FG005|Period 5|Lack of Efficacy|0|||
170747388|NCT01995357|617080407|FG000|Period 5|Adverse Event|1|||
170747389|NCT01995357|617080408|FG001|Period 5|Adverse Event|0|||
170747390|NCT01995357|617080409|FG002|Period 5|Adverse Event|1|||
170747391|NCT01995357|617080410|FG003|Period 5|Adverse Event|0|||
170747392|NCT01995357|617080411|FG004|Period 5|Adverse Event|0|||
170747393|NCT01995357|617080412|FG005|Period 5|Adverse Event|0|||
170747394|NCT03943589|617080413|FG000|Overall Study|Death|1|||
170747395|NCT03943589|617080413|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
170747396|NCT04329104|617080414|FG000|Efficacy Study|Withdrawal by Subject|0|||
170747397|NCT04329104|617080415|FG001|Efficacy Study|Withdrawal by Subject|0|||
170747398|NCT04329104|617080416|FG002|Efficacy Study|Withdrawal by Subject|0|||
170747399|NCT04329104|617080417|FG003|Efficacy Study|Withdrawal by Subject|5|||
170747400|NCT04329104|617080418|FG004|Efficacy Study|Withdrawal by Subject|6|||
170747401|NCT04329104|617080419|FG005|Efficacy Study|Withdrawal by Subject|8|||
170747402|NCT01853254|617080420|FG000|Overall Study|Abnormal Laboratory Test|1|||
170747403|NCT01853254|617080420|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
170747404|NCT01853254|617080420|FG000|Overall Study|Death|1|||
170747405|NCT01853254|617080420|FG000|Overall Study|Failure to Return|43|||
170747406|NCT01853254|617080420|FG000|Overall Study|Insufficient Therapeutic Response|22|||
170747407|NCT01853254|617080420|FG000|Overall Study|Refusal of Treatment|1|||
170747408|NCT01853254|617080420|FG000|Overall Study|Other Protocol Violation|1|||
170747409|NCT01853254|617080420|FG000|Overall Study|Withdrawal of Consent|16|||
170747410|NCT01853254|617080420|FG000|Overall Study|Administrative/Other|16|||
170747411|NCT01238575|617080425|FG000|Overall Study|Lack of Efficacy|2|||
170747412|NCT01238575|617080426|FG001|Overall Study|Lack of Efficacy|4|||
170747413|NCT01238575|617080425|FG000|Overall Study|Adverse Event|2|||
170747414|NCT01238575|617080426|FG001|Overall Study|Adverse Event|0|||
170747415|NCT01383993|617080427|FG000|Overall Study|Adverse Event|1|||
170747416|NCT01383993|617080428|FG001|Overall Study|Adverse Event|1|||
170747417|NCT01383993|617080429|FG002|Overall Study|Adverse Event|0|||
170747418|NCT01383993|617080427|FG000|Overall Study|Withdrawal by Subject|0|||
170747419|NCT01383993|617080428|FG001|Overall Study|Withdrawal by Subject|0|||
170747420|NCT01383993|617080429|FG002|Overall Study|Withdrawal by Subject|1|||
170747421|NCT01383993|617080427|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
170747422|NCT01383993|617080428|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
170747423|NCT01383993|617080429|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
170747424|NCT00593554|617080430|FG000|Overall Study|Death|1|||
170747425|NCT00593554|617080431|FG001|Overall Study|Death|2|||
170747426|NCT00593554|617080430|FG000|Overall Study|Physician Decision|0|||
170747427|NCT00593554|617080431|FG001|Overall Study|Physician Decision|1|||
170747428|NCT00593554|617080430|FG000|Overall Study|Withdrawal by Subject|1|||
170747429|NCT00593554|617080431|FG001|Overall Study|Withdrawal by Subject|0|||
170747430|NCT00593554|617080430|FG000|Overall Study|Disease Progression|1|||
170747431|NCT00593554|617080431|FG001|Overall Study|Disease Progression|2|||
170747432|NCT02091869|617080438|FG000|Overall Study|Withdrawal by Subject|0|||
170747433|NCT02091869|617080439|FG001|Overall Study|Withdrawal by Subject|3|||
170747434|NCT02485353|617080442|FG000|Overall Study|Death|1|||
170747435|NCT02485353|617080442|FG000|Overall Study|Disease Progression|1|||
170747436|NCT02254421|617080446|FG000|Overall Study|Randomized but Not Treated|1|||
170747437|NCT02254421|617080447|FG001|Overall Study|Randomized but Not Treated|0|||
170747438|NCT02254421|617080446|FG000|Overall Study|Death|0|||
170747439|NCT02254421|617080447|FG001|Overall Study|Death|2|||
170747440|NCT02254421|617080446|FG000|Overall Study|Withdrew Consent|1|||
170747441|NCT02254421|617080447|FG001|Overall Study|Withdrew Consent|1|||
170747442|NCT00358150|617080448|FG000|Overall Study|Adverse Event|3|||
170747443|NCT00358150|617080448|FG000|Overall Study|Withdrawal by Subject|1|||
170747444|NCT00358150|617080448|FG000|Overall Study|Undefined|3|||
170747445|NCT00179010|617080449|FG000|Overall Study|Muscle probe defective|1|||
170747446|NCT00179010|617080450|FG001|Overall Study|Muscle probe defective|1|||
170747447|NCT00179010|617080449|FG000|Overall Study|Failure to place arterial line|0|||
170747448|NCT00179010|617080450|FG001|Overall Study|Failure to place arterial line|1|||
170747449|NCT00531011|617080465|FG000|Overall Study|Withdrawal by Subject|2|||
170747450|NCT00531011|617080466|FG001|Overall Study|Withdrawal by Subject|4|||
170747451|NCT00531011|617080465|FG000|Overall Study|Death|1|||
170747452|NCT00531011|617080466|FG001|Overall Study|Death|0|||
170747453|NCT00531011|617080465|FG000|Overall Study|Lost to Follow-up|1|||
170747454|NCT00531011|617080466|FG001|Overall Study|Lost to Follow-up|0|||
170747455|NCT00531011|617080465|FG000|Overall Study|Physician Decision|0|||
170747456|NCT00531011|617080466|FG001|Overall Study|Physician Decision|3|||
170747457|NCT02001974|617080472|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
170747458|NCT02001974|617080473|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
170747459|NCT02001974|617080474|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
170747460|NCT02001974|617080472|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
170747461|NCT02001974|617080473|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
170747462|NCT02001974|617080474|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
170747463|NCT02001974|617080472|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
170747464|NCT02001974|617080473|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
170747465|NCT02001974|617080474|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
170747466|NCT02001974|617080472|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
170747467|NCT02001974|617080473|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
170747468|NCT02001974|617080474|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
170747469|NCT00993317|617080475|FG000|Overall Study|Adverse Event|2|||
170747470|NCT00993317|617080476|FG001|Overall Study|Adverse Event|4|||
170747471|NCT00993317|617080475|FG000|Overall Study|Lack of Efficacy|18|||
170747472|NCT00993317|617080476|FG001|Overall Study|Lack of Efficacy|18|||
170747473|NCT00993317|617080475|FG000|Overall Study|Withdrawal by Subject|0|||
170747474|NCT00993317|617080476|FG001|Overall Study|Withdrawal by Subject|2|||
170747475|NCT00993317|617080475|FG000|Overall Study|Investigator's opinion|0|||
170747476|NCT00993317|617080476|FG001|Overall Study|Investigator's opinion|1|||
170747477|NCT00993317|617080475|FG000|Overall Study|Early study termination at the site|1|||
170747478|NCT00993317|617080476|FG001|Overall Study|Early study termination at the site|0|||
170747479|NCT01964521|617080477|FG000|Overall Study|Lost to Follow-up|4|||
170747480|NCT01463293|617080478|FG000|Overall Study|Lost to Follow-up|1|||
170747481|NCT01463293|617080479|FG001|Overall Study|Lost to Follow-up|4|||
170747482|NCT01463293|617080480|FG002|Overall Study|Lost to Follow-up|5|||
170747483|NCT01463293|617080478|FG000|Overall Study|Adverse Event|1|||
170747484|NCT01463293|617080479|FG001|Overall Study|Adverse Event|2|||
170747485|NCT01463293|617080480|FG002|Overall Study|Adverse Event|0|||
170747486|NCT01463293|617080478|FG000|Overall Study|Withdrawal by Subject|4|||
170747487|NCT01463293|617080479|FG001|Overall Study|Withdrawal by Subject|10|||
170747488|NCT01463293|617080480|FG002|Overall Study|Withdrawal by Subject|5|||
170747489|NCT01463293|617080478|FG000|Overall Study|Other|0|||
170747490|NCT01463293|617080479|FG001|Overall Study|Other|0|||
170747491|NCT01463293|617080480|FG002|Overall Study|Other|2|||
170747492|NCT01284140|617080481|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
170747493|NCT01284140|617080482|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
170747494|NCT01284140|617080481|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
170747495|NCT01284140|617080482|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
170747496|NCT02796963|617080483|FG000|Overall Study|Lost to Follow-up|89|||
170747497|NCT02796963|617080484|FG001|Overall Study|Lost to Follow-up|76|||
170747498|NCT02796963|617080485|FG002|Overall Study|Lost to Follow-up|69|||
170747499|NCT02796963|617080486|FG003|Overall Study|Lost to Follow-up|72|||
170747500|NCT03192215|617080490|FG000|Overall Study|Death|28|||
170747501|NCT03192215|617080491|FG001|Overall Study|Death|23|||
170747502|NCT03192215|617080490|FG000|Overall Study|Lost to Follow-up|10|||
170747503|NCT03192215|617080491|FG001|Overall Study|Lost to Follow-up|15|||
170747504|NCT03192215|617080490|FG000|Overall Study|Withdrawal by Subject|49|||
170747505|NCT03192215|617080491|FG001|Overall Study|Withdrawal by Subject|48|||
170747506|NCT03192215|617080490|FG000|Overall Study|Other as reported in analysis|4|||
170747507|NCT03192215|617080491|FG001|Overall Study|Other as reported in analysis|1|||
170747508|NCT00119262|617080492|FG000|Overall Study|Lack of Efficacy|0|||
170747509|NCT00119262|617080493|FG001|Overall Study|Lack of Efficacy|3|||
170747510|NCT00119262|617080492|FG000|Overall Study|Withdrawal by Subject|12|||
170747511|NCT00119262|617080493|FG001|Overall Study|Withdrawal by Subject|11|||
170747512|NCT00119262|617080492|FG000|Overall Study|Adverse Event|33|||
170747513|NCT00119262|617080493|FG001|Overall Study|Adverse Event|35|||
170747514|NCT00119262|617080492|FG000|Overall Study|other disease|0|||
170747515|NCT00119262|617080493|FG001|Overall Study|other disease|2|||
170747516|NCT00119262|617080492|FG000|Overall Study|ineligble|1|||
170747517|NCT00119262|617080493|FG001|Overall Study|ineligble|2|||
170747518|NCT00119262|617080492|FG000|Overall Study|others|0|||
170747519|NCT00119262|617080493|FG001|Overall Study|others|5|||
170747520|NCT03853317|617080494|FG000|Overall Study|Progressive Disease|5|||
170747521|NCT03853317|617080494|FG000|Overall Study|Adverse Event|1|||
170747522|NCT03853317|617080494|FG000|Overall Study|Death|1|||
170747523|NCT03853317|617080494|FG000|Overall Study|other event|2|||
170747524|NCT01551303|617080496|FG000|Overall Study|failed awareness check on vision test|4|||
170747525|NCT01551303|617080497|FG001|Overall Study|failed awareness check on vision test|7|||
170747526|NCT02589392|617080501|FG000|Overall Study|Adverse Event|1|||
170747527|NCT02589392|617080502|FG001|Overall Study|Adverse Event|1|||
170747528|NCT02589392|617080501|FG000|Overall Study|Withdrawal by Subject|1|||
170747529|NCT02589392|617080502|FG001|Overall Study|Withdrawal by Subject|2|||
170747530|NCT02589392|617080501|FG000|Overall Study|Protocol Violation|1|||
170747531|NCT02589392|617080502|FG001|Overall Study|Protocol Violation|1|||
170747532|NCT02589392|617080501|FG000|Overall Study|Lost to Follow-up|2|||
170747533|NCT02589392|617080502|FG001|Overall Study|Lost to Follow-up|2|||
170747534|NCT02589392|617080501|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
170747535|NCT02589392|617080502|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
170747536|NCT02838628|617080505|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
170747537|NCT02838628|617080506|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
170747538|NCT02838628|617080505|FG000|Recurrence Follow-up Period|Adverse Event|1|||
170747539|NCT02838628|617080506|FG001|Recurrence Follow-up Period|Adverse Event|0|||
170747540|NCT02838628|617080505|FG000|Recurrence Follow-up Period|Non-compliance|0|||
170747541|NCT02838628|617080506|FG001|Recurrence Follow-up Period|Non-compliance|1|||
170747542|NCT02838628|617080505|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
170747543|NCT02838628|617080506|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
170747544|NCT02838628|617080505|FG000|Recurrence Follow-up Period|Other un-specified|1|||
170747545|NCT02838628|617080506|FG001|Recurrence Follow-up Period|Other un-specified|1|||
170747546|NCT05832437|617080508|FG000|Overall Study|time off work|1|||
170747547|NCT05832437|617080509|FG001|Overall Study|time off work|0|||
170747548|NCT05832437|617080510|FG002|Overall Study|time off work|0|||
170747549|NCT05832437|617080511|FG003|Overall Study|time off work|0|||
170747550|NCT05376371|617080512|FG000|Overall Study|change in release date|10|||
170747551|NCT03560245|617080513|FG000|Overall Study|Withdrawal by Subject|3|||
170747552|NCT03560245|617080514|FG001|Overall Study|Withdrawal by Subject|2|||
170747553|NCT03560245|617080513|FG000|Overall Study|Adverse Event|1|||
170747554|NCT03560245|617080514|FG001|Overall Study|Adverse Event|1|||
170747555|NCT03560245|617080513|FG000|Overall Study|Protocol Violation|1|||
170747556|NCT03560245|617080514|FG001|Overall Study|Protocol Violation|0|||
170747557|NCT03560245|617080513|FG000|Overall Study|Death|0|||
170747558|NCT03560245|617080514|FG001|Overall Study|Death|1|||
170747559|NCT03560245|617080513|FG000|Overall Study|Lost to Follow-up|0|||
170747560|NCT03560245|617080514|FG001|Overall Study|Lost to Follow-up|1|||
170747561|NCT03560245|617080513|FG000|Overall Study|Physician Decision|0|||
170747562|NCT03560245|617080514|FG001|Overall Study|Physician Decision|1|||
170747563|NCT03560245|617080513|FG000|Overall Study|Other|0|||
170747564|NCT03560245|617080514|FG001|Overall Study|Other|1|||
170747565|NCT00882921|617080516|FG000|Overall Study|Death|2|||
170747566|NCT00882921|617080516|FG000|Overall Study|Other|3|||
170747567|NCT00882921|617080516|FG000|Overall Study|Lost to Follow-up|2|||
170747568|NCT00882921|617080516|FG000|Overall Study|Termination By Investigator|3|||
170747569|NCT00882921|617080516|FG000|Overall Study|Withdrawal Of Consent|1|||
170747570|NCT00514046|617080522|FG000|Overall Study|transferred to another protocol|2|||
170747571|NCT00514046|617080523|FG001|Overall Study|transferred to another protocol|1|||
170747572|NCT00514046|617080524|FG002|Overall Study|transferred to another protocol|3|||
170747573|NCT00514046|617080525|FG003|Overall Study|transferred to another protocol|0|||
170747574|NCT00514046|617080526|FG004|Overall Study|transferred to another protocol|1|||
170747575|NCT00514046|617080527|FG005|Overall Study|transferred to another protocol|0|||
170747576|NCT00514046|617080528|FG006|Overall Study|transferred to another protocol|0|||
170747577|NCT00514046|617080529|FG007|Overall Study|transferred to another protocol|0|||
170747578|NCT00514046|617080530|FG008|Overall Study|transferred to another protocol|0|||
170747579|NCT00514046|617080522|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
170747580|NCT00514046|617080523|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
170747581|NCT00514046|617080524|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
170747582|NCT00514046|617080525|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
170747583|NCT00514046|617080526|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
170747584|NCT00514046|617080527|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
170747585|NCT00514046|617080528|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
170747586|NCT00514046|617080529|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
170747587|NCT00514046|617080530|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
170747588|NCT00514046|617080522|FG000|Overall Study|Disease progression on study|0|||
170747589|NCT00514046|617080523|FG001|Overall Study|Disease progression on study|0|||
170747590|NCT00514046|617080524|FG002|Overall Study|Disease progression on study|2|||
170747591|NCT00514046|617080525|FG003|Overall Study|Disease progression on study|0|||
170747592|NCT00514046|617080526|FG004|Overall Study|Disease progression on study|0|||
170747593|NCT00514046|617080527|FG005|Overall Study|Disease progression on study|1|||
170747594|NCT00514046|617080528|FG006|Overall Study|Disease progression on study|0|||
170747595|NCT00514046|617080529|FG007|Overall Study|Disease progression on study|0|||
170747596|NCT00514046|617080530|FG008|Overall Study|Disease progression on study|0|||
170747597|NCT04714216|617082529|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
170747598|NCT04714216|617082529|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
170747599|NCT01818141|617082530|FG000|Overall Study|Withdrawal by Subject|2|||
170747600|NCT01818141|617082531|FG001|Overall Study|Withdrawal by Subject|0|||
170747601|NCT01818141|617082530|FG000|Overall Study|No baseline C.diff colonies|1|||
170747602|NCT01818141|617082531|FG001|Overall Study|No baseline C.diff colonies|1|||
170747603|NCT01818141|617082530|FG000|Overall Study|Lost to Follow-up|0|||
170747604|NCT01818141|617082531|FG001|Overall Study|Lost to Follow-up|2|||
170747605|NCT03204695|617082535|FG000|Overall Study|Death|1|||
170747606|NCT03204695|617082535|FG000|Overall Study|Participant was treated with another device|1|||
170747607|NCT03204695|617082535|FG000|Overall Study|Physician Decision|2|||
170747608|NCT02555371|617082536|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
170861463|NCT00723021|617501856|FG000|Intervention Period 4|Adverse Event|0|||
170861464|NCT00723021|617501857|FG001|Intervention Period 4|Adverse Event|0|||
170747609|NCT02555371|617082537|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
170747610|NCT02555371|617082538|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
170747611|NCT02555371|617082539|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
170747612|NCT02555371|617082540|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
170747613|NCT02555371|617082536|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
170747614|NCT02555371|617082537|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
170747615|NCT02555371|617082538|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
170747616|NCT02555371|617082539|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
170747617|NCT02555371|617082540|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
170747618|NCT02555371|617082536|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
170747619|NCT02555371|617082537|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
170747620|NCT02555371|617082538|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
170747621|NCT02555371|617082539|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
170747622|NCT02555371|617082540|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
170747623|NCT02555371|617082536|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
170747624|NCT02555371|617082537|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
170747625|NCT02555371|617082538|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
170747626|NCT02555371|617082539|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
170747627|NCT02555371|617082540|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
170747628|NCT02555371|617082536|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
170747629|NCT02555371|617082537|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
170747630|NCT02555371|617082538|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
170747631|NCT02555371|617082539|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
170747632|NCT02555371|617082540|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
170747633|NCT02555371|617082536|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
170747634|NCT02555371|617082537|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
170747635|NCT02555371|617082538|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
170747636|NCT02555371|617082539|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
170747637|NCT02555371|617082540|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
170747638|NCT02555371|617082536|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
170747639|NCT02555371|617082537|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
170747640|NCT02555371|617082538|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
170747641|NCT02555371|617082539|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
170747642|NCT02555371|617082540|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
170747643|NCT02555371|617082536|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
170747644|NCT02555371|617082537|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
170747645|NCT02555371|617082538|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
170747646|NCT02555371|617082539|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
170747647|NCT02555371|617082540|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
170747648|NCT02555371|617082536|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
170747649|NCT02555371|617082537|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
170747650|NCT02555371|617082538|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
170747651|NCT02555371|617082539|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
170747652|NCT02555371|617082540|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
170747653|NCT02555371|617082536|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
170747654|NCT02555371|617082537|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
170747655|NCT02555371|617082538|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
170747656|NCT02555371|617082539|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
170747657|NCT02555371|617082540|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
170747658|NCT02555371|617082536|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
170747659|NCT02555371|617082537|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
170747660|NCT02555371|617082538|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
170747661|NCT02555371|617082539|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
170747662|NCT02555371|617082540|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
170747663|NCT02555371|617082536|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
170747664|NCT02555371|617082537|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
170747665|NCT02555371|617082538|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
170747666|NCT02555371|617082539|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
170747667|NCT02555371|617082540|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
170747668|NCT02555371|617082536|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
170747669|NCT02555371|617082537|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
170747670|NCT02555371|617082538|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
170747671|NCT02555371|617082539|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
170747672|NCT02555371|617082540|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
170747673|NCT02555371|617082536|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
170747674|NCT02555371|617082537|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
170747675|NCT02555371|617082538|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
170747676|NCT02555371|617082539|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
170747677|NCT02555371|617082540|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
170747678|NCT02930122|617082543|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
170747679|NCT02930122|617082544|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
170747680|NCT02609659|617082545|FG000|Overall Study|Adverse Event|1|||
170747681|NCT02609659|617082545|FG000|Overall Study|Lost to Follow-up|6|||
170747682|NCT02609659|617082545|FG000|Overall Study|Other|1|||
170747683|NCT04129580|617082546|FG000|Overall Study|Lost to Follow-up|14|||
170747684|NCT04129580|617082547|FG001|Overall Study|Lost to Follow-up|25|||
170747685|NCT02462083|617082548|FG000|Overall Study|Sponsor request|39|||
170747686|NCT02462083|617082548|FG000|Overall Study|Withdrawal by Subject|87|||
170747687|NCT02462083|617082548|FG000|Overall Study|Lost to Follow-up|41|||
170747688|NCT02462083|617082548|FG000|Overall Study|Lack of Efficacy|151|||
170747689|NCT02462083|617082548|FG000|Overall Study|Pregnancy|1|||
170747690|NCT02462083|617082548|FG000|Overall Study|Protocol Violation|6|||
170747691|NCT02462083|617082548|FG000|Overall Study|Adverse Event|33|||
170747692|NCT02462083|617082548|FG000|Overall Study|Worsening condition|16|||
170747693|NCT02462083|617082548|FG000|Overall Study|Other than specified|45|||
170747694|NCT02711995|617082549|FG000|Washout (90 Days)|Conflicting medication|1|||
170747695|NCT02176928|617082553|FG000|Overall Study|Lost to Follow-up|2|||
170747696|NCT02176928|617082554|FG001|Overall Study|Lost to Follow-up|4|||
170747697|NCT01668147|617082561|FG000|Overall Study|Withdrawal by Subject|6|||
170747698|NCT01809210|617082562|FG000|Overall Study|Withdrawal by Subject|0|||
170747699|NCT01809210|617082563|FG001|Overall Study|Withdrawal by Subject|0|||
170747700|NCT01809210|617082564|FG002|Overall Study|Withdrawal by Subject|1|||
170747701|NCT01809210|617082565|FG003|Overall Study|Withdrawal by Subject|1|||
170747702|NCT01809210|617082566|FG004|Overall Study|Withdrawal by Subject|1|||
170747703|NCT01809210|617082567|FG005|Overall Study|Withdrawal by Subject|0|||
170747704|NCT01809210|617082568|FG006|Overall Study|Withdrawal by Subject|4|||
170747705|NCT01809210|617082562|FG000|Overall Study|Death|1|||
170747706|NCT01809210|617082563|FG001|Overall Study|Death|1|||
170747707|NCT01809210|617082564|FG002|Overall Study|Death|2|||
170747708|NCT01809210|617082565|FG003|Overall Study|Death|0|||
170747709|NCT01809210|617082566|FG004|Overall Study|Death|1|||
170747710|NCT01809210|617082567|FG005|Overall Study|Death|3|||
170747711|NCT01809210|617082568|FG006|Overall Study|Death|1|||
170747712|NCT00590980|617082571|FG000|Overall Study|Did not meet all inclusion criteria|10|||
170747713|NCT02819479|617082572|FG000|Overall Study|Adverse Event|2|||
170747714|NCT00224133|617082573|FG000|Overall Study|Adverse Event|93|||
170747715|NCT00224133|617082573|FG000|Overall Study|Protocol Violation|6|||
170747716|NCT00224133|617082573|FG000|Overall Study|Withdrawal by Subject|33|||
170747717|NCT00224133|617082573|FG000|Overall Study|Lack of Efficacy|58|||
170747718|NCT00224133|617082573|FG000|Overall Study|Lost to Follow-up|21|||
170747719|NCT00224133|617082573|FG000|Overall Study|Physician Decision|1|||
170747720|NCT00224133|617082573|FG000|Overall Study|Other|14|||
170747721|NCT00506285|617082578|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
170747722|NCT00506285|617082579|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
170747723|NCT00506285|617082578|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
170747724|NCT00506285|617082579|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
170747725|NCT00506285|617082578|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
170747726|NCT00506285|617082579|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
170747727|NCT00506285|617082578|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
170747728|NCT00506285|617082579|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
170747729|NCT00506285|617082578|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
170747730|NCT00506285|617082579|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
170747731|NCT01023308|617082582|FG000|Overall Study|Abnormal test proceedure results|3|||
170747732|NCT01023308|617082583|FG001|Overall Study|Abnormal test proceedure results|8|||
170747733|NCT01023308|617082582|FG000|Overall Study|Administrative problems|2|||
170747734|NCT01023308|617082583|FG001|Overall Study|Administrative problems|1|||
170747735|NCT01023308|617082582|FG000|Overall Study|Adverse Event|130|||
170747736|NCT01023308|617082583|FG001|Overall Study|Adverse Event|66|||
170747737|NCT01023308|617082582|FG000|Overall Study|Death|21|||
170747738|NCT01023308|617082583|FG001|Overall Study|Death|17|||
170747739|NCT01023308|617082582|FG000|Overall Study|Disease progression|82|||
170747740|NCT01023308|617082583|FG001|Overall Study|Disease progression|153|||
170747741|NCT01023308|617082582|FG000|Overall Study|New Cancer therapy|4|||
170747742|NCT01023308|617082583|FG001|Overall Study|New Cancer therapy|7|||
170747743|NCT01023308|617082582|FG000|Overall Study|Protocol Violation|3|||
170747744|NCT01023308|617082583|FG001|Overall Study|Protocol Violation|4|||
170747745|NCT01023308|617082582|FG000|Overall Study|Untreated|5|||
170747746|NCT01023308|617082583|FG001|Overall Study|Untreated|5|||
170747747|NCT01023308|617082582|FG000|Overall Study|Lost to Follow-up|1|||
170747748|NCT01023308|617082583|FG001|Overall Study|Lost to Follow-up|0|||
170747749|NCT01023308|617082582|FG000|Overall Study|Withdrawal by Subject|34|||
170747750|NCT01023308|617082583|FG001|Overall Study|Withdrawal by Subject|18|||
170747751|NCT00551213|617082584|FG000|Overall Study|Adverse Event|6|||
170747752|NCT00551213|617082585|FG001|Overall Study|Adverse Event|3|||
170747753|NCT00551213|617082584|FG000|Overall Study|Progressive Disease|41|||
170747754|NCT00551213|617082585|FG001|Overall Study|Progressive Disease|12|||
170747755|NCT00551213|617082584|FG000|Overall Study|Withdrawal by Subject|2|||
170747756|NCT00551213|617082585|FG001|Overall Study|Withdrawal by Subject|0|||
170747757|NCT00551213|617082584|FG000|Overall Study|Not Treated|1|||
170747758|NCT00551213|617082585|FG001|Overall Study|Not Treated|2|||
170747759|NCT00795132|617082593|FG000|Overall Study|Death|1|||
170747760|NCT00795132|617082593|FG000|Overall Study|Relapse|2|||
170747761|NCT02451930|617082596|FG000|Overall Study|Death|0|||
170747762|NCT02451930|617082597|FG001|Overall Study|Death|15|||
170747763|NCT02451930|617082596|FG000|Overall Study|Lost to Follow-up|0|||
170747764|NCT02451930|617082597|FG001|Overall Study|Lost to Follow-up|3|||
170747765|NCT02451930|617082596|FG000|Overall Study|Sponsor Decision|2|||
170747766|NCT02451930|617082597|FG001|Overall Study|Sponsor Decision|10|||
170747767|NCT02451930|617082596|FG000|Overall Study|Withdrawal by Subject|0|||
170747768|NCT02451930|617082597|FG001|Overall Study|Withdrawal by Subject|1|||
170747769|NCT02451930|617082596|FG000|Overall Study|Other|0|||
170747770|NCT02451930|617082597|FG001|Overall Study|Other|1|||
170747771|NCT00262743|617082598|FG000|Overall Study|Adverse Event|0|||
170747772|NCT00262743|617082599|FG001|Overall Study|Adverse Event|9|||
170747773|NCT00262743|617082598|FG000|Overall Study|Disease progression|0|||
170747774|NCT00262743|617082599|FG001|Overall Study|Disease progression|3|||
170747775|NCT04430335|617082608|FG000|Overall Study|Withdrawal by Subject|1|||
170747776|NCT03249376|617082612|FG000|Overall Study|Adverse Event|11|||
170747777|NCT03249376|617082613|FG001|Overall Study|Adverse Event|5|||
170747778|NCT03249376|617082612|FG000|Overall Study|Lack of Efficacy|2|||
170747779|NCT03249376|617082613|FG001|Overall Study|Lack of Efficacy|4|||
170747780|NCT03249376|617082612|FG000|Overall Study|Protocol Violation|3|||
170747781|NCT03249376|617082613|FG001|Overall Study|Protocol Violation|2|||
170747782|NCT03249376|617082612|FG000|Overall Study|Physician Decision|0|||
170747783|NCT03249376|617082613|FG001|Overall Study|Physician Decision|2|||
170747784|NCT03249376|617082612|FG000|Overall Study|Withdrawal by Subject|3|||
170747785|NCT03249376|617082613|FG001|Overall Study|Withdrawal by Subject|9|||
170747786|NCT03249376|617082612|FG000|Overall Study|LTFU|2|||
170747787|NCT03249376|617082613|FG001|Overall Study|LTFU|1|||
170747788|NCT03268590|617082614|FG000|Overall Study|Previously unknown exclusion criteria|1|||
170747789|NCT01154036|617082617|FG000|Phase I|Physician Decision|0|||
170747790|NCT01154036|617082618|FG001|Phase I|Physician Decision|1|||
170747791|NCT01154036|617082619|FG002|Phase I|Physician Decision|0|||
170747792|NCT01154036|617082620|FG003|Phase I|Physician Decision|0|||
170747793|NCT01154036|617082621|FG004|Phase I|Physician Decision|0|||
170747794|NCT01154036|617082622|FG005|Phase I|Physician Decision|0|||
170747795|NCT01154036|617082623|FG006|Phase I|Physician Decision|0|||
170747796|NCT01154036|617082624|FG007|Phase I|Physician Decision|0|||
170747797|NCT01154036|617082617|FG000|Phase I|Lost to Follow-up|0|||
170747798|NCT01154036|617082618|FG001|Phase I|Lost to Follow-up|3|||
170747799|NCT01154036|617082619|FG002|Phase I|Lost to Follow-up|6|||
170747800|NCT01154036|617082620|FG003|Phase I|Lost to Follow-up|0|||
170747801|NCT01154036|617082621|FG004|Phase I|Lost to Follow-up|0|||
170747802|NCT01154036|617082622|FG005|Phase I|Lost to Follow-up|0|||
170747803|NCT01154036|617082623|FG006|Phase I|Lost to Follow-up|0|||
170747804|NCT01154036|617082624|FG007|Phase I|Lost to Follow-up|0|||
170747805|NCT01154036|617082617|FG000|Phase I|Protocol Violation|0|||
170747806|NCT01154036|617082618|FG001|Phase I|Protocol Violation|3|||
170747807|NCT01154036|617082619|FG002|Phase I|Protocol Violation|9|||
170747808|NCT01154036|617082620|FG003|Phase I|Protocol Violation|0|||
170747809|NCT01154036|617082621|FG004|Phase I|Protocol Violation|0|||
170747810|NCT01154036|617082622|FG005|Phase I|Protocol Violation|0|||
170747811|NCT01154036|617082623|FG006|Phase I|Protocol Violation|0|||
170747812|NCT01154036|617082624|FG007|Phase I|Protocol Violation|0|||
170747813|NCT01154036|617082617|FG000|Phase I|Withdrawal by Subject|2|||
170747814|NCT01154036|617082618|FG001|Phase I|Withdrawal by Subject|10|||
170747815|NCT01154036|617082619|FG002|Phase I|Withdrawal by Subject|29|||
170747816|NCT01154036|617082620|FG003|Phase I|Withdrawal by Subject|0|||
170747817|NCT01154036|617082621|FG004|Phase I|Withdrawal by Subject|0|||
170747818|NCT01154036|617082622|FG005|Phase I|Withdrawal by Subject|0|||
170747819|NCT01154036|617082623|FG006|Phase I|Withdrawal by Subject|0|||
170747820|NCT01154036|617082624|FG007|Phase I|Withdrawal by Subject|0|||
170747821|NCT01154036|617082617|FG000|Phase I|Adverse Event|1|||
170747822|NCT01154036|617082618|FG001|Phase I|Adverse Event|11|||
170747823|NCT01154036|617082619|FG002|Phase I|Adverse Event|12|||
170747824|NCT01154036|617082620|FG003|Phase I|Adverse Event|0|||
170747825|NCT01154036|617082621|FG004|Phase I|Adverse Event|0|||
170747826|NCT01154036|617082622|FG005|Phase I|Adverse Event|0|||
170747827|NCT01154036|617082623|FG006|Phase I|Adverse Event|0|||
170747828|NCT01154036|617082624|FG007|Phase I|Adverse Event|0|||
170747829|NCT01154036|617082617|FG000|Phase II|Adverse Event|0|||
170747830|NCT01154036|617082618|FG001|Phase II|Adverse Event|0|||
170747831|NCT01154036|617082619|FG002|Phase II|Adverse Event|0|||
170747832|NCT01154036|617082620|FG003|Phase II|Adverse Event|0|||
170747833|NCT01154036|617082621|FG004|Phase II|Adverse Event|1|||
170861465|NCT00723021|617501858|FG002|Intervention Period 4|Adverse Event|0|||
170747834|NCT01154036|617082622|FG005|Phase II|Adverse Event|1|||
170747835|NCT01154036|617082623|FG006|Phase II|Adverse Event|1|||
170747836|NCT01154036|617082624|FG007|Phase II|Adverse Event|1|||
170747837|NCT01154036|617082617|FG000|Phase II|Physician Decision|0|||
170747838|NCT01154036|617082618|FG001|Phase II|Physician Decision|0|||
170747839|NCT01154036|617082619|FG002|Phase II|Physician Decision|0|||
170747840|NCT01154036|617082620|FG003|Phase II|Physician Decision|0|||
170747841|NCT01154036|617082621|FG004|Phase II|Physician Decision|0|||
170747842|NCT01154036|617082622|FG005|Phase II|Physician Decision|0|||
170747843|NCT01154036|617082623|FG006|Phase II|Physician Decision|1|||
170747844|NCT01154036|617082624|FG007|Phase II|Physician Decision|0|||
170747845|NCT01154036|617082617|FG000|Phase II|Lost to Follow-up|0|||
170747846|NCT01154036|617082618|FG001|Phase II|Lost to Follow-up|0|||
170747847|NCT01154036|617082619|FG002|Phase II|Lost to Follow-up|0|||
170747848|NCT01154036|617082620|FG003|Phase II|Lost to Follow-up|1|||
170747849|NCT01154036|617082621|FG004|Phase II|Lost to Follow-up|2|||
170747850|NCT01154036|617082622|FG005|Phase II|Lost to Follow-up|0|||
170747851|NCT01154036|617082623|FG006|Phase II|Lost to Follow-up|2|||
170747852|NCT01154036|617082624|FG007|Phase II|Lost to Follow-up|1|||
170747853|NCT01154036|617082617|FG000|Phase II|Protocol Violation|0|||
170747854|NCT01154036|617082618|FG001|Phase II|Protocol Violation|0|||
170747855|NCT01154036|617082619|FG002|Phase II|Protocol Violation|0|||
170747856|NCT01154036|617082620|FG003|Phase II|Protocol Violation|0|||
170747857|NCT01154036|617082621|FG004|Phase II|Protocol Violation|1|||
170747858|NCT01154036|617082622|FG005|Phase II|Protocol Violation|2|||
170747859|NCT01154036|617082623|FG006|Phase II|Protocol Violation|0|||
170747860|NCT01154036|617082624|FG007|Phase II|Protocol Violation|0|||
170747861|NCT01154036|617082617|FG000|Phase II|Withdrawal by Subject|0|||
170747862|NCT01154036|617082618|FG001|Phase II|Withdrawal by Subject|0|||
170747863|NCT01154036|617082619|FG002|Phase II|Withdrawal by Subject|0|||
170747864|NCT01154036|617082620|FG003|Phase II|Withdrawal by Subject|0|||
170747865|NCT01154036|617082621|FG004|Phase II|Withdrawal by Subject|4|||
170747866|NCT01154036|617082622|FG005|Phase II|Withdrawal by Subject|2|||
170747867|NCT01154036|617082623|FG006|Phase II|Withdrawal by Subject|5|||
170747868|NCT01154036|617082624|FG007|Phase II|Withdrawal by Subject|4|||
170747869|NCT04254679|617082625|FG000|Overall Study|Protocol Violation|1|||
170747870|NCT04254679|617082626|FG001|Overall Study|Protocol Violation|1|||
170747871|NCT04254679|617082625|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
170747872|NCT04254679|617082626|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
170747873|NCT02823964|617082627|FG000|Overall Study|Adverse Event|2|||
170747874|NCT02823964|617082627|FG000|Overall Study|Physician Decision|1|||
170747875|NCT02823964|617082627|FG000|Overall Study|Lack of Efficacy|1|||
170747876|NCT02823964|617082627|FG000|Overall Study|Withdrawal by Subject|1|||
170747877|NCT04076020|617082640|FG000|Overall Study|Death|4|||
170747878|NCT04076020|617082641|FG001|Overall Study|Death|6|||
170747879|NCT04076020|617082640|FG000|Overall Study|Withdrawal by Subject|12|||
170747880|NCT04076020|617082641|FG001|Overall Study|Withdrawal by Subject|8|||
170747881|NCT03537261|617082645|FG000|Overall Study|Lost to Follow-up|4|||
170747882|NCT03537261|617082646|FG001|Overall Study|Lost to Follow-up|5|||
170747883|NCT03537261|617082645|FG000|Overall Study|Withdrawal by Subject|4|||
170747884|NCT03537261|617082646|FG001|Overall Study|Withdrawal by Subject|6|||
170747885|NCT03537261|617082645|FG000|Overall Study|Did not return study questionnaires|0|||
170747886|NCT03537261|617082646|FG001|Overall Study|Did not return study questionnaires|1|||
170747887|NCT00610675|617082647|FG000|Overall Study|Untreated|4|||
170747888|NCT00610675|617082647|FG000|Overall Study|Adverse Event|67|||
170747889|NCT00610675|617082647|FG000|Overall Study|Insufficient Effect|31|||
170747890|NCT00610675|617082647|FG000|Overall Study|Withdrawal by Subject|28|||
170747891|NCT00610675|617082647|FG000|Overall Study|Reasons unrelated to trial|27|||
170747892|NCT00610675|617082647|FG000|Overall Study|Lack of Compliance|7|||
170747893|NCT00610675|617082647|FG000|Overall Study|Lost to Follow-up|31|||
170747894|NCT00610675|617082647|FG000|Overall Study|Other reason (not specified)|25|||
170747895|NCT02056119|617082648|FG000|Overall Study|Death|1|||
170747896|NCT02056119|617082649|FG001|Overall Study|Death|2|||
170747897|NCT02056119|617082648|FG000|Overall Study|Intubated for less than 24 hrs|2|||
170747898|NCT02056119|617082649|FG001|Overall Study|Intubated for less than 24 hrs|7|||
170747899|NCT02056119|617082648|FG000|Overall Study|No aerosol treatments were given.|3|||
170747900|NCT02056119|617082649|FG001|Overall Study|No aerosol treatments were given.|2|||
170747901|NCT02056119|617082648|FG000|Overall Study|Received Metaneb treatment|0|||
170747902|NCT02056119|617082649|FG001|Overall Study|Received Metaneb treatment|2|||
170747903|NCT02056119|617082648|FG000|Overall Study|Protocol Violation|4|||
170747904|NCT02056119|617082649|FG001|Overall Study|Protocol Violation|7|||
170747905|NCT01316692|617082650|FG000|Overall Study|Adverse Event|5|||
170747906|NCT01316692|617082650|FG000|Overall Study|Disease Progression|7|||
170747907|NCT00983619|617082660|FG000|Overall Study|Lost to Follow-up|0|||
170747908|NCT00983619|617082661|FG001|Overall Study|Lost to Follow-up|1|||
170747909|NCT00983619|617082662|FG002|Overall Study|Lost to Follow-up|0|||
170747910|NCT00983619|617082663|FG003|Overall Study|Lost to Follow-up|0|||
170747911|NCT00983619|617082664|FG004|Overall Study|Lost to Follow-up|0|||
170747912|NCT00983619|617082665|FG005|Overall Study|Lost to Follow-up|2|||
170747913|NCT00983619|617082666|FG006|Overall Study|Lost to Follow-up|0|||
170747914|NCT00983619|617082667|FG007|Overall Study|Lost to Follow-up|0|||
170747915|NCT00983619|617082668|FG008|Overall Study|Lost to Follow-up|0|||
170747916|NCT00983619|617082669|FG009|Overall Study|Lost to Follow-up|0|||
170747917|NCT00983619|617082670|FG010|Overall Study|Lost to Follow-up|0|||
170747918|NCT00983619|617082671|FG011|Overall Study|Lost to Follow-up|2|||
170747919|NCT00983619|617082660|FG000|Overall Study|Withdrawal by Subject|2|||
170747920|NCT00983619|617082661|FG001|Overall Study|Withdrawal by Subject|1|||
170747921|NCT00983619|617082662|FG002|Overall Study|Withdrawal by Subject|1|||
170747922|NCT00983619|617082663|FG003|Overall Study|Withdrawal by Subject|3|||
170747923|NCT00983619|617082664|FG004|Overall Study|Withdrawal by Subject|1|||
170747924|NCT00983619|617082665|FG005|Overall Study|Withdrawal by Subject|23|||
170747925|NCT00983619|617082666|FG006|Overall Study|Withdrawal by Subject|0|||
170747926|NCT00983619|617082667|FG007|Overall Study|Withdrawal by Subject|0|||
170747927|NCT00983619|617082668|FG008|Overall Study|Withdrawal by Subject|0|||
170747928|NCT00983619|617082669|FG009|Overall Study|Withdrawal by Subject|0|||
170747929|NCT00983619|617082670|FG010|Overall Study|Withdrawal by Subject|1|||
170747930|NCT00983619|617082671|FG011|Overall Study|Withdrawal by Subject|1|||
170747931|NCT00983619|617082660|FG000|Overall Study|Death|0|||
170747932|NCT00983619|617082661|FG001|Overall Study|Death|2|||
170747933|NCT00983619|617082662|FG002|Overall Study|Death|2|||
170747934|NCT00983619|617082663|FG003|Overall Study|Death|1|||
170747935|NCT00983619|617082664|FG004|Overall Study|Death|2|||
170747936|NCT00983619|617082665|FG005|Overall Study|Death|30|||
170747937|NCT00983619|617082666|FG006|Overall Study|Death|1|||
170747938|NCT00983619|617082667|FG007|Overall Study|Death|0|||
170747939|NCT00983619|617082668|FG008|Overall Study|Death|1|||
170747940|NCT00983619|617082669|FG009|Overall Study|Death|2|||
170747941|NCT00983619|617082670|FG010|Overall Study|Death|9|||
170747942|NCT00983619|617082671|FG011|Overall Study|Death|8|||
170747943|NCT00983619|617082660|FG000|Overall Study|Other|1|||
170747944|NCT00983619|617082661|FG001|Overall Study|Other|0|||
170747945|NCT00983619|617082662|FG002|Overall Study|Other|0|||
170747946|NCT00983619|617082663|FG003|Overall Study|Other|1|||
170747947|NCT00983619|617082664|FG004|Overall Study|Other|0|||
170747948|NCT00983619|617082665|FG005|Overall Study|Other|12|||
170747949|NCT00983619|617082666|FG006|Overall Study|Other|2|||
170747950|NCT00983619|617082667|FG007|Overall Study|Other|2|||
170747951|NCT00983619|617082668|FG008|Overall Study|Other|0|||
170747952|NCT00983619|617082669|FG009|Overall Study|Other|1|||
170747953|NCT00983619|617082670|FG010|Overall Study|Other|1|||
170747954|NCT00983619|617082671|FG011|Overall Study|Other|0|||
170747955|NCT01380990|617082674|FG000|Overall Study|Treatment Failure|1|||
170747956|NCT01380990|617082675|FG001|Overall Study|Treatment Failure|0|||
170747957|NCT01380990|617082674|FG000|Overall Study|Death|0|||
170747958|NCT01380990|617082675|FG001|Overall Study|Death|1|||
170747959|NCT01009047|617082676|FG000|Overall Study|Adverse Event|5|||
170747960|NCT01009047|617082677|FG001|Overall Study|Adverse Event|0|||
170747961|NCT01009047|617082676|FG000|Overall Study|Lost to Follow-up|0|||
170747962|NCT01009047|617082677|FG001|Overall Study|Lost to Follow-up|2|||
170747963|NCT01009047|617082676|FG000|Overall Study|Lack of Efficacy|4|||
170747964|NCT01009047|617082677|FG001|Overall Study|Lack of Efficacy|11|||
170747965|NCT01009047|617082676|FG000|Overall Study|Withdrawal by consent|16|||
170747966|NCT01009047|617082677|FG001|Overall Study|Withdrawal by consent|11|||
170747967|NCT01009047|617082676|FG000|Overall Study|Other|3|||
170747968|NCT01009047|617082677|FG001|Overall Study|Other|2|||
170747969|NCT04716881|617082679|FG000|Overall Study|Adverse Event|1|||
170747970|NCT04716881|617082679|FG000|Overall Study|Lost to Follow-up|1|||
170747971|NCT02443103|617082680|FG000|Overall Study|Adverse Event|2|||
170747972|NCT02443103|617082680|FG000|Overall Study|Noncompliance|1|||
170747973|NCT02366936|617082684|FG000|Overall Study|Withdrawal by Subject|2|||
170747974|NCT02366936|617082684|FG000|Overall Study|Lost to Follow-up|4|||
170747975|NCT02366936|617082684|FG000|Overall Study|Physician Decision|2|||
170747976|NCT00363896|617082686|FG000|Overall Study|Withdrawal by Subject|29|||
170747977|NCT00363896|617082687|FG001|Overall Study|Withdrawal by Subject|16|||
170747978|NCT00363896|617082686|FG000|Overall Study|Adverse Event|24|||
170747979|NCT00363896|617082687|FG001|Overall Study|Adverse Event|13|||
170747980|NCT00363896|617082686|FG000|Overall Study|COPD exacerbation|13|||
170747981|NCT00363896|617082687|FG001|Overall Study|COPD exacerbation|7|||
170747982|NCT00363896|617082686|FG000|Overall Study|Lack of Efficacy|12|||
170747983|NCT00363896|617082687|FG001|Overall Study|Lack of Efficacy|8|||
170747984|NCT00363896|617082686|FG000|Overall Study|Protocol Violation|6|||
170747985|NCT00363896|617082687|FG001|Overall Study|Protocol Violation|1|||
170747986|NCT00363896|617082686|FG000|Overall Study|Lost to Follow-up|3|||
170747987|NCT00363896|617082687|FG001|Overall Study|Lost to Follow-up|0|||
170747988|NCT00363896|617082686|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
170747989|NCT00363896|617082687|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
170747990|NCT00363896|617082686|FG000|Overall Study|Other|1|||
170747991|NCT00363896|617082687|FG001|Overall Study|Other|2|||
170747992|NCT04147260|617082688|FG000|Overall Study|Adverse Event|1|||
170747993|NCT04147260|617082689|FG001|Overall Study|Adverse Event|0|||
170747994|NCT04147260|617082690|FG002|Overall Study|Adverse Event|1|||
170747995|NCT04147260|617082691|FG003|Overall Study|Adverse Event|2|||
170747996|NCT04147260|617082692|FG004|Overall Study|Adverse Event|0|||
170747997|NCT04147260|617082688|FG000|Overall Study|Withdrawal by Subject|0|||
170747998|NCT04147260|617082689|FG001|Overall Study|Withdrawal by Subject|0|||
170747999|NCT04147260|617082690|FG002|Overall Study|Withdrawal by Subject|1|||
170748000|NCT04147260|617082691|FG003|Overall Study|Withdrawal by Subject|1|||
170748001|NCT04147260|617082692|FG004|Overall Study|Withdrawal by Subject|0|||
170748002|NCT01555021|617082693|FG000|Overall Study|Lost to Follow-up|1|||
170748003|NCT01555021|617082694|FG001|Overall Study|Lost to Follow-up|2|||
170748004|NCT01388530|617082695|FG000|Overall Study|Lost to Follow-up|5|||
170748005|NCT01088529|617082696|FG000|Overall Study|Did not receive study treatment|0|||
170748006|NCT01088529|617082697|FG001|Overall Study|Did not receive study treatment|1|||
170748007|NCT03406702|617082700|FG000|Overall Study|Missed Day 27 Dosing|1|||
170748008|NCT00735644|617082703|FG000|Overall Study|Did not receive study vaccine|0|||
170748009|NCT00735644|617082704|FG001|Overall Study|Did not receive study vaccine|1|||
170748010|NCT00735644|617082705|FG002|Overall Study|Did not receive study vaccine|0|||
170748011|NCT00735644|617082706|FG003|Overall Study|Did not receive study vaccine|0|||
170748012|NCT00735644|617082707|FG004|Overall Study|Did not receive study vaccine|0|||
170748013|NCT00735644|617082703|FG000|Overall Study|Withdrawal by Subject|0|||
170748014|NCT00735644|617082704|FG001|Overall Study|Withdrawal by Subject|1|||
170748015|NCT00735644|617082705|FG002|Overall Study|Withdrawal by Subject|1|||
170748016|NCT00735644|617082706|FG003|Overall Study|Withdrawal by Subject|1|||
170748017|NCT00735644|617082707|FG004|Overall Study|Withdrawal by Subject|0|||
170748018|NCT00654940|617084746|FG000|Period 1|Adverse Event|0|||
170748019|NCT00654940|617084747|FG001|Period 1|Adverse Event|1|||
170748020|NCT00654940|617084746|FG000|Period 1|Intolerable Pain Level|1|||
170748021|NCT00654940|617084747|FG001|Period 1|Intolerable Pain Level|0|||
170748022|NCT00742885|617084749|FG000|Overall Study|Lost to Follow-up|1|||
170748023|NCT00742885|617084750|FG001|Overall Study|Lost to Follow-up|0|||
170748024|NCT01852162|617084751|FG000|Overall Study|Adverse Event|1|||
170748025|NCT01852162|617084752|FG001|Overall Study|Adverse Event|0|||
170748026|NCT01852162|617084751|FG000|Overall Study|Withdrawal by Subject|3|||
170748027|NCT01852162|617084752|FG001|Overall Study|Withdrawal by Subject|1|||
170748028|NCT01500226|617084753|FG000|Overall Study|Adverse Event|31|||
170748029|NCT01500226|617084754|FG001|Overall Study|Adverse Event|38|||
170748030|NCT01500226|617084753|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
170748031|NCT01500226|617084754|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
170748032|NCT01500226|617084753|FG000|Overall Study|Withdrawal by Subject|93|||
170748033|NCT01500226|617084754|FG001|Overall Study|Withdrawal by Subject|96|||
170748034|NCT01500226|617084753|FG000|Overall Study|Death|12|||
170748035|NCT01500226|617084754|FG001|Overall Study|Death|4|||
170748036|NCT01500226|617084753|FG000|Overall Study|Disease Progression|16|||
170748037|NCT01500226|617084754|FG001|Overall Study|Disease Progression|14|||
170748038|NCT01500226|617084753|FG000|Overall Study|Protocol Violation|53|||
170748039|NCT01500226|617084754|FG001|Overall Study|Protocol Violation|39|||
170748040|NCT01500226|617084753|FG000|Overall Study|Physician Decision|17|||
170748041|NCT01500226|617084754|FG001|Overall Study|Physician Decision|15|||
170748042|NCT01500226|617084753|FG000|Overall Study|Lack of Efficacy|14|||
170748043|NCT01500226|617084754|FG001|Overall Study|Lack of Efficacy|30|||
170748044|NCT01500226|617084753|FG000|Overall Study|Lost to Follow-up|9|||
170748045|NCT01500226|617084754|FG001|Overall Study|Lost to Follow-up|5|||
170748046|NCT01500226|617084753|FG000|Overall Study|Other Reasons|19|||
170748047|NCT01500226|617084754|FG001|Overall Study|Other Reasons|16|||
170748048|NCT02955277|617084755|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
170748049|NCT02955277|617084756|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
170748050|NCT02955277|617084755|FG000|Post to Follow-up|Lost to Follow-up|8|||
170748051|NCT02955277|617084756|FG001|Post to Follow-up|Lost to Follow-up|11|||
170748052|NCT04212169|617084757|FG000|Overall Study|Adverse Event|0|||
170748053|NCT04212169|617084758|FG001|Overall Study|Adverse Event|0|||
170748054|NCT04212169|617084759|FG002|Overall Study|Adverse Event|0|||
170748055|NCT04212169|617084760|FG003|Overall Study|Adverse Event|2|||
170748056|NCT04212169|617084757|FG000|Overall Study|Lost to Follow-up|1|||
170748057|NCT04212169|617084758|FG001|Overall Study|Lost to Follow-up|0|||
170748058|NCT04212169|617084759|FG002|Overall Study|Lost to Follow-up|0|||
170748059|NCT04212169|617084760|FG003|Overall Study|Lost to Follow-up|2|||
170748060|NCT04212169|617084757|FG000|Overall Study|Withdrawal by Subject|10|||
170748061|NCT04212169|617084758|FG001|Overall Study|Withdrawal by Subject|2|||
170748062|NCT04212169|617084759|FG002|Overall Study|Withdrawal by Subject|5|||
170748063|NCT04212169|617084760|FG003|Overall Study|Withdrawal by Subject|7|||
170748064|NCT04212169|617084757|FG000|Overall Study|Other reason, unspecified|3|||
170748065|NCT04212169|617084758|FG001|Overall Study|Other reason, unspecified|1|||
170748066|NCT04212169|617084759|FG002|Overall Study|Other reason, unspecified|0|||
170748067|NCT04212169|617084760|FG003|Overall Study|Other reason, unspecified|2|||
170748068|NCT02018861|617084764|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
170748069|NCT02018861|617084765|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
170748070|NCT02018861|617084766|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
170748071|NCT02018861|617084767|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
170748072|NCT02018861|617084768|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
170748073|NCT02018861|617084769|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
170748074|NCT02018861|617084770|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
170748075|NCT02018861|617084771|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
170748076|NCT02018861|617084772|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
170748077|NCT02018861|617084773|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
170748078|NCT02018861|617084764|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
170748079|NCT02018861|617084765|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
170748080|NCT02018861|617084766|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
170748081|NCT02018861|617084767|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
170748082|NCT02018861|617084768|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
170748083|NCT02018861|617084769|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
170748084|NCT02018861|617084770|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
170748085|NCT02018861|617084771|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
170748086|NCT02018861|617084772|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
170748087|NCT02018861|617084773|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
170748088|NCT02018861|617084764|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
170748089|NCT02018861|617084765|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
170748090|NCT02018861|617084766|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
170748091|NCT02018861|617084767|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
170748092|NCT02018861|617084768|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
170748093|NCT02018861|617084769|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
170748094|NCT02018861|617084770|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
170748095|NCT02018861|617084771|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
170748096|NCT02018861|617084772|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
170748097|NCT02018861|617084773|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
170748098|NCT02018861|617084764|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
170748099|NCT02018861|617084765|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
170748100|NCT02018861|617084766|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
170748101|NCT02018861|617084767|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
170748102|NCT02018861|617084768|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
170748103|NCT02018861|617084769|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
170748104|NCT02018861|617084770|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
170748105|NCT02018861|617084771|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
170748106|NCT02018861|617084772|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
170748107|NCT02018861|617084773|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
170748108|NCT02018861|617084764|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
170748109|NCT02018861|617084765|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
170748110|NCT02018861|617084766|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
170748111|NCT02018861|617084767|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
170748112|NCT02018861|617084768|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
170748113|NCT02018861|617084769|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
170748114|NCT02018861|617084770|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
170748115|NCT02018861|617084771|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
170748116|NCT02018861|617084772|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
170748117|NCT02018861|617084773|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
170748118|NCT02018861|617084764|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748119|NCT02018861|617084765|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748120|NCT02018861|617084766|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748121|NCT02018861|617084767|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748122|NCT02018861|617084768|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
170748123|NCT02018861|617084769|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748124|NCT02018861|617084770|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748125|NCT02018861|617084771|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748126|NCT02018861|617084772|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748127|NCT02018861|617084773|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
170748128|NCT02018861|617084764|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
170748129|NCT02018861|617084765|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
170748130|NCT02018861|617084766|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
170748131|NCT02018861|617084767|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
170748132|NCT02018861|617084768|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
170748133|NCT02018861|617084769|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
170748134|NCT02018861|617084770|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
170748135|NCT02018861|617084771|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
170748136|NCT02018861|617084772|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
170748137|NCT02018861|617084773|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
170748138|NCT02018861|617084764|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
170748139|NCT02018861|617084765|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
170748140|NCT02018861|617084766|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
170748141|NCT02018861|617084767|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
170748142|NCT02018861|617084768|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
170748143|NCT02018861|617084769|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
170748144|NCT02018861|617084770|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
170748145|NCT02018861|617084771|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
170748146|NCT02018861|617084772|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
170748147|NCT02018861|617084773|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
170748148|NCT02018861|617084764|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
170748149|NCT02018861|617084765|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
170748150|NCT02018861|617084766|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
170748151|NCT02018861|617084767|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
170748152|NCT02018861|617084768|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
170748153|NCT02018861|617084769|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
170748154|NCT02018861|617084770|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
170748155|NCT02018861|617084771|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
170748156|NCT02018861|617084772|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
170748157|NCT02018861|617084773|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
170748158|NCT02018861|617084764|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
170748159|NCT02018861|617084765|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
170748160|NCT02018861|617084766|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
170748161|NCT02018861|617084767|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
170748162|NCT02018861|617084768|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
170748163|NCT02018861|617084769|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
170748164|NCT02018861|617084770|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
170748165|NCT02018861|617084771|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
170748166|NCT02018861|617084772|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
170748167|NCT02018861|617084773|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
170748168|NCT02018861|617084764|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748169|NCT02018861|617084765|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748170|NCT02018861|617084766|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748171|NCT02018861|617084767|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748172|NCT02018861|617084768|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748173|NCT02018861|617084769|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748174|NCT02018861|617084770|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748175|NCT02018861|617084771|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748176|NCT02018861|617084772|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
170748177|NCT02018861|617084773|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
170748178|NCT02018861|617084764|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748179|NCT02018861|617084765|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748180|NCT02018861|617084766|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748181|NCT02018861|617084767|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748182|NCT02018861|617084768|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748183|NCT02018861|617084769|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748184|NCT02018861|617084770|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748185|NCT02018861|617084771|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748186|NCT02018861|617084772|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
170748187|NCT02018861|617084773|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
170748188|NCT02018861|617084764|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170748189|NCT02018861|617084765|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170748190|NCT02018861|617084766|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170748191|NCT02018861|617084767|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170748192|NCT02018861|617084768|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170748193|NCT02018861|617084769|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170748194|NCT02018861|617084770|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170748195|NCT02018861|617084771|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170861466|NCT00723021|617501859|FG003|Intervention Period 4|Adverse Event|0|||
170861467|NCT00723021|617501860|FG004|Intervention Period 4|Adverse Event|1|||
170748196|NCT02018861|617084772|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
170748197|NCT02018861|617084773|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
170748198|NCT01642186|617084774|FG000|Overall Study|Death|0|||
170748199|NCT01642186|617084775|FG001|Overall Study|Death|2|||
170861468|NCT02975700|617501864|FG000|Overall Study|Adverse Event|1|||
170748200|NCT01642186|617084776|FG002|Overall Study|Death|2|||
170748201|NCT01642186|617084774|FG000|Overall Study|Lost to Follow-up|0|||
170748202|NCT01642186|617084775|FG001|Overall Study|Lost to Follow-up|0|||
170748203|NCT01642186|617084776|FG002|Overall Study|Lost to Follow-up|1|||
170748204|NCT00163215|617084777|FG000|Overall Study|Lack of Efficacy|3|||
170748205|NCT00163215|617084777|FG000|Overall Study|Withdrawal by Subject|5|||
170748206|NCT00163215|617084777|FG000|Overall Study|Other|7|||
170748207|NCT01115998|617084778|FG000|Overall Study|Lost to Follow-up|6|||
170748208|NCT01115998|617084779|FG001|Overall Study|Lost to Follow-up|6|||
170748209|NCT00504348|617084780|FG000|Overall Study|Adverse Event|3|||
170748210|NCT00504348|617084780|FG000|Overall Study|Lack of Efficacy|4|||
170748211|NCT00504348|617084780|FG000|Overall Study|Physician Decision|1|||
170748212|NCT01646320|617084781|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
170748213|NCT01646320|617084782|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
170748214|NCT01646320|617084781|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
170748215|NCT01646320|617084782|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
170748216|NCT01646320|617084781|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
170748217|NCT01646320|617084782|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
170748218|NCT01646320|617084781|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
170748219|NCT01646320|617084782|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
170748220|NCT01646320|617084781|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
170748221|NCT01646320|617084782|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
170748222|NCT01646320|617084781|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
170748223|NCT01646320|617084782|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
170748224|NCT01646320|617084781|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
170748225|NCT01646320|617084782|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
170748226|NCT01646320|617084781|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
170748227|NCT01646320|617084782|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
170748228|NCT01646320|617084781|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
170748229|NCT01646320|617084782|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
170748230|NCT01646320|617084781|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
170748231|NCT01646320|617084782|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
170748232|NCT01646320|617084781|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
170748233|NCT01646320|617084782|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
170748234|NCT01489020|617084783|FG000|Overall Study|Withdrawal by Subject|1|||
170748235|NCT01489020|617084784|FG001|Overall Study|Withdrawal by Subject|0|||
170748236|NCT01489020|617084785|FG002|Overall Study|Withdrawal by Subject|0|||
170748237|NCT01489020|617084786|FG003|Overall Study|Withdrawal by Subject|0|||
170748238|NCT01489020|617084787|FG004|Overall Study|Withdrawal by Subject|0|||
170748239|NCT01489020|617084788|FG005|Overall Study|Withdrawal by Subject|0|||
170748240|NCT01489020|617084783|FG000|Overall Study|Adverse Event|0|||
170748241|NCT01489020|617084784|FG001|Overall Study|Adverse Event|0|||
170748242|NCT01489020|617084785|FG002|Overall Study|Adverse Event|3|||
170748243|NCT01489020|617084786|FG003|Overall Study|Adverse Event|0|||
170748244|NCT01489020|617084787|FG004|Overall Study|Adverse Event|3|||
170748245|NCT01489020|617084788|FG005|Overall Study|Adverse Event|0|||
170748246|NCT01489020|617084783|FG000|Overall Study|Concomitant disease|0|||
170748247|NCT01489020|617084784|FG001|Overall Study|Concomitant disease|0|||
170748248|NCT01489020|617084785|FG002|Overall Study|Concomitant disease|0|||
170748249|NCT01489020|617084786|FG003|Overall Study|Concomitant disease|0|||
170748250|NCT01489020|617084787|FG004|Overall Study|Concomitant disease|3|||
170748251|NCT01489020|617084788|FG005|Overall Study|Concomitant disease|0|||
170748252|NCT00627042|617084791|FG000|Overall Study|Withdrawal by Subject|2|||
170748253|NCT00794820|617084792|FG000|Overall Study|Adverse Event|11|||
170748254|NCT00794820|617084792|FG000|Overall Study|Secondary Malignancies|2|||
170748255|NCT00794820|617084792|FG000|Overall Study|Resistant Disease|2|||
170748256|NCT00794820|617084792|FG000|Overall Study|Ineligible/Screen Failure|1|||
170748257|NCT00502996|617084798|FG000|Overall Study|Lost to Follow-up|9|||
170748258|NCT00502996|617084798|FG000|Overall Study|Protocol Violation|2|||
170748259|NCT00502996|617084798|FG000|Overall Study|Treatment failure|25|||
170748260|NCT00502996|617084798|FG000|Overall Study|Withdrawal Informed Consent|6|||
170748261|NCT00502996|617084798|FG000|Overall Study|Adverse Event|2|||
170748262|NCT01458249|617084799|FG000|Overall Study|Not treated|1|||
170748263|NCT01458249|617084799|FG000|Overall Study|Adverse Event|4|||
170748264|NCT01458249|617084799|FG000|Overall Study|Other|2|||
170748265|NCT01458249|617084799|FG000|Overall Study|Ongoing|1|||
170748266|NCT01348854|617084802|FG000|Overall Study|Lost to Follow-up|2|||
170748267|NCT01348854|617084803|FG001|Overall Study|Lost to Follow-up|1|||
170748268|NCT01348854|617084802|FG000|Overall Study|Withdrawal by Subject|1|||
170748269|NCT01348854|617084803|FG001|Overall Study|Withdrawal by Subject|0|||
170748270|NCT03220737|617084804|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
170748271|NCT03220737|617084805|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
170748272|NCT03220737|617084806|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
170748273|NCT03220737|617084807|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
170748274|NCT03220737|617084808|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
170748275|NCT03220737|617084809|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
170748276|NCT03220737|617084810|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
170748277|NCT03220737|617084804|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
170748278|NCT03220737|617084805|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
170748279|NCT03220737|617084806|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
170748280|NCT03220737|617084807|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
170748281|NCT03220737|617084808|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
170748282|NCT03220737|617084809|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
170748283|NCT03220737|617084810|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
170748284|NCT03220737|617084804|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
170748285|NCT03220737|617084805|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
170748286|NCT03220737|617084806|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
170748287|NCT03220737|617084807|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
170748288|NCT03220737|617084808|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
170748289|NCT03220737|617084809|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
170748290|NCT03220737|617084810|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
170748291|NCT03220737|617084804|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
170748292|NCT03220737|617084805|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
170748293|NCT03220737|617084806|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
170748294|NCT03220737|617084807|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
170748295|NCT03220737|617084808|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
170748296|NCT03220737|617084809|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
170748297|NCT03220737|617084810|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
170748298|NCT03220737|617084804|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
170748299|NCT03220737|617084805|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
170748300|NCT03220737|617084806|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
170748301|NCT03220737|617084807|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
170748302|NCT03220737|617084808|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
170748303|NCT03220737|617084809|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
170748304|NCT03220737|617084810|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
170748305|NCT03220737|617084804|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
170748306|NCT03220737|617084805|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
170748307|NCT03220737|617084806|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
170748308|NCT03220737|617084807|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
170748309|NCT03220737|617084808|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
170748310|NCT03220737|617084809|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
170748311|NCT03220737|617084810|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
170748312|NCT03220737|617084804|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
170748313|NCT03220737|617084805|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
170748314|NCT03220737|617084806|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
170748315|NCT03220737|617084807|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
170748316|NCT03220737|617084808|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
170748317|NCT03220737|617084809|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
170748318|NCT03220737|617084810|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
170748319|NCT03220737|617084804|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
170748320|NCT03220737|617084805|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
170748321|NCT03220737|617084806|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
170748322|NCT03220737|617084807|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
170748323|NCT03220737|617084808|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
170748324|NCT03220737|617084809|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
170748325|NCT03220737|617084810|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
170748326|NCT00672958|617084815|FG000|Overall Study|Adverse Event|11|||
170748327|NCT00672958|617084816|FG001|Overall Study|Adverse Event|9|||
170748328|NCT00672958|617084815|FG000|Overall Study|Lack of Efficacy|6|||
170748329|NCT00672958|617084816|FG001|Overall Study|Lack of Efficacy|11|||
170748330|NCT00672958|617084815|FG000|Overall Study|Non-compliance with study drug|2|||
170748331|NCT00672958|617084816|FG001|Overall Study|Non-compliance with study drug|3|||
170748332|NCT00672958|617084815|FG000|Overall Study|Protocol deviations|11|||
170748333|NCT00672958|617084816|FG001|Overall Study|Protocol deviations|5|||
170748334|NCT00672958|617084815|FG000|Overall Study|Voluntary withdrawal|12|||
170748335|NCT00672958|617084816|FG001|Overall Study|Voluntary withdrawal|8|||
170748336|NCT00672958|617084815|FG000|Overall Study|Lost to Follow-up|22|||
170748337|NCT00672958|617084816|FG001|Overall Study|Lost to Follow-up|17|||
170748338|NCT00672958|617084815|FG000|Overall Study|Reason not specified|0|||
170748339|NCT00672958|617084816|FG001|Overall Study|Reason not specified|3|||
170748340|NCT02374593|617084817|FG000|Overall Study|non-compliant|2|||
170748341|NCT02374593|617084818|FG001|Overall Study|non-compliant|0|||
170748342|NCT02878213|617084823|FG000|Overall Study|Withdrawal by Subject|2|||
170748343|NCT02878213|617084823|FG000|Overall Study|Adverse Event|1|||
170748344|NCT01558674|617084824|FG000|Part 1|Study Terminated by Sponsor|10|||
170748345|NCT01558674|617084825|FG001|Part 1|Study Terminated by Sponsor|0|||
170748346|NCT01558674|617084824|FG000|Part 1|Withdrawal by Subject|1|||
170748347|NCT01558674|617084825|FG001|Part 1|Withdrawal by Subject|0|||
170748348|NCT01313923|617084830|FG000|Overall Study|Physician Decision|3|||
170748349|NCT02471404|617084833|FG000|Overall Study|Adverse Event|7|||
170748350|NCT02471404|617084834|FG001|Overall Study|Adverse Event|1|||
170748351|NCT02471404|617084835|FG002|Overall Study|Adverse Event|2|||
170748352|NCT02471404|617084833|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
170748353|NCT02471404|617084834|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
170748354|NCT02471404|617084835|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
170748355|NCT02471404|617084833|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
170748356|NCT02471404|617084834|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
170748357|NCT02471404|617084835|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
170748358|NCT02471404|617084833|FG000|Overall Study|Lost to Follow-up|1|||
170748359|NCT02471404|617084834|FG001|Overall Study|Lost to Follow-up|1|||
170748360|NCT02471404|617084835|FG002|Overall Study|Lost to Follow-up|3|||
170748361|NCT02471404|617084833|FG000|Overall Study|Protocol Violation|1|||
170748362|NCT02471404|617084834|FG001|Overall Study|Protocol Violation|0|||
170748363|NCT02471404|617084835|FG002|Overall Study|Protocol Violation|0|||
170748364|NCT02471404|617084833|FG000|Overall Study|Withdrawal by Subject|8|||
170748365|NCT02471404|617084834|FG001|Overall Study|Withdrawal by Subject|4|||
170748366|NCT02471404|617084835|FG002|Overall Study|Withdrawal by Subject|5|||
170748367|NCT02471404|617084833|FG000|Overall Study|Other reasons not specified|10|||
170748368|NCT02471404|617084834|FG001|Overall Study|Other reasons not specified|7|||
170748369|NCT02471404|617084835|FG002|Overall Study|Other reasons not specified|12|||
170748370|NCT00305864|617084836|FG000|Overall Study|Ineligible / No protocol treatment|0|||
170748371|NCT00305864|617084837|FG001|Overall Study|Ineligible / No protocol treatment|1|||
170748372|NCT00305864|617084838|FG002|Overall Study|Ineligible / No protocol treatment|1|||
170748373|NCT00305864|617084839|FG003|Overall Study|Ineligible / No protocol treatment|13|||
170748374|NCT02204293|617084840|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
170748375|NCT02204293|617084841|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
170748376|NCT02204293|617084842|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
170748377|NCT02204293|617084843|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
170748378|NCT02204293|617084844|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
170748379|NCT02204293|617084845|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
170748380|NCT02204293|617084840|FG000|Core Study Part I|Adverse Event|1|||
170748381|NCT02204293|617084841|FG001|Core Study Part I|Adverse Event|0|||
170748382|NCT02204293|617084842|FG002|Core Study Part I|Adverse Event|0|||
170748383|NCT02204293|617084843|FG003|Core Study Part I|Adverse Event|0|||
170748384|NCT02204293|617084844|FG004|Core Study Part I|Adverse Event|0|||
170748385|NCT02204293|617084845|FG005|Core Study Part I|Adverse Event|0|||
170748386|NCT02204293|617084840|FG000|Core Study Part I|Physician Decision|0|||
170748387|NCT02204293|617084841|FG001|Core Study Part I|Physician Decision|3|||
170748388|NCT02204293|617084842|FG002|Core Study Part I|Physician Decision|0|||
170748389|NCT02204293|617084843|FG003|Core Study Part I|Physician Decision|0|||
170748390|NCT02204293|617084844|FG004|Core Study Part I|Physician Decision|0|||
170748391|NCT02204293|617084845|FG005|Core Study Part I|Physician Decision|0|||
170748392|NCT02204293|617084840|FG000|LTE Phase|Study Suspended|0|||
170748393|NCT02204293|617084841|FG001|LTE Phase|Study Suspended|0|||
170748394|NCT02204293|617084842|FG002|LTE Phase|Study Suspended|0|||
170748395|NCT02204293|617084843|FG003|LTE Phase|Study Suspended|0|||
170748396|NCT02204293|617084844|FG004|LTE Phase|Study Suspended|0|||
170748397|NCT02204293|617084845|FG005|LTE Phase|Study Suspended|7|||
170748398|NCT02420327|617084846|FG000|Overall Study|Adverse Event|7|||
170748399|NCT02420327|617084846|FG000|Overall Study|Pregnancy|1|||
170748400|NCT02420327|617084846|FG000|Overall Study|Withdrawal by Subject|6|||
170748401|NCT02420327|617084846|FG000|Overall Study|Lost to Follow-up|1|||
170748402|NCT02420327|617084846|FG000|Overall Study|Protocol Violation|1|||
170748403|NCT01231503|617084847|FG000|Overall Study|Adverse Event|0|||
170748404|NCT01231503|617084848|FG001|Overall Study|Adverse Event|0|||
170748405|NCT01231503|617084849|FG002|Overall Study|Adverse Event|0|||
170748406|NCT01231503|617084850|FG003|Overall Study|Adverse Event|0|||
170748407|NCT01231503|617084851|FG004|Overall Study|Adverse Event|0|||
170748408|NCT01231503|617084852|FG005|Overall Study|Adverse Event|1|||
170748409|NCT01231503|617084853|FG006|Overall Study|Adverse Event|0|||
170748410|NCT01231503|617084854|FG007|Overall Study|Adverse Event|0|||
170748411|NCT01231503|617084847|FG000|Overall Study|Adverse event, serious fatal|0|||
170748412|NCT01231503|617084848|FG001|Overall Study|Adverse event, serious fatal|0|||
170748413|NCT01231503|617084849|FG002|Overall Study|Adverse event, serious fatal|1|||
170518769|NCT00377637|616246004|FG002|Maintenance Phase|Adverse Event|29|||
170748414|NCT01231503|617084850|FG003|Overall Study|Adverse event, serious fatal|1|||
170748415|NCT01231503|617084851|FG004|Overall Study|Adverse event, serious fatal|0|||
170518770|NCT00377637|616246005|FG003|Maintenance Phase|Adverse Event|43|||
170748416|NCT01231503|617084852|FG005|Overall Study|Adverse event, serious fatal|1|||
170748417|NCT01231503|617084853|FG006|Overall Study|Adverse event, serious fatal|0|||
170748418|NCT01231503|617084854|FG007|Overall Study|Adverse event, serious fatal|0|||
170748419|NCT01231503|617084847|FG000|Overall Study|Withdrawal by Subject|6|||
170748420|NCT01231503|617084848|FG001|Overall Study|Withdrawal by Subject|3|||
170748421|NCT01231503|617084849|FG002|Overall Study|Withdrawal by Subject|3|||
170748422|NCT01231503|617084850|FG003|Overall Study|Withdrawal by Subject|1|||
170748423|NCT01231503|617084851|FG004|Overall Study|Withdrawal by Subject|3|||
170748424|NCT01231503|617084852|FG005|Overall Study|Withdrawal by Subject|5|||
170748425|NCT01231503|617084853|FG006|Overall Study|Withdrawal by Subject|1|||
170748426|NCT01231503|617084854|FG007|Overall Study|Withdrawal by Subject|2|||
170748427|NCT01231503|617084847|FG000|Overall Study|Lost to Follow-up|8|||
170748428|NCT01231503|617084848|FG001|Overall Study|Lost to Follow-up|10|||
170748429|NCT01231503|617084849|FG002|Overall Study|Lost to Follow-up|8|||
170748430|NCT01231503|617084850|FG003|Overall Study|Lost to Follow-up|5|||
170748431|NCT01231503|617084851|FG004|Overall Study|Lost to Follow-up|7|||
170748432|NCT01231503|617084852|FG005|Overall Study|Lost to Follow-up|9|||
170748433|NCT01231503|617084853|FG006|Overall Study|Lost to Follow-up|6|||
170748434|NCT01231503|617084854|FG007|Overall Study|Lost to Follow-up|6|||
170748435|NCT01231503|617084847|FG000|Overall Study|Protocol Violation|0|||
170748436|NCT01231503|617084848|FG001|Overall Study|Protocol Violation|0|||
170748437|NCT01231503|617084849|FG002|Overall Study|Protocol Violation|0|||
170748438|NCT01231503|617084850|FG003|Overall Study|Protocol Violation|1|||
170748439|NCT01231503|617084851|FG004|Overall Study|Protocol Violation|0|||
170748440|NCT01231503|617084852|FG005|Overall Study|Protocol Violation|0|||
170748441|NCT01231503|617084853|FG006|Overall Study|Protocol Violation|0|||
170748442|NCT01231503|617084854|FG007|Overall Study|Protocol Violation|0|||
170748443|NCT01225835|617084857|FG000|Overall Study|Completed protocol|2|||
170748444|NCT01225835|617084858|FG001|Overall Study|Completed protocol|1|||
170748445|NCT01225835|617084857|FG000|Overall Study|Did not meet hCG criterion|2|||
170748446|NCT01225835|617084858|FG001|Overall Study|Did not meet hCG criterion|0|||
170748447|NCT01225835|617084857|FG000|Overall Study|Adverse Event|2|||
170748448|NCT01225835|617084858|FG001|Overall Study|Adverse Event|1|||
170748449|NCT01225835|617084857|FG000|Overall Study|Other|1|||
170748450|NCT01225835|617084858|FG001|Overall Study|Other|1|||
170748451|NCT01146574|617084859|FG000|Overall Study|Death|0|||
170748452|NCT01146574|617084860|FG001|Overall Study|Death|1|||
170748453|NCT01146574|617084861|FG002|Overall Study|Death|1|||
170748454|NCT01146574|617084862|FG003|Overall Study|Death|0|||
170748455|NCT01146574|617084863|FG004|Overall Study|Death|0|||
170748456|NCT01146574|617084864|FG005|Overall Study|Death|0|||
170748457|NCT01146574|617084865|FG006|Overall Study|Death|0|||
170748458|NCT01146574|617084859|FG000|Overall Study|Other reasons|0|||
170748459|NCT01146574|617084860|FG001|Overall Study|Other reasons|0|||
170748460|NCT01146574|617084861|FG002|Overall Study|Other reasons|3|||
170748461|NCT01146574|617084862|FG003|Overall Study|Other reasons|0|||
170748462|NCT01146574|617084863|FG004|Overall Study|Other reasons|0|||
170748463|NCT01146574|617084864|FG005|Overall Study|Other reasons|0|||
170748464|NCT01146574|617084865|FG006|Overall Study|Other reasons|0|||
170748465|NCT01146574|617084859|FG000|Overall Study|Kidney transplant|0|||
170748466|NCT01146574|617084860|FG001|Overall Study|Kidney transplant|0|||
170748467|NCT01146574|617084861|FG002|Overall Study|Kidney transplant|1|||
170748468|NCT01146574|617084862|FG003|Overall Study|Kidney transplant|1|||
170748469|NCT01146574|617084863|FG004|Overall Study|Kidney transplant|0|||
170748470|NCT01146574|617084864|FG005|Overall Study|Kidney transplant|0|||
170748471|NCT01146574|617084865|FG006|Overall Study|Kidney transplant|0|||
170748472|NCT01146574|617084859|FG000|Overall Study|Withdrew consent|0|||
170748473|NCT01146574|617084860|FG001|Overall Study|Withdrew consent|0|||
170748474|NCT01146574|617084861|FG002|Overall Study|Withdrew consent|1|||
170748475|NCT01146574|617084862|FG003|Overall Study|Withdrew consent|1|||
170748476|NCT01146574|617084863|FG004|Overall Study|Withdrew consent|2|||
170748477|NCT01146574|617084864|FG005|Overall Study|Withdrew consent|1|||
170748478|NCT01146574|617084865|FG006|Overall Study|Withdrew consent|1|||
170748479|NCT01266993|617084868|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
170748480|NCT01266993|617084869|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
170748481|NCT01266993|617084868|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
170748482|NCT01266993|617084869|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
170748483|NCT03051659|617084870|FG000|Treatment Period|Withdrawal by Subject|0|||
170748484|NCT03051659|617084871|FG001|Treatment Period|Withdrawal by Subject|2|||
170748485|NCT03051659|617084870|FG000|Survival Follow-up|Lost to Follow-up|23|||
170748486|NCT03051659|617084871|FG001|Survival Follow-up|Lost to Follow-up|22|||
170748487|NCT04779242|617084872|FG000|Overall Study|Adverse Event|1|||
170748488|NCT04779242|617084873|FG001|Overall Study|Adverse Event|1|||
170748489|NCT04779242|617084872|FG000|Overall Study|Lost to Follow-up|2|||
170748490|NCT04779242|617084873|FG001|Overall Study|Lost to Follow-up|4|||
170748491|NCT04779242|617084872|FG000|Overall Study|Withdrawal by Subject|7|||
170748492|NCT04779242|617084873|FG001|Overall Study|Withdrawal by Subject|9|||
170748493|NCT04779242|617084872|FG000|Overall Study|Death|6|||
170748494|NCT04779242|617084873|FG001|Overall Study|Death|6|||
170748495|NCT04779242|617084872|FG000|Overall Study|COVID-19 related reasons|2|||
170748496|NCT04779242|617084873|FG001|Overall Study|COVID-19 related reasons|1|||
170748497|NCT04779242|617084872|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
170748498|NCT04779242|617084873|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
170748499|NCT04779242|617084872|FG000|Overall Study|Martial Law in Ukraine|2|||
170748500|NCT04779242|617084873|FG001|Overall Study|Martial Law in Ukraine|3|||
170748501|NCT00849680|617084878|FG000|Overall Study|Adverse Event|0|||
170748502|NCT00849680|617084879|FG001|Overall Study|Adverse Event|0|||
170748503|NCT00849680|617084880|FG002|Overall Study|Adverse Event|0|||
170748504|NCT00849680|617084881|FG003|Overall Study|Adverse Event|0|||
170748505|NCT00849680|617084882|FG004|Overall Study|Adverse Event|0|||
170748506|NCT00849680|617084883|FG005|Overall Study|Adverse Event|0|||
170748507|NCT00849680|617084884|FG006|Overall Study|Adverse Event|2|||
170748508|NCT00849680|617084885|FG007|Overall Study|Adverse Event|0|||
170748509|NCT00849680|617084878|FG000|Overall Study|Lost to Follow-up|7|||
170748510|NCT00849680|617084879|FG001|Overall Study|Lost to Follow-up|3|||
170748511|NCT00849680|617084880|FG002|Overall Study|Lost to Follow-up|12|||
170748512|NCT00849680|617084881|FG003|Overall Study|Lost to Follow-up|11|||
170748513|NCT00849680|617084882|FG004|Overall Study|Lost to Follow-up|8|||
170748514|NCT00849680|617084883|FG005|Overall Study|Lost to Follow-up|11|||
170748515|NCT00849680|617084884|FG006|Overall Study|Lost to Follow-up|12|||
170748516|NCT00849680|617084885|FG007|Overall Study|Lost to Follow-up|5|||
170748517|NCT00849680|617084878|FG000|Overall Study|Subject moved|1|||
170748518|NCT00849680|617084879|FG001|Overall Study|Subject moved|0|||
170748519|NCT00849680|617084880|FG002|Overall Study|Subject moved|3|||
170748520|NCT00849680|617084881|FG003|Overall Study|Subject moved|1|||
170748521|NCT00849680|617084882|FG004|Overall Study|Subject moved|0|||
170748522|NCT00849680|617084883|FG005|Overall Study|Subject moved|2|||
170748523|NCT00849680|617084884|FG006|Overall Study|Subject moved|2|||
170748524|NCT00849680|617084885|FG007|Overall Study|Subject moved|2|||
170748525|NCT00849680|617084878|FG000|Overall Study|Withdrawal by Subject|2|||
170748526|NCT00849680|617084879|FG001|Overall Study|Withdrawal by Subject|0|||
170748527|NCT00849680|617084880|FG002|Overall Study|Withdrawal by Subject|0|||
170748528|NCT00849680|617084881|FG003|Overall Study|Withdrawal by Subject|2|||
170748529|NCT00849680|617084882|FG004|Overall Study|Withdrawal by Subject|2|||
170748530|NCT00849680|617084883|FG005|Overall Study|Withdrawal by Subject|2|||
170748531|NCT00849680|617084884|FG006|Overall Study|Withdrawal by Subject|1|||
170748532|NCT00849680|617084885|FG007|Overall Study|Withdrawal by Subject|1|||
170748533|NCT00849680|617084878|FG000|Overall Study|Subject unable to comply with protocol|1|||
170748534|NCT00849680|617084879|FG001|Overall Study|Subject unable to comply with protocol|0|||
170748535|NCT00849680|617084880|FG002|Overall Study|Subject unable to comply with protocol|0|||
170748536|NCT00849680|617084881|FG003|Overall Study|Subject unable to comply with protocol|0|||
170748537|NCT00849680|617084882|FG004|Overall Study|Subject unable to comply with protocol|0|||
170748538|NCT00849680|617084883|FG005|Overall Study|Subject unable to comply with protocol|0|||
170748539|NCT00849680|617084884|FG006|Overall Study|Subject unable to comply with protocol|0|||
170748540|NCT00849680|617084885|FG007|Overall Study|Subject unable to comply with protocol|0|||
170748541|NCT02087150|617084888|FG000|Overall Study|Death|0|||
170748542|NCT02087150|617084889|FG001|Overall Study|Death|1|||
170748543|NCT02087150|617084890|FG002|Overall Study|Death|0|||
170748544|NCT02087150|617084888|FG000|Overall Study|Lost to Follow-up|6|||
170748545|NCT02087150|617084889|FG001|Overall Study|Lost to Follow-up|13|||
170748546|NCT02087150|617084890|FG002|Overall Study|Lost to Follow-up|7|||
170748547|NCT02087150|617084888|FG000|Overall Study|Withdrawal by Subject|2|||
170748548|NCT02087150|617084889|FG001|Overall Study|Withdrawal by Subject|5|||
170748549|NCT02087150|617084890|FG002|Overall Study|Withdrawal by Subject|3|||
170748550|NCT02087150|617084888|FG000|Overall Study|Physician Decision|0|||
170748551|NCT02087150|617084889|FG001|Overall Study|Physician Decision|1|||
170748552|NCT02087150|617084890|FG002|Overall Study|Physician Decision|0|||
170748553|NCT02087150|617084888|FG000|Overall Study|Procedure not done|1|||
170748554|NCT02087150|617084889|FG001|Overall Study|Procedure not done|13|||
170748555|NCT02087150|617084890|FG002|Overall Study|Procedure not done|0|||
170748556|NCT02087150|617084888|FG000|Overall Study|F/U not completed w/in study window|0|||
170748557|NCT02087150|617084889|FG001|Overall Study|F/U not completed w/in study window|0|||
170748558|NCT02087150|617084890|FG002|Overall Study|F/U not completed w/in study window|1|||
170748559|NCT02087150|617084888|FG000|Overall Study|Other|1|||
170748560|NCT02087150|617084889|FG001|Overall Study|Other|0|||
170748561|NCT02087150|617084890|FG002|Overall Study|Other|0|||
170748562|NCT02087150|617084888|FG000|Overall Study|Pt moved out of town|0|||
170748563|NCT02087150|617084889|FG001|Overall Study|Pt moved out of town|1|||
170748564|NCT02087150|617084890|FG002|Overall Study|Pt moved out of town|0|||
170748565|NCT04230980|617084894|FG000|Overall Study|Lost to Follow-up|1|||
170748566|NCT04230980|617084895|FG001|Overall Study|Lost to Follow-up|2|||
170748567|NCT04230980|617084894|FG000|Overall Study|Adverse Event|0|||
170748568|NCT04230980|617084895|FG001|Overall Study|Adverse Event|1|||
170748569|NCT02269943|617084896|FG000|Treatment Period|Death|0|||
170748570|NCT02269943|617084897|FG001|Treatment Period|Death|1|||
170748571|NCT02269943|617084896|FG000|Treatment Period|Adverse Event|1|||
170748572|NCT02269943|617084897|FG001|Treatment Period|Adverse Event|10|||
170748573|NCT02269943|617084896|FG000|Treatment Period|Progressive Disease|5|||
170748574|NCT02269943|617084897|FG001|Treatment Period|Progressive Disease|17|||
170748575|NCT02269943|617084896|FG000|Treatment Period|Symptomatic Deterioration|0|||
170748576|NCT02269943|617084897|FG001|Treatment Period|Symptomatic Deterioration|2|||
170748577|NCT02269943|617084896|FG000|Follow-Up Survival Period|Death|3|||
170748578|NCT02269943|617084897|FG001|Follow-Up Survival Period|Death|16|||
170748579|NCT02269943|617084896|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
170748580|NCT02269943|617084897|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
170748581|NCT02269943|617084896|FG000|Follow-Up Survival Period|Alive|2|||
170748582|NCT02269943|617084897|FG001|Follow-Up Survival Period|Alive|8|||
170748583|NCT03018106|617084899|FG000|Overall Study|Lost to Follow-up|0|||
170748584|NCT03018106|617084900|FG001|Overall Study|Lost to Follow-up|1|||
170748585|NCT01994720|617084901|FG000|Overall Study|Withdrawal by Subject|46|||
170748586|NCT01994720|617084902|FG001|Overall Study|Withdrawal by Subject|56|||
170748587|NCT00967018|617084903|FG000|Overall Study|Adverse Event|2|||
170748588|NCT00967018|617084903|FG000|Overall Study|Physician Decision|7|||
170748589|NCT00967018|617084903|FG000|Overall Study|Lost to Follow-up|2|||
170748590|NCT00967018|617084903|FG000|Overall Study|Withdrawal by Subject|1|||
170748591|NCT00967018|617084903|FG000|Overall Study|Miscellaneous Reasons|9|||
170748592|NCT00960752|617084905|FG000|Overall Study|Adverse Event|0|||
170748593|NCT00960752|617084906|FG001|Overall Study|Adverse Event|0|||
170748594|NCT00960752|617084907|FG002|Overall Study|Adverse Event|1|||
170748595|NCT00960752|617084905|FG000|Overall Study|Progression|0|||
170748596|NCT00960752|617084906|FG001|Overall Study|Progression|0|||
170748597|NCT00960752|617084907|FG002|Overall Study|Progression|1|||
170748598|NCT01794117|617084908|FG000|Overall Study|Adverse Event|1|||
170748599|NCT01794117|617084909|FG001|Overall Study|Adverse Event|0|||
170748600|NCT01794117|617084910|FG002|Overall Study|Adverse Event|0|||
170748601|NCT01794117|617084911|FG003|Overall Study|Adverse Event|0|||
170748602|NCT01794117|617084908|FG000|Overall Study|Participant noncompliance|0|||
170748603|NCT01794117|617084909|FG001|Overall Study|Participant noncompliance|1|||
170748604|NCT01794117|617084910|FG002|Overall Study|Participant noncompliance|0|||
170748605|NCT01794117|617084911|FG003|Overall Study|Participant noncompliance|0|||
170748606|NCT01794117|617084908|FG000|Overall Study|Refused further treatment|0|||
170748607|NCT01794117|617084909|FG001|Overall Study|Refused further treatment|2|||
170748608|NCT01794117|617084910|FG002|Overall Study|Refused further treatment|0|||
170748609|NCT01794117|617084911|FG003|Overall Study|Refused further treatment|0|||
170748610|NCT00655551|617084912|FG000|All Periods Combined|Adverse Event|0|||
170748611|NCT00655551|617084913|FG001|All Periods Combined|Adverse Event|3|||
170748612|NCT00655551|617084914|FG002|All Periods Combined|Adverse Event|4|||
170748613|NCT00655551|617084912|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
170748614|NCT00655551|617084913|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
170748615|NCT00655551|617084914|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
170748616|NCT00655551|617084912|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
170748617|NCT00655551|617084913|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
170748618|NCT00655551|617084914|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
170748619|NCT00655551|617084912|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
170748620|NCT00655551|617084913|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
170748621|NCT00655551|617084914|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
170748622|NCT02855164|617084915|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
170748623|NCT02855164|617084916|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
170748624|NCT02855164|617084917|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
170748625|NCT02855164|617084918|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
170748626|NCT02855164|617084919|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
170748627|NCT02855164|617084920|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
170748628|NCT02855164|617084921|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
170748629|NCT02855164|617084922|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
170748630|NCT02855164|617084915|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
170748631|NCT02855164|617084916|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
170748632|NCT02855164|617084917|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
170748633|NCT02855164|617084918|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
170748634|NCT02855164|617084919|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
170748635|NCT02855164|617084920|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
170748636|NCT02855164|617084921|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
170748637|NCT02855164|617084922|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
170748638|NCT02855164|617084915|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
170748639|NCT02855164|617084916|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
170748640|NCT02855164|617084917|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
170748641|NCT02855164|617084918|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
170748642|NCT02855164|617084919|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
170748643|NCT02855164|617084920|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
170748644|NCT02855164|617084921|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
170748645|NCT02855164|617084922|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
170748646|NCT02855164|617084915|FG000|Part C (Randomized Set)|Adverse Event|0|||
170748647|NCT02855164|617084916|FG001|Part C (Randomized Set)|Adverse Event|0|||
170402157|NCT04682639|615813352|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
170748648|NCT02855164|617084917|FG002|Part C (Randomized Set)|Adverse Event|0|||
170748649|NCT02855164|617084918|FG003|Part C (Randomized Set)|Adverse Event|0|||
170748650|NCT02855164|617084919|FG004|Part C (Randomized Set)|Adverse Event|0|||
170748651|NCT02855164|617084920|FG005|Part C (Randomized Set)|Adverse Event|5|||
170748652|NCT02855164|617084921|FG006|Part C (Randomized Set)|Adverse Event|9|||
170748653|NCT02855164|617084922|FG007|Part C (Randomized Set)|Adverse Event|2|||
170748654|NCT02855164|617084915|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
170748655|NCT02855164|617084916|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
170748656|NCT02855164|617084917|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
170748657|NCT02855164|617084918|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
170748658|NCT02855164|617084919|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
170748659|NCT02855164|617084920|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
170748660|NCT02855164|617084921|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
170748661|NCT02855164|617084922|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
170748662|NCT02855164|617084915|FG000|Part C (Randomized Set)|Physician Decision|0|||
170748663|NCT02855164|617084916|FG001|Part C (Randomized Set)|Physician Decision|0|||
170748664|NCT02855164|617084917|FG002|Part C (Randomized Set)|Physician Decision|0|||
170748665|NCT02855164|617084918|FG003|Part C (Randomized Set)|Physician Decision|0|||
170748666|NCT02855164|617084919|FG004|Part C (Randomized Set)|Physician Decision|0|||
170748667|NCT02855164|617084920|FG005|Part C (Randomized Set)|Physician Decision|1|||
170748668|NCT02855164|617084921|FG006|Part C (Randomized Set)|Physician Decision|0|||
170748669|NCT02855164|617084922|FG007|Part C (Randomized Set)|Physician Decision|1|||
170748670|NCT02855164|617084915|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
170748671|NCT02855164|617084916|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
170748672|NCT02855164|617084917|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
170748673|NCT02855164|617084918|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
170748674|NCT02855164|617084919|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
170748675|NCT02855164|617084920|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
170748676|NCT02855164|617084921|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
170748677|NCT02855164|617084922|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
170748678|NCT00384059|617084923|FG000|Infant Series|Not consented|2|||
170748679|NCT00384059|617084924|FG001|Infant Series|Not consented|6|||
170748680|NCT00384059|617084923|FG000|Infant Series|Withdrawal by Subject|2|||
170748681|NCT00384059|617084924|FG001|Infant Series|Withdrawal by Subject|2|||
170748682|NCT00384059|617084923|FG000|Infant Series|Adverse Event|1|||
170748683|NCT00384059|617084924|FG001|Infant Series|Adverse Event|2|||
170748684|NCT00384059|617084923|FG000|Infant Series|Protocol Violation|1|||
170748685|NCT00384059|617084924|FG001|Infant Series|Protocol Violation|2|||
170748686|NCT00384059|617084923|FG000|Infant Series|Lost to Follow-up|0|||
170748687|NCT00384059|617084924|FG001|Infant Series|Lost to Follow-up|1|||
170748688|NCT00384059|617084923|FG000|After Infant Series|Protocol Violation|2|||
170748689|NCT00384059|617084924|FG001|After Infant Series|Protocol Violation|3|||
170748690|NCT00384059|617084923|FG000|After Infant Series|Withdrawal by Subject|2|||
170748691|NCT00384059|617084924|FG001|After Infant Series|Withdrawal by Subject|2|||
170748692|NCT00384059|617084923|FG000|After Infant Series|Failed to Return|0|||
170748693|NCT00384059|617084924|FG001|After Infant Series|Failed to Return|2|||
170748694|NCT00384059|617084923|FG000|After Infant Series|Adverse Event|0|||
170748695|NCT00384059|617084924|FG001|After Infant Series|Adverse Event|1|||
170748696|NCT00384059|617084923|FG000|After Infant Series|Physician Decision|0|||
170748697|NCT00384059|617084924|FG001|After Infant Series|Physician Decision|1|||
170748698|NCT00384059|617084923|FG000|After Infant Series|Lost to Follow-up|0|||
170748699|NCT00384059|617084924|FG001|After Infant Series|Lost to Follow-up|1|||
170748700|NCT00384059|617084923|FG000|Toddler Dose|Lost to Follow-up|1|||
170748701|NCT00384059|617084924|FG001|Toddler Dose|Lost to Follow-up|1|||
170748702|NCT00384059|617084923|FG000|Toddler Dose|Failed to return|0|||
170748703|NCT00384059|617084924|FG001|Toddler Dose|Failed to return|1|||
170748704|NCT02169830|617086288|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
170748705|NCT02169830|617086289|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
170748706|NCT02169830|617086290|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
170748707|NCT02169830|617086288|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
170748708|NCT02169830|617086289|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
170748709|NCT02169830|617086290|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
170748710|NCT02169830|617086288|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
170748711|NCT02169830|617086289|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
170748712|NCT02169830|617086290|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
170748713|NCT02169830|617086288|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
170748714|NCT02169830|617086289|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
170748715|NCT02169830|617086290|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
170748716|NCT02169830|617086288|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
170861469|NCT02975700|617501864|FG000|Overall Study|Progressive disease|3|||
170402158|NCT04682639|615813348|FG000|OLE Period (28 Weeks)|Other|1|||
170861470|NCT02975700|617501864|FG000|Overall Study|Failed screening criteria|2|||
170861471|NCT01910181|617501865|FG000|Overall Study|Death|37|||
170748717|NCT02169830|617086289|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
170748718|NCT02169830|617086290|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
170748719|NCT03095599|617086291|FG000|Overall Study|Withdrawal by Subject|1|||
170748720|NCT03095599|617086292|FG001|Overall Study|Withdrawal by Subject|0|||
170748721|NCT03095599|617086291|FG000|Overall Study|Lost to Follow-up|1|||
170748722|NCT03095599|617086292|FG001|Overall Study|Lost to Follow-up|0|||
170748723|NCT03095599|617086291|FG000|Overall Study|Withdrawal prior to vaccination|1|||
170748724|NCT03095599|617086292|FG001|Overall Study|Withdrawal prior to vaccination|0|||
170748725|NCT00513019|617086294|FG000|Overall Study|Adverse Event|1|||
170748726|NCT00513019|617086295|FG001|Overall Study|Adverse Event|0|||
170748727|NCT00513019|617086294|FG000|Overall Study|Withdrawal by Subject|4|||
170748728|NCT00513019|617086295|FG001|Overall Study|Withdrawal by Subject|5|||
170748729|NCT00777803|617086298|FG000|Overall Study|Lost to Follow-up|12|||
170748730|NCT00777803|617086299|FG001|Overall Study|Lost to Follow-up|5|||
170748731|NCT00777803|617086298|FG000|Overall Study|Adverse Event|1|||
170748732|NCT00777803|617086299|FG001|Overall Study|Adverse Event|0|||
170748733|NCT00777803|617086298|FG000|Overall Study|Non-compliance|2|||
170748734|NCT00777803|617086299|FG001|Overall Study|Non-compliance|2|||
170748735|NCT01755689|617086300|FG000|Overall Study|Withdrawal by Subject|1|||
170748736|NCT01755689|617086301|FG001|Overall Study|Withdrawal by Subject|3|||
170748737|NCT01755689|617086302|FG002|Overall Study|Withdrawal by Subject|2|||
170748738|NCT01755689|617086303|FG003|Overall Study|Withdrawal by Subject|1|||
170748739|NCT01755689|617086304|FG004|Overall Study|Withdrawal by Subject|1|||
170748740|NCT01755689|617086300|FG000|Overall Study|Migrated/moved from study area|0|||
170748741|NCT01755689|617086301|FG001|Overall Study|Migrated/moved from study area|1|||
170748742|NCT01755689|617086302|FG002|Overall Study|Migrated/moved from study area|1|||
170748743|NCT01755689|617086303|FG003|Overall Study|Migrated/moved from study area|1|||
170748744|NCT01755689|617086304|FG004|Overall Study|Migrated/moved from study area|1|||
170748745|NCT01755689|617086300|FG000|Overall Study|Lost to Follow-up|1|||
170748746|NCT01755689|617086301|FG001|Overall Study|Lost to Follow-up|0|||
170748747|NCT01755689|617086302|FG002|Overall Study|Lost to Follow-up|1|||
170748748|NCT01755689|617086303|FG003|Overall Study|Lost to Follow-up|0|||
170748749|NCT01755689|617086304|FG004|Overall Study|Lost to Follow-up|2|||
170748750|NCT01755689|617086300|FG000|Overall Study|Pregnancy|1|||
170748751|NCT01755689|617086301|FG001|Overall Study|Pregnancy|1|||
170748752|NCT01755689|617086302|FG002|Overall Study|Pregnancy|2|||
170748753|NCT01755689|617086303|FG003|Overall Study|Pregnancy|4|||
170748754|NCT01755689|617086304|FG004|Overall Study|Pregnancy|2|||
170748755|NCT01004250|617086305|FG000|Induction Therapy Period|Adverse Event|10|||
170748756|NCT01004250|617086305|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
170748757|NCT01004250|617086305|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
170748758|NCT01004250|617086305|FG000|Induction Therapy Period|Physician Decision|2|||
170748759|NCT01004250|617086305|FG000|Maintenance Therapy Period|Adverse Event|15|||
170748760|NCT01004250|617086305|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
170748761|NCT01004250|617086305|FG000|Maintenance Therapy Period|Protocol Violation|1|||
170748762|NCT01004250|617086305|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
170748763|NCT01004250|617086305|FG000|Maintenance Therapy Period|Physician Decision|4|||
170748764|NCT01004250|617086305|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
170748765|NCT00322868|617086306|FG000|Overall Study|disease progression|1|||
170748766|NCT00962585|617086317|FG000|Overall Study|Adverse Event|0|||
170748767|NCT00962585|617086318|FG001|Overall Study|Adverse Event|2|||
170748768|NCT00962585|617086319|FG002|Overall Study|Adverse Event|1|||
170748769|NCT00962585|617086320|FG003|Overall Study|Adverse Event|0|||
170748770|NCT00962585|617086317|FG000|Overall Study|Lost to Follow-up|3|||
170748771|NCT00962585|617086318|FG001|Overall Study|Lost to Follow-up|0|||
170748772|NCT00962585|617086319|FG002|Overall Study|Lost to Follow-up|1|||
170748773|NCT00962585|617086320|FG003|Overall Study|Lost to Follow-up|0|||
170748774|NCT00962585|617086317|FG000|Overall Study|Protocol Violation|0|||
170748775|NCT00962585|617086318|FG001|Overall Study|Protocol Violation|0|||
170748776|NCT00962585|617086319|FG002|Overall Study|Protocol Violation|1|||
170748777|NCT00962585|617086320|FG003|Overall Study|Protocol Violation|0|||
170748778|NCT00962585|617086317|FG000|Overall Study|Withdrawal by Subject|1|||
170748779|NCT00962585|617086318|FG001|Overall Study|Withdrawal by Subject|0|||
170748780|NCT00962585|617086319|FG002|Overall Study|Withdrawal by Subject|0|||
170748781|NCT00962585|617086320|FG003|Overall Study|Withdrawal by Subject|0|||
170748782|NCT00962585|617086317|FG000|Overall Study|Withdrew Consent|2|||
170748783|NCT00962585|617086318|FG001|Overall Study|Withdrew Consent|0|||
170748784|NCT00962585|617086319|FG002|Overall Study|Withdrew Consent|0|||
170748785|NCT00962585|617086320|FG003|Overall Study|Withdrew Consent|0|||
170748786|NCT01950273|617086323|FG000|Overall Study|Protocol Violation|1|||
170748787|NCT01950273|617086324|FG001|Overall Study|Protocol Violation|0|||
170748788|NCT01950273|617086323|FG000|Overall Study|Withdrawal by Subject|2|||
170748789|NCT01950273|617086324|FG001|Overall Study|Withdrawal by Subject|0|||
170748790|NCT01950273|617086323|FG000|Overall Study|Other not defined above|1|||
170748791|NCT01950273|617086324|FG001|Overall Study|Other not defined above|0|||
170748792|NCT02264574|617086327|FG000|Overall Study|Death|21|||
170748793|NCT02264574|617086328|FG001|Overall Study|Death|21|||
170748794|NCT02264574|617086327|FG000|Overall Study|Withdrawal by Subject|8|||
170748795|NCT02264574|617086328|FG001|Overall Study|Withdrawal by Subject|6|||
170748796|NCT02264574|617086327|FG000|Overall Study|Other, Not Specified|0|||
170748797|NCT02264574|617086328|FG001|Overall Study|Other, Not Specified|3|||
170748798|NCT00432679|617086329|FG000|Overall Study|Adverse Event|2|||
170748799|NCT00432679|617086330|FG001|Overall Study|Adverse Event|1|||
170748800|NCT00432679|617086329|FG000|Overall Study|Withdrawal by Subject|3|||
170748801|NCT00432679|617086330|FG001|Overall Study|Withdrawal by Subject|2|||
170748802|NCT02207374|617086335|FG000|Overall Study|Withdrawal by Subject|5|||
170748803|NCT02207374|617086336|FG001|Overall Study|Withdrawal by Subject|9|||
170748804|NCT02207374|617086337|FG002|Overall Study|Withdrawal by Subject|4|||
170748805|NCT02207374|617086335|FG000|Overall Study|Death|1|||
170748806|NCT02207374|617086336|FG001|Overall Study|Death|0|||
170748807|NCT02207374|617086337|FG002|Overall Study|Death|1|||
170748808|NCT02207374|617086335|FG000|Overall Study|Missing follow-up information|0|||
170748809|NCT02207374|617086336|FG001|Overall Study|Missing follow-up information|1|||
170748810|NCT02207374|617086337|FG002|Overall Study|Missing follow-up information|1|||
170748811|NCT00322374|617086338|FG000|Starting Dose|Physician Decision|2|||
170748812|NCT00322374|617086339|FG001|Starting Dose|Physician Decision|0|||
170748813|NCT00322374|617086340|FG002|Starting Dose|Physician Decision|0|||
170748814|NCT00322374|617086341|FG003|Starting Dose|Physician Decision|0|||
170748815|NCT00322374|617086338|FG000|Starting Dose|Study Drug Toxicity|4|||
170748816|NCT00322374|617086339|FG001|Starting Dose|Study Drug Toxicity|0|||
170748817|NCT00322374|617086340|FG002|Starting Dose|Study Drug Toxicity|0|||
170748818|NCT00322374|617086341|FG003|Starting Dose|Study Drug Toxicity|0|||
170748819|NCT00322374|617086338|FG000|First Escalation|Documented Disease Progression|0|||
170748820|NCT00322374|617086339|FG001|First Escalation|Documented Disease Progression|6|||
170748821|NCT00322374|617086340|FG002|First Escalation|Documented Disease Progression|0|||
170748822|NCT00322374|617086341|FG003|First Escalation|Documented Disease Progression|0|||
170748823|NCT00322374|617086338|FG000|First Escalation|Physician Decision|0|||
170748824|NCT00322374|617086339|FG001|First Escalation|Physician Decision|12|||
170748825|NCT00322374|617086340|FG002|First Escalation|Physician Decision|0|||
170748826|NCT00322374|617086341|FG003|First Escalation|Physician Decision|0|||
170748827|NCT00322374|617086338|FG000|First Escalation|Study Drug Toxicity|0|||
170748828|NCT00322374|617086339|FG001|First Escalation|Study Drug Toxicity|11|||
170748829|NCT00322374|617086340|FG002|First Escalation|Study Drug Toxicity|0|||
170748830|NCT00322374|617086341|FG003|First Escalation|Study Drug Toxicity|0|||
170748831|NCT00322374|617086338|FG000|First Escalation|Participant Request|0|||
170748832|NCT00322374|617086339|FG001|First Escalation|Participant Request|1|||
170748833|NCT00322374|617086340|FG002|First Escalation|Participant Request|0|||
170748834|NCT00322374|617086341|FG003|First Escalation|Participant Request|0|||
170748835|NCT00322374|617086338|FG000|Second Escalation|Physician Decision|0|||
170748836|NCT00322374|617086339|FG001|Second Escalation|Physician Decision|0|||
170748837|NCT00322374|617086340|FG002|Second Escalation|Physician Decision|5|||
170748838|NCT00322374|617086341|FG003|Second Escalation|Physician Decision|0|||
170748839|NCT00322374|617086338|FG000|Second Escalation|Study Drug Toxicity|0|||
170748840|NCT00322374|617086339|FG001|Second Escalation|Study Drug Toxicity|0|||
170748841|NCT00322374|617086340|FG002|Second Escalation|Study Drug Toxicity|1|||
170748842|NCT00322374|617086341|FG003|Second Escalation|Study Drug Toxicity|0|||
170748843|NCT01448044|617086344|FG000|Treatment Period|Adverse Event|4|||
170748844|NCT01448044|617086345|FG001|Treatment Period|Adverse Event|3|||
170748845|NCT01448044|617086344|FG000|Treatment Period|Lack of Efficacy|5|||
170748846|NCT01448044|617086345|FG001|Treatment Period|Lack of Efficacy|12|||
170748847|NCT01448044|617086344|FG000|Treatment Period|Subject requested discontinue study drug|1|||
170748848|NCT01448044|617086345|FG001|Treatment Period|Subject requested discontinue study drug|0|||
170748849|NCT01448044|617086344|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
170748850|NCT01448044|617086345|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
170748851|NCT01448044|617086344|FG000|Treatment Period|Participant does not meet study criteria|1|||
170748852|NCT01448044|617086345|FG001|Treatment Period|Participant does not meet study criteria|0|||
170748853|NCT01448044|617086344|FG000|Treatment Period|Lost to Follow-up|2|||
170748854|NCT01448044|617086345|FG001|Treatment Period|Lost to Follow-up|1|||
170748855|NCT01448044|617086344|FG000|Treatment Period|Other reason|2|||
170748856|NCT01448044|617086345|FG001|Treatment Period|Other reason|0|||
170748857|NCT01448044|617086344|FG000|Follow Up Period|Withdrawal by Subject|1|||
170748858|NCT01448044|617086345|FG001|Follow Up Period|Withdrawal by Subject|1|||
170748859|NCT01448044|617086344|FG000|Follow Up Period|Lost to Follow-up|6|||
170748860|NCT01448044|617086345|FG001|Follow Up Period|Lost to Follow-up|2|||
170748861|NCT01448044|617086344|FG000|Follow Up Period|Other|5|||
170748862|NCT01448044|617086345|FG001|Follow Up Period|Other|11|||
170748863|NCT01000376|617086346|FG000|Cycle 1 Day 1|Adverse Event|1|||
170748864|NCT01000376|617086347|FG001|Cycle 1 Day 1|Adverse Event|0|||
170748865|NCT01000376|617086346|FG000|Cycle 1 Day 1|Progressive Disease|1|||
170748866|NCT01000376|617086347|FG001|Cycle 1 Day 1|Progressive Disease|0|||
170748867|NCT00507026|617086348|FG000|Overall Study|Lack of Efficacy|6|||
170748868|NCT00507026|617086349|FG001|Overall Study|Lack of Efficacy|4|||
170748869|NCT00507026|617086350|FG002|Overall Study|Lack of Efficacy|21|||
170748870|NCT00507026|617086348|FG000|Overall Study|Withdrawal by Subject|2|||
170748871|NCT00507026|617086349|FG001|Overall Study|Withdrawal by Subject|0|||
170748872|NCT00507026|617086350|FG002|Overall Study|Withdrawal by Subject|0|||
170748873|NCT00507026|617086348|FG000|Overall Study|Investigator Decision|1|||
170748874|NCT00507026|617086349|FG001|Overall Study|Investigator Decision|0|||
170748875|NCT00507026|617086350|FG002|Overall Study|Investigator Decision|0|||
170748876|NCT00507026|617086348|FG000|Overall Study|Adverse Event|2|||
170748877|NCT00507026|617086349|FG001|Overall Study|Adverse Event|0|||
170748878|NCT00507026|617086350|FG002|Overall Study|Adverse Event|0|||
170748879|NCT00507026|617086348|FG000|Overall Study|Protocol Violation|1|||
170748880|NCT00507026|617086349|FG001|Overall Study|Protocol Violation|0|||
170748881|NCT00507026|617086350|FG002|Overall Study|Protocol Violation|0|||
170748882|NCT00507026|617086348|FG000|Overall Study|Other|1|||
170748883|NCT00507026|617086349|FG001|Overall Study|Other|0|||
170748884|NCT00507026|617086350|FG002|Overall Study|Other|0|||
170748885|NCT03207711|617086351|FG000|Overall Study|Withdrawal by Subject|1|||
170748886|NCT03207711|617086352|FG001|Overall Study|Withdrawal by Subject|2|||
170748887|NCT00918749|617086357|FG000|Overall Study|Adverse Event|1|||
170748888|NCT00918749|617086358|FG001|Overall Study|Adverse Event|0|||
170748889|NCT00918749|617086359|FG002|Overall Study|Adverse Event|1|||
170748890|NCT00918749|617086357|FG000|Overall Study|Lost to Follow-up|0|||
170748891|NCT00918749|617086358|FG001|Overall Study|Lost to Follow-up|0|||
170748892|NCT00918749|617086359|FG002|Overall Study|Lost to Follow-up|1|||
170748893|NCT00918749|617086357|FG000|Overall Study|Withdrawal by Subject|5|||
170748894|NCT00918749|617086358|FG001|Overall Study|Withdrawal by Subject|3|||
170748895|NCT00918749|617086359|FG002|Overall Study|Withdrawal by Subject|5|||
170748896|NCT00918749|617086357|FG000|Overall Study|No Study Medication Taken|1|||
170748897|NCT00918749|617086358|FG001|Overall Study|No Study Medication Taken|0|||
170748898|NCT00918749|617086359|FG002|Overall Study|No Study Medication Taken|0|||
170748899|NCT01951092|617086360|FG000|Overall Study|Lost to Follow-up|10|||
170748900|NCT01951092|617086360|FG000|Overall Study|Incarceration|1|||
170748901|NCT01951092|617086360|FG000|Overall Study|Transfer of Care|1|||
170748902|NCT01712789|617086361|FG000|Overall Study|Lack of Efficacy|2|||
170748903|NCT01712789|617086361|FG000|Overall Study|Lost to Follow-up|1|||
170748904|NCT01712789|617086361|FG000|Overall Study|Progressive Disease|504|||
170748905|NCT01712789|617086361|FG000|Overall Study|Death|57|||
170748906|NCT01712789|617086361|FG000|Overall Study|Adverse Event|52|||
170748907|NCT01712789|617086361|FG000|Overall Study|Miscellaneous|31|||
170748908|NCT01712789|617086361|FG000|Overall Study|Withdrawal by Subject|21|||
170748909|NCT01712789|617086361|FG000|Overall Study|Transition to Commercial Treatment|8|||
170748910|NCT01712789|617086361|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
170748911|NCT00219141|617086362|FG000|Overall Study|Adverse Event|4|||
170748912|NCT00219141|617086363|FG001|Overall Study|Adverse Event|10|||
170748913|NCT00219141|617086364|FG002|Overall Study|Adverse Event|5|||
170748914|NCT00219141|617086362|FG000|Overall Study|Lack of Efficacy|3|||
170748915|NCT00219141|617086363|FG001|Overall Study|Lack of Efficacy|2|||
170748916|NCT00219141|617086364|FG002|Overall Study|Lack of Efficacy|0|||
170748917|NCT00219141|617086362|FG000|Overall Study|Administrative problems|0|||
170748918|NCT00219141|617086363|FG001|Overall Study|Administrative problems|1|||
170748919|NCT00219141|617086364|FG002|Overall Study|Administrative problems|0|||
170748920|NCT00219141|617086362|FG000|Overall Study|Lost to Follow-up|2|||
170748921|NCT00219141|617086363|FG001|Overall Study|Lost to Follow-up|4|||
170748922|NCT00219141|617086364|FG002|Overall Study|Lost to Follow-up|1|||
170748923|NCT00219141|617086362|FG000|Overall Study|Protocol Violation|3|||
170748924|NCT00219141|617086363|FG001|Overall Study|Protocol Violation|1|||
170748925|NCT00219141|617086364|FG002|Overall Study|Protocol Violation|1|||
170748926|NCT00219141|617086362|FG000|Overall Study|Withdrawal by Subject|1|||
170748927|NCT00219141|617086363|FG001|Overall Study|Withdrawal by Subject|3|||
170748928|NCT00219141|617086364|FG002|Overall Study|Withdrawal by Subject|5|||
170748929|NCT00219141|617086362|FG000|Overall Study|Condition no longer requires study drug|1|||
170748930|NCT00219141|617086363|FG001|Overall Study|Condition no longer requires study drug|0|||
170748931|NCT00219141|617086364|FG002|Overall Study|Condition no longer requires study drug|0|||
170748932|NCT04285229|617086365|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
170748933|NCT04285229|617086366|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170748934|NCT04285229|617086367|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170748935|NCT04285229|617086368|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170748936|NCT04285229|617086369|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170748937|NCT04285229|617086370|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170748938|NCT04285229|617086365|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
170748939|NCT04285229|617086366|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
170748940|NCT04285229|617086367|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
170518771|NCT00377637|616246002|FG000|Maintenance Phase|Physician Decision|0|||
170748941|NCT04285229|617086368|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
170748942|NCT04285229|617086369|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
170748943|NCT04285229|617086370|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
170748944|NCT04285229|617086365|FG000|Extended Treatment Period|Adverse Event|0|||
170748945|NCT04285229|617086366|FG001|Extended Treatment Period|Adverse Event|0|||
170748946|NCT04285229|617086367|FG002|Extended Treatment Period|Adverse Event|0|||
170748947|NCT04285229|617086368|FG003|Extended Treatment Period|Adverse Event|1|||
170748948|NCT04285229|617086369|FG004|Extended Treatment Period|Adverse Event|0|||
170748949|NCT04285229|617086370|FG005|Extended Treatment Period|Adverse Event|0|||
170748950|NCT04285229|617086365|FG000|Extended Treatment Period|Physician Decision|0|||
170748951|NCT04285229|617086366|FG001|Extended Treatment Period|Physician Decision|0|||
170748952|NCT04285229|617086367|FG002|Extended Treatment Period|Physician Decision|1|||
170748953|NCT04285229|617086368|FG003|Extended Treatment Period|Physician Decision|0|||
170748954|NCT04285229|617086369|FG004|Extended Treatment Period|Physician Decision|0|||
170748955|NCT04285229|617086370|FG005|Extended Treatment Period|Physician Decision|0|||
170748956|NCT04285229|617086365|FG000|Follow-up Period|Adverse Event|0|||
170748957|NCT04285229|617086366|FG001|Follow-up Period|Adverse Event|0|||
170748958|NCT04285229|617086367|FG002|Follow-up Period|Adverse Event|0|||
170748959|NCT04285229|617086368|FG003|Follow-up Period|Adverse Event|0|||
170748960|NCT04285229|617086369|FG004|Follow-up Period|Adverse Event|1|||
170748961|NCT04285229|617086370|FG005|Follow-up Period|Adverse Event|4|||
170748962|NCT04285229|617086365|FG000|Follow-up Period|Withdrawal by Subject|0|||
170748963|NCT04285229|617086366|FG001|Follow-up Period|Withdrawal by Subject|0|||
170748964|NCT04285229|617086367|FG002|Follow-up Period|Withdrawal by Subject|0|||
170748965|NCT04285229|617086368|FG003|Follow-up Period|Withdrawal by Subject|0|||
170748966|NCT04285229|617086369|FG004|Follow-up Period|Withdrawal by Subject|0|||
170748967|NCT04285229|617086370|FG005|Follow-up Period|Withdrawal by Subject|5|||
170748968|NCT04285229|617086365|FG000|Follow-up Period|Covid-19|0|||
170748969|NCT04285229|617086366|FG001|Follow-up Period|Covid-19|0|||
170748970|NCT04285229|617086367|FG002|Follow-up Period|Covid-19|0|||
170748971|NCT04285229|617086368|FG003|Follow-up Period|Covid-19|0|||
170748972|NCT04285229|617086369|FG004|Follow-up Period|Covid-19|0|||
170748973|NCT04285229|617086370|FG005|Follow-up Period|Covid-19|2|||
170748974|NCT04285229|617086365|FG000|Follow-up Period|Physician Decision|0|||
170748975|NCT04285229|617086366|FG001|Follow-up Period|Physician Decision|0|||
170748976|NCT04285229|617086367|FG002|Follow-up Period|Physician Decision|0|||
170748977|NCT04285229|617086368|FG003|Follow-up Period|Physician Decision|0|||
170748978|NCT04285229|617086369|FG004|Follow-up Period|Physician Decision|0|||
170748979|NCT04285229|617086370|FG005|Follow-up Period|Physician Decision|1|||
170748980|NCT02061761|617086371|FG000|Overall Study|Disease progression|2|||
170748981|NCT02061761|617086372|FG001|Overall Study|Disease progression|8|||
170748982|NCT02061761|617086373|FG002|Overall Study|Disease progression|4|||
170748983|NCT02061761|617086374|FG003|Overall Study|Disease progression|5|||
170748984|NCT02061761|617086375|FG004|Overall Study|Disease progression|9|||
170748985|NCT02061761|617086376|FG005|Overall Study|Disease progression|3|||
170748986|NCT02061761|617086377|FG006|Overall Study|Disease progression|1|||
170748987|NCT02061761|617086378|FG007|Overall Study|Disease progression|2|||
170748988|NCT02061761|617086379|FG008|Overall Study|Disease progression|28|||
170748989|NCT02061761|617086371|FG000|Overall Study|Study Drug toxicity|0|||
170748990|NCT02061761|617086372|FG001|Overall Study|Study Drug toxicity|0|||
170748991|NCT02061761|617086373|FG002|Overall Study|Study Drug toxicity|0|||
170748992|NCT02061761|617086374|FG003|Overall Study|Study Drug toxicity|0|||
170748993|NCT02061761|617086375|FG004|Overall Study|Study Drug toxicity|0|||
170748994|NCT02061761|617086376|FG005|Overall Study|Study Drug toxicity|1|||
170748995|NCT02061761|617086377|FG006|Overall Study|Study Drug toxicity|0|||
170748996|NCT02061761|617086378|FG007|Overall Study|Study Drug toxicity|2|||
170748997|NCT02061761|617086379|FG008|Overall Study|Study Drug toxicity|6|||
170748998|NCT02061761|617086371|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
170748999|NCT02061761|617086372|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
170749000|NCT02061761|617086373|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
170749001|NCT02061761|617086374|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
170749002|NCT02061761|617086375|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
170749003|NCT02061761|617086376|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
170749004|NCT02061761|617086377|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
170749005|NCT02061761|617086378|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
170749006|NCT02061761|617086379|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
170749007|NCT02061761|617086371|FG000|Overall Study|Participant request to discontinue study treatment|0|||
170749008|NCT02061761|617086372|FG001|Overall Study|Participant request to discontinue study treatment|0|||
170749009|NCT02061761|617086373|FG002|Overall Study|Participant request to discontinue study treatment|2|||
170749010|NCT02061761|617086374|FG003|Overall Study|Participant request to discontinue study treatment|2|||
170749011|NCT02061761|617086375|FG004|Overall Study|Participant request to discontinue study treatment|0|||
170749012|NCT02061761|617086376|FG005|Overall Study|Participant request to discontinue study treatment|1|||
170749013|NCT02061761|617086377|FG006|Overall Study|Participant request to discontinue study treatment|0|||
170749014|NCT02061761|617086378|FG007|Overall Study|Participant request to discontinue study treatment|0|||
170749015|NCT02061761|617086379|FG008|Overall Study|Participant request to discontinue study treatment|2|||
170631430|NCT02113982|616664411|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
170749016|NCT02061761|617086371|FG000|Overall Study|Withdrawal by Subject|0|||
170861472|NCT01910181|617501865|FG000|Overall Study|Lost to Follow-up|3|||
170749017|NCT02061761|617086372|FG001|Overall Study|Withdrawal by Subject|0|||
170749018|NCT02061761|617086373|FG002|Overall Study|Withdrawal by Subject|0|||
170749019|NCT02061761|617086374|FG003|Overall Study|Withdrawal by Subject|0|||
170749020|NCT02061761|617086375|FG004|Overall Study|Withdrawal by Subject|0|||
170749021|NCT02061761|617086376|FG005|Overall Study|Withdrawal by Subject|0|||
170749022|NCT02061761|617086377|FG006|Overall Study|Withdrawal by Subject|0|||
170749023|NCT02061761|617086378|FG007|Overall Study|Withdrawal by Subject|0|||
170749024|NCT02061761|617086379|FG008|Overall Study|Withdrawal by Subject|2|||
170749025|NCT02061761|617086371|FG000|Overall Study|Maximum clinical benefit|0|||
170749026|NCT02061761|617086372|FG001|Overall Study|Maximum clinical benefit|0|||
170749027|NCT02061761|617086373|FG002|Overall Study|Maximum clinical benefit|0|||
170749028|NCT02061761|617086374|FG003|Overall Study|Maximum clinical benefit|1|||
170749029|NCT02061761|617086375|FG004|Overall Study|Maximum clinical benefit|0|||
170749030|NCT02061761|617086376|FG005|Overall Study|Maximum clinical benefit|0|||
170749031|NCT02061761|617086377|FG006|Overall Study|Maximum clinical benefit|0|||
170749032|NCT02061761|617086378|FG007|Overall Study|Maximum clinical benefit|0|||
170749033|NCT02061761|617086379|FG008|Overall Study|Maximum clinical benefit|6|||
170749034|NCT02061761|617086371|FG000|Overall Study|Participant no longer meets study criteria|0|||
170749035|NCT02061761|617086372|FG001|Overall Study|Participant no longer meets study criteria|0|||
170749036|NCT02061761|617086373|FG002|Overall Study|Participant no longer meets study criteria|0|||
170749037|NCT02061761|617086374|FG003|Overall Study|Participant no longer meets study criteria|0|||
170749038|NCT02061761|617086375|FG004|Overall Study|Participant no longer meets study criteria|0|||
170749039|NCT02061761|617086376|FG005|Overall Study|Participant no longer meets study criteria|0|||
170749040|NCT02061761|617086377|FG006|Overall Study|Participant no longer meets study criteria|0|||
170749041|NCT02061761|617086378|FG007|Overall Study|Participant no longer meets study criteria|0|||
170749042|NCT02061761|617086379|FG008|Overall Study|Participant no longer meets study criteria|1|||
170749043|NCT02061761|617086371|FG000|Overall Study|Other reasons|0|||
170749044|NCT02061761|617086372|FG001|Overall Study|Other reasons|0|||
170749045|NCT02061761|617086373|FG002|Overall Study|Other reasons|0|||
170749046|NCT02061761|617086374|FG003|Overall Study|Other reasons|0|||
170749047|NCT02061761|617086375|FG004|Overall Study|Other reasons|2|||
170749048|NCT02061761|617086376|FG005|Overall Study|Other reasons|0|||
170749049|NCT02061761|617086377|FG006|Overall Study|Other reasons|0|||
170749050|NCT02061761|617086378|FG007|Overall Study|Other reasons|0|||
170749051|NCT02061761|617086379|FG008|Overall Study|Other reasons|6|||
170749052|NCT01024751|617086380|FG000|Enrolled Participants|Ineligible at baseline|3|||
170749053|NCT01024751|617086381|FG001|Enrolled Participants|Ineligible at baseline|4|||
170749054|NCT01024751|617086380|FG000|Eligible Participants|Withdrawal by Subject|0|||
170749055|NCT01024751|617086381|FG001|Eligible Participants|Withdrawal by Subject|1|||
170749056|NCT01024751|617086380|FG000|Eligible Participants|Lost to Follow-up|0|||
170749057|NCT01024751|617086381|FG001|Eligible Participants|Lost to Follow-up|1|||
170749058|NCT01024751|617086380|FG000|Eligible Participants|Ineligible|0|||
170749059|NCT01024751|617086381|FG001|Eligible Participants|Ineligible|1|||
170749060|NCT00577720|617086386|FG000|Overall Study|Adverse Event|2|||
170749061|NCT00577720|617086387|FG001|Overall Study|Adverse Event|1|||
170749062|NCT00577720|617086388|FG002|Overall Study|Adverse Event|0|||
170749063|NCT00577720|617086389|FG003|Overall Study|Adverse Event|4|||
170749064|NCT00577720|617086386|FG000|Overall Study|Lost to Follow-up|0|||
170749065|NCT00577720|617086387|FG001|Overall Study|Lost to Follow-up|0|||
170749066|NCT00577720|617086388|FG002|Overall Study|Lost to Follow-up|1|||
170749067|NCT00577720|617086389|FG003|Overall Study|Lost to Follow-up|0|||
170749068|NCT00577720|617086386|FG000|Overall Study|Protocol Violation|0|||
170749069|NCT00577720|617086387|FG001|Overall Study|Protocol Violation|0|||
170749070|NCT00577720|617086388|FG002|Overall Study|Protocol Violation|0|||
170749071|NCT00577720|617086389|FG003|Overall Study|Protocol Violation|1|||
170749072|NCT00577720|617086386|FG000|Overall Study|Withdrawal by Subject|2|||
170749073|NCT00577720|617086387|FG001|Overall Study|Withdrawal by Subject|0|||
170749074|NCT00577720|617086388|FG002|Overall Study|Withdrawal by Subject|0|||
170749075|NCT00577720|617086389|FG003|Overall Study|Withdrawal by Subject|2|||
170749076|NCT03246672|617086390|FG000|Overall Study|Lost to Follow-up|2|||
170749077|NCT03260504|617086391|FG000|Overall Study|Adverse Event|0|||
170749078|NCT03260504|617086392|FG001|Overall Study|Adverse Event|1|||
170749079|NCT00846742|617086393|FG000|Overall Study|Withdrawal by Subject|1|||
170749080|NCT01680458|617086394|FG000|Overall Study|Protocol Violation|3|||
170749081|NCT04793464|617086395|FG000|Overall Study|Lost to Follow-up|458|||
170749082|NCT04793464|617086396|FG001|Overall Study|Lost to Follow-up|168|||
170749083|NCT04793464|617086397|FG002|Overall Study|Lost to Follow-up|5|||
170749084|NCT04793464|617086395|FG000|Overall Study|Withdrawal by Subject|43|||
170749085|NCT04793464|617086396|FG001|Overall Study|Withdrawal by Subject|15|||
170749086|NCT04793464|617086397|FG002|Overall Study|Withdrawal by Subject|0|||
170861473|NCT01910181|617501865|FG000|Overall Study|Study Terminated by Sponsor|6|||
170749087|NCT00903786|617086401|FG000|Overall Study|Physician Decision|6|||
170749088|NCT00903786|617086401|FG000|Overall Study|Lack of Efficacy|5|||
170749089|NCT00903786|617086401|FG000|Overall Study|Reason other than lack of efficacy|4|||
170749090|NCT02285595|617086405|FG000|Overall Study|Lost to Follow-up|14|||
170749091|NCT02285595|617086405|FG000|Overall Study|Withdrawal by Subject|1|||
170749092|NCT02696902|617086408|FG000|Overall Study|Lost to Follow-up|0|||
170749093|NCT02696902|617086409|FG001|Overall Study|Lost to Follow-up|1|||
170749094|NCT02696902|617086410|FG002|Overall Study|Lost to Follow-up|1|||
170749095|NCT02696902|617086408|FG000|Overall Study|Withdrawal by Subject|0|||
170749096|NCT02696902|617086409|FG001|Overall Study|Withdrawal by Subject|0|||
170749097|NCT02696902|617086410|FG002|Overall Study|Withdrawal by Subject|1|||
170749098|NCT02696902|617086408|FG000|Overall Study|Death|19|||
170749099|NCT02696902|617086409|FG001|Overall Study|Death|3|||
170749100|NCT02696902|617086410|FG002|Overall Study|Death|24|||
170749101|NCT02696902|617086408|FG000|Overall Study|Participant not fit post-randomization|0|||
170749102|NCT02696902|617086409|FG001|Overall Study|Participant not fit post-randomization|0|||
170749103|NCT02696902|617086410|FG002|Overall Study|Participant not fit post-randomization|1|||
170749104|NCT02696902|617086408|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
170749105|NCT02696902|617086409|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
170749106|NCT02696902|617086410|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
170749107|NCT02696902|617086408|FG000|Overall Study|Principal investigator's decision|1|||
170749108|NCT02696902|617086409|FG001|Overall Study|Principal investigator's decision|0|||
170749109|NCT02696902|617086410|FG002|Overall Study|Principal investigator's decision|0|||
170749110|NCT02696902|617086408|FG000|Overall Study|Sponsor's decision|1|||
170749111|NCT02696902|617086409|FG001|Overall Study|Sponsor's decision|0|||
170749112|NCT02696902|617086410|FG002|Overall Study|Sponsor's decision|0|||
170749113|NCT02696902|617086408|FG000|Overall Study|Transferred to other hospital|1|||
170749114|NCT02696902|617086409|FG001|Overall Study|Transferred to other hospital|0|||
170749115|NCT02696902|617086410|FG002|Overall Study|Transferred to other hospital|0|||
170749116|NCT00003458|617086416|FG000|Overall Study|Not evaluable|4|||
170749117|NCT02924389|617086420|FG000|Overall Study|Lost to Follow-up|1|||
170749118|NCT02924389|617086421|FG001|Overall Study|Lost to Follow-up|0|||
170749119|NCT02924389|617086420|FG000|Overall Study|Physician Decision|2|||
170749120|NCT02924389|617086421|FG001|Overall Study|Physician Decision|0|||
170749121|NCT02924389|617086420|FG000|Overall Study|Withdrawal by Subject|3|||
170749122|NCT02924389|617086421|FG001|Overall Study|Withdrawal by Subject|0|||
170749123|NCT02924389|617086420|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
170749124|NCT02924389|617086421|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
170749125|NCT02718417|617088055|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
170749126|NCT02718417|617088056|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
170749127|NCT02718417|617088057|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
170749128|NCT02718417|617088055|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
170749129|NCT02718417|617088056|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
170749130|NCT02718417|617088057|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
170749131|NCT02718417|617088055|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
170749132|NCT02718417|617088056|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
170749133|NCT02718417|617088057|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
170749134|NCT02718417|617088055|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
170749135|NCT02718417|617088056|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
170749136|NCT02718417|617088057|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
170749137|NCT02718417|617088055|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
170749138|NCT02718417|617088056|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
170749139|NCT02718417|617088057|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
170749140|NCT02718417|617088055|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
170749141|NCT02718417|617088056|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
170749142|NCT02718417|617088057|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
170749143|NCT02718417|617088055|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
170749144|NCT02718417|617088056|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
170749145|NCT02718417|617088057|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
170749146|NCT02718417|617088055|FG000|Chemotherapy Phase (CP)|Other|2|||
170749147|NCT02718417|617088056|FG001|Chemotherapy Phase (CP)|Other|0|||
170749148|NCT02718417|617088057|FG002|Chemotherapy Phase (CP)|Other|1|||
170749149|NCT02718417|617088055|FG000|Maintenance Phase (MP)|Adverse Event|21|||
170749150|NCT02718417|617088056|FG001|Maintenance Phase (MP)|Adverse Event|26|||
170749151|NCT02718417|617088057|FG002|Maintenance Phase (MP)|Adverse Event|0|||
170749152|NCT02718417|617088055|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
170749153|NCT02718417|617088056|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
170749154|NCT02718417|617088057|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
170749155|NCT02718417|617088055|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
170749156|NCT02718417|617088056|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
170749157|NCT02718417|617088057|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
170749158|NCT02718417|617088055|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
170749159|NCT02718417|617088056|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
170749160|NCT02718417|617088057|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
170749161|NCT02718417|617088055|FG000|Maintenance Phase (MP)|Physician's decision|6|||
170749162|NCT02718417|617088056|FG001|Maintenance Phase (MP)|Physician's decision|7|||
170749163|NCT02718417|617088057|FG002|Maintenance Phase (MP)|Physician's decision|0|||
170749164|NCT02718417|617088055|FG000|Maintenance Phase (MP)|Progressive disease|100|||
170749165|NCT02718417|617088056|FG001|Maintenance Phase (MP)|Progressive disease|88|||
170749166|NCT02718417|617088057|FG002|Maintenance Phase (MP)|Progressive disease|0|||
170749167|NCT02718417|617088055|FG000|Maintenance Phase (MP)|Other|2|||
170749168|NCT02718417|617088056|FG001|Maintenance Phase (MP)|Other|1|||
170749169|NCT02718417|617088057|FG002|Maintenance Phase (MP)|Other|0|||
170749170|NCT02718417|617088055|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
170749171|NCT02718417|617088056|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
170749172|NCT02718417|617088057|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
170749173|NCT02718417|617088055|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
170749174|NCT02718417|617088056|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
170749175|NCT02718417|617088057|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
170749176|NCT02718417|617088055|FG000|Observation Phase (OP)|Adverse Event|0|||
170749177|NCT02718417|617088056|FG001|Observation Phase (OP)|Adverse Event|0|||
170749178|NCT02718417|617088057|FG002|Observation Phase (OP)|Adverse Event|1|||
170749179|NCT02718417|617088055|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
170749180|NCT02718417|617088056|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
170749181|NCT02718417|617088057|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
170749182|NCT02718417|617088055|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
170749183|NCT02718417|617088056|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
170749184|NCT02718417|617088057|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
170749185|NCT02718417|617088055|FG000|Observation Phase (OP)|Physician Decision|0|||
170749186|NCT02718417|617088056|FG001|Observation Phase (OP)|Physician Decision|0|||
170749187|NCT02718417|617088057|FG002|Observation Phase (OP)|Physician Decision|9|||
170749188|NCT02718417|617088055|FG000|Observation Phase (OP)|Progressive disease|0|||
170749189|NCT02718417|617088056|FG001|Observation Phase (OP)|Progressive disease|0|||
170749190|NCT02718417|617088057|FG002|Observation Phase (OP)|Progressive disease|92|||
170749191|NCT02718417|617088055|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
170749192|NCT02718417|617088056|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
170749193|NCT02718417|617088057|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
170749194|NCT02718417|617088055|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
170749195|NCT02718417|617088056|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
170749196|NCT02718417|617088057|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
170749197|NCT02718417|617088055|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
170749198|NCT02718417|617088056|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
170749199|NCT02718417|617088057|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
170749200|NCT02718417|617088055|FG000|Observation Phase (OP)|Other|0|||
170749201|NCT02718417|617088056|FG001|Observation Phase (OP)|Other|0|||
170749202|NCT02718417|617088057|FG002|Observation Phase (OP)|Other|7|||
170749203|NCT02718417|617088055|FG000|Follow-up Phase|Adverse Event|3|||
170749204|NCT02718417|617088056|FG001|Follow-up Phase|Adverse Event|1|||
170749205|NCT02718417|617088057|FG002|Follow-up Phase|Adverse Event|1|||
170749206|NCT02718417|617088055|FG000|Follow-up Phase|Other|4|||
170749207|NCT02718417|617088056|FG001|Follow-up Phase|Other|6|||
170749208|NCT02718417|617088057|FG002|Follow-up Phase|Other|4|||
170749209|NCT02718417|617088055|FG000|Follow-up Phase|Withdrawal by Subject|19|||
170749210|NCT02718417|617088056|FG001|Follow-up Phase|Withdrawal by Subject|17|||
170749211|NCT02718417|617088057|FG002|Follow-up Phase|Withdrawal by Subject|5|||
170749212|NCT02718417|617088055|FG000|Follow-up Phase|Study terminated by sponsor|100|||
170749213|NCT02718417|617088056|FG001|Follow-up Phase|Study terminated by sponsor|138|||
170749214|NCT02718417|617088057|FG002|Follow-up Phase|Study terminated by sponsor|6|||
170749215|NCT02718417|617088055|FG000|Follow-up Phase|Lost to Follow-up|2|||
170749216|NCT02718417|617088056|FG001|Follow-up Phase|Lost to Follow-up|3|||
170749217|NCT02718417|617088057|FG002|Follow-up Phase|Lost to Follow-up|0|||
170749218|NCT02718417|617088055|FG000|Follow-up Phase|Death leading to discontinuation|7|||
170749219|NCT02718417|617088056|FG001|Follow-up Phase|Death leading to discontinuation|7|||
170749220|NCT02718417|617088057|FG002|Follow-up Phase|Death leading to discontinuation|3|||
170749221|NCT02718417|617088055|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
170749222|NCT02718417|617088056|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
170749223|NCT02718417|617088057|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
170749224|NCT02718417|617088055|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
170749225|NCT02718417|617088056|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
170749226|NCT02718417|617088057|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
170749227|NCT02718417|617088055|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
170749228|NCT02718417|617088056|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
170749229|NCT02718417|617088057|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
170749230|NCT02718417|617088055|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
170749231|NCT02718417|617088056|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
170749232|NCT02718417|617088057|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
170749233|NCT02718417|617088055|FG000|Long-term Follow-up Phase|Other|0|||
170749234|NCT02718417|617088056|FG001|Long-term Follow-up Phase|Other|2|||
170749235|NCT02718417|617088057|FG002|Long-term Follow-up Phase|Other|0|||
170749236|NCT01890967|617088058|FG000|Overall Study|Adverse Event|3|||
170749237|NCT01890967|617088059|FG001|Overall Study|Adverse Event|3|||
170749238|NCT01890967|617088060|FG002|Overall Study|Adverse Event|3|||
170749239|NCT01890967|617088061|FG003|Overall Study|Adverse Event|2|||
170749240|NCT01890967|617088062|FG004|Overall Study|Adverse Event|1|||
170749241|NCT01890967|617088063|FG005|Overall Study|Adverse Event|7|||
170749242|NCT01890967|617088058|FG000|Overall Study|Death|1|||
170749243|NCT01890967|617088059|FG001|Overall Study|Death|0|||
170749244|NCT01890967|617088060|FG002|Overall Study|Death|0|||
170749245|NCT01890967|617088061|FG003|Overall Study|Death|0|||
170749246|NCT01890967|617088062|FG004|Overall Study|Death|0|||
170749247|NCT01890967|617088063|FG005|Overall Study|Death|0|||
170749248|NCT01890967|617088058|FG000|Overall Study|Lost to Follow-up|1|||
170749249|NCT01890967|617088059|FG001|Overall Study|Lost to Follow-up|1|||
170749250|NCT01890967|617088060|FG002|Overall Study|Lost to Follow-up|1|||
170749251|NCT01890967|617088061|FG003|Overall Study|Lost to Follow-up|1|||
170749252|NCT01890967|617088062|FG004|Overall Study|Lost to Follow-up|0|||
170749253|NCT01890967|617088063|FG005|Overall Study|Lost to Follow-up|1|||
170749254|NCT01890967|617088058|FG000|Overall Study|Protocol Violation|0|||
170749255|NCT01890967|617088059|FG001|Overall Study|Protocol Violation|3|||
170749256|NCT01890967|617088060|FG002|Overall Study|Protocol Violation|3|||
170749257|NCT01890967|617088061|FG003|Overall Study|Protocol Violation|2|||
170749258|NCT01890967|617088062|FG004|Overall Study|Protocol Violation|4|||
170749259|NCT01890967|617088063|FG005|Overall Study|Protocol Violation|1|||
170749260|NCT01890967|617088058|FG000|Overall Study|Sponsor Decision|2|||
170749261|NCT01890967|617088059|FG001|Overall Study|Sponsor Decision|0|||
170749262|NCT01890967|617088060|FG002|Overall Study|Sponsor Decision|1|||
170749263|NCT01890967|617088061|FG003|Overall Study|Sponsor Decision|3|||
170749264|NCT01890967|617088062|FG004|Overall Study|Sponsor Decision|2|||
170749265|NCT01890967|617088063|FG005|Overall Study|Sponsor Decision|3|||
170749266|NCT01890967|617088058|FG000|Overall Study|Withdrawal by Subject|3|||
170749267|NCT01890967|617088059|FG001|Overall Study|Withdrawal by Subject|4|||
170749268|NCT01890967|617088060|FG002|Overall Study|Withdrawal by Subject|2|||
170749269|NCT01890967|617088061|FG003|Overall Study|Withdrawal by Subject|3|||
170749270|NCT01890967|617088062|FG004|Overall Study|Withdrawal by Subject|3|||
170749271|NCT01890967|617088063|FG005|Overall Study|Withdrawal by Subject|1|||
170749272|NCT00867490|617088066|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
170749273|NCT00867490|617088066|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
170749274|NCT00867490|617088066|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
170749275|NCT00867490|617088066|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
170749276|NCT00867490|617088066|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
170749277|NCT03415022|617088069|FG000|Overall Study|Withdrawal by Subject|1|||
170749278|NCT03415022|617088070|FG001|Overall Study|Withdrawal by Subject|2|||
170749279|NCT03415022|617088069|FG000|Overall Study|COVID-19 Suspension|2|||
170749280|NCT03415022|617088070|FG001|Overall Study|COVID-19 Suspension|3|||
170749281|NCT03415022|617088069|FG000|Overall Study|Lost to Follow-up|2|||
170749282|NCT03415022|617088070|FG001|Overall Study|Lost to Follow-up|0|||
170749283|NCT02086552|617088071|FG000|Overall Study|Withdrawal by Subject|1|||
170749284|NCT02206152|617088072|FG000|Pre-Randomization|Withdrawal by Subject|2|||
170749285|NCT02080520|617088073|FG000|Overall Study|Self-reported symptoms|5|||
170749286|NCT02080520|617088074|FG001|Overall Study|Self-reported symptoms|6|||
170749287|NCT02080520|617088073|FG000|Overall Study|Unable to contact|2|||
170749288|NCT02080520|617088074|FG001|Overall Study|Unable to contact|1|||
170749289|NCT02080520|617088073|FG000|Overall Study|Initiated aspirin|2|||
170749290|NCT02080520|617088074|FG001|Overall Study|Initiated aspirin|0|||
170749291|NCT02080520|617088073|FG000|Overall Study|Atrial fibrillation|1|||
170749292|NCT02080520|617088074|FG001|Overall Study|Atrial fibrillation|1|||
170749293|NCT02080520|617088073|FG000|Overall Study|Cancer|1|||
170749294|NCT02080520|617088074|FG001|Overall Study|Cancer|2|||
170749295|NCT02080520|617088073|FG000|Overall Study|Not interested in study|1|||
170749296|NCT02080520|617088074|FG001|Overall Study|Not interested in study|3|||
170749297|NCT02080520|617088073|FG000|Overall Study|Too busy|1|||
170749298|NCT02080520|617088074|FG001|Overall Study|Too busy|1|||
170749299|NCT02080520|617088073|FG000|Overall Study|Work-related injury|1|||
170749300|NCT02080520|617088074|FG001|Overall Study|Work-related injury|0|||
170749301|NCT02080520|617088073|FG000|Overall Study|Personal reasons|0|||
170749302|NCT02080520|617088074|FG001|Overall Study|Personal reasons|3|||
170749303|NCT01349907|617088075|FG000|Overall Study|Adverse Event|37|||
170749304|NCT01349907|617088076|FG001|Overall Study|Adverse Event|11|||
170749305|NCT01349907|617088075|FG000|Overall Study|Treatment failure|13|||
170749306|NCT01349907|617088076|FG001|Overall Study|Treatment failure|4|||
170749307|NCT01349907|617088075|FG000|Overall Study|Lost to Follow-up|25|||
170749308|NCT01349907|617088076|FG001|Overall Study|Lost to Follow-up|6|||
170749309|NCT01349907|617088075|FG000|Overall Study|Withdrawal by Subject|30|||
170749310|NCT01349907|617088076|FG001|Overall Study|Withdrawal by Subject|8|||
170749311|NCT01349907|617088075|FG000|Overall Study|Protocol Violation|33|||
170749312|NCT01349907|617088076|FG001|Overall Study|Protocol Violation|13|||
170749313|NCT01349907|617088075|FG000|Overall Study|Administrative|1|||
170749314|NCT01349907|617088076|FG001|Overall Study|Administrative|1|||
170749315|NCT02406261|617088079|FG000|Period 1|Lost to Follow-up|2|||
170749316|NCT02406261|617088080|FG001|Period 1|Lost to Follow-up|0|||
170749317|NCT02406261|617088079|FG000|Period 1|Adverse Event|1|||
170749318|NCT02406261|617088080|FG001|Period 1|Adverse Event|0|||
170749319|NCT02406261|617088079|FG000|Period 2|Physician Decision|0|||
170749320|NCT02406261|617088080|FG001|Period 2|Physician Decision|1|||
170749321|NCT02406261|617088079|FG000|Period 2|Protocol Violation|0|||
170749322|NCT02406261|617088080|FG001|Period 2|Protocol Violation|1|||
170749323|NCT02406261|617088079|FG000|Period 2|Withdrawal by Subject|0|||
170749324|NCT02406261|617088080|FG001|Period 2|Withdrawal by Subject|1|||
170749325|NCT01591460|617088086|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
170749326|NCT01591460|617088086|FG000|Overall Study|Futility Rule (Week 12)|7|||
170749327|NCT01591460|617088086|FG000|Overall Study|Futility Rule (Week 24)|3|||
170749328|NCT01591460|617088086|FG000|Overall Study|Rebound or Breakthrough|3|||
170749329|NCT01591460|617088086|FG000|Overall Study|Treatment Discontinued by Error|1|||
170749330|NCT01591460|617088086|FG000|Overall Study|Lost to Follow-up|1|||
170749331|NCT01591460|617088086|FG000|Overall Study|Noncompliance|1|||
170749332|NCT01591460|617088086|FG000|Overall Study|Participant Refusal|3|||
170749333|NCT01591460|617088086|FG000|Overall Study|Withdrawal by Subject|1|||
170749334|NCT01591460|617088086|FG000|Overall Study|Protocol Violation|1|||
170749335|NCT04102540|617088089|FG000|Overall Study|Withdrawn by PI|2|||
170749336|NCT04102540|617088089|FG000|Overall Study|Lost to Follow-up|6|||
170749337|NCT01567163|617088090|FG000|Overall Study|Progressive Disease|2|||
170749338|NCT01567163|617088090|FG000|Overall Study|Lost to Follow-up|2|||
170749339|NCT03405662|617088091|FG000|Overall Study|COVID-19 restriction|1|||
170749340|NCT03405662|617088092|FG001|Overall Study|COVID-19 restriction|0|||
170749341|NCT03405662|617088091|FG000|Overall Study|unblinding|0|||
170749342|NCT03405662|617088092|FG001|Overall Study|unblinding|1|||
170749343|NCT03405662|617088091|FG000|Overall Study|placement in memory care facility|0|||
170749344|NCT03405662|617088092|FG001|Overall Study|placement in memory care facility|2|||
170749345|NCT01177813|617088093|FG000|Overall Study|Adverse Event|8|||
170749346|NCT01177813|617088094|FG001|Overall Study|Adverse Event|2|||
170749347|NCT01177813|617088095|FG002|Overall Study|Adverse Event|4|||
170749348|NCT01177813|617088096|FG003|Overall Study|Adverse Event|6|||
170749349|NCT01177813|617088097|FG004|Overall Study|Adverse Event|3|||
170749350|NCT01177813|617088093|FG000|Overall Study|Lack of Efficacy|1|||
170749351|NCT01177813|617088094|FG001|Overall Study|Lack of Efficacy|0|||
170749352|NCT01177813|617088095|FG002|Overall Study|Lack of Efficacy|0|||
170749353|NCT01177813|617088096|FG003|Overall Study|Lack of Efficacy|0|||
170749354|NCT01177813|617088097|FG004|Overall Study|Lack of Efficacy|0|||
170749355|NCT01177813|617088093|FG000|Overall Study|Protocol Violation|3|||
170749356|NCT01177813|617088094|FG001|Overall Study|Protocol Violation|2|||
170749357|NCT01177813|617088095|FG002|Overall Study|Protocol Violation|2|||
170749358|NCT01177813|617088096|FG003|Overall Study|Protocol Violation|0|||
170749359|NCT01177813|617088097|FG004|Overall Study|Protocol Violation|1|||
170749360|NCT01177813|617088093|FG000|Overall Study|Lost to Follow-up|12|||
170749361|NCT01177813|617088094|FG001|Overall Study|Lost to Follow-up|5|||
170749362|NCT01177813|617088095|FG002|Overall Study|Lost to Follow-up|6|||
170749363|NCT01177813|617088096|FG003|Overall Study|Lost to Follow-up|3|||
170749364|NCT01177813|617088097|FG004|Overall Study|Lost to Follow-up|0|||
170749365|NCT01177813|617088093|FG000|Overall Study|Withdrawal by Subject|12|||
170749366|NCT01177813|617088094|FG001|Overall Study|Withdrawal by Subject|7|||
170749367|NCT01177813|617088095|FG002|Overall Study|Withdrawal by Subject|6|||
170749368|NCT01177813|617088096|FG003|Overall Study|Withdrawal by Subject|5|||
170749369|NCT01177813|617088097|FG004|Overall Study|Withdrawal by Subject|3|||
170749370|NCT01177813|617088093|FG000|Overall Study|Other reason not defined above|5|||
170749371|NCT01177813|617088094|FG001|Overall Study|Other reason not defined above|2|||
170749372|NCT01177813|617088095|FG002|Overall Study|Other reason not defined above|2|||
170749373|NCT01177813|617088096|FG003|Overall Study|Other reason not defined above|3|||
170749374|NCT01177813|617088097|FG004|Overall Study|Other reason not defined above|2|||
170749375|NCT04011384|617088098|FG000|Overall Study|Withdrawal by Subject|2|||
170749376|NCT04011384|617088099|FG001|Overall Study|Withdrawal by Subject|0|||
170749377|NCT04827134|617088100|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
170749378|NCT04827134|617088101|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
170749379|NCT04827134|617088102|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
170749380|NCT04827134|617088103|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
170749381|NCT00287469|617088104|FG000|Overall Study|serious adverse event|1|||
170749382|NCT00287469|617088105|FG001|Overall Study|serious adverse event|6|||
170749383|NCT00287469|617088104|FG000|Overall Study|Adverse Event|1|||
170749384|NCT00287469|617088105|FG001|Overall Study|Adverse Event|1|||
170749385|NCT00287469|617088104|FG000|Overall Study|moved from area|144|||
170749386|NCT00287469|617088105|FG001|Overall Study|moved from area|138|||
170749387|NCT00287469|617088104|FG000|Overall Study|Lost to Follow-up|74|||
170749388|NCT00287469|617088105|FG001|Overall Study|Lost to Follow-up|69|||
170749389|NCT03053492|617088106|FG000|Overall Study|Adverse Event|1|||
170749390|NCT03053492|617088107|FG001|Overall Study|Adverse Event|1|||
170749391|NCT03053492|617088106|FG000|Overall Study|Withdrawal by Subject|7|||
170749392|NCT03053492|617088107|FG001|Overall Study|Withdrawal by Subject|5|||
170749393|NCT00393094|617088112|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
170749394|NCT00393094|617088112|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
170749395|NCT00785538|617088113|FG000|Treatment Period|Adverse Event|1|||
170749396|NCT00785538|617088114|FG001|Treatment Period|Adverse Event|2|||
170749397|NCT00785538|617088115|FG002|Treatment Period|Adverse Event|2|||
170749398|NCT00785538|617088116|FG003|Treatment Period|Adverse Event|0|||
170749399|NCT00785538|617088113|FG000|Treatment Period|Withdrawal by Subject|0|||
170749400|NCT00785538|617088114|FG001|Treatment Period|Withdrawal by Subject|0|||
170749401|NCT00785538|617088115|FG002|Treatment Period|Withdrawal by Subject|0|||
170749402|NCT00785538|617088116|FG003|Treatment Period|Withdrawal by Subject|1|||
170749403|NCT02019602|617088117|FG000|Screening Period|Ineligibility|4|||
170749404|NCT02019602|617088118|FG001|Screening Period|Ineligibility|0|||
170749405|NCT02019602|617088117|FG000|Screening Period|Adverse Event|1|||
170749406|NCT02019602|617088118|FG001|Screening Period|Adverse Event|0|||
170749407|NCT00683449|617088119|FG000|Overall Study|Lost to Follow-up|0|||
170749408|NCT00683449|617088120|FG001|Overall Study|Lost to Follow-up|1|||
170749409|NCT00683449|617088121|FG002|Overall Study|Lost to Follow-up|0|||
170749410|NCT00683449|617088122|FG003|Overall Study|Lost to Follow-up|0|||
170749411|NCT00683449|617088123|FG004|Overall Study|Lost to Follow-up|0|||
170749412|NCT02372058|617088126|FG000|Overall Study|Withdrawal by Subject|3|||
170749413|NCT02788006|617088127|FG000|Overall Study|Patient not treated|1|||
170749414|NCT01010217|617088131|FG000|Overall Study|Lost to Follow-up|4|||
170749415|NCT01010217|617088132|FG001|Overall Study|Lost to Follow-up|5|||
170749416|NCT01010217|617088133|FG002|Overall Study|Lost to Follow-up|1|||
170749417|NCT01010217|617088134|FG003|Overall Study|Lost to Follow-up|0|||
170749418|NCT01010217|617088135|FG004|Overall Study|Lost to Follow-up|0|||
170749419|NCT01010217|617088131|FG000|Overall Study|Withdrawal by Subject|1|||
170749420|NCT01010217|617088132|FG001|Overall Study|Withdrawal by Subject|0|||
170749421|NCT01010217|617088133|FG002|Overall Study|Withdrawal by Subject|0|||
170749422|NCT01010217|617088134|FG003|Overall Study|Withdrawal by Subject|0|||
170749423|NCT01010217|617088135|FG004|Overall Study|Withdrawal by Subject|0|||
170749424|NCT01010217|617088131|FG000|Overall Study|Physician Decision|0|||
170749425|NCT01010217|617088132|FG001|Overall Study|Physician Decision|0|||
170749426|NCT01010217|617088133|FG002|Overall Study|Physician Decision|0|||
170749427|NCT01010217|617088134|FG003|Overall Study|Physician Decision|6|||
170749428|NCT01010217|617088135|FG004|Overall Study|Physician Decision|3|||
170749429|NCT02213055|617088136|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
170749430|NCT02213055|617088137|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
170749431|NCT02213055|617088136|FG000|Overall Study|Protocol was not Followed during Study|1|||
170749432|NCT02213055|617088137|FG001|Overall Study|Protocol was not Followed during Study|0|||
170749433|NCT02213055|617088136|FG000|Overall Study|Documentation Issue at Enrollment|1|||
170749434|NCT02213055|617088137|FG001|Overall Study|Documentation Issue at Enrollment|0|||
170749435|NCT02213055|617088136|FG000|Overall Study|Documentation Issue during Study|10|||
170749436|NCT02213055|617088137|FG001|Overall Study|Documentation Issue during Study|0|||
170749437|NCT02213055|617088136|FG000|Overall Study|Did not have Live Lice|8|||
170749438|NCT02213055|617088137|FG001|Overall Study|Did not have Live Lice|0|||
170749439|NCT02213055|617088136|FG000|Overall Study|Had another Treatment during the Study|3|||
170749440|NCT02213055|617088137|FG001|Overall Study|Had another Treatment during the Study|0|||
170749441|NCT02213055|617088136|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
170749442|NCT02213055|617088137|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
170749443|NCT02213055|617088136|FG000|Overall Study|Did not Return to School|5|||
170749444|NCT02213055|617088137|FG001|Overall Study|Did not Return to School|0|||
170749445|NCT05868954|617088143|FG000|Overall Study|Lost to Follow-up|0|||
170749446|NCT05868954|617088144|FG001|Overall Study|Lost to Follow-up|1|||
170749447|NCT05868954|617088143|FG000|Overall Study|Withdrawal by Subject|2|||
170749448|NCT05868954|617088144|FG001|Overall Study|Withdrawal by Subject|2|||
170749449|NCT05868954|617088143|FG000|Overall Study|Participant delivered|1|||
170749450|NCT05868954|617088144|FG001|Overall Study|Participant delivered|1|||
170749451|NCT05868954|617088143|FG000|Overall Study|Miscarriage|0|||
170749452|NCT05868954|617088144|FG001|Overall Study|Miscarriage|1|||
170749453|NCT02258464|617088157|FG000|Overall Study|Progressive disease (PD)|9|||
170749454|NCT02258464|617088158|FG001|Overall Study|Progressive disease (PD)|17|||
170749455|NCT02258464|617088157|FG000|Overall Study|Study drug never administered|1|||
170749456|NCT02258464|617088158|FG001|Overall Study|Study drug never administered|1|||
170749457|NCT02258464|617088157|FG000|Overall Study|AE not related to clinical PD|1|||
170749458|NCT02258464|617088158|FG001|Overall Study|AE not related to clinical PD|3|||
170749459|NCT02258464|617088157|FG000|Overall Study|Withdrawal by Subject|5|||
170749460|NCT02258464|617088158|FG001|Overall Study|Withdrawal by Subject|4|||
170749461|NCT02258464|617088157|FG000|Overall Study|AE related to clinical PD|1|||
170749462|NCT02258464|617088158|FG001|Overall Study|AE related to clinical PD|0|||
170749463|NCT00932646|617088159|FG000|Overall Study|Adverse Event|2|||
170749464|NCT00932646|617088160|FG001|Overall Study|Adverse Event|1|||
170749465|NCT00932646|617088161|FG002|Overall Study|Adverse Event|1|||
170749466|NCT00932646|617088162|FG003|Overall Study|Adverse Event|1|||
170749467|NCT00932646|617088159|FG000|Overall Study|Lost to Follow-up|2|||
170749468|NCT00932646|617088160|FG001|Overall Study|Lost to Follow-up|1|||
170749469|NCT00932646|617088161|FG002|Overall Study|Lost to Follow-up|0|||
170749470|NCT00932646|617088162|FG003|Overall Study|Lost to Follow-up|0|||
170749471|NCT00932646|617088159|FG000|Overall Study|Withdrawal by Subject|1|||
170749472|NCT00932646|617088160|FG001|Overall Study|Withdrawal by Subject|1|||
170749473|NCT00932646|617088161|FG002|Overall Study|Withdrawal by Subject|3|||
170749474|NCT00932646|617088162|FG003|Overall Study|Withdrawal by Subject|0|||
170749475|NCT04170296|617088163|FG000|Overall Study|Adverse Event|1|||
170749476|NCT04170296|617088164|FG001|Overall Study|Adverse Event|0|||
170749477|NCT04170296|617088163|FG000|Overall Study|Withdrawal by Subject|3|||
170749478|NCT04170296|617088164|FG001|Overall Study|Withdrawal by Subject|2|||
170749479|NCT04170296|617088163|FG000|Overall Study|Lost to Follow-up|4|||
170749480|NCT04170296|617088164|FG001|Overall Study|Lost to Follow-up|2|||
170749481|NCT02611830|617088168|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
170749482|NCT02611830|617088169|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
170749483|NCT02611830|617088170|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
170749484|NCT02611830|617088171|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
170749485|NCT02611830|617088168|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
170749486|NCT02611830|617088169|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
170749487|NCT02611830|617088170|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
170749488|NCT02611830|617088171|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
170749489|NCT02611830|617088168|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
170749490|NCT02611830|617088169|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
170749491|NCT02611830|617088170|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
170749492|NCT02611830|617088171|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
170749493|NCT02611830|617088168|FG000|OL Induction Phase|Lack of Efficacy|9|||
170749494|NCT02611830|617088169|FG001|OL Induction Phase|Lack of Efficacy|0|||
170749495|NCT02611830|617088170|FG002|OL Induction Phase|Lack of Efficacy|0|||
170749496|NCT02611830|617088171|FG003|OL Induction Phase|Lack of Efficacy|0|||
170749497|NCT02611830|617088168|FG000|OL Induction Phase|Reason not specified|3|||
170749498|NCT02611830|617088169|FG001|OL Induction Phase|Reason not specified|0|||
170749499|NCT02611830|617088170|FG002|OL Induction Phase|Reason not specified|0|||
170749500|NCT02611830|617088171|FG003|OL Induction Phase|Reason not specified|0|||
170749501|NCT02611830|617088168|FG000|Maintenance Phase|Lack of Efficacy|0|||
170749502|NCT02611830|617088169|FG001|Maintenance Phase|Lack of Efficacy|29|||
170749503|NCT02611830|617088170|FG002|Maintenance Phase|Lack of Efficacy|18|||
170749504|NCT02611830|617088171|FG003|Maintenance Phase|Lack of Efficacy|6|||
170749505|NCT02611830|617088168|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
170749506|NCT02611830|617088169|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
170749507|NCT02611830|617088170|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
170749508|NCT02611830|617088171|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
170749509|NCT02611830|617088168|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
170749510|NCT02611830|617088169|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
170749511|NCT02611830|617088170|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
170749512|NCT02611830|617088171|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
170749513|NCT02611830|617088168|FG000|Maintenance Phase|Lost to Follow-up|0|||
170749514|NCT02611830|617088169|FG001|Maintenance Phase|Lost to Follow-up|0|||
170749515|NCT02611830|617088170|FG002|Maintenance Phase|Lost to Follow-up|0|||
170749516|NCT02611830|617088171|FG003|Maintenance Phase|Lost to Follow-up|1|||
170749517|NCT02611830|617088168|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
170749518|NCT02611830|617088169|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
170749519|NCT02611830|617088170|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
170749520|NCT02611830|617088171|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
170749521|NCT02611830|617088168|FG000|Maintenance Phase|Pregnancy|0|||
170749522|NCT02611830|617088169|FG001|Maintenance Phase|Pregnancy|0|||
170749523|NCT02611830|617088170|FG002|Maintenance Phase|Pregnancy|1|||
170749524|NCT02611830|617088171|FG003|Maintenance Phase|Pregnancy|0|||
170749525|NCT02611830|617088168|FG000|Maintenance Phase|Reason not specified|0|||
170749526|NCT02611830|617088169|FG001|Maintenance Phase|Reason not specified|1|||
170749527|NCT02611830|617088170|FG002|Maintenance Phase|Reason not specified|4|||
170749528|NCT02611830|617088171|FG003|Maintenance Phase|Reason not specified|0|||
170749529|NCT03567993|617088172|FG000|Overall Study|Lost to Follow-up|4|||
170749530|NCT03567993|617088173|FG001|Overall Study|Lost to Follow-up|2|||
170749531|NCT03567993|617088172|FG000|Overall Study|Death|1|||
170749532|NCT03567993|617088173|FG001|Overall Study|Death|1|||
170749533|NCT03567993|617088172|FG000|Overall Study|Withdrawal by Subject|1|||
170749534|NCT03567993|617088173|FG001|Overall Study|Withdrawal by Subject|0|||
170749535|NCT01734434|617088181|FG000|Overall Study|Death Infant|3|||
170749536|NCT01734434|617088182|FG001|Overall Study|Death Infant|1|||
170749537|NCT01734434|617088183|FG002|Overall Study|Death Infant|17|||
170749538|NCT01734434|617088184|FG003|Overall Study|Death Infant|5|||
170749539|NCT01734434|617088181|FG000|Overall Study|Lost to Follow-up|2|||
170749540|NCT01734434|617088182|FG001|Overall Study|Lost to Follow-up|9|||
170749541|NCT01734434|617088183|FG002|Overall Study|Lost to Follow-up|67|||
170749542|NCT01734434|617088184|FG003|Overall Study|Lost to Follow-up|11|||
170749543|NCT01734434|617088181|FG000|Overall Study|No Live Birth|1|||
170749544|NCT01734434|617088182|FG001|Overall Study|No Live Birth|2|||
170749545|NCT01734434|617088183|FG002|Overall Study|No Live Birth|32|||
170749546|NCT01734434|617088184|FG003|Overall Study|No Live Birth|6|||
170749547|NCT01734434|617088181|FG000|Overall Study|Withdrawal by Subject|4|||
170749548|NCT01734434|617088182|FG001|Overall Study|Withdrawal by Subject|0|||
170749549|NCT01734434|617088183|FG002|Overall Study|Withdrawal by Subject|8|||
170749550|NCT01734434|617088184|FG003|Overall Study|Withdrawal by Subject|1|||
170749551|NCT01734434|617088181|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
170749552|NCT01734434|617088182|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
170749553|NCT01734434|617088183|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
170749554|NCT01734434|617088184|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
170749555|NCT01734434|617088181|FG000|Overall Study|Subject Not Reachable|0|||
170749556|NCT01734434|617088182|FG001|Overall Study|Subject Not Reachable|0|||
170749557|NCT01734434|617088183|FG002|Overall Study|Subject Not Reachable|1|||
170749558|NCT01734434|617088184|FG003|Overall Study|Subject Not Reachable|0|||
170749559|NCT01734434|617088181|FG000|Overall Study|Treatment Defaulter|0|||
170749560|NCT01734434|617088182|FG001|Overall Study|Treatment Defaulter|0|||
170749561|NCT01734434|617088183|FG002|Overall Study|Treatment Defaulter|1|||
170749562|NCT01734434|617088184|FG003|Overall Study|Treatment Defaulter|0|||
170749563|NCT01734434|617088181|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
170749564|NCT01734434|617088182|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
170749565|NCT01734434|617088183|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
170749566|NCT01734434|617088184|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
170749567|NCT01734434|617088181|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
170749568|NCT01734434|617088182|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
170749569|NCT01734434|617088183|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
170749570|NCT01734434|617088184|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
170749571|NCT00876460|617088185|FG000|Combination Therapy Phase|Progressive disease|2|||
170749572|NCT00876460|617088186|FG001|Combination Therapy Phase|Progressive disease|3|||
170749573|NCT00876460|617088187|FG002|Combination Therapy Phase|Progressive disease|3|||
170749574|NCT00876460|617088188|FG003|Combination Therapy Phase|Progressive disease|3|||
170749575|NCT00876460|617088189|FG004|Combination Therapy Phase|Progressive disease|3|||
170749576|NCT00876460|617088190|FG005|Combination Therapy Phase|Progressive disease|1|||
170749577|NCT00876460|617088191|FG006|Combination Therapy Phase|Progressive disease|1|||
170749578|NCT00876460|617088192|FG007|Combination Therapy Phase|Progressive disease|1|||
170749579|NCT00876460|617088185|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
170749580|NCT00876460|617088186|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
170749581|NCT00876460|617088187|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
170749582|NCT00876460|617088188|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
170749583|NCT00876460|617088189|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
170749584|NCT00876460|617088190|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
170749585|NCT00876460|617088191|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
170749586|NCT00876460|617088192|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
170749587|NCT00876460|617088185|FG000|Combination Therapy Phase|Adverse Event|0|||
170749588|NCT00876460|617088186|FG001|Combination Therapy Phase|Adverse Event|2|||
170749589|NCT00876460|617088187|FG002|Combination Therapy Phase|Adverse Event|0|||
170749590|NCT00876460|617088188|FG003|Combination Therapy Phase|Adverse Event|2|||
170749591|NCT00876460|617088189|FG004|Combination Therapy Phase|Adverse Event|2|||
170749592|NCT00876460|617088190|FG005|Combination Therapy Phase|Adverse Event|0|||
170749593|NCT00876460|617088191|FG006|Combination Therapy Phase|Adverse Event|3|||
170749594|NCT00876460|617088192|FG007|Combination Therapy Phase|Adverse Event|2|||
170749595|NCT00876460|617088185|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
170749596|NCT00876460|617088186|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
170749597|NCT00876460|617088187|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
170749598|NCT00876460|617088188|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
170749599|NCT00876460|617088189|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
170749600|NCT00876460|617088190|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
170749601|NCT00876460|617088191|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
170749602|NCT00876460|617088192|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
170749603|NCT00876460|617088185|FG000|Combination Therapy Phase|Other reason not defined above|0|||
170749604|NCT00876460|617088186|FG001|Combination Therapy Phase|Other reason not defined above|0|||
170749605|NCT00876460|617088187|FG002|Combination Therapy Phase|Other reason not defined above|0|||
170749606|NCT00876460|617088188|FG003|Combination Therapy Phase|Other reason not defined above|0|||
170749607|NCT00876460|617088189|FG004|Combination Therapy Phase|Other reason not defined above|0|||
170749608|NCT00876460|617088190|FG005|Combination Therapy Phase|Other reason not defined above|0|||
170749609|NCT00876460|617088191|FG006|Combination Therapy Phase|Other reason not defined above|1|||
170749610|NCT00876460|617088192|FG007|Combination Therapy Phase|Other reason not defined above|2|||
170749611|NCT00876460|617088185|FG000|Combination Therapy Phase|Not treated|0|||
170749612|NCT00876460|617088186|FG001|Combination Therapy Phase|Not treated|0|||
170749613|NCT00876460|617088187|FG002|Combination Therapy Phase|Not treated|0|||
170749614|NCT00876460|617088188|FG003|Combination Therapy Phase|Not treated|0|||
170749615|NCT00876460|617088189|FG004|Combination Therapy Phase|Not treated|0|||
170749616|NCT00876460|617088190|FG005|Combination Therapy Phase|Not treated|0|||
170749617|NCT00876460|617088191|FG006|Combination Therapy Phase|Not treated|1|||
170749618|NCT00876460|617088192|FG007|Combination Therapy Phase|Not treated|0|||
170749619|NCT00876460|617088185|FG000|Mono Therapy Phase|Progressive disease|0|||
170749620|NCT00876460|617088186|FG001|Mono Therapy Phase|Progressive disease|0|||
170749621|NCT00876460|617088187|FG002|Mono Therapy Phase|Progressive disease|0|||
170749622|NCT00876460|617088188|FG003|Mono Therapy Phase|Progressive disease|0|||
170749623|NCT00876460|617088189|FG004|Mono Therapy Phase|Progressive disease|2|||
170749624|NCT00876460|617088190|FG005|Mono Therapy Phase|Progressive disease|0|||
170749625|NCT00876460|617088191|FG006|Mono Therapy Phase|Progressive disease|1|||
170749626|NCT00876460|617088192|FG007|Mono Therapy Phase|Progressive disease|3|||
170749627|NCT00876460|617088185|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
170749628|NCT00876460|617088186|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
170749629|NCT00876460|617088187|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
170749630|NCT00876460|617088188|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
170749631|NCT00876460|617088189|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
170749632|NCT00876460|617088190|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
170749633|NCT00876460|617088191|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
170749634|NCT00876460|617088192|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
170749635|NCT00876460|617088185|FG000|Mono Therapy Phase|Adverse Event|0|||
170749636|NCT00876460|617088186|FG001|Mono Therapy Phase|Adverse Event|0|||
170749637|NCT00876460|617088187|FG002|Mono Therapy Phase|Adverse Event|0|||
170749638|NCT00876460|617088188|FG003|Mono Therapy Phase|Adverse Event|1|||
170749639|NCT00876460|617088189|FG004|Mono Therapy Phase|Adverse Event|0|||
170749640|NCT00876460|617088190|FG005|Mono Therapy Phase|Adverse Event|0|||
170749641|NCT00876460|617088191|FG006|Mono Therapy Phase|Adverse Event|0|||
170749642|NCT00876460|617088192|FG007|Mono Therapy Phase|Adverse Event|0|||
170749643|NCT00064025|617088193|FG000|Overall Study|Ineligible|4|||
170749644|NCT00064025|617088193|FG000|Overall Study|Inevaluable|3|||
170749645|NCT01370603|617088194|FG000|Period 1|Adverse Event|5|||
170749646|NCT01370603|617088195|FG001|Period 1|Adverse Event|3|||
170749647|NCT01370603|617088194|FG000|Period 1|Lost to Follow-up|2|||
170749648|NCT01370603|617088195|FG001|Period 1|Lost to Follow-up|0|||
170749649|NCT01370603|617088194|FG000|Period 1|Protocol Violation|2|||
170749650|NCT01370603|617088195|FG001|Period 1|Protocol Violation|2|||
170749651|NCT01370603|617088194|FG000|Period 1|Withdrawal by Subject|5|||
170749652|NCT01370603|617088195|FG001|Period 1|Withdrawal by Subject|5|||
170749653|NCT01370603|617088194|FG000|Crossover Washout|Adverse Event|2|||
170749654|NCT01370603|617088195|FG001|Crossover Washout|Adverse Event|1|||
170749655|NCT01370603|617088194|FG000|Crossover Washout|Lost to Follow-up|2|||
170749656|NCT01370603|617088195|FG001|Crossover Washout|Lost to Follow-up|0|||
170749657|NCT01370603|617088194|FG000|Crossover Washout|Protocol Violation|1|||
170749658|NCT01370603|617088195|FG001|Crossover Washout|Protocol Violation|0|||
170749659|NCT01370603|617088194|FG000|Crossover Washout|Withdrawal by Subject|4|||
170749660|NCT01370603|617088195|FG001|Crossover Washout|Withdrawal by Subject|1|||
170749661|NCT01370603|617088194|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
170749662|NCT01370603|617088195|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
170749663|NCT01370603|617088194|FG000|Period 2|Adverse Event|1|||
170749664|NCT01370603|617088195|FG001|Period 2|Adverse Event|4|||
170749665|NCT01370603|617088194|FG000|Period 2|Lost to Follow-up|1|||
170749666|NCT01370603|617088195|FG001|Period 2|Lost to Follow-up|0|||
170749667|NCT01370603|617088194|FG000|Period 2|Withdrawal by Subject|1|||
170749668|NCT01370603|617088195|FG001|Period 2|Withdrawal by Subject|0|||
170749669|NCT02036515|617088196|FG000|Overall Study|Adverse Event|1|||
170749670|NCT02036515|617088197|FG001|Overall Study|Adverse Event|1|||
170749671|NCT02036515|617088198|FG002|Overall Study|Adverse Event|2|||
170749672|NCT02036515|617088196|FG000|Overall Study|Lost to Follow-up|0|||
170749673|NCT02036515|617088197|FG001|Overall Study|Lost to Follow-up|2|||
170749674|NCT02036515|617088198|FG002|Overall Study|Lost to Follow-up|0|||
170749675|NCT02036515|617088196|FG000|Overall Study|Non-compliance with study drug|0|||
170749676|NCT02036515|617088197|FG001|Overall Study|Non-compliance with study drug|0|||
170749677|NCT02036515|617088198|FG002|Overall Study|Non-compliance with study drug|2|||
170749678|NCT02036515|617088196|FG000|Overall Study|Screen failure|0|||
170749679|NCT02036515|617088197|FG001|Overall Study|Screen failure|2|||
170749680|NCT02036515|617088198|FG002|Overall Study|Screen failure|0|||
170749681|NCT02036515|617088196|FG000|Overall Study|Withdrawal by Subject|4|||
170749682|NCT02036515|617088197|FG001|Overall Study|Withdrawal by Subject|7|||
170749683|NCT02036515|617088198|FG002|Overall Study|Withdrawal by Subject|9|||
170749684|NCT02036515|617088196|FG000|Overall Study|Hyperglycemia|0|||
170749685|NCT02036515|617088197|FG001|Overall Study|Hyperglycemia|0|||
170749686|NCT02036515|617088198|FG002|Overall Study|Hyperglycemia|1|||
170749687|NCT01216293|617088199|FG000|Main Study|Adverse Event|1|||
170749688|NCT01216293|617088200|FG001|Main Study|Adverse Event|4|||
170749689|NCT01216293|617088201|FG002|Main Study|Adverse Event|2|||
170749690|NCT01216293|617088199|FG000|Main Study|Major Protocol Deviation|1|||
170749691|NCT01216293|617088200|FG001|Main Study|Major Protocol Deviation|0|||
170749692|NCT01216293|617088201|FG002|Main Study|Major Protocol Deviation|1|||
170749693|NCT01216293|617088199|FG000|Main Study|Lost to Follow-up|3|||
170749694|NCT01216293|617088200|FG001|Main Study|Lost to Follow-up|1|||
170749695|NCT01216293|617088201|FG002|Main Study|Lost to Follow-up|0|||
170749696|NCT01216293|617088199|FG000|Main Study|Voluntary Withdrawal|2|||
170749697|NCT01216293|617088200|FG001|Main Study|Voluntary Withdrawal|2|||
170749698|NCT01216293|617088201|FG002|Main Study|Voluntary Withdrawal|2|||
170749699|NCT01216293|617088199|FG000|Main Study|Other Reason Not Specified|0|||
170749700|NCT01216293|617088200|FG001|Main Study|Other Reason Not Specified|1|||
170749701|NCT01216293|617088201|FG002|Main Study|Other Reason Not Specified|1|||
170749702|NCT01216293|617088199|FG000|Main Study|Randomized, Not Treated|1|||
170749703|NCT01216293|617088200|FG001|Main Study|Randomized, Not Treated|0|||
170749704|NCT01216293|617088201|FG002|Main Study|Randomized, Not Treated|0|||
170749705|NCT01216293|617088199|FG000|Calcium Absorption Substudy|Adverse Event|0|||
170749706|NCT01216293|617088200|FG001|Calcium Absorption Substudy|Adverse Event|2|||
170749707|NCT01216293|617088201|FG002|Calcium Absorption Substudy|Adverse Event|0|||
170749708|NCT01216293|617088199|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
170749709|NCT01216293|617088200|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
170749710|NCT01216293|617088201|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
170749711|NCT01216293|617088199|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
170749712|NCT01216293|617088200|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
170749713|NCT01216293|617088201|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
170749714|NCT05567952|617090320|FG000|Overall Study|Lost to Follow-up|3|||
170749715|NCT05567952|617090321|FG001|Overall Study|Lost to Follow-up|2|||
170749716|NCT05567952|617090320|FG000|Overall Study|Withdrawal by Subject|6|||
170749717|NCT05567952|617090321|FG001|Overall Study|Withdrawal by Subject|3|||
170749718|NCT05567952|617090320|FG000|Overall Study|Other|3|||
170749719|NCT05567952|617090321|FG001|Overall Study|Other|1|||
170749720|NCT02692235|617090324|FG000|Overall Study|Withdrawal by Subject|2|||
170749721|NCT02692235|617090325|FG001|Overall Study|Withdrawal by Subject|1|||
170749722|NCT02692235|617090324|FG000|Overall Study|Adverse Event|1|||
170749723|NCT02692235|617090325|FG001|Overall Study|Adverse Event|2|||
170749724|NCT00432159|617090326|FG000|Overall Study|Death|0|||
170749725|NCT00432159|617090327|FG001|Overall Study|Death|1|||
170749726|NCT00432159|617090328|FG002|Overall Study|Death|0|||
170749727|NCT00432159|617090329|FG003|Overall Study|Death|0|||
170749728|NCT00432159|617090330|FG004|Overall Study|Death|0|||
170749729|NCT00432159|617090326|FG000|Overall Study|Failure|9|||
170749730|NCT00432159|617090327|FG001|Overall Study|Failure|5|||
170749731|NCT00432159|617090328|FG002|Overall Study|Failure|3|||
170749732|NCT00432159|617090329|FG003|Overall Study|Failure|2|||
170749733|NCT00432159|617090330|FG004|Overall Study|Failure|3|||
170749734|NCT00432159|617090326|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
170749735|NCT00432159|617090327|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
170749736|NCT00432159|617090328|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
170749737|NCT00432159|617090329|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
170749738|NCT00432159|617090330|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
170749739|NCT03615482|617090332|FG000|Overall Study|Death|1|||
170749740|NCT03615482|617090333|FG001|Overall Study|Death|0|||
170749741|NCT03615482|617090332|FG000|Overall Study|Lost to Follow-up|7|||
170749742|NCT03615482|617090333|FG001|Overall Study|Lost to Follow-up|7|||
170749743|NCT03615482|617090332|FG000|Overall Study|Physician Decision|2|||
170749744|NCT03615482|617090333|FG001|Overall Study|Physician Decision|3|||
170749745|NCT03615482|617090332|FG000|Overall Study|Withdrawal by Subject|7|||
170749746|NCT03615482|617090333|FG001|Overall Study|Withdrawal by Subject|7|||
170749747|NCT02892409|617090344|FG000|Overall Study|Adverse Event|1|||
170749748|NCT02892409|617090345|FG001|Overall Study|Adverse Event|0|||
170749749|NCT02892409|617090344|FG000|Overall Study|Withdrawal by Subject|2|||
170749750|NCT02892409|617090345|FG001|Overall Study|Withdrawal by Subject|1|||
170749751|NCT05876351|617090347|FG000|Overall Study|Other than specified|2|||
170749752|NCT05876351|617090347|FG000|Overall Study|Study specific discontinuation criteria|1|||
170749753|NCT00997243|617090350|FG000|Overall Study|Early termination of study by sponsor|7|||
170749754|NCT00478608|617090357|FG000|Overall Study|Adverse Event|1|||
170749755|NCT00478608|617090357|FG000|Overall Study|Serious Adverse Event|14|||
170749756|NCT00478608|617090357|FG000|Overall Study|Withdrawal by Subject|2|||
170749757|NCT00478608|617090357|FG000|Overall Study|Protocol Violation|3|||
170749758|NCT00390455|617090358|FG000|Overall Study|Adverse Event|17|||
170749759|NCT00390455|617090359|FG001|Overall Study|Adverse Event|3|||
170749760|NCT00390455|617090358|FG000|Overall Study|Withdrawal by Subject|8|||
170749761|NCT00390455|617090359|FG001|Overall Study|Withdrawal by Subject|8|||
170749762|NCT00390455|617090358|FG000|Overall Study|Alternate Treatment|0|||
170749763|NCT00390455|617090359|FG001|Overall Study|Alternate Treatment|1|||
170749764|NCT00390455|617090358|FG000|Overall Study|Other Medical Reasons|7|||
170749765|NCT00390455|617090359|FG001|Overall Study|Other Medical Reasons|11|||
170861474|NCT03567434|617501869|FG000|Overall Study|Lost to Follow-up|1|||
170749766|NCT00280293|617090364|FG000|Overall Study|Protocol Violation|3|||
170749767|NCT00280293|617090365|FG001|Overall Study|Protocol Violation|0|||
170749768|NCT00280293|617090364|FG000|Overall Study|Physician Decision|5|||
170749769|NCT00280293|617090365|FG001|Overall Study|Physician Decision|4|||
170861475|NCT03567434|617501870|FG001|Overall Study|Lost to Follow-up|3|||
170749770|NCT00280293|617090364|FG000|Overall Study|Lost to Follow-up|14|||
170749771|NCT00280293|617090365|FG001|Overall Study|Lost to Follow-up|12|||
170749772|NCT00280293|617090364|FG000|Overall Study|Withdrawal by Subject|3|||
170749773|NCT00280293|617090365|FG001|Overall Study|Withdrawal by Subject|5|||
170749774|NCT00280293|617090364|FG000|Overall Study|Incarceration/Legal Reasons|1|||
170749775|NCT00280293|617090365|FG001|Overall Study|Incarceration/Legal Reasons|1|||
170749776|NCT00280293|617090364|FG000|Overall Study|Adverse Event|0|||
170749777|NCT00280293|617090365|FG001|Overall Study|Adverse Event|1|||
170749778|NCT01720797|617090366|FG000|Overall Study|Withdrawal by Subject|3|||
170749779|NCT01720797|617090367|FG001|Overall Study|Withdrawal by Subject|0|||
170749780|NCT00724061|617090368|FG000|Dose Escalation Phase|Adverse Event|2|||
170749781|NCT00724061|617090368|FG000|Dose Escalation Phase|Disease Progression|3|||
170749782|NCT00594932|617090370|FG000|First 3 Months|Withdrawal by Subject|1|||
170749783|NCT00594932|617090371|FG001|First 3 Months|Withdrawal by Subject|3|||
170749784|NCT00594932|617090370|FG000|Final 3 Months|Withdrawal by Subject|4|||
170749785|NCT00594932|617090371|FG001|Final 3 Months|Withdrawal by Subject|3|||
170749786|NCT01686932|617090372|FG000|Period 1|Adverse Event|1|||
170749787|NCT01686932|617090373|FG001|Period 1|Adverse Event|1|||
170749788|NCT01630590|617090376|FG000|Overall Study|Adverse Event|9|||
170749789|NCT01630590|617090376|FG000|Overall Study|Lack of Efficacy|37|||
170749790|NCT01630590|617090376|FG000|Overall Study|Withdrawal by Subject|4|||
170749791|NCT01630590|617090376|FG000|Overall Study|2nd primary tumor|2|||
170749792|NCT01630590|617090376|FG000|Overall Study|Automobile accident|1|||
170749793|NCT01630590|617090376|FG000|Overall Study|Maximum benefit|4|||
170749794|NCT01751113|617090377|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
170749795|NCT01751113|617090378|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
170749796|NCT01751113|617090379|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
170749797|NCT01751113|617090380|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
170749798|NCT01751113|617090381|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
170749799|NCT01751113|617090382|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
170749800|NCT01751113|617090377|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
170749801|NCT01751113|617090378|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
170749802|NCT01751113|617090379|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
170749803|NCT01751113|617090380|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
170749804|NCT01751113|617090381|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
170749805|NCT01751113|617090382|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
170749806|NCT00924469|617090383|FG000|Overall Study|Adverse Event|2|||
170749807|NCT00924469|617090384|FG001|Overall Study|Adverse Event|0|||
170749808|NCT00924469|617090383|FG000|Overall Study|Withdrawal by Subject|0|||
170749809|NCT00924469|617090384|FG001|Overall Study|Withdrawal by Subject|1|||
170749810|NCT00924469|617090383|FG000|Overall Study|Lost to Follow-up|0|||
170749811|NCT00924469|617090384|FG001|Overall Study|Lost to Follow-up|1|||
170749812|NCT01651936|617090386|FG000|Base Study|Adverse Event|3|||
170749813|NCT01651936|617090387|FG001|Base Study|Adverse Event|0|||
170749814|NCT01651936|617090388|FG002|Base Study|Adverse Event|0|||
170749815|NCT01651936|617090386|FG000|Base Study|Withdrawal by Subject|1|||
170749816|NCT01651936|617090387|FG001|Base Study|Withdrawal by Subject|1|||
170749817|NCT01651936|617090388|FG002|Base Study|Withdrawal by Subject|0|||
170749818|NCT01651936|617090386|FG000|Base Study|Early Escape|2|||
170749819|NCT01651936|617090387|FG001|Base Study|Early Escape|8|||
170749820|NCT01651936|617090388|FG002|Base Study|Early Escape|0|||
170749821|NCT01651936|617090386|FG000|Base Study|Study terminated by sponsor|21|||
170749822|NCT01651936|617090387|FG001|Base Study|Study terminated by sponsor|16|||
170749823|NCT01651936|617090388|FG002|Base Study|Study terminated by sponsor|0|||
170749824|NCT01651936|617090386|FG000|Extension Study|Lack of Efficacy|0|||
170749825|NCT01651936|617090387|FG001|Extension Study|Lack of Efficacy|0|||
170749826|NCT01651936|617090388|FG002|Extension Study|Lack of Efficacy|1|||
170749827|NCT01651936|617090386|FG000|Extension Study|Study terminated by sponsor|0|||
170749828|NCT01651936|617090387|FG001|Extension Study|Study terminated by sponsor|0|||
170749829|NCT01651936|617090388|FG002|Extension Study|Study terminated by sponsor|13|||
170749830|NCT03044353|617090389|FG000|Overall Study|Adverse Event|0|||
170749831|NCT03044353|617090390|FG001|Overall Study|Adverse Event|1|||
170749832|NCT03044353|617090391|FG002|Overall Study|Adverse Event|0|||
170749833|NCT03358329|617090401|FG000|Overall Study|Lost to Follow-up|2|||
170749834|NCT03358329|617090401|FG000|Overall Study|Withdrawal by Subject|2|||
170749835|NCT02982720|617090402|FG000|Overall Study|Adverse Event|3|||
170749836|NCT02982720|617090402|FG000|Overall Study|Death|1|||
170749837|NCT03875911|617090405|FG000|Overall Study|Lost to Follow-up|3|||
170749838|NCT03875911|617090406|FG001|Overall Study|Lost to Follow-up|6|||
170749839|NCT03875911|617090407|FG002|Overall Study|Lost to Follow-up|2|||
170749840|NCT03875911|617090405|FG000|Overall Study|Surgery cancelled|1|||
170749841|NCT03875911|617090406|FG001|Overall Study|Surgery cancelled|0|||
170749842|NCT03875911|617090407|FG002|Overall Study|Surgery cancelled|1|||
170749843|NCT03875911|617090405|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
170749844|NCT03875911|617090406|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
170749845|NCT03875911|617090407|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
170749846|NCT01734850|617090408|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
170749847|NCT01734850|617090409|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
170749848|NCT01734850|617090410|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
170749849|NCT01734850|617090408|FG000|Overall Study|Not infused due to manufacturing failure|0|||
170749850|NCT01734850|617090409|FG001|Overall Study|Not infused due to manufacturing failure|0|||
170749851|NCT01734850|617090410|FG002|Overall Study|Not infused due to manufacturing failure|1|||
170749852|NCT03824938|617090411|FG000|Overall Study|Withdrawal by Subject|2|||
170749853|NCT03824938|617090412|FG001|Overall Study|Withdrawal by Subject|1|||
170749854|NCT03824938|617090413|FG002|Overall Study|Withdrawal by Subject|0|||
170749855|NCT03824938|617090414|FG003|Overall Study|Withdrawal by Subject|2|||
170749856|NCT03824938|617090415|FG004|Overall Study|Withdrawal by Subject|0|||
170749857|NCT03824938|617090416|FG005|Overall Study|Withdrawal by Subject|1|||
170749858|NCT03824938|617090411|FG000|Overall Study|Lost to Follow-up|0|||
170749859|NCT03824938|617090412|FG001|Overall Study|Lost to Follow-up|1|||
170749860|NCT03824938|617090413|FG002|Overall Study|Lost to Follow-up|0|||
170749861|NCT03824938|617090414|FG003|Overall Study|Lost to Follow-up|0|||
170749862|NCT03824938|617090415|FG004|Overall Study|Lost to Follow-up|1|||
170749863|NCT03824938|617090416|FG005|Overall Study|Lost to Follow-up|0|||
170749864|NCT05284019|617090417|FG000|Overall Study|Study terminated|2|||
170749865|NCT05284019|617090418|FG001|Overall Study|Study terminated|2|||
170749866|NCT05284019|617090419|FG002|Overall Study|Study terminated|2|||
170749867|NCT05284019|617090420|FG003|Overall Study|Study terminated|5|||
170749868|NCT05284019|617090421|FG004|Overall Study|Study terminated|15|||
170749869|NCT05284019|617090417|FG000|Overall Study|Withdrawal by Subject|0|||
170749870|NCT05284019|617090418|FG001|Overall Study|Withdrawal by Subject|0|||
170749871|NCT05284019|617090419|FG002|Overall Study|Withdrawal by Subject|0|||
170749872|NCT05284019|617090420|FG003|Overall Study|Withdrawal by Subject|1|||
170749873|NCT05284019|617090421|FG004|Overall Study|Withdrawal by Subject|1|||
170749874|NCT05284019|617090417|FG000|Overall Study|Lost to Follow-up|1|||
170749875|NCT05284019|617090418|FG001|Overall Study|Lost to Follow-up|0|||
170749876|NCT05284019|617090419|FG002|Overall Study|Lost to Follow-up|0|||
170749877|NCT05284019|617090420|FG003|Overall Study|Lost to Follow-up|2|||
170749878|NCT05284019|617090421|FG004|Overall Study|Lost to Follow-up|1|||
170749879|NCT01990300|617090422|FG000|Overall Study|Case Report Forms Uncollected|89|||
170749880|NCT01990300|617090422|FG000|Overall Study|Protocol Deviation|53|||
170749881|NCT02293837|617090423|FG000|Overall Study|Lost to Follow-up|0|||
170518772|NCT00377637|616246003|FG001|Maintenance Phase|Physician Decision|0|||
170518773|NCT00377637|616246004|FG002|Maintenance Phase|Physician Decision|5|||
170518774|NCT00377637|616246005|FG003|Maintenance Phase|Physician Decision|4|||
170518775|NCT00377637|616246002|FG000|Maintenance Phase|Lost to Follow-up|0|||
170518776|NCT00377637|616246003|FG001|Maintenance Phase|Lost to Follow-up|0|||
170518777|NCT00377637|616246004|FG002|Maintenance Phase|Lost to Follow-up|3|||
170518778|NCT00377637|616246005|FG003|Maintenance Phase|Lost to Follow-up|1|||
170518779|NCT00377637|616246002|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170518780|NCT00377637|616246003|FG001|Maintenance Phase|Withdrawal by Subject|0|||
170518781|NCT00377637|616246004|FG002|Maintenance Phase|Withdrawal by Subject|3|||
170518782|NCT00377637|616246005|FG003|Maintenance Phase|Withdrawal by Subject|3|||
170518783|NCT00377637|616246002|FG000|Maintenance Phase|Sponsor decision|0|||
170518784|NCT00377637|616246003|FG001|Maintenance Phase|Sponsor decision|0|||
170518785|NCT00377637|616246004|FG002|Maintenance Phase|Sponsor decision|2|||
170518786|NCT00377637|616246005|FG003|Maintenance Phase|Sponsor decision|3|||
170518787|NCT00377637|616246002|FG000|Maintenance Phase|Non-compliance|0|||
170518788|NCT00377637|616246003|FG001|Maintenance Phase|Non-compliance|0|||
170518789|NCT00377637|616246004|FG002|Maintenance Phase|Non-compliance|1|||
170518790|NCT00377637|616246005|FG003|Maintenance Phase|Non-compliance|1|||
170518791|NCT00377637|616246002|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
170518792|NCT00377637|616246003|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
170518793|NCT00377637|616246004|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
170749882|NCT02293837|617090424|FG001|Overall Study|Lost to Follow-up|2|||
170861476|NCT05606328|617501873|FG000|Months 4-6|No longer meets eligibility criteria|1|||
170861477|NCT05606328|617501874|FG001|Months 4-6|No longer meets eligibility criteria|0|||
170861478|NCT05606328|617501875|FG002|Months 4-6|No longer meets eligibility criteria|0|||
170861479|NCT05269355|617501877|FG000|Overall Study|Progressive Disease|104|||
170861480|NCT05269355|617501878|FG001|Overall Study|Progressive Disease|68|||
170861481|NCT05269355|617501877|FG000|Overall Study|Study Terminated by Sponsor|87|||
170861482|NCT05269355|617501878|FG001|Overall Study|Study Terminated by Sponsor|29|||
170861483|NCT05269355|617501877|FG000|Overall Study|Adverse Event|15|||
170861484|NCT05269355|617501878|FG001|Overall Study|Adverse Event|8|||
170861485|NCT05269355|617501877|FG000|Overall Study|Withdrawal by Subject|18|||
170861486|NCT05269355|617501878|FG001|Overall Study|Withdrawal by Subject|5|||
170861487|NCT05269355|617501877|FG000|Overall Study|Physician Decision|6|||
170518794|NCT00377637|616246005|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
170749883|NCT02293837|617090425|FG002|Overall Study|Lost to Follow-up|1|||
170749884|NCT02293837|617090426|FG003|Overall Study|Lost to Follow-up|0|||
170518795|NCT00377637|616246002|FG000|Maintenance Phase|Death|0|||
170749885|NCT02293837|617090423|FG000|Overall Study|Withdrawal by Subject|2|||
170749886|NCT02293837|617090424|FG001|Overall Study|Withdrawal by Subject|1|||
170861488|NCT05269355|617501878|FG001|Overall Study|Physician Decision|4|||
170861489|NCT05269355|617501877|FG000|Overall Study|Death|3|||
170861490|NCT05269355|617501878|FG001|Overall Study|Death|5|||
170861491|NCT05269355|617501877|FG000|Overall Study|Other Than Specified|5|||
170861492|NCT05269355|617501878|FG001|Overall Study|Other Than Specified|1|||
170861493|NCT05269355|617501877|FG000|Overall Study|Randomized But Not Treated|1|||
170861494|NCT05269355|617501878|FG001|Overall Study|Randomized But Not Treated|0|||
170861495|NCT05437510|617501879|FG000|Overall Study|Adverse Event|2|||
170861496|NCT05437510|617501880|FG001|Overall Study|Adverse Event|1|||
170861497|NCT05437510|617501879|FG000|Overall Study|Protocol Deviation|1|||
170861498|NCT05437510|617501880|FG001|Overall Study|Protocol Deviation|6|||
170861499|NCT05437510|617501879|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
170518796|NCT00377637|616246003|FG001|Maintenance Phase|Death|0|||
170518797|NCT00377637|616246004|FG002|Maintenance Phase|Death|0|||
170518798|NCT00377637|616246005|FG003|Maintenance Phase|Death|1|||
170518799|NCT01716806|616246010|FG000|Overall Study|Patient withdrawal of consent|4|||
170518800|NCT01716806|616246011|FG001|Overall Study|Patient withdrawal of consent|2|||
170518801|NCT01716806|616246012|FG002|Overall Study|Patient withdrawal of consent|4|||
170518802|NCT01716806|616246013|FG003|Overall Study|Patient withdrawal of consent|3|||
170518803|NCT01716806|616246014|FG004|Overall Study|Patient withdrawal of consent|2|||
170518804|NCT01716806|616246015|FG005|Overall Study|Patient withdrawal of consent|0|||
170518805|NCT01716806|616246010|FG000|Overall Study|Lost to Follow-up|3|||
170518806|NCT01716806|616246011|FG001|Overall Study|Lost to Follow-up|3|||
170518807|NCT01716806|616246012|FG002|Overall Study|Lost to Follow-up|0|||
170518808|NCT01716806|616246013|FG003|Overall Study|Lost to Follow-up|2|||
170518809|NCT01716806|616246014|FG004|Overall Study|Lost to Follow-up|1|||
170518810|NCT01716806|616246015|FG005|Overall Study|Lost to Follow-up|0|||
170518811|NCT01716806|616246010|FG000|Overall Study|Death|13|||
170518812|NCT01716806|616246011|FG001|Overall Study|Death|9|||
170518813|NCT01716806|616246012|FG002|Overall Study|Death|12|||
170518814|NCT01716806|616246013|FG003|Overall Study|Death|4|||
170518815|NCT01716806|616246014|FG004|Overall Study|Death|10|||
170518816|NCT01716806|616246015|FG005|Overall Study|Death|5|||
170518817|NCT01716806|616246010|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
170518818|NCT01716806|616246011|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
170518819|NCT01716806|616246012|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
170518820|NCT01716806|616246013|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
170518821|NCT01716806|616246014|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
170518822|NCT01716806|616246015|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
170518823|NCT01716806|616246010|FG000|Overall Study|PI decision|0|||
170518824|NCT01716806|616246011|FG001|Overall Study|PI decision|0|||
170518825|NCT01716806|616246012|FG002|Overall Study|PI decision|0|||
170518826|NCT01716806|616246013|FG003|Overall Study|PI decision|0|||
170518827|NCT01716806|616246014|FG004|Overall Study|PI decision|1|||
170518828|NCT01716806|616246015|FG005|Overall Study|PI decision|0|||
170518829|NCT01716806|616246010|FG000|Overall Study|Change in performance status|1|||
170518830|NCT01716806|616246011|FG001|Overall Study|Change in performance status|0|||
170518831|NCT01716806|616246012|FG002|Overall Study|Change in performance status|0|||
170518832|NCT01716806|616246013|FG003|Overall Study|Change in performance status|0|||
170518833|NCT01716806|616246014|FG004|Overall Study|Change in performance status|0|||
170518834|NCT01716806|616246015|FG005|Overall Study|Change in performance status|0|||
170518835|NCT01716806|616246010|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
170518836|NCT01716806|616246011|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
170518837|NCT01716806|616246012|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
170518838|NCT01716806|616246013|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
170518839|NCT01716806|616246014|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
170518840|NCT01716806|616246015|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
170518841|NCT01716806|616246010|FG000|Overall Study|Sponsor direction|7|||
170518842|NCT01716806|616246011|FG001|Overall Study|Sponsor direction|8|||
170518843|NCT01716806|616246012|FG002|Overall Study|Sponsor direction|5|||
170518844|NCT01716806|616246013|FG003|Overall Study|Sponsor direction|12|||
170518845|NCT01716806|616246014|FG004|Overall Study|Sponsor direction|16|||
170518846|NCT01716806|616246015|FG005|Overall Study|Sponsor direction|1|||
170518847|NCT01111565|616246016|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
170518848|NCT01111565|616246017|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
170518849|NCT01111565|616246018|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
170518850|NCT01111565|616246019|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
170518851|NCT01111565|616246020|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
170518852|NCT01111565|616246016|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
170518853|NCT01111565|616246017|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
170861500|NCT05437510|617501880|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
170861501|NCT05437510|617501879|FG000|Overall Study|Lost to Follow-up|265|||
170861502|NCT05437510|617501880|FG001|Overall Study|Lost to Follow-up|358|||
170518854|NCT01111565|616246018|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
170518855|NCT01111565|616246019|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
170518856|NCT01111565|616246020|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
170518857|NCT01111565|616246016|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
170518858|NCT01111565|616246017|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
170518859|NCT01111565|616246018|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
170518860|NCT01111565|616246019|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
170518861|NCT01111565|616246020|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
170518862|NCT01111565|616246016|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
170518863|NCT01111565|616246017|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
170518864|NCT01111565|616246018|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
170518865|NCT01111565|616246019|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
170518866|NCT01111565|616246020|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
170518867|NCT01111565|616246016|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
170518868|NCT01111565|616246017|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
170518869|NCT01111565|616246018|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
170518870|NCT01111565|616246019|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
170518871|NCT01111565|616246020|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
170518872|NCT01111565|616246016|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
170518873|NCT01111565|616246017|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
170518874|NCT01111565|616246018|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
170518875|NCT01111565|616246019|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
170518876|NCT01111565|616246020|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
170518877|NCT01111565|616246016|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
170518878|NCT01111565|616246017|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
170518879|NCT01111565|616246018|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
170518880|NCT01111565|616246019|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
170518881|NCT01111565|616246020|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
170518882|NCT01111565|616246016|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
170518883|NCT01111565|616246017|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
170518884|NCT01111565|616246018|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
170518885|NCT01111565|616246019|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
170749887|NCT02293837|617090425|FG002|Overall Study|Withdrawal by Subject|2|||
170749888|NCT02293837|617090426|FG003|Overall Study|Withdrawal by Subject|1|||
170749889|NCT02293837|617090423|FG000|Overall Study|COVID-19 Related|1|||
170749890|NCT02293837|617090424|FG001|Overall Study|COVID-19 Related|1|||
170749891|NCT02293837|617090425|FG002|Overall Study|COVID-19 Related|0|||
170749892|NCT02293837|617090426|FG003|Overall Study|COVID-19 Related|0|||
170749893|NCT02293837|617090423|FG000|Overall Study|Participant ill and could not be infused|0|||
170749894|NCT02293837|617090424|FG001|Overall Study|Participant ill and could not be infused|0|||
170749895|NCT02293837|617090425|FG002|Overall Study|Participant ill and could not be infused|1|||
170749896|NCT02293837|617090426|FG003|Overall Study|Participant ill and could not be infused|0|||
170749897|NCT01076088|617090427|FG000|Overall Study|Adverse Event|1|||
170749898|NCT01076088|617090428|FG001|Overall Study|Adverse Event|6|||
170749899|NCT01076088|617090429|FG002|Overall Study|Adverse Event|3|||
170749900|NCT01076088|617090430|FG003|Overall Study|Adverse Event|2|||
170749901|NCT01076088|617090431|FG004|Overall Study|Adverse Event|3|||
170749902|NCT01076088|617090432|FG005|Overall Study|Adverse Event|3|||
170749903|NCT01076088|617090427|FG000|Overall Study|Lost to Follow-up|1|||
170749904|NCT01076088|617090428|FG001|Overall Study|Lost to Follow-up|1|||
170749905|NCT01076088|617090429|FG002|Overall Study|Lost to Follow-up|0|||
170749906|NCT01076088|617090430|FG003|Overall Study|Lost to Follow-up|1|||
170749907|NCT01076088|617090431|FG004|Overall Study|Lost to Follow-up|1|||
170749908|NCT01076088|617090432|FG005|Overall Study|Lost to Follow-up|2|||
170749909|NCT01076088|617090427|FG000|Overall Study|Non-compliance with study drug|0|||
170749910|NCT01076088|617090428|FG001|Overall Study|Non-compliance with study drug|0|||
170749911|NCT01076088|617090429|FG002|Overall Study|Non-compliance with study drug|0|||
170749912|NCT01076088|617090430|FG003|Overall Study|Non-compliance with study drug|1|||
170749913|NCT01076088|617090431|FG004|Overall Study|Non-compliance with study drug|0|||
170749914|NCT01076088|617090432|FG005|Overall Study|Non-compliance with study drug|0|||
170749915|NCT01076088|617090427|FG000|Overall Study|Physician Decision|1|||
170749916|NCT01076088|617090428|FG001|Overall Study|Physician Decision|3|||
170749917|NCT01076088|617090429|FG002|Overall Study|Physician Decision|0|||
170749918|NCT01076088|617090430|FG003|Overall Study|Physician Decision|1|||
170749919|NCT01076088|617090431|FG004|Overall Study|Physician Decision|1|||
170749920|NCT01076088|617090432|FG005|Overall Study|Physician Decision|0|||
170518886|NCT01111565|616246020|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
170518887|NCT01111565|616246016|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170518888|NCT01111565|616246017|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170518889|NCT01111565|616246018|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
170749921|NCT01076088|617090427|FG000|Overall Study|Withdrawal by Subject|8|||
170749922|NCT01076088|617090428|FG001|Overall Study|Withdrawal by Subject|8|||
170518890|NCT01111565|616246019|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170518891|NCT01111565|616246020|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170518892|NCT01111565|616246016|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
170518893|NCT01111565|616246017|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
170518894|NCT01111565|616246018|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
170518895|NCT01111565|616246019|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
170518896|NCT01111565|616246020|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
170518897|NCT01111565|616246016|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
170518898|NCT01111565|616246017|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
170518899|NCT01111565|616246018|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
170518900|NCT01111565|616246019|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
170518901|NCT01111565|616246020|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
170518902|NCT01111565|616246016|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
170518903|NCT01111565|616246017|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
170518904|NCT01111565|616246018|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
170518905|NCT01111565|616246019|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
170518906|NCT01111565|616246020|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
170518907|NCT02498678|616246021|FG000|Overall Study|interference from the surgical team|0|||
170518908|NCT02498678|616246022|FG001|Overall Study|interference from the surgical team|2|||
170518909|NCT04131712|616246027|FG000|Overall Study|COVID related|0|||
170749923|NCT01076088|617090429|FG002|Overall Study|Withdrawal by Subject|14|||
170749924|NCT01076088|617090430|FG003|Overall Study|Withdrawal by Subject|10|||
170518910|NCT04131712|616246028|FG001|Overall Study|COVID related|0|||
170518911|NCT04131712|616246029|FG002|Overall Study|COVID related|2|||
170518912|NCT04131712|616246030|FG003|Overall Study|COVID related|0|||
170518913|NCT04131712|616246027|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
170518914|NCT04131712|616246028|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
170518915|NCT04131712|616246029|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
170518916|NCT04131712|616246030|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
170518917|NCT00357877|616246037|FG000|Overall Study|Death|2|||
170518918|NCT00357877|616246038|FG001|Overall Study|Death|1|||
170518919|NCT00357877|616246037|FG000|Overall Study|Lost to Follow-up|20|||
170518920|NCT00357877|616246038|FG001|Overall Study|Lost to Follow-up|23|||
170518921|NCT00357877|616246037|FG000|Overall Study|Withdrawal by Subject|3|||
170518922|NCT00357877|616246038|FG001|Overall Study|Withdrawal by Subject|3|||
170518923|NCT00357877|616246037|FG000|Overall Study|Administrative withdrawal|1|||
170518924|NCT00357877|616246038|FG001|Overall Study|Administrative withdrawal|1|||
170518925|NCT00357877|616246037|FG000|Overall Study|Other|0|||
170518926|NCT00357877|616246038|FG001|Overall Study|Other|2|||
170749925|NCT01076088|617090431|FG004|Overall Study|Withdrawal by Subject|11|||
170749926|NCT01076088|617090432|FG005|Overall Study|Withdrawal by Subject|17|||
170749927|NCT01076088|617090427|FG000|Overall Study|Other protocol specified criteria|0|||
170749928|NCT01076088|617090428|FG001|Overall Study|Other protocol specified criteria|0|||
170749929|NCT01076088|617090429|FG002|Overall Study|Other protocol specified criteria|0|||
170749930|NCT01076088|617090430|FG003|Overall Study|Other protocol specified criteria|0|||
170749931|NCT01076088|617090431|FG004|Overall Study|Other protocol specified criteria|0|||
170749932|NCT01076088|617090432|FG005|Overall Study|Other protocol specified criteria|1|||
170749933|NCT03285113|617090433|FG000|Overall Study|Unable to implant leads|2|||
170749934|NCT01058863|617090437|FG000|Overall Study|Lost to Follow-up|1|||
170749935|NCT01058863|617090437|FG000|Overall Study|Withdrawal by Subject|1|||
170749936|NCT01058863|617090437|FG000|Overall Study|Sponsor requested withdrawal|1|||
170749937|NCT01058863|617090437|FG000|Overall Study|Randomized in error|1|||
170749938|NCT03541642|617090438|FG000|Overall Study|Withdrawal by Subject|1|||
170749939|NCT03541642|617090439|FG001|Overall Study|Withdrawal by Subject|2|||
170749940|NCT03541642|617090438|FG000|Overall Study|Lost to Follow-up|16|||
170749941|NCT03541642|617090439|FG001|Overall Study|Lost to Follow-up|12|||
170749942|NCT03541642|617090438|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
170749943|NCT03541642|617090439|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
170749944|NCT03050398|617090442|FG000|Overall Study|Study terminated by sponsor|8|||
170749945|NCT05108649|617090443|FG000|Overall Study|Lost to Follow-up|0|||
170749946|NCT05108649|617090444|FG001|Overall Study|Lost to Follow-up|4|||
170749947|NCT05108649|617090445|FG002|Overall Study|Lost to Follow-up|3|||
170749948|NCT05108649|617090446|FG003|Overall Study|Lost to Follow-up|6|||
170749949|NCT05108649|617090443|FG000|Overall Study|Not Interested|1|||
170749950|NCT05108649|617090444|FG001|Overall Study|Not Interested|1|||
170749951|NCT05108649|617090445|FG002|Overall Study|Not Interested|0|||
170749952|NCT05108649|617090446|FG003|Overall Study|Not Interested|1|||
170749953|NCT05108649|617090443|FG000|Overall Study|Out of area|0|||
170749954|NCT05108649|617090444|FG001|Overall Study|Out of area|0|||
170749955|NCT05108649|617090445|FG002|Overall Study|Out of area|0|||
170749956|NCT05108649|617090446|FG003|Overall Study|Out of area|1|||
170518927|NCT02619617|616246039|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
170518928|NCT02619617|616246040|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
170518929|NCT02619617|616246039|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
170518930|NCT02619617|616246040|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
170518931|NCT01765296|616246041|FG000|Overall Study|Protocol Violation|0|||
170518932|NCT01765296|616246042|FG001|Overall Study|Protocol Violation|5|||
170518933|NCT01765296|616246043|FG002|Overall Study|Protocol Violation|4|||
170518934|NCT01765296|616246041|FG000|Overall Study|Withdrawal by Subject|4|||
170518935|NCT01765296|616246042|FG001|Overall Study|Withdrawal by Subject|2|||
170518936|NCT01765296|616246043|FG002|Overall Study|Withdrawal by Subject|2|||
170518937|NCT01765296|616246041|FG000|Overall Study|Adverse Event|1|||
170518938|NCT01765296|616246042|FG001|Overall Study|Adverse Event|13|||
170518939|NCT01765296|616246043|FG002|Overall Study|Adverse Event|5|||
170518940|NCT01765296|616246041|FG000|Overall Study|Lack of Efficacy|0|||
170518941|NCT01765296|616246042|FG001|Overall Study|Lack of Efficacy|0|||
170518942|NCT01765296|616246043|FG002|Overall Study|Lack of Efficacy|2|||
170518943|NCT02659943|616246045|FG000|Overall Study|Switched to alternative treatment|1|||
170518944|NCT02659943|616246046|FG001|Overall Study|Switched to alternative treatment|1|||
170518945|NCT02659943|616246047|FG002|Overall Study|Switched to alternative treatment|0|||
170518946|NCT02659943|616246048|FG003|Overall Study|Switched to alternative treatment|2|||
170518947|NCT02659943|616246049|FG004|Overall Study|Switched to alternative treatment|1|||
170518948|NCT02659943|616246050|FG005|Overall Study|Switched to alternative treatment|0|||
170518949|NCT02659943|616246051|FG006|Overall Study|Switched to alternative treatment|1|||
170518950|NCT02659943|616246045|FG000|Overall Study|Disease progression on study|0|||
170518951|NCT02659943|616246046|FG001|Overall Study|Disease progression on study|1|||
170518952|NCT02659943|616246047|FG002|Overall Study|Disease progression on study|1|||
170518953|NCT02659943|616246048|FG003|Overall Study|Disease progression on study|1|||
170518954|NCT02659943|616246049|FG004|Overall Study|Disease progression on study|1|||
170518955|NCT02659943|616246050|FG005|Overall Study|Disease progression on study|4|||
170518956|NCT02659943|616246051|FG006|Overall Study|Disease progression on study|0|||
170518957|NCT02659943|616246045|FG000|Overall Study|Patient's condition per principal investigator|0|||
170518958|NCT02659943|616246046|FG001|Overall Study|Patient's condition per principal investigator|0|||
170518959|NCT02659943|616246047|FG002|Overall Study|Patient's condition per principal investigator|0|||
170518960|NCT02659943|616246048|FG003|Overall Study|Patient's condition per principal investigator|0|||
170518961|NCT02659943|616246049|FG004|Overall Study|Patient's condition per principal investigator|0|||
170518962|NCT02659943|616246050|FG005|Overall Study|Patient's condition per principal investigator|1|||
170518963|NCT02659943|616246051|FG006|Overall Study|Patient's condition per principal investigator|0|||
170518964|NCT02659943|616246045|FG000|Overall Study|Ineligible|0|||
170518965|NCT02659943|616246046|FG001|Overall Study|Ineligible|0|||
170518966|NCT02659943|616246047|FG002|Overall Study|Ineligible|0|||
170518967|NCT02659943|616246048|FG003|Overall Study|Ineligible|0|||
170518968|NCT02659943|616246049|FG004|Overall Study|Ineligible|0|||
170518969|NCT02659943|616246050|FG005|Overall Study|Ineligible|0|||
170518970|NCT02659943|616246051|FG006|Overall Study|Ineligible|1|||
170518971|NCT02659943|616246045|FG000|Overall Study|No longer meets eligibility|0|||
170518972|NCT02659943|616246046|FG001|Overall Study|No longer meets eligibility|0|||
170518973|NCT02659943|616246047|FG002|Overall Study|No longer meets eligibility|0|||
170518974|NCT02659943|616246048|FG003|Overall Study|No longer meets eligibility|0|||
170518975|NCT02659943|616246049|FG004|Overall Study|No longer meets eligibility|0|||
170518976|NCT02659943|616246050|FG005|Overall Study|No longer meets eligibility|0|||
170518977|NCT02659943|616246051|FG006|Overall Study|No longer meets eligibility|1|||
170518978|NCT02659943|616246045|FG000|Overall Study|No treatment, per protocol|0|||
170518979|NCT02659943|616246046|FG001|Overall Study|No treatment, per protocol|0|||
170518980|NCT02659943|616246047|FG002|Overall Study|No treatment, per protocol|0|||
170518981|NCT02659943|616246048|FG003|Overall Study|No treatment, per protocol|0|||
170518982|NCT02659943|616246049|FG004|Overall Study|No treatment, per protocol|0|||
170518983|NCT02659943|616246050|FG005|Overall Study|No treatment, per protocol|0|||
170518984|NCT02659943|616246051|FG006|Overall Study|No treatment, per protocol|3|||
170518985|NCT00891813|616246052|FG000|Overall Study|Adverse Event|3|||
170518986|NCT00891813|616246052|FG000|Overall Study|Withdrawal by Subject|1|||
170518987|NCT00891813|616246052|FG000|Overall Study|Patient Noncompliance|6|||
170518988|NCT00891813|616246052|FG000|Overall Study|Protocol Violation|2|||
170518989|NCT03478371|616246053|FG000|Overall Study|non-compliance|1|||
170518990|NCT03478371|616246053|FG000|Overall Study|Lost to Follow-up|4|||
170518991|NCT03075267|616246056|FG000|Overall Study|Protocol Violation|1|||
170518992|NCT03075267|616246057|FG001|Overall Study|Protocol Violation|0|||
170518993|NCT03075267|616246058|FG002|Overall Study|Protocol Violation|0|||
170518994|NCT03874013|616246059|FG000|Overall Study|Adverse Event|0|||
170518995|NCT03874013|616246060|FG001|Overall Study|Adverse Event|1|||
170518996|NCT02028507|616246066|FG000|Overall Study|Progressive Disease|122|||
170518997|NCT02028507|616246067|FG001|Overall Study|Progressive Disease|90|||
170518998|NCT02028507|616246068|FG002|Overall Study|Progressive Disease|102|||
170518999|NCT02028507|616246069|FG003|Overall Study|Progressive Disease|89|||
170519000|NCT02028507|616246066|FG000|Overall Study|Adverse Event|8|||
170519001|NCT02028507|616246067|FG001|Overall Study|Adverse Event|25|||
170519002|NCT02028507|616246068|FG002|Overall Study|Adverse Event|3|||
170519003|NCT02028507|616246069|FG003|Overall Study|Adverse Event|16|||
170519004|NCT02028507|616246066|FG000|Overall Study|Withdrawal by Subject|6|||
170519005|NCT02028507|616246067|FG001|Overall Study|Withdrawal by Subject|8|||
170519006|NCT02028507|616246068|FG002|Overall Study|Withdrawal by Subject|5|||
170519007|NCT02028507|616246069|FG003|Overall Study|Withdrawal by Subject|9|||
170519008|NCT02028507|616246066|FG000|Overall Study|Protocol Violation|2|||
170519009|NCT02028507|616246067|FG001|Overall Study|Protocol Violation|4|||
170519010|NCT02028507|616246068|FG002|Overall Study|Protocol Violation|1|||
170519011|NCT02028507|616246069|FG003|Overall Study|Protocol Violation|3|||
170519012|NCT02028507|616246066|FG000|Overall Study|Physician Decision|0|||
170519013|NCT02028507|616246067|FG001|Overall Study|Physician Decision|4|||
170519014|NCT02028507|616246068|FG002|Overall Study|Physician Decision|0|||
170519015|NCT02028507|616246069|FG003|Overall Study|Physician Decision|0|||
170519016|NCT02028507|616246066|FG000|Overall Study|Death|1|||
170519017|NCT02028507|616246067|FG001|Overall Study|Death|0|||
170519018|NCT02028507|616246068|FG002|Overall Study|Death|1|||
170519019|NCT02028507|616246069|FG003|Overall Study|Death|3|||
170519020|NCT02028507|616246066|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
170519021|NCT02028507|616246067|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
170519022|NCT02028507|616246068|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
170519023|NCT02028507|616246069|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
170519024|NCT02028507|616246066|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
170519025|NCT02028507|616246067|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
170519026|NCT02028507|616246068|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
170519027|NCT02028507|616246069|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
170519028|NCT02028507|616246066|FG000|Overall Study|Randomized But Not Treated|3|||
170519029|NCT02028507|616246067|FG001|Overall Study|Randomized But Not Treated|6|||
170519030|NCT02028507|616246068|FG002|Overall Study|Randomized But Not Treated|0|||
170519031|NCT02028507|616246069|FG003|Overall Study|Randomized But Not Treated|4|||
170519032|NCT02028507|616246066|FG000|Overall Study|Enzyme defect|0|||
170519033|NCT02028507|616246067|FG001|Overall Study|Enzyme defect|0|||
170519034|NCT02028507|616246068|FG002|Overall Study|Enzyme defect|0|||
170519035|NCT02028507|616246069|FG003|Overall Study|Enzyme defect|1|||
170519036|NCT02028507|616246066|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
170519037|NCT02028507|616246067|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
170519038|NCT02028507|616246068|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
170519039|NCT02028507|616246069|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
170519040|NCT02028507|616246066|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
170519041|NCT02028507|616246067|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
170519042|NCT02028507|616246068|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
170519043|NCT02028507|616246069|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
170519044|NCT03311841|616246071|FG000|14-day Wash-out|Adverse Event|0|||
170519045|NCT03311841|616246072|FG001|14-day Wash-out|Adverse Event|1|||
170519046|NCT03311841|616246073|FG002|14-day Wash-out|Adverse Event|0|||
170519047|NCT03311841|616246074|FG003|14-day Wash-out|Adverse Event|0|||
170519048|NCT03311841|616246075|FG004|14-day Wash-out|Adverse Event|0|||
170519049|NCT03311841|616246071|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
170519050|NCT03311841|616246072|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
170519051|NCT03311841|616246073|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
170519052|NCT03311841|616246074|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
170519053|NCT03311841|616246075|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
170519054|NCT02472886|616246091|FG000|Overall Study|Lack of Efficacy|0|||
170519055|NCT02472886|616246092|FG001|Overall Study|Lack of Efficacy|2|||
170519056|NCT02472886|616246093|FG002|Overall Study|Lack of Efficacy|1|||
170519057|NCT01598610|616246094|FG000|Overall Study|Adverse Event|1|||
170519058|NCT00099632|616246099|FG000|Overall Study|Lost to Follow-up|1|||
170519059|NCT00099632|616246100|FG001|Overall Study|Lost to Follow-up|0|||
170519060|NCT00099632|616246101|FG002|Overall Study|Lost to Follow-up|3|||
170519061|NCT00099632|616246102|FG003|Overall Study|Lost to Follow-up|1|||
170519062|NCT00099632|616246103|FG004|Overall Study|Lost to Follow-up|1|||
170519063|NCT00099632|616246104|FG005|Overall Study|Lost to Follow-up|0|||
170519064|NCT00099632|616246099|FG000|Overall Study|Withdrawal by Subject|0|||
170519065|NCT00099632|616246100|FG001|Overall Study|Withdrawal by Subject|1|||
170519066|NCT00099632|616246101|FG002|Overall Study|Withdrawal by Subject|0|||
170519067|NCT00099632|616246102|FG003|Overall Study|Withdrawal by Subject|0|||
170519068|NCT00099632|616246103|FG004|Overall Study|Withdrawal by Subject|0|||
170519069|NCT00099632|616246104|FG005|Overall Study|Withdrawal by Subject|1|||
170519070|NCT00099632|616246099|FG000|Overall Study|Protocol Violation|0|||
170519071|NCT00099632|616246100|FG001|Overall Study|Protocol Violation|0|||
170519072|NCT00099632|616246101|FG002|Overall Study|Protocol Violation|0|||
170519073|NCT00099632|616246102|FG003|Overall Study|Protocol Violation|0|||
170519074|NCT00099632|616246103|FG004|Overall Study|Protocol Violation|0|||
170519075|NCT00099632|616246104|FG005|Overall Study|Protocol Violation|1|||
170519076|NCT01118663|616246105|FG000|Overall Study|Adverse Event|2|||
170519077|NCT01118663|616246106|FG001|Overall Study|Adverse Event|1|||
170519078|NCT01118663|616246105|FG000|Overall Study|Withdrawal by Subject|0|||
170519079|NCT01118663|616246106|FG001|Overall Study|Withdrawal by Subject|1|||
170519080|NCT03046953|616246113|FG000|Overall Study|Relapse/progressive disease|21|||
170519081|NCT03046953|616246113|FG000|Overall Study|Death|2|||
170519082|NCT03046953|616246113|FG000|Overall Study|Withdrawal by Subject|3|||
170519083|NCT00672633|616246115|FG000|Overall Study|Withdrawal by Subject|0|||
170519084|NCT00672633|616246116|FG001|Overall Study|Withdrawal by Subject|1|||
170519085|NCT01868165|616246117|FG000|Overall Study|Withdrawal by Subject|36|||
170519086|NCT01868165|616246117|FG000|Overall Study|Physician Decision|2|||
170519087|NCT01868165|616246117|FG000|Overall Study|Lost to Follow-up|3|||
170519088|NCT01868165|616246117|FG000|Overall Study|Death|4|||
170519089|NCT01603407|616246118|FG000|Overall Study|Adverse Event|1|||
170519090|NCT01603407|616246119|FG001|Overall Study|Adverse Event|1|||
170519091|NCT01603407|616246120|FG002|Overall Study|Adverse Event|1|||
170519092|NCT01603407|616246118|FG000|Overall Study|Protocol Violation|2|||
170519093|NCT01603407|616246119|FG001|Overall Study|Protocol Violation|2|||
170519094|NCT01603407|616246120|FG002|Overall Study|Protocol Violation|0|||
170519095|NCT01603407|616246118|FG000|Overall Study|Withdrawal by Subject|8|||
170519096|NCT01603407|616246119|FG001|Overall Study|Withdrawal by Subject|5|||
170519097|NCT01603407|616246120|FG002|Overall Study|Withdrawal by Subject|7|||
170519098|NCT01603407|616246118|FG000|Overall Study|Lost to Follow-up|0|||
170519099|NCT01603407|616246119|FG001|Overall Study|Lost to Follow-up|3|||
170519100|NCT01603407|616246120|FG002|Overall Study|Lost to Follow-up|2|||
170519101|NCT05664581|616247514|FG000|Overall Study|Withdrawal by Subject|2|||
170519102|NCT01317641|616247520|FG000|Overall Study|Not treated|0|||
170519103|NCT01317641|616247521|FG001|Overall Study|Not treated|0|||
170519104|NCT01317641|616247522|FG002|Overall Study|Not treated|0|||
170519105|NCT01317641|616247523|FG003|Overall Study|Not treated|0|||
170519106|NCT01317641|616247524|FG004|Overall Study|Not treated|0|||
170519107|NCT01317641|616247525|FG005|Overall Study|Not treated|0|||
170519108|NCT01317641|616247526|FG006|Overall Study|Not treated|0|||
170519109|NCT01317641|616247527|FG007|Overall Study|Not treated|1|||
170519110|NCT01317641|616247528|FG008|Overall Study|Not treated|1|||
170519111|NCT01317641|616247520|FG000|Overall Study|Adverse Event|0|||
170519112|NCT01317641|616247521|FG001|Overall Study|Adverse Event|1|||
170519113|NCT01317641|616247522|FG002|Overall Study|Adverse Event|0|||
170519114|NCT01317641|616247523|FG003|Overall Study|Adverse Event|1|||
170519115|NCT01317641|616247524|FG004|Overall Study|Adverse Event|0|||
170519116|NCT01317641|616247525|FG005|Overall Study|Adverse Event|0|||
170519117|NCT01317641|616247526|FG006|Overall Study|Adverse Event|2|||
170519118|NCT01317641|616247527|FG007|Overall Study|Adverse Event|1|||
170519119|NCT01317641|616247528|FG008|Overall Study|Adverse Event|0|||
170519120|NCT01317641|616247520|FG000|Overall Study|Protocol Violation|1|||
170519121|NCT01317641|616247521|FG001|Overall Study|Protocol Violation|0|||
170519122|NCT01317641|616247522|FG002|Overall Study|Protocol Violation|0|||
170519123|NCT01317641|616247523|FG003|Overall Study|Protocol Violation|0|||
170519124|NCT01317641|616247524|FG004|Overall Study|Protocol Violation|0|||
170519125|NCT01317641|616247525|FG005|Overall Study|Protocol Violation|0|||
170519126|NCT01317641|616247526|FG006|Overall Study|Protocol Violation|0|||
170519127|NCT01317641|616247527|FG007|Overall Study|Protocol Violation|0|||
170519128|NCT01317641|616247528|FG008|Overall Study|Protocol Violation|0|||
170519129|NCT01317641|616247520|FG000|Overall Study|Disease progression|0|||
170519130|NCT01317641|616247521|FG001|Overall Study|Disease progression|0|||
170519131|NCT01317641|616247522|FG002|Overall Study|Disease progression|0|||
170519132|NCT01317641|616247523|FG003|Overall Study|Disease progression|0|||
170519133|NCT01317641|616247524|FG004|Overall Study|Disease progression|0|||
170519134|NCT01317641|616247525|FG005|Overall Study|Disease progression|0|||
170519135|NCT01317641|616247526|FG006|Overall Study|Disease progression|0|||
170519136|NCT01317641|616247527|FG007|Overall Study|Disease progression|3|||
170519137|NCT01317641|616247528|FG008|Overall Study|Disease progression|4|||
170519138|NCT01317641|616247520|FG000|Overall Study|Withdrawal by Subject|0|||
170519139|NCT01317641|616247521|FG001|Overall Study|Withdrawal by Subject|0|||
170519140|NCT01317641|616247522|FG002|Overall Study|Withdrawal by Subject|0|||
170519141|NCT01317641|616247523|FG003|Overall Study|Withdrawal by Subject|0|||
170519142|NCT01317641|616247524|FG004|Overall Study|Withdrawal by Subject|0|||
170519143|NCT01317641|616247525|FG005|Overall Study|Withdrawal by Subject|0|||
170519144|NCT01317641|616247526|FG006|Overall Study|Withdrawal by Subject|1|||
170519145|NCT01317641|616247527|FG007|Overall Study|Withdrawal by Subject|0|||
170519146|NCT01317641|616247528|FG008|Overall Study|Withdrawal by Subject|0|||
170519147|NCT00329108|616247529|FG000|Overall Study|Adverse Event|2|||
170519148|NCT00329108|616247530|FG001|Overall Study|Adverse Event|2|||
170519149|NCT00329108|616247529|FG000|Overall Study|Lack of Efficacy|3|||
170519150|NCT00329108|616247530|FG001|Overall Study|Lack of Efficacy|3|||
170519151|NCT00329108|616247529|FG000|Overall Study|Withdrawal by Subject|0|||
170519152|NCT00329108|616247530|FG001|Overall Study|Withdrawal by Subject|2|||
170519153|NCT00329108|616247529|FG000|Overall Study|symptomatic deterioration|1|||
170519154|NCT00329108|616247530|FG001|Overall Study|symptomatic deterioration|1|||
170519155|NCT00329108|616247529|FG000|Overall Study|Subject no longer willing to participate|2|||
170519156|NCT00329108|616247530|FG001|Overall Study|Subject no longer willing to participate|2|||
170519157|NCT00329108|616247529|FG000|Overall Study|study terminated by sponsor|1|||
170519158|NCT00329108|616247530|FG001|Overall Study|study terminated by sponsor|0|||
170519159|NCT00329108|616247529|FG000|Overall Study|withdrew patient after SAE resolved|1|||
170519160|NCT00329108|616247530|FG001|Overall Study|withdrew patient after SAE resolved|0|||
170519161|NCT00329108|616247529|FG000|Overall Study|Protocol Violation|0|||
170519162|NCT00329108|616247530|FG001|Overall Study|Protocol Violation|2|||
170519163|NCT02692586|616247533|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
170519164|NCT02692586|616247533|FG000|Overall Study|Received adjunctive thrombolytics|2|||
170519165|NCT01396083|616247539|FG000|Overall Study|Adverse Event|2|||
170519166|NCT01396083|616247540|FG001|Overall Study|Adverse Event|28|||
170519167|NCT01396083|616247539|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170519168|NCT01396083|616247540|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
170519169|NCT01396083|616247539|FG000|Overall Study|Consent withdrawn|4|||
170519170|NCT01396083|616247540|FG001|Overall Study|Consent withdrawn|5|||
170519171|NCT01396083|616247539|FG000|Overall Study|Protocol deviation(s)|0|||
170519172|NCT01396083|616247540|FG001|Overall Study|Protocol deviation(s)|1|||
170519173|NCT01396083|616247539|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170519174|NCT01396083|616247540|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170519175|NCT01396083|616247539|FG000|Overall Study|Administrative problems|1|||
170519176|NCT01396083|616247540|FG001|Overall Study|Administrative problems|0|||
170519177|NCT01396083|616247539|FG000|Overall Study|Lost to Follow-up|1|||
170519178|NCT01396083|616247540|FG001|Overall Study|Lost to Follow-up|0|||
170519179|NCT01145482|616247542|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
170519180|NCT01145482|616247543|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
170519181|NCT04547140|616247544|FG000|Overall Study|Adverse Event|0|||
170519182|NCT04547140|616247545|FG001|Overall Study|Adverse Event|1|||
170519183|NCT04547140|616247544|FG000|Overall Study|Withdrawal by Subject|0|||
170519184|NCT04547140|616247545|FG001|Overall Study|Withdrawal by Subject|1|||
170519185|NCT04547140|616247544|FG000|Overall Study|Lost to Follow-up|3|||
170519186|NCT04547140|616247545|FG001|Overall Study|Lost to Follow-up|1|||
170519187|NCT04547140|616247544|FG000|Overall Study|Death|2|||
170519188|NCT04547140|616247545|FG001|Overall Study|Death|1|||
170519189|NCT04547140|616247544|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
170519190|NCT04547140|616247545|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
170519191|NCT04547140|616247544|FG000|Overall Study|Pregnancy|1|||
170519192|NCT04547140|616247545|FG001|Overall Study|Pregnancy|0|||
170519193|NCT04547140|616247544|FG000|Overall Study|Reason Not Specified|4|||
170519194|NCT04547140|616247545|FG001|Overall Study|Reason Not Specified|1|||
170519195|NCT04613739|616247546|FG000|Overall Study|Lost to Follow-up|6|||
170519196|NCT04613739|616247547|FG001|Overall Study|Lost to Follow-up|9|||
170519197|NCT04613739|616247546|FG000|Overall Study|potentially duplicative/fraudulent|1|||
170519198|NCT04613739|616247547|FG001|Overall Study|potentially duplicative/fraudulent|3|||
170861503|NCT04537377|617501881|FG000|Overall Study|Long term follow-up|2|||
170749957|NCT05108649|617090443|FG000|Overall Study|PI decision|1|||
170749958|NCT05108649|617090444|FG001|Overall Study|PI decision|0|||
170749959|NCT05108649|617090445|FG002|Overall Study|PI decision|0|||
170749960|NCT05108649|617090446|FG003|Overall Study|PI decision|0|||
170749961|NCT05108649|617090443|FG000|Overall Study|Significant Non-Compliance|0|||
170749962|NCT05108649|617090444|FG001|Overall Study|Significant Non-Compliance|1|||
170749963|NCT05108649|617090445|FG002|Overall Study|Significant Non-Compliance|0|||
170749964|NCT05108649|617090446|FG003|Overall Study|Significant Non-Compliance|0|||
170749965|NCT05108649|617090443|FG000|Overall Study|Unable to adhere to study protocol|0|||
170749966|NCT05108649|617090444|FG001|Overall Study|Unable to adhere to study protocol|2|||
170749967|NCT05108649|617090445|FG002|Overall Study|Unable to adhere to study protocol|0|||
170749968|NCT05108649|617090446|FG003|Overall Study|Unable to adhere to study protocol|0|||
170749969|NCT03523871|617090447|FG000|Overall Study|Death|1|||
170749970|NCT01083160|617090448|FG000|Overall Study|Adverse Event|1|||
170749971|NCT00972179|617090450|FG000|Overall Study|Noncompliance|1|||
170749972|NCT00972179|617090451|FG001|Overall Study|Noncompliance|0|||
170749973|NCT00972179|617090452|FG002|Overall Study|Noncompliance|0|||
170749974|NCT00972179|617090453|FG003|Overall Study|Noncompliance|0|||
170749975|NCT00972179|617090454|FG004|Overall Study|Noncompliance|1|||
170749976|NCT00972179|617090455|FG005|Overall Study|Noncompliance|0|||
170861504|NCT04537377|617501882|FG001|Overall Study|Long term follow-up|2|||
170519199|NCT01093586|616247548|FG000|Overall Study|Failed to engraft|3|||
170519200|NCT03442088|616247549|FG000|Overall Study|Adverse Event|1|||
170519201|NCT03442088|616247549|FG000|Overall Study|Lack of Efficacy|2|||
170519202|NCT03442088|616247549|FG000|Overall Study|Lost to Follow-up|2|||
170519203|NCT01051557|616247550|FG000|Overall Study|Physician Decision|1|||
170519204|NCT01051557|616247551|FG001|Overall Study|Physician Decision|0|||
170519205|NCT01051557|616247552|FG002|Overall Study|Physician Decision|0|||
170519206|NCT01051557|616247553|FG003|Overall Study|Physician Decision|0|||
170519207|NCT01051557|616247554|FG004|Overall Study|Physician Decision|0|||
170749977|NCT00972179|617090456|FG006|Overall Study|Noncompliance|1|||
170749978|NCT00972179|617090450|FG000|Overall Study|Withdrawal by Subject|0|||
170749979|NCT00972179|617090451|FG001|Overall Study|Withdrawal by Subject|3|||
170749980|NCT00972179|617090452|FG002|Overall Study|Withdrawal by Subject|0|||
170519208|NCT01051557|616247555|FG005|Overall Study|Physician Decision|0|||
170519209|NCT01051557|616247556|FG006|Overall Study|Physician Decision|0|||
170519210|NCT01051557|616247550|FG000|Overall Study|disease progression|3|||
170519211|NCT01051557|616247551|FG001|Overall Study|disease progression|3|||
170519212|NCT01051557|616247552|FG002|Overall Study|disease progression|5|||
170519213|NCT01051557|616247553|FG003|Overall Study|disease progression|2|||
170519214|NCT01051557|616247554|FG004|Overall Study|disease progression|4|||
170519215|NCT01051557|616247555|FG005|Overall Study|disease progression|3|||
170519216|NCT01051557|616247556|FG006|Overall Study|disease progression|1|||
170519217|NCT01051557|616247550|FG000|Overall Study|Withdrawal by Subject|0|||
170519218|NCT01051557|616247551|FG001|Overall Study|Withdrawal by Subject|0|||
170519219|NCT01051557|616247552|FG002|Overall Study|Withdrawal by Subject|1|||
170519220|NCT01051557|616247553|FG003|Overall Study|Withdrawal by Subject|0|||
170519221|NCT01051557|616247554|FG004|Overall Study|Withdrawal by Subject|2|||
170519222|NCT01051557|616247555|FG005|Overall Study|Withdrawal by Subject|0|||
170519223|NCT01051557|616247556|FG006|Overall Study|Withdrawal by Subject|1|||
170519224|NCT01051557|616247550|FG000|Overall Study|Adverse Event|0|||
170519225|NCT01051557|616247551|FG001|Overall Study|Adverse Event|0|||
170519226|NCT01051557|616247552|FG002|Overall Study|Adverse Event|0|||
170519227|NCT01051557|616247553|FG003|Overall Study|Adverse Event|1|||
170519228|NCT01051557|616247554|FG004|Overall Study|Adverse Event|1|||
170519229|NCT01051557|616247555|FG005|Overall Study|Adverse Event|3|||
170519230|NCT01051557|616247556|FG006|Overall Study|Adverse Event|4|||
170519231|NCT00130689|616247557|FG000|Overall Study|Progressive Disease|29|||
170519232|NCT00130689|616247557|FG000|Overall Study|Death|1|||
170519233|NCT00130689|616247557|FG000|Overall Study|Clinical Deterioration|4|||
170519234|NCT00130689|616247557|FG000|Overall Study|Withdrawal by Subject|3|||
170519235|NCT00130689|616247557|FG000|Overall Study|Ineligible|6|||
170519236|NCT00766597|616247558|FG000|Overall Study|Unexpected closure of study|4|||
170519237|NCT00766597|616247558|FG000|Overall Study|Without CCR5-tropic virus|5|||
170519238|NCT00048035|616247559|FG000|Core Period|Early Withdrawals|4|||
170519239|NCT00048035|616247560|FG001|Core Period|Early Withdrawals|2|||
170519240|NCT00048035|616247561|FG002|Core Period|Early Withdrawals|1|||
170519241|NCT00048035|616247562|FG003|Core Period|Early Withdrawals|1|||
170519242|NCT00048035|616247563|FG004|Core Period|Early Withdrawals|1|||
170519243|NCT00048035|616247564|FG005|Core Period|Early Withdrawals|1|||
170519244|NCT00048035|616247565|FG006|Core Period|Early Withdrawals|0|||
170861505|NCT04447027|617501883|FG000|Dose Escalation|Withdrawal by Subject|1|||
170861506|NCT04447027|617501884|FG001|Dose Escalation|Withdrawal by Subject|4|||
170861507|NCT04447027|617501885|FG002|Dose Escalation|Withdrawal by Subject|3|||
170861508|NCT04447027|617501886|FG003|Dose Escalation|Withdrawal by Subject|3|||
170861509|NCT04447027|617501887|FG004|Dose Escalation|Withdrawal by Subject|1|||
170861510|NCT04447027|617501888|FG005|Dose Escalation|Withdrawal by Subject|0|||
170861511|NCT04447027|617501889|FG006|Dose Escalation|Withdrawal by Subject|0|||
170861512|NCT04447027|617501890|FG007|Dose Escalation|Withdrawal by Subject|0|||
170861513|NCT04447027|617501891|FG008|Dose Escalation|Withdrawal by Subject|0|||
170861514|NCT04447027|617501883|FG000|Dose Escalation|Refused further treatment|0|||
170861515|NCT04447027|617501884|FG001|Dose Escalation|Refused further treatment|1|||
170861516|NCT04447027|617501885|FG002|Dose Escalation|Refused further treatment|1|||
170861517|NCT04447027|617501886|FG003|Dose Escalation|Refused further treatment|0|||
170861518|NCT04447027|617501887|FG004|Dose Escalation|Refused further treatment|0|||
170861519|NCT04447027|617501888|FG005|Dose Escalation|Refused further treatment|0|||
170861520|NCT04447027|617501889|FG006|Dose Escalation|Refused further treatment|0|||
170861521|NCT04447027|617501890|FG007|Dose Escalation|Refused further treatment|0|||
170861522|NCT04447027|617501891|FG008|Dose Escalation|Refused further treatment|0|||
170861523|NCT04447027|617501883|FG000|Dose Expansion|Withdrawal by Subject|0|||
170861524|NCT04447027|617501884|FG001|Dose Expansion|Withdrawal by Subject|0|||
170861525|NCT04447027|617501885|FG002|Dose Expansion|Withdrawal by Subject|0|||
170861526|NCT04447027|617501886|FG003|Dose Expansion|Withdrawal by Subject|0|||
170861527|NCT04447027|617501887|FG004|Dose Expansion|Withdrawal by Subject|0|||
170861528|NCT04447027|617501888|FG005|Dose Expansion|Withdrawal by Subject|2|||
170861529|NCT04447027|617501889|FG006|Dose Expansion|Withdrawal by Subject|0|||
170861530|NCT04447027|617501890|FG007|Dose Expansion|Withdrawal by Subject|2|||
170861531|NCT04447027|617501891|FG008|Dose Expansion|Withdrawal by Subject|0|||
170861532|NCT00875056|617501892|FG000|Overall Study|Adverse Event|8|||
170519245|NCT00048035|616247566|FG007|Core Period|Early Withdrawals|0|||
170519246|NCT00048035|616247559|FG000|Extension Year 1|Early Withdrawals|0|||
170519247|NCT00048035|616247560|FG001|Extension Year 1|Early Withdrawals|0|||
170519248|NCT00048035|616247561|FG002|Extension Year 1|Early Withdrawals|0|||
170861533|NCT00875056|617501893|FG001|Overall Study|Adverse Event|1|||
170861534|NCT00875056|617501894|FG002|Overall Study|Adverse Event|2|||
170861535|NCT00875056|617501892|FG000|Overall Study|Physician Decision|2|||
170861536|NCT00875056|617501893|FG001|Overall Study|Physician Decision|0|||
170861537|NCT00875056|617501894|FG002|Overall Study|Physician Decision|0|||
170519249|NCT00048035|616247562|FG003|Extension Year 1|Early Withdrawals|0|||
170519250|NCT00048035|616247563|FG004|Extension Year 1|Early Withdrawals|0|||
170861538|NCT00875056|617501892|FG000|Overall Study|Progressive Disease|20|||
170861539|NCT00875056|617501893|FG001|Overall Study|Progressive Disease|8|||
170861540|NCT00875056|617501894|FG002|Overall Study|Progressive Disease|3|||
170861541|NCT00875056|617501892|FG000|Overall Study|Withdrawal by Subject|4|||
170861542|NCT00875056|617501893|FG001|Overall Study|Withdrawal by Subject|0|||
170861543|NCT00875056|617501894|FG002|Overall Study|Withdrawal by Subject|1|||
170861544|NCT03204188|617501895|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
170861545|NCT03204188|617501895|FG000|Immunotherapy Phase (1 Year)|Death|1|||
170861546|NCT03204188|617501895|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
170861547|NCT03204188|617501895|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
170861548|NCT04486716|617503705|FG000|Core Phase|Subject decision|6|||
170861549|NCT04486716|617503705|FG000|Core Phase|Adverse Event|5|||
170861550|NCT04486716|617503705|FG000|Core Phase|Lost to Follow-up|1|||
170861551|NCT04486716|617503705|FG000|Core Phase|Physician Decision|1|||
170861552|NCT04486716|617503705|FG000|Core Phase|Enrolled subjects not treated|9|||
170519251|NCT00048035|616247564|FG005|Extension Year 1|Early Withdrawals|0|||
170519252|NCT00048035|616247565|FG006|Extension Year 1|Early Withdrawals|11|||
170519253|NCT00048035|616247566|FG007|Extension Year 1|Early Withdrawals|11|||
170519254|NCT00048035|616247559|FG000|Extension Year 2|Early Withdrawals|0|||
170519255|NCT00048035|616247560|FG001|Extension Year 2|Early Withdrawals|0|||
170519256|NCT00048035|616247561|FG002|Extension Year 2|Early Withdrawals|0|||
170861553|NCT03769181|617503706|FG000|Overall Study|Adverse Event|1|||
170861554|NCT03769181|617503707|FG001|Overall Study|Adverse Event|0|||
170861555|NCT03769181|617503708|FG002|Overall Study|Adverse Event|2|||
170861556|NCT03769181|617503709|FG003|Overall Study|Adverse Event|4|||
170519257|NCT00048035|616247562|FG003|Extension Year 2|Early Withdrawals|0|||
170519258|NCT00048035|616247563|FG004|Extension Year 2|Early Withdrawals|0|||
170519259|NCT00048035|616247564|FG005|Extension Year 2|Early Withdrawals|0|||
170519260|NCT00048035|616247565|FG006|Extension Year 2|Early Withdrawals|3|||
170519261|NCT00048035|616247566|FG007|Extension Year 2|Early Withdrawals|3|||
170519262|NCT00509899|616247567|FG000|Overall Study|Progressive disease|1|||
170519263|NCT00509899|616247568|FG001|Overall Study|Progressive disease|3|||
170519264|NCT00509899|616247569|FG002|Overall Study|Progressive disease|5|||
170519265|NCT00509899|616247570|FG003|Overall Study|Progressive disease|1|||
170519266|NCT00509899|616247571|FG004|Overall Study|Progressive disease|0|||
170519267|NCT00509899|616247572|FG005|Overall Study|Progressive disease|1|||
170519268|NCT00509899|616247573|FG006|Overall Study|Progressive disease|0|||
170519269|NCT00509899|616247574|FG007|Overall Study|Progressive disease|0|||
170519270|NCT00509899|616247567|FG000|Overall Study|Unacceptable Toxicity|1|||
170519271|NCT00509899|616247568|FG001|Overall Study|Unacceptable Toxicity|0|||
170519272|NCT00509899|616247569|FG002|Overall Study|Unacceptable Toxicity|0|||
170519273|NCT00509899|616247570|FG003|Overall Study|Unacceptable Toxicity|2|||
170519274|NCT00509899|616247571|FG004|Overall Study|Unacceptable Toxicity|0|||
170519275|NCT00509899|616247572|FG005|Overall Study|Unacceptable Toxicity|0|||
170519276|NCT00509899|616247573|FG006|Overall Study|Unacceptable Toxicity|0|||
170519277|NCT00509899|616247574|FG007|Overall Study|Unacceptable Toxicity|0|||
170519278|NCT00509899|616247567|FG000|Overall Study|Withdrawal by Subject|6|||
170519279|NCT00509899|616247568|FG001|Overall Study|Withdrawal by Subject|2|||
170519280|NCT00509899|616247569|FG002|Overall Study|Withdrawal by Subject|3|||
170519281|NCT00509899|616247570|FG003|Overall Study|Withdrawal by Subject|0|||
170519282|NCT00509899|616247571|FG004|Overall Study|Withdrawal by Subject|3|||
170519283|NCT00509899|616247572|FG005|Overall Study|Withdrawal by Subject|2|||
170519284|NCT00509899|616247573|FG006|Overall Study|Withdrawal by Subject|0|||
170519285|NCT00509899|616247574|FG007|Overall Study|Withdrawal by Subject|0|||
170519286|NCT00509899|616247567|FG000|Overall Study|Physician Decision|4|||
170519287|NCT00509899|616247568|FG001|Overall Study|Physician Decision|2|||
170519288|NCT00509899|616247569|FG002|Overall Study|Physician Decision|7|||
170519289|NCT00509899|616247570|FG003|Overall Study|Physician Decision|0|||
170519290|NCT00509899|616247571|FG004|Overall Study|Physician Decision|1|||
170519291|NCT00509899|616247572|FG005|Overall Study|Physician Decision|4|||
170519292|NCT00509899|616247573|FG006|Overall Study|Physician Decision|0|||
170519293|NCT00509899|616247574|FG007|Overall Study|Physician Decision|0|||
170519294|NCT00509899|616247567|FG000|Overall Study|Intercurrent Illness|1|||
170519295|NCT00509899|616247568|FG001|Overall Study|Intercurrent Illness|0|||
170519296|NCT00509899|616247569|FG002|Overall Study|Intercurrent Illness|0|||
170519297|NCT00509899|616247570|FG003|Overall Study|Intercurrent Illness|1|||
170519298|NCT00509899|616247571|FG004|Overall Study|Intercurrent Illness|0|||
170519299|NCT00509899|616247572|FG005|Overall Study|Intercurrent Illness|1|||
170519300|NCT00509899|616247573|FG006|Overall Study|Intercurrent Illness|0|||
170519301|NCT00509899|616247574|FG007|Overall Study|Intercurrent Illness|0|||
170519302|NCT00509899|616247567|FG000|Overall Study|Death|2|||
170519303|NCT00509899|616247568|FG001|Overall Study|Death|2|||
170519304|NCT00509899|616247569|FG002|Overall Study|Death|3|||
170519305|NCT00509899|616247570|FG003|Overall Study|Death|0|||
170519306|NCT00509899|616247571|FG004|Overall Study|Death|1|||
170519307|NCT00509899|616247572|FG005|Overall Study|Death|1|||
170519308|NCT00509899|616247573|FG006|Overall Study|Death|1|||
170861557|NCT03769181|617503706|FG000|Overall Study|Withdrawal by Subject|1|||
170519309|NCT00509899|616247574|FG007|Overall Study|Death|1|||
170519310|NCT00509899|616247567|FG000|Overall Study|Lack of Efficacy|1|||
170749981|NCT00972179|617090453|FG003|Overall Study|Withdrawal by Subject|1|||
170749982|NCT00972179|617090454|FG004|Overall Study|Withdrawal by Subject|0|||
170749983|NCT00972179|617090455|FG005|Overall Study|Withdrawal by Subject|0|||
170749984|NCT00972179|617090456|FG006|Overall Study|Withdrawal by Subject|2|||
170749985|NCT00972179|617090450|FG000|Overall Study|Administrative Decision|0|||
170749986|NCT00972179|617090451|FG001|Overall Study|Administrative Decision|0|||
170749987|NCT00972179|617090452|FG002|Overall Study|Administrative Decision|0|||
170749988|NCT00972179|617090453|FG003|Overall Study|Administrative Decision|0|||
170749989|NCT00972179|617090454|FG004|Overall Study|Administrative Decision|1|||
170749990|NCT00972179|617090455|FG005|Overall Study|Administrative Decision|0|||
170749991|NCT00972179|617090456|FG006|Overall Study|Administrative Decision|0|||
170749992|NCT00972179|617090450|FG000|Overall Study|Lost to Follow-up|0|||
170749993|NCT00972179|617090451|FG001|Overall Study|Lost to Follow-up|0|||
170749994|NCT00972179|617090452|FG002|Overall Study|Lost to Follow-up|1|||
170749995|NCT00972179|617090453|FG003|Overall Study|Lost to Follow-up|0|||
170749996|NCT00972179|617090454|FG004|Overall Study|Lost to Follow-up|0|||
170749997|NCT00972179|617090455|FG005|Overall Study|Lost to Follow-up|3|||
170749998|NCT00972179|617090456|FG006|Overall Study|Lost to Follow-up|1|||
170749999|NCT00136916|617090457|FG000|Overall Study|Never received study treatment|3|||
170750000|NCT00136916|617090458|FG001|Overall Study|Never received study treatment|5|||
170750001|NCT00136916|617090457|FG000|Overall Study|Death|1|||
170750002|NCT00136916|617090458|FG001|Overall Study|Death|3|||
170750003|NCT00136916|617090457|FG000|Overall Study|Adverse Event|27|||
170750004|NCT00136916|617090458|FG001|Overall Study|Adverse Event|8|||
170750005|NCT00136916|617090457|FG000|Overall Study|Laboratory abnormality|0|||
170750006|NCT00136916|617090458|FG001|Overall Study|Laboratory abnormality|1|||
170750007|NCT00136916|617090457|FG000|Overall Study|Lack of Efficacy|13|||
170750008|NCT00136916|617090458|FG001|Overall Study|Lack of Efficacy|3|||
170750009|NCT00136916|617090457|FG000|Overall Study|Lost to Follow-up|12|||
170750010|NCT00136916|617090458|FG001|Overall Study|Lost to Follow-up|14|||
170750011|NCT00136916|617090457|FG000|Overall Study|Withdrawal by Subject|44|||
170750012|NCT00136916|617090458|FG001|Overall Study|Withdrawal by Subject|46|||
170750013|NCT00136916|617090457|FG000|Overall Study|Other|22|||
170750014|NCT00136916|617090458|FG001|Overall Study|Other|24|||
170750015|NCT00136916|617090457|FG000|Overall Study|Discontinued in follow up period|3|||
170750016|NCT00136916|617090458|FG001|Overall Study|Discontinued in follow up period|0|||
170750017|NCT01012973|617090461|FG000|Overall Study|Adverse Event|5|||
170750018|NCT01012973|617090462|FG001|Overall Study|Adverse Event|5|||
170750019|NCT01012973|617090461|FG000|Overall Study|Lack of Efficacy|0|||
170750020|NCT01012973|617090462|FG001|Overall Study|Lack of Efficacy|5|||
170750021|NCT01012973|617090461|FG000|Overall Study|Lost to Follow-up|1|||
170750022|NCT01012973|617090462|FG001|Overall Study|Lost to Follow-up|0|||
170750023|NCT01012973|617090461|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
170750024|NCT01012973|617090462|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
170750025|NCT01012973|617090461|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
170750026|NCT01012973|617090462|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
170750027|NCT01012973|617090461|FG000|Overall Study|Protocol Violation|5|||
170750028|NCT01012973|617090462|FG001|Overall Study|Protocol Violation|2|||
170750029|NCT01012973|617090461|FG000|Overall Study|Withdrawal by Subject|4|||
170750030|NCT01012973|617090462|FG001|Overall Study|Withdrawal by Subject|6|||
170750031|NCT02040090|617090464|FG000|Overall Study|Adverse Event|2|||
170750032|NCT02040090|617090465|FG001|Overall Study|Adverse Event|0|||
170750033|NCT02040090|617090464|FG000|Overall Study|Physician Decision|1|||
170750034|NCT02040090|617090465|FG001|Overall Study|Physician Decision|0|||
170750035|NCT02040090|617090464|FG000|Overall Study|Withdrawal by Subject|0|||
170750036|NCT02040090|617090465|FG001|Overall Study|Withdrawal by Subject|1|||
170750037|NCT02040090|617090464|FG000|Overall Study|Lost to Follow-up|0|||
170750038|NCT02040090|617090465|FG001|Overall Study|Lost to Follow-up|1|||
170750039|NCT03257995|617090466|FG000|Overall Study|Adverse Event|0|||
170750040|NCT03257995|617090467|FG001|Overall Study|Adverse Event|1|||
170750041|NCT03257995|617090468|FG002|Overall Study|Adverse Event|0|||
170750042|NCT03257995|617090469|FG003|Overall Study|Adverse Event|0|||
170750043|NCT03257995|617090470|FG004|Overall Study|Adverse Event|0|||
170750044|NCT03257995|617090471|FG005|Overall Study|Adverse Event|0|||
170750045|NCT03257995|617090466|FG000|Overall Study|Protocol deviation|0|||
170750046|NCT03257995|617090467|FG001|Overall Study|Protocol deviation|0|||
170750047|NCT03257995|617090468|FG002|Overall Study|Protocol deviation|0|||
170750048|NCT03257995|617090469|FG003|Overall Study|Protocol deviation|0|||
170750049|NCT03257995|617090470|FG004|Overall Study|Protocol deviation|0|||
170750050|NCT03257995|617090471|FG005|Overall Study|Protocol deviation|2|||
170750051|NCT02138747|617090474|FG000|Treatment Period 1|Adverse Event|10|||
170750052|NCT02138747|617090475|FG001|Treatment Period 1|Adverse Event|14|||
170750053|NCT02138747|617090476|FG002|Treatment Period 1|Adverse Event|2|||
170750054|NCT02138747|617090477|FG003|Treatment Period 1|Adverse Event|1|||
170750055|NCT02138747|617090474|FG000|Treatment Period 1|Lost to Follow-up|0|||
170750056|NCT02138747|617090475|FG001|Treatment Period 1|Lost to Follow-up|1|||
170750057|NCT02138747|617090476|FG002|Treatment Period 1|Lost to Follow-up|1|||
170750058|NCT02138747|617090477|FG003|Treatment Period 1|Lost to Follow-up|0|||
170519311|NCT00509899|616247568|FG001|Overall Study|Lack of Efficacy|0|||
170519312|NCT00509899|616247569|FG002|Overall Study|Lack of Efficacy|2|||
170519313|NCT00509899|616247570|FG003|Overall Study|Lack of Efficacy|0|||
170519314|NCT00509899|616247571|FG004|Overall Study|Lack of Efficacy|0|||
170519315|NCT00509899|616247572|FG005|Overall Study|Lack of Efficacy|1|||
170519316|NCT00509899|616247573|FG006|Overall Study|Lack of Efficacy|0|||
170519317|NCT00509899|616247574|FG007|Overall Study|Lack of Efficacy|0|||
170519318|NCT01254656|616247575|FG000|Overall Study|Discontinued due to termination of study|40|||
170519319|NCT01254656|616247576|FG001|Overall Study|Discontinued due to termination of study|39|||
170519320|NCT01254656|616247577|FG002|Overall Study|Discontinued due to termination of study|13|||
170519321|NCT01254656|616247575|FG000|Overall Study|Lack of Efficacy|3|||
170519322|NCT01254656|616247576|FG001|Overall Study|Lack of Efficacy|0|||
170519323|NCT01254656|616247577|FG002|Overall Study|Lack of Efficacy|0|||
170519324|NCT01254656|616247575|FG000|Overall Study|Lost to Follow-up|1|||
170519325|NCT01254656|616247576|FG001|Overall Study|Lost to Follow-up|0|||
170519326|NCT01254656|616247577|FG002|Overall Study|Lost to Follow-up|2|||
170519327|NCT01254656|616247575|FG000|Overall Study|Withdrawal by Subject|2|||
170519328|NCT01254656|616247576|FG001|Overall Study|Withdrawal by Subject|2|||
170519329|NCT01254656|616247577|FG002|Overall Study|Withdrawal by Subject|1|||
170519330|NCT01254656|616247575|FG000|Overall Study|Pregnancy|0|||
170519331|NCT01254656|616247576|FG001|Overall Study|Pregnancy|0|||
170519332|NCT01254656|616247577|FG002|Overall Study|Pregnancy|2|||
170519333|NCT01254656|616247575|FG000|Overall Study|Adverse Event|1|||
170519334|NCT01254656|616247576|FG001|Overall Study|Adverse Event|1|||
170519335|NCT01254656|616247577|FG002|Overall Study|Adverse Event|0|||
170519336|NCT01254656|616247575|FG000|Overall Study|Death|0|||
170519337|NCT01254656|616247576|FG001|Overall Study|Death|1|||
170519338|NCT01254656|616247577|FG002|Overall Study|Death|0|||
170519339|NCT02326272|616247580|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519340|NCT02326272|616247581|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
170519341|NCT02326272|616247582|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
170519342|NCT02326272|616247583|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519343|NCT02326272|616247584|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519344|NCT02326272|616247585|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519345|NCT02326272|616247586|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519346|NCT02326272|616247587|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519347|NCT02326272|616247588|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519348|NCT02326272|616247589|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519349|NCT02326272|616247590|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519350|NCT02326272|616247591|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519351|NCT02326272|616247592|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519352|NCT02326272|616247593|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519353|NCT02326272|616247594|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170519354|NCT02326272|616247580|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
170519355|NCT02326272|616247581|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
170519356|NCT02326272|616247582|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519357|NCT02326272|616247583|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519358|NCT02326272|616247584|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519359|NCT02326272|616247585|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519360|NCT02326272|616247586|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519361|NCT02326272|616247587|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519362|NCT02326272|616247588|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519363|NCT02326272|616247589|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519364|NCT02326272|616247590|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519365|NCT02326272|616247591|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519366|NCT02326272|616247592|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519367|NCT02326272|616247593|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519368|NCT02326272|616247594|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170519369|NCT02326272|616247580|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
170519370|NCT02326272|616247581|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
170519371|NCT02326272|616247582|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
170519372|NCT02326272|616247583|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519373|NCT02326272|616247584|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519374|NCT02326272|616247585|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519375|NCT02326272|616247586|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519376|NCT02326272|616247587|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519377|NCT02326272|616247588|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519378|NCT02326272|616247589|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519379|NCT02326272|616247590|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170402159|NCT04682639|615813349|FG001|OLE Period (28 Weeks)|Other|2|||
170519380|NCT02326272|616247591|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519381|NCT02326272|616247592|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519382|NCT02326272|616247593|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519383|NCT02326272|616247594|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170519384|NCT02326272|616247580|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519385|NCT02326272|616247581|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519386|NCT02326272|616247582|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
170519387|NCT02326272|616247583|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519388|NCT02326272|616247584|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519389|NCT02326272|616247585|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170861558|NCT03769181|617503707|FG001|Overall Study|Withdrawal by Subject|0|||
170861559|NCT03769181|617503708|FG002|Overall Study|Withdrawal by Subject|2|||
170861560|NCT03769181|617503709|FG003|Overall Study|Withdrawal by Subject|1|||
170861561|NCT03769181|617503706|FG000|Overall Study|Progressive disease|9|||
170861562|NCT03769181|617503707|FG001|Overall Study|Progressive disease|7|||
170861563|NCT03769181|617503708|FG002|Overall Study|Progressive disease|13|||
170519390|NCT02326272|616247586|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519391|NCT02326272|616247587|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519392|NCT02326272|616247588|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519393|NCT02326272|616247589|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519394|NCT02326272|616247590|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519395|NCT02326272|616247591|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519396|NCT02326272|616247592|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519397|NCT02326272|616247593|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519398|NCT02326272|616247594|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
170519399|NCT02326272|616247580|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519400|NCT02326272|616247581|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519401|NCT02326272|616247582|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
170519402|NCT02326272|616247583|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519403|NCT02326272|616247584|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519404|NCT02326272|616247585|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519405|NCT02326272|616247586|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519406|NCT02326272|616247587|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519407|NCT02326272|616247588|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519408|NCT02326272|616247589|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519409|NCT02326272|616247590|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519410|NCT02326272|616247591|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519411|NCT02326272|616247592|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519412|NCT02326272|616247593|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519413|NCT02326272|616247594|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
170519414|NCT02326272|616247580|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519415|NCT02326272|616247581|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519416|NCT02326272|616247582|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
170519417|NCT02326272|616247583|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519418|NCT02326272|616247584|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519419|NCT02326272|616247585|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519420|NCT02326272|616247586|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519421|NCT02326272|616247587|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519422|NCT02326272|616247588|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519423|NCT02326272|616247589|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519424|NCT02326272|616247590|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519425|NCT02326272|616247591|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519426|NCT02326272|616247592|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519427|NCT02326272|616247593|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519428|NCT02326272|616247594|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
170519429|NCT02326272|616247580|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519430|NCT02326272|616247581|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519431|NCT02326272|616247582|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
170519432|NCT02326272|616247583|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519433|NCT02326272|616247584|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519434|NCT02326272|616247585|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170861564|NCT03769181|617503709|FG003|Overall Study|Progressive disease|6|||
170861565|NCT03769181|617503706|FG000|Overall Study|Other - Unspecified|2|||
170750059|NCT02138747|617090474|FG000|Treatment Period 1|Protocol Violation|0|||
170750060|NCT02138747|617090475|FG001|Treatment Period 1|Protocol Violation|2|||
170750061|NCT02138747|617090476|FG002|Treatment Period 1|Protocol Violation|0|||
170750062|NCT02138747|617090477|FG003|Treatment Period 1|Protocol Violation|0|||
170750063|NCT02138747|617090474|FG000|Treatment Period 1|Withdrawal by Subject|8|||
170750064|NCT02138747|617090475|FG001|Treatment Period 1|Withdrawal by Subject|4|||
170750065|NCT02138747|617090476|FG002|Treatment Period 1|Withdrawal by Subject|1|||
170750066|NCT02138747|617090477|FG003|Treatment Period 1|Withdrawal by Subject|3|||
170750067|NCT02138747|617090474|FG000|Treatment Period 1|Other - Miscellaneous|2|||
170750068|NCT02138747|617090475|FG001|Treatment Period 1|Other - Miscellaneous|4|||
170750069|NCT02138747|617090476|FG002|Treatment Period 1|Other - Miscellaneous|0|||
170750070|NCT02138747|617090477|FG003|Treatment Period 1|Other - Miscellaneous|0|||
170750071|NCT02138747|617090474|FG000|Treatment Period 2|Adverse Event|6|||
170750072|NCT02138747|617090475|FG001|Treatment Period 2|Adverse Event|3|||
170750073|NCT02138747|617090476|FG002|Treatment Period 2|Adverse Event|1|||
170750074|NCT02138747|617090477|FG003|Treatment Period 2|Adverse Event|1|||
170750075|NCT02138747|617090474|FG000|Treatment Period 2|Lost to Follow-up|2|||
170750076|NCT02138747|617090475|FG001|Treatment Period 2|Lost to Follow-up|0|||
170750077|NCT02138747|617090476|FG002|Treatment Period 2|Lost to Follow-up|0|||
170750078|NCT02138747|617090477|FG003|Treatment Period 2|Lost to Follow-up|0|||
170750079|NCT02138747|617090474|FG000|Treatment Period 2|Protocol Violation|1|||
170750080|NCT02138747|617090475|FG001|Treatment Period 2|Protocol Violation|0|||
170750081|NCT02138747|617090476|FG002|Treatment Period 2|Protocol Violation|0|||
170750082|NCT02138747|617090477|FG003|Treatment Period 2|Protocol Violation|0|||
170750083|NCT02138747|617090474|FG000|Treatment Period 2|Withdrawal by Subject|5|||
170750084|NCT02138747|617090475|FG001|Treatment Period 2|Withdrawal by Subject|4|||
170750085|NCT02138747|617090476|FG002|Treatment Period 2|Withdrawal by Subject|1|||
170750086|NCT02138747|617090477|FG003|Treatment Period 2|Withdrawal by Subject|2|||
170750087|NCT02138747|617090474|FG000|Treatment Period 2|Other - Miscellaneous|3|||
170750088|NCT02138747|617090475|FG001|Treatment Period 2|Other - Miscellaneous|0|||
170750089|NCT02138747|617090476|FG002|Treatment Period 2|Other - Miscellaneous|0|||
170750090|NCT02138747|617090477|FG003|Treatment Period 2|Other - Miscellaneous|0|||
170750091|NCT00653263|617090478|FG000|Overall Study|Withdrawal by Subject|1|||
170750092|NCT00653263|617090478|FG000|Overall Study|Physician Decision|1|||
170750093|NCT02302066|617090479|FG000|Overall Study|Adverse Event|1|||
170750094|NCT02302066|617090480|FG001|Overall Study|Adverse Event|1|||
170750095|NCT02302066|617090481|FG002|Overall Study|Adverse Event|3|||
170750096|NCT02302066|617090482|FG003|Overall Study|Adverse Event|0|||
170750097|NCT02302066|617090479|FG000|Overall Study|Lost to Follow-up|4|||
170750098|NCT02302066|617090480|FG001|Overall Study|Lost to Follow-up|5|||
170750099|NCT02302066|617090481|FG002|Overall Study|Lost to Follow-up|24|||
170750100|NCT02302066|617090482|FG003|Overall Study|Lost to Follow-up|7|||
170750101|NCT02302066|617090479|FG000|Overall Study|Withdrawal by Subject|25|||
170750102|NCT02302066|617090480|FG001|Overall Study|Withdrawal by Subject|58|||
170750103|NCT02302066|617090481|FG002|Overall Study|Withdrawal by Subject|124|||
170750104|NCT02302066|617090482|FG003|Overall Study|Withdrawal by Subject|33|||
170750105|NCT02302066|617090479|FG000|Overall Study|Pregnancy|2|||
170750106|NCT02302066|617090480|FG001|Overall Study|Pregnancy|10|||
170750107|NCT02302066|617090481|FG002|Overall Study|Pregnancy|12|||
170750108|NCT02302066|617090482|FG003|Overall Study|Pregnancy|0|||
170750109|NCT02302066|617090479|FG000|Overall Study|Reason Not Specified|1|||
170750110|NCT02302066|617090480|FG001|Overall Study|Reason Not Specified|1|||
170750111|NCT02302066|617090481|FG002|Overall Study|Reason Not Specified|9|||
170750112|NCT02302066|617090482|FG003|Overall Study|Reason Not Specified|1|||
170750113|NCT00776100|617090486|FG000|Overall Study|Disease Progression|1|||
170750114|NCT00776100|617090487|FG001|Overall Study|Disease Progression|0|||
170750115|NCT04759885|617090492|FG000|Overall Study|Other|1|||
170750116|NCT04759885|617090493|FG001|Overall Study|Other|0|||
170750117|NCT04759885|617090494|FG002|Overall Study|Other|2|||
170750118|NCT04759885|617090495|FG003|Overall Study|Other|0|||
170750119|NCT04759885|617090496|FG004|Overall Study|Other|0|||
170750120|NCT04759885|617090492|FG000|Overall Study|Withdrawal by Subject|0|||
170750121|NCT04759885|617090493|FG001|Overall Study|Withdrawal by Subject|0|||
170750122|NCT04759885|617090494|FG002|Overall Study|Withdrawal by Subject|1|||
170750123|NCT04759885|617090495|FG003|Overall Study|Withdrawal by Subject|9|||
170750124|NCT04759885|617090496|FG004|Overall Study|Withdrawal by Subject|6|||
170750125|NCT04759885|617090492|FG000|Overall Study|Adverse Event|0|||
170750126|NCT04759885|617090493|FG001|Overall Study|Adverse Event|0|||
170750127|NCT04759885|617090494|FG002|Overall Study|Adverse Event|0|||
170750128|NCT04759885|617090495|FG003|Overall Study|Adverse Event|3|||
170750129|NCT04759885|617090496|FG004|Overall Study|Adverse Event|0|||
170750130|NCT04759885|617090492|FG000|Overall Study|Physician Decision|0|||
170750131|NCT04759885|617090493|FG001|Overall Study|Physician Decision|0|||
170750132|NCT04759885|617090494|FG002|Overall Study|Physician Decision|0|||
170750133|NCT04759885|617090495|FG003|Overall Study|Physician Decision|2|||
170750134|NCT04759885|617090496|FG004|Overall Study|Physician Decision|0|||
170750135|NCT01960790|617090498|FG000|Overall Study|Survey forms could not be recovered|3|||
170750136|NCT01960790|617090498|FG000|Overall Study|Treat with Humira outside survey period|3|||
170519435|NCT02326272|616247586|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519436|NCT02326272|616247587|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519437|NCT02326272|616247588|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519438|NCT02326272|616247589|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519439|NCT02326272|616247590|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519440|NCT02326272|616247591|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519441|NCT02326272|616247592|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519442|NCT02326272|616247593|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519443|NCT02326272|616247594|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
170519444|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170519445|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170519446|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170519447|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170750137|NCT01960790|617090498|FG000|Overall Study|Transferred to another hospital|4|||
170750138|NCT01960790|617090498|FG000|Overall Study|Unevaluable for safety|1|||
170750139|NCT01857622|617090501|FG000|Overall Study|Adverse Event|5|||
170750140|NCT01857622|617090502|FG001|Overall Study|Adverse Event|0|||
170750141|NCT01857622|617090503|FG002|Overall Study|Adverse Event|2|||
170750142|NCT01857622|617090501|FG000|Overall Study|Physician Decision|1|||
170750143|NCT01857622|617090502|FG001|Overall Study|Physician Decision|0|||
170750144|NCT01857622|617090503|FG002|Overall Study|Physician Decision|0|||
170750145|NCT01857622|617090501|FG000|Overall Study|Protocol Violation|4|||
170750146|NCT01857622|617090502|FG001|Overall Study|Protocol Violation|1|||
170750147|NCT01857622|617090503|FG002|Overall Study|Protocol Violation|0|||
170750148|NCT01857622|617090501|FG000|Overall Study|Withdrawal by Subject|1|||
170750149|NCT01857622|617090502|FG001|Overall Study|Withdrawal by Subject|0|||
170750150|NCT01857622|617090503|FG002|Overall Study|Withdrawal by Subject|0|||
170750151|NCT01291225|617090505|FG000|Overall Study|Lost to Follow-up|85|||
170750152|NCT01291225|617090506|FG001|Overall Study|Lost to Follow-up|39|||
170750153|NCT00996580|617090509|FG000|Overall Study|Adverse Event|466|||
170750154|NCT00996580|617090509|FG000|Overall Study|Lost to Follow-up|480|||
170750155|NCT00996580|617090509|FG000|Overall Study|Noncompliance with the protocol|137|||
170750156|NCT00996580|617090509|FG000|Overall Study|Physician Decision|5|||
170750157|NCT00996580|617090509|FG000|Overall Study|Pregnancy|68|||
170750158|NCT00996580|617090509|FG000|Overall Study|Protocol Violation|16|||
170750159|NCT00996580|617090509|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
170750160|NCT00996580|617090509|FG000|Overall Study|Withdrawal by Subject|217|||
170750161|NCT00996580|617090509|FG000|Overall Study|Other|29|||
170750162|NCT02468934|617090510|FG000|Overall Study|Withdrawal by Subject|4|||
170750163|NCT02468934|617090510|FG000|Overall Study|Screen Failure|3|||
170750164|NCT00547911|617090518|FG000|Overall Study|Adverse Event|0|||
170750165|NCT00547911|617090519|FG001|Overall Study|Adverse Event|0|||
170750166|NCT00547911|617090520|FG002|Overall Study|Adverse Event|0|||
170750167|NCT00547911|617090521|FG003|Overall Study|Adverse Event|1|||
170750168|NCT00547911|617090522|FG004|Overall Study|Adverse Event|0|||
170750169|NCT00547911|617090523|FG005|Overall Study|Adverse Event|0|||
170750170|NCT01644474|617090524|FG000|Overall Study|Poor compliance to protocol|1|||
170750171|NCT01644474|617090525|FG001|Overall Study|Poor compliance to protocol|0|||
170750172|NCT01644474|617090524|FG000|Overall Study|Consent withdrawn by participant|0|||
170750173|NCT01644474|617090525|FG001|Overall Study|Consent withdrawn by participant|1|||
170750174|NCT01644474|617090524|FG000|Overall Study|Participant moved|0|||
170750175|NCT01644474|617090525|FG001|Overall Study|Participant moved|1|||
170750176|NCT01644474|617090524|FG000|Overall Study|Adverse Event|4|||
170750177|NCT01644474|617090525|FG001|Overall Study|Adverse Event|5|||
170750178|NCT01644474|617090524|FG000|Overall Study|Site scheduling error|1|||
170750179|NCT01644474|617090525|FG001|Overall Study|Site scheduling error|1|||
170750180|NCT01644474|617090524|FG000|Overall Study|Protocol Violation|1|||
170750181|NCT01644474|617090525|FG001|Overall Study|Protocol Violation|0|||
170750182|NCT04039503|617090526|FG000|Overall Study|Adverse Event|3|||
170750183|NCT04039503|617090527|FG001|Overall Study|Adverse Event|0|||
170750184|NCT04039503|617090528|FG002|Overall Study|Adverse Event|2|||
170750185|NCT04039503|617090529|FG003|Overall Study|Adverse Event|0|||
170750186|NCT04039503|617090526|FG000|Overall Study|Lost to Follow-up|0|||
170750187|NCT04039503|617090527|FG001|Overall Study|Lost to Follow-up|0|||
170750188|NCT04039503|617090528|FG002|Overall Study|Lost to Follow-up|1|||
170750189|NCT04039503|617090529|FG003|Overall Study|Lost to Follow-up|0|||
170750190|NCT04039503|617090526|FG000|Overall Study|Protocol Violation|0|||
170750191|NCT04039503|617090527|FG001|Overall Study|Protocol Violation|1|||
170750192|NCT04039503|617090528|FG002|Overall Study|Protocol Violation|2|||
170750193|NCT04039503|617090529|FG003|Overall Study|Protocol Violation|1|||
170750194|NCT04039503|617090526|FG000|Overall Study|Withdrawal by Subject|4|||
170750195|NCT04039503|617090527|FG001|Overall Study|Withdrawal by Subject|3|||
170750196|NCT04039503|617090528|FG002|Overall Study|Withdrawal by Subject|5|||
170750197|NCT04039503|617090529|FG003|Overall Study|Withdrawal by Subject|2|||
170750198|NCT02601937|617090531|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750199|NCT02601937|617090532|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750200|NCT02601937|617090533|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750201|NCT02601937|617090534|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750202|NCT02601937|617090535|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750203|NCT02601937|617090536|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
170750204|NCT02601937|617090537|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750205|NCT02601937|617090538|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750206|NCT02601937|617090539|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750207|NCT02601937|617090540|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750208|NCT02601937|617090541|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
170750209|NCT02601937|617090531|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
170750210|NCT02601937|617090532|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170631431|NCT02113982|616664412|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
170631432|NCT02113982|616664413|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
170631433|NCT02113982|616664414|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
170631434|NCT02113982|616664415|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
170631435|NCT02113982|616664416|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
170631436|NCT02113982|616664417|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
170631437|NCT02113982|616664418|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
170631438|NCT02113982|616664419|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
170631439|NCT02113982|616664420|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
170631440|NCT02113982|616664421|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
170631441|NCT02113982|616664422|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
170631442|NCT02113982|616664423|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
170750211|NCT02601937|617090533|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170750212|NCT02601937|617090534|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170750213|NCT02601937|617090535|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170750214|NCT02601937|617090536|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170750215|NCT02601937|617090537|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
170750216|NCT02601937|617090538|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170750217|NCT02601937|617090539|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170750218|NCT02601937|617090540|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170750219|NCT02601937|617090541|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
170750220|NCT02601937|617090531|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750221|NCT02601937|617090532|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750222|NCT02601937|617090533|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
170750223|NCT02601937|617090534|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750224|NCT02601937|617090535|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750225|NCT02601937|617090536|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750226|NCT02601937|617090537|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750227|NCT02601937|617090538|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750228|NCT02601937|617090539|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750229|NCT02601937|617090540|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750230|NCT02601937|617090541|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
170750231|NCT02601937|617090531|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
170750232|NCT02601937|617090532|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
170750233|NCT02601937|617090533|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
170750234|NCT02601937|617090534|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
170750235|NCT02601937|617090535|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
170750236|NCT02601937|617090536|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
170750237|NCT02601937|617090537|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
170750238|NCT02601937|617090538|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
170750239|NCT02601937|617090539|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
170750240|NCT02601937|617090540|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
170750241|NCT02601937|617090541|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
170750242|NCT02601937|617090531|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170750243|NCT02601937|617090532|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170750244|NCT02601937|617090533|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170750245|NCT02601937|617090534|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170750246|NCT02601937|617090535|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170750247|NCT02601937|617090536|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170750248|NCT02601937|617090537|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170750249|NCT02601937|617090538|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170750250|NCT02601937|617090539|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170631443|NCT02113982|616664410|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
170519448|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
170519449|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
170519450|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
170519451|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
170519452|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
170519453|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170861566|NCT03769181|617503707|FG001|Overall Study|Other - Unspecified|1|||
170861567|NCT03769181|617503708|FG002|Overall Study|Other - Unspecified|0|||
170861568|NCT03769181|617503709|FG003|Overall Study|Other - Unspecified|0|||
170861569|NCT03511053|617503716|FG000|Overall Study|Withdrawal by Subject|1|||
170861570|NCT05116046|617503717|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170861571|NCT05116046|617503718|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170861572|NCT05116046|617503719|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170861573|NCT05116046|617503717|FG000|Overall Study|Study terminated by sponsor|14|||
170861574|NCT05116046|617503718|FG001|Overall Study|Study terminated by sponsor|16|||
170861575|NCT05116046|617503719|FG002|Overall Study|Study terminated by sponsor|1|||
170861576|NCT00892723|617503721|FG000|Overall Study|Lost to Follow-up|1|||
170861577|NCT00892723|617503722|FG001|Overall Study|Lost to Follow-up|3|||
170861578|NCT00892723|617503723|FG002|Overall Study|Lost to Follow-up|1|||
170861579|NCT00892723|617503721|FG000|Overall Study|Withdrawal by Subject|1|||
170861580|NCT00892723|617503722|FG001|Overall Study|Withdrawal by Subject|1|||
170861581|NCT00892723|617503723|FG002|Overall Study|Withdrawal by Subject|1|||
170861582|NCT04328727|617503724|FG000|Overall Study|Guardian Decision|1|||
170861583|NCT04328727|617503724|FG000|Overall Study|Participant decision|4|||
170861584|NCT04328727|617503724|FG000|Overall Study|Death|3|||
170861585|NCT00687973|617503725|FG000|Overall Study|Adverse Event|18|||
170861586|NCT00687973|617503726|FG001|Overall Study|Adverse Event|28|||
170861587|NCT00687973|617503725|FG000|Overall Study|Lack of Efficacy|2|||
170861588|NCT00687973|617503726|FG001|Overall Study|Lack of Efficacy|3|||
170861589|NCT00687973|617503725|FG000|Overall Study|Protocol Violation|1|||
170861590|NCT00687973|617503726|FG001|Overall Study|Protocol Violation|2|||
170861591|NCT00687973|617503725|FG000|Overall Study|Administrative Reasons|0|||
170861592|NCT00687973|617503726|FG001|Overall Study|Administrative Reasons|2|||
170861593|NCT00687973|617503725|FG000|Overall Study|Withdrawal by Subject|3|||
170861594|NCT00687973|617503726|FG001|Overall Study|Withdrawal by Subject|3|||
170861595|NCT01079741|617503734|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
170519454|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170519455|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170519456|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170519457|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170519458|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170519459|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519460|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519461|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519462|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519463|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519464|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
170519465|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
170519466|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519467|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
170519468|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
170519469|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519470|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519471|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519472|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519473|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170519474|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519475|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519476|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519477|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170861596|NCT01079741|617503735|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
170861597|NCT01079741|617503736|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
170861598|NCT01079741|617503737|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
170519478|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519479|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
170519480|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519481|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
170519482|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170861599|NCT01079741|617503738|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
170861600|NCT01079741|617503734|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
170519483|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519484|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519485|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519486|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519487|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170861601|NCT01079741|617503735|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
170861602|NCT01079741|617503736|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
170861603|NCT01079741|617503737|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
170861604|NCT01079741|617503738|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
170861605|NCT00511472|617503739|FG000|Overall Study|Clinical Adverse Event|1|||
170861606|NCT00511472|617503740|FG001|Overall Study|Clinical Adverse Event|2|||
170861607|NCT00511472|617503739|FG000|Overall Study|Laboratory Adverse Event|0|||
170861608|NCT00511472|617503740|FG001|Overall Study|Laboratory Adverse Event|2|||
170861609|NCT00511472|617503739|FG000|Overall Study|Not reported|2|||
170861610|NCT00511472|617503740|FG001|Overall Study|Not reported|2|||
170861611|NCT00446992|617503741|FG000|Overall Study|Adverse Event|11|||
170861612|NCT00446992|617503741|FG000|Overall Study|Lost to Follow-up|5|||
170861613|NCT00406653|617503742|FG000|Induction Period|Adverse Event|1|||
170861614|NCT00406653|617503743|FG001|Induction Period|Adverse Event|10|||
170519488|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170519489|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519490|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519491|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519492|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170519493|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519494|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
170519495|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170519496|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170519497|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519498|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170519499|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519500|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519501|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519502|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170861615|NCT00406653|617503744|FG002|Induction Period|Adverse Event|4|||
170861616|NCT00406653|617503745|FG003|Induction Period|Adverse Event|11|||
170519503|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170519504|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519505|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519506|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519507|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519508|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519509|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519510|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519511|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
170519512|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519513|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519514|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519515|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519516|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519517|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519518|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
170519519|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519520|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519521|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519522|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519523|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519524|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519525|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
170519526|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519527|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519528|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519529|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170861617|NCT00406653|617503746|FG004|Induction Period|Adverse Event|0|||
170861618|NCT00406653|617503747|FG005|Induction Period|Adverse Event|0|||
170861619|NCT00406653|617503748|FG006|Induction Period|Adverse Event|0|||
170861620|NCT00406653|617503742|FG000|Induction Period|Lack of Efficacy|11|||
170861621|NCT00406653|617503743|FG001|Induction Period|Lack of Efficacy|14|||
170861622|NCT00406653|617503744|FG002|Induction Period|Lack of Efficacy|8|||
170861623|NCT00406653|617503745|FG003|Induction Period|Lack of Efficacy|10|||
170861624|NCT00406653|617503746|FG004|Induction Period|Lack of Efficacy|0|||
170861625|NCT00406653|617503747|FG005|Induction Period|Lack of Efficacy|0|||
170519530|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519531|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519532|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519533|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170519534|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519535|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519536|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519537|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519538|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519539|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519540|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519541|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519542|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
170519543|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519544|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519545|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170861626|NCT00406653|617503748|FG006|Induction Period|Lack of Efficacy|0|||
170861627|NCT00406653|617503742|FG000|Induction Period|Lost to Follow-up|0|||
170519546|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519547|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519548|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
170519549|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519550|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519551|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519552|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519553|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519554|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
170519555|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
170519556|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
170519557|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
170519558|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519559|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519560|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519561|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519562|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170519563|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170750251|NCT02601937|617090540|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
170750252|NCT02601937|617090541|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
170861628|NCT00406653|617503743|FG001|Induction Period|Lost to Follow-up|2|||
170861629|NCT00406653|617503744|FG002|Induction Period|Lost to Follow-up|0|||
170861630|NCT00406653|617503745|FG003|Induction Period|Lost to Follow-up|0|||
170861631|NCT00406653|617503746|FG004|Induction Period|Lost to Follow-up|0|||
170861632|NCT00406653|617503747|FG005|Induction Period|Lost to Follow-up|0|||
170861633|NCT00406653|617503748|FG006|Induction Period|Lost to Follow-up|0|||
170861634|NCT00406653|617503742|FG000|Induction Period|Withdrawal of Consent|2|||
170861635|NCT00406653|617503743|FG001|Induction Period|Withdrawal of Consent|5|||
170861636|NCT00406653|617503744|FG002|Induction Period|Withdrawal of Consent|1|||
170861637|NCT00406653|617503745|FG003|Induction Period|Withdrawal of Consent|2|||
170750253|NCT02601937|617090531|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750254|NCT02601937|617090532|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750255|NCT02601937|617090533|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750256|NCT02601937|617090534|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750257|NCT02601937|617090535|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750258|NCT02601937|617090536|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750259|NCT02601937|617090537|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750260|NCT02601937|617090538|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
170750261|NCT02601937|617090539|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750262|NCT02601937|617090540|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170861638|NCT00406653|617503746|FG004|Induction Period|Withdrawal of Consent|0|||
170861639|NCT00406653|617503747|FG005|Induction Period|Withdrawal of Consent|0|||
170519564|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519565|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519566|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519567|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519568|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519569|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
170519570|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519571|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519572|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519573|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519574|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519575|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519576|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519577|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519578|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
170519579|NCT02326272|616247580|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519580|NCT02326272|616247581|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519581|NCT02326272|616247582|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170750263|NCT02601937|617090541|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
170750264|NCT02601937|617090531|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170750265|NCT02601937|617090532|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170750266|NCT02601937|617090533|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170750267|NCT02601937|617090534|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170750268|NCT02601937|617090535|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170519582|NCT02326272|616247583|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519583|NCT02326272|616247584|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519584|NCT02326272|616247585|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519585|NCT02326272|616247586|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
170519586|NCT02326272|616247587|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519587|NCT02326272|616247588|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519588|NCT02326272|616247589|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519589|NCT02326272|616247590|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519590|NCT02326272|616247591|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519591|NCT02326272|616247592|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519592|NCT02326272|616247593|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519593|NCT02326272|616247594|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
170519594|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
170519595|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
170519596|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
170519597|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
170519598|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
170519599|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
170519600|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
170519601|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
170519602|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
170519603|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
170519604|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
170519605|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
170519606|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
170519607|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
170519608|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
170519609|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519610|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519611|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519612|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519613|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519614|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519615|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170750269|NCT02601937|617090536|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170750270|NCT02601937|617090537|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170750271|NCT02601937|617090538|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170519616|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170750272|NCT02601937|617090539|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
170750273|NCT02601937|617090540|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
170750274|NCT02601937|617090541|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
170750275|NCT02601937|617090531|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
170750276|NCT02601937|617090532|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
170750277|NCT02601937|617090533|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
170750278|NCT02601937|617090534|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
170750279|NCT02601937|617090535|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
170750280|NCT02601937|617090536|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
170750281|NCT02601937|617090537|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
170750282|NCT02601937|617090538|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
170750283|NCT02601937|617090539|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
170750284|NCT02601937|617090540|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
170750285|NCT02601937|617090541|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
170750286|NCT02601937|617090531|FG000|Period 2: Dose Expansion Cohort|Other|0|||
170750287|NCT02601937|617090532|FG001|Period 2: Dose Expansion Cohort|Other|0|||
170750288|NCT02601937|617090533|FG002|Period 2: Dose Expansion Cohort|Other|0|||
170750289|NCT02601937|617090534|FG003|Period 2: Dose Expansion Cohort|Other|0|||
170750290|NCT02601937|617090535|FG004|Period 2: Dose Expansion Cohort|Other|0|||
170750291|NCT02601937|617090536|FG005|Period 2: Dose Expansion Cohort|Other|0|||
170750292|NCT02601937|617090537|FG006|Period 2: Dose Expansion Cohort|Other|0|||
170750293|NCT02601937|617090538|FG007|Period 2: Dose Expansion Cohort|Other|0|||
170750294|NCT02601937|617090539|FG008|Period 2: Dose Expansion Cohort|Other|2|||
170750295|NCT02601937|617090540|FG009|Period 2: Dose Expansion Cohort|Other|2|||
170750296|NCT02601937|617090541|FG010|Period 2: Dose Expansion Cohort|Other|0|||
170750297|NCT02601937|617090531|FG000|Period 2: Dose Expansion Cohort|Death|0|||
170750298|NCT02601937|617090532|FG001|Period 2: Dose Expansion Cohort|Death|0|||
170750299|NCT02601937|617090533|FG002|Period 2: Dose Expansion Cohort|Death|0|||
170750300|NCT02601937|617090534|FG003|Period 2: Dose Expansion Cohort|Death|0|||
170750301|NCT02601937|617090535|FG004|Period 2: Dose Expansion Cohort|Death|0|||
170750302|NCT02601937|617090536|FG005|Period 2: Dose Expansion Cohort|Death|0|||
170519617|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519618|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519619|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
170519620|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
170519621|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
170519622|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170519623|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
170750303|NCT02601937|617090537|FG006|Period 2: Dose Expansion Cohort|Death|0|||
170750304|NCT02601937|617090538|FG007|Period 2: Dose Expansion Cohort|Death|0|||
170750305|NCT02601937|617090539|FG008|Period 2: Dose Expansion Cohort|Death|1|||
170750306|NCT02601937|617090540|FG009|Period 2: Dose Expansion Cohort|Death|0|||
170750307|NCT02601937|617090541|FG010|Period 2: Dose Expansion Cohort|Death|0|||
170750308|NCT04423393|617092295|FG000|Overall Study|Withdrawal by Subject|0|||
170750309|NCT04423393|617092296|FG001|Overall Study|Withdrawal by Subject|0|||
170750310|NCT04423393|617092297|FG002|Overall Study|Withdrawal by Subject|0|||
170750311|NCT04423393|617092298|FG003|Overall Study|Withdrawal by Subject|0|||
170750312|NCT04423393|617092299|FG004|Overall Study|Withdrawal by Subject|0|||
170750313|NCT04423393|617092300|FG005|Overall Study|Withdrawal by Subject|1|||
170750314|NCT04423393|617092301|FG006|Overall Study|Withdrawal by Subject|0|||
170750315|NCT04423393|617092302|FG007|Overall Study|Withdrawal by Subject|0|||
170750316|NCT04423393|617092303|FG008|Overall Study|Withdrawal by Subject|0|||
170750317|NCT04423393|617092304|FG009|Overall Study|Withdrawal by Subject|0|||
170750318|NCT04423393|617092305|FG010|Overall Study|Withdrawal by Subject|0|||
170750319|NCT04423393|617092306|FG011|Overall Study|Withdrawal by Subject|0|||
170750320|NCT04423393|617092307|FG012|Overall Study|Withdrawal by Subject|0|||
170750321|NCT04423393|617092308|FG013|Overall Study|Withdrawal by Subject|1|||
170750322|NCT04423393|617092309|FG014|Overall Study|Withdrawal by Subject|0|||
170750323|NCT04423393|617092310|FG015|Overall Study|Withdrawal by Subject|0|||
170750324|NCT04423393|617092311|FG016|Overall Study|Withdrawal by Subject|0|||
170750325|NCT04423393|617092312|FG017|Overall Study|Withdrawal by Subject|0|||
170750326|NCT04423393|617092295|FG000|Overall Study|Sponsor Decision|0|||
170750327|NCT04423393|617092296|FG001|Overall Study|Sponsor Decision|0|||
170750328|NCT04423393|617092297|FG002|Overall Study|Sponsor Decision|0|||
170750329|NCT04423393|617092298|FG003|Overall Study|Sponsor Decision|0|||
170750330|NCT04423393|617092299|FG004|Overall Study|Sponsor Decision|0|||
170750331|NCT04423393|617092300|FG005|Overall Study|Sponsor Decision|0|||
170750332|NCT04423393|617092301|FG006|Overall Study|Sponsor Decision|0|||
170750333|NCT04423393|617092302|FG007|Overall Study|Sponsor Decision|0|||
170750334|NCT04423393|617092303|FG008|Overall Study|Sponsor Decision|0|||
170750335|NCT04423393|617092304|FG009|Overall Study|Sponsor Decision|0|||
170861640|NCT00406653|617503748|FG006|Induction Period|Withdrawal of Consent|0|||
170861641|NCT00406653|617503742|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
170861642|NCT00406653|617503743|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
170861643|NCT00406653|617503744|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
170861644|NCT00406653|617503745|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
170861645|NCT00406653|617503746|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
170861646|NCT00406653|617503747|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
170861647|NCT00406653|617503748|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
170861648|NCT00406653|617503742|FG000|Induction Period|Pregnancy|1|||
170861649|NCT00406653|617503743|FG001|Induction Period|Pregnancy|0|||
170861650|NCT00406653|617503744|FG002|Induction Period|Pregnancy|0|||
170861651|NCT00406653|617503745|FG003|Induction Period|Pregnancy|0|||
170861652|NCT00406653|617503746|FG004|Induction Period|Pregnancy|0|||
170861653|NCT00406653|617503747|FG005|Induction Period|Pregnancy|0|||
170861654|NCT00406653|617503748|FG006|Induction Period|Pregnancy|0|||
170861655|NCT00406653|617503742|FG000|Induction Period|Declined participation but followup done|0|||
170861656|NCT00406653|617503743|FG001|Induction Period|Declined participation but followup done|2|||
170750336|NCT04423393|617092305|FG010|Overall Study|Sponsor Decision|0|||
170750337|NCT04423393|617092306|FG011|Overall Study|Sponsor Decision|0|||
170750338|NCT04423393|617092307|FG012|Overall Study|Sponsor Decision|0|||
170750339|NCT04423393|617092308|FG013|Overall Study|Sponsor Decision|1|||
170750340|NCT04423393|617092309|FG014|Overall Study|Sponsor Decision|0|||
170750341|NCT04423393|617092310|FG015|Overall Study|Sponsor Decision|0|||
170750342|NCT04423393|617092311|FG016|Overall Study|Sponsor Decision|0|||
170750343|NCT04423393|617092312|FG017|Overall Study|Sponsor Decision|0|||
170750344|NCT01929993|617092313|FG000|Overall Study|Protocol Violation|4|||
170750345|NCT01929993|617092314|FG001|Overall Study|Protocol Violation|6|||
170750346|NCT01929993|617092313|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
170750347|NCT01929993|617092314|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
170750348|NCT00107380|617092315|FG000|Overall Study|Adverse Event|7|||
170750349|NCT00107380|617092315|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
170750350|NCT00107380|617092315|FG000|Overall Study|Progression/relapse|4|||
170750351|NCT00107380|617092315|FG000|Overall Study|Death|3|||
170750352|NCT00107380|617092315|FG000|Overall Study|Other - not protocol specified|7|||
170750353|NCT00107380|617092315|FG000|Overall Study|Ineligible|2|||
170750354|NCT03673098|617092316|FG000|Overall Study|Lost to Follow-up|2|||
170750355|NCT03673098|617092317|FG001|Overall Study|Lost to Follow-up|3|||
170750356|NCT03673098|617092316|FG000|Overall Study|Withdrawal by Subject|6|||
170750357|NCT03673098|617092317|FG001|Overall Study|Withdrawal by Subject|1|||
170750358|NCT03673098|617092316|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
170750359|NCT03673098|617092317|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
170750360|NCT01268059|617092318|FG000|Overall Study|Lost to Follow-up|0|||
170750361|NCT01268059|617092319|FG001|Overall Study|Lost to Follow-up|1|||
170750362|NCT01268059|617092320|FG002|Overall Study|Lost to Follow-up|0|||
170750363|NCT01268059|617092321|FG003|Overall Study|Lost to Follow-up|0|||
170750364|NCT01268059|617092318|FG000|Overall Study|Withdrawal by Subject|7|||
170750365|NCT01268059|617092319|FG001|Overall Study|Withdrawal by Subject|4|||
170750366|NCT01268059|617092320|FG002|Overall Study|Withdrawal by Subject|0|||
170861657|NCT00406653|617503744|FG002|Induction Period|Declined participation but followup done|1|||
170861658|NCT00406653|617503745|FG003|Induction Period|Declined participation but followup done|1|||
170861659|NCT00406653|617503746|FG004|Induction Period|Declined participation but followup done|0|||
170861660|NCT00406653|617503747|FG005|Induction Period|Declined participation but followup done|0|||
170861661|NCT00406653|617503748|FG006|Induction Period|Declined participation but followup done|0|||
170861662|NCT00406653|617503742|FG000|Induction Period|Given prohibited drug|0|||
170861663|NCT00406653|617503743|FG001|Induction Period|Given prohibited drug|1|||
170861664|NCT00406653|617503744|FG002|Induction Period|Given prohibited drug|2|||
170861665|NCT00406653|617503745|FG003|Induction Period|Given prohibited drug|0|||
170861666|NCT00406653|617503746|FG004|Induction Period|Given prohibited drug|0|||
170861667|NCT00406653|617503747|FG005|Induction Period|Given prohibited drug|0|||
170861668|NCT00406653|617503748|FG006|Induction Period|Given prohibited drug|0|||
170861669|NCT00406653|617503742|FG000|Induction Period|Incarcerated|0|||
170861670|NCT00406653|617503743|FG001|Induction Period|Incarcerated|0|||
170861671|NCT00406653|617503744|FG002|Induction Period|Incarcerated|1|||
170861672|NCT00406653|617503745|FG003|Induction Period|Incarcerated|0|||
170861673|NCT00406653|617503746|FG004|Induction Period|Incarcerated|0|||
170861674|NCT00406653|617503747|FG005|Induction Period|Incarcerated|0|||
170861675|NCT00406653|617503748|FG006|Induction Period|Incarcerated|0|||
170861676|NCT00406653|617503742|FG000|Induction Period|Patient relocated|0|||
170861677|NCT00406653|617503743|FG001|Induction Period|Patient relocated|0|||
170750367|NCT01268059|617092321|FG003|Overall Study|Withdrawal by Subject|0|||
170861678|NCT00406653|617503744|FG002|Induction Period|Patient relocated|1|||
170861679|NCT00406653|617503745|FG003|Induction Period|Patient relocated|0|||
170861680|NCT00406653|617503746|FG004|Induction Period|Patient relocated|0|||
170861681|NCT00406653|617503747|FG005|Induction Period|Patient relocated|0|||
170402160|NCT04682639|615813350|FG002|OLE Period (28 Weeks)|Other|0|||
170861682|NCT00406653|617503748|FG006|Induction Period|Patient relocated|0|||
170861683|NCT00406653|617503742|FG000|Maintenance Period|Adverse Event|0|||
170861684|NCT00406653|617503743|FG001|Maintenance Period|Adverse Event|0|||
170861685|NCT00406653|617503744|FG002|Maintenance Period|Adverse Event|0|||
170861686|NCT00406653|617503745|FG003|Maintenance Period|Adverse Event|0|||
170861687|NCT00406653|617503746|FG004|Maintenance Period|Adverse Event|1|||
170861688|NCT00406653|617503747|FG005|Maintenance Period|Adverse Event|1|||
170861689|NCT00406653|617503748|FG006|Maintenance Period|Adverse Event|0|||
170861690|NCT00406653|617503742|FG000|Maintenance Period|Lack of Efficacy|0|||
170861691|NCT00406653|617503743|FG001|Maintenance Period|Lack of Efficacy|0|||
170861692|NCT00406653|617503744|FG002|Maintenance Period|Lack of Efficacy|0|||
170861693|NCT00406653|617503745|FG003|Maintenance Period|Lack of Efficacy|0|||
170861694|NCT00406653|617503746|FG004|Maintenance Period|Lack of Efficacy|20|||
170861695|NCT00406653|617503747|FG005|Maintenance Period|Lack of Efficacy|26|||
170861696|NCT00406653|617503748|FG006|Maintenance Period|Lack of Efficacy|0|||
170861697|NCT00406653|617503742|FG000|Maintenance Period|Lost to Follow-up|0|||
170861698|NCT00406653|617503743|FG001|Maintenance Period|Lost to Follow-up|0|||
170861699|NCT00406653|617503744|FG002|Maintenance Period|Lost to Follow-up|0|||
170861700|NCT00406653|617503745|FG003|Maintenance Period|Lost to Follow-up|0|||
170861701|NCT00406653|617503746|FG004|Maintenance Period|Lost to Follow-up|2|||
170861702|NCT00406653|617503747|FG005|Maintenance Period|Lost to Follow-up|1|||
170861703|NCT00406653|617503748|FG006|Maintenance Period|Lost to Follow-up|0|||
170861704|NCT00406653|617503742|FG000|Maintenance Period|Withdrawal of Consent|0|||
170861705|NCT00406653|617503743|FG001|Maintenance Period|Withdrawal of Consent|0|||
170861706|NCT00406653|617503744|FG002|Maintenance Period|Withdrawal of Consent|0|||
170861707|NCT00406653|617503745|FG003|Maintenance Period|Withdrawal of Consent|0|||
170861708|NCT00406653|617503746|FG004|Maintenance Period|Withdrawal of Consent|2|||
170861709|NCT00406653|617503747|FG005|Maintenance Period|Withdrawal of Consent|0|||
170861710|NCT00406653|617503748|FG006|Maintenance Period|Withdrawal of Consent|0|||
170861711|NCT00406653|617503742|FG000|Maintenance Period|Pregnancy|0|||
170861712|NCT00406653|617503743|FG001|Maintenance Period|Pregnancy|0|||
170861713|NCT00406653|617503744|FG002|Maintenance Period|Pregnancy|0|||
170861714|NCT00406653|617503745|FG003|Maintenance Period|Pregnancy|0|||
170861715|NCT00406653|617503746|FG004|Maintenance Period|Pregnancy|0|||
170861716|NCT00406653|617503747|FG005|Maintenance Period|Pregnancy|1|||
170861717|NCT00406653|617503748|FG006|Maintenance Period|Pregnancy|0|||
170861718|NCT00406653|617503742|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
170861719|NCT00406653|617503743|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
170861720|NCT00406653|617503744|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
170861721|NCT00406653|617503745|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
170861722|NCT00406653|617503746|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
170861723|NCT00406653|617503747|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
170750368|NCT01268059|617092318|FG000|Overall Study|Death|20|||
170750369|NCT01268059|617092319|FG001|Overall Study|Death|30|||
170750370|NCT01268059|617092320|FG002|Overall Study|Death|3|||
170750371|NCT01268059|617092321|FG003|Overall Study|Death|5|||
170750372|NCT01268059|617092318|FG000|Overall Study|Progression of disease|1|||
170750373|NCT01268059|617092319|FG001|Overall Study|Progression of disease|0|||
170750374|NCT01268059|617092320|FG002|Overall Study|Progression of disease|0|||
170750375|NCT01268059|617092321|FG003|Overall Study|Progression of disease|0|||
170750376|NCT03660943|617092322|FG000|Overall Study|Adverse Event|5|||
170750377|NCT03660943|617092323|FG001|Overall Study|Adverse Event|3|||
170750378|NCT03660943|617092322|FG000|Overall Study|Death|0|||
170750379|NCT03660943|617092323|FG001|Overall Study|Death|2|||
170750380|NCT03660943|617092322|FG000|Overall Study|Lost to Follow-up|7|||
170750381|NCT03660943|617092323|FG001|Overall Study|Lost to Follow-up|3|||
170750382|NCT03660943|617092322|FG000|Overall Study|Protocol Violation|3|||
170750383|NCT03660943|617092323|FG001|Overall Study|Protocol Violation|5|||
170750384|NCT03660943|617092322|FG000|Overall Study|Withdrawal by Subject|8|||
170750385|NCT03660943|617092323|FG001|Overall Study|Withdrawal by Subject|15|||
170750386|NCT03660943|617092322|FG000|Overall Study|Lack of Efficacy|9|||
170750387|NCT03660943|617092323|FG001|Overall Study|Lack of Efficacy|12|||
170750388|NCT03660943|617092322|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
170750389|NCT03660943|617092323|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
170750390|NCT03850444|617092324|FG000|Overall Study|Adverse Event|16|||
170750391|NCT03850444|617092325|FG001|Overall Study|Adverse Event|10|||
170750392|NCT03850444|617092324|FG000|Overall Study|Death|87|||
170861724|NCT00406653|617503748|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
170861725|NCT00406653|617503742|FG000|Maintenance Period|Error in disease score evaluation|0|||
170861726|NCT00406653|617503743|FG001|Maintenance Period|Error in disease score evaluation|0|||
170861727|NCT00406653|617503744|FG002|Maintenance Period|Error in disease score evaluation|0|||
170750393|NCT03850444|617092325|FG001|Overall Study|Death|107|||
170861728|NCT00406653|617503745|FG003|Maintenance Period|Error in disease score evaluation|0|||
170750394|NCT03850444|617092324|FG000|Overall Study|Lost to Follow-up|1|||
170750395|NCT03850444|617092325|FG001|Overall Study|Lost to Follow-up|1|||
170750396|NCT03850444|617092324|FG000|Overall Study|Withdrawal by Subject|1|||
170861729|NCT00406653|617503746|FG004|Maintenance Period|Error in disease score evaluation|1|||
170861730|NCT00406653|617503747|FG005|Maintenance Period|Error in disease score evaluation|0|||
170861731|NCT00406653|617503748|FG006|Maintenance Period|Error in disease score evaluation|0|||
170861732|NCT00406653|617503742|FG000|Open-Label Period|Death|0|||
170861733|NCT00406653|617503743|FG001|Open-Label Period|Death|0|||
170861734|NCT00406653|617503744|FG002|Open-Label Period|Death|0|||
170861735|NCT00406653|617503745|FG003|Open-Label Period|Death|0|||
170861736|NCT00406653|617503746|FG004|Open-Label Period|Death|0|||
170861737|NCT00406653|617503747|FG005|Open-Label Period|Death|0|||
170861738|NCT00406653|617503748|FG006|Open-Label Period|Death|1|||
170861739|NCT00406653|617503742|FG000|Open-Label Period|Adverse Event|0|||
170631444|NCT02113982|616664411|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
170631445|NCT02113982|616664412|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
170631446|NCT02113982|616664413|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
170631447|NCT02113982|616664414|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
170750397|NCT03850444|617092325|FG001|Overall Study|Withdrawal by Subject|5|||
170750398|NCT03850444|617092324|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
170861740|NCT00406653|617503743|FG001|Open-Label Period|Adverse Event|0|||
170861741|NCT00406653|617503744|FG002|Open-Label Period|Adverse Event|0|||
170861742|NCT00406653|617503745|FG003|Open-Label Period|Adverse Event|0|||
170861743|NCT00406653|617503746|FG004|Open-Label Period|Adverse Event|0|||
170861744|NCT00406653|617503747|FG005|Open-Label Period|Adverse Event|0|||
170861745|NCT00406653|617503748|FG006|Open-Label Period|Adverse Event|18|||
170861746|NCT00406653|617503742|FG000|Open-Label Period|Lack of Efficacy|0|||
170861747|NCT00406653|617503743|FG001|Open-Label Period|Lack of Efficacy|0|||
170861748|NCT00406653|617503744|FG002|Open-Label Period|Lack of Efficacy|0|||
170861749|NCT00406653|617503745|FG003|Open-Label Period|Lack of Efficacy|0|||
170861750|NCT00406653|617503746|FG004|Open-Label Period|Lack of Efficacy|0|||
170861751|NCT00406653|617503747|FG005|Open-Label Period|Lack of Efficacy|0|||
170861752|NCT00406653|617503748|FG006|Open-Label Period|Lack of Efficacy|160|||
170861753|NCT00406653|617503742|FG000|Open-Label Period|Lost to Follow-up|0|||
170861754|NCT00406653|617503743|FG001|Open-Label Period|Lost to Follow-up|0|||
170861755|NCT00406653|617503744|FG002|Open-Label Period|Lost to Follow-up|0|||
170861756|NCT00406653|617503745|FG003|Open-Label Period|Lost to Follow-up|0|||
170861757|NCT00406653|617503746|FG004|Open-Label Period|Lost to Follow-up|0|||
170861758|NCT00406653|617503747|FG005|Open-Label Period|Lost to Follow-up|0|||
170861759|NCT00406653|617503748|FG006|Open-Label Period|Lost to Follow-up|6|||
170861760|NCT00406653|617503742|FG000|Open-Label Period|Withdrawal of Consent|0|||
170861761|NCT00406653|617503743|FG001|Open-Label Period|Withdrawal of Consent|0|||
170861762|NCT00406653|617503744|FG002|Open-Label Period|Withdrawal of Consent|0|||
170861763|NCT00406653|617503745|FG003|Open-Label Period|Withdrawal of Consent|0|||
170861764|NCT00406653|617503746|FG004|Open-Label Period|Withdrawal of Consent|0|||
170861765|NCT00406653|617503747|FG005|Open-Label Period|Withdrawal of Consent|0|||
170861766|NCT00406653|617503748|FG006|Open-Label Period|Withdrawal of Consent|11|||
170861767|NCT00406653|617503742|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
170861768|NCT00406653|617503743|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
170861769|NCT00406653|617503744|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
170861770|NCT00406653|617503745|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
170861771|NCT00406653|617503746|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
170861772|NCT00406653|617503747|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
170861773|NCT00406653|617503748|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
170861774|NCT00406653|617503742|FG000|Open-Label Period|Pregnancy|0|||
170861775|NCT00406653|617503743|FG001|Open-Label Period|Pregnancy|0|||
170861776|NCT00406653|617503744|FG002|Open-Label Period|Pregnancy|0|||
170861777|NCT00406653|617503745|FG003|Open-Label Period|Pregnancy|0|||
170861778|NCT00406653|617503746|FG004|Open-Label Period|Pregnancy|0|||
170861779|NCT00406653|617503747|FG005|Open-Label Period|Pregnancy|0|||
170861780|NCT00406653|617503748|FG006|Open-Label Period|Pregnancy|2|||
170861781|NCT00406653|617503742|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
170861782|NCT00406653|617503743|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
170861783|NCT00406653|617503744|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
170750399|NCT03850444|617092325|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
170750400|NCT03699124|617092326|FG000|Overall Study|Adverse Event|6|||
170750401|NCT03699124|617092327|FG001|Overall Study|Adverse Event|5|||
170750402|NCT03699124|617092328|FG002|Overall Study|Adverse Event|2|||
170750403|NCT03699124|617092326|FG000|Overall Study|Death|0|||
170750404|NCT03699124|617092327|FG001|Overall Study|Death|2|||
170750405|NCT03699124|617092328|FG002|Overall Study|Death|0|||
170750406|NCT03699124|617092326|FG000|Overall Study|Lost to Follow-up|20|||
170750407|NCT03699124|617092327|FG001|Overall Study|Lost to Follow-up|16|||
170861784|NCT00406653|617503745|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
170750408|NCT03699124|617092328|FG002|Overall Study|Lost to Follow-up|15|||
170750409|NCT03699124|617092326|FG000|Overall Study|Protocol Violation|1|||
170861785|NCT00406653|617503746|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
170861786|NCT00406653|617503747|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
170861787|NCT00406653|617503748|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
170861788|NCT00406653|617503742|FG000|Open-Label Period|Declined participation but followup done|0|||
170861789|NCT00406653|617503743|FG001|Open-Label Period|Declined participation but followup done|0|||
170861790|NCT00406653|617503744|FG002|Open-Label Period|Declined participation but followup done|0|||
170861791|NCT00406653|617503745|FG003|Open-Label Period|Declined participation but followup done|0|||
170861792|NCT00406653|617503746|FG004|Open-Label Period|Declined participation but followup done|0|||
170861793|NCT00406653|617503747|FG005|Open-Label Period|Declined participation but followup done|0|||
170861794|NCT00406653|617503748|FG006|Open-Label Period|Declined participation but followup done|8|||
170861795|NCT00406653|617503742|FG000|Open-Label Period|Discontinued by Sponsor|0|||
170861796|NCT00406653|617503743|FG001|Open-Label Period|Discontinued by Sponsor|0|||
170861797|NCT00406653|617503744|FG002|Open-Label Period|Discontinued by Sponsor|0|||
170861798|NCT00406653|617503745|FG003|Open-Label Period|Discontinued by Sponsor|0|||
170861799|NCT00406653|617503746|FG004|Open-Label Period|Discontinued by Sponsor|0|||
170861800|NCT00406653|617503747|FG005|Open-Label Period|Discontinued by Sponsor|0|||
170861801|NCT00406653|617503748|FG006|Open-Label Period|Discontinued by Sponsor|1|||
170861802|NCT00406653|617503742|FG000|Open-Label Period|Refused followup|0|||
170861803|NCT00406653|617503743|FG001|Open-Label Period|Refused followup|0|||
170861804|NCT00406653|617503744|FG002|Open-Label Period|Refused followup|0|||
170861805|NCT00406653|617503745|FG003|Open-Label Period|Refused followup|0|||
170861806|NCT00406653|617503746|FG004|Open-Label Period|Refused followup|0|||
170861807|NCT00406653|617503747|FG005|Open-Label Period|Refused followup|0|||
170861808|NCT00406653|617503748|FG006|Open-Label Period|Refused followup|1|||
170861809|NCT02075541|617503749|FG000|Overall Study|Serious Adverse Event|1|||
170861810|NCT02075541|617503750|FG001|Overall Study|Serious Adverse Event|4|||
170861811|NCT02075541|617503749|FG000|Overall Study|Protocol Violation|1|||
170861812|NCT02075541|617503750|FG001|Overall Study|Protocol Violation|0|||
170861813|NCT02075541|617503749|FG000|Overall Study|Withdrawal by Subject|1|||
170861814|NCT02075541|617503750|FG001|Overall Study|Withdrawal by Subject|3|||
170861815|NCT02075541|617503749|FG000|Overall Study|Sponsor study termination|0|||
170861816|NCT02075541|617503750|FG001|Overall Study|Sponsor study termination|1|||
170861817|NCT02075541|617503749|FG000|Overall Study|Other- unable to perform study procedure|1|||
170861818|NCT02075541|617503750|FG001|Overall Study|Other- unable to perform study procedure|0|||
170861819|NCT00731120|617503751|FG000|Overall Study|Adverse Event|7|||
170861820|NCT00731120|617503752|FG001|Overall Study|Adverse Event|6|||
170861821|NCT00731120|617503753|FG002|Overall Study|Adverse Event|8|||
170861822|NCT00731120|617503751|FG000|Overall Study|Lack of Efficacy|4|||
170861823|NCT00731120|617503752|FG001|Overall Study|Lack of Efficacy|5|||
170861824|NCT00731120|617503753|FG002|Overall Study|Lack of Efficacy|4|||
170861825|NCT00731120|617503751|FG000|Overall Study|Noncompliance with Study Drug|3|||
170861826|NCT00731120|617503752|FG001|Overall Study|Noncompliance with Study Drug|3|||
170861827|NCT00731120|617503753|FG002|Overall Study|Noncompliance with Study Drug|1|||
170861828|NCT00731120|617503751|FG000|Overall Study|Protocol Deviations|1|||
170861829|NCT00731120|617503752|FG001|Overall Study|Protocol Deviations|6|||
170861830|NCT00731120|617503753|FG002|Overall Study|Protocol Deviations|1|||
170861831|NCT00731120|617503751|FG000|Overall Study|Withdrawal of Consent|13|||
170861832|NCT00731120|617503752|FG001|Overall Study|Withdrawal of Consent|8|||
170861833|NCT00731120|617503753|FG002|Overall Study|Withdrawal of Consent|4|||
170861834|NCT00731120|617503751|FG000|Overall Study|Lost to Follow-up|10|||
170861835|NCT00731120|617503752|FG001|Overall Study|Lost to Follow-up|15|||
170861836|NCT00731120|617503753|FG002|Overall Study|Lost to Follow-up|17|||
170861837|NCT00731120|617503751|FG000|Overall Study|Other|4|||
170861838|NCT00731120|617503752|FG001|Overall Study|Other|0|||
170861839|NCT00731120|617503753|FG002|Overall Study|Other|1|||
170861840|NCT01026454|617503754|FG000|Second Intervention|Pregnancy|1|||
170861841|NCT01026454|617503755|FG001|Second Intervention|Pregnancy|1|||
170861842|NCT03037619|617503770|FG000|Overall Study|Lost to Follow-up|0|||
170861843|NCT03037619|617503771|FG001|Overall Study|Lost to Follow-up|1|||
170861844|NCT02571049|617503776|FG000|Screening|Did not meet entry criteria|2|||
170861845|NCT02571049|617503777|FG001|Screening|Did not meet entry criteria|2|||
170861846|NCT02571049|617503776|FG000|Randomization|No migraine attack|0|||
170861847|NCT02571049|617503777|FG001|Randomization|No migraine attack|1|||
170861848|NCT02571049|617503776|FG000|Randomization|Adverse Event|0|||
170861849|NCT02571049|617503777|FG001|Randomization|Adverse Event|1|||
170861850|NCT00561951|617503781|FG000|Overall Study|Adverse Event|11|||
170861851|NCT00561951|617503782|FG001|Overall Study|Adverse Event|14|||
170861852|NCT00561951|617503783|FG002|Overall Study|Adverse Event|14|||
170861853|NCT00561951|617503781|FG000|Overall Study|Lack of Efficacy|5|||
170861854|NCT00561951|617503782|FG001|Overall Study|Lack of Efficacy|3|||
170861855|NCT00561951|617503783|FG002|Overall Study|Lack of Efficacy|2|||
170861856|NCT00561951|617503781|FG000|Overall Study|Lost to Follow-up|1|||
170861857|NCT00561951|617503782|FG001|Overall Study|Lost to Follow-up|1|||
170861858|NCT00561951|617503783|FG002|Overall Study|Lost to Follow-up|0|||
170861859|NCT00561951|617503781|FG000|Overall Study|Withdrawal by Subject|10|||
170861860|NCT00561951|617503782|FG001|Overall Study|Withdrawal by Subject|9|||
170861861|NCT00561951|617503783|FG002|Overall Study|Withdrawal by Subject|10|||
170861862|NCT00561951|617503781|FG000|Overall Study|Protocol Violation|4|||
170861863|NCT00561951|617503782|FG001|Overall Study|Protocol Violation|3|||
170861864|NCT00561951|617503783|FG002|Overall Study|Protocol Violation|4|||
170861865|NCT00561951|617503781|FG000|Overall Study|Physician Decision|1|||
170861866|NCT00561951|617503782|FG001|Overall Study|Physician Decision|0|||
170861867|NCT00561951|617503783|FG002|Overall Study|Physician Decision|0|||
170861868|NCT00561951|617503781|FG000|Overall Study|Pregnancy|0|||
170861869|NCT00561951|617503782|FG001|Overall Study|Pregnancy|1|||
170861870|NCT00561951|617503783|FG002|Overall Study|Pregnancy|0|||
170861871|NCT00561951|617503781|FG000|Overall Study|Meet Withdrawal Criterion|0|||
170861872|NCT00561951|617503782|FG001|Overall Study|Meet Withdrawal Criterion|1|||
170861873|NCT00561951|617503783|FG002|Overall Study|Meet Withdrawal Criterion|1|||
170861874|NCT00561951|617503781|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
170861875|NCT00561951|617503782|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
170861876|NCT00561951|617503783|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
170861877|NCT01536015|617503784|FG000|Overall Study|Adverse Event|1|||
170861878|NCT01536015|617503785|FG001|Overall Study|Adverse Event|4|||
170861879|NCT01536015|617503784|FG000|Overall Study|Lost to Follow-up|0|||
170861880|NCT01536015|617503785|FG001|Overall Study|Lost to Follow-up|1|||
170861881|NCT01536015|617503784|FG000|Overall Study|Inclusion Criterion not met|2|||
170861882|NCT01536015|617503785|FG001|Overall Study|Inclusion Criterion not met|0|||
170861883|NCT01536015|617503784|FG000|Overall Study|Study closure|5|||
170861884|NCT01536015|617503785|FG001|Overall Study|Study closure|5|||
170861885|NCT03562247|617503788|FG000|Overall Study|Lost to Follow-up|3|||
170861886|NCT03562247|617503789|FG001|Overall Study|Lost to Follow-up|1|||
170861887|NCT03562247|617503790|FG002|Overall Study|Lost to Follow-up|1|||
170861888|NCT03261700|617503791|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
170861889|NCT03261700|617503792|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
170861890|NCT01204398|617503793|FG000|Overall Study|Adverse Event|1|||
170861891|NCT01281969|617503796|FG000|Overall Study|not randomized didn't meet criteria|0|||
170861892|NCT01281969|617503797|FG001|Overall Study|not randomized didn't meet criteria|0|||
170861893|NCT01281969|617503798|FG002|Overall Study|not randomized didn't meet criteria|7|||
170861894|NCT01281969|617503796|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
170861895|NCT01281969|617503797|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
170861896|NCT01281969|617503798|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
170861897|NCT01281969|617503796|FG000|Overall Study|not randomized, child consent not given|0|||
170861898|NCT01281969|617503797|FG001|Overall Study|not randomized, child consent not given|0|||
170861899|NCT01281969|617503798|FG002|Overall Study|not randomized, child consent not given|2|||
170861900|NCT01723254|617503799|FG000|Overall Study|Conflict with work schedule|0|||
170861901|NCT01723254|617503800|FG001|Overall Study|Conflict with work schedule|0|||
170861902|NCT01723254|617503801|FG002|Overall Study|Conflict with work schedule|0|||
170861903|NCT01723254|617503802|FG003|Overall Study|Conflict with work schedule|0|||
170861904|NCT01723254|617503803|FG004|Overall Study|Conflict with work schedule|0|||
170861905|NCT01723254|617503804|FG005|Overall Study|Conflict with work schedule|0|||
170861906|NCT01723254|617503805|FG006|Overall Study|Conflict with work schedule|0|||
170861907|NCT01723254|617503806|FG007|Overall Study|Conflict with work schedule|1|||
170861908|NCT01723254|617503799|FG000|Overall Study|Personal issues|0|||
170861909|NCT01723254|617503800|FG001|Overall Study|Personal issues|0|||
170861910|NCT01723254|617503801|FG002|Overall Study|Personal issues|0|||
170861911|NCT01723254|617503802|FG003|Overall Study|Personal issues|0|||
170861912|NCT01723254|617503803|FG004|Overall Study|Personal issues|0|||
170861913|NCT01723254|617503804|FG005|Overall Study|Personal issues|1|||
170861914|NCT01723254|617503805|FG006|Overall Study|Personal issues|0|||
170861915|NCT01723254|617503806|FG007|Overall Study|Personal issues|0|||
170861916|NCT01723254|617503799|FG000|Overall Study|No longer have time to participate|0|||
170861917|NCT01723254|617503800|FG001|Overall Study|No longer have time to participate|0|||
170861918|NCT01723254|617503801|FG002|Overall Study|No longer have time to participate|0|||
170861919|NCT01723254|617503802|FG003|Overall Study|No longer have time to participate|1|||
170861920|NCT01723254|617503803|FG004|Overall Study|No longer have time to participate|0|||
170861921|NCT01723254|617503804|FG005|Overall Study|No longer have time to participate|0|||
170861922|NCT01723254|617503805|FG006|Overall Study|No longer have time to participate|0|||
170861923|NCT01723254|617503806|FG007|Overall Study|No longer have time to participate|0|||
170861924|NCT01723254|617503799|FG000|Overall Study|Move/Left to another country/city|0|||
170861925|NCT01723254|617503800|FG001|Overall Study|Move/Left to another country/city|0|||
170861926|NCT01723254|617503801|FG002|Overall Study|Move/Left to another country/city|2|||
170861927|NCT01723254|617503802|FG003|Overall Study|Move/Left to another country/city|1|||
170861928|NCT01723254|617503803|FG004|Overall Study|Move/Left to another country/city|1|||
170861929|NCT01723254|617503804|FG005|Overall Study|Move/Left to another country/city|0|||
170861930|NCT01723254|617503805|FG006|Overall Study|Move/Left to another country/city|0|||
170861931|NCT01723254|617503806|FG007|Overall Study|Move/Left to another country/city|0|||
170861932|NCT01723254|617503799|FG000|Overall Study|Protocol Violation|0|||
170861933|NCT01723254|617503800|FG001|Overall Study|Protocol Violation|1|||
170861934|NCT01723254|617503801|FG002|Overall Study|Protocol Violation|0|||
170861935|NCT01723254|617503802|FG003|Overall Study|Protocol Violation|0|||
170861936|NCT01723254|617503803|FG004|Overall Study|Protocol Violation|0|||
170861937|NCT01723254|617503804|FG005|Overall Study|Protocol Violation|0|||
170861938|NCT01723254|617503805|FG006|Overall Study|Protocol Violation|0|||
170861939|NCT01723254|617503806|FG007|Overall Study|Protocol Violation|0|||
170861940|NCT01723254|617503799|FG000|Overall Study|Withdrawal by Subject|1|||
170861941|NCT01723254|617503800|FG001|Overall Study|Withdrawal by Subject|2|||
170861942|NCT01723254|617503801|FG002|Overall Study|Withdrawal by Subject|1|||
170861943|NCT01723254|617503802|FG003|Overall Study|Withdrawal by Subject|0|||
170861944|NCT01723254|617503803|FG004|Overall Study|Withdrawal by Subject|1|||
170861945|NCT01723254|617503804|FG005|Overall Study|Withdrawal by Subject|1|||
170861946|NCT01723254|617503805|FG006|Overall Study|Withdrawal by Subject|1|||
170861947|NCT01723254|617503806|FG007|Overall Study|Withdrawal by Subject|2|||
170861948|NCT05497284|617503813|FG000|Overall Study|Adverse Event|1|||
170861949|NCT05497284|617503814|FG001|Overall Study|Adverse Event|0|||
170861950|NCT05497284|617503813|FG000|Overall Study|Physician Decision|0|||
170861951|NCT05497284|617503814|FG001|Overall Study|Physician Decision|1|||
170861952|NCT05497284|617503813|FG000|Overall Study|Study terminated by sponsor|7|||
170861953|NCT05497284|617503814|FG001|Overall Study|Study terminated by sponsor|4|||
170861954|NCT05497284|617503813|FG000|Overall Study|Subject Decision|0|||
170861955|NCT05497284|617503814|FG001|Overall Study|Subject Decision|1|||
170861956|NCT03816891|617503815|FG000|Double-Blind Period|Withdrawal by Subject|1|||
170861957|NCT03816891|617503816|FG001|Double-Blind Period|Withdrawal by Subject|2|||
170861958|NCT03816891|617503817|FG002|Double-Blind Period|Withdrawal by Subject|0|||
170861959|NCT03816891|617503818|FG003|Double-Blind Period|Withdrawal by Subject|2|||
170861960|NCT03816891|617503819|FG004|Double-Blind Period|Withdrawal by Subject|0|||
170861961|NCT03816891|617503820|FG005|Double-Blind Period|Withdrawal by Subject|0|||
170861962|NCT03816891|617503815|FG000|Double-Blind Period|Adverse Event|0|||
170861963|NCT03816891|617503816|FG001|Double-Blind Period|Adverse Event|0|||
170861964|NCT03816891|617503817|FG002|Double-Blind Period|Adverse Event|2|||
170861965|NCT03816891|617503818|FG003|Double-Blind Period|Adverse Event|0|||
170861966|NCT03816891|617503819|FG004|Double-Blind Period|Adverse Event|0|||
170861967|NCT03816891|617503820|FG005|Double-Blind Period|Adverse Event|0|||
170861968|NCT03816891|617503815|FG000|Double-Blind Period|Lost to Follow-up|2|||
170861969|NCT03816891|617503816|FG001|Double-Blind Period|Lost to Follow-up|0|||
170861970|NCT03816891|617503817|FG002|Double-Blind Period|Lost to Follow-up|0|||
170861971|NCT03816891|617503818|FG003|Double-Blind Period|Lost to Follow-up|0|||
170861972|NCT03816891|617503819|FG004|Double-Blind Period|Lost to Follow-up|0|||
170861973|NCT03816891|617503820|FG005|Double-Blind Period|Lost to Follow-up|1|||
170861974|NCT03816891|617503815|FG000|Double-Blind Period|Physician Decision|0|||
170861975|NCT03816891|617503816|FG001|Double-Blind Period|Physician Decision|0|||
170861976|NCT03816891|617503817|FG002|Double-Blind Period|Physician Decision|0|||
170861977|NCT03816891|617503818|FG003|Double-Blind Period|Physician Decision|1|||
170861978|NCT03816891|617503819|FG004|Double-Blind Period|Physician Decision|0|||
170861979|NCT03816891|617503820|FG005|Double-Blind Period|Physician Decision|0|||
170861980|NCT03816891|617503815|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
170861981|NCT03816891|617503816|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
170861982|NCT03816891|617503817|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
170861983|NCT03816891|617503818|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
170861984|NCT03816891|617503819|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
170861985|NCT03816891|617503820|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
170861986|NCT03816891|617503815|FG000|Double-Blind Period|Other|1|||
170861987|NCT03816891|617503816|FG001|Double-Blind Period|Other|0|||
170861988|NCT03816891|617503817|FG002|Double-Blind Period|Other|0|||
170861989|NCT03816891|617503818|FG003|Double-Blind Period|Other|0|||
170861990|NCT03816891|617503819|FG004|Double-Blind Period|Other|0|||
170861991|NCT03816891|617503820|FG005|Double-Blind Period|Other|0|||
170861992|NCT03816891|617503815|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
170861993|NCT03816891|617503816|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
170861994|NCT03816891|617503817|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
170861995|NCT03816891|617503818|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
170861996|NCT03816891|617503819|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
170861997|NCT03816891|617503820|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
170861998|NCT03816891|617503815|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
170861999|NCT03816891|617503816|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
170862000|NCT03816891|617503817|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
170862001|NCT03816891|617503818|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
170862002|NCT03816891|617503819|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
170862003|NCT03816891|617503820|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
170862004|NCT03816891|617503815|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
170862005|NCT03816891|617503816|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
170862006|NCT03816891|617503817|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
170862007|NCT03816891|617503818|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
170862008|NCT03816891|617503819|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
170862009|NCT03816891|617503820|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
170862010|NCT03816891|617503815|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
170862011|NCT03816891|617503816|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
170862012|NCT03816891|617503817|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
170862013|NCT03816891|617503818|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
170862014|NCT03816891|617503819|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
170862015|NCT03816891|617503820|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
170862016|NCT03816891|617503815|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
170862017|NCT03816891|617503816|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
170862018|NCT03816891|617503817|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
170862019|NCT03816891|617503818|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
170862020|NCT03816891|617503819|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
170862021|NCT03816891|617503820|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
170862022|NCT03705832|617503842|FG000|Overall Study|Physician Decision|0|||
170862023|NCT03705832|617503843|FG001|Overall Study|Physician Decision|1|||
170862024|NCT03705832|617503842|FG000|Overall Study|Withdrawal by Subject|1|||
170862025|NCT03705832|617503843|FG001|Overall Study|Withdrawal by Subject|0|||
170862026|NCT02254278|617503844|FG000|Overall Study|Protocol Violation|1|||
170862027|NCT02254278|617503845|FG001|Overall Study|Protocol Violation|1|||
170862028|NCT04379518|617503846|FG000|Overall Study|Physician Decision|2|||
170862029|NCT04379518|617503847|FG001|Overall Study|Physician Decision|0|||
170862030|NCT04379518|617503848|FG002|Overall Study|Physician Decision|0|||
170862031|NCT04379518|617503849|FG003|Overall Study|Physician Decision|0|||
170862032|NCT04379518|617503850|FG004|Overall Study|Physician Decision|0|||
170862033|NCT04379518|617503846|FG000|Overall Study|Withdrawal by Subject|1|||
170862034|NCT04379518|617503847|FG001|Overall Study|Withdrawal by Subject|0|||
170862035|NCT04379518|617503848|FG002|Overall Study|Withdrawal by Subject|0|||
170862036|NCT04379518|617503849|FG003|Overall Study|Withdrawal by Subject|0|||
170862037|NCT04379518|617503850|FG004|Overall Study|Withdrawal by Subject|0|||
170862038|NCT00147823|617503858|FG000|Overall Study|Lost to Follow-up|6|||
170862039|NCT00147823|617503859|FG001|Overall Study|Lost to Follow-up|12|||
170862040|NCT00147823|617503858|FG000|Overall Study|Physician Decision|1|||
170862041|NCT00147823|617503859|FG001|Overall Study|Physician Decision|0|||
170862042|NCT00147823|617503858|FG000|Overall Study|Withdrawal by Subject|0|||
170862043|NCT00147823|617503859|FG001|Overall Study|Withdrawal by Subject|1|||
170862044|NCT00147823|617503858|FG000|Overall Study|Did not receive vitoss due to infection|6|||
170862045|NCT00147823|617503859|FG001|Overall Study|Did not receive vitoss due to infection|2|||
170862046|NCT05199571|617505681|FG000|Treatment period|Participant decision|3|||
170862047|NCT05199571|617505681|FG000|Treatment period|Physician Decision|1|||
170862048|NCT05199571|617505681|FG000|Post-treatment follow up period|Participant decision|3|||
170862049|NCT02892344|617505682|FG000|Overall Study|Protocol deviation|3|||
170862050|NCT02892344|617505683|FG001|Overall Study|Protocol deviation|4|||
170862051|NCT02892344|617505682|FG000|Overall Study|Adverse Event|1|||
170862052|NCT02892344|617505683|FG001|Overall Study|Adverse Event|8|||
170862053|NCT02892344|617505682|FG000|Overall Study|Lost to Follow-up|0|||
170862054|NCT02892344|617505683|FG001|Overall Study|Lost to Follow-up|1|||
170862055|NCT02892344|617505682|FG000|Overall Study|Non-compliance with study treatment|0|||
170862056|NCT02892344|617505683|FG001|Overall Study|Non-compliance with study treatment|1|||
170862057|NCT02892344|617505682|FG000|Overall Study|Physician Decision|0|||
170862058|NCT02892344|617505683|FG001|Overall Study|Physician Decision|2|||
170862059|NCT02892344|617505682|FG000|Overall Study|Subject/guardian decision|0|||
170862060|NCT02892344|617505683|FG001|Overall Study|Subject/guardian decision|4|||
170862061|NCT02892344|617505682|FG000|Overall Study|Technical problems|0|||
170862062|NCT02892344|617505683|FG001|Overall Study|Technical problems|1|||
170862063|NCT03938454|617505684|FG000|Overall Study|Protocol Violation|1|||
170862064|NCT03938454|617505684|FG000|Overall Study|Withdrawal by Subject|2|||
170862065|NCT03938454|617505684|FG000|Overall Study|Lost to Follow-up|3|||
170862066|NCT04441905|617505685|FG000|Overall Study|Lost to Follow-up|1|||
170862067|NCT04441905|617505686|FG001|Overall Study|Lost to Follow-up|0|||
170862068|NCT04441905|617505687|FG002|Overall Study|Lost to Follow-up|0|||
170862069|NCT04441905|617505688|FG003|Overall Study|Lost to Follow-up|0|||
170862070|NCT04441905|617505689|FG004|Overall Study|Lost to Follow-up|0|||
170862071|NCT04441905|617505690|FG005|Overall Study|Lost to Follow-up|0|||
170862072|NCT04441905|617505685|FG000|Overall Study|Enrolled but treatment not administered|0|||
170862073|NCT04441905|617505686|FG001|Overall Study|Enrolled but treatment not administered|1|||
170862074|NCT04441905|617505687|FG002|Overall Study|Enrolled but treatment not administered|0|||
170862075|NCT04441905|617505688|FG003|Overall Study|Enrolled but treatment not administered|0|||
170862076|NCT04441905|617505689|FG004|Overall Study|Enrolled but treatment not administered|0|||
170862077|NCT04441905|617505690|FG005|Overall Study|Enrolled but treatment not administered|0|||
170862078|NCT04441905|617505685|FG000|Overall Study|Became ineligible after enrollment|0|||
170862079|NCT04441905|617505686|FG001|Overall Study|Became ineligible after enrollment|0|||
170862080|NCT04441905|617505687|FG002|Overall Study|Became ineligible after enrollment|0|||
170862081|NCT04441905|617505688|FG003|Overall Study|Became ineligible after enrollment|0|||
170862082|NCT04441905|617505689|FG004|Overall Study|Became ineligible after enrollment|1|||
170862083|NCT04441905|617505690|FG005|Overall Study|Became ineligible after enrollment|0|||
170862084|NCT03922802|617505691|FG000|Overall Study|Withdrawal by Subject|4|||
170862085|NCT05888103|617505692|FG000|Overall Study|Participant decision|3|||
170862086|NCT05888103|617505693|FG001|Overall Study|Participant decision|3|||
170862087|NCT04987307|617505694|FG000|Overall Study|Protocol-specified criteria|2|||
170862088|NCT04987307|617505695|FG001|Overall Study|Protocol-specified criteria|0|||
170862089|NCT04987307|617505696|FG002|Overall Study|Protocol-specified criteria|0|||
170862090|NCT04987307|617505697|FG003|Overall Study|Protocol-specified criteria|3|||
170862091|NCT04987307|617505694|FG000|Overall Study|Withdrawal by Subject|34|||
170862092|NCT04987307|617505695|FG001|Overall Study|Withdrawal by Subject|30|||
170862093|NCT04987307|617505696|FG002|Overall Study|Withdrawal by Subject|29|||
170862094|NCT04987307|617505697|FG003|Overall Study|Withdrawal by Subject|35|||
170862095|NCT04987307|617505694|FG000|Overall Study|Decision by sponsor|10|||
170862096|NCT04987307|617505695|FG001|Overall Study|Decision by sponsor|13|||
170862097|NCT04987307|617505696|FG002|Overall Study|Decision by sponsor|11|||
170862098|NCT04987307|617505697|FG003|Overall Study|Decision by sponsor|9|||
170862099|NCT04987307|617505694|FG000|Overall Study|Lost to Follow-up|1|||
170862100|NCT04987307|617505695|FG001|Overall Study|Lost to Follow-up|0|||
170862101|NCT04987307|617505696|FG002|Overall Study|Lost to Follow-up|0|||
170862102|NCT04987307|617505697|FG003|Overall Study|Lost to Follow-up|0|||
170862103|NCT01028222|617505698|FG000|Overall Study|Protocol deviation|1|||
170862104|NCT01028222|617505699|FG001|Overall Study|Protocol deviation|0|||
170862105|NCT01028222|617505698|FG000|Overall Study|Disease progression|33|||
170862106|NCT01028222|617505699|FG001|Overall Study|Disease progression|9|||
170862107|NCT01028222|617505698|FG000|Overall Study|Administrative problems|1|||
170862108|NCT01028222|617505699|FG001|Overall Study|Administrative problems|1|||
170862109|NCT01028222|617505698|FG000|Overall Study|Lost to Follow-up|0|||
170862110|NCT01028222|617505699|FG001|Overall Study|Lost to Follow-up|1|||
170862111|NCT01028222|617505698|FG000|Overall Study|Withdrawal by Subject|1|||
170862112|NCT01028222|617505699|FG001|Overall Study|Withdrawal by Subject|0|||
170862113|NCT01028222|617505698|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
170862114|NCT01028222|617505699|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
170862115|NCT01028222|617505698|FG000|Overall Study|Adverse Event|2|||
170862116|NCT01028222|617505699|FG001|Overall Study|Adverse Event|0|||
170862117|NCT00146328|617505700|FG000|Overall Study|Adverse Event|39|||
170862118|NCT00146328|617505701|FG001|Overall Study|Adverse Event|48|||
170862119|NCT00146328|617505702|FG002|Overall Study|Adverse Event|79|||
170862120|NCT00146328|617505700|FG000|Overall Study|Protocol Violation|11|||
170862121|NCT00146328|617505701|FG001|Overall Study|Protocol Violation|6|||
170862122|NCT00146328|617505702|FG002|Overall Study|Protocol Violation|12|||
170862123|NCT00146328|617505700|FG000|Overall Study|Lost to Follow-up|7|||
170862124|NCT00146328|617505701|FG001|Overall Study|Lost to Follow-up|4|||
170862125|NCT00146328|617505702|FG002|Overall Study|Lost to Follow-up|7|||
170862126|NCT00146328|617505700|FG000|Overall Study|Withdrawal by Subject|16|||
170862127|NCT00146328|617505701|FG001|Overall Study|Withdrawal by Subject|16|||
170862128|NCT00146328|617505702|FG002|Overall Study|Withdrawal by Subject|22|||
170862129|NCT00146328|617505700|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
170862130|NCT00146328|617505701|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
170862131|NCT00146328|617505702|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
170862132|NCT00146328|617505700|FG000|Overall Study|Trial ended/site closed|8|||
170862133|NCT00146328|617505701|FG001|Overall Study|Trial ended/site closed|2|||
170862134|NCT00146328|617505702|FG002|Overall Study|Trial ended/site closed|19|||
170862135|NCT00146328|617505700|FG000|Overall Study|Patient decision to end|0|||
170862136|NCT00146328|617505701|FG001|Overall Study|Patient decision to end|1|||
170862137|NCT00146328|617505702|FG002|Overall Study|Patient decision to end|6|||
170862138|NCT00146328|617505700|FG000|Overall Study|Enroll into other trial|2|||
170862139|NCT00146328|617505701|FG001|Overall Study|Enroll into other trial|4|||
170862140|NCT00146328|617505702|FG002|Overall Study|Enroll into other trial|2|||
170862141|NCT00146328|617505700|FG000|Overall Study|Death|0|||
170862142|NCT00146328|617505701|FG001|Overall Study|Death|1|||
170862143|NCT00146328|617505702|FG002|Overall Study|Death|1|||
170862144|NCT00146328|617505700|FG000|Overall Study|Moved|2|||
170862145|NCT00146328|617505701|FG001|Overall Study|Moved|0|||
170862146|NCT00146328|617505702|FG002|Overall Study|Moved|0|||
170862147|NCT00146328|617505700|FG000|Overall Study|Interaction with other medication|2|||
170862148|NCT00146328|617505701|FG001|Overall Study|Interaction with other medication|0|||
170862149|NCT00146328|617505702|FG002|Overall Study|Interaction with other medication|1|||
170862150|NCT00792805|617505703|FG000|Overall Study|Adverse Event|12|||
170862151|NCT00792805|617505704|FG001|Overall Study|Adverse Event|10|||
170862152|NCT00792805|617505705|FG002|Overall Study|Adverse Event|10|||
170862153|NCT00792805|617505703|FG000|Overall Study|Subject withdrew consent|5|||
170862154|NCT00792805|617505704|FG001|Overall Study|Subject withdrew consent|6|||
170862155|NCT00792805|617505705|FG002|Overall Study|Subject withdrew consent|5|||
170862156|NCT00792805|617505703|FG000|Overall Study|Administrative problems|2|||
170862157|NCT00792805|617505704|FG001|Overall Study|Administrative problems|0|||
170862158|NCT00792805|617505705|FG002|Overall Study|Administrative problems|4|||
170862159|NCT00792805|617505703|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170862160|NCT00792805|617505704|FG001|Overall Study|Abnormal test procedure result(s)|2|||
170862161|NCT00792805|617505705|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170862162|NCT00792805|617505703|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170862163|NCT00792805|617505704|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
170862164|NCT00792805|617505705|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
170862165|NCT00792805|617505703|FG000|Overall Study|Lost to Follow-up|1|||
170862166|NCT00792805|617505704|FG001|Overall Study|Lost to Follow-up|1|||
170862167|NCT00792805|617505705|FG002|Overall Study|Lost to Follow-up|6|||
170862168|NCT00792805|617505703|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170862169|NCT00792805|617505704|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170862170|NCT00792805|617505705|FG002|Overall Study|Abnormal laboratory value(s)|1|||
170862171|NCT00792805|617505703|FG000|Overall Study|Protocol deviation|0|||
170862172|NCT00792805|617505704|FG001|Overall Study|Protocol deviation|1|||
170862173|NCT00792805|617505705|FG002|Overall Study|Protocol deviation|1|||
170862174|NCT02072434|617505706|FG000|Overall Study|Protocol Violation|10|||
170862175|NCT02072434|617505707|FG001|Overall Study|Protocol Violation|9|||
170862176|NCT02072434|617505706|FG000|Overall Study|Physician Decision|5|||
170862177|NCT02072434|617505707|FG001|Overall Study|Physician Decision|10|||
170862178|NCT02072434|617505706|FG000|Overall Study|Adverse event, serious fatal|1|||
170862179|NCT02072434|617505707|FG001|Overall Study|Adverse event, serious fatal|6|||
170862180|NCT02072434|617505706|FG000|Overall Study|Adverse Event|7|||
170862181|NCT02072434|617505707|FG001|Overall Study|Adverse Event|6|||
170862182|NCT02072434|617505706|FG000|Overall Study|Withdrawal by Subject|17|||
170862183|NCT02072434|617505707|FG001|Overall Study|Withdrawal by Subject|29|||
170862184|NCT02072434|617505706|FG000|Overall Study|Other|14|||
170862185|NCT02072434|617505707|FG001|Overall Study|Other|29|||
170862186|NCT02072434|617505706|FG000|Overall Study|Lost to Follow-up|0|||
170862187|NCT02072434|617505707|FG001|Overall Study|Lost to Follow-up|1|||
170862188|NCT00120406|617505708|FG000|Overall Study|Death|9|||
170862189|NCT00120406|617505709|FG001|Overall Study|Death|4|||
170862190|NCT00120406|617505708|FG000|Overall Study|Withdrawal by Subject|5|||
170862191|NCT00120406|617505709|FG001|Overall Study|Withdrawal by Subject|7|||
170862192|NCT00120406|617505708|FG000|Overall Study|Lost to Follow-up|5|||
170862193|NCT00120406|617505709|FG001|Overall Study|Lost to Follow-up|2|||
170862194|NCT00120406|617505708|FG000|Overall Study|received non-study stent|0|||
170862195|NCT00120406|617505709|FG001|Overall Study|received non-study stent|2|||
170862196|NCT00120406|617505708|FG000|Overall Study|patient moved but has not withdrawn|0|||
170862197|NCT00120406|617505709|FG001|Overall Study|patient moved but has not withdrawn|1|||
170862198|NCT00888433|617505710|FG000|Overall Study|Withdrawal by Subject|1|||
170862199|NCT00888433|617505711|FG001|Overall Study|Withdrawal by Subject|2|||
170862200|NCT00888433|617505710|FG000|Overall Study|Missed Visit|2|||
170862201|NCT00888433|617505711|FG001|Overall Study|Missed Visit|1|||
170862202|NCT04452877|617505712|FG000|Overall Study|Adverse Event|5|||
170862203|NCT04452877|617505712|FG000|Overall Study|Lost to Follow-up|1|||
170862204|NCT04452877|617505712|FG000|Overall Study|Physician Decision|4|||
170862205|NCT04452877|617505712|FG000|Overall Study|Progressive Disease|18|||
170862206|NCT04452877|617505712|FG000|Overall Study|Withdrawal by Subject|3|||
170862207|NCT02065336|617505713|FG000|Extension Phase|Study Terminated by Sponsor|0|||
170862208|NCT02065336|617505714|FG001|Extension Phase|Study Terminated by Sponsor|0|||
170862209|NCT02065336|617505715|FG002|Extension Phase|Study Terminated by Sponsor|0|||
170862210|NCT02065336|617505716|FG003|Extension Phase|Study Terminated by Sponsor|0|||
170862211|NCT02065336|617505717|FG004|Extension Phase|Study Terminated by Sponsor|0|||
170862212|NCT02065336|617505718|FG005|Extension Phase|Study Terminated by Sponsor|0|||
170862213|NCT02065336|617505719|FG006|Extension Phase|Study Terminated by Sponsor|0|||
170862214|NCT02065336|617505720|FG007|Extension Phase|Study Terminated by Sponsor|0|||
170862215|NCT02065336|617505721|FG008|Extension Phase|Study Terminated by Sponsor|2|||
170862216|NCT02065336|617505722|FG009|Extension Phase|Study Terminated by Sponsor|8|||
170862217|NCT02977988|617505731|FG000|Overall Study|Lost to Follow-up|13|||
170862218|NCT02977988|617505732|FG001|Overall Study|Lost to Follow-up|7|||
170862219|NCT00068588|617505733|FG000|Overall Study|Adverse Event|0|||
170862220|NCT00068588|617505734|FG001|Overall Study|Adverse Event|0|||
170862221|NCT00068588|617505735|FG002|Overall Study|Adverse Event|2|||
170862222|NCT00068588|617505733|FG000|Overall Study|Withdrawal by Subject|0|||
170862223|NCT00068588|617505734|FG001|Overall Study|Withdrawal by Subject|0|||
170862224|NCT00068588|617505735|FG002|Overall Study|Withdrawal by Subject|1|||
170862225|NCT00068588|617505733|FG000|Overall Study|Poor KPS|0|||
170862226|NCT00068588|617505734|FG001|Overall Study|Poor KPS|0|||
170862227|NCT00068588|617505735|FG002|Overall Study|Poor KPS|1|||
170862228|NCT03840486|617505736|FG000|Overall Study|Withdrawal by Subject|0|||
170862229|NCT03840486|617505737|FG001|Overall Study|Withdrawal by Subject|1|||
170862230|NCT03840486|617505738|FG002|Overall Study|Withdrawal by Subject|0|||
170862231|NCT03840486|617505739|FG003|Overall Study|Withdrawal by Subject|0|||
170862232|NCT03840486|617505740|FG004|Overall Study|Withdrawal by Subject|0|||
170862233|NCT03840486|617505741|FG005|Overall Study|Withdrawal by Subject|0|||
170862234|NCT03840486|617505742|FG006|Overall Study|Withdrawal by Subject|0|||
170862235|NCT03840486|617505743|FG007|Overall Study|Withdrawal by Subject|0|||
170862236|NCT03840486|617505744|FG008|Overall Study|Withdrawal by Subject|0|||
170862237|NCT03840486|617505745|FG009|Overall Study|Withdrawal by Subject|0|||
170862238|NCT03840486|617505746|FG010|Overall Study|Withdrawal by Subject|0|||
170862239|NCT03840486|617505747|FG011|Overall Study|Withdrawal by Subject|0|||
170862240|NCT03780725|617505748|FG000|Overall Study|Progression of disease|3|||
170862241|NCT03780725|617505749|FG001|Overall Study|Progression of disease|4|||
170862242|NCT03780725|617505748|FG000|Overall Study|Adverse Event|0|||
170862243|NCT03780725|617505749|FG001|Overall Study|Adverse Event|1|||
170862244|NCT02738008|617505750|FG000|Overall Study|Study Terminated by Sponsor|1|||
170862245|NCT02738008|617505751|FG001|Overall Study|Study Terminated by Sponsor|5|||
170862246|NCT02738008|617505752|FG002|Overall Study|Study Terminated by Sponsor|3|||
170862247|NCT02738008|617505750|FG000|Overall Study|Adverse Event|0|||
170862248|NCT02738008|617505751|FG001|Overall Study|Adverse Event|1|||
170862249|NCT02738008|617505752|FG002|Overall Study|Adverse Event|2|||
170862250|NCT03285178|617505753|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
170906112|NCT01446809|617658621|FG001|Overall Study|Failure to complete study procedures|0|||
170750410|NCT03699124|617092327|FG001|Overall Study|Protocol Violation|0|||
170750411|NCT03699124|617092328|FG002|Overall Study|Protocol Violation|0|||
170750412|NCT03699124|617092326|FG000|Overall Study|Withdrawal by Subject|13|||
170750413|NCT03699124|617092327|FG001|Overall Study|Withdrawal by Subject|14|||
170750414|NCT03699124|617092328|FG002|Overall Study|Withdrawal by Subject|13|||
170750415|NCT03699124|617092326|FG000|Overall Study|Other reasons|5|||
170750416|NCT03699124|617092327|FG001|Overall Study|Other reasons|3|||
170750417|NCT03699124|617092328|FG002|Overall Study|Other reasons|10|||
170750418|NCT03595683|617092329|FG000|Overall Study|Adverse Event|1|||
170750419|NCT03595683|617092330|FG001|Overall Study|Adverse Event|0|||
170750420|NCT03595683|617092329|FG000|Overall Study|Pursue alternative therapy|1|||
170750421|NCT03595683|617092330|FG001|Overall Study|Pursue alternative therapy|1|||
170750422|NCT03595683|617092329|FG000|Overall Study|Progressive disease|1|||
170750423|NCT03595683|617092330|FG001|Overall Study|Progressive disease|3|||
170750424|NCT02107274|617092333|FG000|Treatment vs. Placebo|Adverse Event|3|||
170750425|NCT02107274|617092334|FG001|Treatment vs. Placebo|Adverse Event|0|||
170750426|NCT02107274|617092333|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
170750427|NCT02107274|617092334|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
170750428|NCT02107274|617092333|FG000|Control Phase|Lost to Follow-up|1|||
170750429|NCT02107274|617092334|FG001|Control Phase|Lost to Follow-up|1|||
170750430|NCT02107274|617092333|FG000|Control Phase|Death|2|||
170750431|NCT02107274|617092334|FG001|Control Phase|Death|0|||
170750432|NCT02107274|617092333|FG000|Control Phase|Adverse Event|0|||
170750433|NCT02107274|617092334|FG001|Control Phase|Adverse Event|1|||
170750434|NCT01021878|617092335|FG000|Overall Study|Lost to Follow-up|4|||
170750435|NCT01021878|617092336|FG001|Overall Study|Lost to Follow-up|3|||
170750436|NCT01021878|617092335|FG000|Overall Study|Death|0|||
170750437|NCT01021878|617092336|FG001|Overall Study|Death|1|||
170750438|NCT01021878|617092335|FG000|Overall Study|Adverse Event|6|||
170750439|NCT01021878|617092336|FG001|Overall Study|Adverse Event|5|||
170750440|NCT01021878|617092335|FG000|Overall Study|Transplantation|6|||
170750441|NCT01021878|617092336|FG001|Overall Study|Transplantation|1|||
170750442|NCT01155726|617092340|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
170750443|NCT01155726|617092341|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
170750444|NCT01155726|617092342|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
170750445|NCT01155726|617092343|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
170750446|NCT03158948|617092344|FG000|Overall Study|Death|1|||
170750447|NCT03158948|617092345|FG001|Overall Study|Death|1|||
170750448|NCT03158948|617092346|FG002|Overall Study|Death|3|||
170750449|NCT03158948|617092347|FG003|Overall Study|Death|2|||
170750450|NCT03158948|617092344|FG000|Overall Study|Physician Decision|0|||
170750451|NCT03158948|617092345|FG001|Overall Study|Physician Decision|0|||
170750452|NCT03158948|617092346|FG002|Overall Study|Physician Decision|0|||
170750453|NCT03158948|617092347|FG003|Overall Study|Physician Decision|1|||
170750454|NCT00472186|617092351|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
170750455|NCT00472186|617092352|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
170750456|NCT02726399|617092353|FG000|Overall Study|Participant Non-Compliance|1|||
170750457|NCT02726399|617092353|FG000|Overall Study|Adverse Event|2|||
170750458|NCT02726399|617092353|FG000|Overall Study|Progression of disease|4|||
170750459|NCT03468426|617092354|FG000|Overall Study|Progressive disease|3|||
170750460|NCT03468426|617092355|FG001|Overall Study|Progressive disease|0|||
170750461|NCT03468426|617092356|FG002|Overall Study|Progressive disease|4|||
170750462|NCT03468426|617092357|FG003|Overall Study|Progressive disease|20|||
170750463|NCT03468426|617092358|FG004|Overall Study|Progressive disease|23|||
170750464|NCT03468426|617092359|FG005|Overall Study|Progressive disease|15|||
170750465|NCT03468426|617092360|FG006|Overall Study|Progressive disease|24|||
170750466|NCT03468426|617092361|FG007|Overall Study|Progressive disease|27|||
170750467|NCT03468426|617092362|FG008|Overall Study|Progressive disease|13|||
170750468|NCT03468426|617092363|FG009|Overall Study|Progressive disease|13|||
170750469|NCT03468426|617092364|FG010|Overall Study|Progressive disease|0|||
170750470|NCT03468426|617092354|FG000|Overall Study|Other adverse event or clinical progression|0|||
170750471|NCT03468426|617092355|FG001|Overall Study|Other adverse event or clinical progression|1|||
170750472|NCT03468426|617092356|FG002|Overall Study|Other adverse event or clinical progression|3|||
170862251|NCT03285178|617505754|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
170862252|NCT03285178|617505755|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
170862253|NCT03285178|617505756|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
170862254|NCT03285178|617505757|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
170862255|NCT03285178|617505758|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
170862256|NCT03285178|617505759|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
170862257|NCT03285178|617505753|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
170862258|NCT03285178|617505754|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
170862259|NCT03285178|617505755|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
170862260|NCT03285178|617505756|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
170862261|NCT03285178|617505757|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
170862262|NCT03285178|617505758|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
170862263|NCT03285178|617505759|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
170862264|NCT03285178|617505753|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
170862265|NCT03285178|617505754|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
170862266|NCT03285178|617505755|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
170862267|NCT03285178|617505756|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
170862268|NCT03285178|617505757|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
170862269|NCT03285178|617505758|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
170862270|NCT03285178|617505759|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
170862271|NCT03285178|617505753|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
170862272|NCT03285178|617505754|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
170862273|NCT03285178|617505755|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
170862274|NCT03285178|617505756|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
170862275|NCT03285178|617505757|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
170862276|NCT03285178|617505758|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
170862277|NCT03285178|617505759|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
170862278|NCT03285178|617505753|FG000|Single-Blind Run-In Period|Physician Decision|2|||
170862279|NCT03285178|617505754|FG001|Single-Blind Run-In Period|Physician Decision|0|||
170862280|NCT03285178|617505755|FG002|Single-Blind Run-In Period|Physician Decision|0|||
170862281|NCT03285178|617505756|FG003|Single-Blind Run-In Period|Physician Decision|0|||
170862282|NCT03285178|617505757|FG004|Single-Blind Run-In Period|Physician Decision|0|||
170862283|NCT03285178|617505758|FG005|Single-Blind Run-In Period|Physician Decision|0|||
170862284|NCT03285178|617505759|FG006|Single-Blind Run-In Period|Physician Decision|0|||
170862285|NCT03285178|617505753|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
170862286|NCT03285178|617505754|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
170862287|NCT03285178|617505755|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
170862288|NCT03285178|617505756|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
170862289|NCT03285178|617505757|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
170862290|NCT03285178|617505758|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
170862291|NCT03285178|617505759|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
170862292|NCT03285178|617505753|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170862293|NCT03285178|617505754|FG001|Double-Blind Treatment Period|Adverse Event|0|||
170862294|NCT03285178|617505755|FG002|Double-Blind Treatment Period|Adverse Event|0|||
170862295|NCT03285178|617505756|FG003|Double-Blind Treatment Period|Adverse Event|0|||
170862296|NCT03285178|617505757|FG004|Double-Blind Treatment Period|Adverse Event|0|||
170862297|NCT03285178|617505758|FG005|Double-Blind Treatment Period|Adverse Event|0|||
170862298|NCT03285178|617505759|FG006|Double-Blind Treatment Period|Adverse Event|2|||
170862299|NCT03285178|617505753|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170862300|NCT03285178|617505754|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
170862301|NCT03285178|617505755|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
170862302|NCT03285178|617505756|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
170862303|NCT03285178|617505757|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
170862304|NCT03285178|617505758|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
170862305|NCT03285178|617505759|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
170862306|NCT03285178|617505753|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170862307|NCT03285178|617505754|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170862308|NCT03285178|617505755|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170862309|NCT03285178|617505756|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170862310|NCT03285178|617505757|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170862311|NCT03285178|617505758|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
170631448|NCT02113982|616664415|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
170631449|NCT02113982|616664416|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
170631450|NCT02113982|616664417|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
170631451|NCT02113982|616664418|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
170631452|NCT02113982|616664419|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
170631453|NCT02113982|616664420|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
170631454|NCT02113982|616664421|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
170631455|NCT02113982|616664422|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
170631456|NCT02113982|616664423|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
170631457|NCT02113982|616664410|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631458|NCT02113982|616664411|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631459|NCT02113982|616664412|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631460|NCT02113982|616664413|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631461|NCT02113982|616664414|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631462|NCT02113982|616664415|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631463|NCT02113982|616664416|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631464|NCT02113982|616664417|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
170631465|NCT02113982|616664418|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631466|NCT02113982|616664419|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
170631467|NCT02113982|616664420|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
170631468|NCT02113982|616664421|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631469|NCT02113982|616664422|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631470|NCT02113982|616664423|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
170631471|NCT02113982|616664410|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631472|NCT02113982|616664411|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631473|NCT02113982|616664412|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631474|NCT02113982|616664413|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631475|NCT02113982|616664414|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631476|NCT02113982|616664415|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631477|NCT02113982|616664416|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631478|NCT02113982|616664417|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
170631479|NCT02113982|616664418|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631480|NCT02113982|616664419|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
170631481|NCT02113982|616664420|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631482|NCT02113982|616664421|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631483|NCT02113982|616664422|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631484|NCT02113982|616664423|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
170631485|NCT02113982|616664410|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631486|NCT02113982|616664411|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631487|NCT02113982|616664412|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631488|NCT02113982|616664413|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631489|NCT02113982|616664414|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631490|NCT02113982|616664415|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631491|NCT02113982|616664416|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631492|NCT02113982|616664417|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
170631493|NCT02113982|616664418|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631494|NCT02113982|616664419|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631495|NCT02113982|616664420|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631496|NCT02113982|616664421|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631497|NCT02113982|616664422|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631498|NCT02113982|616664423|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
170631499|NCT02113982|616664410|FG000|Stage 2: Cohort Expansion|Transplant|0|||
170631500|NCT02113982|616664411|FG001|Stage 2: Cohort Expansion|Transplant|0|||
170631501|NCT02113982|616664412|FG002|Stage 2: Cohort Expansion|Transplant|0|||
170631502|NCT02113982|616664413|FG003|Stage 2: Cohort Expansion|Transplant|0|||
170631503|NCT02113982|616664414|FG004|Stage 2: Cohort Expansion|Transplant|0|||
170631504|NCT02113982|616664415|FG005|Stage 2: Cohort Expansion|Transplant|0|||
170631505|NCT02113982|616664416|FG006|Stage 2: Cohort Expansion|Transplant|0|||
170631506|NCT02113982|616664417|FG007|Stage 2: Cohort Expansion|Transplant|0|||
170631507|NCT02113982|616664418|FG008|Stage 2: Cohort Expansion|Transplant|0|||
170631508|NCT02113982|616664419|FG009|Stage 2: Cohort Expansion|Transplant|4|||
170631509|NCT02113982|616664420|FG010|Stage 2: Cohort Expansion|Transplant|2|||
170631510|NCT02113982|616664421|FG011|Stage 2: Cohort Expansion|Transplant|0|||
170631511|NCT02113982|616664422|FG012|Stage 2: Cohort Expansion|Transplant|0|||
170631512|NCT02113982|616664423|FG013|Stage 2: Cohort Expansion|Transplant|0|||
170631513|NCT02113982|616664410|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
170631514|NCT02113982|616664411|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
170631515|NCT02113982|616664412|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
170750473|NCT03468426|617092357|FG003|Overall Study|Other adverse event or clinical progression|14|||
170750474|NCT03468426|617092358|FG004|Overall Study|Other adverse event or clinical progression|10|||
170750475|NCT03468426|617092359|FG005|Overall Study|Other adverse event or clinical progression|8|||
170862312|NCT03285178|617505759|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170750476|NCT03468426|617092360|FG006|Overall Study|Other adverse event or clinical progression|5|||
170750477|NCT03468426|617092361|FG007|Overall Study|Other adverse event or clinical progression|4|||
170750478|NCT03468426|617092362|FG008|Overall Study|Other adverse event or clinical progression|6|||
170750479|NCT03468426|617092363|FG009|Overall Study|Other adverse event or clinical progression|11|||
170750480|NCT03468426|617092364|FG010|Overall Study|Other adverse event or clinical progression|0|||
170750481|NCT03468426|617092354|FG000|Overall Study|Refused to continue taking trial medication|0|||
170750482|NCT03468426|617092355|FG001|Overall Study|Refused to continue taking trial medication|0|||
170750483|NCT03468426|617092356|FG002|Overall Study|Refused to continue taking trial medication|0|||
170750484|NCT03468426|617092357|FG003|Overall Study|Refused to continue taking trial medication|2|||
170750485|NCT03468426|617092358|FG004|Overall Study|Refused to continue taking trial medication|0|||
170862313|NCT03285178|617505753|FG000|Double-Blind Treatment Period|COVID-19|0|||
170862314|NCT03285178|617505754|FG001|Double-Blind Treatment Period|COVID-19|0|||
170862315|NCT03285178|617505755|FG002|Double-Blind Treatment Period|COVID-19|1|||
170862316|NCT03285178|617505756|FG003|Double-Blind Treatment Period|COVID-19|0|||
170862317|NCT03285178|617505757|FG004|Double-Blind Treatment Period|COVID-19|0|||
170862318|NCT03285178|617505758|FG005|Double-Blind Treatment Period|COVID-19|0|||
170862319|NCT03285178|617505759|FG006|Double-Blind Treatment Period|COVID-19|0|||
170862320|NCT01128894|617505760|FG000|Overall Study|Adverse Event|31|||
170862321|NCT01128894|617505761|FG001|Overall Study|Adverse Event|41|||
170862322|NCT01128894|617505760|FG000|Overall Study|Protocol Violation|2|||
170862323|NCT01128894|617505761|FG001|Overall Study|Protocol Violation|1|||
170862324|NCT01128894|617505760|FG000|Overall Study|Noncompliance|4|||
170862325|NCT01128894|617505761|FG001|Overall Study|Noncompliance|5|||
170862326|NCT01128894|617505760|FG000|Overall Study|Lost to Follow-up|8|||
170862327|NCT01128894|617505761|FG001|Overall Study|Lost to Follow-up|8|||
170862328|NCT01128894|617505760|FG000|Overall Study|Withdrawal by Subject|10|||
170862329|NCT01128894|617505761|FG001|Overall Study|Withdrawal by Subject|12|||
170862330|NCT01128894|617505760|FG000|Overall Study|Physician Decision|2|||
170862331|NCT01128894|617505761|FG001|Overall Study|Physician Decision|1|||
170862332|NCT01128894|617505760|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
170862333|NCT01128894|617505761|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
170862334|NCT01128738|617505762|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
170862335|NCT01128738|617505763|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
170862336|NCT01128738|617505762|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
170862337|NCT01128738|617505763|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
170862338|NCT01128738|617505762|FG000|Second TP|Lost to Follow-up|0|||
170862339|NCT01128738|617505763|FG001|Second TP|Lost to Follow-up|1|||
170862340|NCT01128738|617505762|FG000|Second TP|Withdrawal by Subject|0|||
170862341|NCT01128738|617505763|FG001|Second TP|Withdrawal by Subject|2|||
170862342|NCT00973362|617505764|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
170862343|NCT00973362|617505765|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
170862344|NCT00973362|617505764|FG000|Baseline Evaluation|No colposcopy visit|62|||
170862345|NCT00973362|617505765|FG001|Baseline Evaluation|No colposcopy visit|0|||
170862346|NCT00973362|617505764|FG000|Baseline Evaluation|Inevaluable|686|||
170862347|NCT00973362|617505765|FG001|Baseline Evaluation|Inevaluable|223|||
170862348|NCT00973362|617505764|FG000|3-Year Follow-up|Lost to Follow-up|17|||
170862349|NCT00973362|617505765|FG001|3-Year Follow-up|Lost to Follow-up|0|||
170862350|NCT02202551|617505768|FG000|Overall Study|Adverse Event|8|||
170862351|NCT02202551|617505769|FG001|Overall Study|Adverse Event|19|||
170862352|NCT02202551|617505770|FG002|Overall Study|Adverse Event|5|||
170862353|NCT02202551|617505771|FG003|Overall Study|Adverse Event|9|||
170862354|NCT02202551|617505768|FG000|Overall Study|Death|3|||
170862355|NCT02202551|617505769|FG001|Overall Study|Death|2|||
170862356|NCT02202551|617505770|FG002|Overall Study|Death|1|||
170862357|NCT02202551|617505771|FG003|Overall Study|Death|1|||
170862358|NCT02202551|617505768|FG000|Overall Study|Lost to Follow-up|0|||
170862359|NCT02202551|617505769|FG001|Overall Study|Lost to Follow-up|1|||
170862360|NCT02202551|617505770|FG002|Overall Study|Lost to Follow-up|0|||
170862361|NCT02202551|617505771|FG003|Overall Study|Lost to Follow-up|1|||
170862362|NCT02202551|617505768|FG000|Overall Study|Needed to take excluded medication|0|||
170862363|NCT02202551|617505769|FG001|Overall Study|Needed to take excluded medication|2|||
170862364|NCT02202551|617505770|FG002|Overall Study|Needed to take excluded medication|0|||
170862365|NCT02202551|617505771|FG003|Overall Study|Needed to take excluded medication|1|||
170862366|NCT02202551|617505768|FG000|Overall Study|Subject moved away|0|||
170862367|NCT02202551|617505769|FG001|Overall Study|Subject moved away|1|||
170862368|NCT02202551|617505770|FG002|Overall Study|Subject moved away|0|||
170862369|NCT02202551|617505771|FG003|Overall Study|Subject moved away|0|||
170862370|NCT02202551|617505768|FG000|Overall Study|DBS surgery|3|||
170862371|NCT02202551|617505769|FG001|Overall Study|DBS surgery|0|||
170862372|NCT02202551|617505770|FG002|Overall Study|DBS surgery|0|||
170862373|NCT02202551|617505771|FG003|Overall Study|DBS surgery|0|||
170862374|NCT02202551|617505768|FG000|Overall Study|Dyskinesia upon taper|1|||
170862375|NCT02202551|617505769|FG001|Overall Study|Dyskinesia upon taper|0|||
170862376|NCT02202551|617505770|FG002|Overall Study|Dyskinesia upon taper|0|||
170862377|NCT02202551|617505771|FG003|Overall Study|Dyskinesia upon taper|0|||
170862378|NCT02202551|617505768|FG000|Overall Study|Lack of Efficacy|0|||
170862379|NCT02202551|617505769|FG001|Overall Study|Lack of Efficacy|1|||
170862380|NCT02202551|617505770|FG002|Overall Study|Lack of Efficacy|0|||
170862381|NCT02202551|617505771|FG003|Overall Study|Lack of Efficacy|0|||
170862382|NCT02202551|617505768|FG000|Overall Study|Physician Decision|1|||
170862383|NCT02202551|617505769|FG001|Overall Study|Physician Decision|0|||
170862384|NCT02202551|617505770|FG002|Overall Study|Physician Decision|0|||
170862385|NCT02202551|617505771|FG003|Overall Study|Physician Decision|0|||
170862386|NCT02202551|617505768|FG000|Overall Study|Site closure|3|||
170862387|NCT02202551|617505769|FG001|Overall Study|Site closure|0|||
170862388|NCT02202551|617505770|FG002|Overall Study|Site closure|0|||
170862389|NCT02202551|617505771|FG003|Overall Study|Site closure|1|||
170862390|NCT02202551|617505768|FG000|Overall Study|Unable to complete visits per protocol|1|||
170862391|NCT02202551|617505769|FG001|Overall Study|Unable to complete visits per protocol|0|||
170862392|NCT02202551|617505770|FG002|Overall Study|Unable to complete visits per protocol|0|||
170862393|NCT02202551|617505771|FG003|Overall Study|Unable to complete visits per protocol|0|||
170862394|NCT02202551|617505768|FG000|Overall Study|Worsening Dyskinesia|0|||
170862395|NCT02202551|617505769|FG001|Overall Study|Worsening Dyskinesia|0|||
170862396|NCT02202551|617505770|FG002|Overall Study|Worsening Dyskinesia|0|||
170862397|NCT02202551|617505771|FG003|Overall Study|Worsening Dyskinesia|1|||
170862398|NCT02202551|617505768|FG000|Overall Study|Protocol Violation|0|||
170862399|NCT02202551|617505769|FG001|Overall Study|Protocol Violation|1|||
170862400|NCT02202551|617505770|FG002|Overall Study|Protocol Violation|0|||
170862401|NCT02202551|617505771|FG003|Overall Study|Protocol Violation|0|||
170862402|NCT02202551|617505768|FG000|Overall Study|Sponsor's decision|2|||
170862403|NCT02202551|617505769|FG001|Overall Study|Sponsor's decision|0|||
170862404|NCT02202551|617505770|FG002|Overall Study|Sponsor's decision|0|||
170862405|NCT02202551|617505771|FG003|Overall Study|Sponsor's decision|0|||
170862406|NCT02202551|617505768|FG000|Overall Study|Subject unwilling to proceed|1|||
170862407|NCT02202551|617505769|FG001|Overall Study|Subject unwilling to proceed|5|||
170750486|NCT03468426|617092359|FG005|Overall Study|Refused to continue taking trial medication|3|||
170750487|NCT03468426|617092360|FG006|Overall Study|Refused to continue taking trial medication|0|||
170750488|NCT03468426|617092361|FG007|Overall Study|Refused to continue taking trial medication|0|||
170750489|NCT03468426|617092362|FG008|Overall Study|Refused to continue taking trial medication|1|||
170750490|NCT03468426|617092363|FG009|Overall Study|Refused to continue taking trial medication|0|||
170750491|NCT03468426|617092364|FG010|Overall Study|Refused to continue taking trial medication|0|||
170750492|NCT03468426|617092354|FG000|Overall Study|Other than listed|0|||
170750493|NCT03468426|617092355|FG001|Overall Study|Other than listed|1|||
170750494|NCT03468426|617092356|FG002|Overall Study|Other than listed|0|||
170750495|NCT03468426|617092357|FG003|Overall Study|Other than listed|0|||
170750496|NCT03468426|617092358|FG004|Overall Study|Other than listed|2|||
170750497|NCT03468426|617092359|FG005|Overall Study|Other than listed|2|||
170750498|NCT03468426|617092360|FG006|Overall Study|Other than listed|0|||
170750499|NCT03468426|617092361|FG007|Overall Study|Other than listed|0|||
170750500|NCT03468426|617092362|FG008|Overall Study|Other than listed|4|||
170750501|NCT03468426|617092363|FG009|Overall Study|Other than listed|4|||
170750502|NCT03468426|617092364|FG010|Overall Study|Other than listed|1|||
170750503|NCT03468426|617092354|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750504|NCT03468426|617092355|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750505|NCT03468426|617092356|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
170750506|NCT03468426|617092357|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750507|NCT03468426|617092358|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750508|NCT03468426|617092359|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750509|NCT03468426|617092360|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750510|NCT03468426|617092361|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750511|NCT03468426|617092362|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750512|NCT03468426|617092363|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750513|NCT03468426|617092364|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170750514|NCT03468426|617092354|FG000|Overall Study|missing reason|0|||
170750515|NCT03468426|617092355|FG001|Overall Study|missing reason|0|||
170750516|NCT03468426|617092356|FG002|Overall Study|missing reason|0|||
170750517|NCT03468426|617092357|FG003|Overall Study|missing reason|0|||
170750518|NCT03468426|617092358|FG004|Overall Study|missing reason|0|||
170750519|NCT03468426|617092359|FG005|Overall Study|missing reason|0|||
170750520|NCT03468426|617092360|FG006|Overall Study|missing reason|0|||
170750521|NCT03468426|617092361|FG007|Overall Study|missing reason|0|||
170750522|NCT03468426|617092362|FG008|Overall Study|missing reason|0|||
170750523|NCT03468426|617092363|FG009|Overall Study|missing reason|1|||
170750524|NCT03468426|617092364|FG010|Overall Study|missing reason|0|||
170750525|NCT02139982|617092371|FG000|Overall Study|Lack of Efficacy|0|||
170862408|NCT02202551|617505770|FG002|Overall Study|Subject unwilling to proceed|3|||
170862409|NCT02202551|617505771|FG003|Overall Study|Subject unwilling to proceed|5|||
170862410|NCT02202551|617505768|FG000|Overall Study|Subject consent withdrawn|0|||
170862411|NCT02202551|617505769|FG001|Overall Study|Subject consent withdrawn|3|||
170862412|NCT02202551|617505770|FG002|Overall Study|Subject consent withdrawn|1|||
170750526|NCT02139982|617092372|FG001|Overall Study|Lack of Efficacy|1|||
170750527|NCT02139982|617092373|FG002|Overall Study|Lack of Efficacy|0|||
170750528|NCT02139982|617092374|FG003|Overall Study|Lack of Efficacy|1|||
170750529|NCT02139982|617092375|FG004|Overall Study|Lack of Efficacy|0|||
170750530|NCT02139982|617092376|FG005|Overall Study|Lack of Efficacy|0|||
170750531|NCT02139982|617092377|FG006|Overall Study|Lack of Efficacy|0|||
170750532|NCT02139982|617092378|FG007|Overall Study|Lack of Efficacy|0|||
170750533|NCT02139982|617092379|FG008|Overall Study|Lack of Efficacy|0|||
170750534|NCT02139982|617092380|FG009|Overall Study|Lack of Efficacy|0|||
170750535|NCT01536145|617092387|FG000|Overall Study|Progressive disease|3|||
170750536|NCT01536145|617092388|FG001|Overall Study|Progressive disease|4|||
170750537|NCT01536145|617092389|FG002|Overall Study|Progressive disease|1|||
170750538|NCT01536145|617092390|FG003|Overall Study|Progressive disease|2|||
170750539|NCT01536145|617092391|FG004|Overall Study|Progressive disease|1|||
170750540|NCT01536145|617092392|FG005|Overall Study|Progressive disease|2|||
170750541|NCT01536145|617092393|FG006|Overall Study|Progressive disease|1|||
170750542|NCT01536145|617092394|FG007|Overall Study|Progressive disease|2|||
170750543|NCT01536145|617092395|FG008|Overall Study|Progressive disease|1|||
170750544|NCT01536145|617092396|FG009|Overall Study|Progressive disease|3|||
170750545|NCT01536145|617092397|FG010|Overall Study|Progressive disease|3|||
170750546|NCT01536145|617092387|FG000|Overall Study|Withdrawal by Subject|0|||
170750547|NCT01536145|617092388|FG001|Overall Study|Withdrawal by Subject|0|||
170750548|NCT01536145|617092389|FG002|Overall Study|Withdrawal by Subject|1|||
170750549|NCT01536145|617092390|FG003|Overall Study|Withdrawal by Subject|0|||
170750550|NCT01536145|617092391|FG004|Overall Study|Withdrawal by Subject|0|||
170750551|NCT01536145|617092392|FG005|Overall Study|Withdrawal by Subject|1|||
170750552|NCT01536145|617092393|FG006|Overall Study|Withdrawal by Subject|0|||
170750553|NCT01536145|617092394|FG007|Overall Study|Withdrawal by Subject|0|||
170750554|NCT01536145|617092395|FG008|Overall Study|Withdrawal by Subject|2|||
170750555|NCT01536145|617092396|FG009|Overall Study|Withdrawal by Subject|0|||
170750556|NCT01536145|617092397|FG010|Overall Study|Withdrawal by Subject|2|||
170750557|NCT01536145|617092387|FG000|Overall Study|Other|0|||
170750558|NCT01536145|617092388|FG001|Overall Study|Other|0|||
170750559|NCT01536145|617092389|FG002|Overall Study|Other|0|||
170750560|NCT01536145|617092390|FG003|Overall Study|Other|0|||
170750561|NCT01536145|617092391|FG004|Overall Study|Other|1|||
170750562|NCT01536145|617092392|FG005|Overall Study|Other|0|||
170750563|NCT01536145|617092393|FG006|Overall Study|Other|0|||
170750564|NCT01536145|617092394|FG007|Overall Study|Other|0|||
170750565|NCT01536145|617092395|FG008|Overall Study|Other|0|||
170750566|NCT01536145|617092396|FG009|Overall Study|Other|3|||
170750567|NCT01536145|617092397|FG010|Overall Study|Other|2|||
170750568|NCT01536145|617092387|FG000|Overall Study|Death|0|||
170750569|NCT01536145|617092388|FG001|Overall Study|Death|0|||
170750570|NCT01536145|617092389|FG002|Overall Study|Death|0|||
170750571|NCT01536145|617092390|FG003|Overall Study|Death|0|||
170750572|NCT01536145|617092391|FG004|Overall Study|Death|0|||
170750573|NCT01536145|617092392|FG005|Overall Study|Death|0|||
170750574|NCT01536145|617092393|FG006|Overall Study|Death|1|||
170750575|NCT01536145|617092394|FG007|Overall Study|Death|0|||
170750576|NCT01536145|617092395|FG008|Overall Study|Death|0|||
170750577|NCT01536145|617092396|FG009|Overall Study|Death|0|||
170750578|NCT01536145|617092397|FG010|Overall Study|Death|0|||
170750579|NCT01536145|617092387|FG000|Overall Study|Adverse Event|0|||
170750580|NCT01536145|617092388|FG001|Overall Study|Adverse Event|0|||
170750581|NCT01536145|617092389|FG002|Overall Study|Adverse Event|0|||
170750582|NCT01536145|617092390|FG003|Overall Study|Adverse Event|0|||
170750583|NCT01536145|617092391|FG004|Overall Study|Adverse Event|0|||
170750584|NCT01536145|617092392|FG005|Overall Study|Adverse Event|0|||
170750585|NCT01536145|617092393|FG006|Overall Study|Adverse Event|0|||
170750586|NCT01536145|617092394|FG007|Overall Study|Adverse Event|2|||
170750587|NCT01536145|617092395|FG008|Overall Study|Adverse Event|0|||
170750588|NCT01536145|617092396|FG009|Overall Study|Adverse Event|0|||
170750589|NCT01536145|617092397|FG010|Overall Study|Adverse Event|3|||
170750590|NCT05199233|617092398|FG000|Overall Study|Lack of Efficacy|1|||
170750591|NCT00688259|617092399|FG000|Overall Study|Lost to Follow-up|2|||
170750592|NCT00688259|617092400|FG001|Overall Study|Lost to Follow-up|4|||
170750593|NCT00688259|617092399|FG000|Overall Study|Physician Decision|1|||
170750594|NCT00688259|617092400|FG001|Overall Study|Physician Decision|0|||
170750595|NCT00688259|617092399|FG000|Overall Study|Withdrawal by Subject|2|||
170750596|NCT00688259|617092400|FG001|Overall Study|Withdrawal by Subject|0|||
170750597|NCT00688259|617092399|FG000|Overall Study|Declined Interview|2|||
170750598|NCT00688259|617092400|FG001|Overall Study|Declined Interview|3|||
170750599|NCT00688259|617092399|FG000|Overall Study|Hospitalized at Follow-up|0|||
170750600|NCT00688259|617092400|FG001|Overall Study|Hospitalized at Follow-up|1|||
170750601|NCT02491892|617092401|FG000|Overall Study|Adverse Event|1|||
170750602|NCT02491892|617092402|FG001|Overall Study|Adverse Event|1|||
170750603|NCT02491892|617092401|FG000|Overall Study|Death|1|||
170750604|NCT02491892|617092402|FG001|Overall Study|Death|1|||
170750605|NCT02491892|617092401|FG000|Overall Study|Lack of Efficacy|37|||
170750606|NCT02491892|617092402|FG001|Overall Study|Lack of Efficacy|36|||
170750607|NCT02491892|617092401|FG000|Overall Study|Refused Treatment|1|||
170750608|NCT02491892|617092402|FG001|Overall Study|Refused Treatment|0|||
170750609|NCT02491892|617092401|FG000|Overall Study|Lost to Follow-up|1|||
170750610|NCT02491892|617092402|FG001|Overall Study|Lost to Follow-up|0|||
170750611|NCT04496167|617092410|FG000|Overall Study|Adverse Event|6|||
170750612|NCT04496167|617092411|FG001|Overall Study|Adverse Event|2|||
170750613|NCT04496167|617092410|FG000|Overall Study|Withdrawal by Subject|7|||
170750614|NCT04496167|617092411|FG001|Overall Study|Withdrawal by Subject|6|||
170750615|NCT04496167|617092410|FG000|Overall Study|Lost to Follow-up|3|||
170750616|NCT04496167|617092411|FG001|Overall Study|Lost to Follow-up|5|||
170750617|NCT04496167|617092410|FG000|Overall Study|Not Treated|1|||
170750618|NCT04496167|617092411|FG001|Overall Study|Not Treated|2|||
170750619|NCT04496167|617092410|FG000|Overall Study|Other Than Specified|1|||
170750620|NCT04496167|617092411|FG001|Overall Study|Other Than Specified|1|||
170750621|NCT00681187|617092412|FG000|Overall Study|Withdrawal by Subject|1|||
170750622|NCT00681187|617092413|FG001|Overall Study|Withdrawal by Subject|0|||
170750623|NCT00681187|617092412|FG000|Overall Study|Death|0|||
170750624|NCT00681187|617092413|FG001|Overall Study|Death|1|||
170750625|NCT00681187|617092412|FG000|Overall Study|Adverse Event|0|||
170750626|NCT00681187|617092413|FG001|Overall Study|Adverse Event|1|||
170750627|NCT03653416|617092414|FG000|Overall Study|Protocol Violation|6|||
170750628|NCT03653416|617092415|FG001|Overall Study|Protocol Violation|1|||
170750629|NCT00318149|617092419|FG000|Overall Study|Adverse Event|0|||
170750630|NCT00318149|617092420|FG001|Overall Study|Adverse Event|0|||
170750631|NCT00318149|617092421|FG002|Overall Study|Adverse Event|0|||
170750632|NCT00318149|617092422|FG003|Overall Study|Adverse Event|0|||
170750633|NCT00318149|617092423|FG004|Overall Study|Adverse Event|0|||
170750634|NCT00318149|617092424|FG005|Overall Study|Adverse Event|2|||
170750635|NCT00598481|617092425|FG000|Treatment|Physician Decision|1|||
170750636|NCT03055832|617092426|FG000|Week 2|Withdrawal by Subject|1|||
170750637|NCT03055832|617092427|FG001|Week 2|Withdrawal by Subject|0|||
170750638|NCT03619174|617092428|FG000|Overall Study|Lost to Follow-up|3|||
170750639|NCT03619174|617092429|FG001|Overall Study|Lost to Follow-up|0|||
170750640|NCT03619174|617092428|FG000|Overall Study|Withdrawal by Subject|4|||
170750641|NCT03619174|617092429|FG001|Overall Study|Withdrawal by Subject|3|||
170750642|NCT03619174|617092428|FG000|Overall Study|Pregnancy|1|||
170750643|NCT03619174|617092429|FG001|Overall Study|Pregnancy|1|||
170750644|NCT03619174|617092428|FG000|Overall Study|Discomfort during treatment|1|||
170750645|NCT03619174|617092429|FG001|Overall Study|Discomfort during treatment|0|||
170750646|NCT01991197|617092430|FG000|Overall Study|Lost to Follow-up|1|||
170750647|NCT01991197|617092431|FG001|Overall Study|Lost to Follow-up|1|||
170750648|NCT01991197|617092430|FG000|Overall Study|Physician Decision|0|||
170750649|NCT01991197|617092431|FG001|Overall Study|Physician Decision|2|||
170750650|NCT01991197|617092430|FG000|Overall Study|Withdrawal by Subject|2|||
170750651|NCT01991197|617092431|FG001|Overall Study|Withdrawal by Subject|0|||
170750652|NCT00231894|617092432|FG000|Overall Study|Withdrawal by Subject|1|||
170750653|NCT00231894|617092433|FG001|Overall Study|Withdrawal by Subject|1|||
170750654|NCT04172987|617092435|FG000|Lead In Period|Adverse Event|1|||
170750655|NCT04172987|617092435|FG000|Lead In Period|Protocol Violation|1|||
170750656|NCT04172987|617092435|FG000|Period 1|Physician Decision|1|||
170750657|NCT04172987|617092435|FG000|Period 2|Adverse Event|5|||
170750658|NCT04172987|617092435|FG000|Period 2|Dosing Termination by Sponsor|4|||
170750659|NCT01603121|617092437|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
170750660|NCT01603121|617092438|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
170750661|NCT04179461|617092441|FG000|Overall Study|Lost to Follow-up|4|||
170750662|NCT00195715|617092446|FG000|Overall Study|Adverse Event|122|||
170750663|NCT00195715|617092446|FG000|Overall Study|Withdrawal by Subject|58|||
170750664|NCT00195715|617092446|FG000|Overall Study|Lost to Follow-up|27|||
170750665|NCT00195715|617092446|FG000|Overall Study|Protocol Violation|13|||
170750666|NCT00195715|617092446|FG000|Overall Study|Lack of Efficacy|93|||
170750667|NCT00195715|617092446|FG000|Overall Study|Pregnancy|14|||
170750668|NCT00195715|617092446|FG000|Overall Study|Investigative site closure|8|||
170750669|NCT00195715|617092446|FG000|Overall Study|Subject moved/relocated|7|||
170750670|NCT00195715|617092446|FG000|Overall Study|Subject non-compliance|6|||
170750671|NCT00195715|617092446|FG000|Overall Study|Subject started commercial Humira|5|||
170750672|NCT00195715|617092446|FG000|Overall Study|Subject choice|3|||
170750673|NCT00195715|617092446|FG000|Overall Study|Loss of response/no improvement|3|||
170750674|NCT00195715|617092446|FG000|Overall Study|Sponsor stopped study|1|||
170750675|NCT00195715|617092446|FG000|Overall Study|Administrative reasons|2|||
170750676|NCT00195715|617092446|FG000|Overall Study|Investigator's decision|2|||
170750677|NCT00195715|617092446|FG000|Overall Study|Subject wants to get pregnant|4|||
170750678|NCT00195715|617092446|FG000|Overall Study|Use of prohibited medication|2|||
170750679|NCT00195715|617092446|FG000|Overall Study|Planned surgery|2|||
170750680|NCT00195715|617092446|FG000|Overall Study|Increased infection rate|1|||
170750681|NCT00195715|617092446|FG000|Overall Study|Ineligible|1|||
170750682|NCT00195715|617092446|FG000|Overall Study|Colonic stricture|1|||
170750683|NCT00195715|617092446|FG000|Overall Study|Sponsor discontinued trial|1|||
170750684|NCT00195715|617092446|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
170750685|NCT00845871|617092447|FG000|Assessment Period|Adverse Event|2|||
170750686|NCT00845871|617092447|FG000|Assessment Period|Abnormal laboratory values|1|||
170750687|NCT00845871|617092447|FG000|Assessment Period|Abnormal test procedure results|1|||
170750688|NCT00845871|617092447|FG000|Assessment Period|Patient withdrew consent|3|||
170750689|NCT01267253|617092449|FG000|Overall Study|Ineligible - required test not done|1|||
170750690|NCT01267253|617092449|FG000|Overall Study|Inevaluable-never received study treatme|2|||
170750691|NCT04318093|617092450|FG000|Overall Study|Adverse Event|2|||
170750692|NCT04318093|617092451|FG001|Overall Study|Adverse Event|2|||
170750693|NCT04318093|617092450|FG000|Overall Study|Participant withdrew consent|1|||
170750694|NCT04318093|617092451|FG001|Overall Study|Participant withdrew consent|0|||
170750695|NCT04318093|617092450|FG000|Overall Study|Other reasons|0|||
170750696|NCT04318093|617092451|FG001|Overall Study|Other reasons|1|||
170750697|NCT02218489|617092454|FG000|Overall Study|Withdrawal by Subject|4|||
170750698|NCT02218489|617092455|FG001|Overall Study|Withdrawal by Subject|3|||
170750699|NCT02218489|617092454|FG000|Overall Study|Lost to Follow-up|1|||
170750700|NCT02218489|617092455|FG001|Overall Study|Lost to Follow-up|0|||
170750701|NCT02133924|617092456|FG000|Overall Study|Death|38|||
170750702|NCT02133924|617092456|FG000|Overall Study|Physician Decision|1|||
170750703|NCT02133924|617092456|FG000|Overall Study|Withdrawal by Subject|3|||
170750704|NCT01163747|617092462|FG000|Overall Study|Adverse Event|0|||
170750705|NCT01163747|617092463|FG001|Overall Study|Adverse Event|5|||
170750706|NCT01163747|617092462|FG000|Overall Study|Insufficient Therapeutic Response|0|||
170750707|NCT01163747|617092463|FG001|Overall Study|Insufficient Therapeutic Response|1|||
170750708|NCT01163747|617092462|FG000|Overall Study|Protocol Violation|0|||
170750709|NCT01163747|617092463|FG001|Overall Study|Protocol Violation|1|||
170750710|NCT01163747|617092462|FG000|Overall Study|Refused Treatment|6|||
170750711|NCT01163747|617092463|FG001|Overall Study|Refused Treatment|4|||
170750712|NCT02044458|617092470|FG000|Overall Study|Protocol Violation|3|||
170750713|NCT02044458|617092471|FG001|Overall Study|Protocol Violation|8|||
170750714|NCT04145349|617094212|FG000|Overall Study|Withdrawal by Subject|3|||
170750715|NCT04145349|617094213|FG001|Overall Study|Withdrawal by Subject|0|||
170750716|NCT04145349|617094212|FG000|Overall Study|Lost to Follow-up|0|||
170750717|NCT04145349|617094213|FG001|Overall Study|Lost to Follow-up|1|||
170750718|NCT04145349|617094212|FG000|Overall Study|On study treatment (Ongoing)|0|||
170750719|NCT04145349|617094213|FG001|Overall Study|On study treatment (Ongoing)|1|||
170750720|NCT03280563|617094215|FG000|Stage 1|Death|2|||
170750721|NCT03280563|617094216|FG001|Stage 1|Death|1|||
170750722|NCT03280563|617094217|FG002|Stage 1|Death|0|||
170750723|NCT03280563|617094218|FG003|Stage 1|Death|0|||
170750724|NCT03280563|617094219|FG004|Stage 1|Death|0|||
170750725|NCT03280563|617094220|FG005|Stage 1|Death|3|||
170750726|NCT03280563|617094221|FG006|Stage 1|Death|0|||
170750727|NCT03280563|617094222|FG007|Stage 1|Death|0|||
170750728|NCT03280563|617094223|FG008|Stage 1|Death|0|||
170750729|NCT03280563|617094215|FG000|Stage 1|Study Ended by Sponsor|0|||
170750730|NCT03280563|617094216|FG001|Stage 1|Study Ended by Sponsor|0|||
170750731|NCT03280563|617094217|FG002|Stage 1|Study Ended by Sponsor|1|||
170750732|NCT03280563|617094218|FG003|Stage 1|Study Ended by Sponsor|0|||
170750733|NCT03280563|617094219|FG004|Stage 1|Study Ended by Sponsor|0|||
170750734|NCT03280563|617094220|FG005|Stage 1|Study Ended by Sponsor|1|||
170750735|NCT03280563|617094221|FG006|Stage 1|Study Ended by Sponsor|0|||
170750736|NCT03280563|617094222|FG007|Stage 1|Study Ended by Sponsor|0|||
170750737|NCT03280563|617094223|FG008|Stage 1|Study Ended by Sponsor|0|||
170750738|NCT03280563|617094215|FG000|Stage 1|Withdrawal by Subject|5|||
170750739|NCT03280563|617094216|FG001|Stage 1|Withdrawal by Subject|1|||
170750740|NCT03280563|617094217|FG002|Stage 1|Withdrawal by Subject|2|||
170750741|NCT03280563|617094218|FG003|Stage 1|Withdrawal by Subject|0|||
170750742|NCT03280563|617094219|FG004|Stage 1|Withdrawal by Subject|0|||
170750743|NCT03280563|617094220|FG005|Stage 1|Withdrawal by Subject|2|||
170750744|NCT03280563|617094221|FG006|Stage 1|Withdrawal by Subject|0|||
170750745|NCT03280563|617094222|FG007|Stage 1|Withdrawal by Subject|0|||
170750746|NCT03280563|617094223|FG008|Stage 1|Withdrawal by Subject|0|||
170750747|NCT03280563|617094215|FG000|Stage 1|Reason Not Specified|0|||
170750748|NCT03280563|617094216|FG001|Stage 1|Reason Not Specified|0|||
170750749|NCT03280563|617094217|FG002|Stage 1|Reason Not Specified|0|||
170750750|NCT03280563|617094218|FG003|Stage 1|Reason Not Specified|0|||
170750751|NCT03280563|617094219|FG004|Stage 1|Reason Not Specified|0|||
170750752|NCT03280563|617094220|FG005|Stage 1|Reason Not Specified|1|||
170750753|NCT03280563|617094221|FG006|Stage 1|Reason Not Specified|0|||
170750754|NCT03280563|617094222|FG007|Stage 1|Reason Not Specified|0|||
170750755|NCT03280563|617094223|FG008|Stage 1|Reason Not Specified|0|||
170750756|NCT03280563|617094215|FG000|Stage 1|Physician Decision|0|||
170750757|NCT03280563|617094216|FG001|Stage 1|Physician Decision|1|||
170862413|NCT02202551|617505771|FG003|Overall Study|Subject consent withdrawn|2|||
170750758|NCT03280563|617094217|FG002|Stage 1|Physician Decision|0|||
170750759|NCT03280563|617094218|FG003|Stage 1|Physician Decision|0|||
170750760|NCT03280563|617094219|FG004|Stage 1|Physician Decision|0|||
170750761|NCT03280563|617094220|FG005|Stage 1|Physician Decision|0|||
170750762|NCT03280563|617094221|FG006|Stage 1|Physician Decision|0|||
170750763|NCT03280563|617094222|FG007|Stage 1|Physician Decision|0|||
170750764|NCT03280563|617094223|FG008|Stage 1|Physician Decision|0|||
170750765|NCT03280563|617094215|FG000|Stage 2|Death|0|||
170750766|NCT03280563|617094216|FG001|Stage 2|Death|0|||
170862414|NCT02202551|617505768|FG000|Overall Study|eGFR<50mL/min/m2|2|||
170862415|NCT02202551|617505769|FG001|Overall Study|eGFR<50mL/min/m2|2|||
170862416|NCT02202551|617505770|FG002|Overall Study|eGFR<50mL/min/m2|0|||
170862417|NCT02202551|617505771|FG003|Overall Study|eGFR<50mL/min/m2|1|||
170862418|NCT05192382|617505775|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
170862419|NCT05192382|617505776|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
170862420|NCT05192382|617505777|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
170862421|NCT05192382|617505775|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
170862422|NCT05192382|617505776|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
170862423|NCT05192382|617505777|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
170862424|NCT05192382|617505775|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
170862425|NCT05192382|617505776|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
170862426|NCT05192382|617505777|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
170862427|NCT05192382|617505775|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
170862428|NCT05192382|617505776|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
170862429|NCT05192382|617505777|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
170862430|NCT00887679|617505778|FG000|Overall Study|Withdrawal by Subject|1|||
170862431|NCT00887679|617505778|FG000|Overall Study|Lost to Follow-up|4|||
170862432|NCT00887679|617505778|FG000|Overall Study|Physician Decision|5|||
170862433|NCT02683941|617505781|FG000|Double-blind Phase|Adverse Event|0|||
170862434|NCT02683941|617505782|FG001|Double-blind Phase|Adverse Event|1|||
170862435|NCT02683941|617505781|FG000|Double-blind Phase|Withdrawal by Subject|4|||
170862436|NCT02683941|617505782|FG001|Double-blind Phase|Withdrawal by Subject|2|||
170862437|NCT02683941|617505781|FG000|Double-blind Phase|Lost to Follow-up|1|||
170862438|NCT02683941|617505782|FG001|Double-blind Phase|Lost to Follow-up|0|||
170862439|NCT02683941|617505781|FG000|Double-blind Phase|Disease Progression|5|||
170862440|NCT02683941|617505782|FG001|Double-blind Phase|Disease Progression|2|||
170862441|NCT02683941|617505781|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
170862442|NCT02683941|617505782|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
170862443|NCT02683941|617505781|FG000|Open-label Treatment Phase|Disease Progression|1|||
170862444|NCT02683941|617505782|FG001|Open-label Treatment Phase|Disease Progression|2|||
170862445|NCT02683941|617505781|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
170862446|NCT02683941|617505782|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
170862447|NCT02683941|617505781|FG000|Open-label Treatment Phase|Other|1|||
170862448|NCT02683941|617505782|FG001|Open-label Treatment Phase|Other|0|||
170862449|NCT02683941|617505781|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
170862450|NCT02683941|617505782|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
170862451|NCT02683941|617505781|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
170862452|NCT02683941|617505782|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
170862453|NCT02683941|617505781|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
170862454|NCT02683941|617505782|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
170862455|NCT02683941|617505781|FG000|Open-label Follow-up Phase|Other|8|||
170862456|NCT02683941|617505782|FG001|Open-label Follow-up Phase|Other|1|||
170862457|NCT00150969|617505785|FG000|24 Month Main Study|Adverse Event|3|||
170862458|NCT00150969|617505786|FG001|24 Month Main Study|Adverse Event|4|||
170862459|NCT00150969|617505785|FG000|24 Month Main Study|Death|1|||
170862460|NCT00150969|617505786|FG001|24 Month Main Study|Death|1|||
170862461|NCT00150969|617505785|FG000|24 Month Main Study|Lack of Efficacy|1|||
170862462|NCT00150969|617505786|FG001|24 Month Main Study|Lack of Efficacy|8|||
170862463|NCT00150969|617505785|FG000|24 Month Main Study|Lost to Follow-up|3|||
170862464|NCT00150969|617505786|FG001|24 Month Main Study|Lost to Follow-up|2|||
170862465|NCT00150969|617505785|FG000|24 Month Main Study|Protocol Violation|4|||
170862466|NCT00150969|617505786|FG001|24 Month Main Study|Protocol Violation|2|||
170862467|NCT00150969|617505785|FG000|24 Month Main Study|Withdrawal by Subject|7|||
170862468|NCT00150969|617505786|FG001|24 Month Main Study|Withdrawal by Subject|4|||
170862469|NCT00150969|617505785|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
170862470|NCT00150969|617505786|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
170862471|NCT00150969|617505785|FG000|24-48 Month Extension|Lack of Efficacy|0|||
170862472|NCT00150969|617505786|FG001|24-48 Month Extension|Lack of Efficacy|1|||
170862473|NCT00150969|617505785|FG000|24-48 Month Extension|Adverse Event|1|||
170862474|NCT00150969|617505786|FG001|24-48 Month Extension|Adverse Event|3|||
170862475|NCT00150969|617505785|FG000|24-48 Month Extension|Other Reason|81|||
170862476|NCT00150969|617505786|FG001|24-48 Month Extension|Other Reason|91|||
170862477|NCT00146757|617505787|FG000|Overall Study|Death|1|||
170862478|NCT00146757|617505788|FG001|Overall Study|Death|0|||
170862479|NCT00146757|617505787|FG000|Overall Study|Adverse Event|1|||
170862480|NCT00146757|617505788|FG001|Overall Study|Adverse Event|0|||
170862481|NCT04702776|617505793|FG000|Overall Study|Adverse Event|1|||
170862482|NCT04702776|617505794|FG001|Overall Study|Adverse Event|2|||
170862483|NCT04702776|617505795|FG002|Overall Study|Adverse Event|1|||
170862484|NCT04702776|617505793|FG000|Overall Study|Lost to Follow-up|2|||
170862485|NCT04702776|617505794|FG001|Overall Study|Lost to Follow-up|1|||
170862486|NCT04702776|617505795|FG002|Overall Study|Lost to Follow-up|4|||
170862487|NCT04702776|617505793|FG000|Overall Study|Protocol Violation|2|||
170402161|NCT04682639|615813351|FG003|OLE Period (28 Weeks)|Other|0|||
170862488|NCT04702776|617505794|FG001|Overall Study|Protocol Violation|2|||
170862489|NCT04702776|617505795|FG002|Overall Study|Protocol Violation|3|||
170862490|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
170862491|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
170862492|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Death|0|||
170862493|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Death|2|||
170862494|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
170862495|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
170862496|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
170862497|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
170862498|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
170862499|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
170862500|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
170862501|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
170862502|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
170862503|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
170862504|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
170862505|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
170862506|NCT00343252|617505802|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
170862507|NCT00343252|617505803|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
170862508|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
170862509|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
170862510|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Death|3|||
170862511|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Death|3|||
170862512|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
170862513|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
170862514|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
170862515|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
170862516|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
170862517|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
170862518|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
170862519|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
170862520|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
170862521|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
170862522|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
170862523|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
170862524|NCT00343252|617505802|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
170862525|NCT00343252|617505803|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
170862526|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
170862527|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
170862528|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Death|4|||
170862529|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Death|5|||
170862530|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
170862531|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
170862532|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
170862533|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
170862534|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
170862535|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
170862536|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
170862537|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
170862538|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
170862539|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
170862540|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
170862541|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
170862542|NCT00343252|617505802|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
170862543|NCT00343252|617505803|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
170862544|NCT02076178|617505804|FG000|Oral Phase|Adverse Event|0|||
170862545|NCT02076178|617505805|FG001|Oral Phase|Adverse Event|7|||
170862546|NCT02076178|617505804|FG000|Oral Phase|Withdrawal by Subject|0|||
170862547|NCT02076178|617505805|FG001|Oral Phase|Withdrawal by Subject|4|||
170862548|NCT02076178|617505804|FG000|Oral Phase|Physician Decision|0|||
170862549|NCT02076178|617505805|FG001|Oral Phase|Physician Decision|1|||
170862550|NCT02076178|617505804|FG000|Injection Phase|Protocol defined stopping criteria|1|||
170862551|NCT02076178|617505805|FG001|Injection Phase|Protocol defined stopping criteria|0|||
170862552|NCT02076178|617505804|FG000|Injection Phase|Withdrawal by Subject|0|||
170862553|NCT02076178|617505805|FG001|Injection Phase|Withdrawal by Subject|3|||
170862554|NCT02076178|617505804|FG000|Injection Phase|Physician Decision|0|||
170862555|NCT02076178|617505805|FG001|Injection Phase|Physician Decision|3|||
170862556|NCT02076178|617505804|FG000|Injection Phase|Lost to Follow-up|0|||
170862557|NCT02076178|617505805|FG001|Injection Phase|Lost to Follow-up|1|||
170862558|NCT01054846|617505808|FG000|Overall Study|Lost to Follow-up|76|||
170750767|NCT03280563|617094217|FG002|Stage 2|Death|0|||
170750768|NCT03280563|617094218|FG003|Stage 2|Death|0|||
170750769|NCT03280563|617094219|FG004|Stage 2|Death|0|||
170750770|NCT03280563|617094220|FG005|Stage 2|Death|0|||
170750771|NCT03280563|617094221|FG006|Stage 2|Death|0|||
170750772|NCT03280563|617094222|FG007|Stage 2|Death|1|||
170750773|NCT03280563|617094223|FG008|Stage 2|Death|0|||
170750774|NCT03280563|617094215|FG000|Stage 2|Progressive Disease|0|||
170750775|NCT03280563|617094216|FG001|Stage 2|Progressive Disease|0|||
170750776|NCT03280563|617094217|FG002|Stage 2|Progressive Disease|0|||
170750777|NCT03280563|617094218|FG003|Stage 2|Progressive Disease|0|||
170750778|NCT03280563|617094219|FG004|Stage 2|Progressive Disease|0|||
170750779|NCT03280563|617094220|FG005|Stage 2|Progressive Disease|0|||
170750780|NCT03280563|617094221|FG006|Stage 2|Progressive Disease|2|||
170750781|NCT03280563|617094222|FG007|Stage 2|Progressive Disease|0|||
170750782|NCT03280563|617094223|FG008|Stage 2|Progressive Disease|0|||
170750783|NCT03280563|617094215|FG000|Long-term Survival Follow-up|Death|10|||
170750784|NCT03280563|617094216|FG001|Long-term Survival Follow-up|Death|14|||
170750785|NCT03280563|617094217|FG002|Long-term Survival Follow-up|Death|15|||
170750786|NCT03280563|617094218|FG003|Long-term Survival Follow-up|Death|3|||
170750787|NCT03280563|617094219|FG004|Long-term Survival Follow-up|Death|6|||
170750788|NCT03280563|617094220|FG005|Long-term Survival Follow-up|Death|18|||
170750789|NCT03280563|617094221|FG006|Long-term Survival Follow-up|Death|11|||
170750790|NCT03280563|617094222|FG007|Long-term Survival Follow-up|Death|1|||
170750791|NCT03280563|617094223|FG008|Long-term Survival Follow-up|Death|3|||
170750792|NCT03280563|617094215|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
170750793|NCT03280563|617094216|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
170750794|NCT03280563|617094217|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
170750795|NCT03280563|617094218|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
170750796|NCT03280563|617094219|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
170750797|NCT03280563|617094220|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
170750798|NCT03280563|617094221|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
170750799|NCT03280563|617094222|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
170750800|NCT03280563|617094223|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
170750801|NCT03280563|617094215|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
170750802|NCT03280563|617094216|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
170750803|NCT03280563|617094217|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
170750804|NCT03280563|617094218|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
170750805|NCT03280563|617094219|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
170750806|NCT03280563|617094220|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
170750807|NCT03280563|617094221|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
170750808|NCT03280563|617094222|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
170750809|NCT03280563|617094223|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
170750810|NCT03280563|617094215|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
170750811|NCT03280563|617094216|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
170750812|NCT03280563|617094217|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
170750813|NCT03280563|617094218|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
170750814|NCT03280563|617094219|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
170750815|NCT03280563|617094220|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
170750816|NCT03280563|617094221|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
170750817|NCT03280563|617094222|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
170750818|NCT03280563|617094223|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
170750819|NCT03038672|617094224|FG000|Initial Treatment|Unacceptable chemistry|0|||
170750820|NCT03038672|617094225|FG001|Initial Treatment|Unacceptable chemistry|1|||
170750821|NCT03038672|617094224|FG000|Initial Treatment|Progression prior to treatment|1|||
170750822|NCT03038672|617094225|FG001|Initial Treatment|Progression prior to treatment|0|||
170750823|NCT03038672|617094224|FG000|Initial Treatment|No treatment per protocol|1|||
170862559|NCT01054846|617505809|FG001|Overall Study|Lost to Follow-up|17|||
170862560|NCT03021954|617505812|FG000|Overall Study|Lost to Follow-up|10|||
170750824|NCT03038672|617094225|FG001|Initial Treatment|No treatment per protocol|0|||
170862561|NCT03021954|617505813|FG001|Overall Study|Lost to Follow-up|43|||
170750825|NCT05220501|617094226|FG000|Overall Study|Withdrawal by Subject|11|||
170750826|NCT05220501|617094227|FG001|Overall Study|Withdrawal by Subject|21|||
170750827|NCT05220501|617094228|FG002|Overall Study|Withdrawal by Subject|32|||
170750828|NCT05220501|617094226|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
170862562|NCT03021954|617505812|FG000|Overall Study|Subjects had avulsion trauma|4|||
170862563|NCT03021954|617505813|FG001|Overall Study|Subjects had avulsion trauma|1|||
170750829|NCT05220501|617094227|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
170750830|NCT05220501|617094228|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
170862564|NCT01592864|617505814|FG000|Overall Study|Withdrawal by Subject|0|||
170862565|NCT01592864|617505815|FG001|Overall Study|Withdrawal by Subject|1|||
170862566|NCT01881750|617505818|FG000|Overall Study|Changes in concomitant therapies|2|||
170862567|NCT01881750|617505819|FG001|Overall Study|Changes in concomitant therapies|3|||
170862568|NCT01881750|617505818|FG000|Overall Study|Lost to Follow-up|0|||
170862569|NCT01881750|617505819|FG001|Overall Study|Lost to Follow-up|1|||
170862570|NCT00051363|617505820|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
170862571|NCT00051363|617505821|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
170862572|NCT00051363|617505820|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
170862573|NCT00051363|617505821|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
170862574|NCT00051363|617505820|FG000|Overall Study|Death|2|||
170862575|NCT00051363|617505821|FG001|Overall Study|Death|2|||
170862576|NCT00051363|617505820|FG000|Overall Study|Excluded Pre-Randomization|2|||
170862577|NCT00051363|617505821|FG001|Overall Study|Excluded Pre-Randomization|5|||
170862578|NCT01209143|617505826|FG000|Overall Study|Adverse Event|2|||
170862579|NCT01209143|617505827|FG001|Overall Study|Adverse Event|1|||
170862580|NCT01209143|617505826|FG000|Overall Study|Death|0|||
170862581|NCT01209143|617505827|FG001|Overall Study|Death|1|||
170862582|NCT01209143|617505826|FG000|Overall Study|Physician Decision|3|||
170862583|NCT01209143|617505827|FG001|Overall Study|Physician Decision|1|||
170862584|NCT01209143|617505826|FG000|Overall Study|Lost to Follow-up|1|||
170862585|NCT01209143|617505827|FG001|Overall Study|Lost to Follow-up|0|||
170862586|NCT01209143|617505826|FG000|Overall Study|Withdrawal by Subject|2|||
170862587|NCT01209143|617505827|FG001|Overall Study|Withdrawal by Subject|1|||
170862588|NCT01209143|617505826|FG000|Overall Study|Disease progression|11|||
170862589|NCT01209143|617505827|FG001|Overall Study|Disease progression|16|||
170862590|NCT02961218|617505833|FG000|Overall Study|Lost to Follow-up|0|||
170862591|NCT02961218|617505834|FG001|Overall Study|Lost to Follow-up|2|||
170862592|NCT02961218|617505833|FG000|Overall Study|Physician Decision|0|||
170862593|NCT02961218|617505834|FG001|Overall Study|Physician Decision|2|||
170862594|NCT02961218|617505833|FG000|Overall Study|Subject/Guardian Decision|3|||
170862595|NCT02961218|617505834|FG001|Overall Study|Subject/Guardian Decision|1|||
170862596|NCT00602667|617505835|FG000|Overall Study|Still on Therapy|0|||
170862597|NCT00602667|617505836|FG001|Overall Study|Still on Therapy|2|||
170862598|NCT00602667|617505837|FG002|Overall Study|Still on Therapy|2|||
170862599|NCT00602667|617505835|FG000|Overall Study|Death|0|||
170862600|NCT00602667|617505836|FG001|Overall Study|Death|1|||
170862601|NCT00602667|617505837|FG002|Overall Study|Death|1|||
170862602|NCT00602667|617505835|FG000|Overall Study|Family request|3|||
170862603|NCT00602667|617505836|FG001|Overall Study|Family request|25|||
170862604|NCT00602667|617505837|FG002|Overall Study|Family request|6|||
170862605|NCT00602667|617505835|FG000|Overall Study|Excessive toxicity|1|||
170862606|NCT00602667|617505836|FG001|Overall Study|Excessive toxicity|1|||
170862607|NCT00602667|617505837|FG002|Overall Study|Excessive toxicity|0|||
170862608|NCT00602667|617505835|FG000|Overall Study|Second malignancy|0|||
170862609|NCT00602667|617505836|FG001|Overall Study|Second malignancy|1|||
170862610|NCT00602667|617505837|FG002|Overall Study|Second malignancy|0|||
170862611|NCT00602667|617505835|FG000|Overall Study|Physician Decision|2|||
170862612|NCT00602667|617505836|FG001|Overall Study|Physician Decision|3|||
170862613|NCT00602667|617505837|FG002|Overall Study|Physician Decision|8|||
170862614|NCT00602667|617505835|FG000|Overall Study|Progressive disease|13|||
170862615|NCT00602667|617505836|FG001|Overall Study|Progressive disease|48|||
170862616|NCT00602667|617505837|FG002|Overall Study|Progressive disease|45|||
170862617|NCT00602667|617505835|FG000|Overall Study|Progressive disease prior to therapy|0|||
170862618|NCT00602667|617505836|FG001|Overall Study|Progressive disease prior to therapy|0|||
170862619|NCT00602667|617505837|FG002|Overall Study|Progressive disease prior to therapy|1|||
170862620|NCT04765059|617505842|FG000|Overall Study|Failure to meet randomization criteria|1|||
170862621|NCT04765059|617505843|FG001|Overall Study|Failure to meet randomization criteria|0|||
170862622|NCT04765059|617505842|FG000|Overall Study|Withdrawal by Subject|1|||
170862623|NCT04765059|617505843|FG001|Overall Study|Withdrawal by Subject|4|||
170862624|NCT04765059|617505842|FG000|Overall Study|Lost to Follow-up|1|||
170862625|NCT04765059|617505843|FG001|Overall Study|Lost to Follow-up|1|||
170862626|NCT04765059|617505842|FG000|Overall Study|Death|25|||
170862627|NCT04765059|617505843|FG001|Overall Study|Death|28|||
170862628|NCT04765059|617505842|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
170862629|NCT04765059|617505843|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
170862630|NCT02656823|617505844|FG000|Overall Study|Adverse Event|3|||
170862631|NCT02656823|617505844|FG000|Overall Study|Lost to Follow-up|2|||
170862632|NCT05135000|617505845|FG000|Overall Study|Adverse Event|2|||
170862633|NCT05135000|617505846|FG001|Overall Study|Adverse Event|0|||
170862634|NCT05135000|617505845|FG000|Overall Study|Lost to Follow-up|1|||
170862635|NCT05135000|617505846|FG001|Overall Study|Lost to Follow-up|0|||
170862636|NCT05135000|617505845|FG000|Overall Study|Study Terminated by Sponsor|6|||
170862637|NCT05135000|617505846|FG001|Overall Study|Study Terminated by Sponsor|3|||
170862638|NCT02903368|617505847|FG000|Part 1|Adverse Event|3|||
170862639|NCT02903368|617505848|FG001|Part 1|Adverse Event|0|||
170862640|NCT02903368|617505849|FG002|Part 1|Adverse Event|0|||
170862641|NCT02903368|617505850|FG003|Part 1|Adverse Event|0|||
170402162|NCT04682639|615813352|FG004|OLE Period (28 Weeks)|Other|1|||
170862642|NCT02903368|617505847|FG000|Part 1|Withdrawal by Subject|1|||
170862643|NCT02903368|617505848|FG001|Part 1|Withdrawal by Subject|0|||
170862644|NCT02903368|617505849|FG002|Part 1|Withdrawal by Subject|0|||
170862645|NCT02903368|617505850|FG003|Part 1|Withdrawal by Subject|0|||
170862646|NCT02903368|617505847|FG000|Part 2|Adverse Event|0|||
170862647|NCT02903368|617505848|FG001|Part 2|Adverse Event|0|||
170862648|NCT02903368|617505849|FG002|Part 2|Adverse Event|5|||
170862649|NCT02903368|617505850|FG003|Part 2|Adverse Event|0|||
170862650|NCT02903368|617505847|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
170862651|NCT02903368|617505848|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
170862652|NCT02903368|617505849|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
170862653|NCT02903368|617505850|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
170862654|NCT02903368|617505847|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
170862655|NCT02903368|617505848|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
170862656|NCT02903368|617505849|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
170862657|NCT02903368|617505850|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
170862658|NCT02903368|617505847|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
170862659|NCT02903368|617505848|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
170862660|NCT02903368|617505849|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
170862661|NCT02903368|617505850|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
170862662|NCT01444651|617508387|FG000|Overall Study|Adverse Event|3|||
170862663|NCT01444651|617508388|FG001|Overall Study|Adverse Event|2|||
170862664|NCT01444651|617508387|FG000|Overall Study|Lost to Follow-up|5|||
170862665|NCT01444651|617508388|FG001|Overall Study|Lost to Follow-up|5|||
170862666|NCT01444651|617508387|FG000|Overall Study|Non-fasting|2|||
170862667|NCT01444651|617508388|FG001|Overall Study|Non-fasting|1|||
170862668|NCT01444651|617508387|FG000|Overall Study|Missing data|1|||
170862669|NCT01444651|617508388|FG001|Overall Study|Missing data|1|||
170862670|NCT01955122|617508389|FG000|Overall Study|Physician Decision|5|||
170862671|NCT01955122|617508390|FG001|Overall Study|Physician Decision|5|||
170862672|NCT01672788|617508391|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
170862673|NCT01672788|617508392|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
170862674|NCT01672788|617508393|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
170862675|NCT01672788|617508394|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
170862676|NCT03650400|617508397|FG000|Overall Study|Study terminated by sponsor|0|||
170862677|NCT03650400|617508398|FG001|Overall Study|Study terminated by sponsor|5|||
170862678|NCT01717989|617508402|FG000|Overall Study|Ineligibility determined|6|||
170862679|NCT01717989|617508402|FG000|Overall Study|Protocol deviation|6|||
170862680|NCT01717989|617508402|FG000|Overall Study|Withdrawal by Subject|11|||
170862681|NCT01717989|617508402|FG000|Overall Study|Physician Decision|2|||
170862682|NCT01717989|617508402|FG000|Overall Study|Lost to Follow-up|11|||
170862683|NCT01717989|617508402|FG000|Overall Study|Death|439|||
170862684|NCT01717989|617508402|FG000|Overall Study|Protocol-specified criteria|551|||
170862685|NCT01717989|617508402|FG000|Overall Study|Other|40|||
170862686|NCT02464228|617508403|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
170862687|NCT02464228|617508404|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
170862688|NCT02464228|617508405|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
170862689|NCT02464228|617508406|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
170862690|NCT02464228|617508403|FG000|Overall Study|Physician Decision|2|||
170862691|NCT02464228|617508404|FG001|Overall Study|Physician Decision|0|||
170862692|NCT02464228|617508405|FG002|Overall Study|Physician Decision|1|||
170862693|NCT02464228|617508406|FG003|Overall Study|Physician Decision|0|||
170862694|NCT02464228|617508403|FG000|Overall Study|Miscellaneous|1|||
170862695|NCT02464228|617508404|FG001|Overall Study|Miscellaneous|0|||
170862696|NCT02464228|617508405|FG002|Overall Study|Miscellaneous|1|||
170862697|NCT02464228|617508406|FG003|Overall Study|Miscellaneous|0|||
170862698|NCT02464228|617508403|FG000|Overall Study|Adverse Event|9|||
170862699|NCT02464228|617508404|FG001|Overall Study|Adverse Event|0|||
170862700|NCT02464228|617508405|FG002|Overall Study|Adverse Event|3|||
170862701|NCT02464228|617508406|FG003|Overall Study|Adverse Event|0|||
170862702|NCT02464228|617508403|FG000|Overall Study|Withdrawal by Subject|1|||
170862703|NCT02464228|617508404|FG001|Overall Study|Withdrawal by Subject|1|||
170862704|NCT02464228|617508405|FG002|Overall Study|Withdrawal by Subject|1|||
170862705|NCT02464228|617508406|FG003|Overall Study|Withdrawal by Subject|0|||
170862706|NCT02464228|617508403|FG000|Overall Study|Disease Progression|22|||
170862707|NCT02464228|617508404|FG001|Overall Study|Disease Progression|12|||
170862708|NCT02464228|617508405|FG002|Overall Study|Disease Progression|5|||
170862709|NCT02464228|617508406|FG003|Overall Study|Disease Progression|2|||
170862710|NCT02952001|617508411|FG000|Overall Study|Adverse Event|3|||
170862711|NCT02952001|617508412|FG001|Overall Study|Adverse Event|0|||
170862712|NCT02952001|617508411|FG000|Overall Study|Prohibited therapy|10|||
170862713|NCT02952001|617508412|FG001|Overall Study|Prohibited therapy|3|||
170862714|NCT02952001|617508411|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
170862715|NCT02952001|617508412|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
170750831|NCT00802841|617094235|FG000|Overall Study|Administrative problems|1|||
170750832|NCT00802841|617094236|FG001|Overall Study|Administrative problems|0|||
170750833|NCT00802841|617094235|FG000|Overall Study|Lost to Follow-up|2|||
170750834|NCT00802841|617094236|FG001|Overall Study|Lost to Follow-up|1|||
170750835|NCT00802841|617094235|FG000|Overall Study|Death|1|||
170750836|NCT00802841|617094236|FG001|Overall Study|Death|2|||
170750837|NCT00802841|617094235|FG000|Overall Study|Adverse Event|8|||
170750838|NCT00802841|617094236|FG001|Overall Study|Adverse Event|2|||
170750839|NCT00802841|617094235|FG000|Overall Study|Disease progression|7|||
170750840|NCT00802841|617094236|FG001|Overall Study|Disease progression|3|||
170750841|NCT00802841|617094235|FG000|Overall Study|Withdrawal by Subject|9|||
170750842|NCT00802841|617094236|FG001|Overall Study|Withdrawal by Subject|5|||
170750843|NCT00802841|617094235|FG000|Overall Study|Protocol deviation|2|||
170750844|NCT00802841|617094236|FG001|Overall Study|Protocol deviation|6|||
170750845|NCT00802841|617094235|FG000|Overall Study|Treatment duration completed|66|||
170750846|NCT00802841|617094236|FG001|Overall Study|Treatment duration completed|76|||
170750847|NCT00924664|617094242|FG000|Overall Study|Adverse Event|23|||
170750848|NCT00924664|617094243|FG001|Overall Study|Adverse Event|39|||
170750849|NCT00924664|617094242|FG000|Overall Study|Lack of Efficacy|10|||
170750850|NCT00924664|617094243|FG001|Overall Study|Lack of Efficacy|15|||
170750851|NCT00924664|617094242|FG000|Overall Study|Lost to Follow-up|10|||
170750852|NCT00924664|617094243|FG001|Overall Study|Lost to Follow-up|12|||
170750853|NCT00924664|617094242|FG000|Overall Study|Withdrawal by Subject|47|||
170750854|NCT00924664|617094243|FG001|Overall Study|Withdrawal by Subject|71|||
170750855|NCT00924664|617094242|FG000|Overall Study|Protocol Violation|2|||
170750856|NCT00924664|617094243|FG001|Overall Study|Protocol Violation|5|||
170750857|NCT00924664|617094242|FG000|Overall Study|Pregnancy|1|||
170750858|NCT00924664|617094243|FG001|Overall Study|Pregnancy|1|||
170750859|NCT00924664|617094242|FG000|Overall Study|Death|0|||
170750860|NCT00924664|617094243|FG001|Overall Study|Death|2|||
170750861|NCT00924664|617094242|FG000|Overall Study|Study terminated by sponsor|199|||
170750862|NCT00924664|617094243|FG001|Overall Study|Study terminated by sponsor|330|||
170750863|NCT00924664|617094242|FG000|Overall Study|Other|29|||
170750864|NCT00924664|617094243|FG001|Overall Study|Other|52|||
170750865|NCT00924664|617094242|FG000|Overall Study|Randomized but not Treated|1|||
170750866|NCT00924664|617094243|FG001|Overall Study|Randomized but not Treated|0|||
170750867|NCT05675709|617094245|FG000|Overall Study|incomplete outcome data|2|||
170750868|NCT05675709|617094246|FG001|Overall Study|incomplete outcome data|8|||
170750869|NCT01254565|617094249|FG000|Overall Study|Non-compliance to Study Procedures|0|||
170750870|NCT01254565|617094250|FG001|Overall Study|Non-compliance to Study Procedures|0|||
170750871|NCT01254565|617094251|FG002|Overall Study|Non-compliance to Study Procedures|0|||
170750872|NCT01254565|617094252|FG003|Overall Study|Non-compliance to Study Procedures|0|||
170750873|NCT01254565|617094253|FG004|Overall Study|Non-compliance to Study Procedures|1|||
170750874|NCT01254565|617094254|FG005|Overall Study|Non-compliance to Study Procedures|0|||
170750875|NCT01254565|617094249|FG000|Overall Study|Did not Receive Treatment|1|||
170750876|NCT01254565|617094250|FG001|Overall Study|Did not Receive Treatment|1|||
170750877|NCT01254565|617094251|FG002|Overall Study|Did not Receive Treatment|0|||
170750878|NCT01254565|617094252|FG003|Overall Study|Did not Receive Treatment|0|||
170750879|NCT01254565|617094253|FG004|Overall Study|Did not Receive Treatment|3|||
170750880|NCT01254565|617094254|FG005|Overall Study|Did not Receive Treatment|4|||
170750881|NCT01254565|617094249|FG000|Overall Study|Other|0|||
170750882|NCT01254565|617094250|FG001|Overall Study|Other|0|||
170750883|NCT01254565|617094251|FG002|Overall Study|Other|0|||
170750884|NCT01254565|617094252|FG003|Overall Study|Other|1|||
170750885|NCT01254565|617094253|FG004|Overall Study|Other|0|||
170750886|NCT01254565|617094254|FG005|Overall Study|Other|0|||
170750887|NCT03354637|617094259|FG000|Double-blind Period|Protocol Violation|2|||
170750888|NCT03354637|617094260|FG001|Double-blind Period|Protocol Violation|0|||
170750889|NCT03354637|617094261|FG002|Double-blind Period|Protocol Violation|0|||
170750890|NCT03354637|617094259|FG000|Double-blind Period|Adverse Event|1|||
170750891|NCT03354637|617094260|FG001|Double-blind Period|Adverse Event|2|||
170750892|NCT03354637|617094261|FG002|Double-blind Period|Adverse Event|0|||
170750893|NCT03354637|617094259|FG000|Double-blind Period|Lost to Follow-up|3|||
170750894|NCT03354637|617094260|FG001|Double-blind Period|Lost to Follow-up|4|||
170750895|NCT03354637|617094261|FG002|Double-blind Period|Lost to Follow-up|3|||
170750896|NCT03354637|617094259|FG000|Double-blind Period|Withdrawal by Subject|10|||
170750897|NCT03354637|617094260|FG001|Double-blind Period|Withdrawal by Subject|6|||
170750898|NCT03354637|617094261|FG002|Double-blind Period|Withdrawal by Subject|4|||
170750899|NCT03354637|617094259|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
170750900|NCT03354637|617094260|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
170750901|NCT03354637|617094261|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
170750902|NCT03354637|617094259|FG000|Open Label Extension|Adverse Event|0|||
170750903|NCT03354637|617094260|FG001|Open Label Extension|Adverse Event|0|||
170750904|NCT03354637|617094261|FG002|Open Label Extension|Adverse Event|1|||
170750905|NCT03354637|617094259|FG000|Open Label Extension|Lost to Follow-up|0|||
170750906|NCT03354637|617094260|FG001|Open Label Extension|Lost to Follow-up|0|||
170750907|NCT03354637|617094261|FG002|Open Label Extension|Lost to Follow-up|2|||
170750908|NCT03354637|617094259|FG000|Open Label Extension|Withdrawal by Subject|0|||
170862716|NCT01117454|617508413|FG000|Overall Study|Pregnancy|0|||
170862717|NCT01117454|617508414|FG001|Overall Study|Pregnancy|1|||
170862718|NCT01681628|617508415|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
170862719|NCT01681628|617508416|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
170862720|NCT01681628|617508415|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
170862721|NCT01681628|617508416|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
170862722|NCT01681628|617508415|FG000|19 Months Follow-up|Death|1|||
170862723|NCT01681628|617508416|FG001|19 Months Follow-up|Death|0|||
170862724|NCT01681628|617508415|FG000|19 Months Follow-up|Lost to Follow-up|61|||
170862725|NCT01681628|617508416|FG001|19 Months Follow-up|Lost to Follow-up|43|||
170862726|NCT05678959|617508419|FG000|Overall Study|Study Terminated by Sponsor|76|||
170862727|NCT05678959|617508420|FG001|Overall Study|Study Terminated by Sponsor|76|||
170862728|NCT05678959|617508419|FG000|Overall Study|Physician Decision|2|||
170862729|NCT05678959|617508420|FG001|Overall Study|Physician Decision|3|||
170862730|NCT05678959|617508419|FG000|Overall Study|Adverse Event|1|||
170862731|NCT05678959|617508420|FG001|Overall Study|Adverse Event|1|||
170862732|NCT05678959|617508419|FG000|Overall Study|Guardian Decision|1|||
170862733|NCT05678959|617508420|FG001|Overall Study|Guardian Decision|0|||
170862734|NCT05678959|617508419|FG000|Overall Study|Protocol Deviation|0|||
170862735|NCT05678959|617508420|FG001|Overall Study|Protocol Deviation|1|||
170862736|NCT05678959|617508419|FG000|Overall Study|Subject Decision|1|||
170862737|NCT05678959|617508420|FG001|Overall Study|Subject Decision|0|||
170862738|NCT05678959|617508419|FG000|Overall Study|Technical Problem|0|||
170862739|NCT05678959|617508420|FG001|Overall Study|Technical Problem|1|||
170862740|NCT02276872|617508421|FG000|Overall Study|Adverse Event|1|||
170862741|NCT02276872|617508422|FG001|Overall Study|Adverse Event|0|||
170862742|NCT02276872|617508423|FG002|Overall Study|Adverse Event|0|||
170862743|NCT04175808|617508424|FG000|Part A|Miscellaneous|2|||
170862744|NCT04175808|617508425|FG001|Part A|Miscellaneous|0|||
170862745|NCT04175808|617508426|FG002|Part A|Miscellaneous|0|||
170862746|NCT04175808|617508427|FG003|Part A|Miscellaneous|0|||
170862747|NCT04175808|617508428|FG004|Part A|Miscellaneous|0|||
170862748|NCT04175808|617508429|FG005|Part A|Miscellaneous|0|||
170862749|NCT04175808|617508430|FG006|Part A|Miscellaneous|0|||
170862750|NCT02544217|617508432|FG000|Overall Study|Withdrawal by Subject|1|||
170862751|NCT02544217|617508433|FG001|Overall Study|Withdrawal by Subject|1|||
170862752|NCT02544217|617508434|FG002|Overall Study|Withdrawal by Subject|0|||
170862753|NCT02544217|617508435|FG003|Overall Study|Withdrawal by Subject|0|||
170862754|NCT02544217|617508436|FG004|Overall Study|Withdrawal by Subject|0|||
170862755|NCT02544217|617508437|FG005|Overall Study|Withdrawal by Subject|0|||
170862756|NCT03226392|617508438|FG000|Overall Study|Protocol Deviation|1|||
170862757|NCT03226392|617508439|FG001|Overall Study|Protocol Deviation|0|||
170862758|NCT03226392|617508438|FG000|Overall Study|Physician Decision|1|||
170862759|NCT03226392|617508439|FG001|Overall Study|Physician Decision|0|||
170862760|NCT03226392|617508438|FG000|Overall Study|Lost to Follow-up|1|||
170862761|NCT03226392|617508439|FG001|Overall Study|Lost to Follow-up|0|||
170862762|NCT03226392|617508438|FG000|Overall Study|Adverse Event|1|||
170862763|NCT03226392|617508439|FG001|Overall Study|Adverse Event|0|||
170862764|NCT03226392|617508438|FG000|Overall Study|Technical Problems|0|||
170750909|NCT03354637|617094260|FG001|Open Label Extension|Withdrawal by Subject|0|||
170750910|NCT03354637|617094261|FG002|Open Label Extension|Withdrawal by Subject|5|||
170750911|NCT03354637|617094259|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
170750912|NCT03354637|617094260|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
170750913|NCT03354637|617094261|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
170750914|NCT03354637|617094259|FG000|Open Label Extension|Subject Noncompliance|0|||
170750915|NCT03354637|617094260|FG001|Open Label Extension|Subject Noncompliance|0|||
170750916|NCT03354637|617094261|FG002|Open Label Extension|Subject Noncompliance|1|||
170750917|NCT03354637|617094259|FG000|Open Label Extension|Lack of Efficacy|0|||
170750918|NCT03354637|617094260|FG001|Open Label Extension|Lack of Efficacy|0|||
170750919|NCT03354637|617094261|FG002|Open Label Extension|Lack of Efficacy|1|||
170750920|NCT03354637|617094259|FG000|Open Label Extension|Physician Decision|0|||
170750921|NCT03354637|617094260|FG001|Open Label Extension|Physician Decision|0|||
170750922|NCT03354637|617094261|FG002|Open Label Extension|Physician Decision|1|||
170750923|NCT01440049|617094266|FG000|Overall Study|Adverse Event|5|||
170750924|NCT02268552|617094267|FG000|Part 1|Death|1|||
170750925|NCT02268552|617094268|FG001|Part 1|Death|1|||
170750926|NCT02268552|617094269|FG002|Part 1|Death|1|||
170750927|NCT02268552|617094270|FG003|Part 1|Death|2|||
170750928|NCT02268552|617094271|FG004|Part 1|Death|0|||
170750929|NCT02268552|617094272|FG005|Part 1|Death|0|||
170862765|NCT03226392|617508439|FG001|Overall Study|Technical Problems|2|||
170862766|NCT03226392|617508438|FG000|Overall Study|Subject/Guardian Decision|7|||
170862767|NCT03226392|617508439|FG001|Overall Study|Subject/Guardian Decision|6|||
170750930|NCT02268552|617094273|FG006|Part 1|Death|0|||
170750931|NCT02268552|617094267|FG000|Part 1|Subject/guardian decision|0|||
170750932|NCT02268552|617094268|FG001|Part 1|Subject/guardian decision|0|||
170750933|NCT02268552|617094269|FG002|Part 1|Subject/guardian decision|0|||
170750934|NCT02268552|617094270|FG003|Part 1|Subject/guardian decision|1|||
170862768|NCT03056755|617508440|FG000|Core Phase|Progressive disease|89|||
170862769|NCT03056755|617508441|FG001|Core Phase|Progressive disease|88|||
170862770|NCT03056755|617508442|FG002|Core Phase|Progressive disease|90|||
170862771|NCT03056755|617508440|FG000|Core Phase|Adverse Event|20|||
170862772|NCT03056755|617508441|FG001|Core Phase|Adverse Event|14|||
170862773|NCT03056755|617508442|FG002|Core Phase|Adverse Event|13|||
170862774|NCT03056755|617508440|FG000|Core Phase|Physician Decision|7|||
170862775|NCT03056755|617508441|FG001|Core Phase|Physician Decision|13|||
170862776|NCT03056755|617508442|FG002|Core Phase|Physician Decision|5|||
170862777|NCT03056755|617508440|FG000|Core Phase|Subject/guardian decision|5|||
170862778|NCT03056755|617508441|FG001|Core Phase|Subject/guardian decision|8|||
170862779|NCT03056755|617508442|FG002|Core Phase|Subject/guardian decision|4|||
170862780|NCT03056755|617508440|FG000|Core Phase|Death|3|||
170862781|NCT03056755|617508441|FG001|Core Phase|Death|2|||
170862782|NCT03056755|617508442|FG002|Core Phase|Death|4|||
170862783|NCT03056755|617508440|FG000|Core Phase|Protocol deviation|1|||
170862784|NCT03056755|617508441|FG001|Core Phase|Protocol deviation|1|||
170862785|NCT03056755|617508442|FG002|Core Phase|Protocol deviation|0|||
170862786|NCT03056755|617508440|FG000|Core Phase|Technical problems|1|||
170862787|NCT03056755|617508441|FG001|Core Phase|Technical problems|0|||
170862788|NCT03056755|617508442|FG002|Core Phase|Technical problems|0|||
170862789|NCT03056755|617508440|FG000|Extension Phase|Physician Decision|1|||
170862790|NCT03056755|617508441|FG001|Extension Phase|Physician Decision|0|||
170862791|NCT03056755|617508442|FG002|Extension Phase|Physician Decision|3|||
170862792|NCT03056755|617508440|FG000|Extension Phase|Adverse Event|0|||
170862793|NCT03056755|617508441|FG001|Extension Phase|Adverse Event|0|||
170862794|NCT03056755|617508442|FG002|Extension Phase|Adverse Event|1|||
170862795|NCT03056755|617508440|FG000|Extension Phase|Subject/guardian decision|0|||
170862796|NCT03056755|617508441|FG001|Extension Phase|Subject/guardian decision|0|||
170862797|NCT03056755|617508442|FG002|Extension Phase|Subject/guardian decision|1|||
170862798|NCT00402363|617508443|FG000|Overall Study|Adverse Event|9|||
170862799|NCT00402363|617508444|FG001|Overall Study|Adverse Event|14|||
170862800|NCT00402363|617508445|FG002|Overall Study|Adverse Event|2|||
170862801|NCT00402363|617508446|FG003|Overall Study|Adverse Event|2|||
170862802|NCT00402363|617508443|FG000|Overall Study|Withdrew Consent|10|||
170862803|NCT00402363|617508444|FG001|Overall Study|Withdrew Consent|5|||
170862804|NCT00402363|617508445|FG002|Overall Study|Withdrew Consent|2|||
170862805|NCT00402363|617508446|FG003|Overall Study|Withdrew Consent|1|||
170862806|NCT00402363|617508443|FG000|Overall Study|Protocol Violation|3|||
170862807|NCT00402363|617508444|FG001|Overall Study|Protocol Violation|5|||
170862808|NCT00402363|617508445|FG002|Overall Study|Protocol Violation|0|||
170862809|NCT00402363|617508446|FG003|Overall Study|Protocol Violation|3|||
170862810|NCT00402363|617508443|FG000|Overall Study|Lost to Follow-up|5|||
170862811|NCT00402363|617508444|FG001|Overall Study|Lost to Follow-up|4|||
170862812|NCT00402363|617508445|FG002|Overall Study|Lost to Follow-up|0|||
170862813|NCT00402363|617508446|FG003|Overall Study|Lost to Follow-up|2|||
170862814|NCT00402363|617508443|FG000|Overall Study|"Captured as Other"|6|||
170862815|NCT00402363|617508444|FG001|Overall Study|"Captured as Other"|2|||
170862816|NCT00402363|617508445|FG002|Overall Study|"Captured as Other"|2|||
170862817|NCT00402363|617508446|FG003|Overall Study|"Captured as Other"|2|||
170862818|NCT04667949|617508454|FG000|Overall Study|Adverse Event|0|||
170862819|NCT04667949|617508455|FG001|Overall Study|Adverse Event|2|||
170862820|NCT04667949|617508454|FG000|Overall Study|Lost to Follow-up|0|||
170862821|NCT04667949|617508455|FG001|Overall Study|Lost to Follow-up|1|||
170862822|NCT04667949|617508454|FG000|Overall Study|Physician Decision|0|||
170862823|NCT04667949|617508455|FG001|Overall Study|Physician Decision|2|||
170862824|NCT04667949|617508454|FG000|Overall Study|Subject decision|1|||
170862825|NCT04667949|617508455|FG001|Overall Study|Subject decision|7|||
170862826|NCT04504630|617508456|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
170862827|NCT04504630|617508457|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
170862828|NCT04504630|617508456|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
170862829|NCT04504630|617508457|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
170862830|NCT00937833|617508458|FG000|Overall Study|Protocol Violation|1|||
170862831|NCT00937833|617508459|FG001|Overall Study|Protocol Violation|2|||
170862832|NCT00937833|617508458|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
170862833|NCT00937833|617508459|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
170862834|NCT00937833|617508458|FG000|Overall Study|Lost to Follow-up|10|||
170862835|NCT00937833|617508459|FG001|Overall Study|Lost to Follow-up|8|||
170862836|NCT00937833|617508458|FG000|Overall Study|Withdrawal by Subject|4|||
170862837|NCT00937833|617508459|FG001|Overall Study|Withdrawal by Subject|6|||
170862838|NCT04266301|617508460|FG000|Overall Study|Progressive Disease|111|||
170862839|NCT04266301|617508461|FG001|Overall Study|Progressive Disease|92|||
170862840|NCT04266301|617508460|FG000|Overall Study|Adverse Event|41|||
170862841|NCT04266301|617508461|FG001|Overall Study|Adverse Event|43|||
170862842|NCT04266301|617508460|FG000|Overall Study|Death|26|||
170862843|NCT04266301|617508461|FG001|Overall Study|Death|35|||
170862844|NCT04266301|617508460|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
170862845|NCT04266301|617508461|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
170862846|NCT04266301|617508460|FG000|Overall Study|Study Terminated by Sponsor|22|||
170862847|NCT04266301|617508461|FG001|Overall Study|Study Terminated by Sponsor|27|||
170862848|NCT04266301|617508460|FG000|Overall Study|Participant Decision|22|||
170862849|NCT04266301|617508461|FG001|Overall Study|Participant Decision|28|||
170862850|NCT04266301|617508460|FG000|Overall Study|Physician Decision|14|||
170862851|NCT04266301|617508461|FG001|Overall Study|Physician Decision|9|||
170862852|NCT04266301|617508460|FG000|Overall Study|New Therapy for Study Indication|2|||
170862853|NCT04266301|617508461|FG001|Overall Study|New Therapy for Study Indication|4|||
170862854|NCT04266301|617508460|FG000|Overall Study|Protocol Deviation|2|||
170862855|NCT04266301|617508461|FG001|Overall Study|Protocol Deviation|4|||
170862856|NCT04266301|617508460|FG000|Overall Study|Guardian Decision|1|||
170862857|NCT04266301|617508461|FG001|Overall Study|Guardian Decision|0|||
170862858|NCT04266301|617508460|FG000|Overall Study|Lost to Follow-up|1|||
170862859|NCT04266301|617508461|FG001|Overall Study|Lost to Follow-up|0|||
170862860|NCT04266301|617508460|FG000|Overall Study|Participants Not Treated|1|||
170862861|NCT04266301|617508461|FG001|Overall Study|Participants Not Treated|1|||
170862862|NCT02175004|617508463|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
170862863|NCT02175004|617508464|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
170862864|NCT02175004|617508463|FG000|Overall Study|Investigator Judgment|1|||
170862865|NCT02175004|617508464|FG001|Overall Study|Investigator Judgment|4|||
170862866|NCT02175004|617508463|FG000|Overall Study|Voluntary Withdrawal|6|||
170862867|NCT02175004|617508464|FG001|Overall Study|Voluntary Withdrawal|19|||
170862868|NCT02175004|617508463|FG000|Overall Study|Liver Transplant|1|||
170862869|NCT02175004|617508464|FG001|Overall Study|Liver Transplant|0|||
170862870|NCT02175004|617508463|FG000|Overall Study|Disease Progression|1|||
170862871|NCT02175004|617508464|FG001|Overall Study|Disease Progression|0|||
170862872|NCT02175004|617508463|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
170862873|NCT02175004|617508464|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
170862874|NCT01369511|617508465|FG000|Overall Study|Adverse Event|1|||
170862875|NCT01369511|617508466|FG001|Overall Study|Adverse Event|1|||
170862876|NCT01369511|617508467|FG002|Overall Study|Adverse Event|5|||
170862877|NCT01369511|617508468|FG003|Overall Study|Adverse Event|0|||
170862878|NCT01369511|617508465|FG000|Overall Study|Entry criteria not met|2|||
170862879|NCT01369511|617508466|FG001|Overall Study|Entry criteria not met|0|||
170862880|NCT01369511|617508467|FG002|Overall Study|Entry criteria not met|0|||
170862881|NCT01369511|617508468|FG003|Overall Study|Entry criteria not met|1|||
170862882|NCT01369511|617508465|FG000|Overall Study|Lost to Follow-up|0|||
170862883|NCT01369511|617508466|FG001|Overall Study|Lost to Follow-up|1|||
170862884|NCT01369511|617508467|FG002|Overall Study|Lost to Follow-up|1|||
170862885|NCT01369511|617508468|FG003|Overall Study|Lost to Follow-up|2|||
170862886|NCT01369511|617508465|FG000|Overall Study|Protocol Violation|0|||
170862887|NCT01369511|617508466|FG001|Overall Study|Protocol Violation|1|||
170862888|NCT01369511|617508467|FG002|Overall Study|Protocol Violation|0|||
170862889|NCT01369511|617508468|FG003|Overall Study|Protocol Violation|2|||
170862890|NCT01369511|617508465|FG000|Overall Study|Physician Decision|3|||
170862891|NCT01369511|617508466|FG001|Overall Study|Physician Decision|4|||
170862892|NCT01369511|617508467|FG002|Overall Study|Physician Decision|0|||
170862893|NCT01369511|617508468|FG003|Overall Study|Physician Decision|0|||
170862894|NCT01369511|617508465|FG000|Overall Study|Sponsor decision|2|||
170862895|NCT01369511|617508466|FG001|Overall Study|Sponsor decision|0|||
170862896|NCT01369511|617508467|FG002|Overall Study|Sponsor decision|1|||
170862897|NCT01369511|617508468|FG003|Overall Study|Sponsor decision|0|||
170862898|NCT01369511|617508465|FG000|Overall Study|Withdrawal by Subject|5|||
170862899|NCT01369511|617508466|FG001|Overall Study|Withdrawal by Subject|6|||
170862900|NCT01369511|617508467|FG002|Overall Study|Withdrawal by Subject|4|||
170862901|NCT01369511|617508468|FG003|Overall Study|Withdrawal by Subject|6|||
170862902|NCT01137955|617508473|FG000|Overall Study|Withdrawal by Subject|5|||
170862903|NCT01137955|617508474|FG001|Overall Study|Withdrawal by Subject|4|||
170862904|NCT04263909|617508481|FG000|Overall Study|Physician Decision|1|||
170862905|NCT04263909|617508482|FG001|Overall Study|Physician Decision|0|||
170862906|NCT04263909|617508483|FG002|Overall Study|Physician Decision|0|||
170862907|NCT04263909|617508481|FG000|Overall Study|Adverse Event|3|||
170862908|NCT04263909|617508482|FG001|Overall Study|Adverse Event|0|||
170862909|NCT04263909|617508483|FG002|Overall Study|Adverse Event|0|||
170862910|NCT04263909|617508481|FG000|Overall Study|Protocol Violation|5|||
170862911|NCT04263909|617508482|FG001|Overall Study|Protocol Violation|0|||
170862912|NCT04263909|617508483|FG002|Overall Study|Protocol Violation|0|||
170862913|NCT05630001|617508484|FG000|Overall Study|Adverse Event|1|||
170862914|NCT05386680|617508485|FG000|Overall Study|Guardian decision|2|||
170862915|NCT03946670|617508486|FG000|Overall Study|Progressive Disease|34|||
170862916|NCT03946670|617508487|FG001|Overall Study|Progressive Disease|27|||
170862917|NCT03946670|617508486|FG000|Overall Study|Adverse Event|7|||
170862918|NCT03946670|617508487|FG001|Overall Study|Adverse Event|10|||
170862919|NCT03946670|617508486|FG000|Overall Study|Physician Decision|6|||
170862920|NCT03946670|617508487|FG001|Overall Study|Physician Decision|5|||
170862921|NCT03946670|617508486|FG000|Overall Study|Death|5|||
170862922|NCT03946670|617508487|FG001|Overall Study|Death|8|||
170862923|NCT03946670|617508486|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
170862924|NCT03946670|617508487|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
170862925|NCT03946670|617508486|FG000|Overall Study|Subject Decision|4|||
170862926|NCT03946670|617508487|FG001|Overall Study|Subject Decision|5|||
170862927|NCT03946670|617508486|FG000|Overall Study|Study Terminated By Sponsor|2|||
170862928|NCT03946670|617508487|FG001|Overall Study|Study Terminated By Sponsor|0|||
170862929|NCT03946670|617508486|FG000|Overall Study|New Therapy For Study Indication|1|||
170862930|NCT03946670|617508487|FG001|Overall Study|New Therapy For Study Indication|0|||
170862931|NCT03946670|617508486|FG000|Overall Study|Not Treated|1|||
170862932|NCT03946670|617508487|FG001|Overall Study|Not Treated|1|||
170862933|NCT02027701|617508490|FG000|Overall Study|Adverse Event|3|||
170862934|NCT02027701|617508490|FG000|Overall Study|Lack of Efficacy|8|||
170862935|NCT02027701|617508490|FG000|Overall Study|Physician Decision|2|||
170862936|NCT02027701|617508490|FG000|Overall Study|Withdrawal by Subject|3|||
170862937|NCT02875977|617508491|FG000|Overall Study|Lost to Follow-up|42|||
170862938|NCT02875977|617508492|FG001|Overall Study|Lost to Follow-up|29|||
170862939|NCT00820027|617508493|FG000|Overall Study|Adverse Event|15|||
170862940|NCT00820027|617508494|FG001|Overall Study|Adverse Event|8|||
170862941|NCT00820027|617508495|FG002|Overall Study|Adverse Event|10|||
170862942|NCT00820027|617508496|FG003|Overall Study|Adverse Event|5|||
170862943|NCT00820027|617508493|FG000|Overall Study|Lack of Efficacy|2|||
170862944|NCT00820027|617508494|FG001|Overall Study|Lack of Efficacy|1|||
170862945|NCT00820027|617508495|FG002|Overall Study|Lack of Efficacy|2|||
170862946|NCT00820027|617508496|FG003|Overall Study|Lack of Efficacy|2|||
170862947|NCT00820027|617508493|FG000|Overall Study|Physician Decision|0|||
170862948|NCT00820027|617508494|FG001|Overall Study|Physician Decision|1|||
170862949|NCT00820027|617508495|FG002|Overall Study|Physician Decision|1|||
170862950|NCT00820027|617508496|FG003|Overall Study|Physician Decision|0|||
170862951|NCT00820027|617508493|FG000|Overall Study|Protocol Violation|3|||
170862952|NCT00820027|617508494|FG001|Overall Study|Protocol Violation|0|||
170862953|NCT00820027|617508495|FG002|Overall Study|Protocol Violation|4|||
170862954|NCT00820027|617508496|FG003|Overall Study|Protocol Violation|0|||
170862955|NCT00820027|617508493|FG000|Overall Study|Withdrawal by Subject|6|||
170862956|NCT00820027|617508494|FG001|Overall Study|Withdrawal by Subject|4|||
170862957|NCT00820027|617508495|FG002|Overall Study|Withdrawal by Subject|4|||
170862958|NCT00820027|617508496|FG003|Overall Study|Withdrawal by Subject|6|||
170862959|NCT01230788|617508503|FG000|Overall Study|Prescribed exclusion drug|1|||
170862960|NCT01142596|617508504|FG000|Overall Study|Withdrawal by Subject|9|||
170862961|NCT01142596|617508505|FG001|Overall Study|Withdrawal by Subject|35|||
170862962|NCT01142596|617508504|FG000|Overall Study|Adverse Event|8|||
170862963|NCT01142596|617508505|FG001|Overall Study|Adverse Event|35|||
170862964|NCT01142596|617508504|FG000|Overall Study|Lack of Efficacy|5|||
170862965|NCT01142596|617508505|FG001|Overall Study|Lack of Efficacy|9|||
170862966|NCT01142596|617508504|FG000|Overall Study|Lost to Follow-up|2|||
170862967|NCT01142596|617508505|FG001|Overall Study|Lost to Follow-up|3|||
170862968|NCT01142596|617508504|FG000|Overall Study|Other reason (not specified)|5|||
170862969|NCT01142596|617508505|FG001|Overall Study|Other reason (not specified)|4|||
170862970|NCT01294683|617508506|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
170862971|NCT01294683|617508507|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
170862972|NCT01294683|617508506|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
170862973|NCT01294683|617508507|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
170862974|NCT01294683|617508506|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
170862975|NCT01294683|617508507|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
170862976|NCT01294683|617508506|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
170862977|NCT01294683|617508507|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
170862978|NCT01294683|617508506|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
170862979|NCT01294683|617508507|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
170862980|NCT01294683|617508506|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
170862981|NCT01294683|617508507|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
170862982|NCT01294683|617508506|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
170862983|NCT01294683|617508507|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
170862984|NCT01294683|617508506|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
170862985|NCT01294683|617508507|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
170862986|NCT01294683|617508506|FG000|Post Crossover (Period III)|Adverse Event|6|||
170862987|NCT01294683|617508507|FG001|Post Crossover (Period III)|Adverse Event|6|||
170862988|NCT01294683|617508506|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
170862989|NCT01294683|617508507|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
170862990|NCT01294683|617508506|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
170862991|NCT01294683|617508507|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
170862992|NCT01294683|617508506|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
170862993|NCT01294683|617508507|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
170862994|NCT01794923|617508508|FG000|Overall Study|Adverse Event|0|||
170862995|NCT01794923|617508509|FG001|Overall Study|Adverse Event|0|||
170862996|NCT01794923|617508510|FG002|Overall Study|Adverse Event|1|||
170862997|NCT03370471|617508511|FG000|Overall Study|Withdrawal by Subject|6|||
170862998|NCT03370471|617508512|FG001|Overall Study|Withdrawal by Subject|1|||
170862999|NCT03370471|617508511|FG000|Overall Study|Unable to access veins for blood draw|0|||
170863000|NCT03370471|617508512|FG001|Overall Study|Unable to access veins for blood draw|1|||
170863001|NCT03370471|617508511|FG000|Overall Study|Screen fail|1|||
170863002|NCT03370471|617508512|FG001|Overall Study|Screen fail|0|||
170863003|NCT01765179|617508514|FG000|Overall Study|Adverse Event|3|||
170863004|NCT01765179|617508514|FG000|Overall Study|Lost to Follow-up|5|||
170863005|NCT01765179|617508514|FG000|Overall Study|Non-compliance with study drug|2|||
170863006|NCT01765179|617508514|FG000|Overall Study|Protocol Violation|1|||
170863007|NCT01765179|617508514|FG000|Overall Study|Withdrawal by Subject|8|||
170863008|NCT01765179|617508514|FG000|Overall Study|Hematocrit >54%|3|||
170863009|NCT01765179|617508514|FG000|Overall Study|prohibited med|1|||
170863010|NCT01765179|617508514|FG000|Overall Study|Out of country unable to finish study|1|||
170863011|NCT01765179|617508514|FG000|Overall Study|lack of venous access|1|||
170863012|NCT01765179|617508514|FG000|Overall Study|work conflict|1|||
170863013|NCT01765179|617508514|FG000|Overall Study|Ca elevated 10.6|1|||
170863014|NCT00710021|617508515|FG000|Overall Study|Lost to Follow-up|1|||
170863015|NCT00710021|617508516|FG001|Overall Study|Lost to Follow-up|0|||
170863016|NCT00710021|617508517|FG002|Overall Study|Lost to Follow-up|0|||
170863017|NCT00710021|617508515|FG000|Overall Study|Subject's Decision|0|||
170863018|NCT00710021|617508516|FG001|Overall Study|Subject's Decision|1|||
170863019|NCT00710021|617508517|FG002|Overall Study|Subject's Decision|0|||
170863020|NCT00710021|617508515|FG000|Overall Study|Subject misrandomized|0|||
170863021|NCT00710021|617508516|FG001|Overall Study|Subject misrandomized|1|||
170863022|NCT00710021|617508517|FG002|Overall Study|Subject misrandomized|1|||
170863023|NCT00710021|617508515|FG000|Overall Study|Physician Decision|0|||
170863024|NCT00710021|617508516|FG001|Overall Study|Physician Decision|1|||
170863025|NCT00710021|617508517|FG002|Overall Study|Physician Decision|0|||
170863026|NCT04526197|617508521|FG000|Period 1|Adverse Event|0|||
170750935|NCT02268552|617094271|FG004|Part 1|Subject/guardian decision|0|||
170750936|NCT02268552|617094272|FG005|Part 1|Subject/guardian decision|0|||
170750937|NCT02268552|617094273|FG006|Part 1|Subject/guardian decision|0|||
170750938|NCT02268552|617094267|FG000|Part 2|Death|0|||
170750939|NCT02268552|617094268|FG001|Part 2|Death|0|||
170750940|NCT02268552|617094269|FG002|Part 2|Death|0|||
170750941|NCT02268552|617094270|FG003|Part 2|Death|0|||
170750942|NCT02268552|617094271|FG004|Part 2|Death|0|||
170750943|NCT02268552|617094272|FG005|Part 2|Death|0|||
170750944|NCT02268552|617094273|FG006|Part 2|Death|2|||
170750945|NCT02268552|617094267|FG000|Part 2|Subject/guardian decision|0|||
170750946|NCT02268552|617094268|FG001|Part 2|Subject/guardian decision|0|||
170750947|NCT02268552|617094269|FG002|Part 2|Subject/guardian decision|0|||
170750948|NCT02268552|617094270|FG003|Part 2|Subject/guardian decision|0|||
170750949|NCT02268552|617094271|FG004|Part 2|Subject/guardian decision|0|||
170750950|NCT02268552|617094272|FG005|Part 2|Subject/guardian decision|0|||
170750951|NCT02268552|617094273|FG006|Part 2|Subject/guardian decision|1|||
170750952|NCT02268552|617094267|FG000|Part 3 Extension|Death|0|||
170750953|NCT02268552|617094268|FG001|Part 3 Extension|Death|1|||
170750954|NCT02268552|617094269|FG002|Part 3 Extension|Death|1|||
170750955|NCT02268552|617094270|FG003|Part 3 Extension|Death|1|||
170750956|NCT02268552|617094271|FG004|Part 3 Extension|Death|1|||
170750957|NCT02268552|617094272|FG005|Part 3 Extension|Death|1|||
170750958|NCT02268552|617094273|FG006|Part 3 Extension|Death|0|||
170750959|NCT02268552|617094267|FG000|Part 3 Extension|Early termination of trial|1|||
170750960|NCT02268552|617094268|FG001|Part 3 Extension|Early termination of trial|0|||
170750961|NCT02268552|617094269|FG002|Part 3 Extension|Early termination of trial|0|||
170750962|NCT02268552|617094270|FG003|Part 3 Extension|Early termination of trial|0|||
170750963|NCT02268552|617094271|FG004|Part 3 Extension|Early termination of trial|2|||
170750964|NCT02268552|617094272|FG005|Part 3 Extension|Early termination of trial|9|||
170750965|NCT02268552|617094273|FG006|Part 3 Extension|Early termination of trial|11|||
170750966|NCT02268552|617094267|FG000|Part 3 Extension|Subject/guardian decision|0|||
170750967|NCT02268552|617094268|FG001|Part 3 Extension|Subject/guardian decision|0|||
170750968|NCT02268552|617094269|FG002|Part 3 Extension|Subject/guardian decision|0|||
170750969|NCT02268552|617094270|FG003|Part 3 Extension|Subject/guardian decision|0|||
170863027|NCT04526197|617508522|FG001|Period 1|Adverse Event|1|||
170863028|NCT04526197|617508521|FG000|Period 1|Withdrawal by Subject|1|||
170863029|NCT04526197|617508522|FG001|Period 1|Withdrawal by Subject|0|||
170863030|NCT04526197|617508521|FG000|Period 2|Adverse Event|0|||
170863031|NCT04526197|617508522|FG001|Period 2|Adverse Event|1|||
170750970|NCT02268552|617094271|FG004|Part 3 Extension|Subject/guardian decision|0|||
170863032|NCT04526197|617508521|FG000|Period 2|Withdrawal by Subject|0|||
170863033|NCT04526197|617508522|FG001|Period 2|Withdrawal by Subject|1|||
170750971|NCT02268552|617094272|FG005|Part 3 Extension|Subject/guardian decision|0|||
170750972|NCT02268552|617094273|FG006|Part 3 Extension|Subject/guardian decision|1|||
170750973|NCT04168385|617094275|FG000|Overall Study|Withdrawal by Subject|1|||
170750974|NCT04168385|617094276|FG001|Overall Study|Withdrawal by Subject|0|||
170750975|NCT04168385|617094275|FG000|Overall Study|Adverse Event|2|||
170863034|NCT02910739|617508523|FG000|Overall Study|Adverse Event|1|||
170863035|NCT02910739|617508524|FG001|Overall Study|Adverse Event|0|||
170863036|NCT02910739|617508525|FG002|Overall Study|Adverse Event|0|||
170750976|NCT04168385|617094276|FG001|Overall Study|Adverse Event|1|||
170750977|NCT04168385|617094275|FG000|Overall Study|Liver transplant|3|||
170863037|NCT02910739|617508526|FG003|Overall Study|Adverse Event|0|||
170863038|NCT02577029|617508529|FG000|Overall Study|Adverse Event|1|||
170863039|NCT02577029|617508530|FG001|Overall Study|Adverse Event|0|||
170863040|NCT02577029|617508531|FG002|Overall Study|Adverse Event|2|||
170863041|NCT02577029|617508532|FG003|Overall Study|Adverse Event|0|||
170863042|NCT02577029|617508533|FG004|Overall Study|Adverse Event|1|||
170863043|NCT02577029|617508534|FG005|Overall Study|Adverse Event|0|||
170863044|NCT02577029|617508535|FG006|Overall Study|Adverse Event|0|||
170863045|NCT02577029|617508536|FG007|Overall Study|Adverse Event|0|||
170863046|NCT02577029|617508529|FG000|Overall Study|Withdrawal by Subject|0|||
170863047|NCT02577029|617508530|FG001|Overall Study|Withdrawal by Subject|0|||
170863048|NCT02577029|617508531|FG002|Overall Study|Withdrawal by Subject|0|||
170863049|NCT02577029|617508532|FG003|Overall Study|Withdrawal by Subject|0|||
170863050|NCT02577029|617508533|FG004|Overall Study|Withdrawal by Subject|0|||
170863051|NCT02577029|617508534|FG005|Overall Study|Withdrawal by Subject|1|||
170863052|NCT02577029|617508535|FG006|Overall Study|Withdrawal by Subject|0|||
170863053|NCT02577029|617508536|FG007|Overall Study|Withdrawal by Subject|0|||
170863054|NCT02577029|617508529|FG000|Overall Study|Sponsor Termination of the Study|9|||
170863055|NCT02577029|617508530|FG001|Overall Study|Sponsor Termination of the Study|2|||
170863056|NCT02577029|617508531|FG002|Overall Study|Sponsor Termination of the Study|5|||
170863057|NCT02577029|617508532|FG003|Overall Study|Sponsor Termination of the Study|12|||
170863058|NCT02577029|617508533|FG004|Overall Study|Sponsor Termination of the Study|10|||
170863059|NCT02577029|617508534|FG005|Overall Study|Sponsor Termination of the Study|12|||
170863060|NCT02577029|617508535|FG006|Overall Study|Sponsor Termination of the Study|12|||
170863061|NCT02577029|617508536|FG007|Overall Study|Sponsor Termination of the Study|12|||
170863062|NCT03338192|617509501|FG000|Year One to Year Two|High Blood Pressure|7|||
170863063|NCT03338192|617509502|FG001|Year One to Year Two|High Blood Pressure|1|||
170863064|NCT03338192|617509501|FG000|Year One to Year Two|HIV +|1|||
170863065|NCT03338192|617509502|FG001|Year One to Year Two|HIV +|0|||
170863066|NCT03338192|617509501|FG000|Year Two to Year Four|High Blood Pressure|1|||
170863067|NCT03338192|617509502|FG001|Year Two to Year Four|High Blood Pressure|0|||
170863068|NCT03338192|617509501|FG000|Year Two to Year Four|HIV +|2|||
170863069|NCT03338192|617509502|FG001|Year Two to Year Four|HIV +|0|||
170863070|NCT03338192|617509501|FG000|Year Four to Year Six|High Blood Pressure|2|||
170863071|NCT03338192|617509502|FG001|Year Four to Year Six|High Blood Pressure|1|||
170863072|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
170863073|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
170863074|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
170863075|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
170863076|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
170863077|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
170863078|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
170863079|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
170863080|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
170863081|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
170863082|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
170863083|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
170863084|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Death|3|||
170863085|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Death|1|||
170863086|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
170863087|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
170863088|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Adverse Event|7|||
170863089|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Adverse Event|8|||
170863090|NCT03236246|617509503|FG000|24-Week Dose Titration Period|Captured as Other|1|||
170863091|NCT03236246|617509504|FG001|24-Week Dose Titration Period|Captured as Other|2|||
170863092|NCT03236246|617509503|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
170863093|NCT03236246|617509504|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
170863094|NCT03236246|617509503|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
170863095|NCT03236246|617509504|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
170863096|NCT03236246|617509503|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
170863097|NCT03236246|617509504|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
170863098|NCT03236246|617509503|FG000|24-Week Dose Maintenance Period|Death|0|||
170863099|NCT03236246|617509504|FG001|24-Week Dose Maintenance Period|Death|1|||
170863100|NCT03236246|617509503|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
170863101|NCT03236246|617509504|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
170863102|NCT01794520|617509511|FG000|Overall Study|Adverse events- related to progression|0|||
170863103|NCT01794520|617509512|FG001|Overall Study|Adverse events- related to progression|0|||
170863104|NCT01794520|617509513|FG002|Overall Study|Adverse events- related to progression|1|||
170863105|NCT01794520|617509514|FG003|Overall Study|Adverse events- related to progression|2|||
170863106|NCT01794520|617509515|FG004|Overall Study|Adverse events- related to progression|0|||
170863107|NCT01794520|617509516|FG005|Overall Study|Adverse events- related to progression|1|||
170863108|NCT01794520|617509517|FG006|Overall Study|Adverse events- related to progression|0|||
170863109|NCT01794520|617509511|FG000|Overall Study|Adverse event- not related to progression|1|||
170863110|NCT01794520|617509512|FG001|Overall Study|Adverse event- not related to progression|1|||
170863111|NCT01794520|617509513|FG002|Overall Study|Adverse event- not related to progression|0|||
170863112|NCT01794520|617509514|FG003|Overall Study|Adverse event- not related to progression|0|||
170863113|NCT01794520|617509515|FG004|Overall Study|Adverse event- not related to progression|2|||
170863114|NCT01794520|617509516|FG005|Overall Study|Adverse event- not related to progression|0|||
170863115|NCT01794520|617509517|FG006|Overall Study|Adverse event- not related to progression|0|||
170863116|NCT01794520|617509511|FG000|Overall Study|Progressive disease|5|||
170863117|NCT01794520|617509512|FG001|Overall Study|Progressive disease|6|||
170863118|NCT01794520|617509513|FG002|Overall Study|Progressive disease|2|||
170863119|NCT01794520|617509514|FG003|Overall Study|Progressive disease|5|||
170863120|NCT01794520|617509515|FG004|Overall Study|Progressive disease|27|||
170863121|NCT01794520|617509516|FG005|Overall Study|Progressive disease|18|||
170863122|NCT01794520|617509517|FG006|Overall Study|Progressive disease|0|||
170863123|NCT01794520|617509511|FG000|Overall Study|Withdrew consent|0|||
170863124|NCT01794520|617509512|FG001|Overall Study|Withdrew consent|0|||
170863125|NCT01794520|617509513|FG002|Overall Study|Withdrew consent|1|||
170863126|NCT01794520|617509514|FG003|Overall Study|Withdrew consent|1|||
170863127|NCT01794520|617509515|FG004|Overall Study|Withdrew consent|0|||
170863128|NCT01794520|617509516|FG005|Overall Study|Withdrew consent|0|||
170863129|NCT01794520|617509517|FG006|Overall Study|Withdrew consent|0|||
170863130|NCT01794520|617509511|FG000|Overall Study|Lost to Follow-up|0|||
170863131|NCT01794520|617509512|FG001|Overall Study|Lost to Follow-up|0|||
170863132|NCT01794520|617509513|FG002|Overall Study|Lost to Follow-up|0|||
170863133|NCT01794520|617509514|FG003|Overall Study|Lost to Follow-up|0|||
170863134|NCT01794520|617509515|FG004|Overall Study|Lost to Follow-up|1|||
170863135|NCT01794520|617509516|FG005|Overall Study|Lost to Follow-up|0|||
170863136|NCT01794520|617509517|FG006|Overall Study|Lost to Follow-up|0|||
170863137|NCT01794520|617509511|FG000|Overall Study|Toxicity|0|||
170863138|NCT01794520|617509512|FG001|Overall Study|Toxicity|2|||
170863139|NCT01794520|617509513|FG002|Overall Study|Toxicity|0|||
170863140|NCT01794520|617509514|FG003|Overall Study|Toxicity|0|||
170863141|NCT01794520|617509515|FG004|Overall Study|Toxicity|0|||
170863142|NCT01794520|617509516|FG005|Overall Study|Toxicity|0|||
170863143|NCT01794520|617509517|FG006|Overall Study|Toxicity|0|||
170863144|NCT01794520|617509511|FG000|Overall Study|Study terminated by sponsor|0|||
170863145|NCT01794520|617509512|FG001|Overall Study|Study terminated by sponsor|0|||
170863146|NCT01794520|617509513|FG002|Overall Study|Study terminated by sponsor|1|||
170863147|NCT01794520|617509514|FG003|Overall Study|Study terminated by sponsor|0|||
170863148|NCT01794520|617509515|FG004|Overall Study|Study terminated by sponsor|1|||
170863149|NCT01794520|617509516|FG005|Overall Study|Study terminated by sponsor|0|||
170863150|NCT01794520|617509517|FG006|Overall Study|Study terminated by sponsor|7|||
170863151|NCT01794520|617509511|FG000|Overall Study|Death|0|||
170863152|NCT01794520|617509512|FG001|Overall Study|Death|0|||
170863153|NCT01794520|617509513|FG002|Overall Study|Death|0|||
170863154|NCT01794520|617509514|FG003|Overall Study|Death|0|||
170863155|NCT01794520|617509515|FG004|Overall Study|Death|1|||
170863156|NCT01794520|617509516|FG005|Overall Study|Death|0|||
170863157|NCT01794520|617509517|FG006|Overall Study|Death|22|||
170863158|NCT01794520|617509511|FG000|Overall Study|Other, not specified|0|||
170863159|NCT01794520|617509512|FG001|Overall Study|Other, not specified|0|||
170863160|NCT01794520|617509513|FG002|Overall Study|Other, not specified|1|||
170863161|NCT01794520|617509514|FG003|Overall Study|Other, not specified|1|||
170863162|NCT01794520|617509515|FG004|Overall Study|Other, not specified|4|||
170863163|NCT01794520|617509516|FG005|Overall Study|Other, not specified|1|||
170863164|NCT01794520|617509517|FG006|Overall Study|Other, not specified|2|||
170863165|NCT01177787|617509518|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
170863166|NCT01177787|617509518|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
170863167|NCT01177787|617509518|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
170863168|NCT01176968|617509519|FG000|Overall Study|Adverse Event|10|||
170863169|NCT01176968|617509520|FG001|Overall Study|Adverse Event|11|||
170863170|NCT01176968|617509519|FG000|Overall Study|Death|2|||
170863171|NCT01176968|617509520|FG001|Overall Study|Death|3|||
170863172|NCT01176968|617509519|FG000|Overall Study|Lack of Efficacy|0|||
170863173|NCT01176968|617509520|FG001|Overall Study|Lack of Efficacy|1|||
170863174|NCT01176968|617509519|FG000|Overall Study|Lost to Follow-up|16|||
170863175|NCT01176968|617509520|FG001|Overall Study|Lost to Follow-up|14|||
170863176|NCT01176968|617509519|FG000|Overall Study|Withdrawal by Subject|48|||
170863177|NCT01176968|617509520|FG001|Overall Study|Withdrawal by Subject|48|||
170863178|NCT01176968|617509519|FG000|Overall Study|Protocol Violation|2|||
170863179|NCT01176968|617509520|FG001|Overall Study|Protocol Violation|1|||
170863180|NCT01176968|617509519|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
170863181|NCT01176968|617509520|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
170863182|NCT01176968|617509519|FG000|Overall Study|Study terminated by sponsor|0|||
170863183|NCT01176968|617509520|FG001|Overall Study|Study terminated by sponsor|1|||
170863184|NCT01176968|617509519|FG000|Overall Study|Reason not defined|5|||
170863185|NCT01176968|617509520|FG001|Overall Study|Reason not defined|3|||
170863186|NCT00718640|617509521|FG000|Overall Study|Adverse Event|4|||
170863187|NCT00718640|617509521|FG000|Overall Study|Death|1|||
170863188|NCT00718640|617509521|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
170863189|NCT00818389|617509522|FG000|Overall Study|Death|1|||
170863190|NCT00818389|617509523|FG001|Overall Study|Death|3|||
170863191|NCT00818389|617509522|FG000|Overall Study|ALS Disease Progression|1|||
170863192|NCT00818389|617509523|FG001|Overall Study|ALS Disease Progression|0|||
170863193|NCT00818389|617509522|FG000|Overall Study|Withdrawal by Subject|2|||
170863194|NCT00818389|617509523|FG001|Overall Study|Withdrawal by Subject|2|||
170863195|NCT00818389|617509522|FG000|Overall Study|Adverse Event|0|||
170863196|NCT00818389|617509523|FG001|Overall Study|Adverse Event|1|||
170863197|NCT05193500|617509524|FG000|Overall Study|Withdrawal by Subject|7|||
170863198|NCT05193500|617509525|FG001|Overall Study|Withdrawal by Subject|4|||
170863199|NCT05193500|617509526|FG002|Overall Study|Withdrawal by Subject|3|||
170863200|NCT05193500|617509527|FG003|Overall Study|Withdrawal by Subject|5|||
170863201|NCT02982187|617509531|FG000|Overall Study|Withdrawal by Subject|0|||
170863202|NCT02982187|617509532|FG001|Overall Study|Withdrawal by Subject|0|||
170863203|NCT02982187|617509533|FG002|Overall Study|Withdrawal by Subject|0|||
170863204|NCT02982187|617509534|FG003|Overall Study|Withdrawal by Subject|0|||
170863205|NCT02982187|617509535|FG004|Overall Study|Withdrawal by Subject|0|||
170863206|NCT02982187|617509536|FG005|Overall Study|Withdrawal by Subject|0|||
170863207|NCT02982187|617509537|FG006|Overall Study|Withdrawal by Subject|1|||
170863208|NCT02982187|617509538|FG007|Overall Study|Withdrawal by Subject|0|||
170863209|NCT01978262|617509539|FG000|Overall Study|Withdrawal by Subject|9|||
170863210|NCT01978262|617509539|FG000|Overall Study|Lost to Follow-up|2|||
170863211|NCT02604433|617509540|FG000|Overall Study|Withdrawal by Subject|37|||
170863212|NCT02604433|617509541|FG001|Overall Study|Withdrawal by Subject|16|||
170863213|NCT02604433|617509540|FG000|Overall Study|Adverse Event|4|||
170863214|NCT02604433|617509541|FG001|Overall Study|Adverse Event|0|||
170863215|NCT02604433|617509540|FG000|Overall Study|Other reasons|3|||
170863216|NCT02604433|617509541|FG001|Overall Study|Other reasons|5|||
170863217|NCT02604433|617509540|FG000|Overall Study|Death|4|||
170863218|NCT02604433|617509541|FG001|Overall Study|Death|1|||
170863219|NCT02604433|617509540|FG000|Overall Study|Transition to Rollover Protocol|169|||
170863220|NCT02604433|617509541|FG001|Overall Study|Transition to Rollover Protocol|82|||
170863221|NCT02604433|617509540|FG000|Overall Study|Physician Decision|1|||
170863222|NCT02604433|617509541|FG001|Overall Study|Physician Decision|1|||
170863223|NCT02604433|617509540|FG000|Overall Study|Lack of Efficacy|0|||
170863224|NCT02604433|617509541|FG001|Overall Study|Lack of Efficacy|1|||
170863225|NCT02168842|617509547|FG000|Overall Study|Withdrawal by Subject|5|||
170863226|NCT02168842|617509548|FG001|Overall Study|Withdrawal by Subject|3|||
170863227|NCT02168842|617509547|FG000|Overall Study|Lost to Follow-up|0|||
170863228|NCT02168842|617509548|FG001|Overall Study|Lost to Follow-up|2|||
170863229|NCT02168842|617509547|FG000|Overall Study|Death|2|||
170863230|NCT02168842|617509548|FG001|Overall Study|Death|1|||
170863231|NCT02168842|617509547|FG000|Overall Study|Physician Decision|1|||
170863232|NCT02168842|617509548|FG001|Overall Study|Physician Decision|2|||
170863233|NCT02465463|617509551|FG000|Overall Study|Lost to Follow-up|2|||
170863234|NCT02465463|617509552|FG001|Overall Study|Lost to Follow-up|1|||
170863235|NCT02465463|617509551|FG000|Overall Study|Death|1|||
170863236|NCT02465463|617509552|FG001|Overall Study|Death|0|||
170863237|NCT02465463|617509551|FG000|Overall Study|Protocol Violation|1|||
170863238|NCT02465463|617509552|FG001|Overall Study|Protocol Violation|0|||
170863239|NCT01067326|617509556|FG000|Overall Study|Adverse Event|0|||
170863240|NCT01067326|617509557|FG001|Overall Study|Adverse Event|2|||
170863241|NCT01067326|617509556|FG000|Overall Study|Withdrawal by Subject|1|||
170863242|NCT01067326|617509557|FG001|Overall Study|Withdrawal by Subject|0|||
170863243|NCT01067326|617509556|FG000|Overall Study|Early Study Termination|1|||
170863244|NCT01067326|617509557|FG001|Overall Study|Early Study Termination|1|||
170863245|NCT01423253|617509558|FG000|Overall Study|Adverse Event|2|||
170863246|NCT01423253|617509558|FG000|Overall Study|Lack of Efficacy|2|||
170863247|NCT01423253|617509558|FG000|Overall Study|Lost to Follow-up|1|||
170863248|NCT01423253|617509558|FG000|Overall Study|Protocol Violation|2|||
170863249|NCT01423253|617509558|FG000|Overall Study|Withdrawal by Subject|2|||
170863250|NCT00178126|617509570|FG000|Overall Study|Lost to Follow-up|21|||
170863251|NCT00178126|617509571|FG001|Overall Study|Lost to Follow-up|21|||
170863252|NCT00178126|617509570|FG000|Overall Study|did not receive intervention|4|||
170863253|NCT00178126|617509571|FG001|Overall Study|did not receive intervention|6|||
170863254|NCT01074216|617509572|FG000|Overall Study|Physician Decision|1|||
170863255|NCT01074216|617509572|FG000|Overall Study|Not Treated|12|||
170863256|NCT00026208|617509577|FG000|Overall Study|Complications of auto accident|1|||
170863257|NCT00026208|617509578|FG001|Overall Study|Complications of auto accident|0|||
170863258|NCT01906346|617509579|FG000|Overall Study|AEs|1|||
170863259|NCT04837040|617509580|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
170863260|NCT04837040|617509581|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
170863261|NCT01411839|617509582|FG000|Overall Study|Lost to Follow-up|4|||
170863262|NCT01411839|617509583|FG001|Overall Study|Lost to Follow-up|3|||
170863263|NCT04300309|617509584|FG000|Overall Study|Lost to Follow-up|1|||
170863264|NCT04300309|617509585|FG001|Overall Study|Lost to Follow-up|0|||
170863265|NCT04647526|617509586|FG000|Overall Study|Death|13|||
170863266|NCT04647526|617509587|FG001|Overall Study|Death|76|||
170863267|NCT04647526|617509588|FG002|Overall Study|Death|32|||
170863268|NCT04647526|617509589|FG003|Overall Study|Death|0|||
170863269|NCT04647526|617509586|FG000|Overall Study|Lost to Follow-up|1|||
170863270|NCT04647526|617509587|FG001|Overall Study|Lost to Follow-up|0|||
170863271|NCT04647526|617509588|FG002|Overall Study|Lost to Follow-up|1|||
170863272|NCT04647526|617509589|FG003|Overall Study|Lost to Follow-up|0|||
170863273|NCT04647526|617509586|FG000|Overall Study|Withdrawal by Subject|4|||
170863274|NCT04647526|617509587|FG001|Overall Study|Withdrawal by Subject|15|||
170863275|NCT04647526|617509588|FG002|Overall Study|Withdrawal by Subject|8|||
170863276|NCT04647526|617509589|FG003|Overall Study|Withdrawal by Subject|1|||
170863277|NCT04647526|617509586|FG000|Overall Study|Incorrect enrollment|0|||
170863278|NCT04647526|617509587|FG001|Overall Study|Incorrect enrollment|1|||
170863279|NCT04647526|617509588|FG002|Overall Study|Incorrect enrollment|1|||
170863280|NCT04647526|617509589|FG003|Overall Study|Incorrect enrollment|0|||
170863281|NCT04647526|617509586|FG000|Overall Study|Physician Decision|0|||
170863282|NCT04647526|617509587|FG001|Overall Study|Physician Decision|1|||
170863283|NCT04647526|617509588|FG002|Overall Study|Physician Decision|1|||
170863284|NCT04647526|617509589|FG003|Overall Study|Physician Decision|0|||
170863285|NCT04647526|617509586|FG000|Overall Study|Ongoing|9|||
170863286|NCT04647526|617509587|FG001|Overall Study|Ongoing|183|||
170863287|NCT04647526|617509588|FG002|Overall Study|Ongoing|93|||
170863288|NCT04647526|617509589|FG003|Overall Study|Ongoing|15|||
170863289|NCT04150029|617509590|FG000|Overall Study|Disease Relapse|0|||
170863290|NCT04150029|617509591|FG001|Overall Study|Disease Relapse|18|||
170863291|NCT04150029|617509590|FG000|Overall Study|Progressive Disease|2|||
170863292|NCT04150029|617509591|FG001|Overall Study|Progressive Disease|16|||
170863293|NCT04150029|617509590|FG000|Overall Study|Adverse Event|1|||
170863294|NCT04150029|617509591|FG001|Overall Study|Adverse Event|11|||
170863295|NCT04150029|617509590|FG000|Overall Study|Physician Decision|0|||
170863296|NCT04150029|617509591|FG001|Overall Study|Physician Decision|10|||
170863297|NCT04150029|617509590|FG000|Overall Study|Study Terminated by Sponsor|1|||
170863298|NCT04150029|617509591|FG001|Overall Study|Study Terminated by Sponsor|10|||
170863299|NCT04150029|617509590|FG000|Overall Study|Death|0|||
170863300|NCT04150029|617509591|FG001|Overall Study|Death|8|||
170863301|NCT04150029|617509590|FG000|Overall Study|Participant Decision|0|||
170863302|NCT04150029|617509591|FG001|Overall Study|Participant Decision|7|||
170863303|NCT04150029|617509590|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
170863304|NCT04150029|617509591|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
170863305|NCT03282240|617509592|FG000|Overall Study|Adverse Event|2|||
170863306|NCT03282240|617509593|FG001|Overall Study|Adverse Event|2|||
170863307|NCT03282240|617509594|FG002|Overall Study|Adverse Event|0|||
170863308|NCT03282240|617509592|FG000|Overall Study|Lost to Follow-up|3|||
170863309|NCT03282240|617509593|FG001|Overall Study|Lost to Follow-up|0|||
170863310|NCT03282240|617509594|FG002|Overall Study|Lost to Follow-up|0|||
170863311|NCT03282240|617509592|FG000|Overall Study|Protocol Deviation|4|||
170863312|NCT03282240|617509593|FG001|Overall Study|Protocol Deviation|1|||
170863313|NCT03282240|617509594|FG002|Overall Study|Protocol Deviation|2|||
170750978|NCT04168385|617094276|FG001|Overall Study|Liver transplant|1|||
170750979|NCT04168385|617094275|FG000|Overall Study|Listed for liver transplant|1|||
170750980|NCT04168385|617094276|FG001|Overall Study|Listed for liver transplant|0|||
170750981|NCT02748512|617094277|FG000|Overall Study|Lost to Follow-up|1|||
170750982|NCT02748512|617094278|FG001|Overall Study|Lost to Follow-up|1|||
170750983|NCT04466618|617094279|FG000|Overall Study|Withdrawal by Subject|0|||
170750984|NCT04466618|617094280|FG001|Overall Study|Withdrawal by Subject|1|||
170750985|NCT03583541|617094286|FG000|Overall Study|Lost to Follow-up|31|||
170750986|NCT03583541|617094287|FG001|Overall Study|Lost to Follow-up|65|||
170750987|NCT00884286|617094289|FG000|Overall Study|Progressive disease|21|||
170750988|NCT00884286|617094290|FG001|Overall Study|Progressive disease|28|||
170750989|NCT00884286|617094289|FG000|Overall Study|Toxicity|4|||
170750990|NCT00884286|617094290|FG001|Overall Study|Toxicity|1|||
170750991|NCT00884286|617094289|FG000|Overall Study|Death|2|||
170750992|NCT00884286|617094290|FG001|Overall Study|Death|2|||
170750993|NCT00884286|617094289|FG000|Overall Study|Physician Decision|1|||
170750994|NCT00884286|617094290|FG001|Overall Study|Physician Decision|0|||
170863314|NCT03282240|617509592|FG000|Overall Study|Withdrawal by Subject|1|||
170863315|NCT03282240|617509593|FG001|Overall Study|Withdrawal by Subject|0|||
170863316|NCT03282240|617509594|FG002|Overall Study|Withdrawal by Subject|1|||
170863317|NCT01675479|617509595|FG000|Overall Study|Lost to Follow-up|11|||
170750995|NCT00884286|617094289|FG000|Overall Study|Septic shock|1|||
170750996|NCT00884286|617094290|FG001|Overall Study|Septic shock|0|||
170750997|NCT00884286|617094289|FG000|Overall Study|Thrombus in right auricle|1|||
170750998|NCT00884286|617094290|FG001|Overall Study|Thrombus in right auricle|0|||
170750999|NCT00884286|617094289|FG000|Overall Study|Not treated|2|||
170863318|NCT05666505|617509596|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
170863319|NCT04751656|617511391|FG000|Overall Study|Lost to Follow-up|1|||
170863320|NCT03566810|617511395|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
170863321|NCT03566810|617511396|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
170863322|NCT03566810|617511397|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
170863323|NCT03566810|617511398|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
170863324|NCT01103245|617511400|FG000|Overall Study|Withdrawal by Subject|1|||
170863325|NCT01103245|617511401|FG001|Overall Study|Withdrawal by Subject|0|||
170863326|NCT01103245|617511402|FG002|Overall Study|Withdrawal by Subject|3|||
170863327|NCT01103245|617511403|FG003|Overall Study|Withdrawal by Subject|0|||
170863328|NCT01103245|617511400|FG000|Overall Study|Inadequate IV access|1|||
170863329|NCT01103245|617511401|FG001|Overall Study|Inadequate IV access|0|||
170863330|NCT01103245|617511402|FG002|Overall Study|Inadequate IV access|0|||
170863331|NCT01103245|617511403|FG003|Overall Study|Inadequate IV access|0|||
170863332|NCT01103245|617511400|FG000|Overall Study|Adverse Event|0|||
170863333|NCT01103245|617511401|FG001|Overall Study|Adverse Event|2|||
170863334|NCT01103245|617511402|FG002|Overall Study|Adverse Event|1|||
170863335|NCT01103245|617511403|FG003|Overall Study|Adverse Event|0|||
170863336|NCT01103245|617511400|FG000|Overall Study|Physician Decision|1|||
170863337|NCT01103245|617511401|FG001|Overall Study|Physician Decision|0|||
170863338|NCT01103245|617511402|FG002|Overall Study|Physician Decision|0|||
170863339|NCT01103245|617511403|FG003|Overall Study|Physician Decision|0|||
170863340|NCT03078907|617511404|FG000|Overall Study|Adverse Event|2|||
170863341|NCT03078907|617511405|FG001|Overall Study|Adverse Event|0|||
170863342|NCT03078907|617511404|FG000|Overall Study|Other|1|||
170863343|NCT03078907|617511405|FG001|Overall Study|Other|0|||
170863344|NCT03078907|617511404|FG000|Overall Study|Protocol Violation|0|||
170863345|NCT03078907|617511405|FG001|Overall Study|Protocol Violation|1|||
170863346|NCT01890148|617511406|FG000|Overall Study|Adverse Event|1|||
170863347|NCT04356183|617511411|FG000|Overall Study|Lost to Follow-up|1|||
170863348|NCT04356183|617511412|FG001|Overall Study|Lost to Follow-up|0|||
170863349|NCT04356183|617511411|FG000|Overall Study|Withdrawal by Subject|1|||
170863350|NCT04356183|617511412|FG001|Overall Study|Withdrawal by Subject|1|||
170863351|NCT05972733|617511415|FG000|Overall Study|Lost to Follow-up|2|||
170863352|NCT05972733|617511415|FG000|Overall Study|Withdrawal by Subject|1|||
170863353|NCT01637623|617511424|FG000|Overall Study|Lost to Follow-up|0|||
170863354|NCT01637623|617511425|FG001|Overall Study|Lost to Follow-up|0|||
170863355|NCT01637623|617511426|FG002|Overall Study|Lost to Follow-up|2|||
170863356|NCT01637623|617511424|FG000|Overall Study|Physician Decision|1|||
170863357|NCT01637623|617511425|FG001|Overall Study|Physician Decision|0|||
170863358|NCT01637623|617511426|FG002|Overall Study|Physician Decision|1|||
170863359|NCT02824263|617511429|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
170863360|NCT02824263|617511430|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
170863361|NCT02824263|617511429|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
170863362|NCT02824263|617511430|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
170863363|NCT00568321|617511431|FG000|Overall Study|Adverse Event|1|||
170863364|NCT00568321|617511432|FG001|Overall Study|Adverse Event|0|||
170863365|NCT00568321|617511433|FG002|Overall Study|Adverse Event|0|||
170863366|NCT00568321|617511431|FG000|Overall Study|Lack of Efficacy|8|||
170863367|NCT00568321|617511432|FG001|Overall Study|Lack of Efficacy|5|||
170751000|NCT00884286|617094290|FG001|Overall Study|Not treated|1|||
170751001|NCT00884286|617094289|FG000|Overall Study|Comprised lung carcinoma|0|||
170751002|NCT00884286|617094290|FG001|Overall Study|Comprised lung carcinoma|1|||
170751003|NCT01094171|617094291|FG000|Overall Study|Lost to Follow-up|2|||
170751004|NCT01094171|617094291|FG000|Overall Study|Informed consent withdrawal|4|||
170751005|NCT01094171|617094291|FG000|Overall Study|Migration from the study area|3|||
170751006|NCT01094171|617094291|FG000|Overall Study|Other|1|||
170751007|NCT02117544|617094294|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
170751008|NCT02117544|617094295|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
170751009|NCT02448719|617094298|FG000|Overall Study|Withdrawal by Subject|0|||
170751010|NCT02448719|617094299|FG001|Overall Study|Withdrawal by Subject|0|||
170751011|NCT02448719|617094300|FG002|Overall Study|Withdrawal by Subject|0|||
170751012|NCT02448719|617094301|FG003|Overall Study|Withdrawal by Subject|0|||
170751013|NCT02448719|617094302|FG004|Overall Study|Withdrawal by Subject|1|||
170751014|NCT02448719|617094303|FG005|Overall Study|Withdrawal by Subject|0|||
170751015|NCT02448719|617094304|FG006|Overall Study|Withdrawal by Subject|0|||
170751016|NCT02448719|617094305|FG007|Overall Study|Withdrawal by Subject|0|||
170863368|NCT00568321|617511433|FG002|Overall Study|Lack of Efficacy|6|||
170863369|NCT00568321|617511431|FG000|Overall Study|Lost to Follow-up|0|||
170863370|NCT00568321|617511432|FG001|Overall Study|Lost to Follow-up|0|||
170863371|NCT00568321|617511433|FG002|Overall Study|Lost to Follow-up|1|||
170863372|NCT00568321|617511431|FG000|Overall Study|Withdrawal by Subject|2|||
170863373|NCT00568321|617511432|FG001|Overall Study|Withdrawal by Subject|0|||
170863374|NCT00568321|617511433|FG002|Overall Study|Withdrawal by Subject|0|||
170751017|NCT02448719|617094306|FG008|Overall Study|Withdrawal by Subject|0|||
170751018|NCT02448719|617094307|FG009|Overall Study|Withdrawal by Subject|0|||
170751019|NCT02448719|617094308|FG010|Overall Study|Withdrawal by Subject|0|||
170751020|NCT01656759|617094309|FG000|Overall Study|Protocol Violation|2|||
170863375|NCT00568321|617511431|FG000|Overall Study|Protocol Violation|0|||
170863376|NCT00568321|617511432|FG001|Overall Study|Protocol Violation|0|||
170863377|NCT00568321|617511433|FG002|Overall Study|Protocol Violation|1|||
170863378|NCT00568321|617511431|FG000|Overall Study|Randomized, not treated|2|||
170863379|NCT00568321|617511432|FG001|Overall Study|Randomized, not treated|0|||
170863380|NCT00568321|617511433|FG002|Overall Study|Randomized, not treated|1|||
170863381|NCT03215758|617511435|FG000|Overall Study|Technical Problems|1|||
170863382|NCT03215758|617511436|FG001|Overall Study|Technical Problems|0|||
170863383|NCT03215758|617511435|FG000|Overall Study|Protocol deviation|0|||
170863384|NCT03215758|617511436|FG001|Overall Study|Protocol deviation|1|||
170863385|NCT03215758|617511435|FG000|Overall Study|Physician Decision|0|||
170863386|NCT03215758|617511436|FG001|Overall Study|Physician Decision|1|||
170863387|NCT03215758|617511435|FG000|Overall Study|Death|0|||
170863388|NCT03215758|617511436|FG001|Overall Study|Death|1|||
170863389|NCT03215758|617511435|FG000|Overall Study|Adverse Event|1|||
170863390|NCT03215758|617511436|FG001|Overall Study|Adverse Event|2|||
170863391|NCT03215758|617511435|FG000|Overall Study|Subject/Guardian Decision|3|||
170863392|NCT03215758|617511436|FG001|Overall Study|Subject/Guardian Decision|3|||
170863393|NCT01676909|617511437|FG000|Overall Study|Withdrawal by Subject|3|||
170863394|NCT01676909|617511438|FG001|Overall Study|Withdrawal by Subject|5|||
170863395|NCT01676909|617511437|FG000|Overall Study|Lost to Follow-up|15|||
170863396|NCT01676909|617511438|FG001|Overall Study|Lost to Follow-up|9|||
170863397|NCT04615247|617511439|FG000|Overall Study|Adverse Event|0|||
170863398|NCT04615247|617511440|FG001|Overall Study|Adverse Event|2|||
170863399|NCT04615247|617511439|FG000|Overall Study|Withdrawal by Subject|1|||
170863400|NCT04615247|617511440|FG001|Overall Study|Withdrawal by Subject|1|||
170863401|NCT03278106|617511443|FG000|Overall Study|No protocol treatment|1|||
170863402|NCT00823901|617511446|FG000|Overall Study|Adverse Event|1|||
170863403|NCT00823901|617511447|FG001|Overall Study|Adverse Event|1|||
170863404|NCT00823901|617511446|FG000|Overall Study|Lack of Efficacy|1|||
170863405|NCT00823901|617511447|FG001|Overall Study|Lack of Efficacy|0|||
170863406|NCT00823901|617511446|FG000|Overall Study|Lost to Follow-up|2|||
170863407|NCT00823901|617511447|FG001|Overall Study|Lost to Follow-up|1|||
170863408|NCT01376349|617511448|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
170863409|NCT01376349|617511449|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
170863410|NCT01376349|617511450|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
170863411|NCT01376349|617511448|FG000|Raondomized Treatment|Adverse Event|13|||
170863412|NCT01376349|617511449|FG001|Raondomized Treatment|Adverse Event|17|||
170863413|NCT01376349|617511450|FG002|Raondomized Treatment|Adverse Event|14|||
170863414|NCT01376349|617511448|FG000|Raondomized Treatment|Unkown|1|||
170863415|NCT01376349|617511449|FG001|Raondomized Treatment|Unkown|2|||
170863416|NCT01376349|617511450|FG002|Raondomized Treatment|Unkown|1|||
170863417|NCT01376349|617511448|FG000|Raondomized Treatment|Alternative Treatment|0|||
170863418|NCT01376349|617511449|FG001|Raondomized Treatment|Alternative Treatment|0|||
170863419|NCT01376349|617511450|FG002|Raondomized Treatment|Alternative Treatment|1|||
170863420|NCT01180998|617511451|FG000|Overall Study|Poor Vision|0|||
170863421|NCT01180998|617511452|FG001|Overall Study|Poor Vision|2|||
170863422|NCT01180998|617511453|FG002|Overall Study|Poor Vision|2|||
170863423|NCT01180998|617511451|FG000|Overall Study|Lost to Follow-up|0|||
170863424|NCT01180998|617511452|FG001|Overall Study|Lost to Follow-up|0|||
170863425|NCT01180998|617511453|FG002|Overall Study|Lost to Follow-up|1|||
170863426|NCT01180998|617511451|FG000|Overall Study|Protocol Violation|1|||
170863427|NCT01180998|617511452|FG001|Overall Study|Protocol Violation|2|||
170863428|NCT01180998|617511453|FG002|Overall Study|Protocol Violation|0|||
170863429|NCT01180998|617511451|FG000|Overall Study|Withdrawal by Subject|0|||
170863430|NCT01180998|617511452|FG001|Overall Study|Withdrawal by Subject|0|||
170863431|NCT01180998|617511453|FG002|Overall Study|Withdrawal by Subject|1|||
170863432|NCT01180998|617511451|FG000|Overall Study|Poor comfort|3|||
170863433|NCT01180998|617511452|FG001|Overall Study|Poor comfort|0|||
170863434|NCT01180998|617511453|FG002|Overall Study|Poor comfort|4|||
170863435|NCT01180998|617511451|FG000|Overall Study|Poor lens handling|0|||
170863436|NCT01180998|617511452|FG001|Overall Study|Poor lens handling|0|||
170863437|NCT01180998|617511453|FG002|Overall Study|Poor lens handling|2|||
170863438|NCT00162032|617511454|FG000|Overall Study|Lost to Follow-up|4|||
170863439|NCT00162032|617511455|FG001|Overall Study|Lost to Follow-up|2|||
170863440|NCT00162032|617511454|FG000|Overall Study|Reason not specified|1|||
170863441|NCT00162032|617511455|FG001|Overall Study|Reason not specified|0|||
170863442|NCT03952806|617511456|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
170863443|NCT03952806|617511457|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
170863444|NCT03952806|617511456|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
170863445|NCT03952806|617511457|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
170863446|NCT03952806|617511456|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
170863447|NCT03952806|617511457|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
170863448|NCT03952806|617511456|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
170863449|NCT03952806|617511457|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
170863450|NCT03952806|617511456|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
170863451|NCT03952806|617511457|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
170863452|NCT03952806|617511456|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
170863453|NCT03952806|617511457|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
170863454|NCT03952806|617511456|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
170863455|NCT03952806|617511457|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
170751021|NCT01656759|617094310|FG001|Overall Study|Protocol Violation|3|||
170751022|NCT01628510|617094311|FG000|Overall Study|Withdrawal by Subject|0|||
170751023|NCT01628510|617094312|FG001|Overall Study|Withdrawal by Subject|4|||
170751024|NCT01628510|617094311|FG000|Overall Study|Death|3|||
170751025|NCT01628510|617094312|FG001|Overall Study|Death|1|||
170751026|NCT04707391|617094313|FG000|Overall Study|Adverse Event|5|||
170751027|NCT04707391|617094314|FG001|Overall Study|Adverse Event|8|||
170751028|NCT04707391|617094313|FG000|Overall Study|Lost to Follow-up|44|||
170751029|NCT04707391|617094314|FG001|Overall Study|Lost to Follow-up|31|||
170751030|NCT04707391|617094313|FG000|Overall Study|Protocol Violation|1|||
170751031|NCT04707391|617094314|FG001|Overall Study|Protocol Violation|5|||
170751032|NCT04707391|617094313|FG000|Overall Study|Withdrawal by Subject|27|||
170751033|NCT04707391|617094314|FG001|Overall Study|Withdrawal by Subject|25|||
170751034|NCT04707391|617094313|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
170751035|NCT04707391|617094314|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
170751036|NCT04707391|617094313|FG000|Overall Study|Other|0|||
170751037|NCT04707391|617094314|FG001|Overall Study|Other|2|||
170751038|NCT03785340|617094316|FG000|Overall Study|Lost to Follow-up|2|||
170751039|NCT03785340|617094317|FG001|Overall Study|Lost to Follow-up|0|||
170751040|NCT03785340|617094316|FG000|Overall Study|Adverse Event|1|||
170751041|NCT03785340|617094317|FG001|Overall Study|Adverse Event|0|||
170751042|NCT01932996|617094320|FG000|Overall Study|Protocol Violation|2|||
170751043|NCT01932996|617094321|FG001|Overall Study|Protocol Violation|0|||
170751044|NCT03160079|617094324|FG000|Overall Study|Adverse Event|2|||
170751045|NCT03160079|617094325|FG001|Overall Study|Adverse Event|0|||
170751046|NCT03160079|617094324|FG000|Overall Study|Disease Progression|1|||
170751047|NCT03160079|617094325|FG001|Overall Study|Disease Progression|0|||
170751048|NCT03160079|617094324|FG000|Overall Study|Physician Decision|1|||
170751049|NCT03160079|617094325|FG001|Overall Study|Physician Decision|0|||
170751050|NCT01435798|617094328|FG000|Overall Study|Withdrawal by Subject|1|||
170751051|NCT02500316|617094329|FG000|Overall Study|Adverse Event|3|||
170751052|NCT02500316|617094329|FG000|Overall Study|Lost to Follow-up|2|||
170751053|NCT02500316|617094329|FG000|Overall Study|Protocol Violation|1|||
170751054|NCT02500316|617094329|FG000|Overall Study|Withdrawal by Subject|15|||
170751055|NCT02500316|617094329|FG000|Overall Study|Final height achieved|5|||
170751056|NCT02500316|617094329|FG000|Overall Study|Due to war activity|1|||
170751057|NCT01848834|617094333|FG000|Overall Study|Adverse Event|3|||
170751058|NCT01848834|617094334|FG001|Overall Study|Adverse Event|11|||
170751059|NCT01848834|617094335|FG002|Overall Study|Adverse Event|3|||
170751060|NCT01848834|617094336|FG003|Overall Study|Adverse Event|5|||
170751061|NCT01848834|617094337|FG004|Overall Study|Adverse Event|9|||
170751062|NCT01848834|617094333|FG000|Overall Study|Death|2|||
170751063|NCT01848834|617094334|FG001|Overall Study|Death|11|||
170751064|NCT01848834|617094335|FG002|Overall Study|Death|1|||
170751065|NCT01848834|617094336|FG003|Overall Study|Death|8|||
170751066|NCT01848834|617094337|FG004|Overall Study|Death|27|||
170751067|NCT01848834|617094333|FG000|Overall Study|Excluded Medication|5|||
170751068|NCT01848834|617094334|FG001|Overall Study|Excluded Medication|4|||
170751069|NCT01848834|617094335|FG002|Overall Study|Excluded Medication|3|||
170751070|NCT01848834|617094336|FG003|Overall Study|Excluded Medication|6|||
170751071|NCT01848834|617094337|FG004|Overall Study|Excluded Medication|6|||
170751072|NCT01848834|617094333|FG000|Overall Study|Lost to Follow-up|5|||
170751073|NCT01848834|617094334|FG001|Overall Study|Lost to Follow-up|5|||
170751074|NCT01848834|617094335|FG002|Overall Study|Lost to Follow-up|3|||
170751075|NCT01848834|617094336|FG003|Overall Study|Lost to Follow-up|0|||
170751076|NCT01848834|617094337|FG004|Overall Study|Lost to Follow-up|3|||
170751077|NCT01848834|617094333|FG000|Overall Study|Physician Decision|1|||
170751078|NCT01848834|617094334|FG001|Overall Study|Physician Decision|3|||
170751079|NCT01848834|617094335|FG002|Overall Study|Physician Decision|4|||
170863456|NCT03952806|617511456|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
170863457|NCT03952806|617511457|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
170751080|NCT01848834|617094336|FG003|Overall Study|Physician Decision|0|||
170751081|NCT01848834|617094337|FG004|Overall Study|Physician Decision|11|||
170751082|NCT01848834|617094333|FG000|Overall Study|Protocol Violation|0|||
170751083|NCT01848834|617094334|FG001|Overall Study|Protocol Violation|0|||
170751084|NCT01848834|617094335|FG002|Overall Study|Protocol Violation|0|||
170751085|NCT01848834|617094336|FG003|Overall Study|Protocol Violation|0|||
170751086|NCT01848834|617094337|FG004|Overall Study|Protocol Violation|1|||
170751087|NCT01848834|617094333|FG000|Overall Study|Sponsor Decision|1|||
170751088|NCT01848834|617094334|FG001|Overall Study|Sponsor Decision|1|||
170751089|NCT01848834|617094335|FG002|Overall Study|Sponsor Decision|0|||
170751090|NCT01848834|617094336|FG003|Overall Study|Sponsor Decision|1|||
170751091|NCT01848834|617094337|FG004|Overall Study|Sponsor Decision|1|||
170751092|NCT01848834|617094333|FG000|Overall Study|Withdrawal by Subject|2|||
170751093|NCT01848834|617094334|FG001|Overall Study|Withdrawal by Subject|13|||
170751094|NCT01848834|617094335|FG002|Overall Study|Withdrawal by Subject|10|||
170751095|NCT01848834|617094336|FG003|Overall Study|Withdrawal by Subject|6|||
170751096|NCT01848834|617094337|FG004|Overall Study|Withdrawal by Subject|36|||
170751097|NCT01406717|617094340|FG000|Overall Study|Subject non-compliance|4|||
170751098|NCT01406717|617094341|FG001|Overall Study|Subject non-compliance|3|||
170751099|NCT01406717|617094340|FG000|Overall Study|Protocol Violation|5|||
170751100|NCT01406717|617094341|FG001|Overall Study|Protocol Violation|1|||
170751101|NCT01406717|617094340|FG000|Overall Study|Lost to Follow-up|14|||
170751102|NCT01406717|617094341|FG001|Overall Study|Lost to Follow-up|8|||
170751103|NCT01406717|617094340|FG000|Overall Study|Withdrawal by Subject|19|||
170751104|NCT01406717|617094341|FG001|Overall Study|Withdrawal by Subject|15|||
170751105|NCT01406717|617094340|FG000|Overall Study|Adverse Event|1|||
170751106|NCT01406717|617094341|FG001|Overall Study|Adverse Event|2|||
170751107|NCT01406717|617094340|FG000|Overall Study|Lack of Efficacy|0|||
170751108|NCT01406717|617094341|FG001|Overall Study|Lack of Efficacy|1|||
170751109|NCT01406717|617094340|FG000|Overall Study|Non-completion of visit activity|0|||
170751110|NCT01406717|617094341|FG001|Overall Study|Non-completion of visit activity|1|||
170751111|NCT02275533|617094342|FG000|Overall Study|Protocol Violation|2|||
170751112|NCT02275533|617094343|FG001|Overall Study|Protocol Violation|0|||
170751113|NCT02275533|617094342|FG000|Overall Study|Never received study treatment|1|||
170751114|NCT02275533|617094343|FG001|Overall Study|Never received study treatment|0|||
170751115|NCT01570868|617094344|FG000|Overall Study|Adverse Event|8|||
170751116|NCT01570868|617094345|FG001|Overall Study|Adverse Event|1|||
170751117|NCT01570868|617094344|FG000|Overall Study|FDA Recommendation|23|||
170751118|NCT01570868|617094345|FG001|Overall Study|FDA Recommendation|3|||
170751119|NCT01570868|617094344|FG000|Overall Study|Physician Decision|10|||
170751120|NCT01570868|617094345|FG001|Overall Study|Physician Decision|4|||
170751121|NCT01570868|617094344|FG000|Overall Study|Lost to Follow-up|1|||
170751122|NCT01570868|617094345|FG001|Overall Study|Lost to Follow-up|0|||
170751123|NCT01570868|617094344|FG000|Overall Study|Withdrawal by Subject|1|||
170751124|NCT01570868|617094345|FG001|Overall Study|Withdrawal by Subject|0|||
170751125|NCT03370276|617094346|FG000|Overall Study|Death|0|||
170751126|NCT03370276|617094347|FG001|Overall Study|Death|2|||
170751127|NCT03370276|617094348|FG002|Overall Study|Death|5|||
170751128|NCT01556763|617094351|FG000|Overall Study|Withdrawal by Subject|0|||
170751129|NCT01556763|617094352|FG001|Overall Study|Withdrawal by Subject|1|||
170751130|NCT01556763|617094353|FG002|Overall Study|Withdrawal by Subject|0|||
170751131|NCT02584855|617094354|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
170751132|NCT02584855|617094355|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
170751133|NCT02584855|617094356|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
170751134|NCT02584855|617094357|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
170751135|NCT02584855|617094358|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
170751136|NCT02584855|617094359|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
170751137|NCT02584855|617094354|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
170751138|NCT02584855|617094355|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
170751139|NCT02584855|617094356|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
170751140|NCT02584855|617094357|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
170751141|NCT02584855|617094358|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
170751142|NCT02584855|617094359|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
170751143|NCT02584855|617094354|FG000|Open-Label Treatment Period|Adverse Event|14|||
170751144|NCT02584855|617094355|FG001|Open-Label Treatment Period|Adverse Event|0|||
170751145|NCT02584855|617094356|FG002|Open-Label Treatment Period|Adverse Event|0|||
170751146|NCT02584855|617094357|FG003|Open-Label Treatment Period|Adverse Event|0|||
170751147|NCT02584855|617094358|FG004|Open-Label Treatment Period|Adverse Event|0|||
170751148|NCT02584855|617094359|FG005|Open-Label Treatment Period|Adverse Event|0|||
170751149|NCT02584855|617094354|FG000|Open-Label Treatment Period|Death|2|||
170751150|NCT02584855|617094355|FG001|Open-Label Treatment Period|Death|0|||
170751151|NCT02584855|617094356|FG002|Open-Label Treatment Period|Death|0|||
170751152|NCT02584855|617094357|FG003|Open-Label Treatment Period|Death|0|||
170751153|NCT02584855|617094358|FG004|Open-Label Treatment Period|Death|0|||
170751154|NCT02584855|617094359|FG005|Open-Label Treatment Period|Death|0|||
170751155|NCT02584855|617094354|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
170751156|NCT02584855|617094355|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
170751157|NCT02584855|617094356|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
170751158|NCT02584855|617094357|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
170751159|NCT02584855|617094358|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
170751160|NCT02584855|617094359|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
170751161|NCT02584855|617094354|FG000|Open-Label Treatment Period|Protocol Violation|1|||
170863458|NCT03952806|617511456|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
170751162|NCT02584855|617094355|FG001|Open-Label Treatment Period|Protocol Violation|0|||
170751163|NCT02584855|617094356|FG002|Open-Label Treatment Period|Protocol Violation|0|||
170751164|NCT02584855|617094357|FG003|Open-Label Treatment Period|Protocol Violation|0|||
170751165|NCT02584855|617094358|FG004|Open-Label Treatment Period|Protocol Violation|0|||
170751166|NCT02584855|617094359|FG005|Open-Label Treatment Period|Protocol Violation|0|||
170751167|NCT02584855|617094354|FG000|Open-Label Treatment Period|No PI Available|2|||
170751168|NCT02584855|617094355|FG001|Open-Label Treatment Period|No PI Available|0|||
170751169|NCT02584855|617094356|FG002|Open-Label Treatment Period|No PI Available|0|||
170751170|NCT02584855|617094357|FG003|Open-Label Treatment Period|No PI Available|0|||
170751171|NCT02584855|617094358|FG004|Open-Label Treatment Period|No PI Available|0|||
170863459|NCT03952806|617511457|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
170751172|NCT02584855|617094359|FG005|Open-Label Treatment Period|No PI Available|0|||
170751173|NCT02584855|617094354|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
170751174|NCT02584855|617094355|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
170751175|NCT02584855|617094356|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
170751176|NCT02584855|617094357|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
170751177|NCT02584855|617094358|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
170751178|NCT02584855|617094359|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
170751179|NCT02584855|617094354|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
170751180|NCT02584855|617094355|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
170751181|NCT02584855|617094356|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
170751182|NCT02584855|617094357|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
170751183|NCT02584855|617094358|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
170751184|NCT02584855|617094359|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
170751185|NCT02584855|617094354|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
170751186|NCT02584855|617094355|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
170751187|NCT02584855|617094356|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
170751188|NCT02584855|617094357|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
170751189|NCT02584855|617094358|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
170751190|NCT02584855|617094359|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
170751191|NCT02584855|617094354|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
170751192|NCT02584855|617094355|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
170751193|NCT02584855|617094356|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
170751194|NCT02584855|617094357|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
170751195|NCT02584855|617094358|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
170751196|NCT02584855|617094359|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
170751197|NCT02584855|617094354|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
170751198|NCT02584855|617094355|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
170751199|NCT02584855|617094356|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
170751200|NCT02584855|617094357|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
170751201|NCT02584855|617094358|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
170751202|NCT02584855|617094359|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
170751203|NCT02584855|617094354|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170751204|NCT02584855|617094355|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170751205|NCT02584855|617094356|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170751206|NCT02584855|617094357|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170751207|NCT02584855|617094358|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
170751208|NCT02584855|617094359|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170751209|NCT02584855|617094354|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
170751210|NCT02584855|617094355|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
170751211|NCT02584855|617094356|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
170751212|NCT02584855|617094357|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
170751213|NCT02584855|617094358|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
170751214|NCT02584855|617094359|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
170751215|NCT00895843|617094360|FG000|Overall Study|Protocol Violation|12|||
170751216|NCT00895843|617094361|FG001|Overall Study|Protocol Violation|12|||
170751217|NCT04963062|617094365|FG000|Overall Study|withdrew by the study team|4|||
170751218|NCT04963062|617094366|FG001|Overall Study|withdrew by the study team|2|||
170751219|NCT01987830|617094374|FG000|Overall Study|Never received baseline scan|1|||
170751220|NCT05764239|617094377|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
170751221|NCT05764239|617094377|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
170751222|NCT05764239|617094377|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
170751223|NCT05764239|617094377|FG000|DEP (Part 1)|Adverse Event|1|||
170751224|NCT05764239|617094377|FG000|DEP (Part 1)|Lost to Follow-up|1|||
170751225|NCT05764239|617094377|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
170751226|NCT05764239|617094377|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
170751227|NCT05764239|617094377|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
170751228|NCT05764239|617094377|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
170751229|NCT00057811|617094378|FG000|Overall Study|Lack of Efficacy|1|||
170751230|NCT00057811|617094379|FG001|Overall Study|Lack of Efficacy|4|||
170751231|NCT00057811|617094378|FG000|Overall Study|Physician Decision|1|||
170751232|NCT00057811|617094379|FG001|Overall Study|Physician Decision|0|||
170751233|NCT00057811|617094378|FG000|Overall Study|Withdrawal by Subject|3|||
170751234|NCT00057811|617094379|FG001|Overall Study|Withdrawal by Subject|4|||
170751235|NCT00057811|617094378|FG000|Overall Study|Ineligible|4|||
170751236|NCT00057811|617094379|FG001|Overall Study|Ineligible|2|||
170751237|NCT00057811|617094378|FG000|Overall Study|Inevaluable|1|||
170751238|NCT00057811|617094379|FG001|Overall Study|Inevaluable|2|||
170751239|NCT05294419|617094380|FG000|Overall Study|Protocol Violation|4|||
170751240|NCT05294419|617094381|FG001|Overall Study|Protocol Violation|0|||
170751241|NCT05294419|617094382|FG002|Overall Study|Protocol Violation|0|||
170751242|NCT05294419|617094380|FG000|Overall Study|Lost to Follow-up|6|||
170751243|NCT05294419|617094381|FG001|Overall Study|Lost to Follow-up|0|||
170751244|NCT05294419|617094382|FG002|Overall Study|Lost to Follow-up|0|||
170751245|NCT05294419|617094380|FG000|Overall Study|Results voided after publishing|2|||
170751246|NCT05294419|617094381|FG001|Overall Study|Results voided after publishing|0|||
170751247|NCT05294419|617094382|FG002|Overall Study|Results voided after publishing|0|||
170751248|NCT04140890|617094385|FG000|Overall Study|Withdrawal by Subject|0|||
170751249|NCT04140890|617094386|FG001|Overall Study|Withdrawal by Subject|1|||
170751250|NCT01518257|617095797|FG000|Overall Study|Lost to Follow-up|1|||
170751251|NCT01518257|617095798|FG001|Overall Study|Lost to Follow-up|0|||
170751252|NCT01518257|617095797|FG000|Overall Study|Other Miscellaneous Reason|1|||
170751253|NCT01518257|617095798|FG001|Overall Study|Other Miscellaneous Reason|0|||
170751254|NCT03531905|617095799|FG000|Overall Study|Withdrawal by Subject|3|||
170751255|NCT03531905|617095800|FG001|Overall Study|Withdrawal by Subject|3|||
170751256|NCT03531905|617095801|FG002|Overall Study|Withdrawal by Subject|2|||
170751257|NCT03531905|617095799|FG000|Overall Study|Lost to Follow-up|2|||
170751258|NCT03531905|617095800|FG001|Overall Study|Lost to Follow-up|2|||
170751259|NCT03531905|617095801|FG002|Overall Study|Lost to Follow-up|1|||
170751260|NCT03531905|617095799|FG000|Overall Study|Participant was out of town|1|||
170751261|NCT03531905|617095800|FG001|Overall Study|Participant was out of town|0|||
170751262|NCT03531905|617095801|FG002|Overall Study|Participant was out of town|0|||
170751263|NCT03531905|617095799|FG000|Overall Study|Could not speak with the participant|1|||
170751264|NCT03531905|617095800|FG001|Overall Study|Could not speak with the participant|0|||
170751265|NCT03531905|617095801|FG002|Overall Study|Could not speak with the participant|0|||
170751266|NCT05305040|617095802|FG000|Overall Study|Not Dosed|37|||
170751267|NCT05305040|617095803|FG001|Overall Study|Not Dosed|37|||
170751268|NCT05305040|617095802|FG000|Overall Study|Study Closure|34|||
170751269|NCT05305040|617095803|FG001|Overall Study|Study Closure|46|||
170751270|NCT05305040|617095802|FG000|Overall Study|Death|14|||
170751271|NCT05305040|617095803|FG001|Overall Study|Death|13|||
170751272|NCT05305040|617095802|FG000|Overall Study|Withdrawal by Subject|15|||
170751273|NCT05305040|617095803|FG001|Overall Study|Withdrawal by Subject|10|||
170751274|NCT05305040|617095802|FG000|Overall Study|Other|13|||
170751275|NCT05305040|617095803|FG001|Overall Study|Other|10|||
170751276|NCT05305040|617095802|FG000|Overall Study|Primary Malignancy Relapse|3|||
170751277|NCT05305040|617095803|FG001|Overall Study|Primary Malignancy Relapse|4|||
170751278|NCT05305040|617095802|FG000|Overall Study|Adverse Event|3|||
170751279|NCT05305040|617095803|FG001|Overall Study|Adverse Event|3|||
170751280|NCT05305040|617095802|FG000|Overall Study|Lost to Follow-up|2|||
170751281|NCT05305040|617095803|FG001|Overall Study|Lost to Follow-up|1|||
170751282|NCT05305040|617095802|FG000|Overall Study|Graft versus host disease|2|||
170751283|NCT05305040|617095803|FG001|Overall Study|Graft versus host disease|0|||
170751284|NCT05305040|617095802|FG000|Overall Study|Investigator's Decision|1|||
170751285|NCT05305040|617095803|FG001|Overall Study|Investigator's Decision|1|||
170751286|NCT05305040|617095802|FG000|Overall Study|COVID-19 Reasons|1|||
170751287|NCT05305040|617095803|FG001|Overall Study|COVID-19 Reasons|0|||
170751288|NCT01195675|617095807|FG000|Overall Study|Adverse Event|1|||
170751289|NCT01195675|617095807|FG000|Overall Study|Withdrawal by Subject|2|||
170751290|NCT02424344|617095808|FG000|Overall Study|Lack of Efficacy|0|||
170863460|NCT03952806|617511456|FG000|OLE Phase (48 Weeks)|Other|16|||
170863461|NCT03952806|617511457|FG001|OLE Phase (48 Weeks)|Other|13|||
170863462|NCT05341115|617511458|FG000|Overall Study|Adverse Event|1|||
170863463|NCT05341115|617511458|FG000|Overall Study|Lost to Follow-up|1|||
170863464|NCT04098068|617511459|FG000|Overall Study|Disease Progression|7|||
170863465|NCT04098068|617511459|FG000|Overall Study|Withdrawal by Subject|2|||
170863466|NCT04098068|617511459|FG000|Overall Study|New Cancer Diagnosis|1|||
170863467|NCT04652726|617511462|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
170751291|NCT02424344|617095809|FG001|Overall Study|Lack of Efficacy|1|||
170751292|NCT02424344|617095808|FG000|Overall Study|Withdrawal by Subject|2|||
170751293|NCT02424344|617095809|FG001|Overall Study|Withdrawal by Subject|1|||
170751294|NCT02424344|617095808|FG000|Overall Study|Lost to Follow-up|1|||
170751295|NCT02424344|617095809|FG001|Overall Study|Lost to Follow-up|0|||
170863468|NCT04652726|617511463|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
170863469|NCT04652726|617511464|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
170863470|NCT04652726|617511462|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
170863471|NCT04652726|617511463|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
170751296|NCT02424344|617095808|FG000|Overall Study|Adverse Event|4|||
170751297|NCT02424344|617095809|FG001|Overall Study|Adverse Event|8|||
170751298|NCT04730947|617095810|FG000|Overall Study|Withdrawal by Subject|0|||
170751299|NCT04730947|617095811|FG001|Overall Study|Withdrawal by Subject|1|||
170751300|NCT01174550|617095812|FG000|Overall Study|Death|75|||
170751301|NCT01174550|617095813|FG001|Overall Study|Death|74|||
170751302|NCT01174550|617095812|FG000|Overall Study|Lost to Follow-up|652|||
170751303|NCT01174550|617095813|FG001|Overall Study|Lost to Follow-up|510|||
170751304|NCT01174550|617095812|FG000|Overall Study|Withdrawal by Subject|543|||
170751305|NCT01174550|617095813|FG001|Overall Study|Withdrawal by Subject|289|||
170751306|NCT02123966|617095814|FG000|Overall Study|Intercurrent Illness|1|||
170751307|NCT01536262|617095815|FG000|Overall Study|Adverse Event|6|||
170751308|NCT01536262|617095816|FG001|Overall Study|Adverse Event|1|||
170751309|NCT01536262|617095817|FG002|Overall Study|Adverse Event|2|||
170751310|NCT01536262|617095815|FG000|Overall Study|Withdrawal by Subject|1|||
170751311|NCT01536262|617095816|FG001|Overall Study|Withdrawal by Subject|1|||
170751312|NCT01536262|617095817|FG002|Overall Study|Withdrawal by Subject|0|||
170751313|NCT01536262|617095815|FG000|Overall Study|Other than stated above|1|||
170751314|NCT01536262|617095816|FG001|Overall Study|Other than stated above|0|||
170751315|NCT01536262|617095817|FG002|Overall Study|Other than stated above|0|||
170751316|NCT01460381|617095818|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
170751317|NCT01460381|617095819|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
170751318|NCT01097655|617095820|FG000|Overall Study|Withdrawal by Subject|1|||
170751319|NCT01097655|617095820|FG000|Overall Study|Subject Documented Twice|1|||
170751320|NCT01097655|617095820|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
170751321|NCT05257837|617095823|FG000|Overall Study|Excluded (did not find the guns)|4|||
170751322|NCT05257837|617095824|FG001|Overall Study|Excluded (did not find the guns)|2|||
170751323|NCT05257837|617095825|FG002|Overall Study|Excluded (did not find the guns)|4|||
170751324|NCT05257837|617095826|FG003|Overall Study|Excluded (did not find the guns)|0|||
170751325|NCT01781611|617095830|FG000|Overall Study|Adverse Event|4|||
170751326|NCT01781611|617095831|FG001|Overall Study|Adverse Event|0|||
170751327|NCT01333943|617095832|FG000|Overall Study|Known neuropathy|1|||
170751328|NCT01333943|617095833|FG001|Overall Study|Known neuropathy|0|||
170751329|NCT03639675|617095834|FG000|Overall Study|Withdrawal by Subject|1|||
170751330|NCT01021332|617095835|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
170751331|NCT01021332|617095835|FG000|Overall Study|Adverse Event|43|||
170751332|NCT01021332|617095835|FG000|Overall Study|Lack of Efficacy|19|||
170751333|NCT01021332|617095835|FG000|Overall Study|Withdrawal of Consent|23|||
170751334|NCT01021332|617095835|FG000|Overall Study|Lost to Follow-up|4|||
170751335|NCT01021332|617095835|FG000|Overall Study|Protocol Violation|9|||
170751336|NCT01021332|617095835|FG000|Overall Study|Miscellaneous|3|||
170751337|NCT05343455|617095840|FG000|Overall Study|Withdrawal by Subject|4|||
170751338|NCT05343455|617095841|FG001|Overall Study|Withdrawal by Subject|9|||
170751339|NCT05343455|617095842|FG002|Overall Study|Withdrawal by Subject|7|||
170751340|NCT05343455|617095840|FG000|Overall Study|Adverse Event|2|||
170751341|NCT05343455|617095841|FG001|Overall Study|Adverse Event|1|||
170751342|NCT05343455|617095842|FG002|Overall Study|Adverse Event|2|||
170751343|NCT05343455|617095840|FG000|Overall Study|Lost to Follow-up|1|||
170751344|NCT05343455|617095841|FG001|Overall Study|Lost to Follow-up|1|||
170751345|NCT05343455|617095842|FG002|Overall Study|Lost to Follow-up|3|||
170751346|NCT05343455|617095840|FG000|Overall Study|Pregnancy|1|||
170751347|NCT05343455|617095841|FG001|Overall Study|Pregnancy|0|||
170751348|NCT05343455|617095842|FG002|Overall Study|Pregnancy|0|||
170751349|NCT05343455|617095840|FG000|Overall Study|Physician Decision|0|||
170751350|NCT05343455|617095841|FG001|Overall Study|Physician Decision|0|||
170751351|NCT05343455|617095842|FG002|Overall Study|Physician Decision|1|||
170751352|NCT05343455|617095840|FG000|Overall Study|Protocol Violation|0|||
170751353|NCT05343455|617095841|FG001|Overall Study|Protocol Violation|1|||
170751354|NCT05343455|617095842|FG002|Overall Study|Protocol Violation|1|||
170751355|NCT04006366|617095844|FG000|Overall Study|Withdrawal by Subject|1|||
170751356|NCT01123161|617095849|FG000|Overall Study|Lost to Follow-up|1|||
170751357|NCT01123161|617095850|FG001|Overall Study|Lost to Follow-up|0|||
170751358|NCT01123161|617095849|FG000|Overall Study|Withdrawal by Subject|1|||
170751359|NCT01123161|617095850|FG001|Overall Study|Withdrawal by Subject|0|||
170751360|NCT02800928|617095861|FG000|Overall Study|Withdrawal by Subject|1|||
170751361|NCT02800928|617095862|FG001|Overall Study|Withdrawal by Subject|1|||
170751362|NCT02800928|617095861|FG000|Overall Study|Protocol Violation|1|||
170751363|NCT02800928|617095862|FG001|Overall Study|Protocol Violation|1|||
170751364|NCT00109928|617095863|FG000|Overall Study|Adverse Event|2|||
170751365|NCT00109928|617095863|FG000|Overall Study|Progression|6|||
170751366|NCT00109928|617095863|FG000|Overall Study|Death|2|||
170751367|NCT00109928|617095863|FG000|Overall Study|not protocol specified|2|||
170751368|NCT00109928|617095863|FG000|Overall Study|not eligible|1|||
170631516|NCT02113982|616664413|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
170631517|NCT02113982|616664414|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
170751369|NCT01676220|617095868|FG000|Overall Study|Randomized But Not Treated|4|||
170751370|NCT01676220|617095869|FG001|Overall Study|Randomized But Not Treated|1|||
170751371|NCT01676220|617095868|FG000|Overall Study|Adverse Event|10|||
170751372|NCT01676220|617095869|FG001|Overall Study|Adverse Event|8|||
170751373|NCT01676220|617095868|FG000|Overall Study|Lack of Efficacy|2|||
170751374|NCT01676220|617095869|FG001|Overall Study|Lack of Efficacy|5|||
170751375|NCT01676220|617095868|FG000|Overall Study|Protocol Violation|11|||
170751376|NCT01676220|617095869|FG001|Overall Study|Protocol Violation|12|||
170751377|NCT01676220|617095868|FG000|Overall Study|Received Rescue Therapy|14|||
170751378|NCT01676220|617095869|FG001|Overall Study|Received Rescue Therapy|22|||
170751379|NCT01676220|617095868|FG000|Overall Study|Personal Reason|34|||
170751380|NCT01676220|617095869|FG001|Overall Study|Personal Reason|45|||
170751381|NCT01676220|617095868|FG000|Overall Study|Lost to Follow-up|11|||
170751382|NCT01676220|617095869|FG001|Overall Study|Lost to Follow-up|18|||
170863472|NCT04652726|617511464|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
170863473|NCT04442737|617511465|FG000|Overall Study|Lost to Follow-up|1|||
170863474|NCT04442737|617511466|FG001|Overall Study|Lost to Follow-up|3|||
170863475|NCT04442737|617511465|FG000|Overall Study|Withdrawal by Subject|3|||
170863476|NCT04442737|617511466|FG001|Overall Study|Withdrawal by Subject|2|||
170863477|NCT04442737|617511465|FG000|Overall Study|Adverse Event|3|||
170863478|NCT04442737|617511466|FG001|Overall Study|Adverse Event|2|||
170863479|NCT04442737|617511465|FG000|Overall Study|Death|0|||
170863480|NCT04442737|617511466|FG001|Overall Study|Death|1|||
170863481|NCT04442737|617511465|FG000|Overall Study|Protocol Violation|0|||
170863482|NCT04442737|617511466|FG001|Overall Study|Protocol Violation|2|||
170863483|NCT04442737|617511465|FG000|Overall Study|Other|1|||
170863484|NCT04442737|617511466|FG001|Overall Study|Other|1|||
170863485|NCT00744523|617511467|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
170863486|NCT00744523|617511468|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
170863487|NCT01139021|617511469|FG000|Overall Study|Adverse Event|0|||
170863488|NCT01139021|617511470|FG001|Overall Study|Adverse Event|0|||
170863489|NCT01139021|617511471|FG002|Overall Study|Adverse Event|0|||
170863490|NCT01139021|617511472|FG003|Overall Study|Adverse Event|0|||
170863491|NCT01139021|617511473|FG004|Overall Study|Adverse Event|1|||
170863492|NCT01139021|617511474|FG005|Overall Study|Adverse Event|0|||
170863493|NCT01139021|617511469|FG000|Overall Study|Lost to Follow-up|0|||
170863494|NCT01139021|617511470|FG001|Overall Study|Lost to Follow-up|0|||
170863495|NCT01139021|617511471|FG002|Overall Study|Lost to Follow-up|0|||
170863496|NCT01139021|617511472|FG003|Overall Study|Lost to Follow-up|0|||
170863497|NCT01139021|617511473|FG004|Overall Study|Lost to Follow-up|2|||
170863498|NCT01139021|617511474|FG005|Overall Study|Lost to Follow-up|0|||
170863499|NCT01139021|617511469|FG000|Overall Study|Protocol Violation|1|||
170863500|NCT01139021|617511470|FG001|Overall Study|Protocol Violation|0|||
170863501|NCT01139021|617511471|FG002|Overall Study|Protocol Violation|0|||
170863502|NCT01139021|617511472|FG003|Overall Study|Protocol Violation|0|||
170863503|NCT01139021|617511473|FG004|Overall Study|Protocol Violation|2|||
170863504|NCT01139021|617511474|FG005|Overall Study|Protocol Violation|0|||
170863505|NCT01139021|617511469|FG000|Overall Study|Withdrawal by Subject|0|||
170863506|NCT01139021|617511470|FG001|Overall Study|Withdrawal by Subject|0|||
170863507|NCT01139021|617511471|FG002|Overall Study|Withdrawal by Subject|0|||
170863508|NCT01139021|617511472|FG003|Overall Study|Withdrawal by Subject|1|||
170631518|NCT02113982|616664415|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
170751383|NCT01676220|617095868|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
170751384|NCT01676220|617095869|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
170751385|NCT01676220|617095868|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
170751386|NCT01676220|617095869|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
170751387|NCT01676220|617095868|FG000|Overall Study|Perceived Lack of Efficacy|3|||
170751388|NCT01676220|617095869|FG001|Overall Study|Perceived Lack of Efficacy|1|||
170751389|NCT01676220|617095868|FG000|Overall Study|Non Serious Hypoglycemia|2|||
170751390|NCT01676220|617095869|FG001|Overall Study|Non Serious Hypoglycemia|0|||
170751391|NCT01676220|617095868|FG000|Overall Study|No More Need of Insulin|1|||
170751392|NCT01676220|617095869|FG001|Overall Study|No More Need of Insulin|0|||
170751393|NCT01310868|617095870|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
170751394|NCT02411591|617095871|FG000|Overall Study|Adverse Event|0|||
170751395|NCT02411591|617095872|FG001|Overall Study|Adverse Event|4|||
170751396|NCT02411591|617095873|FG002|Overall Study|Adverse Event|2|||
170751397|NCT02411591|617095871|FG000|Overall Study|Withdrawal by Subject|0|||
170751398|NCT02411591|617095872|FG001|Overall Study|Withdrawal by Subject|3|||
170751399|NCT02411591|617095873|FG002|Overall Study|Withdrawal by Subject|0|||
170751400|NCT02411591|617095871|FG000|Overall Study|Physician Decision|0|||
170751401|NCT02411591|617095872|FG001|Overall Study|Physician Decision|3|||
170751402|NCT02411591|617095873|FG002|Overall Study|Physician Decision|1|||
170751403|NCT00065468|617095876|FG000|Overall Study|Death|172|||
170751404|NCT00065468|617095877|FG001|Overall Study|Death|169|||
170751405|NCT00065468|617095878|FG002|Overall Study|Death|171|||
170751406|NCT00065468|617095876|FG000|Overall Study|Withdrawal by Subject|3|||
170751407|NCT00065468|617095877|FG001|Overall Study|Withdrawal by Subject|4|||
170751408|NCT00065468|617095878|FG002|Overall Study|Withdrawal by Subject|5|||
170751409|NCT00065468|617095876|FG000|Overall Study|Lost to Follow-up|5|||
170751410|NCT00065468|617095877|FG001|Overall Study|Lost to Follow-up|3|||
170751411|NCT00065468|617095878|FG002|Overall Study|Lost to Follow-up|2|||
170751412|NCT00065468|617095876|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
170751413|NCT00065468|617095877|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
170751414|NCT00065468|617095878|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
170751415|NCT00065468|617095876|FG000|Overall Study|Disease progression|0|||
170751416|NCT00065468|617095877|FG001|Overall Study|Disease progression|0|||
170751417|NCT00065468|617095878|FG002|Overall Study|Disease progression|1|||
170751418|NCT00065468|617095876|FG000|Overall Study|Other|14|||
170751419|NCT00065468|617095877|FG001|Overall Study|Other|24|||
170863509|NCT01139021|617511473|FG004|Overall Study|Withdrawal by Subject|4|||
170863510|NCT01139021|617511474|FG005|Overall Study|Withdrawal by Subject|0|||
170863511|NCT05458479|617511479|FG000|Overall Study|Lost to Follow-up|1|||
170863512|NCT00784693|617511480|FG000|Overall Study|Lost to Follow-up|0|||
170863513|NCT00784693|617511481|FG001|Overall Study|Lost to Follow-up|1|||
170863514|NCT00784693|617511480|FG000|Overall Study|Lack of Efficacy|1|||
170863515|NCT00784693|617511481|FG001|Overall Study|Lack of Efficacy|1|||
170863516|NCT00784693|617511480|FG000|Overall Study|Withdrawal by Subject|0|||
170863517|NCT00784693|617511481|FG001|Overall Study|Withdrawal by Subject|4|||
170863518|NCT00784693|617511480|FG000|Overall Study|Randomized but not Treated|1|||
170863519|NCT00784693|617511481|FG001|Overall Study|Randomized but not Treated|0|||
170863520|NCT00784693|617511480|FG000|Overall Study|Other|1|||
170863521|NCT00784693|617511481|FG001|Overall Study|Other|0|||
170863522|NCT02349451|617511482|FG000|Overall Study|Withdrawal by Subject|0|||
170863523|NCT02349451|617511483|FG001|Overall Study|Withdrawal by Subject|1|||
170863524|NCT02349451|617511484|FG002|Overall Study|Withdrawal by Subject|2|||
170863525|NCT02349451|617511485|FG003|Overall Study|Withdrawal by Subject|1|||
170863526|NCT02147353|617511486|FG000|Overall Study|Lost to Follow-up|2|||
170863527|NCT02147353|617511487|FG001|Overall Study|Lost to Follow-up|0|||
170863528|NCT02147353|617511486|FG000|Overall Study|unable to make visits|4|||
170863529|NCT02147353|617511487|FG001|Overall Study|unable to make visits|0|||
170863530|NCT02147353|617511486|FG000|Overall Study|medication noncompliance|3|||
170863531|NCT02147353|617511487|FG001|Overall Study|medication noncompliance|0|||
170863532|NCT02604199|617511491|FG000|Overall Study|Pregnancy|0|||
170863533|NCT02604199|617511492|FG001|Overall Study|Pregnancy|0|||
170863534|NCT02604199|617511493|FG002|Overall Study|Pregnancy|0|||
170863535|NCT02604199|617511494|FG003|Overall Study|Pregnancy|1|||
170863536|NCT02604199|617511491|FG000|Overall Study|Study terminated by sponsor|0|||
170863537|NCT02604199|617511492|FG001|Overall Study|Study terminated by sponsor|2|||
170863538|NCT02604199|617511493|FG002|Overall Study|Study terminated by sponsor|0|||
170863539|NCT02604199|617511494|FG003|Overall Study|Study terminated by sponsor|2|||
170863540|NCT02604199|617511491|FG000|Overall Study|Withdrawal by Subject|0|||
170863541|NCT02604199|617511492|FG001|Overall Study|Withdrawal by Subject|1|||
170863542|NCT02604199|617511493|FG002|Overall Study|Withdrawal by Subject|0|||
170863543|NCT02604199|617511494|FG003|Overall Study|Withdrawal by Subject|0|||
170863544|NCT02604212|617511496|FG000|Overall Study|Study Terminated by Sponsor|2|||
170863545|NCT02604212|617511497|FG001|Overall Study|Study Terminated by Sponsor|1|||
170863546|NCT02604212|617511498|FG002|Overall Study|Study Terminated by Sponsor|3|||
170863547|NCT02604212|617511499|FG003|Overall Study|Study Terminated by Sponsor|3|||
170863548|NCT02604212|617511496|FG000|Overall Study|Withdrawal by Subject|0|||
170863549|NCT02604212|617511497|FG001|Overall Study|Withdrawal by Subject|0|||
170863550|NCT02604212|617511498|FG002|Overall Study|Withdrawal by Subject|1|||
170863551|NCT02604212|617511499|FG003|Overall Study|Withdrawal by Subject|0|||
170863552|NCT02578862|617511500|FG000|Overall Study|Withdrawal by Subject|0|||
170863553|NCT02578862|617511501|FG001|Overall Study|Withdrawal by Subject|1|||
170863554|NCT02578862|617511500|FG000|Overall Study|Unplanned unilateral procedure|0|||
170863555|NCT02578862|617511501|FG001|Overall Study|Unplanned unilateral procedure|1|||
170863556|NCT01176773|617511504|FG000|Overall Study|Screen Failure|2|||
170863557|NCT01176773|617511504|FG000|Overall Study|Withdrew consent|1|||
170863558|NCT01498289|617511511|FG000|Overall Study|Adverse Event|16|||
170863559|NCT01498289|617511512|FG001|Overall Study|Adverse Event|18|||
170863560|NCT01498289|617511511|FG000|Overall Study|Death|6|||
170863561|NCT01498289|617511512|FG001|Overall Study|Death|8|||
170863562|NCT01498289|617511511|FG000|Overall Study|Withdrawal unrelated to AE|16|||
170863563|NCT01498289|617511512|FG001|Overall Study|Withdrawal unrelated to AE|16|||
170863564|NCT01498289|617511511|FG000|Overall Study|Progression/relapse|53|||
170863565|NCT01498289|617511512|FG001|Overall Study|Progression/relapse|59|||
170863566|NCT01498289|617511511|FG000|Overall Study|Not protocol specified|7|||
170863567|NCT01498289|617511512|FG001|Overall Study|Not protocol specified|2|||
170863568|NCT01498289|617511511|FG000|Overall Study|Reason under review|0|||
170863569|NCT01498289|617511512|FG001|Overall Study|Reason under review|1|||
170863570|NCT00752622|617511534|FG000|Induction Phase|Adverse Event|3|||
170863571|NCT00752622|617511534|FG000|Induction Phase|Other|3|||
170863572|NCT00752622|617511534|FG000|Induction Phase|Non-responder|14|||
170863573|NCT00752622|617511534|FG000|Induction Phase|Withdrawal by Subject|1|||
170863574|NCT00752622|617511534|FG000|Induction Phase|Premature study termination|14|||
170863575|NCT00752622|617511534|FG000|Observational Phase|Premature Study Termination|36|||
170863576|NCT00752622|617511534|FG000|Observational Phase|Non-responder|2|||
170863577|NCT00752622|617511534|FG000|Observational Phase|Withdrawal by Subject|2|||
170863578|NCT00752622|617511534|FG000|Observational Phase|Adverse Event|1|||
170863579|NCT00752622|617511534|FG000|Observational Phase|Other|2|||
170863580|NCT00752622|617511534|FG000|Interventional Phase|Non-responder|2|||
170863581|NCT00752622|617511534|FG000|Interventional Phase|Physician Decision|1|||
170863582|NCT00752622|617511534|FG000|Interventional Phase|Premature Study Termination|5|||
170863583|NCT05358717|617511535|FG000|Overall Study|Adverse Event|0|||
170863584|NCT05358717|617511536|FG001|Overall Study|Adverse Event|1|||
170863585|NCT05358717|617511537|FG002|Overall Study|Adverse Event|1|||
170863586|NCT05358717|617511535|FG000|Overall Study|Death|1|||
170863587|NCT05358717|617511536|FG001|Overall Study|Death|1|||
170863588|NCT05358717|617511537|FG002|Overall Study|Death|0|||
170863589|NCT05358717|617511535|FG000|Overall Study|Withdrawal by Subject|1|||
170751420|NCT00065468|617095878|FG002|Overall Study|Other|18|||
170751421|NCT00873093|617095879|FG000|Overall Study|Adverse Event|0|||
170751422|NCT00873093|617095880|FG001|Overall Study|Adverse Event|2|||
170751423|NCT00873093|617095881|FG002|Overall Study|Adverse Event|0|||
170751424|NCT00873093|617095882|FG003|Overall Study|Adverse Event|0|||
170751425|NCT00873093|617095883|FG004|Overall Study|Adverse Event|0|||
170751426|NCT00873093|617095879|FG000|Overall Study|Death|0|||
170751427|NCT00873093|617095880|FG001|Overall Study|Death|3|||
170751428|NCT00873093|617095881|FG002|Overall Study|Death|2|||
170751429|NCT00873093|617095882|FG003|Overall Study|Death|0|||
170751430|NCT00873093|617095883|FG004|Overall Study|Death|0|||
170751431|NCT00873093|617095879|FG000|Overall Study|Physician Decision|0|||
170751432|NCT00873093|617095880|FG001|Overall Study|Physician Decision|17|||
170751433|NCT00873093|617095881|FG002|Overall Study|Physician Decision|10|||
170751434|NCT00873093|617095882|FG003|Overall Study|Physician Decision|10|||
170751435|NCT00873093|617095883|FG004|Overall Study|Physician Decision|2|||
170751436|NCT00873093|617095879|FG000|Overall Study|Withdrawal by Subject|1|||
170751437|NCT00873093|617095880|FG001|Overall Study|Withdrawal by Subject|4|||
170751438|NCT00873093|617095881|FG002|Overall Study|Withdrawal by Subject|4|||
170751439|NCT00873093|617095882|FG003|Overall Study|Withdrawal by Subject|0|||
170751440|NCT00873093|617095883|FG004|Overall Study|Withdrawal by Subject|0|||
170751441|NCT00873093|617095879|FG000|Overall Study|Ineligible|0|||
170751442|NCT00873093|617095880|FG001|Overall Study|Ineligible|1|||
170751443|NCT00873093|617095881|FG002|Overall Study|Ineligible|0|||
170751444|NCT00873093|617095882|FG003|Overall Study|Ineligible|1|||
170751445|NCT00873093|617095883|FG004|Overall Study|Ineligible|0|||
170751446|NCT01708187|617095884|FG000|Overall Study|Lost to Follow-up|0|||
170751447|NCT01708187|617095885|FG001|Overall Study|Lost to Follow-up|1|||
170751448|NCT00146640|617095887|FG000|Overall Study|Adverse Event|12|||
170751449|NCT00146640|617095888|FG001|Overall Study|Adverse Event|10|||
170751450|NCT00146640|617095887|FG000|Overall Study|Medical Reasons|3|||
170751451|NCT00146640|617095888|FG001|Overall Study|Medical Reasons|0|||
170751452|NCT00146640|617095887|FG000|Overall Study|Non-Medical Reasons|8|||
170751453|NCT00146640|617095888|FG001|Overall Study|Non-Medical Reasons|4|||
170751454|NCT03486899|617095889|FG000|Overall Study|Lost to Follow-up|4|||
170751455|NCT03486899|617095890|FG001|Overall Study|Lost to Follow-up|1|||
170751456|NCT03486899|617095891|FG002|Overall Study|Lost to Follow-up|4|||
170751457|NCT03486899|617095892|FG003|Overall Study|Lost to Follow-up|3|||
170751458|NCT03486899|617095889|FG000|Overall Study|Death|1|||
170751459|NCT03486899|617095890|FG001|Overall Study|Death|0|||
170751460|NCT03486899|617095891|FG002|Overall Study|Death|0|||
170751461|NCT03486899|617095892|FG003|Overall Study|Death|1|||
170751462|NCT03486899|617095889|FG000|Overall Study|Adverse Event|0|||
170751463|NCT03486899|617095890|FG001|Overall Study|Adverse Event|2|||
170751464|NCT03486899|617095891|FG002|Overall Study|Adverse Event|0|||
170751465|NCT03486899|617095892|FG003|Overall Study|Adverse Event|2|||
170751466|NCT03486899|617095889|FG000|Overall Study|Withdrawal by Subject|3|||
170751467|NCT03486899|617095890|FG001|Overall Study|Withdrawal by Subject|7|||
170751468|NCT03486899|617095891|FG002|Overall Study|Withdrawal by Subject|4|||
170751469|NCT03486899|617095892|FG003|Overall Study|Withdrawal by Subject|3|||
170751470|NCT03486899|617095889|FG000|Overall Study|Other Reasons|0|||
170751471|NCT03486899|617095890|FG001|Overall Study|Other Reasons|1|||
170751472|NCT03486899|617095891|FG002|Overall Study|Other Reasons|0|||
170751473|NCT03486899|617095892|FG003|Overall Study|Other Reasons|1|||
170751474|NCT04242875|617095893|FG000|Overall Study|Adverse Event|2|||
170751475|NCT02397460|617095894|FG000|Treatment Period 2|Adverse Event|0|||
170751476|NCT02397460|617095895|FG001|Treatment Period 2|Adverse Event|0|||
170863590|NCT05358717|617511536|FG001|Overall Study|Withdrawal by Subject|1|||
170863591|NCT05358717|617511537|FG002|Overall Study|Withdrawal by Subject|2|||
170863592|NCT05358717|617511535|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
170863593|NCT05358717|617511536|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
170751477|NCT02397460|617095896|FG002|Treatment Period 2|Adverse Event|0|||
170751478|NCT02397460|617095897|FG003|Treatment Period 2|Adverse Event|0|||
170751479|NCT02397460|617095898|FG004|Treatment Period 2|Adverse Event|0|||
170751480|NCT02397460|617095899|FG005|Treatment Period 2|Adverse Event|0|||
170751481|NCT02397460|617095900|FG006|Treatment Period 2|Adverse Event|0|||
170751482|NCT02397460|617095901|FG007|Treatment Period 2|Adverse Event|1|||
170751483|NCT02397460|617095894|FG000|Treatment Period 4|Adverse Event|0|||
170751484|NCT02397460|617095895|FG001|Treatment Period 4|Adverse Event|1|||
170751485|NCT02397460|617095896|FG002|Treatment Period 4|Adverse Event|0|||
170751486|NCT02397460|617095897|FG003|Treatment Period 4|Adverse Event|0|||
170751487|NCT02397460|617095898|FG004|Treatment Period 4|Adverse Event|0|||
170751488|NCT02397460|617095899|FG005|Treatment Period 4|Adverse Event|0|||
170751489|NCT02397460|617095900|FG006|Treatment Period 4|Adverse Event|0|||
170751490|NCT02397460|617095901|FG007|Treatment Period 4|Adverse Event|0|||
170751491|NCT02397460|617095894|FG000|Treatment Period 4|Physician Decision|0|||
170751492|NCT02397460|617095895|FG001|Treatment Period 4|Physician Decision|0|||
170751493|NCT02397460|617095896|FG002|Treatment Period 4|Physician Decision|0|||
170751494|NCT02397460|617095897|FG003|Treatment Period 4|Physician Decision|0|||
170751495|NCT02397460|617095898|FG004|Treatment Period 4|Physician Decision|1|||
170863594|NCT05358717|617511537|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
170863595|NCT02640157|617511539|FG000|Overall Study|Adverse Event|2|||
170863596|NCT02640157|617511540|FG001|Overall Study|Adverse Event|2|||
170863597|NCT02640157|617511541|FG002|Overall Study|Adverse Event|1|||
170863598|NCT02640157|617511539|FG000|Overall Study|Withdrew consent|2|||
170863599|NCT02640157|617511540|FG001|Overall Study|Withdrew consent|0|||
170863600|NCT02640157|617511541|FG002|Overall Study|Withdrew consent|2|||
170863601|NCT02640157|617511539|FG000|Overall Study|Lost to Follow-up|9|||
170863602|NCT02640157|617511540|FG001|Overall Study|Lost to Follow-up|2|||
170863603|NCT02640157|617511541|FG002|Overall Study|Lost to Follow-up|7|||
170863604|NCT02640157|617511539|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
170863605|NCT02640157|617511540|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
170863606|NCT02640157|617511541|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
170863607|NCT00894686|617511542|FG000|Overall Study|Withdrawal by Subject|50|||
170863608|NCT00894686|617511542|FG000|Overall Study|Physician Decision|1|||
170863609|NCT00894686|617511542|FG000|Overall Study|Other|5|||
170863610|NCT00753272|617511546|FG000|Overall Study|Adverse Event|878|||
170863611|NCT00753272|617511547|FG001|Overall Study|Adverse Event|869|||
170863612|NCT00753272|617511546|FG000|Overall Study|Protocol Violation|28|||
170863613|NCT00753272|617511547|FG001|Overall Study|Protocol Violation|46|||
170863614|NCT00753272|617511546|FG000|Overall Study|Withdrawal by Subject|2481|||
170863615|NCT00753272|617511547|FG001|Overall Study|Withdrawal by Subject|2407|||
170863616|NCT00753272|617511546|FG000|Overall Study|Lost to Follow-up|491|||
170863617|NCT00753272|617511547|FG001|Overall Study|Lost to Follow-up|497|||
170863618|NCT00753272|617511546|FG000|Overall Study|Other|1104|||
170863619|NCT00753272|617511547|FG001|Overall Study|Other|1088|||
170863620|NCT00803270|617511548|FG000|Overall Study|Lost to Follow-up|1|||
170863621|NCT00803270|617511549|FG001|Overall Study|Lost to Follow-up|2|||
170863622|NCT02092220|617511551|FG000|Period 1|Unrelated Illness|0|||
170863623|NCT02092220|617511552|FG001|Period 1|Unrelated Illness|2|||
170863624|NCT02092220|617511551|FG000|Period 2|Severe Hypoglycaemia|1|||
170863625|NCT02092220|617511552|FG001|Period 2|Severe Hypoglycaemia|0|||
170863626|NCT02092220|617511551|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
170863627|NCT02092220|617511552|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
170863628|NCT01030198|617511554|FG000|Overall Study|Could not measure efficacy accurately|0|||
170863629|NCT01030198|617511555|FG001|Overall Study|Could not measure efficacy accurately|7|||
170863630|NCT01485354|617513388|FG000|Overall Study|Withdrawal by Subject|5|||
170863631|NCT00523718|617513389|FG000|Overall Study|Withdrawal by Subject|1|||
170863632|NCT00523718|617513390|FG001|Overall Study|Withdrawal by Subject|0|||
170863633|NCT00523718|617513389|FG000|Overall Study|Protocol Violation|2|||
170863634|NCT00523718|617513390|FG001|Overall Study|Protocol Violation|0|||
170863635|NCT01306890|617513391|FG000|Overall Study|Adverse Event|2|||
170863636|NCT01306890|617513391|FG000|Overall Study|Death|1223|||
170863637|NCT01306890|617513391|FG000|Overall Study|Lost to Follow-up|58|||
170863638|NCT01306890|617513391|FG000|Overall Study|Withdrawal by Subject|88|||
170863639|NCT01306890|617513391|FG000|Overall Study|Unspecified reasons|104|||
170863640|NCT01306890|617513391|FG000|Overall Study|Study Termination|3|||
170863641|NCT01306890|617513391|FG000|Overall Study|No discontinuation documentation|41|||
170863642|NCT02217436|617513398|FG000|Overall Study|Protocol Violation|1|||
170863643|NCT02217436|617513399|FG001|Overall Study|Protocol Violation|1|||
170863644|NCT02217436|617513398|FG000|Overall Study|Incomplete data|0|||
170863645|NCT02217436|617513399|FG001|Overall Study|Incomplete data|1|||
170863646|NCT04641299|617513412|FG000|Overall Study|Adverse Event|0|||
170863647|NCT04641299|617513413|FG001|Overall Study|Adverse Event|0|||
170863648|NCT04641299|617513414|FG002|Overall Study|Adverse Event|2|||
170863649|NCT04641299|617513415|FG003|Overall Study|Adverse Event|0|||
170863650|NCT04641299|617513412|FG000|Overall Study|Lost to Follow-up|0|||
170863651|NCT04641299|617513413|FG001|Overall Study|Lost to Follow-up|1|||
170863652|NCT04641299|617513414|FG002|Overall Study|Lost to Follow-up|0|||
170863653|NCT04641299|617513415|FG003|Overall Study|Lost to Follow-up|0|||
170863654|NCT04641299|617513412|FG000|Overall Study|Withdrawal by Subject|1|||
170863655|NCT04641299|617513413|FG001|Overall Study|Withdrawal by Subject|0|||
170863656|NCT04641299|617513414|FG002|Overall Study|Withdrawal by Subject|0|||
170863657|NCT04641299|617513415|FG003|Overall Study|Withdrawal by Subject|0|||
170863658|NCT04641299|617513412|FG000|Overall Study|Reason not given|1|||
170863659|NCT04641299|617513413|FG001|Overall Study|Reason not given|0|||
170863660|NCT04641299|617513414|FG002|Overall Study|Reason not given|0|||
170863661|NCT04641299|617513415|FG003|Overall Study|Reason not given|0|||
170863662|NCT01128361|617513419|FG000|Overall Study|Lost to Follow-up|0|||
170863663|NCT01128361|617513420|FG001|Overall Study|Lost to Follow-up|1|||
170863664|NCT01128361|617513419|FG000|Overall Study|Withdrawal by Subject|5|||
170863665|NCT01128361|617513420|FG001|Overall Study|Withdrawal by Subject|2|||
170863666|NCT04796896|617513421|FG000|Overall Study|Adverse Event|1|||
170863667|NCT04796896|617513422|FG001|Overall Study|Adverse Event|0|||
170863668|NCT04796896|617513423|FG002|Overall Study|Adverse Event|0|||
170863669|NCT04796896|617513424|FG003|Overall Study|Adverse Event|0|||
170863670|NCT04796896|617513425|FG004|Overall Study|Adverse Event|0|||
170863671|NCT04796896|617513426|FG005|Overall Study|Adverse Event|1|||
170863672|NCT04796896|617513427|FG006|Overall Study|Adverse Event|1|||
170863673|NCT04796896|617513428|FG007|Overall Study|Adverse Event|0|||
170863674|NCT04796896|617513429|FG008|Overall Study|Adverse Event|1|||
170863675|NCT04796896|617513430|FG009|Overall Study|Adverse Event|1|||
170863676|NCT04796896|617513431|FG010|Overall Study|Adverse Event|1|||
170863677|NCT04796896|617513432|FG011|Overall Study|Adverse Event|0|||
170863678|NCT04796896|617513421|FG000|Overall Study|Lost to Follow-up|24|||
170863679|NCT04796896|617513422|FG001|Overall Study|Lost to Follow-up|15|||
170863680|NCT04796896|617513423|FG002|Overall Study|Lost to Follow-up|6|||
170863681|NCT04796896|617513424|FG003|Overall Study|Lost to Follow-up|4|||
170863682|NCT04796896|617513425|FG004|Overall Study|Lost to Follow-up|21|||
170863683|NCT04796896|617513426|FG005|Overall Study|Lost to Follow-up|55|||
170863684|NCT04796896|617513427|FG006|Overall Study|Lost to Follow-up|237|||
170863685|NCT04796896|617513428|FG007|Overall Study|Lost to Follow-up|52|||
170863686|NCT04796896|617513429|FG008|Overall Study|Lost to Follow-up|221|||
170863687|NCT04796896|617513430|FG009|Overall Study|Lost to Follow-up|43|||
170863688|NCT04796896|617513431|FG010|Overall Study|Lost to Follow-up|142|||
170863689|NCT04796896|617513432|FG011|Overall Study|Lost to Follow-up|18|||
170863690|NCT04796896|617513421|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
170863691|NCT04796896|617513422|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
170863692|NCT04796896|617513423|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
170863693|NCT04796896|617513424|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
170863694|NCT04796896|617513425|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
170863695|NCT04796896|617513426|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
170863696|NCT04796896|617513427|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
170863697|NCT04796896|617513428|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
170863698|NCT04796896|617513429|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
170863699|NCT04796896|617513430|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
170863700|NCT04796896|617513431|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
170863701|NCT04796896|617513432|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
170863702|NCT04796896|617513421|FG000|Overall Study|Physician Decision|1|||
170863703|NCT04796896|617513422|FG001|Overall Study|Physician Decision|0|||
170863704|NCT04796896|617513423|FG002|Overall Study|Physician Decision|0|||
170863705|NCT04796896|617513424|FG003|Overall Study|Physician Decision|0|||
170863706|NCT04796896|617513425|FG004|Overall Study|Physician Decision|0|||
170863707|NCT04796896|617513426|FG005|Overall Study|Physician Decision|3|||
170863708|NCT04796896|617513427|FG006|Overall Study|Physician Decision|18|||
170863709|NCT04796896|617513428|FG007|Overall Study|Physician Decision|1|||
170863710|NCT04796896|617513429|FG008|Overall Study|Physician Decision|7|||
170863711|NCT04796896|617513430|FG009|Overall Study|Physician Decision|0|||
170863712|NCT04796896|617513431|FG010|Overall Study|Physician Decision|5|||
170863713|NCT04796896|617513432|FG011|Overall Study|Physician Decision|0|||
170863714|NCT04796896|617513421|FG000|Overall Study|Withdrawal by Subject|36|||
170863715|NCT04796896|617513422|FG001|Overall Study|Withdrawal by Subject|31|||
170863716|NCT04796896|617513423|FG002|Overall Study|Withdrawal by Subject|11|||
170863717|NCT04796896|617513424|FG003|Overall Study|Withdrawal by Subject|8|||
170863718|NCT04796896|617513425|FG004|Overall Study|Withdrawal by Subject|16|||
170863719|NCT04796896|617513426|FG005|Overall Study|Withdrawal by Subject|162|||
170863720|NCT04796896|617513427|FG006|Overall Study|Withdrawal by Subject|299|||
170863721|NCT04796896|617513428|FG007|Overall Study|Withdrawal by Subject|149|||
170863722|NCT04796896|617513429|FG008|Overall Study|Withdrawal by Subject|303|||
170863723|NCT04796896|617513430|FG009|Overall Study|Withdrawal by Subject|94|||
170863724|NCT04796896|617513431|FG010|Overall Study|Withdrawal by Subject|192|||
170863725|NCT04796896|617513432|FG011|Overall Study|Withdrawal by Subject|16|||
170863726|NCT04796896|617513421|FG000|Overall Study|Other Than Specified|6|||
170863727|NCT04796896|617513422|FG001|Overall Study|Other Than Specified|5|||
170863728|NCT04796896|617513423|FG002|Overall Study|Other Than Specified|3|||
170863729|NCT04796896|617513424|FG003|Overall Study|Other Than Specified|2|||
170863730|NCT04796896|617513425|FG004|Overall Study|Other Than Specified|6|||
170863731|NCT04796896|617513426|FG005|Overall Study|Other Than Specified|31|||
170863732|NCT04796896|617513427|FG006|Overall Study|Other Than Specified|86|||
170863733|NCT04796896|617513428|FG007|Overall Study|Other Than Specified|66|||
170863734|NCT04796896|617513429|FG008|Overall Study|Other Than Specified|388|||
170863735|NCT04796896|617513430|FG009|Overall Study|Other Than Specified|48|||
170863736|NCT04796896|617513431|FG010|Overall Study|Other Than Specified|258|||
170863737|NCT04796896|617513432|FG011|Overall Study|Other Than Specified|4|||
170863738|NCT04796896|617513421|FG000|Overall Study|Protocol Deviation|0|||
170863739|NCT04796896|617513422|FG001|Overall Study|Protocol Deviation|0|||
170863740|NCT04796896|617513423|FG002|Overall Study|Protocol Deviation|0|||
170863741|NCT04796896|617513424|FG003|Overall Study|Protocol Deviation|1|||
170863742|NCT04796896|617513425|FG004|Overall Study|Protocol Deviation|1|||
170863743|NCT04796896|617513426|FG005|Overall Study|Protocol Deviation|2|||
170863744|NCT04796896|617513427|FG006|Overall Study|Protocol Deviation|2|||
170863745|NCT04796896|617513428|FG007|Overall Study|Protocol Deviation|2|||
170863746|NCT04796896|617513429|FG008|Overall Study|Protocol Deviation|2|||
170863747|NCT04796896|617513430|FG009|Overall Study|Protocol Deviation|1|||
170863748|NCT04796896|617513431|FG010|Overall Study|Protocol Deviation|0|||
170863749|NCT04796896|617513432|FG011|Overall Study|Protocol Deviation|0|||
170863750|NCT04796896|617513421|FG000|Overall Study|Missing|0|||
170863751|NCT04796896|617513422|FG001|Overall Study|Missing|0|||
170863752|NCT04796896|617513423|FG002|Overall Study|Missing|0|||
170863753|NCT04796896|617513424|FG003|Overall Study|Missing|0|||
170863754|NCT04796896|617513425|FG004|Overall Study|Missing|0|||
170863755|NCT04796896|617513426|FG005|Overall Study|Missing|0|||
170863756|NCT04796896|617513427|FG006|Overall Study|Missing|2|||
170863757|NCT04796896|617513428|FG007|Overall Study|Missing|1|||
170863758|NCT04796896|617513429|FG008|Overall Study|Missing|2|||
170863759|NCT04796896|617513430|FG009|Overall Study|Missing|1|||
170863760|NCT04796896|617513431|FG010|Overall Study|Missing|1|||
170863761|NCT04796896|617513432|FG011|Overall Study|Missing|0|||
170863762|NCT04796896|617513421|FG000|Overall Study|Death|0|||
170863763|NCT04796896|617513422|FG001|Overall Study|Death|0|||
170863764|NCT04796896|617513423|FG002|Overall Study|Death|0|||
170863765|NCT04796896|617513424|FG003|Overall Study|Death|0|||
170863766|NCT04796896|617513425|FG004|Overall Study|Death|0|||
170863767|NCT04796896|617513426|FG005|Overall Study|Death|0|||
170863768|NCT04796896|617513427|FG006|Overall Study|Death|0|||
170863769|NCT04796896|617513428|FG007|Overall Study|Death|0|||
170863770|NCT04796896|617513429|FG008|Overall Study|Death|1|||
170863771|NCT04796896|617513430|FG009|Overall Study|Death|0|||
170863772|NCT04796896|617513431|FG010|Overall Study|Death|0|||
170863773|NCT04796896|617513432|FG011|Overall Study|Death|0|||
170863774|NCT02021292|617513433|FG000|Overall Study|Physician Decision|0|||
170863775|NCT02021292|617513434|FG001|Overall Study|Physician Decision|1|||
170863776|NCT02021292|617513433|FG000|Overall Study|Lost to Follow-up|0|||
170863777|NCT02021292|617513434|FG001|Overall Study|Lost to Follow-up|1|||
170863778|NCT02021292|617513433|FG000|Overall Study|Death|0|||
170863779|NCT02021292|617513434|FG001|Overall Study|Death|1|||
170863780|NCT04658186|617513442|FG000|Overall Study|Adverse Event|4|||
170863781|NCT04658186|617513443|FG001|Overall Study|Adverse Event|18|||
170863782|NCT04658186|617513444|FG002|Overall Study|Adverse Event|15|||
170863783|NCT04658186|617513442|FG000|Overall Study|Lack of Efficacy|1|||
170863784|NCT04658186|617513443|FG001|Overall Study|Lack of Efficacy|1|||
170863785|NCT04658186|617513444|FG002|Overall Study|Lack of Efficacy|0|||
170863786|NCT04658186|617513442|FG000|Overall Study|Protocol Violation|0|||
170863787|NCT04658186|617513443|FG001|Overall Study|Protocol Violation|0|||
170863788|NCT04658186|617513444|FG002|Overall Study|Protocol Violation|1|||
170863789|NCT04658186|617513442|FG000|Overall Study|Lost to Follow-up|0|||
170863790|NCT04658186|617513443|FG001|Overall Study|Lost to Follow-up|0|||
170863791|NCT04658186|617513444|FG002|Overall Study|Lost to Follow-up|2|||
170863792|NCT04658186|617513442|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
170863793|NCT04658186|617513443|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
170863794|NCT04658186|617513444|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
170863795|NCT04658186|617513442|FG000|Overall Study|Participant is Moving in Another Province|0|||
170863796|NCT04658186|617513443|FG001|Overall Study|Participant is Moving in Another Province|1|||
170863797|NCT04658186|617513444|FG002|Overall Study|Participant is Moving in Another Province|0|||
170863798|NCT04658186|617513442|FG000|Overall Study|Non-Compliance|0|||
170863799|NCT04658186|617513443|FG001|Overall Study|Non-Compliance|1|||
170863800|NCT04658186|617513444|FG002|Overall Study|Non-Compliance|1|||
170863801|NCT04658186|617513442|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
170863802|NCT04658186|617513443|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
170863803|NCT04658186|617513444|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
170863804|NCT04658186|617513442|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
170863805|NCT04658186|617513443|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
170863806|NCT04658186|617513444|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
170863807|NCT04658186|617513442|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
170863808|NCT04658186|617513443|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
170863809|NCT04658186|617513444|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
170863810|NCT04658186|617513442|FG000|Overall Study|PI Decision due to Participant Safety|0|||
170863811|NCT04658186|617513443|FG001|Overall Study|PI Decision due to Participant Safety|0|||
170863812|NCT04658186|617513444|FG002|Overall Study|PI Decision due to Participant Safety|1|||
170863813|NCT04658186|617513442|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
170863814|NCT04658186|617513443|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
170863815|NCT04658186|617513444|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
170863816|NCT03801902|617513445|FG000|Overall Study|Did not receive protocol treatment.|1|||
170863817|NCT03801902|617513446|FG001|Overall Study|Did not receive protocol treatment.|0|||
170863818|NCT03801902|617513447|FG002|Overall Study|Did not receive protocol treatment.|0|||
170863819|NCT03801902|617513448|FG003|Overall Study|Did not receive protocol treatment.|0|||
170863820|NCT03871829|617513449|FG000|Overall Study|Lost to Follow-up|0|||
170863821|NCT03871829|617513450|FG001|Overall Study|Lost to Follow-up|1|||
170863822|NCT03871829|617513449|FG000|Overall Study|Withdrawal by Subject|1|||
170863823|NCT03871829|617513450|FG001|Overall Study|Withdrawal by Subject|1|||
170863824|NCT03871829|617513449|FG000|Overall Study|Death|12|||
170751496|NCT02397460|617095899|FG005|Treatment Period 4|Physician Decision|0|||
170751497|NCT02397460|617095900|FG006|Treatment Period 4|Physician Decision|0|||
170751498|NCT02397460|617095901|FG007|Treatment Period 4|Physician Decision|0|||
170751499|NCT01723826|617095905|FG000|Overall Study|Adverse Event|4|||
170751500|NCT01723826|617095906|FG001|Overall Study|Adverse Event|1|||
170751501|NCT01723826|617095907|FG002|Overall Study|Adverse Event|4|||
170751502|NCT01723826|617095908|FG003|Overall Study|Adverse Event|5|||
170751503|NCT01723826|617095905|FG000|Overall Study|Death according to AE eCRF|2|||
170863825|NCT03871829|617513450|FG001|Overall Study|Death|8|||
170863826|NCT03871829|617513449|FG000|Overall Study|Study terminated by sponsor|31|||
170863827|NCT03871829|617513450|FG001|Overall Study|Study terminated by sponsor|34|||
170863828|NCT02993523|617513451|FG000|Overall Study|Withdrew Consent|0|||
170863829|NCT02993523|617513452|FG001|Overall Study|Withdrew Consent|0|||
170863830|NCT02993523|617513453|FG002|Overall Study|Withdrew Consent|2|||
170863831|NCT02993523|617513454|FG003|Overall Study|Withdrew Consent|9|||
170863832|NCT02993523|617513455|FG004|Overall Study|Withdrew Consent|0|||
170863833|NCT02993523|617513451|FG000|Overall Study|Lost to Follow-up|0|||
170751504|NCT01723826|617095906|FG001|Overall Study|Death according to AE eCRF|3|||
170751505|NCT01723826|617095907|FG002|Overall Study|Death according to AE eCRF|3|||
170751506|NCT01723826|617095908|FG003|Overall Study|Death according to AE eCRF|7|||
170751507|NCT01723826|617095905|FG000|Overall Study|Lost to Follow-up|1|||
170863834|NCT02993523|617513452|FG001|Overall Study|Lost to Follow-up|0|||
170863835|NCT02993523|617513453|FG002|Overall Study|Lost to Follow-up|3|||
170863836|NCT02993523|617513454|FG003|Overall Study|Lost to Follow-up|6|||
170863837|NCT02993523|617513455|FG004|Overall Study|Lost to Follow-up|0|||
170863838|NCT02993523|617513451|FG000|Overall Study|Death|1|||
170863839|NCT02993523|617513452|FG001|Overall Study|Death|1|||
170863840|NCT02993523|617513453|FG002|Overall Study|Death|138|||
170863841|NCT02993523|617513454|FG003|Overall Study|Death|222|||
170863842|NCT02993523|617513455|FG004|Overall Study|Death|6|||
170863843|NCT02993523|617513451|FG000|Overall Study|Reason not Specified|0|||
170863844|NCT02993523|617513452|FG001|Overall Study|Reason not Specified|0|||
170863845|NCT02993523|617513453|FG002|Overall Study|Reason not Specified|1|||
170863846|NCT02993523|617513454|FG003|Overall Study|Reason not Specified|1|||
170863847|NCT02993523|617513455|FG004|Overall Study|Reason not Specified|0|||
170863848|NCT03694418|617513456|FG000|Overall Study|Lost to Follow-up|115|||
170863849|NCT03694418|617513457|FG001|Overall Study|Lost to Follow-up|23|||
170863850|NCT03694418|617513458|FG002|Overall Study|Lost to Follow-up|12|||
170863851|NCT03694418|617513459|FG003|Overall Study|Lost to Follow-up|12|||
170863852|NCT03694418|617513460|FG004|Overall Study|Lost to Follow-up|13|||
170863853|NCT04288778|617513477|FG000|Overall Study|Withdrawal by Subject|2|||
170863854|NCT04288778|617513477|FG000|Overall Study|Adverse Event|5|||
170863855|NCT04288778|617513477|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170863856|NCT04288778|617513477|FG000|Overall Study|Other|1|||
170863857|NCT04288778|617513477|FG000|Overall Study|Started but not treated|2|||
170863858|NCT01388790|617513478|FG000|Overall Study|Ongoing at data cut-off date|8|||
170863859|NCT00528866|617513479|FG000|Overall Study|Protocol Violation|6|||
170863860|NCT00993915|617513480|FG000|Overall Study|Insufficient clinical response|3|||
170863861|NCT00993915|617513480|FG000|Overall Study|Withdrawal by Subject|2|||
170863862|NCT00993915|617513480|FG000|Overall Study|Other|1|||
170863863|NCT00993915|617513480|FG000|Overall Study|Ongoing|3|||
170751508|NCT01723826|617095906|FG001|Overall Study|Lost to Follow-up|3|||
170863864|NCT01386658|617513481|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
170863865|NCT01386658|617513482|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
170863866|NCT01386658|617513481|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
170863867|NCT01386658|617513482|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
170863868|NCT01290601|617513484|FG000|Overall Study|Adverse Event|0|||
170863869|NCT01290601|617513485|FG001|Overall Study|Adverse Event|2|||
170863870|NCT01290601|617513486|FG002|Overall Study|Adverse Event|0|||
170863871|NCT01290601|617513487|FG003|Overall Study|Adverse Event|0|||
170863872|NCT01290601|617513484|FG000|Overall Study|Lack of Efficacy|2|||
170863873|NCT01290601|617513485|FG001|Overall Study|Lack of Efficacy|1|||
170863874|NCT01290601|617513486|FG002|Overall Study|Lack of Efficacy|0|||
170863875|NCT01290601|617513487|FG003|Overall Study|Lack of Efficacy|0|||
170863876|NCT01290601|617513484|FG000|Overall Study|Lost to Follow-up|7|||
170863877|NCT01290601|617513485|FG001|Overall Study|Lost to Follow-up|2|||
170863878|NCT01290601|617513486|FG002|Overall Study|Lost to Follow-up|0|||
170863879|NCT01290601|617513487|FG003|Overall Study|Lost to Follow-up|0|||
170863880|NCT01290601|617513484|FG000|Overall Study|Other|1|||
170751509|NCT01723826|617095907|FG002|Overall Study|Lost to Follow-up|1|||
170751510|NCT01723826|617095908|FG003|Overall Study|Lost to Follow-up|1|||
170751511|NCT01723826|617095905|FG000|Overall Study|Non-compliance|0|||
170751512|NCT01723826|617095906|FG001|Overall Study|Non-compliance|1|||
170751513|NCT01723826|617095907|FG002|Overall Study|Non-compliance|3|||
170751514|NCT01723826|617095908|FG003|Overall Study|Non-compliance|3|||
170863881|NCT01290601|617513485|FG001|Overall Study|Other|0|||
170863882|NCT01290601|617513486|FG002|Overall Study|Other|0|||
170863883|NCT01290601|617513487|FG003|Overall Study|Other|0|||
170863884|NCT01290601|617513484|FG000|Overall Study|Protocol Violation|1|||
170631519|NCT02113982|616664416|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
170751515|NCT01723826|617095905|FG000|Overall Study|Non-compliance With Study Drug|0|||
170751516|NCT01723826|617095906|FG001|Overall Study|Non-compliance With Study Drug|1|||
170751517|NCT01723826|617095907|FG002|Overall Study|Non-compliance With Study Drug|0|||
170751518|NCT01723826|617095908|FG003|Overall Study|Non-compliance With Study Drug|0|||
170751519|NCT01723826|617095905|FG000|Overall Study|Other Reason|8|||
170751520|NCT01723826|617095906|FG001|Overall Study|Other Reason|6|||
170751521|NCT01723826|617095907|FG002|Overall Study|Other Reason|12|||
170751522|NCT01723826|617095908|FG003|Overall Study|Other Reason|14|||
170751523|NCT01723826|617095905|FG000|Overall Study|Physician Decision|1|||
170751524|NCT01723826|617095906|FG001|Overall Study|Physician Decision|3|||
170751525|NCT01723826|617095907|FG002|Overall Study|Physician Decision|4|||
170751526|NCT01723826|617095908|FG003|Overall Study|Physician Decision|11|||
170751527|NCT01723826|617095905|FG000|Overall Study|Protocol Violation|1|||
170751528|NCT01723826|617095906|FG001|Overall Study|Protocol Violation|1|||
170751529|NCT01723826|617095907|FG002|Overall Study|Protocol Violation|3|||
170751530|NCT01723826|617095908|FG003|Overall Study|Protocol Violation|1|||
170751531|NCT01723826|617095905|FG000|Overall Study|Withdrawal by Subject|10|||
170751532|NCT01723826|617095906|FG001|Overall Study|Withdrawal by Subject|17|||
170751533|NCT01723826|617095907|FG002|Overall Study|Withdrawal by Subject|27|||
170751534|NCT01723826|617095908|FG003|Overall Study|Withdrawal by Subject|48|||
170751535|NCT02025205|617095910|FG000|Overall Study|Withdrawal by Subject|1|||
170751536|NCT02025205|617095911|FG001|Overall Study|Withdrawal by Subject|1|||
170751537|NCT02025205|617095910|FG000|Overall Study|Protocol Violation|2|||
170751538|NCT02025205|617095911|FG001|Overall Study|Protocol Violation|1|||
170751539|NCT02025205|617095910|FG000|Overall Study|Death|0|||
170751540|NCT02025205|617095911|FG001|Overall Study|Death|1|||
170751541|NCT01767129|617095912|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
170751542|NCT01767129|617095913|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
170751543|NCT00847301|617095921|FG000|Overall Study|Adverse Event|35|||
170751544|NCT00847301|617095921|FG000|Overall Study|Switch to other anticoagulants|16|||
170751545|NCT00847301|617095921|FG000|Overall Study|Lost to Follow-up|1|||
170751546|NCT00847301|617095921|FG000|Overall Study|No prescription after hospital discharge|1|||
170751547|NCT00847301|617095921|FG000|Overall Study|Other reason not defined above|1|||
170751548|NCT05822921|617095922|FG000|Overall Study|Lost to Follow-up|1|||
170751549|NCT05822921|617095923|FG001|Overall Study|Lost to Follow-up|1|||
170751550|NCT00544544|617095924|FG000|Overall Study|Withdrawal by Subject|1|||
170751551|NCT00544544|617095924|FG000|Overall Study|Adverse Event|1|||
170751552|NCT00544544|617095924|FG000|Overall Study|Lost to Follow-up|1|||
170751553|NCT00442286|617095926|FG000|Overall Study|Death|2|||
170751554|NCT00442286|617095927|FG001|Overall Study|Death|2|||
170751555|NCT00442286|617095926|FG000|Overall Study|Lost to Follow-up|1|||
170751556|NCT00442286|617095927|FG001|Overall Study|Lost to Follow-up|0|||
170751557|NCT00442286|617095926|FG000|Overall Study|Withdrawal by Subject|2|||
170751558|NCT00442286|617095927|FG001|Overall Study|Withdrawal by Subject|0|||
170751559|NCT00442286|617095926|FG000|Overall Study|System explanted|1|||
170751560|NCT00442286|617095927|FG001|Overall Study|System explanted|0|||
170751561|NCT00442286|617095926|FG000|Overall Study|Patient Injury|1|||
170751562|NCT00442286|617095927|FG001|Overall Study|Patient Injury|0|||
170751563|NCT05221749|617095928|FG000|Overall Study|Lost to Follow-up|2|||
170751564|NCT05221749|617095929|FG001|Overall Study|Lost to Follow-up|3|||
170751565|NCT03428815|617095930|FG000|Overall Study|Lost to Follow-up|2|||
170751566|NCT03428815|617095931|FG001|Overall Study|Lost to Follow-up|2|||
170751567|NCT03428815|617095930|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
170751568|NCT03428815|617095931|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
170751569|NCT03428815|617095930|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
170751570|NCT03428815|617095931|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
170751571|NCT01700348|617095934|FG000|Overall Study|Withdrawal by Subject|22|||
170751572|NCT01700348|617095934|FG000|Overall Study|Lost to Follow-up|1|||
170751573|NCT02102464|617095935|FG000|Randomized Study|Withdrawal by Subject|0|||
170751574|NCT02102464|617095936|FG001|Randomized Study|Withdrawal by Subject|1|||
170751575|NCT02102464|617095937|FG002|Randomized Study|Withdrawal by Subject|0|||
170751576|NCT02388074|617095938|FG000|Overall Study|Lost in Transit|2|||
170751577|NCT02388074|617095938|FG000|Overall Study|Sample Not Returned|1|||
170751578|NCT01778062|617095939|FG000|Overall Study|Adverse Event|1|||
170751579|NCT01778062|617095940|FG001|Overall Study|Adverse Event|3|||
170751580|NCT01778062|617095939|FG000|Overall Study|Consent Withdrawal|1|||
170751581|NCT01778062|617095940|FG001|Overall Study|Consent Withdrawal|5|||
170751582|NCT01778062|617095939|FG000|Overall Study|major protocol deviation|4|||
170751583|NCT01778062|617095940|FG001|Overall Study|major protocol deviation|3|||
170751584|NCT03958630|617095943|FG000|Overall Study|Withdrawal by Subject|0|||
170751585|NCT03958630|617095944|FG001|Overall Study|Withdrawal by Subject|0|||
170751586|NCT03958630|617095945|FG002|Overall Study|Withdrawal by Subject|1|||
170751587|NCT03958630|617095943|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
170751588|NCT03958630|617095944|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
170751589|NCT03958630|617095945|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
170863885|NCT01290601|617513485|FG001|Overall Study|Protocol Violation|0|||
170863886|NCT01290601|617513486|FG002|Overall Study|Protocol Violation|0|||
170863887|NCT01290601|617513487|FG003|Overall Study|Protocol Violation|0|||
170863888|NCT01749540|617513492|FG000|Overall Study|Protocol Violation|0|||
170863889|NCT01749540|617513493|FG001|Overall Study|Protocol Violation|0|||
170863890|NCT01749540|617513494|FG002|Overall Study|Protocol Violation|0|||
170863891|NCT01749540|617513495|FG003|Overall Study|Protocol Violation|0|||
170863892|NCT01749540|617513496|FG004|Overall Study|Protocol Violation|0|||
170863893|NCT01749540|617513497|FG005|Overall Study|Protocol Violation|1|||
170863894|NCT01749540|617513498|FG006|Overall Study|Protocol Violation|1|||
170863895|NCT01749540|617513492|FG000|Overall Study|Withdrawal by Subject|0|||
170863896|NCT01749540|617513493|FG001|Overall Study|Withdrawal by Subject|0|||
170863897|NCT01749540|617513494|FG002|Overall Study|Withdrawal by Subject|0|||
170863898|NCT01749540|617513495|FG003|Overall Study|Withdrawal by Subject|1|||
170863899|NCT01749540|617513496|FG004|Overall Study|Withdrawal by Subject|0|||
170863900|NCT01749540|617513497|FG005|Overall Study|Withdrawal by Subject|0|||
170863901|NCT01749540|617513498|FG006|Overall Study|Withdrawal by Subject|0|||
170863902|NCT01749540|617513492|FG000|Overall Study|Initiated into extension study A536-06|0|||
170863903|NCT01749540|617513493|FG001|Overall Study|Initiated into extension study A536-06|0|||
170751590|NCT04445155|617095948|FG000|Overall Study|Lost to Follow-up|11|||
170751591|NCT04445155|617095949|FG001|Overall Study|Lost to Follow-up|2|||
170751592|NCT04445155|617095950|FG002|Overall Study|Lost to Follow-up|3|||
170751593|NCT04445155|617095951|FG003|Overall Study|Lost to Follow-up|0|||
170751594|NCT04445155|617095948|FG000|Overall Study|Withdrawal by Subject|8|||
170751595|NCT04445155|617095949|FG001|Overall Study|Withdrawal by Subject|0|||
170751596|NCT04445155|617095950|FG002|Overall Study|Withdrawal by Subject|0|||
170751597|NCT04445155|617095951|FG003|Overall Study|Withdrawal by Subject|0|||
170751598|NCT04445155|617095948|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
170751599|NCT04445155|617095949|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
170751600|NCT04445155|617095950|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
170751601|NCT04445155|617095951|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
170751602|NCT04445155|617095948|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
170751603|NCT04445155|617095949|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
170751604|NCT04445155|617095950|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
170751605|NCT04445155|617095951|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
170751606|NCT00394095|617098181|FG000|Screening|Withdrawal by Subject|1|||
170751607|NCT00394095|617098182|FG001|Screening|Withdrawal by Subject|0|||
170751608|NCT00394095|617098181|FG000|Randomized|Withdrawal by Subject|5|||
170751609|NCT00394095|617098182|FG001|Randomized|Withdrawal by Subject|1|||
170751610|NCT00394095|617098181|FG000|Randomized|Adverse Event|1|||
170751611|NCT00394095|617098182|FG001|Randomized|Adverse Event|1|||
170751612|NCT00394095|617098181|FG000|Randomized|Overdose|1|||
170751613|NCT00394095|617098182|FG001|Randomized|Overdose|0|||
170751614|NCT00394095|617098181|FG000|Randomized|Lost to Follow-up|1|||
170751615|NCT00394095|617098182|FG001|Randomized|Lost to Follow-up|2|||
170751616|NCT04213846|617098183|FG000|Overall Study|Withdrawal by Subject|7|||
170751617|NCT04213846|617098184|FG001|Overall Study|Withdrawal by Subject|6|||
170751618|NCT04213846|617098183|FG000|Overall Study|Lost to Follow-up|15|||
170751619|NCT04213846|617098184|FG001|Overall Study|Lost to Follow-up|21|||
170751620|NCT04096365|617098190|FG000|Overall Study|Adverse Event|1|||
170751621|NCT02401529|617098193|FG000|Overall Study|Lost to Follow-up|2|||
170751622|NCT02401529|617098194|FG001|Overall Study|Lost to Follow-up|1|||
170751623|NCT02401529|617098193|FG000|Overall Study|Physician Decision|2|||
170751624|NCT02401529|617098194|FG001|Overall Study|Physician Decision|6|||
170751625|NCT02401529|617098193|FG000|Overall Study|Protocol Violation|5|||
170751626|NCT02401529|617098194|FG001|Overall Study|Protocol Violation|0|||
170751627|NCT01939158|617098197|FG000|Overall Study|Adverse Event|1|||
170751628|NCT01939158|617098198|FG001|Overall Study|Adverse Event|0|||
170751629|NCT01939158|617098199|FG002|Overall Study|Adverse Event|0|||
170751630|NCT01939158|617098200|FG003|Overall Study|Adverse Event|0|||
170751631|NCT01939158|617098197|FG000|Overall Study|Withdrawal by Subject|22|||
170751632|NCT01939158|617098198|FG001|Overall Study|Withdrawal by Subject|25|||
170751633|NCT01939158|617098199|FG002|Overall Study|Withdrawal by Subject|15|||
170751634|NCT01939158|617098200|FG003|Overall Study|Withdrawal by Subject|17|||
170751635|NCT01939158|617098197|FG000|Overall Study|Migrated/moved from study area|5|||
170751636|NCT01939158|617098198|FG001|Overall Study|Migrated/moved from study area|7|||
170751637|NCT01939158|617098199|FG002|Overall Study|Migrated/moved from study area|3|||
170863904|NCT01749540|617513494|FG002|Overall Study|Initiated into extension study A536-06|0|||
170863905|NCT01749540|617513495|FG003|Overall Study|Initiated into extension study A536-06|0|||
170863906|NCT01749540|617513496|FG004|Overall Study|Initiated into extension study A536-06|0|||
170863907|NCT01749540|617513497|FG005|Overall Study|Initiated into extension study A536-06|2|||
170751638|NCT01939158|617098200|FG003|Overall Study|Migrated/moved from study area|6|||
170751639|NCT01939158|617098197|FG000|Overall Study|Lost to Follow-up|18|||
170751640|NCT01939158|617098198|FG001|Overall Study|Lost to Follow-up|17|||
170863908|NCT01749540|617513498|FG006|Overall Study|Initiated into extension study A536-06|24|||
170863909|NCT00392327|617513501|FG000|Overall Study|Death|1|||
170863910|NCT00392327|617513502|FG001|Overall Study|Death|0|||
170863911|NCT00392327|617513503|FG002|Overall Study|Death|1|||
170863912|NCT00392327|617513504|FG003|Overall Study|Death|0|||
170863913|NCT00392327|617513505|FG004|Overall Study|Death|0|||
170863914|NCT00392327|617513506|FG005|Overall Study|Death|0|||
170863915|NCT00392327|617513507|FG006|Overall Study|Death|0|||
170863916|NCT00392327|617513508|FG007|Overall Study|Death|0|||
170863917|NCT00392327|617513501|FG000|Overall Study|Lack of Efficacy|8|||
170863918|NCT00392327|617513502|FG001|Overall Study|Lack of Efficacy|8|||
170863919|NCT00392327|617513503|FG002|Overall Study|Lack of Efficacy|9|||
170863920|NCT00392327|617513504|FG003|Overall Study|Lack of Efficacy|6|||
170863921|NCT00392327|617513505|FG004|Overall Study|Lack of Efficacy|3|||
170863922|NCT00392327|617513506|FG005|Overall Study|Lack of Efficacy|3|||
170863923|NCT00392327|617513507|FG006|Overall Study|Lack of Efficacy|3|||
170863924|NCT00392327|617513508|FG007|Overall Study|Lack of Efficacy|3|||
170863925|NCT00392327|617513501|FG000|Overall Study|Physician Decision|3|||
170863926|NCT00392327|617513502|FG001|Overall Study|Physician Decision|5|||
170863927|NCT00392327|617513503|FG002|Overall Study|Physician Decision|2|||
170863928|NCT00392327|617513504|FG003|Overall Study|Physician Decision|2|||
170863929|NCT00392327|617513505|FG004|Overall Study|Physician Decision|0|||
170863930|NCT00392327|617513506|FG005|Overall Study|Physician Decision|1|||
170863931|NCT00392327|617513507|FG006|Overall Study|Physician Decision|5|||
170863932|NCT00392327|617513508|FG007|Overall Study|Physician Decision|3|||
170863933|NCT00392327|617513501|FG000|Overall Study|Protocol Violation|0|||
170863934|NCT00392327|617513502|FG001|Overall Study|Protocol Violation|0|||
170863935|NCT00392327|617513503|FG002|Overall Study|Protocol Violation|1|||
170863936|NCT00392327|617513504|FG003|Overall Study|Protocol Violation|0|||
170863937|NCT00392327|617513505|FG004|Overall Study|Protocol Violation|0|||
170863938|NCT00392327|617513506|FG005|Overall Study|Protocol Violation|0|||
170863939|NCT00392327|617513507|FG006|Overall Study|Protocol Violation|0|||
170863940|NCT00392327|617513508|FG007|Overall Study|Protocol Violation|0|||
170863941|NCT00392327|617513501|FG000|Overall Study|Withdrawal by Subject|3|||
170863942|NCT00392327|617513502|FG001|Overall Study|Withdrawal by Subject|2|||
170863943|NCT00392327|617513503|FG002|Overall Study|Withdrawal by Subject|4|||
170751641|NCT01939158|617098199|FG002|Overall Study|Lost to Follow-up|17|||
170751642|NCT01939158|617098200|FG003|Overall Study|Lost to Follow-up|17|||
170751643|NCT01939158|617098197|FG000|Overall Study|Death|0|||
170751644|NCT01939158|617098198|FG001|Overall Study|Death|0|||
170751645|NCT01939158|617098199|FG002|Overall Study|Death|1|||
170751646|NCT01939158|617098200|FG003|Overall Study|Death|1|||
170751647|NCT01939158|617098197|FG000|Overall Study|No longer meets eligibility criteria|0|||
170751648|NCT01939158|617098198|FG001|Overall Study|No longer meets eligibility criteria|0|||
170751649|NCT01939158|617098199|FG002|Overall Study|No longer meets eligibility criteria|1|||
170751650|NCT01939158|617098200|FG003|Overall Study|No longer meets eligibility criteria|0|||
170751651|NCT01939158|617098197|FG000|Overall Study|Other|1|||
170751652|NCT01939158|617098198|FG001|Overall Study|Other|3|||
170751653|NCT01939158|617098199|FG002|Overall Study|Other|4|||
170751654|NCT01939158|617098200|FG003|Overall Study|Other|3|||
170863944|NCT00392327|617513504|FG003|Overall Study|Withdrawal by Subject|6|||
170863945|NCT00392327|617513505|FG004|Overall Study|Withdrawal by Subject|0|||
170863946|NCT00392327|617513506|FG005|Overall Study|Withdrawal by Subject|1|||
170863947|NCT00392327|617513507|FG006|Overall Study|Withdrawal by Subject|1|||
170863948|NCT00392327|617513508|FG007|Overall Study|Withdrawal by Subject|5|||
170863949|NCT00392327|617513501|FG000|Overall Study|Ineligible|0|||
170863950|NCT00392327|617513502|FG001|Overall Study|Ineligible|4|||
170863951|NCT00392327|617513503|FG002|Overall Study|Ineligible|3|||
170863952|NCT00392327|617513504|FG003|Overall Study|Ineligible|2|||
170863953|NCT00392327|617513505|FG004|Overall Study|Ineligible|0|||
170863954|NCT00392327|617513506|FG005|Overall Study|Ineligible|0|||
170863955|NCT00392327|617513507|FG006|Overall Study|Ineligible|0|||
170863956|NCT00392327|617513508|FG007|Overall Study|Ineligible|0|||
170863957|NCT00986440|617513509|FG000|Overall Study|Progressive disease|27|||
170863958|NCT00986440|617513510|FG001|Overall Study|Progressive disease|37|||
170863959|NCT00986440|617513509|FG000|Overall Study|Serious adverse event or adverse event|9|||
170863960|NCT00986440|617513510|FG001|Overall Study|Serious adverse event or adverse event|2|||
170863961|NCT00986440|617513509|FG000|Overall Study|Withdrawal by Subject|1|||
170863962|NCT00986440|617513510|FG001|Overall Study|Withdrawal by Subject|2|||
170863963|NCT00986440|617513509|FG000|Overall Study|Screen failure (not dosed)|4|||
170863964|NCT00986440|617513510|FG001|Overall Study|Screen failure (not dosed)|2|||
170863965|NCT01966471|617513513|FG000|Overall Study|Death|44|||
170863966|NCT01966471|617513514|FG001|Overall Study|Death|56|||
170863967|NCT01966471|617513513|FG000|Overall Study|Lost to Follow-up|46|||
170751655|NCT05310084|617098201|FG000|Overall Study|Withdrawal by Subject|2|||
170751656|NCT05310084|617098202|FG001|Overall Study|Withdrawal by Subject|3|||
170863968|NCT01966471|617513514|FG001|Overall Study|Lost to Follow-up|39|||
170863969|NCT01966471|617513513|FG000|Overall Study|Various reasons|4|||
170863970|NCT01966471|617513514|FG001|Overall Study|Various reasons|4|||
170863971|NCT01966471|617513513|FG000|Overall Study|Physician Decision|7|||
170751657|NCT05310084|617098201|FG000|Overall Study|Participant availability|0|||
170863972|NCT01966471|617513514|FG001|Overall Study|Physician Decision|5|||
170863973|NCT01966471|617513513|FG000|Overall Study|Study Terminated By Sponsor|758|||
170863974|NCT01966471|617513514|FG001|Overall Study|Study Terminated By Sponsor|773|||
170863975|NCT01966471|617513513|FG000|Overall Study|Withdrawal by Subject|59|||
170863976|NCT01966471|617513514|FG001|Overall Study|Withdrawal by Subject|51|||
170863977|NCT00960531|617513517|FG000|Overall Study|Lack of Efficacy|1|||
170863978|NCT00960531|617513518|FG001|Overall Study|Lack of Efficacy|0|||
170863979|NCT00960531|617513519|FG002|Overall Study|Lack of Efficacy|0|||
170863980|NCT00960531|617513520|FG003|Overall Study|Lack of Efficacy|0|||
170863981|NCT00960531|617513521|FG004|Overall Study|Lack of Efficacy|0|||
170863982|NCT00960531|617513522|FG005|Overall Study|Lack of Efficacy|0|||
170863983|NCT00960531|617513523|FG006|Overall Study|Lack of Efficacy|0|||
170863984|NCT00960531|617513524|FG007|Overall Study|Lack of Efficacy|0|||
170863985|NCT00960531|617513525|FG008|Overall Study|Lack of Efficacy|0|||
170863986|NCT00960531|617513526|FG009|Overall Study|Lack of Efficacy|0|||
170751658|NCT05310084|617098202|FG001|Overall Study|Participant availability|4|||
170751659|NCT05310084|617098201|FG000|Overall Study|Lost to Follow-up|1|||
170751660|NCT05310084|617098202|FG001|Overall Study|Lost to Follow-up|1|||
170751661|NCT05310084|617098201|FG000|Overall Study|Adverse Event|1|||
170751662|NCT05310084|617098202|FG001|Overall Study|Adverse Event|1|||
170751663|NCT05310084|617098201|FG000|Overall Study|Randomized but not vaccinated|4|||
170751664|NCT05310084|617098202|FG001|Overall Study|Randomized but not vaccinated|2|||
170751665|NCT02065245|617098204|FG000|Infusion 1|Lost to Follow-up|0|||
170751666|NCT02065245|617098205|FG001|Infusion 1|Lost to Follow-up|0|||
170751667|NCT02065245|617098206|FG002|Infusion 1|Lost to Follow-up|0|||
170751668|NCT02065245|617098207|FG003|Infusion 1|Lost to Follow-up|0|||
170751669|NCT02065245|617098208|FG004|Infusion 1|Lost to Follow-up|0|||
170751670|NCT02065245|617098209|FG005|Infusion 1|Lost to Follow-up|0|||
170751671|NCT02065245|617098210|FG006|Infusion 1|Lost to Follow-up|1|||
170751672|NCT02065245|617098204|FG000|Infusion 1|Death|0|||
170751673|NCT02065245|617098205|FG001|Infusion 1|Death|0|||
170751674|NCT02065245|617098206|FG002|Infusion 1|Death|1|||
170751675|NCT02065245|617098207|FG003|Infusion 1|Death|0|||
170751676|NCT02065245|617098208|FG004|Infusion 1|Death|1|||
170751677|NCT02065245|617098209|FG005|Infusion 1|Death|0|||
170751678|NCT02065245|617098210|FG006|Infusion 1|Death|0|||
170751679|NCT02065245|617098204|FG000|Infusion 2|Death|0|||
170751680|NCT02065245|617098205|FG001|Infusion 2|Death|0|||
170751681|NCT02065245|617098206|FG002|Infusion 2|Death|0|||
170751682|NCT02065245|617098207|FG003|Infusion 2|Death|0|||
170751683|NCT02065245|617098208|FG004|Infusion 2|Death|0|||
170751684|NCT02065245|617098209|FG005|Infusion 2|Death|0|||
170751685|NCT02065245|617098210|FG006|Infusion 2|Death|1|||
170751686|NCT02065245|617098204|FG000|Infusion 3|Lost to Follow-up|1|||
170751687|NCT02065245|617098205|FG001|Infusion 3|Lost to Follow-up|1|||
170751688|NCT02065245|617098206|FG002|Infusion 3|Lost to Follow-up|0|||
170751689|NCT02065245|617098207|FG003|Infusion 3|Lost to Follow-up|0|||
170751690|NCT02065245|617098208|FG004|Infusion 3|Lost to Follow-up|0|||
170751691|NCT02065245|617098209|FG005|Infusion 3|Lost to Follow-up|0|||
170751692|NCT02065245|617098210|FG006|Infusion 3|Lost to Follow-up|0|||
170751693|NCT01598987|617098211|FG000|Baseline to Month 12|Administrative problems|2|||
170751694|NCT01598987|617098211|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
170751695|NCT01598987|617098211|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
170751696|NCT01598987|617098211|FG000|Baseline to 24 Month|Administrative problems|2|||
170751697|NCT01598987|617098211|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
170751698|NCT01036087|617098212|FG000|Overall Study|Adverse Event|2|||
170751699|NCT01036087|617098212|FG000|Overall Study|Lack of Efficacy|1|||
170751700|NCT01616563|617098215|FG000|Overall Study|Lost to Follow-up|40|||
170751701|NCT02206685|617098216|FG000|Overall Study|Surgery cancelled/changed|2|||
170751702|NCT02206685|617098217|FG001|Overall Study|Surgery cancelled/changed|3|||
170751703|NCT02206685|617098216|FG000|Overall Study|Withdrawal by Subject|1|||
170751704|NCT02206685|617098217|FG001|Overall Study|Withdrawal by Subject|2|||
170751705|NCT02206685|617098216|FG000|Overall Study|Protocol Violation|2|||
170751706|NCT02206685|617098217|FG001|Overall Study|Protocol Violation|2|||
170751707|NCT00072475|617098218|FG000|Overall Study|Adverse Event|44|||
170751708|NCT00072475|617098218|FG000|Overall Study|Death|3|||
170751709|NCT00072475|617098218|FG000|Overall Study|Withdrawal by Subject|46|||
170751710|NCT00072475|617098218|FG000|Overall Study|Patient/Investigator Decision|4|||
170751711|NCT01033643|617098224|FG000|Overall Study|Withdrew Consent|0|||
170751712|NCT01033643|617098225|FG001|Overall Study|Withdrew Consent|3|||
170751713|NCT01033643|617098226|FG002|Overall Study|Withdrew Consent|0|||
170751714|NCT01033643|617098227|FG003|Overall Study|Withdrew Consent|0|||
170751715|NCT01033643|617098228|FG004|Overall Study|Withdrew Consent|0|||
170751716|NCT01033643|617098229|FG005|Overall Study|Withdrew Consent|1|||
170751717|NCT02561455|617098230|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
170751718|NCT02561455|617098231|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
170751719|NCT02561455|617098232|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
170863987|NCT00960531|617513517|FG000|Overall Study|Withdrawal by Subject|1|||
170863988|NCT00960531|617513518|FG001|Overall Study|Withdrawal by Subject|0|||
170863989|NCT00960531|617513519|FG002|Overall Study|Withdrawal by Subject|5|||
170863990|NCT00960531|617513520|FG003|Overall Study|Withdrawal by Subject|2|||
170863991|NCT00960531|617513521|FG004|Overall Study|Withdrawal by Subject|0|||
170863992|NCT00960531|617513522|FG005|Overall Study|Withdrawal by Subject|0|||
170863993|NCT00960531|617513523|FG006|Overall Study|Withdrawal by Subject|2|||
170863994|NCT00960531|617513524|FG007|Overall Study|Withdrawal by Subject|0|||
170863995|NCT00960531|617513525|FG008|Overall Study|Withdrawal by Subject|1|||
170863996|NCT00960531|617513526|FG009|Overall Study|Withdrawal by Subject|0|||
170863997|NCT00960531|617513517|FG000|Overall Study|Caregiver Request|2|||
170863998|NCT00960531|617513518|FG001|Overall Study|Caregiver Request|0|||
170863999|NCT00960531|617513519|FG002|Overall Study|Caregiver Request|6|||
170864000|NCT00960531|617513520|FG003|Overall Study|Caregiver Request|5|||
170864001|NCT00960531|617513521|FG004|Overall Study|Caregiver Request|0|||
170864002|NCT00960531|617513522|FG005|Overall Study|Caregiver Request|2|||
170864003|NCT00960531|617513523|FG006|Overall Study|Caregiver Request|3|||
170864004|NCT00960531|617513524|FG007|Overall Study|Caregiver Request|1|||
170864005|NCT00960531|617513525|FG008|Overall Study|Caregiver Request|3|||
170864006|NCT00960531|617513526|FG009|Overall Study|Caregiver Request|0|||
170864007|NCT00960531|617513517|FG000|Overall Study|Investigator Request|0|||
170864008|NCT00960531|617513518|FG001|Overall Study|Investigator Request|0|||
170864009|NCT00960531|617513519|FG002|Overall Study|Investigator Request|1|||
170864010|NCT00960531|617513520|FG003|Overall Study|Investigator Request|0|||
170864011|NCT00960531|617513521|FG004|Overall Study|Investigator Request|0|||
170864012|NCT00960531|617513522|FG005|Overall Study|Investigator Request|0|||
170864013|NCT00960531|617513523|FG006|Overall Study|Investigator Request|0|||
170864014|NCT00960531|617513524|FG007|Overall Study|Investigator Request|0|||
170864015|NCT00960531|617513525|FG008|Overall Study|Investigator Request|0|||
170864016|NCT00960531|617513526|FG009|Overall Study|Investigator Request|0|||
170864017|NCT00960531|617513517|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
170864018|NCT00960531|617513518|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
170864019|NCT00960531|617513519|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
170864020|NCT00960531|617513520|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
170864021|NCT00960531|617513521|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
170864022|NCT00960531|617513522|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
170864023|NCT00960531|617513523|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
170864024|NCT00960531|617513524|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
170864025|NCT00960531|617513525|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
170864026|NCT00960531|617513526|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
170864027|NCT00960531|617513517|FG000|Overall Study|Lost to Follow-up|0|||
170864028|NCT00960531|617513518|FG001|Overall Study|Lost to Follow-up|0|||
170864029|NCT00960531|617513519|FG002|Overall Study|Lost to Follow-up|1|||
170864030|NCT00960531|617513520|FG003|Overall Study|Lost to Follow-up|0|||
170864031|NCT00960531|617513521|FG004|Overall Study|Lost to Follow-up|0|||
170864032|NCT00960531|617513522|FG005|Overall Study|Lost to Follow-up|0|||
170864033|NCT00960531|617513523|FG006|Overall Study|Lost to Follow-up|1|||
170864034|NCT00960531|617513524|FG007|Overall Study|Lost to Follow-up|0|||
170864035|NCT00960531|617513525|FG008|Overall Study|Lost to Follow-up|0|||
170864036|NCT00960531|617513526|FG009|Overall Study|Lost to Follow-up|0|||
170864037|NCT00960531|617513517|FG000|Overall Study|Failed to Return|2|||
170864038|NCT00960531|617513518|FG001|Overall Study|Failed to Return|0|||
170864039|NCT00960531|617513519|FG002|Overall Study|Failed to Return|0|||
170864040|NCT00960531|617513520|FG003|Overall Study|Failed to Return|0|||
170864041|NCT00960531|617513521|FG004|Overall Study|Failed to Return|0|||
170864042|NCT00960531|617513522|FG005|Overall Study|Failed to Return|0|||
170864043|NCT00960531|617513523|FG006|Overall Study|Failed to Return|0|||
170864044|NCT00960531|617513524|FG007|Overall Study|Failed to Return|2|||
170864045|NCT00960531|617513525|FG008|Overall Study|Failed to Return|0|||
170864046|NCT00960531|617513526|FG009|Overall Study|Failed to Return|0|||
170864047|NCT00960531|617513517|FG000|Overall Study|Adverse Event (AE)|2|||
170864048|NCT00960531|617513518|FG001|Overall Study|Adverse Event (AE)|0|||
170864049|NCT00960531|617513519|FG002|Overall Study|Adverse Event (AE)|0|||
170864050|NCT00960531|617513520|FG003|Overall Study|Adverse Event (AE)|0|||
170864051|NCT00960531|617513521|FG004|Overall Study|Adverse Event (AE)|0|||
170864052|NCT00960531|617513522|FG005|Overall Study|Adverse Event (AE)|1|||
170864053|NCT00960531|617513523|FG006|Overall Study|Adverse Event (AE)|2|||
170864054|NCT00960531|617513524|FG007|Overall Study|Adverse Event (AE)|0|||
170864055|NCT00960531|617513525|FG008|Overall Study|Adverse Event (AE)|2|||
170864056|NCT00960531|617513526|FG009|Overall Study|Adverse Event (AE)|0|||
170864057|NCT00960531|617513517|FG000|Overall Study|Reason not Specified|2|||
170864058|NCT00960531|617513518|FG001|Overall Study|Reason not Specified|1|||
170864059|NCT00960531|617513519|FG002|Overall Study|Reason not Specified|13|||
170864060|NCT00960531|617513520|FG003|Overall Study|Reason not Specified|1|||
170864061|NCT00960531|617513521|FG004|Overall Study|Reason not Specified|2|||
170864062|NCT00960531|617513522|FG005|Overall Study|Reason not Specified|0|||
170864063|NCT00960531|617513523|FG006|Overall Study|Reason not Specified|16|||
170864064|NCT00960531|617513524|FG007|Overall Study|Reason not Specified|0|||
170864065|NCT00960531|617513525|FG008|Overall Study|Reason not Specified|8|||
170864066|NCT00960531|617513526|FG009|Overall Study|Reason not Specified|1|||
170864067|NCT00593957|617513527|FG000|Overall Study|Physician Decision|0|||
170864068|NCT00593957|617513528|FG001|Overall Study|Physician Decision|1|||
170864069|NCT00593957|617513529|FG002|Overall Study|Physician Decision|2|||
170864070|NCT00494481|617513532|FG000|Overall Study|Condition under investigation worsened|11|||
170864071|NCT00494481|617513533|FG001|Overall Study|Condition under investigation worsened|13|||
170864072|NCT00494481|617513532|FG000|Overall Study|Adverse Event|15|||
170864073|NCT00494481|617513533|FG001|Overall Study|Adverse Event|11|||
170864074|NCT00494481|617513532|FG000|Overall Study|Other|1|||
170864075|NCT00494481|617513533|FG001|Overall Study|Other|0|||
170864076|NCT00494481|617513532|FG000|Overall Study|Never received IP|2|||
170864077|NCT00494481|617513533|FG001|Overall Study|Never received IP|0|||
170864078|NCT02973048|617513534|FG000|Overall Study|Epidural catheter insertion failure|1|||
170864079|NCT02973048|617513535|FG001|Overall Study|Epidural catheter insertion failure|0|||
170864080|NCT02973048|617513534|FG000|Overall Study|Withdrawal by Subject|0|||
170864081|NCT02973048|617513535|FG001|Overall Study|Withdrawal by Subject|3|||
170864082|NCT00332189|617513536|FG000|Overall Study|Adverse Event|3|||
170864083|NCT00332189|617513536|FG000|Overall Study|Uncooperative/Noncompliant|3|||
170864084|NCT00332189|617513536|FG000|Overall Study|Withdrawal by Subject|9|||
170864085|NCT00332189|617513536|FG000|Overall Study|Lack of Efficacy|4|||
170864086|NCT00332189|617513536|FG000|Overall Study|Moved out of country|2|||
170864087|NCT03170154|617513537|FG000|Overall Study|Lost to Follow-up|4|||
170864088|NCT03170154|617513537|FG000|Overall Study|Death|2|||
170864089|NCT03170154|617513537|FG000|Overall Study|Withdrawal by Subject|2|||
170864090|NCT04936841|617513540|FG000|Overall Study|Death|1|||
170864091|NCT02279862|617513541|FG000|Overall Study|Study drug toxicity|3|||
170864092|NCT02279862|617513542|FG001|Overall Study|Study drug toxicity|6|||
170864093|NCT02279862|617513541|FG000|Overall Study|No longer meets criteria|0|||
170864094|NCT02279862|617513542|FG001|Overall Study|No longer meets criteria|1|||
170864095|NCT02279862|617513541|FG000|Overall Study|Administrative reason by sponsor|0|||
170864096|NCT02279862|617513542|FG001|Overall Study|Administrative reason by sponsor|1|||
170864097|NCT02279862|617513541|FG000|Overall Study|Disease progression|5|||
170864098|NCT02279862|617513542|FG001|Overall Study|Disease progression|2|||
170864099|NCT02279862|617513541|FG000|Overall Study|Study closed by sponsor|16|||
170864100|NCT02279862|617513542|FG001|Overall Study|Study closed by sponsor|13|||
170864101|NCT02279862|617513541|FG000|Overall Study|Other|1|||
170864102|NCT02279862|617513542|FG001|Overall Study|Other|2|||
170864103|NCT02279862|617513541|FG000|Overall Study|Withdrawal by Subject|1|||
170864104|NCT02279862|617513542|FG001|Overall Study|Withdrawal by Subject|0|||
170864105|NCT00810394|617513548|FG000|Overall Study|Withdrawal by Subject|3|||
170864106|NCT05089656|617513553|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
170864107|NCT05089656|617513554|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
170864108|NCT05089656|617513553|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
170864109|NCT05089656|617513554|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
170864110|NCT05089656|617513553|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
170864111|NCT05089656|617513554|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
170864112|NCT05089656|617513553|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
170864113|NCT05089656|617513554|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
170864114|NCT02535416|617513555|FG000|Overall Study|Family bereavement overseas|1|||
170864115|NCT02535416|617513556|FG001|Overall Study|Family bereavement overseas|0|||
170864116|NCT02535416|617513557|FG002|Overall Study|Family bereavement overseas|0|||
170864117|NCT02535416|617513558|FG003|Overall Study|Family bereavement overseas|0|||
170864118|NCT02535416|617513559|FG004|Overall Study|Family bereavement overseas|0|||
170864119|NCT02535416|617513560|FG005|Overall Study|Family bereavement overseas|0|||
170864120|NCT02535416|617513561|FG006|Overall Study|Family bereavement overseas|0|||
170864121|NCT02535416|617513562|FG007|Overall Study|Family bereavement overseas|0|||
170864122|NCT02535416|617513563|FG008|Overall Study|Family bereavement overseas|0|||
170864123|NCT00234494|617515509|FG000|Overall Study|Protocol Violation|2|||
170864124|NCT01521897|617515512|FG000|Overall Study|Protocol Violation|18|||
170864125|NCT01521897|617515512|FG000|Overall Study|Lost to Follow-up|5|||
170864126|NCT05736211|617515517|FG000|Overall Study|Lost to Follow-up|6|||
170864127|NCT05736211|617515518|FG001|Overall Study|Lost to Follow-up|0|||
170864128|NCT00992511|617515520|FG000|Overall Study|Migrated/moved from study area|1|||
170864129|NCT00992511|617515521|FG001|Overall Study|Migrated/moved from study area|0|||
170864130|NCT00992511|617515522|FG002|Overall Study|Migrated/moved from study area|1|||
170864131|NCT00992511|617515523|FG003|Overall Study|Migrated/moved from study area|2|||
170864132|NCT00992511|617515520|FG000|Overall Study|Lost to Follow-up|1|||
170864133|NCT00992511|617515521|FG001|Overall Study|Lost to Follow-up|0|||
170864134|NCT00992511|617515522|FG002|Overall Study|Lost to Follow-up|0|||
170864135|NCT00992511|617515523|FG003|Overall Study|Lost to Follow-up|2|||
170864136|NCT00992511|617515520|FG000|Overall Study|Withdrawal by Subject|0|||
170864137|NCT00992511|617515521|FG001|Overall Study|Withdrawal by Subject|0|||
170864138|NCT00992511|617515522|FG002|Overall Study|Withdrawal by Subject|1|||
170751720|NCT02561455|617098233|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
170751721|NCT02561455|617098230|FG000|Overall Study|Withdrawal by Subject|1|||
170751722|NCT02561455|617098231|FG001|Overall Study|Withdrawal by Subject|0|||
170751723|NCT02561455|617098232|FG002|Overall Study|Withdrawal by Subject|1|||
170751724|NCT02561455|617098233|FG003|Overall Study|Withdrawal by Subject|0|||
170751725|NCT02561455|617098230|FG000|Overall Study|Disease Progression|0|||
170751726|NCT02561455|617098231|FG001|Overall Study|Disease Progression|1|||
170751727|NCT02561455|617098232|FG002|Overall Study|Disease Progression|0|||
170751728|NCT02561455|617098233|FG003|Overall Study|Disease Progression|0|||
170751729|NCT03527277|617098234|FG000|Overall Study|Withdrawal by Subject|5|||
170751730|NCT03527277|617098235|FG001|Overall Study|Withdrawal by Subject|0|||
170751731|NCT03527277|617098234|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
170751732|NCT03527277|617098235|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
170751733|NCT03527277|617098234|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
170751734|NCT03527277|617098235|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
170751735|NCT00826280|617098236|FG000|Overall Study|Randomized but drug not received|1|||
170751736|NCT00826280|617098237|FG001|Overall Study|Randomized but drug not received|0|||
170751737|NCT00826280|617098238|FG002|Overall Study|Randomized but drug not received|1|||
170751738|NCT00826280|617098236|FG000|Overall Study|Adverse Event|1|||
170751739|NCT00826280|617098237|FG001|Overall Study|Adverse Event|3|||
170751740|NCT00826280|617098238|FG002|Overall Study|Adverse Event|0|||
170751741|NCT00826280|617098236|FG000|Overall Study|Lost to Follow-up|0|||
170751742|NCT00826280|617098237|FG001|Overall Study|Lost to Follow-up|1|||
170751743|NCT00826280|617098238|FG002|Overall Study|Lost to Follow-up|0|||
170751744|NCT00826280|617098236|FG000|Overall Study|Sponsor discontinued subject or study|1|||
170751745|NCT00826280|617098237|FG001|Overall Study|Sponsor discontinued subject or study|0|||
170751746|NCT00826280|617098238|FG002|Overall Study|Sponsor discontinued subject or study|0|||
170751747|NCT00826280|617098236|FG000|Overall Study|Reversible ischemic defect not present|43|||
170751748|NCT00826280|617098237|FG001|Overall Study|Reversible ischemic defect not present|40|||
170751749|NCT00826280|617098238|FG002|Overall Study|Reversible ischemic defect not present|44|||
170751750|NCT00826280|617098236|FG000|Overall Study|Interpretation Failure|1|||
170751751|NCT00826280|617098237|FG001|Overall Study|Interpretation Failure|0|||
170751752|NCT00826280|617098238|FG002|Overall Study|Interpretation Failure|0|||
170751753|NCT00826280|617098236|FG000|Overall Study|Machine Failure|1|||
170751754|NCT00826280|617098237|FG001|Overall Study|Machine Failure|1|||
170751755|NCT00826280|617098238|FG002|Overall Study|Machine Failure|0|||
170751756|NCT00826280|617098236|FG000|Overall Study|One or more non-interpretable scan|0|||
170751757|NCT00826280|617098237|FG001|Overall Study|One or more non-interpretable scan|1|||
170751758|NCT00826280|617098238|FG002|Overall Study|One or more non-interpretable scan|1|||
170751759|NCT00550732|617098239|FG000|Overall Study|Death|4|||
170751760|NCT00550732|617098239|FG000|Overall Study|Withdrawal by Subject|2|||
170751761|NCT00550732|617098239|FG000|Overall Study|Physician Decision|2|||
170751762|NCT00550732|617098239|FG000|Overall Study|Lost to Follow-up|1|||
170751763|NCT00550732|617098239|FG000|Overall Study|Palliative care|1|||
170751764|NCT00550732|617098239|FG000|Overall Study|Adverse Event|1|||
170751765|NCT02886728|617098250|FG000|Overall Study|Withdrew Consent|31|||
170751766|NCT02886728|617098251|FG001|Overall Study|Withdrew Consent|13|||
170751767|NCT02886728|617098252|FG002|Overall Study|Withdrew Consent|11|||
170751768|NCT02886728|617098253|FG003|Overall Study|Withdrew Consent|47|||
170751769|NCT02886728|617098250|FG000|Overall Study|Lost to Follow-up|12|||
170751770|NCT02886728|617098251|FG001|Overall Study|Lost to Follow-up|6|||
170751771|NCT02886728|617098252|FG002|Overall Study|Lost to Follow-up|13|||
170751772|NCT02886728|617098253|FG003|Overall Study|Lost to Follow-up|12|||
170751773|NCT02886728|617098250|FG000|Overall Study|Adverse Event|13|||
170751774|NCT02886728|617098251|FG001|Overall Study|Adverse Event|5|||
170751775|NCT02886728|617098252|FG002|Overall Study|Adverse Event|5|||
170751776|NCT02886728|617098253|FG003|Overall Study|Adverse Event|11|||
170751777|NCT02886728|617098250|FG000|Overall Study|Investigator's Discretion|11|||
170751778|NCT02886728|617098251|FG001|Overall Study|Investigator's Discretion|7|||
170751779|NCT02886728|617098252|FG002|Overall Study|Investigator's Discretion|5|||
170751780|NCT02886728|617098253|FG003|Overall Study|Investigator's Discretion|11|||
170751781|NCT02886728|617098250|FG000|Overall Study|Death|3|||
170751782|NCT02886728|617098251|FG001|Overall Study|Death|1|||
170751783|NCT02886728|617098252|FG002|Overall Study|Death|0|||
170751784|NCT02886728|617098253|FG003|Overall Study|Death|0|||
170751785|NCT02886728|617098250|FG000|Overall Study|Protocol Violation|0|||
170751786|NCT02886728|617098251|FG001|Overall Study|Protocol Violation|0|||
170751787|NCT02886728|617098252|FG002|Overall Study|Protocol Violation|0|||
170751788|NCT02886728|617098253|FG003|Overall Study|Protocol Violation|4|||
170751789|NCT02886728|617098250|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170751790|NCT02886728|617098251|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170751791|NCT02886728|617098252|FG002|Overall Study|Non-Compliance with Study Drug|1|||
170751792|NCT02886728|617098253|FG003|Overall Study|Non-Compliance with Study Drug|0|||
170751793|NCT02886728|617098250|FG000|Overall Study|Pregnancy|0|||
170751794|NCT02886728|617098251|FG001|Overall Study|Pregnancy|0|||
170402163|NCT04682639|615813348|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
170402164|NCT04682639|615813349|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
170402165|NCT04682639|615813350|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
170402166|NCT04682639|615813351|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
170402167|NCT04682639|615813352|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
170402168|NCT04682639|615813348|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
170402169|NCT04682639|615813349|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
170751795|NCT02886728|617098252|FG002|Overall Study|Pregnancy|1|||
170751796|NCT02886728|617098253|FG003|Overall Study|Pregnancy|0|||
170751797|NCT02886728|617098250|FG000|Overall Study|Randomized but Not Dosed|1|||
170751798|NCT02886728|617098251|FG001|Overall Study|Randomized but Not Dosed|0|||
170751799|NCT02886728|617098252|FG002|Overall Study|Randomized but Not Dosed|0|||
170751800|NCT02886728|617098253|FG003|Overall Study|Randomized but Not Dosed|2|||
170751801|NCT01196104|617098254|FG000|Overall Study|Lost to Follow-up|1|||
170751802|NCT01196104|617098255|FG001|Overall Study|Lost to Follow-up|0|||
170751803|NCT01196104|617098254|FG000|Overall Study|Physician Decision|0|||
170751804|NCT01196104|617098255|FG001|Overall Study|Physician Decision|1|||
170751805|NCT01196104|617098254|FG000|Overall Study|Withdrawal by Subject|3|||
170751806|NCT01196104|617098255|FG001|Overall Study|Withdrawal by Subject|3|||
170751807|NCT01196104|617098254|FG000|Overall Study|Various|0|||
170751808|NCT01196104|617098255|FG001|Overall Study|Various|1|||
170751809|NCT02724020|617098260|FG000|Overall Study|Death|16|||
170751810|NCT02724020|617098261|FG001|Overall Study|Death|18|||
170751811|NCT02724020|617098262|FG002|Overall Study|Death|19|||
170751812|NCT02724020|617098260|FG000|Overall Study|Lost to Follow-up|0|||
170751813|NCT02724020|617098261|FG001|Overall Study|Lost to Follow-up|3|||
170751814|NCT02724020|617098262|FG002|Overall Study|Lost to Follow-up|0|||
170751815|NCT02724020|617098260|FG000|Overall Study|Site Terminated by Sponsor|15|||
170751816|NCT02724020|617098261|FG001|Overall Study|Site Terminated by Sponsor|8|||
170751817|NCT02724020|617098262|FG002|Overall Study|Site Terminated by Sponsor|8|||
170751818|NCT02724020|617098260|FG000|Overall Study|Withdrawal by Subject|1|||
170751819|NCT02724020|617098261|FG001|Overall Study|Withdrawal by Subject|3|||
170751820|NCT02724020|617098262|FG002|Overall Study|Withdrawal by Subject|5|||
170751821|NCT02179918|617098263|FG000|Overall Study|Death|0|||
170751822|NCT02179918|617098264|FG001|Overall Study|Death|0|||
170751823|NCT02179918|617098265|FG002|Overall Study|Death|0|||
170751824|NCT02179918|617098266|FG003|Overall Study|Death|1|||
170751825|NCT02179918|617098267|FG004|Overall Study|Death|0|||
170751826|NCT02179918|617098263|FG000|Overall Study|Lost to Follow-up|0|||
170751827|NCT02179918|617098264|FG001|Overall Study|Lost to Follow-up|0|||
170751828|NCT02179918|617098265|FG002|Overall Study|Lost to Follow-up|1|||
170751829|NCT02179918|617098266|FG003|Overall Study|Lost to Follow-up|0|||
170751830|NCT02179918|617098267|FG004|Overall Study|Lost to Follow-up|0|||
170864139|NCT00992511|617515523|FG003|Overall Study|Withdrawal by Subject|1|||
170864140|NCT01383161|617515528|FG000|Overall Study|Adverse Event|5|||
170864141|NCT01383161|617515529|FG001|Overall Study|Adverse Event|1|||
170864142|NCT01383161|617515528|FG000|Overall Study|Withdrawal by Subject|0|||
170864143|NCT01383161|617515529|FG001|Overall Study|Withdrawal by Subject|2|||
170864144|NCT01383161|617515528|FG000|Overall Study|Lack of Efficacy|0|||
170864145|NCT01383161|617515529|FG001|Overall Study|Lack of Efficacy|1|||
170864146|NCT00833911|617515530|FG000|Titration|Adverse Event|18|||
170864147|NCT00833911|617515530|FG000|Titration|Withdrawal by Subject|3|||
170864148|NCT00833911|617515530|FG000|Maintenance Phase I|Adverse Event|73|||
170864149|NCT00833911|617515530|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
170864150|NCT00833911|617515530|FG000|Maintenance Phase I|Physician Decision|10|||
170864151|NCT00833911|617515530|FG000|Maintenance Phase I|Lack of Efficacy|4|||
170864152|NCT00833911|617515530|FG000|Maintenance Phase II|Adverse Event|6|||
170864153|NCT00833911|617515530|FG000|Maintenance Phase II|Physician Decision|2|||
170864154|NCT00833911|617515530|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
170864155|NCT00833911|617515530|FG000|Maintenance Phase II|Lack of Efficacy|1|||
170864156|NCT05057247|617515531|FG000|Overall Study|Death|4|||
170864157|NCT05057247|617515531|FG000|Overall Study|Physician Decision|3|||
170402170|NCT04682639|615813350|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170402171|NCT04682639|615813351|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170751831|NCT02179918|617098263|FG000|Overall Study|Progressive Disease|4|||
170751832|NCT02179918|617098264|FG001|Overall Study|Progressive Disease|1|||
170751833|NCT02179918|617098265|FG002|Overall Study|Progressive Disease|1|||
170751834|NCT02179918|617098266|FG003|Overall Study|Progressive Disease|2|||
170864158|NCT05057247|617515531|FG000|Overall Study|Progressive Disease|7|||
170864159|NCT05057247|617515531|FG000|Overall Study|Withdrawal by Subject|3|||
170864160|NCT05057247|617515531|FG000|Overall Study|Adverse Event|6|||
170864161|NCT05057247|617515531|FG000|Overall Study|Subject Non-Compliance|1|||
170864162|NCT05057247|617515531|FG000|Overall Study|On treatment|2|||
170864163|NCT03588728|617515533|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
170402172|NCT04682639|615813352|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170751835|NCT02179918|617098267|FG004|Overall Study|Progressive Disease|6|||
170751836|NCT02179918|617098263|FG000|Overall Study|Other|0|||
170751837|NCT02179918|617098264|FG001|Overall Study|Other|1|||
170751838|NCT02179918|617098265|FG002|Overall Study|Other|0|||
170751839|NCT02179918|617098266|FG003|Overall Study|Other|0|||
170751840|NCT02179918|617098267|FG004|Overall Study|Other|1|||
170751841|NCT02179918|617098263|FG000|Overall Study|Subject refused further follow-up|0|||
170751842|NCT02179918|617098264|FG001|Overall Study|Subject refused further follow-up|1|||
170751843|NCT02179918|617098265|FG002|Overall Study|Subject refused further follow-up|0|||
170751844|NCT02179918|617098266|FG003|Overall Study|Subject refused further follow-up|0|||
170751845|NCT02179918|617098267|FG004|Overall Study|Subject refused further follow-up|1|||
170864164|NCT03588728|617515534|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
170864165|NCT03588728|617515535|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
170864166|NCT03588728|617515536|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
170864167|NCT03588728|617515533|FG000|Overall Study|Lab shut down due to COVID-19|0|||
170864168|NCT03588728|617515534|FG001|Overall Study|Lab shut down due to COVID-19|0|||
170864169|NCT03588728|617515535|FG002|Overall Study|Lab shut down due to COVID-19|0|||
170864170|NCT03588728|617515536|FG003|Overall Study|Lab shut down due to COVID-19|1|||
170864171|NCT03588728|617515533|FG000|Overall Study|multiple technical issues|1|||
170864172|NCT03588728|617515534|FG001|Overall Study|multiple technical issues|0|||
170864173|NCT03588728|617515535|FG002|Overall Study|multiple technical issues|0|||
170864174|NCT03588728|617515536|FG003|Overall Study|multiple technical issues|0|||
170864175|NCT03588728|617515533|FG000|Overall Study|Hospitalized for COVID|1|||
170864176|NCT03588728|617515534|FG001|Overall Study|Hospitalized for COVID|0|||
170864177|NCT03588728|617515535|FG002|Overall Study|Hospitalized for COVID|0|||
170864178|NCT03588728|617515536|FG003|Overall Study|Hospitalized for COVID|0|||
170864179|NCT03588728|617515533|FG000|Overall Study|Schedule change unable to attend sessions|1|||
170864180|NCT03588728|617515534|FG001|Overall Study|Schedule change unable to attend sessions|0|||
170864181|NCT03588728|617515535|FG002|Overall Study|Schedule change unable to attend sessions|0|||
170864182|NCT03588728|617515536|FG003|Overall Study|Schedule change unable to attend sessions|0|||
170864183|NCT02121834|617515539|FG000|Overall Study|Protocol Violation|0|||
170864184|NCT02121834|617515540|FG001|Overall Study|Protocol Violation|1|||
170864185|NCT02121834|617515541|FG002|Overall Study|Protocol Violation|0|||
170864186|NCT02121834|617515542|FG003|Overall Study|Protocol Violation|0|||
170864187|NCT02121834|617515543|FG004|Overall Study|Protocol Violation|0|||
170864188|NCT02121834|617515544|FG005|Overall Study|Protocol Violation|0|||
170864189|NCT02121834|617515545|FG006|Overall Study|Protocol Violation|0|||
170864190|NCT02121834|617515539|FG000|Overall Study|Withdrawal by Subject|0|||
170864191|NCT02121834|617515540|FG001|Overall Study|Withdrawal by Subject|1|||
170864192|NCT02121834|617515541|FG002|Overall Study|Withdrawal by Subject|1|||
170864193|NCT02121834|617515542|FG003|Overall Study|Withdrawal by Subject|0|||
170864194|NCT02121834|617515543|FG004|Overall Study|Withdrawal by Subject|0|||
170864195|NCT02121834|617515544|FG005|Overall Study|Withdrawal by Subject|0|||
170864196|NCT02121834|617515545|FG006|Overall Study|Withdrawal by Subject|0|||
170864197|NCT02121834|617515539|FG000|Overall Study|Lost to Follow-up|0|||
170864198|NCT02121834|617515540|FG001|Overall Study|Lost to Follow-up|0|||
170864199|NCT02121834|617515541|FG002|Overall Study|Lost to Follow-up|1|||
170864200|NCT02121834|617515542|FG003|Overall Study|Lost to Follow-up|0|||
170864201|NCT02121834|617515543|FG004|Overall Study|Lost to Follow-up|0|||
170864202|NCT02121834|617515544|FG005|Overall Study|Lost to Follow-up|0|||
170864203|NCT02121834|617515545|FG006|Overall Study|Lost to Follow-up|0|||
170864204|NCT00132496|617515548|FG000|Overall Study|Withdrawal by Subject|1|||
170864205|NCT00132496|617515549|FG001|Overall Study|Withdrawal by Subject|2|||
170864206|NCT00132496|617515548|FG000|Overall Study|Physician Decision|1|||
170864207|NCT00132496|617515549|FG001|Overall Study|Physician Decision|0|||
170864208|NCT03267940|617515550|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
170864209|NCT03267940|617515551|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
170864210|NCT03267940|617515552|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
170864211|NCT03267940|617515553|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
170864212|NCT03267940|617515554|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
170864213|NCT03267940|617515555|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
170864214|NCT03267940|617515550|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
170864215|NCT03267940|617515551|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
170864216|NCT03267940|617515552|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
170864217|NCT03267940|617515553|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
170864218|NCT03267940|617515554|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
170864219|NCT03267940|617515555|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
170864220|NCT03267940|617515550|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
170864221|NCT03267940|617515551|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
170751846|NCT01364727|617098270|FG000|Overall Study|Not Eligible|2|||
170751847|NCT00750893|617098271|FG000|Overall Study|Adverse Event|5|||
170751848|NCT00750893|617098271|FG000|Overall Study|Withdrawal by Subject|10|||
170751849|NCT00750893|617098271|FG000|Overall Study|Lost to Follow-up|510|||
170751850|NCT00750893|617098271|FG000|Overall Study|Other|17|||
170751851|NCT02408549|617098274|FG000|Overall Study|Adverse Event|15|||
170751852|NCT02408549|617098274|FG000|Overall Study|Death|4|||
170402173|NCT04682639|615813348|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
170402174|NCT04682639|615813349|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
170402175|NCT04682639|615813350|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
170402176|NCT04682639|615813351|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
170402177|NCT04682639|615813352|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
170402178|NCT04682639|615813348|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
170402179|NCT04682639|615813349|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
170402180|NCT04682639|615813350|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
170402181|NCT04682639|615813351|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
170402182|NCT04682639|615813352|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
170402183|NCT01791127|615813353|FG000|Overall Study|Death|356|||
170402184|NCT01791127|615813353|FG000|Overall Study|Patient has withdrawn from study|293|||
170402185|NCT01791127|615813353|FG000|Overall Study|Lost to Follow-up|42|||
170402186|NCT01791127|615813353|FG000|Overall Study|All Siello leads are explanted|31|||
170402187|NCT01791127|615813353|FG000|Overall Study|Completion of 30 day safety registry|1|||
170402188|NCT01791127|615813353|FG000|Overall Study|Study terminated for EP Passion|749|||
170402189|NCT00422058|615813361|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
170864222|NCT03267940|617515552|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
170402190|NCT00422058|615813362|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
170402191|NCT00422058|615813363|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
170402192|NCT00422058|615813364|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
170402193|NCT00422058|615813365|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
170864223|NCT03267940|617515553|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
170864224|NCT03267940|617515554|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
170864225|NCT03267940|617515555|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
170864226|NCT03267940|617515550|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
170864227|NCT03267940|617515551|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
170864228|NCT03267940|617515552|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
170864229|NCT03267940|617515553|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
170864230|NCT03267940|617515554|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
170864231|NCT03267940|617515555|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
170864232|NCT03267940|617515550|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
170864233|NCT03267940|617515551|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
170864234|NCT03267940|617515552|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
170864235|NCT03267940|617515553|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
170864236|NCT03267940|617515554|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
170864237|NCT03267940|617515555|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
170864238|NCT03267940|617515550|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
170864239|NCT03267940|617515551|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
170864240|NCT03267940|617515552|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
170864241|NCT03267940|617515553|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
170864242|NCT03267940|617515554|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
170864243|NCT03267940|617515555|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
170864244|NCT03267940|617515550|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
170864245|NCT03267940|617515551|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
170864246|NCT03267940|617515552|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
170864247|NCT03267940|617515553|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
170864248|NCT03267940|617515554|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
170864249|NCT03267940|617515555|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
170864250|NCT03267940|617515550|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
170864251|NCT03267940|617515551|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
170864252|NCT03267940|617515552|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
170864253|NCT03267940|617515553|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
170864254|NCT03267940|617515554|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
170864255|NCT03267940|617515555|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
170864256|NCT03267940|617515550|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
170864257|NCT03267940|617515551|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
170864258|NCT03267940|617515552|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
170864259|NCT03267940|617515553|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
170864260|NCT03267940|617515554|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
170864261|NCT03267940|617515555|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
170864262|NCT00388154|617515556|FG000|Overall Study|Withdrawal by Subject|1|||
170864263|NCT01323634|617515559|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
170402194|NCT00422058|615813366|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
170402195|NCT00422058|615813361|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
170864264|NCT01323634|617515560|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
170864265|NCT01323634|617515561|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
170751853|NCT02408549|617098274|FG000|Overall Study|Lack of Efficacy|17|||
170751854|NCT02408549|617098274|FG000|Overall Study|Protocol Violation|4|||
170751855|NCT02408549|617098274|FG000|Overall Study|Lost to Follow-up|6|||
170751856|NCT02408549|617098274|FG000|Overall Study|Consent withdrawn|30|||
170751857|NCT02408549|617098274|FG000|Overall Study|Neurology research program closing at site|1|||
170751858|NCT02408549|617098274|FG000|Overall Study|Site closure|1|||
170751859|NCT02408549|617098274|FG000|Overall Study|Pregnancy|1|||
170751860|NCT02408549|617098274|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
170751861|NCT02408549|617098274|FG000|Overall Study|Subject moved to another place, far from site|1|||
170751862|NCT02408549|617098274|FG000|Overall Study|Study terminated at site|1|||
170751863|NCT01232556|617098278|FG000|Overall Study|Withdrawal by Subject|21|||
170751864|NCT01232556|617098279|FG001|Overall Study|Withdrawal by Subject|17|||
170751865|NCT01232556|617098278|FG000|Overall Study|Death|97|||
170751866|NCT01232556|617098279|FG001|Overall Study|Death|97|||
170751867|NCT01232556|617098278|FG000|Overall Study|Lost to Follow-up|0|||
170751868|NCT01232556|617098279|FG001|Overall Study|Lost to Follow-up|2|||
170751869|NCT01232556|617098278|FG000|Overall Study|Terminated by Sponsor|35|||
170751870|NCT01232556|617098279|FG001|Overall Study|Terminated by Sponsor|51|||
170751871|NCT01232556|617098278|FG000|Overall Study|Other|6|||
170751872|NCT01232556|617098279|FG001|Overall Study|Other|4|||
170751873|NCT01473420|617098280|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
170751874|NCT01473420|617098281|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
170751875|NCT01473420|617098280|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
170751876|NCT01473420|617098281|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
170751877|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
170864266|NCT01323634|617515559|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
170864267|NCT01323634|617515560|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
170864268|NCT01323634|617515561|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
170864269|NCT01323634|617515559|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
170864270|NCT01323634|617515560|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
170864271|NCT01323634|617515561|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
170864272|NCT01323634|617515559|FG000|2-week Run-in Period|Physician Decision|5|||
170864273|NCT01323634|617515560|FG001|2-week Run-in Period|Physician Decision|0|||
170864274|NCT01323634|617515561|FG002|2-week Run-in Period|Physician Decision|0|||
170864275|NCT01323634|617515559|FG000|2-week Run-in Period|Protocol Violation|1|||
170864276|NCT01323634|617515560|FG001|2-week Run-in Period|Protocol Violation|0|||
170864277|NCT01323634|617515561|FG002|2-week Run-in Period|Protocol Violation|0|||
170864278|NCT01323634|617515559|FG000|2-week Run-in Period|Adverse Event|1|||
170864279|NCT01323634|617515560|FG001|2-week Run-in Period|Adverse Event|0|||
170864280|NCT01323634|617515561|FG002|2-week Run-in Period|Adverse Event|0|||
170864281|NCT01323634|617515559|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170864282|NCT01323634|617515560|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
170864283|NCT01323634|617515561|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
170864284|NCT01323634|617515559|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170864285|NCT01323634|617515560|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170864286|NCT01323634|617515561|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
170864287|NCT01323634|617515559|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170864288|NCT01323634|617515560|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
170864289|NCT01323634|617515561|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
170864290|NCT01323634|617515559|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170864291|NCT01323634|617515560|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
170864292|NCT01323634|617515561|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
170864293|NCT01323634|617515559|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
170864294|NCT01323634|617515560|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
170864295|NCT01323634|617515561|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
170864296|NCT01323634|617515559|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170864297|NCT01323634|617515560|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
170864298|NCT01323634|617515561|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
170864299|NCT01323634|617515559|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
170864300|NCT01323634|617515560|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
170864301|NCT01323634|617515561|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
170402196|NCT00422058|615813362|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
170751878|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
170751879|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
170751880|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
170751881|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
170864302|NCT05056987|617515562|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
170864303|NCT05056987|617515563|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
170864304|NCT05056987|617515562|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
170751882|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
170751883|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
170751884|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
170751885|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
170751886|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
170751887|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
170751888|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
170751889|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
170751890|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
170864305|NCT05056987|617515563|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
170864306|NCT01575028|617515564|FG000|Overall Study|Physician Decision|0|||
170864307|NCT01575028|617515565|FG001|Overall Study|Physician Decision|1|||
170864308|NCT01182194|617515566|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
170864309|NCT01182194|617515567|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
170864310|NCT01948908|617515568|FG000|Overall Study|Protocol Violation|1|||
170864311|NCT01948908|617515569|FG001|Overall Study|Protocol Violation|0|||
170864312|NCT01948908|617515570|FG002|Overall Study|Protocol Violation|2|||
170751891|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
170751892|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
170751893|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
170751894|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
170751895|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
170751896|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
170751897|NCT01473420|617098280|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
170751898|NCT01473420|617098281|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
170751899|NCT00738530|617098282|FG000|Overall Study|Death|220|||
170751900|NCT00738530|617098283|FG001|Overall Study|Death|224|||
170751901|NCT00738530|617098282|FG000|Overall Study|Lost to Follow-up|8|||
170751902|NCT00738530|617098283|FG001|Overall Study|Lost to Follow-up|6|||
170751903|NCT00738530|617098282|FG000|Overall Study|Withdrawal by Subject|6|||
170751904|NCT00738530|617098283|FG001|Overall Study|Withdrawal by Subject|8|||
170751905|NCT05893797|617098286|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
170751906|NCT05893797|617098286|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
170751907|NCT05893797|617098286|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
170751908|NCT05893797|617098286|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
170751909|NCT03873246|617098289|FG000|Overall Study|Adverse Event|1|||
170751910|NCT03873246|617098290|FG001|Overall Study|Adverse Event|3|||
170751911|NCT03873246|617098291|FG002|Overall Study|Adverse Event|3|||
170751912|NCT03873246|617098289|FG000|Overall Study|Lost to Follow-up|4|||
170751913|NCT03873246|617098290|FG001|Overall Study|Lost to Follow-up|4|||
170751914|NCT03873246|617098291|FG002|Overall Study|Lost to Follow-up|5|||
170751915|NCT03873246|617098289|FG000|Overall Study|Protocol Violation|0|||
170751916|NCT03873246|617098290|FG001|Overall Study|Protocol Violation|1|||
170751917|NCT03873246|617098291|FG002|Overall Study|Protocol Violation|0|||
170751918|NCT03873246|617098289|FG000|Overall Study|Withdrawal by Subject|0|||
170751919|NCT03873246|617098290|FG001|Overall Study|Withdrawal by Subject|4|||
170751920|NCT03873246|617098291|FG002|Overall Study|Withdrawal by Subject|1|||
170751921|NCT00885495|617098292|FG000|Overall Study|Adverse Event|1|||
170751922|NCT00885495|617098293|FG001|Overall Study|Adverse Event|2|||
170751923|NCT00885495|617098292|FG000|Overall Study|Protocol Violation|0|||
170751924|NCT00885495|617098293|FG001|Overall Study|Protocol Violation|1|||
170751925|NCT00885495|617098292|FG000|Overall Study|Withdrawal by Subject|1|||
170751926|NCT00885495|617098293|FG001|Overall Study|Withdrawal by Subject|0|||
170751927|NCT03990363|617098297|FG000|Overall Study|Withdrawal by Subject|10|||
170751928|NCT03990363|617098298|FG001|Overall Study|Withdrawal by Subject|9|||
170751929|NCT03990363|617098299|FG002|Overall Study|Withdrawal by Subject|18|||
170751930|NCT03990363|617098300|FG003|Overall Study|Withdrawal by Subject|11|||
170751931|NCT03990363|617098301|FG004|Overall Study|Withdrawal by Subject|9|||
170751932|NCT03990363|617098297|FG000|Overall Study|Physician Decision|1|||
170751933|NCT03990363|617098298|FG001|Overall Study|Physician Decision|0|||
170751934|NCT03990363|617098299|FG002|Overall Study|Physician Decision|0|||
170751935|NCT03990363|617098300|FG003|Overall Study|Physician Decision|0|||
170751936|NCT03990363|617098301|FG004|Overall Study|Physician Decision|0|||
170751937|NCT03990363|617098297|FG000|Overall Study|Adverse Event|1|||
170751938|NCT03990363|617098298|FG001|Overall Study|Adverse Event|3|||
170751939|NCT03990363|617098299|FG002|Overall Study|Adverse Event|2|||
170751940|NCT03990363|617098300|FG003|Overall Study|Adverse Event|2|||
170751941|NCT03990363|617098301|FG004|Overall Study|Adverse Event|0|||
170751942|NCT03990363|617098297|FG000|Overall Study|Death|14|||
170751943|NCT03990363|617098298|FG001|Overall Study|Death|8|||
170751944|NCT03990363|617098299|FG002|Overall Study|Death|14|||
170751945|NCT03990363|617098300|FG003|Overall Study|Death|10|||
170751946|NCT03990363|617098301|FG004|Overall Study|Death|11|||
170751947|NCT03990363|617098297|FG000|Overall Study|Failure to meet randomization criteria|0|||
170751948|NCT03990363|617098298|FG001|Overall Study|Failure to meet randomization criteria|1|||
170751949|NCT03990363|617098299|FG002|Overall Study|Failure to meet randomization criteria|1|||
170751950|NCT03990363|617098300|FG003|Overall Study|Failure to meet randomization criteria|0|||
170864313|NCT01585987|617515571|FG000|Randomized|Withdrawal by Subject|0|||
170864314|NCT01585987|617515572|FG001|Randomized|Withdrawal by Subject|4|||
170864315|NCT01585987|617515571|FG000|Randomized|No longer met criteria|0|||
170864316|NCT01585987|617515572|FG001|Randomized|No longer met criteria|2|||
170402197|NCT00422058|615813363|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
170402198|NCT00422058|615813364|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
170402199|NCT00422058|615813365|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
170402200|NCT00422058|615813366|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
170402201|NCT00422058|615813361|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
170402202|NCT00422058|615813362|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
170402203|NCT00422058|615813363|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
170402204|NCT00422058|615813364|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
170402205|NCT00422058|615813365|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
170402206|NCT00422058|615813366|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
170402207|NCT00422058|615813361|FG000|Double-Blind, Week 0-20|Other|11|||
170402208|NCT00422058|615813362|FG001|Double-Blind, Week 0-20|Other|3|||
170402209|NCT00422058|615813363|FG002|Double-Blind, Week 0-20|Other|8|||
170402210|NCT00422058|615813364|FG003|Double-Blind, Week 0-20|Other|8|||
170402211|NCT00422058|615813365|FG004|Double-Blind, Week 0-20|Other|4|||
170402212|NCT00422058|615813366|FG005|Double-Blind, Week 0-20|Other|10|||
170402213|NCT00422058|615813361|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
170402214|NCT00422058|615813362|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
170402215|NCT00422058|615813363|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
170402216|NCT00422058|615813364|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
170402217|NCT00422058|615813365|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
170402218|NCT00422058|615813366|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
170402219|NCT00422058|615813361|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
170402220|NCT00422058|615813362|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
170751951|NCT03990363|617098301|FG004|Overall Study|Failure to meet randomization criteria|0|||
170751952|NCT03990363|617098297|FG000|Overall Study|Lost to Follow-up|0|||
170751953|NCT03990363|617098298|FG001|Overall Study|Lost to Follow-up|0|||
170751954|NCT03990363|617098299|FG002|Overall Study|Lost to Follow-up|0|||
170751955|NCT03990363|617098300|FG003|Overall Study|Lost to Follow-up|1|||
170751956|NCT03990363|617098301|FG004|Overall Study|Lost to Follow-up|2|||
170751957|NCT03990363|617098297|FG000|Overall Study|Non-compliance with study drug|2|||
170751958|NCT03990363|617098298|FG001|Overall Study|Non-compliance with study drug|1|||
170751959|NCT03990363|617098299|FG002|Overall Study|Non-compliance with study drug|2|||
170751960|NCT03990363|617098300|FG003|Overall Study|Non-compliance with study drug|0|||
170751961|NCT03990363|617098301|FG004|Overall Study|Non-compliance with study drug|0|||
170751962|NCT03990363|617098297|FG000|Overall Study|Study terminated by sponsor|0|||
170751963|NCT03990363|617098298|FG001|Overall Study|Study terminated by sponsor|1|||
170751964|NCT03990363|617098299|FG002|Overall Study|Study terminated by sponsor|0|||
170751965|NCT03990363|617098300|FG003|Overall Study|Study terminated by sponsor|0|||
170751966|NCT03990363|617098301|FG004|Overall Study|Study terminated by sponsor|0|||
170751967|NCT03990363|617098297|FG000|Overall Study|Site terminated by sponsor|2|||
170864317|NCT01585987|617515571|FG000|Treated|Disease Progression|39|||
170864318|NCT01585987|617515572|FG001|Treated|Disease Progression|36|||
170864319|NCT01585987|617515571|FG000|Treated|Study Drug Toxicity|9|||
170864320|NCT01585987|617515572|FG001|Treated|Study Drug Toxicity|5|||
170864321|NCT01585987|617515571|FG000|Treated|Adverse Event|3|||
170864322|NCT01585987|617515572|FG001|Treated|Adverse Event|0|||
170864323|NCT01585987|617515571|FG000|Treated|Withdrawal by Subject|1|||
170864324|NCT01585987|617515572|FG001|Treated|Withdrawal by Subject|2|||
170864325|NCT01585987|617515571|FG000|Treated|Death|1|||
170864326|NCT01585987|617515572|FG001|Treated|Death|0|||
170864327|NCT01585987|617515571|FG000|Treated|Lost to Follow-up|0|||
170864328|NCT01585987|617515572|FG001|Treated|Lost to Follow-up|1|||
170864329|NCT01585987|617515571|FG000|Treated|Maximum Clinical Benefit|0|||
170864330|NCT01585987|617515572|FG001|Treated|Maximum Clinical Benefit|1|||
170864331|NCT01585987|617515571|FG000|Treated|Non-Specified|1|||
170864332|NCT01585987|617515572|FG001|Treated|Non-Specified|2|||
170864333|NCT01585987|617515571|FG000|Treated|Subject Request|0|||
170864334|NCT01585987|617515572|FG001|Treated|Subject Request|1|||
170864335|NCT01585987|617515571|FG000|Treated|Poor/Non-Compliance|0|||
170864336|NCT01585987|617515572|FG001|Treated|Poor/Non-Compliance|1|||
170864337|NCT03291587|617515573|FG000|Overall Study|Lost to Follow-up|62|||
170864338|NCT03291587|617515574|FG001|Overall Study|Lost to Follow-up|43|||
170402221|NCT00422058|615813363|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
170402222|NCT00422058|615813364|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
170751968|NCT03990363|617098298|FG001|Overall Study|Site terminated by sponsor|1|||
170751969|NCT03990363|617098299|FG002|Overall Study|Site terminated by sponsor|2|||
170864339|NCT03291587|617515573|FG000|Overall Study|Refused to Answer|5|||
170864340|NCT03291587|617515574|FG001|Overall Study|Refused to Answer|2|||
170864341|NCT03291587|617515573|FG000|Overall Study|Death|2|||
170864342|NCT03291587|617515574|FG001|Overall Study|Death|4|||
170864343|NCT03291587|617515573|FG000|Overall Study|Not interested in participating|8|||
170864344|NCT03291587|617515574|FG001|Overall Study|Not interested in participating|6|||
170402223|NCT00422058|615813365|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
170402224|NCT00422058|615813366|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
170402225|NCT00422058|615813361|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
170402226|NCT00422058|615813362|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
170402227|NCT00422058|615813363|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
170402228|NCT00422058|615813364|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
170402229|NCT00422058|615813365|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
170402230|NCT00422058|615813366|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
170402231|NCT00422058|615813361|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
170402232|NCT00422058|615813362|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
170402233|NCT00422058|615813363|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
170402234|NCT00422058|615813364|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
170402235|NCT00422058|615813365|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
170402236|NCT00422058|615813366|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
170402237|NCT00422058|615813361|FG000|Open-Label Extension, Week 20-104|Other|13|||
170402238|NCT00422058|615813362|FG001|Open-Label Extension, Week 20-104|Other|14|||
170402239|NCT00422058|615813363|FG002|Open-Label Extension, Week 20-104|Other|6|||
170402240|NCT00422058|615813364|FG003|Open-Label Extension, Week 20-104|Other|13|||
170402241|NCT00422058|615813365|FG004|Open-Label Extension, Week 20-104|Other|16|||
170402242|NCT00422058|615813366|FG005|Open-Label Extension, Week 20-104|Other|18|||
170402243|NCT02065791|615813369|FG000|Overall Study|Closed Site|1|||
170402244|NCT02065791|615813370|FG001|Overall Study|Closed Site|1|||
170402245|NCT02065791|615813369|FG000|Overall Study|Withdrawal by Subject|11|||
170402246|NCT02065791|615813370|FG001|Overall Study|Withdrawal by Subject|5|||
170402247|NCT02065791|615813369|FG000|Overall Study|Lost to Follow-up|13|||
170402248|NCT02065791|615813370|FG001|Overall Study|Lost to Follow-up|9|||
170402249|NCT00683904|615813371|FG000|Dose Level 1|Disease progression|2|||
170402250|NCT00683904|615813372|FG001|Dose Level 1|Disease progression|0|||
170402251|NCT00683904|615813371|FG000|Dose Level 1|Adverse Event|1|||
170402252|NCT00683904|615813372|FG001|Dose Level 1|Adverse Event|0|||
170402253|NCT00683904|615813371|FG000|Dose Level 2|Adverse Event|0|||
170402254|NCT00683904|615813372|FG001|Dose Level 2|Adverse Event|2|||
170402255|NCT02702271|615813373|FG000|Overall Study|Death|36|||
170402256|NCT02702271|615813374|FG001|Overall Study|Death|7|||
170519624|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519625|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519626|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519627|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519628|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519629|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519630|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519631|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519632|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170864345|NCT03291587|617515573|FG000|Overall Study|Too busy to participate|4|||
170864346|NCT03291587|617515574|FG001|Overall Study|Too busy to participate|2|||
170864347|NCT00796120|617515576|FG000|Overall Study|Death|3|||
170402257|NCT02702271|615813373|FG000|Overall Study|Lost to Follow-up|12|||
170864348|NCT00796120|617515577|FG001|Overall Study|Death|0|||
170864349|NCT00796120|617515576|FG000|Overall Study|Adverse Event|11|||
170864350|NCT00796120|617515577|FG001|Overall Study|Adverse Event|6|||
170864351|NCT00796120|617515576|FG000|Overall Study|Progressive disease|22|||
170864352|NCT00796120|617515577|FG001|Overall Study|Progressive disease|13|||
170864353|NCT00796120|617515576|FG000|Overall Study|Participant refusal|3|||
170864354|NCT00796120|617515577|FG001|Overall Study|Participant refusal|4|||
170864355|NCT00796120|617515576|FG000|Overall Study|Other|6|||
170864356|NCT00796120|617515577|FG001|Overall Study|Other|17|||
170864357|NCT00796120|617515576|FG000|Overall Study|Physician Decision|16|||
170864358|NCT00796120|617515577|FG001|Overall Study|Physician Decision|17|||
170864359|NCT00796120|617515576|FG000|Overall Study|Randomized but not treated|0|||
170864360|NCT00796120|617515577|FG001|Overall Study|Randomized but not treated|3|||
170864361|NCT01759407|617515583|FG000|Overall Study|Protocol Violation|0|||
170864362|NCT01759407|617515584|FG001|Overall Study|Protocol Violation|2|||
170864363|NCT02520284|617515585|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
170864364|NCT02520284|617515586|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
170864365|NCT02520284|617515587|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
170864366|NCT02520284|617515585|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
170864367|NCT02520284|617515586|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
170864368|NCT02520284|617515587|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
170864369|NCT02520284|617515585|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
170402258|NCT02702271|615813374|FG001|Overall Study|Lost to Follow-up|0|||
170402259|NCT02702271|615813373|FG000|Overall Study|Withdrawal by Subject|8|||
170864370|NCT02520284|617515586|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
170864371|NCT02520284|617515587|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
170751970|NCT03990363|617098300|FG003|Overall Study|Site terminated by sponsor|0|||
170751971|NCT03990363|617098301|FG004|Overall Study|Site terminated by sponsor|2|||
170751972|NCT03990363|617098297|FG000|Overall Study|Not categorized|5|||
170751973|NCT03990363|617098298|FG001|Overall Study|Not categorized|5|||
170751974|NCT03990363|617098299|FG002|Overall Study|Not categorized|3|||
170751975|NCT03990363|617098300|FG003|Overall Study|Not categorized|2|||
170751976|NCT03990363|617098301|FG004|Overall Study|Not categorized|2|||
170751977|NCT00556374|617098302|FG000|Overall Study|Withdrawal by Subject|235|||
170751978|NCT00556374|617098303|FG001|Overall Study|Withdrawal by Subject|205|||
170751979|NCT00556374|617098302|FG000|Overall Study|Death|158|||
170751980|NCT00556374|617098303|FG001|Overall Study|Death|127|||
170751981|NCT00556374|617098302|FG000|Overall Study|Lost to Follow-up|24|||
170751982|NCT00556374|617098303|FG001|Overall Study|Lost to Follow-up|17|||
170751983|NCT00556374|617098302|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
170751984|NCT00556374|617098303|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
170751985|NCT04630756|617098304|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
170751986|NCT04630756|617098305|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
170751987|NCT04630756|617098306|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
170751988|NCT04131907|617098307|FG000|Overall Study|Adverse Event|2|||
170751989|NCT04131907|617098308|FG001|Overall Study|Adverse Event|0|||
170751990|NCT04131907|617098309|FG002|Overall Study|Adverse Event|0|||
170751991|NCT04131907|617098307|FG000|Overall Study|Physician Decision|4|||
170751992|NCT04131907|617098308|FG001|Overall Study|Physician Decision|22|||
170751993|NCT04131907|617098309|FG002|Overall Study|Physician Decision|0|||
170751994|NCT04131907|617098307|FG000|Overall Study|Withdrawal by Subject|2|||
170751995|NCT04131907|617098308|FG001|Overall Study|Withdrawal by Subject|0|||
170751996|NCT04131907|617098309|FG002|Overall Study|Withdrawal by Subject|1|||
170751997|NCT04131907|617098307|FG000|Overall Study|Treatment failure|2|||
170751998|NCT04131907|617098308|FG001|Overall Study|Treatment failure|0|||
170751999|NCT04131907|617098309|FG002|Overall Study|Treatment failure|1|||
170752000|NCT00641186|617098314|FG000|Overall Study|Adverse Event|3|||
170752001|NCT02404493|617098317|FG000|Overall Study|Adverse Event|1|||
170752002|NCT02404493|617098318|FG001|Overall Study|Adverse Event|1|||
170752003|NCT03317379|617098323|FG000|Overall Study|Lost to Follow-up|0|||
170752004|NCT03317379|617098324|FG001|Overall Study|Lost to Follow-up|3|||
170752005|NCT03317379|617098325|FG002|Overall Study|Lost to Follow-up|2|||
170752006|NCT04157686|617098326|FG000|Overall Study|Adverse Event|1|||
170752007|NCT04157686|617098327|FG001|Overall Study|Adverse Event|0|||
170752008|NCT04157686|617098328|FG002|Overall Study|Adverse Event|1|||
170752009|NCT04157686|617098329|FG003|Overall Study|Adverse Event|0|||
170752010|NCT04157686|617098330|FG004|Overall Study|Adverse Event|1|||
170752011|NCT04157686|617098331|FG005|Overall Study|Adverse Event|0|||
170752012|NCT04157686|617098332|FG006|Overall Study|Adverse Event|0|||
170752013|NCT04157686|617098333|FG007|Overall Study|Adverse Event|0|||
170752014|NCT04157686|617098326|FG000|Overall Study|Pregnancy|0|||
170752015|NCT04157686|617098327|FG001|Overall Study|Pregnancy|1|||
170752016|NCT04157686|617098328|FG002|Overall Study|Pregnancy|3|||
170752017|NCT04157686|617098329|FG003|Overall Study|Pregnancy|0|||
170752018|NCT04157686|617098330|FG004|Overall Study|Pregnancy|0|||
170752019|NCT04157686|617098331|FG005|Overall Study|Pregnancy|0|||
170752020|NCT04157686|617098332|FG006|Overall Study|Pregnancy|3|||
170752021|NCT04157686|617098333|FG007|Overall Study|Pregnancy|0|||
170752022|NCT04157686|617098326|FG000|Overall Study|Lost to Follow-up|1|||
170752023|NCT04157686|617098327|FG001|Overall Study|Lost to Follow-up|2|||
170752024|NCT04157686|617098328|FG002|Overall Study|Lost to Follow-up|8|||
170752025|NCT04157686|617098329|FG003|Overall Study|Lost to Follow-up|6|||
170752026|NCT04157686|617098330|FG004|Overall Study|Lost to Follow-up|6|||
170752027|NCT04157686|617098331|FG005|Overall Study|Lost to Follow-up|3|||
170752028|NCT04157686|617098332|FG006|Overall Study|Lost to Follow-up|7|||
170752029|NCT04157686|617098333|FG007|Overall Study|Lost to Follow-up|9|||
170752030|NCT04157686|617098326|FG000|Overall Study|Lack of Efficacy|0|||
170752031|NCT04157686|617098327|FG001|Overall Study|Lack of Efficacy|0|||
170752032|NCT04157686|617098328|FG002|Overall Study|Lack of Efficacy|0|||
170752033|NCT04157686|617098329|FG003|Overall Study|Lack of Efficacy|0|||
170752034|NCT04157686|617098330|FG004|Overall Study|Lack of Efficacy|0|||
170752035|NCT04157686|617098331|FG005|Overall Study|Lack of Efficacy|2|||
170752036|NCT04157686|617098332|FG006|Overall Study|Lack of Efficacy|0|||
170752037|NCT04157686|617098333|FG007|Overall Study|Lack of Efficacy|1|||
170752038|NCT04157686|617098326|FG000|Overall Study|Withdrawal by Subject|10|||
170906113|NCT01446809|617658622|FG002|Overall Study|Failure to complete study procedures|1|||
170752039|NCT04157686|617098327|FG001|Overall Study|Withdrawal by Subject|10|||
170752040|NCT04157686|617098328|FG002|Overall Study|Withdrawal by Subject|12|||
170752041|NCT04157686|617098329|FG003|Overall Study|Withdrawal by Subject|20|||
170752042|NCT04157686|617098330|FG004|Overall Study|Withdrawal by Subject|12|||
170752043|NCT04157686|617098331|FG005|Overall Study|Withdrawal by Subject|11|||
170752044|NCT04157686|617098332|FG006|Overall Study|Withdrawal by Subject|18|||
170752045|NCT04157686|617098333|FG007|Overall Study|Withdrawal by Subject|24|||
170752046|NCT04157686|617098326|FG000|Overall Study|Physician Decision|0|||
170752047|NCT04157686|617098327|FG001|Overall Study|Physician Decision|0|||
170864372|NCT02520284|617515585|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
170864373|NCT02520284|617515586|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
170864374|NCT02520284|617515587|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
170864375|NCT02520284|617515585|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
170864376|NCT02520284|617515586|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
170864377|NCT02520284|617515587|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
170864378|NCT02520284|617515585|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
170864379|NCT02520284|617515586|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
170864380|NCT02520284|617515587|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
170864381|NCT02520284|617515585|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
170864382|NCT02520284|617515586|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
170864383|NCT02520284|617515587|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
170864384|NCT02520284|617515585|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
170864385|NCT02520284|617515586|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
170864386|NCT02520284|617515587|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
170864387|NCT02520284|617515585|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
170864388|NCT02520284|617515586|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
170864389|NCT02520284|617515587|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
170864390|NCT02520284|617515585|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
170864391|NCT02520284|617515586|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
170864392|NCT02520284|617515587|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
170864393|NCT02520284|617515585|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
170864394|NCT02520284|617515586|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
170864395|NCT02520284|617515587|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
170864396|NCT03737474|617515588|FG000|Overall Study|Adverse Event|18|||
170864397|NCT03737474|617515589|FG001|Overall Study|Adverse Event|48|||
170864398|NCT03737474|617515588|FG000|Overall Study|Lack of Efficacy|1|||
170864399|NCT03737474|617515589|FG001|Overall Study|Lack of Efficacy|3|||
170864400|NCT03737474|617515588|FG000|Overall Study|Protocol Violation|0|||
170864401|NCT03737474|617515589|FG001|Overall Study|Protocol Violation|8|||
170864402|NCT03737474|617515588|FG000|Overall Study|Withdrawal by Subject|5|||
170864403|NCT03737474|617515589|FG001|Overall Study|Withdrawal by Subject|20|||
170864404|NCT03737474|617515588|FG000|Overall Study|Non-compliance With Study Drug|0|||
170864405|NCT03737474|617515589|FG001|Overall Study|Non-compliance With Study Drug|1|||
170864406|NCT03737474|617515588|FG000|Overall Study|Physician Decision|1|||
170864407|NCT03737474|617515589|FG001|Overall Study|Physician Decision|4|||
170864408|NCT02513745|617515590|FG000|Overall Study|Criteria at time of surgery not met.|3|||
170864409|NCT02513745|617515591|FG001|Overall Study|Criteria at time of surgery not met.|3|||
170864410|NCT00381303|617515594|FG000|Overall Study|Lost to Follow-up|25|||
170864411|NCT00381303|617515595|FG001|Overall Study|Lost to Follow-up|9|||
170864412|NCT00381303|617515594|FG000|Overall Study|AE/HIV-related event|22|||
170864413|NCT00381303|617515595|FG001|Overall Study|AE/HIV-related event|6|||
170864414|NCT00381303|617515594|FG000|Overall Study|Non-Adherence|13|||
170864415|NCT00381303|617515595|FG001|Overall Study|Non-Adherence|6|||
170864416|NCT00381303|617515594|FG000|Overall Study|Withdrawal by Subject|13|||
170864417|NCT00381303|617515595|FG001|Overall Study|Withdrawal by Subject|6|||
170864418|NCT00381303|617515594|FG000|Overall Study|Virologic failure|6|||
170864419|NCT00381303|617515595|FG001|Overall Study|Virologic failure|4|||
170864420|NCT00381303|617515594|FG000|Overall Study|Ineligible to continue the trial|2|||
170864421|NCT00381303|617515595|FG001|Overall Study|Ineligible to continue the trial|1|||
170864422|NCT00381303|617515594|FG000|Overall Study|Pregnancy|2|||
170864423|NCT00381303|617515595|FG001|Overall Study|Pregnancy|0|||
170864424|NCT00381303|617515594|FG000|Overall Study|Physician Decision|1|||
170864425|NCT00381303|617515595|FG001|Overall Study|Physician Decision|0|||
170864426|NCT00381303|617515594|FG000|Overall Study|Physician's decision to close the site|3|||
170864427|NCT00381303|617515595|FG001|Overall Study|Physician's decision to close the site|1|||
170864428|NCT00381303|617515594|FG000|Overall Study|Subject moved out of state|2|||
170864429|NCT00381303|617515595|FG001|Overall Study|Subject moved out of state|0|||
170864430|NCT00381303|617515594|FG000|Overall Study|Subject taking too many different meds|1|||
170864431|NCT00381303|617515595|FG001|Overall Study|Subject taking too many different meds|0|||
170864432|NCT00381303|617515594|FG000|Overall Study|No virologic response by week 12|1|||
170864433|NCT00381303|617515595|FG001|Overall Study|No virologic response by week 12|0|||
170864434|NCT00381303|617515594|FG000|Overall Study|Subject was too busy for appointments|1|||
170864435|NCT00381303|617515595|FG001|Overall Study|Subject was too busy for appointments|0|||
170864436|NCT00381303|617515594|FG000|Overall Study|Subject did not continue visits|1|||
170864437|NCT00381303|617515595|FG001|Overall Study|Subject did not continue visits|0|||
170864438|NCT00381303|617515594|FG000|Overall Study|Subject primary physician's decision|1|||
170864439|NCT00381303|617515595|FG001|Overall Study|Subject primary physician's decision|0|||
170864440|NCT01136811|617515596|FG000|Overall Study|Physician Decision|11|||
170864441|NCT01211522|617515597|FG000|Overall Study|Withdrawal by Subject|3|||
170864442|NCT01211522|617515598|FG001|Overall Study|Withdrawal by Subject|7|||
170864443|NCT01211522|617515599|FG002|Overall Study|Withdrawal by Subject|5|||
170864444|NCT01116882|617515605|FG000|30-day|Lost to Follow-up|50|||
170864445|NCT01116882|617515606|FG001|30-day|Lost to Follow-up|21|||
170864446|NCT01116882|617515605|FG000|30-day|Withdrawal by Subject|2|||
170864447|NCT01116882|617515606|FG001|30-day|Withdrawal by Subject|4|||
170864448|NCT01116882|617515605|FG000|30-day|Other Reasons|16|||
170864449|NCT01116882|617515606|FG001|30-day|Other Reasons|6|||
170864450|NCT01116882|617515605|FG000|12-month|Lost to Follow-up|111|||
170864451|NCT01116882|617515606|FG001|12-month|Lost to Follow-up|42|||
170864452|NCT01116882|617515605|FG000|12-month|Other Reasons|151|||
170864453|NCT01116882|617515606|FG001|12-month|Other Reasons|49|||
170864454|NCT01116882|617515605|FG000|12-month|Withdrawal by Subject|5|||
170864455|NCT01116882|617515606|FG001|12-month|Withdrawal by Subject|8|||
170864456|NCT00547365|617515607|FG000|Overall Study|Physician Decision|1|||
170864457|NCT00547365|617515607|FG000|Overall Study|Lost to Follow-up|1|||
170864458|NCT00547365|617515607|FG000|Overall Study|Protocol Violation|2|||
170864459|NCT00547365|617515607|FG000|Overall Study|death (not related to study)|4|||
170864460|NCT01139658|617515608|FG000|Overall Study|Adverse Event|10|||
170864461|NCT01139658|617515609|FG001|Overall Study|Adverse Event|27|||
170864462|NCT01139658|617515608|FG000|Overall Study|Lack of Efficacy|15|||
170864463|NCT01139658|617515609|FG001|Overall Study|Lack of Efficacy|7|||
170864464|NCT01139658|617515608|FG000|Overall Study|Withdrawal by Subject|2|||
170864465|NCT01139658|617515609|FG001|Overall Study|Withdrawal by Subject|4|||
170864466|NCT01139658|617515608|FG000|Overall Study|No documentation of treatment|1|||
170864467|NCT01139658|617515609|FG001|Overall Study|No documentation of treatment|0|||
170864468|NCT01139658|617515608|FG000|Overall Study|Other|28|||
170864469|NCT01139658|617515609|FG001|Overall Study|Other|75|||
170864470|NCT01777269|617515612|FG000|Overall Study|Adverse Event|24|||
170864471|NCT01777269|617515613|FG001|Overall Study|Adverse Event|33|||
170864472|NCT01777269|617515612|FG000|Overall Study|Lack of Efficacy|8|||
170864473|NCT01777269|617515613|FG001|Overall Study|Lack of Efficacy|10|||
170864474|NCT01777269|617515612|FG000|Overall Study|Protocol Violation|4|||
170864475|NCT01777269|617515613|FG001|Overall Study|Protocol Violation|4|||
170864476|NCT01777269|617515612|FG000|Overall Study|Participants reached stopping criteria|1|||
170864477|NCT01777269|617515613|FG001|Overall Study|Participants reached stopping criteria|1|||
170864478|NCT01777269|617515612|FG000|Overall Study|Lost to Follow-up|4|||
170864479|NCT01777269|617515613|FG001|Overall Study|Lost to Follow-up|0|||
170864480|NCT01777269|617515612|FG000|Overall Study|Physician Decision|5|||
170864481|NCT01777269|617515613|FG001|Overall Study|Physician Decision|2|||
170864482|NCT01777269|617515612|FG000|Overall Study|Withdrawal by Subject|9|||
170864483|NCT01777269|617515613|FG001|Overall Study|Withdrawal by Subject|9|||
170864484|NCT00504881|617515614|FG000|Overall Study|Lack of Efficacy|1|||
170864485|NCT00504881|617515615|FG001|Overall Study|Lack of Efficacy|5|||
170864486|NCT00504881|617515614|FG000|Overall Study|Lost to Follow-up|0|||
170864487|NCT00504881|617515615|FG001|Overall Study|Lost to Follow-up|2|||
170864488|NCT00504881|617515614|FG000|Overall Study|Withdrawal by Subject|1|||
170864489|NCT00504881|617515615|FG001|Overall Study|Withdrawal by Subject|4|||
170864490|NCT00504881|617515614|FG000|Overall Study|Non-Compliance|1|||
170864491|NCT00504881|617515615|FG001|Overall Study|Non-Compliance|0|||
170864492|NCT00504881|617515614|FG000|Overall Study|No Birth Control|0|||
170864493|NCT00504881|617515615|FG001|Overall Study|No Birth Control|1|||
170864494|NCT00504881|617515614|FG000|Overall Study|Safety Visit not performed|0|||
170864495|NCT00504881|617515615|FG001|Overall Study|Safety Visit not performed|1|||
170864496|NCT00504881|617515614|FG000|Overall Study|AE, serious fatal|0|||
170864497|NCT00504881|617515615|FG001|Overall Study|AE, serious fatal|1|||
170864498|NCT00504881|617515614|FG000|Overall Study|SAE, non-fatal|2|||
170864499|NCT00504881|617515615|FG001|Overall Study|SAE, non-fatal|6|||
170864500|NCT00504881|617515614|FG000|Overall Study|AE, non-serious non-fatal|4|||
170864501|NCT00504881|617515615|FG001|Overall Study|AE, non-serious non-fatal|14|||
170864502|NCT00504881|617515614|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
170864503|NCT00504881|617515615|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
170864504|NCT00504881|617515614|FG000|Overall Study|AE of unknown type|1|||
170864505|NCT00504881|617515615|FG001|Overall Study|AE of unknown type|0|||
170864506|NCT01009554|617515618|FG000|Overall Study|Adverse Event|1|||
170864507|NCT01009554|617515619|FG001|Overall Study|Adverse Event|1|||
170864508|NCT01009554|617515618|FG000|Overall Study|Withdrawal by Subject|1|||
170864509|NCT01009554|617515619|FG001|Overall Study|Withdrawal by Subject|3|||
170864510|NCT01009554|617515618|FG000|Overall Study|Noncompliant with Study Product|0|||
170864511|NCT01009554|617515619|FG001|Overall Study|Noncompliant with Study Product|3|||
170864512|NCT01605253|617515620|FG000|Overall Study|Physician Decision|3|||
170864513|NCT01605253|617515621|FG001|Overall Study|Physician Decision|2|||
170864514|NCT01605253|617515620|FG000|Overall Study|Lost to Follow-up|3|||
170864515|NCT01605253|617515621|FG001|Overall Study|Lost to Follow-up|1|||
170864516|NCT02370043|617515626|FG000|Overall Study|Withdrawal by Subject|0|||
170864517|NCT02370043|617515627|FG001|Overall Study|Withdrawal by Subject|0|||
170864518|NCT02370043|617515628|FG002|Overall Study|Withdrawal by Subject|0|||
170864519|NCT02370043|617515629|FG003|Overall Study|Withdrawal by Subject|0|||
170864520|NCT02370043|617515630|FG004|Overall Study|Withdrawal by Subject|1|||
170864521|NCT02370043|617515631|FG005|Overall Study|Withdrawal by Subject|1|||
170864522|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
170864523|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
170864524|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
170752048|NCT04157686|617098328|FG002|Overall Study|Physician Decision|1|||
170402260|NCT02702271|615813374|FG001|Overall Study|Withdrawal by Subject|1|||
170402261|NCT02702271|615813373|FG000|Overall Study|Physician Decision|2|||
170752049|NCT04157686|617098329|FG003|Overall Study|Physician Decision|0|||
170752050|NCT04157686|617098330|FG004|Overall Study|Physician Decision|1|||
170752051|NCT04157686|617098331|FG005|Overall Study|Physician Decision|0|||
170752052|NCT04157686|617098332|FG006|Overall Study|Physician Decision|3|||
170752053|NCT04157686|617098333|FG007|Overall Study|Physician Decision|0|||
170752054|NCT04157686|617098326|FG000|Overall Study|Death|0|||
170752055|NCT04157686|617098327|FG001|Overall Study|Death|0|||
170752056|NCT04157686|617098328|FG002|Overall Study|Death|0|||
170752057|NCT04157686|617098329|FG003|Overall Study|Death|2|||
170752058|NCT04157686|617098330|FG004|Overall Study|Death|0|||
170752059|NCT04157686|617098331|FG005|Overall Study|Death|0|||
170752060|NCT04157686|617098332|FG006|Overall Study|Death|0|||
170752061|NCT04157686|617098333|FG007|Overall Study|Death|0|||
170752062|NCT04157686|617098326|FG000|Overall Study|Protocol Violation|0|||
170752063|NCT04157686|617098327|FG001|Overall Study|Protocol Violation|0|||
170752064|NCT04157686|617098328|FG002|Overall Study|Protocol Violation|0|||
170752065|NCT04157686|617098329|FG003|Overall Study|Protocol Violation|0|||
170752066|NCT04157686|617098330|FG004|Overall Study|Protocol Violation|1|||
170752067|NCT04157686|617098331|FG005|Overall Study|Protocol Violation|0|||
170752068|NCT04157686|617098332|FG006|Overall Study|Protocol Violation|0|||
170752069|NCT04157686|617098333|FG007|Overall Study|Protocol Violation|0|||
170752070|NCT04157686|617098326|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
170752071|NCT04157686|617098327|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
170752072|NCT04157686|617098328|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
170752073|NCT04157686|617098329|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
170752074|NCT04157686|617098330|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
170752075|NCT04157686|617098331|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
170752076|NCT04157686|617098332|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
170752077|NCT04157686|617098333|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
170752078|NCT03363659|617098334|FG000|Overall Study|Adverse Event|1|||
170752079|NCT03363659|617098334|FG000|Overall Study|Screen fail|1|||
170752080|NCT03363659|617098334|FG000|Overall Study|Withdrawal by Subject|1|||
170752081|NCT06403605|617098335|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
170752082|NCT06403605|617098336|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
170752083|NCT06403605|617098335|FG000|Follow-up|Adverse Event|4|||
170752084|NCT06403605|617098336|FG001|Follow-up|Adverse Event|2|||
170752085|NCT06403605|617098335|FG000|Follow-up|Withdrawal by Subject|2|||
170752086|NCT06403605|617098336|FG001|Follow-up|Withdrawal by Subject|3|||
170752087|NCT06403605|617098335|FG000|Follow-up|Lost to Follow-up|1|||
170752088|NCT06403605|617098336|FG001|Follow-up|Lost to Follow-up|0|||
170752089|NCT06403605|617098335|FG000|Follow-up|Death|1|||
170752090|NCT06403605|617098336|FG001|Follow-up|Death|0|||
170752091|NCT06403605|617098335|FG000|Follow-up|Other reasons|0|||
170752092|NCT06403605|617098336|FG001|Follow-up|Other reasons|4|||
170752093|NCT02028884|617099670|FG000|Double-blind Period|Adverse Event|5|||
170752094|NCT02028884|617099671|FG001|Double-blind Period|Adverse Event|3|||
170752095|NCT02028884|617099672|FG002|Double-blind Period|Adverse Event|0|||
170752096|NCT02028884|617099670|FG000|Double-blind Period|Eligibility Violation|1|||
170752097|NCT02028884|617099671|FG001|Double-blind Period|Eligibility Violation|0|||
170752098|NCT02028884|617099672|FG002|Double-blind Period|Eligibility Violation|0|||
170752099|NCT02028884|617099670|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
170752100|NCT02028884|617099671|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
170752101|NCT02028884|617099672|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
170752102|NCT02028884|617099670|FG000|Double-blind Period|Withdrawal by Subject|2|||
170752103|NCT02028884|617099671|FG001|Double-blind Period|Withdrawal by Subject|0|||
170752104|NCT02028884|617099672|FG002|Double-blind Period|Withdrawal by Subject|0|||
170752105|NCT02028884|617099670|FG000|Open-label Extension Period|Adverse Event|3|||
170752106|NCT02028884|617099671|FG001|Open-label Extension Period|Adverse Event|1|||
170752107|NCT02028884|617099672|FG002|Open-label Extension Period|Adverse Event|0|||
170752108|NCT02028884|617099670|FG000|Open-label Extension Period|Lack of Efficacy|3|||
170752109|NCT02028884|617099671|FG001|Open-label Extension Period|Lack of Efficacy|0|||
170752110|NCT02028884|617099672|FG002|Open-label Extension Period|Lack of Efficacy|0|||
170752111|NCT02028884|617099670|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
170752112|NCT02028884|617099671|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
170752113|NCT02028884|617099672|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
170752114|NCT02028884|617099670|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
170864525|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
170864526|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
170864527|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
170864528|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
170864529|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
170864530|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
170864531|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
170864532|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
170864533|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
170864534|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
170864535|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
170864536|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
170864537|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
170864538|NCT01231516|617515634|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
170864539|NCT01231516|617515635|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
170864540|NCT01231516|617515634|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
170864541|NCT01231516|617515635|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
170864542|NCT01231516|617515634|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
170864543|NCT01231516|617515635|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
170864544|NCT01231516|617515634|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
170864545|NCT01231516|617515635|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
170864546|NCT01231516|617515634|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
170864547|NCT01231516|617515635|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
170864548|NCT01231516|617515634|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
170864549|NCT01231516|617515635|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
170864550|NCT01231516|617515634|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
170864551|NCT01231516|617515635|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
170864552|NCT01231516|617515634|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
170864553|NCT01231516|617515635|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
170864554|NCT04427501|617515636|FG000|Overall Study|Death|0|||
170864555|NCT04427501|617515637|FG001|Overall Study|Death|0|||
170864556|NCT04427501|617515638|FG002|Overall Study|Death|0|||
170864557|NCT04427501|617515639|FG003|Overall Study|Death|0|||
170864558|NCT04427501|617515640|FG004|Overall Study|Death|0|||
170864559|NCT04427501|617515641|FG005|Overall Study|Death|15|||
170864560|NCT04427501|617515642|FG006|Overall Study|Death|0|||
170864561|NCT04427501|617515643|FG007|Overall Study|Death|0|||
170864562|NCT04427501|617515644|FG008|Overall Study|Death|0|||
170864563|NCT04427501|617515645|FG009|Overall Study|Death|0|||
170864564|NCT04427501|617515646|FG010|Overall Study|Death|0|||
170864565|NCT04427501|617515647|FG011|Overall Study|Death|0|||
170864566|NCT04427501|617515636|FG000|Overall Study|Lost to Follow-up|5|||
170864567|NCT04427501|617515637|FG001|Overall Study|Lost to Follow-up|1|||
170864568|NCT04427501|617515638|FG002|Overall Study|Lost to Follow-up|2|||
170864569|NCT04427501|617515639|FG003|Overall Study|Lost to Follow-up|0|||
170864570|NCT04427501|617515640|FG004|Overall Study|Lost to Follow-up|2|||
170864571|NCT04427501|617515641|FG005|Overall Study|Lost to Follow-up|11|||
170864572|NCT04427501|617515642|FG006|Overall Study|Lost to Follow-up|10|||
170864573|NCT04427501|617515643|FG007|Overall Study|Lost to Follow-up|10|||
170864574|NCT04427501|617515644|FG008|Overall Study|Lost to Follow-up|2|||
170864575|NCT04427501|617515645|FG009|Overall Study|Lost to Follow-up|5|||
170864576|NCT04427501|617515646|FG010|Overall Study|Lost to Follow-up|2|||
170864577|NCT04427501|617515647|FG011|Overall Study|Lost to Follow-up|0|||
170864578|NCT04427501|617515636|FG000|Overall Study|Physician Decision|0|||
170864579|NCT04427501|617515637|FG001|Overall Study|Physician Decision|3|||
170864580|NCT04427501|617515638|FG002|Overall Study|Physician Decision|0|||
170864581|NCT04427501|617515639|FG003|Overall Study|Physician Decision|0|||
170864582|NCT04427501|617515640|FG004|Overall Study|Physician Decision|0|||
170864583|NCT04427501|617515641|FG005|Overall Study|Physician Decision|0|||
170864584|NCT04427501|617515642|FG006|Overall Study|Physician Decision|2|||
170864585|NCT04427501|617515643|FG007|Overall Study|Physician Decision|0|||
170864586|NCT04427501|617515644|FG008|Overall Study|Physician Decision|0|||
170864587|NCT04427501|617515645|FG009|Overall Study|Physician Decision|0|||
170864588|NCT04427501|617515646|FG010|Overall Study|Physician Decision|0|||
170864589|NCT04427501|617515647|FG011|Overall Study|Physician Decision|0|||
170864590|NCT04427501|617515636|FG000|Overall Study|Withdrawal by Subject|9|||
170864591|NCT04427501|617515637|FG001|Overall Study|Withdrawal by Subject|2|||
170402262|NCT02702271|615813374|FG001|Overall Study|Physician Decision|0|||
170864592|NCT04427501|617515638|FG002|Overall Study|Withdrawal by Subject|2|||
170864593|NCT04427501|617515639|FG003|Overall Study|Withdrawal by Subject|3|||
170864594|NCT04427501|617515640|FG004|Overall Study|Withdrawal by Subject|7|||
170864595|NCT04427501|617515641|FG005|Overall Study|Withdrawal by Subject|25|||
170752115|NCT02028884|617099671|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
170752116|NCT02028884|617099672|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
170752117|NCT02028884|617099670|FG000|Open-label Extension Period|Switched to another treatment option|3|||
170752118|NCT02028884|617099671|FG001|Open-label Extension Period|Switched to another treatment option|0|||
170752119|NCT02028884|617099672|FG002|Open-label Extension Period|Switched to another treatment option|0|||
170752120|NCT03302910|617099673|FG000|Overall Study|Protocol Violation|1|||
170752121|NCT03302910|617099674|FG001|Overall Study|Protocol Violation|0|||
170752122|NCT00088205|617099680|FG000|Overall Study|Adverse Event|4|||
170752123|NCT00088205|617099680|FG000|Overall Study|Progressive Disease|51|||
170752124|NCT00088205|617099680|FG000|Overall Study|Physician Decision|1|||
170752125|NCT00088205|617099680|FG000|Overall Study|Death Due to Study Disease|4|||
170752126|NCT01152554|617099690|FG000|Overall Study|Withdrawal by Subject|73|||
170752127|NCT01152554|617099691|FG001|Overall Study|Withdrawal by Subject|28|||
170752128|NCT01152554|617099690|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
170752129|NCT01152554|617099691|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
170752130|NCT01152554|617099690|FG000|Overall Study|Adverse Event|67|||
170752131|NCT01152554|617099691|FG001|Overall Study|Adverse Event|14|||
170752132|NCT01152554|617099690|FG000|Overall Study|Severe non-compliance to protocol|36|||
170752133|NCT01152554|617099691|FG001|Overall Study|Severe non-compliance to protocol|14|||
170752134|NCT01152554|617099690|FG000|Overall Study|Condition under investigation worsened|5|||
170752135|NCT01152554|617099691|FG001|Overall Study|Condition under investigation worsened|2|||
170752136|NCT01152554|617099690|FG000|Overall Study|Lack of Efficacy|20|||
170752137|NCT01152554|617099691|FG001|Overall Study|Lack of Efficacy|3|||
170752138|NCT01152554|617099690|FG000|Overall Study|Study-specific withdrawal criteria|17|||
170752139|NCT01152554|617099691|FG001|Overall Study|Study-specific withdrawal criteria|8|||
170752140|NCT01152554|617099690|FG000|Overall Study|Lost to Follow-up|87|||
170752141|NCT01152554|617099691|FG001|Overall Study|Lost to Follow-up|32|||
170752142|NCT01152554|617099690|FG000|Overall Study|Other|28|||
170752143|NCT01152554|617099691|FG001|Overall Study|Other|8|||
170752144|NCT01152554|617099690|FG000|Overall Study|Death|1|||
170864596|NCT04427501|617515642|FG006|Overall Study|Withdrawal by Subject|15|||
170864597|NCT04427501|617515643|FG007|Overall Study|Withdrawal by Subject|7|||
170864598|NCT04427501|617515644|FG008|Overall Study|Withdrawal by Subject|4|||
170864599|NCT04427501|617515645|FG009|Overall Study|Withdrawal by Subject|1|||
170864600|NCT04427501|617515646|FG010|Overall Study|Withdrawal by Subject|4|||
170864601|NCT04427501|617515647|FG011|Overall Study|Withdrawal by Subject|0|||
170864602|NCT04427501|617515636|FG000|Overall Study|Other - as reported by the investigator|1|||
170864603|NCT04427501|617515637|FG001|Overall Study|Other - as reported by the investigator|0|||
170864604|NCT04427501|617515638|FG002|Overall Study|Other - as reported by the investigator|0|||
170864605|NCT04427501|617515639|FG003|Overall Study|Other - as reported by the investigator|0|||
170864606|NCT04427501|617515640|FG004|Overall Study|Other - as reported by the investigator|0|||
170864607|NCT04427501|617515641|FG005|Overall Study|Other - as reported by the investigator|6|||
170864608|NCT04427501|617515642|FG006|Overall Study|Other - as reported by the investigator|6|||
170864609|NCT04427501|617515643|FG007|Overall Study|Other - as reported by the investigator|0|||
170864610|NCT04427501|617515644|FG008|Overall Study|Other - as reported by the investigator|0|||
170864611|NCT04427501|617515645|FG009|Overall Study|Other - as reported by the investigator|0|||
170864612|NCT04427501|617515646|FG010|Overall Study|Other - as reported by the investigator|0|||
170864613|NCT04427501|617515647|FG011|Overall Study|Other - as reported by the investigator|0|||
170864614|NCT04427501|617515636|FG000|Overall Study|Other|0|||
170864615|NCT04427501|617515637|FG001|Overall Study|Other|0|||
170864616|NCT04427501|617515638|FG002|Overall Study|Other|0|||
170864617|NCT04427501|617515639|FG003|Overall Study|Other|0|||
170864618|NCT04427501|617515640|FG004|Overall Study|Other|0|||
170864619|NCT04427501|617515641|FG005|Overall Study|Other|0|||
170864620|NCT04427501|617515642|FG006|Overall Study|Other|0|||
170864621|NCT04427501|617515643|FG007|Overall Study|Other|0|||
170864622|NCT04427501|617515644|FG008|Overall Study|Other|0|||
170864623|NCT04427501|617515645|FG009|Overall Study|Other|0|||
170864624|NCT04427501|617515646|FG010|Overall Study|Other|0|||
170864625|NCT04427501|617515647|FG011|Overall Study|Other|1|||
170864626|NCT05266586|617515648|FG000|Overall Study|Adverse Event|2|||
170864627|NCT05266586|617515649|FG001|Overall Study|Adverse Event|2|||
170864628|NCT05266586|617515650|FG002|Overall Study|Adverse Event|1|||
170864629|NCT05266586|617515648|FG000|Overall Study|Withdrawal by Subject|1|||
170864630|NCT05266586|617515649|FG001|Overall Study|Withdrawal by Subject|0|||
170864631|NCT05266586|617515650|FG002|Overall Study|Withdrawal by Subject|1|||
170864632|NCT05266586|617515648|FG000|Overall Study|Non-compliance with study drug|0|||
170864633|NCT05266586|617515649|FG001|Overall Study|Non-compliance with study drug|1|||
170752145|NCT01152554|617099691|FG001|Overall Study|Death|1|||
170752146|NCT01439711|617099692|FG000|Overall Study|Ineligible|13|||
170752147|NCT01439711|617099692|FG000|Overall Study|Cancel|3|||
170752148|NCT01439711|617099692|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
170752149|NCT01439711|617099692|FG000|Overall Study|Adverse Event|5|||
170864634|NCT05266586|617515650|FG002|Overall Study|Non-compliance with study drug|0|||
170864635|NCT05266586|617515648|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
170864636|NCT05266586|617515649|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
170864637|NCT05266586|617515650|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
170864638|NCT02225353|617515651|FG000|Overall Study|Lost to Follow-up|0|||
170864639|NCT02225353|617515652|FG001|Overall Study|Lost to Follow-up|1|||
170864640|NCT02225353|617515653|FG002|Overall Study|Lost to Follow-up|3|||
170864641|NCT02225353|617515651|FG000|Overall Study|Protocol Violation|4|||
170864642|NCT02225353|617515652|FG001|Overall Study|Protocol Violation|5|||
170864643|NCT02225353|617515653|FG002|Overall Study|Protocol Violation|12|||
170864644|NCT01193920|617515654|FG000|Overall Study|Withdrawal by Subject|1|||
170864645|NCT01193920|617515655|FG001|Overall Study|Withdrawal by Subject|0|||
170864646|NCT01193920|617515656|FG002|Overall Study|Withdrawal by Subject|5|||
170864647|NCT01193920|617515657|FG003|Overall Study|Withdrawal by Subject|1|||
170864648|NCT01193920|617515658|FG004|Overall Study|Withdrawal by Subject|3|||
170864649|NCT01193920|617515659|FG005|Overall Study|Withdrawal by Subject|1|||
170864650|NCT01193920|617515660|FG006|Overall Study|Withdrawal by Subject|3|||
170864651|NCT01193920|617515661|FG007|Overall Study|Withdrawal by Subject|0|||
170402263|NCT02702271|615813373|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
170402264|NCT02702271|615813374|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
170402265|NCT03467971|615813375|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170402266|NCT03467971|615813376|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170402267|NCT00975884|615813377|FG000|Overall Study|Adverse Event|1|||
170402268|NCT00975884|615813378|FG001|Overall Study|Adverse Event|0|||
170402269|NCT00975884|615813377|FG000|Overall Study|Lost to Follow-up|5|||
170402270|NCT00975884|615813378|FG001|Overall Study|Lost to Follow-up|3|||
170402271|NCT00975884|615813377|FG000|Overall Study|Withdrawal by Subject|9|||
170402272|NCT00975884|615813378|FG001|Overall Study|Withdrawal by Subject|9|||
170402273|NCT00975884|615813377|FG000|Overall Study|Other|1|||
170402274|NCT00975884|615813378|FG001|Overall Study|Other|3|||
170402275|NCT00363129|615813381|FG000|Overall Study|Withdrawal by Subject|11|||
170402276|NCT00363129|615813382|FG001|Overall Study|Withdrawal by Subject|18|||
170402277|NCT00363129|615813381|FG000|Overall Study|Adverse Event|8|||
170402278|NCT00363129|615813382|FG001|Overall Study|Adverse Event|3|||
170402279|NCT00363129|615813381|FG000|Overall Study|Alternate Treatment|2|||
170402280|NCT00363129|615813382|FG001|Overall Study|Alternate Treatment|4|||
170402281|NCT00363129|615813381|FG000|Overall Study|Other Medical Problems|2|||
170402282|NCT00363129|615813382|FG001|Overall Study|Other Medical Problems|4|||
170402283|NCT00363129|615813381|FG000|Overall Study|Death|0|||
170402284|NCT00363129|615813382|FG001|Overall Study|Death|1|||
170402285|NCT00363129|615813381|FG000|Overall Study|Other Reasons|6|||
170402286|NCT00363129|615813382|FG001|Overall Study|Other Reasons|3|||
170402287|NCT03707522|615813383|FG000|Overall Study|Lost to Follow-up|24|||
170402288|NCT03707522|615813384|FG001|Overall Study|Lost to Follow-up|27|||
170402289|NCT03707522|615813385|FG002|Overall Study|Lost to Follow-up|41|||
170402290|NCT03707522|615813386|FG003|Overall Study|Lost to Follow-up|36|||
170402291|NCT05166512|615813387|FG000|Randomized|Lost to Follow-up|2|||
170402292|NCT05166512|615813388|FG001|Randomized|Lost to Follow-up|0|||
170402293|NCT05166512|615813387|FG000|Randomized|Withdrawal by Subject|1|||
170402294|NCT05166512|615813388|FG001|Randomized|Withdrawal by Subject|0|||
170402295|NCT05166512|615813387|FG000|Baseline Data Collection|Lost to Follow-up|0|||
170402296|NCT05166512|615813388|FG001|Baseline Data Collection|Lost to Follow-up|3|||
170402297|NCT05166512|615813387|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
170402298|NCT05166512|615813388|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
170402299|NCT05166512|615813387|FG000|Baseline Data Collection|Protocol Violation|2|||
170402300|NCT05166512|615813388|FG001|Baseline Data Collection|Protocol Violation|0|||
170402301|NCT05166512|615813387|FG000|4 Month Data Collection|Lost to Follow-up|1|||
170402302|NCT05166512|615813388|FG001|4 Month Data Collection|Lost to Follow-up|0|||
170402303|NCT05166512|615813387|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
170402304|NCT05166512|615813388|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
170402305|NCT05166512|615813387|FG000|12 Month Data Collection|Lost to Follow-up|3|||
170402306|NCT05166512|615813388|FG001|12 Month Data Collection|Lost to Follow-up|1|||
170752150|NCT01439711|617099692|FG000|Overall Study|Withdrawal by Subject|3|||
170752151|NCT01439711|617099692|FG000|Overall Study|Progression During Active Tx|3|||
170752152|NCT01439711|617099692|FG000|Overall Study|Noncompliance|3|||
170752153|NCT01439711|617099692|FG000|Overall Study|No MRI|9|||
170752154|NCT01272011|617099693|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
170752155|NCT01272011|617099694|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
170752156|NCT01272011|617099695|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
170752157|NCT02839681|617099697|FG000|Overall Study|Death|2|||
170864652|NCT01193920|617515662|FG008|Overall Study|Withdrawal by Subject|1|||
170864653|NCT01193920|617515663|FG009|Overall Study|Withdrawal by Subject|0|||
170402307|NCT05166512|615813387|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
170402308|NCT05166512|615813388|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
170402309|NCT01892020|615813389|FG000|Period 1|Adverse Event|1|||
170402310|NCT01892020|615813390|FG001|Period 1|Adverse Event|1|||
170402311|NCT01892020|615813389|FG000|Period 1|Protocol Violation|2|||
170402312|NCT01892020|615813390|FG001|Period 1|Protocol Violation|4|||
170864654|NCT01193920|617515654|FG000|Overall Study|Lost to Follow-up|1|||
170864655|NCT01193920|617515655|FG001|Overall Study|Lost to Follow-up|0|||
170864656|NCT01193920|617515656|FG002|Overall Study|Lost to Follow-up|1|||
170864657|NCT01193920|617515657|FG003|Overall Study|Lost to Follow-up|1|||
170864658|NCT01193920|617515658|FG004|Overall Study|Lost to Follow-up|3|||
170864659|NCT01193920|617515659|FG005|Overall Study|Lost to Follow-up|3|||
170864660|NCT01193920|617515660|FG006|Overall Study|Lost to Follow-up|1|||
170864661|NCT01193920|617515661|FG007|Overall Study|Lost to Follow-up|0|||
170864662|NCT01193920|617515662|FG008|Overall Study|Lost to Follow-up|2|||
170864663|NCT01193920|617515663|FG009|Overall Study|Lost to Follow-up|3|||
170864664|NCT01193920|617515654|FG000|Overall Study|Protocol Violation|1|||
170864665|NCT01193920|617515655|FG001|Overall Study|Protocol Violation|0|||
170864666|NCT01193920|617515656|FG002|Overall Study|Protocol Violation|0|||
170864667|NCT01193920|617515657|FG003|Overall Study|Protocol Violation|0|||
170864668|NCT01193920|617515658|FG004|Overall Study|Protocol Violation|0|||
170864669|NCT01193920|617515659|FG005|Overall Study|Protocol Violation|0|||
170864670|NCT01193920|617515660|FG006|Overall Study|Protocol Violation|0|||
170864671|NCT01193920|617515661|FG007|Overall Study|Protocol Violation|0|||
170864672|NCT01193920|617515662|FG008|Overall Study|Protocol Violation|0|||
170864673|NCT01193920|617515663|FG009|Overall Study|Protocol Violation|0|||
170864674|NCT01193920|617515654|FG000|Overall Study|Death|0|||
170864675|NCT01193920|617515655|FG001|Overall Study|Death|0|||
170864676|NCT01193920|617515656|FG002|Overall Study|Death|0|||
170864677|NCT01193920|617515657|FG003|Overall Study|Death|1|||
170864678|NCT01193920|617515658|FG004|Overall Study|Death|0|||
170864679|NCT01193920|617515659|FG005|Overall Study|Death|0|||
170864680|NCT01193920|617515660|FG006|Overall Study|Death|2|||
170864681|NCT01193920|617515661|FG007|Overall Study|Death|3|||
170864682|NCT01193920|617515662|FG008|Overall Study|Death|2|||
170864683|NCT01193920|617515663|FG009|Overall Study|Death|4|||
170864684|NCT01193920|617515654|FG000|Overall Study|Unable to classify|0|||
170864685|NCT01193920|617515655|FG001|Overall Study|Unable to classify|0|||
170864686|NCT01193920|617515656|FG002|Overall Study|Unable to classify|0|||
170864687|NCT01193920|617515657|FG003|Overall Study|Unable to classify|1|||
170864688|NCT01193920|617515658|FG004|Overall Study|Unable to classify|0|||
170864689|NCT01193920|617515659|FG005|Overall Study|Unable to classify|0|||
170864690|NCT01193920|617515660|FG006|Overall Study|Unable to classify|0|||
170864691|NCT01193920|617515661|FG007|Overall Study|Unable to classify|1|||
170864692|NCT01193920|617515662|FG008|Overall Study|Unable to classify|0|||
170864693|NCT01193920|617515663|FG009|Overall Study|Unable to classify|0|||
170864694|NCT03951220|617515664|FG000|Overall Study|Withdrawal by Subject|9|||
170864695|NCT03951220|617515665|FG001|Overall Study|Withdrawal by Subject|2|||
170864696|NCT03951220|617515666|FG002|Overall Study|Withdrawal by Subject|0|||
170864697|NCT03604523|617515669|FG000|Overall Study|Physician Decision|1|||
170864698|NCT03604523|617515670|FG001|Overall Study|Physician Decision|0|||
170864699|NCT05461794|617515671|FG000|Overall Study|Withdrawal by Subject|1|||
170864700|NCT05461794|617515672|FG001|Overall Study|Withdrawal by Subject|1|||
170864701|NCT05461794|617515673|FG002|Overall Study|Withdrawal by Subject|3|||
170864702|NCT05461794|617515671|FG000|Overall Study|Study Terminated By Sponsor|18|||
170864703|NCT05461794|617515672|FG001|Overall Study|Study Terminated By Sponsor|13|||
170864704|NCT05461794|617515673|FG002|Overall Study|Study Terminated By Sponsor|16|||
170864705|NCT05461794|617515671|FG000|Overall Study|Death|20|||
170864706|NCT05461794|617515672|FG001|Overall Study|Death|5|||
170864707|NCT05461794|617515673|FG002|Overall Study|Death|19|||
170864708|NCT01598311|617515676|FG000|Overall Study|Physician Decision|4|||
170864709|NCT01598311|617515677|FG001|Overall Study|Physician Decision|5|||
170864710|NCT01598311|617515676|FG000|Overall Study|Adverse Event|9|||
170864711|NCT01598311|617515677|FG001|Overall Study|Adverse Event|13|||
170864712|NCT01598311|617515676|FG000|Overall Study|Lost to Follow-up|7|||
170864713|NCT01598311|617515677|FG001|Overall Study|Lost to Follow-up|12|||
170864714|NCT01598311|617515676|FG000|Overall Study|Withdrawal by Subject|9|||
170864715|NCT01598311|617515677|FG001|Overall Study|Withdrawal by Subject|13|||
170864716|NCT01598311|617515676|FG000|Overall Study|No reason provided.|0|||
170864717|NCT01598311|617515677|FG001|Overall Study|No reason provided.|5|||
170864718|NCT01598311|617515676|FG000|Overall Study|Randomized but never treated|8|||
170864719|NCT01598311|617515677|FG001|Overall Study|Randomized but never treated|5|||
170864720|NCT01598311|617515676|FG000|Overall Study|Treated but no confirmed CDAD|9|||
170864721|NCT01598311|617515677|FG001|Overall Study|Treated but no confirmed CDAD|8|||
170864722|NCT01598311|617515676|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
170864723|NCT01598311|617515677|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
170864724|NCT03144804|617515678|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
170864725|NCT04223856|617515680|FG000|Overall Study|Progressive disease|153|||
170864726|NCT04223856|617515681|FG001|Overall Study|Progressive disease|73|||
170864727|NCT04223856|617515680|FG000|Overall Study|Adverse Event|97|||
170864728|NCT04223856|617515681|FG001|Overall Study|Adverse Event|62|||
170864729|NCT04223856|617515680|FG000|Overall Study|Physician Decision|9|||
170864730|NCT04223856|617515681|FG001|Overall Study|Physician Decision|28|||
170864731|NCT04223856|617515680|FG000|Overall Study|Withdrawal by Subject|22|||
170864732|NCT04223856|617515681|FG001|Overall Study|Withdrawal by Subject|24|||
170402313|NCT01892020|615813389|FG000|Period 1|Unclassified|0|||
170402314|NCT01892020|615813390|FG001|Period 1|Unclassified|1|||
170402315|NCT01892020|615813389|FG000|Period 2|Protocol Violation|1|||
170402316|NCT01892020|615813390|FG001|Period 2|Protocol Violation|0|||
170752158|NCT00848211|617099698|FG000|Overall Study|Protocol Violation|0|||
170752159|NCT00848211|617099699|FG001|Overall Study|Protocol Violation|1|||
170752160|NCT00848211|617099700|FG002|Overall Study|Protocol Violation|1|||
170752161|NCT00848211|617099701|FG003|Overall Study|Protocol Violation|0|||
170752162|NCT00848211|617099698|FG000|Overall Study|Adverse Event|0|||
170752163|NCT00848211|617099699|FG001|Overall Study|Adverse Event|0|||
170752164|NCT00848211|617099700|FG002|Overall Study|Adverse Event|0|||
170752165|NCT00848211|617099701|FG003|Overall Study|Adverse Event|0|||
170752166|NCT00801242|617099703|FG000|Overall Study|Adverse Event|10|||
170752167|NCT00801242|617099703|FG000|Overall Study|Withdrawal by Subject|13|||
170752168|NCT00801242|617099703|FG000|Overall Study|Protocol Violation|5|||
170752169|NCT00801242|617099703|FG000|Overall Study|Physician Decision|3|||
170402317|NCT02956005|615813391|FG000|Overall Study|Not eligible|1|||
170402318|NCT02956005|615813391|FG000|Overall Study|Withdrawal by Subject|3|||
170402319|NCT02956005|615813391|FG000|Overall Study|Physician Decision|12|||
170402320|NCT03125629|615813392|FG000|Overall Study|Withdrawal by Subject|2|||
170402321|NCT03125629|615813392|FG000|Overall Study|Equipment malfunction|1|||
170402322|NCT00743119|615813393|FG000|Overall Study|unreliable|3|||
170402323|NCT00743119|615813393|FG000|Overall Study|Withdrawal by Subject|1|||
170402324|NCT02602080|615813397|FG000|Overall Study|Protocol Violation|6|||
170402325|NCT02602080|615813398|FG001|Overall Study|Protocol Violation|1|||
170402326|NCT02602080|615813399|FG002|Overall Study|Protocol Violation|3|||
170402327|NCT02574260|615813404|FG000|Overall Study|Disease Progression|1|||
170402328|NCT01066039|615813405|FG000|Overall Study|Adverse Event|6|||
170402329|NCT01066039|615813405|FG000|Overall Study|Withdrawal by Subject|17|||
170402330|NCT01066039|615813405|FG000|Overall Study|Protocol Violation|2|||
170402331|NCT01066039|615813405|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
170402332|NCT01066039|615813405|FG000|Overall Study|Investigator's Request|1|||
170402333|NCT01066039|615813405|FG000|Overall Study|Dropout due to Insulin Administration|1|||
170402334|NCT01066039|615813405|FG000|Overall Study|Additional Antihypertensive Required|4|||
170402335|NCT01066039|615813405|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
170402336|NCT01066039|615813405|FG000|Overall Study|Failure to Control Blood Pressure|1|||
170402337|NCT01066039|615813405|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
170402338|NCT04508621|615813406|FG000|Overall Study|Adverse Event|39|||
170402339|NCT04508621|615813407|FG001|Overall Study|Adverse Event|16|||
170402340|NCT04508621|615813406|FG000|Overall Study|Lack of Efficacy|2|||
170402341|NCT04508621|615813407|FG001|Overall Study|Lack of Efficacy|8|||
170402342|NCT04508621|615813406|FG000|Overall Study|Physician Decision|0|||
170402343|NCT04508621|615813407|FG001|Overall Study|Physician Decision|1|||
170402344|NCT04508621|615813406|FG000|Overall Study|Withdrawal by Subject|10|||
170402345|NCT04508621|615813407|FG001|Overall Study|Withdrawal by Subject|14|||
170402346|NCT04508621|615813406|FG000|Overall Study|Lost to Follow-up|12|||
170402347|NCT04508621|615813407|FG001|Overall Study|Lost to Follow-up|9|||
170402348|NCT04508621|615813406|FG000|Overall Study|COVID-19 related crisis|3|||
170402349|NCT04508621|615813407|FG001|Overall Study|COVID-19 related crisis|0|||
170402350|NCT04508621|615813406|FG000|Overall Study|Subject non-compliance|1|||
170402351|NCT04508621|615813407|FG001|Overall Study|Subject non-compliance|0|||
170402352|NCT00752895|615813408|FG000|Overall Study|Withdrawal by Subject|8|||
170402353|NCT00752895|615813409|FG001|Overall Study|Withdrawal by Subject|3|||
170402354|NCT00883129|615813412|FG000|Overall Study|Adverse Event|7|||
170402355|NCT00883129|615813413|FG001|Overall Study|Adverse Event|15|||
170752170|NCT00801242|617099703|FG000|Overall Study|Lost to Follow-up|1|||
170752171|NCT00801242|617099703|FG000|Overall Study|Miscellaneous reasons|20|||
170864733|NCT04223856|617515680|FG000|Overall Study|Other|7|||
170402356|NCT00883129|615813412|FG000|Overall Study|Withdrawal by Subject|8|||
170752172|NCT00184028|617099704|FG000|Overall Study|Death|1|||
170402357|NCT00883129|615813413|FG001|Overall Study|Withdrawal by Subject|9|||
170402358|NCT00883129|615813412|FG000|Overall Study|Non-compliance|3|||
170402359|NCT00883129|615813413|FG001|Overall Study|Non-compliance|6|||
170402360|NCT00883129|615813412|FG000|Overall Study|Lost to Follow-up|1|||
170402361|NCT00883129|615813413|FG001|Overall Study|Lost to Follow-up|2|||
170402362|NCT00883129|615813412|FG000|Overall Study|Death|1|||
170402363|NCT00883129|615813413|FG001|Overall Study|Death|2|||
170402364|NCT00883129|615813412|FG000|Overall Study|Defined Treatment Failure|0|||
170402365|NCT00883129|615813413|FG001|Overall Study|Defined Treatment Failure|2|||
170402366|NCT03273257|615813414|FG000|Overall Study|Death|0|||
170402367|NCT03273257|615813415|FG001|Overall Study|Death|1|||
170752173|NCT00184028|617099704|FG000|Overall Study|Lack of Efficacy|4|||
170402368|NCT03273257|615813414|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
170752174|NCT00184028|617099704|FG000|Overall Study|Adverse Event|2|||
170752175|NCT00184028|617099704|FG000|Overall Study|Withdrawal by Subject|1|||
170864734|NCT04223856|617515681|FG001|Overall Study|Other|2|||
170402369|NCT03273257|615813415|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
170402370|NCT03273257|615813414|FG000|Overall Study|Study terminated|3|||
170864735|NCT04223856|617515680|FG000|Overall Study|Randomized but not treated|2|||
170864736|NCT04223856|617515681|FG001|Overall Study|Randomized but not treated|11|||
170864737|NCT04223856|617515680|FG000|Overall Study|On-treatment|144|||
170864738|NCT04223856|617515681|FG001|Overall Study|On-treatment|0|||
170864739|NCT06515483|617515684|FG000|Overall Study|Subject withdraw due to family issues|1|||
170864740|NCT06515483|617515685|FG001|Overall Study|Subject withdraw due to family issues|0|||
170864741|NCT05959629|617515686|FG000|Overall Study|partially necrotic/technical issues|2|||
170864742|NCT05959629|617515687|FG001|Overall Study|partially necrotic/technical issues|2|||
170864743|NCT03942406|617517954|FG000|Overall Study|Lost to Follow-up|4|||
170864744|NCT03942406|617517955|FG001|Overall Study|Lost to Follow-up|5|||
170864745|NCT03942406|617517956|FG002|Overall Study|Lost to Follow-up|3|||
170864746|NCT03942406|617517957|FG003|Overall Study|Lost to Follow-up|7|||
170864747|NCT03942406|617517958|FG004|Overall Study|Lost to Follow-up|1|||
170864748|NCT03942406|617517959|FG005|Overall Study|Lost to Follow-up|0|||
170864749|NCT03942406|617517960|FG006|Overall Study|Lost to Follow-up|0|||
170864750|NCT03942406|617517954|FG000|Overall Study|Withdrawal by Subject|3|||
170864751|NCT03942406|617517955|FG001|Overall Study|Withdrawal by Subject|1|||
170864752|NCT03942406|617517956|FG002|Overall Study|Withdrawal by Subject|1|||
170864753|NCT03942406|617517957|FG003|Overall Study|Withdrawal by Subject|3|||
170864754|NCT03942406|617517958|FG004|Overall Study|Withdrawal by Subject|0|||
170864755|NCT03942406|617517959|FG005|Overall Study|Withdrawal by Subject|0|||
170864756|NCT03942406|617517960|FG006|Overall Study|Withdrawal by Subject|0|||
170864757|NCT03942406|617517954|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
170864758|NCT03942406|617517955|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
170864759|NCT03942406|617517956|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
170864760|NCT03942406|617517957|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
170864761|NCT03942406|617517958|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
170864762|NCT03942406|617517959|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
170864763|NCT03942406|617517960|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
170864764|NCT02616614|617517961|FG000|Overall Study|Withdrawal by Subject|10|||
170864765|NCT02616614|617517962|FG001|Overall Study|Withdrawal by Subject|5|||
170864766|NCT02616614|617517963|FG002|Overall Study|Withdrawal by Subject|6|||
170864767|NCT02616614|617517961|FG000|Overall Study|Physician Decision|2|||
170864768|NCT02616614|617517962|FG001|Overall Study|Physician Decision|1|||
170864769|NCT02616614|617517963|FG002|Overall Study|Physician Decision|0|||
170864770|NCT02616614|617517961|FG000|Overall Study|Adverse Event|1|||
170864771|NCT02616614|617517962|FG001|Overall Study|Adverse Event|4|||
170864772|NCT02616614|617517963|FG002|Overall Study|Adverse Event|1|||
170864773|NCT02616614|617517961|FG000|Overall Study|Protocol Violation|0|||
170864774|NCT02616614|617517962|FG001|Overall Study|Protocol Violation|3|||
170864775|NCT02616614|617517963|FG002|Overall Study|Protocol Violation|1|||
170864776|NCT02616614|617517961|FG000|Overall Study|Prohibited Medication|12|||
170864777|NCT02616614|617517962|FG001|Overall Study|Prohibited Medication|9|||
170864778|NCT02616614|617517963|FG002|Overall Study|Prohibited Medication|5|||
170864779|NCT02616614|617517961|FG000|Overall Study|More than 3 applications missed|6|||
170864780|NCT02616614|617517962|FG001|Overall Study|More than 3 applications missed|8|||
170864781|NCT02616614|617517963|FG002|Overall Study|More than 3 applications missed|1|||
170864782|NCT02616614|617517961|FG000|Overall Study|Lost to Follow-up|31|||
170864783|NCT02616614|617517962|FG001|Overall Study|Lost to Follow-up|28|||
170864784|NCT02616614|617517963|FG002|Overall Study|Lost to Follow-up|13|||
170864785|NCT02616614|617517961|FG000|Overall Study|Pregnancy|2|||
170864786|NCT02616614|617517962|FG001|Overall Study|Pregnancy|0|||
170864787|NCT02616614|617517963|FG002|Overall Study|Pregnancy|1|||
170864788|NCT02616614|617517961|FG000|Overall Study|Other|1|||
170864789|NCT02616614|617517962|FG001|Overall Study|Other|2|||
170864790|NCT02616614|617517963|FG002|Overall Study|Other|1|||
170864791|NCT02748018|617517964|FG000|Study Period|Adverse Event|1|||
170864792|NCT02748018|617517965|FG001|Study Period|Adverse Event|3|||
170864793|NCT02748018|617517966|FG002|Study Period|Adverse Event|4|||
170864794|NCT02748018|617517967|FG003|Study Period|Adverse Event|0|||
170864795|NCT02748018|617517968|FG004|Study Period|Adverse Event|3|||
170864796|NCT02748018|617517969|FG005|Study Period|Adverse Event|3|||
170864797|NCT02748018|617517964|FG000|Study Period|Withdrawal by Subject|7|||
170864798|NCT02748018|617517965|FG001|Study Period|Withdrawal by Subject|4|||
170864799|NCT02748018|617517966|FG002|Study Period|Withdrawal by Subject|4|||
170864800|NCT02748018|617517967|FG003|Study Period|Withdrawal by Subject|11|||
170864801|NCT02748018|617517968|FG004|Study Period|Withdrawal by Subject|12|||
170864802|NCT02748018|617517969|FG005|Study Period|Withdrawal by Subject|10|||
170864803|NCT02748018|617517964|FG000|Study Period|Pregnancy|0|||
170864804|NCT02748018|617517965|FG001|Study Period|Pregnancy|1|||
170864805|NCT02748018|617517966|FG002|Study Period|Pregnancy|0|||
170864806|NCT02748018|617517967|FG003|Study Period|Pregnancy|0|||
170864807|NCT02748018|617517968|FG004|Study Period|Pregnancy|1|||
170864808|NCT02748018|617517969|FG005|Study Period|Pregnancy|0|||
170864809|NCT02748018|617517964|FG000|Study Period|Physician Decision|2|||
170864810|NCT02748018|617517965|FG001|Study Period|Physician Decision|2|||
170864811|NCT02748018|617517966|FG002|Study Period|Physician Decision|1|||
170752176|NCT00184028|617099704|FG000|Overall Study|Non-compliance|2|||
170752177|NCT04770220|617099722|FG000|Overall Study|Adverse Event|2|||
170752178|NCT04770220|617099723|FG001|Overall Study|Adverse Event|11|||
170752179|NCT04770220|617099722|FG000|Overall Study|Withdrawal by Subject|5|||
170752180|NCT04770220|617099723|FG001|Overall Study|Withdrawal by Subject|11|||
170752181|NCT04770220|617099722|FG000|Overall Study|Lost to Follow-up|4|||
170752182|NCT04770220|617099723|FG001|Overall Study|Lost to Follow-up|3|||
170752183|NCT04770220|617099722|FG000|Overall Study|not otherwise specified|2|||
170752184|NCT04770220|617099723|FG001|Overall Study|not otherwise specified|3|||
170752185|NCT04770220|617099722|FG000|Overall Study|Physician Decision|1|||
170752186|NCT04770220|617099723|FG001|Overall Study|Physician Decision|3|||
170752187|NCT04894903|617099724|FG000|Overall Study|Death|1|||
170752188|NCT04894903|617099725|FG001|Overall Study|Death|0|||
170752189|NCT04894903|617099724|FG000|Overall Study|Pregnancy|1|||
170752190|NCT04894903|617099725|FG001|Overall Study|Pregnancy|0|||
170752191|NCT04894903|617099724|FG000|Overall Study|Withdrawal by Subject|1|||
170752192|NCT04894903|617099725|FG001|Overall Study|Withdrawal by Subject|1|||
170752193|NCT04894903|617099724|FG000|Overall Study|moved or exited health system|1|||
170752194|NCT04894903|617099725|FG001|Overall Study|moved or exited health system|3|||
170752195|NCT02337478|617099728|FG000|Overall Study|Lack of Efficacy|5|||
170752196|NCT02107443|617099733|FG000|Overall Study|Death|42|||
170752197|NCT02107443|617099734|FG001|Overall Study|Death|30|||
170752198|NCT02107443|617099733|FG000|Overall Study|Study Protocol Violation|3|||
170752199|NCT02107443|617099734|FG001|Overall Study|Study Protocol Violation|1|||
170752200|NCT02107443|617099733|FG000|Overall Study|Registered but Not Eligible|0|||
170752201|NCT02107443|617099734|FG001|Overall Study|Registered but Not Eligible|1|||
170752202|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
170752203|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
170752204|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
170752205|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
170752206|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Changed Mind|2|||
170752207|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Changed Mind|0|||
170864812|NCT02748018|617517967|FG003|Study Period|Physician Decision|0|||
170864813|NCT02748018|617517968|FG004|Study Period|Physician Decision|2|||
170864814|NCT02748018|617517969|FG005|Study Period|Physician Decision|0|||
170864815|NCT02748018|617517964|FG000|Study Period|Lost to Follow-up|0|||
170864816|NCT02748018|617517965|FG001|Study Period|Lost to Follow-up|0|||
170864817|NCT02748018|617517966|FG002|Study Period|Lost to Follow-up|0|||
170864818|NCT02748018|617517967|FG003|Study Period|Lost to Follow-up|2|||
170864819|NCT02748018|617517968|FG004|Study Period|Lost to Follow-up|0|||
170864820|NCT02748018|617517969|FG005|Study Period|Lost to Follow-up|1|||
170864821|NCT02748018|617517964|FG000|Continuation Period|Adverse Event|2|||
170864822|NCT02748018|617517965|FG001|Continuation Period|Adverse Event|0|||
170864823|NCT02748018|617517966|FG002|Continuation Period|Adverse Event|1|||
170864824|NCT02748018|617517967|FG003|Continuation Period|Adverse Event|1|||
170864825|NCT02748018|617517968|FG004|Continuation Period|Adverse Event|1|||
170864826|NCT02748018|617517969|FG005|Continuation Period|Adverse Event|4|||
170864827|NCT02748018|617517964|FG000|Continuation Period|Withdrawal by Subject|3|||
170864828|NCT02748018|617517965|FG001|Continuation Period|Withdrawal by Subject|5|||
170864829|NCT02748018|617517966|FG002|Continuation Period|Withdrawal by Subject|3|||
170864830|NCT02748018|617517967|FG003|Continuation Period|Withdrawal by Subject|9|||
170864831|NCT02748018|617517968|FG004|Continuation Period|Withdrawal by Subject|11|||
170864832|NCT02748018|617517969|FG005|Continuation Period|Withdrawal by Subject|1|||
170864833|NCT02748018|617517964|FG000|Continuation Period|Lost to Follow-up|0|||
170864834|NCT02748018|617517965|FG001|Continuation Period|Lost to Follow-up|2|||
170864835|NCT02748018|617517966|FG002|Continuation Period|Lost to Follow-up|1|||
170864836|NCT02748018|617517967|FG003|Continuation Period|Lost to Follow-up|0|||
170864837|NCT02748018|617517968|FG004|Continuation Period|Lost to Follow-up|1|||
170864838|NCT02748018|617517969|FG005|Continuation Period|Lost to Follow-up|0|||
170864839|NCT02748018|617517964|FG000|Continuation Period|Pregnancy|1|||
170864840|NCT02748018|617517965|FG001|Continuation Period|Pregnancy|2|||
170864841|NCT02748018|617517966|FG002|Continuation Period|Pregnancy|0|||
170864842|NCT02748018|617517967|FG003|Continuation Period|Pregnancy|0|||
170864843|NCT02748018|617517968|FG004|Continuation Period|Pregnancy|0|||
170864844|NCT02748018|617517969|FG005|Continuation Period|Pregnancy|0|||
170864845|NCT02748018|617517964|FG000|Continuation Period|Physician Decision|0|||
170864846|NCT02748018|617517965|FG001|Continuation Period|Physician Decision|1|||
170864847|NCT02748018|617517966|FG002|Continuation Period|Physician Decision|2|||
170864848|NCT02748018|617517967|FG003|Continuation Period|Physician Decision|0|||
170864849|NCT02748018|617517968|FG004|Continuation Period|Physician Decision|2|||
170864850|NCT02748018|617517969|FG005|Continuation Period|Physician Decision|1|||
170864851|NCT02748018|617517964|FG000|Continuation Period|Protocol Violation|0|||
170864852|NCT02748018|617517965|FG001|Continuation Period|Protocol Violation|1|||
170752208|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
170752209|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
170752210|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
170752211|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
170752212|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
170752213|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
170752214|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
170752215|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
170752216|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Other Medical|9|||
170752217|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Other Medical|5|||
170752218|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Disease Progression|4|||
170752219|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Disease Progression|2|||
170752220|NCT02107443|617099733|FG000|Overall Study|Withdrawal: Personal Issues|0|||
170752221|NCT02107443|617099734|FG001|Overall Study|Withdrawal: Personal Issues|3|||
170752222|NCT00946647|617099735|FG000|Phase 1 Part|Adverse Event|2|||
170752223|NCT00946647|617099736|FG001|Phase 1 Part|Adverse Event|5|||
170752224|NCT00946647|617099737|FG002|Phase 1 Part|Adverse Event|3|||
170752225|NCT00946647|617099738|FG003|Phase 1 Part|Adverse Event|0|||
170752226|NCT00946647|617099739|FG004|Phase 1 Part|Adverse Event|0|||
170752227|NCT00946647|617099735|FG000|Phase 1 Part|Disease progression|3|||
170752228|NCT00946647|617099736|FG001|Phase 1 Part|Disease progression|6|||
170752229|NCT00946647|617099737|FG002|Phase 1 Part|Disease progression|1|||
170752230|NCT00946647|617099738|FG003|Phase 1 Part|Disease progression|0|||
170752231|NCT00946647|617099739|FG004|Phase 1 Part|Disease progression|0|||
170752232|NCT00946647|617099735|FG000|Phase 1 Part|Withdrawal by Subject|1|||
170752233|NCT00946647|617099736|FG001|Phase 1 Part|Withdrawal by Subject|4|||
170752234|NCT00946647|617099737|FG002|Phase 1 Part|Withdrawal by Subject|3|||
170752235|NCT00946647|617099738|FG003|Phase 1 Part|Withdrawal by Subject|0|||
170752236|NCT00946647|617099739|FG004|Phase 1 Part|Withdrawal by Subject|0|||
170752237|NCT00946647|617099735|FG000|Phase 1 Part|Abnormal values|0|||
170752238|NCT00946647|617099736|FG001|Phase 1 Part|Abnormal values|2|||
170752239|NCT00946647|617099737|FG002|Phase 1 Part|Abnormal values|0|||
170752240|NCT00946647|617099738|FG003|Phase 1 Part|Abnormal values|0|||
170864853|NCT02748018|617517966|FG002|Continuation Period|Protocol Violation|0|||
170402371|NCT03273257|615813415|FG001|Overall Study|Study terminated|2|||
170402372|NCT02531698|615813417|FG000|Overall Study|Adverse Event|2|||
170402373|NCT02531698|615813418|FG001|Overall Study|Adverse Event|1|||
170402374|NCT02531698|615813417|FG000|Overall Study|Withdrawal by Subject|6|||
170402375|NCT02531698|615813418|FG001|Overall Study|Withdrawal by Subject|1|||
170402376|NCT02531698|615813417|FG000|Overall Study|Protocol Violation|2|||
170402377|NCT02531698|615813418|FG001|Overall Study|Protocol Violation|0|||
170402378|NCT02531698|615813417|FG000|Overall Study|Lost to Follow-up|1|||
170402379|NCT02531698|615813418|FG001|Overall Study|Lost to Follow-up|0|||
170402380|NCT00701558|615813422|FG000|Overall Study|Death|7|||
170402381|NCT00701558|615813422|FG000|Overall Study|Lost to Follow-up|8|||
170402382|NCT01246973|615814864|FG000|Overall Study|Other|38|||
170402383|NCT01246973|615814865|FG001|Overall Study|Other|25|||
170402384|NCT01246973|615814864|FG000|Overall Study|Adverse Event|16|||
170402385|NCT01246973|615814865|FG001|Overall Study|Adverse Event|9|||
170402386|NCT01246973|615814864|FG000|Overall Study|Withdrawal by Subject|7|||
170402387|NCT01246973|615814865|FG001|Overall Study|Withdrawal by Subject|13|||
170402388|NCT01416142|615814866|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
170402389|NCT01416142|615814867|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
170402390|NCT01416142|615814868|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
170402391|NCT02499406|615814871|FG000|Overall Study|missed 3 treatment sessions|4|||
170402392|NCT03591107|615814872|FG000|Overall Study|Same patient in both arms|1|||
170402393|NCT03591107|615814873|FG001|Overall Study|Same patient in both arms|1|||
170402394|NCT03591107|615814872|FG000|Overall Study|Sought care at other clinics|0|||
170402395|NCT03591107|615814873|FG001|Overall Study|Sought care at other clinics|2|||
170402396|NCT03591107|615814872|FG000|Overall Study|Discharged from clinic|0|||
170402397|NCT03591107|615814873|FG001|Overall Study|Discharged from clinic|1|||
170402398|NCT03591107|615814872|FG000|Overall Study|Withdrawal by Subject|0|||
170402399|NCT03591107|615814873|FG001|Overall Study|Withdrawal by Subject|1|||
170402400|NCT00678379|615814874|FG000|Overall Study|Injection performed after tonsillectomy|2|||
170402401|NCT00678379|615814875|FG001|Overall Study|Injection performed after tonsillectomy|0|||
170752241|NCT00946647|617099739|FG004|Phase 1 Part|Abnormal values|0|||
170752242|NCT00946647|617099735|FG000|Phase 1 Part|Reason missing|0|||
170752243|NCT00946647|617099736|FG001|Phase 1 Part|Reason missing|1|||
170402402|NCT00678379|615814876|FG002|Overall Study|Injection performed after tonsillectomy|1|||
170402403|NCT00678379|615814874|FG000|Overall Study|Incomplete Data|4|||
170402404|NCT00678379|615814875|FG001|Overall Study|Incomplete Data|3|||
170402405|NCT00678379|615814876|FG002|Overall Study|Incomplete Data|3|||
170402406|NCT01835470|615814877|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
170402407|NCT01835470|615814877|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
170752244|NCT00946647|617099737|FG002|Phase 1 Part|Reason missing|0|||
170864854|NCT02748018|617517967|FG003|Continuation Period|Protocol Violation|0|||
170906114|NCT01331161|617658623|FG000|Overall Study|Physician Decision|1|||
170752245|NCT00946647|617099738|FG003|Phase 1 Part|Reason missing|0|||
170752246|NCT00946647|617099739|FG004|Phase 1 Part|Reason missing|0|||
170402408|NCT01011907|615814878|FG000|Overall Study|Withdrawal by Subject|13|||
170402409|NCT01011907|615814879|FG001|Overall Study|Withdrawal by Subject|11|||
170402410|NCT01011907|615814878|FG000|Overall Study|Adverse Event|1|||
170402411|NCT01011907|615814879|FG001|Overall Study|Adverse Event|4|||
170402412|NCT00304954|615814882|FG000|Overall Study|Withdrawal by Subject|0|||
170402413|NCT00304954|615814883|FG001|Overall Study|Withdrawal by Subject|0|||
170402414|NCT00304954|615814884|FG002|Overall Study|Withdrawal by Subject|1|||
170402415|NCT00304954|615814885|FG003|Overall Study|Withdrawal by Subject|0|||
170402416|NCT00304954|615814882|FG000|Overall Study|Adverse Event|1|||
170402417|NCT00304954|615814883|FG001|Overall Study|Adverse Event|0|||
170402418|NCT00304954|615814884|FG002|Overall Study|Adverse Event|0|||
170402419|NCT00304954|615814885|FG003|Overall Study|Adverse Event|0|||
170402420|NCT04335110|615814888|FG000|Overall Study|Withdrawal by Subject|1|||
170402421|NCT04335110|615814889|FG001|Overall Study|Withdrawal by Subject|1|||
170402422|NCT04335110|615814888|FG000|Overall Study|Death|0|||
170402423|NCT04335110|615814889|FG001|Overall Study|Death|1|||
170402424|NCT01222715|615814895|FG000|Overall Study|Adverse Event|0|||
170402425|NCT01222715|615814896|FG001|Overall Study|Adverse Event|4|||
170402426|NCT01222715|615814895|FG000|Overall Study|Death|0|||
170402427|NCT01222715|615814896|FG001|Overall Study|Death|1|||
170402428|NCT01222715|615814895|FG000|Overall Study|Lack of Efficacy|22|||
170402429|NCT01222715|615814896|FG001|Overall Study|Lack of Efficacy|14|||
170402430|NCT01222715|615814895|FG000|Overall Study|Physician Decision|12|||
170402431|NCT01222715|615814896|FG001|Overall Study|Physician Decision|2|||
170402432|NCT01222715|615814895|FG000|Overall Study|Refusal of further protocol therapy|0|||
170402433|NCT01222715|615814896|FG001|Overall Study|Refusal of further protocol therapy|4|||
170402434|NCT01222715|615814895|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
170402435|NCT01222715|615814896|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
170402436|NCT01222715|615814895|FG000|Overall Study|Ineligible|0|||
170402437|NCT01222715|615814896|FG001|Overall Study|Ineligible|1|||
170402438|NCT01222715|615814895|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
170402439|NCT01222715|615814896|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
170402440|NCT01835132|615814904|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
170402441|NCT00409188|615814905|FG000|Overall Study|Ongoing at data cut-off|383|||
170402442|NCT00409188|615814906|FG001|Overall Study|Ongoing at data cut-off|175|||
170402443|NCT04242186|615814911|FG000|Overall Study|Death|5|||
170402444|NCT04388527|615814912|FG000|Overall Study|Death|14|||
170402445|NCT04388527|615814912|FG000|Overall Study|Withdrawal by Subject|2|||
170402446|NCT04388527|615814912|FG000|Overall Study|Lost to Follow-up|1|||
170402447|NCT03333382|615814915|FG000|Overall Study|Lost to Follow-up|1|||
170402448|NCT03333382|615814916|FG001|Overall Study|Lost to Follow-up|0|||
170402449|NCT00520494|615814917|FG000|Overall Study|Withdrawal by Subject|1|||
170402450|NCT00525031|615814918|FG000|Overall Study|Disease Progression|1|||
170402451|NCT00525031|615814919|FG001|Overall Study|Disease Progression|1|||
170402452|NCT02454972|615814924|FG000|Overall Study|Progressive disease|17|||
170402453|NCT02454972|615814925|FG001|Overall Study|Progressive disease|16|||
170402454|NCT02454972|615814926|FG002|Overall Study|Progressive disease|59|||
170402455|NCT02454972|615814927|FG003|Overall Study|Progressive disease|23|||
170402456|NCT02454972|615814928|FG004|Overall Study|Progressive disease|16|||
170402457|NCT02454972|615814929|FG005|Overall Study|Progressive disease|12|||
170402458|NCT02454972|615814930|FG006|Overall Study|Progressive disease|19|||
170402459|NCT02454972|615814931|FG007|Overall Study|Progressive disease|27|||
170402460|NCT02454972|615814932|FG008|Overall Study|Progressive disease|0|||
170402461|NCT02454972|615814924|FG000|Overall Study|Death|0|||
170402462|NCT02454972|615814925|FG001|Overall Study|Death|0|||
170402463|NCT02454972|615814926|FG002|Overall Study|Death|5|||
170402464|NCT02454972|615814927|FG003|Overall Study|Death|1|||
170402465|NCT02454972|615814928|FG004|Overall Study|Death|0|||
170402466|NCT02454972|615814929|FG005|Overall Study|Death|0|||
170402467|NCT02454972|615814930|FG006|Overall Study|Death|0|||
170402468|NCT02454972|615814931|FG007|Overall Study|Death|0|||
170402469|NCT02454972|615814932|FG008|Overall Study|Death|95|||
170402470|NCT02454972|615814924|FG000|Overall Study|Physician Decision|0|||
170402471|NCT02454972|615814925|FG001|Overall Study|Physician Decision|1|||
170402472|NCT02454972|615814926|FG002|Overall Study|Physician Decision|2|||
170402473|NCT02454972|615814927|FG003|Overall Study|Physician Decision|1|||
170402474|NCT02454972|615814928|FG004|Overall Study|Physician Decision|2|||
170402475|NCT02454972|615814929|FG005|Overall Study|Physician Decision|0|||
170402476|NCT02454972|615814930|FG006|Overall Study|Physician Decision|0|||
170402477|NCT02454972|615814931|FG007|Overall Study|Physician Decision|1|||
170402478|NCT02454972|615814932|FG008|Overall Study|Physician Decision|0|||
170402479|NCT02454972|615814924|FG000|Overall Study|Non treatment-related adverse event|2|||
170402480|NCT02454972|615814925|FG001|Overall Study|Non treatment-related adverse event|0|||
170402481|NCT02454972|615814926|FG002|Overall Study|Non treatment-related adverse event|1|||
170402482|NCT02454972|615814927|FG003|Overall Study|Non treatment-related adverse event|0|||
170402483|NCT02454972|615814928|FG004|Overall Study|Non treatment-related adverse event|0|||
170402484|NCT02454972|615814929|FG005|Overall Study|Non treatment-related adverse event|1|||
170402485|NCT02454972|615814930|FG006|Overall Study|Non treatment-related adverse event|0|||
170402486|NCT02454972|615814931|FG007|Overall Study|Non treatment-related adverse event|1|||
170402487|NCT02454972|615814932|FG008|Overall Study|Non treatment-related adverse event|0|||
170402488|NCT02454972|615814924|FG000|Overall Study|Treatment-related adverse events|0|||
170402489|NCT02454972|615814925|FG001|Overall Study|Treatment-related adverse events|1|||
170402490|NCT02454972|615814926|FG002|Overall Study|Treatment-related adverse events|1|||
170402491|NCT02454972|615814927|FG003|Overall Study|Treatment-related adverse events|0|||
170402492|NCT02454972|615814928|FG004|Overall Study|Treatment-related adverse events|2|||
170402493|NCT02454972|615814929|FG005|Overall Study|Treatment-related adverse events|0|||
170402494|NCT02454972|615814930|FG006|Overall Study|Treatment-related adverse events|0|||
170402495|NCT02454972|615814931|FG007|Overall Study|Treatment-related adverse events|2|||
170402496|NCT02454972|615814932|FG008|Overall Study|Treatment-related adverse events|0|||
170402497|NCT02454972|615814924|FG000|Overall Study|Patient moves to compassionate use|0|||
170402498|NCT02454972|615814925|FG001|Overall Study|Patient moves to compassionate use|0|||
170402499|NCT02454972|615814926|FG002|Overall Study|Patient moves to compassionate use|0|||
170402500|NCT02454972|615814927|FG003|Overall Study|Patient moves to compassionate use|0|||
170864855|NCT02748018|617517968|FG004|Continuation Period|Protocol Violation|0|||
170864856|NCT02748018|617517969|FG005|Continuation Period|Protocol Violation|0|||
170864857|NCT04485104|617517973|FG000|Overall Study|Physician Decision|2|||
170864858|NCT04485104|617517974|FG001|Overall Study|Physician Decision|0|||
170864859|NCT04485104|617517973|FG000|Overall Study|Decision by sponsor|0|||
170864860|NCT04485104|617517974|FG001|Overall Study|Decision by sponsor|1|||
170864861|NCT01214187|617517975|FG000|Overall Study|Adverse Event|6|||
170864862|NCT01214187|617517976|FG001|Overall Study|Adverse Event|2|||
170864863|NCT01214187|617517975|FG000|Overall Study|Death|1|||
170864864|NCT01214187|617517976|FG001|Overall Study|Death|1|||
170864865|NCT01214187|617517975|FG000|Overall Study|Withdrawal by Subject|0|||
170864866|NCT01214187|617517976|FG001|Overall Study|Withdrawal by Subject|3|||
170864867|NCT02308007|617517981|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
170864868|NCT02308007|617517982|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
170864869|NCT02308007|617517983|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
170864870|NCT02308007|617517981|FG000|Overall Study|Positive for STD at Baseline|7|||
170864871|NCT02308007|617517982|FG001|Overall Study|Positive for STD at Baseline|11|||
170864872|NCT02308007|617517983|FG002|Overall Study|Positive for STD at Baseline|7|||
170864873|NCT02308007|617517981|FG000|Overall Study|Lost to Follow-up|3|||
170864874|NCT02308007|617517982|FG001|Overall Study|Lost to Follow-up|0|||
170864875|NCT02308007|617517983|FG002|Overall Study|Lost to Follow-up|1|||
170864876|NCT03118674|617517984|FG000|Overall Study|Lost to Follow-up|2|||
170864877|NCT03118674|617517984|FG000|Overall Study|Screen Faliure|8|||
170864878|NCT03118674|617517984|FG000|Overall Study|Withdrawal by Subject|5|||
170864879|NCT00908232|617517985|FG000|Cycle 1 to 4|Death|5|||
170864880|NCT00908232|617517986|FG001|Cycle 1 to 4|Death|0|||
170864881|NCT00908232|617517987|FG002|Cycle 1 to 4|Death|0|||
170864882|NCT00908232|617517988|FG003|Cycle 1 to 4|Death|0|||
170864883|NCT00908232|617517985|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
170864884|NCT00908232|617517986|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
170864885|NCT00908232|617517987|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
170864886|NCT00908232|617517988|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
170864887|NCT00908232|617517985|FG000|Cycle 1 to 4|Progressive Disease|6|||
170864888|NCT00908232|617517986|FG001|Cycle 1 to 4|Progressive Disease|0|||
170864889|NCT00908232|617517987|FG002|Cycle 1 to 4|Progressive Disease|0|||
170864890|NCT00908232|617517988|FG003|Cycle 1 to 4|Progressive Disease|0|||
170864891|NCT00908232|617517985|FG000|Cycle 1 to 4|Adverse Event|12|||
170864892|NCT00908232|617517986|FG001|Cycle 1 to 4|Adverse Event|0|||
170864893|NCT00908232|617517987|FG002|Cycle 1 to 4|Adverse Event|0|||
170864894|NCT00908232|617517988|FG003|Cycle 1 to 4|Adverse Event|0|||
170864895|NCT00908232|617517985|FG000|Cycle 1 to 4|Other|1|||
170864896|NCT00908232|617517986|FG001|Cycle 1 to 4|Other|0|||
170864897|NCT00908232|617517987|FG002|Cycle 1 to 4|Other|0|||
170864898|NCT00908232|617517988|FG003|Cycle 1 to 4|Other|0|||
170864899|NCT00908232|617517985|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
170864900|NCT00908232|617517986|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
170864901|NCT00908232|617517987|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
170864902|NCT00908232|617517988|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
170864903|NCT00908232|617517985|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
170864904|NCT00908232|617517986|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
170864905|NCT00908232|617517987|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
170864906|NCT00908232|617517988|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
170402501|NCT02454972|615814928|FG004|Overall Study|Patient moves to compassionate use|0|||
170402502|NCT02454972|615814929|FG005|Overall Study|Patient moves to compassionate use|0|||
170864907|NCT00908232|617517985|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
170864908|NCT00908232|617517986|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
170864909|NCT00908232|617517987|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
170402503|NCT02454972|615814930|FG006|Overall Study|Patient moves to compassionate use|2|||
170864910|NCT00908232|617517988|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
170864911|NCT00908232|617517985|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
170864912|NCT00908232|617517986|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
170864913|NCT00908232|617517987|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
170402504|NCT02454972|615814931|FG007|Overall Study|Patient moves to compassionate use|0|||
170402505|NCT02454972|615814932|FG008|Overall Study|Patient moves to compassionate use|0|||
170402506|NCT02454972|615814924|FG000|Overall Study|Withdrawal by Subject|0|||
170402507|NCT02454972|615814925|FG001|Overall Study|Withdrawal by Subject|1|||
170402508|NCT02454972|615814926|FG002|Overall Study|Withdrawal by Subject|5|||
170402509|NCT02454972|615814927|FG003|Overall Study|Withdrawal by Subject|2|||
170402510|NCT02454972|615814928|FG004|Overall Study|Withdrawal by Subject|3|||
170402511|NCT02454972|615814929|FG005|Overall Study|Withdrawal by Subject|2|||
170402512|NCT02454972|615814930|FG006|Overall Study|Withdrawal by Subject|0|||
170402513|NCT02454972|615814931|FG007|Overall Study|Withdrawal by Subject|1|||
170402514|NCT02454972|615814932|FG008|Overall Study|Withdrawal by Subject|2|||
170402515|NCT02454972|615814924|FG000|Overall Study|Multiple delay/holds on treatment|0|||
170402516|NCT02454972|615814925|FG001|Overall Study|Multiple delay/holds on treatment|0|||
170402517|NCT02454972|615814926|FG002|Overall Study|Multiple delay/holds on treatment|0|||
170402518|NCT02454972|615814927|FG003|Overall Study|Multiple delay/holds on treatment|1|||
170402519|NCT02454972|615814928|FG004|Overall Study|Multiple delay/holds on treatment|0|||
170402520|NCT02454972|615814929|FG005|Overall Study|Multiple delay/holds on treatment|0|||
170402521|NCT02454972|615814930|FG006|Overall Study|Multiple delay/holds on treatment|0|||
170402522|NCT02454972|615814931|FG007|Overall Study|Multiple delay/holds on treatment|0|||
170402523|NCT02454972|615814932|FG008|Overall Study|Multiple delay/holds on treatment|0|||
170402524|NCT02454972|615814924|FG000|Overall Study|Never treated|0|||
170402525|NCT02454972|615814925|FG001|Overall Study|Never treated|0|||
170402526|NCT02454972|615814926|FG002|Overall Study|Never treated|3|||
170402527|NCT02454972|615814927|FG003|Overall Study|Never treated|1|||
170402528|NCT02454972|615814928|FG004|Overall Study|Never treated|1|||
170402529|NCT02454972|615814929|FG005|Overall Study|Never treated|0|||
170402530|NCT02454972|615814930|FG006|Overall Study|Never treated|0|||
170402531|NCT02454972|615814931|FG007|Overall Study|Never treated|0|||
170402532|NCT02454972|615814932|FG008|Overall Study|Never treated|5|||
170402533|NCT02454972|615814924|FG000|Overall Study|Lost to Follow-up|0|||
170402534|NCT02454972|615814925|FG001|Overall Study|Lost to Follow-up|0|||
170402535|NCT02454972|615814926|FG002|Overall Study|Lost to Follow-up|0|||
170402536|NCT02454972|615814927|FG003|Overall Study|Lost to Follow-up|0|||
170402537|NCT02454972|615814928|FG004|Overall Study|Lost to Follow-up|0|||
170402538|NCT02454972|615814929|FG005|Overall Study|Lost to Follow-up|0|||
170402539|NCT02454972|615814930|FG006|Overall Study|Lost to Follow-up|0|||
170402540|NCT02454972|615814931|FG007|Overall Study|Lost to Follow-up|0|||
170402541|NCT02454972|615814932|FG008|Overall Study|Lost to Follow-up|2|||
170402542|NCT02454972|615814924|FG000|Overall Study|Study termination|0|||
170402543|NCT02454972|615814925|FG001|Overall Study|Study termination|0|||
170402544|NCT02454972|615814926|FG002|Overall Study|Study termination|0|||
170402545|NCT02454972|615814927|FG003|Overall Study|Study termination|0|||
170402546|NCT02454972|615814928|FG004|Overall Study|Study termination|0|||
170402547|NCT02454972|615814929|FG005|Overall Study|Study termination|0|||
170402548|NCT02454972|615814930|FG006|Overall Study|Study termination|0|||
170402549|NCT02454972|615814931|FG007|Overall Study|Study termination|0|||
170402550|NCT02454972|615814932|FG008|Overall Study|Study termination|6|||
170402551|NCT00787566|615814933|FG000|Overall Study|AE related to chemotherapy|0|||
170402552|NCT00787566|615814934|FG001|Overall Study|AE related to chemotherapy|1|||
170402553|NCT00787566|615814935|FG002|Overall Study|AE related to chemotherapy|0|||
170402554|NCT02140164|615814936|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
170402555|NCT01814761|615814937|FG000|Overall Study|Other Reasons|1|||
170402556|NCT01814761|615814938|FG001|Overall Study|Other Reasons|10|||
170402557|NCT01814761|615814937|FG000|Overall Study|Ocular Adverse Event|6|||
170402558|NCT01814761|615814938|FG001|Overall Study|Ocular Adverse Event|15|||
170402559|NCT01814761|615814937|FG000|Overall Study|Lost to Follow-up|1|||
170402560|NCT01814761|615814938|FG001|Overall Study|Lost to Follow-up|5|||
170402561|NCT00775983|615814939|FG000|Overall Study|Protocol Violation|1|||
170402562|NCT00775983|615814940|FG001|Overall Study|Protocol Violation|2|||
170402563|NCT02732561|615814945|FG000|Overall Study|Lost to Follow-up|1|||
170402564|NCT02732561|615814946|FG001|Overall Study|Lost to Follow-up|1|||
170402565|NCT02732561|615814945|FG000|Overall Study|Withdrawal by Subject|1|||
170402566|NCT02732561|615814946|FG001|Overall Study|Withdrawal by Subject|0|||
170402567|NCT05180630|615814947|FG000|First Intervention|Physician Decision|0|||
170402568|NCT05180630|615814948|FG001|First Intervention|Physician Decision|0|||
170402569|NCT05180630|615814949|FG002|First Intervention|Physician Decision|3|||
170402570|NCT00829439|615814950|FG000|Overall Study|Adverse Event|0|||
170519633|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170402571|NCT00829439|615814951|FG001|Overall Study|Adverse Event|0|||
170402572|NCT00829439|615814952|FG002|Overall Study|Adverse Event|1|||
170402573|NCT00829439|615814953|FG003|Overall Study|Adverse Event|0|||
170402574|NCT02567266|615814956|FG000|Overall Study|Withdrawal by Subject|10|||
170402575|NCT02567266|615814957|FG001|Overall Study|Withdrawal by Subject|7|||
170402576|NCT02567266|615814958|FG002|Overall Study|Withdrawal by Subject|6|||
170402577|NCT02567266|615814956|FG000|Overall Study|Lost to Follow-up|13|||
170402578|NCT02567266|615814957|FG001|Overall Study|Lost to Follow-up|8|||
170402579|NCT02567266|615814958|FG002|Overall Study|Lost to Follow-up|10|||
170752247|NCT00946647|617099735|FG000|Phase ll Part|Untreated|0|||
170752248|NCT00946647|617099736|FG001|Phase ll Part|Untreated|0|||
170752249|NCT00946647|617099737|FG002|Phase ll Part|Untreated|0|||
170752250|NCT00946647|617099738|FG003|Phase ll Part|Untreated|0|||
170752251|NCT00946647|617099739|FG004|Phase ll Part|Untreated|2|||
170752252|NCT00946647|617099735|FG000|Phase ll Part|Adverse Event|0|||
170752253|NCT00946647|617099736|FG001|Phase ll Part|Adverse Event|0|||
170752254|NCT00946647|617099737|FG002|Phase ll Part|Adverse Event|0|||
170752255|NCT00946647|617099738|FG003|Phase ll Part|Adverse Event|10|||
170752256|NCT00946647|617099739|FG004|Phase ll Part|Adverse Event|6|||
170752257|NCT00946647|617099735|FG000|Phase ll Part|Withdrawal by Subject|0|||
170752258|NCT00946647|617099736|FG001|Phase ll Part|Withdrawal by Subject|0|||
170752259|NCT00946647|617099737|FG002|Phase ll Part|Withdrawal by Subject|0|||
170752260|NCT00946647|617099738|FG003|Phase ll Part|Withdrawal by Subject|8|||
170752261|NCT00946647|617099739|FG004|Phase ll Part|Withdrawal by Subject|6|||
170752262|NCT00946647|617099735|FG000|Phase ll Part|Administrative problems|0|||
170752263|NCT00946647|617099736|FG001|Phase ll Part|Administrative problems|0|||
170752264|NCT00946647|617099737|FG002|Phase ll Part|Administrative problems|0|||
170752265|NCT00946647|617099738|FG003|Phase ll Part|Administrative problems|3|||
170752266|NCT00946647|617099739|FG004|Phase ll Part|Administrative problems|8|||
170752267|NCT00946647|617099735|FG000|Phase ll Part|Death|0|||
170752268|NCT00946647|617099736|FG001|Phase ll Part|Death|0|||
170752269|NCT00946647|617099737|FG002|Phase ll Part|Death|0|||
170752270|NCT00946647|617099738|FG003|Phase ll Part|Death|7|||
170752271|NCT00946647|617099739|FG004|Phase ll Part|Death|4|||
170752272|NCT00946647|617099735|FG000|Phase ll Part|Disease progression|0|||
170752273|NCT00946647|617099736|FG001|Phase ll Part|Disease progression|0|||
170752274|NCT00946647|617099737|FG002|Phase ll Part|Disease progression|0|||
170752275|NCT00946647|617099738|FG003|Phase ll Part|Disease progression|6|||
170752276|NCT00946647|617099739|FG004|Phase ll Part|Disease progression|14|||
170752277|NCT00946647|617099735|FG000|Phase ll Part|Protocol Violation|0|||
170752278|NCT00946647|617099736|FG001|Phase ll Part|Protocol Violation|0|||
170752279|NCT00946647|617099737|FG002|Phase ll Part|Protocol Violation|0|||
170752280|NCT00946647|617099738|FG003|Phase ll Part|Protocol Violation|4|||
170752281|NCT00946647|617099739|FG004|Phase ll Part|Protocol Violation|2|||
170752282|NCT00946647|617099735|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
170752283|NCT00946647|617099736|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
170752284|NCT00946647|617099737|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
170752285|NCT00946647|617099738|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
170752286|NCT00946647|617099739|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
170752287|NCT00519636|617099740|FG000|Treatment Period 1|Adverse Event|1|||
170752288|NCT00519636|617099741|FG001|Treatment Period 1|Adverse Event|0|||
170752289|NCT00519636|617099742|FG002|Treatment Period 1|Adverse Event|1|||
170752290|NCT00519636|617099743|FG003|Treatment Period 1|Adverse Event|0|||
170752291|NCT00519636|617099740|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
170752292|NCT00519636|617099741|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
170752293|NCT00519636|617099742|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
170752294|NCT00519636|617099743|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
170752295|NCT00519636|617099740|FG000|Washout Period|Adverse Event|2|||
170752296|NCT00519636|617099741|FG001|Washout Period|Adverse Event|1|||
170752297|NCT00519636|617099742|FG002|Washout Period|Adverse Event|1|||
170752298|NCT00519636|617099743|FG003|Washout Period|Adverse Event|0|||
170752299|NCT00519636|617099740|FG000|Washout Period|Lost to Follow-up|1|||
170752300|NCT00519636|617099741|FG001|Washout Period|Lost to Follow-up|0|||
170752301|NCT00519636|617099742|FG002|Washout Period|Lost to Follow-up|0|||
170752302|NCT00519636|617099743|FG003|Washout Period|Lost to Follow-up|0|||
170752303|NCT00519636|617099740|FG000|Washout Period|Protocol Violation|0|||
170752304|NCT00519636|617099741|FG001|Washout Period|Protocol Violation|0|||
170752305|NCT00519636|617099742|FG002|Washout Period|Protocol Violation|1|||
170752306|NCT00519636|617099743|FG003|Washout Period|Protocol Violation|2|||
170752307|NCT00519636|617099740|FG000|Washout Period|Withdrawal by Subject|1|||
170752308|NCT00519636|617099741|FG001|Washout Period|Withdrawal by Subject|0|||
170752309|NCT00519636|617099742|FG002|Washout Period|Withdrawal by Subject|1|||
170864914|NCT00908232|617517988|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
170864915|NCT00908232|617517985|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
170864916|NCT00908232|617517986|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
170864917|NCT00908232|617517987|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
170864918|NCT00908232|617517988|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
170752310|NCT00519636|617099743|FG003|Washout Period|Withdrawal by Subject|0|||
170752311|NCT00519636|617099740|FG000|Washout Period|Failed to meet continuation criteria|14|||
170752312|NCT00519636|617099741|FG001|Washout Period|Failed to meet continuation criteria|11|||
170752313|NCT00519636|617099742|FG002|Washout Period|Failed to meet continuation criteria|9|||
170752314|NCT00519636|617099743|FG003|Washout Period|Failed to meet continuation criteria|3|||
170752315|NCT00519636|617099740|FG000|Washout Period|Out of pollen area > 48 hours|1|||
170864919|NCT00908232|617517985|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
170752316|NCT00519636|617099741|FG001|Washout Period|Out of pollen area > 48 hours|0|||
170752317|NCT00519636|617099742|FG002|Washout Period|Out of pollen area > 48 hours|0|||
170752318|NCT00519636|617099743|FG003|Washout Period|Out of pollen area > 48 hours|0|||
170752319|NCT00519636|617099740|FG000|Washout Period|Participating in study at another site|1|||
170752320|NCT00519636|617099741|FG001|Washout Period|Participating in study at another site|0|||
170752321|NCT00519636|617099742|FG002|Washout Period|Participating in study at another site|0|||
170752322|NCT00519636|617099743|FG003|Washout Period|Participating in study at another site|0|||
170752323|NCT00519636|617099740|FG000|Washout Period|Non-compliant|0|||
170752324|NCT00519636|617099741|FG001|Washout Period|Non-compliant|1|||
170752325|NCT00519636|617099742|FG002|Washout Period|Non-compliant|0|||
170752326|NCT00519636|617099743|FG003|Washout Period|Non-compliant|0|||
170752327|NCT00519636|617099740|FG000|Washout Period|Per doctors request|0|||
170752328|NCT00519636|617099741|FG001|Washout Period|Per doctors request|1|||
170752329|NCT00519636|617099742|FG002|Washout Period|Per doctors request|0|||
170752330|NCT00519636|617099743|FG003|Washout Period|Per doctors request|0|||
170752331|NCT00519636|617099740|FG000|Washout Period|Subject randomized in error|0|||
170752332|NCT00519636|617099741|FG001|Washout Period|Subject randomized in error|0|||
170752333|NCT00519636|617099742|FG002|Washout Period|Subject randomized in error|1|||
170752334|NCT00519636|617099743|FG003|Washout Period|Subject randomized in error|0|||
170752335|NCT00519636|617099740|FG000|Washout Period|Prohibited medications|0|||
170752336|NCT00519636|617099741|FG001|Washout Period|Prohibited medications|0|||
170752337|NCT00519636|617099742|FG002|Washout Period|Prohibited medications|1|||
170752338|NCT00519636|617099743|FG003|Washout Period|Prohibited medications|0|||
170752339|NCT00519636|617099740|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
170752340|NCT00519636|617099741|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
170752341|NCT00519636|617099742|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
170752342|NCT00519636|617099743|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
170752343|NCT00519636|617099740|FG000|Treatment Period 2|Subject randomized in error|0|||
170752344|NCT00519636|617099741|FG001|Treatment Period 2|Subject randomized in error|1|||
170752345|NCT00519636|617099742|FG002|Treatment Period 2|Subject randomized in error|0|||
170752346|NCT00519636|617099743|FG003|Treatment Period 2|Subject randomized in error|0|||
170752347|NCT00519636|617099740|FG000|Treatment Period 2|Per doctors request|0|||
170752348|NCT00519636|617099741|FG001|Treatment Period 2|Per doctors request|0|||
170752349|NCT00519636|617099742|FG002|Treatment Period 2|Per doctors request|1|||
170752350|NCT00519636|617099743|FG003|Treatment Period 2|Per doctors request|0|||
170752351|NCT00519636|617099740|FG000|Treatment Period 2|Subject misrandomized|0|||
170752352|NCT00519636|617099741|FG001|Treatment Period 2|Subject misrandomized|0|||
170752353|NCT00519636|617099742|FG002|Treatment Period 2|Subject misrandomized|0|||
170752354|NCT00519636|617099743|FG003|Treatment Period 2|Subject misrandomized|1|||
170752355|NCT00519636|617099740|FG000|Post Study Period|Subject randomized in error|0|||
170752356|NCT00519636|617099741|FG001|Post Study Period|Subject randomized in error|0|||
170752357|NCT00519636|617099742|FG002|Post Study Period|Subject randomized in error|0|||
170752358|NCT00519636|617099743|FG003|Post Study Period|Subject randomized in error|1|||
170752359|NCT04504916|617099744|FG000|Overall Study|Study terminated|7|||
170752360|NCT04504916|617099745|FG001|Overall Study|Study terminated|8|||
170752361|NCT04504916|617099744|FG000|Overall Study|Death|54|||
170752362|NCT04504916|617099745|FG001|Overall Study|Death|18|||
170752363|NCT04504916|617099744|FG000|Overall Study|Lost to Follow-up|1|||
170752364|NCT04504916|617099745|FG001|Overall Study|Lost to Follow-up|1|||
170752365|NCT04504916|617099744|FG000|Overall Study|Withdrawal by Subject|8|||
170752366|NCT04504916|617099745|FG001|Overall Study|Withdrawal by Subject|4|||
170752367|NCT04504916|617099744|FG000|Overall Study|Did not agree to follow-up|0|||
170752368|NCT04504916|617099745|FG001|Overall Study|Did not agree to follow-up|1|||
170752369|NCT01368211|617099746|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
170752370|NCT01368211|617099747|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
170752371|NCT03057834|617099748|FG000|Overall Study|Withdrawal by Subject|25|||
170752372|NCT03057834|617099749|FG001|Overall Study|Withdrawal by Subject|29|||
170752373|NCT00003509|617099753|FG000|Overall Study|Not evaluable|5|||
170402580|NCT01706770|615814959|FG000|Overall Study|Lost to Follow-up|1|||
170402581|NCT01706770|615814960|FG001|Overall Study|Lost to Follow-up|0|||
170402582|NCT01706770|615814959|FG000|Overall Study|Physician Decision|1|||
170402583|NCT01706770|615814960|FG001|Overall Study|Physician Decision|0|||
170402584|NCT00068445|615814963|FG000|Randomization|Cancel|1|||
170402585|NCT00068445|615814964|FG001|Randomization|Cancel|3|||
170402586|NCT00068445|615814963|FG000|Randomization|Ineligible|1|||
170402587|NCT00068445|615814964|FG001|Randomization|Ineligible|1|||
170402588|NCT00068445|615814963|FG000|Treatment|Refused Further Treatment|13|||
170402589|NCT00068445|615814964|FG001|Treatment|Refused Further Treatment|10|||
170402590|NCT00068445|615814963|FG000|Treatment|Adverse Event|7|||
170752374|NCT03803774|617099756|FG000|Dose Escalation|Withdrawal by Subject|0|||
170752375|NCT03803774|617099757|FG001|Dose Escalation|Withdrawal by Subject|0|||
170752376|NCT03803774|617099758|FG002|Dose Escalation|Withdrawal by Subject|0|||
170752377|NCT03803774|617099759|FG003|Dose Escalation|Withdrawal by Subject|1|||
170752378|NCT03803774|617099760|FG004|Dose Escalation|Withdrawal by Subject|0|||
170752379|NCT01513967|617099762|FG000|Overall Study|Pregnancy|0|||
170752380|NCT01513967|617099763|FG001|Overall Study|Pregnancy|0|||
170752381|NCT01513967|617099764|FG002|Overall Study|Pregnancy|0|||
170752382|NCT01513967|617099765|FG003|Overall Study|Pregnancy|0|||
170752383|NCT01513967|617099766|FG004|Overall Study|Pregnancy|0|||
170402591|NCT00068445|615814964|FG001|Treatment|Adverse Event|1|||
170402592|NCT00068445|615814963|FG000|Treatment|Other (Specifics not available)|9|||
170402593|NCT00068445|615814964|FG001|Treatment|Other (Specifics not available)|5|||
170402594|NCT01155284|615814965|FG000|Overall Study|Withdrawal by Subject|4|||
170402595|NCT01155284|615814966|FG001|Overall Study|Withdrawal by Subject|3|||
170402596|NCT01155284|615814965|FG000|Overall Study|Lost to Follow-up|1|||
170402597|NCT01155284|615814966|FG001|Overall Study|Lost to Follow-up|2|||
170402598|NCT01155284|615814965|FG000|Overall Study|Physician Decision|1|||
170402599|NCT01155284|615814966|FG001|Overall Study|Physician Decision|0|||
170402600|NCT01155284|615814965|FG000|Overall Study|Adverse Event|1|||
170402601|NCT01155284|615814966|FG001|Overall Study|Adverse Event|0|||
170402602|NCT01896700|615814967|FG000|Overall Study|Adverse Event|4|||
170402603|NCT01896700|615814968|FG001|Overall Study|Adverse Event|5|||
170402604|NCT01896700|615814967|FG000|Overall Study|Withdrawal by Subject|0|||
170402605|NCT01896700|615814968|FG001|Overall Study|Withdrawal by Subject|1|||
170402606|NCT00123487|615814969|FG000|Randomized|Death prior to starting treatment|0|||
170402607|NCT00123487|615814970|FG001|Randomized|Death prior to starting treatment|1|||
170402608|NCT00123487|615814969|FG000|Randomized|SAE prior to starting treatment|1|||
170402609|NCT00123487|615814970|FG001|Randomized|SAE prior to starting treatment|0|||
170402610|NCT00123487|615814969|FG000|Treated With Study Drug|Adverse Event|23|||
170402611|NCT00123487|615814970|FG001|Treated With Study Drug|Adverse Event|22|||
170402612|NCT00123487|615814969|FG000|Treated With Study Drug|Disease Progression|141|||
170402613|NCT00123487|615814970|FG001|Treated With Study Drug|Disease Progression|122|||
170402614|NCT00123487|615814969|FG000|Treated With Study Drug|Physician Decision|8|||
170402615|NCT00123487|615814970|FG001|Treated With Study Drug|Physician Decision|9|||
170402616|NCT00123487|615814969|FG000|Treated With Study Drug|Other|59|||
170402617|NCT00123487|615814970|FG001|Treated With Study Drug|Other|58|||
170402618|NCT00123487|615814969|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
170402619|NCT00123487|615814970|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
170402620|NCT00123487|615814969|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
170402621|NCT00123487|615814970|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
170402622|NCT00123487|615814969|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
170402623|NCT00123487|615814970|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
170752384|NCT01513967|617099767|FG005|Overall Study|Pregnancy|0|||
170752385|NCT01513967|617099768|FG006|Overall Study|Pregnancy|1|||
170752386|NCT01513967|617099769|FG007|Overall Study|Pregnancy|0|||
170752387|NCT01513967|617099762|FG000|Overall Study|missed a study visit|0|||
170752388|NCT01513967|617099763|FG001|Overall Study|missed a study visit|0|||
170752389|NCT01513967|617099764|FG002|Overall Study|missed a study visit|0|||
170752390|NCT01513967|617099765|FG003|Overall Study|missed a study visit|0|||
170752391|NCT01513967|617099766|FG004|Overall Study|missed a study visit|0|||
170752392|NCT01513967|617099767|FG005|Overall Study|missed a study visit|0|||
170752393|NCT01513967|617099768|FG006|Overall Study|missed a study visit|1|||
170752394|NCT01513967|617099769|FG007|Overall Study|missed a study visit|0|||
170752395|NCT01513967|617099762|FG000|Overall Study|excluded due to positive drug screen|0|||
170752396|NCT01513967|617099763|FG001|Overall Study|excluded due to positive drug screen|0|||
170752397|NCT01513967|617099764|FG002|Overall Study|excluded due to positive drug screen|0|||
170752398|NCT01513967|617099765|FG003|Overall Study|excluded due to positive drug screen|0|||
170752399|NCT01513967|617099766|FG004|Overall Study|excluded due to positive drug screen|0|||
170752400|NCT01513967|617099767|FG005|Overall Study|excluded due to positive drug screen|0|||
170752401|NCT01513967|617099768|FG006|Overall Study|excluded due to positive drug screen|0|||
170752402|NCT01513967|617099769|FG007|Overall Study|excluded due to positive drug screen|2|||
170752403|NCT01513967|617099762|FG000|Overall Study|Physician Decision|0|||
170752404|NCT01513967|617099763|FG001|Overall Study|Physician Decision|0|||
170752405|NCT01513967|617099764|FG002|Overall Study|Physician Decision|0|||
170752406|NCT01513967|617099765|FG003|Overall Study|Physician Decision|0|||
170752407|NCT01513967|617099766|FG004|Overall Study|Physician Decision|0|||
170752408|NCT01513967|617099767|FG005|Overall Study|Physician Decision|1|||
170752409|NCT01513967|617099768|FG006|Overall Study|Physician Decision|0|||
170752410|NCT01513967|617099769|FG007|Overall Study|Physician Decision|0|||
170752411|NCT01349660|617099775|FG000|Overall Study|Still Receiving Study Treatment|0|||
170752412|NCT01349660|617099776|FG001|Overall Study|Still Receiving Study Treatment|0|||
170752413|NCT01349660|617099777|FG002|Overall Study|Still Receiving Study Treatment|1|||
170752414|NCT01349660|617099775|FG000|Overall Study|Disease Progression|2|||
170752415|NCT01349660|617099776|FG001|Overall Study|Disease Progression|4|||
170752416|NCT01349660|617099777|FG002|Overall Study|Disease Progression|50|||
170402624|NCT00527397|615814973|FG000|Overall Study|Adverse Event|3|||
170402625|NCT00527397|615814973|FG000|Overall Study|Lack of Efficacy|1|||
170402626|NCT00527397|615814973|FG000|Overall Study|Protocol Violation|1|||
170402627|NCT00527397|615814973|FG000|Overall Study|Withdrawal by Subject|6|||
170752417|NCT01349660|617099775|FG000|Overall Study|Adverse Event|1|||
170752418|NCT01349660|617099776|FG001|Overall Study|Adverse Event|1|||
170752419|NCT01349660|617099777|FG002|Overall Study|Adverse Event|12|||
170752420|NCT01349660|617099775|FG000|Overall Study|Withdrawal by Subject|2|||
170752421|NCT01349660|617099776|FG001|Overall Study|Withdrawal by Subject|0|||
170752422|NCT01349660|617099777|FG002|Overall Study|Withdrawal by Subject|9|||
170752423|NCT01349660|617099775|FG000|Overall Study|Death|1|||
170752424|NCT01349660|617099776|FG001|Overall Study|Death|1|||
170752425|NCT01349660|617099777|FG002|Overall Study|Death|0|||
170752426|NCT01349660|617099775|FG000|Overall Study|Non-Permitted Interventions|0|||
170752427|NCT01349660|617099776|FG001|Overall Study|Non-Permitted Interventions|0|||
170752428|NCT01349660|617099777|FG002|Overall Study|Non-Permitted Interventions|2|||
170752429|NCT01349660|617099775|FG000|Overall Study|Study Compliance|0|||
170752430|NCT01349660|617099776|FG001|Overall Study|Study Compliance|0|||
170752431|NCT01349660|617099777|FG002|Overall Study|Study Compliance|1|||
170752432|NCT01349660|617099775|FG000|Overall Study|Declining Performance Status|0|||
170752433|NCT01349660|617099776|FG001|Overall Study|Declining Performance Status|0|||
170752434|NCT01349660|617099777|FG002|Overall Study|Declining Performance Status|1|||
170752435|NCT01563978|617099781|FG000|Overall Study|Physician Decision|1|||
170752436|NCT01563978|617099782|FG001|Overall Study|Physician Decision|0|||
170752437|NCT01563978|617099781|FG000|Overall Study|Lost to Follow-up|1|||
170752438|NCT01563978|617099782|FG001|Overall Study|Lost to Follow-up|0|||
170752439|NCT01563978|617099781|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
170752440|NCT01563978|617099782|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
170752441|NCT01563978|617099781|FG000|Overall Study|Adverse Event|1|||
170752442|NCT01563978|617099782|FG001|Overall Study|Adverse Event|2|||
170752443|NCT04248465|617099783|FG000|Randomized-Controlled Period|Death|12|||
170752444|NCT04248465|617099784|FG001|Randomized-Controlled Period|Death|5|||
170752445|NCT04248465|617099783|FG000|Randomized-Controlled Period|Adverse Event|2|||
170752446|NCT04248465|617099784|FG001|Randomized-Controlled Period|Adverse Event|0|||
170752447|NCT04248465|617099783|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
170752448|NCT04248465|617099784|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
170752449|NCT04248465|617099783|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
170752450|NCT04248465|617099784|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
170752451|NCT04248465|617099783|FG000|Randomized-Controlled Period|Physician Decision|1|||
170752452|NCT04248465|617099784|FG001|Randomized-Controlled Period|Physician Decision|1|||
170752453|NCT04248465|617099783|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
170752454|NCT04248465|617099784|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
170752455|NCT04248465|617099783|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
170752456|NCT04248465|617099784|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
170752457|NCT04248465|617099783|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
170752458|NCT04248465|617099784|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
170752459|NCT00238420|617099785|FG000|Overall Study|Protocol Violation|1|||
170752460|NCT00238420|617099786|FG001|Overall Study|Protocol Violation|1|||
170752461|NCT01254890|617099789|FG000|Overall Study|Ineligible|0|||
170752462|NCT01254890|617099790|FG001|Overall Study|Ineligible|3|||
170752463|NCT01254890|617099789|FG000|Overall Study|Withdrawal by Subject|1|||
170752464|NCT01254890|617099790|FG001|Overall Study|Withdrawal by Subject|2|||
170752465|NCT01254890|617099789|FG000|Overall Study|Disease Progression|0|||
170752466|NCT01254890|617099790|FG001|Overall Study|Disease Progression|5|||
170752467|NCT01824472|617099791|FG000|Overall Study|Lost to Follow-up|0|||
170752468|NCT01824472|617099792|FG001|Overall Study|Lost to Follow-up|0|||
170752469|NCT01824472|617099793|FG002|Overall Study|Lost to Follow-up|1|||
170752470|NCT01824472|617099791|FG000|Overall Study|Withdrawal by Subject|1|||
170752471|NCT01824472|617099792|FG001|Overall Study|Withdrawal by Subject|5|||
170752472|NCT01824472|617099793|FG002|Overall Study|Withdrawal by Subject|3|||
170752473|NCT01824472|617099791|FG000|Overall Study|Ineligible post randomization&screening|0|||
170752474|NCT01824472|617099792|FG001|Overall Study|Ineligible post randomization&screening|2|||
170752475|NCT01824472|617099793|FG002|Overall Study|Ineligible post randomization&screening|0|||
170752476|NCT01815736|617099794|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
170752477|NCT01815736|617099795|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
170752478|NCT01815736|617099794|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
170752479|NCT01815736|617099795|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
170752480|NCT01815736|617099794|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
170752481|NCT01815736|617099795|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
170752482|NCT01815736|617099794|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
170752483|NCT01815736|617099795|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
170752484|NCT01815736|617099794|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
170752485|NCT01815736|617099795|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
170752486|NCT01815736|617099794|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
170752487|NCT01815736|617099795|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
170752488|NCT01815736|617099794|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
170752489|NCT01815736|617099795|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
170752490|NCT01815736|617099794|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
170806902|NCT03697603|617301663|FG000|Overall Study|Withdrawal by Subject|5|||
170752491|NCT01815736|617099795|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
170752492|NCT01815736|617099794|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
170752493|NCT01815736|617099795|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
170752494|NCT01815736|617099794|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
170752495|NCT01815736|617099795|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
170752496|NCT01815736|617099794|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
170752497|NCT01815736|617099795|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
170752498|NCT01815736|617099794|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
170752499|NCT01815736|617099795|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
170752500|NCT01815736|617099794|FG000|Extension Treatment Phase- After Week 96|Death|1|||
170752501|NCT01815736|617099795|FG001|Extension Treatment Phase- After Week 96|Death|0|||
170752502|NCT03040687|617099806|FG000|Overall Study|Withdrawal by Subject|1|||
170752503|NCT03040687|617099807|FG001|Overall Study|Withdrawal by Subject|0|||
170752504|NCT03040687|617099808|FG002|Overall Study|Withdrawal by Subject|0|||
170752505|NCT01671748|617099813|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
170752506|NCT01671748|617099814|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
170752507|NCT01671748|617099813|FG000|4 Week run-in Phase|Adverse Event|1|||
170752508|NCT01671748|617099814|FG001|4 Week run-in Phase|Adverse Event|0|||
170752509|NCT01671748|617099813|FG000|4 Week run-in Phase|Not eligible|9|||
170752510|NCT01671748|617099814|FG001|4 Week run-in Phase|Not eligible|0|||
170752511|NCT04191135|617099815|FG000|Induction Treatment|Not Treated|2|||
170752512|NCT04191135|617099816|FG001|Induction Treatment|Not Treated|0|||
170752513|NCT04191135|617099817|FG002|Induction Treatment|Not Treated|0|||
170752514|NCT04191135|617099815|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
170752515|NCT04191135|617099816|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
170752516|NCT04191135|617099817|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
170752517|NCT04191135|617099815|FG000|Induction Treatment|Adverse Event|25|||
170752518|NCT04191135|617099816|FG001|Induction Treatment|Adverse Event|0|||
170752519|NCT04191135|617099817|FG002|Induction Treatment|Adverse Event|0|||
170752520|NCT04191135|617099815|FG000|Induction Treatment|Clinical Progression|8|||
170752521|NCT04191135|617099816|FG001|Induction Treatment|Clinical Progression|0|||
170752522|NCT04191135|617099817|FG002|Induction Treatment|Clinical Progression|0|||
170752523|NCT04191135|617099815|FG000|Induction Treatment|Excluded Medication|1|||
170752524|NCT04191135|617099816|FG001|Induction Treatment|Excluded Medication|0|||
170752525|NCT04191135|617099817|FG002|Induction Treatment|Excluded Medication|0|||
170752526|NCT04191135|617099815|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
170752527|NCT04191135|617099816|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
170752528|NCT04191135|617099817|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
170752529|NCT04191135|617099815|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
170752530|NCT04191135|617099816|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
170752531|NCT04191135|617099817|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
170752532|NCT04191135|617099815|FG000|Induction Treatment|Physician Decision|2|||
170752533|NCT04191135|617099816|FG001|Induction Treatment|Physician Decision|0|||
170752534|NCT04191135|617099817|FG002|Induction Treatment|Physician Decision|0|||
170752535|NCT04191135|617099815|FG000|Induction Treatment|Progressive Disease|135|||
170752536|NCT04191135|617099816|FG001|Induction Treatment|Progressive Disease|0|||
170752537|NCT04191135|617099817|FG002|Induction Treatment|Progressive Disease|0|||
170752538|NCT04191135|617099815|FG000|Induction Treatment|Protocol Violation|10|||
170752539|NCT04191135|617099816|FG001|Induction Treatment|Protocol Violation|0|||
170752540|NCT04191135|617099817|FG002|Induction Treatment|Protocol Violation|0|||
170752541|NCT04191135|617099815|FG000|Induction Treatment|Withdrawal by Subject|4|||
170752542|NCT04191135|617099816|FG001|Induction Treatment|Withdrawal by Subject|0|||
170752543|NCT04191135|617099817|FG002|Induction Treatment|Withdrawal by Subject|0|||
170752544|NCT04191135|617099815|FG000|Randomized Treatment|Death|0|||
170752545|NCT04191135|617099816|FG001|Randomized Treatment|Death|50|||
170752546|NCT04191135|617099817|FG002|Randomized Treatment|Death|54|||
170752547|NCT04191135|617099815|FG000|Randomized Treatment|Lost to Follow-up|0|||
170752548|NCT04191135|617099816|FG001|Randomized Treatment|Lost to Follow-up|0|||
170752549|NCT04191135|617099817|FG002|Randomized Treatment|Lost to Follow-up|1|||
170752550|NCT04191135|617099815|FG000|Randomized Treatment|Withdrawal by Subject|0|||
170752551|NCT04191135|617099816|FG001|Randomized Treatment|Withdrawal by Subject|2|||
170752552|NCT04191135|617099817|FG002|Randomized Treatment|Withdrawal by Subject|0|||
170752553|NCT04191135|617099815|FG000|Randomized Treatment|Ongoing in Trial|0|||
170752554|NCT04191135|617099816|FG001|Randomized Treatment|Ongoing in Trial|83|||
170752555|NCT04191135|617099817|FG002|Randomized Treatment|Ongoing in Trial|81|||
170752556|NCT05296629|617101205|FG000|Overall Study|Withdrawal by Subject|3|||
170752557|NCT05296629|617101206|FG001|Overall Study|Withdrawal by Subject|10|||
170752558|NCT05296629|617101207|FG002|Overall Study|Withdrawal by Subject|4|||
170752559|NCT05296629|617101205|FG000|Overall Study|Lost to Follow-up|2|||
170752560|NCT05296629|617101206|FG001|Overall Study|Lost to Follow-up|7|||
170752561|NCT05296629|617101207|FG002|Overall Study|Lost to Follow-up|1|||
170752562|NCT05296629|617101205|FG000|Overall Study|Adverse Event|0|||
170752563|NCT05296629|617101206|FG001|Overall Study|Adverse Event|4|||
170752564|NCT05296629|617101207|FG002|Overall Study|Adverse Event|2|||
170752565|NCT05296629|617101205|FG000|Overall Study|Protocol Violation|0|||
170752566|NCT05296629|617101206|FG001|Overall Study|Protocol Violation|2|||
170752567|NCT05296629|617101207|FG002|Overall Study|Protocol Violation|0|||
170752568|NCT04034238|617101208|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
170752569|NCT04034238|617101209|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
170752570|NCT04034238|617101210|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
170752571|NCT04034238|617101211|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
170752572|NCT04034238|617101208|FG000|Dose Escalation Phase|Screen failures|0|||
170752573|NCT04034238|617101209|FG001|Dose Escalation Phase|Screen failures|0|||
170752574|NCT04034238|617101210|FG002|Dose Escalation Phase|Screen failures|0|||
170752575|NCT04034238|617101211|FG003|Dose Escalation Phase|Screen failures|2|||
170752576|NCT04034238|617101208|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
170752577|NCT04034238|617101209|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
170752578|NCT04034238|617101210|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
170752579|NCT04034238|617101211|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
170752580|NCT04034238|617101208|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
170752581|NCT04034238|617101209|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
170752582|NCT04034238|617101210|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
170752583|NCT04034238|617101211|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
170752584|NCT02459587|617101214|FG000|3-Month Follow-up Assessment|Death|0|||
170752585|NCT02459587|617101215|FG001|3-Month Follow-up Assessment|Death|2|||
170752586|NCT02459587|617101214|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
170752587|NCT02459587|617101215|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
170752588|NCT02459587|617101214|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
170752589|NCT02459587|617101215|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
170752590|NCT02459587|617101214|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
170752591|NCT02459587|617101215|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
170752592|NCT02459587|617101214|FG000|6-month Follow-up Assessment|Death|2|||
170752593|NCT02459587|617101215|FG001|6-month Follow-up Assessment|Death|1|||
170752594|NCT02459587|617101214|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
170752595|NCT02459587|617101215|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
170752596|NCT02459587|617101214|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
170752597|NCT02459587|617101215|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
170752598|NCT02459587|617101214|FG000|12-month Follow-up Assessment|Death|2|||
170752599|NCT02459587|617101215|FG001|12-month Follow-up Assessment|Death|0|||
170752600|NCT02459587|617101214|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
170752601|NCT02459587|617101215|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
170752602|NCT02459587|617101214|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
170752603|NCT02459587|617101215|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
170752604|NCT02459587|617101214|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
170752605|NCT02459587|617101215|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
170752606|NCT02652130|617101218|FG000|Overall Study|Death|1|||
170752607|NCT03201757|617101222|FG000|Overall Study|Withdrawal by Subject|133|||
170752608|NCT03201757|617101222|FG000|Overall Study|Adverse Event|44|||
170752609|NCT03201757|617101222|FG000|Overall Study|Lost to Follow-up|37|||
170752610|NCT03201757|617101222|FG000|Overall Study|Pregnancy|2|||
170752611|NCT03201757|617101222|FG000|Overall Study|Lack of Efficacy|1|||
170752612|NCT03201757|617101222|FG000|Overall Study|Protocol Violation|20|||
170752613|NCT03201757|617101222|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
170752614|NCT03201757|617101222|FG000|Overall Study|Not Yet Determined|5|||
170752615|NCT03201757|617101222|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
170752616|NCT03201757|617101222|FG000|Overall Study|Other|20|||
170752617|NCT01244763|617101225|FG000|Overall Study|Adverse Event|1|||
170752618|NCT01244763|617101226|FG001|Overall Study|Adverse Event|0|||
170752619|NCT01244763|617101227|FG002|Overall Study|Adverse Event|0|||
170752620|NCT01244763|617101228|FG003|Overall Study|Adverse Event|0|||
170752621|NCT01244763|617101229|FG004|Overall Study|Adverse Event|0|||
170752622|NCT01244763|617101230|FG005|Overall Study|Adverse Event|1|||
170752623|NCT01244763|617101225|FG000|Overall Study|Death|1|||
170752624|NCT01244763|617101226|FG001|Overall Study|Death|0|||
170402628|NCT00527397|615814973|FG000|Overall Study|Study terminated by sponsor|13|||
170402629|NCT01656967|615814977|FG000|Overall Study|faulty monitor|1|||
170752625|NCT01244763|617101227|FG002|Overall Study|Death|1|||
170752626|NCT01244763|617101228|FG003|Overall Study|Death|0|||
170752627|NCT01244763|617101229|FG004|Overall Study|Death|2|||
170752628|NCT01244763|617101230|FG005|Overall Study|Death|0|||
170752629|NCT01244763|617101225|FG000|Overall Study|Physician Decision|0|||
170402630|NCT01656967|615814978|FG001|Overall Study|faulty monitor|0|||
170752630|NCT01244763|617101226|FG001|Overall Study|Physician Decision|0|||
170752631|NCT01244763|617101227|FG002|Overall Study|Physician Decision|1|||
170752632|NCT01244763|617101228|FG003|Overall Study|Physician Decision|0|||
170752633|NCT01244763|617101229|FG004|Overall Study|Physician Decision|0|||
170752634|NCT01244763|617101230|FG005|Overall Study|Physician Decision|0|||
170752635|NCT01244763|617101225|FG000|Overall Study|Withdrawal by Subject|1|||
170752636|NCT01244763|617101226|FG001|Overall Study|Withdrawal by Subject|2|||
170752637|NCT01244763|617101227|FG002|Overall Study|Withdrawal by Subject|0|||
170752638|NCT01244763|617101228|FG003|Overall Study|Withdrawal by Subject|1|||
170752639|NCT01244763|617101229|FG004|Overall Study|Withdrawal by Subject|1|||
170752640|NCT01244763|617101230|FG005|Overall Study|Withdrawal by Subject|2|||
170752641|NCT01244763|617101225|FG000|Overall Study|Lost to Follow-up|0|||
170752642|NCT01244763|617101226|FG001|Overall Study|Lost to Follow-up|1|||
170752643|NCT01244763|617101227|FG002|Overall Study|Lost to Follow-up|0|||
170752644|NCT01244763|617101228|FG003|Overall Study|Lost to Follow-up|0|||
170752645|NCT01244763|617101229|FG004|Overall Study|Lost to Follow-up|0|||
170752646|NCT01244763|617101230|FG005|Overall Study|Lost to Follow-up|0|||
170752647|NCT01244763|617101225|FG000|Overall Study|Enrolled into the Extension Study|0|||
170752648|NCT01244763|617101226|FG001|Overall Study|Enrolled into the Extension Study|0|||
170752649|NCT01244763|617101227|FG002|Overall Study|Enrolled into the Extension Study|0|||
170752650|NCT01244763|617101228|FG003|Overall Study|Enrolled into the Extension Study|0|||
170752651|NCT01244763|617101229|FG004|Overall Study|Enrolled into the Extension Study|0|||
170752652|NCT01244763|617101230|FG005|Overall Study|Enrolled into the Extension Study|1|||
170752653|NCT00519779|617101231|FG000|Overall Study|Withdrawal by Subject|0|||
170752654|NCT00519779|617101232|FG001|Overall Study|Withdrawal by Subject|1|||
170752655|NCT00751790|617101240|FG000|Overall Study|Lost to Follow-up|1|||
170752656|NCT00751790|617101240|FG000|Overall Study|Death|3|||
170752657|NCT00751790|617101240|FG000|Overall Study|Withdrawal by Subject|1|||
170752658|NCT01477749|617101241|FG000|Overall Study|Physician Decision|4|||
170752659|NCT02954575|617101243|FG000|Overall Study|Withdrawal by Subject|2|||
170752660|NCT02954575|617101243|FG000|Overall Study|Adverse Event|1|||
170752661|NCT00570661|617101244|FG000|Overall Study|Disease worsening|5|||
170752662|NCT00570661|617101244|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
170752663|NCT00570661|617101244|FG000|Overall Study|Adverse Event|1|||
170752664|NCT00661258|617101248|FG000|Overall Study|Death|1|||
170752665|NCT00661258|617101249|FG001|Overall Study|Death|0|||
170752666|NCT00661258|617101248|FG000|Overall Study|caught by police and in detox center|2|||
170752667|NCT00661258|617101249|FG001|Overall Study|caught by police and in detox center|1|||
170752668|NCT01628874|617101250|FG000|Overall Study|Physician Decision|1|||
170752669|NCT01628874|617101251|FG001|Overall Study|Physician Decision|1|||
170752670|NCT01628874|617101250|FG000|Overall Study|Age >4 months|4|||
170752671|NCT01628874|617101251|FG001|Overall Study|Age >4 months|2|||
170752672|NCT00087490|617101252|FG000|Overall Study|Death|6|||
170752673|NCT00087490|617101253|FG001|Overall Study|Death|4|||
170752674|NCT00087490|617101252|FG000|Overall Study|Adverse Event|3|||
170752675|NCT00087490|617101253|FG001|Overall Study|Adverse Event|8|||
170752676|NCT00087490|617101252|FG000|Overall Study|Lack of Efficacy|0|||
170752677|NCT00087490|617101253|FG001|Overall Study|Lack of Efficacy|2|||
170752678|NCT00087490|617101252|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
170752679|NCT00087490|617101253|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
170752680|NCT00087490|617101252|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
170752681|NCT00087490|617101253|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
170752682|NCT00087490|617101252|FG000|Overall Study|Randomized but not treated|7|||
170752683|NCT00087490|617101253|FG001|Overall Study|Randomized but not treated|18|||
170752684|NCT02300311|617101257|FG000|Overall Study|Other than the reason specified|1|||
170752685|NCT02300311|617101258|FG001|Overall Study|Other than the reason specified|0|||
170752686|NCT02300311|617101257|FG000|Overall Study|Refused to continue taking medication|18|||
170752687|NCT02300311|617101258|FG001|Overall Study|Refused to continue taking medication|0|||
170752688|NCT00419003|617101259|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
170752689|NCT00419003|617101260|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
170752690|NCT00419003|617101259|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
170752691|NCT00419003|617101260|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
170752692|NCT02687919|617101261|FG000|Overall Study|Withdrawal by Subject|6|||
170752693|NCT02687919|617101262|FG001|Overall Study|Withdrawal by Subject|6|||
170752694|NCT02687919|617101261|FG000|Overall Study|Protocol Violation|2|||
170752695|NCT02687919|617101262|FG001|Overall Study|Protocol Violation|0|||
170752696|NCT02531438|617101263|FG000|Overall Study|Adverse Event|7|||
170752697|NCT02531438|617101264|FG001|Overall Study|Adverse Event|9|||
170752698|NCT02531438|617101263|FG000|Overall Study|Lost to Follow-up|0|||
170752699|NCT02531438|617101264|FG001|Overall Study|Lost to Follow-up|3|||
170752700|NCT02531438|617101263|FG000|Overall Study|Withdrawal by Subject|7|||
170752701|NCT02531438|617101264|FG001|Overall Study|Withdrawal by Subject|8|||
170752702|NCT02531438|617101263|FG000|Overall Study|Physician Decision|0|||
170752703|NCT02531438|617101264|FG001|Overall Study|Physician Decision|1|||
170752704|NCT02531438|617101263|FG000|Overall Study|Death|6|||
170752705|NCT02531438|617101264|FG001|Overall Study|Death|3|||
170752706|NCT02531438|617101263|FG000|Overall Study|Randomized, but Not Treated|4|||
170752707|NCT02531438|617101264|FG001|Overall Study|Randomized, but Not Treated|0|||
170752708|NCT02531438|617101263|FG000|Overall Study|Missed EOT/PTE Visit|5|||
170752709|NCT02531438|617101264|FG001|Overall Study|Missed EOT/PTE Visit|2|||
170752710|NCT02531438|617101263|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
170752711|NCT02531438|617101264|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
170752712|NCT00772928|617101265|FG000|Overall Study|Lost to Follow-up|9|||
170752713|NCT00772928|617101266|FG001|Overall Study|Lost to Follow-up|6|||
170752714|NCT00772928|617101265|FG000|Overall Study|Protocol Violation|10|||
170752715|NCT00772928|617101266|FG001|Overall Study|Protocol Violation|12|||
170752716|NCT00772928|617101265|FG000|Overall Study|Withdrawal by Subject|25|||
170752717|NCT00772928|617101266|FG001|Overall Study|Withdrawal by Subject|22|||
170752718|NCT00772928|617101265|FG000|Overall Study|Did not receive vaccine|0|||
170752719|NCT00772928|617101266|FG001|Overall Study|Did not receive vaccine|1|||
170752720|NCT01653847|617101267|FG000|Overall Study|Withdrawal by Subject|1|||
170752721|NCT01653847|617101268|FG001|Overall Study|Withdrawal by Subject|0|||
170752722|NCT03100838|617101269|FG000|Overall Study|Adverse Event|1|||
170752723|NCT03100838|617101270|FG001|Overall Study|Adverse Event|0|||
170752724|NCT03100838|617101271|FG002|Overall Study|Adverse Event|0|||
170752725|NCT03100838|617101272|FG003|Overall Study|Adverse Event|0|||
170752726|NCT03100838|617101269|FG000|Overall Study|Physician Decision|1|||
170752727|NCT03100838|617101270|FG001|Overall Study|Physician Decision|1|||
170752728|NCT03100838|617101271|FG002|Overall Study|Physician Decision|1|||
170752729|NCT03100838|617101272|FG003|Overall Study|Physician Decision|1|||
170752730|NCT03100838|617101269|FG000|Overall Study|Pregnancy|0|||
170752731|NCT03100838|617101270|FG001|Overall Study|Pregnancy|1|||
170752732|NCT03100838|617101271|FG002|Overall Study|Pregnancy|0|||
170752733|NCT03100838|617101272|FG003|Overall Study|Pregnancy|0|||
170752734|NCT03100838|617101269|FG000|Overall Study|Lost to Follow-up|0|||
170752735|NCT03100838|617101270|FG001|Overall Study|Lost to Follow-up|0|||
170752736|NCT03100838|617101271|FG002|Overall Study|Lost to Follow-up|1|||
170752737|NCT03100838|617101272|FG003|Overall Study|Lost to Follow-up|0|||
170752738|NCT00994279|617101276|FG000|Overall Study|Withdrawal by Subject|2|||
170752739|NCT00994279|617101277|FG001|Overall Study|Withdrawal by Subject|2|||
170752740|NCT00994279|617101276|FG000|Overall Study|Toxicity|1|||
170752741|NCT00994279|617101277|FG001|Overall Study|Toxicity|0|||
170752742|NCT00994279|617101276|FG000|Overall Study|Multiple reasons|1|||
170752743|NCT00994279|617101277|FG001|Overall Study|Multiple reasons|3|||
170752744|NCT01141660|617101278|FG000|Overall Study|Physician Decision|0|||
170752745|NCT01141660|617101279|FG001|Overall Study|Physician Decision|12|||
170752746|NCT01606189|617101280|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
170752747|NCT01606189|617101281|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
170752748|NCT01606189|617101282|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
170752749|NCT01606189|617101283|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
170752750|NCT01606189|617101284|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
170752751|NCT01606189|617101285|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
170752752|NCT01606189|617101280|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
170752753|NCT01606189|617101281|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
170752754|NCT01606189|617101282|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
170752755|NCT01606189|617101283|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
170752756|NCT01606189|617101284|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
170752757|NCT01606189|617101285|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
170752758|NCT04320615|617101287|FG000|Overall Study|Withdrawal by Subject|4|||
170752759|NCT04320615|617101288|FG001|Overall Study|Withdrawal by Subject|10|||
170752760|NCT04320615|617101287|FG000|Overall Study|Physician Decision|2|||
170752761|NCT04320615|617101288|FG001|Overall Study|Physician Decision|0|||
170752762|NCT04320615|617101287|FG000|Overall Study|Other|2|||
170752763|NCT04320615|617101288|FG001|Overall Study|Other|0|||
170752764|NCT04320615|617101287|FG000|Overall Study|Lost to Follow-up|5|||
170752765|NCT04320615|617101288|FG001|Overall Study|Lost to Follow-up|23|||
170752766|NCT04320615|617101287|FG000|Overall Study|Death|35|||
170752767|NCT04320615|617101288|FG001|Overall Study|Death|71|||
170752768|NCT05708846|617101289|FG000|Overall Study|Death|5|||
170752769|NCT05708846|617101289|FG000|Overall Study|Withdrawal by Subject|20|||
170752770|NCT03387514|617101290|FG000|Overall Study|Withdrawal by Subject|2|||
170752771|NCT03387514|617101290|FG000|Overall Study|Physician Decision|1|||
170752772|NCT03387514|617101290|FG000|Overall Study|Lost to Follow-up|2|||
170752773|NCT02846558|617101291|FG000|Overall Study|Adverse Event|1|||
170752774|NCT02846558|617101292|FG001|Overall Study|Adverse Event|0|||
170752775|NCT02846558|617101293|FG002|Overall Study|Adverse Event|0|||
170752776|NCT02846558|617101294|FG003|Overall Study|Adverse Event|0|||
170752777|NCT02846558|617101291|FG000|Overall Study|Withdrawal by Subject|5|||
170752778|NCT02846558|617101292|FG001|Overall Study|Withdrawal by Subject|4|||
170752779|NCT02846558|617101293|FG002|Overall Study|Withdrawal by Subject|2|||
170752780|NCT02846558|617101294|FG003|Overall Study|Withdrawal by Subject|2|||
170864920|NCT00908232|617517986|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
170906115|NCT01331161|617658624|FG001|Overall Study|Physician Decision|0|||
170752781|NCT02846558|617101291|FG000|Overall Study|Lost to Follow-up|2|||
170752782|NCT02846558|617101292|FG001|Overall Study|Lost to Follow-up|0|||
170752783|NCT02846558|617101293|FG002|Overall Study|Lost to Follow-up|0|||
170752784|NCT02846558|617101294|FG003|Overall Study|Lost to Follow-up|0|||
170752785|NCT00550173|617101295|FG000|Overall Study|Death|45|||
170752786|NCT00550173|617101296|FG001|Overall Study|Death|38|||
170752787|NCT00550173|617101297|FG002|Overall Study|Death|50|||
170752788|NCT00550173|617101295|FG000|Overall Study|Physician Decision|1|||
170752789|NCT00550173|617101296|FG001|Overall Study|Physician Decision|2|||
170752790|NCT00550173|617101297|FG002|Overall Study|Physician Decision|2|||
170752791|NCT00550173|617101295|FG000|Overall Study|Withdrawal by Subject|9|||
170752792|NCT00550173|617101296|FG001|Overall Study|Withdrawal by Subject|12|||
170752793|NCT00550173|617101297|FG002|Overall Study|Withdrawal by Subject|17|||
170752794|NCT00550173|617101295|FG000|Overall Study|Sponsor Decision|13|||
170752795|NCT00550173|617101296|FG001|Overall Study|Sponsor Decision|7|||
170752796|NCT00550173|617101297|FG002|Overall Study|Sponsor Decision|1|||
170752797|NCT00550173|617101295|FG000|Overall Study|Lost to Follow-up|4|||
170752798|NCT00550173|617101296|FG001|Overall Study|Lost to Follow-up|4|||
170752799|NCT00550173|617101297|FG002|Overall Study|Lost to Follow-up|3|||
170752800|NCT02419755|617101301|FG000|Overall Study|Death|1|||
170752801|NCT02419755|617101302|FG001|Overall Study|Death|3|||
170752802|NCT02419755|617101301|FG000|Overall Study|Relapse|0|||
170752803|NCT02419755|617101302|FG001|Overall Study|Relapse|1|||
170752804|NCT02419755|617101301|FG000|Overall Study|Ineligible|1|||
170752805|NCT02419755|617101302|FG001|Overall Study|Ineligible|0|||
170752806|NCT02419755|617101301|FG000|Overall Study|Withdrawal by Subject|1|||
170752807|NCT02419755|617101302|FG001|Overall Study|Withdrawal by Subject|0|||
170752808|NCT00810641|617101305|FG000|Overall Study|Withdrawal by Subject|0|||
170752809|NCT00810641|617101306|FG001|Overall Study|Withdrawal by Subject|1|||
170752810|NCT00810641|617101307|FG002|Overall Study|Withdrawal by Subject|2|||
170752811|NCT01388543|617101308|FG000|Day 14|Adverse Event|1|||
170752812|NCT01388543|617101309|FG001|Day 14|Adverse Event|4|||
170752813|NCT01556243|617101310|FG000|Overall Study|Ineligible|34|||
170752814|NCT01556243|617101310|FG000|Overall Study|Converted to mastectomy|14|||
170752815|NCT01556243|617101310|FG000|Overall Study|Unable to achieve negative margins|2|||
170752816|NCT01556243|617101310|FG000|Overall Study|Withdrawal by Subject|16|||
170752817|NCT02325713|617101313|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752818|NCT02325713|617101314|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752819|NCT02325713|617101315|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752820|NCT02325713|617101316|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752821|NCT02325713|617101317|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752822|NCT02325713|617101318|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752823|NCT02325713|617101319|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752824|NCT02325713|617101320|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752825|NCT02325713|617101321|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752826|NCT02325713|617101322|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752827|NCT02325713|617101323|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
170752828|NCT02325713|617101324|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752829|NCT02325713|617101325|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752830|NCT02325713|617101326|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752831|NCT02325713|617101327|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752832|NCT02325713|617101328|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
170752833|NCT02325713|617101313|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
170752834|NCT02325713|617101314|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752835|NCT02325713|617101315|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752836|NCT02325713|617101316|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752837|NCT02325713|617101317|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752838|NCT02325713|617101318|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752839|NCT02325713|617101319|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752840|NCT02325713|617101320|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752841|NCT02325713|617101321|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752842|NCT02325713|617101322|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752843|NCT02325713|617101323|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752844|NCT02325713|617101324|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752845|NCT02325713|617101325|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752846|NCT02325713|617101326|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752847|NCT02325713|617101327|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170752848|NCT02325713|617101328|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
170402631|NCT01656967|615814977|FG000|Overall Study|unsuccessful ETT insertion|3|||
170752849|NCT02325713|617101313|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752850|NCT02325713|617101314|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752851|NCT02325713|617101315|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752852|NCT02325713|617101316|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752853|NCT02325713|617101317|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752854|NCT02325713|617101318|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752855|NCT02325713|617101319|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752856|NCT02325713|617101320|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752857|NCT02325713|617101321|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752858|NCT02325713|617101322|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
170752859|NCT02325713|617101323|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752860|NCT02325713|617101324|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752861|NCT02325713|617101325|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752862|NCT02325713|617101326|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752863|NCT02325713|617101327|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752864|NCT02325713|617101328|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
170752865|NCT04684914|617101329|FG000|Overall Study|Withdrawal by Subject|1|||
170752866|NCT04684914|617101330|FG001|Overall Study|Withdrawal by Subject|0|||
170752867|NCT04684914|617101329|FG000|Overall Study|Discontinued before receiving study treatment|1|||
170752868|NCT04684914|617101330|FG001|Overall Study|Discontinued before receiving study treatment|2|||
170752869|NCT01213173|617101332|FG000|Overall Study|Protocol Violation|2|||
170752870|NCT01213173|617101333|FG001|Overall Study|Protocol Violation|0|||
170752871|NCT01213173|617101332|FG000|Overall Study|Adverse Event|4|||
170752872|NCT01213173|617101333|FG001|Overall Study|Adverse Event|8|||
170752873|NCT01213173|617101332|FG000|Overall Study|Withdrawal by Subject|5|||
170752874|NCT01213173|617101333|FG001|Overall Study|Withdrawal by Subject|5|||
170752875|NCT01213173|617101332|FG000|Overall Study|Incorrect Enrollment|1|||
170752876|NCT01213173|617101333|FG001|Overall Study|Incorrect Enrollment|3|||
170752877|NCT02253316|617101334|FG000|Consolidation|Progression|4|||
170752878|NCT02253316|617101335|FG001|Consolidation|Progression|0|||
170752879|NCT02253316|617101336|FG002|Consolidation|Progression|0|||
170752880|NCT02253316|617101334|FG000|Consolidation|Non-Compliance|1|||
170752881|NCT02253316|617101335|FG001|Consolidation|Non-Compliance|0|||
170752882|NCT02253316|617101336|FG002|Consolidation|Non-Compliance|0|||
170752883|NCT02253316|617101334|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
170752884|NCT02253316|617101335|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
170752885|NCT02253316|617101336|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
170752886|NCT02253316|617101334|FG000|Consolidation|Secondary Malignancy|2|||
170752887|NCT02253316|617101335|FG001|Consolidation|Secondary Malignancy|0|||
170752888|NCT02253316|617101336|FG002|Consolidation|Secondary Malignancy|0|||
170752889|NCT02253316|617101334|FG000|Consolidation|Adverse Event|7|||
170752890|NCT02253316|617101335|FG001|Consolidation|Adverse Event|0|||
170752891|NCT02253316|617101336|FG002|Consolidation|Adverse Event|0|||
170752892|NCT02253316|617101334|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
170752893|NCT02253316|617101335|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
170752894|NCT02253316|617101336|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
170752895|NCT02253316|617101334|FG000|Maintenance|Physician Decision|0|||
170752896|NCT02253316|617101335|FG001|Maintenance|Physician Decision|7|||
170752897|NCT02253316|617101336|FG002|Maintenance|Physician Decision|16|||
170752898|NCT02253316|617101334|FG000|Maintenance|Non-Compliance|0|||
170752899|NCT02253316|617101335|FG001|Maintenance|Non-Compliance|1|||
170752900|NCT02253316|617101336|FG002|Maintenance|Non-Compliance|1|||
170752901|NCT02253316|617101334|FG000|Maintenance|Secondary Malignancy|0|||
170752902|NCT02253316|617101335|FG001|Maintenance|Secondary Malignancy|2|||
170752903|NCT02253316|617101336|FG002|Maintenance|Secondary Malignancy|6|||
170752904|NCT02253316|617101334|FG000|Maintenance|Adverse Event|0|||
170864921|NCT00908232|617517987|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
170864922|NCT00908232|617517988|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
170864923|NCT00908232|617517985|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
170864924|NCT00908232|617517986|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
170864925|NCT00908232|617517987|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
170864926|NCT00908232|617517988|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
170864927|NCT00908232|617517985|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
170864928|NCT00908232|617517986|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
170864929|NCT00908232|617517987|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
170864930|NCT00908232|617517988|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
170864931|NCT03153137|617517989|FG000|Overall Study|Lost to Follow-up|1|||
170864932|NCT03153137|617517990|FG001|Overall Study|Lost to Follow-up|0|||
170864933|NCT03153137|617517989|FG000|Overall Study|Withdrawal by Subject|2|||
170864934|NCT03153137|617517990|FG001|Overall Study|Withdrawal by Subject|1|||
170864935|NCT03153137|617517989|FG000|Overall Study|Physician Decision|0|||
170864936|NCT03153137|617517990|FG001|Overall Study|Physician Decision|3|||
170864937|NCT00195507|617517991|FG000|Overall Study|Adverse Event|24|||
170864938|NCT00195507|617517992|FG001|Overall Study|Adverse Event|13|||
170752905|NCT02253316|617101335|FG001|Maintenance|Adverse Event|8|||
170752906|NCT02253316|617101336|FG002|Maintenance|Adverse Event|12|||
170752907|NCT02253316|617101334|FG000|Maintenance|Still receiving active treatment|0|||
170752908|NCT02253316|617101335|FG001|Maintenance|Still receiving active treatment|4|||
170752909|NCT02253316|617101336|FG002|Maintenance|Still receiving active treatment|0|||
170864939|NCT00195507|617517991|FG000|Overall Study|Death|0|||
170864940|NCT00195507|617517992|FG001|Overall Study|Death|1|||
170864941|NCT00195507|617517991|FG000|Overall Study|Failed to Return|4|||
170752910|NCT02684903|617101339|FG000|Overall Study|COVID-19 shutdown of lab|4|||
170752911|NCT02684903|617101340|FG001|Overall Study|COVID-19 shutdown of lab|6|||
170752912|NCT02684903|617101339|FG000|Overall Study|Lost to Follow-up|31|||
170752913|NCT02684903|617101340|FG001|Overall Study|Lost to Follow-up|41|||
170752914|NCT00904150|617101341|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
170752915|NCT00904150|617101342|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
170752916|NCT00904150|617101341|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
170752917|NCT00904150|617101342|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
170752918|NCT03872388|617101346|FG000|Overall Study|Disease Progression|0|||
170752919|NCT03872388|617101347|FG001|Overall Study|Disease Progression|0|||
170752920|NCT03872388|617101348|FG002|Overall Study|Disease Progression|0|||
170752921|NCT03872388|617101349|FG003|Overall Study|Disease Progression|0|||
170752922|NCT03872388|617101350|FG004|Overall Study|Disease Progression|0|||
170752923|NCT03872388|617101351|FG005|Overall Study|Disease Progression|0|||
170752924|NCT03872388|617101352|FG006|Overall Study|Disease Progression|1|||
170752925|NCT03872388|617101353|FG007|Overall Study|Disease Progression|1|||
170752926|NCT07083843|617101357|FG000|Intervention period.|Withdrawal by Subject|1|||
170752927|NCT07083843|617101358|FG001|Intervention period.|Withdrawal by Subject|0|||
170752928|NCT07083843|617101357|FG000|Intervention period.|Death|0|||
170752929|NCT07083843|617101358|FG001|Intervention period.|Death|1|||
170752930|NCT02153788|617103429|FG000|Overall Study|Physician Decision|2|||
170752931|NCT02153788|617103430|FG001|Overall Study|Physician Decision|1|||
170752932|NCT01106287|617103431|FG000|Overall Study|Adverse Event|1|||
170752933|NCT01106287|617103432|FG001|Overall Study|Adverse Event|0|||
170752934|NCT01106287|617103433|FG002|Overall Study|Adverse Event|0|||
170752935|NCT01106287|617103434|FG003|Overall Study|Adverse Event|0|||
170752936|NCT01450943|617103435|FG000|Overall Study|Screen failure, loss to follow-up|2|||
170752937|NCT01450943|617103436|FG001|Overall Study|Screen failure, loss to follow-up|7|||
170752938|NCT01450943|617103437|FG002|Overall Study|Screen failure, loss to follow-up|6|||
170752939|NCT03303105|617103439|FG000|Overall Study|Adverse Event|0|||
170752940|NCT03303105|617103440|FG001|Overall Study|Adverse Event|2|||
170752941|NCT03303105|617103439|FG000|Overall Study|Lack of Efficacy|1|||
170752942|NCT03303105|617103440|FG001|Overall Study|Lack of Efficacy|0|||
170752943|NCT03303105|617103439|FG000|Overall Study|Protocol Violation|1|||
170752944|NCT03303105|617103440|FG001|Overall Study|Protocol Violation|0|||
170752945|NCT03303105|617103439|FG000|Overall Study|Withdrawal by Subject|0|||
170752946|NCT03303105|617103440|FG001|Overall Study|Withdrawal by Subject|2|||
170752947|NCT04822298|617103441|FG000|Overall Study|Death|3|||
170752948|NCT00465361|617103442|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
170752949|NCT00515086|617103451|FG000|Overall Study|Adverse Event|1|||
170752950|NCT00515086|617103452|FG001|Overall Study|Adverse Event|1|||
170752951|NCT00515086|617103453|FG002|Overall Study|Adverse Event|2|||
170752952|NCT00515086|617103454|FG003|Overall Study|Adverse Event|3|||
170752953|NCT00515086|617103451|FG000|Overall Study|Administrative|1|||
170752954|NCT00515086|617103452|FG001|Overall Study|Administrative|1|||
170752955|NCT00515086|617103453|FG002|Overall Study|Administrative|0|||
170752956|NCT00515086|617103454|FG003|Overall Study|Administrative|0|||
170752957|NCT00515086|617103451|FG000|Overall Study|Withdrawal by Subject|1|||
170752958|NCT00515086|617103452|FG001|Overall Study|Withdrawal by Subject|0|||
170752959|NCT00515086|617103453|FG002|Overall Study|Withdrawal by Subject|0|||
170752960|NCT00515086|617103454|FG003|Overall Study|Withdrawal by Subject|1|||
170752961|NCT00515086|617103451|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
170752962|NCT00515086|617103452|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170752963|NCT00515086|617103453|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
170752964|NCT00515086|617103454|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
170752965|NCT00515086|617103451|FG000|Overall Study|Lost to Follow-up|1|||
170752966|NCT00515086|617103452|FG001|Overall Study|Lost to Follow-up|0|||
170752967|NCT00515086|617103453|FG002|Overall Study|Lost to Follow-up|0|||
170864942|NCT00195507|617517992|FG001|Overall Study|Failed to Return|3|||
170864943|NCT00195507|617517991|FG000|Overall Study|Physician Decision|1|||
170402632|NCT01656967|615814978|FG001|Overall Study|unsuccessful ETT insertion|2|||
170752968|NCT00515086|617103454|FG003|Overall Study|Lost to Follow-up|0|||
170752969|NCT00515086|617103451|FG000|Overall Study|Study drug no longer required|0|||
170752970|NCT00515086|617103452|FG001|Overall Study|Study drug no longer required|1|||
170752971|NCT00515086|617103453|FG002|Overall Study|Study drug no longer required|0|||
170752972|NCT00515086|617103454|FG003|Overall Study|Study drug no longer required|0|||
170752973|NCT00515086|617103451|FG000|Overall Study|Death|2|||
170752974|NCT00515086|617103452|FG001|Overall Study|Death|0|||
170752975|NCT00515086|617103453|FG002|Overall Study|Death|0|||
170752976|NCT00515086|617103454|FG003|Overall Study|Death|0|||
170752977|NCT02373813|617103455|FG000|Run-In Period|Other, Not Specified|5|||
170752978|NCT02373813|617103456|FG001|Run-In Period|Other, Not Specified|0|||
170752979|NCT02373813|617103457|FG002|Run-In Period|Other, Not Specified|0|||
170752980|NCT02373813|617103458|FG003|Run-In Period|Other, Not Specified|0|||
170752981|NCT02373813|617103455|FG000|Run-In Period|Withdrawal by Subject|16|||
170752982|NCT02373813|617103456|FG001|Run-In Period|Withdrawal by Subject|0|||
170752983|NCT02373813|617103457|FG002|Run-In Period|Withdrawal by Subject|0|||
170752984|NCT02373813|617103458|FG003|Run-In Period|Withdrawal by Subject|0|||
170752985|NCT02373813|617103455|FG000|Run-In Period|Decision by Sponsor|11|||
170752986|NCT02373813|617103456|FG001|Run-In Period|Decision by Sponsor|0|||
170752987|NCT02373813|617103457|FG002|Run-In Period|Decision by Sponsor|0|||
170752988|NCT02373813|617103458|FG003|Run-In Period|Decision by Sponsor|0|||
170752989|NCT02373813|617103455|FG000|Run-In Period|Protocol Violation|75|||
170752990|NCT02373813|617103456|FG001|Run-In Period|Protocol Violation|0|||
170752991|NCT02373813|617103457|FG002|Run-In Period|Protocol Violation|0|||
170752992|NCT02373813|617103458|FG003|Run-In Period|Protocol Violation|0|||
170752993|NCT02373813|617103455|FG000|Run-In Period|Lost to Follow-up|2|||
170752994|NCT02373813|617103456|FG001|Run-In Period|Lost to Follow-up|0|||
170752995|NCT02373813|617103457|FG002|Run-In Period|Lost to Follow-up|0|||
170752996|NCT02373813|617103458|FG003|Run-In Period|Lost to Follow-up|0|||
170752997|NCT02373813|617103455|FG000|Run-In Period|Adverse Event|3|||
170752998|NCT02373813|617103456|FG001|Run-In Period|Adverse Event|0|||
170752999|NCT02373813|617103457|FG002|Run-In Period|Adverse Event|0|||
170753000|NCT02373813|617103458|FG003|Run-In Period|Adverse Event|0|||
170753001|NCT02373813|617103455|FG000|Run-In Period|Noncompliance|1|||
170753002|NCT02373813|617103456|FG001|Run-In Period|Noncompliance|0|||
170753003|NCT02373813|617103457|FG002|Run-In Period|Noncompliance|0|||
170753004|NCT02373813|617103458|FG003|Run-In Period|Noncompliance|0|||
170753005|NCT02373813|617103455|FG000|Run-In Period|Ineligibility Determined|3|||
170753006|NCT02373813|617103456|FG001|Run-In Period|Ineligibility Determined|0|||
170753007|NCT02373813|617103457|FG002|Run-In Period|Ineligibility Determined|0|||
170753008|NCT02373813|617103458|FG003|Run-In Period|Ineligibility Determined|0|||
170753009|NCT02373813|617103455|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
170753010|NCT02373813|617103456|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
170753011|NCT02373813|617103457|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
170753012|NCT02373813|617103458|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
170753013|NCT02373813|617103455|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
170753014|NCT02373813|617103456|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
170753015|NCT02373813|617103457|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
170753016|NCT02373813|617103458|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
170753017|NCT02373813|617103455|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170753018|NCT02373813|617103456|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
170753019|NCT02373813|617103457|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
170753020|NCT02373813|617103458|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
170753021|NCT02373813|617103455|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170753022|NCT02373813|617103456|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
170753023|NCT02373813|617103457|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
170753024|NCT02373813|617103458|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
170753025|NCT00354029|617103459|FG000|Overall Study|Protocol Violation|4|||
170753026|NCT00354029|617103460|FG001|Overall Study|Protocol Violation|2|||
170402633|NCT01345058|615814979|FG000|Overall Study|Withdrawal by Subject|1|||
170402634|NCT01345058|615814980|FG001|Overall Study|Withdrawal by Subject|0|||
170402635|NCT01345058|615814979|FG000|Overall Study|Participant Reported Increase in Events|1|||
170402636|NCT01345058|615814980|FG001|Overall Study|Participant Reported Increase in Events|0|||
170402637|NCT01345058|615814979|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
170402638|NCT01345058|615814980|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
170402639|NCT01345058|615814979|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
170402640|NCT01345058|615814980|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
170402641|NCT01345058|615814979|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
170402642|NCT01345058|615814980|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
170402643|NCT00000135|615814981|FG000|Overall Study|Death|27|||
170402644|NCT00000135|615814982|FG001|Overall Study|Death|14|||
170402645|NCT00567996|615814983|FG000|Overall Study|Adverse Event|18|||
170402646|NCT00567996|615814984|FG001|Overall Study|Adverse Event|16|||
170402647|NCT00567996|615814985|FG002|Overall Study|Adverse Event|13|||
170402648|NCT00567996|615814983|FG000|Overall Study|Protocol Deviation|9|||
170402649|NCT00567996|615814984|FG001|Overall Study|Protocol Deviation|11|||
170402650|NCT00567996|615814985|FG002|Overall Study|Protocol Deviation|13|||
170402651|NCT00567996|615814983|FG000|Overall Study|Withdrawal by Subject|8|||
170402652|NCT00567996|615814984|FG001|Overall Study|Withdrawal by Subject|12|||
170402653|NCT00567996|615814985|FG002|Overall Study|Withdrawal by Subject|22|||
170753027|NCT03487666|617103464|FG000|Overall Study|Disease progression|4|||
170753028|NCT03487666|617103465|FG001|Overall Study|Disease progression|2|||
170753029|NCT03487666|617103466|FG002|Overall Study|Disease progression|0|||
170753030|NCT03487666|617103464|FG000|Overall Study|Adverse Event|0|||
170402654|NCT00567996|615814983|FG000|Overall Study|Abnormal Lab value(s)|2|||
170753031|NCT03487666|617103465|FG001|Overall Study|Adverse Event|0|||
170753032|NCT03487666|617103466|FG002|Overall Study|Adverse Event|1|||
170402655|NCT00567996|615814984|FG001|Overall Study|Abnormal Lab value(s)|1|||
170402656|NCT00567996|615814985|FG002|Overall Study|Abnormal Lab value(s)|2|||
170753033|NCT00765362|617103467|FG000|Overall Study|Death|9|||
170753034|NCT00765362|617103467|FG000|Overall Study|Adverse Event|2|||
170753035|NCT00765362|617103467|FG000|Overall Study|Protocol Violation|18|||
170753036|NCT00765362|617103467|FG000|Overall Study|Withdrawal by Subject|13|||
170753037|NCT00765362|617103467|FG000|Overall Study|Lost to Follow-up|95|||
170753038|NCT03930186|617103468|FG000|Weeks 0 to 16|Adverse Event|6|||
170753039|NCT03930186|617103468|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
170753040|NCT03930186|617103468|FG000|Weeks 16 to 32|Adverse Event|1|||
170753041|NCT03930186|617103468|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
170753042|NCT00557505|617103471|FG000|Overall Study|Death|0|||
170753043|NCT00557505|617103472|FG001|Overall Study|Death|0|||
170753044|NCT00557505|617103473|FG002|Overall Study|Death|0|||
170753045|NCT00557505|617103474|FG003|Overall Study|Death|0|||
170753046|NCT00557505|617103475|FG004|Overall Study|Death|0|||
170753047|NCT00557505|617103476|FG005|Overall Study|Death|0|||
170753048|NCT00557505|617103477|FG006|Overall Study|Death|0|||
170753049|NCT00557505|617103478|FG007|Overall Study|Death|0|||
170753050|NCT00557505|617103479|FG008|Overall Study|Death|1|||
170753051|NCT00557505|617103471|FG000|Overall Study|Adverse Event|0|||
170753052|NCT00557505|617103472|FG001|Overall Study|Adverse Event|0|||
170753053|NCT00557505|617103473|FG002|Overall Study|Adverse Event|1|||
170753054|NCT00557505|617103474|FG003|Overall Study|Adverse Event|0|||
170753055|NCT00557505|617103475|FG004|Overall Study|Adverse Event|0|||
170753056|NCT00557505|617103476|FG005|Overall Study|Adverse Event|0|||
170753057|NCT00557505|617103477|FG006|Overall Study|Adverse Event|1|||
170753058|NCT00557505|617103478|FG007|Overall Study|Adverse Event|0|||
170753059|NCT00557505|617103479|FG008|Overall Study|Adverse Event|0|||
170753060|NCT00557505|617103471|FG000|Overall Study|Global deterioration of health|1|||
170753061|NCT00557505|617103472|FG001|Overall Study|Global deterioration of health|0|||
170753062|NCT00557505|617103473|FG002|Overall Study|Global deterioration of health|0|||
170753063|NCT00557505|617103474|FG003|Overall Study|Global deterioration of health|0|||
170753064|NCT00557505|617103475|FG004|Overall Study|Global deterioration of health|0|||
170753065|NCT00557505|617103476|FG005|Overall Study|Global deterioration of health|0|||
170753066|NCT00557505|617103477|FG006|Overall Study|Global deterioration of health|0|||
170753067|NCT00557505|617103478|FG007|Overall Study|Global deterioration of health|0|||
170753068|NCT00557505|617103479|FG008|Overall Study|Global deterioration of health|0|||
170753069|NCT00557505|617103471|FG000|Overall Study|Objective progression or relapse|2|||
170753070|NCT00557505|617103472|FG001|Overall Study|Objective progression or relapse|3|||
170753071|NCT00557505|617103473|FG002|Overall Study|Objective progression or relapse|3|||
170753072|NCT00557505|617103474|FG003|Overall Study|Objective progression or relapse|2|||
170753073|NCT00557505|617103475|FG004|Overall Study|Objective progression or relapse|2|||
170753074|NCT00557505|617103476|FG005|Overall Study|Objective progression or relapse|3|||
170753075|NCT00557505|617103477|FG006|Overall Study|Objective progression or relapse|2|||
170753076|NCT00557505|617103478|FG007|Overall Study|Objective progression or relapse|5|||
170753077|NCT00557505|617103479|FG008|Overall Study|Objective progression or relapse|15|||
170753078|NCT00557505|617103471|FG000|Overall Study|Withdrawal by Subject|0|||
170753079|NCT00557505|617103472|FG001|Overall Study|Withdrawal by Subject|0|||
170753080|NCT00557505|617103473|FG002|Overall Study|Withdrawal by Subject|0|||
170753081|NCT00557505|617103474|FG003|Overall Study|Withdrawal by Subject|1|||
170753082|NCT00557505|617103475|FG004|Overall Study|Withdrawal by Subject|0|||
170753083|NCT00557505|617103476|FG005|Overall Study|Withdrawal by Subject|0|||
170753084|NCT00557505|617103477|FG006|Overall Study|Withdrawal by Subject|0|||
170753085|NCT00557505|617103478|FG007|Overall Study|Withdrawal by Subject|0|||
170753086|NCT00557505|617103479|FG008|Overall Study|Withdrawal by Subject|1|||
170753087|NCT03019458|617103480|FG000|Overall Study|Death|0|||
170753088|NCT03019458|617103481|FG001|Overall Study|Death|1|||
170753089|NCT00031447|617103482|FG000|Overall Study|Lost to Follow-up|0|||
170753090|NCT00031447|617103483|FG001|Overall Study|Lost to Follow-up|1|||
170753091|NCT00031447|617103482|FG000|Overall Study|Non-compliant|1|||
170753092|NCT00031447|617103483|FG001|Overall Study|Non-compliant|1|||
170753093|NCT00031447|617103482|FG000|Overall Study|Re-activation of Disease|2|||
170753094|NCT00031447|617103483|FG001|Overall Study|Re-activation of Disease|1|||
170753095|NCT00031447|617103482|FG000|Overall Study|Disruption of blinded study drug supply|7|||
170753096|NCT00031447|617103483|FG001|Overall Study|Disruption of blinded study drug supply|4|||
170753097|NCT01561079|617103484|FG000|Overall Study|Physician Decision|17|||
170753098|NCT01561079|617103484|FG000|Overall Study|Withdrawal by Subject|59|||
170753099|NCT01561079|617103484|FG000|Overall Study|Protocol Violation|2|||
170753100|NCT01323660|617103492|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
170753101|NCT01323660|617103493|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
170753102|NCT01323660|617103494|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
170753103|NCT01323660|617103495|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
170753104|NCT01323660|617103496|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
170753105|NCT01323660|617103497|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
170753106|NCT01323660|617103492|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
170753107|NCT01323660|617103493|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
170753108|NCT01323660|617103494|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
170753109|NCT01323660|617103495|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
170753110|NCT01323660|617103496|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
170864944|NCT00195507|617517992|FG001|Overall Study|Physician Decision|2|||
170753111|NCT01323660|617103497|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
170753112|NCT01323660|617103492|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
170753113|NCT01323660|617103493|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
170753114|NCT01323660|617103494|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
170753115|NCT01323660|617103495|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
170753116|NCT01323660|617103496|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
170753117|NCT01323660|617103497|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
170753118|NCT01323660|617103492|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
170753119|NCT01323660|617103493|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
170753120|NCT01323660|617103494|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
170753121|NCT01323660|617103495|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
170753122|NCT01323660|617103496|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
170753123|NCT01323660|617103497|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
170753124|NCT01323660|617103492|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170753125|NCT01323660|617103493|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170753126|NCT01323660|617103494|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170753127|NCT01323660|617103495|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170753128|NCT01323660|617103496|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
170753129|NCT01323660|617103497|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170753130|NCT01323660|617103492|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
170753131|NCT01323660|617103493|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170753132|NCT01323660|617103494|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
170753133|NCT01323660|617103495|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
170753134|NCT01323660|617103496|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
170753135|NCT01323660|617103497|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170753136|NCT01323660|617103492|FG000|Washout Period (14 Days)|Adverse Event|0|||
170753137|NCT01323660|617103493|FG001|Washout Period (14 Days)|Adverse Event|0|||
170753138|NCT01323660|617103494|FG002|Washout Period (14 Days)|Adverse Event|0|||
170753139|NCT01323660|617103495|FG003|Washout Period (14 Days)|Adverse Event|0|||
170753140|NCT01323660|617103496|FG004|Washout Period (14 Days)|Adverse Event|1|||
170753141|NCT01323660|617103497|FG005|Washout Period (14 Days)|Adverse Event|0|||
170753142|NCT01323660|617103492|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
170753143|NCT01323660|617103493|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
170753144|NCT01323660|617103494|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
170753145|NCT01323660|617103495|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
170753146|NCT01323660|617103496|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
170753147|NCT01323660|617103497|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
170753148|NCT01323660|617103492|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
170753149|NCT01323660|617103493|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
170753150|NCT01323660|617103494|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
170753151|NCT01323660|617103495|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
170753152|NCT01323660|617103496|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
170753153|NCT01323660|617103497|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
170753154|NCT01323660|617103492|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
170753155|NCT01323660|617103493|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
170753156|NCT01323660|617103494|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
170753157|NCT01323660|617103495|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
170753158|NCT01323660|617103496|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
170753159|NCT01323660|617103497|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
170753160|NCT01323660|617103492|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
170753161|NCT01323660|617103493|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
170753162|NCT01323660|617103494|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
170753163|NCT01323660|617103495|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
170753164|NCT01323660|617103496|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
170753165|NCT01323660|617103497|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
170753166|NCT01323660|617103492|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
170753167|NCT01323660|617103493|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
170753168|NCT01323660|617103494|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
170753169|NCT01323660|617103495|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
170753170|NCT01323660|617103496|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
170753171|NCT01323660|617103497|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
170753172|NCT01323660|617103492|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170753173|NCT01323660|617103493|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170753174|NCT01323660|617103494|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170753175|NCT01323660|617103495|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170753176|NCT01323660|617103496|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
170864945|NCT00195507|617517991|FG000|Overall Study|Lost to Follow-up|3|||
170864946|NCT00195507|617517992|FG001|Overall Study|Lost to Follow-up|2|||
170864947|NCT00195507|617517991|FG000|Overall Study|Protocol Violation|5|||
170402657|NCT00567996|615814983|FG000|Overall Study|Abnormal test procedure result(s)|2|||
170402658|NCT00567996|615814984|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170402659|NCT00567996|615814985|FG002|Overall Study|Abnormal test procedure result(s)|1|||
170402660|NCT00567996|615814983|FG000|Overall Study|Lost to Follow-up|2|||
170402661|NCT00567996|615814984|FG001|Overall Study|Lost to Follow-up|5|||
170402662|NCT00567996|615814985|FG002|Overall Study|Lost to Follow-up|2|||
170402663|NCT00567996|615814983|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170402664|NCT00567996|615814984|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170402665|NCT00567996|615814985|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
170519634|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
170519635|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519636|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
170519637|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519638|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170519639|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519640|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519641|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519642|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519643|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519644|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519645|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519646|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519647|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519648|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519649|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519650|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
170519651|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519652|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519653|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170519654|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519655|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519656|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519657|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519658|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519659|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519660|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519661|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519662|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519663|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519664|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
170519665|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519666|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
170519667|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170519668|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
170519669|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519670|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519671|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519672|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519673|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519674|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519675|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519676|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519677|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519678|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519679|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519680|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
170519681|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519682|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170519683|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
170519684|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170519685|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170519686|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170519687|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170402666|NCT00567996|615814983|FG000|Overall Study|Administrative problems|1|||
170753177|NCT01323660|617103497|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170753178|NCT00180674|617103499|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
170753179|NCT00180674|617103499|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
170753180|NCT04227340|617103504|FG000|Overall Study|Withdrawal by Subject|3|||
170753181|NCT01066156|617103507|FG000|Overall Study|ineligible|2|||
170753182|NCT01066156|617103507|FG000|Overall Study|Lost to Follow-up|7|||
170753183|NCT01066156|617103507|FG000|Overall Study|Withdrawal by Subject|1|||
170753184|NCT01734382|617103508|FG000|Part 1|Adverse Event|2|||
170753185|NCT01734382|617103509|FG001|Part 1|Adverse Event|0|||
170753186|NCT01734382|617103510|FG002|Part 1|Adverse Event|0|||
170753187|NCT01734382|617103508|FG000|Part 2|Adverse Event|0|||
170753188|NCT01734382|617103509|FG001|Part 2|Adverse Event|0|||
170753189|NCT01734382|617103510|FG002|Part 2|Adverse Event|1|||
170753190|NCT01734382|617103508|FG000|Part 2|Lack of Efficacy|0|||
170753191|NCT01734382|617103509|FG001|Part 2|Lack of Efficacy|1|||
170753192|NCT01734382|617103510|FG002|Part 2|Lack of Efficacy|1|||
170753193|NCT01734382|617103508|FG000|Part 2|Other|0|||
170753194|NCT01734382|617103509|FG001|Part 2|Other|0|||
170753195|NCT01734382|617103510|FG002|Part 2|Other|1|||
170753196|NCT01734382|617103508|FG000|Part 2|Physician Decision|0|||
170753197|NCT01734382|617103509|FG001|Part 2|Physician Decision|0|||
170753198|NCT01734382|617103510|FG002|Part 2|Physician Decision|3|||
170753199|NCT01734382|617103508|FG000|Part 2|Protocol Violation|0|||
170753200|NCT01734382|617103509|FG001|Part 2|Protocol Violation|1|||
170753201|NCT01734382|617103510|FG002|Part 2|Protocol Violation|0|||
170753202|NCT01734382|617103508|FG000|Part 2|Withdrawal by Subject|0|||
170753203|NCT01734382|617103509|FG001|Part 2|Withdrawal by Subject|0|||
170753204|NCT01734382|617103510|FG002|Part 2|Withdrawal by Subject|1|||
170753205|NCT04537949|617103511|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
170753206|NCT04537949|617103512|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
170753207|NCT04537949|617103513|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
170753208|NCT04537949|617103514|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
170753209|NCT04537949|617103515|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
170753210|NCT04537949|617103516|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
170753211|NCT04537949|617103517|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
170753212|NCT04537949|617103518|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
170753213|NCT04537949|617103511|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
170753214|NCT04537949|617103512|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
170753215|NCT04537949|617103513|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
170753216|NCT04537949|617103514|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
170753217|NCT04537949|617103515|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
170753218|NCT04537949|617103516|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
170753219|NCT04537949|617103517|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
170753220|NCT04537949|617103518|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
170753221|NCT04537949|617103511|FG000|Follow-up Phase|Lost to Follow-up|0|||
170753222|NCT04537949|617103512|FG001|Follow-up Phase|Lost to Follow-up|3|||
170753223|NCT04537949|617103513|FG002|Follow-up Phase|Lost to Follow-up|0|||
170753224|NCT04537949|617103514|FG003|Follow-up Phase|Lost to Follow-up|0|||
170753225|NCT04537949|617103515|FG004|Follow-up Phase|Lost to Follow-up|0|||
170753226|NCT04537949|617103516|FG005|Follow-up Phase|Lost to Follow-up|0|||
170753227|NCT04537949|617103517|FG006|Follow-up Phase|Lost to Follow-up|0|||
170753228|NCT04537949|617103518|FG007|Follow-up Phase|Lost to Follow-up|0|||
170753229|NCT04537949|617103511|FG000|Follow-up Phase|personal reasons|0|||
170753230|NCT04537949|617103512|FG001|Follow-up Phase|personal reasons|0|||
170753231|NCT04537949|617103513|FG002|Follow-up Phase|personal reasons|0|||
170753232|NCT04537949|617103514|FG003|Follow-up Phase|personal reasons|1|||
170753233|NCT04537949|617103515|FG004|Follow-up Phase|personal reasons|1|||
170753234|NCT04537949|617103516|FG005|Follow-up Phase|personal reasons|0|||
170753235|NCT04537949|617103517|FG006|Follow-up Phase|personal reasons|0|||
170753236|NCT04537949|617103518|FG007|Follow-up Phase|personal reasons|0|||
170753237|NCT04537949|617103511|FG000|Follow-up Phase|Withdrawal by Subject|0|||
170753238|NCT04537949|617103512|FG001|Follow-up Phase|Withdrawal by Subject|0|||
170753239|NCT04537949|617103513|FG002|Follow-up Phase|Withdrawal by Subject|0|||
170753240|NCT04537949|617103514|FG003|Follow-up Phase|Withdrawal by Subject|0|||
170864948|NCT00195507|617517992|FG001|Overall Study|Protocol Violation|4|||
170753241|NCT04537949|617103515|FG004|Follow-up Phase|Withdrawal by Subject|1|||
170753242|NCT04537949|617103516|FG005|Follow-up Phase|Withdrawal by Subject|0|||
170753243|NCT04537949|617103517|FG006|Follow-up Phase|Withdrawal by Subject|0|||
170753244|NCT04537949|617103518|FG007|Follow-up Phase|Withdrawal by Subject|0|||
170753245|NCT04003974|617103519|FG000|Overall Study|Missing|1|||
170753246|NCT04003974|617103520|FG001|Overall Study|Missing|0|||
170753247|NCT04003974|617103519|FG000|Overall Study|Withdrawal by Subject|0|||
170753248|NCT04003974|617103520|FG001|Overall Study|Withdrawal by Subject|2|||
170753249|NCT02059161|617103524|FG000|Overall Study|Pregnancy|0|||
170753250|NCT02059161|617103525|FG001|Overall Study|Pregnancy|2|||
170753251|NCT02059161|617103524|FG000|Overall Study|Adverse Event|2|||
170753252|NCT02059161|617103525|FG001|Overall Study|Adverse Event|6|||
170753253|NCT02059161|617103524|FG000|Overall Study|Lost to Follow-up|20|||
170753254|NCT02059161|617103525|FG001|Overall Study|Lost to Follow-up|12|||
170753255|NCT02059161|617103524|FG000|Overall Study|Physician Decision|4|||
170753256|NCT02059161|617103525|FG001|Overall Study|Physician Decision|4|||
170753257|NCT02059161|617103524|FG000|Overall Study|Protocol Violation|1|||
170753258|NCT02059161|617103525|FG001|Overall Study|Protocol Violation|1|||
170753259|NCT02059161|617103524|FG000|Overall Study|Withdrawal by Subject|16|||
170753260|NCT02059161|617103525|FG001|Overall Study|Withdrawal by Subject|13|||
170753261|NCT02059161|617103524|FG000|Overall Study|Randomized in error, no study drug|0|||
170753262|NCT02059161|617103525|FG001|Overall Study|Randomized in error, no study drug|1|||
170753263|NCT02059161|617103524|FG000|Overall Study|Non-compliance with study drug|6|||
170753264|NCT02059161|617103525|FG001|Overall Study|Non-compliance with study drug|2|||
170753265|NCT02013687|617103526|FG000|Overall Study|Lost to Follow-up|0|||
170753266|NCT02013687|617103527|FG001|Overall Study|Lost to Follow-up|0|||
170753267|NCT02013687|617103528|FG002|Overall Study|Lost to Follow-up|1|||
170753268|NCT02013687|617103529|FG003|Overall Study|Lost to Follow-up|0|||
170753269|NCT02013687|617103526|FG000|Overall Study|Protocol Violation|0|||
170753270|NCT02013687|617103527|FG001|Overall Study|Protocol Violation|0|||
170753271|NCT02013687|617103528|FG002|Overall Study|Protocol Violation|0|||
170753272|NCT02013687|617103529|FG003|Overall Study|Protocol Violation|1|||
170753273|NCT02013687|617103526|FG000|Overall Study|Withdrawal by Subject|0|||
170753274|NCT02013687|617103527|FG001|Overall Study|Withdrawal by Subject|0|||
170753275|NCT02013687|617103528|FG002|Overall Study|Withdrawal by Subject|0|||
170753276|NCT02013687|617103529|FG003|Overall Study|Withdrawal by Subject|1|||
170753277|NCT02013687|617103526|FG000|Overall Study|Missed visits due to patient travel|0|||
170753278|NCT02013687|617103527|FG001|Overall Study|Missed visits due to patient travel|0|||
170753279|NCT02013687|617103528|FG002|Overall Study|Missed visits due to patient travel|1|||
170753280|NCT02013687|617103529|FG003|Overall Study|Missed visits due to patient travel|0|||
170753281|NCT01657032|617103532|FG000|Overall Study|Lost to Follow-up|0|||
170753282|NCT01657032|617103533|FG001|Overall Study|Lost to Follow-up|7|||
170753283|NCT01782326|617103534|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
170753284|NCT01782326|617103535|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
170753285|NCT01782326|617103534|FG000|Planned Treatment Epoch|Death|29|||
170753286|NCT01782326|617103535|FG001|Planned Treatment Epoch|Death|30|||
170753287|NCT01782326|617103534|FG000|Planned Treatment Epoch|Physician Decision|18|||
170753288|NCT01782326|617103535|FG001|Planned Treatment Epoch|Physician Decision|16|||
170753289|NCT01782326|617103534|FG000|Planned Treatment Epoch|Protocol deviation|2|||
170753290|NCT01782326|617103535|FG001|Planned Treatment Epoch|Protocol deviation|3|||
170753291|NCT01782326|617103534|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
170753292|NCT01782326|617103535|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
170753293|NCT01782326|617103534|FG000|Planned Treatment Epoch|Technical problems|0|||
170753294|NCT01782326|617103535|FG001|Planned Treatment Epoch|Technical problems|4|||
170753295|NCT01782326|617103534|FG000|Double-blind Treatment|Adverse Event|129|||
170753296|NCT01782326|617103535|FG001|Double-blind Treatment|Adverse Event|145|||
170753297|NCT01782326|617103534|FG000|Double-blind Treatment|Subject/guardian decision|111|||
170753298|NCT01782326|617103535|FG001|Double-blind Treatment|Subject/guardian decision|125|||
170753299|NCT01782326|617103534|FG000|Double-blind Treatment|Lack of Efficacy|17|||
170753300|NCT01782326|617103535|FG001|Double-blind Treatment|Lack of Efficacy|22|||
170753301|NCT01782326|617103534|FG000|Double-blind Treatment|Physician Decision|13|||
170753302|NCT01782326|617103535|FG001|Double-blind Treatment|Physician Decision|16|||
170753303|NCT01782326|617103534|FG000|Double-blind Treatment|Protocol deviation|8|||
170753304|NCT01782326|617103535|FG001|Double-blind Treatment|Protocol deviation|7|||
170753305|NCT01782326|617103534|FG000|Double-blind Treatment|Technical problems|0|||
170753306|NCT01782326|617103535|FG001|Double-blind Treatment|Technical problems|5|||
170753307|NCT05968482|617103536|FG000|First Crossover Period|Withdrawal by Subject|0|||
170753308|NCT05968482|617103537|FG001|First Crossover Period|Withdrawal by Subject|0|||
170753309|NCT05968482|617103538|FG002|First Crossover Period|Withdrawal by Subject|1|||
170753310|NCT05968482|617103539|FG003|First Crossover Period|Withdrawal by Subject|0|||
170753311|NCT05968482|617103540|FG004|First Crossover Period|Withdrawal by Subject|0|||
170753312|NCT05968482|617103541|FG005|First Crossover Period|Withdrawal by Subject|0|||
170753313|NCT05968482|617103536|FG000|First Crossover Period|Adverse Event|0|||
170753314|NCT05968482|617103537|FG001|First Crossover Period|Adverse Event|0|||
170753315|NCT05968482|617103538|FG002|First Crossover Period|Adverse Event|0|||
170753316|NCT05968482|617103539|FG003|First Crossover Period|Adverse Event|0|||
170753317|NCT05968482|617103540|FG004|First Crossover Period|Adverse Event|0|||
170753318|NCT05968482|617103541|FG005|First Crossover Period|Adverse Event|1|||
170753319|NCT05968482|617103536|FG000|Second Crossover Period|Withdrawal by Subject|0|||
170753320|NCT05968482|617103537|FG001|Second Crossover Period|Withdrawal by Subject|0|||
170753321|NCT05968482|617103538|FG002|Second Crossover Period|Withdrawal by Subject|0|||
170753322|NCT05968482|617103539|FG003|Second Crossover Period|Withdrawal by Subject|0|||
170753323|NCT05968482|617103540|FG004|Second Crossover Period|Withdrawal by Subject|1|||
170753324|NCT05968482|617103541|FG005|Second Crossover Period|Withdrawal by Subject|0|||
170753325|NCT05968482|617103536|FG000|Third Crossover Period|Adverse Event|0|||
170753326|NCT05968482|617103537|FG001|Third Crossover Period|Adverse Event|0|||
170753327|NCT05968482|617103538|FG002|Third Crossover Period|Adverse Event|0|||
170753328|NCT05968482|617103539|FG003|Third Crossover Period|Adverse Event|0|||
170753329|NCT05968482|617103540|FG004|Third Crossover Period|Adverse Event|1|||
170753330|NCT05968482|617103541|FG005|Third Crossover Period|Adverse Event|0|||
170753331|NCT05968482|617103536|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
170753332|NCT05968482|617103537|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
170753333|NCT05968482|617103538|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
170753334|NCT05968482|617103539|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
170753335|NCT05968482|617103540|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
170753336|NCT05968482|617103541|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
170753337|NCT02559817|617103542|FG000|Treatment Period|Adverse Event|1|||
170753338|NCT02559817|617103543|FG001|Treatment Period|Adverse Event|0|||
170753339|NCT02559817|617103544|FG002|Treatment Period|Adverse Event|1|||
170753340|NCT02559817|617103545|FG003|Treatment Period|Adverse Event|0|||
170753341|NCT02559817|617103546|FG004|Treatment Period|Adverse Event|0|||
170753342|NCT02559817|617103542|FG000|Treatment Period|Lack of Efficacy|0|||
170753343|NCT02559817|617103543|FG001|Treatment Period|Lack of Efficacy|1|||
170753344|NCT02559817|617103544|FG002|Treatment Period|Lack of Efficacy|0|||
170753345|NCT02559817|617103545|FG003|Treatment Period|Lack of Efficacy|0|||
170753346|NCT02559817|617103546|FG004|Treatment Period|Lack of Efficacy|0|||
170753347|NCT02559817|617103542|FG000|Treatment Period|Lost to Follow-up|0|||
170753348|NCT02559817|617103543|FG001|Treatment Period|Lost to Follow-up|1|||
170753349|NCT02559817|617103544|FG002|Treatment Period|Lost to Follow-up|0|||
170753350|NCT02559817|617103545|FG003|Treatment Period|Lost to Follow-up|1|||
170753351|NCT02559817|617103546|FG004|Treatment Period|Lost to Follow-up|0|||
170753352|NCT02559817|617103542|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
170753353|NCT02559817|617103543|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
170753354|NCT02559817|617103544|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
170753355|NCT02559817|617103545|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
170753356|NCT02559817|617103546|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
170753357|NCT02559817|617103542|FG000|Treatment Period|Protocol Violation|0|||
170753358|NCT02559817|617103543|FG001|Treatment Period|Protocol Violation|0|||
170753359|NCT02559817|617103544|FG002|Treatment Period|Protocol Violation|0|||
170753360|NCT02559817|617103545|FG003|Treatment Period|Protocol Violation|1|||
170753361|NCT02559817|617103546|FG004|Treatment Period|Protocol Violation|0|||
170753362|NCT03389893|617103547|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
170753363|NCT03389893|617103548|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
170753364|NCT03389893|617103549|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
170753365|NCT03389893|617103550|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
170753366|NCT03389893|617103547|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
170402667|NCT00567996|615814984|FG001|Overall Study|Administrative problems|1|||
170402668|NCT00567996|615814985|FG002|Overall Study|Administrative problems|0|||
170402669|NCT00567996|615814983|FG000|Overall Study|Death|1|||
170402670|NCT00567996|615814984|FG001|Overall Study|Death|0|||
170402671|NCT00567996|615814985|FG002|Overall Study|Death|2|||
170402672|NCT00567996|615814983|FG000|Overall Study|Patient's inability to use the device|0|||
170402673|NCT00567996|615814984|FG001|Overall Study|Patient's inability to use the device|1|||
170402674|NCT00567996|615814985|FG002|Overall Study|Patient's inability to use the device|0|||
170402675|NCT03022799|615814986|FG000|Overall Study|Adverse Event|0|||
170402676|NCT03022799|615814987|FG001|Overall Study|Adverse Event|0|||
170402677|NCT03022799|615814988|FG002|Overall Study|Adverse Event|0|||
170402678|NCT03022799|615814989|FG003|Overall Study|Adverse Event|0|||
170753367|NCT03389893|617103548|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
170753368|NCT03389893|617103549|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
170753369|NCT03389893|617103550|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
170753370|NCT03389893|617103547|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
170753371|NCT03389893|617103548|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
170753372|NCT03389893|617103549|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
170753373|NCT03389893|617103550|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
170753374|NCT03389893|617103547|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
170753375|NCT03389893|617103548|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
170753376|NCT03389893|617103549|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
170753377|NCT03389893|617103550|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
170753378|NCT01719861|617103552|FG000|Cycle 1|Death|4|||
170753379|NCT01719861|617103552|FG000|Cycle 2|Death|1|||
170753380|NCT00958009|617103553|FG000|Overall Study|Adverse Event|1|||
170753381|NCT00958009|617103553|FG000|Overall Study|Subject found device difficult to use|1|||
170753382|NCT01925170|617103565|FG000|Overall Study|Unverified cancer status|53|||
170753383|NCT01077024|617103568|FG000|Overall Study|Lost to Follow-up|20|||
170753384|NCT01077024|617103569|FG001|Overall Study|Lost to Follow-up|14|||
170753385|NCT01077024|617103568|FG000|Overall Study|Withdrawal by Subject|0|||
170753386|NCT01077024|617103569|FG001|Overall Study|Withdrawal by Subject|2|||
170753387|NCT01077024|617103568|FG000|Overall Study|Incarcerated|7|||
170753388|NCT01077024|617103569|FG001|Overall Study|Incarcerated|8|||
170753389|NCT01077024|617103568|FG000|Overall Study|Other|4|||
170864949|NCT00195507|617517991|FG000|Overall Study|Lack of Efficacy|40|||
170402679|NCT03022799|615814990|FG004|Overall Study|Adverse Event|0|||
170402680|NCT03022799|615814991|FG005|Overall Study|Adverse Event|0|||
170753390|NCT01077024|617103569|FG001|Overall Study|Other|4|||
170753391|NCT02034435|617103570|FG000|Overall Study|Withdrawal by Subject|1|||
170753392|NCT02034435|617103571|FG001|Overall Study|Withdrawal by Subject|0|||
170753393|NCT02034435|617103572|FG002|Overall Study|Withdrawal by Subject|0|||
170753394|NCT02034435|617103573|FG003|Overall Study|Withdrawal by Subject|0|||
170753395|NCT02034435|617103570|FG000|Overall Study|Illness|0|||
170753396|NCT02034435|617103571|FG001|Overall Study|Illness|2|||
170753397|NCT02034435|617103572|FG002|Overall Study|Illness|0|||
170753398|NCT02034435|617103573|FG003|Overall Study|Illness|0|||
170753399|NCT02034435|617103570|FG000|Overall Study|Inadequate IV access|1|||
170753400|NCT02034435|617103571|FG001|Overall Study|Inadequate IV access|0|||
170753401|NCT02034435|617103572|FG002|Overall Study|Inadequate IV access|0|||
170753402|NCT02034435|617103573|FG003|Overall Study|Inadequate IV access|1|||
170753403|NCT01347645|617103576|FG000|Overall Study|Death|1|||
170753404|NCT01347645|617103577|FG001|Overall Study|Death|5|||
170753405|NCT01347645|617103578|FG002|Overall Study|Death|2|||
170753406|NCT01347645|617103579|FG003|Overall Study|Death|7|||
170753407|NCT01347645|617103580|FG004|Overall Study|Death|7|||
170753408|NCT01347645|617103576|FG000|Overall Study|Lost to Follow-up|1|||
170753409|NCT01347645|617103577|FG001|Overall Study|Lost to Follow-up|1|||
170753410|NCT01347645|617103578|FG002|Overall Study|Lost to Follow-up|0|||
170753411|NCT01347645|617103579|FG003|Overall Study|Lost to Follow-up|1|||
170753412|NCT01347645|617103580|FG004|Overall Study|Lost to Follow-up|1|||
170753413|NCT01347645|617103576|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
170753414|NCT01347645|617103577|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
170753415|NCT01347645|617103578|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
170753416|NCT01347645|617103579|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
170753417|NCT01347645|617103580|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
170753418|NCT01347645|617103576|FG000|Overall Study|Other|1|||
170753419|NCT01347645|617103577|FG001|Overall Study|Other|0|||
170753420|NCT01347645|617103578|FG002|Overall Study|Other|0|||
170753421|NCT01347645|617103579|FG003|Overall Study|Other|0|||
170753422|NCT01347645|617103580|FG004|Overall Study|Other|1|||
170753423|NCT01347645|617103576|FG000|Overall Study|Withdrawal by Subject|0|||
170753424|NCT01347645|617103577|FG001|Overall Study|Withdrawal by Subject|0|||
170753425|NCT01347645|617103578|FG002|Overall Study|Withdrawal by Subject|0|||
170753426|NCT01347645|617103579|FG003|Overall Study|Withdrawal by Subject|3|||
170753427|NCT01347645|617103580|FG004|Overall Study|Withdrawal by Subject|3|||
170753428|NCT01347645|617103576|FG000|Overall Study|Physician Decision|0|||
170753429|NCT01347645|617103577|FG001|Overall Study|Physician Decision|0|||
170753430|NCT01347645|617103578|FG002|Overall Study|Physician Decision|0|||
170753431|NCT01347645|617103579|FG003|Overall Study|Physician Decision|0|||
170753432|NCT01347645|617103580|FG004|Overall Study|Physician Decision|1|||
170753433|NCT01347645|617103576|FG000|Overall Study|Adverse Event|0|||
170753434|NCT01347645|617103577|FG001|Overall Study|Adverse Event|0|||
170753435|NCT01347645|617103578|FG002|Overall Study|Adverse Event|0|||
170753436|NCT01347645|617103579|FG003|Overall Study|Adverse Event|1|||
170753437|NCT01347645|617103580|FG004|Overall Study|Adverse Event|1|||
170753438|NCT00388362|617103581|FG000|Enrolled|Ineligible|1|||
170753439|NCT00388362|617103581|FG000|Enrolled|Adverse Event|9|||
170753440|NCT00388362|617103581|FG000|Enrolled|Death|1|||
170753441|NCT00388362|617103581|FG000|Enrolled|Loss insurance|1|||
170753442|NCT00388362|617103581|FG000|Enrolled|Withdrawal by Subject|1|||
170753443|NCT00388362|617103581|FG000|Remained on Study Median of 514 Days|Death|2|||
170753444|NCT00209027|617103582|FG000|Overall Study|study terminated|10|||
170753445|NCT00209027|617103583|FG001|Overall Study|study terminated|0|||
170753446|NCT02335268|617103584|FG000|Overall Study|Physician Decision|5|||
170753447|NCT02335268|617103585|FG001|Overall Study|Physician Decision|1|||
170753448|NCT02335268|617103584|FG000|Overall Study|Lack of Efficacy|2|||
170753449|NCT02335268|617103585|FG001|Overall Study|Lack of Efficacy|1|||
170753450|NCT02335268|617103584|FG000|Overall Study|Adverse Event|5|||
170753451|NCT02335268|617103585|FG001|Overall Study|Adverse Event|2|||
170753452|NCT02335268|617103584|FG000|Overall Study|increase blasts|2|||
170753453|NCT02335268|617103585|FG001|Overall Study|increase blasts|0|||
170864950|NCT00195507|617517992|FG001|Overall Study|Lack of Efficacy|67|||
170864951|NCT00195507|617517991|FG000|Overall Study|Withdrawal by Subject|16|||
170753454|NCT02335268|617103584|FG000|Overall Study|Withdrawal by Subject|3|||
170753455|NCT02335268|617103585|FG001|Overall Study|Withdrawal by Subject|2|||
170753456|NCT03259373|617103586|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
170753457|NCT03259373|617103587|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
170753458|NCT03259373|617103586|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
170753459|NCT03259373|617103587|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
170753460|NCT03259373|617103586|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
170753461|NCT03259373|617103587|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
170753462|NCT03259373|617103586|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
170753463|NCT03259373|617103587|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
170753464|NCT03259373|617103586|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
170753465|NCT03259373|617103587|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
170753466|NCT03259373|617103586|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
170753467|NCT03259373|617103587|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
170753468|NCT02550873|617103588|FG000|Randomized Double Blind|Adverse Event|3|||
170753469|NCT02550873|617103589|FG001|Randomized Double Blind|Adverse Event|1|||
170753470|NCT02550873|617103590|FG002|Randomized Double Blind|Adverse Event|0|||
170753471|NCT02550873|617103588|FG000|Randomized Double Blind|Disease progression|1|||
170753472|NCT02550873|617103589|FG001|Randomized Double Blind|Disease progression|1|||
170753473|NCT02550873|617103590|FG002|Randomized Double Blind|Disease progression|0|||
170753474|NCT02550873|617103588|FG000|Open Label Extension|Study ongoing|0|||
170753475|NCT02550873|617103589|FG001|Open Label Extension|Study ongoing|0|||
170753476|NCT02550873|617103590|FG002|Open Label Extension|Study ongoing|111|||
170753477|NCT01822353|617103591|FG000|Overall Study|Adverse Event|1|||
170753478|NCT01822353|617103592|FG001|Overall Study|Adverse Event|3|||
170753479|NCT01822353|617103593|FG002|Overall Study|Adverse Event|1|||
170753480|NCT01822353|617103591|FG000|Overall Study|Pregnancy|0|||
170753481|NCT01822353|617103592|FG001|Overall Study|Pregnancy|1|||
170753482|NCT01822353|617103593|FG002|Overall Study|Pregnancy|0|||
170753483|NCT01822353|617103591|FG000|Overall Study|Withdrawal by Subject|3|||
170753484|NCT01822353|617103592|FG001|Overall Study|Withdrawal by Subject|1|||
170753485|NCT01822353|617103593|FG002|Overall Study|Withdrawal by Subject|0|||
170753486|NCT01857323|617103594|FG000|Overall Study|Adverse Event|1|||
170753487|NCT01857323|617103594|FG000|Overall Study|Withdrawal by Subject|3|||
170753488|NCT01857323|617103594|FG000|Overall Study|Non-compliance|1|||
170753489|NCT01857323|617103594|FG000|Overall Study|Protocol Violation|6|||
170753490|NCT01857323|617103594|FG000|Overall Study|Lost to Follow-up|1|||
170753491|NCT01857323|617103594|FG000|Overall Study|Other|4|||
170753492|NCT01857323|617103594|FG000|Overall Study|Did not complete 180 doses|48|||
170753493|NCT03658811|617103595|FG000|Overall Study|Lost to Follow-up|3|||
170753494|NCT01400893|617103596|FG000|Overall Study|Death|27|||
170753495|NCT01400893|617103597|FG001|Overall Study|Death|21|||
170753496|NCT01400893|617103596|FG000|Overall Study|Lost to Follow-up|0|||
170753497|NCT01400893|617103597|FG001|Overall Study|Lost to Follow-up|6|||
170753498|NCT04951479|617103598|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
170753499|NCT04209790|617103599|FG000|Overall Study|Physician Decision|1|||
170753500|NCT04060680|617103600|FG000|Overall Study|Unsuccessful implant|17|||
170753501|NCT04060680|617103601|FG001|Overall Study|Unsuccessful implant|2|||
170753502|NCT04060680|617103600|FG000|Overall Study|Adverse Event|3|||
170753503|NCT04060680|617103601|FG001|Overall Study|Adverse Event|0|||
170753504|NCT04060680|617103600|FG000|Overall Study|Death|2|||
170753505|NCT04060680|617103601|FG001|Overall Study|Death|0|||
170753506|NCT04060680|617103600|FG000|Overall Study|Study product no longer in use|1|||
170753507|NCT04060680|617103601|FG001|Overall Study|Study product no longer in use|0|||
170753508|NCT04060680|617103600|FG000|Overall Study|Withdrawal by Subject|1|||
170753509|NCT04060680|617103601|FG001|Overall Study|Withdrawal by Subject|0|||
170753510|NCT02906202|617103602|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
170753511|NCT05593211|617103603|FG000|Overall Study|Withdrawal by Subject|1|||
170753512|NCT03077620|617103607|FG000|Overall Study|Unable to place lumbar catheter|1|||
170753513|NCT03077620|617103608|FG001|Overall Study|Unable to place lumbar catheter|0|||
170753514|NCT03077620|617103609|FG002|Overall Study|Unable to place lumbar catheter|1|||
170753515|NCT03077620|617103610|FG003|Overall Study|Unable to place lumbar catheter|0|||
170402681|NCT03022799|615814992|FG006|Overall Study|Adverse Event|0|||
170402682|NCT03022799|615814993|FG007|Overall Study|Adverse Event|0|||
170402683|NCT03022799|615814994|FG008|Overall Study|Adverse Event|0|||
170519688|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170753516|NCT03077620|617103607|FG000|Overall Study|Withdrawal by Subject|0|||
170753517|NCT03077620|617103608|FG001|Overall Study|Withdrawal by Subject|1|||
170753518|NCT03077620|617103609|FG002|Overall Study|Withdrawal by Subject|0|||
170753519|NCT03077620|617103610|FG003|Overall Study|Withdrawal by Subject|0|||
170753520|NCT03077620|617103607|FG000|Overall Study|Physician Decision|0|||
170753521|NCT03077620|617103608|FG001|Overall Study|Physician Decision|0|||
170753522|NCT03077620|617103609|FG002|Overall Study|Physician Decision|1|||
170753523|NCT03077620|617103610|FG003|Overall Study|Physician Decision|0|||
170753524|NCT03225846|617103611|FG000|Overall Study|Adverse Event|0|||
170753525|NCT03225846|617103612|FG001|Overall Study|Adverse Event|0|||
170753526|NCT03225846|617103613|FG002|Overall Study|Adverse Event|0|||
170753527|NCT03225846|617103614|FG003|Overall Study|Adverse Event|0|||
170864952|NCT00195507|617517992|FG001|Overall Study|Withdrawal by Subject|23|||
170753528|NCT03225846|617103615|FG004|Overall Study|Adverse Event|0|||
170753529|NCT03225846|617103616|FG005|Overall Study|Adverse Event|0|||
170753530|NCT03225846|617103617|FG006|Overall Study|Adverse Event|6|||
170753531|NCT03225846|617103611|FG000|Overall Study|Withdrawal by Subject|0|||
170753532|NCT03225846|617103612|FG001|Overall Study|Withdrawal by Subject|1|||
170753533|NCT03225846|617103613|FG002|Overall Study|Withdrawal by Subject|0|||
170753534|NCT03225846|617103614|FG003|Overall Study|Withdrawal by Subject|0|||
170753535|NCT03225846|617103615|FG004|Overall Study|Withdrawal by Subject|0|||
170753536|NCT03225846|617103616|FG005|Overall Study|Withdrawal by Subject|0|||
170753537|NCT03225846|617103617|FG006|Overall Study|Withdrawal by Subject|0|||
170753538|NCT03225846|617103611|FG000|Overall Study|Death|0|||
170753539|NCT03225846|617103612|FG001|Overall Study|Death|1|||
170753540|NCT03225846|617103613|FG002|Overall Study|Death|0|||
170753541|NCT03225846|617103614|FG003|Overall Study|Death|0|||
170753542|NCT03225846|617103615|FG004|Overall Study|Death|0|||
170753543|NCT03225846|617103616|FG005|Overall Study|Death|0|||
170753544|NCT03225846|617103617|FG006|Overall Study|Death|0|||
170753545|NCT03225846|617103611|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
170753546|NCT03225846|617103612|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
170753547|NCT03225846|617103613|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
170753548|NCT03225846|617103614|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
170753549|NCT03225846|617103615|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
170753550|NCT03225846|617103616|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
170753551|NCT03225846|617103617|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
170753552|NCT03225846|617103611|FG000|Overall Study|Patient decision|0|||
170753553|NCT03225846|617103612|FG001|Overall Study|Patient decision|0|||
170753554|NCT03225846|617103613|FG002|Overall Study|Patient decision|0|||
170753555|NCT03225846|617103614|FG003|Overall Study|Patient decision|0|||
170753556|NCT03225846|617103615|FG004|Overall Study|Patient decision|0|||
170753557|NCT03225846|617103616|FG005|Overall Study|Patient decision|0|||
170753558|NCT03225846|617103617|FG006|Overall Study|Patient decision|1|||
170753559|NCT03621982|617103618|FG000|Overall Study|Withdrawal by Subject|1|||
170753560|NCT03621982|617103619|FG001|Overall Study|Withdrawal by Subject|0|||
170753561|NCT03621982|617103620|FG002|Overall Study|Withdrawal by Subject|0|||
170753562|NCT03621982|617103621|FG003|Overall Study|Withdrawal by Subject|1|||
170753563|NCT03621982|617103622|FG004|Overall Study|Withdrawal by Subject|0|||
170753564|NCT03621982|617103623|FG005|Overall Study|Withdrawal by Subject|1|||
170753565|NCT03621982|617103624|FG006|Overall Study|Withdrawal by Subject|1|||
170753566|NCT03621982|617103625|FG007|Overall Study|Withdrawal by Subject|0|||
170753567|NCT03621982|617103626|FG008|Overall Study|Withdrawal by Subject|1|||
170753568|NCT03621982|617103627|FG009|Overall Study|Withdrawal by Subject|0|||
170753569|NCT03621982|617103628|FG010|Overall Study|Withdrawal by Subject|2|||
170753570|NCT03621982|617103629|FG011|Overall Study|Withdrawal by Subject|1|||
170753571|NCT03621982|617103630|FG012|Overall Study|Withdrawal by Subject|2|||
170753572|NCT03621982|617103631|FG013|Overall Study|Withdrawal by Subject|2|||
170753573|NCT03621982|617103618|FG000|Overall Study|Investigator/Sponsor decision|0|||
170753574|NCT03621982|617103619|FG001|Overall Study|Investigator/Sponsor decision|0|||
170753575|NCT03621982|617103620|FG002|Overall Study|Investigator/Sponsor decision|0|||
170753576|NCT03621982|617103621|FG003|Overall Study|Investigator/Sponsor decision|0|||
170753577|NCT03621982|617103622|FG004|Overall Study|Investigator/Sponsor decision|0|||
170753578|NCT03621982|617103623|FG005|Overall Study|Investigator/Sponsor decision|0|||
170753579|NCT03621982|617103624|FG006|Overall Study|Investigator/Sponsor decision|0|||
170753580|NCT03621982|617103625|FG007|Overall Study|Investigator/Sponsor decision|0|||
170753581|NCT03621982|617103626|FG008|Overall Study|Investigator/Sponsor decision|0|||
170753582|NCT03621982|617103627|FG009|Overall Study|Investigator/Sponsor decision|0|||
170753583|NCT03621982|617103628|FG010|Overall Study|Investigator/Sponsor decision|0|||
170753584|NCT03621982|617103629|FG011|Overall Study|Investigator/Sponsor decision|4|||
170753585|NCT03621982|617103630|FG012|Overall Study|Investigator/Sponsor decision|0|||
170864953|NCT00195507|617517991|FG000|Overall Study|Protocol Deviation|6|||
170864954|NCT00195507|617517992|FG001|Overall Study|Protocol Deviation|3|||
170864955|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
170753586|NCT03621982|617103631|FG013|Overall Study|Investigator/Sponsor decision|2|||
170753587|NCT03621982|617103618|FG000|Overall Study|Death|2|||
170753588|NCT03621982|617103619|FG001|Overall Study|Death|4|||
170753589|NCT03621982|617103620|FG002|Overall Study|Death|4|||
170753590|NCT03621982|617103621|FG003|Overall Study|Death|3|||
170753591|NCT03621982|617103622|FG004|Overall Study|Death|8|||
170753592|NCT03621982|617103623|FG005|Overall Study|Death|4|||
170753593|NCT03621982|617103624|FG006|Overall Study|Death|6|||
170753594|NCT03621982|617103625|FG007|Overall Study|Death|3|||
170753595|NCT03621982|617103626|FG008|Overall Study|Death|0|||
170753596|NCT03621982|617103627|FG009|Overall Study|Death|3|||
170753597|NCT03621982|617103628|FG010|Overall Study|Death|8|||
170753598|NCT03621982|617103629|FG011|Overall Study|Death|4|||
170753599|NCT03621982|617103630|FG012|Overall Study|Death|2|||
170753600|NCT03621982|617103631|FG013|Overall Study|Death|2|||
170753601|NCT03621982|617103618|FG000|Overall Study|Lost to Follow-up|0|||
170753602|NCT03621982|617103619|FG001|Overall Study|Lost to Follow-up|0|||
170753603|NCT03621982|617103620|FG002|Overall Study|Lost to Follow-up|1|||
170753604|NCT03621982|617103621|FG003|Overall Study|Lost to Follow-up|0|||
170753605|NCT03621982|617103622|FG004|Overall Study|Lost to Follow-up|0|||
170753606|NCT03621982|617103623|FG005|Overall Study|Lost to Follow-up|0|||
170753607|NCT03621982|617103624|FG006|Overall Study|Lost to Follow-up|1|||
170753608|NCT03621982|617103625|FG007|Overall Study|Lost to Follow-up|0|||
170753609|NCT03621982|617103626|FG008|Overall Study|Lost to Follow-up|0|||
170753610|NCT03621982|617103627|FG009|Overall Study|Lost to Follow-up|1|||
170753611|NCT03621982|617103628|FG010|Overall Study|Lost to Follow-up|0|||
170753612|NCT03621982|617103629|FG011|Overall Study|Lost to Follow-up|0|||
170753613|NCT03621982|617103630|FG012|Overall Study|Lost to Follow-up|0|||
170753614|NCT03621982|617103631|FG013|Overall Study|Lost to Follow-up|0|||
170753615|NCT00245011|617103635|FG000|Overall Study|Lack of Efficacy|1|||
170753616|NCT02353832|617103636|FG000|Overall Study|Ineligible after enrollment|1|||
170753617|NCT02353832|617103636|FG000|Overall Study|Lost to Follow-up|1|||
170753618|NCT04988477|617103637|FG000|Overall Study|Death|1|||
170753619|NCT04988477|617103638|FG001|Overall Study|Death|0|||
170402684|NCT03022799|615814995|FG009|Overall Study|Adverse Event|1|||
170402685|NCT03022799|615814996|FG010|Overall Study|Adverse Event|1|||
170402686|NCT03022799|615814997|FG011|Overall Study|Adverse Event|0|||
170753620|NCT04988477|617103639|FG002|Overall Study|Death|0|||
170753621|NCT04988477|617103637|FG000|Overall Study|Lost to Follow-up|5|||
170753622|NCT04988477|617103638|FG001|Overall Study|Lost to Follow-up|2|||
170753623|NCT04988477|617103639|FG002|Overall Study|Lost to Follow-up|0|||
170753624|NCT04988477|617103637|FG000|Overall Study|Withdrawal by Subject|2|||
170753625|NCT04988477|617103638|FG001|Overall Study|Withdrawal by Subject|0|||
170753626|NCT04988477|617103639|FG002|Overall Study|Withdrawal by Subject|0|||
170753627|NCT05458102|617105209|FG000|Overall Study|Withdrew consent|2|||
170753628|NCT05458102|617105210|FG001|Overall Study|Withdrew consent|0|||
170753629|NCT05458102|617105209|FG000|Overall Study|Adverse Event|1|||
170753630|NCT05458102|617105210|FG001|Overall Study|Adverse Event|0|||
170753631|NCT05458102|617105209|FG000|Overall Study|Enrolled but never treated|1|||
170753632|NCT05458102|617105210|FG001|Overall Study|Enrolled but never treated|0|||
170753633|NCT05458102|617105209|FG000|Overall Study|Protocol Violation|1|||
170753634|NCT05458102|617105210|FG001|Overall Study|Protocol Violation|0|||
170753635|NCT05406791|617105216|FG000|Overall Study|Lost to Follow-up|13|||
170753636|NCT05406791|617105217|FG001|Overall Study|Lost to Follow-up|10|||
170753637|NCT02403674|617105218|FG000|Base Study|Death|1|||
170753638|NCT02403674|617105219|FG001|Base Study|Death|4|||
170753639|NCT02403674|617105218|FG000|Base Study|Adverse Event|11|||
170753640|NCT02403674|617105219|FG001|Base Study|Adverse Event|26|||
170753641|NCT02403674|617105218|FG000|Base Study|Lack of Efficacy|31|||
170753642|NCT02403674|617105219|FG001|Base Study|Lack of Efficacy|23|||
170753643|NCT02403674|617105218|FG000|Base Study|Lost to Follow-up|6|||
170753644|NCT02403674|617105219|FG001|Base Study|Lost to Follow-up|8|||
170753645|NCT02403674|617105218|FG000|Base Study|Withdrawal by Subject|10|||
170753646|NCT02403674|617105219|FG001|Base Study|Withdrawal by Subject|17|||
170753647|NCT02403674|617105218|FG000|Base Study|Physician Decision|2|||
170753648|NCT02403674|617105219|FG001|Base Study|Physician Decision|2|||
170753649|NCT02403674|617105218|FG000|Base Study|Pregnancy|2|||
170753650|NCT02403674|617105219|FG001|Base Study|Pregnancy|2|||
170753651|NCT02403674|617105218|FG000|Base Study|Protocol Violation|8|||
170402687|NCT03022799|615814998|FG012|Overall Study|Adverse Event|0|||
170402688|NCT04881448|615814999|FG000|Overall Study|Study cancelled by sponsor|220|||
170402689|NCT04881448|615814999|FG000|Overall Study|Withdrawal by Subject|2|||
170402690|NCT04881448|615814999|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
170402691|NCT01898884|615815001|FG000|Multiple Dose Period|Adverse Event|0|||
170402692|NCT01898884|615815002|FG001|Multiple Dose Period|Adverse Event|0|||
170402693|NCT01898884|615815003|FG002|Multiple Dose Period|Adverse Event|0|||
170402694|NCT01898884|615815004|FG003|Multiple Dose Period|Adverse Event|0|||
170402695|NCT01898884|615815005|FG004|Multiple Dose Period|Adverse Event|0|||
170402696|NCT01898884|615815006|FG005|Multiple Dose Period|Adverse Event|0|||
170753652|NCT02403674|617105219|FG001|Base Study|Protocol Violation|4|||
170753653|NCT02403674|617105218|FG000|Base Study|Non-Compliance with study drug|1|||
170753654|NCT02403674|617105219|FG001|Base Study|Non-Compliance with study drug|4|||
170753655|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
170753656|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
170753657|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
170402697|NCT01898884|615815007|FG006|Multiple Dose Period|Adverse Event|1|||
170402698|NCT01898884|615815008|FG007|Multiple Dose Period|Adverse Event|0|||
170402699|NCT01898884|615815009|FG008|Multiple Dose Period|Adverse Event|0|||
170402700|NCT01898884|615815001|FG000|Multiple Dose Period|Randomized Not Treated|0|||
170753658|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
170753659|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
170753660|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
170753661|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
170753662|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
170753663|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
170753664|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
170753665|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
170753666|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
170753667|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Death|1|||
170753668|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Death|0|||
170753669|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
170753670|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
170753671|NCT02403674|617105218|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
170753672|NCT02403674|617105219|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
170753673|NCT02403674|617105218|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
170753674|NCT02403674|617105219|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
170753675|NCT02403674|617105218|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
170753676|NCT02403674|617105219|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
170753677|NCT02403674|617105218|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
170753678|NCT02403674|617105219|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
170753679|NCT02403674|617105218|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
170753680|NCT02403674|617105219|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
170753681|NCT02403674|617105218|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
170753682|NCT02403674|617105219|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
170753683|NCT02403674|617105218|FG000|Study Extension 2 (Open-Label)|Death|2|||
170753684|NCT02403674|617105219|FG001|Study Extension 2 (Open-Label)|Death|2|||
170753685|NCT02403674|617105218|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
170753686|NCT02403674|617105219|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
170753687|NCT02403674|617105218|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
170753688|NCT02403674|617105219|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
170753689|NCT02403674|617105218|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
170753690|NCT02403674|617105219|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
170753691|NCT02403674|617105218|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
170753692|NCT02403674|617105219|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
170753693|NCT02403674|617105218|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
170753694|NCT02403674|617105219|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
170753695|NCT02403674|617105218|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
170753696|NCT02403674|617105219|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
170753697|NCT02403674|617105218|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
170753698|NCT02403674|617105219|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
170753699|NCT00839917|617105221|FG000|Overall Study|Lost to Follow-up|1|||
170753700|NCT00839917|617105222|FG001|Overall Study|Lost to Follow-up|0|||
170753701|NCT00839917|617105221|FG000|Overall Study|Did not receive vaccine|0|||
170753702|NCT00839917|617105222|FG001|Overall Study|Did not receive vaccine|1|||
170753703|NCT00926393|617105228|FG000|Overall Study|Withdrawal by Subject|1|||
170864956|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
170864957|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
170864958|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
170864959|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
170864960|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
170864961|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
170864962|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
170864963|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Death|1|||
170864964|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Death|1|||
170864965|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
170864966|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
170864967|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
170864968|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
170864969|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
170864970|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
170864971|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
170864972|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
170864973|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
170864974|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
170864975|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
170864976|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
170864977|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
170864978|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
170753704|NCT00926393|617105229|FG001|Overall Study|Withdrawal by Subject|2|||
170753705|NCT00926393|617105228|FG000|Overall Study|Adverse Event|1|||
170753706|NCT00926393|617105229|FG001|Overall Study|Adverse Event|1|||
170753707|NCT01403987|617105231|FG000|Overall Study|Residents forgot their secret PIN|18|||
170753708|NCT01403987|617105232|FG001|Overall Study|Residents forgot their secret PIN|17|||
170753709|NCT01403987|617105233|FG002|Overall Study|Residents forgot their secret PIN|18|||
170753710|NCT01106976|617105235|FG000|Overall Study|Lost to Follow-up|8|||
170753711|NCT02851511|617105239|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
170753712|NCT02851511|617105240|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
170753713|NCT02851511|617105241|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
170753714|NCT02851511|617105242|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
170753715|NCT02851511|617105239|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
170753716|NCT02851511|617105240|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
170753717|NCT02851511|617105241|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
170753718|NCT02851511|617105242|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
170753719|NCT02851511|617105239|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
170753720|NCT02851511|617105240|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
170753721|NCT02851511|617105241|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
170753722|NCT02851511|617105242|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
170753723|NCT02851511|617105239|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
170753724|NCT02851511|617105240|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
170753725|NCT02851511|617105241|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
170753726|NCT02851511|617105242|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
170753727|NCT02851511|617105239|FG000|Phase I|Physician Decision|0|||
170753728|NCT02851511|617105240|FG001|Phase I|Physician Decision|0|||
170753729|NCT02851511|617105241|FG002|Phase I|Physician Decision|0|||
170753730|NCT02851511|617105242|FG003|Phase I|Physician Decision|1|||
170753731|NCT02851511|617105239|FG000|Phase I|Withdrawal by Subject|2|||
170753732|NCT02851511|617105240|FG001|Phase I|Withdrawal by Subject|1|||
170753733|NCT02851511|617105241|FG002|Phase I|Withdrawal by Subject|0|||
170753734|NCT02851511|617105242|FG003|Phase I|Withdrawal by Subject|3|||
170753735|NCT02851511|617105239|FG000|Phase II|Physician Decision|18|||
170753736|NCT02851511|617105240|FG001|Phase II|Physician Decision|16|||
170753737|NCT02851511|617105241|FG002|Phase II|Physician Decision|0|||
170753738|NCT02851511|617105242|FG003|Phase II|Physician Decision|0|||
170753739|NCT02851511|617105239|FG000|Phase II|Withdrawal by Subject|18|||
170753740|NCT02851511|617105240|FG001|Phase II|Withdrawal by Subject|16|||
170753741|NCT02851511|617105241|FG002|Phase II|Withdrawal by Subject|0|||
170753742|NCT02851511|617105242|FG003|Phase II|Withdrawal by Subject|0|||
170753743|NCT02851511|617105239|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
170753744|NCT02851511|617105240|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
170753745|NCT02851511|617105241|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
170753746|NCT02851511|617105242|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
170753747|NCT02851511|617105239|FG000|Phase II|Lost to Follow-up|0|||
170753748|NCT02851511|617105240|FG001|Phase II|Lost to Follow-up|1|||
170753749|NCT02851511|617105241|FG002|Phase II|Lost to Follow-up|0|||
170753750|NCT02851511|617105242|FG003|Phase II|Lost to Follow-up|0|||
170753751|NCT00051311|617105255|FG000|Overall Study|Starting new study|0|||
170753752|NCT00051311|617105256|FG001|Overall Study|Starting new study|1|||
170753753|NCT00051311|617105255|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
170753754|NCT00051311|617105256|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
170753755|NCT00051311|617105255|FG000|Overall Study|Death of recipient|8|||
170753756|NCT00051311|617105256|FG001|Overall Study|Death of recipient|8|||
170753757|NCT00051311|617105255|FG000|Overall Study|Recipient taken off study|4|||
170753758|NCT00051311|617105256|FG001|Overall Study|Recipient taken off study|4|||
170753759|NCT04170023|617105257|FG000|LTE Period|Withdrawal by Subject|1|||
170753760|NCT04170023|617105258|FG001|LTE Period|Withdrawal by Subject|0|||
170753761|NCT04170023|617105259|FG002|LTE Period|Withdrawal by Subject|0|||
170753762|NCT04170023|617105257|FG000|LTE Period|Study Termination|11|||
170753763|NCT04170023|617105258|FG001|LTE Period|Study Termination|11|||
170753764|NCT04170023|617105259|FG002|LTE Period|Study Termination|5|||
170753765|NCT03712098|617105260|FG000|Overall Study|Lost to Follow-up|3|||
170753766|NCT03712098|617105261|FG001|Overall Study|Lost to Follow-up|7|||
170753767|NCT03712098|617105260|FG000|Overall Study|Withdrawal by Subject|9|||
170753768|NCT03712098|617105261|FG001|Overall Study|Withdrawal by Subject|4|||
170753769|NCT03712098|617105260|FG000|Overall Study|Protocol Violation|2|||
170753770|NCT03712098|617105261|FG001|Overall Study|Protocol Violation|1|||
170753771|NCT03566680|617105271|FG000|Overall Study|Pregnancy|1|||
170753772|NCT03566680|617105271|FG000|Overall Study|Lost to Follow-up|13|||
170753773|NCT03566680|617105271|FG000|Overall Study|Withdrawal by Subject|3|||
170753774|NCT03836664|617105272|FG000|Overall Study|Didn't complete forms and lost drug|3|||
170753775|NCT03836664|617105273|FG001|Overall Study|Didn't complete forms and lost drug|3|||
170753776|NCT01427907|617105275|FG000|Overall Study|Withdrawal by Subject|3|||
170753777|NCT01427907|617105276|FG001|Overall Study|Withdrawal by Subject|4|||
170753778|NCT01818700|617105279|FG000|Overall Study|Adverse Event|67|||
170753779|NCT01818700|617105279|FG000|Overall Study|Lack of Efficacy|2|||
170753780|NCT01818700|617105279|FG000|Overall Study|Lost to Follow-up|5|||
170753781|NCT01818700|617105279|FG000|Overall Study|Withdrawal by Subject|27|||
170753782|NCT01818700|617105279|FG000|Overall Study|Protocol Violation|2|||
170753783|NCT01818700|617105279|FG000|Overall Study|Other|1|||
170753784|NCT02412761|617105280|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170753785|NCT02412761|617105281|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
170753786|NCT02412761|617105282|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
170753787|NCT02412761|617105283|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170753788|NCT02412761|617105284|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170753789|NCT02412761|617105285|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
170753790|NCT01627340|617105286|FG000|Overall Study|Adverse Event|1|||
170753791|NCT01627340|617105287|FG001|Overall Study|Adverse Event|0|||
170753792|NCT01627340|617105286|FG000|Overall Study|Lost to Follow-up|8|||
170753793|NCT01627340|617105287|FG001|Overall Study|Lost to Follow-up|4|||
170753794|NCT01627340|617105286|FG000|Overall Study|Pregnancy|1|||
170753795|NCT01627340|617105287|FG001|Overall Study|Pregnancy|0|||
170753796|NCT01627340|617105286|FG000|Overall Study|Withdrawal by Subject|2|||
170753797|NCT01627340|617105287|FG001|Overall Study|Withdrawal by Subject|0|||
170753798|NCT02240680|617105288|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
170753799|NCT02240680|617105289|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
170753800|NCT02240680|617105290|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
170753801|NCT02240680|617105291|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
170753802|NCT02240680|617105288|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
170753803|NCT02240680|617105289|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
170753804|NCT02240680|617105290|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
170753805|NCT02240680|617105291|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
170753806|NCT02240680|617105288|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
170753807|NCT02240680|617105289|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
170753808|NCT02240680|617105290|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
170753809|NCT02240680|617105291|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
170753810|NCT02240680|617105288|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
170753811|NCT02240680|617105289|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
170753812|NCT02240680|617105290|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
170753813|NCT02240680|617105291|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
170753814|NCT02240680|617105288|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
170753815|NCT02240680|617105289|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
170753816|NCT02240680|617105290|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
170753817|NCT02240680|617105291|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
170753818|NCT02240680|617105288|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
170753819|NCT02240680|617105289|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
170753820|NCT02240680|617105290|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
170753821|NCT02240680|617105291|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
170753822|NCT02240680|617105288|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
170753823|NCT02240680|617105289|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
170753824|NCT02240680|617105290|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
170753825|NCT02240680|617105291|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
170753826|NCT02240680|617105288|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
170753827|NCT02240680|617105289|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
170753828|NCT02240680|617105290|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
170753829|NCT02240680|617105291|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
170753830|NCT03633903|617105292|FG000|Overall Study|Withdrawal by Subject|1|||
170753831|NCT03633903|617105293|FG001|Overall Study|Withdrawal by Subject|2|||
170753832|NCT03633903|617105292|FG000|Overall Study|Lost to Follow-up|5|||
170906116|NCT01331161|617658623|FG000|Overall Study|Lost to Follow-up|0|||
170402701|NCT01898884|615815002|FG001|Multiple Dose Period|Randomized Not Treated|0|||
170519689|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170753833|NCT03633903|617105293|FG001|Overall Study|Lost to Follow-up|5|||
170753834|NCT01653743|617105303|FG000|Overall Study|Withdrawal by Subject|1|||
170753835|NCT01653743|617105304|FG001|Overall Study|Withdrawal by Subject|0|||
170753836|NCT01653743|617105303|FG000|Overall Study|Investigator discretion|3|||
170753837|NCT01653743|617105304|FG001|Overall Study|Investigator discretion|0|||
170753838|NCT02554513|617105305|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
170753839|NCT02554513|617105306|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
170753840|NCT00558753|617105307|FG000|Overall Study|Lost to Follow-up|5|||
170753841|NCT00558753|617105308|FG001|Overall Study|Lost to Follow-up|7|||
170753842|NCT03704298|617105311|FG000|Overall Study|Death|3|||
170753843|NCT03704298|617105312|FG001|Overall Study|Death|1|||
170753844|NCT03704298|617105313|FG002|Overall Study|Death|1|||
170753845|NCT03704298|617105314|FG003|Overall Study|Death|0|||
170753846|NCT03704298|617105311|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
170753847|NCT03704298|617105312|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
170753848|NCT03704298|617105313|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
170753849|NCT03704298|617105314|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
170753850|NCT03704298|617105311|FG000|Overall Study|Withdrawal by Subject|1|||
170753851|NCT03704298|617105312|FG001|Overall Study|Withdrawal by Subject|0|||
170753852|NCT03704298|617105313|FG002|Overall Study|Withdrawal by Subject|0|||
170753853|NCT03704298|617105314|FG003|Overall Study|Withdrawal by Subject|0|||
170753854|NCT03704298|617105311|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
170753855|NCT03704298|617105312|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
170753856|NCT03704298|617105313|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
170753857|NCT03704298|617105314|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
170753858|NCT02303574|617105323|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753859|NCT02303574|617105324|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753860|NCT02303574|617105325|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
170753861|NCT02303574|617105326|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753862|NCT02303574|617105327|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753863|NCT02303574|617105328|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753864|NCT02303574|617105329|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753865|NCT02303574|617105330|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753866|NCT02303574|617105331|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753867|NCT02303574|617105332|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
170753868|NCT02303574|617105323|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753869|NCT02303574|617105324|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753870|NCT02303574|617105325|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753871|NCT02303574|617105326|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753872|NCT02303574|617105327|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753873|NCT02303574|617105328|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753874|NCT02303574|617105329|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753875|NCT02303574|617105330|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
170753876|NCT02303574|617105331|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753877|NCT02303574|617105332|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
170753878|NCT00410384|617105337|FG000|Overall Study|Withdrawal by Subject|28|||
170753879|NCT00410384|617105338|FG001|Overall Study|Withdrawal by Subject|17|||
170753880|NCT00410384|617105339|FG002|Overall Study|Withdrawal by Subject|20|||
170753881|NCT00410384|617105337|FG000|Overall Study|Adverse Event|23|||
170753882|NCT00410384|617105338|FG001|Overall Study|Adverse Event|18|||
170753883|NCT00410384|617105339|FG002|Overall Study|Adverse Event|23|||
170753884|NCT00410384|617105337|FG000|Overall Study|Lack of Efficacy|20|||
170753885|NCT00410384|617105338|FG001|Overall Study|Lack of Efficacy|12|||
170753886|NCT00410384|617105339|FG002|Overall Study|Lack of Efficacy|17|||
170753887|NCT00410384|617105337|FG000|Overall Study|Lack of Compliance|2|||
170753888|NCT00410384|617105338|FG001|Overall Study|Lack of Compliance|2|||
170753889|NCT00410384|617105339|FG002|Overall Study|Lack of Compliance|2|||
170753890|NCT00410384|617105337|FG000|Overall Study|Lost to Follow-up|4|||
170753891|NCT00410384|617105338|FG001|Overall Study|Lost to Follow-up|6|||
170753892|NCT00410384|617105339|FG002|Overall Study|Lost to Follow-up|6|||
170753893|NCT00410384|617105337|FG000|Overall Study|Protocol Violation|6|||
170753894|NCT00410384|617105338|FG001|Overall Study|Protocol Violation|6|||
170753895|NCT00410384|617105339|FG002|Overall Study|Protocol Violation|6|||
170753896|NCT00410384|617105337|FG000|Overall Study|Physician Decision|3|||
170753897|NCT00410384|617105338|FG001|Overall Study|Physician Decision|3|||
170753898|NCT00410384|617105339|FG002|Overall Study|Physician Decision|4|||
170753899|NCT00410384|617105337|FG000|Overall Study|Other|3|||
170753900|NCT00410384|617105338|FG001|Overall Study|Other|8|||
170753901|NCT00410384|617105339|FG002|Overall Study|Other|4|||
170753902|NCT01670500|617105341|FG000|Overall Study|Withdrawal by Subject|1|||
170753903|NCT01670500|617105342|FG001|Overall Study|Withdrawal by Subject|0|||
170753904|NCT03473756|617105343|FG000|Overall Study|Withdrawal by Subject|1|||
170753905|NCT03473756|617105344|FG001|Overall Study|Withdrawal by Subject|4|||
170753906|NCT03473756|617105343|FG000|Overall Study|Adverse Event|6|||
170753907|NCT03473756|617105344|FG001|Overall Study|Adverse Event|7|||
170753908|NCT03473756|617105343|FG000|Overall Study|Lack of Efficacy|3|||
170753909|NCT03473756|617105344|FG001|Overall Study|Lack of Efficacy|10|||
170753910|NCT03473756|617105343|FG000|Overall Study|Physician Decision|0|||
170753911|NCT03473756|617105344|FG001|Overall Study|Physician Decision|2|||
170753912|NCT03473756|617105343|FG000|Overall Study|End of study treatment|0|||
170753913|NCT03473756|617105344|FG001|Overall Study|End of study treatment|2|||
170753914|NCT03473756|617105343|FG000|Overall Study|Lost to Follow-up|0|||
170753915|NCT03473756|617105344|FG001|Overall Study|Lost to Follow-up|1|||
170753916|NCT01923428|617105345|FG000|Overall Study|Adverse Event|8|||
170753917|NCT01923428|617105346|FG001|Overall Study|Adverse Event|6|||
170753918|NCT01923428|617105347|FG002|Overall Study|Adverse Event|3|||
170753919|NCT01923428|617105348|FG003|Overall Study|Adverse Event|3|||
170753920|NCT01923428|617105345|FG000|Overall Study|Withdrawal by Subject|5|||
170753921|NCT01923428|617105346|FG001|Overall Study|Withdrawal by Subject|3|||
170753922|NCT01923428|617105347|FG002|Overall Study|Withdrawal by Subject|0|||
170753923|NCT01923428|617105348|FG003|Overall Study|Withdrawal by Subject|4|||
170864979|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
170864980|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
170753924|NCT01923428|617105345|FG000|Overall Study|Lost to Follow-up|2|||
170753925|NCT01923428|617105346|FG001|Overall Study|Lost to Follow-up|1|||
170753926|NCT01923428|617105347|FG002|Overall Study|Lost to Follow-up|5|||
170753927|NCT01923428|617105348|FG003|Overall Study|Lost to Follow-up|0|||
170753928|NCT01923428|617105345|FG000|Overall Study|Protocol Violation|3|||
170753929|NCT01923428|617105346|FG001|Overall Study|Protocol Violation|0|||
170753930|NCT01923428|617105347|FG002|Overall Study|Protocol Violation|2|||
170753931|NCT01923428|617105348|FG003|Overall Study|Protocol Violation|1|||
170753932|NCT01923428|617105345|FG000|Overall Study|Non Compliance to treatment|1|||
170753933|NCT01923428|617105346|FG001|Overall Study|Non Compliance to treatment|2|||
170753934|NCT01923428|617105347|FG002|Overall Study|Non Compliance to treatment|0|||
170753935|NCT01923428|617105348|FG003|Overall Study|Non Compliance to treatment|1|||
170753936|NCT01923428|617105345|FG000|Overall Study|Lack of Efficacy|0|||
170753937|NCT01923428|617105346|FG001|Overall Study|Lack of Efficacy|0|||
170753938|NCT01923428|617105347|FG002|Overall Study|Lack of Efficacy|1|||
170753939|NCT01923428|617105348|FG003|Overall Study|Lack of Efficacy|1|||
170753940|NCT02487446|617105352|FG000|Period 1|Physician Decision|0|||
170753941|NCT02487446|617105353|FG001|Period 1|Physician Decision|1|||
170753942|NCT02487446|617105352|FG000|Period 1|Lack of Efficacy|1|||
170753943|NCT02487446|617105353|FG001|Period 1|Lack of Efficacy|0|||
170753944|NCT02487446|617105352|FG000|Period 1|Protocol deviation|3|||
170753945|NCT02487446|617105353|FG001|Period 1|Protocol deviation|2|||
170753946|NCT02487446|617105352|FG000|Period 1|Lost to Follow-up|2|||
170753947|NCT02487446|617105353|FG001|Period 1|Lost to Follow-up|0|||
170753948|NCT02487446|617105352|FG000|Period 1|Withdrawal by Subject|2|||
170753949|NCT02487446|617105353|FG001|Period 1|Withdrawal by Subject|0|||
170753950|NCT02487446|617105352|FG000|Period 1|Adverse Event|5|||
170753951|NCT02487446|617105353|FG001|Period 1|Adverse Event|5|||
170753952|NCT02487446|617105352|FG000|Washout|Lost to Follow-up|0|||
170753953|NCT02487446|617105353|FG001|Washout|Lost to Follow-up|2|||
170753954|NCT02487446|617105352|FG000|Washout|Withdrawal by Subject|1|||
170753955|NCT02487446|617105353|FG001|Washout|Withdrawal by Subject|4|||
170753956|NCT02487446|617105352|FG000|Washout|Adverse Event|2|||
170753957|NCT02487446|617105353|FG001|Washout|Adverse Event|2|||
170753958|NCT02487446|617105352|FG000|Period 2|Protocol deviation|0|||
170753959|NCT02487446|617105353|FG001|Period 2|Protocol deviation|1|||
170753960|NCT02487446|617105352|FG000|Period 2|Lost to Follow-up|1|||
170753961|NCT02487446|617105353|FG001|Period 2|Lost to Follow-up|1|||
170753962|NCT02487446|617105352|FG000|Period 2|Withdrawal by Subject|1|||
170753963|NCT02487446|617105353|FG001|Period 2|Withdrawal by Subject|1|||
170753964|NCT02487446|617105352|FG000|Period 2|Adverse Event|6|||
170753965|NCT02487446|617105353|FG001|Period 2|Adverse Event|2|||
170753966|NCT03289455|617105354|FG000|Overall Study|Death|1|||
170753967|NCT03289455|617105355|FG001|Overall Study|Death|0|||
170753968|NCT03289455|617105356|FG002|Overall Study|Death|0|||
170753969|NCT03289455|617105354|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
170753970|NCT03289455|617105355|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
170753971|NCT03289455|617105356|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
170753972|NCT03289455|617105354|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
170753973|NCT03289455|617105355|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
170753974|NCT03289455|617105356|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
170753975|NCT03289455|617105354|FG000|Overall Study|Progressive disease|3|||
170753976|NCT03289455|617105355|FG001|Overall Study|Progressive disease|4|||
170753977|NCT03289455|617105356|FG002|Overall Study|Progressive disease|5|||
170753978|NCT03706690|617105357|FG000|Overall Study|Withdrawal by Subject|8|||
170753979|NCT03706690|617105358|FG001|Overall Study|Withdrawal by Subject|8|||
170753980|NCT03706690|617105357|FG000|Overall Study|Death|143|||
170753981|NCT03706690|617105358|FG001|Overall Study|Death|75|||
170753982|NCT03706690|617105357|FG000|Overall Study|Ongoing at DCO|121|||
170753983|NCT03706690|617105358|FG001|Overall Study|Ongoing at DCO|52|||
170753984|NCT05617040|617105359|FG000|Overall Study|Adverse Event|0|||
170753985|NCT05617040|617105360|FG001|Overall Study|Adverse Event|1|||
170753986|NCT05617040|617105361|FG002|Overall Study|Adverse Event|0|||
170753987|NCT05617040|617105359|FG000|Overall Study|Death|0|||
170753988|NCT05617040|617105360|FG001|Overall Study|Death|0|||
170753989|NCT05617040|617105361|FG002|Overall Study|Death|1|||
170753990|NCT02711826|617105362|FG000|Overall Study|Physician Decision|0|||
170753991|NCT02711826|617105363|FG001|Overall Study|Physician Decision|0|||
170753992|NCT02711826|617105364|FG002|Overall Study|Physician Decision|0|||
170753993|NCT02711826|617105365|FG003|Overall Study|Physician Decision|1|||
170753994|NCT02711826|617105366|FG004|Overall Study|Physician Decision|0|||
170753995|NCT02711826|617105362|FG000|Overall Study|Withdrawal by Subject|0|||
170753996|NCT02711826|617105363|FG001|Overall Study|Withdrawal by Subject|1|||
170753997|NCT02711826|617105364|FG002|Overall Study|Withdrawal by Subject|0|||
170753998|NCT02711826|617105365|FG003|Overall Study|Withdrawal by Subject|4|||
170753999|NCT02711826|617105366|FG004|Overall Study|Withdrawal by Subject|0|||
170754000|NCT02711826|617105362|FG000|Overall Study|Failure to manufacture cellular product|0|||
170754001|NCT02711826|617105363|FG001|Overall Study|Failure to manufacture cellular product|0|||
170754002|NCT02711826|617105364|FG002|Overall Study|Failure to manufacture cellular product|5|||
170754003|NCT02711826|617105365|FG003|Overall Study|Failure to manufacture cellular product|0|||
170754004|NCT02711826|617105366|FG004|Overall Study|Failure to manufacture cellular product|0|||
170754005|NCT02711826|617105362|FG000|Overall Study|Infusion canceled for active infection|0|||
170754006|NCT02711826|617105363|FG001|Overall Study|Infusion canceled for active infection|1|||
170754007|NCT02711826|617105364|FG002|Overall Study|Infusion canceled for active infection|0|||
170754008|NCT02711826|617105365|FG003|Overall Study|Infusion canceled for active infection|0|||
170754009|NCT02711826|617105366|FG004|Overall Study|Infusion canceled for active infection|0|||
170754010|NCT02711826|617105362|FG000|Overall Study|Screen failures|0|||
170754011|NCT02711826|617105363|FG001|Overall Study|Screen failures|0|||
170754012|NCT02711826|617105364|FG002|Overall Study|Screen failures|0|||
170754013|NCT02711826|617105365|FG003|Overall Study|Screen failures|4|||
170754014|NCT02711826|617105366|FG004|Overall Study|Screen failures|0|||
170754015|NCT01544582|617105370|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
170754016|NCT01544582|617105371|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
170754017|NCT01544582|617105372|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
170754018|NCT01544582|617105373|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
170754019|NCT01544582|617105370|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
170754020|NCT01544582|617105371|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
170754021|NCT01544582|617105372|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
170754022|NCT01544582|617105373|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
170754023|NCT01544582|617105370|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
170754024|NCT01544582|617105371|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
170864981|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
170864982|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
170864983|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
170864984|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
170864985|NCT00559585|617517993|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
170864986|NCT00559585|617517994|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
170864987|NCT00559585|617517993|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
170864988|NCT00559585|617517994|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
170864989|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
170864990|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
170864991|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
170864992|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
170864993|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
170864994|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
170864995|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
170864996|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
170864997|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
170864998|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
170906117|NCT01331161|617658624|FG001|Overall Study|Lost to Follow-up|1|||
170754025|NCT01544582|617105372|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
170754026|NCT01544582|617105373|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
170754027|NCT01544582|617105370|FG000|Analysis Population|Physician Decision|0|||
170754028|NCT01544582|617105371|FG001|Analysis Population|Physician Decision|13|||
170754029|NCT01544582|617105372|FG002|Analysis Population|Physician Decision|10|||
170754030|NCT01544582|617105373|FG003|Analysis Population|Physician Decision|9|||
170754031|NCT01544582|617105370|FG000|Analysis Population|Safety Reason|0|||
170754032|NCT01544582|617105371|FG001|Analysis Population|Safety Reason|33|||
170754033|NCT01544582|617105372|FG002|Analysis Population|Safety Reason|31|||
170754034|NCT01544582|617105373|FG003|Analysis Population|Safety Reason|8|||
170754035|NCT01544582|617105370|FG000|Analysis Population|Effectiveness Reason|0|||
170754036|NCT01544582|617105371|FG001|Analysis Population|Effectiveness Reason|48|||
170754037|NCT01544582|617105372|FG002|Analysis Population|Effectiveness Reason|29|||
170754038|NCT01544582|617105373|FG003|Analysis Population|Effectiveness Reason|12|||
170754039|NCT01544582|617105370|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
170754040|NCT01544582|617105371|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
170754041|NCT01544582|617105372|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
170754042|NCT01544582|617105373|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
170754043|NCT01544582|617105370|FG000|Analysis Population|Lost to Follow-up|0|||
170754044|NCT01544582|617105371|FG001|Analysis Population|Lost to Follow-up|6|||
170754045|NCT01544582|617105372|FG002|Analysis Population|Lost to Follow-up|6|||
170754046|NCT01544582|617105373|FG003|Analysis Population|Lost to Follow-up|5|||
170754047|NCT01544582|617105370|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
170754048|NCT01544582|617105371|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
170754049|NCT01544582|617105372|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
170754050|NCT01544582|617105373|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
170754051|NCT01544582|617105370|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
170754052|NCT01544582|617105371|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
170754053|NCT01544582|617105372|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
170754054|NCT01544582|617105373|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
170754055|NCT01544582|617105370|FG000|Analysis Population|Intolerance|0|||
170754056|NCT01544582|617105371|FG001|Analysis Population|Intolerance|1|||
170754057|NCT01544582|617105372|FG002|Analysis Population|Intolerance|0|||
170754058|NCT01544582|617105373|FG003|Analysis Population|Intolerance|0|||
170754059|NCT01544582|617105370|FG000|Analysis Population|Liver Transplantation|0|||
170754060|NCT01544582|617105371|FG001|Analysis Population|Liver Transplantation|0|||
170754061|NCT01544582|617105372|FG002|Analysis Population|Liver Transplantation|1|||
170754062|NCT01544582|617105373|FG003|Analysis Population|Liver Transplantation|0|||
170754063|NCT01544582|617105370|FG000|Analysis Population|No Social Insurance|0|||
170754064|NCT01544582|617105371|FG001|Analysis Population|No Social Insurance|0|||
170754065|NCT01544582|617105372|FG002|Analysis Population|No Social Insurance|1|||
170754066|NCT01544582|617105373|FG003|Analysis Population|No Social Insurance|0|||
170754067|NCT01544582|617105370|FG000|Analysis Population|Poor Adherence|0|||
170754068|NCT01544582|617105371|FG001|Analysis Population|Poor Adherence|0|||
170754069|NCT01544582|617105372|FG002|Analysis Population|Poor Adherence|1|||
170754070|NCT01544582|617105373|FG003|Analysis Population|Poor Adherence|0|||
170754071|NCT01544582|617105370|FG000|Analysis Population|Poor Participant Compliance|0|||
170754072|NCT01544582|617105371|FG001|Analysis Population|Poor Participant Compliance|1|||
170754073|NCT01544582|617105372|FG002|Analysis Population|Poor Participant Compliance|0|||
170754074|NCT01544582|617105373|FG003|Analysis Population|Poor Participant Compliance|0|||
170754075|NCT01544582|617105370|FG000|Analysis Population|Programmed Surgery|0|||
170754076|NCT01544582|617105371|FG001|Analysis Population|Programmed Surgery|1|||
170754077|NCT01544582|617105372|FG002|Analysis Population|Programmed Surgery|0|||
170754078|NCT01544582|617105373|FG003|Analysis Population|Programmed Surgery|0|||
170754079|NCT01544582|617105370|FG000|Analysis Population|Participant in Jail|0|||
170754080|NCT01544582|617105371|FG001|Analysis Population|Participant in Jail|0|||
170754081|NCT01544582|617105372|FG002|Analysis Population|Participant in Jail|1|||
170754082|NCT01544582|617105373|FG003|Analysis Population|Participant in Jail|0|||
170754083|NCT03015740|617105374|FG000|Overall Study|Adverse Event|1|||
170754084|NCT03015740|617105375|FG001|Overall Study|Adverse Event|0|||
170754085|NCT03015740|617105376|FG002|Overall Study|Adverse Event|0|||
170754086|NCT03015740|617105374|FG000|Overall Study|Death|3|||
170754087|NCT03015740|617105375|FG001|Overall Study|Death|5|||
170754088|NCT03015740|617105376|FG002|Overall Study|Death|0|||
170754089|NCT03015740|617105374|FG000|Overall Study|Withdrawal by Subject|2|||
170754090|NCT03015740|617105375|FG001|Overall Study|Withdrawal by Subject|0|||
170754091|NCT03015740|617105376|FG002|Overall Study|Withdrawal by Subject|0|||
170754092|NCT01256476|617106434|FG000|Overall Study|Adverse Event|2|||
170754093|NCT01256476|617106435|FG001|Overall Study|Adverse Event|1|||
170754094|NCT01256476|617106434|FG000|Overall Study|Withdrawal by Subject|2|||
170754095|NCT01256476|617106435|FG001|Overall Study|Withdrawal by Subject|1|||
170754096|NCT01256476|617106434|FG000|Overall Study|Lost to Follow-up|1|||
170754097|NCT01256476|617106435|FG001|Overall Study|Lost to Follow-up|2|||
170754098|NCT01256476|617106434|FG000|Overall Study|Persistent ALT or AST elevation|1|||
170754099|NCT01256476|617106435|FG001|Overall Study|Persistent ALT or AST elevation|0|||
170754100|NCT01256476|617106434|FG000|Overall Study|Physician Decision|0|||
170754101|NCT01256476|617106435|FG001|Overall Study|Physician Decision|1|||
170754102|NCT01256476|617106434|FG000|Overall Study|Subject non-compliance|0|||
170754103|NCT01256476|617106435|FG001|Overall Study|Subject non-compliance|1|||
170754104|NCT01256476|617106434|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
170754105|NCT01256476|617106435|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
170402702|NCT01898884|615815003|FG002|Multiple Dose Period|Randomized Not Treated|0|||
170402703|NCT01898884|615815004|FG003|Multiple Dose Period|Randomized Not Treated|0|||
170402704|NCT01898884|615815005|FG004|Multiple Dose Period|Randomized Not Treated|0|||
170402705|NCT01898884|615815006|FG005|Multiple Dose Period|Randomized Not Treated|0|||
170402706|NCT01898884|615815007|FG006|Multiple Dose Period|Randomized Not Treated|0|||
170402707|NCT01898884|615815008|FG007|Multiple Dose Period|Randomized Not Treated|0|||
170402708|NCT01898884|615815009|FG008|Multiple Dose Period|Randomized Not Treated|1|||
170402709|NCT01556165|615815010|FG000|Overall Study|Adverse Event|5|||
170402710|NCT01556165|615815011|FG001|Overall Study|Adverse Event|3|||
170402711|NCT01556165|615815010|FG000|Overall Study|Protocol Violation|0|||
170402712|NCT01556165|615815011|FG001|Overall Study|Protocol Violation|3|||
170402713|NCT01556165|615815010|FG000|Overall Study|Withdrawal of Consent|7|||
170519690|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170754106|NCT04610684|617106436|FG000|Study Treatment|Withdrawal by Subject|1|||
170754107|NCT04610684|617106436|FG000|Study Treatment|Disease Progression|2|||
170754108|NCT04610684|617106436|FG000|Follow up|Death|2|||
170754109|NCT04610684|617106436|FG000|Follow up|Withdrawal by Subject|1|||
170754110|NCT00940017|617106437|FG000|Overall Study|did not meet entrance criteria|3|||
170754111|NCT00940017|617106437|FG000|Overall Study|Adverse Event|1|||
170754112|NCT01345292|617106438|FG000|Overall Study|Withdrawal by Subject|2|||
170754113|NCT01345292|617106439|FG001|Overall Study|Withdrawal by Subject|0|||
170906118|NCT01331161|617658623|FG000|Overall Study|Pregnancy|0|||
170402714|NCT01556165|615815011|FG001|Overall Study|Withdrawal of Consent|1|||
170754114|NCT01345292|617106440|FG002|Overall Study|Withdrawal by Subject|1|||
170754115|NCT01625338|617106444|FG000|Overall Study|Enrolled but not Treated|0|||
170754116|NCT01625338|617106445|FG001|Overall Study|Enrolled but not Treated|0|||
170754117|NCT01625338|617106446|FG002|Overall Study|Enrolled but not Treated|1|||
170754118|NCT01625338|617106444|FG000|Overall Study|Efficacy Failure|27|||
170754119|NCT01625338|617106445|FG001|Overall Study|Efficacy Failure|39|||
170754120|NCT01625338|617106446|FG002|Overall Study|Efficacy Failure|31|||
170754121|NCT01625338|617106444|FG000|Overall Study|Lost to Follow-up|3|||
170754122|NCT01625338|617106445|FG001|Overall Study|Lost to Follow-up|3|||
170754123|NCT01625338|617106446|FG002|Overall Study|Lost to Follow-up|2|||
170754124|NCT01625338|617106444|FG000|Overall Study|Investigator Decision|0|||
170754125|NCT01625338|617106445|FG001|Overall Study|Investigator Decision|2|||
170754126|NCT01625338|617106446|FG002|Overall Study|Investigator Decision|1|||
170754127|NCT01625338|617106444|FG000|Overall Study|Subject Withdrew Consent|1|||
170754128|NCT01625338|617106445|FG001|Overall Study|Subject Withdrew Consent|0|||
170754129|NCT01625338|617106446|FG002|Overall Study|Subject Withdrew Consent|2|||
170754130|NCT01625338|617106444|FG000|Overall Study|Adverse Event|1|||
170754131|NCT01625338|617106445|FG001|Overall Study|Adverse Event|0|||
170754132|NCT01625338|617106446|FG002|Overall Study|Adverse Event|1|||
170754133|NCT01625338|617106444|FG000|Overall Study|Study Discontinued by Sponsor|0|||
170754134|NCT01625338|617106445|FG001|Overall Study|Study Discontinued by Sponsor|0|||
170754135|NCT01625338|617106446|FG002|Overall Study|Study Discontinued by Sponsor|1|||
170754136|NCT01789203|617106447|FG000|Overall Study|Adverse Event|2|||
170754137|NCT01789203|617106448|FG001|Overall Study|Adverse Event|2|||
170754138|NCT01789203|617106447|FG000|Overall Study|Withdrawal by Subject|1|||
170754139|NCT01789203|617106448|FG001|Overall Study|Withdrawal by Subject|0|||
170754140|NCT01789203|617106447|FG000|Overall Study|Death|1|||
170754141|NCT01789203|617106448|FG001|Overall Study|Death|0|||
170754142|NCT01789203|617106447|FG000|Overall Study|Protocol Violation|2|||
170754143|NCT01789203|617106448|FG001|Overall Study|Protocol Violation|1|||
170754144|NCT01789203|617106447|FG000|Overall Study|Other|1|||
170754145|NCT01789203|617106448|FG001|Overall Study|Other|1|||
170754146|NCT01789203|617106447|FG000|Overall Study|patient non-adherent|2|||
170864999|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
170865000|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
170865001|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
170865002|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
170754147|NCT01789203|617106448|FG001|Overall Study|patient non-adherent|0|||
170754148|NCT01254305|617106452|FG000|Overall Study|Adverse Event|6|||
170754149|NCT01254305|617106453|FG001|Overall Study|Adverse Event|3|||
170754150|NCT01254305|617106454|FG002|Overall Study|Adverse Event|2|||
170754151|NCT01254305|617106452|FG000|Overall Study|Lack of Efficacy|1|||
170754152|NCT01254305|617106453|FG001|Overall Study|Lack of Efficacy|0|||
170754153|NCT01254305|617106454|FG002|Overall Study|Lack of Efficacy|1|||
170754154|NCT01254305|617106452|FG000|Overall Study|Protocol Violation|1|||
170754155|NCT01254305|617106453|FG001|Overall Study|Protocol Violation|7|||
170754156|NCT01254305|617106454|FG002|Overall Study|Protocol Violation|3|||
170754157|NCT01254305|617106452|FG000|Overall Study|Withdrawal by Subject|4|||
170754158|NCT01254305|617106453|FG001|Overall Study|Withdrawal by Subject|2|||
170754159|NCT01254305|617106454|FG002|Overall Study|Withdrawal by Subject|4|||
170754160|NCT01254305|617106452|FG000|Overall Study|Lost to Follow-up|10|||
170754161|NCT01254305|617106453|FG001|Overall Study|Lost to Follow-up|6|||
170754162|NCT01254305|617106454|FG002|Overall Study|Lost to Follow-up|5|||
170754163|NCT01254305|617106452|FG000|Overall Study|Other Reasons|0|||
170754164|NCT01254305|617106453|FG001|Overall Study|Other Reasons|0|||
170754165|NCT01254305|617106454|FG002|Overall Study|Other Reasons|2|||
170754166|NCT01511536|617106455|FG000|Phase 1|Other|0|||
170754167|NCT01511536|617106456|FG001|Phase 1|Other|1|||
170754168|NCT01511536|617106457|FG002|Phase 1|Other|0|||
170754169|NCT01511536|617106455|FG000|Phase 2|Other|0|||
170754170|NCT01511536|617106456|FG001|Phase 2|Other|0|||
170754171|NCT01511536|617106457|FG002|Phase 2|Other|9|||
170754172|NCT02297503|617106458|FG000|Overall Study|Withdrawal by Subject|1|||
170754173|NCT02297503|617106459|FG001|Overall Study|Withdrawal by Subject|1|||
170754174|NCT02297503|617106458|FG000|Overall Study|Protocol Violation|1|||
170754175|NCT02297503|617106459|FG001|Overall Study|Protocol Violation|0|||
170754176|NCT02297503|617106458|FG000|Overall Study|Pregnancy|0|||
170754177|NCT02297503|617106459|FG001|Overall Study|Pregnancy|1|||
170754178|NCT02297503|617106458|FG000|Overall Study|Lost to Follow-up|0|||
170754179|NCT02297503|617106459|FG001|Overall Study|Lost to Follow-up|1|||
170865003|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
170865004|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
170865005|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
170754180|NCT02297503|617106458|FG000|Overall Study|Medical reason|0|||
170754181|NCT02297503|617106459|FG001|Overall Study|Medical reason|1|||
170754182|NCT02703532|617106461|FG000|Overall Study|Withdrawal by Subject|0|||
170754183|NCT02703532|617106462|FG001|Overall Study|Withdrawal by Subject|1|||
170754184|NCT02703532|617106463|FG002|Overall Study|Withdrawal by Subject|0|||
170754185|NCT02703532|617106464|FG003|Overall Study|Withdrawal by Subject|1|||
170754186|NCT02703532|617106461|FG000|Overall Study|Lost to Follow-up|2|||
170754187|NCT02703532|617106462|FG001|Overall Study|Lost to Follow-up|0|||
170754188|NCT02703532|617106463|FG002|Overall Study|Lost to Follow-up|2|||
170754189|NCT02703532|617106464|FG003|Overall Study|Lost to Follow-up|0|||
170754190|NCT01636362|617106468|FG000|Overall Study|Physician Decision|6|||
170754191|NCT01636362|617106468|FG000|Overall Study|Subject healed, not returning|1|||
170754192|NCT01636362|617106468|FG000|Overall Study|Withdrawal by Subject|1|||
170754193|NCT02263885|617106469|FG000|Overall Study|Withdrawal by Subject|7|||
170754194|NCT02263885|617106469|FG000|Overall Study|Alternative Treatment|3|||
170754195|NCT02271594|617106470|FG000|Overall Study|Study closed; recruiting failure|19|||
170754196|NCT02271594|617106471|FG001|Overall Study|Study closed; recruiting failure|12|||
170754197|NCT03330119|617106472|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
170754198|NCT03330119|617106473|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
170754199|NCT01456780|617106476|FG000|Overall Study|Lost to Follow-up|3|||
170754200|NCT01456780|617106477|FG001|Overall Study|Lost to Follow-up|3|||
170754201|NCT01456780|617106478|FG002|Overall Study|Lost to Follow-up|0|||
170754202|NCT00984282|617106484|FG000|Double Blind Treatment|Adverse Event|40|||
170754203|NCT00984282|617106485|FG001|Double Blind Treatment|Adverse Event|6|||
170754204|NCT00984282|617106484|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
170754205|NCT00984282|617106485|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
170754206|NCT00984282|617106484|FG000|Double Blind Treatment|Physician Decision|1|||
170754207|NCT00984282|617106485|FG001|Double Blind Treatment|Physician Decision|2|||
170754208|NCT00984282|617106484|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
170754209|NCT00984282|617106485|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
170754210|NCT00984282|617106484|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
170754211|NCT00984282|617106485|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
170754212|NCT00984282|617106484|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
170754213|NCT00984282|617106485|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
170754214|NCT00984282|617106484|FG000|Double Blind Treatment|Lost to Follow-up|3|||
170754215|NCT00984282|617106485|FG001|Double Blind Treatment|Lost to Follow-up|0|||
170754216|NCT00984282|617106484|FG000|Double Blind Treatment|Death|8|||
170754217|NCT00984282|617106485|FG001|Double Blind Treatment|Death|4|||
170754218|NCT00984282|617106484|FG000|Double Blind Treatment|Not treated|0|||
170754219|NCT00984282|617106485|FG001|Double Blind Treatment|Not treated|1|||
170754220|NCT00984282|617106484|FG000|Double Blind Treatment|Switched to commercial drug|6|||
170754221|NCT00984282|617106485|FG001|Double Blind Treatment|Switched to commercial drug|1|||
170754222|NCT00984282|617106484|FG000|Double Blind Treatment|protocol driven decision point|1|||
170754223|NCT00984282|617106485|FG001|Double Blind Treatment|protocol driven decision point|1|||
170754224|NCT00984282|617106484|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
170754225|NCT00984282|617106485|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
170754226|NCT00984282|617106484|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
170754227|NCT00984282|617106485|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
170754228|NCT00984282|617106484|FG000|Open-label Treatment|Adverse Event|20|||
170754229|NCT00984282|617106485|FG001|Open-label Treatment|Adverse Event|30|||
170754230|NCT00984282|617106484|FG000|Open-label Treatment|Withdrawal by Subject|6|||
170754231|NCT00984282|617106485|FG001|Open-label Treatment|Withdrawal by Subject|21|||
170754232|NCT00984282|617106484|FG000|Open-label Treatment|Death|7|||
170754233|NCT00984282|617106485|FG001|Open-label Treatment|Death|15|||
170754234|NCT00984282|617106484|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
170754235|NCT00984282|617106485|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
170754236|NCT00984282|617106484|FG000|Open-label Treatment|Lost to Follow-up|1|||
170754237|NCT00984282|617106485|FG001|Open-label Treatment|Lost to Follow-up|1|||
170754238|NCT00984282|617106484|FG000|Open-label Treatment|Patient convenience|1|||
170754239|NCT00984282|617106485|FG001|Open-label Treatment|Patient convenience|0|||
170754240|NCT00984282|617106484|FG000|Open-label Treatment|Non-compliant with study medication|1|||
170754241|NCT00984282|617106485|FG001|Open-label Treatment|Non-compliant with study medication|0|||
170754242|NCT00984282|617106484|FG000|Open-label Treatment|Target lesion removed|0|||
170754243|NCT00984282|617106485|FG001|Open-label Treatment|Target lesion removed|1|||
170754244|NCT00984282|617106484|FG000|Open-label Treatment|Protocol driven decision point|1|||
170865006|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
170865007|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
170865008|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
170754245|NCT00984282|617106485|FG001|Open-label Treatment|Protocol driven decision point|1|||
170754246|NCT00984282|617106484|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
170754247|NCT00984282|617106485|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
170754248|NCT00984282|617106484|FG000|Open-label Treatment|Switched to commercial drug|6|||
170754249|NCT00984282|617106485|FG001|Open-label Treatment|Switched to commercial drug|7|||
170754250|NCT00984282|617106484|FG000|Open-label Treatment|Physician Decision|1|||
170754251|NCT00984282|617106485|FG001|Open-label Treatment|Physician Decision|0|||
170402715|NCT01640964|615815016|FG000|Overall Study|Lost to Follow-up|0|||
170754252|NCT00984282|617106484|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
170754253|NCT00984282|617106485|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
170754254|NCT00984282|617106484|FG000|Long Term Follow-up|Death|27|||
170754255|NCT00984282|617106485|FG001|Long Term Follow-up|Death|68|||
170754256|NCT00984282|617106484|FG000|Long Term Follow-up|Lost to Follow-up|3|||
170754257|NCT00984282|617106485|FG001|Long Term Follow-up|Lost to Follow-up|6|||
170754258|NCT00984282|617106484|FG000|Long Term Follow-up|Protocol driven decision point|25|||
170754259|NCT00984282|617106485|FG001|Long Term Follow-up|Protocol driven decision point|26|||
170754260|NCT00984282|617106484|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
170754261|NCT00984282|617106485|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
170754262|NCT00984282|617106484|FG000|Long Term Follow-up|Switched to commercial drug|4|||
170754263|NCT00984282|617106485|FG001|Long Term Follow-up|Switched to commercial drug|2|||
170754264|NCT00984282|617106484|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
170754265|NCT00984282|617106485|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
170754266|NCT04004208|617106487|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170754267|NCT04004208|617106488|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170754268|NCT04004208|617106487|FG000|Overall Study|Death|3|||
170754269|NCT04004208|617106488|FG001|Overall Study|Death|0|||
170754270|NCT04004208|617106487|FG000|Overall Study|COVID-19 pandemic|1|||
170754271|NCT04004208|617106488|FG001|Overall Study|COVID-19 pandemic|0|||
170754272|NCT04004208|617106487|FG000|Overall Study|Physician Decision|1|||
170754273|NCT04004208|617106488|FG001|Overall Study|Physician Decision|0|||
170754274|NCT04004208|617106487|FG000|Overall Study|Adverse Event|1|||
170754275|NCT04004208|617106488|FG001|Overall Study|Adverse Event|1|||
170754276|NCT04990440|617106489|FG000|Overall Study|Sponsor's Decision|0|||
170754277|NCT04990440|617106490|FG001|Overall Study|Sponsor's Decision|0|||
170754278|NCT04990440|617106491|FG002|Overall Study|Sponsor's Decision|1|||
170754279|NCT02256969|617106492|FG000|Overall Study|Screenfailed or withdrew|2|||
170754280|NCT02256969|617106493|FG001|Overall Study|Screenfailed or withdrew|1|||
170754281|NCT02256969|617106494|FG002|Overall Study|Screenfailed or withdrew|1|||
170754282|NCT00372567|617106497|FG000|Phase 3 Study|Adverse Event|5|||
170754283|NCT00372567|617106498|FG001|Phase 3 Study|Adverse Event|1|||
170754284|NCT00372567|617106499|FG002|Phase 3 Study|Adverse Event|1|||
170754285|NCT00372567|617106497|FG000|Phase 3 Study|Death|1|||
170754286|NCT00372567|617106498|FG001|Phase 3 Study|Death|1|||
170754287|NCT00372567|617106499|FG002|Phase 3 Study|Death|0|||
170754288|NCT00372567|617106497|FG000|Phase 3 Study|Protocol Violation|0|||
170754289|NCT00372567|617106498|FG001|Phase 3 Study|Protocol Violation|0|||
170754290|NCT00372567|617106499|FG002|Phase 3 Study|Protocol Violation|1|||
170754291|NCT00372567|617106497|FG000|Phase 3 Study|Objective progression or relapse|10|||
170754292|NCT00372567|617106498|FG001|Phase 3 Study|Objective progression or relapse|13|||
170754293|NCT00372567|617106499|FG002|Phase 3 Study|Objective progression or relapse|4|||
170754294|NCT00372567|617106497|FG000|Phase 3 Study|Global deterioration of health status|0|||
170754295|NCT00372567|617106498|FG001|Phase 3 Study|Global deterioration of health status|1|||
170754296|NCT00372567|617106499|FG002|Phase 3 Study|Global deterioration of health status|0|||
170754297|NCT00372567|617106497|FG000|Phase 3 Study|Other|2|||
170754298|NCT00372567|617106498|FG001|Phase 3 Study|Other|2|||
170754299|NCT00372567|617106499|FG002|Phase 3 Study|Other|1|||
170754300|NCT00372567|617106497|FG000|Phase 3 Study|study terminated by sponsor|13|||
170754301|NCT00372567|617106498|FG001|Phase 3 Study|study terminated by sponsor|8|||
170754302|NCT00372567|617106499|FG002|Phase 3 Study|study terminated by sponsor|5|||
170754303|NCT00425503|617106503|FG000|Overall Study|Adverse Event|2|||
170754304|NCT00425503|617106503|FG000|Overall Study|Protocol Violation|1|||
170754305|NCT02118714|617106506|FG000|Overall Study|Lost to Follow-up|2|||
170754306|NCT02118714|617106506|FG000|Overall Study|Protocol Violation|1|||
170754307|NCT02400307|617106508|FG000|Overall Study|Enrolled and Never Dosed|1|||
170754308|NCT02400307|617106509|FG001|Overall Study|Enrolled and Never Dosed|0|||
170754309|NCT01052662|617106510|FG000|Overall Study|Lost to Follow-up|15|||
170754310|NCT01052662|617106511|FG001|Overall Study|Lost to Follow-up|13|||
170754311|NCT01052662|617106512|FG002|Overall Study|Lost to Follow-up|18|||
170754312|NCT01052662|617106510|FG000|Overall Study|Withdrawal by Subject|3|||
170754313|NCT01052662|617106511|FG001|Overall Study|Withdrawal by Subject|2|||
170754314|NCT01052662|617106512|FG002|Overall Study|Withdrawal by Subject|1|||
170754315|NCT01052662|617106510|FG000|Overall Study|Pharmacy issue|1|||
170754316|NCT01052662|617106511|FG001|Overall Study|Pharmacy issue|3|||
170754317|NCT01052662|617106512|FG002|Overall Study|Pharmacy issue|3|||
170754318|NCT01052662|617106510|FG000|Overall Study|Adverse Event|1|||
170754319|NCT01052662|617106511|FG001|Overall Study|Adverse Event|1|||
170754320|NCT01052662|617106512|FG002|Overall Study|Adverse Event|0|||
170754321|NCT01052662|617106510|FG000|Overall Study|Legal Problem|2|||
170754322|NCT01052662|617106511|FG001|Overall Study|Legal Problem|0|||
170754323|NCT01052662|617106512|FG002|Overall Study|Legal Problem|0|||
170754324|NCT01052662|617106510|FG000|Overall Study|Administrative|0|||
170754325|NCT01052662|617106511|FG001|Overall Study|Administrative|3|||
170754326|NCT01052662|617106512|FG002|Overall Study|Administrative|0|||
170754327|NCT02015663|617106514|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
170754328|NCT02015663|617106515|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
170754329|NCT02015663|617106514|FG000|Overall Study|Withdrawal by Subject|1|||
170754330|NCT02015663|617106515|FG001|Overall Study|Withdrawal by Subject|0|||
170754331|NCT02015663|617106514|FG000|Overall Study|Protocol Violation|0|||
170754332|NCT02015663|617106515|FG001|Overall Study|Protocol Violation|1|||
170754333|NCT02015663|617106514|FG000|Overall Study|Adverse Event|3|||
170754334|NCT02015663|617106515|FG001|Overall Study|Adverse Event|0|||
170754335|NCT02015663|617106514|FG000|Overall Study|Administrative problems|10|||
170754336|NCT02015663|617106515|FG001|Overall Study|Administrative problems|11|||
170754337|NCT00479674|617106516|FG000|Overall Study|Adverse Event|18|||
170754338|NCT00479674|617106516|FG000|Overall Study|Withdrawal by Subject|6|||
170754339|NCT00479674|617106516|FG000|Overall Study|Physician Decision|14|||
170754340|NCT00479674|617106516|FG000|Overall Study|none provided|3|||
170754341|NCT00761774|617106519|FG000|Overall Study|Adverse Event|17|||
170754342|NCT00761774|617106519|FG000|Overall Study|Lack of Efficacy|37|||
170754343|NCT00761774|617106519|FG000|Overall Study|Lost to Follow-up|2|||
170754344|NCT00761774|617106519|FG000|Overall Study|Withdrawal by Subject|9|||
170754345|NCT00761774|617106519|FG000|Overall Study|Non-compliance|4|||
170754346|NCT00761774|617106519|FG000|Overall Study|End of study|2|||
170754347|NCT00761774|617106519|FG000|Overall Study|Reclassification of seizures|1|||
170754348|NCT00761774|617106519|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
170754349|NCT00761774|617106519|FG000|Overall Study|Sponsor decision|1|||
170754350|NCT00761774|617106519|FG000|Overall Study|Investigator clinical judgement|1|||
170754351|NCT00761774|617106519|FG000|Overall Study|Patient moved out of study area|1|||
170754352|NCT00761774|617106519|FG000|Overall Study|Coordinator leaving site|1|||
170754353|NCT00761774|617106519|FG000|Overall Study|Subject IP non-compliance|1|||
170754354|NCT00761774|617106519|FG000|Overall Study|IP stopped by hospital physician|1|||
170754355|NCT00131911|617106524|FG000|Overall Study|Withdrawal by Subject|1|||
170754356|NCT00131911|617106525|FG001|Overall Study|Withdrawal by Subject|0|||
170754357|NCT00783718|617106526|FG000|Induction Phase|Adverse Event|4|||
170754358|NCT00783718|617106527|FG001|Induction Phase|Adverse Event|0|||
170754359|NCT00783718|617106528|FG002|Induction Phase|Adverse Event|7|||
170754360|NCT00783718|617106529|FG003|Induction Phase|Adverse Event|0|||
170754361|NCT00783718|617106530|FG004|Induction Phase|Adverse Event|0|||
170754362|NCT00783718|617106531|FG005|Induction Phase|Adverse Event|0|||
170754363|NCT00783718|617106532|FG006|Induction Phase|Adverse Event|0|||
170754364|NCT00783718|617106526|FG000|Induction Phase|Protocol Violation|1|||
170754365|NCT00783718|617106527|FG001|Induction Phase|Protocol Violation|1|||
170754366|NCT00783718|617106528|FG002|Induction Phase|Protocol Violation|6|||
170754367|NCT00783718|617106529|FG003|Induction Phase|Protocol Violation|0|||
170754368|NCT00783718|617106530|FG004|Induction Phase|Protocol Violation|0|||
170754369|NCT00783718|617106531|FG005|Induction Phase|Protocol Violation|0|||
170754370|NCT00783718|617106532|FG006|Induction Phase|Protocol Violation|0|||
170754371|NCT00783718|617106526|FG000|Induction Phase|Lack of Efficacy|5|||
170754372|NCT00783718|617106527|FG001|Induction Phase|Lack of Efficacy|2|||
170754373|NCT00783718|617106528|FG002|Induction Phase|Lack of Efficacy|14|||
170754374|NCT00783718|617106529|FG003|Induction Phase|Lack of Efficacy|0|||
170754375|NCT00783718|617106530|FG004|Induction Phase|Lack of Efficacy|0|||
170754376|NCT00783718|617106531|FG005|Induction Phase|Lack of Efficacy|0|||
170754377|NCT00783718|617106532|FG006|Induction Phase|Lack of Efficacy|0|||
170754378|NCT00783718|617106526|FG000|Induction Phase|Withdrawal by Subject|3|||
170754379|NCT00783718|617106527|FG001|Induction Phase|Withdrawal by Subject|4|||
170754380|NCT00783718|617106528|FG002|Induction Phase|Withdrawal by Subject|8|||
170754381|NCT00783718|617106529|FG003|Induction Phase|Withdrawal by Subject|0|||
170754382|NCT00783718|617106530|FG004|Induction Phase|Withdrawal by Subject|0|||
170754383|NCT00783718|617106531|FG005|Induction Phase|Withdrawal by Subject|0|||
170754384|NCT00783718|617106532|FG006|Induction Phase|Withdrawal by Subject|0|||
170754385|NCT00783718|617106526|FG000|Induction Phase|Lost to Follow-up|1|||
170754386|NCT00783718|617106527|FG001|Induction Phase|Lost to Follow-up|0|||
170754387|NCT00783718|617106528|FG002|Induction Phase|Lost to Follow-up|1|||
170402716|NCT01640964|615815017|FG001|Overall Study|Lost to Follow-up|0|||
170402717|NCT01640964|615815018|FG002|Overall Study|Lost to Follow-up|1|||
170402718|NCT01640964|615815016|FG000|Overall Study|Protocol Deviation|1|||
170402719|NCT01640964|615815017|FG001|Overall Study|Protocol Deviation|1|||
170402720|NCT01640964|615815018|FG002|Overall Study|Protocol Deviation|2|||
170402721|NCT03471182|615816968|FG000|Overall Study|Withdrawal by Subject|1|||
170754388|NCT00783718|617106529|FG003|Induction Phase|Lost to Follow-up|0|||
170754389|NCT00783718|617106530|FG004|Induction Phase|Lost to Follow-up|0|||
170754390|NCT00783718|617106531|FG005|Induction Phase|Lost to Follow-up|0|||
170754391|NCT00783718|617106532|FG006|Induction Phase|Lost to Follow-up|0|||
170402722|NCT03471182|615816969|FG001|Overall Study|Withdrawal by Subject|1|||
170754392|NCT00783718|617106526|FG000|Maintenance Phase|Adverse Event|12|||
170754393|NCT00783718|617106527|FG001|Maintenance Phase|Adverse Event|0|||
170754394|NCT00783718|617106528|FG002|Maintenance Phase|Adverse Event|0|||
170754395|NCT00783718|617106529|FG003|Maintenance Phase|Adverse Event|15|||
170754396|NCT00783718|617106530|FG004|Maintenance Phase|Adverse Event|7|||
170402723|NCT03471182|615816970|FG002|Overall Study|Withdrawal by Subject|0|||
170402724|NCT03471182|615816968|FG000|Overall Study|Technical failure|2|||
170754397|NCT00783718|617106531|FG005|Maintenance Phase|Adverse Event|6|||
170754398|NCT00783718|617106532|FG006|Maintenance Phase|Adverse Event|16|||
170754399|NCT00783718|617106526|FG000|Maintenance Phase|Protocol Violation|1|||
170754400|NCT00783718|617106527|FG001|Maintenance Phase|Protocol Violation|0|||
170754401|NCT00783718|617106528|FG002|Maintenance Phase|Protocol Violation|0|||
170754402|NCT00783718|617106529|FG003|Maintenance Phase|Protocol Violation|0|||
170754403|NCT00783718|617106530|FG004|Maintenance Phase|Protocol Violation|0|||
170754404|NCT00783718|617106531|FG005|Maintenance Phase|Protocol Violation|0|||
170754405|NCT00783718|617106532|FG006|Maintenance Phase|Protocol Violation|2|||
170754406|NCT00783718|617106526|FG000|Maintenance Phase|Lack of Efficacy|83|||
170754407|NCT00783718|617106527|FG001|Maintenance Phase|Lack of Efficacy|0|||
170754408|NCT00783718|617106528|FG002|Maintenance Phase|Lack of Efficacy|0|||
170754409|NCT00783718|617106529|FG003|Maintenance Phase|Lack of Efficacy|61|||
170754410|NCT00783718|617106530|FG004|Maintenance Phase|Lack of Efficacy|31|||
170754411|NCT00783718|617106531|FG005|Maintenance Phase|Lack of Efficacy|33|||
170754412|NCT00783718|617106532|FG006|Maintenance Phase|Lack of Efficacy|155|||
170754413|NCT00783718|617106526|FG000|Maintenance Phase|Withdrawal by Subject|6|||
170754414|NCT00783718|617106527|FG001|Maintenance Phase|Withdrawal by Subject|0|||
170754415|NCT00783718|617106528|FG002|Maintenance Phase|Withdrawal by Subject|0|||
170754416|NCT00783718|617106529|FG003|Maintenance Phase|Withdrawal by Subject|2|||
170754417|NCT00783718|617106530|FG004|Maintenance Phase|Withdrawal by Subject|5|||
170754418|NCT00783718|617106531|FG005|Maintenance Phase|Withdrawal by Subject|2|||
170754419|NCT00783718|617106532|FG006|Maintenance Phase|Withdrawal by Subject|20|||
170754420|NCT00783718|617106526|FG000|Maintenance Phase|Lost to Follow-up|3|||
170754421|NCT00783718|617106527|FG001|Maintenance Phase|Lost to Follow-up|0|||
170754422|NCT00783718|617106528|FG002|Maintenance Phase|Lost to Follow-up|0|||
170754423|NCT00783718|617106529|FG003|Maintenance Phase|Lost to Follow-up|0|||
170754424|NCT00783718|617106530|FG004|Maintenance Phase|Lost to Follow-up|2|||
170754425|NCT00783718|617106531|FG005|Maintenance Phase|Lost to Follow-up|0|||
170754426|NCT00783718|617106532|FG006|Maintenance Phase|Lost to Follow-up|2|||
170754427|NCT00630539|617106533|FG000|Overall Study|Adverse Event|1|||
170754428|NCT00630539|617106534|FG001|Overall Study|Adverse Event|3|||
170754429|NCT00630539|617106535|FG002|Overall Study|Adverse Event|1|||
170754430|NCT00630539|617106536|FG003|Overall Study|Adverse Event|2|||
170754431|NCT00630539|617106533|FG000|Overall Study|Withdrawal by Subject|0|||
170754432|NCT00630539|617106534|FG001|Overall Study|Withdrawal by Subject|1|||
170754433|NCT00630539|617106535|FG002|Overall Study|Withdrawal by Subject|0|||
170754434|NCT00630539|617106536|FG003|Overall Study|Withdrawal by Subject|1|||
170754435|NCT03782727|617106537|FG000|Overall Study|Lost to Follow-up|32|||
170754436|NCT02234310|617106538|FG000|Overall Study|Physician Decision|1|||
170754437|NCT02234310|617106538|FG000|Overall Study|Adverse Event|1|||
170754438|NCT02234310|617106538|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
170754439|NCT02234310|617106538|FG000|Overall Study|Withdrawal by Subject|2|||
170754440|NCT04482855|617106539|FG000|Overall Study|Lost to Follow-up|1|||
170754441|NCT04482855|617106540|FG001|Overall Study|Lost to Follow-up|0|||
170754442|NCT04482855|617106539|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
170754443|NCT04482855|617106540|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
170754444|NCT04482855|617106539|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
170754445|NCT04482855|617106540|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
170754446|NCT02507219|617106541|FG000|Overall Study|Physician Decision|1|||
170754447|NCT02507219|617106542|FG001|Overall Study|Physician Decision|0|||
170754448|NCT02507219|617106543|FG002|Overall Study|Physician Decision|0|||
170754449|NCT02507219|617106544|FG003|Overall Study|Physician Decision|0|||
170754450|NCT02507219|617106545|FG004|Overall Study|Physician Decision|0|||
170754451|NCT02507219|617106546|FG005|Overall Study|Physician Decision|0|||
170754452|NCT02507219|617106541|FG000|Overall Study|Withdrawal by Subject|0|||
170754453|NCT02507219|617106542|FG001|Overall Study|Withdrawal by Subject|0|||
170754454|NCT02507219|617106543|FG002|Overall Study|Withdrawal by Subject|0|||
170754455|NCT02507219|617106544|FG003|Overall Study|Withdrawal by Subject|0|||
170754456|NCT02507219|617106545|FG004|Overall Study|Withdrawal by Subject|1|||
170754457|NCT02507219|617106546|FG005|Overall Study|Withdrawal by Subject|0|||
170754458|NCT02886936|617106547|FG000|Overall Study|Lost to Follow-up|4|||
170754459|NCT02886936|617106548|FG001|Overall Study|Lost to Follow-up|3|||
170754460|NCT02886936|617106549|FG002|Overall Study|Lost to Follow-up|0|||
170754461|NCT04562779|617106550|FG000|Overall Study|Lost to Follow-up|7|||
170754462|NCT04562779|617106551|FG001|Overall Study|Lost to Follow-up|5|||
170865009|NCT00559585|617517993|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
170631520|NCT02113982|616664417|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
170754463|NCT04562779|617106552|FG002|Overall Study|Lost to Follow-up|10|||
170754464|NCT04562779|617106550|FG000|Overall Study|Protocol Violation|2|||
170754465|NCT04562779|617106551|FG001|Overall Study|Protocol Violation|2|||
170865010|NCT00559585|617517994|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
170754466|NCT04562779|617106552|FG002|Overall Study|Protocol Violation|0|||
170754467|NCT02320721|617106553|FG000|Overall Study|Adverse Event|6|||
170754468|NCT02320721|617106554|FG001|Overall Study|Adverse Event|6|||
170754469|NCT02320721|617106553|FG000|Overall Study|Lack of Efficacy|2|||
170754470|NCT02320721|617106554|FG001|Overall Study|Lack of Efficacy|0|||
170754471|NCT02320721|617106553|FG000|Overall Study|Poor compliance to protocol|3|||
170754472|NCT02320721|617106554|FG001|Overall Study|Poor compliance to protocol|7|||
170754473|NCT02320721|617106553|FG000|Overall Study|Randomized but not treated|0|||
170754474|NCT02320721|617106554|FG001|Overall Study|Randomized but not treated|1|||
170754475|NCT02320721|617106553|FG000|Overall Study|Hypoglycemia|1|||
170754476|NCT02320721|617106554|FG001|Overall Study|Hypoglycemia|0|||
170754477|NCT02320721|617106553|FG000|Overall Study|Other than specified above|15|||
170754478|NCT02320721|617106554|FG001|Overall Study|Other than specified above|20|||
170754479|NCT03173248|617106555|FG000|Overall Study|Death|28|||
170754480|NCT03173248|617106556|FG001|Overall Study|Death|46|||
170754481|NCT03173248|617106555|FG000|Overall Study|Lost to Follow-up|0|||
170754482|NCT03173248|617106556|FG001|Overall Study|Lost to Follow-up|1|||
170754483|NCT03173248|617106555|FG000|Overall Study|Withdrawal by Subject|6|||
170754484|NCT03173248|617106556|FG001|Overall Study|Withdrawal by Subject|4|||
170754485|NCT03173248|617106555|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
170754486|NCT03173248|617106556|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
170754487|NCT02624778|617108375|FG000|Overall Study|Lost to Follow-up|0|||
170754488|NCT02624778|617108376|FG001|Overall Study|Lost to Follow-up|0|||
170754489|NCT02624778|617108377|FG002|Overall Study|Lost to Follow-up|1|||
170754490|NCT02624778|617108378|FG003|Overall Study|Lost to Follow-up|0|||
170754491|NCT02624778|617108379|FG004|Overall Study|Lost to Follow-up|0|||
170754492|NCT02624778|617108380|FG005|Overall Study|Lost to Follow-up|0|||
170754493|NCT02624778|617108381|FG006|Overall Study|Lost to Follow-up|0|||
170754494|NCT02624778|617108382|FG007|Overall Study|Lost to Follow-up|0|||
170754495|NCT02624778|617108383|FG008|Overall Study|Lost to Follow-up|0|||
170754496|NCT02624778|617108375|FG000|Overall Study|Withdrawal by Subject|0|||
170754497|NCT02624778|617108376|FG001|Overall Study|Withdrawal by Subject|1|||
170754498|NCT02624778|617108377|FG002|Overall Study|Withdrawal by Subject|0|||
170754499|NCT02624778|617108378|FG003|Overall Study|Withdrawal by Subject|0|||
170754500|NCT02624778|617108379|FG004|Overall Study|Withdrawal by Subject|0|||
170754501|NCT02624778|617108380|FG005|Overall Study|Withdrawal by Subject|1|||
170754502|NCT02624778|617108381|FG006|Overall Study|Withdrawal by Subject|1|||
170754503|NCT02624778|617108382|FG007|Overall Study|Withdrawal by Subject|1|||
170754504|NCT02624778|617108383|FG008|Overall Study|Withdrawal by Subject|1|||
170754505|NCT02624778|617108375|FG000|Overall Study|Adverse Event|0|||
170754506|NCT02624778|617108376|FG001|Overall Study|Adverse Event|0|||
170754507|NCT02624778|617108377|FG002|Overall Study|Adverse Event|0|||
170754508|NCT02624778|617108378|FG003|Overall Study|Adverse Event|0|||
170754509|NCT02624778|617108379|FG004|Overall Study|Adverse Event|0|||
170754510|NCT02624778|617108380|FG005|Overall Study|Adverse Event|0|||
170754511|NCT02624778|617108381|FG006|Overall Study|Adverse Event|0|||
170754512|NCT02624778|617108382|FG007|Overall Study|Adverse Event|0|||
170754513|NCT02624778|617108383|FG008|Overall Study|Adverse Event|2|||
170754514|NCT02624778|617108375|FG000|Overall Study|Death|0|||
170754515|NCT02624778|617108376|FG001|Overall Study|Death|0|||
170754516|NCT02624778|617108377|FG002|Overall Study|Death|0|||
170754517|NCT02624778|617108378|FG003|Overall Study|Death|0|||
170754518|NCT02624778|617108379|FG004|Overall Study|Death|0|||
170754519|NCT02624778|617108380|FG005|Overall Study|Death|0|||
170754520|NCT02624778|617108381|FG006|Overall Study|Death|1|||
170754521|NCT02624778|617108382|FG007|Overall Study|Death|0|||
170754522|NCT02624778|617108383|FG008|Overall Study|Death|0|||
170754523|NCT02624778|617108375|FG000|Overall Study|Physician Decision|0|||
170754524|NCT02624778|617108376|FG001|Overall Study|Physician Decision|0|||
170754525|NCT02624778|617108377|FG002|Overall Study|Physician Decision|0|||
170754526|NCT02624778|617108378|FG003|Overall Study|Physician Decision|0|||
170754527|NCT02624778|617108379|FG004|Overall Study|Physician Decision|0|||
170754528|NCT02624778|617108380|FG005|Overall Study|Physician Decision|0|||
170754529|NCT02624778|617108381|FG006|Overall Study|Physician Decision|0|||
170865011|NCT04209621|617517995|FG000|Overall Study|Death|1|||
170754530|NCT02624778|617108382|FG007|Overall Study|Physician Decision|3|||
170754531|NCT02624778|617108383|FG008|Overall Study|Physician Decision|3|||
170865012|NCT04209621|617517995|FG000|Overall Study|Study Terminated Early|2|||
170754532|NCT04091672|617108386|FG000|Overall Study|Death|6|||
170754533|NCT04091672|617108387|FG001|Overall Study|Death|6|||
170865013|NCT00769860|617518000|FG000|Overall Study|Withdrawal by Subject|2|||
170865014|NCT00769860|617518001|FG001|Overall Study|Withdrawal by Subject|0|||
170754534|NCT04091672|617108386|FG000|Overall Study|Lost to Follow-up|7|||
170906119|NCT01331161|617658624|FG001|Overall Study|Pregnancy|1|||
170754535|NCT04091672|617108387|FG001|Overall Study|Lost to Follow-up|7|||
170754536|NCT04091672|617108386|FG000|Overall Study|Withdrawal by Subject|3|||
170754537|NCT04091672|617108387|FG001|Overall Study|Withdrawal by Subject|3|||
170754538|NCT04091672|617108386|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
170754539|NCT04091672|617108387|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
170754540|NCT00231179|617108390|FG000|Overall Study|Lost to Follow-up|21|||
170754541|NCT00231179|617108391|FG001|Overall Study|Lost to Follow-up|21|||
170754542|NCT00231179|617108390|FG000|Overall Study|Withdrawal by Subject|3|||
170754543|NCT00231179|617108391|FG001|Overall Study|Withdrawal by Subject|3|||
170754544|NCT02491411|617108392|FG000|Overall Study|Physician Decision|4|||
170754545|NCT00093795|617108396|FG000|Overall Study|No follow up data|20|||
170754546|NCT00093795|617108397|FG001|Overall Study|No follow up data|16|||
170754547|NCT00093795|617108398|FG002|Overall Study|No follow up data|17|||
170754548|NCT02949271|617108401|FG000|Overall Study|Lack of Efficacy|5|||
170754549|NCT02949271|617108402|FG001|Overall Study|Lack of Efficacy|4|||
170754550|NCT02949271|617108401|FG000|Overall Study|Lost to Follow-up|3|||
170754551|NCT02949271|617108402|FG001|Overall Study|Lost to Follow-up|6|||
170754552|NCT02949271|617108401|FG000|Overall Study|Physician Decision|5|||
170754553|NCT02949271|617108402|FG001|Overall Study|Physician Decision|5|||
170754554|NCT02949271|617108401|FG000|Overall Study|Protocol Violation|6|||
170754555|NCT02949271|617108402|FG001|Overall Study|Protocol Violation|3|||
170754556|NCT02949271|617108401|FG000|Overall Study|Withdrawal by Subject|1|||
170754557|NCT02949271|617108402|FG001|Overall Study|Withdrawal by Subject|0|||
170754558|NCT02949271|617108401|FG000|Overall Study|Delivered prior to intervention|7|||
170754559|NCT02949271|617108402|FG001|Overall Study|Delivered prior to intervention|9|||
170754560|NCT02949271|617108401|FG000|Overall Study|Outside the window for cervical dilation|2|||
170754561|NCT02949271|617108402|FG001|Overall Study|Outside the window for cervical dilation|3|||
170754562|NCT03738241|617108403|FG000|Overall Study|Withdrawal by Subject|0|||
170754563|NCT03738241|617108404|FG001|Overall Study|Withdrawal by Subject|0|||
170754564|NCT03738241|617108405|FG002|Overall Study|Withdrawal by Subject|0|||
170754565|NCT03738241|617108406|FG003|Overall Study|Withdrawal by Subject|0|||
170754566|NCT03738241|617108407|FG004|Overall Study|Withdrawal by Subject|0|||
170754567|NCT03738241|617108408|FG005|Overall Study|Withdrawal by Subject|0|||
170754568|NCT03738241|617108409|FG006|Overall Study|Withdrawal by Subject|0|||
170754569|NCT03738241|617108410|FG007|Overall Study|Withdrawal by Subject|0|||
170754570|NCT03738241|617108411|FG008|Overall Study|Withdrawal by Subject|0|||
170754571|NCT03738241|617108412|FG009|Overall Study|Withdrawal by Subject|1|||
170754572|NCT03738241|617108403|FG000|Overall Study|Physician Decision|0|||
170754573|NCT03738241|617108404|FG001|Overall Study|Physician Decision|0|||
170754574|NCT03738241|617108405|FG002|Overall Study|Physician Decision|0|||
170754575|NCT03738241|617108406|FG003|Overall Study|Physician Decision|0|||
170754576|NCT03738241|617108407|FG004|Overall Study|Physician Decision|0|||
170754577|NCT03738241|617108408|FG005|Overall Study|Physician Decision|0|||
170754578|NCT03738241|617108409|FG006|Overall Study|Physician Decision|0|||
170754579|NCT03738241|617108410|FG007|Overall Study|Physician Decision|0|||
170754580|NCT03738241|617108411|FG008|Overall Study|Physician Decision|1|||
170754581|NCT03738241|617108412|FG009|Overall Study|Physician Decision|0|||
170754582|NCT03738241|617108403|FG000|Overall Study|Adverse Event|1|||
170754583|NCT03738241|617108404|FG001|Overall Study|Adverse Event|0|||
170754584|NCT03738241|617108405|FG002|Overall Study|Adverse Event|0|||
170754585|NCT03738241|617108406|FG003|Overall Study|Adverse Event|0|||
170754586|NCT03738241|617108407|FG004|Overall Study|Adverse Event|0|||
170754587|NCT03738241|617108408|FG005|Overall Study|Adverse Event|0|||
170754588|NCT03738241|617108409|FG006|Overall Study|Adverse Event|0|||
170754589|NCT03738241|617108410|FG007|Overall Study|Adverse Event|0|||
170754590|NCT03738241|617108411|FG008|Overall Study|Adverse Event|0|||
170754591|NCT03738241|617108412|FG009|Overall Study|Adverse Event|0|||
170754592|NCT00495469|617108417|FG000|Overall Study|Adverse Event|0|||
170754593|NCT00495469|617108418|FG001|Overall Study|Adverse Event|1|||
170754594|NCT00495469|617108419|FG002|Overall Study|Adverse Event|3|||
170754595|NCT00495469|617108420|FG003|Overall Study|Adverse Event|0|||
170754596|NCT00495469|617108421|FG004|Overall Study|Adverse Event|1|||
170754597|NCT00495469|617108422|FG005|Overall Study|Adverse Event|1|||
170754598|NCT00495469|617108423|FG006|Overall Study|Adverse Event|1|||
170754599|NCT00495469|617108417|FG000|Overall Study|Lost to Follow-up|1|||
170754600|NCT00495469|617108418|FG001|Overall Study|Lost to Follow-up|1|||
170754601|NCT00495469|617108419|FG002|Overall Study|Lost to Follow-up|3|||
170754602|NCT00495469|617108420|FG003|Overall Study|Lost to Follow-up|1|||
170754603|NCT00495469|617108421|FG004|Overall Study|Lost to Follow-up|0|||
170754604|NCT00495469|617108422|FG005|Overall Study|Lost to Follow-up|0|||
170754605|NCT00495469|617108423|FG006|Overall Study|Lost to Follow-up|0|||
170754606|NCT00495469|617108417|FG000|Overall Study|Protocol Violation|0|||
170754607|NCT00495469|617108418|FG001|Overall Study|Protocol Violation|0|||
170754608|NCT00495469|617108419|FG002|Overall Study|Protocol Violation|0|||
170754609|NCT00495469|617108420|FG003|Overall Study|Protocol Violation|0|||
170754610|NCT00495469|617108421|FG004|Overall Study|Protocol Violation|1|||
170754611|NCT00495469|617108422|FG005|Overall Study|Protocol Violation|2|||
170754612|NCT00495469|617108423|FG006|Overall Study|Protocol Violation|0|||
170865015|NCT00323297|617518002|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
170402725|NCT03471182|615816969|FG001|Overall Study|Technical failure|0|||
170754613|NCT00495469|617108417|FG000|Overall Study|Withdrawal by Subject|5|||
170754614|NCT00495469|617108418|FG001|Overall Study|Withdrawal by Subject|3|||
170754615|NCT00495469|617108419|FG002|Overall Study|Withdrawal by Subject|1|||
170754616|NCT00495469|617108420|FG003|Overall Study|Withdrawal by Subject|3|||
170754617|NCT00495469|617108421|FG004|Overall Study|Withdrawal by Subject|3|||
170754618|NCT00495469|617108422|FG005|Overall Study|Withdrawal by Subject|2|||
170754619|NCT00495469|617108423|FG006|Overall Study|Withdrawal by Subject|3|||
170754620|NCT00495469|617108417|FG000|Overall Study|Lack of Efficacy|0|||
170754621|NCT00495469|617108418|FG001|Overall Study|Lack of Efficacy|0|||
170754622|NCT00495469|617108419|FG002|Overall Study|Lack of Efficacy|0|||
170754623|NCT00495469|617108420|FG003|Overall Study|Lack of Efficacy|0|||
170754624|NCT00495469|617108421|FG004|Overall Study|Lack of Efficacy|0|||
170754625|NCT00495469|617108422|FG005|Overall Study|Lack of Efficacy|0|||
170754626|NCT00495469|617108423|FG006|Overall Study|Lack of Efficacy|1|||
170754627|NCT00495469|617108417|FG000|Overall Study|Liver function test abnormality|0|||
170754628|NCT00495469|617108418|FG001|Overall Study|Liver function test abnormality|1|||
170754629|NCT00495469|617108419|FG002|Overall Study|Liver function test abnormality|0|||
170754630|NCT00495469|617108420|FG003|Overall Study|Liver function test abnormality|0|||
170754631|NCT00495469|617108421|FG004|Overall Study|Liver function test abnormality|0|||
170754632|NCT00495469|617108422|FG005|Overall Study|Liver function test abnormality|0|||
170754633|NCT00495469|617108423|FG006|Overall Study|Liver function test abnormality|0|||
170754634|NCT00495469|617108417|FG000|Overall Study|ST depression at randomisation in ECG|0|||
170754635|NCT00495469|617108418|FG001|Overall Study|ST depression at randomisation in ECG|1|||
170754636|NCT00495469|617108419|FG002|Overall Study|ST depression at randomisation in ECG|0|||
170754637|NCT00495469|617108420|FG003|Overall Study|ST depression at randomisation in ECG|0|||
170754638|NCT00495469|617108421|FG004|Overall Study|ST depression at randomisation in ECG|0|||
170754639|NCT00495469|617108422|FG005|Overall Study|ST depression at randomisation in ECG|0|||
170754640|NCT00495469|617108423|FG006|Overall Study|ST depression at randomisation in ECG|0|||
170754641|NCT02757885|617108424|FG000|Overall Study|Screen Failures|4|||
170754642|NCT02459964|617108425|FG000|Overall Study|Withdrawal by Subject|0|||
170754643|NCT02459964|617108426|FG001|Overall Study|Withdrawal by Subject|0|||
170754644|NCT02459964|617108427|FG002|Overall Study|Withdrawal by Subject|1|||
170754645|NCT02459964|617108425|FG000|Overall Study|Abnormal EKG changes|0|||
170754646|NCT02459964|617108426|FG001|Overall Study|Abnormal EKG changes|0|||
170754647|NCT02459964|617108427|FG002|Overall Study|Abnormal EKG changes|1|||
170754648|NCT01175707|617108428|FG000|Overall Study|Adverse Event|4|||
170754649|NCT01175707|617108429|FG001|Overall Study|Adverse Event|6|||
170754650|NCT00278564|617108432|FG000|Overall Study|Lack of Efficacy|4|||
170754651|NCT01094743|617108433|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
170754652|NCT02321540|617108435|FG000|Overall Study|Death|0|||
170754653|NCT02321540|617108436|FG001|Overall Study|Death|1|||
170754654|NCT02321540|617108435|FG000|Overall Study|Progression|3|||
170754655|NCT02321540|617108436|FG001|Overall Study|Progression|9|||
170754656|NCT00953160|617108437|FG000|Overall Study|Lost to Follow-up|23|||
170754657|NCT00953160|617108437|FG000|Overall Study|Withdrawal by Subject|4|||
170754658|NCT02680756|617108438|FG000|Overall Study|Adverse Event|10|||
170754659|NCT02680756|617108439|FG001|Overall Study|Adverse Event|2|||
170754660|NCT02680756|617108438|FG000|Overall Study|Lost to Follow-up|7|||
170754661|NCT02680756|617108439|FG001|Overall Study|Lost to Follow-up|6|||
170754662|NCT02680756|617108438|FG000|Overall Study|Withdrawal by Subject|5|||
170754663|NCT02680756|617108439|FG001|Overall Study|Withdrawal by Subject|5|||
170754664|NCT02680756|617108438|FG000|Overall Study|Physician Decision|4|||
170754665|NCT02680756|617108439|FG001|Overall Study|Physician Decision|1|||
170754666|NCT02680756|617108438|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
170754667|NCT02680756|617108439|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
170754668|NCT02680756|617108438|FG000|Overall Study|Blood transfusion for any reason|0|||
170754669|NCT02680756|617108439|FG001|Overall Study|Blood transfusion for any reason|1|||
170754670|NCT02680756|617108438|FG000|Overall Study|Death|1|||
170754671|NCT02680756|617108439|FG001|Overall Study|Death|0|||
170754672|NCT02680756|617108438|FG000|Overall Study|Protocol Violation|1|||
170754673|NCT02680756|617108439|FG001|Overall Study|Protocol Violation|0|||
170754674|NCT02680756|617108438|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
170754675|NCT02680756|617108439|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
170754676|NCT02680756|617108438|FG000|Overall Study|None of above or not recorded|3|||
170754677|NCT02680756|617108439|FG001|Overall Study|None of above or not recorded|2|||
170754678|NCT02374957|617108440|FG000|Overall Study|Patient did not complete forms correctly|1|||
170754679|NCT02374957|617108441|FG001|Overall Study|Patient did not complete forms correctly|0|||
170865016|NCT00323297|617518003|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
170402726|NCT03471182|615816970|FG002|Overall Study|Technical failure|0|||
170754680|NCT00748969|617108442|FG000|Overall Study|Withdrawal by Subject|1|||
170754681|NCT00748969|617108443|FG001|Overall Study|Withdrawal by Subject|0|||
170754682|NCT00748969|617108442|FG000|Overall Study|Withdrawal by Subject|0|||
170754683|NCT00748969|617108443|FG001|Overall Study|Withdrawal by Subject|1|||
170754684|NCT03278028|617108444|FG000|Overall Study|Lost to Follow-up|1|||
170865017|NCT00323297|617518002|FG000|Part A (Double Blind Randomized)|Death|0|||
170754685|NCT03278028|617108445|FG001|Overall Study|Lost to Follow-up|0|||
170754686|NCT03278028|617108444|FG000|Overall Study|Withdrawal by Subject|3|||
170865018|NCT00323297|617518003|FG001|Part A (Double Blind Randomized)|Death|1|||
170754687|NCT03278028|617108445|FG001|Overall Study|Withdrawal by Subject|1|||
170754688|NCT03278028|617108444|FG000|Overall Study|Pregnancy|0|||
170754689|NCT03278028|617108445|FG001|Overall Study|Pregnancy|1|||
170402727|NCT02773446|615816972|FG000|First Admission|Withdrawal by Subject|0|||
170865019|NCT00323297|617518002|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
170754690|NCT03635112|617108446|FG000|Overall Study|Adverse Event|5|||
170754691|NCT03635112|617108447|FG001|Overall Study|Adverse Event|9|||
170754692|NCT03635112|617108448|FG002|Overall Study|Adverse Event|14|||
170754693|NCT03635112|617108446|FG000|Overall Study|Lost to Follow-up|1|||
170754694|NCT03635112|617108447|FG001|Overall Study|Lost to Follow-up|0|||
170754695|NCT03635112|617108448|FG002|Overall Study|Lost to Follow-up|1|||
170754696|NCT03635112|617108446|FG000|Overall Study|Physician Decision|5|||
170754697|NCT03635112|617108447|FG001|Overall Study|Physician Decision|7|||
170754698|NCT03635112|617108448|FG002|Overall Study|Physician Decision|5|||
170754699|NCT03635112|617108446|FG000|Overall Study|Protocol Violation|0|||
170754700|NCT03635112|617108447|FG001|Overall Study|Protocol Violation|0|||
170754701|NCT03635112|617108448|FG002|Overall Study|Protocol Violation|1|||
170754702|NCT03635112|617108446|FG000|Overall Study|Study Terminated by Sponsor|11|||
170754703|NCT03635112|617108447|FG001|Overall Study|Study Terminated by Sponsor|17|||
170754704|NCT03635112|617108448|FG002|Overall Study|Study Terminated by Sponsor|21|||
170754705|NCT03635112|617108446|FG000|Overall Study|Withdrawal by Subject|4|||
170754706|NCT03635112|617108447|FG001|Overall Study|Withdrawal by Subject|9|||
170754707|NCT03635112|617108448|FG002|Overall Study|Withdrawal by Subject|7|||
170754708|NCT03635112|617108446|FG000|Overall Study|Miscellaneous|0|||
170754709|NCT03635112|617108447|FG001|Overall Study|Miscellaneous|0|||
170754710|NCT03635112|617108448|FG002|Overall Study|Miscellaneous|1|||
170754711|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
170754712|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
170754713|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
170754714|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
170754715|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
170402728|NCT02773446|615816973|FG001|First Admission|Withdrawal by Subject|0|||
170402729|NCT02773446|615816974|FG002|First Admission|Withdrawal by Subject|0|||
170402730|NCT02773446|615816975|FG003|First Admission|Withdrawal by Subject|1|||
170402731|NCT02773446|615816976|FG004|First Admission|Withdrawal by Subject|0|||
170402732|NCT02773446|615816977|FG005|First Admission|Withdrawal by Subject|0|||
170754716|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
170754717|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
170754718|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
170754719|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
170754720|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
170754721|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
170754722|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
170754723|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
170754724|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
170754725|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
170754726|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
170754727|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
170754728|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
170754729|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
170754730|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
170754731|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
170754732|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
170754733|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
170631521|NCT02113982|616664418|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
170631522|NCT02113982|616664419|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
170631523|NCT02113982|616664420|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
170631524|NCT02113982|616664421|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
170631525|NCT02113982|616664422|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
170631526|NCT02113982|616664423|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
170631527|NCT02113982|616664410|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
170631528|NCT02113982|616664411|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
170631529|NCT02113982|616664412|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
170631530|NCT02113982|616664413|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
170631531|NCT02113982|616664414|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
170754734|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
170754735|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
170754736|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
170754737|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
170754738|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
170754739|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
170754740|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
170754741|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
170402733|NCT02773446|615816972|FG000|First Admission|Lost to Follow-up|1|||
170754742|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
170754743|NCT03890120|617108453|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
170754744|NCT03890120|617108454|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
170754745|NCT03890120|617108455|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
170754746|NCT03890120|617108456|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
170754747|NCT03890120|617108453|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
170754748|NCT03890120|617108454|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
170754749|NCT03890120|617108455|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
170754750|NCT03890120|617108456|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
170754751|NCT03890120|617108453|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
170754752|NCT03890120|617108454|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
170754753|NCT03890120|617108455|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
170754754|NCT03890120|617108456|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
170754755|NCT03890120|617108453|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
170754756|NCT03890120|617108454|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
170754757|NCT03890120|617108455|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
170754758|NCT03890120|617108456|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
170754759|NCT03890120|617108453|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
170754760|NCT03890120|617108454|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
170754761|NCT03890120|617108455|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
170754762|NCT03890120|617108456|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
170754763|NCT02950545|617108457|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
170754764|NCT02950545|617108458|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
170754765|NCT02950545|617108459|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
170754766|NCT02950545|617108460|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
170754767|NCT02950545|617108461|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
170754768|NCT02950545|617108462|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
170754769|NCT02950545|617108457|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
170754770|NCT02950545|617108458|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
170754771|NCT02950545|617108459|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
170754772|NCT02950545|617108460|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
170754773|NCT02950545|617108461|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
170754774|NCT02950545|617108462|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
170754775|NCT02950545|617108457|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
170754776|NCT02950545|617108458|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
170754777|NCT02950545|617108459|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
170754778|NCT02950545|617108460|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
170754779|NCT02950545|617108461|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
170754780|NCT02950545|617108462|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
170754781|NCT02950545|617108457|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
170754782|NCT02950545|617108458|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
170754783|NCT02950545|617108459|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
170754784|NCT02950545|617108460|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
170754785|NCT02950545|617108461|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
170754786|NCT02950545|617108462|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
170754787|NCT02950545|617108457|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
170754788|NCT02950545|617108458|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
170754789|NCT02950545|617108459|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
170754790|NCT02950545|617108460|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
170754791|NCT02950545|617108461|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
170754792|NCT02950545|617108462|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
170754793|NCT03283553|617108463|FG000|Patient Participant Flow|Death|5|||
170754794|NCT03283553|617108464|FG001|Patient Participant Flow|Death|10|||
170754795|NCT03283553|617108463|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
170754796|NCT03283553|617108464|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
170754797|NCT03283553|617108463|FG000|Patient Participant Flow|Lost to Follow-up|1|||
170754798|NCT03283553|617108464|FG001|Patient Participant Flow|Lost to Follow-up|1|||
170754799|NCT03283553|617108463|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
170754800|NCT03283553|617108464|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
170754801|NCT03283553|617108463|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
170865020|NCT00323297|617518003|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
170754802|NCT03283553|617108464|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
170754803|NCT03283553|617108463|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
170754804|NCT03283553|617108464|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
170402734|NCT02773446|615816973|FG001|First Admission|Lost to Follow-up|0|||
170754805|NCT01113463|617108465|FG000|Overall Study|Physician Decision|5|||
170754806|NCT03023332|617108467|FG000|Overall Study|Withdrawal by Subject|10|||
170754807|NCT03023332|617108468|FG001|Overall Study|Withdrawal by Subject|5|||
170754808|NCT03023332|617108469|FG002|Overall Study|Withdrawal by Subject|4|||
170754809|NCT03023332|617108470|FG003|Overall Study|Withdrawal by Subject|7|||
170754810|NCT03023332|617108467|FG000|Overall Study|Lost to Follow-up|13|||
170754811|NCT03023332|617108468|FG001|Overall Study|Lost to Follow-up|16|||
170754812|NCT03023332|617108469|FG002|Overall Study|Lost to Follow-up|8|||
170754813|NCT03023332|617108470|FG003|Overall Study|Lost to Follow-up|13|||
170754814|NCT03023332|617108467|FG000|Overall Study|Death|1|||
170754815|NCT03023332|617108468|FG001|Overall Study|Death|0|||
170754816|NCT03023332|617108469|FG002|Overall Study|Death|0|||
170754817|NCT03023332|617108470|FG003|Overall Study|Death|0|||
170754818|NCT01657682|617108471|FG000|Overall Study|Lost to Follow-up|1|||
170754819|NCT01657682|617108472|FG001|Overall Study|Lost to Follow-up|0|||
170754820|NCT01657682|617108473|FG002|Overall Study|Lost to Follow-up|0|||
170754821|NCT01657682|617108471|FG000|Overall Study|Withdrawal by Subject|0|||
170754822|NCT01657682|617108472|FG001|Overall Study|Withdrawal by Subject|1|||
170754823|NCT01657682|617108473|FG002|Overall Study|Withdrawal by Subject|1|||
170754824|NCT01657682|617108471|FG000|Overall Study|Adverse Event|0|||
170754825|NCT01657682|617108472|FG001|Overall Study|Adverse Event|1|||
170754826|NCT01657682|617108473|FG002|Overall Study|Adverse Event|0|||
170754827|NCT01813422|617108476|FG000|Overall Study|Withdrawal by Subject|14|||
170754828|NCT01813422|617108477|FG001|Overall Study|Withdrawal by Subject|8|||
170754829|NCT01813422|617108476|FG000|Overall Study|Death|2|||
170754830|NCT01813422|617108477|FG001|Overall Study|Death|3|||
170754831|NCT01813422|617108476|FG000|Overall Study|Sponsor Decision|2|||
170754832|NCT01813422|617108477|FG001|Overall Study|Sponsor Decision|1|||
170754833|NCT01813422|617108476|FG000|Overall Study|Lost to Follow-up|2|||
170754834|NCT01813422|617108477|FG001|Overall Study|Lost to Follow-up|4|||
170754835|NCT01318811|617108481|FG000|Overall Study|Physician Decision|1|||
170754836|NCT01318811|617108482|FG001|Overall Study|Physician Decision|1|||
170754837|NCT01318811|617108481|FG000|Overall Study|CRRT stopped for head CT|0|||
170754838|NCT01318811|617108482|FG001|Overall Study|CRRT stopped for head CT|1|||
170754839|NCT01318811|617108481|FG000|Overall Study|Death|0|||
170754840|NCT01318811|617108482|FG001|Overall Study|Death|1|||
170754841|NCT01318811|617108481|FG000|Overall Study|CRRT stopped for head MRI|0|||
170754842|NCT01318811|617108482|FG001|Overall Study|CRRT stopped for head MRI|1|||
170754843|NCT00811187|617108483|FG000|Overall Study|Unable to place device / procedure abort|3|||
170754844|NCT00811187|617108484|FG001|Overall Study|Unable to place device / procedure abort|3|||
170754845|NCT00329303|617108485|FG000|Overall Study|Lack of Efficacy|1|||
170754846|NCT00329303|617108486|FG001|Overall Study|Lack of Efficacy|0|||
170754847|NCT00329303|617108485|FG000|Overall Study|Decision of the sponsor|0|||
170754848|NCT00329303|617108486|FG001|Overall Study|Decision of the sponsor|1|||
170754849|NCT00329303|617108485|FG000|Overall Study|Patient no longer available|1|||
170754850|NCT00329303|617108486|FG001|Overall Study|Patient no longer available|0|||
170754851|NCT00329303|617108485|FG000|Overall Study|Patient relocated|0|||
170754852|NCT00329303|617108486|FG001|Overall Study|Patient relocated|1|||
170754853|NCT03582137|617108490|FG000|Overall Study|Adverse Event|1|||
170754854|NCT03582137|617108491|FG001|Overall Study|Adverse Event|0|||
170754855|NCT00859014|617108493|FG000|Overall Study|Death|4|||
170754856|NCT00859014|617108493|FG000|Overall Study|Lost to Follow-up|1|||
170754857|NCT04796935|617108494|FG000|Overall Study|Withdrawal by Subject|0|||
170754858|NCT04796935|617108495|FG001|Overall Study|Withdrawal by Subject|1|||
170754859|NCT04796935|617108494|FG000|Overall Study|Physician Decision|0|||
170754860|NCT04796935|617108495|FG001|Overall Study|Physician Decision|1|||
170754861|NCT04796935|617108494|FG000|Overall Study|Device not available|1|||
170865021|NCT00323297|617518002|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
170865022|NCT00323297|617518003|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
170754862|NCT04796935|617108495|FG001|Overall Study|Device not available|0|||
170754863|NCT04796935|617108494|FG000|Overall Study|Trained provider not available|1|||
170754864|NCT04796935|617108495|FG001|Overall Study|Trained provider not available|0|||
170754865|NCT01163149|617108496|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
170754866|NCT01163149|617108497|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
170754867|NCT01163149|617108498|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
170754868|NCT01163149|617108496|FG000|Extension Treatment Period|Adverse Event|0|||
170754869|NCT01163149|617108497|FG001|Extension Treatment Period|Adverse Event|1|||
170754870|NCT01163149|617108498|FG002|Extension Treatment Period|Adverse Event|0|||
170754871|NCT01163149|617108496|FG000|Extension Treatment Period|Noncompliance|0|||
170754872|NCT01163149|617108497|FG001|Extension Treatment Period|Noncompliance|0|||
170754873|NCT01163149|617108498|FG002|Extension Treatment Period|Noncompliance|1|||
170754874|NCT01192295|617108499|FG000|Overall Study|Adverse Event|3|||
170754875|NCT01192295|617108500|FG001|Overall Study|Adverse Event|7|||
170754876|NCT01192295|617108499|FG000|Overall Study|Withdrawal by Subject|3|||
170754877|NCT01192295|617108500|FG001|Overall Study|Withdrawal by Subject|4|||
170754878|NCT01192295|617108499|FG000|Overall Study|Lost to Follow-up|0|||
170754879|NCT01192295|617108500|FG001|Overall Study|Lost to Follow-up|1|||
170754880|NCT01192295|617108499|FG000|Overall Study|Lack of Efficacy|0|||
170754881|NCT01192295|617108500|FG001|Overall Study|Lack of Efficacy|5|||
170754882|NCT01192295|617108499|FG000|Overall Study|Administrative|4|||
170754883|NCT01192295|617108500|FG001|Overall Study|Administrative|6|||
170754884|NCT01700530|617108503|FG000|Overall Study|Withdrawal by Subject|0|||
170754885|NCT01700530|617108504|FG001|Overall Study|Withdrawal by Subject|3|||
170754886|NCT01700530|617108505|FG002|Overall Study|Withdrawal by Subject|1|||
170754887|NCT00578227|617108509|FG000|Overall Study|Lost to Follow-up|0|||
170754888|NCT00578227|617108510|FG001|Overall Study|Lost to Follow-up|1|||
170754889|NCT00578227|617108511|FG002|Overall Study|Lost to Follow-up|1|||
170754890|NCT00578227|617108509|FG000|Overall Study|Withdrawal by Subject|5|||
170754891|NCT00578227|617108510|FG001|Overall Study|Withdrawal by Subject|1|||
170754892|NCT00578227|617108511|FG002|Overall Study|Withdrawal by Subject|3|||
170754893|NCT02929108|617108517|FG000|Overall Study|Hospice patient death|100|||
170754894|NCT02929108|617108518|FG001|Overall Study|Hospice patient death|64|||
170754895|NCT02929108|617108519|FG002|Overall Study|Hospice patient death|28|||
170754896|NCT02929108|617108520|FG003|Overall Study|Hospice patient death|46|||
170754897|NCT02929108|617108521|FG004|Overall Study|Hospice patient death|55|||
170754898|NCT02929108|617108522|FG005|Overall Study|Hospice patient death|28|||
170754899|NCT02929108|617108523|FG006|Overall Study|Hospice patient death|78|||
170754900|NCT05489224|617108524|FG000|Treatment Period I|Withdrawal by Subject|6|||
170754901|NCT05489224|617108525|FG001|Treatment Period I|Withdrawal by Subject|5|||
170754902|NCT05489224|617108526|FG002|Treatment Period I|Withdrawal by Subject|0|||
170754903|NCT05489224|617108524|FG000|Treatment Period I|Adverse Event|3|||
170754904|NCT05489224|617108525|FG001|Treatment Period I|Adverse Event|11|||
170754905|NCT05489224|617108526|FG002|Treatment Period I|Adverse Event|0|||
170754906|NCT05489224|617108524|FG000|Treatment Period I|Lost to Follow-up|0|||
170754907|NCT05489224|617108525|FG001|Treatment Period I|Lost to Follow-up|1|||
170754908|NCT05489224|617108526|FG002|Treatment Period I|Lost to Follow-up|0|||
170754909|NCT05489224|617108524|FG000|Treatment Period I|Physician Decision|0|||
170754910|NCT05489224|617108525|FG001|Treatment Period I|Physician Decision|1|||
170754911|NCT05489224|617108526|FG002|Treatment Period I|Physician Decision|0|||
170754912|NCT05489224|617108524|FG000|Treatment Period II up to Week 32|Ongoing|222|||
170754913|NCT05489224|617108525|FG001|Treatment Period II up to Week 32|Ongoing|107|||
170754914|NCT05489224|617108526|FG002|Treatment Period II up to Week 32|Ongoing|107|||
170754915|NCT05489224|617108524|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
170754916|NCT05489224|617108525|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
170754917|NCT05489224|617108526|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
170754918|NCT05489224|617108524|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
170754919|NCT05489224|617108525|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
170754920|NCT05489224|617108526|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
170754921|NCT00729690|617108531|FG000|Overall Study|IT Catheter Malfunction|0|||
170754922|NCT00729690|617108532|FG001|Overall Study|IT Catheter Malfunction|2|||
170754923|NCT00729690|617108533|FG002|Overall Study|IT Catheter Malfunction|2|||
170754924|NCT02169219|617108534|FG000|Overall Study|Lack of Efficacy|6|||
170754925|NCT05194735|617110864|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
170754926|NCT05194735|617110865|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
170754927|NCT05194735|617110866|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
170754928|NCT05194735|617110864|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
170754929|NCT05194735|617110865|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
170754930|NCT05194735|617110866|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
170754931|NCT05194735|617110864|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
170754932|NCT05194735|617110865|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
170754933|NCT05194735|617110866|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
170754934|NCT05194735|617110864|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
170754935|NCT05194735|617110865|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
170754936|NCT05194735|617110866|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
170754937|NCT00359619|617110867|FG000|Overall Study|Adverse Event|0|||
170754938|NCT00359619|617110868|FG001|Overall Study|Adverse Event|0|||
170754939|NCT00359619|617110869|FG002|Overall Study|Adverse Event|1|||
170754940|NCT00359619|617110870|FG003|Overall Study|Adverse Event|0|||
170754941|NCT00359619|617110871|FG004|Overall Study|Adverse Event|0|||
170754942|NCT00359619|617110872|FG005|Overall Study|Adverse Event|0|||
170754943|NCT00359619|617110873|FG006|Overall Study|Adverse Event|1|||
170754944|NCT00359619|617110867|FG000|Overall Study|Withdrawal by Subject|3|||
170754945|NCT00359619|617110868|FG001|Overall Study|Withdrawal by Subject|1|||
170754946|NCT00359619|617110869|FG002|Overall Study|Withdrawal by Subject|4|||
170754947|NCT00359619|617110870|FG003|Overall Study|Withdrawal by Subject|2|||
170754948|NCT00359619|617110871|FG004|Overall Study|Withdrawal by Subject|2|||
170754949|NCT00359619|617110872|FG005|Overall Study|Withdrawal by Subject|0|||
170754950|NCT00359619|617110873|FG006|Overall Study|Withdrawal by Subject|3|||
170754951|NCT00359619|617110867|FG000|Overall Study|Other|1|||
170754952|NCT00359619|617110868|FG001|Overall Study|Other|0|||
170754953|NCT00359619|617110869|FG002|Overall Study|Other|0|||
170754954|NCT00359619|617110870|FG003|Overall Study|Other|0|||
170754955|NCT00359619|617110871|FG004|Overall Study|Other|0|||
170754956|NCT00359619|617110872|FG005|Overall Study|Other|0|||
170754957|NCT00359619|617110873|FG006|Overall Study|Other|0|||
170754958|NCT00359619|617110867|FG000|Overall Study|Lost to Follow-up|4|||
170754959|NCT00359619|617110868|FG001|Overall Study|Lost to Follow-up|4|||
170754960|NCT00359619|617110869|FG002|Overall Study|Lost to Follow-up|2|||
170754961|NCT00359619|617110870|FG003|Overall Study|Lost to Follow-up|1|||
170754962|NCT00359619|617110871|FG004|Overall Study|Lost to Follow-up|1|||
170754963|NCT00359619|617110872|FG005|Overall Study|Lost to Follow-up|5|||
170754964|NCT00359619|617110873|FG006|Overall Study|Lost to Follow-up|0|||
170754965|NCT04672460|617110874|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
170754966|NCT04672460|617110875|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
170754967|NCT04672460|617110874|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
170754968|NCT04672460|617110875|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
170754969|NCT04672460|617110874|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
170754970|NCT04672460|617110875|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
170754971|NCT04672460|617110874|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
170754972|NCT04672460|617110875|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
170754973|NCT04672460|617110874|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
170754974|NCT04672460|617110875|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
170754975|NCT04672460|617110874|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
170754976|NCT04672460|617110875|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
170754977|NCT04672460|617110874|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
170754978|NCT04672460|617110875|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
170754979|NCT04672460|617110874|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
170754980|NCT04672460|617110875|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
170754981|NCT04672460|617110874|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
170754982|NCT04672460|617110875|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
170754983|NCT04672460|617110874|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
170754984|NCT04672460|617110875|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
170754985|NCT04672460|617110874|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
170754986|NCT04672460|617110875|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
170754987|NCT04672460|617110874|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
170754988|NCT04672460|617110875|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
170754989|NCT04672460|617110874|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
170754990|NCT04672460|617110875|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
170754991|NCT04672460|617110874|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
170754992|NCT04672460|617110875|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
170754993|NCT04672460|617110874|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
170754994|NCT04672460|617110875|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
170754995|NCT04672460|617110874|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
170754996|NCT04672460|617110875|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
170754997|NCT04672460|617110874|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
170754998|NCT04672460|617110875|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
170754999|NCT01876043|617110878|FG000|Overall Study|Death|1|||
170755000|NCT01876043|617110878|FG000|Overall Study|Withdrawal by Subject|1|||
170755001|NCT00079937|617110880|FG000|Overall Study|Adverse Event|2|||
170755002|NCT00079937|617110881|FG001|Overall Study|Adverse Event|1|||
170755003|NCT00079937|617110880|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170865023|NCT00323297|617518002|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
170865024|NCT00323297|617518003|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
170865025|NCT00323297|617518002|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
170865026|NCT00323297|617518003|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
170865027|NCT00323297|617518002|FG000|Part B (Open-label)|Death|0|||
170865028|NCT00323297|617518003|FG001|Part B (Open-label)|Death|1|||
170865029|NCT00323297|617518002|FG000|Part B (Open-label)|Reason unspecified|0|||
170865030|NCT00323297|617518003|FG001|Part B (Open-label)|Reason unspecified|1|||
170865031|NCT00323297|617518002|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
170865032|NCT00323297|617518003|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
170865033|NCT00323297|617518002|FG000|Part B (Open-label)|Lack of Efficacy|3|||
170865034|NCT00323297|617518003|FG001|Part B (Open-label)|Lack of Efficacy|1|||
170865035|NCT00323297|617518002|FG000|Part B (Open-label)|Adverse Event|5|||
170865036|NCT00323297|617518003|FG001|Part B (Open-label)|Adverse Event|5|||
170865037|NCT00323297|617518002|FG000|Part B (Open-label)|Protocol Violation|0|||
170865038|NCT00323297|617518003|FG001|Part B (Open-label)|Protocol Violation|1|||
170865039|NCT01106404|617518008|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
170865040|NCT01106404|617518009|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
170865041|NCT01106404|617518008|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
170755004|NCT00079937|617110881|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170865042|NCT01106404|617518009|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
170755005|NCT00079937|617110880|FG000|Overall Study|Subject no longer requires study drug|3|||
170755006|NCT00079937|617110881|FG001|Overall Study|Subject no longer requires study drug|0|||
170755007|NCT00079937|617110880|FG000|Overall Study|Protocol Violation|8|||
170755008|NCT00079937|617110881|FG001|Overall Study|Protocol Violation|6|||
170755009|NCT00079937|617110880|FG000|Overall Study|Withdrawal by Subject|21|||
170755010|NCT00079937|617110881|FG001|Overall Study|Withdrawal by Subject|7|||
170755011|NCT00079937|617110880|FG000|Overall Study|Lost to Follow-up|12|||
170755012|NCT00079937|617110881|FG001|Overall Study|Lost to Follow-up|5|||
170755013|NCT00079937|617110880|FG000|Overall Study|Administrative problems|22|||
170755014|NCT00079937|617110881|FG001|Overall Study|Administrative problems|11|||
170755015|NCT00762463|617110882|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
170755016|NCT00762463|617110883|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
170755017|NCT00762463|617110884|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
170631532|NCT02113982|616664415|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
170631533|NCT02113982|616664416|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
170631534|NCT02113982|616664417|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
170631535|NCT02113982|616664418|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
170755018|NCT00762463|617110885|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
170755019|NCT00762463|617110882|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
170755020|NCT00762463|617110883|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
170755021|NCT00762463|617110884|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
170755022|NCT00762463|617110885|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
170755023|NCT00762463|617110882|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
170755024|NCT00762463|617110883|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
170755025|NCT00762463|617110884|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
170755026|NCT00762463|617110885|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
170755027|NCT00762463|617110882|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
170755028|NCT00762463|617110883|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
170755029|NCT00762463|617110884|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
170755030|NCT00762463|617110885|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
170755031|NCT00762463|617110882|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
170755032|NCT00762463|617110883|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
170755033|NCT00762463|617110884|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
170755034|NCT00762463|617110885|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
170755035|NCT00762463|617110882|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
170755036|NCT00762463|617110883|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
170755037|NCT00762463|617110884|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
170755038|NCT00762463|617110885|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
170755039|NCT00762463|617110882|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
170755040|NCT00762463|617110883|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
170755041|NCT00762463|617110884|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
170755042|NCT00762463|617110885|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
170755043|NCT00762463|617110882|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
170755044|NCT00762463|617110883|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
170755045|NCT00762463|617110884|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
170755046|NCT00762463|617110885|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
170755047|NCT05328973|617110886|FG000|Overall Study|Withdrawal by Subject|0|||
170755048|NCT05328973|617110887|FG001|Overall Study|Withdrawal by Subject|1|||
170755049|NCT00852475|617110888|FG000|Overall Study|Lost to Follow-up|3|||
170631536|NCT02113982|616664419|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
170631537|NCT02113982|616664420|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
170631538|NCT02113982|616664421|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
170631539|NCT02113982|616664422|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
170631540|NCT02113982|616664423|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
170631541|NCT02113982|616664410|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631542|NCT02113982|616664411|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631543|NCT02113982|616664412|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631544|NCT02113982|616664413|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631545|NCT02113982|616664414|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631546|NCT02113982|616664415|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631547|NCT02113982|616664416|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631548|NCT02113982|616664417|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
170755050|NCT00852475|617110889|FG001|Overall Study|Lost to Follow-up|4|||
170755051|NCT00664521|617110891|FG000|Overall Study|Adverse Event|4|||
170865043|NCT01106404|617518008|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
170865044|NCT01106404|617518009|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
170865045|NCT01106404|617518008|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
170402735|NCT02773446|615816974|FG002|First Admission|Lost to Follow-up|0|||
170755052|NCT00664521|617110892|FG001|Overall Study|Adverse Event|1|||
170755053|NCT00664521|617110891|FG000|Overall Study|Lost to Follow-up|1|||
170755054|NCT00664521|617110892|FG001|Overall Study|Lost to Follow-up|0|||
170755055|NCT00664521|617110891|FG000|Overall Study|Other|1|||
170755056|NCT00664521|617110892|FG001|Overall Study|Other|0|||
170755057|NCT04531540|617110897|FG000|Overall Study|Adverse Event|1|||
170755058|NCT04531540|617110897|FG000|Overall Study|Protocol Violation|3|||
170755059|NCT04531540|617110897|FG000|Overall Study|Withdrawal by Subject|4|||
170755060|NCT04531540|617110897|FG000|Overall Study|Found to be Ineligible|1|||
170755061|NCT00303303|617110900|FG000|Overall Study|Withdrawal by Subject|0|||
170755062|NCT00303303|617110901|FG001|Overall Study|Withdrawal by Subject|0|||
170755063|NCT00303303|617110902|FG002|Overall Study|Withdrawal by Subject|1|||
170755064|NCT03085017|617110905|FG000|Overall Study|Death|0|||
170755065|NCT03085017|617110906|FG001|Overall Study|Death|3|||
170755066|NCT01528709|617110912|FG000|Overall Study|Death|2|||
170755067|NCT01528709|617110913|FG001|Overall Study|Death|0|||
170755068|NCT01528709|617110912|FG000|Overall Study|Withdrawal by Subject|10|||
170755069|NCT01528709|617110913|FG001|Overall Study|Withdrawal by Subject|15|||
170755070|NCT01528709|617110912|FG000|Overall Study|allergy|1|||
170755071|NCT01528709|617110913|FG001|Overall Study|allergy|0|||
170755072|NCT03293485|617110914|FG000|Overall Study|Death|1|||
170755073|NCT03293485|617110914|FG000|Overall Study|Screen Failure|2|||
170755074|NCT03293485|617110914|FG000|Overall Study|Withdrawal by Subject|2|||
170755075|NCT00372528|617110915|FG000|Overall Study|Lack of Efficacy|1|||
170755076|NCT00372528|617110915|FG000|Overall Study|Adverse Event|1|||
170755077|NCT00372528|617110915|FG000|Overall Study|Study Terminated by Sponsor|18|||
170755078|NCT00372528|617110915|FG000|Overall Study|Other|1|||
170755079|NCT00562965|617110916|FG000|Overall Study|Withdrawal by Subject|0|||
170755080|NCT00562965|617110917|FG001|Overall Study|Withdrawal by Subject|1|||
170755081|NCT00562965|617110916|FG000|Overall Study|Death|2|||
170755082|NCT00562965|617110917|FG001|Overall Study|Death|4|||
170755083|NCT00562965|617110916|FG000|Overall Study|Lost to Follow-up|1|||
170755084|NCT00562965|617110917|FG001|Overall Study|Lost to Follow-up|0|||
170755085|NCT00562965|617110916|FG000|Overall Study|Other|0|||
170755086|NCT00562965|617110917|FG001|Overall Study|Other|1|||
170755087|NCT03379233|617110920|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
170755088|NCT03379233|617110921|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
170755089|NCT00965484|617110922|FG000|Overall Study|Protocol Violation|1|||
170755090|NCT00965484|617110922|FG000|Overall Study|Withdrawal by Subject|1|||
170755091|NCT03432533|617110923|FG000|Overall Study|Lost to Follow-up|1|||
170755092|NCT03432533|617110924|FG001|Overall Study|Lost to Follow-up|2|||
170755093|NCT03432533|617110923|FG000|Overall Study|Withdrawal by Subject|14|||
170755094|NCT03432533|617110924|FG001|Overall Study|Withdrawal by Subject|9|||
170755095|NCT01648283|617110925|FG000|Overall Study|Withdrawal by Subject|14|||
170755096|NCT01124617|617110926|FG000|Overall Study|Adverse Event|5|||
170755097|NCT01124617|617110927|FG001|Overall Study|Adverse Event|2|||
170755098|NCT01124617|617110926|FG000|Overall Study|Lack of Efficacy|2|||
170755099|NCT01124617|617110927|FG001|Overall Study|Lack of Efficacy|1|||
170755100|NCT01124617|617110926|FG000|Overall Study|Protocol Violation|1|||
170755101|NCT01124617|617110927|FG001|Overall Study|Protocol Violation|1|||
170755102|NCT01124617|617110926|FG000|Overall Study|Withdrawal by Subject|9|||
170755103|NCT01124617|617110927|FG001|Overall Study|Withdrawal by Subject|1|||
170755104|NCT01124617|617110926|FG000|Overall Study|Other|2|||
170755105|NCT01124617|617110927|FG001|Overall Study|Other|1|||
170755106|NCT02015195|617110928|FG000|Overall Study|Adverse Event|0|||
170755107|NCT02015195|617110929|FG001|Overall Study|Adverse Event|0|||
170755108|NCT02015195|617110930|FG002|Overall Study|Adverse Event|0|||
170755109|NCT02015195|617110931|FG003|Overall Study|Adverse Event|1|||
170402736|NCT02773446|615816975|FG003|First Admission|Lost to Follow-up|0|||
170402737|NCT02773446|615816976|FG004|First Admission|Lost to Follow-up|0|||
170402738|NCT02773446|615816977|FG005|First Admission|Lost to Follow-up|0|||
170402739|NCT00289731|615816978|FG000|Overall Study|Adverse Event|1|||
170402740|NCT00289731|615816979|FG001|Overall Study|Adverse Event|2|||
170402741|NCT00289731|615816980|FG002|Overall Study|Adverse Event|2|||
170402742|NCT00289731|615816978|FG000|Overall Study|Other|1|||
170402743|NCT00289731|615816979|FG001|Overall Study|Other|0|||
170402744|NCT00289731|615816980|FG002|Overall Study|Other|0|||
170402745|NCT02513459|615816981|FG000|Overall Study|Adverse Event|7|||
170755110|NCT02015195|617110932|FG004|Overall Study|Adverse Event|0|||
170755111|NCT02015195|617110933|FG005|Overall Study|Adverse Event|0|||
170755112|NCT02015195|617110934|FG006|Overall Study|Adverse Event|0|||
170402746|NCT02513459|615816981|FG000|Overall Study|Withdrew consent|5|||
170755113|NCT02825043|617110935|FG000|Overall Study|Lost to Follow-up|4|||
170402747|NCT02513459|615816981|FG000|Overall Study|Loss of efficacy|2|||
170402748|NCT02513459|615816981|FG000|Overall Study|Pregnancy|2|||
170755114|NCT00162942|617110938|FG000|Overall Study|Adverse Event|10|||
170755115|NCT00162942|617110939|FG001|Overall Study|Adverse Event|6|||
170755116|NCT00162942|617110938|FG000|Overall Study|Death|1|||
170755117|NCT00162942|617110939|FG001|Overall Study|Death|0|||
170755118|NCT00162942|617110938|FG000|Overall Study|Withdrawal by Subject|3|||
170755119|NCT00162942|617110939|FG001|Overall Study|Withdrawal by Subject|6|||
170755120|NCT00162942|617110938|FG000|Overall Study|Physician Decision|1|||
170755121|NCT00162942|617110939|FG001|Overall Study|Physician Decision|0|||
170755122|NCT00162942|617110938|FG000|Overall Study|Enter Open-Label Study|76|||
170755123|NCT00162942|617110939|FG001|Overall Study|Enter Open-Label Study|35|||
170755124|NCT00162942|617110938|FG000|Overall Study|Alternate Therapy|6|||
170755125|NCT00162942|617110939|FG001|Overall Study|Alternate Therapy|2|||
170755126|NCT00162942|617110938|FG000|Overall Study|Lack of Efficacy|1|||
170755127|NCT00162942|617110939|FG001|Overall Study|Lack of Efficacy|0|||
170755128|NCT00162942|617110938|FG000|Overall Study|Flare During Active Treatment|7|||
170755129|NCT00162942|617110939|FG001|Overall Study|Flare During Active Treatment|3|||
170755130|NCT00162942|617110938|FG000|Overall Study|2 or more consecutive treatments missed|1|||
170755131|NCT00162942|617110939|FG001|Overall Study|2 or more consecutive treatments missed|0|||
170755132|NCT01167023|617110940|FG000|Overall Study|Lost to Follow-up|0|||
170755133|NCT01167023|617110941|FG001|Overall Study|Lost to Follow-up|1|||
170755134|NCT01167023|617110942|FG002|Overall Study|Lost to Follow-up|1|||
170755135|NCT01167023|617110940|FG000|Overall Study|Screen Failure|0|||
170755136|NCT01167023|617110941|FG001|Overall Study|Screen Failure|1|||
170755137|NCT01167023|617110942|FG002|Overall Study|Screen Failure|0|||
170755138|NCT01167023|617110940|FG000|Overall Study|Sponsor Decision|0|||
170755139|NCT01167023|617110941|FG001|Overall Study|Sponsor Decision|1|||
170755140|NCT01167023|617110942|FG002|Overall Study|Sponsor Decision|0|||
170755141|NCT01167023|617110940|FG000|Overall Study|Withdrawal by Subject|0|||
170755142|NCT01167023|617110941|FG001|Overall Study|Withdrawal by Subject|0|||
170755143|NCT01167023|617110942|FG002|Overall Study|Withdrawal by Subject|1|||
170755144|NCT01027871|617110949|FG000|Overall Study|Physician Decision|1|||
170755145|NCT01027871|617110950|FG001|Overall Study|Physician Decision|5|||
170755146|NCT01027871|617110951|FG002|Overall Study|Physician Decision|0|||
170755147|NCT01027871|617110949|FG000|Overall Study|Protocol Violation|0|||
170755148|NCT01027871|617110950|FG001|Overall Study|Protocol Violation|2|||
170755149|NCT01027871|617110951|FG002|Overall Study|Protocol Violation|2|||
170755150|NCT01027871|617110949|FG000|Overall Study|Withdrawal by Subject|1|||
170755151|NCT01027871|617110950|FG001|Overall Study|Withdrawal by Subject|2|||
170755152|NCT01027871|617110951|FG002|Overall Study|Withdrawal by Subject|2|||
170755153|NCT01027871|617110949|FG000|Overall Study|Adverse Event|0|||
170755154|NCT01027871|617110950|FG001|Overall Study|Adverse Event|2|||
170755155|NCT01027871|617110951|FG002|Overall Study|Adverse Event|2|||
170755156|NCT01027871|617110949|FG000|Overall Study|Sponsor Decision|0|||
170755157|NCT01027871|617110950|FG001|Overall Study|Sponsor Decision|2|||
170755158|NCT01027871|617110951|FG002|Overall Study|Sponsor Decision|0|||
170755159|NCT01027871|617110949|FG000|Overall Study|Discontinued Prior to Treatment|0|||
170755160|NCT01027871|617110950|FG001|Overall Study|Discontinued Prior to Treatment|0|||
170755161|NCT01027871|617110951|FG002|Overall Study|Discontinued Prior to Treatment|1|||
170755162|NCT00052962|617110952|FG000|Overall Study|Not evaluable|0|||
170755163|NCT00052962|617110953|FG001|Overall Study|Not evaluable|2|||
170755164|NCT00052962|617110952|FG000|Overall Study|Not randomized/not evaluable|1|||
170755165|NCT00052962|617110953|FG001|Overall Study|Not randomized/not evaluable|0|||
170755166|NCT01414166|617110954|FG000|Overall Study|Adverse Event|10|||
170755167|NCT01414166|617110955|FG001|Overall Study|Adverse Event|2|||
170755168|NCT01414166|617110954|FG000|Overall Study|Lost to Follow-up|4|||
170755169|NCT01414166|617110955|FG001|Overall Study|Lost to Follow-up|1|||
170755170|NCT01414166|617110954|FG000|Overall Study|Non-compliance with study drug|2|||
170755171|NCT01414166|617110955|FG001|Overall Study|Non-compliance with study drug|0|||
170755172|NCT01414166|617110954|FG000|Overall Study|Physician Decision|2|||
170755173|NCT01414166|617110955|FG001|Overall Study|Physician Decision|0|||
170755174|NCT01414166|617110954|FG000|Overall Study|Protocol Violation|2|||
170755175|NCT01414166|617110955|FG001|Overall Study|Protocol Violation|0|||
170755176|NCT01414166|617110954|FG000|Overall Study|Study terminated by Sponsor|68|||
170755177|NCT01414166|617110955|FG001|Overall Study|Study terminated by Sponsor|75|||
170755178|NCT01414166|617110954|FG000|Overall Study|Withdrawal by Subject|3|||
170755179|NCT01414166|617110955|FG001|Overall Study|Withdrawal by Subject|5|||
170865046|NCT01106404|617518009|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
170631549|NCT02113982|616664418|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631550|NCT02113982|616664419|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631551|NCT02113982|616664420|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631552|NCT02113982|616664421|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
170631553|NCT02113982|616664422|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631554|NCT02113982|616664423|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
170631555|NCT02113982|616664410|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631556|NCT02113982|616664411|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631557|NCT02113982|616664412|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631558|NCT02113982|616664413|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631559|NCT02113982|616664414|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631560|NCT02113982|616664415|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
170865047|NCT01774084|617518010|FG000|Overall Study|Personal reasons|1|||
170865048|NCT01774084|617518011|FG001|Overall Study|Personal reasons|0|||
170402749|NCT02513459|615816981|FG000|Overall Study|Subject decision|2|||
170631561|NCT02113982|616664416|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631562|NCT02113982|616664417|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631563|NCT02113982|616664418|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631564|NCT02113982|616664419|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631565|NCT02113982|616664420|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631566|NCT02113982|616664421|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
170631567|NCT02113982|616664422|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631568|NCT02113982|616664423|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
170631569|NCT02113982|616664410|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631570|NCT02113982|616664411|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631571|NCT02113982|616664412|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631572|NCT02113982|616664413|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631573|NCT02113982|616664414|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631574|NCT02113982|616664415|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631575|NCT02113982|616664416|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631576|NCT02113982|616664417|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631577|NCT02113982|616664418|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631578|NCT02113982|616664419|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631579|NCT02113982|616664420|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631580|NCT02113982|616664421|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
170631581|NCT02113982|616664422|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631582|NCT02113982|616664423|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
170631583|NCT02113982|616664410|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
170631584|NCT02113982|616664411|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
170631585|NCT02113982|616664412|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
170631586|NCT02113982|616664413|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
170631587|NCT02113982|616664414|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
170631588|NCT02113982|616664415|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
170631589|NCT02113982|616664416|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
170631590|NCT02113982|616664417|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
170631591|NCT02113982|616664418|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
170631592|NCT02113982|616664419|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
170631593|NCT02113982|616664420|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
170631594|NCT02113982|616664421|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
170631595|NCT02113982|616664422|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
170631596|NCT02113982|616664423|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
170631597|NCT02113982|616664410|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631598|NCT02113982|616664411|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631599|NCT02113982|616664412|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631600|NCT02113982|616664413|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631601|NCT02113982|616664414|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631602|NCT02113982|616664415|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631603|NCT02113982|616664416|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631604|NCT02113982|616664417|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631605|NCT02113982|616664418|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631606|NCT02113982|616664419|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631607|NCT02113982|616664420|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631608|NCT02113982|616664421|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631609|NCT02113982|616664422|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
170631610|NCT02113982|616664423|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
170631611|NCT02113982|616664410|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631612|NCT02113982|616664411|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631613|NCT02113982|616664412|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631614|NCT02113982|616664413|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631615|NCT02113982|616664414|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631616|NCT02113982|616664415|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631617|NCT02113982|616664416|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631618|NCT02113982|616664417|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631619|NCT02113982|616664418|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631620|NCT02113982|616664419|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631621|NCT02113982|616664420|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631622|NCT02113982|616664421|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
170631623|NCT02113982|616664422|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
170631624|NCT02113982|616664423|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
170631625|NCT02113982|616664410|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631626|NCT02113982|616664411|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631627|NCT02113982|616664412|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631628|NCT02113982|616664413|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631629|NCT02113982|616664414|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631630|NCT02113982|616664415|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170755180|NCT04887285|617110959|FG000|Overall Study|Lost to Follow-up|0|||
170631631|NCT02113982|616664416|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631632|NCT02113982|616664417|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631633|NCT02113982|616664418|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631634|NCT02113982|616664419|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631635|NCT02113982|616664420|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631636|NCT02113982|616664421|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
170631637|NCT02113982|616664422|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
170631638|NCT02113982|616664423|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
170631639|NCT02113982|616664410|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631640|NCT02113982|616664411|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631641|NCT02113982|616664412|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631642|NCT02113982|616664413|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631643|NCT02113982|616664414|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631644|NCT02113982|616664415|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631645|NCT02113982|616664416|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631646|NCT02113982|616664417|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631647|NCT02113982|616664418|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631648|NCT02113982|616664419|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631649|NCT02113982|616664420|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631650|NCT02113982|616664421|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
170631651|NCT02113982|616664422|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
170631652|NCT02113982|616664423|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
170631653|NCT02113982|616664410|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631654|NCT02113982|616664411|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631655|NCT02113982|616664412|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631656|NCT02113982|616664413|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631657|NCT02113982|616664414|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631658|NCT02113982|616664415|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631659|NCT02113982|616664416|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631660|NCT02113982|616664417|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631661|NCT02113982|616664418|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631662|NCT02113982|616664419|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631663|NCT02113982|616664420|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631664|NCT02113982|616664421|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631665|NCT02113982|616664422|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
170631666|NCT02113982|616664423|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
170631667|NCT02113982|616664410|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631668|NCT02113982|616664411|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631669|NCT02113982|616664412|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631670|NCT02113982|616664413|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631671|NCT02113982|616664414|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631672|NCT02113982|616664415|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631673|NCT02113982|616664416|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631674|NCT02113982|616664417|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631675|NCT02113982|616664418|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631676|NCT02113982|616664419|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631677|NCT02113982|616664420|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631678|NCT02113982|616664421|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631679|NCT02113982|616664422|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
170631680|NCT02113982|616664423|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
170631681|NCT02113982|616664410|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631682|NCT02113982|616664411|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631683|NCT02113982|616664412|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631684|NCT02113982|616664413|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631685|NCT02113982|616664414|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631686|NCT02113982|616664415|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631687|NCT02113982|616664416|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631688|NCT02113982|616664417|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631689|NCT02113982|616664418|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631690|NCT02113982|616664419|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631691|NCT02113982|616664420|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631692|NCT02113982|616664421|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631693|NCT02113982|616664422|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
170631694|NCT02113982|616664423|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
170631695|NCT02085161|616664425|FG000|Overall Study|Not Treated|1|||
170631696|NCT02085161|616664426|FG001|Overall Study|Not Treated|0|||
170631697|NCT02085161|616664427|FG002|Overall Study|Not Treated|0|||
170402750|NCT02513459|615816981|FG000|Overall Study|Lack of response|1|||
170402751|NCT02513459|615816981|FG000|Overall Study|Reproductive plans|1|||
170402752|NCT02513459|615816981|FG000|Overall Study|Surgery planned-- not done|1|||
170402753|NCT04023994|615816982|FG000|Overall Study|Lost to Follow-up|0|||
170402754|NCT04023994|615816983|FG001|Overall Study|Lost to Follow-up|1|||
170402755|NCT04023994|615816984|FG002|Overall Study|Lost to Follow-up|2|||
170402756|NCT04023994|615816985|FG003|Overall Study|Lost to Follow-up|0|||
170402757|NCT04023994|615816986|FG004|Overall Study|Lost to Follow-up|0|||
170402758|NCT04023994|615816987|FG005|Overall Study|Lost to Follow-up|0|||
170402759|NCT04023994|615816982|FG000|Overall Study|Withdrawal by Subject|0|||
170631698|NCT02085161|616664428|FG003|Overall Study|Not Treated|0|||
170402760|NCT04023994|615816983|FG001|Overall Study|Withdrawal by Subject|0|||
170402761|NCT04023994|615816984|FG002|Overall Study|Withdrawal by Subject|0|||
170402762|NCT04023994|615816985|FG003|Overall Study|Withdrawal by Subject|1|||
170402763|NCT04023994|615816986|FG004|Overall Study|Withdrawal by Subject|0|||
170402764|NCT04023994|615816987|FG005|Overall Study|Withdrawal by Subject|0|||
170402765|NCT00923195|615816988|FG000|Overall Study|Death|0|||
170402766|NCT00923195|615816989|FG001|Overall Study|Death|1|||
170402767|NCT01613131|615816990|FG000|Overall Study|Withdrawal by Subject|3|||
170402768|NCT01613131|615816991|FG001|Overall Study|Withdrawal by Subject|5|||
170402769|NCT01020305|615816996|FG000|Overall Study|Adverse Event|2|||
170402770|NCT00660790|615817003|FG000|Baseline to 3 Months|Death|1|||
170402771|NCT00660790|615817003|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
170402772|NCT00660790|615817003|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
170402773|NCT00686374|615817004|FG000|Overall Study|Lack of Efficacy|10|||
170402774|NCT00686374|615817004|FG000|Overall Study|Adverse Event|8|||
170402775|NCT00686374|615817004|FG000|Overall Study|Withdrew consent|5|||
170402776|NCT00686374|615817004|FG000|Overall Study|Lost to Follow-up|1|||
170402777|NCT00686374|615817004|FG000|Overall Study|Missing reason|33|||
170402778|NCT00686374|615817004|FG000|Overall Study|Other, not specified|4|||
170402779|NCT01070966|615817005|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
170402780|NCT01070966|615817005|FG000|Participants for Safety Evaluation|Off-label use|9|||
170402781|NCT01070966|615817005|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
170402782|NCT01070966|615817005|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
170402783|NCT01070966|615817005|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
170402784|NCT01070966|615817005|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
170402785|NCT01070966|615817005|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
170402786|NCT01070966|615817005|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
170402787|NCT00618774|615817006|FG000|Overall Study|Adverse Event|5|||
170402788|NCT00618774|615817007|FG001|Overall Study|Adverse Event|3|||
170402789|NCT00618774|615817006|FG000|Overall Study|Withdrawal by Subject|1|||
170402790|NCT00618774|615817007|FG001|Overall Study|Withdrawal by Subject|0|||
170402791|NCT01725113|615817009|FG000|Overall Study|Kidney Transplant|1|||
170402792|NCT01725113|615817010|FG001|Overall Study|Kidney Transplant|1|||
170402793|NCT01725113|615817009|FG000|Overall Study|Withdrawal by Subject|0|||
170402794|NCT01725113|615817010|FG001|Overall Study|Withdrawal by Subject|1|||
170402795|NCT01415921|615817011|FG000|Overall Study|Adverse Event|0|||
170402796|NCT01415921|615817012|FG001|Overall Study|Adverse Event|1|||
170402797|NCT01415921|615817011|FG000|Overall Study|Physician Decision|1|||
170402798|NCT01415921|615817012|FG001|Overall Study|Physician Decision|1|||
170402799|NCT01415921|615817011|FG000|Overall Study|Withdrawal by Subject|0|||
170631699|NCT02085161|616664425|FG000|Overall Study|Adverse Event|8|||
170631700|NCT02085161|616664426|FG001|Overall Study|Adverse Event|5|||
170631701|NCT02085161|616664427|FG002|Overall Study|Adverse Event|4|||
170631702|NCT02085161|616664428|FG003|Overall Study|Adverse Event|5|||
170631703|NCT02085161|616664425|FG000|Overall Study|Protocol Violation|0|||
170631704|NCT02085161|616664426|FG001|Overall Study|Protocol Violation|1|||
170631705|NCT02085161|616664427|FG002|Overall Study|Protocol Violation|0|||
170631706|NCT02085161|616664428|FG003|Overall Study|Protocol Violation|1|||
170631707|NCT02085161|616664425|FG000|Overall Study|Withdrawal by Subject|2|||
170631708|NCT02085161|616664426|FG001|Overall Study|Withdrawal by Subject|4|||
170402800|NCT01415921|615817012|FG001|Overall Study|Withdrawal by Subject|1|||
170402801|NCT01415921|615817011|FG000|Overall Study|Other|2|||
170402802|NCT01415921|615817012|FG001|Overall Study|Other|0|||
170402803|NCT01170364|615817015|FG000|Overall Study|Protocol Violation|4|||
170402804|NCT01170364|615817016|FG001|Overall Study|Protocol Violation|1|||
170402805|NCT00368537|615817018|FG000|Randomization|No study drug dosed|13|||
170402806|NCT00368537|615817019|FG001|Randomization|No study drug dosed|6|||
170402807|NCT00368537|615817018|FG000|Baseline Participants|Lost to Follow-up|16|||
170402808|NCT00368537|615817019|FG001|Baseline Participants|Lost to Follow-up|17|||
170402809|NCT00368537|615817018|FG000|Baseline Participants|Withdrawal by Subject|6|||
170402810|NCT00368537|615817019|FG001|Baseline Participants|Withdrawal by Subject|4|||
170402811|NCT00368537|615817018|FG000|Baseline Participants|Death|1|||
170402812|NCT00368537|615817019|FG001|Baseline Participants|Death|2|||
170631709|NCT02085161|616664427|FG002|Overall Study|Withdrawal by Subject|0|||
170631710|NCT02085161|616664428|FG003|Overall Study|Withdrawal by Subject|3|||
170631711|NCT02085161|616664425|FG000|Overall Study|Other Reason|1|||
170631712|NCT02085161|616664426|FG001|Overall Study|Other Reason|0|||
170631713|NCT02085161|616664427|FG002|Overall Study|Other Reason|1|||
170631714|NCT02085161|616664428|FG003|Overall Study|Other Reason|1|||
170631715|NCT00068692|616664439|FG000|Step 1: Registration|Disese progression/relapse|5|||
170631716|NCT00068692|616664440|FG001|Step 1: Registration|Disese progression/relapse|0|||
170631717|NCT00068692|616664441|FG002|Step 1: Registration|Disese progression/relapse|0|||
170631718|NCT00068692|616664442|FG003|Step 1: Registration|Disese progression/relapse|0|||
170631719|NCT00068692|616664443|FG004|Step 1: Registration|Disese progression/relapse|0|||
170631720|NCT00068692|616664444|FG005|Step 1: Registration|Disese progression/relapse|0|||
170631721|NCT00068692|616664445|FG006|Step 1: Registration|Disese progression/relapse|0|||
170631722|NCT00068692|616664446|FG007|Step 1: Registration|Disese progression/relapse|0|||
170631723|NCT00068692|616664439|FG000|Step 1: Registration|Adverse Event|7|||
170631724|NCT00068692|616664440|FG001|Step 1: Registration|Adverse Event|0|||
170631725|NCT00068692|616664441|FG002|Step 1: Registration|Adverse Event|0|||
170631726|NCT00068692|616664442|FG003|Step 1: Registration|Adverse Event|0|||
170631727|NCT00068692|616664443|FG004|Step 1: Registration|Adverse Event|0|||
170631728|NCT00068692|616664444|FG005|Step 1: Registration|Adverse Event|0|||
170631729|NCT00068692|616664445|FG006|Step 1: Registration|Adverse Event|0|||
170631730|NCT00068692|616664446|FG007|Step 1: Registration|Adverse Event|0|||
170631731|NCT00068692|616664439|FG000|Step 1: Registration|Death|1|||
170631732|NCT00068692|616664440|FG001|Step 1: Registration|Death|0|||
170631733|NCT00068692|616664441|FG002|Step 1: Registration|Death|0|||
170631734|NCT00068692|616664442|FG003|Step 1: Registration|Death|0|||
170631735|NCT00068692|616664443|FG004|Step 1: Registration|Death|0|||
170631736|NCT00068692|616664444|FG005|Step 1: Registration|Death|0|||
170631737|NCT00068692|616664445|FG006|Step 1: Registration|Death|0|||
170631738|NCT00068692|616664446|FG007|Step 1: Registration|Death|0|||
170631739|NCT00068692|616664439|FG000|Step 1: Registration|Withdrawal by Subject|11|||
170631740|NCT00068692|616664440|FG001|Step 1: Registration|Withdrawal by Subject|0|||
170631741|NCT00068692|616664441|FG002|Step 1: Registration|Withdrawal by Subject|0|||
170631742|NCT00068692|616664442|FG003|Step 1: Registration|Withdrawal by Subject|0|||
170631743|NCT00068692|616664443|FG004|Step 1: Registration|Withdrawal by Subject|0|||
170631744|NCT00068692|616664444|FG005|Step 1: Registration|Withdrawal by Subject|0|||
170631745|NCT00068692|616664445|FG006|Step 1: Registration|Withdrawal by Subject|0|||
170631746|NCT00068692|616664446|FG007|Step 1: Registration|Withdrawal by Subject|0|||
170631747|NCT00068692|616664439|FG000|Step 1: Registration|Alternative therapy|2|||
170631748|NCT00068692|616664440|FG001|Step 1: Registration|Alternative therapy|0|||
170631749|NCT00068692|616664441|FG002|Step 1: Registration|Alternative therapy|0|||
170631750|NCT00068692|616664442|FG003|Step 1: Registration|Alternative therapy|0|||
170631751|NCT00068692|616664443|FG004|Step 1: Registration|Alternative therapy|0|||
170631752|NCT00068692|616664444|FG005|Step 1: Registration|Alternative therapy|0|||
170631753|NCT00068692|616664445|FG006|Step 1: Registration|Alternative therapy|0|||
170631754|NCT00068692|616664446|FG007|Step 1: Registration|Alternative therapy|0|||
170631755|NCT00068692|616664439|FG000|Step 1: Registration|Complicating disease|2|||
170631756|NCT00068692|616664440|FG001|Step 1: Registration|Complicating disease|0|||
170631757|NCT00068692|616664441|FG002|Step 1: Registration|Complicating disease|0|||
170631758|NCT00068692|616664442|FG003|Step 1: Registration|Complicating disease|0|||
170631759|NCT00068692|616664443|FG004|Step 1: Registration|Complicating disease|0|||
170631760|NCT00068692|616664444|FG005|Step 1: Registration|Complicating disease|0|||
170631761|NCT00068692|616664445|FG006|Step 1: Registration|Complicating disease|0|||
170631762|NCT00068692|616664446|FG007|Step 1: Registration|Complicating disease|0|||
170631763|NCT00068692|616664439|FG000|Step 1: Registration|Protocol Violation|1|||
170631764|NCT00068692|616664440|FG001|Step 1: Registration|Protocol Violation|0|||
170631765|NCT00068692|616664441|FG002|Step 1: Registration|Protocol Violation|0|||
170631766|NCT00068692|616664442|FG003|Step 1: Registration|Protocol Violation|0|||
170631767|NCT00068692|616664443|FG004|Step 1: Registration|Protocol Violation|0|||
170631768|NCT00068692|616664444|FG005|Step 1: Registration|Protocol Violation|0|||
170631769|NCT00068692|616664445|FG006|Step 1: Registration|Protocol Violation|0|||
170631770|NCT00068692|616664446|FG007|Step 1: Registration|Protocol Violation|0|||
170631771|NCT00068692|616664439|FG000|Step 1: Registration|Not eligible|6|||
170631772|NCT00068692|616664440|FG001|Step 1: Registration|Not eligible|0|||
170631773|NCT00068692|616664441|FG002|Step 1: Registration|Not eligible|0|||
170631774|NCT00068692|616664442|FG003|Step 1: Registration|Not eligible|0|||
170631775|NCT00068692|616664443|FG004|Step 1: Registration|Not eligible|0|||
170631776|NCT00068692|616664444|FG005|Step 1: Registration|Not eligible|0|||
170631777|NCT00068692|616664445|FG006|Step 1: Registration|Not eligible|0|||
170631778|NCT00068692|616664446|FG007|Step 1: Registration|Not eligible|0|||
170631779|NCT00068692|616664439|FG000|Step 1: Registration|Other|2|||
170631780|NCT00068692|616664440|FG001|Step 1: Registration|Other|0|||
170631781|NCT00068692|616664441|FG002|Step 1: Registration|Other|0|||
170631782|NCT00068692|616664442|FG003|Step 1: Registration|Other|0|||
170631783|NCT00068692|616664443|FG004|Step 1: Registration|Other|0|||
170631784|NCT00068692|616664444|FG005|Step 1: Registration|Other|0|||
170631785|NCT00068692|616664445|FG006|Step 1: Registration|Other|0|||
170631786|NCT00068692|616664446|FG007|Step 1: Registration|Other|0|||
170631787|NCT00068692|616664439|FG000|Step 1: Registration|Not start protocol therapy|3|||
170631788|NCT00068692|616664440|FG001|Step 1: Registration|Not start protocol therapy|0|||
170631789|NCT00068692|616664441|FG002|Step 1: Registration|Not start protocol therapy|0|||
170631790|NCT00068692|616664442|FG003|Step 1: Registration|Not start protocol therapy|0|||
170631791|NCT00068692|616664443|FG004|Step 1: Registration|Not start protocol therapy|0|||
170631792|NCT00068692|616664444|FG005|Step 1: Registration|Not start protocol therapy|0|||
170631793|NCT00068692|616664445|FG006|Step 1: Registration|Not start protocol therapy|0|||
170631794|NCT00068692|616664446|FG007|Step 1: Registration|Not start protocol therapy|0|||
170631795|NCT00068692|616664439|FG000|Step 1: Registration|Registered but not randomized|0|||
170402813|NCT00368537|615817018|FG000|Baseline Participants|No susceptibility|1|||
170402814|NCT00368537|615817019|FG001|Baseline Participants|No susceptibility|0|||
170402815|NCT00368537|615817018|FG000|Baseline Participants|Patient uncompliant|0|||
170402816|NCT00368537|615817019|FG001|Baseline Participants|Patient uncompliant|1|||
170402817|NCT01368276|615817033|FG000|Overall Study|Death|1|||
170402818|NCT01368276|615817034|FG001|Overall Study|Death|10|||
170402819|NCT01427920|615817035|FG000|Overall Study|Adverse Event|1|||
170402820|NCT01427920|615817036|FG001|Overall Study|Adverse Event|2|||
170402821|NCT01427920|615817035|FG000|Overall Study|Lack of Efficacy|1|||
170402822|NCT01427920|615817036|FG001|Overall Study|Lack of Efficacy|0|||
170402823|NCT01427920|615817035|FG000|Overall Study|Protocol Violation|1|||
170402824|NCT01427920|615817036|FG001|Overall Study|Protocol Violation|3|||
170402825|NCT01427920|615817035|FG000|Overall Study|Withdrawal Criteria|4|||
170402826|NCT01427920|615817036|FG001|Overall Study|Withdrawal Criteria|4|||
170402827|NCT01427920|615817035|FG000|Overall Study|Unclassified|2|||
170402828|NCT01427920|615817036|FG001|Overall Study|Unclassified|8|||
170402829|NCT03341273|615817037|FG000|Overall Study|Lost to Follow-up|7|||
170402830|NCT03341273|615817038|FG001|Overall Study|Lost to Follow-up|7|||
170402831|NCT03341273|615817037|FG000|Overall Study|Withdrawal by Subject|4|||
170402832|NCT03341273|615817038|FG001|Overall Study|Withdrawal by Subject|2|||
170402833|NCT03341273|615817037|FG000|Overall Study|Physician Decision|1|||
170402834|NCT03341273|615817038|FG001|Overall Study|Physician Decision|0|||
170402835|NCT03341273|615817037|FG000|Overall Study|Protocol Violation|0|||
170402836|NCT03341273|615817038|FG001|Overall Study|Protocol Violation|1|||
170402837|NCT03341273|615817037|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
170402838|NCT03341273|615817038|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
170402839|NCT03341273|615817037|FG000|Overall Study|Became ineligible after enrollment|1|||
170402840|NCT03341273|615817038|FG001|Overall Study|Became ineligible after enrollment|0|||
170402841|NCT03341273|615817037|FG000|Overall Study|Not Eligible at Enrollment|0|||
170402842|NCT03341273|615817038|FG001|Overall Study|Not Eligible at Enrollment|1|||
170402843|NCT03341273|615817037|FG000|Overall Study|Participant incarcerated|1|||
170402844|NCT03341273|615817038|FG001|Overall Study|Participant incarcerated|0|||
170402845|NCT00685919|615817039|FG000|Overall Study|Withdrawal by Subject|0|||
170402846|NCT00685919|615817040|FG001|Overall Study|Withdrawal by Subject|0|||
170402847|NCT00685919|615817041|FG002|Overall Study|Withdrawal by Subject|1|||
170402848|NCT00685919|615817042|FG003|Overall Study|Withdrawal by Subject|0|||
170402849|NCT00685919|615817039|FG000|Overall Study|Physician Decision|1|||
170402850|NCT00685919|615817040|FG001|Overall Study|Physician Decision|0|||
170402851|NCT00685919|615817041|FG002|Overall Study|Physician Decision|0|||
170402852|NCT00685919|615817042|FG003|Overall Study|Physician Decision|0|||
170402853|NCT01717456|615817045|FG000|End of Treatment|Physician Decision|0|||
170402854|NCT01717456|615817046|FG001|End of Treatment|Physician Decision|1|||
170402855|NCT01717456|615817045|FG000|End of Treatment|Lost to Follow-up|0|||
170631796|NCT00068692|616664440|FG001|Step 1: Registration|Registered but not randomized|1|||
170631797|NCT00068692|616664441|FG002|Step 1: Registration|Registered but not randomized|0|||
170631798|NCT00068692|616664442|FG003|Step 1: Registration|Registered but not randomized|0|||
170631799|NCT00068692|616664443|FG004|Step 1: Registration|Registered but not randomized|0|||
170631800|NCT00068692|616664444|FG005|Step 1: Registration|Registered but not randomized|0|||
170631801|NCT00068692|616664445|FG006|Step 1: Registration|Registered but not randomized|0|||
170402856|NCT01717456|615817046|FG001|End of Treatment|Lost to Follow-up|1|||
170402857|NCT01717456|615817045|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
170402858|NCT01717456|615817046|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
170402859|NCT03066440|615817053|FG000|Overall Study|Physician Decision|1|||
170402860|NCT03066440|615817054|FG001|Overall Study|Physician Decision|1|||
170402861|NCT03066440|615817053|FG000|Overall Study|Protocol Violation|0|||
170402862|NCT03066440|615817054|FG001|Overall Study|Protocol Violation|2|||
170402863|NCT00736333|615817055|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
170402864|NCT00736333|615817055|FG000|Overall Study|Data Missing|2|||
170402865|NCT00736333|615817055|FG000|Overall Study|Tumor Progression|75|||
170402866|NCT00736333|615817055|FG000|Overall Study|Toxicity|6|||
170402867|NCT00736333|615817055|FG000|Overall Study|Withdrawal by Subject|10|||
170402868|NCT00736333|615817055|FG000|Overall Study|Death|7|||
170402869|NCT00736333|615817055|FG000|Overall Study|Other|4|||
170402870|NCT04991311|615817057|FG000|Overall Study|Adverse Event|1|||
170402871|NCT00054275|615817059|FG000|Overall Study|Withdrawal by Subject|4|||
170402872|NCT00054275|615817059|FG000|Overall Study|Adverse Event|5|||
170755181|NCT04887285|617110960|FG001|Overall Study|Lost to Follow-up|2|||
170755182|NCT04887285|617110961|FG002|Overall Study|Lost to Follow-up|3|||
170631802|NCT00068692|616664446|FG007|Step 1: Registration|Registered but not randomized|0|||
170631803|NCT00068692|616664439|FG000|Step 2: Randomization|Disesae progression/replase|0|||
170631804|NCT00068692|616664440|FG001|Step 2: Randomization|Disesae progression/replase|0|||
170631805|NCT00068692|616664441|FG002|Step 2: Randomization|Disesae progression/replase|1|||
170631806|NCT00068692|616664442|FG003|Step 2: Randomization|Disesae progression/replase|1|||
170631807|NCT00068692|616664443|FG004|Step 2: Randomization|Disesae progression/replase|0|||
170631808|NCT00068692|616664444|FG005|Step 2: Randomization|Disesae progression/replase|0|||
170631809|NCT00068692|616664445|FG006|Step 2: Randomization|Disesae progression/replase|0|||
170631810|NCT00068692|616664446|FG007|Step 2: Randomization|Disesae progression/replase|0|||
170631811|NCT00068692|616664439|FG000|Step 2: Randomization|Adverse Event|0|||
170631812|NCT00068692|616664440|FG001|Step 2: Randomization|Adverse Event|0|||
170631813|NCT00068692|616664441|FG002|Step 2: Randomization|Adverse Event|4|||
170631814|NCT00068692|616664442|FG003|Step 2: Randomization|Adverse Event|2|||
170631815|NCT00068692|616664443|FG004|Step 2: Randomization|Adverse Event|2|||
170631816|NCT00068692|616664444|FG005|Step 2: Randomization|Adverse Event|3|||
170631817|NCT00068692|616664445|FG006|Step 2: Randomization|Adverse Event|4|||
170631818|NCT00068692|616664446|FG007|Step 2: Randomization|Adverse Event|4|||
170631819|NCT00068692|616664439|FG000|Step 2: Randomization|Death|0|||
170631820|NCT00068692|616664440|FG001|Step 2: Randomization|Death|0|||
170631821|NCT00068692|616664441|FG002|Step 2: Randomization|Death|0|||
170631822|NCT00068692|616664442|FG003|Step 2: Randomization|Death|0|||
170631823|NCT00068692|616664443|FG004|Step 2: Randomization|Death|1|||
170631824|NCT00068692|616664444|FG005|Step 2: Randomization|Death|0|||
170631825|NCT00068692|616664445|FG006|Step 2: Randomization|Death|0|||
170631826|NCT00068692|616664446|FG007|Step 2: Randomization|Death|1|||
170631827|NCT00068692|616664439|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
170631828|NCT00068692|616664440|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
170631829|NCT00068692|616664441|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
170631830|NCT00068692|616664442|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
170631831|NCT00068692|616664443|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
170631832|NCT00068692|616664444|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
170631833|NCT00068692|616664445|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
170631834|NCT00068692|616664446|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
170631835|NCT00068692|616664439|FG000|Step 2: Randomization|alternative therapy|0|||
170631836|NCT00068692|616664440|FG001|Step 2: Randomization|alternative therapy|0|||
170631837|NCT00068692|616664441|FG002|Step 2: Randomization|alternative therapy|0|||
170631838|NCT00068692|616664442|FG003|Step 2: Randomization|alternative therapy|1|||
170631839|NCT00068692|616664443|FG004|Step 2: Randomization|alternative therapy|1|||
170631840|NCT00068692|616664444|FG005|Step 2: Randomization|alternative therapy|0|||
170631841|NCT00068692|616664445|FG006|Step 2: Randomization|alternative therapy|0|||
170631842|NCT00068692|616664446|FG007|Step 2: Randomization|alternative therapy|0|||
170631843|NCT00068692|616664439|FG000|Step 2: Randomization|Physician Decision|0|||
170631844|NCT00068692|616664440|FG001|Step 2: Randomization|Physician Decision|0|||
170631845|NCT00068692|616664441|FG002|Step 2: Randomization|Physician Decision|0|||
170631846|NCT00068692|616664442|FG003|Step 2: Randomization|Physician Decision|1|||
170631847|NCT00068692|616664443|FG004|Step 2: Randomization|Physician Decision|1|||
170631848|NCT00068692|616664444|FG005|Step 2: Randomization|Physician Decision|0|||
170631849|NCT00068692|616664445|FG006|Step 2: Randomization|Physician Decision|0|||
170631850|NCT00068692|616664446|FG007|Step 2: Randomization|Physician Decision|0|||
170631851|NCT00068692|616664439|FG000|Step 2: Randomization|Other|0|||
170631852|NCT00068692|616664440|FG001|Step 2: Randomization|Other|0|||
170631853|NCT00068692|616664441|FG002|Step 2: Randomization|Other|0|||
170631854|NCT00068692|616664442|FG003|Step 2: Randomization|Other|1|||
170631855|NCT00068692|616664443|FG004|Step 2: Randomization|Other|0|||
170631856|NCT00068692|616664444|FG005|Step 2: Randomization|Other|1|||
170631857|NCT00068692|616664445|FG006|Step 2: Randomization|Other|0|||
170631858|NCT00068692|616664446|FG007|Step 2: Randomization|Other|0|||
170631859|NCT00068692|616664439|FG000|Step 2: Randomization|never start protocol therapy|0|||
170865049|NCT00775450|617518012|FG000|Overall Study|Serious Adverse Event|2|||
170865050|NCT00775450|617518013|FG001|Overall Study|Serious Adverse Event|0|||
170865051|NCT00775450|617518014|FG002|Overall Study|Serious Adverse Event|0|||
170402873|NCT00054275|615817059|FG000|Overall Study|Progressive disease in cycle 1|1|||
170402874|NCT00054275|615817059|FG000|Overall Study|Physician Decision|1|||
170402875|NCT03876873|615817060|FG000|Overall Study|Physician Decision|0|||
170631860|NCT00068692|616664440|FG001|Step 2: Randomization|never start protocol therapy|0|||
170631861|NCT00068692|616664441|FG002|Step 2: Randomization|never start protocol therapy|1|||
170631862|NCT00068692|616664442|FG003|Step 2: Randomization|never start protocol therapy|0|||
170631863|NCT00068692|616664443|FG004|Step 2: Randomization|never start protocol therapy|1|||
170631864|NCT00068692|616664444|FG005|Step 2: Randomization|never start protocol therapy|0|||
170631865|NCT00068692|616664445|FG006|Step 2: Randomization|never start protocol therapy|0|||
170631866|NCT00068692|616664446|FG007|Step 2: Randomization|never start protocol therapy|0|||
170631867|NCT02873702|616664447|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
170631868|NCT02873702|616664448|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
170631869|NCT02873702|616664449|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
170631870|NCT02873702|616664450|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
170631871|NCT02873702|616664447|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
170631872|NCT02873702|616664448|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
170631873|NCT02873702|616664449|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
170631874|NCT02873702|616664450|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
170631875|NCT02873702|616664447|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
170631876|NCT02873702|616664448|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
170631877|NCT02873702|616664449|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
170631878|NCT02873702|616664450|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
170631879|NCT02873702|616664447|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
170631880|NCT02873702|616664448|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
170631881|NCT02873702|616664449|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
170631882|NCT02873702|616664450|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
170631883|NCT02873702|616664447|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
170631884|NCT02873702|616664448|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
170631885|NCT02873702|616664449|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
170631886|NCT02873702|616664450|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
170631887|NCT01600716|616664452|FG000|Overall Study|Other Reasons|3|||
170631888|NCT01600716|616664453|FG001|Overall Study|Other Reasons|1|||
170631889|NCT01600716|616664452|FG000|Overall Study|Personal Reasons|0|||
170631890|NCT01600716|616664453|FG001|Overall Study|Personal Reasons|2|||
170631891|NCT01600716|616664452|FG000|Overall Study|Lost to Follow-up|0|||
170631892|NCT01600716|616664453|FG001|Overall Study|Lost to Follow-up|2|||
170631893|NCT01600716|616664452|FG000|Overall Study|Pregnancy|1|||
170631894|NCT01600716|616664453|FG001|Overall Study|Pregnancy|0|||
170631895|NCT01600716|616664452|FG000|Overall Study|Lack of Efficacy|2|||
170631896|NCT01600716|616664453|FG001|Overall Study|Lack of Efficacy|1|||
170631897|NCT01600716|616664452|FG000|Overall Study|Adverse Event|1|||
170631898|NCT01600716|616664453|FG001|Overall Study|Adverse Event|1|||
170631899|NCT03557034|616664459|FG000|Overall Study|Withdrawal by Subject|1|||
170631900|NCT03557034|616664460|FG001|Overall Study|Withdrawal by Subject|0|||
170631901|NCT03252925|616664464|FG000|Overall Study|Withdrawal by Subject|1|||
170631902|NCT03252925|616664465|FG001|Overall Study|Withdrawal by Subject|0|||
170755183|NCT04640571|617110962|FG000|Overall Study|Withdrawal by Subject|0|||
170755184|NCT04640571|617110963|FG001|Overall Study|Withdrawal by Subject|0|||
170755185|NCT04640571|617110964|FG002|Overall Study|Withdrawal by Subject|0|||
170755186|NCT04640571|617110965|FG003|Overall Study|Withdrawal by Subject|0|||
170755187|NCT04640571|617110966|FG004|Overall Study|Withdrawal by Subject|0|||
170755188|NCT04640571|617110967|FG005|Overall Study|Withdrawal by Subject|2|||
170755189|NCT02820051|617110968|FG000|Overall Study|Lost to Follow-up|7|||
170755190|NCT02820051|617110969|FG001|Overall Study|Lost to Follow-up|4|||
170755191|NCT00832780|617110971|FG000|Overall Study|Death|16|||
170755192|NCT00832780|617110971|FG000|Overall Study|Lost to Follow-up|4|||
170755193|NCT00832780|617110971|FG000|Overall Study|no reason given|2|||
170755194|NCT00832780|617110971|FG000|Overall Study|other complicating condition|2|||
170755195|NCT00832780|617110971|FG000|Overall Study|Physician Decision|1|||
170755196|NCT05705167|617110976|FG000|Overall Study|Randomised but not Treated|0|||
170755197|NCT05705167|617110977|FG001|Overall Study|Randomised but not Treated|2|||
170755198|NCT05705167|617110978|FG002|Overall Study|Randomised but not Treated|0|||
170755199|NCT05705167|617110979|FG003|Overall Study|Randomised but not Treated|7|||
170755200|NCT05705167|617110980|FG004|Overall Study|Randomised but not Treated|0|||
170755201|NCT05705167|617110981|FG005|Overall Study|Randomised but not Treated|0|||
170755202|NCT05705167|617110982|FG006|Overall Study|Randomised but not Treated|0|||
170755203|NCT05705167|617110976|FG000|Overall Study|Death|0|||
170755204|NCT05705167|617110977|FG001|Overall Study|Death|0|||
170631903|NCT03252925|616664464|FG000|Overall Study|Protocol Violation|6|||
170631904|NCT03252925|616664465|FG001|Overall Study|Protocol Violation|0|||
170865052|NCT00775450|617518015|FG003|Overall Study|Serious Adverse Event|0|||
170631905|NCT03252925|616664464|FG000|Overall Study|Adverse Event|1|||
170631906|NCT03252925|616664465|FG001|Overall Study|Adverse Event|0|||
170631907|NCT03252925|616664464|FG000|Overall Study|Lost to Follow-up|6|||
170631908|NCT03252925|616664465|FG001|Overall Study|Lost to Follow-up|6|||
170631909|NCT01908803|616664478|FG000|Overall Study|Adverse Event|1|||
170631910|NCT01908803|616664479|FG001|Overall Study|Adverse Event|0|||
170631911|NCT01908803|616664478|FG000|Overall Study|Physician Decision|0|||
170631912|NCT01908803|616664479|FG001|Overall Study|Physician Decision|1|||
170631913|NCT01908803|616664478|FG000|Overall Study|Withdrawal by Subject|1|||
170631914|NCT01908803|616664479|FG001|Overall Study|Withdrawal by Subject|0|||
170631915|NCT01908803|616664478|FG000|Overall Study|Randomization Error|1|||
170631916|NCT01908803|616664479|FG001|Overall Study|Randomization Error|0|||
170631917|NCT01908803|616664478|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
170631918|NCT01908803|616664479|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
170631919|NCT02404025|616664480|FG000|Overall Study|Adverse Event|1|||
170631920|NCT02404025|616664480|FG000|Overall Study|Lack of Efficacy|3|||
170631921|NCT03926611|616664482|FG000|Overall Study|Adverse Event|0|||
170631922|NCT03926611|616664483|FG001|Overall Study|Adverse Event|0|||
170631923|NCT03926611|616664484|FG002|Overall Study|Adverse Event|0|||
170631924|NCT03926611|616664485|FG003|Overall Study|Adverse Event|3|||
170631925|NCT03926611|616664486|FG004|Overall Study|Adverse Event|1|||
170631926|NCT03926611|616664487|FG005|Overall Study|Adverse Event|3|||
170631927|NCT03926611|616664488|FG006|Overall Study|Adverse Event|0|||
170631928|NCT03926611|616664482|FG000|Overall Study|Lack of Efficacy|1|||
170631929|NCT03926611|616664483|FG001|Overall Study|Lack of Efficacy|2|||
170631930|NCT03926611|616664484|FG002|Overall Study|Lack of Efficacy|0|||
170631931|NCT03926611|616664485|FG003|Overall Study|Lack of Efficacy|0|||
170631932|NCT03926611|616664486|FG004|Overall Study|Lack of Efficacy|1|||
170631933|NCT03926611|616664487|FG005|Overall Study|Lack of Efficacy|0|||
170631934|NCT03926611|616664488|FG006|Overall Study|Lack of Efficacy|1|||
170631935|NCT03926611|616664482|FG000|Overall Study|Physician Decision|0|||
170631936|NCT03926611|616664483|FG001|Overall Study|Physician Decision|0|||
170631937|NCT03926611|616664484|FG002|Overall Study|Physician Decision|0|||
170631938|NCT03926611|616664485|FG003|Overall Study|Physician Decision|0|||
170631939|NCT03926611|616664486|FG004|Overall Study|Physician Decision|0|||
170631940|NCT03926611|616664487|FG005|Overall Study|Physician Decision|1|||
170631941|NCT03926611|616664488|FG006|Overall Study|Physician Decision|0|||
170631942|NCT03926611|616664482|FG000|Overall Study|Protocol Violation|1|||
170631943|NCT03926611|616664483|FG001|Overall Study|Protocol Violation|0|||
170631944|NCT03926611|616664484|FG002|Overall Study|Protocol Violation|0|||
170631945|NCT03926611|616664485|FG003|Overall Study|Protocol Violation|1|||
170631946|NCT03926611|616664486|FG004|Overall Study|Protocol Violation|1|||
170631947|NCT03926611|616664487|FG005|Overall Study|Protocol Violation|1|||
170631948|NCT03926611|616664488|FG006|Overall Study|Protocol Violation|1|||
170631949|NCT03926611|616664482|FG000|Overall Study|Technical problems|0|||
170631950|NCT03926611|616664483|FG001|Overall Study|Technical problems|0|||
170631951|NCT03926611|616664484|FG002|Overall Study|Technical problems|0|||
170631952|NCT03926611|616664485|FG003|Overall Study|Technical problems|0|||
170631953|NCT03926611|616664486|FG004|Overall Study|Technical problems|0|||
170631954|NCT03926611|616664487|FG005|Overall Study|Technical problems|1|||
170631955|NCT03926611|616664488|FG006|Overall Study|Technical problems|0|||
170631956|NCT03926611|616664482|FG000|Overall Study|Withdrawal by Subject|1|||
170631957|NCT03926611|616664483|FG001|Overall Study|Withdrawal by Subject|1|||
170631958|NCT03926611|616664484|FG002|Overall Study|Withdrawal by Subject|1|||
170631959|NCT03926611|616664485|FG003|Overall Study|Withdrawal by Subject|0|||
170755205|NCT05705167|617110978|FG002|Overall Study|Death|3|||
170755206|NCT05705167|617110979|FG003|Overall Study|Death|0|||
170755207|NCT05705167|617110980|FG004|Overall Study|Death|1|||
170865053|NCT00775450|617518016|FG004|Overall Study|Serious Adverse Event|0|||
170865054|NCT00775450|617518012|FG000|Overall Study|Protocol Violation|0|||
170865055|NCT00775450|617518013|FG001|Overall Study|Protocol Violation|0|||
170865056|NCT00775450|617518014|FG002|Overall Study|Protocol Violation|0|||
170865057|NCT00775450|617518015|FG003|Overall Study|Protocol Violation|0|||
170402876|NCT03876873|615817061|FG001|Overall Study|Physician Decision|1|||
170755208|NCT05705167|617110981|FG005|Overall Study|Death|1|||
170755209|NCT05705167|617110982|FG006|Overall Study|Death|1|||
170755210|NCT05705167|617110976|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
170755211|NCT05705167|617110977|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
170755212|NCT05705167|617110978|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
170755213|NCT05705167|617110979|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
170755214|NCT05705167|617110980|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
170755215|NCT05705167|617110981|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
170755216|NCT05705167|617110982|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
170755217|NCT04529538|617110984|FG000|Overall Study|Lost to Follow-up|3|||
170755218|NCT04529538|617110985|FG001|Overall Study|Lost to Follow-up|2|||
170755219|NCT04529538|617110986|FG002|Overall Study|Lost to Follow-up|1|||
170755220|NCT04529538|617110987|FG003|Overall Study|Lost to Follow-up|0|||
170755221|NCT04529538|617110988|FG004|Overall Study|Lost to Follow-up|1|||
170755222|NCT04529538|617110989|FG005|Overall Study|Lost to Follow-up|1|||
170755223|NCT04529538|617110990|FG006|Overall Study|Lost to Follow-up|2|||
170755224|NCT04529538|617110991|FG007|Overall Study|Lost to Follow-up|0|||
170755225|NCT04529538|617110984|FG000|Overall Study|Not eligible at enrollment|0|||
170755226|NCT04529538|617110985|FG001|Overall Study|Not eligible at enrollment|1|||
170755227|NCT04529538|617110986|FG002|Overall Study|Not eligible at enrollment|2|||
170755228|NCT04529538|617110987|FG003|Overall Study|Not eligible at enrollment|1|||
170755229|NCT04529538|617110988|FG004|Overall Study|Not eligible at enrollment|0|||
170755230|NCT04529538|617110989|FG005|Overall Study|Not eligible at enrollment|0|||
170755231|NCT04529538|617110990|FG006|Overall Study|Not eligible at enrollment|0|||
170755232|NCT04529538|617110991|FG007|Overall Study|Not eligible at enrollment|1|||
170755233|NCT04529538|617110984|FG000|Overall Study|Withdrawal by Subject|0|||
170755234|NCT04529538|617110985|FG001|Overall Study|Withdrawal by Subject|1|||
170755235|NCT04529538|617110986|FG002|Overall Study|Withdrawal by Subject|1|||
170755236|NCT04529538|617110987|FG003|Overall Study|Withdrawal by Subject|2|||
170755237|NCT04529538|617110988|FG004|Overall Study|Withdrawal by Subject|0|||
170755238|NCT04529538|617110989|FG005|Overall Study|Withdrawal by Subject|2|||
170865058|NCT00775450|617518016|FG004|Overall Study|Protocol Violation|1|||
170755239|NCT04529538|617110990|FG006|Overall Study|Withdrawal by Subject|3|||
170755240|NCT04529538|617110991|FG007|Overall Study|Withdrawal by Subject|0|||
170402877|NCT01106352|615817062|FG000|Overall Study|Subjects untreated|0|||
170402878|NCT01106352|615817063|FG001|Overall Study|Subjects untreated|0|||
170402879|NCT01106352|615817064|FG002|Overall Study|Subjects untreated|0|||
170402880|NCT01106352|615817065|FG003|Overall Study|Subjects untreated|3|||
170402881|NCT01106352|615817066|FG004|Overall Study|Subjects untreated|4|||
170402882|NCT01106352|615817062|FG000|Overall Study|Sponsor Decision|1|||
170402883|NCT01106352|615817063|FG001|Overall Study|Sponsor Decision|0|||
170402884|NCT01106352|615817064|FG002|Overall Study|Sponsor Decision|0|||
170402885|NCT01106352|615817065|FG003|Overall Study|Sponsor Decision|0|||
170402886|NCT01106352|615817066|FG004|Overall Study|Sponsor Decision|0|||
170402887|NCT01106352|615817062|FG000|Overall Study|Too ill to come in for the visit|0|||
170402888|NCT01106352|615817063|FG001|Overall Study|Too ill to come in for the visit|0|||
170402889|NCT01106352|615817064|FG002|Overall Study|Too ill to come in for the visit|1|||
170402890|NCT01106352|615817065|FG003|Overall Study|Too ill to come in for the visit|0|||
170402891|NCT01106352|615817066|FG004|Overall Study|Too ill to come in for the visit|0|||
170402892|NCT01106352|615817062|FG000|Overall Study|Lost to Follow-up|0|||
170402893|NCT01106352|615817063|FG001|Overall Study|Lost to Follow-up|0|||
170402894|NCT01106352|615817064|FG002|Overall Study|Lost to Follow-up|0|||
170402895|NCT01106352|615817065|FG003|Overall Study|Lost to Follow-up|0|||
170402896|NCT01106352|615817066|FG004|Overall Study|Lost to Follow-up|1|||
170402897|NCT01106352|615817062|FG000|Overall Study|Death|0|||
170402898|NCT01106352|615817063|FG001|Overall Study|Death|0|||
170402899|NCT01106352|615817064|FG002|Overall Study|Death|1|||
170755241|NCT04529538|617110984|FG000|Overall Study|Other|0|||
170755242|NCT04529538|617110985|FG001|Overall Study|Other|1|||
170402900|NCT01106352|615817065|FG003|Overall Study|Death|3|||
170402901|NCT01106352|615817066|FG004|Overall Study|Death|1|||
170402902|NCT01106352|615817062|FG000|Overall Study|Disease progression|0|||
170402903|NCT01106352|615817063|FG001|Overall Study|Disease progression|0|||
170402904|NCT01106352|615817064|FG002|Overall Study|Disease progression|0|||
170402905|NCT01106352|615817065|FG003|Overall Study|Disease progression|1|||
170402906|NCT01106352|615817066|FG004|Overall Study|Disease progression|0|||
170402907|NCT01106352|615817062|FG000|Overall Study|Withdrawal by Subject|0|||
170402908|NCT01106352|615817063|FG001|Overall Study|Withdrawal by Subject|0|||
170402909|NCT01106352|615817064|FG002|Overall Study|Withdrawal by Subject|0|||
170402910|NCT01106352|615817065|FG003|Overall Study|Withdrawal by Subject|3|||
170402911|NCT01106352|615817066|FG004|Overall Study|Withdrawal by Subject|2|||
170402912|NCT01106352|615817062|FG000|Overall Study|Went on hospice|0|||
170402913|NCT01106352|615817063|FG001|Overall Study|Went on hospice|0|||
170402914|NCT01106352|615817064|FG002|Overall Study|Went on hospice|0|||
170402915|NCT01106352|615817065|FG003|Overall Study|Went on hospice|1|||
170402916|NCT01106352|615817066|FG004|Overall Study|Went on hospice|0|||
170402917|NCT01106352|615817062|FG000|Overall Study|Subject entered hospice|0|||
170402918|NCT01106352|615817063|FG001|Overall Study|Subject entered hospice|0|||
170402919|NCT01106352|615817064|FG002|Overall Study|Subject entered hospice|0|||
170402920|NCT01106352|615817065|FG003|Overall Study|Subject entered hospice|1|||
170402921|NCT01106352|615817066|FG004|Overall Study|Subject entered hospice|0|||
170402922|NCT01106352|615817062|FG000|Overall Study|Home hospice since July 2013|0|||
170402923|NCT01106352|615817063|FG001|Overall Study|Home hospice since July 2013|0|||
170402924|NCT01106352|615817064|FG002|Overall Study|Home hospice since July 2013|0|||
170402925|NCT01106352|615817065|FG003|Overall Study|Home hospice since July 2013|1|||
170402926|NCT01106352|615817066|FG004|Overall Study|Home hospice since July 2013|0|||
170402927|NCT03944707|615817067|FG000|Overall Study|Adverse Event|0|||
170402928|NCT03944707|615817068|FG001|Overall Study|Adverse Event|2|||
170402929|NCT03944707|615817067|FG000|Overall Study|Study terminated by sponsor|12|||
170402930|NCT03944707|615817068|FG001|Overall Study|Study terminated by sponsor|7|||
170402931|NCT03944707|615817067|FG000|Overall Study|Subject decision|0|||
170402932|NCT03944707|615817068|FG001|Overall Study|Subject decision|1|||
170402933|NCT02444182|615817070|FG000|Overall Study|non-compliance|2|||
170402934|NCT02444182|615817071|FG001|Overall Study|non-compliance|1|||
170402935|NCT02444182|615817070|FG000|Overall Study|Lost to Follow-up|0|||
170402936|NCT02444182|615817071|FG001|Overall Study|Lost to Follow-up|4|||
170402937|NCT01959230|615817074|FG000|Overall Study|Failure to follow study procedures|0|||
170402938|NCT01959230|615817075|FG001|Overall Study|Failure to follow study procedures|1|||
170402939|NCT01959230|615817074|FG000|Overall Study|Administrative reasons|2|||
170402940|NCT01959230|615817075|FG001|Overall Study|Administrative reasons|0|||
170402941|NCT01959230|615817074|FG000|Overall Study|Withdrawal by Subject|2|||
170402942|NCT01959230|615817075|FG001|Overall Study|Withdrawal by Subject|0|||
170402943|NCT01453374|615817076|FG000|Overall Study|Adverse Event|7|||
170402944|NCT01453374|615817076|FG000|Overall Study|Lack of Efficacy|1|||
170402945|NCT01453374|615817076|FG000|Overall Study|Lost to Follow-up|3|||
170402946|NCT01453374|615817076|FG000|Overall Study|Withdrawal by Subject|5|||
170402947|NCT01453374|615817076|FG000|Overall Study|Incarcerated|2|||
170402948|NCT00751998|615817077|FG000|Overall Study|Lost to Follow-up|7|||
170402949|NCT00751998|615817077|FG000|Overall Study|Death|11|||
170755243|NCT04529538|617110986|FG002|Overall Study|Other|0|||
170755244|NCT04529538|617110987|FG003|Overall Study|Other|0|||
170865059|NCT00775450|617518012|FG000|Overall Study|Withdrawal by Subject|1|||
170865060|NCT00775450|617518013|FG001|Overall Study|Withdrawal by Subject|0|||
170865061|NCT00775450|617518014|FG002|Overall Study|Withdrawal by Subject|0|||
170865062|NCT00775450|617518015|FG003|Overall Study|Withdrawal by Subject|0|||
170865063|NCT00775450|617518016|FG004|Overall Study|Withdrawal by Subject|1|||
170865064|NCT02430051|617518017|FG000|Overall Study|Withdrawal by Subject|6|||
170865065|NCT02430051|617518018|FG001|Overall Study|Withdrawal by Subject|3|||
170865066|NCT02430051|617518017|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
170865067|NCT02430051|617518018|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
170865068|NCT02430051|617518017|FG000|Overall Study|Protocol Violation|1|||
170865069|NCT02430051|617518018|FG001|Overall Study|Protocol Violation|0|||
170865070|NCT00576836|617518019|FG000|Overall Study|Death|0|||
170865071|NCT00576836|617518020|FG001|Overall Study|Death|1|||
170865072|NCT00576836|617518019|FG000|Overall Study|Physician Decision|0|||
170865073|NCT00576836|617518020|FG001|Overall Study|Physician Decision|1|||
170865074|NCT01145755|617518023|FG000|Overall Study|Adverse Event|2|||
170865075|NCT01145755|617518024|FG001|Overall Study|Adverse Event|4|||
170865076|NCT01145755|617518025|FG002|Overall Study|Adverse Event|2|||
170865077|NCT01145755|617518023|FG000|Overall Study|Withdrawal by Subject|2|||
170865078|NCT01145755|617518024|FG001|Overall Study|Withdrawal by Subject|2|||
170865079|NCT01145755|617518025|FG002|Overall Study|Withdrawal by Subject|2|||
170865080|NCT01145755|617518023|FG000|Overall Study|Lost to Follow-up|2|||
170865081|NCT01145755|617518024|FG001|Overall Study|Lost to Follow-up|3|||
170865082|NCT01145755|617518025|FG002|Overall Study|Lost to Follow-up|1|||
170865083|NCT01145755|617518023|FG000|Overall Study|Protocol Violation|0|||
170865084|NCT01145755|617518024|FG001|Overall Study|Protocol Violation|3|||
170865085|NCT01145755|617518025|FG002|Overall Study|Protocol Violation|1|||
170865086|NCT01145755|617518023|FG000|Overall Study|Study Closure|14|||
170865087|NCT01145755|617518024|FG001|Overall Study|Study Closure|14|||
170865088|NCT01145755|617518025|FG002|Overall Study|Study Closure|17|||
170865089|NCT01145755|617518023|FG000|Overall Study|Lack of Efficacy|0|||
170865090|NCT01145755|617518024|FG001|Overall Study|Lack of Efficacy|1|||
170865091|NCT01145755|617518025|FG002|Overall Study|Lack of Efficacy|0|||
170865092|NCT01145755|617518023|FG000|Overall Study|Patient could not swollow medication|0|||
170865093|NCT01145755|617518024|FG001|Overall Study|Patient could not swollow medication|0|||
170865094|NCT01145755|617518025|FG002|Overall Study|Patient could not swollow medication|1|||
170865095|NCT01145755|617518023|FG000|Overall Study|Withdrawal by Subject|0|||
170865096|NCT01145755|617518024|FG001|Overall Study|Withdrawal by Subject|0|||
170865097|NCT01145755|617518025|FG002|Overall Study|Withdrawal by Subject|1|||
170865098|NCT01145755|617518023|FG000|Overall Study|Positive urine ethanol|0|||
170865099|NCT01145755|617518024|FG001|Overall Study|Positive urine ethanol|1|||
170865100|NCT01145755|617518025|FG002|Overall Study|Positive urine ethanol|0|||
170865101|NCT00372385|617518026|FG000|Overall Study|Adverse Event|6|||
170865102|NCT00372385|617518027|FG001|Overall Study|Adverse Event|11|||
170865103|NCT00372385|617518028|FG002|Overall Study|Adverse Event|9|||
170865104|NCT00372385|617518029|FG003|Overall Study|Adverse Event|7|||
170865105|NCT00372385|617518026|FG000|Overall Study|Noncompliance|0|||
170865106|NCT00372385|617518027|FG001|Overall Study|Noncompliance|1|||
170865107|NCT00372385|617518028|FG002|Overall Study|Noncompliance|1|||
170865108|NCT00372385|617518029|FG003|Overall Study|Noncompliance|1|||
170865109|NCT00372385|617518026|FG000|Overall Study|Physician Decision|1|||
170865110|NCT00372385|617518027|FG001|Overall Study|Physician Decision|0|||
170865111|NCT00372385|617518028|FG002|Overall Study|Physician Decision|0|||
170865112|NCT00372385|617518029|FG003|Overall Study|Physician Decision|0|||
170865113|NCT00372385|617518026|FG000|Overall Study|Lost to Follow-up|2|||
170865114|NCT00372385|617518027|FG001|Overall Study|Lost to Follow-up|0|||
170865115|NCT00372385|617518028|FG002|Overall Study|Lost to Follow-up|0|||
170865116|NCT00372385|617518029|FG003|Overall Study|Lost to Follow-up|0|||
170865117|NCT00372385|617518026|FG000|Overall Study|Withdrawal by Subject|2|||
170865118|NCT00372385|617518027|FG001|Overall Study|Withdrawal by Subject|1|||
170865119|NCT00372385|617518028|FG002|Overall Study|Withdrawal by Subject|0|||
170865120|NCT00372385|617518029|FG003|Overall Study|Withdrawal by Subject|0|||
170865121|NCT00372385|617518026|FG000|Overall Study|Refusal of Treatment|3|||
170865122|NCT00372385|617518027|FG001|Overall Study|Refusal of Treatment|6|||
170865123|NCT00372385|617518028|FG002|Overall Study|Refusal of Treatment|0|||
170865124|NCT00372385|617518029|FG003|Overall Study|Refusal of Treatment|0|||
170865125|NCT00372385|617518026|FG000|Overall Study|No Response|1|||
170865126|NCT00372385|617518027|FG001|Overall Study|No Response|1|||
170865127|NCT00372385|617518028|FG002|Overall Study|No Response|0|||
170865128|NCT00372385|617518029|FG003|Overall Study|No Response|0|||
170865129|NCT00372385|617518026|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
170865130|NCT00372385|617518027|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
170865131|NCT00372385|617518028|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
170865132|NCT00372385|617518029|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
170865133|NCT00372385|617518026|FG000|Overall Study|Virologic Stopping Rule|17|||
170865134|NCT00372385|617518027|FG001|Overall Study|Virologic Stopping Rule|0|||
170865135|NCT00372385|617518028|FG002|Overall Study|Virologic Stopping Rule|0|||
170755245|NCT04529538|617110988|FG004|Overall Study|Other|0|||
170755246|NCT04529538|617110989|FG005|Overall Study|Other|0|||
170755247|NCT04529538|617110990|FG006|Overall Study|Other|0|||
170755248|NCT04529538|617110991|FG007|Overall Study|Other|0|||
170755249|NCT04529538|617110984|FG000|Overall Study|Adverse Event|0|||
170755250|NCT04529538|617110985|FG001|Overall Study|Adverse Event|0|||
170755251|NCT04529538|617110986|FG002|Overall Study|Adverse Event|0|||
170755252|NCT04529538|617110987|FG003|Overall Study|Adverse Event|1|||
170755253|NCT04529538|617110988|FG004|Overall Study|Adverse Event|0|||
170755254|NCT04529538|617110989|FG005|Overall Study|Adverse Event|0|||
170755255|NCT04529538|617110990|FG006|Overall Study|Adverse Event|0|||
170755256|NCT04529538|617110991|FG007|Overall Study|Adverse Event|0|||
170755257|NCT04529538|617110984|FG000|Overall Study|Protocol Deviation|0|||
170755258|NCT04529538|617110985|FG001|Overall Study|Protocol Deviation|0|||
170755259|NCT04529538|617110986|FG002|Overall Study|Protocol Deviation|0|||
170755260|NCT04529538|617110987|FG003|Overall Study|Protocol Deviation|1|||
170755261|NCT04529538|617110988|FG004|Overall Study|Protocol Deviation|0|||
170755262|NCT04529538|617110989|FG005|Overall Study|Protocol Deviation|0|||
170755263|NCT04529538|617110990|FG006|Overall Study|Protocol Deviation|0|||
170755264|NCT04529538|617110991|FG007|Overall Study|Protocol Deviation|0|||
170755265|NCT04529538|617110984|FG000|Overall Study|Physician Decision|0|||
170755266|NCT04529538|617110985|FG001|Overall Study|Physician Decision|0|||
170755267|NCT04529538|617110986|FG002|Overall Study|Physician Decision|0|||
170402950|NCT00751998|615817077|FG000|Overall Study|Withdrawal by Subject|2|||
170402951|NCT01223196|615817079|FG000|Overall Study|Lost to Follow-up|2|||
170402952|NCT01223196|615817080|FG001|Overall Study|Lost to Follow-up|0|||
170402953|NCT01223196|615817079|FG000|Overall Study|Physician Decision|1|||
170402954|NCT01223196|615817080|FG001|Overall Study|Physician Decision|0|||
170402955|NCT01223196|615817079|FG000|Overall Study|Withdrawal by Subject|1|||
170402956|NCT01223196|615817080|FG001|Overall Study|Withdrawal by Subject|0|||
170402957|NCT04736576|615817081|FG000|Overall Study|Progressive disease|3|||
170402958|NCT04736576|615817082|FG001|Overall Study|Progressive disease|1|||
170402959|NCT04736576|615817081|FG000|Overall Study|Death|1|||
170402960|NCT04736576|615817082|FG001|Overall Study|Death|0|||
170402961|NCT00996918|615817086|FG000|Overall Study|Lack of Efficacy|1|||
170402962|NCT00996918|615817087|FG001|Overall Study|Lack of Efficacy|1|||
170402963|NCT00996918|615817088|FG002|Overall Study|Lack of Efficacy|2|||
170402964|NCT00996918|615817089|FG003|Overall Study|Lack of Efficacy|2|||
170402965|NCT00996918|615817090|FG004|Overall Study|Lack of Efficacy|0|||
170402966|NCT00996918|615817086|FG000|Overall Study|Adverse Event|2|||
170402967|NCT00996918|615817087|FG001|Overall Study|Adverse Event|5|||
170402968|NCT00996918|615817088|FG002|Overall Study|Adverse Event|2|||
170402969|NCT00996918|615817089|FG003|Overall Study|Adverse Event|6|||
170402970|NCT00996918|615817090|FG004|Overall Study|Adverse Event|0|||
170402971|NCT00996918|615817086|FG000|Overall Study|Withdrawal by Subject|1|||
170402972|NCT00996918|615817087|FG001|Overall Study|Withdrawal by Subject|4|||
170402973|NCT00996918|615817088|FG002|Overall Study|Withdrawal by Subject|3|||
170402974|NCT00996918|615817089|FG003|Overall Study|Withdrawal by Subject|3|||
170402975|NCT00996918|615817090|FG004|Overall Study|Withdrawal by Subject|2|||
170402976|NCT00996918|615817086|FG000|Overall Study|Physician Decision|1|||
170402977|NCT00996918|615817087|FG001|Overall Study|Physician Decision|0|||
170402978|NCT00996918|615817088|FG002|Overall Study|Physician Decision|0|||
170402979|NCT00996918|615817089|FG003|Overall Study|Physician Decision|0|||
170402980|NCT00996918|615817090|FG004|Overall Study|Physician Decision|0|||
170402981|NCT00996918|615817086|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
170402982|NCT00996918|615817087|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
170402983|NCT00996918|615817088|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
170402984|NCT00996918|615817089|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
170402985|NCT00996918|615817090|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
170402986|NCT00996918|615817086|FG000|Overall Study|Loss of Caregiver|0|||
170402987|NCT00996918|615817087|FG001|Overall Study|Loss of Caregiver|1|||
170402988|NCT00996918|615817088|FG002|Overall Study|Loss of Caregiver|0|||
170402989|NCT00996918|615817089|FG003|Overall Study|Loss of Caregiver|0|||
170402990|NCT00996918|615817090|FG004|Overall Study|Loss of Caregiver|0|||
170865136|NCT00372385|617518029|FG003|Overall Study|Virologic Stopping Rule|0|||
170402991|NCT00996918|615817086|FG000|Overall Study|Other|3|||
170402992|NCT00996918|615817087|FG001|Overall Study|Other|1|||
170402993|NCT00996918|615817088|FG002|Overall Study|Other|0|||
170402994|NCT00996918|615817089|FG003|Overall Study|Other|0|||
170402995|NCT00996918|615817090|FG004|Overall Study|Other|0|||
170402996|NCT04333199|615817095|FG000|Evaluated Patients|Lost to Follow-up|0|||
170402997|NCT04333199|615817096|FG001|Evaluated Patients|Lost to Follow-up|1|||
170755268|NCT04529538|617110987|FG003|Overall Study|Physician Decision|0|||
170755269|NCT04529538|617110988|FG004|Overall Study|Physician Decision|0|||
170755270|NCT04529538|617110989|FG005|Overall Study|Physician Decision|1|||
170755271|NCT04529538|617110990|FG006|Overall Study|Physician Decision|0|||
170755272|NCT04529538|617110991|FG007|Overall Study|Physician Decision|1|||
170755273|NCT02099539|617110999|FG000|Overall Study|Progressive Disease|3|||
170755274|NCT02099539|617111000|FG001|Overall Study|Progressive Disease|2|||
170402998|NCT04333199|615817097|FG002|Evaluated Patients|Lost to Follow-up|2|||
170402999|NCT00709735|615817099|FG000|Overall Study|Lost to Follow-up|1|||
170403000|NCT00709735|615817100|FG001|Overall Study|Lost to Follow-up|1|||
170403001|NCT00709735|615817099|FG000|Overall Study|Relapse into Opioid Abuse|0|||
170403002|NCT00709735|615817100|FG001|Overall Study|Relapse into Opioid Abuse|1|||
170403003|NCT00709735|615817099|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
170403004|NCT00709735|615817100|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
170403005|NCT02725671|615817102|FG000|Overall Study|Lost to Follow-up|1|||
170403006|NCT00963599|615817103|FG000|Overall Study|Adverse Event|2|||
170403007|NCT00963599|615817104|FG001|Overall Study|Adverse Event|0|||
170403008|NCT00963599|615817105|FG002|Overall Study|Adverse Event|1|||
170403009|NCT00963599|615817106|FG003|Overall Study|Adverse Event|2|||
170403010|NCT00963599|615817103|FG000|Overall Study|Lack of Efficacy|0|||
170403011|NCT00963599|615817104|FG001|Overall Study|Lack of Efficacy|2|||
170403012|NCT00963599|615817105|FG002|Overall Study|Lack of Efficacy|1|||
170403013|NCT00963599|615817106|FG003|Overall Study|Lack of Efficacy|4|||
170403014|NCT00963599|615817103|FG000|Overall Study|Lost to Follow-up|0|||
170403015|NCT00963599|615817104|FG001|Overall Study|Lost to Follow-up|1|||
170403016|NCT00963599|615817105|FG002|Overall Study|Lost to Follow-up|1|||
170403017|NCT00963599|615817106|FG003|Overall Study|Lost to Follow-up|1|||
170403018|NCT00963599|615817103|FG000|Overall Study|Protocol Violation|2|||
170403019|NCT00963599|615817104|FG001|Overall Study|Protocol Violation|2|||
170403020|NCT00963599|615817105|FG002|Overall Study|Protocol Violation|3|||
170403021|NCT00963599|615817106|FG003|Overall Study|Protocol Violation|4|||
170403022|NCT00963599|615817103|FG000|Overall Study|Withdrawal by Subject|2|||
170403023|NCT00963599|615817104|FG001|Overall Study|Withdrawal by Subject|1|||
170403024|NCT00963599|615817105|FG002|Overall Study|Withdrawal by Subject|3|||
170403025|NCT00963599|615817106|FG003|Overall Study|Withdrawal by Subject|3|||
170403026|NCT00190684|615817112|FG000|Overall Study|Adverse Event|86|||
170403027|NCT00190684|615817112|FG000|Overall Study|Satisfactory response|80|||
170403028|NCT00190684|615817112|FG000|Overall Study|Lack of efficacy|204|||
170403029|NCT00190684|615817112|FG000|Overall Study|Lost to Follow-up|232|||
170403030|NCT00190684|615817112|FG000|Overall Study|Patient moved|60|||
170403031|NCT00190684|615817112|FG000|Overall Study|Patient Decision|432|||
170403032|NCT00190684|615817112|FG000|Overall Study|Clinical relapse|67|||
170403033|NCT00190684|615817112|FG000|Overall Study|Sponsor's decision|17|||
170403034|NCT00190684|615817112|FG000|Overall Study|Physician Decision|84|||
170403035|NCT00190684|615817112|FG000|Overall Study|Protocol Violation|123|||
170403036|NCT00190684|615817112|FG000|Overall Study|Study Period III Completed|103|||
170755275|NCT02099539|617111001|FG002|Overall Study|Progressive Disease|2|||
170755276|NCT02099539|617111002|FG003|Overall Study|Progressive Disease|1|||
170755277|NCT02099539|617111003|FG004|Overall Study|Progressive Disease|4|||
170755278|NCT02099539|617111004|FG005|Overall Study|Progressive Disease|2|||
170755279|NCT02099539|617111005|FG006|Overall Study|Progressive Disease|0|||
170755280|NCT02099539|617110999|FG000|Overall Study|Adverse Event|0|||
170755281|NCT02099539|617111000|FG001|Overall Study|Adverse Event|0|||
170755282|NCT02099539|617111001|FG002|Overall Study|Adverse Event|1|||
170755283|NCT02099539|617111002|FG003|Overall Study|Adverse Event|1|||
170755284|NCT02099539|617111003|FG004|Overall Study|Adverse Event|0|||
170755285|NCT02099539|617111004|FG005|Overall Study|Adverse Event|0|||
170755286|NCT02099539|617111005|FG006|Overall Study|Adverse Event|0|||
170755287|NCT02099539|617110999|FG000|Overall Study|Physician Decision|0|||
170755288|NCT02099539|617111000|FG001|Overall Study|Physician Decision|0|||
170755289|NCT02099539|617111001|FG002|Overall Study|Physician Decision|0|||
170755290|NCT02099539|617111002|FG003|Overall Study|Physician Decision|0|||
170755291|NCT02099539|617111003|FG004|Overall Study|Physician Decision|0|||
170755292|NCT02099539|617111004|FG005|Overall Study|Physician Decision|1|||
170755293|NCT02099539|617111005|FG006|Overall Study|Physician Decision|0|||
170755294|NCT04955626|617111006|FG000|Blinded Period|Lost to Follow-up|28|||
170755295|NCT04955626|617111007|FG001|Blinded Period|Lost to Follow-up|28|||
170755296|NCT04955626|617111008|FG002|Blinded Period|Lost to Follow-up|7|||
170403037|NCT00190684|615817112|FG000|Overall Study|Study Period V Completed|1|||
170403038|NCT00078819|615817114|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
170403039|NCT00078819|615817115|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
170755297|NCT04955626|617111009|FG003|Blinded Period|Lost to Follow-up|14|||
170755298|NCT04955626|617111010|FG004|Blinded Period|Lost to Follow-up|3|||
170865137|NCT02411578|617518030|FG000|Crossover Trial Phase|Pregnancy|0|||
170403040|NCT00078819|615817116|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
170403041|NCT00078819|615817117|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
170403042|NCT00078819|615817114|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
170403043|NCT00078819|615817115|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
170403044|NCT00078819|615817116|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
170403045|NCT00078819|615817117|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
170755299|NCT04955626|617111011|FG005|Blinded Period|Lost to Follow-up|2|||
170755300|NCT04955626|617111012|FG006|Blinded Period|Lost to Follow-up|6|||
170755301|NCT04955626|617111013|FG007|Blinded Period|Lost to Follow-up|4|||
170755302|NCT04955626|617111014|FG008|Blinded Period|Lost to Follow-up|5|||
170755303|NCT04955626|617111015|FG009|Blinded Period|Lost to Follow-up|8|||
170755304|NCT04955626|617111016|FG010|Blinded Period|Lost to Follow-up|10|||
170403046|NCT00078819|615817114|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
170403047|NCT00078819|615817115|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
170403048|NCT00078819|615817116|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
170403049|NCT00078819|615817117|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
170403050|NCT00078819|615817114|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
170403051|NCT00078819|615817115|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
170403052|NCT00078819|615817116|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
170403053|NCT00078819|615817117|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
170403054|NCT00078819|615817114|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
170403055|NCT00078819|615817115|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
170403056|NCT00078819|615817116|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
170403057|NCT00078819|615817117|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
170403058|NCT00078819|615817114|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
170403059|NCT00078819|615817115|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
170403060|NCT00078819|615817116|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
170403061|NCT00078819|615817117|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
170403062|NCT00078819|615817114|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
170403063|NCT00078819|615817115|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
170403064|NCT00078819|615817116|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
170403065|NCT00078819|615817117|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
170403066|NCT00078819|615817114|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
170403067|NCT00078819|615817115|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
170403068|NCT00078819|615817116|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
170403069|NCT00078819|615817117|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
170403070|NCT04130919|615817118|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
170403071|NCT04130919|615817119|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
170403072|NCT04130919|615817120|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
170403073|NCT04130919|615817121|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
170403074|NCT04130919|615817122|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
170403075|NCT04130919|615817123|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
170403076|NCT04130919|615817118|FG000|Blinded Treatment Phase|Adverse Event|0|||
170403077|NCT04130919|615817119|FG001|Blinded Treatment Phase|Adverse Event|0|||
170403078|NCT04130919|615817120|FG002|Blinded Treatment Phase|Adverse Event|1|||
170403079|NCT04130919|615817121|FG003|Blinded Treatment Phase|Adverse Event|0|||
170403080|NCT04130919|615817122|FG004|Blinded Treatment Phase|Adverse Event|0|||
170403081|NCT04130919|615817123|FG005|Blinded Treatment Phase|Adverse Event|0|||
170403082|NCT04130919|615817118|FG000|Blinded Treatment Phase|Disease worsening|0|||
170403083|NCT04130919|615817119|FG001|Blinded Treatment Phase|Disease worsening|0|||
170403084|NCT04130919|615817120|FG002|Blinded Treatment Phase|Disease worsening|1|||
170403085|NCT04130919|615817121|FG003|Blinded Treatment Phase|Disease worsening|0|||
170403086|NCT04130919|615817122|FG004|Blinded Treatment Phase|Disease worsening|0|||
170403087|NCT04130919|615817123|FG005|Blinded Treatment Phase|Disease worsening|0|||
170403088|NCT04130919|615817118|FG000|Blinded Treatment Phase|Investigator's decision|0|||
170403089|NCT04130919|615817119|FG001|Blinded Treatment Phase|Investigator's decision|1|||
170403090|NCT04130919|615817120|FG002|Blinded Treatment Phase|Investigator's decision|0|||
170403091|NCT04130919|615817121|FG003|Blinded Treatment Phase|Investigator's decision|0|||
170403092|NCT04130919|615817122|FG004|Blinded Treatment Phase|Investigator's decision|0|||
170403093|NCT04130919|615817123|FG005|Blinded Treatment Phase|Investigator's decision|0|||
170403094|NCT04130919|615817118|FG000|Blinded Treatment Phase|Withdrew consent|1|||
170403095|NCT04130919|615817119|FG001|Blinded Treatment Phase|Withdrew consent|0|||
170403096|NCT04130919|615817120|FG002|Blinded Treatment Phase|Withdrew consent|0|||
170403097|NCT04130919|615817121|FG003|Blinded Treatment Phase|Withdrew consent|0|||
170403098|NCT04130919|615817122|FG004|Blinded Treatment Phase|Withdrew consent|0|||
170403099|NCT04130919|615817123|FG005|Blinded Treatment Phase|Withdrew consent|0|||
170403100|NCT04130919|615817118|FG000|Open-label Treatment Phase|Withdrew consent|0|||
170403101|NCT04130919|615817119|FG001|Open-label Treatment Phase|Withdrew consent|0|||
170403102|NCT04130919|615817120|FG002|Open-label Treatment Phase|Withdrew consent|0|||
170403103|NCT04130919|615817121|FG003|Open-label Treatment Phase|Withdrew consent|1|||
170403104|NCT04130919|615817122|FG004|Open-label Treatment Phase|Withdrew consent|1|||
170403105|NCT04130919|615817123|FG005|Open-label Treatment Phase|Withdrew consent|1|||
170403106|NCT04130919|615817118|FG000|Open-label Treatment Phase|Disease worsening|0|||
170403107|NCT04130919|615817119|FG001|Open-label Treatment Phase|Disease worsening|0|||
170403108|NCT04130919|615817120|FG002|Open-label Treatment Phase|Disease worsening|0|||
170403109|NCT04130919|615817121|FG003|Open-label Treatment Phase|Disease worsening|1|||
170403110|NCT04130919|615817122|FG004|Open-label Treatment Phase|Disease worsening|0|||
170403111|NCT04130919|615817123|FG005|Open-label Treatment Phase|Disease worsening|1|||
170403112|NCT04130919|615817118|FG000|Open-label Treatment Phase|Investigator's decision|0|||
170403113|NCT04130919|615817119|FG001|Open-label Treatment Phase|Investigator's decision|0|||
170755305|NCT04955626|617111017|FG011|Blinded Period|Lost to Follow-up|32|||
170403114|NCT04130919|615817120|FG002|Open-label Treatment Phase|Investigator's decision|0|||
170403115|NCT04130919|615817121|FG003|Open-label Treatment Phase|Investigator's decision|1|||
170403116|NCT04130919|615817122|FG004|Open-label Treatment Phase|Investigator's decision|0|||
170403117|NCT04130919|615817123|FG005|Open-label Treatment Phase|Investigator's decision|0|||
170403118|NCT04130919|615817118|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
170403119|NCT04130919|615817119|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
170403120|NCT04130919|615817120|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
170403121|NCT04130919|615817121|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
170403122|NCT04130919|615817122|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
170403123|NCT04130919|615817123|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
170403124|NCT04130919|615817118|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
170403125|NCT04130919|615817119|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
170403126|NCT04130919|615817120|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
170403127|NCT04130919|615817121|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
170403128|NCT04130919|615817122|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
170403129|NCT04130919|615817123|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
170403130|NCT00370396|615817124|FG000|Overall Study|Withdrawal by Subject|0|||
170403131|NCT00370396|615817125|FG001|Overall Study|Withdrawal by Subject|0|||
170403132|NCT00370396|615817126|FG002|Overall Study|Withdrawal by Subject|1|||
170403133|NCT00370396|615817124|FG000|Overall Study|Lost to Follow-up|11|||
170403134|NCT00370396|615817125|FG001|Overall Study|Lost to Follow-up|1|||
170403135|NCT00370396|615817126|FG002|Overall Study|Lost to Follow-up|0|||
170403136|NCT01462695|615817127|FG000|Overall Study|Adverse Event|1|||
170403137|NCT01462695|615817128|FG001|Overall Study|Adverse Event|1|||
170403138|NCT01462695|615817127|FG000|Overall Study|Death|2|||
170403139|NCT01462695|615817128|FG001|Overall Study|Death|0|||
170403140|NCT01462695|615817127|FG000|Overall Study|Lack of Efficacy|6|||
170403141|NCT01462695|615817128|FG001|Overall Study|Lack of Efficacy|12|||
170403142|NCT01462695|615817127|FG000|Overall Study|Physician Decision|5|||
170403143|NCT01462695|615817128|FG001|Overall Study|Physician Decision|0|||
170403144|NCT01462695|615817127|FG000|Overall Study|Withdrawal by Subject|2|||
170403145|NCT01462695|615817128|FG001|Overall Study|Withdrawal by Subject|0|||
170403146|NCT01462695|615817127|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
170403147|NCT01462695|615817128|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
170403148|NCT02340078|615817137|FG000|Overall Study|Protocol Violation|1|||
170403149|NCT04816877|615817140|FG000|Overall Study|Withdrawal by Subject|1|||
170403150|NCT04816877|615817141|FG001|Overall Study|Withdrawal by Subject|0|||
170755306|NCT04955626|617111018|FG012|Blinded Period|Lost to Follow-up|0|||
170755307|NCT04955626|617111019|FG013|Blinded Period|Lost to Follow-up|0|||
170755308|NCT04955626|617111020|FG014|Blinded Period|Lost to Follow-up|0|||
170403151|NCT02176642|615817142|FG000|Overall Study|Withdrawal by Subject|0|||
170403152|NCT02176642|615817143|FG001|Overall Study|Withdrawal by Subject|1|||
170403153|NCT00295620|615817145|FG000|Overall Study|Lost to Follow-up|9|||
170403154|NCT00295620|615817146|FG001|Overall Study|Lost to Follow-up|5|||
170403155|NCT00295620|615817145|FG000|Overall Study|Withdrawal by Subject|37|||
170403156|NCT00295620|615817146|FG001|Overall Study|Withdrawal by Subject|50|||
170403157|NCT00295620|615817145|FG000|Overall Study|Death|206|||
170403158|NCT00295620|615817146|FG001|Overall Study|Death|207|||
170755309|NCT04955626|617111021|FG015|Blinded Period|Lost to Follow-up|12|||
170403159|NCT00295620|615817145|FG000|Overall Study|Other reasons|10|||
170403160|NCT00295620|615817146|FG001|Overall Study|Other reasons|9|||
170403161|NCT00295620|615817145|FG000|Overall Study|Discontinuation by sponsor|580|||
170403162|NCT00295620|615817146|FG001|Overall Study|Discontinuation by sponsor|593|||
170403163|NCT00295620|615817145|FG000|Overall Study|Protocol Violation|30|||
170403164|NCT00295620|615817146|FG001|Overall Study|Protocol Violation|32|||
170403165|NCT00808015|615817147|FG000|Overall Study|Death|1|||
170403166|NCT00808015|615817147|FG000|Overall Study|Lack of Efficacy|58|||
170403167|NCT00808015|615817147|FG000|Overall Study|Lost to Follow-up|76|||
170755310|NCT04955626|617111022|FG016|Blinded Period|Lost to Follow-up|2|||
170755311|NCT04955626|617111023|FG017|Blinded Period|Lost to Follow-up|5|||
170755312|NCT04955626|617111024|FG018|Blinded Period|Lost to Follow-up|0|||
170755313|NCT04955626|617111025|FG019|Blinded Period|Lost to Follow-up|0|||
170755314|NCT04955626|617111026|FG020|Blinded Period|Lost to Follow-up|0|||
170755315|NCT04955626|617111027|FG021|Blinded Period|Lost to Follow-up|0|||
170755316|NCT04955626|617111028|FG022|Blinded Period|Lost to Follow-up|0|||
170755317|NCT04955626|617111029|FG023|Blinded Period|Lost to Follow-up|0|||
170755318|NCT04955626|617111030|FG024|Blinded Period|Lost to Follow-up|3|||
170755319|NCT04955626|617111031|FG025|Blinded Period|Lost to Follow-up|1|||
170755320|NCT04955626|617111032|FG026|Blinded Period|Lost to Follow-up|2|||
170755321|NCT04955626|617111033|FG027|Blinded Period|Lost to Follow-up|2|||
170755322|NCT04955626|617111034|FG028|Blinded Period|Lost to Follow-up|2|||
170755323|NCT04955626|617111035|FG029|Blinded Period|Lost to Follow-up|0|||
170755324|NCT04955626|617111036|FG030|Blinded Period|Lost to Follow-up|0|||
170755325|NCT04955626|617111037|FG031|Blinded Period|Lost to Follow-up|0|||
170755326|NCT04955626|617111038|FG032|Blinded Period|Lost to Follow-up|0|||
170403168|NCT00808015|615817147|FG000|Overall Study|Participants not willing to participate|158|||
170403169|NCT00808015|615817147|FG000|Overall Study|Adverse Event|22|||
170403170|NCT00808015|615817147|FG000|Overall Study|Other|25|||
170403171|NCT00808015|615817147|FG000|Overall Study|Enrolled but not treated|4|||
170403172|NCT00084617|615817157|FG000|Overall Study|Withdrawal by Subject|7|||
170403173|NCT00084617|615817157|FG000|Overall Study|Lack of Efficacy|1|||
170403174|NCT00084617|615817157|FG000|Overall Study|Protocol Violation|1|||
170403175|NCT01625286|615817158|FG000|Overall Study|Adverse Event|0|||
170403176|NCT01625286|615817159|FG001|Overall Study|Adverse Event|0|||
170403177|NCT01625286|615817160|FG002|Overall Study|Adverse Event|0|||
170403178|NCT01625286|615817161|FG003|Overall Study|Adverse Event|0|||
170403179|NCT01625286|615817162|FG004|Overall Study|Adverse Event|1|||
170403180|NCT01625286|615817163|FG005|Overall Study|Adverse Event|2|||
170403181|NCT01625286|615817164|FG006|Overall Study|Adverse Event|1|||
170403182|NCT01625286|615817158|FG000|Overall Study|Death|0|||
170403183|NCT01625286|615817159|FG001|Overall Study|Death|0|||
170403184|NCT01625286|615817160|FG002|Overall Study|Death|1|||
170403185|NCT01625286|615817161|FG003|Overall Study|Death|1|||
170403186|NCT01625286|615817162|FG004|Overall Study|Death|0|||
170403187|NCT01625286|615817163|FG005|Overall Study|Death|11|||
170403188|NCT01625286|615817164|FG006|Overall Study|Death|16|||
170403189|NCT01625286|615817158|FG000|Overall Study|Withdrawal by Subject|0|||
170403190|NCT01625286|615817159|FG001|Overall Study|Withdrawal by Subject|1|||
170403191|NCT01625286|615817160|FG002|Overall Study|Withdrawal by Subject|0|||
170403192|NCT01625286|615817161|FG003|Overall Study|Withdrawal by Subject|1|||
170403193|NCT01625286|615817162|FG004|Overall Study|Withdrawal by Subject|0|||
170403194|NCT01625286|615817163|FG005|Overall Study|Withdrawal by Subject|0|||
170403195|NCT01625286|615817164|FG006|Overall Study|Withdrawal by Subject|1|||
170403196|NCT01625286|615817158|FG000|Overall Study|Any reason not specifically recorded|0|||
170403197|NCT01625286|615817159|FG001|Overall Study|Any reason not specifically recorded|0|||
170403198|NCT01625286|615817160|FG002|Overall Study|Any reason not specifically recorded|0|||
170403199|NCT01625286|615817161|FG003|Overall Study|Any reason not specifically recorded|0|||
170403200|NCT01625286|615817162|FG004|Overall Study|Any reason not specifically recorded|0|||
170403201|NCT01625286|615817163|FG005|Overall Study|Any reason not specifically recorded|1|||
170403202|NCT01625286|615817164|FG006|Overall Study|Any reason not specifically recorded|0|||
170403203|NCT01625286|615817158|FG000|Overall Study|Progressive disease|6|||
170403204|NCT01625286|615817159|FG001|Overall Study|Progressive disease|3|||
170403205|NCT01625286|615817160|FG002|Overall Study|Progressive disease|4|||
170403206|NCT01625286|615817161|FG003|Overall Study|Progressive disease|5|||
170403207|NCT01625286|615817162|FG004|Overall Study|Progressive disease|5|||
170403208|NCT01625286|615817163|FG005|Overall Study|Progressive disease|0|||
170403209|NCT01625286|615817164|FG006|Overall Study|Progressive disease|0|||
170403210|NCT01625286|615817158|FG000|Overall Study|Lost to Follow-up|0|||
170403211|NCT01625286|615817159|FG001|Overall Study|Lost to Follow-up|0|||
170403212|NCT01625286|615817160|FG002|Overall Study|Lost to Follow-up|0|||
170403213|NCT01625286|615817161|FG003|Overall Study|Lost to Follow-up|0|||
170755327|NCT04955626|617111039|FG033|Blinded Period|Lost to Follow-up|0|||
170755328|NCT04955626|617111040|FG034|Blinded Period|Lost to Follow-up|0|||
170755329|NCT04955626|617111041|FG035|Blinded Period|Lost to Follow-up|0|||
170755330|NCT04955626|617111006|FG000|Blinded Period|Protocol Violation|5|||
170755331|NCT04955626|617111007|FG001|Blinded Period|Protocol Violation|14|||
170755332|NCT04955626|617111008|FG002|Blinded Period|Protocol Violation|0|||
170755333|NCT04955626|617111009|FG003|Blinded Period|Protocol Violation|1|||
170755334|NCT04955626|617111010|FG004|Blinded Period|Protocol Violation|2|||
170755335|NCT04955626|617111011|FG005|Blinded Period|Protocol Violation|2|||
170755336|NCT04955626|617111012|FG006|Blinded Period|Protocol Violation|0|||
170755337|NCT04955626|617111013|FG007|Blinded Period|Protocol Violation|0|||
170755338|NCT04955626|617111014|FG008|Blinded Period|Protocol Violation|0|||
170403214|NCT01625286|615817162|FG004|Overall Study|Lost to Follow-up|0|||
170403215|NCT01625286|615817163|FG005|Overall Study|Lost to Follow-up|0|||
170755339|NCT04955626|617111015|FG009|Blinded Period|Protocol Violation|4|||
170755340|NCT04955626|617111016|FG010|Blinded Period|Protocol Violation|6|||
170755341|NCT04955626|617111017|FG011|Blinded Period|Protocol Violation|1|||
170403216|NCT01625286|615817164|FG006|Overall Study|Lost to Follow-up|1|||
170403217|NCT00434148|615817165|FG000|Overall Study|Adverse Event|18|||
170403218|NCT00434148|615817166|FG001|Overall Study|Adverse Event|18|||
170403219|NCT00434148|615817165|FG000|Overall Study|Lack of Efficacy|25|||
170403220|NCT00434148|615817166|FG001|Overall Study|Lack of Efficacy|28|||
170403221|NCT00434148|615817165|FG000|Overall Study|Withdrawal by Subject|15|||
170403222|NCT00434148|615817166|FG001|Overall Study|Withdrawal by Subject|15|||
170403223|NCT00434148|615817165|FG000|Overall Study|Protocol Violation|4|||
170755342|NCT04955626|617111018|FG012|Blinded Period|Protocol Violation|0|||
170755343|NCT04955626|617111019|FG013|Blinded Period|Protocol Violation|0|||
170755344|NCT04955626|617111020|FG014|Blinded Period|Protocol Violation|2|||
170403224|NCT00434148|615817166|FG001|Overall Study|Protocol Violation|0|||
170403225|NCT00434148|615817165|FG000|Overall Study|Administrative problems|6|||
170403226|NCT00434148|615817166|FG001|Overall Study|Administrative problems|10|||
170403227|NCT00434148|615817165|FG000|Overall Study|Lost to Follow-up|0|||
170755345|NCT04955626|617111021|FG015|Blinded Period|Protocol Violation|6|||
170755346|NCT04955626|617111022|FG016|Blinded Period|Protocol Violation|4|||
170755347|NCT04955626|617111023|FG017|Blinded Period|Protocol Violation|6|||
170755348|NCT04955626|617111024|FG018|Blinded Period|Protocol Violation|0|||
170755349|NCT04955626|617111025|FG019|Blinded Period|Protocol Violation|1|||
170755350|NCT04955626|617111026|FG020|Blinded Period|Protocol Violation|0|||
170755351|NCT04955626|617111027|FG021|Blinded Period|Protocol Violation|1|||
170755352|NCT04955626|617111028|FG022|Blinded Period|Protocol Violation|0|||
170755353|NCT04955626|617111029|FG023|Blinded Period|Protocol Violation|0|||
170755354|NCT04955626|617111030|FG024|Blinded Period|Protocol Violation|4|||
170755355|NCT04955626|617111031|FG025|Blinded Period|Protocol Violation|6|||
170755356|NCT04955626|617111032|FG026|Blinded Period|Protocol Violation|5|||
170755357|NCT04955626|617111033|FG027|Blinded Period|Protocol Violation|3|||
170755358|NCT04955626|617111034|FG028|Blinded Period|Protocol Violation|4|||
170755359|NCT04955626|617111035|FG029|Blinded Period|Protocol Violation|3|||
170755360|NCT04955626|617111036|FG030|Blinded Period|Protocol Violation|0|||
170755361|NCT04955626|617111037|FG031|Blinded Period|Protocol Violation|0|||
170755362|NCT04955626|617111038|FG032|Blinded Period|Protocol Violation|0|||
170755363|NCT04955626|617111039|FG033|Blinded Period|Protocol Violation|0|||
170755364|NCT04955626|617111040|FG034|Blinded Period|Protocol Violation|0|||
170755365|NCT04955626|617111041|FG035|Blinded Period|Protocol Violation|0|||
170755366|NCT04955626|617111006|FG000|Blinded Period|Death|0|||
170755367|NCT04955626|617111007|FG001|Blinded Period|Death|2|||
170755368|NCT04955626|617111008|FG002|Blinded Period|Death|0|||
170755369|NCT04955626|617111009|FG003|Blinded Period|Death|0|||
170755370|NCT04955626|617111010|FG004|Blinded Period|Death|0|||
170755371|NCT04955626|617111011|FG005|Blinded Period|Death|0|||
170755372|NCT04955626|617111012|FG006|Blinded Period|Death|0|||
170755373|NCT04955626|617111013|FG007|Blinded Period|Death|2|||
170755374|NCT04955626|617111014|FG008|Blinded Period|Death|1|||
170755375|NCT04955626|617111015|FG009|Blinded Period|Death|1|||
170755376|NCT04955626|617111016|FG010|Blinded Period|Death|0|||
170755377|NCT04955626|617111017|FG011|Blinded Period|Death|2|||
170755378|NCT04955626|617111018|FG012|Blinded Period|Death|0|||
170755379|NCT04955626|617111019|FG013|Blinded Period|Death|0|||
170755380|NCT04955626|617111020|FG014|Blinded Period|Death|0|||
170755381|NCT04955626|617111021|FG015|Blinded Period|Death|0|||
170755382|NCT04955626|617111022|FG016|Blinded Period|Death|0|||
170755383|NCT04955626|617111023|FG017|Blinded Period|Death|0|||
170755384|NCT04955626|617111024|FG018|Blinded Period|Death|0|||
170755385|NCT04955626|617111025|FG019|Blinded Period|Death|0|||
170755386|NCT04955626|617111026|FG020|Blinded Period|Death|0|||
170755387|NCT04955626|617111027|FG021|Blinded Period|Death|0|||
170755388|NCT04955626|617111028|FG022|Blinded Period|Death|0|||
170755389|NCT04955626|617111029|FG023|Blinded Period|Death|1|||
170755390|NCT04955626|617111030|FG024|Blinded Period|Death|0|||
170755391|NCT04955626|617111031|FG025|Blinded Period|Death|0|||
170755392|NCT04955626|617111032|FG026|Blinded Period|Death|1|||
170755393|NCT04955626|617111033|FG027|Blinded Period|Death|1|||
170755394|NCT04955626|617111034|FG028|Blinded Period|Death|0|||
170755395|NCT04955626|617111035|FG029|Blinded Period|Death|1|||
170755396|NCT04955626|617111036|FG030|Blinded Period|Death|0|||
170755397|NCT04955626|617111037|FG031|Blinded Period|Death|0|||
170755398|NCT04955626|617111038|FG032|Blinded Period|Death|0|||
170755399|NCT04955626|617111039|FG033|Blinded Period|Death|0|||
170755400|NCT04955626|617111040|FG034|Blinded Period|Death|0|||
170755401|NCT04955626|617111041|FG035|Blinded Period|Death|0|||
170755402|NCT04955626|617111006|FG000|Blinded Period|Adverse Event|0|||
170755403|NCT04955626|617111007|FG001|Blinded Period|Adverse Event|1|||
170755404|NCT04955626|617111008|FG002|Blinded Period|Adverse Event|1|||
170755405|NCT04955626|617111009|FG003|Blinded Period|Adverse Event|1|||
170755406|NCT04955626|617111010|FG004|Blinded Period|Adverse Event|0|||
170755407|NCT04955626|617111011|FG005|Blinded Period|Adverse Event|0|||
170755408|NCT04955626|617111012|FG006|Blinded Period|Adverse Event|0|||
170755409|NCT04955626|617111013|FG007|Blinded Period|Adverse Event|0|||
170755410|NCT04955626|617111014|FG008|Blinded Period|Adverse Event|0|||
170755411|NCT04955626|617111015|FG009|Blinded Period|Adverse Event|1|||
170755412|NCT04955626|617111016|FG010|Blinded Period|Adverse Event|1|||
170755413|NCT04955626|617111017|FG011|Blinded Period|Adverse Event|0|||
170755414|NCT04955626|617111018|FG012|Blinded Period|Adverse Event|0|||
170755415|NCT04955626|617111019|FG013|Blinded Period|Adverse Event|0|||
170755416|NCT04955626|617111020|FG014|Blinded Period|Adverse Event|0|||
170755417|NCT04955626|617111021|FG015|Blinded Period|Adverse Event|0|||
170755418|NCT04955626|617111022|FG016|Blinded Period|Adverse Event|0|||
170403228|NCT00434148|615817166|FG001|Overall Study|Lost to Follow-up|1|||
170755419|NCT04955626|617111023|FG017|Blinded Period|Adverse Event|0|||
170755420|NCT04955626|617111024|FG018|Blinded Period|Adverse Event|1|||
170755421|NCT04955626|617111025|FG019|Blinded Period|Adverse Event|0|||
170755422|NCT04955626|617111026|FG020|Blinded Period|Adverse Event|0|||
170755423|NCT04955626|617111027|FG021|Blinded Period|Adverse Event|0|||
170755424|NCT04955626|617111028|FG022|Blinded Period|Adverse Event|0|||
170755425|NCT04955626|617111029|FG023|Blinded Period|Adverse Event|0|||
170755426|NCT04955626|617111030|FG024|Blinded Period|Adverse Event|0|||
170755427|NCT04955626|617111031|FG025|Blinded Period|Adverse Event|0|||
170755428|NCT04955626|617111032|FG026|Blinded Period|Adverse Event|1|||
170755429|NCT04955626|617111033|FG027|Blinded Period|Adverse Event|0|||
170755430|NCT04955626|617111034|FG028|Blinded Period|Adverse Event|0|||
170755431|NCT04955626|617111035|FG029|Blinded Period|Adverse Event|0|||
170755432|NCT04955626|617111036|FG030|Blinded Period|Adverse Event|0|||
170755433|NCT04955626|617111037|FG031|Blinded Period|Adverse Event|0|||
170755434|NCT04955626|617111038|FG032|Blinded Period|Adverse Event|0|||
170755435|NCT04955626|617111039|FG033|Blinded Period|Adverse Event|0|||
170755436|NCT04955626|617111040|FG034|Blinded Period|Adverse Event|0|||
170755437|NCT04955626|617111041|FG035|Blinded Period|Adverse Event|0|||
170755438|NCT04955626|617111006|FG000|Blinded Period|No longer meets eligibility criteria|1|||
170755439|NCT04955626|617111007|FG001|Blinded Period|No longer meets eligibility criteria|2|||
170755440|NCT04955626|617111008|FG002|Blinded Period|No longer meets eligibility criteria|0|||
170755441|NCT04955626|617111009|FG003|Blinded Period|No longer meets eligibility criteria|1|||
170755442|NCT04955626|617111010|FG004|Blinded Period|No longer meets eligibility criteria|0|||
170755443|NCT04955626|617111011|FG005|Blinded Period|No longer meets eligibility criteria|0|||
170755444|NCT04955626|617111012|FG006|Blinded Period|No longer meets eligibility criteria|0|||
170755445|NCT04955626|617111013|FG007|Blinded Period|No longer meets eligibility criteria|0|||
170755446|NCT04955626|617111014|FG008|Blinded Period|No longer meets eligibility criteria|1|||
170755447|NCT04955626|617111015|FG009|Blinded Period|No longer meets eligibility criteria|0|||
170755448|NCT04955626|617111016|FG010|Blinded Period|No longer meets eligibility criteria|1|||
170755449|NCT04955626|617111017|FG011|Blinded Period|No longer meets eligibility criteria|1|||
170755450|NCT04955626|617111018|FG012|Blinded Period|No longer meets eligibility criteria|0|||
170755451|NCT04955626|617111019|FG013|Blinded Period|No longer meets eligibility criteria|0|||
170755452|NCT04955626|617111020|FG014|Blinded Period|No longer meets eligibility criteria|0|||
170755453|NCT04955626|617111021|FG015|Blinded Period|No longer meets eligibility criteria|3|||
170755454|NCT04955626|617111022|FG016|Blinded Period|No longer meets eligibility criteria|0|||
170755455|NCT04955626|617111023|FG017|Blinded Period|No longer meets eligibility criteria|2|||
170755456|NCT04955626|617111024|FG018|Blinded Period|No longer meets eligibility criteria|0|||
170755457|NCT04955626|617111025|FG019|Blinded Period|No longer meets eligibility criteria|0|||
170631960|NCT03926611|616664486|FG004|Overall Study|Withdrawal by Subject|0|||
170631961|NCT03926611|616664487|FG005|Overall Study|Withdrawal by Subject|1|||
170631962|NCT03926611|616664488|FG006|Overall Study|Withdrawal by Subject|3|||
170755458|NCT04955626|617111026|FG020|Blinded Period|No longer meets eligibility criteria|0|||
170755459|NCT04955626|617111027|FG021|Blinded Period|No longer meets eligibility criteria|0|||
170755460|NCT04955626|617111028|FG022|Blinded Period|No longer meets eligibility criteria|0|||
170755461|NCT04955626|617111029|FG023|Blinded Period|No longer meets eligibility criteria|0|||
170755462|NCT04955626|617111030|FG024|Blinded Period|No longer meets eligibility criteria|1|||
170755463|NCT04955626|617111031|FG025|Blinded Period|No longer meets eligibility criteria|0|||
170755464|NCT04955626|617111032|FG026|Blinded Period|No longer meets eligibility criteria|0|||
170755465|NCT04955626|617111033|FG027|Blinded Period|No longer meets eligibility criteria|1|||
170755466|NCT04955626|617111034|FG028|Blinded Period|No longer meets eligibility criteria|0|||
170755467|NCT04955626|617111035|FG029|Blinded Period|No longer meets eligibility criteria|0|||
170755468|NCT04955626|617111036|FG030|Blinded Period|No longer meets eligibility criteria|0|||
170755469|NCT04955626|617111037|FG031|Blinded Period|No longer meets eligibility criteria|0|||
170755470|NCT04955626|617111038|FG032|Blinded Period|No longer meets eligibility criteria|0|||
170755471|NCT04955626|617111039|FG033|Blinded Period|No longer meets eligibility criteria|0|||
170755472|NCT04955626|617111040|FG034|Blinded Period|No longer meets eligibility criteria|0|||
170755473|NCT04955626|617111041|FG035|Blinded Period|No longer meets eligibility criteria|0|||
170755474|NCT04955626|617111006|FG000|Blinded Period|Other|54|||
170755475|NCT04955626|617111007|FG001|Blinded Period|Other|3|||
170755476|NCT04955626|617111008|FG002|Blinded Period|Other|4|||
170755477|NCT04955626|617111009|FG003|Blinded Period|Other|2|||
170755478|NCT04955626|617111010|FG004|Blinded Period|Other|0|||
170755479|NCT04955626|617111011|FG005|Blinded Period|Other|0|||
170755480|NCT04955626|617111012|FG006|Blinded Period|Other|2|||
170755481|NCT04955626|617111013|FG007|Blinded Period|Other|2|||
170755482|NCT04955626|617111014|FG008|Blinded Period|Other|1|||
170755483|NCT04955626|617111015|FG009|Blinded Period|Other|0|||
170755484|NCT04955626|617111016|FG010|Blinded Period|Other|1|||
170755485|NCT04955626|617111017|FG011|Blinded Period|Other|1|||
170755486|NCT04955626|617111018|FG012|Blinded Period|Other|0|||
170755487|NCT04955626|617111019|FG013|Blinded Period|Other|0|||
170755488|NCT04955626|617111020|FG014|Blinded Period|Other|0|||
170755489|NCT04955626|617111021|FG015|Blinded Period|Other|0|||
170755490|NCT04955626|617111022|FG016|Blinded Period|Other|0|||
170755491|NCT04955626|617111023|FG017|Blinded Period|Other|1|||
170755492|NCT04955626|617111024|FG018|Blinded Period|Other|0|||
170755493|NCT04955626|617111025|FG019|Blinded Period|Other|0|||
170755494|NCT04955626|617111026|FG020|Blinded Period|Other|0|||
170755495|NCT04955626|617111027|FG021|Blinded Period|Other|0|||
170755496|NCT04955626|617111028|FG022|Blinded Period|Other|0|||
170755497|NCT04955626|617111029|FG023|Blinded Period|Other|0|||
170755498|NCT04955626|617111030|FG024|Blinded Period|Other|0|||
170755499|NCT04955626|617111031|FG025|Blinded Period|Other|0|||
170755500|NCT04955626|617111032|FG026|Blinded Period|Other|2|||
170755501|NCT04955626|617111033|FG027|Blinded Period|Other|0|||
170755502|NCT04955626|617111034|FG028|Blinded Period|Other|0|||
170755503|NCT04955626|617111035|FG029|Blinded Period|Other|0|||
170755504|NCT04955626|617111036|FG030|Blinded Period|Other|0|||
170755505|NCT04955626|617111037|FG031|Blinded Period|Other|0|||
170755506|NCT04955626|617111038|FG032|Blinded Period|Other|0|||
170755507|NCT04955626|617111039|FG033|Blinded Period|Other|0|||
170755508|NCT04955626|617111040|FG034|Blinded Period|Other|0|||
170755509|NCT04955626|617111041|FG035|Blinded Period|Other|0|||
170755510|NCT04955626|617111006|FG000|Blinded Period|Physician Decision|1|||
170755511|NCT04955626|617111007|FG001|Blinded Period|Physician Decision|1|||
170755512|NCT04955626|617111008|FG002|Blinded Period|Physician Decision|0|||
170755513|NCT04955626|617111009|FG003|Blinded Period|Physician Decision|3|||
170755514|NCT04955626|617111010|FG004|Blinded Period|Physician Decision|0|||
170755515|NCT04955626|617111011|FG005|Blinded Period|Physician Decision|0|||
170755516|NCT04955626|617111012|FG006|Blinded Period|Physician Decision|1|||
170755517|NCT04955626|617111013|FG007|Blinded Period|Physician Decision|1|||
170755518|NCT04955626|617111014|FG008|Blinded Period|Physician Decision|0|||
170755519|NCT04955626|617111015|FG009|Blinded Period|Physician Decision|0|||
170755520|NCT04955626|617111016|FG010|Blinded Period|Physician Decision|0|||
170755521|NCT04955626|617111017|FG011|Blinded Period|Physician Decision|5|||
170755522|NCT04955626|617111018|FG012|Blinded Period|Physician Decision|0|||
170755523|NCT04955626|617111019|FG013|Blinded Period|Physician Decision|0|||
170755524|NCT04955626|617111020|FG014|Blinded Period|Physician Decision|0|||
170755525|NCT04955626|617111021|FG015|Blinded Period|Physician Decision|0|||
170755526|NCT04955626|617111022|FG016|Blinded Period|Physician Decision|0|||
170755527|NCT04955626|617111023|FG017|Blinded Period|Physician Decision|0|||
170755528|NCT04955626|617111024|FG018|Blinded Period|Physician Decision|0|||
170755529|NCT04955626|617111025|FG019|Blinded Period|Physician Decision|0|||
170755530|NCT04955626|617111026|FG020|Blinded Period|Physician Decision|0|||
170755531|NCT04955626|617111027|FG021|Blinded Period|Physician Decision|0|||
170755532|NCT04955626|617111028|FG022|Blinded Period|Physician Decision|0|||
170755533|NCT04955626|617111029|FG023|Blinded Period|Physician Decision|0|||
170755534|NCT04955626|617111030|FG024|Blinded Period|Physician Decision|0|||
170755535|NCT04955626|617111031|FG025|Blinded Period|Physician Decision|0|||
170755536|NCT04955626|617111032|FG026|Blinded Period|Physician Decision|0|||
170755537|NCT04955626|617111033|FG027|Blinded Period|Physician Decision|0|||
170755538|NCT04955626|617111034|FG028|Blinded Period|Physician Decision|0|||
170755539|NCT04955626|617111035|FG029|Blinded Period|Physician Decision|0|||
170755540|NCT04955626|617111036|FG030|Blinded Period|Physician Decision|0|||
170755541|NCT04955626|617111037|FG031|Blinded Period|Physician Decision|0|||
170755542|NCT04955626|617111038|FG032|Blinded Period|Physician Decision|0|||
170755543|NCT04955626|617111039|FG033|Blinded Period|Physician Decision|0|||
170755544|NCT04955626|617111040|FG034|Blinded Period|Physician Decision|0|||
170755545|NCT04955626|617111041|FG035|Blinded Period|Physician Decision|0|||
170755546|NCT04955626|617111006|FG000|Blinded Period|Withdrawal by Subject|26|||
170755547|NCT04955626|617111007|FG001|Blinded Period|Withdrawal by Subject|62|||
170755548|NCT04955626|617111008|FG002|Blinded Period|Withdrawal by Subject|14|||
170755549|NCT04955626|617111009|FG003|Blinded Period|Withdrawal by Subject|16|||
170403229|NCT00434148|615817165|FG000|Overall Study|Condition no longer requires study drug|1|||
170403230|NCT00434148|615817166|FG001|Overall Study|Condition no longer requires study drug|0|||
170403231|NCT00434148|615817165|FG000|Overall Study|Abnormal test procedure result|0|||
170755550|NCT04955626|617111010|FG004|Blinded Period|Withdrawal by Subject|1|||
170755551|NCT04955626|617111011|FG005|Blinded Period|Withdrawal by Subject|2|||
170755552|NCT04955626|617111012|FG006|Blinded Period|Withdrawal by Subject|9|||
170755553|NCT04955626|617111013|FG007|Blinded Period|Withdrawal by Subject|5|||
170755554|NCT04955626|617111014|FG008|Blinded Period|Withdrawal by Subject|3|||
170755555|NCT04955626|617111015|FG009|Blinded Period|Withdrawal by Subject|15|||
170755556|NCT04955626|617111016|FG010|Blinded Period|Withdrawal by Subject|11|||
170755557|NCT04955626|617111017|FG011|Blinded Period|Withdrawal by Subject|7|||
170755558|NCT04955626|617111018|FG012|Blinded Period|Withdrawal by Subject|2|||
170755559|NCT04955626|617111019|FG013|Blinded Period|Withdrawal by Subject|0|||
170755560|NCT04955626|617111020|FG014|Blinded Period|Withdrawal by Subject|1|||
170755561|NCT04955626|617111021|FG015|Blinded Period|Withdrawal by Subject|11|||
170755562|NCT04955626|617111022|FG016|Blinded Period|Withdrawal by Subject|2|||
170755563|NCT04955626|617111023|FG017|Blinded Period|Withdrawal by Subject|5|||
170755564|NCT04955626|617111024|FG018|Blinded Period|Withdrawal by Subject|0|||
170755565|NCT04955626|617111025|FG019|Blinded Period|Withdrawal by Subject|0|||
170755566|NCT04955626|617111026|FG020|Blinded Period|Withdrawal by Subject|1|||
170755567|NCT04955626|617111027|FG021|Blinded Period|Withdrawal by Subject|0|||
170755568|NCT04955626|617111028|FG022|Blinded Period|Withdrawal by Subject|0|||
170403232|NCT00434148|615817166|FG001|Overall Study|Abnormal test procedure result|1|||
170403233|NCT03627195|615818680|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
170755569|NCT04955626|617111029|FG023|Blinded Period|Withdrawal by Subject|0|||
170755570|NCT04955626|617111030|FG024|Blinded Period|Withdrawal by Subject|5|||
170631963|NCT03926611|616664482|FG000|Overall Study|Covid-19 pandemic|0|||
170755571|NCT04955626|617111031|FG025|Blinded Period|Withdrawal by Subject|1|||
170755572|NCT04955626|617111032|FG026|Blinded Period|Withdrawal by Subject|5|||
170755573|NCT04955626|617111033|FG027|Blinded Period|Withdrawal by Subject|1|||
170755574|NCT04955626|617111034|FG028|Blinded Period|Withdrawal by Subject|4|||
170755575|NCT04955626|617111035|FG029|Blinded Period|Withdrawal by Subject|2|||
170755576|NCT04955626|617111036|FG030|Blinded Period|Withdrawal by Subject|0|||
170755577|NCT04955626|617111037|FG031|Blinded Period|Withdrawal by Subject|0|||
170755578|NCT04955626|617111038|FG032|Blinded Period|Withdrawal by Subject|0|||
170755579|NCT04955626|617111039|FG033|Blinded Period|Withdrawal by Subject|0|||
170755580|NCT04955626|617111040|FG034|Blinded Period|Withdrawal by Subject|0|||
170755581|NCT04955626|617111041|FG035|Blinded Period|Withdrawal by Subject|0|||
170755582|NCT04955626|617111006|FG000|Blinded Period|Refused further study procedures|0|||
170755583|NCT04955626|617111007|FG001|Blinded Period|Refused further study procedures|0|||
170755584|NCT04955626|617111008|FG002|Blinded Period|Refused further study procedures|0|||
170755585|NCT04955626|617111009|FG003|Blinded Period|Refused further study procedures|0|||
170755586|NCT04955626|617111010|FG004|Blinded Period|Refused further study procedures|0|||
170755587|NCT04955626|617111011|FG005|Blinded Period|Refused further study procedures|0|||
170755588|NCT04955626|617111012|FG006|Blinded Period|Refused further study procedures|1|||
170755589|NCT04955626|617111013|FG007|Blinded Period|Refused further study procedures|0|||
170755590|NCT04955626|617111014|FG008|Blinded Period|Refused further study procedures|0|||
170755591|NCT04955626|617111015|FG009|Blinded Period|Refused further study procedures|0|||
170755592|NCT04955626|617111016|FG010|Blinded Period|Refused further study procedures|0|||
170755593|NCT04955626|617111017|FG011|Blinded Period|Refused further study procedures|2|||
170755594|NCT04955626|617111018|FG012|Blinded Period|Refused further study procedures|0|||
170755595|NCT04955626|617111019|FG013|Blinded Period|Refused further study procedures|0|||
170755596|NCT04955626|617111020|FG014|Blinded Period|Refused further study procedures|0|||
170755597|NCT04955626|617111021|FG015|Blinded Period|Refused further study procedures|0|||
170755598|NCT04955626|617111022|FG016|Blinded Period|Refused further study procedures|0|||
170755599|NCT04955626|617111023|FG017|Blinded Period|Refused further study procedures|0|||
170755600|NCT04955626|617111024|FG018|Blinded Period|Refused further study procedures|0|||
170755601|NCT04955626|617111025|FG019|Blinded Period|Refused further study procedures|0|||
170755602|NCT04955626|617111026|FG020|Blinded Period|Refused further study procedures|0|||
170755603|NCT04955626|617111027|FG021|Blinded Period|Refused further study procedures|0|||
170755604|NCT04955626|617111028|FG022|Blinded Period|Refused further study procedures|0|||
170755605|NCT04955626|617111029|FG023|Blinded Period|Refused further study procedures|0|||
170755606|NCT04955626|617111030|FG024|Blinded Period|Refused further study procedures|0|||
170755607|NCT04955626|617111031|FG025|Blinded Period|Refused further study procedures|0|||
170755608|NCT04955626|617111032|FG026|Blinded Period|Refused further study procedures|0|||
170755609|NCT04955626|617111033|FG027|Blinded Period|Refused further study procedures|0|||
170755610|NCT04955626|617111034|FG028|Blinded Period|Refused further study procedures|0|||
170755611|NCT04955626|617111035|FG029|Blinded Period|Refused further study procedures|0|||
170755612|NCT04955626|617111036|FG030|Blinded Period|Refused further study procedures|0|||
170755613|NCT04955626|617111037|FG031|Blinded Period|Refused further study procedures|0|||
170755614|NCT04955626|617111038|FG032|Blinded Period|Refused further study procedures|0|||
170755615|NCT04955626|617111039|FG033|Blinded Period|Refused further study procedures|0|||
170755616|NCT04955626|617111040|FG034|Blinded Period|Refused further study procedures|0|||
170755617|NCT04955626|617111041|FG035|Blinded Period|Refused further study procedures|0|||
170755618|NCT04955626|617111006|FG000|Blinded Period|Participants entered open label period|4544|||
170755619|NCT04955626|617111007|FG001|Blinded Period|Participants entered open label period|4906|||
170755620|NCT04955626|617111008|FG002|Blinded Period|Participants entered open label period|0|||
170755621|NCT04955626|617111009|FG003|Blinded Period|Participants entered open label period|0|||
170755622|NCT04955626|617111010|FG004|Blinded Period|Participants entered open label period|0|||
170755623|NCT04955626|617111011|FG005|Blinded Period|Participants entered open label period|0|||
170755624|NCT04955626|617111012|FG006|Blinded Period|Participants entered open label period|0|||
170755625|NCT04955626|617111013|FG007|Blinded Period|Participants entered open label period|0|||
170755626|NCT04955626|617111014|FG008|Blinded Period|Participants entered open label period|0|||
170755627|NCT04955626|617111015|FG009|Blinded Period|Participants entered open label period|0|||
170755628|NCT04955626|617111016|FG010|Blinded Period|Participants entered open label period|0|||
170755629|NCT04955626|617111017|FG011|Blinded Period|Participants entered open label period|0|||
170755630|NCT04955626|617111018|FG012|Blinded Period|Participants entered open label period|0|||
170755631|NCT04955626|617111019|FG013|Blinded Period|Participants entered open label period|0|||
170865138|NCT02411578|617518031|FG001|Crossover Trial Phase|Pregnancy|1|||
170865139|NCT03707925|617518032|FG000|Overall Study|Inevaluable|1|||
170755632|NCT04955626|617111020|FG014|Blinded Period|Participants entered open label period|0|||
170865140|NCT03431857|617518033|FG000|Overall Study|Death|6|||
170865141|NCT03431857|617518033|FG000|Overall Study|Lost to Follow-up|41|||
170865142|NCT03431857|617518033|FG000|Overall Study|Adverse Event|6|||
170865143|NCT03431857|617518033|FG000|Overall Study|Withdrawal by Subject|1|||
170865144|NCT01323621|617518034|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
170865145|NCT01323621|617518035|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
170755633|NCT04955626|617111021|FG015|Blinded Period|Participants entered open label period|0|||
170865146|NCT01323621|617518036|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
170755634|NCT04955626|617111022|FG016|Blinded Period|Participants entered open label period|0|||
170755635|NCT04955626|617111023|FG017|Blinded Period|Participants entered open label period|0|||
170755636|NCT04955626|617111024|FG018|Blinded Period|Participants entered open label period|0|||
170755637|NCT04955626|617111025|FG019|Blinded Period|Participants entered open label period|0|||
170755638|NCT04955626|617111026|FG020|Blinded Period|Participants entered open label period|0|||
170755639|NCT04955626|617111027|FG021|Blinded Period|Participants entered open label period|0|||
170755640|NCT04955626|617111028|FG022|Blinded Period|Participants entered open label period|0|||
170755641|NCT04955626|617111029|FG023|Blinded Period|Participants entered open label period|0|||
170755642|NCT04955626|617111030|FG024|Blinded Period|Participants entered open label period|0|||
170755643|NCT04955626|617111031|FG025|Blinded Period|Participants entered open label period|0|||
170755644|NCT04955626|617111032|FG026|Blinded Period|Participants entered open label period|0|||
170755645|NCT04955626|617111033|FG027|Blinded Period|Participants entered open label period|0|||
170755646|NCT04955626|617111034|FG028|Blinded Period|Participants entered open label period|0|||
170755647|NCT04955626|617111035|FG029|Blinded Period|Participants entered open label period|0|||
170755648|NCT04955626|617111036|FG030|Blinded Period|Participants entered open label period|0|||
170755649|NCT04955626|617111037|FG031|Blinded Period|Participants entered open label period|0|||
170755650|NCT04955626|617111038|FG032|Blinded Period|Participants entered open label period|0|||
170755651|NCT04955626|617111039|FG033|Blinded Period|Participants entered open label period|0|||
170755652|NCT04955626|617111040|FG034|Blinded Period|Participants entered open label period|0|||
170755653|NCT04955626|617111041|FG035|Blinded Period|Participants entered open label period|0|||
170755654|NCT04955626|617111006|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
170755655|NCT04955626|617111007|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
170755656|NCT04955626|617111008|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
170755657|NCT04955626|617111009|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
170755658|NCT04955626|617111010|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
170755659|NCT04955626|617111011|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
170755660|NCT04955626|617111012|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
170755661|NCT04955626|617111013|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
170403234|NCT03627195|615818681|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
170403235|NCT03627195|615818682|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
170403236|NCT03627195|615818683|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
170403237|NCT03627195|615818684|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
170403238|NCT03627195|615818685|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
170403239|NCT00331773|615818699|FG000|Overall Study|Withdrawal by Subject|6|||
170403240|NCT00331773|615818700|FG001|Overall Study|Withdrawal by Subject|4|||
170403241|NCT00331773|615818699|FG000|Overall Study|Protocol Violation|10|||
170403242|NCT00331773|615818700|FG001|Overall Study|Protocol Violation|3|||
170403243|NCT01872689|615818708|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
170403244|NCT01872689|615818709|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
170755662|NCT04955626|617111014|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
170755663|NCT04955626|617111015|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
170755664|NCT04955626|617111016|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
170755665|NCT04955626|617111017|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
170755666|NCT04955626|617111018|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
170755667|NCT04955626|617111019|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
170755668|NCT04955626|617111020|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
170755669|NCT04955626|617111021|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
170755670|NCT04955626|617111022|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
170755671|NCT04955626|617111023|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
170755672|NCT04955626|617111024|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
170755673|NCT04955626|617111025|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
170755674|NCT04955626|617111026|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
170755675|NCT04955626|617111027|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
170755676|NCT04955626|617111028|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
170755677|NCT04955626|617111029|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
170755678|NCT04955626|617111030|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
170755679|NCT04955626|617111031|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
170755680|NCT04955626|617111032|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
170755681|NCT04955626|617111033|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
170755682|NCT04955626|617111034|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
170755683|NCT04955626|617111035|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
170403245|NCT01872689|615818710|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
170403246|NCT01872689|615818711|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
170755684|NCT04955626|617111036|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
170755685|NCT04955626|617111037|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
170755686|NCT04955626|617111038|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
170403247|NCT01872689|615818708|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
170403248|NCT01872689|615818709|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
170403249|NCT01872689|615818710|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
170755687|NCT04955626|617111039|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
170755688|NCT04955626|617111040|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
170755689|NCT04955626|617111041|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
170755690|NCT04955626|617111006|FG000|Blinded Period|Medication error|0|||
170755691|NCT04955626|617111007|FG001|Blinded Period|Medication error|0|||
170755692|NCT04955626|617111008|FG002|Blinded Period|Medication error|0|||
170755693|NCT04955626|617111009|FG003|Blinded Period|Medication error|0|||
170755694|NCT04955626|617111010|FG004|Blinded Period|Medication error|0|||
170631964|NCT03926611|616664483|FG001|Overall Study|Covid-19 pandemic|0|||
170631965|NCT03926611|616664484|FG002|Overall Study|Covid-19 pandemic|1|||
170631966|NCT03926611|616664485|FG003|Overall Study|Covid-19 pandemic|0|||
170631967|NCT03926611|616664486|FG004|Overall Study|Covid-19 pandemic|1|||
170631968|NCT03926611|616664487|FG005|Overall Study|Covid-19 pandemic|2|||
170631969|NCT03926611|616664488|FG006|Overall Study|Covid-19 pandemic|0|||
170631970|NCT02446899|616664489|FG000|Overall Study|Adverse Event|4|||
170631971|NCT02446899|616664490|FG001|Overall Study|Adverse Event|7|||
170631972|NCT02446899|616664489|FG000|Overall Study|Condition Under Investigation Worsened|1|||
170631973|NCT02446899|616664490|FG001|Overall Study|Condition Under Investigation Worsened|4|||
170631974|NCT02446899|616664489|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
170631975|NCT02446899|616664490|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
170631976|NCT02446899|616664489|FG000|Overall Study|Lack of Efficacy|2|||
170631977|NCT02446899|616664490|FG001|Overall Study|Lack of Efficacy|8|||
170631978|NCT02446899|616664489|FG000|Overall Study|Lost to Follow-up|1|||
170631979|NCT02446899|616664490|FG001|Overall Study|Lost to Follow-up|3|||
170631980|NCT02446899|616664489|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
170631981|NCT02446899|616664490|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
170755695|NCT04955626|617111011|FG005|Blinded Period|Medication error|0|||
170755696|NCT04955626|617111012|FG006|Blinded Period|Medication error|0|||
170755697|NCT04955626|617111013|FG007|Blinded Period|Medication error|0|||
170755698|NCT04955626|617111014|FG008|Blinded Period|Medication error|0|||
170755699|NCT04955626|617111015|FG009|Blinded Period|Medication error|0|||
170755700|NCT04955626|617111016|FG010|Blinded Period|Medication error|2|||
170755701|NCT04955626|617111017|FG011|Blinded Period|Medication error|0|||
170755702|NCT04955626|617111018|FG012|Blinded Period|Medication error|0|||
170755703|NCT04955626|617111019|FG013|Blinded Period|Medication error|0|||
170755704|NCT04955626|617111020|FG014|Blinded Period|Medication error|0|||
170755705|NCT04955626|617111021|FG015|Blinded Period|Medication error|0|||
170755706|NCT04955626|617111022|FG016|Blinded Period|Medication error|0|||
170755707|NCT04955626|617111023|FG017|Blinded Period|Medication error|0|||
170755708|NCT04955626|617111024|FG018|Blinded Period|Medication error|0|||
170755709|NCT04955626|617111025|FG019|Blinded Period|Medication error|0|||
170755710|NCT04955626|617111026|FG020|Blinded Period|Medication error|0|||
170755711|NCT04955626|617111027|FG021|Blinded Period|Medication error|0|||
170755712|NCT04955626|617111028|FG022|Blinded Period|Medication error|0|||
170755713|NCT04955626|617111029|FG023|Blinded Period|Medication error|0|||
170755714|NCT04955626|617111030|FG024|Blinded Period|Medication error|0|||
170755715|NCT04955626|617111031|FG025|Blinded Period|Medication error|0|||
170755716|NCT04955626|617111032|FG026|Blinded Period|Medication error|0|||
170755717|NCT04955626|617111033|FG027|Blinded Period|Medication error|0|||
170755718|NCT04955626|617111034|FG028|Blinded Period|Medication error|4|||
170755719|NCT04955626|617111035|FG029|Blinded Period|Medication error|0|||
170755720|NCT04955626|617111036|FG030|Blinded Period|Medication error|0|||
170755721|NCT04955626|617111037|FG031|Blinded Period|Medication error|0|||
170755722|NCT04955626|617111038|FG032|Blinded Period|Medication error|0|||
170755723|NCT04955626|617111039|FG033|Blinded Period|Medication error|0|||
170755724|NCT04955626|617111040|FG034|Blinded Period|Medication error|0|||
170755725|NCT04955626|617111041|FG035|Blinded Period|Medication error|0|||
170755726|NCT04955626|617111006|FG000|Open-Label Period|Lost to Follow-up|109|||
170755727|NCT04955626|617111007|FG001|Open-Label Period|Lost to Follow-up|41|||
170755728|NCT04955626|617111008|FG002|Open-Label Period|Lost to Follow-up|0|||
170755729|NCT04955626|617111009|FG003|Open-Label Period|Lost to Follow-up|0|||
170755730|NCT04955626|617111010|FG004|Open-Label Period|Lost to Follow-up|0|||
170755731|NCT04955626|617111011|FG005|Open-Label Period|Lost to Follow-up|0|||
170755732|NCT04955626|617111012|FG006|Open-Label Period|Lost to Follow-up|0|||
170755733|NCT04955626|617111013|FG007|Open-Label Period|Lost to Follow-up|0|||
170755734|NCT04955626|617111014|FG008|Open-Label Period|Lost to Follow-up|0|||
170755735|NCT04955626|617111015|FG009|Open-Label Period|Lost to Follow-up|0|||
170755736|NCT04955626|617111016|FG010|Open-Label Period|Lost to Follow-up|0|||
170865147|NCT01323621|617518034|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
170865148|NCT01323621|617518035|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
170865149|NCT01323621|617518036|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
170755737|NCT04955626|617111017|FG011|Open-Label Period|Lost to Follow-up|0|||
170755738|NCT04955626|617111018|FG012|Open-Label Period|Lost to Follow-up|0|||
170755739|NCT04955626|617111019|FG013|Open-Label Period|Lost to Follow-up|0|||
170755740|NCT04955626|617111020|FG014|Open-Label Period|Lost to Follow-up|0|||
170755741|NCT04955626|617111021|FG015|Open-Label Period|Lost to Follow-up|0|||
170755742|NCT04955626|617111022|FG016|Open-Label Period|Lost to Follow-up|0|||
170755743|NCT04955626|617111023|FG017|Open-Label Period|Lost to Follow-up|0|||
170755744|NCT04955626|617111024|FG018|Open-Label Period|Lost to Follow-up|0|||
170755745|NCT04955626|617111025|FG019|Open-Label Period|Lost to Follow-up|0|||
170755746|NCT04955626|617111026|FG020|Open-Label Period|Lost to Follow-up|0|||
170755747|NCT04955626|617111027|FG021|Open-Label Period|Lost to Follow-up|0|||
170755748|NCT04955626|617111028|FG022|Open-Label Period|Lost to Follow-up|0|||
170755749|NCT04955626|617111029|FG023|Open-Label Period|Lost to Follow-up|0|||
170755750|NCT04955626|617111030|FG024|Open-Label Period|Lost to Follow-up|0|||
170755751|NCT04955626|617111031|FG025|Open-Label Period|Lost to Follow-up|0|||
170755752|NCT04955626|617111032|FG026|Open-Label Period|Lost to Follow-up|0|||
170755753|NCT04955626|617111033|FG027|Open-Label Period|Lost to Follow-up|0|||
170755754|NCT04955626|617111034|FG028|Open-Label Period|Lost to Follow-up|0|||
170755755|NCT04955626|617111035|FG029|Open-Label Period|Lost to Follow-up|0|||
170755756|NCT04955626|617111036|FG030|Open-Label Period|Lost to Follow-up|0|||
170755757|NCT04955626|617111037|FG031|Open-Label Period|Lost to Follow-up|0|||
170755758|NCT04955626|617111038|FG032|Open-Label Period|Lost to Follow-up|0|||
170755759|NCT04955626|617111039|FG033|Open-Label Period|Lost to Follow-up|0|||
170755760|NCT04955626|617111040|FG034|Open-Label Period|Lost to Follow-up|0|||
170755761|NCT04955626|617111041|FG035|Open-Label Period|Lost to Follow-up|0|||
170755762|NCT04955626|617111006|FG000|Open-Label Period|Protocol Violation|377|||
170755763|NCT04955626|617111007|FG001|Open-Label Period|Protocol Violation|48|||
170755764|NCT04955626|617111008|FG002|Open-Label Period|Protocol Violation|0|||
170755765|NCT04955626|617111009|FG003|Open-Label Period|Protocol Violation|0|||
170755766|NCT04955626|617111010|FG004|Open-Label Period|Protocol Violation|0|||
170755767|NCT04955626|617111011|FG005|Open-Label Period|Protocol Violation|0|||
170755768|NCT04955626|617111012|FG006|Open-Label Period|Protocol Violation|0|||
170755769|NCT04955626|617111013|FG007|Open-Label Period|Protocol Violation|0|||
170755770|NCT04955626|617111014|FG008|Open-Label Period|Protocol Violation|0|||
170755771|NCT04955626|617111015|FG009|Open-Label Period|Protocol Violation|0|||
170755772|NCT04955626|617111016|FG010|Open-Label Period|Protocol Violation|0|||
170755773|NCT04955626|617111017|FG011|Open-Label Period|Protocol Violation|0|||
170755774|NCT04955626|617111018|FG012|Open-Label Period|Protocol Violation|0|||
170755775|NCT04955626|617111019|FG013|Open-Label Period|Protocol Violation|0|||
170755776|NCT04955626|617111020|FG014|Open-Label Period|Protocol Violation|0|||
170755777|NCT04955626|617111021|FG015|Open-Label Period|Protocol Violation|0|||
170755778|NCT04955626|617111022|FG016|Open-Label Period|Protocol Violation|0|||
170755779|NCT04955626|617111023|FG017|Open-Label Period|Protocol Violation|0|||
170755780|NCT04955626|617111024|FG018|Open-Label Period|Protocol Violation|0|||
170755781|NCT04955626|617111025|FG019|Open-Label Period|Protocol Violation|0|||
170755782|NCT04955626|617111026|FG020|Open-Label Period|Protocol Violation|0|||
170755783|NCT04955626|617111027|FG021|Open-Label Period|Protocol Violation|0|||
170755784|NCT04955626|617111028|FG022|Open-Label Period|Protocol Violation|0|||
170755785|NCT04955626|617111029|FG023|Open-Label Period|Protocol Violation|0|||
170755786|NCT04955626|617111030|FG024|Open-Label Period|Protocol Violation|0|||
170755787|NCT04955626|617111031|FG025|Open-Label Period|Protocol Violation|0|||
170755788|NCT04955626|617111032|FG026|Open-Label Period|Protocol Violation|0|||
170403250|NCT01872689|615818711|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
170403251|NCT01872689|615818708|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
170755789|NCT04955626|617111033|FG027|Open-Label Period|Protocol Violation|0|||
170755790|NCT04955626|617111034|FG028|Open-Label Period|Protocol Violation|0|||
170755791|NCT04955626|617111035|FG029|Open-Label Period|Protocol Violation|0|||
170755792|NCT04955626|617111036|FG030|Open-Label Period|Protocol Violation|0|||
170755793|NCT04955626|617111037|FG031|Open-Label Period|Protocol Violation|0|||
170755794|NCT04955626|617111038|FG032|Open-Label Period|Protocol Violation|0|||
170755795|NCT04955626|617111039|FG033|Open-Label Period|Protocol Violation|0|||
170755796|NCT04955626|617111040|FG034|Open-Label Period|Protocol Violation|0|||
170755797|NCT04955626|617111041|FG035|Open-Label Period|Protocol Violation|0|||
170755798|NCT04955626|617111006|FG000|Open-Label Period|Death|5|||
170755799|NCT04955626|617111007|FG001|Open-Label Period|Death|5|||
170755800|NCT04955626|617111008|FG002|Open-Label Period|Death|0|||
170755801|NCT04955626|617111009|FG003|Open-Label Period|Death|0|||
170755802|NCT04955626|617111010|FG004|Open-Label Period|Death|0|||
170755803|NCT04955626|617111011|FG005|Open-Label Period|Death|0|||
170755804|NCT04955626|617111012|FG006|Open-Label Period|Death|0|||
170755805|NCT04955626|617111013|FG007|Open-Label Period|Death|0|||
170755806|NCT04955626|617111014|FG008|Open-Label Period|Death|0|||
170755807|NCT04955626|617111015|FG009|Open-Label Period|Death|0|||
170755808|NCT04955626|617111016|FG010|Open-Label Period|Death|0|||
170755809|NCT04955626|617111017|FG011|Open-Label Period|Death|0|||
170755810|NCT04955626|617111018|FG012|Open-Label Period|Death|0|||
170755811|NCT04955626|617111019|FG013|Open-Label Period|Death|0|||
170755812|NCT04955626|617111020|FG014|Open-Label Period|Death|0|||
170755813|NCT04955626|617111021|FG015|Open-Label Period|Death|0|||
170755814|NCT04955626|617111022|FG016|Open-Label Period|Death|0|||
170755815|NCT04955626|617111023|FG017|Open-Label Period|Death|0|||
170755816|NCT04955626|617111024|FG018|Open-Label Period|Death|0|||
170755817|NCT04955626|617111025|FG019|Open-Label Period|Death|0|||
170755818|NCT04955626|617111026|FG020|Open-Label Period|Death|0|||
170403252|NCT01872689|615818709|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
170403253|NCT01872689|615818710|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
170403254|NCT01872689|615818711|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
170403255|NCT01872689|615818708|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
170403256|NCT01872689|615818709|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
170403257|NCT01872689|615818710|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
170403258|NCT01872689|615818711|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
170403259|NCT01872689|615818708|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
170403260|NCT01872689|615818709|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
170403261|NCT01872689|615818710|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
170403262|NCT01872689|615818711|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
170403263|NCT01872689|615818708|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
170403264|NCT01872689|615818709|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
170403265|NCT01872689|615818710|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
170403266|NCT01872689|615818711|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
170403267|NCT01872689|615818708|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
170403268|NCT01872689|615818709|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
170403269|NCT01872689|615818710|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
170403270|NCT01872689|615818711|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
170403271|NCT01872689|615818708|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
170403272|NCT01872689|615818709|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
170403273|NCT01872689|615818710|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
170403274|NCT01872689|615818711|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
170403275|NCT01872689|615818708|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
170403276|NCT01872689|615818709|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
170403277|NCT01872689|615818710|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
170403278|NCT01872689|615818711|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
170403279|NCT01872689|615818708|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
170403280|NCT01872689|615818709|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
170403281|NCT01872689|615818710|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
170403282|NCT01872689|615818711|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
170403283|NCT01872689|615818708|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
170403284|NCT01872689|615818709|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
170403285|NCT01872689|615818710|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
170403286|NCT01872689|615818711|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
170403287|NCT01872689|615818708|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
170403288|NCT01872689|615818709|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
170403289|NCT01872689|615818710|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
170403290|NCT01872689|615818711|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
170403291|NCT01872689|615818708|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
170403292|NCT01872689|615818709|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
170403293|NCT01872689|615818710|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
170403294|NCT01872689|615818711|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
170403295|NCT01872689|615818708|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
170403296|NCT01872689|615818709|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
170403297|NCT01872689|615818710|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
170403298|NCT01872689|615818711|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
170403299|NCT01456052|615818712|FG000|Overall Study|Adverse Event|1|||
170403300|NCT01456052|615818713|FG001|Overall Study|Adverse Event|1|||
170403301|NCT01456052|615818714|FG002|Overall Study|Adverse Event|2|||
170403302|NCT01456052|615818712|FG000|Overall Study|Consent withdrawn|0|||
170403303|NCT01456052|615818713|FG001|Overall Study|Consent withdrawn|2|||
170403304|NCT01456052|615818714|FG002|Overall Study|Consent withdrawn|1|||
170403305|NCT01456052|615818712|FG000|Overall Study|Protocol Violation|0|||
170403306|NCT01456052|615818713|FG001|Overall Study|Protocol Violation|1|||
170403307|NCT01456052|615818714|FG002|Overall Study|Protocol Violation|0|||
170403308|NCT01456052|615818712|FG000|Overall Study|Physician Decision|1|||
170403309|NCT01456052|615818713|FG001|Overall Study|Physician Decision|0|||
170403310|NCT01456052|615818714|FG002|Overall Study|Physician Decision|1|||
170403311|NCT01456052|615818712|FG000|Overall Study|Treatment Failure|0|||
170403312|NCT01456052|615818713|FG001|Overall Study|Treatment Failure|1|||
170403313|NCT01456052|615818714|FG002|Overall Study|Treatment Failure|1|||
170403314|NCT03547531|615818718|FG000|Overall Study|not coming in data collection : sick|2|||
170519691|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170403315|NCT03547531|615818719|FG001|Overall Study|not coming in data collection : sick|2|||
170403316|NCT03547531|615818718|FG000|Overall Study|having family occasion|0|||
170403317|NCT03547531|615818719|FG001|Overall Study|having family occasion|2|||
170403318|NCT02525562|615818729|FG000|Overall Study|Death|9|||
170403319|NCT02525562|615818730|FG001|Overall Study|Death|0|||
170403320|NCT02525562|615818731|FG002|Overall Study|Death|0|||
170403321|NCT02525562|615818729|FG000|Overall Study|Lost to Follow-up|19|||
170403322|NCT02525562|615818730|FG001|Overall Study|Lost to Follow-up|0|||
170403323|NCT02525562|615818731|FG002|Overall Study|Lost to Follow-up|0|||
170403324|NCT02525562|615818729|FG000|Overall Study|Withdrawal by Subject|37|||
170403325|NCT02525562|615818730|FG001|Overall Study|Withdrawal by Subject|0|||
170403326|NCT02525562|615818731|FG002|Overall Study|Withdrawal by Subject|0|||
170403327|NCT02525562|615818729|FG000|Overall Study|Revision/Removal of Study Device|4|||
170403328|NCT02525562|615818730|FG001|Overall Study|Revision/Removal of Study Device|0|||
170403329|NCT02525562|615818731|FG002|Overall Study|Revision/Removal of Study Device|0|||
170403330|NCT02525562|615818729|FG000|Overall Study|Study Closed by Sponsor|154|||
170403331|NCT02525562|615818730|FG001|Overall Study|Study Closed by Sponsor|0|||
170403332|NCT02525562|615818731|FG002|Overall Study|Study Closed by Sponsor|0|||
170755819|NCT04955626|617111027|FG021|Open-Label Period|Death|0|||
170755820|NCT04955626|617111028|FG022|Open-Label Period|Death|0|||
170755821|NCT04955626|617111029|FG023|Open-Label Period|Death|0|||
170755822|NCT04955626|617111030|FG024|Open-Label Period|Death|0|||
170755823|NCT04955626|617111031|FG025|Open-Label Period|Death|0|||
170755824|NCT04955626|617111032|FG026|Open-Label Period|Death|0|||
170755825|NCT04955626|617111033|FG027|Open-Label Period|Death|0|||
170755826|NCT04955626|617111034|FG028|Open-Label Period|Death|0|||
170755827|NCT04955626|617111035|FG029|Open-Label Period|Death|0|||
170755828|NCT04955626|617111036|FG030|Open-Label Period|Death|0|||
170755829|NCT04955626|617111037|FG031|Open-Label Period|Death|0|||
170755830|NCT04955626|617111038|FG032|Open-Label Period|Death|0|||
170755831|NCT04955626|617111039|FG033|Open-Label Period|Death|0|||
170755832|NCT04955626|617111040|FG034|Open-Label Period|Death|0|||
170755833|NCT04955626|617111041|FG035|Open-Label Period|Death|0|||
170755834|NCT04955626|617111006|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
170755835|NCT04955626|617111007|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
170755836|NCT04955626|617111008|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
170755837|NCT04955626|617111009|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
170755838|NCT04955626|617111010|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
170755839|NCT04955626|617111011|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
170755840|NCT04955626|617111012|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
170755841|NCT04955626|617111013|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
170755842|NCT04955626|617111014|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
170755843|NCT04955626|617111015|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
170755844|NCT04955626|617111016|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
170755845|NCT04955626|617111017|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
170755846|NCT04955626|617111018|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
170755847|NCT04955626|617111019|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
170755848|NCT04955626|617111020|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
170755849|NCT04955626|617111021|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
170755850|NCT04955626|617111022|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
170755851|NCT04955626|617111023|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
170755852|NCT04955626|617111024|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
170755853|NCT04955626|617111025|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
170755854|NCT04955626|617111026|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
170755855|NCT04955626|617111027|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
170755856|NCT04955626|617111028|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
170755857|NCT04955626|617111029|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
170755858|NCT04955626|617111030|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
170755859|NCT04955626|617111031|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
170755860|NCT04955626|617111032|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
170755861|NCT04955626|617111033|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
170755862|NCT04955626|617111034|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
170755863|NCT04955626|617111035|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
170755864|NCT04955626|617111036|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
170755865|NCT04955626|617111037|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
170755866|NCT04955626|617111038|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
170755867|NCT04955626|617111039|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
170755868|NCT04955626|617111040|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
170755869|NCT04955626|617111041|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
170755870|NCT04955626|617111006|FG000|Open-Label Period|Other|621|||
170755871|NCT04955626|617111007|FG001|Open-Label Period|Other|429|||
170755872|NCT04955626|617111008|FG002|Open-Label Period|Other|0|||
170755873|NCT04955626|617111009|FG003|Open-Label Period|Other|0|||
170403333|NCT00423488|615818736|FG000|Overall Study|No evidence of study drug intake|2|||
170403334|NCT00423488|615818737|FG001|Overall Study|No evidence of study drug intake|1|||
170403335|NCT00423488|615818736|FG000|Overall Study|No post baseline data|3|||
170403336|NCT00423488|615818737|FG001|Overall Study|No post baseline data|0|||
170865150|NCT01323621|617518034|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
170865151|NCT01323621|617518035|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
170755874|NCT04955626|617111010|FG004|Open-Label Period|Other|0|||
170755875|NCT04955626|617111011|FG005|Open-Label Period|Other|0|||
170755876|NCT04955626|617111012|FG006|Open-Label Period|Other|0|||
170755877|NCT04955626|617111013|FG007|Open-Label Period|Other|0|||
170755878|NCT04955626|617111014|FG008|Open-Label Period|Other|0|||
170755879|NCT04955626|617111015|FG009|Open-Label Period|Other|0|||
170755880|NCT04955626|617111016|FG010|Open-Label Period|Other|0|||
170755881|NCT04955626|617111017|FG011|Open-Label Period|Other|0|||
170755882|NCT04955626|617111018|FG012|Open-Label Period|Other|0|||
170755883|NCT04955626|617111019|FG013|Open-Label Period|Other|0|||
170755884|NCT04955626|617111020|FG014|Open-Label Period|Other|0|||
170755885|NCT04955626|617111021|FG015|Open-Label Period|Other|0|||
170755886|NCT04955626|617111022|FG016|Open-Label Period|Other|0|||
170755887|NCT04955626|617111023|FG017|Open-Label Period|Other|0|||
170755888|NCT04955626|617111024|FG018|Open-Label Period|Other|0|||
170755889|NCT04955626|617111025|FG019|Open-Label Period|Other|0|||
170755890|NCT04955626|617111026|FG020|Open-Label Period|Other|0|||
170755891|NCT04955626|617111027|FG021|Open-Label Period|Other|0|||
170755892|NCT04955626|617111028|FG022|Open-Label Period|Other|0|||
170755893|NCT04955626|617111029|FG023|Open-Label Period|Other|0|||
170755894|NCT04955626|617111030|FG024|Open-Label Period|Other|0|||
170755895|NCT04955626|617111031|FG025|Open-Label Period|Other|0|||
170755896|NCT04955626|617111032|FG026|Open-Label Period|Other|0|||
170755897|NCT04955626|617111033|FG027|Open-Label Period|Other|0|||
170755898|NCT04955626|617111034|FG028|Open-Label Period|Other|0|||
170755899|NCT04955626|617111035|FG029|Open-Label Period|Other|0|||
170755900|NCT04955626|617111036|FG030|Open-Label Period|Other|0|||
170755901|NCT04955626|617111037|FG031|Open-Label Period|Other|0|||
170755902|NCT04955626|617111038|FG032|Open-Label Period|Other|0|||
170755903|NCT04955626|617111039|FG033|Open-Label Period|Other|0|||
170755904|NCT04955626|617111040|FG034|Open-Label Period|Other|0|||
170755905|NCT04955626|617111041|FG035|Open-Label Period|Other|0|||
170755906|NCT04955626|617111006|FG000|Open-Label Period|Physician Decision|2|||
170755907|NCT04955626|617111007|FG001|Open-Label Period|Physician Decision|0|||
170755908|NCT04955626|617111008|FG002|Open-Label Period|Physician Decision|0|||
170755909|NCT04955626|617111009|FG003|Open-Label Period|Physician Decision|0|||
170755910|NCT04955626|617111010|FG004|Open-Label Period|Physician Decision|0|||
170755911|NCT04955626|617111011|FG005|Open-Label Period|Physician Decision|0|||
170755912|NCT04955626|617111012|FG006|Open-Label Period|Physician Decision|0|||
170755913|NCT04955626|617111013|FG007|Open-Label Period|Physician Decision|0|||
170755914|NCT04955626|617111014|FG008|Open-Label Period|Physician Decision|0|||
170755915|NCT04955626|617111015|FG009|Open-Label Period|Physician Decision|0|||
170755916|NCT04955626|617111016|FG010|Open-Label Period|Physician Decision|0|||
170755917|NCT04955626|617111017|FG011|Open-Label Period|Physician Decision|0|||
170755918|NCT04955626|617111018|FG012|Open-Label Period|Physician Decision|0|||
170755919|NCT04955626|617111019|FG013|Open-Label Period|Physician Decision|0|||
170755920|NCT04955626|617111020|FG014|Open-Label Period|Physician Decision|0|||
170755921|NCT04955626|617111021|FG015|Open-Label Period|Physician Decision|0|||
170755922|NCT04955626|617111022|FG016|Open-Label Period|Physician Decision|0|||
170755923|NCT04955626|617111023|FG017|Open-Label Period|Physician Decision|0|||
170755924|NCT04955626|617111024|FG018|Open-Label Period|Physician Decision|0|||
170755925|NCT04955626|617111025|FG019|Open-Label Period|Physician Decision|0|||
170755926|NCT04955626|617111026|FG020|Open-Label Period|Physician Decision|0|||
170755927|NCT04955626|617111027|FG021|Open-Label Period|Physician Decision|0|||
170755928|NCT04955626|617111028|FG022|Open-Label Period|Physician Decision|0|||
170755929|NCT04955626|617111029|FG023|Open-Label Period|Physician Decision|0|||
170755930|NCT04955626|617111030|FG024|Open-Label Period|Physician Decision|0|||
170755931|NCT04955626|617111031|FG025|Open-Label Period|Physician Decision|0|||
170755932|NCT04955626|617111032|FG026|Open-Label Period|Physician Decision|0|||
170755933|NCT04955626|617111033|FG027|Open-Label Period|Physician Decision|0|||
170755934|NCT04955626|617111034|FG028|Open-Label Period|Physician Decision|0|||
170755935|NCT04955626|617111035|FG029|Open-Label Period|Physician Decision|0|||
170755936|NCT04955626|617111036|FG030|Open-Label Period|Physician Decision|0|||
170755937|NCT04955626|617111037|FG031|Open-Label Period|Physician Decision|0|||
170755938|NCT04955626|617111038|FG032|Open-Label Period|Physician Decision|0|||
170755939|NCT04955626|617111039|FG033|Open-Label Period|Physician Decision|0|||
170755940|NCT04955626|617111040|FG034|Open-Label Period|Physician Decision|0|||
170755941|NCT04955626|617111041|FG035|Open-Label Period|Physician Decision|0|||
170755942|NCT04955626|617111006|FG000|Open-Label Period|Withdrawal by Subject|135|||
170755943|NCT04955626|617111007|FG001|Open-Label Period|Withdrawal by Subject|25|||
170755944|NCT04955626|617111008|FG002|Open-Label Period|Withdrawal by Subject|0|||
170755945|NCT04955626|617111009|FG003|Open-Label Period|Withdrawal by Subject|0|||
170403337|NCT00886782|615818738|FG000|Overall Study|Disease progression|3|||
170755946|NCT04955626|617111010|FG004|Open-Label Period|Withdrawal by Subject|0|||
170755947|NCT04955626|617111011|FG005|Open-Label Period|Withdrawal by Subject|0|||
170755948|NCT04955626|617111012|FG006|Open-Label Period|Withdrawal by Subject|0|||
170755949|NCT04955626|617111013|FG007|Open-Label Period|Withdrawal by Subject|0|||
170865152|NCT01323621|617518036|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
170865153|NCT01323621|617518034|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
170865154|NCT01323621|617518035|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
170865155|NCT01323621|617518036|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
170865156|NCT01323621|617518034|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
170865157|NCT01323621|617518035|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
170865158|NCT01323621|617518036|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
170865159|NCT01323621|617518034|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
170865160|NCT01323621|617518035|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
170865161|NCT01323621|617518036|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
170865162|NCT01323621|617518034|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
170865163|NCT01323621|617518035|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
170865164|NCT01323621|617518036|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
170865165|NCT01323621|617518034|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
170865166|NCT01323621|617518035|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
170865167|NCT01323621|617518036|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
170865168|NCT01323621|617518034|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
170865169|NCT01323621|617518035|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
170865170|NCT01323621|617518036|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
170865171|NCT01323621|617518034|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170865172|NCT01323621|617518035|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
170865173|NCT01323621|617518036|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170865174|NCT01323621|617518034|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
170865175|NCT01323621|617518035|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
170865176|NCT01323621|617518036|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
170865177|NCT01323621|617518034|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
170865178|NCT01323621|617518035|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
170865179|NCT01323621|617518036|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
170865180|NCT02876835|617518038|FG000|Treatment Period (51.1 Month)|Other|1|||
170865181|NCT02876835|617518039|FG001|Treatment Period (51.1 Month)|Other|0|||
170865182|NCT02876835|617518038|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
170865183|NCT02876835|617518039|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
170865184|NCT02876835|617518038|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
170865185|NCT02876835|617518039|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
170865186|NCT02876835|617518038|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
170865187|NCT02876835|617518039|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
170865188|NCT01117857|617518040|FG000|Overall Study|Lost to Follow-up|4|||
170865189|NCT01117857|617518040|FG000|Overall Study|Withdrawal by Subject|4|||
170865190|NCT01117857|617518040|FG000|Overall Study|Physician Decision|1|||
170865191|NCT01119001|617518041|FG000|Overall Study|Withdrawal by Subject|2|||
170865192|NCT00954421|617518042|FG000|Screening|screen failures|3|||
170865193|NCT00954421|617518042|FG000|6 Months of DBS|Withdrawal by Subject|1|||
170865194|NCT00954421|617518042|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
170865195|NCT00403754|617518043|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
170865196|NCT00403754|617518044|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
170865197|NCT00403754|617518045|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
170865198|NCT00403754|617518046|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
170865199|NCT00403754|617518043|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
170865200|NCT00403754|617518044|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
170865201|NCT00403754|617518045|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
170865202|NCT00403754|617518046|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
170865203|NCT04343248|617518049|FG000|Overall Study|Withdrawal by Subject|5|||
170865204|NCT04343248|617518050|FG001|Overall Study|Withdrawal by Subject|6|||
170865205|NCT04343248|617518049|FG000|Overall Study|Death|1|||
170865206|NCT04343248|617518050|FG001|Overall Study|Death|2|||
170865207|NCT04343248|617518049|FG000|Overall Study|Lost to Follow-up|9|||
170865208|NCT04343248|617518050|FG001|Overall Study|Lost to Follow-up|6|||
170865209|NCT04343248|617518049|FG000|Overall Study|Physician Decision|0|||
170865210|NCT04343248|617518050|FG001|Overall Study|Physician Decision|1|||
170865211|NCT04343248|617518049|FG000|Overall Study|Adverse Event|1|||
170865212|NCT04343248|617518050|FG001|Overall Study|Adverse Event|0|||
170865213|NCT05245097|617518055|FG000|Overall Study|Adverse Event|13|||
170865214|NCT05245097|617518056|FG001|Overall Study|Adverse Event|2|||
170865215|NCT05245097|617518055|FG000|Overall Study|Protocol Violation|8|||
170865216|NCT05245097|617518056|FG001|Overall Study|Protocol Violation|6|||
170865217|NCT05245097|617518055|FG000|Overall Study|Withdrawal by Subject|18|||
170865218|NCT05245097|617518056|FG001|Overall Study|Withdrawal by Subject|0|||
170865219|NCT05245097|617518055|FG000|Overall Study|Death|6|||
170403338|NCT00886782|615818739|FG001|Overall Study|Disease progression|3|||
170403339|NCT00886782|615818740|FG002|Overall Study|Disease progression|3|||
170403340|NCT00886782|615818738|FG000|Overall Study|Study drug toxicity|0|||
170403341|NCT00886782|615818739|FG001|Overall Study|Study drug toxicity|0|||
170403342|NCT00886782|615818740|FG002|Overall Study|Study drug toxicity|1|||
170403343|NCT00886782|615818738|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
170403344|NCT00886782|615818739|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
170403345|NCT00886782|615818740|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
170403346|NCT03118765|615818741|FG000|Overall Study|Withdrawal by Subject|0|||
170403347|NCT03118765|615818742|FG001|Overall Study|Withdrawal by Subject|0|||
170403348|NCT03118765|615818743|FG002|Overall Study|Withdrawal by Subject|1|||
170403349|NCT03118765|615818744|FG003|Overall Study|Withdrawal by Subject|0|||
170403350|NCT03118765|615818745|FG004|Overall Study|Withdrawal by Subject|0|||
170403351|NCT03118765|615818741|FG000|Overall Study|Adverse Event|1|||
170403352|NCT03118765|615818742|FG001|Overall Study|Adverse Event|1|||
170403353|NCT03118765|615818743|FG002|Overall Study|Adverse Event|1|||
170403354|NCT03118765|615818744|FG003|Overall Study|Adverse Event|1|||
170403355|NCT03118765|615818745|FG004|Overall Study|Adverse Event|1|||
170403356|NCT03118765|615818741|FG000|Overall Study|Non compliance with Study Procedures|0|||
170403357|NCT03118765|615818742|FG001|Overall Study|Non compliance with Study Procedures|0|||
170403358|NCT03118765|615818743|FG002|Overall Study|Non compliance with Study Procedures|0|||
170403359|NCT03118765|615818744|FG003|Overall Study|Non compliance with Study Procedures|1|||
170403360|NCT03118765|615818745|FG004|Overall Study|Non compliance with Study Procedures|0|||
170403361|NCT03118765|615818741|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
170403362|NCT03118765|615818742|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
170403363|NCT03118765|615818743|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
170403364|NCT03118765|615818744|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
170403365|NCT03118765|615818745|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
170403366|NCT03118765|615818741|FG000|Overall Study|COPD Exacerbation|1|||
170403367|NCT03118765|615818742|FG001|Overall Study|COPD Exacerbation|0|||
170403368|NCT03118765|615818743|FG002|Overall Study|COPD Exacerbation|0|||
170403369|NCT03118765|615818744|FG003|Overall Study|COPD Exacerbation|1|||
170403370|NCT03118765|615818745|FG004|Overall Study|COPD Exacerbation|0|||
170403371|NCT03118765|615818741|FG000|Overall Study|Lost to Follow-up|1|||
170403372|NCT03118765|615818742|FG001|Overall Study|Lost to Follow-up|0|||
170403373|NCT03118765|615818743|FG002|Overall Study|Lost to Follow-up|1|||
170403374|NCT03118765|615818744|FG003|Overall Study|Lost to Follow-up|0|||
170403375|NCT03118765|615818745|FG004|Overall Study|Lost to Follow-up|0|||
170403376|NCT03118765|615818741|FG000|Overall Study|Sponsor Decision|1|||
170403377|NCT03118765|615818742|FG001|Overall Study|Sponsor Decision|0|||
170403378|NCT03118765|615818743|FG002|Overall Study|Sponsor Decision|1|||
170403379|NCT03118765|615818744|FG003|Overall Study|Sponsor Decision|0|||
170403380|NCT03118765|615818745|FG004|Overall Study|Sponsor Decision|1|||
170403381|NCT00849524|615818746|FG000|Overall Study|Lack of Efficacy|3|||
170403382|NCT02643966|615818747|FG000|First Screening Round|ineligible|1|||
170403383|NCT02643966|615818747|FG000|First Screening Round|excluded from analysis|2|||
170403384|NCT02643966|615818747|FG000|First Screening Round|Lost to Follow-up|56|||
170403385|NCT02643966|615818747|FG000|First Screening Round|Withdrawal by Subject|28|||
170403386|NCT02643966|615818747|FG000|First Screening Round|Death|1|||
170403387|NCT02643966|615818747|FG000|Between First and Second Screening|Lost to Follow-up|65|||
170403388|NCT02643966|615818747|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
170403389|NCT02643966|615818747|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
170403390|NCT02643966|615818747|FG000|Second Screening Round|Withdrawal by Subject|20|||
170403391|NCT02643966|615818747|FG000|Second Screening Round|Lost to Follow-up|57|||
170403392|NCT02643966|615818747|FG000|Second Screening Round|Physician Decision|2|||
170403393|NCT02643966|615818747|FG000|Second Screening Round|Death|4|||
170403394|NCT02643966|615818747|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
170403395|NCT02643966|615818747|FG000|Between Second and Third Screening|Death|1|||
170403396|NCT02643966|615818747|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
170403397|NCT02643966|615818747|FG000|Third Screening Round|PI excluded|2|||
170403398|NCT02643966|615818747|FG000|Third Screening Round|Lost to Follow-up|241|||
170403399|NCT01493531|615818748|FG000|Overall Study|Adverse Event|4|||
170403400|NCT01493531|615818749|FG001|Overall Study|Adverse Event|12|||
170403401|NCT01493531|615818750|FG002|Overall Study|Adverse Event|9|||
170403402|NCT01493531|615818748|FG000|Overall Study|Gout flare|3|||
170403403|NCT01493531|615818749|FG001|Overall Study|Gout flare|0|||
170403404|NCT01493531|615818750|FG002|Overall Study|Gout flare|2|||
170403405|NCT01493531|615818748|FG000|Overall Study|Protocol Violation|8|||
170403406|NCT01493531|615818749|FG001|Overall Study|Protocol Violation|15|||
170403407|NCT01493531|615818750|FG002|Overall Study|Protocol Violation|12|||
170403408|NCT01493531|615818748|FG000|Overall Study|Sponsor terminated study|5|||
170403409|NCT01493531|615818749|FG001|Overall Study|Sponsor terminated study|2|||
170403410|NCT01493531|615818750|FG002|Overall Study|Sponsor terminated study|3|||
170403411|NCT01493531|615818748|FG000|Overall Study|Lost to Follow-up|5|||
170403412|NCT01493531|615818749|FG001|Overall Study|Lost to Follow-up|7|||
170403413|NCT01493531|615818750|FG002|Overall Study|Lost to Follow-up|11|||
170403414|NCT01493531|615818748|FG000|Overall Study|Withdrawal by Subject|16|||
170403415|NCT01493531|615818749|FG001|Overall Study|Withdrawal by Subject|13|||
170403416|NCT01493531|615818750|FG002|Overall Study|Withdrawal by Subject|11|||
170403417|NCT01493531|615818748|FG000|Overall Study|Death|0|||
170403418|NCT01493531|615818749|FG001|Overall Study|Death|1|||
170403419|NCT01493531|615818750|FG002|Overall Study|Death|0|||
170403420|NCT01946282|615818751|FG000|Year 1|Did not return FIT kit|4186|||
170403421|NCT01946282|615818752|FG001|Year 1|Did not return FIT kit|608|||
170403422|NCT01946282|615818753|FG002|Year 1|Did not return FIT kit|654|||
170403423|NCT01946282|615818751|FG000|Year 2|Did not return FIT kit|803|||
170403424|NCT01946282|615818752|FG001|Year 2|Did not return FIT kit|131|||
170403425|NCT01946282|615818753|FG002|Year 2|Did not return FIT kit|115|||
170403426|NCT01946282|615818751|FG000|Year 3|Did not return FIT kit|288|||
170403427|NCT01946282|615818752|FG001|Year 3|Did not return FIT kit|43|||
170403428|NCT01946282|615818753|FG002|Year 3|Did not return FIT kit|30|||
170403429|NCT03835975|615818758|FG000|Overall Study|Lost to Follow-up|1|||
170403430|NCT03835975|615818759|FG001|Overall Study|Lost to Follow-up|1|||
170403431|NCT03835975|615818760|FG002|Overall Study|Lost to Follow-up|0|||
170403432|NCT03835975|615818761|FG003|Overall Study|Lost to Follow-up|0|||
170403433|NCT03835975|615818762|FG004|Overall Study|Lost to Follow-up|0|||
170403434|NCT03835975|615818758|FG000|Overall Study|No longer met eligibility criteria|0|||
170403435|NCT03835975|615818759|FG001|Overall Study|No longer met eligibility criteria|1|||
170403436|NCT03835975|615818760|FG002|Overall Study|No longer met eligibility criteria|0|||
170403437|NCT03835975|615818761|FG003|Overall Study|No longer met eligibility criteria|0|||
170403438|NCT03835975|615818762|FG004|Overall Study|No longer met eligibility criteria|0|||
170403439|NCT03835975|615818758|FG000|Overall Study|Protocol Violation|1|||
170403440|NCT03835975|615818759|FG001|Overall Study|Protocol Violation|1|||
170403441|NCT03835975|615818760|FG002|Overall Study|Protocol Violation|2|||
170755950|NCT04955626|617111014|FG008|Open-Label Period|Withdrawal by Subject|0|||
170755951|NCT04955626|617111015|FG009|Open-Label Period|Withdrawal by Subject|0|||
170755952|NCT04955626|617111016|FG010|Open-Label Period|Withdrawal by Subject|0|||
170755953|NCT04955626|617111017|FG011|Open-Label Period|Withdrawal by Subject|0|||
170403442|NCT03835975|615818761|FG003|Overall Study|Protocol Violation|0|||
170403443|NCT03835975|615818762|FG004|Overall Study|Protocol Violation|0|||
170403444|NCT03835975|615818758|FG000|Overall Study|Withdrawal by Subject|1|||
170403445|NCT03835975|615818759|FG001|Overall Study|Withdrawal by Subject|0|||
170403446|NCT03835975|615818760|FG002|Overall Study|Withdrawal by Subject|1|||
170403447|NCT03835975|615818761|FG003|Overall Study|Withdrawal by Subject|1|||
170403448|NCT03835975|615818762|FG004|Overall Study|Withdrawal by Subject|0|||
170403449|NCT03031431|615818763|FG000|Overall Study|Infant removed by maternal request|1|||
170403450|NCT01825876|615818764|FG000|Period 2|Withdrawal by Subject|0|||
170403451|NCT01825876|615818765|FG001|Period 2|Withdrawal by Subject|1|||
170403452|NCT01612702|615818769|FG000|Overall Study|Protocol Violation|11|||
170403453|NCT01612702|615818770|FG001|Overall Study|Protocol Violation|11|||
170403454|NCT03070431|615818771|FG000|Overall Study|Withdrawal by Subject|2|||
170403455|NCT03070431|615818771|FG000|Overall Study|Lost to Follow-up|2|||
170403456|NCT03012815|615818774|FG000|Overall Study|Lost to Follow-up|1|||
170403457|NCT03012815|615818775|FG001|Overall Study|Lost to Follow-up|0|||
170403458|NCT03012815|615818774|FG000|Overall Study|Physician Decision|3|||
170403459|NCT03012815|615818775|FG001|Overall Study|Physician Decision|2|||
170403460|NCT03012815|615818774|FG000|Overall Study|Adverse Event|1|||
170403461|NCT03012815|615818775|FG001|Overall Study|Adverse Event|0|||
170403462|NCT02400905|615818777|FG000|Overall Study|Death|24|||
170403463|NCT02400905|615818777|FG000|Overall Study|Lost to Follow-up|18|||
170403464|NCT02400905|615818777|FG000|Overall Study|Withdrawal by Subject|16|||
170403465|NCT02400905|615818777|FG000|Overall Study|Physician Decision|4|||
170403466|NCT02400905|615818777|FG000|Overall Study|Other|1|||
170403467|NCT03196791|615818778|FG000|Overall Study|Protocol Violation|7|||
170403468|NCT03196791|615818779|FG001|Overall Study|Protocol Violation|3|||
170403469|NCT03196791|615818778|FG000|Overall Study|Withdrawal by Subject|3|||
170403470|NCT03196791|615818779|FG001|Overall Study|Withdrawal by Subject|2|||
170403471|NCT01749033|615818782|FG000|Overall Study|Did not receive allocated intervention|3|||
170403472|NCT01749033|615818783|FG001|Overall Study|Did not receive allocated intervention|3|||
170755954|NCT04955626|617111018|FG012|Open-Label Period|Withdrawal by Subject|0|||
170755955|NCT04955626|617111019|FG013|Open-Label Period|Withdrawal by Subject|0|||
170403473|NCT01749033|615818784|FG002|Overall Study|Did not receive allocated intervention|0|||
170403474|NCT01749033|615818782|FG000|Overall Study|Lost to Follow-up|0|||
170403475|NCT01749033|615818783|FG001|Overall Study|Lost to Follow-up|2|||
170403476|NCT01749033|615818784|FG002|Overall Study|Lost to Follow-up|1|||
170403477|NCT01256398|615818786|FG000|Overall Study|Withdrawal by Subject|1|||
170403478|NCT01039584|615818787|FG000|Overall Study|Withdrawal by Subject|4|||
170403479|NCT01039584|615818788|FG001|Overall Study|Withdrawal by Subject|2|||
170403480|NCT01039584|615818789|FG002|Overall Study|Withdrawal by Subject|1|||
170403481|NCT01039584|615818787|FG000|Overall Study|Protocol Violation|10|||
170403482|NCT01039584|615818788|FG001|Overall Study|Protocol Violation|4|||
170403483|NCT01039584|615818789|FG002|Overall Study|Protocol Violation|6|||
170403484|NCT01039584|615818787|FG000|Overall Study|Lost to Follow-up|5|||
170403485|NCT01039584|615818788|FG001|Overall Study|Lost to Follow-up|3|||
170403486|NCT01039584|615818789|FG002|Overall Study|Lost to Follow-up|4|||
170403487|NCT01039584|615818787|FG000|Overall Study|Negative Baseline culture for Candida|59|||
170403488|NCT01039584|615818788|FG001|Overall Study|Negative Baseline culture for Candida|59|||
170403489|NCT01039584|615818789|FG002|Overall Study|Negative Baseline culture for Candida|24|||
170403490|NCT01039584|615818787|FG000|Overall Study|Lack of Efficacy|7|||
170403491|NCT01039584|615818788|FG001|Overall Study|Lack of Efficacy|6|||
170403492|NCT01039584|615818789|FG002|Overall Study|Lack of Efficacy|10|||
170403493|NCT01039584|615818787|FG000|Overall Study|other|1|||
170403494|NCT01039584|615818788|FG001|Overall Study|other|3|||
170403495|NCT01039584|615818789|FG002|Overall Study|other|1|||
170403496|NCT01039584|615818787|FG000|Overall Study|Pap smear with significant pathology|10|||
170403497|NCT01039584|615818788|FG001|Overall Study|Pap smear with significant pathology|10|||
170403498|NCT01039584|615818789|FG002|Overall Study|Pap smear with significant pathology|3|||
170403499|NCT01039584|615818787|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
170403500|NCT01039584|615818788|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
170403501|NCT01039584|615818789|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
170403502|NCT01174368|615818790|FG000|Overall Study|Withdrawal by Subject|1|||
170403503|NCT00479765|615818791|FG000|Overall Study|study terminated|4|||
170403504|NCT04380701|615818792|FG000|Overall Study|Pregnancy|0|||
170403505|NCT04380701|615818793|FG001|Overall Study|Pregnancy|0|||
170403506|NCT04380701|615818794|FG002|Overall Study|Pregnancy|0|||
170403507|NCT04380701|615818795|FG003|Overall Study|Pregnancy|0|||
170403508|NCT04380701|615818796|FG004|Overall Study|Pregnancy|0|||
170403509|NCT04380701|615818797|FG005|Overall Study|Pregnancy|0|||
170403510|NCT04380701|615818798|FG006|Overall Study|Pregnancy|0|||
170403511|NCT04380701|615818799|FG007|Overall Study|Pregnancy|0|||
170403512|NCT04380701|615818800|FG008|Overall Study|Pregnancy|0|||
170403513|NCT04380701|615818801|FG009|Overall Study|Pregnancy|0|||
170403514|NCT04380701|615818802|FG010|Overall Study|Pregnancy|0|||
170403515|NCT04380701|615818803|FG011|Overall Study|Pregnancy|0|||
170403516|NCT04380701|615818804|FG012|Overall Study|Pregnancy|0|||
170403517|NCT04380701|615818805|FG013|Overall Study|Pregnancy|0|||
170403518|NCT04380701|615818806|FG014|Overall Study|Pregnancy|0|||
170403519|NCT04380701|615818807|FG015|Overall Study|Pregnancy|0|||
170403520|NCT04380701|615818808|FG016|Overall Study|Pregnancy|0|||
170403521|NCT04380701|615818809|FG017|Overall Study|Pregnancy|0|||
170403522|NCT04380701|615818810|FG018|Overall Study|Pregnancy|0|||
170403523|NCT04380701|615818811|FG019|Overall Study|Pregnancy|0|||
170403524|NCT04380701|615818812|FG020|Overall Study|Pregnancy|0|||
170403525|NCT04380701|615818813|FG021|Overall Study|Pregnancy|0|||
170403526|NCT04380701|615818814|FG022|Overall Study|Pregnancy|0|||
170403527|NCT04380701|615818815|FG023|Overall Study|Pregnancy|0|||
170403528|NCT04380701|615818816|FG024|Overall Study|Pregnancy|0|||
170403529|NCT04380701|615818817|FG025|Overall Study|Pregnancy|0|||
170403530|NCT04380701|615818818|FG026|Overall Study|Pregnancy|0|||
170403531|NCT04380701|615818819|FG027|Overall Study|Pregnancy|0|||
170403532|NCT04380701|615818820|FG028|Overall Study|Pregnancy|0|||
170403533|NCT04380701|615818821|FG029|Overall Study|Pregnancy|0|||
170403534|NCT04380701|615818822|FG030|Overall Study|Pregnancy|0|||
170403535|NCT04380701|615818823|FG031|Overall Study|Pregnancy|0|||
170403536|NCT04380701|615818824|FG032|Overall Study|Pregnancy|1|||
170403537|NCT04380701|615818825|FG033|Overall Study|Pregnancy|0|||
170403538|NCT04380701|615818792|FG000|Overall Study|Lost to Follow-up|0|||
170403539|NCT04380701|615818793|FG001|Overall Study|Lost to Follow-up|0|||
170403540|NCT04380701|615818794|FG002|Overall Study|Lost to Follow-up|0|||
170403541|NCT04380701|615818795|FG003|Overall Study|Lost to Follow-up|0|||
170403542|NCT04380701|615818796|FG004|Overall Study|Lost to Follow-up|0|||
170403543|NCT04380701|615818797|FG005|Overall Study|Lost to Follow-up|0|||
170403544|NCT04380701|615818798|FG006|Overall Study|Lost to Follow-up|0|||
170403545|NCT04380701|615818799|FG007|Overall Study|Lost to Follow-up|0|||
170403546|NCT04380701|615818800|FG008|Overall Study|Lost to Follow-up|0|||
170403547|NCT04380701|615818801|FG009|Overall Study|Lost to Follow-up|0|||
170403548|NCT04380701|615818802|FG010|Overall Study|Lost to Follow-up|0|||
170403549|NCT04380701|615818803|FG011|Overall Study|Lost to Follow-up|0|||
170403550|NCT04380701|615818804|FG012|Overall Study|Lost to Follow-up|0|||
170403551|NCT04380701|615818805|FG013|Overall Study|Lost to Follow-up|0|||
170403552|NCT04380701|615818806|FG014|Overall Study|Lost to Follow-up|0|||
170403553|NCT04380701|615818807|FG015|Overall Study|Lost to Follow-up|0|||
170403554|NCT04380701|615818808|FG016|Overall Study|Lost to Follow-up|0|||
170403555|NCT04380701|615818809|FG017|Overall Study|Lost to Follow-up|0|||
170403556|NCT04380701|615818810|FG018|Overall Study|Lost to Follow-up|0|||
170403557|NCT04380701|615818811|FG019|Overall Study|Lost to Follow-up|0|||
170403558|NCT04380701|615818812|FG020|Overall Study|Lost to Follow-up|1|||
170403559|NCT04380701|615818813|FG021|Overall Study|Lost to Follow-up|0|||
170403560|NCT04380701|615818814|FG022|Overall Study|Lost to Follow-up|0|||
170403561|NCT04380701|615818815|FG023|Overall Study|Lost to Follow-up|1|||
170403562|NCT04380701|615818816|FG024|Overall Study|Lost to Follow-up|0|||
170403563|NCT04380701|615818817|FG025|Overall Study|Lost to Follow-up|0|||
170403564|NCT04380701|615818818|FG026|Overall Study|Lost to Follow-up|0|||
170403565|NCT04380701|615818819|FG027|Overall Study|Lost to Follow-up|0|||
170403566|NCT04380701|615818820|FG028|Overall Study|Lost to Follow-up|0|||
170403567|NCT04380701|615818821|FG029|Overall Study|Lost to Follow-up|1|||
170403568|NCT04380701|615818822|FG030|Overall Study|Lost to Follow-up|0|||
170403569|NCT04380701|615818823|FG031|Overall Study|Lost to Follow-up|0|||
170865220|NCT05245097|617518056|FG001|Overall Study|Death|7|||
170865221|NCT05245097|617518055|FG000|Overall Study|Physician Decision|6|||
170865222|NCT05245097|617518056|FG001|Overall Study|Physician Decision|0|||
170865223|NCT05245097|617518055|FG000|Overall Study|Relocation|4|||
170865224|NCT05245097|617518056|FG001|Overall Study|Relocation|3|||
170865225|NCT04683731|617518059|FG000|Overall Study|Withdrawal by Subject|1|||
170865226|NCT04683731|617518060|FG001|Overall Study|Withdrawal by Subject|0|||
170865227|NCT04683731|617518061|FG002|Overall Study|Withdrawal by Subject|3|||
170865228|NCT04683731|617518062|FG003|Overall Study|Withdrawal by Subject|2|||
170865229|NCT04683731|617518059|FG000|Overall Study|Determined patient was not eligible|3|||
170865230|NCT04683731|617518060|FG001|Overall Study|Determined patient was not eligible|3|||
170865231|NCT04683731|617518061|FG002|Overall Study|Determined patient was not eligible|12|||
170865232|NCT04683731|617518062|FG003|Overall Study|Determined patient was not eligible|3|||
170865233|NCT00883051|617518063|FG000|Overall Study|Lost to Follow-up|0|||
170865234|NCT00883051|617518064|FG001|Overall Study|Lost to Follow-up|0|||
170865235|NCT00883051|617518065|FG002|Overall Study|Lost to Follow-up|0|||
170865236|NCT00883051|617518066|FG003|Overall Study|Lost to Follow-up|0|||
170865237|NCT00883051|617518067|FG004|Overall Study|Lost to Follow-up|1|||
170865238|NCT00883051|617518063|FG000|Overall Study|Did not use study medication|24|||
170865239|NCT00883051|617518064|FG001|Overall Study|Did not use study medication|22|||
170865240|NCT00883051|617518065|FG002|Overall Study|Did not use study medication|29|||
170865241|NCT00883051|617518066|FG003|Overall Study|Did not use study medication|29|||
170865242|NCT00883051|617518067|FG004|Overall Study|Did not use study medication|17|||
170865243|NCT02730598|617518070|FG000|Overall Study|Withdrawal by Subject|3|||
170865244|NCT02730598|617518071|FG001|Overall Study|Withdrawal by Subject|3|||
170865245|NCT02730598|617518070|FG000|Overall Study|Protocol Violation|0|||
170865246|NCT02730598|617518071|FG001|Overall Study|Protocol Violation|1|||
170865247|NCT02730598|617518070|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
170865248|NCT02730598|617518071|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
170865249|NCT00467285|617518072|FG000|Overall Study|Lost to Follow-up|4|||
170865250|NCT00467285|617518073|FG001|Overall Study|Lost to Follow-up|4|||
170865251|NCT01210118|617518076|FG000|Overall Study|Lost to Follow-up|1|||
170865252|NCT01210118|617518077|FG001|Overall Study|Lost to Follow-up|1|||
170865253|NCT01210118|617518076|FG000|Overall Study|Protocol Violation|1|||
170865254|NCT01210118|617518077|FG001|Overall Study|Protocol Violation|1|||
170865255|NCT01210118|617518076|FG000|Overall Study|Spontaneous abortion|1|||
170865256|NCT01210118|617518077|FG001|Overall Study|Spontaneous abortion|3|||
170865257|NCT01079130|617518078|FG000|Overall Study|Adverse Event|1|||
170865258|NCT01079130|617518079|FG001|Overall Study|Adverse Event|1|||
170865259|NCT01079130|617518080|FG002|Overall Study|Adverse Event|0|||
170865260|NCT01079130|617518081|FG003|Overall Study|Adverse Event|1|||
170865261|NCT01079130|617518082|FG004|Overall Study|Adverse Event|5|||
170865262|NCT01079130|617518083|FG005|Overall Study|Adverse Event|1|||
170865263|NCT01079130|617518078|FG000|Overall Study|Administrative problems|1|||
170865264|NCT01079130|617518079|FG001|Overall Study|Administrative problems|3|||
170865265|NCT01079130|617518080|FG002|Overall Study|Administrative problems|0|||
170865266|NCT01079130|617518081|FG003|Overall Study|Administrative problems|0|||
170865267|NCT01079130|617518082|FG004|Overall Study|Administrative problems|0|||
170865268|NCT01079130|617518083|FG005|Overall Study|Administrative problems|1|||
170865269|NCT01079130|617518078|FG000|Overall Study|Withdrawal by Subject|0|||
170865270|NCT01079130|617518079|FG001|Overall Study|Withdrawal by Subject|1|||
170865271|NCT01079130|617518080|FG002|Overall Study|Withdrawal by Subject|0|||
170865272|NCT01079130|617518081|FG003|Overall Study|Withdrawal by Subject|0|||
170865273|NCT01079130|617518082|FG004|Overall Study|Withdrawal by Subject|1|||
170865274|NCT01079130|617518083|FG005|Overall Study|Withdrawal by Subject|3|||
170865275|NCT01079130|617518078|FG000|Overall Study|Protocol deviation|0|||
170865276|NCT01079130|617518079|FG001|Overall Study|Protocol deviation|2|||
170865277|NCT01079130|617518080|FG002|Overall Study|Protocol deviation|1|||
170865278|NCT01079130|617518081|FG003|Overall Study|Protocol deviation|2|||
170865279|NCT01079130|617518082|FG004|Overall Study|Protocol deviation|0|||
170865280|NCT01079130|617518083|FG005|Overall Study|Protocol deviation|0|||
170865281|NCT01079130|617518078|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170865282|NCT01079130|617518079|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170865283|NCT01079130|617518080|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170865284|NCT01079130|617518081|FG003|Overall Study|Abnormal test procedure result(s)|0|||
170865285|NCT01079130|617518082|FG004|Overall Study|Abnormal test procedure result(s)|1|||
170865286|NCT01079130|617518083|FG005|Overall Study|Abnormal test procedure result(s)|0|||
170865287|NCT01079130|617518078|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170865288|NCT01079130|617518079|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170865289|NCT01079130|617518080|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170865290|NCT01079130|617518081|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
170865291|NCT01079130|617518082|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
170865292|NCT01079130|617518083|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
170865293|NCT01079130|617518078|FG000|Overall Study|Lost to Follow-up|0|||
170865294|NCT01079130|617518079|FG001|Overall Study|Lost to Follow-up|0|||
170865295|NCT01079130|617518080|FG002|Overall Study|Lost to Follow-up|0|||
170403570|NCT04380701|615818824|FG032|Overall Study|Lost to Follow-up|0|||
170403571|NCT04380701|615818825|FG033|Overall Study|Lost to Follow-up|1|||
170403572|NCT04380701|615818792|FG000|Overall Study|Private reason(s)|0|||
170403573|NCT04380701|615818793|FG001|Overall Study|Private reason(s)|0|||
170403574|NCT04380701|615818794|FG002|Overall Study|Private reason(s)|0|||
170403575|NCT04380701|615818795|FG003|Overall Study|Private reason(s)|0|||
170403576|NCT04380701|615818796|FG004|Overall Study|Private reason(s)|0|||
170403577|NCT04380701|615818797|FG005|Overall Study|Private reason(s)|0|||
170403578|NCT04380701|615818798|FG006|Overall Study|Private reason(s)|1|||
170403579|NCT04380701|615818799|FG007|Overall Study|Private reason(s)|0|||
170403580|NCT04380701|615818800|FG008|Overall Study|Private reason(s)|1|||
170403581|NCT04380701|615818801|FG009|Overall Study|Private reason(s)|1|||
170403582|NCT04380701|615818802|FG010|Overall Study|Private reason(s)|0|||
170403583|NCT04380701|615818803|FG011|Overall Study|Private reason(s)|0|||
170403584|NCT04380701|615818804|FG012|Overall Study|Private reason(s)|0|||
170403585|NCT04380701|615818805|FG013|Overall Study|Private reason(s)|0|||
170403586|NCT04380701|615818806|FG014|Overall Study|Private reason(s)|0|||
170403587|NCT04380701|615818807|FG015|Overall Study|Private reason(s)|0|||
170403588|NCT04380701|615818808|FG016|Overall Study|Private reason(s)|0|||
170403589|NCT04380701|615818809|FG017|Overall Study|Private reason(s)|0|||
170403590|NCT04380701|615818810|FG018|Overall Study|Private reason(s)|0|||
170403591|NCT04380701|615818811|FG019|Overall Study|Private reason(s)|0|||
170403592|NCT04380701|615818812|FG020|Overall Study|Private reason(s)|0|||
170403593|NCT04380701|615818813|FG021|Overall Study|Private reason(s)|0|||
170403594|NCT04380701|615818814|FG022|Overall Study|Private reason(s)|0|||
170403595|NCT04380701|615818815|FG023|Overall Study|Private reason(s)|1|||
170403596|NCT04380701|615818816|FG024|Overall Study|Private reason(s)|0|||
170403597|NCT04380701|615818817|FG025|Overall Study|Private reason(s)|0|||
170403598|NCT04380701|615818818|FG026|Overall Study|Private reason(s)|0|||
170403599|NCT04380701|615818819|FG027|Overall Study|Private reason(s)|0|||
170403600|NCT04380701|615818820|FG028|Overall Study|Private reason(s)|0|||
170403601|NCT04380701|615818821|FG029|Overall Study|Private reason(s)|1|||
170403602|NCT04380701|615818822|FG030|Overall Study|Private reason(s)|0|||
170403603|NCT04380701|615818823|FG031|Overall Study|Private reason(s)|0|||
170403604|NCT04380701|615818824|FG032|Overall Study|Private reason(s)|0|||
170403605|NCT04380701|615818825|FG033|Overall Study|Private reason(s)|0|||
170403606|NCT04380701|615818792|FG000|Overall Study|Withdrawal by Subject|0|||
170403607|NCT04380701|615818793|FG001|Overall Study|Withdrawal by Subject|0|||
170403608|NCT04380701|615818794|FG002|Overall Study|Withdrawal by Subject|0|||
170403609|NCT04380701|615818795|FG003|Overall Study|Withdrawal by Subject|0|||
170403610|NCT04380701|615818796|FG004|Overall Study|Withdrawal by Subject|0|||
170403611|NCT04380701|615818797|FG005|Overall Study|Withdrawal by Subject|0|||
170403612|NCT04380701|615818798|FG006|Overall Study|Withdrawal by Subject|1|||
170403613|NCT04380701|615818799|FG007|Overall Study|Withdrawal by Subject|1|||
170403614|NCT04380701|615818800|FG008|Overall Study|Withdrawal by Subject|0|||
170403615|NCT04380701|615818801|FG009|Overall Study|Withdrawal by Subject|0|||
170403616|NCT04380701|615818802|FG010|Overall Study|Withdrawal by Subject|0|||
170403617|NCT04380701|615818803|FG011|Overall Study|Withdrawal by Subject|1|||
170403618|NCT04380701|615818804|FG012|Overall Study|Withdrawal by Subject|0|||
170403619|NCT04380701|615818805|FG013|Overall Study|Withdrawal by Subject|1|||
170403620|NCT04380701|615818806|FG014|Overall Study|Withdrawal by Subject|0|||
170403621|NCT04380701|615818807|FG015|Overall Study|Withdrawal by Subject|0|||
170403622|NCT04380701|615818808|FG016|Overall Study|Withdrawal by Subject|1|||
170403623|NCT04380701|615818809|FG017|Overall Study|Withdrawal by Subject|0|||
170403624|NCT04380701|615818810|FG018|Overall Study|Withdrawal by Subject|0|||
170403625|NCT04380701|615818811|FG019|Overall Study|Withdrawal by Subject|0|||
170403626|NCT04380701|615818812|FG020|Overall Study|Withdrawal by Subject|0|||
170403627|NCT04380701|615818813|FG021|Overall Study|Withdrawal by Subject|0|||
170403628|NCT04380701|615818814|FG022|Overall Study|Withdrawal by Subject|2|||
170403629|NCT04380701|615818815|FG023|Overall Study|Withdrawal by Subject|2|||
170403630|NCT04380701|615818816|FG024|Overall Study|Withdrawal by Subject|1|||
170403631|NCT04380701|615818817|FG025|Overall Study|Withdrawal by Subject|1|||
170403632|NCT04380701|615818818|FG026|Overall Study|Withdrawal by Subject|0|||
170403633|NCT04380701|615818819|FG027|Overall Study|Withdrawal by Subject|0|||
170403634|NCT04380701|615818820|FG028|Overall Study|Withdrawal by Subject|0|||
170403635|NCT04380701|615818821|FG029|Overall Study|Withdrawal by Subject|0|||
170403636|NCT04380701|615818822|FG030|Overall Study|Withdrawal by Subject|0|||
170403637|NCT04380701|615818823|FG031|Overall Study|Withdrawal by Subject|0|||
170403638|NCT04380701|615818824|FG032|Overall Study|Withdrawal by Subject|0|||
170403639|NCT04380701|615818825|FG033|Overall Study|Withdrawal by Subject|0|||
170403640|NCT04380701|615818792|FG000|Overall Study|Adverse Event|0|||
170403641|NCT04380701|615818793|FG001|Overall Study|Adverse Event|0|||
170403642|NCT04380701|615818794|FG002|Overall Study|Adverse Event|0|||
170403643|NCT04380701|615818795|FG003|Overall Study|Adverse Event|0|||
170403644|NCT04380701|615818796|FG004|Overall Study|Adverse Event|0|||
170403645|NCT04380701|615818797|FG005|Overall Study|Adverse Event|1|||
170403646|NCT04380701|615818798|FG006|Overall Study|Adverse Event|0|||
170403647|NCT04380701|615818799|FG007|Overall Study|Adverse Event|0|||
170865296|NCT01079130|617518081|FG003|Overall Study|Lost to Follow-up|0|||
170865297|NCT01079130|617518082|FG004|Overall Study|Lost to Follow-up|1|||
170865298|NCT01079130|617518083|FG005|Overall Study|Lost to Follow-up|0|||
170865299|NCT01853982|617518084|FG000|Overall Study|Withdrawal by Subject|1|||
170865300|NCT01853982|617518085|FG001|Overall Study|Withdrawal by Subject|0|||
170865301|NCT01853982|617518084|FG000|Overall Study|Death|1|||
170865302|NCT01853982|617518085|FG001|Overall Study|Death|0|||
170865303|NCT01853982|617518084|FG000|Overall Study|Lost to Follow-up|0|||
170865304|NCT01853982|617518085|FG001|Overall Study|Lost to Follow-up|1|||
170865305|NCT00390910|617518086|FG000|Overall Study|Adverse Event|1|||
170865306|NCT00390910|617518087|FG001|Overall Study|Adverse Event|0|||
170865307|NCT00390910|617518088|FG002|Overall Study|Adverse Event|0|||
170865308|NCT00390910|617518086|FG000|Overall Study|Lost to Follow-up|0|||
170865309|NCT00390910|617518087|FG001|Overall Study|Lost to Follow-up|1|||
170865310|NCT00390910|617518088|FG002|Overall Study|Lost to Follow-up|5|||
170865311|NCT00390910|617518086|FG000|Overall Study|Withdrawal by Subject|1|||
170865312|NCT00390910|617518087|FG001|Overall Study|Withdrawal by Subject|3|||
170865313|NCT00390910|617518088|FG002|Overall Study|Withdrawal by Subject|2|||
170865314|NCT00390910|617518086|FG000|Overall Study|Migrated/moved from study area|0|||
170865315|NCT00390910|617518087|FG001|Overall Study|Migrated/moved from study area|0|||
170865316|NCT00390910|617518088|FG002|Overall Study|Migrated/moved from study area|3|||
170865317|NCT05066724|617518092|FG000|Overall Study|Adverse Event|1|||
170865318|NCT05066724|617518092|FG000|Overall Study|Non-Compliance With Study Drug|5|||
170865319|NCT05066724|617518092|FG000|Overall Study|Withdrawal by Subject|6|||
170865320|NCT05066724|617518092|FG000|Overall Study|Physician Decision|2|||
170865321|NCT00475033|617518095|FG000|Infant Series|Failed to return|3|||
170865322|NCT00475033|617518096|FG001|Infant Series|Failed to return|4|||
170865323|NCT00475033|617518095|FG000|Infant Series|Parent or legal guardian request|1|||
170865324|NCT00475033|617518096|FG001|Infant Series|Parent or legal guardian request|5|||
170865325|NCT00475033|617518095|FG000|Infant Series|Protocol Violation|1|||
170865326|NCT00475033|617518096|FG001|Infant Series|Protocol Violation|2|||
170865327|NCT00475033|617518095|FG000|Infant Series|Lost to Follow-up|2|||
170865328|NCT00475033|617518096|FG001|Infant Series|Lost to Follow-up|0|||
170865329|NCT00475033|617518095|FG000|Infant Series|Adverse Event|0|||
170865330|NCT00475033|617518096|FG001|Infant Series|Adverse Event|2|||
170865331|NCT00475033|617518095|FG000|After the Infant Series|Adverse Event|0|||
170865332|NCT00475033|617518096|FG001|After the Infant Series|Adverse Event|4|||
170865333|NCT00475033|617518095|FG000|After the Infant Series|Parent or legal guardian request|2|||
170865334|NCT00475033|617518096|FG001|After the Infant Series|Parent or legal guardian request|2|||
170865335|NCT00475033|617518095|FG000|After the Infant Series|Failed to return|2|||
170865336|NCT00475033|617518096|FG001|After the Infant Series|Failed to return|1|||
170865337|NCT00475033|617518095|FG000|After the Infant Series|Protocol Violation|1|||
170865338|NCT00475033|617518096|FG001|After the Infant Series|Protocol Violation|0|||
170865339|NCT00475033|617518095|FG000|After the Infant Series|Lost to Follow-up|1|||
170865340|NCT00475033|617518096|FG001|After the Infant Series|Lost to Follow-up|0|||
170865341|NCT00475033|617518095|FG000|After the Infant Series|Other|0|||
170865342|NCT00475033|617518096|FG001|After the Infant Series|Other|1|||
170865343|NCT00475033|617518095|FG000|Toddler Dose|Parent or legal guardian request|2|||
170865344|NCT00475033|617518096|FG001|Toddler Dose|Parent or legal guardian request|0|||
170865345|NCT00475033|617518095|FG000|Toddler Dose|Failed to return|1|||
170865346|NCT00475033|617518096|FG001|Toddler Dose|Failed to return|0|||
170865347|NCT00475033|617518095|FG000|Toddler Dose|Lost to Follow-up|1|||
170865348|NCT00475033|617518096|FG001|Toddler Dose|Lost to Follow-up|0|||
170865349|NCT01696942|617518101|FG000|Overall Study|Withdrawal by Subject|1|||
170865350|NCT01696942|617518102|FG001|Overall Study|Withdrawal by Subject|0|||
170865351|NCT01696942|617518101|FG000|Overall Study|Protocol Violation|1|||
170865352|NCT01696942|617518102|FG001|Overall Study|Protocol Violation|2|||
170865353|NCT01696942|617518101|FG000|Overall Study|screen failure|0|||
170865354|NCT01696942|617518102|FG001|Overall Study|screen failure|1|||
170865355|NCT01422850|617518103|FG000|Overall Study|Physician Decision|3|||
170865356|NCT04484831|617518104|FG000|Overall Study|Withdrawal by Subject|1|||
170865357|NCT04484831|617518105|FG001|Overall Study|Withdrawal by Subject|0|||
170865358|NCT00174265|617518108|FG000|Overall Study|Adverse Event|7|||
170865359|NCT00174265|617518109|FG001|Overall Study|Adverse Event|4|||
170865360|NCT00174265|617518108|FG000|Overall Study|Lack of Efficacy|2|||
170865361|NCT00174265|617518109|FG001|Overall Study|Lack of Efficacy|2|||
170865362|NCT00174265|617518108|FG000|Overall Study|Withdrawal by Subject|3|||
170865363|NCT00174265|617518109|FG001|Overall Study|Withdrawal by Subject|5|||
170865364|NCT00174265|617518108|FG000|Overall Study|Lost to Follow-up|1|||
170865365|NCT00174265|617518109|FG001|Overall Study|Lost to Follow-up|0|||
170865366|NCT00174265|617518108|FG000|Overall Study|Other (Not specified)|16|||
170865367|NCT00174265|617518109|FG001|Overall Study|Other (Not specified)|10|||
170865368|NCT03231943|617518110|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865369|NCT03231943|617518111|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
170865370|NCT03231943|617518112|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
170865371|NCT03231943|617518113|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865372|NCT03231943|617518114|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865373|NCT03231943|617518115|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865374|NCT03231943|617518116|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865375|NCT03231943|617518117|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865376|NCT03231943|617518118|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865377|NCT03231943|617518119|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865378|NCT03231943|617518120|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865379|NCT03231943|617518121|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865380|NCT03231943|617518122|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
170865381|NCT03231943|617518110|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865382|NCT03231943|617518111|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
170865383|NCT03231943|617518112|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865384|NCT03231943|617518113|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865385|NCT03231943|617518114|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170755956|NCT04955626|617111020|FG014|Open-Label Period|Withdrawal by Subject|0|||
170755957|NCT04955626|617111021|FG015|Open-Label Period|Withdrawal by Subject|0|||
170755958|NCT04955626|617111022|FG016|Open-Label Period|Withdrawal by Subject|0|||
170755959|NCT04955626|617111023|FG017|Open-Label Period|Withdrawal by Subject|0|||
170755960|NCT04955626|617111024|FG018|Open-Label Period|Withdrawal by Subject|0|||
170755961|NCT04955626|617111025|FG019|Open-Label Period|Withdrawal by Subject|0|||
170755962|NCT04955626|617111026|FG020|Open-Label Period|Withdrawal by Subject|0|||
170755963|NCT04955626|617111027|FG021|Open-Label Period|Withdrawal by Subject|0|||
170755964|NCT04955626|617111028|FG022|Open-Label Period|Withdrawal by Subject|0|||
170755965|NCT04955626|617111029|FG023|Open-Label Period|Withdrawal by Subject|0|||
170755966|NCT04955626|617111030|FG024|Open-Label Period|Withdrawal by Subject|0|||
170755967|NCT04955626|617111031|FG025|Open-Label Period|Withdrawal by Subject|0|||
170755968|NCT04955626|617111032|FG026|Open-Label Period|Withdrawal by Subject|0|||
170755969|NCT04955626|617111033|FG027|Open-Label Period|Withdrawal by Subject|0|||
170755970|NCT04955626|617111034|FG028|Open-Label Period|Withdrawal by Subject|0|||
170755971|NCT04955626|617111035|FG029|Open-Label Period|Withdrawal by Subject|0|||
170755972|NCT04955626|617111036|FG030|Open-Label Period|Withdrawal by Subject|0|||
170755973|NCT04955626|617111037|FG031|Open-Label Period|Withdrawal by Subject|0|||
170755974|NCT04955626|617111038|FG032|Open-Label Period|Withdrawal by Subject|0|||
170755975|NCT04955626|617111039|FG033|Open-Label Period|Withdrawal by Subject|0|||
170755976|NCT04955626|617111040|FG034|Open-Label Period|Withdrawal by Subject|0|||
170755977|NCT04955626|617111041|FG035|Open-Label Period|Withdrawal by Subject|0|||
170755978|NCT04955626|617111006|FG000|Open-Label Period|Refused further study procedures|1|||
170755979|NCT04955626|617111007|FG001|Open-Label Period|Refused further study procedures|0|||
170755980|NCT04955626|617111008|FG002|Open-Label Period|Refused further study procedures|0|||
170755981|NCT04955626|617111009|FG003|Open-Label Period|Refused further study procedures|0|||
170755982|NCT04955626|617111010|FG004|Open-Label Period|Refused further study procedures|0|||
170755983|NCT04955626|617111011|FG005|Open-Label Period|Refused further study procedures|0|||
170755984|NCT04955626|617111012|FG006|Open-Label Period|Refused further study procedures|0|||
170755985|NCT04955626|617111013|FG007|Open-Label Period|Refused further study procedures|0|||
170755986|NCT04955626|617111014|FG008|Open-Label Period|Refused further study procedures|0|||
170755987|NCT04955626|617111015|FG009|Open-Label Period|Refused further study procedures|0|||
170755988|NCT04955626|617111016|FG010|Open-Label Period|Refused further study procedures|0|||
170755989|NCT04955626|617111017|FG011|Open-Label Period|Refused further study procedures|0|||
170755990|NCT04955626|617111018|FG012|Open-Label Period|Refused further study procedures|0|||
170755991|NCT04955626|617111019|FG013|Open-Label Period|Refused further study procedures|0|||
170755992|NCT04955626|617111020|FG014|Open-Label Period|Refused further study procedures|0|||
170755993|NCT04955626|617111021|FG015|Open-Label Period|Refused further study procedures|0|||
170755994|NCT04955626|617111022|FG016|Open-Label Period|Refused further study procedures|0|||
170755995|NCT04955626|617111023|FG017|Open-Label Period|Refused further study procedures|0|||
170755996|NCT04955626|617111024|FG018|Open-Label Period|Refused further study procedures|0|||
170755997|NCT04955626|617111025|FG019|Open-Label Period|Refused further study procedures|0|||
170755998|NCT04955626|617111026|FG020|Open-Label Period|Refused further study procedures|0|||
170755999|NCT04955626|617111027|FG021|Open-Label Period|Refused further study procedures|0|||
170756000|NCT04955626|617111028|FG022|Open-Label Period|Refused further study procedures|0|||
170756001|NCT04955626|617111029|FG023|Open-Label Period|Refused further study procedures|0|||
170756002|NCT04955626|617111030|FG024|Open-Label Period|Refused further study procedures|0|||
170756003|NCT04955626|617111031|FG025|Open-Label Period|Refused further study procedures|0|||
170756004|NCT04955626|617111032|FG026|Open-Label Period|Refused further study procedures|0|||
170756005|NCT04955626|617111033|FG027|Open-Label Period|Refused further study procedures|0|||
170756006|NCT04955626|617111034|FG028|Open-Label Period|Refused further study procedures|0|||
170756007|NCT04955626|617111035|FG029|Open-Label Period|Refused further study procedures|0|||
170756008|NCT04955626|617111036|FG030|Open-Label Period|Refused further study procedures|0|||
170865386|NCT03231943|617518115|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170403648|NCT04380701|615818800|FG008|Overall Study|Adverse Event|0|||
170403649|NCT04380701|615818801|FG009|Overall Study|Adverse Event|0|||
170403650|NCT04380701|615818802|FG010|Overall Study|Adverse Event|0|||
170403651|NCT04380701|615818803|FG011|Overall Study|Adverse Event|0|||
170403652|NCT04380701|615818804|FG012|Overall Study|Adverse Event|0|||
170403653|NCT04380701|615818805|FG013|Overall Study|Adverse Event|0|||
170403654|NCT04380701|615818806|FG014|Overall Study|Adverse Event|0|||
170403655|NCT04380701|615818807|FG015|Overall Study|Adverse Event|1|||
170403656|NCT04380701|615818808|FG016|Overall Study|Adverse Event|0|||
170403657|NCT04380701|615818809|FG017|Overall Study|Adverse Event|0|||
170403658|NCT04380701|615818810|FG018|Overall Study|Adverse Event|0|||
170403659|NCT04380701|615818811|FG019|Overall Study|Adverse Event|1|||
170403660|NCT04380701|615818812|FG020|Overall Study|Adverse Event|0|||
170403661|NCT04380701|615818813|FG021|Overall Study|Adverse Event|0|||
170403662|NCT04380701|615818814|FG022|Overall Study|Adverse Event|0|||
170403663|NCT04380701|615818815|FG023|Overall Study|Adverse Event|0|||
170403664|NCT04380701|615818816|FG024|Overall Study|Adverse Event|0|||
170403665|NCT04380701|615818817|FG025|Overall Study|Adverse Event|0|||
170403666|NCT04380701|615818818|FG026|Overall Study|Adverse Event|0|||
170403667|NCT04380701|615818819|FG027|Overall Study|Adverse Event|0|||
170403668|NCT04380701|615818820|FG028|Overall Study|Adverse Event|0|||
170403669|NCT04380701|615818821|FG029|Overall Study|Adverse Event|0|||
170403670|NCT04380701|615818822|FG030|Overall Study|Adverse Event|0|||
170403671|NCT04380701|615818823|FG031|Overall Study|Adverse Event|0|||
170403672|NCT04380701|615818824|FG032|Overall Study|Adverse Event|0|||
170403673|NCT04380701|615818825|FG033|Overall Study|Adverse Event|0|||
170403674|NCT04380701|615818792|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
170403675|NCT04380701|615818793|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
170403676|NCT04380701|615818794|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
170403677|NCT04380701|615818795|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
170403678|NCT04380701|615818796|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
170403679|NCT04380701|615818797|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
170403680|NCT04380701|615818798|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
170403681|NCT04380701|615818799|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
170403682|NCT04380701|615818800|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
170403683|NCT04380701|615818801|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
170403684|NCT04380701|615818802|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
170403685|NCT04380701|615818803|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
170403686|NCT04380701|615818804|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
170403687|NCT04380701|615818805|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
170403688|NCT04380701|615818806|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
170403689|NCT04380701|615818807|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
170403690|NCT04380701|615818808|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
170403691|NCT04380701|615818809|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
170403692|NCT04380701|615818810|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
170403693|NCT04380701|615818811|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
170403694|NCT04380701|615818812|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
170403695|NCT04380701|615818813|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
170403696|NCT04380701|615818814|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
170403697|NCT04380701|615818815|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
170403698|NCT04380701|615818816|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
170403699|NCT04380701|615818817|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
170403700|NCT04380701|615818818|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
170403701|NCT04380701|615818819|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
170403702|NCT04380701|615818820|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
170403703|NCT04380701|615818821|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
170403704|NCT04380701|615818822|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
170403705|NCT04380701|615818823|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
170403706|NCT04380701|615818824|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
170403707|NCT04380701|615818825|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
170403708|NCT04380701|615818792|FG000|Overall Study|Physician Decision|0|||
170403709|NCT04380701|615818793|FG001|Overall Study|Physician Decision|0|||
170403710|NCT04380701|615818794|FG002|Overall Study|Physician Decision|0|||
170403711|NCT04380701|615818795|FG003|Overall Study|Physician Decision|0|||
170756009|NCT04955626|617111037|FG031|Open-Label Period|Refused further study procedures|0|||
170403712|NCT04380701|615818796|FG004|Overall Study|Physician Decision|0|||
170403713|NCT04380701|615818797|FG005|Overall Study|Physician Decision|0|||
170403714|NCT04380701|615818798|FG006|Overall Study|Physician Decision|0|||
170403715|NCT04380701|615818799|FG007|Overall Study|Physician Decision|0|||
170403716|NCT04380701|615818800|FG008|Overall Study|Physician Decision|0|||
170403717|NCT04380701|615818801|FG009|Overall Study|Physician Decision|0|||
170403718|NCT04380701|615818802|FG010|Overall Study|Physician Decision|0|||
170403719|NCT04380701|615818803|FG011|Overall Study|Physician Decision|0|||
170403720|NCT04380701|615818804|FG012|Overall Study|Physician Decision|0|||
170403721|NCT04380701|615818805|FG013|Overall Study|Physician Decision|0|||
170403722|NCT04380701|615818806|FG014|Overall Study|Physician Decision|0|||
170865387|NCT03231943|617518116|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865388|NCT03231943|617518117|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865389|NCT03231943|617518118|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865390|NCT03231943|617518119|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865391|NCT03231943|617518120|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865392|NCT03231943|617518121|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865393|NCT03231943|617518122|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
170865394|NCT03231943|617518110|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
170865395|NCT03231943|617518111|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865396|NCT03231943|617518112|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865397|NCT03231943|617518113|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865398|NCT03231943|617518114|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865399|NCT03231943|617518115|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865400|NCT03231943|617518116|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865401|NCT03231943|617518117|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865402|NCT03231943|617518118|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865403|NCT03231943|617518119|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865404|NCT03231943|617518120|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865405|NCT03231943|617518121|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865406|NCT03231943|617518122|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
170865407|NCT03231943|617518110|FG000|Part 2|Adverse Event|0|||
170865408|NCT03231943|617518111|FG001|Part 2|Adverse Event|0|||
170865409|NCT03231943|617518112|FG002|Part 2|Adverse Event|0|||
170865410|NCT03231943|617518113|FG003|Part 2|Adverse Event|0|||
170865411|NCT03231943|617518114|FG004|Part 2|Adverse Event|0|||
170865412|NCT03231943|617518115|FG005|Part 2|Adverse Event|0|||
170865413|NCT03231943|617518116|FG006|Part 2|Adverse Event|0|||
170865414|NCT03231943|617518117|FG007|Part 2|Adverse Event|0|||
170865415|NCT03231943|617518118|FG008|Part 2|Adverse Event|0|||
170865416|NCT03231943|617518119|FG009|Part 2|Adverse Event|0|||
170865417|NCT03231943|617518120|FG010|Part 2|Adverse Event|1|||
170865418|NCT03231943|617518121|FG011|Part 2|Adverse Event|0|||
170865419|NCT03231943|617518122|FG012|Part 2|Adverse Event|0|||
170865420|NCT03231943|617518110|FG000|Part 2|Withdrawal by Subject|0|||
170865421|NCT03231943|617518111|FG001|Part 2|Withdrawal by Subject|0|||
170865422|NCT03231943|617518112|FG002|Part 2|Withdrawal by Subject|0|||
170865423|NCT03231943|617518113|FG003|Part 2|Withdrawal by Subject|0|||
170865424|NCT03231943|617518114|FG004|Part 2|Withdrawal by Subject|0|||
170865425|NCT03231943|617518115|FG005|Part 2|Withdrawal by Subject|0|||
170865426|NCT03231943|617518116|FG006|Part 2|Withdrawal by Subject|0|||
170865427|NCT03231943|617518117|FG007|Part 2|Withdrawal by Subject|0|||
170865428|NCT03231943|617518118|FG008|Part 2|Withdrawal by Subject|0|||
170865429|NCT03231943|617518119|FG009|Part 2|Withdrawal by Subject|0|||
170865430|NCT03231943|617518120|FG010|Part 2|Withdrawal by Subject|0|||
170865431|NCT03231943|617518121|FG011|Part 2|Withdrawal by Subject|1|||
170865432|NCT03231943|617518122|FG012|Part 2|Withdrawal by Subject|0|||
170865433|NCT01572922|617518123|FG000|Overall Study|Adverse Event|1|||
170865434|NCT01572922|617518123|FG000|Overall Study|Protocol Violation|1|||
170865435|NCT01572922|617518123|FG000|Overall Study|Death|1|||
170865436|NCT01335009|617518124|FG000|Overall Study|Too ill to travel to study sites|1|||
170865437|NCT01335009|617518125|FG001|Overall Study|Too ill to travel to study sites|0|||
170865438|NCT01335009|617518124|FG000|Overall Study|Death|28|||
170865439|NCT01335009|617518125|FG001|Overall Study|Death|32|||
170865440|NCT01335009|617518124|FG000|Overall Study|Withdrawal by Subject|1|||
170865441|NCT01335009|617518125|FG001|Overall Study|Withdrawal by Subject|1|||
170865442|NCT01335009|617518124|FG000|Overall Study|Lost to Follow-up|1|||
170865443|NCT01335009|617518125|FG001|Overall Study|Lost to Follow-up|0|||
170865444|NCT04824521|617518126|FG000|Overall Study|Lost to Follow-up|1|||
170865445|NCT03335163|617519861|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
170865446|NCT03335163|617519861|FG000|Overall Study|Withdrawal by Subject|18|||
170865447|NCT01215175|617519864|FG000|Overall Study|Lost to Follow-up|0|||
170865448|NCT01215175|617519865|FG001|Overall Study|Lost to Follow-up|1|||
170865449|NCT01215175|617519866|FG002|Overall Study|Lost to Follow-up|0|||
170865450|NCT01215175|617519867|FG003|Overall Study|Lost to Follow-up|1|||
170865451|NCT01215175|617519868|FG004|Overall Study|Lost to Follow-up|0|||
170865452|NCT01016964|617519869|FG000|Overall Study|Lost to Follow-up|3|||
170865453|NCT01016964|617519870|FG001|Overall Study|Lost to Follow-up|3|||
170865454|NCT00352885|617519871|FG000|Overall Study|Withdrawal by Subject|0|||
170865455|NCT00352885|617519872|FG001|Overall Study|Withdrawal by Subject|3|||
170865456|NCT00352885|617519871|FG000|Overall Study|Development of major depression|0|||
170865457|NCT00352885|617519872|FG001|Overall Study|Development of major depression|1|||
170865458|NCT00352885|617519871|FG000|Overall Study|Progression of metastatic melanoma|5|||
170865459|NCT00352885|617519872|FG001|Overall Study|Progression of metastatic melanoma|3|||
170865460|NCT00352885|617519871|FG000|Overall Study|Side effects of IL-2 administration|1|||
170865461|NCT00352885|617519872|FG001|Overall Study|Side effects of IL-2 administration|0|||
170865462|NCT01920594|617519873|FG000|Overall Study|Adverse Event|4|||
170865463|NCT01920594|617519874|FG001|Overall Study|Adverse Event|2|||
170403723|NCT04380701|615818807|FG015|Overall Study|Physician Decision|0|||
170403724|NCT04380701|615818808|FG016|Overall Study|Physician Decision|0|||
170403725|NCT04380701|615818809|FG017|Overall Study|Physician Decision|0|||
170403726|NCT04380701|615818810|FG018|Overall Study|Physician Decision|0|||
170403727|NCT04380701|615818811|FG019|Overall Study|Physician Decision|0|||
170403728|NCT04380701|615818812|FG020|Overall Study|Physician Decision|0|||
170403729|NCT04380701|615818813|FG021|Overall Study|Physician Decision|0|||
170403730|NCT04380701|615818814|FG022|Overall Study|Physician Decision|0|||
170403731|NCT04380701|615818815|FG023|Overall Study|Physician Decision|0|||
170403732|NCT04380701|615818816|FG024|Overall Study|Physician Decision|2|||
170403733|NCT04380701|615818817|FG025|Overall Study|Physician Decision|0|||
170403734|NCT04380701|615818818|FG026|Overall Study|Physician Decision|0|||
170403735|NCT04380701|615818819|FG027|Overall Study|Physician Decision|0|||
170403736|NCT04380701|615818820|FG028|Overall Study|Physician Decision|0|||
170403737|NCT04380701|615818821|FG029|Overall Study|Physician Decision|0|||
170403738|NCT04380701|615818822|FG030|Overall Study|Physician Decision|0|||
170403739|NCT04380701|615818823|FG031|Overall Study|Physician Decision|0|||
170403740|NCT04380701|615818824|FG032|Overall Study|Physician Decision|0|||
170403741|NCT04380701|615818825|FG033|Overall Study|Physician Decision|0|||
170403742|NCT04380701|615818792|FG000|Overall Study|Death|0|||
170403743|NCT04380701|615818793|FG001|Overall Study|Death|0|||
170403744|NCT04380701|615818794|FG002|Overall Study|Death|0|||
170403745|NCT04380701|615818795|FG003|Overall Study|Death|0|||
170403746|NCT04380701|615818796|FG004|Overall Study|Death|0|||
170403747|NCT04380701|615818797|FG005|Overall Study|Death|0|||
170403748|NCT04380701|615818798|FG006|Overall Study|Death|0|||
170403749|NCT04380701|615818799|FG007|Overall Study|Death|0|||
170403750|NCT04380701|615818800|FG008|Overall Study|Death|0|||
170403751|NCT04380701|615818801|FG009|Overall Study|Death|0|||
170403752|NCT04380701|615818802|FG010|Overall Study|Death|0|||
170403753|NCT04380701|615818803|FG011|Overall Study|Death|0|||
170403754|NCT04380701|615818804|FG012|Overall Study|Death|0|||
170403755|NCT04380701|615818805|FG013|Overall Study|Death|0|||
170403756|NCT04380701|615818806|FG014|Overall Study|Death|0|||
170403757|NCT04380701|615818807|FG015|Overall Study|Death|0|||
170403758|NCT04380701|615818808|FG016|Overall Study|Death|0|||
170403759|NCT04380701|615818809|FG017|Overall Study|Death|0|||
170403760|NCT04380701|615818810|FG018|Overall Study|Death|0|||
170403761|NCT04380701|615818811|FG019|Overall Study|Death|0|||
170403762|NCT04380701|615818812|FG020|Overall Study|Death|0|||
170403763|NCT04380701|615818813|FG021|Overall Study|Death|0|||
170403764|NCT04380701|615818814|FG022|Overall Study|Death|0|||
170403765|NCT04380701|615818815|FG023|Overall Study|Death|0|||
170403766|NCT04380701|615818816|FG024|Overall Study|Death|1|||
170403767|NCT04380701|615818817|FG025|Overall Study|Death|0|||
170403768|NCT04380701|615818818|FG026|Overall Study|Death|0|||
170403769|NCT04380701|615818819|FG027|Overall Study|Death|0|||
170403770|NCT04380701|615818820|FG028|Overall Study|Death|0|||
170403771|NCT04380701|615818821|FG029|Overall Study|Death|0|||
170403772|NCT04380701|615818822|FG030|Overall Study|Death|0|||
170403773|NCT04380701|615818823|FG031|Overall Study|Death|0|||
170403774|NCT04380701|615818824|FG032|Overall Study|Death|0|||
170403775|NCT04380701|615818825|FG033|Overall Study|Death|0|||
170403776|NCT04380701|615818792|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403777|NCT04380701|615818793|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403778|NCT04380701|615818794|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403779|NCT04380701|615818795|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403780|NCT04380701|615818796|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403781|NCT04380701|615818797|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403782|NCT04380701|615818798|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403783|NCT04380701|615818799|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403784|NCT04380701|615818800|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403785|NCT04380701|615818801|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403786|NCT04380701|615818802|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403787|NCT04380701|615818803|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403788|NCT04380701|615818804|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403789|NCT04380701|615818805|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403790|NCT04380701|615818806|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403791|NCT04380701|615818807|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170756010|NCT04955626|617111038|FG032|Open-Label Period|Refused further study procedures|0|||
170865464|NCT01920594|617519873|FG000|Overall Study|Lost to Follow-up|1|||
170403792|NCT04380701|615818808|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403793|NCT04380701|615818809|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403794|NCT04380701|615818810|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403795|NCT04380701|615818811|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403796|NCT04380701|615818812|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403797|NCT04380701|615818813|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
170865465|NCT01920594|617519874|FG001|Overall Study|Lost to Follow-up|0|||
170865466|NCT01920594|617519873|FG000|Overall Study|Recovery|2|||
170865467|NCT01920594|617519874|FG001|Overall Study|Recovery|0|||
170865468|NCT01920594|617519873|FG000|Overall Study|Investigator discretion|0|||
170865469|NCT01920594|617519874|FG001|Overall Study|Investigator discretion|1|||
170865470|NCT01678209|617519875|FG000|Overall Study|could not scan twice|1|||
170865471|NCT01678209|617519876|FG001|Overall Study|could not scan twice|1|||
170865472|NCT01678209|617519877|FG002|Overall Study|could not scan twice|1|||
170865473|NCT01678209|617519875|FG000|Overall Study|scheduling conflicts|0|||
170865474|NCT01678209|617519876|FG001|Overall Study|scheduling conflicts|0|||
170865475|NCT01678209|617519877|FG002|Overall Study|scheduling conflicts|1|||
170865476|NCT01678209|617519875|FG000|Overall Study|screen fail|16|||
170865477|NCT01678209|617519876|FG001|Overall Study|screen fail|17|||
170865478|NCT01678209|617519877|FG002|Overall Study|screen fail|16|||
170865479|NCT03756350|617519882|FG000|Overall Study|Lost to Follow-up|1|||
170865480|NCT00440700|617519885|FG000|Overall Study|Withdrawal by Subject|8|||
170865481|NCT00440700|617519886|FG001|Overall Study|Withdrawal by Subject|8|||
170865482|NCT00440700|617519887|FG002|Overall Study|Withdrawal by Subject|4|||
170865483|NCT04906616|617519888|FG000|Overall Study|Divorce|3|||
170865484|NCT04906616|617519889|FG001|Overall Study|Divorce|2|||
170865485|NCT02194062|617519891|FG000|Overall Study|Lost to Follow-up|2|||
170865486|NCT02194062|617519892|FG001|Overall Study|Lost to Follow-up|2|||
170865487|NCT02194062|617519893|FG002|Overall Study|Lost to Follow-up|5|||
170865488|NCT00293722|617519902|FG000|Overall Study|Other|427|||
170865489|NCT02634346|617519907|FG000|Overall Study|Withdrawal by Subject|8|||
170865490|NCT02634346|617519908|FG001|Overall Study|Withdrawal by Subject|9|||
170865491|NCT02634346|617519909|FG002|Overall Study|Withdrawal by Subject|8|||
170865492|NCT02634346|617519907|FG000|Overall Study|Adverse Event|2|||
170865493|NCT02634346|617519908|FG001|Overall Study|Adverse Event|2|||
170865494|NCT02634346|617519909|FG002|Overall Study|Adverse Event|7|||
170865495|NCT02634346|617519907|FG000|Overall Study|Lack of Efficacy|1|||
170865496|NCT02634346|617519908|FG001|Overall Study|Lack of Efficacy|2|||
170865497|NCT02634346|617519909|FG002|Overall Study|Lack of Efficacy|8|||
170865498|NCT02634346|617519907|FG000|Overall Study|Lost to Follow-up|1|||
170865499|NCT02634346|617519908|FG001|Overall Study|Lost to Follow-up|0|||
170865500|NCT02634346|617519909|FG002|Overall Study|Lost to Follow-up|0|||
170865501|NCT02634346|617519907|FG000|Overall Study|Protocol Violation|0|||
170403798|NCT04380701|615818814|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
170865502|NCT02634346|617519908|FG001|Overall Study|Protocol Violation|1|||
170865503|NCT02634346|617519909|FG002|Overall Study|Protocol Violation|0|||
170865504|NCT02170389|617519910|FG000|Overall Study|Study terminated prior to start of treat|1|||
170865505|NCT01008696|617519912|FG000|Overall Study|Participant's evasion of hospital visit|5|||
170865506|NCT01008696|617519913|FG001|Overall Study|Participant's evasion of hospital visit|4|||
170865507|NCT01008696|617519912|FG000|Overall Study|Withdrawal by Subject|2|||
170865508|NCT01008696|617519913|FG001|Overall Study|Withdrawal by Subject|4|||
170865509|NCT01008696|617519912|FG000|Overall Study|Physician Decision|5|||
170865510|NCT01008696|617519913|FG001|Overall Study|Physician Decision|1|||
170865511|NCT01008696|617519912|FG000|Overall Study|Adverse Event|1|||
170865512|NCT01008696|617519913|FG001|Overall Study|Adverse Event|0|||
170865513|NCT01008696|617519912|FG000|Overall Study|Participants' non-cooperation|2|||
170865514|NCT01008696|617519913|FG001|Overall Study|Participants' non-cooperation|3|||
170865515|NCT01008696|617519912|FG000|Overall Study|Other|2|||
170865516|NCT01008696|617519913|FG001|Overall Study|Other|3|||
170865517|NCT01008696|617519912|FG000|Overall Study|Other|0|||
170865518|NCT01008696|617519913|FG001|Overall Study|Other|2|||
170865519|NCT01754857|617519914|FG000|Overall Study|Adverse Event|7|||
170865520|NCT01754857|617519914|FG000|Overall Study|Disease progression|3|||
170865521|NCT01754857|617519914|FG000|Overall Study|Physician Decision|2|||
170865522|NCT01754857|617519914|FG000|Overall Study|Withdrawal by Subject|3|||
170865523|NCT01754857|617519914|FG000|Overall Study|other complicating disease|1|||
170865524|NCT01754857|617519914|FG000|Overall Study|ineligible to continue onto maintenance|1|||
170865525|NCT01754857|617519914|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
170865526|NCT01754857|617519914|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
170865527|NCT04964960|617519915|FG000|Overall Study|Withdrawal by Subject|1|||
170865528|NCT04964960|617519915|FG000|Overall Study|Did not complete cycles|1|||
170865529|NCT02076113|617519916|FG000|Overall Study|Lost to Follow-up|4|||
170865530|NCT02076113|617519917|FG001|Overall Study|Lost to Follow-up|1|||
170865531|NCT02076113|617519916|FG000|Overall Study|Withdrawal by Subject|2|||
170865532|NCT02076113|617519917|FG001|Overall Study|Withdrawal by Subject|3|||
170865533|NCT02076113|617519916|FG000|Overall Study|Death|1|||
170865534|NCT02076113|617519917|FG001|Overall Study|Death|3|||
170865535|NCT01324323|617519919|FG000|Overall Study|Withdrawal by Subject|1|||
170865536|NCT02260882|617519928|FG000|Overall Study|Protocol Violation|0|||
170865537|NCT02260882|617519929|FG001|Overall Study|Protocol Violation|1|||
170865538|NCT01862640|617519932|FG000|Overall Study|Adverse Event|4|||
170865539|NCT01862640|617519933|FG001|Overall Study|Adverse Event|10|||
170865540|NCT01862640|617519934|FG002|Overall Study|Adverse Event|6|||
170865541|NCT01862640|617519935|FG003|Overall Study|Adverse Event|8|||
170403799|NCT04380701|615818815|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
170403800|NCT04380701|615818816|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
170403801|NCT04380701|615818817|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403802|NCT04380701|615818818|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403803|NCT04380701|615818819|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403804|NCT04380701|615818820|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403805|NCT04380701|615818821|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403806|NCT04380701|615818822|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403807|NCT04380701|615818823|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403808|NCT04380701|615818824|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403809|NCT04380701|615818825|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
170403810|NCT01890785|615818826|FG000|Third Intervention|Withdrawal by Subject|0|||
170403811|NCT01890785|615818827|FG001|Third Intervention|Withdrawal by Subject|1|||
170403812|NCT01890785|615818828|FG002|Third Intervention|Withdrawal by Subject|0|||
170403813|NCT01890785|615818829|FG003|Third Intervention|Withdrawal by Subject|0|||
170403814|NCT01890785|615818830|FG004|Third Intervention|Withdrawal by Subject|0|||
170403815|NCT01890785|615818831|FG005|Third Intervention|Withdrawal by Subject|0|||
170403816|NCT03001011|615818832|FG000|Overall Study|Adverse Event|9|||
170403817|NCT03001011|615818833|FG001|Overall Study|Adverse Event|3|||
170403818|NCT03001011|615818832|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
170403819|NCT03001011|615818833|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
170403820|NCT03001011|615818832|FG000|Overall Study|Other than specified above|3|||
170403821|NCT03001011|615818833|FG001|Overall Study|Other than specified above|8|||
170403822|NCT04355767|615818836|FG000|Overall Study|Withdrawal by Subject|2|||
170403823|NCT04355767|615818837|FG001|Overall Study|Withdrawal by Subject|2|||
170403824|NCT04355767|615818836|FG000|Overall Study|Death|5|||
170403825|NCT04355767|615818837|FG001|Overall Study|Death|1|||
170403826|NCT01999322|615818838|FG000|Overall Study|Adverse Event|1|||
170403827|NCT01999322|615818839|FG001|Overall Study|Adverse Event|0|||
170403828|NCT03338673|615818840|FG000|Overall Study|Lost to Follow-up|1|||
170403829|NCT03338673|615818841|FG001|Overall Study|Lost to Follow-up|1|||
170403830|NCT05788237|615818855|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
170403831|NCT05788237|615818856|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
170403832|NCT05788237|615818857|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
170403833|NCT05788237|615818858|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
170403834|NCT05788237|615818855|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
170403835|NCT05788237|615818856|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
170403836|NCT05788237|615818857|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
170403837|NCT05788237|615818858|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
170403838|NCT05788237|615818855|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
170403839|NCT05788237|615818856|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
170403840|NCT05788237|615818857|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
170403841|NCT05788237|615818858|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
170403842|NCT05788237|615818855|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
170403843|NCT05788237|615818856|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
170403844|NCT05788237|615818857|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
170403845|NCT05788237|615818858|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
170403846|NCT05788237|615818855|FG000|SSA (Approximately 2 Months)|Death|0|||
170403847|NCT05788237|615818856|FG001|SSA (Approximately 2 Months)|Death|1|||
170403848|NCT05788237|615818857|FG002|SSA (Approximately 2 Months)|Death|0|||
170403849|NCT05788237|615818858|FG003|SSA (Approximately 2 Months)|Death|0|||
170403850|NCT05788237|615818855|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
170403851|NCT05788237|615818856|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
170403852|NCT05788237|615818857|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
170403853|NCT05788237|615818858|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
170403854|NCT05788237|615818855|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
170403855|NCT05788237|615818856|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
170403856|NCT05788237|615818857|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
170403857|NCT05788237|615818858|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
170403858|NCT05788237|615818855|FG000|SSB (Approximately 1 Month)|Other|0|||
170403859|NCT05788237|615818856|FG001|SSB (Approximately 1 Month)|Other|0|||
170403860|NCT05788237|615818857|FG002|SSB (Approximately 1 Month)|Other|0|||
170403861|NCT05788237|615818858|FG003|SSB (Approximately 1 Month)|Other|1|||
170403862|NCT01963676|615820165|FG000|Overall Study|Withdrawal by Subject|1|||
170403863|NCT01963676|615820166|FG001|Overall Study|Withdrawal by Subject|0|||
170403864|NCT03053622|615820167|FG000|Overall Study|Lost to Follow-up|0|||
170403865|NCT03053622|615820168|FG001|Overall Study|Lost to Follow-up|0|||
170403866|NCT03053622|615820169|FG002|Overall Study|Lost to Follow-up|0|||
170403867|NCT03053622|615820170|FG003|Overall Study|Lost to Follow-up|1|||
170865542|NCT01862640|617519932|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
170403868|NCT01440647|615820171|FG000|Overall Study|Death|2|||
170403869|NCT01440647|615820172|FG001|Overall Study|Death|3|||
170403870|NCT00782275|615820178|FG000|Overall Study|Adverse Event|11|||
170403871|NCT00782275|615820178|FG000|Overall Study|Withdrawal by Subject|1|||
170403872|NCT00782275|615820178|FG000|Overall Study|Progressive Disease|21|||
170403873|NCT00782275|615820178|FG000|Overall Study|Physician Decision|4|||
170403874|NCT00782275|615820178|FG000|Overall Study|Not started treatment|1|||
170403875|NCT00782275|615820178|FG000|Overall Study|Other|3|||
170403876|NCT03451331|615820179|FG000|Overall Study|Withdrawal by Subject|1|||
170403877|NCT03451331|615820180|FG001|Overall Study|Withdrawal by Subject|0|||
170403878|NCT03451331|615820179|FG000|Overall Study|Unable to start treatment.|1|||
170403879|NCT03451331|615820180|FG001|Overall Study|Unable to start treatment.|1|||
170403880|NCT04378010|615820181|FG000|Overall Study|Adverse Event|8|||
170403881|NCT04378010|615820182|FG001|Overall Study|Adverse Event|14|||
170403882|NCT04378010|615820183|FG002|Overall Study|Adverse Event|4|||
170403883|NCT04378010|615820181|FG000|Overall Study|Withdrawal by Subject|0|||
170403884|NCT04378010|615820182|FG001|Overall Study|Withdrawal by Subject|2|||
170403885|NCT04378010|615820183|FG002|Overall Study|Withdrawal by Subject|1|||
170403886|NCT04378010|615820181|FG000|Overall Study|Protocol Violation|2|||
170403887|NCT04378010|615820182|FG001|Overall Study|Protocol Violation|1|||
170403888|NCT04378010|615820183|FG002|Overall Study|Protocol Violation|4|||
170403889|NCT04378010|615820181|FG000|Overall Study|Study terminated by Sponsor|22|||
170403890|NCT04378010|615820182|FG001|Overall Study|Study terminated by Sponsor|16|||
170403891|NCT04378010|615820183|FG002|Overall Study|Study terminated by Sponsor|22|||
170403892|NCT04378010|615820181|FG000|Overall Study|Subject inability to complete study visit|0|||
170403893|NCT04378010|615820182|FG001|Overall Study|Subject inability to complete study visit|0|||
170403894|NCT04378010|615820183|FG002|Overall Study|Subject inability to complete study visit|1|||
170403895|NCT04378010|615820181|FG000|Overall Study|Subject never dosed|0|||
170403896|NCT04378010|615820182|FG001|Overall Study|Subject never dosed|1|||
170403897|NCT04378010|615820183|FG002|Overall Study|Subject never dosed|0|||
170403898|NCT00379587|615820184|FG000|Overall Study|Lost to Follow-up|2|||
170403899|NCT02762565|615820187|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
170403900|NCT02753400|615820190|FG000|Overall Study|Adverse Event|3|||
170403901|NCT02753400|615820191|FG001|Overall Study|Adverse Event|0|||
170403902|NCT02753400|615820190|FG000|Overall Study|Withdrawal by Subject|2|||
170403903|NCT02753400|615820191|FG001|Overall Study|Withdrawal by Subject|1|||
170403904|NCT03989115|615820192|FG000|Overall Study|Withdrawal by Subject|2|||
170403905|NCT03989115|615820193|FG001|Overall Study|Withdrawal by Subject|1|||
170403906|NCT03989115|615820194|FG002|Overall Study|Withdrawal by Subject|3|||
170403907|NCT03989115|615820195|FG003|Overall Study|Withdrawal by Subject|0|||
170403908|NCT03989115|615820196|FG004|Overall Study|Withdrawal by Subject|17|||
170403909|NCT03989115|615820197|FG005|Overall Study|Withdrawal by Subject|1|||
170403910|NCT03989115|615820198|FG006|Overall Study|Withdrawal by Subject|0|||
170403911|NCT03989115|615820199|FG007|Overall Study|Withdrawal by Subject|0|||
170403912|NCT03989115|615820192|FG000|Overall Study|Sponsor decision to terminate the study|1|||
170403913|NCT03989115|615820193|FG001|Overall Study|Sponsor decision to terminate the study|1|||
170403914|NCT03989115|615820194|FG002|Overall Study|Sponsor decision to terminate the study|0|||
170403915|NCT03989115|615820195|FG003|Overall Study|Sponsor decision to terminate the study|1|||
170403916|NCT03989115|615820196|FG004|Overall Study|Sponsor decision to terminate the study|11|||
170403917|NCT03989115|615820197|FG005|Overall Study|Sponsor decision to terminate the study|0|||
170403918|NCT03989115|615820198|FG006|Overall Study|Sponsor decision to terminate the study|2|||
170403919|NCT03989115|615820199|FG007|Overall Study|Sponsor decision to terminate the study|1|||
170403920|NCT03989115|615820192|FG000|Overall Study|Lost to Follow-up|2|||
170403921|NCT03989115|615820193|FG001|Overall Study|Lost to Follow-up|0|||
170403922|NCT03989115|615820194|FG002|Overall Study|Lost to Follow-up|0|||
170403923|NCT03989115|615820195|FG003|Overall Study|Lost to Follow-up|0|||
170403924|NCT03989115|615820196|FG004|Overall Study|Lost to Follow-up|1|||
170403925|NCT03989115|615820197|FG005|Overall Study|Lost to Follow-up|0|||
170403926|NCT03989115|615820198|FG006|Overall Study|Lost to Follow-up|0|||
170403927|NCT03989115|615820199|FG007|Overall Study|Lost to Follow-up|0|||
170403928|NCT03989115|615820192|FG000|Overall Study|Death|2|||
170403929|NCT03989115|615820193|FG001|Overall Study|Death|2|||
170403930|NCT03989115|615820194|FG002|Overall Study|Death|9|||
170403931|NCT03989115|615820195|FG003|Overall Study|Death|6|||
170403932|NCT03989115|615820196|FG004|Overall Study|Death|31|||
170403933|NCT03989115|615820197|FG005|Overall Study|Death|6|||
170403934|NCT03989115|615820198|FG006|Overall Study|Death|2|||
170403935|NCT03989115|615820199|FG007|Overall Study|Death|3|||
170403936|NCT03989115|615820192|FG000|Overall Study|Other|1|||
170403937|NCT03989115|615820193|FG001|Overall Study|Other|2|||
170403938|NCT03989115|615820194|FG002|Overall Study|Other|0|||
170403939|NCT03989115|615820195|FG003|Overall Study|Other|0|||
170403940|NCT03989115|615820196|FG004|Overall Study|Other|5|||
170403941|NCT03989115|615820197|FG005|Overall Study|Other|0|||
170403942|NCT03989115|615820198|FG006|Overall Study|Other|0|||
170403943|NCT03989115|615820199|FG007|Overall Study|Other|0|||
170403944|NCT01042977|615820200|FG000|Overall Study|Adverse Event|4|||
170403945|NCT01042977|615820201|FG001|Overall Study|Adverse Event|12|||
170403946|NCT01042977|615820200|FG000|Overall Study|Death|2|||
170403947|NCT01042977|615820201|FG001|Overall Study|Death|1|||
170403948|NCT01042977|615820200|FG000|Overall Study|Withdrawal by Subject|8|||
170403949|NCT01042977|615820201|FG001|Overall Study|Withdrawal by Subject|16|||
170403950|NCT01042977|615820200|FG000|Overall Study|Lost to Follow-up|0|||
170403951|NCT01042977|615820201|FG001|Overall Study|Lost to Follow-up|2|||
170403952|NCT01042977|615820200|FG000|Overall Study|Poor/non-compliance|3|||
170403953|NCT01042977|615820201|FG001|Overall Study|Poor/non-compliance|4|||
170403954|NCT01042977|615820200|FG000|Overall Study|Subject no longer meets study criteria|15|||
170403955|NCT01042977|615820201|FG001|Overall Study|Subject no longer meets study criteria|13|||
170403956|NCT01042977|615820200|FG000|Overall Study|Incorrect enrollment|6|||
170403957|NCT01042977|615820201|FG001|Overall Study|Incorrect enrollment|4|||
170403958|NCT01042977|615820200|FG000|Overall Study|Safety|0|||
170403959|NCT01042977|615820201|FG001|Overall Study|Safety|2|||
170403960|NCT01042977|615820200|FG000|Overall Study|Administrative reason by sponsor|0|||
170403961|NCT01042977|615820201|FG001|Overall Study|Administrative reason by sponsor|1|||
170403962|NCT01042977|615820200|FG000|Overall Study|Various|3|||
170403963|NCT01042977|615820201|FG001|Overall Study|Various|0|||
170403964|NCT02499354|615820202|FG000|Overall Study|Withdrawal by Subject|1|||
170403965|NCT02499354|615820203|FG001|Overall Study|Withdrawal by Subject|0|||
170403966|NCT02424565|615820204|FG000|Period 1 (D0)|Protocol Violation|0|||
170403967|NCT02424565|615820205|FG001|Period 1 (D0)|Protocol Violation|1|||
170403968|NCT01677910|615820206|FG000|Double-Blind Treatment Period|Adverse Event|6|||
170403969|NCT01677910|615820207|FG001|Double-Blind Treatment Period|Adverse Event|2|||
170403970|NCT01677910|615820208|FG002|Double-Blind Treatment Period|Adverse Event|3|||
170403971|NCT01677910|615820209|FG003|Double-Blind Treatment Period|Adverse Event|0|||
170403972|NCT01677910|615820206|FG000|Double-Blind Treatment Period|Physician Decision|0|||
170403973|NCT01677910|615820207|FG001|Double-Blind Treatment Period|Physician Decision|0|||
170403974|NCT01677910|615820208|FG002|Double-Blind Treatment Period|Physician Decision|1|||
170403975|NCT01677910|615820209|FG003|Double-Blind Treatment Period|Physician Decision|0|||
170403976|NCT01677910|615820206|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
170403977|NCT01677910|615820207|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
170403978|NCT01677910|615820208|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
170403979|NCT01677910|615820209|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
170403980|NCT01677910|615820206|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
170403981|NCT01677910|615820207|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
170403982|NCT01677910|615820208|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
170403983|NCT01677910|615820209|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
170403984|NCT01677910|615820206|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
170403985|NCT01677910|615820207|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
170403986|NCT01677910|615820208|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
170403987|NCT01677910|615820209|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
170403988|NCT01677910|615820206|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
170403989|NCT01677910|615820207|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
170403990|NCT01677910|615820208|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
170403991|NCT01677910|615820209|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
170403992|NCT01677910|615820206|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
170403993|NCT01677910|615820207|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
170403994|NCT01677910|615820208|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
170403995|NCT01677910|615820209|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
170403996|NCT01677910|615820206|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
170403997|NCT01677910|615820207|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
170403998|NCT01677910|615820208|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
170403999|NCT01677910|615820209|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
170404000|NCT01677910|615820206|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
170404001|NCT01677910|615820207|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
170404002|NCT01677910|615820208|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
170404003|NCT01677910|615820209|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
170404004|NCT01677910|615820206|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
170404005|NCT01677910|615820207|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
170404006|NCT01677910|615820208|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
170404007|NCT01677910|615820209|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
170404008|NCT02143947|615820210|FG000|Overall Study|Lost to Follow-up|4|||
170756011|NCT04955626|617111039|FG033|Open-Label Period|Refused further study procedures|0|||
170756012|NCT04955626|617111040|FG034|Open-Label Period|Refused further study procedures|0|||
170756013|NCT04955626|617111041|FG035|Open-Label Period|Refused further study procedures|0|||
170404009|NCT02143947|615820211|FG001|Overall Study|Lost to Follow-up|2|||
170404010|NCT01703741|615820214|FG000|Overall Study|Withdrawal by Subject|6|||
170404011|NCT01703741|615820214|FG000|Overall Study|Adverse Event|2|||
170404012|NCT01703741|615820214|FG000|Overall Study|Physician Decision|2|||
170404013|NCT01703741|615820214|FG000|Overall Study|Protocol Violation|1|||
170404014|NCT01703741|615820214|FG000|Overall Study|Lost to Follow-up|3|||
170404015|NCT01703741|615820214|FG000|Overall Study|Subject did not want to continue|2|||
170404016|NCT01703741|615820214|FG000|Overall Study|Subject cannot comply with study visits|1|||
170404017|NCT01703741|615820214|FG000|Overall Study|Subject started testosterone injections|1|||
170404018|NCT04132232|615820215|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
170404019|NCT04132232|615820216|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
170404020|NCT04132232|615820215|FG000|Overall Study|Lost to Follow-up|6|||
170404021|NCT04132232|615820216|FG001|Overall Study|Lost to Follow-up|7|||
170404022|NCT02041494|615820217|FG000|Overall Study|Death|1|||
170404023|NCT02041494|615820218|FG001|Overall Study|Death|3|||
170404024|NCT02041494|615820217|FG000|Overall Study|Lost to Follow-up|2|||
170404025|NCT02041494|615820218|FG001|Overall Study|Lost to Follow-up|6|||
170404026|NCT02041494|615820217|FG000|Overall Study|study terminated|16|||
170404027|NCT02041494|615820218|FG001|Overall Study|study terminated|11|||
170404028|NCT00755937|615820221|FG000|Recruitment|Unknown if infliximab received|164|||
170404029|NCT00755937|615820221|FG000|Observational Follow-up|Lost to Follow-up|148|||
170404030|NCT02117479|615820224|FG000|Overall Study|Death|13|||
170404031|NCT02117479|615820225|FG001|Overall Study|Death|8|||
170404032|NCT02117479|615820224|FG000|Overall Study|Adverse Event|8|||
170404033|NCT02117479|615820225|FG001|Overall Study|Adverse Event|16|||
170404034|NCT02117479|615820224|FG000|Overall Study|Subject decision|8|||
170404035|NCT02117479|615820225|FG001|Overall Study|Subject decision|9|||
170404036|NCT02117479|615820224|FG000|Overall Study|Disease progression|104|||
170404037|NCT02117479|615820225|FG001|Overall Study|Disease progression|108|||
170404038|NCT02117479|615820224|FG000|Overall Study|Noncompliance with study treatment|1|||
170404039|NCT02117479|615820225|FG001|Overall Study|Noncompliance with study treatment|0|||
170404040|NCT02117479|615820224|FG000|Overall Study|Study terminated by the sponsor|4|||
170404041|NCT02117479|615820225|FG001|Overall Study|Study terminated by the sponsor|6|||
170404042|NCT02117479|615820224|FG000|Overall Study|Physician Decision|7|||
170404043|NCT02117479|615820225|FG001|Overall Study|Physician Decision|2|||
170404044|NCT02117479|615820224|FG000|Overall Study|Other unspecified|11|||
170404045|NCT02117479|615820225|FG001|Overall Study|Other unspecified|7|||
170404046|NCT02629133|615820226|FG000|Overall Study|Lost to Follow-up|3|||
170404047|NCT02629133|615820227|FG001|Overall Study|Lost to Follow-up|1|||
170404048|NCT02629133|615820226|FG000|Overall Study|Withdrawal by Subject|1|||
170404049|NCT02629133|615820227|FG001|Overall Study|Withdrawal by Subject|1|||
170404050|NCT01238822|615820228|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
170404051|NCT02487979|615820229|FG000|Overall Study|Physician Decision|2|||
170404052|NCT02487979|615820229|FG000|Overall Study|Withdrawal by Subject|2|||
170404053|NCT02487979|615820229|FG000|Overall Study|Progressive Disease|17|||
170404054|NCT00447694|615820230|FG000|Overall Study|Adverse Event|2|||
170404055|NCT00447694|615820230|FG000|Overall Study|Abnormal laboratory value|1|||
170404056|NCT00447694|615820230|FG000|Overall Study|Abnormal test procedure result|1|||
170404057|NCT00447694|615820230|FG000|Overall Study|Withdrawal by Subject|2|||
170404058|NCT02410837|615820231|FG000|Overall Study|Death|387|||
170404059|NCT02410837|615820231|FG000|Overall Study|Lost to Follow-up|50|||
170404060|NCT02410837|615820231|FG000|Overall Study|Withdrawal by Subject|44|||
170404061|NCT02410837|615820231|FG000|Overall Study|Physician Decision|6|||
170404062|NCT02410837|615820231|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
170404063|NCT01965535|615820232|FG000|Overall Study|Lack of Efficacy|2|||
170404064|NCT01965535|615820233|FG001|Overall Study|Lack of Efficacy|1|||
170404065|NCT01169987|615820234|FG000|Overall Study|Withdrawal by Subject|3|||
170404066|NCT01169987|615820234|FG000|Overall Study|Lost to Follow-up|24|||
170404067|NCT01169987|615820234|FG000|Overall Study|Other|4|||
170404068|NCT00386100|615820235|FG000|Overall Study|Did not receive study medication|6|||
170404069|NCT00386100|615820236|FG001|Overall Study|Did not receive study medication|4|||
170404070|NCT00386100|615820235|FG000|Overall Study|Adverse Event|15|||
170404071|NCT00386100|615820236|FG001|Overall Study|Adverse Event|25|||
170404072|NCT00386100|615820235|FG000|Overall Study|Death|0|||
170404073|NCT00386100|615820236|FG001|Overall Study|Death|1|||
170404074|NCT00386100|615820235|FG000|Overall Study|Insufficient therapeutic effect|30|||
170404075|NCT00386100|615820236|FG001|Overall Study|Insufficient therapeutic effect|6|||
170404076|NCT00386100|615820235|FG000|Overall Study|Lost to Follow-up|29|||
170404077|NCT00386100|615820236|FG001|Overall Study|Lost to Follow-up|29|||
170404078|NCT00386100|615820235|FG000|Overall Study|Non-compliance|18|||
170404079|NCT00386100|615820236|FG001|Overall Study|Non-compliance|19|||
170404080|NCT00386100|615820235|FG000|Overall Study|Protocol Violation|5|||
170404081|NCT00386100|615820236|FG001|Overall Study|Protocol Violation|3|||
170404082|NCT00386100|615820235|FG000|Overall Study|Withdrawal by Subject|32|||
170404083|NCT00386100|615820236|FG001|Overall Study|Withdrawal by Subject|31|||
170404084|NCT00386100|615820235|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
170404085|NCT00386100|615820236|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
170404086|NCT00386100|615820235|FG000|Overall Study|BMD <2.5|1|||
170404087|NCT00386100|615820236|FG001|Overall Study|BMD <2.5|0|||
170404088|NCT00386100|615820235|FG000|Overall Study|Consecutive elevated Hba1C|1|||
170404089|NCT00386100|615820236|FG001|Overall Study|Consecutive elevated Hba1C|0|||
170404090|NCT00386100|615820235|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
170404091|NCT00386100|615820236|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
170404092|NCT00386100|615820235|FG000|Overall Study|Laboratory findings|1|||
170404093|NCT00386100|615820236|FG001|Overall Study|Laboratory findings|0|||
170404094|NCT00386100|615820235|FG000|Overall Study|Participant's concern due to CPK levels|1|||
170404095|NCT00386100|615820236|FG001|Overall Study|Participant's concern due to CPK levels|0|||
170404096|NCT00386100|615820235|FG000|Overall Study|Participant moving out of state|2|||
170404097|NCT00386100|615820236|FG001|Overall Study|Participant moving out of state|0|||
170404098|NCT00386100|615820235|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
170404099|NCT00386100|615820236|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
170404100|NCT00386100|615820235|FG000|Overall Study|Didn't meet entry criteria|1|||
170404101|NCT00386100|615820236|FG001|Overall Study|Didn't meet entry criteria|1|||
170404102|NCT00386100|615820235|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
170404103|NCT00386100|615820236|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
170404104|NCT00386100|615820235|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
170404105|NCT00386100|615820236|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
170404106|NCT00386100|615820235|FG000|Overall Study|Bad metabolic control & patient security|1|||
170404107|NCT00386100|615820236|FG001|Overall Study|Bad metabolic control & patient security|0|||
170404108|NCT00386100|615820235|FG000|Overall Study|Bone loss by DXA bone scan|1|||
170404109|NCT00386100|615820236|FG001|Overall Study|Bone loss by DXA bone scan|0|||
170404110|NCT00386100|615820235|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
170404111|NCT00386100|615820236|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
170404112|NCT00386100|615820235|FG000|Overall Study|7.6% bone loss|1|||
170404113|NCT00386100|615820236|FG001|Overall Study|7.6% bone loss|0|||
170404114|NCT00386100|615820235|FG000|Overall Study|Osteoporosis|0|||
170404115|NCT00386100|615820236|FG001|Overall Study|Osteoporosis|1|||
170404116|NCT00386100|615820235|FG000|Overall Study|Positive pregnancy test|1|||
170404117|NCT00386100|615820236|FG001|Overall Study|Positive pregnancy test|3|||
170404118|NCT00386100|615820235|FG000|Overall Study|Out of country for 5 months|1|||
170404119|NCT00386100|615820236|FG001|Overall Study|Out of country for 5 months|0|||
170404120|NCT00386100|615820235|FG000|Overall Study|Hb1Ac >8%|0|||
170404121|NCT00386100|615820236|FG001|Overall Study|Hb1Ac >8%|1|||
170404122|NCT00386100|615820235|FG000|Overall Study|Participant randomized in error|1|||
170404123|NCT00386100|615820236|FG001|Overall Study|Participant randomized in error|0|||
170404124|NCT00837577|615820237|FG000|Double-blind Period|Clinical Adverse Event|1|||
170404125|NCT00837577|615820238|FG001|Double-blind Period|Clinical Adverse Event|0|||
170404126|NCT00837577|615820237|FG000|Double-blind Period|Withdrawal by Subject|1|||
170404127|NCT00837577|615820238|FG001|Double-blind Period|Withdrawal by Subject|0|||
170404128|NCT00837577|615820237|FG000|Open-label Period|Clinical Adverse Event|2|||
170404129|NCT00837577|615820238|FG001|Open-label Period|Clinical Adverse Event|2|||
170404130|NCT00837577|615820237|FG000|Open-label Period|Laboratory Adverse Event|0|||
170404131|NCT00837577|615820238|FG001|Open-label Period|Laboratory Adverse Event|1|||
170404132|NCT00837577|615820237|FG000|Open-label Period|Lack of Efficacy|4|||
170404133|NCT00837577|615820238|FG001|Open-label Period|Lack of Efficacy|3|||
170404134|NCT00837577|615820237|FG000|Open-label Period|Withdrawal by Subject|1|||
170404135|NCT00837577|615820238|FG001|Open-label Period|Withdrawal by Subject|2|||
170404136|NCT00837577|615820237|FG000|Open-label Period|Other Reason|1|||
170404137|NCT00837577|615820238|FG001|Open-label Period|Other Reason|1|||
170404138|NCT01027884|615820244|FG000|Overall Study|Adverse Event|2|||
170404139|NCT01027884|615820245|FG001|Overall Study|Adverse Event|1|||
170404140|NCT01027884|615820244|FG000|Overall Study|Protocol Violation|1|||
170404141|NCT01027884|615820245|FG001|Overall Study|Protocol Violation|0|||
170404142|NCT01027884|615820244|FG000|Overall Study|Non-compliance|1|||
170404143|NCT01027884|615820245|FG001|Overall Study|Non-compliance|1|||
170404144|NCT01027884|615820244|FG000|Overall Study|Withdrawal by Subject|0|||
170404145|NCT01027884|615820245|FG001|Overall Study|Withdrawal by Subject|1|||
170404146|NCT01027884|615820244|FG000|Overall Study|Lost to Follow-up|0|||
170404147|NCT01027884|615820245|FG001|Overall Study|Lost to Follow-up|1|||
170404148|NCT01027884|615820244|FG000|Overall Study|Spinal fixation surgery|0|||
170404149|NCT01027884|615820245|FG001|Overall Study|Spinal fixation surgery|3|||
170404150|NCT03636542|615820247|FG000|Overall Study|Lost to Follow-up|1|||
170404151|NCT03636542|615820248|FG001|Overall Study|Lost to Follow-up|1|||
170404152|NCT03636542|615820247|FG000|Overall Study|Physician Decision|0|||
170404153|NCT03636542|615820248|FG001|Overall Study|Physician Decision|1|||
170404154|NCT03636542|615820247|FG000|Overall Study|Withdrawal by Subject|1|||
170404155|NCT03636542|615820248|FG001|Overall Study|Withdrawal by Subject|0|||
170404156|NCT03670537|615820249|FG000|Overall Study|Protocol Violation|1|||
170404157|NCT00033631|615820250|FG000|Overall Study|Protocol Violation|14|||
170404158|NCT00033631|615820251|FG001|Overall Study|Protocol Violation|11|||
170404159|NCT00033631|615820250|FG000|Overall Study|Withdrawal by Subject|4|||
170404160|NCT00033631|615820251|FG001|Overall Study|Withdrawal by Subject|4|||
170404161|NCT01159769|615820252|FG000|Overall Study|Adverse Event|1|||
170404162|NCT00845026|615820253|FG000|Study Period III|Adverse Event|23|||
170404163|NCT00845026|615820254|FG001|Study Period III|Adverse Event|19|||
170404164|NCT00845026|615820253|FG000|Study Period III|Perceived lack of efficacy|27|||
170404165|NCT00845026|615820254|FG001|Study Period III|Perceived lack of efficacy|15|||
170404166|NCT00845026|615820253|FG000|Study Period III|Withdrawal by Subject|19|||
170404167|NCT00845026|615820254|FG001|Study Period III|Withdrawal by Subject|15|||
170404168|NCT00845026|615820253|FG000|Study Period III|Entry Criteria not met|8|||
170404169|NCT00845026|615820254|FG001|Study Period III|Entry Criteria not met|11|||
170404170|NCT00845026|615820253|FG000|Study Period III|Lost to Follow-up|4|||
170404171|NCT00845026|615820254|FG001|Study Period III|Lost to Follow-up|5|||
170404172|NCT00845026|615820253|FG000|Study Period III|Protocol Violation|8|||
170404173|NCT00845026|615820254|FG001|Study Period III|Protocol Violation|1|||
170404174|NCT00845026|615820253|FG000|Study Period III|Scheduled conflict|3|||
170404175|NCT00845026|615820254|FG001|Study Period III|Scheduled conflict|1|||
170404176|NCT00845026|615820253|FG000|Study Period III|Subject is moving or has moved|2|||
170404177|NCT00845026|615820254|FG001|Study Period III|Subject is moving or has moved|4|||
170404178|NCT00845026|615820253|FG000|Study Period III|Transportation issues|1|||
170404179|NCT00845026|615820254|FG001|Study Period III|Transportation issues|1|||
170404180|NCT00845026|615820253|FG000|Study Period IV|Adverse Event|4|||
170404181|NCT00845026|615820254|FG001|Study Period IV|Adverse Event|0|||
170404182|NCT00845026|615820253|FG000|Study Period IV|Perceived lack of efficacy|2|||
170404183|NCT00845026|615820254|FG001|Study Period IV|Perceived lack of efficacy|1|||
170404184|NCT00845026|615820253|FG000|Study Period IV|Protocol Violation|3|||
170404185|NCT00845026|615820254|FG001|Study Period IV|Protocol Violation|1|||
170404186|NCT00845026|615820253|FG000|Study Period IV|Lost to Follow-up|1|||
170404187|NCT00845026|615820254|FG001|Study Period IV|Lost to Follow-up|0|||
170404188|NCT00845026|615820253|FG000|Study Period IV|Withdrawal by Subject|4|||
170404189|NCT00845026|615820254|FG001|Study Period IV|Withdrawal by Subject|1|||
170404190|NCT00845026|615820253|FG000|Study Period IV|Entry Criteria Not Met|1|||
170404191|NCT00845026|615820254|FG001|Study Period IV|Entry Criteria Not Met|0|||
170404192|NCT00845026|615820253|FG000|Study Period IV|Subject is moving or has moved|0|||
170404193|NCT00845026|615820254|FG001|Study Period IV|Subject is moving or has moved|1|||
170404194|NCT00845026|615820253|FG000|Study Period IV|Scheduling conflict|1|||
170404195|NCT00845026|615820254|FG001|Study Period IV|Scheduling conflict|0|||
170404196|NCT01325532|615820255|FG000|Overall Study|Withdrawal by Subject|2|||
170404197|NCT01325532|615820256|FG001|Overall Study|Withdrawal by Subject|0|||
170404198|NCT00065065|615820257|FG000|Overall Study|Adverse Event|3|||
170404199|NCT00065065|615820258|FG001|Overall Study|Adverse Event|2|||
170404200|NCT00065065|615820257|FG000|Overall Study|Withdrawal by Subject|1|||
170404201|NCT00065065|615820258|FG001|Overall Study|Withdrawal by Subject|5|||
170404202|NCT00065065|615820257|FG000|Overall Study|Lack of Efficacy|4|||
170404203|NCT00065065|615820258|FG001|Overall Study|Lack of Efficacy|11|||
170404204|NCT00065065|615820257|FG000|Overall Study|Other|2|||
170404205|NCT00065065|615820258|FG001|Overall Study|Other|2|||
170404206|NCT04363736|615820259|FG000|Overall Study|Withdrawal by Subject|1|||
170404207|NCT04363736|615820260|FG001|Overall Study|Withdrawal by Subject|0|||
170404208|NCT04363736|615820259|FG000|Overall Study|Lost to Follow-up|10|||
170404209|NCT04363736|615820260|FG001|Overall Study|Lost to Follow-up|7|||
170404210|NCT04363736|615820259|FG000|Overall Study|Death|8|||
170404211|NCT04363736|615820260|FG001|Overall Study|Death|6|||
170404212|NCT01021137|615820261|FG000|Overall Study|Lost to Follow-up|9|||
170404213|NCT01021137|615820262|FG001|Overall Study|Lost to Follow-up|4|||
170404214|NCT01021137|615820263|FG002|Overall Study|Lost to Follow-up|2|||
170404215|NCT01021137|615820264|FG003|Overall Study|Lost to Follow-up|6|||
170404216|NCT01021137|615820261|FG000|Overall Study|Withdrawal by Subject|1|||
170404217|NCT01021137|615820262|FG001|Overall Study|Withdrawal by Subject|0|||
170404218|NCT01021137|615820263|FG002|Overall Study|Withdrawal by Subject|0|||
170404219|NCT01021137|615820264|FG003|Overall Study|Withdrawal by Subject|3|||
170404220|NCT03077828|615820265|FG000|Treatment Cycles|Death|1|||
170404221|NCT03077828|615820265|FG000|Treatment Cycles|Withdrawal by Subject|1|||
170404222|NCT03077828|615820265|FG000|Treatment Cycles|Screen Fail|2|||
170404223|NCT03077828|615820265|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
170404224|NCT03077828|615820265|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
170404225|NCT03077828|615820265|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
170404226|NCT03077828|615820265|FG000|Follow-up|Patients still in follow-up|15|||
170404227|NCT02392559|615820266|FG000|Overall Study|Withdrawal by Subject|0|||
170404228|NCT02392559|615820267|FG001|Overall Study|Withdrawal by Subject|1|||
170404229|NCT00729365|615820274|FG000|Overall Study|Physician Decision|33|||
170404230|NCT00729365|615820275|FG001|Overall Study|Physician Decision|6|||
170404231|NCT00729365|615820276|FG002|Overall Study|Physician Decision|7|||
170404232|NCT00944125|615820279|FG000|3 to 6 Months|Withdrawal by Subject|0|||
170404233|NCT00944125|615820280|FG001|3 to 6 Months|Withdrawal by Subject|2|||
170756014|NCT04955626|617111006|FG000|Open-Label Period|Adverse Event|1|||
170756015|NCT04955626|617111007|FG001|Open-Label Period|Adverse Event|0|||
170404234|NCT00944125|615820279|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
170404235|NCT00944125|615820280|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
170404236|NCT03125915|615820281|FG000|1 Month Follow up|Lost to Follow-up|3|||
170404237|NCT03125915|615820282|FG001|1 Month Follow up|Lost to Follow-up|3|||
170404238|NCT03125915|615820283|FG002|1 Month Follow up|Lost to Follow-up|2|||
170756016|NCT04955626|617111008|FG002|Open-Label Period|Adverse Event|0|||
170404239|NCT03125915|615820284|FG003|1 Month Follow up|Lost to Follow-up|3|||
170404240|NCT03125915|615820281|FG000|3 Month Follow-up|Lost to Follow-up|6|||
170404241|NCT03125915|615820282|FG001|3 Month Follow-up|Lost to Follow-up|4|||
170404242|NCT03125915|615820283|FG002|3 Month Follow-up|Lost to Follow-up|4|||
170404243|NCT03125915|615820284|FG003|3 Month Follow-up|Lost to Follow-up|2|||
170404244|NCT03125915|615820281|FG000|6 Month Follow-up|Lost to Follow-up|7|||
170404245|NCT03125915|615820282|FG001|6 Month Follow-up|Lost to Follow-up|3|||
170404246|NCT03125915|615820283|FG002|6 Month Follow-up|Lost to Follow-up|6|||
170404247|NCT03125915|615820284|FG003|6 Month Follow-up|Lost to Follow-up|3|||
170404248|NCT01374906|615820285|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170404249|NCT01374906|615820286|FG001|Overall Study|Abnormal laboratory value(s)|3|||
170404250|NCT01374906|615820285|FG000|Overall Study|Administrative problems|2|||
170404251|NCT01374906|615820286|FG001|Overall Study|Administrative problems|2|||
170404252|NCT01374906|615820285|FG000|Overall Study|Adverse Event|10|||
170404253|NCT01374906|615820286|FG001|Overall Study|Adverse Event|11|||
170404254|NCT01374906|615820285|FG000|Overall Study|Death|0|||
170404255|NCT01374906|615820286|FG001|Overall Study|Death|2|||
170404256|NCT01374906|615820285|FG000|Overall Study|Protocol Violation|2|||
170404257|NCT01374906|615820286|FG001|Overall Study|Protocol Violation|2|||
170404258|NCT01374906|615820285|FG000|Overall Study|Withdrawal by Subject|15|||
170404259|NCT01374906|615820286|FG001|Overall Study|Withdrawal by Subject|9|||
170404260|NCT01374906|615820285|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
170404261|NCT01374906|615820286|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
170404262|NCT01309828|615820287|FG000|Overall Study|Adverse Event|10|||
170404263|NCT01309828|615820288|FG001|Overall Study|Adverse Event|11|||
170404264|NCT01309828|615820287|FG000|Overall Study|Voluntary Withdrawal|5|||
170404265|NCT01309828|615820288|FG001|Overall Study|Voluntary Withdrawal|4|||
170404266|NCT01309828|615820287|FG000|Overall Study|Major Protocol Deviation|0|||
170404267|NCT01309828|615820288|FG001|Overall Study|Major Protocol Deviation|1|||
170404268|NCT01309828|615820287|FG000|Overall Study|Other|1|||
170404269|NCT01309828|615820288|FG001|Overall Study|Other|0|||
170404270|NCT00217971|615820289|FG000|Overall Study|Adverse Event|1|||
170404271|NCT00217971|615820290|FG001|Overall Study|Adverse Event|1|||
170404272|NCT00217971|615820289|FG000|Overall Study|Lost to Follow-up|15|||
170404273|NCT00217971|615820290|FG001|Overall Study|Lost to Follow-up|19|||
170404274|NCT00217971|615820289|FG000|Overall Study|Physician Decision|0|||
170404275|NCT00217971|615820290|FG001|Overall Study|Physician Decision|1|||
170404276|NCT00217971|615820289|FG000|Overall Study|Withdrawal by Subject|7|||
170404277|NCT00217971|615820290|FG001|Overall Study|Withdrawal by Subject|12|||
170404278|NCT00217971|615820289|FG000|Overall Study|non compliant|1|||
170404279|NCT00217971|615820290|FG001|Overall Study|non compliant|0|||
170404280|NCT02556632|615820291|FG000|Overall Study|Lost to Follow-up|1|||
170404281|NCT02556632|615820292|FG001|Overall Study|Lost to Follow-up|0|||
170404282|NCT02556632|615820293|FG002|Overall Study|Lost to Follow-up|0|||
170404283|NCT02556632|615820291|FG000|Overall Study|Disliked Intervention|1|||
170404284|NCT02556632|615820292|FG001|Overall Study|Disliked Intervention|1|||
170404285|NCT02556632|615820293|FG002|Overall Study|Disliked Intervention|1|||
170404286|NCT02556632|615820291|FG000|Overall Study|No Reason|1|||
170404287|NCT02556632|615820292|FG001|Overall Study|No Reason|0|||
170404288|NCT02556632|615820293|FG002|Overall Study|No Reason|1|||
170404289|NCT02556632|615820291|FG000|Overall Study|Personal Issues|0|||
170404290|NCT02556632|615820292|FG001|Overall Study|Personal Issues|1|||
170404291|NCT02556632|615820293|FG002|Overall Study|Personal Issues|1|||
170404292|NCT02556632|615820291|FG000|Overall Study|Changed Mind|0|||
170404293|NCT02556632|615820292|FG001|Overall Study|Changed Mind|1|||
170404294|NCT02556632|615820293|FG002|Overall Study|Changed Mind|0|||
170404295|NCT02556632|615820291|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
170404296|NCT02556632|615820292|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
170404297|NCT02556632|615820293|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
170404298|NCT02556632|615820291|FG000|Overall Study|Unrelated Adverse Event|1|||
170404299|NCT02556632|615820292|FG001|Overall Study|Unrelated Adverse Event|0|||
170404300|NCT02556632|615820293|FG002|Overall Study|Unrelated Adverse Event|3|||
170404301|NCT02556632|615820291|FG000|Overall Study|Related Adverse Event|0|||
170404302|NCT02556632|615820292|FG001|Overall Study|Related Adverse Event|1|||
170404303|NCT02556632|615820293|FG002|Overall Study|Related Adverse Event|0|||
170404304|NCT02556632|615820291|FG000|Overall Study|Possibly Related Adverse Event|0|||
170756017|NCT04955626|617111009|FG003|Open-Label Period|Adverse Event|0|||
170756018|NCT04955626|617111010|FG004|Open-Label Period|Adverse Event|0|||
170756019|NCT04955626|617111011|FG005|Open-Label Period|Adverse Event|0|||
170756020|NCT04955626|617111012|FG006|Open-Label Period|Adverse Event|0|||
170404305|NCT02556632|615820292|FG001|Overall Study|Possibly Related Adverse Event|0|||
170404306|NCT02556632|615820293|FG002|Overall Study|Possibly Related Adverse Event|1|||
170404307|NCT02556632|615820291|FG000|Overall Study|Did Not Start RT|0|||
170404308|NCT02556632|615820292|FG001|Overall Study|Did Not Start RT|1|||
170404309|NCT02556632|615820293|FG002|Overall Study|Did Not Start RT|0|||
170404310|NCT02556632|615820291|FG000|Overall Study|Ineligible|0|||
170404311|NCT02556632|615820292|FG001|Overall Study|Ineligible|1|||
170756021|NCT04955626|617111013|FG007|Open-Label Period|Adverse Event|0|||
170404312|NCT02556632|615820293|FG002|Overall Study|Ineligible|0|||
170404313|NCT02556632|615820291|FG000|Overall Study|Disliked Study Procedures|0|||
170404314|NCT02556632|615820292|FG001|Overall Study|Disliked Study Procedures|0|||
170404315|NCT02556632|615820293|FG002|Overall Study|Disliked Study Procedures|1|||
170404316|NCT02556632|615820291|FG000|Overall Study|Treatment or Change Delay|0|||
170404317|NCT02556632|615820292|FG001|Overall Study|Treatment or Change Delay|0|||
170404318|NCT02556632|615820293|FG002|Overall Study|Treatment or Change Delay|1|||
170404319|NCT04556838|615820298|FG000|Overall Study|Withdrawal by Subject|3|||
170404320|NCT04556838|615820299|FG001|Overall Study|Withdrawal by Subject|1|||
170404321|NCT04556838|615820300|FG002|Overall Study|Withdrawal by Subject|2|||
170404322|NCT04556838|615820298|FG000|Overall Study|Adverse Event|0|||
170404323|NCT04556838|615820299|FG001|Overall Study|Adverse Event|1|||
170404324|NCT04556838|615820300|FG002|Overall Study|Adverse Event|1|||
170404325|NCT04556838|615820298|FG000|Overall Study|Lost to Follow-up|0|||
170404326|NCT04556838|615820299|FG001|Overall Study|Lost to Follow-up|0|||
170404327|NCT04556838|615820300|FG002|Overall Study|Lost to Follow-up|2|||
170404328|NCT04556838|615820298|FG000|Overall Study|Subject travel|0|||
170404329|NCT04556838|615820299|FG001|Overall Study|Subject travel|1|||
170404330|NCT04556838|615820300|FG002|Overall Study|Subject travel|0|||
170404331|NCT04556838|615820298|FG000|Overall Study|Physician Decision|1|||
170404332|NCT04556838|615820299|FG001|Overall Study|Physician Decision|0|||
170404333|NCT04556838|615820300|FG002|Overall Study|Physician Decision|0|||
170404334|NCT04523831|615820301|FG000|Overall Study|Lost to Follow-up|15|||
170404335|NCT04523831|615820302|FG001|Overall Study|Lost to Follow-up|17|||
170404336|NCT04523831|615820301|FG000|Overall Study|Death|0|||
170404337|NCT04523831|615820302|FG001|Overall Study|Death|3|||
170404338|NCT04523831|615820301|FG000|Overall Study|Adverse Event|2|||
170404339|NCT04523831|615820302|FG001|Overall Study|Adverse Event|0|||
170404340|NCT00995930|615820303|FG000|Overall Study|Protocol deviation|2|||
170404341|NCT00995930|615820304|FG001|Overall Study|Protocol deviation|5|||
170404342|NCT00995930|615820303|FG000|Overall Study|Death|0|||
170404343|NCT00995930|615820304|FG001|Overall Study|Death|1|||
170404344|NCT00995930|615820303|FG000|Overall Study|Administrative problems|4|||
170404345|NCT00995930|615820304|FG001|Overall Study|Administrative problems|2|||
170404346|NCT00995930|615820303|FG000|Overall Study|Lost to Follow-up|1|||
170404347|NCT00995930|615820304|FG001|Overall Study|Lost to Follow-up|2|||
170404348|NCT00995930|615820303|FG000|Overall Study|Withdrawal by Subject|3|||
170404349|NCT00995930|615820304|FG001|Overall Study|Withdrawal by Subject|4|||
170404350|NCT00995930|615820303|FG000|Overall Study|Adverse Event|11|||
170404351|NCT00995930|615820304|FG001|Overall Study|Adverse Event|14|||
170404352|NCT00766506|615822223|FG000|Overall Study|Use rescue medication after 3 hours|3|||
170404353|NCT00766506|615822224|FG001|Overall Study|Use rescue medication after 3 hours|0|||
170404354|NCT00766506|615822223|FG000|Overall Study|Other|2|||
170404355|NCT00766506|615822224|FG001|Overall Study|Other|2|||
170404356|NCT01246986|615822225|FG000|Overall Study|Lost to Follow-up|0|||
170404357|NCT01246986|615822226|FG001|Overall Study|Lost to Follow-up|1|||
170404358|NCT01246986|615822227|FG002|Overall Study|Lost to Follow-up|3|||
170404359|NCT01246986|615822228|FG003|Overall Study|Lost to Follow-up|0|||
170404360|NCT01246986|615822229|FG004|Overall Study|Lost to Follow-up|0|||
170404361|NCT01246986|615822230|FG005|Overall Study|Lost to Follow-up|1|||
170404362|NCT01246986|615822231|FG006|Overall Study|Lost to Follow-up|0|||
170404363|NCT01246986|615822225|FG000|Overall Study|Withdrawal by Subject|3|||
170404364|NCT01246986|615822226|FG001|Overall Study|Withdrawal by Subject|4|||
170404365|NCT01246986|615822227|FG002|Overall Study|Withdrawal by Subject|3|||
170404366|NCT01246986|615822228|FG003|Overall Study|Withdrawal by Subject|0|||
170404367|NCT01246986|615822229|FG004|Overall Study|Withdrawal by Subject|4|||
170404368|NCT01246986|615822230|FG005|Overall Study|Withdrawal by Subject|0|||
170404369|NCT01246986|615822231|FG006|Overall Study|Withdrawal by Subject|0|||
170404370|NCT01406873|615822248|FG000|Overall Study|Withdrawal by Subject|1|||
170404371|NCT01406873|615822249|FG001|Overall Study|Withdrawal by Subject|1|||
170404372|NCT03990389|615822250|FG000|Overall Study|Lost to Follow-up|3|||
170404373|NCT03990389|615822251|FG001|Overall Study|Lost to Follow-up|0|||
170404374|NCT00207714|615822252|FG000|Overall Study|Adverse Event|6|||
170404375|NCT00207714|615822253|FG001|Overall Study|Adverse Event|2|||
170404376|NCT00207714|615822254|FG002|Overall Study|Adverse Event|4|||
170404377|NCT00207714|615822255|FG003|Overall Study|Adverse Event|3|||
170404378|NCT00207714|615822256|FG004|Overall Study|Adverse Event|1|||
170865543|NCT01862640|617519933|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
170519692|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170404379|NCT00207714|615822252|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
170404380|NCT00207714|615822253|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170404381|NCT00207714|615822254|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
170404382|NCT00207714|615822255|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
170404383|NCT00207714|615822256|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
170404384|NCT00207714|615822252|FG000|Overall Study|Other|3|||
170404385|NCT00207714|615822253|FG001|Overall Study|Other|2|||
170404386|NCT00207714|615822254|FG002|Overall Study|Other|5|||
170404387|NCT00207714|615822255|FG003|Overall Study|Other|1|||
170404388|NCT00207714|615822256|FG004|Overall Study|Other|0|||
170404389|NCT01165242|615822257|FG000|Overall Study|Unreachable Subjects|1|||
170404390|NCT01165242|615822258|FG001|Overall Study|Unreachable Subjects|0|||
170404391|NCT01165242|615822259|FG002|Overall Study|Unreachable Subjects|0|||
170404392|NCT01165242|615822257|FG000|Overall Study|Incarcerated Subjects|0|||
170404393|NCT01165242|615822258|FG001|Overall Study|Incarcerated Subjects|1|||
170404394|NCT01165242|615822259|FG002|Overall Study|Incarcerated Subjects|0|||
170404395|NCT01165242|615822257|FG000|Overall Study|Visit 2 Declined by Subject|0|||
170404396|NCT01165242|615822258|FG001|Overall Study|Visit 2 Declined by Subject|0|||
170404397|NCT01165242|615822259|FG002|Overall Study|Visit 2 Declined by Subject|1|||
170404398|NCT01165242|615822257|FG000|Overall Study|Withdrawal by Subject|0|||
170404399|NCT01165242|615822258|FG001|Overall Study|Withdrawal by Subject|2|||
170404400|NCT01165242|615822259|FG002|Overall Study|Withdrawal by Subject|2|||
170404401|NCT01165242|615822257|FG000|Overall Study|Extended Holiday|0|||
170404402|NCT01165242|615822258|FG001|Overall Study|Extended Holiday|0|||
170404403|NCT01165242|615822259|FG002|Overall Study|Extended Holiday|1|||
170404404|NCT01165242|615822257|FG000|Overall Study|Lost to Follow-up|9|||
170404405|NCT01165242|615822258|FG001|Overall Study|Lost to Follow-up|7|||
170404406|NCT01165242|615822259|FG002|Overall Study|Lost to Follow-up|10|||
170404407|NCT03770000|615822262|FG000|Overall Study|Premature discontinuation due to PD|0|||
170404408|NCT03770000|615822263|FG001|Overall Study|Premature discontinuation due to PD|0|||
170404409|NCT03770000|615822264|FG002|Overall Study|Premature discontinuation due to PD|1|||
170404410|NCT03770000|615822265|FG003|Overall Study|Premature discontinuation due to PD|3|||
170404411|NCT03770000|615822266|FG004|Overall Study|Premature discontinuation due to PD|2|||
170404412|NCT03877237|615822267|FG000|Overall Study|Adverse Event|1|||
170404413|NCT03877237|615822268|FG001|Overall Study|Adverse Event|2|||
170404414|NCT03877237|615822267|FG000|Overall Study|Death|3|||
170404415|NCT03877237|615822268|FG001|Overall Study|Death|2|||
170404416|NCT03877237|615822267|FG000|Overall Study|Physician Decision|1|||
170404417|NCT03877237|615822268|FG001|Overall Study|Physician Decision|0|||
170404418|NCT03877237|615822267|FG000|Overall Study|Withdrawal by Subject|0|||
170404419|NCT03877237|615822268|FG001|Overall Study|Withdrawal by Subject|2|||
170404420|NCT02595528|615822269|FG000|Overall Study|Withdrawal by Subject|1|||
170404421|NCT02595528|615822270|FG001|Overall Study|Withdrawal by Subject|2|||
170404422|NCT02595528|615822271|FG002|Overall Study|Withdrawal by Subject|1|||
170404423|NCT02595528|615822272|FG003|Overall Study|Withdrawal by Subject|3|||
170404424|NCT02595528|615822269|FG000|Overall Study|Lost to Follow-up|1|||
170404425|NCT02595528|615822270|FG001|Overall Study|Lost to Follow-up|1|||
170404426|NCT02595528|615822271|FG002|Overall Study|Lost to Follow-up|0|||
170404427|NCT02595528|615822272|FG003|Overall Study|Lost to Follow-up|1|||
170404428|NCT03202511|615822273|FG000|Overall Study|Withdrawal by Subject|1|||
170404429|NCT03202511|615822274|FG001|Overall Study|Withdrawal by Subject|0|||
170404430|NCT00686790|615822275|FG000|Overall Study|Adverse Event|2|||
170404431|NCT00686790|615822275|FG000|Overall Study|Withdrawal by Subject|1|||
170404432|NCT00686790|615822275|FG000|Overall Study|Death|1|||
170404433|NCT00686790|615822275|FG000|Overall Study|Lost to Follow-up|12|||
170404434|NCT00096382|615822278|FG000|Overall Study|Not treated|1|||
170404435|NCT00096382|615822279|FG001|Overall Study|Not treated|0|||
170404436|NCT00096382|615822278|FG000|Overall Study|Death during treatment|1|||
170404437|NCT00096382|615822279|FG001|Overall Study|Death during treatment|0|||
170404438|NCT00382291|615822280|FG000|Overall Study|Adverse Event|1|||
170404439|NCT00382291|615822281|FG001|Overall Study|Adverse Event|2|||
170404440|NCT00382291|615822282|FG002|Overall Study|Adverse Event|2|||
170404441|NCT00382291|615822280|FG000|Overall Study|Protocol Violation|1|||
170404442|NCT00382291|615822281|FG001|Overall Study|Protocol Violation|0|||
170404443|NCT00382291|615822282|FG002|Overall Study|Protocol Violation|0|||
170404444|NCT00382291|615822280|FG000|Overall Study|Temporary study suspension|2|||
170404445|NCT00382291|615822281|FG001|Overall Study|Temporary study suspension|2|||
170404446|NCT00382291|615822282|FG002|Overall Study|Temporary study suspension|5|||
170404447|NCT00382291|615822280|FG000|Overall Study|Withdrawal by Subject|0|||
170756022|NCT04955626|617111014|FG008|Open-Label Period|Adverse Event|0|||
170756023|NCT04955626|617111015|FG009|Open-Label Period|Adverse Event|0|||
170756024|NCT04955626|617111016|FG010|Open-Label Period|Adverse Event|0|||
170404448|NCT00382291|615822281|FG001|Overall Study|Withdrawal by Subject|2|||
170404449|NCT00382291|615822282|FG002|Overall Study|Withdrawal by Subject|0|||
170404450|NCT00382291|615822280|FG000|Overall Study|Physician Decision|0|||
170404451|NCT00382291|615822281|FG001|Overall Study|Physician Decision|1|||
170404452|NCT00382291|615822282|FG002|Overall Study|Physician Decision|0|||
170404453|NCT00382291|615822280|FG000|Overall Study|Lack of Efficacy|0|||
170404454|NCT00382291|615822281|FG001|Overall Study|Lack of Efficacy|0|||
170404455|NCT00382291|615822282|FG002|Overall Study|Lack of Efficacy|1|||
170404456|NCT03862625|615822283|FG000|Overall Study|Lost to Follow-up|0|||
170404457|NCT03862625|615822284|FG001|Overall Study|Lost to Follow-up|1|||
170404458|NCT02082912|615822285|FG000|Overall Study|Physician Decision|0|||
170404459|NCT02082912|615822286|FG001|Overall Study|Physician Decision|1|||
170404460|NCT02266706|615822287|FG000|Overall Study|Withdrawal by Subject|0|||
170404461|NCT02266706|615822288|FG001|Overall Study|Withdrawal by Subject|1|||
170404462|NCT02266706|615822289|FG002|Overall Study|Withdrawal by Subject|1|||
170756025|NCT04955626|617111017|FG011|Open-Label Period|Adverse Event|0|||
170404463|NCT02266706|615822290|FG003|Overall Study|Withdrawal by Subject|0|||
170404464|NCT02266706|615822291|FG004|Overall Study|Withdrawal by Subject|0|||
170404465|NCT02266706|615822292|FG005|Overall Study|Withdrawal by Subject|1|||
170404466|NCT02266706|615822293|FG006|Overall Study|Withdrawal by Subject|0|||
170404467|NCT02266706|615822294|FG007|Overall Study|Withdrawal by Subject|0|||
170404468|NCT02266706|615822295|FG008|Overall Study|Withdrawal by Subject|0|||
170404469|NCT02266706|615822287|FG000|Overall Study|Screen failure|0|||
170404470|NCT02266706|615822288|FG001|Overall Study|Screen failure|0|||
170404471|NCT02266706|615822289|FG002|Overall Study|Screen failure|0|||
170404472|NCT02266706|615822290|FG003|Overall Study|Screen failure|0|||
170404473|NCT02266706|615822291|FG004|Overall Study|Screen failure|0|||
170404474|NCT02266706|615822292|FG005|Overall Study|Screen failure|1|||
170404475|NCT02266706|615822293|FG006|Overall Study|Screen failure|1|||
170404476|NCT02266706|615822294|FG007|Overall Study|Screen failure|0|||
170404477|NCT02266706|615822295|FG008|Overall Study|Screen failure|0|||
170404478|NCT02266706|615822287|FG000|Overall Study|Enrollment in another study|0|||
170404479|NCT02266706|615822288|FG001|Overall Study|Enrollment in another study|0|||
170404480|NCT02266706|615822289|FG002|Overall Study|Enrollment in another study|0|||
170404481|NCT02266706|615822290|FG003|Overall Study|Enrollment in another study|1|||
170404482|NCT02266706|615822291|FG004|Overall Study|Enrollment in another study|0|||
170404483|NCT02266706|615822292|FG005|Overall Study|Enrollment in another study|0|||
170404484|NCT02266706|615822293|FG006|Overall Study|Enrollment in another study|0|||
170404485|NCT02266706|615822294|FG007|Overall Study|Enrollment in another study|0|||
170404486|NCT02266706|615822295|FG008|Overall Study|Enrollment in another study|0|||
170404487|NCT02614703|615822297|FG000|Overall Study|Withdrawal by Subject|7|||
170404488|NCT02614703|615822298|FG001|Overall Study|Withdrawal by Subject|1|||
170404489|NCT01977352|615822307|FG000|Overall Study|Lost to Follow-up|1|||
170404490|NCT01977352|615822308|FG001|Overall Study|Lost to Follow-up|2|||
170404491|NCT00856778|615822312|FG000|Overall Study|Adverse Event|7|||
170404492|NCT00856778|615822312|FG000|Overall Study|Withdrawal by Subject|10|||
170404493|NCT00856778|615822312|FG000|Overall Study|Study deviation|2|||
170404494|NCT00856778|615822312|FG000|Overall Study|Lost to Follow-up|5|||
170404495|NCT01681771|615822313|FG000|Overall Study|Lost to Follow-up|4|||
170404496|NCT01681771|615822314|FG001|Overall Study|Lost to Follow-up|2|||
170404497|NCT02270983|615822315|FG000|Overall Study|Adverse Event|3|||
170404498|NCT02270983|615822316|FG001|Overall Study|Adverse Event|2|||
170404499|NCT02270983|615822317|FG002|Overall Study|Adverse Event|6|||
170404500|NCT02270983|615822315|FG000|Overall Study|Lack of Efficacy|2|||
170404501|NCT02270983|615822316|FG001|Overall Study|Lack of Efficacy|1|||
170404502|NCT02270983|615822317|FG002|Overall Study|Lack of Efficacy|1|||
170404503|NCT02270983|615822315|FG000|Overall Study|Withdrawal by Subject|1|||
170404504|NCT02270983|615822316|FG001|Overall Study|Withdrawal by Subject|0|||
170404505|NCT02270983|615822317|FG002|Overall Study|Withdrawal by Subject|2|||
170404506|NCT02270983|615822315|FG000|Overall Study|Lost to Follow-up|1|||
170404507|NCT02270983|615822316|FG001|Overall Study|Lost to Follow-up|1|||
170404508|NCT02270983|615822317|FG002|Overall Study|Lost to Follow-up|2|||
170404509|NCT02270983|615822315|FG000|Overall Study|Protocol Violation|1|||
170404510|NCT02270983|615822316|FG001|Overall Study|Protocol Violation|1|||
170404511|NCT02270983|615822317|FG002|Overall Study|Protocol Violation|1|||
170404512|NCT02270983|615822315|FG000|Overall Study|family emergency|0|||
170404513|NCT02270983|615822316|FG001|Overall Study|family emergency|1|||
170404514|NCT02270983|615822317|FG002|Overall Study|family emergency|0|||
170404515|NCT02270983|615822315|FG000|Overall Study|study procedure non-compliance|1|||
170404516|NCT02270983|615822316|FG001|Overall Study|study procedure non-compliance|0|||
170404517|NCT02270983|615822317|FG002|Overall Study|study procedure non-compliance|0|||
170404518|NCT02270983|615822315|FG000|Overall Study|moved away from study site|0|||
170404519|NCT02270983|615822316|FG001|Overall Study|moved away from study site|1|||
170404520|NCT02270983|615822317|FG002|Overall Study|moved away from study site|0|||
170404521|NCT00265083|615822318|FG000|Overall Study|Adverse Event|5|||
170404522|NCT00265083|615822319|FG001|Overall Study|Adverse Event|13|||
170404523|NCT00265083|615822320|FG002|Overall Study|Adverse Event|15|||
170404524|NCT00265083|615822318|FG000|Overall Study|Lost to Follow-up|3|||
170404525|NCT00265083|615822319|FG001|Overall Study|Lost to Follow-up|4|||
170404526|NCT00265083|615822320|FG002|Overall Study|Lost to Follow-up|4|||
170404527|NCT00265083|615822318|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
170404528|NCT00265083|615822319|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
170404529|NCT00265083|615822320|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
170756026|NCT04955626|617111018|FG012|Open-Label Period|Adverse Event|0|||
170756027|NCT04955626|617111019|FG013|Open-Label Period|Adverse Event|0|||
170404530|NCT00265083|615822318|FG000|Overall Study|Other|1|||
170404531|NCT00265083|615822319|FG001|Overall Study|Other|12|||
170404532|NCT00265083|615822320|FG002|Overall Study|Other|9|||
170404533|NCT03208933|615822321|FG000|Overall Study|Death|3|||
170404534|NCT03208933|615822321|FG000|Overall Study|Withdrawal by Subject|3|||
170404535|NCT03208933|615822321|FG000|Overall Study|Adverse Event|1|||
170404536|NCT03208933|615822321|FG000|Overall Study|Lost to Follow-up|2|||
170404537|NCT03208933|615822321|FG000|Overall Study|Physician Decision|3|||
170404538|NCT03208933|615822321|FG000|Overall Study|Protocol Violation|1|||
170404539|NCT00854620|615822322|FG000|Overall Study|Adverse Event|1|||
170404540|NCT00550420|615822325|FG000|Overall Study|Adverse Event|28|||
170404541|NCT00550420|615822325|FG000|Overall Study|Lost to Follow-up|8|||
170404542|NCT00550420|615822325|FG000|Overall Study|Protocol Violation|11|||
170404543|NCT00550420|615822325|FG000|Overall Study|Withdrawal by Subject|30|||
170404544|NCT00550420|615822325|FG000|Overall Study|Still in study at termination|206|||
170404545|NCT00550420|615822325|FG000|Overall Study|Missing|2|||
170404546|NCT00550420|615822325|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
170404547|NCT00550420|615822325|FG000|Overall Study|Investigators opinion|1|||
170404548|NCT00550420|615822325|FG000|Overall Study|Lack of curative effect|1|||
170404549|NCT00550420|615822325|FG000|Overall Study|Unethical stop of enrollment|2|||
170404550|NCT00550420|615822325|FG000|Overall Study|Caregiver's decision to withdraw|1|||
170404551|NCT00550420|615822325|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
170404552|NCT00550420|615822325|FG000|Overall Study|Exclusion criteria|1|||
170404553|NCT00550420|615822325|FG000|Overall Study|Prohibited medicine|1|||
170404554|NCT02019979|615822326|FG000|Overall Study|study terminated|14|||
170404555|NCT02598193|615822330|FG000|Overall Study|Adverse Event|13|||
170404556|NCT02598193|615822330|FG000|Overall Study|Withdrawal by Subject|1|||
170404557|NCT02598193|615822330|FG000|Overall Study|Listed in active lung transplant list|1|||
170404558|NCT02598193|615822330|FG000|Overall Study|Does not want to take Nintedanib|1|||
170404559|NCT03870997|615822331|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
170404560|NCT03870997|615822332|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
170404561|NCT03870997|615822333|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
170404562|NCT03870997|615822334|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
170404563|NCT03870997|615822335|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
170404564|NCT03870997|615822336|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
170404565|NCT02059187|615822341|FG000|Overall Study|Adverse Event|0|||
170404566|NCT02059187|615822342|FG001|Overall Study|Adverse Event|3|||
170404567|NCT02059187|615822341|FG000|Overall Study|Death|1|||
170404568|NCT02059187|615822342|FG001|Overall Study|Death|1|||
170404569|NCT02059187|615822341|FG000|Overall Study|Lost to Follow-up|9|||
170404570|NCT02059187|615822342|FG001|Overall Study|Lost to Follow-up|8|||
170404571|NCT02059187|615822341|FG000|Overall Study|Non-compliance with study drug|1|||
170404572|NCT02059187|615822342|FG001|Overall Study|Non-compliance with study drug|0|||
170404573|NCT02059187|615822341|FG000|Overall Study|Physician Decision|1|||
170404574|NCT02059187|615822342|FG001|Overall Study|Physician Decision|2|||
170404575|NCT02059187|615822341|FG000|Overall Study|Protocol Violation|1|||
170404576|NCT02059187|615822342|FG001|Overall Study|Protocol Violation|0|||
170404577|NCT02059187|615822341|FG000|Overall Study|Withdrawal by Subject|12|||
170404578|NCT02059187|615822342|FG001|Overall Study|Withdrawal by Subject|8|||
170404579|NCT03751020|615822343|FG000|Overall Study|Withdrawal by Subject|2|||
170404580|NCT03751020|615822344|FG001|Overall Study|Withdrawal by Subject|0|||
170404581|NCT03751020|615822345|FG002|Overall Study|Withdrawal by Subject|0|||
170404582|NCT03751020|615822343|FG000|Overall Study|Lost to Follow-up|7|||
170404583|NCT03751020|615822344|FG001|Overall Study|Lost to Follow-up|4|||
170404584|NCT03751020|615822345|FG002|Overall Study|Lost to Follow-up|10|||
170404585|NCT01889862|615822346|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
170404586|NCT01889862|615822347|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
170404587|NCT01889862|615822348|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
170404588|NCT01889862|615822349|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
170404589|NCT01889862|615822350|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
170404590|NCT01889862|615822346|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
170404591|NCT01889862|615822347|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
170404592|NCT01889862|615822348|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
170404593|NCT01889862|615822349|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
170404594|NCT01889862|615822350|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
170404595|NCT01889862|615822346|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
170404596|NCT01889862|615822347|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
170404597|NCT01889862|615822348|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
170404598|NCT01889862|615822349|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
170404599|NCT01889862|615822350|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
170404600|NCT01889862|615822346|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
170404601|NCT01889862|615822347|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
170404602|NCT01889862|615822348|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
170404603|NCT01889862|615822349|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
170404604|NCT01889862|615822350|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
170404605|NCT01889862|615822346|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
170865544|NCT01862640|617519934|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
170865545|NCT01862640|617519935|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
170865546|NCT01862640|617519932|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
170865547|NCT01862640|617519933|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
170404606|NCT01889862|615822347|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
170404607|NCT01889862|615822348|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
170404608|NCT01889862|615822349|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
170404609|NCT01889862|615822350|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
170404610|NCT01889862|615822346|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
170404611|NCT01889862|615822347|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
170404612|NCT01889862|615822348|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
170404613|NCT01889862|615822349|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
170404614|NCT01889862|615822350|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
170404615|NCT01889862|615822346|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
170404616|NCT01889862|615822347|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
170404617|NCT01889862|615822348|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
170404618|NCT01889862|615822349|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
170404619|NCT01889862|615822350|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
170404620|NCT01889862|615822346|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
170404621|NCT01889862|615822347|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
170404622|NCT01889862|615822348|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
170404623|NCT01889862|615822349|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
170404624|NCT01889862|615822350|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
170404625|NCT01889862|615822346|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
170404626|NCT01889862|615822347|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
170404627|NCT01889862|615822348|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
170404628|NCT01889862|615822349|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
170404629|NCT01889862|615822350|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
170404630|NCT01889862|615822346|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
170404631|NCT01889862|615822347|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
170404632|NCT01889862|615822348|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
170404633|NCT01889862|615822349|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
170404634|NCT01889862|615822350|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
170404635|NCT00528879|615822351|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
170404636|NCT00528879|615822352|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
170404637|NCT00528879|615822353|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
170404638|NCT00528879|615822354|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
170404639|NCT00528879|615822351|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
170404640|NCT00528879|615822352|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
170404641|NCT00528879|615822353|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
170404642|NCT00528879|615822354|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
170404643|NCT00528879|615822351|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
170404644|NCT00528879|615822352|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
170404645|NCT00528879|615822353|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
170404646|NCT00528879|615822354|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
170404647|NCT00528879|615822351|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
170404648|NCT00528879|615822352|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
170404649|NCT00528879|615822353|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
170404650|NCT00528879|615822354|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
170404651|NCT00528879|615822351|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
170404652|NCT00528879|615822352|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
170404653|NCT00528879|615822353|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
170404654|NCT00528879|615822354|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
170404655|NCT00528879|615822351|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
170404656|NCT00528879|615822352|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
170404657|NCT00528879|615822353|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
170404658|NCT00528879|615822354|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
170756028|NCT04955626|617111020|FG014|Open-Label Period|Adverse Event|0|||
170756029|NCT04955626|617111021|FG015|Open-Label Period|Adverse Event|0|||
170756030|NCT04955626|617111022|FG016|Open-Label Period|Adverse Event|0|||
170756031|NCT04955626|617111023|FG017|Open-Label Period|Adverse Event|0|||
170756032|NCT04955626|617111024|FG018|Open-Label Period|Adverse Event|0|||
170756033|NCT04955626|617111025|FG019|Open-Label Period|Adverse Event|0|||
170756034|NCT04955626|617111026|FG020|Open-Label Period|Adverse Event|0|||
170756035|NCT04955626|617111027|FG021|Open-Label Period|Adverse Event|0|||
170756036|NCT04955626|617111028|FG022|Open-Label Period|Adverse Event|0|||
170756037|NCT04955626|617111029|FG023|Open-Label Period|Adverse Event|0|||
170756038|NCT04955626|617111030|FG024|Open-Label Period|Adverse Event|0|||
170756039|NCT04955626|617111031|FG025|Open-Label Period|Adverse Event|0|||
170756040|NCT04955626|617111032|FG026|Open-Label Period|Adverse Event|0|||
170404659|NCT00528879|615822351|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
170404660|NCT00528879|615822352|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
170404661|NCT00528879|615822353|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
170756041|NCT04955626|617111033|FG027|Open-Label Period|Adverse Event|0|||
170756042|NCT04955626|617111034|FG028|Open-Label Period|Adverse Event|0|||
170756043|NCT04955626|617111035|FG029|Open-Label Period|Adverse Event|0|||
170756044|NCT04955626|617111036|FG030|Open-Label Period|Adverse Event|0|||
170404662|NCT00528879|615822354|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
170404663|NCT00528879|615822351|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
170404664|NCT00528879|615822352|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
170404665|NCT00528879|615822353|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
170404666|NCT00528879|615822354|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
170404667|NCT00528879|615822351|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
170404668|NCT00528879|615822352|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
170404669|NCT00528879|615822353|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
170404670|NCT00528879|615822354|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
170404671|NCT00528879|615822351|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
170404672|NCT00528879|615822352|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
170404673|NCT00528879|615822353|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
170404674|NCT00528879|615822354|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
170404675|NCT00528879|615822351|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
170404676|NCT00528879|615822352|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
170404677|NCT00528879|615822353|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
170404678|NCT00528879|615822354|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
170404679|NCT00528879|615822351|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
170404680|NCT00528879|615822352|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
170404681|NCT00528879|615822353|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
170404682|NCT00528879|615822354|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
170404683|NCT00528879|615822351|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
170404684|NCT00528879|615822352|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
170404685|NCT00528879|615822353|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
170404686|NCT00528879|615822354|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
170404687|NCT00528879|615822351|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
170404688|NCT00528879|615822352|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
170404689|NCT00528879|615822353|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
170404690|NCT00528879|615822354|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
170404691|NCT00528879|615822351|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
170404692|NCT00528879|615822352|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
170404693|NCT00528879|615822353|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
170404694|NCT00528879|615822354|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
170404695|NCT00528879|615822351|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
170404696|NCT00528879|615822352|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
170404697|NCT00528879|615822353|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
170404698|NCT00528879|615822354|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
170404699|NCT02555618|615822355|FG000|Overall Study|Sponsor's Circumstances|1|||
170404700|NCT02555618|615822356|FG001|Overall Study|Sponsor's Circumstances|0|||
170404701|NCT01827371|615822357|FG000|Overall Study|Adverse Event|0|||
170404702|NCT01827371|615822358|FG001|Overall Study|Adverse Event|0|||
170404703|NCT01827371|615822359|FG002|Overall Study|Adverse Event|4|||
170404704|NCT01827371|615822360|FG003|Overall Study|Adverse Event|2|||
170404705|NCT01827371|615822357|FG000|Overall Study|Lost to Follow-up|0|||
170404706|NCT01827371|615822358|FG001|Overall Study|Lost to Follow-up|2|||
170404707|NCT01827371|615822359|FG002|Overall Study|Lost to Follow-up|0|||
170404708|NCT01827371|615822360|FG003|Overall Study|Lost to Follow-up|4|||
170404709|NCT01827371|615822357|FG000|Overall Study|Protocol Violation|1|||
170404710|NCT01827371|615822358|FG001|Overall Study|Protocol Violation|0|||
170404711|NCT01827371|615822359|FG002|Overall Study|Protocol Violation|0|||
170404712|NCT01827371|615822360|FG003|Overall Study|Protocol Violation|0|||
170404713|NCT01827371|615822357|FG000|Overall Study|Withdrawal by Subject|1|||
170404714|NCT01827371|615822358|FG001|Overall Study|Withdrawal by Subject|2|||
170404715|NCT01827371|615822359|FG002|Overall Study|Withdrawal by Subject|2|||
170404716|NCT01827371|615822360|FG003|Overall Study|Withdrawal by Subject|3|||
170404717|NCT01827371|615822357|FG000|Overall Study|Physician Decision|0|||
170404718|NCT01827371|615822358|FG001|Overall Study|Physician Decision|1|||
170404719|NCT01827371|615822359|FG002|Overall Study|Physician Decision|0|||
170404720|NCT01827371|615822360|FG003|Overall Study|Physician Decision|1|||
170404721|NCT01827371|615822357|FG000|Overall Study|Temporary study halt to vaccinations|11|||
170404722|NCT01827371|615822358|FG001|Overall Study|Temporary study halt to vaccinations|2|||
170404723|NCT01827371|615822359|FG002|Overall Study|Temporary study halt to vaccinations|5|||
170404724|NCT01827371|615822360|FG003|Overall Study|Temporary study halt to vaccinations|13|||
170404725|NCT02217345|615822361|FG000|Overall Study|Lost to Follow-up|2|||
170404726|NCT02217345|615822362|FG001|Overall Study|Lost to Follow-up|1|||
170404727|NCT02217345|615822361|FG000|Overall Study|Withdrawal by Subject|3|||
170404728|NCT02217345|615822362|FG001|Overall Study|Withdrawal by Subject|2|||
170404729|NCT02217345|615822361|FG000|Overall Study|Adverse Event|2|||
170404730|NCT02217345|615822362|FG001|Overall Study|Adverse Event|1|||
170404731|NCT02217345|615822361|FG000|Overall Study|Physician Decision|0|||
170404732|NCT02217345|615822362|FG001|Overall Study|Physician Decision|1|||
170756045|NCT04955626|617111037|FG031|Open-Label Period|Adverse Event|0|||
170404733|NCT00971204|615822363|FG000|Overall Study|Did not meet all criteria-not treated|14|||
170404734|NCT00971204|615822363|FG000|Overall Study|Lost to Follow-up|10|||
170404735|NCT00272961|615822364|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
170404736|NCT00272961|615822365|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
170404737|NCT00272961|615822366|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
170404738|NCT00272961|615822367|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
170404739|NCT00272961|615822368|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
170404740|NCT00272961|615822364|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
170404741|NCT00272961|615822365|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
170404742|NCT00272961|615822366|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
170404743|NCT00272961|615822367|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
170404744|NCT00272961|615822368|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
170404745|NCT00272961|615822364|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
170404746|NCT00272961|615822365|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
170404747|NCT00272961|615822366|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
170404748|NCT00272961|615822367|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
170404749|NCT00272961|615822368|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
170404750|NCT00272961|615822364|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
170404751|NCT00272961|615822365|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
170404752|NCT00272961|615822366|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
170404753|NCT00272961|615822367|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
170404754|NCT00272961|615822368|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
170404755|NCT00272961|615822364|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
170404756|NCT00272961|615822365|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
170404757|NCT00272961|615822366|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
170404758|NCT00272961|615822367|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
170404759|NCT00272961|615822368|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
170404760|NCT00272961|615822364|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
170404761|NCT00272961|615822365|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
170404762|NCT00272961|615822366|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
170404763|NCT00272961|615822367|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
170404764|NCT00272961|615822368|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
170404765|NCT00272961|615822364|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
170404766|NCT00272961|615822365|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
170404767|NCT00272961|615822366|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
170404768|NCT00272961|615822367|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
170404769|NCT00272961|615822368|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
170404770|NCT00272961|615822364|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
170404771|NCT00272961|615822365|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
170404772|NCT00272961|615822366|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
170404773|NCT00272961|615822367|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
170404774|NCT00272961|615822368|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
170404775|NCT00879970|615822369|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
170404776|NCT00879970|615822370|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
170404777|NCT00879970|615822371|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
170404778|NCT00879970|615822372|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
170404779|NCT00879970|615822373|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
170404780|NCT00879970|615822369|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
170404781|NCT00879970|615822370|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
170404782|NCT00879970|615822371|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
170404783|NCT00879970|615822372|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
170404784|NCT00879970|615822373|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
170404785|NCT00879970|615822369|FG000|Period 1 TZD Randomization|Death|2|||
170404786|NCT00879970|615822370|FG001|Period 1 TZD Randomization|Death|1|||
170404787|NCT00879970|615822371|FG002|Period 1 TZD Randomization|Death|0|||
170404788|NCT00879970|615822372|FG003|Period 1 TZD Randomization|Death|0|||
170404789|NCT00879970|615822373|FG004|Period 1 TZD Randomization|Death|0|||
170404790|NCT00879970|615822369|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
170404791|NCT00879970|615822370|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
170404792|NCT00879970|615822371|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
170404793|NCT00879970|615822372|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
170404794|NCT00879970|615822373|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
170404795|NCT00879970|615822369|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
170404796|NCT00879970|615822370|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
170865548|NCT01862640|617519934|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
170865549|NCT01862640|617519935|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
170404797|NCT00879970|615822371|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
170404798|NCT00879970|615822372|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
170404799|NCT00879970|615822373|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
170404800|NCT00879970|615822369|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
170404801|NCT00879970|615822370|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
170404802|NCT00879970|615822371|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
170404803|NCT00879970|615822372|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
170404804|NCT00879970|615822373|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
170404805|NCT00879970|615822369|FG000|Period 2 Vitamin D Randomization|Death|0|||
170404806|NCT00879970|615822370|FG001|Period 2 Vitamin D Randomization|Death|0|||
170404807|NCT00879970|615822371|FG002|Period 2 Vitamin D Randomization|Death|0|||
170404808|NCT00879970|615822372|FG003|Period 2 Vitamin D Randomization|Death|2|||
170404809|NCT00879970|615822373|FG004|Period 2 Vitamin D Randomization|Death|0|||
170404810|NCT00051636|615822378|FG000|Period 1 - Core|Adverse Event|2|||
170404811|NCT00051636|615822379|FG001|Period 1 - Core|Adverse Event|2|||
170404812|NCT00051636|615822378|FG000|Period 1 - Core|Protocol Violation|1|||
170404813|NCT00051636|615822379|FG001|Period 1 - Core|Protocol Violation|0|||
170404814|NCT00051636|615822378|FG000|Period 1 - Core|Withdrawal by Subject|1|||
170404815|NCT00051636|615822379|FG001|Period 1 - Core|Withdrawal by Subject|2|||
170404816|NCT00051636|615822378|FG000|Period 1 - Core|Lost to Follow-up|0|||
170404817|NCT00051636|615822379|FG001|Period 1 - Core|Lost to Follow-up|2|||
170404818|NCT00051636|615822378|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
170404819|NCT00051636|615822379|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
170404820|NCT00051636|615822378|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
170404821|NCT00051636|615822379|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
170404822|NCT00051636|615822378|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
170404823|NCT00051636|615822379|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
170404824|NCT00051636|615822378|FG000|Period 2- Extended Observation Period|Death|4|||
170404825|NCT00051636|615822379|FG001|Period 2- Extended Observation Period|Death|5|||
170404826|NCT00051636|615822378|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
170404827|NCT00051636|615822379|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
170404828|NCT03056001|615822384|FG000|Overall Study|Death|24|||
170404829|NCT03550794|615822387|FG000|Overall Study|No longer met inclusion criteria|1|||
170404830|NCT03550794|615822388|FG001|Overall Study|No longer met inclusion criteria|2|||
170404831|NCT03550794|615822387|FG000|Overall Study|Goals of care changed|1|||
170404832|NCT03550794|615822388|FG001|Overall Study|Goals of care changed|0|||
170404833|NCT03550794|615822387|FG000|Overall Study|Withdrawal by Subject|2|||
170404834|NCT03550794|615822388|FG001|Overall Study|Withdrawal by Subject|0|||
170404835|NCT03550794|615822387|FG000|Overall Study|Death|0|||
170404836|NCT03550794|615822388|FG001|Overall Study|Death|1|||
170404837|NCT01864525|615822389|FG000|Overall Study|Adverse Event|1|||
170404838|NCT01864525|615822390|FG001|Overall Study|Adverse Event|0|||
170404839|NCT03712228|615822391|FG000|Treatment Period 1|Lack of Efficacy|0|||
170404840|NCT03712228|615822392|FG001|Treatment Period 1|Lack of Efficacy|0|||
170404841|NCT03712228|615822393|FG002|Treatment Period 1|Lack of Efficacy|0|||
170404842|NCT03712228|615822394|FG003|Treatment Period 1|Lack of Efficacy|0|||
170404843|NCT03712228|615822395|FG004|Treatment Period 1|Lack of Efficacy|0|||
170404844|NCT03712228|615822396|FG005|Treatment Period 1|Lack of Efficacy|1|||
170404845|NCT03712228|615822391|FG000|Treatment Period 2|Pregnancy|0|||
170404846|NCT03712228|615822392|FG001|Treatment Period 2|Pregnancy|0|||
170404847|NCT03712228|615822393|FG002|Treatment Period 2|Pregnancy|0|||
170404848|NCT03712228|615822394|FG003|Treatment Period 2|Pregnancy|1|||
170404849|NCT03712228|615822395|FG004|Treatment Period 2|Pregnancy|0|||
170404850|NCT03712228|615822396|FG005|Treatment Period 2|Pregnancy|0|||
170404851|NCT03712228|615822391|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170404852|NCT03712228|615822392|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170404853|NCT03712228|615822393|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170404854|NCT03712228|615822394|FG003|Treatment Period 2|Withdrawal by Subject|1|||
170404855|NCT03712228|615822395|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170404856|NCT03712228|615822396|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170404857|NCT03296553|615822397|FG000|Overall Study|Withdrawal by Subject|1|||
170404858|NCT03296553|615822398|FG001|Overall Study|Withdrawal by Subject|1|||
170756046|NCT04955626|617111038|FG032|Open-Label Period|Adverse Event|0|||
170756047|NCT04955626|617111039|FG033|Open-Label Period|Adverse Event|0|||
170404859|NCT03296553|615822397|FG000|Overall Study|Death|1|||
170404860|NCT03296553|615822398|FG001|Overall Study|Death|0|||
170404861|NCT00558519|615822399|FG000|Overall Study|Ph+|20|||
170404862|NCT00558519|615822399|FG000|Overall Study|Ineligible|1|||
170404863|NCT00558519|615822399|FG000|Overall Study|Insufficient data|1|||
170404864|NCT00558519|615822399|FG000|Overall Study|Never received treatment|1|||
170404865|NCT01050673|615822400|FG000|Overall Study|Physician Decision|4|||
170404866|NCT01050673|615822401|FG001|Overall Study|Physician Decision|5|||
170404867|NCT00520351|615822402|FG000|First Intervention|Withdrawal by Subject|1|||
170756048|NCT04955626|617111040|FG034|Open-Label Period|Adverse Event|0|||
170404868|NCT00520351|615822403|FG001|First Intervention|Withdrawal by Subject|1|||
170404869|NCT03797222|615822406|FG000|Overall Study|Withdrawal by Subject|1|||
170404870|NCT00725725|615822410|FG000|Overall Study|Adverse Event|1|||
170404871|NCT00725725|615822411|FG001|Overall Study|Adverse Event|3|||
170404872|NCT00725725|615822412|FG002|Overall Study|Adverse Event|2|||
170404873|NCT00725725|615822410|FG000|Overall Study|Lost to Follow-up|2|||
170404874|NCT00725725|615822411|FG001|Overall Study|Lost to Follow-up|0|||
170404875|NCT00725725|615822412|FG002|Overall Study|Lost to Follow-up|2|||
170404876|NCT00725725|615822410|FG000|Overall Study|Withdrawal by Subject|1|||
170404877|NCT00725725|615822411|FG001|Overall Study|Withdrawal by Subject|0|||
170404878|NCT00725725|615822412|FG002|Overall Study|Withdrawal by Subject|1|||
170404879|NCT00725725|615822410|FG000|Overall Study|Protocol Violation|0|||
170404880|NCT00725725|615822411|FG001|Overall Study|Protocol Violation|1|||
170404881|NCT00725725|615822412|FG002|Overall Study|Protocol Violation|0|||
170404882|NCT04288115|615822414|FG000|Overall Study|Withdrawal by Subject|0|||
170404883|NCT04288115|615822415|FG001|Overall Study|Withdrawal by Subject|1|||
170404884|NCT04288115|615822414|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
170404885|NCT04288115|615822415|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
170404886|NCT02766400|615822418|FG000|Overall Study|Death|1|||
170404887|NCT02766400|615822419|FG001|Overall Study|Death|2|||
170404888|NCT02766400|615822418|FG000|Overall Study|Withdrawal by Subject|1|||
170404889|NCT02766400|615822419|FG001|Overall Study|Withdrawal by Subject|0|||
170404890|NCT00928135|615822429|FG000|Overall Study|Withdrawal by Subject|1|||
170404891|NCT00928135|615822430|FG001|Overall Study|Withdrawal by Subject|0|||
170404892|NCT01458119|615822435|FG000|Overall Study|Physician Decision|4|||
170404893|NCT01458119|615822435|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
170404894|NCT01458119|615822435|FG000|Overall Study|Pregnancy|1|||
170404895|NCT01458119|615822435|FG000|Overall Study|Death|2|||
170404896|NCT01458119|615822435|FG000|Overall Study|Adverse Event|1|||
170404897|NCT01458119|615822435|FG000|Overall Study|Consent Withdrawn by Participant|8|||
170404898|NCT01458119|615822435|FG000|Overall Study|Non-compliance With Study Drug|3|||
170404899|NCT02290028|615824784|FG000|Overall Study|Death|217|||
170404900|NCT02290028|615824784|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
170404901|NCT02290028|615824784|FG000|Overall Study|No longer under care of study physician|76|||
170404902|NCT02290028|615824784|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
170404903|NCT02290028|615824784|FG000|Overall Study|Withdrawal by Subject|52|||
170404904|NCT02290028|615824784|FG000|Overall Study|Study site closure|44|||
170404905|NCT02290028|615824784|FG000|Overall Study|Lost to Follow-up|34|||
170404906|NCT02290028|615824784|FG000|Overall Study|Miscellaneous|10|||
170404907|NCT02290028|615824784|FG000|Overall Study|Transition to EP PASSION|1295|||
170404908|NCT02290028|615824784|FG000|Overall Study|Planned study completion at 12 months|257|||
170404909|NCT03372083|615824785|FG000|Overall Study|Adverse Event|3|||
170404910|NCT03372083|615824785|FG000|Overall Study|Physician Decision|1|||
170404911|NCT03372083|615824785|FG000|Overall Study|Withdrawal by Subject|1|||
170404912|NCT00833547|615824786|FG000|Overall Study|Withdrawal by Subject|2|||
170404913|NCT00833547|615824787|FG001|Overall Study|Withdrawal by Subject|2|||
170404914|NCT02236754|615824791|FG000|Overall Study|Withdrawal by Subject|1|||
170404915|NCT02236754|615824792|FG001|Overall Study|Withdrawal by Subject|0|||
170404916|NCT01326702|615824793|FG000|Overall Study|Other|1|||
170404917|NCT01326702|615824794|FG001|Overall Study|Other|0|||
170404918|NCT01326702|615824795|FG002|Overall Study|Other|0|||
170404919|NCT01326702|615824796|FG003|Overall Study|Other|0|||
170404920|NCT01326702|615824797|FG004|Overall Study|Other|0|||
170404921|NCT01326702|615824798|FG005|Overall Study|Other|1|||
170404922|NCT01326702|615824799|FG006|Overall Study|Other|0|||
170404923|NCT01326702|615824793|FG000|Overall Study|progressive disease|1|||
170404924|NCT01326702|615824794|FG001|Overall Study|progressive disease|1|||
170404925|NCT01326702|615824795|FG002|Overall Study|progressive disease|3|||
170404926|NCT01326702|615824796|FG003|Overall Study|progressive disease|1|||
170404927|NCT01326702|615824797|FG004|Overall Study|progressive disease|3|||
170404928|NCT01326702|615824798|FG005|Overall Study|progressive disease|2|||
170404929|NCT01326702|615824799|FG006|Overall Study|progressive disease|3|||
170404930|NCT01326702|615824793|FG000|Overall Study|Death|0|||
170404931|NCT01326702|615824794|FG001|Overall Study|Death|1|||
170404932|NCT01326702|615824795|FG002|Overall Study|Death|0|||
170404933|NCT01326702|615824796|FG003|Overall Study|Death|0|||
170404934|NCT01326702|615824797|FG004|Overall Study|Death|0|||
170404935|NCT01326702|615824798|FG005|Overall Study|Death|0|||
170404936|NCT01326702|615824799|FG006|Overall Study|Death|0|||
170404937|NCT01326702|615824793|FG000|Overall Study|Adverse Event|0|||
170404938|NCT01326702|615824794|FG001|Overall Study|Adverse Event|0|||
170404939|NCT01326702|615824795|FG002|Overall Study|Adverse Event|1|||
170404940|NCT01326702|615824796|FG003|Overall Study|Adverse Event|1|||
170404941|NCT01326702|615824797|FG004|Overall Study|Adverse Event|0|||
170404942|NCT01326702|615824798|FG005|Overall Study|Adverse Event|3|||
170404943|NCT01326702|615824799|FG006|Overall Study|Adverse Event|1|||
170404944|NCT01326702|615824793|FG000|Overall Study|Withdrawal by Subject|0|||
170404945|NCT01326702|615824794|FG001|Overall Study|Withdrawal by Subject|0|||
170404946|NCT01326702|615824795|FG002|Overall Study|Withdrawal by Subject|1|||
170404947|NCT01326702|615824796|FG003|Overall Study|Withdrawal by Subject|0|||
170404948|NCT01326702|615824797|FG004|Overall Study|Withdrawal by Subject|1|||
170404949|NCT01326702|615824798|FG005|Overall Study|Withdrawal by Subject|1|||
170404950|NCT01326702|615824799|FG006|Overall Study|Withdrawal by Subject|3|||
170404951|NCT01326702|615824793|FG000|Overall Study|Not Treated|0|||
170404952|NCT01326702|615824794|FG001|Overall Study|Not Treated|0|||
170756049|NCT04955626|617111041|FG035|Open-Label Period|Adverse Event|0|||
170756050|NCT04955626|617111006|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
170756051|NCT04955626|617111007|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
170756052|NCT04955626|617111008|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
170756053|NCT04955626|617111009|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
170756054|NCT04955626|617111010|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
170756055|NCT04955626|617111011|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
170756056|NCT04955626|617111012|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
170756057|NCT04955626|617111013|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
170756058|NCT04955626|617111014|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
170756059|NCT04955626|617111015|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
170756060|NCT04955626|617111016|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
170756061|NCT04955626|617111017|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
170756062|NCT04955626|617111018|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
170756063|NCT04955626|617111019|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
170756064|NCT04955626|617111020|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
170756065|NCT04955626|617111021|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
170756066|NCT04955626|617111022|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
170756067|NCT04955626|617111023|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
170756068|NCT04955626|617111024|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
170756069|NCT04955626|617111025|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
170756070|NCT04955626|617111026|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
170756071|NCT04955626|617111027|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
170756072|NCT04955626|617111028|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
170756073|NCT04955626|617111029|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
170756074|NCT04955626|617111030|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
170756075|NCT04955626|617111031|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
170756076|NCT04955626|617111032|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
170756077|NCT04955626|617111033|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
170756078|NCT04955626|617111034|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
170756079|NCT04955626|617111035|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
170756080|NCT04955626|617111036|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
170756081|NCT04955626|617111037|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
170756082|NCT04955626|617111038|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
170756083|NCT04955626|617111039|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
170756084|NCT04955626|617111040|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
170756085|NCT04955626|617111041|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
170756086|NCT04955626|617111006|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756087|NCT04955626|617111007|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
170756088|NCT04955626|617111008|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756089|NCT04955626|617111009|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756090|NCT04955626|617111010|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756091|NCT04955626|617111011|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756092|NCT04955626|617111012|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756093|NCT04955626|617111013|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756094|NCT04955626|617111014|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756095|NCT04955626|617111015|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756096|NCT04955626|617111016|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756097|NCT04955626|617111017|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756098|NCT04955626|617111018|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756099|NCT04955626|617111019|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756100|NCT04955626|617111020|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756101|NCT04955626|617111021|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756102|NCT04955626|617111022|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170865550|NCT01862640|617519932|FG000|Overall Study|Withdrawal by Subject|2|||
170865551|NCT01862640|617519933|FG001|Overall Study|Withdrawal by Subject|4|||
170865552|NCT01862640|617519934|FG002|Overall Study|Withdrawal by Subject|8|||
170404953|NCT01326702|615824795|FG002|Overall Study|Not Treated|0|||
170404954|NCT01326702|615824796|FG003|Overall Study|Not Treated|1|||
170404955|NCT01326702|615824797|FG004|Overall Study|Not Treated|0|||
170404956|NCT01326702|615824798|FG005|Overall Study|Not Treated|1|||
170404957|NCT01326702|615824799|FG006|Overall Study|Not Treated|0|||
170404958|NCT02544633|615824800|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
170404959|NCT02544633|615824801|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
170404960|NCT02544633|615824802|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
170404961|NCT02544633|615824803|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
170404962|NCT02544633|615824800|FG000|Treatment Period|Adverse Event|7|||
170404963|NCT02544633|615824801|FG001|Treatment Period|Adverse Event|4|||
170404964|NCT02544633|615824802|FG002|Treatment Period|Adverse Event|0|||
170404965|NCT02544633|615824803|FG003|Treatment Period|Adverse Event|5|||
170404966|NCT02544633|615824800|FG000|Treatment Period|Lack of Efficacy|17|||
170404967|NCT02544633|615824801|FG001|Treatment Period|Lack of Efficacy|11|||
170404968|NCT02544633|615824802|FG002|Treatment Period|Lack of Efficacy|5|||
170404969|NCT02544633|615824803|FG003|Treatment Period|Lack of Efficacy|5|||
170404970|NCT02544633|615824800|FG000|Treatment Period|Global Deterioration of Health|3|||
170404971|NCT02544633|615824801|FG001|Treatment Period|Global Deterioration of Health|3|||
170404972|NCT02544633|615824802|FG002|Treatment Period|Global Deterioration of Health|0|||
170404973|NCT02544633|615824803|FG003|Treatment Period|Global Deterioration of Health|1|||
170404974|NCT02544633|615824800|FG000|Treatment Period|Withdrawal by Subject|1|||
170404975|NCT02544633|615824801|FG001|Treatment Period|Withdrawal by Subject|0|||
170404976|NCT02544633|615824802|FG002|Treatment Period|Withdrawal by Subject|0|||
170404977|NCT02544633|615824803|FG003|Treatment Period|Withdrawal by Subject|0|||
170404978|NCT02544633|615824800|FG000|Treatment Period|Lost to Follow-up|0|||
170404979|NCT02544633|615824801|FG001|Treatment Period|Lost to Follow-up|1|||
170404980|NCT02544633|615824802|FG002|Treatment Period|Lost to Follow-up|0|||
170404981|NCT02544633|615824803|FG003|Treatment Period|Lost to Follow-up|0|||
170404982|NCT02544633|615824800|FG000|Treatment Period|Death|0|||
170404983|NCT02544633|615824801|FG001|Treatment Period|Death|0|||
170404984|NCT02544633|615824802|FG002|Treatment Period|Death|1|||
170404985|NCT02544633|615824803|FG003|Treatment Period|Death|0|||
170404986|NCT02544633|615824800|FG000|Treatment Period|Non-compliance|0|||
170404987|NCT02544633|615824801|FG001|Treatment Period|Non-compliance|0|||
170404988|NCT02544633|615824802|FG002|Treatment Period|Non-compliance|1|||
170404989|NCT02544633|615824803|FG003|Treatment Period|Non-compliance|0|||
170404990|NCT02544633|615824800|FG000|Treatment Period|Clinical Disease Progression|0|||
170404991|NCT02544633|615824801|FG001|Treatment Period|Clinical Disease Progression|0|||
170404992|NCT02544633|615824802|FG002|Treatment Period|Clinical Disease Progression|0|||
170404993|NCT02544633|615824803|FG003|Treatment Period|Clinical Disease Progression|1|||
170404994|NCT02544633|615824800|FG000|Survival Follow-up Period|Death|12|||
170404995|NCT02544633|615824801|FG001|Survival Follow-up Period|Death|14|||
170404996|NCT02544633|615824802|FG002|Survival Follow-up Period|Death|3|||
170404997|NCT02544633|615824803|FG003|Survival Follow-up Period|Death|9|||
170404998|NCT02544633|615824800|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
170404999|NCT02544633|615824801|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
170405000|NCT02544633|615824802|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
170405001|NCT02544633|615824803|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
170405002|NCT02544633|615824800|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
170405003|NCT02544633|615824801|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
170405004|NCT02544633|615824802|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
170405005|NCT02544633|615824803|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
170405006|NCT02544633|615824800|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
170405007|NCT02544633|615824801|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
170405008|NCT02544633|615824802|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
170405009|NCT02544633|615824803|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
170405010|NCT02092961|615824804|FG000|Overall Study|Not reported|1|||
170405011|NCT02092961|615824805|FG001|Overall Study|Not reported|0|||
170405012|NCT02092961|615824806|FG002|Overall Study|Not reported|1|||
170405013|NCT02092961|615824804|FG000|Overall Study|Study stopped|13|||
170405014|NCT02092961|615824805|FG001|Overall Study|Study stopped|9|||
170405015|NCT02092961|615824806|FG002|Overall Study|Study stopped|12|||
170405016|NCT02092961|615824804|FG000|Overall Study|Lack of therapeutic response|2|||
170405017|NCT02092961|615824805|FG001|Overall Study|Lack of therapeutic response|1|||
170405018|NCT02092961|615824806|FG002|Overall Study|Lack of therapeutic response|3|||
170405019|NCT02092961|615824804|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
170405020|NCT02092961|615824805|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
170405021|NCT02092961|615824806|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
170405022|NCT02092961|615824804|FG000|Overall Study|Adverse Event|2|||
170405023|NCT02092961|615824805|FG001|Overall Study|Adverse Event|4|||
170865553|NCT01862640|617519935|FG003|Overall Study|Withdrawal by Subject|5|||
170865554|NCT01862640|617519932|FG000|Overall Study|Protocol Deviation|0|||
170405024|NCT02092961|615824806|FG002|Overall Study|Adverse Event|0|||
170405025|NCT01792284|615824807|FG000|Lead-in Period|Adverse Event|15|||
170631982|NCT02446899|616664489|FG000|Overall Study|Withdrawal by Subject|11|||
170405026|NCT01792284|615824808|FG001|Lead-in Period|Adverse Event|0|||
170405027|NCT01792284|615824809|FG002|Lead-in Period|Adverse Event|0|||
170405028|NCT01792284|615824807|FG000|Lead-in Period|Lost to Follow-up|2|||
170865555|NCT01862640|617519933|FG001|Overall Study|Protocol Deviation|0|||
170405029|NCT01792284|615824808|FG001|Lead-in Period|Lost to Follow-up|0|||
170405030|NCT01792284|615824809|FG002|Lead-in Period|Lost to Follow-up|0|||
170405031|NCT01792284|615824807|FG000|Lead-in Period|Protocol Violation|1|||
170405032|NCT01792284|615824808|FG001|Lead-in Period|Protocol Violation|0|||
170405033|NCT01792284|615824809|FG002|Lead-in Period|Protocol Violation|0|||
170405034|NCT01792284|615824807|FG000|Lead-in Period|Withdrawal by Subject|10|||
170405035|NCT01792284|615824808|FG001|Lead-in Period|Withdrawal by Subject|0|||
170405036|NCT01792284|615824809|FG002|Lead-in Period|Withdrawal by Subject|0|||
170405037|NCT01792284|615824807|FG000|Lead-in Period|Physician Decision|1|||
170405038|NCT01792284|615824808|FG001|Lead-in Period|Physician Decision|0|||
170405039|NCT01792284|615824809|FG002|Lead-in Period|Physician Decision|0|||
170405040|NCT01792284|615824807|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
170405041|NCT01792284|615824808|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
170405042|NCT01792284|615824809|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
170405043|NCT01792284|615824807|FG000|Randomization Period 1|Withdrawal by Subject|0|||
170405044|NCT01792284|615824808|FG001|Randomization Period 1|Withdrawal by Subject|1|||
170405045|NCT01792284|615824809|FG002|Randomization Period 1|Withdrawal by Subject|1|||
170405046|NCT01792284|615824807|FG000|Randomization Period 1|Physician Decision|0|||
170405047|NCT01792284|615824808|FG001|Randomization Period 1|Physician Decision|1|||
170405048|NCT01792284|615824809|FG002|Randomization Period 1|Physician Decision|1|||
170405049|NCT01792284|615824807|FG000|Randomization Period 1|Adverse Event|0|||
170405050|NCT01792284|615824808|FG001|Randomization Period 1|Adverse Event|0|||
170405051|NCT01792284|615824809|FG002|Randomization Period 1|Adverse Event|2|||
170405052|NCT01792284|615824807|FG000|Randomization Period 1|Lost to Follow-up|0|||
170405053|NCT01792284|615824808|FG001|Randomization Period 1|Lost to Follow-up|0|||
170405054|NCT01792284|615824809|FG002|Randomization Period 1|Lost to Follow-up|1|||
170405055|NCT01792284|615824807|FG000|Randomization Period 2|Protocol Violation|0|||
170405056|NCT01792284|615824808|FG001|Randomization Period 2|Protocol Violation|1|||
170405057|NCT01792284|615824809|FG002|Randomization Period 2|Protocol Violation|0|||
170405058|NCT01792284|615824807|FG000|Randomization Period 2|Withdrawal by Subject|0|||
170405059|NCT01792284|615824808|FG001|Randomization Period 2|Withdrawal by Subject|2|||
170405060|NCT01792284|615824809|FG002|Randomization Period 2|Withdrawal by Subject|0|||
170405061|NCT03237611|615824811|FG000|Overall Study|Withdrawal by Subject|1|||
170405062|NCT03237611|615824811|FG000|Overall Study|Ineligible|1|||
170405063|NCT00534092|615824816|FG000|Overall Study|Lost to Follow-up|1|||
170405064|NCT00534092|615824817|FG001|Overall Study|Lost to Follow-up|0|||
170405065|NCT00534092|615824816|FG000|Overall Study|personal reasons/family concerns|1|||
170405066|NCT00534092|615824817|FG001|Overall Study|personal reasons/family concerns|0|||
170405067|NCT01169649|615824818|FG000|Overall Study|Patient Not Treated|3|||
170405068|NCT02919475|615824819|FG000|Overall Study|Adverse Event|3|||
170405069|NCT02919475|615824820|FG001|Overall Study|Adverse Event|3|||
170405070|NCT02919475|615824821|FG002|Overall Study|Adverse Event|3|||
170405071|NCT02919475|615824822|FG003|Overall Study|Adverse Event|9|||
170405072|NCT02919475|615824823|FG004|Overall Study|Adverse Event|2|||
170405073|NCT02919475|615824819|FG000|Overall Study|Death|0|||
170405074|NCT02919475|615824820|FG001|Overall Study|Death|1|||
170405075|NCT02919475|615824821|FG002|Overall Study|Death|0|||
170405076|NCT02919475|615824822|FG003|Overall Study|Death|0|||
170405077|NCT02919475|615824823|FG004|Overall Study|Death|0|||
170405078|NCT02919475|615824819|FG000|Overall Study|Lost to Follow-up|0|||
170405079|NCT02919475|615824820|FG001|Overall Study|Lost to Follow-up|0|||
170405080|NCT02919475|615824821|FG002|Overall Study|Lost to Follow-up|0|||
170405081|NCT02919475|615824822|FG003|Overall Study|Lost to Follow-up|1|||
170405082|NCT02919475|615824823|FG004|Overall Study|Lost to Follow-up|0|||
170405083|NCT02919475|615824819|FG000|Overall Study|Withdrawal by Subject|2|||
170405084|NCT02919475|615824820|FG001|Overall Study|Withdrawal by Subject|3|||
170405085|NCT02919475|615824821|FG002|Overall Study|Withdrawal by Subject|1|||
170405086|NCT02919475|615824822|FG003|Overall Study|Withdrawal by Subject|2|||
170405087|NCT02919475|615824823|FG004|Overall Study|Withdrawal by Subject|2|||
170405088|NCT02919475|615824819|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
170405089|NCT02919475|615824820|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
170405090|NCT02919475|615824821|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
170405091|NCT02919475|615824822|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
170405092|NCT02919475|615824823|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170405093|NCT00275028|615824826|FG000|Overall Study|Withdrew consent before treatment began|1|||
170405094|NCT00275028|615824826|FG000|Overall Study|Withdrawal by Subject|5|||
170405095|NCT00275028|615824826|FG000|Overall Study|Adverse Event|9|||
170405096|NCT00275028|615824826|FG000|Overall Study|Progressive Disease|30|||
170519693|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170405097|NCT00275028|615824826|FG000|Overall Study|Physician Decision|2|||
170405098|NCT00830063|615824827|FG000|Overall Study|Adverse Event|7|||
170405099|NCT00830063|615824828|FG001|Overall Study|Adverse Event|13|||
170405100|NCT00830063|615824829|FG002|Overall Study|Adverse Event|16|||
170405101|NCT00830063|615824830|FG003|Overall Study|Adverse Event|13|||
170405102|NCT00830063|615824827|FG000|Overall Study|Death|1|||
170405103|NCT00830063|615824828|FG001|Overall Study|Death|0|||
170405104|NCT00830063|615824829|FG002|Overall Study|Death|0|||
170405105|NCT00830063|615824830|FG003|Overall Study|Death|0|||
170405106|NCT00830063|615824827|FG000|Overall Study|Lost to Follow-up|0|||
170405107|NCT00830063|615824828|FG001|Overall Study|Lost to Follow-up|0|||
170405108|NCT00830063|615824829|FG002|Overall Study|Lost to Follow-up|3|||
170405109|NCT00830063|615824830|FG003|Overall Study|Lost to Follow-up|1|||
170405110|NCT00830063|615824827|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
170405111|NCT00830063|615824828|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
170405112|NCT00830063|615824829|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
170405113|NCT00830063|615824830|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
170405114|NCT00830063|615824827|FG000|Overall Study|Lack of Efficacy|51|||
170405115|NCT00830063|615824828|FG001|Overall Study|Lack of Efficacy|23|||
170405116|NCT00830063|615824829|FG002|Overall Study|Lack of Efficacy|25|||
170405117|NCT00830063|615824830|FG003|Overall Study|Lack of Efficacy|32|||
170405118|NCT00830063|615824827|FG000|Overall Study|Other|5|||
170405119|NCT00830063|615824828|FG001|Overall Study|Other|5|||
170405120|NCT00830063|615824829|FG002|Overall Study|Other|8|||
170405121|NCT00830063|615824830|FG003|Overall Study|Other|6|||
170405122|NCT00830063|615824827|FG000|Overall Study|Withdrawal by Subject|16|||
170405123|NCT00830063|615824828|FG001|Overall Study|Withdrawal by Subject|10|||
170405124|NCT00830063|615824829|FG002|Overall Study|Withdrawal by Subject|16|||
170405125|NCT00830063|615824830|FG003|Overall Study|Withdrawal by Subject|13|||
170405126|NCT00830063|615824827|FG000|Overall Study|Protocol Violation|1|||
170405127|NCT00830063|615824828|FG001|Overall Study|Protocol Violation|0|||
170405128|NCT00830063|615824829|FG002|Overall Study|Protocol Violation|3|||
170405129|NCT00830063|615824830|FG003|Overall Study|Protocol Violation|2|||
170405130|NCT00830063|615824827|FG000|Overall Study|Randomized But Not Treated|0|||
170405131|NCT00830063|615824828|FG001|Overall Study|Randomized But Not Treated|2|||
170405132|NCT00830063|615824829|FG002|Overall Study|Randomized But Not Treated|0|||
170405133|NCT00830063|615824830|FG003|Overall Study|Randomized But Not Treated|2|||
170405134|NCT02323295|615824831|FG000|Overall Study|Adverse Event|0|||
170405135|NCT02323295|615824832|FG001|Overall Study|Adverse Event|1|||
170405136|NCT02323295|615824831|FG000|Overall Study|Withdrawal by Subject|0|||
170405137|NCT02323295|615824832|FG001|Overall Study|Withdrawal by Subject|1|||
170405138|NCT02323295|615824831|FG000|Overall Study|Patient did not have surgery as planned.|0|||
170405139|NCT02323295|615824832|FG001|Overall Study|Patient did not have surgery as planned.|1|||
170405140|NCT01847313|615824835|FG000|Overall Study|Death|0|||
170405141|NCT01847313|615824836|FG001|Overall Study|Death|1|||
170405142|NCT01847313|615824835|FG000|Overall Study|Withdrawal by Subject|0|||
170405143|NCT01847313|615824836|FG001|Overall Study|Withdrawal by Subject|1|||
170405144|NCT02370784|615824837|FG000|Overall Study|Patient started prohibited medication|0|||
170405145|NCT02370784|615824838|FG001|Overall Study|Patient started prohibited medication|1|||
170405146|NCT00598559|615824840|FG000|Overall Study|Adverse Event|11|||
170405147|NCT00598559|615824841|FG001|Overall Study|Adverse Event|7|||
170405148|NCT00598559|615824842|FG002|Overall Study|Adverse Event|0|||
170405149|NCT00598559|615824840|FG000|Overall Study|Withdrawal by Subject|2|||
170405150|NCT00598559|615824841|FG001|Overall Study|Withdrawal by Subject|2|||
170405151|NCT00598559|615824842|FG002|Overall Study|Withdrawal by Subject|0|||
170405152|NCT00598559|615824840|FG000|Overall Study|Protocol Non-compliance|1|||
170405153|NCT00598559|615824841|FG001|Overall Study|Protocol Non-compliance|0|||
170405154|NCT00598559|615824842|FG002|Overall Study|Protocol Non-compliance|0|||
170405155|NCT00598559|615824840|FG000|Overall Study|Early discharge from hospital|9|||
170405156|NCT00598559|615824841|FG001|Overall Study|Early discharge from hospital|12|||
170405157|NCT00598559|615824842|FG002|Overall Study|Early discharge from hospital|3|||
170405158|NCT00598559|615824840|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
170405159|NCT00598559|615824841|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
170405160|NCT00598559|615824842|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
170405161|NCT01059071|615824843|FG000|Overall Study|Lack of Efficacy|1|||
170405162|NCT01059071|615824844|FG001|Overall Study|Lack of Efficacy|4|||
170405163|NCT01059071|615824845|FG002|Overall Study|Lack of Efficacy|2|||
170405164|NCT01059071|615824846|FG003|Overall Study|Lack of Efficacy|3|||
170405165|NCT01059071|615824843|FG000|Overall Study|Withdrawal by Subject|1|||
170405166|NCT01059071|615824844|FG001|Overall Study|Withdrawal by Subject|0|||
170405167|NCT01059071|615824845|FG002|Overall Study|Withdrawal by Subject|0|||
170405168|NCT01059071|615824846|FG003|Overall Study|Withdrawal by Subject|2|||
170405169|NCT01059071|615824843|FG000|Overall Study|Physician Decision|0|||
170405170|NCT01059071|615824844|FG001|Overall Study|Physician Decision|0|||
170405171|NCT01059071|615824845|FG002|Overall Study|Physician Decision|0|||
170865556|NCT01862640|617519934|FG002|Overall Study|Protocol Deviation|1|||
170405172|NCT01059071|615824846|FG003|Overall Study|Physician Decision|1|||
170405173|NCT02962882|615824847|FG000|Overall Study|Adverse Event|2|||
170405174|NCT02962882|615824847|FG000|Overall Study|Withdrawal by Subject|2|||
170405175|NCT02962882|615824847|FG000|Overall Study|Transfer from ICU|32|||
170405176|NCT03763331|615824850|FG000|Overall Study|Lost to Follow-up|1|||
170405177|NCT03763331|615824851|FG001|Overall Study|Lost to Follow-up|0|||
170405178|NCT03763331|615824850|FG000|Overall Study|Withdrawal by Subject|1|||
170405179|NCT03763331|615824851|FG001|Overall Study|Withdrawal by Subject|0|||
170405180|NCT03763331|615824850|FG000|Overall Study|Non-compliance|0|||
170405181|NCT03763331|615824851|FG001|Overall Study|Non-compliance|3|||
170405182|NCT01155063|615824852|FG000|Overall Study|Adverse Event|1|||
170405183|NCT01155063|615824852|FG000|Overall Study|Withdrawal by Subject|1|||
170405184|NCT01155063|615824852|FG000|Overall Study|Study terminated by sponsor|87|||
170405185|NCT00936884|615824853|FG000|Double-blind|Withdrawal by Subject|6|||
170405186|NCT00936884|615824854|FG001|Double-blind|Withdrawal by Subject|4|||
170405187|NCT00936884|615824855|FG002|Double-blind|Withdrawal by Subject|0|||
170405188|NCT00936884|615824853|FG000|Double-blind|Death|2|||
170405189|NCT00936884|615824854|FG001|Double-blind|Death|1|||
170405190|NCT00936884|615824855|FG002|Double-blind|Death|0|||
170405191|NCT00936884|615824853|FG000|Double-blind|Lack of Efficacy|1|||
170405192|NCT00936884|615824854|FG001|Double-blind|Lack of Efficacy|1|||
170405193|NCT00936884|615824855|FG002|Double-blind|Lack of Efficacy|0|||
170405194|NCT00936884|615824853|FG000|Double-blind|Adverse Event|1|||
170405195|NCT00936884|615824854|FG001|Double-blind|Adverse Event|0|||
170405196|NCT00936884|615824855|FG002|Double-blind|Adverse Event|0|||
170405197|NCT00936884|615824853|FG000|Double-blind|Physician Decision|1|||
170405198|NCT00936884|615824854|FG001|Double-blind|Physician Decision|0|||
170405199|NCT00936884|615824855|FG002|Double-blind|Physician Decision|0|||
170405200|NCT00936884|615824853|FG000|Double-blind|No post baseline diary entry|1|||
170405201|NCT00936884|615824854|FG001|Double-blind|No post baseline diary entry|0|||
170405202|NCT00936884|615824855|FG002|Double-blind|No post baseline diary entry|0|||
170405203|NCT00936884|615824853|FG000|Double-blind|Did not receive study drug|0|||
170405204|NCT00936884|615824854|FG001|Double-blind|Did not receive study drug|1|||
170405205|NCT00936884|615824855|FG002|Double-blind|Did not receive study drug|0|||
170405206|NCT01663714|615824856|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
170405207|NCT01663714|615824856|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
170405208|NCT01663714|615824856|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
170405209|NCT01663714|615824856|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
170405210|NCT01663714|615824856|FG000|Long-Term Follow-Up|Death|4|||
170405211|NCT01663714|615824856|FG000|Long-Term Follow-Up|Non-compliance|1|||
170405212|NCT02280421|615824859|FG000|Washout (2 Weeks)|Adverse Event|0|||
170405213|NCT02280421|615824860|FG001|Washout (2 Weeks)|Adverse Event|1|||
170405214|NCT02280421|615824859|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
170405215|NCT02280421|615824860|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
170405216|NCT02791659|615824867|FG000|Overall Study|Protocol Violation|0|||
170405217|NCT02791659|615824868|FG001|Overall Study|Protocol Violation|1|||
170405218|NCT01625845|615824869|FG000|Overall Study|Adverse Event|1|||
170405219|NCT01625845|615824870|FG001|Overall Study|Adverse Event|2|||
170405220|NCT01625845|615824869|FG000|Overall Study|Lost to Follow-up|2|||
170405221|NCT01625845|615824870|FG001|Overall Study|Lost to Follow-up|1|||
170405222|NCT01625845|615824869|FG000|Overall Study|Withdrawal by Subject|2|||
170405223|NCT01625845|615824870|FG001|Overall Study|Withdrawal by Subject|0|||
170405224|NCT01113710|615824871|FG000|Overall Study|Adverse Event|64|||
170405225|NCT01113710|615824871|FG000|Overall Study|Lack of Efficacy|41|||
170405226|NCT01113710|615824871|FG000|Overall Study|No Information Available|40|||
170405227|NCT01113710|615824871|FG000|Overall Study|Withdrawal by Subject|28|||
170405228|NCT01113710|615824871|FG000|Overall Study|Lost to Follow-up|20|||
170405229|NCT01113710|615824871|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
170405230|NCT01113710|615824871|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
170405231|NCT01113710|615824871|FG000|Overall Study|Lack of Patient's Compliance|8|||
170405232|NCT01113710|615824871|FG000|Overall Study|Other|7|||
170405233|NCT01113710|615824871|FG000|Overall Study|Adverse Event/Other|5|||
170405234|NCT01113710|615824871|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
170405235|NCT01113710|615824871|FG000|Overall Study|Lack of Efficacy/Other|4|||
170405236|NCT01113710|615824871|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
170405237|NCT01113710|615824871|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
170405238|NCT01113710|615824871|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
170405239|NCT01113710|615824871|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
170405240|NCT01113710|615824871|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
170405241|NCT01113710|615824871|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
170405242|NCT01113710|615824871|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
170405243|NCT01113710|615824871|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
170405244|NCT01113710|615824871|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
170405245|NCT01113710|615824871|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
170405246|NCT01113710|615824871|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
170405247|NCT01113710|615824871|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
170405248|NCT01113710|615824871|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
170405249|NCT02770716|615824872|FG000|Overall Study|Death|101|||
170405250|NCT02770716|615824873|FG001|Overall Study|Death|45|||
170405251|NCT02770716|615824872|FG000|Overall Study|Withdrawal by Subject|4|||
170405252|NCT02770716|615824873|FG001|Overall Study|Withdrawal by Subject|2|||
170405253|NCT02770716|615824872|FG000|Overall Study|Lost to Follow-up|1|||
170405254|NCT02770716|615824873|FG001|Overall Study|Lost to Follow-up|0|||
170405255|NCT02770716|615824872|FG000|Overall Study|Various reasons|6|||
170405256|NCT02770716|615824873|FG001|Overall Study|Various reasons|2|||
170865557|NCT01862640|617519935|FG003|Overall Study|Protocol Deviation|0|||
170865558|NCT03294109|617519938|FG000|Overall Study|Withdrawal by Subject|6|||
170865559|NCT03294109|617519939|FG001|Overall Study|Withdrawal by Subject|5|||
170865560|NCT03026127|617519944|FG000|CRISP R61|Adverse Event|5|||
170865561|NCT03026127|617519945|FG001|CRISP R61|Adverse Event|0|||
170865562|NCT03026127|617519946|FG002|CRISP R61|Adverse Event|0|||
170865563|NCT03026127|617519944|FG000|CRISP R61|Lost to Follow-up|2|||
170865564|NCT03026127|617519945|FG001|CRISP R61|Lost to Follow-up|0|||
170865565|NCT03026127|617519946|FG002|CRISP R61|Lost to Follow-up|0|||
170865566|NCT03026127|617519944|FG000|CRISP R61|Dropped before therapy|5|||
170865567|NCT03026127|617519945|FG001|CRISP R61|Dropped before therapy|0|||
170865568|NCT03026127|617519946|FG002|CRISP R61|Dropped before therapy|0|||
170865569|NCT03026127|617519944|FG000|CRISP R33|Lost to Follow-up|0|||
170865570|NCT03026127|617519945|FG001|CRISP R33|Lost to Follow-up|5|||
170865571|NCT03026127|617519946|FG002|CRISP R33|Lost to Follow-up|4|||
170865572|NCT03026127|617519944|FG000|CRISP R33|Adverse Event|0|||
170865573|NCT03026127|617519945|FG001|CRISP R33|Adverse Event|9|||
170865574|NCT03026127|617519946|FG002|CRISP R33|Adverse Event|5|||
170865575|NCT03026127|617519944|FG000|CRISP R33|Withdrawal by Subject|0|||
170865576|NCT03026127|617519945|FG001|CRISP R33|Withdrawal by Subject|9|||
170865577|NCT03026127|617519946|FG002|CRISP R33|Withdrawal by Subject|1|||
170865578|NCT03026127|617519944|FG000|CRISP R33|Lack of Efficacy|0|||
170865579|NCT03026127|617519945|FG001|CRISP R33|Lack of Efficacy|3|||
170865580|NCT03026127|617519946|FG002|CRISP R33|Lack of Efficacy|2|||
170865581|NCT03026127|617519944|FG000|CRISP R33|Physician Decision|0|||
170865582|NCT03026127|617519945|FG001|CRISP R33|Physician Decision|3|||
170865583|NCT03026127|617519946|FG002|CRISP R33|Physician Decision|1|||
170865584|NCT03026127|617519944|FG000|CRISP R33|Transportation|0|||
170865585|NCT03026127|617519945|FG001|CRISP R33|Transportation|2|||
170865586|NCT03026127|617519946|FG002|CRISP R33|Transportation|1|||
170865587|NCT01050205|617519949|FG000|Overall Study|Lost to Follow-up|7|||
170865588|NCT01050205|617519950|FG001|Overall Study|Lost to Follow-up|1|||
170865589|NCT01050205|617519949|FG000|Overall Study|Withdrawal by Subject|1|||
170865590|NCT01050205|617519950|FG001|Overall Study|Withdrawal by Subject|1|||
170865591|NCT01050205|617519949|FG000|Overall Study|Relocated from area|1|||
170865592|NCT01050205|617519950|FG001|Overall Study|Relocated from area|2|||
170865593|NCT01050205|617519949|FG000|Overall Study|Discontinued Intervention|2|||
170865594|NCT01050205|617519950|FG001|Overall Study|Discontinued Intervention|0|||
170865595|NCT02511678|617519951|FG000|Overall Study|Withdrawal by Subject|2|||
170865596|NCT02511678|617519951|FG000|Overall Study|Lost to Follow-up|4|||
170865597|NCT02511678|617519951|FG000|Overall Study|Death|19|||
170865598|NCT02511678|617519951|FG000|Overall Study|Adverse Event|1|||
170865599|NCT02511678|617519951|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
170865600|NCT02511678|617519951|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
170865601|NCT02511678|617519951|FG000|Overall Study|Required Radiofrequency Ablation|1|||
170865602|NCT02511678|617519951|FG000|Overall Study|Biopsy was Negative|1|||
170865603|NCT02511678|617519951|FG000|Overall Study|Protocol Violation|1|||
170865604|NCT02511678|617519951|FG000|Overall Study|Received Radiation Treatment|1|||
170865605|NCT00633061|617519952|FG000|Overall Study|Study closed|86|||
170865606|NCT00633061|617519953|FG001|Overall Study|Study closed|0|||
170865607|NCT02000427|617519954|FG000|Overall Study|Death|22|||
170865608|NCT02708095|617519955|FG000|Overall Study|Adverse Event|4|||
170865609|NCT02708095|617519956|FG001|Overall Study|Adverse Event|10|||
170865610|NCT02708095|617519957|FG002|Overall Study|Adverse Event|11|||
170865611|NCT02708095|617519955|FG000|Overall Study|Lack of Efficacy|9|||
170865612|NCT02708095|617519956|FG001|Overall Study|Lack of Efficacy|3|||
170865613|NCT02708095|617519957|FG002|Overall Study|Lack of Efficacy|0|||
170865614|NCT02708095|617519955|FG000|Overall Study|Lost to Follow-up|2|||
170865615|NCT02708095|617519956|FG001|Overall Study|Lost to Follow-up|0|||
170865616|NCT02708095|617519957|FG002|Overall Study|Lost to Follow-up|0|||
170865617|NCT02708095|617519955|FG000|Overall Study|Physician Decision|2|||
170865618|NCT02708095|617519956|FG001|Overall Study|Physician Decision|3|||
170865619|NCT02708095|617519957|FG002|Overall Study|Physician Decision|2|||
170865620|NCT02708095|617519955|FG000|Overall Study|Protocol Violation|0|||
170865621|NCT02708095|617519956|FG001|Overall Study|Protocol Violation|0|||
170865622|NCT02708095|617519957|FG002|Overall Study|Protocol Violation|1|||
170865623|NCT02708095|617519955|FG000|Overall Study|Withdrawal by Subject|5|||
170865624|NCT02708095|617519956|FG001|Overall Study|Withdrawal by Subject|3|||
170865625|NCT02708095|617519957|FG002|Overall Study|Withdrawal by Subject|4|||
170865626|NCT05125679|617519958|FG000|Overall Study|Study Terminated by Sponsor|2|||
170865627|NCT05125679|617519959|FG001|Overall Study|Study Terminated by Sponsor|5|||
170865628|NCT00458341|617519972|FG000|Cycle 1|Adverse Event|1|||
170865629|NCT00458341|617519973|FG001|Cycle 1|Adverse Event|0|||
170865630|NCT04029480|617519976|FG000|Overall Study|Physician Decision|0|||
170865631|NCT04029480|617519977|FG001|Overall Study|Physician Decision|0|||
170865632|NCT04029480|617519978|FG002|Overall Study|Physician Decision|2|||
170865633|NCT04029480|617519979|FG003|Overall Study|Physician Decision|1|||
170865634|NCT04029480|617519976|FG000|Overall Study|Withdrawal by Subject|2|||
170865635|NCT04029480|617519977|FG001|Overall Study|Withdrawal by Subject|0|||
170865636|NCT04029480|617519978|FG002|Overall Study|Withdrawal by Subject|1|||
170405257|NCT01759381|615824879|FG000|Overall Study|Death|1|||
170405258|NCT01759381|615824880|FG001|Overall Study|Death|0|||
170405259|NCT03211156|615824881|FG000|Overall Study|Withdrawal by Subject|0|||
170405260|NCT03211156|615824882|FG001|Overall Study|Withdrawal by Subject|2|||
170405261|NCT03211156|615824881|FG000|Overall Study|Lost to Follow-up|1|||
170405262|NCT03211156|615824882|FG001|Overall Study|Lost to Follow-up|1|||
170405263|NCT03211156|615824881|FG000|Overall Study|Adverse Event|1|||
170405264|NCT03211156|615824882|FG001|Overall Study|Adverse Event|0|||
170405265|NCT00986154|615824888|FG000|Overall Study|Death|136|||
170405266|NCT00986154|615824889|FG001|Overall Study|Death|127|||
170405267|NCT00986154|615824888|FG000|Overall Study|Lost to Follow-up|7|||
170405268|NCT00986154|615824889|FG001|Overall Study|Lost to Follow-up|4|||
170405269|NCT00986154|615824888|FG000|Overall Study|Withdrawal by Subject|32|||
170405270|NCT00986154|615824889|FG001|Overall Study|Withdrawal by Subject|33|||
170405271|NCT00986154|615824888|FG000|Overall Study|investigator/subject decide not continue|6|||
170405272|NCT00986154|615824889|FG001|Overall Study|investigator/subject decide not continue|3|||
170405273|NCT00986154|615824888|FG000|Overall Study|never received study drug|25|||
170405274|NCT00986154|615824889|FG001|Overall Study|never received study drug|27|||
170405275|NCT00667719|615824890|FG000|Overall Study|Adverse Event|39|||
170405276|NCT00667719|615824890|FG000|Overall Study|Abnormal Test Procedure|1|||
170405277|NCT00667719|615824890|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170405278|NCT00667719|615824890|FG000|Overall Study|Protocol Violation|3|||
170405279|NCT00667719|615824890|FG000|Overall Study|Withdrawal by Subject|17|||
170405280|NCT00667719|615824890|FG000|Overall Study|Lost to Follow-up|8|||
170405281|NCT00950599|615824891|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405282|NCT00950599|615824892|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405283|NCT00950599|615824893|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405284|NCT00950599|615824894|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
170405285|NCT00950599|615824895|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405286|NCT00950599|615824896|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405287|NCT00950599|615824897|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405288|NCT00950599|615824898|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405289|NCT00950599|615824899|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405290|NCT00950599|615824900|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
170405291|NCT00950599|615824891|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170405292|NCT00950599|615824892|FG001|Double-Blind Treatment Period|Adverse Event|1|||
170405293|NCT00950599|615824893|FG002|Double-Blind Treatment Period|Adverse Event|1|||
170405294|NCT00950599|615824894|FG003|Double-Blind Treatment Period|Adverse Event|1|||
170405295|NCT00950599|615824895|FG004|Double-Blind Treatment Period|Adverse Event|1|||
170405296|NCT00950599|615824896|FG005|Double-Blind Treatment Period|Adverse Event|1|||
170405297|NCT00950599|615824897|FG006|Double-Blind Treatment Period|Adverse Event|0|||
170405298|NCT00950599|615824898|FG007|Double-Blind Treatment Period|Adverse Event|0|||
170405299|NCT00950599|615824899|FG008|Double-Blind Treatment Period|Adverse Event|0|||
170405300|NCT00950599|615824900|FG009|Double-Blind Treatment Period|Adverse Event|0|||
170405301|NCT00950599|615824891|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
170405302|NCT00950599|615824892|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
170405303|NCT00950599|615824893|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
170405304|NCT00950599|615824894|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
170405305|NCT00950599|615824895|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
170405306|NCT00950599|615824896|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
170405307|NCT00950599|615824897|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
170405308|NCT00950599|615824898|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
170405309|NCT00950599|615824899|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
170405310|NCT00950599|615824900|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
170405311|NCT00950599|615824891|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170405312|NCT00950599|615824892|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
170405313|NCT00950599|615824893|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
170405314|NCT00950599|615824894|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
170405315|NCT00950599|615824895|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
170405316|NCT00950599|615824896|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
170405317|NCT00950599|615824897|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
170405318|NCT00950599|615824898|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
170405319|NCT00950599|615824899|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
170405320|NCT00950599|615824900|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
170405321|NCT00950599|615824891|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
170405322|NCT00950599|615824892|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
170405323|NCT00950599|615824893|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
170405324|NCT00950599|615824894|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
170405325|NCT00950599|615824895|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
170405326|NCT00950599|615824896|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
170405327|NCT00950599|615824897|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
170405328|NCT00950599|615824898|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
170405329|NCT00950599|615824899|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
170405330|NCT00950599|615824900|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
170405331|NCT00950599|615824891|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
170405332|NCT00950599|615824892|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
170405333|NCT00950599|615824893|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
170405334|NCT00950599|615824894|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
170405335|NCT00950599|615824895|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
170405336|NCT00950599|615824896|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
170405337|NCT00950599|615824897|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
170405338|NCT00950599|615824898|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
170405339|NCT00950599|615824899|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
170405340|NCT00950599|615824900|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
170405341|NCT00950599|615824891|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
170405342|NCT00950599|615824892|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
170405343|NCT00950599|615824893|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
170405344|NCT00950599|615824894|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
170405345|NCT00950599|615824895|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
170405346|NCT00950599|615824896|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
170405347|NCT00950599|615824897|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
170405348|NCT00950599|615824898|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
170405349|NCT00950599|615824899|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
170405350|NCT00950599|615824900|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
170405351|NCT00950599|615824891|FG000|Follow-Up Period|Adverse Event|0|||
170405352|NCT00950599|615824892|FG001|Follow-Up Period|Adverse Event|0|||
170405353|NCT00950599|615824893|FG002|Follow-Up Period|Adverse Event|0|||
170405354|NCT00950599|615824894|FG003|Follow-Up Period|Adverse Event|0|||
170405355|NCT00950599|615824895|FG004|Follow-Up Period|Adverse Event|0|||
170405356|NCT00950599|615824896|FG005|Follow-Up Period|Adverse Event|0|||
170405357|NCT00950599|615824897|FG006|Follow-Up Period|Adverse Event|0|||
170405358|NCT00950599|615824898|FG007|Follow-Up Period|Adverse Event|0|||
170405359|NCT00950599|615824899|FG008|Follow-Up Period|Adverse Event|1|||
170405360|NCT00950599|615824900|FG009|Follow-Up Period|Adverse Event|0|||
170405361|NCT00950599|615824891|FG000|Follow-Up Period|Lack of Efficacy|0|||
170405362|NCT00950599|615824892|FG001|Follow-Up Period|Lack of Efficacy|0|||
170405363|NCT00950599|615824893|FG002|Follow-Up Period|Lack of Efficacy|0|||
170405364|NCT00950599|615824894|FG003|Follow-Up Period|Lack of Efficacy|0|||
170405365|NCT00950599|615824895|FG004|Follow-Up Period|Lack of Efficacy|0|||
170405366|NCT00950599|615824896|FG005|Follow-Up Period|Lack of Efficacy|0|||
170405367|NCT00950599|615824897|FG006|Follow-Up Period|Lack of Efficacy|0|||
170405368|NCT00950599|615824898|FG007|Follow-Up Period|Lack of Efficacy|0|||
170405369|NCT00950599|615824899|FG008|Follow-Up Period|Lack of Efficacy|3|||
170405370|NCT00950599|615824900|FG009|Follow-Up Period|Lack of Efficacy|0|||
170405371|NCT00950599|615824891|FG000|Follow-Up Period|Lost to Follow-up|0|||
170405372|NCT00950599|615824892|FG001|Follow-Up Period|Lost to Follow-up|0|||
170405373|NCT00950599|615824893|FG002|Follow-Up Period|Lost to Follow-up|0|||
170405374|NCT00950599|615824894|FG003|Follow-Up Period|Lost to Follow-up|0|||
170405375|NCT00950599|615824895|FG004|Follow-Up Period|Lost to Follow-up|0|||
170405376|NCT00950599|615824896|FG005|Follow-Up Period|Lost to Follow-up|0|||
170405377|NCT00950599|615824897|FG006|Follow-Up Period|Lost to Follow-up|0|||
170405378|NCT00950599|615824898|FG007|Follow-Up Period|Lost to Follow-up|0|||
170405379|NCT00950599|615824899|FG008|Follow-Up Period|Lost to Follow-up|5|||
170405380|NCT00950599|615824900|FG009|Follow-Up Period|Lost to Follow-up|1|||
170405381|NCT00950599|615824891|FG000|Follow-Up Period|Physician Decision|0|||
170405382|NCT00950599|615824892|FG001|Follow-Up Period|Physician Decision|0|||
170405383|NCT00950599|615824893|FG002|Follow-Up Period|Physician Decision|0|||
170405384|NCT00950599|615824894|FG003|Follow-Up Period|Physician Decision|0|||
170405385|NCT00950599|615824895|FG004|Follow-Up Period|Physician Decision|0|||
170405386|NCT00950599|615824896|FG005|Follow-Up Period|Physician Decision|0|||
170405387|NCT00950599|615824897|FG006|Follow-Up Period|Physician Decision|0|||
170405388|NCT00950599|615824898|FG007|Follow-Up Period|Physician Decision|0|||
170405389|NCT00950599|615824899|FG008|Follow-Up Period|Physician Decision|1|||
170405390|NCT00950599|615824900|FG009|Follow-Up Period|Physician Decision|0|||
170405391|NCT00950599|615824891|FG000|Follow-Up Period|Poor/Noncompliance|0|||
170405392|NCT00950599|615824892|FG001|Follow-Up Period|Poor/Noncompliance|0|||
170405393|NCT00950599|615824893|FG002|Follow-Up Period|Poor/Noncompliance|0|||
170405394|NCT00950599|615824894|FG003|Follow-Up Period|Poor/Noncompliance|0|||
170405395|NCT00950599|615824895|FG004|Follow-Up Period|Poor/Noncompliance|0|||
170405396|NCT00950599|615824896|FG005|Follow-Up Period|Poor/Noncompliance|0|||
170405397|NCT00950599|615824897|FG006|Follow-Up Period|Poor/Noncompliance|0|||
170405398|NCT00950599|615824898|FG007|Follow-Up Period|Poor/Noncompliance|0|||
170405399|NCT00950599|615824899|FG008|Follow-Up Period|Poor/Noncompliance|1|||
170405400|NCT00950599|615824900|FG009|Follow-Up Period|Poor/Noncompliance|0|||
170405401|NCT00950599|615824891|FG000|Follow-Up Period|Subject withdrew Consent|0|||
170405402|NCT00950599|615824892|FG001|Follow-Up Period|Subject withdrew Consent|0|||
170405403|NCT00950599|615824893|FG002|Follow-Up Period|Subject withdrew Consent|0|||
170405404|NCT00950599|615824894|FG003|Follow-Up Period|Subject withdrew Consent|0|||
170405405|NCT00950599|615824895|FG004|Follow-Up Period|Subject withdrew Consent|0|||
170405406|NCT00950599|615824896|FG005|Follow-Up Period|Subject withdrew Consent|0|||
170405407|NCT00950599|615824897|FG006|Follow-Up Period|Subject withdrew Consent|0|||
170405408|NCT00950599|615824898|FG007|Follow-Up Period|Subject withdrew Consent|0|||
170405409|NCT00950599|615824899|FG008|Follow-Up Period|Subject withdrew Consent|2|||
170405410|NCT00950599|615824900|FG009|Follow-Up Period|Subject withdrew Consent|1|||
170405411|NCT02624518|615824901|FG000|Overall Study|Physician Decision|1|||
170405412|NCT02729194|615824902|FG000|Overall Study|Withdrawal by Subject|3|||
170405413|NCT02741271|615824907|FG000|Overall Study|Lost to Follow-up|2|||
170405414|NCT02741271|615824908|FG001|Overall Study|Lost to Follow-up|0|||
170405415|NCT02741271|615824907|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170405416|NCT02741271|615824908|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
170405417|NCT03652961|615824909|FG000|Overall Study|Lost to Follow-up|3|||
170405418|NCT03652961|615824909|FG000|Overall Study|Screen Failure|1|||
170405419|NCT00373685|615824910|FG000|Overall Study|Death|2|||
170405420|NCT00373685|615824911|FG001|Overall Study|Death|1|||
170405421|NCT00373685|615824910|FG000|Overall Study|Adverse Event|278|||
170405422|NCT00373685|615824911|FG001|Overall Study|Adverse Event|253|||
170405423|NCT00373685|615824910|FG000|Overall Study|Insufficient clinical response|169|||
170405424|NCT00373685|615824911|FG001|Overall Study|Insufficient clinical response|119|||
170405425|NCT00373685|615824910|FG000|Overall Study|Did not meet entrance criteria|167|||
170405426|NCT00373685|615824911|FG001|Overall Study|Did not meet entrance criteria|184|||
170405427|NCT00373685|615824910|FG000|Overall Study|Lost to follow up|83|||
170405428|NCT00373685|615824911|FG001|Overall Study|Lost to follow up|103|||
170405429|NCT00373685|615824910|FG000|Overall Study|No longer willing to participate|337|||
170405430|NCT00373685|615824911|FG001|Overall Study|No longer willing to participate|352|||
170405431|NCT00373685|615824910|FG000|Overall Study|Other|149|||
170405432|NCT00373685|615824911|FG001|Overall Study|Other|146|||
170405433|NCT00373685|615824910|FG000|Overall Study|Protocol Violation|191|||
170405434|NCT00373685|615824911|FG001|Overall Study|Protocol Violation|182|||
170405435|NCT00373685|615824910|FG000|Overall Study|Final Status Unknown|12|||
170405436|NCT00373685|615824911|FG001|Overall Study|Final Status Unknown|4|||
170405437|NCT00373685|615824910|FG000|Overall Study|Randomized, not treated|51|||
170405438|NCT00373685|615824911|FG001|Overall Study|Randomized, not treated|77|||
170405439|NCT02570165|615824912|FG000|Overall Study|Adverse Event|1|||
170405440|NCT02570165|615824913|FG001|Overall Study|Adverse Event|0|||
170405441|NCT02570165|615824914|FG002|Overall Study|Adverse Event|2|||
170405442|NCT02570165|615824915|FG003|Overall Study|Adverse Event|0|||
170405443|NCT02570165|615824916|FG004|Overall Study|Adverse Event|0|||
170405444|NCT02570165|615824917|FG005|Overall Study|Adverse Event|0|||
170405445|NCT02570165|615824918|FG006|Overall Study|Adverse Event|0|||
170405446|NCT02570165|615824912|FG000|Overall Study|Lack of Efficacy|0|||
170405447|NCT02570165|615824913|FG001|Overall Study|Lack of Efficacy|1|||
170405448|NCT02570165|615824914|FG002|Overall Study|Lack of Efficacy|0|||
170405449|NCT02570165|615824915|FG003|Overall Study|Lack of Efficacy|0|||
170405450|NCT02570165|615824916|FG004|Overall Study|Lack of Efficacy|4|||
170405451|NCT02570165|615824917|FG005|Overall Study|Lack of Efficacy|0|||
170405452|NCT02570165|615824918|FG006|Overall Study|Lack of Efficacy|0|||
170405453|NCT02570165|615824912|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
170405454|NCT02570165|615824913|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
170405455|NCT02570165|615824914|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
170405456|NCT02570165|615824915|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
170405457|NCT02570165|615824916|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
170756103|NCT04955626|617111023|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170405458|NCT02570165|615824917|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
170405459|NCT02570165|615824918|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
170405460|NCT02570165|615824912|FG000|Overall Study|Lost to Follow-up|0|||
170405461|NCT02570165|615824913|FG001|Overall Study|Lost to Follow-up|0|||
170405462|NCT02570165|615824914|FG002|Overall Study|Lost to Follow-up|1|||
170405463|NCT02570165|615824915|FG003|Overall Study|Lost to Follow-up|1|||
170405464|NCT02570165|615824916|FG004|Overall Study|Lost to Follow-up|0|||
170405465|NCT02570165|615824917|FG005|Overall Study|Lost to Follow-up|0|||
170405466|NCT02570165|615824918|FG006|Overall Study|Lost to Follow-up|0|||
170405467|NCT02570165|615824912|FG000|Overall Study|Physician Decision|0|||
170405468|NCT02570165|615824913|FG001|Overall Study|Physician Decision|1|||
170756104|NCT04955626|617111024|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170405469|NCT02570165|615824914|FG002|Overall Study|Physician Decision|0|||
170405470|NCT02570165|615824915|FG003|Overall Study|Physician Decision|0|||
170405471|NCT02570165|615824916|FG004|Overall Study|Physician Decision|0|||
170405472|NCT02570165|615824917|FG005|Overall Study|Physician Decision|0|||
170405473|NCT02570165|615824918|FG006|Overall Study|Physician Decision|0|||
170405474|NCT02570165|615824912|FG000|Overall Study|Withdrawal by Subject|0|||
170405475|NCT02570165|615824913|FG001|Overall Study|Withdrawal by Subject|0|||
170405476|NCT02570165|615824914|FG002|Overall Study|Withdrawal by Subject|0|||
170405477|NCT02570165|615824915|FG003|Overall Study|Withdrawal by Subject|2|||
170405478|NCT02570165|615824916|FG004|Overall Study|Withdrawal by Subject|1|||
170405479|NCT02570165|615824917|FG005|Overall Study|Withdrawal by Subject|0|||
170405480|NCT02570165|615824918|FG006|Overall Study|Withdrawal by Subject|0|||
170405481|NCT02570165|615824912|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
170405482|NCT02570165|615824913|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
170405483|NCT02570165|615824914|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
170405484|NCT02570165|615824915|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
170405485|NCT02570165|615824916|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
170405486|NCT02570165|615824917|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
170405487|NCT02570165|615824918|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
170405488|NCT02570165|615824912|FG000|Overall Study|Withdrawal Request by GSK|0|||
170405489|NCT02570165|615824913|FG001|Overall Study|Withdrawal Request by GSK|0|||
170405490|NCT02570165|615824914|FG002|Overall Study|Withdrawal Request by GSK|2|||
170405491|NCT02570165|615824915|FG003|Overall Study|Withdrawal Request by GSK|0|||
170405492|NCT02570165|615824916|FG004|Overall Study|Withdrawal Request by GSK|0|||
170405493|NCT02570165|615824917|FG005|Overall Study|Withdrawal Request by GSK|0|||
170405494|NCT02570165|615824918|FG006|Overall Study|Withdrawal Request by GSK|0|||
170405495|NCT00995488|615824927|FG000|Overall Study|Withdrawal by Subject|1|||
170405496|NCT00061945|615824928|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
170405497|NCT00061945|615824929|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
170405498|NCT00061945|615824928|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
170405499|NCT00061945|615824929|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
170405500|NCT00061945|615824928|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
170405501|NCT00061945|615824929|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
170405502|NCT00061945|615824928|FG000|Course IV: Alemtuzumab|Early exits|6|||
170405503|NCT00061945|615824929|FG001|Course IV: Alemtuzumab|Early exits|15|||
170405504|NCT01358708|615824932|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
170405505|NCT01358708|615824933|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170405506|NCT01358708|615824932|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
170405507|NCT01358708|615824933|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
170405508|NCT02295280|615824934|FG000|Overall Study|Adverse Event|0|||
170405509|NCT02295280|615824935|FG001|Overall Study|Adverse Event|1|||
170405510|NCT02875067|615824936|FG000|Overall Study|Withdrawal by Subject|1|||
170405511|NCT02875067|615824936|FG000|Overall Study|Withdrawal by Termination of Study|5|||
170405512|NCT02713243|615824938|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
170405513|NCT02713243|615824939|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
170405514|NCT02713243|615824938|FG000|Overall Study|Administrative problems|0|||
170405515|NCT02713243|615824939|FG001|Overall Study|Administrative problems|1|||
170405516|NCT02713243|615824938|FG000|Overall Study|Protocol deviation|0|||
170405517|NCT02713243|615824939|FG001|Overall Study|Protocol deviation|1|||
170405518|NCT00597207|615824942|FG000|Overall Study|Lost to Follow-up|5|||
170405519|NCT00597207|615824943|FG001|Overall Study|Lost to Follow-up|7|||
170405520|NCT03404206|615824953|FG000|Overall Study|Withdrawal by Subject|1|||
170405521|NCT03404206|615824954|FG001|Overall Study|Withdrawal by Subject|1|||
170405522|NCT03404206|615824955|FG002|Overall Study|Withdrawal by Subject|0|||
170405523|NCT03404206|615824953|FG000|Overall Study|Lost to Follow-up|3|||
170405524|NCT03404206|615824954|FG001|Overall Study|Lost to Follow-up|1|||
170405525|NCT03404206|615824955|FG002|Overall Study|Lost to Follow-up|0|||
170405526|NCT00789828|615824956|FG000|Core Period (48 Weeks)|Administrative problems|0|||
170405527|NCT00789828|615824957|FG001|Core Period (48 Weeks)|Administrative problems|1|||
170405528|NCT00789828|615824956|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
170405529|NCT00789828|615824957|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
170405530|NCT00789828|615824956|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
170405531|NCT00789828|615824957|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
170405532|NCT00789828|615824956|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
170405533|NCT00789828|615824957|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
170405534|NCT00789828|615824956|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
170405535|NCT00789828|615824957|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
170405536|NCT00789828|615824956|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
170405537|NCT00789828|615824957|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
170405538|NCT00789828|615824956|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
170405539|NCT00789828|615824957|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
170405540|NCT00789828|615824956|FG000|Open-label Extension Period (4 Years)|Death|1|||
170405541|NCT00789828|615824957|FG001|Open-label Extension Period (4 Years)|Death|0|||
170405542|NCT00789828|615824956|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
170405543|NCT00789828|615824957|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
170405544|NCT00789828|615824956|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
170405545|NCT00789828|615824957|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
170405546|NCT02623426|615824958|FG000|Overall Study|Lost to Follow-up|0|||
170405547|NCT02623426|615824959|FG001|Overall Study|Lost to Follow-up|0|||
170405548|NCT02623426|615824960|FG002|Overall Study|Lost to Follow-up|1|||
170405549|NCT02623426|615824958|FG000|Overall Study|Withdrawal by Subject|1|||
170405550|NCT02623426|615824959|FG001|Overall Study|Withdrawal by Subject|2|||
170405551|NCT02623426|615824960|FG002|Overall Study|Withdrawal by Subject|2|||
170405552|NCT01621490|615826646|FG000|Overall Study|Subject no longer meets study criteria|0|||
170405553|NCT01621490|615826647|FG001|Overall Study|Subject no longer meets study criteria|0|||
170405554|NCT01621490|615826648|FG002|Overall Study|Subject no longer meets study criteria|0|||
170405555|NCT01621490|615826649|FG003|Overall Study|Subject no longer meets study criteria|0|||
170405556|NCT01621490|615826650|FG004|Overall Study|Subject no longer meets study criteria|1|||
170405557|NCT01621490|615826651|FG005|Overall Study|Subject no longer meets study criteria|0|||
170405558|NCT01621490|615826652|FG006|Overall Study|Subject no longer meets study criteria|0|||
170405559|NCT01621490|615826653|FG007|Overall Study|Subject no longer meets study criteria|0|||
170405560|NCT01621490|615826654|FG008|Overall Study|Subject no longer meets study criteria|0|||
170405561|NCT01621490|615826655|FG009|Overall Study|Subject no longer meets study criteria|0|||
170405562|NCT01621490|615826656|FG010|Overall Study|Subject no longer meets study criteria|0|||
170405563|NCT01621490|615826646|FG000|Overall Study|Maximum clinical benefit|3|||
170405564|NCT01621490|615826647|FG001|Overall Study|Maximum clinical benefit|2|||
170405565|NCT01621490|615826648|FG002|Overall Study|Maximum clinical benefit|0|||
170405566|NCT01621490|615826649|FG003|Overall Study|Maximum clinical benefit|0|||
170405567|NCT01621490|615826650|FG004|Overall Study|Maximum clinical benefit|0|||
170405568|NCT01621490|615826651|FG005|Overall Study|Maximum clinical benefit|0|||
170405569|NCT01621490|615826652|FG006|Overall Study|Maximum clinical benefit|1|||
170405570|NCT01621490|615826653|FG007|Overall Study|Maximum clinical benefit|2|||
170405571|NCT01621490|615826654|FG008|Overall Study|Maximum clinical benefit|2|||
170405572|NCT01621490|615826655|FG009|Overall Study|Maximum clinical benefit|0|||
170405573|NCT01621490|615826656|FG010|Overall Study|Maximum clinical benefit|0|||
170405574|NCT01621490|615826646|FG000|Overall Study|Withdrawal by Subject|1|||
170405575|NCT01621490|615826647|FG001|Overall Study|Withdrawal by Subject|0|||
170405576|NCT01621490|615826648|FG002|Overall Study|Withdrawal by Subject|0|||
170405577|NCT01621490|615826649|FG003|Overall Study|Withdrawal by Subject|0|||
170405578|NCT01621490|615826650|FG004|Overall Study|Withdrawal by Subject|0|||
170405579|NCT01621490|615826651|FG005|Overall Study|Withdrawal by Subject|1|||
170405580|NCT01621490|615826652|FG006|Overall Study|Withdrawal by Subject|0|||
170405581|NCT01621490|615826653|FG007|Overall Study|Withdrawal by Subject|0|||
170405582|NCT01621490|615826654|FG008|Overall Study|Withdrawal by Subject|0|||
170405583|NCT01621490|615826655|FG009|Overall Study|Withdrawal by Subject|0|||
170405584|NCT01621490|615826656|FG010|Overall Study|Withdrawal by Subject|0|||
170405585|NCT01621490|615826646|FG000|Overall Study|Subject request to discontinue study|1|||
170405586|NCT01621490|615826647|FG001|Overall Study|Subject request to discontinue study|3|||
170756105|NCT04955626|617111025|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756106|NCT04955626|617111026|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756107|NCT04955626|617111027|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756108|NCT04955626|617111028|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756109|NCT04955626|617111029|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756110|NCT04955626|617111030|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756111|NCT04955626|617111031|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756112|NCT04955626|617111032|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756113|NCT04955626|617111033|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756114|NCT04955626|617111034|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756115|NCT04955626|617111035|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756116|NCT04955626|617111036|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756117|NCT04955626|617111037|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756118|NCT04955626|617111038|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756119|NCT04955626|617111039|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170756120|NCT04955626|617111040|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170405587|NCT01621490|615826648|FG002|Overall Study|Subject request to discontinue study|1|||
170405588|NCT01621490|615826649|FG003|Overall Study|Subject request to discontinue study|1|||
170405589|NCT01621490|615826650|FG004|Overall Study|Subject request to discontinue study|0|||
170405590|NCT01621490|615826651|FG005|Overall Study|Subject request to discontinue study|2|||
170405591|NCT01621490|615826652|FG006|Overall Study|Subject request to discontinue study|1|||
170405592|NCT01621490|615826653|FG007|Overall Study|Subject request to discontinue study|0|||
170405593|NCT01621490|615826654|FG008|Overall Study|Subject request to discontinue study|1|||
170405594|NCT01621490|615826655|FG009|Overall Study|Subject request to discontinue study|0|||
170405595|NCT01621490|615826656|FG010|Overall Study|Subject request to discontinue study|0|||
170405596|NCT01621490|615826646|FG000|Overall Study|Adverse event unrelated to study drug|1|||
170405597|NCT01621490|615826647|FG001|Overall Study|Adverse event unrelated to study drug|1|||
170405598|NCT01621490|615826648|FG002|Overall Study|Adverse event unrelated to study drug|0|||
170405599|NCT01621490|615826649|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170405600|NCT01621490|615826650|FG004|Overall Study|Adverse event unrelated to study drug|0|||
170405601|NCT01621490|615826651|FG005|Overall Study|Adverse event unrelated to study drug|0|||
170405602|NCT01621490|615826652|FG006|Overall Study|Adverse event unrelated to study drug|0|||
170405603|NCT01621490|615826653|FG007|Overall Study|Adverse event unrelated to study drug|2|||
170405604|NCT01621490|615826654|FG008|Overall Study|Adverse event unrelated to study drug|0|||
170405605|NCT01621490|615826655|FG009|Overall Study|Adverse event unrelated to study drug|0|||
170405606|NCT01621490|615826656|FG010|Overall Study|Adverse event unrelated to study drug|0|||
170405607|NCT01621490|615826646|FG000|Overall Study|Disease progression|27|||
170405608|NCT01621490|615826647|FG001|Overall Study|Disease progression|28|||
170405609|NCT01621490|615826648|FG002|Overall Study|Disease progression|1|||
170405610|NCT01621490|615826649|FG003|Overall Study|Disease progression|5|||
170405611|NCT01621490|615826650|FG004|Overall Study|Disease progression|3|||
170405612|NCT01621490|615826651|FG005|Overall Study|Disease progression|8|||
170405613|NCT01621490|615826652|FG006|Overall Study|Disease progression|7|||
170405614|NCT01621490|615826653|FG007|Overall Study|Disease progression|1|||
170405615|NCT01621490|615826654|FG008|Overall Study|Disease progression|4|||
170405616|NCT01621490|615826655|FG009|Overall Study|Disease progression|1|||
170405617|NCT01621490|615826656|FG010|Overall Study|Disease progression|1|||
170405618|NCT01621490|615826646|FG000|Overall Study|Study drug toxicity|1|||
170405619|NCT01621490|615826647|FG001|Overall Study|Study drug toxicity|4|||
170405620|NCT01621490|615826648|FG002|Overall Study|Study drug toxicity|5|||
170405621|NCT01621490|615826649|FG003|Overall Study|Study drug toxicity|3|||
170405622|NCT01621490|615826650|FG004|Overall Study|Study drug toxicity|1|||
170405623|NCT01621490|615826651|FG005|Overall Study|Study drug toxicity|10|||
170405624|NCT01621490|615826652|FG006|Overall Study|Study drug toxicity|1|||
170405625|NCT01621490|615826653|FG007|Overall Study|Study drug toxicity|4|||
170405626|NCT01621490|615826654|FG008|Overall Study|Study drug toxicity|1|||
170405627|NCT01621490|615826655|FG009|Overall Study|Study drug toxicity|0|||
170405628|NCT01621490|615826656|FG010|Overall Study|Study drug toxicity|0|||
170405629|NCT01621490|615826646|FG000|Overall Study|Death|0|||
170405630|NCT01621490|615826647|FG001|Overall Study|Death|0|||
170405631|NCT01621490|615826648|FG002|Overall Study|Death|0|||
170405632|NCT01621490|615826649|FG003|Overall Study|Death|0|||
170405633|NCT01621490|615826650|FG004|Overall Study|Death|0|||
170405634|NCT01621490|615826651|FG005|Overall Study|Death|0|||
170405635|NCT01621490|615826652|FG006|Overall Study|Death|0|||
170405636|NCT01621490|615826653|FG007|Overall Study|Death|0|||
170405637|NCT01621490|615826654|FG008|Overall Study|Death|1|||
170405638|NCT01621490|615826655|FG009|Overall Study|Death|0|||
170405639|NCT01621490|615826656|FG010|Overall Study|Death|0|||
170405640|NCT01621490|615826646|FG000|Overall Study|Other reasons|7|||
170405641|NCT01621490|615826647|FG001|Overall Study|Other reasons|6|||
170405642|NCT01621490|615826648|FG002|Overall Study|Other reasons|4|||
170405643|NCT01621490|615826649|FG003|Overall Study|Other reasons|1|||
170405644|NCT01621490|615826650|FG004|Overall Study|Other reasons|1|||
170405645|NCT01621490|615826651|FG005|Overall Study|Other reasons|3|||
170405646|NCT01621490|615826652|FG006|Overall Study|Other reasons|1|||
170405647|NCT01621490|615826653|FG007|Overall Study|Other reasons|1|||
170405648|NCT01621490|615826654|FG008|Overall Study|Other reasons|1|||
170405649|NCT01621490|615826655|FG009|Overall Study|Other reasons|0|||
170405650|NCT01621490|615826656|FG010|Overall Study|Other reasons|0|||
170405651|NCT00506753|615826657|FG000|Overall Study|Lost to Follow-up|21|||
170405652|NCT00506753|615826658|FG001|Overall Study|Lost to Follow-up|15|||
170405653|NCT00597584|615826659|FG000|Overall Study|Adverse Event|4|||
170405654|NCT00597584|615826660|FG001|Overall Study|Adverse Event|2|||
170405655|NCT00597584|615826659|FG000|Overall Study|Death|53|||
170405656|NCT00597584|615826660|FG001|Overall Study|Death|30|||
170405657|NCT00597584|615826659|FG000|Overall Study|Lack of Efficacy|1|||
170405658|NCT00597584|615826660|FG001|Overall Study|Lack of Efficacy|0|||
170405659|NCT00597584|615826659|FG000|Overall Study|Lost to Follow-up|2|||
170405660|NCT00597584|615826660|FG001|Overall Study|Lost to Follow-up|4|||
170405661|NCT00597584|615826659|FG000|Overall Study|Physician Decision|3|||
170405662|NCT00597584|615826660|FG001|Overall Study|Physician Decision|0|||
170405663|NCT00597584|615826659|FG000|Overall Study|Pregnancy|2|||
170405664|NCT00597584|615826660|FG001|Overall Study|Pregnancy|0|||
170756121|NCT04955626|617111041|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
170405665|NCT00597584|615826659|FG000|Overall Study|Withdrawal by Subject|44|||
170405666|NCT00597584|615826660|FG001|Overall Study|Withdrawal by Subject|12|||
170405667|NCT00597584|615826659|FG000|Overall Study|Discontinued Dialysis|0|||
170405668|NCT00597584|615826660|FG001|Overall Study|Discontinued Dialysis|1|||
170405669|NCT00597584|615826659|FG000|Overall Study|Lost ability to consent|1|||
170405670|NCT00597584|615826660|FG001|Overall Study|Lost ability to consent|1|||
170405671|NCT00597584|615826659|FG000|Overall Study|Never dosed|1|||
170405672|NCT00597584|615826660|FG001|Overall Study|Never dosed|0|||
170405673|NCT00597584|615826659|FG000|Overall Study|Relocation|8|||
170405674|NCT00597584|615826660|FG001|Overall Study|Relocation|6|||
170405675|NCT00597584|615826659|FG000|Overall Study|Renal transplant|9|||
170405676|NCT00597584|615826660|FG001|Overall Study|Renal transplant|7|||
170405677|NCT01904383|615826671|FG000|Overall Study|CRF not collected|117|||
170405678|NCT01904383|615826671|FG000|Overall Study|Reason not listed|147|||
170405679|NCT01904383|615826671|FG000|Overall Study|Lost to Follow-up|674|||
170405680|NCT01904383|615826671|FG000|Overall Study|Lack of Efficacy|370|||
170405681|NCT01904383|615826671|FG000|Overall Study|Improvement|141|||
170405682|NCT01904383|615826671|FG000|Overall Study|Adverse Event|271|||
170405683|NCT01904383|615826671|FG000|Overall Study|No patient visit after entry|54|||
170405684|NCT00326885|615826673|FG000|Overall Study|Adverse Event|1|||
170405685|NCT00326885|615826673|FG000|Overall Study|Withdrawal by Subject|3|||
170405686|NCT00326885|615826673|FG000|Overall Study|Physician Decision|1|||
170405687|NCT00326885|615826673|FG000|Overall Study|Hospice withdrew consent|2|||
170405688|NCT04313283|615826674|FG000|Overall Study|did not complete intervention|4|||
170405689|NCT04356573|615826675|FG000|Overall Study|Didn't Qualify|1|||
170405690|NCT04356573|615826676|FG001|Overall Study|Didn't Qualify|0|||
170405691|NCT01244815|615826677|FG000|Overall Study|Not Treated|0|||
170405692|NCT01244815|615826678|FG001|Overall Study|Not Treated|1|||
170405693|NCT01244815|615826679|FG002|Overall Study|Not Treated|0|||
170405694|NCT01244815|615826680|FG003|Overall Study|Not Treated|0|||
170405695|NCT01244815|615826677|FG000|Overall Study|Adverse Event|4|||
170405696|NCT01244815|615826678|FG001|Overall Study|Adverse Event|7|||
170405697|NCT01244815|615826679|FG002|Overall Study|Adverse Event|5|||
170405698|NCT01244815|615826680|FG003|Overall Study|Adverse Event|5|||
170405699|NCT01244815|615826677|FG000|Overall Study|Treatment Failure|0|||
170405700|NCT01244815|615826678|FG001|Overall Study|Treatment Failure|0|||
170405701|NCT01244815|615826679|FG002|Overall Study|Treatment Failure|0|||
170405702|NCT01244815|615826680|FG003|Overall Study|Treatment Failure|1|||
170405703|NCT01244815|615826677|FG000|Overall Study|Lost to Follow-up|3|||
170405704|NCT01244815|615826678|FG001|Overall Study|Lost to Follow-up|2|||
170405705|NCT01244815|615826679|FG002|Overall Study|Lost to Follow-up|3|||
170405706|NCT01244815|615826680|FG003|Overall Study|Lost to Follow-up|2|||
170405707|NCT01244815|615826677|FG000|Overall Study|Withdrawal by Subject|0|||
170405708|NCT01244815|615826678|FG001|Overall Study|Withdrawal by Subject|2|||
170405709|NCT01244815|615826679|FG002|Overall Study|Withdrawal by Subject|0|||
170405710|NCT01244815|615826680|FG003|Overall Study|Withdrawal by Subject|3|||
170405711|NCT01244815|615826677|FG000|Overall Study|Protocol Violation|7|||
170405712|NCT01244815|615826678|FG001|Overall Study|Protocol Violation|4|||
170405713|NCT01244815|615826679|FG002|Overall Study|Protocol Violation|3|||
170405714|NCT01244815|615826680|FG003|Overall Study|Protocol Violation|1|||
170405715|NCT01244815|615826677|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
170405716|NCT01244815|615826678|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
170405717|NCT01244815|615826679|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
170405718|NCT01244815|615826680|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
170405719|NCT04272775|615826681|FG000|Overall Study|Study Terminated by Sponsor|1|||
170405720|NCT04272775|615826682|FG001|Overall Study|Study Terminated by Sponsor|0|||
170405721|NCT04272775|615826681|FG000|Overall Study|Protocol Violation|0|||
170405722|NCT04272775|615826682|FG001|Overall Study|Protocol Violation|1|||
170405723|NCT04272775|615826681|FG000|Overall Study|Symptomatic Deterioration|1|||
170405724|NCT04272775|615826682|FG001|Overall Study|Symptomatic Deterioration|1|||
170405725|NCT04272775|615826681|FG000|Overall Study|Withdrawal by Subject|1|||
170405726|NCT04272775|615826682|FG001|Overall Study|Withdrawal by Subject|2|||
170405727|NCT04272775|615826681|FG000|Overall Study|Adverse Event|1|||
170405728|NCT04272775|615826682|FG001|Overall Study|Adverse Event|2|||
170405729|NCT04272775|615826681|FG000|Overall Study|Progressive Disease|3|||
170405730|NCT04272775|615826682|FG001|Overall Study|Progressive Disease|1|||
170405731|NCT00738673|615826683|FG000|Overall Study|Adverse Event|1|||
170405732|NCT00738673|615826684|FG001|Overall Study|Adverse Event|0|||
170405733|NCT00738673|615826683|FG000|Overall Study|Lack of Efficacy|19|||
170405734|NCT00738673|615826684|FG001|Overall Study|Lack of Efficacy|8|||
170405735|NCT00738673|615826683|FG000|Overall Study|Protocol Violation|1|||
170756122|NCT03714022|617111043|FG000|Overall Study|Adverse Event|1|||
170756123|NCT03714022|617111044|FG001|Overall Study|Adverse Event|0|||
170405736|NCT00738673|615826684|FG001|Overall Study|Protocol Violation|2|||
170405737|NCT00738673|615826683|FG000|Overall Study|Withdrawal by Subject|3|||
170405738|NCT00738673|615826684|FG001|Overall Study|Withdrawal by Subject|1|||
170405739|NCT02736227|615826685|FG000|Overall Study|Withdrawal by Subject|0|||
170405740|NCT02736227|615826686|FG001|Overall Study|Withdrawal by Subject|0|||
170405741|NCT02736227|615826687|FG002|Overall Study|Withdrawal by Subject|1|||
170405742|NCT02736227|615826685|FG000|Overall Study|Physician Decision|0|||
170405743|NCT02736227|615826686|FG001|Overall Study|Physician Decision|0|||
170405744|NCT02736227|615826687|FG002|Overall Study|Physician Decision|5|||
170405745|NCT02736227|615826685|FG000|Overall Study|Non Compliant|0|||
170405746|NCT02736227|615826686|FG001|Overall Study|Non Compliant|0|||
170519694|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170405747|NCT02736227|615826687|FG002|Overall Study|Non Compliant|2|||
170405748|NCT01967888|615826688|FG000|Overall Study|Lost to Follow-up|6|||
170405749|NCT01967888|615826689|FG001|Overall Study|Lost to Follow-up|4|||
170405750|NCT01967888|615826688|FG000|Overall Study|Withdrawal by Subject|1|||
170405751|NCT01967888|615826689|FG001|Overall Study|Withdrawal by Subject|1|||
170405752|NCT01967888|615826688|FG000|Overall Study|Did Not Have Transplant|1|||
170405753|NCT01967888|615826689|FG001|Overall Study|Did Not Have Transplant|0|||
170405754|NCT01967888|615826688|FG000|Overall Study|Research visit not done, data recorded|1|||
170405755|NCT01967888|615826689|FG001|Overall Study|Research visit not done, data recorded|0|||
170405756|NCT01967888|615826688|FG000|Overall Study|Subject excluded after randomization|1|||
170405757|NCT01967888|615826689|FG001|Overall Study|Subject excluded after randomization|0|||
170405758|NCT01967888|615826688|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
170405759|NCT01967888|615826689|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
170405760|NCT01967888|615826688|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
170405761|NCT01967888|615826689|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
170405762|NCT04126733|615826699|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
170405763|NCT04126733|615826699|FG000|Treatment Period|Adverse Event|8|||
170405764|NCT04126733|615826699|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
170405765|NCT04126733|615826699|FG000|Treatment Period|Physician Decision|5|||
170405766|NCT04126733|615826699|FG000|Treatment Period|Death|1|||
170405767|NCT04126733|615826699|FG000|Treatment Period|Other Reasons|2|||
170405768|NCT04126733|615826699|FG000|Active Follow-up Period|Death|13|||
170405769|NCT04126733|615826699|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
170405770|NCT04126733|615826699|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
170405771|NCT04126733|615826699|FG000|Active Follow-up Period|Other Reasons|1|||
170405772|NCT04126733|615826699|FG000|Long-term Follow-up Period|Death|22|||
170405773|NCT04126733|615826699|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
170405774|NCT04126733|615826699|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
170405775|NCT02114931|615826700|FG000|Overall Study|Withdrawal by Subject|15|||
170405776|NCT02114931|615826701|FG001|Overall Study|Withdrawal by Subject|18|||
170405777|NCT02114931|615826700|FG000|Overall Study|Adverse Event|4|||
170405778|NCT02114931|615826701|FG001|Overall Study|Adverse Event|6|||
170405779|NCT02114931|615826700|FG000|Overall Study|Lost to Follow-up|3|||
170405780|NCT02114931|615826701|FG001|Overall Study|Lost to Follow-up|3|||
170405781|NCT02114931|615826700|FG000|Overall Study|Physician Decision|1|||
170405782|NCT02114931|615826701|FG001|Overall Study|Physician Decision|2|||
170405783|NCT02114931|615826700|FG000|Overall Study|Other|2|||
170405784|NCT02114931|615826701|FG001|Overall Study|Other|1|||
170405785|NCT03726437|615826702|FG000|Overall Study|Lost to Follow-up|85|||
170405786|NCT03726437|615826703|FG001|Overall Study|Lost to Follow-up|76|||
170405787|NCT01507831|615826712|FG000|Overall Study|Randomized but not treated|0|||
170405788|NCT01507831|615826713|FG001|Overall Study|Randomized but not treated|3|||
170405789|NCT01507831|615826712|FG000|Overall Study|Adverse Event|48|||
170405790|NCT01507831|615826713|FG001|Overall Study|Adverse Event|113|||
170405791|NCT01507831|615826712|FG000|Overall Study|Death|6|||
170405792|NCT01507831|615826713|FG001|Overall Study|Death|2|||
170405793|NCT01507831|615826712|FG000|Overall Study|Poor compliance to protocol|38|||
170405794|NCT01507831|615826713|FG001|Overall Study|Poor compliance to protocol|60|||
170405795|NCT01507831|615826712|FG000|Overall Study|Physician Decision|0|||
170405796|NCT01507831|615826713|FG001|Overall Study|Physician Decision|4|||
170405797|NCT01507831|615826712|FG000|Overall Study|Participant moved|5|||
170405798|NCT01507831|615826713|FG001|Overall Study|Participant moved|19|||
170405799|NCT01507831|615826712|FG000|Overall Study|Consent withdrawn by participant|34|||
170405800|NCT01507831|615826713|FG001|Overall Study|Consent withdrawn by participant|72|||
170405801|NCT01507831|615826712|FG000|Overall Study|Related to study drug administration|5|||
170405802|NCT01507831|615826713|FG001|Overall Study|Related to study drug administration|14|||
170405803|NCT01507831|615826712|FG000|Overall Study|Last visit outside protocol visit window|51|||
170405804|NCT01507831|615826713|FG001|Overall Study|Last visit outside protocol visit window|143|||
170405805|NCT01507831|615826712|FG000|Overall Study|Selection criteria finally not met|0|||
170405806|NCT01507831|615826713|FG001|Overall Study|Selection criteria finally not met|1|||
170405807|NCT01507831|615826712|FG000|Overall Study|Site closure|0|||
170405808|NCT01507831|615826713|FG001|Overall Study|Site closure|3|||
170405809|NCT01507831|615826712|FG000|Overall Study|Potential lost to follow-up|3|||
170405810|NCT01507831|615826713|FG001|Overall Study|Potential lost to follow-up|0|||
170405811|NCT01507831|615826712|FG000|Overall Study|Other|3|||
170405812|NCT01507831|615826713|FG001|Overall Study|Other|6|||
170405813|NCT01789281|615826716|FG000|Overall Study|Disease progression|15|||
170405814|NCT01789281|615826717|FG001|Overall Study|Disease progression|4|||
170405815|NCT01789281|615826716|FG000|Overall Study|Adverse Event|5|||
170405816|NCT01789281|615826717|FG001|Overall Study|Adverse Event|5|||
170405817|NCT01789281|615826716|FG000|Overall Study|Withdrawal by Subject|1|||
170405818|NCT01789281|615826717|FG001|Overall Study|Withdrawal by Subject|0|||
170405819|NCT01789281|615826716|FG000|Overall Study|Lost to Follow-up|1|||
170405820|NCT01789281|615826717|FG001|Overall Study|Lost to Follow-up|0|||
170405821|NCT01789281|615826716|FG000|Overall Study|Administrative problems|0|||
170405822|NCT01789281|615826717|FG001|Overall Study|Administrative problems|1|||
170405823|NCT01280981|615826718|FG000|Overall Study|Withdrawal by Subject|11|||
170405824|NCT01280981|615826718|FG000|Overall Study|Protocol Violation|2|||
170405825|NCT01280981|615826718|FG000|Overall Study|Lack of Efficacy|13|||
170405826|NCT01280981|615826718|FG000|Overall Study|Lost to Follow-up|3|||
170405827|NCT01280981|615826718|FG000|Overall Study|Adverse Event|6|||
170405828|NCT01280981|615826718|FG000|Overall Study|Irregular or discontinued menses|3|||
170405829|NCT01280981|615826718|FG000|Overall Study|Failed to return|45|||
170405830|NCT01280981|615826718|FG000|Overall Study|Non-compliance with protocol|3|||
170405831|NCT01280981|615826718|FG000|Overall Study|Withdrawal of consent|3|||
170405832|NCT01280981|615826718|FG000|Overall Study|Elective surgery|2|||
170405833|NCT01280981|615826718|FG000|Overall Study|Study site closure|1|||
170405834|NCT01252238|615826721|FG000|Overall Study|Sponsor terminated study|4|||
170405835|NCT01252238|615826722|FG001|Overall Study|Sponsor terminated study|4|||
170405836|NCT01252238|615826723|FG002|Overall Study|Sponsor terminated study|4|||
170405837|NCT01610167|615826724|FG000|Overall Study|Scheduling conflict.|0|||
170405838|NCT01610167|615826725|FG001|Overall Study|Scheduling conflict.|0|||
170405839|NCT01610167|615826726|FG002|Overall Study|Scheduling conflict.|2|||
170405840|NCT00068237|615826727|FG000|Overall Study|Ineligible|3|||
170405841|NCT00068237|615826727|FG000|Overall Study|No protocol treatment received|2|||
170405842|NCT00411762|615826729|FG000|Overall Study|Withdrawal by Subject|5|||
170405843|NCT03276962|615826730|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
170405844|NCT03276962|615826731|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
170405845|NCT03276962|615826732|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
170405846|NCT03276962|615826733|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
170405847|NCT03276962|615826734|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
170405848|NCT03276962|615826730|FG000|Overall Study|Protocol Deviation|2|||
170405849|NCT03276962|615826731|FG001|Overall Study|Protocol Deviation|0|||
170405850|NCT03276962|615826732|FG002|Overall Study|Protocol Deviation|1|||
170405851|NCT03276962|615826733|FG003|Overall Study|Protocol Deviation|2|||
170405852|NCT03276962|615826734|FG004|Overall Study|Protocol Deviation|1|||
170405853|NCT03276962|615826730|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
170405854|NCT03276962|615826731|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
170405855|NCT03276962|615826732|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
170405856|NCT03276962|615826733|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
170405857|NCT03276962|615826734|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
170405858|NCT03276962|615826730|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
170405859|NCT03276962|615826731|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
170405860|NCT03276962|615826732|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
170405861|NCT03276962|615826733|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
170405862|NCT03276962|615826734|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
170405863|NCT03276962|615826730|FG000|Overall Study|Lost to Follow-up|10|||
170405864|NCT03276962|615826731|FG001|Overall Study|Lost to Follow-up|10|||
170405865|NCT03276962|615826732|FG002|Overall Study|Lost to Follow-up|4|||
170405866|NCT03276962|615826733|FG003|Overall Study|Lost to Follow-up|6|||
170405867|NCT03276962|615826734|FG004|Overall Study|Lost to Follow-up|10|||
170405868|NCT03276962|615826730|FG000|Overall Study|Other|0|||
170405869|NCT03276962|615826731|FG001|Overall Study|Other|2|||
170405870|NCT03276962|615826732|FG002|Overall Study|Other|0|||
170405871|NCT03276962|615826733|FG003|Overall Study|Other|2|||
170405872|NCT03276962|615826734|FG004|Overall Study|Other|1|||
170405873|NCT03672396|615826735|FG000|Overall Study|Withdrawal by Subject|4|||
170405874|NCT03672396|615826735|FG000|Overall Study|Physician Decision|1|||
170405875|NCT03672396|615826735|FG000|Overall Study|Adverse Event|1|||
170405876|NCT04428502|615826736|FG000|Overall Study|Did not meet entrance criteria|14|||
170405877|NCT01964105|615826743|FG000|Overall Study|Lost to Follow-up|2|||
170405878|NCT01964105|615826744|FG001|Overall Study|Lost to Follow-up|13|||
170405879|NCT01964105|615826745|FG002|Overall Study|Lost to Follow-up|0|||
170405880|NCT01430104|615826746|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
170405881|NCT00964223|615826748|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
170405882|NCT03439293|615826749|FG000|Overall Study|Death|22|||
170405883|NCT03439293|615826749|FG000|Overall Study|Withdrawal by Subject|8|||
170405884|NCT03439293|615826749|FG000|Overall Study|Lost to Follow-up|2|||
170405885|NCT03439293|615826749|FG000|Overall Study|Reason Not Specified|28|||
170756124|NCT03714022|617111043|FG000|Overall Study|Consent withdrawal|0|||
170756125|NCT03714022|617111044|FG001|Overall Study|Consent withdrawal|1|||
170405886|NCT03439293|615826749|FG000|Overall Study|Missing|1|||
170405887|NCT03634488|615826754|FG000|Overall Study|Death|1|||
170405888|NCT03634488|615826755|FG001|Overall Study|Death|0|||
170405889|NCT03634488|615826756|FG002|Overall Study|Death|0|||
170756126|NCT03714022|617111043|FG000|Overall Study|Lost to Follow-up|3|||
170756127|NCT03714022|617111044|FG001|Overall Study|Lost to Follow-up|2|||
170756128|NCT01449721|617111045|FG000|Overall Study|Physician Decision|0|||
170405890|NCT03634488|615826754|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
170405891|NCT03634488|615826755|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
170405892|NCT03634488|615826756|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
170405893|NCT00869089|615826757|FG000|Overall Study|Lost to Follow-up|1|||
170756129|NCT01449721|617111046|FG001|Overall Study|Physician Decision|1|||
170756130|NCT01449721|617111045|FG000|Overall Study|Physician Decision|0|||
170756131|NCT01449721|617111046|FG001|Overall Study|Physician Decision|1|||
170756132|NCT01823341|617111061|FG000|Overall Study|Failed run-in|7|||
170756133|NCT01823341|617111061|FG000|Overall Study|Withdrawal by Subject|7|||
170756134|NCT01823341|617111061|FG000|Overall Study|Adverse Event|1|||
170756135|NCT01342887|617111062|FG000|Overall Study|Death|2|||
170756136|NCT00663962|617111063|FG000|Overall Study|somnolence|1|||
170756137|NCT00663962|617111064|FG001|Overall Study|somnolence|0|||
170756138|NCT03253653|617111072|FG000|Overall Study|Withdrawal by Subject|4|||
170756139|NCT03253653|617111073|FG001|Overall Study|Withdrawal by Subject|1|||
170756140|NCT03253653|617111072|FG000|Overall Study|Protocol Violation|0|||
170756141|NCT03253653|617111073|FG001|Overall Study|Protocol Violation|5|||
170405894|NCT00869089|615826757|FG000|Overall Study|Withdrawal by Subject|1|||
170756142|NCT04978363|617112866|FG000|Overall Study|Other medical issues unrelated to the study|0|||
170756143|NCT04978363|617112867|FG001|Overall Study|Other medical issues unrelated to the study|0|||
170756144|NCT04978363|617112868|FG002|Overall Study|Other medical issues unrelated to the study|0|||
170756145|NCT04978363|617112869|FG003|Overall Study|Other medical issues unrelated to the study|0|||
170756146|NCT04978363|617112870|FG004|Overall Study|Other medical issues unrelated to the study|1|||
170756147|NCT04978363|617112871|FG005|Overall Study|Other medical issues unrelated to the study|0|||
170756148|NCT04978363|617112872|FG006|Overall Study|Other medical issues unrelated to the study|0|||
170756149|NCT04978363|617112873|FG007|Overall Study|Other medical issues unrelated to the study|0|||
170756150|NCT04978363|617112874|FG008|Overall Study|Other medical issues unrelated to the study|0|||
170756151|NCT04978363|617112875|FG009|Overall Study|Other medical issues unrelated to the study|0|||
170756152|NCT04978363|617112876|FG010|Overall Study|Other medical issues unrelated to the study|0|||
170756153|NCT04978363|617112866|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
170756154|NCT04978363|617112867|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
170756155|NCT04978363|617112868|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
170756156|NCT04978363|617112869|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
170756157|NCT04978363|617112870|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
170756158|NCT04978363|617112871|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
170756159|NCT04978363|617112872|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
170756160|NCT04978363|617112873|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
170756161|NCT04978363|617112874|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
170756162|NCT04978363|617112875|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
170756163|NCT04978363|617112876|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
170756164|NCT04978363|617112866|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756165|NCT04978363|617112867|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
170756166|NCT04978363|617112868|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756167|NCT04978363|617112869|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756168|NCT04978363|617112870|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756169|NCT04978363|617112871|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756170|NCT04978363|617112872|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756171|NCT04978363|617112873|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756172|NCT04978363|617112874|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756173|NCT04978363|617112875|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756174|NCT04978363|617112876|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
170756175|NCT01251614|617112877|FG000|Overall Study|Adverse Event|1|||
170756176|NCT01251614|617112878|FG001|Overall Study|Adverse Event|0|||
170756177|NCT01251614|617112879|FG002|Overall Study|Adverse Event|1|||
170756178|NCT01251614|617112877|FG000|Overall Study|Lack of Efficacy|1|||
170756179|NCT01251614|617112878|FG001|Overall Study|Lack of Efficacy|9|||
170756180|NCT01251614|617112879|FG002|Overall Study|Lack of Efficacy|4|||
170756181|NCT01251614|617112877|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
170756182|NCT01251614|617112878|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
170756183|NCT01251614|617112879|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
170756184|NCT01251614|617112877|FG000|Overall Study|Pregnancy|0|||
170756185|NCT01251614|617112878|FG001|Overall Study|Pregnancy|0|||
170756186|NCT01251614|617112879|FG002|Overall Study|Pregnancy|2|||
170756187|NCT01251614|617112877|FG000|Overall Study|Loss of Disease Control|0|||
170756188|NCT01251614|617112878|FG001|Overall Study|Loss of Disease Control|1|||
170756189|NCT01251614|617112879|FG002|Overall Study|Loss of Disease Control|0|||
170756190|NCT01251614|617112877|FG000|Overall Study|Withdrawal by Subject|0|||
170756191|NCT01251614|617112878|FG001|Overall Study|Withdrawal by Subject|2|||
170756192|NCT01251614|617112879|FG002|Overall Study|Withdrawal by Subject|1|||
170756193|NCT01251614|617112877|FG000|Overall Study|Lost to Follow-up|0|||
170756194|NCT01251614|617112878|FG001|Overall Study|Lost to Follow-up|1|||
170756195|NCT01251614|617112879|FG002|Overall Study|Lost to Follow-up|0|||
170756196|NCT00613301|617112880|FG000|Overall Study|Adverse Event|49|||
170756197|NCT00613301|617112880|FG000|Overall Study|Lost to Follow-up|88|||
170756198|NCT00613301|617112880|FG000|Overall Study|Withdrawal by Subject|5|||
170756199|NCT00613301|617112880|FG000|Overall Study|Death|6|||
170756200|NCT00613301|617112880|FG000|Overall Study|Lack of Efficacy|13|||
170756201|NCT00613301|617112880|FG000|Overall Study|Physician Decision|2|||
170756202|NCT00613301|617112880|FG000|Overall Study|No data was collected|53|||
170756203|NCT00613301|617112880|FG000|Overall Study|Irregularly enrolled patients|12|||
170756204|NCT00569946|617112881|FG000|Overall Study|Adverse Event|16|||
170756205|NCT00569946|617112881|FG000|Overall Study|Objective Progression or Relapse|42|||
170756206|NCT00569946|617112881|FG000|Overall Study|Global Deterioration of Health Status|1|||
170756207|NCT01684046|617112882|FG000|Period 1, First 30 Days|Adverse Event|0|||
170756208|NCT01684046|617112883|FG001|Period 1, First 30 Days|Adverse Event|2|||
170756209|NCT03837028|617112890|FG000|Overall Study|Lost to Follow-up|4|||
170756210|NCT03837028|617112891|FG001|Overall Study|Lost to Follow-up|0|||
170756211|NCT03837028|617112892|FG002|Overall Study|Lost to Follow-up|2|||
170756212|NCT03837028|617112893|FG003|Overall Study|Lost to Follow-up|0|||
170756213|NCT03837028|617112890|FG000|Overall Study|Withdrawal by Subject|12|||
170756214|NCT03837028|617112891|FG001|Overall Study|Withdrawal by Subject|11|||
170756215|NCT03837028|617112892|FG002|Overall Study|Withdrawal by Subject|11|||
170756216|NCT03837028|617112893|FG003|Overall Study|Withdrawal by Subject|7|||
170756217|NCT01257503|617112894|FG000|Overall Study|Lost to Follow-up|7|||
170756218|NCT01257503|617112895|FG001|Overall Study|Lost to Follow-up|10|||
170756219|NCT01257503|617112894|FG000|Overall Study|Over 5 years old at enrollment|0|||
170756220|NCT01257503|617112895|FG001|Overall Study|Over 5 years old at enrollment|1|||
170756221|NCT01257503|617112894|FG000|Overall Study|strep culture positive at enrollment|1|||
170756222|NCT01257503|617112895|FG001|Overall Study|strep culture positive at enrollment|0|||
170756223|NCT01764386|617112899|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
170756224|NCT01764386|617112900|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
170756225|NCT01764386|617112899|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
170756226|NCT01764386|617112900|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
170756227|NCT01764386|617112899|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
170756228|NCT01764386|617112900|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
170756229|NCT01764386|617112899|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
170405895|NCT00869089|615826757|FG000|Overall Study|Screen Fail|1|||
170405896|NCT01169844|615826765|FG000|Overall Study|Adverse Event|0|||
170405897|NCT01169844|615826766|FG001|Overall Study|Adverse Event|1|||
170756230|NCT01764386|617112900|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
170756231|NCT01764386|617112899|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
170756232|NCT01764386|617112900|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
170756233|NCT01764386|617112899|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
170756234|NCT01764386|617112900|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
170756235|NCT01764386|617112899|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
170756236|NCT01764386|617112900|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
170756237|NCT01764386|617112899|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
170756238|NCT01764386|617112900|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
170756239|NCT03169361|617112901|FG000|Overall Study|Protocol Violation|32|||
170756240|NCT02788656|617112902|FG000|Overall Study|Withdrawal by Subject|1|||
170756241|NCT02788656|617112903|FG001|Overall Study|Withdrawal by Subject|0|||
170756242|NCT00088465|617112904|FG000|Overall Study|Withdrawal by Subject|290|||
170756243|NCT00088465|617112904|FG000|Overall Study|Adverse Event|77|||
170756244|NCT00088465|617112904|FG000|Overall Study|Lost to Follow-up|57|||
170756245|NCT00088465|617112904|FG000|Overall Study|Physician Decision|45|||
170756246|NCT00088465|617112904|FG000|Overall Study|Sponsor Decision|37|||
170756247|NCT00088465|617112904|FG000|Overall Study|Lack of Efficacy|27|||
170756248|NCT00088465|617112904|FG000|Overall Study|Protocol Violation|17|||
170756249|NCT00088465|617112904|FG000|Overall Study|Death|11|||
170756250|NCT00448864|617112909|FG000|Overall Study|Death|1|||
170756251|NCT00448864|617112910|FG001|Overall Study|Death|0|||
170756252|NCT00448864|617112911|FG002|Overall Study|Death|0|||
170756253|NCT00448864|617112909|FG000|Overall Study|Lost to Follow-up|3|||
170865637|NCT04029480|617519979|FG003|Overall Study|Withdrawal by Subject|1|||
170865638|NCT04786119|617519980|FG000|Overall Study|Withdrawal by Subject|4|||
170865639|NCT04786119|617519981|FG001|Overall Study|Withdrawal by Subject|5|||
170865640|NCT04786119|617519980|FG000|Overall Study|Lost to Follow-up|5|||
170405898|NCT01169844|615826765|FG000|Overall Study|Patient withdrew consent|4|||
170405899|NCT01169844|615826766|FG001|Overall Study|Patient withdrew consent|0|||
170405900|NCT01169844|615826765|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170756254|NCT00448864|617112910|FG001|Overall Study|Lost to Follow-up|1|||
170756255|NCT00448864|617112911|FG002|Overall Study|Lost to Follow-up|0|||
170756256|NCT00448864|617112909|FG000|Overall Study|Physician Decision|1|||
170865641|NCT04786119|617519981|FG001|Overall Study|Lost to Follow-up|5|||
170906120|NCT01097044|617658625|FG000|Overall Study|Withdrawal by Subject|4|||
170756257|NCT00448864|617112910|FG001|Overall Study|Physician Decision|0|||
170756258|NCT00448864|617112911|FG002|Overall Study|Physician Decision|1|||
170756259|NCT00448864|617112909|FG000|Overall Study|Withdrawal by Subject|0|||
170756260|NCT00448864|617112910|FG001|Overall Study|Withdrawal by Subject|2|||
170756261|NCT00448864|617112911|FG002|Overall Study|Withdrawal by Subject|0|||
170405901|NCT01169844|615826766|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170405902|NCT03499249|615826767|FG000|Overall Study|Physician Decision|1|||
170405903|NCT02475980|615826770|FG000|Overall Study|Lost to Follow-up|4|||
170405904|NCT02475980|615826770|FG000|Overall Study|Withdrawal by Subject|1|||
170405905|NCT00430638|615826773|FG000|Overall Study|Adverse Event|15|||
170405906|NCT00430638|615826774|FG001|Overall Study|Adverse Event|15|||
170405907|NCT00430638|615826773|FG000|Overall Study|Uncontrolled blood pressure|48|||
170405908|NCT00430638|615826774|FG001|Overall Study|Uncontrolled blood pressure|13|||
170405909|NCT00430638|615826773|FG000|Overall Study|Lost to Follow-up|1|||
170405910|NCT00430638|615826774|FG001|Overall Study|Lost to Follow-up|7|||
170405911|NCT00430638|615826773|FG000|Overall Study|Protocol Violation|6|||
170405912|NCT00430638|615826774|FG001|Overall Study|Protocol Violation|4|||
170405913|NCT00430638|615826773|FG000|Overall Study|Withdrawal by Subject|4|||
170405914|NCT00430638|615826774|FG001|Overall Study|Withdrawal by Subject|6|||
170405915|NCT00430638|615826773|FG000|Overall Study|Non-compliant|2|||
170405916|NCT00430638|615826774|FG001|Overall Study|Non-compliant|1|||
170405917|NCT00430638|615826773|FG000|Overall Study|Other|2|||
170405918|NCT00430638|615826774|FG001|Overall Study|Other|2|||
170405919|NCT01529749|615826775|FG000|Overall Study|Lost to Follow-up|0|||
170405920|NCT01529749|615826776|FG001|Overall Study|Lost to Follow-up|1|||
170405921|NCT01529749|615826777|FG002|Overall Study|Lost to Follow-up|1|||
170405922|NCT01529749|615826778|FG003|Overall Study|Lost to Follow-up|0|||
170405923|NCT01529749|615826775|FG000|Overall Study|Physician Decision|0|||
170405924|NCT01529749|615826776|FG001|Overall Study|Physician Decision|0|||
170405925|NCT01529749|615826777|FG002|Overall Study|Physician Decision|0|||
170405926|NCT01529749|615826778|FG003|Overall Study|Physician Decision|1|||
170405927|NCT01529749|615826775|FG000|Overall Study|Withdrawal by Subject|0|||
170405928|NCT01529749|615826776|FG001|Overall Study|Withdrawal by Subject|1|||
170405929|NCT01529749|615826777|FG002|Overall Study|Withdrawal by Subject|1|||
170405930|NCT01529749|615826778|FG003|Overall Study|Withdrawal by Subject|0|||
170756262|NCT00448864|617112909|FG000|Overall Study|Protocol Violation|0|||
170756263|NCT00448864|617112910|FG001|Overall Study|Protocol Violation|2|||
170405931|NCT01529749|615826775|FG000|Overall Study|Protocol Violation|0|||
170405932|NCT01529749|615826776|FG001|Overall Study|Protocol Violation|0|||
170405933|NCT01529749|615826777|FG002|Overall Study|Protocol Violation|0|||
170405934|NCT01529749|615826778|FG003|Overall Study|Protocol Violation|1|||
170405935|NCT02094937|615826779|FG000|8 Weeks in Period 1|Adverse Event|9|||
170405936|NCT02094937|615826780|FG001|8 Weeks in Period 1|Adverse Event|0|||
170405937|NCT02094937|615826781|FG002|8 Weeks in Period 1|Adverse Event|0|||
170405938|NCT02094937|615826782|FG003|8 Weeks in Period 1|Adverse Event|0|||
170405939|NCT02094937|615826779|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
170405940|NCT02094937|615826780|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
170405941|NCT02094937|615826781|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
170405942|NCT02094937|615826782|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
170405943|NCT02094937|615826779|FG000|8 Weeks in Period 1|Protocol Violation|2|||
170405944|NCT02094937|615826780|FG001|8 Weeks in Period 1|Protocol Violation|0|||
170405945|NCT02094937|615826781|FG002|8 Weeks in Period 1|Protocol Violation|0|||
170405946|NCT02094937|615826782|FG003|8 Weeks in Period 1|Protocol Violation|0|||
170405947|NCT02094937|615826779|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
170756264|NCT00448864|617112911|FG002|Overall Study|Protocol Violation|0|||
170756265|NCT02688621|617112913|FG000|Overall Study|Pregnancy|1|||
170756266|NCT02688621|617112914|FG001|Overall Study|Pregnancy|3|||
170756267|NCT02688621|617112913|FG000|Overall Study|Lost to Follow-up|38|||
170865642|NCT04786119|617519980|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
170405948|NCT02094937|615826780|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
170405949|NCT02094937|615826781|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
170405950|NCT02094937|615826782|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
170405951|NCT02094937|615826779|FG000|8 Weeks in Period 1|Physician Decision|1|||
170756268|NCT02688621|617112914|FG001|Overall Study|Lost to Follow-up|15|||
170756269|NCT02688621|617112913|FG000|Overall Study|Withdrawal by Subject|1|||
170756270|NCT02688621|617112914|FG001|Overall Study|Withdrawal by Subject|0|||
170405952|NCT02094937|615826780|FG001|8 Weeks in Period 1|Physician Decision|0|||
170756271|NCT03239210|617112915|FG000|Overall Study|Lost to Follow-up|2|||
170756272|NCT03239210|617112916|FG001|Overall Study|Lost to Follow-up|2|||
170405953|NCT02094937|615826781|FG002|8 Weeks in Period 1|Physician Decision|0|||
170405954|NCT02094937|615826782|FG003|8 Weeks in Period 1|Physician Decision|0|||
170405955|NCT02094937|615826779|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
170405956|NCT02094937|615826780|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
170405957|NCT02094937|615826781|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
170405958|NCT02094937|615826782|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
170405959|NCT02094937|615826779|FG000|12 Weeks in Period 2|Adverse Event|0|||
170405960|NCT02094937|615826780|FG001|12 Weeks in Period 2|Adverse Event|2|||
170756273|NCT03239210|617112915|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
170756274|NCT03239210|617112916|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
170756275|NCT03239210|617112915|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
170756276|NCT03239210|617112916|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
170756277|NCT01575860|617112917|FG000|Overall Study|Withdrawal by Subject|1|||
170756278|NCT01575860|617112917|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
170756279|NCT05349864|617112922|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
170756280|NCT05349864|617112923|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
170756281|NCT02223793|617112924|FG000|Overall Study|Lost to Follow-up|10|||
170756282|NCT02223793|617112925|FG001|Overall Study|Lost to Follow-up|1|||
170756283|NCT02223793|617112926|FG002|Overall Study|Lost to Follow-up|2|||
170756284|NCT02223793|617112924|FG000|Overall Study|Withdrawal by Subject|3|||
170756285|NCT02223793|617112925|FG001|Overall Study|Withdrawal by Subject|2|||
170756286|NCT02223793|617112926|FG002|Overall Study|Withdrawal by Subject|3|||
170756287|NCT02223793|617112924|FG000|Overall Study|Moved/studycenter unable to participate|4|||
170756288|NCT02223793|617112925|FG001|Overall Study|Moved/studycenter unable to participate|6|||
170756289|NCT02223793|617112926|FG002|Overall Study|Moved/studycenter unable to participate|8|||
170756290|NCT02359435|617112928|FG000|Overall Study|Lost to Follow-up|4|||
170756291|NCT02359435|617112929|FG001|Overall Study|Lost to Follow-up|4|||
170756292|NCT00315055|617112930|FG000|Overall Study|Protocol Violation|2|||
170631983|NCT02446899|616664490|FG001|Overall Study|Withdrawal by Subject|19|||
170631984|NCT02446899|616664489|FG000|Overall Study|Miscellaneous|5|||
170631985|NCT02446899|616664490|FG001|Overall Study|Miscellaneous|4|||
170631986|NCT02446899|616664489|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
170631987|NCT02446899|616664490|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
170631988|NCT02230670|616664493|FG000|Overall Study|Adverse Event|1|||
170631989|NCT02230670|616664494|FG001|Overall Study|Adverse Event|2|||
170631990|NCT02230670|616664493|FG000|Overall Study|Withdrawal by Subject|2|||
170405961|NCT02094937|615826781|FG002|12 Weeks in Period 2|Adverse Event|4|||
170405962|NCT02094937|615826782|FG003|12 Weeks in Period 2|Adverse Event|1|||
170405963|NCT02094937|615826779|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
170405964|NCT02094937|615826780|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
170405965|NCT02094937|615826781|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
170405966|NCT02094937|615826782|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
170405967|NCT02094937|615826779|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
170405968|NCT02094937|615826780|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
170405969|NCT02094937|615826781|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
170405970|NCT02094937|615826782|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
170405971|NCT02094937|615826779|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
170405972|NCT02094937|615826780|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
170405973|NCT02094937|615826781|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
170405974|NCT02094937|615826782|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
170405975|NCT02094937|615826779|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
170405976|NCT02094937|615826780|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
170405977|NCT02094937|615826781|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
170405978|NCT02094937|615826782|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
170405979|NCT00555399|615826785|FG000|Overall Study|Withdrawal by Subject|0|||
170405980|NCT00555399|615826786|FG001|Overall Study|Withdrawal by Subject|0|||
170405981|NCT00555399|615826787|FG002|Overall Study|Withdrawal by Subject|1|||
170405982|NCT00555399|615826788|FG003|Overall Study|Withdrawal by Subject|0|||
170405983|NCT00555399|615826789|FG004|Overall Study|Withdrawal by Subject|0|||
170405984|NCT00555399|615826790|FG005|Overall Study|Withdrawal by Subject|0|||
170405985|NCT00555399|615826791|FG006|Overall Study|Withdrawal by Subject|0|||
170405986|NCT00555399|615826792|FG007|Overall Study|Withdrawal by Subject|0|||
170631991|NCT02230670|616664494|FG001|Overall Study|Withdrawal by Subject|2|||
170631992|NCT02230670|616664493|FG000|Overall Study|Physician Decision|0|||
170631993|NCT02230670|616664494|FG001|Overall Study|Physician Decision|1|||
170631994|NCT02230670|616664493|FG000|Overall Study|Protocol Violation|0|||
170405987|NCT00555399|615826793|FG008|Overall Study|Withdrawal by Subject|0|||
170405988|NCT00555399|615826794|FG009|Overall Study|Withdrawal by Subject|0|||
170405989|NCT00555399|615826795|FG010|Overall Study|Withdrawal by Subject|0|||
170631995|NCT02230670|616664494|FG001|Overall Study|Protocol Violation|1|||
170631996|NCT02230670|616664493|FG000|Overall Study|Progression to Child-Pugh C|1|||
170631997|NCT02230670|616664494|FG001|Overall Study|Progression to Child-Pugh C|2|||
170631998|NCT00836693|616664498|FG000|Overall Study|Adverse Event|4|||
170631999|NCT00836693|616664499|FG001|Overall Study|Adverse Event|1|||
170632000|NCT00836693|616664498|FG000|Overall Study|Sponsor Decision|0|||
170405990|NCT00555399|615826796|FG011|Overall Study|Withdrawal by Subject|1|||
170405991|NCT00555399|615826785|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
170405992|NCT00555399|615826786|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
170405993|NCT00555399|615826787|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
170632001|NCT00836693|616664499|FG001|Overall Study|Sponsor Decision|1|||
170632002|NCT00836693|616664498|FG000|Overall Study|Physician Decision|2|||
170632003|NCT00836693|616664499|FG001|Overall Study|Physician Decision|0|||
170632004|NCT00836693|616664498|FG000|Overall Study|Withdrawal by Subject|9|||
170632005|NCT00836693|616664499|FG001|Overall Study|Withdrawal by Subject|4|||
170632006|NCT00836693|616664498|FG000|Overall Study|Protocol Violation|1|||
170632007|NCT00836693|616664499|FG001|Overall Study|Protocol Violation|0|||
170632008|NCT00836693|616664498|FG000|Overall Study|Lost to Follow-up|1|||
170632009|NCT00836693|616664499|FG001|Overall Study|Lost to Follow-up|0|||
170632010|NCT02612779|616664500|FG000|Overall Study|Administrative reason by sponsor|4|||
170632011|NCT02612779|616664501|FG001|Overall Study|Administrative reason by sponsor|1|||
170632012|NCT02612779|616664500|FG000|Overall Study|No longer meet study criteria|0|||
170632013|NCT02612779|616664501|FG001|Overall Study|No longer meet study criteria|1|||
170632014|NCT02612779|616664500|FG000|Overall Study|Disease progression|29|||
170632015|NCT02612779|616664501|FG001|Overall Study|Disease progression|2|||
170632016|NCT02612779|616664500|FG000|Overall Study|Study drug toxicity|10|||
170632017|NCT02612779|616664501|FG001|Overall Study|Study drug toxicity|1|||
170632018|NCT02612779|616664500|FG000|Overall Study|Death|1|||
170632019|NCT02612779|616664501|FG001|Overall Study|Death|0|||
170632020|NCT02612779|616664500|FG000|Overall Study|Adverse event unrelated to study drug|5|||
170632021|NCT02612779|616664501|FG001|Overall Study|Adverse event unrelated to study drug|0|||
170405994|NCT00555399|615826788|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
170405995|NCT00555399|615826789|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
170405996|NCT00555399|615826790|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
170405997|NCT00555399|615826791|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
170405998|NCT00555399|615826792|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
170405999|NCT00555399|615826793|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
170406000|NCT00555399|615826794|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
170406001|NCT00555399|615826795|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
170406002|NCT00555399|615826796|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
170406003|NCT05458895|615826797|FG000|Overall Study|Withdrawal by Subject|8|||
170406004|NCT05458895|615826797|FG000|Overall Study|Lost to Follow-up|17|||
170406005|NCT05458895|615826797|FG000|Overall Study|Pregnancy|2|||
170406006|NCT05458895|615826797|FG000|Overall Study|Withdrawal by Study Team|1|||
170406007|NCT04639310|615826798|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
170406008|NCT04639310|615826799|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
170406009|NCT05166421|615826800|FG000|Overall Study|Other|3|||
170406010|NCT05166421|615826801|FG001|Overall Study|Other|1|||
170406011|NCT05166421|615826802|FG002|Overall Study|Other|1|||
170406012|NCT05166421|615826800|FG000|Overall Study|Withdrawal by Subject|5|||
170406013|NCT05166421|615826801|FG001|Overall Study|Withdrawal by Subject|3|||
170406014|NCT05166421|615826802|FG002|Overall Study|Withdrawal by Subject|6|||
170406015|NCT05166421|615826800|FG000|Overall Study|Lost to Follow-up|4|||
170406016|NCT05166421|615826801|FG001|Overall Study|Lost to Follow-up|1|||
170406017|NCT05166421|615826802|FG002|Overall Study|Lost to Follow-up|7|||
170406018|NCT00343642|615828447|FG000|Overall Study|Lost to Follow-up|0|||
170406019|NCT00343642|615828448|FG001|Overall Study|Lost to Follow-up|1|||
170406020|NCT00343642|615828449|FG002|Overall Study|Lost to Follow-up|0|||
170406021|NCT00343642|615828447|FG000|Overall Study|Pregnancy|1|||
170406022|NCT00343642|615828448|FG001|Overall Study|Pregnancy|0|||
170406023|NCT00343642|615828449|FG002|Overall Study|Pregnancy|2|||
170406024|NCT00343642|615828447|FG000|Overall Study|Withdrawal by Subject|2|||
170406025|NCT00343642|615828448|FG001|Overall Study|Withdrawal by Subject|3|||
170406026|NCT00343642|615828449|FG002|Overall Study|Withdrawal by Subject|4|||
170406027|NCT00343642|615828447|FG000|Overall Study|Adverse Event|0|||
170406028|NCT00343642|615828448|FG001|Overall Study|Adverse Event|0|||
170406029|NCT00343642|615828449|FG002|Overall Study|Adverse Event|1|||
170406030|NCT00343642|615828447|FG000|Overall Study|Flare up|6|||
170406031|NCT00343642|615828448|FG001|Overall Study|Flare up|4|||
170406032|NCT00343642|615828449|FG002|Overall Study|Flare up|0|||
170406033|NCT00860574|615828452|FG000|Overall Study|Death|2|||
170406034|NCT00860574|615828452|FG000|Overall Study|Relapse|1|||
170406035|NCT02496221|615828453|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
170406036|NCT02496221|615828454|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
170406037|NCT02496221|615828453|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
170632022|NCT02612779|616664500|FG000|Overall Study|Participant withdrew consent|4|||
170632023|NCT02612779|616664501|FG001|Overall Study|Participant withdrew consent|0|||
170406038|NCT02496221|615828454|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
170406039|NCT02496221|615828453|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
170406040|NCT02496221|615828454|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
170406041|NCT01335399|615828455|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
170406042|NCT01335399|615828456|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
170632024|NCT02612779|616664500|FG000|Overall Study|Lost to Follow-up|1|||
170632025|NCT02612779|616664501|FG001|Overall Study|Lost to Follow-up|0|||
170632026|NCT02612779|616664500|FG000|Overall Study|Maximum clinical benefit|10|||
170632027|NCT02612779|616664501|FG001|Overall Study|Maximum clinical benefit|1|||
170632028|NCT02612779|616664500|FG000|Overall Study|Other reasons|4|||
170632029|NCT02612779|616664501|FG001|Overall Study|Other reasons|0|||
170632030|NCT01907854|616664506|FG000|Overall Study|Protocol Violation|1|||
170632031|NCT01907854|616664507|FG001|Overall Study|Protocol Violation|1|||
170632032|NCT01907854|616664506|FG000|Overall Study|Withdrawal by Subject|9|||
170632033|NCT01907854|616664507|FG001|Overall Study|Withdrawal by Subject|7|||
170632034|NCT01907854|616664506|FG000|Overall Study|Lost to Follow-up|2|||
170632035|NCT01907854|616664507|FG001|Overall Study|Lost to Follow-up|2|||
170756293|NCT00315055|617112931|FG001|Overall Study|Protocol Violation|4|||
170756294|NCT00315055|617112930|FG000|Overall Study|Lost to Follow-up|1|||
170756295|NCT00315055|617112931|FG001|Overall Study|Lost to Follow-up|1|||
170756296|NCT03606460|617112932|FG000|Overall Study|Lost to Follow-up|1|||
170756297|NCT03606460|617112933|FG001|Overall Study|Lost to Follow-up|8|||
170756298|NCT00003377|617112934|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
170756299|NCT00003377|617112935|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
170756300|NCT00003377|617112936|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
170756301|NCT00003377|617112937|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
170756302|NCT00003377|617112938|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
170756303|NCT00003377|617112934|FG000|Period II|Ureteral stent complications|0|||
170756304|NCT00003377|617112935|FG001|Period II|Ureteral stent complications|0|||
170756305|NCT00003377|617112936|FG002|Period II|Ureteral stent complications|0|||
170756306|NCT00003377|617112937|FG003|Period II|Ureteral stent complications|0|||
170756307|NCT00003377|617112938|FG004|Period II|Ureteral stent complications|1|||
170756308|NCT04541186|617112942|FG000|Main Study|Adverse Event|0|||
170756309|NCT04541186|617112943|FG001|Main Study|Adverse Event|0|||
170756310|NCT04541186|617112944|FG002|Main Study|Adverse Event|4|||
170756311|NCT04541186|617112945|FG003|Main Study|Adverse Event|0|||
170756312|NCT04541186|617112946|FG004|Main Study|Adverse Event|0|||
170756313|NCT04541186|617112942|FG000|Main Study|Investigator Decision|0|||
170756314|NCT04541186|617112943|FG001|Main Study|Investigator Decision|0|||
170756315|NCT04541186|617112944|FG002|Main Study|Investigator Decision|1|||
170756316|NCT04541186|617112945|FG003|Main Study|Investigator Decision|1|||
170756317|NCT04541186|617112946|FG004|Main Study|Investigator Decision|0|||
170756318|NCT04541186|617112942|FG000|Main Study|Withdrawal by Subject|1|||
170756319|NCT04541186|617112943|FG001|Main Study|Withdrawal by Subject|1|||
170756320|NCT04541186|617112944|FG002|Main Study|Withdrawal by Subject|0|||
170756321|NCT04541186|617112945|FG003|Main Study|Withdrawal by Subject|0|||
170756322|NCT04541186|617112946|FG004|Main Study|Withdrawal by Subject|0|||
170756323|NCT04541186|617112942|FG000|Main Study|COVID-19-related Dose Interruption|0|||
170756324|NCT04541186|617112943|FG001|Main Study|COVID-19-related Dose Interruption|0|||
170756325|NCT04541186|617112944|FG002|Main Study|COVID-19-related Dose Interruption|0|||
170756326|NCT04541186|617112945|FG003|Main Study|COVID-19-related Dose Interruption|0|||
170756327|NCT04541186|617112946|FG004|Main Study|COVID-19-related Dose Interruption|1|||
170756328|NCT04541186|617112942|FG000|Main Study|Randomized in Error Not Treated|0|||
170756329|NCT04541186|617112943|FG001|Main Study|Randomized in Error Not Treated|0|||
170756330|NCT04541186|617112944|FG002|Main Study|Randomized in Error Not Treated|1|||
170756331|NCT04541186|617112945|FG003|Main Study|Randomized in Error Not Treated|0|||
170756332|NCT04541186|617112946|FG004|Main Study|Randomized in Error Not Treated|0|||
170756333|NCT04541186|617112942|FG000|Fibrate Expansion Study|Other than Specified|0|||
170756334|NCT04541186|617112943|FG001|Fibrate Expansion Study|Other than Specified|0|||
170756335|NCT04541186|617112944|FG002|Fibrate Expansion Study|Other than Specified|0|||
170756336|NCT04541186|617112945|FG003|Fibrate Expansion Study|Other than Specified|0|||
170756337|NCT04541186|617112946|FG004|Fibrate Expansion Study|Other than Specified|1|||
170756338|NCT00058058|617112951|FG000|Overall Study|Withdrawal by Subject|4|||
170756339|NCT00058058|617112951|FG000|Overall Study|Ineligible|20|||
170756340|NCT00058058|617112951|FG000|Overall Study|Claustrophobic|5|||
170756341|NCT00058058|617112951|FG000|Overall Study|technical issues|6|||
170756342|NCT00058058|617112951|FG000|Overall Study|Poor positioning, illness,pain|3|||
170756343|NCT00582790|617112952|FG000|Overall Study|Rapid progression of disease|1|||
170756344|NCT00480441|617112957|FG000|Screening|Not Eligible|37|||
170756345|NCT00480441|617112958|FG001|Screening|Not Eligible|0|||
170756346|NCT00480441|617112959|FG002|Screening|Not Eligible|0|||
170756347|NCT00480441|617112957|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
170756348|NCT00480441|617112958|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
170756349|NCT00480441|617112959|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
170756350|NCT00480441|617112957|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
170756351|NCT00480441|617112958|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
170756352|NCT00480441|617112959|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
170756353|NCT00480441|617112957|FG000|Baseline Functional MRI|physical contraindication|4|||
170756354|NCT00480441|617112958|FG001|Baseline Functional MRI|physical contraindication|0|||
170756355|NCT00480441|617112959|FG002|Baseline Functional MRI|physical contraindication|0|||
170756356|NCT00480441|617112957|FG000|Randomization|Lost to Follow-up|0|||
170756357|NCT00480441|617112958|FG001|Randomization|Lost to Follow-up|7|||
170756358|NCT00480441|617112959|FG002|Randomization|Lost to Follow-up|2|||
170632036|NCT01907854|616664506|FG000|Overall Study|Unclassified|4|||
170632037|NCT01907854|616664507|FG001|Overall Study|Unclassified|3|||
170632038|NCT01744977|616664510|FG000|Overall Study|Withdrawal by Subject|1|||
170756359|NCT03613129|617112960|FG000|Pre-treatment Assessment|Protocol Violation|2|||
170756360|NCT03613129|617112961|FG001|Pre-treatment Assessment|Protocol Violation|0|||
170756361|NCT03613129|617112962|FG002|Pre-treatment Assessment|Protocol Violation|0|||
170756362|NCT03613129|617112963|FG003|Pre-treatment Assessment|Protocol Violation|0|||
170756363|NCT03613129|617112964|FG004|Pre-treatment Assessment|Protocol Violation|0|||
170756364|NCT03613129|617112960|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
170756365|NCT03613129|617112961|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
170756366|NCT03613129|617112962|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
170756367|NCT03613129|617112963|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
170756368|NCT03613129|617112964|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
170756369|NCT02334306|617112965|FG000|Double-blind Period|Adverse Event|0|||
170756370|NCT02334306|617112966|FG001|Double-blind Period|Adverse Event|1|||
170756371|NCT02334306|617112965|FG000|Double-blind Period|Withdrawal by Subject|1|||
170756372|NCT02334306|617112966|FG001|Double-blind Period|Withdrawal by Subject|1|||
170756373|NCT01687270|617112967|FG000|Overall Study|Lack of Efficacy|11|||
170756374|NCT01687270|617112967|FG000|Overall Study|Lost to Follow-up|1|||
170756375|NCT00711646|617112968|FG000|Overall Study|Adverse Event|6|||
170756376|NCT00711646|617112969|FG001|Overall Study|Adverse Event|1|||
170756377|NCT00711646|617112968|FG000|Overall Study|Withdrawal by Subject|4|||
170756378|NCT00711646|617112969|FG001|Overall Study|Withdrawal by Subject|0|||
170756379|NCT00711646|617112968|FG000|Overall Study|Protocol Violation|0|||
170756380|NCT00711646|617112969|FG001|Overall Study|Protocol Violation|1|||
170756381|NCT00711646|617112968|FG000|Overall Study|Lost to Follow-up|1|||
170756382|NCT00711646|617112969|FG001|Overall Study|Lost to Follow-up|0|||
170756383|NCT00711646|617112968|FG000|Overall Study|administrative decision|0|||
170756384|NCT00711646|617112969|FG001|Overall Study|administrative decision|1|||
170756385|NCT00711646|617112968|FG000|Overall Study|patient non-compliance|1|||
170756386|NCT00711646|617112969|FG001|Overall Study|patient non-compliance|0|||
170756387|NCT03532178|617112970|FG000|First Period|Withdrawal by Subject|1|||
170756388|NCT03532178|617112971|FG001|First Period|Withdrawal by Subject|3|||
170756389|NCT03532178|617112970|FG000|First Period|technical issues in data collection Technical issues|0|||
170756390|NCT03532178|617112971|FG001|First Period|technical issues in data collection Technical issues|1|||
170756391|NCT03532178|617112970|FG000|Second Period|Withdrawal by Subject|1|||
170756392|NCT03532178|617112971|FG001|Second Period|Withdrawal by Subject|1|||
170756393|NCT03532178|617112970|FG000|Second Period|Technical issues|0|||
170756394|NCT03532178|617112971|FG001|Second Period|Technical issues|1|||
170756395|NCT03302156|617112972|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
170756396|NCT03302156|617112973|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
170756397|NCT03302156|617112974|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
170756398|NCT03441360|617112975|FG000|Overall Study|Radiological disease progression|5|||
170756399|NCT03441360|617112976|FG001|Overall Study|Radiological disease progression|6|||
170756400|NCT03441360|617112977|FG002|Overall Study|Radiological disease progression|4|||
170756401|NCT03441360|617112975|FG000|Overall Study|Clinical disease progression|2|||
170756402|NCT03441360|617112976|FG001|Overall Study|Clinical disease progression|2|||
170756403|NCT03441360|617112977|FG002|Overall Study|Clinical disease progression|0|||
170756404|NCT03441360|617112975|FG000|Overall Study|Adverse Event|1|||
170756405|NCT03441360|617112976|FG001|Overall Study|Adverse Event|0|||
170756406|NCT03441360|617112977|FG002|Overall Study|Adverse Event|1|||
170756407|NCT02390557|617112978|FG000|Wave 2|Survey non-respondent|72|||
170756408|NCT02390557|617112979|FG001|Wave 2|Survey non-respondent|41|||
170756409|NCT02390557|617112980|FG002|Wave 2|Survey non-respondent|23|||
170756410|NCT01360840|617112981|FG000|Overall Study|Ongoing at data cut-off|10|||
170756411|NCT01360840|617112982|FG001|Overall Study|Ongoing at data cut-off|10|||
170756412|NCT01360840|617112983|FG002|Overall Study|Ongoing at data cut-off|9|||
170756413|NCT00920686|617112984|FG000|Overall Study|Lost to Follow-up|2|||
170756414|NCT00920686|617112985|FG001|Overall Study|Lost to Follow-up|3|||
170756415|NCT00920686|617112986|FG002|Overall Study|Lost to Follow-up|1|||
170756416|NCT00920686|617112984|FG000|Overall Study|Study drug dosing criteria not met|17|||
170756417|NCT00920686|617112985|FG001|Overall Study|Study drug dosing criteria not met|19|||
170756418|NCT00920686|617112986|FG002|Overall Study|Study drug dosing criteria not met|12|||
170756419|NCT03006341|617112987|FG000|Overall Study|Not linked in the EMR|25069|||
170756420|NCT03006341|617112988|FG001|Overall Study|Not linked in the EMR|67505|||
170756421|NCT03006341|617112989|FG002|Overall Study|Not linked in the EMR|30993|||
170865643|NCT04786119|617519981|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
170865644|NCT03049735|617519984|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
170756422|NCT03006341|617112990|FG003|Overall Study|Not linked in the EMR|10685|||
170756423|NCT03686683|617112992|FG000|Overall Study|Withdrawal by Subject|52|||
170756424|NCT03686683|617112993|FG001|Overall Study|Withdrawal by Subject|32|||
170756425|NCT03686683|617112992|FG000|Overall Study|Lost to Follow-up|23|||
170756426|NCT03686683|617112993|FG001|Overall Study|Lost to Follow-up|19|||
170865645|NCT03049735|617519985|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
170865646|NCT03049735|617519986|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
170756427|NCT03686683|617112992|FG000|Overall Study|Adverse Event|1|||
170756428|NCT03686683|617112993|FG001|Overall Study|Adverse Event|0|||
170756429|NCT03686683|617112992|FG000|Overall Study|Death|10|||
170756430|NCT03686683|617112993|FG001|Overall Study|Death|5|||
170756431|NCT03686683|617112992|FG000|Overall Study|Progressive Disease|1|||
170756432|NCT03686683|617112993|FG001|Overall Study|Progressive Disease|1|||
170756433|NCT03686683|617112992|FG000|Overall Study|Noncompliance|1|||
170756434|NCT03686683|617112993|FG001|Overall Study|Noncompliance|0|||
170756435|NCT03686683|617112992|FG000|Overall Study|Physician Decision|1|||
170756436|NCT03686683|617112993|FG001|Overall Study|Physician Decision|1|||
170756437|NCT03686683|617112992|FG000|Overall Study|Screen fail post-randomization|1|||
170756438|NCT03686683|617112993|FG001|Overall Study|Screen fail post-randomization|0|||
170756439|NCT03686683|617112992|FG000|Overall Study|Protocol Violation|3|||
170756440|NCT03686683|617112993|FG001|Overall Study|Protocol Violation|0|||
170756441|NCT03686683|617112992|FG000|Overall Study|No data available|1|||
170756442|NCT03686683|617112993|FG001|Overall Study|No data available|0|||
170756443|NCT02478359|617112995|FG000|Overall Study|Disenrolled from health plan|106|||
170756444|NCT02478359|617112996|FG001|Overall Study|Disenrolled from health plan|65|||
170756445|NCT01417000|617112999|FG000|Overall Study|Death|59|||
170756446|NCT01417000|617113000|FG001|Overall Study|Death|28|||
170756447|NCT01417000|617112999|FG000|Overall Study|Lost to Follow-up|1|||
170756448|NCT01417000|617113000|FG001|Overall Study|Lost to Follow-up|0|||
170756449|NCT01417000|617112999|FG000|Overall Study|Study Terminated by Sponsor|1|||
170756450|NCT01417000|617113000|FG001|Overall Study|Study Terminated by Sponsor|1|||
170756451|NCT02338609|617113001|FG000|Overall Study|Physician Decision|1|||
170756452|NCT02338609|617113001|FG000|Overall Study|Death|1|||
170756453|NCT02223182|617113003|FG000|Double-Blind Period|Adverse Event|0|||
170756454|NCT02223182|617113004|FG001|Double-Blind Period|Adverse Event|2|||
170756455|NCT02223182|617113005|FG002|Double-Blind Period|Adverse Event|1|||
170756456|NCT02223182|617113006|FG003|Double-Blind Period|Adverse Event|0|||
170756457|NCT02223182|617113003|FG000|Double-Blind Period|Withdrawal by Subject|1|||
170756458|NCT02223182|617113004|FG001|Double-Blind Period|Withdrawal by Subject|1|||
170756459|NCT02223182|617113005|FG002|Double-Blind Period|Withdrawal by Subject|1|||
170756460|NCT02223182|617113006|FG003|Double-Blind Period|Withdrawal by Subject|0|||
170406043|NCT01335399|615828455|FG000|Pre-treatment Period|Participant request to discontinue|0|||
170406044|NCT01335399|615828456|FG001|Pre-treatment Period|Participant request to discontinue|1|||
170406045|NCT01335399|615828455|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
170406046|NCT01335399|615828456|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
170406047|NCT01335399|615828455|FG000|Pre-treatment Period|Consent withdrawal|3|||
170406048|NCT01335399|615828456|FG001|Pre-treatment Period|Consent withdrawal|0|||
170406049|NCT01335399|615828455|FG000|Treatment Period|Disease progression|117|||
170756461|NCT02223182|617113003|FG000|Double-Blind Period|Lost to Follow-up|0|||
170756462|NCT02223182|617113004|FG001|Double-Blind Period|Lost to Follow-up|1|||
170756463|NCT02223182|617113005|FG002|Double-Blind Period|Lost to Follow-up|0|||
170756464|NCT02223182|617113006|FG003|Double-Blind Period|Lost to Follow-up|0|||
170756465|NCT02223182|617113003|FG000|Double-Blind Period|Non Compliance|0|||
170756466|NCT02223182|617113004|FG001|Double-Blind Period|Non Compliance|0|||
170756467|NCT02223182|617113005|FG002|Double-Blind Period|Non Compliance|0|||
170756468|NCT02223182|617113006|FG003|Double-Blind Period|Non Compliance|1|||
170756469|NCT02223182|617113003|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
170756470|NCT02223182|617113004|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
170756471|NCT02223182|617113005|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
170756472|NCT02223182|617113006|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
170756473|NCT02223182|617113003|FG000|Open-Label 500 Period|Adverse Event|1|||
170756474|NCT02223182|617113004|FG001|Open-Label 500 Period|Adverse Event|0|||
170756475|NCT02223182|617113005|FG002|Open-Label 500 Period|Adverse Event|2|||
170756476|NCT02223182|617113006|FG003|Open-Label 500 Period|Adverse Event|1|||
170756477|NCT02223182|617113003|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
170406050|NCT01335399|615828456|FG001|Treatment Period|Disease progression|145|||
170756478|NCT02223182|617113004|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
170756479|NCT02223182|617113005|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
170756480|NCT02223182|617113006|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
170756481|NCT02223182|617113003|FG000|Open-Label 500 Period|Physician Decision|0|||
170865647|NCT03049735|617519984|FG000|Overall Study|Other|5|||
170406051|NCT01335399|615828455|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
170756482|NCT02223182|617113004|FG001|Open-Label 500 Period|Physician Decision|0|||
170756483|NCT02223182|617113005|FG002|Open-Label 500 Period|Physician Decision|0|||
170756484|NCT02223182|617113006|FG003|Open-Label 500 Period|Physician Decision|1|||
170756485|NCT02223182|617113003|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
170756486|NCT02223182|617113004|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
170756487|NCT02223182|617113005|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
170756488|NCT02223182|617113006|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
170756489|NCT02223182|617113003|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
170756490|NCT02223182|617113004|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
170756491|NCT02223182|617113005|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
170865648|NCT03049735|617519985|FG001|Overall Study|Other|3|||
170406052|NCT01335399|615828456|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
170406053|NCT01335399|615828455|FG000|Treatment Period|Study drug toxicity|52|||
170406054|NCT01335399|615828456|FG001|Treatment Period|Study drug toxicity|64|||
170406055|NCT01335399|615828455|FG000|Treatment Period|Participant request to discontinue|30|||
170406056|NCT01335399|615828456|FG001|Treatment Period|Participant request to discontinue|22|||
170406057|NCT01335399|615828455|FG000|Treatment Period|Other reasons|30|||
170406058|NCT01335399|615828456|FG001|Treatment Period|Other reasons|30|||
170406059|NCT01335399|615828455|FG000|Treatment Period|Consent withdrawal|10|||
170406060|NCT01335399|615828456|FG001|Treatment Period|Consent withdrawal|7|||
170406061|NCT01335399|615828455|FG000|Treatment Period|Death|7|||
170406062|NCT01335399|615828456|FG001|Treatment Period|Death|6|||
170406063|NCT01335399|615828455|FG000|Treatment Period|Poor/Non-compliance|3|||
170406064|NCT01335399|615828456|FG001|Treatment Period|Poor/Non-compliance|4|||
170406065|NCT01335399|615828455|FG000|Treatment Period|Lost to Follow-up|2|||
170406066|NCT01335399|615828456|FG001|Treatment Period|Lost to Follow-up|2|||
170406067|NCT01335399|615828455|FG000|Treatment Period|Maximum clinical benefit|1|||
170406068|NCT01335399|615828456|FG001|Treatment Period|Maximum clinical benefit|1|||
170406069|NCT01335399|615828455|FG000|Treatment Period|No longer meet study criteria|1|||
170406070|NCT01335399|615828456|FG001|Treatment Period|No longer meet study criteria|1|||
170406071|NCT01335399|615828455|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
170406072|NCT01335399|615828456|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
170406073|NCT03262233|615828457|FG000|Overall Study|Withdrawal by Subject|12|||
170406074|NCT03262233|615828458|FG001|Overall Study|Withdrawal by Subject|8|||
170406075|NCT03262233|615828459|FG002|Overall Study|Withdrawal by Subject|21|||
170406076|NCT03262233|615828460|FG003|Overall Study|Withdrawal by Subject|13|||
170406077|NCT03262233|615828457|FG000|Overall Study|Declined due to shock|1|||
170406078|NCT03262233|615828458|FG001|Overall Study|Declined due to shock|2|||
170406079|NCT03262233|615828459|FG002|Overall Study|Declined due to shock|2|||
170406080|NCT03262233|615828460|FG003|Overall Study|Declined due to shock|3|||
170406081|NCT03262233|615828457|FG000|Overall Study|Protocol Violation|5|||
170406082|NCT03262233|615828458|FG001|Overall Study|Protocol Violation|10|||
170406083|NCT03262233|615828459|FG002|Overall Study|Protocol Violation|2|||
170406084|NCT03262233|615828460|FG003|Overall Study|Protocol Violation|13|||
170406085|NCT03262233|615828457|FG000|Overall Study|data collection artifact|0|||
170406086|NCT03262233|615828458|FG001|Overall Study|data collection artifact|1|||
170406087|NCT03262233|615828459|FG002|Overall Study|data collection artifact|0|||
170406088|NCT03262233|615828460|FG003|Overall Study|data collection artifact|0|||
170406089|NCT01120600|615828463|FG000|Overall Study|Adverse Event|7|||
170406090|NCT01120600|615828464|FG001|Overall Study|Adverse Event|7|||
170406091|NCT01120600|615828463|FG000|Overall Study|Excessive Bone Loss|0|||
170406092|NCT01120600|615828464|FG001|Overall Study|Excessive Bone Loss|4|||
170406093|NCT01120600|615828463|FG000|Overall Study|Lost to Follow-up|1|||
170406094|NCT01120600|615828464|FG001|Overall Study|Lost to Follow-up|3|||
170406095|NCT01120600|615828463|FG000|Overall Study|Physician Decision|1|||
170406096|NCT01120600|615828464|FG001|Overall Study|Physician Decision|3|||
170406097|NCT01120600|615828463|FG000|Overall Study|Protocol Violation|0|||
170406098|NCT01120600|615828464|FG001|Overall Study|Protocol Violation|4|||
170406099|NCT01120600|615828463|FG000|Overall Study|Withdrawal by Subject|10|||
170406100|NCT01120600|615828464|FG001|Overall Study|Withdrawal by Subject|11|||
170406101|NCT00566098|615828465|FG000|Collection of MILs|Withdrawal by Subject|1|||
170406102|NCT00566098|615828465|FG000|Collection of MILs|Relapsed|1|||
170406103|NCT00566098|615828465|FG000|Generation of MILs Product|Relapsed|1|||
170406104|NCT00566098|615828465|FG000|Administration of ASCT+MILs|Death|10|||
170406105|NCT00566098|615828465|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
170406106|NCT01690520|615828466|FG000|Overall Study|Death|25|||
170406107|NCT01690520|615828467|FG001|Overall Study|Death|21|||
170756492|NCT02223182|617113006|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
170756493|NCT02223182|617113003|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
170756494|NCT02223182|617113004|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
170406108|NCT01690520|615828466|FG000|Overall Study|Lost to Follow-up|2|||
170406109|NCT01690520|615828467|FG001|Overall Study|Lost to Follow-up|3|||
170406110|NCT01690520|615828466|FG000|Overall Study|Withdrawal by Subject|2|||
170406111|NCT01690520|615828467|FG001|Overall Study|Withdrawal by Subject|0|||
170406112|NCT01690520|615828466|FG000|Overall Study|Relapse|0|||
170756495|NCT02223182|617113005|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
170756496|NCT02223182|617113006|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
170756497|NCT02223182|617113003|FG000|Open-Label 300 Period|Non Compliance|0|||
170756498|NCT02223182|617113004|FG001|Open-Label 300 Period|Non Compliance|2|||
170406113|NCT01690520|615828467|FG001|Overall Study|Relapse|1|||
170406114|NCT01690520|615828466|FG000|Overall Study|Other|0|||
170406115|NCT01690520|615828467|FG001|Overall Study|Other|1|||
170406116|NCT01690520|615828466|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
170406117|NCT01690520|615828467|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
170406118|NCT00434161|615828477|FG000|Overall Study|Adverse Event|5|||
170406119|NCT00434161|615828478|FG001|Overall Study|Adverse Event|1|||
170756499|NCT02223182|617113005|FG002|Open-Label 300 Period|Non Compliance|1|||
170406120|NCT00434161|615828479|FG002|Overall Study|Adverse Event|4|||
170756500|NCT02223182|617113006|FG003|Open-Label 300 Period|Non Compliance|0|||
170756501|NCT03251378|617113007|FG000|Overall Study|Death|3|||
170756502|NCT03251378|617113008|FG001|Overall Study|Death|2|||
170756503|NCT03251378|617113009|FG002|Overall Study|Death|3|||
170756504|NCT03251378|617113010|FG003|Overall Study|Death|30|||
170756505|NCT03251378|617113011|FG004|Overall Study|Death|24|||
170756506|NCT03251378|617113012|FG005|Overall Study|Death|12|||
170756507|NCT03251378|617113013|FG006|Overall Study|Death|12|||
170756508|NCT03251378|617113007|FG000|Overall Study|Lost to Follow-up|0|||
170756509|NCT03251378|617113008|FG001|Overall Study|Lost to Follow-up|0|||
170756510|NCT03251378|617113009|FG002|Overall Study|Lost to Follow-up|1|||
170756511|NCT03251378|617113010|FG003|Overall Study|Lost to Follow-up|3|||
170756512|NCT03251378|617113011|FG004|Overall Study|Lost to Follow-up|0|||
170756513|NCT03251378|617113012|FG005|Overall Study|Lost to Follow-up|0|||
170756514|NCT03251378|617113013|FG006|Overall Study|Lost to Follow-up|0|||
170756515|NCT03251378|617113007|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
170756516|NCT03251378|617113008|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
170756517|NCT03251378|617113009|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
170756518|NCT03251378|617113010|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
170756519|NCT03251378|617113011|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
170756520|NCT03251378|617113012|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
170756521|NCT03251378|617113013|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
170756522|NCT03251378|617113007|FG000|Overall Study|Progressive disease|2|||
170756523|NCT03251378|617113008|FG001|Overall Study|Progressive disease|0|||
170756524|NCT03251378|617113009|FG002|Overall Study|Progressive disease|0|||
170756525|NCT03251378|617113010|FG003|Overall Study|Progressive disease|1|||
170756526|NCT03251378|617113011|FG004|Overall Study|Progressive disease|0|||
170756527|NCT03251378|617113012|FG005|Overall Study|Progressive disease|0|||
170756528|NCT03251378|617113013|FG006|Overall Study|Progressive disease|0|||
170756529|NCT03251378|617113007|FG000|Overall Study|Physician Decision|0|||
170756530|NCT03251378|617113008|FG001|Overall Study|Physician Decision|2|||
170756531|NCT03251378|617113009|FG002|Overall Study|Physician Decision|0|||
170756532|NCT03251378|617113010|FG003|Overall Study|Physician Decision|0|||
170756533|NCT03251378|617113011|FG004|Overall Study|Physician Decision|0|||
170756534|NCT03251378|617113012|FG005|Overall Study|Physician Decision|0|||
170756535|NCT03251378|617113013|FG006|Overall Study|Physician Decision|0|||
170756536|NCT03251378|617113007|FG000|Overall Study|Other|2|||
170756537|NCT03251378|617113008|FG001|Overall Study|Other|3|||
170756538|NCT03251378|617113009|FG002|Overall Study|Other|2|||
170756539|NCT03251378|617113010|FG003|Overall Study|Other|0|||
170756540|NCT03251378|617113011|FG004|Overall Study|Other|1|||
170756541|NCT03251378|617113012|FG005|Overall Study|Other|1|||
170756542|NCT03251378|617113013|FG006|Overall Study|Other|1|||
170756543|NCT03251378|617113007|FG000|Overall Study|Other|0|||
170756544|NCT03251378|617113008|FG001|Overall Study|Other|0|||
170756545|NCT03251378|617113009|FG002|Overall Study|Other|0|||
170756546|NCT03251378|617113010|FG003|Overall Study|Other|4|||
170756547|NCT03251378|617113011|FG004|Overall Study|Other|13|||
170865649|NCT03049735|617519986|FG002|Overall Study|Other|1|||
170865650|NCT03049735|617519984|FG000|Overall Study|Lack of Efficacy|4|||
170865651|NCT03049735|617519985|FG001|Overall Study|Lack of Efficacy|0|||
170756548|NCT03251378|617113012|FG005|Overall Study|Other|0|||
170756549|NCT03251378|617113013|FG006|Overall Study|Other|0|||
170756550|NCT05780047|617113015|FG000|Overall Study|Did not submit baseline urine test kit|226|||
170756551|NCT05780047|617113015|FG000|Overall Study|Lost to Follow-up|34|||
170756552|NCT05780047|617113015|FG000|Overall Study|Did not submit second urine test kit|124|||
170756553|NCT04739423|617113018|FG000|Overall Study|Protocol Violation|0|||
170756554|NCT04739423|617113019|FG001|Overall Study|Protocol Violation|1|||
170756555|NCT04739423|617113020|FG002|Overall Study|Protocol Violation|0|||
170756556|NCT04739423|617113021|FG003|Overall Study|Protocol Violation|0|||
170756557|NCT04739423|617113022|FG004|Overall Study|Protocol Violation|0|||
170756558|NCT04739423|617113023|FG005|Overall Study|Protocol Violation|0|||
170756559|NCT04739423|617113018|FG000|Overall Study|Adverse Event|0|||
170756560|NCT04739423|617113019|FG001|Overall Study|Adverse Event|0|||
170756561|NCT04739423|617113020|FG002|Overall Study|Adverse Event|1|||
170756562|NCT04739423|617113021|FG003|Overall Study|Adverse Event|0|||
170756563|NCT04739423|617113022|FG004|Overall Study|Adverse Event|1|||
170756564|NCT04739423|617113023|FG005|Overall Study|Adverse Event|0|||
170756565|NCT04739423|617113018|FG000|Overall Study|Withdrawal by Subject|0|||
170756566|NCT04739423|617113019|FG001|Overall Study|Withdrawal by Subject|0|||
170865652|NCT03049735|617519986|FG002|Overall Study|Lack of Efficacy|3|||
170756567|NCT04739423|617113020|FG002|Overall Study|Withdrawal by Subject|0|||
170756568|NCT04739423|617113021|FG003|Overall Study|Withdrawal by Subject|0|||
170756569|NCT04739423|617113022|FG004|Overall Study|Withdrawal by Subject|0|||
170865653|NCT03049735|617519984|FG000|Overall Study|Protocol deviation|1|||
170756570|NCT04739423|617113023|FG005|Overall Study|Withdrawal by Subject|1|||
170756571|NCT01007552|617113024|FG000|Overall Study|Withdrawal by Subject|1|||
170865654|NCT03049735|617519985|FG001|Overall Study|Protocol deviation|0|||
170756572|NCT03212365|617113035|FG000|Overall Study|Discharged prior to Xa level|12|||
170756573|NCT03212365|617113036|FG001|Overall Study|Discharged prior to Xa level|8|||
170756574|NCT03212365|617113035|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
170756575|NCT03212365|617113036|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
170756576|NCT03212365|617113035|FG000|Overall Study|Refused study medication|3|||
170756577|NCT03212365|617113036|FG001|Overall Study|Refused study medication|0|||
170756578|NCT03212365|617113035|FG000|Overall Study|Initiated heparin infusion on floor|1|||
170756579|NCT03212365|617113036|FG001|Overall Study|Initiated heparin infusion on floor|1|||
170756580|NCT03212365|617113035|FG000|Overall Study|Unexpected return to OR|1|||
170756581|NCT03212365|617113036|FG001|Overall Study|Unexpected return to OR|1|||
170756582|NCT03212365|617113035|FG000|Overall Study|Medication distribution error|1|||
170756583|NCT03212365|617113036|FG001|Overall Study|Medication distribution error|0|||
170756584|NCT03212365|617113035|FG000|Overall Study|Required epidural placement|1|||
170756585|NCT03212365|617113036|FG001|Overall Study|Required epidural placement|0|||
170756586|NCT03212365|617113035|FG000|Overall Study|Withdrawal by Subject|0|||
170756587|NCT03212365|617113036|FG001|Overall Study|Withdrawal by Subject|1|||
170756588|NCT03212365|617113035|FG000|Overall Study|developed acute renal failure|0|||
170756589|NCT03212365|617113036|FG001|Overall Study|developed acute renal failure|1|||
170756590|NCT00333138|617113037|FG000|Core Study (6 Months)|Adverse Event|4|||
170756591|NCT00333138|617113038|FG001|Core Study (6 Months)|Adverse Event|5|||
170756592|NCT00333138|617113039|FG002|Core Study (6 Months)|Adverse Event|8|||
170756593|NCT00333138|617113037|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
170756594|NCT00333138|617113038|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
170756595|NCT00333138|617113039|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
170756596|NCT00333138|617113037|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
170756597|NCT00333138|617113038|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
170756598|NCT00333138|617113039|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
170756599|NCT00333138|617113037|FG000|Core Study (6 Months)|Protocol Violation|1|||
170756600|NCT00333138|617113038|FG001|Core Study (6 Months)|Protocol Violation|0|||
170756601|NCT00333138|617113039|FG002|Core Study (6 Months)|Protocol Violation|1|||
170756602|NCT00333138|617113037|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
170756603|NCT00333138|617113038|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
170756604|NCT00333138|617113039|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
170756605|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
170756606|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
170756607|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
170756608|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
170756609|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
170756610|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
170756611|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
170756612|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
170756613|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
170756614|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
170756615|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
170756616|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
170756617|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
170756618|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
170756619|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
170756620|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
170756621|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
170756622|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
170756623|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
170756624|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
170756625|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
170756626|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
170756627|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
170756628|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
170756629|NCT00333138|617113037|FG000|Extension Study (Month6 to End of Study)|Death|0|||
170756630|NCT00333138|617113038|FG001|Extension Study (Month6 to End of Study)|Death|1|||
170756631|NCT00333138|617113039|FG002|Extension Study (Month6 to End of Study)|Death|0|||
170756632|NCT03005288|617113040|FG000|Overall Study|Withdrawal by Subject|7|||
170756633|NCT03005288|617113041|FG001|Overall Study|Withdrawal by Subject|5|||
170756634|NCT03005288|617113040|FG000|Overall Study|Lost to Follow-up|0|||
170756635|NCT03005288|617113041|FG001|Overall Study|Lost to Follow-up|1|||
170756636|NCT03005288|617113040|FG000|Overall Study|Adverse Event|5|||
170756637|NCT03005288|617113041|FG001|Overall Study|Adverse Event|0|||
170756638|NCT03005288|617113040|FG000|Overall Study|Protocol deviation|0|||
170406121|NCT00434161|615828477|FG000|Overall Study|Lost to Follow-up|0|||
170756639|NCT03005288|617113041|FG001|Overall Study|Protocol deviation|1|||
170756640|NCT03005288|617113040|FG000|Overall Study|Physician Decision|0|||
170756641|NCT03005288|617113041|FG001|Overall Study|Physician Decision|1|||
170406122|NCT00434161|615828478|FG001|Overall Study|Lost to Follow-up|1|||
170756642|NCT04438785|617113046|FG000|Overall Study|change of weight, give up intervention|2|||
170756643|NCT04438785|617113047|FG001|Overall Study|change of weight, give up intervention|10|||
170756644|NCT04011033|617113048|FG000|Overall Study|Physician Decision|2|||
170756645|NCT04011033|617113049|FG001|Overall Study|Physician Decision|3|||
170756646|NCT04011033|617113048|FG000|Overall Study|Withdrawal by Subject|1|||
170756647|NCT04011033|617113049|FG001|Overall Study|Withdrawal by Subject|0|||
170756648|NCT01734811|617113054|FG000|Overall Study|Lost to Follow-up|2|||
170756649|NCT01734811|617113055|FG001|Overall Study|Lost to Follow-up|3|||
170756650|NCT01734811|617113054|FG000|Overall Study|Withdrawal by Subject|2|||
170406123|NCT00434161|615828479|FG002|Overall Study|Lost to Follow-up|0|||
170406124|NCT00434161|615828477|FG000|Overall Study|Death|1|||
170406125|NCT00434161|615828478|FG001|Overall Study|Death|0|||
170406126|NCT00434161|615828479|FG002|Overall Study|Death|1|||
170406127|NCT00434161|615828477|FG000|Overall Study|Non-Compliance|1|||
170406128|NCT00434161|615828478|FG001|Overall Study|Non-Compliance|1|||
170406129|NCT00434161|615828479|FG002|Overall Study|Non-Compliance|0|||
170406130|NCT00434161|615828477|FG000|Overall Study|Withdrawal by Subject|2|||
170406131|NCT00434161|615828478|FG001|Overall Study|Withdrawal by Subject|0|||
170406132|NCT00434161|615828479|FG002|Overall Study|Withdrawal by Subject|3|||
170406133|NCT00434161|615828477|FG000|Overall Study|Logistical error study assessments|1|||
170406134|NCT00434161|615828478|FG001|Overall Study|Logistical error study assessments|0|||
170406135|NCT00434161|615828479|FG002|Overall Study|Logistical error study assessments|3|||
170406136|NCT04741503|615828480|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
170406137|NCT04741503|615828481|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
170406138|NCT04741503|615828482|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
170406139|NCT04741503|615828480|FG000|Initial Enrollment|Overquotas removed|0|||
170406140|NCT04741503|615828481|FG001|Initial Enrollment|Overquotas removed|0|||
170406141|NCT04741503|615828482|FG002|Initial Enrollment|Overquotas removed|186|||
170406142|NCT04741503|615828480|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
170406143|NCT04741503|615828481|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
170756651|NCT01734811|617113055|FG001|Overall Study|Withdrawal by Subject|0|||
170756652|NCT01449929|617113056|FG000|Randomization Phase 96 Week|Adverse Event|5|||
170756653|NCT01449929|617113057|FG001|Randomization Phase 96 Week|Adverse Event|13|||
170756654|NCT01449929|617113058|FG002|Randomization Phase 96 Week|Adverse Event|0|||
170756655|NCT01449929|617113056|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
170756656|NCT01449929|617113057|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
170756657|NCT01449929|617113058|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
170756658|NCT01449929|617113056|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
170756659|NCT01449929|617113057|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
170756660|NCT01449929|617113058|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
170756661|NCT01449929|617113056|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
170756662|NCT01449929|617113057|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
170756663|NCT01449929|617113058|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
170406144|NCT04741503|615828482|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
170406145|NCT02451670|615828483|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
170406146|NCT02451670|615828484|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
170406147|NCT00461500|615828485|FG000|Overall Study|Adverse Event|1|||
170406148|NCT00461500|615828486|FG001|Overall Study|Adverse Event|0|||
170406149|NCT00461500|615828485|FG000|Overall Study|Lack of Efficacy|0|||
170406150|NCT00461500|615828486|FG001|Overall Study|Lack of Efficacy|1|||
170406151|NCT00461500|615828485|FG000|Overall Study|Expired Drug Treatment|1|||
170406152|NCT00461500|615828486|FG001|Overall Study|Expired Drug Treatment|1|||
170406153|NCT00461500|615828485|FG000|Overall Study|Study Stopped|1|||
170406154|NCT00461500|615828486|FG001|Overall Study|Study Stopped|2|||
170406155|NCT00461500|615828485|FG000|Overall Study|Drug Treatment Misuse|1|||
170406156|NCT00461500|615828486|FG001|Overall Study|Drug Treatment Misuse|0|||
170406157|NCT00461500|615828485|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
170756664|NCT01449929|617113056|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
170756665|NCT01449929|617113057|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
170756666|NCT01449929|617113058|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
170756667|NCT01449929|617113056|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
170756668|NCT01449929|617113057|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
170756669|NCT01449929|617113058|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
170756670|NCT01449929|617113056|FG000|Randomization Phase 96 Week|Physician Decision|2|||
170756671|NCT01449929|617113057|FG001|Randomization Phase 96 Week|Physician Decision|3|||
170756672|NCT01449929|617113058|FG002|Randomization Phase 96 Week|Physician Decision|0|||
170756673|NCT01449929|617113056|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
170756674|NCT01449929|617113057|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
170756675|NCT01449929|617113058|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
170756676|NCT01449929|617113056|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
170756677|NCT01449929|617113057|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
170756678|NCT01449929|617113058|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
170756679|NCT01449929|617113056|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
170756680|NCT01449929|617113057|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
170756681|NCT01449929|617113058|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
170756682|NCT01449929|617113056|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
170756683|NCT01449929|617113057|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
170756684|NCT01449929|617113058|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
170756685|NCT00731042|617115474|FG000|Second Intervention|Did not meet inclusion criteria|0|||
170756686|NCT00731042|617115475|FG001|Second Intervention|Did not meet inclusion criteria|2|||
170756687|NCT02738840|617115476|FG000|Overall Study|MRI Scan not Performed|5|||
170756688|NCT02738840|617115476|FG000|Overall Study|Lost to Follow-up|1|||
170756689|NCT02738840|617115476|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
170756690|NCT02738840|617115476|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
170756691|NCT02268396|617115478|FG000|Overall Study|Adverse Event|3|||
170756692|NCT02268396|617115478|FG000|Overall Study|Administrative|2|||
170756693|NCT02268396|617115478|FG000|Overall Study|Withdrawal by Subject|1|||
170756694|NCT02268396|617115478|FG000|Overall Study|Lost to Follow-up|2|||
170756695|NCT02268396|617115478|FG000|Overall Study|Protocol-Specified Criteria|2|||
170756696|NCT02268396|617115478|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
170756697|NCT01311648|617115479|FG000|Main Study|Protocol Violation|0|||
170756698|NCT01311648|617115480|FG001|Main Study|Protocol Violation|1|||
170756699|NCT01311648|617115479|FG000|Main Study|Adverse Event|0|||
170756700|NCT01311648|617115480|FG001|Main Study|Adverse Event|1|||
170756701|NCT01311648|617115479|FG000|Main Study|Inhibitor management|0|||
170756702|NCT01311648|617115480|FG001|Main Study|Inhibitor management|17|||
170756703|NCT01311648|617115479|FG000|Main Study|Withdrawal by Subject|0|||
170756704|NCT01311648|617115480|FG001|Main Study|Withdrawal by Subject|2|||
170756705|NCT01311648|617115479|FG000|Extension Study|Physician Decision|0|||
170756706|NCT01311648|617115480|FG001|Extension Study|Physician Decision|1|||
170756707|NCT01311648|617115479|FG000|Extension Study|ITI therapy with marketed product|0|||
170756708|NCT01311648|617115480|FG001|Extension Study|ITI therapy with marketed product|1|||
170756709|NCT01311648|617115479|FG000|Extension Study|Incorrect visit planning|0|||
170756710|NCT01311648|617115480|FG001|Extension Study|Incorrect visit planning|1|||
170756711|NCT01311648|617115479|FG000|Extension Study|Family's decision|0|||
170756712|NCT01311648|617115480|FG001|Extension Study|Family's decision|1|||
170756713|NCT01311648|617115479|FG000|Extension Study|Failure of ITI therapy|0|||
170756714|NCT01311648|617115480|FG001|Extension Study|Failure of ITI therapy|3|||
170756715|NCT01311648|617115479|FG000|Extension Study|Long travel|0|||
170756716|NCT01311648|617115480|FG001|Extension Study|Long travel|1|||
170756717|NCT01311648|617115479|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
170756718|NCT01311648|617115480|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
170756719|NCT01311648|617115479|FG000|Extension Study|Withdrawal by Subject|0|||
170756720|NCT01311648|617115480|FG001|Extension Study|Withdrawal by Subject|1|||
170756721|NCT01311648|617115479|FG000|Extension Study|Inhibitor management|0|||
170756722|NCT01311648|617115480|FG001|Extension Study|Inhibitor management|2|||
170756723|NCT00049517|617115484|FG000|Induction|Disease progression|0|||
170756724|NCT00049517|617115485|FG001|Induction|Disease progression|0|||
170756725|NCT00049517|617115486|FG002|Induction|Disease progression|0|||
170756726|NCT00049517|617115487|FG003|Induction|Disease progression|0|||
170756727|NCT00049517|617115488|FG004|Induction|Disease progression|18|||
170756728|NCT00049517|617115489|FG005|Induction|Disease progression|11|||
170756729|NCT00049517|617115484|FG000|Induction|Adverse Event|0|||
170756730|NCT00049517|617115485|FG001|Induction|Adverse Event|0|||
170756731|NCT00049517|617115486|FG002|Induction|Adverse Event|0|||
170756732|NCT00049517|617115487|FG003|Induction|Adverse Event|0|||
170756733|NCT00049517|617115488|FG004|Induction|Adverse Event|5|||
170865655|NCT03049735|617519986|FG002|Overall Study|Protocol deviation|0|||
170865656|NCT03049735|617519984|FG000|Overall Study|Pregnancy|0|||
170406158|NCT00461500|615828486|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
170406159|NCT00461500|615828485|FG000|Overall Study|Lost to Follow-up|2|||
170406160|NCT00461500|615828486|FG001|Overall Study|Lost to Follow-up|2|||
170756734|NCT00049517|617115489|FG005|Induction|Adverse Event|7|||
170756735|NCT00049517|617115484|FG000|Induction|Death|0|||
170756736|NCT00049517|617115485|FG001|Induction|Death|0|||
170865657|NCT03049735|617519985|FG001|Overall Study|Pregnancy|0|||
170756737|NCT00049517|617115486|FG002|Induction|Death|0|||
170756738|NCT00049517|617115487|FG003|Induction|Death|0|||
170756739|NCT00049517|617115488|FG004|Induction|Death|9|||
170756740|NCT00049517|617115489|FG005|Induction|Death|6|||
170756741|NCT00049517|617115484|FG000|Induction|Withdrawal by Subject|0|||
170865658|NCT03049735|617519986|FG002|Overall Study|Pregnancy|1|||
170865659|NCT03049735|617519984|FG000|Overall Study|Adverse Event|7|||
170406161|NCT01267266|615828490|FG000|Enrollment Phase|Withdrawal by Subject|2|||
170756742|NCT00049517|617115485|FG001|Induction|Withdrawal by Subject|0|||
170756743|NCT00049517|617115486|FG002|Induction|Withdrawal by Subject|0|||
170756744|NCT00049517|617115487|FG003|Induction|Withdrawal by Subject|0|||
170756745|NCT00049517|617115488|FG004|Induction|Withdrawal by Subject|1|||
170756746|NCT00049517|617115489|FG005|Induction|Withdrawal by Subject|3|||
170756747|NCT00049517|617115484|FG000|Induction|Alternative therapy|0|||
170756748|NCT00049517|617115485|FG001|Induction|Alternative therapy|0|||
170756749|NCT00049517|617115486|FG002|Induction|Alternative therapy|0|||
170756750|NCT00049517|617115487|FG003|Induction|Alternative therapy|0|||
170756751|NCT00049517|617115488|FG004|Induction|Alternative therapy|2|||
170756752|NCT00049517|617115489|FG005|Induction|Alternative therapy|2|||
170756753|NCT00049517|617115484|FG000|Induction|Other complicating disease|0|||
170756754|NCT00049517|617115485|FG001|Induction|Other complicating disease|0|||
170756755|NCT00049517|617115486|FG002|Induction|Other complicating disease|0|||
170756756|NCT00049517|617115487|FG003|Induction|Other complicating disease|0|||
170756757|NCT00049517|617115488|FG004|Induction|Other complicating disease|3|||
170865660|NCT03049735|617519985|FG001|Overall Study|Adverse Event|18|||
170865661|NCT03049735|617519986|FG002|Overall Study|Adverse Event|5|||
170865662|NCT03049735|617519984|FG000|Overall Study|Withdrawal by Subject|10|||
170865663|NCT03049735|617519985|FG001|Overall Study|Withdrawal by Subject|3|||
170865664|NCT03049735|617519986|FG002|Overall Study|Withdrawal by Subject|7|||
170865665|NCT03049735|617519984|FG000|Overall Study|Lost to Follow-up|1|||
170865666|NCT03049735|617519985|FG001|Overall Study|Lost to Follow-up|5|||
170865667|NCT03049735|617519986|FG002|Overall Study|Lost to Follow-up|5|||
170865668|NCT02593786|617519987|FG000|Overall Study|Disease progression|12|||
170865669|NCT02593786|617519988|FG001|Overall Study|Disease progression|16|||
170865670|NCT02593786|617519989|FG002|Overall Study|Disease progression|10|||
170865671|NCT02593786|617519990|FG003|Overall Study|Disease progression|7|||
170406162|NCT01267266|615828491|FG001|Enrollment Phase|Withdrawal by Subject|0|||
170406163|NCT01267266|615828490|FG000|Lead-in Phase|Lack of Efficacy|20|||
170406164|NCT01267266|615828491|FG001|Lead-in Phase|Lack of Efficacy|0|||
170406165|NCT01267266|615828490|FG000|Lead-in Phase|Adverse Event|2|||
170756758|NCT00049517|617115489|FG005|Induction|Other complicating disease|0|||
170756759|NCT00049517|617115484|FG000|Induction|Reasons not reported|0|||
170756760|NCT00049517|617115485|FG001|Induction|Reasons not reported|0|||
170756761|NCT00049517|617115486|FG002|Induction|Reasons not reported|0|||
170756762|NCT00049517|617115487|FG003|Induction|Reasons not reported|0|||
170756763|NCT00049517|617115488|FG004|Induction|Reasons not reported|22|||
170756764|NCT00049517|617115489|FG005|Induction|Reasons not reported|25|||
170756765|NCT00049517|617115484|FG000|Conditioning/Transplant|Disease progression|14|||
170756766|NCT00049517|617115485|FG001|Conditioning/Transplant|Disease progression|6|||
170756767|NCT00049517|617115486|FG002|Conditioning/Transplant|Disease progression|10|||
170756768|NCT00049517|617115487|FG003|Conditioning/Transplant|Disease progression|6|||
170756769|NCT00049517|617115488|FG004|Conditioning/Transplant|Disease progression|0|||
170756770|NCT00049517|617115489|FG005|Conditioning/Transplant|Disease progression|0|||
170756771|NCT00049517|617115484|FG000|Conditioning/Transplant|Adverse Event|2|||
170756772|NCT00049517|617115485|FG001|Conditioning/Transplant|Adverse Event|1|||
170756773|NCT00049517|617115486|FG002|Conditioning/Transplant|Adverse Event|4|||
170756774|NCT00049517|617115487|FG003|Conditioning/Transplant|Adverse Event|8|||
170756775|NCT00049517|617115488|FG004|Conditioning/Transplant|Adverse Event|0|||
170756776|NCT00049517|617115489|FG005|Conditioning/Transplant|Adverse Event|0|||
170756777|NCT00049517|617115484|FG000|Conditioning/Transplant|Death|1|||
170756778|NCT00049517|617115485|FG001|Conditioning/Transplant|Death|0|||
170756779|NCT00049517|617115486|FG002|Conditioning/Transplant|Death|0|||
170406166|NCT01267266|615828491|FG001|Lead-in Phase|Adverse Event|0|||
170406167|NCT01267266|615828490|FG000|Lead-in Phase|Withdrawal by Subject|1|||
170756780|NCT00049517|617115487|FG003|Conditioning/Transplant|Death|2|||
170756781|NCT00049517|617115488|FG004|Conditioning/Transplant|Death|0|||
170756782|NCT00049517|617115489|FG005|Conditioning/Transplant|Death|0|||
170756783|NCT00049517|617115484|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
170756784|NCT00049517|617115485|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
170756785|NCT00049517|617115486|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
170756786|NCT00049517|617115487|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
170756787|NCT00049517|617115488|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
170756788|NCT00049517|617115489|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
170756789|NCT00049517|617115484|FG000|Conditioning/Transplant|Alternative therapy|4|||
170756790|NCT00049517|617115485|FG001|Conditioning/Transplant|Alternative therapy|4|||
170756791|NCT00049517|617115486|FG002|Conditioning/Transplant|Alternative therapy|2|||
170756792|NCT00049517|617115487|FG003|Conditioning/Transplant|Alternative therapy|1|||
170756793|NCT00049517|617115488|FG004|Conditioning/Transplant|Alternative therapy|1|||
170756794|NCT00049517|617115489|FG005|Conditioning/Transplant|Alternative therapy|0|||
170756795|NCT00049517|617115484|FG000|Conditioning/Transplant|Other complicating disease|2|||
170406168|NCT01267266|615828491|FG001|Lead-in Phase|Withdrawal by Subject|0|||
170406169|NCT01335477|615828493|FG000|Overall Study|Adverse Event|30|||
170865672|NCT02593786|617519987|FG000|Overall Study|Study drug toxicity|1|||
170865673|NCT02593786|617519988|FG001|Overall Study|Study drug toxicity|0|||
170865674|NCT02593786|617519989|FG002|Overall Study|Study drug toxicity|0|||
170756796|NCT00049517|617115485|FG001|Conditioning/Transplant|Other complicating disease|0|||
170756797|NCT00049517|617115486|FG002|Conditioning/Transplant|Other complicating disease|0|||
170756798|NCT00049517|617115487|FG003|Conditioning/Transplant|Other complicating disease|4|||
170756799|NCT00049517|617115488|FG004|Conditioning/Transplant|Other complicating disease|0|||
170756800|NCT00049517|617115489|FG005|Conditioning/Transplant|Other complicating disease|1|||
170756801|NCT00049517|617115484|FG000|Conditioning/Transplant|Reasons not reported|25|||
170756802|NCT00049517|617115485|FG001|Conditioning/Transplant|Reasons not reported|31|||
170756803|NCT00049517|617115486|FG002|Conditioning/Transplant|Reasons not reported|18|||
170756804|NCT00049517|617115487|FG003|Conditioning/Transplant|Reasons not reported|15|||
170756805|NCT00049517|617115488|FG004|Conditioning/Transplant|Reasons not reported|5|||
170756806|NCT00049517|617115489|FG005|Conditioning/Transplant|Reasons not reported|5|||
170756807|NCT02857283|617115490|FG000|First Exposure|Withdrawal by Subject|1|||
170756808|NCT02857283|617115491|FG001|First Exposure|Withdrawal by Subject|0|||
170756809|NCT00587288|617115494|FG000|Overall Study|Adverse Event|0|||
170756810|NCT00587288|617115495|FG001|Overall Study|Adverse Event|1|||
170756811|NCT00587288|617115494|FG000|Overall Study|Lack of Efficacy|2|||
170756812|NCT00587288|617115495|FG001|Overall Study|Lack of Efficacy|8|||
170756813|NCT00587288|617115494|FG000|Overall Study|Protocol Violation|1|||
170756814|NCT00587288|617115495|FG001|Overall Study|Protocol Violation|0|||
170756815|NCT04358549|617115504|FG000|Overall Study|Adverse Event|0|||
170756816|NCT04358549|617115505|FG001|Overall Study|Adverse Event|1|||
170756817|NCT04358549|617115504|FG000|Overall Study|Death|1|||
170756818|NCT04358549|617115505|FG001|Overall Study|Death|0|||
170756819|NCT04358549|617115504|FG000|Overall Study|Lost to Follow-up|2|||
170756820|NCT04358549|617115505|FG001|Overall Study|Lost to Follow-up|1|||
170756821|NCT04358549|617115504|FG000|Overall Study|Withdrawal by Subject|6|||
170756822|NCT04358549|617115505|FG001|Overall Study|Withdrawal by Subject|6|||
170756823|NCT04358549|617115504|FG000|Overall Study|Start remdesivir|1|||
170756824|NCT04358549|617115505|FG001|Overall Study|Start remdesivir|0|||
170756825|NCT00946114|617115511|FG000|Overall Study|Death|5|||
170756826|NCT00946114|617115512|FG001|Overall Study|Death|2|||
170756827|NCT00946114|617115511|FG000|Overall Study|Other|1|||
170756828|NCT00946114|617115512|FG001|Overall Study|Other|0|||
170756829|NCT00946114|617115511|FG000|Overall Study|Withdrawal by Subject|2|||
170756830|NCT00946114|617115512|FG001|Overall Study|Withdrawal by Subject|0|||
170756831|NCT00646451|617115514|FG000|Overall Study|Adverse Event|3|||
170756832|NCT00646451|617115515|FG001|Overall Study|Adverse Event|0|||
170756833|NCT00646451|617115514|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
170756834|NCT00646451|617115515|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
170756835|NCT03784963|617115516|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
170756836|NCT03784963|617115517|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
170756837|NCT03784963|617115518|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
170756838|NCT03784963|617115519|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
170756839|NCT05355116|617115520|FG000|Overall Study|Withdrawal by Subject|2|||
170756840|NCT00498186|617115521|FG000|Overall Study|Protocol Violation|10|||
170756841|NCT00498186|617115521|FG000|Overall Study|Lack of Efficacy|31|||
170756842|NCT00498186|617115521|FG000|Overall Study|Adverse Event|89|||
170756843|NCT00498186|617115521|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
170756844|NCT00498186|617115521|FG000|Overall Study|Withdrawal by Subject|18|||
170756845|NCT00498186|617115521|FG000|Overall Study|Lost to Follow-up|3|||
170756846|NCT00498186|617115521|FG000|Overall Study|Other|10|||
170756847|NCT01770860|617115523|FG000|Overall Study|Withdrawal by Subject|4|||
170756848|NCT01770860|617115523|FG000|Overall Study|Lost to Follow-up|1|||
170756849|NCT01770860|617115523|FG000|Overall Study|Administrative decision made by the PI|1|||
170756850|NCT01237678|617115524|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
170756851|NCT01237678|617115525|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
170756852|NCT01237678|617115526|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
170756853|NCT01237678|617115524|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
170756854|NCT01237678|617115525|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
170756855|NCT01237678|617115526|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
170756856|NCT01237678|617115524|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
170756857|NCT01237678|617115525|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
170756858|NCT01237678|617115526|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
170756859|NCT01237678|617115524|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
170756860|NCT01237678|617115525|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
170756861|NCT01237678|617115526|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
170756862|NCT01237678|617115524|FG000|Phase II|Adverse Event|0|||
170756863|NCT01237678|617115525|FG001|Phase II|Adverse Event|39|||
170756864|NCT01237678|617115526|FG002|Phase II|Adverse Event|9|||
170756865|NCT01237678|617115524|FG000|Phase II|Death|0|||
170756866|NCT01237678|617115525|FG001|Phase II|Death|0|||
170756867|NCT01237678|617115526|FG002|Phase II|Death|2|||
170756868|NCT01237678|617115524|FG000|Phase II|Lack of Efficacy|0|||
170756869|NCT01237678|617115525|FG001|Phase II|Lack of Efficacy|25|||
170756870|NCT01237678|617115526|FG002|Phase II|Lack of Efficacy|3|||
170756871|NCT01237678|617115524|FG000|Phase II|Withdrawal by Subject|0|||
170756872|NCT01237678|617115525|FG001|Phase II|Withdrawal by Subject|1|||
170756873|NCT01237678|617115526|FG002|Phase II|Withdrawal by Subject|5|||
170756874|NCT01237678|617115524|FG000|Phase II|Completed Cycles 4-6|0|||
170756875|NCT01237678|617115525|FG001|Phase II|Completed Cycles 4-6|11|||
170756876|NCT01237678|617115526|FG002|Phase II|Completed Cycles 4-6|21|||
170756877|NCT01237678|617115524|FG000|Phase II|Sponsor Decision/Study Closed|0|||
170756878|NCT01237678|617115525|FG001|Phase II|Sponsor Decision/Study Closed|18|||
170756879|NCT01237678|617115526|FG002|Phase II|Sponsor Decision/Study Closed|7|||
170756880|NCT01237678|617115524|FG000|Phase II|Randomized but were not treated|0|||
170756881|NCT01237678|617115525|FG001|Phase II|Randomized but were not treated|4|||
170756882|NCT01237678|617115526|FG002|Phase II|Randomized but were not treated|3|||
170756883|NCT05124899|617115529|FG000|Overall Study|Lost to Follow-up|3|||
170756884|NCT00945477|617115534|FG000|Overall Study|Adverse Event|3|||
170756885|NCT00945477|617115534|FG000|Overall Study|Lack of Efficacy|2|||
170756886|NCT00945477|617115534|FG000|Overall Study|Withdrawal by Subject|1|||
170756887|NCT01354938|617115539|FG000|Overall Study|Lost to Follow-up|1|||
170756888|NCT01253200|617115540|FG000|Overall Study|Death|1|||
170756889|NCT01253200|617115541|FG001|Overall Study|Death|0|||
170756890|NCT01253200|617115542|FG002|Overall Study|Death|0|||
170756891|NCT01253200|617115543|FG003|Overall Study|Death|0|||
170756892|NCT01253200|617115544|FG004|Overall Study|Death|0|||
170756893|NCT01253200|617115540|FG000|Overall Study|Lost to Follow-up|1|||
170756894|NCT01253200|617115541|FG001|Overall Study|Lost to Follow-up|1|||
170756895|NCT01253200|617115542|FG002|Overall Study|Lost to Follow-up|0|||
170756896|NCT01253200|617115543|FG003|Overall Study|Lost to Follow-up|0|||
170756897|NCT01253200|617115544|FG004|Overall Study|Lost to Follow-up|0|||
170756898|NCT01253200|617115540|FG000|Overall Study|Withdrawal by Subject|2|||
170756899|NCT01253200|617115541|FG001|Overall Study|Withdrawal by Subject|0|||
170756900|NCT01253200|617115542|FG002|Overall Study|Withdrawal by Subject|0|||
170756901|NCT01253200|617115543|FG003|Overall Study|Withdrawal by Subject|0|||
170756902|NCT01253200|617115544|FG004|Overall Study|Withdrawal by Subject|0|||
170756903|NCT01253200|617115540|FG000|Overall Study|Protocol Violation|1|||
170756904|NCT01253200|617115541|FG001|Overall Study|Protocol Violation|4|||
170756905|NCT01253200|617115542|FG002|Overall Study|Protocol Violation|0|||
170756906|NCT01253200|617115543|FG003|Overall Study|Protocol Violation|0|||
170756907|NCT01253200|617115544|FG004|Overall Study|Protocol Violation|5|||
170756908|NCT01253200|617115540|FG000|Overall Study|intents|10|||
170756909|NCT01253200|617115541|FG001|Overall Study|intents|10|||
170756910|NCT01253200|617115542|FG002|Overall Study|intents|1|||
170756911|NCT01253200|617115543|FG003|Overall Study|intents|3|||
170756912|NCT01253200|617115544|FG004|Overall Study|intents|0|||
170756913|NCT01253200|617115540|FG000|Overall Study|Attempts|6|||
170756914|NCT01253200|617115541|FG001|Overall Study|Attempts|4|||
170756915|NCT01253200|617115542|FG002|Overall Study|Attempts|1|||
170756916|NCT01253200|617115543|FG003|Overall Study|Attempts|2|||
170756917|NCT01253200|617115544|FG004|Overall Study|Attempts|0|||
170756918|NCT02049437|617115545|FG000|Period 1|Adverse Event|1|||
170756919|NCT02049437|617115546|FG001|Period 1|Adverse Event|1|||
170756920|NCT02049437|617115545|FG000|Period 1|Adverse Event|1|||
170756921|NCT02049437|617115546|FG001|Period 1|Adverse Event|0|||
170756922|NCT00797225|617115552|FG000|Weeks 1 to 12|Adverse Event|0|||
170756923|NCT00797225|617115553|FG001|Weeks 1 to 12|Adverse Event|0|||
170756924|NCT00797225|617115554|FG002|Weeks 1 to 12|Adverse Event|1|||
170756925|NCT00797225|617115555|FG003|Weeks 1 to 12|Adverse Event|0|||
170756926|NCT00797225|617115556|FG004|Weeks 1 to 12|Adverse Event|0|||
170756927|NCT00797225|617115557|FG005|Weeks 1 to 12|Adverse Event|0|||
170756928|NCT00797225|617115558|FG006|Weeks 1 to 12|Adverse Event|0|||
170756929|NCT00797225|617115559|FG007|Weeks 1 to 12|Adverse Event|0|||
170756930|NCT00797225|617115552|FG000|Weeks 1 to 12|Non-compliance|0|||
170756931|NCT00797225|617115553|FG001|Weeks 1 to 12|Non-compliance|1|||
170865675|NCT02593786|617519990|FG003|Overall Study|Study drug toxicity|0|||
170865676|NCT02593786|617519987|FG000|Overall Study|Adverse event unrelated to study drug|1|||
170865677|NCT02593786|617519988|FG001|Overall Study|Adverse event unrelated to study drug|1|||
170865678|NCT02593786|617519989|FG002|Overall Study|Adverse event unrelated to study drug|1|||
170756932|NCT00797225|617115554|FG002|Weeks 1 to 12|Non-compliance|0|||
170756933|NCT00797225|617115555|FG003|Weeks 1 to 12|Non-compliance|0|||
170756934|NCT00797225|617115556|FG004|Weeks 1 to 12|Non-compliance|0|||
170756935|NCT00797225|617115557|FG005|Weeks 1 to 12|Non-compliance|0|||
170756936|NCT00797225|617115558|FG006|Weeks 1 to 12|Non-compliance|0|||
170756937|NCT00797225|617115559|FG007|Weeks 1 to 12|Non-compliance|0|||
170756938|NCT00797225|617115552|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
170756939|NCT00797225|617115553|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
170756940|NCT00797225|617115554|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
170756941|NCT00797225|617115555|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
170756942|NCT00797225|617115556|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
170756943|NCT00797225|617115557|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
170756944|NCT00797225|617115558|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
170756945|NCT00797225|617115559|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
170756946|NCT00797225|617115552|FG000|Weeks 1 to 12|Sponsor Decision|1|||
170756947|NCT00797225|617115553|FG001|Weeks 1 to 12|Sponsor Decision|0|||
170756948|NCT00797225|617115554|FG002|Weeks 1 to 12|Sponsor Decision|0|||
170756949|NCT00797225|617115555|FG003|Weeks 1 to 12|Sponsor Decision|0|||
170756950|NCT00797225|617115556|FG004|Weeks 1 to 12|Sponsor Decision|0|||
170756951|NCT00797225|617115557|FG005|Weeks 1 to 12|Sponsor Decision|0|||
170756952|NCT00797225|617115558|FG006|Weeks 1 to 12|Sponsor Decision|0|||
170756953|NCT00797225|617115559|FG007|Weeks 1 to 12|Sponsor Decision|0|||
170756954|NCT00797225|617115552|FG000|Weeks 13 to 24|Non-compliance|0|||
170756955|NCT00797225|617115553|FG001|Weeks 13 to 24|Non-compliance|2|||
170756956|NCT00797225|617115554|FG002|Weeks 13 to 24|Non-compliance|0|||
170756957|NCT00797225|617115555|FG003|Weeks 13 to 24|Non-compliance|0|||
170756958|NCT00797225|617115556|FG004|Weeks 13 to 24|Non-compliance|0|||
170756959|NCT00797225|617115557|FG005|Weeks 13 to 24|Non-compliance|0|||
170756960|NCT00797225|617115558|FG006|Weeks 13 to 24|Non-compliance|0|||
170756961|NCT00797225|617115559|FG007|Weeks 13 to 24|Non-compliance|0|||
170756962|NCT00797225|617115552|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
170756963|NCT00797225|617115553|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
170756964|NCT00797225|617115554|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
170756965|NCT00797225|617115555|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
170756966|NCT00797225|617115556|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
170756967|NCT00797225|617115557|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
170756968|NCT00797225|617115558|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
170756969|NCT00797225|617115559|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
170756970|NCT00797225|617115552|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
170756971|NCT00797225|617115553|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
170756972|NCT00797225|617115554|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
170756973|NCT00797225|617115555|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
170756974|NCT00797225|617115556|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
170756975|NCT00797225|617115557|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
170756976|NCT00797225|617115558|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
170756977|NCT00797225|617115559|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
170756978|NCT00797225|617115552|FG000|Weeks 13 to 24|Adverse Event|0|||
170756979|NCT00797225|617115553|FG001|Weeks 13 to 24|Adverse Event|1|||
170756980|NCT00797225|617115554|FG002|Weeks 13 to 24|Adverse Event|0|||
170756981|NCT00797225|617115555|FG003|Weeks 13 to 24|Adverse Event|0|||
170756982|NCT00797225|617115556|FG004|Weeks 13 to 24|Adverse Event|0|||
170756983|NCT00797225|617115557|FG005|Weeks 13 to 24|Adverse Event|0|||
170756984|NCT00797225|617115558|FG006|Weeks 13 to 24|Adverse Event|1|||
170756985|NCT00797225|617115559|FG007|Weeks 13 to 24|Adverse Event|0|||
170756986|NCT00797225|617115552|FG000|Weeks 13 to 24|Sponsor Decision|0|||
170756987|NCT00797225|617115553|FG001|Weeks 13 to 24|Sponsor Decision|0|||
170756988|NCT00797225|617115554|FG002|Weeks 13 to 24|Sponsor Decision|0|||
170756989|NCT00797225|617115555|FG003|Weeks 13 to 24|Sponsor Decision|0|||
170756990|NCT00797225|617115556|FG004|Weeks 13 to 24|Sponsor Decision|0|||
170756991|NCT00797225|617115557|FG005|Weeks 13 to 24|Sponsor Decision|0|||
170756992|NCT00797225|617115558|FG006|Weeks 13 to 24|Sponsor Decision|1|||
170756993|NCT00797225|617115559|FG007|Weeks 13 to 24|Sponsor Decision|0|||
170756994|NCT01511250|617115560|FG000|Overall Study|Withdrawal of Consent|1|||
170756995|NCT01511250|617115561|FG001|Overall Study|Withdrawal of Consent|0|||
170756996|NCT01511250|617115562|FG002|Overall Study|Withdrawal of Consent|0|||
170756997|NCT01511250|617115563|FG003|Overall Study|Withdrawal of Consent|0|||
170756998|NCT01511250|617115564|FG004|Overall Study|Withdrawal of Consent|0|||
170756999|NCT01511250|617115565|FG005|Overall Study|Withdrawal of Consent|0|||
170757000|NCT01511250|617115566|FG006|Overall Study|Withdrawal of Consent|0|||
170757001|NCT01511250|617115567|FG007|Overall Study|Withdrawal of Consent|1|||
170757002|NCT01511250|617115568|FG008|Overall Study|Withdrawal of Consent|1|||
170757003|NCT01511250|617115569|FG009|Overall Study|Withdrawal of Consent|0|||
170757004|NCT01511250|617115560|FG000|Overall Study|Sponsor/Investigator Decision|1|||
170757005|NCT01511250|617115561|FG001|Overall Study|Sponsor/Investigator Decision|0|||
170757006|NCT01511250|617115562|FG002|Overall Study|Sponsor/Investigator Decision|0|||
170757007|NCT01511250|617115563|FG003|Overall Study|Sponsor/Investigator Decision|0|||
170757008|NCT01511250|617115564|FG004|Overall Study|Sponsor/Investigator Decision|0|||
170757009|NCT01511250|617115565|FG005|Overall Study|Sponsor/Investigator Decision|0|||
170757010|NCT01511250|617115566|FG006|Overall Study|Sponsor/Investigator Decision|0|||
170757011|NCT01511250|617115567|FG007|Overall Study|Sponsor/Investigator Decision|0|||
170757012|NCT01511250|617115568|FG008|Overall Study|Sponsor/Investigator Decision|0|||
170757013|NCT01511250|617115569|FG009|Overall Study|Sponsor/Investigator Decision|0|||
170757014|NCT01511250|617115560|FG000|Overall Study|Lost to Follow-up|7|||
170757015|NCT01511250|617115561|FG001|Overall Study|Lost to Follow-up|3|||
170757016|NCT01511250|617115562|FG002|Overall Study|Lost to Follow-up|3|||
170757017|NCT01511250|617115563|FG003|Overall Study|Lost to Follow-up|3|||
170757018|NCT01511250|617115564|FG004|Overall Study|Lost to Follow-up|0|||
170757019|NCT01511250|617115565|FG005|Overall Study|Lost to Follow-up|0|||
170757020|NCT01511250|617115566|FG006|Overall Study|Lost to Follow-up|2|||
170757021|NCT01511250|617115567|FG007|Overall Study|Lost to Follow-up|3|||
170757022|NCT01511250|617115568|FG008|Overall Study|Lost to Follow-up|13|||
170757023|NCT01511250|617115569|FG009|Overall Study|Lost to Follow-up|5|||
170757024|NCT01511250|617115560|FG000|Overall Study|Protocol Violation|0|||
170757025|NCT01511250|617115561|FG001|Overall Study|Protocol Violation|2|||
170757026|NCT01511250|617115562|FG002|Overall Study|Protocol Violation|1|||
170757027|NCT01511250|617115563|FG003|Overall Study|Protocol Violation|0|||
170757028|NCT01511250|617115564|FG004|Overall Study|Protocol Violation|0|||
170757029|NCT01511250|617115565|FG005|Overall Study|Protocol Violation|0|||
170757030|NCT01511250|617115566|FG006|Overall Study|Protocol Violation|0|||
170757031|NCT01511250|617115567|FG007|Overall Study|Protocol Violation|0|||
170757032|NCT01511250|617115568|FG008|Overall Study|Protocol Violation|0|||
170757033|NCT01511250|617115569|FG009|Overall Study|Protocol Violation|0|||
170757034|NCT01763047|617115574|FG000|Period 1|Test Article Not Available|4|||
170757035|NCT01763047|617115575|FG001|Period 1|Test Article Not Available|1|||
170757036|NCT01763047|617115574|FG000|Period 1|Protocol Violation|4|||
170757037|NCT01763047|617115575|FG001|Period 1|Protocol Violation|4|||
170757038|NCT01763047|617115574|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
170757039|NCT01763047|617115575|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
170757040|NCT01763047|617115574|FG000|Period 1|Adverse Event|0|||
170757041|NCT01763047|617115575|FG001|Period 1|Adverse Event|1|||
170757042|NCT01763047|617115574|FG000|Period 1|Unsatisfactory Visual Response|0|||
170757043|NCT01763047|617115575|FG001|Period 1|Unsatisfactory Visual Response|3|||
170757044|NCT01763047|617115574|FG000|Period 1|Lens Power Not Available|0|||
170757045|NCT01763047|617115575|FG001|Period 1|Lens Power Not Available|1|||
170757046|NCT01763047|617115574|FG000|Period 1|Study Site office Closed|0|||
170757047|NCT01763047|617115575|FG001|Period 1|Study Site office Closed|1|||
170757048|NCT01763047|617115574|FG000|Period 2|Lens Discomfort|1|||
170757049|NCT01763047|617115575|FG001|Period 2|Lens Discomfort|0|||
170757050|NCT01763047|617115574|FG000|Period 2|No longer meets Eligibility Criteria|1|||
170757051|NCT01763047|617115575|FG001|Period 2|No longer meets Eligibility Criteria|0|||
170757052|NCT01763047|617115574|FG000|Period 2|Study Site office Closed|1|||
170757053|NCT01763047|617115575|FG001|Period 2|Study Site office Closed|1|||
170757054|NCT01763047|617115574|FG000|Period 2|Unsatisfactory Visual Response|1|||
170757055|NCT01763047|617115575|FG001|Period 2|Unsatisfactory Visual Response|1|||
170757056|NCT01763047|617115574|FG000|Period 2|Protocol Violation|0|||
170757057|NCT01763047|617115575|FG001|Period 2|Protocol Violation|2|||
170757058|NCT01763047|617115574|FG000|Period 2|Unsatisfactory lens Fitting|0|||
170757059|NCT01763047|617115575|FG001|Period 2|Unsatisfactory lens Fitting|1|||
170757060|NCT00916006|617115580|FG000|Overall Study|Adverse Event|1|||
170757061|NCT00916006|617115581|FG001|Overall Study|Adverse Event|1|||
170757062|NCT00916006|617115580|FG000|Overall Study|Withdrawal by Subject|2|||
170757063|NCT00916006|617115581|FG001|Overall Study|Withdrawal by Subject|5|||
170757064|NCT00916006|617115580|FG000|Overall Study|Protocol Violation|0|||
170757065|NCT00916006|617115581|FG001|Overall Study|Protocol Violation|1|||
170757066|NCT00577629|617115582|FG000|Treatment Period|Death|1|||
170757067|NCT00577629|617115582|FG000|Long Term Follow-Up|Death|15|||
170757068|NCT00577629|617115582|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
170757069|NCT00577629|617115582|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
170757070|NCT00577629|617115582|FG000|Long Term Follow-Up|Physician Decision|1|||
170757071|NCT01605136|617115583|FG000|Study Period|Withdrawal by Subject|2|||
170757072|NCT01605136|617115584|FG001|Study Period|Withdrawal by Subject|0|||
170757073|NCT01605136|617115583|FG000|Study Period|Physician Decision|1|||
170757074|NCT01605136|617115584|FG001|Study Period|Physician Decision|1|||
170757075|NCT01605136|617115583|FG000|Study Period|Lost to Follow-up|0|||
170757076|NCT01605136|617115584|FG001|Study Period|Lost to Follow-up|2|||
170757077|NCT01605136|617115583|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
170757078|NCT01605136|617115584|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
170757079|NCT01072929|617115585|FG000|Overall Study|Adverse Event|8|||
170757080|NCT01072929|617115586|FG001|Overall Study|Adverse Event|11|||
170757081|NCT01072929|617115587|FG002|Overall Study|Adverse Event|2|||
170757082|NCT01072929|617115585|FG000|Overall Study|Lack of Efficacy|7|||
170757083|NCT01072929|617115586|FG001|Overall Study|Lack of Efficacy|4|||
170757084|NCT01072929|617115587|FG002|Overall Study|Lack of Efficacy|0|||
170757085|NCT01072929|617115585|FG000|Overall Study|Withdrawal by Subject|7|||
170757086|NCT01072929|617115586|FG001|Overall Study|Withdrawal by Subject|15|||
170757087|NCT01072929|617115587|FG002|Overall Study|Withdrawal by Subject|3|||
170757088|NCT01072929|617115585|FG000|Overall Study|Protocol Violation|13|||
170757089|NCT01072929|617115586|FG001|Overall Study|Protocol Violation|11|||
170757090|NCT01072929|617115587|FG002|Overall Study|Protocol Violation|2|||
170757091|NCT01072929|617115585|FG000|Overall Study|Lost to Follow-up|8|||
170757092|NCT01072929|617115586|FG001|Overall Study|Lost to Follow-up|4|||
170757093|NCT01072929|617115587|FG002|Overall Study|Lost to Follow-up|1|||
170757094|NCT01072929|617115585|FG000|Overall Study|Noncompliance with study medication|0|||
170757095|NCT01072929|617115586|FG001|Overall Study|Noncompliance with study medication|3|||
170757096|NCT01072929|617115587|FG002|Overall Study|Noncompliance with study medication|0|||
170757097|NCT01072929|617115585|FG000|Overall Study|Noncompliance with study procedures|1|||
170757098|NCT01072929|617115586|FG001|Overall Study|Noncompliance with study procedures|0|||
170757099|NCT01072929|617115587|FG002|Overall Study|Noncompliance with study procedures|1|||
170757100|NCT01072929|617115585|FG000|Overall Study|Other|0|||
170757101|NCT01072929|617115586|FG001|Overall Study|Other|3|||
170757102|NCT01072929|617115587|FG002|Overall Study|Other|0|||
170757103|NCT01008748|617115588|FG000|Overall Study|Lost to Follow-up|80|||
170757104|NCT01008748|617115588|FG000|Overall Study|Other|1|||
170757105|NCT03441984|617115589|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757106|NCT03441984|617115590|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757107|NCT03441984|617115591|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
170757108|NCT03441984|617115592|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757109|NCT03441984|617115593|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757110|NCT03441984|617115594|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757111|NCT03441984|617115595|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757112|NCT03441984|617115596|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757113|NCT03441984|617115597|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757114|NCT03441984|617115598|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757115|NCT03441984|617115599|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757116|NCT03441984|617115600|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
170757117|NCT04833855|617115603|FG000|Overall Study|Decision by sponsor|0|||
170757118|NCT04833855|617115604|FG001|Overall Study|Decision by sponsor|1|||
170757119|NCT04833855|617115605|FG002|Overall Study|Decision by sponsor|0|||
170757120|NCT04833855|617115606|FG003|Overall Study|Decision by sponsor|0|||
170757121|NCT04833855|617115603|FG000|Overall Study|Withdrawal by Subject|4|||
170757122|NCT04833855|617115604|FG001|Overall Study|Withdrawal by Subject|1|||
170757123|NCT04833855|617115605|FG002|Overall Study|Withdrawal by Subject|3|||
170757124|NCT04833855|617115606|FG003|Overall Study|Withdrawal by Subject|1|||
170757125|NCT04833855|617115603|FG000|Overall Study|Lost to Follow-up|1|||
170757126|NCT04833855|617115604|FG001|Overall Study|Lost to Follow-up|0|||
170757127|NCT04833855|617115605|FG002|Overall Study|Lost to Follow-up|2|||
170757128|NCT04833855|617115606|FG003|Overall Study|Lost to Follow-up|2|||
170757129|NCT04833855|617115603|FG000|Overall Study|Protocol specified criteria|0|||
170757130|NCT04833855|617115604|FG001|Overall Study|Protocol specified criteria|0|||
170757131|NCT04833855|617115605|FG002|Overall Study|Protocol specified criteria|2|||
170757132|NCT04833855|617115606|FG003|Overall Study|Protocol specified criteria|1|||
170757133|NCT04088188|617115608|FG000|Overall Study|Withdrawal by Subject|2|||
170757134|NCT04088188|617115609|FG001|Overall Study|Withdrawal by Subject|0|||
170757135|NCT04088188|617115608|FG000|Overall Study|Adverse Event|2|||
170757136|NCT04088188|617115609|FG001|Overall Study|Adverse Event|0|||
170757137|NCT02806336|617115610|FG000|Overall Study|Physician Decision|1|||
170757138|NCT02806336|617115611|FG001|Overall Study|Physician Decision|0|||
170757139|NCT02806336|617115610|FG000|Overall Study|Withdrawal by Subject|2|||
170757140|NCT02806336|617115611|FG001|Overall Study|Withdrawal by Subject|4|||
170757141|NCT02806336|617115610|FG000|Overall Study|COVID-19 research shut down|3|||
170757142|NCT02806336|617115611|FG001|Overall Study|COVID-19 research shut down|4|||
170757143|NCT02806336|617115610|FG000|Overall Study|Lack of Efficacy|0|||
170757144|NCT02806336|617115611|FG001|Overall Study|Lack of Efficacy|1|||
170757145|NCT03682536|617115612|FG000|Randomization|Withdrawal by Subject|0|||
170757146|NCT03682536|617115613|FG001|Randomization|Withdrawal by Subject|2|||
170757147|NCT03682536|617115612|FG000|Treatment|Other Reasons|8|||
170757148|NCT03682536|617115613|FG001|Treatment|Other Reasons|7|||
170757149|NCT03682536|617115612|FG000|Treatment|Physician Decision|5|||
170757150|NCT03682536|617115613|FG001|Treatment|Physician Decision|5|||
170757151|NCT03682536|617115612|FG000|Treatment|Protocol Violation|1|||
170757152|NCT03682536|617115613|FG001|Treatment|Protocol Violation|0|||
170757153|NCT03682536|617115612|FG000|Treatment|Study Terminated by Sponsor|1|||
170757154|NCT03682536|617115613|FG001|Treatment|Study Terminated by Sponsor|2|||
170757155|NCT03682536|617115612|FG000|Treatment|Lost to Follow-up|0|||
170757156|NCT03682536|617115613|FG001|Treatment|Lost to Follow-up|1|||
170757157|NCT03682536|617115612|FG000|Treatment|Withdrawal by Subject|16|||
170757158|NCT03682536|617115613|FG001|Treatment|Withdrawal by Subject|18|||
170757159|NCT03682536|617115612|FG000|Treatment|Lack of Efficacy|41|||
170757160|NCT03682536|617115613|FG001|Treatment|Lack of Efficacy|68|||
170757161|NCT03682536|617115612|FG000|Treatment|Disease Progression|9|||
170757162|NCT03682536|617115613|FG001|Treatment|Disease Progression|7|||
170865679|NCT02593786|617519990|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170865680|NCT02593786|617519987|FG000|Overall Study|Participant request to discontinue study therapy|0|||
170406170|NCT01335477|615828494|FG001|Overall Study|Adverse Event|42|||
170757163|NCT03682536|617115612|FG000|Treatment|Adverse Event|9|||
170757164|NCT03682536|617115613|FG001|Treatment|Adverse Event|5|||
170757165|NCT03682536|617115612|FG000|Treatment|Death|14|||
170757166|NCT03682536|617115613|FG001|Treatment|Death|13|||
170757167|NCT04824131|617115614|FG000|CAB LA Oral Phase|Adverse Event|1|||
170757168|NCT04824131|617115614|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
170757169|NCT04824131|617115614|FG000|Step 3|Withdrawal by Subject|2|||
170757170|NCT03008122|617115621|FG000|Overall Study|Physician Decision|3|||
170757171|NCT03008122|617115622|FG001|Overall Study|Physician Decision|2|||
170757172|NCT03008122|617115623|FG002|Overall Study|Physician Decision|0|||
170757173|NCT03008122|617115621|FG000|Overall Study|Withdrawal by Subject|1|||
170757174|NCT03008122|617115622|FG001|Overall Study|Withdrawal by Subject|3|||
170757175|NCT03008122|617115623|FG002|Overall Study|Withdrawal by Subject|0|||
170757176|NCT03008122|617115621|FG000|Overall Study|Lost to Follow-up|4|||
170757177|NCT03008122|617115622|FG001|Overall Study|Lost to Follow-up|8|||
170757178|NCT03008122|617115623|FG002|Overall Study|Lost to Follow-up|3|||
170757179|NCT03008122|617115621|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
170757180|NCT03008122|617115622|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
170757181|NCT03008122|617115623|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
170757182|NCT03008122|617115621|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
170757183|NCT03008122|617115622|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
170757184|NCT03008122|617115623|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
170757185|NCT03008122|617115621|FG000|Overall Study|Death|0|||
170757186|NCT03008122|617115622|FG001|Overall Study|Death|0|||
170757187|NCT03008122|617115623|FG002|Overall Study|Death|1|||
170757188|NCT04159896|617115624|FG000|Overall Study|Lack of Efficacy|7|||
170757189|NCT04159896|617115624|FG000|Overall Study|Withdrawal by Subject|1|||
170757190|NCT04159896|617115624|FG000|Overall Study|Adverse Event|1|||
170757191|NCT04159896|617115624|FG000|Overall Study|A transient ischaemic attack|1|||
170757192|NCT01222247|617115626|FG000|Overall Study|Lost to Follow-up|2|||
170757193|NCT01222247|617115627|FG001|Overall Study|Lost to Follow-up|2|||
170757194|NCT02084082|617115628|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
170757195|NCT02084082|617115629|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
170757196|NCT02084082|617115630|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
170757197|NCT02084082|617115631|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
170757198|NCT02084082|617115628|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
170757199|NCT02084082|617115629|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
170757200|NCT02084082|617115630|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
170757201|NCT02084082|617115631|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
170757202|NCT04736056|617115632|FG000|Overall Study|Death|0|||
170757203|NCT04736056|617115633|FG001|Overall Study|Death|0|||
170757204|NCT04736056|617115634|FG002|Overall Study|Death|0|||
170757205|NCT04736056|617115635|FG003|Overall Study|Death|1|||
170757206|NCT04736056|617115632|FG000|Overall Study|Lost to Follow-up|1|||
170757207|NCT04736056|617115633|FG001|Overall Study|Lost to Follow-up|0|||
170757208|NCT04736056|617115634|FG002|Overall Study|Lost to Follow-up|1|||
170757209|NCT04736056|617115635|FG003|Overall Study|Lost to Follow-up|1|||
170757210|NCT04736056|617115632|FG000|Overall Study|Withdrawal by Subject|2|||
170757211|NCT04736056|617115633|FG001|Overall Study|Withdrawal by Subject|0|||
170757212|NCT04736056|617115634|FG002|Overall Study|Withdrawal by Subject|0|||
170757213|NCT04736056|617115635|FG003|Overall Study|Withdrawal by Subject|0|||
170757214|NCT04736056|617115632|FG000|Overall Study|Physician Decision|1|||
170757215|NCT04736056|617115633|FG001|Overall Study|Physician Decision|0|||
170757216|NCT04736056|617115634|FG002|Overall Study|Physician Decision|1|||
170757217|NCT04736056|617115635|FG003|Overall Study|Physician Decision|0|||
170757218|NCT04956692|617115639|FG000|Overall Study|Death|115|||
170757219|NCT04956692|617115640|FG001|Overall Study|Death|47|||
170757220|NCT04956692|617115639|FG000|Overall Study|Lost to Follow-up|0|||
170757221|NCT04956692|617115640|FG001|Overall Study|Lost to Follow-up|1|||
170757222|NCT04956692|617115639|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
170757223|NCT04956692|617115640|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170757224|NCT04956692|617115639|FG000|Overall Study|Withdrawal by Subject|5|||
170757225|NCT04956692|617115640|FG001|Overall Study|Withdrawal by Subject|2|||
170757226|NCT04956692|617115639|FG000|Overall Study|Ongoing in Study|236|||
170757227|NCT04956692|617115640|FG001|Overall Study|Ongoing in Study|123|||
170757228|NCT02148718|617115643|FG000|Overall Study|Protocol Violation|26|||
170757229|NCT02148718|617115643|FG000|Overall Study|Discontinued Study Prematurely|5|||
170757230|NCT01822821|617115644|FG000|Overall Study|Eligible surgery cancelled|1|||
170757231|NCT01822821|617115645|FG001|Overall Study|Eligible surgery cancelled|1|||
170757232|NCT01822821|617115644|FG000|Overall Study|Other reasons|1|||
170757233|NCT01822821|617115645|FG001|Overall Study|Other reasons|0|||
170757234|NCT00333788|617115648|FG000|Overall Study|Adverse Event|44|||
170757235|NCT00333788|617115648|FG000|Overall Study|Lack of Efficacy|80|||
170757236|NCT00333788|617115648|FG000|Overall Study|Lost to Follow-up|2|||
170757237|NCT00333788|617115648|FG000|Overall Study|Withdrawal by Subject|24|||
170757238|NCT00333788|617115648|FG000|Overall Study|Other: Non-compliance|2|||
170757239|NCT00333788|617115648|FG000|Overall Study|Other: Moved|2|||
170757240|NCT00333788|617115648|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
170757241|NCT00333788|617115648|FG000|Overall Study|Other: Investigator decision|1|||
170757242|NCT00333788|617115648|FG000|Overall Study|Other: Quality of life concern|1|||
170757243|NCT00333788|617115648|FG000|Overall Study|Other: Sponsor decision|1|||
170757244|NCT00333788|617115648|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
170757245|NCT00333788|617115648|FG000|Overall Study|Other: Medical monitor decision|1|||
170757246|NCT00333788|617115648|FG000|Overall Study|Other: Physician decision|1|||
170757247|NCT00333788|617115648|FG000|Overall Study|Other: Signed consent for another study|1|||
170865681|NCT02593786|617519988|FG001|Overall Study|Participant request to discontinue study therapy|2|||
170757248|NCT00114959|617115649|FG000|Overall Study|Lack of Efficacy|6|||
170757249|NCT00114959|617115649|FG000|Overall Study|Physician Decision|1|||
170757250|NCT00114959|617115649|FG000|Overall Study|Death|1|||
170757251|NCT02322775|617115655|FG000|Overall Study|Adverse Event|1|||
170757252|NCT02322775|617115656|FG001|Overall Study|Adverse Event|0|||
170757253|NCT02322775|617115655|FG000|Overall Study|Lost to Follow-up|0|||
170757254|NCT02322775|617115656|FG001|Overall Study|Lost to Follow-up|1|||
170757255|NCT02322775|617115655|FG000|Overall Study|Protocol Violation|1|||
170757256|NCT02322775|617115656|FG001|Overall Study|Protocol Violation|0|||
170757257|NCT02322775|617115655|FG000|Overall Study|Withdrawal by Subject|3|||
170757258|NCT02322775|617115656|FG001|Overall Study|Withdrawal by Subject|4|||
170757259|NCT02322775|617115655|FG000|Overall Study|Not willing to perform all FU visits|0|||
170757260|NCT02322775|617115656|FG001|Overall Study|Not willing to perform all FU visits|1|||
170757261|NCT05397470|617115657|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
170757262|NCT05397470|617115658|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
170757263|NCT05397470|617115659|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
170757264|NCT05397470|617115657|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
170757265|NCT05397470|617115658|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
170757266|NCT05397470|617115659|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
170757267|NCT05397470|617115657|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
170757268|NCT05397470|617115658|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
170757269|NCT05397470|617115659|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
170757270|NCT05397470|617115657|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
170757271|NCT05397470|617115658|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
170757272|NCT05397470|617115659|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
170757273|NCT05397470|617115657|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
170757274|NCT05397470|617115658|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
170757275|NCT05397470|617115659|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
170757276|NCT05397470|617115657|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
170757277|NCT05397470|617115658|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
170757278|NCT05397470|617115659|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
170757279|NCT05397470|617115657|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
170757280|NCT05397470|617115658|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
170757281|NCT05397470|617115659|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
170757282|NCT01645111|617117410|FG000|Overall Study|Did not require Clevidipine|15|||
170757283|NCT01304706|617117416|FG000|Overall Study|Adverse Event|2|||
170757284|NCT01304706|617117416|FG000|Overall Study|Lack of Efficacy|1|||
170757285|NCT01304706|617117416|FG000|Overall Study|Death|3|||
170757286|NCT01304706|617117416|FG000|Overall Study|Withdrawal by Subject|3|||
170757287|NCT01304706|617117416|FG000|Overall Study|Lost to Follow-up|7|||
170757288|NCT01304706|617117416|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
170757289|NCT05526911|617117417|FG000|Overall Study|Adverse Event|2|||
170757290|NCT00256308|617117418|FG000|Overall Study|Death|2|||
170757291|NCT00531479|617117420|FG000|Overall Study|Death|68|||
170757292|NCT00531479|617117421|FG001|Overall Study|Death|71|||
170757293|NCT00531479|617117420|FG000|Overall Study|Lost to Follow-up|0|||
170757294|NCT00531479|617117421|FG001|Overall Study|Lost to Follow-up|2|||
170757295|NCT00531479|617117420|FG000|Overall Study|Other|0|||
170757296|NCT00531479|617117421|FG001|Overall Study|Other|1|||
170757297|NCT00531479|617117420|FG000|Overall Study|Withdrawal by Subject|6|||
170757298|NCT00531479|617117421|FG001|Overall Study|Withdrawal by Subject|6|||
170406171|NCT01335477|615828493|FG000|Overall Study|Non compliant with protocol|0|||
170406172|NCT01335477|615828494|FG001|Overall Study|Non compliant with protocol|2|||
170406173|NCT01335477|615828493|FG000|Overall Study|Lost to Follow-up|1|||
170406174|NCT01335477|615828494|FG001|Overall Study|Lost to Follow-up|2|||
170406175|NCT01335477|615828493|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
170406176|NCT01335477|615828494|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
170406177|NCT01335477|615828493|FG000|Overall Study|Not treated|1|||
170406178|NCT01335477|615828494|FG001|Overall Study|Not treated|2|||
170406179|NCT01335477|615828493|FG000|Overall Study|Reason other than those stated above|2|||
170406180|NCT01335477|615828494|FG001|Overall Study|Reason other than those stated above|2|||
170406181|NCT00515073|615828495|FG000|Overall Study|Withdrawal by Subject|1|||
170757299|NCT00531479|617117420|FG000|Overall Study|Did not receive treatment|2|||
170757300|NCT00531479|617117421|FG001|Overall Study|Did not receive treatment|3|||
170757301|NCT00797862|617117422|FG000|Overall Study|Adverse Event|86|||
170757302|NCT00797862|617117423|FG001|Overall Study|Adverse Event|44|||
170865682|NCT02593786|617519989|FG002|Overall Study|Participant request to discontinue study therapy|0|||
170406182|NCT00515073|615828495|FG000|Overall Study|Physician Decision|1|||
170406183|NCT02764489|615828496|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
170406184|NCT02764489|615828497|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
170757303|NCT00797862|617117424|FG002|Overall Study|Adverse Event|58|||
170757304|NCT00797862|617117422|FG000|Overall Study|Abnormal Test Procedure Result|0|||
170406185|NCT02764489|615828496|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
170406186|NCT02764489|615828497|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
170406187|NCT02764489|615828496|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
170406188|NCT02764489|615828497|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
170406189|NCT02764489|615828496|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
170406190|NCT02764489|615828497|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
170406191|NCT00881959|615828498|FG000|Overall Study|Lost to Follow-up|2|||
170406192|NCT00881959|615828499|FG001|Overall Study|Lost to Follow-up|4|||
170406193|NCT03840811|615828500|FG000|Overall Study|Lost to Follow-up|0|||
170406194|NCT03840811|615828501|FG001|Overall Study|Lost to Follow-up|0|||
170406195|NCT03840811|615828502|FG002|Overall Study|Lost to Follow-up|1|||
170406196|NCT01294592|615828503|FG000|Overall Study|Adverse Event|28|||
170406197|NCT01294592|615828504|FG001|Overall Study|Adverse Event|13|||
170406198|NCT01294592|615828503|FG000|Overall Study|Lack of Efficacy|7|||
170406199|NCT01294592|615828504|FG001|Overall Study|Lack of Efficacy|5|||
170406200|NCT01294592|615828503|FG000|Overall Study|Protocol Violation|1|||
170406201|NCT01294592|615828504|FG001|Overall Study|Protocol Violation|7|||
170406202|NCT01294592|615828503|FG000|Overall Study|Lost to Follow-up|7|||
170406203|NCT01294592|615828504|FG001|Overall Study|Lost to Follow-up|9|||
170406204|NCT01294592|615828503|FG000|Overall Study|Physician Decision|6|||
170406205|NCT01294592|615828504|FG001|Overall Study|Physician Decision|11|||
170406206|NCT01294592|615828503|FG000|Overall Study|Withdrawal by Subject|28|||
170406207|NCT01294592|615828504|FG001|Overall Study|Withdrawal by Subject|28|||
170406208|NCT03549130|615828505|FG000|Overall Study|Adverse Event|0|||
170406209|NCT03549130|615828506|FG001|Overall Study|Adverse Event|1|||
170406210|NCT03549130|615828505|FG000|Overall Study|Lost to Follow-up|0|||
170406211|NCT03549130|615828506|FG001|Overall Study|Lost to Follow-up|1|||
170406212|NCT00623623|615828507|FG000|Overall Study|Previous enrolment into this study|1|||
170406213|NCT00623623|615828508|FG001|Overall Study|Previous enrolment into this study|1|||
170406214|NCT00693784|615828509|FG000|Overall Study|Lost to Follow-up|2|||
170406215|NCT00693784|615828509|FG000|Overall Study|Withdrawal by Subject|2|||
170406216|NCT02265952|615828510|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
170406217|NCT02265952|615828511|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
170406218|NCT02265952|615828510|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
170406219|NCT02265952|615828511|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
170406220|NCT01084005|615828514|FG000|Overall Study|Adverse Event|1|||
170406221|NCT01084005|615828515|FG001|Overall Study|Adverse Event|8|||
170406222|NCT01084005|615828514|FG000|Overall Study|Protocol Violation|3|||
170406223|NCT01084005|615828515|FG001|Overall Study|Protocol Violation|7|||
170406224|NCT01084005|615828514|FG000|Overall Study|Withdrawal by Subject|1|||
170406225|NCT01084005|615828515|FG001|Overall Study|Withdrawal by Subject|1|||
170406226|NCT02480010|615828516|FG000|Overall Study|Adverse Event|3|||
170406227|NCT02480010|615828517|FG001|Overall Study|Adverse Event|1|||
170406228|NCT02480010|615828516|FG000|Overall Study|Death|1|||
170406229|NCT02480010|615828517|FG001|Overall Study|Death|0|||
170406230|NCT02480010|615828516|FG000|Overall Study|Insufficient therapeutic response|31|||
170406231|NCT02480010|615828517|FG001|Overall Study|Insufficient therapeutic response|29|||
170406232|NCT02480010|615828516|FG000|Overall Study|Refused Treatment|0|||
170406233|NCT02480010|615828517|FG001|Overall Study|Refused Treatment|3|||
170406234|NCT03377556|615828523|FG000|Overall Study|Adverse Event|5|||
170406235|NCT03377556|615828523|FG000|Overall Study|Refusal unrelated to adverse events|1|||
170406236|NCT03377556|615828523|FG000|Overall Study|Progression/relapse|38|||
170757305|NCT00797862|617117423|FG001|Overall Study|Abnormal Test Procedure Result|1|||
170757306|NCT00797862|617117424|FG002|Overall Study|Abnormal Test Procedure Result|1|||
170757307|NCT00797862|617117422|FG000|Overall Study|Lack of Efficacy|1|||
170757308|NCT00797862|617117423|FG001|Overall Study|Lack of Efficacy|7|||
170757309|NCT00797862|617117424|FG002|Overall Study|Lack of Efficacy|6|||
170757310|NCT00797862|617117422|FG000|Overall Study|No longer required study medication|1|||
170757311|NCT00797862|617117423|FG001|Overall Study|No longer required study medication|0|||
170757312|NCT00797862|617117424|FG002|Overall Study|No longer required study medication|0|||
170757313|NCT00797862|617117422|FG000|Overall Study|Withdrawal by Subject|14|||
170757314|NCT00797862|617117423|FG001|Overall Study|Withdrawal by Subject|7|||
170757315|NCT00797862|617117424|FG002|Overall Study|Withdrawal by Subject|7|||
170757316|NCT00797862|617117422|FG000|Overall Study|Lost to Follow-up|11|||
170757317|NCT00797862|617117423|FG001|Overall Study|Lost to Follow-up|0|||
170406237|NCT03377556|615828523|FG000|Overall Study|Death|3|||
170406238|NCT00472446|615828524|FG000|Overall Study|Protocol Violation|0|||
170406239|NCT00472446|615828525|FG001|Overall Study|Protocol Violation|0|||
170406240|NCT00472446|615828526|FG002|Overall Study|Protocol Violation|0|||
170406241|NCT00472446|615828527|FG003|Overall Study|Protocol Violation|1|||
170406242|NCT00472446|615828524|FG000|Overall Study|Reintervention|0|||
170406243|NCT00472446|615828525|FG001|Overall Study|Reintervention|0|||
170406244|NCT00472446|615828526|FG002|Overall Study|Reintervention|1|||
170406245|NCT00472446|615828527|FG003|Overall Study|Reintervention|1|||
170406246|NCT00472446|615828524|FG000|Overall Study|Questionnaires not returned|5|||
170757318|NCT00797862|617117424|FG002|Overall Study|Lost to Follow-up|5|||
170757319|NCT00797862|617117422|FG000|Overall Study|Administrative Problem|4|||
170865683|NCT02593786|617519990|FG003|Overall Study|Participant request to discontinue study therapy|0|||
170406247|NCT00472446|615828525|FG001|Overall Study|Questionnaires not returned|6|||
170757320|NCT00797862|617117423|FG001|Overall Study|Administrative Problem|0|||
170757321|NCT00797862|617117424|FG002|Overall Study|Administrative Problem|0|||
170757322|NCT00797862|617117422|FG000|Overall Study|Protocol Violation|4|||
170757323|NCT00797862|617117423|FG001|Overall Study|Protocol Violation|6|||
170757324|NCT00797862|617117424|FG002|Overall Study|Protocol Violation|8|||
170757325|NCT00797862|617117422|FG000|Overall Study|Mis-randomized|3|||
170757326|NCT00797862|617117423|FG001|Overall Study|Mis-randomized|3|||
170757327|NCT00797862|617117424|FG002|Overall Study|Mis-randomized|1|||
170757328|NCT05074498|617117425|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
170757329|NCT05074498|617117426|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
170757330|NCT05074498|617117427|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
170757331|NCT05074498|617117428|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
170757332|NCT05074498|617117429|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
170757333|NCT05074498|617117430|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
170757334|NCT05074498|617117425|FG000|Part 1 (Upto Day 104)|Other|1|||
170757335|NCT05074498|617117426|FG001|Part 1 (Upto Day 104)|Other|0|||
170757336|NCT05074498|617117427|FG002|Part 1 (Upto Day 104)|Other|0|||
170757337|NCT05074498|617117428|FG003|Part 1 (Upto Day 104)|Other|0|||
170757338|NCT05074498|617117429|FG004|Part 1 (Upto Day 104)|Other|0|||
170757339|NCT05074498|617117430|FG005|Part 1 (Upto Day 104)|Other|0|||
170757340|NCT05074498|617117425|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
170757341|NCT05074498|617117426|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
170757342|NCT05074498|617117427|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
170757343|NCT05074498|617117428|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
170757344|NCT05074498|617117429|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
170757345|NCT05074498|617117430|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
170757346|NCT05074498|617117425|FG000|Part 2 (Upto Day 104)|Death|0|||
170757347|NCT05074498|617117426|FG001|Part 2 (Upto Day 104)|Death|0|||
170757348|NCT05074498|617117427|FG002|Part 2 (Upto Day 104)|Death|0|||
170757349|NCT05074498|617117428|FG003|Part 2 (Upto Day 104)|Death|0|||
170757350|NCT05074498|617117429|FG004|Part 2 (Upto Day 104)|Death|1|||
170757351|NCT05074498|617117430|FG005|Part 2 (Upto Day 104)|Death|0|||
170757352|NCT05074498|617117425|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
170757353|NCT05074498|617117426|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
170757354|NCT05074498|617117427|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
170757355|NCT05074498|617117428|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
170757356|NCT05074498|617117429|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
170757357|NCT05074498|617117430|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
170757358|NCT05074498|617117425|FG000|Part 2 (Upto Day 104)|Other|0|||
170757359|NCT05074498|617117426|FG001|Part 2 (Upto Day 104)|Other|0|||
170757360|NCT05074498|617117427|FG002|Part 2 (Upto Day 104)|Other|0|||
170757361|NCT05074498|617117428|FG003|Part 2 (Upto Day 104)|Other|0|||
170757362|NCT05074498|617117429|FG004|Part 2 (Upto Day 104)|Other|1|||
170757363|NCT05074498|617117430|FG005|Part 2 (Upto Day 104)|Other|0|||
170757364|NCT01306331|617117432|FG000|Overall Study|Adverse Event|28|||
170757365|NCT01306331|617117433|FG001|Overall Study|Adverse Event|25|||
170757366|NCT01306331|617117432|FG000|Overall Study|Lost to Follow-up|321|||
170757367|NCT01306331|617117433|FG001|Overall Study|Lost to Follow-up|323|||
170757368|NCT01306331|617117432|FG000|Overall Study|Physician Decision|26|||
170757369|NCT01306331|617117433|FG001|Overall Study|Physician Decision|22|||
170757370|NCT01306331|617117432|FG000|Overall Study|Pregnancy|136|||
170757371|NCT01306331|617117433|FG001|Overall Study|Pregnancy|151|||
170757372|NCT01306331|617117432|FG000|Overall Study|Protocol Violation|154|||
170757373|NCT01306331|617117433|FG001|Overall Study|Protocol Violation|124|||
170757374|NCT01306331|617117432|FG000|Overall Study|Withdrawal by Subject|163|||
170757375|NCT01306331|617117433|FG001|Overall Study|Withdrawal by Subject|152|||
170757376|NCT01306331|617117432|FG000|Overall Study|Not sexually active|29|||
170757377|NCT01306331|617117433|FG001|Overall Study|Not sexually active|28|||
170757378|NCT01306331|617117432|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
170757379|NCT01306331|617117433|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
170757380|NCT01306331|617117432|FG000|Overall Study|Other|34|||
170757381|NCT01306331|617117433|FG001|Overall Study|Other|32|||
170757382|NCT00172185|617117436|FG000|Overall Study|Adverse Event|0|||
170757383|NCT00172185|617117437|FG001|Overall Study|Adverse Event|1|||
170757384|NCT00172185|617117438|FG002|Overall Study|Adverse Event|3|||
170757385|NCT00172185|617117439|FG003|Overall Study|Adverse Event|4|||
170757386|NCT00172185|617117436|FG000|Overall Study|Physician Decision|0|||
170757387|NCT00172185|617117437|FG001|Overall Study|Physician Decision|0|||
170519695|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
170757388|NCT00172185|617117438|FG002|Overall Study|Physician Decision|1|||
170757389|NCT00172185|617117439|FG003|Overall Study|Physician Decision|0|||
170757390|NCT00172185|617117436|FG000|Overall Study|SPONSOR Decision|0|||
170757391|NCT00172185|617117437|FG001|Overall Study|SPONSOR Decision|1|||
170757392|NCT00172185|617117438|FG002|Overall Study|SPONSOR Decision|0|||
170757393|NCT00172185|617117439|FG003|Overall Study|SPONSOR Decision|0|||
170757394|NCT00172185|617117436|FG000|Overall Study|Withdrawal by Subject|0|||
170757395|NCT00172185|617117437|FG001|Overall Study|Withdrawal by Subject|0|||
170757396|NCT00172185|617117438|FG002|Overall Study|Withdrawal by Subject|1|||
170757397|NCT00172185|617117439|FG003|Overall Study|Withdrawal by Subject|0|||
170757398|NCT01677936|617117440|FG000|Overall Study|Lost to Follow-up|4|||
170757399|NCT01677936|617117441|FG001|Overall Study|Lost to Follow-up|1|||
170757400|NCT01677936|617117440|FG000|Overall Study|Protocol Violation|3|||
170757401|NCT01677936|617117441|FG001|Overall Study|Protocol Violation|0|||
170757402|NCT01677936|617117440|FG000|Overall Study|Adverse Event|1|||
170757403|NCT01677936|617117441|FG001|Overall Study|Adverse Event|0|||
170757404|NCT01677936|617117440|FG000|Overall Study|Lost to Follow-up|1|||
170757405|NCT01677936|617117441|FG001|Overall Study|Lost to Follow-up|0|||
170757406|NCT01677936|617117440|FG000|Overall Study|Protocol Violation|0|||
170757407|NCT01677936|617117441|FG001|Overall Study|Protocol Violation|4|||
170757408|NCT02790606|617117442|FG000|Overall Study|Death|27|||
170757409|NCT02790606|617117442|FG000|Overall Study|Lost to Follow-up|4|||
170757410|NCT02790606|617117442|FG000|Overall Study|Physician Decision|3|||
170757411|NCT02790606|617117442|FG000|Overall Study|Withdrawal by Subject|1|||
170757412|NCT02735915|617117443|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
170757413|NCT02735915|617117443|FG000|Overall Study|Withdrawal following SAE|2|||
170757414|NCT02735915|617117443|FG000|Overall Study|Withdrawal by Subject|1|||
170757415|NCT02466516|617117444|FG000|Overall Study|Adverse Event|1|||
170757416|NCT02466516|617117445|FG001|Overall Study|Adverse Event|1|||
170757417|NCT02466516|617117446|FG002|Overall Study|Adverse Event|0|||
170757418|NCT02466516|617117447|FG003|Overall Study|Adverse Event|0|||
170757419|NCT02466516|617117448|FG004|Overall Study|Adverse Event|0|||
170757420|NCT02466516|617117444|FG000|Overall Study|Withdrew Consent|1|||
170757421|NCT02466516|617117445|FG001|Overall Study|Withdrew Consent|0|||
170757422|NCT02466516|617117446|FG002|Overall Study|Withdrew Consent|0|||
170757423|NCT02466516|617117447|FG003|Overall Study|Withdrew Consent|0|||
170757424|NCT02466516|617117448|FG004|Overall Study|Withdrew Consent|0|||
170757425|NCT02466516|617117444|FG000|Overall Study|Lost to Follow-up|2|||
170757426|NCT02466516|617117445|FG001|Overall Study|Lost to Follow-up|0|||
170757427|NCT02466516|617117446|FG002|Overall Study|Lost to Follow-up|1|||
170757428|NCT02466516|617117447|FG003|Overall Study|Lost to Follow-up|0|||
170757429|NCT02466516|617117448|FG004|Overall Study|Lost to Follow-up|0|||
170757430|NCT03712930|617117449|FG000|Overall Study|Death|7|||
170757431|NCT03712930|617117449|FG000|Overall Study|Physician Decision|1|||
170757432|NCT03712930|617117449|FG000|Overall Study|Study Terminated by Sponsor|3|||
170757433|NCT03712930|617117449|FG000|Overall Study|Progressive Disease|2|||
170757434|NCT00409708|617117450|FG000|Treatment|Abnormal test procedure result(s)|1|||
170757435|NCT00409708|617117451|FG001|Treatment|Abnormal test procedure result(s)|0|||
170757436|NCT00409708|617117450|FG000|Treatment|Lack of Efficacy|0|||
170757437|NCT00409708|617117451|FG001|Treatment|Lack of Efficacy|1|||
170757438|NCT00409708|617117450|FG000|Treatment|Protocol Violation|6|||
170757439|NCT00409708|617117451|FG001|Treatment|Protocol Violation|2|||
170757440|NCT00409708|617117450|FG000|Treatment|Withdrawal by Subject|3|||
170757441|NCT00409708|617117451|FG001|Treatment|Withdrawal by Subject|8|||
170757442|NCT00409708|617117450|FG000|Treatment|Lost to Follow-up|0|||
170757443|NCT00409708|617117451|FG001|Treatment|Lost to Follow-up|6|||
170757444|NCT00409708|617117450|FG000|Treatment|Administrative problems|5|||
170757445|NCT00409708|617117451|FG001|Treatment|Administrative problems|0|||
170757446|NCT00409708|617117450|FG000|Washout|Lack of Efficacy|9|||
170757447|NCT00409708|617117451|FG001|Washout|Lack of Efficacy|1|||
170757448|NCT00409708|617117450|FG000|Washout|Protocol Violation|0|||
170757449|NCT00409708|617117451|FG001|Washout|Protocol Violation|1|||
170757450|NCT00409708|617117450|FG000|Washout|Withdrawal by Subject|11|||
170757451|NCT00409708|617117451|FG001|Washout|Withdrawal by Subject|5|||
170757452|NCT00409708|617117450|FG000|Washout|Lost to Follow-up|1|||
170757453|NCT00409708|617117451|FG001|Washout|Lost to Follow-up|3|||
170757454|NCT00723294|617117454|FG000|Overall Study|Lobular histology|2|||
170757455|NCT00723294|617117454|FG000|Overall Study|>25% intraductal component|1|||
170757456|NCT00723294|617117454|FG000|Overall Study|No MRI tumor enhancement|1|||
170757457|NCT00723294|617117454|FG000|Overall Study|1.0-Tesla MRI|1|||
170757458|NCT00723294|617117454|FG000|Overall Study|No cryoabalation|2|||
170757459|NCT00723294|617117454|FG000|Overall Study|Did not undergo surgery|1|||
170757460|NCT00723294|617117454|FG000|Overall Study|Treated prior to registration|1|||
170757461|NCT00723294|617117454|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
170757462|NCT00723294|617117454|FG000|Overall Study|Benign lesion|1|||
170757463|NCT00723294|617117454|FG000|Overall Study|Withdrawal by Subject|1|||
170757464|NCT00723294|617117454|FG000|Overall Study|No treatment due to probe failure|1|||
170757465|NCT01062126|617117455|FG000|Overall Study|Death|209|||
170757466|NCT01062126|617117455|FG000|Overall Study|All Withdrawals|324|||
170757467|NCT00157014|617117456|FG000|Overall Study|Death|4|||
170757468|NCT00157014|617117457|FG001|Overall Study|Death|2|||
170757469|NCT00157014|617117458|FG002|Overall Study|Death|1|||
170757470|NCT00157014|617117459|FG003|Overall Study|Death|1|||
170757471|NCT00157014|617117456|FG000|Overall Study|Physician Decision|0|||
170757472|NCT00157014|617117457|FG001|Overall Study|Physician Decision|1|||
170757473|NCT00157014|617117458|FG002|Overall Study|Physician Decision|0|||
170757474|NCT00157014|617117459|FG003|Overall Study|Physician Decision|0|||
170757475|NCT00157014|617117456|FG000|Overall Study|Medications withdrawn on family request|0|||
170757476|NCT00157014|617117457|FG001|Overall Study|Medications withdrawn on family request|1|||
170757477|NCT00157014|617117458|FG002|Overall Study|Medications withdrawn on family request|0|||
170757478|NCT00157014|617117459|FG003|Overall Study|Medications withdrawn on family request|0|||
170757479|NCT00157014|617117456|FG000|Overall Study|Patient withdrawn by investigator|1|||
170757480|NCT00157014|617117457|FG001|Overall Study|Patient withdrawn by investigator|0|||
170757481|NCT00157014|617117458|FG002|Overall Study|Patient withdrawn by investigator|0|||
170757482|NCT00157014|617117459|FG003|Overall Study|Patient withdrawn by investigator|0|||
170757483|NCT00157014|617117456|FG000|Overall Study|Patient unable to return in nursing home|1|||
170757484|NCT00157014|617117457|FG001|Overall Study|Patient unable to return in nursing home|0|||
170757485|NCT00157014|617117458|FG002|Overall Study|Patient unable to return in nursing home|0|||
170757486|NCT00157014|617117459|FG003|Overall Study|Patient unable to return in nursing home|0|||
170757487|NCT00157014|617117456|FG000|Overall Study|Patient would not receive transplant|0|||
170757488|NCT00157014|617117457|FG001|Overall Study|Patient would not receive transplant|1|||
170757489|NCT00157014|617117458|FG002|Overall Study|Patient would not receive transplant|0|||
170757490|NCT00157014|617117459|FG003|Overall Study|Patient would not receive transplant|0|||
170757491|NCT00157014|617117456|FG000|Overall Study|Withdrawal by Subject|1|||
170757492|NCT00157014|617117457|FG001|Overall Study|Withdrawal by Subject|0|||
170757493|NCT00157014|617117458|FG002|Overall Study|Withdrawal by Subject|0|||
170757494|NCT00157014|617117459|FG003|Overall Study|Withdrawal by Subject|0|||
170757495|NCT01362491|617117460|FG000|Overall Study|Ineligible|1|||
170757496|NCT01362491|617117461|FG001|Overall Study|Ineligible|0|||
170757497|NCT01362491|617117462|FG002|Overall Study|Ineligible|0|||
170757498|NCT01211665|617117463|FG000|Overall Study|Withdrawal by Subject|1|||
170757499|NCT01211665|617117464|FG001|Overall Study|Withdrawal by Subject|0|||
170757500|NCT01211665|617117463|FG000|Overall Study|Death|1|||
170757501|NCT01211665|617117464|FG001|Overall Study|Death|0|||
170757502|NCT03929302|617117469|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
170757503|NCT03929302|617117470|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
170757504|NCT03929302|617117471|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
170757505|NCT03929302|617117469|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
170757506|NCT03929302|617117470|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
170757507|NCT03929302|617117471|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
170757508|NCT03929302|617117469|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
170757509|NCT03929302|617117470|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
170757510|NCT03929302|617117471|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
170757511|NCT04454567|617117472|FG000|Overall Study|Study Terminated by Sponsor|1|||
170757512|NCT04454567|617117473|FG001|Overall Study|Study Terminated by Sponsor|1|||
170757513|NCT01474538|617117477|FG000|Treatment Period 1|Death|1|||
170757514|NCT01474538|617117478|FG001|Treatment Period 1|Death|0|||
170757515|NCT01474538|617117477|FG000|Treatment Period 1|Physician Decision|1|||
170757516|NCT01474538|617117478|FG001|Treatment Period 1|Physician Decision|0|||
170757517|NCT01474538|617117477|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170757518|NCT01474538|617117478|FG001|Treatment Period 1|Withdrawal by Subject|3|||
170757519|NCT01474538|617117477|FG000|Treatment Period 1|Protocol Violation|0|||
170757520|NCT01474538|617117478|FG001|Treatment Period 1|Protocol Violation|1|||
170757521|NCT01474538|617117477|FG000|Treatment Period 2|Death|1|||
170757522|NCT01474538|617117478|FG001|Treatment Period 2|Death|0|||
170757523|NCT01474538|617117477|FG000|Treatment Period 2|Adverse Event|1|||
170757524|NCT01474538|617117478|FG001|Treatment Period 2|Adverse Event|1|||
170757525|NCT01474538|617117477|FG000|Treatment Period 2|Withdrawal by Subject|2|||
170757526|NCT01474538|617117478|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170757527|NCT01474538|617117477|FG000|Treatment Period 2|Sponsor decision|1|||
170757528|NCT01474538|617117478|FG001|Treatment Period 2|Sponsor decision|0|||
170757529|NCT01474538|617117477|FG000|Treatment Period 2|Physician Decision|0|||
170406248|NCT00472446|615828526|FG002|Overall Study|Questionnaires not returned|6|||
170406249|NCT00472446|615828527|FG003|Overall Study|Questionnaires not returned|4|||
170406250|NCT00827827|615828528|FG000|Overall Study|Lost to Follow-up|3|||
170406251|NCT00827827|615828529|FG001|Overall Study|Lost to Follow-up|0|||
170406252|NCT00827827|615828528|FG000|Overall Study|Fall at home- hospitalization|1|||
170406253|NCT00827827|615828529|FG001|Overall Study|Fall at home- hospitalization|0|||
170406254|NCT00827827|615828528|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
170406255|NCT00827827|615828529|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
170406256|NCT00827827|615828528|FG000|Overall Study|Gout|1|||
170406257|NCT00827827|615828529|FG001|Overall Study|Gout|0|||
170406258|NCT00827827|615828528|FG000|Overall Study|Transportation issues|1|||
170406259|NCT00827827|615828529|FG001|Overall Study|Transportation issues|0|||
170406260|NCT00827827|615828528|FG000|Overall Study|Burned with water at home|1|||
170757530|NCT01474538|617117478|FG001|Treatment Period 2|Physician Decision|1|||
170406261|NCT00827827|615828529|FG001|Overall Study|Burned with water at home|0|||
170757531|NCT01474538|617117477|FG000|Treatment Period 2|Protocol Violation|1|||
170757532|NCT01474538|617117478|FG001|Treatment Period 2|Protocol Violation|0|||
170757533|NCT00367237|617117479|FG000|Overall Study|Adverse Event|7|||
170406262|NCT00295854|615828532|FG000|Overall Study|Adverse Event|7|||
170406263|NCT00295854|615828533|FG001|Overall Study|Adverse Event|7|||
170406264|NCT00295854|615828534|FG002|Overall Study|Adverse Event|6|||
170757534|NCT00367237|617117480|FG001|Overall Study|Adverse Event|2|||
170757535|NCT00367237|617117479|FG000|Overall Study|Lost to Follow-up|1|||
170757536|NCT00367237|617117480|FG001|Overall Study|Lost to Follow-up|0|||
170757537|NCT00367237|617117479|FG000|Overall Study|Withdrawal by Subject|0|||
170757538|NCT00367237|617117480|FG001|Overall Study|Withdrawal by Subject|4|||
170757539|NCT00367237|617117479|FG000|Overall Study|Protocol Violation|2|||
170757540|NCT00367237|617117480|FG001|Overall Study|Protocol Violation|5|||
170757541|NCT00868231|617117481|FG000|Treatment Period 1|Adverse Event|0|||
170757542|NCT00868231|617117482|FG001|Treatment Period 1|Adverse Event|0|||
170757543|NCT00868231|617117483|FG002|Treatment Period 1|Adverse Event|0|||
170757544|NCT00868231|617117484|FG003|Treatment Period 1|Adverse Event|0|||
170757545|NCT00868231|617117485|FG004|Treatment Period 1|Adverse Event|1|||
170757546|NCT00868231|617117486|FG005|Treatment Period 1|Adverse Event|0|||
170757547|NCT00868231|617117481|FG000|Treatment Period 2|Adverse Event|1|||
170757548|NCT00868231|617117482|FG001|Treatment Period 2|Adverse Event|0|||
170757549|NCT00868231|617117483|FG002|Treatment Period 2|Adverse Event|0|||
170757550|NCT00868231|617117484|FG003|Treatment Period 2|Adverse Event|0|||
170757551|NCT00868231|617117485|FG004|Treatment Period 2|Adverse Event|0|||
170757552|NCT00868231|617117486|FG005|Treatment Period 2|Adverse Event|0|||
170757553|NCT00868231|617117481|FG000|Treatment Period 3|Adverse Event|0|||
170757554|NCT00868231|617117482|FG001|Treatment Period 3|Adverse Event|0|||
170757555|NCT00868231|617117483|FG002|Treatment Period 3|Adverse Event|1|||
170757556|NCT00868231|617117484|FG003|Treatment Period 3|Adverse Event|0|||
170757557|NCT00868231|617117485|FG004|Treatment Period 3|Adverse Event|0|||
170757558|NCT00868231|617117486|FG005|Treatment Period 3|Adverse Event|0|||
170757559|NCT04565249|617117487|FG000|Overall Study|Death|0|||
170757560|NCT04565249|617117488|FG001|Overall Study|Death|0|||
170757561|NCT04565249|617117489|FG002|Overall Study|Death|0|||
170757562|NCT04565249|617117490|FG003|Overall Study|Death|1|||
170757563|NCT00886613|617117491|FG000|Overall Study|Protocol deviation (Part B)|1|||
170757564|NCT00886613|617117492|FG001|Overall Study|Protocol deviation (Part B)|0|||
170757565|NCT00886613|617117493|FG002|Overall Study|Protocol deviation (Part B)|0|||
170757566|NCT00886613|617117491|FG000|Overall Study|Lost to follow-up (Part B)|1|||
170757567|NCT00886613|617117492|FG001|Overall Study|Lost to follow-up (Part B)|0|||
170757568|NCT00886613|617117493|FG002|Overall Study|Lost to follow-up (Part B)|1|||
170757569|NCT00886613|617117491|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
170757570|NCT00886613|617117492|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
170757571|NCT00886613|617117493|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
170757572|NCT02347943|617117495|FG000|Overall Study|Study was cancelled|140|||
170757573|NCT02347943|617117496|FG001|Overall Study|Study was cancelled|67|||
170757574|NCT02347943|617117497|FG002|Overall Study|Study was cancelled|45|||
170757575|NCT01688973|617117506|FG000|Overall Study|Ineligible|2|||
170757576|NCT01688973|617117507|FG001|Overall Study|Ineligible|3|||
170757577|NCT04337489|617117513|FG000|Overall Study|Withdrawal by Subject|1|||
170757578|NCT00688688|617117514|FG000|Overall Study|Eligibility criterion not met|7|||
170757579|NCT00688688|617117515|FG001|Overall Study|Eligibility criterion not met|7|||
170757580|NCT00688688|617117516|FG002|Overall Study|Eligibility criterion not met|10|||
170757581|NCT00688688|617117514|FG000|Overall Study|Adverse Event|52|||
170757582|NCT00688688|617117515|FG001|Overall Study|Adverse Event|51|||
170757583|NCT00688688|617117516|FG002|Overall Study|Adverse Event|50|||
170757584|NCT00688688|617117514|FG000|Overall Study|Lack of Efficacy|34|||
170757585|NCT00688688|617117515|FG001|Overall Study|Lack of Efficacy|25|||
170757586|NCT00688688|617117516|FG002|Overall Study|Lack of Efficacy|45|||
170757587|NCT00688688|617117514|FG000|Overall Study|Withdrawal by Subject|66|||
170757588|NCT00688688|617117515|FG001|Overall Study|Withdrawal by Subject|75|||
170757589|NCT00688688|617117516|FG002|Overall Study|Withdrawal by Subject|65|||
170757590|NCT00688688|617117514|FG000|Overall Study|Lost to Follow-up|14|||
170757591|NCT00688688|617117515|FG001|Overall Study|Lost to Follow-up|7|||
170757592|NCT00688688|617117516|FG002|Overall Study|Lost to Follow-up|7|||
170757593|NCT00688688|617117514|FG000|Overall Study|Protocol Violation|6|||
170757594|NCT00688688|617117515|FG001|Overall Study|Protocol Violation|9|||
170406265|NCT00295854|615828532|FG000|Overall Study|Protocol Violation|1|||
170406266|NCT00295854|615828533|FG001|Overall Study|Protocol Violation|1|||
170406267|NCT00295854|615828534|FG002|Overall Study|Protocol Violation|1|||
170757595|NCT00688688|617117516|FG002|Overall Study|Protocol Violation|11|||
170757596|NCT00688688|617117514|FG000|Overall Study|Randomized but never received study drug|1|||
170757597|NCT00688688|617117515|FG001|Overall Study|Randomized but never received study drug|0|||
170757598|NCT00688688|617117516|FG002|Overall Study|Randomized but never received study drug|0|||
170757599|NCT00688688|617117514|FG000|Overall Study|Non-compliance with study procedures|5|||
170757600|NCT00688688|617117515|FG001|Overall Study|Non-compliance with study procedures|3|||
170757601|NCT00688688|617117516|FG002|Overall Study|Non-compliance with study procedures|4|||
170757602|NCT00688688|617117514|FG000|Overall Study|Taking exclusionary medications|1|||
170757603|NCT00688688|617117515|FG001|Overall Study|Taking exclusionary medications|0|||
170757604|NCT00688688|617117516|FG002|Overall Study|Taking exclusionary medications|0|||
170406268|NCT00295854|615828532|FG000|Overall Study|Lost to Follow-up|2|||
170406269|NCT00295854|615828533|FG001|Overall Study|Lost to Follow-up|0|||
170757605|NCT00688688|617117514|FG000|Overall Study|Site closure|0|||
170757606|NCT00688688|617117515|FG001|Overall Study|Site closure|1|||
170757607|NCT00688688|617117516|FG002|Overall Study|Site closure|0|||
170757608|NCT00688688|617117514|FG000|Overall Study|Violation of exclusion criterion|0|||
170757609|NCT00688688|617117515|FG001|Overall Study|Violation of exclusion criterion|1|||
170757610|NCT00688688|617117516|FG002|Overall Study|Violation of exclusion criterion|0|||
170757611|NCT04296942|617117517|FG000|Overall Study|Study closure by sponsor|1|||
170757612|NCT04296942|617117518|FG001|Overall Study|Study closure by sponsor|0|||
170757613|NCT04296942|617117519|FG002|Overall Study|Study closure by sponsor|0|||
170757614|NCT03255941|617117520|FG000|Overall Study|Not eligible or refused injection|37|||
170757615|NCT03255941|617117521|FG001|Overall Study|Not eligible or refused injection|44|||
170757616|NCT03255941|617117522|FG002|Overall Study|Not eligible or refused injection|5|||
170757617|NCT03255941|617117523|FG003|Overall Study|Not eligible or refused injection|6|||
170757618|NCT03255941|617117520|FG000|Overall Study|Did not complete exit interview|1|||
170757619|NCT03255941|617117521|FG001|Overall Study|Did not complete exit interview|2|||
170757620|NCT03255941|617117522|FG002|Overall Study|Did not complete exit interview|0|||
170757621|NCT03255941|617117523|FG003|Overall Study|Did not complete exit interview|0|||
170757622|NCT00335153|617117535|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
170757623|NCT00335153|617117535|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
170757624|NCT00335153|617117535|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
170757625|NCT00335153|617117535|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
170757626|NCT00335153|617117535|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
170757627|NCT00335153|617117535|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
170757628|NCT00335153|617117535|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
170757629|NCT00335153|617117535|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
170757630|NCT00335153|617117535|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
170757631|NCT00335153|617117535|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
170757632|NCT01982760|617117539|FG000|Overall Study|Physician Decision|1|||
170757633|NCT01982760|617117540|FG001|Overall Study|Physician Decision|0|||
170757634|NCT00530777|617117541|FG000|Overall Study|Lost to Follow-up|0|||
170757635|NCT00530777|617117542|FG001|Overall Study|Lost to Follow-up|1|||
170757636|NCT00530777|617117541|FG000|Overall Study|Death|1|||
170757637|NCT00530777|617117542|FG001|Overall Study|Death|2|||
170757638|NCT00530777|617117541|FG000|Overall Study|Physician Decision|1|||
170757639|NCT00530777|617117542|FG001|Overall Study|Physician Decision|0|||
170757640|NCT00530777|617117541|FG000|Overall Study|Withdrawal by Subject|0|||
170757641|NCT00530777|617117542|FG001|Overall Study|Withdrawal by Subject|1|||
170757642|NCT00530777|617117541|FG000|Overall Study|Unable to adhere to visit schedule|5|||
170757643|NCT00530777|617117542|FG001|Overall Study|Unable to adhere to visit schedule|1|||
170757644|NCT04555044|617117543|FG000|Overall Study|Adverse Event|0|||
170757645|NCT04555044|617117544|FG001|Overall Study|Adverse Event|1|||
170757646|NCT02320253|617117545|FG000|Overall Study|Withdrawal by Subject|3|||
170757647|NCT02320253|617117546|FG001|Overall Study|Withdrawal by Subject|0|||
170757648|NCT02320253|617117547|FG002|Overall Study|Withdrawal by Subject|0|||
170757649|NCT02320253|617117545|FG000|Overall Study|Lost to Follow-up|2|||
170757650|NCT02320253|617117546|FG001|Overall Study|Lost to Follow-up|2|||
170757651|NCT02320253|617117547|FG002|Overall Study|Lost to Follow-up|1|||
170757652|NCT02320253|617117545|FG000|Overall Study|Death|1|||
170757653|NCT02320253|617117546|FG001|Overall Study|Death|0|||
170757654|NCT02320253|617117547|FG002|Overall Study|Death|1|||
170757655|NCT04831775|617117553|FG000|Overall Study|Lost to Follow-up|11|||
170757656|NCT04831775|617117554|FG001|Overall Study|Lost to Follow-up|13|||
170757657|NCT01394991|617117559|FG000|Overall Study|Adverse Event|0|||
170757658|NCT01394991|617117560|FG001|Overall Study|Adverse Event|4|||
170757659|NCT01394991|617117559|FG000|Overall Study|Lack of Efficacy|5|||
170757660|NCT01394991|617117560|FG001|Overall Study|Lack of Efficacy|7|||
170757661|NCT01394991|617117559|FG000|Overall Study|Lost to Follow-up|6|||
170757662|NCT01394991|617117560|FG001|Overall Study|Lost to Follow-up|8|||
170757663|NCT01394991|617117559|FG000|Overall Study|Physician Decision|1|||
170757664|NCT01394991|617117560|FG001|Overall Study|Physician Decision|3|||
170757665|NCT01394991|617117559|FG000|Overall Study|Protocol Violation|1|||
170757666|NCT01394991|617117560|FG001|Overall Study|Protocol Violation|1|||
170757667|NCT01394991|617117559|FG000|Overall Study|Withdrawal by Subject|20|||
170865684|NCT02593786|617519987|FG000|Overall Study|Other reasons|1|||
170865685|NCT02593786|617519988|FG001|Overall Study|Other reasons|1|||
170865686|NCT02593786|617519989|FG002|Overall Study|Other reasons|0|||
170757668|NCT01394991|617117560|FG001|Overall Study|Withdrawal by Subject|17|||
170865687|NCT02593786|617519990|FG003|Overall Study|Other reasons|5|||
170757669|NCT01394991|617117559|FG000|Overall Study|Chemotherapy Termination|10|||
170757670|NCT01394991|617117560|FG001|Overall Study|Chemotherapy Termination|15|||
170757671|NCT01394991|617117559|FG000|Overall Study|Disease Progression|7|||
170757672|NCT01394991|617117560|FG001|Overall Study|Disease Progression|7|||
170757673|NCT01394991|617117559|FG000|Overall Study|Prematurely Termination of Trial|9|||
170757674|NCT01394991|617117560|FG001|Overall Study|Prematurely Termination of Trial|10|||
170757675|NCT01515319|617117561|FG000|Overall Study|Withdrawal by Subject|0|||
170757676|NCT01515319|617117562|FG001|Overall Study|Withdrawal by Subject|0|||
170757677|NCT01515319|617117563|FG002|Overall Study|Withdrawal by Subject|0|||
170865688|NCT02146326|617519991|FG000|Overall Study|Lost to Follow-up|3|||
170757678|NCT01515319|617117564|FG003|Overall Study|Withdrawal by Subject|0|||
170757679|NCT01515319|617117565|FG004|Overall Study|Withdrawal by Subject|0|||
170757680|NCT01515319|617117566|FG005|Overall Study|Withdrawal by Subject|0|||
170757681|NCT01515319|617117567|FG006|Overall Study|Withdrawal by Subject|1|||
170757682|NCT01515319|617117568|FG007|Overall Study|Withdrawal by Subject|0|||
170757683|NCT01515319|617117569|FG008|Overall Study|Withdrawal by Subject|0|||
170757684|NCT01515319|617117570|FG009|Overall Study|Withdrawal by Subject|0|||
170757685|NCT01515319|617117561|FG000|Overall Study|Adverse Event|0|||
170757686|NCT01515319|617117562|FG001|Overall Study|Adverse Event|0|||
170757687|NCT01515319|617117563|FG002|Overall Study|Adverse Event|0|||
170757688|NCT01515319|617117564|FG003|Overall Study|Adverse Event|0|||
170757689|NCT01515319|617117565|FG004|Overall Study|Adverse Event|0|||
170865689|NCT02146326|617519992|FG001|Overall Study|Lost to Follow-up|3|||
170406270|NCT00295854|615828534|FG002|Overall Study|Lost to Follow-up|1|||
170406271|NCT00295854|615828532|FG000|Overall Study|Withdrawal by Subject|3|||
170406272|NCT00295854|615828533|FG001|Overall Study|Withdrawal by Subject|7|||
170406273|NCT00295854|615828534|FG002|Overall Study|Withdrawal by Subject|4|||
170406274|NCT00295854|615828532|FG000|Overall Study|did not continue to meet criteria|1|||
170406275|NCT00295854|615828533|FG001|Overall Study|did not continue to meet criteria|1|||
170406276|NCT00295854|615828534|FG002|Overall Study|did not continue to meet criteria|2|||
170406277|NCT00295854|615828532|FG000|Overall Study|required a prohibited medication|1|||
170406278|NCT00295854|615828533|FG001|Overall Study|required a prohibited medication|0|||
170406279|NCT00295854|615828534|FG002|Overall Study|required a prohibited medication|0|||
170406280|NCT00295854|615828532|FG000|Overall Study|Other|3|||
170406281|NCT00295854|615828533|FG001|Overall Study|Other|5|||
170406282|NCT00295854|615828534|FG002|Overall Study|Other|1|||
170406283|NCT01361607|615828542|FG000|Overall Study|Adverse Event|38|||
170406284|NCT01361607|615828543|FG001|Overall Study|Adverse Event|29|||
170406285|NCT01361607|615828542|FG000|Overall Study|Withdrawal by Subject|19|||
170406286|NCT01361607|615828543|FG001|Overall Study|Withdrawal by Subject|8|||
170406287|NCT01361607|615828542|FG000|Overall Study|Withdrawal by Investigator|5|||
170406288|NCT01361607|615828543|FG001|Overall Study|Withdrawal by Investigator|3|||
170406289|NCT01361607|615828542|FG000|Overall Study|Lost to Follow-up|1|||
170406290|NCT01361607|615828543|FG001|Overall Study|Lost to Follow-up|0|||
170406291|NCT01361607|615828542|FG000|Overall Study|Met Withdrawal Criteria|1|||
170406292|NCT01361607|615828543|FG001|Overall Study|Met Withdrawal Criteria|1|||
170406293|NCT00410410|615828546|FG000|Induction Period (IP)|Death|1|||
170406294|NCT00410410|615828547|FG001|Induction Period (IP)|Death|0|||
170406295|NCT00410410|615828548|FG002|Induction Period (IP)|Death|0|||
170406296|NCT00410410|615828549|FG003|Induction Period (IP)|Death|0|||
170406297|NCT00410410|615828550|FG004|Induction Period (IP)|Death|0|||
170406298|NCT00410410|615828551|FG005|Induction Period (IP)|Death|0|||
170406299|NCT00410410|615828552|FG006|Induction Period (IP)|Death|0|||
170406300|NCT00410410|615828553|FG007|Induction Period (IP)|Death|0|||
170406301|NCT00410410|615828554|FG008|Induction Period (IP)|Death|0|||
170406302|NCT00410410|615828546|FG000|Induction Period (IP)|Adverse Event|3|||
170406303|NCT00410410|615828547|FG001|Induction Period (IP)|Adverse Event|4|||
170406304|NCT00410410|615828548|FG002|Induction Period (IP)|Adverse Event|2|||
170406305|NCT00410410|615828549|FG003|Induction Period (IP)|Adverse Event|4|||
170406306|NCT00410410|615828550|FG004|Induction Period (IP)|Adverse Event|1|||
170406307|NCT00410410|615828551|FG005|Induction Period (IP)|Adverse Event|0|||
170406308|NCT00410410|615828552|FG006|Induction Period (IP)|Adverse Event|0|||
170406309|NCT00410410|615828553|FG007|Induction Period (IP)|Adverse Event|0|||
170406310|NCT00410410|615828554|FG008|Induction Period (IP)|Adverse Event|0|||
170406311|NCT00410410|615828546|FG000|Induction Period (IP)|Lack of Efficacy|26|||
170406312|NCT00410410|615828547|FG001|Induction Period (IP)|Lack of Efficacy|24|||
170406313|NCT00410410|615828548|FG002|Induction Period (IP)|Lack of Efficacy|8|||
170406314|NCT00410410|615828549|FG003|Induction Period (IP)|Lack of Efficacy|8|||
170406315|NCT00410410|615828550|FG004|Induction Period (IP)|Lack of Efficacy|7|||
170406316|NCT00410410|615828551|FG005|Induction Period (IP)|Lack of Efficacy|7|||
170406317|NCT00410410|615828552|FG006|Induction Period (IP)|Lack of Efficacy|0|||
170406318|NCT00410410|615828553|FG007|Induction Period (IP)|Lack of Efficacy|0|||
170406319|NCT00410410|615828554|FG008|Induction Period (IP)|Lack of Efficacy|0|||
170406320|NCT00410410|615828546|FG000|Induction Period (IP)|Lost to Follow-up|2|||
170406321|NCT00410410|615828547|FG001|Induction Period (IP)|Lost to Follow-up|2|||
170757690|NCT01515319|617117566|FG005|Overall Study|Adverse Event|0|||
170757691|NCT01515319|617117567|FG006|Overall Study|Adverse Event|0|||
170757692|NCT01515319|617117568|FG007|Overall Study|Adverse Event|0|||
170757693|NCT01515319|617117569|FG008|Overall Study|Adverse Event|3|||
170865690|NCT02146326|617519993|FG002|Overall Study|Lost to Follow-up|11|||
170865691|NCT02146326|617519994|FG003|Overall Study|Lost to Follow-up|19|||
170865692|NCT02146326|617519991|FG000|Overall Study|Withdrawal by Subject|2|||
170406322|NCT00410410|615828548|FG002|Induction Period (IP)|Lost to Follow-up|2|||
170406323|NCT00410410|615828549|FG003|Induction Period (IP)|Lost to Follow-up|3|||
170406324|NCT00410410|615828550|FG004|Induction Period (IP)|Lost to Follow-up|0|||
170406325|NCT00410410|615828551|FG005|Induction Period (IP)|Lost to Follow-up|1|||
170406326|NCT00410410|615828552|FG006|Induction Period (IP)|Lost to Follow-up|0|||
170757694|NCT01515319|617117570|FG009|Overall Study|Adverse Event|0|||
170757695|NCT01515319|617117561|FG000|Overall Study|Protocol Violation|0|||
170757696|NCT01515319|617117562|FG001|Overall Study|Protocol Violation|0|||
170757697|NCT01515319|617117563|FG002|Overall Study|Protocol Violation|0|||
170757698|NCT01515319|617117564|FG003|Overall Study|Protocol Violation|0|||
170757699|NCT01515319|617117565|FG004|Overall Study|Protocol Violation|0|||
170757700|NCT01515319|617117566|FG005|Overall Study|Protocol Violation|0|||
170757701|NCT01515319|617117567|FG006|Overall Study|Protocol Violation|0|||
170757702|NCT01515319|617117568|FG007|Overall Study|Protocol Violation|0|||
170757703|NCT01515319|617117569|FG008|Overall Study|Protocol Violation|2|||
170757704|NCT01515319|617117570|FG009|Overall Study|Protocol Violation|0|||
170757705|NCT01871285|617117571|FG000|First Intervention (1 Day)|Adverse Event|1|||
170757706|NCT01871285|617117572|FG001|First Intervention (1 Day)|Adverse Event|0|||
170757707|NCT01871285|617117573|FG002|First Intervention (1 Day)|Adverse Event|0|||
170757708|NCT01871285|617117574|FG003|First Intervention (1 Day)|Adverse Event|0|||
170757709|NCT01871285|617117571|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
170757710|NCT01871285|617117572|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
170757711|NCT01871285|617117573|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
170757712|NCT01871285|617117574|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
170757713|NCT01919619|617117575|FG000|Overall Study|Physician Decision|1|||
170757714|NCT01919619|617117576|FG001|Overall Study|Physician Decision|1|||
170757715|NCT02501629|617119296|FG000|Overall Study|Death|0|||
170757716|NCT02501629|617119297|FG001|Overall Study|Death|1|||
170757717|NCT02501629|617119296|FG000|Overall Study|Withdrawn from study by sponsor|1|||
170757718|NCT02501629|617119297|FG001|Overall Study|Withdrawn from study by sponsor|0|||
170757719|NCT02501629|617119296|FG000|Overall Study|Early termination by sponsor|1|||
170757720|NCT02501629|617119297|FG001|Overall Study|Early termination by sponsor|0|||
170757721|NCT02501629|617119296|FG000|Overall Study|Withdrawal by Subject|3|||
170757722|NCT02501629|617119297|FG001|Overall Study|Withdrawal by Subject|5|||
170757723|NCT02501629|617119296|FG000|Overall Study|Subject did not return to site|0|||
170757724|NCT02501629|617119297|FG001|Overall Study|Subject did not return to site|1|||
170757725|NCT00349908|617119300|FG000|Overall Study|Withdrawal by Subject|0|||
170757726|NCT00349908|617119301|FG001|Overall Study|Withdrawal by Subject|4|||
170757727|NCT03120676|617119302|FG000|Overall Study|Not treated|1|||
170757728|NCT02333630|617119307|FG000|Overall Study|Lost to Follow-up|5|||
170757729|NCT02333630|617119308|FG001|Overall Study|Lost to Follow-up|2|||
170757730|NCT01244984|617119309|FG000|Overall Study|Adverse Event|2|||
170757731|NCT01244984|617119310|FG001|Overall Study|Adverse Event|11|||
170757732|NCT01244984|617119311|FG002|Overall Study|Adverse Event|2|||
170757733|NCT01244984|617119309|FG000|Overall Study|Protocol Violation|1|||
170757734|NCT01244984|617119310|FG001|Overall Study|Protocol Violation|0|||
170757735|NCT01244984|617119311|FG002|Overall Study|Protocol Violation|0|||
170757736|NCT01244984|617119309|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
170757737|NCT01244984|617119310|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
170757738|NCT01244984|617119311|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
170757739|NCT01244984|617119309|FG000|Overall Study|Withdrawal by Subject|1|||
170757740|NCT01244984|617119310|FG001|Overall Study|Withdrawal by Subject|2|||
170757741|NCT01244984|617119311|FG002|Overall Study|Withdrawal by Subject|2|||
170757742|NCT00672256|617119312|FG000|Overall Study|PI dropped, bad data|44|||
170757743|NCT01801930|617119313|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
170757744|NCT01801930|617119314|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
170757745|NCT01801930|617119315|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
170757746|NCT01801930|617119316|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
170757747|NCT01801930|617119313|FG000|Overall Study|DLT occurs|0|||
170757748|NCT01801930|617119314|FG001|Overall Study|DLT occurs|1|||
170757749|NCT01801930|617119315|FG002|Overall Study|DLT occurs|0|||
170757750|NCT01801930|617119316|FG003|Overall Study|DLT occurs|0|||
170757751|NCT03255018|617119317|FG000|Overall Study|Death on study|0|||
170757752|NCT03255018|617119318|FG001|Overall Study|Death on study|5|||
170757753|NCT03255018|617119317|FG000|Overall Study|Withdrawal by Subject|0|||
170757754|NCT03255018|617119318|FG001|Overall Study|Withdrawal by Subject|2|||
170757755|NCT01720043|617119319|FG000|Overall Study|Withdrawal by Subject|1|||
170757756|NCT01124162|617119320|FG000|First Intervention|Adverse Event|2|||
170757757|NCT01124162|617119321|FG001|First Intervention|Adverse Event|0|||
170757758|NCT01124162|617119320|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
170757759|NCT01124162|617119321|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
170757760|NCT02534896|617119327|FG000|Overall Study|Adverse Event|2|||
170757761|NCT02534896|617119328|FG001|Overall Study|Adverse Event|1|||
170757762|NCT02534896|617119329|FG002|Overall Study|Adverse Event|1|||
170757763|NCT02534896|617119327|FG000|Overall Study|Insufficient therapeutic response|2|||
170757764|NCT02534896|617119328|FG001|Overall Study|Insufficient therapeutic response|0|||
170757765|NCT02534896|617119329|FG002|Overall Study|Insufficient therapeutic response|0|||
170757766|NCT02954055|617119334|FG000|Overall Study|Did not initiate therapy|6|||
170757767|NCT02954055|617119335|FG001|Overall Study|Did not initiate therapy|1|||
170757768|NCT02096003|617119338|FG000|Overall Study|Protocol Violation|0|||
170757769|NCT02096003|617119339|FG001|Overall Study|Protocol Violation|2|||
170757770|NCT02096003|617119338|FG000|Overall Study|additional surgery|2|||
170757771|NCT02096003|617119339|FG001|Overall Study|additional surgery|1|||
170757772|NCT04668144|617119340|FG000|Overall Study|Protocol Violation|0|||
170757773|NCT04668144|617119341|FG001|Overall Study|Protocol Violation|1|||
170757774|NCT04668144|617119342|FG002|Overall Study|Protocol Violation|2|||
170757775|NCT02095158|617119350|FG000|Overall Study|Adverse Event|14|||
170757776|NCT02095158|617119350|FG000|Overall Study|Lack of Efficacy|3|||
170757777|NCT02095158|617119350|FG000|Overall Study|Pregnancy|1|||
170757778|NCT02095158|617119350|FG000|Overall Study|Lost to Follow-up|20|||
170757779|NCT02095158|617119350|FG000|Overall Study|Personal Reasons|35|||
170757780|NCT02095158|617119350|FG000|Overall Study|Protocol Violation|1|||
170757781|NCT02095158|617119350|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170757782|NCT01941316|617119351|FG000|Overall Study|Adverse Event|0|||
170757783|NCT01941316|617119352|FG001|Overall Study|Adverse Event|1|||
170757784|NCT01941316|617119353|FG002|Overall Study|Adverse Event|0|||
170757785|NCT01941316|617119354|FG003|Overall Study|Adverse Event|7|||
170757786|NCT01941316|617119351|FG000|Overall Study|Progressive Disease|3|||
170757787|NCT01941316|617119352|FG001|Overall Study|Progressive Disease|6|||
170757788|NCT01941316|617119353|FG002|Overall Study|Progressive Disease|2|||
170757789|NCT01941316|617119354|FG003|Overall Study|Progressive Disease|29|||
170757790|NCT01941316|617119351|FG000|Overall Study|Withdrawal by Subject|0|||
170757791|NCT01941316|617119352|FG001|Overall Study|Withdrawal by Subject|2|||
170757792|NCT01941316|617119353|FG002|Overall Study|Withdrawal by Subject|1|||
170757793|NCT01941316|617119354|FG003|Overall Study|Withdrawal by Subject|8|||
170757794|NCT01941316|617119351|FG000|Overall Study|Death|0|||
170757795|NCT01941316|617119352|FG001|Overall Study|Death|0|||
170757796|NCT01941316|617119353|FG002|Overall Study|Death|0|||
170757797|NCT01941316|617119354|FG003|Overall Study|Death|3|||
170757798|NCT01941316|617119351|FG000|Overall Study|Physician Decision|0|||
170757799|NCT01941316|617119352|FG001|Overall Study|Physician Decision|0|||
170757800|NCT01941316|617119353|FG002|Overall Study|Physician Decision|0|||
170757801|NCT01941316|617119354|FG003|Overall Study|Physician Decision|3|||
170757802|NCT01941316|617119351|FG000|Overall Study|Protocol Violation|0|||
170757803|NCT01941316|617119352|FG001|Overall Study|Protocol Violation|0|||
170757804|NCT01941316|617119353|FG002|Overall Study|Protocol Violation|0|||
170757805|NCT01941316|617119354|FG003|Overall Study|Protocol Violation|3|||
170757806|NCT01941316|617119351|FG000|Overall Study|Intercurrent illness|0|||
170757807|NCT01941316|617119352|FG001|Overall Study|Intercurrent illness|0|||
170757808|NCT01941316|617119353|FG002|Overall Study|Intercurrent illness|0|||
170757809|NCT01941316|617119354|FG003|Overall Study|Intercurrent illness|1|||
170757810|NCT01941316|617119351|FG000|Overall Study|Other, not specified|0|||
170757811|NCT01941316|617119352|FG001|Overall Study|Other, not specified|0|||
170757812|NCT01941316|617119353|FG002|Overall Study|Other, not specified|0|||
170757813|NCT01941316|617119354|FG003|Overall Study|Other, not specified|1|||
170757814|NCT02775435|617119355|FG000|Overall Study|Adverse Event|32|||
170757815|NCT02775435|617119356|FG001|Overall Study|Adverse Event|27|||
170757816|NCT02775435|617119355|FG000|Overall Study|Lost to Follow-up|2|||
170757817|NCT02775435|617119356|FG001|Overall Study|Lost to Follow-up|2|||
170757818|NCT02775435|617119355|FG000|Overall Study|Sponsor decision|44|||
170757819|NCT02775435|617119356|FG001|Overall Study|Sponsor decision|19|||
170757820|NCT02775435|617119355|FG000|Overall Study|Withdrawal by Subject|4|||
170757821|NCT02775435|617119356|FG001|Overall Study|Withdrawal by Subject|9|||
170757822|NCT02775435|617119355|FG000|Overall Study|Death|196|||
170757823|NCT02775435|617119356|FG001|Overall Study|Death|224|||
170757824|NCT00320489|617119357|FG000|Overall Study|Adverse Event|26|||
170757825|NCT00320489|617119358|FG001|Overall Study|Adverse Event|25|||
170757826|NCT00320489|617119357|FG000|Overall Study|Clinical Relapse|26|||
170757827|NCT00320489|617119358|FG001|Overall Study|Clinical Relapse|20|||
170757828|NCT00320489|617119357|FG000|Overall Study|Death|0|||
170757829|NCT00320489|617119358|FG001|Overall Study|Death|2|||
170757830|NCT00320489|617119357|FG000|Overall Study|Entry Criteria Exclusion|2|||
170757831|NCT00320489|617119358|FG001|Overall Study|Entry Criteria Exclusion|4|||
170757832|NCT00320489|617119357|FG000|Overall Study|Lack of Efficacy|16|||
170757833|NCT00320489|617119358|FG001|Overall Study|Lack of Efficacy|7|||
170757834|NCT00320489|617119357|FG000|Overall Study|Lost to Follow-up|21|||
170757835|NCT00320489|617119358|FG001|Overall Study|Lost to Follow-up|22|||
170757836|NCT00320489|617119357|FG000|Overall Study|Physician Decision|8|||
170757837|NCT00320489|617119358|FG001|Overall Study|Physician Decision|8|||
170757838|NCT00320489|617119357|FG000|Overall Study|Protocol Violation|4|||
170757839|NCT00320489|617119358|FG001|Overall Study|Protocol Violation|4|||
170757840|NCT00320489|617119357|FG000|Overall Study|Sponsor Decision|3|||
170757841|NCT00320489|617119358|FG001|Overall Study|Sponsor Decision|3|||
170865693|NCT02146326|617519992|FG001|Overall Study|Withdrawal by Subject|1|||
170757842|NCT00320489|617119357|FG000|Overall Study|Withdrawal by Subject|39|||
170757843|NCT00320489|617119358|FG001|Overall Study|Withdrawal by Subject|41|||
170757844|NCT02282527|617119359|FG000|Overall Study|Lost to Follow-up|0|||
170757845|NCT02282527|617119360|FG001|Overall Study|Lost to Follow-up|1|||
170757846|NCT02282527|617119359|FG000|Overall Study|Lack of home health aid|1|||
170757847|NCT02282527|617119360|FG001|Overall Study|Lack of home health aid|0|||
170757848|NCT00941031|617119361|FG000|Induction Period|Lack of Efficacy|2|||
170757849|NCT00941031|617119362|FG001|Induction Period|Lack of Efficacy|1|||
170757850|NCT00941031|617119363|FG002|Induction Period|Lack of Efficacy|0|||
170757851|NCT00941031|617119364|FG003|Induction Period|Lack of Efficacy|5|||
170757852|NCT00941031|617119365|FG004|Induction Period|Lack of Efficacy|0|||
170757853|NCT00941031|617119366|FG005|Induction Period|Lack of Efficacy|0|||
170757854|NCT00941031|617119367|FG006|Induction Period|Lack of Efficacy|0|||
170757855|NCT00941031|617119361|FG000|Induction Period|Withdrawal by Subject|1|||
170757856|NCT00941031|617119362|FG001|Induction Period|Withdrawal by Subject|2|||
170757857|NCT00941031|617119363|FG002|Induction Period|Withdrawal by Subject|2|||
170757858|NCT00941031|617119364|FG003|Induction Period|Withdrawal by Subject|2|||
170757859|NCT00941031|617119365|FG004|Induction Period|Withdrawal by Subject|0|||
170757860|NCT00941031|617119366|FG005|Induction Period|Withdrawal by Subject|0|||
170757861|NCT00941031|617119367|FG006|Induction Period|Withdrawal by Subject|0|||
170757862|NCT00941031|617119361|FG000|Induction Period|Adminstative Problems|1|||
170757863|NCT00941031|617119362|FG001|Induction Period|Adminstative Problems|1|||
170757864|NCT00941031|617119363|FG002|Induction Period|Adminstative Problems|1|||
170757865|NCT00941031|617119364|FG003|Induction Period|Adminstative Problems|0|||
170757866|NCT00941031|617119365|FG004|Induction Period|Adminstative Problems|0|||
170757867|NCT00941031|617119366|FG005|Induction Period|Adminstative Problems|0|||
170757868|NCT00941031|617119367|FG006|Induction Period|Adminstative Problems|0|||
170757869|NCT00941031|617119361|FG000|Induction Period|Adverse Event|1|||
170757870|NCT00941031|617119362|FG001|Induction Period|Adverse Event|0|||
170757871|NCT00941031|617119363|FG002|Induction Period|Adverse Event|3|||
170757872|NCT00941031|617119364|FG003|Induction Period|Adverse Event|2|||
170757873|NCT00941031|617119365|FG004|Induction Period|Adverse Event|0|||
170757874|NCT00941031|617119366|FG005|Induction Period|Adverse Event|0|||
170757875|NCT00941031|617119367|FG006|Induction Period|Adverse Event|0|||
170757876|NCT00941031|617119361|FG000|Maintenance Period|Withdrawal by Subject|0|||
170757877|NCT00941031|617119362|FG001|Maintenance Period|Withdrawal by Subject|0|||
170757878|NCT00941031|617119363|FG002|Maintenance Period|Withdrawal by Subject|0|||
170757879|NCT00941031|617119364|FG003|Maintenance Period|Withdrawal by Subject|0|||
170757880|NCT00941031|617119365|FG004|Maintenance Period|Withdrawal by Subject|6|||
170757881|NCT00941031|617119366|FG005|Maintenance Period|Withdrawal by Subject|2|||
170757882|NCT00941031|617119367|FG006|Maintenance Period|Withdrawal by Subject|13|||
170757883|NCT00941031|617119361|FG000|Maintenance Period|Administrative Problems|0|||
170757884|NCT00941031|617119362|FG001|Maintenance Period|Administrative Problems|0|||
170757885|NCT00941031|617119363|FG002|Maintenance Period|Administrative Problems|0|||
170757886|NCT00941031|617119364|FG003|Maintenance Period|Administrative Problems|0|||
170757887|NCT00941031|617119365|FG004|Maintenance Period|Administrative Problems|1|||
170757888|NCT00941031|617119366|FG005|Maintenance Period|Administrative Problems|0|||
170757889|NCT00941031|617119367|FG006|Maintenance Period|Administrative Problems|1|||
170757890|NCT00941031|617119361|FG000|Maintenance Period|Protocol Violation|0|||
170757891|NCT00941031|617119362|FG001|Maintenance Period|Protocol Violation|0|||
170757892|NCT00941031|617119363|FG002|Maintenance Period|Protocol Violation|0|||
170757893|NCT00941031|617119364|FG003|Maintenance Period|Protocol Violation|0|||
170757894|NCT00941031|617119365|FG004|Maintenance Period|Protocol Violation|0|||
170757895|NCT00941031|617119366|FG005|Maintenance Period|Protocol Violation|0|||
170757896|NCT00941031|617119367|FG006|Maintenance Period|Protocol Violation|1|||
170757897|NCT00941031|617119361|FG000|Maintenance Period|Adverse Event|0|||
170757898|NCT00941031|617119362|FG001|Maintenance Period|Adverse Event|0|||
170757899|NCT00941031|617119363|FG002|Maintenance Period|Adverse Event|0|||
170757900|NCT00941031|617119364|FG003|Maintenance Period|Adverse Event|0|||
170757901|NCT00941031|617119365|FG004|Maintenance Period|Adverse Event|0|||
170757902|NCT00941031|617119366|FG005|Maintenance Period|Adverse Event|2|||
170757903|NCT00941031|617119367|FG006|Maintenance Period|Adverse Event|8|||
170757904|NCT00941031|617119361|FG000|Maintenance Period|Lost to Follow-up|0|||
170757905|NCT00941031|617119362|FG001|Maintenance Period|Lost to Follow-up|0|||
170757906|NCT00941031|617119363|FG002|Maintenance Period|Lost to Follow-up|0|||
170757907|NCT00941031|617119364|FG003|Maintenance Period|Lost to Follow-up|0|||
170757908|NCT00941031|617119365|FG004|Maintenance Period|Lost to Follow-up|2|||
170757909|NCT00941031|617119366|FG005|Maintenance Period|Lost to Follow-up|2|||
170757910|NCT00941031|617119367|FG006|Maintenance Period|Lost to Follow-up|7|||
170757911|NCT00941031|617119361|FG000|Maintenance Period|Lack of Efficacy|0|||
170757912|NCT00941031|617119362|FG001|Maintenance Period|Lack of Efficacy|0|||
170406327|NCT00410410|615828553|FG007|Induction Period (IP)|Lost to Follow-up|0|||
170757913|NCT00941031|617119363|FG002|Maintenance Period|Lack of Efficacy|0|||
170757914|NCT00941031|617119364|FG003|Maintenance Period|Lack of Efficacy|0|||
170757915|NCT00941031|617119365|FG004|Maintenance Period|Lack of Efficacy|0|||
170757916|NCT00941031|617119366|FG005|Maintenance Period|Lack of Efficacy|0|||
170757917|NCT00941031|617119367|FG006|Maintenance Period|Lack of Efficacy|13|||
170757918|NCT01872611|617119368|FG000|Overall Study|Adverse Event|3|||
170757919|NCT01872611|617119369|FG001|Overall Study|Adverse Event|1|||
170757920|NCT01872611|617119368|FG000|Overall Study|Adverse Event, prior to treatment|0|||
170757921|NCT01872611|617119369|FG001|Overall Study|Adverse Event, prior to treatment|1|||
170757922|NCT01872611|617119368|FG000|Overall Study|Death|0|||
170757923|NCT01872611|617119369|FG001|Overall Study|Death|1|||
170757924|NCT01872611|617119368|FG000|Overall Study|Death, prior to treatment|0|||
170757925|NCT01872611|617119369|FG001|Overall Study|Death, prior to treatment|1|||
170757926|NCT01872611|617119368|FG000|Overall Study|Lost to Follow-up|8|||
170757927|NCT01872611|617119369|FG001|Overall Study|Lost to Follow-up|1|||
170757928|NCT01872611|617119368|FG000|Overall Study|Physician Decision|1|||
170757929|NCT01872611|617119369|FG001|Overall Study|Physician Decision|0|||
170757930|NCT01872611|617119368|FG000|Overall Study|Withdrawal by Subject|6|||
170757931|NCT01872611|617119369|FG001|Overall Study|Withdrawal by Subject|1|||
170757932|NCT01872611|617119368|FG000|Overall Study|Reason not provided|6|||
170757933|NCT01872611|617119369|FG001|Overall Study|Reason not provided|6|||
170757934|NCT02696785|617119376|FG000|Blinded Treatment Period|Adverse Event|0|||
170757935|NCT02696785|617119377|FG001|Blinded Treatment Period|Adverse Event|1|||
170757936|NCT02696785|617119378|FG002|Blinded Treatment Period|Adverse Event|3|||
170757937|NCT02696785|617119379|FG003|Blinded Treatment Period|Adverse Event|0|||
170757938|NCT02696785|617119376|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
170757939|NCT02696785|617119377|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
170757940|NCT02696785|617119378|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
170757941|NCT02696785|617119379|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
170757942|NCT02696785|617119376|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
170757943|NCT02696785|617119377|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
170757944|NCT02696785|617119378|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
170757945|NCT02696785|617119379|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
170757946|NCT02696785|617119376|FG000|Blinded Treatment Period|Screen Failure|1|||
170757947|NCT02696785|617119377|FG001|Blinded Treatment Period|Screen Failure|0|||
170757948|NCT02696785|617119378|FG002|Blinded Treatment Period|Screen Failure|0|||
170757949|NCT02696785|617119379|FG003|Blinded Treatment Period|Screen Failure|0|||
170757950|NCT02696785|617119376|FG000|Washout Period|Withdrawal by Subject|0|||
170757951|NCT02696785|617119377|FG001|Washout Period|Withdrawal by Subject|1|||
170757952|NCT02696785|617119378|FG002|Washout Period|Withdrawal by Subject|0|||
170757953|NCT02696785|617119379|FG003|Washout Period|Withdrawal by Subject|0|||
170757954|NCT02696785|617119376|FG000|Washout Period|Lack of Efficacy|0|||
170757955|NCT02696785|617119377|FG001|Washout Period|Lack of Efficacy|1|||
170757956|NCT02696785|617119378|FG002|Washout Period|Lack of Efficacy|0|||
170757957|NCT02696785|617119379|FG003|Washout Period|Lack of Efficacy|0|||
170757958|NCT02696785|617119376|FG000|Extended Treatment Period|Adverse Event|2|||
170757959|NCT02696785|617119377|FG001|Extended Treatment Period|Adverse Event|3|||
170757960|NCT02696785|617119378|FG002|Extended Treatment Period|Adverse Event|2|||
170757961|NCT02696785|617119379|FG003|Extended Treatment Period|Adverse Event|1|||
170757962|NCT02696785|617119376|FG000|Extended Treatment Period|Lack of Efficacy|0|||
170757963|NCT02696785|617119377|FG001|Extended Treatment Period|Lack of Efficacy|1|||
170757964|NCT02696785|617119378|FG002|Extended Treatment Period|Lack of Efficacy|0|||
170757965|NCT02696785|617119379|FG003|Extended Treatment Period|Lack of Efficacy|0|||
170757966|NCT02696785|617119376|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
170757967|NCT02696785|617119377|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
170757968|NCT02696785|617119378|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
170757969|NCT02696785|617119379|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
170757970|NCT02696785|617119376|FG000|Follow-up Period|Adverse Event|0|||
170757971|NCT02696785|617119377|FG001|Follow-up Period|Adverse Event|0|||
170757972|NCT02696785|617119378|FG002|Follow-up Period|Adverse Event|8|||
170757973|NCT02696785|617119379|FG003|Follow-up Period|Adverse Event|2|||
170757974|NCT02696785|617119376|FG000|Follow-up Period|Lost to Follow-up|0|||
170757975|NCT02696785|617119377|FG001|Follow-up Period|Lost to Follow-up|0|||
170757976|NCT02696785|617119378|FG002|Follow-up Period|Lost to Follow-up|0|||
170757977|NCT02696785|617119379|FG003|Follow-up Period|Lost to Follow-up|1|||
170757978|NCT02696785|617119376|FG000|Follow-up Period|Lack of Efficacy|0|||
170757979|NCT02696785|617119377|FG001|Follow-up Period|Lack of Efficacy|0|||
170757980|NCT02696785|617119378|FG002|Follow-up Period|Lack of Efficacy|0|||
170757981|NCT02696785|617119379|FG003|Follow-up Period|Lack of Efficacy|1|||
170757982|NCT02696785|617119376|FG000|Follow-up Period|Withdrawal by Subject|1|||
170757983|NCT02696785|617119377|FG001|Follow-up Period|Withdrawal by Subject|0|||
170757984|NCT02696785|617119378|FG002|Follow-up Period|Withdrawal by Subject|5|||
170757985|NCT02696785|617119379|FG003|Follow-up Period|Withdrawal by Subject|4|||
170757986|NCT02431533|617119380|FG000|Overall Study|Withdrawal by Subject|1|||
170757987|NCT02431533|617119381|FG001|Overall Study|Withdrawal by Subject|3|||
170757988|NCT02431533|617119380|FG000|Overall Study|Developed Exclusionary criteria|1|||
170757989|NCT02431533|617119381|FG001|Overall Study|Developed Exclusionary criteria|0|||
170757990|NCT00770211|617119384|FG000|Overall Study|Lost to Follow-up|1|||
170757991|NCT00770211|617119385|FG001|Overall Study|Lost to Follow-up|0|||
170757992|NCT00770211|617119384|FG000|Overall Study|Withdrawal by Subject|0|||
170757993|NCT00770211|617119385|FG001|Overall Study|Withdrawal by Subject|2|||
170757994|NCT01740557|617119386|FG000|Overall Study|Ineligible|1|||
170757995|NCT01740557|617119386|FG000|Overall Study|Screen failure|1|||
170757996|NCT02482233|617119387|FG000|Overall Study|Lost to Follow-up|1|||
170757997|NCT02482233|617119388|FG001|Overall Study|Lost to Follow-up|1|||
170757998|NCT00764868|617119390|FG000|Overall Study|Adverse Event|18|||
170757999|NCT00764868|617119390|FG000|Overall Study|Withdrawal by Subject|31|||
170758000|NCT00764868|617119390|FG000|Overall Study|Non-compliance|16|||
170758001|NCT00764868|617119390|FG000|Overall Study|Lost to Follow-up|25|||
170758002|NCT00764868|617119390|FG000|Overall Study|Lack of Efficacy|5|||
170758003|NCT00764868|617119390|FG000|Overall Study|Subject moved|7|||
170758004|NCT00764868|617119390|FG000|Overall Study|Pregnancy|3|||
170758005|NCT00764868|617119390|FG000|Overall Study|Prohibited medication|1|||
170758006|NCT00764868|617119390|FG000|Overall Study|Out of town|1|||
170758007|NCT00764868|617119390|FG000|Overall Study|Misuse and compliance of study drug|1|||
170758008|NCT00764868|617119390|FG000|Overall Study|Subject sent to boarding school|1|||
170758009|NCT00764868|617119390|FG000|Overall Study|Met an exclusion criteria|1|||
170758010|NCT00764868|617119390|FG000|Overall Study|Positive drug screen|2|||
170758011|NCT00764868|617119390|FG000|Overall Study|Sponsor requested withdrawal|1|||
170758012|NCT03568162|617119391|FG000|Overall Study|Adverse Event|0|||
170758013|NCT03568162|617119392|FG001|Overall Study|Adverse Event|1|||
170758014|NCT03568162|617119393|FG002|Overall Study|Adverse Event|2|||
170758015|NCT03568162|617119394|FG003|Overall Study|Adverse Event|0|||
170758016|NCT03568162|617119395|FG004|Overall Study|Adverse Event|0|||
170758017|NCT03568162|617119396|FG005|Overall Study|Adverse Event|1|||
170758018|NCT03568162|617119391|FG000|Overall Study|Death|0|||
170758019|NCT03568162|617119392|FG001|Overall Study|Death|0|||
170758020|NCT03568162|617119393|FG002|Overall Study|Death|0|||
170758021|NCT03568162|617119394|FG003|Overall Study|Death|0|||
170758022|NCT03568162|617119395|FG004|Overall Study|Death|1|||
170758023|NCT03568162|617119396|FG005|Overall Study|Death|0|||
170758024|NCT03568162|617119391|FG000|Overall Study|Lost to Follow-up|3|||
170758025|NCT03568162|617119392|FG001|Overall Study|Lost to Follow-up|2|||
170758026|NCT03568162|617119393|FG002|Overall Study|Lost to Follow-up|4|||
170758027|NCT03568162|617119394|FG003|Overall Study|Lost to Follow-up|2|||
170758028|NCT03568162|617119395|FG004|Overall Study|Lost to Follow-up|3|||
170758029|NCT03568162|617119396|FG005|Overall Study|Lost to Follow-up|2|||
170758030|NCT03568162|617119391|FG000|Overall Study|Physician Decision|0|||
170758031|NCT03568162|617119392|FG001|Overall Study|Physician Decision|1|||
170758032|NCT03568162|617119393|FG002|Overall Study|Physician Decision|1|||
170758033|NCT03568162|617119394|FG003|Overall Study|Physician Decision|0|||
170758034|NCT03568162|617119395|FG004|Overall Study|Physician Decision|1|||
170758035|NCT03568162|617119396|FG005|Overall Study|Physician Decision|0|||
170758036|NCT03568162|617119391|FG000|Overall Study|Pregnancy|0|||
170758037|NCT03568162|617119392|FG001|Overall Study|Pregnancy|0|||
170758038|NCT03568162|617119393|FG002|Overall Study|Pregnancy|0|||
170758039|NCT03568162|617119394|FG003|Overall Study|Pregnancy|1|||
170758040|NCT03568162|617119395|FG004|Overall Study|Pregnancy|0|||
170758041|NCT03568162|617119396|FG005|Overall Study|Pregnancy|0|||
170758042|NCT03568162|617119391|FG000|Overall Study|Protocol Violation|1|||
170758043|NCT03568162|617119392|FG001|Overall Study|Protocol Violation|0|||
170758044|NCT03568162|617119393|FG002|Overall Study|Protocol Violation|1|||
170758045|NCT03568162|617119394|FG003|Overall Study|Protocol Violation|1|||
170758046|NCT03568162|617119395|FG004|Overall Study|Protocol Violation|1|||
170758047|NCT03568162|617119396|FG005|Overall Study|Protocol Violation|1|||
170758048|NCT03568162|617119391|FG000|Overall Study|Withdrawal by Subject|15|||
170758049|NCT03568162|617119392|FG001|Overall Study|Withdrawal by Subject|15|||
170758050|NCT03568162|617119393|FG002|Overall Study|Withdrawal by Subject|26|||
170758051|NCT03568162|617119394|FG003|Overall Study|Withdrawal by Subject|22|||
170758052|NCT03568162|617119395|FG004|Overall Study|Withdrawal by Subject|6|||
170758053|NCT03568162|617119396|FG005|Overall Study|Withdrawal by Subject|9|||
170758054|NCT03568162|617119391|FG000|Overall Study|Others|3|||
170758055|NCT03568162|617119392|FG001|Overall Study|Others|4|||
170758056|NCT03568162|617119393|FG002|Overall Study|Others|1|||
170758057|NCT03568162|617119394|FG003|Overall Study|Others|4|||
170758058|NCT03568162|617119395|FG004|Overall Study|Others|2|||
170758059|NCT03568162|617119396|FG005|Overall Study|Others|1|||
170758060|NCT00768066|617119397|FG000|Overall Study|Did not receive study product injection.|3|||
170758061|NCT00768066|617119398|FG001|Overall Study|Did not receive study product injection.|3|||
170865694|NCT02146326|617519993|FG002|Overall Study|Withdrawal by Subject|15|||
170865695|NCT02146326|617519994|FG003|Overall Study|Withdrawal by Subject|11|||
170758062|NCT00768066|617119399|FG002|Overall Study|Did not receive study product injection.|0|||
170758063|NCT00337818|617119400|FG000|Overall Study|Lost to Follow-up|289|||
170758064|NCT00337818|617119401|FG001|Overall Study|Lost to Follow-up|91|||
170758065|NCT00337818|617119402|FG002|Overall Study|Lost to Follow-up|107|||
170865696|NCT02146326|617519991|FG000|Overall Study|Separated from mental health center|23|||
170865697|NCT02146326|617519992|FG001|Overall Study|Separated from mental health center|33|||
170758066|NCT02027935|617119404|FG000|Overall Study|Death|1|||
170758067|NCT02027935|617119404|FG000|Overall Study|Lack of Efficacy|5|||
170758068|NCT02027935|617119404|FG000|Overall Study|Study Closure|1|||
170758069|NCT03115346|617119405|FG000|Overall Study|Did not have AAA surgery|28|||
170758070|NCT03115346|617119406|FG001|Overall Study|Did not have AAA surgery|15|||
170758071|NCT03115346|617119405|FG000|Overall Study|Death|3|||
170758072|NCT03115346|617119406|FG001|Overall Study|Death|1|||
170758073|NCT03115346|617119405|FG000|Overall Study|Withdrawal by Subject|0|||
170758074|NCT03115346|617119406|FG001|Overall Study|Withdrawal by Subject|3|||
170758075|NCT03115346|617119405|FG000|Overall Study|Lost to Follow-up|0|||
170406328|NCT00410410|615828554|FG008|Induction Period (IP)|Lost to Follow-up|0|||
170758076|NCT03115346|617119406|FG001|Overall Study|Lost to Follow-up|3|||
170758077|NCT00689104|617119407|FG000|Overall Study|Eligibility criterion not met|5|||
170758078|NCT00689104|617119408|FG001|Overall Study|Eligibility criterion not met|8|||
170758079|NCT00689104|617119409|FG002|Overall Study|Eligibility criterion not met|0|||
170758080|NCT00689104|617119410|FG003|Overall Study|Eligibility criterion not met|4|||
170758081|NCT00689104|617119407|FG000|Overall Study|Adverse Event|13|||
170758082|NCT00689104|617119408|FG001|Overall Study|Adverse Event|25|||
170758083|NCT00689104|617119409|FG002|Overall Study|Adverse Event|16|||
170758084|NCT00689104|617119410|FG003|Overall Study|Adverse Event|24|||
170758085|NCT00689104|617119407|FG000|Overall Study|Lack of Efficacy|5|||
170758086|NCT00689104|617119408|FG001|Overall Study|Lack of Efficacy|6|||
170758087|NCT00689104|617119409|FG002|Overall Study|Lack of Efficacy|2|||
170758088|NCT00689104|617119410|FG003|Overall Study|Lack of Efficacy|3|||
170758089|NCT00689104|617119407|FG000|Overall Study|Withdrawal by Subject|12|||
170758090|NCT00689104|617119408|FG001|Overall Study|Withdrawal by Subject|11|||
170758091|NCT00689104|617119409|FG002|Overall Study|Withdrawal by Subject|18|||
170758092|NCT00689104|617119410|FG003|Overall Study|Withdrawal by Subject|11|||
170758093|NCT00689104|617119407|FG000|Overall Study|Lost to Follow-up|4|||
170758094|NCT00689104|617119408|FG001|Overall Study|Lost to Follow-up|3|||
170758095|NCT00689104|617119409|FG002|Overall Study|Lost to Follow-up|2|||
170758096|NCT00689104|617119410|FG003|Overall Study|Lost to Follow-up|5|||
170758097|NCT00689104|617119407|FG000|Overall Study|Protocol Violation|2|||
170758098|NCT00689104|617119408|FG001|Overall Study|Protocol Violation|3|||
170758099|NCT00689104|617119409|FG002|Overall Study|Protocol Violation|5|||
170758100|NCT00689104|617119410|FG003|Overall Study|Protocol Violation|3|||
170758101|NCT00689104|617119407|FG000|Overall Study|Randomized but never received study drug|2|||
170758102|NCT00689104|617119408|FG001|Overall Study|Randomized but never received study drug|1|||
170758103|NCT00689104|617119409|FG002|Overall Study|Randomized but never received study drug|1|||
170758104|NCT00689104|617119410|FG003|Overall Study|Randomized but never received study drug|0|||
170758105|NCT00689104|617119407|FG000|Overall Study|Physician Decision|1|||
170758106|NCT00689104|617119408|FG001|Overall Study|Physician Decision|0|||
170758107|NCT00689104|617119409|FG002|Overall Study|Physician Decision|0|||
170758108|NCT00689104|617119410|FG003|Overall Study|Physician Decision|0|||
170758109|NCT00689104|617119407|FG000|Overall Study|Non-compliance with study procedures|0|||
170758110|NCT00689104|617119408|FG001|Overall Study|Non-compliance with study procedures|0|||
170758111|NCT00689104|617119409|FG002|Overall Study|Non-compliance with study procedures|1|||
170758112|NCT00689104|617119410|FG003|Overall Study|Non-compliance with study procedures|0|||
170758113|NCT01737268|617119411|FG000|Overall Study|Adverse Event|6|||
170758114|NCT01737268|617119411|FG000|Overall Study|Worsening of Target Disease|2|||
170758115|NCT01737268|617119411|FG000|Overall Study|In consideration of the patient's safety|1|||
170758116|NCT00924560|617119415|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
170758117|NCT00924560|617119416|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
170758118|NCT00924560|617119417|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
170758119|NCT00924560|617119415|FG000|Overall Study|Non Compliance with the Protocol|20|||
170758120|NCT00924560|617119416|FG001|Overall Study|Non Compliance with the Protocol|15|||
170758121|NCT00924560|617119417|FG002|Overall Study|Non Compliance with the Protocol|4|||
170758122|NCT00924560|617119415|FG000|Overall Study|Physician Decision|2|||
170758123|NCT00924560|617119416|FG001|Overall Study|Physician Decision|3|||
170758124|NCT00924560|617119417|FG002|Overall Study|Physician Decision|4|||
170758125|NCT00924560|617119415|FG000|Overall Study|Withdrawal by Subject|50|||
170758126|NCT00924560|617119416|FG001|Overall Study|Withdrawal by Subject|44|||
170758127|NCT00924560|617119417|FG002|Overall Study|Withdrawal by Subject|18|||
170758128|NCT00924560|617119415|FG000|Overall Study|Adverse Event|39|||
170758129|NCT00924560|617119416|FG001|Overall Study|Adverse Event|33|||
170758130|NCT00924560|617119417|FG002|Overall Study|Adverse Event|0|||
170758131|NCT00924560|617119415|FG000|Overall Study|Pregnancy|5|||
170758132|NCT00924560|617119416|FG001|Overall Study|Pregnancy|7|||
170758133|NCT00924560|617119417|FG002|Overall Study|Pregnancy|1|||
170758134|NCT00924560|617119415|FG000|Overall Study|Lost to Follow-up|78|||
170758135|NCT00924560|617119416|FG001|Overall Study|Lost to Follow-up|94|||
170758136|NCT00924560|617119417|FG002|Overall Study|Lost to Follow-up|45|||
170758137|NCT00924560|617119415|FG000|Overall Study|Miscellaneous Reasons|13|||
170758138|NCT00924560|617119416|FG001|Overall Study|Miscellaneous Reasons|10|||
170758139|NCT00924560|617119417|FG002|Overall Study|Miscellaneous Reasons|10|||
170758140|NCT01190176|617119418|FG000|Overall Study|Withdrawal by Subject|1|||
170758141|NCT01190176|617119418|FG000|Overall Study|Lost to Follow-up|1|||
170758142|NCT02696226|617119419|FG000|Overall Study|Study terminated - lack of enrollment|1|||
170758143|NCT02696226|617119420|FG001|Overall Study|Study terminated - lack of enrollment|0|||
170758144|NCT02696226|617119421|FG002|Overall Study|Study terminated - lack of enrollment|2|||
170758145|NCT02696226|617119422|FG003|Overall Study|Study terminated - lack of enrollment|0|||
170758146|NCT02909101|617119423|FG000|Overall Study|Lost to Follow-up|1|||
170758147|NCT02909101|617119424|FG001|Overall Study|Lost to Follow-up|1|||
170758148|NCT01221181|617119425|FG000|Overall Study|Lost to Follow-up|1|||
170758149|NCT02698436|617119426|FG000|Overall Study|Adverse Event|1|||
170758150|NCT02698436|617119427|FG001|Overall Study|Adverse Event|0|||
170758151|NCT02698436|617119426|FG000|Overall Study|Withdrawal by Subject|3|||
170758152|NCT02698436|617119427|FG001|Overall Study|Withdrawal by Subject|3|||
170758153|NCT02698436|617119426|FG000|Overall Study|Lost to Follow-up|2|||
170758154|NCT02698436|617119427|FG001|Overall Study|Lost to Follow-up|4|||
170758155|NCT02698436|617119426|FG000|Overall Study|Non-compliance with study regimen|1|||
170758156|NCT02698436|617119427|FG001|Overall Study|Non-compliance with study regimen|0|||
170758157|NCT00665561|617119428|FG000|Overall Study|Death recorded on subject summary pages|75|||
170758158|NCT00665561|617119429|FG001|Overall Study|Death recorded on subject summary pages|75|||
170758159|NCT00665561|617119428|FG000|Overall Study|Does not meet entrance criteria|19|||
170758160|NCT00665561|617119429|FG001|Overall Study|Does not meet entrance criteria|21|||
170758161|NCT00665561|617119428|FG000|Overall Study|Lost to Follow-up|203|||
170758162|NCT00665561|617119429|FG001|Overall Study|Lost to Follow-up|264|||
170758163|NCT00665561|617119428|FG000|Overall Study|Withdrawal by Subject|74|||
170758164|NCT00665561|617119429|FG001|Overall Study|Withdrawal by Subject|65|||
170758165|NCT00665561|617119428|FG000|Overall Study|Other|123|||
170758166|NCT00665561|617119429|FG001|Overall Study|Other|108|||
170758167|NCT00665561|617119428|FG000|Overall Study|Site closed|8|||
170758168|NCT00665561|617119429|FG001|Overall Study|Site closed|0|||
170758169|NCT00665561|617119428|FG000|Overall Study|Withdrawn due to pregnancy|0|||
170758170|NCT00665561|617119429|FG001|Overall Study|Withdrawn due to pregnancy|1|||
170758171|NCT02337361|617119430|FG000|3-month Follow-up|Lost to Follow-up|19|||
170758172|NCT02337361|617119431|FG001|3-month Follow-up|Lost to Follow-up|14|||
170758173|NCT02337361|617119430|FG000|6-month Follow-up|Lost to Follow-up|2|||
170758174|NCT02337361|617119431|FG001|6-month Follow-up|Lost to Follow-up|4|||
170758175|NCT03073005|617119432|FG000|Overall Study|Death|6|||
170758176|NCT03073005|617119433|FG001|Overall Study|Death|0|||
170758177|NCT03073005|617119434|FG002|Overall Study|Death|7|||
170758178|NCT03073005|617119435|FG003|Overall Study|Death|0|||
170758179|NCT03073005|617119432|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
170758180|NCT03073005|617119433|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
170758181|NCT03073005|617119434|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
170758182|NCT03073005|617119435|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
170758183|NCT03073005|617119432|FG000|Overall Study|Lost to Follow-up|2|||
170758184|NCT03073005|617119433|FG001|Overall Study|Lost to Follow-up|2|||
170758185|NCT03073005|617119434|FG002|Overall Study|Lost to Follow-up|1|||
170758186|NCT03073005|617119435|FG003|Overall Study|Lost to Follow-up|2|||
170758187|NCT03073005|617119432|FG000|Overall Study|Withdrawal by Subject|0|||
170758188|NCT03073005|617119433|FG001|Overall Study|Withdrawal by Subject|4|||
170758189|NCT03073005|617119434|FG002|Overall Study|Withdrawal by Subject|4|||
170758190|NCT03073005|617119435|FG003|Overall Study|Withdrawal by Subject|4|||
170758191|NCT00062868|617119443|FG000|Dose Level 1|Death|2|||
170758192|NCT00062868|617119444|FG001|Dose Level 1|Death|0|||
170758193|NCT00062868|617119445|FG002|Dose Level 1|Death|0|||
170758194|NCT00062868|617119446|FG003|Dose Level 1|Death|2|||
170758195|NCT00062868|617119447|FG004|Dose Level 1|Death|0|||
170758196|NCT00062868|617119448|FG005|Dose Level 1|Death|0|||
170758197|NCT00062868|617119449|FG006|Dose Level 1|Death|3|||
170758198|NCT00062868|617119450|FG007|Dose Level 1|Death|0|||
170758199|NCT00062868|617119451|FG008|Dose Level 1|Death|0|||
170758200|NCT00062868|617119452|FG009|Dose Level 1|Death|0|||
170758201|NCT00062868|617119453|FG010|Dose Level 1|Death|0|||
170758202|NCT00062868|617119454|FG011|Dose Level 1|Death|0|||
170758203|NCT00062868|617119455|FG012|Dose Level 1|Death|0|||
170758204|NCT00062868|617119456|FG013|Dose Level 1|Death|0|||
170758205|NCT00062868|617119457|FG014|Dose Level 1|Death|0|||
170758206|NCT00062868|617119458|FG015|Dose Level 1|Death|0|||
170758207|NCT00062868|617119459|FG016|Dose Level 1|Death|0|||
170758208|NCT00062868|617119460|FG017|Dose Level 1|Death|0|||
170758209|NCT00062868|617119461|FG018|Dose Level 1|Death|7|||
170865698|NCT02146326|617519993|FG002|Overall Study|Separated from mental health center|0|||
170865699|NCT02146326|617519994|FG003|Overall Study|Separated from mental health center|0|||
170406329|NCT00410410|615828546|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
170758210|NCT00062868|617119462|FG019|Dose Level 1|Death|0|||
170758211|NCT00062868|617119463|FG020|Dose Level 1|Death|1|||
170758212|NCT00062868|617119443|FG000|Dose Level 1|Lost to Follow-up|0|||
170758213|NCT00062868|617119444|FG001|Dose Level 1|Lost to Follow-up|0|||
170758214|NCT00062868|617119445|FG002|Dose Level 1|Lost to Follow-up|0|||
170758215|NCT00062868|617119446|FG003|Dose Level 1|Lost to Follow-up|0|||
170758216|NCT00062868|617119447|FG004|Dose Level 1|Lost to Follow-up|0|||
170758217|NCT00062868|617119448|FG005|Dose Level 1|Lost to Follow-up|0|||
170758218|NCT00062868|617119449|FG006|Dose Level 1|Lost to Follow-up|0|||
170758219|NCT00062868|617119450|FG007|Dose Level 1|Lost to Follow-up|0|||
170758220|NCT00062868|617119451|FG008|Dose Level 1|Lost to Follow-up|0|||
170758221|NCT00062868|617119452|FG009|Dose Level 1|Lost to Follow-up|0|||
170758222|NCT00062868|617119453|FG010|Dose Level 1|Lost to Follow-up|0|||
170758223|NCT00062868|617119454|FG011|Dose Level 1|Lost to Follow-up|0|||
170758224|NCT00062868|617119455|FG012|Dose Level 1|Lost to Follow-up|1|||
170758225|NCT00062868|617119456|FG013|Dose Level 1|Lost to Follow-up|0|||
170758226|NCT00062868|617119457|FG014|Dose Level 1|Lost to Follow-up|0|||
170758227|NCT00062868|617119458|FG015|Dose Level 1|Lost to Follow-up|0|||
170758228|NCT00062868|617119459|FG016|Dose Level 1|Lost to Follow-up|0|||
170758229|NCT00062868|617119460|FG017|Dose Level 1|Lost to Follow-up|0|||
170758230|NCT00062868|617119461|FG018|Dose Level 1|Lost to Follow-up|2|||
170758231|NCT00062868|617119462|FG019|Dose Level 1|Lost to Follow-up|0|||
170758232|NCT00062868|617119463|FG020|Dose Level 1|Lost to Follow-up|1|||
170758233|NCT00062868|617119443|FG000|Dose Level 2|Death|0|||
170758234|NCT00062868|617119444|FG001|Dose Level 2|Death|3|||
170758235|NCT00062868|617119445|FG002|Dose Level 2|Death|0|||
170865700|NCT02146326|617519991|FG000|Overall Study|Incarcerated|0|||
170865701|NCT02146326|617519992|FG001|Overall Study|Incarcerated|0|||
170865702|NCT02146326|617519993|FG002|Overall Study|Incarcerated|3|||
170865703|NCT02146326|617519994|FG003|Overall Study|Incarcerated|8|||
170865704|NCT02146326|617519991|FG000|Overall Study|Death|0|||
170865705|NCT02146326|617519992|FG001|Overall Study|Death|0|||
170865706|NCT02146326|617519993|FG002|Overall Study|Death|4|||
170865707|NCT02146326|617519994|FG003|Overall Study|Death|4|||
170865708|NCT02146326|617519991|FG000|Overall Study|Unable to complete interview|0|||
170865709|NCT02146326|617519992|FG001|Overall Study|Unable to complete interview|0|||
170865710|NCT02146326|617519993|FG002|Overall Study|Unable to complete interview|10|||
170865711|NCT02146326|617519994|FG003|Overall Study|Unable to complete interview|6|||
170865712|NCT03153111|617519995|FG000|Overall Study|Death|2|||
170865713|NCT03153111|617519996|FG001|Overall Study|Death|5|||
170865714|NCT03153111|617519995|FG000|Overall Study|Lost to Follow-up|1|||
170865715|NCT03153111|617519996|FG001|Overall Study|Lost to Follow-up|0|||
170865716|NCT03153111|617519995|FG000|Overall Study|Physician Decision|5|||
170865717|NCT03153111|617519996|FG001|Overall Study|Physician Decision|1|||
170865718|NCT03153111|617519995|FG000|Overall Study|Withdrawal by Subject|3|||
170865719|NCT03153111|617519996|FG001|Overall Study|Withdrawal by Subject|3|||
170865720|NCT03891524|617519997|FG000|Overall Study|Death|0|||
170865721|NCT03891524|617519998|FG001|Overall Study|Death|0|||
170865722|NCT03891524|617519999|FG002|Overall Study|Death|0|||
170865723|NCT03891524|617520000|FG003|Overall Study|Death|0|||
170865724|NCT03891524|617520001|FG004|Overall Study|Death|0|||
170865725|NCT03891524|617520002|FG005|Overall Study|Death|0|||
170865726|NCT03891524|617520003|FG006|Overall Study|Death|0|||
170865727|NCT03891524|617520004|FG007|Overall Study|Death|1|||
170865728|NCT03891524|617519997|FG000|Overall Study|Withdrawal by Subject|0|||
170865729|NCT03891524|617519998|FG001|Overall Study|Withdrawal by Subject|1|||
170865730|NCT03891524|617519999|FG002|Overall Study|Withdrawal by Subject|2|||
170865731|NCT03891524|617520000|FG003|Overall Study|Withdrawal by Subject|1|||
170865732|NCT03891524|617520001|FG004|Overall Study|Withdrawal by Subject|2|||
170865733|NCT03891524|617520002|FG005|Overall Study|Withdrawal by Subject|2|||
170865734|NCT03891524|617520003|FG006|Overall Study|Withdrawal by Subject|2|||
170865735|NCT03891524|617520004|FG007|Overall Study|Withdrawal by Subject|1|||
170865736|NCT02244996|617520007|FG000|Overall Study|Lack of Efficacy|2|||
170865737|NCT02244996|617520008|FG001|Overall Study|Lack of Efficacy|6|||
170865738|NCT02038920|617520012|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
170865739|NCT02038920|617520013|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
170865740|NCT02038920|617520014|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
170865741|NCT02038920|617520015|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
170865742|NCT02038920|617520016|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
170865743|NCT02038920|617520017|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
170865744|NCT02038920|617520012|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
170865745|NCT02038920|617520013|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
170865746|NCT02038920|617520014|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
170865747|NCT02038920|617520015|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
170865748|NCT02038920|617520016|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
170865749|NCT02038920|617520017|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
170865750|NCT02038920|617520012|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
170865751|NCT02038920|617520013|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
170865752|NCT02038920|617520014|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
170865753|NCT02038920|617520015|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
170865754|NCT02038920|617520016|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
170865755|NCT02038920|617520017|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
170865756|NCT02038920|617520012|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
170865757|NCT02038920|617520013|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
170865758|NCT02038920|617520014|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
170519696|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
170758236|NCT00062868|617119446|FG003|Dose Level 2|Death|0|||
170865759|NCT02038920|617520015|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
170865760|NCT02038920|617520016|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
170865761|NCT02038920|617520017|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
170865762|NCT02038920|617520012|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
170865763|NCT02038920|617520013|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
170758237|NCT00062868|617119447|FG004|Dose Level 2|Death|2|||
170758238|NCT00062868|617119448|FG005|Dose Level 2|Death|0|||
170758239|NCT00062868|617119449|FG006|Dose Level 2|Death|0|||
170758240|NCT00062868|617119450|FG007|Dose Level 2|Death|0|||
170758241|NCT00062868|617119451|FG008|Dose Level 2|Death|0|||
170758242|NCT00062868|617119452|FG009|Dose Level 2|Death|0|||
170758243|NCT00062868|617119453|FG010|Dose Level 2|Death|1|||
170758244|NCT00062868|617119454|FG011|Dose Level 2|Death|0|||
170758245|NCT00062868|617119455|FG012|Dose Level 2|Death|0|||
170758246|NCT00062868|617119456|FG013|Dose Level 2|Death|0|||
170758247|NCT00062868|617119457|FG014|Dose Level 2|Death|0|||
170758248|NCT00062868|617119458|FG015|Dose Level 2|Death|0|||
170758249|NCT00062868|617119459|FG016|Dose Level 2|Death|2|||
170758250|NCT00062868|617119460|FG017|Dose Level 2|Death|0|||
170758251|NCT00062868|617119461|FG018|Dose Level 2|Death|0|||
170758252|NCT00062868|617119462|FG019|Dose Level 2|Death|0|||
170758253|NCT00062868|617119463|FG020|Dose Level 2|Death|0|||
170758254|NCT00062868|617119443|FG000|Dose Level 2|Lost to Follow-up|0|||
170758255|NCT00062868|617119444|FG001|Dose Level 2|Lost to Follow-up|0|||
170758256|NCT00062868|617119445|FG002|Dose Level 2|Lost to Follow-up|0|||
170758257|NCT00062868|617119446|FG003|Dose Level 2|Lost to Follow-up|0|||
170758258|NCT00062868|617119447|FG004|Dose Level 2|Lost to Follow-up|0|||
170758259|NCT00062868|617119448|FG005|Dose Level 2|Lost to Follow-up|0|||
170758260|NCT00062868|617119449|FG006|Dose Level 2|Lost to Follow-up|0|||
170758261|NCT00062868|617119450|FG007|Dose Level 2|Lost to Follow-up|0|||
170758262|NCT00062868|617119451|FG008|Dose Level 2|Lost to Follow-up|0|||
170758263|NCT00062868|617119452|FG009|Dose Level 2|Lost to Follow-up|0|||
170758264|NCT00062868|617119453|FG010|Dose Level 2|Lost to Follow-up|0|||
170758265|NCT00062868|617119454|FG011|Dose Level 2|Lost to Follow-up|0|||
170758266|NCT00062868|617119455|FG012|Dose Level 2|Lost to Follow-up|0|||
170758267|NCT00062868|617119456|FG013|Dose Level 2|Lost to Follow-up|1|||
170758268|NCT00062868|617119457|FG014|Dose Level 2|Lost to Follow-up|0|||
170758269|NCT00062868|617119458|FG015|Dose Level 2|Lost to Follow-up|0|||
170758270|NCT00062868|617119459|FG016|Dose Level 2|Lost to Follow-up|1|||
170758271|NCT00062868|617119460|FG017|Dose Level 2|Lost to Follow-up|0|||
170758272|NCT00062868|617119461|FG018|Dose Level 2|Lost to Follow-up|0|||
170758273|NCT00062868|617119462|FG019|Dose Level 2|Lost to Follow-up|0|||
170758274|NCT00062868|617119463|FG020|Dose Level 2|Lost to Follow-up|0|||
170758275|NCT00062868|617119443|FG000|Dose Level 3|Death|0|||
170758276|NCT00062868|617119444|FG001|Dose Level 3|Death|0|||
170758277|NCT00062868|617119445|FG002|Dose Level 3|Death|0|||
170758278|NCT00062868|617119446|FG003|Dose Level 3|Death|0|||
170758279|NCT00062868|617119447|FG004|Dose Level 3|Death|0|||
170758280|NCT00062868|617119448|FG005|Dose Level 3|Death|0|||
170758281|NCT00062868|617119449|FG006|Dose Level 3|Death|0|||
170758282|NCT00062868|617119450|FG007|Dose Level 3|Death|0|||
170758283|NCT00062868|617119451|FG008|Dose Level 3|Death|0|||
170758284|NCT00062868|617119452|FG009|Dose Level 3|Death|0|||
170758285|NCT00062868|617119453|FG010|Dose Level 3|Death|0|||
170758286|NCT00062868|617119454|FG011|Dose Level 3|Death|1|||
170758287|NCT00062868|617119455|FG012|Dose Level 3|Death|0|||
170758288|NCT00062868|617119456|FG013|Dose Level 3|Death|0|||
170758289|NCT00062868|617119457|FG014|Dose Level 3|Death|0|||
170758290|NCT00062868|617119458|FG015|Dose Level 3|Death|0|||
170758291|NCT00062868|617119459|FG016|Dose Level 3|Death|0|||
170758292|NCT00062868|617119460|FG017|Dose Level 3|Death|1|||
170758293|NCT00062868|617119461|FG018|Dose Level 3|Death|0|||
170758294|NCT00062868|617119462|FG019|Dose Level 3|Death|0|||
170758295|NCT00062868|617119463|FG020|Dose Level 3|Death|0|||
170758296|NCT00062868|617119443|FG000|Dose Level 3|Lost to Follow-up|0|||
170758297|NCT00062868|617119444|FG001|Dose Level 3|Lost to Follow-up|0|||
170865764|NCT02038920|617520014|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
170758298|NCT00062868|617119445|FG002|Dose Level 3|Lost to Follow-up|0|||
170758299|NCT00062868|617119446|FG003|Dose Level 3|Lost to Follow-up|0|||
170758300|NCT00062868|617119447|FG004|Dose Level 3|Lost to Follow-up|0|||
170758301|NCT00062868|617119448|FG005|Dose Level 3|Lost to Follow-up|0|||
170758302|NCT00062868|617119449|FG006|Dose Level 3|Lost to Follow-up|0|||
170758303|NCT00062868|617119450|FG007|Dose Level 3|Lost to Follow-up|0|||
170758304|NCT00062868|617119451|FG008|Dose Level 3|Lost to Follow-up|0|||
170758305|NCT00062868|617119452|FG009|Dose Level 3|Lost to Follow-up|0|||
170758306|NCT00062868|617119453|FG010|Dose Level 3|Lost to Follow-up|0|||
170758307|NCT00062868|617119454|FG011|Dose Level 3|Lost to Follow-up|0|||
170865765|NCT02038920|617520015|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
170758308|NCT00062868|617119455|FG012|Dose Level 3|Lost to Follow-up|0|||
170758309|NCT00062868|617119456|FG013|Dose Level 3|Lost to Follow-up|0|||
170758310|NCT00062868|617119457|FG014|Dose Level 3|Lost to Follow-up|1|||
170758311|NCT00062868|617119458|FG015|Dose Level 3|Lost to Follow-up|0|||
170758312|NCT00062868|617119459|FG016|Dose Level 3|Lost to Follow-up|0|||
170758313|NCT00062868|617119460|FG017|Dose Level 3|Lost to Follow-up|0|||
170758314|NCT00062868|617119461|FG018|Dose Level 3|Lost to Follow-up|0|||
170758315|NCT00062868|617119462|FG019|Dose Level 3|Lost to Follow-up|0|||
170758316|NCT00062868|617119463|FG020|Dose Level 3|Lost to Follow-up|0|||
170758317|NCT00062868|617119443|FG000|Dose Level 3|Withdrew|0|||
170758318|NCT00062868|617119444|FG001|Dose Level 3|Withdrew|0|||
170758319|NCT00062868|617119445|FG002|Dose Level 3|Withdrew|2|||
170758320|NCT00062868|617119446|FG003|Dose Level 3|Withdrew|0|||
170758321|NCT00062868|617119447|FG004|Dose Level 3|Withdrew|0|||
170758322|NCT00062868|617119448|FG005|Dose Level 3|Withdrew|0|||
170758323|NCT00062868|617119449|FG006|Dose Level 3|Withdrew|0|||
170758324|NCT00062868|617119450|FG007|Dose Level 3|Withdrew|0|||
170758325|NCT00062868|617119451|FG008|Dose Level 3|Withdrew|0|||
170758326|NCT00062868|617119452|FG009|Dose Level 3|Withdrew|0|||
170758327|NCT00062868|617119453|FG010|Dose Level 3|Withdrew|0|||
170758328|NCT00062868|617119454|FG011|Dose Level 3|Withdrew|0|||
170758329|NCT00062868|617119455|FG012|Dose Level 3|Withdrew|0|||
170758330|NCT00062868|617119456|FG013|Dose Level 3|Withdrew|0|||
170758331|NCT00062868|617119457|FG014|Dose Level 3|Withdrew|0|||
170758332|NCT00062868|617119458|FG015|Dose Level 3|Withdrew|0|||
170758333|NCT00062868|617119459|FG016|Dose Level 3|Withdrew|0|||
170758334|NCT00062868|617119460|FG017|Dose Level 3|Withdrew|0|||
170758335|NCT00062868|617119461|FG018|Dose Level 3|Withdrew|0|||
170758336|NCT00062868|617119462|FG019|Dose Level 3|Withdrew|0|||
170758337|NCT00062868|617119463|FG020|Dose Level 3|Withdrew|0|||
170758338|NCT02427646|617119464|FG000|Overall Study|Lack of Efficacy|2|||
170758339|NCT02427646|617119465|FG001|Overall Study|Lack of Efficacy|3|||
170758340|NCT02427646|617119464|FG000|Overall Study|Physician Decision|1|||
170758341|NCT02427646|617119465|FG001|Overall Study|Physician Decision|4|||
170758342|NCT02427646|617119464|FG000|Overall Study|Protocol Violation|3|||
170758343|NCT02427646|617119465|FG001|Overall Study|Protocol Violation|3|||
170758344|NCT02427646|617119464|FG000|Overall Study|Bothersome hand weakness|2|||
170758345|NCT02427646|617119465|FG001|Overall Study|Bothersome hand weakness|4|||
170758346|NCT03824236|617119466|FG000|Overall Study|Lost to Follow-up|0|||
170758347|NCT03824236|617119467|FG001|Overall Study|Lost to Follow-up|0|||
170758348|NCT03824236|617119468|FG002|Overall Study|Lost to Follow-up|1|||
170758349|NCT04949399|617119469|FG000|Overall Study|Lost to Follow-up|11|||
170758350|NCT04949399|617119470|FG001|Overall Study|Lost to Follow-up|6|||
170758351|NCT04949399|617119469|FG000|Overall Study|Withdrawal by Subject|2|||
170758352|NCT04949399|617119470|FG001|Overall Study|Withdrawal by Subject|3|||
170758353|NCT01712685|617119471|FG000|Overall Study|pt declined to participate before trmt|1|||
170758354|NCT01354106|617119472|FG000|Overall Study|Withdrawal by Subject|2|||
170758355|NCT00901485|617119473|FG000|Overall Study|Lack of Efficacy|0|||
170758356|NCT00901485|617119474|FG001|Overall Study|Lack of Efficacy|2|||
170758357|NCT00901485|617119473|FG000|Overall Study|Withdrawal by Subject|1|||
170758358|NCT00901485|617119474|FG001|Overall Study|Withdrawal by Subject|2|||
170758359|NCT01419717|617121291|FG000|Overall Study|Protocol-specified Criteria|62|||
170758360|NCT01419717|617121291|FG000|Overall Study|Adverse Event|19|||
170758361|NCT01419717|617121291|FG000|Overall Study|Death|17|||
170758362|NCT01419717|617121291|FG000|Overall Study|Withdrawal by Subject|10|||
170758363|NCT01419717|617121291|FG000|Overall Study|Disease Progression|9|||
170758364|NCT01419717|617121291|FG000|Overall Study|Other|4|||
170758365|NCT01419717|617121291|FG000|Overall Study|Lost to Follow-up|2|||
170758366|NCT01419717|617121291|FG000|Overall Study|Administrative Decision|1|||
170758367|NCT01419717|617121291|FG000|Overall Study|Noncompliance|1|||
170758368|NCT01537133|617121292|FG000|Overall Study|Withdrawal by Subject|2|||
170758369|NCT01537133|617121293|FG001|Overall Study|Withdrawal by Subject|0|||
170758370|NCT01537133|617121294|FG002|Overall Study|Withdrawal by Subject|0|||
170758371|NCT01537133|617121295|FG003|Overall Study|Withdrawal by Subject|0|||
170758372|NCT01537133|617121292|FG000|Overall Study|Lost to Follow-up|1|||
170758373|NCT01537133|617121293|FG001|Overall Study|Lost to Follow-up|0|||
170758374|NCT01537133|617121294|FG002|Overall Study|Lost to Follow-up|0|||
170758375|NCT01537133|617121295|FG003|Overall Study|Lost to Follow-up|0|||
170758376|NCT01240356|617121296|FG000|Overall Study|Withdrawal by Subject|2|||
170758377|NCT01240356|617121297|FG001|Overall Study|Withdrawal by Subject|0|||
170758378|NCT01240356|617121296|FG000|Overall Study|MRI contraindication|1|||
170758379|NCT01240356|617121297|FG001|Overall Study|MRI contraindication|0|||
170758380|NCT04048135|617121298|FG000|Overall Study|Withdrawal by Subject|1|||
170758381|NCT04048135|617121299|FG001|Overall Study|Withdrawal by Subject|1|||
170758382|NCT04048135|617121300|FG002|Overall Study|Withdrawal by Subject|1|||
170758383|NCT04048135|617121301|FG003|Overall Study|Withdrawal by Subject|2|||
170758384|NCT04048135|617121302|FG004|Overall Study|Withdrawal by Subject|0|||
170758385|NCT04048135|617121303|FG005|Overall Study|Withdrawal by Subject|0|||
170758386|NCT04048135|617121304|FG006|Overall Study|Withdrawal by Subject|1|||
170758387|NCT04048135|617121305|FG007|Overall Study|Withdrawal by Subject|1|||
170758388|NCT04048135|617121298|FG000|Overall Study|Adverse Event|0|||
170758389|NCT04048135|617121299|FG001|Overall Study|Adverse Event|0|||
170758390|NCT04048135|617121300|FG002|Overall Study|Adverse Event|0|||
170758391|NCT04048135|617121301|FG003|Overall Study|Adverse Event|1|||
170758392|NCT04048135|617121302|FG004|Overall Study|Adverse Event|1|||
170758393|NCT04048135|617121303|FG005|Overall Study|Adverse Event|0|||
170758394|NCT04048135|617121304|FG006|Overall Study|Adverse Event|0|||
170758395|NCT04048135|617121305|FG007|Overall Study|Adverse Event|0|||
170758396|NCT04048135|617121298|FG000|Overall Study|Protocol Violation|0|||
170758397|NCT04048135|617121299|FG001|Overall Study|Protocol Violation|0|||
170758398|NCT04048135|617121300|FG002|Overall Study|Protocol Violation|0|||
170758399|NCT04048135|617121301|FG003|Overall Study|Protocol Violation|0|||
170758400|NCT04048135|617121302|FG004|Overall Study|Protocol Violation|0|||
170758401|NCT04048135|617121303|FG005|Overall Study|Protocol Violation|1|||
170758402|NCT04048135|617121304|FG006|Overall Study|Protocol Violation|0|||
170758403|NCT04048135|617121305|FG007|Overall Study|Protocol Violation|0|||
170758404|NCT01390857|617121307|FG000|Overall Study|Protocol Violation|2|||
170758405|NCT01390857|617121307|FG000|Overall Study|Lost to Follow-up|1|||
170758406|NCT01390857|617121307|FG000|Overall Study|No Visit after the First Visit|7|||
170758407|NCT01704846|617121308|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170758408|NCT01704846|617121309|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170758409|NCT01168401|617121314|FG000|Overall Study|Lost to Follow-up|1|||
170758410|NCT01168401|617121315|FG001|Overall Study|Lost to Follow-up|1|||
170758411|NCT01168401|617121316|FG002|Overall Study|Lost to Follow-up|2|||
170758412|NCT01168401|617121317|FG003|Overall Study|Lost to Follow-up|1|||
170758413|NCT01168401|617121318|FG004|Overall Study|Lost to Follow-up|0|||
170758414|NCT01168401|617121319|FG005|Overall Study|Lost to Follow-up|0|||
170758415|NCT01168401|617121320|FG006|Overall Study|Lost to Follow-up|0|||
170758416|NCT01168401|617121321|FG007|Overall Study|Lost to Follow-up|0|||
170758417|NCT01168401|617121322|FG008|Overall Study|Lost to Follow-up|0|||
170758418|NCT01168401|617121323|FG009|Overall Study|Lost to Follow-up|0|||
170758419|NCT01168401|617121324|FG010|Overall Study|Lost to Follow-up|0|||
170758420|NCT01168401|617121314|FG000|Overall Study|Withdrawal by Subject|0|||
170758421|NCT01168401|617121315|FG001|Overall Study|Withdrawal by Subject|0|||
170758422|NCT01168401|617121316|FG002|Overall Study|Withdrawal by Subject|0|||
170758423|NCT01168401|617121317|FG003|Overall Study|Withdrawal by Subject|1|||
170758424|NCT01168401|617121318|FG004|Overall Study|Withdrawal by Subject|0|||
170758425|NCT01168401|617121319|FG005|Overall Study|Withdrawal by Subject|0|||
170758426|NCT01168401|617121320|FG006|Overall Study|Withdrawal by Subject|0|||
170758427|NCT01168401|617121321|FG007|Overall Study|Withdrawal by Subject|0|||
170758428|NCT01168401|617121322|FG008|Overall Study|Withdrawal by Subject|0|||
170758429|NCT01168401|617121323|FG009|Overall Study|Withdrawal by Subject|0|||
170758430|NCT01168401|617121324|FG010|Overall Study|Withdrawal by Subject|0|||
170758431|NCT03681691|617121334|FG000|Overall Study|COVID|1|||
170758432|NCT03681691|617121335|FG001|Overall Study|COVID|0|||
170758433|NCT03681691|617121334|FG000|Overall Study|prolonged bleeding|1|||
170758434|NCT03681691|617121335|FG001|Overall Study|prolonged bleeding|0|||
170758435|NCT03681691|617121334|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
170758436|NCT03681691|617121335|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
170758437|NCT00465985|617121336|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
170758438|NCT00465985|617121337|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
170758439|NCT00465985|617121336|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
170758440|NCT00465985|617121337|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
170758441|NCT00465985|617121336|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
170758442|NCT00465985|617121337|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
170758443|NCT00465985|617121336|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
170758444|NCT00465985|617121337|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
170758445|NCT03439124|617121340|FG000|Overall Study|Adverse Event|2|||
170758446|NCT03439124|617121341|FG001|Overall Study|Adverse Event|0|||
170758447|NCT03439124|617121340|FG000|Overall Study|Lost to Follow-up|1|||
170758448|NCT03439124|617121341|FG001|Overall Study|Lost to Follow-up|0|||
170758449|NCT03439124|617121340|FG000|Overall Study|Other reasons|1|||
170758450|NCT03439124|617121341|FG001|Overall Study|Other reasons|0|||
170758451|NCT00463151|617121342|FG000|Overall Study|Adverse Event|0|||
170758452|NCT00463151|617121343|FG001|Overall Study|Adverse Event|0|||
170758453|NCT00463151|617121344|FG002|Overall Study|Adverse Event|1|||
170758454|NCT00463151|617121345|FG003|Overall Study|Adverse Event|0|||
170758455|NCT00463151|617121342|FG000|Overall Study|Lack of Efficacy|2|||
170758456|NCT00463151|617121343|FG001|Overall Study|Lack of Efficacy|5|||
170758457|NCT00463151|617121344|FG002|Overall Study|Lack of Efficacy|2|||
170758458|NCT00463151|617121345|FG003|Overall Study|Lack of Efficacy|5|||
170758459|NCT00463151|617121342|FG000|Overall Study|Protocol Violation|0|||
170758460|NCT00463151|617121343|FG001|Overall Study|Protocol Violation|0|||
170758461|NCT00463151|617121344|FG002|Overall Study|Protocol Violation|0|||
170406330|NCT00410410|615828547|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
170406331|NCT00410410|615828548|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
170758462|NCT00463151|617121345|FG003|Overall Study|Protocol Violation|1|||
170758463|NCT00463151|617121342|FG000|Overall Study|Withdrawal by Subject|0|||
170758464|NCT00463151|617121343|FG001|Overall Study|Withdrawal by Subject|0|||
170758465|NCT00463151|617121344|FG002|Overall Study|Withdrawal by Subject|0|||
170758466|NCT00463151|617121345|FG003|Overall Study|Withdrawal by Subject|1|||
170758467|NCT00972543|617121346|FG000|Overall Study|Adverse Event|1|||
170758468|NCT00972543|617121347|FG001|Overall Study|Adverse Event|0|||
170758469|NCT00972543|617121346|FG000|Overall Study|Early study termination by sponsor|4|||
170758470|NCT00972543|617121347|FG001|Overall Study|Early study termination by sponsor|1|||
170758471|NCT00293462|617121348|FG000|Overall Study|Withdrawal by Subject|4|||
170406332|NCT00410410|615828549|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
170758472|NCT00293462|617121349|FG001|Overall Study|Withdrawal by Subject|3|||
170758473|NCT00293462|617121350|FG002|Overall Study|Withdrawal by Subject|8|||
170758474|NCT00293462|617121348|FG000|Overall Study|Death|1|||
170758475|NCT00293462|617121349|FG001|Overall Study|Death|0|||
170758476|NCT00293462|617121350|FG002|Overall Study|Death|0|||
170758477|NCT00293462|617121348|FG000|Overall Study|Lost to Follow-up|0|||
170758478|NCT00293462|617121349|FG001|Overall Study|Lost to Follow-up|1|||
170758479|NCT00293462|617121350|FG002|Overall Study|Lost to Follow-up|0|||
170758480|NCT00293462|617121348|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
170758481|NCT00293462|617121349|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
170758482|NCT00293462|617121350|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
170758483|NCT00293462|617121348|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
170758484|NCT00293462|617121349|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
170758485|NCT00293462|617121350|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
170758486|NCT00293462|617121348|FG000|Overall Study|Refuse Radiation Treatment|1|||
170758487|NCT00293462|617121349|FG001|Overall Study|Refuse Radiation Treatment|0|||
170758488|NCT00293462|617121350|FG002|Overall Study|Refuse Radiation Treatment|0|||
170758489|NCT00293462|617121348|FG000|Overall Study|No Show|0|||
170758490|NCT00293462|617121349|FG001|Overall Study|No Show|0|||
170758491|NCT00293462|617121350|FG002|Overall Study|No Show|1|||
170758492|NCT00293462|617121348|FG000|Overall Study|Went back to his home country|0|||
170758493|NCT00293462|617121349|FG001|Overall Study|Went back to his home country|0|||
170758494|NCT00293462|617121350|FG002|Overall Study|Went back to his home country|1|||
170758495|NCT00293462|617121348|FG000|Overall Study|Blood clot after chemotherapy|0|||
170758496|NCT00293462|617121349|FG001|Overall Study|Blood clot after chemotherapy|0|||
170758497|NCT00293462|617121350|FG002|Overall Study|Blood clot after chemotherapy|1|||
170758498|NCT00293462|617121348|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
170758499|NCT00293462|617121349|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
170758500|NCT00293462|617121350|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
170758501|NCT00293462|617121348|FG000|Overall Study|Possible Tracheostomy leakage|0|||
170758502|NCT00293462|617121349|FG001|Overall Study|Possible Tracheostomy leakage|1|||
170758503|NCT00293462|617121350|FG002|Overall Study|Possible Tracheostomy leakage|0|||
170758504|NCT00293462|617121348|FG000|Overall Study|Low radiation dose in oral cavity|0|||
170758505|NCT00293462|617121349|FG001|Overall Study|Low radiation dose in oral cavity|1|||
170758506|NCT00293462|617121350|FG002|Overall Study|Low radiation dose in oral cavity|0|||
170758507|NCT00293462|617121348|FG000|Overall Study|Physician Decision|0|||
170758508|NCT00293462|617121349|FG001|Overall Study|Physician Decision|1|||
170758509|NCT00293462|617121350|FG002|Overall Study|Physician Decision|0|||
170758510|NCT03101592|617121351|FG000|Overall Study|participant files could not be located|111|||
170758511|NCT03101592|617121352|FG001|Overall Study|participant files could not be located|170|||
170758512|NCT03101592|617121353|FG002|Overall Study|participant files could not be located|118|||
170758513|NCT00372060|617121354|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
170758514|NCT00372060|617121355|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
170758515|NCT00372060|617121354|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
170758516|NCT00372060|617121355|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
170758517|NCT00372060|617121354|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
170758518|NCT00372060|617121355|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
170758519|NCT00372060|617121354|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
170758520|NCT00372060|617121355|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
170758521|NCT00372060|617121354|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
170758522|NCT00372060|617121355|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
170758523|NCT00372060|617121354|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
170758524|NCT00372060|617121355|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
170758525|NCT01579578|617121356|FG000|Overall Study|Death|4|||
170758526|NCT01579578|617121357|FG001|Overall Study|Death|1|||
170758527|NCT01579578|617121356|FG000|Overall Study|Lost to Follow-up|1|||
170758528|NCT01579578|617121357|FG001|Overall Study|Lost to Follow-up|1|||
170758529|NCT01579578|617121356|FG000|Overall Study|Withdrawal by Subject|2|||
170758530|NCT01579578|617121357|FG001|Overall Study|Withdrawal by Subject|1|||
170758531|NCT01579578|617121356|FG000|Overall Study|Eligibility criteria|3|||
170758532|NCT01579578|617121357|FG001|Overall Study|Eligibility criteria|9|||
170758533|NCT01579578|617121356|FG000|Overall Study|Ongoing|3|||
170758534|NCT01579578|617121357|FG001|Overall Study|Ongoing|0|||
170758535|NCT01004263|617121360|FG000|Overall Study|Adverse Event|15|||
170758536|NCT01004263|617121360|FG000|Overall Study|Withdrawal by Subject|58|||
170758537|NCT01004263|617121360|FG000|Overall Study|Protocol Violation|10|||
170758538|NCT01004263|617121360|FG000|Overall Study|Lost to Follow-up|64|||
170758539|NCT01004263|617121360|FG000|Overall Study|Lack of Efficacy|13|||
170758540|NCT01004263|617121360|FG000|Overall Study|Pregnancy|2|||
170758541|NCT01004263|617121360|FG000|Overall Study|Physician Decision|15|||
170758542|NCT01004263|617121360|FG000|Overall Study|Lack of Qualifying Event|2|||
170758543|NCT00821236|617121362|FG000|Overall Study|Lost to Follow-up|3|||
170758544|NCT01582243|617121364|FG000|Overall Study|Withdrawal by Subject|1|||
170758545|NCT01582243|617121364|FG000|Overall Study|Adverse Event|1|||
170758546|NCT01582243|617121364|FG000|Overall Study|Lost to Follow-up|1|||
170758547|NCT02397889|617121366|FG000|Overall Study|Physician Decision|1|||
170758548|NCT02397889|617121367|FG001|Overall Study|Physician Decision|0|||
170758549|NCT02219490|617121368|FG000|Overall Study|Adverse Event|24|||
170758550|NCT02219490|617121368|FG000|Overall Study|Withdrew consent|96|||
170758551|NCT02219490|617121368|FG000|Overall Study|Lost to Follow-up|126|||
170758552|NCT02219490|617121368|FG000|Overall Study|COVID-19 infection|2|||
170758553|NCT02219490|617121368|FG000|Overall Study|COVID-19 logistical restrictions|33|||
170758554|NCT02219490|617121368|FG000|Overall Study|Other, not specified|57|||
170758555|NCT01928940|617121373|FG000|Overall Study|Adverse Event|0|||
170758556|NCT01928940|617121374|FG001|Overall Study|Adverse Event|1|||
170758557|NCT01352507|617121381|FG000|Treatment Period 1|Adverse Event|3|||
170758558|NCT01352507|617121382|FG001|Treatment Period 1|Adverse Event|0|||
170758559|NCT01352507|617121381|FG000|Treatment Period 1|Lost to Follow-up|3|||
170758560|NCT01352507|617121382|FG001|Treatment Period 1|Lost to Follow-up|4|||
170758561|NCT01352507|617121381|FG000|Treatment Period 1|Withdrawal by Subject|7|||
170758562|NCT01352507|617121382|FG001|Treatment Period 1|Withdrawal by Subject|5|||
170758563|NCT01352507|617121381|FG000|Treatment Period 1|Physician Decision|1|||
170758564|NCT01352507|617121382|FG001|Treatment Period 1|Physician Decision|0|||
170758565|NCT01352507|617121381|FG000|Washout Period|Withdrawal by Subject|0|||
170758566|NCT01352507|617121382|FG001|Washout Period|Withdrawal by Subject|1|||
170758567|NCT01352507|617121381|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
170758568|NCT01352507|617121382|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
170758569|NCT01352507|617121381|FG000|Treatment Period 2|Withdrawal by Subject|4|||
170758570|NCT01352507|617121382|FG001|Treatment Period 2|Withdrawal by Subject|3|||
170758571|NCT01352507|617121381|FG000|Treatment Period 2|Lack of Efficacy|1|||
170758572|NCT01352507|617121382|FG001|Treatment Period 2|Lack of Efficacy|0|||
170758573|NCT01119703|617121383|FG000|Overall Study|Adverse Event|0|||
170758574|NCT01119703|617121384|FG001|Overall Study|Adverse Event|1|||
170758575|NCT01767909|617121386|FG000|Overall Study|Withdrawal by Subject|4|||
170758576|NCT01767909|617121387|FG001|Overall Study|Withdrawal by Subject|7|||
170758577|NCT01767909|617121386|FG000|Overall Study|Adverse Event|3|||
170758578|NCT01767909|617121387|FG001|Overall Study|Adverse Event|1|||
170758579|NCT01767909|617121386|FG000|Overall Study|Withdrawal by Study Partner|3|||
170758580|NCT01767909|617121387|FG001|Overall Study|Withdrawal by Study Partner|1|||
170758581|NCT01767909|617121386|FG000|Overall Study|Non-Compliance|2|||
170758582|NCT01767909|617121387|FG001|Overall Study|Non-Compliance|0|||
170758583|NCT01767909|617121386|FG000|Overall Study|Perceived Lack of Efficacy|1|||
170758584|NCT01767909|617121387|FG001|Overall Study|Perceived Lack of Efficacy|0|||
170758585|NCT01767909|617121386|FG000|Overall Study|Investigator Recommendation|0|||
170758586|NCT01767909|617121387|FG001|Overall Study|Investigator Recommendation|1|||
170758587|NCT01767909|617121386|FG000|Overall Study|Lost to Follow-up|0|||
170758588|NCT01767909|617121387|FG001|Overall Study|Lost to Follow-up|1|||
170758589|NCT01767909|617121386|FG000|Overall Study|LP uncessessful|0|||
170758590|NCT01767909|617121387|FG001|Overall Study|LP uncessessful|1|||
170758591|NCT05174065|617121388|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
170758592|NCT05174065|617121389|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
170758593|NCT05174065|617121390|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
170758594|NCT05174065|617121388|FG000|Placebo-controlled Period|Other|0|||
170758595|NCT05174065|617121389|FG001|Placebo-controlled Period|Other|1|||
170758596|NCT05174065|617121390|FG002|Placebo-controlled Period|Other|0|||
170758597|NCT05174065|617121388|FG000|Placebo-controlled Period|Adverse Event|1|||
170758598|NCT05174065|617121389|FG001|Placebo-controlled Period|Adverse Event|1|||
170758599|NCT05174065|617121390|FG002|Placebo-controlled Period|Adverse Event|0|||
170758600|NCT05174065|617121388|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
170758601|NCT05174065|617121389|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
170758602|NCT05174065|617121390|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
170758603|NCT05174065|617121388|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
170758604|NCT05174065|617121389|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
170758605|NCT05174065|617121390|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
170758606|NCT05174065|617121388|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
170758607|NCT05174065|617121389|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
170758608|NCT05174065|617121390|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
170758609|NCT04873817|617121391|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
170758610|NCT04873817|617121391|FG000|Overall Study|Lost to Follow-up|4|||
170758611|NCT04873817|617121391|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
170758612|NCT04873817|617121391|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
170758613|NCT04873817|617121391|FG000|Overall Study|Other Reasons|3|||
170758614|NCT03677375|617121398|FG000|Overall Study|Incomplete procedure|8|||
170758615|NCT03677375|617121398|FG000|Overall Study|Adverse Event|3|||
170758616|NCT03677375|617121398|FG000|Overall Study|Physician Decision|1|||
170758617|NCT00725010|617121399|FG000|Overall Study|Toxicity|9|||
170758618|NCT00725010|617121399|FG000|Overall Study|Tumor Progression|7|||
170758619|NCT00725010|617121399|FG000|Overall Study|Withdrawal by Subject|2|||
170758620|NCT00725010|617121399|FG000|Overall Study|Death|1|||
170758621|NCT00725010|617121399|FG000|Overall Study|Lost to Follow-up|1|||
170758622|NCT00725010|617121399|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
170758623|NCT00725010|617121399|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
170758624|NCT00725010|617121399|FG000|Overall Study|No further documentation|1|||
170758625|NCT00725010|617121399|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
170758626|NCT01290094|617121400|FG000|Overall Study|Withdrawal by Subject|1|||
170758627|NCT01290094|617121400|FG000|Overall Study|Lost to Follow-up|5|||
170758628|NCT01641861|617121401|FG000|Overall Study|Lost to Follow-up|21|||
170758629|NCT01641861|617121402|FG001|Overall Study|Lost to Follow-up|16|||
170758630|NCT01641861|617121401|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
170758631|NCT01641861|617121402|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
170758632|NCT01641861|617121401|FG000|Overall Study|Died due to drowning|0|||
170758633|NCT01641861|617121402|FG001|Overall Study|Died due to drowning|1|||
170758634|NCT01555762|617121410|FG000|Overall Study|No information on Bevacizumab intake|11|||
170758635|NCT01555762|617121410|FG000|Overall Study|Missing start date of infusion|8|||
170758636|NCT01555762|617121410|FG000|Overall Study|75 years old or more ticked No|1|||
170758637|NCT01555762|617121410|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
170758638|NCT01555762|617121410|FG000|Overall Study|Death linked to progression of disease|165|||
170758639|NCT01555762|617121410|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
170758640|NCT01555762|617121410|FG000|Overall Study|Investigator's decision|10|||
170758641|NCT01555762|617121410|FG000|Overall Study|Participant not wishing to continue|5|||
170758642|NCT01555762|617121410|FG000|Overall Study|Missing data|1|||
170758643|NCT01555762|617121410|FG000|Overall Study|Death linked to an adverse event|14|||
170758644|NCT01101542|617121411|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
170758645|NCT01101542|617121411|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
170758646|NCT01101542|617121411|FG000|Year 4 Surveillance Period|Other|287|||
170758647|NCT01101542|617121411|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
170758648|NCT01101542|617121411|FG000|Year 5 Surveillance Period|Pregnancy|1|||
170758649|NCT01101542|617121411|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
170758650|NCT01101542|617121411|FG000|Year 6 Surveillance Period|Pregnancy|1|||
170758651|NCT01101542|617121411|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
170758652|NCT00299702|617121414|FG000|Overall Study|Death|1|||
170758653|NCT00299702|617121415|FG001|Overall Study|Death|0|||
170758654|NCT00299702|617121414|FG000|Overall Study|Adverse Event|0|||
170758655|NCT00299702|617121415|FG001|Overall Study|Adverse Event|4|||
170758656|NCT00299702|617121414|FG000|Overall Study|Lost to Follow-up|18|||
170758657|NCT00299702|617121415|FG001|Overall Study|Lost to Follow-up|10|||
170758658|NCT00299702|617121414|FG000|Overall Study|Withdrawal by Subject|25|||
170758659|NCT00299702|617121415|FG001|Overall Study|Withdrawal by Subject|23|||
170758660|NCT00299702|617121414|FG000|Overall Study|Pregnancy|0|||
170758661|NCT00299702|617121415|FG001|Overall Study|Pregnancy|1|||
170758662|NCT00299702|617121414|FG000|Overall Study|Insufficient Response|4|||
170758663|NCT00299702|617121415|FG001|Overall Study|Insufficient Response|3|||
170758664|NCT00299702|617121414|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
170758665|NCT00299702|617121415|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
170758666|NCT04580407|617121416|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
170758667|NCT05460663|617121419|FG000|Overall Study|Withdrawal by Subject|2|||
170758668|NCT05460663|617121420|FG001|Overall Study|Withdrawal by Subject|5|||
170758669|NCT00670540|617121423|FG000|Overall Study|ineligible|17|||
170758670|NCT00670540|617121423|FG000|Overall Study|not living in France|348|||
170758671|NCT00670540|617121423|FG000|Overall Study|refused to participate|189|||
170758672|NCT00670540|617121423|FG000|Overall Study|controls randomised for no follow up|2770|||
170758673|NCT00670540|617121423|FG000|Overall Study|missing information inclusion criteria|1|||
170758674|NCT00681811|617121424|FG000|Overall Study|Adverse Event|1|||
170758675|NCT00681811|617121425|FG001|Overall Study|Adverse Event|1|||
170758676|NCT00681811|617121424|FG000|Overall Study|Withdrawal by Subject|2|||
170758677|NCT00681811|617121425|FG001|Overall Study|Withdrawal by Subject|2|||
170758678|NCT00681811|617121424|FG000|Overall Study|Non-compliance|0|||
170758679|NCT00681811|617121425|FG001|Overall Study|Non-compliance|1|||
170758680|NCT00814489|617121451|FG000|Overall Study|Other|2|||
170758681|NCT00814489|617121452|FG001|Overall Study|Other|0|||
170758682|NCT00814489|617121453|FG002|Overall Study|Other|1|||
170758683|NCT05025449|617123461|FG000|Overall Study|Withdrawal by Subject|1|||
170758684|NCT05025449|617123461|FG000|Overall Study|Patient emergently taken to operating room|1|||
170758685|NCT04577183|617123465|FG000|Overall Study|Death|1|||
170758686|NCT04577183|617123465|FG000|Overall Study|Withdrawal by Subject|3|||
170758687|NCT04577183|617123465|FG000|Overall Study|Early termination|2|||
170758688|NCT02072226|617123468|FG000|Overall Study|Lost to Follow-up|11|||
170758689|NCT02072226|617123469|FG001|Overall Study|Lost to Follow-up|7|||
170758690|NCT02072226|617123468|FG000|Overall Study|Patient Non-compliance|2|||
170758691|NCT02072226|617123469|FG001|Overall Study|Patient Non-compliance|3|||
170758692|NCT02072226|617123468|FG000|Overall Study|Death|1|||
170758693|NCT02072226|617123469|FG001|Overall Study|Death|0|||
170758694|NCT02072226|617123468|FG000|Overall Study|Patient Withdrawal of Consent|1|||
170758695|NCT02072226|617123469|FG001|Overall Study|Patient Withdrawal of Consent|0|||
170758696|NCT00269399|617123471|FG000|Overall Study|Lack of Efficacy|27|||
170406333|NCT00410410|615828550|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
170406334|NCT00410410|615828551|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
170406335|NCT00410410|615828552|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
170406336|NCT00410410|615828553|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
170406337|NCT00410410|615828554|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
170406338|NCT00410410|615828546|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
170406339|NCT00410410|615828547|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
170406340|NCT00410410|615828548|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
170406341|NCT00410410|615828549|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
170406342|NCT00410410|615828550|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
170406343|NCT00410410|615828551|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
170406344|NCT00410410|615828552|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
170406345|NCT00410410|615828553|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
170406346|NCT00410410|615828554|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
170406347|NCT00410410|615828546|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
170406348|NCT00410410|615828547|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
170406349|NCT00410410|615828548|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
170406350|NCT00410410|615828549|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
170406351|NCT00410410|615828550|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
170406352|NCT00410410|615828551|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
170406353|NCT00410410|615828552|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
170406354|NCT00410410|615828553|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
170406355|NCT00410410|615828554|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
170406356|NCT00410410|615828546|FG000|Induction Period (IP)|Other|0|||
170406357|NCT00410410|615828547|FG001|Induction Period (IP)|Other|0|||
170406358|NCT00410410|615828548|FG002|Induction Period (IP)|Other|1|||
170406359|NCT00410410|615828549|FG003|Induction Period (IP)|Other|0|||
170406360|NCT00410410|615828550|FG004|Induction Period (IP)|Other|0|||
170406361|NCT00410410|615828551|FG005|Induction Period (IP)|Other|0|||
170406362|NCT00410410|615828552|FG006|Induction Period (IP)|Other|0|||
170406363|NCT00410410|615828553|FG007|Induction Period (IP)|Other|0|||
170406364|NCT00410410|615828554|FG008|Induction Period (IP)|Other|0|||
170406365|NCT00410410|615828546|FG000|Maintenance Period (MP)|Death|0|||
170406366|NCT00410410|615828547|FG001|Maintenance Period (MP)|Death|0|||
170406367|NCT00410410|615828548|FG002|Maintenance Period (MP)|Death|0|||
170406368|NCT00410410|615828549|FG003|Maintenance Period (MP)|Death|0|||
170406369|NCT00410410|615828550|FG004|Maintenance Period (MP)|Death|0|||
170406370|NCT00410410|615828551|FG005|Maintenance Period (MP)|Death|0|||
170406371|NCT00410410|615828552|FG006|Maintenance Period (MP)|Death|1|||
170406372|NCT00410410|615828553|FG007|Maintenance Period (MP)|Death|0|||
170406373|NCT00410410|615828554|FG008|Maintenance Period (MP)|Death|0|||
170406374|NCT00410410|615828546|FG000|Maintenance Period (MP)|Adverse Event|0|||
170406375|NCT00410410|615828547|FG001|Maintenance Period (MP)|Adverse Event|0|||
170406376|NCT00410410|615828548|FG002|Maintenance Period (MP)|Adverse Event|0|||
170406377|NCT00410410|615828549|FG003|Maintenance Period (MP)|Adverse Event|0|||
170406378|NCT00410410|615828550|FG004|Maintenance Period (MP)|Adverse Event|0|||
170406379|NCT00410410|615828551|FG005|Maintenance Period (MP)|Adverse Event|0|||
170406380|NCT00410410|615828552|FG006|Maintenance Period (MP)|Adverse Event|1|||
170406381|NCT00410410|615828553|FG007|Maintenance Period (MP)|Adverse Event|3|||
170406382|NCT00410410|615828554|FG008|Maintenance Period (MP)|Adverse Event|0|||
170406383|NCT00410410|615828546|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
170406384|NCT00410410|615828547|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
170406385|NCT00410410|615828548|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
170406386|NCT00410410|615828549|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
170406387|NCT00410410|615828550|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
170406388|NCT00410410|615828551|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
170406389|NCT00410410|615828552|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
170406390|NCT00410410|615828553|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
170406391|NCT00410410|615828554|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
170406392|NCT00410410|615828546|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
170406393|NCT00410410|615828547|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
170758697|NCT00269399|617123472|FG001|Overall Study|Lack of Efficacy|10|||
170406394|NCT00410410|615828548|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
170406395|NCT00410410|615828549|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
170406396|NCT00410410|615828550|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
170406397|NCT00410410|615828551|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
170406398|NCT00410410|615828552|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
170406399|NCT00410410|615828553|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
170406400|NCT00410410|615828554|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
170519697|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170519698|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
170758698|NCT00269399|617123471|FG000|Overall Study|Adverse Event|10|||
170758699|NCT00269399|617123472|FG001|Overall Study|Adverse Event|4|||
170758700|NCT00269399|617123471|FG000|Overall Study|Withdrawal by Subject|2|||
170758701|NCT00269399|617123472|FG001|Overall Study|Withdrawal by Subject|5|||
170865766|NCT02038920|617520016|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
170406401|NCT00410410|615828546|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
170758702|NCT00269399|617123471|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
170758703|NCT00269399|617123472|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
170758704|NCT00269399|617123471|FG000|Overall Study|Other|0|||
170758705|NCT00269399|617123472|FG001|Overall Study|Other|4|||
170406402|NCT00410410|615828547|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
170406403|NCT00410410|615828548|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
170406404|NCT00410410|615828549|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
170406405|NCT00410410|615828550|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
170758706|NCT00269399|617123471|FG000|Overall Study|Development of exclusion criteria|0|||
170758707|NCT00269399|617123472|FG001|Overall Study|Development of exclusion criteria|1|||
170406406|NCT00410410|615828551|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
170406407|NCT00410410|615828552|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
170406408|NCT00410410|615828553|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
170406409|NCT00410410|615828554|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
170406410|NCT00410410|615828546|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
170406411|NCT00410410|615828547|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
170406412|NCT00410410|615828548|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
170406413|NCT00410410|615828549|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
170406414|NCT00410410|615828550|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
170406415|NCT00410410|615828551|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
170406416|NCT00410410|615828552|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
170406417|NCT00410410|615828553|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
170406418|NCT00410410|615828554|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
170406419|NCT00410410|615828546|FG000|Open-Label Period (OL)|Death|0|||
170406420|NCT00410410|615828547|FG001|Open-Label Period (OL)|Death|0|||
170406421|NCT00410410|615828548|FG002|Open-Label Period (OL)|Death|0|||
170406422|NCT00410410|615828549|FG003|Open-Label Period (OL)|Death|0|||
170406423|NCT00410410|615828550|FG004|Open-Label Period (OL)|Death|0|||
170406424|NCT00410410|615828551|FG005|Open-Label Period (OL)|Death|0|||
170406425|NCT00410410|615828552|FG006|Open-Label Period (OL)|Death|0|||
170406426|NCT00410410|615828553|FG007|Open-Label Period (OL)|Death|0|||
170406427|NCT00410410|615828554|FG008|Open-Label Period (OL)|Death|1|||
170406428|NCT00410410|615828546|FG000|Open-Label Period (OL)|Adverse Event|0|||
170406429|NCT00410410|615828547|FG001|Open-Label Period (OL)|Adverse Event|0|||
170406430|NCT00410410|615828548|FG002|Open-Label Period (OL)|Adverse Event|0|||
170406431|NCT00410410|615828549|FG003|Open-Label Period (OL)|Adverse Event|0|||
170406432|NCT00410410|615828550|FG004|Open-Label Period (OL)|Adverse Event|0|||
170406433|NCT00410410|615828551|FG005|Open-Label Period (OL)|Adverse Event|0|||
170406434|NCT00410410|615828552|FG006|Open-Label Period (OL)|Adverse Event|0|||
170406435|NCT00410410|615828553|FG007|Open-Label Period (OL)|Adverse Event|0|||
170406436|NCT00410410|615828554|FG008|Open-Label Period (OL)|Adverse Event|10|||
170406437|NCT00410410|615828546|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
170406438|NCT00410410|615828547|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
170406439|NCT00410410|615828548|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
170406440|NCT00410410|615828549|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
170406441|NCT00410410|615828550|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
170406442|NCT00410410|615828551|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
170406443|NCT00410410|615828552|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
170406444|NCT00410410|615828553|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
170406445|NCT00410410|615828554|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
170406446|NCT00410410|615828546|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
170406447|NCT00410410|615828547|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
170406448|NCT00410410|615828548|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
170406449|NCT00410410|615828549|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
170406450|NCT00410410|615828550|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
170758708|NCT03396835|617123473|FG000|Overall Study|Withdrawn prior to completion|1|||
170758709|NCT03396835|617123473|FG000|Overall Study|Did not meet criteria for data analysis|1|||
170758710|NCT04353037|617123475|FG000|Overall Study|Lost to Follow-up|0|||
170758711|NCT04353037|617123476|FG001|Overall Study|Lost to Follow-up|1|||
170758712|NCT04353037|617123477|FG002|Overall Study|Lost to Follow-up|2|||
170758713|NCT04353037|617123478|FG003|Overall Study|Lost to Follow-up|3|||
170758714|NCT04353037|617123475|FG000|Overall Study|Withdrawal by Subject|0|||
170758715|NCT04353037|617123476|FG001|Overall Study|Withdrawal by Subject|2|||
170406451|NCT00410410|615828551|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
170406452|NCT00410410|615828552|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
170406453|NCT00410410|615828553|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
170406454|NCT00410410|615828554|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
170406455|NCT00410410|615828546|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
170758716|NCT04353037|617123477|FG002|Overall Study|Withdrawal by Subject|3|||
170758717|NCT04353037|617123478|FG003|Overall Study|Withdrawal by Subject|5|||
170758718|NCT04353037|617123475|FG000|Overall Study|Adverse Event|0|||
170758719|NCT04353037|617123476|FG001|Overall Study|Adverse Event|0|||
170758720|NCT04353037|617123477|FG002|Overall Study|Adverse Event|2|||
170758721|NCT04353037|617123478|FG003|Overall Study|Adverse Event|0|||
170758722|NCT04353037|617123475|FG000|Overall Study|Exposure Change|0|||
170758723|NCT04353037|617123476|FG001|Overall Study|Exposure Change|0|||
170758724|NCT04353037|617123477|FG002|Overall Study|Exposure Change|0|||
170758725|NCT04353037|617123478|FG003|Overall Study|Exposure Change|2|||
170758726|NCT01720446|617123479|FG000|Overall Study|Lost to Follow-up|12|||
170758727|NCT01720446|617123480|FG001|Overall Study|Lost to Follow-up|6|||
170758728|NCT01720446|617123481|FG002|Overall Study|Lost to Follow-up|16|||
170758729|NCT01720446|617123482|FG003|Overall Study|Lost to Follow-up|16|||
170758730|NCT01720446|617123479|FG000|Overall Study|Withdrawal by Subject|2|||
170758731|NCT01720446|617123480|FG001|Overall Study|Withdrawal by Subject|5|||
170758732|NCT01720446|617123481|FG002|Overall Study|Withdrawal by Subject|4|||
170758733|NCT01720446|617123482|FG003|Overall Study|Withdrawal by Subject|4|||
170758734|NCT03710564|617123485|FG000|Overall Study|Study Terminated by Sponsor|104|||
170758735|NCT03710564|617123486|FG001|Overall Study|Study Terminated by Sponsor|55|||
170758736|NCT03710564|617123485|FG000|Overall Study|Withdrawal by Subject|57|||
170758737|NCT03710564|617123486|FG001|Overall Study|Withdrawal by Subject|25|||
170758738|NCT03710564|617123485|FG000|Overall Study|Death|10|||
170758739|NCT03710564|617123486|FG001|Overall Study|Death|4|||
170758740|NCT03710564|617123485|FG000|Overall Study|Lost to Follow-up|5|||
170758741|NCT03710564|617123486|FG001|Overall Study|Lost to Follow-up|4|||
170758742|NCT03710564|617123485|FG000|Overall Study|Protocol Violation|3|||
170758743|NCT03710564|617123486|FG001|Overall Study|Protocol Violation|2|||
170758744|NCT03710564|617123485|FG000|Overall Study|Adverse Event|3|||
170758745|NCT03710564|617123486|FG001|Overall Study|Adverse Event|0|||
170758746|NCT03710564|617123485|FG000|Overall Study|Physician Decision|2|||
170758747|NCT03710564|617123486|FG001|Overall Study|Physician Decision|3|||
170758748|NCT01803646|617123487|FG000|Overall Study|Protocol Violation|1|||
170758749|NCT01803646|617123488|FG001|Overall Study|Protocol Violation|0|||
170758750|NCT01803646|617123487|FG000|Overall Study|Adverse Event|1|||
170758751|NCT01803646|617123488|FG001|Overall Study|Adverse Event|1|||
170758752|NCT01803646|617123487|FG000|Overall Study|Withdrawal by Subject|9|||
170758753|NCT01803646|617123488|FG001|Overall Study|Withdrawal by Subject|6|||
170758754|NCT01803646|617123487|FG000|Overall Study|Randomization error|1|||
170758755|NCT01803646|617123488|FG001|Overall Study|Randomization error|2|||
170758756|NCT01803646|617123487|FG000|Overall Study|Lost to Follow-up|5|||
170758757|NCT01803646|617123488|FG001|Overall Study|Lost to Follow-up|1|||
170758758|NCT01167426|617123490|FG000|Overall Study|Lost to Follow-up|6|||
170758759|NCT01167426|617123490|FG000|Overall Study|Protocol Violation|1|||
170758760|NCT01167426|617123490|FG000|Overall Study|Withdrawal by Subject|2|||
170758761|NCT01167426|617123490|FG000|Overall Study|Sponsor Decision|1|||
170758762|NCT05349084|617123491|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
170758763|NCT01466881|617123492|FG000|Overall Study|Ineligible|5|||
170758764|NCT01466881|617123492|FG000|Overall Study|Adverse Event|6|||
170758765|NCT01466881|617123492|FG000|Overall Study|Progression/relapse|20|||
170758766|NCT01466881|617123492|FG000|Overall Study|Death|4|||
170406456|NCT00410410|615828547|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
170406457|NCT00410410|615828548|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
170758767|NCT01466881|617123492|FG000|Overall Study|Other reason not protocol specified|5|||
170758768|NCT03398356|617123495|FG000|Before Treatment|Lost to Follow-up|1|||
170758769|NCT03398356|617123496|FG001|Before Treatment|Lost to Follow-up|2|||
170758770|NCT03398356|617123497|FG002|Before Treatment|Lost to Follow-up|0|||
170758771|NCT03398356|617123495|FG000|Before Treatment|drug intolerance|2|||
170758772|NCT03398356|617123496|FG001|Before Treatment|drug intolerance|1|||
170865767|NCT02038920|617520017|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
170406458|NCT00410410|615828549|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
170406459|NCT00410410|615828550|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
170865768|NCT02038920|617520012|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
170406460|NCT00410410|615828551|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
170406461|NCT00410410|615828552|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
170865769|NCT02038920|617520013|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
170406462|NCT00410410|615828553|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
170758773|NCT03398356|617123497|FG002|Before Treatment|drug intolerance|0|||
170758774|NCT03398356|617123495|FG000|Before Treatment|Withdrawal by Subject|0|||
170758775|NCT03398356|617123496|FG001|Before Treatment|Withdrawal by Subject|5|||
170865770|NCT02038920|617520014|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
170865771|NCT02038920|617520015|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
170758776|NCT03398356|617123497|FG002|Before Treatment|Withdrawal by Subject|0|||
170758777|NCT03398356|617123495|FG000|Before Treatment|Physician Decision|0|||
170758778|NCT03398356|617123496|FG001|Before Treatment|Physician Decision|0|||
170865772|NCT02038920|617520016|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
170406463|NCT00410410|615828554|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
170406464|NCT00410410|615828546|FG000|Open-Label Period (OL)|Pregnancy|0|||
170406465|NCT00410410|615828547|FG001|Open-Label Period (OL)|Pregnancy|0|||
170406466|NCT00410410|615828548|FG002|Open-Label Period (OL)|Pregnancy|0|||
170406467|NCT00410410|615828549|FG003|Open-Label Period (OL)|Pregnancy|0|||
170406468|NCT00410410|615828550|FG004|Open-Label Period (OL)|Pregnancy|0|||
170406469|NCT00410410|615828551|FG005|Open-Label Period (OL)|Pregnancy|0|||
170406470|NCT00410410|615828552|FG006|Open-Label Period (OL)|Pregnancy|0|||
170406471|NCT00410410|615828553|FG007|Open-Label Period (OL)|Pregnancy|0|||
170406472|NCT00410410|615828554|FG008|Open-Label Period (OL)|Pregnancy|1|||
170406473|NCT00410410|615828546|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
170406474|NCT00410410|615828547|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
170406475|NCT00410410|615828548|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
170406476|NCT00410410|615828549|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
170406477|NCT00410410|615828550|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
170406478|NCT00410410|615828551|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
170406479|NCT00410410|615828552|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
170406480|NCT00410410|615828553|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
170406481|NCT00410410|615828554|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
170406482|NCT00410410|615828546|FG000|Open-Label Period (OL)|Other|0|||
170406483|NCT00410410|615828547|FG001|Open-Label Period (OL)|Other|0|||
170406484|NCT00410410|615828548|FG002|Open-Label Period (OL)|Other|0|||
170406485|NCT00410410|615828549|FG003|Open-Label Period (OL)|Other|0|||
170406486|NCT00410410|615828550|FG004|Open-Label Period (OL)|Other|0|||
170406487|NCT00410410|615828551|FG005|Open-Label Period (OL)|Other|0|||
170406488|NCT00410410|615828552|FG006|Open-Label Period (OL)|Other|0|||
170406489|NCT00410410|615828553|FG007|Open-Label Period (OL)|Other|0|||
170406490|NCT00410410|615828554|FG008|Open-Label Period (OL)|Other|7|||
170406491|NCT01783496|615828555|FG000|Overall Study|Lost to Follow-up|0|||
170406492|NCT01783496|615828556|FG001|Overall Study|Lost to Follow-up|0|||
170406493|NCT01783496|615828557|FG002|Overall Study|Lost to Follow-up|0|||
170406494|NCT01783496|615828558|FG003|Overall Study|Lost to Follow-up|2|||
170406495|NCT01783496|615828559|FG004|Overall Study|Lost to Follow-up|0|||
170406496|NCT01783496|615828560|FG005|Overall Study|Lost to Follow-up|1|||
170406497|NCT01783496|615828555|FG000|Overall Study|Withdrawal by Subject|1|||
170406498|NCT01783496|615828556|FG001|Overall Study|Withdrawal by Subject|0|||
170406499|NCT01783496|615828557|FG002|Overall Study|Withdrawal by Subject|0|||
170406500|NCT01783496|615828558|FG003|Overall Study|Withdrawal by Subject|0|||
170758779|NCT03398356|617123497|FG002|Before Treatment|Physician Decision|11|||
170758780|NCT03398356|617123495|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
170758781|NCT03398356|617123496|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
170758782|NCT03398356|617123497|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
170758783|NCT00647348|617123500|FG000|Overall Study|Lost to Follow-up|3|||
170758784|NCT00647348|617123501|FG001|Overall Study|Lost to Follow-up|6|||
170758785|NCT03382821|617123502|FG000|Overall Study|Did not receive allocated intervention.|0|||
170758786|NCT03382821|617123503|FG001|Overall Study|Did not receive allocated intervention.|3|||
170758787|NCT00631917|617123513|FG000|Overall Study|Adverse Event|34|||
170758788|NCT00631917|617123514|FG001|Overall Study|Adverse Event|45|||
170758789|NCT00631917|617123513|FG000|Overall Study|Abnormal laboratory value(s)|2|||
170758790|NCT00631917|617123514|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170758791|NCT00631917|617123513|FG000|Overall Study|Abnormal test procedure result(s)|3|||
170758792|NCT00631917|617123514|FG001|Overall Study|Abnormal test procedure result(s)|2|||
170758793|NCT00631917|617123513|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
170758794|NCT00631917|617123514|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
170758795|NCT00631917|617123513|FG000|Overall Study|No longer required study drug|0|||
170758796|NCT00631917|617123514|FG001|Overall Study|No longer required study drug|1|||
170758797|NCT00631917|617123513|FG000|Overall Study|Protocol deviation|6|||
170406501|NCT01783496|615828559|FG004|Overall Study|Withdrawal by Subject|0|||
170406502|NCT01783496|615828560|FG005|Overall Study|Withdrawal by Subject|0|||
170406503|NCT01023269|615828561|FG000|Overall Study|early termination of the study|2|||
170406504|NCT01023269|615828562|FG001|Overall Study|early termination of the study|0|||
170406505|NCT01953783|615828563|FG000|Overall Study|Progressive disease|2|||
170406506|NCT00947011|615828564|FG000|Overall Study|Study was terminated,PI left institution|12|||
170406507|NCT05266456|615828565|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
170406508|NCT05266456|615828566|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
170406509|NCT05266456|615828567|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
170406510|NCT05266456|615828568|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
170406511|NCT05266456|615828565|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
170406512|NCT05266456|615828566|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
170406513|NCT05266456|615828567|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
170758798|NCT00631917|617123514|FG001|Overall Study|Protocol deviation|5|||
170758799|NCT00631917|617123513|FG000|Overall Study|Subject withdrew consent|25|||
170758800|NCT00631917|617123514|FG001|Overall Study|Subject withdrew consent|33|||
170758801|NCT00631917|617123513|FG000|Overall Study|Lost to Follow-up|7|||
170758802|NCT00631917|617123514|FG001|Overall Study|Lost to Follow-up|7|||
170758803|NCT00631917|617123513|FG000|Overall Study|Administrative problems|2|||
170758804|NCT00631917|617123514|FG001|Overall Study|Administrative problems|0|||
170758805|NCT00631917|617123513|FG000|Overall Study|Death|1|||
170758806|NCT00631917|617123514|FG001|Overall Study|Death|0|||
170758807|NCT03686384|617123517|FG000|Overall Study|Lack of Efficacy|4|||
170758808|NCT03686384|617123518|FG001|Overall Study|Lack of Efficacy|13|||
170758809|NCT03686384|617123517|FG000|Overall Study|Lost to Follow-up|3|||
170758810|NCT03686384|617123518|FG001|Overall Study|Lost to Follow-up|0|||
170758811|NCT03686384|617123517|FG000|Overall Study|Physician Decision|0|||
170865773|NCT02038920|617520017|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
170865774|NCT02038920|617520012|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
170865775|NCT02038920|617520013|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
170865776|NCT02038920|617520014|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
170758812|NCT03686384|617123518|FG001|Overall Study|Physician Decision|1|||
170758813|NCT03686384|617123517|FG000|Overall Study|Took prohibited medication|0|||
170758814|NCT03686384|617123518|FG001|Overall Study|Took prohibited medication|1|||
170758815|NCT04319094|617123523|FG000|Baseline|Lost to Follow-up|4|||
170758816|NCT04319094|617123524|FG001|Baseline|Lost to Follow-up|5|||
170758817|NCT04319094|617123523|FG000|Baseline|Protocol Violation|0|||
170758818|NCT04319094|617123524|FG001|Baseline|Protocol Violation|3|||
170758819|NCT04319094|617123523|FG000|Baseline|Withdrawal by Subject|2|||
170758820|NCT04319094|617123524|FG001|Baseline|Withdrawal by Subject|1|||
170758821|NCT04319094|617123523|FG000|Post-Intervention|Death|0|||
170758822|NCT04319094|617123524|FG001|Post-Intervention|Death|1|||
170758823|NCT04319094|617123523|FG000|Post-Intervention|Lost to Follow-up|4|||
170758824|NCT04319094|617123524|FG001|Post-Intervention|Lost to Follow-up|4|||
170758825|NCT04319094|617123523|FG000|Post-Intervention|Withdrawal by Subject|8|||
170758826|NCT04319094|617123524|FG001|Post-Intervention|Withdrawal by Subject|5|||
170758827|NCT04319094|617123523|FG000|Post-Intervention|Incomplete Data Collection|1|||
170758828|NCT04319094|617123524|FG001|Post-Intervention|Incomplete Data Collection|3|||
170758829|NCT04319094|617123523|FG000|3-month|Death|1|||
170758830|NCT04319094|617123524|FG001|3-month|Death|0|||
170758831|NCT04319094|617123523|FG000|3-month|Lost to Follow-up|2|||
170758832|NCT04319094|617123524|FG001|3-month|Lost to Follow-up|2|||
170758833|NCT04319094|617123523|FG000|3-month|Withdrawal by Subject|0|||
170758834|NCT04319094|617123524|FG001|3-month|Withdrawal by Subject|3|||
170758835|NCT04319094|617123523|FG000|3-month|Incomplete data collection|9|||
170758836|NCT04319094|617123524|FG001|3-month|Incomplete data collection|7|||
170758837|NCT04319094|617123523|FG000|6-month|Lost to Follow-up|1|||
170758838|NCT04319094|617123524|FG001|6-month|Lost to Follow-up|1|||
170758839|NCT04319094|617123523|FG000|6-month|Withdrawal by Subject|0|||
170758840|NCT04319094|617123524|FG001|6-month|Withdrawal by Subject|3|||
170758841|NCT04319094|617123523|FG000|6-month|Incomplete data collection|14|||
170758842|NCT04319094|617123524|FG001|6-month|Incomplete data collection|9|||
170758843|NCT04319094|617123523|FG000|9-month|Lost to Follow-up|8|||
170758844|NCT04319094|617123524|FG001|9-month|Lost to Follow-up|4|||
170758845|NCT04319094|617123523|FG000|9-month|Withdrawal by Subject|0|||
170758846|NCT04319094|617123524|FG001|9-month|Withdrawal by Subject|1|||
170758847|NCT04319094|617123523|FG000|9-month|Incomplete data collection|8|||
170758848|NCT04319094|617123524|FG001|9-month|Incomplete data collection|5|||
170758849|NCT04319094|617123523|FG000|12-month|Lost to Follow-up|11|||
170758850|NCT04319094|617123524|FG001|12-month|Lost to Follow-up|8|||
170758851|NCT04639947|617123527|FG000|Overall Study|Screen fail|1|||
170758852|NCT00877851|617123531|FG000|Overall Study|Lost to Follow-up|5|||
170758853|NCT00877851|617123532|FG001|Overall Study|Lost to Follow-up|5|||
170758854|NCT00877851|617123531|FG000|Overall Study|computer problem|3|||
170758855|NCT00877851|617123532|FG001|Overall Study|computer problem|0|||
170758856|NCT00877851|617123531|FG000|Overall Study|no longer interested in participating|1|||
170865777|NCT02038920|617520015|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
170865778|NCT02038920|617520016|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
170865779|NCT02038920|617520017|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
170406514|NCT05266456|615828568|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
170406515|NCT05266456|615828565|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
170406516|NCT05266456|615828566|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
170758857|NCT00877851|617123532|FG001|Overall Study|no longer interested in participating|0|||
170758858|NCT03285711|617123533|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
170758859|NCT03285711|617123534|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
170758860|NCT03285711|617123535|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
170758861|NCT03285711|617123536|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
170758862|NCT03285711|617123533|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
170758863|NCT03285711|617123534|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
170758864|NCT03285711|617123535|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
170758865|NCT03285711|617123536|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
170758866|NCT03285711|617123533|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
170758867|NCT03285711|617123534|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
170758868|NCT03285711|617123535|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
170758869|NCT03285711|617123536|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
170758870|NCT03285711|617123533|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
170758871|NCT03285711|617123534|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
170758872|NCT03285711|617123535|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
170758873|NCT03285711|617123536|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
170758874|NCT03424239|617123537|FG000|Overall Study|Withdrawal by Subject|2|||
170758875|NCT00235495|617123545|FG000|Overall Study|Death|52|||
170758876|NCT00235495|617123546|FG001|Overall Study|Death|42|||
170758877|NCT00235495|617123545|FG000|Overall Study|Withdrawal by Subject|5|||
170758878|NCT00235495|617123546|FG001|Overall Study|Withdrawal by Subject|3|||
170758879|NCT00235495|617123545|FG000|Overall Study|Lost to Follow-up|11|||
170758880|NCT00235495|617123546|FG001|Overall Study|Lost to Follow-up|13|||
170758881|NCT00235495|617123545|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
170758882|NCT00235495|617123546|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
170758883|NCT01446003|617123547|FG000|Period 1|Protocol Violation|2|||
170758884|NCT01446003|617123548|FG001|Period 1|Protocol Violation|0|||
170758885|NCT01446003|617123547|FG000|Period 2|Adverse Event|1|||
170758886|NCT01446003|617123548|FG001|Period 2|Adverse Event|0|||
170758887|NCT00318656|617123549|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
170758888|NCT00318656|617123550|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
170758889|NCT00318656|617123549|FG000|Overall Study|Did not receive any treatment|0|||
170758890|NCT00318656|617123550|FG001|Overall Study|Did not receive any treatment|1|||
170758891|NCT05750745|617123552|FG000|Overall Study|Adverse Event|1|||
170758892|NCT05750745|617123553|FG001|Overall Study|Adverse Event|0|||
170758893|NCT05750745|617123554|FG002|Overall Study|Adverse Event|0|||
170758894|NCT05750745|617123552|FG000|Overall Study|Protocol Violation|1|||
170758895|NCT05750745|617123553|FG001|Overall Study|Protocol Violation|0|||
170758896|NCT05750745|617123554|FG002|Overall Study|Protocol Violation|0|||
170758897|NCT05750745|617123552|FG000|Overall Study|Withdrawal by Subject|0|||
170758898|NCT05750745|617123553|FG001|Overall Study|Withdrawal by Subject|1|||
170758899|NCT05750745|617123554|FG002|Overall Study|Withdrawal by Subject|0|||
170758900|NCT01516892|617123556|FG000|Overall Study|Adverse Event|25|||
170758901|NCT01516892|617123556|FG000|Overall Study|Lack of Efficacy|35|||
170758902|NCT01516892|617123556|FG000|Overall Study|Pregnancy|5|||
170758903|NCT01516892|617123556|FG000|Overall Study|Lost to Follow-up|82|||
170758904|NCT01516892|617123556|FG000|Overall Study|Subject Withdrew Consent|92|||
170758905|NCT01516892|617123556|FG000|Overall Study|Protocol Violation|60|||
170758906|NCT01516892|617123556|FG000|Overall Study|Other Miscellaneous Reasons|43|||
170758907|NCT01516892|617123556|FG000|Overall Study|Missing|1|||
170758908|NCT05096884|617123557|FG000|Overall Study|Excluded based on negative tilt table test|4|||
170758909|NCT02956967|617123558|FG000|Overall Study|Adverse Event|3|||
170758910|NCT02956967|617123558|FG000|Overall Study|Reason non-related to neutropenia|10|||
170758911|NCT02956967|617123558|FG000|Overall Study|Lost to Follow-up|5|||
170758912|NCT02956967|617123558|FG000|Overall Study|Missing|1|||
170758913|NCT02956967|617123558|FG000|Overall Study|Termination of Nivestim administration|29|||
170758914|NCT04888585|617123559|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
170758915|NCT04888585|617123560|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
170758916|NCT04888585|617123561|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
170758917|NCT04888585|617123562|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
170758918|NCT04888585|617123563|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
170758919|NCT04888585|617123564|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
170758920|NCT04888585|617123565|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
170758921|NCT04888585|617123566|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
170758922|NCT04888585|617123567|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
170758923|NCT04888585|617123568|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
170758924|NCT04888585|617123569|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
170758925|NCT04888585|617123559|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
170758926|NCT04888585|617123560|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
170758927|NCT04888585|617123561|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
170758928|NCT04888585|617123562|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
170758929|NCT04888585|617123563|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
170758930|NCT04888585|617123564|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
170758931|NCT04888585|617123565|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
170758932|NCT04888585|617123566|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
170758933|NCT04888585|617123567|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
170758934|NCT04888585|617123568|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
170758935|NCT04888585|617123569|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
170758936|NCT04888585|617123559|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758937|NCT04888585|617123560|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758938|NCT04888585|617123561|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
170758939|NCT04888585|617123562|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758940|NCT04888585|617123563|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
170758941|NCT04888585|617123564|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758942|NCT04888585|617123565|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758943|NCT04888585|617123566|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758944|NCT04888585|617123567|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758945|NCT04888585|617123568|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758946|NCT04888585|617123569|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
170758947|NCT04888585|617123559|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758948|NCT04888585|617123560|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758949|NCT04888585|617123561|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758950|NCT04888585|617123562|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758951|NCT04888585|617123563|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758952|NCT04888585|617123564|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758953|NCT04888585|617123565|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758954|NCT04888585|617123566|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
170758955|NCT04888585|617123567|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758956|NCT04888585|617123568|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
170758957|NCT04888585|617123569|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
170758958|NCT04888585|617123559|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
170758959|NCT04888585|617123560|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
170758960|NCT04888585|617123561|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
170758961|NCT04888585|617123562|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
170758962|NCT04888585|617123563|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
170758963|NCT04888585|617123564|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
170758964|NCT04888585|617123565|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
170758965|NCT04888585|617123566|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
170758966|NCT04888585|617123567|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
170758967|NCT04888585|617123568|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
170758968|NCT04888585|617123569|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
170758969|NCT04888585|617123559|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
170758970|NCT04888585|617123560|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
170758971|NCT04888585|617123561|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
170758972|NCT04888585|617123562|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
170758973|NCT04888585|617123563|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
170758974|NCT04888585|617123564|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
170758975|NCT04888585|617123565|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
170758976|NCT04888585|617123566|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
170758977|NCT04888585|617123567|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
170758978|NCT04888585|617123568|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
170758979|NCT04888585|617123569|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
170758980|NCT04888585|617123559|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
170758981|NCT04888585|617123560|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
170758982|NCT04888585|617123561|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
170758983|NCT04888585|617123562|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
170758984|NCT04888585|617123563|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
170758985|NCT04888585|617123564|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
170758986|NCT04888585|617123565|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
170758987|NCT04888585|617123566|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
170758988|NCT04888585|617123567|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
170758989|NCT04888585|617123568|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
170758990|NCT04888585|617123569|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
170758991|NCT04888585|617123559|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
170758992|NCT04888585|617123560|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
170758993|NCT04888585|617123561|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
170758994|NCT04888585|617123562|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
170758995|NCT04888585|617123563|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
170758996|NCT04888585|617123564|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
170758997|NCT04888585|617123565|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
170758998|NCT04888585|617123566|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
170758999|NCT04888585|617123567|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
170759000|NCT04888585|617123568|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
170759001|NCT04888585|617123569|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
170759002|NCT04927975|617123570|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
170759003|NCT04927975|617123571|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
170759004|NCT04927975|617123572|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
170759005|NCT04927975|617123573|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
170759006|NCT04927975|617123574|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
170759007|NCT04927975|617123575|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
170759008|NCT04927975|617123570|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
170759009|NCT04927975|617123571|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
170759010|NCT04927975|617123572|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
170759011|NCT04927975|617123573|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
170759012|NCT04927975|617123574|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
170759013|NCT04927975|617123575|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
170759014|NCT04927975|617123570|FG000|Period 1 (Baseline-Week 24)|Death|0|||
170759015|NCT04927975|617123571|FG001|Period 1 (Baseline-Week 24)|Death|0|||
170759016|NCT04927975|617123572|FG002|Period 1 (Baseline-Week 24)|Death|0|||
170759017|NCT04927975|617123573|FG003|Period 1 (Baseline-Week 24)|Death|0|||
170759018|NCT04927975|617123574|FG004|Period 1 (Baseline-Week 24)|Death|0|||
170759019|NCT04927975|617123575|FG005|Period 1 (Baseline-Week 24)|Death|1|||
170759020|NCT04927975|617123570|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
170759021|NCT04927975|617123571|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
170759022|NCT04927975|617123572|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
170759023|NCT04927975|617123573|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
170759024|NCT04927975|617123574|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
170759025|NCT04927975|617123575|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
170759026|NCT04927975|617123570|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
170759027|NCT04927975|617123571|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
170759028|NCT04927975|617123572|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
170759029|NCT04927975|617123573|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
170759030|NCT04927975|617123574|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
170759031|NCT04927975|617123575|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
170759032|NCT00783692|617123580|FG000|Induction Phase|Adverse Event|7|||
170759033|NCT00783692|617123581|FG001|Induction Phase|Adverse Event|9|||
170759034|NCT00783692|617123582|FG002|Induction Phase|Adverse Event|24|||
170759035|NCT00783692|617123583|FG003|Induction Phase|Adverse Event|0|||
170759036|NCT00783692|617123584|FG004|Induction Phase|Adverse Event|0|||
170759037|NCT00783692|617123585|FG005|Induction Phase|Adverse Event|0|||
170759038|NCT00783692|617123586|FG006|Induction Phase|Adverse Event|0|||
170759039|NCT00783692|617123580|FG000|Induction Phase|Protocol Violation|0|||
170759040|NCT00783692|617123581|FG001|Induction Phase|Protocol Violation|0|||
170759041|NCT00783692|617123582|FG002|Induction Phase|Protocol Violation|1|||
170759042|NCT00783692|617123583|FG003|Induction Phase|Protocol Violation|0|||
170759043|NCT00783692|617123584|FG004|Induction Phase|Protocol Violation|0|||
170759044|NCT00783692|617123585|FG005|Induction Phase|Protocol Violation|0|||
170759045|NCT00783692|617123586|FG006|Induction Phase|Protocol Violation|0|||
170759046|NCT00783692|617123580|FG000|Induction Phase|Lack of Efficacy|1|||
170759047|NCT00783692|617123581|FG001|Induction Phase|Lack of Efficacy|3|||
170759048|NCT00783692|617123582|FG002|Induction Phase|Lack of Efficacy|28|||
170759049|NCT00783692|617123583|FG003|Induction Phase|Lack of Efficacy|0|||
170759050|NCT00783692|617123584|FG004|Induction Phase|Lack of Efficacy|0|||
170759051|NCT00783692|617123585|FG005|Induction Phase|Lack of Efficacy|0|||
170759052|NCT00783692|617123586|FG006|Induction Phase|Lack of Efficacy|0|||
170759053|NCT00783692|617123580|FG000|Induction Phase|Withdrawal by Subject|3|||
170759054|NCT00783692|617123581|FG001|Induction Phase|Withdrawal by Subject|9|||
170759055|NCT00783692|617123582|FG002|Induction Phase|Withdrawal by Subject|16|||
170759056|NCT00783692|617123583|FG003|Induction Phase|Withdrawal by Subject|0|||
170759057|NCT00783692|617123584|FG004|Induction Phase|Withdrawal by Subject|0|||
170759058|NCT00783692|617123585|FG005|Induction Phase|Withdrawal by Subject|0|||
170759059|NCT00783692|617123586|FG006|Induction Phase|Withdrawal by Subject|0|||
170759060|NCT00783692|617123580|FG000|Induction Phase|Lost to Follow-up|0|||
170759061|NCT00783692|617123581|FG001|Induction Phase|Lost to Follow-up|0|||
170759062|NCT00783692|617123582|FG002|Induction Phase|Lost to Follow-up|3|||
170759063|NCT00783692|617123583|FG003|Induction Phase|Lost to Follow-up|0|||
170759064|NCT00783692|617123584|FG004|Induction Phase|Lost to Follow-up|0|||
170759065|NCT00783692|617123585|FG005|Induction Phase|Lost to Follow-up|0|||
170759066|NCT00783692|617123586|FG006|Induction Phase|Lost to Follow-up|0|||
170759067|NCT00783692|617123580|FG000|Induction Phase|Other|0|||
170759068|NCT00783692|617123581|FG001|Induction Phase|Other|0|||
170759069|NCT00783692|617123582|FG002|Induction Phase|Other|2|||
170865780|NCT02038920|617520012|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
170865781|NCT02038920|617520013|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
170759070|NCT00783692|617123583|FG003|Induction Phase|Other|0|||
170759071|NCT00783692|617123584|FG004|Induction Phase|Other|0|||
170759072|NCT00783692|617123585|FG005|Induction Phase|Other|0|||
170865782|NCT02038920|617520014|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
170759073|NCT00783692|617123586|FG006|Induction Phase|Other|0|||
170759074|NCT00783692|617123580|FG000|Maintenance Phase|Adverse Event|7|||
170759075|NCT00783692|617123581|FG001|Maintenance Phase|Adverse Event|0|||
170759076|NCT00783692|617123582|FG002|Maintenance Phase|Adverse Event|0|||
170759077|NCT00783692|617123583|FG003|Maintenance Phase|Adverse Event|15|||
170759078|NCT00783692|617123584|FG004|Maintenance Phase|Adverse Event|12|||
170759079|NCT00783692|617123585|FG005|Maintenance Phase|Adverse Event|9|||
170759080|NCT00783692|617123586|FG006|Maintenance Phase|Adverse Event|38|||
170759081|NCT00783692|617123580|FG000|Maintenance Phase|Protocol Violation|0|||
170759082|NCT00783692|617123581|FG001|Maintenance Phase|Protocol Violation|0|||
170759083|NCT00783692|617123582|FG002|Maintenance Phase|Protocol Violation|0|||
170759084|NCT00783692|617123583|FG003|Maintenance Phase|Protocol Violation|1|||
170759085|NCT00783692|617123584|FG004|Maintenance Phase|Protocol Violation|2|||
170759086|NCT00783692|617123585|FG005|Maintenance Phase|Protocol Violation|3|||
170759087|NCT00783692|617123586|FG006|Maintenance Phase|Protocol Violation|4|||
170759088|NCT00783692|617123580|FG000|Maintenance Phase|Lack of Efficacy|79|||
170759089|NCT00783692|617123581|FG001|Maintenance Phase|Lack of Efficacy|0|||
170759090|NCT00783692|617123582|FG002|Maintenance Phase|Lack of Efficacy|0|||
170759091|NCT00783692|617123583|FG003|Maintenance Phase|Lack of Efficacy|64|||
170759092|NCT00783692|617123584|FG004|Maintenance Phase|Lack of Efficacy|58|||
170759093|NCT00783692|617123585|FG005|Maintenance Phase|Lack of Efficacy|48|||
170759094|NCT00783692|617123586|FG006|Maintenance Phase|Lack of Efficacy|177|||
170759095|NCT00783692|617123580|FG000|Maintenance Phase|Withdrawal by Subject|7|||
170759096|NCT00783692|617123581|FG001|Maintenance Phase|Withdrawal by Subject|0|||
170759097|NCT00783692|617123582|FG002|Maintenance Phase|Withdrawal by Subject|0|||
170759098|NCT00783692|617123583|FG003|Maintenance Phase|Withdrawal by Subject|7|||
170759099|NCT00783692|617123584|FG004|Maintenance Phase|Withdrawal by Subject|6|||
170759100|NCT00783692|617123585|FG005|Maintenance Phase|Withdrawal by Subject|9|||
170759101|NCT00783692|617123586|FG006|Maintenance Phase|Withdrawal by Subject|24|||
170759102|NCT00783692|617123580|FG000|Maintenance Phase|Lost to Follow-up|2|||
170759103|NCT00783692|617123581|FG001|Maintenance Phase|Lost to Follow-up|0|||
170759104|NCT00783692|617123582|FG002|Maintenance Phase|Lost to Follow-up|0|||
170759105|NCT00783692|617123583|FG003|Maintenance Phase|Lost to Follow-up|1|||
170759106|NCT00783692|617123584|FG004|Maintenance Phase|Lost to Follow-up|3|||
170759107|NCT00783692|617123585|FG005|Maintenance Phase|Lost to Follow-up|2|||
170759108|NCT00783692|617123586|FG006|Maintenance Phase|Lost to Follow-up|5|||
170759109|NCT00783692|617123580|FG000|Maintenance Phase|Other|0|||
170759110|NCT00783692|617123581|FG001|Maintenance Phase|Other|0|||
170759111|NCT00783692|617123582|FG002|Maintenance Phase|Other|0|||
170759112|NCT00783692|617123583|FG003|Maintenance Phase|Other|1|||
170759113|NCT00783692|617123584|FG004|Maintenance Phase|Other|0|||
170759114|NCT00783692|617123585|FG005|Maintenance Phase|Other|1|||
170759115|NCT00783692|617123586|FG006|Maintenance Phase|Other|1|||
170759116|NCT05550337|617123587|FG000|Overall Study|Lack of Efficacy|0|||
170759117|NCT05550337|617123588|FG001|Overall Study|Lack of Efficacy|0|||
170759118|NCT05550337|617123589|FG002|Overall Study|Lack of Efficacy|1|||
170759119|NCT05550337|617123587|FG000|Overall Study|Adverse Event|1|||
170759120|NCT05550337|617123588|FG001|Overall Study|Adverse Event|5|||
170759121|NCT05550337|617123589|FG002|Overall Study|Adverse Event|0|||
170759122|NCT05550337|617123587|FG000|Overall Study|Withdrawal by Subject|8|||
170759123|NCT05550337|617123588|FG001|Overall Study|Withdrawal by Subject|14|||
170759124|NCT05550337|617123589|FG002|Overall Study|Withdrawal by Subject|10|||
170759125|NCT05550337|617123587|FG000|Overall Study|Pregnancy|0|||
170759126|NCT05550337|617123588|FG001|Overall Study|Pregnancy|0|||
170759127|NCT05550337|617123589|FG002|Overall Study|Pregnancy|1|||
170759128|NCT05550337|617123587|FG000|Overall Study|Protocol Violation|1|||
170759129|NCT05550337|617123588|FG001|Overall Study|Protocol Violation|3|||
170759130|NCT05550337|617123589|FG002|Overall Study|Protocol Violation|4|||
170759131|NCT05550337|617123587|FG000|Overall Study|Physician Decision|2|||
170759132|NCT05550337|617123588|FG001|Overall Study|Physician Decision|1|||
170759133|NCT05550337|617123589|FG002|Overall Study|Physician Decision|1|||
170759134|NCT05550337|617123587|FG000|Overall Study|Lost to Follow-up|16|||
170759135|NCT05550337|617123588|FG001|Overall Study|Lost to Follow-up|11|||
170759136|NCT05550337|617123589|FG002|Overall Study|Lost to Follow-up|11|||
170759137|NCT00938340|617123590|FG000|Overall Study|Withdrawal by Subject|3|||
170759138|NCT00938340|617123590|FG000|Overall Study|Protocol Violation|1|||
170759139|NCT00938340|617123590|FG000|Overall Study|Adverse Event|1|||
170759140|NCT00209274|617123594|FG000|Overall Study|Missed visit|3|||
170865783|NCT02038920|617520015|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
170759141|NCT00209274|617123595|FG001|Overall Study|Missed visit|2|||
170759142|NCT00209274|617123594|FG000|Overall Study|Death|32|||
170759143|NCT00209274|617123595|FG001|Overall Study|Death|15|||
170759144|NCT00209274|617123594|FG000|Overall Study|Withdrawal by Subject|30|||
170759145|NCT00209274|617123595|FG001|Overall Study|Withdrawal by Subject|15|||
170759146|NCT00209274|617123594|FG000|Overall Study|Randomized not treated (RNT)|6|||
170759147|NCT00209274|617123595|FG001|Overall Study|Randomized not treated (RNT)|15|||
170759148|NCT03369951|617123596|FG000|Overall Study|Withdrawal by Subject|3|||
170759149|NCT03369951|617123596|FG000|Overall Study|Death|1|||
170759150|NCT03369951|617123596|FG000|Overall Study|Lost to Follow-up|1|||
170865784|NCT02038920|617520016|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
170759151|NCT03369951|617123596|FG000|Overall Study|Protocol Violation|1|||
170759152|NCT00819910|617123597|FG000|Overall Study|Adverse Event|0|||
170759153|NCT00819910|617123598|FG001|Overall Study|Adverse Event|0|||
170759154|NCT00819910|617123599|FG002|Overall Study|Adverse Event|2|||
170759155|NCT00819910|617123600|FG003|Overall Study|Adverse Event|1|||
170759156|NCT00819910|617123597|FG000|Overall Study|Withdrawal by Subject|1|||
170759157|NCT00819910|617123598|FG001|Overall Study|Withdrawal by Subject|1|||
170759158|NCT00819910|617123599|FG002|Overall Study|Withdrawal by Subject|1|||
170759159|NCT00819910|617123600|FG003|Overall Study|Withdrawal by Subject|0|||
170759160|NCT00819910|617123597|FG000|Overall Study|Lost to Follow-up|1|||
170759161|NCT00819910|617123598|FG001|Overall Study|Lost to Follow-up|0|||
170759162|NCT00819910|617123599|FG002|Overall Study|Lost to Follow-up|0|||
170759163|NCT00819910|617123600|FG003|Overall Study|Lost to Follow-up|0|||
170759164|NCT00701311|617123603|FG000|Overall Study|Lack of Efficacy|3|||
170759165|NCT00701311|617123603|FG000|Overall Study|Adverse Event|3|||
170759166|NCT00701311|617123603|FG000|Overall Study|Withdrawal by Subject|2|||
170759167|NCT01772719|617123609|FG000|Overall Study|Withdrawal by Subject|3|||
170759168|NCT01772719|617123609|FG000|Overall Study|Adverse Event|2|||
170759169|NCT01772719|617123609|FG000|Overall Study|Protocol Violation|1|||
170759170|NCT01772719|617123609|FG000|Overall Study|Lost to Follow-up|1|||
170759171|NCT02931396|617123612|FG000|Overall Study|Lost to Follow-up|3|||
170759172|NCT02931396|617123613|FG001|Overall Study|Lost to Follow-up|0|||
170759173|NCT02931396|617123612|FG000|Overall Study|Withdrawal by Subject|2|||
170759174|NCT02931396|617123613|FG001|Overall Study|Withdrawal by Subject|0|||
170759175|NCT05273801|617123614|FG000|Overall Study|Physician Decision|1|||
170759176|NCT01866917|617123621|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
170759177|NCT01866917|617123622|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
170759178|NCT01140347|617123623|FG000|Overall Study|Lost to Follow-up|5|||
170759179|NCT01140347|617123624|FG001|Overall Study|Lost to Follow-up|6|||
170759180|NCT01140347|617123623|FG000|Overall Study|Withdrawal by Subject|13|||
170759181|NCT01140347|617123624|FG001|Overall Study|Withdrawal by Subject|8|||
170759182|NCT00828919|617123625|FG000|Overall Study|Death|0|||
170759183|NCT00828919|617123626|FG001|Overall Study|Death|1|||
170759184|NCT00828919|617123627|FG002|Overall Study|Death|2|||
170759185|NCT00828919|617123628|FG003|Overall Study|Death|0|||
170759186|NCT00828919|617123629|FG004|Overall Study|Death|0|||
170759187|NCT00828919|617123625|FG000|Overall Study|Adverse Event|2|||
170759188|NCT00828919|617123626|FG001|Overall Study|Adverse Event|2|||
170759189|NCT00828919|617123627|FG002|Overall Study|Adverse Event|2|||
170759190|NCT00828919|617123628|FG003|Overall Study|Adverse Event|1|||
170759191|NCT00828919|617123629|FG004|Overall Study|Adverse Event|3|||
170759192|NCT00828919|617123625|FG000|Overall Study|Objective progression or relapse|4|||
170759193|NCT00828919|617123626|FG001|Overall Study|Objective progression or relapse|4|||
170759194|NCT00828919|617123627|FG002|Overall Study|Objective progression or relapse|11|||
170759195|NCT00828919|617123628|FG003|Overall Study|Objective progression or relapse|0|||
170759196|NCT00828919|617123629|FG004|Overall Study|Objective progression or relapse|5|||
170759197|NCT00828919|617123625|FG000|Overall Study|No longer willing to participate in study|0|||
170759198|NCT00828919|617123626|FG001|Overall Study|No longer willing to participate in study|0|||
170759199|NCT00828919|617123627|FG002|Overall Study|No longer willing to participate in study|2|||
170759200|NCT00828919|617123628|FG003|Overall Study|No longer willing to participate in study|0|||
170759201|NCT00828919|617123629|FG004|Overall Study|No longer willing to participate in study|0|||
170759202|NCT00828919|617123625|FG000|Overall Study|Insufficient Clinical Response|0|||
170759203|NCT00828919|617123626|FG001|Overall Study|Insufficient Clinical Response|1|||
170759204|NCT00828919|617123627|FG002|Overall Study|Insufficient Clinical Response|2|||
170759205|NCT00828919|617123628|FG003|Overall Study|Insufficient Clinical Response|0|||
170759206|NCT00828919|617123629|FG004|Overall Study|Insufficient Clinical Response|0|||
170759207|NCT00828919|617123625|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
170759208|NCT00828919|617123626|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
170759209|NCT00828919|617123627|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
170759210|NCT00828919|617123628|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
170759211|NCT00828919|617123629|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
170759212|NCT00828919|617123625|FG000|Overall Study|Other|1|||
170759213|NCT00828919|617123626|FG001|Overall Study|Other|0|||
170759214|NCT00828919|617123627|FG002|Overall Study|Other|1|||
170759215|NCT00828919|617123628|FG003|Overall Study|Other|1|||
170759216|NCT00828919|617123629|FG004|Overall Study|Other|0|||
170759217|NCT00828919|617123625|FG000|Overall Study|Lost to Follow-up|0|||
170759218|NCT00828919|617123626|FG001|Overall Study|Lost to Follow-up|1|||
170865785|NCT02038920|617520017|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
170759219|NCT00828919|617123627|FG002|Overall Study|Lost to Follow-up|0|||
170759220|NCT00828919|617123628|FG003|Overall Study|Lost to Follow-up|0|||
170759221|NCT00828919|617123629|FG004|Overall Study|Lost to Follow-up|0|||
170759222|NCT01562743|617123634|FG000|Overall Study|Adverse Event|29|||
170759223|NCT01562743|617123634|FG000|Overall Study|Lack of Efficacy|3|||
170759224|NCT01562743|617123634|FG000|Overall Study|Withdrawal by Subject|13|||
170759225|NCT01562743|617123634|FG000|Overall Study|Protocol Violation|1|||
170865786|NCT02038920|617520012|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
170759226|NCT01562743|617123634|FG000|Overall Study|Discontinuation criteria|2|||
170759227|NCT01562743|617123634|FG000|Overall Study|Lost to Follow-up|2|||
170759228|NCT01562743|617123634|FG000|Overall Study|Physician Decision|2|||
170759229|NCT05567159|617123635|FG000|Overall Study|Adverse Event|4|||
170759230|NCT05567159|617123635|FG000|Overall Study|Physician Decision|3|||
170759231|NCT05567159|617123635|FG000|Overall Study|Protocol deviation|1|||
170759232|NCT04880161|617123637|FG000|Overall Study|Withdrawal by Subject|1|||
170759233|NCT04880161|617123638|FG001|Overall Study|Withdrawal by Subject|0|||
170759234|NCT04880161|617123637|FG000|Overall Study|Lack of Compliance|1|||
170759235|NCT04880161|617123638|FG001|Overall Study|Lack of Compliance|1|||
170759236|NCT04880161|617123637|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
170759237|NCT04880161|617123638|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
170759238|NCT04880161|617123637|FG000|Overall Study|Screen Failure|0|||
170759239|NCT04880161|617123638|FG001|Overall Study|Screen Failure|1|||
170759240|NCT01959880|617123639|FG000|Overall Study|Withdrawal by Subject|11|||
170759241|NCT01959880|617123640|FG001|Overall Study|Withdrawal by Subject|13|||
170759242|NCT01959880|617123641|FG002|Overall Study|Withdrawal by Subject|8|||
170759243|NCT01959880|617123642|FG003|Overall Study|Withdrawal by Subject|7|||
170759244|NCT01959880|617123639|FG000|Overall Study|Death|1|||
170759245|NCT01959880|617123640|FG001|Overall Study|Death|10|||
170759246|NCT01959880|617123641|FG002|Overall Study|Death|1|||
170759247|NCT01959880|617123642|FG003|Overall Study|Death|2|||
170759248|NCT01959880|617123639|FG000|Overall Study|Lost to Follow-up|95|||
170759249|NCT01959880|617123640|FG001|Overall Study|Lost to Follow-up|18|||
170759250|NCT01959880|617123641|FG002|Overall Study|Lost to Follow-up|15|||
170759251|NCT01959880|617123642|FG003|Overall Study|Lost to Follow-up|8|||
170759252|NCT01959880|617123639|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
170759253|NCT01959880|617123640|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
170759254|NCT01959880|617123641|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
170759255|NCT01959880|617123642|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
170759256|NCT01959880|617123639|FG000|Overall Study|Study completed early-FDA approved|1003|||
170759257|NCT01959880|617123640|FG001|Overall Study|Study completed early-FDA approved|311|||
170759258|NCT01959880|617123641|FG002|Overall Study|Study completed early-FDA approved|179|||
170759259|NCT01959880|617123642|FG003|Overall Study|Study completed early-FDA approved|152|||
170759260|NCT03895034|617125499|FG000|Overall Study|Lost to Follow-up|2|||
170759261|NCT01510912|617125500|FG000|Overall Study|Adverse Event|99|||
170759262|NCT01510912|617125500|FG000|Overall Study|Lack of Efficacy|12|||
170759263|NCT01510912|617125500|FG000|Overall Study|Non-compliance with trial drug|23|||
170759264|NCT01510912|617125500|FG000|Overall Study|Withdrawal by Subject|49|||
170759265|NCT01510912|617125500|FG000|Overall Study|Physician Decision|1|||
170759266|NCT01510912|617125500|FG000|Overall Study|Protocol Violation|27|||
170759267|NCT01510912|617125500|FG000|Overall Study|Lost to Follow-up|26|||
170759268|NCT01510912|617125500|FG000|Overall Study|Other, including joint replacement|5|||
170759269|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
170759270|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
170759271|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
170759272|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
170759273|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Adverse Event|198|||
170759274|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Adverse Event|0|||
170759275|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Adverse Event|0|||
170759276|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Adverse Event|0|||
170759277|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Death|62|||
170759278|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Death|0|||
170759279|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Death|0|||
170759280|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Death|0|||
170759281|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
170759282|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
170759283|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
170759284|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
170759285|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Complicating disease|13|||
170406517|NCT05266456|615828567|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
170759286|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Complicating disease|0|||
170406518|NCT05266456|615828568|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
170406519|NCT05266456|615828565|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
170759287|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Complicating disease|0|||
170759288|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Complicating disease|0|||
170759289|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
170759290|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
170759291|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
170759292|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
170759293|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
170759294|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
170759295|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
170759296|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
170759297|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Non-compliance|4|||
170759298|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Non-compliance|0|||
170759299|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Non-compliance|0|||
170759300|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Non-compliance|0|||
170759301|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Pain|4|||
170759302|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Pain|0|||
170759303|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Pain|0|||
170759304|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Pain|0|||
170759305|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
170759306|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
170759307|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
170759308|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
170759309|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Hospice care|1|||
170759310|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Hospice care|0|||
170759311|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Hospice care|0|||
170759312|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Hospice care|0|||
170759313|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Physician Decision|1|||
170759314|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Physician Decision|0|||
170759315|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Physician Decision|0|||
170759316|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Physician Decision|0|||
170759317|NCT01107626|617125503|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
170759318|NCT01107626|617125504|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
170759319|NCT01107626|617125505|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
170759320|NCT01107626|617125506|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
170759321|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
170759322|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
170759323|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
170759324|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
170759325|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
170759326|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
170759327|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
170759328|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
170759329|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Death|0|||
170759330|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Death|8|||
170759331|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Death|2|||
170759332|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Death|13|||
170759333|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
170759334|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
170759335|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
170759336|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
170759337|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
170759338|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
170759339|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
170759340|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
170759341|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
170759342|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
170759343|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
170759344|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
170759345|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
170759346|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
170759347|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
170759348|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
170759349|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
170759350|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
170759351|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
170759352|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
170759353|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
170759354|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
170759355|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
170759356|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
170759357|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
170759358|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
170759359|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
170759360|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
170759361|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
170759362|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
170759363|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
170759364|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
170759365|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
170759366|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
170759367|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
170759368|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
170759369|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
170759370|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
170759371|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
170759372|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
170759373|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Pain|0|||
170759374|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Pain|0|||
170759375|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Pain|0|||
170759376|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Pain|1|||
170759377|NCT01107626|617125503|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
170759378|NCT01107626|617125504|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
170759379|NCT01107626|617125505|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
170759380|NCT01107626|617125506|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
170759381|NCT01977612|617125507|FG000|Overall Study|Lost to Follow-up|1|||
170759382|NCT01977612|617125508|FG001|Overall Study|Lost to Follow-up|1|||
170759383|NCT02715258|617125509|FG000|Overall Study|Withdrawal by Subject|6|||
170759384|NCT02715258|617125510|FG001|Overall Study|Withdrawal by Subject|1|||
170759385|NCT02715258|617125509|FG000|Overall Study|Lost to Follow-up|7|||
170759386|NCT02715258|617125510|FG001|Overall Study|Lost to Follow-up|1|||
170759387|NCT02715258|617125509|FG000|Overall Study|Terminated by Sponsor|0|||
170759388|NCT02715258|617125510|FG001|Overall Study|Terminated by Sponsor|1|||
170759389|NCT02715258|617125509|FG000|Overall Study|Death|0|||
170759390|NCT02715258|617125510|FG001|Overall Study|Death|1|||
170759391|NCT02715258|617125509|FG000|Overall Study|Subject non-compliant|1|||
170759392|NCT02715258|617125510|FG001|Overall Study|Subject non-compliant|1|||
170759393|NCT02715258|617125509|FG000|Overall Study|GCP violation|2|||
170759394|NCT02715258|617125510|FG001|Overall Study|GCP violation|1|||
170759395|NCT03467724|617125511|FG000|Overall Study|Lost to Follow-up|5|||
170759396|NCT03467724|617125511|FG000|Overall Study|Withdrawal by Subject|1|||
170759397|NCT03467724|617125511|FG000|Overall Study|Protocol Violation|1|||
170759398|NCT03467724|617125511|FG000|Overall Study|Adverse Event|1|||
170759399|NCT04310579|617125512|FG000|Overall Study|Adverse Event|0|||
170759400|NCT04310579|617125513|FG001|Overall Study|Adverse Event|0|||
170759401|NCT04310579|617125514|FG002|Overall Study|Adverse Event|0|||
170759402|NCT04310579|617125515|FG003|Overall Study|Adverse Event|0|||
170759403|NCT04310579|617125516|FG004|Overall Study|Adverse Event|0|||
170759404|NCT04310579|617125517|FG005|Overall Study|Adverse Event|0|||
170759405|NCT04310579|617125518|FG006|Overall Study|Adverse Event|2|||
170759406|NCT04310579|617125519|FG007|Overall Study|Adverse Event|0|||
170759407|NCT04310579|617125520|FG008|Overall Study|Adverse Event|1|||
170759408|NCT04310579|617125521|FG009|Overall Study|Adverse Event|1|||
170759409|NCT04310579|617125522|FG010|Overall Study|Adverse Event|0|||
170759410|NCT04310579|617125512|FG000|Overall Study|Withdrawal by Subject|0|||
170759411|NCT04310579|617125513|FG001|Overall Study|Withdrawal by Subject|0|||
170759412|NCT04310579|617125514|FG002|Overall Study|Withdrawal by Subject|0|||
170759413|NCT04310579|617125515|FG003|Overall Study|Withdrawal by Subject|0|||
170759414|NCT04310579|617125516|FG004|Overall Study|Withdrawal by Subject|0|||
170759415|NCT04310579|617125517|FG005|Overall Study|Withdrawal by Subject|1|||
170759416|NCT04310579|617125518|FG006|Overall Study|Withdrawal by Subject|0|||
170759417|NCT04310579|617125519|FG007|Overall Study|Withdrawal by Subject|0|||
170759418|NCT04310579|617125520|FG008|Overall Study|Withdrawal by Subject|0|||
170759419|NCT04310579|617125521|FG009|Overall Study|Withdrawal by Subject|0|||
170759420|NCT04310579|617125522|FG010|Overall Study|Withdrawal by Subject|0|||
170759421|NCT04310579|617125512|FG000|Overall Study|Positive COVID-19 test|0|||
170759422|NCT04310579|617125513|FG001|Overall Study|Positive COVID-19 test|0|||
170759423|NCT04310579|617125514|FG002|Overall Study|Positive COVID-19 test|0|||
170759424|NCT04310579|617125515|FG003|Overall Study|Positive COVID-19 test|0|||
170759425|NCT04310579|617125516|FG004|Overall Study|Positive COVID-19 test|0|||
170759426|NCT04310579|617125517|FG005|Overall Study|Positive COVID-19 test|0|||
170759427|NCT04310579|617125518|FG006|Overall Study|Positive COVID-19 test|0|||
170759428|NCT04310579|617125519|FG007|Overall Study|Positive COVID-19 test|0|||
170759429|NCT04310579|617125520|FG008|Overall Study|Positive COVID-19 test|0|||
170759430|NCT04310579|617125521|FG009|Overall Study|Positive COVID-19 test|0|||
170759431|NCT04310579|617125522|FG010|Overall Study|Positive COVID-19 test|1|||
170759432|NCT00686517|617125533|FG000|Treatment|Serious Adverse Event|1|||
170759433|NCT00686517|617125534|FG001|Treatment|Serious Adverse Event|2|||
170759434|NCT00686517|617125535|FG002|Treatment|Serious Adverse Event|1|||
170759435|NCT00686517|617125533|FG000|Treatment|Adverse Event|2|||
170759436|NCT00686517|617125534|FG001|Treatment|Adverse Event|0|||
170759437|NCT00686517|617125535|FG002|Treatment|Adverse Event|0|||
170759438|NCT00686517|617125533|FG000|Treatment|Poor Protocol Compliance|1|||
170759439|NCT00686517|617125534|FG001|Treatment|Poor Protocol Compliance|0|||
170759440|NCT00686517|617125535|FG002|Treatment|Poor Protocol Compliance|0|||
170759441|NCT00686517|617125533|FG000|Treatment|Protocol Violation|2|||
170759442|NCT00686517|617125534|FG001|Treatment|Protocol Violation|1|||
170759443|NCT00686517|617125535|FG002|Treatment|Protocol Violation|0|||
170759444|NCT01020838|617125536|FG000|Overall Study|Death|90|||
170759445|NCT01020838|617125536|FG000|Overall Study|Adverse Event|1|||
170759446|NCT01020838|617125536|FG000|Overall Study|Withdrawal by Subject|9|||
170759447|NCT01020838|617125536|FG000|Overall Study|Lost to Follow-up|6|||
170759448|NCT01020838|617125536|FG000|Overall Study|Most common: Study ended by sponsor|77|||
170759449|NCT02993471|617125537|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
170759450|NCT02993471|617125537|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
170759451|NCT02145182|617125538|FG000|Overall Study|Adverse Event|4|||
170759452|NCT02145182|617125539|FG001|Overall Study|Adverse Event|1|||
170759453|NCT02145182|617125538|FG000|Overall Study|Death|7|||
170759454|NCT02145182|617125539|FG001|Overall Study|Death|7|||
170759455|NCT02145182|617125538|FG000|Overall Study|Lost to Follow-up|2|||
170759456|NCT02145182|617125539|FG001|Overall Study|Lost to Follow-up|2|||
170759457|NCT02145182|617125538|FG000|Overall Study|Pre-transplant Withdrawal|0|||
170759458|NCT02145182|617125539|FG001|Overall Study|Pre-transplant Withdrawal|2|||
170759459|NCT02145182|617125538|FG000|Overall Study|Withdrawal by Subject|5|||
170759460|NCT02145182|617125539|FG001|Overall Study|Withdrawal by Subject|4|||
170759461|NCT00282438|617125541|FG000|Overall Study|Lack of Efficacy|1|||
170759462|NCT00282438|617125542|FG001|Overall Study|Lack of Efficacy|0|||
170759463|NCT00282438|617125541|FG000|Overall Study|Death|0|||
170759464|NCT00282438|617125542|FG001|Overall Study|Death|1|||
170759465|NCT03178201|617125546|FG000|Overall Study|Off study|5|||
170759466|NCT00880906|617125549|FG000|Overall Study|Lost to Follow-up|0|||
170759467|NCT00880906|617125550|FG001|Overall Study|Lost to Follow-up|1|||
170759468|NCT00880906|617125549|FG000|Overall Study|Did not meet criteria following patholog|12|||
170759469|NCT00880906|617125550|FG001|Overall Study|Did not meet criteria following patholog|6|||
170759470|NCT05487703|617125553|FG000|Overall Study|Other|19|||
170759471|NCT05487703|617125553|FG000|Overall Study|Participant not well|5|||
170759472|NCT05487703|617125553|FG000|Overall Study|Insurance Reasons|6|||
170759473|NCT05487703|617125553|FG000|Overall Study|Physician Decision|19|||
170759474|NCT05487703|617125553|FG000|Overall Study|Lack of Efficacy|60|||
170759475|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
170759476|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
170759477|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
170759478|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Death|3|||
170759479|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Death|0|||
170759480|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Death|0|||
170759481|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
170759482|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
170759483|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
170759484|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
170759485|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
170759486|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
170759487|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
170759488|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
170759489|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
170759490|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
170759491|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
170759492|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
170759493|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
170759494|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
170759495|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
170759496|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Other|1|||
170759497|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Other|0|||
170759498|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Other|0|||
170759499|NCT02403323|617125554|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
170759500|NCT02403323|617125555|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
170759501|NCT02403323|617125556|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
170759502|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
170759503|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
170759504|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
170759505|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
170759506|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
170759507|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
170759508|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
170759509|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
170759510|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
170759511|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
170759512|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
170759513|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
170759514|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
170759515|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
170759516|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
170759517|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
170759518|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
170759519|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
170759520|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
170759521|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
170759522|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
170759523|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
170759524|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
170759525|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
170759526|NCT02403323|617125554|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
170759527|NCT02403323|617125555|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
170759528|NCT02403323|617125556|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
170759529|NCT01076335|617125559|FG000|Overall Study|Withdrawal by Subject|3|||
170759530|NCT01076335|617125559|FG000|Overall Study|Withdrawal without treatment|1|||
170759531|NCT02939183|617125562|FG000|Overall Study|Death|0|||
170759532|NCT02939183|617125563|FG001|Overall Study|Death|0|||
170759533|NCT02939183|617125564|FG002|Overall Study|Death|1|||
170759534|NCT02939183|617125565|FG003|Overall Study|Death|0|||
170759535|NCT02939183|617125566|FG004|Overall Study|Death|0|||
170759536|NCT02939183|617125567|FG005|Overall Study|Death|2|||
170759537|NCT02939183|617125568|FG006|Overall Study|Death|1|||
170759538|NCT02939183|617125569|FG007|Overall Study|Death|0|||
170759539|NCT02939183|617125570|FG008|Overall Study|Death|0|||
170759540|NCT02939183|617125562|FG000|Overall Study|Sponsor decision|0|||
170759541|NCT02939183|617125563|FG001|Overall Study|Sponsor decision|1|||
170759542|NCT02939183|617125564|FG002|Overall Study|Sponsor decision|0|||
170759543|NCT02939183|617125565|FG003|Overall Study|Sponsor decision|1|||
170759544|NCT02939183|617125566|FG004|Overall Study|Sponsor decision|2|||
170759545|NCT02939183|617125567|FG005|Overall Study|Sponsor decision|0|||
170759546|NCT02939183|617125568|FG006|Overall Study|Sponsor decision|3|||
170759547|NCT02939183|617125569|FG007|Overall Study|Sponsor decision|1|||
170759548|NCT02939183|617125570|FG008|Overall Study|Sponsor decision|4|||
170759549|NCT02939183|617125562|FG000|Overall Study|Withdrawal by Subject|0|||
170759550|NCT02939183|617125563|FG001|Overall Study|Withdrawal by Subject|2|||
170759551|NCT02939183|617125564|FG002|Overall Study|Withdrawal by Subject|0|||
170759552|NCT02939183|617125565|FG003|Overall Study|Withdrawal by Subject|1|||
170759553|NCT02939183|617125566|FG004|Overall Study|Withdrawal by Subject|0|||
170759554|NCT02939183|617125567|FG005|Overall Study|Withdrawal by Subject|0|||
170759555|NCT02939183|617125568|FG006|Overall Study|Withdrawal by Subject|2|||
170759556|NCT02939183|617125569|FG007|Overall Study|Withdrawal by Subject|2|||
170759557|NCT02939183|617125570|FG008|Overall Study|Withdrawal by Subject|2|||
170759558|NCT02939183|617125562|FG000|Overall Study|Not treated due to adverse event|0|||
170759559|NCT02939183|617125563|FG001|Overall Study|Not treated due to adverse event|0|||
170759560|NCT02939183|617125564|FG002|Overall Study|Not treated due to adverse event|0|||
170759561|NCT02939183|617125565|FG003|Overall Study|Not treated due to adverse event|1|||
170759562|NCT02939183|617125566|FG004|Overall Study|Not treated due to adverse event|0|||
170759563|NCT02939183|617125567|FG005|Overall Study|Not treated due to adverse event|0|||
170759564|NCT02939183|617125568|FG006|Overall Study|Not treated due to adverse event|1|||
170759565|NCT02939183|617125569|FG007|Overall Study|Not treated due to adverse event|0|||
170759566|NCT02939183|617125570|FG008|Overall Study|Not treated due to adverse event|0|||
170759567|NCT05015478|617125571|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
170759568|NCT05015478|617125572|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
170759569|NCT05015478|617125573|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
170759570|NCT05015478|617125574|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
170759571|NCT04939428|617125575|FG000|Overall Study|Death|0|||
170759572|NCT04939428|617125576|FG001|Overall Study|Death|1|||
170759573|NCT04939428|617125577|FG002|Overall Study|Death|0|||
170759574|NCT04939428|617125575|FG000|Overall Study|Lost to Follow-up|0|||
170759575|NCT04939428|617125576|FG001|Overall Study|Lost to Follow-up|5|||
170759576|NCT04939428|617125577|FG002|Overall Study|Lost to Follow-up|0|||
170759577|NCT04939428|617125575|FG000|Overall Study|Physician Decision|1|||
170759578|NCT04939428|617125576|FG001|Overall Study|Physician Decision|0|||
170759579|NCT04939428|617125577|FG002|Overall Study|Physician Decision|0|||
170759580|NCT04939428|617125575|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170759581|NCT04939428|617125576|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170759582|NCT04939428|617125577|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170759583|NCT04939428|617125575|FG000|Overall Study|Withdrawal by Subject|10|||
170759584|NCT04939428|617125576|FG001|Overall Study|Withdrawal by Subject|11|||
170759585|NCT04939428|617125577|FG002|Overall Study|Withdrawal by Subject|0|||
170759586|NCT04939428|617125575|FG000|Overall Study|Unkown|6|||
170759587|NCT04939428|617125576|FG001|Overall Study|Unkown|3|||
170759588|NCT04939428|617125577|FG002|Overall Study|Unkown|0|||
170759589|NCT04939428|617125575|FG000|Overall Study|Discotinued per protocol|0|||
170759590|NCT04939428|617125576|FG001|Overall Study|Discotinued per protocol|0|||
170759591|NCT04939428|617125577|FG002|Overall Study|Discotinued per protocol|902|||
170759592|NCT01018511|617125580|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
170759593|NCT01018511|617125581|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
170759594|NCT01018511|617125582|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
170759595|NCT01018511|617125583|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
170759596|NCT01018511|617125580|FG000|Overall Study|Adverse Event|5|||
170759597|NCT01018511|617125581|FG001|Overall Study|Adverse Event|9|||
170759598|NCT01018511|617125582|FG002|Overall Study|Adverse Event|13|||
170759599|NCT01018511|617125583|FG003|Overall Study|Adverse Event|10|||
170759600|NCT01018511|617125580|FG000|Overall Study|Lack of Efficacy|4|||
170759601|NCT01018511|617125581|FG001|Overall Study|Lack of Efficacy|1|||
170759602|NCT01018511|617125582|FG002|Overall Study|Lack of Efficacy|1|||
170759603|NCT01018511|617125583|FG003|Overall Study|Lack of Efficacy|2|||
170759604|NCT01018511|617125580|FG000|Overall Study|Withdrawal by Subject|6|||
170759605|NCT01018511|617125581|FG001|Overall Study|Withdrawal by Subject|5|||
170759606|NCT01018511|617125582|FG002|Overall Study|Withdrawal by Subject|11|||
170759607|NCT01018511|617125583|FG003|Overall Study|Withdrawal by Subject|9|||
170759608|NCT01018511|617125580|FG000|Overall Study|Lost to Follow-up|0|||
170759609|NCT01018511|617125581|FG001|Overall Study|Lost to Follow-up|0|||
170759610|NCT01018511|617125582|FG002|Overall Study|Lost to Follow-up|1|||
170759611|NCT01018511|617125583|FG003|Overall Study|Lost to Follow-up|0|||
170759612|NCT01018511|617125580|FG000|Overall Study|Protocol Violation|5|||
170759613|NCT01018511|617125581|FG001|Overall Study|Protocol Violation|8|||
170759614|NCT01018511|617125582|FG002|Overall Study|Protocol Violation|7|||
170759615|NCT01018511|617125583|FG003|Overall Study|Protocol Violation|9|||
170759616|NCT01018511|617125580|FG000|Overall Study|Miscellaneous|0|||
170759617|NCT01018511|617125581|FG001|Overall Study|Miscellaneous|2|||
170759618|NCT01018511|617125582|FG002|Overall Study|Miscellaneous|0|||
170759619|NCT01018511|617125583|FG003|Overall Study|Miscellaneous|0|||
170759620|NCT04863898|617125585|FG000|Overall Study|Away from study clinic during intervention training period|2|||
170759621|NCT04863898|617125585|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
170759622|NCT04863898|617125585|FG000|Overall Study|Lost to Follow-up|3|||
170865787|NCT02038920|617520013|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
170865788|NCT02038920|617520014|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
170865789|NCT02038920|617520015|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
170865790|NCT02038920|617520016|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
170865791|NCT02038920|617520017|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
170865792|NCT02038920|617520012|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
170865793|NCT02038920|617520013|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
170865794|NCT02038920|617520014|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
170865795|NCT02038920|617520015|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
170865796|NCT02038920|617520016|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
170865797|NCT02038920|617520017|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
170865798|NCT02038920|617520012|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
170865799|NCT02038920|617520013|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
170865800|NCT02038920|617520014|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
170865801|NCT02038920|617520015|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
170865802|NCT02038920|617520016|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
170865803|NCT02038920|617520017|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
170865804|NCT02038920|617520012|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
170865805|NCT02038920|617520013|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
170865806|NCT02038920|617520014|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
170865807|NCT02038920|617520015|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
170865808|NCT02038920|617520016|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
170865809|NCT02038920|617520017|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
170865810|NCT03040622|617520018|FG000|Overall Study|unable to implant device|3|||
170865811|NCT02818920|617520019|FG000|Overall Study|Unresectable|4|||
170865812|NCT02818920|617520019|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
170759623|NCT04863898|617125585|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
170759624|NCT04863898|617125585|FG000|Overall Study|No longer employed at clinic|3|||
170759625|NCT00654238|617125586|FG000|Overall Study|Screen Failures|4|||
170759626|NCT00614744|617125587|FG000|Overall Study|Lost to Follow-up|5|||
170865813|NCT02818920|617520019|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
170865814|NCT02818920|617520019|FG000|Overall Study|Adverse Event|3|||
170759627|NCT00614744|617125588|FG001|Overall Study|Lost to Follow-up|4|||
170759628|NCT00614744|617125587|FG000|Overall Study|Incomplete for Behavior Issues|0|||
170865815|NCT02818920|617520019|FG000|Overall Study|Developed Other Disease|1|||
170759629|NCT00614744|617125588|FG001|Overall Study|Incomplete for Behavior Issues|2|||
170759630|NCT03905135|617125589|FG000|Dose Escalation|Adverse Event|1|||
170759631|NCT03905135|617125590|FG001|Dose Escalation|Adverse Event|1|||
170759632|NCT03905135|617125589|FG000|Dose Escalation|Progressive disease|3|||
170759633|NCT03905135|617125590|FG001|Dose Escalation|Progressive disease|1|||
170759634|NCT03905135|617125589|FG000|Dose Escalation|Intercurrent illness|1|||
170759635|NCT03905135|617125590|FG001|Dose Escalation|Intercurrent illness|0|||
170759636|NCT04523181|617125591|FG000|Overall Study|Withdrawal by Subject|4|||
170759637|NCT04523181|617125592|FG001|Overall Study|Withdrawal by Subject|5|||
170759638|NCT04523181|617125591|FG000|Overall Study|Lost to Follow-up|2|||
170759639|NCT04523181|617125592|FG001|Overall Study|Lost to Follow-up|3|||
170759640|NCT04523181|617125591|FG000|Overall Study|Physician Decision|1|||
170759641|NCT04523181|617125592|FG001|Overall Study|Physician Decision|0|||
170759642|NCT04523181|617125591|FG000|Overall Study|Transferred to external facility.|1|||
170759643|NCT04523181|617125592|FG001|Overall Study|Transferred to external facility.|1|||
170759644|NCT00490555|617125593|FG000|Overall Study|noncompliant with drug administration|0|||
170759645|NCT00490555|617125594|FG001|Overall Study|noncompliant with drug administration|0|||
170759646|NCT00490555|617125595|FG002|Overall Study|noncompliant with drug administration|2|||
170759647|NCT00490555|617125596|FG003|Overall Study|noncompliant with drug administration|0|||
170759648|NCT01268566|617125597|FG000|Overall Study|Lost to Follow-up|1|||
170759649|NCT01268566|617125597|FG000|Overall Study|Withdrawal by Subject|12|||
170759650|NCT01268566|617125597|FG000|Overall Study|Death|30|||
170759651|NCT01649427|617125604|FG000|Overall Study|Adverse Event|1|||
170759652|NCT01649427|617125605|FG001|Overall Study|Adverse Event|1|||
170759653|NCT01649427|617125604|FG000|Overall Study|Withdrawal by Subject|8|||
170759654|NCT01649427|617125605|FG001|Overall Study|Withdrawal by Subject|7|||
170759655|NCT01649427|617125604|FG000|Overall Study|Lost to Follow-up|0|||
170759656|NCT01649427|617125605|FG001|Overall Study|Lost to Follow-up|1|||
170759657|NCT01649427|617125604|FG000|Overall Study|Graft loss|0|||
170759658|NCT01649427|617125605|FG001|Overall Study|Graft loss|1|||
170759659|NCT01649427|617125604|FG000|Overall Study|Surgical problems during nephrectomy|2|||
170759660|NCT01649427|617125605|FG001|Overall Study|Surgical problems during nephrectomy|2|||
170759661|NCT01007149|617125608|FG000|Overall Study|Administrative problems|0|||
170759662|NCT01007149|617125609|FG001|Overall Study|Administrative problems|1|||
170759663|NCT00603538|617125610|FG000|Overall Study|Adverse Event|0|||
170759664|NCT00603538|617125611|FG001|Overall Study|Adverse Event|4|||
170759665|NCT00603538|617125612|FG002|Overall Study|Adverse Event|2|||
170759666|NCT00603538|617125610|FG000|Overall Study|Objective progression or relapse|3|||
170759667|NCT00603538|617125611|FG001|Overall Study|Objective progression or relapse|0|||
170759668|NCT00603538|617125612|FG002|Overall Study|Objective progression or relapse|0|||
170759669|NCT03822351|617125618|FG000|Overall Study|Death|27|||
170759670|NCT03822351|617125619|FG001|Overall Study|Death|23|||
170759671|NCT03822351|617125620|FG002|Overall Study|Death|24|||
170759672|NCT03822351|617125618|FG000|Overall Study|Lost to Follow-up|6|||
170759673|NCT03822351|617125619|FG001|Overall Study|Lost to Follow-up|2|||
170759674|NCT03822351|617125620|FG002|Overall Study|Lost to Follow-up|1|||
170759675|NCT03822351|617125618|FG000|Overall Study|Withdrawal by Subject|10|||
170759676|NCT03822351|617125619|FG001|Overall Study|Withdrawal by Subject|4|||
170759677|NCT03822351|617125620|FG002|Overall Study|Withdrawal by Subject|6|||
170759678|NCT03822351|617125618|FG000|Overall Study|Progressive Disease|2|||
170759679|NCT03822351|617125619|FG001|Overall Study|Progressive Disease|1|||
170759680|NCT03822351|617125620|FG002|Overall Study|Progressive Disease|0|||
170759681|NCT03822351|617125618|FG000|Overall Study|Not Treated|1|||
170759682|NCT03822351|617125619|FG001|Overall Study|Not Treated|1|||
170759683|NCT03822351|617125620|FG002|Overall Study|Not Treated|1|||
170759684|NCT01096056|617125621|FG000|Overall Study|Lost to Follow-up|0|||
170759685|NCT01096056|617125622|FG001|Overall Study|Lost to Follow-up|1|||
170759686|NCT02753530|617125629|FG000|Overall Study|Adverse Event|7|||
170759687|NCT02753530|617125630|FG001|Overall Study|Adverse Event|1|||
170759688|NCT02753530|617125629|FG000|Overall Study|Death|0|||
170759689|NCT02753530|617125630|FG001|Overall Study|Death|1|||
170759690|NCT02753530|617125629|FG000|Overall Study|Physician Decision|0|||
170759691|NCT02753530|617125630|FG001|Overall Study|Physician Decision|1|||
170759692|NCT02753530|617125629|FG000|Overall Study|Protocol Violation|1|||
170759693|NCT02753530|617125630|FG001|Overall Study|Protocol Violation|0|||
170759694|NCT02753530|617125629|FG000|Overall Study|Withdrawal by Subject|4|||
170759695|NCT02753530|617125630|FG001|Overall Study|Withdrawal by Subject|3|||
170759696|NCT03590743|617125631|FG000|Overall Study|Withdrawal by Subject|0|||
170759697|NCT03590743|617125632|FG001|Overall Study|Withdrawal by Subject|1|||
170759698|NCT01836458|617125633|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
170759699|NCT01836458|617125634|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170759700|NCT01836458|617125635|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
170759701|NCT01836458|617125636|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
170759702|NCT02189863|617125637|FG000|First 2 Weeks|Motion Sickness|4|||
170759703|NCT02189863|617125638|FG001|First 2 Weeks|Motion Sickness|2|||
170759704|NCT02926937|617125641|FG000|Overall Study|Adverse Event|0|||
170759705|NCT02926937|617125642|FG001|Overall Study|Adverse Event|1|||
170759706|NCT02926937|617125643|FG002|Overall Study|Adverse Event|1|||
170759707|NCT02926937|617125641|FG000|Overall Study|Poor Compliance to Protocol|1|||
170759708|NCT02926937|617125642|FG001|Overall Study|Poor Compliance to Protocol|0|||
170759709|NCT02926937|617125643|FG002|Overall Study|Poor Compliance to Protocol|0|||
170759710|NCT02926937|617125641|FG000|Overall Study|Lost to Follow-up|4|||
170759711|NCT02926937|617125642|FG001|Overall Study|Lost to Follow-up|5|||
170759712|NCT02926937|617125643|FG002|Overall Study|Lost to Follow-up|0|||
170759713|NCT02926937|617125641|FG000|Overall Study|At the Participant's own Request|11|||
170759714|NCT02926937|617125642|FG001|Overall Study|At the Participant's own Request|5|||
170759715|NCT02926937|617125643|FG002|Overall Study|At the Participant's own Request|8|||
170759716|NCT02926937|617125641|FG000|Overall Study|Reason not Specified|3|||
170759717|NCT02926937|617125642|FG001|Overall Study|Reason not Specified|4|||
170759718|NCT02926937|617125643|FG002|Overall Study|Reason not Specified|2|||
170759719|NCT00097370|617125644|FG000|Stage 1|Adverse Event|3|||
170759720|NCT00097370|617125644|FG000|Stage 1|Withdrawal by Subject|1|||
170759721|NCT00097370|617125644|FG000|Stage 1|Lack of Efficacy|2|||
170759722|NCT00097370|617125644|FG000|Stage 2|Adverse Event|5|||
170759723|NCT00097370|617125644|FG000|Stage 2|Withdrawal by Subject|1|||
170759724|NCT00097370|617125644|FG000|Stage 2|Lack of Efficacy|3|||
170759725|NCT00097370|617125644|FG000|Stage 2|Pregnancy|1|||
170759726|NCT00097370|617125644|FG000|Stage 2|Sponsor Terminated Study|2|||
170759727|NCT00097370|617125644|FG000|Stage 2|Lost to Follow-up|1|||
170759728|NCT00097370|617125644|FG000|Stage 3|Adverse Event|2|||
170759729|NCT00097370|617125644|FG000|Stage 3|Withdrawal by Subject|3|||
170759730|NCT00097370|617125644|FG000|Stage 3|Lack of Efficacy|1|||
170759731|NCT00097370|617125644|FG000|Stage 3|Sponsor Terminated Study|52|||
170759732|NCT00097370|617125644|FG000|Stage 3|Lost to Follow-up|1|||
170759733|NCT00561574|617125654|FG000|Overall Study|Adverse Event|21|||
170759734|NCT00561574|617125655|FG001|Overall Study|Adverse Event|24|||
170759735|NCT00561574|617125654|FG000|Overall Study|Lack of Efficacy|11|||
170759736|NCT00561574|617125655|FG001|Overall Study|Lack of Efficacy|21|||
170759737|NCT00561574|617125654|FG000|Overall Study|Withdrawal by Subject|4|||
170759738|NCT00561574|617125655|FG001|Overall Study|Withdrawal by Subject|4|||
170759739|NCT00561574|617125654|FG000|Overall Study|Reason Unrelated to Trial|6|||
170759740|NCT00561574|617125655|FG001|Overall Study|Reason Unrelated to Trial|2|||
170759741|NCT00561574|617125654|FG000|Overall Study|Lost to Follow-up|1|||
170759742|NCT00561574|617125655|FG001|Overall Study|Lost to Follow-up|0|||
170759743|NCT00561574|617125654|FG000|Overall Study|Other|5|||
170759744|NCT00561574|617125655|FG001|Overall Study|Other|7|||
170759745|NCT00477412|617125656|FG000|Overall Study|Death|0|||
170759746|NCT00477412|617125657|FG001|Overall Study|Death|0|||
170759747|NCT00477412|617125658|FG002|Overall Study|Death|0|||
170759748|NCT00477412|617125659|FG003|Overall Study|Death|4|||
170759749|NCT00477412|617125656|FG000|Overall Study|Lost to Follow-up|0|||
170759750|NCT00477412|617125657|FG001|Overall Study|Lost to Follow-up|0|||
170759751|NCT00477412|617125658|FG002|Overall Study|Lost to Follow-up|0|||
170759752|NCT00477412|617125659|FG003|Overall Study|Lost to Follow-up|1|||
170759753|NCT00477412|617125656|FG000|Overall Study|Withdrawal by Subject|0|||
170759754|NCT00477412|617125657|FG001|Overall Study|Withdrawal by Subject|0|||
170759755|NCT00477412|617125658|FG002|Overall Study|Withdrawal by Subject|0|||
170759756|NCT00477412|617125659|FG003|Overall Study|Withdrawal by Subject|2|||
170759757|NCT00477412|617125656|FG000|Overall Study|Second Malignancy|0|||
170759758|NCT00477412|617125657|FG001|Overall Study|Second Malignancy|0|||
170759759|NCT00477412|617125658|FG002|Overall Study|Second Malignancy|0|||
170759760|NCT00477412|617125659|FG003|Overall Study|Second Malignancy|1|||
170759761|NCT00477412|617125656|FG000|Overall Study|Adverse Event|1|||
170759762|NCT00477412|617125657|FG001|Overall Study|Adverse Event|0|||
170759763|NCT00477412|617125658|FG002|Overall Study|Adverse Event|1|||
170759764|NCT00477412|617125659|FG003|Overall Study|Adverse Event|0|||
170759765|NCT01560949|617125660|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
170759766|NCT01560949|617125660|FG000|Surgery Phase|Physician Decision|3|||
170759767|NCT00662909|617125661|FG000|Overall Study|Adverse Event|17|||
170759768|NCT00662909|617125662|FG001|Overall Study|Adverse Event|18|||
170759769|NCT00662909|617125663|FG002|Overall Study|Adverse Event|19|||
170759770|NCT00662909|617125661|FG000|Overall Study|Lack of Efficacy|9|||
170759771|NCT00662909|617125662|FG001|Overall Study|Lack of Efficacy|1|||
170759772|NCT00662909|617125663|FG002|Overall Study|Lack of Efficacy|5|||
170759773|NCT00662909|617125661|FG000|Overall Study|Withdrawal by Subject|29|||
170759774|NCT00662909|617125662|FG001|Overall Study|Withdrawal by Subject|22|||
170759775|NCT00662909|617125663|FG002|Overall Study|Withdrawal by Subject|16|||
170759776|NCT00662909|617125661|FG000|Overall Study|Lost to Follow-up|2|||
170759777|NCT00662909|617125662|FG001|Overall Study|Lost to Follow-up|9|||
170759778|NCT00662909|617125663|FG002|Overall Study|Lost to Follow-up|3|||
170759779|NCT00662909|617125661|FG000|Overall Study|Protocol Violation|7|||
170759780|NCT00662909|617125662|FG001|Overall Study|Protocol Violation|4|||
170759781|NCT00662909|617125663|FG002|Overall Study|Protocol Violation|5|||
170759782|NCT00662909|617125661|FG000|Overall Study|Randomized- never received study drug|1|||
170759783|NCT00662909|617125662|FG001|Overall Study|Randomized- never received study drug|0|||
170759784|NCT00662909|617125663|FG002|Overall Study|Randomized- never received study drug|0|||
170759785|NCT00662909|617125661|FG000|Overall Study|Non-compliance with study procedures|3|||
170759786|NCT00662909|617125662|FG001|Overall Study|Non-compliance with study procedures|3|||
170759787|NCT00662909|617125663|FG002|Overall Study|Non-compliance with study procedures|2|||
170759788|NCT00662909|617125661|FG000|Overall Study|Physician Decision|1|||
170759789|NCT00662909|617125662|FG001|Overall Study|Physician Decision|1|||
170759790|NCT00662909|617125663|FG002|Overall Study|Physician Decision|2|||
170759791|NCT00662909|617125661|FG000|Overall Study|Eligibility criterion not met|0|||
170759792|NCT00662909|617125662|FG001|Overall Study|Eligibility criterion not met|1|||
170759793|NCT00662909|617125663|FG002|Overall Study|Eligibility criterion not met|1|||
170759794|NCT04199728|617127654|FG000|Overall Study|Adverse Event|1|||
170759795|NCT04199728|617127655|FG001|Overall Study|Adverse Event|0|||
170759796|NCT04199728|617127654|FG000|Overall Study|Withdrawal by Subject|8|||
170759797|NCT04199728|617127655|FG001|Overall Study|Withdrawal by Subject|3|||
170759798|NCT04199728|617127654|FG000|Overall Study|Screen fail after consent|0|||
170759799|NCT04199728|617127655|FG001|Overall Study|Screen fail after consent|1|||
170759800|NCT04199728|617127654|FG000|Overall Study|Early withdraw criteria met|0|||
170759801|NCT04199728|617127655|FG001|Overall Study|Early withdraw criteria met|1|||
170759802|NCT04199728|617127654|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
170759803|NCT04199728|617127655|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
170759804|NCT01875250|617127658|FG000|Overall Study|Adverse Event|2|||
170759805|NCT01875250|617127659|FG001|Overall Study|Adverse Event|0|||
170759806|NCT01331824|617127675|FG000|Overall Study|Adverse Event|2|||
170759807|NCT01331824|617127675|FG000|Overall Study|Death|1|||
170759808|NCT01331824|617127675|FG000|Overall Study|Disease Progression|9|||
170759809|NCT01331824|617127675|FG000|Overall Study|Withdrawal by Subject|1|||
170759810|NCT01091454|617127678|FG000|Overall Study|Ineligible|1|||
170759811|NCT03181958|617127682|FG000|Overall Study|Lost to Follow-up|17|||
170759812|NCT03181958|617127683|FG001|Overall Study|Lost to Follow-up|21|||
170759813|NCT03181958|617127684|FG002|Overall Study|Lost to Follow-up|15|||
170759814|NCT00149630|617127687|FG000|Overall Study|Incarceration|2|||
170759815|NCT00149630|617127688|FG001|Overall Study|Incarceration|0|||
170759816|NCT00149630|617127687|FG000|Overall Study|Treatment Programs|4|||
170759817|NCT00149630|617127688|FG001|Overall Study|Treatment Programs|5|||
170759818|NCT00149630|617127687|FG000|Overall Study|Adverse Event|2|||
170759819|NCT00149630|617127688|FG001|Overall Study|Adverse Event|0|||
170759820|NCT01289119|617127691|FG000|Overall Study|Adverse Event|2|||
170759821|NCT01289119|617127692|FG001|Overall Study|Adverse Event|1|||
170759822|NCT01289119|617127693|FG002|Overall Study|Adverse Event|0|||
170759823|NCT01289119|617127694|FG003|Overall Study|Adverse Event|2|||
170759824|NCT01289119|617127695|FG004|Overall Study|Adverse Event|1|||
170759825|NCT01289119|617127696|FG005|Overall Study|Adverse Event|0|||
170759826|NCT01289119|617127691|FG000|Overall Study|Major Protocol Deviation|2|||
170759827|NCT01289119|617127692|FG001|Overall Study|Major Protocol Deviation|1|||
170759828|NCT01289119|617127693|FG002|Overall Study|Major Protocol Deviation|3|||
170759829|NCT01289119|617127694|FG003|Overall Study|Major Protocol Deviation|0|||
170759830|NCT01289119|617127695|FG004|Overall Study|Major Protocol Deviation|2|||
170759831|NCT01289119|617127696|FG005|Overall Study|Major Protocol Deviation|1|||
170759832|NCT01289119|617127691|FG000|Overall Study|Lost to Follow-up|0|||
170759833|NCT01289119|617127692|FG001|Overall Study|Lost to Follow-up|3|||
170759834|NCT01289119|617127693|FG002|Overall Study|Lost to Follow-up|0|||
170406520|NCT05266456|615828566|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
170406521|NCT05266456|615828567|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
170759835|NCT01289119|617127694|FG003|Overall Study|Lost to Follow-up|0|||
170759836|NCT01289119|617127695|FG004|Overall Study|Lost to Follow-up|0|||
170759837|NCT01289119|617127696|FG005|Overall Study|Lost to Follow-up|1|||
170759838|NCT01289119|617127691|FG000|Overall Study|Withdrawal by Subject|4|||
170759839|NCT01289119|617127692|FG001|Overall Study|Withdrawal by Subject|2|||
170759840|NCT01289119|617127693|FG002|Overall Study|Withdrawal by Subject|4|||
170759841|NCT01289119|617127694|FG003|Overall Study|Withdrawal by Subject|3|||
170759842|NCT01289119|617127695|FG004|Overall Study|Withdrawal by Subject|1|||
170759843|NCT01289119|617127696|FG005|Overall Study|Withdrawal by Subject|1|||
170759844|NCT01289119|617127691|FG000|Overall Study|Pregnancy|0|||
170759845|NCT01289119|617127692|FG001|Overall Study|Pregnancy|1|||
170759846|NCT01289119|617127693|FG002|Overall Study|Pregnancy|0|||
170759847|NCT01289119|617127694|FG003|Overall Study|Pregnancy|0|||
170759848|NCT01289119|617127695|FG004|Overall Study|Pregnancy|0|||
170406522|NCT05266456|615828568|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
170406523|NCT05266456|615828565|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
170406524|NCT05266456|615828566|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
170759849|NCT01289119|617127696|FG005|Overall Study|Pregnancy|0|||
170406525|NCT05266456|615828567|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
170759850|NCT01289119|617127691|FG000|Overall Study|Lack of Efficacy|0|||
170759851|NCT01289119|617127692|FG001|Overall Study|Lack of Efficacy|1|||
170759852|NCT01289119|617127693|FG002|Overall Study|Lack of Efficacy|1|||
170759853|NCT01289119|617127694|FG003|Overall Study|Lack of Efficacy|1|||
170759854|NCT01289119|617127695|FG004|Overall Study|Lack of Efficacy|1|||
170759855|NCT01289119|617127696|FG005|Overall Study|Lack of Efficacy|1|||
170759856|NCT01289119|617127691|FG000|Overall Study|Other|1|||
170759857|NCT01289119|617127692|FG001|Overall Study|Other|0|||
170759858|NCT01289119|617127693|FG002|Overall Study|Other|1|||
170759859|NCT01289119|617127694|FG003|Overall Study|Other|0|||
170759860|NCT01289119|617127695|FG004|Overall Study|Other|0|||
170759861|NCT01289119|617127696|FG005|Overall Study|Other|0|||
170759862|NCT00530335|617127699|FG000|Overall Study|Adverse Event|3|||
170759863|NCT00530335|617127699|FG000|Overall Study|Protocol Violation|1|||
170759864|NCT00530335|617127699|FG000|Overall Study|Withdrawal by Subject|1|||
170759865|NCT00530335|617127699|FG000|Overall Study|Physician Decision|1|||
170759866|NCT01063036|617127702|FG000|Participants Treated With Study Drug|Adverse Event|1|||
170759867|NCT01063036|617127702|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
170759868|NCT01063036|617127702|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
170759869|NCT01063036|617127702|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
170759870|NCT01063036|617127702|FG000|Participants Treated With Study Drug|Pregnancy|1|||
170759871|NCT01063036|617127702|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
170759872|NCT01063036|617127702|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
170759873|NCT01063036|617127702|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
170759874|NCT04381494|617127703|FG000|Overall Study|Early termination of trial|19|||
170759875|NCT04381494|617127703|FG000|Overall Study|Investigator's discretion|1|||
170759876|NCT04381494|617127703|FG000|Overall Study|Withdrawal by Subject|9|||
170759877|NCT04381494|617127703|FG000|Overall Study|NSCLC disease progression|4|||
170759878|NCT04381494|617127703|FG000|Overall Study|Device-Related Adverse Event|2|||
170759879|NCT01451814|617127705|FG000|Overall Study|Withdrawal by Subject|1|||
170759880|NCT01451814|617127706|FG001|Overall Study|Withdrawal by Subject|1|||
170759881|NCT01451814|617127705|FG000|Overall Study|Lost to Follow-up|5|||
170759882|NCT01451814|617127706|FG001|Overall Study|Lost to Follow-up|4|||
170759883|NCT02236559|617127710|FG000|Overall Study|Met Exclusion|3|||
170759884|NCT02236559|617127711|FG001|Overall Study|Met Exclusion|6|||
170759885|NCT02236559|617127710|FG000|Overall Study|Did not Meet Inclusion|3|||
170759886|NCT02236559|617127711|FG001|Overall Study|Did not Meet Inclusion|3|||
170759887|NCT02236559|617127710|FG000|Overall Study|Subject Did Not Consent|4|||
170759888|NCT02236559|617127711|FG001|Overall Study|Subject Did Not Consent|2|||
170759889|NCT02236559|617127710|FG000|Overall Study|Physician Decision|1|||
170759890|NCT02236559|617127711|FG001|Overall Study|Physician Decision|1|||
170759891|NCT02236559|617127710|FG000|Overall Study|Withdrawal by Subject|1|||
170759892|NCT02236559|617127711|FG001|Overall Study|Withdrawal by Subject|0|||
170759893|NCT02049866|617127712|FG000|Overall Study|Withdrawal by Subject|1|||
170759894|NCT03107611|617127713|FG000|Overall Study|Adverse Event|1|||
170759895|NCT03107611|617127714|FG001|Overall Study|Adverse Event|0|||
170759896|NCT03107611|617127715|FG002|Overall Study|Adverse Event|2|||
170759897|NCT03107611|617127713|FG000|Overall Study|Lost to Follow-up|3|||
170759898|NCT03107611|617127714|FG001|Overall Study|Lost to Follow-up|3|||
170759899|NCT03107611|617127715|FG002|Overall Study|Lost to Follow-up|3|||
170759900|NCT03107611|617127713|FG000|Overall Study|Protocol Violation|0|||
170759901|NCT03107611|617127714|FG001|Overall Study|Protocol Violation|0|||
170759902|NCT03107611|617127715|FG002|Overall Study|Protocol Violation|1|||
170759903|NCT03107611|617127713|FG000|Overall Study|Withdrawal by Subject|1|||
170759904|NCT03107611|617127714|FG001|Overall Study|Withdrawal by Subject|0|||
170759905|NCT03107611|617127715|FG002|Overall Study|Withdrawal by Subject|1|||
170759906|NCT03107611|617127713|FG000|Overall Study|Worsening signs/symptoms|2|||
170759907|NCT03107611|617127714|FG001|Overall Study|Worsening signs/symptoms|1|||
170759908|NCT03107611|617127715|FG002|Overall Study|Worsening signs/symptoms|2|||
170759909|NCT01072357|617127716|FG000|Overall Study|Lost to Follow-up|0|||
170759910|NCT01072357|617127717|FG001|Overall Study|Lost to Follow-up|1|||
170759911|NCT00891618|617127718|FG000|Overall Study|Withdrawal by Subject|1|||
170759912|NCT01048788|617127719|FG000|Overall Study|Adverse Event|5|||
170759913|NCT01048788|617127720|FG001|Overall Study|Adverse Event|1|||
170759914|NCT01048788|617127721|FG002|Overall Study|Adverse Event|1|||
170759915|NCT01048788|617127719|FG000|Overall Study|Lack of Efficacy|0|||
170759916|NCT01048788|617127720|FG001|Overall Study|Lack of Efficacy|0|||
170759917|NCT01048788|617127721|FG002|Overall Study|Lack of Efficacy|1|||
170759918|NCT01048788|617127719|FG000|Overall Study|Withdrawal by Subject|0|||
170759919|NCT01048788|617127720|FG001|Overall Study|Withdrawal by Subject|1|||
170865816|NCT02818920|617520019|FG000|Overall Study|Refused Further Treatment|1|||
170865817|NCT00959647|617520021|FG000|Overall Study|Adverse Event|2|||
170865818|NCT00959647|617520021|FG000|Overall Study|Progressive disease|6|||
170865819|NCT00959647|617520021|FG000|Overall Study|Study terminated by sponsor|4|||
170865820|NCT00959647|617520021|FG000|Overall Study|Withdrawal by Subject|7|||
170865821|NCT01831544|617521366|FG000|Overall Study|Death|1|||
170759920|NCT01048788|617127721|FG002|Overall Study|Withdrawal by Subject|0|||
170759921|NCT01064817|617127722|FG000|Study Completion|Physician Decision|1|||
170759922|NCT01064817|617127723|FG001|Study Completion|Physician Decision|0|||
170759923|NCT01064817|617127722|FG000|Study Completion|Withdrawal by Subject|1|||
170759924|NCT01064817|617127723|FG001|Study Completion|Withdrawal by Subject|0|||
170759925|NCT02082158|617127724|FG000|Overall Study|Withdrawal by Subject|0|||
170759926|NCT02082158|617127725|FG001|Overall Study|Withdrawal by Subject|0|||
170759927|NCT02082158|617127726|FG002|Overall Study|Withdrawal by Subject|0|||
170759928|NCT02082158|617127727|FG003|Overall Study|Withdrawal by Subject|0|||
170759929|NCT02082158|617127728|FG004|Overall Study|Withdrawal by Subject|1|||
170759930|NCT02082158|617127729|FG005|Overall Study|Withdrawal by Subject|0|||
170759931|NCT02082158|617127724|FG000|Overall Study|Failed Fit-testing|8|||
170759932|NCT02082158|617127725|FG001|Overall Study|Failed Fit-testing|8|||
170759933|NCT02082158|617127726|FG002|Overall Study|Failed Fit-testing|14|||
170759934|NCT02082158|617127727|FG003|Overall Study|Failed Fit-testing|4|||
170759935|NCT02082158|617127728|FG004|Overall Study|Failed Fit-testing|3|||
170759936|NCT02082158|617127729|FG005|Overall Study|Failed Fit-testing|7|||
170759937|NCT01313182|617127730|FG000|Overall Study|Protocol Violation|66|||
170759938|NCT01313182|617127731|FG001|Overall Study|Protocol Violation|92|||
170759939|NCT00742274|617127732|FG000|Overall Study|Death|1|||
170759940|NCT00742274|617127733|FG001|Overall Study|Death|0|||
170759941|NCT00742274|617127732|FG000|Overall Study|Withdrawal by Subject|1|||
170759942|NCT00742274|617127733|FG001|Overall Study|Withdrawal by Subject|2|||
170759943|NCT00742274|617127732|FG000|Overall Study|Removed for medical reasons|1|||
170759944|NCT00742274|617127733|FG001|Overall Study|Removed for medical reasons|1|||
170759945|NCT01101165|617127734|FG000|Period 1|Adverse Event|1|||
170759946|NCT01101165|617127735|FG001|Period 1|Adverse Event|2|||
170759947|NCT01101165|617127734|FG000|Period 1|Withdrawal by Subject|0|||
170759948|NCT01101165|617127735|FG001|Period 1|Withdrawal by Subject|2|||
170759949|NCT01101165|617127734|FG000|Period 1|Positive Drug Screen|0|||
170759950|NCT01101165|617127735|FG001|Period 1|Positive Drug Screen|1|||
170759951|NCT01101165|617127734|FG000|Period 1|Lost to Follow-up|1|||
170759952|NCT01101165|617127735|FG001|Period 1|Lost to Follow-up|0|||
170759953|NCT01101165|617127734|FG000|Period 2|Withdrawal by Subject|3|||
170759954|NCT01101165|617127735|FG001|Period 2|Withdrawal by Subject|1|||
170759955|NCT01101165|617127734|FG000|Period 2|Adverse Event|1|||
170759956|NCT01101165|617127735|FG001|Period 2|Adverse Event|0|||
170759957|NCT00831792|617127740|FG000|Overall Study|Not Eligible|3|||
170759958|NCT00831792|617127740|FG000|Overall Study|Adverse Event|1|||
170759959|NCT00831792|617127740|FG000|Overall Study|Death|1|||
170759960|NCT00831792|617127740|FG000|Overall Study|Lack of Efficacy|1|||
170759961|NCT03736785|617127741|FG000|Overall Study|Adverse Event|1|||
170759962|NCT03736785|617127742|FG001|Overall Study|Adverse Event|1|||
170759963|NCT03736785|617127743|FG002|Overall Study|Adverse Event|1|||
170759964|NCT03736785|617127741|FG000|Overall Study|Death|1|||
170759965|NCT03736785|617127742|FG001|Overall Study|Death|0|||
170759966|NCT03736785|617127743|FG002|Overall Study|Death|1|||
170759967|NCT03736785|617127741|FG000|Overall Study|Lost to Follow-up|0|||
170759968|NCT03736785|617127742|FG001|Overall Study|Lost to Follow-up|2|||
170759969|NCT03736785|617127743|FG002|Overall Study|Lost to Follow-up|3|||
170759970|NCT03736785|617127741|FG000|Overall Study|Non compliance with study drug|1|||
170759971|NCT03736785|617127742|FG001|Overall Study|Non compliance with study drug|1|||
170759972|NCT03736785|617127743|FG002|Overall Study|Non compliance with study drug|0|||
170759973|NCT03736785|617127741|FG000|Overall Study|Physician Decision|0|||
170759974|NCT03736785|617127742|FG001|Overall Study|Physician Decision|1|||
170759975|NCT03736785|617127743|FG002|Overall Study|Physician Decision|1|||
170759976|NCT03736785|617127741|FG000|Overall Study|Protocol Violation|1|||
170759977|NCT03736785|617127742|FG001|Overall Study|Protocol Violation|4|||
170759978|NCT03736785|617127743|FG002|Overall Study|Protocol Violation|3|||
170759979|NCT03736785|617127741|FG000|Overall Study|Sponsor Decision|1|||
170759980|NCT03736785|617127742|FG001|Overall Study|Sponsor Decision|0|||
170759981|NCT03736785|617127743|FG002|Overall Study|Sponsor Decision|0|||
170759982|NCT03736785|617127741|FG000|Overall Study|Unknown/Missing data|3|||
170759983|NCT03736785|617127742|FG001|Overall Study|Unknown/Missing data|2|||
170759984|NCT03736785|617127743|FG002|Overall Study|Unknown/Missing data|1|||
170759985|NCT03736785|617127741|FG000|Overall Study|Withdrawal by Subject|9|||
170632039|NCT01744977|616664511|FG001|Overall Study|Withdrawal by Subject|2|||
170632040|NCT01744977|616664510|FG000|Overall Study|Death|2|||
170632041|NCT01744977|616664511|FG001|Overall Study|Death|3|||
170632042|NCT01744977|616664510|FG000|Overall Study|Lost to Follow-up|2|||
170632043|NCT01744977|616664511|FG001|Overall Study|Lost to Follow-up|0|||
170632044|NCT01744977|616664510|FG000|Overall Study|No longer meets inclusion|6|||
170632045|NCT01744977|616664511|FG001|Overall Study|No longer meets inclusion|0|||
170632046|NCT01750229|616664512|FG000|Randomized Crossover Phase|Adverse Event|1|||
170632047|NCT01750229|616664512|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
170632048|NCT01750229|616664512|FG000|Long-term Follow-up Phase|Adverse Event|2|||
170632049|NCT01750229|616664512|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
170632050|NCT03774576|616664513|FG000|Period 2|Adverse Event|1|||
170632051|NCT04455815|616664514|FG000|Randomisation Phase|Adverse Event|1|||
170632052|NCT04455815|616664515|FG001|Randomisation Phase|Adverse Event|0|||
170632053|NCT04455815|616664514|FG000|Treatment Phase|Adverse Event|0|||
170632054|NCT04455815|616664515|FG001|Treatment Phase|Adverse Event|1|||
170632055|NCT04455815|616664514|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
170632056|NCT04455815|616664515|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
170632057|NCT04455815|616664514|FG000|Treatment Phase|Withdrawal by Subject|1|||
170632058|NCT04455815|616664515|FG001|Treatment Phase|Withdrawal by Subject|1|||
170632059|NCT02968004|616664520|FG000|Main Study Phase|Adverse Event|1|||
170759986|NCT03736785|617127742|FG001|Overall Study|Withdrawal by Subject|6|||
170759987|NCT03736785|617127743|FG002|Overall Study|Withdrawal by Subject|4|||
170759988|NCT03256344|617127746|FG000|Overall Study|Death|6|||
170406526|NCT05266456|615828568|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
170406527|NCT01364298|615828570|FG000|Overall Study|Adverse Event|3|||
170406528|NCT01364298|615828571|FG001|Overall Study|Adverse Event|4|||
170406529|NCT01364298|615828570|FG000|Overall Study|Lack of adherence to treatment|1|||
170406530|NCT01364298|615828571|FG001|Overall Study|Lack of adherence to treatment|3|||
170406531|NCT01364298|615828570|FG000|Overall Study|Lack of Efficacy|1|||
170406532|NCT01364298|615828571|FG001|Overall Study|Lack of Efficacy|0|||
170406533|NCT01364298|615828570|FG000|Overall Study|Lost to Follow-up|5|||
170406534|NCT01364298|615828571|FG001|Overall Study|Lost to Follow-up|10|||
170406535|NCT01364298|615828570|FG000|Overall Study|Withdrawal by Subject|3|||
170406536|NCT01364298|615828571|FG001|Overall Study|Withdrawal by Subject|3|||
170406537|NCT01364298|615828570|FG000|Overall Study|Other|1|||
170406538|NCT01364298|615828571|FG001|Overall Study|Other|3|||
170406539|NCT05288673|615828573|FG000|Overall Study|Consent withdrawn by subject|0|||
170406540|NCT05288673|615828574|FG001|Overall Study|Consent withdrawn by subject|0|||
170406541|NCT05288673|615828575|FG002|Overall Study|Consent withdrawn by subject|1|||
170406542|NCT03056352|615828576|FG000|Overall Study|Lost to Follow-up|1|||
170406543|NCT03811249|615828581|FG000|Overall Study|Withdrawal by Subject|44|||
170406544|NCT03811249|615828581|FG000|Overall Study|Missed Visit|24|||
170406545|NCT01504867|615828585|FG000|Overall Study|Inclusion criteria not met|2|||
170406546|NCT01504867|615828586|FG001|Overall Study|Inclusion criteria not met|2|||
170406547|NCT01504867|615828585|FG000|Overall Study|Consent revoked|5|||
170406548|NCT01504867|615828586|FG001|Overall Study|Consent revoked|1|||
170406549|NCT01254045|615828587|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
170406550|NCT01254045|615828588|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
170406551|NCT01254045|615828589|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
170406552|NCT01254045|615828590|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
170406553|NCT01254045|615828591|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
170406554|NCT01254045|615828592|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
170406555|NCT02971605|615828593|FG000|Overall Study|Withdrawal by Subject|1|||
170406556|NCT01154153|615828598|FG000|Overall Study|Poor compliance to protocol|2|||
170406557|NCT01154153|615828599|FG001|Overall Study|Poor compliance to protocol|0|||
170406558|NCT01154153|615828598|FG000|Overall Study|Unable to use labs|2|||
170406559|NCT01154153|615828599|FG001|Overall Study|Unable to use labs|3|||
170406560|NCT01154153|615828598|FG000|Overall Study|Withdrew consent|1|||
170406561|NCT01154153|615828599|FG001|Overall Study|Withdrew consent|0|||
170406562|NCT00435825|615828605|FG000|Overall Study|Abnormality of Laboratory Test|0|||
170406563|NCT00435825|615828606|FG001|Overall Study|Abnormality of Laboratory Test|1|||
170406564|NCT00435825|615828607|FG002|Overall Study|Abnormality of Laboratory Test|0|||
170406565|NCT00435825|615828608|FG003|Overall Study|Abnormality of Laboratory Test|0|||
170406566|NCT00435825|615828605|FG000|Overall Study|Insufficient Therapeutic Response|3|||
170406567|NCT00435825|615828606|FG001|Overall Study|Insufficient Therapeutic Response|1|||
170406568|NCT00435825|615828607|FG002|Overall Study|Insufficient Therapeutic Response|0|||
170406569|NCT00435825|615828608|FG003|Overall Study|Insufficient Therapeutic Response|3|||
170406570|NCT00435825|615828605|FG000|Overall Study|Other Protocol Violation|1|||
170406571|NCT00435825|615828606|FG001|Overall Study|Other Protocol Violation|0|||
170406572|NCT00435825|615828607|FG002|Overall Study|Other Protocol Violation|0|||
170406573|NCT00435825|615828608|FG003|Overall Study|Other Protocol Violation|0|||
170406574|NCT00435825|615828605|FG000|Overall Study|Refused treatment|2|||
170406575|NCT00435825|615828606|FG001|Overall Study|Refused treatment|0|||
170406576|NCT00435825|615828607|FG002|Overall Study|Refused treatment|0|||
170406577|NCT00435825|615828608|FG003|Overall Study|Refused treatment|5|||
170406578|NCT00435825|615828605|FG000|Overall Study|Failure to return|5|||
170406579|NCT00435825|615828606|FG001|Overall Study|Failure to return|0|||
170406580|NCT00435825|615828607|FG002|Overall Study|Failure to return|4|||
170406581|NCT00435825|615828608|FG003|Overall Study|Failure to return|0|||
170406582|NCT00435825|615828605|FG000|Overall Study|Did not receive study drug|1|||
170406583|NCT00435825|615828606|FG001|Overall Study|Did not receive study drug|0|||
170759989|NCT03256344|617127747|FG001|Overall Study|Death|22|||
170759990|NCT03256344|617127746|FG000|Overall Study|Withdrawal by Subject|3|||
170759991|NCT03256344|617127747|FG001|Overall Study|Withdrawal by Subject|3|||
170406584|NCT00435825|615828607|FG002|Overall Study|Did not receive study drug|2|||
170406585|NCT00435825|615828608|FG003|Overall Study|Did not receive study drug|0|||
170406586|NCT00435825|615828605|FG000|Overall Study|Did not enter follow-up|0|||
170406587|NCT00435825|615828606|FG001|Overall Study|Did not enter follow-up|4|||
170406588|NCT00435825|615828607|FG002|Overall Study|Did not enter follow-up|1|||
170406589|NCT00435825|615828608|FG003|Overall Study|Did not enter follow-up|3|||
170406590|NCT00435825|615828605|FG000|Overall Study|Did not complete full follow-up period|6|||
170406591|NCT00435825|615828606|FG001|Overall Study|Did not complete full follow-up period|6|||
170406592|NCT00435825|615828607|FG002|Overall Study|Did not complete full follow-up period|4|||
170406593|NCT00435825|615828608|FG003|Overall Study|Did not complete full follow-up period|5|||
170406594|NCT03033069|615828609|FG000|Overall Study|Adverse Event|6|||
170406595|NCT03033069|615828610|FG001|Overall Study|Adverse Event|7|||
170406596|NCT03033069|615828611|FG002|Overall Study|Adverse Event|4|||
170406597|NCT03033069|615828612|FG003|Overall Study|Adverse Event|6|||
170759992|NCT03256344|617127746|FG000|Overall Study|Sponsor Decision|1|||
170759993|NCT03256344|617127747|FG001|Overall Study|Sponsor Decision|0|||
170759994|NCT03124108|617127748|FG000|Overall Study|Adverse Event|0|||
170759995|NCT03124108|617127749|FG001|Overall Study|Adverse Event|1|||
170759996|NCT03124108|617127750|FG002|Overall Study|Adverse Event|0|||
170759997|NCT01670019|617127758|FG000|Overall Study|Adverse Event|3|||
170759998|NCT01670019|617127759|FG001|Overall Study|Adverse Event|0|||
170759999|NCT01670019|617127758|FG000|Overall Study|Withdrawal by Subject|6|||
170760000|NCT01670019|617127759|FG001|Overall Study|Withdrawal by Subject|0|||
170760001|NCT03586167|617127760|FG000|Overall Study|Other|1|||
170760002|NCT03586167|617127761|FG001|Overall Study|Other|0|||
170760003|NCT03537651|617127762|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
170760004|NCT03537651|617127762|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
170760005|NCT03537651|617127762|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
170760006|NCT03537651|617127762|FG000|Part A (Up to 96 Weeks)|Other|1|||
170760007|NCT03537651|617127762|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
170760008|NCT03537651|617127762|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
170519699|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519700|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519701|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519702|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519703|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519704|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170760009|NCT03537651|617127762|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
170760010|NCT03537651|617127762|FG000|Part B (Up to 192 Weeks)|Other|1|||
170406598|NCT03033069|615828609|FG000|Overall Study|Lack of Efficacy|0|||
170406599|NCT03033069|615828610|FG001|Overall Study|Lack of Efficacy|0|||
170406600|NCT03033069|615828611|FG002|Overall Study|Lack of Efficacy|1|||
170406601|NCT03033069|615828612|FG003|Overall Study|Lack of Efficacy|0|||
170406602|NCT03033069|615828609|FG000|Overall Study|Lost to Follow-up|6|||
170406603|NCT03033069|615828610|FG001|Overall Study|Lost to Follow-up|5|||
170760011|NCT04163458|617127763|FG000|Overall Study|Protocol Deviation|7|||
170760012|NCT04163458|617127764|FG001|Overall Study|Protocol Deviation|13|||
170760013|NCT04163458|617127763|FG000|Overall Study|Adverse Event|5|||
170760014|NCT04163458|617127764|FG001|Overall Study|Adverse Event|8|||
170760015|NCT04163458|617127763|FG000|Overall Study|Due to COVID-19 pandemic|4|||
170406604|NCT03033069|615828611|FG002|Overall Study|Lost to Follow-up|5|||
170406605|NCT03033069|615828612|FG003|Overall Study|Lost to Follow-up|6|||
170406606|NCT03033069|615828609|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170406607|NCT03033069|615828610|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170406608|NCT03033069|615828611|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170406609|NCT03033069|615828612|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170406610|NCT03033069|615828609|FG000|Overall Study|Protocol Deviation|0|||
170406611|NCT03033069|615828610|FG001|Overall Study|Protocol Deviation|1|||
170406612|NCT03033069|615828611|FG002|Overall Study|Protocol Deviation|0|||
170406613|NCT03033069|615828612|FG003|Overall Study|Protocol Deviation|0|||
170406614|NCT03033069|615828609|FG000|Overall Study|Withdrawal by Subject|10|||
170406615|NCT03033069|615828610|FG001|Overall Study|Withdrawal by Subject|10|||
170406616|NCT03033069|615828611|FG002|Overall Study|Withdrawal by Subject|11|||
170760016|NCT04163458|617127764|FG001|Overall Study|Due to COVID-19 pandemic|2|||
170760017|NCT04163458|617127763|FG000|Overall Study|Participant withdrew consent|2|||
170760018|NCT04163458|617127764|FG001|Overall Study|Participant withdrew consent|3|||
170760019|NCT04163458|617127763|FG000|Overall Study|Randomization failure|2|||
170760020|NCT04163458|617127764|FG001|Overall Study|Randomization failure|2|||
170760021|NCT04163458|617127763|FG000|Overall Study|Other|4|||
170760022|NCT04163458|617127764|FG001|Overall Study|Other|2|||
170760023|NCT00197236|617127766|FG000|Overall Study|Adverse Event|1|||
170760024|NCT00197236|617127767|FG001|Overall Study|Adverse Event|0|||
170760025|NCT00197236|617127768|FG002|Overall Study|Adverse Event|1|||
170760026|NCT00197236|617127766|FG000|Overall Study|Lost to Follow-up|5|||
170760027|NCT00197236|617127767|FG001|Overall Study|Lost to Follow-up|14|||
170760028|NCT00197236|617127768|FG002|Overall Study|Lost to Follow-up|6|||
170760029|NCT00197236|617127766|FG000|Overall Study|Protocol Violation|0|||
170760030|NCT00197236|617127767|FG001|Overall Study|Protocol Violation|0|||
170760031|NCT00197236|617127768|FG002|Overall Study|Protocol Violation|1|||
170760032|NCT00197236|617127766|FG000|Overall Study|Withdrawal by Subject|7|||
170760033|NCT00197236|617127767|FG001|Overall Study|Withdrawal by Subject|3|||
170406617|NCT03033069|615828612|FG003|Overall Study|Withdrawal by Subject|6|||
170406618|NCT03033069|615828609|FG000|Overall Study|Withdrawal By Caregiver|1|||
170406619|NCT03033069|615828610|FG001|Overall Study|Withdrawal By Caregiver|0|||
170406620|NCT03033069|615828611|FG002|Overall Study|Withdrawal By Caregiver|0|||
170406621|NCT03033069|615828612|FG003|Overall Study|Withdrawal By Caregiver|0|||
170406622|NCT03033069|615828609|FG000|Overall Study|Reason not Specified|0|||
170406623|NCT03033069|615828610|FG001|Overall Study|Reason not Specified|1|||
170760034|NCT00197236|617127768|FG002|Overall Study|Withdrawal by Subject|11|||
170760035|NCT00197236|617127766|FG000|Overall Study|Study drug/medication expiration|1|||
170406624|NCT03033069|615828611|FG002|Overall Study|Reason not Specified|0|||
170406625|NCT03033069|615828612|FG003|Overall Study|Reason not Specified|1|||
170406626|NCT00530439|615828613|FG000|Overall Study|GDM|9|||
170406627|NCT00530439|615828614|FG001|Overall Study|GDM|3|||
170406628|NCT00530439|615828613|FG000|Overall Study|Withdraw|18|||
170406629|NCT00530439|615828614|FG001|Overall Study|Withdraw|14|||
170406630|NCT00530439|615828613|FG000|Overall Study|Missed abortion|1|||
170406631|NCT00530439|615828614|FG001|Overall Study|Missed abortion|4|||
170406632|NCT00530439|615828613|FG000|Overall Study|Misclassification|2|||
170406633|NCT00530439|615828614|FG001|Overall Study|Misclassification|0|||
170406634|NCT00530439|615828613|FG000|Overall Study|Twin pregnancy|0|||
170406635|NCT00530439|615828614|FG001|Overall Study|Twin pregnancy|2|||
170406636|NCT00530439|615828613|FG000|Overall Study|Severe malformation/abortion|0|||
170406637|NCT00530439|615828614|FG001|Overall Study|Severe malformation/abortion|3|||
170406638|NCT01270841|615830562|FG000|Overall Study|Adverse Event|0|||
170406639|NCT01270841|615830563|FG001|Overall Study|Adverse Event|1|||
170406640|NCT01270841|615830564|FG002|Overall Study|Adverse Event|0|||
170406641|NCT01270841|615830565|FG003|Overall Study|Adverse Event|3|||
170406642|NCT01270841|615830562|FG000|Overall Study|Withdrawal by Subject|3|||
170406643|NCT01270841|615830563|FG001|Overall Study|Withdrawal by Subject|2|||
170406644|NCT01270841|615830564|FG002|Overall Study|Withdrawal by Subject|3|||
170406645|NCT01270841|615830565|FG003|Overall Study|Withdrawal by Subject|3|||
170406646|NCT01270841|615830562|FG000|Overall Study|Lost to Follow-up|3|||
170406647|NCT01270841|615830563|FG001|Overall Study|Lost to Follow-up|1|||
170406648|NCT01270841|615830564|FG002|Overall Study|Lost to Follow-up|4|||
170406649|NCT01270841|615830565|FG003|Overall Study|Lost to Follow-up|2|||
170406650|NCT01270841|615830562|FG000|Overall Study|Physician Decision|0|||
170406651|NCT01270841|615830563|FG001|Overall Study|Physician Decision|1|||
170406652|NCT01270841|615830564|FG002|Overall Study|Physician Decision|0|||
170406653|NCT01270841|615830565|FG003|Overall Study|Physician Decision|0|||
170406654|NCT01270841|615830562|FG000|Overall Study|Did not qualify|6|||
170406655|NCT01270841|615830563|FG001|Overall Study|Did not qualify|3|||
170406656|NCT01270841|615830564|FG002|Overall Study|Did not qualify|4|||
170406657|NCT01270841|615830565|FG003|Overall Study|Did not qualify|5|||
170406658|NCT01270841|615830562|FG000|Overall Study|Protocol Violation|1|||
170406659|NCT01270841|615830563|FG001|Overall Study|Protocol Violation|5|||
170406660|NCT01270841|615830564|FG002|Overall Study|Protocol Violation|0|||
170406661|NCT01270841|615830565|FG003|Overall Study|Protocol Violation|0|||
170406662|NCT01270841|615830562|FG000|Overall Study|Enrolled in error|0|||
170406663|NCT01270841|615830563|FG001|Overall Study|Enrolled in error|1|||
170406664|NCT01270841|615830564|FG002|Overall Study|Enrolled in error|0|||
170406665|NCT01270841|615830565|FG003|Overall Study|Enrolled in error|0|||
170406666|NCT01375010|615830566|FG000|Overall Study|Lost to Follow-up|8|||
170406667|NCT01375010|615830567|FG001|Overall Study|Lost to Follow-up|2|||
170406668|NCT01375010|615830566|FG000|Overall Study|Withdrawal by Subject|4|||
170406669|NCT01375010|615830567|FG001|Overall Study|Withdrawal by Subject|2|||
170406670|NCT02402933|615830568|FG000|Overall Study|Withdrawal by Subject|4|||
170406671|NCT02402933|615830568|FG000|Overall Study|Discontinued; Site Termination|10|||
170406672|NCT01623830|615830573|FG000|Overall Study|Withdrawal by Subject|6|||
170406673|NCT01623830|615830574|FG001|Overall Study|Withdrawal by Subject|7|||
170406674|NCT01623830|615830573|FG000|Overall Study|Exclusion from Study|1|||
170406675|NCT01623830|615830574|FG001|Overall Study|Exclusion from Study|2|||
170406676|NCT00928252|615830575|FG000|Overall Study|Physician Decision|3|||
170406677|NCT02257632|615830576|FG000|Overall Study|Withdrawal by Subject|0|||
170406678|NCT02257632|615830577|FG001|Overall Study|Withdrawal by Subject|1|||
170406679|NCT02257632|615830576|FG000|Overall Study|Adverse Event|1|||
170406680|NCT02257632|615830577|FG001|Overall Study|Adverse Event|2|||
170406681|NCT01605461|615830578|FG000|Overall Study|Lost to Follow-up|3|||
170406682|NCT01605461|615830578|FG000|Overall Study|Withdrawal by Subject|1|||
170406683|NCT02024698|615830582|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
170406684|NCT02024698|615830583|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
170406685|NCT03322462|615830584|FG000|Overall Study|Technical difficulties|2|||
170406686|NCT03322462|615830584|FG000|Overall Study|Other|1|||
170406687|NCT01393990|615830585|FG000|Overall Study|Adverse Event|0|||
170406688|NCT01393990|615830586|FG001|Overall Study|Adverse Event|0|||
170406689|NCT01393990|615830587|FG002|Overall Study|Adverse Event|0|||
170406690|NCT01393990|615830588|FG003|Overall Study|Adverse Event|0|||
170406691|NCT01393990|615830589|FG004|Overall Study|Adverse Event|0|||
170406692|NCT01393990|615830590|FG005|Overall Study|Adverse Event|0|||
170406693|NCT01393990|615830591|FG006|Overall Study|Adverse Event|0|||
170406694|NCT01393990|615830592|FG007|Overall Study|Adverse Event|0|||
170406695|NCT01393990|615830593|FG008|Overall Study|Adverse Event|0|||
170406696|NCT01393990|615830594|FG009|Overall Study|Adverse Event|0|||
170406697|NCT01393990|615830595|FG010|Overall Study|Adverse Event|0|||
170406698|NCT01393990|615830596|FG011|Overall Study|Adverse Event|0|||
170406699|NCT01393990|615830597|FG012|Overall Study|Adverse Event|0|||
170406700|NCT01393990|615830598|FG013|Overall Study|Adverse Event|0|||
170406701|NCT01393990|615830599|FG014|Overall Study|Adverse Event|1|||
170406702|NCT01393990|615830600|FG015|Overall Study|Adverse Event|1|||
170406703|NCT01393990|615830601|FG016|Overall Study|Adverse Event|0|||
170406704|NCT01393990|615830602|FG017|Overall Study|Adverse Event|0|||
170406705|NCT01393990|615830585|FG000|Overall Study|Progressive Disease|1|||
170406706|NCT01393990|615830586|FG001|Overall Study|Progressive Disease|0|||
170406707|NCT01393990|615830587|FG002|Overall Study|Progressive Disease|0|||
170406708|NCT01393990|615830588|FG003|Overall Study|Progressive Disease|1|||
170406709|NCT01393990|615830589|FG004|Overall Study|Progressive Disease|1|||
170406710|NCT01393990|615830590|FG005|Overall Study|Progressive Disease|1|||
170406711|NCT01393990|615830591|FG006|Overall Study|Progressive Disease|1|||
170406712|NCT01393990|615830592|FG007|Overall Study|Progressive Disease|1|||
170406713|NCT01393990|615830593|FG008|Overall Study|Progressive Disease|3|||
170406714|NCT01393990|615830594|FG009|Overall Study|Progressive Disease|1|||
170406715|NCT01393990|615830595|FG010|Overall Study|Progressive Disease|0|||
170406716|NCT01393990|615830596|FG011|Overall Study|Progressive Disease|0|||
170406717|NCT01393990|615830597|FG012|Overall Study|Progressive Disease|0|||
170406718|NCT01393990|615830598|FG013|Overall Study|Progressive Disease|1|||
170406719|NCT01393990|615830599|FG014|Overall Study|Progressive Disease|6|||
170406720|NCT01393990|615830600|FG015|Overall Study|Progressive Disease|1|||
170406721|NCT01393990|615830601|FG016|Overall Study|Progressive Disease|0|||
170760036|NCT00197236|617127767|FG001|Overall Study|Study drug/medication expiration|0|||
170760037|NCT00197236|617127768|FG002|Overall Study|Study drug/medication expiration|3|||
170406722|NCT01393990|615830602|FG017|Overall Study|Progressive Disease|0|||
170406723|NCT01393990|615830585|FG000|Overall Study|Death|0|||
170406724|NCT01393990|615830586|FG001|Overall Study|Death|0|||
170406725|NCT01393990|615830587|FG002|Overall Study|Death|0|||
170406726|NCT01393990|615830588|FG003|Overall Study|Death|0|||
170406727|NCT01393990|615830589|FG004|Overall Study|Death|1|||
170406728|NCT01393990|615830590|FG005|Overall Study|Death|0|||
170406729|NCT01393990|615830591|FG006|Overall Study|Death|0|||
170406730|NCT01393990|615830592|FG007|Overall Study|Death|0|||
170406731|NCT01393990|615830593|FG008|Overall Study|Death|0|||
170406732|NCT01393990|615830594|FG009|Overall Study|Death|0|||
170406733|NCT01393990|615830595|FG010|Overall Study|Death|0|||
170406734|NCT01393990|615830596|FG011|Overall Study|Death|0|||
170406735|NCT01393990|615830597|FG012|Overall Study|Death|0|||
170406736|NCT01393990|615830598|FG013|Overall Study|Death|1|||
170406737|NCT01393990|615830599|FG014|Overall Study|Death|1|||
170406738|NCT01393990|615830600|FG015|Overall Study|Death|0|||
170406739|NCT01393990|615830601|FG016|Overall Study|Death|0|||
170406740|NCT01393990|615830602|FG017|Overall Study|Death|0|||
170406741|NCT01393990|615830585|FG000|Overall Study|Withdrawal by Subject|0|||
170406742|NCT01393990|615830586|FG001|Overall Study|Withdrawal by Subject|0|||
170406743|NCT01393990|615830587|FG002|Overall Study|Withdrawal by Subject|0|||
170406744|NCT01393990|615830588|FG003|Overall Study|Withdrawal by Subject|0|||
170406745|NCT01393990|615830589|FG004|Overall Study|Withdrawal by Subject|0|||
170406746|NCT01393990|615830590|FG005|Overall Study|Withdrawal by Subject|0|||
170406747|NCT01393990|615830591|FG006|Overall Study|Withdrawal by Subject|0|||
170406748|NCT01393990|615830592|FG007|Overall Study|Withdrawal by Subject|0|||
170760038|NCT00197236|617127766|FG000|Overall Study|Returned out of specified time window|0|||
170406749|NCT01393990|615830593|FG008|Overall Study|Withdrawal by Subject|0|||
170406750|NCT01393990|615830594|FG009|Overall Study|Withdrawal by Subject|0|||
170406751|NCT01393990|615830595|FG010|Overall Study|Withdrawal by Subject|0|||
170406752|NCT01393990|615830596|FG011|Overall Study|Withdrawal by Subject|0|||
170406753|NCT01393990|615830597|FG012|Overall Study|Withdrawal by Subject|0|||
170406754|NCT01393990|615830598|FG013|Overall Study|Withdrawal by Subject|0|||
170406755|NCT01393990|615830599|FG014|Overall Study|Withdrawal by Subject|1|||
170406756|NCT01393990|615830600|FG015|Overall Study|Withdrawal by Subject|1|||
170406757|NCT01393990|615830601|FG016|Overall Study|Withdrawal by Subject|0|||
170406758|NCT01393990|615830602|FG017|Overall Study|Withdrawal by Subject|0|||
170519705|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170760039|NCT00197236|617127767|FG001|Overall Study|Returned out of specified time window|0|||
170760040|NCT00197236|617127768|FG002|Overall Study|Returned out of specified time window|1|||
170760041|NCT00746330|617127769|FG000|Period 1|Abnormal test procedure result|0|||
170760042|NCT00746330|617127770|FG001|Period 1|Abnormal test procedure result|0|||
170406759|NCT02806232|615830606|FG000|Overall Study|Lost to Follow-up|1|||
170406760|NCT02806232|615830607|FG001|Overall Study|Lost to Follow-up|2|||
170406761|NCT02806232|615830608|FG002|Overall Study|Lost to Follow-up|1|||
170406762|NCT02806232|615830609|FG003|Overall Study|Lost to Follow-up|0|||
170406763|NCT02806232|615830610|FG004|Overall Study|Lost to Follow-up|0|||
170406764|NCT02806232|615830611|FG005|Overall Study|Lost to Follow-up|1|||
170406765|NCT02806232|615830612|FG006|Overall Study|Lost to Follow-up|0|||
170406766|NCT02806232|615830613|FG007|Overall Study|Lost to Follow-up|0|||
170406767|NCT02806232|615830614|FG008|Overall Study|Lost to Follow-up|0|||
170406768|NCT02806232|615830606|FG000|Overall Study|Withdrawal by Subject|0|||
170406769|NCT02806232|615830607|FG001|Overall Study|Withdrawal by Subject|2|||
170406770|NCT02806232|615830608|FG002|Overall Study|Withdrawal by Subject|0|||
170406771|NCT02806232|615830609|FG003|Overall Study|Withdrawal by Subject|0|||
170406772|NCT02806232|615830610|FG004|Overall Study|Withdrawal by Subject|2|||
170406773|NCT02806232|615830611|FG005|Overall Study|Withdrawal by Subject|1|||
170406774|NCT02806232|615830612|FG006|Overall Study|Withdrawal by Subject|0|||
170406775|NCT02806232|615830613|FG007|Overall Study|Withdrawal by Subject|0|||
170406776|NCT02806232|615830614|FG008|Overall Study|Withdrawal by Subject|0|||
170406777|NCT01133821|615830615|FG000|Overall Study|Lost to Follow-up|8|||
170406778|NCT01133821|615830616|FG001|Overall Study|Lost to Follow-up|11|||
170406779|NCT01133821|615830615|FG000|Overall Study|Withdrawal by Subject|8|||
170406780|NCT01133821|615830616|FG001|Overall Study|Withdrawal by Subject|3|||
170406781|NCT01133821|615830615|FG000|Overall Study|preferred other treatment|1|||
170406782|NCT01133821|615830616|FG001|Overall Study|preferred other treatment|1|||
170406783|NCT01133821|615830615|FG000|Overall Study|Protocol Violation|0|||
170406784|NCT01133821|615830616|FG001|Overall Study|Protocol Violation|1|||
170406785|NCT01133821|615830615|FG000|Overall Study|Refused participation|1|||
170406786|NCT01133821|615830616|FG001|Overall Study|Refused participation|3|||
170406787|NCT00463866|615830619|FG000|Overall Study|Adverse Event|70|||
170406788|NCT00463866|615830620|FG001|Overall Study|Adverse Event|93|||
170406789|NCT00463866|615830619|FG000|Overall Study|Withdrawal by Subject|81|||
170406790|NCT00463866|615830620|FG001|Overall Study|Withdrawal by Subject|79|||
170406791|NCT00463866|615830619|FG000|Overall Study|Lost to Follow-up|46|||
170406792|NCT00463866|615830620|FG001|Overall Study|Lost to Follow-up|55|||
170406793|NCT00463866|615830619|FG000|Overall Study|Incorrect Enrolment|64|||
170406794|NCT00463866|615830620|FG001|Overall Study|Incorrect Enrolment|66|||
170406795|NCT00463866|615830619|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
170406796|NCT00463866|615830620|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
170406797|NCT00463866|615830619|FG000|Overall Study|Safety Reason|1|||
170406798|NCT00463866|615830620|FG001|Overall Study|Safety Reason|3|||
170406799|NCT00463866|615830619|FG000|Overall Study|Mis-Randomization of subject|0|||
170406800|NCT00463866|615830620|FG001|Overall Study|Mis-Randomization of subject|1|||
170406801|NCT00463866|615830619|FG000|Overall Study|Other|22|||
170406802|NCT00463866|615830620|FG001|Overall Study|Other|22|||
170406803|NCT00606684|615830633|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
170406804|NCT00606684|615830634|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
170406805|NCT00606684|615830635|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
170406806|NCT00606684|615830636|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
170406807|NCT00606684|615830637|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
170406808|NCT00606684|615830638|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
170406809|NCT00606684|615830639|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
170406810|NCT00606684|615830633|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
170406811|NCT00606684|615830634|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
170760043|NCT00746330|617127771|FG002|Period 1|Abnormal test procedure result|1|||
170760044|NCT00746330|617127772|FG003|Period 1|Abnormal test procedure result|0|||
170406812|NCT00606684|615830635|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
170519706|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519707|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519708|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519709|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519710|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
170406813|NCT00606684|615830636|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
170406814|NCT00606684|615830637|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
170406815|NCT00606684|615830638|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
170406816|NCT00606684|615830639|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
170406817|NCT00606684|615830633|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
170406818|NCT00606684|615830634|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
170406819|NCT00606684|615830635|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
170406820|NCT00606684|615830636|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
170406821|NCT00606684|615830637|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
170406822|NCT00606684|615830638|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
170406823|NCT00606684|615830639|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
170406824|NCT00606684|615830633|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
170406825|NCT00606684|615830634|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
170406826|NCT00606684|615830635|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
170406827|NCT00606684|615830636|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
170406828|NCT00606684|615830637|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
170406829|NCT00606684|615830638|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
170519711|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519712|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170406830|NCT00606684|615830639|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
170406831|NCT00606684|615830633|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
170406832|NCT00606684|615830634|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
170406833|NCT00606684|615830635|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
170406834|NCT00606684|615830636|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
170406835|NCT00606684|615830637|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
170406836|NCT00606684|615830638|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
170406837|NCT00606684|615830639|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
170519713|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
170519714|NCT02326272|616247580|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170519715|NCT02326272|616247581|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170519716|NCT02326272|616247582|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170519717|NCT02326272|616247583|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170519718|NCT02326272|616247584|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170406838|NCT00606684|615830633|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
170406839|NCT00606684|615830634|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
170406840|NCT00606684|615830635|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
170406841|NCT00606684|615830636|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
170406842|NCT00606684|615830637|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
170406843|NCT00606684|615830638|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
170406844|NCT00606684|615830639|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
170406845|NCT00606684|615830633|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
170406846|NCT00606684|615830634|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
170406847|NCT00606684|615830635|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
170406848|NCT00606684|615830636|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
170406849|NCT00606684|615830637|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
170406850|NCT00606684|615830638|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
170406851|NCT00606684|615830639|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
170406852|NCT00606684|615830633|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170406853|NCT00606684|615830634|FG001|Double-Blind Treatment Period|Adverse Event|3|||
170406854|NCT00606684|615830635|FG002|Double-Blind Treatment Period|Adverse Event|2|||
170406855|NCT00606684|615830636|FG003|Double-Blind Treatment Period|Adverse Event|4|||
170406856|NCT00606684|615830637|FG004|Double-Blind Treatment Period|Adverse Event|2|||
170406857|NCT00606684|615830638|FG005|Double-Blind Treatment Period|Adverse Event|0|||
170406858|NCT00606684|615830639|FG006|Double-Blind Treatment Period|Adverse Event|1|||
170406859|NCT00606684|615830633|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
170406860|NCT00606684|615830634|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
170406861|NCT00606684|615830635|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
170406862|NCT00606684|615830636|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
170406863|NCT00606684|615830637|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
170406864|NCT00606684|615830638|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
170406865|NCT00606684|615830639|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
170406866|NCT00606684|615830633|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
170406867|NCT00606684|615830634|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
170406868|NCT00606684|615830635|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
170760045|NCT00517933|617127774|FG000|Period 1|Death|2|||
170760046|NCT00517933|617127775|FG001|Period 1|Death|1|||
170760047|NCT00517933|617127774|FG000|Period 1|Adverse Event|4|||
170760048|NCT00517933|617127775|FG001|Period 1|Adverse Event|4|||
170760049|NCT00517933|617127774|FG000|Period 1|Lost to Follow-up|2|||
170760050|NCT00517933|617127775|FG001|Period 1|Lost to Follow-up|0|||
170760051|NCT00517933|617127774|FG000|Period 1|Underwent lung transplant|0|||
170760052|NCT00517933|617127775|FG001|Period 1|Underwent lung transplant|1|||
170760053|NCT00517933|617127774|FG000|Period 2|Death|2|||
170760054|NCT00517933|617127775|FG001|Period 2|Death|4|||
170760055|NCT00517933|617127774|FG000|Period 2|Adverse Event|2|||
170406869|NCT00606684|615830636|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
170406870|NCT00606684|615830637|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
170406871|NCT00606684|615830638|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
170406872|NCT00606684|615830639|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
170406873|NCT00606684|615830633|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
170406874|NCT00606684|615830634|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
170406875|NCT00606684|615830635|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
170406876|NCT00606684|615830636|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
170406877|NCT00606684|615830637|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
170760056|NCT00517933|617127775|FG001|Period 2|Adverse Event|4|||
170760057|NCT00517933|617127774|FG000|Period 2|Physician Decision|1|||
170760058|NCT00517933|617127775|FG001|Period 2|Physician Decision|0|||
170760059|NCT00517933|617127774|FG000|Period 2|Withdrawal by Subject|1|||
170760060|NCT00517933|617127775|FG001|Period 2|Withdrawal by Subject|3|||
170760061|NCT00517933|617127774|FG000|Period 2|Underwent lung transplant|0|||
170865822|NCT01831544|617521366|FG000|Overall Study|Still on original MVAD device|2|||
170406878|NCT00606684|615830638|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
170406879|NCT00606684|615830639|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
170760062|NCT00517933|617127775|FG001|Period 2|Underwent lung transplant|2|||
170760063|NCT01835899|617127777|FG000|Overall Study|Adverse Event|0|||
170760064|NCT01835899|617127778|FG001|Overall Study|Adverse Event|0|||
170760065|NCT01835899|617127779|FG002|Overall Study|Adverse Event|1|||
170760066|NCT01835899|617127777|FG000|Overall Study|Other than stated above|0|||
170760067|NCT01835899|617127778|FG001|Overall Study|Other than stated above|1|||
170760068|NCT01835899|617127779|FG002|Overall Study|Other than stated above|0|||
170760069|NCT02616263|617127787|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
170760070|NCT02616263|617127788|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
170760071|NCT02616263|617127787|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
170760072|NCT02616263|617127788|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
170760073|NCT02616263|617127787|FG000|6 Month to 1.5 Year|Death|1|||
170760074|NCT02616263|617127788|FG001|6 Month to 1.5 Year|Death|0|||
170760075|NCT02616263|617127787|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
170760076|NCT02616263|617127788|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
170760077|NCT02616263|617127787|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
170760078|NCT02616263|617127788|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
170760079|NCT02616263|617127787|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
170760080|NCT02616263|617127788|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
170760081|NCT00819234|617127799|FG000|Overall Study|Withdrawal by Subject|8|||
170760082|NCT00819234|617127800|FG001|Overall Study|Withdrawal by Subject|13|||
170865823|NCT00385203|617521367|FG000|Overall Study|Adverse Event|5|||
170865824|NCT00385203|617521368|FG001|Overall Study|Adverse Event|4|||
170406880|NCT00606684|615830633|FG000|Double-Blind Treatment Period|Physician Decision|0|||
170406881|NCT00606684|615830634|FG001|Double-Blind Treatment Period|Physician Decision|5|||
170406882|NCT00606684|615830635|FG002|Double-Blind Treatment Period|Physician Decision|1|||
170406883|NCT00606684|615830636|FG003|Double-Blind Treatment Period|Physician Decision|0|||
170406884|NCT00606684|615830637|FG004|Double-Blind Treatment Period|Physician Decision|3|||
170406885|NCT00606684|615830638|FG005|Double-Blind Treatment Period|Physician Decision|1|||
170406886|NCT00606684|615830639|FG006|Double-Blind Treatment Period|Physician Decision|2|||
170406887|NCT00606684|615830633|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170406888|NCT00606684|615830634|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170406889|NCT00606684|615830635|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170406890|NCT00606684|615830636|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
170406891|NCT00606684|615830637|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170406892|NCT00606684|615830638|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
170406893|NCT00606684|615830639|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170406894|NCT01034137|615830644|FG000|Overall Study|Adverse Event|9|||
170406895|NCT01034137|615830645|FG001|Overall Study|Adverse Event|10|||
170406896|NCT01034137|615830646|FG002|Overall Study|Adverse Event|8|||
170406897|NCT01034137|615830644|FG000|Overall Study|Withdrawal by Subject|4|||
170406898|NCT01034137|615830645|FG001|Overall Study|Withdrawal by Subject|3|||
170406899|NCT01034137|615830646|FG002|Overall Study|Withdrawal by Subject|3|||
170406900|NCT01034137|615830644|FG000|Overall Study|Lack of Efficacy|9|||
170406901|NCT01034137|615830645|FG001|Overall Study|Lack of Efficacy|4|||
170406902|NCT01034137|615830646|FG002|Overall Study|Lack of Efficacy|13|||
170406903|NCT01034137|615830644|FG000|Overall Study|Protocol Violation|2|||
170406904|NCT01034137|615830645|FG001|Overall Study|Protocol Violation|2|||
170406905|NCT01034137|615830646|FG002|Overall Study|Protocol Violation|1|||
170406906|NCT01034137|615830644|FG000|Overall Study|Refused treatment or did not cooperate|2|||
170406907|NCT01034137|615830645|FG001|Overall Study|Refused treatment or did not cooperate|0|||
170406908|NCT01034137|615830646|FG002|Overall Study|Refused treatment or did not cooperate|1|||
170406909|NCT01034137|615830644|FG000|Overall Study|Administrative or other|2|||
170406910|NCT01034137|615830645|FG001|Overall Study|Administrative or other|3|||
170406911|NCT01034137|615830646|FG002|Overall Study|Administrative or other|4|||
170406912|NCT00901628|615830654|FG000|Overall Study|disconnection of catheter|4|||
170406913|NCT00901628|615830655|FG001|Overall Study|disconnection of catheter|8|||
170406914|NCT00901628|615830654|FG000|Overall Study|disconnection of drain|0|||
170406915|NCT00901628|615830655|FG001|Overall Study|disconnection of drain|1|||
170406916|NCT00901628|615830654|FG000|Overall Study|peroneal nerve palsy|0|||
170865825|NCT00385203|617521367|FG000|Overall Study|Death|1|||
170865826|NCT00385203|617521368|FG001|Overall Study|Death|0|||
170865827|NCT00385203|617521367|FG000|Overall Study|Condition under investigation worsened|18|||
170519719|NCT02326272|616247585|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170632060|NCT02968004|616664521|FG001|Main Study Phase|Adverse Event|0|||
170760083|NCT00819234|617127801|FG002|Overall Study|Withdrawal by Subject|6|||
170760084|NCT00819234|617127802|FG003|Overall Study|Withdrawal by Subject|3|||
170406917|NCT00901628|615830655|FG001|Overall Study|peroneal nerve palsy|1|||
170406918|NCT00608205|615830656|FG000|Overall Study|Adverse Event|3|||
170406919|NCT00608205|615830657|FG001|Overall Study|Adverse Event|2|||
170406920|NCT00608205|615830656|FG000|Overall Study|Patient non-compliant|0|||
170406921|NCT00608205|615830657|FG001|Overall Study|Patient non-compliant|1|||
170406922|NCT02008721|615830660|FG000|Overall Study|Withdrawal by Subject|5|||
170406923|NCT02008721|615830661|FG001|Overall Study|Withdrawal by Subject|1|||
170406924|NCT02008721|615830660|FG000|Overall Study|Death|4|||
170406925|NCT02008721|615830661|FG001|Overall Study|Death|2|||
170406926|NCT02008721|615830660|FG000|Overall Study|Adverse Event|3|||
170406927|NCT02008721|615830661|FG001|Overall Study|Adverse Event|5|||
170406928|NCT02008721|615830660|FG000|Overall Study|Protocol Violation|3|||
170865828|NCT00385203|617521368|FG001|Overall Study|Condition under investigation worsened|3|||
170865829|NCT00385203|617521367|FG000|Overall Study|Incorrect enrollment|2|||
170865830|NCT00385203|617521368|FG001|Overall Study|Incorrect enrollment|0|||
170865831|NCT01131351|617521369|FG000|Overall Study|Adverse Event|0|||
170865832|NCT01131351|617521370|FG001|Overall Study|Adverse Event|2|||
170865833|NCT01131351|617521369|FG000|Overall Study|Protocol Deviation|0|||
170865834|NCT01131351|617521370|FG001|Overall Study|Protocol Deviation|1|||
170865835|NCT03422172|617521371|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
170865836|NCT03422172|617521371|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
170865837|NCT03422172|617521371|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
170865838|NCT04498169|617521375|FG000|Study Completion|Adverse Event|1|||
170865839|NCT04498169|617521376|FG001|Study Completion|Adverse Event|1|||
170865840|NCT02960854|617521377|FG000|Overall Study|Not Disclosed|2|||
170865841|NCT02960854|617521378|FG001|Overall Study|Not Disclosed|2|||
170865842|NCT02960854|617521377|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
170865843|NCT02960854|617521378|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
170865844|NCT02960854|617521377|FG000|Overall Study|Subject Withdrew Consent|0|||
170865845|NCT02960854|617521378|FG001|Overall Study|Subject Withdrew Consent|1|||
170865846|NCT02960854|617521377|FG000|Overall Study|Death|4|||
170865847|NCT02960854|617521378|FG001|Overall Study|Death|6|||
170865848|NCT00221195|617521379|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
170865849|NCT00221195|617521380|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
170865850|NCT00221195|617521379|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
170865851|NCT00221195|617521380|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
170865852|NCT00221195|617521379|FG000|Washout Period (Months 7-9)|Death|0|||
170865853|NCT00221195|617521380|FG001|Washout Period (Months 7-9)|Death|1|||
170865854|NCT00221195|617521379|FG000|Therapy 2 (Months 10-15)|Death|1|||
170865855|NCT00221195|617521380|FG001|Therapy 2 (Months 10-15)|Death|0|||
170865856|NCT00221195|617521379|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
170865857|NCT00221195|617521380|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
170865858|NCT06069778|617521381|FG000|Overall Study|Withdrawal by Subject|1|||
170865859|NCT03189862|617521384|FG000|Overall Study|Withdrawal by Subject|1|||
170865860|NCT03189862|617521385|FG001|Overall Study|Withdrawal by Subject|0|||
170865861|NCT03189862|617521384|FG000|Overall Study|Lost to Follow-up|54|||
170865862|NCT03189862|617521385|FG001|Overall Study|Lost to Follow-up|62|||
170865863|NCT01829360|617521386|FG000|Overall Study|Protocol Violation|0|||
170865864|NCT01829360|617521387|FG001|Overall Study|Protocol Violation|0|||
170865865|NCT01829360|617521388|FG002|Overall Study|Protocol Violation|1|||
170865866|NCT01829360|617521389|FG003|Overall Study|Protocol Violation|0|||
170865867|NCT02249767|617521390|FG000|Overall Study|Did not use medication|8|||
170865868|NCT02249767|617521391|FG001|Overall Study|Did not use medication|9|||
170865869|NCT02249767|617521392|FG002|Overall Study|Did not use medication|8|||
170865870|NCT00867113|617521393|FG000|Treatment Period|Adverse Event|15|||
170865871|NCT00867113|617521393|FG000|Treatment Period|Death|2|||
170865872|NCT00867113|617521393|FG000|Treatment Period|Withdrawal by Subject|19|||
170865873|NCT00867113|617521393|FG000|Treatment Period|Lost to Follow-up|3|||
170865874|NCT00867113|617521393|FG000|Treatment Period|Administrative problems|1|||
170865875|NCT00867113|617521393|FG000|Treatment Period|Disease progression/relapse|1|||
170865876|NCT00867113|617521393|FG000|Treatment Period|Protocol Violation|4|||
170865877|NCT00867113|617521393|FG000|Post Treatment After Survival Follow-up|Death|1|||
170865878|NCT00867113|617521393|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
170865879|NCT00867113|617521393|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
170865880|NCT00867113|617521393|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
170865881|NCT01886313|617521396|FG000|Overall Study|Adverse Event|1|||
170865882|NCT01886313|617521397|FG001|Overall Study|Adverse Event|1|||
170865883|NCT01603082|617521402|FG000|Overall Study|Adverse Event|0|||
170865884|NCT01603082|617521403|FG001|Overall Study|Adverse Event|1|||
170865885|NCT01603082|617521402|FG000|Overall Study|Withdrawal by Subject|1|||
170865886|NCT01603082|617521403|FG001|Overall Study|Withdrawal by Subject|0|||
170406929|NCT02008721|615830661|FG001|Overall Study|Protocol Violation|2|||
170406930|NCT01797120|615830664|FG000|Overall Study|Disesae progression|37|||
170865887|NCT01603082|617521402|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
170865888|NCT01603082|617521403|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
170865889|NCT02545322|617521409|FG000|Overall Study|Withdrawal by Subject|3|||
170865890|NCT00041067|617521410|FG000|Overall Study|Adverse Event|20|||
170865891|NCT00041067|617521410|FG000|Overall Study|Progression|19|||
170865892|NCT00041067|617521410|FG000|Overall Study|Patient refusal|12|||
170865893|NCT00041067|617521410|FG000|Overall Study|Other reasons|23|||
170865894|NCT00041067|617521410|FG000|Overall Study|Ineligible|2|||
170865895|NCT01717768|617521411|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170865896|NCT01717768|617521412|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
170406931|NCT01797120|615830665|FG001|Overall Study|Disesae progression|49|||
170406932|NCT01797120|615830664|FG000|Overall Study|Adverse Event|13|||
170406933|NCT01797120|615830665|FG001|Overall Study|Adverse Event|5|||
170406934|NCT01797120|615830664|FG000|Overall Study|Withdrawal by Subject|6|||
170406935|NCT01797120|615830665|FG001|Overall Study|Withdrawal by Subject|6|||
170406936|NCT01797120|615830664|FG000|Overall Study|Symptomatic progression|2|||
170406937|NCT01797120|615830665|FG001|Overall Study|Symptomatic progression|1|||
170406938|NCT01797120|615830664|FG000|Overall Study|Non-compliance|1|||
170406939|NCT01797120|615830665|FG001|Overall Study|Non-compliance|0|||
170406940|NCT01797120|615830664|FG000|Overall Study|Physician Decision|3|||
170406941|NCT01797120|615830665|FG001|Overall Study|Physician Decision|0|||
170406942|NCT01797120|615830664|FG000|Overall Study|still on treatment|2|||
170406943|NCT01797120|615830665|FG001|Overall Study|still on treatment|4|||
170406944|NCT01797120|615830664|FG000|Overall Study|never start protocol therapy|2|||
170406945|NCT01797120|615830665|FG001|Overall Study|never start protocol therapy|0|||
170406946|NCT05751629|615830667|FG000|Overall Study|Withdrawal by Subject|6|||
170406947|NCT05751629|615830667|FG000|Overall Study|Death|25|||
170406948|NCT05751629|615830667|FG000|Overall Study|Study Site Closed|9|||
170406949|NCT05751629|615830667|FG000|Overall Study|Physician Decision|1|||
170406950|NCT01909466|615830669|FG000|Overall Study|Lost to Follow-up|5|||
170406951|NCT01909466|615830670|FG001|Overall Study|Lost to Follow-up|7|||
170406952|NCT01909466|615830669|FG000|Overall Study|Adverse Event|3|||
170406953|NCT01909466|615830670|FG001|Overall Study|Adverse Event|4|||
170406954|NCT01909466|615830669|FG000|Overall Study|Met Withdrawal Criteria|0|||
170406955|NCT01909466|615830670|FG001|Overall Study|Met Withdrawal Criteria|3|||
170406956|NCT01909466|615830669|FG000|Overall Study|Physician Decision|2|||
170406957|NCT01909466|615830670|FG001|Overall Study|Physician Decision|0|||
170406958|NCT01909466|615830669|FG000|Overall Study|Withdrawal by Subject|11|||
170406959|NCT01909466|615830670|FG001|Overall Study|Withdrawal by Subject|9|||
170406960|NCT01909466|615830669|FG000|Overall Study|Lack of Efficacy|1|||
170406961|NCT01909466|615830670|FG001|Overall Study|Lack of Efficacy|0|||
170406962|NCT00772577|615830673|FG000|Overall Study|Adverse Event|6|||
170406963|NCT00772577|615830674|FG001|Overall Study|Adverse Event|3|||
170406964|NCT00772577|615830673|FG000|Overall Study|Abnormal laboratory values|0|||
170406965|NCT00772577|615830674|FG001|Overall Study|Abnormal laboratory values|1|||
170406966|NCT00772577|615830673|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170406967|NCT00772577|615830674|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
170406968|NCT00772577|615830673|FG000|Overall Study|Patient withdrew consent|8|||
170406969|NCT00772577|615830674|FG001|Overall Study|Patient withdrew consent|5|||
170406970|NCT00772577|615830673|FG000|Overall Study|Lost to Follow-up|4|||
170406971|NCT00772577|615830674|FG001|Overall Study|Lost to Follow-up|3|||
170406972|NCT00772577|615830673|FG000|Overall Study|Administrative problems|2|||
170406973|NCT00772577|615830674|FG001|Overall Study|Administrative problems|1|||
170406974|NCT00772577|615830673|FG000|Overall Study|Protocol Deviation|3|||
170406975|NCT00772577|615830674|FG001|Overall Study|Protocol Deviation|2|||
170406976|NCT00672620|615830675|FG000|Overall Study|Adverse Event|7|||
170406977|NCT00672620|615830676|FG001|Overall Study|Adverse Event|7|||
170406978|NCT00672620|615830677|FG002|Overall Study|Adverse Event|12|||
170406979|NCT00672620|615830678|FG003|Overall Study|Adverse Event|17|||
170406980|NCT00672620|615830675|FG000|Overall Study|Lack of Efficacy|1|||
170406981|NCT00672620|615830676|FG001|Overall Study|Lack of Efficacy|2|||
170406982|NCT00672620|615830677|FG002|Overall Study|Lack of Efficacy|2|||
170406983|NCT00672620|615830678|FG003|Overall Study|Lack of Efficacy|0|||
170406984|NCT00672620|615830675|FG000|Overall Study|Noncompliance with Study Drug|3|||
170406985|NCT00672620|615830676|FG001|Overall Study|Noncompliance with Study Drug|4|||
170406986|NCT00672620|615830677|FG002|Overall Study|Noncompliance with Study Drug|0|||
170406987|NCT00672620|615830678|FG003|Overall Study|Noncompliance with Study Drug|2|||
170406988|NCT00672620|615830675|FG000|Overall Study|Protocol Deviations|5|||
170406989|NCT00672620|615830676|FG001|Overall Study|Protocol Deviations|7|||
170406990|NCT00672620|615830677|FG002|Overall Study|Protocol Deviations|2|||
170406991|NCT00672620|615830678|FG003|Overall Study|Protocol Deviations|5|||
170406992|NCT00672620|615830675|FG000|Overall Study|Withdrawal of Consent|6|||
170406993|NCT00672620|615830676|FG001|Overall Study|Withdrawal of Consent|12|||
170406994|NCT00672620|615830677|FG002|Overall Study|Withdrawal of Consent|5|||
170406995|NCT00672620|615830678|FG003|Overall Study|Withdrawal of Consent|6|||
170406996|NCT00672620|615830675|FG000|Overall Study|Lost to Follow-up|8|||
170406997|NCT00672620|615830676|FG001|Overall Study|Lost to Follow-up|19|||
170406998|NCT00672620|615830677|FG002|Overall Study|Lost to Follow-up|8|||
170406999|NCT00672620|615830678|FG003|Overall Study|Lost to Follow-up|11|||
170760085|NCT00819234|617127803|FG004|Overall Study|Withdrawal by Subject|0|||
170407000|NCT00672620|615830675|FG000|Overall Study|Reason not Specified|3|||
170407001|NCT00672620|615830676|FG001|Overall Study|Reason not Specified|3|||
170407002|NCT00672620|615830677|FG002|Overall Study|Reason not Specified|2|||
170407003|NCT00672620|615830678|FG003|Overall Study|Reason not Specified|1|||
170407004|NCT02965820|615830679|FG000|Period 2, Second 30 Days|Adverse Event|1|||
170407005|NCT02965820|615830680|FG001|Period 2, Second 30 Days|Adverse Event|1|||
170407006|NCT02622074|615830689|FG000|Overall Study|Death|4|||
170407007|NCT02622074|615830690|FG001|Overall Study|Death|0|||
170407008|NCT02622074|615830691|FG002|Overall Study|Death|0|||
170407009|NCT02622074|615830692|FG003|Overall Study|Death|1|||
170407010|NCT02622074|615830693|FG004|Overall Study|Death|1|||
170407011|NCT02622074|615830694|FG005|Overall Study|Death|0|||
170407012|NCT02622074|615830689|FG000|Overall Study|Withdrawal by Subject|0|||
170407013|NCT02622074|615830690|FG001|Overall Study|Withdrawal by Subject|1|||
170407014|NCT02622074|615830691|FG002|Overall Study|Withdrawal by Subject|0|||
170407015|NCT02622074|615830692|FG003|Overall Study|Withdrawal by Subject|0|||
170407016|NCT02622074|615830693|FG004|Overall Study|Withdrawal by Subject|0|||
170407017|NCT02622074|615830694|FG005|Overall Study|Withdrawal by Subject|0|||
170407018|NCT03565211|615830695|FG000|Overall Study|Withdrawal by Subject|2|||
170407019|NCT03565211|615830695|FG000|Overall Study|Lost to Follow-up|1|||
170407020|NCT03565211|615830695|FG000|Overall Study|Adverse Event|44|||
170407021|NCT03565211|615830695|FG000|Overall Study|Personal issues|1|||
170407022|NCT00267007|615830696|FG000|Overall Study|Withdrawal by Subject|6|||
170407023|NCT00267007|615830697|FG001|Overall Study|Withdrawal by Subject|0|||
170407024|NCT00267007|615830696|FG000|Overall Study|Lost to Follow-up|1|||
170407025|NCT00267007|615830697|FG001|Overall Study|Lost to Follow-up|0|||
170407026|NCT00267007|615830696|FG000|Overall Study|Non-compliance|0|||
170407027|NCT00267007|615830697|FG001|Overall Study|Non-compliance|1|||
170407028|NCT00267007|615830696|FG000|Overall Study|Adverse Event|1|||
170407029|NCT00267007|615830697|FG001|Overall Study|Adverse Event|0|||
170407030|NCT01205529|615830702|FG000|Overall Study|Procedure Cancelled|4|||
170407031|NCT01205529|615830702|FG000|Overall Study|Withdrawal by Subject|2|||
170407032|NCT01205529|615830702|FG000|Overall Study|Physician Decision|4|||
170407033|NCT01205529|615830702|FG000|Overall Study|Unstable post op|15|||
170407034|NCT01205529|615830702|FG000|Overall Study|No longer met criteria|30|||
170407035|NCT04133519|615830703|FG000|Overall Study|Withdrawal by Subject|5|||
170407036|NCT04133519|615830704|FG001|Overall Study|Withdrawal by Subject|4|||
170407037|NCT04133519|615830703|FG000|Overall Study|Protocol Violation|0|||
170407038|NCT04133519|615830704|FG001|Overall Study|Protocol Violation|1|||
170407039|NCT04133519|615830703|FG000|Overall Study|Never started treatment|1|||
170407040|NCT04133519|615830704|FG001|Overall Study|Never started treatment|1|||
170407041|NCT00323609|615830705|FG000|Overall Study|Death|16|||
170407042|NCT00323609|615830706|FG001|Overall Study|Death|21|||
170407043|NCT00323609|615830707|FG002|Overall Study|Death|0|||
170407044|NCT00323609|615830708|FG003|Overall Study|Death|0|||
170407045|NCT00323609|615830705|FG000|Overall Study|Lost to Follow-up|9|||
170407046|NCT00323609|615830706|FG001|Overall Study|Lost to Follow-up|10|||
170407047|NCT00323609|615830707|FG002|Overall Study|Lost to Follow-up|0|||
170407048|NCT00323609|615830708|FG003|Overall Study|Lost to Follow-up|0|||
170407049|NCT00323609|615830705|FG000|Overall Study|Physician Decision|2|||
170407050|NCT00323609|615830706|FG001|Overall Study|Physician Decision|0|||
170407051|NCT00323609|615830707|FG002|Overall Study|Physician Decision|0|||
170407052|NCT00323609|615830708|FG003|Overall Study|Physician Decision|1|||
170407053|NCT00323609|615830705|FG000|Overall Study|Withdrawal by Subject|11|||
170407054|NCT00323609|615830706|FG001|Overall Study|Withdrawal by Subject|23|||
170407055|NCT00323609|615830707|FG002|Overall Study|Withdrawal by Subject|4|||
170407056|NCT00323609|615830708|FG003|Overall Study|Withdrawal by Subject|4|||
170407057|NCT00323609|615830705|FG000|Overall Study|Other non-VCF-related medical condition|3|||
170407058|NCT00323609|615830706|FG001|Overall Study|Other non-VCF-related medical condition|2|||
170407059|NCT00323609|615830707|FG002|Overall Study|Other non-VCF-related medical condition|0|||
170407060|NCT00323609|615830708|FG003|Overall Study|Other non-VCF-related medical condition|0|||
170407061|NCT00323609|615830705|FG000|Overall Study|Sponsor discontinued trial|29|||
170407062|NCT00323609|615830706|FG001|Overall Study|Sponsor discontinued trial|29|||
170407063|NCT00323609|615830707|FG002|Overall Study|Sponsor discontinued trial|0|||
170407064|NCT00323609|615830708|FG003|Overall Study|Sponsor discontinued trial|0|||
170407065|NCT00323609|615830705|FG000|Overall Study|Unrelenting or severe back pain|1|||
170407066|NCT00323609|615830706|FG001|Overall Study|Unrelenting or severe back pain|1|||
170407067|NCT00323609|615830707|FG002|Overall Study|Unrelenting or severe back pain|0|||
170407068|NCT00323609|615830708|FG003|Overall Study|Unrelenting or severe back pain|0|||
170407069|NCT00323609|615830705|FG000|Overall Study|Logistical withdrawal|9|||
170407070|NCT00323609|615830706|FG001|Overall Study|Logistical withdrawal|5|||
170760086|NCT00819234|617127804|FG005|Overall Study|Withdrawal by Subject|4|||
170760087|NCT00819234|617127805|FG006|Overall Study|Withdrawal by Subject|4|||
170407071|NCT00323609|615830707|FG002|Overall Study|Logistical withdrawal|0|||
170407072|NCT00323609|615830708|FG003|Overall Study|Logistical withdrawal|1|||
170407073|NCT00323609|615830705|FG000|Overall Study|Other reason|11|||
170407074|NCT00323609|615830706|FG001|Overall Study|Other reason|8|||
170407075|NCT00323609|615830707|FG002|Overall Study|Other reason|4|||
170760088|NCT00819234|617127806|FG007|Overall Study|Withdrawal by Subject|8|||
170760089|NCT00819234|617127807|FG008|Overall Study|Withdrawal by Subject|5|||
170407076|NCT00323609|615830708|FG003|Overall Study|Other reason|9|||
170407077|NCT02063698|615830714|FG000|Overall Study|did not complete booklet for days 2-8|1|||
170407078|NCT02063698|615830715|FG001|Overall Study|did not complete booklet for days 2-8|2|||
170407079|NCT01684722|615830716|FG000|Overall Study|Lost to Follow-up|78|||
170407080|NCT01684722|615830717|FG001|Overall Study|Lost to Follow-up|56|||
170407081|NCT01684722|615830718|FG002|Overall Study|Lost to Follow-up|75|||
170407082|NCT01684722|615830719|FG003|Overall Study|Lost to Follow-up|89|||
170407083|NCT01684722|615830716|FG000|Overall Study|Death|19|||
170407084|NCT01684722|615830717|FG001|Overall Study|Death|21|||
170407085|NCT01684722|615830718|FG002|Overall Study|Death|19|||
170407086|NCT01684722|615830719|FG003|Overall Study|Death|21|||
170407087|NCT01092702|615830720|FG000|Overall Study|Withdrawal by Subject|7|||
170407088|NCT01092702|615830720|FG000|Overall Study|Lost to Follow-up|2|||
170407089|NCT01664494|615830721|FG000|Overall Study|Withdrawal by Subject|27|||
170407090|NCT01664494|615830721|FG000|Overall Study|Death|18|||
170407091|NCT01664494|615830721|FG000|Overall Study|Other|49|||
170407092|NCT01664494|615830721|FG000|Overall Study|Lost to Follow-up|99|||
170407093|NCT00219557|615830723|FG000|Phase 1|Lack of Efficacy|3|||
170407094|NCT00219557|615830724|FG001|Phase 1|Lack of Efficacy|0|||
170407095|NCT00219557|615830725|FG002|Phase 1|Lack of Efficacy|0|||
170407096|NCT00219557|615830723|FG000|Phase 1|Adverse Event|2|||
170407097|NCT00219557|615830724|FG001|Phase 1|Adverse Event|0|||
170407098|NCT00219557|615830725|FG002|Phase 1|Adverse Event|0|||
170407099|NCT00219557|615830723|FG000|Phase 1|Withdrawal by Subject|1|||
170407100|NCT00219557|615830724|FG001|Phase 1|Withdrawal by Subject|0|||
170407101|NCT00219557|615830725|FG002|Phase 1|Withdrawal by Subject|0|||
170407102|NCT00219557|615830723|FG000|Phase 1|Started chemotherapy at other institute|1|||
170407103|NCT00219557|615830724|FG001|Phase 1|Started chemotherapy at other institute|0|||
170407104|NCT00219557|615830725|FG002|Phase 1|Started chemotherapy at other institute|0|||
170407105|NCT00219557|615830723|FG000|Phase 2|Lack of Efficacy|0|||
170407106|NCT00219557|615830724|FG001|Phase 2|Lack of Efficacy|21|||
170407107|NCT00219557|615830725|FG002|Phase 2|Lack of Efficacy|15|||
170407108|NCT00219557|615830723|FG000|Phase 2|Adverse Event|0|||
170407109|NCT00219557|615830724|FG001|Phase 2|Adverse Event|22|||
170407110|NCT00219557|615830725|FG002|Phase 2|Adverse Event|2|||
170407111|NCT00219557|615830723|FG000|Phase 2|Death|0|||
170407112|NCT00219557|615830724|FG001|Phase 2|Death|8|||
170407113|NCT00219557|615830725|FG002|Phase 2|Death|2|||
170407114|NCT00219557|615830723|FG000|Phase 2|Other|0|||
170407115|NCT00219557|615830724|FG001|Phase 2|Other|8|||
170407116|NCT00219557|615830725|FG002|Phase 2|Other|6|||
170407117|NCT00219557|615830723|FG000|Phase 2|Withdrawal by Subject|0|||
170407118|NCT00219557|615830724|FG001|Phase 2|Withdrawal by Subject|9|||
170760090|NCT00819234|617127808|FG009|Overall Study|Withdrawal by Subject|3|||
170760091|NCT00819234|617127799|FG000|Overall Study|Adverse Event|0|||
170760092|NCT00819234|617127800|FG001|Overall Study|Adverse Event|0|||
170760093|NCT00819234|617127801|FG002|Overall Study|Adverse Event|1|||
170760094|NCT00819234|617127802|FG003|Overall Study|Adverse Event|0|||
170760095|NCT00819234|617127803|FG004|Overall Study|Adverse Event|0|||
170760096|NCT00819234|617127804|FG005|Overall Study|Adverse Event|2|||
170760097|NCT00819234|617127805|FG006|Overall Study|Adverse Event|0|||
170760098|NCT00819234|617127806|FG007|Overall Study|Adverse Event|0|||
170760099|NCT00819234|617127807|FG008|Overall Study|Adverse Event|0|||
170760100|NCT00819234|617127808|FG009|Overall Study|Adverse Event|0|||
170760101|NCT00819234|617127799|FG000|Overall Study|Physician Decision|0|||
170760102|NCT00819234|617127800|FG001|Overall Study|Physician Decision|0|||
170760103|NCT00819234|617127801|FG002|Overall Study|Physician Decision|0|||
170760104|NCT00819234|617127802|FG003|Overall Study|Physician Decision|1|||
170760105|NCT00819234|617127803|FG004|Overall Study|Physician Decision|0|||
170760106|NCT00819234|617127804|FG005|Overall Study|Physician Decision|0|||
170760107|NCT00819234|617127805|FG006|Overall Study|Physician Decision|0|||
170760108|NCT00819234|617127806|FG007|Overall Study|Physician Decision|0|||
170760109|NCT00819234|617127807|FG008|Overall Study|Physician Decision|0|||
170760110|NCT00819234|617127808|FG009|Overall Study|Physician Decision|2|||
170760111|NCT00819234|617127799|FG000|Overall Study|Protocol Violation|0|||
170760112|NCT00819234|617127800|FG001|Overall Study|Protocol Violation|0|||
170760113|NCT00819234|617127801|FG002|Overall Study|Protocol Violation|1|||
170865897|NCT01717768|617521413|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170865898|NCT01717768|617521414|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170865899|NCT01717768|617521415|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170407119|NCT00219557|615830725|FG002|Phase 2|Withdrawal by Subject|5|||
170760114|NCT00819234|617127802|FG003|Overall Study|Protocol Violation|0|||
170407120|NCT00219557|615830723|FG000|Phase 2|Treatment not received|0|||
170407121|NCT00219557|615830724|FG001|Phase 2|Treatment not received|1|||
170407122|NCT00219557|615830725|FG002|Phase 2|Treatment not received|3|||
170407123|NCT03063632|615830727|FG000|Overall Study|Death|4|||
170407124|NCT03063632|615830728|FG001|Overall Study|Death|6|||
170407125|NCT03063632|615830727|FG000|Overall Study|Lost to Follow-up|0|||
170407126|NCT03063632|615830728|FG001|Overall Study|Lost to Follow-up|1|||
170760115|NCT00819234|617127803|FG004|Overall Study|Protocol Violation|0|||
170760116|NCT00819234|617127804|FG005|Overall Study|Protocol Violation|0|||
170760117|NCT00819234|617127805|FG006|Overall Study|Protocol Violation|0|||
170760118|NCT00819234|617127806|FG007|Overall Study|Protocol Violation|0|||
170407127|NCT03063632|615830727|FG000|Overall Study|Withdrawal by Subject|0|||
170407128|NCT03063632|615830728|FG001|Overall Study|Withdrawal by Subject|2|||
170760119|NCT00819234|617127807|FG008|Overall Study|Protocol Violation|0|||
170760120|NCT00819234|617127808|FG009|Overall Study|Protocol Violation|0|||
170407129|NCT03063632|615830727|FG000|Overall Study|Physician Decision|2|||
170407130|NCT03063632|615830728|FG001|Overall Study|Physician Decision|0|||
170407131|NCT03063632|615830727|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
170407132|NCT03063632|615830728|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
170407133|NCT01612156|615830729|FG000|Overall Study|Protocol Violation|2|||
170407134|NCT01612156|615830730|FG001|Overall Study|Protocol Violation|0|||
170407135|NCT00106028|615830731|FG000|Overall Study|Adverse Event|3|||
170407136|NCT00106028|615830732|FG001|Overall Study|Adverse Event|2|||
170407137|NCT00106028|615830731|FG000|Overall Study|Protocol Violation|1|||
170407138|NCT00106028|615830732|FG001|Overall Study|Protocol Violation|1|||
170407139|NCT00106028|615830731|FG000|Overall Study|Withdrawal by Subject|2|||
170407140|NCT00106028|615830732|FG001|Overall Study|Withdrawal by Subject|8|||
170407141|NCT00106028|615830731|FG000|Overall Study|Lost to Follow-up|0|||
170407142|NCT00106028|615830732|FG001|Overall Study|Lost to Follow-up|1|||
170407143|NCT06371079|615830737|FG000|Overall Study|Missing data|88|||
170407144|NCT06371079|615830738|FG001|Overall Study|Missing data|247|||
170407145|NCT00575328|615830742|FG000|Overall Study|Adverse Event|1|||
170407146|NCT00575328|615830743|FG001|Overall Study|Adverse Event|1|||
170407147|NCT00575328|615830742|FG000|Overall Study|Lost to Follow-up|2|||
170407148|NCT00575328|615830743|FG001|Overall Study|Lost to Follow-up|1|||
170407149|NCT00571922|615830749|FG000|Overall Study|Completion unknown|36|||
170407150|NCT00571922|615830750|FG001|Overall Study|Completion unknown|36|||
170407151|NCT05478603|615830751|FG000|Overall Study|Withdrawal by Subject|0|||
170760121|NCT00819234|617127799|FG000|Overall Study|Lost to Follow-up|2|||
170760122|NCT00819234|617127800|FG001|Overall Study|Lost to Follow-up|2|||
170760123|NCT00819234|617127801|FG002|Overall Study|Lost to Follow-up|0|||
170760124|NCT00819234|617127802|FG003|Overall Study|Lost to Follow-up|2|||
170760125|NCT00819234|617127803|FG004|Overall Study|Lost to Follow-up|1|||
170760126|NCT00819234|617127804|FG005|Overall Study|Lost to Follow-up|1|||
170760127|NCT00819234|617127805|FG006|Overall Study|Lost to Follow-up|1|||
170760128|NCT00819234|617127806|FG007|Overall Study|Lost to Follow-up|1|||
170407152|NCT05478603|615830752|FG001|Overall Study|Withdrawal by Subject|1|||
170407153|NCT05478603|615830753|FG002|Overall Study|Withdrawal by Subject|0|||
170407154|NCT05478603|615830754|FG003|Overall Study|Withdrawal by Subject|0|||
170407155|NCT05037409|615830755|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
170407156|NCT05037409|615830756|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
170407157|NCT05037409|615830757|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
170407158|NCT05003167|615830761|FG000|Overall Study|Withdrawal by Subject|1|||
170407159|NCT01010230|615830762|FG000|Overall Study|Withdrawal by Subject|6|||
170407160|NCT01010230|615830763|FG001|Overall Study|Withdrawal by Subject|5|||
170407161|NCT01010230|615830762|FG000|Overall Study|Lost to Follow-up|4|||
170407162|NCT01010230|615830763|FG001|Overall Study|Lost to Follow-up|2|||
170407163|NCT02367781|615830766|FG000|Overall Study|Withdrawal by Subject|20|||
170407164|NCT02367781|615830767|FG001|Overall Study|Withdrawal by Subject|13|||
170407165|NCT02367781|615830766|FG000|Overall Study|Protocol Violation|0|||
170407166|NCT02367781|615830767|FG001|Overall Study|Protocol Violation|1|||
170407167|NCT02367781|615830766|FG000|Overall Study|Physician Decision|7|||
170407168|NCT02367781|615830767|FG001|Overall Study|Physician Decision|0|||
170407169|NCT02367781|615830766|FG000|Overall Study|Randomized in Error|5|||
170407170|NCT02367781|615830767|FG001|Overall Study|Randomized in Error|4|||
170407171|NCT02367781|615830766|FG000|Overall Study|Non-Compliance|1|||
170407172|NCT02367781|615830767|FG001|Overall Study|Non-Compliance|0|||
170407173|NCT02367781|615830766|FG000|Overall Study|Lost to Follow-up|1|||
170407174|NCT02367781|615830767|FG001|Overall Study|Lost to Follow-up|2|||
170407175|NCT02367781|615830766|FG000|Overall Study|Death|330|||
170407176|NCT02367781|615830767|FG001|Overall Study|Death|176|||
170407177|NCT02367781|615830766|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
170407178|NCT02367781|615830767|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
170407179|NCT02367781|615830766|FG000|Overall Study|Prolonged Hospitalization|1|||
170407180|NCT02367781|615830767|FG001|Overall Study|Prolonged Hospitalization|0|||
170407181|NCT02367781|615830766|FG000|Overall Study|Death Prior First Dose|1|||
170407182|NCT02367781|615830767|FG001|Overall Study|Death Prior First Dose|0|||
170407183|NCT02367781|615830766|FG000|Overall Study|Administrative-Change Facility|1|||
170407184|NCT02367781|615830767|FG001|Overall Study|Administrative-Change Facility|0|||
170407185|NCT02367781|615830766|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
170407186|NCT02367781|615830767|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
170407187|NCT02367781|615830766|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
170760129|NCT00819234|617127807|FG008|Overall Study|Lost to Follow-up|1|||
170865900|NCT01717768|617521416|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170407188|NCT02367781|615830767|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
170407189|NCT02367781|615830766|FG000|Overall Study|Study Terminated by Sponsor|3|||
170407190|NCT02367781|615830767|FG001|Overall Study|Study Terminated by Sponsor|1|||
170519720|NCT02326272|616247586|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170760130|NCT00819234|617127808|FG009|Overall Study|Lost to Follow-up|2|||
170760131|NCT03697460|617127810|FG000|Overall Study|Withdrawal by Subject|3|||
170407191|NCT02367781|615830766|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
170407192|NCT02367781|615830767|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
170407193|NCT02367781|615830766|FG000|Overall Study|Sponsor Decision|2|||
170407194|NCT02367781|615830767|FG001|Overall Study|Sponsor Decision|0|||
170407195|NCT02367781|615830766|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
170407196|NCT02367781|615830767|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
170407197|NCT01133392|615830768|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
170407198|NCT01133392|615830769|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
170407199|NCT01133392|615830768|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
170865901|NCT01717768|617521417|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170865902|NCT01717768|617521418|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170407200|NCT01133392|615830769|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
170407201|NCT02468557|615832416|FG000|Overall Study|Adverse Event|1|||
170407202|NCT02468557|615832416|FG000|Overall Study|Death|1|||
170407203|NCT02468557|615832416|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
170407204|NCT02468557|615832416|FG000|Overall Study|All Enrolled but Never Dosed|4|||
170407205|NCT00331630|615832427|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
170407206|NCT00331630|615832427|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
170407207|NCT00331630|615832427|FG000|Follow up for 5 Years|Death|5|||
170407208|NCT00331630|615832427|FG000|Follow up for 5 Years|Data collection was stopped|24|||
170407209|NCT00720798|615832428|FG000|Overall Study|Adverse Event|304|||
170407210|NCT00720798|615832428|FG000|Overall Study|Death|39|||
170407211|NCT00720798|615832428|FG000|Overall Study|Insufficient Therapeutic Response|129|||
170407212|NCT00720798|615832428|FG000|Overall Study|Protocol Violation|4|||
170407213|NCT00720798|615832428|FG000|Overall Study|Refused Treatment|151|||
170407214|NCT00720798|615832428|FG000|Overall Study|Failure to Return|46|||
170407215|NCT00720798|615832428|FG000|Overall Study|Reason not Specified|83|||
170407216|NCT00433381|615832429|FG000|Overall Study|Ineligible / no protocol treatment|3|||
170407217|NCT00433381|615832430|FG001|Overall Study|Ineligible / no protocol treatment|3|||
170407218|NCT03342898|615832431|FG000|Overall Study|Adverse Event|3|||
170407219|NCT03342898|615832432|FG001|Overall Study|Adverse Event|1|||
170407220|NCT03342898|615832433|FG002|Overall Study|Adverse Event|0|||
170407221|NCT03342898|615832431|FG000|Overall Study|Lost to Follow-up|44|||
170407222|NCT03342898|615832432|FG001|Overall Study|Lost to Follow-up|40|||
170407223|NCT03342898|615832433|FG002|Overall Study|Lost to Follow-up|42|||
170407224|NCT03342898|615832431|FG000|Overall Study|Withdrawal of Consent|5|||
170407225|NCT03342898|615832432|FG001|Overall Study|Withdrawal of Consent|9|||
170407226|NCT03342898|615832433|FG002|Overall Study|Withdrawal of Consent|11|||
170407227|NCT03342898|615832431|FG000|Overall Study|Death|0|||
170407228|NCT03342898|615832432|FG001|Overall Study|Death|1|||
170407229|NCT03342898|615832433|FG002|Overall Study|Death|1|||
170407230|NCT03342898|615832431|FG000|Overall Study|Reason not Specified|2|||
170407231|NCT03342898|615832432|FG001|Overall Study|Reason not Specified|2|||
170407232|NCT03342898|615832433|FG002|Overall Study|Reason not Specified|0|||
170407233|NCT01387282|615832434|FG000|Overall Study|Death|47|||
170407234|NCT01387282|615832435|FG001|Overall Study|Death|16|||
170407235|NCT01387282|615832434|FG000|Overall Study|Other|5|||
170407236|NCT01387282|615832435|FG001|Overall Study|Other|1|||
170407237|NCT01387282|615832434|FG000|Overall Study|Unrelated AE|6|||
170407238|NCT01387282|615832435|FG001|Overall Study|Unrelated AE|4|||
170407239|NCT01387282|615832434|FG000|Overall Study|Withdrawal by patient|33|||
170407240|NCT01387282|615832435|FG001|Overall Study|Withdrawal by patient|23|||
170407241|NCT01387282|615832434|FG000|Overall Study|Study drug-related AE|2|||
170407242|NCT01387282|615832435|FG001|Overall Study|Study drug-related AE|2|||
170407243|NCT01387282|615832434|FG000|Overall Study|Lost to Follow-up|4|||
170407244|NCT01387282|615832435|FG001|Overall Study|Lost to Follow-up|1|||
170407245|NCT00458302|615832436|FG000|Overall Study|Adverse Event|4|||
170407246|NCT00458302|615832437|FG001|Overall Study|Adverse Event|14|||
170407247|NCT00458302|615832436|FG000|Overall Study|Pregnancy|2|||
170407248|NCT00458302|615832437|FG001|Overall Study|Pregnancy|1|||
170407249|NCT00458302|615832436|FG000|Overall Study|Protocol Violation|0|||
170407250|NCT00458302|615832437|FG001|Overall Study|Protocol Violation|2|||
170407251|NCT00458302|615832436|FG000|Overall Study|Withdrawal by Subject|6|||
170407252|NCT00458302|615832437|FG001|Overall Study|Withdrawal by Subject|4|||
170407253|NCT00458302|615832436|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
170407254|NCT00458302|615832437|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
170407255|NCT00458302|615832436|FG000|Overall Study|Study Termination By Sponsor|1|||
170407256|NCT00458302|615832437|FG001|Overall Study|Study Termination By Sponsor|0|||
170407257|NCT00458302|615832436|FG000|Overall Study|Lost to Follow-up|2|||
170865903|NCT01717768|617521419|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170865904|NCT01717768|617521420|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170407258|NCT00458302|615832437|FG001|Overall Study|Lost to Follow-up|0|||
170407259|NCT00458302|615832436|FG000|Overall Study|Other|4|||
170407260|NCT00458302|615832437|FG001|Overall Study|Other|2|||
170407261|NCT03997448|615832440|FG000|Study Treatment|Disease Progression|1|||
170407262|NCT03997448|615832440|FG000|Study Treatment|Symptomatic Deterioration|1|||
170407263|NCT03997448|615832440|FG000|Follow up|Death|2|||
170407264|NCT03997448|615832440|FG000|Follow up|study terminated|1|||
170407265|NCT01312779|615832441|FG000|Overall Study|Withdrawal by Subject|2|||
170407266|NCT01312779|615832441|FG000|Overall Study|Death|3|||
170407267|NCT01312779|615832441|FG000|Overall Study|Not Implanted with Device|27|||
170407268|NCT01513551|615832442|FG000|Overall Study|Death|0|||
170407269|NCT01513551|615832443|FG001|Overall Study|Death|1|||
170407270|NCT01513551|615832444|FG002|Overall Study|Death|0|||
170407271|NCT01513551|615832442|FG000|Overall Study|Lost to Follow-up|3|||
170407272|NCT01513551|615832443|FG001|Overall Study|Lost to Follow-up|5|||
170407273|NCT01513551|615832444|FG002|Overall Study|Lost to Follow-up|2|||
170407274|NCT01513551|615832442|FG000|Overall Study|Withdrawal by Subject|1|||
170407275|NCT01513551|615832443|FG001|Overall Study|Withdrawal by Subject|0|||
170407276|NCT01513551|615832444|FG002|Overall Study|Withdrawal by Subject|2|||
170407277|NCT01513551|615832442|FG000|Overall Study|Randomized but not vaccinated|0|||
170407278|NCT01513551|615832443|FG001|Overall Study|Randomized but not vaccinated|0|||
170407279|NCT01513551|615832444|FG002|Overall Study|Randomized but not vaccinated|1|||
170407280|NCT02853929|615832446|FG000|Overall Study|Lost to Follow-up|3|||
170407281|NCT02853929|615832447|FG001|Overall Study|Lost to Follow-up|0|||
170407282|NCT02853929|615832446|FG000|Overall Study|Withdrawal by Subject|1|||
170407283|NCT02853929|615832447|FG001|Overall Study|Withdrawal by Subject|0|||
170407284|NCT02853929|615832446|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
170407285|NCT02853929|615832447|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
170407286|NCT01078623|615832448|FG000|Treatment Period 1|Adverse Event|1|||
170407287|NCT01078623|615832449|FG001|Treatment Period 1|Adverse Event|1|||
170407288|NCT01078623|615832450|FG002|Treatment Period 1|Adverse Event|1|||
170407289|NCT01078623|615832451|FG003|Treatment Period 1|Adverse Event|0|||
170407290|NCT01078623|615832452|FG004|Treatment Period 1|Adverse Event|0|||
170407291|NCT01078623|615832453|FG005|Treatment Period 1|Adverse Event|0|||
170407292|NCT01078623|615832454|FG006|Treatment Period 1|Adverse Event|1|||
170407293|NCT01078623|615832455|FG007|Treatment Period 1|Adverse Event|0|||
170407294|NCT01078623|615832456|FG008|Treatment Period 1|Adverse Event|1|||
170407295|NCT01078623|615832457|FG009|Treatment Period 1|Adverse Event|1|||
170407296|NCT01078623|615832458|FG010|Treatment Period 1|Adverse Event|0|||
170407297|NCT01078623|615832459|FG011|Treatment Period 1|Adverse Event|0|||
170407298|NCT01078623|615832460|FG012|Treatment Period 1|Adverse Event|0|||
170407299|NCT01078623|615832461|FG013|Treatment Period 1|Adverse Event|0|||
170407300|NCT01078623|615832462|FG014|Treatment Period 1|Adverse Event|0|||
170407301|NCT01078623|615832463|FG015|Treatment Period 1|Adverse Event|0|||
170407302|NCT01078623|615832464|FG016|Treatment Period 1|Adverse Event|0|||
170407303|NCT01078623|615832465|FG017|Treatment Period 1|Adverse Event|0|||
170407304|NCT01078623|615832466|FG018|Treatment Period 1|Adverse Event|0|||
170407305|NCT01078623|615832467|FG019|Treatment Period 1|Adverse Event|0|||
170407306|NCT01078623|615832448|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170407307|NCT01078623|615832449|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170407308|NCT01078623|615832450|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170407309|NCT01078623|615832451|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170407310|NCT01078623|615832452|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170407311|NCT01078623|615832453|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170407312|NCT01078623|615832454|FG006|Treatment Period 1|Withdrawal by Subject|0|||
170407313|NCT01078623|615832455|FG007|Treatment Period 1|Withdrawal by Subject|1|||
170407314|NCT01078623|615832456|FG008|Treatment Period 1|Withdrawal by Subject|0|||
170407315|NCT01078623|615832457|FG009|Treatment Period 1|Withdrawal by Subject|0|||
170407316|NCT01078623|615832458|FG010|Treatment Period 1|Withdrawal by Subject|1|||
170407317|NCT01078623|615832459|FG011|Treatment Period 1|Withdrawal by Subject|0|||
170407318|NCT01078623|615832460|FG012|Treatment Period 1|Withdrawal by Subject|0|||
170407319|NCT01078623|615832461|FG013|Treatment Period 1|Withdrawal by Subject|0|||
170407320|NCT01078623|615832462|FG014|Treatment Period 1|Withdrawal by Subject|0|||
170407321|NCT01078623|615832463|FG015|Treatment Period 1|Withdrawal by Subject|0|||
170407322|NCT01078623|615832464|FG016|Treatment Period 1|Withdrawal by Subject|0|||
170407323|NCT01078623|615832465|FG017|Treatment Period 1|Withdrawal by Subject|0|||
170519721|NCT02326272|616247587|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170760132|NCT00429793|617127811|FG000|Overall Study|Improper pre-protocol treatment|3|||
170760133|NCT00429793|617127811|FG000|Overall Study|Required test not done|1|||
170760134|NCT00429793|617127811|FG000|Overall Study|Never treated|1|||
170760135|NCT00429793|617127811|FG000|Overall Study|Non-measurable|1|||
170760136|NCT00813488|617127813|FG000|Titration Period 1|Adverse Event|6|||
170407324|NCT01078623|615832466|FG018|Treatment Period 1|Withdrawal by Subject|0|||
170407325|NCT01078623|615832467|FG019|Treatment Period 1|Withdrawal by Subject|0|||
170407326|NCT01078623|615832448|FG000|Treatment Period 1|Protocol Violation|0|||
170407327|NCT01078623|615832449|FG001|Treatment Period 1|Protocol Violation|0|||
170407328|NCT01078623|615832450|FG002|Treatment Period 1|Protocol Violation|0|||
170407329|NCT01078623|615832451|FG003|Treatment Period 1|Protocol Violation|0|||
170407330|NCT01078623|615832452|FG004|Treatment Period 1|Protocol Violation|0|||
170407331|NCT01078623|615832453|FG005|Treatment Period 1|Protocol Violation|1|||
170760137|NCT00813488|617127814|FG001|Titration Period 1|Adverse Event|1|||
170760138|NCT00813488|617127813|FG000|Titration Period 1|Lack of Efficacy|9|||
170407332|NCT01078623|615832454|FG006|Treatment Period 1|Protocol Violation|0|||
170407333|NCT01078623|615832455|FG007|Treatment Period 1|Protocol Violation|0|||
170407334|NCT01078623|615832456|FG008|Treatment Period 1|Protocol Violation|0|||
170407335|NCT01078623|615832457|FG009|Treatment Period 1|Protocol Violation|0|||
170407336|NCT01078623|615832458|FG010|Treatment Period 1|Protocol Violation|0|||
170407337|NCT01078623|615832459|FG011|Treatment Period 1|Protocol Violation|0|||
170407338|NCT01078623|615832460|FG012|Treatment Period 1|Protocol Violation|0|||
170407339|NCT01078623|615832461|FG013|Treatment Period 1|Protocol Violation|0|||
170407340|NCT01078623|615832462|FG014|Treatment Period 1|Protocol Violation|0|||
170407341|NCT01078623|615832463|FG015|Treatment Period 1|Protocol Violation|0|||
170407342|NCT01078623|615832464|FG016|Treatment Period 1|Protocol Violation|0|||
170407343|NCT01078623|615832465|FG017|Treatment Period 1|Protocol Violation|0|||
170407344|NCT01078623|615832466|FG018|Treatment Period 1|Protocol Violation|0|||
170407345|NCT01078623|615832467|FG019|Treatment Period 1|Protocol Violation|0|||
170407346|NCT01078623|615832448|FG000|Treatment Period 2|Adverse Event|0|||
170407347|NCT01078623|615832449|FG001|Treatment Period 2|Adverse Event|0|||
170407348|NCT01078623|615832450|FG002|Treatment Period 2|Adverse Event|0|||
170407349|NCT01078623|615832451|FG003|Treatment Period 2|Adverse Event|0|||
170407350|NCT01078623|615832452|FG004|Treatment Period 2|Adverse Event|0|||
170407351|NCT01078623|615832453|FG005|Treatment Period 2|Adverse Event|0|||
170407352|NCT01078623|615832454|FG006|Treatment Period 2|Adverse Event|1|||
170407353|NCT01078623|615832455|FG007|Treatment Period 2|Adverse Event|0|||
170407354|NCT01078623|615832456|FG008|Treatment Period 2|Adverse Event|0|||
170407355|NCT01078623|615832457|FG009|Treatment Period 2|Adverse Event|0|||
170407356|NCT01078623|615832458|FG010|Treatment Period 2|Adverse Event|0|||
170407357|NCT01078623|615832459|FG011|Treatment Period 2|Adverse Event|0|||
170407358|NCT01078623|615832460|FG012|Treatment Period 2|Adverse Event|0|||
170407359|NCT01078623|615832461|FG013|Treatment Period 2|Adverse Event|0|||
170407360|NCT01078623|615832462|FG014|Treatment Period 2|Adverse Event|0|||
170407361|NCT01078623|615832463|FG015|Treatment Period 2|Adverse Event|0|||
170407362|NCT01078623|615832464|FG016|Treatment Period 2|Adverse Event|0|||
170407363|NCT01078623|615832465|FG017|Treatment Period 2|Adverse Event|0|||
170407364|NCT01078623|615832466|FG018|Treatment Period 2|Adverse Event|1|||
170407365|NCT01078623|615832467|FG019|Treatment Period 2|Adverse Event|0|||
170407366|NCT01078623|615832448|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170407367|NCT01078623|615832449|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170407368|NCT01078623|615832450|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170407369|NCT01078623|615832451|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170407370|NCT01078623|615832452|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170407371|NCT01078623|615832453|FG005|Treatment Period 2|Withdrawal by Subject|1|||
170760139|NCT00813488|617127814|FG001|Titration Period 1|Lack of Efficacy|7|||
170760140|NCT00813488|617127813|FG000|Titration Period 1|Withdrawal by Subject|2|||
170407372|NCT01078623|615832454|FG006|Treatment Period 2|Withdrawal by Subject|0|||
170407373|NCT01078623|615832455|FG007|Treatment Period 2|Withdrawal by Subject|0|||
170407374|NCT01078623|615832456|FG008|Treatment Period 2|Withdrawal by Subject|0|||
170407375|NCT01078623|615832457|FG009|Treatment Period 2|Withdrawal by Subject|0|||
170407376|NCT01078623|615832458|FG010|Treatment Period 2|Withdrawal by Subject|0|||
170407377|NCT01078623|615832459|FG011|Treatment Period 2|Withdrawal by Subject|0|||
170407378|NCT01078623|615832460|FG012|Treatment Period 2|Withdrawal by Subject|0|||
170407379|NCT01078623|615832461|FG013|Treatment Period 2|Withdrawal by Subject|0|||
170407380|NCT01078623|615832462|FG014|Treatment Period 2|Withdrawal by Subject|0|||
170407381|NCT01078623|615832463|FG015|Treatment Period 2|Withdrawal by Subject|0|||
170407382|NCT01078623|615832464|FG016|Treatment Period 2|Withdrawal by Subject|0|||
170407383|NCT01078623|615832465|FG017|Treatment Period 2|Withdrawal by Subject|0|||
170407384|NCT01078623|615832466|FG018|Treatment Period 2|Withdrawal by Subject|0|||
170407385|NCT01078623|615832467|FG019|Treatment Period 2|Withdrawal by Subject|0|||
170407386|NCT01078623|615832448|FG000|Treatment Period 3|Adverse Event|0|||
170407387|NCT01078623|615832449|FG001|Treatment Period 3|Adverse Event|0|||
170407388|NCT01078623|615832450|FG002|Treatment Period 3|Adverse Event|0|||
170407389|NCT01078623|615832451|FG003|Treatment Period 3|Adverse Event|0|||
170407390|NCT01078623|615832452|FG004|Treatment Period 3|Adverse Event|1|||
170407391|NCT01078623|615832453|FG005|Treatment Period 3|Adverse Event|0|||
170407392|NCT01078623|615832454|FG006|Treatment Period 3|Adverse Event|0|||
170407393|NCT01078623|615832455|FG007|Treatment Period 3|Adverse Event|0|||
170407394|NCT01078623|615832456|FG008|Treatment Period 3|Adverse Event|0|||
170760141|NCT00813488|617127814|FG001|Titration Period 1|Withdrawal by Subject|2|||
170760142|NCT00813488|617127813|FG000|Titration Period 1|Protocol Violation|4|||
170407395|NCT01078623|615832457|FG009|Treatment Period 3|Adverse Event|0|||
170407396|NCT01078623|615832458|FG010|Treatment Period 3|Adverse Event|0|||
170407397|NCT01078623|615832459|FG011|Treatment Period 3|Adverse Event|0|||
170407398|NCT01078623|615832460|FG012|Treatment Period 3|Adverse Event|0|||
170407399|NCT01078623|615832461|FG013|Treatment Period 3|Adverse Event|1|||
170407400|NCT01078623|615832462|FG014|Treatment Period 3|Adverse Event|0|||
170407401|NCT01078623|615832463|FG015|Treatment Period 3|Adverse Event|0|||
170407402|NCT01078623|615832464|FG016|Treatment Period 3|Adverse Event|0|||
170407403|NCT01078623|615832465|FG017|Treatment Period 3|Adverse Event|0|||
170407404|NCT01078623|615832466|FG018|Treatment Period 3|Adverse Event|0|||
170760143|NCT00813488|617127814|FG001|Titration Period 1|Protocol Violation|3|||
170407405|NCT01078623|615832467|FG019|Treatment Period 3|Adverse Event|0|||
170407406|NCT01078623|615832448|FG000|Treatment Period 4|Adverse Event|0|||
170407407|NCT01078623|615832449|FG001|Treatment Period 4|Adverse Event|0|||
170407408|NCT01078623|615832450|FG002|Treatment Period 4|Adverse Event|1|||
170407409|NCT01078623|615832451|FG003|Treatment Period 4|Adverse Event|0|||
170407410|NCT01078623|615832452|FG004|Treatment Period 4|Adverse Event|0|||
170407411|NCT01078623|615832453|FG005|Treatment Period 4|Adverse Event|0|||
170407412|NCT01078623|615832454|FG006|Treatment Period 4|Adverse Event|0|||
170407413|NCT01078623|615832455|FG007|Treatment Period 4|Adverse Event|0|||
170407414|NCT01078623|615832456|FG008|Treatment Period 4|Adverse Event|0|||
170407415|NCT01078623|615832457|FG009|Treatment Period 4|Adverse Event|0|||
170407416|NCT01078623|615832458|FG010|Treatment Period 4|Adverse Event|0|||
170407417|NCT01078623|615832459|FG011|Treatment Period 4|Adverse Event|0|||
170407418|NCT01078623|615832460|FG012|Treatment Period 4|Adverse Event|0|||
170407419|NCT01078623|615832461|FG013|Treatment Period 4|Adverse Event|0|||
170760144|NCT00813488|617127813|FG000|Titration Period 1|Non-compliance to study medication|4|||
170760145|NCT00813488|617127814|FG001|Titration Period 1|Non-compliance to study medication|1|||
170760146|NCT00813488|617127813|FG000|Titration Period 1|Non-compliance to study procedures|2|||
170407420|NCT01078623|615832462|FG014|Treatment Period 4|Adverse Event|0|||
170407421|NCT01078623|615832463|FG015|Treatment Period 4|Adverse Event|0|||
170407422|NCT01078623|615832464|FG016|Treatment Period 4|Adverse Event|0|||
170407423|NCT01078623|615832465|FG017|Treatment Period 4|Adverse Event|0|||
170407424|NCT01078623|615832466|FG018|Treatment Period 4|Adverse Event|0|||
170407425|NCT01078623|615832467|FG019|Treatment Period 4|Adverse Event|0|||
170760147|NCT00813488|617127814|FG001|Titration Period 1|Non-compliance to study procedures|2|||
170760148|NCT00813488|617127813|FG000|Titration Period 1|Technical Difficulties|0|||
170760149|NCT00813488|617127814|FG001|Titration Period 1|Technical Difficulties|1|||
170407426|NCT01078623|615832448|FG000|Treatment Period 4|Withdrawal by Subject|0|||
170407427|NCT01078623|615832449|FG001|Treatment Period 4|Withdrawal by Subject|0|||
170407428|NCT01078623|615832450|FG002|Treatment Period 4|Withdrawal by Subject|0|||
170407429|NCT01078623|615832451|FG003|Treatment Period 4|Withdrawal by Subject|0|||
170407430|NCT01078623|615832452|FG004|Treatment Period 4|Withdrawal by Subject|0|||
170407431|NCT01078623|615832453|FG005|Treatment Period 4|Withdrawal by Subject|0|||
170407432|NCT01078623|615832454|FG006|Treatment Period 4|Withdrawal by Subject|0|||
170407433|NCT01078623|615832455|FG007|Treatment Period 4|Withdrawal by Subject|0|||
170407434|NCT01078623|615832456|FG008|Treatment Period 4|Withdrawal by Subject|0|||
170407435|NCT01078623|615832457|FG009|Treatment Period 4|Withdrawal by Subject|0|||
170407436|NCT01078623|615832458|FG010|Treatment Period 4|Withdrawal by Subject|0|||
170407437|NCT01078623|615832459|FG011|Treatment Period 4|Withdrawal by Subject|0|||
170407438|NCT01078623|615832460|FG012|Treatment Period 4|Withdrawal by Subject|0|||
170407439|NCT01078623|615832461|FG013|Treatment Period 4|Withdrawal by Subject|0|||
170407440|NCT01078623|615832462|FG014|Treatment Period 4|Withdrawal by Subject|0|||
170407441|NCT01078623|615832463|FG015|Treatment Period 4|Withdrawal by Subject|1|||
170407442|NCT01078623|615832464|FG016|Treatment Period 4|Withdrawal by Subject|0|||
170407443|NCT01078623|615832465|FG017|Treatment Period 4|Withdrawal by Subject|0|||
170407444|NCT01078623|615832466|FG018|Treatment Period 4|Withdrawal by Subject|0|||
170407445|NCT01078623|615832467|FG019|Treatment Period 4|Withdrawal by Subject|0|||
170407446|NCT01706198|615832468|FG000|Overall Study|Adverse Event|12|||
170407447|NCT01706198|615832469|FG001|Overall Study|Adverse Event|15|||
170407448|NCT01706198|615832468|FG000|Overall Study|Protocol Violation|7|||
170407449|NCT01706198|615832469|FG001|Overall Study|Protocol Violation|5|||
170407450|NCT01706198|615832468|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
170407451|NCT01706198|615832469|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
170407452|NCT01706198|615832468|FG000|Overall Study|Lost to Follow-up|97|||
170407453|NCT01706198|615832469|FG001|Overall Study|Lost to Follow-up|93|||
170407454|NCT01706198|615832468|FG000|Overall Study|Physician Decision|23|||
170407455|NCT01706198|615832469|FG001|Overall Study|Physician Decision|37|||
170407456|NCT01706198|615832468|FG000|Overall Study|Withdrawal by Subject|23|||
170407457|NCT01706198|615832469|FG001|Overall Study|Withdrawal by Subject|31|||
170407458|NCT03568500|615832474|FG000|Overall Study|Lost to Follow-up|1|||
170407459|NCT03568500|615832475|FG001|Overall Study|Lost to Follow-up|1|||
170407460|NCT03568500|615832476|FG002|Overall Study|Lost to Follow-up|2|||
170407461|NCT03568500|615832474|FG000|Overall Study|Adverse Event|1|||
170407462|NCT03568500|615832475|FG001|Overall Study|Adverse Event|1|||
170407463|NCT03568500|615832476|FG002|Overall Study|Adverse Event|2|||
170407464|NCT03568500|615832474|FG000|Overall Study|Physician Decision|1|||
170407465|NCT03568500|615832475|FG001|Overall Study|Physician Decision|0|||
170407466|NCT03568500|615832476|FG002|Overall Study|Physician Decision|0|||
170407467|NCT03568500|615832474|FG000|Overall Study|Withdrawal by Subject|4|||
170407468|NCT03568500|615832475|FG001|Overall Study|Withdrawal by Subject|2|||
170407469|NCT03568500|615832476|FG002|Overall Study|Withdrawal by Subject|0|||
170407470|NCT03568500|615832474|FG000|Overall Study|Technical Problems|2|||
170407471|NCT03568500|615832475|FG001|Overall Study|Technical Problems|1|||
170407472|NCT03568500|615832476|FG002|Overall Study|Technical Problems|0|||
170407473|NCT03568500|615832474|FG000|Overall Study|Participant Noncompliance|1|||
170407474|NCT03568500|615832475|FG001|Overall Study|Participant Noncompliance|1|||
170407475|NCT03568500|615832476|FG002|Overall Study|Participant Noncompliance|0|||
170407476|NCT03572933|615832480|FG000|Overall Study|Adverse Event|4|||
170407477|NCT03572933|615832481|FG001|Overall Study|Adverse Event|1|||
170407478|NCT03572933|615832480|FG000|Overall Study|Withdrawal by Subject|0|||
170407479|NCT03572933|615832481|FG001|Overall Study|Withdrawal by Subject|1|||
170407480|NCT01466686|615832484|FG000|Overall Study|Withdrawal by Subject|1|||
170407481|NCT00910858|615832485|FG000|Pharmacokinetic Phase|Adverse Event|1|||
170407482|NCT00910858|615832486|FG001|Pharmacokinetic Phase|Adverse Event|0|||
170407483|NCT00910858|615832487|FG002|Pharmacokinetic Phase|Adverse Event|0|||
170407484|NCT00910858|615832485|FG000|Monotherapy Phase|Adverse Event|3|||
170407485|NCT00910858|615832486|FG001|Monotherapy Phase|Adverse Event|2|||
170407486|NCT00910858|615832487|FG002|Monotherapy Phase|Adverse Event|0|||
170407487|NCT00910858|615832485|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
170407488|NCT00910858|615832486|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
170407489|NCT00910858|615832487|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
170407490|NCT00910858|615832485|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
170407491|NCT00910858|615832486|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
170407492|NCT00910858|615832487|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
170407493|NCT00910858|615832485|FG000|Monotherapy Phase|Protocol Violation|1|||
170407494|NCT00910858|615832486|FG001|Monotherapy Phase|Protocol Violation|0|||
170407495|NCT00910858|615832487|FG002|Monotherapy Phase|Protocol Violation|0|||
170407496|NCT00910858|615832485|FG000|Monotherapy Phase|Other|3|||
170407497|NCT00910858|615832486|FG001|Monotherapy Phase|Other|4|||
170407498|NCT00910858|615832487|FG002|Monotherapy Phase|Other|2|||
170407499|NCT00910858|615832485|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
170407500|NCT00910858|615832486|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
170407501|NCT00910858|615832487|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
170407502|NCT00910858|615832485|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
170407503|NCT00910858|615832486|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
170407504|NCT00910858|615832487|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
170407505|NCT00910858|615832485|FG000|Combined Treatment Phase|Protocol Violation|1|||
170407506|NCT00910858|615832486|FG001|Combined Treatment Phase|Protocol Violation|0|||
170407507|NCT00910858|615832487|FG002|Combined Treatment Phase|Protocol Violation|0|||
170407508|NCT00910858|615832485|FG000|Combined Treatment Phase|Other|0|||
170407509|NCT00910858|615832486|FG001|Combined Treatment Phase|Other|2|||
170407510|NCT00910858|615832487|FG002|Combined Treatment Phase|Other|1|||
170407511|NCT00447603|615832492|FG000|Screening|Withdrawal by Subject|1|||
170407512|NCT00447603|615832493|FG001|Screening|Withdrawal by Subject|0|||
170407513|NCT00447603|615832494|FG002|Screening|Withdrawal by Subject|0|||
170407514|NCT00447603|615832492|FG000|Screening|Protocol Violation|1|||
170407515|NCT00447603|615832493|FG001|Screening|Protocol Violation|0|||
170407516|NCT00447603|615832494|FG002|Screening|Protocol Violation|0|||
170407517|NCT00447603|615832492|FG000|Screening|Screen Failure|4|||
170407518|NCT00447603|615832493|FG001|Screening|Screen Failure|0|||
170407519|NCT00447603|615832494|FG002|Screening|Screen Failure|0|||
170407520|NCT00447603|615832492|FG000|Screening|Study Terminated by Sponsor|15|||
170407521|NCT00447603|615832493|FG001|Screening|Study Terminated by Sponsor|0|||
170407522|NCT00447603|615832494|FG002|Screening|Study Terminated by Sponsor|0|||
170407523|NCT00447603|615832492|FG000|Filter Period|Adverse Event|0|||
170407524|NCT00447603|615832493|FG001|Filter Period|Adverse Event|0|||
170407525|NCT00447603|615832494|FG002|Filter Period|Adverse Event|1|||
170407526|NCT00447603|615832492|FG000|Filter Period|Screen Failure|0|||
170407527|NCT00447603|615832493|FG001|Filter Period|Screen Failure|3|||
170407528|NCT00447603|615832494|FG002|Filter Period|Screen Failure|4|||
170407529|NCT00447603|615832492|FG000|Filter Period|Study terminated by Sponsor|0|||
170407530|NCT00447603|615832493|FG001|Filter Period|Study terminated by Sponsor|1|||
170407531|NCT00447603|615832494|FG002|Filter Period|Study terminated by Sponsor|10|||
170407532|NCT01381900|615832495|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
170407533|NCT01381900|615832496|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
170407534|NCT01381900|615832497|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
170407535|NCT01381900|615832495|FG000|Overall Study|Adverse Event|4|||
170407536|NCT01381900|615832496|FG001|Overall Study|Adverse Event|6|||
170407537|NCT01381900|615832497|FG002|Overall Study|Adverse Event|7|||
170407538|NCT01381900|615832495|FG000|Overall Study|Noncompliance with study drug|0|||
170407539|NCT01381900|615832496|FG001|Overall Study|Noncompliance with study drug|0|||
170760150|NCT00813488|617127813|FG000|Titration Period 2|Adverse Event|2|||
170407540|NCT01381900|615832497|FG002|Overall Study|Noncompliance with study drug|1|||
170407541|NCT01381900|615832495|FG000|Overall Study|Physician Decision|0|||
170519722|NCT02326272|616247588|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170760151|NCT00813488|617127814|FG001|Titration Period 2|Adverse Event|3|||
170407542|NCT01381900|615832496|FG001|Overall Study|Physician Decision|1|||
170407543|NCT01381900|615832497|FG002|Overall Study|Physician Decision|1|||
170407544|NCT01381900|615832495|FG000|Overall Study|Protocol Violation|0|||
170407545|NCT01381900|615832496|FG001|Overall Study|Protocol Violation|1|||
170407546|NCT01381900|615832497|FG002|Overall Study|Protocol Violation|1|||
170407547|NCT01381900|615832495|FG000|Overall Study|Withdrawal by Subject|0|||
170407548|NCT01381900|615832496|FG001|Overall Study|Withdrawal by Subject|0|||
170407549|NCT01381900|615832497|FG002|Overall Study|Withdrawal by Subject|1|||
170407550|NCT01381900|615832495|FG000|Overall Study|Early withdraw|3|||
170407551|NCT01381900|615832496|FG001|Overall Study|Early withdraw|1|||
170760152|NCT00813488|617127813|FG000|Titration Period 2|Lack of Efficacy|8|||
170760153|NCT00813488|617127814|FG001|Titration Period 2|Lack of Efficacy|4|||
170760154|NCT00813488|617127813|FG000|Titration Period 2|Protocol Violation|3|||
170760155|NCT00813488|617127814|FG001|Titration Period 2|Protocol Violation|2|||
170760156|NCT00813488|617127813|FG000|Titration Period 2|Lost to Follow-up|1|||
170760157|NCT00813488|617127814|FG001|Titration Period 2|Lost to Follow-up|0|||
170407552|NCT01381900|615832497|FG002|Overall Study|Early withdraw|1|||
170407553|NCT01165684|615832500|FG000|Overall Study|Adverse Event|1|||
170407554|NCT01165684|615832501|FG001|Overall Study|Adverse Event|1|||
170407555|NCT01165684|615832500|FG000|Overall Study|Lack of Efficacy|2|||
170407556|NCT01165684|615832501|FG001|Overall Study|Lack of Efficacy|1|||
170407557|NCT01165684|615832500|FG000|Overall Study|Protocol Violation|7|||
170407558|NCT01165684|615832501|FG001|Overall Study|Protocol Violation|15|||
170407559|NCT01165684|615832500|FG000|Overall Study|Withdrawal Criteria|2|||
170407560|NCT01165684|615832501|FG001|Overall Study|Withdrawal Criteria|13|||
170407561|NCT01165684|615832500|FG000|Overall Study|Unclassified|16|||
170407562|NCT01165684|615832501|FG001|Overall Study|Unclassified|22|||
170407563|NCT01886300|615832502|FG000|Overall Study|Trial terminated by sponsor|16|||
170407564|NCT04120194|615832505|FG000|Overall Study|Lost to Follow-up|11|||
170407565|NCT04120194|615832506|FG001|Overall Study|Lost to Follow-up|8|||
170407566|NCT04120194|615832505|FG000|Overall Study|Adverse Event|4|||
170407567|NCT04120194|615832506|FG001|Overall Study|Adverse Event|5|||
170407568|NCT04120194|615832505|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
170407569|NCT04120194|615832506|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
170407570|NCT04120194|615832505|FG000|Overall Study|Miscellaneous|4|||
170407571|NCT04120194|615832506|FG001|Overall Study|Miscellaneous|5|||
170407572|NCT03840135|615832507|FG000|Overall Study|Protocol Violation|6|||
170407573|NCT03840135|615832508|FG001|Overall Study|Protocol Violation|1|||
170407574|NCT03840135|615832507|FG000|Overall Study|Withdrawal by Subject|1|||
170407575|NCT03840135|615832508|FG001|Overall Study|Withdrawal by Subject|0|||
170407576|NCT02974114|615832510|FG000|Overall Study|Other (Not specified)|0|||
170407577|NCT02974114|615832511|FG001|Overall Study|Other (Not specified)|1|||
170407578|NCT02974114|615832512|FG002|Overall Study|Other (Not specified)|2|||
170407579|NCT00545233|615832515|FG000|Overall Study|Adverse Event|10|||
170407580|NCT00545233|615832516|FG001|Overall Study|Adverse Event|5|||
170407581|NCT00545233|615832515|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
170407582|NCT00545233|615832516|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
170407583|NCT00545233|615832515|FG000|Overall Study|Protocol Violation|2|||
170407584|NCT00545233|615832516|FG001|Overall Study|Protocol Violation|0|||
170407585|NCT00545233|615832515|FG000|Overall Study|Refused Treatment|9|||
170407586|NCT00545233|615832516|FG001|Overall Study|Refused Treatment|7|||
170407587|NCT00545233|615832515|FG000|Overall Study|Failure to Return|4|||
170407588|NCT00545233|615832516|FG001|Overall Study|Failure to Return|6|||
170407589|NCT00545233|615832515|FG000|Overall Study|Insufficient response|14|||
170407590|NCT00545233|615832516|FG001|Overall Study|Insufficient response|15|||
170407591|NCT00545233|615832515|FG000|Overall Study|Physician Decision|2|||
170407592|NCT00545233|615832516|FG001|Overall Study|Physician Decision|1|||
170407593|NCT02746705|615832517|FG000|Overall Study|Physician Decision|1|||
170407594|NCT02746705|615832518|FG001|Overall Study|Physician Decision|1|||
170407595|NCT02746705|615832517|FG000|Overall Study|Lost to Follow-up|1|||
170407596|NCT02746705|615832518|FG001|Overall Study|Lost to Follow-up|0|||
170407597|NCT02746705|615832517|FG000|Overall Study|outlier scores deemed not valid|0|||
170407598|NCT02746705|615832518|FG001|Overall Study|outlier scores deemed not valid|1|||
170407599|NCT00479401|615832519|FG000|Overall Study|Adverse Event|24|||
170407600|NCT00479401|615832520|FG001|Overall Study|Adverse Event|20|||
170407601|NCT00479401|615832521|FG002|Overall Study|Adverse Event|4|||
170407602|NCT00479401|615832519|FG000|Overall Study|Lack of Efficacy|2|||
170407603|NCT00479401|615832520|FG001|Overall Study|Lack of Efficacy|2|||
170407604|NCT00479401|615832521|FG002|Overall Study|Lack of Efficacy|4|||
170407605|NCT00479401|615832519|FG000|Overall Study|Protocol Violation|2|||
170407606|NCT00479401|615832520|FG001|Overall Study|Protocol Violation|1|||
170407607|NCT00479401|615832521|FG002|Overall Study|Protocol Violation|1|||
170407608|NCT00479401|615832519|FG000|Overall Study|Lost to Follow-up|1|||
170407609|NCT00479401|615832520|FG001|Overall Study|Lost to Follow-up|1|||
170407610|NCT00479401|615832521|FG002|Overall Study|Lost to Follow-up|1|||
170407611|NCT00479401|615832519|FG000|Overall Study|Withdrawal by Subject|16|||
170407612|NCT00479401|615832520|FG001|Overall Study|Withdrawal by Subject|10|||
170407613|NCT00479401|615832521|FG002|Overall Study|Withdrawal by Subject|2|||
170407614|NCT00479401|615832519|FG000|Overall Study|Exclusion criteria, relocation|4|||
170407615|NCT00479401|615832520|FG001|Overall Study|Exclusion criteria, relocation|3|||
170407616|NCT00479401|615832521|FG002|Overall Study|Exclusion criteria, relocation|0|||
170407617|NCT02124746|615832522|FG000|Overall Study|Adverse Event|2|||
170407618|NCT02124746|615832523|FG001|Overall Study|Adverse Event|1|||
170407619|NCT02124746|615832524|FG002|Overall Study|Adverse Event|2|||
170760158|NCT00813488|617127813|FG000|Titration Period 2|Non-compliance with study procedures|2|||
170407620|NCT02124746|615832522|FG000|Overall Study|Death|2|||
170407621|NCT02124746|615832523|FG001|Overall Study|Death|1|||
170407622|NCT02124746|615832524|FG002|Overall Study|Death|3|||
170407623|NCT02124746|615832522|FG000|Overall Study|Lack of Efficacy|3|||
170407624|NCT02124746|615832523|FG001|Overall Study|Lack of Efficacy|2|||
170407625|NCT02124746|615832524|FG002|Overall Study|Lack of Efficacy|2|||
170407626|NCT02124746|615832522|FG000|Overall Study|Physician Decision|6|||
170407627|NCT02124746|615832523|FG001|Overall Study|Physician Decision|4|||
170407628|NCT02124746|615832524|FG002|Overall Study|Physician Decision|5|||
170407629|NCT02124746|615832522|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170407630|NCT02124746|615832523|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170407631|NCT02124746|615832524|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170407632|NCT02124746|615832522|FG000|Overall Study|Withdrawal by Subject|3|||
170407633|NCT02124746|615832523|FG001|Overall Study|Withdrawal by Subject|3|||
170407634|NCT02124746|615832524|FG002|Overall Study|Withdrawal by Subject|0|||
170407635|NCT02124746|615832522|FG000|Overall Study|Study Terminated by Sponsor|0|||
170407636|NCT02124746|615832523|FG001|Overall Study|Study Terminated by Sponsor|0|||
170407637|NCT02124746|615832524|FG002|Overall Study|Study Terminated by Sponsor|6|||
170407638|NCT02124746|615832522|FG000|Overall Study|Disease Progression|3|||
170407639|NCT02124746|615832523|FG001|Overall Study|Disease Progression|6|||
170407640|NCT02124746|615832524|FG002|Overall Study|Disease Progression|4|||
170407641|NCT01722266|615832525|FG000|Overall Study|Withdrawal by Subject|1|||
170407642|NCT01722266|615832526|FG001|Overall Study|Withdrawal by Subject|2|||
170407643|NCT01722266|615832527|FG002|Overall Study|Withdrawal by Subject|0|||
170407644|NCT01722266|615832528|FG003|Overall Study|Withdrawal by Subject|0|||
170407645|NCT01722266|615832525|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
170407646|NCT01722266|615832526|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
170407647|NCT01722266|615832527|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
170407648|NCT01722266|615832528|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
170407649|NCT01722266|615832525|FG000|Overall Study|Dropped out due to Nausea|0|||
170407650|NCT01722266|615832526|FG001|Overall Study|Dropped out due to Nausea|0|||
170407651|NCT01722266|615832527|FG002|Overall Study|Dropped out due to Nausea|2|||
170407652|NCT01722266|615832528|FG003|Overall Study|Dropped out due to Nausea|0|||
170407653|NCT01335464|615832529|FG000|Overall Study|Adverse Event|15|||
170407654|NCT01335464|615832530|FG001|Overall Study|Adverse Event|25|||
170407655|NCT01335464|615832529|FG000|Overall Study|Non compliant with protocol|2|||
170407656|NCT01335464|615832530|FG001|Overall Study|Non compliant with protocol|0|||
170407657|NCT01335464|615832529|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
170407658|NCT01335464|615832530|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
170407659|NCT01335464|615832529|FG000|Overall Study|Not treated|2|||
170407660|NCT01335464|615832530|FG001|Overall Study|Not treated|0|||
170865905|NCT01717768|617521421|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170865906|NCT01717768|617521422|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
170865907|NCT01717768|617521411|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170865908|NCT01717768|617521412|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170865909|NCT01717768|617521413|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170865910|NCT01717768|617521414|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170865911|NCT01717768|617521415|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170407661|NCT01335464|615832529|FG000|Overall Study|Reason other than those stated above|1|||
170407662|NCT01335464|615832530|FG001|Overall Study|Reason other than those stated above|1|||
170407663|NCT00124449|615832531|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
170407664|NCT00124449|615832532|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
170407665|NCT00124449|615832531|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
170407666|NCT00124449|615832532|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
170407667|NCT00124449|615832531|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
170407668|NCT00124449|615832532|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
170407669|NCT00124449|615832531|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
170407670|NCT00124449|615832532|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
170407671|NCT00124449|615832531|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
170407672|NCT00124449|615832532|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
170407673|NCT00124449|615832531|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
170407674|NCT00124449|615832532|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
170407675|NCT00124449|615832531|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
170407676|NCT00124449|615832532|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
170407677|NCT00124449|615832531|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
170407678|NCT00124449|615832532|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
170865912|NCT01717768|617521416|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170407679|NCT00124449|615832531|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
170407680|NCT00124449|615832532|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
170407681|NCT00124449|615832531|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
170407682|NCT00124449|615832532|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
170407683|NCT00124449|615832531|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
170407684|NCT00124449|615832532|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
170407685|NCT00124449|615832531|FG000|18-Month Untreated Observation Period|Relocated|1|||
170407686|NCT00124449|615832532|FG001|18-Month Untreated Observation Period|Relocated|0|||
170407687|NCT02473510|615832533|FG000|Overall Study|Lost to Follow-up|1|||
170407688|NCT02473510|615832534|FG001|Overall Study|Lost to Follow-up|2|||
170407689|NCT03182686|615832535|FG000|Overall Study|Lost to Follow-up|2|||
170407690|NCT03182686|615832536|FG001|Overall Study|Lost to Follow-up|0|||
170407691|NCT03182686|615832535|FG000|Overall Study|Adverse Event|2|||
170407692|NCT03182686|615832536|FG001|Overall Study|Adverse Event|0|||
170407693|NCT03182686|615832535|FG000|Overall Study|Withdrawal by Subject|3|||
170407694|NCT03182686|615832536|FG001|Overall Study|Withdrawal by Subject|0|||
170407695|NCT01697449|615832537|FG000|Overall Study|Disease progression|47|||
170407696|NCT01697449|615832537|FG000|Overall Study|Adverse Event|7|||
170407697|NCT01697449|615832537|FG000|Overall Study|Lost to Follow-up|5|||
170407698|NCT01697449|615832537|FG000|Overall Study|Withdrawal by Subject|2|||
170407699|NCT01697449|615832537|FG000|Overall Study|Physician Decision|1|||
170407700|NCT01697449|615832537|FG000|Overall Study|Death|2|||
170407701|NCT01697449|615832537|FG000|Overall Study|Other|1|||
170407702|NCT01697449|615832537|FG000|Overall Study|Missing|25|||
170407703|NCT01559818|615832539|FG000|Overall Study|Physician Decision|1|||
170407704|NCT01559818|615832539|FG000|Overall Study|Pregnancy|1|||
170407705|NCT01559818|615832539|FG000|Overall Study|Study terminated by Sponsor|4|||
170407706|NCT01559818|615832539|FG000|Overall Study|Withdrawal by Subject|1|||
170407707|NCT00096486|615832540|FG000|Overall Study|Withdrawal by Subject|0|||
170407708|NCT00096486|615832541|FG001|Overall Study|Withdrawal by Subject|0|||
170407709|NCT00096486|615832542|FG002|Overall Study|Withdrawal by Subject|1|||
170407710|NCT00096486|615832543|FG003|Overall Study|Withdrawal by Subject|1|||
170407711|NCT00096486|615832540|FG000|Overall Study|Not Treated|0|||
170407712|NCT00096486|615832541|FG001|Overall Study|Not Treated|0|||
170407713|NCT00096486|615832542|FG002|Overall Study|Not Treated|1|||
170407714|NCT00096486|615832543|FG003|Overall Study|Not Treated|1|||
170407715|NCT01512979|615832544|FG000|Overall Study|Adverse Event|2|||
170407716|NCT01512979|615832545|FG001|Overall Study|Adverse Event|2|||
170407717|NCT01512979|615832544|FG000|Overall Study|Protocol Violation|1|||
170407718|NCT01512979|615832545|FG001|Overall Study|Protocol Violation|4|||
170407719|NCT01512979|615832544|FG000|Overall Study|Lost to Follow-up|2|||
170407720|NCT01512979|615832545|FG001|Overall Study|Lost to Follow-up|5|||
170407721|NCT01512979|615832544|FG000|Overall Study|Withdrawal by Subject|1|||
170407722|NCT01512979|615832545|FG001|Overall Study|Withdrawal by Subject|2|||
170407723|NCT01512979|615832544|FG000|Overall Study|Reason other than stated above|13|||
170407724|NCT01512979|615832545|FG001|Overall Study|Reason other than stated above|9|||
170407725|NCT00529568|615832546|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
170407726|NCT00529568|615832547|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
170407727|NCT00529568|615832548|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
170407728|NCT00529568|615832546|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
170407729|NCT00529568|615832547|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
170407730|NCT00529568|615832548|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
170407731|NCT00529568|615832546|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
170407732|NCT00529568|615832547|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
170407733|NCT00529568|615832548|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
170407734|NCT00529568|615832546|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
170407735|NCT00529568|615832547|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
170407736|NCT00529568|615832548|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
170407737|NCT00529568|615832546|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
170407738|NCT00529568|615832547|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
170407739|NCT00529568|615832548|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
170407740|NCT00529568|615832546|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
170407741|NCT00529568|615832547|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
170407742|NCT00529568|615832548|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
170407743|NCT00529568|615832546|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
170407744|NCT00529568|615832547|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
170407745|NCT00529568|615832548|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
170760159|NCT00813488|617127814|FG001|Titration Period 2|Non-compliance with study procedures|1|||
170760160|NCT00813488|617127813|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
170760161|NCT00813488|617127814|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
170407746|NCT00529568|615832546|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
170407747|NCT00529568|615832547|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
170407748|NCT00529568|615832548|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
170407749|NCT00529568|615832546|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
170407750|NCT00529568|615832547|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
170407751|NCT00529568|615832548|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
170407752|NCT00529568|615832546|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
170407753|NCT00529568|615832547|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
170407754|NCT00529568|615832548|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
170407755|NCT00529568|615832546|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
170407756|NCT00529568|615832547|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
170407757|NCT00529568|615832548|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
170407758|NCT04049552|615832549|FG000|Overall Study|Lost to Follow-up|1|||
170407759|NCT00738920|615832551|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
170407760|NCT00738920|615832552|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
170407761|NCT00738920|615832553|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
170407762|NCT00738920|615832551|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
170407763|NCT00738920|615832552|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
170407764|NCT00738920|615832553|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
170407765|NCT00738920|615832551|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
170407766|NCT00738920|615832552|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
170407767|NCT00738920|615832553|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
170407768|NCT00738920|615832551|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
170407769|NCT00738920|615832552|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
170407770|NCT00738920|615832553|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
170407771|NCT00738920|615832551|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
170407772|NCT00738920|615832552|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
170407773|NCT00738920|615832553|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
170407774|NCT00738920|615832551|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
170407775|NCT00738920|615832552|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
170407776|NCT00738920|615832553|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
170407777|NCT00738920|615832551|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
170407778|NCT00738920|615832552|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
170407779|NCT00738920|615832553|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
170407780|NCT00738920|615832551|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
170407781|NCT00738920|615832552|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
170407782|NCT00738920|615832553|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
170407783|NCT00738920|615832551|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
170407784|NCT00738920|615832552|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
170407785|NCT00738920|615832553|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
170407786|NCT00738920|615832551|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
170407787|NCT00738920|615832552|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
170407788|NCT00738920|615832553|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
170407789|NCT04147611|615832555|FG000|Overall Study|Physician Decision|0|||
170407790|NCT04147611|615832556|FG001|Overall Study|Physician Decision|1|||
170407791|NCT01585831|615832563|FG000|Overall Study|Physician Decision|0|||
170407792|NCT01585831|615832564|FG001|Overall Study|Physician Decision|1|||
170407793|NCT01585831|615832563|FG000|Overall Study|Withdrawal by Subject|2|||
170407794|NCT01585831|615832564|FG001|Overall Study|Withdrawal by Subject|1|||
170407795|NCT04385199|615832565|FG000|Overall Study|Withdrawal by Subject|1|||
170407796|NCT04385199|615832566|FG001|Overall Study|Withdrawal by Subject|0|||
170760162|NCT00813488|617127813|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
170760163|NCT00813488|617127814|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
170760164|NCT00813488|617127813|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
170760165|NCT00813488|617127814|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
170760166|NCT00813488|617127813|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
170760167|NCT00813488|617127814|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
170760168|NCT00813488|617127813|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
170760169|NCT00813488|617127814|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
170760170|NCT00813488|617127813|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
170760171|NCT00813488|617127814|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
170760172|NCT00813488|617127813|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
170760173|NCT00813488|617127814|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
170760174|NCT00813488|617127813|FG000|Double-blind Treatment Period 2|Other|1|||
170760175|NCT00813488|617127814|FG001|Double-blind Treatment Period 2|Other|0|||
170760176|NCT00813488|617127813|FG000|Open-label Extension|Adverse Event|1|||
170760177|NCT00813488|617127814|FG001|Open-label Extension|Adverse Event|2|||
170760178|NCT00813488|617127813|FG000|Open-label Extension|Lack of Efficacy|3|||
170760179|NCT00813488|617127814|FG001|Open-label Extension|Lack of Efficacy|0|||
170760180|NCT00813488|617127813|FG000|Open-label Extension|Withdrawal by Subject|0|||
170865913|NCT01717768|617521417|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170760181|NCT00813488|617127814|FG001|Open-label Extension|Withdrawal by Subject|2|||
170407797|NCT01225991|615832567|FG000|Overall Study|Withdrawal by Subject|6|||
170407798|NCT00378482|615832568|FG000|Overall Study|Lost to Follow-up|1|||
170407799|NCT00378482|615832568|FG000|Overall Study|Lack of Efficacy|8|||
170760182|NCT00813488|617127813|FG000|Open-label Extension|Protocol Violation|1|||
170407800|NCT00378482|615832568|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
170407801|NCT00378482|615832568|FG000|Overall Study|Withdrawal by Subject|4|||
170407802|NCT00378482|615832568|FG000|Overall Study|Adverse Event|9|||
170407803|NCT03751124|615832569|FG000|Overall Study|Adverse Event|4|||
170407804|NCT03751124|615832570|FG001|Overall Study|Adverse Event|3|||
170407805|NCT03751124|615832569|FG000|Overall Study|Protocol Deviation|0|||
170407806|NCT03751124|615832570|FG001|Overall Study|Protocol Deviation|1|||
170407807|NCT03751124|615832569|FG000|Overall Study|Lost to Follow-up|6|||
170407808|NCT03751124|615832570|FG001|Overall Study|Lost to Follow-up|4|||
170407809|NCT03751124|615832569|FG000|Overall Study|Withdrawal by Subject|6|||
170407810|NCT03751124|615832570|FG001|Overall Study|Withdrawal by Subject|8|||
170407811|NCT03751124|615832569|FG000|Overall Study|Lack of Efficacy|1|||
170407812|NCT03751124|615832570|FG001|Overall Study|Lack of Efficacy|1|||
170407813|NCT03751124|615832569|FG000|Overall Study|Pregnancy|0|||
170407814|NCT03751124|615832570|FG001|Overall Study|Pregnancy|1|||
170407815|NCT03751124|615832569|FG000|Overall Study|Other|9|||
170407816|NCT03751124|615832570|FG001|Overall Study|Other|9|||
170407817|NCT03751124|615832569|FG000|Overall Study|Participants who did not receive any study drug|0|||
170407818|NCT03751124|615832570|FG001|Overall Study|Participants who did not receive any study drug|1|||
170407819|NCT01859390|615834089|FG000|Overall Study|Insufficient Sputum Collected|1|||
170407820|NCT01859390|615834090|FG001|Overall Study|Insufficient Sputum Collected|3|||
170407821|NCT01859390|615834089|FG000|Overall Study|Sample Missing Collection Date|0|||
170407822|NCT01859390|615834090|FG001|Overall Study|Sample Missing Collection Date|1|||
170407823|NCT01859390|615834089|FG000|Overall Study|Tube Cracked|0|||
170407824|NCT01859390|615834090|FG001|Overall Study|Tube Cracked|2|||
170407825|NCT01859390|615834089|FG000|Overall Study|Shipment Error|0|||
170407826|NCT01859390|615834090|FG001|Overall Study|Shipment Error|1|||
170407827|NCT01806597|615834091|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
170407828|NCT01806597|615834092|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
170407829|NCT01806597|615834093|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
170407830|NCT01806597|615834094|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
170407831|NCT01806597|615834095|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
170407832|NCT01806597|615834096|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
170407833|NCT01806597|615834091|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
170407834|NCT01806597|615834092|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
170407835|NCT01806597|615834093|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
170407836|NCT01806597|615834094|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
170407837|NCT01806597|615834095|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
170407838|NCT01806597|615834096|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
170407839|NCT01806597|615834091|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
170407840|NCT01806597|615834092|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
170407841|NCT01806597|615834093|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
170407842|NCT01806597|615834094|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
170407843|NCT01806597|615834095|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
170407844|NCT01806597|615834096|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
170407845|NCT01806597|615834091|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
170407846|NCT01806597|615834092|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
170407847|NCT01806597|615834093|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
170407848|NCT01806597|615834094|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
170407849|NCT01806597|615834095|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
170407850|NCT01806597|615834096|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
170407851|NCT01806597|615834091|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
170407852|NCT01806597|615834092|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
170407853|NCT01806597|615834093|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
170760183|NCT00813488|617127814|FG001|Open-label Extension|Protocol Violation|2|||
170407854|NCT01806597|615834094|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
170407855|NCT01806597|615834095|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
170407856|NCT01806597|615834096|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
170407857|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
170407858|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
170407859|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
170407860|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
170407861|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
170407862|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
170407863|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
170407864|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
170407865|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
170407866|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
170407867|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
170407868|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
170407869|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
170407870|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
170407871|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
170407872|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
170407873|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
170407874|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
170407875|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
170407876|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
170407877|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
170407878|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
170407879|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
170407880|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
170407881|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
170407882|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
170407883|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
170407884|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
170407885|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
170407886|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
170407887|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
170407888|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
170407889|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
170407890|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
170407891|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
170407892|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
170407893|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
170407894|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
170407895|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
170407896|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
170407897|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
170407898|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
170407899|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
170407900|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
170407901|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
170407902|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
170407903|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
170407904|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
170407905|NCT01806597|615834091|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
170407906|NCT01806597|615834092|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
170407907|NCT01806597|615834093|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
170407908|NCT01806597|615834094|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
170407909|NCT01806597|615834095|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
170407910|NCT01806597|615834096|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
170407911|NCT01806597|615834091|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
170407912|NCT01806597|615834092|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
170407913|NCT01806597|615834093|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
170407914|NCT01806597|615834094|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
170407915|NCT01806597|615834095|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
170407916|NCT01806597|615834096|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
170407917|NCT01806597|615834091|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
170865914|NCT01717768|617521418|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170865915|NCT01717768|617521419|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170865916|NCT01717768|617521420|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170865917|NCT01717768|617521421|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
170865918|NCT01717768|617521422|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
170865919|NCT01717768|617521411|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865920|NCT01717768|617521412|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865921|NCT01717768|617521413|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865922|NCT01717768|617521414|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170407918|NCT01806597|615834092|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
170407919|NCT01806597|615834093|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
170407920|NCT01806597|615834094|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
170407921|NCT01806597|615834095|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
170407922|NCT01806597|615834096|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
170407923|NCT01806597|615834091|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
170407924|NCT01806597|615834092|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
170407925|NCT01806597|615834093|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
170407926|NCT01806597|615834094|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
170407927|NCT01806597|615834095|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
170407928|NCT01806597|615834096|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
170407929|NCT01806597|615834091|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
170407930|NCT01806597|615834092|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
170407931|NCT01806597|615834093|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
170407932|NCT01806597|615834094|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
170407933|NCT01806597|615834095|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
170407934|NCT01806597|615834096|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
170407935|NCT01806597|615834091|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
170407936|NCT01806597|615834092|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
170407937|NCT01806597|615834093|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
170407938|NCT01806597|615834094|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
170407939|NCT01806597|615834095|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
170407940|NCT01806597|615834096|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
170407941|NCT02482805|615834097|FG000|Overall Study|Lost to Follow-up|4|||
170407942|NCT02482805|615834098|FG001|Overall Study|Lost to Follow-up|4|||
170407943|NCT02482805|615834099|FG002|Overall Study|Lost to Follow-up|0|||
170407944|NCT01144663|615834100|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
170407945|NCT01144663|615834101|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
170407946|NCT01144663|615834102|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
170407947|NCT01144663|615834103|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
170407948|NCT01144663|615834100|FG000|Primary Vaccination Phase|Adverse Event|1|||
170407949|NCT01144663|615834101|FG001|Primary Vaccination Phase|Adverse Event|0|||
170407950|NCT01144663|615834102|FG002|Primary Vaccination Phase|Adverse Event|0|||
170407951|NCT01144663|615834103|FG003|Primary Vaccination Phase|Adverse Event|1|||
170407952|NCT01144663|615834100|FG000|Primary Vaccination Phase|Protocol Violation|2|||
170407953|NCT01144663|615834101|FG001|Primary Vaccination Phase|Protocol Violation|0|||
170407954|NCT01144663|615834102|FG002|Primary Vaccination Phase|Protocol Violation|1|||
170407955|NCT01144663|615834103|FG003|Primary Vaccination Phase|Protocol Violation|0|||
170407956|NCT01144663|615834100|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
170407957|NCT01144663|615834101|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
170407958|NCT01144663|615834102|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
170407959|NCT01144663|615834103|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
170407960|NCT01144663|615834100|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
170407961|NCT01144663|615834101|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
170407962|NCT01144663|615834102|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
170407963|NCT01144663|615834103|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
170407964|NCT01144663|615834100|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
170407965|NCT01144663|615834101|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
170407966|NCT01144663|615834102|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
170407967|NCT01144663|615834103|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
170407968|NCT01144663|615834100|FG000|Primary Vaccination Phase|Other|0|||
170407969|NCT01144663|615834101|FG001|Primary Vaccination Phase|Other|1|||
170407970|NCT01144663|615834102|FG002|Primary Vaccination Phase|Other|0|||
170407971|NCT01144663|615834103|FG003|Primary Vaccination Phase|Other|2|||
170407972|NCT01144663|615834100|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
170407973|NCT01144663|615834101|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
170407974|NCT01144663|615834102|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
170407975|NCT01144663|615834103|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
170407976|NCT01144663|615834100|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
170407977|NCT01144663|615834101|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
170407978|NCT01144663|615834102|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
170407979|NCT01144663|615834103|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
170407980|NCT01144663|615834100|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
170407981|NCT01144663|615834101|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
170407982|NCT01144663|615834102|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
170407983|NCT01144663|615834103|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
170407984|NCT01144663|615834100|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
170407985|NCT01144663|615834101|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
170407986|NCT01144663|615834102|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
170407987|NCT01144663|615834103|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
170407988|NCT01144663|615834100|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
170407989|NCT01144663|615834101|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
170407990|NCT01144663|615834102|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
170407991|NCT01144663|615834103|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
170407992|NCT01144663|615834100|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
170760184|NCT00813488|617127813|FG000|Open-label Extension|Non-compliance study medication|4|||
170760185|NCT00813488|617127814|FG001|Open-label Extension|Non-compliance study medication|0|||
170760186|NCT00813488|617127813|FG000|Open-label Extension|Non-compliance study procedures|2|||
170760187|NCT00813488|617127814|FG001|Open-label Extension|Non-compliance study procedures|1|||
170760188|NCT00813488|617127813|FG000|Open-label Extension|Other|1|||
170760189|NCT00813488|617127814|FG001|Open-label Extension|Other|0|||
170760190|NCT01559090|617127815|FG000|Stage I|Withdrawal by Subject|2|||
170760191|NCT01559090|617127816|FG001|Stage I|Withdrawal by Subject|2|||
170760192|NCT01559090|617127817|FG002|Stage I|Withdrawal by Subject|3|||
170760193|NCT01559090|617127815|FG000|Stage II|Withdrawal by Subject|1|||
170760194|NCT01559090|617127816|FG001|Stage II|Withdrawal by Subject|0|||
170760195|NCT01559090|617127817|FG002|Stage II|Withdrawal by Subject|0|||
170760196|NCT03499600|617127818|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
170760197|NCT03499600|617127819|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
170760198|NCT02414828|617127820|FG000|Overall Study|Lost to Follow-up|0|||
170760199|NCT02414828|617127821|FG001|Overall Study|Lost to Follow-up|1|||
170760200|NCT02414828|617127822|FG002|Overall Study|Lost to Follow-up|1|||
170760201|NCT02414828|617127823|FG003|Overall Study|Lost to Follow-up|2|||
170760202|NCT00445692|617127824|FG000|Overall Study|Adverse Event|11|||
170760203|NCT00445692|617127824|FG000|Overall Study|Lack of Efficacy|5|||
170760204|NCT03971357|617127825|FG000|Overall Study|Lack of Efficacy|0|||
170760205|NCT03971357|617127826|FG001|Overall Study|Lack of Efficacy|1|||
170760206|NCT01143077|617127831|FG000|Overall Study|Lack of Efficacy|0|||
170760207|NCT01143077|617127832|FG001|Overall Study|Lack of Efficacy|2|||
170760208|NCT01143077|617127833|FG002|Overall Study|Lack of Efficacy|1|||
170760209|NCT01143077|617127831|FG000|Overall Study|Adverse Event|5|||
170760210|NCT01143077|617127832|FG001|Overall Study|Adverse Event|6|||
170760211|NCT01143077|617127833|FG002|Overall Study|Adverse Event|5|||
170760212|NCT01143077|617127831|FG000|Overall Study|Lost to Follow-up|2|||
170760213|NCT01143077|617127832|FG001|Overall Study|Lost to Follow-up|3|||
170760214|NCT01143077|617127833|FG002|Overall Study|Lost to Follow-up|4|||
170760215|NCT01143077|617127831|FG000|Overall Study|Protocol Violation|2|||
170760216|NCT01143077|617127832|FG001|Overall Study|Protocol Violation|0|||
170760217|NCT01143077|617127833|FG002|Overall Study|Protocol Violation|0|||
170760218|NCT01143077|617127831|FG000|Overall Study|Withdrawal by Subject|4|||
170760219|NCT01143077|617127832|FG001|Overall Study|Withdrawal by Subject|3|||
170760220|NCT01143077|617127833|FG002|Overall Study|Withdrawal by Subject|3|||
170760221|NCT01143077|617127831|FG000|Overall Study|Non-compliance with study drug|0|||
170760222|NCT01143077|617127832|FG001|Overall Study|Non-compliance with study drug|1|||
170760223|NCT01143077|617127833|FG002|Overall Study|Non-compliance with study drug|1|||
170760224|NCT01143077|617127831|FG000|Overall Study|Administrative|1|||
170760225|NCT01143077|617127832|FG001|Overall Study|Administrative|0|||
170760226|NCT01143077|617127833|FG002|Overall Study|Administrative|0|||
170760227|NCT01143077|617127831|FG000|Overall Study|Principal Investigator Decision|2|||
170760228|NCT01143077|617127832|FG001|Overall Study|Principal Investigator Decision|0|||
170760229|NCT01143077|617127833|FG002|Overall Study|Principal Investigator Decision|1|||
170760230|NCT00630864|617127834|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
170760231|NCT00630864|617127834|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
170760232|NCT00430677|617127835|FG000|Short-term Period|Death|1|||
170760233|NCT00430677|617127836|FG001|Short-term Period|Death|1|||
170760234|NCT00430677|617127837|FG002|Short-term Period|Death|5|||
170760235|NCT00430677|617127835|FG000|Short-term Period|Adverse Event|15|||
170760236|NCT00430677|617127836|FG001|Short-term Period|Adverse Event|13|||
170760237|NCT00430677|617127837|FG002|Short-term Period|Adverse Event|9|||
170760238|NCT00430677|617127835|FG000|Short-term Period|Lack of Efficacy|5|||
170760239|NCT00430677|617127836|FG001|Short-term Period|Lack of Efficacy|6|||
170760240|NCT00430677|617127837|FG002|Short-term Period|Lack of Efficacy|4|||
170760241|NCT00430677|617127835|FG000|Short-term Period|Withdrawal by Subject|1|||
170760242|NCT00430677|617127836|FG001|Short-term Period|Withdrawal by Subject|1|||
170760243|NCT00430677|617127837|FG002|Short-term Period|Withdrawal by Subject|2|||
170760244|NCT00430677|617127835|FG000|Short-term Period|Participant no longer met study criteria|1|||
170760245|NCT00430677|617127836|FG001|Short-term Period|Participant no longer met study criteria|1|||
170760246|NCT00430677|617127837|FG002|Short-term Period|Participant no longer met study criteria|2|||
170760247|NCT00430677|617127835|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
170760248|NCT00430677|617127836|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
170760249|NCT00430677|617127837|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
170760250|NCT00430677|617127835|FG000|Short-term Period|Pregnancy|0|||
170865923|NCT01717768|617521415|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865924|NCT01717768|617521416|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865925|NCT01717768|617521417|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865926|NCT01717768|617521418|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
170865927|NCT01717768|617521419|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865928|NCT01717768|617521420|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865929|NCT01717768|617521421|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865930|NCT01717768|617521422|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
170865931|NCT01717768|617521411|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865932|NCT01717768|617521412|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865933|NCT01717768|617521413|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865934|NCT01717768|617521414|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865935|NCT01717768|617521415|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170407993|NCT01144663|615834101|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
170407994|NCT01144663|615834102|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
170407995|NCT01144663|615834103|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
170407996|NCT01473758|615834105|FG000|Cycle 1|Adverse Event|10|||
170407997|NCT01473758|615834106|FG001|Cycle 1|Adverse Event|2|||
170407998|NCT01473758|615834107|FG002|Cycle 1|Adverse Event|0|||
170407999|NCT01473758|615834108|FG003|Cycle 1|Adverse Event|0|||
170408000|NCT01473758|615834105|FG000|Cycle 1|Withdrawal by Subject|1|||
170408001|NCT01473758|615834106|FG001|Cycle 1|Withdrawal by Subject|1|||
170408002|NCT01473758|615834107|FG002|Cycle 1|Withdrawal by Subject|0|||
170408003|NCT01473758|615834108|FG003|Cycle 1|Withdrawal by Subject|0|||
170408004|NCT01473758|615834105|FG000|Cycle 2|Adverse Event|0|||
170408005|NCT01473758|615834106|FG001|Cycle 2|Adverse Event|0|||
170408006|NCT01473758|615834107|FG002|Cycle 2|Adverse Event|5|||
170408007|NCT01473758|615834108|FG003|Cycle 2|Adverse Event|0|||
170408008|NCT02763579|615834109|FG000|Global Period|Death|167|||
170408009|NCT02763579|615834110|FG001|Global Period|Death|151|||
170408010|NCT02763579|615834111|FG002|Global Period|Death|0|||
170408011|NCT02763579|615834112|FG003|Global Period|Death|0|||
170408012|NCT02763579|615834109|FG000|Global Period|Lost to Follow-up|2|||
170408013|NCT02763579|615834110|FG001|Global Period|Lost to Follow-up|4|||
170408014|NCT02763579|615834111|FG002|Global Period|Lost to Follow-up|0|||
170408015|NCT02763579|615834112|FG003|Global Period|Lost to Follow-up|0|||
170408016|NCT02763579|615834109|FG000|Global Period|Physician Decision|0|||
170408017|NCT02763579|615834110|FG001|Global Period|Physician Decision|2|||
170408018|NCT02763579|615834111|FG002|Global Period|Physician Decision|0|||
170408019|NCT02763579|615834112|FG003|Global Period|Physician Decision|0|||
170408020|NCT02763579|615834109|FG000|Global Period|Study Terminated By Sponsor|21|||
170408021|NCT02763579|615834110|FG001|Global Period|Study Terminated By Sponsor|26|||
170408022|NCT02763579|615834111|FG002|Global Period|Study Terminated By Sponsor|0|||
170408023|NCT02763579|615834112|FG003|Global Period|Study Terminated By Sponsor|0|||
170408024|NCT02763579|615834109|FG000|Global Period|Withdrawal by Subject|12|||
170408025|NCT02763579|615834110|FG001|Global Period|Withdrawal by Subject|18|||
170408026|NCT02763579|615834111|FG002|Global Period|Withdrawal by Subject|0|||
170408027|NCT02763579|615834112|FG003|Global Period|Withdrawal by Subject|0|||
170408028|NCT02763579|615834109|FG000|China Period|Death|0|||
170408029|NCT02763579|615834110|FG001|China Period|Death|0|||
170408030|NCT02763579|615834111|FG002|China Period|Death|46|||
170408031|NCT02763579|615834112|FG003|China Period|Death|48|||
170408032|NCT02763579|615834109|FG000|China Period|Lost to Follow-up|0|||
170408033|NCT02763579|615834110|FG001|China Period|Lost to Follow-up|0|||
170408034|NCT02763579|615834111|FG002|China Period|Lost to Follow-up|1|||
170408035|NCT02763579|615834112|FG003|China Period|Lost to Follow-up|1|||
170408036|NCT02763579|615834109|FG000|China Period|Physician Decision|0|||
170408037|NCT02763579|615834110|FG001|China Period|Physician Decision|0|||
170408038|NCT02763579|615834111|FG002|China Period|Physician Decision|0|||
170408039|NCT02763579|615834112|FG003|China Period|Physician Decision|1|||
170408040|NCT02763579|615834109|FG000|China Period|Study Terminated By Sponsor|0|||
170408041|NCT02763579|615834110|FG001|China Period|Study Terminated By Sponsor|0|||
170408042|NCT02763579|615834111|FG002|China Period|Study Terminated By Sponsor|3|||
170865936|NCT01717768|617521416|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170408043|NCT02763579|615834112|FG003|China Period|Study Terminated By Sponsor|4|||
170408044|NCT02763579|615834109|FG000|China Period|Withdrawal by Subject|0|||
170408045|NCT02763579|615834110|FG001|China Period|Withdrawal by Subject|0|||
170408046|NCT02763579|615834111|FG002|China Period|Withdrawal by Subject|3|||
170408047|NCT02763579|615834112|FG003|China Period|Withdrawal by Subject|3|||
170408048|NCT03273387|615834126|FG000|Overall Study|Death|2|||
170408049|NCT03273387|615834127|FG001|Overall Study|Death|2|||
170408050|NCT03273387|615834126|FG000|Overall Study|Withdrawal by Subject|1|||
170408051|NCT03273387|615834127|FG001|Overall Study|Withdrawal by Subject|1|||
170408052|NCT01907737|615834135|FG000|Overall Study|Withdrawal by Subject|1|||
170408053|NCT00909727|615834172|FG000|Overall Study|Adverse Event|1|||
170408054|NCT00909727|615834173|FG001|Overall Study|Adverse Event|0|||
170865937|NCT01717768|617521417|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865938|NCT01717768|617521418|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865939|NCT01717768|617521419|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865940|NCT01717768|617521420|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
170865941|NCT01717768|617521421|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865942|NCT01717768|617521422|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
170865943|NCT00448435|617521423|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
170865944|NCT00448435|617521424|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
170865945|NCT00412971|617521425|FG000|Overall Study|Lost to Follow-up|17|||
170865946|NCT00412971|617521426|FG001|Overall Study|Lost to Follow-up|9|||
170865947|NCT00412971|617521425|FG000|Overall Study|Protocol Violation|13|||
170865948|NCT00412971|617521426|FG001|Overall Study|Protocol Violation|1|||
170865949|NCT04195581|617521427|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
170865950|NCT04195581|617521427|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
170865951|NCT04195581|617521427|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
170865952|NCT04195581|617521427|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
170865953|NCT04195581|617521427|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
170865954|NCT04195581|617521427|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
170865955|NCT00821431|617521428|FG000|Overall Study|Adverse Event|6|||
170865956|NCT00821431|617521429|FG001|Overall Study|Adverse Event|3|||
170865957|NCT00821431|617521428|FG000|Overall Study|Withdrawal by Subject|5|||
170865958|NCT00821431|617521429|FG001|Overall Study|Withdrawal by Subject|0|||
170865959|NCT00821431|617521428|FG000|Overall Study|Lost to Follow-up|1|||
170865960|NCT00821431|617521429|FG001|Overall Study|Lost to Follow-up|0|||
170865961|NCT00821431|617521428|FG000|Overall Study|Protocol Violation|3|||
170865962|NCT00821431|617521429|FG001|Overall Study|Protocol Violation|1|||
170865963|NCT00821431|617521428|FG000|Overall Study|Physician Decision|0|||
170865964|NCT00821431|617521429|FG001|Overall Study|Physician Decision|1|||
170865965|NCT01387230|617521430|FG000|Overall Study|Adverse Event|0|||
170865966|NCT01387230|617521431|FG001|Overall Study|Adverse Event|1|||
170865967|NCT01387230|617521432|FG002|Overall Study|Adverse Event|3|||
170865968|NCT01387230|617521430|FG000|Overall Study|Lack of Efficacy|8|||
170865969|NCT01387230|617521431|FG001|Overall Study|Lack of Efficacy|5|||
170865970|NCT01387230|617521432|FG002|Overall Study|Lack of Efficacy|4|||
170865971|NCT01387230|617521430|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
170865972|NCT01387230|617521431|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
170865973|NCT01387230|617521432|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
170865974|NCT01387230|617521430|FG000|Overall Study|Lost to Follow-up|0|||
170865975|NCT01387230|617521431|FG001|Overall Study|Lost to Follow-up|0|||
170865976|NCT01387230|617521432|FG002|Overall Study|Lost to Follow-up|1|||
170865977|NCT01387230|617521430|FG000|Overall Study|Withdrawal by Subject|4|||
170865978|NCT01387230|617521431|FG001|Overall Study|Withdrawal by Subject|1|||
170865979|NCT01387230|617521432|FG002|Overall Study|Withdrawal by Subject|0|||
170865980|NCT01182766|617521433|FG000|Overall Study|Lost to Follow-up|32|||
170865981|NCT01182766|617521434|FG001|Overall Study|Lost to Follow-up|36|||
170865982|NCT01182766|617521435|FG002|Overall Study|Lost to Follow-up|29|||
170865983|NCT01182766|617521433|FG000|Overall Study|Withdrawal by Subject|14|||
170865984|NCT01182766|617521434|FG001|Overall Study|Withdrawal by Subject|3|||
170865985|NCT01182766|617521435|FG002|Overall Study|Withdrawal by Subject|6|||
170865986|NCT01182766|617521433|FG000|Overall Study|Physician Decision|1|||
170865987|NCT01182766|617521434|FG001|Overall Study|Physician Decision|0|||
170865988|NCT01182766|617521435|FG002|Overall Study|Physician Decision|0|||
170865989|NCT01182766|617521433|FG000|Overall Study|Non-compliance|1|||
170865990|NCT01182766|617521434|FG001|Overall Study|Non-compliance|1|||
170865991|NCT01182766|617521435|FG002|Overall Study|Non-compliance|1|||
170865992|NCT03027557|617521436|FG000|Overall Study|Adverse Event|1|||
170865993|NCT03027557|617521437|FG001|Overall Study|Adverse Event|0|||
170865994|NCT03027557|617521438|FG002|Overall Study|Adverse Event|0|||
170865995|NCT02030405|617521444|FG000|Overall Study|Withdrawal by Subject|1|||
170408055|NCT00909727|615834172|FG000|Overall Study|Wrong Genotype|1|||
170408056|NCT00909727|615834173|FG001|Overall Study|Wrong Genotype|0|||
170408057|NCT00909727|615834172|FG000|Overall Study|Withdrawal of Consent|1|||
170408058|NCT00909727|615834173|FG001|Overall Study|Withdrawal of Consent|0|||
170408059|NCT00909727|615834172|FG000|Overall Study|Prohibited Medication|1|||
170408060|NCT00909727|615834173|FG001|Overall Study|Prohibited Medication|0|||
170408061|NCT04480463|615834174|FG000|Overall Study|Death|0|||
170408062|NCT04480463|615834175|FG001|Overall Study|Death|1|||
170408063|NCT04480463|615834174|FG000|Overall Study|Adverse Event|6|||
170408064|NCT04480463|615834175|FG001|Overall Study|Adverse Event|8|||
170408065|NCT04480463|615834174|FG000|Overall Study|Lost to Follow-up|3|||
170408066|NCT04480463|615834175|FG001|Overall Study|Lost to Follow-up|2|||
170408067|NCT04480463|615834174|FG000|Overall Study|Physician Decision|2|||
170408068|NCT04480463|615834175|FG001|Overall Study|Physician Decision|5|||
170408069|NCT04480463|615834174|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
170408070|NCT04480463|615834175|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
170408071|NCT04480463|615834174|FG000|Overall Study|Protocol Violation|2|||
170408072|NCT04480463|615834175|FG001|Overall Study|Protocol Violation|1|||
170408073|NCT04480463|615834174|FG000|Overall Study|Withdrawal by Subject|6|||
170408074|NCT04480463|615834175|FG001|Overall Study|Withdrawal by Subject|7|||
170408075|NCT04480463|615834174|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
170408076|NCT04480463|615834175|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
170408077|NCT04480463|615834174|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
170408078|NCT04480463|615834175|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
170408079|NCT04480463|615834174|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
170408080|NCT04480463|615834175|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
170408081|NCT04480463|615834174|FG000|Overall Study|Other|6|||
170408082|NCT04480463|615834175|FG001|Overall Study|Other|4|||
170408083|NCT01399723|615834176|FG000|Overall Study|Lost to Follow-up|0|||
170408084|NCT01399723|615834177|FG001|Overall Study|Lost to Follow-up|1|||
170408085|NCT01567306|615834179|FG000|Overall Study|Protocol Violation|2|||
170408086|NCT01567306|615834180|FG001|Overall Study|Protocol Violation|2|||
170408087|NCT01567306|615834181|FG002|Overall Study|Protocol Violation|0|||
170408088|NCT01567306|615834182|FG003|Overall Study|Protocol Violation|3|||
170408089|NCT01567306|615834183|FG004|Overall Study|Protocol Violation|1|||
170408090|NCT01567306|615834184|FG005|Overall Study|Protocol Violation|1|||
170408091|NCT01567306|615834179|FG000|Overall Study|Change site living|1|||
170408092|NCT01567306|615834180|FG001|Overall Study|Change site living|0|||
170408093|NCT01567306|615834181|FG002|Overall Study|Change site living|0|||
170408094|NCT01567306|615834182|FG003|Overall Study|Change site living|0|||
170408095|NCT01567306|615834183|FG004|Overall Study|Change site living|0|||
170408096|NCT01567306|615834184|FG005|Overall Study|Change site living|0|||
170408097|NCT01567306|615834179|FG000|Overall Study|Adverse Event|0|||
170408098|NCT01567306|615834180|FG001|Overall Study|Adverse Event|0|||
170408099|NCT01567306|615834181|FG002|Overall Study|Adverse Event|0|||
170408100|NCT01567306|615834182|FG003|Overall Study|Adverse Event|2|||
170408101|NCT01567306|615834183|FG004|Overall Study|Adverse Event|4|||
170408102|NCT01567306|615834184|FG005|Overall Study|Adverse Event|1|||
170408103|NCT01567306|615834179|FG000|Overall Study|Lost to Follow-up|0|||
170408104|NCT01567306|615834180|FG001|Overall Study|Lost to Follow-up|0|||
170408105|NCT01567306|615834181|FG002|Overall Study|Lost to Follow-up|0|||
170408106|NCT01567306|615834182|FG003|Overall Study|Lost to Follow-up|0|||
170408107|NCT01567306|615834183|FG004|Overall Study|Lost to Follow-up|2|||
170408108|NCT01567306|615834184|FG005|Overall Study|Lost to Follow-up|0|||
170408109|NCT01567306|615834179|FG000|Overall Study|Withdrawal by Subject|0|||
170408110|NCT01567306|615834180|FG001|Overall Study|Withdrawal by Subject|0|||
170408111|NCT01567306|615834181|FG002|Overall Study|Withdrawal by Subject|0|||
170408112|NCT01567306|615834182|FG003|Overall Study|Withdrawal by Subject|0|||
170408113|NCT01567306|615834183|FG004|Overall Study|Withdrawal by Subject|0|||
170408114|NCT01567306|615834184|FG005|Overall Study|Withdrawal by Subject|1|||
170408115|NCT00829413|615834187|FG000|Overall Study|No study drug admimnistered|13|||
170408116|NCT00829413|615834187|FG000|Overall Study|Training Patients|67|||
170408117|NCT00829413|615834187|FG000|Overall Study|No truth standard procedure available|9|||
170408118|NCT00829413|615834187|FG000|Overall Study|Technically inadequate truth standard|2|||
170408119|NCT00829413|615834187|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
170408120|NCT00124020|615834194|FG000|Overall Study|Death|67|||
170408121|NCT00124020|615834195|FG001|Overall Study|Death|71|||
170408122|NCT00124020|615834194|FG000|Overall Study|Withdrawal by Subject|13|||
170408123|NCT00124020|615834195|FG001|Overall Study|Withdrawal by Subject|11|||
170408124|NCT00124020|615834194|FG000|Overall Study|Lost to Follow-up|5|||
170408125|NCT00124020|615834195|FG001|Overall Study|Lost to Follow-up|8|||
170408126|NCT00124020|615834194|FG000|Overall Study|Other|1|||
170408127|NCT00124020|615834195|FG001|Overall Study|Other|1|||
170760251|NCT00430677|617127836|FG001|Short-term Period|Pregnancy|2|||
170760252|NCT00430677|617127837|FG002|Short-term Period|Pregnancy|0|||
170760253|NCT00430677|617127835|FG000|Long-term Extension Period|Death|1|||
170760254|NCT00430677|617127836|FG001|Long-term Extension Period|Death|0|||
170865996|NCT02030405|617521444|FG000|Overall Study|Lost to Follow-up|1|||
170865997|NCT00564018|617521445|FG000|Overall Study|Withdrawal by Subject|2|||
170865998|NCT00564018|617521446|FG001|Overall Study|Withdrawal by Subject|3|||
170865999|NCT00564018|617521447|FG002|Overall Study|Withdrawal by Subject|1|||
170866000|NCT02554903|617521450|FG000|Overall Study|Death|1|||
170866001|NCT02554903|617521451|FG001|Overall Study|Death|1|||
170866002|NCT02554903|617521450|FG000|Overall Study|Physician Decision|2|||
170866003|NCT02554903|617521451|FG001|Overall Study|Physician Decision|2|||
170866004|NCT02554903|617521450|FG000|Overall Study|Heart Transplant|1|||
170866005|NCT02554903|617521451|FG001|Overall Study|Heart Transplant|2|||
170866006|NCT04201821|617521453|FG000|Overall Study|Withdrawal by Subject|2|||
170866007|NCT04226833|617521455|FG000|Overall Study|Death|0|||
170866008|NCT04226833|617521456|FG001|Overall Study|Death|0|||
170866009|NCT04226833|617521457|FG002|Overall Study|Death|1|||
170866010|NCT04226833|617521458|FG003|Overall Study|Death|0|||
170866011|NCT01163721|617521460|FG000|Overall Study|Adverse Event|5|||
170866012|NCT01163721|617521461|FG001|Overall Study|Adverse Event|6|||
170866013|NCT01163721|617521460|FG000|Overall Study|Withdrawal by Subject|3|||
170866014|NCT01163721|617521461|FG001|Overall Study|Withdrawal by Subject|4|||
170866015|NCT01163721|617521460|FG000|Overall Study|Lost to Follow-up|0|||
170866016|NCT01163721|617521461|FG001|Overall Study|Lost to Follow-up|1|||
170866017|NCT01163721|617521460|FG000|Overall Study|Physician Decision|0|||
170866018|NCT01163721|617521461|FG001|Overall Study|Physician Decision|1|||
170866019|NCT01472380|617521462|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
170866020|NCT01472380|617521462|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
170866021|NCT03254485|617521467|FG000|Overall Study|Adverse Event|3|||
170866022|NCT03254485|617521468|FG001|Overall Study|Adverse Event|0|||
170866023|NCT03254485|617521469|FG002|Overall Study|Adverse Event|0|||
170866024|NCT03254485|617521470|FG003|Overall Study|Adverse Event|6|||
170866025|NCT03254485|617521467|FG000|Overall Study|Protocol Violation|6|||
170866026|NCT03254485|617521468|FG001|Overall Study|Protocol Violation|0|||
170866027|NCT03254485|617521469|FG002|Overall Study|Protocol Violation|0|||
170866028|NCT03254485|617521470|FG003|Overall Study|Protocol Violation|2|||
170866029|NCT03254485|617521467|FG000|Overall Study|Withdrawal by Subject|1|||
170866030|NCT03254485|617521468|FG001|Overall Study|Withdrawal by Subject|0|||
170866031|NCT03254485|617521469|FG002|Overall Study|Withdrawal by Subject|0|||
170866032|NCT03254485|617521470|FG003|Overall Study|Withdrawal by Subject|4|||
170866033|NCT03254485|617521467|FG000|Overall Study|Death|0|||
170866034|NCT03254485|617521468|FG001|Overall Study|Death|0|||
170866035|NCT03254485|617521469|FG002|Overall Study|Death|0|||
170866036|NCT03254485|617521470|FG003|Overall Study|Death|1|||
170866037|NCT03254485|617521467|FG000|Overall Study|Lost to Follow-up|1|||
170866038|NCT03254485|617521468|FG001|Overall Study|Lost to Follow-up|0|||
170866039|NCT03254485|617521469|FG002|Overall Study|Lost to Follow-up|0|||
170866040|NCT03254485|617521470|FG003|Overall Study|Lost to Follow-up|0|||
170866041|NCT03254485|617521467|FG000|Overall Study|Other|1|||
170866042|NCT03254485|617521468|FG001|Overall Study|Other|0|||
170866043|NCT03254485|617521469|FG002|Overall Study|Other|0|||
170866044|NCT03254485|617521470|FG003|Overall Study|Other|2|||
170866045|NCT02958267|617521471|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
170866046|NCT02958267|617521472|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
170866047|NCT02958267|617521471|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
170866048|NCT02958267|617521472|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
170408128|NCT00124020|615834194|FG000|Overall Study|Transfer to another hospital|2|||
170866049|NCT02958267|617521471|FG000|Follow-up Visits|Additional treatment pursued|2|||
170866050|NCT02958267|617521472|FG001|Follow-up Visits|Additional treatment pursued|1|||
170866051|NCT00047320|617521473|FG000|Overall Study|Lack of Efficacy|8|||
170866052|NCT00047320|617521473|FG000|Overall Study|Lost to Follow-up|1|||
170408129|NCT00124020|615834195|FG001|Overall Study|Transfer to another hospital|0|||
170408130|NCT03255031|615834216|FG000|Overall Study|Adverse Event|5|||
170408131|NCT03255031|615834217|FG001|Overall Study|Adverse Event|3|||
170408132|NCT03255031|615834216|FG000|Overall Study|Physician Decision|2|||
170408133|NCT03255031|615834217|FG001|Overall Study|Physician Decision|1|||
170866053|NCT00047320|617521473|FG000|Overall Study|Physician Decision|8|||
170866054|NCT00047320|617521473|FG000|Overall Study|Withdrawal by Subject|9|||
170408134|NCT03255031|615834216|FG000|Overall Study|Withdrawal by Subject|9|||
170408135|NCT03255031|615834217|FG001|Overall Study|Withdrawal by Subject|3|||
170408136|NCT01238211|615834222|FG000|Overall Study|Continues active treatment|31|||
170408137|NCT01238211|615834222|FG000|Overall Study|Adverse Event|7|||
170866055|NCT00047320|617521473|FG000|Overall Study|Ineligible|2|||
170866056|NCT00445068|617521474|FG000|Overall Study|Disease progression|26|||
170866057|NCT00445068|617521474|FG000|Overall Study|Adverse Event|5|||
170408138|NCT01238211|615834222|FG000|Overall Study|Death|4|||
170866058|NCT00445068|617521474|FG000|Overall Study|Abnormal laboratory value|2|||
170866059|NCT00445068|617521474|FG000|Overall Study|Withdrawal by Subject|2|||
170866060|NCT00445068|617521474|FG000|Overall Study|Death|1|||
170866061|NCT00658684|617521477|FG000|Overall Study|Adverse Event|10|||
170866062|NCT00658684|617521478|FG001|Overall Study|Adverse Event|8|||
170866063|NCT00658684|617521479|FG002|Overall Study|Adverse Event|2|||
170866064|NCT00658684|617521480|FG003|Overall Study|Adverse Event|0|||
170866065|NCT00658684|617521477|FG000|Overall Study|Withdrawal by Subject|6|||
170866066|NCT00658684|617521478|FG001|Overall Study|Withdrawal by Subject|4|||
170866067|NCT00658684|617521479|FG002|Overall Study|Withdrawal by Subject|1|||
170866068|NCT00658684|617521480|FG003|Overall Study|Withdrawal by Subject|1|||
170866069|NCT00658684|617521477|FG000|Overall Study|Lack of Efficacy|1|||
170866070|NCT00658684|617521478|FG001|Overall Study|Lack of Efficacy|1|||
170866071|NCT00658684|617521479|FG002|Overall Study|Lack of Efficacy|0|||
170866072|NCT00658684|617521480|FG003|Overall Study|Lack of Efficacy|0|||
170866073|NCT00658684|617521477|FG000|Overall Study|Protocol Violation|1|||
170866074|NCT00658684|617521478|FG001|Overall Study|Protocol Violation|1|||
170866075|NCT00658684|617521479|FG002|Overall Study|Protocol Violation|0|||
170866076|NCT00658684|617521480|FG003|Overall Study|Protocol Violation|0|||
170866077|NCT00658684|617521477|FG000|Overall Study|Pregnancy|1|||
170866078|NCT00658684|617521478|FG001|Overall Study|Pregnancy|1|||
170866079|NCT00658684|617521479|FG002|Overall Study|Pregnancy|0|||
170866080|NCT00658684|617521480|FG003|Overall Study|Pregnancy|0|||
170866081|NCT00688103|617521481|FG000|Overall Study|Adverse Event|4|||
170866082|NCT00688103|617521482|FG001|Overall Study|Adverse Event|1|||
170866083|NCT00688103|617521481|FG000|Overall Study|Lack of Efficacy|11|||
170866084|NCT00688103|617521482|FG001|Overall Study|Lack of Efficacy|1|||
170866085|NCT00688103|617521481|FG000|Overall Study|Withdrawal by Subject|4|||
170866086|NCT00688103|617521482|FG001|Overall Study|Withdrawal by Subject|2|||
170866087|NCT00688103|617521481|FG000|Overall Study|complex reasons|11|||
170866088|NCT00688103|617521482|FG001|Overall Study|complex reasons|9|||
170866089|NCT03602261|617521484|FG000|Overall Study|Adverse Event|5|||
170866090|NCT03602261|617521485|FG001|Overall Study|Adverse Event|1|||
170866091|NCT03602261|617521484|FG000|Overall Study|Physician Decision|1|||
170866092|NCT03602261|617521485|FG001|Overall Study|Physician Decision|0|||
170866093|NCT03602261|617521484|FG000|Overall Study|Withdrawal by Subject|1|||
170866094|NCT03602261|617521485|FG001|Overall Study|Withdrawal by Subject|1|||
170866095|NCT03602261|617521484|FG000|Overall Study|Lack of Efficacy|0|||
170866096|NCT03602261|617521485|FG001|Overall Study|Lack of Efficacy|1|||
170866097|NCT03602261|617521484|FG000|Overall Study|Subject moving out of state|1|||
170866098|NCT03602261|617521485|FG001|Overall Study|Subject moving out of state|0|||
170866099|NCT06071754|617521486|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
170866100|NCT03226275|617521487|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
170866101|NCT03226275|617521488|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
170866102|NCT03226275|617521489|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
170866103|NCT03226275|617521490|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
170866104|NCT03226275|617521487|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
170866105|NCT03226275|617521488|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
170866106|NCT03226275|617521489|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
170866107|NCT03226275|617521490|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
170866108|NCT03442114|617521491|FG000|Overall Study|Lost to Follow-up|13|||
170866109|NCT03442114|617521492|FG001|Overall Study|Lost to Follow-up|13|||
170866110|NCT03442114|617521491|FG000|Overall Study|Physician Decision|2|||
170408139|NCT01238211|615834222|FG000|Overall Study|Relapse/Progression|2|||
170866111|NCT03442114|617521492|FG001|Overall Study|Physician Decision|2|||
170866112|NCT03442114|617521491|FG000|Overall Study|Protocol Violation|0|||
170866113|NCT03442114|617521492|FG001|Overall Study|Protocol Violation|2|||
170866114|NCT03442114|617521491|FG000|Overall Study|Withdrawal by Subject|1|||
170866115|NCT03442114|617521492|FG001|Overall Study|Withdrawal by Subject|3|||
170866116|NCT03442114|617521491|FG000|Overall Study|Guardianship Change|0|||
170866117|NCT03442114|617521492|FG001|Overall Study|Guardianship Change|1|||
170866118|NCT01436071|617523495|FG000|Overall Study|Adverse Event|1|||
170866119|NCT01436071|617523496|FG001|Overall Study|Adverse Event|0|||
170866120|NCT01436071|617523495|FG000|Overall Study|Lack of Efficacy|16|||
170866121|NCT01436071|617523496|FG001|Overall Study|Lack of Efficacy|7|||
170866122|NCT01436071|617523495|FG000|Overall Study|Protocol Violation|0|||
170408140|NCT01238211|615834222|FG000|Overall Study|Withdrawal by Subject|7|||
170408141|NCT01238211|615834222|FG000|Overall Study|Non-protocol treatment|4|||
170408142|NCT01238211|615834222|FG000|Overall Study|Investigator/Patient Decision|3|||
170408143|NCT00449930|615834223|FG000|Overall Study|Adverse Event|9|||
170408144|NCT00449930|615834224|FG001|Overall Study|Adverse Event|19|||
170408145|NCT00449930|615834223|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
170408146|NCT00449930|615834224|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
170408147|NCT00449930|615834223|FG000|Overall Study|Lack of Efficacy|10|||
170866123|NCT01436071|617523496|FG001|Overall Study|Protocol Violation|1|||
170408148|NCT00449930|615834224|FG001|Overall Study|Lack of Efficacy|1|||
170408149|NCT00449930|615834223|FG000|Overall Study|Lost to Follow-up|9|||
170408150|NCT00449930|615834224|FG001|Overall Study|Lost to Follow-up|14|||
170866124|NCT01436071|617523495|FG000|Overall Study|Lost to Follow-up|3|||
170866125|NCT01436071|617523496|FG001|Overall Study|Lost to Follow-up|1|||
170866126|NCT01436071|617523495|FG000|Overall Study|Physician Decision|1|||
170866127|NCT01436071|617523496|FG001|Overall Study|Physician Decision|0|||
170866128|NCT01436071|617523495|FG000|Overall Study|Withdrawal by Subject|2|||
170866129|NCT01436071|617523496|FG001|Overall Study|Withdrawal by Subject|2|||
170866130|NCT01436071|617523495|FG000|Overall Study|Did Not Receive Trial Medication|3|||
170866131|NCT01436071|617523496|FG001|Overall Study|Did Not Receive Trial Medication|3|||
170866132|NCT03047551|617523499|FG000|Overall Study|Did not receive TAS|1|||
170866133|NCT03047551|617523500|FG001|Overall Study|Did not receive TAS|0|||
170866134|NCT03047551|617523499|FG000|Overall Study|Physician Decision|1|||
170866135|NCT03047551|617523500|FG001|Overall Study|Physician Decision|0|||
170866136|NCT03047551|617523499|FG000|Overall Study|Withdrawal by Subject|0|||
170866137|NCT03047551|617523500|FG001|Overall Study|Withdrawal by Subject|1|||
170866138|NCT03047551|617523499|FG000|Overall Study|Probe malfunction|0|||
170866139|NCT03047551|617523500|FG001|Overall Study|Probe malfunction|1|||
170866140|NCT03047551|617523499|FG000|Overall Study|Ineligible|0|||
170866141|NCT03047551|617523500|FG001|Overall Study|Ineligible|1|||
170866142|NCT03808688|617523501|FG000|Overall Study|Adverse Event|13|||
170866143|NCT03808688|617523502|FG001|Overall Study|Adverse Event|17|||
170866144|NCT03808688|617523501|FG000|Overall Study|Lack of Efficacy|2|||
170866145|NCT03808688|617523502|FG001|Overall Study|Lack of Efficacy|0|||
170866146|NCT03808688|617523501|FG000|Overall Study|Lost to Follow-up|0|||
170866147|NCT03808688|617523502|FG001|Overall Study|Lost to Follow-up|2|||
170866148|NCT03808688|617523501|FG000|Overall Study|Withdrawal by Subject|1|||
170866149|NCT03808688|617523502|FG001|Overall Study|Withdrawal by Subject|0|||
170866150|NCT03808688|617523501|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
170866151|NCT03808688|617523502|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
170866152|NCT03808688|617523501|FG000|Overall Study|IOP Too High|1|||
170866153|NCT03808688|617523502|FG001|Overall Study|IOP Too High|1|||
170866154|NCT03808688|617523501|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
170866155|NCT03808688|617523502|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
170866156|NCT03808688|617523501|FG000|Overall Study|Visit Out of Window|0|||
170866157|NCT03808688|617523502|FG001|Overall Study|Visit Out of Window|1|||
170866158|NCT03808688|617523501|FG000|Overall Study|Medication Non-Compliance|0|||
170866159|NCT03808688|617523502|FG001|Overall Study|Medication Non-Compliance|1|||
170866160|NCT03872453|617523507|FG000|Overall Study|Adverse Event|1|||
170866161|NCT03872453|617523508|FG001|Overall Study|Adverse Event|1|||
170866162|NCT03872453|617523509|FG002|Overall Study|Adverse Event|0|||
170866163|NCT03872453|617523510|FG003|Overall Study|Adverse Event|0|||
170866164|NCT03872453|617523507|FG000|Overall Study|Lost to Follow-up|8|||
170866165|NCT03872453|617523508|FG001|Overall Study|Lost to Follow-up|7|||
170866166|NCT03872453|617523509|FG002|Overall Study|Lost to Follow-up|4|||
170866167|NCT03872453|617523510|FG003|Overall Study|Lost to Follow-up|4|||
170866168|NCT03872453|617523507|FG000|Overall Study|Never Treated Migraine|19|||
170866169|NCT03872453|617523508|FG001|Overall Study|Never Treated Migraine|17|||
170866170|NCT03872453|617523509|FG002|Overall Study|Never Treated Migraine|13|||
170866171|NCT03872453|617523510|FG003|Overall Study|Never Treated Migraine|12|||
170866172|NCT03872453|617523507|FG000|Overall Study|Pregnancy|1|||
170866173|NCT03872453|617523508|FG001|Overall Study|Pregnancy|0|||
170866174|NCT03872453|617523509|FG002|Overall Study|Pregnancy|0|||
170866175|NCT03872453|617523510|FG003|Overall Study|Pregnancy|0|||
170866176|NCT03872453|617523507|FG000|Overall Study|Protocol Deviation|2|||
170866177|NCT03872453|617523508|FG001|Overall Study|Protocol Deviation|0|||
170866178|NCT03872453|617523509|FG002|Overall Study|Protocol Deviation|0|||
170866179|NCT03872453|617523510|FG003|Overall Study|Protocol Deviation|2|||
170866180|NCT03872453|617523507|FG000|Overall Study|Withdrawal by Subject|0|||
170866181|NCT03872453|617523508|FG001|Overall Study|Withdrawal by Subject|1|||
170866182|NCT03872453|617523509|FG002|Overall Study|Withdrawal by Subject|2|||
170866183|NCT03872453|617523510|FG003|Overall Study|Withdrawal by Subject|0|||
170866184|NCT03872453|617523507|FG000|Overall Study|Other Than Specified|1|||
170866185|NCT03872453|617523508|FG001|Overall Study|Other Than Specified|0|||
170866186|NCT03872453|617523509|FG002|Overall Study|Other Than Specified|0|||
170866187|NCT03872453|617523510|FG003|Overall Study|Other Than Specified|0|||
170866188|NCT00928564|617523514|FG000|Overall Study|Lost to Follow-up|6|||
170866189|NCT00928564|617523515|FG001|Overall Study|Lost to Follow-up|0|||
170866190|NCT01096342|617523518|FG000|Overall Study|Protocol Violation|1|||
170866191|NCT01448213|617523519|FG000|Overall Study|Lost to Follow-up|12|||
170866192|NCT01448213|617523520|FG001|Overall Study|Lost to Follow-up|10|||
170866193|NCT01448213|617523519|FG000|Overall Study|Adverse Event|4|||
170866194|NCT01448213|617523520|FG001|Overall Study|Adverse Event|10|||
170866195|NCT01448213|617523519|FG000|Overall Study|Protocol Violation|1|||
170866196|NCT01448213|617523520|FG001|Overall Study|Protocol Violation|2|||
170866197|NCT03503513|617523525|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
170866198|NCT03503513|617523525|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
170866199|NCT03503513|617523525|FG000|Overall Study|Physician Decision|3|||
170866200|NCT03503513|617523525|FG000|Overall Study|Withdrawal by Subject|2|||
170866201|NCT03503513|617523525|FG000|Overall Study|Lost to Follow-up|1|||
170408151|NCT00449930|615834223|FG000|Overall Study|Physician Decision|1|||
170408152|NCT00449930|615834224|FG001|Overall Study|Physician Decision|2|||
170408153|NCT00449930|615834223|FG000|Overall Study|Protocol Violation|14|||
170408154|NCT00449930|615834224|FG001|Overall Study|Protocol Violation|15|||
170408155|NCT00449930|615834223|FG000|Overall Study|Withdrawal by Subject|16|||
170408156|NCT00449930|615834224|FG001|Overall Study|Withdrawal by Subject|23|||
170408157|NCT00449930|615834223|FG000|Overall Study|Glycemic discontinuation criteria|1|||
170408158|NCT00449930|615834224|FG001|Overall Study|Glycemic discontinuation criteria|1|||
170408159|NCT01208402|615834226|FG000|Overall Study|Withdrawal by Subject|1|||
170408160|NCT01208402|615834227|FG001|Overall Study|Withdrawal by Subject|0|||
170408161|NCT01571635|615834228|FG000|Overall Study|Adverse Event|3|||
170408162|NCT01571635|615834229|FG001|Overall Study|Adverse Event|0|||
170408163|NCT01571635|615834230|FG002|Overall Study|Adverse Event|2|||
170408164|NCT01571635|615834231|FG003|Overall Study|Adverse Event|3|||
170408165|NCT01571635|615834232|FG004|Overall Study|Adverse Event|5|||
170408166|NCT01571635|615834228|FG000|Overall Study|Other reasons|2|||
170408167|NCT01571635|615834229|FG001|Overall Study|Other reasons|1|||
170408168|NCT01571635|615834230|FG002|Overall Study|Other reasons|2|||
170408169|NCT01571635|615834231|FG003|Overall Study|Other reasons|2|||
170408170|NCT01571635|615834232|FG004|Overall Study|Other reasons|1|||
170408171|NCT01571635|615834228|FG000|Overall Study|Study terminated by sponsor|0|||
170408172|NCT01571635|615834229|FG001|Overall Study|Study terminated by sponsor|4|||
170408173|NCT01571635|615834230|FG002|Overall Study|Study terminated by sponsor|1|||
170408174|NCT01571635|615834231|FG003|Overall Study|Study terminated by sponsor|3|||
170408175|NCT01571635|615834232|FG004|Overall Study|Study terminated by sponsor|1|||
170408176|NCT01571635|615834228|FG000|Overall Study|Withdrew consent|1|||
170408177|NCT01571635|615834229|FG001|Overall Study|Withdrew consent|1|||
170408178|NCT01571635|615834230|FG002|Overall Study|Withdrew consent|2|||
170408179|NCT01571635|615834231|FG003|Overall Study|Withdrew consent|3|||
170408180|NCT01571635|615834232|FG004|Overall Study|Withdrew consent|0|||
170408181|NCT01571635|615834228|FG000|Overall Study|Lack of Efficacy|0|||
170408182|NCT01571635|615834229|FG001|Overall Study|Lack of Efficacy|2|||
170408183|NCT01571635|615834230|FG002|Overall Study|Lack of Efficacy|0|||
170408184|NCT01571635|615834231|FG003|Overall Study|Lack of Efficacy|1|||
170408185|NCT01571635|615834232|FG004|Overall Study|Lack of Efficacy|2|||
170408186|NCT02868281|615834233|FG000|Overall Study|Adverse Event|2|||
170408187|NCT02868281|615834234|FG001|Overall Study|Adverse Event|2|||
170408188|NCT02868281|615834233|FG000|Overall Study|Protocol Violation|13|||
170408189|NCT02868281|615834234|FG001|Overall Study|Protocol Violation|10|||
170408190|NCT02868281|615834233|FG000|Overall Study|Lost to Follow-up|3|||
170408191|NCT02868281|615834234|FG001|Overall Study|Lost to Follow-up|6|||
170408192|NCT02868281|615834233|FG000|Overall Study|Withdrawal by Subject|11|||
170408193|NCT02868281|615834234|FG001|Overall Study|Withdrawal by Subject|15|||
170408194|NCT02868281|615834233|FG000|Overall Study|Physician Decision|2|||
170408195|NCT02868281|615834234|FG001|Overall Study|Physician Decision|0|||
170408196|NCT02868281|615834233|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
170408197|NCT02868281|615834234|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
170408198|NCT02868281|615834233|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
170408199|NCT02868281|615834234|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
170408200|NCT02868281|615834233|FG000|Overall Study|Long journey/moving away|1|||
170408201|NCT02868281|615834234|FG001|Overall Study|Long journey/moving away|1|||
170408202|NCT03124381|615834237|FG000|Overall Study|Lost to Follow-up|1|||
170408203|NCT03124381|615834238|FG001|Overall Study|Lost to Follow-up|1|||
170408204|NCT03124381|615834237|FG000|Overall Study|Withdrawal by Subject|6|||
170408205|NCT03124381|615834238|FG001|Overall Study|Withdrawal by Subject|3|||
170408206|NCT03124381|615834237|FG000|Overall Study|Protocol Violation|0|||
170408207|NCT03124381|615834238|FG001|Overall Study|Protocol Violation|1|||
170408208|NCT03124381|615834237|FG000|Overall Study|Adverse Event|1|||
170408209|NCT03124381|615834238|FG001|Overall Study|Adverse Event|1|||
170408210|NCT03124381|615834237|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
170408211|NCT03124381|615834238|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
170408212|NCT00003102|615834240|FG000|Overall Study|Physician Decision|1|||
170408213|NCT00003102|615834241|FG001|Overall Study|Physician Decision|1|||
170408214|NCT00003102|615834242|FG002|Overall Study|Physician Decision|0|||
170408215|NCT00003102|615834240|FG000|Overall Study|Progressive Disease|0|||
170408216|NCT00003102|615834241|FG001|Overall Study|Progressive Disease|1|||
170408217|NCT00003102|615834242|FG002|Overall Study|Progressive Disease|0|||
170408218|NCT00003102|615834240|FG000|Overall Study|Adverse Event|0|||
170408219|NCT00003102|615834241|FG001|Overall Study|Adverse Event|1|||
170408220|NCT00003102|615834242|FG002|Overall Study|Adverse Event|1|||
170408221|NCT00003102|615834240|FG000|Overall Study|Death|0|||
170408222|NCT00003102|615834241|FG001|Overall Study|Death|0|||
170408223|NCT00003102|615834242|FG002|Overall Study|Death|1|||
170866202|NCT01990534|617523526|FG000|Overall Study|Death|22|||
170408224|NCT00990093|615834244|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
170408225|NCT00990093|615834245|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
170408226|NCT00990093|615834244|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
170408227|NCT00990093|615834245|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
170408228|NCT00990093|615834244|FG000|Test Period 1 (1-14 Days)|Other|1|||
170408229|NCT00990093|615834245|FG001|Test Period 1 (1-14 Days)|Other|0|||
170408230|NCT00990093|615834244|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
170866203|NCT01990534|617523526|FG000|Overall Study|Progressive disease|3|||
170866204|NCT01990534|617523526|FG000|Overall Study|Protocol Violation|1|||
170866205|NCT01990534|617523526|FG000|Overall Study|Withdrawal of Informed Consent|2|||
170866206|NCT01990534|617523526|FG000|Overall Study|Symptomatic Deterioration|1|||
170866207|NCT01990534|617523526|FG000|Overall Study|Withdrawal by Subject|3|||
170866208|NCT01990534|617523526|FG000|Overall Study|Reason not Specified|2|||
170866209|NCT01990534|617523526|FG000|Overall Study|Lost to Follow-up|1|||
170866210|NCT01205438|617523527|FG000|Overall Study|Adverse Event|19|||
170866211|NCT01205438|617523528|FG001|Overall Study|Adverse Event|17|||
170866212|NCT01205438|617523529|FG002|Overall Study|Adverse Event|24|||
170866213|NCT01205438|617523527|FG000|Overall Study|Death|1|||
170866214|NCT01205438|617523528|FG001|Overall Study|Death|1|||
170866215|NCT01205438|617523529|FG002|Overall Study|Death|3|||
170866216|NCT01205438|617523527|FG000|Overall Study|Entry Criteria Not Met|16|||
170866217|NCT01205438|617523528|FG001|Overall Study|Entry Criteria Not Met|15|||
170866218|NCT01205438|617523529|FG002|Overall Study|Entry Criteria Not Met|13|||
170866219|NCT01205438|617523527|FG000|Overall Study|Lack of Efficacy|14|||
170866220|NCT01205438|617523528|FG001|Overall Study|Lack of Efficacy|11|||
170866221|NCT01205438|617523529|FG002|Overall Study|Lack of Efficacy|14|||
170866222|NCT01205438|617523527|FG000|Overall Study|Lost to Follow-up|6|||
170866223|NCT01205438|617523528|FG001|Overall Study|Lost to Follow-up|7|||
170866224|NCT01205438|617523529|FG002|Overall Study|Lost to Follow-up|8|||
170866225|NCT01205438|617523527|FG000|Overall Study|Withdrawal by Subject|19|||
170866226|NCT01205438|617523528|FG001|Overall Study|Withdrawal by Subject|25|||
170866227|NCT01205438|617523529|FG002|Overall Study|Withdrawal by Subject|19|||
170866228|NCT01205438|617523527|FG000|Overall Study|Physician Decision|0|||
170866229|NCT01205438|617523528|FG001|Overall Study|Physician Decision|3|||
170866230|NCT01205438|617523529|FG002|Overall Study|Physician Decision|2|||
170866231|NCT01205438|617523527|FG000|Overall Study|Protocol Violation|2|||
170866232|NCT01205438|617523528|FG001|Overall Study|Protocol Violation|7|||
170866233|NCT01205438|617523529|FG002|Overall Study|Protocol Violation|4|||
170866234|NCT01205438|617523527|FG000|Overall Study|Sponsor Decision|0|||
170866235|NCT01205438|617523528|FG001|Overall Study|Sponsor Decision|1|||
170866236|NCT01205438|617523529|FG002|Overall Study|Sponsor Decision|1|||
170866237|NCT04147234|617523530|FG000|Overall Study|Clinical deterioration|0|||
170866238|NCT04147234|617523531|FG001|Overall Study|Clinical deterioration|0|||
170866239|NCT04147234|617523532|FG002|Overall Study|Clinical deterioration|1|||
170866240|NCT04147234|617523533|FG003|Overall Study|Clinical deterioration|0|||
170866241|NCT04147234|617523534|FG004|Overall Study|Clinical deterioration|0|||
170866242|NCT04147234|617523535|FG005|Overall Study|Clinical deterioration|0|||
170866243|NCT04147234|617523536|FG006|Overall Study|Clinical deterioration|0|||
170866244|NCT04147234|617523530|FG000|Overall Study|Withdrawal by Subject|0|||
170866245|NCT04147234|617523531|FG001|Overall Study|Withdrawal by Subject|1|||
170866246|NCT04147234|617523532|FG002|Overall Study|Withdrawal by Subject|1|||
170866247|NCT04147234|617523533|FG003|Overall Study|Withdrawal by Subject|0|||
170866248|NCT04147234|617523534|FG004|Overall Study|Withdrawal by Subject|0|||
170866249|NCT04147234|617523535|FG005|Overall Study|Withdrawal by Subject|0|||
170866250|NCT04147234|617523536|FG006|Overall Study|Withdrawal by Subject|0|||
170866251|NCT04147234|617523530|FG000|Overall Study|Clinical disease progression|1|||
170866252|NCT04147234|617523531|FG001|Overall Study|Clinical disease progression|3|||
170866253|NCT04147234|617523532|FG002|Overall Study|Clinical disease progression|1|||
170866254|NCT04147234|617523533|FG003|Overall Study|Clinical disease progression|1|||
170866255|NCT04147234|617523534|FG004|Overall Study|Clinical disease progression|0|||
170866256|NCT04147234|617523535|FG005|Overall Study|Clinical disease progression|1|||
170866257|NCT04147234|617523536|FG006|Overall Study|Clinical disease progression|0|||
170866258|NCT04147234|617523530|FG000|Overall Study|Objective disease progression|6|||
170866259|NCT04147234|617523531|FG001|Overall Study|Objective disease progression|4|||
170866260|NCT04147234|617523532|FG002|Overall Study|Objective disease progression|3|||
170866261|NCT04147234|617523533|FG003|Overall Study|Objective disease progression|3|||
170866262|NCT04147234|617523534|FG004|Overall Study|Objective disease progression|5|||
170866263|NCT04147234|617523535|FG005|Overall Study|Objective disease progression|2|||
170866264|NCT04147234|617523536|FG006|Overall Study|Objective disease progression|3|||
170866265|NCT04147234|617523530|FG000|Overall Study|Adverse Event|0|||
170866266|NCT04147234|617523531|FG001|Overall Study|Adverse Event|0|||
170866267|NCT04147234|617523532|FG002|Overall Study|Adverse Event|0|||
170866268|NCT04147234|617523533|FG003|Overall Study|Adverse Event|0|||
170866269|NCT04147234|617523534|FG004|Overall Study|Adverse Event|1|||
170866270|NCT04147234|617523535|FG005|Overall Study|Adverse Event|0|||
170866271|NCT04147234|617523536|FG006|Overall Study|Adverse Event|0|||
170866272|NCT01207596|617523537|FG000|Overall Study|Physician Decision|4|||
170866273|NCT01207596|617523537|FG000|Overall Study|Lack of Efficacy|1|||
170866274|NCT01207596|617523537|FG000|Overall Study|Adverse Event|3|||
170866275|NCT01207596|617523537|FG000|Overall Study|Withdrawal by Subject|1|||
170866276|NCT03083847|617523538|FG000|Main|Physician Decision|0|||
170866277|NCT03083847|617523539|FG001|Main|Physician Decision|0|||
170866278|NCT03083847|617523540|FG002|Main|Physician Decision|0|||
170866279|NCT03083847|617523541|FG003|Main|Physician Decision|0|||
170866280|NCT03083847|617523542|FG004|Main|Physician Decision|0|||
170408231|NCT00990093|615834245|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
170866281|NCT03083847|617523543|FG005|Main|Physician Decision|1|||
170866282|NCT03083847|617523544|FG006|Main|Physician Decision|0|||
170866283|NCT03083847|617523545|FG007|Main|Physician Decision|0|||
170866284|NCT03083847|617523546|FG008|Main|Physician Decision|0|||
170866285|NCT03083847|617523547|FG009|Main|Physician Decision|0|||
170866286|NCT03083847|617523538|FG000|Main|Pregnancy|0|||
170866287|NCT03083847|617523539|FG001|Main|Pregnancy|0|||
170866288|NCT03083847|617523540|FG002|Main|Pregnancy|0|||
170866289|NCT03083847|617523541|FG003|Main|Pregnancy|0|||
170866290|NCT03083847|617523542|FG004|Main|Pregnancy|0|||
170866291|NCT03083847|617523543|FG005|Main|Pregnancy|0|||
170866292|NCT03083847|617523544|FG006|Main|Pregnancy|0|||
170866293|NCT03083847|617523545|FG007|Main|Pregnancy|1|||
170866294|NCT03083847|617523546|FG008|Main|Pregnancy|0|||
170866295|NCT03083847|617523547|FG009|Main|Pregnancy|0|||
170866296|NCT03083847|617523538|FG000|Main|Adverse Event|0|||
170866297|NCT03083847|617523539|FG001|Main|Adverse Event|0|||
170866298|NCT03083847|617523540|FG002|Main|Adverse Event|0|||
170866299|NCT03083847|617523541|FG003|Main|Adverse Event|0|||
170866300|NCT03083847|617523542|FG004|Main|Adverse Event|0|||
170866301|NCT03083847|617523543|FG005|Main|Adverse Event|0|||
170866302|NCT03083847|617523544|FG006|Main|Adverse Event|0|||
170866303|NCT03083847|617523545|FG007|Main|Adverse Event|2|||
170866304|NCT03083847|617523546|FG008|Main|Adverse Event|0|||
170866305|NCT03083847|617523547|FG009|Main|Adverse Event|0|||
170866306|NCT03083847|617523538|FG000|Main|Withdrawal by Subject|0|||
170866307|NCT03083847|617523539|FG001|Main|Withdrawal by Subject|0|||
170866308|NCT03083847|617523540|FG002|Main|Withdrawal by Subject|0|||
170866309|NCT03083847|617523541|FG003|Main|Withdrawal by Subject|0|||
170866310|NCT03083847|617523542|FG004|Main|Withdrawal by Subject|0|||
170866311|NCT03083847|617523543|FG005|Main|Withdrawal by Subject|0|||
170866312|NCT03083847|617523544|FG006|Main|Withdrawal by Subject|1|||
170866313|NCT03083847|617523545|FG007|Main|Withdrawal by Subject|1|||
170866314|NCT03083847|617523546|FG008|Main|Withdrawal by Subject|0|||
170866315|NCT03083847|617523547|FG009|Main|Withdrawal by Subject|0|||
170866316|NCT00216203|617523548|FG000|Overall Study|Withdrawal by Subject|2|||
170866317|NCT00733304|617523551|FG000|Overall Study|Adverse Event|3|||
170866318|NCT00733304|617523552|FG001|Overall Study|Adverse Event|0|||
170866319|NCT00733304|617523553|FG002|Overall Study|Adverse Event|0|||
170866320|NCT00733304|617523551|FG000|Overall Study|Lack of Efficacy|0|||
170866321|NCT00733304|617523552|FG001|Overall Study|Lack of Efficacy|0|||
170866322|NCT00733304|617523553|FG002|Overall Study|Lack of Efficacy|2|||
170866323|NCT00733304|617523551|FG000|Overall Study|Lost to Follow-up|0|||
170866324|NCT00733304|617523552|FG001|Overall Study|Lost to Follow-up|1|||
170866325|NCT00733304|617523553|FG002|Overall Study|Lost to Follow-up|0|||
170866326|NCT00733304|617523551|FG000|Overall Study|Physician Decision|3|||
170866327|NCT00733304|617523552|FG001|Overall Study|Physician Decision|1|||
170866328|NCT00733304|617523553|FG002|Overall Study|Physician Decision|3|||
170866329|NCT00733304|617523551|FG000|Overall Study|Withdrawal by Subject|1|||
170866330|NCT00733304|617523552|FG001|Overall Study|Withdrawal by Subject|1|||
170866331|NCT00733304|617523553|FG002|Overall Study|Withdrawal by Subject|0|||
170866332|NCT02310672|617523554|FG000|Overall Study|Death|1|||
170408232|NCT00990093|615834244|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
170408233|NCT00990093|615834245|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
170408234|NCT00990093|615834244|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
170408235|NCT00990093|615834245|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
170408236|NCT00990093|615834244|FG000|Test Period 2 (15-28 Days)|Other|0|||
170408237|NCT00990093|615834245|FG001|Test Period 2 (15-28 Days)|Other|1|||
170408238|NCT02173301|615834246|FG000|Overall Study|Adverse Event|7|||
170408239|NCT02173301|615834247|FG001|Overall Study|Adverse Event|8|||
170408240|NCT02173301|615834248|FG002|Overall Study|Adverse Event|13|||
170866333|NCT02310672|617523554|FG000|Overall Study|Lost to Follow-up|1|||
170866334|NCT02310672|617523554|FG000|Overall Study|Withdrawal by Subject|1|||
170866335|NCT02310672|617523554|FG000|Overall Study|Sponsor's decision|12|||
170519723|NCT02326272|616247589|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170519724|NCT02326272|616247590|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170519725|NCT02326272|616247591|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170866336|NCT04704336|617523555|FG000|Overall Study|Death|2|||
170866337|NCT04704336|617523556|FG001|Overall Study|Death|2|||
170866338|NCT04704336|617523555|FG000|Overall Study|Lost to Follow-up|33|||
170866339|NCT04704336|617523556|FG001|Overall Study|Lost to Follow-up|40|||
170866340|NCT00537485|617523557|FG000|Overall Study|Adverse Event|10|||
170866341|NCT00537485|617523558|FG001|Overall Study|Adverse Event|5|||
170866342|NCT00537485|617523557|FG000|Overall Study|Withdrawal by Subject|3|||
170866343|NCT00537485|617523558|FG001|Overall Study|Withdrawal by Subject|2|||
170866344|NCT00537485|617523557|FG000|Overall Study|Withdrawal by Subject|1|||
170866345|NCT00537485|617523558|FG001|Overall Study|Withdrawal by Subject|3|||
170408241|NCT02173301|615834249|FG003|Overall Study|Adverse Event|5|||
170866346|NCT00537485|617523557|FG000|Overall Study|Physician Decision|1|||
170866347|NCT00537485|617523558|FG001|Overall Study|Physician Decision|0|||
170866348|NCT01601847|617523559|FG000|Overall Study|Death|1|||
170866349|NCT01601847|617523560|FG001|Overall Study|Death|0|||
170866350|NCT01601847|617523559|FG000|Overall Study|Withdrawal by Subject|11|||
170866351|NCT01601847|617523560|FG001|Overall Study|Withdrawal by Subject|7|||
170866352|NCT01601847|617523559|FG000|Overall Study|Lost to Follow-up|1|||
170866353|NCT01601847|617523560|FG001|Overall Study|Lost to Follow-up|3|||
170866354|NCT00631189|617523561|FG000|Initial Phase|Protocol Violation|347|||
170866355|NCT00631189|617523562|FG001|Initial Phase|Protocol Violation|0|||
170866356|NCT00631189|617523563|FG002|Initial Phase|Protocol Violation|0|||
170866357|NCT00631189|617523564|FG003|Initial Phase|Protocol Violation|0|||
170866358|NCT00631189|617523561|FG000|Initial Phase|Withdrawal by Subject|4|||
170866359|NCT00631189|617523562|FG001|Initial Phase|Withdrawal by Subject|0|||
170866360|NCT00631189|617523563|FG002|Initial Phase|Withdrawal by Subject|0|||
170866361|NCT00631189|617523564|FG003|Initial Phase|Withdrawal by Subject|0|||
170866362|NCT00631189|617523561|FG000|Treatment Phase|Withdrawal by Subject|0|||
170866363|NCT00631189|617523562|FG001|Treatment Phase|Withdrawal by Subject|2|||
170866364|NCT00631189|617523563|FG002|Treatment Phase|Withdrawal by Subject|1|||
170866365|NCT00631189|617523564|FG003|Treatment Phase|Withdrawal by Subject|1|||
170866366|NCT00631189|617523561|FG000|Treatment Phase|Protocol Violation|0|||
170866367|NCT00631189|617523562|FG001|Treatment Phase|Protocol Violation|1|||
170866368|NCT00631189|617523563|FG002|Treatment Phase|Protocol Violation|6|||
170866369|NCT00631189|617523564|FG003|Treatment Phase|Protocol Violation|2|||
170866370|NCT00631189|617523561|FG000|Treatment Phase|Adverse Event|0|||
170866371|NCT00631189|617523562|FG001|Treatment Phase|Adverse Event|3|||
170866372|NCT00631189|617523563|FG002|Treatment Phase|Adverse Event|2|||
170866373|NCT00631189|617523564|FG003|Treatment Phase|Adverse Event|4|||
170866374|NCT00631189|617523561|FG000|Treatment Phase|Lost to Follow-up|0|||
170866375|NCT00631189|617523562|FG001|Treatment Phase|Lost to Follow-up|1|||
170866376|NCT00631189|617523563|FG002|Treatment Phase|Lost to Follow-up|0|||
170866377|NCT00631189|617523564|FG003|Treatment Phase|Lost to Follow-up|0|||
170866378|NCT00631189|617523561|FG000|Treatment Phase|Pregnancy|0|||
170866379|NCT00631189|617523562|FG001|Treatment Phase|Pregnancy|0|||
170866380|NCT00631189|617523563|FG002|Treatment Phase|Pregnancy|1|||
170866381|NCT00631189|617523564|FG003|Treatment Phase|Pregnancy|0|||
170866382|NCT00631189|617523561|FG000|Treatment Phase|patient did not take pravastatin|0|||
170866383|NCT00631189|617523562|FG001|Treatment Phase|patient did not take pravastatin|0|||
170866384|NCT00631189|617523563|FG002|Treatment Phase|patient did not take pravastatin|1|||
170866385|NCT00631189|617523564|FG003|Treatment Phase|patient did not take pravastatin|0|||
170866386|NCT04464265|617523565|FG000|Overall Study|Physician Decision|2|||
170866387|NCT01284062|617523570|FG000|Overall Study|Adverse Event|4|||
170866388|NCT01284062|617523571|FG001|Overall Study|Adverse Event|5|||
170866389|NCT01284062|617523572|FG002|Overall Study|Adverse Event|0|||
170866390|NCT01284062|617523573|FG003|Overall Study|Adverse Event|5|||
170866391|NCT01284062|617523570|FG000|Overall Study|Lack of Efficacy|3|||
170866392|NCT01284062|617523571|FG001|Overall Study|Lack of Efficacy|2|||
170519726|NCT02326272|616247592|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
170519727|NCT02326272|616247593|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170866393|NCT01284062|617523572|FG002|Overall Study|Lack of Efficacy|2|||
170866394|NCT01284062|617523573|FG003|Overall Study|Lack of Efficacy|1|||
170866395|NCT01284062|617523570|FG000|Overall Study|Medication error without adverse event|0|||
170866396|NCT01284062|617523571|FG001|Overall Study|Medication error without adverse event|0|||
170866397|NCT01284062|617523572|FG002|Overall Study|Medication error without adverse event|1|||
170866398|NCT01284062|617523573|FG003|Overall Study|Medication error without adverse event|0|||
170866399|NCT01284062|617523570|FG000|Overall Study|Protocol Violation|1|||
170866400|NCT01284062|617523571|FG001|Overall Study|Protocol Violation|0|||
170866401|NCT01284062|617523572|FG002|Overall Study|Protocol Violation|0|||
170866402|NCT01284062|617523573|FG003|Overall Study|Protocol Violation|2|||
170866403|NCT01284062|617523570|FG000|Overall Study|Withdrawal by Subject|3|||
170866404|NCT01284062|617523571|FG001|Overall Study|Withdrawal by Subject|1|||
170866405|NCT01284062|617523572|FG002|Overall Study|Withdrawal by Subject|2|||
170866406|NCT01284062|617523573|FG003|Overall Study|Withdrawal by Subject|5|||
170866407|NCT01284062|617523570|FG000|Overall Study|Other|0|||
170866408|NCT01284062|617523571|FG001|Overall Study|Other|0|||
170866409|NCT01284062|617523572|FG002|Overall Study|Other|0|||
170866410|NCT01284062|617523573|FG003|Overall Study|Other|1|||
170866411|NCT01284062|617523570|FG000|Overall Study|Site Closed|0|||
170866412|NCT01284062|617523571|FG001|Overall Study|Site Closed|0|||
170866413|NCT01284062|617523572|FG002|Overall Study|Site Closed|1|||
170866414|NCT01284062|617523573|FG003|Overall Study|Site Closed|0|||
170866415|NCT00954174|617523574|FG000|Overall Study|Adverse Event|28|||
170866416|NCT00954174|617523575|FG001|Overall Study|Adverse Event|23|||
170866417|NCT00954174|617523576|FG002|Overall Study|Adverse Event|4|||
170866418|NCT00954174|617523577|FG003|Overall Study|Adverse Event|9|||
170866419|NCT00954174|617523574|FG000|Overall Study|Death|4|||
170866420|NCT00954174|617523575|FG001|Overall Study|Death|2|||
170866421|NCT00954174|617523576|FG002|Overall Study|Death|0|||
170866422|NCT00954174|617523577|FG003|Overall Study|Death|0|||
170866423|NCT00954174|617523574|FG000|Overall Study|Lack of Efficacy|32|||
170866424|NCT00954174|617523575|FG001|Overall Study|Lack of Efficacy|22|||
170866425|NCT00954174|617523576|FG002|Overall Study|Lack of Efficacy|8|||
170866426|NCT00954174|617523577|FG003|Overall Study|Lack of Efficacy|6|||
170866427|NCT00954174|617523574|FG000|Overall Study|Withdrawal by Subject|14|||
170866428|NCT00954174|617523575|FG001|Overall Study|Withdrawal by Subject|10|||
170866429|NCT00954174|617523576|FG002|Overall Study|Withdrawal by Subject|4|||
170866430|NCT00954174|617523577|FG003|Overall Study|Withdrawal by Subject|3|||
170866431|NCT00954174|617523574|FG000|Overall Study|Medical Reason|4|||
170866432|NCT00954174|617523575|FG001|Overall Study|Medical Reason|2|||
170866433|NCT00954174|617523576|FG002|Overall Study|Medical Reason|1|||
170866434|NCT00954174|617523577|FG003|Overall Study|Medical Reason|0|||
170866435|NCT00954174|617523574|FG000|Overall Study|Ineligible|40|||
170866436|NCT00954174|617523575|FG001|Overall Study|Ineligible|47|||
170866437|NCT00954174|617523576|FG002|Overall Study|Ineligible|7|||
170866438|NCT00954174|617523577|FG003|Overall Study|Ineligible|4|||
170866439|NCT00954174|617523574|FG000|Overall Study|Never Treated|4|||
170866440|NCT00954174|617523575|FG001|Overall Study|Never Treated|17|||
170866441|NCT00954174|617523576|FG002|Overall Study|Never Treated|0|||
170866442|NCT00954174|617523577|FG003|Overall Study|Never Treated|3|||
170866443|NCT01122576|617523578|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
170866444|NCT01122576|617523579|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
170866445|NCT01122576|617523580|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
170408242|NCT02173301|615834246|FG000|Overall Study|Withdrawal by Subject|8|||
170408243|NCT02173301|615834247|FG001|Overall Study|Withdrawal by Subject|10|||
170408244|NCT02173301|615834248|FG002|Overall Study|Withdrawal by Subject|4|||
170408245|NCT02173301|615834249|FG003|Overall Study|Withdrawal by Subject|8|||
170408246|NCT02173301|615834246|FG000|Overall Study|Lost to Follow-up|4|||
170408247|NCT02173301|615834247|FG001|Overall Study|Lost to Follow-up|4|||
170408248|NCT02173301|615834248|FG002|Overall Study|Lost to Follow-up|2|||
170408249|NCT02173301|615834249|FG003|Overall Study|Lost to Follow-up|2|||
170408250|NCT02173301|615834246|FG000|Overall Study|Protocol Violation|0|||
170408251|NCT02173301|615834247|FG001|Overall Study|Protocol Violation|1|||
170408252|NCT02173301|615834248|FG002|Overall Study|Protocol Violation|0|||
170408253|NCT02173301|615834249|FG003|Overall Study|Protocol Violation|0|||
170408254|NCT02173301|615834246|FG000|Overall Study|Physician Decision|0|||
170408255|NCT02173301|615834247|FG001|Overall Study|Physician Decision|0|||
170408256|NCT02173301|615834248|FG002|Overall Study|Physician Decision|1|||
170408257|NCT02173301|615834249|FG003|Overall Study|Physician Decision|0|||
170408258|NCT02173301|615834246|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
170408259|NCT02173301|615834247|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
170408260|NCT02173301|615834248|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
170408261|NCT02173301|615834249|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
170408262|NCT04444752|615834250|FG000|Overall Study|Adverse Event|1|||
170408263|NCT04444752|615834251|FG001|Overall Study|Adverse Event|0|||
170408264|NCT04444752|615834252|FG002|Overall Study|Adverse Event|0|||
170408265|NCT04444752|615834253|FG003|Overall Study|Adverse Event|2|||
170408266|NCT04444752|615834250|FG000|Overall Study|Lost to Follow-up|2|||
170408267|NCT04444752|615834251|FG001|Overall Study|Lost to Follow-up|6|||
170408268|NCT04444752|615834252|FG002|Overall Study|Lost to Follow-up|2|||
170408269|NCT04444752|615834253|FG003|Overall Study|Lost to Follow-up|5|||
170866446|NCT01122576|617523578|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
170866447|NCT01122576|617523579|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
170866448|NCT01122576|617523580|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
170866449|NCT01122576|617523578|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
170866450|NCT01122576|617523579|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
170866451|NCT01122576|617523580|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
170866452|NCT05696236|617523581|FG000|Overall Study|Lost to Follow-up|1|||
170408270|NCT04444752|615834250|FG000|Overall Study|Physician Decision|0|||
170866453|NCT05696236|617523582|FG001|Overall Study|Lost to Follow-up|0|||
170866454|NCT05696236|617523581|FG000|Overall Study|Later determined to not be eligible for participation|0|||
170866455|NCT05696236|617523582|FG001|Overall Study|Later determined to not be eligible for participation|1|||
170866456|NCT05696236|617523581|FG000|Overall Study|Withdrawal by Subject|2|||
170866457|NCT05696236|617523582|FG001|Overall Study|Withdrawal by Subject|2|||
170866458|NCT02234323|617523585|FG000|All Enrolled|Not Treated: Completed study in database|2|||
170866459|NCT02234323|617523585|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
170408271|NCT04444752|615834251|FG001|Overall Study|Physician Decision|0|||
170408272|NCT04444752|615834252|FG002|Overall Study|Physician Decision|0|||
170408273|NCT04444752|615834253|FG003|Overall Study|Physician Decision|2|||
170408274|NCT04444752|615834250|FG000|Overall Study|Pregnancy|0|||
170408275|NCT04444752|615834251|FG001|Overall Study|Pregnancy|0|||
170408276|NCT04444752|615834252|FG002|Overall Study|Pregnancy|0|||
170408277|NCT04444752|615834253|FG003|Overall Study|Pregnancy|1|||
170408278|NCT04444752|615834250|FG000|Overall Study|Withdrawal by Subject|6|||
170408279|NCT04444752|615834251|FG001|Overall Study|Withdrawal by Subject|5|||
170408280|NCT04444752|615834252|FG002|Overall Study|Withdrawal by Subject|3|||
170408281|NCT04444752|615834253|FG003|Overall Study|Withdrawal by Subject|4|||
170408282|NCT04444752|615834250|FG000|Overall Study|Protocol Violation|1|||
170760255|NCT00430677|617127837|FG002|Long-term Extension Period|Death|0|||
170760256|NCT00430677|617127835|FG000|Long-term Extension Period|Adverse Event|3|||
170760257|NCT00430677|617127836|FG001|Long-term Extension Period|Adverse Event|2|||
170760258|NCT00430677|617127837|FG002|Long-term Extension Period|Adverse Event|5|||
170760259|NCT00430677|617127835|FG000|Long-term Extension Period|Lack of Efficacy|5|||
170760260|NCT00430677|617127836|FG001|Long-term Extension Period|Lack of Efficacy|3|||
170760261|NCT00430677|617127837|FG002|Long-term Extension Period|Lack of Efficacy|8|||
170760262|NCT00430677|617127835|FG000|Long-term Extension Period|Lost to Follow-up|1|||
170760263|NCT00430677|617127836|FG001|Long-term Extension Period|Lost to Follow-up|1|||
170760264|NCT00430677|617127837|FG002|Long-term Extension Period|Lost to Follow-up|1|||
170760265|NCT00430677|617127835|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
170760266|NCT00430677|617127836|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
170760267|NCT00430677|617127837|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
170760268|NCT00430677|617127835|FG000|Long-term Extension Period|Pregnancy|1|||
170760269|NCT00430677|617127836|FG001|Long-term Extension Period|Pregnancy|1|||
170760270|NCT00430677|617127837|FG002|Long-term Extension Period|Pregnancy|0|||
170760271|NCT00430677|617127835|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
170760272|NCT00430677|617127836|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
170760273|NCT00430677|617127837|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
170760274|NCT00430677|617127835|FG000|Long-term Extension Period|Other|2|||
170760275|NCT00430677|617127836|FG001|Long-term Extension Period|Other|1|||
170760276|NCT00430677|617127837|FG002|Long-term Extension Period|Other|1|||
170760277|NCT00430677|617127835|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
170760278|NCT00430677|617127836|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
170760279|NCT00430677|617127837|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
170760280|NCT05570006|617129313|FG000|Overall Study|Lost to Follow-up|2|||
170760281|NCT05570006|617129313|FG000|Overall Study|Withdrawal by Subject|5|||
170760282|NCT05570006|617129313|FG000|Overall Study|Other than Specified|5|||
170760283|NCT05298111|617129314|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
170760284|NCT05298111|617129315|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
170760285|NCT01280591|617129324|FG000|Overall Study|Withdrawal by Subject|0|||
170760286|NCT01280591|617129325|FG001|Overall Study|Withdrawal by Subject|0|||
170760287|NCT01280591|617129326|FG002|Overall Study|Withdrawal by Subject|0|||
170760288|NCT01280591|617129327|FG003|Overall Study|Withdrawal by Subject|2|||
170760289|NCT01280591|617129324|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
170760290|NCT01280591|617129325|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
170760291|NCT01280591|617129326|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
170760292|NCT01280591|617129327|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
170760293|NCT02955069|617129328|FG000|Overall Study|Adverse Event|7|||
170760294|NCT02955069|617129329|FG001|Overall Study|Adverse Event|2|||
170760295|NCT02955069|617129328|FG000|Overall Study|Death|7|||
170760296|NCT02955069|617129329|FG001|Overall Study|Death|3|||
170760297|NCT02955069|617129328|FG000|Overall Study|Physician Decision|10|||
170760298|NCT02955069|617129329|FG001|Overall Study|Physician Decision|2|||
170760299|NCT02955069|617129328|FG000|Overall Study|Progressive disease|64|||
170760300|NCT02955069|617129329|FG001|Overall Study|Progressive disease|13|||
170760301|NCT02955069|617129328|FG000|Overall Study|Study terminated by sponsor|4|||
170760302|NCT02955069|617129329|FG001|Overall Study|Study terminated by sponsor|0|||
170760303|NCT02955069|617129328|FG000|Overall Study|Subject/Guardian decision|3|||
170760304|NCT02955069|617129329|FG001|Overall Study|Subject/Guardian decision|1|||
170760305|NCT04148937|617129330|FG000|Overall Study|Withdrawal by Subject|0|||
170760306|NCT04148937|617129331|FG001|Overall Study|Withdrawal by Subject|0|||
170760307|NCT04148937|617129332|FG002|Overall Study|Withdrawal by Subject|0|||
170760308|NCT04148937|617129333|FG003|Overall Study|Withdrawal by Subject|1|||
170760309|NCT04148937|617129334|FG004|Overall Study|Withdrawal by Subject|0|||
170760310|NCT04148937|617129335|FG005|Overall Study|Withdrawal by Subject|1|||
170760311|NCT04148937|617129336|FG006|Overall Study|Withdrawal by Subject|1|||
170760312|NCT04148937|617129337|FG007|Overall Study|Withdrawal by Subject|0|||
170760313|NCT04148937|617129330|FG000|Overall Study|Lost to Follow-up|0|||
170760314|NCT04148937|617129331|FG001|Overall Study|Lost to Follow-up|0|||
170760315|NCT04148937|617129332|FG002|Overall Study|Lost to Follow-up|1|||
170760316|NCT04148937|617129333|FG003|Overall Study|Lost to Follow-up|0|||
170760317|NCT04148937|617129334|FG004|Overall Study|Lost to Follow-up|0|||
170760318|NCT04148937|617129335|FG005|Overall Study|Lost to Follow-up|2|||
170760319|NCT04148937|617129336|FG006|Overall Study|Lost to Follow-up|0|||
170760320|NCT04148937|617129337|FG007|Overall Study|Lost to Follow-up|0|||
170760321|NCT01908634|617129338|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
170760322|NCT01908634|617129338|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
170760323|NCT01876511|617129339|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
170760324|NCT01876511|617129340|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
170760325|NCT01876511|617129341|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
170760326|NCT01876511|617129339|FG000|Overall Study|Death (unrelated)|3|||
170760327|NCT01876511|617129340|FG001|Overall Study|Death (unrelated)|0|||
170760328|NCT01876511|617129341|FG002|Overall Study|Death (unrelated)|2|||
170408283|NCT04444752|615834251|FG001|Overall Study|Protocol Violation|1|||
170408284|NCT04444752|615834252|FG002|Overall Study|Protocol Violation|0|||
170408285|NCT04444752|615834253|FG003|Overall Study|Protocol Violation|0|||
170408286|NCT04444752|615834250|FG000|Overall Study|Patient moving out of town|1|||
170866460|NCT02234323|617523585|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
170866461|NCT02234323|617523585|FG000|All Treated|Death|1|||
170866462|NCT02234323|617523585|FG000|All Treated|Physician Decision|5|||
170866463|NCT02234323|617523585|FG000|All Treated|Lack of Efficacy|3|||
170866464|NCT02234323|617523585|FG000|All Treated|Exceeded lab value limit|2|||
170866465|NCT02234323|617523585|FG000|All Treated|Other|7|||
170866466|NCT01372410|617523586|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
170866467|NCT01372410|617523587|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
170866468|NCT01372410|617523588|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
170866469|NCT01372410|617523589|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
170866470|NCT01372410|617523590|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
170866471|NCT01372410|617523591|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
170866472|NCT01372410|617523592|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
170866473|NCT01372410|617523593|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
170866474|NCT01372410|617523586|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
170866475|NCT01372410|617523587|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
170866476|NCT01372410|617523588|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
170866477|NCT01372410|617523589|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
170866478|NCT01372410|617523590|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
170866479|NCT01372410|617523591|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
170866480|NCT01372410|617523592|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
170866481|NCT01372410|617523593|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
170866482|NCT01372410|617523586|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170866483|NCT01372410|617523587|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170866484|NCT01372410|617523588|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170866485|NCT01372410|617523589|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170866486|NCT01372410|617523590|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
170866487|NCT01372410|617523591|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170866488|NCT01372410|617523592|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170866489|NCT01372410|617523593|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170866490|NCT01372410|617523586|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
170866491|NCT01372410|617523587|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
170866492|NCT01372410|617523588|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
170866493|NCT01372410|617523589|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
170866494|NCT01372410|617523590|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
170866495|NCT01372410|617523591|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
170866496|NCT01372410|617523592|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
170866497|NCT01372410|617523593|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
170866498|NCT01372410|617523586|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
170866499|NCT01372410|617523587|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
170866500|NCT01372410|617523588|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
170866501|NCT01372410|617523589|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
170866502|NCT01372410|617523590|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
170866503|NCT01372410|617523591|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
170866504|NCT01372410|617523592|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
170866505|NCT01372410|617523593|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
170866506|NCT01372410|617523586|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
170866507|NCT01372410|617523587|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
170866508|NCT01372410|617523588|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
170866509|NCT01372410|617523589|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
170866510|NCT01372410|617523590|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
170866511|NCT01372410|617523591|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
170866512|NCT01372410|617523592|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
170866513|NCT01372410|617523593|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
170866514|NCT01372410|617523586|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
170866515|NCT01372410|617523587|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
170866516|NCT01372410|617523588|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
170866517|NCT01372410|617523589|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
170866518|NCT01372410|617523590|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
170866519|NCT01372410|617523591|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
170866520|NCT01372410|617523592|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
170408287|NCT04444752|615834251|FG001|Overall Study|Patient moving out of town|0|||
170408288|NCT04444752|615834252|FG002|Overall Study|Patient moving out of town|0|||
170408289|NCT04444752|615834253|FG003|Overall Study|Patient moving out of town|1|||
170408290|NCT04444752|615834250|FG000|Overall Study|Lack of Efficacy|0|||
170408291|NCT04444752|615834251|FG001|Overall Study|Lack of Efficacy|0|||
170408292|NCT04444752|615834252|FG002|Overall Study|Lack of Efficacy|0|||
170408293|NCT04444752|615834253|FG003|Overall Study|Lack of Efficacy|1|||
170408294|NCT04444752|615834250|FG000|Overall Study|Death|0|||
170408295|NCT04444752|615834251|FG001|Overall Study|Death|0|||
170408296|NCT04444752|615834252|FG002|Overall Study|Death|1|||
170408297|NCT04444752|615834253|FG003|Overall Study|Death|0|||
170408298|NCT00579254|615834254|FG000|Overall Study|Lost to Follow-up|39|||
170408299|NCT00579254|615834254|FG000|Overall Study|Discontinued when study terminated|73|||
170408300|NCT02557672|615834255|FG000|Overall Study|Withdrawal by Subject|4|||
170408301|NCT02557672|615834256|FG001|Overall Study|Withdrawal by Subject|2|||
170408302|NCT03705169|615834257|FG000|Overall Study|Lost to Follow-up|0|||
170408303|NCT03705169|615834258|FG001|Overall Study|Lost to Follow-up|0|||
170408304|NCT03705169|615834259|FG002|Overall Study|Lost to Follow-up|0|||
170408305|NCT03705169|615834260|FG003|Overall Study|Lost to Follow-up|2|||
170408306|NCT03705169|615834261|FG004|Overall Study|Lost to Follow-up|0|||
170408307|NCT03705169|615834262|FG005|Overall Study|Lost to Follow-up|2|||
170408308|NCT03705169|615834263|FG006|Overall Study|Lost to Follow-up|1|||
170408309|NCT03705169|615834264|FG007|Overall Study|Lost to Follow-up|0|||
170408310|NCT03705169|615834265|FG008|Overall Study|Lost to Follow-up|0|||
170408311|NCT03705169|615834266|FG009|Overall Study|Lost to Follow-up|1|||
170408312|NCT03705169|615834257|FG000|Overall Study|Adverse Event|0|||
170408313|NCT03705169|615834258|FG001|Overall Study|Adverse Event|0|||
170408314|NCT03705169|615834259|FG002|Overall Study|Adverse Event|0|||
170408315|NCT03705169|615834260|FG003|Overall Study|Adverse Event|1|||
170408316|NCT03705169|615834261|FG004|Overall Study|Adverse Event|0|||
170408317|NCT03705169|615834262|FG005|Overall Study|Adverse Event|0|||
170408318|NCT03705169|615834263|FG006|Overall Study|Adverse Event|0|||
170408319|NCT03705169|615834264|FG007|Overall Study|Adverse Event|0|||
170408320|NCT03705169|615834265|FG008|Overall Study|Adverse Event|0|||
170408321|NCT03705169|615834266|FG009|Overall Study|Adverse Event|0|||
170408322|NCT03705169|615834257|FG000|Overall Study|Site Closure|0|||
170408323|NCT03705169|615834258|FG001|Overall Study|Site Closure|0|||
170408324|NCT03705169|615834259|FG002|Overall Study|Site Closure|0|||
170408325|NCT03705169|615834260|FG003|Overall Study|Site Closure|1|||
170408326|NCT03705169|615834261|FG004|Overall Study|Site Closure|0|||
170408327|NCT03705169|615834262|FG005|Overall Study|Site Closure|0|||
170408328|NCT03705169|615834263|FG006|Overall Study|Site Closure|0|||
170408329|NCT03705169|615834264|FG007|Overall Study|Site Closure|0|||
170408330|NCT03705169|615834265|FG008|Overall Study|Site Closure|0|||
170408331|NCT03705169|615834266|FG009|Overall Study|Site Closure|0|||
170408332|NCT03705169|615834257|FG000|Overall Study|Did not receive study treatment|0|||
170408333|NCT03705169|615834258|FG001|Overall Study|Did not receive study treatment|0|||
170408334|NCT03705169|615834259|FG002|Overall Study|Did not receive study treatment|0|||
170408335|NCT03705169|615834260|FG003|Overall Study|Did not receive study treatment|1|||
170408336|NCT03705169|615834261|FG004|Overall Study|Did not receive study treatment|0|||
170408337|NCT03705169|615834262|FG005|Overall Study|Did not receive study treatment|0|||
170408338|NCT03705169|615834263|FG006|Overall Study|Did not receive study treatment|0|||
170408339|NCT03705169|615834264|FG007|Overall Study|Did not receive study treatment|0|||
170408340|NCT03705169|615834265|FG008|Overall Study|Did not receive study treatment|0|||
170408341|NCT03705169|615834266|FG009|Overall Study|Did not receive study treatment|0|||
170408342|NCT03705169|615834257|FG000|Overall Study|Concerns about study visit compliance|0|||
170408343|NCT03705169|615834258|FG001|Overall Study|Concerns about study visit compliance|0|||
170408344|NCT03705169|615834259|FG002|Overall Study|Concerns about study visit compliance|0|||
170408345|NCT03705169|615834260|FG003|Overall Study|Concerns about study visit compliance|1|||
170408346|NCT03705169|615834261|FG004|Overall Study|Concerns about study visit compliance|0|||
170408347|NCT03705169|615834262|FG005|Overall Study|Concerns about study visit compliance|0|||
170408348|NCT03705169|615834263|FG006|Overall Study|Concerns about study visit compliance|0|||
170408349|NCT03705169|615834264|FG007|Overall Study|Concerns about study visit compliance|0|||
170408350|NCT03705169|615834265|FG008|Overall Study|Concerns about study visit compliance|0|||
170408351|NCT03705169|615834266|FG009|Overall Study|Concerns about study visit compliance|0|||
170408352|NCT03185949|615834267|FG000|ITT Analysis|Withdrawal by Subject|4|||
170408353|NCT03185949|615834268|FG001|ITT Analysis|Withdrawal by Subject|3|||
170408354|NCT03185949|615834267|FG000|PP Analysis|Protocol Violation|2|||
170408355|NCT03185949|615834268|FG001|PP Analysis|Protocol Violation|2|||
170408356|NCT03185949|615834267|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
170408357|NCT03185949|615834268|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
170408358|NCT02038634|615835547|FG000|Overall Study|Lost to Follow-up|0|||
170408359|NCT02038634|615835548|FG001|Overall Study|Lost to Follow-up|1|||
170408360|NCT00549198|615835549|FG000|Overall Study|Adverse Event|28|||
170408361|NCT00549198|615835550|FG001|Overall Study|Adverse Event|26|||
170408362|NCT00549198|615835549|FG000|Overall Study|Insufficient Viral Load Response|4|||
170408363|NCT00549198|615835550|FG001|Overall Study|Insufficient Viral Load Response|2|||
170408364|NCT00549198|615835549|FG000|Overall Study|Protocol-defined Virological Failure|7|||
170408365|NCT00549198|615835550|FG001|Overall Study|Protocol-defined Virological Failure|0|||
170408366|NCT00549198|615835549|FG000|Overall Study|Non-compliance|2|||
170866521|NCT01372410|617523593|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
170866522|NCT01372410|617523586|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
170866523|NCT01372410|617523587|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
170866524|NCT01372410|617523588|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
170866525|NCT01372410|617523589|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
170866526|NCT01372410|617523590|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
170866527|NCT01372410|617523591|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
170866528|NCT01372410|617523592|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
170866529|NCT01372410|617523593|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
170866530|NCT01372410|617523586|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
170866531|NCT01372410|617523587|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
170866532|NCT01372410|617523588|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
170866533|NCT01372410|617523589|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
170866534|NCT01372410|617523590|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
170866535|NCT01372410|617523591|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
170866536|NCT01372410|617523592|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
170866537|NCT01372410|617523593|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
170866538|NCT01372410|617523586|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
170866539|NCT01372410|617523587|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
170866540|NCT01372410|617523588|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
170866541|NCT01372410|617523589|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
170866542|NCT01372410|617523590|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
170866543|NCT01372410|617523591|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
170866544|NCT01372410|617523592|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
170866545|NCT01372410|617523593|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
170866546|NCT02644941|617523594|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
170866547|NCT02644941|617523595|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
170866548|NCT04585646|617523596|FG000|First Intervention|Physician Decision|1|||
170866549|NCT04585646|617523597|FG001|First Intervention|Physician Decision|0|||
170866550|NCT04585646|617523596|FG000|First Intervention|Lost to Follow-up|0|||
170866551|NCT04585646|617523597|FG001|First Intervention|Lost to Follow-up|3|||
170866552|NCT04585646|617523596|FG000|First Intervention|Withdrawal by Subject|0|||
170866553|NCT04585646|617523597|FG001|First Intervention|Withdrawal by Subject|1|||
170866554|NCT01145495|617523599|FG000|Overall Study|Adverse Event|6|||
170866555|NCT01145495|617523599|FG000|Overall Study|Withdrawal by Subject|6|||
170866556|NCT01145495|617523599|FG000|Overall Study|Disease progression after respone|2|||
170866557|NCT00931944|617523600|FG000|Overall Study|Adverse Event|4|||
170866558|NCT00931944|617523600|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
170866559|NCT00931944|617523600|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
170866560|NCT00931944|617523600|FG000|Overall Study|Death|28|||
170866561|NCT00931944|617523600|FG000|Overall Study|Other|2|||
170866562|NCT04614662|617523601|FG000|Overall Study|Withdrawal by Subject|0|||
170866563|NCT04614662|617523602|FG001|Overall Study|Withdrawal by Subject|1|||
170866564|NCT00634010|617523607|FG000|Overall Study|Adverse Event|2|||
170866565|NCT00634010|617523608|FG001|Overall Study|Adverse Event|5|||
170866566|NCT00634010|617523607|FG000|Overall Study|Withdrawal by Subject|5|||
170866567|NCT00634010|617523608|FG001|Overall Study|Withdrawal by Subject|6|||
170866568|NCT00634010|617523607|FG000|Overall Study|Physician Decision|1|||
170866569|NCT00634010|617523608|FG001|Overall Study|Physician Decision|1|||
170866570|NCT00634010|617523607|FG000|Overall Study|Disease Progression|1|||
170866571|NCT00634010|617523608|FG001|Overall Study|Disease Progression|1|||
170866572|NCT00634010|617523607|FG000|Overall Study|Non-Compliant|1|||
170866573|NCT00634010|617523608|FG001|Overall Study|Non-Compliant|1|||
170866574|NCT02178553|617523609|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
170866575|NCT02178553|617523610|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
170866576|NCT02178553|617523609|FG000|Overall Study|Physician Decision|0|||
170866577|NCT02178553|617523610|FG001|Overall Study|Physician Decision|4|||
170866578|NCT02178553|617523609|FG000|Overall Study|Technical problem with injection|1|||
170866579|NCT02178553|617523610|FG001|Overall Study|Technical problem with injection|3|||
170866580|NCT05085665|617523611|FG000|Overall Study|Physician Decision|2|||
170866581|NCT01641809|617523613|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
170866582|NCT01641809|617523614|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
170866583|NCT01641809|617523615|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
170866584|NCT01641809|617523616|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
170866585|NCT01641809|617523613|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
170866586|NCT01641809|617523614|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
170866587|NCT01641809|617523615|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
170866588|NCT01641809|617523616|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
170866589|NCT01641809|617523613|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
170519728|NCT02326272|616247594|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
170408367|NCT00549198|615835550|FG001|Overall Study|Non-compliance|4|||
170760329|NCT01876511|617129339|FG000|Overall Study|Drug-related Toxicity|5|||
170760330|NCT01876511|617129340|FG001|Overall Study|Drug-related Toxicity|1|||
170760331|NCT01876511|617129341|FG002|Overall Study|Drug-related Toxicity|6|||
170760332|NCT01876511|617129339|FG000|Overall Study|Patient Decision|3|||
170760333|NCT01876511|617129340|FG001|Overall Study|Patient Decision|0|||
170408368|NCT00549198|615835549|FG000|Overall Study|Lost to Follow-up|7|||
170408369|NCT00549198|615835550|FG001|Overall Study|Lost to Follow-up|8|||
170408370|NCT00549198|615835549|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
170408371|NCT00549198|615835550|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
170408372|NCT00549198|615835549|FG000|Overall Study|Protocol Violation|7|||
170408373|NCT00549198|615835550|FG001|Overall Study|Protocol Violation|2|||
170408374|NCT00549198|615835549|FG000|Overall Study|Investigator Decision|4|||
170408375|NCT00549198|615835550|FG001|Overall Study|Investigator Decision|3|||
170408376|NCT00549198|615835549|FG000|Overall Study|Withdrawal by Subject|7|||
170408377|NCT00549198|615835550|FG001|Overall Study|Withdrawal by Subject|7|||
170408378|NCT00549198|615835549|FG000|Overall Study|Disease Progression|1|||
170408379|NCT00549198|615835550|FG001|Overall Study|Disease Progression|0|||
170408380|NCT00549198|615835549|FG000|Overall Study|Participant Moved|2|||
170408381|NCT00549198|615835550|FG001|Overall Study|Participant Moved|0|||
170408382|NCT00549198|615835549|FG000|Overall Study|Participant not able to perform Week 96|1|||
170408383|NCT00549198|615835550|FG001|Overall Study|Participant not able to perform Week 96|0|||
170408384|NCT00549198|615835549|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
170408385|NCT00549198|615835550|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
170408386|NCT00549198|615835549|FG000|Overall Study|Prohibited Medication|1|||
170408387|NCT00549198|615835550|FG001|Overall Study|Prohibited Medication|2|||
170408388|NCT00549198|615835549|FG000|Overall Study|Participant planning pregnancy|1|||
170408389|NCT00549198|615835550|FG001|Overall Study|Participant planning pregnancy|0|||
170408390|NCT00549198|615835549|FG000|Overall Study|Participant overweight, no scan possible|1|||
170408391|NCT00549198|615835550|FG001|Overall Study|Participant overweight, no scan possible|0|||
170408392|NCT00549198|615835549|FG000|Overall Study|No scan facilities|0|||
170408393|NCT00549198|615835550|FG001|Overall Study|No scan facilities|2|||
170408394|NCT00549198|615835549|FG000|Overall Study|Pregnancy|0|||
170408395|NCT00549198|615835550|FG001|Overall Study|Pregnancy|3|||
170408396|NCT00549198|615835549|FG000|Overall Study|Not Exposed to Study Drug|3|||
170408397|NCT00549198|615835550|FG001|Overall Study|Not Exposed to Study Drug|4|||
170408398|NCT01764854|615835554|FG000|Overall Study|Adverse Event|0|||
170408399|NCT01764854|615835555|FG001|Overall Study|Adverse Event|0|||
170408400|NCT01764854|615835556|FG002|Overall Study|Adverse Event|2|||
170408401|NCT01764854|615835557|FG003|Overall Study|Adverse Event|0|||
170408402|NCT01764854|615835554|FG000|Overall Study|Withdrawal by Subject|0|||
170408403|NCT01764854|615835555|FG001|Overall Study|Withdrawal by Subject|0|||
170408404|NCT01764854|615835556|FG002|Overall Study|Withdrawal by Subject|1|||
170408405|NCT01764854|615835557|FG003|Overall Study|Withdrawal by Subject|0|||
170408406|NCT01764854|615835554|FG000|Overall Study|relocation|0|||
170408407|NCT01764854|615835555|FG001|Overall Study|relocation|0|||
170408408|NCT01764854|615835556|FG002|Overall Study|relocation|2|||
170408409|NCT01764854|615835557|FG003|Overall Study|relocation|0|||
170408410|NCT01764854|615835554|FG000|Overall Study|Protocol Violation|0|||
170408411|NCT01764854|615835555|FG001|Overall Study|Protocol Violation|0|||
170408412|NCT01764854|615835556|FG002|Overall Study|Protocol Violation|1|||
170408413|NCT01764854|615835557|FG003|Overall Study|Protocol Violation|2|||
170408414|NCT01003886|615835558|FG000|Overall Study|Lack of Efficacy|5|||
170408415|NCT01003886|615835558|FG000|Overall Study|Lost to Follow-up|169|||
170408416|NCT01003886|615835558|FG000|Overall Study|Withdrawal by Subject|39|||
170408417|NCT01003886|615835558|FG000|Overall Study|Other|14|||
170408418|NCT01003886|615835558|FG000|Overall Study|Adverse Event|3|||
170408419|NCT02322879|615835559|FG000|First Intervention|Physician Decision|1|||
170408420|NCT02322879|615835560|FG001|First Intervention|Physician Decision|0|||
170408421|NCT00673361|615835563|FG000|Overall Study|Screen Failure|2|||
170408422|NCT00752791|615835565|FG000|Overall Study|Adverse Event|7|||
170408423|NCT00752791|615835565|FG000|Overall Study|Withdrawal by Subject|1|||
170408424|NCT00752791|615835565|FG000|Overall Study|Physician Decision|1|||
170408425|NCT00752791|615835565|FG000|Overall Study|Death|1|||
170408426|NCT00752791|615835565|FG000|Overall Study|Renal transplant|3|||
170408427|NCT00752791|615835565|FG000|Overall Study|Switched to hemodialysis|2|||
170408428|NCT00752791|615835565|FG000|Overall Study|Protocol deviation|1|||
170408429|NCT01489956|615835566|FG000|Overall Study|Lost to Follow-up|1|||
170408430|NCT01489956|615835567|FG001|Overall Study|Lost to Follow-up|0|||
170408431|NCT01489956|615835568|FG002|Overall Study|Lost to Follow-up|0|||
170408432|NCT01489956|615835566|FG000|Overall Study|Withdrawal by Subject|0|||
170408433|NCT01489956|615835567|FG001|Overall Study|Withdrawal by Subject|0|||
170408434|NCT01489956|615835568|FG002|Overall Study|Withdrawal by Subject|1|||
170408435|NCT00891774|615835569|FG000|Overall Study|Lost to Follow-up|5|||
170408436|NCT00891774|615835569|FG000|Overall Study|Illness (Self/Mother)|3|||
170408437|NCT00891774|615835569|FG000|Overall Study|Withdrawal by Subject|2|||
170408438|NCT00891774|615835569|FG000|Overall Study|Protocol Violation|4|||
170760334|NCT01876511|617129341|FG002|Overall Study|Patient Decision|6|||
170408439|NCT03175120|615835571|FG000|Overall Study|Adverse Event|2|||
170408440|NCT03175120|615835572|FG001|Overall Study|Adverse Event|2|||
170408441|NCT03175120|615835571|FG000|Overall Study|Protocol Violation|5|||
170408442|NCT03175120|615835572|FG001|Overall Study|Protocol Violation|2|||
170408443|NCT03175120|615835571|FG000|Overall Study|Lost to Follow-up|1|||
170408444|NCT03175120|615835572|FG001|Overall Study|Lost to Follow-up|0|||
170408445|NCT03175120|615835571|FG000|Overall Study|Withdrawal by Subject|2|||
170408446|NCT03175120|615835572|FG001|Overall Study|Withdrawal by Subject|5|||
170408447|NCT03175120|615835571|FG000|Overall Study|Other|2|||
170408448|NCT03175120|615835572|FG001|Overall Study|Other|3|||
170408449|NCT00175019|615835575|FG000|Overall Study|Adverse Event|54|||
170408450|NCT00175019|615835576|FG001|Overall Study|Adverse Event|22|||
170408451|NCT00175019|615835577|FG002|Overall Study|Adverse Event|2|||
170408452|NCT00175019|615835575|FG000|Overall Study|Protocol Violation|6|||
170408453|NCT00175019|615835576|FG001|Overall Study|Protocol Violation|3|||
170408454|NCT00175019|615835577|FG002|Overall Study|Protocol Violation|3|||
170408455|NCT00175019|615835575|FG000|Overall Study|Lost to Follow-up|42|||
170408456|NCT00175019|615835576|FG001|Overall Study|Lost to Follow-up|39|||
170408457|NCT00175019|615835577|FG002|Overall Study|Lost to Follow-up|9|||
170408458|NCT00175019|615835575|FG000|Overall Study|Did not continue under Amendment 4|1|||
170408459|NCT00175019|615835576|FG001|Overall Study|Did not continue under Amendment 4|1|||
170408460|NCT00175019|615835577|FG002|Overall Study|Did not continue under Amendment 4|2|||
170760335|NCT01876511|617129339|FG000|Overall Study|Physician Decision|1|||
170760336|NCT01876511|617129340|FG001|Overall Study|Physician Decision|0|||
170760337|NCT01876511|617129341|FG002|Overall Study|Physician Decision|1|||
170760338|NCT05790408|617129342|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
170760339|NCT01233050|617129343|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
170760340|NCT01233050|617129344|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
170760341|NCT03999554|617129349|FG000|Overall Study|Lost to Follow-up|4|||
170760342|NCT03999554|617129350|FG001|Overall Study|Lost to Follow-up|5|||
170760343|NCT03999554|617129351|FG002|Overall Study|Lost to Follow-up|4|||
170760344|NCT03999554|617129352|FG003|Overall Study|Lost to Follow-up|5|||
170760345|NCT03999554|617129353|FG004|Overall Study|Lost to Follow-up|8|||
170760346|NCT03999554|617129349|FG000|Overall Study|Protocol Violation|0|||
170760347|NCT03999554|617129350|FG001|Overall Study|Protocol Violation|0|||
170760348|NCT03999554|617129351|FG002|Overall Study|Protocol Violation|5|||
170760349|NCT03999554|617129352|FG003|Overall Study|Protocol Violation|0|||
170760350|NCT03999554|617129353|FG004|Overall Study|Protocol Violation|0|||
170760351|NCT03999554|617129349|FG000|Overall Study|Pregnancy|0|||
170760352|NCT03999554|617129350|FG001|Overall Study|Pregnancy|0|||
170760353|NCT03999554|617129351|FG002|Overall Study|Pregnancy|1|||
170760354|NCT03999554|617129352|FG003|Overall Study|Pregnancy|0|||
170760355|NCT03999554|617129353|FG004|Overall Study|Pregnancy|0|||
170760356|NCT03999554|617129349|FG000|Overall Study|Withdrawal by Subject|2|||
170760357|NCT03999554|617129350|FG001|Overall Study|Withdrawal by Subject|2|||
170760358|NCT03999554|617129351|FG002|Overall Study|Withdrawal by Subject|2|||
170760359|NCT03999554|617129352|FG003|Overall Study|Withdrawal by Subject|1|||
170760360|NCT03999554|617129353|FG004|Overall Study|Withdrawal by Subject|1|||
170760361|NCT03999554|617129349|FG000|Overall Study|failure to comply with protocol requirements|0|||
170760362|NCT03999554|617129350|FG001|Overall Study|failure to comply with protocol requirements|0|||
170760363|NCT03999554|617129351|FG002|Overall Study|failure to comply with protocol requirements|0|||
170760364|NCT03999554|617129352|FG003|Overall Study|failure to comply with protocol requirements|1|||
170760365|NCT03999554|617129353|FG004|Overall Study|failure to comply with protocol requirements|0|||
170760366|NCT04582877|617129356|FG000|Overall Study|Did not use device measurement|5|||
170760367|NCT04582877|617129356|FG000|Overall Study|No fractional flow reserve test results|2|||
170760368|NCT04582877|617129356|FG000|Overall Study|Protocol Violation|1|||
170760369|NCT04012853|617129357|FG000|Overall Study|Withdrawal by Subject|1|||
170760370|NCT04012853|617129358|FG001|Overall Study|Withdrawal by Subject|1|||
170760371|NCT04012853|617129357|FG000|Overall Study|Protocol Violation|1|||
170760372|NCT04012853|617129358|FG001|Overall Study|Protocol Violation|0|||
170760373|NCT04012853|617129357|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
170760374|NCT04012853|617129358|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
170408461|NCT00175019|615835575|FG000|Overall Study|Personal Reason(s)|39|||
170760375|NCT04304534|617129359|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
170760376|NCT04304534|617129360|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
170760377|NCT04304534|617129361|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
170760378|NCT04304534|617129362|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
170760379|NCT04304534|617129359|FG000|Overall Study|Non-Compliance with study drug|0|||
170408462|NCT00175019|615835576|FG001|Overall Study|Personal Reason(s)|31|||
170408463|NCT00175019|615835577|FG002|Overall Study|Personal Reason(s)|8|||
170408464|NCT00175019|615835575|FG000|Overall Study|Therapeutic Failure|10|||
170408465|NCT00175019|615835576|FG001|Overall Study|Therapeutic Failure|38|||
170408466|NCT00175019|615835577|FG002|Overall Study|Therapeutic Failure|22|||
170408467|NCT00175019|615835575|FG000|Overall Study|Gout Flare|2|||
170408468|NCT00175019|615835576|FG001|Overall Study|Gout Flare|3|||
170408469|NCT00175019|615835577|FG002|Overall Study|Gout Flare|0|||
170760380|NCT04304534|617129360|FG001|Overall Study|Non-Compliance with study drug|1|||
170760381|NCT04304534|617129361|FG002|Overall Study|Non-Compliance with study drug|1|||
170760382|NCT04304534|617129362|FG003|Overall Study|Non-Compliance with study drug|1|||
170760383|NCT04304534|617129359|FG000|Overall Study|Lost to Follow-up|0|||
170760384|NCT04304534|617129360|FG001|Overall Study|Lost to Follow-up|1|||
170760385|NCT04304534|617129361|FG002|Overall Study|Lost to Follow-up|2|||
170760386|NCT04304534|617129362|FG003|Overall Study|Lost to Follow-up|3|||
170760387|NCT04304534|617129359|FG000|Overall Study|Unspecific|4|||
170760388|NCT04304534|617129360|FG001|Overall Study|Unspecific|2|||
170760389|NCT04304534|617129361|FG002|Overall Study|Unspecific|2|||
170760390|NCT04304534|617129362|FG003|Overall Study|Unspecific|2|||
170760391|NCT04304534|617129359|FG000|Overall Study|Technical Problems|2|||
170760392|NCT04304534|617129360|FG001|Overall Study|Technical Problems|2|||
170760393|NCT04304534|617129361|FG002|Overall Study|Technical Problems|3|||
170760394|NCT04304534|617129362|FG003|Overall Study|Technical Problems|4|||
170760395|NCT04304534|617129359|FG000|Overall Study|Death|7|||
170760396|NCT04304534|617129360|FG001|Overall Study|Death|2|||
170760397|NCT04304534|617129361|FG002|Overall Study|Death|4|||
170760398|NCT04304534|617129362|FG003|Overall Study|Death|3|||
170760399|NCT04304534|617129359|FG000|Overall Study|Withdrawal by Subject|7|||
170760400|NCT04304534|617129360|FG001|Overall Study|Withdrawal by Subject|2|||
170760401|NCT04304534|617129361|FG002|Overall Study|Withdrawal by Subject|7|||
170760402|NCT04304534|617129362|FG003|Overall Study|Withdrawal by Subject|4|||
170760403|NCT04304534|617129359|FG000|Overall Study|Physician Decision|4|||
170760404|NCT04304534|617129360|FG001|Overall Study|Physician Decision|9|||
170760405|NCT04304534|617129361|FG002|Overall Study|Physician Decision|9|||
170760406|NCT04304534|617129362|FG003|Overall Study|Physician Decision|5|||
170760407|NCT04304534|617129359|FG000|Overall Study|Subject Decision|34|||
170760408|NCT04304534|617129360|FG001|Overall Study|Subject Decision|25|||
170760409|NCT04304534|617129361|FG002|Overall Study|Subject Decision|25|||
170760410|NCT04304534|617129362|FG003|Overall Study|Subject Decision|26|||
170760411|NCT04304534|617129359|FG000|Overall Study|Adverse Event|35|||
170760412|NCT04304534|617129360|FG001|Overall Study|Adverse Event|40|||
170760413|NCT04304534|617129361|FG002|Overall Study|Adverse Event|39|||
170760414|NCT04304534|617129362|FG003|Overall Study|Adverse Event|44|||
170760415|NCT01695317|617129363|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
170760416|NCT01695317|617129364|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
170760417|NCT01695317|617129363|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
170760418|NCT01695317|617129364|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
170760419|NCT00619151|617129367|FG000|Overall Study|Study terminated prior to followup|1|||
170760420|NCT00619151|617129368|FG001|Overall Study|Study terminated prior to followup|0|||
170760421|NCT02524288|617129375|FG000|Overall Study|Adverse Event|115|||
170760422|NCT02524288|617129375|FG000|Overall Study|Lost to Follow-up|216|||
170760423|NCT02524288|617129375|FG000|Overall Study|Non-Compliance With Protocol|32|||
170760424|NCT02524288|617129375|FG000|Overall Study|Non-Compliance With Study Drug|14|||
170760425|NCT02524288|617129375|FG000|Overall Study|Pregnancy Wish|6|||
170760426|NCT02524288|617129375|FG000|Overall Study|Protocol Violation|6|||
170760427|NCT02524288|617129375|FG000|Overall Study|Screen Failure|2|||
170760428|NCT02524288|617129375|FG000|Overall Study|Site Discontinued Study Participation|1|||
170760429|NCT02524288|617129375|FG000|Overall Study|Study Terminated By Sponsor|1417|||
170760430|NCT02524288|617129375|FG000|Overall Study|Subject Moved|32|||
170760431|NCT02524288|617129375|FG000|Overall Study|Withdrawal by Subject|76|||
170760432|NCT02524288|617129375|FG000|Overall Study|Pregnancy|22|||
170760433|NCT02524288|617129375|FG000|Overall Study|Physician Decision|2|||
170760434|NCT02042443|617129379|FG000|Overall Study|Adverse Event|2|||
170760435|NCT02042443|617129380|FG001|Overall Study|Adverse Event|1|||
170760436|NCT02042443|617129379|FG000|Overall Study|Withdrawal by Subject|0|||
170760437|NCT02042443|617129380|FG001|Overall Study|Withdrawal by Subject|1|||
170760438|NCT02042443|617129379|FG000|Overall Study|Progression|21|||
170760439|NCT02042443|617129380|FG001|Overall Study|Progression|17|||
170760440|NCT02042443|617129379|FG000|Overall Study|not protocol specified|1|||
170760441|NCT02042443|617129380|FG001|Overall Study|not protocol specified|1|||
170760442|NCT02042443|617129379|FG000|Overall Study|Not eligible/not analyzable|3|||
170760443|NCT02042443|617129380|FG001|Overall Study|Not eligible/not analyzable|6|||
170760444|NCT02138916|617129381|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
170760445|NCT02138916|617129382|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
170760446|NCT02138916|617129383|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
170760447|NCT02138916|617129381|FG000|Overall Study|Death|14|||
170760448|NCT02138916|617129382|FG001|Overall Study|Death|11|||
170760449|NCT02138916|617129383|FG002|Overall Study|Death|12|||
170760450|NCT02138916|617129381|FG000|Overall Study|Withdrawal by Subject|27|||
170760451|NCT02138916|617129382|FG001|Overall Study|Withdrawal by Subject|31|||
170760452|NCT02138916|617129383|FG002|Overall Study|Withdrawal by Subject|32|||
170760453|NCT02138916|617129381|FG000|Overall Study|Study specific withdrawal criteria|0|||
170760454|NCT02138916|617129382|FG001|Overall Study|Study specific withdrawal criteria|0|||
170760455|NCT02138916|617129383|FG002|Overall Study|Study specific withdrawal criteria|1|||
170760456|NCT02138916|617129381|FG000|Overall Study|incorrect enrolment|1|||
170760457|NCT02138916|617129382|FG001|Overall Study|incorrect enrolment|1|||
170760458|NCT02138916|617129383|FG002|Overall Study|incorrect enrolment|0|||
170760459|NCT02138916|617129381|FG000|Overall Study|Severe non-compliance|1|||
170760460|NCT02138916|617129382|FG001|Overall Study|Severe non-compliance|2|||
170760461|NCT02138916|617129383|FG002|Overall Study|Severe non-compliance|1|||
170760462|NCT02138916|617129381|FG000|Overall Study|Lost to Follow-up|4|||
170760463|NCT02138916|617129382|FG001|Overall Study|Lost to Follow-up|2|||
170760464|NCT02138916|617129383|FG002|Overall Study|Lost to Follow-up|3|||
170760465|NCT02138916|617129381|FG000|Overall Study|Adverse Event|4|||
170760466|NCT02138916|617129382|FG001|Overall Study|Adverse Event|4|||
170760467|NCT02138916|617129383|FG002|Overall Study|Adverse Event|3|||
170760468|NCT02784704|617129384|FG000|Overall Study|Adverse Event|4|||
170760469|NCT02784704|617129385|FG001|Overall Study|Adverse Event|2|||
170760470|NCT02784704|617129384|FG000|Overall Study|Lost to Follow-up|6|||
170866590|NCT01641809|617523614|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
170760471|NCT02784704|617129385|FG001|Overall Study|Lost to Follow-up|4|||
170760472|NCT02784704|617129384|FG000|Overall Study|Withdrawal by Subject|1|||
170760473|NCT02784704|617129385|FG001|Overall Study|Withdrawal by Subject|3|||
170760474|NCT02784704|617129384|FG000|Overall Study|Subject Non Compliance|2|||
170866591|NCT01641809|617523615|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
170866592|NCT01641809|617523616|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
170760475|NCT02784704|617129385|FG001|Overall Study|Subject Non Compliance|0|||
170760476|NCT01913340|617129386|FG000|Overall Study|Death|2|||
170760477|NCT01913340|617129387|FG001|Overall Study|Death|5|||
170866593|NCT01641809|617523613|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
170866594|NCT01641809|617523614|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
170866595|NCT01641809|617523615|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
170866596|NCT01641809|617523616|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
170866597|NCT01641809|617523613|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
170866598|NCT01641809|617523614|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
170866599|NCT01641809|617523615|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
170866600|NCT01641809|617523616|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
170866601|NCT01641809|617523613|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
170866602|NCT01641809|617523614|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
170866603|NCT01641809|617523615|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
170866604|NCT01641809|617523616|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
170866605|NCT01641809|617523613|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
170866606|NCT01641809|617523614|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
170866607|NCT01641809|617523615|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
170866608|NCT01641809|617523616|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
170866609|NCT01641809|617523613|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
170866610|NCT01641809|617523614|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
170866611|NCT01641809|617523615|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
170866612|NCT01641809|617523616|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
170866613|NCT01641809|617523613|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
170866614|NCT01641809|617523614|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
170866615|NCT01641809|617523615|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
170866616|NCT01641809|617523616|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
170866617|NCT01641809|617523613|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
170866618|NCT01641809|617523614|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
170866619|NCT01641809|617523615|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
170866620|NCT01641809|617523616|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
170866621|NCT01641809|617523613|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
170866622|NCT01641809|617523614|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
170866623|NCT01641809|617523615|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
170866624|NCT01641809|617523616|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
170866625|NCT01641809|617523613|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
170866626|NCT01641809|617523614|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
170866627|NCT01641809|617523615|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
170866628|NCT01641809|617523616|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
170866629|NCT01641809|617523613|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
170760478|NCT01913340|617129386|FG000|Overall Study|Lost to Follow-up|1|||
170760479|NCT01913340|617129387|FG001|Overall Study|Lost to Follow-up|1|||
170760480|NCT04794179|617129390|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
170760481|NCT04794179|617129391|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
170760482|NCT00604786|617129398|FG000|Overall Study|Lost to Follow-up|2|||
170760483|NCT00604786|617129399|FG001|Overall Study|Lost to Follow-up|0|||
170760484|NCT01729871|617129403|FG000|Overall Study|Adverse Event|7|||
170760485|NCT01729871|617129404|FG001|Overall Study|Adverse Event|7|||
170760486|NCT01729871|617129403|FG000|Overall Study|Death|0|||
170760487|NCT01729871|617129404|FG001|Overall Study|Death|1|||
170760488|NCT01729871|617129403|FG000|Overall Study|Lack of Efficacy|0|||
170760489|NCT01729871|617129404|FG001|Overall Study|Lack of Efficacy|1|||
170760490|NCT01729871|617129403|FG000|Overall Study|Physician Decision|0|||
170760491|NCT01729871|617129404|FG001|Overall Study|Physician Decision|2|||
170760492|NCT01729871|617129403|FG000|Overall Study|Protocol Violation|1|||
170760493|NCT01729871|617129404|FG001|Overall Study|Protocol Violation|0|||
170760494|NCT01729871|617129403|FG000|Overall Study|Withdrawal by Subject|0|||
170760495|NCT01729871|617129404|FG001|Overall Study|Withdrawal by Subject|3|||
170760496|NCT01729871|617129403|FG000|Overall Study|Other|4|||
170760497|NCT01729871|617129404|FG001|Overall Study|Other|9|||
170760498|NCT01333514|617129405|FG000|Overall Study|Withdrawal by Subject|1|||
170760499|NCT01333514|617129406|FG001|Overall Study|Withdrawal by Subject|0|||
170760500|NCT00836810|617129407|FG000|Overall Study|New diagnosis|1|||
170760501|NCT00836810|617129408|FG001|Overall Study|New diagnosis|0|||
170760502|NCT00871429|617129409|FG000|Overall Study|Lost to Follow-up|6|||
170760503|NCT00871429|617129409|FG000|Overall Study|Withdrawal by Subject|17|||
170760504|NCT00871429|617129409|FG000|Overall Study|Questionnaire not completed|1|||
170760505|NCT03102242|617129410|FG000|Overall Study|Adverse Event|2|||
170760506|NCT00389519|617129411|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
170760507|NCT00389519|617129412|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
170760508|NCT00389519|617129413|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
170760509|NCT00389519|617129414|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
170760510|NCT00389519|617129411|FG000|Placebo Run-In|Withdrawal by Subject|19|||
170408470|NCT00175019|615835575|FG000|Overall Study|Reason Not Specified|40|||
170760511|NCT00389519|617129412|FG001|Placebo Run-In|Withdrawal by Subject|0|||
170760512|NCT00389519|617129413|FG002|Placebo Run-In|Withdrawal by Subject|0|||
170760513|NCT00389519|617129414|FG003|Placebo Run-In|Withdrawal by Subject|0|||
170408471|NCT00175019|615835576|FG001|Overall Study|Reason Not Specified|34|||
170408472|NCT00175019|615835577|FG002|Overall Study|Reason Not Specified|11|||
170408473|NCT01405820|615835578|FG000|Randomized Treatment Period|Adverse Event|3|||
170408474|NCT01405820|615835579|FG001|Randomized Treatment Period|Adverse Event|3|||
170408475|NCT01405820|615835580|FG002|Randomized Treatment Period|Adverse Event|3|||
170408476|NCT01405820|615835581|FG003|Randomized Treatment Period|Adverse Event|0|||
170408477|NCT01405820|615835582|FG004|Randomized Treatment Period|Adverse Event|2|||
170408478|NCT01405820|615835583|FG005|Randomized Treatment Period|Adverse Event|1|||
170408479|NCT01405820|615835578|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
170408480|NCT01405820|615835579|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
170408481|NCT01405820|615835580|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
170408482|NCT01405820|615835581|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
170408483|NCT01405820|615835582|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
170408484|NCT01405820|615835583|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
170408485|NCT01405820|615835578|FG000|Randomized Treatment Period|Other|2|||
170408486|NCT01405820|615835579|FG001|Randomized Treatment Period|Other|2|||
170408487|NCT01405820|615835580|FG002|Randomized Treatment Period|Other|1|||
170408488|NCT01405820|615835581|FG003|Randomized Treatment Period|Other|1|||
170408489|NCT01405820|615835582|FG004|Randomized Treatment Period|Other|0|||
170408490|NCT01405820|615835583|FG005|Randomized Treatment Period|Other|0|||
170408491|NCT01405820|615835578|FG000|Randomized Treatment Period|Physician Decision|0|||
170408492|NCT01405820|615835579|FG001|Randomized Treatment Period|Physician Decision|2|||
170408493|NCT01405820|615835580|FG002|Randomized Treatment Period|Physician Decision|1|||
170408494|NCT01405820|615835581|FG003|Randomized Treatment Period|Physician Decision|0|||
170408495|NCT01405820|615835582|FG004|Randomized Treatment Period|Physician Decision|0|||
170408496|NCT01405820|615835583|FG005|Randomized Treatment Period|Physician Decision|0|||
170408497|NCT01405820|615835578|FG000|Randomized Treatment Period|Rescue|0|||
170408498|NCT01405820|615835579|FG001|Randomized Treatment Period|Rescue|1|||
170408499|NCT01405820|615835580|FG002|Randomized Treatment Period|Rescue|13|||
170408500|NCT01405820|615835581|FG003|Randomized Treatment Period|Rescue|10|||
170408501|NCT01405820|615835582|FG004|Randomized Treatment Period|Rescue|8|||
170408502|NCT01405820|615835583|FG005|Randomized Treatment Period|Rescue|8|||
170408503|NCT01405820|615835578|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
170408504|NCT01405820|615835579|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
170408505|NCT01405820|615835580|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
170408506|NCT01405820|615835581|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
170408507|NCT01405820|615835582|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
170408508|NCT01405820|615835583|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
170408509|NCT01405820|615835578|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
170760514|NCT00389519|617129411|FG000|Placebo Run-In|Reason not specified|40|||
170760515|NCT00389519|617129412|FG001|Placebo Run-In|Reason not specified|0|||
170760516|NCT00389519|617129413|FG002|Placebo Run-In|Reason not specified|0|||
170408510|NCT01405820|615835579|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
170408511|NCT01405820|615835580|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
170408512|NCT01405820|615835581|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
170408513|NCT01405820|615835582|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
170408514|NCT01405820|615835583|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
170760517|NCT00389519|617129414|FG003|Placebo Run-In|Reason not specified|0|||
170760518|NCT00389519|617129411|FG000|Randomized|Did not receive study drug|2|||
170760519|NCT00389519|617129412|FG001|Randomized|Did not receive study drug|0|||
170760520|NCT00389519|617129413|FG002|Randomized|Did not receive study drug|0|||
170760521|NCT00389519|617129414|FG003|Randomized|Did not receive study drug|0|||
170760522|NCT00389519|617129411|FG000|Treated|Adverse Event|1|||
170760523|NCT00389519|617129412|FG001|Treated|Adverse Event|0|||
170760524|NCT00389519|617129413|FG002|Treated|Adverse Event|0|||
170760525|NCT00389519|617129414|FG003|Treated|Adverse Event|2|||
170760526|NCT00389519|617129411|FG000|Treated|Reason not specified|1|||
170760527|NCT00389519|617129412|FG001|Treated|Reason not specified|1|||
170760528|NCT00389519|617129413|FG002|Treated|Reason not specified|0|||
170760529|NCT00389519|617129414|FG003|Treated|Reason not specified|2|||
170760530|NCT03425539|617129417|FG000|Overall Study|Randomized but not treated|0|||
170760531|NCT03425539|617129418|FG001|Overall Study|Randomized but not treated|1|||
170760532|NCT03425539|617129417|FG000|Overall Study|Adverse Event|2|||
170760533|NCT03425539|617129418|FG001|Overall Study|Adverse Event|2|||
170760534|NCT03425539|617129417|FG000|Overall Study|Withdrawal by Subject|3|||
170760535|NCT03425539|617129418|FG001|Overall Study|Withdrawal by Subject|0|||
170760536|NCT03425539|617129417|FG000|Overall Study|Lost to Follow-up|0|||
170760537|NCT03425539|617129418|FG001|Overall Study|Lost to Follow-up|1|||
170760538|NCT02040844|617129419|FG000|Overall Study|Adverse Event|0|||
170760539|NCT02040844|617129420|FG001|Overall Study|Adverse Event|0|||
170760540|NCT02040844|617129421|FG002|Overall Study|Adverse Event|1|||
170760541|NCT02040844|617129419|FG000|Overall Study|Withdrawal by Subject|16|||
170760542|NCT02040844|617129420|FG001|Overall Study|Withdrawal by Subject|22|||
170760543|NCT02040844|617129421|FG002|Overall Study|Withdrawal by Subject|25|||
170760544|NCT02040844|617129419|FG000|Overall Study|Lost to Follow-up|12|||
170760545|NCT02040844|617129420|FG001|Overall Study|Lost to Follow-up|9|||
170760546|NCT02040844|617129421|FG002|Overall Study|Lost to Follow-up|13|||
170760547|NCT02040844|617129419|FG000|Overall Study|Missing|13|||
170760548|NCT02040844|617129420|FG001|Overall Study|Missing|3|||
170760549|NCT02040844|617129421|FG002|Overall Study|Missing|2|||
170760550|NCT02040844|617129419|FG000|Overall Study|Non-specified|8|||
170760551|NCT02040844|617129420|FG001|Overall Study|Non-specified|2|||
170760552|NCT02040844|617129421|FG002|Overall Study|Non-specified|5|||
170760553|NCT02040844|617129419|FG000|Overall Study|Concomitant medication|1|||
170760554|NCT02040844|617129420|FG001|Overall Study|Concomitant medication|3|||
170760555|NCT02040844|617129421|FG002|Overall Study|Concomitant medication|1|||
170760556|NCT00946192|617129422|FG000|Overall Study|Lost to Follow-up|6|||
170760557|NCT00946192|617129423|FG001|Overall Study|Lost to Follow-up|11|||
170760558|NCT00946192|617129424|FG002|Overall Study|Lost to Follow-up|9|||
170760559|NCT00946192|617129422|FG000|Overall Study|Withdrawal by Subject|10|||
170760560|NCT00946192|617129423|FG001|Overall Study|Withdrawal by Subject|7|||
170760561|NCT00946192|617129424|FG002|Overall Study|Withdrawal by Subject|3|||
170760562|NCT00946192|617129422|FG000|Overall Study|Did not start medication|2|||
170760563|NCT00946192|617129423|FG001|Overall Study|Did not start medication|0|||
170760564|NCT00946192|617129424|FG002|Overall Study|Did not start medication|0|||
170760565|NCT01080131|617129425|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
170760566|NCT01080131|617129426|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
170760567|NCT01080131|617129425|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
170760568|NCT01080131|617129426|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
170760569|NCT01080131|617129425|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
170760570|NCT01080131|617129426|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
170760571|NCT01080131|617129425|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
170760572|NCT01080131|617129426|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
170760573|NCT01080131|617129425|FG000|Core Study (0- 12 Weeks)|Death|1|||
170760574|NCT01080131|617129426|FG001|Core Study (0- 12 Weeks)|Death|0|||
170760575|NCT01080131|617129425|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
170760576|NCT01080131|617129426|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
170760577|NCT01080131|617129425|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
170760578|NCT01080131|617129426|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
170760579|NCT01080131|617129425|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
170760580|NCT01080131|617129426|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
170760581|NCT01080131|617129425|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
170760582|NCT01080131|617129426|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
170760583|NCT01080131|617129425|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
170760584|NCT01080131|617129426|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
170760585|NCT01080131|617129425|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
170760586|NCT01080131|617129426|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
170760587|NCT01080131|617129425|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
170760588|NCT01080131|617129426|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
170760589|NCT01080131|617129425|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
170760590|NCT01080131|617129426|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
170760591|NCT02014558|617129427|FG000|Overall Study|Never Received Study Drug|0|||
170760592|NCT02014558|617129428|FG001|Overall Study|Never Received Study Drug|0|||
170760593|NCT02014558|617129429|FG002|Overall Study|Never Received Study Drug|0|||
170760594|NCT02014558|617129430|FG003|Overall Study|Never Received Study Drug|0|||
170760595|NCT02014558|617129431|FG004|Overall Study|Never Received Study Drug|1|||
170760596|NCT02014558|617129432|FG005|Overall Study|Never Received Study Drug|0|||
170760597|NCT02014558|617129433|FG006|Overall Study|Never Received Study Drug|1|||
170760598|NCT02014558|617129434|FG007|Overall Study|Never Received Study Drug|0|||
170760599|NCT02014558|617129435|FG008|Overall Study|Never Received Study Drug|2|||
170760600|NCT02014558|617129436|FG009|Overall Study|Never Received Study Drug|0|||
170760601|NCT02014558|617129437|FG010|Overall Study|Never Received Study Drug|2|||
170760602|NCT02014558|617129438|FG011|Overall Study|Never Received Study Drug|2|||
170760603|NCT02014558|617129439|FG012|Overall Study|Never Received Study Drug|0|||
170760604|NCT02014558|617129427|FG000|Overall Study|Adverse Event|0|||
170760605|NCT02014558|617129428|FG001|Overall Study|Adverse Event|0|||
170760606|NCT02014558|617129429|FG002|Overall Study|Adverse Event|0|||
170760607|NCT02014558|617129430|FG003|Overall Study|Adverse Event|0|||
170760608|NCT02014558|617129431|FG004|Overall Study|Adverse Event|1|||
170760609|NCT02014558|617129432|FG005|Overall Study|Adverse Event|0|||
170760610|NCT02014558|617129433|FG006|Overall Study|Adverse Event|0|||
170760611|NCT02014558|617129434|FG007|Overall Study|Adverse Event|0|||
170760612|NCT02014558|617129435|FG008|Overall Study|Adverse Event|2|||
170760613|NCT02014558|617129436|FG009|Overall Study|Adverse Event|2|||
170760614|NCT02014558|617129437|FG010|Overall Study|Adverse Event|5|||
170760615|NCT02014558|617129438|FG011|Overall Study|Adverse Event|21|||
170760616|NCT02014558|617129439|FG012|Overall Study|Adverse Event|3|||
170760617|NCT02014558|617129427|FG000|Overall Study|Death|1|||
170760618|NCT02014558|617129428|FG001|Overall Study|Death|0|||
170760619|NCT02014558|617129429|FG002|Overall Study|Death|0|||
170760620|NCT02014558|617129430|FG003|Overall Study|Death|0|||
170760621|NCT02014558|617129431|FG004|Overall Study|Death|0|||
170760622|NCT02014558|617129432|FG005|Overall Study|Death|0|||
170760623|NCT02014558|617129433|FG006|Overall Study|Death|1|||
170760624|NCT02014558|617129434|FG007|Overall Study|Death|1|||
170760625|NCT02014558|617129435|FG008|Overall Study|Death|2|||
170760626|NCT02014558|617129436|FG009|Overall Study|Death|5|||
170760627|NCT02014558|617129437|FG010|Overall Study|Death|5|||
170760628|NCT02014558|617129438|FG011|Overall Study|Death|19|||
170760629|NCT02014558|617129439|FG012|Overall Study|Death|2|||
170760630|NCT02014558|617129427|FG000|Overall Study|Lack of Efficacy|1|||
170760631|NCT02014558|617129428|FG001|Overall Study|Lack of Efficacy|2|||
170760632|NCT02014558|617129429|FG002|Overall Study|Lack of Efficacy|1|||
170760633|NCT02014558|617129430|FG003|Overall Study|Lack of Efficacy|1|||
170760634|NCT02014558|617129431|FG004|Overall Study|Lack of Efficacy|0|||
170760635|NCT02014558|617129432|FG005|Overall Study|Lack of Efficacy|0|||
170760636|NCT02014558|617129433|FG006|Overall Study|Lack of Efficacy|1|||
170760637|NCT02014558|617129434|FG007|Overall Study|Lack of Efficacy|3|||
170760638|NCT02014558|617129435|FG008|Overall Study|Lack of Efficacy|3|||
170760639|NCT02014558|617129436|FG009|Overall Study|Lack of Efficacy|3|||
170760640|NCT02014558|617129437|FG010|Overall Study|Lack of Efficacy|16|||
170760641|NCT02014558|617129438|FG011|Overall Study|Lack of Efficacy|8|||
170760642|NCT02014558|617129439|FG012|Overall Study|Lack of Efficacy|5|||
170760643|NCT02014558|617129427|FG000|Overall Study|Lost to Follow-up|0|||
170760644|NCT02014558|617129428|FG001|Overall Study|Lost to Follow-up|0|||
170760645|NCT02014558|617129429|FG002|Overall Study|Lost to Follow-up|0|||
170760646|NCT02014558|617129430|FG003|Overall Study|Lost to Follow-up|0|||
170866630|NCT01641809|617523614|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
170866631|NCT01641809|617523615|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
170866632|NCT01641809|617523616|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
170866633|NCT01641809|617523613|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
170866634|NCT01641809|617523614|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
170866635|NCT01641809|617523615|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
170866636|NCT01641809|617523616|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
170866637|NCT01641809|617523613|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
170866638|NCT01641809|617523614|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
170866639|NCT01641809|617523615|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
170866640|NCT01641809|617523616|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
170866641|NCT01641809|617523613|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
170760647|NCT02014558|617129431|FG004|Overall Study|Lost to Follow-up|0|||
170760648|NCT02014558|617129432|FG005|Overall Study|Lost to Follow-up|0|||
170760649|NCT02014558|617129433|FG006|Overall Study|Lost to Follow-up|0|||
170760650|NCT02014558|617129434|FG007|Overall Study|Lost to Follow-up|0|||
170760651|NCT02014558|617129435|FG008|Overall Study|Lost to Follow-up|0|||
170760652|NCT02014558|617129436|FG009|Overall Study|Lost to Follow-up|0|||
170760653|NCT02014558|617129437|FG010|Overall Study|Lost to Follow-up|1|||
170760654|NCT02014558|617129438|FG011|Overall Study|Lost to Follow-up|0|||
170760655|NCT02014558|617129439|FG012|Overall Study|Lost to Follow-up|0|||
170760656|NCT02014558|617129427|FG000|Overall Study|Progressive Disease|1|||
170760657|NCT02014558|617129428|FG001|Overall Study|Progressive Disease|0|||
170866642|NCT01641809|617523614|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
170866643|NCT01641809|617523615|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
170866644|NCT01641809|617523616|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
170760658|NCT02014558|617129429|FG002|Overall Study|Progressive Disease|1|||
170760659|NCT02014558|617129430|FG003|Overall Study|Progressive Disease|1|||
170760660|NCT02014558|617129431|FG004|Overall Study|Progressive Disease|1|||
170760661|NCT02014558|617129432|FG005|Overall Study|Progressive Disease|2|||
170760662|NCT02014558|617129433|FG006|Overall Study|Progressive Disease|1|||
170760663|NCT02014558|617129434|FG007|Overall Study|Progressive Disease|6|||
170760664|NCT02014558|617129435|FG008|Overall Study|Progressive Disease|5|||
170760665|NCT02014558|617129436|FG009|Overall Study|Progressive Disease|6|||
170760666|NCT02014558|617129437|FG010|Overall Study|Progressive Disease|22|||
170760667|NCT02014558|617129438|FG011|Overall Study|Progressive Disease|31|||
170760668|NCT02014558|617129439|FG012|Overall Study|Progressive Disease|6|||
170760669|NCT02014558|617129427|FG000|Overall Study|Withdrawal by Subject|0|||
170760670|NCT02014558|617129428|FG001|Overall Study|Withdrawal by Subject|0|||
170760671|NCT02014558|617129429|FG002|Overall Study|Withdrawal by Subject|0|||
170760672|NCT02014558|617129430|FG003|Overall Study|Withdrawal by Subject|0|||
170760673|NCT02014558|617129431|FG004|Overall Study|Withdrawal by Subject|1|||
170760674|NCT02014558|617129432|FG005|Overall Study|Withdrawal by Subject|0|||
170760675|NCT02014558|617129433|FG006|Overall Study|Withdrawal by Subject|0|||
170760676|NCT02014558|617129434|FG007|Overall Study|Withdrawal by Subject|0|||
170760677|NCT02014558|617129435|FG008|Overall Study|Withdrawal by Subject|0|||
170760678|NCT02014558|617129436|FG009|Overall Study|Withdrawal by Subject|2|||
170760679|NCT02014558|617129437|FG010|Overall Study|Withdrawal by Subject|6|||
170760680|NCT02014558|617129438|FG011|Overall Study|Withdrawal by Subject|10|||
170760681|NCT02014558|617129439|FG012|Overall Study|Withdrawal by Subject|0|||
170760682|NCT02014558|617129427|FG000|Overall Study|Miscellaneous|2|||
170760683|NCT02014558|617129428|FG001|Overall Study|Miscellaneous|1|||
170760684|NCT02014558|617129429|FG002|Overall Study|Miscellaneous|1|||
170760685|NCT02014558|617129430|FG003|Overall Study|Miscellaneous|1|||
170760686|NCT02014558|617129431|FG004|Overall Study|Miscellaneous|0|||
170760687|NCT02014558|617129432|FG005|Overall Study|Miscellaneous|1|||
170760688|NCT02014558|617129433|FG006|Overall Study|Miscellaneous|0|||
170760689|NCT02014558|617129434|FG007|Overall Study|Miscellaneous|1|||
170760690|NCT02014558|617129435|FG008|Overall Study|Miscellaneous|1|||
170760691|NCT02014558|617129436|FG009|Overall Study|Miscellaneous|3|||
170866645|NCT01641809|617523613|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
170866646|NCT01641809|617523614|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
170866647|NCT01641809|617523615|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
170866648|NCT01641809|617523616|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
170866649|NCT01641809|617523613|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
170866650|NCT01641809|617523614|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
170866651|NCT01641809|617523615|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
170866652|NCT01641809|617523616|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
170866653|NCT00890929|617523617|FG000|Overall Study|Death before treatment|2|||
170866654|NCT00890929|617523617|FG000|Overall Study|Withdrawal by Subject|3|||
170866655|NCT00890929|617523617|FG000|Overall Study|Physician Decision|1|||
170866656|NCT00882310|617523621|FG000|Overall Study|Screen Failure|10|||
170866657|NCT00882310|617523621|FG000|Overall Study|Never received treatment|1|||
170866658|NCT00882310|617523621|FG000|Overall Study|Death|6|||
170866659|NCT00882310|617523621|FG000|Overall Study|Progression of disease|4|||
170866660|NCT00882310|617523621|FG000|Overall Study|Adverse Event|1|||
170866661|NCT04233164|617523622|FG000|Overall Study|Unable to obtain specimen|0|||
170866662|NCT04233164|617523623|FG001|Overall Study|Unable to obtain specimen|1|||
170866663|NCT01843218|617523624|FG000|Overall Study|Withdrawal by Subject|5|||
170866664|NCT01395316|617523627|FG000|Overall Study|Lost to Follow-up|2|||
170866665|NCT01395316|617523627|FG000|Overall Study|poor MRI quality|1|||
170866666|NCT01019980|617523628|FG000|Overall Study|Drug not available.|2|||
170866667|NCT01019980|617523629|FG001|Overall Study|Drug not available.|0|||
170866668|NCT03471871|617523630|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
170866669|NCT03471871|617523631|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
170866670|NCT03471871|617523632|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
170866671|NCT03471871|617523633|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
170760692|NCT02014558|617129437|FG010|Overall Study|Miscellaneous|12|||
170760693|NCT02014558|617129438|FG011|Overall Study|Miscellaneous|11|||
170866672|NCT03471871|617523634|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
170866673|NCT03471871|617523630|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
170866674|NCT03471871|617523631|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
170760694|NCT02014558|617129439|FG012|Overall Study|Miscellaneous|1|||
170760695|NCT04155424|617129440|FG000|Overall Study|Other than specified|3|||
170760696|NCT04155424|617129440|FG000|Overall Study|Withdrawal by Subject|1|||
170760697|NCT04155424|617129440|FG000|Overall Study|Adverse Event|1|||
170866675|NCT03471871|617523632|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
170866676|NCT03471871|617523633|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
170866677|NCT03471871|617523634|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
170866678|NCT03471871|617523630|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
170866679|NCT03471871|617523631|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
170866680|NCT03471871|617523632|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
170866681|NCT03471871|617523633|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
170866682|NCT03471871|617523634|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
170866683|NCT03471871|617523630|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
170866684|NCT03471871|617523631|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
170866685|NCT03471871|617523632|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
170866686|NCT03471871|617523633|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
170866687|NCT03471871|617523634|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
170866688|NCT03471871|617523630|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
170866689|NCT03471871|617523631|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
170866690|NCT03471871|617523632|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
170866691|NCT03471871|617523633|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
170866692|NCT03471871|617523634|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
170866693|NCT00866697|617523635|FG000|Overall Study|Study closed/terminated|156|||
170866694|NCT00866697|617523636|FG001|Overall Study|Study closed/terminated|138|||
170866695|NCT00866697|617523635|FG000|Overall Study|Lost to Follow-up|22|||
170866696|NCT00866697|617523636|FG001|Overall Study|Lost to Follow-up|28|||
170866697|NCT00866697|617523635|FG000|Overall Study|Physician Decision|3|||
170866698|NCT00866697|617523636|FG001|Overall Study|Physician Decision|5|||
170866699|NCT00866697|617523635|FG000|Overall Study|Withdrawal by Subject|33|||
170866700|NCT00866697|617523636|FG001|Overall Study|Withdrawal by Subject|57|||
170866701|NCT02906787|617523639|FG000|Overall Study|Withdrawal by Subject|12|||
170866702|NCT02906787|617523640|FG001|Overall Study|Withdrawal by Subject|10|||
170866703|NCT02906787|617523639|FG000|Overall Study|Missed|24|||
170866704|NCT02906787|617523640|FG001|Overall Study|Missed|22|||
170866705|NCT00447382|617523641|FG000|Overall Study|Adverse Event|1|||
170866706|NCT00447382|617523642|FG001|Overall Study|Adverse Event|1|||
170866707|NCT00447382|617523641|FG000|Overall Study|Lack of Efficacy|1|||
170866708|NCT00447382|617523642|FG001|Overall Study|Lack of Efficacy|0|||
170866709|NCT00447382|617523641|FG000|Overall Study|Protocol Violation|2|||
170866710|NCT00447382|617523642|FG001|Overall Study|Protocol Violation|0|||
170866711|NCT00447382|617523641|FG000|Overall Study|Unclassified|2|||
170866712|NCT00447382|617523642|FG001|Overall Study|Unclassified|5|||
170866713|NCT02673619|617523643|FG000|Overall Study|Lost to Follow-up|1|||
170866714|NCT02673619|617523644|FG001|Overall Study|Lost to Follow-up|0|||
170866715|NCT02673619|617523645|FG002|Overall Study|Lost to Follow-up|0|||
170866716|NCT02673619|617523646|FG003|Overall Study|Lost to Follow-up|0|||
170866717|NCT02673619|617523643|FG000|Overall Study|Withdrawal by Subject|1|||
170866718|NCT02673619|617523644|FG001|Overall Study|Withdrawal by Subject|1|||
170866719|NCT02673619|617523645|FG002|Overall Study|Withdrawal by Subject|1|||
170866720|NCT02673619|617523646|FG003|Overall Study|Withdrawal by Subject|0|||
170866721|NCT02673619|617523643|FG000|Overall Study|Adverse Event|0|||
170866722|NCT02673619|617523644|FG001|Overall Study|Adverse Event|0|||
170866723|NCT02673619|617523645|FG002|Overall Study|Adverse Event|1|||
170866724|NCT02673619|617523646|FG003|Overall Study|Adverse Event|0|||
170866725|NCT02673619|617523643|FG000|Overall Study|Lack of Efficacy|0|||
170866726|NCT02673619|617523644|FG001|Overall Study|Lack of Efficacy|0|||
170866727|NCT02673619|617523645|FG002|Overall Study|Lack of Efficacy|1|||
170866728|NCT02673619|617523646|FG003|Overall Study|Lack of Efficacy|0|||
170866729|NCT04821869|617523647|FG000|Overall Study|Adverse Event|4|||
170866730|NCT04821869|617523647|FG000|Overall Study|Withdrawal by Subject|2|||
170866731|NCT04821869|617523647|FG000|Overall Study|Did not meet FEV1 criteria|1|||
170866732|NCT03444324|617523650|FG000|Overall Study|Withdrawal by Subject|0|||
170866733|NCT03444324|617523651|FG001|Overall Study|Withdrawal by Subject|1|||
170866734|NCT03444324|617523650|FG000|Overall Study|Lost to Follow-up|4|||
170866735|NCT03444324|617523651|FG001|Overall Study|Lost to Follow-up|2|||
170866736|NCT03444324|617523650|FG000|Overall Study|Protocol Violation|0|||
170866737|NCT03444324|617523651|FG001|Overall Study|Protocol Violation|1|||
170866738|NCT03444324|617523650|FG000|Overall Study|Lack of Trial Compliance|1|||
170866739|NCT03444324|617523651|FG001|Overall Study|Lack of Trial Compliance|1|||
170866740|NCT03444324|617523650|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
170866741|NCT03444324|617523651|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
170866742|NCT04600336|617523652|FG000|Initial Treatment|Withdrawal by Subject|1|||
170866743|NCT04600336|617523653|FG001|Initial Treatment|Withdrawal by Subject|2|||
170866744|NCT04600336|617523654|FG002|Initial Treatment|Withdrawal by Subject|0|||
170866745|NCT04600336|617523655|FG003|Initial Treatment|Withdrawal by Subject|0|||
170866746|NCT04600336|617523652|FG000|Initial Treatment|Adverse Event|0|||
170866747|NCT04600336|617523653|FG001|Initial Treatment|Adverse Event|2|||
170866748|NCT04600336|617523654|FG002|Initial Treatment|Adverse Event|0|||
170866749|NCT04600336|617523655|FG003|Initial Treatment|Adverse Event|0|||
170866750|NCT04600336|617523652|FG000|Initial Treatment|Other complicating disease|0|||
170866751|NCT04600336|617523653|FG001|Initial Treatment|Other complicating disease|0|||
170866752|NCT04600336|617523654|FG002|Initial Treatment|Other complicating disease|1|||
170866753|NCT04600336|617523655|FG003|Initial Treatment|Other complicating disease|0|||
170866754|NCT04600336|617523652|FG000|Crossover Treatment|Withdrawal by Subject|0|||
170866755|NCT04600336|617523653|FG001|Crossover Treatment|Withdrawal by Subject|0|||
170866756|NCT04600336|617523654|FG002|Crossover Treatment|Withdrawal by Subject|2|||
170866757|NCT04600336|617523655|FG003|Crossover Treatment|Withdrawal by Subject|1|||
170866758|NCT04600336|617523652|FG000|Crossover Treatment|Adverse Event|0|||
170866759|NCT04600336|617523653|FG001|Crossover Treatment|Adverse Event|0|||
170866760|NCT04600336|617523654|FG002|Crossover Treatment|Adverse Event|1|||
170866761|NCT04600336|617523655|FG003|Crossover Treatment|Adverse Event|1|||
170866762|NCT01313117|617523658|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
170866763|NCT01313117|617523658|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
170866764|NCT04890054|617525154|FG000|Overall Study|Lost to Follow-up|202|||
170866765|NCT04890054|617525155|FG001|Overall Study|Lost to Follow-up|219|||
170866766|NCT04313153|617525156|FG000|Overall Study|Adverse Event (includes Death)|14|||
170866767|NCT04313153|617525157|FG001|Overall Study|Adverse Event (includes Death)|19|||
170866768|NCT04313153|617525158|FG002|Overall Study|Adverse Event (includes Death)|10|||
170866769|NCT04313153|617525156|FG000|Overall Study|Physician Decision|4|||
170866770|NCT04313153|617525157|FG001|Overall Study|Physician Decision|2|||
170866771|NCT04313153|617525158|FG002|Overall Study|Physician Decision|1|||
170866772|NCT04313153|617525156|FG000|Overall Study|Withdrawal by Subject|7|||
170866773|NCT04313153|617525157|FG001|Overall Study|Withdrawal by Subject|6|||
170866774|NCT04313153|617525158|FG002|Overall Study|Withdrawal by Subject|2|||
170866775|NCT04313153|617525156|FG000|Overall Study|Lack of Efficacy|3|||
170866776|NCT04313153|617525157|FG001|Overall Study|Lack of Efficacy|3|||
170866777|NCT04313153|617525158|FG002|Overall Study|Lack of Efficacy|0|||
170866778|NCT04313153|617525156|FG000|Overall Study|Lost to Follow-up|1|||
170866779|NCT04313153|617525157|FG001|Overall Study|Lost to Follow-up|0|||
170866780|NCT04313153|617525158|FG002|Overall Study|Lost to Follow-up|2|||
170866781|NCT04313153|617525156|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
170866782|NCT04313153|617525157|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
170866783|NCT04313153|617525158|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
170866784|NCT04313153|617525156|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
170866785|NCT04313153|617525157|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
170866786|NCT04313153|617525158|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
170866787|NCT04313153|617525156|FG000|Overall Study|Change in Dialysis Modality|0|||
170866788|NCT04313153|617525157|FG001|Overall Study|Change in Dialysis Modality|1|||
170866789|NCT04313153|617525158|FG002|Overall Study|Change in Dialysis Modality|2|||
170866790|NCT04313153|617525156|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
170866791|NCT04313153|617525157|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
170866792|NCT04313153|617525158|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
170866793|NCT04313153|617525156|FG000|Overall Study|Other|5|||
170866794|NCT04313153|617525157|FG001|Overall Study|Other|3|||
170866795|NCT04313153|617525158|FG002|Overall Study|Other|2|||
170866796|NCT05586269|617525159|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
170866797|NCT05586269|617525160|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
170408515|NCT01405820|615835578|FG000|Randomized Treatment Period|Death|0|||
170408516|NCT01405820|615835579|FG001|Randomized Treatment Period|Death|0|||
170408517|NCT01405820|615835580|FG002|Randomized Treatment Period|Death|0|||
170408518|NCT01405820|615835581|FG003|Randomized Treatment Period|Death|1|||
170408519|NCT01405820|615835582|FG004|Randomized Treatment Period|Death|0|||
170408520|NCT01405820|615835583|FG005|Randomized Treatment Period|Death|0|||
170408521|NCT01405820|615835578|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
170408522|NCT01405820|615835579|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
170408523|NCT01405820|615835580|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
170408524|NCT01405820|615835581|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
170408525|NCT01405820|615835582|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
170408526|NCT01405820|615835583|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
170408527|NCT01405820|615835578|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
170866798|NCT05586269|617525161|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
170866799|NCT05586269|617525162|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
170866800|NCT05586269|617525159|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
170866801|NCT05586269|617525160|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
170866802|NCT05586269|617525161|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
170866803|NCT05586269|617525162|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
170408528|NCT01405820|615835579|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
170408529|NCT01405820|615835580|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
170408530|NCT01405820|615835581|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
170760698|NCT04159506|617129441|FG000|Overall Study|Lost to Follow-up|2|||
170760699|NCT04159506|617129442|FG001|Overall Study|Lost to Follow-up|5|||
170760700|NCT01144468|617130840|FG000|Overall Study|Lost to Follow-up|4|||
170760701|NCT01144468|617130841|FG001|Overall Study|Lost to Follow-up|7|||
170760702|NCT01144468|617130840|FG000|Overall Study|Adverse Event|3|||
170760703|NCT01144468|617130841|FG001|Overall Study|Adverse Event|2|||
170760704|NCT01144468|617130840|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
170760705|NCT01144468|617130841|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
170760706|NCT04057196|617130844|FG000|Overall Study|Withdrawal by Subject|3|||
170760707|NCT04057196|617130844|FG000|Overall Study|Death|3|||
170760708|NCT03068468|617130845|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
170760709|NCT03068468|617130846|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
170760710|NCT03068468|617130847|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
170760711|NCT03068468|617130848|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
170760712|NCT03068468|617130845|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
170760713|NCT03068468|617130846|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
170760714|NCT03068468|617130847|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
170760715|NCT03068468|617130848|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
170760716|NCT03068468|617130845|FG000|Placebo-Controlled Period|Adverse Event|16|||
170760717|NCT03068468|617130846|FG001|Placebo-Controlled Period|Adverse Event|21|||
170760718|NCT03068468|617130847|FG002|Placebo-Controlled Period|Adverse Event|0|||
170760719|NCT03068468|617130848|FG003|Placebo-Controlled Period|Adverse Event|0|||
170760720|NCT03068468|617130845|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
170760721|NCT03068468|617130846|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
170760722|NCT03068468|617130847|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
170760723|NCT03068468|617130848|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
170760724|NCT03068468|617130845|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
170760725|NCT03068468|617130846|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
170760726|NCT03068468|617130847|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170760727|NCT03068468|617130848|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170760728|NCT03068468|617130845|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
170760729|NCT03068468|617130846|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
170760730|NCT03068468|617130847|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
170760731|NCT03068468|617130848|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
170760732|NCT03068468|617130845|FG000|Placebo-Controlled Period|Death|0|||
170760733|NCT03068468|617130846|FG001|Placebo-Controlled Period|Death|1|||
170760734|NCT03068468|617130847|FG002|Placebo-Controlled Period|Death|0|||
170760735|NCT03068468|617130848|FG003|Placebo-Controlled Period|Death|0|||
170760736|NCT03068468|617130845|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
170760737|NCT03068468|617130846|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
170760738|NCT03068468|617130847|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
170760739|NCT03068468|617130848|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
170760740|NCT03068468|617130845|FG000|Open-Label Extension Period|Adverse Event|0|||
170760741|NCT03068468|617130846|FG001|Open-Label Extension Period|Adverse Event|0|||
170760742|NCT03068468|617130847|FG002|Open-Label Extension Period|Adverse Event|13|||
170760743|NCT03068468|617130848|FG003|Open-Label Extension Period|Adverse Event|17|||
170760744|NCT03068468|617130845|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
170760745|NCT03068468|617130846|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
170760746|NCT03068468|617130847|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
170760747|NCT03068468|617130848|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
170760748|NCT03068468|617130845|FG000|Open-Label Extension Period|Death|0|||
170760749|NCT03068468|617130846|FG001|Open-Label Extension Period|Death|0|||
170760750|NCT03068468|617130847|FG002|Open-Label Extension Period|Death|0|||
170760751|NCT03068468|617130848|FG003|Open-Label Extension Period|Death|1|||
170760752|NCT03068468|617130845|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
170760753|NCT03068468|617130846|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
170760754|NCT03068468|617130847|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
170760755|NCT03068468|617130848|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
170760756|NCT03068468|617130845|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
170760757|NCT03068468|617130846|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
170760758|NCT03068468|617130847|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
170760759|NCT03068468|617130848|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
170760760|NCT03068468|617130845|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
170760761|NCT03068468|617130846|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
170760762|NCT03068468|617130847|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
170760763|NCT03068468|617130848|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
170760764|NCT03068468|617130845|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
170760765|NCT03068468|617130846|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
170760766|NCT03068468|617130847|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
170760767|NCT03068468|617130848|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
170760768|NCT03068468|617130845|FG000|Open-Label Extension Period|Reason not Specified|0|||
170408531|NCT01405820|615835582|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
170760769|NCT03068468|617130846|FG001|Open-Label Extension Period|Reason not Specified|0|||
170760770|NCT03068468|617130847|FG002|Open-Label Extension Period|Reason not Specified|1|||
170760771|NCT03068468|617130848|FG003|Open-Label Extension Period|Reason not Specified|4|||
170760772|NCT01118377|617130850|FG000|Overall Study|Did Not Receive Study Medication|1|||
170760773|NCT01118377|617130850|FG000|Overall Study|Death|38|||
170760774|NCT01118377|617130850|FG000|Overall Study|Failure to Return|3|||
170760775|NCT03140176|617130851|FG000|Overall Study|Reason missing|23|||
170760776|NCT03140176|617130851|FG000|Overall Study|Death|33|||
170760777|NCT03140176|617130851|FG000|Overall Study|Disease progression|1|||
170760778|NCT03140176|617130851|FG000|Overall Study|Physician Decision|1|||
170760779|NCT03140176|617130851|FG000|Overall Study|Withdrawal by Subject|1|||
170760780|NCT03140176|617130851|FG000|Overall Study|Lost to Follow-up|15|||
170760781|NCT00739102|617130852|FG000|Overall Study|Death|5|||
170760782|NCT00739102|617130852|FG000|Overall Study|Withdrawal by Subject|10|||
170760783|NCT03179787|617130854|FG000|Overall Study|Lost to Follow-up|15|||
170760784|NCT03179787|617130854|FG000|Overall Study|Case report failures|2|||
170760785|NCT03179787|617130854|FG000|Overall Study|Treatment not administered|1|||
170760786|NCT02030028|617130855|FG000|Overall Study|Withdrawal by Subject|4|||
170408532|NCT01405820|615835583|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
170408533|NCT01405820|615835578|FG000|Open-Label Treatment Period|Other|1|||
170408534|NCT01405820|615835579|FG001|Open-Label Treatment Period|Other|1|||
170408535|NCT01405820|615835580|FG002|Open-Label Treatment Period|Other|1|||
170408536|NCT01405820|615835581|FG003|Open-Label Treatment Period|Other|1|||
170408537|NCT01405820|615835582|FG004|Open-Label Treatment Period|Other|1|||
170408538|NCT01405820|615835583|FG005|Open-Label Treatment Period|Other|1|||
170408539|NCT01405820|615835578|FG000|Open-Label Treatment Period|Physician Decision|0|||
170408540|NCT01405820|615835579|FG001|Open-Label Treatment Period|Physician Decision|0|||
170408541|NCT01405820|615835580|FG002|Open-Label Treatment Period|Physician Decision|1|||
170408542|NCT01405820|615835581|FG003|Open-Label Treatment Period|Physician Decision|2|||
170408543|NCT01405820|615835582|FG004|Open-Label Treatment Period|Physician Decision|1|||
170408544|NCT01405820|615835583|FG005|Open-Label Treatment Period|Physician Decision|0|||
170408545|NCT01405820|615835578|FG000|Open-Label Treatment Period|Adverse Event|0|||
170408546|NCT01405820|615835579|FG001|Open-Label Treatment Period|Adverse Event|0|||
170408547|NCT01405820|615835580|FG002|Open-Label Treatment Period|Adverse Event|0|||
170408548|NCT01405820|615835581|FG003|Open-Label Treatment Period|Adverse Event|1|||
170408549|NCT01405820|615835582|FG004|Open-Label Treatment Period|Adverse Event|0|||
170408550|NCT01405820|615835583|FG005|Open-Label Treatment Period|Adverse Event|0|||
170408551|NCT03222141|615835584|FG000|Overall Study|Death|15|||
170408552|NCT03222141|615835584|FG000|Overall Study|Lost to Follow-up|3|||
170408553|NCT02436135|615835586|FG000|Overall Study|Progressive Disease|3|||
170408554|NCT02436135|615835587|FG001|Overall Study|Progressive Disease|1|||
170408555|NCT02436135|615835586|FG000|Overall Study|Investigator Discretion|1|||
170408556|NCT02436135|615835587|FG001|Overall Study|Investigator Discretion|2|||
170408557|NCT02436135|615835586|FG000|Overall Study|Adverse Event|1|||
170408558|NCT02436135|615835587|FG001|Overall Study|Adverse Event|0|||
170760787|NCT02030028|617130855|FG000|Overall Study|lack of transportation|1|||
170760788|NCT00661778|617130856|FG000|Overall Study|Disease Progression|23|||
170760789|NCT00661778|617130856|FG000|Overall Study|Adverse Event|18|||
170760790|NCT00661778|617130856|FG000|Overall Study|Reason not Specified|6|||
170760791|NCT00661778|617130856|FG000|Overall Study|Protocol Violation|2|||
170760792|NCT00661778|617130856|FG000|Overall Study|Withdrawal of Consent|1|||
170760793|NCT00991276|617130862|FG000|First Intervention Period|Adverse Event|0|||
170760794|NCT00991276|617130863|FG001|First Intervention Period|Adverse Event|1|||
170760795|NCT00991276|617130864|FG002|First Intervention Period|Adverse Event|0|||
170760796|NCT00991276|617130865|FG003|First Intervention Period|Adverse Event|1|||
170760797|NCT00991276|617130866|FG004|First Intervention Period|Adverse Event|0|||
170760798|NCT00991276|617130867|FG005|First Intervention Period|Adverse Event|0|||
170760799|NCT00991276|617130862|FG000|First Intervention Period|Protocol Violation|0|||
170760800|NCT00991276|617130863|FG001|First Intervention Period|Protocol Violation|0|||
170760801|NCT00991276|617130864|FG002|First Intervention Period|Protocol Violation|0|||
170760802|NCT00991276|617130865|FG003|First Intervention Period|Protocol Violation|0|||
170408559|NCT02436135|615835586|FG000|Overall Study|Withdrawal by Participant|1|||
170408560|NCT02436135|615835587|FG001|Overall Study|Withdrawal by Participant|0|||
170408561|NCT02436135|615835586|FG000|Overall Study|Study Terminated By Sponsor|0|||
170408562|NCT02436135|615835587|FG001|Overall Study|Study Terminated By Sponsor|1|||
170408563|NCT00475852|615835588|FG000|Overall Study|Death|444|||
170408564|NCT00475852|615835589|FG001|Overall Study|Death|456|||
170760803|NCT00991276|617130866|FG004|First Intervention Period|Protocol Violation|2|||
170760804|NCT00991276|617130867|FG005|First Intervention Period|Protocol Violation|0|||
170760805|NCT00991276|617130862|FG000|First Intervention Period|Insufficient clinical response|0|||
170760806|NCT00991276|617130863|FG001|First Intervention Period|Insufficient clinical response|0|||
170408565|NCT00475852|615835588|FG000|Overall Study|Withdrawal by Subject|19|||
170760807|NCT00991276|617130864|FG002|First Intervention Period|Insufficient clinical response|0|||
170408566|NCT00475852|615835589|FG001|Overall Study|Withdrawal by Subject|24|||
170760808|NCT00991276|617130865|FG003|First Intervention Period|Insufficient clinical response|0|||
170408567|NCT00475852|615835588|FG000|Overall Study|Lost to Follow-up|54|||
170408568|NCT00475852|615835589|FG001|Overall Study|Lost to Follow-up|68|||
170408569|NCT00297479|615835590|FG000|Overall Study|Lost to Follow-up|37|||
170408570|NCT00297479|615835591|FG001|Overall Study|Lost to Follow-up|54|||
170408571|NCT00297479|615835592|FG002|Overall Study|Lost to Follow-up|51|||
170408572|NCT03263819|615835593|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
170408573|NCT03263819|615835594|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
170408574|NCT00863057|615835599|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
170408575|NCT00863057|615835600|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
170760809|NCT00991276|617130866|FG004|First Intervention Period|Insufficient clinical response|1|||
170760810|NCT00991276|617130867|FG005|First Intervention Period|Insufficient clinical response|0|||
170760811|NCT00991276|617130862|FG000|First Intervention Period|Other|0|||
170760812|NCT00991276|617130863|FG001|First Intervention Period|Other|0|||
170760813|NCT00991276|617130864|FG002|First Intervention Period|Other|0|||
170760814|NCT00991276|617130865|FG003|First Intervention Period|Other|1|||
170760815|NCT00991276|617130866|FG004|First Intervention Period|Other|1|||
170760816|NCT00991276|617130867|FG005|First Intervention Period|Other|0|||
170760817|NCT00991276|617130862|FG000|First Intervention Period|Withdrawal by Subject|0|||
170760818|NCT00991276|617130863|FG001|First Intervention Period|Withdrawal by Subject|1|||
170760819|NCT00991276|617130864|FG002|First Intervention Period|Withdrawal by Subject|0|||
170760820|NCT00991276|617130865|FG003|First Intervention Period|Withdrawal by Subject|1|||
170760821|NCT00991276|617130866|FG004|First Intervention Period|Withdrawal by Subject|0|||
170760822|NCT00991276|617130867|FG005|First Intervention Period|Withdrawal by Subject|1|||
170760823|NCT00991276|617130862|FG000|First Intervention Period|Lost to Follow-up|0|||
170760824|NCT00991276|617130863|FG001|First Intervention Period|Lost to Follow-up|1|||
170760825|NCT00991276|617130864|FG002|First Intervention Period|Lost to Follow-up|0|||
170760826|NCT00991276|617130865|FG003|First Intervention Period|Lost to Follow-up|1|||
170760827|NCT00991276|617130866|FG004|First Intervention Period|Lost to Follow-up|0|||
170760828|NCT00991276|617130867|FG005|First Intervention Period|Lost to Follow-up|0|||
170760829|NCT00991276|617130862|FG000|Second Intervention Period|Adverse Event|0|||
170760830|NCT00991276|617130863|FG001|Second Intervention Period|Adverse Event|2|||
170760831|NCT00991276|617130864|FG002|Second Intervention Period|Adverse Event|0|||
170760832|NCT00991276|617130865|FG003|Second Intervention Period|Adverse Event|1|||
170760833|NCT00991276|617130866|FG004|Second Intervention Period|Adverse Event|1|||
170760834|NCT00991276|617130867|FG005|Second Intervention Period|Adverse Event|0|||
170760835|NCT00991276|617130862|FG000|Second Intervention Period|Protocol Violation|1|||
170760836|NCT00991276|617130863|FG001|Second Intervention Period|Protocol Violation|0|||
170760837|NCT00991276|617130864|FG002|Second Intervention Period|Protocol Violation|0|||
170760838|NCT00991276|617130865|FG003|Second Intervention Period|Protocol Violation|0|||
170760839|NCT00991276|617130866|FG004|Second Intervention Period|Protocol Violation|0|||
170760840|NCT00991276|617130867|FG005|Second Intervention Period|Protocol Violation|0|||
170760841|NCT00991276|617130862|FG000|Second Intervention Period|Other|0|||
170760842|NCT00991276|617130863|FG001|Second Intervention Period|Other|0|||
170760843|NCT00991276|617130864|FG002|Second Intervention Period|Other|0|||
170760844|NCT00991276|617130865|FG003|Second Intervention Period|Other|1|||
170760845|NCT00991276|617130866|FG004|Second Intervention Period|Other|0|||
170760846|NCT00991276|617130867|FG005|Second Intervention Period|Other|1|||
170760847|NCT00991276|617130862|FG000|Third Intervention Period|Protocol Violation|1|||
170760848|NCT00991276|617130863|FG001|Third Intervention Period|Protocol Violation|0|||
170760849|NCT00991276|617130864|FG002|Third Intervention Period|Protocol Violation|0|||
170760850|NCT00991276|617130865|FG003|Third Intervention Period|Protocol Violation|0|||
170760851|NCT00991276|617130866|FG004|Third Intervention Period|Protocol Violation|0|||
170760852|NCT00991276|617130867|FG005|Third Intervention Period|Protocol Violation|0|||
170760853|NCT00991276|617130862|FG000|Third Intervention Period|Other|0|||
170760854|NCT00991276|617130863|FG001|Third Intervention Period|Other|0|||
170760855|NCT00991276|617130864|FG002|Third Intervention Period|Other|0|||
170760856|NCT00991276|617130865|FG003|Third Intervention Period|Other|0|||
170760857|NCT00991276|617130866|FG004|Third Intervention Period|Other|0|||
170760858|NCT00991276|617130867|FG005|Third Intervention Period|Other|1|||
170760859|NCT00991276|617130862|FG000|Third Intervention Period|Adverse Event|0|||
170632061|NCT02968004|616664520|FG000|Main Study Phase|Withdrawal by Subject|0|||
170760860|NCT00991276|617130863|FG001|Third Intervention Period|Adverse Event|0|||
170760861|NCT00991276|617130864|FG002|Third Intervention Period|Adverse Event|1|||
170760862|NCT00991276|617130865|FG003|Third Intervention Period|Adverse Event|0|||
170760863|NCT00991276|617130866|FG004|Third Intervention Period|Adverse Event|0|||
170760864|NCT00991276|617130867|FG005|Third Intervention Period|Adverse Event|0|||
170760865|NCT00991276|617130862|FG000|Third Intervention Period|Withdrawal by Subject|0|||
170760866|NCT00991276|617130863|FG001|Third Intervention Period|Withdrawal by Subject|0|||
170760867|NCT00991276|617130864|FG002|Third Intervention Period|Withdrawal by Subject|0|||
170760868|NCT00991276|617130865|FG003|Third Intervention Period|Withdrawal by Subject|1|||
170760869|NCT00991276|617130866|FG004|Third Intervention Period|Withdrawal by Subject|0|||
170760870|NCT00991276|617130867|FG005|Third Intervention Period|Withdrawal by Subject|0|||
170760871|NCT01268891|617130869|FG000|Overall Study|Adverse Event|3|||
170760872|NCT01268891|617130870|FG001|Overall Study|Adverse Event|7|||
170760873|NCT01268891|617130869|FG000|Overall Study|Lack of Efficacy|1|||
170760874|NCT01268891|617130870|FG001|Overall Study|Lack of Efficacy|0|||
170760875|NCT01268891|617130869|FG000|Overall Study|Withdrawal of Consent|3|||
170760876|NCT01268891|617130870|FG001|Overall Study|Withdrawal of Consent|1|||
170760877|NCT01268891|617130869|FG000|Overall Study|Administrative or other reason(s)|1|||
170760878|NCT01268891|617130870|FG001|Overall Study|Administrative or other reason(s)|0|||
170760879|NCT02001623|617130872|FG000|Overall Study|Disease Progression|2|||
170760880|NCT02001623|617130873|FG001|Overall Study|Disease Progression|2|||
170760881|NCT02001623|617130874|FG002|Overall Study|Disease Progression|3|||
170760882|NCT02001623|617130875|FG003|Overall Study|Disease Progression|2|||
170760883|NCT02001623|617130876|FG004|Overall Study|Disease Progression|3|||
170760884|NCT02001623|617130877|FG005|Overall Study|Disease Progression|2|||
170760885|NCT02001623|617130878|FG006|Overall Study|Disease Progression|3|||
170760886|NCT02001623|617130879|FG007|Overall Study|Disease Progression|3|||
170760887|NCT02001623|617130880|FG008|Overall Study|Disease Progression|7|||
170760888|NCT02001623|617130881|FG009|Overall Study|Disease Progression|40|||
170760889|NCT02001623|617130882|FG010|Overall Study|Disease Progression|5|||
170760890|NCT02001623|617130883|FG011|Overall Study|Disease Progression|9|||
170760891|NCT02001623|617130884|FG012|Overall Study|Disease Progression|9|||
170760892|NCT02001623|617130885|FG013|Overall Study|Disease Progression|20|||
170760893|NCT02001623|617130886|FG014|Overall Study|Disease Progression|9|||
170760894|NCT02001623|617130872|FG000|Overall Study|Physician Decision|0|||
170760895|NCT02001623|617130873|FG001|Overall Study|Physician Decision|0|||
170760896|NCT02001623|617130874|FG002|Overall Study|Physician Decision|0|||
170760897|NCT02001623|617130875|FG003|Overall Study|Physician Decision|0|||
170760898|NCT02001623|617130876|FG004|Overall Study|Physician Decision|0|||
170760899|NCT02001623|617130877|FG005|Overall Study|Physician Decision|0|||
170760900|NCT02001623|617130878|FG006|Overall Study|Physician Decision|0|||
170760901|NCT02001623|617130879|FG007|Overall Study|Physician Decision|0|||
170760902|NCT02001623|617130880|FG008|Overall Study|Physician Decision|3|||
170760903|NCT02001623|617130881|FG009|Overall Study|Physician Decision|2|||
170760904|NCT02001623|617130882|FG010|Overall Study|Physician Decision|3|||
170760905|NCT02001623|617130883|FG011|Overall Study|Physician Decision|3|||
170760906|NCT02001623|617130884|FG012|Overall Study|Physician Decision|1|||
170760907|NCT02001623|617130885|FG013|Overall Study|Physician Decision|2|||
170760908|NCT02001623|617130886|FG014|Overall Study|Physician Decision|1|||
170760909|NCT02001623|617130872|FG000|Overall Study|Death|0|||
170760910|NCT02001623|617130873|FG001|Overall Study|Death|1|||
170760911|NCT02001623|617130874|FG002|Overall Study|Death|0|||
170760912|NCT02001623|617130875|FG003|Overall Study|Death|0|||
170760913|NCT02001623|617130876|FG004|Overall Study|Death|0|||
170760914|NCT02001623|617130877|FG005|Overall Study|Death|0|||
170760915|NCT02001623|617130878|FG006|Overall Study|Death|0|||
170760916|NCT02001623|617130879|FG007|Overall Study|Death|0|||
170760917|NCT02001623|617130880|FG008|Overall Study|Death|0|||
170408576|NCT00863057|615835601|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
170408577|NCT00863057|615835602|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
170408578|NCT00863057|615835599|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
170408579|NCT00863057|615835600|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
170408580|NCT00863057|615835601|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
170408581|NCT00863057|615835602|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
170408582|NCT00863057|615835599|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
170408583|NCT00863057|615835600|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
170408584|NCT00863057|615835601|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
170408585|NCT00863057|615835602|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
170408586|NCT00863057|615835599|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
170408587|NCT00863057|615835600|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
170408588|NCT00863057|615835601|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
170408589|NCT00863057|615835602|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
170408590|NCT01698320|615835603|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
170408591|NCT01698320|615835604|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
170760918|NCT02001623|617130881|FG009|Overall Study|Death|0|||
170760919|NCT02001623|617130882|FG010|Overall Study|Death|0|||
170760920|NCT02001623|617130883|FG011|Overall Study|Death|0|||
170408592|NCT01698320|615835605|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
170408593|NCT01698320|615835603|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
170760921|NCT02001623|617130884|FG012|Overall Study|Death|0|||
170760922|NCT02001623|617130885|FG013|Overall Study|Death|0|||
170760923|NCT02001623|617130886|FG014|Overall Study|Death|0|||
170760924|NCT02001623|617130872|FG000|Overall Study|Adverse Event|0|||
170760925|NCT02001623|617130873|FG001|Overall Study|Adverse Event|0|||
170760926|NCT02001623|617130874|FG002|Overall Study|Adverse Event|0|||
170760927|NCT02001623|617130875|FG003|Overall Study|Adverse Event|0|||
170760928|NCT02001623|617130876|FG004|Overall Study|Adverse Event|0|||
170760929|NCT02001623|617130877|FG005|Overall Study|Adverse Event|1|||
170760930|NCT02001623|617130878|FG006|Overall Study|Adverse Event|0|||
170760931|NCT02001623|617130879|FG007|Overall Study|Adverse Event|3|||
170760932|NCT02001623|617130880|FG008|Overall Study|Adverse Event|4|||
170866804|NCT01310803|617525168|FG000|Overall Study|Subject terminated by Sponsor|1|||
170866805|NCT01310803|617525169|FG001|Overall Study|Subject terminated by Sponsor|0|||
170866806|NCT00726622|617525172|FG000|Overall Study|Withdrawal by Subject|16|||
170866807|NCT00726622|617525173|FG001|Overall Study|Withdrawal by Subject|2|||
170866808|NCT00726622|617525172|FG000|Overall Study|Physician Decision|0|||
170866809|NCT00726622|617525173|FG001|Overall Study|Physician Decision|1|||
170866810|NCT00726622|617525172|FG000|Overall Study|Metastasis|2|||
170866811|NCT00726622|617525173|FG001|Overall Study|Metastasis|0|||
170866812|NCT00594516|617525175|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
170866813|NCT00594516|617525176|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
170866814|NCT00594516|617525177|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
170866815|NCT00594516|617525175|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
170866816|NCT00594516|617525176|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
170866817|NCT00594516|617525177|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
170866818|NCT00594516|617525175|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
170866819|NCT00594516|617525176|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
170866820|NCT00594516|617525177|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
170866821|NCT00594516|617525175|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
170866822|NCT00594516|617525176|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
170866823|NCT00594516|617525177|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
170866824|NCT00594516|617525175|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
170866825|NCT00594516|617525176|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
170866826|NCT00594516|617525177|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
170866827|NCT00594516|617525175|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
170866828|NCT00594516|617525176|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
170866829|NCT00594516|617525177|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
170866830|NCT00594516|617525175|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
170866831|NCT00594516|617525176|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
170866832|NCT00594516|617525177|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
170866833|NCT00594516|617525175|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
170866834|NCT00594516|617525176|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
170866835|NCT00594516|617525177|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
170866836|NCT00594516|617525175|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
170866837|NCT00594516|617525176|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
170866838|NCT00594516|617525177|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
170866839|NCT04606771|617525180|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
170866840|NCT04606771|617525181|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
170866841|NCT04606771|617525180|FG000|Overall Study|Death|5|||
170866842|NCT04606771|617525181|FG001|Overall Study|Death|6|||
170866843|NCT04606771|617525180|FG000|Overall Study|Wrong randomisation|0|||
170866844|NCT04606771|617525181|FG001|Overall Study|Wrong randomisation|1|||
170760933|NCT02001623|617130881|FG009|Overall Study|Adverse Event|6|||
170760934|NCT02001623|617130882|FG010|Overall Study|Adverse Event|4|||
170760935|NCT02001623|617130883|FG011|Overall Study|Adverse Event|0|||
170760936|NCT02001623|617130884|FG012|Overall Study|Adverse Event|3|||
170760937|NCT02001623|617130885|FG013|Overall Study|Adverse Event|5|||
170760938|NCT02001623|617130886|FG014|Overall Study|Adverse Event|6|||
170760939|NCT02001623|617130872|FG000|Overall Study|Other - Miscellaneous|0|||
170760940|NCT02001623|617130873|FG001|Overall Study|Other - Miscellaneous|0|||
170760941|NCT02001623|617130874|FG002|Overall Study|Other - Miscellaneous|0|||
170760942|NCT02001623|617130875|FG003|Overall Study|Other - Miscellaneous|0|||
170760943|NCT02001623|617130876|FG004|Overall Study|Other - Miscellaneous|0|||
170760944|NCT02001623|617130877|FG005|Overall Study|Other - Miscellaneous|0|||
170760945|NCT02001623|617130878|FG006|Overall Study|Other - Miscellaneous|0|||
170760946|NCT02001623|617130879|FG007|Overall Study|Other - Miscellaneous|0|||
170760947|NCT02001623|617130880|FG008|Overall Study|Other - Miscellaneous|0|||
170760948|NCT02001623|617130881|FG009|Overall Study|Other - Miscellaneous|1|||
170760949|NCT02001623|617130882|FG010|Overall Study|Other - Miscellaneous|0|||
170760950|NCT02001623|617130883|FG011|Overall Study|Other - Miscellaneous|0|||
170760951|NCT02001623|617130884|FG012|Overall Study|Other - Miscellaneous|0|||
170760952|NCT02001623|617130885|FG013|Overall Study|Other - Miscellaneous|1|||
170760953|NCT02001623|617130886|FG014|Overall Study|Other - Miscellaneous|0|||
170760954|NCT02001623|617130872|FG000|Overall Study|Withdrawal by Subject|1|||
170760955|NCT02001623|617130873|FG001|Overall Study|Withdrawal by Subject|0|||
170760956|NCT02001623|617130874|FG002|Overall Study|Withdrawal by Subject|0|||
170760957|NCT02001623|617130875|FG003|Overall Study|Withdrawal by Subject|0|||
170760958|NCT02001623|617130876|FG004|Overall Study|Withdrawal by Subject|0|||
170760959|NCT02001623|617130877|FG005|Overall Study|Withdrawal by Subject|0|||
170760960|NCT02001623|617130878|FG006|Overall Study|Withdrawal by Subject|0|||
170760961|NCT02001623|617130879|FG007|Overall Study|Withdrawal by Subject|0|||
170760962|NCT02001623|617130880|FG008|Overall Study|Withdrawal by Subject|1|||
170760963|NCT02001623|617130881|FG009|Overall Study|Withdrawal by Subject|3|||
170866845|NCT01423812|617525182|FG000|Overall Study|Lost to Follow-up|2|||
170866846|NCT01423812|617525183|FG001|Overall Study|Lost to Follow-up|2|||
170866847|NCT01423812|617525182|FG000|Overall Study|Withdrawal by Subject|1|||
170866848|NCT01423812|617525183|FG001|Overall Study|Withdrawal by Subject|2|||
170866849|NCT02596620|617525184|FG000|Overall Study|Lost to Follow-up|1|||
170866850|NCT02596620|617525185|FG001|Overall Study|Lost to Follow-up|1|||
170866851|NCT03155373|617525186|FG000|Overall Study|No longer required surgery|1|||
170866852|NCT03155373|617525186|FG000|Overall Study|Protocol Violation|1|||
170866853|NCT03155373|617525186|FG000|Overall Study|Death|2|||
170866854|NCT03155373|617525186|FG000|Overall Study|Withdrawal by Subject|3|||
170866855|NCT02856893|617525187|FG000|Overall Study|Lack of Efficacy|27|||
170866856|NCT02856893|617525188|FG001|Overall Study|Lack of Efficacy|15|||
170866857|NCT02856893|617525189|FG002|Overall Study|Lack of Efficacy|19|||
170866858|NCT02856893|617525187|FG000|Overall Study|Death|1|||
170866859|NCT02856893|617525188|FG001|Overall Study|Death|0|||
170866860|NCT02856893|617525189|FG002|Overall Study|Death|0|||
170866861|NCT02856893|617525187|FG000|Overall Study|Adverse Event|2|||
170866862|NCT02856893|617525188|FG001|Overall Study|Adverse Event|0|||
170866863|NCT02856893|617525189|FG002|Overall Study|Adverse Event|0|||
170866864|NCT02856893|617525187|FG000|Overall Study|Physician Decision|0|||
170866865|NCT02856893|617525188|FG001|Overall Study|Physician Decision|2|||
170866866|NCT02856893|617525189|FG002|Overall Study|Physician Decision|3|||
170866867|NCT02856893|617525187|FG000|Overall Study|Withdrawal by Subject|1|||
170866868|NCT02856893|617525188|FG001|Overall Study|Withdrawal by Subject|1|||
170866869|NCT02856893|617525189|FG002|Overall Study|Withdrawal by Subject|0|||
170866870|NCT02856893|617525187|FG000|Overall Study|Other reasons|2|||
170866871|NCT02856893|617525188|FG001|Overall Study|Other reasons|1|||
170866872|NCT02856893|617525189|FG002|Overall Study|Other reasons|2|||
170866873|NCT01233869|617525194|FG000|Initial Treatment Period (24 Months)|Death|1|||
170866874|NCT01233869|617525195|FG001|Initial Treatment Period (24 Months)|Death|0|||
170760964|NCT02001623|617130882|FG010|Overall Study|Withdrawal by Subject|2|||
170760965|NCT02001623|617130883|FG011|Overall Study|Withdrawal by Subject|2|||
170760966|NCT02001623|617130884|FG012|Overall Study|Withdrawal by Subject|1|||
170760967|NCT02001623|617130885|FG013|Overall Study|Withdrawal by Subject|5|||
170760968|NCT02001623|617130886|FG014|Overall Study|Withdrawal by Subject|2|||
170760969|NCT02001623|617130872|FG000|Overall Study|Lost to Follow-up|0|||
170760970|NCT02001623|617130873|FG001|Overall Study|Lost to Follow-up|0|||
170760971|NCT02001623|617130874|FG002|Overall Study|Lost to Follow-up|0|||
170760972|NCT02001623|617130875|FG003|Overall Study|Lost to Follow-up|0|||
170760973|NCT02001623|617130876|FG004|Overall Study|Lost to Follow-up|0|||
170760974|NCT02001623|617130877|FG005|Overall Study|Lost to Follow-up|0|||
170760975|NCT02001623|617130878|FG006|Overall Study|Lost to Follow-up|0|||
170760976|NCT02001623|617130879|FG007|Overall Study|Lost to Follow-up|0|||
170760977|NCT02001623|617130880|FG008|Overall Study|Lost to Follow-up|0|||
170760978|NCT02001623|617130881|FG009|Overall Study|Lost to Follow-up|1|||
170760979|NCT02001623|617130882|FG010|Overall Study|Lost to Follow-up|0|||
170760980|NCT02001623|617130883|FG011|Overall Study|Lost to Follow-up|0|||
170760981|NCT02001623|617130884|FG012|Overall Study|Lost to Follow-up|0|||
170760982|NCT02001623|617130885|FG013|Overall Study|Lost to Follow-up|0|||
170760983|NCT02001623|617130886|FG014|Overall Study|Lost to Follow-up|0|||
170760984|NCT02001623|617130872|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
170760985|NCT02001623|617130873|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
170760986|NCT02001623|617130874|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
170760987|NCT02001623|617130875|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
170760988|NCT02001623|617130876|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
170760989|NCT02001623|617130877|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
170760990|NCT02001623|617130878|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
170760991|NCT02001623|617130879|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
170760992|NCT02001623|617130880|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
170866875|NCT01233869|617525196|FG002|Initial Treatment Period (24 Months)|Death|0|||
170866876|NCT01233869|617525197|FG003|Initial Treatment Period (24 Months)|Death|0|||
170866877|NCT01233869|617525194|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
170866878|NCT01233869|617525195|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
170866879|NCT01233869|617525196|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
170866880|NCT01233869|617525197|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
170760993|NCT02001623|617130881|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
170760994|NCT02001623|617130882|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
170760995|NCT02001623|617130883|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
170760996|NCT02001623|617130884|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
170760997|NCT02001623|617130885|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
170866881|NCT01233869|617525194|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
170866882|NCT01233869|617525195|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
170866883|NCT01233869|617525196|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
170866884|NCT01233869|617525197|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
170866885|NCT01233869|617525194|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
170760998|NCT02001623|617130886|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
170760999|NCT02001623|617130872|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
170761000|NCT02001623|617130873|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
170761001|NCT02001623|617130874|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
170761002|NCT02001623|617130875|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
170761003|NCT02001623|617130876|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
170761004|NCT02001623|617130877|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
170761005|NCT02001623|617130878|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
170761006|NCT02001623|617130879|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
170761007|NCT02001623|617130880|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
170761008|NCT02001623|617130881|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
170761009|NCT02001623|617130882|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
170761010|NCT02001623|617130883|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
170761011|NCT02001623|617130884|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
170761012|NCT02001623|617130885|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
170761013|NCT02001623|617130886|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
170761014|NCT00109967|617130893|FG000|Overall Study|Cancel Prior to Treatment|2|||
170761015|NCT00109967|617130894|FG001|Overall Study|Cancel Prior to Treatment|0|||
170761016|NCT00109967|617130893|FG000|Overall Study|Adverse Event|12|||
170761017|NCT00109967|617130894|FG001|Overall Study|Adverse Event|1|||
170761018|NCT00109967|617130893|FG000|Overall Study|Withdrawal by Subject|5|||
170761019|NCT00109967|617130894|FG001|Overall Study|Withdrawal by Subject|0|||
170761020|NCT00109967|617130893|FG000|Overall Study|Physician Decision|1|||
170761021|NCT00109967|617130894|FG001|Overall Study|Physician Decision|3|||
170761022|NCT00109967|617130893|FG000|Overall Study|Death|0|||
170761023|NCT00109967|617130894|FG001|Overall Study|Death|2|||
170761024|NCT02263508|617130897|FG000|Overall Study|Withdrawal by Subject|1|||
170761025|NCT02263508|617130898|FG001|Overall Study|Withdrawal by Subject|23|||
170761026|NCT02263508|617130899|FG002|Overall Study|Withdrawal by Subject|17|||
170761027|NCT02263508|617130897|FG000|Overall Study|Sponsor Decision|12|||
170761028|NCT02263508|617130898|FG001|Overall Study|Sponsor Decision|165|||
170761029|NCT02263508|617130899|FG002|Overall Study|Sponsor Decision|182|||
170761030|NCT02263508|617130897|FG000|Overall Study|Lost to Follow-up|2|||
170761031|NCT02263508|617130898|FG001|Overall Study|Lost to Follow-up|7|||
170761032|NCT02263508|617130899|FG002|Overall Study|Lost to Follow-up|7|||
170761033|NCT02263508|617130897|FG000|Overall Study|Death|6|||
170761034|NCT02263508|617130898|FG001|Overall Study|Death|151|||
170761035|NCT02263508|617130899|FG002|Overall Study|Death|140|||
170761036|NCT03721016|617130901|FG000|Overall Study|Adverse Event|0|||
170761037|NCT03721016|617130902|FG001|Overall Study|Adverse Event|1|||
170761038|NCT03721016|617130903|FG002|Overall Study|Adverse Event|1|||
170761039|NCT03721016|617130901|FG000|Overall Study|Withdrawal by Subject|8|||
170761040|NCT03721016|617130902|FG001|Overall Study|Withdrawal by Subject|16|||
170761041|NCT03721016|617130903|FG002|Overall Study|Withdrawal by Subject|13|||
170761042|NCT03721016|617130901|FG000|Overall Study|Lost to Follow-up|4|||
170761043|NCT03721016|617130902|FG001|Overall Study|Lost to Follow-up|6|||
170761044|NCT03721016|617130903|FG002|Overall Study|Lost to Follow-up|5|||
170761045|NCT03721016|617130901|FG000|Overall Study|Physician Decision|0|||
170761046|NCT03721016|617130902|FG001|Overall Study|Physician Decision|1|||
170761047|NCT03721016|617130903|FG002|Overall Study|Physician Decision|2|||
170761048|NCT03721016|617130901|FG000|Overall Study|Protocol Violation|0|||
170761049|NCT03721016|617130902|FG001|Overall Study|Protocol Violation|1|||
170761050|NCT03721016|617130903|FG002|Overall Study|Protocol Violation|0|||
170761051|NCT03721016|617130901|FG000|Overall Study|Site terminated by sponsor|3|||
170761052|NCT03721016|617130902|FG001|Overall Study|Site terminated by sponsor|7|||
170761053|NCT03721016|617130903|FG002|Overall Study|Site terminated by sponsor|6|||
170761054|NCT03721016|617130901|FG000|Overall Study|Subject exited early due to COVID-19|1|||
170761055|NCT03721016|617130902|FG001|Overall Study|Subject exited early due to COVID-19|0|||
170761056|NCT03721016|617130903|FG002|Overall Study|Subject exited early due to COVID-19|0|||
170761057|NCT02232178|617130904|FG000|Overall Study|Lost to Follow-up|0|||
170761058|NCT02232178|617130905|FG001|Overall Study|Lost to Follow-up|1|||
170761059|NCT02232178|617130906|FG002|Overall Study|Lost to Follow-up|0|||
170761060|NCT02232178|617130904|FG000|Overall Study|ineligibility|0|||
170761061|NCT02232178|617130905|FG001|Overall Study|ineligibility|0|||
170761062|NCT02232178|617130906|FG002|Overall Study|ineligibility|1|||
170761063|NCT02232178|617130904|FG000|Overall Study|surgical complication|1|||
170761064|NCT02232178|617130905|FG001|Overall Study|surgical complication|0|||
170632062|NCT02968004|616664521|FG001|Main Study Phase|Withdrawal by Subject|1|||
170632063|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
170632064|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
170632065|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
170632066|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
170632067|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
170632068|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
170632069|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
170632070|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
170761065|NCT02232178|617130906|FG002|Overall Study|surgical complication|0|||
170632071|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
170632072|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
170632073|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
170632074|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
170632075|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
170632076|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
170632077|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
170632078|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
170632079|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
170632080|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
170632081|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
170632082|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
170632083|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
170632084|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
170632085|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
170632086|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
170761066|NCT01149681|617130907|FG000|Overall Study|Withdrawal by Subject|7|||
170761067|NCT01149681|617130907|FG000|Overall Study|Progressive disease|1|||
170761068|NCT01149681|617130907|FG000|Overall Study|Physician Decision|2|||
170761069|NCT01149681|617130907|FG000|Overall Study|adverse events nonrelated study drug|2|||
170761070|NCT04176458|617130909|FG000|Overall Study|Covid 19|4|||
170761071|NCT02131324|617130910|FG000|Overall Study|Withdrawal by Subject|1|||
170761072|NCT02131324|617130911|FG001|Overall Study|Withdrawal by Subject|2|||
170761073|NCT02131324|617130910|FG000|Overall Study|Lost to Follow-up|1|||
170761074|NCT02131324|617130911|FG001|Overall Study|Lost to Follow-up|1|||
170761075|NCT01693614|617130912|FG000|Overall Study|Adverse Event|7|||
170761076|NCT01693614|617130913|FG001|Overall Study|Adverse Event|11|||
170761077|NCT01693614|617130914|FG002|Overall Study|Adverse Event|5|||
170761078|NCT01693614|617130912|FG000|Overall Study|Disease progression|11|||
170761079|NCT01693614|617130913|FG001|Overall Study|Disease progression|8|||
170761080|NCT01693614|617130914|FG002|Overall Study|Disease progression|7|||
170632087|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
170632088|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
170632089|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
170632090|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
170632091|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
170632092|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
170761081|NCT01693614|617130912|FG000|Overall Study|Protocol Violation|5|||
170761082|NCT01693614|617130913|FG001|Overall Study|Protocol Violation|2|||
170761083|NCT01693614|617130914|FG002|Overall Study|Protocol Violation|1|||
170761084|NCT01693614|617130912|FG000|Overall Study|Death|1|||
170761085|NCT01693614|617130913|FG001|Overall Study|Death|0|||
170761086|NCT01693614|617130914|FG002|Overall Study|Death|0|||
170761087|NCT01693614|617130912|FG000|Overall Study|Physician Decision|1|||
170761088|NCT01693614|617130913|FG001|Overall Study|Physician Decision|1|||
170761089|NCT01693614|617130914|FG002|Overall Study|Physician Decision|4|||
170761090|NCT01693614|617130912|FG000|Overall Study|Withdrawal by subject/guardian|0|||
170761091|NCT01693614|617130913|FG001|Overall Study|Withdrawal by subject/guardian|0|||
170761092|NCT01693614|617130914|FG002|Overall Study|Withdrawal by subject/guardian|2|||
170761093|NCT01693614|617130912|FG000|Overall Study|Withdrawal by Subject|1|||
170761094|NCT01693614|617130913|FG001|Overall Study|Withdrawal by Subject|0|||
170761095|NCT01693614|617130914|FG002|Overall Study|Withdrawal by Subject|5|||
170761096|NCT05419557|617130915|FG000|Overall Study|Lost to Follow-up|11|||
170761097|NCT05419557|617130916|FG001|Overall Study|Lost to Follow-up|4|||
170761098|NCT01368406|617130917|FG000|Overall Study|Lost to Follow-up|8|||
170761099|NCT01368406|617130918|FG001|Overall Study|Lost to Follow-up|4|||
170761100|NCT01368406|617130917|FG000|Overall Study|Withdrawal by Subject|8|||
170761101|NCT01368406|617130918|FG001|Overall Study|Withdrawal by Subject|4|||
170761102|NCT01368406|617130917|FG000|Overall Study|relapse of the disease|3|||
170761103|NCT01368406|617130918|FG001|Overall Study|relapse of the disease|2|||
170761104|NCT01368406|617130917|FG000|Overall Study|started working|2|||
170761105|NCT01368406|617130918|FG001|Overall Study|started working|3|||
170761106|NCT00543725|617130921|FG000|Overall Study|Adverse Event|18|||
170761107|NCT00543725|617130922|FG001|Overall Study|Adverse Event|27|||
170761108|NCT00543725|617130921|FG000|Overall Study|Sponsor's Decision|0|||
170761109|NCT00543725|617130922|FG001|Overall Study|Sponsor's Decision|1|||
170761110|NCT00543725|617130921|FG000|Overall Study|Subject Non-Compliant|4|||
170761111|NCT00543725|617130922|FG001|Overall Study|Subject Non-Compliant|4|||
170761112|NCT00543725|617130921|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
170761113|NCT00543725|617130922|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
170761114|NCT00543725|617130921|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
170761115|NCT00543725|617130922|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
170761116|NCT00543725|617130921|FG000|Overall Study|Protocol Violation|0|||
170761117|NCT00543725|617130922|FG001|Overall Study|Protocol Violation|1|||
170761118|NCT00543725|617130921|FG000|Overall Study|Withdrawal by Subject|4|||
170761119|NCT00543725|617130922|FG001|Overall Study|Withdrawal by Subject|13|||
170761120|NCT00543725|617130921|FG000|Overall Study|Lost to Follow-up|15|||
170761121|NCT00543725|617130922|FG001|Overall Study|Lost to Follow-up|11|||
170866886|NCT01233869|617525195|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
170866887|NCT01233869|617525196|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
170866888|NCT01233869|617525197|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
170408594|NCT01698320|615835604|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
170408595|NCT01698320|615835605|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
170408596|NCT01698320|615835603|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
170761122|NCT00543725|617130921|FG000|Overall Study|Other|3|||
170761123|NCT00543725|617130922|FG001|Overall Study|Other|3|||
170761124|NCT01599325|617130930|FG000|Primary Parent Phase|Adverse Event|5|||
170761125|NCT01599325|617130930|FG000|Primary Parent Phase|Disease Progression|7|||
170761126|NCT01599325|617130930|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
170761127|NCT01599325|617130930|FG000|Primary Parent Phase|Death|13|||
170761128|NCT01599325|617130930|FG000|Primary Parent Phase|Protocol Violation|1|||
170761129|NCT01599325|617130930|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
170761130|NCT01599325|617130930|FG000|Primary Parent Phase|Other|2|||
170761131|NCT01599325|617130930|FG000|Extension Phase|Study Closure|1|||
170761132|NCT01599325|617130930|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
170761133|NCT01599325|617130930|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
170761134|NCT01599325|617130930|FG000|Extension Phase|Disease Progression|1|||
170761135|NCT01599325|617130930|FG000|Extension Phase|Withdrawal by Subject|8|||
170761136|NCT01878890|617130931|FG000|Overall Study|Protocol Violation|0|||
170761137|NCT01878890|617130932|FG001|Overall Study|Protocol Violation|1|||
170761138|NCT01878890|617130933|FG002|Overall Study|Protocol Violation|0|||
170761139|NCT01878890|617130934|FG003|Overall Study|Protocol Violation|0|||
170761140|NCT01710514|617130939|FG000|Overall Study|Adverse Event|6|||
170761141|NCT01710514|617130940|FG001|Overall Study|Adverse Event|7|||
170761142|NCT01710514|617130939|FG000|Overall Study|Withdrawal by Subject|1|||
170761143|NCT01710514|617130940|FG001|Overall Study|Withdrawal by Subject|0|||
170761144|NCT02846415|617130941|FG000|Overall Study|Lost to Follow-up|2|||
170761145|NCT02846415|617130942|FG001|Overall Study|Lost to Follow-up|0|||
170761146|NCT02846415|617130941|FG000|Overall Study|Withdrawal by Subject|1|||
170761147|NCT02846415|617130942|FG001|Overall Study|Withdrawal by Subject|1|||
170761148|NCT00567164|617130943|FG000|Overall Study|Withdrawal by Subject|171|||
170408597|NCT01698320|615835604|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
170408598|NCT01698320|615835605|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
170408599|NCT01698320|615835603|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
170408600|NCT01698320|615835604|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
170408601|NCT01698320|615835605|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
170408602|NCT01698320|615835603|FG000|12-Week Double-Blind Period|Adverse Event|0|||
170408603|NCT01698320|615835604|FG001|12-Week Double-Blind Period|Adverse Event|1|||
170408604|NCT01698320|615835605|FG002|12-Week Double-Blind Period|Adverse Event|1|||
170408605|NCT01698320|615835603|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
170408606|NCT01698320|615835604|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
170408607|NCT01698320|615835605|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
170408608|NCT01698320|615835603|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
170408609|NCT01698320|615835604|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
170408610|NCT01698320|615835605|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
170408611|NCT01698320|615835603|FG000|12-Week Double-Blind Period|Pregnancy|0|||
170408612|NCT01698320|615835604|FG001|12-Week Double-Blind Period|Pregnancy|1|||
170408613|NCT01698320|615835605|FG002|12-Week Double-Blind Period|Pregnancy|1|||
170408614|NCT01698320|615835603|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
170408615|NCT01698320|615835604|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
170408616|NCT01698320|615835605|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
170408617|NCT01698320|615835603|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
170408618|NCT01698320|615835604|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
170408619|NCT01698320|615835605|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
170408620|NCT01698320|615835603|FG000|40-Week Open-Label Period|Adverse Event|0|||
170408621|NCT01698320|615835604|FG001|40-Week Open-Label Period|Adverse Event|3|||
170408622|NCT01698320|615835605|FG002|40-Week Open-Label Period|Adverse Event|2|||
170519729|NCT00268983|616247608|FG000|Overall Study|Death|3|||
170761149|NCT00567164|617130944|FG001|Overall Study|Withdrawal by Subject|21|||
170761150|NCT00567164|617130945|FG002|Overall Study|Withdrawal by Subject|17|||
170761151|NCT00567164|617130943|FG000|Overall Study|Protocol Violation|23|||
170761152|NCT00567164|617130944|FG001|Overall Study|Protocol Violation|4|||
170761153|NCT00567164|617130945|FG002|Overall Study|Protocol Violation|2|||
170761154|NCT00567164|617130943|FG000|Overall Study|Adverse Event|92|||
170761155|NCT00567164|617130944|FG001|Overall Study|Adverse Event|13|||
170761156|NCT00567164|617130945|FG002|Overall Study|Adverse Event|9|||
170761157|NCT00567164|617130943|FG000|Overall Study|Death|0|||
170761158|NCT00567164|617130944|FG001|Overall Study|Death|0|||
170761159|NCT00567164|617130945|FG002|Overall Study|Death|1|||
170761160|NCT00567164|617130943|FG000|Overall Study|Lost to Follow-up|202|||
170761161|NCT00567164|617130944|FG001|Overall Study|Lost to Follow-up|23|||
170761162|NCT00567164|617130945|FG002|Overall Study|Lost to Follow-up|21|||
170761163|NCT00567164|617130943|FG000|Overall Study|Pregnancy|20|||
170761164|NCT00567164|617130944|FG001|Overall Study|Pregnancy|4|||
170761165|NCT00567164|617130945|FG002|Overall Study|Pregnancy|6|||
170761166|NCT00567164|617130943|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
170761167|NCT00567164|617130944|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
170761168|NCT00567164|617130945|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
170761169|NCT00567164|617130943|FG000|Overall Study|Missing|1|||
170761170|NCT00567164|617130944|FG001|Overall Study|Missing|0|||
170761171|NCT00567164|617130945|FG002|Overall Study|Missing|0|||
170761172|NCT04044664|617130946|FG000|Stage 1|Adverse Event|3|||
170761173|NCT04044664|617130947|FG001|Stage 1|Adverse Event|3|||
170761174|NCT04044664|617130948|FG002|Stage 1|Adverse Event|1|||
170761175|NCT04044664|617130946|FG000|Stage 1|Lost to Follow-up|3|||
170761176|NCT04044664|617130947|FG001|Stage 1|Lost to Follow-up|2|||
170761177|NCT04044664|617130948|FG002|Stage 1|Lost to Follow-up|2|||
170761178|NCT04044664|617130946|FG000|Stage 1|Withdrawal by Subject|9|||
170761179|NCT04044664|617130947|FG001|Stage 1|Withdrawal by Subject|1|||
170761180|NCT04044664|617130948|FG002|Stage 1|Withdrawal by Subject|0|||
170761181|NCT04044664|617130946|FG000|Stage 1|noncompliance, personal reason|2|||
170761182|NCT04044664|617130947|FG001|Stage 1|noncompliance, personal reason|0|||
170761183|NCT04044664|617130948|FG002|Stage 1|noncompliance, personal reason|0|||
170761184|NCT04044664|617130946|FG000|Stage 1|randomization error|0|||
170761185|NCT04044664|617130947|FG001|Stage 1|randomization error|1|||
170761186|NCT04044664|617130948|FG002|Stage 1|randomization error|0|||
170761187|NCT04044664|617130946|FG000|Stage 2|Adverse Event|2|||
170761188|NCT04044664|617130947|FG001|Stage 2|Adverse Event|0|||
170761189|NCT04044664|617130948|FG002|Stage 2|Adverse Event|0|||
170761190|NCT04044664|617130946|FG000|Stage 2|Lost to Follow-up|3|||
170761191|NCT04044664|617130947|FG001|Stage 2|Lost to Follow-up|2|||
170761192|NCT04044664|617130948|FG002|Stage 2|Lost to Follow-up|1|||
170761193|NCT04044664|617130946|FG000|Stage 2|Withdrawal by Subject|3|||
170761194|NCT04044664|617130947|FG001|Stage 2|Withdrawal by Subject|0|||
170761195|NCT04044664|617130948|FG002|Stage 2|Withdrawal by Subject|0|||
170761196|NCT04044664|617130946|FG000|Stage 2|protocol deviation|1|||
170761197|NCT04044664|617130947|FG001|Stage 2|protocol deviation|0|||
170761198|NCT04044664|617130948|FG002|Stage 2|protocol deviation|0|||
170761199|NCT01348087|617130955|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
170761200|NCT01348087|617130955|FG000|Overall Study|Administrative problems|79|||
170761201|NCT01348087|617130955|FG000|Overall Study|protocol deviation|1|||
170761202|NCT01348087|617130955|FG000|Overall Study|Lost to Follow-up|1|||
170761203|NCT01348087|617130955|FG000|Overall Study|Subject withdrew consent|7|||
170761204|NCT01348087|617130955|FG000|Overall Study|Adverse Event|25|||
170761205|NCT02449044|617130956|FG000|Overall Study|Lost to Follow-up|2|||
170761206|NCT02449044|617130956|FG000|Overall Study|Withdrawal by Subject|13|||
170761207|NCT02449044|617130956|FG000|Overall Study|Adverse Event|30|||
170761208|NCT02449044|617130956|FG000|Overall Study|Met Withdrawal Criteria|7|||
170761209|NCT02449044|617130956|FG000|Overall Study|Physician Decision|9|||
170761210|NCT02449044|617130956|FG000|Overall Study|Sponsor Discontinued Trial|3|||
170761211|NCT04257058|617133144|FG000|Overall Study|Lost to Follow-up|31|||
170761212|NCT03227757|617133145|FG000|Overall Study|Death|25|||
170761213|NCT03227757|617133145|FG000|Overall Study|Withdrawal|10|||
170761214|NCT03227757|617133145|FG000|Overall Study|Missed visits|1|||
170761215|NCT03227757|617133145|FG000|Overall Study|Lost to Follow-up|2|||
170761216|NCT02960659|617133147|FG000|Overall Study|Withdrawal by Subject|1|||
170761217|NCT02960659|617133148|FG001|Overall Study|Withdrawal by Subject|0|||
170761218|NCT02960659|617133147|FG000|Overall Study|Poor compliance|0|||
170761219|NCT02960659|617133148|FG001|Overall Study|Poor compliance|1|||
170761220|NCT02987543|617133151|FG000|Overall Study|Ongoing study at data cut off|49|||
170761221|NCT02987543|617133152|FG001|Overall Study|Ongoing study at data cut off|21|||
170761222|NCT02987543|617133153|FG002|Overall Study|Ongoing study at data cut off|19|||
170761223|NCT02987543|617133154|FG003|Overall Study|Ongoing study at data cut off|12|||
170761224|NCT02987543|617133151|FG000|Overall Study|Death|88|||
170761225|NCT02987543|617133152|FG001|Overall Study|Death|54|||
170761226|NCT02987543|617133153|FG002|Overall Study|Death|67|||
170761227|NCT02987543|617133154|FG003|Overall Study|Death|28|||
170761228|NCT02987543|617133151|FG000|Overall Study|Lost to Follow-up|3|||
170761229|NCT02987543|617133152|FG001|Overall Study|Lost to Follow-up|0|||
170761230|NCT02987543|617133153|FG002|Overall Study|Lost to Follow-up|1|||
170761231|NCT02987543|617133154|FG003|Overall Study|Lost to Follow-up|0|||
170761232|NCT02987543|617133151|FG000|Overall Study|Screen failure|0|||
170761233|NCT02987543|617133152|FG001|Overall Study|Screen failure|0|||
170761234|NCT02987543|617133153|FG002|Overall Study|Screen failure|0|||
170761235|NCT02987543|617133154|FG003|Overall Study|Screen failure|1|||
170761236|NCT02987543|617133151|FG000|Overall Study|Withdrawal by Subject|21|||
170761237|NCT02987543|617133152|FG001|Overall Study|Withdrawal by Subject|7|||
170761238|NCT02987543|617133153|FG002|Overall Study|Withdrawal by Subject|7|||
170761239|NCT02987543|617133154|FG003|Overall Study|Withdrawal by Subject|6|||
170408623|NCT01698320|615835603|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
170408624|NCT01698320|615835604|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
170408625|NCT01698320|615835605|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
170408626|NCT01698320|615835603|FG000|40-Week Open-Label Period|Pregnancy|0|||
170408627|NCT01698320|615835604|FG001|40-Week Open-Label Period|Pregnancy|2|||
170408628|NCT01698320|615835605|FG002|40-Week Open-Label Period|Pregnancy|1|||
170408629|NCT01698320|615835603|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
170408630|NCT01698320|615835604|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
170408631|NCT01698320|615835605|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
170408632|NCT01698320|615835603|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
170408633|NCT01698320|615835604|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
170408634|NCT01698320|615835605|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
170408635|NCT00686920|615835607|FG000|Overall Study|Death|45|||
170408636|NCT00686920|615835608|FG001|Overall Study|Death|14|||
170408637|NCT00686920|615835607|FG000|Overall Study|Liver Transplant|23|||
170408638|NCT00686920|615835608|FG001|Overall Study|Liver Transplant|8|||
170408639|NCT00686920|615835607|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
170408640|NCT00686920|615835608|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
170408641|NCT00686920|615835607|FG000|Overall Study|Withdrawal by Subject|23|||
170408642|NCT00686920|615835608|FG001|Overall Study|Withdrawal by Subject|5|||
170408643|NCT00686920|615835607|FG000|Overall Study|Protocol Violation|2|||
170408644|NCT00686920|615835608|FG001|Overall Study|Protocol Violation|1|||
170408645|NCT00686920|615835607|FG000|Overall Study|Adverse Event|10|||
170761240|NCT02987543|617133151|FG000|Overall Study|Study terminated by sponsor|1|||
170761241|NCT02987543|617133152|FG001|Overall Study|Study terminated by sponsor|0|||
170761242|NCT02987543|617133153|FG002|Overall Study|Study terminated by sponsor|0|||
170408646|NCT00686920|615835608|FG001|Overall Study|Adverse Event|2|||
170408647|NCT00686920|615835607|FG000|Overall Study|Personal Reason|0|||
170408648|NCT00686920|615835608|FG001|Overall Study|Personal Reason|1|||
170408649|NCT00686920|615835607|FG000|Overall Study|Lost to Follow-up|15|||
170408650|NCT00686920|615835608|FG001|Overall Study|Lost to Follow-up|3|||
170408651|NCT00686920|615835607|FG000|Overall Study|Moved to Another State|1|||
170408652|NCT00686920|615835608|FG001|Overall Study|Moved to Another State|0|||
170408653|NCT00686920|615835607|FG000|Overall Study|Transferred to Nursing Home|1|||
170408654|NCT00686920|615835608|FG001|Overall Study|Transferred to Nursing Home|0|||
170408655|NCT00686920|615835607|FG000|Overall Study|Noncompliance|9|||
170408656|NCT00686920|615835608|FG001|Overall Study|Noncompliance|0|||
170408657|NCT00686920|615835607|FG000|Overall Study|Principal Investigator Decision|2|||
170408658|NCT00686920|615835608|FG001|Overall Study|Principal Investigator Decision|0|||
170408659|NCT00814658|615835613|FG000|Overall Study|Lost to Follow-up|0|||
170408660|NCT00814658|615835614|FG001|Overall Study|Lost to Follow-up|1|||
170408661|NCT00814658|615835613|FG000|Overall Study|Physician Decision|1|||
170408662|NCT00814658|615835614|FG001|Overall Study|Physician Decision|0|||
170761243|NCT02987543|617133154|FG003|Overall Study|Study terminated by sponsor|0|||
170761244|NCT02987543|617133151|FG000|Overall Study|Investigator decision|0|||
170761245|NCT02987543|617133152|FG001|Overall Study|Investigator decision|1|||
170761246|NCT02987543|617133153|FG002|Overall Study|Investigator decision|0|||
170761247|NCT02987543|617133154|FG003|Overall Study|Investigator decision|0|||
170761248|NCT02987543|617133151|FG000|Overall Study|Disease progression|0|||
170761249|NCT02987543|617133152|FG001|Overall Study|Disease progression|0|||
170761250|NCT02987543|617133153|FG002|Overall Study|Disease progression|0|||
170761251|NCT02987543|617133154|FG003|Overall Study|Disease progression|1|||
170761252|NCT01117480|617133159|FG000|Overall Study|Protocol Violation|8|||
170761253|NCT01117480|617133159|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
170761254|NCT00943605|617133160|FG000|Overall Study|Study termination|30|||
170761255|NCT00943605|617133161|FG001|Overall Study|Study termination|30|||
170761256|NCT03357341|617133163|FG000|Overall Study|Withdrawal by Subject|3|||
170761257|NCT03357341|617133164|FG001|Overall Study|Withdrawal by Subject|6|||
170761258|NCT03357341|617133163|FG000|Overall Study|Lost to Follow-up|4|||
170761259|NCT03357341|617133164|FG001|Overall Study|Lost to Follow-up|5|||
170761260|NCT03357341|617133163|FG000|Overall Study|Death|0|||
170761261|NCT03357341|617133164|FG001|Overall Study|Death|1|||
170761262|NCT01259102|617133165|FG000|Overall Study|Adverse Event|1|||
170761263|NCT01259102|617133166|FG001|Overall Study|Adverse Event|0|||
170761264|NCT01259102|617133167|FG002|Overall Study|Adverse Event|1|||
170761265|NCT01259102|617133168|FG003|Overall Study|Adverse Event|1|||
170408663|NCT00814658|615835613|FG000|Overall Study|Adverse Event|3|||
170761266|NCT01259102|617133169|FG004|Overall Study|Adverse Event|0|||
170761267|NCT01259102|617133165|FG000|Overall Study|Other|0|||
170761268|NCT01259102|617133166|FG001|Overall Study|Other|0|||
170408664|NCT00814658|615835614|FG001|Overall Study|Adverse Event|3|||
170408665|NCT02087046|615835615|FG000|Overall Study|Adverse Event|4|||
170408666|NCT02087046|615835615|FG000|Overall Study|Death|1|||
170408667|NCT02087046|615835615|FG000|Overall Study|Lost to Follow-up|3|||
170761269|NCT01259102|617133167|FG002|Overall Study|Other|1|||
170761270|NCT01259102|617133168|FG003|Overall Study|Other|1|||
170761271|NCT01259102|617133169|FG004|Overall Study|Other|1|||
170761272|NCT00817635|617133170|FG000|Overall Study|Adverse Event|1|||
170761273|NCT00817635|617133171|FG001|Overall Study|Adverse Event|0|||
170761274|NCT00817635|617133172|FG002|Overall Study|Adverse Event|0|||
170761275|NCT00817635|617133173|FG003|Overall Study|Adverse Event|1|||
170761276|NCT00817635|617133174|FG004|Overall Study|Adverse Event|1|||
170761277|NCT00817635|617133170|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
170761278|NCT00817635|617133171|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
170761279|NCT00817635|617133172|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
170761280|NCT00817635|617133173|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
170761281|NCT00817635|617133174|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
170761282|NCT00817635|617133170|FG000|Overall Study|Withdrawal by Subject|2|||
170761283|NCT00817635|617133171|FG001|Overall Study|Withdrawal by Subject|1|||
170761284|NCT00817635|617133172|FG002|Overall Study|Withdrawal by Subject|0|||
170761285|NCT00817635|617133173|FG003|Overall Study|Withdrawal by Subject|1|||
170761286|NCT00817635|617133174|FG004|Overall Study|Withdrawal by Subject|2|||
170761287|NCT00817635|617133170|FG000|Overall Study|Lost to Follow-up|0|||
170761288|NCT00817635|617133171|FG001|Overall Study|Lost to Follow-up|1|||
170761289|NCT00817635|617133172|FG002|Overall Study|Lost to Follow-up|0|||
170761290|NCT00817635|617133173|FG003|Overall Study|Lost to Follow-up|1|||
170761291|NCT00817635|617133174|FG004|Overall Study|Lost to Follow-up|0|||
170761292|NCT00817635|617133170|FG000|Overall Study|Administrative Problems|0|||
170761293|NCT00817635|617133171|FG001|Overall Study|Administrative Problems|0|||
170761294|NCT00817635|617133172|FG002|Overall Study|Administrative Problems|0|||
170761295|NCT00817635|617133173|FG003|Overall Study|Administrative Problems|0|||
170761296|NCT00817635|617133174|FG004|Overall Study|Administrative Problems|1|||
170761297|NCT00817635|617133170|FG000|Overall Study|Protocol Violation|5|||
170761298|NCT00817635|617133171|FG001|Overall Study|Protocol Violation|1|||
170761299|NCT00817635|617133172|FG002|Overall Study|Protocol Violation|3|||
170761300|NCT00817635|617133173|FG003|Overall Study|Protocol Violation|2|||
170761301|NCT00817635|617133174|FG004|Overall Study|Protocol Violation|3|||
170761302|NCT00918957|617133175|FG000|Overall Study|Adverse Event|2|||
170761303|NCT00918957|617133176|FG001|Overall Study|Adverse Event|0|||
170761304|NCT00918957|617133175|FG000|Overall Study|Withdrawal by Subject|1|||
170761305|NCT00918957|617133176|FG001|Overall Study|Withdrawal by Subject|0|||
170761306|NCT01956669|617133178|FG000|Overall Study|Disease Progression|12|||
170761307|NCT01956669|617133179|FG001|Overall Study|Disease Progression|7|||
170761308|NCT01956669|617133180|FG002|Overall Study|Disease Progression|7|||
170761309|NCT01956669|617133181|FG003|Overall Study|Disease Progression|8|||
170761310|NCT01956669|617133182|FG004|Overall Study|Disease Progression|4|||
170761311|NCT01956669|617133183|FG005|Overall Study|Disease Progression|3|||
170761312|NCT01956669|617133184|FG006|Overall Study|Disease Progression|5|||
170761313|NCT01956669|617133178|FG000|Overall Study|Adverse Event|0|||
170761314|NCT01956669|617133179|FG001|Overall Study|Adverse Event|2|||
170761315|NCT01956669|617133180|FG002|Overall Study|Adverse Event|2|||
170761316|NCT01956669|617133181|FG003|Overall Study|Adverse Event|1|||
170761317|NCT01956669|617133182|FG004|Overall Study|Adverse Event|0|||
170761318|NCT01956669|617133183|FG005|Overall Study|Adverse Event|0|||
170761319|NCT01956669|617133184|FG006|Overall Study|Adverse Event|0|||
170761320|NCT01956669|617133178|FG000|Overall Study|Physician Decision|0|||
170761321|NCT01956669|617133179|FG001|Overall Study|Physician Decision|2|||
170761322|NCT01956669|617133180|FG002|Overall Study|Physician Decision|0|||
170761323|NCT01956669|617133181|FG003|Overall Study|Physician Decision|0|||
170761324|NCT01956669|617133182|FG004|Overall Study|Physician Decision|0|||
170761325|NCT01956669|617133183|FG005|Overall Study|Physician Decision|1|||
170761326|NCT01956669|617133184|FG006|Overall Study|Physician Decision|0|||
170761327|NCT01956669|617133178|FG000|Overall Study|Withdrawal by Subject|0|||
170761328|NCT01956669|617133179|FG001|Overall Study|Withdrawal by Subject|0|||
170761329|NCT01956669|617133180|FG002|Overall Study|Withdrawal by Subject|1|||
170761330|NCT01956669|617133181|FG003|Overall Study|Withdrawal by Subject|1|||
170761331|NCT01956669|617133182|FG004|Overall Study|Withdrawal by Subject|0|||
170761332|NCT01956669|617133183|FG005|Overall Study|Withdrawal by Subject|0|||
170761333|NCT01956669|617133184|FG006|Overall Study|Withdrawal by Subject|1|||
170761334|NCT00930813|617133187|FG000|Overall Study|Death|4|||
170761335|NCT00930813|617133188|FG001|Overall Study|Death|5|||
170761336|NCT00930813|617133187|FG000|Overall Study|Withdrawal by Subject|2|||
170761337|NCT00930813|617133188|FG001|Overall Study|Withdrawal by Subject|5|||
170761338|NCT00930813|617133187|FG000|Overall Study|Lost to Follow-up|2|||
170761339|NCT00930813|617133188|FG001|Overall Study|Lost to Follow-up|4|||
170761340|NCT01131494|617133189|FG000|Overall Study|Withdrawal by Subject|2|||
170761341|NCT01196988|617133190|FG000|Overall Study|Adverse Event|1|||
170761342|NCT01196988|617133191|FG001|Overall Study|Adverse Event|2|||
170761343|NCT01196988|617133192|FG002|Overall Study|Adverse Event|0|||
170761344|NCT01196988|617133193|FG003|Overall Study|Adverse Event|0|||
170761345|NCT01196988|617133190|FG000|Overall Study|Withdrawal by Subject|5|||
170761346|NCT01196988|617133191|FG001|Overall Study|Withdrawal by Subject|1|||
170761347|NCT01196988|617133192|FG002|Overall Study|Withdrawal by Subject|4|||
170519730|NCT00268983|616247609|FG001|Overall Study|Death|0|||
170761348|NCT01196988|617133193|FG003|Overall Study|Withdrawal by Subject|0|||
170761349|NCT01196988|617133190|FG000|Overall Study|Lost to Follow-up|16|||
170761350|NCT01196988|617133191|FG001|Overall Study|Lost to Follow-up|29|||
170761351|NCT01196988|617133192|FG002|Overall Study|Lost to Follow-up|21|||
170761352|NCT01196988|617133193|FG003|Overall Study|Lost to Follow-up|1|||
170761353|NCT01196988|617133190|FG000|Overall Study|Other|2|||
170761354|NCT01196988|617133191|FG001|Overall Study|Other|0|||
170761355|NCT01196988|617133192|FG002|Overall Study|Other|0|||
170761356|NCT01196988|617133193|FG003|Overall Study|Other|0|||
170761357|NCT00588666|617133195|FG000|Overall Study|Adverse Event|4|||
170761358|NCT02281318|617133196|FG000|Overall Study|Adverse Event|2|||
170761359|NCT02281318|617133197|FG001|Overall Study|Adverse Event|2|||
170761360|NCT02281318|617133196|FG000|Overall Study|Lack of Efficacy|2|||
170761361|NCT02281318|617133197|FG001|Overall Study|Lack of Efficacy|0|||
170761362|NCT02281318|617133196|FG000|Overall Study|Lost to Follow-up|2|||
170761363|NCT02281318|617133197|FG001|Overall Study|Lost to Follow-up|1|||
170761364|NCT02281318|617133196|FG000|Overall Study|Physician Decision|2|||
170761365|NCT02281318|617133197|FG001|Overall Study|Physician Decision|0|||
170761366|NCT02281318|617133196|FG000|Overall Study|Withdrawal by Subject|6|||
170761367|NCT02281318|617133197|FG001|Overall Study|Withdrawal by Subject|2|||
170761368|NCT00703911|617133198|FG000|Overall Study|Death|1|||
170761369|NCT00703911|617133198|FG000|Overall Study|Physician Decision|6|||
170761370|NCT00703911|617133198|FG000|Overall Study|Lost to Follow-up|1|||
170761371|NCT00703911|617133198|FG000|Overall Study|Withdrawal by Subject|2|||
170761372|NCT03102710|617133199|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
170761373|NCT03102710|617133200|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
170761374|NCT03102710|617133201|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
170761375|NCT03102710|617133199|FG000|Overall Study|Technical issues during final MRI scan|0|||
170761376|NCT03102710|617133200|FG001|Overall Study|Technical issues during final MRI scan|1|||
170761377|NCT03102710|617133201|FG002|Overall Study|Technical issues during final MRI scan|0|||
170761378|NCT03102710|617133199|FG000|Overall Study|Nausea during MRI scan|0|||
170761379|NCT03102710|617133200|FG001|Overall Study|Nausea during MRI scan|1|||
170761380|NCT03102710|617133201|FG002|Overall Study|Nausea during MRI scan|0|||
170761381|NCT03102710|617133199|FG000|Overall Study|Subject unable to attend final session|0|||
170761382|NCT03102710|617133200|FG001|Overall Study|Subject unable to attend final session|1|||
170761383|NCT03102710|617133201|FG002|Overall Study|Subject unable to attend final session|0|||
170761384|NCT04936035|617133206|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761385|NCT04936035|617133207|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
170761386|NCT04936035|617133208|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761387|NCT04936035|617133209|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761388|NCT04936035|617133210|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761389|NCT04936035|617133211|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761390|NCT04936035|617133212|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761391|NCT04936035|617133213|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761392|NCT04936035|617133214|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761393|NCT04936035|617133215|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761394|NCT04936035|617133216|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761395|NCT04936035|617133217|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170761396|NCT04936035|617133218|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
170408668|NCT02087046|615835615|FG000|Overall Study|Withdrawal by Subject|2|||
170408669|NCT02087046|615835615|FG000|Overall Study|Physician Decision|1|||
170408670|NCT01107535|615835616|FG000|Overall Study|Death|5|||
170408671|NCT02444533|615835617|FG000|Overall Study|Not able to complete forms|0|||
170408672|NCT02444533|615835618|FG001|Overall Study|Not able to complete forms|2|||
170408673|NCT02444533|615835617|FG000|Overall Study|Only gave post-procedure complications|2|||
170408674|NCT02444533|615835618|FG001|Overall Study|Only gave post-procedure complications|2|||
170408675|NCT01155583|615835619|FG000|Phase I|Screen failure - did not start treatment|0|||
170408676|NCT01155583|615835620|FG001|Phase I|Screen failure - did not start treatment|0|||
170408677|NCT01155583|615835621|FG002|Phase I|Screen failure - did not start treatment|0|||
170408678|NCT01155583|615835622|FG003|Phase I|Screen failure - did not start treatment|0|||
170408679|NCT01155583|615835623|FG004|Phase I|Screen failure - did not start treatment|1|||
170408680|NCT01155583|615835624|FG005|Phase I|Screen failure - did not start treatment|0|||
170408681|NCT01155583|615835625|FG006|Phase I|Screen failure - did not start treatment|0|||
170408682|NCT01155583|615835626|FG007|Phase I|Screen failure - did not start treatment|2|||
170408683|NCT01155583|615835627|FG008|Phase I|Screen failure - did not start treatment|0|||
170408684|NCT01155583|615835619|FG000|Phase I|Withdrawal by Subject|0|||
170408685|NCT01155583|615835620|FG001|Phase I|Withdrawal by Subject|0|||
170408686|NCT01155583|615835621|FG002|Phase I|Withdrawal by Subject|0|||
170408687|NCT01155583|615835622|FG003|Phase I|Withdrawal by Subject|0|||
170408688|NCT01155583|615835623|FG004|Phase I|Withdrawal by Subject|0|||
170408689|NCT01155583|615835624|FG005|Phase I|Withdrawal by Subject|0|||
170408690|NCT01155583|615835625|FG006|Phase I|Withdrawal by Subject|0|||
170408691|NCT01155583|615835626|FG007|Phase I|Withdrawal by Subject|1|||
170408692|NCT01155583|615835627|FG008|Phase I|Withdrawal by Subject|0|||
170408693|NCT02168270|615835632|FG000|Overall Study|Lack of Efficacy|4|||
170408694|NCT03210259|615835633|FG000|12-Week Run-in Period|Adverse Event|1|||
170408695|NCT03210259|615835634|FG001|12-Week Run-in Period|Adverse Event|0|||
170408696|NCT03210259|615835635|FG002|12-Week Run-in Period|Adverse Event|0|||
170408697|NCT03210259|615835633|FG000|12-Week Run-in Period|Death|1|||
170408698|NCT03210259|615835634|FG001|12-Week Run-in Period|Death|0|||
170761397|NCT04936035|617133206|FG000|6-Month Placebo-controlled DB Period|Death|0|||
170761398|NCT04936035|617133207|FG001|6-Month Placebo-controlled DB Period|Death|0|||
170761399|NCT04936035|617133208|FG002|6-Month Placebo-controlled DB Period|Death|0|||
170761400|NCT04936035|617133209|FG003|6-Month Placebo-controlled DB Period|Death|1|||
170761401|NCT04936035|617133210|FG004|6-Month Placebo-controlled DB Period|Death|0|||
170761402|NCT04936035|617133211|FG005|6-Month Placebo-controlled DB Period|Death|0|||
170761403|NCT04936035|617133212|FG006|6-Month Placebo-controlled DB Period|Death|0|||
170761404|NCT04936035|617133213|FG007|6-Month Placebo-controlled DB Period|Death|0|||
170761405|NCT04936035|617133214|FG008|6-Month Placebo-controlled DB Period|Death|0|||
170761406|NCT04936035|617133215|FG009|6-Month Placebo-controlled DB Period|Death|0|||
170761407|NCT04936035|617133216|FG010|6-Month Placebo-controlled DB Period|Death|0|||
170761408|NCT04936035|617133217|FG011|6-Month Placebo-controlled DB Period|Death|0|||
170761409|NCT04936035|617133218|FG012|6-Month Placebo-controlled DB Period|Death|0|||
170761410|NCT04936035|617133206|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761411|NCT04936035|617133207|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
170761412|NCT04936035|617133208|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
170761413|NCT04936035|617133209|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
170761414|NCT04936035|617133210|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
170761415|NCT04936035|617133211|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761416|NCT04936035|617133212|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761417|NCT04936035|617133213|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761418|NCT04936035|617133214|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761419|NCT04936035|617133215|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761420|NCT04936035|617133216|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761421|NCT04936035|617133217|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761422|NCT04936035|617133218|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
170761423|NCT04936035|617133206|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761424|NCT04936035|617133207|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
170761425|NCT04936035|617133208|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761426|NCT04936035|617133209|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761427|NCT04936035|617133210|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761428|NCT04936035|617133211|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761429|NCT04936035|617133212|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761430|NCT04936035|617133213|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761431|NCT04936035|617133214|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761432|NCT04936035|617133215|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761433|NCT04936035|617133216|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761434|NCT04936035|617133217|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761435|NCT04936035|617133218|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
170761436|NCT04936035|617133206|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761437|NCT04936035|617133207|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761438|NCT04936035|617133208|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
170761439|NCT04936035|617133209|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761440|NCT04936035|617133210|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761441|NCT04936035|617133211|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761442|NCT04936035|617133212|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761443|NCT04936035|617133213|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761444|NCT04936035|617133214|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761445|NCT04936035|617133215|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761446|NCT04936035|617133216|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761447|NCT04936035|617133217|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761448|NCT04936035|617133218|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
170761449|NCT04936035|617133206|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
170761450|NCT04936035|617133207|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
170761451|NCT04936035|617133208|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
170761452|NCT04936035|617133209|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
170761453|NCT04936035|617133210|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
170761454|NCT04936035|617133211|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
170866889|NCT01233869|617525194|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
170866890|NCT01233869|617525195|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
170866891|NCT01233869|617525196|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
170866892|NCT01233869|617525197|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
170866893|NCT01233869|617525194|FG000|Extended Treatment Period (46 Months)|Other|3|||
170866894|NCT01233869|617525195|FG001|Extended Treatment Period (46 Months)|Other|0|||
170866895|NCT01233869|617525196|FG002|Extended Treatment Period (46 Months)|Other|0|||
170866896|NCT01233869|617525197|FG003|Extended Treatment Period (46 Months)|Other|3|||
170866897|NCT01233869|617525194|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
170866898|NCT01233869|617525195|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
170866899|NCT01233869|617525196|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
170866900|NCT01233869|617525197|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
170866901|NCT02119325|617525203|FG000|Washout Period 1|Adverse Event|0|||
170866902|NCT02119325|617525204|FG001|Washout Period 1|Adverse Event|1|||
170866903|NCT02804178|617525207|FG000|Overall Study|Adverse Event|1|||
170866904|NCT00108069|617525208|FG000|Overall Study|Never rec'd study drug|0|||
170866905|NCT00108069|617525209|FG001|Overall Study|Never rec'd study drug|1|||
170866906|NCT00108069|617525208|FG000|Overall Study|Adverse Event|1|||
170866907|NCT00108069|617525209|FG001|Overall Study|Adverse Event|1|||
170866908|NCT00108069|617525208|FG000|Overall Study|Withdrawal by Subject|1|||
170866909|NCT00108069|617525209|FG001|Overall Study|Withdrawal by Subject|0|||
170866910|NCT00108069|617525208|FG000|Overall Study|Death|1|||
170866911|NCT00108069|617525209|FG001|Overall Study|Death|0|||
170866912|NCT00108069|617525208|FG000|Overall Study|Progessive disease|27|||
170866913|NCT00108069|617525209|FG001|Overall Study|Progessive disease|11|||
170866914|NCT02558231|617525210|FG000|Overall Study|Death|4|||
170866915|NCT02558231|617525211|FG001|Overall Study|Death|12|||
170866916|NCT02558231|617525210|FG000|Overall Study|Lost to Follow-up|7|||
170866917|NCT02558231|617525211|FG001|Overall Study|Lost to Follow-up|4|||
170866918|NCT02558231|617525210|FG000|Overall Study|Withdrawal by Subject|7|||
170866919|NCT02558231|617525211|FG001|Overall Study|Withdrawal by Subject|4|||
170866920|NCT02558231|617525210|FG000|Overall Study|Physician Decision|7|||
170866921|NCT02558231|617525211|FG001|Overall Study|Physician Decision|5|||
170866922|NCT02558231|617525210|FG000|Overall Study|Sponsor Decision|0|||
170866923|NCT02558231|617525211|FG001|Overall Study|Sponsor Decision|1|||
170866924|NCT03836807|617525212|FG000|Overall Study|Physician Decision|1|||
170866925|NCT03836807|617525213|FG001|Overall Study|Physician Decision|0|||
170866926|NCT01699789|617525214|FG000|Overall Study|Withdrawal by Subject|18|||
170866927|NCT01699789|617525215|FG001|Overall Study|Withdrawal by Subject|23|||
170866928|NCT01699789|617525214|FG000|Overall Study|Death|1|||
170866929|NCT01699789|617525215|FG001|Overall Study|Death|2|||
170866930|NCT01699789|617525214|FG000|Overall Study|Lost to Follow-up|83|||
170866931|NCT01699789|617525215|FG001|Overall Study|Lost to Follow-up|101|||
170866932|NCT00651157|617525216|FG000|Overall Study|Death|1|||
170866933|NCT00651157|617525216|FG000|Overall Study|Protocol Violation|1|||
170866934|NCT02536755|617525218|FG000|Overall Study|Adverse Event|4|||
170866935|NCT00364156|617525224|FG000|Overall Study|Withdrawal by Subject|73|||
170866936|NCT00364156|617525225|FG001|Overall Study|Withdrawal by Subject|80|||
170866937|NCT00364156|617525224|FG000|Overall Study|Protocol Violation|6|||
170866938|NCT00364156|617525225|FG001|Overall Study|Protocol Violation|1|||
170866939|NCT01295281|617525226|FG000|First Intervention (7 Days)|Death|0|||
170866940|NCT01295281|617525227|FG001|First Intervention (7 Days)|Death|1|||
170866941|NCT00292461|617525228|FG000|Overall Study|Adverse Event|4|||
170866942|NCT00292461|617525229|FG001|Overall Study|Adverse Event|2|||
170866943|NCT00292461|617525228|FG000|Overall Study|Lack of Efficacy|1|||
170866944|NCT00292461|617525229|FG001|Overall Study|Lack of Efficacy|0|||
170866945|NCT00292461|617525228|FG000|Overall Study|Withdrawal by Subject|0|||
170866946|NCT00292461|617525229|FG001|Overall Study|Withdrawal by Subject|1|||
170866947|NCT00292461|617525228|FG000|Overall Study|Protocol Violation|4|||
170866948|NCT00292461|617525229|FG001|Overall Study|Protocol Violation|3|||
170866949|NCT00292461|617525228|FG000|Overall Study|Lost to Follow-up|1|||
170866950|NCT00292461|617525229|FG001|Overall Study|Lost to Follow-up|0|||
170866951|NCT01891721|617525237|FG000|Overall Study|Lost to Follow-up|10|||
170866952|NCT01891721|617525238|FG001|Overall Study|Lost to Follow-up|5|||
170866953|NCT01891721|617525239|FG002|Overall Study|Lost to Follow-up|1|||
170866954|NCT04484259|617525242|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
170866955|NCT04484259|617525243|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
170866956|NCT04484259|617525244|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
170866957|NCT04484259|617525245|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
170866958|NCT04484259|617525246|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
170866959|NCT04484259|617525242|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
170866960|NCT04484259|617525243|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
170866961|NCT04484259|617525244|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
170408699|NCT03210259|615835635|FG002|12-Week Run-in Period|Death|0|||
170408700|NCT03210259|615835633|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
170408701|NCT03210259|615835634|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
170519731|NCT02254772|616247610|FG000|Overall Study|Ineligible|1|||
170866962|NCT04484259|617525245|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
170866963|NCT04484259|617525246|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
170761455|NCT04936035|617133212|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
170761456|NCT04936035|617133213|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
170761457|NCT04936035|617133214|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
170761458|NCT04936035|617133215|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
170761459|NCT04936035|617133216|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
170761460|NCT04936035|617133217|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
170761461|NCT04936035|617133218|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
170761462|NCT04936035|617133206|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761463|NCT04936035|617133207|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761464|NCT04936035|617133208|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761465|NCT04936035|617133209|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761466|NCT04936035|617133210|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
170761467|NCT04936035|617133211|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761468|NCT04936035|617133212|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761469|NCT04936035|617133213|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761470|NCT04936035|617133214|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761471|NCT04936035|617133215|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761472|NCT04936035|617133216|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761473|NCT04936035|617133217|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761474|NCT04936035|617133218|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
170761475|NCT04936035|617133206|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
170761476|NCT04936035|617133207|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761477|NCT04936035|617133208|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761478|NCT04936035|617133209|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761479|NCT04936035|617133210|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761480|NCT04936035|617133211|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761481|NCT04936035|617133212|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761482|NCT04936035|617133213|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761483|NCT04936035|617133214|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761484|NCT04936035|617133215|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761485|NCT04936035|617133216|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761486|NCT04936035|617133217|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761487|NCT04936035|617133218|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
170761488|NCT04936035|617133206|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
170761489|NCT04936035|617133207|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
170761490|NCT04936035|617133208|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
170761491|NCT04936035|617133209|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
170761492|NCT04936035|617133210|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
170761493|NCT04936035|617133211|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
170761494|NCT04936035|617133212|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
170761495|NCT04936035|617133213|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
170761496|NCT04936035|617133214|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
170761497|NCT04936035|617133215|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
170761498|NCT04936035|617133216|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
170761499|NCT04936035|617133217|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
170761500|NCT04936035|617133218|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
170761501|NCT04936035|617133206|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
170761502|NCT04936035|617133207|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
170761503|NCT04936035|617133208|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
170761504|NCT04936035|617133209|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
170761505|NCT04936035|617133210|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
170761506|NCT04936035|617133211|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
170761507|NCT04936035|617133212|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
170761508|NCT04936035|617133213|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
170761509|NCT04936035|617133214|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
170761510|NCT04936035|617133215|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
170761511|NCT04936035|617133216|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
170761512|NCT04936035|617133217|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
170761513|NCT04936035|617133218|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
170761514|NCT04936035|617133206|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
170408702|NCT03210259|615835635|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
170866964|NCT04484259|617525242|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
170866965|NCT04484259|617525243|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
170866966|NCT04484259|617525244|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
170866967|NCT04484259|617525245|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
170866968|NCT04484259|617525246|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
170866969|NCT04484259|617525242|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
170866970|NCT04484259|617525243|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
170866971|NCT04484259|617525244|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
170866972|NCT04484259|617525245|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
170866973|NCT04484259|617525246|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
170866974|NCT04484259|617525242|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
170866975|NCT04484259|617525243|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
170866976|NCT04484259|617525244|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
170866977|NCT04484259|617525245|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
170866978|NCT04484259|617525246|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
170866979|NCT04484259|617525242|FG000|Randomized Treatment|Withdrawal by Subject|1|||
170866980|NCT04484259|617525243|FG001|Randomized Treatment|Withdrawal by Subject|0|||
170866981|NCT04484259|617525244|FG002|Randomized Treatment|Withdrawal by Subject|0|||
170866982|NCT04484259|617525245|FG003|Randomized Treatment|Withdrawal by Subject|0|||
170866983|NCT04484259|617525246|FG004|Randomized Treatment|Withdrawal by Subject|0|||
170866984|NCT04498832|617525248|FG000|Overall Study|Adverse Event|1|||
170866985|NCT04498832|617525249|FG001|Overall Study|Adverse Event|3|||
170866986|NCT04498832|617525248|FG000|Overall Study|Withdrawal by Subject|0|||
170866987|NCT04498832|617525249|FG001|Overall Study|Withdrawal by Subject|1|||
170866988|NCT04908189|617525250|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
170866989|NCT04908189|617525251|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
170866990|NCT04908189|617525252|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
170866991|NCT04908189|617525250|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
170866992|NCT04908189|617525251|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
170866993|NCT04908189|617525252|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
170866994|NCT04908189|617525250|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
170866995|NCT04908189|617525251|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
170866996|NCT04908189|617525252|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
170866997|NCT04908189|617525250|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
170866998|NCT04908189|617525251|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
170866999|NCT04908189|617525252|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
170867000|NCT04908189|617525250|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
170867001|NCT04908189|617525251|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
170867002|NCT04908189|617525252|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
170867003|NCT04908189|617525250|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
170867004|NCT04908189|617525251|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
170867005|NCT04908189|617525252|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
170867006|NCT04908189|617525250|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
170867007|NCT04908189|617525251|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
170867008|NCT04908189|617525252|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
170867009|NCT04908189|617525250|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
170761515|NCT04936035|617133207|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761516|NCT04936035|617133208|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761517|NCT04936035|617133209|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761518|NCT04936035|617133210|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761519|NCT04936035|617133211|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761520|NCT04936035|617133212|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761521|NCT04936035|617133213|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761522|NCT04936035|617133214|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761523|NCT04936035|617133215|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
170761524|NCT04936035|617133216|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
170761525|NCT04936035|617133217|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
170761526|NCT04936035|617133218|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
170867010|NCT04908189|617525251|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
170867011|NCT04908189|617525252|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
170867012|NCT04908189|617525250|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
170408703|NCT03210259|615835633|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
170761527|NCT04936035|617133206|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761528|NCT04936035|617133207|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761529|NCT04936035|617133208|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761530|NCT04936035|617133209|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761531|NCT04936035|617133210|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761532|NCT04936035|617133211|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
170761533|NCT04936035|617133212|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761534|NCT04936035|617133213|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
170761535|NCT04936035|617133214|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761536|NCT04936035|617133215|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761537|NCT04936035|617133216|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761538|NCT04936035|617133217|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761539|NCT04936035|617133218|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
170761540|NCT04936035|617133206|FG000|Post-6-Month DB Period (30months)|Death|0|||
170761541|NCT04936035|617133207|FG001|Post-6-Month DB Period (30months)|Death|0|||
170761542|NCT04936035|617133208|FG002|Post-6-Month DB Period (30months)|Death|0|||
170761543|NCT04936035|617133209|FG003|Post-6-Month DB Period (30months)|Death|0|||
170761544|NCT04936035|617133210|FG004|Post-6-Month DB Period (30months)|Death|0|||
170761545|NCT04936035|617133211|FG005|Post-6-Month DB Period (30months)|Death|0|||
170408704|NCT03210259|615835634|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
170408705|NCT03210259|615835635|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
170408706|NCT03210259|615835633|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
170761546|NCT04936035|617133212|FG006|Post-6-Month DB Period (30months)|Death|0|||
170761547|NCT04936035|617133213|FG007|Post-6-Month DB Period (30months)|Death|0|||
170761548|NCT04936035|617133214|FG008|Post-6-Month DB Period (30months)|Death|0|||
170761549|NCT04936035|617133215|FG009|Post-6-Month DB Period (30months)|Death|1|||
170761550|NCT04936035|617133216|FG010|Post-6-Month DB Period (30months)|Death|0|||
170867013|NCT04908189|617525251|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
170867014|NCT04908189|617525252|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
170867015|NCT04908189|617525250|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
170867016|NCT04908189|617525251|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
170867017|NCT04908189|617525252|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
170867018|NCT04908189|617525250|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
170867019|NCT04908189|617525251|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
170867020|NCT04908189|617525252|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
170867021|NCT04908189|617525250|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
170867022|NCT04908189|617525251|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
170867023|NCT04908189|617525252|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
170867024|NCT05118204|617525258|FG000|Overall Study|Lost to Follow-up|3|||
170867025|NCT05118204|617525259|FG001|Overall Study|Lost to Follow-up|2|||
170867026|NCT05118204|617525258|FG000|Overall Study|Withdrawal by Subject|0|||
170867027|NCT05118204|617525259|FG001|Overall Study|Withdrawal by Subject|2|||
170867028|NCT00607022|617525260|FG000|Overall Study|Withdrawal by Subject|1|||
170867029|NCT00607022|617525261|FG001|Overall Study|Withdrawal by Subject|0|||
170867030|NCT00607022|617525262|FG002|Overall Study|Withdrawal by Subject|0|||
170761551|NCT04936035|617133217|FG011|Post-6-Month DB Period (30months)|Death|0|||
170761552|NCT04936035|617133218|FG012|Post-6-Month DB Period (30months)|Death|0|||
170761553|NCT04936035|617133206|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170761554|NCT04936035|617133207|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170867031|NCT01313650|617525263|FG000|Overall Study|Adverse Event|9|||
170867032|NCT01313650|617525264|FG001|Overall Study|Adverse Event|34|||
170408707|NCT03210259|615835634|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
170867033|NCT01313650|617525265|FG002|Overall Study|Adverse Event|24|||
170867034|NCT01313650|617525266|FG003|Overall Study|Adverse Event|23|||
170867035|NCT01313650|617525263|FG000|Overall Study|Lack of Efficacy|37|||
170408708|NCT03210259|615835635|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
170408709|NCT03210259|615835633|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
170408710|NCT03210259|615835634|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
170408711|NCT03210259|615835635|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
170408712|NCT03210259|615835633|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
170408713|NCT03210259|615835634|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
170408714|NCT03210259|615835635|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
170408715|NCT03210259|615835633|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
170408716|NCT03210259|615835634|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
170761555|NCT04936035|617133208|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170408717|NCT03210259|615835635|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
170761556|NCT04936035|617133209|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170761557|NCT04936035|617133210|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170761558|NCT04936035|617133211|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
170867036|NCT01313650|617525264|FG001|Overall Study|Lack of Efficacy|20|||
170867037|NCT01313650|617525265|FG002|Overall Study|Lack of Efficacy|32|||
170867038|NCT01313650|617525266|FG003|Overall Study|Lack of Efficacy|20|||
170867039|NCT01313650|617525263|FG000|Overall Study|Lost to Follow-up|1|||
170867040|NCT01313650|617525264|FG001|Overall Study|Lost to Follow-up|0|||
170867041|NCT01313650|617525265|FG002|Overall Study|Lost to Follow-up|3|||
170867042|NCT01313650|617525266|FG003|Overall Study|Lost to Follow-up|2|||
170867043|NCT01313650|617525263|FG000|Overall Study|Withdrawal by Subject|16|||
170867044|NCT01313650|617525264|FG001|Overall Study|Withdrawal by Subject|20|||
170867045|NCT01313650|617525265|FG002|Overall Study|Withdrawal by Subject|15|||
170867046|NCT01313650|617525266|FG003|Overall Study|Withdrawal by Subject|15|||
170867047|NCT01313650|617525263|FG000|Overall Study|Protocol Violation|4|||
170867048|NCT01313650|617525264|FG001|Overall Study|Protocol Violation|7|||
170867049|NCT01313650|617525265|FG002|Overall Study|Protocol Violation|5|||
170867050|NCT01313650|617525266|FG003|Overall Study|Protocol Violation|6|||
170867051|NCT01313650|617525263|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
170867052|NCT01313650|617525264|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
170867053|NCT01313650|617525265|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
170867054|NCT01313650|617525266|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
170867055|NCT04409353|617525267|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
170867056|NCT04409353|617525268|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
170867057|NCT04409353|617525269|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
170867058|NCT04409353|617525267|FG000|Overall Study|Lost to Follow-up|6|||
170867059|NCT04409353|617525268|FG001|Overall Study|Lost to Follow-up|8|||
170867060|NCT04409353|617525269|FG002|Overall Study|Lost to Follow-up|7|||
170867061|NCT04409353|617525267|FG000|Overall Study|Major surgery during participation window|4|||
170867062|NCT04409353|617525268|FG001|Overall Study|Major surgery during participation window|3|||
170867063|NCT04409353|617525269|FG002|Overall Study|Major surgery during participation window|3|||
170867064|NCT04409353|617525267|FG000|Overall Study|Life event occurred during participation window|3|||
170867065|NCT04409353|617525268|FG001|Overall Study|Life event occurred during participation window|2|||
170867066|NCT04409353|617525269|FG002|Overall Study|Life event occurred during participation window|4|||
170867067|NCT04409353|617525267|FG000|Overall Study|Lack of Efficacy|4|||
170867068|NCT04409353|617525268|FG001|Overall Study|Lack of Efficacy|1|||
170867069|NCT04409353|617525269|FG002|Overall Study|Lack of Efficacy|3|||
170867070|NCT04409353|617525267|FG000|Overall Study|Adverse Event|2|||
170867071|NCT04409353|617525268|FG001|Overall Study|Adverse Event|1|||
170867072|NCT04409353|617525269|FG002|Overall Study|Adverse Event|1|||
170867073|NCT04409353|617525267|FG000|Overall Study|Disease burden - unable to participate|0|||
170867074|NCT04409353|617525268|FG001|Overall Study|Disease burden - unable to participate|1|||
170867075|NCT04409353|617525269|FG002|Overall Study|Disease burden - unable to participate|1|||
170867076|NCT04409353|617525267|FG000|Overall Study|Intervention too complicated|1|||
170867077|NCT04409353|617525268|FG001|Overall Study|Intervention too complicated|0|||
170867078|NCT04409353|617525269|FG002|Overall Study|Intervention too complicated|1|||
170867079|NCT01012739|617525270|FG000|Treatment Period 1|Adverse Event|0|||
170867080|NCT01012739|617525271|FG001|Treatment Period 1|Adverse Event|0|||
170867081|NCT01012739|617525272|FG002|Treatment Period 1|Adverse Event|0|||
170867082|NCT01012739|617525273|FG003|Treatment Period 1|Adverse Event|1|||
170867083|NCT01012739|617525270|FG000|Treatment Period 2|Abnormal test procedure results|0|||
170867084|NCT01012739|617525271|FG001|Treatment Period 2|Abnormal test procedure results|0|||
170867085|NCT01012739|617525272|FG002|Treatment Period 2|Abnormal test procedure results|0|||
170867086|NCT01012739|617525273|FG003|Treatment Period 2|Abnormal test procedure results|1|||
170867087|NCT04540133|617525274|FG000|Overall Study|Lost to Follow-up|1|||
170867088|NCT04540133|617525275|FG001|Overall Study|Lost to Follow-up|0|||
170867089|NCT04014361|617525278|FG000|Period 2|Physician Decision|0|||
170867090|NCT04014361|617525279|FG001|Period 2|Physician Decision|0|||
170867091|NCT04014361|617525280|FG002|Period 2|Physician Decision|0|||
170867092|NCT04014361|617525281|FG003|Period 2|Physician Decision|1|||
170867093|NCT04014361|617525282|FG004|Period 2|Physician Decision|0|||
170867094|NCT04014361|617525283|FG005|Period 2|Physician Decision|0|||
170867095|NCT04014361|617525284|FG006|Period 2|Physician Decision|0|||
170867096|NCT04014361|617525285|FG007|Period 2|Physician Decision|0|||
170867097|NCT06308666|617525286|FG000|Overall Study|Withdrawal by Subject|1|||
170867098|NCT06308666|617525286|FG000|Overall Study|Protocol Violation|2|||
170867099|NCT06268288|617525287|FG000|Overall Study|Withdrawal by Subject|1|||
170867100|NCT06268288|617525288|FG001|Overall Study|Withdrawal by Subject|2|||
170867101|NCT04252287|617525289|FG000|Overall Study|Death|5|||
170408718|NCT03210259|615835633|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
170408719|NCT03210259|615835634|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
170408720|NCT03210259|615835635|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
170867102|NCT04252287|617525290|FG001|Overall Study|Death|3|||
170867103|NCT04252287|617525289|FG000|Overall Study|Lost to Follow-up|4|||
170408721|NCT03210259|615835633|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
170867104|NCT04252287|617525290|FG001|Overall Study|Lost to Follow-up|6|||
170867105|NCT04252287|617525289|FG000|Overall Study|Withdrawal by Subject|19|||
170867106|NCT04252287|617525290|FG001|Overall Study|Withdrawal by Subject|16|||
170867107|NCT04252287|617525289|FG000|Overall Study|Protocol Violation|3|||
170867108|NCT04252287|617525290|FG001|Overall Study|Protocol Violation|4|||
170867109|NCT00777946|617525291|FG000|Overall Study|Adverse Event|11|||
170761559|NCT04936035|617133212|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170761560|NCT04936035|617133213|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170761561|NCT04936035|617133214|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170761562|NCT04936035|617133215|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
170761563|NCT04936035|617133216|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
170761564|NCT04936035|617133217|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170761565|NCT04936035|617133218|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
170761566|NCT00003656|617133219|FG000|Overall Study|Adverse Event|0|||
170761567|NCT00003656|617133220|FG001|Overall Study|Adverse Event|1|||
170761568|NCT02759731|617133221|FG000|Overall Study|Did not complete treatment.|8|||
170761569|NCT00957229|617133226|FG000|Study Start|Adverse Event|0|||
170761570|NCT00957229|617133227|FG001|Study Start|Adverse Event|3|||
170761571|NCT00957229|617133226|FG000|Study Start|Disease Progression|1|||
170761572|NCT00957229|617133227|FG001|Study Start|Disease Progression|0|||
170761573|NCT00957229|617133226|FG000|Reallocated to or Continued Vismodegib|Death|1|||
170761574|NCT00957229|617133227|FG001|Reallocated to or Continued Vismodegib|Death|1|||
170761575|NCT00957229|617133226|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
170761576|NCT00957229|617133227|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
170761577|NCT00763282|617133228|FG000|Overall Study|Withdrawal by Subject|6|||
170761578|NCT00763282|617133229|FG001|Overall Study|Withdrawal by Subject|5|||
170761579|NCT00763282|617133228|FG000|Overall Study|Death|4|||
170761580|NCT00763282|617133229|FG001|Overall Study|Death|3|||
170761581|NCT00763282|617133228|FG000|Overall Study|Lost to Follow-up|22|||
170761582|NCT00763282|617133229|FG001|Overall Study|Lost to Follow-up|26|||
170761583|NCT00606580|617133230|FG000|Overall Study|Lost to Follow-up|1|||
170761584|NCT00606580|617133231|FG001|Overall Study|Lost to Follow-up|1|||
170761585|NCT00606580|617133232|FG002|Overall Study|Lost to Follow-up|4|||
170761586|NCT00606580|617133230|FG000|Overall Study|Clinical failures|1|||
170761587|NCT00606580|617133231|FG001|Overall Study|Clinical failures|0|||
170761588|NCT00606580|617133232|FG002|Overall Study|Clinical failures|12|||
170761589|NCT00606580|617133230|FG000|Overall Study|Withdrawal by investigator|0|||
170761590|NCT00606580|617133231|FG001|Overall Study|Withdrawal by investigator|1|||
170761591|NCT00606580|617133232|FG002|Overall Study|Withdrawal by investigator|6|||
170761592|NCT00606580|617133230|FG000|Overall Study|Withdrawal by Subject|0|||
170761593|NCT00606580|617133231|FG001|Overall Study|Withdrawal by Subject|1|||
170761594|NCT00606580|617133232|FG002|Overall Study|Withdrawal by Subject|0|||
170761595|NCT00601640|617133233|FG000|Overall Study|Withdrawal by Subject|3|||
170761596|NCT00601640|617133234|FG001|Overall Study|Withdrawal by Subject|0|||
170761597|NCT00601640|617133235|FG002|Overall Study|Withdrawal by Subject|7|||
170761598|NCT00601640|617133233|FG000|Overall Study|Death|1|||
170761599|NCT00601640|617133234|FG001|Overall Study|Death|0|||
170761600|NCT00601640|617133235|FG002|Overall Study|Death|0|||
170761601|NCT00601640|617133233|FG000|Overall Study|Adverse Event|0|||
170761602|NCT00601640|617133234|FG001|Overall Study|Adverse Event|4|||
170761603|NCT00601640|617133235|FG002|Overall Study|Adverse Event|2|||
170761604|NCT00601640|617133233|FG000|Overall Study|intercurrent illness|1|||
170761605|NCT00601640|617133234|FG001|Overall Study|intercurrent illness|0|||
170761606|NCT00601640|617133235|FG002|Overall Study|intercurrent illness|0|||
170761607|NCT00601640|617133233|FG000|Overall Study|change in eligibility status|0|||
170761608|NCT00601640|617133234|FG001|Overall Study|change in eligibility status|1|||
170761609|NCT00601640|617133235|FG002|Overall Study|change in eligibility status|1|||
170761610|NCT01250002|617133238|FG000|Overall Study|Change to open surgical procedure|4|||
170761611|NCT01250002|617133239|FG001|Overall Study|Change to open surgical procedure|3|||
170761612|NCT00335556|617133240|FG000|Overall Study|Death|0|||
170761613|NCT00335556|617133241|FG001|Overall Study|Death|5|||
170761614|NCT00335556|617133242|FG002|Overall Study|Death|0|||
170761615|NCT00335556|617133243|FG003|Overall Study|Death|0|||
170761616|NCT00335556|617133244|FG004|Overall Study|Death|1|||
170761617|NCT00335556|617133245|FG005|Overall Study|Death|0|||
170761618|NCT00335556|617133240|FG000|Overall Study|Lack of Efficacy|0|||
170761619|NCT00335556|617133241|FG001|Overall Study|Lack of Efficacy|19|||
170761620|NCT00335556|617133242|FG002|Overall Study|Lack of Efficacy|3|||
170761621|NCT00335556|617133243|FG003|Overall Study|Lack of Efficacy|3|||
170761622|NCT00335556|617133244|FG004|Overall Study|Lack of Efficacy|0|||
170761623|NCT00335556|617133245|FG005|Overall Study|Lack of Efficacy|1|||
170761624|NCT00335556|617133240|FG000|Overall Study|Physician Decision|0|||
170761625|NCT00335556|617133241|FG001|Overall Study|Physician Decision|6|||
170761626|NCT00335556|617133242|FG002|Overall Study|Physician Decision|2|||
170761627|NCT00335556|617133243|FG003|Overall Study|Physician Decision|1|||
170761628|NCT00335556|617133244|FG004|Overall Study|Physician Decision|0|||
170761629|NCT00335556|617133245|FG005|Overall Study|Physician Decision|0|||
170761630|NCT00335556|617133240|FG000|Overall Study|Ineligible|2|||
170761631|NCT00335556|617133241|FG001|Overall Study|Ineligible|0|||
170761632|NCT00335556|617133242|FG002|Overall Study|Ineligible|0|||
170761633|NCT00335556|617133243|FG003|Overall Study|Ineligible|0|||
170761634|NCT00335556|617133244|FG004|Overall Study|Ineligible|0|||
170761635|NCT00335556|617133245|FG005|Overall Study|Ineligible|0|||
170761636|NCT00335556|617133240|FG000|Overall Study|Refusal of further protocol therapy|0|||
170867110|NCT00777946|617525292|FG001|Overall Study|Adverse Event|1|||
170867111|NCT00777946|617525293|FG002|Overall Study|Adverse Event|3|||
170867112|NCT00777946|617525291|FG000|Overall Study|Lack of Efficacy|0|||
170867113|NCT00777946|617525292|FG001|Overall Study|Lack of Efficacy|0|||
170867114|NCT00777946|617525293|FG002|Overall Study|Lack of Efficacy|9|||
170867115|NCT00777946|617525291|FG000|Overall Study|Condition no longer required study drug|1|||
170867116|NCT00777946|617525292|FG001|Overall Study|Condition no longer required study drug|0|||
170867117|NCT00777946|617525293|FG002|Overall Study|Condition no longer required study drug|0|||
170867118|NCT00777946|617525291|FG000|Overall Study|Patient withdrew consent|3|||
170867119|NCT00777946|617525292|FG001|Overall Study|Patient withdrew consent|2|||
170867120|NCT00777946|617525293|FG002|Overall Study|Patient withdrew consent|3|||
170867121|NCT00777946|617525291|FG000|Overall Study|Lost to Follow-up|3|||
170867122|NCT00777946|617525292|FG001|Overall Study|Lost to Follow-up|1|||
170867123|NCT00777946|617525293|FG002|Overall Study|Lost to Follow-up|0|||
170867124|NCT00777946|617525291|FG000|Overall Study|Protocol deviation|2|||
170867125|NCT00777946|617525292|FG001|Overall Study|Protocol deviation|1|||
170867126|NCT00777946|617525293|FG002|Overall Study|Protocol deviation|1|||
170867127|NCT00777946|617525291|FG000|Overall Study|Randomized in error|1|||
170867128|NCT00777946|617525292|FG001|Overall Study|Randomized in error|1|||
170867129|NCT00777946|617525293|FG002|Overall Study|Randomized in error|0|||
170867130|NCT02684357|617525294|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
170867131|NCT02684357|617525295|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
170867132|NCT02684357|617525296|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
170867133|NCT02684357|617525297|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
170867134|NCT02684357|617525298|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
170867135|NCT02684357|617525299|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
170867136|NCT02684357|617525294|FG000|Part A|Lost to Follow-up|0|||
170867137|NCT02684357|617525295|FG001|Part A|Lost to Follow-up|2|||
170867138|NCT02684357|617525296|FG002|Part A|Lost to Follow-up|2|||
170867139|NCT02684357|617525297|FG003|Part A|Lost to Follow-up|0|||
170867140|NCT02684357|617525298|FG004|Part A|Lost to Follow-up|0|||
170867141|NCT02684357|617525299|FG005|Part A|Lost to Follow-up|0|||
170867142|NCT02684357|617525294|FG000|Part A|Withdrawal by Subject|3|||
170867143|NCT02684357|617525295|FG001|Part A|Withdrawal by Subject|0|||
170867144|NCT02684357|617525296|FG002|Part A|Withdrawal by Subject|0|||
170867145|NCT02684357|617525297|FG003|Part A|Withdrawal by Subject|0|||
170867146|NCT02684357|617525298|FG004|Part A|Withdrawal by Subject|0|||
170867147|NCT02684357|617525299|FG005|Part A|Withdrawal by Subject|0|||
170867148|NCT02684357|617525294|FG000|Part A|Other|0|||
170867149|NCT02684357|617525295|FG001|Part A|Other|1|||
170867150|NCT02684357|617525296|FG002|Part A|Other|0|||
170867151|NCT02684357|617525297|FG003|Part A|Other|0|||
170867152|NCT02684357|617525298|FG004|Part A|Other|0|||
170867153|NCT02684357|617525299|FG005|Part A|Other|0|||
170867154|NCT02684357|617525294|FG000|Part B|Adverse Event (Other)|0|||
170867155|NCT02684357|617525295|FG001|Part B|Adverse Event (Other)|0|||
170867156|NCT02684357|617525296|FG002|Part B|Adverse Event (Other)|0|||
170867157|NCT02684357|617525297|FG003|Part B|Adverse Event (Other)|1|||
170867158|NCT02684357|617525298|FG004|Part B|Adverse Event (Other)|1|||
170867159|NCT02684357|617525299|FG005|Part B|Adverse Event (Other)|1|||
170867160|NCT02684357|617525294|FG000|Part B|Lost to Follow-up|0|||
170867161|NCT02684357|617525295|FG001|Part B|Lost to Follow-up|0|||
170867162|NCT02684357|617525296|FG002|Part B|Lost to Follow-up|0|||
170867163|NCT02684357|617525297|FG003|Part B|Lost to Follow-up|1|||
170867164|NCT02684357|617525298|FG004|Part B|Lost to Follow-up|1|||
170867165|NCT02684357|617525299|FG005|Part B|Lost to Follow-up|7|||
170867166|NCT02684357|617525294|FG000|Part B|Withdrawal by Subject|0|||
170867167|NCT02684357|617525295|FG001|Part B|Withdrawal by Subject|0|||
170867168|NCT02684357|617525296|FG002|Part B|Withdrawal by Subject|0|||
170867169|NCT02684357|617525297|FG003|Part B|Withdrawal by Subject|0|||
170867170|NCT02684357|617525298|FG004|Part B|Withdrawal by Subject|2|||
170867171|NCT02684357|617525299|FG005|Part B|Withdrawal by Subject|4|||
170408722|NCT03210259|615835634|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
170408723|NCT03210259|615835635|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
170867172|NCT02684357|617525294|FG000|Part B|Other|0|||
170867173|NCT02684357|617525295|FG001|Part B|Other|0|||
170867174|NCT02684357|617525296|FG002|Part B|Other|0|||
170867175|NCT02684357|617525297|FG003|Part B|Other|1|||
170867176|NCT02684357|617525298|FG004|Part B|Other|0|||
170867177|NCT02684357|617525299|FG005|Part B|Other|1|||
170867178|NCT00835120|617525312|FG000|Overall Study|Lack of Efficacy|1|||
170867179|NCT00835120|617525312|FG000|Overall Study|Lost to Follow-up|3|||
170408724|NCT03210259|615835633|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
170408725|NCT03210259|615835634|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
170867180|NCT00835120|617525312|FG000|Overall Study|Adverse Event|2|||
170867181|NCT00835120|617525312|FG000|Overall Study|Withdrawal by Subject|2|||
170867182|NCT01658826|617525314|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
170867183|NCT01658826|617525315|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
170867184|NCT01658826|617525314|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
170867185|NCT01658826|617525315|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
170867186|NCT01658826|617525314|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
170408726|NCT03210259|615835635|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
170408727|NCT02533999|615835636|FG000|Overall Study|Lost to Follow-up|3|||
170408728|NCT02533999|615835637|FG001|Overall Study|Lost to Follow-up|5|||
170408729|NCT02533999|615835636|FG000|Overall Study|Protocol Violation|3|||
170408730|NCT02533999|615835637|FG001|Overall Study|Protocol Violation|0|||
170408731|NCT02533999|615835636|FG000|Overall Study|Adverse Event|0|||
170408732|NCT02533999|615835637|FG001|Overall Study|Adverse Event|1|||
170408733|NCT02533999|615835636|FG000|Overall Study|Randomized but intervention not received|0|||
170408734|NCT02533999|615835637|FG001|Overall Study|Randomized but intervention not received|1|||
170408735|NCT05017493|615835638|FG000|Overall Study|Withdrawal by Subject|26|||
170408736|NCT05017493|615835639|FG001|Overall Study|Withdrawal by Subject|0|||
170408737|NCT05017493|615835638|FG000|Overall Study|Physician Decision|15|||
170408738|NCT05017493|615835639|FG001|Overall Study|Physician Decision|0|||
170408739|NCT05017493|615835638|FG000|Overall Study|Protocol Violation|81|||
170408740|NCT05017493|615835639|FG001|Overall Study|Protocol Violation|0|||
170408741|NCT00593333|615835640|FG000|Overall Study|Lost to Follow-up|10|||
170408742|NCT00593333|615835641|FG001|Overall Study|Lost to Follow-up|11|||
170408743|NCT04304950|615835645|FG000|Overall Study|Lost to Follow-up|1|||
170408744|NCT04304950|615835646|FG001|Overall Study|Lost to Follow-up|1|||
170408745|NCT02006147|615835647|FG000|Overall Study|Protocol Violation|1|||
170408746|NCT02006147|615835648|FG001|Overall Study|Protocol Violation|1|||
170408747|NCT02006147|615835649|FG002|Overall Study|Protocol Violation|0|||
170408748|NCT02006147|615835650|FG003|Overall Study|Protocol Violation|0|||
170408749|NCT02006147|615835647|FG000|Overall Study|Withdrawal by Subject|0|||
170408750|NCT02006147|615835648|FG001|Overall Study|Withdrawal by Subject|1|||
170408751|NCT02006147|615835649|FG002|Overall Study|Withdrawal by Subject|0|||
170408752|NCT02006147|615835650|FG003|Overall Study|Withdrawal by Subject|0|||
170408753|NCT02006147|615835647|FG000|Overall Study|Withdrawal by Sponsor|1|||
170408754|NCT02006147|615835648|FG001|Overall Study|Withdrawal by Sponsor|0|||
170408755|NCT02006147|615835649|FG002|Overall Study|Withdrawal by Sponsor|0|||
170408756|NCT02006147|615835650|FG003|Overall Study|Withdrawal by Sponsor|0|||
170408757|NCT01154127|615835655|FG000|Period 1 (21 Days)|Adverse Event|3|||
170408758|NCT01154127|615835656|FG001|Period 1 (21 Days)|Adverse Event|4|||
170408759|NCT01154127|615835655|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
170408760|NCT01154127|615835656|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
170408761|NCT01154127|615835655|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
170408762|NCT01154127|615835656|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
170408763|NCT01154127|615835655|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
170408764|NCT01154127|615835656|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
170408765|NCT01154127|615835655|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
170408766|NCT01154127|615835656|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
170408767|NCT03740100|615835660|FG000|Overall Study|Adverse Event|1|||
170408768|NCT03740100|615835660|FG000|Overall Study|Death|1|||
170408769|NCT02046369|615835661|FG000|Overall Study|Adverse Event|3|||
170408770|NCT02046369|615835662|FG001|Overall Study|Adverse Event|3|||
170408771|NCT02046369|615835661|FG000|Overall Study|Lack of Efficacy|3|||
170408772|NCT02046369|615835662|FG001|Overall Study|Lack of Efficacy|3|||
170408773|NCT02046369|615835661|FG000|Overall Study|Lost to Follow-up|3|||
170408774|NCT02046369|615835662|FG001|Overall Study|Lost to Follow-up|3|||
170408775|NCT02046369|615835661|FG000|Overall Study|Protocol Violation|1|||
170408776|NCT02046369|615835662|FG001|Overall Study|Protocol Violation|2|||
170408777|NCT02046369|615835661|FG000|Overall Study|Withdrawal by Subject|3|||
170408778|NCT02046369|615835662|FG001|Overall Study|Withdrawal by Subject|6|||
170408779|NCT02046369|615835661|FG000|Overall Study|never received study drug|0|||
170408780|NCT02046369|615835662|FG001|Overall Study|never received study drug|1|||
170408781|NCT02046369|615835661|FG000|Overall Study|non compliance|1|||
170408782|NCT02046369|615835662|FG001|Overall Study|non compliance|0|||
170867187|NCT01658826|617525315|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
170408783|NCT01123980|615835663|FG000|Overall Study|Adverse Event|1|||
170408784|NCT01123980|615835664|FG001|Overall Study|Adverse Event|1|||
170408785|NCT01123980|615835663|FG000|Overall Study|Lack of Efficacy|1|||
170408786|NCT01123980|615835664|FG001|Overall Study|Lack of Efficacy|0|||
170408787|NCT01123980|615835663|FG000|Overall Study|Physician Decision|0|||
170408788|NCT01123980|615835664|FG001|Overall Study|Physician Decision|1|||
170408789|NCT01123980|615835663|FG000|Overall Study|Lost to Follow-up|0|||
170408790|NCT01123980|615835664|FG001|Overall Study|Lost to Follow-up|6|||
170408791|NCT01123980|615835663|FG000|Overall Study|Protocol Violation|6|||
170408792|NCT01123980|615835664|FG001|Overall Study|Protocol Violation|6|||
170408793|NCT01123980|615835663|FG000|Overall Study|Withdrawal by Subject|5|||
170408794|NCT01123980|615835664|FG001|Overall Study|Withdrawal by Subject|3|||
170408795|NCT01123980|615835663|FG000|Overall Study|Unclassified|6|||
170408796|NCT01123980|615835664|FG001|Overall Study|Unclassified|7|||
170408797|NCT04079842|615835665|FG000|Overall Study|Request of subject|2|||
170408798|NCT04079842|615835665|FG000|Overall Study|Unable to draw Arterial samples|1|||
170408799|NCT02904200|615835666|FG000|Overall Study|Withdrawal by Subject|1|||
170408800|NCT02904200|615835667|FG001|Overall Study|Withdrawal by Subject|0|||
170408801|NCT02133352|615835668|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
170408802|NCT01715415|615835671|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
170408803|NCT01715415|615835672|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
170408804|NCT01715415|615835671|FG000|Double-blind Treatment|Adverse Event|3|||
170408805|NCT01715415|615835672|FG001|Double-blind Treatment|Adverse Event|0|||
170408806|NCT01715415|615835671|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
170408807|NCT01715415|615835672|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
170408808|NCT01715415|615835671|FG000|Double-blind Treatment|Other|1|||
170408809|NCT01715415|615835672|FG001|Double-blind Treatment|Other|0|||
170408810|NCT01715415|615835671|FG000|Open-label Treatment|Adverse Event|0|||
170408811|NCT01715415|615835672|FG001|Open-label Treatment|Adverse Event|1|||
170408812|NCT01715415|615835671|FG000|Open-label Treatment|Subject Noncompliant|0|||
170408813|NCT01715415|615835672|FG001|Open-label Treatment|Subject Noncompliant|1|||
170408814|NCT01015612|615835673|FG000|Overall Study|Death|113|||
170408815|NCT01015612|615835673|FG000|Overall Study|Withdrawal by Subject|40|||
170408816|NCT04582266|615837969|FG000|Overall Study|Lost to Follow-up|7|||
170408817|NCT04582266|615837970|FG001|Overall Study|Lost to Follow-up|5|||
170408818|NCT04582266|615837969|FG000|Overall Study|Withdrawal by Subject|1|||
170408819|NCT04582266|615837970|FG001|Overall Study|Withdrawal by Subject|0|||
170408820|NCT04582266|615837969|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
170408821|NCT04582266|615837970|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
170408822|NCT03740698|615837973|FG000|Overall Study|Physician Decision|0|||
170408823|NCT03740698|615837974|FG001|Overall Study|Physician Decision|1|||
170408824|NCT03740698|615837975|FG002|Overall Study|Physician Decision|1|||
170408825|NCT01405950|615837977|FG000|Overall Study|Withdrawal by Subject|1|||
170408826|NCT01405950|615837978|FG001|Overall Study|Withdrawal by Subject|0|||
170408827|NCT01405950|615837979|FG002|Overall Study|Withdrawal by Subject|0|||
170408828|NCT01405950|615837980|FG003|Overall Study|Withdrawal by Subject|0|||
170408829|NCT01772368|615837983|FG000|Overall Study|Adverse Event|1|||
170408830|NCT01772368|615837983|FG000|Overall Study|Withdrawal by Subject|3|||
170408831|NCT01772368|615837983|FG000|Overall Study|Protocol Violation|2|||
170408832|NCT01772368|615837983|FG000|Overall Study|Other|1|||
170408833|NCT03551730|615837987|FG000|Overall Study|Adverse Event|1|||
170408834|NCT03551730|615837988|FG001|Overall Study|Adverse Event|0|||
170408835|NCT03551730|615837989|FG002|Overall Study|Adverse Event|0|||
170408836|NCT03551730|615837990|FG003|Overall Study|Adverse Event|0|||
170408837|NCT02668783|615838004|FG000|Overall Study|Pregnancy|0|||
170408838|NCT02668783|615838005|FG001|Overall Study|Pregnancy|1|||
170408839|NCT02668783|615838004|FG000|Overall Study|Protocol Violation|2|||
170408840|NCT02668783|615838005|FG001|Overall Study|Protocol Violation|1|||
170408841|NCT02668783|615838004|FG000|Overall Study|Study terminated by sponsor|9|||
170408842|NCT02668783|615838005|FG001|Overall Study|Study terminated by sponsor|10|||
170408843|NCT02668783|615838004|FG000|Overall Study|Subject moved|1|||
170408844|NCT02668783|615838005|FG001|Overall Study|Subject moved|0|||
170408845|NCT02668783|615838004|FG000|Overall Study|Withdrawal by Subject|1|||
170408846|NCT02668783|615838005|FG001|Overall Study|Withdrawal by Subject|0|||
170408847|NCT01628120|615838006|FG000|Overall Study|Withdrawal by Subject|7|||
170408848|NCT01628120|615838006|FG000|Overall Study|Adverse Event|12|||
170408849|NCT01628120|615838006|FG000|Overall Study|Lost to Follow-up|1|||
170408850|NCT01628120|615838006|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
170408851|NCT01628120|615838006|FG000|Overall Study|Non-compliant with Study Procedures|1|||
170408852|NCT01628120|615838006|FG000|Overall Study|Not Treated|3|||
170408853|NCT01628120|615838006|FG000|Overall Study|Sponsor Decision|5|||
170408854|NCT01628120|615838006|FG000|Overall Study|Switched Dialysis Method|2|||
170408855|NCT01628120|615838006|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
170408856|NCT01628120|615838006|FG000|Overall Study|Moved or Relocated|5|||
170408857|NCT01628120|615838006|FG000|Overall Study|Kidney Transplant|2|||
170408858|NCT01628120|615838006|FG000|Overall Study|Use of Standard of Care|1|||
170408859|NCT02891200|615838011|FG000|Overall Study|Lost to Follow-up|31|||
170408860|NCT02891200|615838012|FG001|Overall Study|Lost to Follow-up|36|||
170408861|NCT02891200|615838011|FG000|Overall Study|Death|10|||
170408862|NCT02891200|615838012|FG001|Overall Study|Death|9|||
170408863|NCT02891200|615838011|FG000|Overall Study|Withdrawal by Subject|1|||
170408864|NCT02891200|615838012|FG001|Overall Study|Withdrawal by Subject|4|||
170408865|NCT04467697|615838013|FG000|Overall Study|Adverse Event|2|||
170408866|NCT04467697|615838013|FG000|Overall Study|Lost to Follow-up|6|||
170408867|NCT04467697|615838013|FG000|Overall Study|Withdrawal by Subject|9|||
170408868|NCT04467697|615838013|FG000|Overall Study|Protocol Violation|3|||
170408869|NCT02231710|615838014|FG000|Overall Study|Physician Decision|1|||
170408870|NCT01339910|615838015|FG000|Overall Study|Withdrawal by Subject|1|||
170408871|NCT01339910|615838016|FG001|Overall Study|Withdrawal by Subject|0|||
170408872|NCT01339910|615838015|FG000|Overall Study|Physician Decision|1|||
170408873|NCT01339910|615838016|FG001|Overall Study|Physician Decision|0|||
170408874|NCT01339910|615838015|FG000|Overall Study|Disease relapse|1|||
170408875|NCT01339910|615838016|FG001|Overall Study|Disease relapse|4|||
170408876|NCT03487796|615838017|FG000|Overall Study|Lost to Follow-up|18|||
170408877|NCT03487796|615838018|FG001|Overall Study|Lost to Follow-up|6|||
170408878|NCT01075763|615838019|FG000|Overall Study|Lost to Follow-up|2|||
170408879|NCT01075763|615838020|FG001|Overall Study|Lost to Follow-up|1|||
170408880|NCT01075763|615838019|FG000|Overall Study|Lack of Efficacy|0|||
170408881|NCT01075763|615838020|FG001|Overall Study|Lack of Efficacy|1|||
170408882|NCT01075763|615838019|FG000|Overall Study|Withdrawal by Subject|2|||
170408883|NCT01075763|615838020|FG001|Overall Study|Withdrawal by Subject|2|||
170408884|NCT03083483|615838021|FG000|Overall Study|Adverse Event|1|||
170408885|NCT03083483|615838022|FG001|Overall Study|Adverse Event|1|||
170408886|NCT03083483|615838023|FG002|Overall Study|Adverse Event|1|||
170408887|NCT03083483|615838021|FG000|Overall Study|Lost to Follow-up|2|||
170408888|NCT03083483|615838022|FG001|Overall Study|Lost to Follow-up|1|||
170408889|NCT03083483|615838023|FG002|Overall Study|Lost to Follow-up|1|||
170408890|NCT03083483|615838021|FG000|Overall Study|technological issues|1|||
170408891|NCT03083483|615838022|FG001|Overall Study|technological issues|0|||
170408892|NCT03083483|615838023|FG002|Overall Study|technological issues|1|||
170408893|NCT00268346|615838025|FG000|Overall Study|Adverse Event|0|||
170408894|NCT00268346|615838026|FG001|Overall Study|Adverse Event|1|||
170408895|NCT00268346|615838025|FG000|Overall Study|Death|0|||
170408896|NCT00268346|615838026|FG001|Overall Study|Death|1|||
170408897|NCT00268346|615838025|FG000|Overall Study|Withdrawal by Subject|0|||
170408898|NCT00268346|615838026|FG001|Overall Study|Withdrawal by Subject|1|||
170408899|NCT00613574|615838027|FG000|Overall Study|Adverse Event|3|||
170408900|NCT00613574|615838027|FG000|Overall Study|Lost to Follow-up|2|||
170408901|NCT00613574|615838027|FG000|Overall Study|Other|1|||
170408902|NCT01799590|615838030|FG000|Overall Study|Adverse Event|13|||
170408903|NCT01799590|615838031|FG001|Overall Study|Adverse Event|7|||
170408904|NCT01799590|615838032|FG002|Overall Study|Adverse Event|5|||
170408905|NCT01799590|615838030|FG000|Overall Study|Pregnancy|2|||
170408906|NCT01799590|615838031|FG001|Overall Study|Pregnancy|0|||
170408907|NCT01799590|615838032|FG002|Overall Study|Pregnancy|0|||
170408908|NCT01799590|615838030|FG000|Overall Study|Lack of Efficacy|3|||
170408909|NCT01799590|615838031|FG001|Overall Study|Lack of Efficacy|1|||
170408910|NCT01799590|615838032|FG002|Overall Study|Lack of Efficacy|3|||
170408911|NCT01799590|615838030|FG000|Overall Study|Participants convenience|4|||
170408912|NCT01799590|615838031|FG001|Overall Study|Participants convenience|4|||
170408913|NCT01799590|615838032|FG002|Overall Study|Participants convenience|2|||
170408914|NCT01799590|615838030|FG000|Overall Study|Aggravation of complications|0|||
170408915|NCT01799590|615838031|FG001|Overall Study|Aggravation of complications|1|||
170408916|NCT01799590|615838032|FG002|Overall Study|Aggravation of complications|1|||
170408917|NCT01799590|615838030|FG000|Overall Study|Using drugs with restricted days of use|0|||
170408918|NCT01799590|615838031|FG001|Overall Study|Using drugs with restricted days of use|3|||
170408919|NCT01799590|615838032|FG002|Overall Study|Using drugs with restricted days of use|2|||
170408920|NCT01799590|615838030|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
170408921|NCT01799590|615838031|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
170408922|NCT01799590|615838032|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
170408923|NCT01799590|615838030|FG000|Overall Study|Other|3|||
170408924|NCT01799590|615838031|FG001|Overall Study|Other|0|||
170408925|NCT01799590|615838032|FG002|Overall Study|Other|1|||
170408926|NCT00582036|615838033|FG000|Overall Study|Withdrawal by Subject|0|||
170408927|NCT00582036|615838034|FG001|Overall Study|Withdrawal by Subject|1|||
170408928|NCT02711956|615838035|FG000|Overall Study|Adverse Event|0|||
170408929|NCT02711956|615838036|FG001|Overall Study|Adverse Event|0|||
170408930|NCT02711956|615838037|FG002|Overall Study|Adverse Event|0|||
170408931|NCT02711956|615838038|FG003|Overall Study|Adverse Event|1|||
170408932|NCT02711956|615838039|FG004|Overall Study|Adverse Event|2|||
170408933|NCT02711956|615838040|FG005|Overall Study|Adverse Event|0|||
170408934|NCT02711956|615838041|FG006|Overall Study|Adverse Event|0|||
170408935|NCT02711956|615838042|FG007|Overall Study|Adverse Event|1|||
170408936|NCT02711956|615838043|FG008|Overall Study|Adverse Event|1|||
170408937|NCT02711956|615838044|FG009|Overall Study|Adverse Event|1|||
170408938|NCT02711956|615838045|FG010|Overall Study|Adverse Event|1|||
170408939|NCT02711956|615838046|FG011|Overall Study|Adverse Event|0|||
170408940|NCT02711956|615838047|FG012|Overall Study|Adverse Event|0|||
170408941|NCT02711956|615838048|FG013|Overall Study|Adverse Event|0|||
170408942|NCT02711956|615838049|FG014|Overall Study|Adverse Event|2|||
170408943|NCT02711956|615838035|FG000|Overall Study|Physician Decision|0|||
170408944|NCT02711956|615838036|FG001|Overall Study|Physician Decision|0|||
170408945|NCT02711956|615838037|FG002|Overall Study|Physician Decision|0|||
170408946|NCT02711956|615838038|FG003|Overall Study|Physician Decision|2|||
170867188|NCT01658826|617525314|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
170408947|NCT02711956|615838039|FG004|Overall Study|Physician Decision|0|||
170408948|NCT02711956|615838040|FG005|Overall Study|Physician Decision|0|||
170408949|NCT02711956|615838041|FG006|Overall Study|Physician Decision|0|||
170519732|NCT02254772|616247610|FG000|Overall Study|Withdrawal by Subject|1|||
170867189|NCT01658826|617525315|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
170408950|NCT02711956|615838042|FG007|Overall Study|Physician Decision|0|||
170408951|NCT02711956|615838043|FG008|Overall Study|Physician Decision|0|||
170408952|NCT02711956|615838044|FG009|Overall Study|Physician Decision|0|||
170408953|NCT02711956|615838045|FG010|Overall Study|Physician Decision|0|||
170408954|NCT02711956|615838046|FG011|Overall Study|Physician Decision|0|||
170408955|NCT02711956|615838047|FG012|Overall Study|Physician Decision|0|||
170408956|NCT02711956|615838048|FG013|Overall Study|Physician Decision|0|||
170408957|NCT02711956|615838049|FG014|Overall Study|Physician Decision|0|||
170408958|NCT02711956|615838035|FG000|Overall Study|Withdrawal by Subject|0|||
170408959|NCT02711956|615838036|FG001|Overall Study|Withdrawal by Subject|0|||
170408960|NCT02711956|615838037|FG002|Overall Study|Withdrawal by Subject|0|||
170408961|NCT02711956|615838038|FG003|Overall Study|Withdrawal by Subject|0|||
170408962|NCT02711956|615838039|FG004|Overall Study|Withdrawal by Subject|0|||
170408963|NCT02711956|615838040|FG005|Overall Study|Withdrawal by Subject|0|||
170408964|NCT02711956|615838041|FG006|Overall Study|Withdrawal by Subject|1|||
170408965|NCT02711956|615838042|FG007|Overall Study|Withdrawal by Subject|0|||
170408966|NCT02711956|615838043|FG008|Overall Study|Withdrawal by Subject|0|||
170408967|NCT02711956|615838044|FG009|Overall Study|Withdrawal by Subject|0|||
170408968|NCT02711956|615838045|FG010|Overall Study|Withdrawal by Subject|0|||
170408969|NCT02711956|615838046|FG011|Overall Study|Withdrawal by Subject|1|||
170408970|NCT02711956|615838047|FG012|Overall Study|Withdrawal by Subject|6|||
170408971|NCT02711956|615838048|FG013|Overall Study|Withdrawal by Subject|0|||
170408972|NCT02711956|615838049|FG014|Overall Study|Withdrawal by Subject|1|||
170408973|NCT02711956|615838035|FG000|Overall Study|Clinical progression|1|||
170408974|NCT02711956|615838036|FG001|Overall Study|Clinical progression|0|||
170408975|NCT02711956|615838037|FG002|Overall Study|Clinical progression|0|||
170408976|NCT02711956|615838038|FG003|Overall Study|Clinical progression|0|||
170408977|NCT02711956|615838039|FG004|Overall Study|Clinical progression|0|||
170408978|NCT02711956|615838040|FG005|Overall Study|Clinical progression|0|||
170408979|NCT02711956|615838041|FG006|Overall Study|Clinical progression|1|||
170408980|NCT02711956|615838042|FG007|Overall Study|Clinical progression|0|||
170408981|NCT02711956|615838043|FG008|Overall Study|Clinical progression|1|||
170408982|NCT02711956|615838044|FG009|Overall Study|Clinical progression|0|||
170408983|NCT02711956|615838045|FG010|Overall Study|Clinical progression|0|||
170408984|NCT02711956|615838046|FG011|Overall Study|Clinical progression|2|||
170408985|NCT02711956|615838047|FG012|Overall Study|Clinical progression|4|||
170408986|NCT02711956|615838048|FG013|Overall Study|Clinical progression|1|||
170408987|NCT02711956|615838049|FG014|Overall Study|Clinical progression|1|||
170408988|NCT02711956|615838035|FG000|Overall Study|Radiographic progression|1|||
170408989|NCT02711956|615838036|FG001|Overall Study|Radiographic progression|1|||
170408990|NCT02711956|615838037|FG002|Overall Study|Radiographic progression|2|||
170408991|NCT02711956|615838038|FG003|Overall Study|Radiographic progression|0|||
170408992|NCT02711956|615838039|FG004|Overall Study|Radiographic progression|1|||
170408993|NCT02711956|615838040|FG005|Overall Study|Radiographic progression|0|||
170408994|NCT02711956|615838041|FG006|Overall Study|Radiographic progression|0|||
170408995|NCT02711956|615838042|FG007|Overall Study|Radiographic progression|0|||
170408996|NCT02711956|615838043|FG008|Overall Study|Radiographic progression|2|||
170408997|NCT02711956|615838044|FG009|Overall Study|Radiographic progression|1|||
170408998|NCT02711956|615838045|FG010|Overall Study|Radiographic progression|0|||
170408999|NCT02711956|615838046|FG011|Overall Study|Radiographic progression|5|||
170409000|NCT02711956|615838047|FG012|Overall Study|Radiographic progression|3|||
170409001|NCT02711956|615838048|FG013|Overall Study|Radiographic progression|0|||
170409002|NCT02711956|615838049|FG014|Overall Study|Radiographic progression|1|||
170409003|NCT02711956|615838035|FG000|Overall Study|PSA progression with clinical progression|0|||
170409004|NCT02711956|615838036|FG001|Overall Study|PSA progression with clinical progression|0|||
170409005|NCT02711956|615838037|FG002|Overall Study|PSA progression with clinical progression|0|||
170409006|NCT02711956|615838038|FG003|Overall Study|PSA progression with clinical progression|0|||
170409007|NCT02711956|615838039|FG004|Overall Study|PSA progression with clinical progression|1|||
170409008|NCT02711956|615838040|FG005|Overall Study|PSA progression with clinical progression|0|||
170409009|NCT02711956|615838041|FG006|Overall Study|PSA progression with clinical progression|0|||
170409010|NCT02711956|615838042|FG007|Overall Study|PSA progression with clinical progression|0|||
170409011|NCT02711956|615838043|FG008|Overall Study|PSA progression with clinical progression|0|||
170409012|NCT02711956|615838044|FG009|Overall Study|PSA progression with clinical progression|0|||
170409013|NCT02711956|615838045|FG010|Overall Study|PSA progression with clinical progression|0|||
170409014|NCT02711956|615838046|FG011|Overall Study|PSA progression with clinical progression|0|||
170409015|NCT02711956|615838047|FG012|Overall Study|PSA progression with clinical progression|1|||
170409016|NCT02711956|615838048|FG013|Overall Study|PSA progression with clinical progression|1|||
170409017|NCT02711956|615838049|FG014|Overall Study|PSA progression with clinical progression|0|||
170409018|NCT02711956|615838035|FG000|Overall Study|PSA progression with radiographic progression|0|||
170409019|NCT02711956|615838036|FG001|Overall Study|PSA progression with radiographic progression|1|||
170409020|NCT02711956|615838037|FG002|Overall Study|PSA progression with radiographic progression|0|||
170409021|NCT02711956|615838038|FG003|Overall Study|PSA progression with radiographic progression|0|||
170409022|NCT02711956|615838039|FG004|Overall Study|PSA progression with radiographic progression|0|||
170409023|NCT02711956|615838040|FG005|Overall Study|PSA progression with radiographic progression|2|||
170409024|NCT02711956|615838041|FG006|Overall Study|PSA progression with radiographic progression|2|||
170519733|NCT03006562|616247611|FG000|Overall Study|Lost to Follow-up|0|||
170409025|NCT02711956|615838042|FG007|Overall Study|PSA progression with radiographic progression|1|||
170409026|NCT02711956|615838043|FG008|Overall Study|PSA progression with radiographic progression|0|||
170409027|NCT02711956|615838044|FG009|Overall Study|PSA progression with radiographic progression|1|||
170409028|NCT02711956|615838045|FG010|Overall Study|PSA progression with radiographic progression|0|||
170409029|NCT02711956|615838046|FG011|Overall Study|PSA progression with radiographic progression|1|||
170409030|NCT02711956|615838047|FG012|Overall Study|PSA progression with radiographic progression|2|||
170409031|NCT02711956|615838048|FG013|Overall Study|PSA progression with radiographic progression|3|||
170409032|NCT02711956|615838049|FG014|Overall Study|PSA progression with radiographic progression|3|||
170409033|NCT01769378|615838051|FG000|Overall Study|Adverse Event|10|||
170409034|NCT01769378|615838052|FG001|Overall Study|Adverse Event|0|||
170409035|NCT01769378|615838051|FG000|Overall Study|Entry criteria not met|1|||
170409036|NCT01769378|615838052|FG001|Overall Study|Entry criteria not met|0|||
170409037|NCT01769378|615838051|FG000|Overall Study|Protocol Violation|1|||
170409038|NCT01769378|615838052|FG001|Overall Study|Protocol Violation|1|||
170409039|NCT01769378|615838051|FG000|Overall Study|Withdrawal by Subject|10|||
170409040|NCT01769378|615838052|FG001|Overall Study|Withdrawal by Subject|3|||
170409041|NCT01769378|615838051|FG000|Overall Study|Sponsor Decision|1|||
170409042|NCT01769378|615838052|FG001|Overall Study|Sponsor Decision|0|||
170409043|NCT01769378|615838051|FG000|Overall Study|Lost to Follow-up|2|||
170409044|NCT01769378|615838052|FG001|Overall Study|Lost to Follow-up|0|||
170409045|NCT05431153|615838053|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170409046|NCT05431153|615838054|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170409047|NCT05431153|615838055|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170409048|NCT05431153|615838056|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170409049|NCT05431153|615838057|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
170409050|NCT05431153|615838058|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170409051|NCT00678392|615838059|FG000|Overall Study|Adverse Event|0|||
170409052|NCT00678392|615838060|FG001|Overall Study|Adverse Event|6|||
170409053|NCT00678392|615838059|FG000|Overall Study|Death|280|||
170409054|NCT00678392|615838060|FG001|Overall Study|Death|269|||
170409055|NCT00678392|615838059|FG000|Overall Study|Lost to Follow-up|15|||
170409056|NCT00678392|615838060|FG001|Overall Study|Lost to Follow-up|13|||
170409057|NCT00678392|615838059|FG000|Overall Study|Objective Progression or Relapse|3|||
170409058|NCT00678392|615838060|FG001|Overall Study|Objective Progression or Relapse|8|||
170409059|NCT00678392|615838059|FG000|Overall Study|Sponsor's Decision|1|||
170409060|NCT00678392|615838060|FG001|Overall Study|Sponsor's Decision|2|||
170409061|NCT00678392|615838059|FG000|Overall Study|Withdrawal by Subject|4|||
170409062|NCT00678392|615838060|FG001|Overall Study|Withdrawal by Subject|4|||
170409063|NCT00678392|615838059|FG000|Overall Study|Randomized But Not Treated|2|||
170409064|NCT00678392|615838060|FG001|Overall Study|Randomized But Not Treated|7|||
170409065|NCT00678392|615838059|FG000|Overall Study|Other|56|||
170409066|NCT00678392|615838060|FG001|Overall Study|Other|53|||
170409067|NCT01958281|615838061|FG000|Overall Study|Lack of Efficacy|5|||
170409068|NCT01958281|615838062|FG001|Overall Study|Lack of Efficacy|2|||
170409069|NCT01958281|615838063|FG002|Overall Study|Lack of Efficacy|0|||
170409070|NCT01958281|615838061|FG000|Overall Study|Adverse Event|0|||
170409071|NCT01958281|615838062|FG001|Overall Study|Adverse Event|2|||
170409072|NCT01958281|615838063|FG002|Overall Study|Adverse Event|0|||
170409073|NCT01958281|615838061|FG000|Overall Study|Withdrew Consent|1|||
170409074|NCT01958281|615838062|FG001|Overall Study|Withdrew Consent|0|||
170409075|NCT01958281|615838063|FG002|Overall Study|Withdrew Consent|0|||
170409076|NCT03038113|615838064|FG000|Overall Study|Withdrawal by Subject|0|||
170409077|NCT03038113|615838065|FG001|Overall Study|Withdrawal by Subject|0|||
170409078|NCT03038113|615838066|FG002|Overall Study|Withdrawal by Subject|1|||
170409079|NCT03038113|615838067|FG003|Overall Study|Withdrawal by Subject|0|||
170409080|NCT03038113|615838068|FG004|Overall Study|Withdrawal by Subject|0|||
170409081|NCT03038113|615838069|FG005|Overall Study|Withdrawal by Subject|0|||
170409082|NCT03038113|615838070|FG006|Overall Study|Withdrawal by Subject|0|||
170409083|NCT03038113|615838071|FG007|Overall Study|Withdrawal by Subject|0|||
170409084|NCT03038113|615838072|FG008|Overall Study|Withdrawal by Subject|0|||
170409085|NCT03038113|615838073|FG009|Overall Study|Withdrawal by Subject|0|||
170409086|NCT03038113|615838074|FG010|Overall Study|Withdrawal by Subject|0|||
170409087|NCT03038113|615838075|FG011|Overall Study|Withdrawal by Subject|0|||
170409088|NCT03038113|615838076|FG012|Overall Study|Withdrawal by Subject|0|||
170409089|NCT03038113|615838077|FG013|Overall Study|Withdrawal by Subject|1|||
170409090|NCT03038113|615838064|FG000|Overall Study|Lost to Follow-up|0|||
170409091|NCT03038113|615838065|FG001|Overall Study|Lost to Follow-up|0|||
170409092|NCT03038113|615838066|FG002|Overall Study|Lost to Follow-up|0|||
170409093|NCT03038113|615838067|FG003|Overall Study|Lost to Follow-up|0|||
170409094|NCT03038113|615838068|FG004|Overall Study|Lost to Follow-up|0|||
170409095|NCT03038113|615838069|FG005|Overall Study|Lost to Follow-up|0|||
170409096|NCT03038113|615838070|FG006|Overall Study|Lost to Follow-up|1|||
170409097|NCT03038113|615838071|FG007|Overall Study|Lost to Follow-up|0|||
170409098|NCT03038113|615838072|FG008|Overall Study|Lost to Follow-up|0|||
170409099|NCT03038113|615838073|FG009|Overall Study|Lost to Follow-up|0|||
170409100|NCT03038113|615838074|FG010|Overall Study|Lost to Follow-up|0|||
170761637|NCT00335556|617133241|FG001|Overall Study|Refusal of further protocol therapy|4|||
170761638|NCT00335556|617133242|FG002|Overall Study|Refusal of further protocol therapy|0|||
170761639|NCT00335556|617133243|FG003|Overall Study|Refusal of further protocol therapy|1|||
170761640|NCT00335556|617133244|FG004|Overall Study|Refusal of further protocol therapy|0|||
170761641|NCT00335556|617133245|FG005|Overall Study|Refusal of further protocol therapy|0|||
170761642|NCT01674569|617133246|FG000|Overall Study|Adverse Event|0|||
170761643|NCT01674569|617133247|FG001|Overall Study|Adverse Event|2|||
170761644|NCT01674569|617133248|FG002|Overall Study|Adverse Event|0|||
170761645|NCT01674569|617133249|FG003|Overall Study|Adverse Event|1|||
170761646|NCT01674569|617133250|FG004|Overall Study|Adverse Event|2|||
170761647|NCT01674569|617133251|FG005|Overall Study|Adverse Event|2|||
170761648|NCT01674569|617133246|FG000|Overall Study|Protocol Violation|0|||
170867190|NCT01658826|617525314|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
170867191|NCT01658826|617525315|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
170867192|NCT01658826|617525314|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
170867193|NCT01658826|617525315|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
170867194|NCT01658826|617525314|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
170867195|NCT01658826|617525315|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
170867196|NCT01658826|617525314|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
170519734|NCT03006562|616247612|FG001|Overall Study|Lost to Follow-up|1|||
170761649|NCT01674569|617133247|FG001|Overall Study|Protocol Violation|1|||
170761650|NCT01674569|617133248|FG002|Overall Study|Protocol Violation|1|||
170761651|NCT01674569|617133249|FG003|Overall Study|Protocol Violation|0|||
170409101|NCT03038113|615838075|FG011|Overall Study|Lost to Follow-up|0|||
170409102|NCT03038113|615838076|FG012|Overall Study|Lost to Follow-up|0|||
170409103|NCT03038113|615838077|FG013|Overall Study|Lost to Follow-up|0|||
170409104|NCT02784106|615838078|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
170409105|NCT02784106|615838079|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
170409106|NCT02784106|615838080|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
170409107|NCT02784106|615838081|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
170409108|NCT02784106|615838078|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
170409109|NCT02784106|615838079|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
170409110|NCT02784106|615838080|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170409111|NCT02784106|615838081|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170409112|NCT02784106|615838078|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
170409113|NCT02784106|615838079|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
170409114|NCT02784106|615838080|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
170867197|NCT01658826|617525315|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
170867198|NCT01658826|617525314|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
170867199|NCT01658826|617525315|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
170867200|NCT00977574|617525325|FG000|Overall Study|Never Treated|4|||
170867201|NCT00977574|617525326|FG001|Overall Study|Never Treated|2|||
170867202|NCT00977574|617525327|FG002|Overall Study|Never Treated|4|||
170867203|NCT04223791|617525328|FG000|Overall Study|Lost to Follow-up|0|||
170867204|NCT04223791|617525329|FG001|Overall Study|Lost to Follow-up|4|||
170867205|NCT04223791|617525328|FG000|Overall Study|Physician Decision|5|||
170867206|NCT04223791|617525329|FG001|Overall Study|Physician Decision|1|||
170867207|NCT04223791|617525328|FG000|Overall Study|Protocol Violation|1|||
170867208|NCT04223791|617525329|FG001|Overall Study|Protocol Violation|1|||
170867209|NCT04223791|617525328|FG000|Overall Study|Withdrawal by Subject|10|||
170867210|NCT04223791|617525329|FG001|Overall Study|Withdrawal by Subject|12|||
170867211|NCT04223791|617525328|FG000|Overall Study|Pregnancy|1|||
170867212|NCT04223791|617525329|FG001|Overall Study|Pregnancy|1|||
170867213|NCT04223791|617525328|FG000|Overall Study|Ongoing in Study|305|||
170867214|NCT04223791|617525329|FG001|Overall Study|Ongoing in Study|302|||
170867215|NCT02462928|617526541|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
170867216|NCT02462928|617526542|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
170867217|NCT02462928|617526543|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
170867218|NCT02462928|617526541|FG000|Overall Study|Adverse Event|47|||
170409115|NCT02784106|615838081|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
170409116|NCT02784106|615838078|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
170409117|NCT02784106|615838079|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
170761652|NCT01674569|617133250|FG004|Overall Study|Protocol Violation|0|||
170761653|NCT01674569|617133251|FG005|Overall Study|Protocol Violation|0|||
170761654|NCT01674569|617133246|FG000|Overall Study|Withdrawal by Subject|0|||
170761655|NCT01674569|617133247|FG001|Overall Study|Withdrawal by Subject|0|||
170761656|NCT01674569|617133248|FG002|Overall Study|Withdrawal by Subject|1|||
170761657|NCT01674569|617133249|FG003|Overall Study|Withdrawal by Subject|0|||
170761658|NCT01674569|617133250|FG004|Overall Study|Withdrawal by Subject|0|||
170761659|NCT01674569|617133251|FG005|Overall Study|Withdrawal by Subject|0|||
170761660|NCT02365298|617133254|FG000|Period 2|incorrect Rx dispensed|1|||
170761661|NCT02365298|617133255|FG001|Period 2|incorrect Rx dispensed|0|||
170761662|NCT02365298|617133254|FG000|Period 2|Discontinued at request of Sponsor|1|||
170761663|NCT02365298|617133255|FG001|Period 2|Discontinued at request of Sponsor|0|||
170761664|NCT02365298|617133254|FG000|Period 2|Test Article longer available|0|||
170761665|NCT02365298|617133255|FG001|Period 2|Test Article longer available|1|||
170761666|NCT02365298|617133254|FG000|Period 2|Protocol Violation|0|||
170761667|NCT02365298|617133255|FG001|Period 2|Protocol Violation|1|||
170761668|NCT03404843|617133258|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
170761669|NCT03404843|617133259|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
170761670|NCT00001575|617133263|FG000|Overall Study|Screening failures-Ph I portion|22|||
170761671|NCT00001575|617133263|FG000|Overall Study|Withdrawn/deaths|23|||
170761672|NCT02974010|617133265|FG000|Overall Study|Lost to Follow-up|3|||
170867219|NCT02462928|617526542|FG001|Overall Study|Adverse Event|51|||
170867220|NCT02462928|617526543|FG002|Overall Study|Adverse Event|25|||
170867221|NCT02462928|617526541|FG000|Overall Study|Lack of Efficacy|3|||
170867222|NCT02462928|617526542|FG001|Overall Study|Lack of Efficacy|8|||
170867223|NCT02462928|617526543|FG002|Overall Study|Lack of Efficacy|3|||
170867224|NCT02462928|617526541|FG000|Overall Study|Lost to Follow-up|4|||
170761673|NCT02974010|617133266|FG001|Overall Study|Lost to Follow-up|1|||
170867225|NCT02462928|617526542|FG001|Overall Study|Lost to Follow-up|4|||
170761674|NCT02974010|617133267|FG002|Overall Study|Lost to Follow-up|0|||
170867226|NCT02462928|617526543|FG002|Overall Study|Lost to Follow-up|1|||
170761675|NCT02974010|617133268|FG003|Overall Study|Lost to Follow-up|0|||
170761676|NCT02974010|617133265|FG000|Overall Study|Withdrawal by Subject|2|||
170761677|NCT02974010|617133266|FG001|Overall Study|Withdrawal by Subject|1|||
170867227|NCT02462928|617526541|FG000|Overall Study|Withdrawal by Patient|31|||
170867228|NCT02462928|617526542|FG001|Overall Study|Withdrawal by Patient|21|||
170867229|NCT02462928|617526543|FG002|Overall Study|Withdrawal by Patient|21|||
170867230|NCT02462928|617526541|FG000|Overall Study|Protocol Violation|0|||
170867231|NCT02462928|617526542|FG001|Overall Study|Protocol Violation|1|||
170867232|NCT02462928|617526543|FG002|Overall Study|Protocol Violation|0|||
170867233|NCT02462928|617526541|FG000|Overall Study|Reason not Specified|4|||
170867234|NCT02462928|617526542|FG001|Overall Study|Reason not Specified|6|||
170761678|NCT02974010|617133267|FG002|Overall Study|Withdrawal by Subject|0|||
170761679|NCT02974010|617133268|FG003|Overall Study|Withdrawal by Subject|0|||
170761680|NCT02974010|617133265|FG000|Overall Study|Adverse Event|0|||
170761681|NCT02974010|617133266|FG001|Overall Study|Adverse Event|1|||
170761682|NCT02974010|617133267|FG002|Overall Study|Adverse Event|0|||
170761683|NCT02974010|617133268|FG003|Overall Study|Adverse Event|0|||
170761684|NCT02974010|617133265|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
170761685|NCT02974010|617133266|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
170761686|NCT02974010|617133267|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
170761687|NCT02974010|617133268|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
170761688|NCT02974010|617133265|FG000|Overall Study|Lack of Efficacy|0|||
170761689|NCT02974010|617133266|FG001|Overall Study|Lack of Efficacy|0|||
170761690|NCT02974010|617133267|FG002|Overall Study|Lack of Efficacy|1|||
170761691|NCT02974010|617133268|FG003|Overall Study|Lack of Efficacy|0|||
170761692|NCT02322216|617133273|FG000|Overall Study|Adverse Event|1|||
170761693|NCT02322216|617133274|FG001|Overall Study|Adverse Event|0|||
170761694|NCT02322216|617133273|FG000|Overall Study|Withdrawal by Subject|1|||
170761695|NCT02322216|617133274|FG001|Overall Study|Withdrawal by Subject|4|||
170761696|NCT00404079|617133275|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
170761697|NCT00404079|617133276|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
170761698|NCT00580801|617133278|FG000|Overall Study|Physician Decision|1|||
170761699|NCT00580801|617133279|FG001|Overall Study|Physician Decision|0|||
170761700|NCT00580801|617133280|FG002|Overall Study|Physician Decision|0|||
170761701|NCT00580801|617133278|FG000|Overall Study|Adverse Event|2|||
170761702|NCT00580801|617133279|FG001|Overall Study|Adverse Event|0|||
170761703|NCT00580801|617133280|FG002|Overall Study|Adverse Event|0|||
170761704|NCT00580801|617133278|FG000|Overall Study|Lost to Follow-up|2|||
170761705|NCT00580801|617133279|FG001|Overall Study|Lost to Follow-up|0|||
170761706|NCT00580801|617133280|FG002|Overall Study|Lost to Follow-up|0|||
170761707|NCT00580801|617133278|FG000|Overall Study|Reached a virologic endpoint|0|||
170761708|NCT00580801|617133279|FG001|Overall Study|Reached a virologic endpoint|1|||
170761709|NCT00580801|617133280|FG002|Overall Study|Reached a virologic endpoint|2|||
170761710|NCT00580801|617133278|FG000|Overall Study|Participant non-compliant|0|||
170761711|NCT00580801|617133279|FG001|Overall Study|Participant non-compliant|0|||
170761712|NCT00580801|617133280|FG002|Overall Study|Participant non-compliant|1|||
170761713|NCT00580801|617133278|FG000|Overall Study|Travel|1|||
170761714|NCT00580801|617133279|FG001|Overall Study|Travel|0|||
170761715|NCT00580801|617133280|FG002|Overall Study|Travel|0|||
170761716|NCT02595398|617133281|FG000|Overall Study|Non-compliance|1|||
170761717|NCT02595398|617133282|FG001|Overall Study|Non-compliance|0|||
170761718|NCT02595398|617133281|FG000|Overall Study|Withdrawal by Subject|2|||
170761719|NCT02595398|617133282|FG001|Overall Study|Withdrawal by Subject|1|||
170761720|NCT02595398|617133281|FG000|Overall Study|Lost to Follow-up|1|||
170761721|NCT02595398|617133282|FG001|Overall Study|Lost to Follow-up|0|||
170761722|NCT00502593|617133283|FG000|Overall Study|Withdrawn unspecified reason|1|||
170761723|NCT00502593|617133284|FG001|Overall Study|Withdrawn unspecified reason|1|||
170761724|NCT00502593|617133285|FG002|Overall Study|Withdrawn unspecified reason|3|||
170761725|NCT00502593|617133286|FG003|Overall Study|Withdrawn unspecified reason|1|||
170761726|NCT00502593|617133287|FG004|Overall Study|Withdrawn unspecified reason|2|||
170761727|NCT00502593|617133288|FG005|Overall Study|Withdrawn unspecified reason|0|||
170761728|NCT00502593|617133289|FG006|Overall Study|Withdrawn unspecified reason|2|||
170761729|NCT00502593|617133290|FG007|Overall Study|Withdrawn unspecified reason|0|||
170761730|NCT00502593|617133291|FG008|Overall Study|Withdrawn unspecified reason|0|||
170761731|NCT00502593|617133292|FG009|Overall Study|Withdrawn unspecified reason|0|||
170867235|NCT02462928|617526543|FG002|Overall Study|Reason not Specified|5|||
170867236|NCT00395863|617526544|FG000|Overall Study|Patients did not complete both exams|2|||
170867237|NCT00395863|617526545|FG001|Overall Study|Patients did not complete both exams|3|||
170761732|NCT00502593|617133293|FG010|Overall Study|Withdrawn unspecified reason|0|||
170761733|NCT00502593|617133294|FG011|Overall Study|Withdrawn unspecified reason|0|||
170867238|NCT01493557|617526546|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
170867239|NCT01493557|617526547|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
170761734|NCT00502593|617133283|FG000|Overall Study|Withdrawal by Subject|0|||
170761735|NCT00502593|617133284|FG001|Overall Study|Withdrawal by Subject|0|||
170761736|NCT00502593|617133285|FG002|Overall Study|Withdrawal by Subject|6|||
170761737|NCT00502593|617133286|FG003|Overall Study|Withdrawal by Subject|2|||
170761738|NCT00502593|617133287|FG004|Overall Study|Withdrawal by Subject|2|||
170761739|NCT00502593|617133288|FG005|Overall Study|Withdrawal by Subject|0|||
170761740|NCT00502593|617133289|FG006|Overall Study|Withdrawal by Subject|3|||
170761741|NCT00502593|617133290|FG007|Overall Study|Withdrawal by Subject|0|||
170761742|NCT00502593|617133291|FG008|Overall Study|Withdrawal by Subject|3|||
170761743|NCT00502593|617133292|FG009|Overall Study|Withdrawal by Subject|0|||
170761744|NCT00502593|617133293|FG010|Overall Study|Withdrawal by Subject|1|||
170761745|NCT00502593|617133294|FG011|Overall Study|Withdrawal by Subject|0|||
170761746|NCT00502593|617133283|FG000|Overall Study|Lost to Follow-up|2|||
170761747|NCT00502593|617133284|FG001|Overall Study|Lost to Follow-up|1|||
170761748|NCT00502593|617133285|FG002|Overall Study|Lost to Follow-up|1|||
170761749|NCT00502593|617133286|FG003|Overall Study|Lost to Follow-up|1|||
170761750|NCT00502593|617133287|FG004|Overall Study|Lost to Follow-up|0|||
170761751|NCT00502593|617133288|FG005|Overall Study|Lost to Follow-up|0|||
170761752|NCT00502593|617133289|FG006|Overall Study|Lost to Follow-up|0|||
170761753|NCT00502593|617133290|FG007|Overall Study|Lost to Follow-up|0|||
170761754|NCT00502593|617133291|FG008|Overall Study|Lost to Follow-up|3|||
170761755|NCT00502593|617133292|FG009|Overall Study|Lost to Follow-up|0|||
170761756|NCT00502593|617133293|FG010|Overall Study|Lost to Follow-up|1|||
170761757|NCT00502593|617133294|FG011|Overall Study|Lost to Follow-up|0|||
170761758|NCT05576051|617133295|FG000|Overall Study|Lack of Efficacy|543|||
170761759|NCT05576051|617133296|FG001|Overall Study|Lack of Efficacy|343|||
170761760|NCT05576051|617133297|FG002|Overall Study|Lack of Efficacy|108|||
170761761|NCT05576051|617133298|FG003|Overall Study|Lack of Efficacy|72|||
170761762|NCT05576051|617133299|FG004|Overall Study|Lack of Efficacy|28|||
170761763|NCT05576051|617133300|FG005|Overall Study|Lack of Efficacy|50|||
170761764|NCT05576051|617133295|FG000|Overall Study|Safety|78|||
170761765|NCT05576051|617133296|FG001|Overall Study|Safety|74|||
170761766|NCT05576051|617133297|FG002|Overall Study|Safety|16|||
170761767|NCT05576051|617133298|FG003|Overall Study|Safety|14|||
170761768|NCT05576051|617133299|FG004|Overall Study|Safety|4|||
170761769|NCT05576051|617133300|FG005|Overall Study|Safety|5|||
170761770|NCT05576051|617133295|FG000|Overall Study|Efficacy + Safety|10|||
170761771|NCT05576051|617133296|FG001|Overall Study|Efficacy + Safety|7|||
170761772|NCT05576051|617133297|FG002|Overall Study|Efficacy + Safety|3|||
170761773|NCT05576051|617133298|FG003|Overall Study|Efficacy + Safety|0|||
170761774|NCT05576051|617133299|FG004|Overall Study|Efficacy + Safety|0|||
170761775|NCT05576051|617133300|FG005|Overall Study|Efficacy + Safety|0|||
170761776|NCT05576051|617133295|FG000|Overall Study|Other|231|||
170761777|NCT05576051|617133296|FG001|Overall Study|Other|127|||
170761778|NCT05576051|617133297|FG002|Overall Study|Other|35|||
170761779|NCT05576051|617133298|FG003|Overall Study|Other|14|||
170761780|NCT05576051|617133299|FG004|Overall Study|Other|6|||
170761781|NCT05576051|617133300|FG005|Overall Study|Other|0|||
170761782|NCT04154943|617133301|FG000|Overall Study|Study Ongoing|68|||
170761783|NCT04154943|617133301|FG000|Overall Study|Lost to Follow-up|1|||
170761784|NCT04154943|617133301|FG000|Overall Study|Decision by the Investigator|1|||
170761785|NCT04154943|617133301|FG000|Overall Study|Death|5|||
170761786|NCT04154943|617133301|FG000|Overall Study|Withdrawal by Subject|4|||
170761787|NCT00544440|617133303|FG000|Overall Study|Other|1|||
170761788|NCT00544440|617133303|FG000|Overall Study|Adverse Event|1|||
170761789|NCT00544440|617133303|FG000|Overall Study|Withdrawal by Subject|2|||
170761790|NCT00544440|617133303|FG000|Overall Study|Subject Non-compliance|1|||
170761791|NCT00544440|617133303|FG000|Overall Study|Progressive Disease|47|||
170761792|NCT00544440|617133303|FG000|Overall Study|Other|5|||
170761793|NCT03601507|617133304|FG000|Overall Study|Adverse Event|1|||
170761794|NCT01664104|617133305|FG000|Overall Study|Adverse Event|6|||
170761795|NCT01664104|617133305|FG000|Overall Study|Lack of Efficacy|2|||
170761796|NCT01664104|617133305|FG000|Overall Study|Withdrawal by Subject|1|||
170761797|NCT01664104|617133305|FG000|Overall Study|Lost to Follow-up|4|||
170761798|NCT01664104|617133305|FG000|Overall Study|Other|1|||
170761799|NCT01664104|617133305|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
170761800|NCT01460342|617133308|FG000|Overall Study|Adverse Event|5|||
170761801|NCT01460342|617133309|FG001|Overall Study|Adverse Event|4|||
170761802|NCT01460342|617133308|FG000|Overall Study|Lost to Follow-up|1|||
170761803|NCT01460342|617133309|FG001|Overall Study|Lost to Follow-up|2|||
170761804|NCT01460342|617133308|FG000|Overall Study|Protocol Violation|0|||
170761805|NCT01460342|617133309|FG001|Overall Study|Protocol Violation|1|||
170867240|NCT01493557|617526548|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
170761806|NCT01460342|617133308|FG000|Overall Study|Withdrawal by Subject|3|||
170761807|NCT01460342|617133309|FG001|Overall Study|Withdrawal by Subject|4|||
170761808|NCT01460342|617133308|FG000|Overall Study|Physician Decision|1|||
170761809|NCT01460342|617133309|FG001|Overall Study|Physician Decision|3|||
170761810|NCT01460342|617133308|FG000|Overall Study|Lack of Efficacy|1|||
170761811|NCT01460342|617133309|FG001|Overall Study|Lack of Efficacy|0|||
170761812|NCT02107014|617133310|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
170761813|NCT00591838|617133311|FG000|Overall Study|Withdrawal by Subject|0|||
170761814|NCT00591838|617133312|FG001|Overall Study|Withdrawal by Subject|0|||
170761815|NCT00591838|617133313|FG002|Overall Study|Withdrawal by Subject|0|||
170761816|NCT00591838|617133314|FG003|Overall Study|Withdrawal by Subject|1|||
170761817|NCT00591838|617133315|FG004|Overall Study|Withdrawal by Subject|0|||
170761818|NCT03761784|617133316|FG000|Overall Study|Adverse Event|4|||
170867241|NCT01493557|617526546|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
170867242|NCT01493557|617526547|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
170867243|NCT01493557|617526548|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
170867244|NCT01493557|617526546|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
170867245|NCT01493557|617526547|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
170867246|NCT01493557|617526548|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
170867247|NCT01493557|617526546|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
170867248|NCT01493557|617526547|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
170867249|NCT01493557|617526548|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
170867250|NCT01493557|617526546|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
170867251|NCT01493557|617526547|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
170867252|NCT01493557|617526548|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
170867253|NCT01493557|617526546|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
170867254|NCT01493557|617526547|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
170867255|NCT01493557|617526548|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
170867256|NCT01493557|617526546|FG000|Not Randomized to Management Strategies|Early termination|0|||
170867257|NCT01493557|617526547|FG001|Not Randomized to Management Strategies|Early termination|0|||
170867258|NCT01493557|617526548|FG002|Not Randomized to Management Strategies|Early termination|34|||
170867259|NCT01493557|617526546|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
170867260|NCT01493557|617526547|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
170867261|NCT01493557|617526548|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
170867262|NCT01493557|617526546|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
170867263|NCT01493557|617526547|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
170867264|NCT01493557|617526548|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
170867265|NCT01493557|617526546|FG000|Randomized to Management Strategies|Other adverse event|8|||
170867266|NCT01493557|617526547|FG001|Randomized to Management Strategies|Other adverse event|5|||
170867267|NCT01493557|617526548|FG002|Randomized to Management Strategies|Other adverse event|0|||
170867268|NCT01493557|617526546|FG000|Randomized to Management Strategies|Protocol Violation|3|||
170867269|NCT01493557|617526547|FG001|Randomized to Management Strategies|Protocol Violation|0|||
170867270|NCT01493557|617526548|FG002|Randomized to Management Strategies|Protocol Violation|0|||
170867271|NCT01493557|617526546|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
170867272|NCT01493557|617526547|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
170867273|NCT01493557|617526548|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
170867274|NCT01493557|617526546|FG000|Randomized to Management Strategies|Other than stated above|1|||
170867275|NCT01493557|617526547|FG001|Randomized to Management Strategies|Other than stated above|3|||
170867276|NCT01493557|617526548|FG002|Randomized to Management Strategies|Other than stated above|0|||
170867277|NCT01493557|617526546|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
170867278|NCT01493557|617526547|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
170867279|NCT01493557|617526548|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
170867280|NCT01493557|617526546|FG000|Adding the Second Strategy|Other adverse event|1|||
170867281|NCT01493557|617526547|FG001|Adding the Second Strategy|Other adverse event|2|||
170867282|NCT01493557|617526548|FG002|Adding the Second Strategy|Other adverse event|0|||
170867283|NCT01493557|617526546|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
170867284|NCT01493557|617526547|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
170867285|NCT01493557|617526548|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
170867286|NCT01940354|617526552|FG000|Overall Study|Withdrawal by Subject|4|||
170867287|NCT01940354|617526553|FG001|Overall Study|Withdrawal by Subject|2|||
170867288|NCT02020863|617526554|FG000|Overall Study|Discovery of Metastatic disease|4|||
170867289|NCT02020863|617526554|FG000|Overall Study|Team chose not to place an a line|1|||
170867290|NCT03873493|617526555|FG000|Overall Study|Withdrawal by Subject|1|||
170867291|NCT03873493|617526555|FG000|Overall Study|Death|9|||
170867292|NCT03873493|617526555|FG000|Overall Study|Lost to Follow-up|1|||
170867293|NCT03873493|617526555|FG000|Overall Study|Study Terminated by Sponsor|1|||
170867294|NCT03873493|617526555|FG000|Overall Study|Other|2|||
170867295|NCT00702845|617526557|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
170867296|NCT00702845|617526558|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
170867297|NCT00702845|617526557|FG000|Overall Study|Too high ovarian response|5|||
170867298|NCT00702845|617526558|FG001|Overall Study|Too high ovarian response|1|||
170867299|NCT00702845|617526557|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
170867300|NCT00702845|617526558|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
170867301|NCT00702845|617526557|FG000|Overall Study|Insufficient ovarian response|1|||
170867302|NCT00702845|617526558|FG001|Overall Study|Insufficient ovarian response|0|||
170867303|NCT00702845|617526557|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
170867304|NCT00702845|617526558|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
170519735|NCT02427841|616247626|FG000|Overall Study|Lack of Efficacy|5|||
170761819|NCT03761784|617133317|FG001|Overall Study|Adverse Event|0|||
170761820|NCT03761784|617133316|FG000|Overall Study|Lost to Follow-up|10|||
170761821|NCT03761784|617133317|FG001|Overall Study|Lost to Follow-up|7|||
170761822|NCT03761784|617133316|FG000|Overall Study|Pregnancy|1|||
170761823|NCT03761784|617133317|FG001|Overall Study|Pregnancy|0|||
170761824|NCT03761784|617133316|FG000|Overall Study|Protocol Violation|2|||
170761825|NCT03761784|617133317|FG001|Overall Study|Protocol Violation|0|||
170761826|NCT03761784|617133316|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
170761827|NCT03761784|617133317|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
170761828|NCT03761784|617133316|FG000|Overall Study|Withdrawal by Subject|9|||
170761829|NCT03761784|617133317|FG001|Overall Study|Withdrawal by Subject|4|||
170761830|NCT03761784|617133316|FG000|Overall Study|Physician Decision|1|||
170761831|NCT03761784|617133317|FG001|Overall Study|Physician Decision|0|||
170761832|NCT03761784|617133316|FG000|Overall Study|Other Than Specified|1|||
170761833|NCT03761784|617133317|FG001|Overall Study|Other Than Specified|0|||
170761834|NCT01549652|617133318|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
170761835|NCT01549652|617133319|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
170761836|NCT01549652|617133320|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
170761837|NCT01549652|617133321|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
170761838|NCT01549652|617133318|FG000|Overall Study|Study Drug Titration Failure|5|||
170761839|NCT01549652|617133319|FG001|Overall Study|Study Drug Titration Failure|6|||
170761840|NCT01549652|617133320|FG002|Overall Study|Study Drug Titration Failure|0|||
170761841|NCT01549652|617133321|FG003|Overall Study|Study Drug Titration Failure|0|||
170761842|NCT01549652|617133318|FG000|Overall Study|Withdrawal Effect|0|||
170761843|NCT01549652|617133319|FG001|Overall Study|Withdrawal Effect|2|||
170761844|NCT01549652|617133320|FG002|Overall Study|Withdrawal Effect|0|||
170761845|NCT01549652|617133321|FG003|Overall Study|Withdrawal Effect|0|||
170761846|NCT01549652|617133318|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
170761847|NCT01549652|617133319|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
170761848|NCT01549652|617133320|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
170761849|NCT01549652|617133321|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
170761850|NCT01549652|617133318|FG000|Overall Study|Problem with Infusion|1|||
170761851|NCT01549652|617133319|FG001|Overall Study|Problem with Infusion|0|||
170761852|NCT01549652|617133320|FG002|Overall Study|Problem with Infusion|0|||
170761853|NCT01549652|617133321|FG003|Overall Study|Problem with Infusion|0|||
170761854|NCT01549652|617133318|FG000|Overall Study|Titration Non-Compliance|1|||
170761855|NCT01549652|617133319|FG001|Overall Study|Titration Non-Compliance|3|||
170761856|NCT01549652|617133320|FG002|Overall Study|Titration Non-Compliance|4|||
170761857|NCT01549652|617133321|FG003|Overall Study|Titration Non-Compliance|5|||
170761858|NCT01549652|617133318|FG000|Overall Study|Titration Side Effects|0|||
170761859|NCT01549652|617133319|FG001|Overall Study|Titration Side Effects|0|||
170761860|NCT01549652|617133320|FG002|Overall Study|Titration Side Effects|6|||
170761861|NCT01549652|617133321|FG003|Overall Study|Titration Side Effects|3|||
170761862|NCT01549652|617133318|FG000|Overall Study|Withdrawal by Subject|0|||
170761863|NCT01549652|617133319|FG001|Overall Study|Withdrawal by Subject|0|||
170761864|NCT01549652|617133320|FG002|Overall Study|Withdrawal by Subject|5|||
170761865|NCT01549652|617133321|FG003|Overall Study|Withdrawal by Subject|3|||
170761866|NCT00586339|617133322|FG000|Overall Study|Withdrawal by Subject|1|||
170761867|NCT00586339|617133323|FG001|Overall Study|Withdrawal by Subject|3|||
170761868|NCT00586339|617133324|FG002|Overall Study|Withdrawal by Subject|1|||
170761869|NCT00586339|617133322|FG000|Overall Study|Migrated/moved from study area|3|||
170761870|NCT00586339|617133323|FG001|Overall Study|Migrated/moved from study area|2|||
170761871|NCT00586339|617133324|FG002|Overall Study|Migrated/moved from study area|4|||
170761872|NCT00586339|617133322|FG000|Overall Study|Lost to Follow-up|3|||
170761873|NCT00586339|617133323|FG001|Overall Study|Lost to Follow-up|2|||
170761874|NCT00586339|617133324|FG002|Overall Study|Lost to Follow-up|1|||
170761875|NCT00559949|617133325|FG000|Overall Study|Progressive Disease during cycle 1|1|||
170761876|NCT00559949|617133325|FG000|Overall Study|Adverse Event|1|||
170761877|NCT00559949|617133325|FG000|Overall Study|Withdrawal by Subject|4|||
170761878|NCT00559949|617133325|FG000|Overall Study|No disease evaluation per protocol|1|||
170761879|NCT02512042|617133326|FG000|Overall Study|Adverse Event|0|||
170761880|NCT02512042|617133327|FG001|Overall Study|Adverse Event|4|||
170761881|NCT02512042|617133326|FG000|Overall Study|Withdrawal by Subject|6|||
170761882|NCT02512042|617133327|FG001|Overall Study|Withdrawal by Subject|6|||
170761883|NCT02512042|617133326|FG000|Overall Study|Non-compliance with study drug|1|||
170761884|NCT02512042|617133327|FG001|Overall Study|Non-compliance with study drug|2|||
170761885|NCT02512042|617133326|FG000|Overall Study|Lost to Follow-up|5|||
170761886|NCT02512042|617133327|FG001|Overall Study|Lost to Follow-up|2|||
170761887|NCT02512042|617133326|FG000|Overall Study|Other|11|||
170761888|NCT02512042|617133327|FG001|Overall Study|Other|11|||
170761889|NCT01194258|617133330|FG000|Titration Period|Withdrawal by Subject|6|||
170761890|NCT01194258|617133331|FG001|Titration Period|Withdrawal by Subject|0|||
170761891|NCT01194258|617133332|FG002|Titration Period|Withdrawal by Subject|0|||
170761892|NCT01194258|617133333|FG003|Titration Period|Withdrawal by Subject|0|||
170761893|NCT01194258|617133334|FG004|Titration Period|Withdrawal by Subject|0|||
170761894|NCT01194258|617133330|FG000|Titration Period|Lost to Follow-up|2|||
170761895|NCT01194258|617133331|FG001|Titration Period|Lost to Follow-up|0|||
170761896|NCT01194258|617133332|FG002|Titration Period|Lost to Follow-up|0|||
170761897|NCT01194258|617133333|FG003|Titration Period|Lost to Follow-up|0|||
170761898|NCT01194258|617133334|FG004|Titration Period|Lost to Follow-up|0|||
170761899|NCT01194258|617133330|FG000|Titration Period|Titration failure|3|||
170761900|NCT01194258|617133331|FG001|Titration Period|Titration failure|0|||
170761901|NCT01194258|617133332|FG002|Titration Period|Titration failure|0|||
170761902|NCT01194258|617133333|FG003|Titration Period|Titration failure|0|||
170761903|NCT01194258|617133334|FG004|Titration Period|Titration failure|0|||
170761904|NCT01194258|617133330|FG000|Period 1 (12 Weeks)|Death|0|||
170761905|NCT01194258|617133331|FG001|Period 1 (12 Weeks)|Death|0|||
170761906|NCT01194258|617133332|FG002|Period 1 (12 Weeks)|Death|0|||
170761907|NCT01194258|617133333|FG003|Period 1 (12 Weeks)|Death|0|||
170761908|NCT01194258|617133334|FG004|Period 1 (12 Weeks)|Death|1|||
170761909|NCT01194258|617133330|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
170761910|NCT01194258|617133331|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
170761911|NCT01194258|617133332|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
170761912|NCT01194258|617133333|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
170761913|NCT01194258|617133334|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
170761914|NCT01194258|617133330|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
170761915|NCT01194258|617133331|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
170761916|NCT01194258|617133332|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
170761917|NCT01194258|617133333|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
170761918|NCT01194258|617133334|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
170761919|NCT01194258|617133330|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170761920|NCT01194258|617133331|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170761921|NCT01194258|617133332|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170761922|NCT01194258|617133333|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170761923|NCT01194258|617133334|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170761924|NCT03852433|617133335|FG000|Overall Study|Withdrawal of consent|5|||
170761925|NCT03852433|617133336|FG001|Overall Study|Withdrawal of consent|8|||
170761926|NCT03852433|617133337|FG002|Overall Study|Withdrawal of consent|1|||
170761927|NCT03852433|617133338|FG003|Overall Study|Withdrawal of consent|1|||
170761928|NCT03852433|617133335|FG000|Overall Study|Adverse Event|1|||
170761929|NCT03852433|617133336|FG001|Overall Study|Adverse Event|1|||
170761930|NCT03852433|617133337|FG002|Overall Study|Adverse Event|1|||
170761931|NCT03852433|617133338|FG003|Overall Study|Adverse Event|1|||
170761932|NCT03852433|617133335|FG000|Overall Study|Lost to Follow-up|0|||
170761933|NCT03852433|617133336|FG001|Overall Study|Lost to Follow-up|1|||
170761934|NCT03852433|617133337|FG002|Overall Study|Lost to Follow-up|0|||
170761935|NCT03852433|617133338|FG003|Overall Study|Lost to Follow-up|1|||
170761936|NCT03852433|617133335|FG000|Overall Study|Pregnancy|0|||
170761937|NCT03852433|617133336|FG001|Overall Study|Pregnancy|1|||
170761938|NCT03852433|617133337|FG002|Overall Study|Pregnancy|1|||
170761939|NCT03852433|617133338|FG003|Overall Study|Pregnancy|0|||
170761940|NCT03852433|617133335|FG000|Overall Study|Protocol Violation|0|||
170761941|NCT03852433|617133336|FG001|Overall Study|Protocol Violation|0|||
170761942|NCT03852433|617133337|FG002|Overall Study|Protocol Violation|1|||
170761943|NCT03852433|617133338|FG003|Overall Study|Protocol Violation|1|||
170761944|NCT03852433|617133335|FG000|Overall Study|Death|0|||
170761945|NCT03852433|617133336|FG001|Overall Study|Death|0|||
170761946|NCT03852433|617133337|FG002|Overall Study|Death|1|||
170761947|NCT03852433|617133338|FG003|Overall Study|Death|0|||
170761948|NCT03852433|617133335|FG000|Overall Study|Lack of Efficacy|0|||
170761949|NCT03852433|617133336|FG001|Overall Study|Lack of Efficacy|1|||
170761950|NCT03852433|617133337|FG002|Overall Study|Lack of Efficacy|0|||
170761951|NCT03852433|617133338|FG003|Overall Study|Lack of Efficacy|0|||
170761952|NCT03852433|617133335|FG000|Overall Study|Non-compliance with study drug|0|||
170761953|NCT03852433|617133336|FG001|Overall Study|Non-compliance with study drug|0|||
170761954|NCT03852433|617133337|FG002|Overall Study|Non-compliance with study drug|0|||
170761955|NCT03852433|617133338|FG003|Overall Study|Non-compliance with study drug|1|||
170761956|NCT03852433|617133335|FG000|Overall Study|Physician Decision|1|||
170761957|NCT03852433|617133336|FG001|Overall Study|Physician Decision|0|||
170761958|NCT03852433|617133337|FG002|Overall Study|Physician Decision|0|||
170761959|NCT03852433|617133338|FG003|Overall Study|Physician Decision|0|||
170761960|NCT03852433|617133335|FG000|Overall Study|Randomized but never treated|1|||
170761961|NCT03852433|617133336|FG001|Overall Study|Randomized but never treated|0|||
170761962|NCT03852433|617133337|FG002|Overall Study|Randomized but never treated|0|||
170761963|NCT03852433|617133338|FG003|Overall Study|Randomized but never treated|0|||
170761964|NCT06269367|617133339|FG000|Phase I|Unable to perform study procedures|0|||
170761965|NCT06269367|617133340|FG001|Phase I|Unable to perform study procedures|1|||
170761966|NCT06269367|617133339|FG000|Phase I|Could not continue study for personal reasons.|1|||
170761967|NCT06269367|617133340|FG001|Phase I|Could not continue study for personal reasons.|0|||
170761968|NCT00124982|617133342|FG000|Short-term Period|Death|1|||
170761969|NCT00124982|617133343|FG001|Short-term Period|Death|1|||
170761970|NCT00124982|617133344|FG002|Short-term Period|Death|0|||
170761971|NCT00124982|617133342|FG000|Short-term Period|Adverse Event|17|||
170761972|NCT00124982|617133343|FG001|Short-term Period|Adverse Event|22|||
170761973|NCT00124982|617133344|FG002|Short-term Period|Adverse Event|0|||
170761974|NCT00124982|617133342|FG000|Short-term Period|Lack of Efficacy|32|||
170761975|NCT00124982|617133343|FG001|Short-term Period|Lack of Efficacy|73|||
170761976|NCT00124982|617133344|FG002|Short-term Period|Lack of Efficacy|0|||
170761977|NCT00124982|617133342|FG000|Short-term Period|Lost to Follow-up|8|||
170761978|NCT00124982|617133343|FG001|Short-term Period|Lost to Follow-up|5|||
170761979|NCT00124982|617133344|FG002|Short-term Period|Lost to Follow-up|0|||
170761980|NCT00124982|617133342|FG000|Short-term Period|Withdrawal of Consent|7|||
170761981|NCT00124982|617133343|FG001|Short-term Period|Withdrawal of Consent|9|||
170761982|NCT00124982|617133344|FG002|Short-term Period|Withdrawal of Consent|0|||
170761983|NCT00124982|617133342|FG000|Short-term Period|Poor/Non-compliance|3|||
170761984|NCT00124982|617133343|FG001|Short-term Period|Poor/Non-compliance|1|||
170761985|NCT00124982|617133344|FG002|Short-term Period|Poor/Non-compliance|0|||
170761986|NCT00124982|617133342|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
170761987|NCT00124982|617133343|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
170761988|NCT00124982|617133344|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
170761989|NCT00124982|617133342|FG000|Short-term Period|Participant Decision|1|||
170761990|NCT00124982|617133343|FG001|Short-term Period|Participant Decision|0|||
170761991|NCT00124982|617133344|FG002|Short-term Period|Participant Decision|0|||
170761992|NCT00124982|617133342|FG000|Short-term Period|Participant Chose Own Doctor|0|||
170761993|NCT00124982|617133343|FG001|Short-term Period|Participant Chose Own Doctor|1|||
170761994|NCT00124982|617133344|FG002|Short-term Period|Participant Chose Own Doctor|0|||
170761995|NCT00124982|617133342|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
170409118|NCT02784106|615838080|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
170409119|NCT02784106|615838081|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
170409120|NCT02784106|615838078|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
170409121|NCT02784106|615838079|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
170409122|NCT02784106|615838080|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
170409123|NCT02784106|615838081|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
170409124|NCT02784106|615838078|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
170409125|NCT02784106|615838079|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
170409126|NCT02784106|615838080|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
170409127|NCT02784106|615838081|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
170409128|NCT01787825|615838082|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
170409129|NCT01787825|615838083|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
170409130|NCT01787825|615838082|FG000|Overall Study|Data Not Analyzable|5|||
170409131|NCT01787825|615838083|FG001|Overall Study|Data Not Analyzable|1|||
170409132|NCT00553540|615838084|FG000|Overall Study|discharged after first visit|2|||
170409133|NCT00553540|615838085|FG001|Overall Study|discharged after first visit|5|||
170409134|NCT01755858|615838088|FG000|Overall Study|Adverse Event|1|||
170409135|NCT01755858|615838089|FG001|Overall Study|Adverse Event|1|||
170409136|NCT00782509|615838090|FG000|Overall Study|Adverse Event|20|||
170409137|NCT00782509|615838091|FG001|Overall Study|Adverse Event|10|||
170409138|NCT00782509|615838092|FG002|Overall Study|Adverse Event|20|||
170761996|NCT00124982|617133343|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
170761997|NCT00124982|617133344|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
170761998|NCT00124982|617133342|FG000|Short-term Period|Participant Had Lymphopenia|1|||
170761999|NCT00124982|617133343|FG001|Short-term Period|Participant Had Lymphopenia|0|||
170762000|NCT00124982|617133344|FG002|Short-term Period|Participant Had Lymphopenia|0|||
170762001|NCT00124982|617133342|FG000|Long-term Period|Death|0|||
170762002|NCT00124982|617133343|FG001|Long-term Period|Death|0|||
170762003|NCT00124982|617133344|FG002|Long-term Period|Death|1|||
170762004|NCT00124982|617133342|FG000|Long-term Period|Adverse Event|0|||
170762005|NCT00124982|617133343|FG001|Long-term Period|Adverse Event|0|||
170409139|NCT00782509|615838090|FG000|Overall Study|Lost to Follow-up|1|||
170409140|NCT00782509|615838091|FG001|Overall Study|Lost to Follow-up|2|||
170409141|NCT00782509|615838092|FG002|Overall Study|Lost to Follow-up|3|||
170409142|NCT00782509|615838090|FG000|Overall Study|Withdrawal by Subject|3|||
170409143|NCT00782509|615838091|FG001|Overall Study|Withdrawal by Subject|5|||
170409144|NCT00782509|615838092|FG002|Overall Study|Withdrawal by Subject|8|||
170409145|NCT00782509|615838090|FG000|Overall Study|Non compliance with protocol|2|||
170409146|NCT00782509|615838091|FG001|Overall Study|Non compliance with protocol|0|||
170409147|NCT00782509|615838092|FG002|Overall Study|Non compliance with protocol|0|||
170409148|NCT00782509|615838090|FG000|Overall Study|Other reasons not stated above|5|||
170409149|NCT00782509|615838091|FG001|Overall Study|Other reasons not stated above|2|||
170409150|NCT00782509|615838092|FG002|Overall Study|Other reasons not stated above|3|||
170762006|NCT00124982|617133344|FG002|Long-term Period|Adverse Event|17|||
170762007|NCT00124982|617133342|FG000|Long-term Period|Lack of Efficacy|0|||
170762008|NCT00124982|617133343|FG001|Long-term Period|Lack of Efficacy|0|||
170762009|NCT00124982|617133344|FG002|Long-term Period|Lack of Efficacy|46|||
170409151|NCT00782509|615838090|FG000|Overall Study|Lack of Efficacy|10|||
170409152|NCT00782509|615838091|FG001|Overall Study|Lack of Efficacy|5|||
170762010|NCT00124982|617133342|FG000|Long-term Period|Lost to Follow-up|0|||
170762011|NCT00124982|617133343|FG001|Long-term Period|Lost to Follow-up|0|||
170762012|NCT00124982|617133344|FG002|Long-term Period|Lost to Follow-up|4|||
170762013|NCT00124982|617133342|FG000|Long-term Period|Withdrawal by Subject|0|||
170762014|NCT00124982|617133343|FG001|Long-term Period|Withdrawal by Subject|0|||
170762015|NCT00124982|617133344|FG002|Long-term Period|Withdrawal by Subject|16|||
170762016|NCT00124982|617133342|FG000|Long-term Period|Pregnancy|0|||
170762017|NCT00124982|617133343|FG001|Long-term Period|Pregnancy|0|||
170762018|NCT00124982|617133344|FG002|Long-term Period|Pregnancy|1|||
170762019|NCT00124982|617133342|FG000|Long-term Period|Poor/Non-compliance|0|||
170762020|NCT00124982|617133343|FG001|Long-term Period|Poor/Non-compliance|0|||
170762021|NCT00124982|617133344|FG002|Long-term Period|Poor/Non-compliance|2|||
170762022|NCT00124982|617133342|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
170762023|NCT00124982|617133343|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
170762024|NCT00124982|617133344|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
170762025|NCT00124982|617133342|FG000|Long-term Period|Neurologist Recommendation|0|||
170762026|NCT00124982|617133343|FG001|Long-term Period|Neurologist Recommendation|0|||
170762027|NCT00124982|617133344|FG002|Long-term Period|Neurologist Recommendation|1|||
170762028|NCT04804605|617134826|FG000|Overall Study|Withdrawal by Subject|46|||
170762029|NCT04804605|617134827|FG001|Overall Study|Withdrawal by Subject|26|||
170762030|NCT04804605|617134828|FG002|Overall Study|Withdrawal by Subject|37|||
170762031|NCT04804605|617134829|FG003|Overall Study|Withdrawal by Subject|21|||
170762032|NCT04804605|617134826|FG000|Overall Study|Lost to Follow-up|47|||
170762033|NCT04804605|617134827|FG001|Overall Study|Lost to Follow-up|21|||
170762034|NCT04804605|617134828|FG002|Overall Study|Lost to Follow-up|30|||
170762035|NCT04804605|617134829|FG003|Overall Study|Lost to Follow-up|17|||
170762036|NCT04804605|617134826|FG000|Overall Study|Lack of Efficacy|28|||
170762037|NCT04804605|617134827|FG001|Overall Study|Lack of Efficacy|11|||
170762038|NCT04804605|617134828|FG002|Overall Study|Lack of Efficacy|37|||
170762039|NCT04804605|617134829|FG003|Overall Study|Lack of Efficacy|8|||
170762040|NCT04804605|617134826|FG000|Overall Study|Adverse Event|10|||
170762041|NCT04804605|617134827|FG001|Overall Study|Adverse Event|10|||
170762042|NCT04804605|617134828|FG002|Overall Study|Adverse Event|10|||
170762043|NCT04804605|617134829|FG003|Overall Study|Adverse Event|7|||
170762044|NCT04804605|617134826|FG000|Overall Study|Non-compliance|8|||
170762045|NCT04804605|617134827|FG001|Overall Study|Non-compliance|3|||
170762046|NCT04804605|617134828|FG002|Overall Study|Non-compliance|5|||
170762047|NCT04804605|617134829|FG003|Overall Study|Non-compliance|1|||
170762048|NCT04804605|617134826|FG000|Overall Study|Physician Decision|3|||
170762049|NCT04804605|617134827|FG001|Overall Study|Physician Decision|0|||
170762050|NCT04804605|617134828|FG002|Overall Study|Physician Decision|5|||
170762051|NCT04804605|617134829|FG003|Overall Study|Physician Decision|0|||
170762052|NCT04804605|617134826|FG000|Overall Study|Protocol Violation|1|||
170762053|NCT04804605|617134827|FG001|Overall Study|Protocol Violation|0|||
170762054|NCT04804605|617134828|FG002|Overall Study|Protocol Violation|0|||
170762055|NCT04804605|617134829|FG003|Overall Study|Protocol Violation|1|||
170762056|NCT04804605|617134826|FG000|Overall Study|Miscellaneous|7|||
170762057|NCT04804605|617134827|FG001|Overall Study|Miscellaneous|3|||
170762058|NCT04804605|617134828|FG002|Overall Study|Miscellaneous|4|||
170762059|NCT04804605|617134829|FG003|Overall Study|Miscellaneous|2|||
170762060|NCT04018066|617134830|FG000|Overall Study|participants started taking medications during the study period|3|||
170762061|NCT04018066|617134830|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
170762062|NCT05257798|617134831|FG000|Follow-up Phase|Lost to Follow-up|1|||
170762063|NCT05257798|617134832|FG001|Follow-up Phase|Lost to Follow-up|0|||
170762064|NCT00464672|617134833|FG000|Overall Study|withdrawal of consent|0|||
170762065|NCT00464672|617134834|FG001|Overall Study|withdrawal of consent|0|||
170762066|NCT00464672|617134835|FG002|Overall Study|withdrawal of consent|0|||
170762067|NCT00464672|617134836|FG003|Overall Study|withdrawal of consent|1|||
170762068|NCT00464672|617134837|FG004|Overall Study|withdrawal of consent|9|||
170762069|NCT00464672|617134838|FG005|Overall Study|withdrawal of consent|4|||
170762070|NCT00464672|617134833|FG000|Overall Study|Lost to Follow-up|25|||
170762071|NCT00464672|617134834|FG001|Overall Study|Lost to Follow-up|10|||
170762072|NCT00464672|617134835|FG002|Overall Study|Lost to Follow-up|0|||
170762073|NCT00464672|617134836|FG003|Overall Study|Lost to Follow-up|0|||
170762074|NCT00464672|617134837|FG004|Overall Study|Lost to Follow-up|1|||
170762075|NCT00464672|617134838|FG005|Overall Study|Lost to Follow-up|0|||
170762076|NCT02299635|617134842|FG000|Overall Study|Adverse Event|2|||
170762077|NCT02299635|617134842|FG000|Overall Study|Death|1|||
170762078|NCT02299635|617134842|FG000|Overall Study|Global deterioration of health status|1|||
170762079|NCT02299635|617134842|FG000|Overall Study|Objective progression or relapse|10|||
170762080|NCT02299635|617134842|FG000|Overall Study|Withdrawal by Subject|2|||
170762081|NCT02299635|617134842|FG000|Overall Study|Other|3|||
170762082|NCT00828672|617134843|FG000|Study Treatment|Lost to Follow-up|1|||
170762083|NCT00828672|617134844|FG001|Study Treatment|Lost to Follow-up|0|||
170762084|NCT00828672|617134843|FG000|Study Treatment|Adverse Event|0|||
170867305|NCT00702845|617526557|FG000|Overall Study|No or abnormal fertilization|4|||
170762085|NCT00828672|617134844|FG001|Study Treatment|Adverse Event|1|||
170762086|NCT00828672|617134843|FG000|Study Treatment|Complete response, no surgery|1|||
170867306|NCT00702845|617526558|FG001|Overall Study|No or abnormal fertilization|2|||
170762087|NCT00828672|617134844|FG001|Study Treatment|Complete response, no surgery|1|||
170762088|NCT00828672|617134843|FG000|Post-surgery (<30 Days)|No central review materials|0|||
170762089|NCT00828672|617134844|FG001|Post-surgery (<30 Days)|No central review materials|1|||
170762090|NCT04889118|617134845|FG000|Overall Study|Death|49|||
170762091|NCT04889118|617134846|FG001|Overall Study|Death|47|||
170762092|NCT04889118|617134845|FG000|Overall Study|Sponsor Decision|15|||
170762093|NCT04889118|617134846|FG001|Overall Study|Sponsor Decision|20|||
170762094|NCT00015457|617134848|FG000|First Intervention|Adverse Event|0|||
170762095|NCT00015457|617134849|FG001|First Intervention|Adverse Event|2|||
170762096|NCT00015457|617134848|FG000|First Intervention|Lack of Efficacy|0|||
170762097|NCT00015457|617134849|FG001|First Intervention|Lack of Efficacy|1|||
170762098|NCT00015457|617134848|FG000|Second Intervention|Withdrawal by Subject|1|||
170762099|NCT00015457|617134849|FG001|Second Intervention|Withdrawal by Subject|0|||
170762100|NCT01456936|617134850|FG000|Overall Study|Other reason|41|||
170762101|NCT01456936|617134851|FG001|Overall Study|Other reason|30|||
170762102|NCT01456936|617134852|FG002|Overall Study|Other reason|36|||
170762103|NCT01456936|617134853|FG003|Overall Study|Other reason|33|||
170762104|NCT01456936|617134850|FG000|Overall Study|No longer meets eligibility criteria|4|||
170762105|NCT01456936|617134851|FG001|Overall Study|No longer meets eligibility criteria|8|||
170762106|NCT01456936|617134852|FG002|Overall Study|No longer meets eligibility criteria|6|||
170762107|NCT01456936|617134853|FG003|Overall Study|No longer meets eligibility criteria|5|||
170762108|NCT01456936|617134850|FG000|Overall Study|Protocol Violation|4|||
170762109|NCT01456936|617134851|FG001|Overall Study|Protocol Violation|2|||
170762110|NCT01456936|617134852|FG002|Overall Study|Protocol Violation|5|||
170762111|NCT01456936|617134853|FG003|Overall Study|Protocol Violation|5|||
170762112|NCT01456936|617134850|FG000|Overall Study|Pregnancy|1|||
170762113|NCT01456936|617134851|FG001|Overall Study|Pregnancy|0|||
170762114|NCT01456936|617134852|FG002|Overall Study|Pregnancy|0|||
170762115|NCT01456936|617134853|FG003|Overall Study|Pregnancy|1|||
170762116|NCT01456936|617134850|FG000|Overall Study|Insufficient clinical response|4|||
170762117|NCT01456936|617134851|FG001|Overall Study|Insufficient clinical response|4|||
170762118|NCT01456936|617134852|FG002|Overall Study|Insufficient clinical response|14|||
170762119|NCT01456936|617134853|FG003|Overall Study|Insufficient clinical response|13|||
170762120|NCT01456936|617134850|FG000|Overall Study|No longer willing to participate|195|||
170762121|NCT01456936|617134851|FG001|Overall Study|No longer willing to participate|218|||
170762122|NCT01456936|617134852|FG002|Overall Study|No longer willing to participate|224|||
170762123|NCT01456936|617134853|FG003|Overall Study|No longer willing to participate|248|||
170762124|NCT01456936|617134850|FG000|Overall Study|Lost to Follow-up|135|||
170762125|NCT01456936|617134851|FG001|Overall Study|Lost to Follow-up|126|||
170762126|NCT01456936|617134852|FG002|Overall Study|Lost to Follow-up|144|||
170762127|NCT01456936|617134853|FG003|Overall Study|Lost to Follow-up|127|||
170762128|NCT01456936|617134850|FG000|Overall Study|Medication error|0|||
170762129|NCT01456936|617134851|FG001|Overall Study|Medication error|1|||
170762130|NCT01456936|617134852|FG002|Overall Study|Medication error|0|||
170762131|NCT01456936|617134853|FG003|Overall Study|Medication error|1|||
170762132|NCT01456936|617134850|FG000|Overall Study|Adverse event (study drug)|25|||
170762133|NCT01456936|617134851|FG001|Overall Study|Adverse event (study drug)|21|||
170762134|NCT01456936|617134852|FG002|Overall Study|Adverse event (study drug)|26|||
170762135|NCT01456936|617134853|FG003|Overall Study|Adverse event (study drug)|17|||
170762136|NCT01456936|617134850|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
170762137|NCT01456936|617134851|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
170762138|NCT01456936|617134852|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
170762139|NCT01456936|617134853|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
170762140|NCT01456936|617134850|FG000|Overall Study|Death|0|||
170762141|NCT01456936|617134851|FG001|Overall Study|Death|3|||
170762142|NCT01456936|617134852|FG002|Overall Study|Death|1|||
170867307|NCT00702845|617526557|FG000|Overall Study|Patient's decision|2|||
170762143|NCT01456936|617134853|FG003|Overall Study|Death|3|||
170762144|NCT01456936|617134850|FG000|Overall Study|Randomized but not treated|21|||
170762145|NCT01456936|617134851|FG001|Overall Study|Randomized but not treated|28|||
170762146|NCT01456936|617134852|FG002|Overall Study|Randomized but not treated|16|||
170762147|NCT01456936|617134853|FG003|Overall Study|Randomized but not treated|21|||
170762148|NCT02317705|617134854|FG000|Overall Study|Withdrawal by Subject|3|||
170762149|NCT02317705|617134854|FG000|Overall Study|Physician Decision|1|||
170762150|NCT02317705|617134854|FG000|Overall Study|Drug not usable|1|||
170762151|NCT03095508|617134855|FG000|Overall Study|Adverse Event|0|||
170762152|NCT03095508|617134856|FG001|Overall Study|Adverse Event|1|||
170762153|NCT01744691|617134857|FG000|Overall Study|Progressive Disease|18|||
170867308|NCT00702845|617526558|FG001|Overall Study|Patient's decision|1|||
170762154|NCT01744691|617134857|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
170762155|NCT01744691|617134857|FG000|Overall Study|Withdrawal of consent for treatment|3|||
170762156|NCT01744691|617134857|FG000|Overall Study|Physician Decision|4|||
170762157|NCT02701361|617134858|FG000|Overall Study|Lost to Follow-up|5|||
170762158|NCT02701361|617134859|FG001|Overall Study|Lost to Follow-up|2|||
170762159|NCT02701361|617134860|FG002|Overall Study|Lost to Follow-up|1|||
170762160|NCT02701361|617134858|FG000|Overall Study|Withdrawal by Subject|4|||
170762161|NCT02701361|617134859|FG001|Overall Study|Withdrawal by Subject|0|||
170762162|NCT02701361|617134860|FG002|Overall Study|Withdrawal by Subject|0|||
170762163|NCT02701361|617134858|FG000|Overall Study|timed out in rehab center|0|||
170762164|NCT02701361|617134859|FG001|Overall Study|timed out in rehab center|1|||
170762165|NCT02701361|617134860|FG002|Overall Study|timed out in rehab center|0|||
170762166|NCT02701361|617134858|FG000|Overall Study|incarceration|0|||
170762167|NCT02701361|617134859|FG001|Overall Study|incarceration|0|||
170762168|NCT02701361|617134860|FG002|Overall Study|incarceration|1|||
170762169|NCT04588480|617134861|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
170762170|NCT04588480|617134862|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
170762171|NCT04588480|617134863|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
170762172|NCT04588480|617134861|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
170762173|NCT04588480|617134862|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
170762174|NCT04588480|617134863|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
170762175|NCT01242085|617134864|FG000|Overall Study|Withdrawal by Subject|4|||
170762176|NCT01242085|617134865|FG001|Overall Study|Withdrawal by Subject|2|||
170762177|NCT01242085|617134866|FG002|Overall Study|Withdrawal by Subject|0|||
170762178|NCT01242085|617134864|FG000|Overall Study|medically unable to have surgery|4|||
170762179|NCT01242085|617134865|FG001|Overall Study|medically unable to have surgery|5|||
170762180|NCT01242085|617134866|FG002|Overall Study|medically unable to have surgery|0|||
170762181|NCT01178762|617134867|FG000|Overall Study|Lost to Follow-up|15|||
170762182|NCT02430532|617134879|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
170762183|NCT02430532|617134880|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
170762184|NCT02430532|617134879|FG000|Overall Study|Consent Withdrawn|0|||
170762185|NCT02430532|617134880|FG001|Overall Study|Consent Withdrawn|2|||
170762186|NCT02430532|617134879|FG000|Overall Study|Adverse Event|0|||
170762187|NCT02430532|617134880|FG001|Overall Study|Adverse Event|1|||
170762188|NCT01190150|617134881|FG000|First Treatment|Withdrawal by Subject|1|||
170762189|NCT01190150|617134882|FG001|First Treatment|Withdrawal by Subject|0|||
170762190|NCT01190150|617134881|FG000|Washout|Withdrawal by Subject|0|||
170762191|NCT01190150|617134882|FG001|Washout|Withdrawal by Subject|1|||
170762192|NCT01190150|617134881|FG000|Washout|Difficulty in adherence|0|||
170762193|NCT01190150|617134882|FG001|Washout|Difficulty in adherence|1|||
170762194|NCT01585038|617134883|FG000|Overall Study|Adverse Event|2|||
170762195|NCT01585038|617134884|FG001|Overall Study|Adverse Event|2|||
170762196|NCT00678795|617134885|FG000|Overall Study|Adverse Event|7|||
170762197|NCT00678795|617134886|FG001|Overall Study|Adverse Event|3|||
170762198|NCT00678795|617134885|FG000|Overall Study|Withdrawal by Subject|3|||
170762199|NCT00678795|617134886|FG001|Overall Study|Withdrawal by Subject|0|||
170762200|NCT00678795|617134885|FG000|Overall Study|Protocol Violation|0|||
170762201|NCT00678795|617134886|FG001|Overall Study|Protocol Violation|1|||
170762202|NCT00678795|617134885|FG000|Overall Study|Lost to Follow-up|0|||
170762203|NCT00678795|617134886|FG001|Overall Study|Lost to Follow-up|1|||
170762204|NCT00678795|617134885|FG000|Overall Study|Lack of Efficacy|1|||
170762205|NCT00678795|617134886|FG001|Overall Study|Lack of Efficacy|1|||
170762206|NCT00853827|617134890|FG000|Single Blind Period (1 Week)|Other|4|||
170762207|NCT00853827|617134891|FG001|Single Blind Period (1 Week)|Other|0|||
170762208|NCT00853827|617134890|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
170762209|NCT00853827|617134891|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
170762210|NCT00853827|617134890|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
170762211|NCT00853827|617134891|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
170762212|NCT00853827|617134890|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
170762213|NCT00853827|617134891|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
170762214|NCT00853827|617134890|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
170762215|NCT00853827|617134891|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
170762216|NCT00853827|617134890|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
170762217|NCT00853827|617134891|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
170762218|NCT00853827|617134890|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
170762219|NCT00853827|617134891|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
170762220|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
170762221|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
170762222|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
170762223|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
170762224|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
170762225|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
170762226|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
170762227|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
170762228|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
170762229|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
170762230|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
170762231|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
170762232|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
170762233|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
170762234|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
170762235|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
170762236|NCT00853827|617134890|FG000|Double Blind Period (103 Weeks)|Death|1|||
170762237|NCT00853827|617134891|FG001|Double Blind Period (103 Weeks)|Death|6|||
170762238|NCT03885596|617134904|FG000|Overall Study|Withdrawal by Subject|2|||
170762239|NCT03885596|617134905|FG001|Overall Study|Withdrawal by Subject|1|||
170762240|NCT03885596|617134906|FG002|Overall Study|Withdrawal by Subject|0|||
170762241|NCT03885596|617134907|FG003|Overall Study|Withdrawal by Subject|0|||
170762242|NCT01467700|617134908|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
170762243|NCT01467700|617134909|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
170762244|NCT01467700|617134910|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
170762245|NCT01467700|617134911|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
170762246|NCT01467700|617134908|FG000|Overall Study|Major Protocol Deviation|3|||
170762247|NCT01467700|617134909|FG001|Overall Study|Major Protocol Deviation|3|||
170762248|NCT01467700|617134910|FG002|Overall Study|Major Protocol Deviation|2|||
170762249|NCT01467700|617134911|FG003|Overall Study|Major Protocol Deviation|3|||
170762250|NCT01467700|617134908|FG000|Overall Study|Lost to Follow-up|6|||
170762251|NCT01467700|617134909|FG001|Overall Study|Lost to Follow-up|5|||
170762252|NCT01467700|617134910|FG002|Overall Study|Lost to Follow-up|2|||
170762253|NCT01467700|617134911|FG003|Overall Study|Lost to Follow-up|3|||
170762254|NCT01467700|617134908|FG000|Overall Study|Voluntary Withdrawal|5|||
170762255|NCT01467700|617134909|FG001|Overall Study|Voluntary Withdrawal|7|||
170762256|NCT01467700|617134910|FG002|Overall Study|Voluntary Withdrawal|6|||
170762257|NCT01467700|617134911|FG003|Overall Study|Voluntary Withdrawal|2|||
170762258|NCT01467700|617134908|FG000|Overall Study|Study Termination|6|||
170762259|NCT01467700|617134909|FG001|Overall Study|Study Termination|5|||
170762260|NCT01467700|617134910|FG002|Overall Study|Study Termination|10|||
170762261|NCT01467700|617134911|FG003|Overall Study|Study Termination|7|||
170762262|NCT01467700|617134908|FG000|Overall Study|Pregnancy|0|||
170762263|NCT01467700|617134909|FG001|Overall Study|Pregnancy|1|||
170762264|NCT01467700|617134910|FG002|Overall Study|Pregnancy|1|||
170762265|NCT01467700|617134911|FG003|Overall Study|Pregnancy|0|||
170762266|NCT01467700|617134908|FG000|Overall Study|Lack of Efficacy|2|||
170762267|NCT01467700|617134909|FG001|Overall Study|Lack of Efficacy|0|||
170762268|NCT01467700|617134910|FG002|Overall Study|Lack of Efficacy|2|||
170867309|NCT00702845|617526557|FG000|Overall Study|Not randomized|0|||
170867310|NCT00702845|617526558|FG001|Overall Study|Not randomized|1|||
170867311|NCT03876171|617526563|FG000|Overall Study|Withdrawal by Subject|3|||
170762269|NCT01467700|617134911|FG003|Overall Study|Lack of Efficacy|1|||
170762270|NCT01467700|617134908|FG000|Overall Study|Reason not Specified|1|||
170762271|NCT01467700|617134909|FG001|Overall Study|Reason not Specified|3|||
170762272|NCT01467700|617134910|FG002|Overall Study|Reason not Specified|2|||
170762273|NCT01467700|617134911|FG003|Overall Study|Reason not Specified|8|||
170762274|NCT03381274|617134914|FG000|Overall Study|Death|2|||
170762275|NCT03381274|617134915|FG001|Overall Study|Death|9|||
170762276|NCT03381274|617134916|FG002|Overall Study|Death|3|||
170762277|NCT03381274|617134917|FG003|Overall Study|Death|2|||
170762278|NCT03381274|617134918|FG004|Overall Study|Death|3|||
170762279|NCT03381274|617134914|FG000|Overall Study|Lost to Follow-up|0|||
170762280|NCT03381274|617134915|FG001|Overall Study|Lost to Follow-up|0|||
170762281|NCT03381274|617134916|FG002|Overall Study|Lost to Follow-up|0|||
170762282|NCT03381274|617134917|FG003|Overall Study|Lost to Follow-up|1|||
170762283|NCT03381274|617134918|FG004|Overall Study|Lost to Follow-up|0|||
170762284|NCT03381274|617134914|FG000|Overall Study|Withdrawal by Subject|2|||
170762285|NCT03381274|617134915|FG001|Overall Study|Withdrawal by Subject|1|||
170762286|NCT03381274|617134916|FG002|Overall Study|Withdrawal by Subject|3|||
170762287|NCT03381274|617134917|FG003|Overall Study|Withdrawal by Subject|1|||
170762288|NCT03381274|617134918|FG004|Overall Study|Withdrawal by Subject|0|||
170762289|NCT03381274|617134914|FG000|Overall Study|Other|1|||
170762290|NCT03381274|617134915|FG001|Overall Study|Other|11|||
170762291|NCT03381274|617134916|FG002|Overall Study|Other|0|||
170762292|NCT03381274|617134917|FG003|Overall Study|Other|2|||
170762293|NCT03381274|617134918|FG004|Overall Study|Other|2|||
170762294|NCT00121199|617134919|FG000|Overall Study|Adverse Event|11|||
170762295|NCT00121199|617134919|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
170762296|NCT00121199|617134919|FG000|Overall Study|Progression/Relapse|1|||
170762297|NCT00121199|617134919|FG000|Overall Study|Death|3|||
170762298|NCT00121199|617134919|FG000|Overall Study|Other - Not Protocol Specified|3|||
170762299|NCT00121199|617134919|FG000|Overall Study|Ineligible|9|||
170762300|NCT03168438|617134920|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
170762301|NCT03168438|617134921|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
170762302|NCT04109118|617134924|FG000|Overall Study|Lost to Follow-up|3|||
170762303|NCT03235349|617134925|FG000|Overall Study|Adverse Event|1|||
170762304|NCT03235349|617134925|FG000|Overall Study|Other|1|||
170762305|NCT03781804|617134930|FG000|Overall Study|Adverse Event|2|||
170867312|NCT03876171|617526564|FG001|Overall Study|Withdrawal by Subject|3|||
170762306|NCT03781804|617134931|FG001|Overall Study|Adverse Event|2|||
170762307|NCT03781804|617134932|FG002|Overall Study|Adverse Event|3|||
170762308|NCT03781804|617134930|FG000|Overall Study|Lost to Follow-up|1|||
170762309|NCT03781804|617134931|FG001|Overall Study|Lost to Follow-up|1|||
170762310|NCT03781804|617134932|FG002|Overall Study|Lost to Follow-up|2|||
170762311|NCT03781804|617134930|FG000|Overall Study|Lack of Efficacy|4|||
170762312|NCT03781804|617134931|FG001|Overall Study|Lack of Efficacy|2|||
170762313|NCT03781804|617134932|FG002|Overall Study|Lack of Efficacy|9|||
170762314|NCT03781804|617134930|FG000|Overall Study|Protocol Violation|0|||
170762315|NCT03781804|617134931|FG001|Overall Study|Protocol Violation|0|||
170762316|NCT03781804|617134932|FG002|Overall Study|Protocol Violation|1|||
170762317|NCT03781804|617134930|FG000|Overall Study|Withdrawal by Subject|0|||
170762318|NCT03781804|617134931|FG001|Overall Study|Withdrawal by Subject|1|||
170762319|NCT03781804|617134932|FG002|Overall Study|Withdrawal by Subject|1|||
170762320|NCT03781804|617134930|FG000|Overall Study|Reason not provided|2|||
170762321|NCT03781804|617134931|FG001|Overall Study|Reason not provided|2|||
170762322|NCT03781804|617134932|FG002|Overall Study|Reason not provided|0|||
170762323|NCT03717194|617134933|FG000|Overall Study|Withdrawal by Subject|2|||
170762324|NCT03717194|617134934|FG001|Overall Study|Withdrawal by Subject|4|||
170762325|NCT03717194|617134933|FG000|Overall Study|Adverse Event|1|||
170762326|NCT03717194|617134934|FG001|Overall Study|Adverse Event|1|||
170762327|NCT02081391|617134935|FG000|12-hour Treatment|Withdrawal by Subject|3|||
170762328|NCT02081391|617134936|FG001|12-hour Treatment|Withdrawal by Subject|2|||
170762329|NCT02081391|617134937|FG002|12-hour Treatment|Withdrawal by Subject|0|||
170762330|NCT02081391|617134938|FG003|12-hour Treatment|Withdrawal by Subject|0|||
170762331|NCT02081391|617134935|FG000|12-hour Treatment|Physician Decision|4|||
170762332|NCT02081391|617134936|FG001|12-hour Treatment|Physician Decision|1|||
170762333|NCT02081391|617134937|FG002|12-hour Treatment|Physician Decision|0|||
170762334|NCT02081391|617134938|FG003|12-hour Treatment|Physician Decision|0|||
170762335|NCT02081391|617134935|FG000|12-hour Treatment|Lack of Efficacy|3|||
170762336|NCT02081391|617134936|FG001|12-hour Treatment|Lack of Efficacy|0|||
170762337|NCT02081391|617134937|FG002|12-hour Treatment|Lack of Efficacy|0|||
170762338|NCT02081391|617134938|FG003|12-hour Treatment|Lack of Efficacy|0|||
170762339|NCT02081391|617134935|FG000|12-hour Treatment|Adverse Event|4|||
170762340|NCT02081391|617134936|FG001|12-hour Treatment|Adverse Event|2|||
170762341|NCT02081391|617134937|FG002|12-hour Treatment|Adverse Event|0|||
170762342|NCT02081391|617134938|FG003|12-hour Treatment|Adverse Event|0|||
170762343|NCT02081391|617134935|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
170762344|NCT02081391|617134936|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
170762345|NCT02081391|617134937|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
170762346|NCT02081391|617134938|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
170762347|NCT02081391|617134935|FG000|12-hour Treatment|Further reasons|2|||
170762348|NCT02081391|617134936|FG001|12-hour Treatment|Further reasons|1|||
170762349|NCT02081391|617134937|FG002|12-hour Treatment|Further reasons|0|||
170762350|NCT02081391|617134938|FG003|12-hour Treatment|Further reasons|0|||
170762351|NCT02081391|617134935|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
170762352|NCT02081391|617134936|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
170762353|NCT02081391|617134937|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
170762354|NCT02081391|617134938|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
170762355|NCT02081391|617134935|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
170762356|NCT02081391|617134936|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
170762357|NCT02081391|617134937|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
170762358|NCT02081391|617134938|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
170762359|NCT02081391|617134935|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
170762360|NCT02081391|617134936|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
170762361|NCT02081391|617134937|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
170762362|NCT02081391|617134938|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
170762363|NCT02081391|617134935|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
170762364|NCT02081391|617134936|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
170762365|NCT02081391|617134937|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
170762366|NCT02081391|617134938|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
170762367|NCT02081391|617134935|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
170762368|NCT02081391|617134936|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
170762369|NCT02081391|617134937|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
170762370|NCT02081391|617134938|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
170762371|NCT02081391|617134935|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
170762372|NCT02081391|617134936|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
170762373|NCT02081391|617134937|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
170762374|NCT02081391|617134938|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
170762375|NCT00751036|617134941|FG000|Overall Study|Disease Progression|28|||
170762376|NCT00751036|617134942|FG001|Overall Study|Disease Progression|29|||
170762377|NCT00751036|617134941|FG000|Overall Study|Adverse Event|6|||
170762378|NCT00751036|617134942|FG001|Overall Study|Adverse Event|4|||
170867313|NCT03876171|617526563|FG000|Overall Study|Re-arrest|0|||
170762379|NCT00751036|617134941|FG000|Overall Study|Administrative Problems|3|||
170867314|NCT03876171|617526564|FG001|Overall Study|Re-arrest|4|||
170867315|NCT03434353|617526565|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
170867316|NCT03434353|617526566|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
170867317|NCT03434353|617526567|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
170867318|NCT03434353|617526568|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
170867319|NCT03434353|617526569|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
170867320|NCT03434353|617526565|FG000|Overall Study|Withdrew consent|1|||
170867321|NCT03434353|617526566|FG001|Overall Study|Withdrew consent|0|||
170867322|NCT03434353|617526567|FG002|Overall Study|Withdrew consent|3|||
170867323|NCT03434353|617526568|FG003|Overall Study|Withdrew consent|0|||
170867324|NCT03434353|617526569|FG004|Overall Study|Withdrew consent|0|||
170867325|NCT03434353|617526565|FG000|Overall Study|Adverse Event|1|||
170867326|NCT03434353|617526566|FG001|Overall Study|Adverse Event|0|||
170867327|NCT03434353|617526567|FG002|Overall Study|Adverse Event|0|||
170867328|NCT03434353|617526568|FG003|Overall Study|Adverse Event|0|||
170867329|NCT03434353|617526569|FG004|Overall Study|Adverse Event|1|||
170867330|NCT03434353|617526565|FG000|Overall Study|Lost to Follow-up|2|||
170867331|NCT03434353|617526566|FG001|Overall Study|Lost to Follow-up|0|||
170867332|NCT03434353|617526567|FG002|Overall Study|Lost to Follow-up|0|||
170867333|NCT03434353|617526568|FG003|Overall Study|Lost to Follow-up|0|||
170867334|NCT03434353|617526569|FG004|Overall Study|Lost to Follow-up|0|||
170867335|NCT01170039|617526570|FG000|Overall Study|Withdrawal by Subject|5|||
170867336|NCT01170039|617526571|FG001|Overall Study|Withdrawal by Subject|3|||
170867337|NCT01170039|617526570|FG000|Overall Study|Lack of funding, drug not available|3|||
170867338|NCT01170039|617526571|FG001|Overall Study|Lack of funding, drug not available|3|||
170867339|NCT02953639|617526572|FG000|Overall Study|Adverse Event|2|||
170867340|NCT02953639|617526573|FG001|Overall Study|Adverse Event|0|||
170867341|NCT02953639|617526574|FG002|Overall Study|Adverse Event|1|||
170867342|NCT02953639|617526572|FG000|Overall Study|Lost to Follow-up|8|||
170762380|NCT00751036|617134942|FG001|Overall Study|Administrative Problems|4|||
170762381|NCT00751036|617134941|FG000|Overall Study|Withdrawal by Subject|5|||
170762382|NCT00751036|617134942|FG001|Overall Study|Withdrawal by Subject|2|||
170762383|NCT00751036|617134941|FG000|Overall Study|Death|3|||
170762384|NCT00751036|617134942|FG001|Overall Study|Death|3|||
170762385|NCT00751036|617134941|FG000|Overall Study|Lost to Follow-up|0|||
170762386|NCT00751036|617134942|FG001|Overall Study|Lost to Follow-up|1|||
170762387|NCT00751036|617134941|FG000|Overall Study|Protocol Violation|1|||
170762388|NCT00751036|617134942|FG001|Overall Study|Protocol Violation|0|||
170762389|NCT00751036|617134941|FG000|Overall Study|Missing end of Treatment Page|2|||
170762390|NCT00751036|617134942|FG001|Overall Study|Missing end of Treatment Page|3|||
170762391|NCT06688370|617134948|FG000|Overall Study|Discontinued the treatment|1|||
170762392|NCT06688370|617134948|FG000|Overall Study|Prohibited treatment taken|4|||
170762393|NCT03568318|617136556|FG000|Overall Study|Adverse Event|3|||
170762394|NCT03568318|617136557|FG001|Overall Study|Adverse Event|1|||
170762395|NCT03568318|617136558|FG002|Overall Study|Adverse Event|1|||
170762396|NCT03568318|617136559|FG003|Overall Study|Adverse Event|0|||
170762397|NCT03568318|617136560|FG004|Overall Study|Adverse Event|1|||
170762398|NCT03568318|617136561|FG005|Overall Study|Adverse Event|0|||
170762399|NCT03568318|617136556|FG000|Overall Study|Withdrawal by Subject|6|||
170762400|NCT03568318|617136557|FG001|Overall Study|Withdrawal by Subject|5|||
170762401|NCT03568318|617136558|FG002|Overall Study|Withdrawal by Subject|2|||
170762402|NCT03568318|617136559|FG003|Overall Study|Withdrawal by Subject|1|||
170762403|NCT03568318|617136560|FG004|Overall Study|Withdrawal by Subject|0|||
170762404|NCT03568318|617136561|FG005|Overall Study|Withdrawal by Subject|0|||
170762405|NCT03568318|617136556|FG000|Overall Study|Lost to Follow-up|3|||
170762406|NCT03568318|617136557|FG001|Overall Study|Lost to Follow-up|2|||
170762407|NCT03568318|617136558|FG002|Overall Study|Lost to Follow-up|2|||
170762408|NCT03568318|617136559|FG003|Overall Study|Lost to Follow-up|2|||
170867343|NCT02953639|617526573|FG001|Overall Study|Lost to Follow-up|4|||
170867344|NCT02953639|617526574|FG002|Overall Study|Lost to Follow-up|3|||
170867345|NCT02953639|617526572|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170867346|NCT02953639|617526573|FG001|Overall Study|Non-Compliance With Study Drug|2|||
170762409|NCT03568318|617136560|FG004|Overall Study|Lost to Follow-up|1|||
170762410|NCT03568318|617136561|FG005|Overall Study|Lost to Follow-up|0|||
170867347|NCT02953639|617526574|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170867348|NCT02953639|617526572|FG000|Overall Study|Multiple Reasons|1|||
170867349|NCT02953639|617526573|FG001|Overall Study|Multiple Reasons|0|||
170762411|NCT03568318|617136556|FG000|Overall Study|Other|3|||
170762412|NCT03568318|617136557|FG001|Overall Study|Other|1|||
170762413|NCT03568318|617136558|FG002|Overall Study|Other|3|||
170762414|NCT03568318|617136559|FG003|Overall Study|Other|0|||
170762415|NCT03568318|617136560|FG004|Overall Study|Other|0|||
170867350|NCT02953639|617526574|FG002|Overall Study|Multiple Reasons|1|||
170867351|NCT02953639|617526572|FG000|Overall Study|Physician Decision|1|||
170762416|NCT03568318|617136561|FG005|Overall Study|Other|0|||
170762417|NCT03568318|617136556|FG000|Overall Study|Ongoing at Time of Analysis|5|||
170762418|NCT03568318|617136557|FG001|Overall Study|Ongoing at Time of Analysis|3|||
170762419|NCT03568318|617136558|FG002|Overall Study|Ongoing at Time of Analysis|2|||
170762420|NCT03568318|617136559|FG003|Overall Study|Ongoing at Time of Analysis|1|||
170762421|NCT03568318|617136560|FG004|Overall Study|Ongoing at Time of Analysis|0|||
170762422|NCT03568318|617136561|FG005|Overall Study|Ongoing at Time of Analysis|0|||
170762423|NCT00567879|617136565|FG000|Overall Study|Adverse Event|2|||
170762424|NCT00567879|617136566|FG001|Overall Study|Adverse Event|0|||
170762425|NCT00567879|617136567|FG002|Overall Study|Adverse Event|1|||
170762426|NCT00567879|617136568|FG003|Overall Study|Adverse Event|0|||
170762427|NCT00567879|617136569|FG004|Overall Study|Adverse Event|1|||
170762428|NCT00567879|617136570|FG005|Overall Study|Adverse Event|0|||
170762429|NCT00567879|617136565|FG000|Overall Study|Abnormal test procedure(s)|0|||
170762430|NCT00567879|617136566|FG001|Overall Study|Abnormal test procedure(s)|0|||
170762431|NCT00567879|617136567|FG002|Overall Study|Abnormal test procedure(s)|1|||
170762432|NCT00567879|617136568|FG003|Overall Study|Abnormal test procedure(s)|0|||
170762433|NCT00567879|617136569|FG004|Overall Study|Abnormal test procedure(s)|0|||
170762434|NCT00567879|617136570|FG005|Overall Study|Abnormal test procedure(s)|0|||
170762435|NCT00567879|617136565|FG000|Overall Study|Withdrawal by Subject|0|||
170762436|NCT00567879|617136566|FG001|Overall Study|Withdrawal by Subject|0|||
170762437|NCT00567879|617136567|FG002|Overall Study|Withdrawal by Subject|3|||
170762438|NCT00567879|617136568|FG003|Overall Study|Withdrawal by Subject|1|||
170762439|NCT00567879|617136569|FG004|Overall Study|Withdrawal by Subject|0|||
170762440|NCT00567879|617136570|FG005|Overall Study|Withdrawal by Subject|0|||
170762441|NCT00567879|617136565|FG000|Overall Study|New cancer therapy|0|||
170762442|NCT00567879|617136566|FG001|Overall Study|New cancer therapy|0|||
170762443|NCT00567879|617136567|FG002|Overall Study|New cancer therapy|1|||
170867352|NCT02953639|617526573|FG001|Overall Study|Physician Decision|0|||
170762444|NCT00567879|617136568|FG003|Overall Study|New cancer therapy|0|||
170762445|NCT00567879|617136569|FG004|Overall Study|New cancer therapy|0|||
170762446|NCT00567879|617136570|FG005|Overall Study|New cancer therapy|0|||
170762447|NCT00567879|617136565|FG000|Overall Study|Disease progression|5|||
170762448|NCT00567879|617136566|FG001|Overall Study|Disease progression|7|||
170762449|NCT00567879|617136567|FG002|Overall Study|Disease progression|15|||
170762450|NCT00567879|617136568|FG003|Overall Study|Disease progression|5|||
170762451|NCT00567879|617136569|FG004|Overall Study|Disease progression|11|||
170762452|NCT00567879|617136570|FG005|Overall Study|Disease progression|3|||
170762453|NCT03518112|617136574|FG000|Overall Study|Withdrawal by Subject|1|||
170762454|NCT01546155|617136575|FG000|Overall Study|could not tolerate long scan duration|3|||
170762455|NCT00151996|617136576|FG000|Overall Study|Adverse Event|3|||
170762456|NCT00151996|617136577|FG001|Overall Study|Adverse Event|2|||
170762457|NCT00151996|617136576|FG000|Overall Study|Withdrawal by Subject|1|||
170762458|NCT00151996|617136577|FG001|Overall Study|Withdrawal by Subject|1|||
170762459|NCT00151996|617136576|FG000|Overall Study|Protocol Violation|1|||
170762460|NCT00151996|617136577|FG001|Overall Study|Protocol Violation|2|||
170762461|NCT00151996|617136576|FG000|Overall Study|Sponsor's decision|0|||
170762462|NCT00151996|617136577|FG001|Overall Study|Sponsor's decision|2|||
170762463|NCT01649791|617136585|FG000|Overall Study|Disease Progression|2|||
170762464|NCT01649791|617136585|FG000|Overall Study|Adverse Event|1|||
170762465|NCT01570751|617136588|FG000|Period A (16 Weeks)|Protocol Violation|1|||
170762466|NCT01570751|617136589|FG001|Period A (16 Weeks)|Protocol Violation|1|||
170762467|NCT01570751|617136588|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
170762468|NCT01570751|617136589|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
170762469|NCT01570751|617136588|FG000|Period A (16 Weeks)|Unclassified|2|||
170762470|NCT01570751|617136589|FG001|Period A (16 Weeks)|Unclassified|3|||
170762471|NCT01570751|617136588|FG000|Period B (16 Weeks)|Adverse Event|1|||
170762472|NCT01570751|617136589|FG001|Period B (16 Weeks)|Adverse Event|0|||
170762473|NCT01570751|617136588|FG000|Period B (16 Weeks)|Protocol Violation|0|||
170762474|NCT01570751|617136589|FG001|Period B (16 Weeks)|Protocol Violation|1|||
170762475|NCT01281813|617136594|FG000|Overall Study|Adverse Event|0|||
170762476|NCT01281813|617136595|FG001|Overall Study|Adverse Event|0|||
170762477|NCT01281813|617136596|FG002|Overall Study|Adverse Event|10|||
170762478|NCT01281813|617136594|FG000|Overall Study|Lost to Follow-up|0|||
170762479|NCT01281813|617136595|FG001|Overall Study|Lost to Follow-up|0|||
170762480|NCT01281813|617136596|FG002|Overall Study|Lost to Follow-up|31|||
170762481|NCT01281813|617136594|FG000|Overall Study|Withdrawal by Subject|0|||
170762482|NCT01281813|617136595|FG001|Overall Study|Withdrawal by Subject|0|||
170762483|NCT01281813|617136596|FG002|Overall Study|Withdrawal by Subject|13|||
170762484|NCT01281813|617136594|FG000|Overall Study|Subject Non-Compliant|0|||
170867353|NCT02953639|617526574|FG002|Overall Study|Physician Decision|0|||
170409153|NCT00782509|615838092|FG002|Overall Study|Lack of Efficacy|2|||
170409154|NCT03882047|615838093|FG000|Overall Study|Adverse Event|0|||
170762485|NCT01281813|617136595|FG001|Overall Study|Subject Non-Compliant|0|||
170762486|NCT01281813|617136596|FG002|Overall Study|Subject Non-Compliant|6|||
170762487|NCT01281813|617136594|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
170762488|NCT01281813|617136595|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
170762489|NCT01281813|617136596|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
170762490|NCT01281813|617136594|FG000|Overall Study|Sponsor's Decision|4|||
170762491|NCT01281813|617136595|FG001|Overall Study|Sponsor's Decision|3|||
170762492|NCT01281813|617136596|FG002|Overall Study|Sponsor's Decision|7|||
170762493|NCT01281813|617136594|FG000|Overall Study|Switched to Commercially Available Medication|0|||
170762494|NCT01281813|617136595|FG001|Overall Study|Switched to Commercially Available Medication|0|||
170762495|NCT01281813|617136596|FG002|Overall Study|Switched to Commercially Available Medication|26|||
170762496|NCT01281813|617136594|FG000|Overall Study|Other|0|||
170762497|NCT01281813|617136595|FG001|Overall Study|Other|1|||
170762498|NCT01281813|617136596|FG002|Overall Study|Other|39|||
170762499|NCT03546907|617136597|FG000|Overall Study|Lack of Efficacy|1|||
170762500|NCT03546907|617136598|FG001|Overall Study|Lack of Efficacy|1|||
170762501|NCT03546907|617136597|FG000|Overall Study|Withdrawal by Subject|8|||
170762502|NCT03546907|617136598|FG001|Overall Study|Withdrawal by Subject|9|||
170762503|NCT03546907|617136597|FG000|Overall Study|Adverse events (AEs)|7|||
170762504|NCT03546907|617136598|FG001|Overall Study|Adverse events (AEs)|10|||
170762505|NCT03546907|617136597|FG000|Overall Study|Other-unspecified|1|||
170762506|NCT03546907|617136598|FG001|Overall Study|Other-unspecified|1|||
170762507|NCT03720210|617136605|FG000|Overall Study|Lost to Follow-up|1|||
170762508|NCT04033432|617136606|FG000|Overall Study|Progressive Disease|8|||
170762509|NCT04033432|617136606|FG000|Overall Study|Adverse Event|4|||
170762510|NCT04033432|617136606|FG000|Overall Study|Death|1|||
170762511|NCT02274493|617136607|FG000|Overall Study|Withdrawal by Subject|1|||
170762512|NCT04580303|617136613|FG000|Overall Study|Adverse Event|0|||
170762513|NCT04580303|617136614|FG001|Overall Study|Adverse Event|1|||
170762514|NCT04580303|617136615|FG002|Overall Study|Adverse Event|0|||
170762515|NCT04580303|617136616|FG003|Overall Study|Adverse Event|0|||
170762516|NCT04580303|617136613|FG000|Overall Study|Withdrawal by Subject|0|||
170762517|NCT04580303|617136614|FG001|Overall Study|Withdrawal by Subject|0|||
170762518|NCT04580303|617136615|FG002|Overall Study|Withdrawal by Subject|1|||
170762519|NCT04580303|617136616|FG003|Overall Study|Withdrawal by Subject|0|||
170762520|NCT01833065|617136618|FG000|Overall Study|Adverse Event|6|||
170762521|NCT01833065|617136619|FG001|Overall Study|Adverse Event|1|||
170762522|NCT01833065|617136620|FG002|Overall Study|Adverse Event|0|||
170762523|NCT01833065|617136621|FG003|Overall Study|Adverse Event|2|||
170762524|NCT01833065|617136622|FG004|Overall Study|Adverse Event|3|||
170762525|NCT01833065|617136618|FG000|Overall Study|Protocol Violation|1|||
170762526|NCT01833065|617136619|FG001|Overall Study|Protocol Violation|0|||
170762527|NCT01833065|617136620|FG002|Overall Study|Protocol Violation|0|||
170762528|NCT01833065|617136621|FG003|Overall Study|Protocol Violation|0|||
170762529|NCT01833065|617136622|FG004|Overall Study|Protocol Violation|2|||
170762530|NCT01833065|617136618|FG000|Overall Study|Lost to Follow-up|1|||
170762531|NCT01833065|617136619|FG001|Overall Study|Lost to Follow-up|0|||
170762532|NCT01833065|617136620|FG002|Overall Study|Lost to Follow-up|0|||
170762533|NCT01833065|617136621|FG003|Overall Study|Lost to Follow-up|0|||
170762534|NCT01833065|617136622|FG004|Overall Study|Lost to Follow-up|3|||
170762535|NCT01833065|617136618|FG000|Overall Study|Withdrawal by Subject|6|||
170762536|NCT01833065|617136619|FG001|Overall Study|Withdrawal by Subject|2|||
170762537|NCT01833065|617136620|FG002|Overall Study|Withdrawal by Subject|4|||
170762538|NCT01833065|617136621|FG003|Overall Study|Withdrawal by Subject|3|||
170762539|NCT01833065|617136622|FG004|Overall Study|Withdrawal by Subject|11|||
170762540|NCT01833065|617136618|FG000|Overall Study|Subject's substantial non-compliance|0|||
170762541|NCT01833065|617136619|FG001|Overall Study|Subject's substantial non-compliance|1|||
170762542|NCT01833065|617136620|FG002|Overall Study|Subject's substantial non-compliance|0|||
170762543|NCT01833065|617136621|FG003|Overall Study|Subject's substantial non-compliance|0|||
170762544|NCT01833065|617136622|FG004|Overall Study|Subject's substantial non-compliance|0|||
170762545|NCT01833065|617136618|FG000|Overall Study|Trial terminated by sponsor|8|||
170762546|NCT01833065|617136619|FG001|Overall Study|Trial terminated by sponsor|8|||
170762547|NCT01833065|617136620|FG002|Overall Study|Trial terminated by sponsor|7|||
170762548|NCT01833065|617136621|FG003|Overall Study|Trial terminated by sponsor|3|||
170762549|NCT01833065|617136622|FG004|Overall Study|Trial terminated by sponsor|13|||
170762550|NCT01833065|617136618|FG000|Overall Study|Others|2|||
170762551|NCT01833065|617136619|FG001|Overall Study|Others|1|||
170409155|NCT03882047|615838094|FG001|Overall Study|Adverse Event|2|||
170762552|NCT01833065|617136620|FG002|Overall Study|Others|1|||
170867354|NCT02953639|617526572|FG000|Overall Study|Withdrawal by Subject|7|||
170867355|NCT02953639|617526573|FG001|Overall Study|Withdrawal by Subject|8|||
170409156|NCT03882047|615838095|FG002|Overall Study|Adverse Event|2|||
170409157|NCT03882047|615838093|FG000|Overall Study|Treatment Failure|3|||
170409158|NCT03882047|615838094|FG001|Overall Study|Treatment Failure|3|||
170409159|NCT03882047|615838095|FG002|Overall Study|Treatment Failure|12|||
170409160|NCT03882047|615838093|FG000|Overall Study|Lost to Follow-up|0|||
170409161|NCT03882047|615838094|FG001|Overall Study|Lost to Follow-up|1|||
170409162|NCT03882047|615838095|FG002|Overall Study|Lost to Follow-up|0|||
170762553|NCT01833065|617136621|FG003|Overall Study|Others|1|||
170762554|NCT01833065|617136622|FG004|Overall Study|Others|4|||
170762555|NCT00927823|617136625|FG000|Continuous Dosing Period|Death|0|||
170762556|NCT00927823|617136626|FG001|Continuous Dosing Period|Death|0|||
170762557|NCT00927823|617136627|FG002|Continuous Dosing Period|Death|6|||
170762558|NCT00927823|617136628|FG003|Continuous Dosing Period|Death|0|||
170762559|NCT00927823|617136625|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
170409163|NCT03882047|615838093|FG000|Overall Study|Did Not Wish to Continue|1|||
170409164|NCT03882047|615838094|FG001|Overall Study|Did Not Wish to Continue|4|||
170409165|NCT03882047|615838095|FG002|Overall Study|Did Not Wish to Continue|1|||
170409166|NCT03882047|615838093|FG000|Overall Study|Noncompliance With Protocol|2|||
170409167|NCT03882047|615838094|FG001|Overall Study|Noncompliance With Protocol|0|||
170409168|NCT03882047|615838095|FG002|Overall Study|Noncompliance With Protocol|0|||
170409169|NCT03882047|615838093|FG000|Overall Study|Did Not Meet Eligibility|0|||
170762560|NCT00927823|617136626|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
170762561|NCT00927823|617136627|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
170762562|NCT00927823|617136628|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
170762563|NCT00927823|617136625|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
170762564|NCT00927823|617136626|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
170762565|NCT00927823|617136627|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
170762566|NCT00927823|617136628|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
170762567|NCT00927823|617136625|FG000|Continuous Dosing Period|Other|1|||
170762568|NCT00927823|617136626|FG001|Continuous Dosing Period|Other|2|||
170762569|NCT00927823|617136627|FG002|Continuous Dosing Period|Other|9|||
170762570|NCT00927823|617136628|FG003|Continuous Dosing Period|Other|3|||
170762571|NCT00906698|617136629|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
170762572|NCT00906698|617136630|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
170762573|NCT00906698|617136631|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
170762574|NCT00906698|617136632|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
170762575|NCT00906698|617136633|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
170762576|NCT00906698|617136634|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
170762577|NCT00906698|617136629|FG000|Overall Study|Adverse Event|0|||
170762578|NCT00906698|617136630|FG001|Overall Study|Adverse Event|0|||
170762579|NCT00906698|617136631|FG002|Overall Study|Adverse Event|2|||
170762580|NCT00906698|617136632|FG003|Overall Study|Adverse Event|0|||
170762581|NCT00906698|617136633|FG004|Overall Study|Adverse Event|4|||
170762582|NCT00906698|617136634|FG005|Overall Study|Adverse Event|1|||
170762583|NCT00906698|617136629|FG000|Overall Study|Disease progression|3|||
170762584|NCT00906698|617136630|FG001|Overall Study|Disease progression|12|||
170762585|NCT00906698|617136631|FG002|Overall Study|Disease progression|4|||
170409170|NCT03882047|615838094|FG001|Overall Study|Did Not Meet Eligibility|0|||
170409171|NCT03882047|615838095|FG002|Overall Study|Did Not Meet Eligibility|1|||
170409172|NCT00723554|615838097|FG000|Overall Study|Adverse Event|12|||
170519736|NCT02427841|616247626|FG000|Overall Study|Physician Decision|2|||
170519737|NCT02427841|616247626|FG000|Overall Study|Withdrawal by Subject|1|||
170519738|NCT02154139|616247628|FG000|Overall Study|Injection not administered|2|||
170519739|NCT02154139|616247628|FG000|Overall Study|Other|2|||
170519740|NCT02154139|616247628|FG000|Overall Study|Investigator transferred|3|||
170519741|NCT03257436|616247629|FG000|Overall Study|Withdrawal by Subject|76|||
170519742|NCT03257436|616247629|FG000|Overall Study|Death|19|||
170519743|NCT01723072|616247634|FG000|Overall Study|Withdrawal by Subject|7|||
170519744|NCT01723072|616247635|FG001|Overall Study|Withdrawal by Subject|13|||
170519745|NCT01723072|616247634|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
170519746|NCT01723072|616247635|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
170519747|NCT01723072|616247634|FG000|Overall Study|Other|4|||
170519748|NCT01723072|616247635|FG001|Overall Study|Other|3|||
170519749|NCT01610037|616247637|FG000|All Patients|Adverse Event|27|||
170519750|NCT01610037|616247638|FG001|All Patients|Adverse Event|22|||
170519751|NCT01610037|616247639|FG002|All Patients|Adverse Event|26|||
170519752|NCT01610037|616247637|FG000|All Patients|Withdrawal by Subject|12|||
170519753|NCT01610037|616247638|FG001|All Patients|Withdrawal by Subject|10|||
170519754|NCT01610037|616247639|FG002|All Patients|Withdrawal by Subject|20|||
170519755|NCT01610037|616247637|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
170519756|NCT01610037|616247638|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
170519757|NCT01610037|616247639|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
170519758|NCT01610037|616247637|FG000|All Patients|Death|4|||
170519759|NCT01610037|616247638|FG001|All Patients|Death|2|||
170519760|NCT01610037|616247639|FG002|All Patients|Death|1|||
170519761|NCT01610037|616247637|FG000|All Patients|Protocol deviation|4|||
170519762|NCT01610037|616247638|FG001|All Patients|Protocol deviation|3|||
170519763|NCT01610037|616247639|FG002|All Patients|Protocol deviation|3|||
170409173|NCT00723554|615838097|FG000|Overall Study|Investigator's judgement|5|||
170409174|NCT00723554|615838097|FG000|Overall Study|Inhaled medication other than iloprost|4|||
170519764|NCT01610037|616247637|FG000|All Patients|Abnormal laboratory value|1|||
170519765|NCT01610037|616247638|FG001|All Patients|Abnormal laboratory value|1|||
170762586|NCT00906698|617136632|FG003|Overall Study|Disease progression|4|||
170762587|NCT00906698|617136633|FG004|Overall Study|Disease progression|12|||
170762588|NCT00906698|617136634|FG005|Overall Study|Disease progression|4|||
170762589|NCT00906698|617136629|FG000|Overall Study|Withdrawal by Subject|0|||
170762590|NCT00906698|617136630|FG001|Overall Study|Withdrawal by Subject|0|||
170762591|NCT00906698|617136631|FG002|Overall Study|Withdrawal by Subject|0|||
170519766|NCT01610037|616247639|FG002|All Patients|Abnormal laboratory value|0|||
170519767|NCT01610037|616247637|FG000|All Patients|Administrative problems|1|||
170867356|NCT02953639|617526574|FG002|Overall Study|Withdrawal by Subject|10|||
170867357|NCT02953639|617526572|FG000|Overall Study|Completed or Discontinued information is missing|1|||
170867358|NCT02953639|617526573|FG001|Overall Study|Completed or Discontinued information is missing|0|||
170867359|NCT02953639|617526574|FG002|Overall Study|Completed or Discontinued information is missing|0|||
170519768|NCT01610037|616247638|FG001|All Patients|Administrative problems|4|||
170762592|NCT00906698|617136632|FG003|Overall Study|Withdrawal by Subject|0|||
170867360|NCT01830855|617526575|FG000|Overall Study|Other|7|||
170867361|NCT01830855|617526576|FG001|Overall Study|Other|1|||
170867362|NCT01830855|617526577|FG002|Overall Study|Other|4|||
170867363|NCT01830855|617526578|FG003|Overall Study|Other|4|||
170867364|NCT01830855|617526575|FG000|Overall Study|Medication error without associated AE|1|||
170867365|NCT01830855|617526576|FG001|Overall Study|Medication error without associated AE|0|||
170867366|NCT01830855|617526577|FG002|Overall Study|Medication error without associated AE|0|||
170867367|NCT01830855|617526578|FG003|Overall Study|Medication error without associated AE|1|||
170867368|NCT01830855|617526575|FG000|Overall Study|Pregnancy|3|||
170867369|NCT01830855|617526576|FG001|Overall Study|Pregnancy|1|||
170867370|NCT01830855|617526577|FG002|Overall Study|Pregnancy|2|||
170867371|NCT01830855|617526578|FG003|Overall Study|Pregnancy|1|||
170867372|NCT01830855|617526575|FG000|Overall Study|No longer meets eligibility criteria|11|||
170867373|NCT01830855|617526576|FG001|Overall Study|No longer meets eligibility criteria|2|||
170867374|NCT01830855|617526577|FG002|Overall Study|No longer meets eligibility criteria|3|||
170867375|NCT01830855|617526578|FG003|Overall Study|No longer meets eligibility criteria|5|||
170867376|NCT01830855|617526575|FG000|Overall Study|Adverse Event|11|||
170867377|NCT01830855|617526576|FG001|Overall Study|Adverse Event|5|||
170867378|NCT01830855|617526577|FG002|Overall Study|Adverse Event|6|||
170867379|NCT01830855|617526578|FG003|Overall Study|Adverse Event|3|||
170867380|NCT01830855|617526575|FG000|Overall Study|Protocol deviation|10|||
170867381|NCT01830855|617526576|FG001|Overall Study|Protocol deviation|5|||
170867382|NCT01830855|617526577|FG002|Overall Study|Protocol deviation|6|||
170867383|NCT01830855|617526578|FG003|Overall Study|Protocol deviation|6|||
170867384|NCT01830855|617526575|FG000|Overall Study|Withdrawal by Subject|33|||
170867385|NCT01830855|617526576|FG001|Overall Study|Withdrawal by Subject|14|||
170867386|NCT01830855|617526577|FG002|Overall Study|Withdrawal by Subject|10|||
170867387|NCT01830855|617526578|FG003|Overall Study|Withdrawal by Subject|12|||
170867388|NCT01830855|617526575|FG000|Overall Study|No longer willing to participate|32|||
170867389|NCT01830855|617526576|FG001|Overall Study|No longer willing to participate|13|||
170867390|NCT01830855|617526577|FG002|Overall Study|No longer willing to participate|12|||
170867391|NCT01830855|617526578|FG003|Overall Study|No longer willing to participate|17|||
170867392|NCT01830855|617526575|FG000|Overall Study|Lost to Follow-up|47|||
170867393|NCT01830855|617526576|FG001|Overall Study|Lost to Follow-up|20|||
170867394|NCT01830855|617526577|FG002|Overall Study|Lost to Follow-up|23|||
170867395|NCT01830855|617526578|FG003|Overall Study|Lost to Follow-up|33|||
170867396|NCT03034460|617526579|FG000|Overall Study|Adverse Event|0|||
170867397|NCT03034460|617526580|FG001|Overall Study|Adverse Event|1|||
170867398|NCT03034460|617526579|FG000|Overall Study|Withdrawal by Subject|2|||
170867399|NCT03034460|617526580|FG001|Overall Study|Withdrawal by Subject|2|||
170867400|NCT03034460|617526579|FG000|Overall Study|Personal Reasons|1|||
170867401|NCT03034460|617526580|FG001|Overall Study|Personal Reasons|0|||
170867402|NCT03308942|617526581|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
170867403|NCT03308942|617526582|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
170867404|NCT03308942|617526583|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
170867405|NCT03308942|617526584|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
170867406|NCT03308942|617526585|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
170867407|NCT03308942|617526581|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
170867408|NCT03308942|617526582|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
170762593|NCT00906698|617136633|FG004|Overall Study|Withdrawal by Subject|1|||
170762594|NCT00906698|617136634|FG005|Overall Study|Withdrawal by Subject|0|||
170762595|NCT00906698|617136629|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
170762596|NCT00906698|617136630|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
170762597|NCT00906698|617136631|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
170762598|NCT00906698|617136632|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
170762599|NCT00906698|617136633|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
170762600|NCT00906698|617136634|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
170762601|NCT02155829|617136641|FG000|Overall Study|Adverse Event|1|||
170762602|NCT02155829|617136642|FG001|Overall Study|Adverse Event|0|||
170867409|NCT03308942|617526583|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
170867410|NCT03308942|617526584|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
170867411|NCT03308942|617526585|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
170762603|NCT02155829|617136641|FG000|Overall Study|Withdrawal by Subject|3|||
170867412|NCT03308942|617526581|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
170867413|NCT03308942|617526582|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
170519769|NCT01610037|616247639|FG002|All Patients|Administrative problems|4|||
170519770|NCT01610037|616247637|FG000|All Patients|Lost to Follow-up|1|||
170867414|NCT03308942|617526583|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
170867415|NCT03308942|617526584|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
170762604|NCT02155829|617136642|FG001|Overall Study|Withdrawal by Subject|3|||
170762605|NCT02155829|617136641|FG000|Overall Study|Protocol Violation|2|||
170762606|NCT02155829|617136642|FG001|Overall Study|Protocol Violation|0|||
170762607|NCT04982575|617136643|FG000|Overall Study|Withdrawal by Subject|2|||
170762608|NCT04982575|617136644|FG001|Overall Study|Withdrawal by Subject|0|||
170762609|NCT04982575|617136645|FG002|Overall Study|Withdrawal by Subject|2|||
170762610|NCT03038022|617136648|FG000|Overall Study|Withdrawal by Subject|2|||
170762611|NCT03038022|617136649|FG001|Overall Study|Withdrawal by Subject|0|||
170762612|NCT03038022|617136648|FG000|Overall Study|Adverse Event|4|||
170762613|NCT03038022|617136649|FG001|Overall Study|Adverse Event|2|||
170762614|NCT04925752|617136650|FG000|Overall Study|Still on Study|1826|||
170762615|NCT04925752|617136651|FG001|Overall Study|Still on Study|926|||
170762616|NCT04925752|617136650|FG000|Overall Study|Withdrew Consent|128|||
170762617|NCT04925752|617136651|FG001|Overall Study|Withdrew Consent|59|||
170762618|NCT04925752|617136650|FG000|Overall Study|Lost to Follow-up|73|||
170762619|NCT04925752|617136651|FG001|Overall Study|Lost to Follow-up|47|||
170762620|NCT04925752|617136650|FG000|Overall Study|Randomized but Never Treated|12|||
170762621|NCT04925752|617136651|FG001|Overall Study|Randomized but Never Treated|9|||
170762622|NCT04925752|617136650|FG000|Overall Study|Hiv-1 Infection|6|||
170762623|NCT04925752|617136651|FG001|Overall Study|Hiv-1 Infection|7|||
170762624|NCT04925752|617136650|FG000|Overall Study|Investigator's discretion|8|||
170762625|NCT04925752|617136651|FG001|Overall Study|Investigator's discretion|5|||
170762626|NCT04925752|617136650|FG000|Overall Study|Non-compliance with Study Drug|8|||
170762627|NCT04925752|617136651|FG001|Overall Study|Non-compliance with Study Drug|5|||
170762628|NCT04925752|617136650|FG000|Overall Study|Adverse Event|5|||
170762629|NCT04925752|617136651|FG001|Overall Study|Adverse Event|2|||
170762630|NCT04925752|617136650|FG000|Overall Study|Death|4|||
170762631|NCT04925752|617136651|FG001|Overall Study|Death|2|||
170762632|NCT04925752|617136650|FG000|Overall Study|Protocol Violation|1|||
170762633|NCT04925752|617136651|FG001|Overall Study|Protocol Violation|3|||
170762634|NCT04925752|617136650|FG000|Overall Study|Withdrew Assent|1|||
170762635|NCT04925752|617136651|FG001|Overall Study|Withdrew Assent|0|||
170762636|NCT03887936|617136652|FG000|Overall Study|Relocation|2|||
170762637|NCT03887936|617136653|FG001|Overall Study|Relocation|2|||
170762638|NCT03887936|617136652|FG000|Overall Study|Physician Decision|0|||
170762639|NCT03887936|617136653|FG001|Overall Study|Physician Decision|1|||
170867416|NCT03308942|617526585|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
170409175|NCT00723554|615838097|FG000|Overall Study|Withdrawal of consent|3|||
170409176|NCT00723554|615838097|FG000|Overall Study|Other|3|||
170409177|NCT00723554|615838097|FG000|Overall Study|Lost to Follow-up|1|||
170409178|NCT00723554|615838097|FG000|Overall Study|Non-compliance|1|||
170409179|NCT01894984|615838098|FG000|Overall Study|Other|314|||
170409180|NCT01894984|615838099|FG001|Overall Study|Other|175|||
170409181|NCT01809314|615838100|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
170409182|NCT01809314|615838100|FG000|Overall Study|Adverse Event|6|||
170409183|NCT01809314|615838100|FG000|Overall Study|Insufficient Therapeutic Response|14|||
170409184|NCT01809314|615838100|FG000|Overall Study|Lost to Follow-up|724|||
170409185|NCT00415532|615838101|FG000|Treatment Period|Adverse Event|2|||
170409186|NCT00415532|615838102|FG001|Treatment Period|Adverse Event|3|||
170409187|NCT00415532|615838101|FG000|Treatment Period|Death|2|||
170409188|NCT00415532|615838102|FG001|Treatment Period|Death|1|||
170409189|NCT00415532|615838101|FG000|Treatment Period|Lost to Follow-up|1|||
170409190|NCT00415532|615838102|FG001|Treatment Period|Lost to Follow-up|1|||
170409191|NCT00415532|615838101|FG000|Treatment Period|Protocol Violation|1|||
170409192|NCT00415532|615838102|FG001|Treatment Period|Protocol Violation|0|||
170409193|NCT00415532|615838101|FG000|Treatment Period|Withdrawal by Subject|6|||
170409194|NCT00415532|615838102|FG001|Treatment Period|Withdrawal by Subject|6|||
170409195|NCT00415532|615838101|FG000|Treatment Period|Other|2|||
170409196|NCT00415532|615838102|FG001|Treatment Period|Other|2|||
170519771|NCT01610037|616247638|FG001|All Patients|Lost to Follow-up|0|||
170409197|NCT00415532|615838101|FG000|Treatment Period|Ineligibility determined|1|||
170409198|NCT00415532|615838102|FG001|Treatment Period|Ineligibility determined|1|||
170519772|NCT01610037|616247639|FG002|All Patients|Lost to Follow-up|0|||
170519773|NCT01610037|616247637|FG000|All Patients|Abnormal test procedure result(s)|0|||
170519774|NCT01610037|616247638|FG001|All Patients|Abnormal test procedure result(s)|1|||
170409199|NCT00415532|615838101|FG000|Treatment Period|Noncompliance|1|||
170519775|NCT01610037|616247639|FG002|All Patients|Abnormal test procedure result(s)|3|||
170519776|NCT01610037|616247637|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
170519777|NCT01610037|616247638|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
170762640|NCT03887936|617136652|FG000|Overall Study|Withdrawal by Subject|0|||
170762641|NCT03887936|617136653|FG001|Overall Study|Withdrawal by Subject|1|||
170762642|NCT02824432|617136659|FG000|Overall Study|Major Protocol Deviation|1|||
170762643|NCT02824432|617136660|FG001|Overall Study|Major Protocol Deviation|0|||
170409200|NCT00415532|615838102|FG001|Treatment Period|Noncompliance|1|||
170762644|NCT02912260|617136661|FG000|Main Study|Lost to Follow-up|5|||
170867417|NCT03308942|617526581|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
170409201|NCT00415532|615838101|FG000|Treatment Period|Requirement for alternative therapy|1|||
170409202|NCT00415532|615838102|FG001|Treatment Period|Requirement for alternative therapy|0|||
170409203|NCT00415532|615838101|FG000|Safety Follow Up Period|Adverse Event|1|||
170409204|NCT00415532|615838102|FG001|Safety Follow Up Period|Adverse Event|3|||
170409205|NCT00415532|615838101|FG000|Safety Follow Up Period|Death|3|||
170409206|NCT00415532|615838102|FG001|Safety Follow Up Period|Death|0|||
170409207|NCT00415532|615838101|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
170409208|NCT00415532|615838102|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
170409209|NCT00415532|615838101|FG000|Safety Follow Up Period|Other|1|||
170762645|NCT02912260|617136662|FG001|Main Study|Lost to Follow-up|4|||
170762646|NCT02912260|617136661|FG000|Main Study|Withdrawal by Subject|2|||
170762647|NCT02912260|617136662|FG001|Main Study|Withdrawal by Subject|2|||
170762648|NCT02912260|617136661|FG000|Main Study|Adverse Event|3|||
170762649|NCT02912260|617136662|FG001|Main Study|Adverse Event|0|||
170762650|NCT02912260|617136661|FG000|Main Study|Physician Decision|0|||
170762651|NCT02912260|617136662|FG001|Main Study|Physician Decision|1|||
170762652|NCT02912260|617136661|FG000|Extension Study|Withdrawal by Subject|1|||
170762653|NCT02912260|617136662|FG001|Extension Study|Withdrawal by Subject|1|||
170762654|NCT04678830|617136663|FG000|Overall Study|Lack of Efficacy|2|||
170762655|NCT04678830|617136664|FG001|Overall Study|Lack of Efficacy|0|||
170762656|NCT04678830|617136663|FG000|Overall Study|Withdrawal by Subject|0|||
170762657|NCT04678830|617136664|FG001|Overall Study|Withdrawal by Subject|1|||
170762658|NCT01458275|617136665|FG000|Overall Study|Adverse Event|3|||
170762659|NCT01458275|617136666|FG001|Overall Study|Adverse Event|4|||
170762660|NCT01458275|617136667|FG002|Overall Study|Adverse Event|1|||
170762661|NCT01458275|617136665|FG000|Overall Study|Lost to Follow-up|3|||
170762662|NCT01458275|617136666|FG001|Overall Study|Lost to Follow-up|2|||
170762663|NCT01458275|617136667|FG002|Overall Study|Lost to Follow-up|5|||
170762664|NCT01458275|617136665|FG000|Overall Study|Protocol Violation|5|||
170762665|NCT01458275|617136666|FG001|Overall Study|Protocol Violation|5|||
170762666|NCT01458275|617136667|FG002|Overall Study|Protocol Violation|2|||
170762667|NCT01458275|617136665|FG000|Overall Study|Withdrawal by Subject|3|||
170762668|NCT01458275|617136666|FG001|Overall Study|Withdrawal by Subject|2|||
170762669|NCT01458275|617136667|FG002|Overall Study|Withdrawal by Subject|1|||
170762670|NCT03878446|617136673|FG000|Overall Study|Withdrawn by parent or guardian|1|||
170762671|NCT03878446|617136674|FG001|Overall Study|Withdrawn by parent or guardian|0|||
170762672|NCT03878446|617136675|FG002|Overall Study|Withdrawn by parent or guardian|0|||
170762673|NCT03878446|617136676|FG003|Overall Study|Withdrawn by parent or guardian|0|||
170762674|NCT03878446|617136677|FG004|Overall Study|Withdrawn by parent or guardian|0|||
170762675|NCT04540835|617136680|FG000|Week 1|Lost to Follow-up|1|||
170762676|NCT04540835|617136680|FG000|Week 6|Pregnancy|1|||
170762677|NCT04540835|617136680|FG000|Week 6|Lack of Efficacy|1|||
170762678|NCT03105336|617136681|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
170762679|NCT03105336|617136682|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
170762680|NCT03105336|617136681|FG000|Overall Study|Death|40|||
170762681|NCT03105336|617136682|FG001|Overall Study|Death|8|||
170762682|NCT03105336|617136681|FG000|Overall Study|Lost to Follow-up|13|||
170762683|NCT03105336|617136682|FG001|Overall Study|Lost to Follow-up|2|||
170762684|NCT03105336|617136681|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
170762685|NCT03105336|617136682|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
170762686|NCT03105336|617136681|FG000|Overall Study|Reason Not Specified|3|||
170762687|NCT03105336|617136682|FG001|Overall Study|Reason Not Specified|3|||
170762688|NCT03105336|617136681|FG000|Overall Study|Investigator Decision|3|||
170762689|NCT03105336|617136682|FG001|Overall Study|Investigator Decision|0|||
170762690|NCT02501811|617136686|FG000|Overall Study|Death|1|||
170762691|NCT02501811|617136687|FG001|Overall Study|Death|3|||
170762692|NCT02501811|617136688|FG002|Overall Study|Death|2|||
170762693|NCT02501811|617136689|FG003|Overall Study|Death|3|||
170762694|NCT02501811|617136686|FG000|Overall Study|Withdrawal by Subject|3|||
170762695|NCT02501811|617136687|FG001|Overall Study|Withdrawal by Subject|3|||
170409210|NCT00415532|615838102|FG001|Safety Follow Up Period|Other|4|||
170632093|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
170762696|NCT02501811|617136688|FG002|Overall Study|Withdrawal by Subject|2|||
170762697|NCT02501811|617136689|FG003|Overall Study|Withdrawal by Subject|3|||
170762698|NCT02501811|617136686|FG000|Overall Study|Lost to Follow-up|0|||
170762699|NCT02501811|617136687|FG001|Overall Study|Lost to Follow-up|0|||
170762700|NCT02501811|617136688|FG002|Overall Study|Lost to Follow-up|2|||
170762701|NCT02501811|617136689|FG003|Overall Study|Lost to Follow-up|1|||
170762702|NCT03944512|617136690|FG000|Overall Study|Death|0|||
170762703|NCT03944512|617136691|FG001|Overall Study|Death|0|||
170762704|NCT03944512|617136692|FG002|Overall Study|Death|1|||
170762705|NCT03944512|617136693|FG003|Overall Study|Death|2|||
170762706|NCT03944512|617136690|FG000|Overall Study|Lost to Follow-up|0|||
170762707|NCT03944512|617136691|FG001|Overall Study|Lost to Follow-up|0|||
170762708|NCT03944512|617136692|FG002|Overall Study|Lost to Follow-up|4|||
170762709|NCT03944512|617136693|FG003|Overall Study|Lost to Follow-up|4|||
170409211|NCT00415532|615838101|FG000|Safety Follow Up Period|Ineligibility determined|1|||
170762710|NCT03944512|617136690|FG000|Overall Study|refused follow-up|0|||
170867418|NCT03308942|617526582|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
170867419|NCT03308942|617526583|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
170867420|NCT03308942|617526584|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
170867421|NCT03308942|617526585|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
170867422|NCT03308942|617526581|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
170867423|NCT03308942|617526582|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
170867424|NCT03308942|617526583|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
170867425|NCT03308942|617526584|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
170867426|NCT03308942|617526585|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
170867427|NCT03308942|617526581|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
170867428|NCT03308942|617526582|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
170867429|NCT03308942|617526583|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
170867430|NCT03308942|617526584|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
170867431|NCT03308942|617526585|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
170867432|NCT03308942|617526581|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
170867433|NCT03308942|617526582|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
170867434|NCT03308942|617526583|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
170867435|NCT03308942|617526584|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
170867436|NCT03308942|617526585|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
170867437|NCT02294682|617526586|FG000|Overall Study|Could not swallow pills|1|||
170867438|NCT02294682|617526587|FG001|Overall Study|Could not swallow pills|0|||
170867439|NCT01516970|617526588|FG000|Overall Study|Lost to Follow-up|7|||
170867440|NCT01516970|617526589|FG001|Overall Study|Lost to Follow-up|8|||
170867441|NCT01516970|617526588|FG000|Overall Study|Adverse Event|1|||
170867442|NCT01516970|617526589|FG001|Overall Study|Adverse Event|5|||
170867443|NCT01516970|617526588|FG000|Overall Study|Withdrawal by Subject|1|||
170867444|NCT01516970|617526589|FG001|Overall Study|Withdrawal by Subject|1|||
170867445|NCT01516970|617526588|FG000|Overall Study|Other|9|||
170867446|NCT01516970|617526589|FG001|Overall Study|Other|7|||
170409212|NCT00415532|615838102|FG001|Safety Follow Up Period|Ineligibility determined|1|||
170762711|NCT03944512|617136691|FG001|Overall Study|refused follow-up|0|||
170762712|NCT03944512|617136692|FG002|Overall Study|refused follow-up|2|||
170409213|NCT00415532|615838101|FG000|Safety Follow Up Period|Noncompliance|1|||
170409214|NCT00415532|615838102|FG001|Safety Follow Up Period|Noncompliance|0|||
170409215|NCT00415532|615838101|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
170409216|NCT00415532|615838102|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
170409217|NCT03567057|615838104|FG000|Overall Study|Adverse Event|56|||
170409218|NCT03567057|615838105|FG001|Overall Study|Adverse Event|53|||
170409219|NCT03567057|615838106|FG002|Overall Study|Adverse Event|28|||
170409220|NCT03567057|615838104|FG000|Overall Study|Withdrawal by Subject|22|||
170409221|NCT03567057|615838105|FG001|Overall Study|Withdrawal by Subject|24|||
170409222|NCT03567057|615838106|FG002|Overall Study|Withdrawal by Subject|13|||
170409223|NCT03567057|615838104|FG000|Overall Study|Lost to Follow-up|3|||
170409224|NCT03567057|615838105|FG001|Overall Study|Lost to Follow-up|5|||
170762713|NCT03944512|617136693|FG003|Overall Study|refused follow-up|2|||
170762714|NCT01090024|617138653|FG000|Period 1|Met exclusion criteria|0|||
170762715|NCT01090024|617138654|FG001|Period 1|Met exclusion criteria|0|||
170762716|NCT01090024|617138655|FG002|Period 1|Met exclusion criteria|0|||
170762717|NCT01090024|617138656|FG003|Period 1|Met exclusion criteria|0|||
170762718|NCT01090024|617138657|FG004|Period 1|Met exclusion criteria|0|||
170762719|NCT01090024|617138658|FG005|Period 1|Met exclusion criteria|0|||
170762720|NCT01090024|617138659|FG006|Period 1|Met exclusion criteria|0|||
170762721|NCT01090024|617138660|FG007|Period 1|Met exclusion criteria|0|||
170762722|NCT01090024|617138661|FG008|Period 1|Met exclusion criteria|0|||
170762723|NCT01090024|617138662|FG009|Period 1|Met exclusion criteria|0|||
170762724|NCT01090024|617138663|FG010|Period 1|Met exclusion criteria|0|||
170409225|NCT03567057|615838106|FG002|Overall Study|Lost to Follow-up|2|||
170409226|NCT03567057|615838104|FG000|Overall Study|COVID-19 pandemic|4|||
170409227|NCT03567057|615838105|FG001|Overall Study|COVID-19 pandemic|3|||
170409228|NCT03567057|615838106|FG002|Overall Study|COVID-19 pandemic|0|||
170867447|NCT03823404|617526592|FG000|Overall Study|Lost to Follow-up|1|||
170867448|NCT03823404|617526593|FG001|Overall Study|Lost to Follow-up|2|||
170867449|NCT03823404|617526594|FG002|Overall Study|Lost to Follow-up|3|||
170867450|NCT03823404|617526592|FG000|Overall Study|Protocol Violation|2|||
170519778|NCT01610037|616247639|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
170519779|NCT01610037|616247637|FG000|Treatment and Follow up Period|Death|10|||
170762725|NCT01090024|617138664|FG011|Period 1|Met exclusion criteria|0|||
170867451|NCT03823404|617526593|FG001|Overall Study|Protocol Violation|0|||
170762726|NCT01090024|617138665|FG012|Period 1|Met exclusion criteria|0|||
170409229|NCT03567057|615838104|FG000|Overall Study|Non-compliance with study drug|4|||
170409230|NCT03567057|615838105|FG001|Overall Study|Non-compliance with study drug|2|||
170762727|NCT01090024|617138666|FG013|Period 1|Met exclusion criteria|0|||
170762728|NCT01090024|617138667|FG014|Period 1|Met exclusion criteria|1|||
170762729|NCT01090024|617138668|FG015|Period 1|Met exclusion criteria|0|||
170762730|NCT01090024|617138669|FG016|Period 1|Met exclusion criteria|0|||
170762731|NCT01090024|617138670|FG017|Period 1|Met exclusion criteria|0|||
170762732|NCT01090024|617138653|FG000|Period 1|Adverse Event|0|||
170762733|NCT01090024|617138654|FG001|Period 1|Adverse Event|0|||
170762734|NCT01090024|617138655|FG002|Period 1|Adverse Event|0|||
170762735|NCT01090024|617138656|FG003|Period 1|Adverse Event|0|||
170762736|NCT01090024|617138657|FG004|Period 1|Adverse Event|0|||
170762737|NCT01090024|617138658|FG005|Period 1|Adverse Event|0|||
170762738|NCT01090024|617138659|FG006|Period 1|Adverse Event|0|||
170409231|NCT03567057|615838106|FG002|Overall Study|Non-compliance with study drug|0|||
170409232|NCT03567057|615838104|FG000|Overall Study|Lack of Efficacy|3|||
170409233|NCT03567057|615838105|FG001|Overall Study|Lack of Efficacy|0|||
170409234|NCT03567057|615838106|FG002|Overall Study|Lack of Efficacy|1|||
170409235|NCT03567057|615838104|FG000|Overall Study|Death|1|||
170409236|NCT03567057|615838105|FG001|Overall Study|Death|0|||
170409237|NCT03567057|615838106|FG002|Overall Study|Death|0|||
170409238|NCT03567057|615838104|FG000|Overall Study|Physician Decision|1|||
170409239|NCT03567057|615838105|FG001|Overall Study|Physician Decision|0|||
170409240|NCT03567057|615838106|FG002|Overall Study|Physician Decision|0|||
170409241|NCT03567057|615838104|FG000|Overall Study|Unstable medical condition|1|||
170409242|NCT03567057|615838105|FG001|Overall Study|Unstable medical condition|0|||
170409243|NCT03567057|615838106|FG002|Overall Study|Unstable medical condition|0|||
170409244|NCT03567057|615838104|FG000|Overall Study|Medical history event|0|||
170409245|NCT03567057|615838105|FG001|Overall Study|Medical history event|0|||
170409246|NCT03567057|615838106|FG002|Overall Study|Medical history event|1|||
170409247|NCT03567057|615838104|FG000|Overall Study|Other|0|||
170409248|NCT03567057|615838105|FG001|Overall Study|Other|0|||
170409249|NCT03567057|615838106|FG002|Overall Study|Other|1|||
170409250|NCT01141283|615838107|FG000|Overall Study|Adverse Event|56|||
170409251|NCT01141283|615838107|FG000|Overall Study|Lost to Follow-up|4|||
170409252|NCT01141283|615838107|FG000|Overall Study|Withdrawal by Subject|14|||
170409253|NCT01141283|615838107|FG000|Overall Study|Administrative|4|||
170409254|NCT01141283|615838107|FG000|Overall Study|Lack of Efficacy|10|||
170409255|NCT00886483|615838114|FG000|Overall Study|Lost to Follow-up|0|||
170409256|NCT00886483|615838115|FG001|Overall Study|Lost to Follow-up|1|||
170762739|NCT01090024|617138660|FG007|Period 1|Adverse Event|0|||
170762740|NCT01090024|617138661|FG008|Period 1|Adverse Event|0|||
170762741|NCT01090024|617138662|FG009|Period 1|Adverse Event|1|||
170762742|NCT01090024|617138663|FG010|Period 1|Adverse Event|0|||
170762743|NCT01090024|617138664|FG011|Period 1|Adverse Event|1|||
170762744|NCT01090024|617138665|FG012|Period 1|Adverse Event|0|||
170762745|NCT01090024|617138666|FG013|Period 1|Adverse Event|0|||
170762746|NCT01090024|617138667|FG014|Period 1|Adverse Event|0|||
170762747|NCT01090024|617138668|FG015|Period 1|Adverse Event|0|||
170762748|NCT01090024|617138669|FG016|Period 1|Adverse Event|0|||
170762749|NCT01090024|617138670|FG017|Period 1|Adverse Event|1|||
170762750|NCT01090024|617138653|FG000|Period 1|Withdrawal by Subject|0|||
170762751|NCT01090024|617138654|FG001|Period 1|Withdrawal by Subject|0|||
170762752|NCT01090024|617138655|FG002|Period 1|Withdrawal by Subject|0|||
170762753|NCT01090024|617138656|FG003|Period 1|Withdrawal by Subject|1|||
170762754|NCT01090024|617138657|FG004|Period 1|Withdrawal by Subject|0|||
170762755|NCT01090024|617138658|FG005|Period 1|Withdrawal by Subject|0|||
170762756|NCT01090024|617138659|FG006|Period 1|Withdrawal by Subject|0|||
170762757|NCT01090024|617138660|FG007|Period 1|Withdrawal by Subject|0|||
170762758|NCT01090024|617138661|FG008|Period 1|Withdrawal by Subject|0|||
170762759|NCT01090024|617138662|FG009|Period 1|Withdrawal by Subject|0|||
170762760|NCT01090024|617138663|FG010|Period 1|Withdrawal by Subject|0|||
170762761|NCT01090024|617138664|FG011|Period 1|Withdrawal by Subject|0|||
170762762|NCT01090024|617138665|FG012|Period 1|Withdrawal by Subject|0|||
170762763|NCT01090024|617138666|FG013|Period 1|Withdrawal by Subject|0|||
170762764|NCT01090024|617138667|FG014|Period 1|Withdrawal by Subject|0|||
170762765|NCT01090024|617138668|FG015|Period 1|Withdrawal by Subject|0|||
170762766|NCT01090024|617138669|FG016|Period 1|Withdrawal by Subject|0|||
170762767|NCT01090024|617138670|FG017|Period 1|Withdrawal by Subject|0|||
170762768|NCT01090024|617138653|FG000|Period 1|Lost to Follow-up|0|||
170762769|NCT01090024|617138654|FG001|Period 1|Lost to Follow-up|1|||
170762770|NCT01090024|617138655|FG002|Period 1|Lost to Follow-up|0|||
170409257|NCT00886483|615838114|FG000|Overall Study|Pursue medications|1|||
170409258|NCT00886483|615838115|FG001|Overall Study|Pursue medications|2|||
170409259|NCT00886483|615838114|FG000|Overall Study|Distance to center, poor grades|1|||
170409260|NCT00886483|615838115|FG001|Overall Study|Distance to center, poor grades|0|||
170409261|NCT01001169|615838116|FG000|Overall Study|Withdrawal by Subject|2|||
170409262|NCT01001169|615838117|FG001|Overall Study|Withdrawal by Subject|1|||
170409263|NCT02040766|615838118|FG000|Overall Study|Adverse Event|1|||
170762771|NCT01090024|617138656|FG003|Period 1|Lost to Follow-up|0|||
170762772|NCT01090024|617138657|FG004|Period 1|Lost to Follow-up|0|||
170762773|NCT01090024|617138658|FG005|Period 1|Lost to Follow-up|0|||
170762774|NCT01090024|617138659|FG006|Period 1|Lost to Follow-up|0|||
170762775|NCT01090024|617138660|FG007|Period 1|Lost to Follow-up|0|||
170762776|NCT01090024|617138661|FG008|Period 1|Lost to Follow-up|0|||
170762777|NCT01090024|617138662|FG009|Period 1|Lost to Follow-up|0|||
170762778|NCT01090024|617138663|FG010|Period 1|Lost to Follow-up|0|||
170762779|NCT01090024|617138664|FG011|Period 1|Lost to Follow-up|0|||
170762780|NCT01090024|617138665|FG012|Period 1|Lost to Follow-up|0|||
170762781|NCT01090024|617138666|FG013|Period 1|Lost to Follow-up|0|||
170762782|NCT01090024|617138667|FG014|Period 1|Lost to Follow-up|0|||
170762783|NCT01090024|617138668|FG015|Period 1|Lost to Follow-up|0|||
170762784|NCT01090024|617138669|FG016|Period 1|Lost to Follow-up|0|||
170762785|NCT01090024|617138670|FG017|Period 1|Lost to Follow-up|0|||
170762786|NCT01090024|617138653|FG000|Period 2|Lost to Follow-up|0|||
170762787|NCT01090024|617138654|FG001|Period 2|Lost to Follow-up|0|||
170762788|NCT01090024|617138655|FG002|Period 2|Lost to Follow-up|0|||
170762789|NCT01090024|617138656|FG003|Period 2|Lost to Follow-up|1|||
170762790|NCT01090024|617138657|FG004|Period 2|Lost to Follow-up|0|||
170762791|NCT01090024|617138658|FG005|Period 2|Lost to Follow-up|0|||
170762792|NCT01090024|617138659|FG006|Period 2|Lost to Follow-up|0|||
170762793|NCT01090024|617138660|FG007|Period 2|Lost to Follow-up|0|||
170762794|NCT01090024|617138661|FG008|Period 2|Lost to Follow-up|0|||
170762795|NCT01090024|617138662|FG009|Period 2|Lost to Follow-up|0|||
170762796|NCT01090024|617138663|FG010|Period 2|Lost to Follow-up|0|||
170762797|NCT01090024|617138664|FG011|Period 2|Lost to Follow-up|0|||
170762798|NCT01090024|617138665|FG012|Period 2|Lost to Follow-up|0|||
170762799|NCT01090024|617138666|FG013|Period 2|Lost to Follow-up|0|||
170762800|NCT01090024|617138667|FG014|Period 2|Lost to Follow-up|0|||
170762801|NCT01090024|617138668|FG015|Period 2|Lost to Follow-up|0|||
170762802|NCT01090024|617138669|FG016|Period 2|Lost to Follow-up|0|||
170762803|NCT01090024|617138670|FG017|Period 2|Lost to Follow-up|0|||
170762804|NCT01090024|617138653|FG000|Period 2|Adverse Event|1|||
170762805|NCT01090024|617138654|FG001|Period 2|Adverse Event|0|||
170762806|NCT01090024|617138655|FG002|Period 2|Adverse Event|0|||
170762807|NCT01090024|617138656|FG003|Period 2|Adverse Event|0|||
170762808|NCT01090024|617138657|FG004|Period 2|Adverse Event|0|||
170762809|NCT01090024|617138658|FG005|Period 2|Adverse Event|0|||
170762810|NCT01090024|617138659|FG006|Period 2|Adverse Event|0|||
170762811|NCT01090024|617138660|FG007|Period 2|Adverse Event|0|||
170762812|NCT01090024|617138661|FG008|Period 2|Adverse Event|0|||
170762813|NCT01090024|617138662|FG009|Period 2|Adverse Event|0|||
170762814|NCT01090024|617138663|FG010|Period 2|Adverse Event|0|||
170762815|NCT01090024|617138664|FG011|Period 2|Adverse Event|0|||
170762816|NCT01090024|617138665|FG012|Period 2|Adverse Event|0|||
170762817|NCT01090024|617138666|FG013|Period 2|Adverse Event|0|||
170762818|NCT01090024|617138667|FG014|Period 2|Adverse Event|0|||
170762819|NCT01090024|617138668|FG015|Period 2|Adverse Event|0|||
170762820|NCT01090024|617138669|FG016|Period 2|Adverse Event|0|||
170762821|NCT01090024|617138670|FG017|Period 2|Adverse Event|0|||
170762822|NCT01090024|617138653|FG000|Period 3|Withdrawal by Subject|0|||
170762823|NCT01090024|617138654|FG001|Period 3|Withdrawal by Subject|0|||
170762824|NCT01090024|617138655|FG002|Period 3|Withdrawal by Subject|0|||
170762825|NCT01090024|617138656|FG003|Period 3|Withdrawal by Subject|0|||
170762826|NCT01090024|617138657|FG004|Period 3|Withdrawal by Subject|0|||
170762827|NCT01090024|617138658|FG005|Period 3|Withdrawal by Subject|0|||
170762828|NCT01090024|617138659|FG006|Period 3|Withdrawal by Subject|0|||
170762829|NCT01090024|617138660|FG007|Period 3|Withdrawal by Subject|0|||
170762830|NCT01090024|617138661|FG008|Period 3|Withdrawal by Subject|0|||
170762831|NCT01090024|617138662|FG009|Period 3|Withdrawal by Subject|0|||
170762832|NCT01090024|617138663|FG010|Period 3|Withdrawal by Subject|0|||
170762833|NCT01090024|617138664|FG011|Period 3|Withdrawal by Subject|0|||
170762834|NCT01090024|617138665|FG012|Period 3|Withdrawal by Subject|0|||
170762835|NCT01090024|617138666|FG013|Period 3|Withdrawal by Subject|0|||
170762836|NCT01090024|617138667|FG014|Period 3|Withdrawal by Subject|0|||
170762837|NCT01090024|617138668|FG015|Period 3|Withdrawal by Subject|1|||
170762838|NCT01090024|617138669|FG016|Period 3|Withdrawal by Subject|0|||
170519780|NCT01610037|616247638|FG001|Treatment and Follow up Period|Death|5|||
170762839|NCT01090024|617138670|FG017|Period 3|Withdrawal by Subject|0|||
170762840|NCT01090024|617138653|FG000|Period 3|Protocol Violation|0|||
170762841|NCT01090024|617138654|FG001|Period 3|Protocol Violation|0|||
170762842|NCT01090024|617138655|FG002|Period 3|Protocol Violation|0|||
170762843|NCT01090024|617138656|FG003|Period 3|Protocol Violation|0|||
170762844|NCT01090024|617138657|FG004|Period 3|Protocol Violation|0|||
170762845|NCT01090024|617138658|FG005|Period 3|Protocol Violation|0|||
170762846|NCT01090024|617138659|FG006|Period 3|Protocol Violation|0|||
170762847|NCT01090024|617138660|FG007|Period 3|Protocol Violation|0|||
170762848|NCT01090024|617138661|FG008|Period 3|Protocol Violation|1|||
170519781|NCT01610037|616247639|FG002|Treatment and Follow up Period|Death|4|||
170762849|NCT01090024|617138662|FG009|Period 3|Protocol Violation|0|||
170762850|NCT01090024|617138663|FG010|Period 3|Protocol Violation|0|||
170762851|NCT01090024|617138664|FG011|Period 3|Protocol Violation|0|||
170762852|NCT01090024|617138665|FG012|Period 3|Protocol Violation|0|||
170762853|NCT01090024|617138666|FG013|Period 3|Protocol Violation|0|||
170762854|NCT01090024|617138667|FG014|Period 3|Protocol Violation|0|||
170762855|NCT01090024|617138668|FG015|Period 3|Protocol Violation|0|||
170762856|NCT01090024|617138669|FG016|Period 3|Protocol Violation|0|||
170867452|NCT03823404|617526594|FG002|Overall Study|Protocol Violation|2|||
170867453|NCT03823404|617526592|FG000|Overall Study|Adverse Event|35|||
170762857|NCT01090024|617138670|FG017|Period 3|Protocol Violation|0|||
170762858|NCT01090024|617138653|FG000|Period 3|Adverse Event|0|||
170762859|NCT01090024|617138654|FG001|Period 3|Adverse Event|0|||
170867454|NCT03823404|617526593|FG001|Overall Study|Adverse Event|38|||
170867455|NCT03823404|617526594|FG002|Overall Study|Adverse Event|8|||
170762860|NCT01090024|617138655|FG002|Period 3|Adverse Event|0|||
170762861|NCT01090024|617138656|FG003|Period 3|Adverse Event|0|||
170762862|NCT01090024|617138657|FG004|Period 3|Adverse Event|0|||
170762863|NCT01090024|617138658|FG005|Period 3|Adverse Event|1|||
170762864|NCT01090024|617138659|FG006|Period 3|Adverse Event|0|||
170762865|NCT01090024|617138660|FG007|Period 3|Adverse Event|0|||
170762866|NCT01090024|617138661|FG008|Period 3|Adverse Event|0|||
170762867|NCT01090024|617138662|FG009|Period 3|Adverse Event|0|||
170762868|NCT01090024|617138663|FG010|Period 3|Adverse Event|0|||
170762869|NCT01090024|617138664|FG011|Period 3|Adverse Event|0|||
170762870|NCT01090024|617138665|FG012|Period 3|Adverse Event|0|||
170762871|NCT01090024|617138666|FG013|Period 3|Adverse Event|0|||
170762872|NCT01090024|617138667|FG014|Period 3|Adverse Event|0|||
170762873|NCT01090024|617138668|FG015|Period 3|Adverse Event|0|||
170762874|NCT01090024|617138669|FG016|Period 3|Adverse Event|0|||
170762875|NCT01090024|617138670|FG017|Period 3|Adverse Event|0|||
170762876|NCT01249092|617138673|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
170762877|NCT01249092|617138673|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
170762878|NCT02380742|617138674|FG000|Overall Study|Withdrawal by Subject|1|||
170762879|NCT02380742|617138675|FG001|Overall Study|Withdrawal by Subject|0|||
170762880|NCT02689349|617138678|FG000|Overall Study|Not implanted|4|||
170762881|NCT02689349|617138679|FG001|Overall Study|Not implanted|0|||
170409264|NCT02040766|615838119|FG001|Overall Study|Adverse Event|1|||
170409265|NCT02040766|615838120|FG002|Overall Study|Adverse Event|1|||
170409266|NCT02040766|615838121|FG003|Overall Study|Adverse Event|0|||
170409267|NCT02040766|615838122|FG004|Overall Study|Adverse Event|2|||
170409268|NCT02040766|615838118|FG000|Overall Study|Withdrawal by Subject|4|||
170409269|NCT02040766|615838119|FG001|Overall Study|Withdrawal by Subject|3|||
170409270|NCT02040766|615838120|FG002|Overall Study|Withdrawal by Subject|2|||
170762882|NCT02689349|617138678|FG000|Overall Study|Withdrawal by Subject|9|||
170867456|NCT03823404|617526592|FG000|Overall Study|Withdrawal by Subject|38|||
170867457|NCT03823404|617526593|FG001|Overall Study|Withdrawal by Subject|40|||
170867458|NCT03823404|617526594|FG002|Overall Study|Withdrawal by Subject|35|||
170867459|NCT03823404|617526592|FG000|Overall Study|Death|4|||
170867460|NCT03823404|617526593|FG001|Overall Study|Death|0|||
170867461|NCT03823404|617526594|FG002|Overall Study|Death|0|||
170762883|NCT02689349|617138679|FG001|Overall Study|Withdrawal by Subject|0|||
170762884|NCT02930343|617138680|FG000|Overall Study|Lost to Follow-up|9|||
170867462|NCT03823404|617526592|FG000|Overall Study|Other: Various reasons provided|5|||
170409271|NCT02040766|615838121|FG003|Overall Study|Withdrawal by Subject|3|||
170409272|NCT02040766|615838122|FG004|Overall Study|Withdrawal by Subject|2|||
170762885|NCT02930343|617138681|FG001|Overall Study|Lost to Follow-up|7|||
170762886|NCT01025843|617138682|FG000|Washout 4|Withdrawal by Subject|0|||
170409273|NCT02040766|615838118|FG000|Overall Study|Non-compliance|0|||
170867463|NCT03823404|617526593|FG001|Overall Study|Other: Various reasons provided|5|||
170867464|NCT03823404|617526594|FG002|Overall Study|Other: Various reasons provided|6|||
170867465|NCT01524133|617526599|FG000|Treatment Phase|Withdrawal by Subject|13|||
170867466|NCT01524133|617526600|FG001|Treatment Phase|Withdrawal by Subject|28|||
170867467|NCT01524133|617526601|FG002|Treatment Phase|Withdrawal by Subject|31|||
170867468|NCT01524133|617526599|FG000|Treatment Phase|Physician Decision|6|||
170867469|NCT01524133|617526600|FG001|Treatment Phase|Physician Decision|3|||
170867470|NCT01524133|617526601|FG002|Treatment Phase|Physician Decision|3|||
170409274|NCT02040766|615838119|FG001|Overall Study|Non-compliance|1|||
170409275|NCT02040766|615838120|FG002|Overall Study|Non-compliance|0|||
170409276|NCT02040766|615838121|FG003|Overall Study|Non-compliance|0|||
170409277|NCT02040766|615838122|FG004|Overall Study|Non-compliance|0|||
170409278|NCT02040766|615838118|FG000|Overall Study|Protocol Violation|2|||
170409279|NCT02040766|615838119|FG001|Overall Study|Protocol Violation|1|||
170409280|NCT02040766|615838120|FG002|Overall Study|Protocol Violation|2|||
170409281|NCT02040766|615838121|FG003|Overall Study|Protocol Violation|3|||
170409282|NCT02040766|615838122|FG004|Overall Study|Protocol Violation|0|||
170409283|NCT02040766|615838118|FG000|Overall Study|Lost to Follow-up|4|||
170409284|NCT02040766|615838119|FG001|Overall Study|Lost to Follow-up|1|||
170409285|NCT02040766|615838120|FG002|Overall Study|Lost to Follow-up|3|||
170409286|NCT02040766|615838121|FG003|Overall Study|Lost to Follow-up|1|||
170409287|NCT02040766|615838122|FG004|Overall Study|Lost to Follow-up|4|||
170409288|NCT02040766|615838118|FG000|Overall Study|Not reported|1|||
170409289|NCT02040766|615838119|FG001|Overall Study|Not reported|0|||
170409290|NCT02040766|615838120|FG002|Overall Study|Not reported|0|||
170409291|NCT02040766|615838121|FG003|Overall Study|Not reported|0|||
170409292|NCT02040766|615838122|FG004|Overall Study|Not reported|0|||
170409293|NCT02040766|615838118|FG000|Overall Study|Lack of Efficacy|6|||
170409294|NCT02040766|615838119|FG001|Overall Study|Lack of Efficacy|3|||
170409295|NCT02040766|615838120|FG002|Overall Study|Lack of Efficacy|4|||
170409296|NCT02040766|615838121|FG003|Overall Study|Lack of Efficacy|6|||
170409297|NCT02040766|615838122|FG004|Overall Study|Lack of Efficacy|5|||
170409298|NCT00602030|615838123|FG000|Lead-in Phase|Disease Progression|2|||
170409299|NCT00602030|615838124|FG001|Lead-in Phase|Disease Progression|3|||
170409300|NCT00602030|615838125|FG002|Lead-in Phase|Disease Progression|0|||
170409301|NCT00602030|615838126|FG003|Lead-in Phase|Disease Progression|0|||
170409302|NCT00602030|615838127|FG004|Lead-in Phase|Disease Progression|0|||
170409303|NCT00602030|615838123|FG000|Lead-in Phase|Adverse Event|0|||
170409304|NCT00602030|615838124|FG001|Lead-in Phase|Adverse Event|2|||
170409305|NCT00602030|615838125|FG002|Lead-in Phase|Adverse Event|0|||
170409306|NCT00602030|615838126|FG003|Lead-in Phase|Adverse Event|0|||
170409307|NCT00602030|615838127|FG004|Lead-in Phase|Adverse Event|0|||
170409308|NCT00602030|615838123|FG000|Double-blind Phase|Disease progression|0|||
170409309|NCT00602030|615838124|FG001|Double-blind Phase|Disease progression|0|||
170409310|NCT00602030|615838125|FG002|Double-blind Phase|Disease progression|33|||
170409311|NCT00602030|615838126|FG003|Double-blind Phase|Disease progression|30|||
170409312|NCT00602030|615838127|FG004|Double-blind Phase|Disease progression|0|||
170409313|NCT00602030|615838123|FG000|Double-blind Phase|Adverse Event|0|||
170409314|NCT00602030|615838124|FG001|Double-blind Phase|Adverse Event|0|||
170409315|NCT00602030|615838125|FG002|Double-blind Phase|Adverse Event|9|||
170409316|NCT00602030|615838126|FG003|Double-blind Phase|Adverse Event|18|||
170409317|NCT00602030|615838127|FG004|Double-blind Phase|Adverse Event|0|||
170409318|NCT00602030|615838123|FG000|Double-blind Phase|Consent withdrawal|0|||
170409319|NCT00602030|615838124|FG001|Double-blind Phase|Consent withdrawal|0|||
170409320|NCT00602030|615838125|FG002|Double-blind Phase|Consent withdrawal|4|||
170409321|NCT00602030|615838126|FG003|Double-blind Phase|Consent withdrawal|3|||
170409322|NCT00602030|615838127|FG004|Double-blind Phase|Consent withdrawal|0|||
170409323|NCT00602030|615838123|FG000|Double-blind Phase|Death|0|||
170409324|NCT00602030|615838124|FG001|Double-blind Phase|Death|0|||
170409325|NCT00602030|615838125|FG002|Double-blind Phase|Death|3|||
170409326|NCT00602030|615838126|FG003|Double-blind Phase|Death|3|||
170409327|NCT00602030|615838127|FG004|Double-blind Phase|Death|0|||
170519782|NCT01610037|616247637|FG000|Treatment and Follow up Period|Administrative problems|1|||
170867471|NCT01524133|617526599|FG000|Treatment Phase|Lost to Follow-up|0|||
170867472|NCT01524133|617526600|FG001|Treatment Phase|Lost to Follow-up|1|||
170867473|NCT01524133|617526601|FG002|Treatment Phase|Lost to Follow-up|2|||
170867474|NCT01524133|617526599|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
170409328|NCT00602030|615838123|FG000|Double-blind Phase|Administrative decision|0|||
170409329|NCT00602030|615838124|FG001|Double-blind Phase|Administrative decision|0|||
170409330|NCT00602030|615838125|FG002|Double-blind Phase|Administrative decision|0|||
170409331|NCT00602030|615838126|FG003|Double-blind Phase|Administrative decision|2|||
170409332|NCT00602030|615838127|FG004|Double-blind Phase|Administrative decision|0|||
170409333|NCT00602030|615838123|FG000|Double-blind Phase|Ineligibility|0|||
170409334|NCT00602030|615838124|FG001|Double-blind Phase|Ineligibility|0|||
170409335|NCT00602030|615838125|FG002|Double-blind Phase|Ineligibility|0|||
170409336|NCT00602030|615838126|FG003|Double-blind Phase|Ineligibility|1|||
170409337|NCT00602030|615838127|FG004|Double-blind Phase|Ineligibility|0|||
170409338|NCT00602030|615838123|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
170762887|NCT01025843|617138683|FG001|Washout 4|Withdrawal by Subject|0|||
170762888|NCT01025843|617138684|FG002|Washout 4|Withdrawal by Subject|1|||
170762889|NCT01025843|617138685|FG003|Washout 4|Withdrawal by Subject|1|||
170762890|NCT01025843|617138686|FG004|Washout 4|Withdrawal by Subject|0|||
170762891|NCT01025843|617138687|FG005|Washout 4|Withdrawal by Subject|0|||
170762892|NCT01025843|617138688|FG006|Washout 4|Withdrawal by Subject|0|||
170762893|NCT01025843|617138689|FG007|Washout 4|Withdrawal by Subject|0|||
170762894|NCT01025843|617138690|FG008|Washout 4|Withdrawal by Subject|0|||
170762895|NCT01025843|617138691|FG009|Washout 4|Withdrawal by Subject|0|||
170762896|NCT03646669|617138692|FG000|Overall Study|Withdrawal by Subject|5|||
170762897|NCT03646669|617138693|FG001|Overall Study|Withdrawal by Subject|0|||
170762898|NCT00377455|617138694|FG000|Overall Study|Withdrawal by Subject|1|||
170762899|NCT00309452|617138695|FG000|Overall Study|Withdrawal by Subject|3|||
170762900|NCT00309452|617138696|FG001|Overall Study|Withdrawal by Subject|0|||
170762901|NCT02814643|617138701|FG000|Overall Study|Lost to Follow-up|0|||
170762902|NCT02814643|617138702|FG001|Overall Study|Lost to Follow-up|1|||
170762903|NCT02814643|617138701|FG000|Overall Study|Withdrawal by Subject|1|||
170762904|NCT02814643|617138702|FG001|Overall Study|Withdrawal by Subject|2|||
170867475|NCT01524133|617526600|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
170409339|NCT00602030|615838124|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
170409340|NCT00602030|615838125|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
170409341|NCT00602030|615838126|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
170409342|NCT00602030|615838127|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
170409343|NCT00602030|615838123|FG000|Double-blind Phase|Reason not specified|0|||
170409344|NCT00602030|615838124|FG001|Double-blind Phase|Reason not specified|0|||
170409345|NCT00602030|615838125|FG002|Double-blind Phase|Reason not specified|4|||
170409346|NCT00602030|615838126|FG003|Double-blind Phase|Reason not specified|2|||
170409347|NCT00602030|615838127|FG004|Double-blind Phase|Reason not specified|0|||
170409348|NCT00602030|615838123|FG000|Crossover Phase|Disease Progression|0|||
170409349|NCT00602030|615838124|FG001|Crossover Phase|Disease Progression|0|||
170409350|NCT00602030|615838125|FG002|Crossover Phase|Disease Progression|0|||
170409351|NCT00602030|615838126|FG003|Crossover Phase|Disease Progression|0|||
170409352|NCT00602030|615838127|FG004|Crossover Phase|Disease Progression|11|||
170409353|NCT00602030|615838123|FG000|Crossover Phase|Adverse Event|0|||
170409354|NCT00602030|615838124|FG001|Crossover Phase|Adverse Event|0|||
170409355|NCT00602030|615838125|FG002|Crossover Phase|Adverse Event|0|||
170409356|NCT00602030|615838126|FG003|Crossover Phase|Adverse Event|0|||
170409357|NCT00602030|615838127|FG004|Crossover Phase|Adverse Event|3|||
170409358|NCT00602030|615838123|FG000|Crossover Phase|Consent withdrawal|0|||
170409359|NCT00602030|615838124|FG001|Crossover Phase|Consent withdrawal|0|||
170409360|NCT00602030|615838125|FG002|Crossover Phase|Consent withdrawal|0|||
170409361|NCT00602030|615838126|FG003|Crossover Phase|Consent withdrawal|0|||
170409362|NCT00602030|615838127|FG004|Crossover Phase|Consent withdrawal|2|||
170409363|NCT01138150|615838132|FG000|Overall Study|blood unable to be processed|0|||
170409364|NCT01138150|615838133|FG001|Overall Study|blood unable to be processed|1|||
170409365|NCT01138150|615838132|FG000|Overall Study|Physician Decision|1|||
170409366|NCT01138150|615838133|FG001|Overall Study|Physician Decision|0|||
170409367|NCT01724359|615838135|FG000|Overall Study|Adverse Event|10|||
170409368|NCT01724359|615838135|FG000|Overall Study|Death|1|||
170409369|NCT01724359|615838135|FG000|Overall Study|Other|20|||
170409370|NCT02191579|615838147|FG000|Treatment 1|Multiple Reasons Specified|27|||
170409371|NCT02191579|615838148|FG001|Treatment 1|Multiple Reasons Specified|58|||
170409372|NCT02191579|615838147|FG000|Treatment 2|Multiple Reasons Specified|0|||
170409373|NCT02191579|615838148|FG001|Treatment 2|Multiple Reasons Specified|25|||
170409374|NCT02862535|615838149|FG000|Overall Study|Death|7|||
170409375|NCT02862535|615838150|FG001|Overall Study|Death|3|||
170409376|NCT02862535|615838151|FG002|Overall Study|Death|2|||
170409377|NCT02862535|615838152|FG003|Overall Study|Death|5|||
170409378|NCT02862535|615838149|FG000|Overall Study|Study Terminated by Sponsor|1|||
170409379|NCT02862535|615838150|FG001|Overall Study|Study Terminated by Sponsor|3|||
170409380|NCT02862535|615838151|FG002|Overall Study|Study Terminated by Sponsor|8|||
170409381|NCT02862535|615838152|FG003|Overall Study|Study Terminated by Sponsor|5|||
170409382|NCT02862535|615838149|FG000|Overall Study|Enrolled, not Treated|1|||
170762905|NCT03265210|617138704|FG000|Overall Study|Withdrawal by Subject|7|||
170762906|NCT03265210|617138705|FG001|Overall Study|Withdrawal by Subject|9|||
170762907|NCT03265210|617138704|FG000|Overall Study|Lost to Follow-up|2|||
170762908|NCT03265210|617138705|FG001|Overall Study|Lost to Follow-up|0|||
170762909|NCT03265210|617138704|FG000|Overall Study|Physician Decision|2|||
170762910|NCT03265210|617138705|FG001|Overall Study|Physician Decision|0|||
170867476|NCT01524133|617526601|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
170409383|NCT02862535|615838150|FG001|Overall Study|Enrolled, not Treated|0|||
170409384|NCT02862535|615838151|FG002|Overall Study|Enrolled, not Treated|0|||
170409385|NCT02862535|615838152|FG003|Overall Study|Enrolled, not Treated|1|||
170409386|NCT01965652|615838156|FG000|Overall Study|Adverse Event|40|||
170409387|NCT01965652|615838157|FG001|Overall Study|Adverse Event|37|||
170409388|NCT01965652|615838156|FG000|Overall Study|Withdrawal by Subject|62|||
170409389|NCT01965652|615838157|FG001|Overall Study|Withdrawal by Subject|69|||
170409390|NCT01965652|615838156|FG000|Overall Study|Lost to Follow-up|53|||
170409391|NCT01965652|615838157|FG001|Overall Study|Lost to Follow-up|40|||
170409392|NCT01965652|615838156|FG000|Overall Study|Protocol Violation|34|||
170409393|NCT01965652|615838157|FG001|Overall Study|Protocol Violation|38|||
170409394|NCT01965652|615838156|FG000|Overall Study|Death|3|||
170409395|NCT01965652|615838157|FG001|Overall Study|Death|4|||
170409396|NCT01965652|615838156|FG000|Overall Study|Other - Miscellaneous|18|||
170409397|NCT01965652|615838157|FG001|Overall Study|Other - Miscellaneous|21|||
170409398|NCT01965652|615838156|FG000|Overall Study|Pregnancy|0|||
170409399|NCT01965652|615838157|FG001|Overall Study|Pregnancy|1|||
170409400|NCT03493698|615838160|FG000|Treatment Period C|Adverse Event|1|||
170409401|NCT03493698|615838160|FG000|Treatment Period C|Withdrawal by Subject|1|||
170409402|NCT00299728|615838163|FG000|Overall Study|Lost to Follow-up|0|||
170409403|NCT00299728|615838164|FG001|Overall Study|Lost to Follow-up|1|||
170409404|NCT00299728|615838163|FG000|Overall Study|Withdrawal by Subject|0|||
170409405|NCT00299728|615838164|FG001|Overall Study|Withdrawal by Subject|1|||
170409406|NCT00299728|615838163|FG000|Overall Study|Progressive disease|0|||
170409407|NCT00299728|615838164|FG001|Overall Study|Progressive disease|1|||
170409408|NCT01337050|615838165|FG000|Overall Study|Death|0|||
170409409|NCT01337050|615838166|FG001|Overall Study|Death|0|||
170409410|NCT01337050|615838167|FG002|Overall Study|Death|4|||
170409411|NCT01337050|615838165|FG000|Overall Study|Other|4|||
170409412|NCT01337050|615838166|FG001|Overall Study|Other|6|||
170409413|NCT01337050|615838167|FG002|Overall Study|Other|8|||
170409414|NCT01337050|615838165|FG000|Overall Study|Participants refused further follow-up|0|||
170409415|NCT01337050|615838166|FG001|Overall Study|Participants refused further follow-up|7|||
170409416|NCT01337050|615838167|FG002|Overall Study|Participants refused further follow-up|7|||
170409417|NCT04071626|615838168|FG000|Overall Study|Withdrawal by Subject|1|||
170409418|NCT04071626|615838169|FG001|Overall Study|Withdrawal by Subject|1|||
170409419|NCT04071626|615838168|FG000|Overall Study|Protocol Violation|0|||
170409420|NCT04071626|615838169|FG001|Overall Study|Protocol Violation|1|||
170409421|NCT00125359|615838170|FG000|Overall Study|Death|4|||
170409422|NCT00125359|615838170|FG000|Overall Study|Adverse Event|5|||
170409423|NCT00125359|615838170|FG000|Overall Study|Physician Decision|14|||
170409424|NCT02049359|615840011|FG000|Overall Study|Lost to Follow-up|26|||
170409425|NCT02049359|615840012|FG001|Overall Study|Lost to Follow-up|19|||
170409426|NCT02410252|615840018|FG000|Overall Study|Withdrawal by Subject|4|||
170409427|NCT02410252|615840018|FG000|Overall Study|Physician Decision|2|||
170409428|NCT03433001|615840019|FG000|Overall Study|Lack of Efficacy|109|||
170409429|NCT03433001|615840019|FG000|Overall Study|Adverse Event|69|||
170409430|NCT03433001|615840019|FG000|Overall Study|Withdrawal by Subject|10|||
170409431|NCT03433001|615840019|FG000|Overall Study|Death|12|||
170409432|NCT03433001|615840019|FG000|Overall Study|Lost to Follow-up|4|||
170409433|NCT03433001|615840019|FG000|Overall Study|Other|25|||
170762911|NCT03265210|617138704|FG000|Overall Study|Adverse Event|1|||
170762912|NCT03265210|617138705|FG001|Overall Study|Adverse Event|0|||
170762913|NCT01227278|617138710|FG000|Overall Study|Withdrawal by Subject|4|||
170762914|NCT01227278|617138711|FG001|Overall Study|Withdrawal by Subject|4|||
170762915|NCT01227278|617138710|FG000|Overall Study|Death|0|||
170762916|NCT01227278|617138711|FG001|Overall Study|Death|2|||
170762917|NCT01227278|617138710|FG000|Overall Study|Other|1|||
170762918|NCT01227278|617138711|FG001|Overall Study|Other|2|||
170762919|NCT00420316|617138714|FG000|Overall Study|Withdrawal by Subject|0|||
170762920|NCT00420316|617138715|FG001|Overall Study|Withdrawal by Subject|1|||
170762921|NCT00420316|617138714|FG000|Overall Study|Lost to Follow-up|12|||
170762922|NCT00420316|617138715|FG001|Overall Study|Lost to Follow-up|8|||
170762923|NCT00868192|617138721|FG000|Overall Study|Ineligible|4|||
170762924|NCT03673124|617138723|FG000|Overall Study|Eligible with no protocol therapy|2|||
170762925|NCT03055767|617138724|FG000|Open-Label Period|Lost to Follow-up|0|||
170762926|NCT03055767|617138725|FG001|Open-Label Period|Lost to Follow-up|0|||
170762927|NCT03055767|617138726|FG002|Open-Label Period|Lost to Follow-up|2|||
170762928|NCT03055767|617138727|FG003|Open-Label Period|Lost to Follow-up|0|||
170762929|NCT03055767|617138724|FG000|Open-Label Period|Withdrawal by Subject|0|||
170762930|NCT03055767|617138725|FG001|Open-Label Period|Withdrawal by Subject|0|||
170762931|NCT03055767|617138726|FG002|Open-Label Period|Withdrawal by Subject|0|||
170762932|NCT03055767|617138727|FG003|Open-Label Period|Withdrawal by Subject|1|||
170762933|NCT05827926|617138728|FG000|Overall Study|Lost to Follow-up|1|||
170762934|NCT05827926|617138729|FG001|Overall Study|Lost to Follow-up|0|||
170409434|NCT01007916|615840020|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
170409435|NCT01007916|615840021|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
170409436|NCT01007916|615840020|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
170409437|NCT01007916|615840021|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
170409438|NCT00387712|615840024|FG000|Overall Study|Physician Decision|6|||
170762935|NCT05827926|617138730|FG002|Overall Study|Lost to Follow-up|0|||
170409439|NCT00387712|615840025|FG001|Overall Study|Physician Decision|4|||
170409440|NCT00387712|615840024|FG000|Overall Study|Lost to Follow-up|17|||
170409441|NCT00387712|615840025|FG001|Overall Study|Lost to Follow-up|20|||
170409442|NCT00387712|615840024|FG000|Overall Study|Withdrawal by Subject|6|||
170409443|NCT00387712|615840025|FG001|Overall Study|Withdrawal by Subject|12|||
170409444|NCT00555009|615840030|FG000|Overall Study|Withdrawal by Subject|0|||
170409445|NCT00555009|615840031|FG001|Overall Study|Withdrawal by Subject|1|||
170409446|NCT00555009|615840030|FG000|Overall Study|Terminated by Sponsor|2|||
170409447|NCT00555009|615840031|FG001|Overall Study|Terminated by Sponsor|5|||
170762936|NCT05827926|617138731|FG003|Overall Study|Lost to Follow-up|0|||
170762937|NCT05827926|617138732|FG004|Overall Study|Lost to Follow-up|0|||
170762938|NCT05827926|617138733|FG005|Overall Study|Lost to Follow-up|1|||
170762939|NCT05827926|617138734|FG006|Overall Study|Lost to Follow-up|0|||
170762940|NCT05827926|617138735|FG007|Overall Study|Lost to Follow-up|0|||
170762941|NCT05827926|617138736|FG008|Overall Study|Lost to Follow-up|0|||
170762942|NCT05827926|617138737|FG009|Overall Study|Lost to Follow-up|0|||
170762943|NCT05827926|617138738|FG010|Overall Study|Lost to Follow-up|0|||
170762944|NCT05827926|617138739|FG011|Overall Study|Lost to Follow-up|0|||
170762945|NCT05827926|617138740|FG012|Overall Study|Lost to Follow-up|1|||
170762946|NCT05827926|617138741|FG013|Overall Study|Lost to Follow-up|1|||
170762947|NCT05827926|617138742|FG014|Overall Study|Lost to Follow-up|0|||
170409448|NCT02040428|615840032|FG000|Overall Study|Death|4|||
170409449|NCT02040428|615840033|FG001|Overall Study|Death|3|||
170409450|NCT02040428|615840032|FG000|Overall Study|Withdrawal by Subject|1|||
170409451|NCT02040428|615840033|FG001|Overall Study|Withdrawal by Subject|1|||
170409452|NCT00832078|615840034|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
170409453|NCT00832078|615840035|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
170409454|NCT00832078|615840034|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
170409455|NCT00832078|615840035|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
170409456|NCT02961920|615840036|FG000|Overall Study|did not achive stydy protocol schedule|1|||
170409457|NCT02961920|615840037|FG001|Overall Study|did not achive stydy protocol schedule|1|||
170409458|NCT04633837|615840038|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
170409459|NCT04633837|615840039|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
170409460|NCT00112489|615840040|FG000|Overall Study|Refused further treatment|8|||
170409461|NCT00112489|615840040|FG000|Overall Study|Adverse Event|12|||
170409462|NCT00112489|615840040|FG000|Overall Study|Death|2|||
170409463|NCT00112489|615840040|FG000|Overall Study|Other, Not Specified|9|||
170409464|NCT00112489|615840040|FG000|Overall Study|Patient never treated|2|||
170409465|NCT00112489|615840040|FG000|Overall Study|Ineligible|7|||
170409466|NCT01506323|615840041|FG000|Overall Study|Lost to Follow-up|5|||
170409467|NCT01506323|615840042|FG001|Overall Study|Lost to Follow-up|4|||
170409468|NCT01506323|615840041|FG000|Overall Study|Withdrawal by Subject|4|||
170409469|NCT01506323|615840042|FG001|Overall Study|Withdrawal by Subject|4|||
170409470|NCT01506323|615840041|FG000|Overall Study|Lack of Efficacy|1|||
170409471|NCT01506323|615840042|FG001|Overall Study|Lack of Efficacy|3|||
170409472|NCT01506323|615840041|FG000|Overall Study|Moved out of area|5|||
170409473|NCT01506323|615840042|FG001|Overall Study|Moved out of area|2|||
170409474|NCT01506323|615840041|FG000|Overall Study|Schedule or Transportation conflict|8|||
170409475|NCT01506323|615840042|FG001|Overall Study|Schedule or Transportation conflict|0|||
170409476|NCT01506323|615840041|FG000|Overall Study|Started another treatment|1|||
170409477|NCT01506323|615840042|FG001|Overall Study|Started another treatment|0|||
170409478|NCT03907280|615840044|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
170409479|NCT03907280|615840045|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
170409480|NCT03907280|615840046|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
170409481|NCT02637076|615840050|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
170409482|NCT02637076|615840051|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
170409483|NCT02637076|615840050|FG000|Overall Study|Withdrawal by Subject|0|||
170409484|NCT02637076|615840051|FG001|Overall Study|Withdrawal by Subject|4|||
170409485|NCT00130520|615840052|FG000|Overall Study|Adverse Event|11|||
170409486|NCT00130520|615840052|FG000|Overall Study|Death|1|||
170409487|NCT00130520|615840052|FG000|Overall Study|Physician Decision|1|||
170409488|NCT00130520|615840052|FG000|Overall Study|Withdrawal by Subject|1|||
170409489|NCT00130520|615840052|FG000|Overall Study|Disease Progression|23|||
170409490|NCT00130520|615840052|FG000|Overall Study|Protocol non-compliance|1|||
170409491|NCT00130520|615840052|FG000|Overall Study|Did not meet re-treatment criteria|1|||
170409492|NCT00586521|615840053|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
170762948|NCT05827926|617138743|FG015|Overall Study|Lost to Follow-up|1|||
170762949|NCT05827926|617138744|FG016|Overall Study|Lost to Follow-up|2|||
170762950|NCT05827926|617138745|FG017|Overall Study|Lost to Follow-up|0|||
170762951|NCT05827926|617138746|FG018|Overall Study|Lost to Follow-up|0|||
170762952|NCT05827926|617138747|FG019|Overall Study|Lost to Follow-up|0|||
170762953|NCT05827926|617138748|FG020|Overall Study|Lost to Follow-up|1|||
170409493|NCT04604184|615840055|FG000|Overall Study|Adverse Event|5|||
170409494|NCT04604184|615840056|FG001|Overall Study|Adverse Event|5|||
170409495|NCT04604184|615840055|FG000|Overall Study|Death|2|||
170409496|NCT04604184|615840056|FG001|Overall Study|Death|1|||
170409497|NCT04604184|615840055|FG000|Overall Study|Withdrawal by Subject|1|||
170762954|NCT05827926|617138749|FG021|Overall Study|Lost to Follow-up|2|||
170409498|NCT04604184|615840056|FG001|Overall Study|Withdrawal by Subject|3|||
170409499|NCT04604184|615840055|FG000|Overall Study|Not treated|2|||
170409500|NCT04604184|615840056|FG001|Overall Study|Not treated|2|||
170409501|NCT04604184|615840055|FG000|Overall Study|Due to sponsor decision|9|||
170409502|NCT04604184|615840056|FG001|Overall Study|Due to sponsor decision|7|||
170409503|NCT04604184|615840055|FG000|Overall Study|Physician Decision|0|||
170409504|NCT04604184|615840056|FG001|Overall Study|Physician Decision|1|||
170409505|NCT04604184|615840055|FG000|Overall Study|Transfer to healthcare|1|||
170409506|NCT04604184|615840056|FG001|Overall Study|Transfer to healthcare|0|||
170409507|NCT01751412|615840057|FG000|Overall Study|Disease Progression Before Treatment|1|||
170409508|NCT03734237|615840058|FG000|Overall Study|Lost to Follow-up|1|||
170409509|NCT03734237|615840059|FG001|Overall Study|Lost to Follow-up|3|||
170409510|NCT03734237|615840060|FG002|Overall Study|Lost to Follow-up|0|||
170409511|NCT03734237|615840058|FG000|Overall Study|Withdrawal by Subject|7|||
170409512|NCT03734237|615840059|FG001|Overall Study|Withdrawal by Subject|9|||
170409513|NCT03734237|615840060|FG002|Overall Study|Withdrawal by Subject|10|||
170409514|NCT01844583|615840063|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
170409515|NCT01844583|615840064|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
170409516|NCT01625377|615840065|FG000|Overall Study|Death|1|||
170409517|NCT01625377|615840066|FG001|Overall Study|Death|1|||
170409518|NCT01625377|615840065|FG000|Overall Study|Administrative Problem|1|||
170762955|NCT05827926|617138750|FG022|Overall Study|Lost to Follow-up|1|||
170762956|NCT05827926|617138751|FG023|Overall Study|Lost to Follow-up|1|||
170409519|NCT01625377|615840066|FG001|Overall Study|Administrative Problem|1|||
170409520|NCT01625377|615840065|FG000|Overall Study|Protocol Violation|0|||
170409521|NCT01625377|615840066|FG001|Overall Study|Protocol Violation|3|||
170762957|NCT05827926|617138752|FG024|Overall Study|Lost to Follow-up|2|||
170762958|NCT05827926|617138753|FG025|Overall Study|Lost to Follow-up|1|||
170762959|NCT05827926|617138754|FG026|Overall Study|Lost to Follow-up|4|||
170762960|NCT05827926|617138755|FG027|Overall Study|Lost to Follow-up|1|||
170762961|NCT05827926|617138756|FG028|Overall Study|Lost to Follow-up|2|||
170762962|NCT05827926|617138757|FG029|Overall Study|Lost to Follow-up|1|||
170762963|NCT05827926|617138758|FG030|Overall Study|Lost to Follow-up|5|||
170762964|NCT05827926|617138759|FG031|Overall Study|Lost to Follow-up|0|||
170762965|NCT05827926|617138760|FG032|Overall Study|Lost to Follow-up|3|||
170762966|NCT05827926|617138761|FG033|Overall Study|Lost to Follow-up|2|||
170762967|NCT05827926|617138762|FG034|Overall Study|Lost to Follow-up|1|||
170762968|NCT05827926|617138763|FG035|Overall Study|Lost to Follow-up|3|||
170762969|NCT05827926|617138764|FG036|Overall Study|Lost to Follow-up|4|||
170762970|NCT05827926|617138728|FG000|Overall Study|Withdrawal by Subject|1|||
170762971|NCT05827926|617138729|FG001|Overall Study|Withdrawal by Subject|0|||
170762972|NCT05827926|617138730|FG002|Overall Study|Withdrawal by Subject|1|||
170762973|NCT05827926|617138731|FG003|Overall Study|Withdrawal by Subject|1|||
170762974|NCT05827926|617138732|FG004|Overall Study|Withdrawal by Subject|0|||
170762975|NCT05827926|617138733|FG005|Overall Study|Withdrawal by Subject|0|||
170762976|NCT05827926|617138734|FG006|Overall Study|Withdrawal by Subject|0|||
170762977|NCT05827926|617138735|FG007|Overall Study|Withdrawal by Subject|0|||
170762978|NCT05827926|617138736|FG008|Overall Study|Withdrawal by Subject|0|||
170762979|NCT05827926|617138737|FG009|Overall Study|Withdrawal by Subject|0|||
170762980|NCT05827926|617138738|FG010|Overall Study|Withdrawal by Subject|0|||
170762981|NCT05827926|617138739|FG011|Overall Study|Withdrawal by Subject|0|||
170762982|NCT05827926|617138740|FG012|Overall Study|Withdrawal by Subject|1|||
170762983|NCT05827926|617138741|FG013|Overall Study|Withdrawal by Subject|1|||
170762984|NCT05827926|617138742|FG014|Overall Study|Withdrawal by Subject|1|||
170762985|NCT05827926|617138743|FG015|Overall Study|Withdrawal by Subject|2|||
170762986|NCT05827926|617138744|FG016|Overall Study|Withdrawal by Subject|1|||
170762987|NCT05827926|617138745|FG017|Overall Study|Withdrawal by Subject|1|||
170762988|NCT05827926|617138746|FG018|Overall Study|Withdrawal by Subject|0|||
170762989|NCT05827926|617138747|FG019|Overall Study|Withdrawal by Subject|0|||
170762990|NCT05827926|617138748|FG020|Overall Study|Withdrawal by Subject|1|||
170762991|NCT05827926|617138749|FG021|Overall Study|Withdrawal by Subject|0|||
170762992|NCT05827926|617138750|FG022|Overall Study|Withdrawal by Subject|0|||
170762993|NCT05827926|617138751|FG023|Overall Study|Withdrawal by Subject|2|||
170867477|NCT01524133|617526599|FG000|Overall Study 52 Weeks|Physician Decision|1|||
170762994|NCT05827926|617138752|FG024|Overall Study|Withdrawal by Subject|1|||
170762995|NCT05827926|617138753|FG025|Overall Study|Withdrawal by Subject|0|||
170762996|NCT05827926|617138754|FG026|Overall Study|Withdrawal by Subject|0|||
170409522|NCT01625377|615840065|FG000|Overall Study|Adverse Event|3|||
170762997|NCT05827926|617138755|FG027|Overall Study|Withdrawal by Subject|1|||
170762998|NCT05827926|617138756|FG028|Overall Study|Withdrawal by Subject|0|||
170762999|NCT05827926|617138757|FG029|Overall Study|Withdrawal by Subject|0|||
170763000|NCT05827926|617138758|FG030|Overall Study|Withdrawal by Subject|0|||
170409523|NCT01625377|615840066|FG001|Overall Study|Adverse Event|16|||
170409524|NCT01625377|615840065|FG000|Overall Study|Graft loss|1|||
170409525|NCT01625377|615840066|FG001|Overall Study|Graft loss|0|||
170409526|NCT01625377|615840065|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170409527|NCT01625377|615840066|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170409528|NCT01625377|615840065|FG000|Overall Study|Abnormal laboratory values|1|||
170409529|NCT01625377|615840066|FG001|Overall Study|Abnormal laboratory values|0|||
170409530|NCT00294723|615840069|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
170409531|NCT00294723|615840070|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
170409532|NCT00294723|615840071|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
170409533|NCT00294723|615840069|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
170409534|NCT00294723|615840070|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
170409535|NCT00294723|615840071|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
170409536|NCT00294723|615840069|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
170409537|NCT00294723|615840070|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
170409538|NCT00294723|615840071|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
170409539|NCT00294723|615840069|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
170409540|NCT00294723|615840070|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
170409541|NCT00294723|615840071|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
170409542|NCT00294723|615840069|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
170409543|NCT00294723|615840070|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
170409544|NCT00294723|615840071|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
170409545|NCT00294723|615840069|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
170409546|NCT00294723|615840070|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
170409547|NCT00294723|615840071|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
170409548|NCT00294723|615840069|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
170409549|NCT00294723|615840070|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
170409550|NCT00294723|615840071|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
170409551|NCT00294723|615840069|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
170409552|NCT00294723|615840070|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
170409553|NCT00294723|615840071|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
170409554|NCT00294723|615840069|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
170409555|NCT00294723|615840070|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
170409556|NCT00294723|615840071|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
170409557|NCT00294723|615840069|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
170409558|NCT00294723|615840070|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
170409559|NCT00294723|615840071|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
170409560|NCT00294723|615840069|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
170409561|NCT00294723|615840070|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
170409562|NCT00294723|615840071|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
170409563|NCT00294723|615840069|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
170409564|NCT00294723|615840070|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
170409565|NCT00294723|615840071|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
170409566|NCT02043366|615840072|FG000|Overall Study|Lost to Follow-up|2|||
170409567|NCT02043366|615840073|FG001|Overall Study|Lost to Follow-up|2|||
170409568|NCT02043366|615840074|FG002|Overall Study|Lost to Follow-up|2|||
170409569|NCT02043366|615840075|FG003|Overall Study|Lost to Follow-up|2|||
170763001|NCT05827926|617138759|FG031|Overall Study|Withdrawal by Subject|2|||
170763002|NCT05827926|617138760|FG032|Overall Study|Withdrawal by Subject|0|||
170763003|NCT05827926|617138761|FG033|Overall Study|Withdrawal by Subject|0|||
170763004|NCT05827926|617138762|FG034|Overall Study|Withdrawal by Subject|0|||
170763005|NCT05827926|617138763|FG035|Overall Study|Withdrawal by Subject|0|||
170763006|NCT05827926|617138764|FG036|Overall Study|Withdrawal by Subject|1|||
170763007|NCT05827926|617138728|FG000|Overall Study|Other Than Specified|0|||
170763008|NCT05827926|617138729|FG001|Overall Study|Other Than Specified|0|||
170763009|NCT05827926|617138730|FG002|Overall Study|Other Than Specified|0|||
170763010|NCT05827926|617138731|FG003|Overall Study|Other Than Specified|1|||
170763011|NCT05827926|617138732|FG004|Overall Study|Other Than Specified|0|||
170763012|NCT05827926|617138733|FG005|Overall Study|Other Than Specified|0|||
170763013|NCT05827926|617138734|FG006|Overall Study|Other Than Specified|1|||
170763014|NCT05827926|617138735|FG007|Overall Study|Other Than Specified|0|||
170763015|NCT05827926|617138736|FG008|Overall Study|Other Than Specified|0|||
170763016|NCT05827926|617138737|FG009|Overall Study|Other Than Specified|0|||
170763017|NCT05827926|617138738|FG010|Overall Study|Other Than Specified|0|||
170763018|NCT05827926|617138739|FG011|Overall Study|Other Than Specified|0|||
170763019|NCT05827926|617138740|FG012|Overall Study|Other Than Specified|0|||
170409570|NCT02043366|615840076|FG004|Overall Study|Lost to Follow-up|2|||
170409571|NCT02043366|615840077|FG005|Overall Study|Lost to Follow-up|2|||
170409572|NCT00958256|615840081|FG000|Overall Study|Adverse Event|3|||
170409573|NCT01090765|615840084|FG000|Overall Study|Patient withdrew consent|0|||
170763020|NCT05827926|617138741|FG013|Overall Study|Other Than Specified|1|||
170763021|NCT05827926|617138742|FG014|Overall Study|Other Than Specified|0|||
170763022|NCT05827926|617138743|FG015|Overall Study|Other Than Specified|1|||
170409574|NCT01090765|615840085|FG001|Overall Study|Patient withdrew consent|0|||
170409575|NCT01090765|615840086|FG002|Overall Study|Patient withdrew consent|0|||
170409576|NCT01090765|615840087|FG003|Overall Study|Patient withdrew consent|0|||
170409577|NCT01090765|615840088|FG004|Overall Study|Patient withdrew consent|1|||
170409578|NCT01090765|615840089|FG005|Overall Study|Patient withdrew consent|1|||
170409579|NCT01090765|615840084|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
170409580|NCT01090765|615840085|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
170409581|NCT01090765|615840086|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
170409582|NCT01090765|615840087|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
170409583|NCT01090765|615840088|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
170409584|NCT01090765|615840089|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
170409585|NCT01090765|615840084|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
170409586|NCT01090765|615840085|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
170409587|NCT01090765|615840086|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
170409588|NCT01090765|615840087|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
170409589|NCT01090765|615840088|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
170409590|NCT01090765|615840089|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
170409591|NCT01977092|615840090|FG000|Overall Study|Death|3|||
170409592|NCT01977092|615840091|FG001|Overall Study|Death|4|||
170409593|NCT01977092|615840090|FG000|Overall Study|Lost to Follow-up|23|||
170409594|NCT01977092|615840091|FG001|Overall Study|Lost to Follow-up|14|||
170409595|NCT01977092|615840090|FG000|Overall Study|Withdrawal by Subject|2|||
170409596|NCT01977092|615840091|FG001|Overall Study|Withdrawal by Subject|1|||
170409597|NCT01977092|615840090|FG000|Overall Study|In prison|3|||
170409598|NCT01977092|615840091|FG001|Overall Study|In prison|11|||
170409599|NCT03341507|615840092|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
170409600|NCT00989261|615840099|FG000|Overall Study|Still in follow up|12|||
170409601|NCT00989261|615840100|FG001|Overall Study|Still in follow up|21|||
170409602|NCT00989261|615840099|FG000|Overall Study|Withdrawal by Subject|0|||
170409603|NCT00989261|615840100|FG001|Overall Study|Withdrawal by Subject|1|||
170409604|NCT00989261|615840099|FG000|Overall Study|Lost to Follow-up|3|||
170409605|NCT00989261|615840100|FG001|Overall Study|Lost to Follow-up|0|||
170409606|NCT02927847|615840101|FG000|Overall Study|Lost to Follow-up|1|||
170409607|NCT02927847|615840102|FG001|Overall Study|Lost to Follow-up|0|||
170409608|NCT02927847|615840101|FG000|Overall Study|Withdrawal by Subject|4|||
170409609|NCT02927847|615840102|FG001|Overall Study|Withdrawal by Subject|2|||
170409610|NCT02927847|615840101|FG000|Overall Study|PI withdrawn due to missed visits|1|||
170409611|NCT02927847|615840102|FG001|Overall Study|PI withdrawn due to missed visits|1|||
170409612|NCT00718159|615840103|FG000|Overall Study|Progressive Disease|3|||
170409613|NCT00718159|615840104|FG001|Overall Study|Progressive Disease|3|||
170409614|NCT00718159|615840105|FG002|Overall Study|Progressive Disease|2|||
170409615|NCT00718159|615840106|FG003|Overall Study|Progressive Disease|0|||
170409616|NCT00718159|615840107|FG004|Overall Study|Progressive Disease|6|||
170409617|NCT00718159|615840108|FG005|Overall Study|Progressive Disease|0|||
170409618|NCT00718159|615840109|FG006|Overall Study|Progressive Disease|0|||
170409619|NCT00718159|615840103|FG000|Overall Study|Death due to Adverse Event|0|||
170409620|NCT00718159|615840104|FG001|Overall Study|Death due to Adverse Event|0|||
170409621|NCT00718159|615840105|FG002|Overall Study|Death due to Adverse Event|0|||
170763023|NCT05827926|617138744|FG016|Overall Study|Other Than Specified|0|||
170763024|NCT05827926|617138745|FG017|Overall Study|Other Than Specified|0|||
170763025|NCT05827926|617138746|FG018|Overall Study|Other Than Specified|0|||
170763026|NCT05827926|617138747|FG019|Overall Study|Other Than Specified|0|||
170763027|NCT05827926|617138748|FG020|Overall Study|Other Than Specified|0|||
170763028|NCT05827926|617138749|FG021|Overall Study|Other Than Specified|1|||
170763029|NCT05827926|617138750|FG022|Overall Study|Other Than Specified|1|||
170763030|NCT05827926|617138751|FG023|Overall Study|Other Than Specified|0|||
170763031|NCT05827926|617138752|FG024|Overall Study|Other Than Specified|0|||
170763032|NCT05827926|617138753|FG025|Overall Study|Other Than Specified|1|||
170763033|NCT05827926|617138754|FG026|Overall Study|Other Than Specified|0|||
170763034|NCT05827926|617138755|FG027|Overall Study|Other Than Specified|0|||
170763035|NCT05827926|617138756|FG028|Overall Study|Other Than Specified|0|||
170763036|NCT05827926|617138757|FG029|Overall Study|Other Than Specified|0|||
170763037|NCT05827926|617138758|FG030|Overall Study|Other Than Specified|0|||
170763038|NCT05827926|617138759|FG031|Overall Study|Other Than Specified|1|||
170763039|NCT05827926|617138760|FG032|Overall Study|Other Than Specified|0|||
170763040|NCT05827926|617138761|FG033|Overall Study|Other Than Specified|0|||
170763041|NCT05827926|617138762|FG034|Overall Study|Other Than Specified|0|||
170763042|NCT05827926|617138763|FG035|Overall Study|Other Than Specified|0|||
170409622|NCT00718159|615840106|FG003|Overall Study|Death due to Adverse Event|2|||
170409623|NCT00718159|615840107|FG004|Overall Study|Death due to Adverse Event|2|||
170409624|NCT00718159|615840108|FG005|Overall Study|Death due to Adverse Event|0|||
170409625|NCT00718159|615840109|FG006|Overall Study|Death due to Adverse Event|0|||
170409626|NCT00718159|615840103|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
170409627|NCT00718159|615840104|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
170409628|NCT00718159|615840105|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
170409629|NCT00718159|615840106|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
170409630|NCT00718159|615840107|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
170409631|NCT00718159|615840108|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
170409632|NCT00718159|615840109|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
170409633|NCT00718159|615840103|FG000|Overall Study|Investigator Decision|0|||
170409634|NCT00718159|615840104|FG001|Overall Study|Investigator Decision|0|||
170409635|NCT00718159|615840105|FG002|Overall Study|Investigator Decision|0|||
170409636|NCT00718159|615840106|FG003|Overall Study|Investigator Decision|0|||
170867478|NCT01524133|617526600|FG001|Overall Study 52 Weeks|Physician Decision|0|||
170867479|NCT01524133|617526601|FG002|Overall Study 52 Weeks|Physician Decision|2|||
170867480|NCT01524133|617526599|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
170867481|NCT01524133|617526600|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
170867482|NCT01524133|617526601|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
170867483|NCT01087957|617526602|FG000|Overall Study|Death|2|||
170867484|NCT01087957|617526603|FG001|Overall Study|Death|2|||
170867485|NCT01087957|617526602|FG000|Overall Study|Lost to Follow-up|3|||
170867486|NCT01087957|617526603|FG001|Overall Study|Lost to Follow-up|4|||
170867487|NCT01087957|617526602|FG000|Overall Study|Protocol Violation|13|||
170867488|NCT01087957|617526603|FG001|Overall Study|Protocol Violation|25|||
170867489|NCT01087957|617526602|FG000|Overall Study|Withdrawal by Subject|18|||
170867490|NCT01087957|617526603|FG001|Overall Study|Withdrawal by Subject|15|||
170867491|NCT01087957|617526602|FG000|Overall Study|Physician Decision|5|||
170867492|NCT01087957|617526603|FG001|Overall Study|Physician Decision|9|||
170867493|NCT02366728|617526604|FG000|Overall Study|Death|0|||
170867494|NCT02366728|617526605|FG001|Overall Study|Death|0|||
170867495|NCT02366728|617526606|FG002|Overall Study|Death|1|||
170867496|NCT02366728|617526604|FG000|Overall Study|Adverse Event|1|||
170867497|NCT02366728|617526605|FG001|Overall Study|Adverse Event|0|||
170867498|NCT02366728|617526606|FG002|Overall Study|Adverse Event|0|||
170867499|NCT02366728|617526604|FG000|Overall Study|Screen Failure|2|||
170867500|NCT02366728|617526605|FG001|Overall Study|Screen Failure|1|||
170867501|NCT02366728|617526606|FG002|Overall Study|Screen Failure|0|||
170867502|NCT02366728|617526604|FG000|Overall Study|Only yielded 2 vaccines|1|||
170867503|NCT02366728|617526605|FG001|Overall Study|Only yielded 2 vaccines|0|||
170867504|NCT02366728|617526606|FG002|Overall Study|Only yielded 2 vaccines|0|||
170867505|NCT00059839|617526612|FG000|Overall Study|Death|1|||
170867506|NCT00059839|617526613|FG001|Overall Study|Death|1|||
170867507|NCT00059839|617526612|FG000|Overall Study|Lack of Efficacy|6|||
170867508|NCT00059839|617526613|FG001|Overall Study|Lack of Efficacy|5|||
170867509|NCT00059839|617526612|FG000|Overall Study|Lost to Follow-up|2|||
170867510|NCT00059839|617526613|FG001|Overall Study|Lost to Follow-up|0|||
170867511|NCT00059839|617526612|FG000|Overall Study|Physician Decision|1|||
170867512|NCT00059839|617526613|FG001|Overall Study|Physician Decision|2|||
170867513|NCT00059839|617526612|FG000|Overall Study|Withdrawal by Subject|1|||
170867514|NCT00059839|617526613|FG001|Overall Study|Withdrawal by Subject|6|||
170867515|NCT00059839|617526612|FG000|Overall Study|Ineligible|1|||
170867516|NCT00059839|617526613|FG001|Overall Study|Ineligible|3|||
170867517|NCT01054144|617526623|FG000|Overall Study|Death|2|||
170867518|NCT01026142|617526627|FG000|Overall Study|Death|136|||
170763043|NCT05827926|617138764|FG036|Overall Study|Other Than Specified|0|||
170763044|NCT05827926|617138728|FG000|Overall Study|Physician Decision|0|||
170763045|NCT05827926|617138729|FG001|Overall Study|Physician Decision|0|||
170763046|NCT05827926|617138730|FG002|Overall Study|Physician Decision|0|||
170867519|NCT01026142|617526628|FG001|Overall Study|Death|134|||
170763047|NCT05827926|617138731|FG003|Overall Study|Physician Decision|0|||
170763048|NCT05827926|617138732|FG004|Overall Study|Physician Decision|0|||
170763049|NCT05827926|617138733|FG005|Overall Study|Physician Decision|0|||
170763050|NCT05827926|617138734|FG006|Overall Study|Physician Decision|0|||
170763051|NCT05827926|617138735|FG007|Overall Study|Physician Decision|0|||
170763052|NCT05827926|617138736|FG008|Overall Study|Physician Decision|0|||
170763053|NCT05827926|617138737|FG009|Overall Study|Physician Decision|0|||
170763054|NCT05827926|617138738|FG010|Overall Study|Physician Decision|0|||
170763055|NCT05827926|617138739|FG011|Overall Study|Physician Decision|0|||
170763056|NCT05827926|617138740|FG012|Overall Study|Physician Decision|0|||
170867520|NCT01026142|617526627|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
170867521|NCT01026142|617526628|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
170867522|NCT01019317|617526632|FG000|Overall Study|Not Eligible|4|||
170867523|NCT00728481|617526633|FG000|Overall Study|Withdrawal by Subject|0|||
170867524|NCT00728481|617526634|FG001|Overall Study|Withdrawal by Subject|1|||
170867525|NCT00728481|617526633|FG000|Overall Study|Adverse Event|0|||
170867526|NCT00728481|617526634|FG001|Overall Study|Adverse Event|1|||
170867527|NCT00728481|617526633|FG000|Overall Study|Study medication non-compliance|0|||
170409637|NCT00718159|615840107|FG004|Overall Study|Investigator Decision|0|||
170763057|NCT05827926|617138741|FG013|Overall Study|Physician Decision|0|||
170763058|NCT05827926|617138742|FG014|Overall Study|Physician Decision|0|||
170763059|NCT05827926|617138743|FG015|Overall Study|Physician Decision|0|||
170763060|NCT05827926|617138744|FG016|Overall Study|Physician Decision|0|||
170867528|NCT00728481|617526634|FG001|Overall Study|Study medication non-compliance|2|||
170867529|NCT00728481|617526633|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
170867530|NCT00728481|617526634|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
170763061|NCT05827926|617138745|FG017|Overall Study|Physician Decision|0|||
170763062|NCT05827926|617138746|FG018|Overall Study|Physician Decision|1|||
170763063|NCT05827926|617138747|FG019|Overall Study|Physician Decision|0|||
170763064|NCT05827926|617138748|FG020|Overall Study|Physician Decision|0|||
170763065|NCT05827926|617138749|FG021|Overall Study|Physician Decision|0|||
170763066|NCT05827926|617138750|FG022|Overall Study|Physician Decision|0|||
170763067|NCT05827926|617138751|FG023|Overall Study|Physician Decision|0|||
170763068|NCT05827926|617138752|FG024|Overall Study|Physician Decision|0|||
170763069|NCT05827926|617138753|FG025|Overall Study|Physician Decision|0|||
170763070|NCT05827926|617138754|FG026|Overall Study|Physician Decision|0|||
170763071|NCT05827926|617138755|FG027|Overall Study|Physician Decision|0|||
170763072|NCT05827926|617138756|FG028|Overall Study|Physician Decision|0|||
170763073|NCT05827926|617138757|FG029|Overall Study|Physician Decision|0|||
170763074|NCT05827926|617138758|FG030|Overall Study|Physician Decision|0|||
170763075|NCT05827926|617138759|FG031|Overall Study|Physician Decision|0|||
170763076|NCT05827926|617138760|FG032|Overall Study|Physician Decision|0|||
170763077|NCT05827926|617138761|FG033|Overall Study|Physician Decision|0|||
170763078|NCT05827926|617138762|FG034|Overall Study|Physician Decision|0|||
170763079|NCT05827926|617138763|FG035|Overall Study|Physician Decision|0|||
170763080|NCT05827926|617138764|FG036|Overall Study|Physician Decision|0|||
170763081|NCT00798096|617138765|FG000|Overall Study|Ongoing|2|||
170763082|NCT02873754|617138769|FG000|Overall Study|Lost to Follow-up|5|||
170763083|NCT02873754|617138769|FG000|Overall Study|Couldn't complete study procedures|1|||
170763084|NCT03247543|617138770|FG000|Overall Study|Adverse Event|3|||
170763085|NCT03247543|617138771|FG001|Overall Study|Adverse Event|6|||
170763086|NCT03247543|617138772|FG002|Overall Study|Adverse Event|4|||
170763087|NCT03247543|617138770|FG000|Overall Study|Lost to Follow-up|10|||
170763088|NCT03247543|617138771|FG001|Overall Study|Lost to Follow-up|7|||
170409638|NCT00718159|615840108|FG005|Overall Study|Investigator Decision|1|||
170409639|NCT00718159|615840109|FG006|Overall Study|Investigator Decision|1|||
170409640|NCT01238848|615840111|FG000|Overall Study|Physician Decision|13|||
170409641|NCT01238848|615840112|FG001|Overall Study|Physician Decision|5|||
170409642|NCT02907203|615840122|FG000|Overall Study|Death|1|||
170763089|NCT03247543|617138772|FG002|Overall Study|Lost to Follow-up|8|||
170763090|NCT03247543|617138770|FG000|Overall Study|Consent withdrawn by caregiver|2|||
170763091|NCT03247543|617138771|FG001|Overall Study|Consent withdrawn by caregiver|2|||
170763092|NCT03247543|617138772|FG002|Overall Study|Consent withdrawn by caregiver|9|||
170763093|NCT03247543|617138770|FG000|Overall Study|Withdrawal by Subject|0|||
170763094|NCT03247543|617138771|FG001|Overall Study|Withdrawal by Subject|0|||
170763095|NCT03247543|617138772|FG002|Overall Study|Withdrawal by Subject|1|||
170763096|NCT03247543|617138770|FG000|Overall Study|Failure to Follow study procedures|1|||
170763097|NCT03247543|617138771|FG001|Overall Study|Failure to Follow study procedures|3|||
170763098|NCT03247543|617138772|FG002|Overall Study|Failure to Follow study procedures|1|||
170763099|NCT03247543|617138770|FG000|Overall Study|Lack of Efficacy|1|||
170763100|NCT03247543|617138771|FG001|Overall Study|Lack of Efficacy|0|||
170763101|NCT03247543|617138772|FG002|Overall Study|Lack of Efficacy|0|||
170763102|NCT03247543|617138770|FG000|Overall Study|Non-compliance with study visits|0|||
170763103|NCT03247543|617138771|FG001|Overall Study|Non-compliance with study visits|1|||
170763104|NCT03247543|617138772|FG002|Overall Study|Non-compliance with study visits|0|||
170763105|NCT02059980|617138779|FG000|Overall Study|Lost to Follow-up|2|||
170763106|NCT02059980|617138780|FG001|Overall Study|Lost to Follow-up|1|||
170763107|NCT01321606|617138781|FG000|Overall Study|Lost to Follow-up|0|||
170763108|NCT01321606|617138782|FG001|Overall Study|Lost to Follow-up|0|||
170763109|NCT01321606|617138783|FG002|Overall Study|Lost to Follow-up|0|||
170763110|NCT01321606|617138784|FG003|Overall Study|Lost to Follow-up|1|||
170763111|NCT01582945|617138787|FG000|Overall Study|Intolerable side-effects|1|||
170763112|NCT01582945|617138787|FG000|Overall Study|Scheduling conflicts|1|||
170409643|NCT02907203|615840122|FG000|Overall Study|Lost to Follow-up|3|||
170409644|NCT02907203|615840122|FG000|Overall Study|Withdrawal by Subject|3|||
170409645|NCT02907203|615840122|FG000|Overall Study|Surgical bypass|1|||
170409646|NCT01783730|615840123|FG000|Overall Study|Failed to meet inclusion criteria|6|||
170409647|NCT00871169|615840124|FG000|Overall Study|Protocol Violation|1|||
170409648|NCT00871169|615840124|FG000|Overall Study|Patient did not receive study treatment|2|||
170409649|NCT00252187|615840125|FG000|Overall Study|Adverse Event|3|||
170409650|NCT00252187|615840126|FG001|Overall Study|Adverse Event|1|||
170409651|NCT00252187|615840125|FG000|Overall Study|Withdrawal by Subject|1|||
170409652|NCT00252187|615840126|FG001|Overall Study|Withdrawal by Subject|0|||
170409653|NCT01752920|615840129|FG000|Overall Study|Adverse Event|1|||
170409654|NCT01752920|615840130|FG001|Overall Study|Adverse Event|0|||
170409655|NCT01752920|615840131|FG002|Overall Study|Adverse Event|5|||
170409656|NCT01752920|615840132|FG003|Overall Study|Adverse Event|10|||
170409657|NCT01752920|615840129|FG000|Overall Study|Clinical Disease Progression|6|||
170519783|NCT01610037|616247638|FG001|Treatment and Follow up Period|Administrative problems|3|||
170763113|NCT01726023|617138790|FG000|Overall Study|Death|1|||
170763114|NCT01726023|617138791|FG001|Overall Study|Death|1|||
170763115|NCT01726023|617138790|FG000|Overall Study|Lost to Follow-up|5|||
170763116|NCT01726023|617138791|FG001|Overall Study|Lost to Follow-up|10|||
170763117|NCT01726023|617138790|FG000|Overall Study|Other Eligibility criteria|7|||
170867531|NCT03690141|617526635|FG000|Overall Study|Adverse Event|5|||
170867532|NCT03690141|617526635|FG000|Overall Study|Withdrawal by Subject|3|||
170867533|NCT03690141|617526635|FG000|Overall Study|Physician Decision|4|||
170867534|NCT03690141|617526635|FG000|Overall Study|Disease progression|4|||
170867535|NCT00778622|617526636|FG000|Overall Study|Adverse Event|5|||
170867536|NCT00778622|617526637|FG001|Overall Study|Adverse Event|4|||
170867537|NCT00778622|617526638|FG002|Overall Study|Adverse Event|7|||
170867538|NCT00778622|617526636|FG000|Overall Study|Withdrawal by Subject|4|||
170867539|NCT00778622|617526637|FG001|Overall Study|Withdrawal by Subject|5|||
170867540|NCT00778622|617526638|FG002|Overall Study|Withdrawal by Subject|5|||
170867541|NCT00778622|617526636|FG000|Overall Study|Lost to Follow-up|3|||
170867542|NCT00778622|617526637|FG001|Overall Study|Lost to Follow-up|3|||
170867543|NCT00778622|617526638|FG002|Overall Study|Lost to Follow-up|2|||
170867544|NCT00778622|617526636|FG000|Overall Study|Protocol Violation|0|||
170867545|NCT00778622|617526637|FG001|Overall Study|Protocol Violation|3|||
170867546|NCT00778622|617526638|FG002|Overall Study|Protocol Violation|0|||
170867547|NCT00778622|617526636|FG000|Overall Study|Lack of Efficacy|2|||
170867548|NCT00778622|617526637|FG001|Overall Study|Lack of Efficacy|0|||
170867549|NCT00778622|617526638|FG002|Overall Study|Lack of Efficacy|0|||
170867550|NCT00778622|617526636|FG000|Overall Study|immigration|1|||
170867551|NCT00778622|617526637|FG001|Overall Study|immigration|0|||
170867552|NCT00778622|617526638|FG002|Overall Study|immigration|0|||
170867553|NCT00778622|617526636|FG000|Overall Study|Other|1|||
170867554|NCT00778622|617526637|FG001|Overall Study|Other|0|||
170867555|NCT00778622|617526638|FG002|Overall Study|Other|1|||
170867556|NCT01505010|617526639|FG000|Overall Study|Protocol Violation|0|||
170867557|NCT01505010|617526640|FG001|Overall Study|Protocol Violation|1|||
170867558|NCT01505010|617526639|FG000|Overall Study|Lost to Follow-up|0|||
170867559|NCT01505010|617526640|FG001|Overall Study|Lost to Follow-up|1|||
170867560|NCT04744285|617526641|FG000|Overall Study|Withdrawal by Subject|1|||
170867561|NCT04744285|617526642|FG001|Overall Study|Withdrawal by Subject|1|||
170867562|NCT04744285|617526643|FG002|Overall Study|Withdrawal by Subject|2|||
170867563|NCT04744285|617526644|FG003|Overall Study|Withdrawal by Subject|1|||
170867564|NCT01968070|617526650|FG000|Period 1|Withdrawal by Subject|0|||
170867565|NCT01968070|617526651|FG001|Period 1|Withdrawal by Subject|1|||
170867566|NCT01968070|617526652|FG002|Period 1|Withdrawal by Subject|0|||
170867567|NCT01968070|617526653|FG003|Period 1|Withdrawal by Subject|0|||
170867568|NCT01968070|617526654|FG004|Period 1|Withdrawal by Subject|0|||
170867569|NCT01968070|617526655|FG005|Period 1|Withdrawal by Subject|0|||
170867570|NCT01968070|617526656|FG006|Period 1|Withdrawal by Subject|1|||
170867571|NCT01968070|617526657|FG007|Period 1|Withdrawal by Subject|0|||
170867572|NCT01968070|617526658|FG008|Period 1|Withdrawal by Subject|0|||
170867573|NCT01968070|617526659|FG009|Period 1|Withdrawal by Subject|0|||
170867574|NCT01968070|617526660|FG010|Period 1|Withdrawal by Subject|0|||
170867575|NCT01968070|617526661|FG011|Period 1|Withdrawal by Subject|0|||
170867576|NCT01968070|617526662|FG012|Period 1|Withdrawal by Subject|0|||
170763118|NCT01726023|617138791|FG001|Overall Study|Other Eligibility criteria|7|||
170763119|NCT01726023|617138790|FG000|Overall Study|Withdrawal by Subject|16|||
170763120|NCT01726023|617138791|FG001|Overall Study|Withdrawal by Subject|8|||
170763121|NCT03394027|617138792|FG000|Overall Study|Ineligible|3|||
170763122|NCT03394027|617138793|FG001|Overall Study|Ineligible|1|||
170763123|NCT03394027|617138794|FG002|Overall Study|Ineligible|3|||
170763124|NCT03394027|617138792|FG000|Overall Study|Participant declined to participate before treatment started|0|||
170763125|NCT03394027|617138793|FG001|Overall Study|Participant declined to participate before treatment started|0|||
170763126|NCT03394027|617138794|FG002|Overall Study|Participant declined to participate before treatment started|1|||
170763127|NCT03473743|617138797|FG000|Overall Study|Withdrawal by Subject|0|||
170763128|NCT03473743|617138798|FG001|Overall Study|Withdrawal by Subject|0|||
170763129|NCT03473743|617138799|FG002|Overall Study|Withdrawal by Subject|0|||
170763130|NCT03473743|617138800|FG003|Overall Study|Withdrawal by Subject|0|||
170763131|NCT03473743|617138801|FG004|Overall Study|Withdrawal by Subject|0|||
170763132|NCT03473743|617138802|FG005|Overall Study|Withdrawal by Subject|0|||
170763133|NCT03473743|617138803|FG006|Overall Study|Withdrawal by Subject|0|||
170763134|NCT03473743|617138804|FG007|Overall Study|Withdrawal by Subject|3|||
170763135|NCT03473743|617138797|FG000|Overall Study|Other|0|||
170763136|NCT03473743|617138798|FG001|Overall Study|Other|0|||
170763137|NCT03473743|617138799|FG002|Overall Study|Other|0|||
170763138|NCT03473743|617138800|FG003|Overall Study|Other|1|||
170763139|NCT03473743|617138801|FG004|Overall Study|Other|0|||
170763140|NCT03473743|617138802|FG005|Overall Study|Other|0|||
170763141|NCT03473743|617138803|FG006|Overall Study|Other|0|||
170763142|NCT03473743|617138804|FG007|Overall Study|Other|0|||
170763143|NCT03473743|617138797|FG000|Overall Study|Ongoing|0|||
170763144|NCT03473743|617138798|FG001|Overall Study|Ongoing|0|||
170763145|NCT03473743|617138799|FG002|Overall Study|Ongoing|6|||
170763146|NCT03473743|617138800|FG003|Overall Study|Ongoing|8|||
170763147|NCT03473743|617138801|FG004|Overall Study|Ongoing|1|||
170763148|NCT03473743|617138802|FG005|Overall Study|Ongoing|1|||
170867577|NCT01968070|617526663|FG013|Period 1|Withdrawal by Subject|0|||
170867578|NCT01968070|617526664|FG014|Period 1|Withdrawal by Subject|0|||
170867579|NCT01968070|617526665|FG015|Period 1|Withdrawal by Subject|1|||
170867580|NCT01968070|617526666|FG016|Period 1|Withdrawal by Subject|0|||
170763149|NCT03473743|617138803|FG006|Overall Study|Ongoing|22|||
170763150|NCT03473743|617138804|FG007|Overall Study|Ongoing|24|||
170763151|NCT03473743|617138797|FG000|Overall Study|Randomized but not treated|0|||
170763152|NCT03473743|617138798|FG001|Overall Study|Randomized but not treated|0|||
170763153|NCT03473743|617138799|FG002|Overall Study|Randomized but not treated|0|||
170763154|NCT03473743|617138800|FG003|Overall Study|Randomized but not treated|0|||
170763155|NCT03473743|617138801|FG004|Overall Study|Randomized but not treated|0|||
170867581|NCT01968070|617526667|FG017|Period 1|Withdrawal by Subject|0|||
170867582|NCT01968070|617526650|FG000|Period 1|Protocol Violation|0|||
170867583|NCT01968070|617526651|FG001|Period 1|Protocol Violation|0|||
170867584|NCT01968070|617526652|FG002|Period 1|Protocol Violation|0|||
170867585|NCT01968070|617526653|FG003|Period 1|Protocol Violation|1|||
170763156|NCT03473743|617138802|FG005|Overall Study|Randomized but not treated|0|||
170763157|NCT03473743|617138803|FG006|Overall Study|Randomized but not treated|1|||
170867586|NCT01968070|617526654|FG004|Period 1|Protocol Violation|1|||
170867587|NCT01968070|617526655|FG005|Period 1|Protocol Violation|0|||
170867588|NCT01968070|617526656|FG006|Period 1|Protocol Violation|0|||
170867589|NCT01968070|617526657|FG007|Period 1|Protocol Violation|0|||
170867590|NCT01968070|617526658|FG008|Period 1|Protocol Violation|0|||
170867591|NCT01968070|617526659|FG009|Period 1|Protocol Violation|0|||
170867592|NCT01968070|617526660|FG010|Period 1|Protocol Violation|0|||
170867593|NCT01968070|617526661|FG011|Period 1|Protocol Violation|0|||
170763158|NCT03473743|617138804|FG007|Overall Study|Randomized but not treated|1|||
170763159|NCT04536077|617138810|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
170763160|NCT04536077|617138811|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
170763161|NCT04536077|617138810|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
170763162|NCT04536077|617138811|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
170763163|NCT01467427|617138814|FG000|Overall Study|Withdrawal by Subject|1|||
170763164|NCT01467427|617138815|FG001|Overall Study|Withdrawal by Subject|0|||
170763165|NCT01467427|617138814|FG000|Overall Study|Not continuing in extension phase|0|||
170763166|NCT01467427|617138815|FG001|Overall Study|Not continuing in extension phase|2|||
170763167|NCT01467427|617138814|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
170763168|NCT01467427|617138815|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
170763169|NCT01467427|617138814|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
170763170|NCT01467427|617138815|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
170763171|NCT01467427|617138814|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
170763172|NCT01467427|617138815|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
170763173|NCT01467427|617138814|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
170763174|NCT01467427|617138815|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
170763175|NCT03805295|617138816|FG000|Overall Study|Lost to Follow-up|17|||
170763176|NCT03805295|617138817|FG001|Overall Study|Lost to Follow-up|43|||
170763177|NCT04269200|617138818|FG000|Global Cohort|Death|72|||
170763178|NCT04269200|617138819|FG001|Global Cohort|Death|54|||
170763179|NCT04269200|617138820|FG002|Global Cohort|Death|49|||
170763180|NCT04269200|617138818|FG000|Global Cohort|Lost to Follow-up|0|||
170763181|NCT04269200|617138819|FG001|Global Cohort|Lost to Follow-up|0|||
170763182|NCT04269200|617138820|FG002|Global Cohort|Lost to Follow-up|2|||
170763183|NCT04269200|617138818|FG000|Global Cohort|Withdrawal by Subject|22|||
170763184|NCT04269200|617138819|FG001|Global Cohort|Withdrawal by Subject|25|||
170763185|NCT04269200|617138820|FG002|Global Cohort|Withdrawal by Subject|18|||
170763186|NCT04269200|617138818|FG000|China Cohort|Death|12|||
170763187|NCT04269200|617138819|FG001|China Cohort|Death|11|||
170763188|NCT04269200|617138820|FG002|China Cohort|Death|13|||
170763189|NCT04269200|617138818|FG000|China Cohort|Lost to Follow-up|0|||
170763190|NCT04269200|617138819|FG001|China Cohort|Lost to Follow-up|1|||
170763191|NCT04269200|617138820|FG002|China Cohort|Lost to Follow-up|1|||
170763192|NCT04269200|617138818|FG000|China Cohort|Withdrawal by Subject|2|||
170763193|NCT04269200|617138819|FG001|China Cohort|Withdrawal by Subject|2|||
170763194|NCT04269200|617138820|FG002|China Cohort|Withdrawal by Subject|4|||
170763195|NCT03331250|617138821|FG000|Overall Study|Withdrawal by Subject|1|||
170763196|NCT05824351|617138826|FG000|Overall Study|Adverse Event|6|||
170763197|NCT02357784|617138827|FG000|Overall Study|Withdrawal by Subject|1|||
170763198|NCT02137850|617138830|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
170763199|NCT02137850|617138831|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
170763200|NCT02137850|617138832|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
170763201|NCT02137850|617138830|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
170763202|NCT02137850|617138831|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
170763203|NCT02137850|617138832|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
170763204|NCT02137850|617138830|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
170763205|NCT02137850|617138831|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
170763206|NCT02137850|617138832|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
170763207|NCT02137850|617138830|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
170763208|NCT02137850|617138831|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
170763209|NCT02137850|617138832|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
170763210|NCT02137850|617138830|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
170763211|NCT02137850|617138831|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
170763212|NCT02137850|617138832|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
170763213|NCT02137850|617138830|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
170763214|NCT02137850|617138831|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
170867594|NCT01968070|617526662|FG012|Period 1|Protocol Violation|0|||
170763215|NCT02137850|617138832|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
170763216|NCT02137850|617138830|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
170763217|NCT02137850|617138831|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
170867595|NCT01968070|617526663|FG013|Period 1|Protocol Violation|0|||
170867596|NCT01968070|617526664|FG014|Period 1|Protocol Violation|0|||
170763218|NCT02137850|617138832|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
170763219|NCT02137850|617138830|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
170763220|NCT02137850|617138831|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
170867597|NCT01968070|617526665|FG015|Period 1|Protocol Violation|0|||
170763221|NCT02137850|617138832|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
170763222|NCT02137850|617138830|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
170763223|NCT02137850|617138831|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
170763224|NCT02137850|617138832|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
170763225|NCT02137850|617138830|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
170763226|NCT02137850|617138831|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
170763227|NCT02137850|617138832|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
170763228|NCT02137850|617138830|FG000|Main Phase: Prophylaxis|Other|0|||
170763229|NCT02137850|617138831|FG001|Main Phase: Prophylaxis|Other|1|||
170763230|NCT02137850|617138832|FG002|Main Phase: Prophylaxis|Other|0|||
170763231|NCT02137850|617138830|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
170763232|NCT02137850|617138831|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
170763233|NCT02137850|617138832|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
170763234|NCT02137850|617138830|FG000|Main Phase: Prophylaxis|Early site closure|0|||
170763235|NCT02137850|617138831|FG001|Main Phase: Prophylaxis|Early site closure|2|||
170763236|NCT02137850|617138832|FG002|Main Phase: Prophylaxis|Early site closure|0|||
170763237|NCT02137850|617138830|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
170763238|NCT02137850|617138831|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
170763239|NCT02137850|617138832|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
170763240|NCT02137850|617138830|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
170763241|NCT02137850|617138831|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
170763242|NCT02137850|617138832|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
170763243|NCT02137850|617138830|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
170763244|NCT02137850|617138831|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
170409658|NCT01752920|615840130|FG001|Overall Study|Clinical Disease Progression|4|||
170409659|NCT01752920|615840131|FG002|Overall Study|Clinical Disease Progression|1|||
170409660|NCT01752920|615840132|FG003|Overall Study|Clinical Disease Progression|13|||
170763245|NCT02137850|617138832|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
170763246|NCT02137850|617138830|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
170763247|NCT02137850|617138831|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
170763248|NCT02137850|617138832|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
170763249|NCT02137850|617138830|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
170763250|NCT02137850|617138831|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
170763251|NCT02137850|617138832|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
170763252|NCT02137850|617138830|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
170763253|NCT02137850|617138831|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
170763254|NCT02137850|617138832|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
170763255|NCT02137850|617138830|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
170763256|NCT02137850|617138831|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
170763257|NCT02137850|617138832|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
170763258|NCT02137850|617138830|FG000|Extension Phase: Prophylaxis|Other|0|||
170763259|NCT02137850|617138831|FG001|Extension Phase: Prophylaxis|Other|1|||
170763260|NCT02137850|617138832|FG002|Extension Phase: Prophylaxis|Other|0|||
170763261|NCT02137850|617138830|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
170763262|NCT02137850|617138831|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
170763263|NCT02137850|617138832|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
170763264|NCT03681678|617138833|FG000|Overall Study|Lost to Follow-up|20|||
170763265|NCT00828945|617138836|FG000|Overall Study|Death|4|||
170763266|NCT00828945|617138836|FG000|Overall Study|Participant was missing|1|||
170763267|NCT00828945|617138836|FG000|Overall Study|Other|36|||
170763268|NCT03431350|617138837|FG000|Overall Study|ONGOING|0|||
170763269|NCT03431350|617138838|FG001|Overall Study|ONGOING|0|||
170763270|NCT03431350|617138839|FG002|Overall Study|ONGOING|2|||
170763271|NCT03431350|617138840|FG003|Overall Study|ONGOING|0|||
170763272|NCT03431350|617138841|FG004|Overall Study|ONGOING|1|||
170763273|NCT03431350|617138842|FG005|Overall Study|ONGOING|3|||
170763274|NCT03431350|617138843|FG006|Overall Study|ONGOING|0|||
170763275|NCT03431350|617138844|FG007|Overall Study|ONGOING|1|||
170763276|NCT03431350|617138845|FG008|Overall Study|ONGOING|3|||
170763277|NCT03431350|617138846|FG009|Overall Study|ONGOING|4|||
170763278|NCT03431350|617138847|FG010|Overall Study|ONGOING|2|||
170763279|NCT03431350|617138848|FG011|Overall Study|ONGOING|1|||
170763280|NCT03431350|617138837|FG000|Overall Study|Death|6|||
170763281|NCT03431350|617138838|FG001|Overall Study|Death|5|||
170763282|NCT03431350|617138839|FG002|Overall Study|Death|18|||
170763283|NCT03431350|617138840|FG003|Overall Study|Death|7|||
170763284|NCT03431350|617138841|FG004|Overall Study|Death|4|||
170763285|NCT03431350|617138842|FG005|Overall Study|Death|3|||
170763286|NCT03431350|617138843|FG006|Overall Study|Death|2|||
170763287|NCT03431350|617138844|FG007|Overall Study|Death|0|||
170763288|NCT03431350|617138845|FG008|Overall Study|Death|0|||
170763289|NCT03431350|617138846|FG009|Overall Study|Death|0|||
170763290|NCT03431350|617138847|FG010|Overall Study|Death|4|||
170763291|NCT03431350|617138848|FG011|Overall Study|Death|0|||
170763292|NCT03431350|617138837|FG000|Overall Study|Lost to Follow-up|0|||
170763293|NCT03431350|617138838|FG001|Overall Study|Lost to Follow-up|1|||
170409661|NCT01752920|615840129|FG000|Overall Study|Physician Decision|1|||
170409662|NCT01752920|615840130|FG001|Overall Study|Physician Decision|0|||
170409663|NCT01752920|615840131|FG002|Overall Study|Physician Decision|0|||
170409664|NCT01752920|615840132|FG003|Overall Study|Physician Decision|3|||
170409665|NCT01752920|615840129|FG000|Overall Study|Radiographic Disease Progression|20|||
170409666|NCT01752920|615840130|FG001|Overall Study|Radiographic Disease Progression|7|||
170763294|NCT03431350|617138839|FG002|Overall Study|Lost to Follow-up|0|||
170763295|NCT03431350|617138840|FG003|Overall Study|Lost to Follow-up|0|||
170763296|NCT03431350|617138841|FG004|Overall Study|Lost to Follow-up|0|||
170763297|NCT03431350|617138842|FG005|Overall Study|Lost to Follow-up|0|||
170763298|NCT03431350|617138843|FG006|Overall Study|Lost to Follow-up|0|||
170763299|NCT03431350|617138844|FG007|Overall Study|Lost to Follow-up|0|||
170763300|NCT03431350|617138845|FG008|Overall Study|Lost to Follow-up|0|||
170763301|NCT03431350|617138846|FG009|Overall Study|Lost to Follow-up|0|||
170763302|NCT03431350|617138847|FG010|Overall Study|Lost to Follow-up|0|||
170763303|NCT03431350|617138848|FG011|Overall Study|Lost to Follow-up|0|||
170763304|NCT03431350|617138837|FG000|Overall Study|Withdrawal by Subject|0|||
170763305|NCT03431350|617138838|FG001|Overall Study|Withdrawal by Subject|0|||
170763306|NCT03431350|617138839|FG002|Overall Study|Withdrawal by Subject|0|||
170763307|NCT03431350|617138840|FG003|Overall Study|Withdrawal by Subject|1|||
170763308|NCT03431350|617138841|FG004|Overall Study|Withdrawal by Subject|1|||
170763309|NCT03431350|617138842|FG005|Overall Study|Withdrawal by Subject|1|||
170763310|NCT03431350|617138843|FG006|Overall Study|Withdrawal by Subject|0|||
170763311|NCT03431350|617138844|FG007|Overall Study|Withdrawal by Subject|0|||
170763312|NCT03431350|617138845|FG008|Overall Study|Withdrawal by Subject|0|||
170763313|NCT03431350|617138846|FG009|Overall Study|Withdrawal by Subject|2|||
170763314|NCT03431350|617138847|FG010|Overall Study|Withdrawal by Subject|0|||
170763315|NCT03431350|617138848|FG011|Overall Study|Withdrawal by Subject|1|||
170763316|NCT03431350|617138837|FG000|Overall Study|Other|0|||
170763317|NCT03431350|617138838|FG001|Overall Study|Other|0|||
170763318|NCT03431350|617138839|FG002|Overall Study|Other|1|||
170763319|NCT03431350|617138840|FG003|Overall Study|Other|3|||
170763320|NCT03431350|617138841|FG004|Overall Study|Other|2|||
170763321|NCT03431350|617138842|FG005|Overall Study|Other|2|||
170763322|NCT03431350|617138843|FG006|Overall Study|Other|4|||
170763323|NCT03431350|617138844|FG007|Overall Study|Other|0|||
170763324|NCT03431350|617138845|FG008|Overall Study|Other|14|||
170763325|NCT03431350|617138846|FG009|Overall Study|Other|11|||
170763326|NCT03431350|617138847|FG010|Overall Study|Other|11|||
170763327|NCT03431350|617138848|FG011|Overall Study|Other|15|||
170763328|NCT02141074|617138849|FG000|Pre-prophylaxis|Adverse Event|3|||
170763329|NCT02141074|617138850|FG001|Pre-prophylaxis|Adverse Event|0|||
170763330|NCT02141074|617138849|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
170763331|NCT02141074|617138850|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
170763332|NCT02141074|617138849|FG000|Prophylaxis|Adverse Event|0|||
170763333|NCT02141074|617138850|FG001|Prophylaxis|Adverse Event|4|||
170763334|NCT02141074|617138849|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
170763335|NCT02141074|617138850|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
170763336|NCT02141074|617138849|FG000|Prophylaxis|Withdrawal by Subject|0|||
170763337|NCT02141074|617138850|FG001|Prophylaxis|Withdrawal by Subject|1|||
170763338|NCT03563053|617138851|FG000|Overall Study|Withdrawal by Subject|17|||
170763339|NCT03563053|617138851|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
170763340|NCT03563053|617138851|FG000|Overall Study|Adverse Event|3|||
170763341|NCT03563053|617138851|FG000|Overall Study|Physician Decision|1|||
170763342|NCT03563053|617138851|FG000|Overall Study|study terminated by sponsor|71|||
170763343|NCT03536884|617138852|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
170763344|NCT03536884|617138853|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
170763345|NCT03536884|617138854|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763346|NCT03536884|617138855|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763347|NCT03536884|617138856|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763348|NCT03536884|617138857|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763349|NCT03536884|617138858|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763350|NCT03536884|617138859|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763351|NCT03536884|617138860|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763352|NCT03536884|617138861|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763353|NCT03536884|617138862|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763354|NCT03536884|617138863|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
170763355|NCT03536884|617138852|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763356|NCT03536884|617138853|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
170763357|NCT03536884|617138854|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763358|NCT03536884|617138855|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170409667|NCT01752920|615840131|FG002|Overall Study|Radiographic Disease Progression|12|||
170763359|NCT03536884|617138856|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763360|NCT03536884|617138857|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763361|NCT03536884|617138858|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763362|NCT03536884|617138859|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763363|NCT03536884|617138860|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763364|NCT03536884|617138861|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763365|NCT03536884|617138862|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763366|NCT03536884|617138863|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
170763367|NCT03536884|617138852|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
170763368|NCT03536884|617138853|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
170763369|NCT03536884|617138854|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763370|NCT03536884|617138855|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763371|NCT03536884|617138856|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763372|NCT03536884|617138857|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763373|NCT03536884|617138858|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763374|NCT03536884|617138859|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763375|NCT03536884|617138860|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763376|NCT03536884|617138861|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763377|NCT03536884|617138862|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763378|NCT03536884|617138863|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
170763379|NCT03536884|617138852|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763380|NCT03536884|617138853|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
170763381|NCT03536884|617138854|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763382|NCT03536884|617138855|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763383|NCT03536884|617138856|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763384|NCT03536884|617138857|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763385|NCT03536884|617138858|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763386|NCT03536884|617138859|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763387|NCT03536884|617138860|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763388|NCT03536884|617138861|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763389|NCT03536884|617138862|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763390|NCT03536884|617138863|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
170763391|NCT03536884|617138852|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763392|NCT03536884|617138853|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
170763393|NCT03536884|617138854|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763394|NCT03536884|617138855|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763395|NCT03536884|617138856|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763396|NCT03536884|617138857|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763397|NCT03536884|617138858|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763398|NCT03536884|617138859|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763399|NCT03536884|617138860|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763400|NCT03536884|617138861|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763401|NCT03536884|617138862|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763402|NCT03536884|617138863|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
170763403|NCT03536884|617138852|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763404|NCT03536884|617138853|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
170763405|NCT03536884|617138854|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763406|NCT03536884|617138855|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763407|NCT03536884|617138856|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763408|NCT03536884|617138857|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763409|NCT03536884|617138858|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763410|NCT03536884|617138859|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763411|NCT03536884|617138860|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763412|NCT03536884|617138861|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763413|NCT03536884|617138862|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763414|NCT03536884|617138863|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
170763415|NCT03536884|617138852|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763416|NCT03536884|617138853|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763417|NCT03536884|617138854|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
170763418|NCT03536884|617138855|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763419|NCT03536884|617138856|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
170867598|NCT01968070|617526666|FG016|Period 1|Protocol Violation|0|||
170867599|NCT01968070|617526667|FG017|Period 1|Protocol Violation|0|||
170763420|NCT03536884|617138857|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763421|NCT03536884|617138858|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763422|NCT03536884|617138859|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763423|NCT03536884|617138860|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763424|NCT03536884|617138861|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763425|NCT03536884|617138862|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763426|NCT03536884|617138863|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
170763427|NCT03536884|617138852|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763428|NCT03536884|617138853|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763429|NCT03536884|617138854|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
170763430|NCT03536884|617138855|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
170763431|NCT03536884|617138856|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
170763432|NCT03536884|617138857|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763433|NCT03536884|617138858|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763434|NCT03536884|617138859|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763435|NCT03536884|617138860|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763436|NCT03536884|617138861|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763437|NCT03536884|617138862|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763438|NCT03536884|617138863|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
170763439|NCT03536884|617138852|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763440|NCT03536884|617138853|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763441|NCT03536884|617138854|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763442|NCT03536884|617138855|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
170763443|NCT03536884|617138856|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
170763444|NCT03536884|617138857|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763445|NCT03536884|617138858|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763446|NCT03536884|617138859|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763447|NCT03536884|617138860|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763448|NCT03536884|617138861|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763449|NCT03536884|617138862|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763450|NCT03536884|617138863|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
170763451|NCT03536884|617138852|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763452|NCT03536884|617138853|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763453|NCT03536884|617138854|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
170763454|NCT03536884|617138855|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
170763455|NCT03536884|617138856|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
170763456|NCT03536884|617138857|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763457|NCT03536884|617138858|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763458|NCT03536884|617138859|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763459|NCT03536884|617138860|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763460|NCT03536884|617138861|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763461|NCT03536884|617138862|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763462|NCT03536884|617138863|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
170763463|NCT03536884|617138852|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763464|NCT03536884|617138853|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763465|NCT03536884|617138854|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
170763466|NCT03536884|617138855|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
170763467|NCT03536884|617138856|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
170763468|NCT03536884|617138857|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763469|NCT03536884|617138858|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763470|NCT03536884|617138859|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763471|NCT03536884|617138860|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763472|NCT03536884|617138861|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763473|NCT03536884|617138862|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763474|NCT03536884|617138863|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
170763475|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
170763476|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
170763477|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
170763478|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
170763479|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
170763480|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
170763481|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
170763482|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
170763483|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
170763484|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
170763485|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
170763486|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
170763487|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
170763488|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
170763489|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
170763490|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
170763491|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
170763492|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
170763493|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
170763494|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
170763495|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
170763496|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
170763497|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
170763498|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
170763499|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763500|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763501|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763502|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763503|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763504|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
170763505|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763506|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
170763507|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763508|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763509|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763510|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
170763511|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763512|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763513|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763514|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763515|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763516|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
170763517|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763518|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
170763519|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
170763520|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763521|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763522|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
170763523|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
170763524|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
170763525|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
170763526|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
170763527|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
170763528|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
170763529|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
170763530|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
170763531|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
170763532|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
170763533|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
170763534|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
170763535|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763536|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763537|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763538|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763539|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763540|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
170763541|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763542|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763543|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763544|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763545|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763546|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
170763547|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763548|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763549|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763550|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763551|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763552|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763553|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
170763554|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763555|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763556|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763557|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763558|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
170763559|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763560|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763561|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763562|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763563|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763564|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763565|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
170763566|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763567|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763568|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170867600|NCT01968070|617526650|FG000|Period 1|Lost to Follow-up|0|||
170867601|NCT01968070|617526651|FG001|Period 1|Lost to Follow-up|0|||
170867602|NCT01968070|617526652|FG002|Period 1|Lost to Follow-up|0|||
170763569|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763570|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
170763571|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763572|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763573|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763574|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763575|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763576|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
170763577|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763578|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
170867603|NCT01968070|617526653|FG003|Period 1|Lost to Follow-up|1|||
170867604|NCT01968070|617526654|FG004|Period 1|Lost to Follow-up|0|||
170867605|NCT01968070|617526655|FG005|Period 1|Lost to Follow-up|0|||
170867606|NCT01968070|617526656|FG006|Period 1|Lost to Follow-up|0|||
170867607|NCT01968070|617526657|FG007|Period 1|Lost to Follow-up|0|||
170867608|NCT01968070|617526658|FG008|Period 1|Lost to Follow-up|0|||
170867609|NCT01968070|617526659|FG009|Period 1|Lost to Follow-up|0|||
170867610|NCT01968070|617526660|FG010|Period 1|Lost to Follow-up|0|||
170867611|NCT01968070|617526661|FG011|Period 1|Lost to Follow-up|0|||
170867612|NCT01968070|617526662|FG012|Period 1|Lost to Follow-up|0|||
170867613|NCT01968070|617526663|FG013|Period 1|Lost to Follow-up|0|||
170867614|NCT01968070|617526664|FG014|Period 1|Lost to Follow-up|0|||
170867615|NCT01968070|617526665|FG015|Period 1|Lost to Follow-up|0|||
170867616|NCT01968070|617526666|FG016|Period 1|Lost to Follow-up|0|||
170867617|NCT01968070|617526667|FG017|Period 1|Lost to Follow-up|0|||
170867618|NCT01968070|617526650|FG000|Period 1|Adverse Event|0|||
170867619|NCT01968070|617526651|FG001|Period 1|Adverse Event|0|||
170867620|NCT01968070|617526652|FG002|Period 1|Adverse Event|0|||
170867621|NCT01968070|617526653|FG003|Period 1|Adverse Event|0|||
170867622|NCT01968070|617526654|FG004|Period 1|Adverse Event|0|||
170867623|NCT01968070|617526655|FG005|Period 1|Adverse Event|0|||
170867624|NCT01968070|617526656|FG006|Period 1|Adverse Event|1|||
170867625|NCT01968070|617526657|FG007|Period 1|Adverse Event|0|||
170867626|NCT01968070|617526658|FG008|Period 1|Adverse Event|0|||
170867627|NCT01968070|617526659|FG009|Period 1|Adverse Event|0|||
170867628|NCT01968070|617526660|FG010|Period 1|Adverse Event|0|||
170867629|NCT01968070|617526661|FG011|Period 1|Adverse Event|0|||
170867630|NCT01968070|617526662|FG012|Period 1|Adverse Event|0|||
170867631|NCT01968070|617526663|FG013|Period 1|Adverse Event|0|||
170867632|NCT01968070|617526664|FG014|Period 1|Adverse Event|0|||
170867633|NCT01968070|617526665|FG015|Period 1|Adverse Event|0|||
170867634|NCT01968070|617526666|FG016|Period 1|Adverse Event|0|||
170867635|NCT01968070|617526667|FG017|Period 1|Adverse Event|0|||
170867636|NCT01968070|617526650|FG000|Period 1|Physician Decision|0|||
170867637|NCT01968070|617526651|FG001|Period 1|Physician Decision|0|||
170867638|NCT01968070|617526652|FG002|Period 1|Physician Decision|0|||
170867639|NCT01968070|617526653|FG003|Period 1|Physician Decision|0|||
170867640|NCT01968070|617526654|FG004|Period 1|Physician Decision|0|||
170867641|NCT01968070|617526655|FG005|Period 1|Physician Decision|0|||
170867642|NCT01968070|617526656|FG006|Period 1|Physician Decision|0|||
170867643|NCT01968070|617526657|FG007|Period 1|Physician Decision|0|||
170409668|NCT01752920|615840132|FG003|Overall Study|Radiographic Disease Progression|29|||
170409669|NCT01752920|615840129|FG000|Overall Study|Study Terminated by Sponsor|0|||
170409670|NCT01752920|615840130|FG001|Overall Study|Study Terminated by Sponsor|0|||
170867644|NCT01968070|617526658|FG008|Period 1|Physician Decision|0|||
170867645|NCT01968070|617526659|FG009|Period 1|Physician Decision|0|||
170867646|NCT01968070|617526660|FG010|Period 1|Physician Decision|0|||
170409671|NCT01752920|615840131|FG002|Overall Study|Study Terminated by Sponsor|0|||
170409672|NCT01752920|615840132|FG003|Overall Study|Study Terminated by Sponsor|1|||
170409673|NCT01752920|615840129|FG000|Overall Study|Withdrawal by Subject|0|||
170867647|NCT01968070|617526661|FG011|Period 1|Physician Decision|1|||
170409674|NCT01752920|615840130|FG001|Overall Study|Withdrawal by Subject|1|||
170409675|NCT01752920|615840131|FG002|Overall Study|Withdrawal by Subject|0|||
170409676|NCT01752920|615840132|FG003|Overall Study|Withdrawal by Subject|1|||
170409677|NCT01752920|615840129|FG000|Overall Study|Lack of clinical benefit|1|||
170409678|NCT01752920|615840130|FG001|Overall Study|Lack of clinical benefit|1|||
170409679|NCT01752920|615840131|FG002|Overall Study|Lack of clinical benefit|1|||
170409680|NCT01752920|615840132|FG003|Overall Study|Lack of clinical benefit|1|||
170409681|NCT01738581|615840133|FG000|Overall Study|Lost to Follow-up|1|||
170409682|NCT01738581|615840134|FG001|Overall Study|Lost to Follow-up|0|||
170409683|NCT03940586|615840141|FG000|Overall Study|Death|3|||
170409684|NCT03940586|615840142|FG001|Overall Study|Death|2|||
170763579|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763580|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763581|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763582|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
170763583|NCT03536884|617138852|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763584|NCT03536884|617138853|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763585|NCT03536884|617138854|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763586|NCT03536884|617138855|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763587|NCT03536884|617138856|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763588|NCT03536884|617138857|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763589|NCT03536884|617138858|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763590|NCT03536884|617138859|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763591|NCT03536884|617138860|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
170763592|NCT03536884|617138861|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763593|NCT03536884|617138862|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763594|NCT03536884|617138863|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
170763595|NCT03536884|617138852|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763596|NCT03536884|617138853|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763597|NCT03536884|617138854|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763598|NCT03536884|617138855|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763599|NCT03536884|617138856|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763600|NCT03536884|617138857|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763601|NCT03536884|617138858|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763602|NCT03536884|617138859|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763603|NCT03536884|617138860|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170763604|NCT03536884|617138861|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
170763605|NCT03536884|617138862|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
170763606|NCT03536884|617138863|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
170763607|NCT03536884|617138852|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170763608|NCT03536884|617138853|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170763609|NCT03536884|617138854|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170763610|NCT03536884|617138855|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170763611|NCT03536884|617138856|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170763612|NCT03536884|617138857|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170763613|NCT03536884|617138858|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170763614|NCT03536884|617138859|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170409685|NCT03940586|615840143|FG002|Overall Study|Death|0|||
170409686|NCT03940586|615840141|FG000|Overall Study|Physician Decision|1|||
170409687|NCT03940586|615840142|FG001|Overall Study|Physician Decision|0|||
170409688|NCT03940586|615840143|FG002|Overall Study|Physician Decision|1|||
170409689|NCT03940586|615840141|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
170409690|NCT03940586|615840142|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
170409691|NCT03940586|615840143|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
170409692|NCT03940586|615840141|FG000|Overall Study|Not Treated|0|||
170409693|NCT03940586|615840142|FG001|Overall Study|Not Treated|2|||
170409694|NCT03940586|615840143|FG002|Overall Study|Not Treated|0|||
170409695|NCT00771901|615840144|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
170409696|NCT00771901|615840145|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
170409697|NCT00771901|615840146|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
170409698|NCT01086215|615840147|FG000|Overall Study|Death|14|||
170409699|NCT01086215|615840148|FG001|Overall Study|Death|8|||
170409700|NCT01086215|615840149|FG002|Overall Study|Death|8|||
170409701|NCT01086215|615840150|FG003|Overall Study|Death|1|||
170409702|NCT01086215|615840147|FG000|Overall Study|Lost to Follow-up|22|||
170409703|NCT01086215|615840148|FG001|Overall Study|Lost to Follow-up|39|||
170409704|NCT01086215|615840149|FG002|Overall Study|Lost to Follow-up|18|||
170409705|NCT01086215|615840150|FG003|Overall Study|Lost to Follow-up|2|||
170409706|NCT01121900|615840153|FG000|First Intervention Period|Adverse Event|1|||
170409707|NCT01121900|615840154|FG001|First Intervention Period|Adverse Event|1|||
170409708|NCT01121900|615840153|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
170409709|NCT01121900|615840154|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
170867648|NCT01968070|617526662|FG012|Period 1|Physician Decision|0|||
170867649|NCT01968070|617526663|FG013|Period 1|Physician Decision|0|||
170867650|NCT01968070|617526664|FG014|Period 1|Physician Decision|0|||
170867651|NCT01968070|617526665|FG015|Period 1|Physician Decision|0|||
170867652|NCT01968070|617526666|FG016|Period 1|Physician Decision|0|||
170867653|NCT01968070|617526667|FG017|Period 1|Physician Decision|0|||
170867654|NCT01968070|617526650|FG000|Period 2|Withdrawal by Subject|0|||
170867655|NCT01968070|617526651|FG001|Period 2|Withdrawal by Subject|0|||
170867656|NCT01968070|617526652|FG002|Period 2|Withdrawal by Subject|0|||
170867657|NCT01968070|617526653|FG003|Period 2|Withdrawal by Subject|0|||
170867658|NCT01968070|617526654|FG004|Period 2|Withdrawal by Subject|1|||
170867659|NCT01968070|617526655|FG005|Period 2|Withdrawal by Subject|0|||
170867660|NCT01968070|617526656|FG006|Period 2|Withdrawal by Subject|0|||
170867661|NCT01968070|617526657|FG007|Period 2|Withdrawal by Subject|0|||
170867662|NCT01968070|617526658|FG008|Period 2|Withdrawal by Subject|0|||
170867663|NCT01968070|617526659|FG009|Period 2|Withdrawal by Subject|0|||
170867664|NCT01968070|617526660|FG010|Period 2|Withdrawal by Subject|0|||
170867665|NCT01968070|617526661|FG011|Period 2|Withdrawal by Subject|0|||
170867666|NCT01968070|617526662|FG012|Period 2|Withdrawal by Subject|0|||
170867667|NCT01968070|617526663|FG013|Period 2|Withdrawal by Subject|0|||
170867668|NCT01968070|617526664|FG014|Period 2|Withdrawal by Subject|0|||
170867669|NCT01968070|617526665|FG015|Period 2|Withdrawal by Subject|0|||
170867670|NCT01968070|617526666|FG016|Period 2|Withdrawal by Subject|0|||
170867671|NCT01968070|617526667|FG017|Period 2|Withdrawal by Subject|0|||
170867672|NCT00639223|617526676|FG000|Overall Study|Lost to Follow-up|0|||
170867673|NCT00639223|617526677|FG001|Overall Study|Lost to Follow-up|2|||
170867674|NCT01130051|617526682|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
170867675|NCT01130051|617526683|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
170867676|NCT01130051|617526682|FG000|Washout Period of 14 Days|Protocol Violation|1|||
170763615|NCT03536884|617138860|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170763616|NCT03536884|617138861|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
170763617|NCT03536884|617138862|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
170763618|NCT03536884|617138863|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
170763619|NCT03536884|617138852|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763620|NCT03536884|617138853|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763621|NCT03536884|617138854|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763622|NCT03536884|617138855|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763623|NCT03536884|617138856|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763624|NCT03536884|617138857|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763625|NCT03536884|617138858|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763626|NCT03536884|617138859|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763627|NCT03536884|617138860|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763628|NCT03536884|617138861|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763629|NCT03536884|617138862|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
170763630|NCT03536884|617138863|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
170763631|NCT03536884|617138852|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763632|NCT03536884|617138853|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763633|NCT03536884|617138854|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763634|NCT03536884|617138855|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763635|NCT03536884|617138856|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763636|NCT03536884|617138857|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763637|NCT03536884|617138858|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763638|NCT03536884|617138859|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763639|NCT03536884|617138860|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763640|NCT03536884|617138861|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763641|NCT03536884|617138862|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
170763642|NCT03536884|617138863|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
170763643|NCT03536884|617138852|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170867677|NCT01130051|617526683|FG001|Washout Period of 14 Days|Protocol Violation|1|||
170867678|NCT01839487|617526684|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
170867679|NCT01839487|617526685|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
170867680|NCT01839487|617526686|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
170867681|NCT01839487|617526687|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
170867682|NCT01839487|617526688|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
170867683|NCT01839487|617526689|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
170867684|NCT01839487|617526684|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
170763644|NCT03536884|617138853|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763645|NCT03536884|617138854|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763646|NCT03536884|617138855|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763647|NCT03536884|617138856|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763648|NCT03536884|617138857|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763649|NCT03536884|617138858|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763650|NCT03536884|617138859|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763651|NCT03536884|617138860|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763652|NCT03536884|617138861|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763653|NCT03536884|617138862|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
170763654|NCT03536884|617138863|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
170763655|NCT03722446|617138864|FG000|Overall Study|Protocol Violation|15|||
170763656|NCT03722446|617138865|FG001|Overall Study|Protocol Violation|2|||
170763657|NCT01137292|617138866|FG000|Overall Study|Death|30|||
170763658|NCT01137292|617138866|FG000|Overall Study|Adverse Event|3|||
170763659|NCT01137292|617138866|FG000|Overall Study|Lack of Efficacy|13|||
170409710|NCT01328054|615840155|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
170409711|NCT01328054|615840156|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
170409712|NCT01328054|615840155|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
170409713|NCT01328054|615840156|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
170409714|NCT01328054|615840155|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
170409715|NCT01328054|615840156|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
170409716|NCT02472977|615840157|FG000|Overall Study|Disease progression|4|||
170409717|NCT02472977|615840158|FG001|Overall Study|Disease progression|25|||
170409718|NCT02472977|615840159|FG002|Overall Study|Disease progression|6|||
170409719|NCT02472977|615840157|FG000|Overall Study|Withdrawal by Subject|0|||
170409720|NCT02472977|615840158|FG001|Overall Study|Withdrawal by Subject|1|||
170409721|NCT02472977|615840159|FG002|Overall Study|Withdrawal by Subject|0|||
170409722|NCT02472977|615840157|FG000|Overall Study|Study drug toxicity|2|||
170409723|NCT02472977|615840158|FG001|Overall Study|Study drug toxicity|0|||
170409724|NCT02472977|615840159|FG002|Overall Study|Study drug toxicity|2|||
170409725|NCT02472977|615840157|FG000|Overall Study|Subject request to discontinue treatment|0|||
170409726|NCT02472977|615840158|FG001|Overall Study|Subject request to discontinue treatment|1|||
170409727|NCT02472977|615840159|FG002|Overall Study|Subject request to discontinue treatment|0|||
170409728|NCT00345683|615840160|FG000|Overall Study|Lost to Follow-up|19|||
170409729|NCT00345683|615840161|FG001|Overall Study|Lost to Follow-up|7|||
170409730|NCT00345683|615840160|FG000|Overall Study|Other|6|||
170409731|NCT00345683|615840161|FG001|Overall Study|Other|2|||
170409732|NCT00291330|615840162|FG000|Overall Study|Adverse Event|47|||
170409733|NCT00291330|615840163|FG001|Overall Study|Adverse Event|40|||
170409734|NCT00291330|615840162|FG000|Overall Study|Protocol Violation|13|||
170409735|NCT00291330|615840163|FG001|Overall Study|Protocol Violation|20|||
170409736|NCT00291330|615840162|FG000|Overall Study|Lost to Follow-up|16|||
170763660|NCT01137292|617138866|FG000|Overall Study|Lost to Follow-up|1|||
170763661|NCT01137292|617138866|FG000|Overall Study|Other|7|||
170763662|NCT01311713|617138867|FG000|Overall Study|Death|0|||
170763663|NCT01311713|617138868|FG001|Overall Study|Death|0|||
170763664|NCT01311713|617138869|FG002|Overall Study|Death|1|||
170763665|NCT01311713|617138870|FG003|Overall Study|Death|1|||
170763666|NCT01311713|617138871|FG004|Overall Study|Death|0|||
170763667|NCT01311713|617138872|FG005|Overall Study|Death|1|||
170763668|NCT01311713|617138873|FG006|Overall Study|Death|0|||
170763669|NCT01311713|617138867|FG000|Overall Study|Adverse Event|0|||
170763670|NCT01311713|617138868|FG001|Overall Study|Adverse Event|1|||
170763671|NCT01311713|617138869|FG002|Overall Study|Adverse Event|0|||
170763672|NCT01311713|617138870|FG003|Overall Study|Adverse Event|2|||
170763673|NCT01311713|617138871|FG004|Overall Study|Adverse Event|0|||
170763674|NCT01311713|617138872|FG005|Overall Study|Adverse Event|0|||
170763675|NCT01311713|617138873|FG006|Overall Study|Adverse Event|2|||
170763676|NCT01311713|617138867|FG000|Overall Study|Withdrawal by Subject|0|||
170763677|NCT01311713|617138868|FG001|Overall Study|Withdrawal by Subject|1|||
170763678|NCT01311713|617138869|FG002|Overall Study|Withdrawal by Subject|1|||
170763679|NCT01311713|617138870|FG003|Overall Study|Withdrawal by Subject|0|||
170763680|NCT01311713|617138871|FG004|Overall Study|Withdrawal by Subject|0|||
170763681|NCT01311713|617138872|FG005|Overall Study|Withdrawal by Subject|1|||
170763682|NCT01311713|617138873|FG006|Overall Study|Withdrawal by Subject|2|||
170763683|NCT01311713|617138867|FG000|Overall Study|Disease progression|3|||
170763684|NCT01311713|617138868|FG001|Overall Study|Disease progression|4|||
170763685|NCT01311713|617138869|FG002|Overall Study|Disease progression|3|||
170763686|NCT01311713|617138870|FG003|Overall Study|Disease progression|2|||
170763687|NCT01311713|617138871|FG004|Overall Study|Disease progression|4|||
170409737|NCT00291330|615840163|FG001|Overall Study|Lost to Follow-up|11|||
170409738|NCT00291330|615840162|FG000|Overall Study|Withdrawal by Subject|22|||
170763688|NCT01311713|617138872|FG005|Overall Study|Disease progression|4|||
170763689|NCT01311713|617138873|FG006|Overall Study|Disease progression|5|||
170763690|NCT01311713|617138867|FG000|Overall Study|Lost to Follow-up|0|||
170763691|NCT01311713|617138868|FG001|Overall Study|Lost to Follow-up|0|||
170763692|NCT01311713|617138869|FG002|Overall Study|Lost to Follow-up|1|||
170763693|NCT01311713|617138870|FG003|Overall Study|Lost to Follow-up|0|||
170763694|NCT01311713|617138871|FG004|Overall Study|Lost to Follow-up|0|||
170763695|NCT01311713|617138872|FG005|Overall Study|Lost to Follow-up|0|||
170763696|NCT01311713|617138873|FG006|Overall Study|Lost to Follow-up|0|||
170763697|NCT01311713|617138867|FG000|Overall Study|Stopped taking study medication|0|||
170763698|NCT01311713|617138868|FG001|Overall Study|Stopped taking study medication|0|||
170763699|NCT01311713|617138869|FG002|Overall Study|Stopped taking study medication|0|||
170763700|NCT01311713|617138870|FG003|Overall Study|Stopped taking study medication|1|||
170763701|NCT01311713|617138871|FG004|Overall Study|Stopped taking study medication|1|||
170763702|NCT01311713|617138872|FG005|Overall Study|Stopped taking study medication|0|||
170763703|NCT01311713|617138873|FG006|Overall Study|Stopped taking study medication|0|||
170763704|NCT01311713|617138867|FG000|Overall Study|Enrolled but not treated|0|||
170519784|NCT01610037|616247639|FG002|Treatment and Follow up Period|Administrative problems|2|||
170763705|NCT01311713|617138868|FG001|Overall Study|Enrolled but not treated|0|||
170763706|NCT01311713|617138869|FG002|Overall Study|Enrolled but not treated|1|||
170763707|NCT01311713|617138870|FG003|Overall Study|Enrolled but not treated|0|||
170763708|NCT01311713|617138871|FG004|Overall Study|Enrolled but not treated|0|||
170763709|NCT01311713|617138872|FG005|Overall Study|Enrolled but not treated|0|||
170763710|NCT01311713|617138873|FG006|Overall Study|Enrolled but not treated|0|||
170763711|NCT01311713|617138867|FG000|Overall Study|Other than specified|0|||
170763712|NCT01311713|617138868|FG001|Overall Study|Other than specified|1|||
170763713|NCT01311713|617138869|FG002|Overall Study|Other than specified|2|||
170763714|NCT01311713|617138870|FG003|Overall Study|Other than specified|0|||
170763715|NCT01311713|617138871|FG004|Overall Study|Other than specified|0|||
170763716|NCT01311713|617138872|FG005|Overall Study|Other than specified|0|||
170763717|NCT01311713|617138873|FG006|Overall Study|Other than specified|0|||
170763718|NCT05803720|617138875|FG000|Overall Study|Lost to Follow-up|3|||
170763719|NCT05803720|617138876|FG001|Overall Study|Lost to Follow-up|4|||
170763720|NCT05803720|617138875|FG000|Overall Study|Family leave/emergency|1|||
170763721|NCT05803720|617138876|FG001|Overall Study|Family leave/emergency|1|||
170763722|NCT01838200|617138877|FG000|Overall Study|Adverse Event|0|||
170763723|NCT01838200|617138878|FG001|Overall Study|Adverse Event|2|||
170763724|NCT01838200|617138877|FG000|Overall Study|Progressive disease|3|||
170763725|NCT01838200|617138878|FG001|Overall Study|Progressive disease|0|||
170763726|NCT00470626|617140218|FG000|Overall Study|Lost to Follow-up|10|||
170763727|NCT00470626|617140218|FG000|Overall Study|Withdrawal by Subject|7|||
170763728|NCT00777556|617140219|FG000|Overall Study|Inappropriate self-selection|34|||
170763729|NCT00777556|617140219|FG000|Overall Study|Dispensed but did not use product|12|||
170763730|NCT00777556|617140219|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
170763731|NCT00486759|617140220|FG000|Treatment|Adverse event/intercurrent illness|86|||
170763732|NCT00486759|617140221|FG001|Treatment|Adverse event/intercurrent illness|39|||
170763733|NCT00486759|617140220|FG000|Treatment|Insufficient therapeutic response|37|||
170763734|NCT00486759|617140221|FG001|Treatment|Insufficient therapeutic response|39|||
170763735|NCT00486759|617140220|FG000|Treatment|Death|17|||
170763736|NCT00486759|617140221|FG001|Treatment|Death|10|||
170763737|NCT00486759|617140220|FG000|Treatment|Withdrew consent|15|||
170763738|NCT00486759|617140221|FG001|Treatment|Withdrew consent|12|||
170763739|NCT00486759|617140220|FG000|Treatment|Administrative/reason not specified|17|||
170763740|NCT00486759|617140221|FG001|Treatment|Administrative/reason not specified|21|||
170763741|NCT00486759|617140220|FG000|Treatment|Refused treatment|10|||
170763742|NCT00486759|617140221|FG001|Treatment|Refused treatment|7|||
170763743|NCT00486759|617140220|FG000|Treatment|Violation of selection criteria at entry|3|||
170763744|NCT00486759|617140221|FG001|Treatment|Violation of selection criteria at entry|3|||
170763745|NCT00486759|617140220|FG000|Treatment|Other protocol violation|1|||
170763746|NCT00486759|617140221|FG001|Treatment|Other protocol violation|5|||
170763747|NCT00486759|617140220|FG000|Treatment|Failure to return|1|||
170763748|NCT00486759|617140221|FG001|Treatment|Failure to return|1|||
170763749|NCT00486759|617140220|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
170763750|NCT00486759|617140221|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
170763751|NCT00486759|617140220|FG000|Safety Follow-up|Death|40|||
170763752|NCT00486759|617140221|FG001|Safety Follow-up|Death|29|||
170763753|NCT00486759|617140220|FG000|Safety Follow-up|Withdrew consent|32|||
170763754|NCT00486759|617140221|FG001|Safety Follow-up|Withdrew consent|23|||
170763755|NCT00486759|617140220|FG000|Safety Follow-up|Failure to return|9|||
170763756|NCT00486759|617140221|FG001|Safety Follow-up|Failure to return|6|||
170763757|NCT00486759|617140220|FG000|Safety Follow-up|Administrative/not specified|8|||
170763758|NCT00486759|617140221|FG001|Safety Follow-up|Administrative/not specified|6|||
170763759|NCT00486759|617140220|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
170763760|NCT00486759|617140221|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
170763761|NCT00486759|617140220|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
170867685|NCT01839487|617526685|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
170867686|NCT01839487|617526686|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
170867687|NCT01839487|617526687|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
170867688|NCT01839487|617526688|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
170867689|NCT01839487|617526689|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
170867690|NCT01839487|617526684|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
170867691|NCT01839487|617526685|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
170867692|NCT01839487|617526686|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
170867693|NCT01839487|617526687|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
170519785|NCT01610037|616247637|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
170519786|NCT01610037|616247638|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
170519787|NCT01610037|616247639|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
170519788|NCT03804268|616247650|FG000|Overall Study|Adverse Event|2|||
170519789|NCT03804268|616247651|FG001|Overall Study|Adverse Event|2|||
170519790|NCT03804268|616247650|FG000|Overall Study|Withdrawal by Subject|2|||
170519791|NCT03804268|616247651|FG001|Overall Study|Withdrawal by Subject|0|||
170519792|NCT03804268|616247650|FG000|Overall Study|Lost to Follow-up|1|||
170867694|NCT01839487|617526688|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
170867695|NCT01839487|617526689|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
170867696|NCT01839487|617526684|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
170867697|NCT01839487|617526685|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
170867698|NCT01839487|617526686|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
170867699|NCT01839487|617526687|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
170867700|NCT01839487|617526688|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
170867701|NCT01839487|617526689|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
170867702|NCT01839487|617526684|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
170867703|NCT01839487|617526685|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
170867704|NCT01839487|617526686|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
170867705|NCT01839487|617526687|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
170867706|NCT01839487|617526688|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
170867707|NCT01839487|617526689|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
170867708|NCT01839487|617526684|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
170867709|NCT01839487|617526685|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
170867710|NCT01839487|617526686|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
170867711|NCT01839487|617526687|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
170867712|NCT01839487|617526688|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
170867713|NCT01839487|617526689|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
170867714|NCT01839487|617526684|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
170867715|NCT01839487|617526685|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
170867716|NCT01839487|617526686|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
170867717|NCT01839487|617526687|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
170867718|NCT01839487|617526688|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
170867719|NCT01839487|617526689|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
170867720|NCT01839487|617526684|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
170867721|NCT01839487|617526685|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
170867722|NCT01839487|617526686|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
170867723|NCT01839487|617526687|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
170867724|NCT01839487|617526688|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
170867725|NCT01839487|617526689|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
170867726|NCT01839487|617526684|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
170867727|NCT01839487|617526685|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
170867728|NCT01839487|617526686|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
170867729|NCT01839487|617526687|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
170867730|NCT01839487|617526688|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
170867731|NCT01839487|617526689|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
170519793|NCT03804268|616247651|FG001|Overall Study|Lost to Follow-up|0|||
170519794|NCT03804268|616247650|FG000|Overall Study|Physician Decision|2|||
170519795|NCT03804268|616247651|FG001|Overall Study|Physician Decision|0|||
170519796|NCT02989402|616247654|FG000|Overall Study|Adverse event, or serious adverse event|4|||
170519797|NCT02989402|616247654|FG000|Overall Study|Death|2|||
170519798|NCT02989402|616247654|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
170519799|NCT02989402|616247654|FG000|Overall Study|Lost to Follow-up|8|||
170519800|NCT02989402|616247654|FG000|Overall Study|Patient no longer on monotherapy|1|||
170519801|NCT02989402|616247654|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
170519802|NCT02989402|616247654|FG000|Overall Study|Withdrawal by Subject|7|||
170519803|NCT02989402|616247654|FG000|Overall Study|Other|2|||
170519804|NCT03066830|616247655|FG000|Overall Study|At the Participant's own Request|16|||
170867732|NCT02383589|617526691|FG000|Treatment Period|Adverse Event|1|||
170867733|NCT02383589|617526692|FG001|Treatment Period|Adverse Event|3|||
170867734|NCT02383589|617526691|FG000|Treatment Period|Lost to Follow-up|0|||
170867735|NCT02383589|617526692|FG001|Treatment Period|Lost to Follow-up|1|||
170867736|NCT02383589|617526691|FG000|Treatment Period|Withdrawal by Subject|0|||
170867737|NCT02383589|617526692|FG001|Treatment Period|Withdrawal by Subject|5|||
170867738|NCT02383589|617526691|FG000|Treatment Period|Non-compliance with study drug|0|||
170867739|NCT02383589|617526692|FG001|Treatment Period|Non-compliance with study drug|1|||
170867740|NCT02383589|617526691|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
170867741|NCT02383589|617526692|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
170867742|NCT02383589|617526691|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
170867743|NCT02383589|617526692|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
170867744|NCT02383589|617526691|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
170867745|NCT02383589|617526692|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
170867746|NCT04752475|617528181|FG000|Overall Study|Withdrawal by Subject|1|||
170867747|NCT04752475|617528182|FG001|Overall Study|Withdrawal by Subject|1|||
170409739|NCT00291330|615840163|FG001|Overall Study|Withdrawal by Subject|25|||
170763762|NCT00486759|617140221|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
170763763|NCT01185522|617140222|FG000|Overall Study|Lack of Efficacy|28|||
170763764|NCT01185522|617140222|FG000|Overall Study|Lost to Follow-up|19|||
170763765|NCT01185522|617140222|FG000|Overall Study|Withdrawal by Subject|10|||
170763766|NCT01185522|617140222|FG000|Overall Study|Poor tolerance|39|||
170763767|NCT01185522|617140222|FG000|Overall Study|Other reasons|12|||
170763768|NCT01729819|617140223|FG000|Overall Study|Adverse Event|2|||
170763769|NCT01729819|617140224|FG001|Overall Study|Adverse Event|4|||
170763770|NCT01729819|617140223|FG000|Overall Study|Lack of Efficacy|1|||
170763771|NCT01729819|617140224|FG001|Overall Study|Lack of Efficacy|0|||
170763772|NCT01729819|617140223|FG000|Overall Study|Lost to Follow-up|2|||
170763773|NCT01729819|617140224|FG001|Overall Study|Lost to Follow-up|0|||
170763774|NCT01729819|617140223|FG000|Overall Study|Other reason|1|||
170763775|NCT01729819|617140224|FG001|Overall Study|Other reason|0|||
170763776|NCT01729819|617140223|FG000|Overall Study|Protocol Violation|0|||
170763777|NCT01729819|617140224|FG001|Overall Study|Protocol Violation|1|||
170763778|NCT01729819|617140223|FG000|Overall Study|Withdrawal by Subject|0|||
170763779|NCT01729819|617140224|FG001|Overall Study|Withdrawal by Subject|2|||
170763780|NCT02962674|617140227|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
170763781|NCT00771667|617140229|FG000|Induction Phase|Adverse Event|5|||
170763782|NCT00771667|617140230|FG001|Induction Phase|Adverse Event|2|||
170763783|NCT00771667|617140231|FG002|Induction Phase|Adverse Event|4|||
170763784|NCT00771667|617140232|FG003|Induction Phase|Adverse Event|1|||
170763785|NCT00771667|617140233|FG004|Induction Phase|Adverse Event|0|||
170763786|NCT00771667|617140234|FG005|Induction Phase|Adverse Event|0|||
170763787|NCT00771667|617140235|FG006|Induction Phase|Adverse Event|0|||
170763788|NCT00771667|617140236|FG007|Induction Phase|Adverse Event|0|||
170763789|NCT00771667|617140237|FG008|Induction Phase|Adverse Event|0|||
170763790|NCT00771667|617140238|FG009|Induction Phase|Adverse Event|0|||
170763791|NCT00771667|617140229|FG000|Induction Phase|Lack of Efficacy|9|||
170763792|NCT00771667|617140230|FG001|Induction Phase|Lack of Efficacy|2|||
170763793|NCT00771667|617140231|FG002|Induction Phase|Lack of Efficacy|4|||
170763794|NCT00771667|617140232|FG003|Induction Phase|Lack of Efficacy|3|||
170763795|NCT00771667|617140233|FG004|Induction Phase|Lack of Efficacy|0|||
170763796|NCT00771667|617140234|FG005|Induction Phase|Lack of Efficacy|0|||
170763797|NCT00771667|617140235|FG006|Induction Phase|Lack of Efficacy|0|||
170763798|NCT00771667|617140236|FG007|Induction Phase|Lack of Efficacy|0|||
170763799|NCT00771667|617140237|FG008|Induction Phase|Lack of Efficacy|0|||
170763800|NCT00771667|617140238|FG009|Induction Phase|Lack of Efficacy|0|||
170763801|NCT00771667|617140229|FG000|Induction Phase|Lost to Follow-up|1|||
170763802|NCT00771667|617140230|FG001|Induction Phase|Lost to Follow-up|0|||
170763803|NCT00771667|617140231|FG002|Induction Phase|Lost to Follow-up|1|||
170763804|NCT00771667|617140232|FG003|Induction Phase|Lost to Follow-up|0|||
170763805|NCT00771667|617140233|FG004|Induction Phase|Lost to Follow-up|0|||
170763806|NCT00771667|617140234|FG005|Induction Phase|Lost to Follow-up|0|||
170409740|NCT00291330|615840162|FG000|Overall Study|Other|3|||
170409741|NCT00291330|615840163|FG001|Overall Study|Other|1|||
170409742|NCT00566709|615840164|FG000|Overall Study|Protocol Violation|5|||
170409743|NCT00566709|615840165|FG001|Overall Study|Protocol Violation|0|||
170409744|NCT01829295|615840166|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
170409745|NCT01829295|615840167|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
170409746|NCT01829295|615840168|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
170409747|NCT01829295|615840169|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
170763807|NCT00771667|617140235|FG006|Induction Phase|Lost to Follow-up|0|||
170763808|NCT00771667|617140236|FG007|Induction Phase|Lost to Follow-up|0|||
170763809|NCT00771667|617140237|FG008|Induction Phase|Lost to Follow-up|0|||
170763810|NCT00771667|617140238|FG009|Induction Phase|Lost to Follow-up|0|||
170763811|NCT00771667|617140229|FG000|Induction Phase|Other|4|||
170763812|NCT00771667|617140230|FG001|Induction Phase|Other|6|||
170763813|NCT00771667|617140231|FG002|Induction Phase|Other|3|||
170519805|NCT03066830|616247656|FG001|Overall Study|At the Participant's own Request|17|||
170519806|NCT03066830|616247655|FG000|Overall Study|Other|3|||
170519807|NCT03066830|616247656|FG001|Overall Study|Other|0|||
170519808|NCT03066830|616247655|FG000|Overall Study|Poor Compliance to Protocol|1|||
170519809|NCT03066830|616247656|FG001|Overall Study|Poor Compliance to Protocol|0|||
170519810|NCT03066830|616247655|FG000|Overall Study|Adverse Event|2|||
170519811|NCT03066830|616247656|FG001|Overall Study|Adverse Event|2|||
170519812|NCT03066830|616247655|FG000|Overall Study|Lost to Follow-up|11|||
170519813|NCT03066830|616247656|FG001|Overall Study|Lost to Follow-up|3|||
170519814|NCT03131687|616247679|FG000|Overall Study|Adverse Event|0|||
170519815|NCT03131687|616247680|FG001|Overall Study|Adverse Event|1|||
170519816|NCT03131687|616247681|FG002|Overall Study|Adverse Event|0|||
170519817|NCT03131687|616247682|FG003|Overall Study|Adverse Event|1|||
170519818|NCT03131687|616247683|FG004|Overall Study|Adverse Event|2|||
170867748|NCT02973425|617528195|FG000|Overall Study|Lost to Follow-up|49|||
170867749|NCT02973425|617528196|FG001|Overall Study|Lost to Follow-up|53|||
170867750|NCT00909792|617528197|FG000|Period 1|Did not meet inclusion criteria|0|||
170867751|NCT00909792|617528198|FG001|Period 1|Did not meet inclusion criteria|1|||
170867752|NCT00909792|617528197|FG000|Period 2|Biomicroscopy|1|||
170867753|NCT00909792|617528198|FG001|Period 2|Biomicroscopy|0|||
170867754|NCT00909792|617528197|FG000|Period 2|Lost to Follow-up|0|||
170867755|NCT00909792|617528198|FG001|Period 2|Lost to Follow-up|1|||
170867756|NCT02012296|617528199|FG000|Overall Study|Lack of Efficacy|0|||
170519819|NCT03131687|616247684|FG005|Overall Study|Adverse Event|2|||
170519820|NCT03131687|616247679|FG000|Overall Study|Death|1|||
170519821|NCT03131687|616247680|FG001|Overall Study|Death|0|||
170519822|NCT03131687|616247681|FG002|Overall Study|Death|0|||
170519823|NCT03131687|616247682|FG003|Overall Study|Death|0|||
170519824|NCT03131687|616247683|FG004|Overall Study|Death|0|||
170519825|NCT03131687|616247684|FG005|Overall Study|Death|0|||
170519826|NCT03131687|616247679|FG000|Overall Study|Withdrawal by Subject|3|||
170763814|NCT00771667|617140232|FG003|Induction Phase|Other|4|||
170763815|NCT00771667|617140233|FG004|Induction Phase|Other|0|||
170867757|NCT02012296|617528200|FG001|Overall Study|Lack of Efficacy|0|||
170867758|NCT02012296|617528201|FG002|Overall Study|Lack of Efficacy|15|||
170867759|NCT02012296|617528199|FG000|Overall Study|Adverse Event|0|||
170867760|NCT02012296|617528200|FG001|Overall Study|Adverse Event|0|||
170867761|NCT02012296|617528201|FG002|Overall Study|Adverse Event|2|||
170867762|NCT02012296|617528199|FG000|Overall Study|Early study closure|0|||
170867763|NCT02012296|617528200|FG001|Overall Study|Early study closure|0|||
170867764|NCT02012296|617528201|FG002|Overall Study|Early study closure|5|||
170867765|NCT02012296|617528199|FG000|Overall Study|Protocol Violation|0|||
170867766|NCT02012296|617528200|FG001|Overall Study|Protocol Violation|1|||
170867767|NCT02012296|617528201|FG002|Overall Study|Protocol Violation|0|||
170763816|NCT00771667|617140234|FG005|Induction Phase|Other|0|||
170763817|NCT00771667|617140235|FG006|Induction Phase|Other|0|||
170763818|NCT00771667|617140236|FG007|Induction Phase|Other|0|||
170763819|NCT00771667|617140237|FG008|Induction Phase|Other|0|||
170763820|NCT00771667|617140238|FG009|Induction Phase|Other|0|||
170763821|NCT00771667|617140229|FG000|Maintenance Phase|Adverse Event|0|||
170763822|NCT00771667|617140230|FG001|Maintenance Phase|Adverse Event|0|||
170763823|NCT00771667|617140231|FG002|Maintenance Phase|Adverse Event|0|||
170763824|NCT00771667|617140232|FG003|Maintenance Phase|Adverse Event|0|||
170763825|NCT00771667|617140233|FG004|Maintenance Phase|Adverse Event|1|||
170763826|NCT00771667|617140234|FG005|Maintenance Phase|Adverse Event|3|||
170763827|NCT00771667|617140235|FG006|Maintenance Phase|Adverse Event|5|||
170763828|NCT00771667|617140236|FG007|Maintenance Phase|Adverse Event|1|||
170763829|NCT00771667|617140237|FG008|Maintenance Phase|Adverse Event|8|||
170763830|NCT00771667|617140238|FG009|Maintenance Phase|Adverse Event|7|||
170763831|NCT00771667|617140229|FG000|Maintenance Phase|Lack of Efficacy|0|||
170763832|NCT00771667|617140230|FG001|Maintenance Phase|Lack of Efficacy|0|||
170763833|NCT00771667|617140231|FG002|Maintenance Phase|Lack of Efficacy|0|||
170763834|NCT00771667|617140232|FG003|Maintenance Phase|Lack of Efficacy|0|||
170763835|NCT00771667|617140233|FG004|Maintenance Phase|Lack of Efficacy|1|||
170867768|NCT03739762|617528202|FG000|Overall Study|Lost to Follow-up|1|||
170867769|NCT03739762|617528203|FG001|Overall Study|Lost to Follow-up|1|||
170867770|NCT03739762|617528202|FG000|Overall Study|Withdrawal by Subject|2|||
170867771|NCT03739762|617528203|FG001|Overall Study|Withdrawal by Subject|6|||
170867772|NCT00929656|617528204|FG000|Overall Study|Lost to Follow-up|0|||
170867773|NCT00929656|617528205|FG001|Overall Study|Lost to Follow-up|1|||
170763836|NCT00771667|617140234|FG005|Maintenance Phase|Lack of Efficacy|3|||
170867774|NCT00607880|617528206|FG000|Overall Study|Unable to place port due to occlusion|1|||
170519827|NCT03131687|616247680|FG001|Overall Study|Withdrawal by Subject|3|||
170519828|NCT03131687|616247681|FG002|Overall Study|Withdrawal by Subject|3|||
170519829|NCT03131687|616247682|FG003|Overall Study|Withdrawal by Subject|1|||
170519830|NCT03131687|616247683|FG004|Overall Study|Withdrawal by Subject|2|||
170867775|NCT00607880|617528207|FG001|Overall Study|Unable to place port due to occlusion|0|||
170867776|NCT00727649|617528210|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
170763837|NCT00771667|617140235|FG006|Maintenance Phase|Lack of Efficacy|3|||
170763838|NCT00771667|617140236|FG007|Maintenance Phase|Lack of Efficacy|2|||
170867777|NCT00727649|617528211|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
170867778|NCT00727649|617528210|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
170867779|NCT00727649|617528211|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
170867780|NCT00727649|617528210|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
170867781|NCT00727649|617528211|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
170867782|NCT00727649|617528210|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
170867783|NCT00727649|617528211|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
170867784|NCT00727649|617528210|FG000|Second Intervention (4-weeks)|Death|1|||
170867785|NCT00727649|617528211|FG001|Second Intervention (4-weeks)|Death|0|||
170867786|NCT00727649|617528210|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
170867787|NCT00727649|617528211|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
170867788|NCT00727649|617528210|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
170867789|NCT00727649|617528211|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
170867790|NCT01650285|617528212|FG000|Overall Study|Adverse Event|1|||
170867791|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
170867792|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
170867793|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
170867794|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
170867795|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
170867796|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
170867797|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
170867798|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
170867799|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
170867800|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
170867801|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
170867802|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
170867803|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
170867804|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
170519831|NCT03131687|616247684|FG005|Overall Study|Withdrawal by Subject|1|||
170519832|NCT03131687|616247679|FG000|Overall Study|Lost to Follow-up|1|||
170867805|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
170867806|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
170867807|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
170867808|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
170867809|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
170867810|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
170867811|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
170867812|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
170867813|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
170867814|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
170867815|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
170867816|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
170867817|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
170867818|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
170867819|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
170867820|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
170867821|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
170867822|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
170867823|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
170867824|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
170867825|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
170867826|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
170867827|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
170867828|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
170867829|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
170867830|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
170867831|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
170867832|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
170867833|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
170867834|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
170867835|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
170867836|NCT03627767|617528215|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
170867837|NCT03627767|617528216|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
170519833|NCT03131687|616247680|FG001|Overall Study|Lost to Follow-up|4|||
170763839|NCT00771667|617140237|FG008|Maintenance Phase|Lack of Efficacy|11|||
170763840|NCT00771667|617140238|FG009|Maintenance Phase|Lack of Efficacy|7|||
170763841|NCT00771667|617140229|FG000|Maintenance Phase|Other|0|||
170763842|NCT00771667|617140230|FG001|Maintenance Phase|Other|0|||
170763843|NCT00771667|617140231|FG002|Maintenance Phase|Other|0|||
170763844|NCT00771667|617140232|FG003|Maintenance Phase|Other|0|||
170763845|NCT00771667|617140233|FG004|Maintenance Phase|Other|0|||
170763846|NCT00771667|617140234|FG005|Maintenance Phase|Other|1|||
170763847|NCT00771667|617140235|FG006|Maintenance Phase|Other|2|||
170763848|NCT00771667|617140236|FG007|Maintenance Phase|Other|2|||
170763849|NCT00771667|617140237|FG008|Maintenance Phase|Other|3|||
170763850|NCT00771667|617140238|FG009|Maintenance Phase|Other|3|||
170763851|NCT01897233|617140239|FG000|Part B (24 Weeks)|Adverse Event|1|||
170763852|NCT01897233|617140239|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
170763853|NCT01897233|617140239|FG000|Part B (24 Weeks)|Physician Decision|1|||
170763854|NCT00628862|617140240|FG000|Overall Study|Adverse Event|6|||
170763855|NCT00628862|617140241|FG001|Overall Study|Adverse Event|8|||
170763856|NCT00628862|617140242|FG002|Overall Study|Adverse Event|10|||
170763857|NCT00628862|617140240|FG000|Overall Study|Withdrawal by Subject|4|||
170763858|NCT00628862|617140241|FG001|Overall Study|Withdrawal by Subject|6|||
170763859|NCT00628862|617140242|FG002|Overall Study|Withdrawal by Subject|11|||
170763860|NCT00628862|617140240|FG000|Overall Study|Lost to Follow-up|0|||
170763861|NCT00628862|617140241|FG001|Overall Study|Lost to Follow-up|2|||
170763862|NCT00628862|617140242|FG002|Overall Study|Lost to Follow-up|1|||
170763863|NCT00628862|617140240|FG000|Overall Study|Protocol Violation|1|||
170763864|NCT00628862|617140241|FG001|Overall Study|Protocol Violation|0|||
170763865|NCT00628862|617140242|FG002|Overall Study|Protocol Violation|0|||
170763866|NCT00628862|617140240|FG000|Overall Study|COPD Exacerbation|0|||
170763867|NCT00628862|617140241|FG001|Overall Study|COPD Exacerbation|1|||
170763868|NCT00628862|617140242|FG002|Overall Study|COPD Exacerbation|0|||
170763869|NCT02469064|617140243|FG000|Overall Study|Request not to receive intervention.|1|||
170763870|NCT02469064|617140244|FG001|Overall Study|Request not to receive intervention.|3|||
170763871|NCT02750709|617140247|FG000|Treatment Period 1|Adverse Event|0|||
170763872|NCT02750709|617140248|FG001|Treatment Period 1|Adverse Event|0|||
170763873|NCT02750709|617140249|FG002|Treatment Period 1|Adverse Event|0|||
170763874|NCT02750709|617140250|FG003|Treatment Period 1|Adverse Event|0|||
170763875|NCT02750709|617140251|FG004|Treatment Period 1|Adverse Event|0|||
170763876|NCT02750709|617140252|FG005|Treatment Period 1|Adverse Event|1|||
170763877|NCT01120275|617140254|FG000|Overall Study|Adverse Event|3|||
170763878|NCT01120275|617140254|FG000|Overall Study|Progression|27|||
170763879|NCT01120275|617140254|FG000|Overall Study|Ineligible|3|||
170763880|NCT01120275|617140254|FG000|Overall Study|Withdrawal by Subject|1|||
170763881|NCT01120275|617140254|FG000|Overall Study|Refusal|1|||
170763882|NCT01120275|617140254|FG000|Overall Study|Not specific|1|||
170763883|NCT00290732|617140255|FG000|Overall Study|Inability to instill drug intraductally.|0|||
170763884|NCT00290732|617140256|FG001|Overall Study|Inability to instill drug intraductally.|1|||
170763885|NCT00290732|617140257|FG002|Overall Study|Inability to instill drug intraductally.|1|||
170763886|NCT00290732|617140258|FG003|Overall Study|Inability to instill drug intraductally.|0|||
170763887|NCT00290732|617140259|FG004|Overall Study|Inability to instill drug intraductally.|0|||
170763888|NCT01833832|617140260|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
170763889|NCT01156116|617140261|FG000|Overall Study|Withdrawal by Subject|3|||
170763890|NCT01156116|617140262|FG001|Overall Study|Withdrawal by Subject|1|||
170763891|NCT01156116|617140261|FG000|Overall Study|CPAP intolerance|2|||
170763892|NCT01156116|617140262|FG001|Overall Study|CPAP intolerance|0|||
170763893|NCT00843193|617140263|FG000|Overall Study|Adverse Event|2|||
170763894|NCT00843193|617140264|FG001|Overall Study|Adverse Event|4|||
170763895|NCT00843193|617140263|FG000|Overall Study|Lack of Efficacy|1|||
170763896|NCT00843193|617140264|FG001|Overall Study|Lack of Efficacy|1|||
170763897|NCT00843193|617140263|FG000|Overall Study|Protocol Violation|1|||
170763898|NCT00843193|617140264|FG001|Overall Study|Protocol Violation|2|||
170763899|NCT00843193|617140263|FG000|Overall Study|Lost to Follow-up|1|||
170763900|NCT00843193|617140264|FG001|Overall Study|Lost to Follow-up|0|||
170763901|NCT00843193|617140263|FG000|Overall Study|Physician Decision|0|||
170763902|NCT00843193|617140264|FG001|Overall Study|Physician Decision|1|||
170763903|NCT00843193|617140263|FG000|Overall Study|Withdrawal by Subject|3|||
170763904|NCT00843193|617140264|FG001|Overall Study|Withdrawal by Subject|3|||
170763905|NCT02057718|617140265|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
170763906|NCT02057718|617140266|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
170867838|NCT03627767|617528217|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
170519834|NCT03131687|616247681|FG002|Overall Study|Lost to Follow-up|0|||
170519835|NCT03131687|616247682|FG003|Overall Study|Lost to Follow-up|1|||
170763907|NCT02057718|617140265|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
170763908|NCT02057718|617140266|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
170763909|NCT02057718|617140265|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
170763910|NCT02057718|617140266|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
170763911|NCT02057718|617140265|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
170519836|NCT03131687|616247683|FG004|Overall Study|Lost to Follow-up|4|||
170519837|NCT03131687|616247684|FG005|Overall Study|Lost to Follow-up|2|||
170519838|NCT03131687|616247679|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
170519839|NCT03131687|616247680|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
170519840|NCT03131687|616247681|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
170519841|NCT03131687|616247682|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
170519842|NCT03131687|616247683|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
170519843|NCT03131687|616247684|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
170519844|NCT03131687|616247679|FG000|Overall Study|Principle Investigator Decision|0|||
170519845|NCT03131687|616247680|FG001|Overall Study|Principle Investigator Decision|1|||
170519846|NCT03131687|616247681|FG002|Overall Study|Principle Investigator Decision|0|||
170519847|NCT03131687|616247682|FG003|Overall Study|Principle Investigator Decision|0|||
170519848|NCT03131687|616247683|FG004|Overall Study|Principle Investigator Decision|0|||
170519849|NCT03131687|616247684|FG005|Overall Study|Principle Investigator Decision|0|||
170519850|NCT03131687|616247679|FG000|Overall Study|Inadvertent Enrollment|0|||
170519851|NCT03131687|616247680|FG001|Overall Study|Inadvertent Enrollment|0|||
170519852|NCT03131687|616247681|FG002|Overall Study|Inadvertent Enrollment|0|||
170519853|NCT03131687|616247682|FG003|Overall Study|Inadvertent Enrollment|1|||
170519854|NCT03131687|616247683|FG004|Overall Study|Inadvertent Enrollment|0|||
170519855|NCT03131687|616247684|FG005|Overall Study|Inadvertent Enrollment|0|||
170519856|NCT03134911|616247686|FG000|Overall Study|Screen failure|31|||
170519857|NCT03134911|616247686|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
170519858|NCT00656175|616247689|FG000|Overall Study|Adverse Event|1|||
170519859|NCT00656175|616247690|FG001|Overall Study|Adverse Event|0|||
170519860|NCT00656175|616247689|FG000|Overall Study|Transportation issues|0|||
170519861|NCT00656175|616247690|FG001|Overall Study|Transportation issues|1|||
170519862|NCT02149264|616247696|FG000|Overall Study|Withdrawal by Subject|9|||
170519863|NCT02149264|616247696|FG000|Overall Study|Adverse Event|7|||
170519864|NCT02149264|616247696|FG000|Overall Study|Physician Decision|3|||
170519865|NCT02149264|616247696|FG000|Overall Study|Protocol Violation|1|||
170519866|NCT02499120|616247702|FG000|Overall Study|Death|52|||
170519867|NCT02499120|616247703|FG001|Overall Study|Death|43|||
170763912|NCT02057718|617140266|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
170763913|NCT02057718|617140265|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
170763914|NCT02057718|617140266|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
170763915|NCT02057718|617140265|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
170763916|NCT02057718|617140266|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
170763917|NCT02057718|617140265|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
170763918|NCT02057718|617140266|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
170763919|NCT02057718|617140265|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
170763920|NCT02057718|617140266|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
170763921|NCT02057718|617140265|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
170763922|NCT02057718|617140266|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
170763923|NCT02057718|617140265|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
170763924|NCT02057718|617140266|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
170763925|NCT02057718|617140265|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
170763926|NCT02057718|617140266|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
170763927|NCT00197015|617140267|FG000|Overall Study|Adverse Event|3|||
170763928|NCT00197015|617140268|FG001|Overall Study|Adverse Event|0|||
170763929|NCT00197015|617140269|FG002|Overall Study|Adverse Event|1|||
170763930|NCT00197015|617140267|FG000|Overall Study|Protocol Violation|0|||
170763931|NCT00197015|617140268|FG001|Overall Study|Protocol Violation|3|||
170763932|NCT00197015|617140269|FG002|Overall Study|Protocol Violation|3|||
170763933|NCT00197015|617140267|FG000|Overall Study|Withdrawal by Subject|17|||
170763934|NCT00197015|617140268|FG001|Overall Study|Withdrawal by Subject|37|||
170763935|NCT00197015|617140269|FG002|Overall Study|Withdrawal by Subject|34|||
170763936|NCT00197015|617140267|FG000|Overall Study|Lost to Follow-up|28|||
170763937|NCT00197015|617140268|FG001|Overall Study|Lost to Follow-up|46|||
170763938|NCT00197015|617140269|FG002|Overall Study|Lost to Follow-up|37|||
170763939|NCT00197015|617140267|FG000|Overall Study|Other|2|||
170763940|NCT00197015|617140268|FG001|Overall Study|Other|3|||
170763941|NCT00197015|617140269|FG002|Overall Study|Other|2|||
170763942|NCT04511650|617140272|FG000|Overall Study|Lost to Follow-up|1|||
170763943|NCT04511650|617140273|FG001|Overall Study|Lost to Follow-up|0|||
170763944|NCT04511650|617140274|FG002|Overall Study|Lost to Follow-up|0|||
170763945|NCT04511650|617140272|FG000|Overall Study|Withdrawal by Subject|1|||
170763946|NCT04511650|617140273|FG001|Overall Study|Withdrawal by Subject|0|||
170763947|NCT04511650|617140274|FG002|Overall Study|Withdrawal by Subject|0|||
170763948|NCT04511650|617140272|FG000|Overall Study|reason not provided|0|||
170763949|NCT04511650|617140273|FG001|Overall Study|reason not provided|0|||
170763950|NCT04511650|617140274|FG002|Overall Study|reason not provided|1|||
170763951|NCT04511650|617140272|FG000|Overall Study|Death|1|||
170867839|NCT03627767|617528218|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
170867840|NCT03627767|617528219|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
170867841|NCT03627767|617528215|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
170867842|NCT03627767|617528216|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
170867843|NCT03627767|617528217|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
170867844|NCT03627767|617528218|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
170867845|NCT03627767|617528219|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
170867846|NCT03627767|617528215|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
170867847|NCT03627767|617528216|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
170867848|NCT03627767|617528217|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
170867849|NCT03627767|617528218|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
170867850|NCT03627767|617528219|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
170867851|NCT03627767|617528215|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
170867852|NCT03627767|617528216|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
170867853|NCT03627767|617528217|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
170867854|NCT03627767|617528218|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
170867855|NCT03627767|617528219|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
170867856|NCT03627767|617528215|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
170867857|NCT03627767|617528216|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
170867858|NCT03627767|617528217|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
170867859|NCT03627767|617528218|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
170867860|NCT03627767|617528219|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
170867861|NCT03627767|617528215|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
170867862|NCT03627767|617528216|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
170867863|NCT03627767|617528217|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
170867864|NCT03627767|617528218|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
170867865|NCT03627767|617528219|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
170867866|NCT03627767|617528215|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
170867867|NCT03627767|617528216|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
170867868|NCT03627767|617528217|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
170867869|NCT03627767|617528218|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
170867870|NCT03627767|617528219|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
170867871|NCT03627767|617528215|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
170867872|NCT03627767|617528216|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
170867873|NCT03627767|617528217|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
170867874|NCT03627767|617528218|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
170867875|NCT03627767|617528219|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
170867876|NCT03627767|617528215|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
170867877|NCT03627767|617528216|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
170867878|NCT03627767|617528217|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
170867879|NCT03627767|617528218|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
170867880|NCT03627767|617528219|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
170867881|NCT03627767|617528215|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
170867882|NCT03627767|617528216|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
170867883|NCT03627767|617528217|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
170867884|NCT03627767|617528218|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
170409748|NCT01829295|615840166|FG000|6-12 Months|Adverse Event|0|||
170409749|NCT01829295|615840167|FG001|6-12 Months|Adverse Event|0|||
170409750|NCT01829295|615840168|FG002|6-12 Months|Adverse Event|3|||
170409751|NCT01829295|615840169|FG003|6-12 Months|Adverse Event|2|||
170763952|NCT04511650|617140273|FG001|Overall Study|Death|1|||
170763953|NCT04511650|617140274|FG002|Overall Study|Death|1|||
170763954|NCT00608907|617140275|FG000|Overall Study|Adverse Event|6|||
170763955|NCT00608907|617140276|FG001|Overall Study|Adverse Event|0|||
170763956|NCT00608907|617140277|FG002|Overall Study|Adverse Event|1|||
170763957|NCT00608907|617140275|FG000|Overall Study|Death|1|||
170763958|NCT00608907|617140276|FG001|Overall Study|Death|0|||
170763959|NCT00608907|617140277|FG002|Overall Study|Death|0|||
170763960|NCT00608907|617140275|FG000|Overall Study|Withdrawal by Subject|4|||
170763961|NCT00608907|617140276|FG001|Overall Study|Withdrawal by Subject|0|||
170763962|NCT00608907|617140277|FG002|Overall Study|Withdrawal by Subject|0|||
170763963|NCT00608907|617140275|FG000|Overall Study|Progressive Disease|1|||
170763964|NCT00608907|617140276|FG001|Overall Study|Progressive Disease|0|||
170409752|NCT01829295|615840166|FG000|6-12 Months|Lost to Follow-up|2|||
170763965|NCT00608907|617140277|FG002|Overall Study|Progressive Disease|0|||
170763966|NCT05650333|617140278|FG000|Treatment Period (7 Days)|Adverse Event|1|||
170763967|NCT02982213|617140279|FG000|Overall Study|Did not complete follow up questionnaire|5|||
170763968|NCT02982213|617140280|FG001|Overall Study|Did not complete follow up questionnaire|1|||
170763969|NCT02596035|617140281|FG000|Overall Study|Disease Progression|64|||
170763970|NCT02596035|617140282|FG001|Overall Study|Disease Progression|32|||
170763971|NCT02596035|617140283|FG002|Overall Study|Disease Progression|1|||
170763972|NCT02596035|617140281|FG000|Overall Study|study drug toxicity|12|||
170763973|NCT02596035|617140282|FG001|Overall Study|study drug toxicity|3|||
170763974|NCT02596035|617140283|FG002|Overall Study|study drug toxicity|0|||
170763975|NCT02596035|617140281|FG000|Overall Study|AE unrelated to study drug|5|||
170763976|NCT02596035|617140282|FG001|Overall Study|AE unrelated to study drug|2|||
170763977|NCT02596035|617140283|FG002|Overall Study|AE unrelated to study drug|0|||
170763978|NCT02596035|617140281|FG000|Overall Study|participant request to discontinue study treatment|2|||
170763979|NCT02596035|617140282|FG001|Overall Study|participant request to discontinue study treatment|0|||
170763980|NCT02596035|617140283|FG002|Overall Study|participant request to discontinue study treatment|0|||
170763981|NCT02596035|617140281|FG000|Overall Study|participant withdrew consent|2|||
170763982|NCT02596035|617140282|FG001|Overall Study|participant withdrew consent|2|||
170763983|NCT02596035|617140283|FG002|Overall Study|participant withdrew consent|0|||
170763984|NCT02596035|617140281|FG000|Overall Study|Poor/Non Comlpiance|0|||
170763985|NCT02596035|617140282|FG001|Overall Study|Poor/Non Comlpiance|1|||
170763986|NCT02596035|617140283|FG002|Overall Study|Poor/Non Comlpiance|0|||
170763987|NCT02596035|617140281|FG000|Overall Study|participant no longer meets study criteria|1|||
170763988|NCT02596035|617140282|FG001|Overall Study|participant no longer meets study criteria|0|||
170763989|NCT02596035|617140283|FG002|Overall Study|participant no longer meets study criteria|0|||
170763990|NCT02596035|617140281|FG000|Overall Study|other reasons|11|||
170763991|NCT02596035|617140282|FG001|Overall Study|other reasons|4|||
170763992|NCT02596035|617140283|FG002|Overall Study|other reasons|0|||
170763993|NCT01981850|617140284|FG000|Main Phase Stage 1|Death|2|||
170763994|NCT01981850|617140285|FG001|Main Phase Stage 1|Death|0|||
170763995|NCT01981850|617140286|FG002|Main Phase Stage 1|Death|0|||
170763996|NCT01981850|617140287|FG003|Main Phase Stage 1|Death|0|||
170763997|NCT01981850|617140288|FG004|Main Phase Stage 1|Death|0|||
170763998|NCT01981850|617140289|FG005|Main Phase Stage 1|Death|0|||
170763999|NCT01981850|617140290|FG006|Main Phase Stage 1|Death|0|||
170764000|NCT01981850|617140291|FG007|Main Phase Stage 1|Death|0|||
170764001|NCT01981850|617140292|FG008|Main Phase Stage 1|Death|0|||
170764002|NCT01981850|617140293|FG009|Main Phase Stage 1|Death|0|||
170764003|NCT01981850|617140284|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
170764004|NCT01981850|617140285|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764005|NCT01981850|617140286|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764006|NCT01981850|617140287|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764007|NCT01981850|617140288|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764008|NCT01981850|617140289|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764009|NCT01981850|617140290|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764010|NCT01981850|617140291|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764011|NCT01981850|617140292|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764012|NCT01981850|617140293|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
170764013|NCT01981850|617140284|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
170764014|NCT01981850|617140285|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
170764015|NCT01981850|617140286|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
170764016|NCT01981850|617140287|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
170764017|NCT01981850|617140288|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
170764018|NCT01981850|617140289|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
170764019|NCT01981850|617140290|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
170764020|NCT01981850|617140291|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
170764021|NCT01981850|617140292|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
170764022|NCT01981850|617140293|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
170764023|NCT01981850|617140284|FG000|Main Phase Stage 1|Various reasons|0|||
170764024|NCT01981850|617140285|FG001|Main Phase Stage 1|Various reasons|0|||
170764025|NCT01981850|617140286|FG002|Main Phase Stage 1|Various reasons|2|||
170867885|NCT03627767|617528219|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
170519868|NCT02499120|616247702|FG000|Overall Study|Lost to Follow-up|1|||
170764026|NCT01981850|617140287|FG003|Main Phase Stage 1|Various reasons|0|||
170764027|NCT01981850|617140288|FG004|Main Phase Stage 1|Various reasons|0|||
170764028|NCT01981850|617140289|FG005|Main Phase Stage 1|Various reasons|0|||
170764029|NCT01981850|617140290|FG006|Main Phase Stage 1|Various reasons|0|||
170764030|NCT01981850|617140291|FG007|Main Phase Stage 1|Various reasons|0|||
170764031|NCT01981850|617140292|FG008|Main Phase Stage 1|Various reasons|0|||
170764032|NCT01981850|617140293|FG009|Main Phase Stage 1|Various reasons|0|||
170764033|NCT01981850|617140284|FG000|Main Phase Stage 2|Adverse Event|0|||
170764034|NCT01981850|617140285|FG001|Main Phase Stage 2|Adverse Event|0|||
170764035|NCT01981850|617140286|FG002|Main Phase Stage 2|Adverse Event|0|||
170519869|NCT02499120|616247703|FG001|Overall Study|Lost to Follow-up|2|||
170764036|NCT01981850|617140287|FG003|Main Phase Stage 2|Adverse Event|0|||
170764037|NCT01981850|617140288|FG004|Main Phase Stage 2|Adverse Event|6|||
170764038|NCT01981850|617140289|FG005|Main Phase Stage 2|Adverse Event|5|||
170764039|NCT01981850|617140290|FG006|Main Phase Stage 2|Adverse Event|7|||
170764040|NCT01981850|617140291|FG007|Main Phase Stage 2|Adverse Event|0|||
170867886|NCT03627767|617528215|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
170519870|NCT02499120|616247702|FG000|Overall Study|Participant refused further follow-up|1|||
170519871|NCT02499120|616247703|FG001|Overall Study|Participant refused further follow-up|0|||
170519872|NCT02499120|616247702|FG000|Overall Study|Withdrawal by Subject|2|||
170519873|NCT02499120|616247703|FG001|Overall Study|Withdrawal by Subject|5|||
170519874|NCT02499120|616247702|FG000|Overall Study|Other|9|||
170519875|NCT02499120|616247703|FG001|Overall Study|Other|10|||
170519876|NCT02282163|616247704|FG000|Overall Study|Protocol Violation|1|||
170519877|NCT01839916|616247705|FG000|Overall Study|Death|9|||
170519878|NCT01839916|616247705|FG000|Overall Study|Physician Decision|17|||
170519879|NCT01839916|616247705|FG000|Overall Study|Relapse|12|||
170519880|NCT01839916|616247705|FG000|Overall Study|GVHD|2|||
170519881|NCT01839916|616247705|FG000|Overall Study|Graft Failure|1|||
170519882|NCT00964028|616247706|FG000|Overall Study|Withdrawal by Subject|0|||
170519883|NCT00964028|616247707|FG001|Overall Study|Withdrawal by Subject|1|||
170519884|NCT03472521|616247708|FG000|Overall Study|Lost to Follow-up|3|||
170519885|NCT03472521|616247709|FG001|Overall Study|Lost to Follow-up|2|||
170519886|NCT03472521|616247708|FG000|Overall Study|Discontinued intervention|3|||
170519887|NCT03472521|616247709|FG001|Overall Study|Discontinued intervention|1|||
170519888|NCT05219968|616247712|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
170519889|NCT05219968|616247713|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
170519890|NCT05219968|616247714|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
170519891|NCT05219968|616247715|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
170519892|NCT05219968|616247716|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
170519893|NCT05219968|616247712|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
170519894|NCT05219968|616247713|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
170519895|NCT05219968|616247714|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
170519896|NCT05219968|616247715|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
170519897|NCT05219968|616247716|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
170519898|NCT05219968|616247712|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
170519899|NCT05219968|616247713|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
170519900|NCT05219968|616247714|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
170519901|NCT05219968|616247715|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
170519902|NCT05219968|616247716|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
170519903|NCT05219968|616247712|FG000|Week 24 Treatment Period|Adverse Event|3|||
170519904|NCT05219968|616247713|FG001|Week 24 Treatment Period|Adverse Event|0|||
170519905|NCT05219968|616247714|FG002|Week 24 Treatment Period|Adverse Event|0|||
170519906|NCT05219968|616247715|FG003|Week 24 Treatment Period|Adverse Event|0|||
170519907|NCT05219968|616247716|FG004|Week 24 Treatment Period|Adverse Event|0|||
170519908|NCT05219968|616247712|FG000|Week 24 Treatment Period|Physician Decision|0|||
170519909|NCT05219968|616247713|FG001|Week 24 Treatment Period|Physician Decision|1|||
170519910|NCT05219968|616247714|FG002|Week 24 Treatment Period|Physician Decision|0|||
170519911|NCT05219968|616247715|FG003|Week 24 Treatment Period|Physician Decision|0|||
170519912|NCT05219968|616247716|FG004|Week 24 Treatment Period|Physician Decision|0|||
170632094|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
170632095|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
170632096|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
170632097|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
170632098|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
170632099|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
170632100|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
170632101|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
170632102|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
170632103|NCT02968004|616664520|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
170632104|NCT02968004|616664521|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
170632105|NCT03041038|616664522|FG000|Overall Study|Withdrawal by Subject|4|||
170632106|NCT03041038|616664523|FG001|Overall Study|Withdrawal by Subject|0|||
170632107|NCT03041038|616664522|FG000|Overall Study|Lost to Follow-up|1|||
170632108|NCT03041038|616664523|FG001|Overall Study|Lost to Follow-up|1|||
170632109|NCT03041038|616664522|FG000|Overall Study|Protocol Violation|1|||
170632110|NCT03041038|616664523|FG001|Overall Study|Protocol Violation|1|||
170632111|NCT00803569|616664524|FG000|Overall Study|Progressive Disease|3|||
170632112|NCT00803569|616664524|FG000|Overall Study|Noncompliance|1|||
170632113|NCT01527370|616664525|FG000|Overall Study|Withdrawal by Subject|4|||
170632114|NCT01527370|616664525|FG000|Overall Study|Physician Decision|1|||
170519913|NCT05219968|616247712|FG000|Week 24 Treatment Period|Other, not specified|3|||
170519914|NCT05219968|616247713|FG001|Week 24 Treatment Period|Other, not specified|0|||
170519915|NCT05219968|616247714|FG002|Week 24 Treatment Period|Other, not specified|0|||
170632115|NCT01527370|616664525|FG000|Overall Study|Death|1|||
170632116|NCT00907335|616664528|FG000|Overall Study|Withdrawal by Subject|2|||
170632117|NCT00907335|616664529|FG001|Overall Study|Withdrawal by Subject|0|||
170632118|NCT00907335|616664528|FG000|Overall Study|Adverse Event|4|||
170764041|NCT01981850|617140292|FG008|Main Phase Stage 2|Adverse Event|0|||
170764042|NCT01981850|617140293|FG009|Main Phase Stage 2|Adverse Event|0|||
170764043|NCT01981850|617140284|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
170764044|NCT01981850|617140285|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
170764045|NCT01981850|617140286|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
170764046|NCT01981850|617140287|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
170764047|NCT01981850|617140288|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
170764048|NCT01981850|617140289|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
170764049|NCT01981850|617140290|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
170764050|NCT01981850|617140291|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
170764051|NCT01981850|617140292|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
170764052|NCT01981850|617140293|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
170764053|NCT01981850|617140284|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
170764054|NCT01981850|617140285|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
170764055|NCT01981850|617140286|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
170764056|NCT01981850|617140287|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
170764057|NCT01981850|617140288|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
170764058|NCT01981850|617140289|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
170764059|NCT01981850|617140290|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
170764060|NCT01981850|617140291|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
170764061|NCT01981850|617140292|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
170764062|NCT01981850|617140293|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
170764063|NCT01981850|617140284|FG000|Main Phase Stage 2|Various reasons|0|||
170764064|NCT01981850|617140285|FG001|Main Phase Stage 2|Various reasons|0|||
170764065|NCT01981850|617140286|FG002|Main Phase Stage 2|Various reasons|0|||
170764066|NCT01981850|617140287|FG003|Main Phase Stage 2|Various reasons|0|||
170764067|NCT01981850|617140288|FG004|Main Phase Stage 2|Various reasons|2|||
170764068|NCT01981850|617140289|FG005|Main Phase Stage 2|Various reasons|0|||
170764069|NCT01981850|617140290|FG006|Main Phase Stage 2|Various reasons|1|||
170764070|NCT01981850|617140291|FG007|Main Phase Stage 2|Various reasons|0|||
170764071|NCT01981850|617140292|FG008|Main Phase Stage 2|Various reasons|0|||
170764072|NCT01981850|617140293|FG009|Main Phase Stage 2|Various reasons|0|||
170764073|NCT01981850|617140284|FG000|Main Phase Stage 2|Progressive Disease|0|||
170764074|NCT01981850|617140285|FG001|Main Phase Stage 2|Progressive Disease|0|||
170519916|NCT05219968|616247715|FG003|Week 24 Treatment Period|Other, not specified|0|||
170519917|NCT05219968|616247716|FG004|Week 24 Treatment Period|Other, not specified|0|||
170519918|NCT05219968|616247712|FG000|Safety Extension Period|Treatment administration failure|0|||
170519919|NCT05219968|616247713|FG001|Safety Extension Period|Treatment administration failure|0|||
170519920|NCT05219968|616247714|FG002|Safety Extension Period|Treatment administration failure|0|||
170519921|NCT05219968|616247715|FG003|Safety Extension Period|Treatment administration failure|1|||
170764075|NCT01981850|617140286|FG002|Main Phase Stage 2|Progressive Disease|0|||
170764076|NCT01981850|617140287|FG003|Main Phase Stage 2|Progressive Disease|0|||
170764077|NCT01981850|617140288|FG004|Main Phase Stage 2|Progressive Disease|0|||
170764078|NCT01981850|617140289|FG005|Main Phase Stage 2|Progressive Disease|6|||
170764079|NCT01981850|617140290|FG006|Main Phase Stage 2|Progressive Disease|6|||
170764080|NCT01981850|617140291|FG007|Main Phase Stage 2|Progressive Disease|0|||
170764081|NCT01981850|617140292|FG008|Main Phase Stage 2|Progressive Disease|0|||
170764082|NCT01981850|617140293|FG009|Main Phase Stage 2|Progressive Disease|0|||
170764083|NCT01981850|617140284|FG000|Open Label Extension (OLE)|Adverse Event|0|||
170764084|NCT01981850|617140285|FG001|Open Label Extension (OLE)|Adverse Event|0|||
170764085|NCT01981850|617140286|FG002|Open Label Extension (OLE)|Adverse Event|0|||
170764086|NCT01981850|617140287|FG003|Open Label Extension (OLE)|Adverse Event|0|||
170764087|NCT01981850|617140288|FG004|Open Label Extension (OLE)|Adverse Event|0|||
170764088|NCT01981850|617140289|FG005|Open Label Extension (OLE)|Adverse Event|0|||
170764089|NCT01981850|617140290|FG006|Open Label Extension (OLE)|Adverse Event|0|||
170764090|NCT01981850|617140291|FG007|Open Label Extension (OLE)|Adverse Event|2|||
170764091|NCT01981850|617140292|FG008|Open Label Extension (OLE)|Adverse Event|1|||
170764092|NCT01981850|617140293|FG009|Open Label Extension (OLE)|Adverse Event|8|||
170764093|NCT01981850|617140284|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
170764094|NCT01981850|617140285|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
170764095|NCT01981850|617140286|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
170764096|NCT01981850|617140287|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
170764097|NCT01981850|617140288|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
170764098|NCT01981850|617140289|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
170764099|NCT01981850|617140290|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
170764100|NCT01981850|617140291|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
170764101|NCT01981850|617140292|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
170764102|NCT01981850|617140293|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
170764103|NCT01981850|617140284|FG000|Open Label Extension (OLE)|Various reasons|0|||
170764104|NCT01981850|617140285|FG001|Open Label Extension (OLE)|Various reasons|0|||
170764105|NCT01981850|617140286|FG002|Open Label Extension (OLE)|Various reasons|0|||
170764106|NCT01981850|617140287|FG003|Open Label Extension (OLE)|Various reasons|0|||
170632119|NCT00907335|616664529|FG001|Overall Study|Adverse Event|1|||
170519922|NCT05219968|616247716|FG004|Safety Extension Period|Treatment administration failure|4|||
170519923|NCT05219968|616247712|FG000|Safety Extension Period|Bilateral dislodgement|0|||
170519924|NCT05219968|616247713|FG001|Safety Extension Period|Bilateral dislodgement|0|||
170519925|NCT05219968|616247714|FG002|Safety Extension Period|Bilateral dislodgement|4|||
170519926|NCT05219968|616247715|FG003|Safety Extension Period|Bilateral dislodgement|0|||
170519927|NCT05219968|616247716|FG004|Safety Extension Period|Bilateral dislodgement|1|||
170519928|NCT05219968|616247712|FG000|Safety Extension Period|Withdrawal by Subject|0|||
170519929|NCT05219968|616247713|FG001|Safety Extension Period|Withdrawal by Subject|0|||
170519930|NCT05219968|616247714|FG002|Safety Extension Period|Withdrawal by Subject|2|||
170632120|NCT00907335|616664528|FG000|Overall Study|Lost to Follow-up|2|||
170632121|NCT00907335|616664529|FG001|Overall Study|Lost to Follow-up|0|||
170632122|NCT02177032|616664530|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
170632123|NCT02177032|616664531|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
170632124|NCT02177032|616664532|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
170632125|NCT02177032|616664533|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
170632126|NCT02177032|616664530|FG000|Overall Study|Lost to Follow-up|0|||
170632127|NCT02177032|616664531|FG001|Overall Study|Lost to Follow-up|2|||
170632128|NCT02177032|616664532|FG002|Overall Study|Lost to Follow-up|0|||
170764107|NCT01981850|617140288|FG004|Open Label Extension (OLE)|Various reasons|0|||
170764108|NCT01981850|617140289|FG005|Open Label Extension (OLE)|Various reasons|0|||
170764109|NCT01981850|617140290|FG006|Open Label Extension (OLE)|Various reasons|0|||
170764110|NCT01981850|617140291|FG007|Open Label Extension (OLE)|Various reasons|3|||
170764111|NCT01981850|617140292|FG008|Open Label Extension (OLE)|Various reasons|1|||
170764112|NCT01981850|617140293|FG009|Open Label Extension (OLE)|Various reasons|3|||
170764113|NCT01981850|617140284|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
170764114|NCT01981850|617140285|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
170764115|NCT01981850|617140286|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
170764116|NCT01981850|617140287|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
170764117|NCT01981850|617140288|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
170764118|NCT01981850|617140289|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
170764119|NCT01981850|617140290|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
170764120|NCT01981850|617140291|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
170764121|NCT01981850|617140292|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
170764122|NCT01981850|617140293|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
170764123|NCT01981850|617140284|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764124|NCT01981850|617140285|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764125|NCT01981850|617140286|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764126|NCT01981850|617140287|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764127|NCT01981850|617140288|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764128|NCT01981850|617140289|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764129|NCT01981850|617140290|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764130|NCT01981850|617140291|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764131|NCT01981850|617140292|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
170764132|NCT01981850|617140293|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
170764133|NCT01981850|617140284|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764134|NCT01981850|617140285|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764135|NCT01981850|617140286|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764136|NCT01981850|617140287|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764137|NCT01981850|617140288|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764138|NCT01981850|617140289|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764139|NCT01981850|617140290|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764140|NCT01981850|617140291|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764141|NCT01981850|617140292|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
170764142|NCT01981850|617140293|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
170764143|NCT03523962|617140294|FG000|Closed Fractures|Death|86|||
170764144|NCT03523962|617140295|FG001|Closed Fractures|Death|71|||
170764145|NCT03523962|617140296|FG002|Closed Fractures|Death|0|||
170764146|NCT03523962|617140297|FG003|Closed Fractures|Death|0|||
170764147|NCT03523962|617140294|FG000|Closed Fractures|Lost to Follow-up|62|||
170764148|NCT03523962|617140295|FG001|Closed Fractures|Lost to Follow-up|36|||
170764149|NCT03523962|617140296|FG002|Closed Fractures|Lost to Follow-up|0|||
170764150|NCT03523962|617140297|FG003|Closed Fractures|Lost to Follow-up|0|||
170764151|NCT03523962|617140294|FG000|Closed Fractures|Withdrawal by Subject|19|||
170764152|NCT03523962|617140295|FG001|Closed Fractures|Withdrawal by Subject|29|||
170764153|NCT03523962|617140296|FG002|Closed Fractures|Withdrawal by Subject|0|||
170764154|NCT03523962|617140297|FG003|Closed Fractures|Withdrawal by Subject|0|||
170764155|NCT03523962|617140294|FG000|Closed Fractures|Incarceration|1|||
170632129|NCT02177032|616664533|FG003|Overall Study|Lost to Follow-up|0|||
170632130|NCT02177032|616664530|FG000|Overall Study|OTHER|2|||
170632131|NCT02177032|616664531|FG001|Overall Study|OTHER|0|||
170632132|NCT02177032|616664532|FG002|Overall Study|OTHER|1|||
170867887|NCT03627767|617528216|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
170867888|NCT03627767|617528217|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
170867889|NCT03627767|617528218|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
170867890|NCT03627767|617528219|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
170867891|NCT04163900|617528220|FG000|Overall Study|Radiological disease progression|112|||
170867892|NCT04163900|617528221|FG001|Overall Study|Radiological disease progression|127|||
170867893|NCT04163900|617528220|FG000|Overall Study|Study closure|98|||
170867894|NCT04163900|617528221|FG001|Overall Study|Study closure|133|||
170867895|NCT04163900|617528220|FG000|Overall Study|Adverse Event|78|||
170867896|NCT04163900|617528221|FG001|Overall Study|Adverse Event|32|||
170867897|NCT04163900|617528220|FG000|Overall Study|Withdrawal by Subject|37|||
170867898|NCT04163900|617528221|FG001|Overall Study|Withdrawal by Subject|34|||
170867899|NCT04163900|617528220|FG000|Overall Study|Death|29|||
170867900|NCT04163900|617528221|FG001|Overall Study|Death|16|||
170867901|NCT04163900|617528220|FG000|Overall Study|Physician Decision|17|||
170867902|NCT04163900|617528221|FG001|Overall Study|Physician Decision|25|||
170867903|NCT04163900|617528220|FG000|Overall Study|Clinical disease progression|14|||
170867904|NCT04163900|617528221|FG001|Overall Study|Clinical disease progression|13|||
170867905|NCT04163900|617528220|FG000|Overall Study|Protocol Violation|3|||
170867906|NCT04163900|617528221|FG001|Overall Study|Protocol Violation|4|||
170867907|NCT04163900|617528220|FG000|Overall Study|Lost to Follow-up|0|||
170867908|NCT04163900|617528221|FG001|Overall Study|Lost to Follow-up|1|||
170867909|NCT00283049|617528222|FG000|Overall Study|Adverse Event|6|||
170867910|NCT00283049|617528223|FG001|Overall Study|Adverse Event|1|||
170867911|NCT00283049|617528224|FG002|Overall Study|Adverse Event|4|||
170867912|NCT00283049|617528222|FG000|Overall Study|Protocol Violation|3|||
170867913|NCT00283049|617528223|FG001|Overall Study|Protocol Violation|0|||
170867914|NCT00283049|617528224|FG002|Overall Study|Protocol Violation|3|||
170867915|NCT00283049|617528222|FG000|Overall Study|Death|1|||
170867916|NCT00283049|617528223|FG001|Overall Study|Death|1|||
170867917|NCT00283049|617528224|FG002|Overall Study|Death|1|||
170867918|NCT00283049|617528222|FG000|Overall Study|Lack of Efficacy|0|||
170867919|NCT00283049|617528223|FG001|Overall Study|Lack of Efficacy|1|||
170519931|NCT05219968|616247715|FG003|Safety Extension Period|Withdrawal by Subject|0|||
170519932|NCT05219968|616247716|FG004|Safety Extension Period|Withdrawal by Subject|4|||
170519933|NCT05219968|616247712|FG000|Safety Extension Period|Adverse Event|0|||
170519934|NCT05219968|616247713|FG001|Safety Extension Period|Adverse Event|0|||
170519935|NCT05219968|616247714|FG002|Safety Extension Period|Adverse Event|2|||
170519936|NCT05219968|616247715|FG003|Safety Extension Period|Adverse Event|1|||
170519937|NCT05219968|616247716|FG004|Safety Extension Period|Adverse Event|1|||
170519938|NCT05219968|616247712|FG000|Safety Extension Period|Lost to Follow-up|0|||
170519939|NCT05219968|616247713|FG001|Safety Extension Period|Lost to Follow-up|0|||
170519940|NCT05219968|616247714|FG002|Safety Extension Period|Lost to Follow-up|0|||
170519941|NCT05219968|616247715|FG003|Safety Extension Period|Lost to Follow-up|1|||
170519942|NCT05219968|616247716|FG004|Safety Extension Period|Lost to Follow-up|0|||
170519943|NCT04587336|616247717|FG000|Overall Study|Lost to Follow-up|1|||
170867920|NCT00283049|617528224|FG002|Overall Study|Lack of Efficacy|1|||
170867921|NCT00283049|617528222|FG000|Overall Study|Lost to Follow-up|4|||
170867922|NCT00283049|617528223|FG001|Overall Study|Lost to Follow-up|2|||
170867923|NCT00283049|617528224|FG002|Overall Study|Lost to Follow-up|5|||
170867924|NCT00283049|617528222|FG000|Overall Study|Withdrawal by Subject|26|||
170867925|NCT00283049|617528223|FG001|Overall Study|Withdrawal by Subject|24|||
170867926|NCT00283049|617528224|FG002|Overall Study|Withdrawal by Subject|19|||
170867927|NCT00283049|617528222|FG000|Overall Study|Discontinuation of Study|18|||
170867928|NCT00283049|617528223|FG001|Overall Study|Discontinuation of Study|16|||
170867929|NCT00283049|617528224|FG002|Overall Study|Discontinuation of Study|20|||
170867930|NCT00283049|617528222|FG000|Overall Study|No longer requires study treatment|0|||
170867931|NCT00283049|617528223|FG001|Overall Study|No longer requires study treatment|0|||
170867932|NCT00283049|617528224|FG002|Overall Study|No longer requires study treatment|1|||
170867933|NCT01667081|617528225|FG000|Overall Study|Death|43|||
170867934|NCT01667081|617528226|FG001|Overall Study|Death|3|||
170867935|NCT01667081|617528225|FG000|Overall Study|Lost to Follow-up|99|||
170519944|NCT04587336|616247718|FG001|Overall Study|Lost to Follow-up|0|||
170519945|NCT02723188|616249890|FG000|Overall Study|Withdrawal by Subject|1|||
170519946|NCT02723188|616249891|FG001|Overall Study|Withdrawal by Subject|0|||
170867936|NCT01667081|617528226|FG001|Overall Study|Lost to Follow-up|48|||
170867937|NCT01667081|617528225|FG000|Overall Study|Physician Decision|16|||
170867938|NCT01667081|617528226|FG001|Overall Study|Physician Decision|2|||
170867939|NCT01667081|617528225|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
170867940|NCT01667081|617528226|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
170867941|NCT01667081|617528225|FG000|Overall Study|Withdrawal by Subject|90|||
170867942|NCT01667081|617528226|FG001|Overall Study|Withdrawal by Subject|35|||
170867943|NCT02315898|617528230|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
170519947|NCT02723188|616249892|FG002|Overall Study|Withdrawal by Subject|0|||
170867944|NCT02315898|617528231|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
170867945|NCT02315898|617528232|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
170867946|NCT02315898|617528233|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
170867947|NCT01330914|617528234|FG000|Overall Study|Withdrawal by Subject|4|||
170867948|NCT01330914|617528234|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
170867949|NCT00528567|617528235|FG000|Overall Study|Death|4|||
170867950|NCT00528567|617528236|FG001|Overall Study|Death|5|||
170867951|NCT00528567|617528235|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
170867952|NCT00528567|617528236|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
170867953|NCT00528567|617528235|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
170867954|NCT00528567|617528236|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
170867955|NCT00528567|617528235|FG000|Overall Study|Violation Criteria at Entry|3|||
170867956|NCT00528567|617528236|FG001|Overall Study|Violation Criteria at Entry|17|||
170867957|NCT00528567|617528235|FG000|Overall Study|Withdrew Consent|59|||
170867958|NCT00528567|617528236|FG001|Overall Study|Withdrew Consent|55|||
170867959|NCT00528567|617528235|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
170867960|NCT00528567|617528236|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
170867961|NCT00528567|617528235|FG000|Overall Study|Failure to Return|1|||
170867962|NCT00528567|617528236|FG001|Overall Study|Failure to Return|4|||
170867963|NCT00528567|617528235|FG000|Overall Study|Other Protocol Violation|5|||
170867964|NCT00528567|617528236|FG001|Overall Study|Other Protocol Violation|21|||
170867965|NCT00528567|617528235|FG000|Overall Study|Administrative/Other|22|||
170867966|NCT00528567|617528236|FG001|Overall Study|Administrative/Other|75|||
170867967|NCT01674712|617528239|FG000|Overall Study|Adverse Event|5|||
170867968|NCT01674712|617528240|FG001|Overall Study|Adverse Event|6|||
170867969|NCT01674712|617528241|FG002|Overall Study|Adverse Event|3|||
170867970|NCT01674712|617528242|FG003|Overall Study|Adverse Event|4|||
170867971|NCT01674712|617528243|FG004|Overall Study|Adverse Event|6|||
170867972|NCT01674712|617528239|FG000|Overall Study|Lost to Follow-up|1|||
170867973|NCT01674712|617528240|FG001|Overall Study|Lost to Follow-up|0|||
170867974|NCT01674712|617528241|FG002|Overall Study|Lost to Follow-up|0|||
170764156|NCT03523962|617140295|FG001|Closed Fractures|Incarceration|4|||
170764157|NCT03523962|617140296|FG002|Closed Fractures|Incarceration|0|||
170764158|NCT03523962|617140297|FG003|Closed Fractures|Incarceration|0|||
170764159|NCT03523962|617140294|FG000|Open Fractures|Death|0|||
170764160|NCT03523962|617140295|FG001|Open Fractures|Death|0|||
170764161|NCT03523962|617140296|FG002|Open Fractures|Death|11|||
170764162|NCT03523962|617140297|FG003|Open Fractures|Death|6|||
170764163|NCT03523962|617140294|FG000|Open Fractures|Lost to Follow-up|0|||
170764164|NCT03523962|617140295|FG001|Open Fractures|Lost to Follow-up|0|||
170764165|NCT03523962|617140296|FG002|Open Fractures|Lost to Follow-up|15|||
170764166|NCT03523962|617140297|FG003|Open Fractures|Lost to Follow-up|8|||
170764167|NCT03523962|617140294|FG000|Open Fractures|Withdrawal by Subject|0|||
170764168|NCT03523962|617140295|FG001|Open Fractures|Withdrawal by Subject|0|||
170764169|NCT03523962|617140296|FG002|Open Fractures|Withdrawal by Subject|6|||
170764170|NCT03523962|617140297|FG003|Open Fractures|Withdrawal by Subject|2|||
170764171|NCT03523962|617140294|FG000|Open Fractures|Incarceration|0|||
170764172|NCT03523962|617140295|FG001|Open Fractures|Incarceration|0|||
170764173|NCT03523962|617140296|FG002|Open Fractures|Incarceration|1|||
170764174|NCT03523962|617140297|FG003|Open Fractures|Incarceration|0|||
170764175|NCT00835380|617140298|FG000|Overall Study|Withdrawal by Subject|2|||
170764176|NCT01081145|617140301|FG000|Open-Label Phase|Lack of Efficacy|56|||
170764177|NCT01081145|617140302|FG001|Open-Label Phase|Lack of Efficacy|0|||
170764178|NCT01081145|617140301|FG000|Open-Label Phase|Response criteria not met|46|||
170764179|NCT01081145|617140302|FG001|Open-Label Phase|Response criteria not met|0|||
170764180|NCT01081145|617140301|FG000|Open-Label Phase|Adverse Event|42|||
170764181|NCT01081145|617140302|FG001|Open-Label Phase|Adverse Event|0|||
170764182|NCT01081145|617140301|FG000|Open-Label Phase|Withdrawal by Subject|41|||
170764183|NCT01081145|617140302|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170764184|NCT01081145|617140301|FG000|Open-Label Phase|Other|12|||
170764185|NCT01081145|617140302|FG001|Open-Label Phase|Other|0|||
170764186|NCT01081145|617140301|FG000|Open-Label Phase|Lost to Follow-up|11|||
170764187|NCT01081145|617140302|FG001|Open-Label Phase|Lost to Follow-up|0|||
170867975|NCT01674712|617528242|FG003|Overall Study|Lost to Follow-up|0|||
170867976|NCT01674712|617528243|FG004|Overall Study|Lost to Follow-up|0|||
170867977|NCT01674712|617528239|FG000|Overall Study|Protocol Violation|2|||
170867978|NCT01674712|617528240|FG001|Overall Study|Protocol Violation|0|||
170867979|NCT01674712|617528241|FG002|Overall Study|Protocol Violation|0|||
170867980|NCT01674712|617528242|FG003|Overall Study|Protocol Violation|0|||
170867981|NCT01674712|617528243|FG004|Overall Study|Protocol Violation|0|||
170867982|NCT01674712|617528239|FG000|Overall Study|Withdrawal by Subject|2|||
170764188|NCT01081145|617140301|FG000|Open-Label Phase|Protocol Violation|4|||
170764189|NCT01081145|617140302|FG001|Open-Label Phase|Protocol Violation|0|||
170764190|NCT01081145|617140301|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
170764191|NCT01081145|617140302|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
170764192|NCT01081145|617140301|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
170764193|NCT01081145|617140302|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
170764194|NCT01081145|617140301|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
170764195|NCT01081145|617140302|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
170764196|NCT01081145|617140301|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
170764197|NCT01081145|617140302|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
170764198|NCT01081145|617140301|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
170764199|NCT01081145|617140302|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
170764200|NCT01081145|617140301|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
170764201|NCT01081145|617140302|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
170764202|NCT01081145|617140301|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
170409753|NCT01829295|615840167|FG001|6-12 Months|Lost to Follow-up|0|||
170409754|NCT01829295|615840168|FG002|6-12 Months|Lost to Follow-up|0|||
170409755|NCT01829295|615840169|FG003|6-12 Months|Lost to Follow-up|0|||
170409756|NCT01829295|615840166|FG000|6-12 Months|Withdrawal by Subject|2|||
170409757|NCT01829295|615840167|FG001|6-12 Months|Withdrawal by Subject|2|||
170764203|NCT01081145|617140302|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
170764204|NCT03593070|617140303|FG000|Overall Study|administrative withdrawal|1|||
170764205|NCT03593070|617140304|FG001|Overall Study|administrative withdrawal|1|||
170764206|NCT04075266|617140305|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
170764207|NCT04075266|617140306|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
170764208|NCT04075266|617140305|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
170764209|NCT04075266|617140306|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
170764210|NCT03643211|617140309|FG000|Overall Study|Contract violation/deficiency|12|||
170764211|NCT03643211|617140309|FG000|Overall Study|Invalid registration|3|||
170764212|NCT03643211|617140309|FG000|Overall Study|No treatment information|2|||
170764213|NCT03643211|617140309|FG000|Overall Study|No adverse event information - No revisit|4|||
170764214|NCT00539591|617140310|FG000|Overall Study|Toxicity|3|||
170764215|NCT00539591|617140311|FG001|Overall Study|Toxicity|0|||
170764216|NCT00539591|617140312|FG002|Overall Study|Toxicity|0|||
170764217|NCT00539591|617140310|FG000|Overall Study|Disease progression|2|||
170764218|NCT00539591|617140311|FG001|Overall Study|Disease progression|2|||
170764219|NCT00539591|617140312|FG002|Overall Study|Disease progression|3|||
170764220|NCT04305912|617140314|FG000|First Intervention|COVID-19 Suspension|2|||
170764221|NCT04305912|617140315|FG001|First Intervention|COVID-19 Suspension|0|||
170764222|NCT04305912|617140314|FG000|First Intervention|Withdrawal by Subject|0|||
170764223|NCT04305912|617140315|FG001|First Intervention|Withdrawal by Subject|1|||
170764224|NCT04305912|617140314|FG000|Second Intervention|Adverse Event|0|||
170764225|NCT04305912|617140315|FG001|Second Intervention|Adverse Event|1|||
170764226|NCT01155869|617140316|FG000|Overall Study|Lost to Follow-up|3|||
170764227|NCT01155869|617140317|FG001|Overall Study|Lost to Follow-up|1|||
170764228|NCT00881335|617140319|FG000|Overall Study|Lost to Follow-up|3|||
170764229|NCT00881335|617140320|FG001|Overall Study|Lost to Follow-up|2|||
170764230|NCT00117988|617140323|FG000|Overall Study|Death|3|||
170764231|NCT00117988|617140323|FG000|Overall Study|Adverse Event|1|||
170764232|NCT05196737|617140324|FG000|Non-intervention Week|Lost to Follow-up|2|||
170764233|NCT05196737|617140324|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
170764234|NCT00708097|617140325|FG000|Period 1|Protocol Violation|0|||
170764235|NCT00708097|617140326|FG001|Period 1|Protocol Violation|1|||
170764236|NCT00708097|617140327|FG002|Period 1|Protocol Violation|0|||
170764237|NCT00708097|617140328|FG003|Period 1|Protocol Violation|2|||
170764238|NCT00708097|617140329|FG004|Period 1|Protocol Violation|0|||
170764239|NCT00708097|617140325|FG000|Period 1|Other Reason|0|||
170764240|NCT00708097|617140326|FG001|Period 1|Other Reason|0|||
170764241|NCT00708097|617140327|FG002|Period 1|Other Reason|0|||
170764242|NCT00708097|617140328|FG003|Period 1|Other Reason|0|||
170764243|NCT00708097|617140329|FG004|Period 1|Other Reason|1|||
170764244|NCT00708097|617140325|FG000|Period 2|Protocol Violation|0|||
170764245|NCT00708097|617140326|FG001|Period 2|Protocol Violation|1|||
170764246|NCT00708097|617140327|FG002|Period 2|Protocol Violation|1|||
170764247|NCT00708097|617140328|FG003|Period 2|Protocol Violation|1|||
170764248|NCT00708097|617140329|FG004|Period 2|Protocol Violation|0|||
170764249|NCT07214922|617140331|FG000|Overall Study|Adverse Event|0|||
170764250|NCT07214922|617140332|FG001|Overall Study|Adverse Event|0|||
170764251|NCT07214922|617140333|FG002|Overall Study|Adverse Event|1|||
170764252|NCT07214922|617140334|FG003|Overall Study|Adverse Event|0|||
170764253|NCT07214922|617140331|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
170764254|NCT07214922|617140332|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
170764255|NCT07214922|617140333|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
170764256|NCT07214922|617140334|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
170764257|NCT00726596|617141791|FG000|Overall Study|Adverse Event|2|||
170764258|NCT00726596|617141792|FG001|Overall Study|Adverse Event|1|||
170764259|NCT00726596|617141791|FG000|Overall Study|Withdrawal by Subject|3|||
170764260|NCT00726596|617141792|FG001|Overall Study|Withdrawal by Subject|3|||
170764261|NCT01883492|617141804|FG000|Overall Study|Lost to Follow-up|3|||
170764262|NCT01883492|617141805|FG001|Overall Study|Lost to Follow-up|4|||
170764263|NCT01883492|617141804|FG000|Overall Study|Surgery on contra-lateral hip|0|||
170764264|NCT01883492|617141805|FG001|Overall Study|Surgery on contra-lateral hip|1|||
170764265|NCT01883492|617141804|FG000|Overall Study|Poor X-ray quality|7|||
170764266|NCT01883492|617141805|FG001|Overall Study|Poor X-ray quality|4|||
170764267|NCT01883492|617141804|FG000|Overall Study|Withdrawal by Subject|1|||
170764268|NCT01883492|617141805|FG001|Overall Study|Withdrawal by Subject|0|||
170764269|NCT01883492|617141804|FG000|Overall Study|inappropriate implant used|1|||
170764270|NCT01883492|617141805|FG001|Overall Study|inappropriate implant used|1|||
170764271|NCT01883492|617141804|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
170764272|NCT01883492|617141805|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
170764273|NCT02192606|617141818|FG000|Overall Study|surgery type was changed|1|||
170764274|NCT02192606|617141819|FG001|Overall Study|surgery type was changed|1|||
170764275|NCT02192606|617141818|FG000|Overall Study|Physician Decision|1|||
170764276|NCT02192606|617141819|FG001|Overall Study|Physician Decision|2|||
170764277|NCT02192606|617141818|FG000|Overall Study|3D equipment rep unable to join|0|||
170764278|NCT02192606|617141819|FG001|Overall Study|3D equipment rep unable to join|1|||
170764279|NCT00549848|617141820|FG000|Overall Study|Death|1|||
170764280|NCT00549848|617141821|FG001|Overall Study|Death|4|||
170764281|NCT00549848|617141822|FG002|Overall Study|Death|13|||
170764282|NCT00549848|617141820|FG000|Overall Study|Physician Decision|0|||
170764283|NCT00549848|617141821|FG001|Overall Study|Physician Decision|0|||
170764284|NCT00549848|617141822|FG002|Overall Study|Physician Decision|4|||
170764285|NCT00549848|617141820|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
170764286|NCT00549848|617141821|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
170764287|NCT00549848|617141822|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
170764288|NCT00549848|617141820|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
170764289|NCT00549848|617141821|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
170764290|NCT00549848|617141822|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
170764291|NCT00549848|617141820|FG000|Overall Study|Participant/Family Withdraw|2|||
170764292|NCT00549848|617141821|FG001|Overall Study|Participant/Family Withdraw|3|||
170764293|NCT00549848|617141822|FG002|Overall Study|Participant/Family Withdraw|5|||
170764294|NCT00549848|617141820|FG000|Overall Study|Second Malignancy|1|||
170764295|NCT00549848|617141821|FG001|Overall Study|Second Malignancy|0|||
170764296|NCT00549848|617141822|FG002|Overall Study|Second Malignancy|0|||
170764297|NCT00549848|617141820|FG000|Overall Study|Transplant|3|||
170764298|NCT00549848|617141821|FG001|Overall Study|Transplant|3|||
170764299|NCT00549848|617141822|FG002|Overall Study|Transplant|18|||
170764300|NCT00549848|617141820|FG000|Overall Study|Unacceptable Toxicity|1|||
170764301|NCT00549848|617141821|FG001|Overall Study|Unacceptable Toxicity|6|||
170764302|NCT00549848|617141822|FG002|Overall Study|Unacceptable Toxicity|6|||
170764303|NCT00558363|617141823|FG000|Overall Study|Physician Decision|18|||
170764304|NCT00558363|617141824|FG001|Overall Study|Physician Decision|4|||
170764305|NCT00558363|617141823|FG000|Overall Study|Withdrawal by Subject|11|||
170764306|NCT00558363|617141824|FG001|Overall Study|Withdrawal by Subject|4|||
170764307|NCT00558363|617141823|FG000|Overall Study|Adverse Event|5|||
170764308|NCT00558363|617141824|FG001|Overall Study|Adverse Event|5|||
170764309|NCT00558363|617141823|FG000|Overall Study|Lack of Efficacy|2|||
170764310|NCT00558363|617141824|FG001|Overall Study|Lack of Efficacy|2|||
170764311|NCT00558363|617141823|FG000|Overall Study|Protocol Violation|2|||
170764312|NCT00558363|617141824|FG001|Overall Study|Protocol Violation|1|||
170764313|NCT00558363|617141823|FG000|Overall Study|Lost to Follow-up|0|||
170764314|NCT00558363|617141824|FG001|Overall Study|Lost to Follow-up|1|||
170764315|NCT00558363|617141823|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
170764316|NCT00558363|617141824|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
170764317|NCT00558363|617141823|FG000|Overall Study|Randomized in Error|1|||
170764318|NCT00558363|617141824|FG001|Overall Study|Randomized in Error|2|||
170764319|NCT00558363|617141823|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
170764320|NCT00558363|617141824|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
170764321|NCT02174562|617141825|FG000|Overall Study|Withdrawal by Subject|7|||
170764322|NCT02174562|617141826|FG001|Overall Study|Withdrawal by Subject|2|||
170764323|NCT02174562|617141825|FG000|Overall Study|Death|2|||
170764324|NCT02174562|617141826|FG001|Overall Study|Death|0|||
170764325|NCT02174562|617141825|FG000|Overall Study|Lost to Follow-up|0|||
170764326|NCT02174562|617141826|FG001|Overall Study|Lost to Follow-up|3|||
170764327|NCT05193318|617141827|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
170764328|NCT05193318|617141827|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
170764329|NCT03670602|617141828|FG000|Overall Study|Lost to Follow-up|1|||
170764330|NCT03670602|617141829|FG001|Overall Study|Lost to Follow-up|0|||
170764331|NCT03670602|617141828|FG000|Overall Study|Withdrawal by Subject|0|||
170764332|NCT03670602|617141829|FG001|Overall Study|Withdrawal by Subject|3|||
170764333|NCT00957658|617141830|FG000|Overall Study|Death|1|||
170764334|NCT00957658|617141830|FG000|Overall Study|Lost to Follow-up|4|||
170764335|NCT00957658|617141830|FG000|Overall Study|Withdrawal by Subject|12|||
170764336|NCT00957658|617141830|FG000|Overall Study|Revision|1|||
170764337|NCT00957658|617141830|FG000|Overall Study|Incomplete 2 yr data|28|||
170764338|NCT00957658|617141830|FG000|Overall Study|Site termination|10|||
170867983|NCT01674712|617528240|FG001|Overall Study|Withdrawal by Subject|2|||
170867984|NCT01674712|617528241|FG002|Overall Study|Withdrawal by Subject|5|||
170867985|NCT01674712|617528242|FG003|Overall Study|Withdrawal by Subject|4|||
170867986|NCT01674712|617528243|FG004|Overall Study|Withdrawal by Subject|3|||
170764339|NCT00957658|617141830|FG000|Overall Study|unwilling/unable to return|2|||
170764340|NCT00957658|617141830|FG000|Overall Study|surgery cancelled|2|||
170764341|NCT00957658|617141830|FG000|Overall Study|Protocol Violation|5|||
170764342|NCT00975806|617141837|FG000|Overall Study|Adverse Event|2|||
170764343|NCT00975806|617141838|FG001|Overall Study|Adverse Event|1|||
170764344|NCT00975806|617141839|FG002|Overall Study|Adverse Event|2|||
170764345|NCT00975806|617141837|FG000|Overall Study|Disease Progression|1|||
170764346|NCT00975806|617141838|FG001|Overall Study|Disease Progression|5|||
170764347|NCT00975806|617141839|FG002|Overall Study|Disease Progression|1|||
170764348|NCT00975806|617141837|FG000|Overall Study|Withdrawal by Subject|1|||
170764349|NCT00975806|617141838|FG001|Overall Study|Withdrawal by Subject|0|||
170764350|NCT00975806|617141839|FG002|Overall Study|Withdrawal by Subject|0|||
170764351|NCT00975806|617141837|FG000|Overall Study|Death|0|||
170764352|NCT00975806|617141838|FG001|Overall Study|Death|1|||
170764353|NCT00975806|617141839|FG002|Overall Study|Death|0|||
170764354|NCT00975806|617141837|FG000|Overall Study|Physician decision and disease related|1|||
170764355|NCT00975806|617141838|FG001|Overall Study|Physician decision and disease related|0|||
170764356|NCT00975806|617141839|FG002|Overall Study|Physician decision and disease related|1|||
170764357|NCT00246012|617141840|FG000|Overall Study|Adverse Event|0|||
170764358|NCT00246012|617141841|FG001|Overall Study|Adverse Event|0|||
170764359|NCT00246012|617141842|FG002|Overall Study|Adverse Event|0|||
170764360|NCT00246012|617141843|FG003|Overall Study|Adverse Event|0|||
170764361|NCT00246012|617141844|FG004|Overall Study|Adverse Event|0|||
170764362|NCT00246012|617141845|FG005|Overall Study|Adverse Event|1|||
170764363|NCT00246012|617141846|FG006|Overall Study|Adverse Event|0|||
170764364|NCT00246012|617141847|FG007|Overall Study|Adverse Event|0|||
170764365|NCT00246012|617141848|FG008|Overall Study|Adverse Event|2|||
170764366|NCT00246012|617141840|FG000|Overall Study|Withdrawal by Subject|0|||
170764367|NCT00246012|617141841|FG001|Overall Study|Withdrawal by Subject|0|||
170764368|NCT00246012|617141842|FG002|Overall Study|Withdrawal by Subject|0|||
170764369|NCT00246012|617141843|FG003|Overall Study|Withdrawal by Subject|0|||
170764370|NCT00246012|617141844|FG004|Overall Study|Withdrawal by Subject|0|||
170764371|NCT00246012|617141845|FG005|Overall Study|Withdrawal by Subject|1|||
170764372|NCT00246012|617141846|FG006|Overall Study|Withdrawal by Subject|0|||
170764373|NCT00246012|617141847|FG007|Overall Study|Withdrawal by Subject|0|||
170764374|NCT00246012|617141848|FG008|Overall Study|Withdrawal by Subject|0|||
170764375|NCT00246012|617141840|FG000|Overall Study|Disease progression|3|||
170764376|NCT00246012|617141841|FG001|Overall Study|Disease progression|1|||
170764377|NCT00246012|617141842|FG002|Overall Study|Disease progression|2|||
170764378|NCT00246012|617141843|FG003|Overall Study|Disease progression|3|||
170764379|NCT00246012|617141844|FG004|Overall Study|Disease progression|3|||
170764380|NCT00246012|617141845|FG005|Overall Study|Disease progression|25|||
170764381|NCT00246012|617141846|FG006|Overall Study|Disease progression|30|||
170764382|NCT00246012|617141847|FG007|Overall Study|Disease progression|27|||
170764383|NCT00246012|617141848|FG008|Overall Study|Disease progression|26|||
170764384|NCT00246012|617141840|FG000|Overall Study|Other|0|||
170764385|NCT00246012|617141841|FG001|Overall Study|Other|0|||
170764386|NCT00246012|617141842|FG002|Overall Study|Other|0|||
170764387|NCT00246012|617141843|FG003|Overall Study|Other|0|||
170764388|NCT00246012|617141844|FG004|Overall Study|Other|0|||
170764389|NCT00246012|617141845|FG005|Overall Study|Other|0|||
170764390|NCT00246012|617141846|FG006|Overall Study|Other|0|||
170764391|NCT00246012|617141847|FG007|Overall Study|Other|1|||
170764392|NCT00246012|617141848|FG008|Overall Study|Other|0|||
170764393|NCT00246012|617141840|FG000|Overall Study|Randomly assigned but not treated|0|||
170764394|NCT00246012|617141841|FG001|Overall Study|Randomly assigned but not treated|0|||
170764395|NCT00246012|617141842|FG002|Overall Study|Randomly assigned but not treated|0|||
170764396|NCT00246012|617141843|FG003|Overall Study|Randomly assigned but not treated|0|||
170764397|NCT00246012|617141844|FG004|Overall Study|Randomly assigned but not treated|0|||
170764398|NCT00246012|617141845|FG005|Overall Study|Randomly assigned but not treated|1|||
170764399|NCT00246012|617141846|FG006|Overall Study|Randomly assigned but not treated|1|||
170764400|NCT00246012|617141847|FG007|Overall Study|Randomly assigned but not treated|0|||
170764401|NCT00246012|617141848|FG008|Overall Study|Randomly assigned but not treated|0|||
170764402|NCT02377362|617141849|FG000|Part A Second Treatment|Protocol Violation|0|||
170764403|NCT02377362|617141850|FG001|Part A Second Treatment|Protocol Violation|0|||
170867987|NCT01674712|617528239|FG000|Overall Study|Administrative|0|||
170867988|NCT01674712|617528240|FG001|Overall Study|Administrative|1|||
170519948|NCT01051921|616249893|FG000|Overall Study|Physician Decision|9|||
170519949|NCT01051921|616249893|FG000|Overall Study|Adverse Event|8|||
170632133|NCT02177032|616664533|FG003|Overall Study|OTHER|0|||
170764404|NCT02377362|617141851|FG002|Part A Second Treatment|Protocol Violation|0|||
170764405|NCT02377362|617141852|FG003|Part A Second Treatment|Protocol Violation|0|||
170764406|NCT02377362|617141853|FG004|Part A Second Treatment|Protocol Violation|1|||
170867989|NCT01674712|617528241|FG002|Overall Study|Administrative|0|||
170867990|NCT01674712|617528242|FG003|Overall Study|Administrative|0|||
170867991|NCT01674712|617528243|FG004|Overall Study|Administrative|1|||
170867992|NCT01674712|617528239|FG000|Overall Study|Lack of Efficacy|0|||
170867993|NCT01674712|617528240|FG001|Overall Study|Lack of Efficacy|0|||
170867994|NCT01674712|617528241|FG002|Overall Study|Lack of Efficacy|1|||
170867995|NCT01674712|617528242|FG003|Overall Study|Lack of Efficacy|0|||
170867996|NCT01674712|617528243|FG004|Overall Study|Lack of Efficacy|1|||
170867997|NCT03974334|617528246|FG000|Overall Study|Lost to Follow-up|1|||
170867998|NCT00024167|617528247|FG000|Overall Study|Death|53|||
170867999|NCT00024167|617528248|FG001|Overall Study|Death|47|||
170868000|NCT01109173|617528249|FG000|Overall Study|Adverse Event|15|||
170868001|NCT01109173|617528250|FG001|Overall Study|Adverse Event|17|||
170868002|NCT01109173|617528251|FG002|Overall Study|Adverse Event|9|||
170868003|NCT01109173|617528252|FG003|Overall Study|Adverse Event|6|||
170868004|NCT01109173|617528249|FG000|Overall Study|Lost to Follow-up|0|||
170868005|NCT01109173|617528250|FG001|Overall Study|Lost to Follow-up|1|||
170519950|NCT01051921|616249893|FG000|Overall Study|Withdrawal by Subject|7|||
170764407|NCT02377362|617141854|FG005|Part A Second Treatment|Protocol Violation|0|||
170764408|NCT02377362|617141855|FG006|Part A Second Treatment|Protocol Violation|0|||
170764409|NCT02377362|617141856|FG007|Part A Second Treatment|Protocol Violation|0|||
170764410|NCT02377362|617141857|FG008|Part A Second Treatment|Protocol Violation|0|||
170764411|NCT02377362|617141858|FG009|Part A Second Treatment|Protocol Violation|0|||
170764412|NCT02377362|617141859|FG010|Part A Second Treatment|Protocol Violation|0|||
170764413|NCT02377362|617141860|FG011|Part A Second Treatment|Protocol Violation|0|||
170764414|NCT02377362|617141861|FG012|Part A Second Treatment|Protocol Violation|0|||
170764415|NCT02377362|617141849|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764416|NCT02377362|617141850|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764417|NCT02377362|617141851|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764418|NCT02377362|617141852|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
170764419|NCT02377362|617141853|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
170764420|NCT02377362|617141854|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
170764421|NCT02377362|617141855|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764422|NCT02377362|617141856|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764423|NCT02377362|617141857|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764424|NCT02377362|617141858|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764425|NCT02377362|617141859|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764426|NCT02377362|617141860|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764427|NCT02377362|617141861|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
170764428|NCT02377362|617141849|FG000|Part B Overall|Protocol Violation|0|||
170764429|NCT02377362|617141850|FG001|Part B Overall|Protocol Violation|0|||
170764430|NCT02377362|617141851|FG002|Part B Overall|Protocol Violation|0|||
170764431|NCT02377362|617141852|FG003|Part B Overall|Protocol Violation|0|||
170764432|NCT02377362|617141853|FG004|Part B Overall|Protocol Violation|0|||
170764433|NCT02377362|617141854|FG005|Part B Overall|Protocol Violation|0|||
170764434|NCT02377362|617141855|FG006|Part B Overall|Protocol Violation|0|||
170764435|NCT02377362|617141856|FG007|Part B Overall|Protocol Violation|0|||
170764436|NCT02377362|617141857|FG008|Part B Overall|Protocol Violation|0|||
170764437|NCT02377362|617141858|FG009|Part B Overall|Protocol Violation|1|||
170764438|NCT02377362|617141859|FG010|Part B Overall|Protocol Violation|0|||
170764439|NCT02377362|617141860|FG011|Part B Overall|Protocol Violation|0|||
170764440|NCT02377362|617141861|FG012|Part B Overall|Protocol Violation|0|||
170764441|NCT02377362|617141849|FG000|Part B Overall|Adverse Event|0|||
170764442|NCT02377362|617141850|FG001|Part B Overall|Adverse Event|0|||
170764443|NCT02377362|617141851|FG002|Part B Overall|Adverse Event|0|||
170764444|NCT02377362|617141852|FG003|Part B Overall|Adverse Event|0|||
170764445|NCT02377362|617141853|FG004|Part B Overall|Adverse Event|0|||
170764446|NCT02377362|617141854|FG005|Part B Overall|Adverse Event|0|||
170764447|NCT02377362|617141855|FG006|Part B Overall|Adverse Event|1|||
170764448|NCT02377362|617141856|FG007|Part B Overall|Adverse Event|1|||
170764449|NCT02377362|617141857|FG008|Part B Overall|Adverse Event|0|||
170764450|NCT02377362|617141858|FG009|Part B Overall|Adverse Event|0|||
170764451|NCT02377362|617141859|FG010|Part B Overall|Adverse Event|0|||
170764452|NCT02377362|617141860|FG011|Part B Overall|Adverse Event|0|||
170764453|NCT02377362|617141861|FG012|Part B Overall|Adverse Event|0|||
170868006|NCT01109173|617528251|FG002|Overall Study|Lost to Follow-up|0|||
170868007|NCT01109173|617528252|FG003|Overall Study|Lost to Follow-up|0|||
170868008|NCT01109173|617528249|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
170764454|NCT02377362|617141849|FG000|Part B Overall|Withdrawal by Subject|0|||
170764455|NCT02377362|617141850|FG001|Part B Overall|Withdrawal by Subject|0|||
170764456|NCT02377362|617141851|FG002|Part B Overall|Withdrawal by Subject|0|||
170764457|NCT02377362|617141852|FG003|Part B Overall|Withdrawal by Subject|0|||
170764458|NCT02377362|617141853|FG004|Part B Overall|Withdrawal by Subject|0|||
170764459|NCT02377362|617141854|FG005|Part B Overall|Withdrawal by Subject|0|||
170868009|NCT01109173|617528250|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
170868010|NCT01109173|617528251|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
170764460|NCT02377362|617141855|FG006|Part B Overall|Withdrawal by Subject|1|||
170764461|NCT02377362|617141856|FG007|Part B Overall|Withdrawal by Subject|0|||
170764462|NCT02377362|617141857|FG008|Part B Overall|Withdrawal by Subject|0|||
170764463|NCT02377362|617141858|FG009|Part B Overall|Withdrawal by Subject|0|||
170764464|NCT02377362|617141859|FG010|Part B Overall|Withdrawal by Subject|0|||
170764465|NCT02377362|617141860|FG011|Part B Overall|Withdrawal by Subject|1|||
170764466|NCT02377362|617141861|FG012|Part B Overall|Withdrawal by Subject|0|||
170764467|NCT04889664|617141864|FG000|Screen|Lost to Follow-up|1|||
170764468|NCT04889664|617141864|FG000|Screen|Failed to meet screening criteria|1|||
170764469|NCT04889664|617141864|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
170764470|NCT01651949|617141866|FG000|Overall Study|Unknown status|4|||
170764471|NCT01651949|617141867|FG001|Overall Study|Unknown status|4|||
170764472|NCT01651949|617141868|FG002|Overall Study|Unknown status|0|||
170764473|NCT01651949|617141866|FG000|Overall Study|Lost to Follow-up|30|||
170764474|NCT01651949|617141867|FG001|Overall Study|Lost to Follow-up|56|||
170764475|NCT01651949|617141868|FG002|Overall Study|Lost to Follow-up|20|||
170764476|NCT01651949|617141866|FG000|Overall Study|Protocol Violation|0|||
170764477|NCT01651949|617141867|FG001|Overall Study|Protocol Violation|2|||
170764478|NCT01651949|617141868|FG002|Overall Study|Protocol Violation|1|||
170764479|NCT01651949|617141866|FG000|Overall Study|Physician Decision|0|||
170764480|NCT01651949|617141867|FG001|Overall Study|Physician Decision|2|||
170764481|NCT01651949|617141868|FG002|Overall Study|Physician Decision|0|||
170764482|NCT01651949|617141866|FG000|Overall Study|Adverse Event|0|||
170764483|NCT01651949|617141867|FG001|Overall Study|Adverse Event|2|||
170764484|NCT01651949|617141868|FG002|Overall Study|Adverse Event|1|||
170764485|NCT01651949|617141866|FG000|Overall Study|Screen failure|2|||
170764486|NCT01651949|617141867|FG001|Overall Study|Screen failure|2|||
170764487|NCT01651949|617141868|FG002|Overall Study|Screen failure|0|||
170764488|NCT01651949|617141866|FG000|Overall Study|Withdrawal by Subject|17|||
170764489|NCT01651949|617141867|FG001|Overall Study|Withdrawal by Subject|18|||
170764490|NCT01651949|617141868|FG002|Overall Study|Withdrawal by Subject|9|||
170764491|NCT01806714|617141871|FG000|Overall Study|No functioning phone number|200|||
170764492|NCT01806714|617141872|FG001|Overall Study|No functioning phone number|170|||
170764493|NCT00771849|617141874|FG000|Overall Study|Lost to Follow-up|1|||
170764494|NCT00771849|617141875|FG001|Overall Study|Lost to Follow-up|2|||
170764495|NCT00771849|617141874|FG000|Overall Study|Withdrawal by Subject|1|||
170764496|NCT00771849|617141875|FG001|Overall Study|Withdrawal by Subject|1|||
170764497|NCT00771849|617141874|FG000|Overall Study|Not vaccinated|0|||
170764498|NCT00771849|617141875|FG001|Overall Study|Not vaccinated|1|||
170764499|NCT00964366|617141879|FG000|Overall Study|Did not qualify at Day 1|1|||
170764500|NCT00964366|617141880|FG001|Overall Study|Did not qualify at Day 1|0|||
170764501|NCT00964366|617141879|FG000|Overall Study|Withdrawal by Subject|0|||
170764502|NCT00964366|617141880|FG001|Overall Study|Withdrawal by Subject|1|||
170764503|NCT02736799|617141881|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
170764504|NCT02736799|617141882|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
170868011|NCT01109173|617528252|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
170409758|NCT01829295|615840168|FG002|6-12 Months|Withdrawal by Subject|0|||
170409759|NCT01829295|615840169|FG003|6-12 Months|Withdrawal by Subject|0|||
170409760|NCT03443869|615840170|FG000|Overall Study|Death|3|||
170409761|NCT03443869|615840171|FG001|Overall Study|Death|3|||
170409762|NCT03443869|615840170|FG000|Overall Study|Withdrawal by Subject|34|||
170409763|NCT03443869|615840171|FG001|Overall Study|Withdrawal by Subject|22|||
170409764|NCT03443869|615840170|FG000|Overall Study|Lost to Follow-up|1|||
170409765|NCT03443869|615840171|FG001|Overall Study|Lost to Follow-up|2|||
170409766|NCT03443869|615840170|FG000|Overall Study|Physician Decision|3|||
170409767|NCT03443869|615840171|FG001|Overall Study|Physician Decision|3|||
170409768|NCT03443869|615840170|FG000|Overall Study|Other|4|||
170409769|NCT03443869|615840171|FG001|Overall Study|Other|4|||
170409770|NCT02390219|615840172|FG000|Overall Study|Death|1|||
170409771|NCT02390219|615840172|FG000|Overall Study|Physician Decision|1|||
170409772|NCT02390219|615840172|FG000|Overall Study|Adverse Event|6|||
170409773|NCT02390219|615840172|FG000|Overall Study|Withdrawal by Subject|1|||
170409774|NCT02390219|615840172|FG000|Overall Study|Lost to Follow-up|2|||
170409775|NCT02390219|615840172|FG000|Overall Study|Other|2|||
170409776|NCT00931385|615840173|FG000|Overall Study|Adverse Event|2|||
170409777|NCT00931385|615840174|FG001|Overall Study|Adverse Event|1|||
170409778|NCT00931385|615840175|FG002|Overall Study|Adverse Event|0|||
170409779|NCT00931385|615840176|FG003|Overall Study|Adverse Event|3|||
170409780|NCT00931385|615840173|FG000|Overall Study|Protocol Violation|0|||
170409781|NCT00931385|615840174|FG001|Overall Study|Protocol Violation|0|||
170409782|NCT00931385|615840175|FG002|Overall Study|Protocol Violation|1|||
170409783|NCT00931385|615840176|FG003|Overall Study|Protocol Violation|0|||
170409784|NCT00931385|615840173|FG000|Overall Study|Withdrawal by Subject|0|||
170764505|NCT02736799|617141883|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
170764506|NCT02736799|617141884|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
170764507|NCT00130637|617141891|FG000|Overall Study|Adverse Event|2|||
170764508|NCT00130637|617141891|FG000|Overall Study|Withdrawal by Subject|1|||
170519951|NCT01051921|616249893|FG000|Overall Study|Lost to Follow-up|4|||
170519952|NCT01051921|616249893|FG000|Overall Study|virological failure|1|||
170519953|NCT01051921|616249893|FG000|Overall Study|patient moved|1|||
170519954|NCT00379834|616249894|FG000|Overall Study|Time constraints|2|||
170519955|NCT01519817|616249895|FG000|Overall Study|Withdrawal by Subject|1|||
170519956|NCT01519817|616249896|FG001|Overall Study|Withdrawal by Subject|0|||
170519957|NCT01519817|616249897|FG002|Overall Study|Withdrawal by Subject|0|||
170519958|NCT01519817|616249898|FG003|Overall Study|Withdrawal by Subject|0|||
170519959|NCT01519817|616249895|FG000|Overall Study|Off study due to infection|0|||
170519960|NCT01519817|616249896|FG001|Overall Study|Off study due to infection|0|||
170519961|NCT01519817|616249897|FG002|Overall Study|Off study due to infection|0|||
170519962|NCT01519817|616249898|FG003|Overall Study|Off study due to infection|1|||
170519963|NCT03934216|616249903|FG000|Overall Study|Other Reasons|5|||
170519964|NCT03934216|616249904|FG001|Overall Study|Other Reasons|5|||
170519965|NCT03934216|616249903|FG000|Overall Study|Adverse Event|22|||
170519966|NCT03934216|616249904|FG001|Overall Study|Adverse Event|11|||
170519967|NCT03934216|616249903|FG000|Overall Study|Lack of Efficacy|8|||
170519968|NCT03934216|616249904|FG001|Overall Study|Lack of Efficacy|7|||
170764509|NCT00217672|617141896|FG000|Allocation|Ineligible|2|||
170764510|NCT00217672|617141897|FG001|Allocation|Ineligible|0|||
170764511|NCT00217672|617141896|FG000|Treatment|disease progression|33|||
170764512|NCT00217672|617141897|FG001|Treatment|disease progression|4|||
170764513|NCT00217672|617141896|FG000|Treatment|Adverse Event|18|||
170764514|NCT00217672|617141897|FG001|Treatment|Adverse Event|2|||
170764515|NCT00217672|617141896|FG000|Treatment|reqd treatment not permitted by protocol|6|||
170868012|NCT01109173|617528249|FG000|Overall Study|Noncompliance|0|||
170764516|NCT00217672|617141897|FG001|Treatment|reqd treatment not permitted by protocol|0|||
170764517|NCT00217672|617141896|FG000|Treatment|Physician Decision|6|||
170764518|NCT00217672|617141897|FG001|Treatment|Physician Decision|0|||
170764519|NCT00217672|617141896|FG000|Treatment|insurance issues|1|||
170764520|NCT00217672|617141897|FG001|Treatment|insurance issues|1|||
170764521|NCT00217672|617141896|FG000|Treatment|Death|2|||
170764522|NCT00217672|617141897|FG001|Treatment|Death|0|||
170764523|NCT00217672|617141896|FG000|Treatment|secondary malignancy|1|||
170764524|NCT00217672|617141897|FG001|Treatment|secondary malignancy|0|||
170764525|NCT00217672|617141896|FG000|Follow-up|Withdrawal by Subject|4|||
170764526|NCT00217672|617141897|FG001|Follow-up|Withdrawal by Subject|0|||
170764527|NCT00217672|617141896|FG000|Follow-up|Lost to Follow-up|1|||
170764528|NCT00217672|617141897|FG001|Follow-up|Lost to Follow-up|0|||
170764529|NCT01157182|617141901|FG000|Washout of 28 Days|Adverse Event|2|||
170764530|NCT01157182|617141902|FG001|Washout of 28 Days|Adverse Event|0|||
170764531|NCT00319436|617141907|FG000|Overall Study|Withdrawal by Subject|6|||
170764532|NCT00319436|617141908|FG001|Overall Study|Withdrawal by Subject|7|||
170764533|NCT02914522|617141911|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
170764534|NCT02914522|617141912|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
170764535|NCT02914522|617141913|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
170764536|NCT02914522|617141914|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
170764537|NCT02914522|617141915|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
170764538|NCT02914522|617141916|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
170764539|NCT02914522|617141917|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
170764540|NCT02914522|617141918|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
170764541|NCT02914522|617141919|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
170764542|NCT02914522|617141920|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
170764543|NCT02914522|617141921|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
170764544|NCT02914522|617141911|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
170764545|NCT02914522|617141912|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
170764546|NCT02914522|617141913|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
170764547|NCT02914522|617141914|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
170764548|NCT02914522|617141915|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
170764549|NCT02914522|617141916|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
170764550|NCT02914522|617141917|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
170764551|NCT02914522|617141918|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
170764552|NCT02914522|617141919|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
170764553|NCT02914522|617141920|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
170764554|NCT02914522|617141921|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
170764555|NCT02914522|617141911|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
170764556|NCT02914522|617141912|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
170519969|NCT03934216|616249903|FG000|Overall Study|Lost to Follow-up|2|||
170519970|NCT03934216|616249904|FG001|Overall Study|Lost to Follow-up|0|||
170519971|NCT03934216|616249903|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170764557|NCT02914522|617141913|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
170519972|NCT03934216|616249904|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170764558|NCT02914522|617141914|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
170764559|NCT02914522|617141915|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
170764560|NCT02914522|617141916|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
170868013|NCT01109173|617528250|FG001|Overall Study|Noncompliance|1|||
170519973|NCT03934216|616249903|FG000|Overall Study|Pregnancy|1|||
170519974|NCT03934216|616249904|FG001|Overall Study|Pregnancy|0|||
170519975|NCT03934216|616249903|FG000|Overall Study|Withdrawal by Subject|18|||
170519976|NCT03934216|616249904|FG001|Overall Study|Withdrawal by Subject|6|||
170519977|NCT03934216|616249903|FG000|Overall Study|Randomized but not treated|1|||
170519978|NCT03934216|616249904|FG001|Overall Study|Randomized but not treated|1|||
170519979|NCT00735709|616249905|FG000|Overall Study|Adverse Event|2|||
170519980|NCT00735709|616249906|FG001|Overall Study|Adverse Event|3|||
170519981|NCT00735709|616249907|FG002|Overall Study|Adverse Event|1|||
170519982|NCT00735709|616249908|FG003|Overall Study|Adverse Event|5|||
170519983|NCT00735709|616249905|FG000|Overall Study|Lack of Efficacy|8|||
170519984|NCT00735709|616249906|FG001|Overall Study|Lack of Efficacy|4|||
170519985|NCT00735709|616249907|FG002|Overall Study|Lack of Efficacy|2|||
170519986|NCT00735709|616249908|FG003|Overall Study|Lack of Efficacy|3|||
170519987|NCT00735709|616249905|FG000|Overall Study|Noncompliance|0|||
170519988|NCT00735709|616249906|FG001|Overall Study|Noncompliance|0|||
170519989|NCT00735709|616249907|FG002|Overall Study|Noncompliance|1|||
170519990|NCT00735709|616249908|FG003|Overall Study|Noncompliance|0|||
170519991|NCT00735709|616249905|FG000|Overall Study|Protocol deviations|1|||
170519992|NCT00735709|616249906|FG001|Overall Study|Protocol deviations|2|||
170519993|NCT00735709|616249907|FG002|Overall Study|Protocol deviations|1|||
170519994|NCT00735709|616249908|FG003|Overall Study|Protocol deviations|1|||
170519995|NCT00735709|616249905|FG000|Overall Study|Voluntary Withdrawal|1|||
170519996|NCT00735709|616249906|FG001|Overall Study|Voluntary Withdrawal|3|||
170519997|NCT00735709|616249907|FG002|Overall Study|Voluntary Withdrawal|5|||
170519998|NCT00735709|616249908|FG003|Overall Study|Voluntary Withdrawal|7|||
170519999|NCT00735709|616249905|FG000|Overall Study|Lost to Follow-up|0|||
170520000|NCT00735709|616249906|FG001|Overall Study|Lost to Follow-up|1|||
170520001|NCT00735709|616249907|FG002|Overall Study|Lost to Follow-up|1|||
170520002|NCT00735709|616249908|FG003|Overall Study|Lost to Follow-up|1|||
170520003|NCT00735709|616249905|FG000|Overall Study|Excluded medication|1|||
170520004|NCT00735709|616249906|FG001|Overall Study|Excluded medication|0|||
170520005|NCT00735709|616249907|FG002|Overall Study|Excluded medication|0|||
170520006|NCT00735709|616249908|FG003|Overall Study|Excluded medication|1|||
170520007|NCT02119299|616249913|FG000|Overall Study|Withdrawal by Subject|7|||
170520008|NCT02119299|616249913|FG000|Overall Study|Lack of Efficacy|1|||
170520009|NCT02119299|616249913|FG000|Overall Study|Pregnancy|1|||
170520010|NCT05137717|616249920|FG000|Overall Study|Death|2|||
170520011|NCT05137717|616249920|FG000|Overall Study|Withdrawal by Subject|6|||
170520012|NCT01265394|616249924|FG000|Overall Study|Subjects withdrawn|37|||
170520013|NCT00735943|616249925|FG000|Overall Study|Lost to Follow-up|1|||
170520014|NCT00735943|616249925|FG000|Overall Study|Adverse Event|1|||
170520015|NCT02595502|616249929|FG000|Period 1|Adverse Event|0|||
170520016|NCT02595502|616249930|FG001|Period 1|Adverse Event|1|||
170520017|NCT02595502|616249929|FG000|Period 1|Withdrawal by Subject|1|||
170520018|NCT02595502|616249930|FG001|Period 1|Withdrawal by Subject|0|||
170520019|NCT02595502|616249929|FG000|Period 1|Lost to Follow-up|0|||
170520020|NCT02595502|616249930|FG001|Period 1|Lost to Follow-up|1|||
170520021|NCT02595502|616249929|FG000|Period 2|Adverse Event|1|||
170520022|NCT02595502|616249930|FG001|Period 2|Adverse Event|1|||
170520023|NCT02595502|616249929|FG000|Period 2|Received incorrect lens at Period 1|0|||
170520024|NCT02595502|616249930|FG001|Period 2|Received incorrect lens at Period 1|1|||
170520025|NCT02595502|616249929|FG000|Period 3|Protocol Violation|0|||
170520026|NCT02595502|616249930|FG001|Period 3|Protocol Violation|1|||
170520027|NCT02595502|616249929|FG000|Period 3|Lost to Follow-up|1|||
170520028|NCT02595502|616249930|FG001|Period 3|Lost to Follow-up|0|||
170520029|NCT02595502|616249929|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
170520030|NCT02595502|616249930|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
170520031|NCT00974311|616249931|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
170520032|NCT00974311|616249932|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
170520033|NCT00974311|616249931|FG000|DB Phase (up to 24 Months)|Death|561|||
170520034|NCT00974311|616249932|FG001|DB Phase (up to 24 Months)|Death|298|||
170520035|NCT00974311|616249931|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
170520036|NCT00974311|616249932|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
170520037|NCT00974311|616249931|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
170520038|NCT00974311|616249932|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
170520039|NCT00974311|616249931|FG000|DB Phase (up to 24 Months)|Other|1|||
170520040|NCT00974311|616249932|FG001|DB Phase (up to 24 Months)|Other|0|||
170520041|NCT00974311|616249931|FG000|OLE Phase (up to 77 Months)|Death|14|||
170520042|NCT00974311|616249932|FG001|OLE Phase (up to 77 Months)|Death|21|||
170520043|NCT00974311|616249931|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
170520044|NCT00974311|616249932|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
170520045|NCT00974311|616249931|FG000|OLE Phase (up to 77 Months)|Other|15|||
170520046|NCT00974311|616249932|FG001|OLE Phase (up to 77 Months)|Other|2|||
170520047|NCT00974311|616249931|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
170520048|NCT00974311|616249932|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
170520049|NCT00458003|616249935|FG000|Overall Study|Non protocol spinal anesthesia|1|||
170520050|NCT00458003|616249936|FG001|Overall Study|Non protocol spinal anesthesia|1|||
170764561|NCT02914522|617141917|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
170764562|NCT02914522|617141918|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
170764563|NCT02914522|617141919|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
170764564|NCT02914522|617141920|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
170764565|NCT02914522|617141921|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
170764566|NCT02914522|617141911|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
170764567|NCT02914522|617141912|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
170764568|NCT02914522|617141913|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
170764569|NCT02914522|617141914|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
170764570|NCT02914522|617141915|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
170764571|NCT02914522|617141916|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
170764572|NCT02914522|617141917|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
170764573|NCT02914522|617141918|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
170764574|NCT02914522|617141919|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
170764575|NCT02914522|617141920|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
170764576|NCT02914522|617141921|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
170764577|NCT02914522|617141911|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764578|NCT02914522|617141912|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764579|NCT02914522|617141913|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764580|NCT02914522|617141914|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764581|NCT02914522|617141915|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
170764582|NCT02914522|617141916|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764583|NCT02914522|617141917|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764584|NCT02914522|617141918|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764585|NCT02914522|617141919|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170409785|NCT00931385|615840174|FG001|Overall Study|Withdrawal by Subject|1|||
170409786|NCT00931385|615840175|FG002|Overall Study|Withdrawal by Subject|0|||
170409787|NCT00931385|615840176|FG003|Overall Study|Withdrawal by Subject|1|||
170409788|NCT00931385|615840173|FG000|Overall Study|Lost to Follow-up|0|||
170409789|NCT00931385|615840174|FG001|Overall Study|Lost to Follow-up|0|||
170409790|NCT00931385|615840175|FG002|Overall Study|Lost to Follow-up|0|||
170409791|NCT00931385|615840176|FG003|Overall Study|Lost to Follow-up|1|||
170409792|NCT02230085|615840179|FG000|Overall Study|Physician Decision|1|||
170409793|NCT02230085|615840179|FG000|Overall Study|Withdrawal by Subject|3|||
170409794|NCT00580983|615840180|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
170409795|NCT01360632|615840181|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
170409796|NCT01360632|615840182|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
170409797|NCT01360632|615840183|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
170409798|NCT01360632|615840184|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
170409799|NCT01360632|615840185|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
170409800|NCT01360632|615840181|FG000|Phase A (8 Weeks)|Adverse Event|60|||
170409801|NCT01360632|615840182|FG001|Phase A (8 Weeks)|Adverse Event|0|||
170409802|NCT01360632|615840183|FG002|Phase A (8 Weeks)|Adverse Event|0|||
170409803|NCT01360632|615840184|FG003|Phase A (8 Weeks)|Adverse Event|0|||
170409804|NCT01360632|615840185|FG004|Phase A (8 Weeks)|Adverse Event|0|||
170409805|NCT01360632|615840181|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
170409806|NCT01360632|615840182|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
170409807|NCT01360632|615840183|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
170409808|NCT01360632|615840184|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
170764586|NCT02914522|617141920|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764587|NCT02914522|617141921|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
170764588|NCT02914522|617141911|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
170764589|NCT02914522|617141912|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764590|NCT02914522|617141913|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764591|NCT02914522|617141914|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764592|NCT02914522|617141915|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764593|NCT02914522|617141916|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764594|NCT02914522|617141917|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764595|NCT02914522|617141918|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764596|NCT02914522|617141919|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764597|NCT02914522|617141920|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764598|NCT02914522|617141921|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
170764599|NCT02914522|617141911|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
170764600|NCT02914522|617141912|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
170764601|NCT02914522|617141913|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
170764602|NCT02914522|617141914|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
170764603|NCT02914522|617141915|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
170764604|NCT02914522|617141916|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
170764605|NCT02914522|617141917|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
170409809|NCT01360632|615840185|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
170520051|NCT03286218|616249937|FG000|Qualification Phase Period 1|Adverse Event|1|||
170520052|NCT03286218|616249938|FG001|Qualification Phase Period 1|Adverse Event|0|||
170520053|NCT03286218|616249939|FG002|Qualification Phase Period 1|Adverse Event|0|||
170764606|NCT02914522|617141918|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
170764607|NCT02914522|617141919|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
170764608|NCT02914522|617141920|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
170764609|NCT02914522|617141921|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
170764610|NCT02914522|617141911|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
170764611|NCT02914522|617141912|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
170764612|NCT02914522|617141913|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
170764613|NCT02914522|617141914|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
170764614|NCT02914522|617141915|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
170764615|NCT02914522|617141916|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
170764616|NCT02914522|617141917|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
170764617|NCT02914522|617141918|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
170764618|NCT02914522|617141919|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
170764619|NCT02914522|617141920|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
170764620|NCT02914522|617141921|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
170764621|NCT02914522|617141911|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
170764622|NCT02914522|617141912|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
170409810|NCT01360632|615840181|FG000|Phase A (8 Weeks)|Physician Decision|10|||
170409811|NCT01360632|615840182|FG001|Phase A (8 Weeks)|Physician Decision|0|||
170409812|NCT01360632|615840183|FG002|Phase A (8 Weeks)|Physician Decision|0|||
170409813|NCT01360632|615840184|FG003|Phase A (8 Weeks)|Physician Decision|0|||
170409814|NCT01360632|615840185|FG004|Phase A (8 Weeks)|Physician Decision|0|||
170409815|NCT01360632|615840181|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
170409816|NCT01360632|615840182|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
170409817|NCT01360632|615840183|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
170409818|NCT01360632|615840184|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
170409819|NCT01360632|615840185|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
170409820|NCT01360632|615840181|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
170409821|NCT01360632|615840182|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
170409822|NCT01360632|615840183|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
170409823|NCT01360632|615840184|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
170409824|NCT01360632|615840185|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
170409825|NCT01360632|615840181|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
170409826|NCT01360632|615840182|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
170409827|NCT01360632|615840183|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
170409828|NCT01360632|615840184|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
170409829|NCT01360632|615840185|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
170409830|NCT01360632|615840181|FG000|Phase B (6 Weeks)|Adverse Event|0|||
170409831|NCT01360632|615840182|FG001|Phase B (6 Weeks)|Adverse Event|3|||
170409832|NCT01360632|615840183|FG002|Phase B (6 Weeks)|Adverse Event|9|||
170409833|NCT01360632|615840184|FG003|Phase B (6 Weeks)|Adverse Event|3|||
170409834|NCT01360632|615840185|FG004|Phase B (6 Weeks)|Adverse Event|0|||
170409835|NCT01360632|615840181|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
170409836|NCT01360632|615840182|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
170409837|NCT01360632|615840183|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
170409838|NCT01360632|615840184|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
170409839|NCT01360632|615840185|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
170409840|NCT01360632|615840181|FG000|Phase B (6 Weeks)|Physician Decision|0|||
170409841|NCT01360632|615840182|FG001|Phase B (6 Weeks)|Physician Decision|0|||
170409842|NCT01360632|615840183|FG002|Phase B (6 Weeks)|Physician Decision|0|||
170409843|NCT01360632|615840184|FG003|Phase B (6 Weeks)|Physician Decision|1|||
170409844|NCT01360632|615840185|FG004|Phase B (6 Weeks)|Physician Decision|0|||
170409845|NCT01360632|615840181|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
170409846|NCT01360632|615840182|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
170409847|NCT01360632|615840183|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
170409848|NCT01360632|615840184|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
170409849|NCT01360632|615840185|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
170409850|NCT01360632|615840181|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
170409851|NCT01360632|615840182|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
170409852|NCT01360632|615840183|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
170409853|NCT01360632|615840184|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
170409854|NCT01360632|615840185|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
170409855|NCT01360632|615840181|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
170409856|NCT01360632|615840182|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
170409857|NCT01360632|615840183|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
170409858|NCT01360632|615840184|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
170409859|NCT01360632|615840185|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
170409860|NCT01360632|615840181|FG000|Phase A+|Lost to Follow-up|0|||
170409861|NCT01360632|615840182|FG001|Phase A+|Lost to Follow-up|0|||
170520054|NCT03286218|616249940|FG003|Qualification Phase Period 1|Adverse Event|0|||
170520055|NCT03286218|616249941|FG004|Qualification Phase Period 1|Adverse Event|0|||
170520056|NCT03286218|616249942|FG005|Qualification Phase Period 1|Adverse Event|0|||
170520057|NCT03286218|616249943|FG006|Qualification Phase Period 1|Adverse Event|0|||
170520058|NCT03286218|616249944|FG007|Qualification Phase Period 1|Adverse Event|0|||
170520059|NCT03286218|616249945|FG008|Qualification Phase Period 1|Adverse Event|0|||
170520060|NCT03286218|616249946|FG009|Qualification Phase Period 1|Adverse Event|0|||
170520061|NCT03286218|616249947|FG010|Qualification Phase Period 1|Adverse Event|0|||
170520062|NCT03286218|616249948|FG011|Qualification Phase Period 1|Adverse Event|0|||
170520063|NCT03286218|616249937|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520064|NCT03286218|616249938|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
170520065|NCT03286218|616249939|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520066|NCT03286218|616249940|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520067|NCT03286218|616249941|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520068|NCT03286218|616249942|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520069|NCT03286218|616249943|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520070|NCT03286218|616249944|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520071|NCT03286218|616249945|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520072|NCT03286218|616249946|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520073|NCT03286218|616249947|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
170409862|NCT01360632|615840183|FG002|Phase A+|Lost to Follow-up|0|||
170409863|NCT01360632|615840184|FG003|Phase A+|Lost to Follow-up|0|||
170409864|NCT01360632|615840185|FG004|Phase A+|Lost to Follow-up|2|||
170409865|NCT01360632|615840181|FG000|Phase A+|Adverse Event|0|||
170409866|NCT01360632|615840182|FG001|Phase A+|Adverse Event|0|||
170409867|NCT01360632|615840183|FG002|Phase A+|Adverse Event|0|||
170409868|NCT01360632|615840184|FG003|Phase A+|Adverse Event|0|||
170409869|NCT01360632|615840185|FG004|Phase A+|Adverse Event|2|||
170409870|NCT01360632|615840181|FG000|Phase A+|Met Withdrawal Criteria|0|||
170409871|NCT01360632|615840182|FG001|Phase A+|Met Withdrawal Criteria|0|||
170409872|NCT01360632|615840183|FG002|Phase A+|Met Withdrawal Criteria|0|||
170409873|NCT01360632|615840184|FG003|Phase A+|Met Withdrawal Criteria|0|||
170764623|NCT02914522|617141913|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
170764624|NCT02914522|617141914|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
170764625|NCT02914522|617141915|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
170764626|NCT02914522|617141916|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
170764627|NCT02914522|617141917|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
170764628|NCT02914522|617141918|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
170764629|NCT02914522|617141919|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
170764630|NCT02914522|617141920|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
170764631|NCT02914522|617141921|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
170764632|NCT02914522|617141911|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
170764633|NCT02914522|617141912|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
170764634|NCT02914522|617141913|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
170764635|NCT02914522|617141914|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
170764636|NCT02914522|617141915|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
170764637|NCT02914522|617141916|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
170764638|NCT02914522|617141917|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
170764639|NCT02914522|617141918|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
170764640|NCT02914522|617141919|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
170764641|NCT02914522|617141920|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
170764642|NCT02914522|617141921|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
170764643|NCT02914522|617141911|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
170764644|NCT02914522|617141912|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
170764645|NCT02914522|617141913|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
170764646|NCT02914522|617141914|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
170764647|NCT02914522|617141915|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
170764648|NCT02914522|617141916|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
170520074|NCT03286218|616249948|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
170520075|NCT03286218|616249937|FG000|Qualification Phase Period 2|Adverse Event|0|||
170520076|NCT03286218|616249938|FG001|Qualification Phase Period 2|Adverse Event|1|||
170632134|NCT02177032|616664530|FG000|Overall Study|Withdrawal by Subject|1|||
170632135|NCT02177032|616664531|FG001|Overall Study|Withdrawal by Subject|0|||
170409874|NCT01360632|615840185|FG004|Phase A+|Met Withdrawal Criteria|7|||
170409875|NCT01360632|615840181|FG000|Phase A+|Physician Decision|0|||
170409876|NCT01360632|615840182|FG001|Phase A+|Physician Decision|0|||
170409877|NCT01360632|615840183|FG002|Phase A+|Physician Decision|0|||
170409878|NCT01360632|615840184|FG003|Phase A+|Physician Decision|0|||
170764649|NCT02914522|617141917|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
170764650|NCT02914522|617141918|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
170764651|NCT02914522|617141919|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
170764652|NCT02914522|617141920|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
170764653|NCT02914522|617141921|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
170764654|NCT02914522|617141911|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
170764655|NCT02914522|617141912|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
170764656|NCT02914522|617141913|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
170764657|NCT02914522|617141914|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
170764658|NCT02914522|617141915|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
170764659|NCT02914522|617141916|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
170764660|NCT02914522|617141917|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
170764661|NCT02914522|617141918|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
170764662|NCT02914522|617141919|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
170764663|NCT02914522|617141920|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
170764664|NCT02914522|617141921|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
170764665|NCT02914522|617141911|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
170764666|NCT02914522|617141912|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
170764667|NCT02914522|617141913|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
170764668|NCT02914522|617141914|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
170764669|NCT02914522|617141915|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
170764670|NCT02914522|617141916|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
170764671|NCT02914522|617141917|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
170764672|NCT02914522|617141918|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
170764673|NCT02914522|617141919|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
170764674|NCT02914522|617141920|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
170764675|NCT02914522|617141921|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
170764676|NCT02914522|617141911|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764677|NCT02914522|617141912|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764678|NCT02914522|617141913|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764679|NCT02914522|617141914|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764680|NCT02914522|617141915|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764681|NCT02914522|617141916|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764682|NCT02914522|617141917|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764683|NCT02914522|617141918|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
170764684|NCT02914522|617141919|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
170764685|NCT02914522|617141920|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764686|NCT02914522|617141921|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
170764687|NCT02914522|617141911|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764688|NCT02914522|617141912|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764689|NCT02914522|617141913|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764690|NCT02914522|617141914|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764691|NCT02914522|617141915|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764692|NCT02914522|617141916|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764693|NCT02914522|617141917|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764694|NCT02914522|617141918|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764695|NCT02914522|617141919|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
170764696|NCT02914522|617141920|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
170764697|NCT02914522|617141921|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
170764698|NCT02914522|617141911|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764699|NCT02914522|617141912|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764700|NCT02914522|617141913|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764701|NCT02914522|617141914|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764702|NCT02914522|617141915|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764703|NCT02914522|617141916|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764704|NCT02914522|617141917|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764705|NCT02914522|617141918|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764706|NCT02914522|617141919|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764707|NCT02914522|617141920|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
170764708|NCT02914522|617141921|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
170764709|NCT01253226|617141922|FG000|Overall Study|Adverse Event|0|||
170764710|NCT01253226|617141923|FG001|Overall Study|Adverse Event|0|||
170764711|NCT01253226|617141924|FG002|Overall Study|Adverse Event|1|||
170764712|NCT01253226|617141925|FG003|Overall Study|Adverse Event|0|||
170409879|NCT01360632|615840185|FG004|Phase A+|Physician Decision|3|||
170409880|NCT01360632|615840181|FG000|Phase A+|Withdrawal by Subject|0|||
170764713|NCT01253226|617141926|FG004|Overall Study|Adverse Event|0|||
170764714|NCT01253226|617141922|FG000|Overall Study|Death|0|||
170764715|NCT01253226|617141923|FG001|Overall Study|Death|1|||
170764716|NCT01253226|617141924|FG002|Overall Study|Death|0|||
170764717|NCT01253226|617141925|FG003|Overall Study|Death|0|||
170764718|NCT01253226|617141926|FG004|Overall Study|Death|0|||
170764719|NCT01253226|617141922|FG000|Overall Study|Physician Decision|0|||
170409881|NCT01360632|615840182|FG001|Phase A+|Withdrawal by Subject|0|||
170409882|NCT01360632|615840183|FG002|Phase A+|Withdrawal by Subject|0|||
170409883|NCT01360632|615840184|FG003|Phase A+|Withdrawal by Subject|0|||
170409884|NCT01360632|615840185|FG004|Phase A+|Withdrawal by Subject|8|||
170409885|NCT01360632|615840181|FG000|Phase A+|Protocol Deviation|0|||
170409886|NCT01360632|615840182|FG001|Phase A+|Protocol Deviation|0|||
170409887|NCT01360632|615840183|FG002|Phase A+|Protocol Deviation|0|||
170409888|NCT01360632|615840184|FG003|Phase A+|Protocol Deviation|0|||
170409889|NCT01360632|615840185|FG004|Phase A+|Protocol Deviation|3|||
170764720|NCT01253226|617141923|FG001|Overall Study|Physician Decision|0|||
170764721|NCT01253226|617141924|FG002|Overall Study|Physician Decision|0|||
170764722|NCT01253226|617141925|FG003|Overall Study|Physician Decision|0|||
170764723|NCT01253226|617141926|FG004|Overall Study|Physician Decision|2|||
170764724|NCT01253226|617141922|FG000|Overall Study|Withdrawal by Subject|0|||
170764725|NCT01253226|617141923|FG001|Overall Study|Withdrawal by Subject|0|||
170764726|NCT01253226|617141924|FG002|Overall Study|Withdrawal by Subject|0|||
170764727|NCT01253226|617141925|FG003|Overall Study|Withdrawal by Subject|1|||
170764728|NCT01253226|617141926|FG004|Overall Study|Withdrawal by Subject|0|||
170764729|NCT04858425|617141927|FG000|Overall Study|Adverse Event|2|||
170764730|NCT04858425|617141928|FG001|Overall Study|Adverse Event|2|||
170764731|NCT04858425|617141927|FG000|Overall Study|Withdrawal by Subject|3|||
170764732|NCT04858425|617141928|FG001|Overall Study|Withdrawal by Subject|1|||
170764733|NCT04858425|617141927|FG000|Overall Study|Lost to Follow-up|4|||
170764734|NCT04858425|617141928|FG001|Overall Study|Lost to Follow-up|2|||
170764735|NCT04858425|617141927|FG000|Overall Study|Lost to Follow-up|1|||
170764736|NCT04858425|617141928|FG001|Overall Study|Lost to Follow-up|0|||
170764737|NCT02864992|617141929|FG000|Overall Study|still on treatment|15|||
170764738|NCT02864992|617141930|FG001|Overall Study|still on treatment|1|||
170764739|NCT02864992|617141931|FG002|Overall Study|still on treatment|33|||
170764740|NCT00554801|617141933|FG000|Overall Study|left area before completion|5|||
170764741|NCT00554801|617141934|FG001|Overall Study|left area before completion|0|||
170764742|NCT00554801|617141933|FG000|Overall Study|Withdrawal by Subject|14|||
170764743|NCT00554801|617141934|FG001|Overall Study|Withdrawal by Subject|0|||
170764744|NCT00768651|617141937|FG000|Overall Study|Withdrawal by Subject|1|||
170764745|NCT02104765|617141938|FG000|Overall Study|Lost to Follow-up|0|||
170764746|NCT02104765|617141939|FG001|Overall Study|Lost to Follow-up|0|||
170764747|NCT02104765|617141940|FG002|Overall Study|Lost to Follow-up|1|||
170764748|NCT02104765|617141941|FG003|Overall Study|Lost to Follow-up|0|||
170764749|NCT02104765|617141942|FG004|Overall Study|Lost to Follow-up|0|||
170764750|NCT02104765|617141943|FG005|Overall Study|Lost to Follow-up|0|||
170764751|NCT02104765|617141944|FG006|Overall Study|Lost to Follow-up|0|||
170764752|NCT02104765|617141938|FG000|Overall Study|Withdrawal by Subject|0|||
170764753|NCT02104765|617141939|FG001|Overall Study|Withdrawal by Subject|0|||
170764754|NCT02104765|617141940|FG002|Overall Study|Withdrawal by Subject|0|||
170764755|NCT02104765|617141941|FG003|Overall Study|Withdrawal by Subject|1|||
170764756|NCT02104765|617141942|FG004|Overall Study|Withdrawal by Subject|1|||
170764757|NCT02104765|617141943|FG005|Overall Study|Withdrawal by Subject|0|||
170764758|NCT02104765|617141944|FG006|Overall Study|Withdrawal by Subject|1|||
170764759|NCT04771273|617141945|FG000|Dose Escalation Period|Not treated with trial medication|0|||
170764760|NCT04771273|617141946|FG001|Dose Escalation Period|Not treated with trial medication|1|||
170764761|NCT04771273|617141947|FG002|Dose Escalation Period|Not treated with trial medication|1|||
170764762|NCT04771273|617141948|FG003|Dose Escalation Period|Not treated with trial medication|0|||
170764763|NCT04771273|617141945|FG000|Dose Escalation Period|Other reasons than listed|2|||
170764764|NCT04771273|617141946|FG001|Dose Escalation Period|Other reasons than listed|0|||
170764765|NCT04771273|617141947|FG002|Dose Escalation Period|Other reasons than listed|2|||
170764766|NCT04771273|617141948|FG003|Dose Escalation Period|Other reasons than listed|1|||
170764767|NCT04771273|617141945|FG000|Dose Escalation Period|Protocol Violation|0|||
170764768|NCT04771273|617141946|FG001|Dose Escalation Period|Protocol Violation|0|||
170764769|NCT04771273|617141947|FG002|Dose Escalation Period|Protocol Violation|3|||
170764770|NCT04771273|617141948|FG003|Dose Escalation Period|Protocol Violation|1|||
170764771|NCT04771273|617141945|FG000|Dose Escalation Period|Burden of study procedures|1|||
170764772|NCT04771273|617141946|FG001|Dose Escalation Period|Burden of study procedures|0|||
170764773|NCT04771273|617141947|FG002|Dose Escalation Period|Burden of study procedures|0|||
170764774|NCT04771273|617141948|FG003|Dose Escalation Period|Burden of study procedures|0|||
170764775|NCT04771273|617141945|FG000|Dose Escalation Period|Change of residence|0|||
170764776|NCT04771273|617141946|FG001|Dose Escalation Period|Change of residence|0|||
170764777|NCT04771273|617141947|FG002|Dose Escalation Period|Change of residence|0|||
170764778|NCT04771273|617141948|FG003|Dose Escalation Period|Change of residence|1|||
170764779|NCT04771273|617141945|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
170868014|NCT01109173|617528251|FG002|Overall Study|Noncompliance|0|||
170520077|NCT03286218|616249939|FG002|Qualification Phase Period 2|Adverse Event|0|||
170520078|NCT03286218|616249940|FG003|Qualification Phase Period 2|Adverse Event|0|||
170520079|NCT03286218|616249941|FG004|Qualification Phase Period 2|Adverse Event|0|||
170520080|NCT03286218|616249942|FG005|Qualification Phase Period 2|Adverse Event|0|||
170520081|NCT03286218|616249943|FG006|Qualification Phase Period 2|Adverse Event|0|||
170520082|NCT03286218|616249944|FG007|Qualification Phase Period 2|Adverse Event|0|||
170520083|NCT03286218|616249945|FG008|Qualification Phase Period 2|Adverse Event|0|||
170520084|NCT03286218|616249946|FG009|Qualification Phase Period 2|Adverse Event|0|||
170520085|NCT03286218|616249947|FG010|Qualification Phase Period 2|Adverse Event|0|||
170520086|NCT03286218|616249948|FG011|Qualification Phase Period 2|Adverse Event|0|||
170520087|NCT03286218|616249937|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
170520088|NCT03286218|616249938|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
170520089|NCT03286218|616249939|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520090|NCT03286218|616249940|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520091|NCT03286218|616249941|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520092|NCT03286218|616249942|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520093|NCT03286218|616249943|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520094|NCT03286218|616249944|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520095|NCT03286218|616249945|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520096|NCT03286218|616249946|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520097|NCT03286218|616249947|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520098|NCT03286218|616249948|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
170520099|NCT03286218|616249937|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
170520100|NCT03286218|616249938|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
170520101|NCT03286218|616249939|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
170520102|NCT03286218|616249940|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
170520103|NCT03286218|616249941|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
170520104|NCT03286218|616249942|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
170520105|NCT03286218|616249943|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
170520106|NCT03286218|616249944|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
170520107|NCT03286218|616249945|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
170520108|NCT03286218|616249946|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
170520109|NCT03286218|616249947|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
170520110|NCT03286218|616249948|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
170520111|NCT03286218|616249937|FG000|Qualification Phase Period 2|Protocol Violation|2|||
170520112|NCT03286218|616249938|FG001|Qualification Phase Period 2|Protocol Violation|0|||
170520113|NCT03286218|616249939|FG002|Qualification Phase Period 2|Protocol Violation|0|||
170520114|NCT03286218|616249940|FG003|Qualification Phase Period 2|Protocol Violation|0|||
170520115|NCT03286218|616249941|FG004|Qualification Phase Period 2|Protocol Violation|0|||
170520116|NCT03286218|616249942|FG005|Qualification Phase Period 2|Protocol Violation|0|||
170520117|NCT03286218|616249943|FG006|Qualification Phase Period 2|Protocol Violation|0|||
170520118|NCT03286218|616249944|FG007|Qualification Phase Period 2|Protocol Violation|0|||
170520119|NCT03286218|616249945|FG008|Qualification Phase Period 2|Protocol Violation|0|||
170520120|NCT03286218|616249946|FG009|Qualification Phase Period 2|Protocol Violation|0|||
170520121|NCT03286218|616249947|FG010|Qualification Phase Period 2|Protocol Violation|0|||
170520122|NCT03286218|616249948|FG011|Qualification Phase Period 2|Protocol Violation|0|||
170520123|NCT03286218|616249937|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
170520124|NCT03286218|616249938|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
170520125|NCT03286218|616249939|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520126|NCT03286218|616249940|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520127|NCT03286218|616249941|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520128|NCT03286218|616249942|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520129|NCT03286218|616249943|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520130|NCT03286218|616249944|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520131|NCT03286218|616249945|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520132|NCT03286218|616249946|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520133|NCT03286218|616249947|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520134|NCT03286218|616249948|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
170520135|NCT03286218|616249937|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
170520136|NCT03286218|616249938|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
170520137|NCT03286218|616249939|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
170520138|NCT03286218|616249940|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
170520139|NCT03286218|616249941|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
170520140|NCT03286218|616249942|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
170520141|NCT03286218|616249943|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
170868015|NCT01109173|617528252|FG003|Overall Study|Noncompliance|0|||
170868016|NCT01109173|617528249|FG000|Overall Study|Treatment Failure|25|||
170520142|NCT03286218|616249944|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
170520143|NCT03286218|616249945|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
170520144|NCT03286218|616249946|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
170520145|NCT03286218|616249947|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
170520146|NCT03286218|616249948|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
170520147|NCT03286218|616249937|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520148|NCT03286218|616249938|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520149|NCT03286218|616249939|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520150|NCT03286218|616249940|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520151|NCT03286218|616249941|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520152|NCT03286218|616249942|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520153|NCT03286218|616249943|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520154|NCT03286218|616249944|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520155|NCT03286218|616249945|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520156|NCT03286218|616249946|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520157|NCT03286218|616249947|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
170520158|NCT03286218|616249948|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
170520159|NCT01348139|616249951|FG000|Period 1|Adverse Event|1|||
170520160|NCT01348139|616249952|FG001|Period 1|Adverse Event|0|||
170520161|NCT01348139|616249953|FG002|Period 1|Adverse Event|0|||
170520162|NCT01348139|616249954|FG003|Period 1|Adverse Event|0|||
170520163|NCT01348139|616249955|FG004|Period 1|Adverse Event|0|||
170520164|NCT01348139|616249956|FG005|Period 1|Adverse Event|0|||
170520165|NCT00165503|616249957|FG000|Overall Study|Death|1|||
170520166|NCT00165503|616249957|FG000|Overall Study|Lost to Follow-up|12|||
170520167|NCT00165503|616249957|FG000|Overall Study|Unresectable|3|||
170520168|NCT02976519|616249958|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
170520169|NCT02976519|616249959|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
170520170|NCT02976519|616249960|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
170520171|NCT02976519|616249961|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
170520172|NCT02976519|616249962|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
170520173|NCT02976519|616249963|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
170520174|NCT02976519|616249964|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
170520175|NCT02976519|616249958|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
170520176|NCT02976519|616249959|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
170520177|NCT02976519|616249960|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
170520178|NCT02976519|616249961|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
170520179|NCT02976519|616249962|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
170520180|NCT02976519|616249963|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
170520181|NCT02976519|616249964|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
170520182|NCT02976519|616249958|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
170520183|NCT02976519|616249959|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
170520184|NCT02976519|616249960|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
170520185|NCT02976519|616249961|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
170520186|NCT02976519|616249962|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
170520187|NCT02976519|616249963|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
170520188|NCT02976519|616249964|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
170520189|NCT02976519|616249958|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
170520190|NCT02976519|616249959|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
170520191|NCT02976519|616249960|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
170520192|NCT02976519|616249961|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
170520193|NCT02976519|616249962|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
170520194|NCT02976519|616249963|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
170520195|NCT02976519|616249964|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
170520196|NCT02976519|616249958|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
170520197|NCT02976519|616249959|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
170520198|NCT02976519|616249960|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
170520199|NCT02976519|616249961|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
170520200|NCT02976519|616249962|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
170520201|NCT02976519|616249963|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
170520202|NCT02976519|616249964|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
170520203|NCT00483652|616249965|FG000|Double-blind Treatment Period|Protocol Violation|2|||
170520204|NCT00483652|616249966|FG001|Double-blind Treatment Period|Protocol Violation|1|||
170520205|NCT00483652|616249965|FG000|Double-blind Treatment Period|Adverse Event|3|||
170520206|NCT00483652|616249966|FG001|Double-blind Treatment Period|Adverse Event|4|||
170520207|NCT00483652|616249965|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
170520208|NCT00483652|616249966|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
170764780|NCT04771273|617141946|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
170764781|NCT04771273|617141947|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
170868017|NCT01109173|617528250|FG001|Overall Study|Treatment Failure|32|||
170764782|NCT04771273|617141948|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
170764783|NCT04771273|617141945|FG000|Dose Escalation Period|Adverse Event|8|||
170764784|NCT04771273|617141946|FG001|Dose Escalation Period|Adverse Event|9|||
170764785|NCT04771273|617141947|FG002|Dose Escalation Period|Adverse Event|12|||
170764786|NCT04771273|617141948|FG003|Dose Escalation Period|Adverse Event|2|||
170764787|NCT04771273|617141945|FG000|Maintenance Period|Other than listed|4|||
170764788|NCT04771273|617141946|FG001|Maintenance Period|Other than listed|2|||
170764789|NCT04771273|617141947|FG002|Maintenance Period|Other than listed|0|||
170764790|NCT04771273|617141948|FG003|Maintenance Period|Other than listed|3|||
170764791|NCT04771273|617141945|FG000|Maintenance Period|Burden of study procedures|1|||
170764792|NCT04771273|617141946|FG001|Maintenance Period|Burden of study procedures|0|||
170764793|NCT04771273|617141947|FG002|Maintenance Period|Burden of study procedures|0|||
170764794|NCT04771273|617141948|FG003|Maintenance Period|Burden of study procedures|0|||
170764795|NCT04771273|617141945|FG000|Maintenance Period|Change of residence|0|||
170764796|NCT04771273|617141946|FG001|Maintenance Period|Change of residence|1|||
170764797|NCT04771273|617141947|FG002|Maintenance Period|Change of residence|3|||
170764798|NCT04771273|617141948|FG003|Maintenance Period|Change of residence|0|||
170764799|NCT04771273|617141945|FG000|Maintenance Period|Perceived lack of efficacy|0|||
170764800|NCT04771273|617141946|FG001|Maintenance Period|Perceived lack of efficacy|0|||
170764801|NCT04771273|617141947|FG002|Maintenance Period|Perceived lack of efficacy|0|||
170764802|NCT04771273|617141948|FG003|Maintenance Period|Perceived lack of efficacy|1|||
170764803|NCT04771273|617141945|FG000|Maintenance Period|Adverse Event|4|||
170764804|NCT04771273|617141946|FG001|Maintenance Period|Adverse Event|5|||
170764805|NCT04771273|617141947|FG002|Maintenance Period|Adverse Event|5|||
170764806|NCT04771273|617141948|FG003|Maintenance Period|Adverse Event|0|||
170764807|NCT01543685|617141952|FG000|Overall Study|Lack of Efficacy|1|||
170764808|NCT01543685|617141953|FG001|Overall Study|Lack of Efficacy|2|||
170764809|NCT01543685|617141954|FG002|Overall Study|Lack of Efficacy|2|||
170764810|NCT01543685|617141955|FG003|Overall Study|Lack of Efficacy|0|||
170764811|NCT01543685|617141956|FG004|Overall Study|Lack of Efficacy|2|||
170764812|NCT01543685|617141952|FG000|Overall Study|Adverse Event|2|||
170764813|NCT01543685|617141953|FG001|Overall Study|Adverse Event|1|||
170764814|NCT01543685|617141954|FG002|Overall Study|Adverse Event|0|||
170764815|NCT01543685|617141955|FG003|Overall Study|Adverse Event|0|||
170764816|NCT01543685|617141956|FG004|Overall Study|Adverse Event|2|||
170764817|NCT00603447|617141958|FG000|Overall Study|Adverse Event|0|||
170764818|NCT00603447|617141959|FG001|Overall Study|Adverse Event|1|||
170764819|NCT00603447|617141960|FG002|Overall Study|Adverse Event|1|||
170764820|NCT00603447|617141961|FG003|Overall Study|Adverse Event|2|||
170764821|NCT00603447|617141962|FG004|Overall Study|Adverse Event|1|||
170764822|NCT00603447|617141963|FG005|Overall Study|Adverse Event|2|||
170764823|NCT00603447|617141964|FG006|Overall Study|Adverse Event|10|||
170764824|NCT00603447|617141958|FG000|Overall Study|Other|0|||
170764825|NCT00603447|617141959|FG001|Overall Study|Other|0|||
170764826|NCT00603447|617141960|FG002|Overall Study|Other|1|||
170764827|NCT00603447|617141961|FG003|Overall Study|Other|0|||
170764828|NCT00603447|617141962|FG004|Overall Study|Other|3|||
170764829|NCT00603447|617141963|FG005|Overall Study|Other|0|||
170764830|NCT00603447|617141964|FG006|Overall Study|Other|13|||
170764831|NCT00603447|617141958|FG000|Overall Study|Withdrew Consent|0|||
170764832|NCT00603447|617141959|FG001|Overall Study|Withdrew Consent|2|||
170764833|NCT00603447|617141960|FG002|Overall Study|Withdrew Consent|0|||
170764834|NCT00603447|617141961|FG003|Overall Study|Withdrew Consent|0|||
170764835|NCT00603447|617141962|FG004|Overall Study|Withdrew Consent|1|||
170764836|NCT00603447|617141963|FG005|Overall Study|Withdrew Consent|0|||
170764837|NCT00603447|617141964|FG006|Overall Study|Withdrew Consent|1|||
170764838|NCT03425643|617141965|FG000|Overall Study|Withdrawal by Subject|10|||
170764839|NCT03425643|617141966|FG001|Overall Study|Withdrawal by Subject|12|||
170764840|NCT03425643|617141965|FG000|Overall Study|Lost to Follow-up|2|||
170764841|NCT03425643|617141966|FG001|Overall Study|Lost to Follow-up|0|||
170764842|NCT03425643|617141965|FG000|Overall Study|Death|109|||
170764843|NCT03425643|617141966|FG001|Overall Study|Death|141|||
170764844|NCT03425643|617141965|FG000|Overall Study|Ongoing in study|276|||
170764845|NCT03425643|617141966|FG001|Overall Study|Ongoing in study|247|||
170764846|NCT00589667|617143270|FG000|Overall Study|Adverse Event|2|||
170764847|NCT00589667|617143270|FG000|Overall Study|Withdrawal by Subject|1|||
170764848|NCT00482729|617143273|FG000|Overall Study|Adverse Event|29|||
170764849|NCT00482729|617143274|FG001|Overall Study|Adverse Event|33|||
170764850|NCT00482729|617143273|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
170764851|NCT00482729|617143274|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
170764852|NCT00482729|617143273|FG000|Overall Study|Hyperglycemia Criteria|7|||
170764853|NCT00482729|617143274|FG001|Overall Study|Hyperglycemia Criteria|5|||
170632136|NCT02177032|616664532|FG002|Overall Study|Withdrawal by Subject|1|||
170764854|NCT00482729|617143273|FG000|Overall Study|Lack of Efficacy|4|||
170764855|NCT00482729|617143274|FG001|Overall Study|Lack of Efficacy|16|||
170764856|NCT00482729|617143273|FG000|Overall Study|Lost to Follow-up|86|||
170764857|NCT00482729|617143274|FG001|Overall Study|Lost to Follow-up|66|||
170764858|NCT00482729|617143273|FG000|Overall Study|Physician Decision|10|||
170764859|NCT00482729|617143274|FG001|Overall Study|Physician Decision|7|||
170520209|NCT00483652|616249965|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
170520210|NCT00483652|616249966|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
170520211|NCT01278342|616249967|FG000|Overall Study|Physician Decision|0|||
170520212|NCT01278342|616249968|FG001|Overall Study|Physician Decision|1|||
170520213|NCT01278342|616249969|FG002|Overall Study|Physician Decision|0|||
170520214|NCT01278342|616249967|FG000|Overall Study|Lost to Follow-up|1|||
170520215|NCT01278342|616249968|FG001|Overall Study|Lost to Follow-up|0|||
170520216|NCT01278342|616249969|FG002|Overall Study|Lost to Follow-up|0|||
170520217|NCT01278342|616249967|FG000|Overall Study|Administrative problems|2|||
170520218|NCT01278342|616249968|FG001|Overall Study|Administrative problems|0|||
170520219|NCT01278342|616249969|FG002|Overall Study|Administrative problems|0|||
170520220|NCT01278342|616249967|FG000|Overall Study|Other|1|||
170520221|NCT01278342|616249968|FG001|Overall Study|Other|0|||
170520222|NCT01278342|616249969|FG002|Overall Study|Other|0|||
170520223|NCT00970489|616249970|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
170520224|NCT00970489|616249971|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
170520225|NCT05417412|616249972|FG000|Overall Study|Lost to Follow-up|2|||
170520226|NCT01576575|616249973|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
170520227|NCT01576575|616249973|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
170520228|NCT01576575|616249973|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
170520229|NCT00807885|616249979|FG000|Overall Study|Lost to Follow-up|0|||
170520230|NCT00807885|616249980|FG001|Overall Study|Lost to Follow-up|0|||
170520231|NCT00807885|616249981|FG002|Overall Study|Lost to Follow-up|0|||
170520232|NCT00807885|616249982|FG003|Overall Study|Lost to Follow-up|0|||
170520233|NCT00807885|616249983|FG004|Overall Study|Lost to Follow-up|0|||
170520234|NCT00807885|616249984|FG005|Overall Study|Lost to Follow-up|1|||
170520235|NCT00807885|616249985|FG006|Overall Study|Lost to Follow-up|0|||
170520236|NCT00807885|616249986|FG007|Overall Study|Lost to Follow-up|0|||
170520237|NCT00807885|616249987|FG008|Overall Study|Lost to Follow-up|0|||
170520238|NCT03489343|616249988|FG000|Overall Study|Documented progressive disease|1|||
170520239|NCT03489343|616249989|FG001|Overall Study|Documented progressive disease|0|||
170520240|NCT03489343|616249990|FG002|Overall Study|Documented progressive disease|3|||
170520241|NCT03489343|616249991|FG003|Overall Study|Documented progressive disease|1|||
170520242|NCT03489343|616249992|FG004|Overall Study|Documented progressive disease|3|||
170520243|NCT03489343|616249993|FG005|Overall Study|Documented progressive disease|5|||
170520244|NCT03489343|616249994|FG006|Overall Study|Documented progressive disease|4|||
170520245|NCT03489343|616249988|FG000|Overall Study|Adverse Event|0|||
170520246|NCT03489343|616249989|FG001|Overall Study|Adverse Event|1|||
170520247|NCT03489343|616249990|FG002|Overall Study|Adverse Event|0|||
170520248|NCT03489343|616249991|FG003|Overall Study|Adverse Event|0|||
170520249|NCT03489343|616249992|FG004|Overall Study|Adverse Event|0|||
170520250|NCT03489343|616249993|FG005|Overall Study|Adverse Event|1|||
170520251|NCT03489343|616249994|FG006|Overall Study|Adverse Event|0|||
170520252|NCT03489343|616249988|FG000|Overall Study|Withdrawal by Subject|0|||
170520253|NCT03489343|616249989|FG001|Overall Study|Withdrawal by Subject|0|||
170520254|NCT03489343|616249990|FG002|Overall Study|Withdrawal by Subject|0|||
170520255|NCT03489343|616249991|FG003|Overall Study|Withdrawal by Subject|1|||
170520256|NCT03489343|616249992|FG004|Overall Study|Withdrawal by Subject|0|||
170520257|NCT03489343|616249993|FG005|Overall Study|Withdrawal by Subject|1|||
170520258|NCT03489343|616249994|FG006|Overall Study|Withdrawal by Subject|1|||
170520259|NCT03489343|616249988|FG000|Overall Study|Clinical progression|0|||
170520260|NCT03489343|616249989|FG001|Overall Study|Clinical progression|0|||
170520261|NCT03489343|616249990|FG002|Overall Study|Clinical progression|0|||
170520262|NCT03489343|616249991|FG003|Overall Study|Clinical progression|1|||
170520263|NCT03489343|616249992|FG004|Overall Study|Clinical progression|0|||
170520264|NCT03489343|616249993|FG005|Overall Study|Clinical progression|0|||
170520265|NCT03489343|616249994|FG006|Overall Study|Clinical progression|1|||
170520266|NCT01630135|616249996|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
170520267|NCT01630135|616249997|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
170520268|NCT02899065|616249998|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
170520269|NCT02899065|616249999|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
170520270|NCT02899065|616249998|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
170520271|NCT02899065|616249999|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
170520272|NCT02899065|616249998|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
170520273|NCT02899065|616249999|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
170520274|NCT02658669|616250000|FG000|Overall Study|Lost to Follow-up|7|||
170520275|NCT02658669|616250001|FG001|Overall Study|Lost to Follow-up|5|||
170520276|NCT05225389|616250002|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
170520277|NCT04805671|616250003|FG000|Overall Study|Death|2|||
170520278|NCT04805671|616250004|FG001|Overall Study|Death|7|||
170520279|NCT04805671|616250003|FG000|Overall Study|Lost to Follow-up|1|||
170520280|NCT04805671|616250004|FG001|Overall Study|Lost to Follow-up|0|||
170520281|NCT04805671|616250003|FG000|Overall Study|Withdrawal by Subject|9|||
170520282|NCT04805671|616250004|FG001|Overall Study|Withdrawal by Subject|7|||
170520283|NCT04805671|616250003|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
170520284|NCT04805671|616250004|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
170520285|NCT02849587|616250005|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
170520286|NCT02849587|616250006|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
170520287|NCT02849587|616250007|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
170520288|NCT02849587|616250005|FG000|Overall Study|Withdrawal by Subject|0|||
170520289|NCT02849587|616250006|FG001|Overall Study|Withdrawal by Subject|1|||
170520290|NCT02849587|616250007|FG002|Overall Study|Withdrawal by Subject|0|||
170520291|NCT03380377|616250008|FG000|Overall Study|Physician Decision|1|||
170520292|NCT03380377|616250008|FG000|Overall Study|Withdrawal by Subject|1|||
170520293|NCT00128661|616250009|FG000|Overall Study|Adverse Event|14|||
170520294|NCT00128661|616250010|FG001|Overall Study|Adverse Event|11|||
170520295|NCT00128661|616250009|FG000|Overall Study|Lost to Follow-up|10|||
170520296|NCT00128661|616250010|FG001|Overall Study|Lost to Follow-up|7|||
170520297|NCT00128661|616250009|FG000|Overall Study|Withdrawal by Subject|243|||
170520298|NCT00128661|616250010|FG001|Overall Study|Withdrawal by Subject|232|||
170520299|NCT00128661|616250009|FG000|Overall Study|Other|7|||
170520300|NCT00128661|616250010|FG001|Overall Study|Other|8|||
170520301|NCT01261390|616250011|FG000|Overall Study|Significant Concurrent Illness|1|||
170520302|NCT01261390|616250012|FG001|Overall Study|Significant Concurrent Illness|0|||
170520303|NCT01261390|616250013|FG002|Overall Study|Significant Concurrent Illness|1|||
170520304|NCT01261390|616250014|FG003|Overall Study|Significant Concurrent Illness|0|||
170520305|NCT01261390|616250011|FG000|Overall Study|Dissatisfaction with Treatment|2|||
170520306|NCT01261390|616250012|FG001|Overall Study|Dissatisfaction with Treatment|1|||
170520307|NCT01261390|616250013|FG002|Overall Study|Dissatisfaction with Treatment|1|||
170520308|NCT01261390|616250014|FG003|Overall Study|Dissatisfaction with Treatment|2|||
170520309|NCT01261390|616250011|FG000|Overall Study|Relocation|0|||
170520310|NCT01261390|616250012|FG001|Overall Study|Relocation|1|||
170520311|NCT01261390|616250013|FG002|Overall Study|Relocation|0|||
170520312|NCT01261390|616250014|FG003|Overall Study|Relocation|0|||
170520313|NCT01261390|616250011|FG000|Overall Study|Loss of Interest in the Study|3|||
170520314|NCT01261390|616250012|FG001|Overall Study|Loss of Interest in the Study|1|||
170520315|NCT01261390|616250013|FG002|Overall Study|Loss of Interest in the Study|0|||
170520316|NCT01261390|616250014|FG003|Overall Study|Loss of Interest in the Study|0|||
170520317|NCT01261390|616250011|FG000|Overall Study|Lost to Follow-up|1|||
170520318|NCT01261390|616250012|FG001|Overall Study|Lost to Follow-up|6|||
170520319|NCT01261390|616250013|FG002|Overall Study|Lost to Follow-up|5|||
170520320|NCT01261390|616250014|FG003|Overall Study|Lost to Follow-up|6|||
170520321|NCT03421379|616250016|FG000|Period 1|Withdrawal by Subject|0|||
170520322|NCT03421379|616250017|FG001|Period 1|Withdrawal by Subject|1|||
170520323|NCT03421379|616250016|FG000|Period 1|Physician Decision|1|||
170520324|NCT03421379|616250017|FG001|Period 1|Physician Decision|1|||
170520325|NCT03421379|616250016|FG000|Period 1|Did not receive treatment|1|||
170520326|NCT03421379|616250017|FG001|Period 1|Did not receive treatment|2|||
170520327|NCT01951417|616250018|FG000|Overall Study|Withdrawal by Subject|1|||
170520328|NCT01951417|616250018|FG000|Overall Study|Protocol Violation|2|||
170520329|NCT01951417|616250018|FG000|Overall Study|Lost to Follow-up|6|||
170520330|NCT00977613|616250021|FG000|Overall Study|Lost to Follow-up|16|||
170520331|NCT05464420|616250022|FG000|Overall Study|Death|0|||
170520332|NCT05464420|616250023|FG001|Overall Study|Death|0|||
170520333|NCT05464420|616250024|FG002|Overall Study|Death|0|||
170520334|NCT05464420|616250025|FG003|Overall Study|Death|1|||
170520335|NCT05464420|616250022|FG000|Overall Study|Lost to Follow-up|16|||
170520336|NCT05464420|616250023|FG001|Overall Study|Lost to Follow-up|11|||
170520337|NCT05464420|616250024|FG002|Overall Study|Lost to Follow-up|11|||
170520338|NCT05464420|616250025|FG003|Overall Study|Lost to Follow-up|11|||
170520339|NCT05464420|616250022|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
170520340|NCT05464420|616250023|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
170520341|NCT05464420|616250024|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
170520342|NCT05464420|616250025|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
170868018|NCT01109173|617528251|FG002|Overall Study|Treatment Failure|69|||
170868019|NCT01109173|617528252|FG003|Overall Study|Treatment Failure|64|||
170868020|NCT01109173|617528249|FG000|Overall Study|Protocol Violation|4|||
170868021|NCT01109173|617528250|FG001|Overall Study|Protocol Violation|5|||
170868022|NCT01109173|617528251|FG002|Overall Study|Protocol Violation|1|||
170520343|NCT05464420|616250022|FG000|Overall Study|Withdrawal by Subject|4|||
170520344|NCT05464420|616250023|FG001|Overall Study|Withdrawal by Subject|8|||
170520345|NCT05464420|616250024|FG002|Overall Study|Withdrawal by Subject|3|||
170520346|NCT05464420|616250025|FG003|Overall Study|Withdrawal by Subject|1|||
170520347|NCT05464420|616250022|FG000|Overall Study|Protocol Violation|0|||
170520348|NCT05464420|616250023|FG001|Overall Study|Protocol Violation|0|||
170520349|NCT05464420|616250024|FG002|Overall Study|Protocol Violation|1|||
170520350|NCT05464420|616250025|FG003|Overall Study|Protocol Violation|1|||
170520351|NCT05464420|616250022|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
170868023|NCT01109173|617528252|FG003|Overall Study|Protocol Violation|2|||
170520352|NCT05464420|616250023|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
170520353|NCT05464420|616250024|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
170520354|NCT05464420|616250025|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
170520355|NCT01383018|616250028|FG000|Overall Study|Adverse Event|14|||
170520356|NCT01383018|616250028|FG000|Overall Study|Death|10|||
170520357|NCT01383018|616250028|FG000|Overall Study|Lost to Follow-up|5|||
170520358|NCT01383018|616250028|FG000|Overall Study|Physician Decision|5|||
170520359|NCT01383018|616250028|FG000|Overall Study|Withdrawal by Subject|9|||
170520360|NCT01383018|616250028|FG000|Overall Study|Subject not implanted|76|||
170520361|NCT01383018|616250028|FG000|Overall Study|Missed Visit|247|||
170520362|NCT01383018|616250028|FG000|Overall Study|Site closed early-not compliance related|7|||
170520363|NCT01383018|616250028|FG000|Overall Study|Patient moved away from site|1|||
170520364|NCT01383018|616250028|FG000|Overall Study|Subject Incarcerated|1|||
170520365|NCT01051817|616250029|FG000|Overall Study|Adverse Event|0|||
170520366|NCT01051817|616250030|FG001|Overall Study|Adverse Event|2|||
170520367|NCT01051817|616250029|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
170520368|NCT01051817|616250030|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
170520369|NCT01051817|616250029|FG000|Overall Study|Withdrawal by Subject|3|||
170520370|NCT01051817|616250030|FG001|Overall Study|Withdrawal by Subject|5|||
170520371|NCT01051817|616250029|FG000|Overall Study|Protocol Violation|0|||
170520372|NCT01051817|616250030|FG001|Overall Study|Protocol Violation|1|||
170520373|NCT03771963|616250035|FG000|Overall Study|Lost to Follow-up|22|||
170520374|NCT03771963|616250035|FG000|Overall Study|Withdrawal of Consent|10|||
170520375|NCT00627926|616250036|FG000|Overall Study|Adverse Event|26|||
170520376|NCT00627926|616250037|FG001|Overall Study|Adverse Event|37|||
170520377|NCT00627926|616250038|FG002|Overall Study|Adverse Event|36|||
170520378|NCT00627926|616250036|FG000|Overall Study|Death|1|||
170520379|NCT00627926|616250037|FG001|Overall Study|Death|0|||
170520380|NCT00627926|616250038|FG002|Overall Study|Death|0|||
170520381|NCT00627926|616250036|FG000|Overall Study|Lost to Follow-up|4|||
170520382|NCT00627926|616250037|FG001|Overall Study|Lost to Follow-up|3|||
170520383|NCT00627926|616250038|FG002|Overall Study|Lost to Follow-up|4|||
170520384|NCT00627926|616250036|FG000|Overall Study|Withdrawal by Subject|2|||
170520385|NCT00627926|616250037|FG001|Overall Study|Withdrawal by Subject|1|||
170520386|NCT00627926|616250038|FG002|Overall Study|Withdrawal by Subject|0|||
170520387|NCT00627926|616250036|FG000|Overall Study|Lack of Efficacy|118|||
170520388|NCT00627926|616250037|FG001|Overall Study|Lack of Efficacy|40|||
170520389|NCT00627926|616250038|FG002|Overall Study|Lack of Efficacy|38|||
170520390|NCT00627926|616250036|FG000|Overall Study|Noncompliance/unspecified|8|||
170520391|NCT00627926|616250037|FG001|Overall Study|Noncompliance/unspecified|23|||
170520392|NCT00627926|616250038|FG002|Overall Study|Noncompliance/unspecified|17|||
170520393|NCT02039778|616250042|FG000|Overall Study|Death|2|||
170520394|NCT02039778|616250042|FG000|Overall Study|Withdrawal by Subject|1|||
170520395|NCT02039778|616250042|FG000|Overall Study|Never started the protocol treatment|1|||
170520396|NCT03414229|616250043|FG000|Overall Study|Adverse Event|1|||
170520397|NCT03414229|616250044|FG001|Overall Study|Adverse Event|0|||
170520398|NCT03414229|616250045|FG002|Overall Study|Adverse Event|2|||
170520399|NCT03414229|616250046|FG003|Overall Study|Adverse Event|1|||
170520400|NCT03414229|616250043|FG000|Overall Study|Lack of Efficacy|7|||
170520401|NCT03414229|616250044|FG001|Overall Study|Lack of Efficacy|4|||
170520402|NCT03414229|616250045|FG002|Overall Study|Lack of Efficacy|1|||
170520403|NCT03414229|616250046|FG003|Overall Study|Lack of Efficacy|9|||
170520404|NCT03414229|616250043|FG000|Overall Study|Change in therapy|1|||
170520405|NCT03414229|616250044|FG001|Overall Study|Change in therapy|0|||
170520406|NCT03414229|616250045|FG002|Overall Study|Change in therapy|0|||
170520407|NCT03414229|616250046|FG003|Overall Study|Change in therapy|0|||
170520408|NCT03414229|616250043|FG000|Overall Study|Pregnancy|0|||
170520409|NCT03414229|616250044|FG001|Overall Study|Pregnancy|0|||
170520410|NCT03414229|616250045|FG002|Overall Study|Pregnancy|1|||
170520411|NCT03414229|616250046|FG003|Overall Study|Pregnancy|0|||
170520412|NCT03414229|616250043|FG000|Overall Study|Withdrawal by Subject|0|||
170520413|NCT03414229|616250044|FG001|Overall Study|Withdrawal by Subject|1|||
170520414|NCT03414229|616250045|FG002|Overall Study|Withdrawal by Subject|1|||
170520415|NCT03414229|616250046|FG003|Overall Study|Withdrawal by Subject|0|||
170520416|NCT02137226|616250049|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
170520417|NCT02137226|616250050|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
170520418|NCT02137226|616250051|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
170520419|NCT02137226|616250052|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
170520420|NCT02137226|616250053|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
170520421|NCT02137226|616250049|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
170520422|NCT02137226|616250050|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
170520423|NCT02137226|616250051|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
170520424|NCT02137226|616250052|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
170520425|NCT02137226|616250053|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
170520426|NCT02137226|616250049|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
170520427|NCT02137226|616250050|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
170764860|NCT00482729|617143273|FG000|Overall Study|Pregnancy|4|||
170520428|NCT02137226|616250051|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
170520429|NCT02137226|616250052|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
170520430|NCT02137226|616250053|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
170520431|NCT02137226|616250049|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
170520432|NCT02137226|616250050|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
170520433|NCT02137226|616250051|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
170520434|NCT02137226|616250052|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
170520435|NCT02137226|616250053|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
170520436|NCT02137226|616250049|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
170520437|NCT02137226|616250050|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
170520438|NCT02137226|616250051|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
170520439|NCT02137226|616250052|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
170520440|NCT02137226|616250053|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
170520441|NCT02137226|616250049|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
170520442|NCT02137226|616250050|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
170520443|NCT02137226|616250051|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
170520444|NCT02137226|616250052|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
170520445|NCT02137226|616250053|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
170520446|NCT02137226|616250049|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
170520447|NCT02137226|616250050|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
170520448|NCT02137226|616250051|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
170520449|NCT02137226|616250052|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
170520450|NCT02137226|616250053|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
170520451|NCT02137226|616250049|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
170520452|NCT02137226|616250050|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
170520453|NCT02137226|616250051|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
170520454|NCT02137226|616250052|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
170520455|NCT02137226|616250053|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
170520456|NCT02137226|616250049|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
170520457|NCT02137226|616250050|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
170520458|NCT02137226|616250051|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
170520459|NCT02137226|616250052|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
170520460|NCT02137226|616250053|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
170520461|NCT02137226|616250049|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
170520462|NCT02137226|616250050|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
170520463|NCT02137226|616250051|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
170520464|NCT02137226|616250052|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
170520465|NCT02137226|616250053|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
170520466|NCT02137226|616250049|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
170520467|NCT02137226|616250050|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
170520468|NCT02137226|616250051|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
170520469|NCT02137226|616250052|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
170520470|NCT02137226|616250053|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
170520471|NCT02137226|616250049|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
170520472|NCT02137226|616250050|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
170520473|NCT02137226|616250051|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
170520474|NCT02137226|616250052|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
170520475|NCT02137226|616250053|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
170520476|NCT01462110|616250054|FG000|Overall Study|Adverse Event|1|||
170520477|NCT01462110|616250055|FG001|Overall Study|Adverse Event|0|||
170520478|NCT00753675|616250056|FG000|Overall Study|other reason|11|||
170520479|NCT00753675|616250057|FG001|Overall Study|other reason|12|||
170520480|NCT00753675|616250058|FG002|Overall Study|other reason|13|||
170520481|NCT00753675|616250056|FG000|Overall Study|Death|1|||
170520482|NCT00753675|616250057|FG001|Overall Study|Death|2|||
170520483|NCT00753675|616250058|FG002|Overall Study|Death|4|||
170520484|NCT00753675|616250056|FG000|Overall Study|Adverse Event|11|||
170520485|NCT00753675|616250057|FG001|Overall Study|Adverse Event|9|||
170520486|NCT00753675|616250058|FG002|Overall Study|Adverse Event|4|||
170520487|NCT00753675|616250056|FG000|Overall Study|Objective progression of disease|35|||
170520488|NCT00753675|616250057|FG001|Overall Study|Objective progression of disease|35|||
170520489|NCT00753675|616250058|FG002|Overall Study|Objective progression of disease|35|||
170520490|NCT00753675|616250056|FG000|Overall Study|Withdrawal by Subject|0|||
170520491|NCT00753675|616250057|FG001|Overall Study|Withdrawal by Subject|1|||
170520492|NCT00753675|616250058|FG002|Overall Study|Withdrawal by Subject|0|||
170520493|NCT00753675|616250056|FG000|Overall Study|Lost to Follow-up|1|||
170520494|NCT00753675|616250057|FG001|Overall Study|Lost to Follow-up|0|||
170520495|NCT00753675|616250058|FG002|Overall Study|Lost to Follow-up|0|||
170764861|NCT00482729|617143274|FG001|Overall Study|Pregnancy|2|||
170764862|NCT00482729|617143273|FG000|Overall Study|Protocol Violation|10|||
170764863|NCT00482729|617143274|FG001|Overall Study|Protocol Violation|18|||
170520496|NCT05279131|616250059|FG000|Overall Study|Lost to Follow-up|1|||
170764864|NCT00482729|617143273|FG000|Overall Study|Withdrawal by Subject|67|||
170764865|NCT00482729|617143274|FG001|Overall Study|Withdrawal by Subject|69|||
170764866|NCT02488980|617143279|FG000|Overall Study|Protocol Violation|2|||
170764867|NCT02488980|617143280|FG001|Overall Study|Protocol Violation|2|||
170764868|NCT02488980|617143281|FG002|Overall Study|Protocol Violation|2|||
170764869|NCT00738699|617143284|FG000|Overall Study|Withdrawal by Subject|5|||
170764870|NCT00738699|617143285|FG001|Overall Study|Withdrawal by Subject|0|||
170764871|NCT00738699|617143284|FG000|Overall Study|Lost to Follow-up|1|||
170764872|NCT00738699|617143285|FG001|Overall Study|Lost to Follow-up|0|||
170764873|NCT00738699|617143284|FG000|Overall Study|Death|144|||
170764874|NCT00738699|617143285|FG001|Overall Study|Death|68|||
170764875|NCT00738699|617143284|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
170764876|NCT00738699|617143285|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
170764877|NCT00738699|617143284|FG000|Overall Study|Other|2|||
170764878|NCT00738699|617143285|FG001|Overall Study|Other|0|||
170764879|NCT01811706|617143286|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
170764880|NCT01811706|617143287|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
170764881|NCT05174013|617143288|FG000|Overall Study|Lost to Follow-up|0|||
170764882|NCT05174013|617143289|FG001|Overall Study|Lost to Follow-up|0|||
170764883|NCT05174013|617143290|FG002|Overall Study|Lost to Follow-up|0|||
170764884|NCT05174013|617143291|FG003|Overall Study|Lost to Follow-up|1|||
170764885|NCT05174013|617143292|FG004|Overall Study|Lost to Follow-up|0|||
170764886|NCT05174013|617143293|FG005|Overall Study|Lost to Follow-up|0|||
170764887|NCT05174013|617143288|FG000|Overall Study|Withdrawal by Subject|0|||
170764888|NCT05174013|617143289|FG001|Overall Study|Withdrawal by Subject|0|||
170764889|NCT05174013|617143290|FG002|Overall Study|Withdrawal by Subject|1|||
170764890|NCT05174013|617143291|FG003|Overall Study|Withdrawal by Subject|0|||
170764891|NCT05174013|617143292|FG004|Overall Study|Withdrawal by Subject|0|||
170764892|NCT05174013|617143293|FG005|Overall Study|Withdrawal by Subject|0|||
170764893|NCT04107805|617143294|FG000|Overall Study|Adverse Event|0|||
170764894|NCT04107805|617143295|FG001|Overall Study|Adverse Event|0|||
170409890|NCT00665626|615840188|FG000|Overall Study|Lack of Efficacy|8|||
170409891|NCT00665626|615840189|FG001|Overall Study|Lack of Efficacy|5|||
170409892|NCT00665626|615840188|FG000|Overall Study|Lost to Follow-up|0|||
170409893|NCT00665626|615840189|FG001|Overall Study|Lost to Follow-up|2|||
170409894|NCT00665626|615840188|FG000|Overall Study|Withdrawal by Subject|0|||
170409895|NCT00665626|615840189|FG001|Overall Study|Withdrawal by Subject|1|||
170764895|NCT04107805|617143296|FG002|Overall Study|Adverse Event|0|||
170764896|NCT04107805|617143297|FG003|Overall Study|Adverse Event|1|||
170764897|NCT04107805|617143298|FG004|Overall Study|Adverse Event|0|||
170764898|NCT04107805|617143299|FG005|Overall Study|Adverse Event|1|||
170764899|NCT04107805|617143300|FG006|Overall Study|Adverse Event|0|||
170764900|NCT04107805|617143301|FG007|Overall Study|Adverse Event|0|||
170764901|NCT04107805|617143302|FG008|Overall Study|Adverse Event|1|||
170764902|NCT02957539|617143304|FG000|Baseline to Week 16|Lost to Follow-up|8|||
170764903|NCT02957539|617143305|FG001|Baseline to Week 16|Lost to Follow-up|10|||
170764904|NCT02957539|617143306|FG002|Baseline to Week 16|Lost to Follow-up|16|||
170764905|NCT02957539|617143304|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
170764906|NCT02957539|617143305|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
170409896|NCT00665626|615840188|FG000|Overall Study|Protocol Violation|0|||
170409897|NCT00665626|615840189|FG001|Overall Study|Protocol Violation|2|||
170409898|NCT00665626|615840188|FG000|Overall Study|Adverse Event|1|||
170409899|NCT00665626|615840189|FG001|Overall Study|Adverse Event|9|||
170409900|NCT00665626|615840188|FG000|Overall Study|Due to exclusion criteria|0|||
170409901|NCT00665626|615840189|FG001|Overall Study|Due to exclusion criteria|1|||
170409902|NCT00665626|615840188|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
170409903|NCT00665626|615840189|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
170409904|NCT00665626|615840188|FG000|Overall Study|Unably to comply with dosing regimen|0|||
170409905|NCT00665626|615840189|FG001|Overall Study|Unably to comply with dosing regimen|1|||
170409906|NCT00665626|615840188|FG000|Overall Study|Death|1|||
170409907|NCT00665626|615840189|FG001|Overall Study|Death|0|||
170409908|NCT01629693|615840190|FG000|Overall Study|Lost to Follow-up|2|||
170409909|NCT01629693|615840191|FG001|Overall Study|Lost to Follow-up|4|||
170409910|NCT01629693|615840190|FG000|Overall Study|Withdrawal by Subject|2|||
170409911|NCT01629693|615840191|FG001|Overall Study|Withdrawal by Subject|2|||
170409912|NCT01629693|615840190|FG000|Overall Study|Adverse Event|1|||
170409913|NCT01629693|615840191|FG001|Overall Study|Adverse Event|0|||
170409914|NCT01629693|615840190|FG000|Overall Study|Investigator decision|0|||
170409915|NCT01629693|615840191|FG001|Overall Study|Investigator decision|1|||
170409916|NCT01629693|615840190|FG000|Overall Study|Poor comfort of study lenses|0|||
170409917|NCT01629693|615840191|FG001|Overall Study|Poor comfort of study lenses|2|||
170409918|NCT01629693|615840190|FG000|Overall Study|Subject decision unrelated to AE|0|||
170409919|NCT01629693|615840191|FG001|Overall Study|Subject decision unrelated to AE|1|||
170520497|NCT05279131|616250059|FG000|Overall Study|Death|1|||
170764907|NCT02957539|617143306|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
170764908|NCT02957539|617143304|FG000|Week 16 to 32|Withdrawal by Subject|3|||
170764909|NCT02957539|617143305|FG001|Week 16 to 32|Withdrawal by Subject|3|||
170764910|NCT02957539|617143306|FG002|Week 16 to 32|Withdrawal by Subject|1|||
170520498|NCT05279131|616250059|FG000|Overall Study|Physician Decision|1|||
170520499|NCT02824627|616250060|FG000|Overall Study|Adverse Event|1|||
170520500|NCT02824627|616250061|FG001|Overall Study|Adverse Event|2|||
170520501|NCT02824627|616250060|FG000|Overall Study|Lost to Follow-up|2|||
170520502|NCT02824627|616250061|FG001|Overall Study|Lost to Follow-up|1|||
170520503|NCT01938846|616250062|FG000|Overall Study|Progressive disease|26|||
170520504|NCT01938846|616250063|FG001|Overall Study|Progressive disease|18|||
170520505|NCT01938846|616250064|FG002|Overall Study|Progressive disease|16|||
170520506|NCT01938846|616250062|FG000|Overall Study|Adverse Event|8|||
170520507|NCT01938846|616250063|FG001|Overall Study|Adverse Event|4|||
170520508|NCT01938846|616250064|FG002|Overall Study|Adverse Event|3|||
170520509|NCT01938846|616250062|FG000|Overall Study|Withdrawal by Subject|2|||
170520510|NCT01938846|616250063|FG001|Overall Study|Withdrawal by Subject|2|||
170520511|NCT01938846|616250064|FG002|Overall Study|Withdrawal by Subject|1|||
170520512|NCT01938846|616250062|FG000|Overall Study|Other than listed|5|||
170520513|NCT01938846|616250063|FG001|Overall Study|Other than listed|1|||
170520514|NCT01938846|616250064|FG002|Overall Study|Other than listed|4|||
170520515|NCT02106351|616250066|FG000|Treatment Cycle 1|Adverse Event|2|||
170520516|NCT02106351|616250067|FG001|Treatment Cycle 1|Adverse Event|0|||
170520517|NCT02106351|616250068|FG002|Treatment Cycle 1|Adverse Event|0|||
170520518|NCT02106351|616250066|FG000|Treatment Cycle 1|Consent withdrawn|1|||
170520519|NCT02106351|616250067|FG001|Treatment Cycle 1|Consent withdrawn|0|||
170520520|NCT02106351|616250068|FG002|Treatment Cycle 1|Consent withdrawn|2|||
170520521|NCT02106351|616250066|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
170520522|NCT02106351|616250067|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
170520523|NCT02106351|616250068|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
170520524|NCT02106351|616250066|FG000|Treatment Cycle 1|Other|0|||
170520525|NCT02106351|616250067|FG001|Treatment Cycle 1|Other|3|||
170520526|NCT02106351|616250068|FG002|Treatment Cycle 1|Other|1|||
170520527|NCT02106351|616250066|FG000|Treatment Cycle 1|Randomised but not treated|1|||
170520528|NCT02106351|616250067|FG001|Treatment Cycle 1|Randomised but not treated|0|||
170520529|NCT02106351|616250068|FG002|Treatment Cycle 1|Randomised but not treated|1|||
170520530|NCT02106351|616250066|FG000|Treatment Cycle 2|Adverse Event|0|||
170520531|NCT02106351|616250067|FG001|Treatment Cycle 2|Adverse Event|2|||
170520532|NCT02106351|616250068|FG002|Treatment Cycle 2|Adverse Event|0|||
170520533|NCT02106351|616250066|FG000|Treatment Cycle 2|Consent withdrawn|0|||
170520534|NCT02106351|616250067|FG001|Treatment Cycle 2|Consent withdrawn|1|||
170520535|NCT02106351|616250068|FG002|Treatment Cycle 2|Consent withdrawn|1|||
170520536|NCT02106351|616250066|FG000|Treatment Cycle 2|Other|0|||
170520537|NCT02106351|616250067|FG001|Treatment Cycle 2|Other|2|||
170520538|NCT02106351|616250068|FG002|Treatment Cycle 2|Other|2|||
170520539|NCT02106351|616250066|FG000|Treatment Cycle 3|Adverse Event|0|||
170520540|NCT02106351|616250067|FG001|Treatment Cycle 3|Adverse Event|1|||
170520541|NCT02106351|616250068|FG002|Treatment Cycle 3|Adverse Event|0|||
170520542|NCT02106351|616250066|FG000|Treatment Cycle 3|Consent withdrawn|0|||
170520543|NCT02106351|616250067|FG001|Treatment Cycle 3|Consent withdrawn|0|||
170520544|NCT02106351|616250068|FG002|Treatment Cycle 3|Consent withdrawn|2|||
170520545|NCT02106351|616250066|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
170520546|NCT02106351|616250067|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
170520547|NCT02106351|616250068|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
170520548|NCT02106351|616250066|FG000|Treatment Cycle 3|Other|0|||
170520549|NCT02106351|616250067|FG001|Treatment Cycle 3|Other|2|||
170520550|NCT02106351|616250068|FG002|Treatment Cycle 3|Other|3|||
170520551|NCT02106351|616250066|FG000|Treatment Cycle 4|Consent withdrawn|0|||
170520552|NCT02106351|616250067|FG001|Treatment Cycle 4|Consent withdrawn|0|||
170520553|NCT02106351|616250068|FG002|Treatment Cycle 4|Consent withdrawn|2|||
170520554|NCT02106351|616250066|FG000|Treatment Cycle 4|Other|0|||
170520555|NCT02106351|616250067|FG001|Treatment Cycle 4|Other|1|||
170520556|NCT02106351|616250068|FG002|Treatment Cycle 4|Other|0|||
170520557|NCT00069823|616250073|FG000|Overall Study|Did not have follow-up diary cards|6|||
170520558|NCT00069823|616250074|FG001|Overall Study|Did not have follow-up diary cards|3|||
170868024|NCT01109173|617528249|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
170868025|NCT01109173|617528250|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
170868026|NCT01109173|617528251|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
170520559|NCT01210482|616250075|FG000|Overall Study|Protocol Violation|1|||
170520560|NCT01210482|616250075|FG000|Overall Study|Case Report Forms were not collected|18|||
170520561|NCT01210482|616250075|FG000|Overall Study|Duplicated|2|||
170520562|NCT01210482|616250075|FG000|Overall Study|No Drug Administration|28|||
170520563|NCT00765817|616250076|FG000|Overall Study|Adverse Event|13|||
170520564|NCT00765817|616250077|FG001|Overall Study|Adverse Event|1|||
170520565|NCT00765817|616250076|FG000|Overall Study|Death|0|||
170520566|NCT00765817|616250077|FG001|Overall Study|Death|1|||
170520567|NCT00765817|616250076|FG000|Overall Study|Entry criteria not met|2|||
170520568|NCT00765817|616250077|FG001|Overall Study|Entry criteria not met|2|||
170520569|NCT00765817|616250076|FG000|Overall Study|Loss of glucose control|0|||
170520570|NCT00765817|616250077|FG001|Overall Study|Loss of glucose control|2|||
170520571|NCT00765817|616250076|FG000|Overall Study|Lost to Follow-up|1|||
170520572|NCT00765817|616250077|FG001|Overall Study|Lost to Follow-up|3|||
170520573|NCT00765817|616250076|FG000|Overall Study|Physician Decision|2|||
170520574|NCT00765817|616250077|FG001|Overall Study|Physician Decision|1|||
170520575|NCT00765817|616250076|FG000|Overall Study|Protocol Violation|1|||
170520576|NCT00765817|616250077|FG001|Overall Study|Protocol Violation|1|||
170520577|NCT00765817|616250076|FG000|Overall Study|Subject decision|7|||
170520578|NCT00765817|616250077|FG001|Overall Study|Subject decision|11|||
170520579|NCT02058589|616250078|FG000|Overall Study|Serious Adverse Event|1|||
170520580|NCT02058589|616250079|FG001|Overall Study|Serious Adverse Event|1|||
170520581|NCT02058589|616250078|FG000|Overall Study|Non-Serious Adverse Event|1|||
170520582|NCT02058589|616250079|FG001|Overall Study|Non-Serious Adverse Event|0|||
170520583|NCT02058589|616250078|FG000|Overall Study|Withdrawal by Subject|0|||
170520584|NCT02058589|616250079|FG001|Overall Study|Withdrawal by Subject|1|||
170520585|NCT02143024|616250081|FG000|Overall Study|Lost to Follow-up|1|||
170520586|NCT02143024|616250082|FG001|Overall Study|Lost to Follow-up|1|||
170520587|NCT02143024|616250081|FG000|Overall Study|Withdrawal by Subject|1|||
170520588|NCT02143024|616250082|FG001|Overall Study|Withdrawal by Subject|0|||
170520589|NCT02308228|616250083|FG000|Overall Study|Adverse Event|3|||
170520590|NCT02308228|616250084|FG001|Overall Study|Adverse Event|4|||
170520591|NCT02308228|616250083|FG000|Overall Study|Withdrawal by Subject|5|||
170520592|NCT02308228|616250084|FG001|Overall Study|Withdrawal by Subject|3|||
170520593|NCT01212094|616251686|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
170520594|NCT01212094|616251687|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
170520595|NCT01212094|616251688|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
170520596|NCT01212094|616251686|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
170520597|NCT01212094|616251687|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
170520598|NCT01212094|616251688|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
170520599|NCT01212094|616251686|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
170520600|NCT01212094|616251687|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
170520601|NCT01212094|616251688|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
170520602|NCT01212094|616251686|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
170520603|NCT01212094|616251687|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
170520604|NCT01212094|616251688|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
170520605|NCT01212094|616251686|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
170520606|NCT01212094|616251687|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
170520607|NCT01212094|616251688|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
170520608|NCT01212094|616251686|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
170520609|NCT01212094|616251687|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
170520610|NCT01212094|616251688|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
170764911|NCT02957539|617143304|FG000|Week 16 to 32|Lost to Follow-up|8|||
170764912|NCT02957539|617143305|FG001|Week 16 to 32|Lost to Follow-up|7|||
170764913|NCT02957539|617143306|FG002|Week 16 to 32|Lost to Follow-up|5|||
170764914|NCT02957539|617143304|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
170764915|NCT02957539|617143305|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
170764916|NCT02957539|617143306|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
170764917|NCT02957539|617143304|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
170764918|NCT02957539|617143305|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
170764919|NCT02957539|617143306|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
170764920|NCT00139737|617143309|FG000|Overall Study|Withdrawal by Subject|190|||
170764921|NCT00139737|617143309|FG000|Overall Study|Adverse Event|58|||
170764922|NCT00139737|617143309|FG000|Overall Study|Lack of Efficacy|40|||
170764923|NCT00139737|617143309|FG000|Overall Study|Lost to Follow-up|8|||
170764924|NCT00139737|617143309|FG000|Overall Study|Death|3|||
170764925|NCT00139737|617143309|FG000|Overall Study|Laboratory Abnormality|2|||
170764926|NCT00139737|617143309|FG000|Overall Study|Protocol Violation|18|||
170764927|NCT00139737|617143309|FG000|Overall Study|Withdrew During Screening Phase|8|||
170868027|NCT01109173|617528252|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
170409920|NCT02378506|615840192|FG000|Overall Study|Lack of Efficacy|3|||
170409921|NCT02378506|615840192|FG000|Overall Study|Withdrawal by Subject|4|||
170409922|NCT02378506|615840192|FG000|Overall Study|Protocol Violation|2|||
170409923|NCT02378506|615840192|FG000|Overall Study|Death|1|||
170409924|NCT02378506|615840192|FG000|Overall Study|Adverse Event|14|||
170409925|NCT02378506|615840192|FG000|Overall Study|Randomized But Not Treated|1|||
170409926|NCT00395083|615840194|FG000|Overall Study|Withdrawal by Subject|6|||
170409927|NCT00395083|615840195|FG001|Overall Study|Withdrawal by Subject|5|||
170409928|NCT00395083|615840194|FG000|Overall Study|Developed another disease|4|||
170409929|NCT00395083|615840195|FG001|Overall Study|Developed another disease|3|||
170409930|NCT03381248|615841737|FG000|0-6 Months|Withdrawal by Subject|4|||
170409931|NCT03381248|615841738|FG001|0-6 Months|Withdrawal by Subject|1|||
170409932|NCT03381248|615841737|FG000|0-6 Months|Lost to Follow-up|3|||
170409933|NCT03381248|615841738|FG001|0-6 Months|Lost to Follow-up|2|||
170409934|NCT03381248|615841737|FG000|0-6 Months|Lack of Efficacy|1|||
170409935|NCT03381248|615841738|FG001|0-6 Months|Lack of Efficacy|0|||
170520611|NCT02371616|616251690|FG000|Overall Study|Protocol Violation|2|||
170409936|NCT03381248|615841737|FG000|0-6 Months|Adverse Event|1|||
170409937|NCT03381248|615841738|FG001|0-6 Months|Adverse Event|0|||
170520612|NCT02371616|616251691|FG001|Overall Study|Protocol Violation|1|||
170520613|NCT02371616|616251690|FG000|Overall Study|Adverse Event|0|||
170520614|NCT02371616|616251691|FG001|Overall Study|Adverse Event|1|||
170520615|NCT02371616|616251690|FG000|Overall Study|Withdrawal of Consent|1|||
170520616|NCT02371616|616251691|FG001|Overall Study|Withdrawal of Consent|0|||
170520617|NCT02371616|616251690|FG000|Overall Study|Other (Not specified)|1|||
170520618|NCT02371616|616251691|FG001|Overall Study|Other (Not specified)|5|||
170520619|NCT00593814|616251692|FG000|Overall Study|Death|7|||
170520620|NCT00593814|616251693|FG001|Overall Study|Death|0|||
170520621|NCT00593814|616251692|FG000|Overall Study|Withdrawal by Subject|7|||
170520622|NCT00593814|616251693|FG001|Overall Study|Withdrawal by Subject|0|||
170520623|NCT00593814|616251692|FG000|Overall Study|Lost to Follow-up|7|||
170520624|NCT00593814|616251693|FG001|Overall Study|Lost to Follow-up|0|||
170764928|NCT00139737|617143309|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
170764929|NCT00139737|617143309|FG000|Overall Study|Screened, Not Treated|13|||
170764930|NCT00770965|617143320|FG000|Safety Set|Withdrawal by Subject|0|||
170764931|NCT00770965|617143321|FG001|Safety Set|Withdrawal by Subject|0|||
170764932|NCT00770965|617143322|FG002|Safety Set|Withdrawal by Subject|0|||
170764933|NCT00770965|617143323|FG003|Safety Set|Withdrawal by Subject|1|||
170764934|NCT00770965|617143320|FG000|Safety Set|Protocol deviation|0|||
170764935|NCT00770965|617143321|FG001|Safety Set|Protocol deviation|0|||
170764936|NCT00770965|617143322|FG002|Safety Set|Protocol deviation|1|||
170764937|NCT00770965|617143323|FG003|Safety Set|Protocol deviation|0|||
170764938|NCT00770965|617143320|FG000|Excluded Set|Administrative problems|14|||
170764939|NCT00770965|617143321|FG001|Excluded Set|Administrative problems|12|||
170409938|NCT03381248|615841737|FG000|0-6 Months|Protocol Violation|2|||
170409939|NCT03381248|615841738|FG001|0-6 Months|Protocol Violation|1|||
170409940|NCT03381248|615841737|FG000|0-6 Months|Physician Decision|1|||
170409941|NCT03381248|615841738|FG001|0-6 Months|Physician Decision|0|||
170409942|NCT03381248|615841737|FG000|0-6 Months|Planning another procedure|1|||
170409943|NCT03381248|615841738|FG001|0-6 Months|Planning another procedure|2|||
170409944|NCT03381248|615841737|FG000|6-12 Months|Withdrawal by Subject|1|||
170409945|NCT03381248|615841738|FG001|6-12 Months|Withdrawal by Subject|3|||
170409946|NCT03381248|615841737|FG000|6-12 Months|Lost to Follow-up|0|||
170409947|NCT03381248|615841738|FG001|6-12 Months|Lost to Follow-up|2|||
170409948|NCT03381248|615841737|FG000|6-12 Months|Protocol Violation|3|||
170409949|NCT03381248|615841738|FG001|6-12 Months|Protocol Violation|2|||
170409950|NCT03381248|615841737|FG000|6-12 Months|Planning another procedure|6|||
170409951|NCT03381248|615841738|FG001|6-12 Months|Planning another procedure|2|||
170409952|NCT03381248|615841737|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
170409953|NCT03381248|615841738|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
170409954|NCT03381248|615841737|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
170409955|NCT03381248|615841738|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
170409956|NCT03381248|615841737|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
170409957|NCT03381248|615841738|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
170409958|NCT01341639|615841743|FG000|Infant Series|Protocol Violation|1|||
170409959|NCT01341639|615841744|FG001|Infant Series|Protocol Violation|0|||
170409960|NCT01341639|615841743|FG000|Infant Series|Not Vaccinated|0|||
170409961|NCT01341639|615841744|FG001|Infant Series|Not Vaccinated|1|||
170409962|NCT01341639|615841743|FG000|Infant Series|Adverse Event|0|||
170409963|NCT01341639|615841744|FG001|Infant Series|Adverse Event|5|||
170409964|NCT01341639|615841743|FG000|Infant Series|Withdrawal by Subject|11|||
170409965|NCT01341639|615841744|FG001|Infant Series|Withdrawal by Subject|8|||
170409966|NCT01341639|615841743|FG000|Infant Series|Lost to Follow-up|0|||
170409967|NCT01341639|615841744|FG001|Infant Series|Lost to Follow-up|2|||
170409968|NCT01341639|615841743|FG000|Infant Series|Site 0048 Participants|17|||
170409969|NCT01341639|615841744|FG001|Infant Series|Site 0048 Participants|16|||
170409970|NCT01341639|615841743|FG000|Interim Period|Withdrawal by Subject|6|||
170409971|NCT01341639|615841744|FG001|Interim Period|Withdrawal by Subject|7|||
170409972|NCT01341639|615841743|FG000|Interim Period|Lost to Follow-up|2|||
170409973|NCT01341639|615841744|FG001|Interim Period|Lost to Follow-up|0|||
170409974|NCT01341639|615841743|FG000|Interim Period|Physician Decision|0|||
170520625|NCT00593814|616251692|FG000|Overall Study|Physician Decision|3|||
170520626|NCT00593814|616251693|FG001|Overall Study|Physician Decision|0|||
170520627|NCT02787304|616251694|FG000|Overall Study|Adverse Event|9|||
170520628|NCT02787304|616251695|FG001|Overall Study|Adverse Event|3|||
170520629|NCT02787304|616251696|FG002|Overall Study|Adverse Event|8|||
170520630|NCT02787304|616251697|FG003|Overall Study|Adverse Event|1|||
170520631|NCT02787304|616251694|FG000|Overall Study|Withdrawal by Subject|1|||
170520632|NCT02787304|616251695|FG001|Overall Study|Withdrawal by Subject|4|||
170409975|NCT01341639|615841744|FG001|Interim Period|Physician Decision|1|||
170409976|NCT01341639|615841743|FG000|Interim Period|Protocol Violation|0|||
170409977|NCT01341639|615841744|FG001|Interim Period|Protocol Violation|1|||
170409978|NCT01341639|615841743|FG000|Post-Treatment|Withdrawal by Subject|0|||
170520633|NCT02787304|616251696|FG002|Overall Study|Withdrawal by Subject|0|||
170764940|NCT00770965|617143322|FG002|Excluded Set|Administrative problems|12|||
170764941|NCT00770965|617143323|FG003|Excluded Set|Administrative problems|10|||
170520634|NCT02787304|616251697|FG003|Overall Study|Withdrawal by Subject|0|||
170520635|NCT02787304|616251694|FG000|Overall Study|Lost to Follow-up|1|||
170520636|NCT02787304|616251695|FG001|Overall Study|Lost to Follow-up|0|||
170520637|NCT02787304|616251696|FG002|Overall Study|Lost to Follow-up|0|||
170520638|NCT02787304|616251697|FG003|Overall Study|Lost to Follow-up|1|||
170520639|NCT02787304|616251694|FG000|Overall Study|Noncompliance with study drug|0|||
170520640|NCT02787304|616251695|FG001|Overall Study|Noncompliance with study drug|0|||
170520641|NCT02787304|616251696|FG002|Overall Study|Noncompliance with study drug|1|||
170520642|NCT02787304|616251697|FG003|Overall Study|Noncompliance with study drug|0|||
170520643|NCT02787304|616251694|FG000|Overall Study|Physician Decision|0|||
170520644|NCT02787304|616251695|FG001|Overall Study|Physician Decision|0|||
170520645|NCT02787304|616251696|FG002|Overall Study|Physician Decision|1|||
170868028|NCT01109173|617528249|FG000|Overall Study|Not Specifiied|5|||
170868029|NCT01109173|617528250|FG001|Overall Study|Not Specifiied|4|||
170868030|NCT01109173|617528251|FG002|Overall Study|Not Specifiied|9|||
170868031|NCT01109173|617528252|FG003|Overall Study|Not Specifiied|14|||
170868032|NCT01132612|617528253|FG000|Overall Study|Death|0|||
170868033|NCT01132612|617528254|FG001|Overall Study|Death|0|||
170520646|NCT02787304|616251697|FG003|Overall Study|Physician Decision|0|||
170520647|NCT02787304|616251694|FG000|Overall Study|Study terminated by sponsor|25|||
170520648|NCT02787304|616251695|FG001|Overall Study|Study terminated by sponsor|31|||
170520649|NCT02787304|616251696|FG002|Overall Study|Study terminated by sponsor|31|||
170520650|NCT02787304|616251697|FG003|Overall Study|Study terminated by sponsor|32|||
170520651|NCT04771013|616251698|FG000|Overall Study|Withdrawal by Subject|2|||
170520652|NCT04771013|616251699|FG001|Overall Study|Withdrawal by Subject|0|||
170520653|NCT04771013|616251698|FG000|Overall Study|Death|0|||
170520654|NCT04771013|616251699|FG001|Overall Study|Death|5|||
170520655|NCT04771013|616251698|FG000|Overall Study|Referred to another hospital before day 20|0|||
170520656|NCT04771013|616251699|FG001|Overall Study|Referred to another hospital before day 20|1|||
170520657|NCT00419757|616251704|FG000|Overall Study|Adverse Event|1|||
170520658|NCT00419757|616251705|FG001|Overall Study|Adverse Event|4|||
170520659|NCT00419757|616251704|FG000|Overall Study|Lost to Follow-up|1|||
170520660|NCT00419757|616251705|FG001|Overall Study|Lost to Follow-up|4|||
170520661|NCT00419757|616251704|FG000|Overall Study|Withdrawal by Subject|7|||
170520662|NCT00419757|616251705|FG001|Overall Study|Withdrawal by Subject|1|||
170520663|NCT00419757|616251704|FG000|Overall Study|Protocol Violation|2|||
170520664|NCT00419757|616251705|FG001|Overall Study|Protocol Violation|3|||
170520665|NCT00419757|616251704|FG000|Overall Study|Study specific discontinuation criteria|4|||
170520666|NCT00419757|616251705|FG001|Overall Study|Study specific discontinuation criteria|8|||
170520667|NCT00419757|616251704|FG000|Overall Study|Multiple reasons|3|||
170520668|NCT00419757|616251705|FG001|Overall Study|Multiple reasons|1|||
170520669|NCT01711983|616251709|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
170520670|NCT01711983|616251709|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
170520671|NCT01711983|616251709|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
170520672|NCT01711983|616251709|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
170520673|NCT00737100|616251713|FG000|Overall Study|Adverse Event|6|||
170520674|NCT00737100|616251714|FG001|Overall Study|Adverse Event|5|||
170520675|NCT00737100|616251715|FG002|Overall Study|Adverse Event|3|||
170520676|NCT00737100|616251713|FG000|Overall Study|Lost to Follow-up|0|||
170520677|NCT00737100|616251714|FG001|Overall Study|Lost to Follow-up|1|||
170520678|NCT00737100|616251715|FG002|Overall Study|Lost to Follow-up|0|||
170520679|NCT00737100|616251713|FG000|Overall Study|Withdrawal by Subject|0|||
170520680|NCT00737100|616251714|FG001|Overall Study|Withdrawal by Subject|0|||
170520681|NCT00737100|616251715|FG002|Overall Study|Withdrawal by Subject|3|||
170520682|NCT00737100|616251713|FG000|Overall Study|Reason discontinued not explained above|1|||
170520683|NCT00737100|616251714|FG001|Overall Study|Reason discontinued not explained above|1|||
170520684|NCT00737100|616251715|FG002|Overall Study|Reason discontinued not explained above|1|||
170520685|NCT01064414|616251716|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
170520686|NCT01064414|616251717|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
170520687|NCT01064414|616251718|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
170520688|NCT01064414|616251716|FG000|Core Period: Baseline to Week 26|Death|0|||
170868034|NCT01132612|617528255|FG002|Overall Study|Death|1|||
170868035|NCT01132612|617528253|FG000|Overall Study|Protocol deviation|0|||
170520689|NCT01064414|616251717|FG001|Core Period: Baseline to Week 26|Death|1|||
170520690|NCT01064414|616251718|FG002|Core Period: Baseline to Week 26|Death|0|||
170520691|NCT01064414|616251716|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
170520692|NCT01064414|616251717|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
170520693|NCT01064414|616251718|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
170520694|NCT01064414|616251716|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
170520695|NCT01064414|616251717|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
170520696|NCT01064414|616251718|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
170520697|NCT01064414|616251716|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
170868036|NCT01132612|617528254|FG001|Overall Study|Protocol deviation|0|||
170868037|NCT01132612|617528255|FG002|Overall Study|Protocol deviation|3|||
170868038|NCT01132612|617528253|FG000|Overall Study|Lost to Follow-up|2|||
170520698|NCT01064414|616251717|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
170520699|NCT01064414|616251718|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
170520700|NCT01064414|616251716|FG000|Core Period: Baseline to Week 26|Other|4|||
170409979|NCT01341639|615841744|FG001|Post-Treatment|Withdrawal by Subject|1|||
170409980|NCT01341639|615841743|FG000|Post-Treatment|Adverse Event|0|||
170409981|NCT01341639|615841744|FG001|Post-Treatment|Adverse Event|2|||
170409982|NCT02224456|615841745|FG000|Overall Study|Lack of Efficacy|1|||
170409983|NCT02224456|615841745|FG000|Overall Study|Lost to Follow-up|15|||
170409984|NCT02224456|615841745|FG000|Overall Study|Withdrawal by Subject|9|||
170409985|NCT02224456|615841745|FG000|Overall Study|Physician Decision|3|||
170409986|NCT02224456|615841745|FG000|Overall Study|Death|2|||
170520701|NCT01064414|616251717|FG001|Core Period: Baseline to Week 26|Other|7|||
170520702|NCT01064414|616251718|FG002|Core Period: Baseline to Week 26|Other|2|||
170520703|NCT01064414|616251716|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
170520704|NCT01064414|616251717|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
170520705|NCT01064414|616251718|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
170520706|NCT01064414|616251716|FG000|Extension Period: Week 26 to Week 52|Death|0|||
170520707|NCT01064414|616251717|FG001|Extension Period: Week 26 to Week 52|Death|1|||
170520708|NCT01064414|616251718|FG002|Extension Period: Week 26 to Week 52|Death|0|||
170520709|NCT01064414|616251716|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
170520710|NCT01064414|616251717|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
170520711|NCT01064414|616251718|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
170520712|NCT01064414|616251716|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
170520713|NCT01064414|616251717|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
170520714|NCT01064414|616251718|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
170520715|NCT01064414|616251716|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
170520716|NCT01064414|616251717|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
170520717|NCT01064414|616251718|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
170520718|NCT01064414|616251716|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
170520719|NCT01064414|616251717|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
170520720|NCT01064414|616251718|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
170520721|NCT01064414|616251716|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
170520722|NCT01064414|616251717|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
170520723|NCT01064414|616251718|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
170520724|NCT01064414|616251716|FG000|Extension Period: Week 26 to Week 52|Other|5|||
170520725|NCT01064414|616251717|FG001|Extension Period: Week 26 to Week 52|Other|2|||
170520726|NCT01064414|616251718|FG002|Extension Period: Week 26 to Week 52|Other|1|||
170520727|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Death|20|||
170520728|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Death|26|||
170520729|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
170520730|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
170520731|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
170520732|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
170520733|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
170520734|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
170520735|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
170520736|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
170520737|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
170409987|NCT02224456|615841745|FG000|Overall Study|Pregnancy|4|||
170409988|NCT02224456|615841745|FG000|Overall Study|Protocol Violation|1|||
170764942|NCT00770965|617143320|FG000|Excluded Set|Withdrawal by Subject|1|||
170764943|NCT00770965|617143321|FG001|Excluded Set|Withdrawal by Subject|1|||
170764944|NCT00770965|617143322|FG002|Excluded Set|Withdrawal by Subject|2|||
170764945|NCT00770965|617143323|FG003|Excluded Set|Withdrawal by Subject|3|||
170764946|NCT04567888|617143324|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
170764947|NCT04567888|617143325|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
170764948|NCT04567888|617143324|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
170764949|NCT04567888|617143325|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
170764950|NCT04567888|617143324|FG000|Overall Study|Reported Unusual Birth Year|2|||
170764951|NCT04567888|617143325|FG001|Overall Study|Reported Unusual Birth Year|3|||
170764952|NCT04567888|617143324|FG000|Overall Study|Duplicate Responses|0|||
170764953|NCT04567888|617143325|FG001|Overall Study|Duplicate Responses|1|||
170764954|NCT00509769|617143326|FG000|Overall Study|Progressive disease|77|||
170764955|NCT00509769|617143326|FG000|Overall Study|Adverse Event|4|||
170868039|NCT01132612|617528254|FG001|Overall Study|Lost to Follow-up|2|||
170409989|NCT02224456|615841745|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
170409990|NCT01241461|615841746|FG000|Overall Study|Progressive Disease|3|||
170409991|NCT01241461|615841747|FG001|Overall Study|Progressive Disease|6|||
170409992|NCT01379781|615841748|FG000|Overall Study|Lost to Follow-up|11|||
170409993|NCT01379781|615841749|FG001|Overall Study|Lost to Follow-up|8|||
170409994|NCT02247479|615841750|FG000|Overall Study|Adverse Event|8|||
170764956|NCT00509769|617143326|FG000|Overall Study|Patient's decision|1|||
170764957|NCT00509769|617143326|FG000|Overall Study|Physician Decision|8|||
170764958|NCT00509769|617143326|FG000|Overall Study|Use of prohibited therapies during study|1|||
170764959|NCT02371746|617143327|FG000|Overall Study|Consent withdrawn|0|||
170764960|NCT02371746|617143328|FG001|Overall Study|Consent withdrawn|0|||
170764961|NCT02371746|617143329|FG002|Overall Study|Consent withdrawn|0|||
170764962|NCT02371746|617143330|FG003|Overall Study|Consent withdrawn|0|||
170764963|NCT02371746|617143331|FG004|Overall Study|Consent withdrawn|0|||
170764964|NCT02371746|617143332|FG005|Overall Study|Consent withdrawn|0|||
170409995|NCT02247479|615841751|FG001|Overall Study|Adverse Event|9|||
170520738|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
170520739|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
170520740|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
170520741|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
170520742|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
170520743|NCT00643201|616251721|FG000|Randomized, Completed 6 Months of Study|Other|107|||
170520744|NCT00643201|616251722|FG001|Randomized, Completed 6 Months of Study|Other|107|||
170520745|NCT00643201|616251721|FG000|Completed Study Follow Up|Death|28|||
170520746|NCT00643201|616251722|FG001|Completed Study Follow Up|Death|34|||
170520747|NCT00643201|616251721|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
170520748|NCT00643201|616251722|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
170409996|NCT02247479|615841752|FG002|Overall Study|Adverse Event|8|||
170409997|NCT02247479|615841750|FG000|Overall Study|Death|5|||
170409998|NCT02247479|615841751|FG001|Overall Study|Death|4|||
170409999|NCT02247479|615841752|FG002|Overall Study|Death|6|||
170410000|NCT02247479|615841750|FG000|Overall Study|Lost to Follow-up|3|||
170410001|NCT02247479|615841751|FG001|Overall Study|Lost to Follow-up|3|||
170410002|NCT02247479|615841752|FG002|Overall Study|Lost to Follow-up|1|||
170410003|NCT02247479|615841750|FG000|Overall Study|Non-compliance|0|||
170410004|NCT02247479|615841751|FG001|Overall Study|Non-compliance|0|||
170410005|NCT02247479|615841752|FG002|Overall Study|Non-compliance|1|||
170410006|NCT02247479|615841750|FG000|Overall Study|Withdrawal by Subject|25|||
170410007|NCT02247479|615841751|FG001|Overall Study|Withdrawal by Subject|29|||
170410008|NCT02247479|615841752|FG002|Overall Study|Withdrawal by Subject|24|||
170410009|NCT02247479|615841750|FG000|Overall Study|Study Terminated by Sponsor|98|||
170410010|NCT02247479|615841751|FG001|Overall Study|Study Terminated by Sponsor|88|||
170410011|NCT02247479|615841752|FG002|Overall Study|Study Terminated by Sponsor|94|||
170410012|NCT02247479|615841750|FG000|Overall Study|Physician Decision|1|||
170410013|NCT02247479|615841751|FG001|Overall Study|Physician Decision|0|||
170410014|NCT02247479|615841752|FG002|Overall Study|Physician Decision|2|||
170410015|NCT02247479|615841750|FG000|Overall Study|Unspecified Reason|2|||
170410016|NCT02247479|615841751|FG001|Overall Study|Unspecified Reason|5|||
170410017|NCT02247479|615841752|FG002|Overall Study|Unspecified Reason|2|||
170410018|NCT03031899|615841755|FG000|Overall Study|Protocol Violation|1|||
170410019|NCT03031899|615841755|FG000|Overall Study|lesion disappeared after stopping habit|1|||
170410020|NCT01664052|615841756|FG000|Phase 1|No device placement|6|||
170410021|NCT01664052|615841757|FG001|Phase 1|No device placement|0|||
170410022|NCT01664052|615841756|FG000|Phase 1|No HSG 1 hr post placement|1|||
170410023|NCT01664052|615841757|FG001|Phase 1|No HSG 1 hr post placement|0|||
170410024|NCT01664052|615841756|FG000|Phase 2|No device placement|0|||
170410025|NCT01664052|615841757|FG001|Phase 2|No device placement|4|||
170410026|NCT01060670|615841758|FG000|Run In|screen failure|0|||
170410027|NCT01060670|615841759|FG001|Run In|screen failure|238|||
170410028|NCT05216978|615841766|FG000|Overall Study|Withdrawal by Subject|3|||
170410029|NCT05216978|615841766|FG000|Overall Study|Lost to Follow-up|5|||
170410030|NCT00658320|615841768|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
170410031|NCT00658320|615841769|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
170410032|NCT00658320|615841768|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
170410033|NCT00658320|615841769|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
170410034|NCT00658320|615841768|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
170410035|NCT00658320|615841769|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
170410036|NCT00658320|615841768|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
170410037|NCT00658320|615841769|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
170410038|NCT00444795|615841782|FG000|Overall Study|Not Treated|1|||
170410039|NCT00444795|615841782|FG000|Overall Study|Treated Prior to the Contract Date|2|||
170410040|NCT03532009|615841786|FG000|Overall Study|Other|1|||
170410041|NCT03532009|615841787|FG001|Overall Study|Other|1|||
170410042|NCT03532009|615841786|FG000|Overall Study|Death|1|||
170410043|NCT03532009|615841787|FG001|Overall Study|Death|1|||
170410044|NCT03532009|615841786|FG000|Overall Study|Withdrawal by Patient|0|||
170410045|NCT03532009|615841787|FG001|Overall Study|Withdrawal by Patient|2|||
170410046|NCT00368966|615841788|FG000|Infant Series|Withdrawal by Subject|11|||
170764965|NCT02371746|617143333|FG006|Overall Study|Consent withdrawn|1|||
170764966|NCT00436644|617143334|FG000|Overall Study|Adverse Event|2|||
170764967|NCT00436644|617143334|FG000|Overall Study|Death|1|||
170764968|NCT01490580|617143337|FG000|Overall Study|Parents withdrew consent|0|||
170410047|NCT00368966|615841789|FG001|Infant Series|Withdrawal by Subject|6|||
170410048|NCT00368966|615841788|FG000|Infant Series|Protocol Violation|2|||
170410049|NCT00368966|615841789|FG001|Infant Series|Protocol Violation|1|||
170410050|NCT00368966|615841788|FG000|Infant Series|Lost to Follow-up|2|||
170410051|NCT00368966|615841789|FG001|Infant Series|Lost to Follow-up|0|||
170410052|NCT00368966|615841788|FG000|Infant Series|Randomization error|0|||
170410053|NCT00368966|615841789|FG001|Infant Series|Randomization error|1|||
170410054|NCT00368966|615841788|FG000|Infant Series|Failed to meet eligibility criteria|0|||
170410055|NCT00368966|615841789|FG001|Infant Series|Failed to meet eligibility criteria|1|||
170410056|NCT00368966|615841788|FG000|Infant Series|Adverse Event|0|||
170410057|NCT00368966|615841789|FG001|Infant Series|Adverse Event|1|||
170410058|NCT00368966|615841788|FG000|Infant Series|Failed to return|1|||
170410059|NCT00368966|615841789|FG001|Infant Series|Failed to return|0|||
170410060|NCT00368966|615841788|FG000|After Infant|Failed to return|3|||
170410061|NCT00368966|615841789|FG001|After Infant|Failed to return|1|||
170410062|NCT00368966|615841788|FG000|After Infant|Adverse Event|1|||
170410063|NCT00368966|615841789|FG001|After Infant|Adverse Event|2|||
170410064|NCT00368966|615841788|FG000|After Infant|Withdrawal by Subject|1|||
170410065|NCT00368966|615841789|FG001|After Infant|Withdrawal by Subject|1|||
170410066|NCT00368966|615841788|FG000|After Infant|Death|1|||
170410067|NCT00368966|615841789|FG001|After Infant|Death|0|||
170410068|NCT00368966|615841788|FG000|After Infant|Lost to Follow-up|0|||
170410069|NCT00368966|615841789|FG001|After Infant|Lost to Follow-up|1|||
170410070|NCT00368966|615841788|FG000|Toddler Dose|Withdrawal by Subject|1|||
170410071|NCT00368966|615841789|FG001|Toddler Dose|Withdrawal by Subject|1|||
170410072|NCT00368966|615841788|FG000|Toddler Dose|Lost to Follow-up|0|||
170410073|NCT00368966|615841789|FG001|Toddler Dose|Lost to Follow-up|2|||
170410074|NCT02866175|615841794|FG000|Overall Study|Adverse Event|56|||
170410075|NCT02866175|615841795|FG001|Overall Study|Adverse Event|54|||
170410076|NCT02866175|615841794|FG000|Overall Study|Withdrawal by Subject|31|||
170410077|NCT02866175|615841795|FG001|Overall Study|Withdrawal by Subject|52|||
170410078|NCT02866175|615841794|FG000|Overall Study|Death|30|||
170410079|NCT02866175|615841795|FG001|Overall Study|Death|23|||
170410080|NCT02866175|615841794|FG000|Overall Study|Other|7|||
170410081|NCT02866175|615841795|FG001|Overall Study|Other|14|||
170410082|NCT02866175|615841794|FG000|Overall Study|Progressive disease|1|||
170410083|NCT02866175|615841795|FG001|Overall Study|Progressive disease|1|||
170410084|NCT02866175|615841794|FG000|Overall Study|Lost to Follow-up|2|||
170410085|NCT02866175|615841795|FG001|Overall Study|Lost to Follow-up|0|||
170410086|NCT02866175|615841794|FG000|Overall Study|Lack of Efficacy|0|||
170410087|NCT02866175|615841795|FG001|Overall Study|Lack of Efficacy|1|||
170410088|NCT02866175|615841794|FG000|Overall Study|Physician Decision|3|||
170410089|NCT02866175|615841795|FG001|Overall Study|Physician Decision|15|||
170410090|NCT02866175|615841794|FG000|Overall Study|Did not receive treatment|5|||
170410091|NCT02866175|615841795|FG001|Overall Study|Did not receive treatment|15|||
170410092|NCT01418352|615841796|FG000|Overall Study|Lost to Follow-up|2|||
170410093|NCT01418352|615841797|FG001|Overall Study|Lost to Follow-up|0|||
170410094|NCT01418352|615841798|FG002|Overall Study|Lost to Follow-up|0|||
170410095|NCT01418352|615841799|FG003|Overall Study|Lost to Follow-up|0|||
170410096|NCT01418352|615841796|FG000|Overall Study|Adverse Event|0|||
170410097|NCT01418352|615841797|FG001|Overall Study|Adverse Event|1|||
170410098|NCT01418352|615841798|FG002|Overall Study|Adverse Event|0|||
170410099|NCT01418352|615841799|FG003|Overall Study|Adverse Event|0|||
170410100|NCT01418352|615841796|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
170410101|NCT01418352|615841797|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
170410102|NCT01418352|615841798|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
170410103|NCT01418352|615841799|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
170410104|NCT01418352|615841796|FG000|Overall Study|Subject Withdrew Consent|0|||
170410105|NCT01418352|615841797|FG001|Overall Study|Subject Withdrew Consent|1|||
170410106|NCT01418352|615841798|FG002|Overall Study|Subject Withdrew Consent|2|||
170410107|NCT01418352|615841799|FG003|Overall Study|Subject Withdrew Consent|1|||
170410108|NCT01418352|615841796|FG000|Overall Study|Protocol Deviation|0|||
170410109|NCT01418352|615841797|FG001|Overall Study|Protocol Deviation|0|||
170410110|NCT01418352|615841798|FG002|Overall Study|Protocol Deviation|1|||
170410111|NCT01418352|615841799|FG003|Overall Study|Protocol Deviation|0|||
170410112|NCT01418352|615841796|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
170410113|NCT01418352|615841797|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
170410114|NCT01418352|615841798|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
170410115|NCT01418352|615841799|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
170764969|NCT01490580|617143338|FG001|Overall Study|Parents withdrew consent|2|||
170410116|NCT00827359|615841800|FG000|Overall Study|Progressive Diseas|19|||
170410117|NCT00827359|615841800|FG000|Overall Study|Unacceptable Toxicity|5|||
170410118|NCT00827359|615841800|FG000|Overall Study|Ineligible|1|||
170410119|NCT01814137|615841803|FG000|Overall Study|Adverse Event|0|||
170410120|NCT01814137|615841804|FG001|Overall Study|Adverse Event|1|||
170410121|NCT01814137|615841803|FG000|Overall Study|Withdrawal by Subject|2|||
170520749|NCT00643201|616251721|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
170520750|NCT00643201|616251722|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
170868040|NCT01132612|617528255|FG002|Overall Study|Lost to Follow-up|7|||
170868041|NCT01132612|617528253|FG000|Overall Study|Adverse Event|5|||
170868042|NCT01132612|617528254|FG001|Overall Study|Adverse Event|2|||
170868043|NCT01132612|617528255|FG002|Overall Study|Adverse Event|15|||
170410122|NCT01814137|615841804|FG001|Overall Study|Withdrawal by Subject|2|||
170410123|NCT01814137|615841803|FG000|Overall Study|Physician Decision|1|||
170410124|NCT01814137|615841804|FG001|Overall Study|Physician Decision|1|||
170410125|NCT01814137|615841803|FG000|Overall Study|Unclassified|2|||
170410126|NCT01814137|615841804|FG001|Overall Study|Unclassified|1|||
170410127|NCT01427803|615841805|FG000|Overall Study|Lost to Follow-up|32|||
170410128|NCT01427803|615841806|FG001|Overall Study|Lost to Follow-up|26|||
170410129|NCT01427803|615841805|FG000|Overall Study|Withdrawal by Subject|20|||
170410130|NCT01427803|615841806|FG001|Overall Study|Withdrawal by Subject|0|||
170410131|NCT01427803|615841805|FG000|Overall Study|Unable to complete full treatment period|6|||
170410132|NCT01427803|615841806|FG001|Overall Study|Unable to complete full treatment period|0|||
170410133|NCT01427803|615841805|FG000|Overall Study|Protocol Violation|1|||
170410134|NCT01427803|615841806|FG001|Overall Study|Protocol Violation|0|||
170410135|NCT01427803|615841805|FG000|Overall Study|Physician Decision|3|||
170410136|NCT01427803|615841806|FG001|Overall Study|Physician Decision|0|||
170410137|NCT01427803|615841805|FG000|Overall Study|did not take product|1|||
170410138|NCT01427803|615841806|FG001|Overall Study|did not take product|0|||
170410139|NCT03412019|615841807|FG000|Overall Study|Withdrawal by Subject|1|||
170410140|NCT03412019|615841808|FG001|Overall Study|Withdrawal by Subject|1|||
170410141|NCT01952574|615841810|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
170410142|NCT01952574|615841811|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
170410143|NCT01952574|615841812|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
170410144|NCT01952574|615841813|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
170410145|NCT01952574|615841814|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170410146|NCT01952574|615841815|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170410147|NCT01952574|615841816|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170410148|NCT01952574|615841810|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
170410149|NCT01952574|615841811|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
170410150|NCT01952574|615841812|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
170410151|NCT01952574|615841813|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
170410152|NCT01952574|615841814|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
170410153|NCT01952574|615841815|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
170410154|NCT01952574|615841816|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
170410155|NCT01952574|615841810|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
170410156|NCT01952574|615841811|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
170410157|NCT01952574|615841812|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
170410158|NCT01952574|615841813|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
170410159|NCT01952574|615841814|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
170410160|NCT01952574|615841815|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
170410161|NCT01952574|615841816|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
170410162|NCT01952574|615841810|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
170410163|NCT01952574|615841811|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
170410164|NCT01952574|615841812|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
170410165|NCT01952574|615841813|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
170410166|NCT01952574|615841814|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
170410167|NCT01952574|615841815|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
170410168|NCT01952574|615841816|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
170410169|NCT01952574|615841810|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
170410170|NCT01952574|615841811|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
170410171|NCT01952574|615841812|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
170410172|NCT01952574|615841813|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
170410173|NCT01952574|615841814|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
170410174|NCT01952574|615841815|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
170410175|NCT01952574|615841816|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
170410176|NCT01952574|615841810|FG000|Open-label Treatment Phase|Missing|0|||
170410177|NCT01952574|615841811|FG001|Open-label Treatment Phase|Missing|0|||
170410178|NCT01952574|615841812|FG002|Open-label Treatment Phase|Missing|0|||
170410179|NCT01952574|615841813|FG003|Open-label Treatment Phase|Missing|0|||
170410180|NCT01952574|615841814|FG004|Open-label Treatment Phase|Missing|4|||
170410181|NCT01952574|615841815|FG005|Open-label Treatment Phase|Missing|0|||
170410182|NCT01952574|615841816|FG006|Open-label Treatment Phase|Missing|0|||
170410183|NCT01952574|615841810|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
170410184|NCT01952574|615841811|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
170868044|NCT01132612|617528253|FG000|Overall Study|Withdrawal by Subject|5|||
170410185|NCT01952574|615841812|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
170410186|NCT01952574|615841813|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
170410187|NCT01952574|615841814|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
170410188|NCT01952574|615841815|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
170410189|NCT01952574|615841816|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
170410190|NCT01952574|615841810|FG000|Open-label Treatment Phase|Death|0|||
170410191|NCT01952574|615841811|FG001|Open-label Treatment Phase|Death|0|||
170410192|NCT01952574|615841812|FG002|Open-label Treatment Phase|Death|0|||
170410193|NCT01952574|615841813|FG003|Open-label Treatment Phase|Death|0|||
170410194|NCT01952574|615841814|FG004|Open-label Treatment Phase|Death|1|||
170410195|NCT01952574|615841815|FG005|Open-label Treatment Phase|Death|0|||
170410196|NCT01952574|615841816|FG006|Open-label Treatment Phase|Death|0|||
170410197|NCT01952574|615841810|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
170410198|NCT01952574|615841811|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
170410199|NCT01952574|615841812|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
170410200|NCT01952574|615841813|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
170410201|NCT01952574|615841814|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
170410202|NCT01952574|615841815|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
170410203|NCT01952574|615841816|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
170410204|NCT01952574|615841810|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
170410205|NCT01952574|615841811|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
170410206|NCT01952574|615841812|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
170410207|NCT01952574|615841813|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
170520751|NCT00643201|616251721|FG000|Completed Study Follow Up|non-specified|1|||
170520752|NCT00643201|616251722|FG001|Completed Study Follow Up|non-specified|0|||
170520753|NCT01781962|616251723|FG000|Overall Study|Other Miscellaneous Reasons|5|||
170520754|NCT02513550|616251733|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
170520755|NCT02513550|616251734|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
170520756|NCT02513550|616251735|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
170520757|NCT02513550|616251736|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
170520758|NCT02513550|616251737|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
170520759|NCT02513550|616251738|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
170520760|NCT02513550|616251733|FG000|Double Blind Treatment Period|Adverse Event|5|||
170520761|NCT02513550|616251734|FG001|Double Blind Treatment Period|Adverse Event|13|||
170520762|NCT02513550|616251735|FG002|Double Blind Treatment Period|Adverse Event|17|||
170520763|NCT02513550|616251736|FG003|Double Blind Treatment Period|Adverse Event|0|||
170520764|NCT02513550|616251737|FG004|Double Blind Treatment Period|Adverse Event|1|||
170520765|NCT02513550|616251738|FG005|Double Blind Treatment Period|Adverse Event|0|||
170520766|NCT02513550|616251733|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
170520767|NCT02513550|616251734|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
170520768|NCT02513550|616251735|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
170520769|NCT02513550|616251736|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
170520770|NCT02513550|616251737|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
170520771|NCT02513550|616251738|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
170520772|NCT02513550|616251733|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
170520773|NCT02513550|616251734|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
170520774|NCT02513550|616251735|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
170410208|NCT01952574|615841814|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
170410209|NCT01952574|615841815|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
170410210|NCT01952574|615841816|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
170410211|NCT02536378|615841821|FG000|Overall Study|Physician Decision|0|||
170410212|NCT02536378|615841822|FG001|Overall Study|Physician Decision|2|||
170410213|NCT02536378|615841821|FG000|Overall Study|Withdrawal by Subject|0|||
170410214|NCT02536378|615841822|FG001|Overall Study|Withdrawal by Subject|1|||
170410215|NCT02536378|615841821|FG000|Overall Study|Death|1|||
170410216|NCT02536378|615841822|FG001|Overall Study|Death|2|||
170410217|NCT02536378|615841821|FG000|Overall Study|Patient refused further follow up|6|||
170410218|NCT02536378|615841822|FG001|Overall Study|Patient refused further follow up|2|||
170410219|NCT01271933|615841823|FG000|Single-Blind Phase|Lack of Efficacy|37|||
170410220|NCT01271933|615841824|FG001|Single-Blind Phase|Lack of Efficacy|0|||
170410221|NCT01271933|615841825|FG002|Single-Blind Phase|Lack of Efficacy|0|||
170410222|NCT01271933|615841823|FG000|Single-Blind Phase|Lost to Follow-up|10|||
170410223|NCT01271933|615841824|FG001|Single-Blind Phase|Lost to Follow-up|0|||
170410224|NCT01271933|615841825|FG002|Single-Blind Phase|Lost to Follow-up|0|||
170410225|NCT01271933|615841823|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
170410226|NCT01271933|615841824|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
170410227|NCT01271933|615841825|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
170520775|NCT02513550|616251736|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
170520776|NCT02513550|616251737|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
170520777|NCT02513550|616251738|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
170410228|NCT01271933|615841823|FG000|Single-Blind Phase|Protocol Violation|3|||
170410229|NCT01271933|615841824|FG001|Single-Blind Phase|Protocol Violation|0|||
170410230|NCT01271933|615841825|FG002|Single-Blind Phase|Protocol Violation|0|||
170410231|NCT01271933|615841823|FG000|Single-Blind Phase|Adverse Event|52|||
170520778|NCT02513550|616251733|FG000|Double Blind Treatment Period|Protocol Violation|1|||
170520779|NCT02513550|616251734|FG001|Double Blind Treatment Period|Protocol Violation|1|||
170520780|NCT02513550|616251735|FG002|Double Blind Treatment Period|Protocol Violation|4|||
170520781|NCT02513550|616251736|FG003|Double Blind Treatment Period|Protocol Violation|0|||
170520782|NCT02513550|616251737|FG004|Double Blind Treatment Period|Protocol Violation|0|||
170520783|NCT02513550|616251738|FG005|Double Blind Treatment Period|Protocol Violation|0|||
170520784|NCT02513550|616251733|FG000|Double Blind Treatment Period|Physician Decision|2|||
170520785|NCT02513550|616251734|FG001|Double Blind Treatment Period|Physician Decision|0|||
170520786|NCT02513550|616251735|FG002|Double Blind Treatment Period|Physician Decision|4|||
170520787|NCT02513550|616251736|FG003|Double Blind Treatment Period|Physician Decision|0|||
170520788|NCT02513550|616251737|FG004|Double Blind Treatment Period|Physician Decision|0|||
170520789|NCT02513550|616251738|FG005|Double Blind Treatment Period|Physician Decision|0|||
170520790|NCT02513550|616251733|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
170520791|NCT02513550|616251734|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
170520792|NCT02513550|616251735|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
170520793|NCT02513550|616251736|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
170520794|NCT02513550|616251737|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
170520795|NCT02513550|616251738|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
170520796|NCT02513550|616251733|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
170520797|NCT02513550|616251734|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
170520798|NCT02513550|616251735|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
170520799|NCT02513550|616251736|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
170520800|NCT02513550|616251737|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
170520801|NCT02513550|616251738|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
170520802|NCT02513550|616251733|FG000|Double Blind Treatment Period|Due to personal business|2|||
170520803|NCT02513550|616251734|FG001|Double Blind Treatment Period|Due to personal business|0|||
170520804|NCT02513550|616251735|FG002|Double Blind Treatment Period|Due to personal business|1|||
170520805|NCT02513550|616251736|FG003|Double Blind Treatment Period|Due to personal business|0|||
170520806|NCT02513550|616251737|FG004|Double Blind Treatment Period|Due to personal business|0|||
170520807|NCT02513550|616251738|FG005|Double Blind Treatment Period|Due to personal business|0|||
170520808|NCT02513550|616251733|FG000|Double Blind Treatment Period|Death|1|||
170520809|NCT02513550|616251734|FG001|Double Blind Treatment Period|Death|0|||
170520810|NCT02513550|616251735|FG002|Double Blind Treatment Period|Death|2|||
170520811|NCT02513550|616251736|FG003|Double Blind Treatment Period|Death|0|||
170520812|NCT02513550|616251737|FG004|Double Blind Treatment Period|Death|0|||
170520813|NCT02513550|616251738|FG005|Double Blind Treatment Period|Death|0|||
170520814|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
170520815|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
170520816|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
170520817|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170520818|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170520819|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
170520820|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
170520821|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
170520822|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
170520823|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
170520824|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
170520825|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
170520826|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
170520827|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
170520828|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
170520829|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170520830|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170520831|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
170520832|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
170520833|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
170520834|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
170520835|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
170520836|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
170520837|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
170520838|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
170520839|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
170520840|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
170520841|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
170764970|NCT00878722|617143342|FG000|Overall Study|Progressive disease|3|||
170764971|NCT00878722|617143343|FG001|Overall Study|Progressive disease|3|||
170764972|NCT00878722|617143344|FG002|Overall Study|Progressive disease|3|||
170410232|NCT01271933|615841824|FG001|Single-Blind Phase|Adverse Event|0|||
170410233|NCT01271933|615841825|FG002|Single-Blind Phase|Adverse Event|0|||
170410234|NCT01271933|615841823|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
170410235|NCT01271933|615841824|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
170410236|NCT01271933|615841825|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
170410237|NCT01271933|615841823|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
170410238|NCT01271933|615841824|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
170410239|NCT01271933|615841825|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
170410240|NCT01271933|615841823|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
170410241|NCT01271933|615841824|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
170410242|NCT01271933|615841825|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
170410243|NCT01271933|615841823|FG000|Double-Blind Phase|Randomized but not treated|0|||
170410244|NCT01271933|615841824|FG001|Double-Blind Phase|Randomized but not treated|0|||
170410245|NCT01271933|615841825|FG002|Double-Blind Phase|Randomized but not treated|1|||
170410246|NCT01271933|615841823|FG000|Double-Blind Phase|Lack of Efficacy|0|||
170410247|NCT01271933|615841824|FG001|Double-Blind Phase|Lack of Efficacy|6|||
170410248|NCT01271933|615841825|FG002|Double-Blind Phase|Lack of Efficacy|9|||
170410249|NCT01271933|615841823|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170410250|NCT01271933|615841824|FG001|Double-Blind Phase|Lost to Follow-up|1|||
170410251|NCT01271933|615841825|FG002|Double-Blind Phase|Lost to Follow-up|1|||
170410252|NCT01271933|615841823|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
170410253|NCT01271933|615841824|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
170410254|NCT01271933|615841825|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
170410255|NCT01271933|615841823|FG000|Double-Blind Phase|Adverse Event|0|||
170410256|NCT01271933|615841824|FG001|Double-Blind Phase|Adverse Event|3|||
170410257|NCT01271933|615841825|FG002|Double-Blind Phase|Adverse Event|0|||
170410258|NCT01271933|615841823|FG000|Double-Blind Phase|Participant request-personal reason|0|||
170410259|NCT01271933|615841824|FG001|Double-Blind Phase|Participant request-personal reason|1|||
170410260|NCT01271933|615841825|FG002|Double-Blind Phase|Participant request-personal reason|0|||
170410261|NCT01620983|615841826|FG000|Overall Study|Lost to Follow-up|8|||
170410262|NCT01620983|615841827|FG001|Overall Study|Lost to Follow-up|4|||
170410263|NCT01620983|615841828|FG002|Overall Study|Lost to Follow-up|9|||
170410264|NCT01620983|615841826|FG000|Overall Study|Withdrawal by Subject|6|||
170410265|NCT01620983|615841827|FG001|Overall Study|Withdrawal by Subject|8|||
170410266|NCT01620983|615841828|FG002|Overall Study|Withdrawal by Subject|1|||
170410267|NCT01620983|615841826|FG000|Overall Study|Death|2|||
170410268|NCT01620983|615841827|FG001|Overall Study|Death|0|||
170410269|NCT01620983|615841828|FG002|Overall Study|Death|0|||
170410270|NCT01620983|615841826|FG000|Overall Study|Physician Decision|3|||
170410271|NCT01620983|615841827|FG001|Overall Study|Physician Decision|10|||
170410272|NCT01620983|615841828|FG002|Overall Study|Physician Decision|5|||
170410273|NCT01580020|615841829|FG000|Overall Study|Lack of Efficacy|0|||
170410274|NCT01580020|615841830|FG001|Overall Study|Lack of Efficacy|5|||
170410275|NCT01580020|615841831|FG002|Overall Study|Lack of Efficacy|0|||
170410276|NCT01580020|615841832|FG003|Overall Study|Lack of Efficacy|1|||
170410277|NCT01580020|615841829|FG000|Overall Study|Withdrawal by Subject|0|||
170410278|NCT01580020|615841830|FG001|Overall Study|Withdrawal by Subject|1|||
170410279|NCT01580020|615841831|FG002|Overall Study|Withdrawal by Subject|1|||
170410280|NCT01580020|615841832|FG003|Overall Study|Withdrawal by Subject|0|||
170410281|NCT01580020|615841829|FG000|Overall Study|Adverse Event|1|||
170410282|NCT01580020|615841830|FG001|Overall Study|Adverse Event|1|||
170410283|NCT01580020|615841831|FG002|Overall Study|Adverse Event|1|||
170410284|NCT01580020|615841832|FG003|Overall Study|Adverse Event|1|||
170410285|NCT01580020|615841829|FG000|Overall Study|Administrative Problems|0|||
170410286|NCT01580020|615841830|FG001|Overall Study|Administrative Problems|0|||
170410287|NCT01580020|615841831|FG002|Overall Study|Administrative Problems|1|||
170410288|NCT01580020|615841832|FG003|Overall Study|Administrative Problems|0|||
170410289|NCT01580020|615841829|FG000|Overall Study|Lost to Follow-up|0|||
170410290|NCT01580020|615841830|FG001|Overall Study|Lost to Follow-up|0|||
170410291|NCT01580020|615841831|FG002|Overall Study|Lost to Follow-up|1|||
170410292|NCT01580020|615841832|FG003|Overall Study|Lost to Follow-up|0|||
170410293|NCT00798889|615841834|FG000|Overall Study|Adverse Event|53|||
170410294|NCT00798889|615841834|FG000|Overall Study|Protocol Violation|2|||
170410295|NCT00798889|615841834|FG000|Overall Study|Withdrawal by Subject|31|||
170410296|NCT00798889|615841834|FG000|Overall Study|Lost to Follow-up|1|||
170410297|NCT00798889|615841834|FG000|Overall Study|Lack of Efficacy|213|||
170410298|NCT00798889|615841834|FG000|Overall Study|Decision of Sponsor|11|||
170410299|NCT00798889|615841834|FG000|Overall Study|Enrolled, Not treated|3|||
170410300|NCT00617461|615841835|FG000|First Treatment Intervention Period|Adverse Event|2|||
170410301|NCT00617461|615841836|FG001|First Treatment Intervention Period|Adverse Event|0|||
170764973|NCT00878722|617143345|FG003|Overall Study|Progressive disease|7|||
170410302|NCT00617461|615841835|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
170410303|NCT00617461|615841836|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
170410304|NCT00617461|615841835|FG000|First Treatment Intervention Period|Protocol Violation|2|||
170410305|NCT00617461|615841836|FG001|First Treatment Intervention Period|Protocol Violation|1|||
170520842|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
170520843|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
170520844|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Death|0|||
170520845|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Death|0|||
170520846|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Death|1|||
170520847|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Death|0|||
170520848|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Death|0|||
170520849|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Death|0|||
170520850|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
170520851|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
170520852|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
170520853|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
170520854|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
170520855|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
170520856|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
170520857|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
170520858|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
170520859|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
170520860|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
170520861|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
170520862|NCT02513550|616251733|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
170520863|NCT02513550|616251734|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
170520864|NCT02513550|616251735|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
170520865|NCT02513550|616251736|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
170520866|NCT02513550|616251737|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
170520867|NCT02513550|616251738|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
170520868|NCT04176939|616251745|FG000|Overall Study|Withdrawal by Subject|5|||
170520869|NCT04176939|616251745|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
170520870|NCT04176939|616251745|FG000|Overall Study|Lost to Follow-up|2|||
170520871|NCT04176939|616251745|FG000|Overall Study|Unspecified reason|4|||
170520872|NCT04176939|616251745|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
170520873|NCT00809445|616251746|FG000|1 Month Follow-up|Lost contact|1|||
170520874|NCT00809445|616251747|FG001|1 Month Follow-up|Lost contact|2|||
170520875|NCT00809445|616251748|FG002|1 Month Follow-up|Lost contact|1|||
170520876|NCT00809445|616251746|FG000|1 Month Follow-up|Withdrew consent|1|||
170520877|NCT00809445|616251747|FG001|1 Month Follow-up|Withdrew consent|1|||
170520878|NCT00809445|616251748|FG002|1 Month Follow-up|Withdrew consent|1|||
170520879|NCT00809445|616251746|FG000|1 Month Follow-up|Death|0|||
170520880|NCT00809445|616251747|FG001|1 Month Follow-up|Death|1|||
170520881|NCT00809445|616251748|FG002|1 Month Follow-up|Death|1|||
170520882|NCT00809445|616251746|FG000|1 Month Follow-up|Incarcerated|0|||
170520883|NCT00809445|616251747|FG001|1 Month Follow-up|Incarcerated|0|||
170520884|NCT00809445|616251748|FG002|1 Month Follow-up|Incarcerated|1|||
170520885|NCT00809445|616251746|FG000|6 Month Follow-up|Lost contact|16|||
170520886|NCT00809445|616251747|FG001|6 Month Follow-up|Lost contact|14|||
170520887|NCT00809445|616251748|FG002|6 Month Follow-up|Lost contact|14|||
170520888|NCT00809445|616251746|FG000|6 Month Follow-up|Death|2|||
170520889|NCT00809445|616251747|FG001|6 Month Follow-up|Death|1|||
170520890|NCT00809445|616251748|FG002|6 Month Follow-up|Death|1|||
170520891|NCT00809445|616251746|FG000|6 Month Follow-up|Incarcerated|6|||
170520892|NCT00809445|616251747|FG001|6 Month Follow-up|Incarcerated|8|||
170520893|NCT00809445|616251748|FG002|6 Month Follow-up|Incarcerated|8|||
170520894|NCT00809445|616251746|FG000|6 Month Follow-up|Withdrew consent|0|||
170520895|NCT00809445|616251747|FG001|6 Month Follow-up|Withdrew consent|0|||
170520896|NCT00809445|616251748|FG002|6 Month Follow-up|Withdrew consent|1|||
170520897|NCT04919317|616251750|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
170520898|NCT04919317|616251751|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
170520899|NCT04919317|616251750|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
170520900|NCT04919317|616251751|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
170520901|NCT00321906|616251752|FG000|Overall Study|Adverse Event|36|||
170520902|NCT00321906|616251753|FG001|Overall Study|Adverse Event|44|||
170520903|NCT00321906|616251752|FG000|Overall Study|Death|9|||
170520904|NCT00321906|616251753|FG001|Overall Study|Death|6|||
170520905|NCT00321906|616251752|FG000|Overall Study|Lost to Follow-up|1|||
170520906|NCT00321906|616251753|FG001|Overall Study|Lost to Follow-up|2|||
170520907|NCT00321906|616251752|FG000|Overall Study|Withdrawal by Subject|0|||
170520908|NCT00321906|616251753|FG001|Overall Study|Withdrawal by Subject|4|||
170520909|NCT01272908|616251754|FG000|Initial Treatment Period|Adverse Event|1|||
170520910|NCT01272908|616251754|FG000|Initial Treatment Period|Lack of Efficacy|5|||
170520911|NCT01272908|616251754|FG000|Initial Treatment Period|Protocol Violation|1|||
170520912|NCT01272908|616251754|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
170520913|NCT01272908|616251754|FG000|Re-Treatment Period|Adverse Event|2|||
170520914|NCT01272908|616251754|FG000|Re-Treatment Period|Lack of Efficacy|3|||
170520915|NCT01272908|616251754|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
170520916|NCT00149396|616251757|FG000|Overall Study|Death|15|||
170520917|NCT00149396|616251757|FG000|Overall Study|Withdrawal by Subject|1|||
170520918|NCT00149396|616251757|FG000|Overall Study|Subject noncompliance|2|||
170520919|NCT00149396|616251757|FG000|Overall Study|other treatment|5|||
170520920|NCT00327717|616251761|FG000|Overall Study|Adverse Event|6|||
170520921|NCT00327717|616251762|FG001|Overall Study|Adverse Event|6|||
170520922|NCT00327717|616251761|FG000|Overall Study|Lack of Efficacy|0|||
170520923|NCT00327717|616251762|FG001|Overall Study|Lack of Efficacy|1|||
170520924|NCT00327717|616251761|FG000|Overall Study|Withdrawal by Subject|3|||
170520925|NCT00327717|616251762|FG001|Overall Study|Withdrawal by Subject|7|||
170520926|NCT00186485|616251766|FG000|Overall Study|Lost to Follow-up|3|||
170520927|NCT01166750|616251767|FG000|Overall Study|Lost to Follow-up|1|||
170520928|NCT01166750|616251768|FG001|Overall Study|Lost to Follow-up|0|||
170520929|NCT02417753|616251769|FG000|Overall Study|Death|1|||
170520930|NCT03113968|616251770|FG000|Overall Study|Withdrawal by Subject|31|||
170520931|NCT03113968|616251771|FG001|Overall Study|Withdrawal by Subject|4|||
170520932|NCT00901342|616251772|FG000|Overall Study|Adverse Event|1|||
170520933|NCT00901342|616251772|FG000|Overall Study|Death|4|||
170520934|NCT00901342|616251772|FG000|Overall Study|Disease progression|1|||
170520935|NCT00901342|616251772|FG000|Overall Study|Withdrawal by Subject|9|||
170520936|NCT02782741|616251773|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
170520937|NCT02782741|616251774|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
170520938|NCT02782741|616251775|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
170520939|NCT02782741|616251773|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
170520940|NCT02782741|616251774|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
170520941|NCT02782741|616251775|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
170520942|NCT02782741|616251773|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
170520943|NCT02782741|616251774|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
170520944|NCT02782741|616251775|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
170520945|NCT02782741|616251773|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
170520946|NCT02782741|616251774|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
170520947|NCT02782741|616251775|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
170520948|NCT02782741|616251773|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
170520949|NCT02782741|616251774|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
170520950|NCT02782741|616251775|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
170520951|NCT04010461|616251776|FG000|Overall Study|COVID based withdrawal|5|||
170520952|NCT04010461|616251776|FG000|Overall Study|Withdrawal by Subject|5|||
170520953|NCT04010461|616251776|FG000|Overall Study|Adverse Event|1|||
170520954|NCT04010461|616251776|FG000|Overall Study|No Motor Threshold obtainable|1|||
170520955|NCT04010461|616251776|FG000|Overall Study|Physician Decision|1|||
170520956|NCT01026948|616251779|FG000|Overall Study|Physician Decision|8|||
170520957|NCT00102596|616251780|FG000|Part A|Screen failures|6|||
170520958|NCT00102596|616251781|FG001|Part A|Screen failures|0|||
170520959|NCT00102596|616251780|FG000|Part A|Adverse Event|1|||
170520960|NCT00102596|616251781|FG001|Part A|Adverse Event|0|||
170520961|NCT05116202|616251784|FG000|Overall Study|Study Terminated by Sponsor|21|||
170520962|NCT05116202|616251785|FG001|Overall Study|Study Terminated by Sponsor|38|||
170520963|NCT05116202|616251786|FG002|Overall Study|Study Terminated by Sponsor|17|||
170520964|NCT05116202|616251787|FG003|Overall Study|Study Terminated by Sponsor|18|||
170520965|NCT05116202|616251788|FG004|Overall Study|Study Terminated by Sponsor|0|||
170520966|NCT05116202|616251784|FG000|Overall Study|Withdrawal by Subject|0|||
170520967|NCT05116202|616251785|FG001|Overall Study|Withdrawal by Subject|1|||
170520968|NCT05116202|616251786|FG002|Overall Study|Withdrawal by Subject|1|||
170520969|NCT05116202|616251787|FG003|Overall Study|Withdrawal by Subject|1|||
170520970|NCT05116202|616251788|FG004|Overall Study|Withdrawal by Subject|1|||
170520971|NCT05116202|616251784|FG000|Overall Study|Lost to Follow-up|0|||
170520972|NCT05116202|616251785|FG001|Overall Study|Lost to Follow-up|0|||
170520973|NCT05116202|616251786|FG002|Overall Study|Lost to Follow-up|0|||
170520974|NCT05116202|616251787|FG003|Overall Study|Lost to Follow-up|0|||
170520975|NCT05116202|616251788|FG004|Overall Study|Lost to Follow-up|2|||
170520976|NCT05116202|616251784|FG000|Overall Study|Death|1|||
170520977|NCT05116202|616251785|FG001|Overall Study|Death|1|||
170520978|NCT05116202|616251786|FG002|Overall Study|Death|2|||
170520979|NCT05116202|616251787|FG003|Overall Study|Death|1|||
170520980|NCT05116202|616251788|FG004|Overall Study|Death|5|||
170520981|NCT02797678|616251789|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
170520982|NCT02797678|616251790|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
170520983|NCT02797678|616251791|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
170520984|NCT02797678|616251792|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
170520985|NCT02797678|616251789|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
170520986|NCT02797678|616251790|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
170520987|NCT02797678|616251791|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
170520988|NCT02797678|616251792|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
170764974|NCT00878722|617143346|FG004|Overall Study|Progressive disease|7|||
170410306|NCT00617461|615841835|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
170410307|NCT00617461|615841836|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
170410308|NCT00617461|615841835|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
170410309|NCT00617461|615841836|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
170410310|NCT00617461|615841835|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
170410311|NCT00617461|615841836|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
170410312|NCT00617461|615841835|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
170410313|NCT00617461|615841836|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
170410314|NCT00617461|615841835|FG000|Second Treatment Intervention Period|Adverse Event|0|||
170410315|NCT00617461|615841836|FG001|Second Treatment Intervention Period|Adverse Event|1|||
170410316|NCT00617461|615841835|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
170410317|NCT00617461|615841836|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
170410318|NCT00617461|615841835|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
170410319|NCT00617461|615841836|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
170410320|NCT00617461|615841835|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
170410321|NCT00617461|615841836|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
170410322|NCT05085964|615841837|FG000|Overall Study|Premature termination of study|21|||
170410323|NCT05085964|615841838|FG001|Overall Study|Premature termination of study|0|||
170410324|NCT01821625|615841839|FG000|Overall Study|Withdrawal by Subject|2|||
170410325|NCT01821625|615841839|FG000|Overall Study|Lack of Efficacy|2|||
170410326|NCT01821625|615841839|FG000|Overall Study|Adverse Event|1|||
170410327|NCT01821625|615841839|FG000|Overall Study|Medical contraindication|1|||
170410328|NCT03156270|615841841|FG000|Overall Study|Failed pre-treatment screening|1|||
170410329|NCT03156270|615841841|FG000|Overall Study|Lost to Follow-up|1|||
170410330|NCT00591253|615841842|FG000|Overall Study|Adverse Event|3|||
170410331|NCT00591253|615841843|FG001|Overall Study|Adverse Event|3|||
170410332|NCT00591253|615841844|FG002|Overall Study|Adverse Event|1|||
170410333|NCT00591253|615841842|FG000|Overall Study|Protocol Violation|2|||
170410334|NCT00591253|615841843|FG001|Overall Study|Protocol Violation|2|||
170410335|NCT00591253|615841844|FG002|Overall Study|Protocol Violation|2|||
170410336|NCT00591253|615841842|FG000|Overall Study|Lost to Follow-up|2|||
170410337|NCT00591253|615841843|FG001|Overall Study|Lost to Follow-up|4|||
170410338|NCT00591253|615841844|FG002|Overall Study|Lost to Follow-up|0|||
170410339|NCT00591253|615841842|FG000|Overall Study|Withdrawal by Subject|1|||
170410340|NCT00591253|615841843|FG001|Overall Study|Withdrawal by Subject|7|||
170410341|NCT00591253|615841844|FG002|Overall Study|Withdrawal by Subject|6|||
170410342|NCT00591253|615841842|FG000|Overall Study|Lack of Efficacy|1|||
170410343|NCT00591253|615841843|FG001|Overall Study|Lack of Efficacy|0|||
170410344|NCT00591253|615841844|FG002|Overall Study|Lack of Efficacy|3|||
170410345|NCT00591253|615841842|FG000|Overall Study|Other|5|||
170410346|NCT00591253|615841843|FG001|Overall Study|Other|5|||
170410347|NCT00591253|615841844|FG002|Overall Study|Other|3|||
170410348|NCT01841359|615841848|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
170410349|NCT01841359|615841848|FG000|Overall Study|Concommitant medical issues|2|||
170410350|NCT01841359|615841848|FG000|Overall Study|Adverse Event|3|||
170410351|NCT01841359|615841848|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
170410352|NCT02151461|615841849|FG000|Overall Study|Adverse Event|5|||
170410353|NCT02151461|615841850|FG001|Overall Study|Adverse Event|1|||
170410354|NCT02151461|615841851|FG002|Overall Study|Adverse Event|0|||
170410355|NCT02151461|615841852|FG003|Overall Study|Adverse Event|2|||
170410356|NCT02151461|615841849|FG000|Overall Study|Lost to Follow-up|0|||
170410357|NCT02151461|615841850|FG001|Overall Study|Lost to Follow-up|0|||
170410358|NCT02151461|615841851|FG002|Overall Study|Lost to Follow-up|1|||
170410359|NCT02151461|615841852|FG003|Overall Study|Lost to Follow-up|1|||
170410360|NCT02151461|615841849|FG000|Overall Study|Withdrawal by Subject|1|||
170410361|NCT02151461|615841850|FG001|Overall Study|Withdrawal by Subject|0|||
170410362|NCT02151461|615841851|FG002|Overall Study|Withdrawal by Subject|1|||
170410363|NCT02151461|615841852|FG003|Overall Study|Withdrawal by Subject|1|||
170410364|NCT02151461|615841849|FG000|Overall Study|Treatment discontinuation|0|||
170410365|NCT02151461|615841850|FG001|Overall Study|Treatment discontinuation|0|||
170410366|NCT02151461|615841851|FG002|Overall Study|Treatment discontinuation|1|||
170410367|NCT02151461|615841852|FG003|Overall Study|Treatment discontinuation|0|||
170410368|NCT01620489|615841853|FG000|Overall Study|Adverse Event|17|||
170410369|NCT01620489|615841854|FG001|Overall Study|Adverse Event|4|||
170410370|NCT01620489|615841853|FG000|Overall Study|Protocol Violation|0|||
170410371|NCT01620489|615841854|FG001|Overall Study|Protocol Violation|3|||
170410372|NCT01620489|615841853|FG000|Overall Study|Withdrawal Criteria|17|||
170410373|NCT01620489|615841854|FG001|Overall Study|Withdrawal Criteria|25|||
170410374|NCT01620489|615841853|FG000|Overall Study|Unclassified|1|||
170410375|NCT01620489|615841854|FG001|Overall Study|Unclassified|2|||
170410376|NCT00210626|615841855|FG000|Overall Study|Adverse Event|1|||
170410377|NCT00210626|615841856|FG001|Overall Study|Adverse Event|2|||
170410378|NCT00210626|615841855|FG000|Overall Study|Protocol Violation|1|||
170764975|NCT00878722|617143347|FG005|Overall Study|Progressive disease|1|||
170410379|NCT00210626|615841856|FG001|Overall Study|Protocol Violation|5|||
170764976|NCT00878722|617143348|FG006|Overall Study|Progressive disease|4|||
170764977|NCT00878722|617143349|FG007|Overall Study|Progressive disease|3|||
170764978|NCT00878722|617143342|FG000|Overall Study|Death|0|||
170764979|NCT00878722|617143343|FG001|Overall Study|Death|0|||
170764980|NCT00878722|617143344|FG002|Overall Study|Death|0|||
170764981|NCT00878722|617143345|FG003|Overall Study|Death|1|||
170410380|NCT00210626|615841855|FG000|Overall Study|Lost to Follow-up|11|||
170410381|NCT00210626|615841856|FG001|Overall Study|Lost to Follow-up|11|||
170410382|NCT00210626|615841855|FG000|Overall Study|Death|1|||
170410383|NCT00210626|615841856|FG001|Overall Study|Death|0|||
170410384|NCT00210626|615841855|FG000|Overall Study|Withdrawal by Subject|29|||
170410385|NCT00210626|615841856|FG001|Overall Study|Withdrawal by Subject|20|||
170410386|NCT00210626|615841855|FG000|Overall Study|Physician Decision|0|||
170410387|NCT00210626|615841856|FG001|Overall Study|Physician Decision|2|||
170410388|NCT00210626|615841855|FG000|Overall Study|Sponser Request|1|||
170410389|NCT00210626|615841856|FG001|Overall Study|Sponser Request|0|||
170410390|NCT00210626|615841855|FG000|Overall Study|Other|4|||
170410391|NCT00210626|615841856|FG001|Overall Study|Other|5|||
170410392|NCT00501046|615841857|FG000|Overall Study|Adverse Event|21|||
170410393|NCT00501046|615841858|FG001|Overall Study|Adverse Event|25|||
170410394|NCT00501046|615841857|FG000|Overall Study|Death|23|||
170410395|NCT00501046|615841858|FG001|Overall Study|Death|30|||
170410396|NCT00501046|615841857|FG000|Overall Study|Lost to Follow-up|14|||
170410397|NCT00501046|615841858|FG001|Overall Study|Lost to Follow-up|13|||
170410398|NCT00501046|615841857|FG000|Overall Study|Physician Decision|7|||
170410399|NCT00501046|615841858|FG001|Overall Study|Physician Decision|2|||
170410400|NCT00501046|615841857|FG000|Overall Study|Pregnancy|0|||
170410401|NCT00501046|615841858|FG001|Overall Study|Pregnancy|3|||
170410402|NCT00501046|615841857|FG000|Overall Study|Protocol Violation|2|||
170410403|NCT00501046|615841858|FG001|Overall Study|Protocol Violation|1|||
170410404|NCT00501046|615841857|FG000|Overall Study|Withdrawal by Subject|84|||
170410405|NCT00501046|615841858|FG001|Overall Study|Withdrawal by Subject|83|||
170410406|NCT00501046|615841857|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
170410407|NCT00501046|615841858|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
170410408|NCT05056727|615841859|FG000|Initiation Phase|Lost to Follow-up|1|||
170410409|NCT05056727|615841860|FG001|Initiation Phase|Lost to Follow-up|0|||
170410410|NCT05056727|615841861|FG002|Initiation Phase|Lost to Follow-up|0|||
170410411|NCT05056727|615841862|FG003|Initiation Phase|Lost to Follow-up|0|||
170410412|NCT05056727|615841859|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
170410413|NCT05056727|615841860|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
170410414|NCT05056727|615841861|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
170410415|NCT05056727|615841862|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
170410416|NCT05056727|615841859|FG000|Initiation Phase|Withdrawal by Subject|9|||
170410417|NCT05056727|615841860|FG001|Initiation Phase|Withdrawal by Subject|0|||
170410418|NCT05056727|615841861|FG002|Initiation Phase|Withdrawal by Subject|0|||
170410419|NCT05056727|615841862|FG003|Initiation Phase|Withdrawal by Subject|0|||
170410420|NCT05056727|615841859|FG000|Initiation Phase|Physician Decision|4|||
170410421|NCT05056727|615841860|FG001|Initiation Phase|Physician Decision|0|||
170410422|NCT05056727|615841861|FG002|Initiation Phase|Physician Decision|0|||
170410423|NCT05056727|615841862|FG003|Initiation Phase|Physician Decision|0|||
170410424|NCT05056727|615841859|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
170410425|NCT05056727|615841860|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
170410426|NCT05056727|615841861|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
170410427|NCT05056727|615841862|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
170410428|NCT05056727|615841859|FG000|Run-in Phase|Death|0|||
170410429|NCT05056727|615841860|FG001|Run-in Phase|Death|3|||
170410430|NCT05056727|615841861|FG002|Run-in Phase|Death|0|||
170410431|NCT05056727|615841862|FG003|Run-in Phase|Death|0|||
170410432|NCT05056727|615841859|FG000|Run-in Phase|Withdrawal by Subject|0|||
170410433|NCT05056727|615841860|FG001|Run-in Phase|Withdrawal by Subject|25|||
170410434|NCT05056727|615841861|FG002|Run-in Phase|Withdrawal by Subject|0|||
170410435|NCT05056727|615841862|FG003|Run-in Phase|Withdrawal by Subject|0|||
170410436|NCT05056727|615841859|FG000|Run-in Phase|Physician Decision|0|||
170410437|NCT05056727|615841860|FG001|Run-in Phase|Physician Decision|20|||
170410438|NCT05056727|615841861|FG002|Run-in Phase|Physician Decision|0|||
170410439|NCT05056727|615841862|FG003|Run-in Phase|Physician Decision|0|||
170410440|NCT05056727|615841859|FG000|Run-in Phase|Lost to Follow-up|0|||
170410441|NCT05056727|615841860|FG001|Run-in Phase|Lost to Follow-up|1|||
170410442|NCT05056727|615841861|FG002|Run-in Phase|Lost to Follow-up|0|||
170410443|NCT05056727|615841862|FG003|Run-in Phase|Lost to Follow-up|0|||
170410444|NCT05056727|615841859|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
170410445|NCT05056727|615841860|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
170410446|NCT05056727|615841861|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
170520989|NCT02797678|616251789|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
170764982|NCT00878722|617143346|FG004|Overall Study|Death|0|||
170764983|NCT00878722|617143347|FG005|Overall Study|Death|1|||
170520990|NCT02797678|616251790|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
170520991|NCT02797678|616251791|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
170520992|NCT02797678|616251792|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
170520993|NCT01670045|616251796|FG000|Overall Study|Withdrawal by Subject|3|||
170520994|NCT01670045|616251796|FG000|Overall Study|Adverse Event|1|||
170520995|NCT01670045|616251796|FG000|Overall Study|Death|1|||
170520996|NCT01670045|616251796|FG000|Overall Study|Lost to Follow-up|11|||
170520997|NCT03360019|616251797|FG000|Overall Study|Withdrawal by Subject|2|||
170520998|NCT03360019|616251798|FG001|Overall Study|Withdrawal by Subject|0|||
170520999|NCT03360019|616251799|FG002|Overall Study|Withdrawal by Subject|0|||
170521000|NCT03360019|616251797|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
170521001|NCT03360019|616251798|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
170521002|NCT03360019|616251799|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
170521003|NCT02686164|616251806|FG000|Overall Study|Adverse Event|1|||
170521004|NCT02686164|616251806|FG000|Overall Study|Withdrawal of consent|1|||
170521005|NCT02686164|616251806|FG000|Overall Study|Clinical progression|1|||
170521006|NCT01827592|616251811|FG000|Overall Study|Adverse Event|11|||
170521007|NCT01827592|616251812|FG001|Overall Study|Adverse Event|9|||
170521008|NCT01827592|616251813|FG002|Overall Study|Adverse Event|2|||
170521009|NCT01827592|616251811|FG000|Overall Study|Physician Decision|0|||
170521010|NCT01827592|616251812|FG001|Overall Study|Physician Decision|2|||
170521011|NCT01827592|616251813|FG002|Overall Study|Physician Decision|1|||
170521012|NCT01827592|616251811|FG000|Overall Study|Protocol Violation|2|||
170521013|NCT01827592|616251812|FG001|Overall Study|Protocol Violation|1|||
170521014|NCT01827592|616251813|FG002|Overall Study|Protocol Violation|0|||
170521015|NCT01827592|616251811|FG000|Overall Study|Lost to Follow-up|1|||
170521016|NCT01827592|616251812|FG001|Overall Study|Lost to Follow-up|2|||
170521017|NCT01827592|616251813|FG002|Overall Study|Lost to Follow-up|2|||
170521018|NCT01827592|616251811|FG000|Overall Study|Withdrawal by Subject|12|||
170521019|NCT01827592|616251812|FG001|Overall Study|Withdrawal by Subject|11|||
170521020|NCT01827592|616251813|FG002|Overall Study|Withdrawal by Subject|11|||
170521021|NCT01827592|616251811|FG000|Overall Study|Patient's substantial non-compliance|1|||
170521022|NCT01827592|616251812|FG001|Overall Study|Patient's substantial non-compliance|1|||
170521023|NCT01827592|616251813|FG002|Overall Study|Patient's substantial non-compliance|6|||
170521024|NCT01827592|616251811|FG000|Overall Study|Trial terminated by Sponsor|47|||
170521025|NCT01827592|616251812|FG001|Overall Study|Trial terminated by Sponsor|53|||
170521026|NCT01827592|616251813|FG002|Overall Study|Trial terminated by Sponsor|51|||
170521027|NCT01827592|616251811|FG000|Overall Study|Others|0|||
170521028|NCT01827592|616251812|FG001|Overall Study|Others|1|||
170521029|NCT01827592|616251813|FG002|Overall Study|Others|3|||
170521030|NCT02324361|616251816|FG000|Overall Study|Lost to Follow-up|5|||
170521031|NCT02324361|616251817|FG001|Overall Study|Lost to Follow-up|2|||
170521032|NCT03560869|616251820|FG000|Overall Study|Withdrawal by Subject|3|||
170521033|NCT03560869|616251821|FG001|Overall Study|Withdrawal by Subject|4|||
170521034|NCT03560869|616251820|FG000|Overall Study|Screening failure|4|||
170521035|NCT03560869|616251821|FG001|Overall Study|Screening failure|4|||
170521036|NCT03560869|616251820|FG000|Overall Study|Withdrawal by PI|0|||
170521037|NCT03560869|616251821|FG001|Overall Study|Withdrawal by PI|1|||
170521038|NCT01801111|616251822|FG000|Overall Study|Adverse Event|12|||
170521039|NCT01801111|616251822|FG000|Overall Study|Death|8|||
170521040|NCT01801111|616251822|FG000|Overall Study|Physician Decision|5|||
170521041|NCT01801111|616251822|FG000|Overall Study|Other|1|||
170521042|NCT01801111|616251822|FG000|Overall Study|Withdrawal by Subject|4|||
170521043|NCT01801111|616251822|FG000|Overall Study|Study Terminated by Sponsor|27|||
170521044|NCT01801111|616251822|FG000|Overall Study|Progressive Disease|81|||
170521045|NCT01223937|616251823|FG000|Overall Study|Withdrawal by Subject|3|||
170521046|NCT01223937|616251824|FG001|Overall Study|Withdrawal by Subject|2|||
170521047|NCT01223937|616251823|FG000|Overall Study|Lost to Follow-up|1|||
170521048|NCT01223937|616251824|FG001|Overall Study|Lost to Follow-up|4|||
170521049|NCT01223937|616251823|FG000|Overall Study|Adverse Event|1|||
170521050|NCT01223937|616251824|FG001|Overall Study|Adverse Event|4|||
170521051|NCT01223937|616251823|FG000|Overall Study|Protocol Violation|8|||
170521052|NCT01223937|616251824|FG001|Overall Study|Protocol Violation|7|||
170764984|NCT00878722|617143348|FG006|Overall Study|Death|0|||
170764985|NCT00878722|617143349|FG007|Overall Study|Death|2|||
170764986|NCT00878722|617143342|FG000|Overall Study|Adverse Event|0|||
170521053|NCT01223937|616251823|FG000|Overall Study|Other|4|||
170521054|NCT01223937|616251824|FG001|Overall Study|Other|1|||
170764987|NCT00878722|617143343|FG001|Overall Study|Adverse Event|0|||
170764988|NCT00878722|617143344|FG002|Overall Study|Adverse Event|0|||
170521055|NCT03284853|616251825|FG000|Overall Study|Adverse Event|40|||
170521056|NCT03284853|616251826|FG001|Overall Study|Adverse Event|4|||
170521057|NCT03284853|616251825|FG000|Overall Study|Withdrawal by Subject|5|||
170521058|NCT03284853|616251826|FG001|Overall Study|Withdrawal by Subject|1|||
170521059|NCT03284853|616251825|FG000|Overall Study|Lost to Follow-up|1|||
170521060|NCT03284853|616251826|FG001|Overall Study|Lost to Follow-up|0|||
170521061|NCT03284853|616251825|FG000|Overall Study|Lack of Efficacy|1|||
170521062|NCT03284853|616251826|FG001|Overall Study|Lack of Efficacy|0|||
170521063|NCT03284853|616251825|FG000|Overall Study|Disallowed Concurrent Medication|1|||
170521064|NCT03284853|616251826|FG001|Overall Study|Disallowed Concurrent Medication|1|||
170521065|NCT03284853|616251825|FG000|Overall Study|Protocol Violation|3|||
170521066|NCT03284853|616251826|FG001|Overall Study|Protocol Violation|3|||
170521067|NCT03284853|616251825|FG000|Overall Study|Death|0|||
170521068|NCT03284853|616251826|FG001|Overall Study|Death|1|||
170521069|NCT03284853|616251825|FG000|Overall Study|Other - Reason not reported in CSR|4|||
170521070|NCT03284853|616251826|FG001|Overall Study|Other - Reason not reported in CSR|3|||
170521071|NCT06597084|616251828|FG000|Overall Study|Withdrawal by Subject|4|||
170521072|NCT06597084|616251829|FG001|Overall Study|Withdrawal by Subject|9|||
170521073|NCT06597084|616251828|FG000|Overall Study|Consent was not given by the patient until V2|0|||
170521074|NCT06597084|616251829|FG001|Overall Study|Consent was not given by the patient until V2|3|||
170521075|NCT06597084|616251828|FG000|Overall Study|Physician Decision|1|||
170521076|NCT06597084|616251829|FG001|Overall Study|Physician Decision|0|||
170521077|NCT06597084|616251828|FG000|Overall Study|Adverse Event|3|||
170521078|NCT06597084|616251829|FG001|Overall Study|Adverse Event|2|||
170521079|NCT06597084|616251828|FG000|Overall Study|Death|4|||
170868045|NCT01132612|617528254|FG001|Overall Study|Withdrawal by Subject|8|||
170868046|NCT01132612|617528255|FG002|Overall Study|Withdrawal by Subject|19|||
170868047|NCT01132612|617528253|FG000|Overall Study|Administrative problems|5|||
170868048|NCT01132612|617528254|FG001|Overall Study|Administrative problems|1|||
170868049|NCT01132612|617528255|FG002|Overall Study|Administrative problems|52|||
170868050|NCT01132612|617528253|FG000|Overall Study|Lack of Efficacy|23|||
170868051|NCT01132612|617528254|FG001|Overall Study|Lack of Efficacy|22|||
170868052|NCT01132612|617528255|FG002|Overall Study|Lack of Efficacy|73|||
170868053|NCT02252536|617528256|FG000|Overall Study|Lost to Follow-up|5|||
170868054|NCT02252536|617528257|FG001|Overall Study|Lost to Follow-up|3|||
170868055|NCT01438151|617528259|FG000|Overall Study|study terminated|8|||
170521080|NCT06597084|616251829|FG001|Overall Study|Death|0|||
170521081|NCT06597084|616251828|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
170521082|NCT06597084|616251829|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
170521083|NCT06597084|616251828|FG000|Overall Study|Lost to Follow-up|4|||
170521084|NCT06597084|616251829|FG001|Overall Study|Lost to Follow-up|2|||
170521085|NCT06597084|616251828|FG000|Overall Study|Other. Not specified|1|||
170521086|NCT06597084|616251829|FG001|Overall Study|Other. Not specified|0|||
170521087|NCT00490971|616251832|FG000|Acute/Continuation|Adverse Event|62|||
170521088|NCT00490971|616251833|FG001|Acute/Continuation|Adverse Event|13|||
170521089|NCT00490971|616251834|FG002|Acute/Continuation|Adverse Event|0|||
170521090|NCT00490971|616251835|FG003|Acute/Continuation|Adverse Event|0|||
170521091|NCT00490971|616251836|FG004|Acute/Continuation|Adverse Event|0|||
170521092|NCT00490971|616251832|FG000|Acute/Continuation|Death|2|||
170521093|NCT00490971|616251833|FG001|Acute/Continuation|Death|0|||
170521094|NCT00490971|616251834|FG002|Acute/Continuation|Death|0|||
170521095|NCT00490971|616251835|FG003|Acute/Continuation|Death|0|||
170521096|NCT00490971|616251836|FG004|Acute/Continuation|Death|0|||
170521097|NCT00490971|616251832|FG000|Acute/Continuation|Lack of Efficacy|106|||
170521098|NCT00490971|616251833|FG001|Acute/Continuation|Lack of Efficacy|12|||
170521099|NCT00490971|616251834|FG002|Acute/Continuation|Lack of Efficacy|0|||
170521100|NCT00490971|616251835|FG003|Acute/Continuation|Lack of Efficacy|0|||
170521101|NCT00490971|616251836|FG004|Acute/Continuation|Lack of Efficacy|0|||
170521102|NCT00490971|616251832|FG000|Acute/Continuation|Lost to Follow-up|23|||
170521103|NCT00490971|616251833|FG001|Acute/Continuation|Lost to Follow-up|7|||
170521104|NCT00490971|616251834|FG002|Acute/Continuation|Lost to Follow-up|0|||
170521105|NCT00490971|616251835|FG003|Acute/Continuation|Lost to Follow-up|0|||
170521106|NCT00490971|616251836|FG004|Acute/Continuation|Lost to Follow-up|0|||
170521107|NCT00490971|616251832|FG000|Acute/Continuation|Protocol Violation|10|||
170521108|NCT00490971|616251833|FG001|Acute/Continuation|Protocol Violation|2|||
170521109|NCT00490971|616251834|FG002|Acute/Continuation|Protocol Violation|0|||
170521110|NCT00490971|616251835|FG003|Acute/Continuation|Protocol Violation|0|||
170521111|NCT00490971|616251836|FG004|Acute/Continuation|Protocol Violation|0|||
170521112|NCT00490971|616251832|FG000|Acute/Continuation|Withdrawal by Subject|92|||
170521113|NCT00490971|616251833|FG001|Acute/Continuation|Withdrawal by Subject|24|||
170521114|NCT00490971|616251834|FG002|Acute/Continuation|Withdrawal by Subject|0|||
170521115|NCT00490971|616251835|FG003|Acute/Continuation|Withdrawal by Subject|0|||
170521116|NCT00490971|616251836|FG004|Acute/Continuation|Withdrawal by Subject|0|||
170521117|NCT00490971|616251832|FG000|Acute/Continuation|Other|11|||
170868056|NCT02378220|617528266|FG000|Overall Study|Death|6|||
170521118|NCT00490971|616251833|FG001|Acute/Continuation|Other|4|||
170521119|NCT00490971|616251834|FG002|Acute/Continuation|Other|0|||
170521120|NCT00490971|616251835|FG003|Acute/Continuation|Other|0|||
170521121|NCT00490971|616251836|FG004|Acute/Continuation|Other|0|||
170521122|NCT00490971|616251832|FG000|Maintenance|Adverse Event|0|||
170521123|NCT00490971|616251833|FG001|Maintenance|Adverse Event|0|||
170521124|NCT00490971|616251834|FG002|Maintenance|Adverse Event|4|||
170521125|NCT00490971|616251835|FG003|Maintenance|Adverse Event|5|||
170521126|NCT00490971|616251836|FG004|Maintenance|Adverse Event|7|||
170868057|NCT02378220|617528267|FG001|Overall Study|Death|1|||
170410447|NCT05056727|615841862|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
170410448|NCT05056727|615841859|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170410449|NCT05056727|615841860|FG001|Maintenance Phase|Withdrawal by Subject|0|||
170410450|NCT05056727|615841861|FG002|Maintenance Phase|Withdrawal by Subject|19|||
170410451|NCT05056727|615841862|FG003|Maintenance Phase|Withdrawal by Subject|21|||
170410452|NCT05056727|615841859|FG000|Maintenance Phase|Physician Decision|0|||
170410453|NCT05056727|615841860|FG001|Maintenance Phase|Physician Decision|0|||
170410454|NCT05056727|615841861|FG002|Maintenance Phase|Physician Decision|4|||
170410455|NCT05056727|615841862|FG003|Maintenance Phase|Physician Decision|16|||
170410456|NCT05056727|615841859|FG000|Maintenance Phase|Lost to Follow-up|0|||
170410457|NCT05056727|615841860|FG001|Maintenance Phase|Lost to Follow-up|0|||
170410458|NCT05056727|615841861|FG002|Maintenance Phase|Lost to Follow-up|2|||
170410459|NCT05056727|615841862|FG003|Maintenance Phase|Lost to Follow-up|2|||
170410460|NCT05056727|615841859|FG000|Maintenance Phase|Death|0|||
170410461|NCT05056727|615841860|FG001|Maintenance Phase|Death|0|||
170410462|NCT05056727|615841861|FG002|Maintenance Phase|Death|4|||
170410463|NCT05056727|615841862|FG003|Maintenance Phase|Death|2|||
170410464|NCT02622113|615841863|FG000|Overall Study|Adverse Event|4|||
170410465|NCT02622113|615841864|FG001|Overall Study|Adverse Event|4|||
170410466|NCT02622113|615841863|FG000|Overall Study|Physician Decision|0|||
170410467|NCT02622113|615841864|FG001|Overall Study|Physician Decision|1|||
170410468|NCT02622113|615841863|FG000|Overall Study|Withdrawal by Subject|0|||
170410469|NCT02622113|615841864|FG001|Overall Study|Withdrawal by Subject|2|||
170410470|NCT02622113|615841863|FG000|Overall Study|Stopping Criteria|1|||
170410471|NCT02622113|615841864|FG001|Overall Study|Stopping Criteria|3|||
170410472|NCT02280356|615841865|FG000|Overall Study|Not Treated|2|||
170410473|NCT02280356|615841865|FG000|Overall Study|Withdrawal by Subject|1|||
170410474|NCT02280356|615841865|FG000|Overall Study|Not evaluable|2|||
170410475|NCT01855126|615841869|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
170410476|NCT01855126|615841870|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
170410477|NCT01855126|615841869|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
170410478|NCT01855126|615841870|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
170410479|NCT01201356|615841871|FG000|Overall Study|Adverse Event|170|||
170410480|NCT01201356|615841871|FG000|Overall Study|Abnormal laboratory value(s)|51|||
170410481|NCT01201356|615841871|FG000|Overall Study|Abnormal test procedure result(s)|3|||
170410482|NCT01201356|615841871|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
170410483|NCT01201356|615841871|FG000|Overall Study|Condition no longer requires study drug|12|||
170410484|NCT01201356|615841871|FG000|Overall Study|Withdrawal by Subject|144|||
170410485|NCT01201356|615841871|FG000|Overall Study|Lost to Follow-up|50|||
170410486|NCT01201356|615841871|FG000|Overall Study|administrative problems|74|||
170410487|NCT01201356|615841871|FG000|Overall Study|Death|16|||
170410488|NCT01201356|615841871|FG000|Overall Study|Protocol Violation|12|||
170410489|NCT02123459|615841875|FG000|Washout Period (1 Day)|Adverse Event|1|||
170410490|NCT02123459|615841876|FG001|Washout Period (1 Day)|Adverse Event|0|||
170410491|NCT02196506|615841881|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
170410492|NCT02196506|615841882|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
170410493|NCT02196506|615841883|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
170410494|NCT02196506|615841884|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
170410495|NCT02196506|615841881|FG000|Phase A|Withdrawal by Subject|34|||
170410496|NCT02196506|615841882|FG001|Phase A|Withdrawal by Subject|0|||
170410497|NCT02196506|615841883|FG002|Phase A|Withdrawal by Subject|0|||
170410498|NCT02196506|615841884|FG003|Phase A|Withdrawal by Subject|0|||
170410499|NCT02196506|615841881|FG000|Phase A|Adverse Event|22|||
170410500|NCT02196506|615841882|FG001|Phase A|Adverse Event|0|||
170410501|NCT02196506|615841883|FG002|Phase A|Adverse Event|0|||
170410502|NCT02196506|615841884|FG003|Phase A|Adverse Event|0|||
170410503|NCT02196506|615841881|FG000|Phase A|Lost to Follow-up|9|||
170410504|NCT02196506|615841882|FG001|Phase A|Lost to Follow-up|0|||
170410505|NCT02196506|615841883|FG002|Phase A|Lost to Follow-up|0|||
170410506|NCT02196506|615841884|FG003|Phase A|Lost to Follow-up|0|||
170410507|NCT02196506|615841881|FG000|Phase A|Protocol deviation|12|||
170410508|NCT02196506|615841882|FG001|Phase A|Protocol deviation|0|||
170410509|NCT02196506|615841883|FG002|Phase A|Protocol deviation|0|||
170410510|NCT02196506|615841884|FG003|Phase A|Protocol deviation|0|||
170410511|NCT02196506|615841881|FG000|Phase A|Participant withdrawn by investigator|10|||
170410512|NCT02196506|615841882|FG001|Phase A|Participant withdrawn by investigator|0|||
170410513|NCT02196506|615841883|FG002|Phase A|Participant withdrawn by investigator|0|||
170410514|NCT02196506|615841884|FG003|Phase A|Participant withdrawn by investigator|0|||
170410515|NCT02196506|615841881|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
170410516|NCT02196506|615841882|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
170410517|NCT02196506|615841883|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
170410518|NCT02196506|615841884|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
170410519|NCT02196506|615841881|FG000|Phase B|Lack of Efficacy|0|||
170410520|NCT02196506|615841882|FG001|Phase B|Lack of Efficacy|1|||
170410521|NCT02196506|615841883|FG002|Phase B|Lack of Efficacy|2|||
170410522|NCT02196506|615841884|FG003|Phase B|Lack of Efficacy|0|||
170410523|NCT02196506|615841881|FG000|Phase B|Withdrawal by Participant|0|||
170410524|NCT02196506|615841882|FG001|Phase B|Withdrawal by Participant|8|||
170410525|NCT02196506|615841883|FG002|Phase B|Withdrawal by Participant|1|||
170410526|NCT02196506|615841884|FG003|Phase B|Withdrawal by Participant|0|||
170410527|NCT02196506|615841881|FG000|Phase B|Adverse Event|0|||
170410528|NCT02196506|615841882|FG001|Phase B|Adverse Event|4|||
170410529|NCT02196506|615841883|FG002|Phase B|Adverse Event|1|||
170410530|NCT02196506|615841884|FG003|Phase B|Adverse Event|0|||
170410531|NCT02196506|615841881|FG000|Phase B|Lost to Follow-up|0|||
170410532|NCT02196506|615841882|FG001|Phase B|Lost to Follow-up|2|||
170410533|NCT02196506|615841883|FG002|Phase B|Lost to Follow-up|1|||
170410534|NCT02196506|615841884|FG003|Phase B|Lost to Follow-up|0|||
170410535|NCT02196506|615841881|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
170410536|NCT02196506|615841882|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
170410537|NCT02196506|615841883|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
170410538|NCT02196506|615841884|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
170410539|NCT02196506|615841881|FG000|Phase A+|Withdrawal by Participant|0|||
170410540|NCT02196506|615841882|FG001|Phase A+|Withdrawal by Participant|0|||
170410541|NCT02196506|615841883|FG002|Phase A+|Withdrawal by Participant|0|||
170410542|NCT02196506|615841884|FG003|Phase A+|Withdrawal by Participant|5|||
170410543|NCT02196506|615841881|FG000|Phase A+|Adverse Event|0|||
170410544|NCT02196506|615841882|FG001|Phase A+|Adverse Event|0|||
170410545|NCT02196506|615841883|FG002|Phase A+|Adverse Event|0|||
170410546|NCT02196506|615841884|FG003|Phase A+|Adverse Event|1|||
170410547|NCT02196506|615841881|FG000|Phase A+|Lost to Follow-up|0|||
170410548|NCT02196506|615841882|FG001|Phase A+|Lost to Follow-up|0|||
170410549|NCT02196506|615841883|FG002|Phase A+|Lost to Follow-up|0|||
170410550|NCT02196506|615841884|FG003|Phase A+|Lost to Follow-up|6|||
170410551|NCT02196506|615841881|FG000|Phase A+|Participant withdrawn by investigator|0|||
170410552|NCT02196506|615841882|FG001|Phase A+|Participant withdrawn by investigator|0|||
170410553|NCT02196506|615841883|FG002|Phase A+|Participant withdrawn by investigator|0|||
170410554|NCT02196506|615841884|FG003|Phase A+|Participant withdrawn by investigator|1|||
170410555|NCT03387059|615841885|FG000|Overall Study|Study termination|5|||
170410556|NCT03387059|615841886|FG001|Overall Study|Study termination|4|||
170410557|NCT00185211|615841887|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
170410558|NCT00185211|615841888|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
170410559|NCT00185211|615841887|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
170410560|NCT00185211|615841888|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
170410561|NCT00185211|615841887|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
170410562|NCT00185211|615841888|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
170410563|NCT00185211|615841887|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
170410564|NCT00185211|615841888|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
170410565|NCT00185211|615841887|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
170410566|NCT00185211|615841888|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
170410567|NCT00185211|615841887|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
170410568|NCT00185211|615841888|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
170410569|NCT00185211|615841887|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
170410570|NCT00185211|615841888|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
170410571|NCT00185211|615841887|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
170410572|NCT00185211|615841888|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
170410573|NCT00185211|615841887|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
170410574|NCT00185211|615841888|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
170410575|NCT00185211|615841887|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
170410576|NCT00185211|615841888|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
170410577|NCT00185211|615841887|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
170410578|NCT00185211|615841888|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
170410579|NCT00185211|615841887|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
170410580|NCT00185211|615841888|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
170410581|NCT05028751|615841889|FG000|Overall Study|Study Terminated by Sponsor|3|||
170410582|NCT05028751|615841890|FG001|Overall Study|Study Terminated by Sponsor|0|||
170410583|NCT05028751|615841891|FG002|Overall Study|Study Terminated by Sponsor|0|||
170410584|NCT05028751|615841892|FG003|Overall Study|Study Terminated by Sponsor|0|||
170410585|NCT05028751|615841889|FG000|Overall Study|Death|9|||
170410586|NCT05028751|615841890|FG001|Overall Study|Death|3|||
170410587|NCT05028751|615841891|FG002|Overall Study|Death|2|||
170410588|NCT05028751|615841892|FG003|Overall Study|Death|4|||
170410589|NCT05028751|615841889|FG000|Overall Study|Withdrawal by Subject|0|||
170410590|NCT05028751|615841890|FG001|Overall Study|Withdrawal by Subject|0|||
170410591|NCT05028751|615841891|FG002|Overall Study|Withdrawal by Subject|1|||
170410592|NCT05028751|615841892|FG003|Overall Study|Withdrawal by Subject|0|||
170410593|NCT05028751|615841889|FG000|Overall Study|Miscellaneous|2|||
170410594|NCT05028751|615841890|FG001|Overall Study|Miscellaneous|0|||
170410595|NCT05028751|615841891|FG002|Overall Study|Miscellaneous|0|||
170410596|NCT05028751|615841892|FG003|Overall Study|Miscellaneous|0|||
170410597|NCT00972153|615841895|FG000|Overall Study|Equipment malfunction during case|0|||
170410598|NCT00972153|615841896|FG001|Overall Study|Equipment malfunction during case|1|||
170410599|NCT00972153|615841897|FG002|Overall Study|Equipment malfunction during case|0|||
170410600|NCT04136626|615841898|FG000|Treatment Phase|Withdrawal by Subject|1|||
170410601|NCT04136626|615841899|FG001|Treatment Phase|Withdrawal by Subject|9|||
170410602|NCT04136626|615841898|FG000|Treatment Phase|Adverse Event|1|||
170410603|NCT04136626|615841899|FG001|Treatment Phase|Adverse Event|0|||
170410604|NCT04136626|615841898|FG000|Treatment Phase|Lost to Follow-up|1|||
170410605|NCT04136626|615841899|FG001|Treatment Phase|Lost to Follow-up|5|||
170410606|NCT04136626|615841898|FG000|12-month Follow-up|Lost to Follow-up|8|||
170410607|NCT04136626|615841899|FG001|12-month Follow-up|Lost to Follow-up|7|||
170410608|NCT00874757|615841900|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
170410609|NCT00982410|615843499|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
170410610|NCT00982410|615843500|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
170410611|NCT00982410|615843499|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
170410612|NCT00982410|615843500|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
170410613|NCT00982410|615843499|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
170410614|NCT00982410|615843500|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
170410615|NCT00982410|615843499|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
170410616|NCT00982410|615843500|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
170410617|NCT00982410|615843499|FG000|6-month Follow-up Assessment|participant no transportation|1|||
170410618|NCT00982410|615843500|FG001|6-month Follow-up Assessment|participant no transportation|0|||
170410619|NCT00982410|615843499|FG000|6-month Follow-up Assessment|incarceration|0|||
170410620|NCT00982410|615843500|FG001|6-month Follow-up Assessment|incarceration|2|||
170410621|NCT00982410|615843499|FG000|6-month Follow-up Assessment|patent surgery|0|||
170410622|NCT00982410|615843500|FG001|6-month Follow-up Assessment|patent surgery|1|||
170410623|NCT00982410|615843499|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
170410624|NCT00982410|615843500|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
170410625|NCT00982410|615843499|FG000|12-month Follow-up Assessment|Death|0|||
170410626|NCT00982410|615843500|FG001|12-month Follow-up Assessment|Death|2|||
170410627|NCT00982410|615843499|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
170410628|NCT00982410|615843500|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
170410629|NCT00982410|615843499|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
170410630|NCT00982410|615843500|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
170410631|NCT00982410|615843499|FG000|12-month Follow-up Assessment|incarceration|2|||
170410632|NCT00982410|615843500|FG001|12-month Follow-up Assessment|incarceration|1|||
170410633|NCT00982410|615843499|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
170410634|NCT00982410|615843500|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
170410635|NCT00313703|615843502|FG000|Overall Study|Lost to Follow-up|11|||
170410636|NCT00313703|615843503|FG001|Overall Study|Lost to Follow-up|2|||
170410637|NCT00313703|615843504|FG002|Overall Study|Lost to Follow-up|5|||
170410638|NCT00313703|615843505|FG003|Overall Study|Lost to Follow-up|12|||
170410639|NCT02497391|615843506|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
170410640|NCT02497391|615843507|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
170410641|NCT02497391|615843508|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
170410642|NCT02497391|615843509|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
170410643|NCT02497391|615843510|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
170410644|NCT02497391|615843511|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
170410645|NCT02497391|615843506|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
170410646|NCT02497391|615843507|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
170410647|NCT02497391|615843508|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
170410648|NCT02497391|615843509|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
170410649|NCT02497391|615843510|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
170410650|NCT02497391|615843511|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
170410651|NCT02497391|615843506|FG000|Period 3 (14 Days)|Adverse Event|0|||
170410652|NCT02497391|615843507|FG001|Period 3 (14 Days)|Adverse Event|1|||
170410653|NCT02497391|615843508|FG002|Period 3 (14 Days)|Adverse Event|0|||
170410654|NCT02497391|615843509|FG003|Period 3 (14 Days)|Adverse Event|0|||
170410655|NCT02497391|615843510|FG004|Period 3 (14 Days)|Adverse Event|0|||
170410656|NCT02497391|615843511|FG005|Period 3 (14 Days)|Adverse Event|0|||
170410657|NCT02497391|615843506|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
170410658|NCT02497391|615843507|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
170410659|NCT02497391|615843508|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
170410660|NCT02497391|615843509|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
170410661|NCT02497391|615843510|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
170764989|NCT00878722|617143345|FG003|Overall Study|Adverse Event|0|||
170410662|NCT02497391|615843511|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
170764990|NCT00878722|617143346|FG004|Overall Study|Adverse Event|0|||
170410663|NCT02497391|615843506|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
170410664|NCT02497391|615843507|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
170410665|NCT02497391|615843508|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
170410666|NCT02497391|615843509|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
170410667|NCT02497391|615843510|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
170410668|NCT02497391|615843511|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
170410669|NCT00633152|615843512|FG000|Overall Study|Adverse Event|1|||
170410670|NCT00633152|615843513|FG001|Overall Study|Adverse Event|0|||
170410671|NCT00633152|615843512|FG000|Overall Study|Randomized, did not receive study drug|5|||
170410672|NCT00633152|615843513|FG001|Overall Study|Randomized, did not receive study drug|2|||
170410673|NCT00633152|615843512|FG000|Overall Study|Withdrawal by Subject|1|||
170410674|NCT00633152|615843513|FG001|Overall Study|Withdrawal by Subject|1|||
170410675|NCT00633152|615843512|FG000|Overall Study|Lost to Follow-up|4|||
170410676|NCT00633152|615843513|FG001|Overall Study|Lost to Follow-up|1|||
170410677|NCT00633152|615843512|FG000|Overall Study|Miscellaneous Other|3|||
170410678|NCT00633152|615843513|FG001|Overall Study|Miscellaneous Other|2|||
170410679|NCT02180061|615843514|FG000|Overall Study|Adverse Event|4|||
170410680|NCT02180061|615843515|FG001|Overall Study|Adverse Event|2|||
170410681|NCT02180061|615843514|FG000|Overall Study|Clinical Progression|5|||
170410682|NCT02180061|615843515|FG001|Overall Study|Clinical Progression|1|||
170410683|NCT02180061|615843514|FG000|Overall Study|Progressive Disease|15|||
170410684|NCT02180061|615843515|FG001|Overall Study|Progressive Disease|5|||
170410685|NCT02180061|615843514|FG000|Overall Study|Physician Decision|1|||
170410686|NCT02180061|615843515|FG001|Overall Study|Physician Decision|0|||
170410687|NCT01469364|615843516|FG000|Overall Study|Adverse Event|1|||
170410688|NCT01469364|615843516|FG000|Overall Study|Withdrawal by Subject|1|||
170410689|NCT01299038|615843520|FG000|Overall Study|Withdrawal by Subject|1|||
170410690|NCT01299038|615843521|FG001|Overall Study|Withdrawal by Subject|0|||
170410691|NCT01162499|615843522|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
170410692|NCT01162499|615843523|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
170410693|NCT00322556|615843524|FG000|Overall Study|Adverse Event|1|||
170410694|NCT00322556|615843524|FG000|Overall Study|Withdrawal by Subject|1|||
170410695|NCT00322556|615843524|FG000|Overall Study|Lost to Follow-up|3|||
170410696|NCT00322556|615843524|FG000|Overall Study|Other Reason|7|||
170410697|NCT01590433|615843525|FG000|Overall Study|Lost to Follow-up|20|||
170764991|NCT00878722|617143347|FG005|Overall Study|Adverse Event|0|||
170410698|NCT01590433|615843526|FG001|Overall Study|Lost to Follow-up|8|||
170410699|NCT01590433|615843525|FG000|Overall Study|Withdrawal by Subject|21|||
170410700|NCT01590433|615843526|FG001|Overall Study|Withdrawal by Subject|11|||
170410701|NCT01590433|615843525|FG000|Overall Study|Adverse Event|11|||
170410702|NCT01590433|615843526|FG001|Overall Study|Adverse Event|3|||
170410703|NCT02058628|615843527|FG000|Overall Study|Adverse Event|1|||
170410704|NCT02058628|615843528|FG001|Overall Study|Adverse Event|0|||
170410705|NCT02058628|615843527|FG000|Overall Study|Withdrawal by Subject|2|||
170410706|NCT02058628|615843528|FG001|Overall Study|Withdrawal by Subject|2|||
170410707|NCT02058628|615843527|FG000|Overall Study|Lost to Follow-up|2|||
170410708|NCT02058628|615843528|FG001|Overall Study|Lost to Follow-up|4|||
170410709|NCT02058628|615843527|FG000|Overall Study|Not in time schedule|0|||
170410710|NCT02058628|615843528|FG001|Overall Study|Not in time schedule|1|||
170410711|NCT02058628|615843527|FG000|Overall Study|The visit date was not in timeline|0|||
170410712|NCT02058628|615843528|FG001|Overall Study|The visit date was not in timeline|1|||
170410713|NCT02058628|615843527|FG000|Overall Study|A lot of time for study for participant|1|||
170410714|NCT02058628|615843528|FG001|Overall Study|A lot of time for study for participant|0|||
170410715|NCT02058628|615843527|FG000|Overall Study|Non compliance|1|||
170410716|NCT02058628|615843528|FG001|Overall Study|Non compliance|0|||
170410717|NCT04527471|615843531|FG000|Overall Study|Adverse Event|1|||
170410718|NCT04527471|615843532|FG001|Overall Study|Adverse Event|0|||
170410719|NCT04527471|615843531|FG000|Overall Study|Lost to Follow-up|1|||
170410720|NCT04527471|615843532|FG001|Overall Study|Lost to Follow-up|0|||
170410721|NCT01387737|615843533|FG000|Overall Study|Adverse Event|20|||
170410722|NCT01387737|615843534|FG001|Overall Study|Adverse Event|30|||
170410723|NCT01387737|615843533|FG000|Overall Study|Lack of Efficacy|1|||
170410724|NCT01387737|615843534|FG001|Overall Study|Lack of Efficacy|0|||
170410725|NCT01387737|615843533|FG000|Overall Study|Physician Decision|3|||
170410726|NCT01387737|615843534|FG001|Overall Study|Physician Decision|10|||
170410727|NCT01387737|615843533|FG000|Overall Study|Withdrawal by Subject|27|||
170410728|NCT01387737|615843534|FG001|Overall Study|Withdrawal by Subject|31|||
170410729|NCT01387737|615843533|FG000|Overall Study|Clearly not eligible for the study|1|||
170410730|NCT01387737|615843534|FG001|Overall Study|Clearly not eligible for the study|3|||
170410731|NCT01464827|615843535|FG000|Overall Study|Adverse Event|0|||
170410732|NCT01464827|615843536|FG001|Overall Study|Adverse Event|0|||
170410733|NCT01464827|615843537|FG002|Overall Study|Adverse Event|0|||
170410734|NCT01464827|615843538|FG003|Overall Study|Adverse Event|0|||
170410735|NCT01464827|615843539|FG004|Overall Study|Adverse Event|0|||
170410736|NCT01464827|615843540|FG005|Overall Study|Adverse Event|0|||
170410737|NCT01464827|615843541|FG006|Overall Study|Adverse Event|0|||
170410738|NCT01464827|615843542|FG007|Overall Study|Adverse Event|0|||
170410739|NCT01464827|615843543|FG008|Overall Study|Adverse Event|0|||
170410740|NCT01464827|615843544|FG009|Overall Study|Adverse Event|0|||
170410741|NCT01464827|615843545|FG010|Overall Study|Adverse Event|0|||
170410742|NCT01464827|615843546|FG011|Overall Study|Adverse Event|0|||
170410743|NCT01464827|615843547|FG012|Overall Study|Adverse Event|1|||
170410744|NCT01464827|615843548|FG013|Overall Study|Adverse Event|0|||
170410745|NCT01464827|615843535|FG000|Overall Study|Withdrawal by Subject|1|||
170410746|NCT01464827|615843536|FG001|Overall Study|Withdrawal by Subject|0|||
170410747|NCT01464827|615843537|FG002|Overall Study|Withdrawal by Subject|0|||
170410748|NCT01464827|615843538|FG003|Overall Study|Withdrawal by Subject|0|||
170410749|NCT01464827|615843539|FG004|Overall Study|Withdrawal by Subject|1|||
170410750|NCT01464827|615843540|FG005|Overall Study|Withdrawal by Subject|0|||
170410751|NCT01464827|615843541|FG006|Overall Study|Withdrawal by Subject|0|||
170410752|NCT01464827|615843542|FG007|Overall Study|Withdrawal by Subject|1|||
170410753|NCT01464827|615843543|FG008|Overall Study|Withdrawal by Subject|0|||
170410754|NCT01464827|615843544|FG009|Overall Study|Withdrawal by Subject|0|||
170410755|NCT01464827|615843545|FG010|Overall Study|Withdrawal by Subject|0|||
170410756|NCT01464827|615843546|FG011|Overall Study|Withdrawal by Subject|0|||
170410757|NCT01464827|615843547|FG012|Overall Study|Withdrawal by Subject|0|||
170410758|NCT01464827|615843548|FG013|Overall Study|Withdrawal by Subject|0|||
170410759|NCT01464827|615843535|FG000|Overall Study|Lost to Follow-up|0|||
170410760|NCT01464827|615843536|FG001|Overall Study|Lost to Follow-up|2|||
170410761|NCT01464827|615843537|FG002|Overall Study|Lost to Follow-up|0|||
170410762|NCT01464827|615843538|FG003|Overall Study|Lost to Follow-up|2|||
170410763|NCT01464827|615843539|FG004|Overall Study|Lost to Follow-up|3|||
170410764|NCT01464827|615843540|FG005|Overall Study|Lost to Follow-up|1|||
170410765|NCT01464827|615843541|FG006|Overall Study|Lost to Follow-up|2|||
170410766|NCT01464827|615843542|FG007|Overall Study|Lost to Follow-up|2|||
170410767|NCT01464827|615843543|FG008|Overall Study|Lost to Follow-up|0|||
170410768|NCT01464827|615843544|FG009|Overall Study|Lost to Follow-up|0|||
170410769|NCT01464827|615843545|FG010|Overall Study|Lost to Follow-up|0|||
170410770|NCT01464827|615843546|FG011|Overall Study|Lost to Follow-up|1|||
170410771|NCT01464827|615843547|FG012|Overall Study|Lost to Follow-up|0|||
170410772|NCT01464827|615843548|FG013|Overall Study|Lost to Follow-up|1|||
170410773|NCT01464827|615843535|FG000|Overall Study|Other|2|||
170410774|NCT01464827|615843536|FG001|Overall Study|Other|3|||
170410775|NCT01464827|615843537|FG002|Overall Study|Other|0|||
170410776|NCT01464827|615843538|FG003|Overall Study|Other|2|||
170410777|NCT01464827|615843539|FG004|Overall Study|Other|3|||
170410778|NCT01464827|615843540|FG005|Overall Study|Other|0|||
170632137|NCT02177032|616664533|FG003|Overall Study|Withdrawal by Subject|0|||
170410779|NCT01464827|615843541|FG006|Overall Study|Other|1|||
170410780|NCT01464827|615843542|FG007|Overall Study|Other|0|||
170410781|NCT01464827|615843543|FG008|Overall Study|Other|3|||
170410782|NCT01464827|615843544|FG009|Overall Study|Other|1|||
170410783|NCT01464827|615843545|FG010|Overall Study|Other|2|||
170868058|NCT00312221|617528268|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
170868059|NCT00312221|617528269|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
170868060|NCT00312221|617528270|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
170868061|NCT00312221|617528271|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
170868062|NCT00312221|617528268|FG000|Open-label Run-in Period|Adverse Event|74|||
170868063|NCT00312221|617528269|FG001|Open-label Run-in Period|Adverse Event|0|||
170868064|NCT00312221|617528270|FG002|Open-label Run-in Period|Adverse Event|0|||
170868065|NCT00312221|617528271|FG003|Open-label Run-in Period|Adverse Event|0|||
170868066|NCT00312221|617528268|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
170868067|NCT00312221|617528269|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
170868068|NCT00312221|617528270|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
170868069|NCT00312221|617528271|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
170868070|NCT00312221|617528268|FG000|Open-label Run-in Period|Administrative|42|||
170868071|NCT00312221|617528269|FG001|Open-label Run-in Period|Administrative|0|||
170868072|NCT00312221|617528270|FG002|Open-label Run-in Period|Administrative|0|||
170868073|NCT00312221|617528271|FG003|Open-label Run-in Period|Administrative|0|||
170868074|NCT00312221|617528268|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
170868075|NCT00312221|617528269|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
170868076|NCT00312221|617528270|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
170868077|NCT00312221|617528271|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
170868078|NCT00312221|617528268|FG000|Open-label Run-in Period|Did not qualify|5|||
170868079|NCT00312221|617528269|FG001|Open-label Run-in Period|Did not qualify|0|||
170868080|NCT00312221|617528270|FG002|Open-label Run-in Period|Did not qualify|0|||
170868081|NCT00312221|617528271|FG003|Open-label Run-in Period|Did not qualify|0|||
170868082|NCT00312221|617528268|FG000|Double-blind Phase|Withdrawal by Subject|0|||
170868083|NCT00312221|617528269|FG001|Double-blind Phase|Withdrawal by Subject|6|||
170868084|NCT00312221|617528270|FG002|Double-blind Phase|Withdrawal by Subject|8|||
170868085|NCT00312221|617528271|FG003|Double-blind Phase|Withdrawal by Subject|7|||
170868086|NCT00312221|617528268|FG000|Double-blind Phase|Adverse Event|0|||
170868087|NCT00312221|617528269|FG001|Double-blind Phase|Adverse Event|10|||
170868088|NCT00312221|617528270|FG002|Double-blind Phase|Adverse Event|19|||
170868089|NCT00312221|617528271|FG003|Double-blind Phase|Adverse Event|18|||
170868090|NCT00312221|617528268|FG000|Double-blind Phase|Lost to Follow-up|0|||
170868091|NCT00312221|617528269|FG001|Double-blind Phase|Lost to Follow-up|0|||
170868092|NCT00312221|617528270|FG002|Double-blind Phase|Lost to Follow-up|2|||
170868093|NCT00312221|617528271|FG003|Double-blind Phase|Lost to Follow-up|2|||
170868094|NCT00312221|617528268|FG000|Double-blind Phase|Administrative|0|||
170868095|NCT00312221|617528269|FG001|Double-blind Phase|Administrative|26|||
170868096|NCT00312221|617528270|FG002|Double-blind Phase|Administrative|37|||
170868097|NCT00312221|617528271|FG003|Double-blind Phase|Administrative|33|||
170868098|NCT00312221|617528268|FG000|Double-blind Phase|Lack of Efficacy|0|||
170868099|NCT00312221|617528269|FG001|Double-blind Phase|Lack of Efficacy|17|||
170868100|NCT00312221|617528270|FG002|Double-blind Phase|Lack of Efficacy|6|||
170868101|NCT00312221|617528271|FG003|Double-blind Phase|Lack of Efficacy|10|||
170868102|NCT01822522|617528274|FG000|Overall Study|Adverse Event|1|||
170868103|NCT01822522|617528275|FG001|Overall Study|Adverse Event|1|||
170868104|NCT01822522|617528276|FG002|Overall Study|Adverse Event|1|||
170868105|NCT01822522|617528277|FG003|Overall Study|Adverse Event|0|||
170868106|NCT01822522|617528278|FG004|Overall Study|Adverse Event|0|||
170868107|NCT01822522|617528279|FG005|Overall Study|Adverse Event|1|||
170868108|NCT01822522|617528274|FG000|Overall Study|Death|3|||
170868109|NCT01822522|617528275|FG001|Overall Study|Death|0|||
170868110|NCT01822522|617528276|FG002|Overall Study|Death|2|||
170868111|NCT01822522|617528277|FG003|Overall Study|Death|0|||
170868112|NCT01822522|617528278|FG004|Overall Study|Death|0|||
170868113|NCT01822522|617528279|FG005|Overall Study|Death|0|||
170868114|NCT01822522|617528274|FG000|Overall Study|Lost to Follow-up|0|||
170868115|NCT01822522|617528275|FG001|Overall Study|Lost to Follow-up|0|||
170868116|NCT01822522|617528276|FG002|Overall Study|Lost to Follow-up|1|||
170868117|NCT01822522|617528277|FG003|Overall Study|Lost to Follow-up|1|||
170868118|NCT01822522|617528278|FG004|Overall Study|Lost to Follow-up|0|||
170868119|NCT01822522|617528279|FG005|Overall Study|Lost to Follow-up|1|||
170868120|NCT01822522|617528274|FG000|Overall Study|Withdrawal by Subject|0|||
170868121|NCT01822522|617528275|FG001|Overall Study|Withdrawal by Subject|0|||
170868122|NCT01822522|617528276|FG002|Overall Study|Withdrawal by Subject|0|||
170868123|NCT01822522|617528277|FG003|Overall Study|Withdrawal by Subject|1|||
170868124|NCT01822522|617528278|FG004|Overall Study|Withdrawal by Subject|0|||
170868125|NCT01822522|617528279|FG005|Overall Study|Withdrawal by Subject|0|||
170868126|NCT01822522|617528274|FG000|Overall Study|Lack of Efficacy|0|||
170868127|NCT01822522|617528275|FG001|Overall Study|Lack of Efficacy|0|||
170868128|NCT01822522|617528276|FG002|Overall Study|Lack of Efficacy|0|||
170868129|NCT01822522|617528277|FG003|Overall Study|Lack of Efficacy|0|||
170868130|NCT01822522|617528278|FG004|Overall Study|Lack of Efficacy|0|||
170868131|NCT01822522|617528279|FG005|Overall Study|Lack of Efficacy|2|||
170868132|NCT01807923|617528280|FG000|Overall Study|Adverse Event|2|||
170868133|NCT01807923|617528281|FG001|Overall Study|Adverse Event|1|||
170868134|NCT01807923|617528282|FG002|Overall Study|Adverse Event|2|||
170410784|NCT01464827|615843546|FG011|Overall Study|Other|0|||
170410785|NCT01464827|615843547|FG012|Overall Study|Other|1|||
170410786|NCT01464827|615843548|FG013|Overall Study|Other|0|||
170410787|NCT01464827|615843535|FG000|Overall Study|Not Treated|0|||
170410788|NCT01464827|615843536|FG001|Overall Study|Not Treated|2|||
170410789|NCT01464827|615843537|FG002|Overall Study|Not Treated|0|||
170410790|NCT01464827|615843538|FG003|Overall Study|Not Treated|0|||
170410791|NCT01464827|615843539|FG004|Overall Study|Not Treated|1|||
170410792|NCT01464827|615843540|FG005|Overall Study|Not Treated|0|||
170410793|NCT01464827|615843541|FG006|Overall Study|Not Treated|1|||
170410794|NCT01464827|615843542|FG007|Overall Study|Not Treated|0|||
170410795|NCT01464827|615843543|FG008|Overall Study|Not Treated|0|||
170410796|NCT01464827|615843544|FG009|Overall Study|Not Treated|2|||
170410797|NCT01464827|615843545|FG010|Overall Study|Not Treated|0|||
170410798|NCT01464827|615843546|FG011|Overall Study|Not Treated|1|||
170410799|NCT01464827|615843547|FG012|Overall Study|Not Treated|0|||
170410800|NCT01464827|615843548|FG013|Overall Study|Not Treated|2|||
170410801|NCT02295774|615843549|FG000|Overall Study|Physician Decision|1|||
170410802|NCT02295774|615843549|FG000|Overall Study|Withdrawal by Subject|2|||
170410803|NCT00619619|615843552|FG000|Overall Study|Physician Decision|0|||
170410804|NCT00619619|615843553|FG001|Overall Study|Physician Decision|0|||
170410805|NCT00619619|615843554|FG002|Overall Study|Physician Decision|1|||
170410806|NCT00619619|615843555|FG003|Overall Study|Physician Decision|0|||
170410807|NCT00619619|615843556|FG004|Overall Study|Physician Decision|0|||
170410808|NCT00619619|615843557|FG005|Overall Study|Physician Decision|0|||
170410809|NCT00619619|615843558|FG006|Overall Study|Physician Decision|0|||
170410810|NCT00619619|615843559|FG007|Overall Study|Physician Decision|0|||
170410811|NCT00619619|615843552|FG000|Overall Study|Protocol Violation|0|||
170410812|NCT00619619|615843553|FG001|Overall Study|Protocol Violation|0|||
170410813|NCT00619619|615843554|FG002|Overall Study|Protocol Violation|0|||
170410814|NCT00619619|615843555|FG003|Overall Study|Protocol Violation|1|||
170410815|NCT00619619|615843556|FG004|Overall Study|Protocol Violation|0|||
170410816|NCT00619619|615843557|FG005|Overall Study|Protocol Violation|0|||
170410817|NCT00619619|615843558|FG006|Overall Study|Protocol Violation|1|||
170410818|NCT00619619|615843559|FG007|Overall Study|Protocol Violation|1|||
170410819|NCT00619619|615843552|FG000|Overall Study|Adverse Event|0|||
170410820|NCT00619619|615843553|FG001|Overall Study|Adverse Event|0|||
170410821|NCT00619619|615843554|FG002|Overall Study|Adverse Event|0|||
170410822|NCT00619619|615843555|FG003|Overall Study|Adverse Event|0|||
170410823|NCT00619619|615843556|FG004|Overall Study|Adverse Event|2|||
170410824|NCT00619619|615843557|FG005|Overall Study|Adverse Event|0|||
170410825|NCT00619619|615843558|FG006|Overall Study|Adverse Event|0|||
170410826|NCT00619619|615843559|FG007|Overall Study|Adverse Event|2|||
170410827|NCT01401478|615843560|FG000|Overall Study|Study drug not available|6|||
170410828|NCT01401478|615843560|FG000|Overall Study|Adverse Event|5|||
170410829|NCT01401478|615843560|FG000|Overall Study|Hyperphosphatemia|5|||
170410830|NCT01401478|615843560|FG000|Overall Study|Lost to Follow-up|5|||
170410831|NCT01401478|615843560|FG000|Overall Study|Kidney transplantation|3|||
170410832|NCT01401478|615843560|FG000|Overall Study|Withdrawal by Subject|3|||
170410833|NCT01401478|615843560|FG000|Overall Study|Blood samples not available|1|||
170410834|NCT01401478|615843560|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
170410835|NCT01401478|615843560|FG000|Overall Study|Low intact parathyroid hormone|1|||
170410836|NCT01401478|615843560|FG000|Overall Study|Serious adverse event|1|||
170521127|NCT00490971|616251832|FG000|Maintenance|Death|0|||
170868135|NCT01807923|617528280|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
170868136|NCT01807923|617528281|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
170868137|NCT01807923|617528282|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
170868138|NCT01807923|617528280|FG000|Overall Study|Physician Decision|0|||
170868139|NCT01807923|617528281|FG001|Overall Study|Physician Decision|0|||
170410837|NCT01798485|615843561|FG000|Overall Study|Adverse Event|32|||
170410838|NCT01798485|615843562|FG001|Overall Study|Adverse Event|40|||
170410839|NCT01798485|615843561|FG000|Overall Study|Withdrawal by Subject|27|||
170410840|NCT01798485|615843562|FG001|Overall Study|Withdrawal by Subject|31|||
170410841|NCT01798485|615843561|FG000|Overall Study|Lost to Follow-up|0|||
170410842|NCT01798485|615843562|FG001|Overall Study|Lost to Follow-up|3|||
170410843|NCT01798485|615843561|FG000|Overall Study|Physician Decision|14|||
170410844|NCT01798485|615843562|FG001|Overall Study|Physician Decision|10|||
170410845|NCT01798485|615843561|FG000|Overall Study|Objective Disease Progression|152|||
170410846|NCT01798485|615843562|FG001|Overall Study|Objective Disease Progression|106|||
170521128|NCT00490971|616251833|FG001|Maintenance|Death|0|||
170410847|NCT01798485|615843561|FG000|Overall Study|Death|25|||
170410848|NCT01798485|615843562|FG001|Overall Study|Death|22|||
170410849|NCT01798485|615843561|FG000|Overall Study|Sponsor Decision|61|||
170868140|NCT01807923|617528282|FG002|Overall Study|Physician Decision|1|||
170410850|NCT01798485|615843562|FG001|Overall Study|Sponsor Decision|54|||
170410851|NCT01798485|615843561|FG000|Overall Study|Clinical Progression|35|||
170410852|NCT01798485|615843562|FG001|Overall Study|Clinical Progression|24|||
170410853|NCT00770991|615843566|FG000|Overall Study|Physician Decision|2|||
170410854|NCT00770991|615843567|FG001|Overall Study|Physician Decision|0|||
170410855|NCT00770991|615843566|FG000|Overall Study|Withdrawal by Subject|1|||
170521129|NCT00490971|616251834|FG002|Maintenance|Death|0|||
170521130|NCT00490971|616251835|FG003|Maintenance|Death|2|||
170521131|NCT00490971|616251836|FG004|Maintenance|Death|0|||
170521132|NCT00490971|616251832|FG000|Maintenance|Lost to Follow-up|0|||
170521133|NCT00490971|616251833|FG001|Maintenance|Lost to Follow-up|0|||
170764992|NCT00878722|617143348|FG006|Overall Study|Adverse Event|2|||
170764993|NCT00878722|617143349|FG007|Overall Study|Adverse Event|0|||
170764994|NCT00878722|617143342|FG000|Overall Study|Withdrawal by Subject|0|||
170764995|NCT00878722|617143343|FG001|Overall Study|Withdrawal by Subject|0|||
170410856|NCT00770991|615843567|FG001|Overall Study|Withdrawal by Subject|0|||
170410857|NCT00770991|615843566|FG000|Overall Study|Adverse Event|1|||
170410858|NCT00770991|615843567|FG001|Overall Study|Adverse Event|5|||
170410859|NCT00770991|615843566|FG000|Overall Study|Pregnancy|1|||
170410860|NCT00770991|615843567|FG001|Overall Study|Pregnancy|0|||
170410861|NCT03687125|615843568|FG000|Overall Study|Progressive Disease|2|||
170410862|NCT03687125|615843569|FG001|Overall Study|Progressive Disease|1|||
170410863|NCT03687125|615843568|FG000|Overall Study|Protocol Violation|1|||
170410864|NCT03687125|615843569|FG001|Overall Study|Protocol Violation|0|||
170410865|NCT01214603|615843571|FG000|Overall Study|Adverse Event|0|||
170410866|NCT01214603|615843572|FG001|Overall Study|Adverse Event|0|||
170410867|NCT01214603|615843573|FG002|Overall Study|Adverse Event|1|||
170410868|NCT01214603|615843571|FG000|Overall Study|Death|1|||
170410869|NCT01214603|615843572|FG001|Overall Study|Death|0|||
170410870|NCT01214603|615843573|FG002|Overall Study|Death|0|||
170410871|NCT01214603|615843571|FG000|Overall Study|Progressive Disease|4|||
170410872|NCT01214603|615843572|FG001|Overall Study|Progressive Disease|1|||
170410873|NCT01214603|615843573|FG002|Overall Study|Progressive Disease|3|||
170410874|NCT01507896|615843574|FG000|Overall Study|Withdrawal by Subject|1|||
170410875|NCT01507896|615843574|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
170410876|NCT00490061|615843575|FG000|Overall Study|Physician Decision|1|||
170410877|NCT00952484|615843576|FG000|Overall Study|Withdrawal by Subject|0|||
170410878|NCT00952484|615843577|FG001|Overall Study|Withdrawal by Subject|1|||
170410879|NCT00952484|615843578|FG002|Overall Study|Withdrawal by Subject|0|||
170410880|NCT02750306|615843583|FG000|Overall Study|Withdrawal by Subject|5|||
170410881|NCT02750306|615843584|FG001|Overall Study|Withdrawal by Subject|2|||
170410882|NCT02750306|615843583|FG000|Overall Study|Protocol Violation|1|||
170410883|NCT02750306|615843584|FG001|Overall Study|Protocol Violation|0|||
170410884|NCT00192296|615843587|FG000|Overall Study|Withdrawal by Subject|0|||
170410885|NCT00192296|615843588|FG001|Overall Study|Withdrawal by Subject|1|||
170410886|NCT00192296|615843589|FG002|Overall Study|Withdrawal by Subject|0|||
170410887|NCT00192296|615843590|FG003|Overall Study|Withdrawal by Subject|0|||
170410888|NCT00457665|615843593|FG000|12 Months|Drug allergy|1|||
170410889|NCT00457665|615843594|FG001|12 Months|Drug allergy|1|||
170410890|NCT00457665|615843593|FG000|12 Months|High HIV viral load|5|||
170410891|NCT00457665|615843594|FG001|12 Months|High HIV viral load|1|||
170410892|NCT00457665|615843593|FG000|12 Months|Lipodystrophy|2|||
170410893|NCT00457665|615843594|FG001|12 Months|Lipodystrophy|0|||
170410894|NCT00457665|615843593|FG000|12 Months|Withdrawal by Subject|0|||
170410895|NCT00457665|615843594|FG001|12 Months|Withdrawal by Subject|2|||
170410896|NCT00457665|615843593|FG000|12 Months|Abnormal Liver function tests|0|||
170410897|NCT00457665|615843594|FG001|12 Months|Abnormal Liver function tests|5|||
170410898|NCT00457665|615843593|FG000|24 Months|Withdrawal by Subject|3|||
170410899|NCT00457665|615843594|FG001|24 Months|Withdrawal by Subject|2|||
170410900|NCT00457665|615843593|FG000|24 Months|Lipodystrophy|1|||
170410901|NCT00457665|615843594|FG001|24 Months|Lipodystrophy|1|||
170410902|NCT00457665|615843593|FG000|24 Months|Abnormal liver function tests|1|||
170410903|NCT00457665|615843594|FG001|24 Months|Abnormal liver function tests|5|||
170410904|NCT00446654|615843595|FG000|Overall Study|Withdrawal by Subject|1|||
170410905|NCT00446654|615843596|FG001|Overall Study|Withdrawal by Subject|0|||
170410906|NCT00446654|615843595|FG000|Overall Study|Adverse Event|1|||
170410907|NCT00446654|615843596|FG001|Overall Study|Adverse Event|0|||
170410908|NCT02535000|615843597|FG000|Overall Study|Cancellation of surgery.|1|||
170410909|NCT02535000|615843598|FG001|Overall Study|Cancellation of surgery.|2|||
170410910|NCT04317781|615843600|FG000|Overall Study|Adverse Event|1|||
170410911|NCT04317781|615843600|FG000|Overall Study|Disease relapse|1|||
170410912|NCT04317781|615843600|FG000|Overall Study|Withdrawal by Subject|1|||
170410913|NCT01102777|615843603|FG000|Overall Study|Death|2|||
170410914|NCT01102777|615843604|FG001|Overall Study|Death|6|||
170410915|NCT01102777|615843603|FG000|Overall Study|Lost to Follow-up|7|||
170410916|NCT01102777|615843604|FG001|Overall Study|Lost to Follow-up|10|||
170410917|NCT00706706|615843605|FG000|Overall Study|Death|53|||
170410918|NCT00706706|615843605|FG000|Overall Study|Lost to Follow-up|7|||
170410919|NCT00706706|615843605|FG000|Overall Study|Study endpoint had reached|45|||
170410920|NCT02175966|615843610|FG000|Follow-up Period|Lack of Efficacy|10|||
170764996|NCT00878722|617143344|FG002|Overall Study|Withdrawal by Subject|0|||
170764997|NCT00878722|617143345|FG003|Overall Study|Withdrawal by Subject|0|||
170764998|NCT00878722|617143346|FG004|Overall Study|Withdrawal by Subject|0|||
170764999|NCT00878722|617143347|FG005|Overall Study|Withdrawal by Subject|0|||
170410921|NCT02175966|615843611|FG001|Follow-up Period|Lack of Efficacy|6|||
170410922|NCT00947856|615843612|FG000|Treatment Period|Progressive Disease|33|||
170410923|NCT00947856|615843613|FG001|Treatment Period|Progressive Disease|12|||
170410924|NCT00947856|615843612|FG000|Treatment Period|Adverse Event|15|||
170410925|NCT00947856|615843613|FG001|Treatment Period|Adverse Event|9|||
170410926|NCT00947856|615843612|FG000|Treatment Period|Physician Decision|14|||
170410927|NCT00947856|615843613|FG001|Treatment Period|Physician Decision|6|||
170521134|NCT00490971|616251834|FG002|Maintenance|Lost to Follow-up|5|||
170521135|NCT00490971|616251835|FG003|Maintenance|Lost to Follow-up|8|||
170521136|NCT00490971|616251836|FG004|Maintenance|Lost to Follow-up|10|||
170521137|NCT00490971|616251832|FG000|Maintenance|Pregnancy|0|||
170521138|NCT00490971|616251833|FG001|Maintenance|Pregnancy|0|||
170521139|NCT00490971|616251834|FG002|Maintenance|Pregnancy|1|||
170521140|NCT00490971|616251835|FG003|Maintenance|Pregnancy|0|||
170521141|NCT00490971|616251836|FG004|Maintenance|Pregnancy|0|||
170521142|NCT00490971|616251832|FG000|Maintenance|Protocol Violation|0|||
170521143|NCT00490971|616251833|FG001|Maintenance|Protocol Violation|0|||
170868141|NCT01807923|617528280|FG000|Overall Study|Not Eligible (Genotype)|0|||
170868142|NCT01807923|617528281|FG001|Overall Study|Not Eligible (Genotype)|0|||
170410928|NCT00947856|615843612|FG000|Treatment Period|Study Stopped by Sponsor|4|||
170410929|NCT00947856|615843613|FG001|Treatment Period|Study Stopped by Sponsor|4|||
170410930|NCT00947856|615843612|FG000|Treatment Period|Withdrawal by Subject|12|||
170410931|NCT00947856|615843613|FG001|Treatment Period|Withdrawal by Subject|1|||
170410932|NCT00947856|615843612|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
170410933|NCT00947856|615843613|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
170410934|NCT00947856|615843612|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
170410935|NCT00947856|615843613|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
170410936|NCT00947856|615843612|FG000|Follow-up Period|Lost to Follow-up|7|||
170410937|NCT00947856|615843613|FG001|Follow-up Period|Lost to Follow-up|0|||
170410938|NCT00947856|615843612|FG000|Follow-up Period|Patient unavailable for site visits|1|||
170410939|NCT00947856|615843613|FG001|Follow-up Period|Patient unavailable for site visits|0|||
170410940|NCT00947856|615843612|FG000|Follow-up Period|Withdrawal by Subject|1|||
170410941|NCT00947856|615843613|FG001|Follow-up Period|Withdrawal by Subject|0|||
170410942|NCT03361956|615843616|FG000|Overall Study|Adverse Event|1|||
170410943|NCT03361956|615843617|FG001|Overall Study|Adverse Event|0|||
170410944|NCT03361956|615843618|FG002|Overall Study|Adverse Event|1|||
170410945|NCT03361956|615843619|FG003|Overall Study|Adverse Event|1|||
170410946|NCT03361956|615843620|FG004|Overall Study|Adverse Event|0|||
170410947|NCT03361956|615843616|FG000|Overall Study|Other|0|||
170410948|NCT03361956|615843617|FG001|Overall Study|Other|0|||
170410949|NCT03361956|615843618|FG002|Overall Study|Other|0|||
170410950|NCT03361956|615843619|FG003|Overall Study|Other|1|||
170410951|NCT03361956|615843620|FG004|Overall Study|Other|0|||
170410952|NCT03361956|615843616|FG000|Overall Study|Withdrawal by Subject|2|||
170410953|NCT03361956|615843617|FG001|Overall Study|Withdrawal by Subject|2|||
170410954|NCT03361956|615843618|FG002|Overall Study|Withdrawal by Subject|2|||
170410955|NCT03361956|615843619|FG003|Overall Study|Withdrawal by Subject|0|||
170410956|NCT03361956|615843620|FG004|Overall Study|Withdrawal by Subject|3|||
170410957|NCT03361956|615843616|FG000|Overall Study|Disease Relapse|0|||
170410958|NCT03361956|615843617|FG001|Overall Study|Disease Relapse|0|||
170410959|NCT03361956|615843618|FG002|Overall Study|Disease Relapse|1|||
170410960|NCT03361956|615843619|FG003|Overall Study|Disease Relapse|0|||
170410961|NCT03361956|615843620|FG004|Overall Study|Disease Relapse|0|||
170410962|NCT03361956|615843616|FG000|Overall Study|Physician Decision|0|||
170410963|NCT03361956|615843617|FG001|Overall Study|Physician Decision|2|||
170410964|NCT03361956|615843618|FG002|Overall Study|Physician Decision|0|||
170410965|NCT03361956|615843619|FG003|Overall Study|Physician Decision|1|||
170410966|NCT03361956|615843620|FG004|Overall Study|Physician Decision|0|||
170410967|NCT03361956|615843616|FG000|Overall Study|Lost to Follow-up|0|||
170410968|NCT03361956|615843617|FG001|Overall Study|Lost to Follow-up|0|||
170410969|NCT03361956|615843618|FG002|Overall Study|Lost to Follow-up|1|||
170410970|NCT03361956|615843619|FG003|Overall Study|Lost to Follow-up|1|||
170410971|NCT03361956|615843620|FG004|Overall Study|Lost to Follow-up|2|||
170410972|NCT02418910|615843621|FG000|Overall Study|Lost to Follow-up|3|||
170410973|NCT02418910|615843621|FG000|Overall Study|Withdrawal by Subject|4|||
170410974|NCT02277769|615843622|FG000|Overall Study|Protocol Violation|3|||
170410975|NCT02277769|615843623|FG001|Overall Study|Protocol Violation|3|||
170410976|NCT02277769|615843624|FG002|Overall Study|Protocol Violation|5|||
170410977|NCT02277769|615843622|FG000|Overall Study|Lack of Efficacy|17|||
170410978|NCT02277769|615843623|FG001|Overall Study|Lack of Efficacy|0|||
170410979|NCT02277769|615843624|FG002|Overall Study|Lack of Efficacy|4|||
170410980|NCT02277769|615843622|FG000|Overall Study|Adverse Event|14|||
170410981|NCT02277769|615843623|FG001|Overall Study|Adverse Event|2|||
170410982|NCT02277769|615843624|FG002|Overall Study|Adverse Event|4|||
170868143|NCT01807923|617528282|FG002|Overall Study|Not Eligible (Genotype)|1|||
170410983|NCT02277769|615843622|FG000|Overall Study|Other than specified above|12|||
170410984|NCT02277769|615843623|FG001|Overall Study|Other than specified above|8|||
170410985|NCT02277769|615843624|FG002|Overall Study|Other than specified above|5|||
170410986|NCT03775681|615843627|FG000|Overall Study|Physician Decision|3|||
170410987|NCT01078090|615843628|FG000|Overall Study|Lost to Follow-up|2363|||
170410988|NCT01078090|615843628|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
170410989|NCT01078090|615843628|FG000|Overall Study|Lack of Efficacy|1193|||
170410990|NCT01078090|615843628|FG000|Overall Study|ADR and lack of efficacy|61|||
170521144|NCT00490971|616251834|FG002|Maintenance|Protocol Violation|4|||
170521145|NCT00490971|616251835|FG003|Maintenance|Protocol Violation|1|||
170521146|NCT00490971|616251836|FG004|Maintenance|Protocol Violation|1|||
170521147|NCT00490971|616251832|FG000|Maintenance|Withdrawal by Subject|0|||
170521148|NCT00490971|616251833|FG001|Maintenance|Withdrawal by Subject|0|||
170521149|NCT00490971|616251834|FG002|Maintenance|Withdrawal by Subject|26|||
170521150|NCT00490971|616251835|FG003|Maintenance|Withdrawal by Subject|28|||
170521151|NCT00490971|616251836|FG004|Maintenance|Withdrawal by Subject|18|||
170521152|NCT00490971|616251832|FG000|Maintenance|Other|0|||
170521153|NCT00490971|616251833|FG001|Maintenance|Other|0|||
170521154|NCT00490971|616251834|FG002|Maintenance|Other|11|||
170521155|NCT00490971|616251835|FG003|Maintenance|Other|9|||
170521156|NCT00490971|616251836|FG004|Maintenance|Other|3|||
170521157|NCT04754542|616251840|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
170521158|NCT04754542|616251841|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
170521159|NCT01386606|616254069|FG000|Overall Study|Adverse Event|0|||
170521160|NCT01386606|616254070|FG001|Overall Study|Adverse Event|1|||
170521161|NCT01386606|616254071|FG002|Overall Study|Adverse Event|0|||
170521162|NCT01386606|616254072|FG003|Overall Study|Adverse Event|0|||
170521163|NCT01386606|616254069|FG000|Overall Study|Withdrawal by Subject|0|||
170521164|NCT01386606|616254070|FG001|Overall Study|Withdrawal by Subject|1|||
170521165|NCT01386606|616254071|FG002|Overall Study|Withdrawal by Subject|1|||
170521166|NCT01386606|616254072|FG003|Overall Study|Withdrawal by Subject|0|||
170521167|NCT01386606|616254069|FG000|Overall Study|Protocol Violation|1|||
170521168|NCT01386606|616254070|FG001|Overall Study|Protocol Violation|0|||
170521169|NCT01386606|616254071|FG002|Overall Study|Protocol Violation|1|||
170521170|NCT01386606|616254072|FG003|Overall Study|Protocol Violation|1|||
170521171|NCT01386606|616254069|FG000|Overall Study|Lost to Follow-up|2|||
170521172|NCT01386606|616254070|FG001|Overall Study|Lost to Follow-up|0|||
170521173|NCT01386606|616254071|FG002|Overall Study|Lost to Follow-up|0|||
170521174|NCT01386606|616254072|FG003|Overall Study|Lost to Follow-up|0|||
170521175|NCT01386606|616254069|FG000|Overall Study|Subject incarcerated|0|||
170521176|NCT01386606|616254070|FG001|Overall Study|Subject incarcerated|1|||
170521177|NCT01386606|616254071|FG002|Overall Study|Subject incarcerated|0|||
170521178|NCT01386606|616254072|FG003|Overall Study|Subject incarcerated|0|||
170521179|NCT01386606|616254069|FG000|Overall Study|Unable to draw PK|1|||
170521180|NCT01386606|616254070|FG001|Overall Study|Unable to draw PK|0|||
170521181|NCT01386606|616254071|FG002|Overall Study|Unable to draw PK|0|||
170521182|NCT01386606|616254072|FG003|Overall Study|Unable to draw PK|0|||
170521183|NCT01386606|616254069|FG000|Overall Study|T levels too high|0|||
170521184|NCT01386606|616254070|FG001|Overall Study|T levels too high|1|||
170521185|NCT01386606|616254071|FG002|Overall Study|T levels too high|1|||
170521186|NCT01386606|616254072|FG003|Overall Study|T levels too high|0|||
170521187|NCT00945243|616254073|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
170521188|NCT03627832|616254083|FG000|Overall Study|Withdrawal by Subject|10|||
170521189|NCT03627832|616254084|FG001|Overall Study|Withdrawal by Subject|1|||
170521190|NCT00873730|616254086|FG000|Overall Study|Protocol Deviation|5|||
170521191|NCT00873730|616254087|FG001|Overall Study|Protocol Deviation|2|||
170521192|NCT00873730|616254086|FG000|Overall Study|Adverse Event|0|||
170521193|NCT00873730|616254087|FG001|Overall Study|Adverse Event|2|||
170521194|NCT00873730|616254086|FG000|Overall Study|Withdrawal by Subject|0|||
170521195|NCT00873730|616254087|FG001|Overall Study|Withdrawal by Subject|1|||
170521196|NCT00873730|616254086|FG000|Overall Study|Sponsor decision|1|||
170521197|NCT00873730|616254087|FG001|Overall Study|Sponsor decision|0|||
170521198|NCT02026141|616254090|FG000|Overall Study|Protocol Violation|0|||
170521199|NCT02026141|616254091|FG001|Overall Study|Protocol Violation|1|||
170521200|NCT02169505|616254092|FG000|Overall Study|Withdrawal by Subject|1|||
170521201|NCT04110314|616254093|FG000|Overall Study|Did not meet inclusion criteria|35255|||
170521202|NCT04110314|616254094|FG001|Overall Study|Did not meet inclusion criteria|35104|||
170521203|NCT04110314|616254095|FG002|Overall Study|Did not meet inclusion criteria|35636|||
170521204|NCT04110314|616254096|FG003|Overall Study|Did not meet inclusion criteria|35135|||
170521205|NCT04110314|616254097|FG004|Overall Study|Did not meet inclusion criteria|35247|||
170521206|NCT04110314|616254098|FG005|Overall Study|Did not meet inclusion criteria|35727|||
170632138|NCT04041414|616664534|FG000|Overall Study|Lost to Follow-up|1|||
170632139|NCT04041414|616664535|FG001|Overall Study|Lost to Follow-up|2|||
170521207|NCT00115778|616254106|FG000|Overall Study|Withdrawal by Subject|0|||
170521208|NCT00115778|616254107|FG001|Overall Study|Withdrawal by Subject|1|||
170521209|NCT01607593|616254108|FG000|Overall Study|Adverse Event|15|||
170521210|NCT01607593|616254108|FG000|Overall Study|Lack of Efficacy|16|||
170521211|NCT01607593|616254108|FG000|Overall Study|Lost to Follow-up|25|||
170632140|NCT01598532|616664536|FG000|Overall Study|Lost to Follow-up|3|||
170521212|NCT01607593|616254108|FG000|Overall Study|Continuation|33|||
170521213|NCT01607593|616254108|FG000|Overall Study|Other|4|||
170521214|NCT00528424|616254112|FG000|Overall Study|Lost to Follow-up|13|||
170521215|NCT00528424|616254112|FG000|Overall Study|Withdrew consent|2|||
170521216|NCT00528424|616254112|FG000|Overall Study|Administrative reason|2|||
170521217|NCT00528424|616254112|FG000|Overall Study|Other|12|||
170521218|NCT03713684|616254113|FG000|Overall Study|Adverse Event|1|||
170521219|NCT03713684|616254114|FG001|Overall Study|Adverse Event|3|||
170521220|NCT03713684|616254115|FG002|Overall Study|Adverse Event|1|||
170521221|NCT03713684|616254116|FG003|Overall Study|Adverse Event|0|||
170632141|NCT01598532|616664536|FG000|Overall Study|Did not meet inclusion criteria|8|||
170521222|NCT03713684|616254113|FG000|Overall Study|Poor compliance to protocol|2|||
170521223|NCT03713684|616254114|FG001|Overall Study|Poor compliance to protocol|1|||
170521224|NCT03713684|616254115|FG002|Overall Study|Poor compliance to protocol|0|||
170521225|NCT03713684|616254116|FG003|Overall Study|Poor compliance to protocol|1|||
170521226|NCT03713684|616254113|FG000|Overall Study|Withdrawal by Subject|14|||
170521227|NCT03713684|616254114|FG001|Overall Study|Withdrawal by Subject|6|||
170521228|NCT03713684|616254115|FG002|Overall Study|Withdrawal by Subject|14|||
170521229|NCT03713684|616254116|FG003|Overall Study|Withdrawal by Subject|16|||
170521230|NCT03713684|616254113|FG000|Overall Study|Other than specified|69|||
170521231|NCT03713684|616254114|FG001|Overall Study|Other than specified|77|||
170521232|NCT03713684|616254115|FG002|Overall Study|Other than specified|73|||
170521233|NCT03713684|616254116|FG003|Overall Study|Other than specified|70|||
170521234|NCT03131167|616254119|FG000|Overall Study|Other (Unspecified)|0|||
170521235|NCT03131167|616254120|FG001|Overall Study|Other (Unspecified)|0|||
170521236|NCT03131167|616254121|FG002|Overall Study|Other (Unspecified)|0|||
170521237|NCT03131167|616254122|FG003|Overall Study|Other (Unspecified)|0|||
170521238|NCT03131167|616254123|FG004|Overall Study|Other (Unspecified)|0|||
170521239|NCT03131167|616254124|FG005|Overall Study|Other (Unspecified)|1|||
170521240|NCT03131167|616254125|FG006|Overall Study|Other (Unspecified)|0|||
170521241|NCT03131167|616254126|FG007|Overall Study|Other (Unspecified)|0|||
170521242|NCT03131167|616254127|FG008|Overall Study|Other (Unspecified)|0|||
170521243|NCT03131167|616254128|FG009|Overall Study|Other (Unspecified)|0|||
170521244|NCT03131167|616254129|FG010|Overall Study|Other (Unspecified)|0|||
170521245|NCT03131167|616254130|FG011|Overall Study|Other (Unspecified)|0|||
170521246|NCT03131167|616254131|FG012|Overall Study|Other (Unspecified)|0|||
170521247|NCT02346708|616254132|FG000|Overall Study|Adverse Event|2|||
170521248|NCT02346708|616254133|FG001|Overall Study|Adverse Event|0|||
170521249|NCT02346708|616254132|FG000|Overall Study|Protocol Violation|0|||
170521250|NCT02346708|616254133|FG001|Overall Study|Protocol Violation|1|||
170521251|NCT00473655|616254142|FG000|Overall Study|Lost to Follow-up|9|||
170521252|NCT00473655|616254143|FG001|Overall Study|Lost to Follow-up|5|||
170521253|NCT00473655|616254144|FG002|Overall Study|Lost to Follow-up|8|||
170521254|NCT01841970|616254145|FG000|Overall Study|Withdrawal by Subject|1|||
170521255|NCT01841970|616254145|FG000|Overall Study|Physician Decision|2|||
170410991|NCT01078090|615843628|FG000|Overall Study|Other|523|||
170410992|NCT03035227|615843629|FG000|Overall Study|study stopped due to PI leaving institut|1|||
170410993|NCT03035227|615843630|FG001|Overall Study|study stopped due to PI leaving institut|1|||
170410994|NCT03529955|615843631|FG000|Overall Study|Adverse Event|1|||
170410995|NCT03529955|615843631|FG000|Overall Study|Lack of Efficacy|1|||
170410996|NCT00811070|615843632|FG000|Overall Study|Death|0|||
170410997|NCT00811070|615843633|FG001|Overall Study|Death|0|||
170410998|NCT00811070|615843634|FG002|Overall Study|Death|0|||
170410999|NCT00811070|615843635|FG003|Overall Study|Death|2|||
170411000|NCT00811070|615843636|FG004|Overall Study|Death|5|||
170411001|NCT00811070|615843637|FG005|Overall Study|Death|0|||
170411002|NCT00811070|615843632|FG000|Overall Study|Other|1|||
170411003|NCT00811070|615843633|FG001|Overall Study|Other|0|||
170411004|NCT00811070|615843634|FG002|Overall Study|Other|0|||
170411005|NCT00811070|615843635|FG003|Overall Study|Other|0|||
170411006|NCT00811070|615843636|FG004|Overall Study|Other|0|||
170411007|NCT00811070|615843637|FG005|Overall Study|Other|0|||
170411008|NCT00811070|615843632|FG000|Overall Study|Withdrawal by Subject|0|||
170411009|NCT00811070|615843633|FG001|Overall Study|Withdrawal by Subject|1|||
170411010|NCT00811070|615843634|FG002|Overall Study|Withdrawal by Subject|0|||
170411011|NCT00811070|615843635|FG003|Overall Study|Withdrawal by Subject|0|||
170411012|NCT00811070|615843636|FG004|Overall Study|Withdrawal by Subject|0|||
170411013|NCT00811070|615843637|FG005|Overall Study|Withdrawal by Subject|0|||
170411014|NCT00811070|615843632|FG000|Overall Study|Physician Decision|0|||
170411015|NCT00811070|615843633|FG001|Overall Study|Physician Decision|0|||
170411016|NCT00811070|615843634|FG002|Overall Study|Physician Decision|0|||
170411017|NCT00811070|615843635|FG003|Overall Study|Physician Decision|0|||
170521256|NCT01841970|616254145|FG000|Overall Study|Lost to Follow-up|8|||
170521257|NCT02849743|616254148|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
170411018|NCT00811070|615843636|FG004|Overall Study|Physician Decision|0|||
170521258|NCT02849743|616254149|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
170521259|NCT02849743|616254148|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
170521260|NCT02849743|616254149|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
170521261|NCT01566604|616254160|FG000|Overall Study|Patient's inability to use the device|1|||
170765000|NCT00878722|617143348|FG006|Overall Study|Withdrawal by Subject|0|||
170765001|NCT00878722|617143349|FG007|Overall Study|Withdrawal by Subject|2|||
170521262|NCT01566604|616254161|FG001|Overall Study|Patient's inability to use the device|0|||
170521263|NCT01566604|616254160|FG000|Overall Study|Administrative problems|1|||
170765002|NCT00878722|617143342|FG000|Overall Study|Relapse|0|||
170411019|NCT00811070|615843637|FG005|Overall Study|Physician Decision|1|||
170411020|NCT01298596|615843638|FG000|Overall Study|Withdrawal by Subject|1|||
170411021|NCT01298596|615843639|FG001|Overall Study|Withdrawal by Subject|1|||
170411022|NCT01298596|615843638|FG000|Overall Study|Death|5|||
170411023|NCT01298596|615843639|FG001|Overall Study|Death|3|||
170521264|NCT01566604|616254161|FG001|Overall Study|Administrative problems|0|||
170521265|NCT01566604|616254160|FG000|Overall Study|Lack of Efficacy|1|||
170521266|NCT01566604|616254161|FG001|Overall Study|Lack of Efficacy|2|||
170521267|NCT01566604|616254160|FG000|Overall Study|Protocol deviation|2|||
170521268|NCT01566604|616254161|FG001|Overall Study|Protocol deviation|0|||
170521269|NCT01566604|616254160|FG000|Overall Study|Abnormal laboratory value|2|||
170521270|NCT01566604|616254161|FG001|Overall Study|Abnormal laboratory value|0|||
170521271|NCT01566604|616254160|FG000|Overall Study|Death|4|||
170521272|NCT01566604|616254161|FG001|Overall Study|Death|1|||
170521273|NCT01566604|616254160|FG000|Overall Study|Adverse Event|4|||
170521274|NCT01566604|616254161|FG001|Overall Study|Adverse Event|2|||
170521275|NCT01566604|616254160|FG000|Overall Study|Withdrawal by Subject|9|||
170521276|NCT01566604|616254161|FG001|Overall Study|Withdrawal by Subject|6|||
170521277|NCT00274742|616254163|FG000|Overall Study|Adverse Event|0|||
170521278|NCT00274742|616254164|FG001|Overall Study|Adverse Event|4|||
170521279|NCT00274742|616254165|FG002|Overall Study|Adverse Event|1|||
170521280|NCT00274742|616254166|FG003|Overall Study|Adverse Event|4|||
170521281|NCT00274742|616254167|FG004|Overall Study|Adverse Event|12|||
170521282|NCT00274742|616254168|FG005|Overall Study|Adverse Event|3|||
170521283|NCT00274742|616254163|FG000|Overall Study|Lost to Follow-up|0|||
170521284|NCT00274742|616254164|FG001|Overall Study|Lost to Follow-up|0|||
170521285|NCT00274742|616254165|FG002|Overall Study|Lost to Follow-up|0|||
170521286|NCT00274742|616254166|FG003|Overall Study|Lost to Follow-up|0|||
170521287|NCT00274742|616254167|FG004|Overall Study|Lost to Follow-up|1|||
170521288|NCT00274742|616254168|FG005|Overall Study|Lost to Follow-up|0|||
170521289|NCT00274742|616254163|FG000|Overall Study|End of Study|0|||
170521290|NCT00274742|616254164|FG001|Overall Study|End of Study|0|||
170521291|NCT00274742|616254165|FG002|Overall Study|End of Study|0|||
170521292|NCT00274742|616254166|FG003|Overall Study|End of Study|1|||
170521293|NCT00274742|616254167|FG004|Overall Study|End of Study|0|||
170521294|NCT00274742|616254168|FG005|Overall Study|End of Study|0|||
170521295|NCT00274742|616254163|FG000|Overall Study|Disease Progression|0|||
170521296|NCT00274742|616254164|FG001|Overall Study|Disease Progression|1|||
170521297|NCT00274742|616254165|FG002|Overall Study|Disease Progression|1|||
170521298|NCT00274742|616254166|FG003|Overall Study|Disease Progression|0|||
170521299|NCT00274742|616254167|FG004|Overall Study|Disease Progression|1|||
170521300|NCT00274742|616254168|FG005|Overall Study|Disease Progression|0|||
170521301|NCT00274742|616254163|FG000|Overall Study|Other|0|||
170521302|NCT00274742|616254164|FG001|Overall Study|Other|3|||
170521303|NCT00274742|616254165|FG002|Overall Study|Other|0|||
170521304|NCT00274742|616254166|FG003|Overall Study|Other|0|||
170521305|NCT00274742|616254167|FG004|Overall Study|Other|2|||
170521306|NCT00274742|616254168|FG005|Overall Study|Other|0|||
170521307|NCT06060496|616254169|FG000|Overall Study|Withdrawal by Subject|2|||
170521308|NCT06060496|616254169|FG000|Overall Study|Lost to Follow-up|2|||
170521309|NCT02221648|616254172|FG000|Overall Study|Withdrawal by Subject|3|||
170521310|NCT02221648|616254173|FG001|Overall Study|Withdrawal by Subject|3|||
170521311|NCT00810069|616254174|FG000|Lead-in Period I|Adverse Event|43|||
170521312|NCT00810069|616254175|FG001|Lead-in Period I|Adverse Event|0|||
170521313|NCT00810069|616254176|FG002|Lead-in Period I|Adverse Event|0|||
170521314|NCT00810069|616254174|FG000|Lead-in Period I|Lack of Efficacy|1|||
170521315|NCT00810069|616254175|FG001|Lead-in Period I|Lack of Efficacy|0|||
170521316|NCT00810069|616254176|FG002|Lead-in Period I|Lack of Efficacy|0|||
170521317|NCT00810069|616254174|FG000|Lead-in Period I|Lost to Follow-up|19|||
170521318|NCT00810069|616254175|FG001|Lead-in Period I|Lost to Follow-up|0|||
170521319|NCT00810069|616254176|FG002|Lead-in Period I|Lost to Follow-up|0|||
170521320|NCT00810069|616254174|FG000|Lead-in Period I|Physician Decision|1|||
170521321|NCT00810069|616254175|FG001|Lead-in Period I|Physician Decision|0|||
170521322|NCT00810069|616254176|FG002|Lead-in Period I|Physician Decision|0|||
170521323|NCT00810069|616254174|FG000|Lead-in Period I|Protocol Violation|1|||
170521324|NCT00810069|616254175|FG001|Lead-in Period I|Protocol Violation|0|||
170521325|NCT00810069|616254176|FG002|Lead-in Period I|Protocol Violation|0|||
170521326|NCT00810069|616254174|FG000|Lead-in Period I|Withdrawal by Subject|46|||
170521327|NCT00810069|616254175|FG001|Lead-in Period I|Withdrawal by Subject|0|||
170521328|NCT00810069|616254176|FG002|Lead-in Period I|Withdrawal by Subject|0|||
170521329|NCT00810069|616254174|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
170521330|NCT00810069|616254175|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
170521331|NCT00810069|616254176|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
170521332|NCT00810069|616254174|FG000|Lead-in Period I|Randomization criteria not met|158|||
170521333|NCT00810069|616254175|FG001|Lead-in Period I|Randomization criteria not met|0|||
170521334|NCT00810069|616254176|FG002|Lead-in Period I|Randomization criteria not met|0|||
170521335|NCT00810069|616254174|FG000|Double-Blind Period II|Adverse Event|0|||
170521336|NCT00810069|616254175|FG001|Double-Blind Period II|Adverse Event|9|||
170521337|NCT00810069|616254176|FG002|Double-Blind Period II|Adverse Event|8|||
170521338|NCT00810069|616254174|FG000|Double-Blind Period II|Lack of Efficacy|0|||
170521339|NCT00810069|616254175|FG001|Double-Blind Period II|Lack of Efficacy|7|||
170521340|NCT00810069|616254176|FG002|Double-Blind Period II|Lack of Efficacy|12|||
170521341|NCT00810069|616254174|FG000|Double-Blind Period II|Lost to Follow-up|0|||
170521342|NCT00810069|616254175|FG001|Double-Blind Period II|Lost to Follow-up|9|||
170521343|NCT00810069|616254176|FG002|Double-Blind Period II|Lost to Follow-up|9|||
170521344|NCT00810069|616254174|FG000|Double-Blind Period II|Physician Decision|0|||
170521345|NCT00810069|616254175|FG001|Double-Blind Period II|Physician Decision|0|||
170521346|NCT00810069|616254176|FG002|Double-Blind Period II|Physician Decision|1|||
170521347|NCT00810069|616254174|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
170521348|NCT00810069|616254175|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
170521349|NCT00810069|616254176|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
170521350|NCT00810069|616254174|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
170521351|NCT00810069|616254175|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
170521352|NCT00810069|616254176|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
170521353|NCT00810069|616254174|FG000|Double-Blind Period II|Clinical relapse|0|||
170521354|NCT00810069|616254175|FG001|Double-Blind Period II|Clinical relapse|3|||
170521355|NCT00810069|616254176|FG002|Double-Blind Period II|Clinical relapse|0|||
170521356|NCT00810069|616254174|FG000|Double-Blind Period II|Protocol Violation|0|||
170521357|NCT00810069|616254175|FG001|Double-Blind Period II|Protocol Violation|7|||
170521358|NCT00810069|616254176|FG002|Double-Blind Period II|Protocol Violation|6|||
170521359|NCT00426764|616254177|FG000|Overall Study|Protocol Violation|1|||
170521360|NCT00426764|616254177|FG000|Overall Study|Withdrawal by Subject|4|||
170521361|NCT00426764|616254177|FG000|Overall Study|Physician Decision|6|||
170521362|NCT00426764|616254177|FG000|Overall Study|Compassionate Use|1|||
170521363|NCT00426764|616254177|FG000|Overall Study|Progressive Disease|83|||
170521364|NCT00426764|616254177|FG000|Overall Study|Adverse Event|24|||
170521365|NCT00426764|616254177|FG000|Overall Study|Other|1|||
170521366|NCT00426764|616254177|FG000|Overall Study|Death|1|||
170521367|NCT00426764|616254177|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
170521368|NCT01922258|616254178|FG000|Overall Study|Lost to Follow-up|1|||
170521369|NCT01922258|616254179|FG001|Overall Study|Lost to Follow-up|1|||
170521370|NCT01922258|616254178|FG000|Overall Study|Adverse Event|9|||
170521371|NCT01922258|616254179|FG001|Overall Study|Adverse Event|2|||
170521372|NCT01922258|616254178|FG000|Overall Study|Met Withdrawal Criteria|0|||
170521373|NCT01922258|616254179|FG001|Overall Study|Met Withdrawal Criteria|4|||
170521374|NCT01922258|616254178|FG000|Overall Study|Withdrawn by the Investigator|1|||
170521375|NCT01922258|616254179|FG001|Overall Study|Withdrawn by the Investigator|4|||
170521376|NCT01922258|616254178|FG000|Overall Study|Withdrawal by participant|5|||
170521377|NCT01922258|616254179|FG001|Overall Study|Withdrawal by participant|5|||
170521378|NCT00385918|616254180|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
170521379|NCT00385918|616254181|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
170521380|NCT00385918|616254182|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
170521381|NCT00385918|616254180|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
170521382|NCT00385918|616254181|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
170521383|NCT00385918|616254182|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
170521384|NCT00385918|616254180|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
170521385|NCT00385918|616254181|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
170521386|NCT00385918|616254182|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
170521387|NCT00385918|616254180|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
170521388|NCT00385918|616254181|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
170521389|NCT00385918|616254182|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
170521390|NCT00385918|616254180|FG000|Intervention Phase After Randomization|Physician Decision|1|||
170521391|NCT00385918|616254181|FG001|Intervention Phase After Randomization|Physician Decision|0|||
170521392|NCT00385918|616254182|FG002|Intervention Phase After Randomization|Physician Decision|0|||
170521393|NCT00385918|616254180|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
170521394|NCT00385918|616254181|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
170521395|NCT00385918|616254182|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
170521396|NCT01676701|616254183|FG000|Overall Study|Protocol Violation|1|||
170521397|NCT01676701|616254184|FG001|Overall Study|Protocol Violation|0|||
170521398|NCT01676701|616254183|FG000|Overall Study|Sponsor Decision|3|||
170521399|NCT01676701|616254184|FG001|Overall Study|Sponsor Decision|4|||
170521400|NCT05607576|616254186|FG000|Overall Study|immediate sensor error|2|||
170521401|NCT05607576|616254186|FG000|Overall Study|Physician Decision|2|||
170521402|NCT05616013|616254187|FG000|Overall Study|Adverse Event|6|||
170521403|NCT05616013|616254188|FG001|Overall Study|Adverse Event|12|||
170521404|NCT05616013|616254189|FG002|Overall Study|Adverse Event|8|||
170521405|NCT05616013|616254190|FG003|Overall Study|Adverse Event|4|||
170521406|NCT05616013|616254191|FG004|Overall Study|Adverse Event|6|||
170521407|NCT05616013|616254192|FG005|Overall Study|Adverse Event|8|||
170521408|NCT05616013|616254193|FG006|Overall Study|Adverse Event|3|||
170521409|NCT05616013|616254194|FG007|Overall Study|Adverse Event|6|||
170521410|NCT05616013|616254195|FG008|Overall Study|Adverse Event|1|||
170521411|NCT05616013|616254187|FG000|Overall Study|Lost to Follow-up|5|||
170521412|NCT05616013|616254188|FG001|Overall Study|Lost to Follow-up|4|||
170521413|NCT05616013|616254189|FG002|Overall Study|Lost to Follow-up|3|||
170521414|NCT05616013|616254190|FG003|Overall Study|Lost to Follow-up|2|||
170521415|NCT05616013|616254191|FG004|Overall Study|Lost to Follow-up|0|||
170521416|NCT05616013|616254192|FG005|Overall Study|Lost to Follow-up|5|||
170765003|NCT00878722|617143343|FG001|Overall Study|Relapse|0|||
170765004|NCT00878722|617143344|FG002|Overall Study|Relapse|0|||
170765005|NCT00878722|617143345|FG003|Overall Study|Relapse|1|||
170765006|NCT00878722|617143346|FG004|Overall Study|Relapse|0|||
170765007|NCT00878722|617143347|FG005|Overall Study|Relapse|0|||
170765008|NCT00878722|617143348|FG006|Overall Study|Relapse|0|||
170765009|NCT00878722|617143349|FG007|Overall Study|Relapse|0|||
170765010|NCT00383188|617143350|FG000|Overall Study|Adverse Event|4|||
170765011|NCT00383188|617143351|FG001|Overall Study|Adverse Event|7|||
170765012|NCT00383188|617143352|FG002|Overall Study|Adverse Event|9|||
170765013|NCT00383188|617143353|FG003|Overall Study|Adverse Event|8|||
170765014|NCT00383188|617143354|FG004|Overall Study|Adverse Event|8|||
170765015|NCT00383188|617143350|FG000|Overall Study|Lack of Efficacy|9|||
170765016|NCT00383188|617143351|FG001|Overall Study|Lack of Efficacy|3|||
170765017|NCT00383188|617143352|FG002|Overall Study|Lack of Efficacy|3|||
170765018|NCT00383188|617143353|FG003|Overall Study|Lack of Efficacy|2|||
170765019|NCT00383188|617143354|FG004|Overall Study|Lack of Efficacy|6|||
170765020|NCT00383188|617143350|FG000|Overall Study|Other|3|||
170411024|NCT01298596|615843638|FG000|Overall Study|Lost to Follow-up|6|||
170765021|NCT00383188|617143351|FG001|Overall Study|Other|1|||
170765022|NCT00383188|617143352|FG002|Overall Study|Other|0|||
170765023|NCT00383188|617143353|FG003|Overall Study|Other|2|||
170765024|NCT00383188|617143354|FG004|Overall Study|Other|6|||
170765025|NCT00383188|617143350|FG000|Overall Study|No longer willing to participate|1|||
170765026|NCT00383188|617143351|FG001|Overall Study|No longer willing to participate|0|||
170765027|NCT00383188|617143352|FG002|Overall Study|No longer willing to participate|1|||
170765028|NCT00383188|617143353|FG003|Overall Study|No longer willing to participate|0|||
170765029|NCT00383188|617143354|FG004|Overall Study|No longer willing to participate|2|||
170765030|NCT00383188|617143350|FG000|Overall Study|Lost to Follow-up|0|||
170765031|NCT00383188|617143351|FG001|Overall Study|Lost to Follow-up|0|||
170765032|NCT00383188|617143352|FG002|Overall Study|Lost to Follow-up|0|||
170765033|NCT00383188|617143353|FG003|Overall Study|Lost to Follow-up|0|||
170411025|NCT01298596|615843639|FG001|Overall Study|Lost to Follow-up|14|||
170411026|NCT01298596|615843638|FG000|Overall Study|Referred for further management|16|||
170411027|NCT01298596|615843639|FG001|Overall Study|Referred for further management|15|||
170411028|NCT03120520|615843640|FG000|Overall Study|Lost to Follow-up|1|||
170411029|NCT03120520|615843641|FG001|Overall Study|Lost to Follow-up|1|||
170411030|NCT03120520|615843642|FG002|Overall Study|Lost to Follow-up|1|||
170411031|NCT03120520|615843643|FG003|Overall Study|Lost to Follow-up|1|||
170411032|NCT03120520|615843640|FG000|Overall Study|Withdrawal by Subject|3|||
170411033|NCT03120520|615843641|FG001|Overall Study|Withdrawal by Subject|2|||
170411034|NCT03120520|615843642|FG002|Overall Study|Withdrawal by Subject|3|||
170411035|NCT03120520|615843643|FG003|Overall Study|Withdrawal by Subject|2|||
170411036|NCT03120520|615843640|FG000|Overall Study|Other|0|||
170411037|NCT03120520|615843641|FG001|Overall Study|Other|1|||
170411038|NCT03120520|615843642|FG002|Overall Study|Other|0|||
170411039|NCT03120520|615843643|FG003|Overall Study|Other|0|||
170411040|NCT04345471|615843646|FG000|Overall Study|Adverse Event|8|||
170411041|NCT04345471|615843647|FG001|Overall Study|Adverse Event|5|||
170411042|NCT04345471|615843648|FG002|Overall Study|Adverse Event|6|||
170411043|NCT04345471|615843646|FG000|Overall Study|Lack of Efficacy|1|||
170411044|NCT04345471|615843647|FG001|Overall Study|Lack of Efficacy|1|||
170411045|NCT04345471|615843648|FG002|Overall Study|Lack of Efficacy|0|||
170411046|NCT04345471|615843646|FG000|Overall Study|Protocol Violation|0|||
170411047|NCT04345471|615843647|FG001|Overall Study|Protocol Violation|1|||
170411048|NCT04345471|615843648|FG002|Overall Study|Protocol Violation|2|||
170765034|NCT00383188|617143354|FG004|Overall Study|Lost to Follow-up|1|||
170765035|NCT00410124|617143355|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
170765036|NCT00410124|617143356|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
170765037|NCT00410124|617143355|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
170765038|NCT00410124|617143356|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
170411049|NCT04345471|615843646|FG000|Overall Study|Withdrawal by Subject|10|||
170411050|NCT04345471|615843647|FG001|Overall Study|Withdrawal by Subject|5|||
170411051|NCT04345471|615843648|FG002|Overall Study|Withdrawal by Subject|10|||
170411052|NCT01025193|615843649|FG000|Overall Study|Protocol Violation|1|||
170411053|NCT01025193|615843649|FG000|Overall Study|Adverse Event|3|||
170411054|NCT00254397|615843652|FG000|Overall Study|Disease Progression|4|||
170411055|NCT00254397|615843653|FG001|Overall Study|Disease Progression|1|||
170411056|NCT00254397|615843654|FG002|Overall Study|Disease Progression|16|||
170411057|NCT00254397|615843655|FG003|Overall Study|Disease Progression|23|||
170411058|NCT00254397|615843652|FG000|Overall Study|Non-Compliant|0|||
170411059|NCT00254397|615843653|FG001|Overall Study|Non-Compliant|0|||
170411060|NCT00254397|615843654|FG002|Overall Study|Non-Compliant|0|||
170411061|NCT00254397|615843655|FG003|Overall Study|Non-Compliant|1|||
170411062|NCT00254397|615843652|FG000|Overall Study|Adverse Event|2|||
170765039|NCT00410124|617143355|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
170411063|NCT00254397|615843653|FG001|Overall Study|Adverse Event|0|||
170411064|NCT00254397|615843654|FG002|Overall Study|Adverse Event|3|||
170411065|NCT00254397|615843655|FG003|Overall Study|Adverse Event|1|||
170521417|NCT05616013|616254193|FG006|Overall Study|Lost to Follow-up|2|||
170521418|NCT05616013|616254194|FG007|Overall Study|Lost to Follow-up|1|||
170521419|NCT05616013|616254195|FG008|Overall Study|Lost to Follow-up|2|||
170521420|NCT05616013|616254187|FG000|Overall Study|Non-compliance with study requirements|2|||
170521421|NCT05616013|616254188|FG001|Overall Study|Non-compliance with study requirements|2|||
170521422|NCT05616013|616254189|FG002|Overall Study|Non-compliance with study requirements|2|||
170521423|NCT05616013|616254190|FG003|Overall Study|Non-compliance with study requirements|3|||
170521424|NCT05616013|616254191|FG004|Overall Study|Non-compliance with study requirements|0|||
170521425|NCT05616013|616254192|FG005|Overall Study|Non-compliance with study requirements|2|||
170521426|NCT05616013|616254193|FG006|Overall Study|Non-compliance with study requirements|1|||
170521427|NCT05616013|616254194|FG007|Overall Study|Non-compliance with study requirements|1|||
170521428|NCT05616013|616254195|FG008|Overall Study|Non-compliance with study requirements|4|||
170521429|NCT05616013|616254187|FG000|Overall Study|Withdrawal by Subject|11|||
170521430|NCT05616013|616254188|FG001|Overall Study|Withdrawal by Subject|9|||
170521431|NCT05616013|616254189|FG002|Overall Study|Withdrawal by Subject|8|||
170521432|NCT05616013|616254190|FG003|Overall Study|Withdrawal by Subject|6|||
170521433|NCT05616013|616254191|FG004|Overall Study|Withdrawal by Subject|3|||
170521434|NCT05616013|616254192|FG005|Overall Study|Withdrawal by Subject|4|||
170521435|NCT05616013|616254193|FG006|Overall Study|Withdrawal by Subject|6|||
170521436|NCT05616013|616254194|FG007|Overall Study|Withdrawal by Subject|5|||
170521437|NCT05616013|616254195|FG008|Overall Study|Withdrawal by Subject|4|||
170521438|NCT05616013|616254187|FG000|Overall Study|Physician Decision|0|||
170521439|NCT05616013|616254188|FG001|Overall Study|Physician Decision|0|||
170521440|NCT05616013|616254189|FG002|Overall Study|Physician Decision|1|||
170521441|NCT05616013|616254190|FG003|Overall Study|Physician Decision|0|||
170521442|NCT05616013|616254191|FG004|Overall Study|Physician Decision|0|||
170521443|NCT05616013|616254192|FG005|Overall Study|Physician Decision|1|||
170521444|NCT05616013|616254193|FG006|Overall Study|Physician Decision|3|||
170521445|NCT05616013|616254194|FG007|Overall Study|Physician Decision|0|||
170521446|NCT05616013|616254195|FG008|Overall Study|Physician Decision|0|||
170521447|NCT05616013|616254187|FG000|Overall Study|Protocol Violation|0|||
170521448|NCT05616013|616254188|FG001|Overall Study|Protocol Violation|0|||
170521449|NCT05616013|616254189|FG002|Overall Study|Protocol Violation|0|||
170521450|NCT05616013|616254190|FG003|Overall Study|Protocol Violation|0|||
170521451|NCT05616013|616254191|FG004|Overall Study|Protocol Violation|0|||
170521452|NCT05616013|616254192|FG005|Overall Study|Protocol Violation|0|||
170521453|NCT05616013|616254193|FG006|Overall Study|Protocol Violation|1|||
170521454|NCT05616013|616254194|FG007|Overall Study|Protocol Violation|0|||
170521455|NCT05616013|616254195|FG008|Overall Study|Protocol Violation|2|||
170521456|NCT05616013|616254187|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
170521457|NCT05616013|616254188|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
170521458|NCT05616013|616254189|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
170521459|NCT05616013|616254190|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
170521460|NCT05616013|616254191|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
170521461|NCT05616013|616254192|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
170521462|NCT05616013|616254193|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
170521463|NCT05616013|616254194|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
170521464|NCT05616013|616254195|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
170521465|NCT05616013|616254187|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
170521466|NCT05616013|616254188|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
170521467|NCT05616013|616254189|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
170521468|NCT05616013|616254190|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
170521469|NCT05616013|616254191|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
170521470|NCT05616013|616254192|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
170521471|NCT05616013|616254193|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
170521472|NCT05616013|616254194|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
170521473|NCT05616013|616254195|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
170521474|NCT05616013|616254187|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
170521475|NCT05616013|616254188|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
170868144|NCT01807923|617528280|FG000|Overall Study|Randomized But Not Treated|3|||
170521476|NCT05616013|616254189|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
170868145|NCT01807923|617528281|FG001|Overall Study|Randomized But Not Treated|2|||
170521477|NCT05616013|616254190|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
170521478|NCT05616013|616254191|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
170521479|NCT05616013|616254192|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
170521480|NCT05616013|616254193|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
170521481|NCT05616013|616254194|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
170632142|NCT02556177|616664537|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
170632143|NCT02556177|616664538|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
170521482|NCT05616013|616254195|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
170521483|NCT05616013|616254187|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
170521484|NCT05616013|616254188|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
170521485|NCT05616013|616254189|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
170521486|NCT05616013|616254190|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
170521487|NCT05616013|616254191|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
170521488|NCT05616013|616254192|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
170521489|NCT05616013|616254193|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
170521490|NCT05616013|616254194|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
170521491|NCT05616013|616254195|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
170521492|NCT05616013|616254187|FG000|Overall Study|Participant Decision, Time Constraints|0|||
170521493|NCT05616013|616254188|FG001|Overall Study|Participant Decision, Time Constraints|1|||
170521494|NCT05616013|616254189|FG002|Overall Study|Participant Decision, Time Constraints|0|||
170521495|NCT05616013|616254190|FG003|Overall Study|Participant Decision, Time Constraints|0|||
170521496|NCT05616013|616254191|FG004|Overall Study|Participant Decision, Time Constraints|0|||
170521497|NCT05616013|616254192|FG005|Overall Study|Participant Decision, Time Constraints|0|||
170521498|NCT05616013|616254193|FG006|Overall Study|Participant Decision, Time Constraints|0|||
170521499|NCT05616013|616254194|FG007|Overall Study|Participant Decision, Time Constraints|0|||
170521500|NCT05616013|616254195|FG008|Overall Study|Participant Decision, Time Constraints|0|||
170521501|NCT05616013|616254187|FG000|Overall Study|Prohibited Concomitant Medication|0|||
170521502|NCT05616013|616254188|FG001|Overall Study|Prohibited Concomitant Medication|0|||
170521503|NCT05616013|616254189|FG002|Overall Study|Prohibited Concomitant Medication|1|||
170521504|NCT05616013|616254190|FG003|Overall Study|Prohibited Concomitant Medication|0|||
170521505|NCT05616013|616254191|FG004|Overall Study|Prohibited Concomitant Medication|0|||
170521506|NCT05616013|616254192|FG005|Overall Study|Prohibited Concomitant Medication|0|||
170521507|NCT05616013|616254193|FG006|Overall Study|Prohibited Concomitant Medication|0|||
170521508|NCT05616013|616254194|FG007|Overall Study|Prohibited Concomitant Medication|0|||
170521509|NCT05616013|616254195|FG008|Overall Study|Prohibited Concomitant Medication|0|||
170521510|NCT05616013|616254187|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
170521511|NCT05616013|616254188|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
170521512|NCT05616013|616254189|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
170521513|NCT05616013|616254190|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
170521514|NCT05616013|616254191|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
170521515|NCT05616013|616254192|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
170521516|NCT05616013|616254193|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
170521517|NCT05616013|616254194|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
170521518|NCT05616013|616254195|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
170521519|NCT05616013|616254187|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
170521520|NCT05616013|616254188|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
170521521|NCT05616013|616254189|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
170521522|NCT05616013|616254190|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
170521523|NCT05616013|616254191|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
170632144|NCT01134055|616664539|FG000|Overall Study|Adverse Event|5|||
170868146|NCT01807923|617528282|FG002|Overall Study|Randomized But Not Treated|5|||
170868147|NCT02066051|617528285|FG000|Overall Study|Subject developed active GVHD|1|||
170868148|NCT02469896|617528288|FG000|Overall Study|Withdrawal by Subject|2|||
170868149|NCT02469896|617528289|FG001|Overall Study|Withdrawal by Subject|0|||
170868150|NCT02019420|617528290|FG000|Overall Study|Did not receive study drug|2|||
170868151|NCT02019420|617528291|FG001|Overall Study|Did not receive study drug|2|||
170868152|NCT02019420|617528290|FG000|Overall Study|Withdrawal by Subject|1|||
170868153|NCT02019420|617528291|FG001|Overall Study|Withdrawal by Subject|3|||
170868154|NCT02019420|617528290|FG000|Overall Study|At request of sponsor or investigator|0|||
170868155|NCT02019420|617528291|FG001|Overall Study|At request of sponsor or investigator|1|||
170868156|NCT02019420|617528290|FG000|Overall Study|Death|104|||
170868157|NCT02019420|617528291|FG001|Overall Study|Death|99|||
170868158|NCT02019420|617528290|FG000|Overall Study|Transferred to other care facility|1|||
170868159|NCT02019420|617528291|FG001|Overall Study|Transferred to other care facility|1|||
170868160|NCT02510560|617528292|FG000|Overall Study|Discontinued from Treatment|27|||
170868161|NCT02510560|617528293|FG001|Overall Study|Discontinued from Treatment|18|||
170868162|NCT02510560|617528294|FG002|Overall Study|Discontinued from Treatment|19|||
170868163|NCT02510560|617528292|FG000|Overall Study|Other|4|||
170868164|NCT02510560|617528293|FG001|Overall Study|Other|4|||
170868165|NCT02510560|617528294|FG002|Overall Study|Other|3|||
170868166|NCT01294150|617528295|FG000|Overall Study|Physician Decision|2|||
170868167|NCT01294150|617528296|FG001|Overall Study|Physician Decision|2|||
170521524|NCT05616013|616254192|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
170521525|NCT05616013|616254193|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
170521526|NCT05616013|616254194|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
170521527|NCT05616013|616254195|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
170521528|NCT05616013|616254187|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
170521529|NCT05616013|616254188|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
170521530|NCT05616013|616254189|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
170521531|NCT05616013|616254190|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
170521532|NCT05616013|616254191|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
170521533|NCT05616013|616254192|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
170521534|NCT05616013|616254193|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
170521535|NCT05616013|616254194|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
170521536|NCT05616013|616254195|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
170521537|NCT05616013|616254187|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
170521538|NCT05616013|616254188|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
170521539|NCT05616013|616254189|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
170521540|NCT05616013|616254190|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
170521541|NCT05616013|616254191|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
170521542|NCT05616013|616254192|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
170521543|NCT05616013|616254193|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
170521544|NCT05616013|616254194|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
170521545|NCT05616013|616254195|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
170521546|NCT05616013|616254187|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
170521547|NCT05616013|616254188|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
170521548|NCT05616013|616254189|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
170521549|NCT05616013|616254190|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
170521550|NCT05616013|616254191|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
170521551|NCT05616013|616254192|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
170521552|NCT05616013|616254193|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
170521553|NCT05616013|616254194|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
170521554|NCT05616013|616254195|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
170521555|NCT00715403|616254211|FG000|Overall Study|Progressive disease|0|||
170521556|NCT00715403|616254212|FG001|Overall Study|Progressive disease|1|||
170521557|NCT00715403|616254213|FG002|Overall Study|Progressive disease|3|||
170521558|NCT00715403|616254214|FG003|Overall Study|Progressive disease|9|||
170521559|NCT00715403|616254215|FG004|Overall Study|Progressive disease|5|||
170521560|NCT00715403|616254216|FG005|Overall Study|Progressive disease|14|||
170521561|NCT00715403|616254217|FG006|Overall Study|Progressive disease|1|||
170521562|NCT00715403|616254211|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
170521563|NCT00715403|616254212|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
170521564|NCT00715403|616254213|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
170521565|NCT00715403|616254214|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
170521566|NCT00715403|616254215|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
170521567|NCT00715403|616254216|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
170521568|NCT00715403|616254217|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
170521569|NCT00715403|616254211|FG000|Overall Study|Other Adverse Event than DLT|1|||
170521570|NCT00715403|616254212|FG001|Overall Study|Other Adverse Event than DLT|0|||
170521571|NCT00715403|616254213|FG002|Overall Study|Other Adverse Event than DLT|0|||
170521572|NCT00715403|616254214|FG003|Overall Study|Other Adverse Event than DLT|0|||
170765040|NCT00410124|617143356|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
170765041|NCT00410124|617143355|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
170765042|NCT00410124|617143356|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
170765043|NCT00410124|617143355|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
170765044|NCT00410124|617143356|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
170765045|NCT00410124|617143355|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
170765046|NCT00410124|617143356|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
170765047|NCT00410124|617143355|FG000|Core Phase Double Blind (15 Months)|Death|7|||
170765048|NCT00410124|617143356|FG001|Core Phase Double Blind (15 Months)|Death|4|||
170765049|NCT00410124|617143355|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
170765050|NCT00410124|617143356|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
170765051|NCT00410124|617143355|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
170765052|NCT00410124|617143356|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
170521573|NCT00715403|616254215|FG004|Overall Study|Other Adverse Event than DLT|0|||
170868168|NCT02401412|617528297|FG000|Overall Study|Lost to Follow-up|1|||
170411066|NCT01759537|615843656|FG000|Overall Study|Death|1|||
170411067|NCT01759537|615843657|FG001|Overall Study|Death|1|||
170411068|NCT01759537|615843656|FG000|Overall Study|Pregnancy|1|||
170411069|NCT01759537|615843657|FG001|Overall Study|Pregnancy|1|||
170411070|NCT01759537|615843656|FG000|Overall Study|Lost to Follow-up|9|||
170411071|NCT01759537|615843657|FG001|Overall Study|Lost to Follow-up|9|||
170411072|NCT01759537|615843656|FG000|Overall Study|Accident involving jaw fracture|1|||
170411073|NCT01759537|615843657|FG001|Overall Study|Accident involving jaw fracture|1|||
170411074|NCT01759537|615843656|FG000|Overall Study|Subcrestal implant too coronal|1|||
170411075|NCT01759537|615843657|FG001|Overall Study|Subcrestal implant too coronal|1|||
170411076|NCT00420290|615843661|FG000|Overall Study|Adverse Event|3|||
170411077|NCT00420290|615843662|FG001|Overall Study|Adverse Event|1|||
170411078|NCT00420290|615843661|FG000|Overall Study|Withdrawal by Subject|0|||
170411079|NCT00420290|615843662|FG001|Overall Study|Withdrawal by Subject|2|||
170411080|NCT00420290|615843661|FG000|Overall Study|did not meet inclusion/exclusion|1|||
170411081|NCT00420290|615843662|FG001|Overall Study|did not meet inclusion/exclusion|1|||
170411082|NCT03586830|615843663|FG000|Overall Study|Site terminated by Sponsor|1|||
170411083|NCT03586830|615843664|FG001|Overall Study|Site terminated by Sponsor|4|||
170411084|NCT03586830|615843665|FG002|Overall Study|Site terminated by Sponsor|3|||
170411085|NCT03586830|615843666|FG003|Overall Study|Site terminated by Sponsor|3|||
170411086|NCT03586830|615843663|FG000|Overall Study|Lost to Follow-up|0|||
170411087|NCT03586830|615843664|FG001|Overall Study|Lost to Follow-up|2|||
170411088|NCT03586830|615843665|FG002|Overall Study|Lost to Follow-up|2|||
170411089|NCT03586830|615843666|FG003|Overall Study|Lost to Follow-up|1|||
170521574|NCT00715403|616254216|FG005|Overall Study|Other Adverse Event than DLT|2|||
170765053|NCT00410124|617143355|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
170765054|NCT00410124|617143356|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
170765055|NCT00410124|617143355|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
170765056|NCT00410124|617143356|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
170765057|NCT00410124|617143355|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
170765058|NCT00410124|617143356|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
170765059|NCT00410124|617143355|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
170765060|NCT00410124|617143356|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
170765061|NCT00410124|617143355|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
170765062|NCT00410124|617143356|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
170765063|NCT00410124|617143355|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
170765064|NCT00410124|617143356|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
170765065|NCT00410124|617143355|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
170765066|NCT00410124|617143356|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
170765067|NCT01839877|617143359|FG000|Overall Study|Protocol Violation|1|||
170765068|NCT00906282|617143368|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
170765069|NCT00906282|617143368|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
170765070|NCT00906282|617143368|FG000|Preoperative Chemotherapy|Progressive disease|6|||
170765071|NCT00906282|617143368|FG000|Preoperative Chemotherapy|Toxicity|1|||
170765072|NCT01144182|617143369|FG000|Overall Study|Death|5|||
170765073|NCT01144182|617143370|FG001|Overall Study|Death|6|||
170765074|NCT01144182|617143369|FG000|Overall Study|Withdrawal by Subject|3|||
170765075|NCT01144182|617143370|FG001|Overall Study|Withdrawal by Subject|6|||
170765076|NCT01144182|617143369|FG000|Overall Study|Lost to Follow-up|9|||
170765077|NCT01144182|617143370|FG001|Overall Study|Lost to Follow-up|9|||
170765078|NCT01867580|617143380|FG000|Overall Study|Withdrawal by Subject|2|||
170765079|NCT01867580|617143381|FG001|Overall Study|Withdrawal by Subject|3|||
170765080|NCT01867580|617143380|FG000|Overall Study|Physician Decision|17|||
170765081|NCT01867580|617143381|FG001|Overall Study|Physician Decision|12|||
170765082|NCT01867580|617143380|FG000|Overall Study|Lost to Follow-up|3|||
170765083|NCT01867580|617143381|FG001|Overall Study|Lost to Follow-up|5|||
170765084|NCT01867580|617143380|FG000|Overall Study|Sponsor terminated study|1|||
170765085|NCT01867580|617143381|FG001|Overall Study|Sponsor terminated study|0|||
170765086|NCT01867580|617143380|FG000|Overall Study|Missed follow-up assessment|2|||
170765087|NCT01867580|617143381|FG001|Overall Study|Missed follow-up assessment|1|||
170411090|NCT03586830|615843663|FG000|Overall Study|Withdrawal by Subject|1|||
170411091|NCT03586830|615843664|FG001|Overall Study|Withdrawal by Subject|0|||
170411092|NCT03586830|615843665|FG002|Overall Study|Withdrawal by Subject|3|||
170411093|NCT03586830|615843666|FG003|Overall Study|Withdrawal by Subject|1|||
170411094|NCT04578548|615843667|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
170411095|NCT04578548|615843668|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
170411096|NCT04578548|615843667|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
170411097|NCT04578548|615843668|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
170411098|NCT04578548|615843667|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
170411099|NCT04578548|615843668|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
170411100|NCT04578548|615843667|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
170765088|NCT01867580|617143380|FG000|Overall Study|Interruption to therapy|3|||
170765089|NCT01867580|617143381|FG001|Overall Study|Interruption to therapy|0|||
170765090|NCT01867580|617143380|FG000|Overall Study|Osteomyelitis|0|||
170765091|NCT01867580|617143381|FG001|Overall Study|Osteomyelitis|1|||
170765092|NCT01867580|617143380|FG000|Overall Study|Continuation of therapy|0|||
170765093|NCT01867580|617143381|FG001|Overall Study|Continuation of therapy|1|||
170765094|NCT01867580|617143380|FG000|Overall Study|Wound recurrence|0|||
170765095|NCT01867580|617143381|FG001|Overall Study|Wound recurrence|1|||
170765096|NCT00798265|617143382|FG000|Overall Study|Lost to Follow-up|1|||
170765097|NCT00798265|617143383|FG001|Overall Study|Lost to Follow-up|10|||
170765098|NCT00798265|617143382|FG000|Overall Study|Study closing|7|||
170765099|NCT00798265|617143383|FG001|Overall Study|Study closing|6|||
170765100|NCT00798265|617143382|FG000|Overall Study|Withdrawal by Subject|0|||
170765101|NCT00798265|617143383|FG001|Overall Study|Withdrawal by Subject|1|||
170765102|NCT00798265|617143382|FG000|Overall Study|Screen failure|0|||
170765103|NCT00798265|617143383|FG001|Overall Study|Screen failure|1|||
170765104|NCT03354390|617143384|FG000|Level 1|Death|2|||
170765105|NCT03354390|617143385|FG001|Level 1|Death|0|||
170765106|NCT03354390|617143386|FG002|Level 1|Death|0|||
170765107|NCT03354390|617143387|FG003|Level 1|Death|0|||
170765108|NCT03354390|617143384|FG000|Level 1|Physician Decision|1|||
170765109|NCT03354390|617143385|FG001|Level 1|Physician Decision|0|||
170765110|NCT03354390|617143386|FG002|Level 1|Physician Decision|0|||
170765111|NCT03354390|617143387|FG003|Level 1|Physician Decision|0|||
170765112|NCT03354390|617143384|FG000|Level 2|Physician Decision|0|||
170765113|NCT03354390|617143385|FG001|Level 2|Physician Decision|2|||
170765114|NCT03354390|617143386|FG002|Level 2|Physician Decision|0|||
170765115|NCT03354390|617143387|FG003|Level 2|Physician Decision|0|||
170765116|NCT03354390|617143384|FG000|Level 2|Lack of Efficacy|0|||
170765117|NCT03354390|617143385|FG001|Level 2|Lack of Efficacy|1|||
170765118|NCT03354390|617143386|FG002|Level 2|Lack of Efficacy|0|||
170765119|NCT03354390|617143387|FG003|Level 2|Lack of Efficacy|0|||
170765120|NCT03354390|617143384|FG000|Level 2|Lost to Follow-up|0|||
170765121|NCT03354390|617143385|FG001|Level 2|Lost to Follow-up|1|||
170765122|NCT03354390|617143386|FG002|Level 2|Lost to Follow-up|0|||
170765123|NCT03354390|617143387|FG003|Level 2|Lost to Follow-up|0|||
170765124|NCT03354390|617143384|FG000|Level 3|Death|0|||
170765125|NCT03354390|617143385|FG001|Level 3|Death|0|||
170765126|NCT03354390|617143386|FG002|Level 3|Death|1|||
170765127|NCT03354390|617143387|FG003|Level 3|Death|0|||
170765128|NCT03354390|617143384|FG000|Level 3|Physician Decision|0|||
170765129|NCT03354390|617143385|FG001|Level 3|Physician Decision|0|||
170765130|NCT03354390|617143386|FG002|Level 3|Physician Decision|2|||
170765131|NCT03354390|617143387|FG003|Level 3|Physician Decision|0|||
170765132|NCT03354390|617143384|FG000|Level 4|Death|0|||
170765133|NCT03354390|617143385|FG001|Level 4|Death|0|||
170765134|NCT03354390|617143386|FG002|Level 4|Death|0|||
170765135|NCT03354390|617143387|FG003|Level 4|Death|3|||
170765136|NCT03284957|617144907|FG000|Overall Study|Adverse Event|0|||
170765137|NCT03284957|617144908|FG001|Overall Study|Adverse Event|0|||
170765138|NCT03284957|617144909|FG002|Overall Study|Adverse Event|0|||
170765139|NCT03284957|617144910|FG003|Overall Study|Adverse Event|0|||
170765140|NCT03284957|617144911|FG004|Overall Study|Adverse Event|0|||
170765141|NCT03284957|617144912|FG005|Overall Study|Adverse Event|1|||
170765142|NCT03284957|617144913|FG006|Overall Study|Adverse Event|1|||
170411101|NCT04578548|615843668|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
170411102|NCT04578548|615843667|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
170411103|NCT04578548|615843668|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
170411104|NCT04578548|615843667|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
170411105|NCT04578548|615843668|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
170411106|NCT01077713|615843669|FG000|Overall Study|Withdrawal by Subject|1|||
170411107|NCT01077713|615843670|FG001|Overall Study|Withdrawal by Subject|2|||
170411108|NCT01077713|615843669|FG000|Overall Study|Progressive Disease (PD)|0|||
170411109|NCT01077713|615843670|FG001|Overall Study|Progressive Disease (PD)|1|||
170411110|NCT01077713|615843669|FG000|Overall Study|Death|28|||
170411111|NCT01077713|615843670|FG001|Overall Study|Death|29|||
170411112|NCT01077713|615843669|FG000|Overall Study|Lost to Follow-up|1|||
170411113|NCT01077713|615843670|FG001|Overall Study|Lost to Follow-up|1|||
170411114|NCT01077713|615843669|FG000|Overall Study|Adverse Event|2|||
170411115|NCT01077713|615843670|FG001|Overall Study|Adverse Event|1|||
170411116|NCT01077713|615843669|FG000|Overall Study|Other|4|||
170411117|NCT01077713|615843670|FG001|Overall Study|Other|2|||
170632145|NCT01134055|616664540|FG001|Overall Study|Adverse Event|2|||
170765143|NCT03284957|617144914|FG007|Overall Study|Adverse Event|1|||
170765144|NCT03284957|617144915|FG008|Overall Study|Adverse Event|0|||
170765145|NCT03284957|617144916|FG009|Overall Study|Adverse Event|4|||
170411118|NCT03507439|615843671|FG000|Overall Study|Other|2|||
170765146|NCT03284957|617144917|FG010|Overall Study|Adverse Event|1|||
170765147|NCT03284957|617144918|FG011|Overall Study|Adverse Event|1|||
170765148|NCT03284957|617144919|FG012|Overall Study|Adverse Event|0|||
170765149|NCT03284957|617144920|FG013|Overall Study|Adverse Event|0|||
170765150|NCT03284957|617144921|FG014|Overall Study|Adverse Event|0|||
170868169|NCT02401412|617528298|FG001|Overall Study|Lost to Follow-up|0|||
170868170|NCT02401412|617528297|FG000|Overall Study|Discontinued Intervention|15|||
170868171|NCT02401412|617528298|FG001|Overall Study|Discontinued Intervention|21|||
170868172|NCT02401412|617528297|FG000|Overall Study|Withdrawal by Subject|4|||
170868173|NCT02401412|617528298|FG001|Overall Study|Withdrawal by Subject|4|||
170868174|NCT02401412|617528297|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
170868175|NCT02401412|617528298|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
170868176|NCT02401412|617528297|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
170868177|NCT02401412|617528298|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
170868178|NCT01093625|617528299|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
170868179|NCT01093625|617528300|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
170868180|NCT01093625|617528299|FG000|2-Week Visit|Withdrawal by Subject|1|||
170868181|NCT01093625|617528300|FG001|2-Week Visit|Withdrawal by Subject|0|||
170868182|NCT01093625|617528299|FG000|1-Month Visit|Lost to Follow-up|2|||
170868183|NCT01093625|617528300|FG001|1-Month Visit|Lost to Follow-up|0|||
170868184|NCT01093625|617528299|FG000|3-Month Visit|Lost to Follow-up|2|||
170868185|NCT01093625|617528300|FG001|3-Month Visit|Lost to Follow-up|0|||
170868186|NCT01093625|617528299|FG000|6-Month Visit|Withdrawal by Subject|6|||
170868187|NCT01093625|617528300|FG001|6-Month Visit|Withdrawal by Subject|7|||
170868188|NCT01093625|617528299|FG000|6-Month Visit|Lost to Follow-up|2|||
170868189|NCT01093625|617528300|FG001|6-Month Visit|Lost to Follow-up|2|||
170868190|NCT01093625|617528299|FG000|1-Year Visit|Lost to Follow-up|5|||
170868191|NCT01093625|617528300|FG001|1-Year Visit|Lost to Follow-up|3|||
170868192|NCT02146599|617528301|FG000|Overall Study|Failed to meet inclusion criteria|5|||
170868193|NCT03684642|617528302|FG000|Overall Study|Adverse Event|6|||
170868194|NCT03684642|617528303|FG001|Overall Study|Adverse Event|15|||
170868195|NCT03684642|617528304|FG002|Overall Study|Adverse Event|11|||
170868196|NCT03684642|617528302|FG000|Overall Study|Withdrawal by Subject|35|||
170868197|NCT03684642|617528303|FG001|Overall Study|Withdrawal by Subject|53|||
170868198|NCT03684642|617528304|FG002|Overall Study|Withdrawal by Subject|23|||
170868199|NCT03684642|617528302|FG000|Overall Study|Lack of Efficacy|0|||
170868200|NCT03684642|617528303|FG001|Overall Study|Lack of Efficacy|0|||
170868201|NCT03684642|617528304|FG002|Overall Study|Lack of Efficacy|1|||
170868202|NCT03684642|617528302|FG000|Overall Study|Poor compliance to protocol|0|||
170868203|NCT03684642|617528303|FG001|Overall Study|Poor compliance to protocol|4|||
170868204|NCT03684642|617528304|FG002|Overall Study|Poor compliance to protocol|1|||
170868205|NCT03684642|617528302|FG000|Overall Study|Other than specified|62|||
170868206|NCT03684642|617528303|FG001|Overall Study|Other than specified|60|||
170868207|NCT03684642|617528304|FG002|Overall Study|Other than specified|67|||
170868208|NCT03684642|617528302|FG000|Overall Study|Randomized and not treated|0|||
170868209|NCT03684642|617528303|FG001|Overall Study|Randomized and not treated|0|||
170868210|NCT03684642|617528304|FG002|Overall Study|Randomized and not treated|1|||
170868211|NCT03684642|617528302|FG000|Overall Study|Missing completion status but alive at last contact|0|||
170868212|NCT03684642|617528303|FG001|Overall Study|Missing completion status but alive at last contact|1|||
170868213|NCT03684642|617528304|FG002|Overall Study|Missing completion status but alive at last contact|2|||
170868214|NCT01431534|617528308|FG000|Treatment Phase|Adverse Event|0|||
170868215|NCT01431534|617528309|FG001|Treatment Phase|Adverse Event|0|||
170868216|NCT01431534|617528310|FG002|Treatment Phase|Adverse Event|1|||
170868217|NCT01431534|617528308|FG000|Treatment Phase|Progressive Disease|4|||
170868218|NCT01431534|617528309|FG001|Treatment Phase|Progressive Disease|3|||
170868219|NCT01431534|617528310|FG002|Treatment Phase|Progressive Disease|10|||
170868220|NCT02101021|617528311|FG000|Overall Study|Death|4|||
170868221|NCT02101021|617528312|FG001|Overall Study|Death|3|||
170868222|NCT02101021|617528313|FG002|Overall Study|Death|6|||
170868223|NCT02101021|617528314|FG003|Overall Study|Death|0|||
170868224|NCT02101021|617528315|FG004|Overall Study|Death|3|||
170868225|NCT02101021|617528311|FG000|Overall Study|Withdrew Consent from study|1|||
170868226|NCT02101021|617528312|FG001|Overall Study|Withdrew Consent from study|1|||
170868227|NCT02101021|617528313|FG002|Overall Study|Withdrew Consent from study|0|||
170868228|NCT02101021|617528314|FG003|Overall Study|Withdrew Consent from study|2|||
170868229|NCT02101021|617528315|FG004|Overall Study|Withdrew Consent from study|0|||
170868230|NCT02101021|617528311|FG000|Overall Study|Lost to Follow-up|1|||
170868231|NCT02101021|617528312|FG001|Overall Study|Lost to Follow-up|0|||
170868232|NCT02101021|617528313|FG002|Overall Study|Lost to Follow-up|0|||
170868233|NCT02101021|617528314|FG003|Overall Study|Lost to Follow-up|0|||
170868234|NCT02101021|617528315|FG004|Overall Study|Lost to Follow-up|0|||
170868235|NCT02101021|617528311|FG000|Overall Study|Study Terminated by Sponsor|1|||
170868236|NCT02101021|617528312|FG001|Overall Study|Study Terminated by Sponsor|0|||
170868237|NCT02101021|617528313|FG002|Overall Study|Study Terminated by Sponsor|1|||
170868238|NCT02101021|617528314|FG003|Overall Study|Study Terminated by Sponsor|1|||
170868239|NCT02101021|617528315|FG004|Overall Study|Study Terminated by Sponsor|1|||
170868240|NCT01621542|617528316|FG000|Overall Study|Adverse Event|0|||
170868241|NCT01621542|617528317|FG001|Overall Study|Adverse Event|0|||
170868242|NCT01621542|617528318|FG002|Overall Study|Adverse Event|1|||
170868243|NCT01621542|617528319|FG003|Overall Study|Adverse Event|3|||
170868244|NCT01621542|617528320|FG004|Overall Study|Adverse Event|0|||
170868245|NCT01621542|617528321|FG005|Overall Study|Adverse Event|0|||
170521575|NCT00715403|616254217|FG006|Overall Study|Other Adverse Event than DLT|0|||
170521576|NCT00715403|616254211|FG000|Overall Study|Protocol Violation|0|||
170521577|NCT00715403|616254212|FG001|Overall Study|Protocol Violation|0|||
170521578|NCT00715403|616254213|FG002|Overall Study|Protocol Violation|0|||
170521579|NCT00715403|616254214|FG003|Overall Study|Protocol Violation|0|||
170521580|NCT00715403|616254215|FG004|Overall Study|Protocol Violation|0|||
170521581|NCT00715403|616254216|FG005|Overall Study|Protocol Violation|1|||
170521582|NCT00715403|616254217|FG006|Overall Study|Protocol Violation|0|||
170521583|NCT00715403|616254211|FG000|Overall Study|Other reason not defined above|0|||
170521584|NCT00715403|616254212|FG001|Overall Study|Other reason not defined above|0|||
170521585|NCT00715403|616254213|FG002|Overall Study|Other reason not defined above|1|||
170521586|NCT00715403|616254214|FG003|Overall Study|Other reason not defined above|0|||
170521587|NCT00715403|616254215|FG004|Overall Study|Other reason not defined above|1|||
170521588|NCT00715403|616254216|FG005|Overall Study|Other reason not defined above|1|||
170521589|NCT00715403|616254217|FG006|Overall Study|Other reason not defined above|0|||
170521590|NCT00101868|616254224|FG000|Overall Study|Death|10|||
170521591|NCT00101868|616254225|FG001|Overall Study|Death|10|||
170521592|NCT00101868|616254224|FG000|Overall Study|Withdrawal by Subject|8|||
170521593|NCT00101868|616254225|FG001|Overall Study|Withdrawal by Subject|9|||
170521594|NCT00101868|616254224|FG000|Overall Study|Protocol Violation|3|||
170521595|NCT00101868|616254225|FG001|Overall Study|Protocol Violation|0|||
170521596|NCT00101868|616254224|FG000|Overall Study|Lost to Follow-up|8|||
170521597|NCT00101868|616254225|FG001|Overall Study|Lost to Follow-up|13|||
170521598|NCT04001803|616254226|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
170521599|NCT04001803|616254226|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
170521600|NCT04001803|616254226|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
170521601|NCT04001803|616254226|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
170521602|NCT04001803|616254226|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
170521603|NCT04001803|616254226|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
170521604|NCT04001803|616254226|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
170521605|NCT04001803|616254226|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
170521606|NCT04001803|616254226|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
170521607|NCT04001803|616254226|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
170521608|NCT01931397|616254229|FG000|Overall Study|Physician Decision|2|||
170521609|NCT01931397|616254229|FG000|Overall Study|Withdrawal by Subject|8|||
170521610|NCT01931397|616254229|FG000|Overall Study|moved out of state|1|||
170521611|NCT00520039|616254232|FG000|Overall Study|Exclusion criteria met at first visit|7|||
170521612|NCT00520039|616254233|FG001|Overall Study|Exclusion criteria met at first visit|5|||
170521613|NCT02493517|616254237|FG000|Overall Study|Protocol Violation|1|||
170521614|NCT02493517|616254238|FG001|Overall Study|Protocol Violation|2|||
170521615|NCT02493517|616254237|FG000|Overall Study|Withdrawal by Subject|1|||
170521616|NCT02493517|616254238|FG001|Overall Study|Withdrawal by Subject|2|||
170521617|NCT02493517|616254237|FG000|Overall Study|Adverse Event|0|||
170521618|NCT02493517|616254238|FG001|Overall Study|Adverse Event|2|||
170521619|NCT02493517|616254237|FG000|Overall Study|Missed study visit|0|||
170521620|NCT02493517|616254238|FG001|Overall Study|Missed study visit|1|||
170521621|NCT05176717|616254239|FG000|Overall Study|Sponsor Decision|1|||
170521622|NCT05176717|616254240|FG001|Overall Study|Sponsor Decision|2|||
170521623|NCT05176717|616254241|FG002|Overall Study|Sponsor Decision|2|||
170521624|NCT01683604|616254249|FG000|Overall Study|Adverse Event|2|||
170521625|NCT01683604|616254249|FG000|Overall Study|Lack of Efficacy|1|||
170521626|NCT01683604|616254249|FG000|Overall Study|Other|2|||
170521627|NCT03999749|616254250|FG000|Overall Study|Toxicity|16|||
170521628|NCT03999749|616254250|FG000|Overall Study|Withdrawal by Subject|3|||
170521629|NCT03999749|616254250|FG000|Overall Study|Disease progression|26|||
170521630|NCT03999749|616254250|FG000|Overall Study|Physician Decision|4|||
170521631|NCT03999749|616254250|FG000|Overall Study|Death|5|||
170521632|NCT03999749|616254250|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
170521633|NCT00255164|616254251|FG000|Overall Study|Adverse Event|10|||
170868246|NCT01621542|617528316|FG000|Overall Study|Death|0|||
170868247|NCT01621542|617528317|FG001|Overall Study|Death|1|||
170521634|NCT00255164|616254252|FG001|Overall Study|Adverse Event|6|||
170632146|NCT01134055|616664541|FG002|Overall Study|Adverse Event|2|||
170868248|NCT01621542|617528318|FG002|Overall Study|Death|0|||
170521635|NCT00255164|616254253|FG002|Overall Study|Adverse Event|9|||
170632147|NCT01134055|616664542|FG003|Overall Study|Adverse Event|2|||
170868249|NCT01621542|617528319|FG003|Overall Study|Death|0|||
170521636|NCT00255164|616254251|FG000|Overall Study|Lost to Follow-up|4|||
170521637|NCT00255164|616254252|FG001|Overall Study|Lost to Follow-up|3|||
170521638|NCT00255164|616254253|FG002|Overall Study|Lost to Follow-up|4|||
170521639|NCT00255164|616254251|FG000|Overall Study|Withdrawal by Subject|18|||
170521640|NCT00255164|616254252|FG001|Overall Study|Withdrawal by Subject|17|||
170521641|NCT00255164|616254253|FG002|Overall Study|Withdrawal by Subject|8|||
170521642|NCT00255164|616254251|FG000|Overall Study|Noncompliance|0|||
170521643|NCT00255164|616254252|FG001|Overall Study|Noncompliance|1|||
170632148|NCT01134055|616664543|FG004|Overall Study|Adverse Event|5|||
170868250|NCT01621542|617528320|FG004|Overall Study|Death|0|||
170521644|NCT00255164|616254253|FG002|Overall Study|Noncompliance|2|||
170521645|NCT00255164|616254251|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
170521646|NCT00255164|616254252|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
170521647|NCT00255164|616254253|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
170521648|NCT00255164|616254251|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
170521649|NCT00255164|616254252|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
170521650|NCT00255164|616254253|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
170521651|NCT00255164|616254251|FG000|Overall Study|Possible Barrett's Esophagus|1|||
170521652|NCT00255164|616254252|FG001|Overall Study|Possible Barrett's Esophagus|3|||
170521653|NCT00255164|616254253|FG002|Overall Study|Possible Barrett's Esophagus|8|||
170521654|NCT00255164|616254251|FG000|Overall Study|Esophageal Stricture|0|||
170521655|NCT00255164|616254252|FG001|Overall Study|Esophageal Stricture|0|||
170521656|NCT00255164|616254253|FG002|Overall Study|Esophageal Stricture|1|||
170521657|NCT00255164|616254251|FG000|Overall Study|Therapeutic Failure|11|||
170521658|NCT00255164|616254252|FG001|Overall Study|Therapeutic Failure|2|||
170521659|NCT00255164|616254253|FG002|Overall Study|Therapeutic Failure|3|||
170521660|NCT02481050|616256081|FG000|Overall Study|Adverse Event|1|||
170521661|NCT02481050|616256081|FG000|Overall Study|Disease Progression|47|||
170521662|NCT02481050|616256081|FG000|Overall Study|Withdrawal by Subject|7|||
170521663|NCT02481050|616256081|FG000|Overall Study|Other|3|||
170521664|NCT01548599|616256084|FG000|Overall Study|Lost to Follow-up|0|||
170521665|NCT01548599|616256085|FG001|Overall Study|Lost to Follow-up|1|||
170521666|NCT01548599|616256084|FG000|Overall Study|Withdrawal by Subject|4|||
170521667|NCT01548599|616256085|FG001|Overall Study|Withdrawal by Subject|0|||
170521668|NCT01548599|616256084|FG000|Overall Study|Death|2|||
170521669|NCT01548599|616256085|FG001|Overall Study|Death|1|||
170521670|NCT00916578|616256086|FG000|Overall Study|Physician Decision|2|||
170521671|NCT00916578|616256086|FG000|Overall Study|Withdrawal by Subject|3|||
170521672|NCT00916578|616256086|FG000|Overall Study|Insurance Denial|2|||
170521673|NCT04969289|616256089|FG000|Overall Study|Lost to Follow-up|13|||
170521674|NCT04969289|616256090|FG001|Overall Study|Lost to Follow-up|9|||
170521675|NCT02699996|616256091|FG000|Overall Study|Withdrawal by Subject|5|||
170521676|NCT02699996|616256092|FG001|Overall Study|Withdrawal by Subject|2|||
170521677|NCT03110354|616256095|FG000|Overall Study|Death|1|||
170521678|NCT03110354|616256096|FG001|Overall Study|Death|0|||
170521679|NCT03110354|616256097|FG002|Overall Study|Death|0|||
170521680|NCT03110354|616256098|FG003|Overall Study|Death|1|||
170521681|NCT03110354|616256099|FG004|Overall Study|Death|0|||
170521682|NCT03110354|616256095|FG000|Overall Study|Start of new therapy|0|||
170521683|NCT03110354|616256096|FG001|Overall Study|Start of new therapy|0|||
170521684|NCT03110354|616256097|FG002|Overall Study|Start of new therapy|0|||
170521685|NCT03110354|616256098|FG003|Overall Study|Start of new therapy|0|||
170521686|NCT03110354|616256099|FG004|Overall Study|Start of new therapy|1|||
170521687|NCT03110354|616256095|FG000|Overall Study|Failure to achieve response|2|||
170521688|NCT03110354|616256096|FG001|Overall Study|Failure to achieve response|3|||
170521689|NCT03110354|616256097|FG002|Overall Study|Failure to achieve response|0|||
170521690|NCT03110354|616256098|FG003|Overall Study|Failure to achieve response|2|||
170521691|NCT03110354|616256099|FG004|Overall Study|Failure to achieve response|1|||
170521692|NCT03110354|616256095|FG000|Overall Study|Progressive disease|1|||
170521693|NCT03110354|616256096|FG001|Overall Study|Progressive disease|1|||
170521694|NCT03110354|616256097|FG002|Overall Study|Progressive disease|3|||
170521695|NCT03110354|616256098|FG003|Overall Study|Progressive disease|4|||
170521696|NCT03110354|616256099|FG004|Overall Study|Progressive disease|2|||
170521697|NCT03110354|616256095|FG000|Overall Study|Adverse Event|0|||
170521698|NCT03110354|616256096|FG001|Overall Study|Adverse Event|0|||
170521699|NCT03110354|616256097|FG002|Overall Study|Adverse Event|0|||
170521700|NCT03110354|616256098|FG003|Overall Study|Adverse Event|2|||
170521701|NCT03110354|616256099|FG004|Overall Study|Adverse Event|2|||
170521702|NCT03110354|616256095|FG000|Overall Study|Other|0|||
170521703|NCT03110354|616256096|FG001|Overall Study|Other|0|||
170765151|NCT03284957|617144922|FG015|Overall Study|Adverse Event|0|||
170765152|NCT03284957|617144907|FG000|Overall Study|Progressive Disease|3|||
170765153|NCT03284957|617144908|FG001|Overall Study|Progressive Disease|3|||
170765154|NCT03284957|617144909|FG002|Overall Study|Progressive Disease|4|||
170521704|NCT03110354|616256097|FG002|Overall Study|Other|0|||
170521705|NCT03110354|616256098|FG003|Overall Study|Other|1|||
170521706|NCT03110354|616256099|FG004|Overall Study|Other|1|||
170521707|NCT01307787|616256102|FG000|Overall Study|Withdrawal by Subject|2|||
170521708|NCT01307787|616256103|FG001|Overall Study|Withdrawal by Subject|0|||
170521709|NCT02515630|616256109|FG000|Overall Study|Withdrawal by Subject|5|||
170521710|NCT02515630|616256109|FG000|Overall Study|Adverse Event|4|||
170521711|NCT02515630|616256109|FG000|Overall Study|Physician Decision|4|||
170521712|NCT02515630|616256109|FG000|Overall Study|Death|2|||
170521713|NCT02515630|616256109|FG000|Overall Study|Disease Progression|1|||
170521714|NCT02185417|616256110|FG000|Overall Study|Death|448|||
170521715|NCT02185417|616256111|FG001|Overall Study|Death|446|||
170632149|NCT01134055|616664544|FG005|Overall Study|Adverse Event|7|||
170765155|NCT03284957|617144910|FG003|Overall Study|Progressive Disease|3|||
170765156|NCT03284957|617144911|FG004|Overall Study|Progressive Disease|3|||
170868251|NCT01621542|617528321|FG005|Overall Study|Death|0|||
170868252|NCT01621542|617528316|FG000|Overall Study|Physician Decision|1|||
170868253|NCT01621542|617528317|FG001|Overall Study|Physician Decision|0|||
170868254|NCT01621542|617528318|FG002|Overall Study|Physician Decision|1|||
170868255|NCT01621542|617528319|FG003|Overall Study|Physician Decision|13|||
170868256|NCT01621542|617528320|FG004|Overall Study|Physician Decision|3|||
170868257|NCT01621542|617528321|FG005|Overall Study|Physician Decision|1|||
170411119|NCT03507439|615843672|FG001|Overall Study|Other|1|||
170411120|NCT03507439|615843671|FG000|Overall Study|Withdrawal by Subject|1|||
170411121|NCT03507439|615843672|FG001|Overall Study|Withdrawal by Subject|0|||
170411122|NCT03507439|615843671|FG000|Overall Study|Death|1|||
170411123|NCT03507439|615843672|FG001|Overall Study|Death|1|||
170411124|NCT04014959|615845309|FG000|Baseline MRI and Assessments|Physician Decision|2|||
170411125|NCT04014959|615845309|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
170411126|NCT04014959|615845309|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
170411127|NCT02004847|615845311|FG000|Overall Study|Protocol Violation|1|||
170411128|NCT02004847|615845312|FG001|Overall Study|Protocol Violation|1|||
170411129|NCT02034799|615845313|FG000|Overall Study|Withdrawal by Subject|0|||
170411130|NCT02034799|615845314|FG001|Overall Study|Withdrawal by Subject|2|||
170411131|NCT02034799|615845313|FG000|Overall Study|Lost to Follow-up|0|||
170411132|NCT02034799|615845314|FG001|Overall Study|Lost to Follow-up|1|||
170411133|NCT02034799|615845313|FG000|Overall Study|Death|2|||
170411134|NCT02034799|615845314|FG001|Overall Study|Death|1|||
170411135|NCT05188521|615845316|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
170411136|NCT05188521|615845317|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
170411137|NCT02220920|615845318|FG000|Overall Study|Adverse Event|1|||
170411138|NCT02220920|615845319|FG001|Overall Study|Adverse Event|0|||
170411139|NCT02220920|615845318|FG000|Overall Study|Lack of Efficacy|0|||
170411140|NCT02220920|615845319|FG001|Overall Study|Lack of Efficacy|1|||
170411141|NCT02220920|615845318|FG000|Overall Study|Withdrawal by Subject|1|||
170411142|NCT02220920|615845319|FG001|Overall Study|Withdrawal by Subject|0|||
170411143|NCT02220920|615845318|FG000|Overall Study|Conflict with the stopping criteria|1|||
170411144|NCT02220920|615845319|FG001|Overall Study|Conflict with the stopping criteria|2|||
170411145|NCT03705351|615845320|FG000|Overall Study|Study termination|3|||
170411146|NCT03705351|615845320|FG000|Overall Study|Death|1|||
170411147|NCT03705351|615845320|FG000|Overall Study|Lack of Efficacy|2|||
170411148|NCT03705351|615845320|FG000|Overall Study|Withdrawal by Subject|1|||
170411149|NCT00056160|615845327|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
170411150|NCT00056160|615845328|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
170411151|NCT00056160|615845327|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
170411152|NCT00056160|615845328|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
170411153|NCT00056160|615845327|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
170411154|NCT00056160|615845328|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
170411155|NCT00056160|615845327|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
170411156|NCT00056160|615845328|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
170411157|NCT00056160|615845327|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
170411158|NCT00056160|615845328|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
170411159|NCT00056160|615845327|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
170411160|NCT00056160|615845328|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
170411161|NCT00056160|615845327|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
170411162|NCT00056160|615845328|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
170411163|NCT00056160|615845327|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
170411164|NCT00056160|615845328|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
170411165|NCT00056160|615845327|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
170411166|NCT00056160|615845328|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
170411167|NCT00056160|615845327|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
170411168|NCT00056160|615845328|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
170411169|NCT00056160|615845327|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
170411170|NCT00056160|615845328|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
170411171|NCT00056160|615845327|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
170411172|NCT00056160|615845328|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
170411173|NCT00056160|615845327|FG000|Final Follow-up|Transferred into expanded access study.|3|||
170411174|NCT00056160|615845328|FG001|Final Follow-up|Transferred into expanded access study.|0|||
170411175|NCT00056160|615845327|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
170411176|NCT00056160|615845328|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
170411177|NCT00056160|615845327|FG000|Final Follow-up|Adverse Event|1|||
170868258|NCT01621542|617528316|FG000|Overall Study|Withdrawal by Subject|2|||
170411178|NCT00056160|615845328|FG001|Final Follow-up|Adverse Event|0|||
170411179|NCT02811861|615845329|FG000|Overall Study|Radiological Disease Progression|123|||
170411180|NCT02811861|615845330|FG001|Overall Study|Radiological Disease Progression|97|||
170411181|NCT02811861|615845331|FG002|Overall Study|Radiological Disease Progression|174|||
170411182|NCT02811861|615845329|FG000|Overall Study|Clinical Disease Progression|20|||
170411183|NCT02811861|615845330|FG001|Overall Study|Clinical Disease Progression|19|||
170765157|NCT03284957|617144912|FG005|Overall Study|Progressive Disease|5|||
170765158|NCT03284957|617144913|FG006|Overall Study|Progressive Disease|45|||
170765159|NCT03284957|617144914|FG007|Overall Study|Progressive Disease|8|||
170765160|NCT03284957|617144915|FG008|Overall Study|Progressive Disease|5|||
170765161|NCT03284957|617144916|FG009|Overall Study|Progressive Disease|18|||
170765162|NCT03284957|617144917|FG010|Overall Study|Progressive Disease|7|||
170765163|NCT03284957|617144918|FG011|Overall Study|Progressive Disease|2|||
170765164|NCT03284957|617144919|FG012|Overall Study|Progressive Disease|3|||
170765165|NCT03284957|617144920|FG013|Overall Study|Progressive Disease|1|||
170765166|NCT03284957|617144921|FG014|Overall Study|Progressive Disease|1|||
170765167|NCT03284957|617144922|FG015|Overall Study|Progressive Disease|2|||
170765168|NCT03284957|617144907|FG000|Overall Study|Withdrawal by Subject|0|||
170765169|NCT03284957|617144908|FG001|Overall Study|Withdrawal by Subject|0|||
170765170|NCT03284957|617144909|FG002|Overall Study|Withdrawal by Subject|0|||
170765171|NCT03284957|617144910|FG003|Overall Study|Withdrawal by Subject|0|||
170765172|NCT03284957|617144911|FG004|Overall Study|Withdrawal by Subject|0|||
170765173|NCT03284957|617144912|FG005|Overall Study|Withdrawal by Subject|0|||
170765174|NCT03284957|617144913|FG006|Overall Study|Withdrawal by Subject|0|||
170765175|NCT03284957|617144914|FG007|Overall Study|Withdrawal by Subject|0|||
170765176|NCT03284957|617144915|FG008|Overall Study|Withdrawal by Subject|0|||
170765177|NCT03284957|617144916|FG009|Overall Study|Withdrawal by Subject|2|||
170765178|NCT03284957|617144917|FG010|Overall Study|Withdrawal by Subject|0|||
170765179|NCT03284957|617144918|FG011|Overall Study|Withdrawal by Subject|0|||
170765180|NCT03284957|617144919|FG012|Overall Study|Withdrawal by Subject|0|||
170765181|NCT03284957|617144920|FG013|Overall Study|Withdrawal by Subject|0|||
170765182|NCT03284957|617144921|FG014|Overall Study|Withdrawal by Subject|0|||
170411184|NCT02811861|615845331|FG002|Overall Study|Clinical Disease Progression|22|||
170411185|NCT02811861|615845329|FG000|Overall Study|Adverse Event|63|||
170411186|NCT02811861|615845330|FG001|Overall Study|Adverse Event|60|||
170411187|NCT02811861|615845331|FG002|Overall Study|Adverse Event|41|||
170411188|NCT02811861|615845329|FG000|Overall Study|Lost to Follow-up|0|||
170411189|NCT02811861|615845330|FG001|Overall Study|Lost to Follow-up|0|||
170411190|NCT02811861|615845331|FG002|Overall Study|Lost to Follow-up|1|||
170411191|NCT02811861|615845329|FG000|Overall Study|Subject Choice|29|||
170411192|NCT02811861|615845330|FG001|Overall Study|Subject Choice|17|||
170411193|NCT02811861|615845331|FG002|Overall Study|Subject Choice|23|||
170411194|NCT02811861|615845329|FG000|Overall Study|Withdrawal by Subject|4|||
170411195|NCT02811861|615845330|FG001|Overall Study|Withdrawal by Subject|4|||
170411196|NCT02811861|615845331|FG002|Overall Study|Withdrawal by Subject|9|||
170411197|NCT02811861|615845329|FG000|Overall Study|Other|4|||
170411198|NCT02811861|615845330|FG001|Overall Study|Other|13|||
170411199|NCT02811861|615845331|FG002|Overall Study|Other|3|||
170411200|NCT02811861|615845329|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
170411201|NCT02811861|615845330|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
170411202|NCT02811861|615845331|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
170411203|NCT02811861|615845329|FG000|Overall Study|Randomized but not treated|2|||
170411204|NCT02811861|615845330|FG001|Overall Study|Randomized but not treated|3|||
170411205|NCT02811861|615845331|FG002|Overall Study|Randomized but not treated|17|||
170411206|NCT01452529|615845337|FG000|Run-in Period|Adverse Event|96|||
170411207|NCT01452529|615845338|FG001|Run-in Period|Adverse Event|0|||
170411208|NCT01452529|615845339|FG002|Run-in Period|Adverse Event|0|||
170411209|NCT01452529|615845337|FG000|Run-in Period|Withdrawal by Subject|49|||
170411210|NCT01452529|615845338|FG001|Run-in Period|Withdrawal by Subject|0|||
170411211|NCT01452529|615845339|FG002|Run-in Period|Withdrawal by Subject|0|||
170411212|NCT01452529|615845337|FG000|Run-in Period|Lost to Follow-up|19|||
170411213|NCT01452529|615845338|FG001|Run-in Period|Lost to Follow-up|0|||
170411214|NCT01452529|615845339|FG002|Run-in Period|Lost to Follow-up|0|||
170411215|NCT01452529|615845337|FG000|Run-in Period|Lack of Efficacy|46|||
170411216|NCT01452529|615845338|FG001|Run-in Period|Lack of Efficacy|0|||
170411217|NCT01452529|615845339|FG002|Run-in Period|Lack of Efficacy|0|||
170411218|NCT01452529|615845337|FG000|Run-in Period|Confirmed or suspected diversion|23|||
170411219|NCT01452529|615845338|FG001|Run-in Period|Confirmed or suspected diversion|0|||
170765183|NCT03284957|617144922|FG015|Overall Study|Withdrawal by Subject|0|||
170765184|NCT03284957|617144907|FG000|Overall Study|Other|0|||
170765185|NCT03284957|617144908|FG001|Overall Study|Other|0|||
170765186|NCT03284957|617144909|FG002|Overall Study|Other|0|||
170765187|NCT03284957|617144910|FG003|Overall Study|Other|0|||
170765188|NCT03284957|617144911|FG004|Overall Study|Other|0|||
170765189|NCT03284957|617144912|FG005|Overall Study|Other|0|||
170868259|NCT01621542|617528317|FG001|Overall Study|Withdrawal by Subject|0|||
170868260|NCT01621542|617528318|FG002|Overall Study|Withdrawal by Subject|1|||
170411220|NCT01452529|615845339|FG002|Run-in Period|Confirmed or suspected diversion|0|||
170411221|NCT01452529|615845337|FG000|Run-in Period|Administrative|21|||
170411222|NCT01452529|615845338|FG001|Run-in Period|Administrative|0|||
170411223|NCT01452529|615845339|FG002|Run-in Period|Administrative|0|||
170411224|NCT01452529|615845337|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
170411225|NCT01452529|615845338|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
170765190|NCT03284957|617144913|FG006|Overall Study|Other|3|||
170868261|NCT01621542|617528319|FG003|Overall Study|Withdrawal by Subject|3|||
170868262|NCT01621542|617528320|FG004|Overall Study|Withdrawal by Subject|3|||
170868263|NCT01621542|617528321|FG005|Overall Study|Withdrawal by Subject|3|||
170411226|NCT01452529|615845339|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
170411227|NCT01452529|615845337|FG000|Double-blind (DB) Period|Adverse Event|0|||
170411228|NCT01452529|615845338|FG001|Double-blind (DB) Period|Adverse Event|18|||
170411229|NCT01452529|615845339|FG002|Double-blind (DB) Period|Adverse Event|11|||
170411230|NCT01452529|615845337|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
170411231|NCT01452529|615845338|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
170411232|NCT01452529|615845339|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
170411233|NCT01452529|615845337|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
170411234|NCT01452529|615845338|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
170411235|NCT01452529|615845339|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
170411236|NCT01452529|615845337|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
170411237|NCT01452529|615845338|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
170411238|NCT01452529|615845339|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
170411239|NCT01452529|615845337|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
170411240|NCT01452529|615845338|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
170411241|NCT01452529|615845339|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
170411242|NCT01452529|615845337|FG000|Double-blind (DB) Period|Administrative|0|||
170411243|NCT01452529|615845338|FG001|Double-blind (DB) Period|Administrative|11|||
170411244|NCT01452529|615845339|FG002|Double-blind (DB) Period|Administrative|7|||
170411245|NCT03347695|615845343|FG000|Overall Study|Death|0|||
170411246|NCT03347695|615845344|FG001|Overall Study|Death|4|||
170411247|NCT03347695|615845343|FG000|Overall Study|Lost to Follow-up|0|||
170411248|NCT03347695|615845344|FG001|Overall Study|Lost to Follow-up|1|||
170411249|NCT02884206|615845355|FG000|Valsartan Run-in Period|Death|1|||
170411250|NCT02884206|615845356|FG001|Valsartan Run-in Period|Death|0|||
170411251|NCT02884206|615845357|FG002|Valsartan Run-in Period|Death|0|||
170411252|NCT02884206|615845355|FG000|Valsartan Run-in Period|Adverse Event|31|||
170411253|NCT02884206|615845356|FG001|Valsartan Run-in Period|Adverse Event|0|||
170411254|NCT02884206|615845357|FG002|Valsartan Run-in Period|Adverse Event|0|||
170411255|NCT02884206|615845355|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
170411256|NCT02884206|615845356|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
170411257|NCT02884206|615845357|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
170411258|NCT02884206|615845355|FG000|Valsartan Run-in Period|Protocol deviation|4|||
170411259|NCT02884206|615845356|FG001|Valsartan Run-in Period|Protocol deviation|0|||
170411260|NCT02884206|615845357|FG002|Valsartan Run-in Period|Protocol deviation|0|||
170411261|NCT02884206|615845355|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
170411262|NCT02884206|615845356|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
170411263|NCT02884206|615845357|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
170411264|NCT02884206|615845355|FG000|Valsartan Run-in Period|Physician Decision|1|||
170411265|NCT02884206|615845356|FG001|Valsartan Run-in Period|Physician Decision|0|||
170411266|NCT02884206|615845357|FG002|Valsartan Run-in Period|Physician Decision|0|||
170411267|NCT02884206|615845355|FG000|LCZ696 Run-in Period|Adverse Event|38|||
170411268|NCT02884206|615845356|FG001|LCZ696 Run-in Period|Adverse Event|0|||
170411269|NCT02884206|615845357|FG002|LCZ696 Run-in Period|Adverse Event|0|||
170411270|NCT02884206|615845355|FG000|LCZ696 Run-in Period|Death|2|||
170411271|NCT02884206|615845356|FG001|LCZ696 Run-in Period|Death|0|||
170411272|NCT02884206|615845357|FG002|LCZ696 Run-in Period|Death|0|||
170411273|NCT02884206|615845355|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
170411274|NCT02884206|615845356|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
170411275|NCT02884206|615845357|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
170411276|NCT02884206|615845355|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
170411277|NCT02884206|615845356|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
170411278|NCT02884206|615845357|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
170411279|NCT02884206|615845355|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
170411280|NCT02884206|615845356|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
170411281|NCT02884206|615845357|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
170411282|NCT02884206|615845355|FG000|LCZ696 Run-in Period|Physician Decision|1|||
170411283|NCT02884206|615845356|FG001|LCZ696 Run-in Period|Physician Decision|0|||
170521716|NCT02185417|616256112|FG002|Overall Study|Death|0|||
170521717|NCT02185417|616256110|FG000|Overall Study|Withdrawal by Subject|7|||
170521718|NCT02185417|616256111|FG001|Overall Study|Withdrawal by Subject|12|||
170521719|NCT02185417|616256112|FG002|Overall Study|Withdrawal by Subject|0|||
170868264|NCT01621542|617528316|FG000|Overall Study|progression/treatment failure|2|||
170868265|NCT01621542|617528317|FG001|Overall Study|progression/treatment failure|4|||
170868266|NCT01621542|617528318|FG002|Overall Study|progression/treatment failure|3|||
170411284|NCT02884206|615845357|FG002|LCZ696 Run-in Period|Physician Decision|0|||
170411285|NCT02884206|615845355|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
170411286|NCT02884206|615845356|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
170411287|NCT02884206|615845357|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
170521720|NCT00126594|616256117|FG000|Overall Study|Ineligible|2|||
170868267|NCT01621542|617528319|FG003|Overall Study|progression/treatment failure|7|||
170868268|NCT01621542|617528320|FG004|Overall Study|progression/treatment failure|3|||
170868269|NCT01621542|617528321|FG005|Overall Study|progression/treatment failure|5|||
170868270|NCT01621542|617528316|FG000|Overall Study|Protocol Violation|0|||
170868271|NCT01621542|617528317|FG001|Overall Study|Protocol Violation|0|||
170868272|NCT01621542|617528318|FG002|Overall Study|Protocol Violation|0|||
170411288|NCT02884206|615845355|FG000|Double-Blind Period|Death|0|||
170411289|NCT02884206|615845356|FG001|Double-Blind Period|Death|28|||
170411290|NCT02884206|615845357|FG002|Double-Blind Period|Death|39|||
170411291|NCT02884206|615845355|FG000|Double-Blind Period|Patient/guardian decision|0|||
170411292|NCT02884206|615845356|FG001|Double-Blind Period|Patient/guardian decision|10|||
170411293|NCT02884206|615845357|FG002|Double-Blind Period|Patient/guardian decision|13|||
170411294|NCT02884206|615845355|FG000|Double-Blind Period|Lost to Follow-up|0|||
170411295|NCT02884206|615845356|FG001|Double-Blind Period|Lost to Follow-up|4|||
170411296|NCT02884206|615845357|FG002|Double-Blind Period|Lost to Follow-up|4|||
170411297|NCT02884206|615845355|FG000|Double-Blind Period|Physician Decision|0|||
170411298|NCT02884206|615845356|FG001|Double-Blind Period|Physician Decision|2|||
170411299|NCT02884206|615845357|FG002|Double-Blind Period|Physician Decision|0|||
170411300|NCT02884206|615845355|FG000|Double-Blind Period|Adverse Event|0|||
170411301|NCT02884206|615845356|FG001|Double-Blind Period|Adverse Event|0|||
170411302|NCT02884206|615845357|FG002|Double-Blind Period|Adverse Event|3|||
170411303|NCT02884206|615845355|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
170411304|NCT02884206|615845356|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
170411305|NCT02884206|615845357|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
170411306|NCT00096265|615845360|FG000|Overall Study|Ineligible|1|||
170411307|NCT00096265|615845361|FG001|Overall Study|Ineligible|0|||
170411308|NCT00096265|615845362|FG002|Overall Study|Ineligible|0|||
170411309|NCT02232074|615845365|FG000|Overall Study|Withdrawal by Subject|5|||
170411310|NCT02232074|615845366|FG001|Overall Study|Withdrawal by Subject|3|||
170411311|NCT02232074|615845365|FG000|Overall Study|No legal concerns at baseline|36|||
170411312|NCT02232074|615845366|FG001|Overall Study|No legal concerns at baseline|41|||
170411313|NCT02232074|615845365|FG000|Overall Study|deemed ineligible|0|||
170411314|NCT02232074|615845366|FG001|Overall Study|deemed ineligible|1|||
170411315|NCT01927757|615845367|FG000|Overall Study|Withdrawal by Subject|14|||
170411316|NCT01927757|615845367|FG000|Overall Study|Lost to Follow-up|2|||
170411317|NCT01927757|615845367|FG000|Overall Study|Decision by Sponsor|2|||
170411318|NCT01927757|615845367|FG000|Overall Study|Other|1|||
170411319|NCT01927757|615845367|FG000|Overall Study|Ethical Reasons|4|||
170411320|NCT00988169|615845369|FG000|Overall Study|Withdrawal by Subject|1|||
170411321|NCT00704418|615845370|FG000|Overall Study|Withdrawal by Subject|2|||
170411322|NCT00704418|615845371|FG001|Overall Study|Withdrawal by Subject|0|||
170411323|NCT00704418|615845370|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
170411324|NCT00704418|615845371|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
170411325|NCT04081337|615845372|FG000|Overall Study|Adverse Event|0|||
170411326|NCT04081337|615845373|FG001|Overall Study|Adverse Event|1|||
170411327|NCT04081337|615845372|FG000|Overall Study|Withdrawal by Subject|2|||
170411328|NCT04081337|615845373|FG001|Overall Study|Withdrawal by Subject|0|||
170411329|NCT04081337|615845372|FG000|Overall Study|Physician Decision|1|||
170411330|NCT04081337|615845373|FG001|Overall Study|Physician Decision|2|||
170411331|NCT04081337|615845372|FG000|Overall Study|Lost to Follow-up|1|||
170411332|NCT04081337|615845373|FG001|Overall Study|Lost to Follow-up|0|||
170765191|NCT03284957|617144914|FG007|Overall Study|Other|0|||
170765192|NCT03284957|617144915|FG008|Overall Study|Other|1|||
170765193|NCT03284957|617144916|FG009|Overall Study|Other|6|||
170765194|NCT03284957|617144917|FG010|Overall Study|Other|0|||
170765195|NCT03284957|617144918|FG011|Overall Study|Other|0|||
170765196|NCT03284957|617144919|FG012|Overall Study|Other|0|||
170765197|NCT03284957|617144920|FG013|Overall Study|Other|0|||
170765198|NCT03284957|617144921|FG014|Overall Study|Other|2|||
170765199|NCT03284957|617144922|FG015|Overall Study|Other|0|||
170765200|NCT02614560|617144923|FG000|Overall Study|Death|6|||
170765201|NCT02614560|617144924|FG001|Overall Study|Death|2|||
170765202|NCT00094809|617144925|FG000|Overall Study|Protocol deviation|2|||
170765203|NCT00094809|617144926|FG001|Overall Study|Protocol deviation|2|||
170765204|NCT00094809|617144925|FG000|Overall Study|Noncompliance|1|||
170765205|NCT00094809|617144926|FG001|Overall Study|Noncompliance|0|||
170411333|NCT06624072|615845374|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
170765206|NCT00094809|617144925|FG000|Overall Study|Adverse Event|3|||
170765207|NCT00094809|617144926|FG001|Overall Study|Adverse Event|1|||
170411334|NCT06624072|615845375|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
170765208|NCT00094809|617144925|FG000|Overall Study|Withdrawal by Subject|8|||
170765209|NCT00094809|617144926|FG001|Overall Study|Withdrawal by Subject|9|||
170411335|NCT06624072|615845376|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
170411336|NCT01579474|615845377|FG000|Overall Study|Adverse Event|1|||
170765210|NCT00094809|617144925|FG000|Overall Study|Disease progression|3|||
170765211|NCT00094809|617144926|FG001|Overall Study|Disease progression|3|||
170868273|NCT01621542|617528319|FG003|Overall Study|Protocol Violation|1|||
170765212|NCT00094809|617144925|FG000|Overall Study|Physician Decision|3|||
170868274|NCT01621542|617528320|FG004|Overall Study|Protocol Violation|0|||
170521721|NCT00126594|616256118|FG001|Overall Study|Ineligible|0|||
170521722|NCT00126594|616256117|FG000|Overall Study|Withdrawal by Subject|0|||
170521723|NCT00126594|616256118|FG001|Overall Study|Withdrawal by Subject|4|||
170521724|NCT00126594|616256117|FG000|Overall Study|Physician Decision|1|||
170521725|NCT00126594|616256118|FG001|Overall Study|Physician Decision|3|||
170521726|NCT00126594|616256117|FG000|Overall Study|Adverse Event|7|||
170521727|NCT00126594|616256118|FG001|Overall Study|Adverse Event|5|||
170521728|NCT00126594|616256117|FG000|Overall Study|Non-compliance|0|||
170521729|NCT00126594|616256118|FG001|Overall Study|Non-compliance|1|||
170521730|NCT00126594|616256117|FG000|Overall Study|Disease Progression|29|||
170521731|NCT00126594|616256118|FG001|Overall Study|Disease Progression|24|||
170521732|NCT04556760|616256121|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
170521733|NCT04556760|616256122|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
170521734|NCT04556760|616256123|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
170521735|NCT04556760|616256124|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
170521736|NCT04556760|616256125|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
170521737|NCT04556760|616256126|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
170521738|NCT04556760|616256121|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
170521739|NCT04556760|616256122|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
170521740|NCT04556760|616256123|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
170521741|NCT04556760|616256124|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
170521742|NCT04556760|616256125|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
170521743|NCT04556760|616256126|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
170521744|NCT02157519|616256127|FG000|Overall Study|Death|3|||
170521745|NCT02157519|616256128|FG001|Overall Study|Death|1|||
170521746|NCT02157519|616256127|FG000|Overall Study|Withdrawal by Subject|7|||
170521747|NCT02157519|616256128|FG001|Overall Study|Withdrawal by Subject|0|||
170521748|NCT02157519|616256127|FG000|Overall Study|Lost to Follow-up|1|||
170765213|NCT00094809|617144926|FG001|Overall Study|Physician Decision|5|||
170765214|NCT00094809|617144925|FG000|Overall Study|Lost to Follow-up|6|||
170765215|NCT00094809|617144926|FG001|Overall Study|Lost to Follow-up|6|||
170765216|NCT00094809|617144925|FG000|Overall Study|Death|19|||
170765217|NCT00094809|617144926|FG001|Overall Study|Death|25|||
170765218|NCT00094809|617144925|FG000|Overall Study|Protocol-specified criteria|1|||
170765219|NCT00094809|617144926|FG001|Overall Study|Protocol-specified criteria|1|||
170765220|NCT00094809|617144925|FG000|Overall Study|Other|2|||
170765221|NCT00094809|617144926|FG001|Overall Study|Other|4|||
170765222|NCT00094809|617144925|FG000|Overall Study|Informed consent signed after treatment|1|||
170765223|NCT00094809|617144926|FG001|Overall Study|Informed consent signed after treatment|0|||
170765224|NCT00094809|617144925|FG000|Overall Study|Study drug not received|2|||
170765225|NCT00094809|617144926|FG001|Overall Study|Study drug not received|8|||
170765226|NCT00094809|617144925|FG000|Overall Study|Other|1|||
170765227|NCT00094809|617144926|FG001|Overall Study|Other|1|||
170765228|NCT01329328|617144927|FG000|Overall Study|Withdrawal by Subject|2|||
170765229|NCT01329328|617144928|FG001|Overall Study|Withdrawal by Subject|4|||
170765230|NCT01329328|617144929|FG002|Overall Study|Withdrawal by Subject|3|||
170765231|NCT01191086|617144945|FG000|Overall Study|Adverse Event|20|||
170765232|NCT01191086|617144945|FG000|Overall Study|Lack of Efficacy|10|||
170765233|NCT01191086|617144945|FG000|Overall Study|Lost to Follow-up|4|||
170765234|NCT01191086|617144945|FG000|Overall Study|Physician Decision|2|||
170765235|NCT01191086|617144945|FG000|Overall Study|Withdrawal by Subject|24|||
170765236|NCT01191086|617144945|FG000|Overall Study|Discontinuation criterion met|1|||
170765237|NCT01191086|617144945|FG000|Overall Study|Other|1|||
170765238|NCT02046616|617144949|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
170765239|NCT02046616|617144949|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
170765240|NCT02046616|617144949|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
170765241|NCT02046616|617144949|FG000|24-Week Treatment Period|Physician Decision|3|||
170765242|NCT02046616|617144949|FG000|24-Week Treatment Period|Other|1|||
170765243|NCT02046616|617144949|FG000|8-Week FU Period|Lost to Follow-up|1|||
170765244|NCT04842604|617144954|FG000|Overall Study|Death|1|||
170765245|NCT04842604|617144955|FG001|Overall Study|Death|0|||
170765246|NCT04842604|617144954|FG000|Overall Study|Other|4|||
170765247|NCT04842604|617144955|FG001|Overall Study|Other|4|||
170765248|NCT04842604|617144954|FG000|Overall Study|Randomized but not treated|1|||
170765249|NCT04842604|617144955|FG001|Overall Study|Randomized but not treated|0|||
170765250|NCT01193153|617144956|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
170521749|NCT02157519|616256128|FG001|Overall Study|Lost to Follow-up|0|||
170521750|NCT01656395|616256129|FG000|Overall Study|Adverse Event|1|||
170521751|NCT01656395|616256130|FG001|Overall Study|Adverse Event|14|||
170521752|NCT01656395|616256131|FG002|Overall Study|Adverse Event|5|||
170765251|NCT01193153|617144957|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
170765252|NCT01193153|617144956|FG000|Open-label Lead in Period|Pregnancy|1|||
170868275|NCT01621542|617528321|FG005|Overall Study|Protocol Violation|0|||
170411337|NCT01579474|615845378|FG001|Overall Study|Adverse Event|13|||
170411338|NCT01579474|615845379|FG002|Overall Study|Adverse Event|2|||
170411339|NCT01579474|615845380|FG003|Overall Study|Adverse Event|0|||
170411340|NCT01579474|615845381|FG004|Overall Study|Adverse Event|0|||
170411341|NCT01579474|615845382|FG005|Overall Study|Adverse Event|1|||
170411342|NCT01579474|615845377|FG000|Overall Study|Lack of Efficacy|1|||
170411343|NCT01579474|615845378|FG001|Overall Study|Lack of Efficacy|0|||
170411344|NCT01579474|615845379|FG002|Overall Study|Lack of Efficacy|0|||
170411345|NCT01579474|615845380|FG003|Overall Study|Lack of Efficacy|0|||
170411346|NCT01579474|615845381|FG004|Overall Study|Lack of Efficacy|1|||
170411347|NCT01579474|615845382|FG005|Overall Study|Lack of Efficacy|0|||
170411348|NCT01579474|615845377|FG000|Overall Study|Withdrawal by Subject|1|||
170411349|NCT01579474|615845378|FG001|Overall Study|Withdrawal by Subject|0|||
170411350|NCT01579474|615845379|FG002|Overall Study|Withdrawal by Subject|0|||
170411351|NCT01579474|615845380|FG003|Overall Study|Withdrawal by Subject|0|||
170411352|NCT01579474|615845381|FG004|Overall Study|Withdrawal by Subject|0|||
170411353|NCT01579474|615845382|FG005|Overall Study|Withdrawal by Subject|0|||
170411354|NCT02458638|615845383|FG000|Overall Study|Death|309|||
170411355|NCT02458638|615845383|FG000|Overall Study|End of Cohort/End of Study|67|||
170411356|NCT02458638|615845383|FG000|Overall Study|Lost to Follow-up|31|||
170411357|NCT02458638|615845383|FG000|Overall Study|Other Reasons|4|||
170411358|NCT02458638|615845383|FG000|Overall Study|Physician Decision|1|||
170411359|NCT02458638|615845383|FG000|Overall Study|Withdrawal by Subject|47|||
170411360|NCT02227849|615845387|FG000|Overall Study|Adverse Event|4|||
170411361|NCT02227849|615845387|FG000|Overall Study|Physician Decision|1|||
170411362|NCT02227849|615845387|FG000|Overall Study|Withdrawal by Subject|3|||
170411363|NCT04029090|615845394|FG000|Overall Study|Protocol Violation|1|||
170411364|NCT04029090|615845395|FG001|Overall Study|Protocol Violation|0|||
170411365|NCT04029090|615845396|FG002|Overall Study|Protocol Violation|0|||
170411366|NCT04029090|615845394|FG000|Overall Study|Withdrawal by Subject|0|||
170411367|NCT04029090|615845395|FG001|Overall Study|Withdrawal by Subject|1|||
170411368|NCT04029090|615845396|FG002|Overall Study|Withdrawal by Subject|0|||
170411369|NCT00506441|615845397|FG000|Period 1; Open-label Period|Adverse Event|21|||
170411370|NCT00506441|615845398|FG001|Period 1; Open-label Period|Adverse Event|0|||
170411371|NCT00506441|615845397|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
170411372|NCT00506441|615845398|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
170411373|NCT00506441|615845397|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
170411374|NCT00506441|615845398|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
170411375|NCT00506441|615845397|FG000|Period 1; Open-label Period|Physician Decision|5|||
170411376|NCT00506441|615845398|FG001|Period 1; Open-label Period|Physician Decision|0|||
170411377|NCT00506441|615845397|FG000|Period 1; Open-label Period|Protocol Violation|9|||
170411378|NCT00506441|615845398|FG001|Period 1; Open-label Period|Protocol Violation|0|||
170411379|NCT00506441|615845397|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
170411380|NCT00506441|615845398|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
170411381|NCT00506441|615845397|FG000|Period 1; Open-label Period|Other Reasons|13|||
170411382|NCT00506441|615845398|FG001|Period 1; Open-label Period|Other Reasons|0|||
170411383|NCT00506441|615845397|FG000|Period 2; Double-blind Period|Adverse Event|0|||
170411384|NCT00506441|615845398|FG001|Period 2; Double-blind Period|Adverse Event|1|||
170411385|NCT00506441|615845397|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
170411386|NCT00506441|615845398|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
170411387|NCT00506441|615845397|FG000|Period 2; Double-blind Period|Physician Decision|1|||
170411388|NCT00506441|615845398|FG001|Period 2; Double-blind Period|Physician Decision|1|||
170411389|NCT00506441|615845397|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
170411390|NCT00506441|615845398|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
170411391|NCT00506441|615845397|FG000|Period 2; Double-blind Period|Other Reason|1|||
170411392|NCT00506441|615845398|FG001|Period 2; Double-blind Period|Other Reason|1|||
170411393|NCT03289208|615845400|FG000|Overall Study|Adverse Event|1|||
170411394|NCT03289208|615845401|FG001|Overall Study|Adverse Event|0|||
170411395|NCT03289208|615845402|FG002|Overall Study|Adverse Event|0|||
170411396|NCT01840605|615845403|FG000|Overall Study|Adverse Event|0|||
170411397|NCT01840605|615845404|FG001|Overall Study|Adverse Event|1|||
170411398|NCT01840605|615845403|FG000|Overall Study|Physician Decision|2|||
170411399|NCT01840605|615845404|FG001|Overall Study|Physician Decision|1|||
170411400|NCT03075527|615845405|FG000|Overall Study|Death|1|||
170411401|NCT03075527|615845405|FG000|Overall Study|Withdrawal by Subject|1|||
170411402|NCT03075527|615845405|FG000|Overall Study|Physician Decision|3|||
170411403|NCT03075527|615845405|FG000|Overall Study|Progression/Relapse|14|||
170411404|NCT00408876|615845411|FG000|Overall Study|Adverse Event|9|||
170411405|NCT00408876|615845412|FG001|Overall Study|Adverse Event|17|||
170411406|NCT00408876|615845413|FG002|Overall Study|Adverse Event|27|||
170411407|NCT00408876|615845414|FG003|Overall Study|Adverse Event|10|||
170411408|NCT00408876|615845411|FG000|Overall Study|Withdrawal by Subject|3|||
170411409|NCT00408876|615845412|FG001|Overall Study|Withdrawal by Subject|6|||
170411410|NCT00408876|615845413|FG002|Overall Study|Withdrawal by Subject|6|||
170868276|NCT01621542|617528316|FG000|Overall Study|study stopped by sponsor|0|||
170765253|NCT01193153|617144957|FG001|Open-label Lead in Period|Pregnancy|0|||
170765254|NCT01193153|617144956|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
170765255|NCT01193153|617144957|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
170765256|NCT01193153|617144956|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
170765257|NCT01193153|617144957|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
170765258|NCT01193153|617144956|FG000|Open-label Lead in Period|Other|14|||
170765259|NCT01193153|617144957|FG001|Open-label Lead in Period|Other|0|||
170765260|NCT01193153|617144956|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
170765261|NCT01193153|617144957|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
170765262|NCT01193153|617144956|FG000|Open-label Lead in Period|Adverse Event|41|||
170765263|NCT01193153|617144957|FG001|Open-label Lead in Period|Adverse Event|0|||
170765264|NCT01193153|617144956|FG000|Open-label Lead in Period|Death|1|||
170765265|NCT01193153|617144957|FG001|Open-label Lead in Period|Death|0|||
170765266|NCT01193153|617144956|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
170765267|NCT01193153|617144957|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
170765268|NCT01193153|617144956|FG000|Open-label Stabilization Period|Adverse Event|9|||
170765269|NCT01193153|617144957|FG001|Open-label Stabilization Period|Adverse Event|0|||
170765270|NCT01193153|617144956|FG000|Open-label Stabilization Period|Death|2|||
170765271|NCT01193153|617144957|FG001|Open-label Stabilization Period|Death|0|||
170765272|NCT01193153|617144956|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
170765273|NCT01193153|617144957|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
170765274|NCT01193153|617144956|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
170765275|NCT01193153|617144957|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
170765276|NCT01193153|617144956|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
170765277|NCT01193153|617144957|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
170765278|NCT01193153|617144956|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
170765279|NCT01193153|617144957|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
170765280|NCT01193153|617144956|FG000|Open-label Stabilization Period|Other|8|||
170765281|NCT01193153|617144957|FG001|Open-label Stabilization Period|Other|0|||
170765282|NCT01193153|617144956|FG000|Double Blind Relapse Prevention Period|Other|2|||
170765283|NCT01193153|617144957|FG001|Double Blind Relapse Prevention Period|Other|3|||
170765284|NCT01193153|617144956|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
170765285|NCT01193153|617144957|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
170765286|NCT01193153|617144956|FG000|Double Blind Relapse Prevention Period|Death|2|||
170765287|NCT01193153|617144957|FG001|Double Blind Relapse Prevention Period|Death|0|||
170765288|NCT01193153|617144956|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
170765289|NCT01193153|617144957|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
170765290|NCT01193153|617144956|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
170765291|NCT01193153|617144957|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
170765292|NCT01193153|617144956|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
170765293|NCT01193153|617144957|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
170765294|NCT01193153|617144956|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
170765295|NCT01193153|617144957|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
170765296|NCT01193153|617144956|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
170765297|NCT01193153|617144957|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
170765298|NCT01563354|617144958|FG000|Core Phase|Adverse Event|5|||
170765299|NCT01563354|617144959|FG001|Core Phase|Adverse Event|15|||
170765300|NCT01563354|617144960|FG002|Core Phase|Adverse Event|13|||
170765301|NCT01563354|617144958|FG000|Core Phase|Withdrawal by Subject|1|||
170765302|NCT01563354|617144959|FG001|Core Phase|Withdrawal by Subject|0|||
170765303|NCT01563354|617144960|FG002|Core Phase|Withdrawal by Subject|3|||
170765304|NCT01563354|617144958|FG000|Core Phase|Lost to Follow-up|1|||
170765305|NCT01563354|617144959|FG001|Core Phase|Lost to Follow-up|0|||
170765306|NCT01563354|617144960|FG002|Core Phase|Lost to Follow-up|0|||
170765307|NCT01563354|617144958|FG000|Core Phase|Death|1|||
170765308|NCT01563354|617144959|FG001|Core Phase|Death|5|||
170765309|NCT01563354|617144960|FG002|Core Phase|Death|2|||
170765310|NCT01563354|617144958|FG000|Core Phase|Diseasse progression|18|||
170765311|NCT01563354|617144959|FG001|Core Phase|Diseasse progression|7|||
170765312|NCT01563354|617144960|FG002|Core Phase|Diseasse progression|8|||
170765313|NCT01563354|617144958|FG000|Core Phase|Protocol deviation|2|||
170765314|NCT01563354|617144959|FG001|Core Phase|Protocol deviation|0|||
170765315|NCT01563354|617144960|FG002|Core Phase|Protocol deviation|0|||
170765316|NCT01563354|617144958|FG000|Core Phase|PI decision - did not enter extension|0|||
170765317|NCT01563354|617144959|FG001|Core Phase|PI decision - did not enter extension|1|||
170411411|NCT00408876|615845414|FG003|Overall Study|Withdrawal by Subject|14|||
170411412|NCT00408876|615845411|FG000|Overall Study|Lack of Efficacy|2|||
170411413|NCT00408876|615845412|FG001|Overall Study|Lack of Efficacy|4|||
170411414|NCT00408876|615845413|FG002|Overall Study|Lack of Efficacy|5|||
170411415|NCT00408876|615845414|FG003|Overall Study|Lack of Efficacy|6|||
170411416|NCT00408876|615845411|FG000|Overall Study|Lost to Follow-up|1|||
170411417|NCT00408876|615845412|FG001|Overall Study|Lost to Follow-up|6|||
170411418|NCT00408876|615845413|FG002|Overall Study|Lost to Follow-up|5|||
170765318|NCT01563354|617144960|FG002|Core Phase|PI decision - did not enter extension|0|||
170765319|NCT01563354|617144958|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
170765320|NCT01563354|617144959|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
170765321|NCT01563354|617144960|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
170411419|NCT00408876|615845414|FG003|Overall Study|Lost to Follow-up|2|||
170411420|NCT00408876|615845411|FG000|Overall Study|Protocol Violation|0|||
170411421|NCT00408876|615845412|FG001|Overall Study|Protocol Violation|3|||
170411422|NCT00408876|615845413|FG002|Overall Study|Protocol Violation|4|||
170411423|NCT00408876|615845414|FG003|Overall Study|Protocol Violation|3|||
170411424|NCT00408876|615845411|FG000|Overall Study|Physician Decision|1|||
170411425|NCT00408876|615845412|FG001|Overall Study|Physician Decision|0|||
170411426|NCT00408876|615845413|FG002|Overall Study|Physician Decision|3|||
170411427|NCT00408876|615845414|FG003|Overall Study|Physician Decision|0|||
170411428|NCT02629965|615845420|FG000|Period 1|Adverse Event|1|||
170411429|NCT02629965|615845421|FG001|Period 1|Adverse Event|0|||
170411430|NCT02629965|615845420|FG000|Period 1|Unexpected worsening of disease|2|||
170411431|NCT02629965|615845421|FG001|Period 1|Unexpected worsening of disease|0|||
170411432|NCT02629965|615845420|FG000|Period 1|Other than listed above|1|||
170411433|NCT02629965|615845421|FG001|Period 1|Other than listed above|2|||
170411434|NCT02629965|615845420|FG000|Period 2|Adverse Event|1|||
170411435|NCT02629965|615845421|FG001|Period 2|Adverse Event|0|||
170411436|NCT02330081|615845422|FG000|Overall Study|Adverse Event|1|||
170411437|NCT02330081|615845422|FG000|Overall Study|Donation did not meet criteria|1|||
170411438|NCT02330081|615845422|FG000|Overall Study|Protocol Violation|6|||
170411439|NCT00895583|615845426|FG000|Overall Study|Adverse Event|28|||
170411440|NCT00895583|615845427|FG001|Overall Study|Adverse Event|4|||
170411441|NCT00895583|615845426|FG000|Overall Study|Death|2|||
170411442|NCT00895583|615845427|FG001|Overall Study|Death|1|||
170411443|NCT00895583|615845426|FG000|Overall Study|Physician Decision|3|||
170411444|NCT00895583|615845427|FG001|Overall Study|Physician Decision|1|||
170411445|NCT00895583|615845426|FG000|Overall Study|Lost to Follow-up|1|||
170411446|NCT00895583|615845427|FG001|Overall Study|Lost to Follow-up|3|||
170411447|NCT00895583|615845426|FG000|Overall Study|Protocol Violation|1|||
170411448|NCT00895583|615845427|FG001|Overall Study|Protocol Violation|0|||
170411449|NCT00895583|615845426|FG000|Overall Study|Withdrawal by Subject|4|||
170411450|NCT00895583|615845427|FG001|Overall Study|Withdrawal by Subject|2|||
170411451|NCT00895583|615845426|FG000|Overall Study|Lack of Efficacy|5|||
170411452|NCT00895583|615845427|FG001|Overall Study|Lack of Efficacy|0|||
170411453|NCT00895583|615845426|FG000|Overall Study|Other|0|||
170411454|NCT00895583|615845427|FG001|Overall Study|Other|1|||
170411455|NCT01606137|615845430|FG000|Overall Study|Adverse Event|85|||
170411456|NCT01606137|615845430|FG000|Overall Study|Withdrawal by Subject|74|||
170411457|NCT01606137|615845430|FG000|Overall Study|Lack of Efficacy|56|||
170411458|NCT01606137|615845430|FG000|Overall Study|Lost to Follow-up|15|||
170411459|NCT01606137|615845430|FG000|Overall Study|Protocol Violation|1|||
170411460|NCT01606137|615845430|FG000|Overall Study|Patient non-compliance|9|||
170411461|NCT01606137|615845430|FG000|Overall Study|Death|1|||
170411462|NCT01606137|615845430|FG000|Overall Study|Decreased/no pain|4|||
170411463|NCT01606137|615845430|FG000|Overall Study|Issues with driving|4|||
170411464|NCT01606137|615845430|FG000|Overall Study|multiple sclerosis less stable|1|||
170411465|NCT01606137|615845430|FG000|Overall Study|Increased bilirubin|1|||
170411466|NCT01606137|615845430|FG000|Overall Study|Spray causes nausea|1|||
170411467|NCT01606137|615845430|FG000|Overall Study|Not enough improvement|4|||
170411468|NCT01606137|615845430|FG000|Overall Study|Wanted to try another treatment|1|||
170411469|NCT01606137|615845430|FG000|Overall Study|Patient leaving country|1|||
170411470|NCT01606137|615845430|FG000|Overall Study|Personal reasons|1|||
170411471|NCT01606137|615845430|FG000|Overall Study|Unable to tolerate study med. taste|1|||
170411472|NCT01606137|615845430|FG000|Overall Study|Patient moving|1|||
170411473|NCT01606137|615845430|FG000|Overall Study|Unable to collect consistent data|1|||
170411474|NCT01098240|615845432|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
170411475|NCT01098240|615845433|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
170411476|NCT01098240|615845434|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
170411477|NCT01098240|615845432|FG000|Open-Label Phase|Protocol Violation|4|||
170411478|NCT01098240|615845433|FG001|Open-Label Phase|Protocol Violation|0|||
170411479|NCT01098240|615845434|FG002|Open-Label Phase|Protocol Violation|0|||
170411480|NCT01098240|615845432|FG000|Open-Label Phase|Lost to Follow-up|13|||
170411481|NCT01098240|615845433|FG001|Open-Label Phase|Lost to Follow-up|0|||
170411482|NCT01098240|615845434|FG002|Open-Label Phase|Lost to Follow-up|0|||
170411483|NCT01098240|615845432|FG000|Open-Label Phase|Other|19|||
170411484|NCT01098240|615845433|FG001|Open-Label Phase|Other|0|||
170411485|NCT01098240|615845434|FG002|Open-Label Phase|Other|0|||
170411486|NCT01098240|615845432|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
170765322|NCT01563354|617144958|FG000|Extension Phase|Adverse Event|0|||
170765323|NCT01563354|617144959|FG001|Extension Phase|Adverse Event|3|||
170765324|NCT01563354|617144960|FG002|Extension Phase|Adverse Event|2|||
170411487|NCT01098240|615845433|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
170411488|NCT01098240|615845434|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
170411489|NCT01098240|615845432|FG000|Open-Label Phase|Pregnancy|1|||
170521753|NCT01656395|616256132|FG003|Overall Study|Adverse Event|4|||
170521754|NCT01656395|616256133|FG004|Overall Study|Adverse Event|5|||
170521755|NCT01656395|616256134|FG005|Overall Study|Adverse Event|7|||
170521756|NCT01656395|616256135|FG006|Overall Study|Adverse Event|0|||
170521757|NCT01656395|616256136|FG007|Overall Study|Adverse Event|0|||
170521758|NCT01656395|616256129|FG000|Overall Study|Lack of Efficacy|1|||
170521759|NCT01656395|616256130|FG001|Overall Study|Lack of Efficacy|8|||
170521760|NCT01656395|616256131|FG002|Overall Study|Lack of Efficacy|6|||
170521761|NCT01656395|616256132|FG003|Overall Study|Lack of Efficacy|1|||
170521762|NCT01656395|616256133|FG004|Overall Study|Lack of Efficacy|1|||
170521763|NCT01656395|616256134|FG005|Overall Study|Lack of Efficacy|6|||
170521764|NCT01656395|616256135|FG006|Overall Study|Lack of Efficacy|0|||
170521765|NCT01656395|616256136|FG007|Overall Study|Lack of Efficacy|0|||
170521766|NCT01656395|616256129|FG000|Overall Study|Lost to Follow-up|1|||
170521767|NCT01656395|616256130|FG001|Overall Study|Lost to Follow-up|0|||
170521768|NCT01656395|616256131|FG002|Overall Study|Lost to Follow-up|0|||
170521769|NCT01656395|616256132|FG003|Overall Study|Lost to Follow-up|0|||
170521770|NCT01656395|616256133|FG004|Overall Study|Lost to Follow-up|0|||
170521771|NCT01656395|616256134|FG005|Overall Study|Lost to Follow-up|0|||
170521772|NCT01656395|616256135|FG006|Overall Study|Lost to Follow-up|0|||
170521773|NCT01656395|616256136|FG007|Overall Study|Lost to Follow-up|0|||
170521774|NCT01656395|616256129|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170521775|NCT01656395|616256130|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170521776|NCT01656395|616256131|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170521777|NCT01656395|616256132|FG003|Overall Study|Non-Compliance with Study Drug|0|||
170521778|NCT01656395|616256133|FG004|Overall Study|Non-Compliance with Study Drug|1|||
170521779|NCT01656395|616256134|FG005|Overall Study|Non-Compliance with Study Drug|1|||
170521780|NCT01656395|616256135|FG006|Overall Study|Non-Compliance with Study Drug|0|||
170521781|NCT01656395|616256136|FG007|Overall Study|Non-Compliance with Study Drug|0|||
170521782|NCT01656395|616256129|FG000|Overall Study|Other|0|||
170521783|NCT01656395|616256130|FG001|Overall Study|Other|0|||
170521784|NCT01656395|616256131|FG002|Overall Study|Other|1|||
170521785|NCT01656395|616256132|FG003|Overall Study|Other|0|||
170521786|NCT01656395|616256133|FG004|Overall Study|Other|0|||
170521787|NCT01656395|616256134|FG005|Overall Study|Other|1|||
170521788|NCT01656395|616256135|FG006|Overall Study|Other|0|||
170521789|NCT01656395|616256136|FG007|Overall Study|Other|0|||
170521790|NCT01656395|616256129|FG000|Overall Study|Physician Decision|2|||
170521791|NCT01656395|616256130|FG001|Overall Study|Physician Decision|3|||
170521792|NCT01656395|616256131|FG002|Overall Study|Physician Decision|3|||
170521793|NCT01656395|616256132|FG003|Overall Study|Physician Decision|2|||
170765325|NCT01563354|617144958|FG000|Extension Phase|Withdrawal by Subject|0|||
170765326|NCT01563354|617144959|FG001|Extension Phase|Withdrawal by Subject|1|||
170765327|NCT01563354|617144960|FG002|Extension Phase|Withdrawal by Subject|0|||
170765328|NCT01563354|617144958|FG000|Extension Phase|Administration problems|3|||
170765329|NCT01563354|617144959|FG001|Extension Phase|Administration problems|2|||
170765330|NCT01563354|617144960|FG002|Extension Phase|Administration problems|3|||
170765331|NCT01563354|617144958|FG000|Extension Phase|Disease progression|9|||
170765332|NCT01563354|617144959|FG001|Extension Phase|Disease progression|8|||
170765333|NCT01563354|617144960|FG002|Extension Phase|Disease progression|10|||
170765334|NCT01972152|617144963|FG000|First Treatment Visit|Lost to Follow-up|0|||
170765335|NCT01972152|617144964|FG001|First Treatment Visit|Lost to Follow-up|1|||
170765336|NCT01972152|617144965|FG002|First Treatment Visit|Lost to Follow-up|0|||
170765337|NCT01972152|617144966|FG003|First Treatment Visit|Lost to Follow-up|0|||
170765338|NCT01972152|617144967|FG004|First Treatment Visit|Lost to Follow-up|0|||
170765339|NCT01972152|617144968|FG005|First Treatment Visit|Lost to Follow-up|0|||
170765340|NCT01972152|617144963|FG000|Second Treatment Visit|Protocol Violation|0|||
170765341|NCT01972152|617144964|FG001|Second Treatment Visit|Protocol Violation|1|||
170765342|NCT01972152|617144965|FG002|Second Treatment Visit|Protocol Violation|0|||
170765343|NCT01972152|617144966|FG003|Second Treatment Visit|Protocol Violation|0|||
170765344|NCT01972152|617144967|FG004|Second Treatment Visit|Protocol Violation|0|||
170765345|NCT01972152|617144968|FG005|Second Treatment Visit|Protocol Violation|0|||
170765346|NCT04379713|617144977|FG000|Overall Study|Adverse Event|2|||
170765347|NCT04379713|617144978|FG001|Overall Study|Adverse Event|0|||
170765348|NCT04379713|617144977|FG000|Overall Study|Physician Decision|2|||
170765349|NCT04379713|617144978|FG001|Overall Study|Physician Decision|1|||
170765350|NCT04379713|617144977|FG000|Overall Study|Protocol Violation|11|||
170765351|NCT04379713|617144978|FG001|Overall Study|Protocol Violation|6|||
170765352|NCT04379713|617144977|FG000|Overall Study|No longer met eligibility criteria|14|||
170765353|NCT04379713|617144978|FG001|Overall Study|No longer met eligibility criteria|11|||
170521794|NCT01656395|616256133|FG004|Overall Study|Physician Decision|3|||
170765354|NCT04379713|617144977|FG000|Overall Study|Withdrawal by parent/guardian|36|||
170521795|NCT01656395|616256134|FG005|Overall Study|Physician Decision|3|||
170521796|NCT01656395|616256135|FG006|Overall Study|Physician Decision|0|||
170521797|NCT01656395|616256136|FG007|Overall Study|Physician Decision|0|||
170521798|NCT01656395|616256129|FG000|Overall Study|Pregnancy|0|||
170521799|NCT01656395|616256130|FG001|Overall Study|Pregnancy|0|||
170521800|NCT01656395|616256131|FG002|Overall Study|Pregnancy|1|||
170765355|NCT04379713|617144978|FG001|Overall Study|Withdrawal by parent/guardian|15|||
170765356|NCT04379713|617144977|FG000|Overall Study|Lost to Follow-up|31|||
170765357|NCT04379713|617144978|FG001|Overall Study|Lost to Follow-up|21|||
170765358|NCT02148133|617144979|FG000|Overall Study|Investigator discretion|1|||
170765359|NCT02148133|617144979|FG000|Overall Study|Lack of Efficacy|1|||
170765360|NCT02148133|617144979|FG000|Overall Study|Protocol deviation|1|||
170765361|NCT02148133|617144979|FG000|Overall Study|Protocol-defined stopping criteria|2|||
170868277|NCT01621542|617528317|FG001|Overall Study|study stopped by sponsor|0|||
170868278|NCT01621542|617528318|FG002|Overall Study|study stopped by sponsor|0|||
170868279|NCT01621542|617528319|FG003|Overall Study|study stopped by sponsor|1|||
170868280|NCT01621542|617528320|FG004|Overall Study|study stopped by sponsor|0|||
170521801|NCT01656395|616256132|FG003|Overall Study|Pregnancy|0|||
170521802|NCT01656395|616256133|FG004|Overall Study|Pregnancy|0|||
170521803|NCT01656395|616256134|FG005|Overall Study|Pregnancy|0|||
170521804|NCT01656395|616256135|FG006|Overall Study|Pregnancy|0|||
170521805|NCT01656395|616256136|FG007|Overall Study|Pregnancy|0|||
170521806|NCT01656395|616256129|FG000|Overall Study|Progressive Disease|0|||
170521807|NCT01656395|616256130|FG001|Overall Study|Progressive Disease|0|||
170521808|NCT01656395|616256131|FG002|Overall Study|Progressive Disease|0|||
170521809|NCT01656395|616256132|FG003|Overall Study|Progressive Disease|0|||
170521810|NCT01656395|616256133|FG004|Overall Study|Progressive Disease|0|||
170521811|NCT01656395|616256134|FG005|Overall Study|Progressive Disease|1|||
170521812|NCT01656395|616256135|FG006|Overall Study|Progressive Disease|0|||
170521813|NCT01656395|616256136|FG007|Overall Study|Progressive Disease|0|||
170521814|NCT01656395|616256129|FG000|Overall Study|Protocol Violation|6|||
170521815|NCT01656395|616256130|FG001|Overall Study|Protocol Violation|6|||
170521816|NCT01656395|616256131|FG002|Overall Study|Protocol Violation|9|||
170521817|NCT01656395|616256132|FG003|Overall Study|Protocol Violation|2|||
170521818|NCT01656395|616256133|FG004|Overall Study|Protocol Violation|4|||
170521819|NCT01656395|616256134|FG005|Overall Study|Protocol Violation|10|||
170521820|NCT01656395|616256135|FG006|Overall Study|Protocol Violation|0|||
170521821|NCT01656395|616256136|FG007|Overall Study|Protocol Violation|0|||
170521822|NCT01656395|616256129|FG000|Overall Study|Screen Failure|2|||
170521823|NCT01656395|616256130|FG001|Overall Study|Screen Failure|1|||
170521824|NCT01656395|616256131|FG002|Overall Study|Screen Failure|7|||
170521825|NCT01656395|616256132|FG003|Overall Study|Screen Failure|1|||
170521826|NCT01656395|616256133|FG004|Overall Study|Screen Failure|0|||
170521827|NCT01656395|616256134|FG005|Overall Study|Screen Failure|8|||
170521828|NCT01656395|616256135|FG006|Overall Study|Screen Failure|0|||
170521829|NCT01656395|616256136|FG007|Overall Study|Screen Failure|0|||
170521830|NCT01656395|616256129|FG000|Overall Study|Withdrawal by Subject|3|||
170521831|NCT01656395|616256130|FG001|Overall Study|Withdrawal by Subject|1|||
170521832|NCT01656395|616256131|FG002|Overall Study|Withdrawal by Subject|4|||
170521833|NCT01656395|616256132|FG003|Overall Study|Withdrawal by Subject|2|||
170521834|NCT01656395|616256133|FG004|Overall Study|Withdrawal by Subject|0|||
170521835|NCT01656395|616256134|FG005|Overall Study|Withdrawal by Subject|3|||
170521836|NCT01656395|616256135|FG006|Overall Study|Withdrawal by Subject|0|||
170521837|NCT01656395|616256136|FG007|Overall Study|Withdrawal by Subject|0|||
170521838|NCT02168491|616256141|FG000|Overall Study|Withdrawal by Subject|1|||
170521839|NCT00676403|616256142|FG000|Overall Study|Adverse Event|1|||
170521840|NCT00676403|616256143|FG001|Overall Study|Adverse Event|2|||
170521841|NCT00676403|616256144|FG002|Overall Study|Adverse Event|0|||
170521842|NCT00676403|616256145|FG003|Overall Study|Adverse Event|5|||
170765362|NCT00158054|617144980|FG000|Overall Study|Refused to continue|3|||
170765363|NCT00158054|617144981|FG001|Overall Study|Refused to continue|0|||
170765364|NCT00158054|617144980|FG000|Overall Study|Unavailable for follow up|7|||
170765365|NCT00158054|617144981|FG001|Overall Study|Unavailable for follow up|3|||
170765366|NCT00414648|617144982|FG000|Overall Study|Adverse Event|5|||
170765367|NCT00414648|617144983|FG001|Overall Study|Adverse Event|5|||
170765368|NCT00414648|617144982|FG000|Overall Study|Death|0|||
170765369|NCT00414648|617144983|FG001|Overall Study|Death|1|||
170765370|NCT00414648|617144982|FG000|Overall Study|Lack of Efficacy|0|||
170765371|NCT00414648|617144983|FG001|Overall Study|Lack of Efficacy|2|||
170765372|NCT00414648|617144982|FG000|Overall Study|Withdrawal by Subject|0|||
170765373|NCT00414648|617144983|FG001|Overall Study|Withdrawal by Subject|1|||
170868281|NCT01621542|617528321|FG005|Overall Study|study stopped by sponsor|0|||
170868282|NCT01368042|617528323|FG000|Overall Study|Death|14|||
170521843|NCT00676403|616256146|FG004|Overall Study|Adverse Event|1|||
170521844|NCT00676403|616256147|FG005|Overall Study|Adverse Event|2|||
170765374|NCT00754936|617144984|FG000|Overall Study|Lost to Follow-up|3|||
170521845|NCT00676403|616256142|FG000|Overall Study|Lost to Follow-up|0|||
170521846|NCT00676403|616256143|FG001|Overall Study|Lost to Follow-up|0|||
170521847|NCT00676403|616256144|FG002|Overall Study|Lost to Follow-up|0|||
170521848|NCT00676403|616256145|FG003|Overall Study|Lost to Follow-up|0|||
170521849|NCT00676403|616256146|FG004|Overall Study|Lost to Follow-up|0|||
170765375|NCT00754936|617144984|FG000|Overall Study|Physician Decision|1|||
170521850|NCT00676403|616256147|FG005|Overall Study|Lost to Follow-up|1|||
170521851|NCT00676403|616256142|FG000|Overall Study|Reason Unspecified|1|||
170521852|NCT00676403|616256143|FG001|Overall Study|Reason Unspecified|0|||
170521853|NCT00676403|616256144|FG002|Overall Study|Reason Unspecified|1|||
170765376|NCT00754936|617144984|FG000|Overall Study|Withdrawal by Subject|2|||
170765377|NCT00754936|617144984|FG000|Overall Study|Side Effects|3|||
170765378|NCT00754936|617144984|FG000|Overall Study|Inter-current medical events|3|||
170765379|NCT00972504|617144989|FG000|Overall Study|Adverse Event|2|||
170765380|NCT00972504|617144989|FG000|Overall Study|Investigator discretion|1|||
170765381|NCT00880048|617144990|FG000|Overall Study|Adverse Event|2|||
170765382|NCT00880048|617144991|FG001|Overall Study|Adverse Event|3|||
170765383|NCT00880048|617144992|FG002|Overall Study|Adverse Event|5|||
170765384|NCT00880048|617144990|FG000|Overall Study|Lack of Efficacy|1|||
170765385|NCT00880048|617144991|FG001|Overall Study|Lack of Efficacy|2|||
170765386|NCT00880048|617144992|FG002|Overall Study|Lack of Efficacy|2|||
170765387|NCT00880048|617144990|FG000|Overall Study|Protocol Violation|4|||
170765388|NCT00880048|617144991|FG001|Overall Study|Protocol Violation|6|||
170765389|NCT00880048|617144992|FG002|Overall Study|Protocol Violation|5|||
170765390|NCT00880048|617144990|FG000|Overall Study|Lost to Follow-up|6|||
170765391|NCT00880048|617144991|FG001|Overall Study|Lost to Follow-up|6|||
170765392|NCT00880048|617144992|FG002|Overall Study|Lost to Follow-up|5|||
170765393|NCT00880048|617144990|FG000|Overall Study|Physician Decision|1|||
170765394|NCT00880048|617144991|FG001|Overall Study|Physician Decision|1|||
170765395|NCT00880048|617144992|FG002|Overall Study|Physician Decision|7|||
170765396|NCT00880048|617144990|FG000|Overall Study|Withdrawal by Subject|5|||
170765397|NCT00880048|617144991|FG001|Overall Study|Withdrawal by Subject|8|||
170765398|NCT00880048|617144992|FG002|Overall Study|Withdrawal by Subject|5|||
170765399|NCT00880048|617144990|FG000|Overall Study|Study closed/terminated|9|||
170765400|NCT00880048|617144991|FG001|Overall Study|Study closed/terminated|7|||
170765401|NCT00880048|617144992|FG002|Overall Study|Study closed/terminated|6|||
170765402|NCT01104415|617144993|FG000|Core Phase|Consent withdrawn by subjects|1|||
170765403|NCT01104415|617144994|FG001|Core Phase|Consent withdrawn by subjects|0|||
170765404|NCT01104415|617144993|FG000|Extension Period|Progressive disease|0|||
170765405|NCT01104415|617144994|FG001|Extension Period|Progressive disease|4|||
170765406|NCT01104415|617144993|FG000|Extension Period|Death|0|||
170765407|NCT01104415|617144994|FG001|Extension Period|Death|1|||
170765408|NCT01104415|617144993|FG000|Extension Period|Physician Decision|0|||
170765409|NCT01104415|617144994|FG001|Extension Period|Physician Decision|1|||
170765410|NCT01104415|617144993|FG000|Extension Period|Transition to Study LX1606.302|0|||
170765411|NCT01104415|617144994|FG001|Extension Period|Transition to Study LX1606.302|4|||
170765412|NCT01104415|617144993|FG000|Extension Period|Heart surgery/feeling miserable|0|||
170765413|NCT01104415|617144994|FG001|Extension Period|Heart surgery/feeling miserable|1|||
170765414|NCT00597519|617144997|FG000|Overall Study|Death|1|||
170765415|NCT03098030|617144998|FG000|Overall Study|Death|10|||
170765416|NCT03098030|617144999|FG001|Overall Study|Death|156|||
170765417|NCT03098030|617145000|FG002|Overall Study|Death|156|||
170765418|NCT03098030|617145001|FG003|Overall Study|Death|82|||
170765419|NCT03098030|617144998|FG000|Overall Study|Withdrawal by Subject|0|||
170765420|NCT03098030|617144999|FG001|Overall Study|Withdrawal by Subject|7|||
170765421|NCT03098030|617145000|FG002|Overall Study|Withdrawal by Subject|8|||
170765422|NCT03098030|617145001|FG003|Overall Study|Withdrawal by Subject|2|||
170765423|NCT03098030|617144998|FG000|Overall Study|Lost to Follow-up|0|||
170765424|NCT03098030|617144999|FG001|Overall Study|Lost to Follow-up|0|||
170765425|NCT03098030|617145000|FG002|Overall Study|Lost to Follow-up|2|||
170765426|NCT03098030|617145001|FG003|Overall Study|Lost to Follow-up|1|||
170765427|NCT03368001|617145008|FG000|Allocation|Lost to Pretest|16|||
170765428|NCT03368001|617145009|FG001|Allocation|Lost to Pretest|25|||
170765429|NCT03368001|617145008|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
170765430|NCT03368001|617145009|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
170765431|NCT03368001|617145008|FG000|Posttest|Lost to Posttest|7|||
170765432|NCT03368001|617145009|FG001|Posttest|Lost to Posttest|11|||
170765433|NCT03368001|617145008|FG000|Posttest|Discontinued Intervention|6|||
170765434|NCT03368001|617145009|FG001|Posttest|Discontinued Intervention|19|||
170765435|NCT03368001|617145008|FG000|Follow-up|Lost to Follow-up|6|||
170765436|NCT03368001|617145009|FG001|Follow-up|Lost to Follow-up|3|||
170765437|NCT03612804|617145010|FG000|Overall Study|Death|0|||
170765438|NCT03612804|617145011|FG001|Overall Study|Death|7|||
170765439|NCT03612804|617145012|FG002|Overall Study|Death|0|||
170765440|NCT03612804|617145013|FG003|Overall Study|Death|8|||
170765441|NCT03612804|617145010|FG000|Overall Study|Medication copay coverage issues|0|||
170765442|NCT03612804|617145011|FG001|Overall Study|Medication copay coverage issues|0|||
170765443|NCT03612804|617145012|FG002|Overall Study|Medication copay coverage issues|0|||
170765444|NCT03612804|617145013|FG003|Overall Study|Medication copay coverage issues|17|||
170765445|NCT03612804|617145010|FG000|Overall Study|Not current smoker at time of screening|0|||
170765446|NCT03612804|617145011|FG001|Overall Study|Not current smoker at time of screening|1|||
170411490|NCT01098240|615845433|FG001|Open-Label Phase|Pregnancy|0|||
170765447|NCT03612804|617145012|FG002|Overall Study|Not current smoker at time of screening|0|||
170765448|NCT03612804|617145013|FG003|Overall Study|Not current smoker at time of screening|3|||
170765449|NCT03612804|617145010|FG000|Overall Study|Non-veteran status|0|||
170765450|NCT03612804|617145011|FG001|Overall Study|Non-veteran status|1|||
170765451|NCT03612804|617145012|FG002|Overall Study|Non-veteran status|0|||
170411491|NCT01098240|615845434|FG002|Open-Label Phase|Pregnancy|0|||
170411492|NCT01098240|615845432|FG000|Open-Label Phase|Withdrawal by Subject|9|||
170411493|NCT01098240|615845433|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170411494|NCT01098240|615845434|FG002|Open-Label Phase|Withdrawal by Subject|0|||
170411495|NCT01098240|615845432|FG000|Open-Label Phase|Adverse Event|12|||
170411496|NCT01098240|615845433|FG001|Open-Label Phase|Adverse Event|0|||
170411497|NCT01098240|615845434|FG002|Open-Label Phase|Adverse Event|0|||
170411498|NCT01098240|615845432|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
170411499|NCT01098240|615845433|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
170411500|NCT01098240|615845434|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
170411501|NCT01098240|615845432|FG000|Double-Blind Phase|Protocol Violation|0|||
170411502|NCT01098240|615845433|FG001|Double-Blind Phase|Protocol Violation|2|||
170411503|NCT01098240|615845434|FG002|Double-Blind Phase|Protocol Violation|4|||
170411504|NCT01098240|615845432|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170411505|NCT01098240|615845433|FG001|Double-Blind Phase|Lost to Follow-up|2|||
170411506|NCT01098240|615845434|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170411507|NCT01098240|615845432|FG000|Double-Blind Phase|Other|0|||
170411508|NCT01098240|615845433|FG001|Double-Blind Phase|Other|2|||
170411509|NCT01098240|615845434|FG002|Double-Blind Phase|Other|2|||
170411510|NCT01098240|615845432|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
170411511|NCT01098240|615845433|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
170411512|NCT01098240|615845434|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
170411513|NCT01098240|615845432|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
170411514|NCT01098240|615845433|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
170411515|NCT01098240|615845434|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
170411516|NCT01098240|615845432|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
170411517|NCT01098240|615845433|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
170411518|NCT01098240|615845434|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
170411519|NCT01098240|615845432|FG000|Double-Blind Phase|Adverse Event|0|||
170411520|NCT01098240|615845433|FG001|Double-Blind Phase|Adverse Event|3|||
170411521|NCT01098240|615845434|FG002|Double-Blind Phase|Adverse Event|3|||
170411522|NCT01070394|615845435|FG000|Overall Study|Adverse Event|6|||
170411523|NCT01070394|615845435|FG000|Overall Study|Withdrawal by Subject|1|||
170411524|NCT00066807|615845444|FG000|Overall Study|Study was terminated early|14|||
170411525|NCT00066807|615845445|FG001|Overall Study|Study was terminated early|15|||
170411526|NCT03346538|615847125|FG000|Overall Study|Physician Decision|0|||
170411527|NCT03346538|615847126|FG001|Overall Study|Physician Decision|1|||
170411528|NCT03346538|615847127|FG002|Overall Study|Physician Decision|0|||
170411529|NCT03346538|615847125|FG000|Overall Study|Withdrawal by Subject|3|||
170411530|NCT03346538|615847126|FG001|Overall Study|Withdrawal by Subject|2|||
170411531|NCT03346538|615847127|FG002|Overall Study|Withdrawal by Subject|0|||
170411532|NCT03346538|615847125|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
170411533|NCT03346538|615847126|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
170411534|NCT03346538|615847127|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
170411535|NCT01132118|615847128|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
170411536|NCT01132118|615847129|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
170411537|NCT01132118|615847128|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
170411538|NCT01132118|615847129|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
170411539|NCT01132118|615847128|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
170411540|NCT01132118|615847129|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
170411541|NCT01644890|615847130|FG000|Overall Study|Adverse Event|7|||
170411542|NCT01644890|615847131|FG001|Overall Study|Adverse Event|20|||
170411543|NCT01644890|615847130|FG000|Overall Study|Death|1|||
170411544|NCT01644890|615847131|FG001|Overall Study|Death|3|||
170411545|NCT01644890|615847130|FG000|Overall Study|Physician Decision|3|||
170411546|NCT01644890|615847131|FG001|Overall Study|Physician Decision|9|||
170411547|NCT01644890|615847130|FG000|Overall Study|Protocol Violation|6|||
170411548|NCT01644890|615847131|FG001|Overall Study|Protocol Violation|7|||
170521854|NCT00676403|616256145|FG003|Overall Study|Reason Unspecified|0|||
170521855|NCT00676403|616256146|FG004|Overall Study|Reason Unspecified|0|||
170521856|NCT00676403|616256147|FG005|Overall Study|Reason Unspecified|1|||
170521857|NCT00676403|616256142|FG000|Overall Study|Withdrawal by Subject|0|||
170521858|NCT00676403|616256143|FG001|Overall Study|Withdrawal by Subject|0|||
170632150|NCT01134055|616664545|FG006|Overall Study|Adverse Event|2|||
170521859|NCT00676403|616256144|FG002|Overall Study|Withdrawal by Subject|0|||
170521860|NCT00676403|616256145|FG003|Overall Study|Withdrawal by Subject|0|||
170521861|NCT00676403|616256146|FG004|Overall Study|Withdrawal by Subject|0|||
170521862|NCT00676403|616256147|FG005|Overall Study|Withdrawal by Subject|1|||
170521863|NCT03225170|616256149|FG000|Overall Study|Lost to Follow-up|4|||
170521864|NCT03225170|616256150|FG001|Overall Study|Lost to Follow-up|4|||
170521865|NCT03225170|616256151|FG002|Overall Study|Lost to Follow-up|0|||
170521866|NCT03225170|616256149|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
170521867|NCT03225170|616256150|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
170521868|NCT03225170|616256151|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
170521869|NCT00661089|616256152|FG000|Overall Study|1 subject withdrawal|0|||
170521870|NCT00661089|616256153|FG001|Overall Study|1 subject withdrawal|1|||
170521871|NCT00661089|616256152|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
170521872|NCT00661089|616256153|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
170521873|NCT05209880|616256154|FG000|1-Month Follow-up|Spoke with Doctor|5|||
170521874|NCT05209880|616256155|FG001|1-Month Follow-up|Spoke with Doctor|5|||
170521875|NCT05209880|616256154|FG000|1-Month Follow-up|Lost to Follow-up|7|||
170521876|NCT05209880|616256155|FG001|1-Month Follow-up|Lost to Follow-up|9|||
170521877|NCT05209880|616256154|FG000|1-Month Follow-up|Discontinued|0|||
170521878|NCT05209880|616256155|FG001|1-Month Follow-up|Discontinued|1|||
170521879|NCT05209880|616256154|FG000|3-Month Follow-up|Spoke with Doctor|17|||
170521880|NCT05209880|616256155|FG001|3-Month Follow-up|Spoke with Doctor|7|||
170521881|NCT05209880|616256154|FG000|3-Month Follow-up|Lost to Follow-up|8|||
170521882|NCT05209880|616256155|FG001|3-Month Follow-up|Lost to Follow-up|10|||
170521883|NCT05209880|616256154|FG000|3-Month Follow-up|Discontinued|1|||
170521884|NCT05209880|616256155|FG001|3-Month Follow-up|Discontinued|3|||
170521885|NCT05209880|616256154|FG000|6-Month Follow-up|Spoke with Doctor|25|||
170521886|NCT05209880|616256155|FG001|6-Month Follow-up|Spoke with Doctor|14|||
170521887|NCT05209880|616256154|FG000|6-Month Follow-up|Lost to Follow-up|9|||
170521888|NCT05209880|616256155|FG001|6-Month Follow-up|Lost to Follow-up|14|||
170521889|NCT05209880|616256154|FG000|6-Month Follow-up|Discontinued|1|||
170521890|NCT05209880|616256155|FG001|6-Month Follow-up|Discontinued|3|||
170521891|NCT01443858|616256156|FG000|Overall Study|Withdrawal by Subject|9|||
170521892|NCT01443858|616256157|FG001|Overall Study|Withdrawal by Subject|8|||
170521893|NCT01443858|616256158|FG002|Overall Study|Withdrawal by Subject|5|||
170521894|NCT01443858|616256156|FG000|Overall Study|Lack of Efficacy|1|||
170521895|NCT01443858|616256157|FG001|Overall Study|Lack of Efficacy|0|||
170521896|NCT01443858|616256158|FG002|Overall Study|Lack of Efficacy|0|||
170521897|NCT01443858|616256156|FG000|Overall Study|Lost to Follow-up|5|||
170521898|NCT01443858|616256157|FG001|Overall Study|Lost to Follow-up|5|||
170521899|NCT01443858|616256158|FG002|Overall Study|Lost to Follow-up|2|||
170521900|NCT00971867|616256164|FG000|Overall Study|Adverse Event|4|||
170521901|NCT00971867|616256164|FG000|Overall Study|Participant Withdrew Consent|1|||
170521902|NCT00971867|616256164|FG000|Overall Study|Disease Progression|6|||
170521903|NCT03727841|616256165|FG000|Overall Study|Physician Decision|3|||
170521904|NCT03727841|616256166|FG001|Overall Study|Physician Decision|1|||
170521905|NCT02689804|616256173|FG000|Overall Study|Withdrawal by Subject|2|||
170521906|NCT02689804|616256174|FG001|Overall Study|Withdrawal by Subject|0|||
170521907|NCT00905424|616256175|FG000|Overall Study|Lost to Follow-up|3|||
170521908|NCT00905424|616256176|FG001|Overall Study|Lost to Follow-up|3|||
170521909|NCT00905424|616256175|FG000|Overall Study|Withdrawal by Subject|1|||
170521910|NCT00905424|616256176|FG001|Overall Study|Withdrawal by Subject|2|||
170521911|NCT00905424|616256175|FG000|Overall Study|Adverse Event|4|||
170521912|NCT00905424|616256176|FG001|Overall Study|Adverse Event|2|||
170521913|NCT00905424|616256175|FG000|Overall Study|Non-compliance with study medication|2|||
170521914|NCT00905424|616256176|FG001|Overall Study|Non-compliance with study medication|0|||
170521915|NCT00905424|616256175|FG000|Overall Study|Sponsor decision|1|||
170521916|NCT00905424|616256176|FG001|Overall Study|Sponsor decision|0|||
170521917|NCT00905424|616256175|FG000|Overall Study|Positive urine drug screen|0|||
170521918|NCT00905424|616256176|FG001|Overall Study|Positive urine drug screen|1|||
170521919|NCT00905424|616256175|FG000|Overall Study|Non-adherence to visit schedule|0|||
170521920|NCT00905424|616256176|FG001|Overall Study|Non-adherence to visit schedule|1|||
170521921|NCT04396626|616256177|FG000|Overall Study|Premature termination of study|975|||
170521922|NCT01657162|616256178|FG000|Overall Study|Adverse Event|26|||
170521923|NCT01657162|616256179|FG001|Overall Study|Adverse Event|36|||
170521924|NCT01657162|616256178|FG000|Overall Study|Withdrawal by Subject|13|||
170521925|NCT01657162|616256179|FG001|Overall Study|Withdrawal by Subject|13|||
170521926|NCT01657162|616256178|FG000|Overall Study|Continuing Significant Deterioration|9|||
170521927|NCT01657162|616256179|FG001|Overall Study|Continuing Significant Deterioration|3|||
170521928|NCT01657162|616256178|FG000|Overall Study|Refusal of Treatment|4|||
170521929|NCT01657162|616256179|FG001|Overall Study|Refusal of Treatment|6|||
170521930|NCT01657162|616256178|FG000|Overall Study|Lost to Follow-up|3|||
170521931|NCT01657162|616256179|FG001|Overall Study|Lost to Follow-up|4|||
170521932|NCT01657162|616256178|FG000|Overall Study|Death|2|||
170521933|NCT01657162|616256179|FG001|Overall Study|Death|3|||
170521934|NCT01657162|616256178|FG000|Overall Study|Inability to Complete Study Procedures|1|||
170521935|NCT01657162|616256179|FG001|Overall Study|Inability to Complete Study Procedures|7|||
170521936|NCT01657162|616256178|FG000|Overall Study|Protocol Violation|1|||
170521937|NCT01657162|616256179|FG001|Overall Study|Protocol Violation|0|||
170521938|NCT01657162|616256178|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
170521939|NCT01657162|616256179|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
170521940|NCT01657162|616256178|FG000|Overall Study|Other than Specified|0|||
170521941|NCT01657162|616256179|FG001|Overall Study|Other than Specified|2|||
170521942|NCT02716779|616256182|FG000|Monotherapy|Adverse Event|0|||
170521943|NCT02716779|616256183|FG001|Monotherapy|Adverse Event|1|||
170521944|NCT02716779|616256184|FG002|Monotherapy|Adverse Event|1|||
170521945|NCT02716779|616256182|FG000|Combination Therapy|Adverse Event|0|||
170521946|NCT02716779|616256183|FG001|Combination Therapy|Adverse Event|2|||
170521947|NCT02716779|616256184|FG002|Combination Therapy|Adverse Event|1|||
170521948|NCT02600923|616256185|FG000|Overall Study|Death|10|||
170521949|NCT02600923|616256185|FG000|Overall Study|Adverse Event|3|||
170521950|NCT02600923|616256185|FG000|Overall Study|Global deterioration of health status|2|||
170521951|NCT02600923|616256185|FG000|Overall Study|Insufficient clinical response|6|||
170521952|NCT02600923|616256185|FG000|Overall Study|Lost to Follow-up|1|||
170521953|NCT02600923|616256185|FG000|Overall Study|Withdrawal by Subject|5|||
170521954|NCT02600923|616256185|FG000|Overall Study|Objective progression or relapse|50|||
170521955|NCT02600923|616256185|FG000|Overall Study|Study terminated by Sponsor|53|||
170521956|NCT02600923|616256185|FG000|Overall Study|Not treated|1|||
170521957|NCT02421419|616256189|FG000|Overall Study|Physician Decision|0|||
170521958|NCT02421419|616256190|FG001|Overall Study|Physician Decision|0|||
170521959|NCT02421419|616256191|FG002|Overall Study|Physician Decision|1|||
170521960|NCT01747499|616256193|FG000|Overall Study|Steroid refractory aGvHD|1|||
170521961|NCT01747499|616256194|FG001|Overall Study|Steroid refractory aGvHD|0|||
170521962|NCT01747499|616256195|FG002|Overall Study|Steroid refractory aGvHD|0|||
170521963|NCT01747499|616256196|FG003|Overall Study|Steroid refractory aGvHD|1|||
170521964|NCT01747499|616256197|FG004|Overall Study|Steroid refractory aGvHD|4|||
170521965|NCT01747499|616256193|FG000|Overall Study|Physician Decision|0|||
170521966|NCT01747499|616256194|FG001|Overall Study|Physician Decision|1|||
170521967|NCT01747499|616256195|FG002|Overall Study|Physician Decision|0|||
170521968|NCT01747499|616256196|FG003|Overall Study|Physician Decision|0|||
170521969|NCT01747499|616256197|FG004|Overall Study|Physician Decision|2|||
170521970|NCT01747499|616256193|FG000|Overall Study|Death|0|||
170521971|NCT01747499|616256194|FG001|Overall Study|Death|0|||
170521972|NCT01747499|616256195|FG002|Overall Study|Death|0|||
170521973|NCT01747499|616256196|FG003|Overall Study|Death|1|||
170521974|NCT01747499|616256197|FG004|Overall Study|Death|1|||
170521975|NCT01747499|616256193|FG000|Overall Study|Withdrawal by Subject|0|||
170521976|NCT01747499|616256194|FG001|Overall Study|Withdrawal by Subject|0|||
170521977|NCT01747499|616256195|FG002|Overall Study|Withdrawal by Subject|0|||
170521978|NCT01747499|616256196|FG003|Overall Study|Withdrawal by Subject|0|||
170521979|NCT01747499|616256197|FG004|Overall Study|Withdrawal by Subject|6|||
170521980|NCT01747499|616256193|FG000|Overall Study|Developed AML and death|0|||
170521981|NCT01747499|616256194|FG001|Overall Study|Developed AML and death|0|||
170521982|NCT01747499|616256195|FG002|Overall Study|Developed AML and death|0|||
170521983|NCT01747499|616256196|FG003|Overall Study|Developed AML and death|0|||
170521984|NCT01747499|616256197|FG004|Overall Study|Developed AML and death|1|||
170521985|NCT01747499|616256193|FG000|Overall Study|Determined not to be eligible|0|||
170521986|NCT01747499|616256194|FG001|Overall Study|Determined not to be eligible|0|||
170521987|NCT01747499|616256195|FG002|Overall Study|Determined not to be eligible|0|||
170521988|NCT01747499|616256196|FG003|Overall Study|Determined not to be eligible|0|||
170521989|NCT01747499|616256197|FG004|Overall Study|Determined not to be eligible|1|||
170521990|NCT00196105|616256199|FG000|Overall Study|Lost to Follow-up|4|||
170521991|NCT00196105|616256200|FG001|Overall Study|Lost to Follow-up|5|||
170521992|NCT00196105|616256201|FG002|Overall Study|Lost to Follow-up|7|||
170765452|NCT03612804|617145013|FG003|Overall Study|Non-veteran status|0|||
170765453|NCT03612804|617145010|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
170765454|NCT03612804|617145011|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
170521993|NCT04058028|616256205|FG000|Overall Study|Withdrawal of Consent from Study|12|||
170521994|NCT04058028|616256206|FG001|Overall Study|Withdrawal of Consent from Study|8|||
170521995|NCT04058028|616256207|FG002|Overall Study|Withdrawal of Consent from Study|6|||
170521996|NCT04058028|616256208|FG003|Overall Study|Withdrawal of Consent from Study|7|||
170521997|NCT04058028|616256205|FG000|Overall Study|Decision by Sponsor|13|||
170521998|NCT04058028|616256206|FG001|Overall Study|Decision by Sponsor|4|||
170521999|NCT04058028|616256207|FG002|Overall Study|Decision by Sponsor|1|||
170522000|NCT04058028|616256208|FG003|Overall Study|Decision by Sponsor|35|||
170632151|NCT01134055|616664539|FG000|Overall Study|Lost to Follow-up|0|||
170868283|NCT01368042|617528323|FG000|Overall Study|Protocol Violation|11|||
170522001|NCT04058028|616256205|FG000|Overall Study|Lost to Follow-up|1|||
170522002|NCT04058028|616256206|FG001|Overall Study|Lost to Follow-up|1|||
170522003|NCT04058028|616256207|FG002|Overall Study|Lost to Follow-up|1|||
170522004|NCT04058028|616256208|FG003|Overall Study|Lost to Follow-up|0|||
170522005|NCT04058028|616256205|FG000|Overall Study|Death|0|||
170522006|NCT04058028|616256206|FG001|Overall Study|Death|1|||
170522007|NCT04058028|616256207|FG002|Overall Study|Death|0|||
170868284|NCT01368042|617528323|FG000|Overall Study|Lost to Follow-up|4|||
170868285|NCT01368042|617528323|FG000|Overall Study|Transplanted|1|||
170868286|NCT03739437|617528326|FG000|Overall Study|Lost to Follow-up|2|||
170868287|NCT03739437|617528327|FG001|Overall Study|Lost to Follow-up|5|||
170868288|NCT01351623|617528328|FG000|Overall Study|Protocol Violation|2|||
170868289|NCT01351623|617528328|FG000|Overall Study|Adverse Event|4|||
170868290|NCT01351623|617528328|FG000|Overall Study|Withdrawal by Subject|1|||
170868291|NCT01351623|617528328|FG000|Overall Study|Death|2|||
170632152|NCT01134055|616664540|FG001|Overall Study|Lost to Follow-up|1|||
170632153|NCT01134055|616664541|FG002|Overall Study|Lost to Follow-up|0|||
170632154|NCT01134055|616664542|FG003|Overall Study|Lost to Follow-up|1|||
170632155|NCT01134055|616664543|FG004|Overall Study|Lost to Follow-up|0|||
170632156|NCT01134055|616664544|FG005|Overall Study|Lost to Follow-up|0|||
170632157|NCT01134055|616664545|FG006|Overall Study|Lost to Follow-up|0|||
170632158|NCT01134055|616664539|FG000|Overall Study|Withdrawal by Subject|3|||
170632159|NCT01134055|616664540|FG001|Overall Study|Withdrawal by Subject|3|||
170632160|NCT01134055|616664541|FG002|Overall Study|Withdrawal by Subject|1|||
170632161|NCT01134055|616664542|FG003|Overall Study|Withdrawal by Subject|2|||
170411549|NCT01644890|615847130|FG000|Overall Study|Withdrawal by Subject|19|||
170411550|NCT01644890|615847131|FG001|Overall Study|Withdrawal by Subject|27|||
170411551|NCT01644890|615847130|FG000|Overall Study|Progression Disease|160|||
170411552|NCT01644890|615847131|FG001|Overall Study|Progression Disease|131|||
170411553|NCT01644890|615847130|FG000|Overall Study|Clinical Progression|6|||
170411554|NCT01644890|615847131|FG001|Overall Study|Clinical Progression|6|||
170411555|NCT01644890|615847130|FG000|Overall Study|> 28 days since last dose of study drug|6|||
170411556|NCT01644890|615847131|FG001|Overall Study|> 28 days since last dose of study drug|3|||
170411557|NCT01644890|615847130|FG000|Overall Study|Other|8|||
170411558|NCT01644890|615847131|FG001|Overall Study|Other|9|||
170411559|NCT01165996|615847136|FG000|Overall Study|Death|1|||
170411560|NCT01165996|615847136|FG000|Overall Study|Physician Decision|1|||
170411561|NCT00416520|615847137|FG000|Open-label Period|Adverse Event|28|||
170411562|NCT00416520|615847138|FG001|Open-label Period|Adverse Event|10|||
170411563|NCT00416520|615847139|FG002|Open-label Period|Adverse Event|0|||
170411564|NCT00416520|615847140|FG003|Open-label Period|Adverse Event|0|||
170411565|NCT00416520|615847137|FG000|Open-label Period|Death|2|||
170411566|NCT00416520|615847138|FG001|Open-label Period|Death|1|||
170411567|NCT00416520|615847139|FG002|Open-label Period|Death|0|||
170411568|NCT00416520|615847140|FG003|Open-label Period|Death|0|||
170411569|NCT00416520|615847137|FG000|Open-label Period|Lack of Efficacy|8|||
170411570|NCT00416520|615847138|FG001|Open-label Period|Lack of Efficacy|1|||
170411571|NCT00416520|615847139|FG002|Open-label Period|Lack of Efficacy|0|||
170411572|NCT00416520|615847140|FG003|Open-label Period|Lack of Efficacy|0|||
170411573|NCT00416520|615847137|FG000|Open-label Period|Protocol Violation|3|||
170411574|NCT00416520|615847138|FG001|Open-label Period|Protocol Violation|3|||
170411575|NCT00416520|615847139|FG002|Open-label Period|Protocol Violation|0|||
170411576|NCT00416520|615847140|FG003|Open-label Period|Protocol Violation|0|||
170411577|NCT00416520|615847137|FG000|Open-label Period|Withdrawal by Subject|16|||
170411578|NCT00416520|615847138|FG001|Open-label Period|Withdrawal by Subject|5|||
170411579|NCT00416520|615847139|FG002|Open-label Period|Withdrawal by Subject|0|||
170411580|NCT00416520|615847140|FG003|Open-label Period|Withdrawal by Subject|0|||
170411581|NCT00416520|615847137|FG000|Open-label Period|Other Reasons|3|||
170411582|NCT00416520|615847138|FG001|Open-label Period|Other Reasons|12|||
170411583|NCT00416520|615847139|FG002|Open-label Period|Other Reasons|0|||
170411584|NCT00416520|615847140|FG003|Open-label Period|Other Reasons|0|||
170411585|NCT00416520|615847137|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
170411586|NCT00416520|615847138|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
170411587|NCT00416520|615847139|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
170411588|NCT00416520|615847140|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
170411589|NCT00416520|615847137|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
170411590|NCT00416520|615847138|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
170411591|NCT00416520|615847139|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
170411592|NCT00416520|615847140|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
170411593|NCT00416520|615847137|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
170868292|NCT01130974|617528329|FG000|Overall Study|Protocol Violation|10|||
170411594|NCT00416520|615847138|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
170411595|NCT00416520|615847139|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
170411596|NCT00416520|615847140|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
170411597|NCT02710071|615847145|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
170411598|NCT02710071|615847146|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
170411599|NCT02710071|615847145|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
170868293|NCT01130974|617528330|FG001|Overall Study|Protocol Violation|10|||
170868294|NCT01130974|617528329|FG000|Overall Study|Withdrawal by Subject|0|||
170411600|NCT02710071|615847146|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
170411601|NCT00707954|615847147|FG000|Overall Study|Physician Decision|0|||
170411602|NCT00707954|615847148|FG001|Overall Study|Physician Decision|0|||
170868295|NCT01130974|617528330|FG001|Overall Study|Withdrawal by Subject|1|||
170868296|NCT01130974|617528329|FG000|Overall Study|Ineligibility criteria|5|||
170868297|NCT01130974|617528330|FG001|Overall Study|Ineligibility criteria|2|||
170868298|NCT01326728|617528331|FG000|Overall Study|Death|13|||
170868299|NCT01326728|617528332|FG001|Overall Study|Death|0|||
170868300|NCT01326728|617528331|FG000|Overall Study|Early closure of study|34|||
170868301|NCT01326728|617528332|FG001|Overall Study|Early closure of study|9|||
170868302|NCT02540538|617528333|FG000|Overall Study|Pregnancy|0|||
170868303|NCT02540538|617528334|FG001|Overall Study|Pregnancy|1|||
170868304|NCT02540538|617528335|FG002|Overall Study|Pregnancy|0|||
170868305|NCT03610165|617528341|FG000|Overall Study|Device didn't work|0|||
170868306|NCT03610165|617528342|FG001|Overall Study|Device didn't work|1|||
170868307|NCT02113579|617530283|FG000|Overall Study|Adverse Event|1|||
170868308|NCT02113579|617530284|FG001|Overall Study|Adverse Event|0|||
170868309|NCT02113579|617530283|FG000|Overall Study|Withdrawal by Subject|3|||
170868310|NCT02113579|617530284|FG001|Overall Study|Withdrawal by Subject|2|||
170868311|NCT02113579|617530283|FG000|Overall Study|Lost to Follow-up|6|||
170868312|NCT02113579|617530284|FG001|Overall Study|Lost to Follow-up|2|||
170868313|NCT00332839|617530285|FG000|Core (Months 0 - 12)|Administrative problems|1|||
170868314|NCT00332839|617530286|FG001|Core (Months 0 - 12)|Administrative problems|1|||
170765455|NCT03612804|617145012|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
170765456|NCT03612804|617145013|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
170868315|NCT00332839|617530285|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
170868316|NCT00332839|617530286|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
170868317|NCT00332839|617530285|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
170868318|NCT00332839|617530286|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
170868319|NCT00332839|617530285|FG000|Core (Months 0 - 12)|Adverse Event|5|||
170868320|NCT00332839|617530286|FG001|Core (Months 0 - 12)|Adverse Event|15|||
170868321|NCT00332839|617530285|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
170868322|NCT00332839|617530286|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
170868323|NCT00332839|617530285|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
170868324|NCT00332839|617530286|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
170868325|NCT00332839|617530285|FG000|Follow-up (Months 12 - 60)|Death|1|||
170868326|NCT00332839|617530286|FG001|Follow-up (Months 12 - 60)|Death|1|||
170868327|NCT02592551|617530290|FG000|Overall Study|Not evaluable|1|||
170868328|NCT02592551|617530291|FG001|Overall Study|Not evaluable|3|||
170868329|NCT02592551|617530292|FG002|Overall Study|Not evaluable|0|||
170868330|NCT01876251|617530293|FG000|Overall Study|Clinical progression|1|||
170868331|NCT01876251|617530294|FG001|Overall Study|Clinical progression|0|||
170868332|NCT01876251|617530295|FG002|Overall Study|Clinical progression|0|||
170868333|NCT01876251|617530293|FG000|Overall Study|Death|2|||
170868334|NCT01876251|617530294|FG001|Overall Study|Death|0|||
170868335|NCT01876251|617530295|FG002|Overall Study|Death|1|||
170868336|NCT01876251|617530293|FG000|Overall Study|Participant started new treatment|1|||
170411603|NCT00707954|615847149|FG002|Overall Study|Physician Decision|0|||
170411604|NCT00707954|615847150|FG003|Overall Study|Physician Decision|0|||
170411605|NCT00707954|615847151|FG004|Overall Study|Physician Decision|1|||
170765457|NCT03612804|617145010|FG000|Overall Study|Provider retired from VA|0|||
170765458|NCT03612804|617145011|FG001|Overall Study|Provider retired from VA|0|||
170765459|NCT03612804|617145012|FG002|Overall Study|Provider retired from VA|2|||
170765460|NCT03612804|617145013|FG003|Overall Study|Provider retired from VA|0|||
170765461|NCT03612804|617145010|FG000|Overall Study|Withdrawal by Subject|0|||
170765462|NCT03612804|617145011|FG001|Overall Study|Withdrawal by Subject|0|||
170765463|NCT03612804|617145012|FG002|Overall Study|Withdrawal by Subject|7|||
170765464|NCT03612804|617145013|FG003|Overall Study|Withdrawal by Subject|0|||
170765465|NCT03612804|617145010|FG000|Overall Study|Provider involved with study activities|1|||
170765466|NCT03612804|617145011|FG001|Overall Study|Provider involved with study activities|0|||
170765467|NCT03612804|617145012|FG002|Overall Study|Provider involved with study activities|0|||
170765468|NCT03612804|617145013|FG003|Overall Study|Provider involved with study activities|0|||
170765469|NCT05484726|617145014|FG000|Overall Study|Protocol Violation|3|||
170765470|NCT05484726|617145015|FG001|Overall Study|Protocol Violation|3|||
170868337|NCT01876251|617530294|FG001|Overall Study|Participant started new treatment|0|||
170868338|NCT01876251|617530295|FG002|Overall Study|Participant started new treatment|1|||
170411606|NCT03731182|615847154|FG000|Overall Study|Lost to Follow-up|2|||
170411607|NCT03731182|615847155|FG001|Overall Study|Lost to Follow-up|0|||
170765471|NCT05484726|617145014|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
170765472|NCT05484726|617145015|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
170868339|NCT01876251|617530293|FG000|Overall Study|Participant refused further follow-up|0|||
170868340|NCT01876251|617530294|FG001|Overall Study|Participant refused further follow-up|0|||
170868341|NCT01876251|617530295|FG002|Overall Study|Participant refused further follow-up|1|||
170868342|NCT01876251|617530293|FG000|Overall Study|Study terminated|1|||
170868343|NCT01876251|617530294|FG001|Overall Study|Study terminated|0|||
170411608|NCT03731182|615847154|FG000|Overall Study|Physician Decision|1|||
170868344|NCT01876251|617530295|FG002|Overall Study|Study terminated|0|||
170868345|NCT01876251|617530293|FG000|Overall Study|Objective progression or relapse|10|||
170868346|NCT01876251|617530294|FG001|Overall Study|Objective progression or relapse|3|||
170868347|NCT01876251|617530295|FG002|Overall Study|Objective progression or relapse|8|||
170868348|NCT00698451|617530298|FG000|Overall Study|Adverse Event|22|||
170868349|NCT00698451|617530298|FG000|Overall Study|Physician Decision|2|||
170868350|NCT00698451|617530298|FG000|Overall Study|Protocol Violation|6|||
170868351|NCT00698451|617530298|FG000|Overall Study|Withdrawal by Subject|6|||
170868352|NCT00698451|617530298|FG000|Overall Study|Disease progression|3|||
170868353|NCT03678103|617530301|FG000|Overall Study|Withdrawn prior to completion|4|||
170868354|NCT03085758|617530303|FG000|Overall Study|Death|26|||
170868355|NCT03085758|617530304|FG001|Overall Study|Death|24|||
170868356|NCT03085758|617530305|FG002|Overall Study|Death|53|||
170868357|NCT03085758|617530303|FG000|Overall Study|Lost to Follow-up|1|||
170868358|NCT03085758|617530304|FG001|Overall Study|Lost to Follow-up|1|||
170868359|NCT03085758|617530305|FG002|Overall Study|Lost to Follow-up|1|||
170868360|NCT03085758|617530303|FG000|Overall Study|Withdrawal by Subject|2|||
170868361|NCT03085758|617530304|FG001|Overall Study|Withdrawal by Subject|2|||
170868362|NCT03085758|617530305|FG002|Overall Study|Withdrawal by Subject|1|||
170868363|NCT03085758|617530303|FG000|Overall Study|Refusal to recall it up to day 90|0|||
170868364|NCT03085758|617530304|FG001|Overall Study|Refusal to recall it up to day 90|0|||
170868365|NCT03085758|617530305|FG002|Overall Study|Refusal to recall it up to day 90|1|||
170868366|NCT03085758|617530303|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
170868367|NCT03085758|617530304|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
170868368|NCT03085758|617530305|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
170868369|NCT00056862|617530306|FG000|Overall Study|Protocol Violation|1|||
170868370|NCT00056862|617530307|FG001|Overall Study|Protocol Violation|0|||
170868371|NCT00381563|617530311|FG000|Overall Study|Withdrawal by Subject|5|||
170868372|NCT00381563|617530312|FG001|Overall Study|Withdrawal by Subject|5|||
170868373|NCT00381563|617530311|FG000|Overall Study|Lost to Follow-up|2|||
170868374|NCT00381563|617530312|FG001|Overall Study|Lost to Follow-up|0|||
170868375|NCT00381563|617530311|FG000|Overall Study|Protocol Violation|0|||
170868376|NCT00381563|617530312|FG001|Overall Study|Protocol Violation|1|||
170868377|NCT01271803|617530313|FG000|Overall Study|Progressive disease|0|||
170868378|NCT01271803|617530314|FG001|Overall Study|Progressive disease|0|||
170868379|NCT01271803|617530315|FG002|Overall Study|Progressive disease|2|||
170868380|NCT01271803|617530313|FG000|Overall Study|Death|53|||
170868381|NCT01271803|617530314|FG001|Overall Study|Death|34|||
170868382|NCT01271803|617530315|FG002|Overall Study|Death|0|||
170868383|NCT01271803|617530313|FG000|Overall Study|Withdrawal by Subject|1|||
170868384|NCT01271803|617530314|FG001|Overall Study|Withdrawal by Subject|5|||
170868385|NCT01271803|617530315|FG002|Overall Study|Withdrawal by Subject|0|||
170868386|NCT01271803|617530313|FG000|Overall Study|Lost to Follow-up|1|||
170868387|NCT01271803|617530314|FG001|Overall Study|Lost to Follow-up|0|||
170868388|NCT01271803|617530315|FG002|Overall Study|Lost to Follow-up|0|||
170868389|NCT05211739|617530316|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
170868390|NCT05211739|617530317|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
170868391|NCT05211739|617530316|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
170868392|NCT05211739|617530317|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
170868393|NCT05211739|617530316|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
170868394|NCT05211739|617530317|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
170868395|NCT05211739|617530316|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
170868396|NCT05211739|617530317|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
170868397|NCT04178967|617530318|FG000|Induction Period|Adverse Event|4|||
170868398|NCT04178967|617530319|FG001|Induction Period|Adverse Event|6|||
170868399|NCT04178967|617530320|FG002|Induction Period|Adverse Event|0|||
170868400|NCT04178967|617530321|FG003|Induction Period|Adverse Event|0|||
170868401|NCT04178967|617530322|FG004|Induction Period|Adverse Event|0|||
170868402|NCT04178967|617530323|FG005|Induction Period|Adverse Event|0|||
170868403|NCT04178967|617530324|FG006|Induction Period|Adverse Event|0|||
170868404|NCT04178967|617530325|FG007|Induction Period|Adverse Event|0|||
170868405|NCT04178967|617530326|FG008|Induction Period|Adverse Event|0|||
170868406|NCT04178967|617530327|FG009|Induction Period|Adverse Event|0|||
170868407|NCT04178967|617530328|FG010|Induction Period|Adverse Event|0|||
170868408|NCT04178967|617530318|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
170868409|NCT04178967|617530319|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
170868410|NCT04178967|617530320|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
170868411|NCT04178967|617530321|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
170868412|NCT04178967|617530322|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
170868413|NCT04178967|617530323|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
170868414|NCT04178967|617530324|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
170868415|NCT04178967|617530325|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
170868416|NCT04178967|617530326|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
170868417|NCT04178967|617530327|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
170868418|NCT04178967|617530328|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
170868419|NCT04178967|617530318|FG000|Induction Period|Lack of Efficacy|4|||
170868420|NCT04178967|617530319|FG001|Induction Period|Lack of Efficacy|1|||
170868421|NCT04178967|617530320|FG002|Induction Period|Lack of Efficacy|0|||
170868422|NCT04178967|617530321|FG003|Induction Period|Lack of Efficacy|0|||
170765473|NCT05484726|617145014|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
170765474|NCT05484726|617145015|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
170765475|NCT05484726|617145014|FG000|Overall Study|continued need of mechanical ventilation|2|||
170765476|NCT05484726|617145015|FG001|Overall Study|continued need of mechanical ventilation|3|||
170765477|NCT05484726|617145014|FG000|Overall Study|Withdrawal by Subject|2|||
170765478|NCT05484726|617145015|FG001|Overall Study|Withdrawal by Subject|3|||
170765479|NCT05484726|617145014|FG000|Overall Study|IVH (G III & IV)|2|||
170765480|NCT05484726|617145015|FG001|Overall Study|IVH (G III & IV)|1|||
170765481|NCT05484726|617145014|FG000|Overall Study|NEC (stage II & III)|2|||
170765482|NCT05484726|617145015|FG001|Overall Study|NEC (stage II & III)|3|||
170765483|NCT04550039|617145016|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
170765484|NCT04550039|617145017|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
170765485|NCT04550039|617145016|FG000|Overall Study|patient self-withdrew from study|0|||
170765486|NCT04550039|617145017|FG001|Overall Study|patient self-withdrew from study|1|||
170765487|NCT01656304|617145018|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
170765488|NCT04391309|617145019|FG000|Overall Study|Death|1|||
170765489|NCT04391309|617145020|FG001|Overall Study|Death|1|||
170765490|NCT04391309|617145019|FG000|Overall Study|Lost to Follow-up|3|||
170765491|NCT04391309|617145020|FG001|Overall Study|Lost to Follow-up|2|||
170765492|NCT04391309|617145019|FG000|Overall Study|Withdrawal by Subject|2|||
170765493|NCT04391309|617145020|FG001|Overall Study|Withdrawal by Subject|2|||
170765494|NCT05826431|617145023|FG000|Overall Study|Withdrawal by Subject|1|||
170765495|NCT00462943|617145026|FG000|Overall Study|Failure to achieve a response|5|||
170765496|NCT00462943|617145027|FG001|Overall Study|Failure to achieve a response|5|||
170765497|NCT00462943|617145028|FG002|Overall Study|Failure to achieve a response|1|||
170765498|NCT00462943|617145026|FG000|Overall Study|Adverse Event|6|||
170765499|NCT00462943|617145027|FG001|Overall Study|Adverse Event|4|||
170765500|NCT00462943|617145028|FG002|Overall Study|Adverse Event|1|||
170765501|NCT00462943|617145026|FG000|Overall Study|Protocol Violation|1|||
170765502|NCT00462943|617145027|FG001|Overall Study|Protocol Violation|0|||
170765503|NCT00462943|617145028|FG002|Overall Study|Protocol Violation|0|||
170765504|NCT00462943|617145026|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
170765505|NCT00462943|617145027|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
170765506|NCT00462943|617145028|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
170765507|NCT00462943|617145026|FG000|Overall Study|Disease Progression|15|||
170765508|NCT00462943|617145027|FG001|Overall Study|Disease Progression|15|||
170765509|NCT00462943|617145028|FG002|Overall Study|Disease Progression|9|||
170765510|NCT00462943|617145026|FG000|Overall Study|Death|5|||
170765511|NCT00462943|617145027|FG001|Overall Study|Death|2|||
170765512|NCT00462943|617145028|FG002|Overall Study|Death|7|||
170765513|NCT00462943|617145026|FG000|Overall Study|Stem Cell Transplant|1|||
170765514|NCT00462943|617145027|FG001|Overall Study|Stem Cell Transplant|1|||
170765515|NCT00462943|617145028|FG002|Overall Study|Stem Cell Transplant|0|||
170765516|NCT00462943|617145026|FG000|Overall Study|Bone Marrow Transplant|1|||
170765517|NCT00462943|617145027|FG001|Overall Study|Bone Marrow Transplant|0|||
170765518|NCT00462943|617145028|FG002|Overall Study|Bone Marrow Transplant|0|||
170765519|NCT00462943|617145026|FG000|Overall Study|Required Lymphocyte Infusion|1|||
170765520|NCT00462943|617145027|FG001|Overall Study|Required Lymphocyte Infusion|0|||
170765521|NCT00462943|617145028|FG002|Overall Study|Required Lymphocyte Infusion|0|||
170765522|NCT00462943|617145026|FG000|Overall Study|Transplant - not specified|1|||
170765523|NCT00462943|617145027|FG001|Overall Study|Transplant - not specified|0|||
170765524|NCT00462943|617145028|FG002|Overall Study|Transplant - not specified|1|||
170765525|NCT00462943|617145026|FG000|Overall Study|Physician Decision|1|||
170765526|NCT00462943|617145027|FG001|Overall Study|Physician Decision|0|||
170765527|NCT00462943|617145028|FG002|Overall Study|Physician Decision|0|||
170765528|NCT00462943|617145026|FG000|Overall Study|Withdrawal by Subject|0|||
170765529|NCT00462943|617145027|FG001|Overall Study|Withdrawal by Subject|1|||
170765530|NCT00462943|617145028|FG002|Overall Study|Withdrawal by Subject|0|||
170765531|NCT04222959|617145033|FG000|Overall Study|Lost to Follow-up|76|||
170765532|NCT04222959|617145034|FG001|Overall Study|Lost to Follow-up|28|||
170765533|NCT02698241|617145035|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
170765534|NCT02698241|617145035|FG000|Overall Study|Screening not met|7|||
170765535|NCT02698241|617145035|FG000|Overall Study|Withdrawal by Subject|7|||
170765536|NCT02698241|617145035|FG000|Overall Study|Physician Decision|2|||
170765537|NCT02698241|617145035|FG000|Overall Study|Subject underwent system modification|2|||
170868423|NCT04178967|617530322|FG004|Induction Period|Lack of Efficacy|0|||
170765538|NCT02698241|617145035|FG000|Overall Study|Lost to Follow-up|3|||
170765539|NCT02698241|617145035|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
170765540|NCT02698241|617145035|FG000|Overall Study|geographic and licensing issue|1|||
170765541|NCT02698241|617145035|FG000|Overall Study|Death|2|||
170765542|NCT01838551|617145036|FG000|Overall Study|Adverse Event|16|||
170868424|NCT04178967|617530323|FG005|Induction Period|Lack of Efficacy|0|||
170765543|NCT01838551|617145036|FG000|Overall Study|Death|1|||
170765544|NCT01838551|617145036|FG000|Overall Study|Lack of Efficacy|10|||
170765545|NCT01838551|617145036|FG000|Overall Study|Physician Decision|4|||
170868425|NCT04178967|617530324|FG006|Induction Period|Lack of Efficacy|0|||
170868426|NCT04178967|617530325|FG007|Induction Period|Lack of Efficacy|0|||
170868427|NCT04178967|617530326|FG008|Induction Period|Lack of Efficacy|0|||
170868428|NCT04178967|617530327|FG009|Induction Period|Lack of Efficacy|0|||
170868429|NCT04178967|617530328|FG010|Induction Period|Lack of Efficacy|0|||
170868430|NCT04178967|617530318|FG000|Induction Period|Protocol Violation|0|||
170868431|NCT04178967|617530319|FG001|Induction Period|Protocol Violation|6|||
170868432|NCT04178967|617530320|FG002|Induction Period|Protocol Violation|0|||
170868433|NCT04178967|617530321|FG003|Induction Period|Protocol Violation|0|||
170868434|NCT04178967|617530322|FG004|Induction Period|Protocol Violation|0|||
170868435|NCT04178967|617530323|FG005|Induction Period|Protocol Violation|0|||
170868436|NCT04178967|617530324|FG006|Induction Period|Protocol Violation|0|||
170868437|NCT04178967|617530325|FG007|Induction Period|Protocol Violation|0|||
170868438|NCT04178967|617530326|FG008|Induction Period|Protocol Violation|0|||
170868439|NCT04178967|617530327|FG009|Induction Period|Protocol Violation|0|||
170868440|NCT04178967|617530328|FG010|Induction Period|Protocol Violation|0|||
170868441|NCT04178967|617530318|FG000|Induction Period|Withdrawal by Subject|6|||
170868442|NCT04178967|617530319|FG001|Induction Period|Withdrawal by Subject|4|||
170868443|NCT04178967|617530320|FG002|Induction Period|Withdrawal by Subject|0|||
170868444|NCT04178967|617530321|FG003|Induction Period|Withdrawal by Subject|0|||
170868445|NCT04178967|617530322|FG004|Induction Period|Withdrawal by Subject|0|||
170868446|NCT04178967|617530323|FG005|Induction Period|Withdrawal by Subject|0|||
170868447|NCT04178967|617530324|FG006|Induction Period|Withdrawal by Subject|0|||
170868448|NCT04178967|617530325|FG007|Induction Period|Withdrawal by Subject|0|||
170868449|NCT04178967|617530326|FG008|Induction Period|Withdrawal by Subject|0|||
170868450|NCT04178967|617530327|FG009|Induction Period|Withdrawal by Subject|0|||
170868451|NCT04178967|617530328|FG010|Induction Period|Withdrawal by Subject|0|||
170868452|NCT04178967|617530318|FG000|Induction Period|Lost to Follow-up|2|||
170868453|NCT04178967|617530319|FG001|Induction Period|Lost to Follow-up|0|||
170868454|NCT04178967|617530320|FG002|Induction Period|Lost to Follow-up|0|||
170868455|NCT04178967|617530321|FG003|Induction Period|Lost to Follow-up|0|||
170868456|NCT04178967|617530322|FG004|Induction Period|Lost to Follow-up|0|||
170868457|NCT04178967|617530323|FG005|Induction Period|Lost to Follow-up|0|||
170868458|NCT04178967|617530324|FG006|Induction Period|Lost to Follow-up|0|||
170868459|NCT04178967|617530325|FG007|Induction Period|Lost to Follow-up|0|||
170868460|NCT04178967|617530326|FG008|Induction Period|Lost to Follow-up|0|||
170868461|NCT04178967|617530327|FG009|Induction Period|Lost to Follow-up|0|||
170868462|NCT04178967|617530328|FG010|Induction Period|Lost to Follow-up|0|||
170868463|NCT04178967|617530318|FG000|Induction Period|Participant Missed Study Visits|0|||
170868464|NCT04178967|617530319|FG001|Induction Period|Participant Missed Study Visits|1|||
170868465|NCT04178967|617530320|FG002|Induction Period|Participant Missed Study Visits|0|||
170868466|NCT04178967|617530321|FG003|Induction Period|Participant Missed Study Visits|0|||
170868467|NCT04178967|617530322|FG004|Induction Period|Participant Missed Study Visits|0|||
170868468|NCT04178967|617530323|FG005|Induction Period|Participant Missed Study Visits|0|||
170868469|NCT04178967|617530324|FG006|Induction Period|Participant Missed Study Visits|0|||
170868470|NCT04178967|617530325|FG007|Induction Period|Participant Missed Study Visits|0|||
170868471|NCT04178967|617530326|FG008|Induction Period|Participant Missed Study Visits|0|||
170868472|NCT04178967|617530327|FG009|Induction Period|Participant Missed Study Visits|0|||
170868473|NCT04178967|617530328|FG010|Induction Period|Participant Missed Study Visits|0|||
170868474|NCT04178967|617530318|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
170868475|NCT04178967|617530319|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
170868476|NCT04178967|617530320|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
170868477|NCT04178967|617530321|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
170868478|NCT04178967|617530322|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
170868479|NCT04178967|617530323|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
170868480|NCT04178967|617530324|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
170411609|NCT03731182|615847155|FG001|Overall Study|Physician Decision|0|||
170868481|NCT04178967|617530325|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
170868482|NCT04178967|617530326|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
170868483|NCT04178967|617530327|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
170868484|NCT04178967|617530328|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
170868485|NCT04178967|617530318|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868486|NCT04178967|617530319|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868487|NCT04178967|617530320|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868488|NCT04178967|617530321|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868489|NCT04178967|617530322|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868490|NCT04178967|617530323|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
170868491|NCT04178967|617530324|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868492|NCT04178967|617530325|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868493|NCT04178967|617530326|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170411610|NCT03731182|615847154|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
170868494|NCT04178967|617530327|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868495|NCT04178967|617530328|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170868496|NCT04178967|617530318|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868497|NCT04178967|617530319|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868498|NCT04178967|617530320|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868499|NCT04178967|617530321|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
170868500|NCT04178967|617530322|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868501|NCT04178967|617530323|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868502|NCT04178967|617530324|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868503|NCT04178967|617530325|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868504|NCT04178967|617530326|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868505|NCT04178967|617530327|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868506|NCT04178967|617530328|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170868507|NCT04178967|617530318|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868508|NCT04178967|617530319|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868509|NCT04178967|617530320|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868510|NCT04178967|617530321|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868511|NCT04178967|617530322|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868512|NCT04178967|617530323|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868513|NCT04178967|617530324|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
170868514|NCT04178967|617530325|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868515|NCT04178967|617530326|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868516|NCT04178967|617530327|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868517|NCT04178967|617530328|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
170868518|NCT04178967|617530318|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170868519|NCT04178967|617530319|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170868520|NCT04178967|617530320|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170868521|NCT04178967|617530321|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170868522|NCT04178967|617530322|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
170868523|NCT04178967|617530323|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
170868524|NCT04178967|617530324|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170868525|NCT04178967|617530325|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
170868526|NCT04178967|617530326|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170868527|NCT04178967|617530327|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170868528|NCT04178967|617530328|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170868529|NCT04178967|617530318|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
170868530|NCT04178967|617530319|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
170868531|NCT04178967|617530320|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
170868532|NCT04178967|617530321|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
170868533|NCT04178967|617530322|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
170868534|NCT04178967|617530323|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
170868535|NCT04178967|617530324|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
170868536|NCT04178967|617530325|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
170868537|NCT04178967|617530326|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
170868538|NCT04178967|617530327|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
170868539|NCT04178967|617530328|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
170868540|NCT04178967|617530318|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170868541|NCT04178967|617530319|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170868542|NCT04178967|617530320|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170868543|NCT04178967|617530321|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
170868544|NCT04178967|617530322|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170868545|NCT04178967|617530323|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
170868546|NCT04178967|617530324|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
170868547|NCT04178967|617530325|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
170868548|NCT04178967|617530326|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170868549|NCT04178967|617530327|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170868550|NCT04178967|617530328|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170868551|NCT04178967|617530318|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
170868552|NCT04178967|617530319|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
170868553|NCT04178967|617530320|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
170868554|NCT04178967|617530321|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
170868555|NCT04178967|617530322|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
170868556|NCT04178967|617530323|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
170868557|NCT04178967|617530324|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
170868558|NCT04178967|617530325|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
170765546|NCT01838551|617145036|FG000|Overall Study|Withdrawal by Subject|10|||
170765547|NCT01838551|617145036|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
170765548|NCT03254394|617145039|FG000|Overall Study|Withdrawal by Subject|0|||
170765549|NCT03254394|617145040|FG001|Overall Study|Withdrawal by Subject|2|||
170765550|NCT02163915|617145041|FG000|Overall Study|Withdrawal by Subject|2|||
170765551|NCT02163915|617145042|FG001|Overall Study|Withdrawal by Subject|0|||
170765552|NCT02163915|617145043|FG002|Overall Study|Withdrawal by Subject|2|||
170765553|NCT02163915|617145044|FG003|Overall Study|Withdrawal by Subject|2|||
170765554|NCT02163915|617145045|FG004|Overall Study|Withdrawal by Subject|2|||
170765555|NCT02163915|617145041|FG000|Overall Study|Study termination|1|||
170765556|NCT02163915|617145042|FG001|Overall Study|Study termination|0|||
170765557|NCT02163915|617145043|FG002|Overall Study|Study termination|0|||
170765558|NCT02163915|617145044|FG003|Overall Study|Study termination|0|||
170765559|NCT02163915|617145045|FG004|Overall Study|Study termination|2|||
170765560|NCT02163915|617145041|FG000|Overall Study|Physician Decision|0|||
170765561|NCT02163915|617145042|FG001|Overall Study|Physician Decision|0|||
170765562|NCT02163915|617145043|FG002|Overall Study|Physician Decision|0|||
170765563|NCT02163915|617145044|FG003|Overall Study|Physician Decision|1|||
170765564|NCT02163915|617145045|FG004|Overall Study|Physician Decision|0|||
170765565|NCT01751724|617145048|FG000|Overall Study|extubated bef.start assigned treatment|1|||
170765566|NCT01751724|617145049|FG001|Overall Study|extubated bef.start assigned treatment|0|||
170765567|NCT01751724|617145048|FG000|Overall Study|withdrawn by parent|0|||
170765568|NCT01751724|617145049|FG001|Overall Study|withdrawn by parent|2|||
170765569|NCT02685033|617145053|FG000|Overall Study|Withdrawal of Consent|0|||
170765570|NCT02685033|617145054|FG001|Overall Study|Withdrawal of Consent|1|||
170765571|NCT02685033|617145053|FG000|Overall Study|Lost to Follow-up|2|||
170765572|NCT02685033|617145054|FG001|Overall Study|Lost to Follow-up|1|||
170765573|NCT02685033|617145053|FG000|Overall Study|Adverse Event|1|||
170765574|NCT02685033|617145054|FG001|Overall Study|Adverse Event|0|||
170765575|NCT04845620|617145059|FG000|Overall Study|Withdrawal by Subject|11|||
170765576|NCT04845620|617145060|FG001|Overall Study|Withdrawal by Subject|10|||
170765577|NCT04845620|617145059|FG000|Overall Study|Adverse Event|5|||
170765578|NCT04845620|617145060|FG001|Overall Study|Adverse Event|4|||
170765579|NCT04845620|617145059|FG000|Overall Study|Lost to Follow-up|5|||
170765580|NCT04845620|617145060|FG001|Overall Study|Lost to Follow-up|4|||
170765581|NCT04845620|617145059|FG000|Overall Study|Lack of Efficacy|4|||
170765582|NCT04845620|617145060|FG001|Overall Study|Lack of Efficacy|4|||
170765583|NCT04845620|617145059|FG000|Overall Study|Physician Decision|2|||
170765584|NCT04845620|617145060|FG001|Overall Study|Physician Decision|1|||
170765585|NCT02013037|617145061|FG000|Overall Study|Death|6|||
170765586|NCT02013037|617145061|FG000|Overall Study|Withdrawal by Subject|1|||
170765587|NCT02013037|617145061|FG000|Overall Study|Awaiting Transplantation|7|||
170765588|NCT02013037|617145061|FG000|Overall Study|Transplanted without DSA|2|||
170765589|NCT02465359|617145062|FG000|Overall Study|Lack of Efficacy|1|||
170765590|NCT02465359|617145062|FG000|Overall Study|Withdrawal by Subject|1|||
170765591|NCT02465359|617145062|FG000|Overall Study|Adverse Event|1|||
170765592|NCT03141788|617145063|FG000|Overall Study|Lost to Follow-up|1|||
170765593|NCT03141788|617145063|FG000|Overall Study|Protocol Violation|3|||
170765594|NCT03141788|617145063|FG000|Overall Study|Withdrawal by Subject|4|||
170765595|NCT04133363|617145064|FG000|Overall Study|Lost to Follow-up|2|||
170765596|NCT04133363|617145065|FG001|Overall Study|Lost to Follow-up|1|||
170765597|NCT04133363|617145066|FG002|Overall Study|Lost to Follow-up|4|||
170765598|NCT02812966|617145067|FG000|Overall Study|Death|1|||
170765599|NCT02812966|617145068|FG001|Overall Study|Death|0|||
170765600|NCT01066923|617145069|FG000|Overall Study|Withdrawal by Subject|3|||
170765601|NCT01066923|617145070|FG001|Overall Study|Withdrawal by Subject|3|||
170765602|NCT01066923|617145071|FG002|Overall Study|Withdrawal by Subject|8|||
170765603|NCT01066923|617145072|FG003|Overall Study|Withdrawal by Subject|8|||
170765604|NCT03544515|617146570|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
170765605|NCT03544515|617146571|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
170765606|NCT03544515|617146570|FG000|Overall Study|Lost to Follow-up|2|||
170765607|NCT03544515|617146571|FG001|Overall Study|Lost to Follow-up|0|||
170765608|NCT03169244|617146572|FG000|Overall Study|Lost to Follow-up|1|||
170765609|NCT03169244|617146573|FG001|Overall Study|Lost to Follow-up|2|||
170765610|NCT03169244|617146572|FG000|Overall Study|Adverse Event|1|||
170765611|NCT03169244|617146573|FG001|Overall Study|Adverse Event|0|||
170765612|NCT03169244|617146572|FG000|Overall Study|Withdrawal by Subject|2|||
170765613|NCT03169244|617146573|FG001|Overall Study|Withdrawal by Subject|2|||
170765614|NCT03169244|617146572|FG000|Overall Study|Physician Decision|1|||
170765615|NCT03169244|617146573|FG001|Overall Study|Physician Decision|0|||
170765616|NCT02577523|617146575|FG000|Overall Study|Adverse Event|1|||
170765617|NCT02577523|617146576|FG001|Overall Study|Adverse Event|1|||
170765618|NCT02577523|617146575|FG000|Overall Study|Lack of Efficacy|1|||
170765619|NCT02577523|617146576|FG001|Overall Study|Lack of Efficacy|1|||
170765620|NCT02577523|617146575|FG000|Overall Study|Withdrawal by Subject|1|||
170765621|NCT02577523|617146576|FG001|Overall Study|Withdrawal by Subject|0|||
170765622|NCT03201809|617146577|FG000|Overall Study|Lost to Follow-up|2|||
170522008|NCT04058028|616256208|FG003|Overall Study|Death|0|||
170522009|NCT02227784|616256209|FG000|Double-Blind Phase|Adverse Event|3|||
170522010|NCT02227784|616256210|FG001|Double-Blind Phase|Adverse Event|2|||
170522011|NCT02227784|616256211|FG002|Double-Blind Phase|Adverse Event|1|||
170765623|NCT03201809|617146578|FG001|Overall Study|Lost to Follow-up|0|||
170765624|NCT00864682|617146579|FG000|Overall Study|Protocol Violation|2|||
170765625|NCT00864682|617146580|FG001|Overall Study|Protocol Violation|1|||
170765626|NCT00864682|617146581|FG002|Overall Study|Protocol Violation|2|||
170765627|NCT00545844|617146582|FG000|Overall Study|Lost to Follow-up|9|||
170765628|NCT00545844|617146582|FG000|Overall Study|Protocol Violation|1|||
170765629|NCT00545844|617146582|FG000|Overall Study|Withdrawal by Subject|2|||
170765630|NCT03383887|617146583|FG000|Overall Study|Lost to Follow-up|0|||
170765631|NCT03383887|617146584|FG001|Overall Study|Lost to Follow-up|1|||
170765632|NCT01370694|617146589|FG000|Overall Study|Switched to rituximab|4|||
170765633|NCT01370694|617146589|FG000|Overall Study|Progressive disease|2|||
170765634|NCT00344019|617146592|FG000|Overall Study|did not meet final inclusion criteria|0|||
170765635|NCT00344019|617146593|FG001|Overall Study|did not meet final inclusion criteria|0|||
170765636|NCT00344019|617146594|FG002|Overall Study|did not meet final inclusion criteria|74|||
170765637|NCT02503202|617146597|FG000|Base Study: Up to Month 6|Death|1|||
170765638|NCT02503202|617146598|FG001|Base Study: Up to Month 6|Death|1|||
170765639|NCT02503202|617146599|FG002|Base Study: Up to Month 6|Death|0|||
170765640|NCT02503202|617146600|FG003|Base Study: Up to Month 6|Death|0|||
170765641|NCT02503202|617146601|FG004|Base Study: Up to Month 6|Death|0|||
170765642|NCT02503202|617146597|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
170765643|NCT02503202|617146598|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
170765644|NCT02503202|617146599|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
170765645|NCT02503202|617146600|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
170765646|NCT02503202|617146601|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
170765647|NCT02503202|617146597|FG000|Base Study: Up to Month 6|Physician Decision|0|||
170765648|NCT02503202|617146598|FG001|Base Study: Up to Month 6|Physician Decision|0|||
170765649|NCT02503202|617146599|FG002|Base Study: Up to Month 6|Physician Decision|0|||
170765650|NCT02503202|617146600|FG003|Base Study: Up to Month 6|Physician Decision|0|||
170765651|NCT02503202|617146601|FG004|Base Study: Up to Month 6|Physician Decision|1|||
170765652|NCT02503202|617146597|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
170765653|NCT02503202|617146598|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
170765654|NCT02503202|617146599|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
170765655|NCT02503202|617146600|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
170765656|NCT02503202|617146601|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
170765657|NCT02503202|617146597|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
170765658|NCT02503202|617146598|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
170765659|NCT02503202|617146599|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
170765660|NCT02503202|617146600|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
170765661|NCT02503202|617146601|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
170765662|NCT02503202|617146597|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
170765663|NCT02503202|617146598|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
170765664|NCT02503202|617146599|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
170765665|NCT02503202|617146600|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
170765666|NCT02503202|617146601|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
170765667|NCT02503202|617146597|FG000|Extension: Month 6 to 24|Death|1|||
170765668|NCT02503202|617146598|FG001|Extension: Month 6 to 24|Death|0|||
170765669|NCT02503202|617146599|FG002|Extension: Month 6 to 24|Death|0|||
170765670|NCT02503202|617146600|FG003|Extension: Month 6 to 24|Death|0|||
170765671|NCT02503202|617146601|FG004|Extension: Month 6 to 24|Death|0|||
170765672|NCT02503202|617146597|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
170765673|NCT02503202|617146598|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
170765674|NCT02503202|617146599|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
170765675|NCT02503202|617146600|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
170765676|NCT02503202|617146601|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
170765677|NCT02503202|617146597|FG000|Extension: Month 6 to 24|Physician Decision|1|||
170765678|NCT02503202|617146598|FG001|Extension: Month 6 to 24|Physician Decision|0|||
170522012|NCT02227784|616256212|FG003|Double-Blind Phase|Adverse Event|3|||
170522013|NCT02227784|616256213|FG004|Double-Blind Phase|Adverse Event|0|||
170522014|NCT02227784|616256209|FG000|Double-Blind Phase|Physician Decision|1|||
170765679|NCT02503202|617146599|FG002|Extension: Month 6 to 24|Physician Decision|1|||
170765680|NCT02503202|617146600|FG003|Extension: Month 6 to 24|Physician Decision|3|||
170765681|NCT02503202|617146601|FG004|Extension: Month 6 to 24|Physician Decision|0|||
170765682|NCT02503202|617146597|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
170765683|NCT02503202|617146598|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
170765684|NCT02503202|617146599|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
170765685|NCT02503202|617146600|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
170765686|NCT02503202|617146601|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
170765687|NCT00906035|617146609|FG000|Overall Study|Withdrawal by Subject|2|||
170765688|NCT00906035|617146610|FG001|Overall Study|Withdrawal by Subject|3|||
170765689|NCT00906035|617146611|FG002|Overall Study|Withdrawal by Subject|0|||
170765690|NCT01050569|617146614|FG000|Overall Study|Lost to Follow-up|20|||
170765691|NCT01050569|617146615|FG001|Overall Study|Lost to Follow-up|14|||
170765692|NCT01050569|617146616|FG002|Overall Study|Lost to Follow-up|16|||
170765693|NCT01050569|617146614|FG000|Overall Study|Withdrawal by Subject|9|||
170765694|NCT01050569|617146615|FG001|Overall Study|Withdrawal by Subject|3|||
170765695|NCT01050569|617146616|FG002|Overall Study|Withdrawal by Subject|11|||
170765696|NCT01050569|617146614|FG000|Overall Study|Lack of Efficacy|5|||
170765697|NCT01050569|617146615|FG001|Overall Study|Lack of Efficacy|4|||
170765698|NCT01050569|617146616|FG002|Overall Study|Lack of Efficacy|3|||
170765699|NCT01050569|617146614|FG000|Overall Study|Adverse Event|1|||
170765700|NCT01050569|617146615|FG001|Overall Study|Adverse Event|0|||
170765701|NCT01050569|617146616|FG002|Overall Study|Adverse Event|0|||
170765702|NCT01050569|617146614|FG000|Overall Study|Physician Decision|3|||
170765703|NCT01050569|617146615|FG001|Overall Study|Physician Decision|3|||
170765704|NCT01050569|617146616|FG002|Overall Study|Physician Decision|3|||
170765705|NCT03525119|617146617|FG000|Overall Study|Adverse Event|0|||
170765706|NCT03525119|617146618|FG001|Overall Study|Adverse Event|1|||
170765707|NCT03525119|617146619|FG002|Overall Study|Adverse Event|0|||
170765708|NCT03525119|617146617|FG000|Overall Study|Lost to Follow-up|32|||
170765709|NCT03525119|617146618|FG001|Overall Study|Lost to Follow-up|33|||
170765710|NCT03525119|617146619|FG002|Overall Study|Lost to Follow-up|37|||
170765711|NCT03525119|617146617|FG000|Overall Study|Withdrawal by Subject|5|||
170765712|NCT03525119|617146618|FG001|Overall Study|Withdrawal by Subject|4|||
170765713|NCT03525119|617146619|FG002|Overall Study|Withdrawal by Subject|2|||
170765714|NCT03525119|617146617|FG000|Overall Study|Reason not Specified|2|||
170765715|NCT03525119|617146618|FG001|Overall Study|Reason not Specified|1|||
170765716|NCT03525119|617146619|FG002|Overall Study|Reason not Specified|2|||
170765717|NCT03525119|617146617|FG000|Overall Study|Randomized but not Vaccinated|1|||
170765718|NCT03525119|617146618|FG001|Overall Study|Randomized but not Vaccinated|0|||
170765719|NCT03525119|617146619|FG002|Overall Study|Randomized but not Vaccinated|2|||
170765720|NCT03781336|617146620|FG000|Overall Study|Withdrawal by Subject|2|||
170765721|NCT03781336|617146621|FG001|Overall Study|Withdrawal by Subject|2|||
170765722|NCT05046132|617146622|FG000|Overall Study|Adverse Event|4|||
170765723|NCT05046132|617146623|FG001|Overall Study|Adverse Event|0|||
170765724|NCT05046132|617146624|FG002|Overall Study|Adverse Event|0|||
170765725|NCT05046132|617146622|FG000|Overall Study|Withdrawal by Subject|3|||
170765726|NCT05046132|617146623|FG001|Overall Study|Withdrawal by Subject|0|||
170765727|NCT05046132|617146624|FG002|Overall Study|Withdrawal by Subject|0|||
170765728|NCT05046132|617146622|FG000|Overall Study|Positive Covid19 Result.|0|||
170765729|NCT05046132|617146623|FG001|Overall Study|Positive Covid19 Result.|1|||
170765730|NCT05046132|617146624|FG002|Overall Study|Positive Covid19 Result.|0|||
170765731|NCT01959412|617146625|FG000|Overall Study|Protocol deviation|1|||
170765732|NCT01959412|617146626|FG001|Overall Study|Protocol deviation|1|||
170765733|NCT01959412|617146627|FG002|Overall Study|Protocol deviation|0|||
170765734|NCT01959412|617146628|FG003|Overall Study|Protocol deviation|1|||
170765735|NCT01959412|617146629|FG004|Overall Study|Protocol deviation|3|||
170765736|NCT01959412|617146630|FG005|Overall Study|Protocol deviation|0|||
170765737|NCT01959412|617146625|FG000|Overall Study|Adverse Event|0|||
170765738|NCT01959412|617146626|FG001|Overall Study|Adverse Event|0|||
170765739|NCT01959412|617146627|FG002|Overall Study|Adverse Event|0|||
170765740|NCT01959412|617146628|FG003|Overall Study|Adverse Event|1|||
170765741|NCT01959412|617146629|FG004|Overall Study|Adverse Event|0|||
170765742|NCT01959412|617146630|FG005|Overall Study|Adverse Event|0|||
170765743|NCT01186848|617146631|FG000|Overall Study|Lost to Follow-up|4|||
170765744|NCT01186848|617146631|FG000|Overall Study|Withdrawal by Subject|2|||
170765745|NCT01186848|617146631|FG000|Overall Study|Adverse Event|2|||
170765746|NCT00612586|617146641|FG000|Overall Study|Adverse Event|6|||
170765747|NCT00612586|617146642|FG001|Overall Study|Adverse Event|2|||
170765748|NCT00612586|617146641|FG000|Overall Study|Death|1|||
170868559|NCT04178967|617530326|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
170868560|NCT04178967|617530327|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
170868561|NCT04178967|617530328|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
170868562|NCT04178967|617530318|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170765749|NCT00612586|617146642|FG001|Overall Study|Death|0|||
170765750|NCT00612586|617146641|FG000|Overall Study|Entry Criteria Not Met|0|||
170765751|NCT00612586|617146642|FG001|Overall Study|Entry Criteria Not Met|2|||
170765752|NCT00612586|617146641|FG000|Overall Study|Withdrawal by Subject|7|||
170765753|NCT00612586|617146642|FG001|Overall Study|Withdrawal by Subject|9|||
170765754|NCT00612586|617146641|FG000|Overall Study|Physician Decision|1|||
170765755|NCT00612586|617146642|FG001|Overall Study|Physician Decision|2|||
170765756|NCT00612586|617146641|FG000|Overall Study|Sponsor Decision|1|||
170765757|NCT00612586|617146642|FG001|Overall Study|Sponsor Decision|1|||
170765758|NCT00612586|617146641|FG000|Overall Study|Progressive Disease|26|||
170765759|NCT00612586|617146642|FG001|Overall Study|Progressive Disease|24|||
170765760|NCT00612586|617146641|FG000|Overall Study|Randomized and Not Treated|1|||
170765761|NCT00612586|617146642|FG001|Overall Study|Randomized and Not Treated|1|||
170765762|NCT01235949|617146643|FG000|Primary Phase|Migrated/moved from study area|1|||
170765763|NCT01235949|617146644|FG001|Primary Phase|Migrated/moved from study area|1|||
170765764|NCT01235949|617146645|FG002|Primary Phase|Migrated/moved from study area|0|||
170765765|NCT01235949|617146646|FG003|Primary Phase|Migrated/moved from study area|0|||
170765766|NCT01235949|617146647|FG004|Primary Phase|Migrated/moved from study area|1|||
170765767|NCT01235949|617146648|FG005|Primary Phase|Migrated/moved from study area|2|||
170765768|NCT01235949|617146649|FG006|Primary Phase|Migrated/moved from study area|0|||
170765769|NCT01235949|617146650|FG007|Primary Phase|Migrated/moved from study area|0|||
170765770|NCT01235949|617146651|FG008|Primary Phase|Migrated/moved from study area|0|||
170765771|NCT01235949|617146652|FG009|Primary Phase|Migrated/moved from study area|0|||
170765772|NCT01235949|617146653|FG010|Primary Phase|Migrated/moved from study area|0|||
170765773|NCT01235949|617146654|FG011|Primary Phase|Migrated/moved from study area|0|||
170765774|NCT01235949|617146655|FG012|Primary Phase|Migrated/moved from study area|0|||
170765775|NCT01235949|617146656|FG013|Primary Phase|Migrated/moved from study area|0|||
170765776|NCT01235949|617146657|FG014|Primary Phase|Migrated/moved from study area|0|||
170765777|NCT01235949|617146658|FG015|Primary Phase|Migrated/moved from study area|0|||
170765778|NCT01235949|617146659|FG016|Primary Phase|Migrated/moved from study area|0|||
170765779|NCT01235949|617146660|FG017|Primary Phase|Migrated/moved from study area|0|||
170765780|NCT01235949|617146643|FG000|Primary Phase|Adverse Event|0|||
170765781|NCT01235949|617146644|FG001|Primary Phase|Adverse Event|0|||
170765782|NCT01235949|617146645|FG002|Primary Phase|Adverse Event|0|||
170765783|NCT01235949|617146646|FG003|Primary Phase|Adverse Event|1|||
170765784|NCT01235949|617146647|FG004|Primary Phase|Adverse Event|0|||
170765785|NCT01235949|617146648|FG005|Primary Phase|Adverse Event|0|||
170765786|NCT01235949|617146649|FG006|Primary Phase|Adverse Event|0|||
170765787|NCT01235949|617146650|FG007|Primary Phase|Adverse Event|0|||
170765788|NCT01235949|617146651|FG008|Primary Phase|Adverse Event|0|||
170765789|NCT01235949|617146652|FG009|Primary Phase|Adverse Event|0|||
170765790|NCT01235949|617146653|FG010|Primary Phase|Adverse Event|0|||
170765791|NCT01235949|617146654|FG011|Primary Phase|Adverse Event|0|||
170765792|NCT01235949|617146655|FG012|Primary Phase|Adverse Event|0|||
170765793|NCT01235949|617146656|FG013|Primary Phase|Adverse Event|0|||
170765794|NCT01235949|617146657|FG014|Primary Phase|Adverse Event|0|||
170765795|NCT01235949|617146658|FG015|Primary Phase|Adverse Event|0|||
170765796|NCT01235949|617146659|FG016|Primary Phase|Adverse Event|0|||
170765797|NCT01235949|617146660|FG017|Primary Phase|Adverse Event|0|||
170765798|NCT01235949|617146643|FG000|Primary Phase|Withdrawal by Subject|3|||
170765799|NCT01235949|617146644|FG001|Primary Phase|Withdrawal by Subject|2|||
170765800|NCT01235949|617146645|FG002|Primary Phase|Withdrawal by Subject|2|||
170765801|NCT01235949|617146646|FG003|Primary Phase|Withdrawal by Subject|0|||
170765802|NCT01235949|617146647|FG004|Primary Phase|Withdrawal by Subject|0|||
170765803|NCT01235949|617146648|FG005|Primary Phase|Withdrawal by Subject|3|||
170765804|NCT01235949|617146649|FG006|Primary Phase|Withdrawal by Subject|0|||
170765805|NCT01235949|617146650|FG007|Primary Phase|Withdrawal by Subject|0|||
170765806|NCT01235949|617146651|FG008|Primary Phase|Withdrawal by Subject|0|||
170765807|NCT01235949|617146652|FG009|Primary Phase|Withdrawal by Subject|0|||
170765808|NCT01235949|617146653|FG010|Primary Phase|Withdrawal by Subject|0|||
170765809|NCT01235949|617146654|FG011|Primary Phase|Withdrawal by Subject|0|||
170765810|NCT01235949|617146655|FG012|Primary Phase|Withdrawal by Subject|0|||
170765811|NCT01235949|617146656|FG013|Primary Phase|Withdrawal by Subject|0|||
170765812|NCT01235949|617146657|FG014|Primary Phase|Withdrawal by Subject|0|||
170765813|NCT01235949|617146658|FG015|Primary Phase|Withdrawal by Subject|0|||
170765814|NCT01235949|617146659|FG016|Primary Phase|Withdrawal by Subject|0|||
170765815|NCT01235949|617146660|FG017|Primary Phase|Withdrawal by Subject|0|||
170765816|NCT01235949|617146643|FG000|Primary Phase|Lost to Follow-up|0|||
170765817|NCT01235949|617146644|FG001|Primary Phase|Lost to Follow-up|0|||
170765818|NCT01235949|617146645|FG002|Primary Phase|Lost to Follow-up|1|||
170765819|NCT01235949|617146646|FG003|Primary Phase|Lost to Follow-up|1|||
170765820|NCT01235949|617146647|FG004|Primary Phase|Lost to Follow-up|0|||
170765821|NCT01235949|617146648|FG005|Primary Phase|Lost to Follow-up|2|||
170765822|NCT01235949|617146649|FG006|Primary Phase|Lost to Follow-up|0|||
170765823|NCT01235949|617146650|FG007|Primary Phase|Lost to Follow-up|0|||
170765824|NCT01235949|617146651|FG008|Primary Phase|Lost to Follow-up|0|||
170765825|NCT01235949|617146652|FG009|Primary Phase|Lost to Follow-up|0|||
170765826|NCT01235949|617146653|FG010|Primary Phase|Lost to Follow-up|0|||
170765827|NCT01235949|617146654|FG011|Primary Phase|Lost to Follow-up|0|||
170765828|NCT01235949|617146655|FG012|Primary Phase|Lost to Follow-up|0|||
170765829|NCT01235949|617146656|FG013|Primary Phase|Lost to Follow-up|0|||
170765830|NCT01235949|617146657|FG014|Primary Phase|Lost to Follow-up|0|||
170765831|NCT01235949|617146658|FG015|Primary Phase|Lost to Follow-up|0|||
170765832|NCT01235949|617146659|FG016|Primary Phase|Lost to Follow-up|0|||
170765833|NCT01235949|617146660|FG017|Primary Phase|Lost to Follow-up|0|||
170765834|NCT01235949|617146643|FG000|Booster Phase|Migrated/moved from study area|0|||
170765835|NCT01235949|617146644|FG001|Booster Phase|Migrated/moved from study area|0|||
170765836|NCT01235949|617146645|FG002|Booster Phase|Migrated/moved from study area|0|||
170765837|NCT01235949|617146646|FG003|Booster Phase|Migrated/moved from study area|0|||
170765838|NCT01235949|617146647|FG004|Booster Phase|Migrated/moved from study area|0|||
170868563|NCT04178967|617530319|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170868564|NCT04178967|617530320|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170765839|NCT01235949|617146648|FG005|Booster Phase|Migrated/moved from study area|0|||
170765840|NCT01235949|617146649|FG006|Booster Phase|Migrated/moved from study area|0|||
170765841|NCT01235949|617146650|FG007|Booster Phase|Migrated/moved from study area|0|||
170765842|NCT01235949|617146651|FG008|Booster Phase|Migrated/moved from study area|0|||
170765843|NCT01235949|617146652|FG009|Booster Phase|Migrated/moved from study area|0|||
170765844|NCT01235949|617146653|FG010|Booster Phase|Migrated/moved from study area|0|||
170765845|NCT01235949|617146654|FG011|Booster Phase|Migrated/moved from study area|1|||
170765846|NCT01235949|617146655|FG012|Booster Phase|Migrated/moved from study area|1|||
170765847|NCT01235949|617146656|FG013|Booster Phase|Migrated/moved from study area|0|||
170765848|NCT01235949|617146657|FG014|Booster Phase|Migrated/moved from study area|0|||
170765849|NCT01235949|617146658|FG015|Booster Phase|Migrated/moved from study area|0|||
170765850|NCT01235949|617146659|FG016|Booster Phase|Migrated/moved from study area|0|||
170765851|NCT01235949|617146660|FG017|Booster Phase|Migrated/moved from study area|1|||
170765852|NCT01235949|617146643|FG000|Booster Phase|Adverse Event|0|||
170765853|NCT01235949|617146644|FG001|Booster Phase|Adverse Event|0|||
170765854|NCT01235949|617146645|FG002|Booster Phase|Adverse Event|0|||
170765855|NCT01235949|617146646|FG003|Booster Phase|Adverse Event|0|||
170765856|NCT01235949|617146647|FG004|Booster Phase|Adverse Event|0|||
170765857|NCT01235949|617146648|FG005|Booster Phase|Adverse Event|0|||
170765858|NCT01235949|617146649|FG006|Booster Phase|Adverse Event|0|||
170765859|NCT01235949|617146650|FG007|Booster Phase|Adverse Event|0|||
170765860|NCT01235949|617146651|FG008|Booster Phase|Adverse Event|0|||
170765861|NCT01235949|617146652|FG009|Booster Phase|Adverse Event|0|||
170765862|NCT01235949|617146653|FG010|Booster Phase|Adverse Event|0|||
170765863|NCT01235949|617146654|FG011|Booster Phase|Adverse Event|0|||
170765864|NCT01235949|617146655|FG012|Booster Phase|Adverse Event|0|||
170765865|NCT01235949|617146656|FG013|Booster Phase|Adverse Event|0|||
170765866|NCT01235949|617146657|FG014|Booster Phase|Adverse Event|0|||
170765867|NCT01235949|617146658|FG015|Booster Phase|Adverse Event|1|||
170765868|NCT01235949|617146659|FG016|Booster Phase|Adverse Event|0|||
170765869|NCT01235949|617146660|FG017|Booster Phase|Adverse Event|0|||
170765870|NCT01235949|617146643|FG000|Booster Phase|Withdrawal by Subject|0|||
170765871|NCT01235949|617146644|FG001|Booster Phase|Withdrawal by Subject|0|||
170868565|NCT04178967|617530321|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170868566|NCT04178967|617530322|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170868567|NCT04178967|617530323|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170868568|NCT04178967|617530324|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170868569|NCT04178967|617530325|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170868570|NCT04178967|617530326|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
170868571|NCT04178967|617530327|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
170868572|NCT04178967|617530328|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
170868573|NCT04178967|617530318|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868574|NCT04178967|617530319|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868575|NCT04178967|617530320|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868576|NCT04178967|617530321|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868577|NCT04178967|617530322|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868578|NCT04178967|617530323|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868579|NCT04178967|617530324|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868580|NCT04178967|617530325|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868581|NCT04178967|617530326|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868582|NCT04178967|617530327|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
170868583|NCT04178967|617530328|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170868584|NCT04178967|617530318|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170868585|NCT04178967|617530319|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170868586|NCT04178967|617530320|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170868587|NCT04178967|617530321|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170868588|NCT04178967|617530322|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170868589|NCT04178967|617530323|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170868590|NCT04178967|617530324|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170868591|NCT04178967|617530325|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170868592|NCT04178967|617530326|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
170868593|NCT04178967|617530327|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
170868594|NCT04178967|617530328|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
170868595|NCT04178967|617530318|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170868596|NCT04178967|617530319|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170765872|NCT01235949|617146645|FG002|Booster Phase|Withdrawal by Subject|0|||
170765873|NCT01235949|617146646|FG003|Booster Phase|Withdrawal by Subject|0|||
170765874|NCT01235949|617146647|FG004|Booster Phase|Withdrawal by Subject|0|||
170868597|NCT04178967|617530320|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170868598|NCT04178967|617530321|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170868599|NCT04178967|617530322|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170868600|NCT04178967|617530323|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170868601|NCT04178967|617530324|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170765875|NCT01235949|617146648|FG005|Booster Phase|Withdrawal by Subject|0|||
170765876|NCT01235949|617146649|FG006|Booster Phase|Withdrawal by Subject|0|||
170765877|NCT01235949|617146650|FG007|Booster Phase|Withdrawal by Subject|1|||
170765878|NCT01235949|617146651|FG008|Booster Phase|Withdrawal by Subject|1|||
170765879|NCT01235949|617146652|FG009|Booster Phase|Withdrawal by Subject|0|||
170765880|NCT01235949|617146653|FG010|Booster Phase|Withdrawal by Subject|1|||
170765881|NCT01235949|617146654|FG011|Booster Phase|Withdrawal by Subject|1|||
170765882|NCT01235949|617146655|FG012|Booster Phase|Withdrawal by Subject|2|||
170765883|NCT01235949|617146656|FG013|Booster Phase|Withdrawal by Subject|0|||
170765884|NCT01235949|617146657|FG014|Booster Phase|Withdrawal by Subject|2|||
170765885|NCT01235949|617146658|FG015|Booster Phase|Withdrawal by Subject|0|||
170765886|NCT01235949|617146659|FG016|Booster Phase|Withdrawal by Subject|0|||
170765887|NCT01235949|617146660|FG017|Booster Phase|Withdrawal by Subject|0|||
170765888|NCT01235949|617146643|FG000|Booster Phase|Lost to Follow-up|0|||
170765889|NCT01235949|617146644|FG001|Booster Phase|Lost to Follow-up|0|||
170765890|NCT01235949|617146645|FG002|Booster Phase|Lost to Follow-up|0|||
170765891|NCT01235949|617146646|FG003|Booster Phase|Lost to Follow-up|0|||
170765892|NCT01235949|617146647|FG004|Booster Phase|Lost to Follow-up|0|||
170765893|NCT01235949|617146648|FG005|Booster Phase|Lost to Follow-up|0|||
170765894|NCT01235949|617146649|FG006|Booster Phase|Lost to Follow-up|0|||
170765895|NCT01235949|617146650|FG007|Booster Phase|Lost to Follow-up|0|||
170765896|NCT01235949|617146651|FG008|Booster Phase|Lost to Follow-up|1|||
170765897|NCT01235949|617146652|FG009|Booster Phase|Lost to Follow-up|1|||
170765898|NCT01235949|617146653|FG010|Booster Phase|Lost to Follow-up|1|||
170765899|NCT01235949|617146654|FG011|Booster Phase|Lost to Follow-up|1|||
170765900|NCT01235949|617146655|FG012|Booster Phase|Lost to Follow-up|0|||
170765901|NCT01235949|617146656|FG013|Booster Phase|Lost to Follow-up|0|||
170765902|NCT01235949|617146657|FG014|Booster Phase|Lost to Follow-up|0|||
170765903|NCT01235949|617146658|FG015|Booster Phase|Lost to Follow-up|0|||
170765904|NCT01235949|617146659|FG016|Booster Phase|Lost to Follow-up|0|||
170765905|NCT01235949|617146660|FG017|Booster Phase|Lost to Follow-up|1|||
170765906|NCT00619645|617146661|FG000|Overall Study|Adverse Event|1|||
170765907|NCT04364269|617146662|FG000|Overall Study|Adverse Event|1|||
170765908|NCT04364269|617146663|FG001|Overall Study|Adverse Event|0|||
170765909|NCT04364269|617146664|FG002|Overall Study|Adverse Event|0|||
170765910|NCT04364269|617146662|FG000|Overall Study|Withdrawal by Subject|0|||
170765911|NCT04364269|617146663|FG001|Overall Study|Withdrawal by Subject|1|||
170765912|NCT04364269|617146664|FG002|Overall Study|Withdrawal by Subject|0|||
170765913|NCT04173572|617146665|FG000|Overall Study|Withdrawal by Subject|1|||
170765914|NCT04173572|617146666|FG001|Overall Study|Withdrawal by Subject|5|||
170765915|NCT04173572|617146665|FG000|Overall Study|Lost to Follow-up|3|||
170765916|NCT04173572|617146666|FG001|Overall Study|Lost to Follow-up|1|||
170765917|NCT02026258|617146667|FG000|Randomized|Did not start treatment|2|||
170765918|NCT02026258|617146668|FG001|Randomized|Did not start treatment|1|||
170765919|NCT02026258|617146667|FG000|Randomized|Change in treatment plan|1|||
170765920|NCT02026258|617146668|FG001|Randomized|Change in treatment plan|0|||
170765921|NCT02026258|617146667|FG000|Randomized|Presence of periodontal disease|1|||
170765922|NCT02026258|617146668|FG001|Randomized|Presence of periodontal disease|1|||
170765923|NCT02026258|617146667|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
170765924|NCT02026258|617146668|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
170765925|NCT02026258|617146667|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
170765926|NCT02026258|617146668|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
170765927|NCT04439799|617146669|FG000|Overall Study|Lost to Follow-up|6|||
170765928|NCT04439799|617146670|FG001|Overall Study|Lost to Follow-up|6|||
170765929|NCT04439799|617146669|FG000|Overall Study|Withdrawal by Subject|2|||
170765930|NCT04439799|617146670|FG001|Overall Study|Withdrawal by Subject|6|||
170765931|NCT04439799|617146669|FG000|Overall Study|Adverse Event|2|||
170868602|NCT04178967|617530325|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170765932|NCT04439799|617146670|FG001|Overall Study|Adverse Event|5|||
170765933|NCT03478696|617146677|FG000|Overall Study|Adverse Event|1|||
170765934|NCT03478696|617146678|FG001|Overall Study|Adverse Event|5|||
170765935|NCT03478696|617146677|FG000|Overall Study|Lost to Follow-up|1|||
170765936|NCT03478696|617146678|FG001|Overall Study|Lost to Follow-up|0|||
170765937|NCT03478696|617146677|FG000|Overall Study|Physician Decision|6|||
170765938|NCT03478696|617146678|FG001|Overall Study|Physician Decision|3|||
170765939|NCT03478696|617146677|FG000|Overall Study|Withdrawal by Subject|9|||
170765940|NCT03478696|617146678|FG001|Overall Study|Withdrawal by Subject|4|||
170765941|NCT00639002|617146679|FG000|Overall Study|Death|1|||
170765942|NCT00639002|617146679|FG000|Overall Study|Adverse Event|1|||
170765943|NCT00639002|617146679|FG000|Overall Study|Protocol Violation|1|||
170765944|NCT00639002|617146679|FG000|Overall Study|Disease progression|3|||
170765945|NCT00639002|617146679|FG000|Overall Study|Physician Decision|6|||
170765946|NCT00639002|617146679|FG000|Overall Study|Lack of Efficacy|1|||
170765947|NCT01161498|617146681|FG000|Overall Study|Disease Progression|0|||
170765948|NCT01161498|617146682|FG001|Overall Study|Disease Progression|1|||
170765949|NCT00823979|617146693|FG000|Overall Study|Lack of Efficacy|13|||
170765950|NCT00823979|617146694|FG001|Overall Study|Lack of Efficacy|16|||
170765951|NCT00823979|617146695|FG002|Overall Study|Lack of Efficacy|9|||
170765952|NCT00823979|617146693|FG000|Overall Study|Lost to Follow-up|2|||
170765953|NCT00823979|617146694|FG001|Overall Study|Lost to Follow-up|1|||
170765954|NCT00823979|617146695|FG002|Overall Study|Lost to Follow-up|0|||
170765955|NCT00823979|617146693|FG000|Overall Study|Withdrawal by Subject|2|||
170765956|NCT00823979|617146694|FG001|Overall Study|Withdrawal by Subject|3|||
170765957|NCT00823979|617146695|FG002|Overall Study|Withdrawal by Subject|2|||
170765958|NCT00823979|617146693|FG000|Overall Study|Protocol Violation|1|||
170765959|NCT00823979|617146694|FG001|Overall Study|Protocol Violation|1|||
170765960|NCT00823979|617146695|FG002|Overall Study|Protocol Violation|0|||
170765961|NCT00823979|617146693|FG000|Overall Study|Pregnancy|0|||
170765962|NCT00823979|617146694|FG001|Overall Study|Pregnancy|1|||
170765963|NCT00823979|617146695|FG002|Overall Study|Pregnancy|0|||
170765964|NCT00823979|617146693|FG000|Overall Study|Adverse Event|0|||
170765965|NCT00823979|617146694|FG001|Overall Study|Adverse Event|2|||
170765966|NCT00823979|617146695|FG002|Overall Study|Adverse Event|4|||
170765967|NCT00823979|617146693|FG000|Overall Study|Other|2|||
170765968|NCT00823979|617146694|FG001|Overall Study|Other|0|||
170765969|NCT00823979|617146695|FG002|Overall Study|Other|1|||
170765970|NCT00823979|617146693|FG000|Overall Study|Randomized but not Treated|4|||
170765971|NCT00823979|617146694|FG001|Overall Study|Randomized but not Treated|3|||
170765972|NCT00823979|617146695|FG002|Overall Study|Randomized but not Treated|1|||
170765973|NCT00823979|617146693|FG000|Overall Study|Study Terminated by Sponsor|5|||
170765974|NCT00823979|617146694|FG001|Overall Study|Study Terminated by Sponsor|5|||
170765975|NCT00823979|617146695|FG002|Overall Study|Study Terminated by Sponsor|7|||
170765976|NCT02781584|617146696|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
170765977|NCT02781584|617146697|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
170765978|NCT02781584|617146698|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
170765979|NCT02781584|617146699|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
170765980|NCT02781584|617146700|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
170765981|NCT02781584|617146701|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
170765982|NCT02781584|617146702|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
170765983|NCT02781584|617146703|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
170765984|NCT02781584|617146704|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
170765985|NCT02781584|617146705|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
170765986|NCT02781584|617146706|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
170765987|NCT02781584|617146707|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
170765988|NCT02781584|617146708|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
170765989|NCT02781584|617146696|FG000|Pre-treatment Phase|Adverse Event|0|||
170765990|NCT02781584|617146697|FG001|Pre-treatment Phase|Adverse Event|0|||
170765991|NCT02781584|617146698|FG002|Pre-treatment Phase|Adverse Event|0|||
170765992|NCT02781584|617146699|FG003|Pre-treatment Phase|Adverse Event|0|||
170765993|NCT02781584|617146700|FG004|Pre-treatment Phase|Adverse Event|0|||
170765994|NCT02781584|617146701|FG005|Pre-treatment Phase|Adverse Event|0|||
170765995|NCT02781584|617146702|FG006|Pre-treatment Phase|Adverse Event|0|||
170765996|NCT02781584|617146703|FG007|Pre-treatment Phase|Adverse Event|0|||
170765997|NCT02781584|617146704|FG008|Pre-treatment Phase|Adverse Event|0|||
170765998|NCT02781584|617146705|FG009|Pre-treatment Phase|Adverse Event|0|||
170765999|NCT02781584|617146706|FG010|Pre-treatment Phase|Adverse Event|0|||
170766000|NCT02781584|617146707|FG011|Pre-treatment Phase|Adverse Event|1|||
170766001|NCT02781584|617146708|FG012|Pre-treatment Phase|Adverse Event|0|||
170766002|NCT02781584|617146696|FG000|Treatment Phase|Withdrew Consent|0|||
170766003|NCT02781584|617146697|FG001|Treatment Phase|Withdrew Consent|0|||
170868603|NCT04178967|617530326|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170411611|NCT03731182|615847155|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
170411612|NCT05487456|615847160|FG000|Overall Study|Withdrawal by Subject|0|||
170411613|NCT05487456|615847161|FG001|Overall Study|Withdrawal by Subject|0|||
170411614|NCT05487456|615847162|FG002|Overall Study|Withdrawal by Subject|1|||
170411615|NCT05487456|615847163|FG003|Overall Study|Withdrawal by Subject|0|||
170411616|NCT03294538|615847164|FG000|Overall Study|Adverse Event|0|||
170411617|NCT03294538|615847165|FG001|Overall Study|Adverse Event|1|||
170411618|NCT03294538|615847166|FG002|Overall Study|Adverse Event|1|||
170411619|NCT03294538|615847164|FG000|Overall Study|Lost to Follow-up|1|||
170411620|NCT03294538|615847165|FG001|Overall Study|Lost to Follow-up|0|||
170411621|NCT03294538|615847166|FG002|Overall Study|Lost to Follow-up|0|||
170411622|NCT03294538|615847164|FG000|Overall Study|Outside of Visit Window|4|||
170411623|NCT03294538|615847165|FG001|Overall Study|Outside of Visit Window|4|||
170766004|NCT02781584|617146698|FG002|Treatment Phase|Withdrew Consent|0|||
170766005|NCT02781584|617146699|FG003|Treatment Phase|Withdrew Consent|0|||
170766006|NCT02781584|617146700|FG004|Treatment Phase|Withdrew Consent|0|||
170766007|NCT02781584|617146701|FG005|Treatment Phase|Withdrew Consent|1|||
170411624|NCT03294538|615847166|FG002|Overall Study|Outside of Visit Window|1|||
170411625|NCT02207621|615847168|FG000|Overall Study|Adverse Event|71|||
170766008|NCT02781584|617146702|FG006|Treatment Phase|Withdrew Consent|0|||
170766009|NCT02781584|617146703|FG007|Treatment Phase|Withdrew Consent|0|||
170766010|NCT02781584|617146704|FG008|Treatment Phase|Withdrew Consent|0|||
170766011|NCT02781584|617146705|FG009|Treatment Phase|Withdrew Consent|0|||
170766012|NCT02781584|617146706|FG010|Treatment Phase|Withdrew Consent|1|||
170766013|NCT02781584|617146707|FG011|Treatment Phase|Withdrew Consent|2|||
170766014|NCT02781584|617146708|FG012|Treatment Phase|Withdrew Consent|0|||
170766015|NCT02781584|617146696|FG000|Treatment Phase|Adverse Event|0|||
170766016|NCT02781584|617146697|FG001|Treatment Phase|Adverse Event|0|||
170766017|NCT02781584|617146698|FG002|Treatment Phase|Adverse Event|0|||
170766018|NCT02781584|617146699|FG003|Treatment Phase|Adverse Event|0|||
170766019|NCT02781584|617146700|FG004|Treatment Phase|Adverse Event|0|||
170766020|NCT02781584|617146701|FG005|Treatment Phase|Adverse Event|0|||
170766021|NCT02781584|617146702|FG006|Treatment Phase|Adverse Event|0|||
170766022|NCT02781584|617146703|FG007|Treatment Phase|Adverse Event|1|||
170766023|NCT02781584|617146704|FG008|Treatment Phase|Adverse Event|0|||
170766024|NCT02781584|617146705|FG009|Treatment Phase|Adverse Event|0|||
170766025|NCT02781584|617146706|FG010|Treatment Phase|Adverse Event|0|||
170766026|NCT02781584|617146707|FG011|Treatment Phase|Adverse Event|0|||
170766027|NCT02781584|617146708|FG012|Treatment Phase|Adverse Event|0|||
170766028|NCT03523091|617146709|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
170766029|NCT03523091|617146710|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
170766030|NCT03523091|617146709|FG000|Overall Study|Withdrawal by Subject|0|||
170766031|NCT03523091|617146710|FG001|Overall Study|Withdrawal by Subject|3|||
170766032|NCT03523091|617146709|FG000|Overall Study|Increase Botox dose|0|||
170766033|NCT03523091|617146710|FG001|Overall Study|Increase Botox dose|1|||
170766034|NCT00995709|617146711|FG000|Overall Study|Adverse Event|4|||
170766035|NCT00995709|617146712|FG001|Overall Study|Adverse Event|2|||
170766036|NCT00995709|617146713|FG002|Overall Study|Adverse Event|0|||
170766037|NCT00995709|617146711|FG000|Overall Study|Lack of Efficacy|0|||
170766038|NCT00995709|617146712|FG001|Overall Study|Lack of Efficacy|1|||
170766039|NCT00995709|617146713|FG002|Overall Study|Lack of Efficacy|4|||
170766040|NCT00995709|617146711|FG000|Overall Study|Withdrawal by Subject|0|||
170766041|NCT00995709|617146712|FG001|Overall Study|Withdrawal by Subject|4|||
170766042|NCT00995709|617146713|FG002|Overall Study|Withdrawal by Subject|1|||
170766043|NCT00995709|617146711|FG000|Overall Study|Lost to Follow-up|1|||
170766044|NCT00995709|617146712|FG001|Overall Study|Lost to Follow-up|0|||
170766045|NCT00995709|617146713|FG002|Overall Study|Lost to Follow-up|0|||
170766046|NCT00995709|617146711|FG000|Overall Study|Death|0|||
170766047|NCT00995709|617146712|FG001|Overall Study|Death|1|||
170766048|NCT00995709|617146713|FG002|Overall Study|Death|0|||
170766049|NCT00995709|617146711|FG000|Overall Study|Protocol Violation|2|||
170766050|NCT00995709|617146712|FG001|Overall Study|Protocol Violation|1|||
170766051|NCT00995709|617146713|FG002|Overall Study|Protocol Violation|0|||
170766052|NCT01697319|617146714|FG000|Primary Phase|Withdrawal by Subject|1|||
170766053|NCT01697319|617146714|FG000|Extension Phase|Terminated by Sponsor|15|||
170766054|NCT00604721|617146717|FG000|Overall Study|Physician Decision|1|||
170766055|NCT00604721|617146717|FG000|Overall Study|Withdrawal by Subject|1|||
170766056|NCT04776213|617146720|FG000|Overall Study|Other|1|||
170766057|NCT04776213|617146720|FG000|Overall Study|Withdrawal by Subject|7|||
170766058|NCT04776213|617146720|FG000|Overall Study|Protocol Violation|1|||
170766059|NCT04776213|617146720|FG000|Overall Study|Lost to Follow-up|2|||
170766060|NCT01769391|617146721|FG000|Overall Study|Death|10|||
170766061|NCT01769391|617146722|FG001|Overall Study|Death|1|||
170766062|NCT01769391|617146721|FG000|Overall Study|Adverse Event|0|||
170766063|NCT01769391|617146722|FG001|Overall Study|Adverse Event|3|||
170766064|NCT01769391|617146721|FG000|Overall Study|Progressive Disease|1|||
170766065|NCT01769391|617146722|FG001|Overall Study|Progressive Disease|2|||
170766066|NCT01769391|617146721|FG000|Overall Study|Withdrawal by Subject|4|||
170766067|NCT01769391|617146722|FG001|Overall Study|Withdrawal by Subject|3|||
170766068|NCT01769391|617146721|FG000|Overall Study|Investigator Decision|2|||
170411626|NCT02207621|615847169|FG001|Overall Study|Adverse Event|15|||
170766069|NCT01769391|617146722|FG001|Overall Study|Investigator Decision|0|||
170411627|NCT02207621|615847170|FG002|Overall Study|Adverse Event|132|||
170766070|NCT00038103|617146723|FG000|Overall Study|Adverse Event|5|||
170766071|NCT00038103|617146724|FG001|Overall Study|Adverse Event|6|||
170766072|NCT00038103|617146723|FG000|Overall Study|Lack of Efficacy|48|||
170766073|NCT00038103|617146724|FG001|Overall Study|Lack of Efficacy|41|||
170766074|NCT00038103|617146723|FG000|Overall Study|Withdrawal by Subject|0|||
170766075|NCT00038103|617146724|FG001|Overall Study|Withdrawal by Subject|3|||
170766076|NCT00038103|617146723|FG000|Overall Study|Lost to Follow-up|0|||
170766077|NCT00038103|617146724|FG001|Overall Study|Lost to Follow-up|3|||
170766078|NCT00038103|617146723|FG000|Overall Study|Protocol Violation|0|||
170766079|NCT00038103|617146724|FG001|Overall Study|Protocol Violation|2|||
170766080|NCT00038103|617146723|FG000|Overall Study|Sponsor Decision|0|||
170766081|NCT00038103|617146724|FG001|Overall Study|Sponsor Decision|1|||
170766082|NCT00038103|617146723|FG000|Overall Study|Randomized/never treated|2|||
170766083|NCT00038103|617146724|FG001|Overall Study|Randomized/never treated|0|||
170766084|NCT00208767|617146731|FG000|Overall Study|Adverse Event|9|||
170766085|NCT00208767|617146732|FG001|Overall Study|Adverse Event|1|||
170522015|NCT02227784|616256210|FG001|Double-Blind Phase|Physician Decision|0|||
170522016|NCT02227784|616256211|FG002|Double-Blind Phase|Physician Decision|0|||
170522017|NCT02227784|616256212|FG003|Double-Blind Phase|Physician Decision|1|||
170522018|NCT02227784|616256213|FG004|Double-Blind Phase|Physician Decision|0|||
170522019|NCT02227784|616256209|FG000|Double-Blind Phase|Protocol Violation|0|||
170522020|NCT02227784|616256210|FG001|Double-Blind Phase|Protocol Violation|0|||
170522021|NCT02227784|616256211|FG002|Double-Blind Phase|Protocol Violation|1|||
170522022|NCT02227784|616256212|FG003|Double-Blind Phase|Protocol Violation|1|||
170522023|NCT02227784|616256213|FG004|Double-Blind Phase|Protocol Violation|0|||
170522024|NCT02227784|616256209|FG000|Double-Blind Phase|Sponsor Decision|34|||
170522025|NCT02227784|616256210|FG001|Double-Blind Phase|Sponsor Decision|15|||
170522026|NCT02227784|616256211|FG002|Double-Blind Phase|Sponsor Decision|14|||
170766086|NCT00208767|617146731|FG000|Overall Study|Withdrawal by Subject|14|||
170766087|NCT00208767|617146732|FG001|Overall Study|Withdrawal by Subject|3|||
170766088|NCT00208767|617146731|FG000|Overall Study|Death|1|||
170766089|NCT00208767|617146732|FG001|Overall Study|Death|0|||
170766090|NCT00208767|617146731|FG000|Overall Study|Lost to Follow-up|3|||
170766091|NCT00208767|617146732|FG001|Overall Study|Lost to Follow-up|3|||
170766092|NCT03418324|617146733|FG000|Overall Study|Death|0|||
170766093|NCT03418324|617146734|FG001|Overall Study|Death|1|||
170766094|NCT03418324|617146733|FG000|Overall Study|Physician Decision|1|||
170766095|NCT03418324|617146734|FG001|Overall Study|Physician Decision|1|||
170766096|NCT01768676|617146735|FG000|Overall Study|Adverse Event|3|||
170766097|NCT01768676|617146736|FG001|Overall Study|Adverse Event|3|||
170766098|NCT01768676|617146735|FG000|Overall Study|Lost to Follow-up|13|||
170766099|NCT01768676|617146736|FG001|Overall Study|Lost to Follow-up|16|||
170766100|NCT01768676|617146735|FG000|Overall Study|Protocol Violation|1|||
170766101|NCT01768676|617146736|FG001|Overall Study|Protocol Violation|1|||
170766102|NCT01768676|617146735|FG000|Overall Study|Physician Decision|4|||
170766103|NCT01768676|617146736|FG001|Overall Study|Physician Decision|1|||
170766104|NCT01768676|617146735|FG000|Overall Study|Withdrawal by Subject|3|||
170766105|NCT01768676|617146736|FG001|Overall Study|Withdrawal by Subject|10|||
170766106|NCT03395353|617146737|FG000|Overall Study|Adverse Event|20|||
170766107|NCT03395353|617146737|FG000|Overall Study|Protocol Violation|1|||
170766108|NCT03395353|617146737|FG000|Overall Study|Lack of Efficacy|3|||
170766109|NCT03395353|617146737|FG000|Overall Study|Withdrawal by Subject|24|||
170766110|NCT03395353|617146737|FG000|Overall Study|Discontinued visit|1|||
170766111|NCT03395353|617146737|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
170766112|NCT03395353|617146737|FG000|Overall Study|Physician Decision|4|||
170766113|NCT03395353|617146737|FG000|Overall Study|Early termination of overall study|33|||
170766114|NCT04248829|617146740|FG000|Overall Study|Disease progression|44|||
170766115|NCT04248829|617146741|FG001|Overall Study|Disease progression|109|||
170766116|NCT04248829|617146740|FG000|Overall Study|Adverse Event|19|||
170766117|NCT04248829|617146741|FG001|Overall Study|Adverse Event|18|||
170766118|NCT04248829|617146740|FG000|Overall Study|Withdrawal by Subject|11|||
170766119|NCT04248829|617146741|FG001|Overall Study|Withdrawal by Subject|2|||
170766120|NCT04248829|617146740|FG000|Overall Study|Lost to Follow-up|0|||
170766121|NCT04248829|617146741|FG001|Overall Study|Lost to Follow-up|1|||
170766122|NCT04248829|617146740|FG000|Overall Study|Death|12|||
170766123|NCT04248829|617146741|FG001|Overall Study|Death|14|||
170766124|NCT04248829|617146740|FG000|Overall Study|Physician Decision|2|||
170766125|NCT04248829|617146741|FG001|Overall Study|Physician Decision|4|||
170766126|NCT04248829|617146740|FG000|Overall Study|Any reason not specifically recorded|0|||
170766127|NCT04248829|617146741|FG001|Overall Study|Any reason not specifically recorded|2|||
170766128|NCT02299336|617146742|FG000|Overall Study|Withdrawal by Subject|11|||
170766129|NCT02299336|617146742|FG000|Overall Study|Adverse Event|1|||
170766130|NCT02299336|617146742|FG000|Overall Study|Death|1|||
170766131|NCT02299336|617146742|FG000|Overall Study|Lost to Follow-up|1|||
170766132|NCT01304147|617146744|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
170522027|NCT02227784|616256212|FG003|Double-Blind Phase|Sponsor Decision|32|||
170522028|NCT02227784|616256213|FG004|Double-Blind Phase|Sponsor Decision|0|||
170522029|NCT02227784|616256209|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
170522030|NCT02227784|616256210|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
170522031|NCT02227784|616256211|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
170522032|NCT02227784|616256212|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
170766133|NCT01304147|617146745|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
170766134|NCT01278862|617146746|FG000|Overall Study|Lost to Follow-up|1|||
170766135|NCT01278862|617146747|FG001|Overall Study|Lost to Follow-up|1|||
170522033|NCT02227784|616256213|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
170766136|NCT02952261|617146748|FG000|Overall Study|Withdrawal by Subject|4|||
170766137|NCT02952261|617146749|FG001|Overall Study|Withdrawal by Subject|5|||
170766138|NCT02952261|617146748|FG000|Overall Study|Protocol Violation|1|||
170766139|NCT02952261|617146749|FG001|Overall Study|Protocol Violation|0|||
170766140|NCT03215927|617149018|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
170766141|NCT03215927|617149019|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
170766142|NCT03215927|617149018|FG000|Open Label Extension|Adverse Event|1|||
170766143|NCT03215927|617149019|FG001|Open Label Extension|Adverse Event|0|||
170766144|NCT03215927|617149018|FG000|Open Label Extension|Lack of Efficacy|1|||
170868604|NCT04178967|617530327|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
170868605|NCT04178967|617530328|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
170868606|NCT04178967|617530318|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868607|NCT04178967|617530319|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868608|NCT04178967|617530320|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868609|NCT04178967|617530321|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868610|NCT04178967|617530322|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868611|NCT04178967|617530323|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868612|NCT04178967|617530324|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868613|NCT04178967|617530325|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868614|NCT04178967|617530326|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868615|NCT04178967|617530327|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
170868616|NCT04178967|617530328|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
170868617|NCT01975428|617530329|FG000|Overall Study|Lost to Follow-up|17|||
170868618|NCT01975428|617530330|FG001|Overall Study|Lost to Follow-up|4|||
170868619|NCT01975428|617530329|FG000|Overall Study|Withdrawal by Subject|3|||
170868620|NCT01975428|617530330|FG001|Overall Study|Withdrawal by Subject|10|||
170868621|NCT02187809|617530331|FG000|Overall Study|The study was terminated|3|||
170868622|NCT00628251|617530332|FG000|Randomised Part|Withdrawal by Subject|0|||
170868623|NCT00628251|617530333|FG001|Randomised Part|Withdrawal by Subject|0|||
170868624|NCT00628251|617530334|FG002|Randomised Part|Withdrawal by Subject|1|||
170868625|NCT00628251|617530332|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
170868626|NCT00628251|617530333|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
170868627|NCT00628251|617530334|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
170868628|NCT00628251|617530332|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
170868629|NCT00628251|617530333|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
170868630|NCT00628251|617530334|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
170868631|NCT00628251|617530332|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
170868632|NCT00628251|617530333|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
170868633|NCT00628251|617530334|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
170868634|NCT00628251|617530332|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
170868635|NCT00628251|617530333|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
170868636|NCT00628251|617530334|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
170868637|NCT00628251|617530332|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
170868638|NCT00628251|617530333|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
170868639|NCT00628251|617530334|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
170868640|NCT00995007|617530336|FG000|Overall Study|Withdrew consent|1|||
170868641|NCT00995007|617530337|FG001|Overall Study|Withdrew consent|0|||
170868642|NCT00995007|617530336|FG000|Overall Study|Refused further treatment|8|||
170868643|NCT00995007|617530337|FG001|Overall Study|Refused further treatment|2|||
170868644|NCT00995007|617530336|FG000|Overall Study|Toxicity|8|||
170868645|NCT00995007|617530337|FG001|Overall Study|Toxicity|0|||
170868646|NCT01237340|617530342|FG000|Overall Study|Adverse Event|3|||
170868647|NCT01237340|617530342|FG000|Overall Study|Withdrawal by Subject|1|||
170868648|NCT01237340|617530342|FG000|Overall Study|Early termination of the trial|36|||
170868649|NCT01610687|617530343|FG000|Overall Study|Lack of Efficacy|26|||
170868650|NCT01610687|617530343|FG000|Overall Study|Adverse Event|18|||
170868651|NCT01610687|617530343|FG000|Overall Study|Moved out of area|6|||
170868652|NCT01610687|617530343|FG000|Overall Study|Withdrawal by Subject|7|||
170868653|NCT01610687|617530343|FG000|Overall Study|Lost to Follow-up|4|||
170868654|NCT01610687|617530343|FG000|Overall Study|Symptom control without study medication|2|||
170868655|NCT01610687|617530343|FG000|Overall Study|Unable to make journey|1|||
170868656|NCT01610687|617530343|FG000|Overall Study|Death|1|||
170868657|NCT01610687|617530343|FG000|Overall Study|Cannabis affecting job|1|||
170868658|NCT01610687|617530343|FG000|Overall Study|Felt more alter without study medication|1|||
170868659|NCT00685685|617530344|FG000|Washout Period of 7 Days|Adverse Event|2|||
170868660|NCT00685685|617530345|FG001|Washout Period of 7 Days|Adverse Event|0|||
170868661|NCT00685685|617530344|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
170868662|NCT00685685|617530345|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
170868663|NCT04029116|617530346|FG000|Overall Study|Adverse Event|0|||
170868664|NCT04029116|617530347|FG001|Overall Study|Adverse Event|2|||
170868665|NCT04029116|617530346|FG000|Overall Study|Lost to Follow-up|3|||
170868666|NCT04029116|617530347|FG001|Overall Study|Lost to Follow-up|5|||
170868667|NCT04029116|617530346|FG000|Overall Study|Physician Decision|2|||
170868668|NCT04029116|617530347|FG001|Overall Study|Physician Decision|0|||
170868669|NCT04029116|617530346|FG000|Overall Study|Pregnancy|1|||
170868670|NCT04029116|617530347|FG001|Overall Study|Pregnancy|2|||
170411628|NCT02207621|615847168|FG000|Overall Study|Withdrawal by Subject|9|||
170411629|NCT02207621|615847169|FG001|Overall Study|Withdrawal by Subject|9|||
170868671|NCT04029116|617530346|FG000|Overall Study|Withdrawal by Subject|4|||
170868672|NCT04029116|617530347|FG001|Overall Study|Withdrawal by Subject|6|||
170411630|NCT02207621|615847170|FG002|Overall Study|Withdrawal by Subject|13|||
170411631|NCT02207621|615847168|FG000|Overall Study|Non-Compliant|3|||
170766145|NCT03215927|617149019|FG001|Open Label Extension|Lack of Efficacy|0|||
170766146|NCT03215927|617149018|FG000|Open Label Extension|Death|0|||
170766147|NCT03215927|617149019|FG001|Open Label Extension|Death|1|||
170766148|NCT03779048|617149020|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
170766149|NCT03779048|617149021|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
170766150|NCT03779048|617149022|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
170766151|NCT03779048|617149020|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
170766152|NCT03779048|617149021|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
170766153|NCT03779048|617149022|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
170766154|NCT03779048|617149020|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
170766155|NCT03779048|617149021|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
170766156|NCT03779048|617149022|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
170766157|NCT05147233|617149023|FG000|Overall Study|Adverse Event|0|||
170766158|NCT05147233|617149024|FG001|Overall Study|Adverse Event|1|||
170766159|NCT05147233|617149023|FG000|Overall Study|Lost to Follow-up|1|||
170766160|NCT05147233|617149024|FG001|Overall Study|Lost to Follow-up|1|||
170766161|NCT05147233|617149023|FG000|Overall Study|Protocol Violation|0|||
170766162|NCT05147233|617149024|FG001|Overall Study|Protocol Violation|1|||
170766163|NCT05147233|617149023|FG000|Overall Study|Withdrawal by Subject|2|||
170766164|NCT05147233|617149024|FG001|Overall Study|Withdrawal by Subject|1|||
170766165|NCT04517864|617149025|FG000|Placebo-Controlled Phase|Adverse Event|1|||
170766166|NCT04517864|617149026|FG001|Placebo-Controlled Phase|Adverse Event|0|||
170766167|NCT04517864|617149027|FG002|Placebo-Controlled Phase|Adverse Event|0|||
170766168|NCT04517864|617149025|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
170766169|NCT04517864|617149026|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
170766170|NCT04517864|617149027|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
170766171|NCT04517864|617149025|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
170766172|NCT04517864|617149026|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
170766173|NCT04517864|617149027|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
170766174|NCT04517864|617149025|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
170766175|NCT04517864|617149026|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
170766176|NCT04517864|617149027|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
170766177|NCT04517864|617149025|FG000|Active Therapy Extension Phase|Adverse Event|1|||
170766178|NCT04517864|617149026|FG001|Active Therapy Extension Phase|Adverse Event|0|||
170766179|NCT04517864|617149027|FG002|Active Therapy Extension Phase|Adverse Event|0|||
170766180|NCT04517864|617149025|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
170766181|NCT04517864|617149026|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
170766182|NCT04517864|617149027|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
170766183|NCT04517864|617149025|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
170766184|NCT04517864|617149026|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
170766185|NCT04517864|617149027|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
170766186|NCT04517864|617149025|FG000|Active Therapy Extension Phase|Physician Decision|1|||
170766187|NCT04517864|617149026|FG001|Active Therapy Extension Phase|Physician Decision|0|||
170766188|NCT04517864|617149027|FG002|Active Therapy Extension Phase|Physician Decision|0|||
170766189|NCT04517864|617149025|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
170766190|NCT04517864|617149026|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
170766191|NCT04517864|617149027|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
170766192|NCT04517864|617149025|FG000|Extension Phase|Adverse Event|0|||
170766193|NCT04517864|617149026|FG001|Extension Phase|Adverse Event|0|||
170766194|NCT04517864|617149027|FG002|Extension Phase|Adverse Event|1|||
170766195|NCT04517864|617149025|FG000|Extension Phase|Lack of Efficacy|0|||
170766196|NCT04517864|617149026|FG001|Extension Phase|Lack of Efficacy|0|||
170766197|NCT04517864|617149027|FG002|Extension Phase|Lack of Efficacy|2|||
170766198|NCT04517864|617149025|FG000|Extension Phase|Study Terminated By Sponsor|0|||
170766199|NCT04517864|617149026|FG001|Extension Phase|Study Terminated By Sponsor|0|||
170766200|NCT04517864|617149027|FG002|Extension Phase|Study Terminated By Sponsor|32|||
170766201|NCT04517864|617149025|FG000|Extension Phase|Withdrawal by Subject|0|||
170766202|NCT04517864|617149026|FG001|Extension Phase|Withdrawal by Subject|0|||
170766203|NCT04517864|617149027|FG002|Extension Phase|Withdrawal by Subject|3|||
170766204|NCT04517864|617149025|FG000|Extension Phase|Approved Drug Available for Indication|0|||
170766205|NCT04517864|617149026|FG001|Extension Phase|Approved Drug Available for Indication|0|||
170766206|NCT04517864|617149027|FG002|Extension Phase|Approved Drug Available for Indication|7|||
170766207|NCT03538041|617149028|FG000|12-Week Treatment Period|Adverse Event|1|||
170766208|NCT03538041|617149029|FG001|12-Week Treatment Period|Adverse Event|1|||
170766209|NCT03538041|617149028|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
170766210|NCT03538041|617149029|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
170766211|NCT03538041|617149028|FG000|Treatment Extension Period|Adverse Event|4|||
170766212|NCT03538041|617149029|FG001|Treatment Extension Period|Adverse Event|1|||
170766213|NCT03538041|617149028|FG000|Treatment Extension Period|Physician Decision|1|||
170766214|NCT03538041|617149029|FG001|Treatment Extension Period|Physician Decision|1|||
170766215|NCT03538041|617149028|FG000|Treatment Extension Period|Lack of Efficacy|1|||
170766216|NCT03538041|617149029|FG001|Treatment Extension Period|Lack of Efficacy|4|||
170766217|NCT03538041|617149028|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
170766218|NCT03538041|617149029|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
170766219|NCT03538041|617149028|FG000|Treatment Extension Period|Death|0|||
170766220|NCT03538041|617149029|FG001|Treatment Extension Period|Death|1|||
170766221|NCT03351075|617149030|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
170766222|NCT03351075|617149031|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
170766223|NCT03351075|617149030|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
170766224|NCT03351075|617149031|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
170766225|NCT03351075|617149030|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
170766226|NCT03351075|617149031|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
170766227|NCT03351075|617149030|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
170766228|NCT03351075|617149031|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
170766229|NCT01049503|617149032|FG000|Overall Study|Lost to Follow-up|11|||
170766230|NCT01049503|617149033|FG001|Overall Study|Lost to Follow-up|12|||
170766231|NCT01049503|617149034|FG002|Overall Study|Lost to Follow-up|24|||
170766232|NCT01049503|617149035|FG003|Overall Study|Lost to Follow-up|26|||
170766233|NCT01049503|617149036|FG004|Overall Study|Lost to Follow-up|27|||
170766234|NCT01049503|617149037|FG005|Overall Study|Lost to Follow-up|8|||
170766235|NCT05219253|617149047|FG000|Overall Study|Withdrawal by Subject|1|||
170766236|NCT05219253|617149048|FG001|Overall Study|Withdrawal by Subject|2|||
170766237|NCT03086369|617149049|FG000|Overall Study|Lost to Follow-up|1|||
170766238|NCT03086369|617149050|FG001|Overall Study|Lost to Follow-up|0|||
170766239|NCT03086369|617149051|FG002|Overall Study|Lost to Follow-up|0|||
170766240|NCT03086369|617149052|FG003|Overall Study|Lost to Follow-up|2|||
170766241|NCT03086369|617149053|FG004|Overall Study|Lost to Follow-up|1|||
170766242|NCT03086369|617149049|FG000|Overall Study|Physician Decision|0|||
170766243|NCT03086369|617149050|FG001|Overall Study|Physician Decision|0|||
170766244|NCT03086369|617149051|FG002|Overall Study|Physician Decision|0|||
170766245|NCT03086369|617149052|FG003|Overall Study|Physician Decision|1|||
170766246|NCT03086369|617149053|FG004|Overall Study|Physician Decision|2|||
170766247|NCT03086369|617149049|FG000|Overall Study|Withdrawal by Subject|0|||
170766248|NCT03086369|617149050|FG001|Overall Study|Withdrawal by Subject|0|||
170766249|NCT03086369|617149051|FG002|Overall Study|Withdrawal by Subject|0|||
170766250|NCT03086369|617149052|FG003|Overall Study|Withdrawal by Subject|5|||
170766251|NCT03086369|617149053|FG004|Overall Study|Withdrawal by Subject|3|||
170766252|NCT03086369|617149049|FG000|Overall Study|Progressive Disease|0|||
170766253|NCT03086369|617149050|FG001|Overall Study|Progressive Disease|0|||
170766254|NCT03086369|617149051|FG002|Overall Study|Progressive Disease|0|||
170766255|NCT03086369|617149052|FG003|Overall Study|Progressive Disease|1|||
170766256|NCT03086369|617149053|FG004|Overall Study|Progressive Disease|1|||
170766257|NCT00954707|617149054|FG000|Overall Study|Death|34|||
170766258|NCT00954707|617149054|FG000|Overall Study|Withdrawal by Subject|100|||
170766259|NCT00954707|617149054|FG000|Overall Study|Lost to Follow-up|33|||
170766260|NCT02631148|617149055|FG000|Overall Study|8 were ineligible|8|||
170766261|NCT02631148|617149056|FG001|Overall Study|8 were ineligible|0|||
170766262|NCT02631148|617149055|FG000|Overall Study|Withdrawal by Subject|1|||
170766263|NCT02631148|617149056|FG001|Overall Study|Withdrawal by Subject|0|||
170766264|NCT02631148|617149055|FG000|Overall Study|PAH not available to study participant|1|||
170766265|NCT02631148|617149056|FG001|Overall Study|PAH not available to study participant|0|||
170766266|NCT00357396|617149060|FG000|Overall Study|Adverse Event|1|||
170766267|NCT00357396|617149061|FG001|Overall Study|Adverse Event|0|||
170766268|NCT00487578|617149062|FG000|Overall Study|Adverse Event|1|||
170766269|NCT00487578|617149063|FG001|Overall Study|Adverse Event|2|||
170766270|NCT00487578|617149062|FG000|Overall Study|Lack of Efficacy|0|||
170766271|NCT00487578|617149063|FG001|Overall Study|Lack of Efficacy|1|||
170766272|NCT00487578|617149062|FG000|Overall Study|Lost to Follow-up|0|||
170766273|NCT00487578|617149063|FG001|Overall Study|Lost to Follow-up|1|||
170766274|NCT02525796|617149064|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
170766275|NCT02525796|617149065|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
170411632|NCT02207621|615847169|FG001|Overall Study|Non-Compliant|3|||
170411633|NCT02207621|615847170|FG002|Overall Study|Non-Compliant|1|||
170411634|NCT02207621|615847168|FG000|Overall Study|Lost to Follow-up|1|||
170411635|NCT02207621|615847169|FG001|Overall Study|Lost to Follow-up|0|||
170411636|NCT02207621|615847170|FG002|Overall Study|Lost to Follow-up|3|||
170766276|NCT02525796|617149066|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
170411637|NCT02207621|615847168|FG000|Overall Study|Lack of Efficacy|10|||
170411638|NCT02207621|615847169|FG001|Overall Study|Lack of Efficacy|2|||
170411639|NCT02207621|615847170|FG002|Overall Study|Lack of Efficacy|4|||
170766277|NCT02525796|617149064|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
170766278|NCT02525796|617149065|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
170766279|NCT02525796|617149066|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
170766280|NCT02525796|617149064|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
170766281|NCT02525796|617149065|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
170766282|NCT02525796|617149066|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
170766283|NCT02525796|617149064|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
170766284|NCT02525796|617149065|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
170766285|NCT02525796|617149066|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
170766286|NCT02525796|617149064|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
170766287|NCT02525796|617149065|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
170766288|NCT02525796|617149066|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
170766289|NCT00726999|617149069|FG000|Overall Study|Physician Decision|0|||
170766290|NCT00726999|617149070|FG001|Overall Study|Physician Decision|1|||
170766291|NCT00726999|617149069|FG000|Overall Study|Withdrawal by Subject|2|||
170766292|NCT00726999|617149070|FG001|Overall Study|Withdrawal by Subject|0|||
170766293|NCT00726999|617149069|FG000|Overall Study|Protocol Violation|1|||
170766294|NCT00726999|617149070|FG001|Overall Study|Protocol Violation|0|||
170766295|NCT00955825|617149071|FG000|Overall Study|Adverse Event|15|||
170766296|NCT00955825|617149072|FG001|Overall Study|Adverse Event|2|||
170766297|NCT00955825|617149071|FG000|Overall Study|Withdrawal by Subject|4|||
170766298|NCT00955825|617149072|FG001|Overall Study|Withdrawal by Subject|6|||
170766299|NCT00955825|617149071|FG000|Overall Study|Any other reason not above-mentioned|7|||
170766300|NCT00955825|617149072|FG001|Overall Study|Any other reason not above-mentioned|9|||
170766301|NCT00708032|617149073|FG000|Overall Study|Adverse Event|0|||
170766302|NCT00708032|617149074|FG001|Overall Study|Adverse Event|2|||
170766303|NCT00708032|617149073|FG000|Overall Study|Lost to Follow-up|1|||
170766304|NCT00708032|617149074|FG001|Overall Study|Lost to Follow-up|2|||
170766305|NCT00708032|617149073|FG000|Overall Study|Pregnancy|0|||
170766306|NCT00708032|617149074|FG001|Overall Study|Pregnancy|1|||
170766307|NCT00708032|617149073|FG000|Overall Study|Poor vision|0|||
170766308|NCT00708032|617149074|FG001|Overall Study|Poor vision|6|||
170766309|NCT00708032|617149073|FG000|Overall Study|Visit out of range at month 12|4|||
170766310|NCT00708032|617149074|FG001|Overall Study|Visit out of range at month 12|1|||
170766311|NCT00708032|617149073|FG000|Overall Study|Did not meet protocol criteria|1|||
170766312|NCT00708032|617149074|FG001|Overall Study|Did not meet protocol criteria|2|||
170766313|NCT00708032|617149073|FG000|Overall Study|Protocol Violation|4|||
170766314|NCT00708032|617149074|FG001|Overall Study|Protocol Violation|1|||
170766315|NCT00708032|617149073|FG000|Overall Study|Withdrawal by Subject|0|||
170766316|NCT00708032|617149074|FG001|Overall Study|Withdrawal by Subject|1|||
170766317|NCT00391846|617149075|FG000|Overall Study|Adverse Event|4|||
170766318|NCT00391846|617149076|FG001|Overall Study|Adverse Event|1|||
170766319|NCT00391846|617149075|FG000|Overall Study|Did not meet the required elig. crit|2|||
170766320|NCT00391846|617149076|FG001|Overall Study|Did not meet the required elig. crit|2|||
170411640|NCT02207621|615847168|FG000|Overall Study|Disallowed Concurrent Medication|2|||
170411641|NCT02207621|615847169|FG001|Overall Study|Disallowed Concurrent Medication|5|||
170411642|NCT02207621|615847170|FG002|Overall Study|Disallowed Concurrent Medication|2|||
170411643|NCT02207621|615847168|FG000|Overall Study|Physician Decision|1|||
170411644|NCT02207621|615847169|FG001|Overall Study|Physician Decision|2|||
170766321|NCT00391846|617149075|FG000|Overall Study|Withdrawal by Subject|2|||
170766322|NCT00391846|617149076|FG001|Overall Study|Withdrawal by Subject|3|||
170766323|NCT00391846|617149075|FG000|Overall Study|Developed study specific DC criteria|0|||
170766324|NCT00391846|617149076|FG001|Overall Study|Developed study specific DC criteria|1|||
170766325|NCT02477670|617149079|FG000|Stage 1|Adverse Event|2|||
170766326|NCT02477670|617149080|FG001|Stage 1|Adverse Event|7|||
170766327|NCT02477670|617149081|FG002|Stage 1|Adverse Event|0|||
170766328|NCT02477670|617149082|FG003|Stage 1|Adverse Event|0|||
170766329|NCT02477670|617149083|FG004|Stage 1|Adverse Event|0|||
170411645|NCT02207621|615847170|FG002|Overall Study|Physician Decision|2|||
170411646|NCT02207621|615847168|FG000|Overall Study|Protocol Violation|4|||
170411647|NCT02207621|615847169|FG001|Overall Study|Protocol Violation|10|||
170411648|NCT02207621|615847170|FG002|Overall Study|Protocol Violation|6|||
170411649|NCT02207621|615847168|FG000|Overall Study|Death|2|||
170411650|NCT02207621|615847169|FG001|Overall Study|Death|0|||
170411651|NCT02207621|615847170|FG002|Overall Study|Death|0|||
170411652|NCT02207621|615847168|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
170411653|NCT02207621|615847169|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
170411654|NCT02207621|615847170|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
170411655|NCT00449072|615847174|FG000|Overall Study|Adverse Event|3|||
170766330|NCT02477670|617149084|FG005|Stage 1|Adverse Event|0|||
170766331|NCT02477670|617149085|FG006|Stage 1|Adverse Event|0|||
170766332|NCT02477670|617149079|FG000|Stage 1|Lost to Follow-up|0|||
170766333|NCT02477670|617149080|FG001|Stage 1|Lost to Follow-up|2|||
170766334|NCT02477670|617149081|FG002|Stage 1|Lost to Follow-up|0|||
170766335|NCT02477670|617149082|FG003|Stage 1|Lost to Follow-up|0|||
170766336|NCT02477670|617149083|FG004|Stage 1|Lost to Follow-up|0|||
170766337|NCT02477670|617149084|FG005|Stage 1|Lost to Follow-up|0|||
170766338|NCT02477670|617149085|FG006|Stage 1|Lost to Follow-up|0|||
170766339|NCT02477670|617149079|FG000|Stage 1|Withdrawal by Subject|1|||
170766340|NCT02477670|617149080|FG001|Stage 1|Withdrawal by Subject|2|||
170411656|NCT00449072|615847175|FG001|Overall Study|Adverse Event|1|||
170522034|NCT02227784|616256209|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
170522035|NCT02227784|616256210|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
170522036|NCT02227784|616256211|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
170522037|NCT02227784|616256212|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
170522038|NCT02227784|616256213|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
170522039|NCT02227784|616256209|FG000|Open-Label Extension Phase (OLE)|Death|0|||
170522040|NCT02227784|616256210|FG001|Open-Label Extension Phase (OLE)|Death|0|||
170522041|NCT02227784|616256211|FG002|Open-Label Extension Phase (OLE)|Death|0|||
170522042|NCT02227784|616256212|FG003|Open-Label Extension Phase (OLE)|Death|0|||
170522043|NCT02227784|616256213|FG004|Open-Label Extension Phase (OLE)|Death|1|||
170522044|NCT02227784|616256209|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
170522045|NCT02227784|616256210|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
170522046|NCT02227784|616256211|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
170522047|NCT02227784|616256212|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
170522048|NCT02227784|616256213|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
170522049|NCT02227784|616256209|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
170522050|NCT02227784|616256210|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
170522051|NCT02227784|616256211|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
170522052|NCT02227784|616256212|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
170522053|NCT02227784|616256213|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
170522054|NCT02864407|616256215|FG000|Overall Study|Protocol Violation|3|||
170522055|NCT02864407|616256215|FG000|Overall Study|Lost to Follow-up|115|||
170522056|NCT02864407|616256215|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
170522057|NCT02864407|616256215|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
170522058|NCT02864407|616256215|FG000|Overall Study|Consent prior to the contract date|1|||
170522059|NCT00096538|616256223|FG000|Overall Study|Withdrawal by Subject|1|||
170522060|NCT00003471|616256237|FG000|Overall Study|Not evaluable|4|||
170522061|NCT02329327|616256238|FG000|Overall Study|Death|78|||
170522062|NCT02329327|616256239|FG001|Overall Study|Death|0|||
170522063|NCT02329327|616256238|FG000|Overall Study|Withdrawal by Subject|3|||
170522064|NCT02329327|616256239|FG001|Overall Study|Withdrawal by Subject|0|||
170522065|NCT02329327|616256238|FG000|Overall Study|Lost to Follow-up|4|||
170522066|NCT02329327|616256239|FG001|Overall Study|Lost to Follow-up|0|||
170522067|NCT01367249|616256240|FG000|Overall Study|Withdrawal by Subject|6|||
170522068|NCT01367249|616256241|FG001|Overall Study|Withdrawal by Subject|6|||
170522069|NCT01367249|616256240|FG000|Overall Study|Other|3|||
170522070|NCT01367249|616256241|FG001|Overall Study|Other|10|||
170522071|NCT03718429|616256242|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
170522072|NCT03718429|616256243|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
170522073|NCT03718429|616256244|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
170522074|NCT03718429|616256245|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
170522075|NCT05404711|616256246|FG000|Completed Study Visit|Withdrawal by Subject|1|||
170522076|NCT05404711|616256246|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
170522077|NCT05404711|616256246|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
170522078|NCT05404711|616256246|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
170522079|NCT05404711|616256246|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
170522080|NCT05404711|616256246|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
170522081|NCT00325819|616256247|FG000|Overall Study|Study product lost in mail|2|||
170522082|NCT00325819|616256248|FG001|Overall Study|Study product lost in mail|1|||
170522083|NCT00325819|616256247|FG000|Overall Study|Did not take a dose of study product|4|||
170522084|NCT00325819|616256248|FG001|Overall Study|Did not take a dose of study product|9|||
170522085|NCT00325819|616256247|FG000|Overall Study|Lost to Follow-up|3|||
170522086|NCT00325819|616256248|FG001|Overall Study|Lost to Follow-up|3|||
170522087|NCT02346877|616256249|FG000|Overall Study|Adverse Event|1|||
170522088|NCT02346877|616256250|FG001|Overall Study|Adverse Event|0|||
170522089|NCT02346877|616256249|FG000|Overall Study|Administrative Decision|1|||
170522090|NCT02346877|616256250|FG001|Overall Study|Administrative Decision|0|||
170522091|NCT02346877|616256249|FG000|Overall Study|Sponsor Decision|12|||
170522092|NCT02346877|616256250|FG001|Overall Study|Sponsor Decision|0|||
170766341|NCT02477670|617149081|FG002|Stage 1|Withdrawal by Subject|0|||
170766342|NCT02477670|617149082|FG003|Stage 1|Withdrawal by Subject|0|||
170766343|NCT02477670|617149083|FG004|Stage 1|Withdrawal by Subject|0|||
170766344|NCT02477670|617149084|FG005|Stage 1|Withdrawal by Subject|0|||
170522093|NCT02346877|616256249|FG000|Overall Study|Missing|5|||
170522094|NCT02346877|616256250|FG001|Overall Study|Missing|0|||
170522095|NCT02357459|616258055|FG000|Overall Study|Adverse Event|0|||
170522096|NCT02357459|616258056|FG001|Overall Study|Adverse Event|1|||
170522097|NCT02357459|616258057|FG002|Overall Study|Adverse Event|1|||
170766345|NCT02477670|617149085|FG006|Stage 1|Withdrawal by Subject|0|||
170522098|NCT02357459|616258055|FG000|Overall Study|Withdrawal by Subject|5|||
170766346|NCT02477670|617149079|FG000|Stage 1|Non-compliance with Study Drug|1|||
170766347|NCT02477670|617149080|FG001|Stage 1|Non-compliance with Study Drug|2|||
170522099|NCT02357459|616258056|FG001|Overall Study|Withdrawal by Subject|3|||
170868673|NCT04029116|617530346|FG000|Overall Study|Other|2|||
170868674|NCT04029116|617530347|FG001|Overall Study|Other|1|||
170868675|NCT01272947|617530348|FG000|Overall Study|Abnormal Laboratory Value|2|||
170868676|NCT01272947|617530349|FG001|Overall Study|Abnormal Laboratory Value|2|||
170868677|NCT03675776|617530352|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
170868678|NCT03675776|617530353|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
170868679|NCT03675776|617530354|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
170868680|NCT03675776|617530352|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
170868681|NCT03675776|617530353|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
170868682|NCT03675776|617530354|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
170868683|NCT00698932|617530355|FG000|Overall Study|Adverse Event|0|||
170868684|NCT00698932|617530356|FG001|Overall Study|Adverse Event|2|||
170868685|NCT00698932|617530355|FG000|Overall Study|Incorrect enrollment|0|||
170868686|NCT00698932|617530356|FG001|Overall Study|Incorrect enrollment|2|||
170868687|NCT00698932|617530355|FG000|Overall Study|Study specific discontinuation criteria|3|||
170868688|NCT00698932|617530356|FG001|Overall Study|Study specific discontinuation criteria|4|||
170868689|NCT00698932|617530355|FG000|Overall Study|Withdrawal by Subject|11|||
170766348|NCT02477670|617149081|FG002|Stage 1|Non-compliance with Study Drug|0|||
170766349|NCT02477670|617149082|FG003|Stage 1|Non-compliance with Study Drug|0|||
170766350|NCT02477670|617149083|FG004|Stage 1|Non-compliance with Study Drug|0|||
170766351|NCT02477670|617149084|FG005|Stage 1|Non-compliance with Study Drug|0|||
170766352|NCT02477670|617149085|FG006|Stage 1|Non-compliance with Study Drug|0|||
170766353|NCT02477670|617149079|FG000|Stage 2|Adverse Event|0|||
170766354|NCT02477670|617149080|FG001|Stage 2|Adverse Event|0|||
170766355|NCT02477670|617149081|FG002|Stage 2|Adverse Event|1|||
170766356|NCT02477670|617149082|FG003|Stage 2|Adverse Event|0|||
170766357|NCT02477670|617149083|FG004|Stage 2|Adverse Event|0|||
170766358|NCT02477670|617149084|FG005|Stage 2|Adverse Event|0|||
170766359|NCT02477670|617149085|FG006|Stage 2|Adverse Event|0|||
170766360|NCT02477670|617149079|FG000|Stage 2|Antipsychotic Medication Changed|0|||
170766361|NCT02477670|617149080|FG001|Stage 2|Antipsychotic Medication Changed|0|||
170766362|NCT02477670|617149081|FG002|Stage 2|Antipsychotic Medication Changed|1|||
170766363|NCT02477670|617149082|FG003|Stage 2|Antipsychotic Medication Changed|0|||
170766364|NCT02477670|617149083|FG004|Stage 2|Antipsychotic Medication Changed|0|||
170766365|NCT02477670|617149084|FG005|Stage 2|Antipsychotic Medication Changed|0|||
170766366|NCT02477670|617149085|FG006|Stage 2|Antipsychotic Medication Changed|0|||
170766367|NCT02477670|617149079|FG000|Stage 2|Withdrawal by Subject|0|||
170766368|NCT02477670|617149080|FG001|Stage 2|Withdrawal by Subject|0|||
170766369|NCT02477670|617149081|FG002|Stage 2|Withdrawal by Subject|0|||
170766370|NCT02477670|617149082|FG003|Stage 2|Withdrawal by Subject|1|||
170766371|NCT02477670|617149083|FG004|Stage 2|Withdrawal by Subject|0|||
170766372|NCT02477670|617149084|FG005|Stage 2|Withdrawal by Subject|0|||
170766373|NCT02477670|617149085|FG006|Stage 2|Withdrawal by Subject|0|||
170766374|NCT00970307|617149086|FG000|Overall Study|Serious Adverse Event|1|||
170766375|NCT00970307|617149087|FG001|Overall Study|Serious Adverse Event|0|||
170766376|NCT00970307|617149088|FG002|Overall Study|Serious Adverse Event|0|||
170766377|NCT00970307|617149086|FG000|Overall Study|Withdrawal by Subject|2|||
170766378|NCT00970307|617149087|FG001|Overall Study|Withdrawal by Subject|3|||
170766379|NCT00970307|617149088|FG002|Overall Study|Withdrawal by Subject|2|||
170766380|NCT02810080|617149089|FG000|Overall Study|Adverse Event|3|||
170766381|NCT02810080|617149090|FG001|Overall Study|Adverse Event|0|||
170766382|NCT02810080|617149089|FG000|Overall Study|Death|0|||
170766383|NCT02810080|617149090|FG001|Overall Study|Death|2|||
170766384|NCT02810080|617149089|FG000|Overall Study|Physician Decision|4|||
170766385|NCT02810080|617149090|FG001|Overall Study|Physician Decision|0|||
170766386|NCT02810080|617149089|FG000|Overall Study|Withdrawal by Subject|0|||
170766387|NCT02810080|617149090|FG001|Overall Study|Withdrawal by Subject|2|||
170766388|NCT02937831|617149091|FG000|Overall Study|Protocol Violation|4|||
170766389|NCT01759264|617149092|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
170868690|NCT00698932|617530356|FG001|Overall Study|Withdrawal by Subject|23|||
170868691|NCT00698932|617530355|FG000|Overall Study|Lost to Follow-up|6|||
170868692|NCT00698932|617530356|FG001|Overall Study|Lost to Follow-up|1|||
170868693|NCT00698932|617530355|FG000|Overall Study|Severe non-compliance to protocol|1|||
170868694|NCT00698932|617530356|FG001|Overall Study|Severe non-compliance to protocol|2|||
170868695|NCT00698932|617530355|FG000|Overall Study|Safety reasons|0|||
170868696|NCT00698932|617530356|FG001|Overall Study|Safety reasons|2|||
170868697|NCT00698932|617530355|FG000|Overall Study|Death|1|||
170766390|NCT01759264|617149092|FG000|Overall Study|Adverse Event|1|||
170766391|NCT01759264|617149092|FG000|Overall Study|Other|2|||
170766392|NCT01759264|617149092|FG000|Overall Study|Lost to Follow-up|2|||
170766393|NCT01759264|617149092|FG000|Overall Study|Withdrawal by Subject|3|||
170766394|NCT01759264|617149092|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
170766395|NCT03622580|617149100|FG000|Overall Study|Death|16|||
170766396|NCT03622580|617149101|FG001|Overall Study|Death|21|||
170868698|NCT00698932|617530356|FG001|Overall Study|Death|0|||
170868699|NCT02742766|617530357|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868700|NCT02742766|617530358|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170522100|NCT02357459|616258057|FG002|Overall Study|Withdrawal by Subject|3|||
170522101|NCT02357459|616258055|FG000|Overall Study|Physician Decision|0|||
170766397|NCT03622580|617149102|FG002|Overall Study|Death|13|||
170766398|NCT03622580|617149100|FG000|Overall Study|Adverse Event|6|||
170766399|NCT03622580|617149101|FG001|Overall Study|Adverse Event|6|||
170766400|NCT03622580|617149102|FG002|Overall Study|Adverse Event|5|||
170766401|NCT03622580|617149100|FG000|Overall Study|Withdrawal by Subject|12|||
170766402|NCT03622580|617149101|FG001|Overall Study|Withdrawal by Subject|7|||
170766403|NCT03622580|617149102|FG002|Overall Study|Withdrawal by Subject|19|||
170766404|NCT03622580|617149100|FG000|Overall Study|Lost to Follow-up|12|||
170766405|NCT03622580|617149101|FG001|Overall Study|Lost to Follow-up|9|||
170766406|NCT03622580|617149102|FG002|Overall Study|Lost to Follow-up|9|||
170766407|NCT03622580|617149100|FG000|Overall Study|Protocol Violation|1|||
170766408|NCT03622580|617149101|FG001|Overall Study|Protocol Violation|0|||
170766409|NCT03622580|617149102|FG002|Overall Study|Protocol Violation|1|||
170766410|NCT03622580|617149100|FG000|Overall Study|Physician Decision|3|||
170766411|NCT03622580|617149101|FG001|Overall Study|Physician Decision|0|||
170766412|NCT03622580|617149102|FG002|Overall Study|Physician Decision|1|||
170766413|NCT03622580|617149100|FG000|Overall Study|Pregnancy|0|||
170766414|NCT03622580|617149101|FG001|Overall Study|Pregnancy|1|||
170766415|NCT03622580|617149102|FG002|Overall Study|Pregnancy|0|||
170766416|NCT03622580|617149100|FG000|Overall Study|Lack of Efficacy|0|||
170766417|NCT03622580|617149101|FG001|Overall Study|Lack of Efficacy|0|||
170766418|NCT03622580|617149102|FG002|Overall Study|Lack of Efficacy|1|||
170766419|NCT03622580|617149100|FG000|Overall Study|Other|2|||
170766420|NCT03622580|617149101|FG001|Overall Study|Other|0|||
170766421|NCT03622580|617149102|FG002|Overall Study|Other|3|||
170766422|NCT00753012|617149106|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
170766423|NCT00753012|617149107|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
170766424|NCT00753012|617149106|FG000|Overall Study|Adverse Event|2|||
170766425|NCT00753012|617149107|FG001|Overall Study|Adverse Event|0|||
170766426|NCT00753012|617149106|FG000|Overall Study|Withdrawal by Subject|0|||
170766427|NCT00753012|617149107|FG001|Overall Study|Withdrawal by Subject|1|||
170766428|NCT00753012|617149106|FG000|Overall Study|Lost to Follow-up|4|||
170766429|NCT00753012|617149107|FG001|Overall Study|Lost to Follow-up|0|||
170766430|NCT00753012|617149106|FG000|Overall Study|Confounded endpoint data|1|||
170766431|NCT00753012|617149107|FG001|Overall Study|Confounded endpoint data|0|||
170766432|NCT01930045|617149108|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
170766433|NCT01930045|617149109|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
170766434|NCT01930045|617149110|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
170766435|NCT01930045|617149111|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
170766436|NCT01930045|617149112|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
170766437|NCT01930045|617149113|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
170411657|NCT00449072|615847174|FG000|Overall Study|Protocol Violation|14|||
170411658|NCT00449072|615847175|FG001|Overall Study|Protocol Violation|12|||
170411659|NCT00449072|615847174|FG000|Overall Study|Lost to Follow-up|5|||
170411660|NCT00449072|615847175|FG001|Overall Study|Lost to Follow-up|7|||
170411661|NCT00449072|615847174|FG000|Overall Study|Withdrawal by Subject|11|||
170411662|NCT00449072|615847175|FG001|Overall Study|Withdrawal by Subject|8|||
170411663|NCT00449072|615847174|FG000|Overall Study|Lack of Efficacy|1|||
170411664|NCT00449072|615847175|FG001|Overall Study|Lack of Efficacy|1|||
170411665|NCT00449072|615847174|FG000|Overall Study|Physician Decision|1|||
170411666|NCT00449072|615847175|FG001|Overall Study|Physician Decision|0|||
170766438|NCT01930045|617149108|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
170766439|NCT01930045|617149109|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
170766440|NCT01930045|617149110|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
170766441|NCT01930045|617149111|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
170766442|NCT01930045|617149112|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
170766443|NCT01930045|617149113|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
170766444|NCT00241644|617149114|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
170766445|NCT00241644|617149115|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
170766446|NCT00241644|617149116|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
170766447|NCT00241644|617149117|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
170766448|NCT00241644|617149114|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
170766449|NCT00241644|617149115|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
170766450|NCT00241644|617149116|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
170766451|NCT00241644|617149117|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
170766452|NCT00241644|617149114|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
170766453|NCT00241644|617149115|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
170766454|NCT00241644|617149116|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
170766455|NCT00241644|617149117|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
170766456|NCT00241644|617149114|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
170411667|NCT00449072|615847174|FG000|Overall Study|Not treated|0|||
170766457|NCT00241644|617149115|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
170766458|NCT00241644|617149116|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
170411668|NCT00449072|615847175|FG001|Overall Study|Not treated|1|||
170411669|NCT00449072|615847174|FG000|Overall Study|Excluded medication|0|||
170522102|NCT02357459|616258056|FG001|Overall Study|Physician Decision|2|||
170522103|NCT02357459|616258057|FG002|Overall Study|Physician Decision|0|||
170522104|NCT02357459|616258055|FG000|Overall Study|Protocol Violation|1|||
170522105|NCT02357459|616258056|FG001|Overall Study|Protocol Violation|1|||
170522106|NCT02357459|616258057|FG002|Overall Study|Protocol Violation|0|||
170522107|NCT02357459|616258055|FG000|Overall Study|Lost to Follow-up|1|||
170522108|NCT02357459|616258056|FG001|Overall Study|Lost to Follow-up|3|||
170522109|NCT02357459|616258057|FG002|Overall Study|Lost to Follow-up|0|||
170522110|NCT02357459|616258055|FG000|Overall Study|Lack of Efficacy|7|||
170522111|NCT02357459|616258056|FG001|Overall Study|Lack of Efficacy|4|||
170522112|NCT02357459|616258057|FG002|Overall Study|Lack of Efficacy|4|||
170522113|NCT02357459|616258055|FG000|Overall Study|Patient Relocated|2|||
170522114|NCT02357459|616258056|FG001|Overall Study|Patient Relocated|0|||
170766459|NCT00241644|617149117|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
170766460|NCT00241644|617149114|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
170766461|NCT00241644|617149115|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
170766462|NCT00241644|617149116|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
170766463|NCT00241644|617149117|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
170766464|NCT00241644|617149114|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
170766465|NCT00241644|617149115|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
170766466|NCT00241644|617149116|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
170766467|NCT00241644|617149117|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
170766468|NCT00241644|617149114|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
170766469|NCT00241644|617149115|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
170766470|NCT00241644|617149116|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
170766471|NCT00241644|617149117|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
170766472|NCT00241644|617149114|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
170766473|NCT00241644|617149115|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
170766474|NCT00241644|617149116|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
170766475|NCT00241644|617149117|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
170766476|NCT00241644|617149114|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
170766477|NCT00241644|617149115|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
170766478|NCT00241644|617149116|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
170766479|NCT00241644|617149117|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
170766480|NCT00241644|617149114|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
170766481|NCT00241644|617149115|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
170766482|NCT00241644|617149116|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
170766483|NCT00241644|617149117|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
170766484|NCT00241644|617149114|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
170766485|NCT00241644|617149115|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
170766486|NCT00241644|617149116|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
170766487|NCT00241644|617149117|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
170766488|NCT00241644|617149114|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
170766489|NCT00241644|617149115|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
170766490|NCT00241644|617149116|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
170766491|NCT00241644|617149117|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
170766492|NCT00241644|617149114|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
170766493|NCT00241644|617149115|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
170766494|NCT00241644|617149116|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
170766495|NCT00241644|617149117|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
170766496|NCT03959241|617149118|FG000|Overall Study|Withdrawal by Subject|7|||
170766497|NCT03959241|617149119|FG001|Overall Study|Withdrawal by Subject|8|||
170766498|NCT03959241|617149118|FG000|Overall Study|Lost to Follow-up|1|||
170766499|NCT03959241|617149119|FG001|Overall Study|Lost to Follow-up|0|||
170766500|NCT03959241|617149118|FG000|Overall Study|Move to Hospice Care|1|||
170766501|NCT03959241|617149119|FG001|Overall Study|Move to Hospice Care|0|||
170766502|NCT03959241|617149118|FG000|Overall Study|Screen Failure|1|||
170766503|NCT03959241|617149119|FG001|Overall Study|Screen Failure|0|||
170766504|NCT03959241|617149118|FG000|Overall Study|Disease Relapse|0|||
170766505|NCT03959241|617149119|FG001|Overall Study|Disease Relapse|1|||
170766506|NCT03959241|617149118|FG000|Overall Study|Off Study|1|||
170522115|NCT02357459|616258057|FG002|Overall Study|Patient Relocated|0|||
170766507|NCT03959241|617149119|FG001|Overall Study|Off Study|0|||
170766508|NCT00831415|617149120|FG000|Overall Study|Adverse Event|14|||
170766509|NCT00831415|617149120|FG000|Overall Study|Failed to return|3|||
170766510|NCT00831415|617149120|FG000|Overall Study|Physician Decision|6|||
170766511|NCT00831415|617149120|FG000|Overall Study|Lost to Follow-up|9|||
170766512|NCT00831415|617149120|FG000|Overall Study|Protocol Violation|3|||
170766513|NCT00831415|617149120|FG000|Overall Study|Withdrawal by Subject|35|||
170522116|NCT02357459|616258055|FG000|Overall Study|Instruction from PCP|1|||
170522117|NCT02357459|616258056|FG001|Overall Study|Instruction from PCP|0|||
170522118|NCT02357459|616258057|FG002|Overall Study|Instruction from PCP|0|||
170522119|NCT02357459|616258055|FG000|Overall Study|Incarceration|0|||
170522120|NCT02357459|616258056|FG001|Overall Study|Incarceration|0|||
170522121|NCT02357459|616258057|FG002|Overall Study|Incarceration|1|||
170522122|NCT02357459|616258055|FG000|Overall Study|Pre-planned Knee surgery|0|||
170522123|NCT02357459|616258056|FG001|Overall Study|Pre-planned Knee surgery|0|||
170522124|NCT02357459|616258057|FG002|Overall Study|Pre-planned Knee surgery|2|||
170522125|NCT02357459|616258055|FG000|Overall Study|Job Commitments|0|||
170766514|NCT00831415|617149120|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
170766515|NCT00831415|617149120|FG000|Overall Study|Death|1|||
170766516|NCT00813904|617149121|FG000|Overall Study|Death|1|||
170766517|NCT02506257|617149122|FG000|Overall Study|Adverse Event|0|||
170766518|NCT02506257|617149123|FG001|Overall Study|Adverse Event|2|||
170766519|NCT02506257|617149124|FG002|Overall Study|Adverse Event|3|||
170766520|NCT02506257|617149125|FG003|Overall Study|Adverse Event|0|||
170766521|NCT02506257|617149122|FG000|Overall Study|Protocol Violation|0|||
170766522|NCT02506257|617149123|FG001|Overall Study|Protocol Violation|0|||
170766523|NCT02506257|617149124|FG002|Overall Study|Protocol Violation|1|||
170766524|NCT02506257|617149125|FG003|Overall Study|Protocol Violation|0|||
170766525|NCT03058991|617149128|FG000|Overall Study|Lost to Follow-up|17|||
170766526|NCT03058991|617149129|FG001|Overall Study|Lost to Follow-up|12|||
170766527|NCT03058991|617149130|FG002|Overall Study|Lost to Follow-up|12|||
170766528|NCT03058991|617149128|FG000|Overall Study|Withdrawal by Subject|1|||
170766529|NCT03058991|617149129|FG001|Overall Study|Withdrawal by Subject|0|||
170766530|NCT03058991|617149130|FG002|Overall Study|Withdrawal by Subject|0|||
170766531|NCT01988233|617149131|FG000|Overall Study|Lost to Follow-up|64|||
170766532|NCT01988233|617149132|FG001|Overall Study|Lost to Follow-up|51|||
170766533|NCT01689519|617149133|FG000|Intent to Treat|Death|157|||
170766534|NCT01689519|617149134|FG001|Intent to Treat|Death|167|||
170766535|NCT01689519|617149133|FG000|Intent to Treat|Lost to Follow-up|4|||
170766536|NCT01689519|617149134|FG001|Intent to Treat|Lost to Follow-up|8|||
170766537|NCT01689519|617149133|FG000|Intent to Treat|Other|2|||
170766538|NCT01689519|617149134|FG001|Intent to Treat|Other|4|||
170766539|NCT01689519|617149133|FG000|Intent to Treat|Physician Decision|4|||
170632162|NCT01134055|616664543|FG004|Overall Study|Withdrawal by Subject|0|||
170632163|NCT01134055|616664544|FG005|Overall Study|Withdrawal by Subject|0|||
170632164|NCT01134055|616664545|FG006|Overall Study|Withdrawal by Subject|8|||
170522126|NCT02357459|616258056|FG001|Overall Study|Job Commitments|0|||
170766540|NCT01689519|617149134|FG001|Intent to Treat|Physician Decision|1|||
170766541|NCT01689519|617149133|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
170766542|NCT01689519|617149134|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
170766543|NCT01689519|617149133|FG000|Intent to Treat|Withdrawal by Subject|21|||
170766544|NCT01689519|617149134|FG001|Intent to Treat|Withdrawal by Subject|20|||
170766545|NCT01689519|617149133|FG000|Safety Population|Death|158|||
170766546|NCT01689519|617149134|FG001|Safety Population|Death|165|||
170766547|NCT01689519|617149133|FG000|Safety Population|Lost to Follow-up|4|||
170766548|NCT01689519|617149134|FG001|Safety Population|Lost to Follow-up|8|||
170766549|NCT01689519|617149133|FG000|Safety Population|Other|2|||
170766550|NCT01689519|617149134|FG001|Safety Population|Other|4|||
170766551|NCT01689519|617149133|FG000|Safety Population|Physician Decision|4|||
170766552|NCT01689519|617149134|FG001|Safety Population|Physician Decision|1|||
170766553|NCT01689519|617149133|FG000|Safety Population|Study Terminated By Sponsor|60|||
170766554|NCT01689519|617149134|FG001|Safety Population|Study Terminated By Sponsor|47|||
170766555|NCT01689519|617149133|FG000|Safety Population|Withdrawal by Subject|20|||
170766556|NCT01689519|617149134|FG001|Safety Population|Withdrawal by Subject|20|||
170766557|NCT01591616|617149136|FG000|Overall Study|Withdrawal by Subject|1|||
170766558|NCT01713530|617149137|FG000|Overall Study|Adverse Event|0|||
170766559|NCT01713530|617149138|FG001|Overall Study|Adverse Event|5|||
170766560|NCT01713530|617149137|FG000|Overall Study|Withdrawal criteria|21|||
170522127|NCT02357459|616258057|FG002|Overall Study|Job Commitments|1|||
170766561|NCT01713530|617149138|FG001|Overall Study|Withdrawal criteria|12|||
170766562|NCT01713530|617149137|FG000|Overall Study|Unclassified|4|||
170766563|NCT01713530|617149138|FG001|Overall Study|Unclassified|2|||
170766564|NCT00758602|617149139|FG000|Overall Study|Adverse Event|11|||
170766565|NCT00758602|617149140|FG001|Overall Study|Adverse Event|10|||
170766566|NCT00758602|617149139|FG000|Overall Study|Lost to Follow-up|4|||
170766567|NCT00758602|617149140|FG001|Overall Study|Lost to Follow-up|3|||
170766568|NCT00758602|617149139|FG000|Overall Study|Withdrawal by Subject|1|||
170766569|NCT00758602|617149140|FG001|Overall Study|Withdrawal by Subject|3|||
170766570|NCT00758602|617149139|FG000|Overall Study|Protocol Violation|0|||
170766571|NCT00758602|617149140|FG001|Overall Study|Protocol Violation|2|||
170766572|NCT00758602|617149139|FG000|Overall Study|Death|0|||
170766573|NCT00758602|617149140|FG001|Overall Study|Death|1|||
170766574|NCT00758602|617149139|FG000|Overall Study|Reason not specified|3|||
170766575|NCT00758602|617149140|FG001|Overall Study|Reason not specified|3|||
170766576|NCT03987451|617149141|FG000|Overall Study|Lost to Follow-up|1|||
170766577|NCT03987451|617149142|FG001|Overall Study|Lost to Follow-up|0|||
170766578|NCT03987451|617149141|FG000|Overall Study|Withdrawal by Subject|1|||
170766579|NCT03987451|617149142|FG001|Overall Study|Withdrawal by Subject|1|||
170632165|NCT01134055|616664539|FG000|Overall Study|Protocol Violation|0|||
170868701|NCT02742766|617530359|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868702|NCT02742766|617530360|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868703|NCT02742766|617530361|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868704|NCT02742766|617530362|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868705|NCT02742766|617530363|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868706|NCT02742766|617530364|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868707|NCT02742766|617530365|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868708|NCT02742766|617530366|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868709|NCT02742766|617530367|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868710|NCT02742766|617530368|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868711|NCT02742766|617530369|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868712|NCT02742766|617530370|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
170868713|NCT02742766|617530371|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868714|NCT02742766|617530372|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868715|NCT02742766|617530373|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868716|NCT02742766|617530374|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868717|NCT02742766|617530375|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
170868718|NCT02742766|617530357|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868719|NCT02742766|617530358|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868720|NCT02742766|617530359|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868721|NCT02742766|617530360|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868722|NCT02742766|617530361|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868723|NCT02742766|617530362|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868724|NCT02742766|617530363|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868725|NCT02742766|617530364|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868726|NCT02742766|617530365|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868727|NCT02742766|617530366|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868728|NCT02742766|617530367|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868729|NCT02742766|617530368|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868730|NCT02742766|617530369|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
170868731|NCT02742766|617530370|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
170868732|NCT02742766|617530371|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868733|NCT02742766|617530372|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
170868734|NCT02742766|617530373|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868735|NCT02742766|617530374|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868736|NCT02742766|617530375|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
170868737|NCT03359590|617530379|FG000|First Intervention|Withdrawal by Subject|1|||
170868738|NCT03359590|617530380|FG001|First Intervention|Withdrawal by Subject|1|||
170868739|NCT03359590|617530379|FG000|First Intervention|Protocol Violation|0|||
170868740|NCT03359590|617530380|FG001|First Intervention|Protocol Violation|1|||
170868741|NCT00688181|617530381|FG000|Overall Study|Lost to Follow-up|17|||
170868742|NCT00688181|617530381|FG000|Overall Study|Unknown Reason|4|||
170868743|NCT00688181|617530381|FG000|Overall Study|Non-clinical Reason|2|||
170868744|NCT02322229|617530382|FG000|Overall Study|Physician Decision|2|||
170868745|NCT00521053|617530383|FG000|Observation Phase|Disease Progression|55|||
170868746|NCT00521053|617530383|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
170868747|NCT00521053|617530383|FG000|Observation Phase|Death|2|||
170868748|NCT00521053|617530383|FG000|Observation Phase|Adverse Event|1|||
170868749|NCT00521053|617530383|FG000|Observation Phase|Other non-study melanoma treatment|1|||
170868750|NCT00521053|617530383|FG000|Observation Phase|Physician Decision|1|||
170868751|NCT02281357|617530384|FG000|Overall Study|Adverse Event|2|||
170868752|NCT02281357|617530385|FG001|Overall Study|Adverse Event|1|||
170868753|NCT02281357|617530384|FG000|Overall Study|Lost to Follow-up|1|||
170868754|NCT02281357|617530385|FG001|Overall Study|Lost to Follow-up|0|||
170868755|NCT02281357|617530384|FG000|Overall Study|Withdrawal by Subject|4|||
170868756|NCT02281357|617530385|FG001|Overall Study|Withdrawal by Subject|3|||
170868757|NCT01162239|617530386|FG000|Treatment Phase|Withdrawal by Subject|1|||
170868758|NCT01162239|617530387|FG001|Treatment Phase|Withdrawal by Subject|3|||
170868759|NCT01162239|617530388|FG002|Treatment Phase|Withdrawal by Subject|2|||
170868760|NCT01162239|617530389|FG003|Treatment Phase|Withdrawal by Subject|3|||
170868761|NCT01162239|617530386|FG000|Treatment Phase|Death|0|||
170868762|NCT01162239|617530387|FG001|Treatment Phase|Death|0|||
170868763|NCT01162239|617530388|FG002|Treatment Phase|Death|0|||
170868764|NCT01162239|617530389|FG003|Treatment Phase|Death|1|||
170868765|NCT01162239|617530386|FG000|Treatment Phase|Lost to Follow-up|5|||
170868766|NCT01162239|617530387|FG001|Treatment Phase|Lost to Follow-up|4|||
170868767|NCT01162239|617530388|FG002|Treatment Phase|Lost to Follow-up|2|||
170868768|NCT01162239|617530389|FG003|Treatment Phase|Lost to Follow-up|1|||
170868769|NCT01162239|617530386|FG000|Extended Follow-up|Lost to Follow-up|8|||
170868770|NCT01162239|617530387|FG001|Extended Follow-up|Lost to Follow-up|13|||
170868771|NCT01162239|617530388|FG002|Extended Follow-up|Lost to Follow-up|8|||
170868772|NCT01162239|617530389|FG003|Extended Follow-up|Lost to Follow-up|6|||
170868773|NCT02846532|617530390|FG000|Overall Study|Lost to Follow-up|0|||
170868774|NCT02846532|617530391|FG001|Overall Study|Lost to Follow-up|1|||
170868775|NCT02846532|617530392|FG002|Overall Study|Lost to Follow-up|1|||
170868776|NCT02846532|617530390|FG000|Overall Study|Withdrawal by Subject|1|||
170411670|NCT00449072|615847175|FG001|Overall Study|Excluded medication|2|||
170411671|NCT00449072|615847174|FG000|Overall Study|Non-compliance|2|||
170411672|NCT00449072|615847175|FG001|Overall Study|Non-compliance|5|||
170411673|NCT00449072|615847174|FG000|Overall Study|Sponsor decision|1|||
170411674|NCT00449072|615847175|FG001|Overall Study|Sponsor decision|3|||
170411675|NCT00449072|615847174|FG000|Overall Study|Relocation|3|||
170411676|NCT00449072|615847175|FG001|Overall Study|Relocation|2|||
170411677|NCT03036579|615847178|FG000|2 Years|Lost to Follow-up|1|||
170411678|NCT03036579|615847179|FG001|2 Years|Lost to Follow-up|0|||
170411679|NCT03036579|615847178|FG000|3 Years|Lost to Follow-up|0|||
170411680|NCT03036579|615847179|FG001|3 Years|Lost to Follow-up|1|||
170411681|NCT02352337|615847180|FG000|Overall Study|Patients never treated|4|||
170411682|NCT02352337|615847181|FG001|Overall Study|Patients never treated|1|||
170411683|NCT02352337|615847182|FG002|Overall Study|Patients never treated|2|||
170411684|NCT06509100|615847183|FG000|Overall Study|Withdrawal by Subject|1|||
170411685|NCT06509100|615847183|FG000|Overall Study|Lost to Follow-up|1|||
170411686|NCT05002569|615847192|FG000|Randomized|Withdrew Consent|3|||
170411687|NCT05002569|615847193|FG001|Randomized|Withdrew Consent|0|||
170411688|NCT05002569|615847192|FG000|Randomized|No longer meets study criteria|0|||
170411689|NCT05002569|615847193|FG001|Randomized|No longer meets study criteria|1|||
170411690|NCT05002569|615847192|FG000|Randomized|AE unrelated to study drug|1|||
170411691|NCT05002569|615847193|FG001|Randomized|AE unrelated to study drug|0|||
170411692|NCT05002569|615847192|FG000|Treatment Period|Requested to Discontinue|26|||
170411693|NCT05002569|615847193|FG001|Treatment Period|Requested to Discontinue|5|||
170411694|NCT05002569|615847192|FG000|Treatment Period|Withdrew Consent|7|||
170411695|NCT05002569|615847193|FG001|Treatment Period|Withdrew Consent|1|||
170411696|NCT05002569|615847192|FG000|Treatment Period|Study Drug Toxicity|114|||
170411697|NCT05002569|615847193|FG001|Treatment Period|Study Drug Toxicity|64|||
170766580|NCT03808883|617149143|FG000|Overall Study|Withdrawal by Subject|2|||
170766581|NCT03808883|617149144|FG001|Overall Study|Withdrawal by Subject|0|||
170766582|NCT03808883|617149143|FG000|Overall Study|Did not complete pre test or post test survey|4|||
170766583|NCT03808883|617149144|FG001|Overall Study|Did not complete pre test or post test survey|3|||
170766584|NCT02534350|617149147|FG000|Overall Study|Randomized But Not Treated|1|||
170766585|NCT02534350|617149148|FG001|Overall Study|Randomized But Not Treated|0|||
170766586|NCT02534350|617149147|FG000|Overall Study|Protocol Violation|1|||
170766587|NCT02534350|617149148|FG001|Overall Study|Protocol Violation|0|||
170766588|NCT02534350|617149147|FG000|Overall Study|Withdrew Consent|2|||
170766589|NCT02534350|617149148|FG001|Overall Study|Withdrew Consent|0|||
170766590|NCT01802632|617149166|FG000|Overall Study|Death|28|||
170766591|NCT01802632|617149167|FG001|Overall Study|Death|1|||
170766592|NCT01802632|617149168|FG002|Overall Study|Death|38|||
170766593|NCT01802632|617149169|FG003|Overall Study|Death|0|||
170766594|NCT01802632|617149170|FG004|Overall Study|Death|2|||
170766595|NCT01802632|617149171|FG005|Overall Study|Death|0|||
170766596|NCT01802632|617149166|FG000|Overall Study|Withdrawal by Subject|4|||
170766597|NCT01802632|617149167|FG001|Overall Study|Withdrawal by Subject|2|||
170766598|NCT01802632|617149168|FG002|Overall Study|Withdrawal by Subject|7|||
170766599|NCT01802632|617149169|FG003|Overall Study|Withdrawal by Subject|3|||
170766600|NCT01802632|617149170|FG004|Overall Study|Withdrawal by Subject|0|||
170766601|NCT01802632|617149171|FG005|Overall Study|Withdrawal by Subject|1|||
170766602|NCT01802632|617149166|FG000|Overall Study|Objective Disease Progression|1|||
170766603|NCT01802632|617149167|FG001|Overall Study|Objective Disease Progression|12|||
170766604|NCT01802632|617149168|FG002|Overall Study|Objective Disease Progression|104|||
170766605|NCT01802632|617149169|FG003|Overall Study|Objective Disease Progression|6|||
170766606|NCT01802632|617149170|FG004|Overall Study|Objective Disease Progression|4|||
170766607|NCT01802632|617149171|FG005|Overall Study|Objective Disease Progression|4|||
170766608|NCT01802632|617149166|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
170766609|NCT01802632|617149167|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
170766610|NCT01802632|617149168|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
170766611|NCT01802632|617149169|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
170766612|NCT01802632|617149170|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
170766613|NCT01802632|617149171|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
170766614|NCT01802632|617149166|FG000|Overall Study|Other (not specified)|0|||
170411698|NCT05002569|615847192|FG000|Treatment Period|AE unrelated to study drug|6|||
170411699|NCT05002569|615847193|FG001|Treatment Period|AE unrelated to study drug|12|||
170411700|NCT05002569|615847192|FG000|Treatment Period|Disease Recurrence|102|||
170411701|NCT05002569|615847193|FG001|Treatment Period|Disease Recurrence|128|||
170411702|NCT05002569|615847192|FG000|Treatment Period|Other Reasons|4|||
170766615|NCT01802632|617149167|FG001|Overall Study|Other (not specified)|0|||
170766616|NCT01802632|617149168|FG002|Overall Study|Other (not specified)|7|||
170868777|NCT02846532|617530391|FG001|Overall Study|Withdrawal by Subject|2|||
170411703|NCT05002569|615847193|FG001|Treatment Period|Other Reasons|7|||
170411704|NCT05002569|615847192|FG000|Treatment Period|Death|1|||
170411705|NCT05002569|615847193|FG001|Treatment Period|Death|1|||
170411706|NCT05002569|615847192|FG000|Follow Up|Death|78|||
170411707|NCT05002569|615847193|FG001|Follow Up|Death|69|||
170766617|NCT01802632|617149169|FG003|Overall Study|Other (not specified)|1|||
170766618|NCT01802632|617149170|FG004|Overall Study|Other (not specified)|0|||
170766619|NCT01802632|617149171|FG005|Overall Study|Other (not specified)|1|||
170766620|NCT03299816|617149172|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
170766621|NCT03299816|617149173|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
170766622|NCT03299816|617149172|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
170766623|NCT03299816|617149173|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
170766624|NCT03299816|617149172|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
170411708|NCT05002569|615847192|FG000|Follow Up|Lost to Follow-up|3|||
170411709|NCT05002569|615847193|FG001|Follow Up|Lost to Follow-up|3|||
170411710|NCT05002569|615847192|FG000|Follow Up|Withdrew consent|17|||
170411711|NCT05002569|615847193|FG001|Follow Up|Withdrew consent|16|||
170411712|NCT05002569|615847192|FG000|Follow Up|Other Reasons|444|||
170411713|NCT05002569|615847193|FG001|Follow Up|Other Reasons|452|||
170411714|NCT02398188|615847194|FG000|Overall Study|Adverse Event|2|||
170411715|NCT02398188|615847195|FG001|Overall Study|Adverse Event|3|||
170411716|NCT02398188|615847194|FG000|Overall Study|Lost to Follow-up|5|||
170411717|NCT02398188|615847195|FG001|Overall Study|Lost to Follow-up|0|||
170411718|NCT02398188|615847194|FG000|Overall Study|Non-compliance|4|||
170411719|NCT02398188|615847195|FG001|Overall Study|Non-compliance|4|||
170411720|NCT02398188|615847194|FG000|Overall Study|Protocol Violation|6|||
170411721|NCT02398188|615847195|FG001|Overall Study|Protocol Violation|10|||
170411722|NCT02398188|615847194|FG000|Overall Study|Sponsor Decision|2|||
170411723|NCT02398188|615847195|FG001|Overall Study|Sponsor Decision|1|||
170411724|NCT02398188|615847194|FG000|Overall Study|Pregnancy|1|||
170411725|NCT02398188|615847195|FG001|Overall Study|Pregnancy|0|||
170411726|NCT02398188|615847194|FG000|Overall Study|Withdrawal by Subject|7|||
170411727|NCT02398188|615847195|FG001|Overall Study|Withdrawal by Subject|16|||
170411728|NCT00220701|615847200|FG000|Overall Study|Lost to Follow-up|5|||
170411729|NCT00220701|615847201|FG001|Overall Study|Lost to Follow-up|4|||
170411730|NCT04041570|615847202|FG000|Overall Study|Moved from Area|0|||
170411731|NCT04041570|615847203|FG001|Overall Study|Moved from Area|2|||
170411732|NCT05211336|615847204|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
170411733|NCT05211336|615847205|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
170411734|NCT05211336|615847204|FG000|Overall Study|Progressive disease|0|||
170411735|NCT05211336|615847205|FG001|Overall Study|Progressive disease|4|||
170411736|NCT05211336|615847204|FG000|Overall Study|Death due to myocardial infarction|0|||
170411737|NCT05211336|615847205|FG001|Overall Study|Death due to myocardial infarction|1|||
170411738|NCT05211336|615847204|FG000|Overall Study|Death due to unknown cause|0|||
170411739|NCT05211336|615847205|FG001|Overall Study|Death due to unknown cause|1|||
170411740|NCT05211336|615847204|FG000|Overall Study|Worsening kidney function and quality of response|0|||
170411741|NCT05211336|615847205|FG001|Overall Study|Worsening kidney function and quality of response|1|||
170411742|NCT01694485|615847208|FG000|Overall Study|Withdrawal by Subject|20|||
170411743|NCT01694485|615847209|FG001|Overall Study|Withdrawal by Subject|6|||
170411744|NCT01694485|615847210|FG002|Overall Study|Withdrawal by Subject|7|||
170411745|NCT01694485|615847211|FG003|Overall Study|Withdrawal by Subject|25|||
170411746|NCT01694485|615847212|FG004|Overall Study|Withdrawal by Subject|18|||
170411747|NCT01694485|615847208|FG000|Overall Study|Sponsor Decision|3|||
170411748|NCT01694485|615847209|FG001|Overall Study|Sponsor Decision|0|||
170411749|NCT01694485|615847210|FG002|Overall Study|Sponsor Decision|0|||
170411750|NCT01694485|615847211|FG003|Overall Study|Sponsor Decision|2|||
170411751|NCT01694485|615847212|FG004|Overall Study|Sponsor Decision|0|||
170411752|NCT01694485|615847208|FG000|Overall Study|Lost to Follow-up|9|||
170411753|NCT01694485|615847209|FG001|Overall Study|Lost to Follow-up|1|||
170411754|NCT01694485|615847210|FG002|Overall Study|Lost to Follow-up|6|||
170411755|NCT01694485|615847211|FG003|Overall Study|Lost to Follow-up|10|||
170411756|NCT01694485|615847212|FG004|Overall Study|Lost to Follow-up|7|||
170411757|NCT01694485|615847208|FG000|Overall Study|Death|1|||
170411758|NCT01694485|615847209|FG001|Overall Study|Death|0|||
170411759|NCT01694485|615847210|FG002|Overall Study|Death|0|||
170411760|NCT01694485|615847211|FG003|Overall Study|Death|1|||
170411761|NCT01694485|615847212|FG004|Overall Study|Death|0|||
170411762|NCT00729859|615847213|FG000|Overall Study|Adverse Event|0|||
170411763|NCT00729859|615847214|FG001|Overall Study|Adverse Event|1|||
170411764|NCT00729859|615847215|FG002|Overall Study|Adverse Event|0|||
170411765|NCT00729859|615847213|FG000|Overall Study|Withdrawal by Subject|0|||
170411766|NCT00729859|615847214|FG001|Overall Study|Withdrawal by Subject|1|||
170411767|NCT00729859|615847215|FG002|Overall Study|Withdrawal by Subject|0|||
170411768|NCT02337829|615847216|FG000|Overall Study|Death|0|||
170411769|NCT02337829|615847217|FG001|Overall Study|Death|1|||
170411770|NCT02337829|615847218|FG002|Overall Study|Death|0|||
170411771|NCT02337829|615847219|FG003|Overall Study|Death|0|||
170766625|NCT03299816|617149173|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
170411772|NCT02337829|615847216|FG000|Overall Study|Study terminated by sponsor|12|||
170411773|NCT02337829|615847217|FG001|Overall Study|Study terminated by sponsor|10|||
170411774|NCT02337829|615847218|FG002|Overall Study|Study terminated by sponsor|5|||
170632166|NCT01134055|616664540|FG001|Overall Study|Protocol Violation|0|||
170411775|NCT02337829|615847219|FG003|Overall Study|Study terminated by sponsor|6|||
170632167|NCT01134055|616664541|FG002|Overall Study|Protocol Violation|0|||
170868778|NCT02846532|617530392|FG002|Overall Study|Withdrawal by Subject|0|||
170868779|NCT04598477|617530394|FG000|Overall Study|Adverse Event|2|||
170868780|NCT04598477|617530395|FG001|Overall Study|Adverse Event|0|||
170868781|NCT04598477|617530394|FG000|Overall Study|Death|0|||
170868782|NCT04598477|617530395|FG001|Overall Study|Death|1|||
170868783|NCT04598477|617530394|FG000|Overall Study|Lost to Follow-up|1|||
170868784|NCT04598477|617530395|FG001|Overall Study|Lost to Follow-up|0|||
170868785|NCT04598477|617530394|FG000|Overall Study|Physician Decision|7|||
170868786|NCT04598477|617530395|FG001|Overall Study|Physician Decision|2|||
170868787|NCT04598477|617530394|FG000|Overall Study|Pregnancy|0|||
170868788|NCT04598477|617530395|FG001|Overall Study|Pregnancy|1|||
170868789|NCT04598477|617530394|FG000|Overall Study|Requires Prohibited Medication|0|||
170868790|NCT04598477|617530395|FG001|Overall Study|Requires Prohibited Medication|1|||
170868791|NCT04598477|617530394|FG000|Overall Study|Study Terminated by Sponsor|18|||
170868792|NCT04598477|617530395|FG001|Overall Study|Study Terminated by Sponsor|12|||
170868793|NCT04598477|617530394|FG000|Overall Study|Withdrawal by Subject|16|||
170868794|NCT04598477|617530395|FG001|Overall Study|Withdrawal by Subject|12|||
170868795|NCT04598477|617530394|FG000|Overall Study|Other|15|||
170868796|NCT04598477|617530395|FG001|Overall Study|Other|8|||
170868797|NCT05579990|617530401|FG000|Overall Study|Lost to Follow-up|3|||
170868798|NCT04448756|617530404|FG000|Overall Study|Adverse Event|0|||
170868799|NCT04448756|617530405|FG001|Overall Study|Adverse Event|1|||
170868800|NCT04448756|617530406|FG002|Overall Study|Adverse Event|0|||
170868801|NCT04448756|617530404|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
170868802|NCT04448756|617530405|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
170868803|NCT04448756|617530406|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
170868804|NCT04448756|617530404|FG000|Overall Study|Withdrawal by Subject|0|||
170868805|NCT04448756|617530405|FG001|Overall Study|Withdrawal by Subject|3|||
170868806|NCT04448756|617530406|FG002|Overall Study|Withdrawal by Subject|1|||
170868807|NCT04448756|617530404|FG000|Overall Study|Death|2|||
170868808|NCT04448756|617530405|FG001|Overall Study|Death|1|||
170868809|NCT04448756|617530406|FG002|Overall Study|Death|0|||
170868810|NCT02733185|617530407|FG000|Overall Study|Withdrawal by Subject|12|||
170868811|NCT02733185|617530408|FG001|Overall Study|Withdrawal by Subject|10|||
170411776|NCT02337829|615847216|FG000|Overall Study|discontinued for other reasons|6|||
170411777|NCT02337829|615847217|FG001|Overall Study|discontinued for other reasons|3|||
170411778|NCT02337829|615847218|FG002|Overall Study|discontinued for other reasons|1|||
170522128|NCT02188160|616258058|FG000|Overall Study|Adverse Event|1|||
170522129|NCT02188160|616258059|FG001|Overall Study|Adverse Event|0|||
170522130|NCT02188160|616258058|FG000|Overall Study|Use of an excluded medication|0|||
170522131|NCT02188160|616258059|FG001|Overall Study|Use of an excluded medication|1|||
170522132|NCT03973996|616258060|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170522133|NCT03973996|616258061|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170411779|NCT02337829|615847219|FG003|Overall Study|discontinued for other reasons|4|||
170411780|NCT01992107|615847222|FG000|Overall Study|Administrative reasons|2|||
170411781|NCT01992107|615847223|FG001|Overall Study|Administrative reasons|0|||
170411782|NCT01992107|615847224|FG002|Overall Study|Administrative reasons|0|||
170411783|NCT01992107|615847222|FG000|Overall Study|Adverse Event|0|||
170411784|NCT01992107|615847223|FG001|Overall Study|Adverse Event|1|||
170411785|NCT01992107|615847224|FG002|Overall Study|Adverse Event|0|||
170411786|NCT01992107|615847222|FG000|Overall Study|Lost to Follow-up|46|||
170411787|NCT01992107|615847223|FG001|Overall Study|Lost to Follow-up|22|||
170411788|NCT01992107|615847224|FG002|Overall Study|Lost to Follow-up|26|||
170411789|NCT01992107|615847222|FG000|Overall Study|noncompliance and were unavailable|7|||
170411790|NCT01992107|615847223|FG001|Overall Study|noncompliance and were unavailable|3|||
170411791|NCT01992107|615847224|FG002|Overall Study|noncompliance and were unavailable|2|||
170411792|NCT01992107|615847222|FG000|Overall Study|Withdrawal by Subject|13|||
170411793|NCT01992107|615847223|FG001|Overall Study|Withdrawal by Subject|7|||
170411794|NCT01992107|615847224|FG002|Overall Study|Withdrawal by Subject|8|||
170868812|NCT02733185|617530409|FG002|Overall Study|Withdrawal by Subject|17|||
170868813|NCT02733185|617530410|FG003|Overall Study|Withdrawal by Subject|21|||
170868814|NCT02733185|617530407|FG000|Overall Study|Death|46|||
170868815|NCT02733185|617530408|FG001|Overall Study|Death|34|||
170411795|NCT02022007|615847225|FG000|Overall Study|Withdrawal by Subject|1|||
170411796|NCT02022007|615847226|FG001|Overall Study|Withdrawal by Subject|1|||
170411797|NCT02022007|615847227|FG002|Overall Study|Withdrawal by Subject|1|||
170411798|NCT02022007|615847225|FG000|Overall Study|Noncompliant|0|||
170411799|NCT02022007|615847226|FG001|Overall Study|Noncompliant|0|||
170411800|NCT02022007|615847227|FG002|Overall Study|Noncompliant|1|||
170632168|NCT01134055|616664542|FG003|Overall Study|Protocol Violation|1|||
170868816|NCT02733185|617530409|FG002|Overall Study|Death|35|||
170868817|NCT02733185|617530410|FG003|Overall Study|Death|43|||
170868818|NCT02733185|617530407|FG000|Overall Study|Lost to Follow-up|17|||
170868819|NCT02733185|617530408|FG001|Overall Study|Lost to Follow-up|18|||
170868820|NCT02733185|617530409|FG002|Overall Study|Lost to Follow-up|16|||
170868821|NCT02733185|617530410|FG003|Overall Study|Lost to Follow-up|11|||
170868822|NCT00671554|617530411|FG000|Overall Study|Disease progression|3|||
170868823|NCT07052682|617530419|FG000|Overall Study|Withdrawal by Subject|4|||
170766626|NCT00082810|617149174|FG000|Overall Study|Adverse Event|3|||
170766627|NCT00082810|617149174|FG000|Overall Study|Progressive disease|24|||
170766628|NCT00082810|617149174|FG000|Overall Study|Withdrawal by Subject|4|||
170766629|NCT00741988|617149180|FG000|Overall Study|Adverse Event|2|||
170766630|NCT00741988|617149181|FG001|Overall Study|Adverse Event|4|||
170766631|NCT00741988|617149180|FG000|Overall Study|Lack of Efficacy|2|||
170766632|NCT00741988|617149181|FG001|Overall Study|Lack of Efficacy|0|||
170766633|NCT03545984|617149182|FG000|Overall Study|CSF cases not present during rotation|11|||
170766634|NCT03545984|617149183|FG001|Overall Study|CSF cases not present during rotation|9|||
170766635|NCT03121950|617149184|FG000|Overall Study|Withdrawal by Subject|11|||
170766636|NCT03121950|617149185|FG001|Overall Study|Withdrawal by Subject|2|||
170766637|NCT03979365|617151149|FG000|Overall Study|Death|1|||
170766638|NCT03979365|617151150|FG001|Overall Study|Death|3|||
170766639|NCT03979365|617151149|FG000|Overall Study|Withdrawal by Subject|0|||
170766640|NCT03979365|617151150|FG001|Overall Study|Withdrawal by Subject|1|||
170766641|NCT03979365|617151149|FG000|Overall Study|Drug Conversion|0|||
170766642|NCT03979365|617151150|FG001|Overall Study|Drug Conversion|3|||
170766643|NCT03175172|617151151|FG000|Overall Study|Death|3|||
170766644|NCT03175172|617151151|FG000|Overall Study|Withdrawal by Subject|3|||
170766645|NCT03175172|617151151|FG000|Overall Study|Lost to Follow-up|1|||
170766646|NCT03175172|617151151|FG000|Overall Study|Study Terminated by Sponsor|3|||
170766647|NCT01070888|617151152|FG000|First Intervention (14 Days)|Adverse Event|0|||
170766648|NCT01070888|617151153|FG001|First Intervention (14 Days)|Adverse Event|1|||
170766649|NCT01070888|617151152|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
170766650|NCT01070888|617151153|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
170766651|NCT01070888|617151152|FG000|Washout (14 Days)|Physician Decision|1|||
170766652|NCT01070888|617151153|FG001|Washout (14 Days)|Physician Decision|0|||
170766653|NCT00178399|617151154|FG000|Overall Study|Physician Decision|4|||
170766654|NCT00178399|617151154|FG000|Overall Study|Withdrawal by Subject|8|||
170766655|NCT00178399|617151154|FG000|Overall Study|Lost to Follow-up|1|||
170766656|NCT01499134|617151157|FG000|Overall Study|Withdrawal by Subject|0|||
170766657|NCT01499134|617151158|FG001|Overall Study|Withdrawal by Subject|1|||
170766658|NCT01198275|617151159|FG000|Overall Study|Adverse Event|2|||
170766659|NCT01198275|617151160|FG001|Overall Study|Adverse Event|3|||
170766660|NCT01198275|617151159|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
170766661|NCT01198275|617151160|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
170766662|NCT02385669|617151165|FG000|Overall Study|Adverse Event|2|||
170766663|NCT00393848|617151170|FG000|Overall Study|Surgical schedule|0|||
170766664|NCT00393848|617151171|FG001|Overall Study|Surgical schedule|0|||
170766665|NCT00393848|617151172|FG002|Overall Study|Surgical schedule|0|||
170766666|NCT00393848|617151173|FG003|Overall Study|Surgical schedule|1|||
170766667|NCT00393848|617151170|FG000|Overall Study|Personal reasons|0|||
170766668|NCT00393848|617151171|FG001|Overall Study|Personal reasons|0|||
170766669|NCT00393848|617151172|FG002|Overall Study|Personal reasons|2|||
170766670|NCT00393848|617151173|FG003|Overall Study|Personal reasons|0|||
170766671|NCT02567656|617151176|FG000|Overall Study|Premature discontinuation due to PD|1|||
170766672|NCT02567656|617151177|FG001|Overall Study|Premature discontinuation due to PD|1|||
170766673|NCT02567656|617151178|FG002|Overall Study|Premature discontinuation due to PD|2|||
170766674|NCT02567656|617151179|FG003|Overall Study|Premature discontinuation due to PD|0|||
170766675|NCT02567656|617151180|FG004|Overall Study|Premature discontinuation due to PD|0|||
170766676|NCT02567656|617151181|FG005|Overall Study|Premature discontinuation due to PD|0|||
170766677|NCT02034916|617151182|FG000|Overall Study|Death|39|||
170766678|NCT02034916|617151183|FG001|Overall Study|Death|28|||
170766679|NCT02034916|617151182|FG000|Overall Study|Withdrawal by Subject|2|||
170766680|NCT02034916|617151183|FG001|Overall Study|Withdrawal by Subject|1|||
170766681|NCT02034916|617151182|FG000|Overall Study|Lost to Follow-up|4|||
170766682|NCT02034916|617151183|FG001|Overall Study|Lost to Follow-up|1|||
170766683|NCT02034916|617151182|FG000|Overall Study|Study terminated by sponsor|4|||
170766684|NCT02034916|617151183|FG001|Overall Study|Study terminated by sponsor|5|||
170766685|NCT00486330|617151185|FG000|Overall Study|Adverse Event|2|||
170766686|NCT01290224|617151186|FG000|Overall Study|Adverse Event|1|||
170766687|NCT01290224|617151186|FG000|Overall Study|Refused Further Treatment|4|||
170766688|NCT05694065|617151187|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
170766689|NCT05694065|617151187|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
170766690|NCT05694065|617151187|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
170766691|NCT01087762|617151189|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
170766692|NCT01087762|617151190|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
170766693|NCT01087762|617151191|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
170766694|NCT01087762|617151192|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
170766695|NCT01087762|617151193|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
170766696|NCT01087762|617151189|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
170766697|NCT01087762|617151190|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
170766698|NCT01087762|617151191|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
170411801|NCT00585351|615847229|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
170766699|NCT01087762|617151192|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
170766700|NCT01087762|617151193|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
170766701|NCT01087762|617151189|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
170766702|NCT01087762|617151190|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
170766703|NCT01087762|617151191|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
170766704|NCT01087762|617151192|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
170766705|NCT01087762|617151193|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
170766706|NCT01087762|617151189|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
170766707|NCT01087762|617151190|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
170766708|NCT01087762|617151191|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
170766709|NCT01087762|617151192|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
170766710|NCT01087762|617151193|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
170766711|NCT01087762|617151189|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
170766712|NCT01087762|617151190|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
170766713|NCT01087762|617151191|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
170766714|NCT01087762|617151192|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
170766715|NCT01087762|617151193|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
170766716|NCT01087762|617151189|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
170766717|NCT01087762|617151190|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
170766718|NCT01087762|617151191|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
170766719|NCT01087762|617151192|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
170766720|NCT01087762|617151193|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
170766721|NCT01087762|617151189|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
170766722|NCT01087762|617151190|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
170766723|NCT01087762|617151191|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
170766724|NCT01087762|617151192|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
170766725|NCT01087762|617151193|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
170766726|NCT01087762|617151189|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
170766727|NCT01087762|617151190|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
170766728|NCT01087762|617151191|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
170766729|NCT01087762|617151192|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
170766730|NCT01087762|617151193|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
170766731|NCT01087762|617151189|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
170766732|NCT01087762|617151190|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
170766733|NCT01087762|617151191|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
170766734|NCT01087762|617151192|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
170766735|NCT01087762|617151193|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
170766736|NCT01087762|617151189|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
170766737|NCT01087762|617151190|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
170766738|NCT01087762|617151191|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
170766739|NCT01087762|617151192|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
170766740|NCT01087762|617151193|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
170766741|NCT01087762|617151189|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
170766742|NCT01087762|617151190|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
170766743|NCT01087762|617151191|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
170766744|NCT01087762|617151192|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
170766745|NCT01087762|617151193|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
170766746|NCT01087762|617151189|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
170766747|NCT01087762|617151190|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
170766748|NCT01087762|617151191|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
170766749|NCT01087762|617151192|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
170766750|NCT01087762|617151193|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
170766751|NCT01087762|617151189|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
170766752|NCT01087762|617151190|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
170411802|NCT00585351|615847230|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
170411803|NCT00585351|615847231|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
170411804|NCT00585351|615847232|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
170411805|NCT00585351|615847233|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
170411806|NCT00585351|615847234|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
170632169|NCT01134055|616664543|FG004|Overall Study|Protocol Violation|1|||
170766753|NCT01087762|617151191|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
170766754|NCT01087762|617151192|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
170766755|NCT01087762|617151193|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
170766756|NCT01405924|617151197|FG000|Overall Study|Protocol Violation|8|||
170766757|NCT01405924|617151197|FG000|Overall Study|Missing/Incomplete Data|2|||
170766758|NCT01924767|617151199|FG000|Overall Study|Adverse Event|1|||
170632170|NCT01134055|616664544|FG005|Overall Study|Protocol Violation|0|||
170868824|NCT04667247|617530420|FG000|Overall Study|Withdrawal by Subject|0|||
170868825|NCT04667247|617530421|FG001|Overall Study|Withdrawal by Subject|1|||
170868826|NCT05460273|617530422|FG000|Overall Study|Death|43|||
170868827|NCT05460273|617530423|FG001|Overall Study|Death|9|||
170868828|NCT05460273|617530422|FG000|Overall Study|Lost to Follow-up|7|||
170868829|NCT05460273|617530423|FG001|Overall Study|Lost to Follow-up|0|||
170868830|NCT05460273|617530422|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
170868831|NCT05460273|617530423|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
170868832|NCT04124614|617530424|FG000|Placebo Run-in Period|Not Randomized|34|||
170868833|NCT04124614|617530425|FG001|Placebo Run-in Period|Not Randomized|0|||
170868834|NCT04124614|617530426|FG002|Placebo Run-in Period|Not Randomized|0|||
170868835|NCT04124614|617530424|FG000|Double Blind Treatment Period|Adverse Event|0|||
170868836|NCT04124614|617530425|FG001|Double Blind Treatment Period|Adverse Event|7|||
170868837|NCT04124614|617530426|FG002|Double Blind Treatment Period|Adverse Event|22|||
170868838|NCT04124614|617530424|FG000|Double Blind Treatment Period|Death|0|||
170868839|NCT04124614|617530425|FG001|Double Blind Treatment Period|Death|0|||
170868840|NCT04124614|617530426|FG002|Double Blind Treatment Period|Death|1|||
170868841|NCT04124614|617530424|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
170868842|NCT04124614|617530425|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
170868843|NCT04124614|617530426|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
170411807|NCT00585351|615847235|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
170411808|NCT00585351|615847236|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
170411809|NCT00585351|615847229|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
170411810|NCT00585351|615847230|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
170411811|NCT00585351|615847231|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
170411812|NCT00585351|615847232|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
170411813|NCT00585351|615847233|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
170411814|NCT00585351|615847234|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
170411815|NCT00585351|615847235|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
170411816|NCT00585351|615847236|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
170411817|NCT00585351|615847229|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
170411818|NCT00585351|615847230|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
170411819|NCT00585351|615847231|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
170411820|NCT00585351|615847232|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
170411821|NCT00585351|615847233|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
170411822|NCT00585351|615847234|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
170411823|NCT00585351|615847235|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
170411824|NCT00585351|615847236|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
170411825|NCT00585351|615847229|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
170411826|NCT00585351|615847230|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
170411827|NCT00585351|615847231|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
170411828|NCT00585351|615847232|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
170411829|NCT00585351|615847233|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
170411830|NCT00585351|615847234|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
170411831|NCT00585351|615847235|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
170411832|NCT00585351|615847236|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
170411833|NCT00585351|615847229|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
170411834|NCT00585351|615847230|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
170411835|NCT00585351|615847231|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
170411836|NCT00585351|615847232|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
170411837|NCT00585351|615847233|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
170411838|NCT00585351|615847234|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
170411839|NCT00585351|615847235|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
170411840|NCT00585351|615847236|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
170411841|NCT00585351|615847229|FG000|Enrollment Period (Intervention)|Death|0|||
170411842|NCT00585351|615847230|FG001|Enrollment Period (Intervention)|Death|0|||
170411843|NCT00585351|615847231|FG002|Enrollment Period (Intervention)|Death|0|||
170411844|NCT00585351|615847232|FG003|Enrollment Period (Intervention)|Death|0|||
170411845|NCT00585351|615847233|FG004|Enrollment Period (Intervention)|Death|1|||
170411846|NCT00585351|615847234|FG005|Enrollment Period (Intervention)|Death|0|||
170411847|NCT00585351|615847235|FG006|Enrollment Period (Intervention)|Death|1|||
170411848|NCT00585351|615847236|FG007|Enrollment Period (Intervention)|Death|0|||
170411849|NCT00585351|615847229|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
170868844|NCT04124614|617530424|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
170868845|NCT04124614|617530425|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
170868846|NCT04124614|617530426|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
170766759|NCT01924767|617151200|FG001|Overall Study|Adverse Event|0|||
170766760|NCT01924767|617151201|FG002|Overall Study|Adverse Event|1|||
170766761|NCT01924767|617151202|FG003|Overall Study|Adverse Event|0|||
170766762|NCT01924767|617151203|FG004|Overall Study|Adverse Event|0|||
170766763|NCT01648140|617151204|FG000|Overall Study|Physician Decision|1|||
170766764|NCT01648140|617151205|FG001|Overall Study|Physician Decision|0|||
170766765|NCT01648140|617151206|FG002|Overall Study|Physician Decision|0|||
170766766|NCT01648140|617151207|FG003|Overall Study|Physician Decision|0|||
170766767|NCT01648140|617151204|FG000|Overall Study|Lack of Efficacy|4|||
170766768|NCT01648140|617151205|FG001|Overall Study|Lack of Efficacy|7|||
170766769|NCT01648140|617151206|FG002|Overall Study|Lack of Efficacy|1|||
170766770|NCT01648140|617151207|FG003|Overall Study|Lack of Efficacy|0|||
170766771|NCT01648140|617151204|FG000|Overall Study|Adverse Event|3|||
170766772|NCT01648140|617151205|FG001|Overall Study|Adverse Event|1|||
170766773|NCT01648140|617151206|FG002|Overall Study|Adverse Event|2|||
170766774|NCT01648140|617151207|FG003|Overall Study|Adverse Event|0|||
170766775|NCT01648140|617151204|FG000|Overall Study|Withdrawal by Subject|2|||
170766776|NCT01648140|617151205|FG001|Overall Study|Withdrawal by Subject|3|||
170766777|NCT01648140|617151206|FG002|Overall Study|Withdrawal by Subject|3|||
170766778|NCT01648140|617151207|FG003|Overall Study|Withdrawal by Subject|2|||
170766779|NCT01648140|617151204|FG000|Overall Study|Lost to Follow-up|2|||
170766780|NCT01648140|617151205|FG001|Overall Study|Lost to Follow-up|1|||
170766781|NCT01648140|617151206|FG002|Overall Study|Lost to Follow-up|2|||
170766782|NCT01648140|617151207|FG003|Overall Study|Lost to Follow-up|0|||
170766783|NCT01119950|617151208|FG000|Overall Study|Adverse Event|25|||
170766784|NCT01119950|617151208|FG000|Overall Study|Withdrawal by Subject|9|||
170766785|NCT01119950|617151208|FG000|Overall Study|Protocol Violation|5|||
170766786|NCT01119950|617151208|FG000|Overall Study|Lost to Follow-up|4|||
170766787|NCT01119950|617151208|FG000|Overall Study|Administrative|2|||
170766788|NCT01119950|617151208|FG000|Overall Study|Abnormal lab value|1|||
170766789|NCT01119950|617151208|FG000|Overall Study|Death|1|||
170766790|NCT00855465|617151211|FG000|Treatment Period|Adverse Event|4|||
170766791|NCT00855465|617151212|FG001|Treatment Period|Adverse Event|2|||
170766792|NCT00855465|617151211|FG000|Treatment Period|Death|2|||
170766793|NCT00855465|617151212|FG001|Treatment Period|Death|2|||
170766794|NCT00855465|617151211|FG000|Treatment Period|Lack of Efficacy|2|||
170766795|NCT00855465|617151212|FG001|Treatment Period|Lack of Efficacy|1|||
170766796|NCT00855465|617151211|FG000|Treatment Period|Non-compliance|1|||
170766797|NCT00855465|617151212|FG001|Treatment Period|Non-compliance|0|||
170766798|NCT00855465|617151211|FG000|Treatment Period|Protocol Violation|2|||
170766799|NCT00855465|617151212|FG001|Treatment Period|Protocol Violation|0|||
170766800|NCT00855465|617151211|FG000|Treatment Period|Withdrawal by Subject|2|||
170766801|NCT00855465|617151212|FG001|Treatment Period|Withdrawal by Subject|0|||
170766802|NCT00855465|617151211|FG000|Treatment Period|Not treated|1|||
170766803|NCT00855465|617151212|FG001|Treatment Period|Not treated|0|||
170766804|NCT00855465|617151211|FG000|Follow-up Period (FUP)|Adverse Event|0|||
170766805|NCT00855465|617151212|FG001|Follow-up Period (FUP)|Adverse Event|1|||
170766806|NCT00855465|617151211|FG000|Follow-up Period (FUP)|Death|0|||
170766807|NCT00855465|617151212|FG001|Follow-up Period (FUP)|Death|1|||
170766808|NCT00855465|617151211|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
170766809|NCT00855465|617151212|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
170766810|NCT00855465|617151211|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
170766811|NCT00855465|617151212|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
170766812|NCT00855465|617151211|FG000|Follow-up Period (FUP)|Missing|1|||
170766813|NCT00855465|617151212|FG001|Follow-up Period (FUP)|Missing|0|||
170766814|NCT02613364|617151223|FG000|Overall Study|Other|19|||
170766815|NCT02613364|617151224|FG001|Overall Study|Other|29|||
170766816|NCT02613364|617151225|FG002|Overall Study|Other|17|||
170766817|NCT02613364|617151223|FG000|Overall Study|Too time consuming|21|||
170766818|NCT02613364|617151224|FG001|Overall Study|Too time consuming|26|||
170766819|NCT02613364|617151225|FG002|Overall Study|Too time consuming|26|||
170766820|NCT02613364|617151223|FG000|Overall Study|Withdrawal by Subject|13|||
170766821|NCT02613364|617151224|FG001|Overall Study|Withdrawal by Subject|18|||
170868847|NCT04124614|617530424|FG000|Double Blind Treatment Period|Physician Decision|0|||
170766822|NCT02613364|617151225|FG002|Overall Study|Withdrawal by Subject|17|||
170766823|NCT02613364|617151223|FG000|Overall Study|Medical|12|||
170868848|NCT04124614|617530425|FG001|Double Blind Treatment Period|Physician Decision|0|||
170766824|NCT02613364|617151224|FG001|Overall Study|Medical|13|||
170766825|NCT02613364|617151225|FG002|Overall Study|Medical|9|||
170766826|NCT02613364|617151223|FG000|Overall Study|Disliked Study Procedure|1|||
170766827|NCT02613364|617151224|FG001|Overall Study|Disliked Study Procedure|1|||
170766828|NCT02613364|617151225|FG002|Overall Study|Disliked Study Procedure|4|||
170766829|NCT02613364|617151223|FG000|Overall Study|Disliked Intervention|0|||
170868849|NCT04124614|617530426|FG002|Double Blind Treatment Period|Physician Decision|3|||
170868850|NCT04124614|617530424|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
170766830|NCT02613364|617151224|FG001|Overall Study|Disliked Intervention|3|||
170766831|NCT02613364|617151225|FG002|Overall Study|Disliked Intervention|3|||
170766832|NCT01909336|617151226|FG000|Overall Study|Lost to Follow-up|4|||
170766833|NCT01909336|617151227|FG001|Overall Study|Lost to Follow-up|2|||
170411850|NCT00585351|615847230|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
170411851|NCT00585351|615847231|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
170411852|NCT00585351|615847232|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
170766834|NCT01909336|617151228|FG002|Overall Study|Lost to Follow-up|2|||
170766835|NCT01909336|617151226|FG000|Overall Study|Physician Decision|0|||
170766836|NCT01909336|617151227|FG001|Overall Study|Physician Decision|1|||
170766837|NCT01909336|617151228|FG002|Overall Study|Physician Decision|1|||
170766838|NCT03743246|617151229|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
170766839|NCT03743246|617151230|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
170766840|NCT03743246|617151231|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
170766841|NCT03743246|617151232|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
170766842|NCT03743246|617151229|FG000|Pre-Treatment Period|Death|0|||
170766843|NCT03743246|617151230|FG001|Pre-Treatment Period|Death|1|||
170766844|NCT03743246|617151231|FG002|Pre-Treatment Period|Death|0|||
170766845|NCT03743246|617151232|FG003|Pre-Treatment Period|Death|1|||
170766846|NCT03743246|617151229|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
170766847|NCT03743246|617151230|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
170766848|NCT03743246|617151231|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
170766849|NCT03743246|617151232|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
170766850|NCT03743246|617151229|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
170766851|NCT03743246|617151230|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
170766852|NCT03743246|617151231|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
170766853|NCT03743246|617151232|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
170766854|NCT03743246|617151229|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
170766855|NCT03743246|617151230|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
170766856|NCT03743246|617151231|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
170766857|NCT03743246|617151232|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
170766858|NCT03743246|617151229|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
170766859|NCT03743246|617151230|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
170766860|NCT03743246|617151231|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
170766861|NCT03743246|617151232|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
170766862|NCT03743246|617151229|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
170766863|NCT03743246|617151230|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
170766864|NCT03743246|617151231|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
170766865|NCT03743246|617151232|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
170766866|NCT03743246|617151229|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
170766867|NCT03743246|617151230|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
170766868|NCT03743246|617151231|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
170766869|NCT03743246|617151232|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
170766870|NCT03743246|617151229|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
170766871|NCT03743246|617151230|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
170766872|NCT03743246|617151231|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
170766873|NCT03743246|617151232|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
170766874|NCT00395018|617151233|FG000|On-Treatment|Death|4|||
170766875|NCT00395018|617151233|FG000|On-Treatment|Other Reason|2|||
170766876|NCT00395018|617151233|FG000|On-Treatment|Poor/non-compliance|2|||
170766877|NCT00395018|617151233|FG000|On-Treatment|Subject no longer meets study criteria|2|||
170766878|NCT00395018|617151233|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
170766879|NCT00395018|617151233|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
170766880|NCT00395018|617151233|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
170766881|NCT00371566|617151234|FG000|Treatment Phase|Withdrawal by Subject|0|||
170766882|NCT00371566|617151235|FG001|Treatment Phase|Withdrawal by Subject|1|||
170766883|NCT00371566|617151234|FG000|Treatment Phase|Adverse Event|0|||
170766884|NCT00371566|617151235|FG001|Treatment Phase|Adverse Event|1|||
170766885|NCT00371566|617151234|FG000|Treatment Phase|Protocol Violation|0|||
170766886|NCT00371566|617151235|FG001|Treatment Phase|Protocol Violation|1|||
170766887|NCT00371566|617151234|FG000|Chemoradiation Phase|Physician Decision|2|||
170766888|NCT00371566|617151235|FG001|Chemoradiation Phase|Physician Decision|0|||
170766889|NCT00371566|617151234|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
170766890|NCT00371566|617151235|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
170766891|NCT00371566|617151234|FG000|Chemoradiation Phase|Non compliant|0|||
170766892|NCT00371566|617151235|FG001|Chemoradiation Phase|Non compliant|1|||
170766893|NCT00371566|617151234|FG000|Chemoradiation Phase|Progressive Disease|1|||
170766894|NCT00371566|617151235|FG001|Chemoradiation Phase|Progressive Disease|1|||
170766895|NCT00371566|617151234|FG000|Chemoradiation Phase|Death|2|||
170766896|NCT00371566|617151235|FG001|Chemoradiation Phase|Death|0|||
170766897|NCT00371566|617151234|FG000|Follow Up Phase|Death|0|||
170766898|NCT00371566|617151235|FG001|Follow Up Phase|Death|5|||
170766899|NCT00371566|617151234|FG000|Follow Up Phase|Disease progression|1|||
170632171|NCT01134055|616664545|FG006|Overall Study|Protocol Violation|0|||
170766900|NCT00371566|617151235|FG001|Follow Up Phase|Disease progression|0|||
170766901|NCT00371566|617151234|FG000|Follow Up Phase|Withdrawal by Subject|0|||
170868851|NCT04124614|617530425|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
170868852|NCT04124614|617530426|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
170868853|NCT04124614|617530424|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
170868854|NCT04124614|617530425|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
170868855|NCT04124614|617530426|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
170868856|NCT04124614|617530424|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
170868857|NCT04124614|617530425|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
170868858|NCT04124614|617530426|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
170868859|NCT05749952|617530427|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
170868860|NCT00761306|617531945|FG000|Overall Study|Adverse Event|5|||
170868861|NCT00761306|617531945|FG000|Overall Study|Lack of Efficacy|4|||
170868862|NCT00761306|617531945|FG000|Overall Study|Protocol Violation|2|||
170868863|NCT00761306|617531945|FG000|Overall Study|Withdrawal of Consent|3|||
170868864|NCT00761306|617531945|FG000|Overall Study|Lost to Follow-up|1|||
170868865|NCT00761306|617531945|FG000|Overall Study|Administrative or Other Reasons|5|||
170868866|NCT02460497|617531946|FG000|Overall Study|Participant Requested Withdrawal|4|||
170868867|NCT02460497|617531946|FG000|Overall Study|Non-Compliance|1|||
170766902|NCT00371566|617151235|FG001|Follow Up Phase|Withdrawal by Subject|1|||
170766903|NCT00371566|617151234|FG000|Follow Up Phase|Physician Decision|1|||
170766904|NCT00371566|617151235|FG001|Follow Up Phase|Physician Decision|1|||
170766905|NCT00371566|617151234|FG000|Follow Up Phase|Lost to Follow-up|1|||
170766906|NCT00371566|617151235|FG001|Follow Up Phase|Lost to Follow-up|0|||
170766907|NCT03257813|617151236|FG000|Overall Study|Protocol Violation|6|||
170766908|NCT03257813|617151237|FG001|Overall Study|Protocol Violation|3|||
170766909|NCT04246762|617151238|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
170766910|NCT02878330|617151239|FG000|Overall Study|Death|3|||
170766911|NCT02878330|617151240|FG001|Overall Study|Death|2|||
170766912|NCT02878330|617151239|FG000|Overall Study|Lost to Follow-up|11|||
170766913|NCT02878330|617151240|FG001|Overall Study|Lost to Follow-up|26|||
170766914|NCT02878330|617151239|FG000|Overall Study|Withdrawal by Subject|11|||
170766915|NCT02878330|617151240|FG001|Overall Study|Withdrawal by Subject|21|||
170766916|NCT02878330|617151239|FG000|Overall Study|Other|4|||
170766917|NCT02878330|617151240|FG001|Overall Study|Other|7|||
170766918|NCT03615924|617151241|FG000|Overall Study|Withdrawal by Subject|2|||
170766919|NCT03615924|617151242|FG001|Overall Study|Withdrawal by Subject|5|||
170766920|NCT03615924|617151241|FG000|Overall Study|Death|3|||
170766921|NCT03615924|617151242|FG001|Overall Study|Death|1|||
170868868|NCT02460497|617531946|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
170868869|NCT02460497|617531946|FG000|Overall Study|Lost to Follow-up|2|||
170868870|NCT02460497|617531946|FG000|Overall Study|Investigator Decision|1|||
170868871|NCT02982239|617531949|FG000|Overall Study|Lost to Follow-up|3|||
170868872|NCT02982239|617531950|FG001|Overall Study|Lost to Follow-up|2|||
170411853|NCT00585351|615847233|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
170411854|NCT00585351|615847234|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
170411855|NCT00585351|615847235|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
170411856|NCT00585351|615847236|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
170411857|NCT01842958|615847237|FG000|Overall Study|Lost to Follow-up|1|||
170411858|NCT01842958|615847238|FG001|Overall Study|Lost to Follow-up|1|||
170411859|NCT00299156|615847243|FG000|Period 2 (Randomized)|Screen Failure|0|||
170411860|NCT00299156|615847244|FG001|Period 2 (Randomized)|Screen Failure|1|||
170411861|NCT00299156|615847245|FG002|Period 2 (Randomized)|Screen Failure|0|||
170411862|NCT00283686|615847246|FG000|Overall Study|Death|1|||
170411863|NCT00283686|615847247|FG001|Overall Study|Death|1|||
170411864|NCT00283686|615847248|FG002|Overall Study|Death|1|||
170411865|NCT00283686|615847249|FG003|Overall Study|Death|0|||
170411866|NCT00283686|615847246|FG000|Overall Study|Lost to Follow-up|21|||
170411867|NCT00283686|615847247|FG001|Overall Study|Lost to Follow-up|31|||
170411868|NCT00283686|615847248|FG002|Overall Study|Lost to Follow-up|26|||
170411869|NCT00283686|615847249|FG003|Overall Study|Lost to Follow-up|20|||
170411870|NCT00283686|615847246|FG000|Overall Study|Less than full participation|7|||
170411871|NCT00283686|615847247|FG001|Overall Study|Less than full participation|9|||
170411872|NCT00283686|615847248|FG002|Overall Study|Less than full participation|6|||
170411873|NCT00283686|615847249|FG003|Overall Study|Less than full participation|12|||
170411874|NCT01875445|615847250|FG000|Overall Study|Lost to Follow-up|5|||
170411875|NCT01875445|615847251|FG001|Overall Study|Lost to Follow-up|0|||
170411876|NCT01875445|615847250|FG000|Overall Study|Withdrawal by Subject|2|||
170411877|NCT01875445|615847251|FG001|Overall Study|Withdrawal by Subject|0|||
170411878|NCT04864405|615847252|FG000|Overall Study|Withdrawal by Subject|4|||
170411879|NCT04864405|615847253|FG001|Overall Study|Withdrawal by Subject|6|||
170632172|NCT01134055|616664539|FG000|Overall Study|Physician Decision|0|||
170766922|NCT03615924|617151241|FG000|Overall Study|Lost to Follow-up|1|||
170766923|NCT03615924|617151242|FG001|Overall Study|Lost to Follow-up|0|||
170766924|NCT03615924|617151241|FG000|Overall Study|Randomized in error|1|||
170766925|NCT03615924|617151242|FG001|Overall Study|Randomized in error|0|||
170766926|NCT03615924|617151241|FG000|Overall Study|Study termination by Sponsor|94|||
170868873|NCT00930722|617531952|FG000|Overall Study|Lost to Follow-up|16|||
170868874|NCT00930722|617531952|FG000|Overall Study|No longer willing to participate|9|||
170868875|NCT00930722|617531952|FG000|Overall Study|Study terminated by sponsor|2|||
170868876|NCT02230254|617531955|FG000|Overall Study|Lost to Follow-up|3|||
170868877|NCT00295633|617531957|FG000|Overall Study|Lack of Efficacy|19|||
170868878|NCT00295633|617531958|FG001|Overall Study|Lack of Efficacy|7|||
170868879|NCT00295633|617531959|FG002|Overall Study|Lack of Efficacy|16|||
170868880|NCT00295633|617531957|FG000|Overall Study|Withdrawal of consent by subject|16|||
170868881|NCT00295633|617531958|FG001|Overall Study|Withdrawal of consent by subject|16|||
170868882|NCT00295633|617531959|FG002|Overall Study|Withdrawal of consent by subject|26|||
170868883|NCT00295633|617531957|FG000|Overall Study|Adverse Event|9|||
170868884|NCT00295633|617531958|FG001|Overall Study|Adverse Event|17|||
170868885|NCT00295633|617531959|FG002|Overall Study|Adverse Event|9|||
170868886|NCT00295633|617531957|FG000|Overall Study|Lost to Follow-up|6|||
170868887|NCT00295633|617531958|FG001|Overall Study|Lost to Follow-up|11|||
170868888|NCT00295633|617531959|FG002|Overall Study|Lost to Follow-up|7|||
170868889|NCT00295633|617531957|FG000|Overall Study|Physician Decision|9|||
170868890|NCT00295633|617531958|FG001|Overall Study|Physician Decision|10|||
170868891|NCT00295633|617531959|FG002|Overall Study|Physician Decision|8|||
170868892|NCT00295633|617531957|FG000|Overall Study|Poor/Noncompliance|2|||
170868893|NCT00295633|617531958|FG001|Overall Study|Poor/Noncompliance|2|||
170868894|NCT00295633|617531959|FG002|Overall Study|Poor/Noncompliance|6|||
170868895|NCT00295633|617531957|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
170868896|NCT00295633|617531958|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
170868897|NCT00295633|617531959|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
170868898|NCT00295633|617531957|FG000|Overall Study|Death|1|||
170868899|NCT00295633|617531958|FG001|Overall Study|Death|1|||
170868900|NCT00295633|617531959|FG002|Overall Study|Death|0|||
170868901|NCT00295633|617531957|FG000|Overall Study|Administrative reason by sponsor|0|||
170868902|NCT00295633|617531958|FG001|Overall Study|Administrative reason by sponsor|0|||
170868903|NCT00295633|617531959|FG002|Overall Study|Administrative reason by sponsor|1|||
170868904|NCT01950247|617531960|FG000|Overall Study|Withdrawal by Subject|28|||
170868905|NCT01950247|617531961|FG001|Overall Study|Withdrawal by Subject|13|||
170868906|NCT01950247|617531960|FG000|Overall Study|Lost to Follow-up|18|||
170868907|NCT01950247|617531961|FG001|Overall Study|Lost to Follow-up|16|||
170868908|NCT01950247|617531960|FG000|Overall Study|Physician Decision|3|||
170868909|NCT01950247|617531961|FG001|Overall Study|Physician Decision|4|||
170868910|NCT01950247|617531960|FG000|Overall Study|Adverse Event|3|||
170868911|NCT01950247|617531961|FG001|Overall Study|Adverse Event|2|||
170868912|NCT01950247|617531960|FG000|Overall Study|Death|1|||
170868913|NCT01950247|617531961|FG001|Overall Study|Death|1|||
170868914|NCT01950247|617531960|FG000|Overall Study|Not Defined|4|||
170868915|NCT01950247|617531961|FG001|Overall Study|Not Defined|10|||
170868916|NCT01798992|617531964|FG000|Overall Study|Administrative withdrawal|0|||
170868917|NCT01798992|617531965|FG001|Overall Study|Administrative withdrawal|1|||
170868918|NCT01798992|617531966|FG002|Overall Study|Administrative withdrawal|0|||
170868919|NCT01798992|617531967|FG003|Overall Study|Administrative withdrawal|1|||
170868920|NCT01798992|617531964|FG000|Overall Study|Lost to Follow-up|0|||
170868921|NCT01798992|617531965|FG001|Overall Study|Lost to Follow-up|1|||
170868922|NCT01798992|617531966|FG002|Overall Study|Lost to Follow-up|1|||
170868923|NCT01798992|617531967|FG003|Overall Study|Lost to Follow-up|0|||
170868924|NCT01798992|617531964|FG000|Overall Study|Insufficient biopsy tissue|0|||
170868925|NCT01798992|617531965|FG001|Overall Study|Insufficient biopsy tissue|0|||
170868926|NCT01798992|617531966|FG002|Overall Study|Insufficient biopsy tissue|1|||
170868927|NCT01798992|617531967|FG003|Overall Study|Insufficient biopsy tissue|0|||
170868928|NCT01069120|617531968|FG000|Overall Study|Study prematurely terminated|27|||
170411880|NCT04864405|615847252|FG000|Overall Study|Did not want endocrine therapy|3|||
170411881|NCT04864405|615847253|FG001|Overall Study|Did not want endocrine therapy|5|||
170411882|NCT04969939|615847255|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
170411883|NCT04969939|615847256|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
170411884|NCT04969939|615847257|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
170411885|NCT04969939|615847258|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
170411886|NCT04969939|615847259|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
170411887|NCT04969939|615847260|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
170522134|NCT03973996|616258062|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170522135|NCT03973996|616258063|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
170868929|NCT00434421|617531969|FG000|Overall Study|Withdrawal by Subject|1|||
170868930|NCT00434421|617531969|FG000|Overall Study|Non-compliance with study treatment|1|||
170868931|NCT03631667|617531970|FG000|Overall Study|Withdrawal by Subject|3|||
170868932|NCT05097716|617531971|FG000|Period 1|Adverse Event|1|||
170868933|NCT05097716|617531971|FG000|Period 1|Close contact with highly-transmissible infection|1|||
170868934|NCT01399190|617531972|FG000|Overall Study|Not Eligible for Final Analysis|5|||
170868935|NCT01399190|617531972|FG000|Overall Study|Adverse Event|8|||
170868936|NCT01399190|617531972|FG000|Overall Study|Participant's Request|5|||
170868937|NCT01399190|617531972|FG000|Overall Study|Physician Decision|2|||
170868938|NCT00791258|617531973|FG000|Overall Study|Adverse Event|87|||
170868939|NCT00791258|617531973|FG000|Overall Study|Lost to Follow-up|18|||
170868940|NCT00791258|617531973|FG000|Overall Study|Protocol Violation|109|||
170868941|NCT00791258|617531973|FG000|Overall Study|Withdrawal by Subject|40|||
170868942|NCT00791258|617531973|FG000|Overall Study|Did not take medication for >3 days|1|||
170868943|NCT00791258|617531973|FG000|Overall Study|subject left area|2|||
170868944|NCT00791258|617531973|FG000|Overall Study|non-compliance|3|||
170868945|NCT00791258|617531973|FG000|Overall Study|Subject incarcerated|1|||
170868946|NCT00791258|617531973|FG000|Overall Study|Subject required restricted medication|1|||
170868947|NCT00791258|617531973|FG000|Overall Study|Lack of Efficacy|1|||
170868948|NCT00436618|617531977|FG000|Overall Study|Withdrawal by Subject|5|||
170868949|NCT00436618|617531978|FG001|Overall Study|Withdrawal by Subject|8|||
170868950|NCT00436618|617531979|FG002|Overall Study|Withdrawal by Subject|11|||
170868951|NCT00436618|617531977|FG000|Overall Study|Adverse Event|8|||
170868952|NCT00436618|617531978|FG001|Overall Study|Adverse Event|8|||
170868953|NCT00436618|617531979|FG002|Overall Study|Adverse Event|9|||
170868954|NCT00436618|617531977|FG000|Overall Study|Alternate Treatment|3|||
170868955|NCT00436618|617531978|FG001|Overall Study|Alternate Treatment|4|||
170868956|NCT00436618|617531979|FG002|Overall Study|Alternate Treatment|12|||
170868957|NCT00436618|617531977|FG000|Overall Study|Other Medical Problems|3|||
170868958|NCT00436618|617531978|FG001|Overall Study|Other Medical Problems|1|||
170868959|NCT00436618|617531979|FG002|Overall Study|Other Medical Problems|7|||
170868960|NCT00436618|617531977|FG000|Overall Study|Death|4|||
170868961|NCT00436618|617531978|FG001|Overall Study|Death|2|||
170868962|NCT00436618|617531979|FG002|Overall Study|Death|3|||
170868963|NCT00436618|617531977|FG000|Overall Study|New Primary or Other Reasons|6|||
170868964|NCT00436618|617531978|FG001|Overall Study|New Primary or Other Reasons|2|||
170868965|NCT00436618|617531979|FG002|Overall Study|New Primary or Other Reasons|12|||
170868966|NCT00436618|617531977|FG000|Overall Study|Still on treatment|1|||
170868967|NCT00436618|617531978|FG001|Overall Study|Still on treatment|2|||
170868968|NCT00436618|617531979|FG002|Overall Study|Still on treatment|7|||
170868969|NCT03829241|617531980|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
170868970|NCT03829241|617531981|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
170868971|NCT03829241|617531980|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
170868972|NCT03829241|617531981|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
170868973|NCT03829241|617531980|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
170868974|NCT03829241|617531981|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
170868975|NCT03829241|617531980|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
170868976|NCT03829241|617531981|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
170868977|NCT03829241|617531980|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
170868978|NCT03829241|617531981|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
170868979|NCT03829241|617531980|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
170868980|NCT03829241|617531981|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
170868981|NCT03829241|617531980|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
170868982|NCT03829241|617531981|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
170868983|NCT03829241|617531980|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
170868984|NCT03829241|617531981|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
170868985|NCT03829241|617531980|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
170868986|NCT03829241|617531981|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
170868987|NCT03829241|617531980|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
170868988|NCT03829241|617531981|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
170868989|NCT03829241|617531980|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
170868990|NCT03829241|617531981|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
170868991|NCT03829241|617531980|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
170868992|NCT03829241|617531981|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
170868993|NCT03829241|617531980|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
170868994|NCT03829241|617531981|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
170868995|NCT03829241|617531980|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
170868996|NCT03829241|617531981|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
170868997|NCT00698204|617531982|FG000|Overall Study|Withdrawal by Subject|1|||
170868998|NCT00698204|617531983|FG001|Overall Study|Withdrawal by Subject|0|||
170868999|NCT02224599|617531986|FG000|Overall Study|Physician Decision|1|||
170869000|NCT02224599|617531986|FG000|Overall Study|Progression of Disease|1|||
170869001|NCT00314249|617531987|FG000|Overall Study|Adverse Event|73|||
170411888|NCT04969939|615847261|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
170411889|NCT04969939|615847255|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
170411890|NCT04969939|615847256|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
170869002|NCT00314249|617531988|FG001|Overall Study|Adverse Event|94|||
170411891|NCT04969939|615847257|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
170869003|NCT00314249|617531987|FG000|Overall Study|Lack of Efficacy|33|||
170869004|NCT00314249|617531988|FG001|Overall Study|Lack of Efficacy|24|||
170411892|NCT04969939|615847258|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
170869005|NCT00314249|617531987|FG000|Overall Study|Withdrawal by Subject|21|||
170869006|NCT00314249|617531988|FG001|Overall Study|Withdrawal by Subject|28|||
170766927|NCT03615924|617151242|FG001|Overall Study|Study termination by Sponsor|86|||
170766928|NCT00716144|617151243|FG000|Overall Study|Withdrawal by Subject|4|||
170766929|NCT00716144|617151244|FG001|Overall Study|Withdrawal by Subject|2|||
170766930|NCT00716144|617151245|FG002|Overall Study|Withdrawal by Subject|6|||
170766931|NCT00716144|617151246|FG003|Overall Study|Withdrawal by Subject|6|||
170766932|NCT00716144|617151243|FG000|Overall Study|Lost to Follow-up|2|||
170766933|NCT00716144|617151244|FG001|Overall Study|Lost to Follow-up|2|||
170766934|NCT00716144|617151245|FG002|Overall Study|Lost to Follow-up|1|||
170766935|NCT00716144|617151246|FG003|Overall Study|Lost to Follow-up|2|||
170869007|NCT00314249|617531987|FG000|Overall Study|Lost to Follow-up|15|||
170869008|NCT00314249|617531988|FG001|Overall Study|Lost to Follow-up|9|||
170869009|NCT00314249|617531987|FG000|Overall Study|Physician Decision|1|||
170869010|NCT00314249|617531988|FG001|Overall Study|Physician Decision|1|||
170869011|NCT00314249|617531987|FG000|Overall Study|Withdrawn for other reasons|4|||
170869012|NCT00314249|617531988|FG001|Overall Study|Withdrawn for other reasons|1|||
170869013|NCT00314249|617531987|FG000|Overall Study|Non-Compliant|5|||
170869014|NCT00314249|617531988|FG001|Overall Study|Non-Compliant|6|||
170869015|NCT01949155|617531989|FG000|Overall Study|Lost to Follow-up|1|||
170869016|NCT01949155|617531990|FG001|Overall Study|Lost to Follow-up|0|||
170869017|NCT01949155|617531989|FG000|Overall Study|Protocol Violation|1|||
170869018|NCT01949155|617531990|FG001|Overall Study|Protocol Violation|0|||
170869019|NCT01187550|617531991|FG000|Overall Study|Protocol Violation|3|||
170869020|NCT01187550|617531992|FG001|Overall Study|Protocol Violation|1|||
170766936|NCT00716144|617151243|FG000|Overall Study|Adverse Event|0|||
170766937|NCT00716144|617151244|FG001|Overall Study|Adverse Event|0|||
170766938|NCT00716144|617151245|FG002|Overall Study|Adverse Event|0|||
170766939|NCT00716144|617151246|FG003|Overall Study|Adverse Event|2|||
170766940|NCT00716144|617151243|FG000|Overall Study|Non-compliance|1|||
170766941|NCT00716144|617151244|FG001|Overall Study|Non-compliance|0|||
170766942|NCT00716144|617151245|FG002|Overall Study|Non-compliance|0|||
170766943|NCT00716144|617151246|FG003|Overall Study|Non-compliance|0|||
170766944|NCT00716144|617151243|FG000|Overall Study|Protocol Violation|2|||
170766945|NCT00716144|617151244|FG001|Overall Study|Protocol Violation|0|||
170766946|NCT00716144|617151245|FG002|Overall Study|Protocol Violation|1|||
170766947|NCT00716144|617151246|FG003|Overall Study|Protocol Violation|0|||
170766948|NCT00716144|617151243|FG000|Overall Study|Physician Decision|0|||
170766949|NCT00716144|617151244|FG001|Overall Study|Physician Decision|1|||
170766950|NCT00716144|617151245|FG002|Overall Study|Physician Decision|2|||
170766951|NCT00716144|617151246|FG003|Overall Study|Physician Decision|2|||
170766952|NCT00716144|617151243|FG000|Overall Study|Intercurrent illness|0|||
170766953|NCT00716144|617151244|FG001|Overall Study|Intercurrent illness|0|||
170766954|NCT00716144|617151245|FG002|Overall Study|Intercurrent illness|1|||
170766955|NCT00716144|617151246|FG003|Overall Study|Intercurrent illness|0|||
170766956|NCT00716144|617151243|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
170766957|NCT00716144|617151244|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
170766958|NCT00716144|617151245|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
170766959|NCT00716144|617151246|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
170766960|NCT00716144|617151243|FG000|Overall Study|Adverse event: left foot pain|0|||
170766961|NCT00716144|617151244|FG001|Overall Study|Adverse event: left foot pain|1|||
170766962|NCT00716144|617151245|FG002|Overall Study|Adverse event: left foot pain|0|||
170869021|NCT01187550|617531991|FG000|Overall Study|Other|3|||
170869022|NCT01187550|617531992|FG001|Overall Study|Other|0|||
170869023|NCT01187550|617531991|FG000|Overall Study|Randomized but not treated|8|||
170869024|NCT01187550|617531992|FG001|Overall Study|Randomized but not treated|0|||
170411893|NCT04969939|615847259|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
170411894|NCT04969939|615847260|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
170411895|NCT04969939|615847261|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
170411896|NCT04969939|615847255|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
170411897|NCT04969939|615847256|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
170411898|NCT04969939|615847257|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
170411899|NCT04969939|615847258|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
170411900|NCT04969939|615847259|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
170411901|NCT04969939|615847260|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
170411902|NCT04969939|615847261|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
170766963|NCT00716144|617151246|FG003|Overall Study|Adverse event: left foot pain|0|||
170766964|NCT00716144|617151243|FG000|Overall Study|Clinical Depression|0|||
170766965|NCT00716144|617151244|FG001|Overall Study|Clinical Depression|1|||
170869025|NCT00129623|617531993|FG000|Overall Study|Adverse Event|3|||
170411903|NCT04969939|615847255|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
170766966|NCT00716144|617151245|FG002|Overall Study|Clinical Depression|0|||
170766967|NCT00716144|617151246|FG003|Overall Study|Clinical Depression|0|||
170766968|NCT02954848|617151249|FG000|Overall Study|Randomized but Not Treated|0|||
170766969|NCT02954848|617151250|FG001|Overall Study|Randomized but Not Treated|1|||
170766970|NCT02954848|617151249|FG000|Overall Study|Adverse Event|2|||
170869026|NCT00129623|617531994|FG001|Overall Study|Adverse Event|7|||
170869027|NCT00129623|617531993|FG000|Overall Study|Refused Treatment|5|||
170869028|NCT00129623|617531994|FG001|Overall Study|Refused Treatment|3|||
170869029|NCT00129623|617531993|FG000|Overall Study|Failure to Return|1|||
170869030|NCT00129623|617531994|FG001|Overall Study|Failure to Return|1|||
170869031|NCT00129623|617531993|FG000|Overall Study|Relocated job out of state|1|||
170869032|NCT00129623|617531994|FG001|Overall Study|Relocated job out of state|0|||
170869033|NCT00129623|617531993|FG000|Overall Study|Uncertainty to return|0|||
170869034|NCT00129623|617531994|FG001|Overall Study|Uncertainty to return|1|||
170869035|NCT00596934|617531995|FG000|Overall Study|Protocol Violation|1|||
170869036|NCT00596934|617531995|FG000|Overall Study|Withdrawal by Subject|1|||
170869037|NCT02445755|617532000|FG000|Overall Study|Withdrawal by Subject|2|||
170869038|NCT02445755|617532000|FG000|Overall Study|Protocol Violation|6|||
170869039|NCT02445755|617532000|FG000|Overall Study|Screen Failure|5|||
170869040|NCT03239483|617532001|FG000|Overall Study|Lost to Follow-up|1|||
170869041|NCT03239483|617532002|FG001|Overall Study|Lost to Follow-up|0|||
170869042|NCT03239483|617532001|FG000|Overall Study|Withdrawal by Subject|1|||
170869043|NCT03239483|617532002|FG001|Overall Study|Withdrawal by Subject|0|||
170869044|NCT05352048|617532003|FG000|Overall Study|Lost to Follow-up|1|||
170869045|NCT05352048|617532003|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
170869046|NCT01296035|617532013|FG000|Overall Study|Withdrawal by Subject|1|||
170869047|NCT00851682|617532017|FG000|Overall Study|screen failure|5|||
170869048|NCT00851682|617532018|FG001|Overall Study|screen failure|0|||
170869049|NCT00006392|617532021|FG000|Overall Study|Ineligible|11|||
170869050|NCT00006392|617532022|FG001|Overall Study|Ineligible|3|||
170869051|NCT00006392|617532023|FG002|Overall Study|Ineligible|5|||
170869052|NCT00006392|617532024|FG003|Overall Study|Ineligible|5|||
170869053|NCT00006392|617532021|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
170869054|NCT00006392|617532022|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
170869055|NCT00006392|617532023|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
170869056|NCT00006392|617532024|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
170869057|NCT02459769|617532025|FG000|Overall Study|Withdrawal by Subject|7|||
170869058|NCT02459769|617532026|FG001|Overall Study|Withdrawal by Subject|4|||
170869059|NCT02459769|617532027|FG002|Overall Study|Withdrawal by Subject|8|||
170869060|NCT02459769|617532028|FG003|Overall Study|Withdrawal by Subject|5|||
170869061|NCT02459769|617532025|FG000|Overall Study|Lost to Follow-up|1|||
170869062|NCT02459769|617532026|FG001|Overall Study|Lost to Follow-up|0|||
170869063|NCT02459769|617532027|FG002|Overall Study|Lost to Follow-up|1|||
170869064|NCT02459769|617532028|FG003|Overall Study|Lost to Follow-up|0|||
170869065|NCT01186796|617532029|FG000|Overall Study|Adverse Event|3|||
170869066|NCT01186796|617532030|FG001|Overall Study|Adverse Event|0|||
170869067|NCT01186796|617532029|FG000|Overall Study|Withdrawal by Subject|1|||
170869068|NCT01186796|617532030|FG001|Overall Study|Withdrawal by Subject|1|||
170869069|NCT01186796|617532029|FG000|Overall Study|Protocol Violation|0|||
170869070|NCT01186796|617532030|FG001|Overall Study|Protocol Violation|1|||
170869071|NCT03838198|617532031|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
170869072|NCT03838198|617532032|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
170869073|NCT03838198|617532033|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
170869074|NCT03838198|617532034|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
170869075|NCT03838198|617532031|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
170869076|NCT03838198|617532032|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
170869077|NCT03838198|617532033|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
170869078|NCT03838198|617532034|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
170869079|NCT02060721|617532043|FG000|Overall Study|Lost to Follow-up|1|||
170869080|NCT02060721|617532043|FG000|Overall Study|Physician Decision|2|||
170869081|NCT02060721|617532043|FG000|Overall Study|Death|14|||
170869082|NCT02060721|617532043|FG000|Overall Study|Withdrawal by Subject|2|||
170869083|NCT02060721|617532043|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
170411904|NCT04969939|615847256|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
170411905|NCT04969939|615847257|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
170411906|NCT04969939|615847258|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
170411907|NCT04969939|615847259|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
170411908|NCT04969939|615847260|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
170869084|NCT00117507|617532044|FG000|Overall Study|Adverse Event|4|||
170869085|NCT00117507|617532044|FG000|Overall Study|Abnormal laboratory values|3|||
170869086|NCT00117507|617532044|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170869087|NCT00117507|617532044|FG000|Overall Study|Patient withdrew consent|4|||
170869088|NCT00117507|617532044|FG000|Overall Study|Death|3|||
170411909|NCT04969939|615847261|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
170411910|NCT04969939|615847255|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
170411911|NCT04969939|615847256|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
170869089|NCT00866723|617532045|FG000|Overall Study|Withdrawal by Subject|1|||
170869090|NCT00866723|617532045|FG000|Overall Study|Disease Progression|4|||
170869091|NCT05105789|617532046|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
170869092|NCT00590044|617532049|FG000|Overall Study|Withdrawal by Subject|2|||
170869093|NCT00590044|617532050|FG001|Overall Study|Withdrawal by Subject|2|||
170869094|NCT00590044|617532049|FG000|Overall Study|wrong insulin arm assigned|1|||
170869095|NCT00590044|617532050|FG001|Overall Study|wrong insulin arm assigned|0|||
170869096|NCT00590044|617532049|FG000|Overall Study|Protocol Violation|1|||
170869097|NCT00590044|617532050|FG001|Overall Study|Protocol Violation|0|||
170869098|NCT00601705|617532051|FG000|Overall Study|Withdrawal by Subject|1|||
170869099|NCT02608879|617532055|FG000|Overall Study|Lost to Follow-up|1|||
170869100|NCT02608879|617532056|FG001|Overall Study|Lost to Follow-up|0|||
170869101|NCT02608879|617532057|FG002|Overall Study|Lost to Follow-up|0|||
170869102|NCT02608879|617532055|FG000|Overall Study|Did not meet continuation criteria|0|||
170869103|NCT02608879|617532056|FG001|Overall Study|Did not meet continuation criteria|0|||
170869104|NCT02608879|617532057|FG002|Overall Study|Did not meet continuation criteria|3|||
170869105|NCT02632721|617532061|FG000|Overall Study|Adverse Event|0|||
170869106|NCT02632721|617532062|FG001|Overall Study|Adverse Event|0|||
170869107|NCT02632721|617532063|FG002|Overall Study|Adverse Event|2|||
170869108|NCT02632721|617532064|FG003|Overall Study|Adverse Event|5|||
170869109|NCT02632721|617532065|FG004|Overall Study|Adverse Event|3|||
170869110|NCT02632721|617532061|FG000|Overall Study|Dose limiting toxicity|0|||
170869111|NCT02632721|617532062|FG001|Overall Study|Dose limiting toxicity|0|||
170869112|NCT02632721|617532063|FG002|Overall Study|Dose limiting toxicity|0|||
170869113|NCT02632721|617532064|FG003|Overall Study|Dose limiting toxicity|1|||
170869114|NCT02632721|617532065|FG004|Overall Study|Dose limiting toxicity|0|||
170869115|NCT02632721|617532061|FG000|Overall Study|Progressive disease|3|||
170869116|NCT02632721|617532062|FG001|Overall Study|Progressive disease|0|||
170869117|NCT02632721|617532063|FG002|Overall Study|Progressive disease|4|||
170869118|NCT02632721|617532064|FG003|Overall Study|Progressive disease|6|||
170869119|NCT02632721|617532065|FG004|Overall Study|Progressive disease|5|||
170869120|NCT02632721|617532061|FG000|Overall Study|Refused to continue taking trial medication|0|||
170869121|NCT02632721|617532062|FG001|Overall Study|Refused to continue taking trial medication|1|||
170869122|NCT02632721|617532063|FG002|Overall Study|Refused to continue taking trial medication|1|||
170869123|NCT02632721|617532064|FG003|Overall Study|Refused to continue taking trial medication|1|||
170869124|NCT02632721|617532065|FG004|Overall Study|Refused to continue taking trial medication|2|||
170869125|NCT02632721|617532061|FG000|Overall Study|Inadequate clinical condition|0|||
170869126|NCT02632721|617532062|FG001|Overall Study|Inadequate clinical condition|0|||
170869127|NCT02632721|617532063|FG002|Overall Study|Inadequate clinical condition|0|||
170869128|NCT02632721|617532064|FG003|Overall Study|Inadequate clinical condition|0|||
170869129|NCT02632721|617532065|FG004|Overall Study|Inadequate clinical condition|1|||
170869130|NCT02632721|617532061|FG000|Overall Study|No meet eligibility|0|||
170869131|NCT02632721|617532062|FG001|Overall Study|No meet eligibility|0|||
170869132|NCT02632721|617532063|FG002|Overall Study|No meet eligibility|0|||
170869133|NCT02632721|617532064|FG003|Overall Study|No meet eligibility|0|||
170869134|NCT02632721|617532065|FG004|Overall Study|No meet eligibility|1|||
170869135|NCT02632721|617532061|FG000|Overall Study|Allergic reaction|0|||
170869136|NCT02632721|617532062|FG001|Overall Study|Allergic reaction|0|||
170869137|NCT02632721|617532063|FG002|Overall Study|Allergic reaction|0|||
170869138|NCT02632721|617532064|FG003|Overall Study|Allergic reaction|1|||
170869139|NCT02632721|617532065|FG004|Overall Study|Allergic reaction|0|||
170869140|NCT02632721|617532061|FG000|Overall Study|Receiving Decitabine locally|0|||
170766971|NCT02954848|617151250|FG001|Overall Study|Adverse Event|3|||
170766972|NCT02954848|617151249|FG000|Overall Study|Withdrawal by Participant|0|||
170766973|NCT02954848|617151250|FG001|Overall Study|Withdrawal by Participant|1|||
170766974|NCT01069341|617151251|FG000|Overall Study|Lost to Follow-up|1|||
170766975|NCT01184508|617151252|FG000|Overall Study|Adverse Event|4|||
170766976|NCT01184508|617151253|FG001|Overall Study|Adverse Event|6|||
170766977|NCT01184508|617151252|FG000|Overall Study|Lack of Efficacy|1|||
170766978|NCT01184508|617151253|FG001|Overall Study|Lack of Efficacy|1|||
170766979|NCT01184508|617151252|FG000|Overall Study|Lost to Follow-up|1|||
170766980|NCT01184508|617151253|FG001|Overall Study|Lost to Follow-up|1|||
170766981|NCT01184508|617151252|FG000|Overall Study|Physician Decision|1|||
170766982|NCT01184508|617151253|FG001|Overall Study|Physician Decision|0|||
170766983|NCT01184508|617151252|FG000|Overall Study|Protocol Violation|3|||
170869141|NCT02632721|617532062|FG001|Overall Study|Receiving Decitabine locally|0|||
170869142|NCT02632721|617532063|FG002|Overall Study|Receiving Decitabine locally|1|||
170869143|NCT02632721|617532064|FG003|Overall Study|Receiving Decitabine locally|0|||
170869144|NCT02632721|617532065|FG004|Overall Study|Receiving Decitabine locally|0|||
170869145|NCT02632721|617532061|FG000|Overall Study|No benefit from study treatment|1|||
170869146|NCT02632721|617532062|FG001|Overall Study|No benefit from study treatment|1|||
170869147|NCT02632721|617532063|FG002|Overall Study|No benefit from study treatment|0|||
170869148|NCT02632721|617532064|FG003|Overall Study|No benefit from study treatment|0|||
170869149|NCT02632721|617532065|FG004|Overall Study|No benefit from study treatment|1|||
170869150|NCT02632721|617532061|FG000|Overall Study|Patient wish for other treatment|0|||
170869151|NCT02632721|617532062|FG001|Overall Study|Patient wish for other treatment|1|||
170766984|NCT01184508|617151253|FG001|Overall Study|Protocol Violation|1|||
170869152|NCT02632721|617532063|FG002|Overall Study|Patient wish for other treatment|0|||
170766985|NCT01184508|617151252|FG000|Overall Study|Sponsor Decision|5|||
170869153|NCT02632721|617532064|FG003|Overall Study|Patient wish for other treatment|0|||
170869154|NCT02632721|617532065|FG004|Overall Study|Patient wish for other treatment|0|||
170869155|NCT02632721|617532061|FG000|Overall Study|Relapsed Pneumonia|0|||
170869156|NCT02632721|617532062|FG001|Overall Study|Relapsed Pneumonia|0|||
170869157|NCT02632721|617532063|FG002|Overall Study|Relapsed Pneumonia|0|||
170869158|NCT02632721|617532064|FG003|Overall Study|Relapsed Pneumonia|0|||
170869159|NCT02632721|617532065|FG004|Overall Study|Relapsed Pneumonia|1|||
170869160|NCT02632721|617532061|FG000|Overall Study|Therapy refractory AML|0|||
170869161|NCT02632721|617532062|FG001|Overall Study|Therapy refractory AML|0|||
170869162|NCT02632721|617532063|FG002|Overall Study|Therapy refractory AML|0|||
170869163|NCT02632721|617532064|FG003|Overall Study|Therapy refractory AML|0|||
170869164|NCT02632721|617532065|FG004|Overall Study|Therapy refractory AML|1|||
170869165|NCT02632721|617532061|FG000|Overall Study|Increase of white blood cell count|0|||
170869166|NCT02632721|617532062|FG001|Overall Study|Increase of white blood cell count|0|||
170869167|NCT02632721|617532063|FG002|Overall Study|Increase of white blood cell count|0|||
170869168|NCT02632721|617532064|FG003|Overall Study|Increase of white blood cell count|0|||
170869169|NCT02632721|617532065|FG004|Overall Study|Increase of white blood cell count|1|||
170869170|NCT02632721|617532061|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
170869171|NCT02632721|617532062|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
170869172|NCT02632721|617532063|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
170869173|NCT02632721|617532064|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
170869174|NCT02632721|617532065|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
170869175|NCT01572675|617532069|FG000|Overall Study|End of prescribed treatment|140|||
170869176|NCT01572675|617532070|FG001|Overall Study|End of prescribed treatment|118|||
170869177|NCT01572675|617532069|FG000|Overall Study|Recovery|16|||
170869178|NCT01572675|617532070|FG001|Overall Study|Recovery|23|||
170869179|NCT01572675|617532069|FG000|Overall Study|Lack of Efficacy|31|||
170869180|NCT01572675|617532070|FG001|Overall Study|Lack of Efficacy|31|||
170869181|NCT01572675|617532069|FG000|Overall Study|Intolerance|6|||
170869182|NCT01572675|617532070|FG001|Overall Study|Intolerance|5|||
170869183|NCT01572675|617532069|FG000|Overall Study|Improved symptoms|8|||
170869184|NCT01572675|617532070|FG001|Overall Study|Improved symptoms|2|||
170869185|NCT01572675|617532069|FG000|Overall Study|Surgical intervention|3|||
170869186|NCT01572675|617532070|FG001|Overall Study|Surgical intervention|6|||
170869187|NCT01572675|617532069|FG000|Overall Study|Withdrawal by Subject|5|||
170869188|NCT01572675|617532070|FG001|Overall Study|Withdrawal by Subject|1|||
170869189|NCT01572675|617532069|FG000|Overall Study|Physician Decision|2|||
170869190|NCT01572675|617532070|FG001|Overall Study|Physician Decision|2|||
170869191|NCT01572675|617532069|FG000|Overall Study|Death unrelated to coxibs|1|||
170869192|NCT01572675|617532070|FG001|Overall Study|Death unrelated to coxibs|1|||
170869193|NCT01572675|617532069|FG000|Overall Study|Other disease detected|1|||
170869194|NCT01572675|617532070|FG001|Overall Study|Other disease detected|1|||
170869195|NCT01572675|617532069|FG000|Overall Study|Unknown reason|1|||
170869196|NCT01572675|617532070|FG001|Overall Study|Unknown reason|1|||
170869197|NCT01572675|617532069|FG000|Overall Study|Rheumatologist new evaluation|0|||
170869198|NCT01572675|617532070|FG001|Overall Study|Rheumatologist new evaluation|1|||
170869199|NCT01572675|617532069|FG000|Overall Study|Missing data|1|||
170869200|NCT01572675|617532070|FG001|Overall Study|Missing data|4|||
170869201|NCT01572675|617532069|FG000|Overall Study|Lost to Follow-up|22|||
170869202|NCT01572675|617532070|FG001|Overall Study|Lost to Follow-up|27|||
170869203|NCT02499770|617532088|FG000|Overall Study|Death|17|||
170869204|NCT02499770|617532089|FG001|Overall Study|Death|56|||
170869205|NCT02499770|617532088|FG000|Overall Study|Study completion|1|||
170869206|NCT02499770|617532089|FG001|Overall Study|Study completion|10|||
170869207|NCT02499770|617532088|FG000|Overall Study|Withdrawal by Subject|0|||
170869208|NCT02499770|617532089|FG001|Overall Study|Withdrawal by Subject|7|||
170869209|NCT02499770|617532088|FG000|Overall Study|Lost to Follow-up|0|||
170869210|NCT02499770|617532089|FG001|Overall Study|Lost to Follow-up|2|||
170869211|NCT02499770|617532088|FG000|Overall Study|Subject declined further treatment|1|||
170869212|NCT02499770|617532089|FG001|Overall Study|Subject declined further treatment|0|||
170869213|NCT02499770|617532088|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
170869214|NCT02499770|617532089|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
170869215|NCT02499770|617532088|FG000|Overall Study|Randomized but not enrolled|0|||
170869216|NCT02499770|617532089|FG001|Overall Study|Randomized but not enrolled|1|||
170411912|NCT04969939|615847257|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
170411913|NCT04969939|615847258|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
170411914|NCT04969939|615847259|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
170869217|NCT00601250|617532094|FG000|Overall Study|Adverse Event|3|||
170869218|NCT00601250|617532095|FG001|Overall Study|Adverse Event|9|||
170869219|NCT00601250|617532094|FG000|Overall Study|Protocol Violation|3|||
170869220|NCT00601250|617532095|FG001|Overall Study|Protocol Violation|2|||
170869221|NCT00601250|617532094|FG000|Overall Study|Lost to Follow-up|2|||
170869222|NCT00601250|617532095|FG001|Overall Study|Lost to Follow-up|6|||
170869223|NCT00601250|617532094|FG000|Overall Study|Withdrawal by Subject|4|||
170869224|NCT00601250|617532095|FG001|Overall Study|Withdrawal by Subject|13|||
170766986|NCT01184508|617151253|FG001|Overall Study|Sponsor Decision|2|||
170766987|NCT01184508|617151252|FG000|Overall Study|Withdrawal by Subject|1|||
170766988|NCT01184508|617151253|FG001|Overall Study|Withdrawal by Subject|3|||
170766989|NCT01184508|617151252|FG000|Overall Study|Randomized, Not Treated|0|||
170766990|NCT01184508|617151253|FG001|Overall Study|Randomized, Not Treated|1|||
170766991|NCT00790790|617151254|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
170766992|NCT00790790|617151255|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
170766993|NCT00790790|617151256|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
170766994|NCT00790790|617151254|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
170766995|NCT00790790|617151255|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
170766996|NCT00790790|617151256|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
170766997|NCT00790790|617151254|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
170766998|NCT00790790|617151255|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
170766999|NCT00790790|617151256|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
170767000|NCT00790790|617151254|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
170767001|NCT00790790|617151255|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
170767002|NCT00790790|617151256|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
170767003|NCT00790790|617151254|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
170767004|NCT00790790|617151255|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
170767005|NCT00790790|617151256|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
170767006|NCT02969863|617151257|FG000|Overall Study|Physician Decision|1|||
170767007|NCT02969863|617151258|FG001|Overall Study|Physician Decision|0|||
170767008|NCT02969863|617151259|FG002|Overall Study|Physician Decision|0|||
170767009|NCT02969863|617151260|FG003|Overall Study|Physician Decision|0|||
170767010|NCT02969863|617151261|FG004|Overall Study|Physician Decision|0|||
170767011|NCT02969863|617151262|FG005|Overall Study|Physician Decision|0|||
170767012|NCT03310983|617151267|FG000|Overall Study|Lost to Follow-up|15|||
170767013|NCT03310983|617151268|FG001|Overall Study|Lost to Follow-up|17|||
170767014|NCT01093534|617151269|FG000|Overall Study|Adverse Event|2|||
170767015|NCT01093534|617151270|FG001|Overall Study|Adverse Event|5|||
170767016|NCT01093534|617151271|FG002|Overall Study|Adverse Event|2|||
170767017|NCT01093534|617151269|FG000|Overall Study|Lack of Efficacy|2|||
170767018|NCT01093534|617151270|FG001|Overall Study|Lack of Efficacy|1|||
170767019|NCT01093534|617151271|FG002|Overall Study|Lack of Efficacy|1|||
170767020|NCT01093534|617151269|FG000|Overall Study|Withdrawal by Subject|5|||
170767021|NCT01093534|617151270|FG001|Overall Study|Withdrawal by Subject|7|||
170767022|NCT01093534|617151271|FG002|Overall Study|Withdrawal by Subject|2|||
170767023|NCT01093534|617151269|FG000|Overall Study|Other|1|||
170767024|NCT01093534|617151270|FG001|Overall Study|Other|3|||
170767025|NCT01093534|617151271|FG002|Overall Study|Other|4|||
170767026|NCT03863834|617151278|FG000|Overall Study|Lost to Follow-up|3|||
170767027|NCT02685488|617151282|FG000|Overall Study|Withdrawal by Subject|0|||
170767028|NCT02685488|617151283|FG001|Overall Study|Withdrawal by Subject|1|||
170767029|NCT04436120|617151284|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
170767030|NCT04436120|617151285|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
170767031|NCT04436120|617151286|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
170767032|NCT04436120|617151287|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
170767033|NCT04436120|617151288|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
170767034|NCT04436120|617151289|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
170767035|NCT04436120|617151290|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
170767036|NCT01773122|617151293|FG000|Overall Study|Due to amended age eligibility criteria|3|||
170767037|NCT01773122|617151294|FG001|Overall Study|Due to amended age eligibility criteria|1|||
170767038|NCT01773122|617151295|FG002|Overall Study|Due to amended age eligibility criteria|0|||
170767039|NCT01773122|617151296|FG003|Overall Study|Due to amended age eligibility criteria|1|||
170767040|NCT02908464|617151297|FG000|Overall Study|Withdrawal by Subject|2|||
170767041|NCT02908464|617151298|FG001|Overall Study|Withdrawal by Subject|1|||
170767042|NCT02908464|617151297|FG000|Overall Study|Found ineligible after randomization|0|||
170767043|NCT02908464|617151298|FG001|Overall Study|Found ineligible after randomization|2|||
170767044|NCT03386929|617151299|FG000|Overall Study|Death|0|||
170767045|NCT03386929|617151300|FG001|Overall Study|Death|0|||
170767046|NCT03386929|617151301|FG002|Overall Study|Death|1|||
170869225|NCT00601250|617532094|FG000|Overall Study|Other incl. lack of efficacy|2|||
170869226|NCT00601250|617532095|FG001|Overall Study|Other incl. lack of efficacy|9|||
170869227|NCT01810016|617532096|FG000|Overall Study|Progressive disease|1|||
170869228|NCT01810016|617532097|FG001|Overall Study|Progressive disease|1|||
170767047|NCT03386929|617151299|FG000|Overall Study|Withdrawal by Subject|0|||
170767048|NCT03386929|617151300|FG001|Overall Study|Withdrawal by Subject|1|||
170767049|NCT03386929|617151301|FG002|Overall Study|Withdrawal by Subject|0|||
170767050|NCT03386929|617151299|FG000|Overall Study|Physician Decision|0|||
170767051|NCT03386929|617151300|FG001|Overall Study|Physician Decision|0|||
170767052|NCT03386929|617151301|FG002|Overall Study|Physician Decision|1|||
170522136|NCT01022203|616258066|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
170767053|NCT03386929|617151299|FG000|Overall Study|Progression|4|||
170767054|NCT03386929|617151300|FG001|Overall Study|Progression|4|||
170767055|NCT03386929|617151301|FG002|Overall Study|Progression|0|||
170767056|NCT03386929|617151299|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
170767057|NCT03386929|617151300|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
170767058|NCT03386929|617151301|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
170767059|NCT03386929|617151299|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
170767060|NCT03386929|617151300|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
170767061|NCT03386929|617151301|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
170767062|NCT05328297|617153766|FG000|Overall Study|Adverse Event|5|||
170767063|NCT05328297|617153767|FG001|Overall Study|Adverse Event|7|||
170767064|NCT05328297|617153766|FG000|Overall Study|Withdrawal by Subject|4|||
170767065|NCT05328297|617153767|FG001|Overall Study|Withdrawal by Subject|3|||
170767066|NCT05328297|617153766|FG000|Overall Study|Lack of Efficacy|1|||
170767067|NCT05328297|617153767|FG001|Overall Study|Lack of Efficacy|0|||
170767068|NCT05328297|617153766|FG000|Overall Study|Lost to Follow-up|1|||
170767069|NCT05328297|617153767|FG001|Overall Study|Lost to Follow-up|0|||
170767070|NCT05328297|617153766|FG000|Overall Study|Protocol Violation|1|||
170767071|NCT05328297|617153767|FG001|Overall Study|Protocol Violation|0|||
170767072|NCT05328297|617153766|FG000|Overall Study|Randomized but not treated|1|||
170767073|NCT05328297|617153767|FG001|Overall Study|Randomized but not treated|1|||
170767074|NCT04513522|617153768|FG000|Overall Study|Other reasons|1|||
170767075|NCT04513522|617153768|FG000|Overall Study|Adverse event unrelated to study drug|9|||
170767076|NCT04513522|617153768|FG000|Overall Study|Study drug toxicity|14|||
170767077|NCT04513522|617153768|FG000|Overall Study|Disease progression|39|||
170767078|NCT04513522|617153768|FG000|Overall Study|Participants withdrew consent|2|||
170767079|NCT04722003|617153769|FG000|Overall Study|Lost to Follow-up|2|||
170767080|NCT04722003|617153770|FG001|Overall Study|Lost to Follow-up|0|||
170767081|NCT04722003|617153769|FG000|Overall Study|Physician Decision|1|||
170767082|NCT04722003|617153770|FG001|Overall Study|Physician Decision|0|||
170767083|NCT05758415|617153773|FG000|Overall Study|Subject Decision|2|||
170767084|NCT05758415|617153774|FG001|Overall Study|Subject Decision|5|||
170767085|NCT05758415|617153773|FG000|Overall Study|Lost to Follow-up|0|||
170767086|NCT05758415|617153774|FG001|Overall Study|Lost to Follow-up|1|||
170767087|NCT00941655|617153777|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
170767088|NCT00941655|617153778|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
170767089|NCT00941655|617153777|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
170767090|NCT00941655|617153778|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
170767091|NCT00941655|617153777|FG000|Overall Study|progressed while on chemo|0|||
170767092|NCT00941655|617153778|FG001|Overall Study|progressed while on chemo|2|||
170767093|NCT00941655|617153777|FG000|Overall Study|refused further treatment|0|||
170767094|NCT00941655|617153778|FG001|Overall Study|refused further treatment|1|||
170767095|NCT00941655|617153777|FG000|Overall Study|withdrew consent|0|||
170767096|NCT00941655|617153778|FG001|Overall Study|withdrew consent|1|||
170767097|NCT00941655|617153777|FG000|Overall Study|non-compliant|0|||
170767098|NCT00941655|617153778|FG001|Overall Study|non-compliant|1|||
170767099|NCT00004124|617153779|FG000|Overall Study|Received no protocol therapy|12|||
170767100|NCT00004124|617153780|FG001|Overall Study|Received no protocol therapy|20|||
170767101|NCT00446550|617153781|FG000|Overall Study|Adverse Event|1|||
170767102|NCT00446550|617153782|FG001|Overall Study|Adverse Event|0|||
170767103|NCT02027558|617153787|FG000|Overall Study|Death|0|||
170767104|NCT02027558|617153788|FG001|Overall Study|Death|1|||
170767105|NCT02027558|617153787|FG000|Overall Study|Withdrawal by Subject|2|||
170767106|NCT02027558|617153788|FG001|Overall Study|Withdrawal by Subject|0|||
170869229|NCT01810016|617532098|FG002|Overall Study|Progressive disease|0|||
170869230|NCT01810016|617532096|FG000|Overall Study|Death|0|||
170869231|NCT01810016|617532097|FG001|Overall Study|Death|0|||
170767107|NCT02027558|617153787|FG000|Overall Study|Lost to Follow-up|4|||
170767108|NCT02027558|617153788|FG001|Overall Study|Lost to Follow-up|1|||
170767109|NCT02027558|617153787|FG000|Overall Study|Refused assessment|3|||
170767110|NCT02027558|617153788|FG001|Overall Study|Refused assessment|0|||
170767111|NCT02698891|617153789|FG000|Overall Study|Withdrawal by Subject|2|||
170767112|NCT02698891|617153789|FG000|Overall Study|deemed ineligible|1|||
170767113|NCT02698891|617153789|FG000|Overall Study|Adverse Event|9|||
170767114|NCT00516386|617153790|FG000|Overall Study|not interested in the study|4|||
170767115|NCT00516386|617153790|FG000|Overall Study|Lost to Follow-up|2|||
170767116|NCT00002842|617153791|FG000|Overall Study|ineligible for surgical resection|27|||
170767117|NCT02694978|617153796|FG000|Overall Study|Adverse Event|10|||
170767118|NCT02694978|617153797|FG001|Overall Study|Adverse Event|9|||
170767119|NCT02694978|617153796|FG000|Overall Study|Withdrawal by Subject|22|||
170767120|NCT02694978|617153797|FG001|Overall Study|Withdrawal by Subject|19|||
170767121|NCT02694978|617153796|FG000|Overall Study|Lost to Follow-up|14|||
170767122|NCT02694978|617153797|FG001|Overall Study|Lost to Follow-up|17|||
170767123|NCT02694978|617153796|FG000|Overall Study|Death|4|||
170767124|NCT02694978|617153797|FG001|Overall Study|Death|1|||
170767125|NCT02694978|617153796|FG000|Overall Study|Other-Decision of Participant|6|||
170767126|NCT02694978|617153797|FG001|Overall Study|Other-Decision of Participant|1|||
170869232|NCT01810016|617532098|FG002|Overall Study|Death|1|||
170767127|NCT02694978|617153796|FG000|Overall Study|Other-Investigator's decision|1|||
170767128|NCT02694978|617153797|FG001|Overall Study|Other-Investigator's decision|0|||
170767129|NCT02694978|617153796|FG000|Overall Study|Other-Unable to be reached|0|||
170767130|NCT02694978|617153797|FG001|Overall Study|Other-Unable to be reached|1|||
170767131|NCT02694978|617153796|FG000|Overall Study|Other-Protocol noncompliant|2|||
170767132|NCT02694978|617153797|FG001|Overall Study|Other-Protocol noncompliant|1|||
170767133|NCT02694978|617153796|FG000|Overall Study|Other-Personal reasons|3|||
170767134|NCT02694978|617153797|FG001|Overall Study|Other-Personal reasons|3|||
170767135|NCT02694978|617153796|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
170767136|NCT02694978|617153797|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
170767137|NCT01376089|617153803|FG000|Overall Study|Patient received no contrast media|3|||
170767138|NCT01376089|617153804|FG001|Overall Study|Patient received no contrast media|4|||
170767139|NCT03262935|617153805|FG000|Overall Study|Withdrawal by Subject|6|||
170767140|NCT03262935|617153806|FG001|Overall Study|Withdrawal by Subject|7|||
170767141|NCT03262935|617153805|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
170767142|NCT03262935|617153806|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
170767143|NCT03262935|617153805|FG000|Overall Study|Death|181|||
170767144|NCT03262935|617153806|FG001|Overall Study|Death|94|||
170767145|NCT03262935|617153805|FG000|Overall Study|Lost to Follow-up|9|||
170767146|NCT03262935|617153806|FG001|Overall Study|Lost to Follow-up|4|||
170767147|NCT03262935|617153805|FG000|Overall Study|Other reason|5|||
170767148|NCT03262935|617153806|FG001|Overall Study|Other reason|0|||
170767149|NCT03557008|617153807|FG000|Overall Study|Withdrawal by Subject|2|||
170767150|NCT03557008|617153808|FG001|Overall Study|Withdrawal by Subject|2|||
170767151|NCT03557008|617153807|FG000|Overall Study|Early termination from study|3|||
170767152|NCT03557008|617153808|FG001|Overall Study|Early termination from study|1|||
170767153|NCT02224924|617153812|FG000|Overall Study|Withdrawal by Subject|7|||
170767154|NCT02224924|617153813|FG001|Overall Study|Withdrawal by Subject|6|||
170767155|NCT02224924|617153812|FG000|Overall Study|Biopsy cancelled|20|||
170767156|NCT02224924|617153813|FG001|Overall Study|Biopsy cancelled|14|||
170767157|NCT02224924|617153812|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
170767158|NCT02224924|617153813|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
170767159|NCT02224924|617153812|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
170767160|NCT02224924|617153813|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
170767161|NCT01458210|617153814|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
170767162|NCT01458210|617153814|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
170767163|NCT01458210|617153814|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
170767164|NCT01458210|617153814|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
170767165|NCT01867216|617153815|FG000|Overall Study|Withdrawal by Subject|2|||
170767166|NCT01867216|617153816|FG001|Overall Study|Withdrawal by Subject|0|||
170767167|NCT01867216|617153817|FG002|Overall Study|Withdrawal by Subject|0|||
170767168|NCT01867216|617153818|FG003|Overall Study|Withdrawal by Subject|0|||
170767169|NCT01867216|617153819|FG004|Overall Study|Withdrawal by Subject|1|||
170767170|NCT01867216|617153820|FG005|Overall Study|Withdrawal by Subject|0|||
170767171|NCT01867216|617153821|FG006|Overall Study|Withdrawal by Subject|1|||
170767172|NCT01867216|617153815|FG000|Overall Study|Physician Decision|1|||
170767173|NCT01867216|617153816|FG001|Overall Study|Physician Decision|0|||
170767174|NCT01867216|617153817|FG002|Overall Study|Physician Decision|0|||
170767175|NCT01867216|617153818|FG003|Overall Study|Physician Decision|0|||
170767176|NCT01867216|617153819|FG004|Overall Study|Physician Decision|0|||
170767177|NCT01867216|617153820|FG005|Overall Study|Physician Decision|0|||
170767178|NCT01867216|617153821|FG006|Overall Study|Physician Decision|0|||
170767179|NCT01867216|617153815|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
170767180|NCT01867216|617153816|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
170767181|NCT01867216|617153817|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
170767182|NCT01867216|617153818|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
170869233|NCT00708175|617532099|FG000|Overall Study|Adverse Event|4|||
170869234|NCT00708175|617532100|FG001|Overall Study|Adverse Event|5|||
170869235|NCT00708175|617532099|FG000|Overall Study|Protocol Violation|2|||
170869236|NCT00708175|617532100|FG001|Overall Study|Protocol Violation|3|||
170869237|NCT00708175|617532099|FG000|Overall Study|Lost to Follow-up|5|||
170767183|NCT01867216|617153819|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
170767184|NCT01867216|617153820|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
170767185|NCT01867216|617153821|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
170767186|NCT03020745|617153822|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767187|NCT03020745|617153823|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767188|NCT03020745|617153824|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767189|NCT03020745|617153825|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767190|NCT03020745|617153826|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767191|NCT03020745|617153827|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767192|NCT03020745|617153828|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767193|NCT03020745|617153829|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767194|NCT03020745|617153830|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
170869238|NCT00708175|617532100|FG001|Overall Study|Lost to Follow-up|3|||
170869239|NCT00708175|617532099|FG000|Overall Study|Withdrawal by Subject|5|||
170869240|NCT00708175|617532100|FG001|Overall Study|Withdrawal by Subject|7|||
170869241|NCT00708175|617532099|FG000|Overall Study|BMD loss >7%|2|||
170869242|NCT00708175|617532100|FG001|Overall Study|BMD loss >7%|3|||
170869243|NCT04275297|617532103|FG000|Overall Study|Lost to Follow-up|1|||
170869244|NCT04275297|617532104|FG001|Overall Study|Lost to Follow-up|1|||
170869245|NCT01791803|617532105|FG000|Overall Study|Withdrawal by Subject|0|||
170869246|NCT01791803|617532106|FG001|Overall Study|Withdrawal by Subject|0|||
170869247|NCT01791803|617532107|FG002|Overall Study|Withdrawal by Subject|0|||
170869248|NCT01791803|617532108|FG003|Overall Study|Withdrawal by Subject|2|||
170869249|NCT01791803|617532105|FG000|Overall Study|Physician Decision|0|||
170869250|NCT01791803|617532106|FG001|Overall Study|Physician Decision|2|||
170869251|NCT01791803|617532107|FG002|Overall Study|Physician Decision|0|||
170869252|NCT01791803|617532108|FG003|Overall Study|Physician Decision|1|||
170869253|NCT01791803|617532105|FG000|Overall Study|Death|0|||
170869254|NCT01791803|617532106|FG001|Overall Study|Death|0|||
170869255|NCT01791803|617532107|FG002|Overall Study|Death|2|||
170869256|NCT01791803|617532108|FG003|Overall Study|Death|2|||
170869257|NCT04435782|617532109|FG000|Overall Study|Study terminated by sponsor|4|||
170869258|NCT00257166|617534028|FG000|Overall Study|Adverse Event|18|||
170869259|NCT00257166|617534029|FG001|Overall Study|Adverse Event|13|||
170869260|NCT00257166|617534028|FG000|Overall Study|Laboratory abnormality|1|||
170869261|NCT00257166|617534029|FG001|Overall Study|Laboratory abnormality|0|||
170869262|NCT00257166|617534028|FG000|Overall Study|Lost to Follow-up|8|||
170869263|NCT00257166|617534029|FG001|Overall Study|Lost to Follow-up|1|||
170869264|NCT00257166|617534028|FG000|Overall Study|Withdrawal by Subject|9|||
170869265|NCT00257166|617534029|FG001|Overall Study|Withdrawal by Subject|2|||
170869266|NCT00257166|617534028|FG000|Overall Study|Other|16|||
170869267|NCT00257166|617534029|FG001|Overall Study|Other|21|||
170869268|NCT00257166|617534028|FG000|Overall Study|Randomized, but not treated|1|||
170869269|NCT00257166|617534029|FG001|Overall Study|Randomized, but not treated|0|||
170869270|NCT05162027|617534030|FG000|Overall Study|Adverse Event|1|||
170869271|NCT05162027|617534031|FG001|Overall Study|Adverse Event|0|||
170869272|NCT00908583|617534035|FG000|Phase 1|Withdrawal by Subject|1|||
170869273|NCT00908583|617534035|FG000|Phase 1|Adverse Event|4|||
170869274|NCT00908583|617534035|FG000|Phase 2|Physician Decision|1|||
170869275|NCT00908583|617534035|FG000|Phase 2|Adverse Event|1|||
170869276|NCT00908583|617534035|FG000|Phase 3|Adverse Event|2|||
170869277|NCT00908583|617534035|FG000|Phase 4|Adverse Event|1|||
170869278|NCT00908583|617534035|FG000|Phase 4|Physician Decision|1|||
170869279|NCT00908583|617534035|FG000|Phase 5|Adverse Event|3|||
170869280|NCT00993954|617534036|FG000|Overall Study|Protocol Violation|21|||
170869281|NCT00993954|617534037|FG001|Overall Study|Protocol Violation|2|||
170869282|NCT00860951|617534038|FG000|Overall Study|Withdrawal by Subject|2|||
170869283|NCT00860951|617534038|FG000|Overall Study|Lost to Follow-up|5|||
170869284|NCT00907257|617534042|FG000|Overall Study|Adverse Event|0|||
170869285|NCT00907257|617534043|FG001|Overall Study|Adverse Event|4|||
170869286|NCT00907257|617534042|FG000|Overall Study|Protocol Violation|1|||
170869287|NCT00907257|617534043|FG001|Overall Study|Protocol Violation|2|||
170869288|NCT00907257|617534042|FG000|Overall Study|Lost to Follow-up|3|||
170869289|NCT00907257|617534043|FG001|Overall Study|Lost to Follow-up|3|||
170869290|NCT00907257|617534042|FG000|Overall Study|Withdrawal by Subject|1|||
170869291|NCT00907257|617534043|FG001|Overall Study|Withdrawal by Subject|2|||
170869292|NCT00907257|617534042|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
170869293|NCT00907257|617534043|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
170869294|NCT00907257|617534042|FG000|Overall Study|Moved|1|||
170869295|NCT00907257|617534043|FG001|Overall Study|Moved|0|||
170869296|NCT00907257|617534042|FG000|Overall Study|Personal Reasons|6|||
170869297|NCT00907257|617534043|FG001|Overall Study|Personal Reasons|1|||
170869298|NCT01873417|617534044|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
170869299|NCT01873417|617534044|FG000|Overall Study|Adverse Event|24|||
170869300|NCT01873417|617534044|FG000|Overall Study|Lost to Follow-up|2|||
170869301|NCT01873417|617534044|FG000|Overall Study|Withdrawal by Subject|2|||
170869302|NCT01873417|617534044|FG000|Overall Study|Physician Decision|3|||
170869303|NCT00785044|617534045|FG000|Overall Study|Dosed at non-participating sites|152|||
170869304|NCT00785044|617534045|FG000|Overall Study|Death|77|||
170869305|NCT00785044|617534045|FG000|Overall Study|Lost to Follow-up|266|||
170869306|NCT00785044|617534045|FG000|Overall Study|Withdrawal by Subject|1|||
170869307|NCT01628107|617534046|FG000|Overall Study|Withdrawal by Subject|17|||
170869308|NCT01628107|617534046|FG000|Overall Study|Lost to Follow-up|4|||
170869309|NCT01628107|617534046|FG000|Overall Study|Adverse Event|33|||
170522137|NCT01022203|616258067|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
170522138|NCT01022203|616258066|FG000|Post Treatment Assessment|Physician Decision|2|||
170869310|NCT01628107|617534046|FG000|Overall Study|Physician Decision|2|||
170869311|NCT01628107|617534046|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
170869312|NCT01628107|617534046|FG000|Overall Study|Non-compliant with Study Procedures|10|||
170869313|NCT01628107|617534046|FG000|Overall Study|Not Treated|8|||
170869314|NCT01628107|617534046|FG000|Overall Study|Sponsor Decision|11|||
170869315|NCT01628107|617534046|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
170869316|NCT01628107|617534046|FG000|Overall Study|Relocated|8|||
170767195|NCT03020745|617153831|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
170767196|NCT03020745|617153822|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767197|NCT03020745|617153823|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767198|NCT03020745|617153824|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767199|NCT03020745|617153825|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767200|NCT03020745|617153826|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767201|NCT03020745|617153827|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767202|NCT03020745|617153828|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767203|NCT03020745|617153829|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
170767204|NCT03020745|617153830|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767205|NCT03020745|617153831|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
170767206|NCT03020745|617153822|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
170767207|NCT03020745|617153823|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
170767208|NCT03020745|617153824|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
170767209|NCT03020745|617153825|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
170767210|NCT03020745|617153826|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
170767211|NCT03020745|617153827|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
170767212|NCT03020745|617153828|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
170767213|NCT03020745|617153829|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
170767214|NCT03020745|617153830|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
170767215|NCT03020745|617153831|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
170767216|NCT03020745|617153822|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767217|NCT03020745|617153823|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767218|NCT03020745|617153824|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767219|NCT03020745|617153825|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767220|NCT03020745|617153826|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767221|NCT03020745|617153827|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767222|NCT03020745|617153828|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767223|NCT03020745|617153829|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767224|NCT03020745|617153830|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
170767225|NCT03020745|617153831|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
170767226|NCT00186186|617153832|FG000|Overall Study|Lack of Efficacy|3|||
170767227|NCT00186186|617153832|FG000|Overall Study|Withdrawal by Subject|3|||
170767228|NCT00186186|617153832|FG000|Overall Study|Not reported as to reason|2|||
170767229|NCT01183780|617153836|FG000|Overall Study|Withdrawal by Subject|25|||
170869317|NCT01628107|617534046|FG000|Overall Study|Kidney Transplant|9|||
170869318|NCT01628107|617534046|FG000|Overall Study|Use of Standard of Care|9|||
170869319|NCT01086410|617534047|FG000|Overall Study|Adverse Event|1|||
170411915|NCT04969939|615847260|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
170411916|NCT04969939|615847261|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
170411917|NCT04969939|615847255|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
170411918|NCT04969939|615847256|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
170411919|NCT04969939|615847257|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
170411920|NCT04969939|615847258|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
170411921|NCT04969939|615847259|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
170411922|NCT04969939|615847260|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
170411923|NCT04969939|615847261|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
170411924|NCT03843359|615847262|FG000|Escalation Phase|Lost to Follow-up|0|||
170411925|NCT03843359|615847263|FG001|Escalation Phase|Lost to Follow-up|0|||
170411926|NCT03843359|615847264|FG002|Escalation Phase|Lost to Follow-up|0|||
170411927|NCT03843359|615847265|FG003|Escalation Phase|Lost to Follow-up|0|||
170411928|NCT03843359|615847266|FG004|Escalation Phase|Lost to Follow-up|0|||
170411929|NCT03843359|615847267|FG005|Escalation Phase|Lost to Follow-up|0|||
170411930|NCT03843359|615847268|FG006|Escalation Phase|Lost to Follow-up|0|||
170411931|NCT03843359|615847269|FG007|Escalation Phase|Lost to Follow-up|0|||
170411932|NCT03843359|615847270|FG008|Escalation Phase|Lost to Follow-up|1|||
170411933|NCT03843359|615847271|FG009|Escalation Phase|Lost to Follow-up|0|||
170411934|NCT03843359|615847272|FG010|Escalation Phase|Lost to Follow-up|0|||
170411935|NCT03843359|615847273|FG011|Escalation Phase|Lost to Follow-up|0|||
170411936|NCT03843359|615847274|FG012|Escalation Phase|Lost to Follow-up|0|||
170411937|NCT03843359|615847275|FG013|Escalation Phase|Lost to Follow-up|0|||
170411938|NCT03843359|615847276|FG014|Escalation Phase|Lost to Follow-up|0|||
170767230|NCT01183780|617153837|FG001|Overall Study|Withdrawal by Subject|14|||
170767231|NCT01183780|617153836|FG000|Overall Study|Lost to Follow-up|6|||
170767232|NCT01183780|617153837|FG001|Overall Study|Lost to Follow-up|11|||
170767233|NCT00079183|617153838|FG000|Overall Study|Withdrawal by Subject|4|||
170767234|NCT00079183|617153838|FG000|Overall Study|Study medication non-compliance|2|||
170767235|NCT00079183|617153838|FG000|Overall Study|Specimen collection non-compliance|1|||
170411939|NCT03843359|615847277|FG015|Escalation Phase|Lost to Follow-up|0|||
170411940|NCT03843359|615847262|FG000|Escalation Phase|Physician Decision|0|||
170869320|NCT01086410|617534048|FG001|Overall Study|Adverse Event|0|||
170869321|NCT01086410|617534049|FG002|Overall Study|Adverse Event|0|||
170869322|NCT01086410|617534050|FG003|Overall Study|Adverse Event|2|||
170869323|NCT01086410|617534047|FG000|Overall Study|Lack of Efficacy|1|||
170869324|NCT01086410|617534048|FG001|Overall Study|Lack of Efficacy|1|||
170869325|NCT01086410|617534049|FG002|Overall Study|Lack of Efficacy|0|||
170869326|NCT01086410|617534050|FG003|Overall Study|Lack of Efficacy|0|||
170869327|NCT01086410|617534047|FG000|Overall Study|Protocol Violation|1|||
170869328|NCT01086410|617534048|FG001|Overall Study|Protocol Violation|1|||
170869329|NCT01086410|617534049|FG002|Overall Study|Protocol Violation|0|||
170869330|NCT01086410|617534050|FG003|Overall Study|Protocol Violation|0|||
170869331|NCT01086410|617534047|FG000|Overall Study|Lost to Follow-up|0|||
170869332|NCT01086410|617534048|FG001|Overall Study|Lost to Follow-up|0|||
170869333|NCT01086410|617534049|FG002|Overall Study|Lost to Follow-up|1|||
170869334|NCT01086410|617534050|FG003|Overall Study|Lost to Follow-up|0|||
170869335|NCT00763971|617534051|FG000|Overall Study|Adverse Event|5|||
170869336|NCT00763971|617534052|FG001|Overall Study|Adverse Event|2|||
170869337|NCT00763971|617534053|FG002|Overall Study|Adverse Event|4|||
170869338|NCT00763971|617534051|FG000|Overall Study|Protocol Violation|3|||
170869339|NCT00763971|617534052|FG001|Overall Study|Protocol Violation|3|||
170869340|NCT00763971|617534053|FG002|Overall Study|Protocol Violation|2|||
170869341|NCT00763971|617534051|FG000|Overall Study|Withdrawal by Subject|4|||
170869342|NCT00763971|617534052|FG001|Overall Study|Withdrawal by Subject|5|||
170869343|NCT00763971|617534053|FG002|Overall Study|Withdrawal by Subject|5|||
170869344|NCT00763971|617534051|FG000|Overall Study|Lost to Follow-up|0|||
170869345|NCT00763971|617534052|FG001|Overall Study|Lost to Follow-up|1|||
170869346|NCT00763971|617534053|FG002|Overall Study|Lost to Follow-up|0|||
170869347|NCT00763971|617534051|FG000|Overall Study|Lack of Efficacy|11|||
170869348|NCT00763971|617534052|FG001|Overall Study|Lack of Efficacy|22|||
170869349|NCT00763971|617534053|FG002|Overall Study|Lack of Efficacy|54|||
170869350|NCT00763971|617534051|FG000|Overall Study|Unable to swallow capsule|2|||
170869351|NCT00763971|617534052|FG001|Overall Study|Unable to swallow capsule|1|||
170869352|NCT00763971|617534053|FG002|Overall Study|Unable to swallow capsule|1|||
170869353|NCT00763971|617534051|FG000|Overall Study|Personal reason|3|||
170869354|NCT00763971|617534052|FG001|Overall Study|Personal reason|0|||
170869355|NCT00763971|617534053|FG002|Overall Study|Personal reason|0|||
170869356|NCT00763971|617534051|FG000|Overall Study|Exclusion criteria met|1|||
170869357|NCT00763971|617534052|FG001|Overall Study|Exclusion criteria met|0|||
170869358|NCT00763971|617534053|FG002|Overall Study|Exclusion criteria met|0|||
170869359|NCT00763971|617534051|FG000|Overall Study|Sponsor decision|1|||
170869360|NCT00763971|617534052|FG001|Overall Study|Sponsor decision|0|||
170869361|NCT00763971|617534053|FG002|Overall Study|Sponsor decision|0|||
170869362|NCT00763971|617534051|FG000|Overall Study|Due to holiday season|2|||
170869363|NCT00763971|617534052|FG001|Overall Study|Due to holiday season|0|||
170869364|NCT00763971|617534053|FG002|Overall Study|Due to holiday season|1|||
170869365|NCT00763971|617534051|FG000|Overall Study|Randomization error|0|||
170869366|NCT00763971|617534052|FG001|Overall Study|Randomization error|0|||
170869367|NCT00763971|617534053|FG002|Overall Study|Randomization error|1|||
170869368|NCT00763971|617534051|FG000|Overall Study|Medical monitor decision|0|||
170869369|NCT00763971|617534052|FG001|Overall Study|Medical monitor decision|0|||
170869370|NCT00763971|617534053|FG002|Overall Study|Medical monitor decision|1|||
170869371|NCT00763971|617534051|FG000|Overall Study|Moved to another country|0|||
170869372|NCT00763971|617534052|FG001|Overall Study|Moved to another country|1|||
170869373|NCT00763971|617534053|FG002|Overall Study|Moved to another country|0|||
170411941|NCT03843359|615847263|FG001|Escalation Phase|Physician Decision|0|||
170411942|NCT03843359|615847264|FG002|Escalation Phase|Physician Decision|1|||
170411943|NCT03843359|615847265|FG003|Escalation Phase|Physician Decision|0|||
170411944|NCT03843359|615847266|FG004|Escalation Phase|Physician Decision|0|||
170411945|NCT03843359|615847267|FG005|Escalation Phase|Physician Decision|1|||
170411946|NCT03843359|615847268|FG006|Escalation Phase|Physician Decision|0|||
170411947|NCT03843359|615847269|FG007|Escalation Phase|Physician Decision|0|||
170411948|NCT03843359|615847270|FG008|Escalation Phase|Physician Decision|0|||
170411949|NCT03843359|615847271|FG009|Escalation Phase|Physician Decision|0|||
170411950|NCT03843359|615847272|FG010|Escalation Phase|Physician Decision|0|||
170869374|NCT00763971|617534051|FG000|Overall Study|Subject wanted dose reduction|0|||
170869375|NCT00763971|617534052|FG001|Overall Study|Subject wanted dose reduction|1|||
170869376|NCT00763971|617534053|FG002|Overall Study|Subject wanted dose reduction|0|||
170411951|NCT03843359|615847273|FG011|Escalation Phase|Physician Decision|0|||
170869377|NCT00763971|617534051|FG000|Overall Study|Lack of availability|0|||
170869378|NCT00763971|617534052|FG001|Overall Study|Lack of availability|1|||
170869379|NCT00763971|617534053|FG002|Overall Study|Lack of availability|0|||
170869380|NCT00763971|617534051|FG000|Overall Study|Performed final visit on phone|0|||
170869381|NCT00763971|617534052|FG001|Overall Study|Performed final visit on phone|1|||
170869382|NCT00763971|617534053|FG002|Overall Study|Performed final visit on phone|0|||
170869383|NCT00763971|617534051|FG000|Overall Study|Participation in 489-326 required|1|||
170869384|NCT00763971|617534052|FG001|Overall Study|Participation in 489-326 required|0|||
170869385|NCT00763971|617534053|FG002|Overall Study|Participation in 489-326 required|0|||
170869386|NCT02713542|617534054|FG000|Overall Study|Use of prohibited medication|14|||
170869387|NCT02713542|617534055|FG001|Overall Study|Use of prohibited medication|5|||
170869388|NCT02713542|617534054|FG000|Overall Study|Withdrawal by Subject|4|||
170869389|NCT02713542|617534055|FG001|Overall Study|Withdrawal by Subject|1|||
170869390|NCT01301456|617534056|FG000|Stage 1|Withdrawal by Subject|0|||
170869391|NCT01301456|617534057|FG001|Stage 1|Withdrawal by Subject|0|||
170869392|NCT01301456|617534058|FG002|Stage 1|Withdrawal by Subject|1|||
170869393|NCT01301456|617534059|FG003|Stage 1|Withdrawal by Subject|0|||
170869394|NCT01301456|617534060|FG004|Stage 1|Withdrawal by Subject|1|||
170869395|NCT01301456|617534061|FG005|Stage 1|Withdrawal by Subject|0|||
170869396|NCT01301456|617534062|FG006|Stage 1|Withdrawal by Subject|0|||
170869397|NCT01301456|617534063|FG007|Stage 1|Withdrawal by Subject|0|||
170869398|NCT01301456|617534064|FG008|Stage 1|Withdrawal by Subject|0|||
170869399|NCT01301456|617534065|FG009|Stage 1|Withdrawal by Subject|0|||
170869400|NCT01301456|617534066|FG010|Stage 1|Withdrawal by Subject|0|||
170869401|NCT01301456|617534067|FG011|Stage 1|Withdrawal by Subject|0|||
170869402|NCT01301456|617534056|FG000|Stage 1|Randomized but not treated|0|||
170869403|NCT01301456|617534057|FG001|Stage 1|Randomized but not treated|0|||
170869404|NCT01301456|617534058|FG002|Stage 1|Randomized but not treated|0|||
170869405|NCT01301456|617534059|FG003|Stage 1|Randomized but not treated|0|||
170869406|NCT01301456|617534060|FG004|Stage 1|Randomized but not treated|0|||
170869407|NCT01301456|617534061|FG005|Stage 1|Randomized but not treated|0|||
170869408|NCT01301456|617534062|FG006|Stage 1|Randomized but not treated|1|||
170869409|NCT01301456|617534063|FG007|Stage 1|Randomized but not treated|0|||
170869410|NCT01301456|617534064|FG008|Stage 1|Randomized but not treated|0|||
170869411|NCT01301456|617534065|FG009|Stage 1|Randomized but not treated|0|||
170869412|NCT01301456|617534066|FG010|Stage 1|Randomized but not treated|0|||
170869413|NCT01301456|617534067|FG011|Stage 1|Randomized but not treated|0|||
170869414|NCT01301456|617534056|FG000|Stage 2|Adverse Event|0|||
170869415|NCT01301456|617534057|FG001|Stage 2|Adverse Event|0|||
170869416|NCT01301456|617534058|FG002|Stage 2|Adverse Event|0|||
170869417|NCT01301456|617534059|FG003|Stage 2|Adverse Event|0|||
170869418|NCT01301456|617534060|FG004|Stage 2|Adverse Event|0|||
170869419|NCT01301456|617534061|FG005|Stage 2|Adverse Event|0|||
170869420|NCT01301456|617534062|FG006|Stage 2|Adverse Event|0|||
170869421|NCT01301456|617534063|FG007|Stage 2|Adverse Event|0|||
170869422|NCT01301456|617534064|FG008|Stage 2|Adverse Event|0|||
170869423|NCT01301456|617534065|FG009|Stage 2|Adverse Event|0|||
170869424|NCT01301456|617534066|FG010|Stage 2|Adverse Event|1|||
170869425|NCT01301456|617534067|FG011|Stage 2|Adverse Event|0|||
170869426|NCT03842163|617534074|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
170869427|NCT03842163|617534074|FG000|Overall Study|Scintigraphy was not performed|44|||
170869428|NCT04060563|617534076|FG000|Overall Study|Lost to Follow-up|1|||
170869429|NCT04060563|617534077|FG001|Overall Study|Lost to Follow-up|1|||
170869430|NCT04060563|617534076|FG000|Overall Study|Physician Decision|0|||
170869431|NCT04060563|617534077|FG001|Overall Study|Physician Decision|1|||
170869432|NCT00578786|617534078|FG000|Overall Study|Adverse Event|27|||
170869433|NCT00578786|617534079|FG001|Overall Study|Adverse Event|37|||
170869434|NCT00578786|617534080|FG002|Overall Study|Adverse Event|17|||
170869435|NCT00578786|617534078|FG000|Overall Study|Lack of Efficacy|2|||
170869436|NCT00578786|617534079|FG001|Overall Study|Lack of Efficacy|5|||
170869437|NCT00578786|617534080|FG002|Overall Study|Lack of Efficacy|2|||
170869438|NCT00578786|617534078|FG000|Overall Study|Early Escape from Prior Study|2|||
170869439|NCT00578786|617534079|FG001|Overall Study|Early Escape from Prior Study|1|||
170869440|NCT00578786|617534080|FG002|Overall Study|Early Escape from Prior Study|2|||
170869441|NCT00578786|617534078|FG000|Overall Study|Withdrawal by Subject|7|||
170869442|NCT00578786|617534079|FG001|Overall Study|Withdrawal by Subject|8|||
170869443|NCT00578786|617534080|FG002|Overall Study|Withdrawal by Subject|5|||
170869444|NCT00578786|617534078|FG000|Overall Study|Protocol Violation|0|||
170869445|NCT00578786|617534079|FG001|Overall Study|Protocol Violation|3|||
170869446|NCT00578786|617534080|FG002|Overall Study|Protocol Violation|1|||
170869447|NCT00578786|617534078|FG000|Overall Study|Physician Decision|1|||
170869448|NCT00578786|617534079|FG001|Overall Study|Physician Decision|0|||
170869449|NCT00578786|617534080|FG002|Overall Study|Physician Decision|1|||
170869450|NCT00578786|617534078|FG000|Overall Study|Sponsor Decision|0|||
170869451|NCT00578786|617534079|FG001|Overall Study|Sponsor Decision|0|||
170869452|NCT00578786|617534080|FG002|Overall Study|Sponsor Decision|1|||
170869453|NCT00578786|617534078|FG000|Overall Study|Lost to Follow-up|0|||
170869454|NCT00578786|617534079|FG001|Overall Study|Lost to Follow-up|4|||
170869455|NCT00578786|617534080|FG002|Overall Study|Lost to Follow-up|0|||
170869456|NCT00578786|617534078|FG000|Overall Study|Pregnancy|0|||
170869457|NCT00578786|617534079|FG001|Overall Study|Pregnancy|1|||
170869458|NCT00578786|617534080|FG002|Overall Study|Pregnancy|0|||
170869459|NCT00578786|617534078|FG000|Overall Study|Not Otherwise Specified|0|||
170869460|NCT00578786|617534079|FG001|Overall Study|Not Otherwise Specified|4|||
170869461|NCT00578786|617534080|FG002|Overall Study|Not Otherwise Specified|1|||
170869462|NCT00578786|617534078|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
170869463|NCT00578786|617534079|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
170869464|NCT00578786|617534080|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
170869465|NCT01003990|617534084|FG000|Overall Study|Adverse Event|8|||
170869466|NCT01003990|617534085|FG001|Overall Study|Adverse Event|5|||
170869467|NCT01003990|617534086|FG002|Overall Study|Adverse Event|11|||
170869468|NCT01003990|617534084|FG000|Overall Study|Death|0|||
170869469|NCT01003990|617534085|FG001|Overall Study|Death|8|||
170869470|NCT01003990|617534086|FG002|Overall Study|Death|1|||
170869471|NCT01003990|617534084|FG000|Overall Study|Lack of Efficacy|10|||
170869472|NCT01003990|617534085|FG001|Overall Study|Lack of Efficacy|2|||
170869473|NCT01003990|617534086|FG002|Overall Study|Lack of Efficacy|3|||
170869474|NCT01003990|617534084|FG000|Overall Study|Lost to Follow-up|30|||
170869475|NCT01003990|617534085|FG001|Overall Study|Lost to Follow-up|12|||
170869476|NCT01003990|617534086|FG002|Overall Study|Lost to Follow-up|7|||
170869477|NCT01003990|617534084|FG000|Overall Study|Reasons Not Identified|14|||
170869478|NCT01003990|617534085|FG001|Overall Study|Reasons Not Identified|13|||
170869479|NCT01003990|617534086|FG002|Overall Study|Reasons Not Identified|8|||
170869480|NCT01003990|617534084|FG000|Overall Study|Poor/Non-compliance|4|||
170869481|NCT01003990|617534085|FG001|Overall Study|Poor/Non-compliance|3|||
170869482|NCT01003990|617534086|FG002|Overall Study|Poor/Non-compliance|2|||
170869483|NCT01003990|617534084|FG000|Overall Study|Pregnancy|10|||
170869484|NCT01003990|617534085|FG001|Overall Study|Pregnancy|2|||
170869485|NCT01003990|617534086|FG002|Overall Study|Pregnancy|4|||
170869486|NCT01003990|617534084|FG000|Overall Study|No Longer Met Study Criteria|4|||
170869487|NCT01003990|617534085|FG001|Overall Study|No Longer Met Study Criteria|1|||
170869488|NCT01003990|617534086|FG002|Overall Study|No Longer Met Study Criteria|0|||
170869489|NCT01003990|617534084|FG000|Overall Study|Subject Withdrew Consent|12|||
170869490|NCT01003990|617534085|FG001|Overall Study|Subject Withdrew Consent|5|||
170869491|NCT01003990|617534086|FG002|Overall Study|Subject Withdrew Consent|7|||
170869492|NCT02871778|617534088|FG000|Part A: Treatment Period 1|Adverse Event|1|||
170869493|NCT02871778|617534089|FG001|Part A: Treatment Period 1|Adverse Event|1|||
170869494|NCT02871778|617534090|FG002|Part A: Treatment Period 1|Adverse Event|1|||
170869495|NCT02871778|617534091|FG003|Part A: Treatment Period 1|Adverse Event|0|||
170869496|NCT02871778|617534092|FG004|Part A: Treatment Period 1|Adverse Event|0|||
170411952|NCT03843359|615847274|FG012|Escalation Phase|Physician Decision|0|||
170411953|NCT03843359|615847275|FG013|Escalation Phase|Physician Decision|0|||
170411954|NCT03843359|615847276|FG014|Escalation Phase|Physician Decision|0|||
170767236|NCT01596504|617153839|FG000|Overall Study|Participant's Private Reason|0|||
170767237|NCT01596504|617153840|FG001|Overall Study|Participant's Private Reason|1|||
170767238|NCT01596504|617153841|FG002|Overall Study|Participant's Private Reason|0|||
170767239|NCT01596504|617153839|FG000|Overall Study|Adverse Event|1|||
170767240|NCT01596504|617153840|FG001|Overall Study|Adverse Event|2|||
170767241|NCT01596504|617153841|FG002|Overall Study|Adverse Event|1|||
170767242|NCT01596504|617153839|FG000|Overall Study|Withdrawal by Subject|1|||
170767243|NCT01596504|617153840|FG001|Overall Study|Withdrawal by Subject|0|||
170767244|NCT01596504|617153841|FG002|Overall Study|Withdrawal by Subject|0|||
170767245|NCT00949975|617153842|FG000|Overall Study|Voluntary discontinuation|6|||
170767246|NCT00949975|617153843|FG001|Overall Study|Voluntary discontinuation|5|||
170767247|NCT00949975|617153844|FG002|Overall Study|Voluntary discontinuation|3|||
170767248|NCT00949975|617153845|FG003|Overall Study|Voluntary discontinuation|6|||
170767249|NCT00949975|617153842|FG000|Overall Study|Adverse Event|11|||
170767250|NCT00949975|617153843|FG001|Overall Study|Adverse Event|11|||
170767251|NCT00949975|617153844|FG002|Overall Study|Adverse Event|10|||
170767252|NCT00949975|617153845|FG003|Overall Study|Adverse Event|10|||
170767253|NCT00949975|617153842|FG000|Overall Study|Safety reason|0|||
170767254|NCT00949975|617153843|FG001|Overall Study|Safety reason|1|||
170767255|NCT00949975|617153844|FG002|Overall Study|Safety reason|0|||
170767256|NCT00949975|617153845|FG003|Overall Study|Safety reason|0|||
170767257|NCT00949975|617153842|FG000|Overall Study|Study-specific criteria|0|||
170767258|NCT00949975|617153843|FG001|Overall Study|Study-specific criteria|1|||
170767259|NCT00949975|617153844|FG002|Overall Study|Study-specific criteria|1|||
170767260|NCT00949975|617153845|FG003|Overall Study|Study-specific criteria|0|||
170767261|NCT00949975|617153842|FG000|Overall Study|Incorrect enrolment|5|||
170767262|NCT00949975|617153843|FG001|Overall Study|Incorrect enrolment|10|||
170767263|NCT00949975|617153844|FG002|Overall Study|Incorrect enrolment|4|||
170869497|NCT02871778|617534093|FG005|Part A: Treatment Period 1|Adverse Event|0|||
170869498|NCT02871778|617534094|FG006|Part A: Treatment Period 1|Adverse Event|0|||
170869499|NCT02871778|617534095|FG007|Part A: Treatment Period 1|Adverse Event|0|||
170869500|NCT02871778|617534088|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
170869501|NCT02871778|617534089|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
170869502|NCT02871778|617534090|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
170767264|NCT00949975|617153845|FG003|Overall Study|Incorrect enrolment|7|||
170767265|NCT00949975|617153842|FG000|Overall Study|Severe non-compliance|3|||
170767266|NCT00949975|617153843|FG001|Overall Study|Severe non-compliance|1|||
170767267|NCT00949975|617153844|FG002|Overall Study|Severe non-compliance|0|||
170767268|NCT00949975|617153845|FG003|Overall Study|Severe non-compliance|2|||
170767269|NCT00949975|617153842|FG000|Overall Study|Lost to Follow-up|1|||
170767270|NCT00949975|617153843|FG001|Overall Study|Lost to Follow-up|0|||
170767271|NCT00949975|617153844|FG002|Overall Study|Lost to Follow-up|1|||
170767272|NCT00949975|617153845|FG003|Overall Study|Lost to Follow-up|3|||
170767273|NCT00949975|617153842|FG000|Overall Study|Other|1|||
170767274|NCT00949975|617153843|FG001|Overall Study|Other|0|||
170767275|NCT00949975|617153844|FG002|Overall Study|Other|0|||
170767276|NCT00949975|617153845|FG003|Overall Study|Other|0|||
170767277|NCT04347954|617153846|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
170767278|NCT04347954|617153847|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
170767279|NCT04347954|617153848|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
170767280|NCT04347954|617153846|FG000|Overall Study|Lost to Follow-up|0|||
170767281|NCT04347954|617153847|FG001|Overall Study|Lost to Follow-up|1|||
170767282|NCT04347954|617153848|FG002|Overall Study|Lost to Follow-up|0|||
170767283|NCT00367991|617153849|FG000|Overall Study|Withdrawal by Subject|1|||
170767284|NCT00367991|617153850|FG001|Overall Study|Withdrawal by Subject|1|||
170767285|NCT00367991|617153849|FG000|Overall Study|Adverse Event|1|||
170767286|NCT00367991|617153850|FG001|Overall Study|Adverse Event|1|||
170767287|NCT02341625|617153851|FG000|Overall Study|Disease Progression|2|||
170767288|NCT02341625|617153852|FG001|Overall Study|Disease Progression|2|||
170767289|NCT02341625|617153853|FG002|Overall Study|Disease Progression|3|||
170767290|NCT02341625|617153854|FG003|Overall Study|Disease Progression|6|||
170767291|NCT02341625|617153855|FG004|Overall Study|Disease Progression|7|||
170767292|NCT02341625|617153856|FG005|Overall Study|Disease Progression|7|||
170767293|NCT02341625|617153857|FG006|Overall Study|Disease Progression|28|||
170767294|NCT02341625|617153858|FG007|Overall Study|Disease Progression|5|||
170767295|NCT02341625|617153859|FG008|Overall Study|Disease Progression|4|||
170767296|NCT02341625|617153860|FG009|Overall Study|Disease Progression|19|||
170767297|NCT02341625|617153851|FG000|Overall Study|Study Drug Toxicity|0|||
170767298|NCT02341625|617153852|FG001|Overall Study|Study Drug Toxicity|0|||
170767299|NCT02341625|617153853|FG002|Overall Study|Study Drug Toxicity|0|||
170767300|NCT02341625|617153854|FG003|Overall Study|Study Drug Toxicity|1|||
170767301|NCT02341625|617153855|FG004|Overall Study|Study Drug Toxicity|0|||
170767302|NCT02341625|617153856|FG005|Overall Study|Study Drug Toxicity|3|||
170767303|NCT02341625|617153857|FG006|Overall Study|Study Drug Toxicity|10|||
170767304|NCT02341625|617153858|FG007|Overall Study|Study Drug Toxicity|0|||
170767305|NCT02341625|617153859|FG008|Overall Study|Study Drug Toxicity|0|||
170767306|NCT02341625|617153860|FG009|Overall Study|Study Drug Toxicity|3|||
170767307|NCT02341625|617153851|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170767308|NCT02341625|617153852|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170767309|NCT02341625|617153853|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170767310|NCT02341625|617153854|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170767311|NCT02341625|617153855|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170767312|NCT02341625|617153856|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170767313|NCT02341625|617153857|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
170767314|NCT02341625|617153858|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
170767315|NCT02341625|617153859|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170767316|NCT02341625|617153860|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
170767317|NCT02341625|617153851|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
170767318|NCT02341625|617153852|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
170767319|NCT02341625|617153853|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
170767320|NCT02341625|617153854|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
170767321|NCT02341625|617153855|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
170767322|NCT02341625|617153856|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
170767323|NCT02341625|617153857|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
170767324|NCT02341625|617153858|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
170767325|NCT02341625|617153859|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
170767326|NCT02341625|617153860|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
170767327|NCT02341625|617153851|FG000|Overall Study|Participant Withdrew Consent|0|||
170767328|NCT02341625|617153852|FG001|Overall Study|Participant Withdrew Consent|0|||
170767329|NCT02341625|617153853|FG002|Overall Study|Participant Withdrew Consent|0|||
170767330|NCT02341625|617153854|FG003|Overall Study|Participant Withdrew Consent|1|||
170767331|NCT02341625|617153855|FG004|Overall Study|Participant Withdrew Consent|0|||
170767332|NCT02341625|617153856|FG005|Overall Study|Participant Withdrew Consent|0|||
170767333|NCT02341625|617153857|FG006|Overall Study|Participant Withdrew Consent|0|||
170767334|NCT02341625|617153858|FG007|Overall Study|Participant Withdrew Consent|0|||
170767335|NCT02341625|617153859|FG008|Overall Study|Participant Withdrew Consent|0|||
170767336|NCT02341625|617153860|FG009|Overall Study|Participant Withdrew Consent|0|||
170767337|NCT02341625|617153851|FG000|Overall Study|Completed Treatment as per Protocol|0|||
170767338|NCT02341625|617153852|FG001|Overall Study|Completed Treatment as per Protocol|0|||
170767339|NCT02341625|617153853|FG002|Overall Study|Completed Treatment as per Protocol|0|||
170767340|NCT02341625|617153854|FG003|Overall Study|Completed Treatment as per Protocol|0|||
170767341|NCT02341625|617153855|FG004|Overall Study|Completed Treatment as per Protocol|0|||
170767342|NCT02341625|617153856|FG005|Overall Study|Completed Treatment as per Protocol|0|||
170869503|NCT02871778|617534091|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
170869504|NCT02871778|617534092|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
170869505|NCT02871778|617534093|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
170869506|NCT02871778|617534094|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
170869507|NCT02871778|617534095|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
170869508|NCT02871778|617534088|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
170869509|NCT02871778|617534089|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
170869510|NCT02871778|617534090|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
170869511|NCT02871778|617534091|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
170869512|NCT02871778|617534092|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
170869513|NCT02871778|617534093|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
170869514|NCT02871778|617534094|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
170869515|NCT02871778|617534095|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
170869516|NCT02871778|617534088|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
170869517|NCT02871778|617534089|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
170869518|NCT02871778|617534090|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
170869519|NCT02871778|617534091|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
170869520|NCT02871778|617534092|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
170869521|NCT02871778|617534093|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
170869522|NCT02871778|617534094|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
170869523|NCT02871778|617534095|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
170869524|NCT02871778|617534088|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
170869525|NCT02871778|617534089|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
170869526|NCT02871778|617534090|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
170767343|NCT02341625|617153857|FG006|Overall Study|Completed Treatment as per Protocol|0|||
170767344|NCT02341625|617153858|FG007|Overall Study|Completed Treatment as per Protocol|0|||
170767345|NCT02341625|617153859|FG008|Overall Study|Completed Treatment as per Protocol|0|||
170767346|NCT02341625|617153860|FG009|Overall Study|Completed Treatment as per Protocol|1|||
170767347|NCT02341625|617153851|FG000|Overall Study|Other Reasons|0|||
170869527|NCT02871778|617534091|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
170869528|NCT02871778|617534092|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
170869529|NCT02871778|617534093|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
170869530|NCT02871778|617534094|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
170869531|NCT02871778|617534095|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
170869532|NCT02871778|617534088|FG000|Part A: Treatment Period 2|Adverse Event|2|||
170869533|NCT02871778|617534089|FG001|Part A: Treatment Period 2|Adverse Event|2|||
170869534|NCT02871778|617534090|FG002|Part A: Treatment Period 2|Adverse Event|0|||
170869535|NCT02871778|617534091|FG003|Part A: Treatment Period 2|Adverse Event|0|||
170869536|NCT02871778|617534092|FG004|Part A: Treatment Period 2|Adverse Event|0|||
170869537|NCT02871778|617534093|FG005|Part A: Treatment Period 2|Adverse Event|0|||
170869538|NCT02871778|617534094|FG006|Part A: Treatment Period 2|Adverse Event|0|||
170869539|NCT02871778|617534095|FG007|Part A: Treatment Period 2|Adverse Event|0|||
170869540|NCT02871778|617534088|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
170869541|NCT02871778|617534089|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
170869542|NCT02871778|617534090|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
170767348|NCT02341625|617153852|FG001|Overall Study|Other Reasons|0|||
170767349|NCT02341625|617153853|FG002|Overall Study|Other Reasons|0|||
170767350|NCT02341625|617153854|FG003|Overall Study|Other Reasons|0|||
170767351|NCT02341625|617153855|FG004|Overall Study|Other Reasons|1|||
170767352|NCT02341625|617153856|FG005|Overall Study|Other Reasons|0|||
170767353|NCT02341625|617153857|FG006|Overall Study|Other Reasons|5|||
170767354|NCT02341625|617153858|FG007|Overall Study|Other Reasons|0|||
170767355|NCT02341625|617153859|FG008|Overall Study|Other Reasons|0|||
170767356|NCT02341625|617153860|FG009|Overall Study|Other Reasons|2|||
170767357|NCT02341625|617153851|FG000|Overall Study|Not Reported|0|||
170767358|NCT02341625|617153852|FG001|Overall Study|Not Reported|0|||
170767359|NCT02341625|617153853|FG002|Overall Study|Not Reported|0|||
170767360|NCT02341625|617153854|FG003|Overall Study|Not Reported|0|||
170767361|NCT02341625|617153855|FG004|Overall Study|Not Reported|0|||
170767362|NCT02341625|617153856|FG005|Overall Study|Not Reported|0|||
170767363|NCT02341625|617153857|FG006|Overall Study|Not Reported|0|||
170767364|NCT02341625|617153858|FG007|Overall Study|Not Reported|0|||
170869543|NCT02871778|617534091|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
170869544|NCT02871778|617534092|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
170869545|NCT02871778|617534093|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
170632173|NCT01134055|616664540|FG001|Overall Study|Physician Decision|0|||
170767365|NCT02341625|617153859|FG008|Overall Study|Not Reported|0|||
170767366|NCT02341625|617153860|FG009|Overall Study|Not Reported|3|||
170767367|NCT00756730|617153861|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
170767368|NCT00756730|617153862|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
170767369|NCT00756730|617153861|FG000|Overall Study|persistent low-level viremmia|0|||
170869546|NCT02871778|617534094|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
170869547|NCT02871778|617534095|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
170869548|NCT02871778|617534088|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
170869549|NCT02871778|617534089|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
170869550|NCT02871778|617534090|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
170869551|NCT02871778|617534091|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
170869552|NCT02871778|617534092|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
170869553|NCT02871778|617534093|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
170869554|NCT02871778|617534094|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
170869555|NCT02871778|617534095|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
170869556|NCT02871778|617534088|FG000|Part B: Treatment Period 3|Adverse Event|0|||
170869557|NCT02871778|617534089|FG001|Part B: Treatment Period 3|Adverse Event|0|||
170869558|NCT02871778|617534090|FG002|Part B: Treatment Period 3|Adverse Event|0|||
170869559|NCT02871778|617534091|FG003|Part B: Treatment Period 3|Adverse Event|0|||
170869560|NCT02871778|617534092|FG004|Part B: Treatment Period 3|Adverse Event|1|||
170869561|NCT02871778|617534093|FG005|Part B: Treatment Period 3|Adverse Event|1|||
170869562|NCT02871778|617534094|FG006|Part B: Treatment Period 3|Adverse Event|1|||
170869563|NCT02871778|617534095|FG007|Part B: Treatment Period 3|Adverse Event|0|||
170869564|NCT01230554|617534096|FG000|Overall Study|Lost to Follow-up|2|||
170869565|NCT01230554|617534096|FG000|Overall Study|Inability to maintain visit schedule|1|||
170869566|NCT01251120|617534107|FG000|Overall Study|Lack of Efficacy|0|||
170869567|NCT01251120|617534108|FG001|Overall Study|Lack of Efficacy|1|||
170869568|NCT00369785|617534109|FG000|Overall Study|Physician Decision|3|||
170869569|NCT00369785|617534110|FG001|Overall Study|Physician Decision|2|||
170869570|NCT00369785|617534109|FG000|Overall Study|Death|1|||
170869571|NCT00369785|617534110|FG001|Overall Study|Death|2|||
170869572|NCT00369785|617534109|FG000|Overall Study|Withdrawal by Subject|7|||
170869573|NCT00369785|617534110|FG001|Overall Study|Withdrawal by Subject|6|||
170869574|NCT00369785|617534109|FG000|Overall Study|Toxicity|6|||
170869575|NCT00369785|617534110|FG001|Overall Study|Toxicity|4|||
170869576|NCT00369785|617534109|FG000|Overall Study|Never started|0|||
170869577|NCT00369785|617534110|FG001|Overall Study|Never started|2|||
170411955|NCT03843359|615847277|FG015|Escalation Phase|Physician Decision|0|||
170411956|NCT03843359|615847262|FG000|Escalation Phase|Investigator site closed|0|||
170411957|NCT03843359|615847263|FG001|Escalation Phase|Investigator site closed|1|||
170411958|NCT03843359|615847264|FG002|Escalation Phase|Investigator site closed|0|||
170411959|NCT03843359|615847265|FG003|Escalation Phase|Investigator site closed|1|||
170411960|NCT03843359|615847266|FG004|Escalation Phase|Investigator site closed|1|||
170411961|NCT03843359|615847267|FG005|Escalation Phase|Investigator site closed|0|||
170411962|NCT03843359|615847268|FG006|Escalation Phase|Investigator site closed|1|||
170869578|NCT00369785|617534109|FG000|Overall Study|Progression|4|||
170869579|NCT00369785|617534110|FG001|Overall Study|Progression|4|||
170869580|NCT00369785|617534109|FG000|Overall Study|Multiple reasons|6|||
170869581|NCT00369785|617534110|FG001|Overall Study|Multiple reasons|5|||
170869582|NCT03933397|617534111|FG000|Overall Study|No emergency department visit|65|||
170869583|NCT03933397|617534112|FG001|Overall Study|No emergency department visit|71|||
170869584|NCT03933397|617534111|FG000|Overall Study|Missed emergency department visit|25|||
170869585|NCT03933397|617534112|FG001|Overall Study|Missed emergency department visit|30|||
170869586|NCT03933397|617534111|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
170869587|NCT03933397|617534112|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
170869588|NCT03933397|617534111|FG000|Overall Study|Withdrawal by Subject|1|||
170869589|NCT03933397|617534112|FG001|Overall Study|Withdrawal by Subject|0|||
170869590|NCT03933397|617534111|FG000|Overall Study|Physician Decision|1|||
170411963|NCT03843359|615847269|FG007|Escalation Phase|Investigator site closed|0|||
170411964|NCT03843359|615847270|FG008|Escalation Phase|Investigator site closed|2|||
170411965|NCT03843359|615847271|FG009|Escalation Phase|Investigator site closed|0|||
170869591|NCT03933397|617534112|FG001|Overall Study|Physician Decision|1|||
170869592|NCT03933397|617534111|FG000|Overall Study|missing pain score|1|||
170869593|NCT03933397|617534112|FG001|Overall Study|missing pain score|1|||
170869594|NCT03933397|617534111|FG000|Overall Study|Confirmed COVID-19|1|||
170411966|NCT03843359|615847272|FG010|Escalation Phase|Investigator site closed|0|||
170411967|NCT03843359|615847273|FG011|Escalation Phase|Investigator site closed|0|||
170411968|NCT03843359|615847274|FG012|Escalation Phase|Investigator site closed|0|||
170411969|NCT03843359|615847275|FG013|Escalation Phase|Investigator site closed|0|||
170411970|NCT03843359|615847276|FG014|Escalation Phase|Investigator site closed|0|||
170869595|NCT03933397|617534112|FG001|Overall Study|Confirmed COVID-19|2|||
170869596|NCT01514136|617534115|FG000|Test Period 1; Test A|Protocol Violation|1|||
170869597|NCT01514136|617534116|FG001|Test Period 1; Test A|Protocol Violation|0|||
170869598|NCT01514136|617534117|FG002|Test Period 1; Test A|Protocol Violation|0|||
170869599|NCT01514136|617534118|FG003|Test Period 1; Test A|Protocol Violation|0|||
170869600|NCT01514136|617534119|FG004|Test Period 1; Test A|Protocol Violation|0|||
170869601|NCT01514136|617534120|FG005|Test Period 1; Test A|Protocol Violation|0|||
170869602|NCT01514136|617534121|FG006|Test Period 1; Test A|Protocol Violation|0|||
170869603|NCT01514136|617534122|FG007|Test Period 1; Test A|Protocol Violation|0|||
170869604|NCT01514136|617534115|FG000|Test Period 1; Test A|Break from study holiday|2|||
170411971|NCT03843359|615847277|FG015|Escalation Phase|Investigator site closed|0|||
170411972|NCT03843359|615847262|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
170411973|NCT03843359|615847263|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
170411974|NCT03843359|615847264|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
170411975|NCT03843359|615847265|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
170411976|NCT03843359|615847266|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
170411977|NCT03843359|615847267|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
170411978|NCT03843359|615847268|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
170411979|NCT03843359|615847269|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
170411980|NCT03843359|615847270|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
170411981|NCT03843359|615847271|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
170411982|NCT03843359|615847272|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
170411983|NCT03843359|615847273|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
170411984|NCT03843359|615847274|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
170411985|NCT03843359|615847275|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
170411986|NCT03843359|615847276|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
170411987|NCT03843359|615847277|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
170411988|NCT03843359|615847262|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170767370|NCT00756730|617153862|FG001|Overall Study|persistent low-level viremmia|1|||
170767371|NCT00177216|617153865|FG000|Overall Study|Withdrawal by Subject|6|||
170767372|NCT00177216|617153866|FG001|Overall Study|Withdrawal by Subject|3|||
170767373|NCT00177216|617153867|FG002|Overall Study|Withdrawal by Subject|1|||
170767374|NCT05382104|617153869|FG000|Period 2 (2 Days)|Adverse Event|0|||
170767375|NCT05382104|617153870|FG001|Period 2 (2 Days)|Adverse Event|1|||
170767376|NCT05382104|617153871|FG002|Period 2 (2 Days)|Adverse Event|0|||
170767377|NCT05382104|617153872|FG003|Period 2 (2 Days)|Adverse Event|0|||
170767378|NCT05382104|617153873|FG004|Period 2 (2 Days)|Adverse Event|0|||
170767379|NCT05382104|617153874|FG005|Period 2 (2 Days)|Adverse Event|0|||
170767380|NCT00988637|617153875|FG000|Overall Study|Lost to Follow-up|2|||
170767381|NCT00988637|617153876|FG001|Overall Study|Lost to Follow-up|1|||
170767382|NCT00988637|617153875|FG000|Overall Study|Withdrawal by Subject|1|||
170767383|NCT00988637|617153876|FG001|Overall Study|Withdrawal by Subject|1|||
170767384|NCT00988637|617153875|FG000|Overall Study|non-compliance with study drug|0|||
170767385|NCT00988637|617153876|FG001|Overall Study|non-compliance with study drug|1|||
170767386|NCT03210402|617153878|FG000|Overall Study|Withdrawal by Subject|0|||
170767387|NCT03210402|617153879|FG001|Overall Study|Withdrawal by Subject|1|||
170767388|NCT03396913|617153896|FG000|Overall Study|Lost to Follow-up|0|||
170767389|NCT03396913|617153897|FG001|Overall Study|Lost to Follow-up|6|||
170767390|NCT00539292|617153898|FG000|Overall Study|Physician Decision|1|||
170767391|NCT00539292|617153899|FG001|Overall Study|Physician Decision|0|||
170767392|NCT02020616|617153902|FG000|Overall Study|Adverse Event|0|||
170767393|NCT02020616|617153903|FG001|Overall Study|Adverse Event|0|||
170767394|NCT02020616|617153904|FG002|Overall Study|Adverse Event|0|||
170767395|NCT02020616|617153905|FG003|Overall Study|Adverse Event|0|||
170767396|NCT02020616|617153906|FG004|Overall Study|Adverse Event|0|||
170767397|NCT02020616|617153907|FG005|Overall Study|Adverse Event|1|||
170767398|NCT02020616|617153908|FG006|Overall Study|Adverse Event|1|||
170767399|NCT02020616|617153902|FG000|Overall Study|Physician Decision|0|||
170767400|NCT02020616|617153903|FG001|Overall Study|Physician Decision|0|||
170767401|NCT02020616|617153904|FG002|Overall Study|Physician Decision|0|||
170767402|NCT02020616|617153905|FG003|Overall Study|Physician Decision|0|||
170767403|NCT02020616|617153906|FG004|Overall Study|Physician Decision|0|||
170767404|NCT02020616|617153907|FG005|Overall Study|Physician Decision|1|||
170767405|NCT02020616|617153908|FG006|Overall Study|Physician Decision|2|||
170767406|NCT02020616|617153902|FG000|Overall Study|Withdrawal by Subject|0|||
170767407|NCT02020616|617153903|FG001|Overall Study|Withdrawal by Subject|0|||
170767408|NCT02020616|617153904|FG002|Overall Study|Withdrawal by Subject|1|||
170767409|NCT02020616|617153905|FG003|Overall Study|Withdrawal by Subject|0|||
170767410|NCT02020616|617153906|FG004|Overall Study|Withdrawal by Subject|0|||
170767411|NCT02020616|617153907|FG005|Overall Study|Withdrawal by Subject|1|||
170767412|NCT02020616|617153908|FG006|Overall Study|Withdrawal by Subject|1|||
170767413|NCT02020616|617153902|FG000|Overall Study|Lost to Follow-up|0|||
170767414|NCT02020616|617153903|FG001|Overall Study|Lost to Follow-up|1|||
170767415|NCT02020616|617153904|FG002|Overall Study|Lost to Follow-up|0|||
170767416|NCT02020616|617153905|FG003|Overall Study|Lost to Follow-up|1|||
170767417|NCT02020616|617153906|FG004|Overall Study|Lost to Follow-up|1|||
170767418|NCT02020616|617153907|FG005|Overall Study|Lost to Follow-up|1|||
170767419|NCT02020616|617153908|FG006|Overall Study|Lost to Follow-up|0|||
170767420|NCT02020616|617153902|FG000|Overall Study|Early Termination Criteria Met|0|||
170767421|NCT02020616|617153903|FG001|Overall Study|Early Termination Criteria Met|0|||
170767422|NCT02020616|617153904|FG002|Overall Study|Early Termination Criteria Met|1|||
170767423|NCT02020616|617153905|FG003|Overall Study|Early Termination Criteria Met|0|||
170767424|NCT02020616|617153906|FG004|Overall Study|Early Termination Criteria Met|0|||
170767425|NCT02020616|617153907|FG005|Overall Study|Early Termination Criteria Met|1|||
170767426|NCT02020616|617153908|FG006|Overall Study|Early Termination Criteria Met|0|||
170869605|NCT01514136|617534116|FG001|Test Period 1; Test A|Break from study holiday|0|||
170869606|NCT01514136|617534117|FG002|Test Period 1; Test A|Break from study holiday|0|||
170869607|NCT01514136|617534118|FG003|Test Period 1; Test A|Break from study holiday|0|||
170869608|NCT01514136|617534119|FG004|Test Period 1; Test A|Break from study holiday|0|||
170869609|NCT01514136|617534120|FG005|Test Period 1; Test A|Break from study holiday|0|||
170869610|NCT01514136|617534121|FG006|Test Period 1; Test A|Break from study holiday|0|||
170869611|NCT01514136|617534122|FG007|Test Period 1; Test A|Break from study holiday|0|||
170869612|NCT01514136|617534115|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
170869613|NCT01514136|617534116|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
170869614|NCT01514136|617534117|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
170869615|NCT01514136|617534118|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
170869616|NCT01514136|617534119|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
170869617|NCT01514136|617534120|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
170869618|NCT01514136|617534121|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
170869619|NCT01514136|617534122|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
170869620|NCT01514136|617534115|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
170869621|NCT01514136|617534116|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
170869622|NCT01514136|617534117|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
170869623|NCT01514136|617534118|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
170869624|NCT01514136|617534119|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
170869625|NCT01514136|617534120|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
170869626|NCT01514136|617534121|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
170869627|NCT01514136|617534122|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
170869628|NCT01514136|617534115|FG000|Test Period 2; Test A*|Adverse Event|0|||
170869629|NCT01514136|617534116|FG001|Test Period 2; Test A*|Adverse Event|0|||
170869630|NCT01514136|617534117|FG002|Test Period 2; Test A*|Adverse Event|0|||
170869631|NCT01514136|617534118|FG003|Test Period 2; Test A*|Adverse Event|0|||
170869632|NCT01514136|617534119|FG004|Test Period 2; Test A*|Adverse Event|1|||
170869633|NCT01514136|617534120|FG005|Test Period 2; Test A*|Adverse Event|0|||
170869634|NCT01514136|617534121|FG006|Test Period 2; Test A*|Adverse Event|0|||
170869635|NCT01514136|617534122|FG007|Test Period 2; Test A*|Adverse Event|0|||
170869636|NCT01514136|617534115|FG000|Test Period 2; Test A*|Holiday|0|||
170869637|NCT01514136|617534116|FG001|Test Period 2; Test A*|Holiday|0|||
170869638|NCT01514136|617534117|FG002|Test Period 2; Test A*|Holiday|0|||
170869639|NCT01514136|617534118|FG003|Test Period 2; Test A*|Holiday|0|||
170869640|NCT01514136|617534119|FG004|Test Period 2; Test A*|Holiday|1|||
170869641|NCT01514136|617534120|FG005|Test Period 2; Test A*|Holiday|0|||
170869642|NCT01514136|617534121|FG006|Test Period 2; Test A*|Holiday|0|||
170869643|NCT01514136|617534122|FG007|Test Period 2; Test A*|Holiday|0|||
170869644|NCT01514136|617534115|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
170869645|NCT01514136|617534116|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
170869646|NCT01514136|617534117|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
170869647|NCT01514136|617534118|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
170869648|NCT01514136|617534119|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
170869649|NCT01514136|617534120|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
170869650|NCT01514136|617534121|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
170869651|NCT01514136|617534122|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
170869652|NCT01514136|617534115|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
170767427|NCT02020616|617153902|FG000|Overall Study|Randomized in Error|0|||
170767428|NCT02020616|617153903|FG001|Overall Study|Randomized in Error|0|||
170767429|NCT02020616|617153904|FG002|Overall Study|Randomized in Error|0|||
170767430|NCT02020616|617153905|FG003|Overall Study|Randomized in Error|1|||
170767431|NCT02020616|617153906|FG004|Overall Study|Randomized in Error|0|||
170767432|NCT02020616|617153907|FG005|Overall Study|Randomized in Error|0|||
170767433|NCT02020616|617153908|FG006|Overall Study|Randomized in Error|0|||
170767434|NCT02020616|617153902|FG000|Overall Study|Lack of Efficacy|0|||
170767435|NCT02020616|617153903|FG001|Overall Study|Lack of Efficacy|0|||
170767436|NCT02020616|617153904|FG002|Overall Study|Lack of Efficacy|0|||
170767437|NCT02020616|617153905|FG003|Overall Study|Lack of Efficacy|0|||
170869653|NCT01514136|617534116|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
170869654|NCT01514136|617534117|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
170869655|NCT01514136|617534118|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
170869656|NCT01514136|617534119|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
170767438|NCT02020616|617153906|FG004|Overall Study|Lack of Efficacy|1|||
170869657|NCT01514136|617534120|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
170869658|NCT01514136|617534121|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
170869659|NCT01514136|617534122|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
170869660|NCT01514136|617534115|FG000|Test Period 2; Test C*|holiday|0|||
170869661|NCT01514136|617534116|FG001|Test Period 2; Test C*|holiday|0|||
170869662|NCT01514136|617534117|FG002|Test Period 2; Test C*|holiday|0|||
170869663|NCT01514136|617534118|FG003|Test Period 2; Test C*|holiday|0|||
170869664|NCT01514136|617534119|FG004|Test Period 2; Test C*|holiday|0|||
170869665|NCT01514136|617534120|FG005|Test Period 2; Test C*|holiday|0|||
170767439|NCT02020616|617153907|FG005|Overall Study|Lack of Efficacy|0|||
170869666|NCT01514136|617534121|FG006|Test Period 2; Test C*|holiday|1|||
170869667|NCT01514136|617534122|FG007|Test Period 2; Test C*|holiday|0|||
170869668|NCT01514136|617534115|FG000|Test Period 2; Test C*|Protocol Violation|0|||
170869669|NCT01514136|617534116|FG001|Test Period 2; Test C*|Protocol Violation|0|||
170869670|NCT01514136|617534117|FG002|Test Period 2; Test C*|Protocol Violation|0|||
170869671|NCT01514136|617534118|FG003|Test Period 2; Test C*|Protocol Violation|0|||
170869672|NCT01514136|617534119|FG004|Test Period 2; Test C*|Protocol Violation|0|||
170869673|NCT01514136|617534120|FG005|Test Period 2; Test C*|Protocol Violation|0|||
170869674|NCT01514136|617534121|FG006|Test Period 2; Test C*|Protocol Violation|1|||
170869675|NCT01514136|617534122|FG007|Test Period 2; Test C*|Protocol Violation|0|||
170869676|NCT00888381|617534123|FG000|Overall Study|Lost to Follow-up|0|||
170869677|NCT00888381|617534124|FG001|Overall Study|Lost to Follow-up|1|||
170869678|NCT01245387|617534125|FG000|Overall Study|Lost to Follow-up|106|||
170869679|NCT01245387|617534125|FG000|Overall Study|Lack of Efficacy|195|||
170869680|NCT01245387|617534125|FG000|Overall Study|Adverse Event|9|||
170869681|NCT01245387|617534125|FG000|Overall Study|Death|3|||
170869682|NCT01245387|617534125|FG000|Overall Study|Other|131|||
170869683|NCT01245387|617534125|FG000|Overall Study|Missing discontinuation status|369|||
170869684|NCT04513665|617534126|FG000|Overall Study|Adverse Event|2|||
170869685|NCT04513665|617534127|FG001|Overall Study|Adverse Event|0|||
170869686|NCT04513665|617534126|FG000|Overall Study|Lack of Efficacy|14|||
170869687|NCT04513665|617534127|FG001|Overall Study|Lack of Efficacy|0|||
170869688|NCT02014740|617534128|FG000|Overall Study|Lost to Follow-up|4|||
170869689|NCT02014740|617534129|FG001|Overall Study|Lost to Follow-up|4|||
170767440|NCT02020616|617153908|FG006|Overall Study|Lack of Efficacy|0|||
170767441|NCT05019729|617153909|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
170767442|NCT05019729|617153910|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
170767443|NCT05019729|617153911|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
170767444|NCT05019729|617153912|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
170767445|NCT05019729|617153913|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
170767446|NCT05019729|617153914|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
170767447|NCT03008915|617153919|FG000|Treatment 1|Withdrawal by Subject|0|||
170767448|NCT03008915|617153920|FG001|Treatment 1|Withdrawal by Subject|1|||
170767449|NCT01264718|617153921|FG000|Overall Study|Lost to Follow-up|3|||
170767450|NCT01264718|617153922|FG001|Overall Study|Lost to Follow-up|2|||
170767451|NCT01264718|617153921|FG000|Overall Study|Withdrawal by Subject|9|||
170411989|NCT03843359|615847263|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170411990|NCT03843359|615847264|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
170411991|NCT03843359|615847265|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170411992|NCT03843359|615847266|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
170411993|NCT03843359|615847267|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170411994|NCT03843359|615847268|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170767452|NCT01264718|617153922|FG001|Overall Study|Withdrawal by Subject|15|||
170767453|NCT01264718|617153921|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
170767454|NCT01264718|617153922|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
170767455|NCT03538054|617153927|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
170767456|NCT03538054|617153927|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
170869690|NCT02014740|617534128|FG000|Overall Study|Withdrawal by Subject|2|||
170869691|NCT02014740|617534129|FG001|Overall Study|Withdrawal by Subject|1|||
170869692|NCT00544648|617534130|FG000|Overall Study|Withdrawal by Subject|1|||
170869693|NCT00544648|617534131|FG001|Overall Study|Withdrawal by Subject|0|||
170869694|NCT00544648|617534130|FG000|Overall Study|Adverse Event|1|||
170869695|NCT00544648|617534131|FG001|Overall Study|Adverse Event|1|||
170869696|NCT00544648|617534130|FG000|Overall Study|progression of disease|1|||
170869697|NCT00544648|617534131|FG001|Overall Study|progression of disease|0|||
170869698|NCT00999713|617534132|FG000|Overall Study|Physician Decision|2|||
170869699|NCT00999713|617534133|FG001|Overall Study|Physician Decision|0|||
170869700|NCT03346057|617534135|FG000|Overall Study|Death|1|||
170411995|NCT03843359|615847269|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170411996|NCT03843359|615847270|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170411997|NCT03843359|615847271|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170411998|NCT03843359|615847272|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170411999|NCT03843359|615847273|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170412000|NCT03843359|615847274|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170412001|NCT03843359|615847275|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170632174|NCT01134055|616664541|FG002|Overall Study|Physician Decision|0|||
170869701|NCT03346057|617534136|FG001|Overall Study|Death|2|||
170869702|NCT03346057|617534137|FG002|Overall Study|Death|0|||
170869703|NCT03346057|617534138|FG003|Overall Study|Death|0|||
170869704|NCT03346057|617534135|FG000|Overall Study|Lost to Follow-up|0|||
170869705|NCT03346057|617534136|FG001|Overall Study|Lost to Follow-up|2|||
170869706|NCT03346057|617534137|FG002|Overall Study|Lost to Follow-up|1|||
170869707|NCT03346057|617534138|FG003|Overall Study|Lost to Follow-up|0|||
170869708|NCT03346057|617534135|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
170869709|NCT03346057|617534136|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
170522139|NCT01022203|616258067|FG001|Post Treatment Assessment|Physician Decision|0|||
170869710|NCT03346057|617534137|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
170869711|NCT03346057|617534138|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
170869712|NCT03346057|617534135|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
170869713|NCT03346057|617534136|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
170869714|NCT03346057|617534137|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
170869715|NCT03346057|617534138|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
170869716|NCT03346057|617534135|FG000|Overall Study|Physician Decision|3|||
170869717|NCT03346057|617534136|FG001|Overall Study|Physician Decision|2|||
170869718|NCT03346057|617534137|FG002|Overall Study|Physician Decision|0|||
170869719|NCT03346057|617534138|FG003|Overall Study|Physician Decision|2|||
170869720|NCT03346057|617534135|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
170869721|NCT03346057|617534136|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
170869722|NCT03346057|617534137|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
170869723|NCT03346057|617534138|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
170869724|NCT03346057|617534135|FG000|Overall Study|Withdrawal by Subject|1|||
170869725|NCT03346057|617534136|FG001|Overall Study|Withdrawal by Subject|0|||
170869726|NCT03346057|617534137|FG002|Overall Study|Withdrawal by Subject|0|||
170869727|NCT03346057|617534138|FG003|Overall Study|Withdrawal by Subject|0|||
170869728|NCT02921269|617534139|FG000|Overall Study|Did not complete DLT period|1|||
170869729|NCT00387764|617534141|FG000|Overall Study|Adverse Event|12|||
170869730|NCT00387764|617534141|FG000|Overall Study|Withdrawal by Subject|8|||
170869731|NCT00387764|617534141|FG000|Overall Study|Sponsor Terminated Study|1|||
170869732|NCT00387764|617534141|FG000|Overall Study|Physician Decision|1|||
170869733|NCT00387764|617534141|FG000|Overall Study|Other|2|||
170869734|NCT00387764|617534141|FG000|Overall Study|Death|7|||
170869735|NCT02966223|617534144|FG000|Overall Study|Physician Decision|3|||
170869736|NCT02966223|617534144|FG000|Overall Study|Withdrawal by Subject|11|||
170869737|NCT02966223|617534144|FG000|Overall Study|Lost to Follow-up|1|||
170869738|NCT01184053|617534145|FG000|Overall Study|progression while on treatment|3|||
170869739|NCT04399122|617534146|FG000|Overall Study|Lost to Follow-up|2|||
170869740|NCT04399122|617534147|FG001|Overall Study|Lost to Follow-up|0|||
170869741|NCT04399122|617534146|FG000|Overall Study|Withdrawal by Subject|1|||
170869742|NCT04399122|617534147|FG001|Overall Study|Withdrawal by Subject|0|||
170869743|NCT01174238|617534151|FG000|Overall Study|Lost to Follow-up|2|||
170869744|NCT02301936|617534152|FG000|Overall Study|Lost to Follow-up|1|||
170869745|NCT02301936|617534153|FG001|Overall Study|Lost to Follow-up|0|||
170869746|NCT03065023|617534156|FG000|Overall Study|Progressive Disease|0|||
170869747|NCT03065023|617534157|FG001|Overall Study|Progressive Disease|1|||
170869748|NCT03065023|617534158|FG002|Overall Study|Progressive Disease|0|||
170869749|NCT03065023|617534159|FG003|Overall Study|Progressive Disease|0|||
170869750|NCT03065023|617534160|FG004|Overall Study|Progressive Disease|0|||
170869751|NCT03065023|617534156|FG000|Overall Study|Death|2|||
170522140|NCT01022203|616258066|FG000|Post Treatment Assessment|Adverse Event|0|||
170522141|NCT01022203|616258067|FG001|Post Treatment Assessment|Adverse Event|2|||
170522142|NCT01022203|616258066|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
170522143|NCT01022203|616258067|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
170522144|NCT03163446|616258070|FG000|Overall Study|Unable to return for Day 180 visit|2|||
170522145|NCT03163446|616258071|FG001|Overall Study|Unable to return for Day 180 visit|0|||
170522146|NCT03163446|616258070|FG000|Overall Study|Withdrawal by Subject|2|||
170522147|NCT03163446|616258071|FG001|Overall Study|Withdrawal by Subject|6|||
170522148|NCT03163446|616258070|FG000|Overall Study|Death|16|||
170522149|NCT03163446|616258071|FG001|Overall Study|Death|5|||
170522150|NCT03163446|616258070|FG000|Overall Study|Lost to Follow-up|6|||
170869752|NCT03065023|617534157|FG001|Overall Study|Death|0|||
170869753|NCT03065023|617534158|FG002|Overall Study|Death|1|||
170869754|NCT03065023|617534159|FG003|Overall Study|Death|1|||
170522151|NCT03163446|616258071|FG001|Overall Study|Lost to Follow-up|5|||
170522152|NCT03163446|616258070|FG000|Overall Study|Physician Decision|1|||
170869755|NCT03065023|617534160|FG004|Overall Study|Death|0|||
170869756|NCT03065023|617534156|FG000|Overall Study|Lost to Follow-up|0|||
170869757|NCT03065023|617534157|FG001|Overall Study|Lost to Follow-up|1|||
170869758|NCT03065023|617534158|FG002|Overall Study|Lost to Follow-up|0|||
170869759|NCT03065023|617534159|FG003|Overall Study|Lost to Follow-up|0|||
170869760|NCT03065023|617534160|FG004|Overall Study|Lost to Follow-up|0|||
170522153|NCT03163446|616258071|FG001|Overall Study|Physician Decision|1|||
170869761|NCT03065023|617534156|FG000|Overall Study|Participant Decision|0|||
170869762|NCT03065023|617534157|FG001|Overall Study|Participant Decision|0|||
170869763|NCT03065023|617534158|FG002|Overall Study|Participant Decision|0|||
170869764|NCT03065023|617534159|FG003|Overall Study|Participant Decision|1|||
170869765|NCT03065023|617534160|FG004|Overall Study|Participant Decision|0|||
170869766|NCT03065023|617534156|FG000|Overall Study|Withdrawal by Subject|0|||
170869767|NCT03065023|617534157|FG001|Overall Study|Withdrawal by Subject|0|||
170869768|NCT03065023|617534158|FG002|Overall Study|Withdrawal by Subject|0|||
170869769|NCT03065023|617534159|FG003|Overall Study|Withdrawal by Subject|1|||
170869770|NCT03065023|617534160|FG004|Overall Study|Withdrawal by Subject|0|||
170869771|NCT00705432|617534161|FG000|Treatment Period|Adverse Event|45|||
170869772|NCT00705432|617534162|FG001|Treatment Period|Adverse Event|37|||
170869773|NCT00705432|617534163|FG002|Treatment Period|Adverse Event|51|||
170869774|NCT00705432|617534164|FG003|Treatment Period|Adverse Event|12|||
170869775|NCT00705432|617534165|FG004|Treatment Period|Adverse Event|8|||
170869776|NCT00705432|617534166|FG005|Treatment Period|Adverse Event|9|||
170869777|NCT00705432|617534161|FG000|Treatment Period|Treatment failure|92|||
170869778|NCT00705432|617534162|FG001|Treatment Period|Treatment failure|42|||
170869779|NCT00705432|617534163|FG002|Treatment Period|Treatment failure|33|||
170869780|NCT00705432|617534164|FG003|Treatment Period|Treatment failure|25|||
170869781|NCT00705432|617534165|FG004|Treatment Period|Treatment failure|13|||
170869782|NCT00705432|617534166|FG005|Treatment Period|Treatment failure|14|||
170869783|NCT00705432|617534161|FG000|Treatment Period|Non medical reason|26|||
170869784|NCT00705432|617534162|FG001|Treatment Period|Non medical reason|32|||
170869785|NCT00705432|617534163|FG002|Treatment Period|Non medical reason|37|||
170869786|NCT00705432|617534164|FG003|Treatment Period|Non medical reason|4|||
170869787|NCT00705432|617534165|FG004|Treatment Period|Non medical reason|7|||
170869788|NCT00705432|617534166|FG005|Treatment Period|Non medical reason|7|||
170869789|NCT00705432|617534161|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
170869790|NCT00705432|617534162|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
170869791|NCT00705432|617534163|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
170869792|NCT00705432|617534164|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
170869793|NCT00705432|617534165|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
170869794|NCT00705432|617534166|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
170869795|NCT00705432|617534161|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
170869796|NCT00705432|617534162|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
170869797|NCT00705432|617534163|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
170869798|NCT00705432|617534164|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
170869799|NCT00705432|617534165|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
170869800|NCT00705432|617534166|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
170869801|NCT01667107|617534167|FG000|Overall Study|Adverse Event|4|||
170869802|NCT01667107|617534168|FG001|Overall Study|Adverse Event|3|||
170869803|NCT01667107|617534167|FG000|Overall Study|Tolerability issues|0|||
170869804|NCT01667107|617534168|FG001|Overall Study|Tolerability issues|2|||
170869805|NCT01667107|617534167|FG000|Overall Study|Protocol Violation|0|||
170869806|NCT01667107|617534168|FG001|Overall Study|Protocol Violation|1|||
170869807|NCT01667107|617534167|FG000|Overall Study|Lack of Efficacy|0|||
170869808|NCT01667107|617534168|FG001|Overall Study|Lack of Efficacy|1|||
170869809|NCT00232141|617534172|FG000|Overall Study|Adverse Event|9|||
170869810|NCT00232141|617534173|FG001|Overall Study|Adverse Event|4|||
170869811|NCT00232141|617534172|FG000|Overall Study|Lack of Efficacy|0|||
170869812|NCT00232141|617534173|FG001|Overall Study|Lack of Efficacy|3|||
170869813|NCT00232141|617534172|FG000|Overall Study|Lost to Follow-up|9|||
170869814|NCT00232141|617534173|FG001|Overall Study|Lost to Follow-up|6|||
170869815|NCT00232141|617534172|FG000|Overall Study|Other|8|||
170869816|NCT00232141|617534173|FG001|Overall Study|Other|10|||
170869817|NCT00232141|617534172|FG000|Overall Study|Withdrawal by Subject|5|||
170869818|NCT00232141|617534173|FG001|Overall Study|Withdrawal by Subject|3|||
170869819|NCT02129205|617534177|FG000|Overall Study|Withdrawal by Subject|0|||
170869820|NCT02129205|617534178|FG001|Overall Study|Withdrawal by Subject|0|||
170632175|NCT01134055|616664542|FG003|Overall Study|Physician Decision|0|||
170522154|NCT03163446|616258070|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
170869821|NCT02129205|617534179|FG002|Overall Study|Withdrawal by Subject|0|||
170869822|NCT02129205|617534180|FG003|Overall Study|Withdrawal by Subject|0|||
170869823|NCT02129205|617534181|FG004|Overall Study|Withdrawal by Subject|1|||
170869824|NCT02129205|617534182|FG005|Overall Study|Withdrawal by Subject|1|||
170869825|NCT02129205|617534183|FG006|Overall Study|Withdrawal by Subject|1|||
170869826|NCT02129205|617534184|FG007|Overall Study|Withdrawal by Subject|0|||
170869827|NCT02129205|617534185|FG008|Overall Study|Withdrawal by Subject|1|||
170869828|NCT02129205|617534186|FG009|Overall Study|Withdrawal by Subject|0|||
170869829|NCT02129205|617534177|FG000|Overall Study|Other|1|||
170869830|NCT02129205|617534178|FG001|Overall Study|Other|0|||
170869831|NCT02129205|617534179|FG002|Overall Study|Other|0|||
170869832|NCT02129205|617534180|FG003|Overall Study|Other|0|||
170869833|NCT02129205|617534181|FG004|Overall Study|Other|2|||
170869834|NCT02129205|617534182|FG005|Overall Study|Other|3|||
170869835|NCT02129205|617534183|FG006|Overall Study|Other|3|||
170869836|NCT02129205|617534184|FG007|Overall Study|Other|2|||
170869837|NCT02129205|617534185|FG008|Overall Study|Other|1|||
170869838|NCT02129205|617534186|FG009|Overall Study|Other|0|||
170869839|NCT01479829|617534189|FG000|Overall Study|Withdrawal by Subject|8|||
170869840|NCT01479829|617534190|FG001|Overall Study|Withdrawal by Subject|10|||
170869841|NCT02877927|617534191|FG000|Overall Study|Adverse Event|1|||
170869842|NCT02877927|617534192|FG001|Overall Study|Adverse Event|0|||
170869843|NCT02877927|617534191|FG000|Overall Study|Lost to Follow-up|37|||
170869844|NCT02877927|617534192|FG001|Overall Study|Lost to Follow-up|38|||
170869845|NCT02877927|617534191|FG000|Overall Study|Withdrawal by Subject|11|||
170869846|NCT02877927|617534192|FG001|Overall Study|Withdrawal by Subject|12|||
170869847|NCT02877927|617534191|FG000|Overall Study|Physician Decision|0|||
170869848|NCT02877927|617534192|FG001|Overall Study|Physician Decision|1|||
170869849|NCT02877927|617534191|FG000|Overall Study|Missed EOT/PTE Visit|5|||
170869850|NCT02877927|617534192|FG001|Overall Study|Missed EOT/PTE Visit|6|||
170869851|NCT02142738|617535619|FG000|Overall Study|Adverse Event|13|||
170869852|NCT02142738|617535620|FG001|Overall Study|Adverse Event|9|||
170869853|NCT02142738|617535619|FG000|Overall Study|Death|92|||
170869854|NCT02142738|617535620|FG001|Overall Study|Death|112|||
170869855|NCT02142738|617535619|FG000|Overall Study|Lost to Follow-up|0|||
170869856|NCT02142738|617535620|FG001|Overall Study|Lost to Follow-up|3|||
170869857|NCT02142738|617535619|FG000|Overall Study|Withdrawal by Subject|6|||
170869858|NCT02142738|617535620|FG001|Overall Study|Withdrawal by Subject|7|||
170869859|NCT02142738|617535619|FG000|Overall Study|Follow up ended by sponsor|43|||
170869860|NCT02142738|617535620|FG001|Overall Study|Follow up ended by sponsor|20|||
170869861|NCT00659529|617535623|FG000|Overall Study|Withdrawal by Subject|4|||
170869862|NCT00659529|617535623|FG000|Overall Study|Protocol Violation|3|||
170869863|NCT00659529|617535623|FG000|Overall Study|Screen failure|9|||
170869864|NCT00621751|617535624|FG000|Overall Study|Adverse Event|0|||
170869865|NCT00621751|617535625|FG001|Overall Study|Adverse Event|1|||
170869866|NCT00832117|617535628|FG000|Overall Study|Death|1|||
170869867|NCT00832117|617535628|FG000|Overall Study|Disease Progression|11|||
170869868|NCT04439071|617535629|FG000|Overall Study|Lost to Follow-up|0|||
170869869|NCT04439071|617535630|FG001|Overall Study|Lost to Follow-up|3|||
170869870|NCT04439071|617535629|FG000|Overall Study|Withdrawal by Subject|3|||
170869871|NCT04439071|617535630|FG001|Overall Study|Withdrawal by Subject|8|||
170869872|NCT04439071|617535629|FG000|Overall Study|Death|6|||
170869873|NCT04439071|617535630|FG001|Overall Study|Death|4|||
170869874|NCT04439071|617535629|FG000|Overall Study|Other than specified|3|||
170869875|NCT04439071|617535630|FG001|Overall Study|Other than specified|3|||
170869876|NCT04439071|617535629|FG000|Overall Study|Randomized but not treated|2|||
170869877|NCT04439071|617535630|FG001|Overall Study|Randomized but not treated|0|||
170869878|NCT00892177|617535631|FG000|Phase II|Ineligible|0|||
170869879|NCT00892177|617535632|FG001|Phase II|Ineligible|0|||
170869880|NCT00892177|617535633|FG002|Phase II|Ineligible|0|||
170869881|NCT00892177|617535634|FG003|Phase II|Ineligible|0|||
170869882|NCT00892177|617535635|FG004|Phase II|Ineligible|1|||
170869883|NCT00892177|617535636|FG005|Phase II|Ineligible|1|||
170869884|NCT00892177|617535631|FG000|Phase II|Withdrawal by Subject|0|||
170869885|NCT00892177|617535632|FG001|Phase II|Withdrawal by Subject|0|||
170869886|NCT00892177|617535633|FG002|Phase II|Withdrawal by Subject|0|||
170869887|NCT00892177|617535634|FG003|Phase II|Withdrawal by Subject|0|||
170869888|NCT00892177|617535635|FG004|Phase II|Withdrawal by Subject|4|||
170869889|NCT00892177|617535636|FG005|Phase II|Withdrawal by Subject|1|||
170869890|NCT03583450|617535637|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
170869891|NCT03583450|617535638|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
170869892|NCT01446016|617535639|FG000|Overall Study|Lost to Follow-up|3|||
170869893|NCT01446016|617535639|FG000|Overall Study|Withdrawal by Subject|1|||
170869894|NCT01446016|617535639|FG000|Overall Study|Toxicity|3|||
170869895|NCT00404066|617535640|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
170869896|NCT00404066|617535640|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
170869897|NCT01372150|617535641|FG000|Overall Study|Lack of Efficacy|3|||
170869898|NCT01372150|617535642|FG001|Overall Study|Lack of Efficacy|0|||
170869899|NCT01372150|617535643|FG002|Overall Study|Lack of Efficacy|1|||
170869900|NCT01372150|617535641|FG000|Overall Study|Lost to Follow-up|4|||
170869901|NCT01372150|617535642|FG001|Overall Study|Lost to Follow-up|5|||
170869902|NCT01372150|617535643|FG002|Overall Study|Lost to Follow-up|6|||
170869903|NCT01372150|617535641|FG000|Overall Study|Protocol Violation|1|||
170869904|NCT01372150|617535642|FG001|Overall Study|Protocol Violation|0|||
170869905|NCT01372150|617535643|FG002|Overall Study|Protocol Violation|3|||
170869906|NCT01372150|617535641|FG000|Overall Study|Withdrawal by Subject|2|||
170869907|NCT01372150|617535642|FG001|Overall Study|Withdrawal by Subject|7|||
170869908|NCT01372150|617535643|FG002|Overall Study|Withdrawal by Subject|2|||
170869909|NCT01372150|617535641|FG000|Overall Study|Other|1|||
170869910|NCT01372150|617535642|FG001|Overall Study|Other|0|||
170869911|NCT01372150|617535643|FG002|Overall Study|Other|2|||
170869912|NCT01372150|617535641|FG000|Overall Study|Adverse Event|2|||
170869913|NCT01372150|617535642|FG001|Overall Study|Adverse Event|1|||
170869914|NCT01372150|617535643|FG002|Overall Study|Adverse Event|2|||
170869915|NCT01372150|617535641|FG000|Overall Study|Randomized but not treated|0|||
170869916|NCT01372150|617535642|FG001|Overall Study|Randomized but not treated|1|||
170869917|NCT01372150|617535643|FG002|Overall Study|Randomized but not treated|0|||
170869918|NCT00823823|617535644|FG000|Overall Study|Lost to Follow-up|3|||
170869919|NCT00823823|617535645|FG001|Overall Study|Lost to Follow-up|1|||
170869920|NCT00823823|617535644|FG000|Overall Study|Protocol Violation|5|||
170869921|NCT00823823|617535645|FG001|Overall Study|Protocol Violation|5|||
170869922|NCT01835015|617535646|FG000|Overall Study|Adverse Event|0|||
170869923|NCT01835015|617535647|FG001|Overall Study|Adverse Event|0|||
170869924|NCT01835015|617535648|FG002|Overall Study|Adverse Event|1|||
170869925|NCT01835015|617535649|FG003|Overall Study|Adverse Event|0|||
170869926|NCT01835015|617535650|FG004|Overall Study|Adverse Event|0|||
170869927|NCT03781323|617535651|FG000|Overall Study|Withdrawal by Subject|1|||
170869928|NCT01338415|617535652|FG000|Core + Extension|Adverse Event|8|||
170869929|NCT01338415|617535653|FG001|Core + Extension|Adverse Event|6|||
170869930|NCT01338415|617535654|FG002|Core + Extension|Adverse Event|0|||
170869931|NCT01338415|617535652|FG000|Core + Extension|Withdrawal by Subject|1|||
170869932|NCT01338415|617535653|FG001|Core + Extension|Withdrawal by Subject|1|||
170869933|NCT01338415|617535654|FG002|Core + Extension|Withdrawal by Subject|0|||
170869934|NCT01338415|617535652|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
170869935|NCT01338415|617535653|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
170869936|NCT01338415|617535654|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
170869937|NCT01338415|617535652|FG000|Core + Extension|Other (administrative reason)|1|||
170869938|NCT01338415|617535653|FG001|Core + Extension|Other (administrative reason)|0|||
170869939|NCT01338415|617535654|FG002|Core + Extension|Other (administrative reason)|0|||
170869940|NCT01338415|617535652|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
170869941|NCT01338415|617535653|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
170869942|NCT01338415|617535654|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
170869943|NCT01338415|617535652|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
170869944|NCT01338415|617535653|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
170869945|NCT01338415|617535654|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
170869946|NCT01338415|617535652|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
170869947|NCT01338415|617535653|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
170869948|NCT01338415|617535654|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
170869949|NCT01338415|617535652|FG000|Exceptional Use Treatment Period|Death|0|||
170869950|NCT01338415|617535653|FG001|Exceptional Use Treatment Period|Death|0|||
170869951|NCT01338415|617535654|FG002|Exceptional Use Treatment Period|Death|1|||
170869952|NCT05395104|617535661|FG000|Overall Study|Met Liver Stopping Criteria|1|||
170869953|NCT05395104|617535661|FG000|Overall Study|Withdrawal by Subject|1|||
170869954|NCT02448225|617535662|FG000|Overall Study|Withdrawal by Subject|1|||
170869955|NCT02448225|617535662|FG000|Overall Study|Did not get FSPG scan|18|||
170869956|NCT02448225|617535662|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
170869957|NCT04422990|617535669|FG000|Overall Study|Withdrawal by Subject|0|||
170869958|NCT04422990|617535670|FG001|Overall Study|Withdrawal by Subject|1|||
170869959|NCT04422990|617535669|FG000|Overall Study|Travel|3|||
170869960|NCT04422990|617535670|FG001|Overall Study|Travel|0|||
170869961|NCT02486653|617535676|FG000|Overall Study|Withdrawal by Subject|1|||
170869962|NCT02486653|617535677|FG001|Overall Study|Withdrawal by Subject|3|||
170869963|NCT02486653|617535676|FG000|Overall Study|Protocol Violation|1|||
170869964|NCT02486653|617535677|FG001|Overall Study|Protocol Violation|0|||
170869965|NCT02486653|617535676|FG000|Overall Study|surgery cancelled|4|||
170869966|NCT02486653|617535677|FG001|Overall Study|surgery cancelled|1|||
170869967|NCT05372653|617535678|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
170869968|NCT05372653|617535679|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
170869969|NCT05372653|617535678|FG000|Overall Study|Adverse Event|0|||
170869970|NCT05372653|617535679|FG001|Overall Study|Adverse Event|1|||
170869971|NCT03740997|617535685|FG000|Overall Study|Withdrawal by Subject|1|||
170869972|NCT03740997|617535686|FG001|Overall Study|Withdrawal by Subject|0|||
170869973|NCT03740997|617535685|FG000|Overall Study|Participant was unable to complete study procedures|1|||
170869974|NCT03740997|617535686|FG001|Overall Study|Participant was unable to complete study procedures|0|||
170869975|NCT01829425|617535689|FG000|Overall Study|Withdrawal by Subject|4|||
170869976|NCT01829425|617535690|FG001|Overall Study|Withdrawal by Subject|3|||
170412002|NCT03843359|615847276|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170412003|NCT03843359|615847277|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170412004|NCT03843359|615847262|FG000|Crossover|Withdrawal by Subject|0|||
170412005|NCT03843359|615847263|FG001|Crossover|Withdrawal by Subject|0|||
170412006|NCT03843359|615847264|FG002|Crossover|Withdrawal by Subject|0|||
170412007|NCT03843359|615847265|FG003|Crossover|Withdrawal by Subject|0|||
170412008|NCT03843359|615847266|FG004|Crossover|Withdrawal by Subject|0|||
170522155|NCT03163446|616258071|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
170522156|NCT03638128|616258072|FG000|Overall Study|Withdrawal by Subject|1|||
170869977|NCT01829425|617535689|FG000|Overall Study|Lost to Follow-up|2|||
170869978|NCT01829425|617535690|FG001|Overall Study|Lost to Follow-up|1|||
170869979|NCT01020448|617535691|FG000|Pre-assignment|Adverse Event|6|||
170869980|NCT01020448|617535691|FG000|Pre-assignment|Withdrawal by Subject|5|||
170522157|NCT03638128|616258073|FG001|Overall Study|Withdrawal by Subject|7|||
170412009|NCT03843359|615847267|FG005|Crossover|Withdrawal by Subject|0|||
170522158|NCT03638128|616258074|FG002|Overall Study|Withdrawal by Subject|6|||
170412010|NCT03843359|615847268|FG006|Crossover|Withdrawal by Subject|0|||
170412011|NCT03843359|615847269|FG007|Crossover|Withdrawal by Subject|0|||
170412012|NCT03843359|615847270|FG008|Crossover|Withdrawal by Subject|0|||
170412013|NCT03843359|615847271|FG009|Crossover|Withdrawal by Subject|0|||
170869981|NCT01020448|617535691|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
170869982|NCT01020448|617535691|FG000|Treatment|Adverse Event|11|||
170869983|NCT01020448|617535691|FG000|Treatment|Consent Withdrawn|3|||
170869984|NCT01020448|617535691|FG000|Treatment|Disease Progression|2|||
170869985|NCT01020448|617535691|FG000|Treatment|Lack of Efficacy|8|||
170869986|NCT01020448|617535691|FG000|Treatment|Lost to Follow-up|2|||
170869987|NCT00800683|617535692|FG000|Overall Study|Adverse Event|11|||
170869988|NCT00800683|617535693|FG001|Overall Study|Adverse Event|8|||
170869989|NCT00800683|617535692|FG000|Overall Study|Lost to Follow-up|3|||
170869990|NCT00800683|617535693|FG001|Overall Study|Lost to Follow-up|1|||
170869991|NCT00800683|617535692|FG000|Overall Study|Withdrawal by Subject|1|||
170869992|NCT00800683|617535693|FG001|Overall Study|Withdrawal by Subject|7|||
170869993|NCT00800683|617535692|FG000|Overall Study|Lack of Efficacy|1|||
170869994|NCT00800683|617535693|FG001|Overall Study|Lack of Efficacy|1|||
170869995|NCT00800683|617535692|FG000|Overall Study|Other|1|||
170869996|NCT00800683|617535693|FG001|Overall Study|Other|2|||
170869997|NCT01006265|617535694|FG000|Overall Study|Lost to Follow-up|1|||
170869998|NCT01006265|617535695|FG001|Overall Study|Lost to Follow-up|0|||
170869999|NCT01006265|617535696|FG002|Overall Study|Lost to Follow-up|1|||
170870000|NCT01006265|617535697|FG003|Overall Study|Lost to Follow-up|0|||
170870001|NCT01006265|617535694|FG000|Overall Study|Withdrawal by Subject|4|||
170870002|NCT01006265|617535695|FG001|Overall Study|Withdrawal by Subject|7|||
170870003|NCT01006265|617535696|FG002|Overall Study|Withdrawal by Subject|5|||
170870004|NCT01006265|617535697|FG003|Overall Study|Withdrawal by Subject|5|||
170870005|NCT01006265|617535694|FG000|Overall Study|Administrative reason|1|||
170870006|NCT01006265|617535695|FG001|Overall Study|Administrative reason|2|||
170870007|NCT01006265|617535696|FG002|Overall Study|Administrative reason|3|||
170870008|NCT01006265|617535697|FG003|Overall Study|Administrative reason|0|||
170870009|NCT01390272|617535698|FG000|Overall Study|Death|3|||
170870010|NCT01390272|617535699|FG001|Overall Study|Death|2|||
170870011|NCT01390272|617535698|FG000|Overall Study|Withdrawal by Subject|9|||
170870012|NCT01390272|617535699|FG001|Overall Study|Withdrawal by Subject|5|||
170870013|NCT01390272|617535698|FG000|Overall Study|Patient moved, no longer eligible|5|||
170870014|NCT01390272|617535699|FG001|Overall Study|Patient moved, no longer eligible|8|||
170870015|NCT01177384|617535700|FG000|Overall Study|Adverse Event|6|||
170870016|NCT01177384|617535701|FG001|Overall Study|Adverse Event|4|||
170870017|NCT01177384|617535700|FG000|Overall Study|Lack of Efficacy|0|||
170870018|NCT01177384|617535701|FG001|Overall Study|Lack of Efficacy|1|||
170870019|NCT01177384|617535700|FG000|Overall Study|Lost to Follow-up|3|||
170870020|NCT01177384|617535701|FG001|Overall Study|Lost to Follow-up|4|||
170870021|NCT01177384|617535700|FG000|Overall Study|Physician Decision|0|||
170870022|NCT01177384|617535701|FG001|Overall Study|Physician Decision|3|||
170870023|NCT01177384|617535700|FG000|Overall Study|Protocol Violation|0|||
170870024|NCT01177384|617535701|FG001|Overall Study|Protocol Violation|2|||
170870025|NCT01177384|617535700|FG000|Overall Study|Withdrawal by Subject|5|||
170870026|NCT01177384|617535701|FG001|Overall Study|Withdrawal by Subject|12|||
170870027|NCT00911625|617535704|FG000|Overall Study|Lost to Follow-up|7|||
170870028|NCT00911625|617535705|FG001|Overall Study|Lost to Follow-up|0|||
170870029|NCT01102803|617535710|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
170870030|NCT01102803|617535711|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
170870031|NCT01102803|617535710|FG000|Post to Follow-Up|Lost to Follow-up|1|||
170870032|NCT01102803|617535711|FG001|Post to Follow-Up|Lost to Follow-up|3|||
170870033|NCT01557348|617535712|FG000|Overall Study|Adverse Event|6|||
170870034|NCT01557348|617535713|FG001|Overall Study|Adverse Event|16|||
170870035|NCT01557348|617535712|FG000|Overall Study|Infusion reaction event|5|||
170870036|NCT01557348|617535713|FG001|Overall Study|Infusion reaction event|5|||
170870037|NCT01557348|617535712|FG000|Overall Study|Death|7|||
170870038|NCT01557348|617535713|FG001|Overall Study|Death|4|||
170870039|NCT01557348|617535712|FG000|Overall Study|Insufficient Therapeutic Response|13|||
170870040|NCT01557348|617535713|FG001|Overall Study|Insufficient Therapeutic Response|28|||
170870041|NCT01557348|617535712|FG000|Overall Study|Withdrawal by Subject|5|||
170412014|NCT03843359|615847272|FG010|Crossover|Withdrawal by Subject|0|||
170870042|NCT01557348|617535713|FG001|Overall Study|Withdrawal by Subject|4|||
170870043|NCT01557348|617535712|FG000|Overall Study|Lost to Follow-up|26|||
170870044|NCT01557348|617535713|FG001|Overall Study|Lost to Follow-up|22|||
170870045|NCT01557348|617535712|FG000|Overall Study|Administrative|18|||
170870046|NCT01557348|617535713|FG001|Overall Study|Administrative|11|||
170870047|NCT03427125|617535714|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
170870048|NCT03427125|617535715|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
170412015|NCT03843359|615847273|FG011|Crossover|Withdrawal by Subject|0|||
170870049|NCT03427125|617535716|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
170870050|NCT06132425|617535717|FG000|Overall Study|Withdrawal by Subject|3|||
170870051|NCT06132425|617535718|FG001|Overall Study|Withdrawal by Subject|0|||
170870052|NCT06132425|617535717|FG000|Overall Study|Did not follow study instructions|0|||
170870053|NCT06132425|617535718|FG001|Overall Study|Did not follow study instructions|2|||
170870054|NCT06132425|617535717|FG000|Overall Study|Lost to Follow-up|3|||
170870055|NCT06132425|617535718|FG001|Overall Study|Lost to Follow-up|5|||
170870056|NCT05975840|617535719|FG000|Overall Study|Other|1|||
170870057|NCT05975840|617535720|FG001|Overall Study|Other|0|||
170870058|NCT05975840|617535721|FG002|Overall Study|Other|0|||
170870059|NCT05975840|617535722|FG003|Overall Study|Other|0|||
170870060|NCT05975840|617535723|FG004|Overall Study|Other|1|||
170522159|NCT03638128|616258072|FG000|Overall Study|Sponsor Decision|15|||
170522160|NCT03638128|616258073|FG001|Overall Study|Sponsor Decision|12|||
170522161|NCT03638128|616258074|FG002|Overall Study|Sponsor Decision|19|||
170522162|NCT03638128|616258072|FG000|Overall Study|Lost to Follow-up|0|||
170522163|NCT03638128|616258073|FG001|Overall Study|Lost to Follow-up|0|||
170522164|NCT03638128|616258074|FG002|Overall Study|Lost to Follow-up|1|||
170522165|NCT00611806|616258075|FG000|Overall Study|Withdrawal by Subject|8|||
170522166|NCT00611806|616258076|FG001|Overall Study|Withdrawal by Subject|2|||
170522167|NCT00611806|616258075|FG000|Overall Study|Adverse Event|2|||
170522168|NCT00611806|616258076|FG001|Overall Study|Adverse Event|1|||
170522169|NCT00611806|616258075|FG000|Overall Study|Lost to Follow-up|6|||
170522170|NCT00611806|616258076|FG001|Overall Study|Lost to Follow-up|0|||
170522171|NCT00903201|616258078|FG000|Overall Study|Adverse Event|1|||
170522172|NCT00903201|616258079|FG001|Overall Study|Adverse Event|4|||
170522173|NCT00903201|616258080|FG002|Overall Study|Adverse Event|0|||
170522174|NCT00903201|616258078|FG000|Overall Study|Protocol Violation|2|||
170522175|NCT00903201|616258079|FG001|Overall Study|Protocol Violation|1|||
170522176|NCT00903201|616258080|FG002|Overall Study|Protocol Violation|0|||
170522177|NCT00903201|616258078|FG000|Overall Study|Lost to Follow-up|0|||
170522178|NCT00903201|616258079|FG001|Overall Study|Lost to Follow-up|1|||
170522179|NCT00903201|616258080|FG002|Overall Study|Lost to Follow-up|0|||
170522180|NCT00903201|616258078|FG000|Overall Study|Physician Decision|1|||
170522181|NCT00903201|616258079|FG001|Overall Study|Physician Decision|0|||
170522182|NCT00903201|616258080|FG002|Overall Study|Physician Decision|1|||
170522183|NCT00903201|616258078|FG000|Overall Study|Withdrawal by Subject|1|||
170522184|NCT00903201|616258079|FG001|Overall Study|Withdrawal by Subject|0|||
170522185|NCT00903201|616258080|FG002|Overall Study|Withdrawal by Subject|1|||
170522186|NCT01094288|616258081|FG000|Overall Study|Adverse Event|0|||
170522187|NCT01094288|616258082|FG001|Overall Study|Adverse Event|3|||
170522188|NCT01094288|616258083|FG002|Overall Study|Adverse Event|1|||
170522189|NCT01094288|616258084|FG003|Overall Study|Adverse Event|1|||
170522190|NCT01094288|616258085|FG004|Overall Study|Adverse Event|0|||
170522191|NCT01094288|616258086|FG005|Overall Study|Adverse Event|0|||
170522192|NCT01094288|616258087|FG006|Overall Study|Adverse Event|0|||
170522193|NCT01094288|616258088|FG007|Overall Study|Adverse Event|0|||
170522194|NCT01094288|616258081|FG000|Overall Study|Withdrawal by Subject|0|||
170522195|NCT01094288|616258082|FG001|Overall Study|Withdrawal by Subject|1|||
170522196|NCT01094288|616258083|FG002|Overall Study|Withdrawal by Subject|2|||
170522197|NCT01094288|616258084|FG003|Overall Study|Withdrawal by Subject|0|||
170522198|NCT01094288|616258085|FG004|Overall Study|Withdrawal by Subject|0|||
170522199|NCT01094288|616258086|FG005|Overall Study|Withdrawal by Subject|0|||
170522200|NCT01094288|616258087|FG006|Overall Study|Withdrawal by Subject|0|||
170522201|NCT01094288|616258088|FG007|Overall Study|Withdrawal by Subject|2|||
170522202|NCT01094288|616258081|FG000|Overall Study|Initiation of Alternative Therapy|0|||
170522203|NCT01094288|616258082|FG001|Overall Study|Initiation of Alternative Therapy|0|||
170522204|NCT01094288|616258083|FG002|Overall Study|Initiation of Alternative Therapy|1|||
170522205|NCT01094288|616258084|FG003|Overall Study|Initiation of Alternative Therapy|0|||
170522206|NCT01094288|616258085|FG004|Overall Study|Initiation of Alternative Therapy|0|||
170522207|NCT01094288|616258086|FG005|Overall Study|Initiation of Alternative Therapy|0|||
170522208|NCT01094288|616258087|FG006|Overall Study|Initiation of Alternative Therapy|0|||
170522209|NCT01094288|616258088|FG007|Overall Study|Initiation of Alternative Therapy|0|||
170870061|NCT05975840|617535724|FG005|Overall Study|Other|0|||
170522210|NCT01094288|616258081|FG000|Overall Study|Reason not Specified|2|||
170522211|NCT01094288|616258082|FG001|Overall Study|Reason not Specified|3|||
170522212|NCT01094288|616258083|FG002|Overall Study|Reason not Specified|0|||
170522213|NCT01094288|616258084|FG003|Overall Study|Reason not Specified|1|||
170522214|NCT01094288|616258085|FG004|Overall Study|Reason not Specified|0|||
170522215|NCT01094288|616258086|FG005|Overall Study|Reason not Specified|0|||
170522216|NCT01094288|616258087|FG006|Overall Study|Reason not Specified|0|||
170522217|NCT01094288|616258088|FG007|Overall Study|Reason not Specified|0|||
170522218|NCT01094288|616258081|FG000|Overall Study|Ongoing Participants|0|||
170870062|NCT05975840|617535725|FG006|Overall Study|Other|0|||
170870063|NCT05975840|617535726|FG007|Overall Study|Other|0|||
170870064|NCT05975840|617535719|FG000|Overall Study|Lost to Follow-up|3|||
170522219|NCT01094288|616258082|FG001|Overall Study|Ongoing Participants|3|||
170522220|NCT01094288|616258083|FG002|Overall Study|Ongoing Participants|0|||
170522221|NCT01094288|616258084|FG003|Overall Study|Ongoing Participants|0|||
170522222|NCT01094288|616258085|FG004|Overall Study|Ongoing Participants|0|||
170870065|NCT05975840|617535720|FG001|Overall Study|Lost to Follow-up|6|||
170767457|NCT03538054|617153927|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
170767458|NCT02351180|617153930|FG000|Overall Study|Withdrawal by Subject|1|||
170767459|NCT02351180|617153931|FG001|Overall Study|Withdrawal by Subject|0|||
170767460|NCT02317016|617153932|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
170767461|NCT02317016|617153932|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
170767462|NCT02317016|617153932|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
170767463|NCT02317016|617153932|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
170767464|NCT02317016|617153932|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
170767465|NCT02317016|617153932|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
170767466|NCT02317016|617153932|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
170767467|NCT01981356|617153933|FG000|Overall Study|Lost to Follow-up|4|||
170767468|NCT01981356|617153934|FG001|Overall Study|Lost to Follow-up|1|||
170767469|NCT01981356|617153933|FG000|Overall Study|Withdrawal by Subject|1|||
170767470|NCT01981356|617153934|FG001|Overall Study|Withdrawal by Subject|1|||
170767471|NCT01981356|617153933|FG000|Overall Study|Protocol Violation|2|||
170767472|NCT01981356|617153934|FG001|Overall Study|Protocol Violation|0|||
170767473|NCT00605033|617153935|FG000|Overall Study|Adverse Event|2|||
170767474|NCT00605033|617153936|FG001|Overall Study|Adverse Event|2|||
170767475|NCT00605033|617153935|FG000|Overall Study|Lost to Follow-up|1|||
170767476|NCT00605033|617153936|FG001|Overall Study|Lost to Follow-up|1|||
170767477|NCT00605033|617153935|FG000|Overall Study|Withdrawal by Subject|3|||
170767478|NCT00605033|617153936|FG001|Overall Study|Withdrawal by Subject|4|||
170767479|NCT00605033|617153935|FG000|Overall Study|Protocol Violation|1|||
170767480|NCT00605033|617153936|FG001|Overall Study|Protocol Violation|1|||
170767481|NCT01196429|617153937|FG000|Overall Study|Ineligible - inadequate pathology|1|||
170767482|NCT01196429|617153938|FG001|Overall Study|Ineligible - inadequate pathology|0|||
170767483|NCT01196429|617153937|FG000|Overall Study|Ineligible - wrong cell type|1|||
170767484|NCT01196429|617153938|FG001|Overall Study|Ineligible - wrong cell type|0|||
170767485|NCT01196429|617153937|FG000|Overall Study|Refused - Never Treated|1|||
170767486|NCT01196429|617153938|FG001|Overall Study|Refused - Never Treated|0|||
170767487|NCT00430300|617153941|FG000|Overall Study|Adverse Event|0|||
170767488|NCT00430300|617153942|FG001|Overall Study|Adverse Event|2|||
170767489|NCT00430300|617153943|FG002|Overall Study|Adverse Event|1|||
170767490|NCT00430300|617153944|FG003|Overall Study|Adverse Event|1|||
170767491|NCT00430300|617153941|FG000|Overall Study|Withdrawal by Subject|1|||
170767492|NCT00430300|617153942|FG001|Overall Study|Withdrawal by Subject|0|||
170767493|NCT00430300|617153943|FG002|Overall Study|Withdrawal by Subject|5|||
170767494|NCT00430300|617153944|FG003|Overall Study|Withdrawal by Subject|0|||
170767495|NCT00430300|617153941|FG000|Overall Study|Laboratory abnormality|1|||
170767496|NCT00430300|617153942|FG001|Overall Study|Laboratory abnormality|0|||
170767497|NCT00430300|617153943|FG002|Overall Study|Laboratory abnormality|0|||
170767498|NCT00430300|617153944|FG003|Overall Study|Laboratory abnormality|0|||
170767499|NCT00430300|617153941|FG000|Overall Study|Other|0|||
170767500|NCT00430300|617153942|FG001|Overall Study|Other|0|||
170767501|NCT00430300|617153943|FG002|Overall Study|Other|0|||
170767502|NCT00430300|617153944|FG003|Overall Study|Other|1|||
170767503|NCT02041104|617153945|FG000|Overall Study|Lost to Follow-up|1|||
170767504|NCT02041104|617153946|FG001|Overall Study|Lost to Follow-up|4|||
170767505|NCT02041104|617153945|FG000|Overall Study|discomfort during OGTT|0|||
170767506|NCT02041104|617153946|FG001|Overall Study|discomfort during OGTT|3|||
170767507|NCT03183518|617153947|FG000|Overall Study|Other (Not specified)|2|||
170767508|NCT03183518|617153947|FG000|Overall Study|Other (Withdrawal of consent)|1|||
170767509|NCT02132702|617153948|FG000|Overall Study|Protocol Violation|2|||
170767510|NCT02132702|617153948|FG000|Overall Study|Adverse Event|3|||
170767511|NCT02132702|617153948|FG000|Overall Study|Withdrawal by Subject|3|||
170767512|NCT01244828|617153949|FG000|Overall Study|Adverse Event|37|||
170767513|NCT01244828|617153949|FG000|Overall Study|Withdrawal by Subject|31|||
170767514|NCT01244828|617153949|FG000|Overall Study|Lack of Efficacy|7|||
170412016|NCT03843359|615847274|FG012|Crossover|Withdrawal by Subject|0|||
170412017|NCT03843359|615847275|FG013|Crossover|Withdrawal by Subject|0|||
170412018|NCT03843359|615847276|FG014|Crossover|Withdrawal by Subject|0|||
170412019|NCT03843359|615847277|FG015|Crossover|Withdrawal by Subject|1|||
170412020|NCT03843359|615847262|FG000|Crossover|Investigator site closed|0|||
170412021|NCT03843359|615847263|FG001|Crossover|Investigator site closed|0|||
170412022|NCT03843359|615847264|FG002|Crossover|Investigator site closed|0|||
170412023|NCT03843359|615847265|FG003|Crossover|Investigator site closed|0|||
170522223|NCT01094288|616258086|FG005|Overall Study|Ongoing Participants|0|||
170767515|NCT01244828|617153949|FG000|Overall Study|Lost to Follow-up|2|||
170767516|NCT01244828|617153949|FG000|Overall Study|Other reason (not specified)|1|||
170767517|NCT05233085|617153951|FG000|Overall Study|Adverse Event|1|||
170767518|NCT05233085|617153952|FG001|Overall Study|Adverse Event|0|||
170767519|NCT05233085|617153953|FG002|Overall Study|Adverse Event|0|||
170767520|NCT05233085|617153954|FG003|Overall Study|Adverse Event|0|||
170767521|NCT01212757|617153955|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
170767522|NCT01212757|617153956|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
170767523|NCT01212757|617153957|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
170767524|NCT01212757|617153958|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170767525|NCT01212757|617153959|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170767526|NCT01212757|617153960|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170767527|NCT01212757|617153961|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170767528|NCT01212757|617153962|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170767529|NCT01212757|617153963|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170767530|NCT01212757|617153955|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
170767531|NCT01212757|617153956|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
170767532|NCT01212757|617153957|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
170767533|NCT01212757|617153958|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170767534|NCT01212757|617153959|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170767535|NCT01212757|617153960|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170767536|NCT01212757|617153961|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170767537|NCT01212757|617153962|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170767538|NCT01212757|617153963|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170767539|NCT01212757|617153955|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
170767540|NCT01212757|617153956|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
170767541|NCT01212757|617153957|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
170767542|NCT01212757|617153958|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170767543|NCT01212757|617153959|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170767544|NCT01212757|617153960|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170767545|NCT01212757|617153961|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170767546|NCT01212757|617153962|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170767547|NCT01212757|617153963|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170767548|NCT01212757|617153955|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
170767549|NCT01212757|617153956|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170767550|NCT01212757|617153957|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
170767551|NCT01212757|617153958|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170767552|NCT01212757|617153959|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170767553|NCT01212757|617153960|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170870066|NCT05975840|617535721|FG002|Overall Study|Lost to Follow-up|3|||
170870067|NCT05975840|617535722|FG003|Overall Study|Lost to Follow-up|1|||
170870068|NCT05975840|617535723|FG004|Overall Study|Lost to Follow-up|4|||
170870069|NCT05975840|617535724|FG005|Overall Study|Lost to Follow-up|1|||
170870070|NCT05975840|617535725|FG006|Overall Study|Lost to Follow-up|2|||
170870071|NCT05975840|617535726|FG007|Overall Study|Lost to Follow-up|4|||
170870072|NCT05975840|617535719|FG000|Overall Study|Migrated/moved from the study area|1|||
170870073|NCT05975840|617535720|FG001|Overall Study|Migrated/moved from the study area|0|||
170870074|NCT05975840|617535721|FG002|Overall Study|Migrated/moved from the study area|0|||
170870075|NCT05975840|617535722|FG003|Overall Study|Migrated/moved from the study area|0|||
170870076|NCT05975840|617535723|FG004|Overall Study|Migrated/moved from the study area|0|||
170870077|NCT05975840|617535724|FG005|Overall Study|Migrated/moved from the study area|0|||
170870078|NCT05975840|617535725|FG006|Overall Study|Migrated/moved from the study area|0|||
170870079|NCT05975840|617535726|FG007|Overall Study|Migrated/moved from the study area|0|||
170870080|NCT05975840|617535719|FG000|Overall Study|Withdrawal by Subject|0|||
170870081|NCT05975840|617535720|FG001|Overall Study|Withdrawal by Subject|5|||
170870082|NCT05975840|617535721|FG002|Overall Study|Withdrawal by Subject|2|||
170870083|NCT05975840|617535722|FG003|Overall Study|Withdrawal by Subject|2|||
170870084|NCT05975840|617535723|FG004|Overall Study|Withdrawal by Subject|0|||
170870085|NCT05975840|617535724|FG005|Overall Study|Withdrawal by Subject|2|||
170870086|NCT05975840|617535725|FG006|Overall Study|Withdrawal by Subject|2|||
170870087|NCT05975840|617535726|FG007|Overall Study|Withdrawal by Subject|1|||
170870088|NCT05975840|617535719|FG000|Overall Study|Protocol Violation|0|||
170870089|NCT05975840|617535720|FG001|Overall Study|Protocol Violation|1|||
170870090|NCT05975840|617535721|FG002|Overall Study|Protocol Violation|0|||
170870091|NCT05975840|617535722|FG003|Overall Study|Protocol Violation|0|||
170870092|NCT05975840|617535723|FG004|Overall Study|Protocol Violation|0|||
170412024|NCT03843359|615847266|FG004|Crossover|Investigator site closed|0|||
170412025|NCT03843359|615847267|FG005|Crossover|Investigator site closed|0|||
170412026|NCT03843359|615847268|FG006|Crossover|Investigator site closed|0|||
170412027|NCT03843359|615847269|FG007|Crossover|Investigator site closed|0|||
170412028|NCT03843359|615847270|FG008|Crossover|Investigator site closed|0|||
170412029|NCT03843359|615847271|FG009|Crossover|Investigator site closed|0|||
170870093|NCT05975840|617535724|FG005|Overall Study|Protocol Violation|0|||
170870094|NCT05975840|617535725|FG006|Overall Study|Protocol Violation|0|||
170870095|NCT05975840|617535726|FG007|Overall Study|Protocol Violation|0|||
170870096|NCT05975840|617535719|FG000|Overall Study|Adverse Event|0|||
170870097|NCT05975840|617535720|FG001|Overall Study|Adverse Event|0|||
170870098|NCT05975840|617535721|FG002|Overall Study|Adverse Event|0|||
170870099|NCT05975840|617535722|FG003|Overall Study|Adverse Event|1|||
170870100|NCT05975840|617535723|FG004|Overall Study|Adverse Event|0|||
170870101|NCT05975840|617535724|FG005|Overall Study|Adverse Event|0|||
170870102|NCT05975840|617535725|FG006|Overall Study|Adverse Event|0|||
170870103|NCT05975840|617535726|FG007|Overall Study|Adverse Event|0|||
170870104|NCT05975840|617535719|FG000|Overall Study|Death|0|||
170870105|NCT05975840|617535720|FG001|Overall Study|Death|1|||
170870106|NCT05975840|617535721|FG002|Overall Study|Death|0|||
170870107|NCT05975840|617535722|FG003|Overall Study|Death|0|||
170870108|NCT05975840|617535723|FG004|Overall Study|Death|0|||
170870109|NCT05975840|617535724|FG005|Overall Study|Death|0|||
170870110|NCT05975840|617535725|FG006|Overall Study|Death|0|||
170870111|NCT05975840|617535726|FG007|Overall Study|Death|1|||
170870112|NCT05390580|617535729|FG000|Overall Study|Physician Decision|3|||
170870113|NCT05390580|617535730|FG001|Overall Study|Physician Decision|2|||
170870114|NCT04376060|617535731|FG000|Overall Study|Physician Decision|1|||
170870115|NCT04572854|617535734|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
170870116|NCT04572854|617535735|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
170870117|NCT04572854|617535736|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
170870118|NCT04572854|617535737|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
170870119|NCT04572854|617535734|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
170870120|NCT04572854|617535735|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
170870121|NCT04572854|617535736|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
170870122|NCT04572854|617535737|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
170870123|NCT00972777|617535740|FG000|Overall Study|Adverse Event|3|||
170870124|NCT00972777|617535741|FG001|Overall Study|Adverse Event|2|||
170870125|NCT00972777|617535740|FG000|Overall Study|Lost to Follow-up|0|||
170870126|NCT00972777|617535741|FG001|Overall Study|Lost to Follow-up|4|||
170870127|NCT00972777|617535740|FG000|Overall Study|Withdrawal by Subject|4|||
170870128|NCT00972777|617535741|FG001|Overall Study|Withdrawal by Subject|5|||
170870129|NCT00972777|617535740|FG000|Overall Study|Physician Decision|4|||
170870130|NCT00972777|617535741|FG001|Overall Study|Physician Decision|0|||
170870131|NCT00972777|617535740|FG000|Overall Study|Protocol Violation|0|||
170870132|NCT00972777|617535741|FG001|Overall Study|Protocol Violation|2|||
170870133|NCT00972777|617535740|FG000|Overall Study|Screening Failure|2|||
170870134|NCT00972777|617535741|FG001|Overall Study|Screening Failure|1|||
170870135|NCT00972777|617535740|FG000|Overall Study|Missed visit|1|||
170870136|NCT00972777|617535741|FG001|Overall Study|Missed visit|0|||
170870137|NCT01093326|617535742|FG000|Overall Study|Death|0|||
170870138|NCT01093326|617535743|FG001|Overall Study|Death|1|||
170870139|NCT01093326|617535744|FG002|Overall Study|Death|0|||
170870140|NCT01093326|617535742|FG000|Overall Study|Lack of Efficacy|7|||
170870141|NCT01093326|617535743|FG001|Overall Study|Lack of Efficacy|6|||
170870142|NCT01093326|617535744|FG002|Overall Study|Lack of Efficacy|3|||
170870143|NCT01093326|617535742|FG000|Overall Study|Lost to Follow-up|2|||
170870144|NCT01093326|617535743|FG001|Overall Study|Lost to Follow-up|5|||
170870145|NCT01093326|617535744|FG002|Overall Study|Lost to Follow-up|4|||
170870146|NCT01093326|617535742|FG000|Overall Study|Physician Decision|3|||
170870147|NCT01093326|617535743|FG001|Overall Study|Physician Decision|1|||
170870148|NCT01093326|617535744|FG002|Overall Study|Physician Decision|3|||
170870149|NCT01093326|617535742|FG000|Overall Study|Withdrawal by Subject|30|||
170870150|NCT01093326|617535743|FG001|Overall Study|Withdrawal by Subject|27|||
170870151|NCT01093326|617535744|FG002|Overall Study|Withdrawal by Subject|26|||
170870152|NCT01093326|617535742|FG000|Overall Study|Adverse Event|2|||
170870153|NCT01093326|617535743|FG001|Overall Study|Adverse Event|1|||
170870154|NCT01093326|617535744|FG002|Overall Study|Adverse Event|4|||
170870155|NCT01093326|617535742|FG000|Overall Study|Other|0|||
170870156|NCT01093326|617535743|FG001|Overall Study|Other|0|||
170522224|NCT01094288|616258087|FG006|Overall Study|Ongoing Participants|0|||
170522225|NCT01094288|616258088|FG007|Overall Study|Ongoing Participants|0|||
170632176|NCT01134055|616664543|FG004|Overall Study|Physician Decision|0|||
170870157|NCT01093326|617535744|FG002|Overall Study|Other|1|||
170870158|NCT03672461|617535745|FG000|Overall Study|COVID Related|4|||
170870159|NCT03672461|617535746|FG001|Overall Study|COVID Related|2|||
170870160|NCT03672461|617535745|FG000|Overall Study|Adverse Event|2|||
170870161|NCT03672461|617535746|FG001|Overall Study|Adverse Event|0|||
170870162|NCT03672461|617535745|FG000|Overall Study|Serious Adverse Event|0|||
170870163|NCT03672461|617535746|FG001|Overall Study|Serious Adverse Event|1|||
170870164|NCT03672461|617535745|FG000|Overall Study|Too Busy|3|||
170870165|NCT03672461|617535746|FG001|Overall Study|Too Busy|1|||
170870166|NCT03672461|617535745|FG000|Overall Study|Lost to Follow-up|1|||
170870167|NCT03672461|617535746|FG001|Overall Study|Lost to Follow-up|2|||
170870168|NCT03672461|617535745|FG000|Overall Study|Family|2|||
170870169|NCT03672461|617535746|FG001|Overall Study|Family|2|||
170870170|NCT03672461|617535745|FG000|Overall Study|No remote technology access|0|||
170870171|NCT03672461|617535746|FG001|Overall Study|No remote technology access|1|||
170870172|NCT03672461|617535745|FG000|Overall Study|Withdrawal by Subject|1|||
170870173|NCT03672461|617535746|FG001|Overall Study|Withdrawal by Subject|0|||
170870174|NCT03672461|617535745|FG000|Overall Study|Cannot tolerate intervention|1|||
170870175|NCT03672461|617535746|FG001|Overall Study|Cannot tolerate intervention|0|||
170412030|NCT03843359|615847272|FG010|Crossover|Investigator site closed|0|||
170412031|NCT03843359|615847273|FG011|Crossover|Investigator site closed|0|||
170412032|NCT03843359|615847274|FG012|Crossover|Investigator site closed|0|||
170412033|NCT03843359|615847275|FG013|Crossover|Investigator site closed|0|||
170412034|NCT03843359|615847276|FG014|Crossover|Investigator site closed|2|||
170412035|NCT03843359|615847277|FG015|Crossover|Investigator site closed|2|||
170412036|NCT03843359|615847262|FG000|Crossover|Ongoing at the time of analysis|0|||
170412037|NCT03843359|615847263|FG001|Crossover|Ongoing at the time of analysis|0|||
170412038|NCT03843359|615847264|FG002|Crossover|Ongoing at the time of analysis|0|||
170412039|NCT03843359|615847265|FG003|Crossover|Ongoing at the time of analysis|0|||
170412040|NCT03843359|615847266|FG004|Crossover|Ongoing at the time of analysis|0|||
170412041|NCT03843359|615847267|FG005|Crossover|Ongoing at the time of analysis|0|||
170412042|NCT03843359|615847268|FG006|Crossover|Ongoing at the time of analysis|0|||
170412043|NCT03843359|615847269|FG007|Crossover|Ongoing at the time of analysis|0|||
170412044|NCT03843359|615847270|FG008|Crossover|Ongoing at the time of analysis|0|||
170412045|NCT03843359|615847271|FG009|Crossover|Ongoing at the time of analysis|0|||
170412046|NCT03843359|615847272|FG010|Crossover|Ongoing at the time of analysis|0|||
170412047|NCT03843359|615847273|FG011|Crossover|Ongoing at the time of analysis|0|||
170412048|NCT03843359|615847274|FG012|Crossover|Ongoing at the time of analysis|0|||
170412049|NCT03843359|615847275|FG013|Crossover|Ongoing at the time of analysis|1|||
170412050|NCT03843359|615847276|FG014|Crossover|Ongoing at the time of analysis|0|||
170412051|NCT03843359|615847277|FG015|Crossover|Ongoing at the time of analysis|0|||
170412052|NCT05308472|615847278|FG000|Overall Study|Adverse Event|0|||
170412053|NCT05308472|615847279|FG001|Overall Study|Adverse Event|0|||
170412054|NCT05308472|615847280|FG002|Overall Study|Adverse Event|3|||
170412055|NCT03469271|615847281|FG000|Overall Study|Withdrawal by Subject|2|||
170412056|NCT03469271|615847282|FG001|Overall Study|Withdrawal by Subject|0|||
170412057|NCT03469271|615847283|FG002|Overall Study|Withdrawal by Subject|0|||
170412058|NCT03469271|615847284|FG003|Overall Study|Withdrawal by Subject|1|||
170412059|NCT05359003|615847287|FG000|Overall Study|Withdrawal by Subject|1|||
170412060|NCT05359003|615847288|FG001|Overall Study|Withdrawal by Subject|3|||
170412061|NCT06202521|615847291|FG000|Overall Study|Withdrawal by Subject|0|||
170412062|NCT06202521|615847292|FG001|Overall Study|Withdrawal by Subject|1|||
170412063|NCT06202521|615847293|FG002|Overall Study|Withdrawal by Subject|0|||
170412064|NCT06202521|615847294|FG003|Overall Study|Withdrawal by Subject|1|||
170412065|NCT06202521|615847291|FG000|Overall Study|Adverse Event|0|||
170412066|NCT06202521|615847292|FG001|Overall Study|Adverse Event|0|||
170412067|NCT06202521|615847293|FG002|Overall Study|Adverse Event|1|||
170412068|NCT06202521|615847294|FG003|Overall Study|Adverse Event|0|||
170412069|NCT04535583|615847303|FG000|Overall Study|Lost to Follow-up|1|||
170412070|NCT04535583|615847303|FG000|Overall Study|Physician Decision|1|||
170412071|NCT04535583|615847303|FG000|Overall Study|Withdrawal by Subject|1|||
170412072|NCT01748890|615847304|FG000|Overall Study|Insufficient recruitment for analysis|4|||
170870176|NCT03672461|617535745|FG000|Overall Study|Incomplete outcome data|6|||
170870177|NCT03672461|617535746|FG001|Overall Study|Incomplete outcome data|1|||
170870178|NCT04263896|617535747|FG000|Overall Study|Withdrawal by Subject|2|||
170870179|NCT04263896|617535748|FG001|Overall Study|Withdrawal by Subject|4|||
170870180|NCT04263896|617535747|FG000|Overall Study|converted to open procedure|0|||
170870181|NCT04263896|617535748|FG001|Overall Study|converted to open procedure|1|||
170870182|NCT04263896|617535747|FG000|Overall Study|Lost to Follow-up|9|||
170870183|NCT04263896|617535748|FG001|Overall Study|Lost to Follow-up|11|||
170767554|NCT01212757|617153961|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170767555|NCT01212757|617153962|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170767556|NCT01212757|617153963|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170767557|NCT01212757|617153955|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
170767558|NCT01212757|617153956|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
170767559|NCT01212757|617153957|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
170767560|NCT01212757|617153958|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170767561|NCT01212757|617153959|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170767562|NCT01212757|617153960|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170767563|NCT01212757|617153961|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170767564|NCT01212757|617153962|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170767565|NCT01212757|617153963|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170767566|NCT01212757|617153955|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170870184|NCT04263896|617535747|FG000|Overall Study|surveys lost in mail|5|||
170412073|NCT01680159|615847305|FG000|Screening Period|Not meet criteria for dose-up period|7|||
170412074|NCT01680159|615847305|FG000|Increased Dose Period|Adverse Event|6|||
170412075|NCT01680159|615847305|FG000|Increased Dose Period|Withdrawal by Subject|2|||
170870185|NCT04263896|617535748|FG001|Overall Study|surveys lost in mail|3|||
170412076|NCT02100956|615847306|FG000|At Least One Week Between Injections|Adverse Event|0|||
170412077|NCT02100956|615847307|FG001|At Least One Week Between Injections|Adverse Event|1|||
170412078|NCT03016078|615847314|FG000|Overall Study|Protocol Violation|1|||
170412079|NCT03016078|615847314|FG000|Overall Study|Protocol Violation|1|||
170412080|NCT04526899|615847315|FG000|Overall Study|Withdrawal by Subject|3|||
170412081|NCT04526899|615847316|FG001|Overall Study|Withdrawal by Subject|2|||
170412082|NCT04526899|615847317|FG002|Overall Study|Withdrawal by Subject|2|||
170412083|NCT04526899|615847315|FG000|Overall Study|Lost to Follow-up|3|||
170412084|NCT04526899|615847316|FG001|Overall Study|Lost to Follow-up|3|||
170412085|NCT04526899|615847317|FG002|Overall Study|Lost to Follow-up|1|||
170412086|NCT04526899|615847315|FG000|Overall Study|Investigator's decision|1|||
170412087|NCT04526899|615847316|FG001|Overall Study|Investigator's decision|0|||
170412088|NCT04526899|615847317|FG002|Overall Study|Investigator's decision|0|||
170412089|NCT04526899|615847315|FG000|Overall Study|Death|33|||
170412090|NCT04526899|615847316|FG001|Overall Study|Death|17|||
170412091|NCT04526899|615847317|FG002|Overall Study|Death|13|||
170412092|NCT04526899|615847315|FG000|Overall Study|Other|1|||
170412093|NCT04526899|615847316|FG001|Overall Study|Other|0|||
170412094|NCT04526899|615847317|FG002|Overall Study|Other|0|||
170412095|NCT04526899|615847315|FG000|Overall Study|On-Treatment|19|||
170412096|NCT04526899|615847316|FG001|Overall Study|On-Treatment|10|||
170412097|NCT04526899|615847317|FG002|Overall Study|On-Treatment|12|||
170412098|NCT04526899|615847315|FG000|Overall Study|Survival Follow-up|34|||
170412099|NCT04526899|615847316|FG001|Overall Study|Survival Follow-up|14|||
170412100|NCT04526899|615847317|FG002|Overall Study|Survival Follow-up|16|||
170522226|NCT02611882|616258091|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
170522227|NCT02611882|616258092|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
170767567|NCT01212757|617153956|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
170767568|NCT01212757|617153957|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
170767569|NCT01212757|617153958|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170767570|NCT01212757|617153959|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170767571|NCT01212757|617153960|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170767572|NCT01212757|617153961|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170767573|NCT01212757|617153962|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170767574|NCT01212757|617153963|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170767575|NCT01212757|617153955|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
170767576|NCT01212757|617153956|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
170767577|NCT01212757|617153957|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170767578|NCT01212757|617153958|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170767579|NCT01212757|617153959|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170767580|NCT01212757|617153960|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170767581|NCT01212757|617153961|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170767582|NCT01212757|617153962|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170767583|NCT01212757|617153963|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170767584|NCT01212757|617153955|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
170767585|NCT01212757|617153956|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
170767586|NCT01212757|617153957|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
170767587|NCT01212757|617153958|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
170767588|NCT01212757|617153959|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
170767589|NCT01212757|617153960|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
170767590|NCT01212757|617153961|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
170767591|NCT01212757|617153962|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
170767592|NCT01212757|617153963|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
170767593|NCT01212757|617153955|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
170767594|NCT01212757|617153956|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
170767595|NCT01212757|617153957|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
170767596|NCT01212757|617153958|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
170767597|NCT01212757|617153959|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
170767598|NCT01212757|617153960|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
170767599|NCT01212757|617153961|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
170767600|NCT01212757|617153962|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
170767601|NCT01212757|617153963|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
170767602|NCT01212757|617153955|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
170767603|NCT01212757|617153956|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
170767604|NCT01212757|617153957|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
170767605|NCT01212757|617153958|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
170767606|NCT01212757|617153959|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
170767607|NCT01212757|617153960|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
170767608|NCT01212757|617153961|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
170412101|NCT05576012|615847318|FG000|Overall Study|Physician Decision|0|||
170522228|NCT02611882|616258093|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
170412102|NCT05576012|615847319|FG001|Overall Study|Physician Decision|0|||
170412103|NCT05576012|615847320|FG002|Overall Study|Physician Decision|0|||
170870186|NCT04263896|617535747|FG000|Overall Study|excluded from analysis|1|||
170870187|NCT04263896|617535748|FG001|Overall Study|excluded from analysis|0|||
170870188|NCT04225806|617535749|FG000|Overall Study|Trial termination|15|||
170870189|NCT06950879|617535752|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
170870190|NCT02060383|617537338|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
170870191|NCT02060383|617537339|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
170870192|NCT02060383|617537340|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
170870193|NCT02060383|617537341|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
170870194|NCT02060383|617537342|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
170870195|NCT02060383|617537338|FG000|Core Phase|Adverse Event|2|||
170870196|NCT02060383|617537339|FG001|Core Phase|Adverse Event|0|||
170870197|NCT02060383|617537340|FG002|Core Phase|Adverse Event|0|||
170870198|NCT02060383|617537341|FG003|Core Phase|Adverse Event|2|||
170870199|NCT02060383|617537342|FG004|Core Phase|Adverse Event|6|||
170870200|NCT02060383|617537338|FG000|Core Phase|Administrative problems|0|||
170870201|NCT02060383|617537339|FG001|Core Phase|Administrative problems|1|||
170870202|NCT02060383|617537340|FG002|Core Phase|Administrative problems|0|||
170870203|NCT02060383|617537341|FG003|Core Phase|Administrative problems|0|||
170870204|NCT02060383|617537342|FG004|Core Phase|Administrative problems|0|||
170870205|NCT02060383|617537338|FG000|Core Phase|Protocol Violation|0|||
170870206|NCT02060383|617537339|FG001|Core Phase|Protocol Violation|0|||
170870207|NCT02060383|617537340|FG002|Core Phase|Protocol Violation|0|||
170870208|NCT02060383|617537341|FG003|Core Phase|Protocol Violation|1|||
170870209|NCT02060383|617537342|FG004|Core Phase|Protocol Violation|0|||
170870210|NCT02060383|617537338|FG000|Core Phase|Withdrawal by Subject|0|||
170870211|NCT02060383|617537339|FG001|Core Phase|Withdrawal by Subject|0|||
170870212|NCT02060383|617537340|FG002|Core Phase|Withdrawal by Subject|0|||
170870213|NCT02060383|617537341|FG003|Core Phase|Withdrawal by Subject|4|||
170870214|NCT02060383|617537342|FG004|Core Phase|Withdrawal by Subject|2|||
170870215|NCT02060383|617537338|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
170870216|NCT02060383|617537339|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
170870217|NCT02060383|617537340|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
170870218|NCT02060383|617537341|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
170870219|NCT02060383|617537342|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
170870220|NCT02060383|617537338|FG000|Extension Phase|Adverse Event|1|||
170870221|NCT02060383|617537339|FG001|Extension Phase|Adverse Event|1|||
170870222|NCT02060383|617537340|FG002|Extension Phase|Adverse Event|2|||
170870223|NCT02060383|617537341|FG003|Extension Phase|Adverse Event|0|||
170870224|NCT02060383|617537342|FG004|Extension Phase|Adverse Event|1|||
170870225|NCT02060383|617537338|FG000|Extension Phase|Withdrawal by Subject|0|||
170870226|NCT02060383|617537339|FG001|Extension Phase|Withdrawal by Subject|1|||
170870227|NCT02060383|617537340|FG002|Extension Phase|Withdrawal by Subject|0|||
170870228|NCT02060383|617537341|FG003|Extension Phase|Withdrawal by Subject|0|||
170870229|NCT02060383|617537342|FG004|Extension Phase|Withdrawal by Subject|2|||
170870230|NCT02060383|617537338|FG000|Extension Phase|Administrative problems|1|||
170870231|NCT02060383|617537339|FG001|Extension Phase|Administrative problems|0|||
170870232|NCT02060383|617537340|FG002|Extension Phase|Administrative problems|0|||
170870233|NCT02060383|617537341|FG003|Extension Phase|Administrative problems|0|||
170870234|NCT02060383|617537342|FG004|Extension Phase|Administrative problems|0|||
170870235|NCT02060383|617537338|FG000|Extension Phase|Death|0|||
170870236|NCT02060383|617537339|FG001|Extension Phase|Death|0|||
170870237|NCT02060383|617537340|FG002|Extension Phase|Death|1|||
170870238|NCT02060383|617537341|FG003|Extension Phase|Death|0|||
170870239|NCT02060383|617537342|FG004|Extension Phase|Death|1|||
170870240|NCT02060383|617537338|FG000|Extension Phase|Protocol Violation|0|||
170870241|NCT02060383|617537339|FG001|Extension Phase|Protocol Violation|0|||
170870242|NCT02060383|617537340|FG002|Extension Phase|Protocol Violation|0|||
170870243|NCT02060383|617537341|FG003|Extension Phase|Protocol Violation|0|||
170870244|NCT02060383|617537342|FG004|Extension Phase|Protocol Violation|1|||
170870245|NCT00088907|617537343|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
170870246|NCT00088907|617537344|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
170870247|NCT00088907|617537343|FG000|Randomized Study (Step 1)|Adverse Event|14|||
170870248|NCT00088907|617537344|FG001|Randomized Study (Step 1)|Adverse Event|19|||
170870249|NCT00088907|617537343|FG000|Randomized Study (Step 1)|Death|11|||
170870250|NCT00088907|617537344|FG001|Randomized Study (Step 1)|Death|12|||
170870251|NCT00088907|617537343|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
170870252|NCT00088907|617537344|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
170870253|NCT00088907|617537343|FG000|Randomized Study (Step 1)|complicating disease|3|||
170870254|NCT00088907|617537344|FG001|Randomized Study (Step 1)|complicating disease|1|||
170870255|NCT00088907|617537343|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
170870256|NCT00088907|617537344|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
170870257|NCT00088907|617537343|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
170870258|NCT00088907|617537344|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
170870259|NCT00088907|617537343|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
170870260|NCT00088907|617537344|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
170870261|NCT00088907|617537343|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
170767609|NCT01212757|617153962|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
170767610|NCT01212757|617153963|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
170767611|NCT01212757|617153955|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
170767612|NCT01212757|617153956|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
170767613|NCT01212757|617153957|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
170767614|NCT01212757|617153958|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
170767615|NCT01212757|617153959|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
170767616|NCT01212757|617153960|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
170767617|NCT01212757|617153961|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
170767618|NCT01212757|617153962|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
170767619|NCT01212757|617153963|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
170767620|NCT01212757|617153955|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170767621|NCT01212757|617153956|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
170767622|NCT01212757|617153957|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170767623|NCT01212757|617153958|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170767624|NCT01212757|617153959|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
170767625|NCT01212757|617153960|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170767626|NCT01212757|617153961|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170767627|NCT01212757|617153962|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170767628|NCT01212757|617153963|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170767629|NCT01212757|617153955|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
170767630|NCT01212757|617153956|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
170767631|NCT01212757|617153957|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
170767632|NCT01212757|617153958|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
170767633|NCT01212757|617153959|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
170767634|NCT01212757|617153960|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
170767635|NCT01212757|617153961|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
170767636|NCT01212757|617153962|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
170767637|NCT01212757|617153963|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
170767638|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
170767639|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
170767640|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
170767641|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
170767642|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
170767643|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
170767644|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
170767645|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
170767646|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
170767647|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
170767648|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
170767649|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
170767650|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
170767651|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
170767652|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
170767653|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
170767654|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
170767655|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
170767656|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
170767657|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
170767658|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
170767659|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
170767660|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
170767661|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
170767662|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
170767663|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
170522229|NCT01228591|616258094|FG000|Baseline|Lack of Efficacy|1|||
170767664|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
170767665|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170412104|NCT05576012|615847321|FG003|Overall Study|Physician Decision|0|||
170412105|NCT05576012|615847322|FG004|Overall Study|Physician Decision|0|||
170412106|NCT05576012|615847323|FG005|Overall Study|Physician Decision|0|||
170412107|NCT05576012|615847324|FG006|Overall Study|Physician Decision|0|||
170412108|NCT05576012|615847325|FG007|Overall Study|Physician Decision|0|||
170412109|NCT05576012|615847326|FG008|Overall Study|Physician Decision|1|||
170412110|NCT05576012|615847327|FG009|Overall Study|Physician Decision|0|||
170412111|NCT00628745|615847328|FG000|Overall Study|Withdrawal by Subject|63|||
170412112|NCT00628745|615847329|FG001|Overall Study|Withdrawal by Subject|3|||
170412113|NCT00628745|615847330|FG002|Overall Study|Withdrawal by Subject|9|||
170767666|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
170767667|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
170767668|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170767669|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170767670|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170767671|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170767672|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
170767673|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
170767674|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
170767675|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
170767676|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
170767677|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
170767678|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
170767679|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
170767680|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
170767681|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
170767682|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
170767683|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
170767684|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
170767685|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
170767686|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
170767687|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
170767688|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
170767689|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
170767690|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
170767691|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
170767692|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
170767693|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
170767694|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
170767695|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
170767696|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
170767697|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
170767698|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
170767699|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
170767700|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
170767701|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
170767702|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
170767703|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
170767704|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
170767705|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
170767706|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
170767707|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
170870262|NCT00088907|617537344|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
170870263|NCT00088907|617537343|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
170870264|NCT00088907|617537344|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
170412114|NCT00628745|615847331|FG003|Overall Study|Withdrawal by Subject|2|||
170412115|NCT00628745|615847332|FG004|Overall Study|Withdrawal by Subject|69|||
170412116|NCT00628745|615847328|FG000|Overall Study|Does not meet inclusion criteria|0|||
170412117|NCT00628745|615847329|FG001|Overall Study|Does not meet inclusion criteria|12|||
170412118|NCT00628745|615847330|FG002|Overall Study|Does not meet inclusion criteria|0|||
170412119|NCT00628745|615847331|FG003|Overall Study|Does not meet inclusion criteria|0|||
170412120|NCT00628745|615847332|FG004|Overall Study|Does not meet inclusion criteria|18|||
170412121|NCT00628745|615847328|FG000|Overall Study|Participation in an interventional clinical trial|81|||
170412122|NCT00628745|615847329|FG001|Overall Study|Participation in an interventional clinical trial|4|||
170412123|NCT00628745|615847330|FG002|Overall Study|Participation in an interventional clinical trial|7|||
170412124|NCT00628745|615847331|FG003|Overall Study|Participation in an interventional clinical trial|0|||
170412125|NCT00628745|615847332|FG004|Overall Study|Participation in an interventional clinical trial|63|||
170412126|NCT00628745|615847328|FG000|Overall Study|Physician Decision|8|||
170412127|NCT00628745|615847329|FG001|Overall Study|Physician Decision|4|||
170412128|NCT00628745|615847330|FG002|Overall Study|Physician Decision|3|||
170412129|NCT00628745|615847331|FG003|Overall Study|Physician Decision|0|||
170412130|NCT00628745|615847332|FG004|Overall Study|Physician Decision|30|||
170412131|NCT00628745|615847328|FG000|Overall Study|Lost to Follow-up|109|||
170412132|NCT00628745|615847329|FG001|Overall Study|Lost to Follow-up|7|||
170412133|NCT00628745|615847330|FG002|Overall Study|Lost to Follow-up|7|||
170412134|NCT00628745|615847331|FG003|Overall Study|Lost to Follow-up|0|||
170412135|NCT00628745|615847332|FG004|Overall Study|Lost to Follow-up|498|||
170412136|NCT00628745|615847328|FG000|Overall Study|Death|197|||
170412137|NCT00628745|615847329|FG001|Overall Study|Death|81|||
170412138|NCT00628745|615847330|FG002|Overall Study|Death|12|||
170767708|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
170767709|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
170767710|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170767711|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
170767712|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
170767713|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170767714|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170767715|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170767716|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170767717|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
170767718|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
170767719|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
170767720|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
170767721|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
170767722|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
170767723|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
170767724|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
170767725|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
170767726|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
170767727|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
170767728|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
170767729|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
170767730|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
170767731|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
170767732|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
170767733|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
170767734|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
170767735|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
170767736|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
170767737|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
170767738|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
170767739|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
170767740|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
170767741|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
170767742|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
170767743|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
170767744|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
170767745|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
170767746|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
170767747|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
170767748|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
170767749|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
170767750|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
170767751|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
170767752|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
170767753|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
170767754|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
170767755|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
170767756|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
170767757|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
170767758|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
170767759|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
170767760|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
170767761|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
170767762|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
170767763|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
170767764|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
170767765|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
170767766|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
170767767|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
170767768|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
170767769|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
170767770|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
170767771|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
170767772|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
170767773|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170767774|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
170412139|NCT00628745|615847331|FG003|Overall Study|Death|4|||
170767775|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
170767776|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170767777|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170767778|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170767779|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170767780|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
170767781|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
170870265|NCT00088907|617537343|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
170870266|NCT00088907|617537344|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
170870267|NCT03426787|617537345|FG000|Overall Study|Withdrawal by Subject|6|||
170870268|NCT03426787|617537345|FG000|Overall Study|Lost to Follow-up|7|||
170870269|NCT03426787|617537345|FG000|Overall Study|Unrelated to intervention death|1|||
170870270|NCT04050670|617537348|FG000|Period 3|Physician Decision|0|||
170870271|NCT04050670|617537349|FG001|Period 3|Physician Decision|1|||
170870272|NCT04050670|617537350|FG002|Period 3|Physician Decision|0|||
170870273|NCT00525044|617537351|FG000|Overall Study|Lost to Follow-up|0|||
170870274|NCT00525044|617537352|FG001|Overall Study|Lost to Follow-up|1|||
170870275|NCT03523728|617537358|FG000|Stage 1 (24 Months)|Adverse Event|2|||
170870276|NCT03523728|617537359|FG001|Stage 1 (24 Months)|Adverse Event|2|||
170870277|NCT03523728|617537360|FG002|Stage 1 (24 Months)|Adverse Event|4|||
170870278|NCT03523728|617537361|FG003|Stage 1 (24 Months)|Adverse Event|0|||
170870279|NCT03523728|617537362|FG004|Stage 1 (24 Months)|Adverse Event|0|||
170870280|NCT03523728|617537358|FG000|Stage 1 (24 Months)|Progressive disease|0|||
170870281|NCT03523728|617537359|FG001|Stage 1 (24 Months)|Progressive disease|0|||
170767782|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
170767783|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
170767784|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
170870282|NCT03523728|617537360|FG002|Stage 1 (24 Months)|Progressive disease|1|||
170412140|NCT00628745|615847332|FG004|Overall Study|Death|939|||
170412141|NCT00628745|615847328|FG000|Overall Study|Participant transferred to another THAOS site|6|||
170412142|NCT00628745|615847329|FG001|Overall Study|Participant transferred to another THAOS site|0|||
170412143|NCT00628745|615847330|FG002|Overall Study|Participant transferred to another THAOS site|0|||
170412144|NCT00628745|615847331|FG003|Overall Study|Participant transferred to another THAOS site|0|||
170412145|NCT00628745|615847332|FG004|Overall Study|Participant transferred to another THAOS site|7|||
170412146|NCT00628745|615847328|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
170412147|NCT00628745|615847329|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
170412148|NCT00628745|615847330|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
170412149|NCT00628745|615847331|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
170412150|NCT00628745|615847332|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
170412151|NCT00628745|615847328|FG000|Overall Study|Site closure|152|||
170412152|NCT00628745|615847329|FG001|Overall Study|Site closure|146|||
170412153|NCT00628745|615847330|FG002|Overall Study|Site closure|6|||
170412154|NCT00628745|615847331|FG003|Overall Study|Site closure|8|||
170412155|NCT00628745|615847332|FG004|Overall Study|Site closure|691|||
170412156|NCT00628745|615847328|FG000|Overall Study|Duplicate participant|0|||
170412157|NCT00628745|615847329|FG001|Overall Study|Duplicate participant|0|||
170412158|NCT00628745|615847330|FG002|Overall Study|Duplicate participant|0|||
170412159|NCT00628745|615847331|FG003|Overall Study|Duplicate participant|0|||
170412160|NCT00628745|615847332|FG004|Overall Study|Duplicate participant|1|||
170412161|NCT00628745|615847328|FG000|Overall Study|Missing|4|||
170412162|NCT00628745|615847329|FG001|Overall Study|Missing|3|||
170412163|NCT00628745|615847330|FG002|Overall Study|Missing|0|||
170412164|NCT00628745|615847331|FG003|Overall Study|Missing|0|||
170412165|NCT00628745|615847332|FG004|Overall Study|Missing|10|||
170412166|NCT00628745|615847328|FG000|Overall Study|Othe reasons|987|||
170412167|NCT00628745|615847329|FG001|Overall Study|Othe reasons|373|||
170412168|NCT00628745|615847330|FG002|Overall Study|Othe reasons|105|||
170412169|NCT00628745|615847331|FG003|Overall Study|Othe reasons|1|||
170412170|NCT00628745|615847332|FG004|Overall Study|Othe reasons|1772|||
170412171|NCT01413204|615849177|FG000|Overall Study|Adverse Event|1|||
170412172|NCT01413204|615849178|FG001|Overall Study|Adverse Event|2|||
170412173|NCT01413204|615849179|FG002|Overall Study|Adverse Event|2|||
170412174|NCT01413204|615849177|FG000|Overall Study|Physician Decision|3|||
170412175|NCT01413204|615849178|FG001|Overall Study|Physician Decision|0|||
170412176|NCT01413204|615849179|FG002|Overall Study|Physician Decision|2|||
170412177|NCT01413204|615849177|FG000|Overall Study|Withdrawal by Subject|1|||
170412178|NCT01413204|615849178|FG001|Overall Study|Withdrawal by Subject|4|||
170412179|NCT01413204|615849179|FG002|Overall Study|Withdrawal by Subject|4|||
170412180|NCT01413204|615849177|FG000|Overall Study|Clearly not eligible for the study|0|||
170412181|NCT01413204|615849178|FG001|Overall Study|Clearly not eligible for the study|0|||
170767785|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
170767786|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
170870283|NCT03523728|617537361|FG003|Stage 1 (24 Months)|Progressive disease|0|||
170767787|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
170767788|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
170767789|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
170767790|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
170767791|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
170767792|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
170767793|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
170767794|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
170767795|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
170767796|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
170767797|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
170767798|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
170767799|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
170767800|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170767801|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
170767802|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
170767803|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170767804|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170767805|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170767806|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170767807|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
170767808|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
170767809|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
170767810|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
170767811|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
170767812|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
170767813|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
170767814|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
170767815|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
170767816|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
170767817|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
170767818|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
170767819|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
170767820|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
170767821|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
170767822|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
170767823|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
170767824|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
170767825|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
170767826|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
170767827|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
170767828|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
170767829|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
170767830|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
170767831|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
170767832|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
170767833|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
170767834|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
170767835|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
170767836|NCT01212757|617153955|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
170767837|NCT01212757|617153956|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
170767838|NCT01212757|617153957|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
170767839|NCT01212757|617153958|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
170767840|NCT01212757|617153959|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
170767841|NCT01212757|617153960|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
170767842|NCT01212757|617153961|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
170767843|NCT01212757|617153962|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
170767844|NCT01212757|617153963|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
170767845|NCT00849147|617153964|FG000|Overall Study|Withdrawal by Subject|1|||
170767846|NCT00849147|617153964|FG000|Overall Study|Protocol Violation|2|||
170767847|NCT00849147|617153964|FG000|Overall Study|Disease Relapse/Progression|2|||
170767848|NCT04668339|617155353|FG000|Overall Study|Physician Decision|1|||
170767849|NCT04668339|617155354|FG001|Overall Study|Physician Decision|0|||
170767850|NCT04668339|617155355|FG002|Overall Study|Physician Decision|1|||
170767851|NCT04668339|617155356|FG003|Overall Study|Physician Decision|1|||
170767852|NCT04668339|617155353|FG000|Overall Study|Lost to Follow-up|14|||
170767853|NCT04668339|617155354|FG001|Overall Study|Lost to Follow-up|12|||
170767854|NCT04668339|617155355|FG002|Overall Study|Lost to Follow-up|8|||
170767855|NCT04668339|617155356|FG003|Overall Study|Lost to Follow-up|5|||
170522230|NCT01228591|616258095|FG001|Baseline|Lack of Efficacy|2|||
170870284|NCT03523728|617537362|FG004|Stage 1 (24 Months)|Progressive disease|0|||
170870285|NCT03523728|617537358|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
170870286|NCT03523728|617537359|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
170870287|NCT03523728|617537360|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
170870288|NCT03523728|617537361|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
170870289|NCT03523728|617537362|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
170870290|NCT03523728|617537358|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
170870291|NCT03523728|617537359|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
170870292|NCT03523728|617537360|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
170870293|NCT03523728|617537361|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
170870294|NCT03523728|617537362|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
170870295|NCT03523728|617537358|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
170870296|NCT03523728|617537359|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
170870297|NCT03523728|617537360|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
170870298|NCT03523728|617537361|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
170870299|NCT03523728|617537362|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
170870300|NCT03523728|617537358|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
170870301|NCT03523728|617537359|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
170870302|NCT03523728|617537360|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
170870303|NCT03523728|617537361|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
170870304|NCT03523728|617537362|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
170870305|NCT03523728|617537358|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
170870306|NCT03523728|617537359|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
170870307|NCT03523728|617537360|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
170870308|NCT03523728|617537361|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
170870309|NCT03523728|617537362|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
170870310|NCT03523728|617537358|FG000|Stage 2 (24 Months)|Adverse Event|0|||
170870311|NCT03523728|617537359|FG001|Stage 2 (24 Months)|Adverse Event|0|||
170870312|NCT03523728|617537360|FG002|Stage 2 (24 Months)|Adverse Event|0|||
170870313|NCT03523728|617537361|FG003|Stage 2 (24 Months)|Adverse Event|1|||
170870314|NCT03523728|617537362|FG004|Stage 2 (24 Months)|Adverse Event|2|||
170870315|NCT03523728|617537358|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
170870316|NCT03523728|617537359|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
170870317|NCT03523728|617537360|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
170870318|NCT03523728|617537361|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
170870319|NCT03523728|617537362|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
170870320|NCT03523728|617537358|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
170870321|NCT03523728|617537359|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
170870322|NCT03523728|617537360|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
170870323|NCT03523728|617537361|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
170870324|NCT03523728|617537362|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
170870325|NCT03523728|617537358|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
170870326|NCT03523728|617537359|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
170870327|NCT03523728|617537360|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
170870328|NCT03523728|617537361|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
170870329|NCT03523728|617537362|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
170870330|NCT03523728|617537358|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
170870331|NCT03523728|617537359|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
170870332|NCT03523728|617537360|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
170870333|NCT03523728|617537361|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
170870334|NCT03523728|617537362|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
170870335|NCT02023242|617537363|FG000|Overall Study|Lost to Follow-up|3|||
170870336|NCT02023242|617537364|FG001|Overall Study|Lost to Follow-up|1|||
170870337|NCT02023242|617537363|FG000|Overall Study|Death|0|||
170870338|NCT02023242|617537364|FG001|Overall Study|Death|1|||
170870339|NCT00884325|617537373|FG000|Overall Study|Lost to Follow-up|1|||
170870340|NCT00884325|617537374|FG001|Overall Study|Lost to Follow-up|2|||
170870341|NCT00884325|617537373|FG000|Overall Study|Lack of Efficacy|0|||
170870342|NCT00884325|617537374|FG001|Overall Study|Lack of Efficacy|1|||
170870343|NCT00884325|617537373|FG000|Overall Study|Withdrawal by Subject|1|||
170870344|NCT00884325|617537374|FG001|Overall Study|Withdrawal by Subject|1|||
170870345|NCT00884325|617537373|FG000|Overall Study|Not provided|1|||
170870346|NCT00884325|617537374|FG001|Overall Study|Not provided|0|||
170870347|NCT01641237|617537386|FG000|Period II|Withdrawal by Subject|1|||
170870348|NCT01641237|617537387|FG001|Period II|Withdrawal by Subject|0|||
170870349|NCT01641237|617537388|FG002|Period II|Withdrawal by Subject|0|||
170870350|NCT01641237|617537389|FG003|Period II|Withdrawal by Subject|0|||
170870351|NCT01641237|617537386|FG000|Period III|Lost to Follow-up|1|||
170870352|NCT01641237|617537387|FG001|Period III|Lost to Follow-up|0|||
170870353|NCT01641237|617537388|FG002|Period III|Lost to Follow-up|0|||
170870354|NCT01641237|617537389|FG003|Period III|Lost to Follow-up|0|||
170870355|NCT01186939|617537390|FG000|Overall Study|Death|7|||
170870356|NCT01186939|617537390|FG000|Overall Study|Withdrawal by Subject|2|||
170870357|NCT01186939|617537390|FG000|Overall Study|No longer receiving clinical benefit|17|||
170412182|NCT01413204|615849179|FG002|Overall Study|Clearly not eligible for the study|1|||
170522231|NCT01389232|616258096|FG000|Overall Study|Had scaffold removed|15|||
170522232|NCT01389232|616258096|FG000|Overall Study|Personal reasons|2|||
170522233|NCT01389232|616258096|FG000|Overall Study|Adverse Event|1|||
170522234|NCT01389232|616258096|FG000|Overall Study|Death|1|||
170522235|NCT01317940|616258097|FG000|Overall Study|Death|1|||
170522236|NCT01317940|616258098|FG001|Overall Study|Death|0|||
170522237|NCT01317940|616258099|FG002|Overall Study|Death|1|||
170522238|NCT01317940|616258100|FG003|Overall Study|Death|0|||
170522239|NCT01317940|616258101|FG004|Overall Study|Death|0|||
170522240|NCT01317940|616258102|FG005|Overall Study|Death|0|||
170522241|NCT01317940|616258097|FG000|Overall Study|Lost to Follow-up|0|||
170522242|NCT01317940|616258098|FG001|Overall Study|Lost to Follow-up|0|||
170522243|NCT01317940|616258099|FG002|Overall Study|Lost to Follow-up|1|||
170522244|NCT01317940|616258100|FG003|Overall Study|Lost to Follow-up|1|||
170522245|NCT01317940|616258101|FG004|Overall Study|Lost to Follow-up|1|||
170522246|NCT01317940|616258102|FG005|Overall Study|Lost to Follow-up|0|||
170522247|NCT01317940|616258097|FG000|Overall Study|Change in therapy plan|0|||
170522248|NCT01317940|616258098|FG001|Overall Study|Change in therapy plan|0|||
170767856|NCT04668339|617155353|FG000|Overall Study|Adverse Event|0|||
170767857|NCT04668339|617155354|FG001|Overall Study|Adverse Event|0|||
170767858|NCT04668339|617155355|FG002|Overall Study|Adverse Event|1|||
170767859|NCT04668339|617155356|FG003|Overall Study|Adverse Event|0|||
170767860|NCT04668339|617155353|FG000|Overall Study|Other than specified|3|||
170767861|NCT04668339|617155354|FG001|Overall Study|Other than specified|0|||
170767862|NCT04668339|617155355|FG002|Overall Study|Other than specified|1|||
170767863|NCT04668339|617155356|FG003|Overall Study|Other than specified|0|||
170767864|NCT04668339|617155353|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
170767865|NCT04668339|617155354|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
170767866|NCT04668339|617155355|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
170767867|NCT04668339|617155356|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
170767868|NCT04668339|617155353|FG000|Overall Study|Vaccine not Administered|0|||
170767869|NCT04668339|617155354|FG001|Overall Study|Vaccine not Administered|0|||
170767870|NCT04668339|617155355|FG002|Overall Study|Vaccine not Administered|1|||
170767871|NCT04668339|617155356|FG003|Overall Study|Vaccine not Administered|0|||
170767872|NCT04668339|617155353|FG000|Overall Study|Protocol Violation|18|||
170767873|NCT04668339|617155354|FG001|Overall Study|Protocol Violation|23|||
170767874|NCT04668339|617155355|FG002|Overall Study|Protocol Violation|12|||
170767875|NCT04668339|617155356|FG003|Overall Study|Protocol Violation|20|||
170767876|NCT04668339|617155353|FG000|Overall Study|Withdrawal by Subject|45|||
170767877|NCT04668339|617155354|FG001|Overall Study|Withdrawal by Subject|46|||
170767878|NCT04668339|617155355|FG002|Overall Study|Withdrawal by Subject|46|||
170767879|NCT04668339|617155356|FG003|Overall Study|Withdrawal by Subject|27|||
170767880|NCT04668339|617155353|FG000|Overall Study|Study Terminated by Sponsor|59|||
170767881|NCT04668339|617155354|FG001|Overall Study|Study Terminated by Sponsor|59|||
170767882|NCT04668339|617155355|FG002|Overall Study|Study Terminated by Sponsor|71|||
170767883|NCT04668339|617155356|FG003|Overall Study|Study Terminated by Sponsor|1|||
170767884|NCT03253848|617155360|FG000|Overall Study|Adverse Event|7|||
170767885|NCT03253848|617155360|FG000|Overall Study|Death|5|||
170767886|NCT03253848|617155360|FG000|Overall Study|initiation of other treatments|3|||
170767887|NCT03253848|617155360|FG000|Overall Study|Other complicating disease|1|||
170767888|NCT03253848|617155360|FG000|Overall Study|Withdrawal by Subject|1|||
170767889|NCT03253848|617155360|FG000|Overall Study|Declining health|1|||
170767890|NCT01266265|617155362|FG000|Overall Study|Death|95|||
170767891|NCT01266265|617155363|FG001|Overall Study|Death|73|||
170767892|NCT01266265|617155362|FG000|Overall Study|Lost to Follow-up|23|||
170767893|NCT01266265|617155363|FG001|Overall Study|Lost to Follow-up|28|||
170767894|NCT01266265|617155362|FG000|Overall Study|Withdrawal by Subject|13|||
170767895|NCT01266265|617155363|FG001|Overall Study|Withdrawal by Subject|11|||
170767896|NCT01266265|617155362|FG000|Overall Study|Respiratory-related adverse event|2|||
170767897|NCT01266265|617155363|FG001|Overall Study|Respiratory-related adverse event|1|||
170767898|NCT01266265|617155362|FG000|Overall Study|Transferred care to another provider|22|||
170767899|NCT01266265|617155363|FG001|Overall Study|Transferred care to another provider|28|||
170767900|NCT01266265|617155362|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
170767901|NCT01266265|617155363|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
170767902|NCT01266265|617155362|FG000|Overall Study|Enrolled in another clinical study|15|||
170870358|NCT01186939|617537390|FG000|Overall Study|Program closed|5|||
170522249|NCT01317940|616258099|FG002|Overall Study|Change in therapy plan|3|||
170522250|NCT01317940|616258100|FG003|Overall Study|Change in therapy plan|0|||
170522251|NCT01317940|616258101|FG004|Overall Study|Change in therapy plan|0|||
170522252|NCT01317940|616258102|FG005|Overall Study|Change in therapy plan|0|||
170522253|NCT00754741|616258104|FG000|Overall Study|Died or disenrolled|57|||
170522254|NCT00754741|616258105|FG001|Overall Study|Died or disenrolled|69|||
170767903|NCT01266265|617155363|FG001|Overall Study|Enrolled in another clinical study|26|||
170767904|NCT01266265|617155362|FG000|Overall Study|Non-compliance|8|||
170767905|NCT01266265|617155363|FG001|Overall Study|Non-compliance|5|||
170767906|NCT01266265|617155362|FG000|Overall Study|Lung transplant|6|||
170767907|NCT01266265|617155363|FG001|Overall Study|Lung transplant|5|||
170767908|NCT01266265|617155362|FG000|Overall Study|Site closed early|4|||
170767909|NCT01266265|617155363|FG001|Overall Study|Site closed early|3|||
170767910|NCT01266265|617155362|FG000|Overall Study|Clinical worsening|1|||
170767911|NCT01266265|617155363|FG001|Overall Study|Clinical worsening|1|||
170767912|NCT00028769|617155364|FG000|Overall Study|Adverse Event|2|||
170767913|NCT00028769|617155364|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
170767914|NCT00028769|617155364|FG000|Overall Study|Progression or Death|31|||
170767915|NCT00028769|617155364|FG000|Overall Study|Other - Not Protocol Specified|1|||
170767916|NCT00028769|617155364|FG000|Overall Study|Ineligible|5|||
170767917|NCT00028769|617155364|FG000|Overall Study|Not Analyzable|1|||
170767918|NCT01134562|617155365|FG000|Overall Study|Adverse Event|0|||
170767919|NCT01134562|617155366|FG001|Overall Study|Adverse Event|1|||
170767920|NCT01134562|617155367|FG002|Overall Study|Adverse Event|0|||
170767921|NCT01134562|617155368|FG003|Overall Study|Adverse Event|0|||
170767922|NCT01134562|617155369|FG004|Overall Study|Adverse Event|0|||
170767923|NCT02496702|617155372|FG000|Overall Study|Lost to Follow-up|8|||
170767924|NCT02496702|617155373|FG001|Overall Study|Lost to Follow-up|6|||
170767925|NCT02496702|617155372|FG000|Overall Study|Only partially tested|0|||
170767926|NCT02496702|617155373|FG001|Overall Study|Only partially tested|2|||
170767927|NCT00150176|617155376|FG000|Overall Study|Adverse Event|16|||
170767928|NCT00150176|617155377|FG001|Overall Study|Adverse Event|53|||
170767929|NCT00150176|617155376|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
170412183|NCT01413204|615849177|FG000|Overall Study|Fasting plasma glucose level increased|1|||
170412184|NCT01413204|615849178|FG001|Overall Study|Fasting plasma glucose level increased|0|||
170412185|NCT01413204|615849179|FG002|Overall Study|Fasting plasma glucose level increased|10|||
170412186|NCT03355742|615849180|FG000|Overall Study|Lost to Follow-up|4|||
170412187|NCT03355742|615849180|FG000|Overall Study|Withdrawal by Subject|29|||
170412188|NCT03355742|615849180|FG000|Overall Study|Physician Decision|6|||
170412189|NCT03355742|615849180|FG000|Overall Study|Death|55|||
170412190|NCT03355742|615849180|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
170412191|NCT00671879|615849181|FG000|Overall Study|Withdrawal by Subject|0|||
170412192|NCT00671879|615849182|FG001|Overall Study|Withdrawal by Subject|4|||
170412193|NCT00671879|615849183|FG002|Overall Study|Withdrawal by Subject|6|||
170412194|NCT01259869|615849200|FG000|Overall Study|Duplicated registration|1|||
170412195|NCT01612000|615849201|FG000|Overall Study|Lost to Follow-up|6|||
170412196|NCT01612000|615849202|FG001|Overall Study|Lost to Follow-up|4|||
170412197|NCT01612000|615849203|FG002|Overall Study|Lost to Follow-up|4|||
170412198|NCT01612000|615849204|FG003|Overall Study|Lost to Follow-up|8|||
170412199|NCT01612000|615849201|FG000|Overall Study|Physician Decision|0|||
170412200|NCT01612000|615849202|FG001|Overall Study|Physician Decision|0|||
170412201|NCT01612000|615849203|FG002|Overall Study|Physician Decision|1|||
170412202|NCT01612000|615849204|FG003|Overall Study|Physician Decision|0|||
170412203|NCT01612000|615849201|FG000|Overall Study|Withdrawal by Subject|3|||
170412204|NCT01612000|615849202|FG001|Overall Study|Withdrawal by Subject|1|||
170412205|NCT01612000|615849203|FG002|Overall Study|Withdrawal by Subject|2|||
170412206|NCT01612000|615849204|FG003|Overall Study|Withdrawal by Subject|2|||
170412207|NCT00634907|615849207|FG000|Overall Study|Withdrawal by Subject|3|||
170412208|NCT00634907|615849208|FG001|Overall Study|Withdrawal by Subject|0|||
170412209|NCT00634907|615849207|FG000|Overall Study|Physician Decision|3|||
170412210|NCT00634907|615849208|FG001|Overall Study|Physician Decision|9|||
170412211|NCT00634907|615849207|FG000|Overall Study|Withdrawal by Subject|11|||
170412212|NCT00634907|615849208|FG001|Overall Study|Withdrawal by Subject|8|||
170412213|NCT01180244|615849212|FG000|Overall Study|Lack of Efficacy|0|||
170412214|NCT01180244|615849213|FG001|Overall Study|Lack of Efficacy|7|||
170412215|NCT01180244|615849212|FG000|Overall Study|Physician Decision|3|||
170412216|NCT01180244|615849213|FG001|Overall Study|Physician Decision|0|||
170412217|NCT01180244|615849212|FG000|Overall Study|Adverse Event|1|||
170412218|NCT01180244|615849213|FG001|Overall Study|Adverse Event|0|||
170412219|NCT01180244|615849212|FG000|Overall Study|Withdrawal by Subject|0|||
170412220|NCT01180244|615849213|FG001|Overall Study|Withdrawal by Subject|1|||
170412221|NCT01180244|615849212|FG000|Overall Study|Protocol Violation|1|||
170412222|NCT01180244|615849213|FG001|Overall Study|Protocol Violation|0|||
170412223|NCT01180244|615849212|FG000|Overall Study|Lost to Follow-up|1|||
170412224|NCT01180244|615849213|FG001|Overall Study|Lost to Follow-up|0|||
170412225|NCT03425331|615849214|FG000|Overall Study|Withdrawal by Subject|1|||
170412226|NCT03425331|615849214|FG000|Overall Study|Death|1|||
170412227|NCT03425331|615849214|FG000|Overall Study|Adverse Event|1|||
170412228|NCT03425331|615849214|FG000|Overall Study|Disease Progression|2|||
170412229|NCT00620763|615849217|FG000|Period: First Intervention|Withdrawal by Subject|0|||
170412230|NCT00620763|615849218|FG001|Period: First Intervention|Withdrawal by Subject|2|||
170412231|NCT00620763|615849217|FG000|Period: First Intervention|Protocol Violation|0|||
170412232|NCT00620763|615849218|FG001|Period: First Intervention|Protocol Violation|3|||
170412233|NCT00620763|615849217|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
170412234|NCT00620763|615849218|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
170412235|NCT03433274|615849219|FG000|Overall Study|Withdrawal by Subject|2|||
170767930|NCT00150176|617155377|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
170767931|NCT00150176|617155376|FG000|Overall Study|Withdrawal by Subject|19|||
170870359|NCT01186939|617537390|FG000|Overall Study|Sponsor decision|4|||
170870360|NCT01186939|617537390|FG000|Overall Study|Started additional treatment|1|||
170870361|NCT01186939|617537390|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
170870362|NCT01186939|617537390|FG000|Overall Study|Myocardial infarction|1|||
170870363|NCT01186939|617537390|FG000|Overall Study|Bone marrow transplant|1|||
170870364|NCT01186939|617537390|FG000|Overall Study|Transformation to AML|1|||
170870365|NCT04912245|617537391|FG000|Overall Study|Withdrawal by Subject|21|||
170870366|NCT04912245|617537392|FG001|Overall Study|Withdrawal by Subject|4|||
170870367|NCT04912245|617537391|FG000|Overall Study|Lost to Follow-up|5|||
170870368|NCT04912245|617537392|FG001|Overall Study|Lost to Follow-up|11|||
170870369|NCT01205230|617537393|FG000|Overall Study|Adverse Event|4|||
170870370|NCT01205230|617537394|FG001|Overall Study|Adverse Event|0|||
170870371|NCT01205230|617537393|FG000|Overall Study|Physician Decision|1|||
170870372|NCT01205230|617537394|FG001|Overall Study|Physician Decision|0|||
170870373|NCT01011439|617537397|FG000|Overall Study|Death|37|||
170870374|NCT01011439|617537397|FG000|Overall Study|Lost to Follow-up|4|||
170870375|NCT01011439|617537397|FG000|Overall Study|Withdrawal by Subject|1|||
170870376|NCT01011439|617537397|FG000|Overall Study|Sponsor's decision|15|||
170870377|NCT00210184|617537398|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
170870378|NCT03861936|617537399|FG000|Overall Study|Withdrawal by Subject|4|||
170870379|NCT03861936|617537400|FG001|Overall Study|Withdrawal by Subject|1|||
170870380|NCT03861936|617537401|FG002|Overall Study|Withdrawal by Subject|3|||
170870381|NCT03861936|617537399|FG000|Overall Study|Lost to Follow-up|5|||
170870382|NCT03861936|617537400|FG001|Overall Study|Lost to Follow-up|3|||
170870383|NCT03861936|617537401|FG002|Overall Study|Lost to Follow-up|3|||
170870384|NCT03861936|617537399|FG000|Overall Study|Physician Decision|0|||
170870385|NCT03861936|617537400|FG001|Overall Study|Physician Decision|1|||
170870386|NCT03861936|617537401|FG002|Overall Study|Physician Decision|0|||
170870387|NCT03861936|617537399|FG000|Overall Study|Protocol Deviation|0|||
170870388|NCT03861936|617537400|FG001|Overall Study|Protocol Deviation|0|||
170870389|NCT03861936|617537401|FG002|Overall Study|Protocol Deviation|1|||
170870390|NCT03861936|617537399|FG000|Overall Study|Reason not Specified|5|||
170870391|NCT03861936|617537400|FG001|Overall Study|Reason not Specified|5|||
170870392|NCT03861936|617537401|FG002|Overall Study|Reason not Specified|3|||
170870393|NCT02066311|617537402|FG000|Overall Study|Adverse Event|4|||
170870394|NCT02066311|617537402|FG000|Overall Study|Withdrawal by Subject|1|||
170870395|NCT00975715|617537405|FG000|Titration Period|Adverse Event|6|||
170870396|NCT00975715|617537406|FG001|Titration Period|Adverse Event|0|||
170870397|NCT00975715|617537405|FG000|Titration Period|Protocol Violation|1|||
170870398|NCT00975715|617537406|FG001|Titration Period|Protocol Violation|0|||
170870399|NCT00975715|617537405|FG000|Maintenance Period|Adverse Event|2|||
170870400|NCT00975715|617537406|FG001|Maintenance Period|Adverse Event|1|||
170870401|NCT04004429|617537407|FG000|Overall Study|Protocol Violation|1|||
170870402|NCT04004429|617537408|FG001|Overall Study|Protocol Violation|0|||
170870403|NCT04004429|617537409|FG002|Overall Study|Protocol Violation|0|||
170870404|NCT04004429|617537407|FG000|Overall Study|Physician Decision|0|||
170870405|NCT04004429|617537408|FG001|Overall Study|Physician Decision|1|||
170870406|NCT04004429|617537409|FG002|Overall Study|Physician Decision|1|||
170870407|NCT04004429|617537407|FG000|Overall Study|Withdrawal by Subject|1|||
170870408|NCT04004429|617537408|FG001|Overall Study|Withdrawal by Subject|1|||
170870409|NCT04004429|617537409|FG002|Overall Study|Withdrawal by Subject|1|||
170870410|NCT01379573|617537426|FG000|Overall Study|Lost to Follow-up|1|||
170870411|NCT01379573|617537426|FG000|Overall Study|Screen Failure|10|||
170522255|NCT00754741|616258106|FG002|Overall Study|Died or disenrolled|54|||
170522256|NCT04152200|616258107|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
170522257|NCT04152200|616258108|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
170522258|NCT04069715|616258109|FG000|Overall Study|Lost to Follow-up|1|||
170522259|NCT04069715|616258110|FG001|Overall Study|Lost to Follow-up|1|||
170522260|NCT04069715|616258109|FG000|Overall Study|Physician Decision|1|||
170522261|NCT04069715|616258110|FG001|Overall Study|Physician Decision|1|||
170522262|NCT04069715|616258109|FG000|Overall Study|Withdrawal by Subject|3|||
170522263|NCT04069715|616258110|FG001|Overall Study|Withdrawal by Subject|3|||
170870412|NCT00433914|617537427|FG000|Overall Study|Withdrawal by Subject|0|||
170870413|NCT00433914|617537428|FG001|Overall Study|Withdrawal by Subject|2|||
170870414|NCT00433914|617537427|FG000|Overall Study|Lost to Follow-up|0|||
170870415|NCT00433914|617537428|FG001|Overall Study|Lost to Follow-up|1|||
170870416|NCT02844920|617537429|FG000|Overall Study|Lost to Follow-up|2|||
170870417|NCT00770770|617537430|FG000|Overall Study|Lost to Follow-up|1|||
170870418|NCT00770770|617537431|FG001|Overall Study|Lost to Follow-up|0|||
170870419|NCT00770770|617537430|FG000|Overall Study|Withdrawal by Subject|1|||
170870420|NCT00770770|617537431|FG001|Overall Study|Withdrawal by Subject|0|||
170870421|NCT00770770|617537430|FG000|Overall Study|Death|0|||
170870422|NCT00770770|617537431|FG001|Overall Study|Death|1|||
170870423|NCT00770770|617537430|FG000|Overall Study|Study Terminated|8|||
170870424|NCT00770770|617537431|FG001|Overall Study|Study Terminated|0|||
170870425|NCT04534491|617537432|FG000|Overall Study|Not completed end-of-study interview|24|||
170870426|NCT04534491|617537432|FG000|Overall Study|Non-users|70|||
170522264|NCT03205150|616258111|FG000|Overall Study|Protocol deviation|1|||
170522265|NCT03205150|616258112|FG001|Overall Study|Protocol deviation|3|||
170522266|NCT03205150|616258113|FG002|Overall Study|Protocol deviation|0|||
170522267|NCT03205150|616258111|FG000|Overall Study|Patient/guardian decision|0|||
170522268|NCT03205150|616258112|FG001|Overall Study|Patient/guardian decision|3|||
170522269|NCT03205150|616258113|FG002|Overall Study|Patient/guardian decision|0|||
170522270|NCT03205150|616258111|FG000|Overall Study|Adverse Event|1|||
170522271|NCT03205150|616258112|FG001|Overall Study|Adverse Event|1|||
170522272|NCT03205150|616258113|FG002|Overall Study|Adverse Event|1|||
170522273|NCT03205150|616258111|FG000|Overall Study|Lost to Follow-up|0|||
170522274|NCT03205150|616258112|FG001|Overall Study|Lost to Follow-up|0|||
170522275|NCT03205150|616258113|FG002|Overall Study|Lost to Follow-up|1|||
170522276|NCT01095835|616258114|FG000|Overall Study|Adverse Event|8|||
170522277|NCT01095835|616258115|FG001|Overall Study|Adverse Event|6|||
170522278|NCT01095835|616258116|FG002|Overall Study|Adverse Event|6|||
170522279|NCT01095835|616258114|FG000|Overall Study|Lack of Efficacy|0|||
170767932|NCT00150176|617155377|FG001|Overall Study|Withdrawal by Subject|12|||
170767933|NCT00150176|617155376|FG000|Overall Study|Lost to Follow-up|3|||
170767934|NCT00150176|617155377|FG001|Overall Study|Lost to Follow-up|3|||
170767935|NCT00150176|617155376|FG000|Overall Study|OTHER|11|||
170767936|NCT00150176|617155377|FG001|Overall Study|OTHER|13|||
170767937|NCT04035668|617155378|FG000|Overall Study|Adverse Event|3|||
170767938|NCT04035668|617155379|FG001|Overall Study|Adverse Event|4|||
170767939|NCT04035668|617155380|FG002|Overall Study|Adverse Event|2|||
170767940|NCT04035668|617155378|FG000|Overall Study|Lost to Follow-up|0|||
170767941|NCT04035668|617155379|FG001|Overall Study|Lost to Follow-up|1|||
170767942|NCT04035668|617155380|FG002|Overall Study|Lost to Follow-up|0|||
170767943|NCT04035668|617155378|FG000|Overall Study|Physician Decision|2|||
170767944|NCT04035668|617155379|FG001|Overall Study|Physician Decision|1|||
170767945|NCT04035668|617155380|FG002|Overall Study|Physician Decision|1|||
170767946|NCT04035668|617155378|FG000|Overall Study|Subject Decision|2|||
170767947|NCT04035668|617155379|FG001|Overall Study|Subject Decision|2|||
170767948|NCT04035668|617155380|FG002|Overall Study|Subject Decision|0|||
170767949|NCT02983617|617155390|FG000|Overall Study|Adverse Event|0|||
170767950|NCT02983617|617155391|FG001|Overall Study|Adverse Event|7|||
170767951|NCT02983617|617155390|FG000|Overall Study|Death|0|||
170767952|NCT02983617|617155391|FG001|Overall Study|Death|1|||
170767953|NCT02983617|617155390|FG000|Overall Study|Investigator's Discretion|0|||
170767954|NCT02983617|617155391|FG001|Overall Study|Investigator's Discretion|1|||
170767955|NCT00114244|617155394|FG000|Overall Study|Adverse Event|2|||
170767956|NCT00114244|617155395|FG001|Overall Study|Adverse Event|5|||
170767957|NCT00114244|617155394|FG000|Overall Study|Withdrawal by Subject|0|||
170767958|NCT00114244|617155395|FG001|Overall Study|Withdrawal by Subject|2|||
170767959|NCT04218110|617155396|FG000|Overall Study|Withdrawal by Subject|0|||
170767960|NCT04218110|617155397|FG001|Overall Study|Withdrawal by Subject|0|||
170767961|NCT04218110|617155398|FG002|Overall Study|Withdrawal by Subject|0|||
170767962|NCT04218110|617155399|FG003|Overall Study|Withdrawal by Subject|1|||
170767963|NCT03923491|617155404|FG000|Overall Study|Lost to Follow-up|5|||
170767964|NCT03923491|617155405|FG001|Overall Study|Lost to Follow-up|8|||
170767965|NCT03923491|617155404|FG000|Overall Study|Withdrawal by Subject|4|||
170767966|NCT03923491|617155405|FG001|Overall Study|Withdrawal by Subject|6|||
170767967|NCT00943735|617155414|FG000|Overall Study|Adverse Event|12|||
170767968|NCT00943735|617155414|FG000|Overall Study|Withdrawal by Subject|8|||
170767969|NCT00943735|617155414|FG000|Overall Study|Death|1|||
170767970|NCT00943735|617155414|FG000|Overall Study|Other|8|||
170767971|NCT00943735|617155414|FG000|Overall Study|Other|3|||
170767972|NCT01786564|617155415|FG000|Overall Study|Lost to Follow-up|47|||
170767973|NCT01786564|617155415|FG000|Overall Study|Ineligible|17|||
170767974|NCT01027286|617155416|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
170767975|NCT01027286|617155417|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
170767976|NCT01027286|617155416|FG000|Overall Study|Lost to Follow-up|0|||
170767977|NCT01027286|617155417|FG001|Overall Study|Lost to Follow-up|1|||
170522280|NCT01095835|616258115|FG001|Overall Study|Lack of Efficacy|1|||
170522281|NCT01095835|616258116|FG002|Overall Study|Lack of Efficacy|0|||
170522282|NCT01095835|616258114|FG000|Overall Study|Physician Decision|0|||
170522283|NCT01095835|616258115|FG001|Overall Study|Physician Decision|0|||
170522284|NCT01095835|616258116|FG002|Overall Study|Physician Decision|1|||
170522285|NCT01095835|616258114|FG000|Overall Study|Withdrawal by Subject|1|||
170522286|NCT01095835|616258115|FG001|Overall Study|Withdrawal by Subject|3|||
170522287|NCT01095835|616258116|FG002|Overall Study|Withdrawal by Subject|0|||
170767978|NCT03192046|617155418|FG000|Overall Study|Withdrawal by Subject|1|||
170767979|NCT03192046|617155419|FG001|Overall Study|Withdrawal by Subject|1|||
170767980|NCT00762606|617155420|FG000|Overall Study|Lost to Follow-up|18|||
170767981|NCT00762606|617155421|FG001|Overall Study|Lost to Follow-up|13|||
170767982|NCT00530842|617155422|FG000|Overall Study|Adverse Event|10|||
170767983|NCT00530842|617155423|FG001|Overall Study|Adverse Event|6|||
170767984|NCT00530842|617155422|FG000|Overall Study|Lack of Efficacy|2|||
170767985|NCT00530842|617155423|FG001|Overall Study|Lack of Efficacy|1|||
170767986|NCT00530842|617155422|FG000|Overall Study|Lost to Follow-up|0|||
170767987|NCT00530842|617155423|FG001|Overall Study|Lost to Follow-up|4|||
170870427|NCT04534491|617537432|FG000|Overall Study|Non-verifiable users|58|||
170870428|NCT01299376|617537433|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
170870429|NCT01299376|617537434|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
170870430|NCT01299376|617537433|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
170870431|NCT01299376|617537434|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
170870432|NCT01299376|617537433|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
170870433|NCT01299376|617537434|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
170870434|NCT01299376|617537433|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
170870435|NCT01299376|617537434|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
170870436|NCT01299376|617537433|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
170870437|NCT01299376|617537434|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
170870438|NCT01299376|617537433|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
170870439|NCT01299376|617537434|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
170870440|NCT01299376|617537433|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
170870441|NCT01299376|617537434|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
170870442|NCT01299376|617537433|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
170870443|NCT01299376|617537434|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
170870444|NCT01299376|617537433|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
170870445|NCT01299376|617537434|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
170870446|NCT01299376|617537433|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
170870447|NCT01299376|617537434|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
170870448|NCT01299376|617537433|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
170870449|NCT01299376|617537434|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
170870450|NCT00766090|617537437|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870451|NCT00766090|617537438|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870452|NCT00766090|617537439|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870453|NCT00766090|617537440|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870454|NCT00766090|617537441|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870455|NCT00766090|617537442|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870456|NCT00766090|617537443|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870457|NCT00766090|617537444|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870458|NCT00766090|617537445|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
170870459|NCT00766090|617537446|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870460|NCT00766090|617537447|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870461|NCT00766090|617537448|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170870462|NCT00766090|617537437|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
170522288|NCT01095835|616258114|FG000|Overall Study|Non study compliance|0|||
170522289|NCT01095835|616258115|FG001|Overall Study|Non study compliance|0|||
170522290|NCT01095835|616258116|FG002|Overall Study|Non study compliance|1|||
170522291|NCT01095835|616258114|FG000|Overall Study|Protocol Violation|1|||
170522292|NCT01095835|616258115|FG001|Overall Study|Protocol Violation|2|||
170522293|NCT01095835|616258116|FG002|Overall Study|Protocol Violation|0|||
170522294|NCT02486692|616258117|FG000|Overall Study|did not login for randomization|4|||
170522295|NCT02486692|616258118|FG001|Overall Study|did not login for randomization|7|||
170522296|NCT03028142|616258119|FG000|Overall Study|Adverse Event|1|||
170522297|NCT03028142|616258120|FG001|Overall Study|Adverse Event|1|||
170522298|NCT03028142|616258121|FG002|Overall Study|Adverse Event|0|||
170522299|NCT03028142|616258122|FG003|Overall Study|Adverse Event|0|||
170522300|NCT03028142|616258123|FG004|Overall Study|Adverse Event|0|||
170522301|NCT03028142|616258124|FG005|Overall Study|Adverse Event|1|||
170522302|NCT03028142|616258119|FG000|Overall Study|Withdrawal by Subject|0|||
170522303|NCT03028142|616258120|FG001|Overall Study|Withdrawal by Subject|0|||
170522304|NCT03028142|616258121|FG002|Overall Study|Withdrawal by Subject|0|||
170522305|NCT03028142|616258122|FG003|Overall Study|Withdrawal by Subject|0|||
170522306|NCT03028142|616258123|FG004|Overall Study|Withdrawal by Subject|1|||
170522307|NCT03028142|616258124|FG005|Overall Study|Withdrawal by Subject|0|||
170522308|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
170522309|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
170522310|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
170522311|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
170522312|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
170522313|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
170522314|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
170522315|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
170522316|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
170522317|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
170522318|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
170522319|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
170522320|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
170522321|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
170522322|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
170767988|NCT00530842|617155422|FG000|Overall Study|Protocol Violation|3|||
170767989|NCT00530842|617155423|FG001|Overall Study|Protocol Violation|2|||
170412236|NCT03433274|615849219|FG000|Overall Study|Missed visit|5|||
170412237|NCT03433274|615849219|FG000|Overall Study|Death|23|||
170412238|NCT00441584|615849220|FG000|Overall Study|Lack of Efficacy|79|||
170412239|NCT00441584|615849220|FG000|Overall Study|Withdrawal by Subject|8|||
170412240|NCT00441584|615849220|FG000|Overall Study|Adverse Event|6|||
170412241|NCT00441584|615849220|FG000|Overall Study|Protocol Violation|5|||
170412242|NCT00441584|615849220|FG000|Overall Study|Lost to Follow-up|4|||
170412243|NCT00441584|615849220|FG000|Overall Study|Failure to meet eligibility criteria|3|||
170412244|NCT01595009|615849221|FG000|Core|Patients completed per protocol|85|||
170412245|NCT01595009|615849222|FG001|Core|Patients completed per protocol|44|||
170412246|NCT01595009|615849223|FG002|Core|Patients completed per protocol|0|||
170412247|NCT01595009|615849224|FG003|Core|Patients completed per protocol|0|||
170412248|NCT01595009|615849221|FG000|Core|Adverse Event|19|||
170412249|NCT01595009|615849222|FG001|Core|Adverse Event|23|||
170412250|NCT01595009|615849223|FG002|Core|Adverse Event|0|||
170767990|NCT00530842|617155422|FG000|Overall Study|Withdrawal by Subject|4|||
170767991|NCT00530842|617155423|FG001|Overall Study|Withdrawal by Subject|5|||
170767992|NCT00530842|617155422|FG000|Overall Study|Individual different reasons|4|||
170767993|NCT00530842|617155423|FG001|Overall Study|Individual different reasons|3|||
170767994|NCT00530842|617155422|FG000|Period 1|Adverse Event|7|||
170767995|NCT00530842|617155423|FG001|Period 1|Adverse Event|3|||
170767996|NCT00530842|617155422|FG000|Period 1|Lack of Efficacy|1|||
170767997|NCT00530842|617155423|FG001|Period 1|Lack of Efficacy|1|||
170767998|NCT00530842|617155422|FG000|Period 1|Protocol Violation|2|||
170767999|NCT00530842|617155423|FG001|Period 1|Protocol Violation|1|||
170768000|NCT00530842|617155422|FG000|Period 1|Withdrawal by Subject|2|||
170768001|NCT00530842|617155423|FG001|Period 1|Withdrawal by Subject|3|||
170768002|NCT00530842|617155422|FG000|Period 1|Individual different reasons|2|||
170768003|NCT00530842|617155423|FG001|Period 1|Individual different reasons|3|||
170768004|NCT00530842|617155422|FG000|Period 2|Adverse Event|3|||
170768005|NCT00530842|617155423|FG001|Period 2|Adverse Event|3|||
170768006|NCT00530842|617155422|FG000|Period 2|Lack of Efficacy|1|||
170768007|NCT00530842|617155423|FG001|Period 2|Lack of Efficacy|0|||
170768008|NCT00530842|617155422|FG000|Period 2|Lost to Follow-up|0|||
170768009|NCT00530842|617155423|FG001|Period 2|Lost to Follow-up|4|||
170768010|NCT00530842|617155422|FG000|Period 2|Protocol Violation|1|||
170768011|NCT00530842|617155423|FG001|Period 2|Protocol Violation|0|||
170768012|NCT00530842|617155422|FG000|Period 2|Withdrawal by Subject|1|||
170768013|NCT00530842|617155423|FG001|Period 2|Withdrawal by Subject|2|||
170768014|NCT00530842|617155422|FG000|Period 2|Individual different reasons|2|||
170768015|NCT00530842|617155423|FG001|Period 2|Individual different reasons|0|||
170768016|NCT02808338|617155428|FG000|Screening|Screen Failure|10|||
170768017|NCT02808338|617155428|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
170768018|NCT02808338|617155428|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
170768019|NCT02194933|617155429|FG000|Overall Study|Lost to Follow-up|1|||
170768020|NCT02194933|617155430|FG001|Overall Study|Lost to Follow-up|2|||
170768021|NCT02194933|617155429|FG000|Overall Study|Participant met withdrawal criteria|1|||
170768022|NCT02194933|617155430|FG001|Overall Study|Participant met withdrawal criteria|3|||
170768023|NCT02194933|617155429|FG000|Overall Study|Withdrawal by Subject|0|||
170768024|NCT02194933|617155430|FG001|Overall Study|Withdrawal by Subject|2|||
170768025|NCT02194933|617155429|FG000|Overall Study|Lack of Efficacy|1|||
170768026|NCT02194933|617155430|FG001|Overall Study|Lack of Efficacy|2|||
170768027|NCT00057837|617155433|FG000|Overall Study|Progression/relapse|12|||
170768028|NCT00057837|617155434|FG001|Overall Study|Progression/relapse|14|||
170768029|NCT00057837|617155433|FG000|Overall Study|Adverse Event|2|||
170768030|NCT00057837|617155434|FG001|Overall Study|Adverse Event|12|||
170768031|NCT00057837|617155433|FG000|Overall Study|Death|5|||
170768032|NCT00057837|617155434|FG001|Overall Study|Death|4|||
170768033|NCT00057837|617155433|FG000|Overall Study|Withdrawal by Subject|5|||
170768034|NCT00057837|617155434|FG001|Overall Study|Withdrawal by Subject|3|||
170768035|NCT00057837|617155433|FG000|Overall Study|Alternative therapy|0|||
170768036|NCT00057837|617155434|FG001|Overall Study|Alternative therapy|1|||
170768037|NCT00057837|617155433|FG000|Overall Study|Other complicating disease|2|||
170768038|NCT00057837|617155434|FG001|Overall Study|Other complicating disease|1|||
170768039|NCT00057837|617155433|FG000|Overall Study|Physician Decision|1|||
170768040|NCT00057837|617155434|FG001|Overall Study|Physician Decision|0|||
170412251|NCT01595009|615849224|FG003|Core|Adverse Event|0|||
170412252|NCT01595009|615849221|FG000|Core|Disease progression|14|||
170412253|NCT01595009|615849222|FG001|Core|Disease progression|26|||
170768041|NCT00057837|617155433|FG000|Overall Study|Ineligible|3|||
170768042|NCT00057837|617155434|FG001|Overall Study|Ineligible|3|||
170768043|NCT00057837|617155433|FG000|Overall Study|Never started treatment|1|||
170768044|NCT00057837|617155434|FG001|Overall Study|Never started treatment|1|||
170768045|NCT02000817|617155435|FG000|Overall Study|Withdrawal by Subject|2|||
170768046|NCT02000817|617155436|FG001|Overall Study|Withdrawal by Subject|0|||
170768047|NCT02000817|617155437|FG002|Overall Study|Withdrawal by Subject|0|||
170870463|NCT00766090|617537438|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870464|NCT00766090|617537439|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870465|NCT00766090|617537440|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870466|NCT00766090|617537441|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870467|NCT00766090|617537442|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870468|NCT00766090|617537443|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870469|NCT00766090|617537444|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870470|NCT00766090|617537445|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870471|NCT00766090|617537446|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870472|NCT00766090|617537447|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870473|NCT00766090|617537448|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
170870474|NCT00766090|617537437|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
170870475|NCT00766090|617537438|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870476|NCT00766090|617537439|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870477|NCT00766090|617537440|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
170870478|NCT00766090|617537441|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870479|NCT00766090|617537442|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870480|NCT00766090|617537443|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870481|NCT00766090|617537444|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870482|NCT00766090|617537445|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870483|NCT00766090|617537446|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870484|NCT00766090|617537447|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870485|NCT00766090|617537448|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170870486|NCT00766090|617537437|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870487|NCT00766090|617537438|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870488|NCT00766090|617537439|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
170870489|NCT00766090|617537440|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870490|NCT00766090|617537441|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870491|NCT00766090|617537442|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870492|NCT00766090|617537443|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870493|NCT00766090|617537444|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870494|NCT00766090|617537445|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870495|NCT00766090|617537446|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870496|NCT00766090|617537447|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870497|NCT00766090|617537448|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
170870498|NCT00766090|617537437|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870499|NCT00766090|617537438|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870500|NCT00766090|617537439|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870501|NCT00766090|617537440|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870502|NCT00766090|617537441|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
170412254|NCT01595009|615849223|FG002|Core|Disease progression|0|||
170412255|NCT01595009|615849224|FG003|Core|Disease progression|0|||
170412256|NCT01595009|615849221|FG000|Core|Withdrawal by Subject|4|||
170412257|NCT01595009|615849222|FG001|Core|Withdrawal by Subject|17|||
170412258|NCT01595009|615849223|FG002|Core|Withdrawal by Subject|0|||
170412259|NCT01595009|615849224|FG003|Core|Withdrawal by Subject|0|||
170412260|NCT01595009|615849221|FG000|Core|Death|3|||
170412261|NCT01595009|615849222|FG001|Core|Death|6|||
170412262|NCT01595009|615849223|FG002|Core|Death|0|||
170412263|NCT01595009|615849224|FG003|Core|Death|0|||
170412264|NCT01595009|615849221|FG000|Core|Lost to Follow-up|1|||
170412265|NCT01595009|615849222|FG001|Core|Lost to Follow-up|2|||
170412266|NCT01595009|615849223|FG002|Core|Lost to Follow-up|0|||
170412267|NCT01595009|615849224|FG003|Core|Lost to Follow-up|0|||
170412268|NCT01595009|615849221|FG000|Core|Protocol deviation|0|||
170412269|NCT01595009|615849222|FG001|Core|Protocol deviation|1|||
170412270|NCT01595009|615849223|FG002|Core|Protocol deviation|0|||
170412271|NCT01595009|615849224|FG003|Core|Protocol deviation|0|||
170412272|NCT01595009|615849221|FG000|Core|Administrative problems|0|||
170412273|NCT01595009|615849222|FG001|Core|Administrative problems|1|||
170870503|NCT00766090|617537442|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870504|NCT00766090|617537443|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870505|NCT00766090|617537444|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870506|NCT00766090|617537445|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870507|NCT00766090|617537446|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170412274|NCT01595009|615849223|FG002|Core|Administrative problems|0|||
170412275|NCT01595009|615849224|FG003|Core|Administrative problems|0|||
170412276|NCT01595009|615849221|FG000|Extension|Administrative problems|0|||
170412277|NCT01595009|615849222|FG001|Extension|Administrative problems|0|||
170412278|NCT01595009|615849223|FG002|Extension|Administrative problems|0|||
170412279|NCT01595009|615849224|FG003|Extension|Administrative problems|1|||
170412280|NCT01595009|615849221|FG000|Extension|Patients completed per protocol|0|||
170412281|NCT01595009|615849222|FG001|Extension|Patients completed per protocol|0|||
170870508|NCT00766090|617537447|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170412282|NCT01595009|615849223|FG002|Extension|Patients completed per protocol|0|||
170768048|NCT02000817|617155438|FG003|Overall Study|Withdrawal by Subject|0|||
170768049|NCT02000817|617155435|FG000|Overall Study|Adverse Event|0|||
170768050|NCT02000817|617155436|FG001|Overall Study|Adverse Event|1|||
170768051|NCT02000817|617155437|FG002|Overall Study|Adverse Event|0|||
170768052|NCT02000817|617155438|FG003|Overall Study|Adverse Event|0|||
170768053|NCT02000817|617155435|FG000|Overall Study|Lost to Follow-up|0|||
170768054|NCT02000817|617155436|FG001|Overall Study|Lost to Follow-up|0|||
170768055|NCT02000817|617155437|FG002|Overall Study|Lost to Follow-up|1|||
170768056|NCT02000817|617155438|FG003|Overall Study|Lost to Follow-up|0|||
170768057|NCT05686421|617155441|FG000|Overall Study|Screen failure|22|||
170768058|NCT05686421|617155442|FG001|Overall Study|Screen failure|0|||
170768059|NCT05686421|617155443|FG002|Overall Study|Screen failure|0|||
170768060|NCT05686421|617155444|FG003|Overall Study|Screen failure|0|||
170768061|NCT02807493|617155445|FG000|Overall Study|Adverse Event|5|||
170768062|NCT02807493|617155446|FG001|Overall Study|Adverse Event|2|||
170768063|NCT02807493|617155445|FG000|Overall Study|Lost to Follow-up|6|||
170768064|NCT02807493|617155446|FG001|Overall Study|Lost to Follow-up|0|||
170768065|NCT02807493|617155445|FG000|Overall Study|Physician Decision|4|||
170768066|NCT02807493|617155446|FG001|Overall Study|Physician Decision|1|||
170768067|NCT02807493|617155445|FG000|Overall Study|Protocol Violation|7|||
170768068|NCT02807493|617155446|FG001|Overall Study|Protocol Violation|0|||
170768069|NCT02807493|617155445|FG000|Overall Study|Withdrawal by Subject|17|||
170768070|NCT02807493|617155446|FG001|Overall Study|Withdrawal by Subject|10|||
170768071|NCT02807493|617155445|FG000|Overall Study|Other withdrawal|17|||
170768072|NCT02807493|617155446|FG001|Overall Study|Other withdrawal|0|||
170768073|NCT02807493|617155445|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
170768074|NCT02807493|617155446|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
170768075|NCT01493778|617155447|FG000|Overall Study|Withdrawal by Subject|8|||
170768076|NCT00940992|617155448|FG000|Overall Study|Adverse Event|2|||
170768077|NCT00940992|617155449|FG001|Overall Study|Adverse Event|0|||
170768078|NCT00940992|617155450|FG002|Overall Study|Adverse Event|1|||
170768079|NCT00940992|617155448|FG000|Overall Study|subject request|2|||
170768080|NCT00940992|617155449|FG001|Overall Study|subject request|1|||
170768081|NCT00940992|617155450|FG002|Overall Study|subject request|0|||
170768082|NCT00940992|617155448|FG000|Overall Study|Lost to Follow-up|0|||
170768083|NCT00940992|617155449|FG001|Overall Study|Lost to Follow-up|1|||
170768084|NCT00940992|617155450|FG002|Overall Study|Lost to Follow-up|1|||
170768085|NCT00811057|617155454|FG000|Overall Study|Protocol Violation|5|||
170768086|NCT00811057|617155455|FG001|Overall Study|Protocol Violation|10|||
170768087|NCT00811057|617155456|FG002|Overall Study|Protocol Violation|10|||
170768088|NCT02289560|617155467|FG000|Overall Study|Lost to Follow-up|6|||
170768089|NCT02289560|617155467|FG000|Overall Study|Alternative Treatment|4|||
170768090|NCT02289560|617155467|FG000|Overall Study|Inadequate Treatment|2|||
170768091|NCT02289560|617155467|FG000|Overall Study|Withdrawal by Subject|23|||
170768092|NCT02540213|617155468|FG000|Overall Study|Death/adverse event|18|||
170768093|NCT02540213|617155468|FG000|Overall Study|Administrative reasons|3|||
170768094|NCT02540213|617155468|FG000|Overall Study|Kidney transplant|3|||
170768095|NCT02540213|617155468|FG000|Overall Study|Lack of Efficacy|6|||
170768096|NCT02540213|617155468|FG000|Overall Study|Consent withdrawn|7|||
170412283|NCT01595009|615849224|FG003|Extension|Patients completed per protocol|2|||
170412284|NCT01595009|615849221|FG000|Extension|Disease progression|0|||
170412285|NCT01595009|615849222|FG001|Extension|Disease progression|0|||
170412286|NCT01595009|615849223|FG002|Extension|Disease progression|4|||
170412287|NCT01595009|615849224|FG003|Extension|Disease progression|7|||
170412288|NCT01595009|615849221|FG000|Extension|Adverse Event|0|||
170412289|NCT01595009|615849222|FG001|Extension|Adverse Event|0|||
170412290|NCT01595009|615849223|FG002|Extension|Adverse Event|0|||
170412291|NCT01595009|615849224|FG003|Extension|Adverse Event|1|||
170412292|NCT02623829|615849231|FG000|Overall Study|Lost to Follow-up|1|||
170412293|NCT02623829|615849232|FG001|Overall Study|Lost to Follow-up|1|||
170412294|NCT00681863|615849235|FG000|Overall Study|Adverse Event|1|||
170412295|NCT00681863|615849235|FG000|Overall Study|Lost to Follow-up|2|||
170412296|NCT00681863|615849235|FG000|Overall Study|Lack of Efficacy|2|||
170768097|NCT02540213|617155468|FG000|Overall Study|Enrolled but not treated|2|||
170412297|NCT00681863|615849235|FG000|Overall Study|Other|18|||
170412298|NCT01388647|615849250|FG000|Overall Study|Adverse Event|1|||
170412299|NCT01388647|615849251|FG001|Overall Study|Adverse Event|2|||
170412300|NCT00542386|615849252|FG000|Overall Study|Adverse Event|1|||
170768098|NCT00536380|617155469|FG000|Overall Study|Adverse Event|0|||
170768099|NCT00536380|617155470|FG001|Overall Study|Adverse Event|2|||
170768100|NCT00536380|617155471|FG002|Overall Study|Adverse Event|2|||
170768101|NCT00536380|617155469|FG000|Overall Study|Lost to Follow-up|0|||
170768102|NCT00536380|617155470|FG001|Overall Study|Lost to Follow-up|0|||
170768103|NCT00536380|617155471|FG002|Overall Study|Lost to Follow-up|1|||
170768104|NCT00536380|617155469|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
170768105|NCT00536380|617155470|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
170768106|NCT00536380|617155471|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
170768107|NCT00536380|617155469|FG000|Overall Study|Withdrawal related to study drug|7|||
170768108|NCT00536380|617155470|FG001|Overall Study|Withdrawal related to study drug|5|||
170870509|NCT00766090|617537448|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170870510|NCT00766090|617537437|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870511|NCT00766090|617537438|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870512|NCT00766090|617537439|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
170870513|NCT00766090|617537440|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870514|NCT00766090|617537441|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870515|NCT00766090|617537442|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870516|NCT00766090|617537443|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870517|NCT00766090|617537444|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870518|NCT00766090|617537445|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870519|NCT00766090|617537446|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870520|NCT00766090|617537447|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870521|NCT00766090|617537448|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
170870522|NCT00766090|617537437|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
170870523|NCT00766090|617537438|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
170870524|NCT00766090|617537439|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
170870525|NCT00766090|617537440|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
170870526|NCT00766090|617537441|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
170870527|NCT00766090|617537442|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
170870528|NCT00766090|617537443|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
170870529|NCT00766090|617537444|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
170870530|NCT00766090|617537445|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
170870531|NCT00766090|617537446|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
170870532|NCT00766090|617537447|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
170870533|NCT00766090|617537448|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
170870534|NCT00766090|617537437|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870535|NCT00766090|617537438|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870536|NCT00766090|617537439|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870537|NCT00766090|617537440|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870538|NCT00766090|617537441|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870539|NCT00766090|617537442|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
170870540|NCT00766090|617537443|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870541|NCT00766090|617537444|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870542|NCT00766090|617537445|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870543|NCT00766090|617537446|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870544|NCT00766090|617537447|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870545|NCT00766090|617537448|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
170870546|NCT00766090|617537437|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870547|NCT00766090|617537438|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
170870548|NCT00766090|617537439|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870549|NCT00766090|617537440|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
170870550|NCT00766090|617537441|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870551|NCT00766090|617537442|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870552|NCT00766090|617537443|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870553|NCT00766090|617537444|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870554|NCT00766090|617537445|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870555|NCT00766090|617537446|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870556|NCT00766090|617537447|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
170870557|NCT00766090|617537448|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
170870558|NCT00766090|617537437|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870559|NCT00766090|617537438|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870560|NCT00766090|617537439|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870561|NCT00766090|617537440|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870562|NCT00766090|617537441|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
170870563|NCT00766090|617537442|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870564|NCT00766090|617537443|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870565|NCT00766090|617537444|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870566|NCT00766090|617537445|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870567|NCT00766090|617537446|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870568|NCT00766090|617537447|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870569|NCT00766090|617537448|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
170870570|NCT00800436|617537449|FG000|Overall Study|Withdrawal by Subject|0|||
170870571|NCT00800436|617537450|FG001|Overall Study|Withdrawal by Subject|0|||
170870572|NCT00800436|617537451|FG002|Overall Study|Withdrawal by Subject|1|||
170870573|NCT00800436|617537452|FG003|Overall Study|Withdrawal by Subject|1|||
170870574|NCT00800436|617537453|FG004|Overall Study|Withdrawal by Subject|0|||
170870575|NCT00800436|617537454|FG005|Overall Study|Withdrawal by Subject|0|||
170870576|NCT00800436|617537455|FG006|Overall Study|Withdrawal by Subject|0|||
170870577|NCT00711529|617537464|FG000|Overall Study|Protocol Violation|2|||
170870578|NCT00711529|617537465|FG001|Overall Study|Protocol Violation|0|||
170870579|NCT00711529|617537464|FG000|Overall Study|Withdrawal by Subject|2|||
170870580|NCT00711529|617537465|FG001|Overall Study|Withdrawal by Subject|6|||
170870581|NCT03024970|617537471|FG000|First Intervention|Adverse Event|1|||
170870582|NCT03024970|617537472|FG001|First Intervention|Adverse Event|0|||
170870583|NCT03024970|617537471|FG000|Second Intervention|Lost to Follow-up|1|||
170870584|NCT03024970|617537472|FG001|Second Intervention|Lost to Follow-up|0|||
170870585|NCT03681951|617537475|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
170870586|NCT03681951|617537476|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
170870587|NCT03681951|617537477|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
170870588|NCT03681951|617537478|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
170870589|NCT03681951|617537479|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
170870590|NCT03681951|617537480|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
170870591|NCT03681951|617537481|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
170870592|NCT03681951|617537482|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
170870593|NCT03681951|617537475|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
170870594|NCT03681951|617537476|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
170870595|NCT03681951|617537477|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
170870596|NCT03681951|617537478|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
170870597|NCT03681951|617537479|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
170870598|NCT03681951|617537480|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
170870599|NCT03681951|617537481|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
170870600|NCT03681951|617537482|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
170870601|NCT03681951|617537475|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
170870602|NCT03681951|617537476|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
170870603|NCT03681951|617537477|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
170870604|NCT03681951|617537478|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
170870605|NCT03681951|617537479|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
170870606|NCT03681951|617537480|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
170870607|NCT03681951|617537481|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
170870608|NCT03681951|617537482|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
170870609|NCT00131469|617537483|FG000|Overall Study|Withdrawal by Subject|3|||
170870610|NCT00131469|617537484|FG001|Overall Study|Withdrawal by Subject|4|||
170870611|NCT00131469|617537483|FG000|Overall Study|Protocol Violation|3|||
170870612|NCT00131469|617537484|FG001|Overall Study|Protocol Violation|1|||
170870613|NCT00131469|617537483|FG000|Overall Study|Death|0|||
170870614|NCT00131469|617537484|FG001|Overall Study|Death|1|||
170870615|NCT00131469|617537483|FG000|Overall Study|Lost to Follow-up|0|||
170870616|NCT00131469|617537484|FG001|Overall Study|Lost to Follow-up|1|||
170870617|NCT00131469|617537483|FG000|Overall Study|scan not analyzable|3|||
170870618|NCT00131469|617537484|FG001|Overall Study|scan not analyzable|6|||
170870619|NCT01106027|617537485|FG000|Overall Study|Lost graft early, discontinued|1|||
170870620|NCT02653300|617537487|FG000|Overall Study|Withdrawal by Subject|2|||
170870621|NCT00356889|617537488|FG000|Overall Study|Protocol Violation|2|||
170870622|NCT00356889|617537488|FG000|Overall Study|Adverse Event|1|||
170870623|NCT02247960|617537489|FG000|Patient Consent and Randomization|Physician Decision|2|||
170870624|NCT02247960|617537490|FG001|Patient Consent and Randomization|Physician Decision|2|||
170870625|NCT02247960|617537489|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
170870626|NCT02247960|617537490|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
170870627|NCT02247960|617537489|FG000|Catheter Removed|Lost to Follow-up|7|||
170870628|NCT02247960|617537490|FG001|Catheter Removed|Lost to Follow-up|10|||
170870629|NCT01848353|617537491|FG000|Phase 1|Withdrawal by Subject|3|||
170870630|NCT01848353|617537492|FG001|Phase 1|Withdrawal by Subject|1|||
170870631|NCT01848353|617537493|FG002|Phase 1|Withdrawal by Subject|0|||
170870632|NCT01848353|617537494|FG003|Phase 1|Withdrawal by Subject|0|||
170870633|NCT01848353|617537491|FG000|Phase 2|Withdrawal by Subject|3|||
170870634|NCT01848353|617537492|FG001|Phase 2|Withdrawal by Subject|2|||
170870635|NCT01848353|617537493|FG002|Phase 2|Withdrawal by Subject|0|||
170870636|NCT01848353|617537494|FG003|Phase 2|Withdrawal by Subject|0|||
170870637|NCT01848353|617537491|FG000|Phase 3|Withdrawal by Subject|1|||
170870638|NCT01848353|617537492|FG001|Phase 3|Withdrawal by Subject|1|||
170870639|NCT01848353|617537493|FG002|Phase 3|Withdrawal by Subject|0|||
170412301|NCT00542386|615849253|FG001|Overall Study|Adverse Event|7|||
170412302|NCT00542386|615849254|FG002|Overall Study|Adverse Event|7|||
170412303|NCT00542386|615849255|FG003|Overall Study|Adverse Event|8|||
170870640|NCT01848353|617537494|FG003|Phase 3|Withdrawal by Subject|0|||
170870641|NCT01910116|617537499|FG000|Overall Study|Adverse Event|0|||
170870642|NCT01910116|617537500|FG001|Overall Study|Adverse Event|3|||
170870643|NCT01910116|617537499|FG000|Overall Study|Lack of Efficacy|3|||
170870644|NCT01910116|617537500|FG001|Overall Study|Lack of Efficacy|4|||
170870645|NCT01910116|617537499|FG000|Overall Study|Lost to Follow-up|1|||
170870646|NCT01910116|617537500|FG001|Overall Study|Lost to Follow-up|0|||
170870647|NCT01910116|617537499|FG000|Overall Study|Protocol Violation|1|||
170870648|NCT01910116|617537500|FG001|Overall Study|Protocol Violation|2|||
170870649|NCT01910116|617537499|FG000|Overall Study|Withdrawal by Subject|8|||
170522323|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
170522324|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
170522325|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
170522326|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
170522327|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
170522328|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
170522329|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
170522330|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
170522331|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
170522332|NCT01198002|616258125|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
170522333|NCT01198002|616258126|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
170522334|NCT01198002|616258127|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
170522335|NCT01198002|616258125|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
170522336|NCT01198002|616258126|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
170522337|NCT01198002|616258127|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
170522338|NCT01198002|616258125|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
170522339|NCT01198002|616258126|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
170522340|NCT01198002|616258127|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
170522341|NCT01198002|616258125|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
170522342|NCT01198002|616258126|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
170522343|NCT01198002|616258127|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
170522344|NCT01198002|616258125|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
170522345|NCT01198002|616258126|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
170522346|NCT01198002|616258127|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
170522347|NCT01198002|616258125|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
170522348|NCT01198002|616258126|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
170522349|NCT01198002|616258127|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
170522350|NCT01198002|616258125|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
170522351|NCT01198002|616258126|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
170522352|NCT01198002|616258127|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
170522353|NCT00116688|616258131|FG000|Overall Study|Protocol deviation|1|||
170522354|NCT00116688|616258132|FG001|Overall Study|Protocol deviation|0|||
170522355|NCT00116688|616258131|FG000|Overall Study|Noncompliance|3|||
170522356|NCT00116688|616258132|FG001|Overall Study|Noncompliance|1|||
170522357|NCT00116688|616258131|FG000|Overall Study|Adverse Event|11|||
170522358|NCT00116688|616258132|FG001|Overall Study|Adverse Event|0|||
170768109|NCT00536380|617155471|FG002|Overall Study|Withdrawal related to study drug|2|||
170768110|NCT00536380|617155469|FG000|Overall Study|Noncompliance with protocol|3|||
170768111|NCT00536380|617155470|FG001|Overall Study|Noncompliance with protocol|2|||
170768112|NCT00536380|617155471|FG002|Overall Study|Noncompliance with protocol|2|||
170768113|NCT00536380|617155469|FG000|Overall Study|Did not meet protocol eligibility|0|||
170768114|NCT00536380|617155470|FG001|Overall Study|Did not meet protocol eligibility|0|||
170768115|NCT00536380|617155471|FG002|Overall Study|Did not meet protocol eligibility|1|||
170768116|NCT00536380|617155469|FG000|Overall Study|Administrative|0|||
170768117|NCT00536380|617155470|FG001|Overall Study|Administrative|0|||
170768118|NCT00536380|617155471|FG002|Overall Study|Administrative|1|||
170768119|NCT00290706|617155472|FG000|Overall Study|Withdrawal by Subject|2|||
170768120|NCT00290706|617155473|FG001|Overall Study|Withdrawal by Subject|0|||
170768121|NCT00290706|617155474|FG002|Overall Study|Withdrawal by Subject|0|||
170768122|NCT00290706|617155475|FG003|Overall Study|Withdrawal by Subject|0|||
170768123|NCT00290706|617155472|FG000|Overall Study|Progressive Disease|3|||
170768124|NCT00290706|617155473|FG001|Overall Study|Progressive Disease|5|||
170768125|NCT00290706|617155474|FG002|Overall Study|Progressive Disease|4|||
170768126|NCT00290706|617155475|FG003|Overall Study|Progressive Disease|10|||
170768127|NCT00290706|617155472|FG000|Overall Study|Adverse Event|0|||
170768128|NCT00290706|617155473|FG001|Overall Study|Adverse Event|1|||
170768129|NCT00290706|617155474|FG002|Overall Study|Adverse Event|2|||
170768130|NCT00290706|617155475|FG003|Overall Study|Adverse Event|0|||
170768131|NCT00290706|617155472|FG000|Overall Study|Receive auto transplant or radiation|0|||
170768132|NCT00290706|617155473|FG001|Overall Study|Receive auto transplant or radiation|0|||
170768133|NCT00290706|617155474|FG002|Overall Study|Receive auto transplant or radiation|0|||
170870650|NCT01910116|617537500|FG001|Overall Study|Withdrawal by Subject|3|||
170522359|NCT00116688|616258131|FG000|Overall Study|Withdrawal by Subject|26|||
170522360|NCT00116688|616258132|FG001|Overall Study|Withdrawal by Subject|2|||
170768134|NCT00290706|617155475|FG003|Overall Study|Receive auto transplant or radiation|1|||
170768135|NCT00290706|617155472|FG000|Overall Study|Physician Decision|0|||
170768136|NCT00290706|617155473|FG001|Overall Study|Physician Decision|0|||
170768137|NCT00290706|617155474|FG002|Overall Study|Physician Decision|0|||
170768138|NCT00290706|617155475|FG003|Overall Study|Physician Decision|1|||
170768139|NCT03768206|617155478|FG000|Overall Study|Lost to Follow-up|2|||
170768140|NCT03768206|617155479|FG001|Overall Study|Lost to Follow-up|1|||
170768141|NCT03768206|617155478|FG000|Overall Study|Withdrawal by Subject|0|||
170870651|NCT01910116|617537499|FG000|Overall Study|uncertain allocation|1|||
170870652|NCT01910116|617537500|FG001|Overall Study|uncertain allocation|3|||
170870653|NCT01910116|617537499|FG000|Overall Study|incomplete data|0|||
170870654|NCT01910116|617537500|FG001|Overall Study|incomplete data|1|||
170870655|NCT02289352|617537501|FG000|Overall Study|Withdrawal by Subject|1|||
170870656|NCT02289352|617537502|FG001|Overall Study|Withdrawal by Subject|1|||
170870657|NCT02289352|617537503|FG002|Overall Study|Withdrawal by Subject|0|||
170870658|NCT03606980|617537504|FG000|Overall Study|Lost to Follow-up|3|||
170870659|NCT03606980|617537505|FG001|Overall Study|Lost to Follow-up|2|||
170870660|NCT03606980|617537506|FG002|Overall Study|Lost to Follow-up|3|||
170870661|NCT03606980|617537504|FG000|Overall Study|Withdrawal by Subject|1|||
170870662|NCT03606980|617537505|FG001|Overall Study|Withdrawal by Subject|0|||
170870663|NCT03606980|617537506|FG002|Overall Study|Withdrawal by Subject|4|||
170870664|NCT01849497|617537507|FG000|Overall Study|Withdrawal by Subject|1|||
170870665|NCT01849497|617537508|FG001|Overall Study|Withdrawal by Subject|2|||
170870666|NCT01849497|617537507|FG000|Overall Study|Sponsor Decision|0|||
170870667|NCT01849497|617537508|FG001|Overall Study|Sponsor Decision|1|||
170870668|NCT01849497|617537507|FG000|Overall Study|Lost to Follow-up|0|||
170870669|NCT01849497|617537508|FG001|Overall Study|Lost to Follow-up|1|||
170870670|NCT02729740|617537509|FG000|Overall Study|Early Termination|130|||
170870671|NCT02729740|617537509|FG000|Overall Study|Other|1|||
170870672|NCT00307333|617537510|FG000|Overall Study|Lost to Follow-up|11|||
170870673|NCT00307333|617537511|FG001|Overall Study|Lost to Follow-up|3|||
170870674|NCT00375219|617537513|FG000|Overall Study|Failure to achieve a response|16|||
170870675|NCT00375219|617537514|FG001|Overall Study|Failure to achieve a response|2|||
170870676|NCT00375219|617537515|FG002|Overall Study|Failure to achieve a response|0|||
170870677|NCT00375219|617537513|FG000|Overall Study|Adverse Event|8|||
170870678|NCT00375219|617537514|FG001|Overall Study|Adverse Event|2|||
170870679|NCT00375219|617537515|FG002|Overall Study|Adverse Event|1|||
170870680|NCT00375219|617537513|FG000|Overall Study|Protocol Violation|1|||
170870681|NCT00375219|617537514|FG001|Overall Study|Protocol Violation|0|||
170870682|NCT00375219|617537515|FG002|Overall Study|Protocol Violation|1|||
170870683|NCT00375219|617537513|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
170870684|NCT00375219|617537514|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
170870685|NCT00375219|617537515|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
170870686|NCT00375219|617537513|FG000|Overall Study|Lost to Follow-up|1|||
170870687|NCT00375219|617537514|FG001|Overall Study|Lost to Follow-up|1|||
170870688|NCT00375219|617537515|FG002|Overall Study|Lost to Follow-up|0|||
170870689|NCT00375219|617537513|FG000|Overall Study|Disease progression|18|||
170870690|NCT00375219|617537514|FG001|Overall Study|Disease progression|9|||
170870691|NCT00375219|617537515|FG002|Overall Study|Disease progression|12|||
170870692|NCT00375219|617537513|FG000|Overall Study|Death|4|||
170870693|NCT00375219|617537514|FG001|Overall Study|Death|3|||
170870694|NCT00375219|617537515|FG002|Overall Study|Death|7|||
170870695|NCT00375219|617537513|FG000|Overall Study|Hematologic resistance|1|||
170870696|NCT00375219|617537514|FG001|Overall Study|Hematologic resistance|0|||
170870697|NCT00375219|617537515|FG002|Overall Study|Hematologic resistance|0|||
170870698|NCT00375219|617537513|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
170870699|NCT00375219|617537514|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
170870700|NCT00375219|617537515|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
170870701|NCT00375219|617537513|FG000|Overall Study|Allograft|2|||
170870702|NCT00375219|617537514|FG001|Overall Study|Allograft|0|||
170870703|NCT00375219|617537515|FG002|Overall Study|Allograft|0|||
170870704|NCT00375219|617537513|FG000|Overall Study|Cord blood transplantation|1|||
170870705|NCT00375219|617537514|FG001|Overall Study|Cord blood transplantation|0|||
170870706|NCT00375219|617537515|FG002|Overall Study|Cord blood transplantation|0|||
170870707|NCT00375219|617537513|FG000|Overall Study|Withdrawal by Subject|1|||
170870708|NCT00375219|617537514|FG001|Overall Study|Withdrawal by Subject|0|||
170870709|NCT00375219|617537515|FG002|Overall Study|Withdrawal by Subject|0|||
170870710|NCT00228566|617537518|FG000|Overall Study|Adverse Event|31|||
170870711|NCT00228566|617537518|FG000|Overall Study|Lack of Efficacy|14|||
170870712|NCT00228566|617537518|FG000|Overall Study|Lost to Follow-up|16|||
170412304|NCT00542386|615849256|FG004|Overall Study|Adverse Event|13|||
170412305|NCT00542386|615849257|FG005|Overall Study|Adverse Event|4|||
170870713|NCT00228566|617537518|FG000|Overall Study|Physician Decision|5|||
170870714|NCT00228566|617537518|FG000|Overall Study|Withdrawal by Subject|4|||
170870715|NCT00228566|617537518|FG000|Overall Study|Miscellaneous|1|||
170870716|NCT02246582|617539001|FG000|Overall Study|Withdrawal by Subject|3|||
170870717|NCT02246582|617539002|FG001|Overall Study|Withdrawal by Subject|4|||
170412306|NCT00542386|615849252|FG000|Overall Study|Death|0|||
170870718|NCT02229539|617539003|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
170870719|NCT02229539|617539004|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
170870720|NCT02229539|617539005|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
170870721|NCT02229539|617539003|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
170870722|NCT02229539|617539004|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
170870723|NCT02229539|617539005|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
170870724|NCT02229539|617539003|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
170522361|NCT00116688|616258131|FG000|Overall Study|Requirement for alternative therapy|11|||
170522362|NCT00116688|616258132|FG001|Overall Study|Requirement for alternative therapy|1|||
170522363|NCT00116688|616258131|FG000|Overall Study|Physician Decision|7|||
170522364|NCT00116688|616258132|FG001|Overall Study|Physician Decision|0|||
170522365|NCT00116688|616258131|FG000|Overall Study|Lost to Follow-up|3|||
170768142|NCT03768206|617155479|FG001|Overall Study|Withdrawal by Subject|1|||
170768143|NCT01286272|617157366|FG000|Overall Study|Ineligible after beginning treatment|1|||
170768144|NCT01286272|617157367|FG001|Overall Study|Ineligible after beginning treatment|3|||
170768145|NCT04496960|617157370|FG000|Overall Study|Physician Decision|0|||
170768146|NCT04496960|617157371|FG001|Overall Study|Physician Decision|1|||
170768147|NCT03622593|617157372|FG000|Overall Study|Withdrawal by Subject|11|||
170768148|NCT03622593|617157373|FG001|Overall Study|Withdrawal by Subject|9|||
170768149|NCT03622593|617157374|FG002|Overall Study|Withdrawal by Subject|13|||
170768150|NCT03622593|617157372|FG000|Overall Study|Death|12|||
170768151|NCT03622593|617157373|FG001|Overall Study|Death|9|||
170768152|NCT03622593|617157374|FG002|Overall Study|Death|10|||
170768153|NCT03622593|617157372|FG000|Overall Study|Lost to Follow-up|11|||
170768154|NCT03622593|617157373|FG001|Overall Study|Lost to Follow-up|5|||
170768155|NCT03622593|617157374|FG002|Overall Study|Lost to Follow-up|8|||
170768156|NCT03622593|617157372|FG000|Overall Study|Adverse Event|4|||
170768157|NCT03622593|617157373|FG001|Overall Study|Adverse Event|5|||
170768158|NCT03622593|617157374|FG002|Overall Study|Adverse Event|6|||
170768159|NCT03622593|617157372|FG000|Overall Study|Physician Decision|2|||
170768160|NCT03622593|617157373|FG001|Overall Study|Physician Decision|1|||
170768161|NCT03622593|617157374|FG002|Overall Study|Physician Decision|6|||
170768162|NCT03622593|617157372|FG000|Overall Study|Other|2|||
170768163|NCT03622593|617157373|FG001|Overall Study|Other|2|||
170768164|NCT03622593|617157374|FG002|Overall Study|Other|3|||
170768165|NCT03622593|617157372|FG000|Overall Study|Protocol Violation|0|||
170768166|NCT03622593|617157373|FG001|Overall Study|Protocol Violation|0|||
170768167|NCT03622593|617157374|FG002|Overall Study|Protocol Violation|1|||
170768168|NCT03622593|617157372|FG000|Overall Study|Pregnancy|0|||
170768169|NCT03622593|617157373|FG001|Overall Study|Pregnancy|0|||
170768170|NCT03622593|617157374|FG002|Overall Study|Pregnancy|1|||
170768171|NCT01393119|617157375|FG000|Overall Study|Adverse Event|1|||
170768172|NCT01393119|617157376|FG001|Overall Study|Adverse Event|1|||
170768173|NCT01393119|617157377|FG002|Overall Study|Adverse Event|0|||
170768174|NCT01393119|617157378|FG003|Overall Study|Adverse Event|1|||
170768175|NCT01393119|617157375|FG000|Overall Study|Withdrawal by Subject|0|||
170768176|NCT01393119|617157376|FG001|Overall Study|Withdrawal by Subject|1|||
170768177|NCT01393119|617157377|FG002|Overall Study|Withdrawal by Subject|1|||
170768178|NCT01393119|617157378|FG003|Overall Study|Withdrawal by Subject|0|||
170768179|NCT01393119|617157375|FG000|Overall Study|Lack of Efficacy|1|||
170870725|NCT02229539|617539004|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
170870726|NCT02229539|617539005|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
170412307|NCT00542386|615849253|FG001|Overall Study|Death|0|||
170412308|NCT00542386|615849254|FG002|Overall Study|Death|1|||
170412309|NCT00542386|615849255|FG003|Overall Study|Death|2|||
170412310|NCT00542386|615849256|FG004|Overall Study|Death|1|||
170412311|NCT00542386|615849257|FG005|Overall Study|Death|2|||
170412312|NCT00542386|615849252|FG000|Overall Study|Lack of Efficacy|32|||
170412313|NCT00542386|615849253|FG001|Overall Study|Lack of Efficacy|12|||
170412314|NCT00542386|615849254|FG002|Overall Study|Lack of Efficacy|10|||
170412315|NCT00542386|615849255|FG003|Overall Study|Lack of Efficacy|13|||
170412316|NCT00542386|615849256|FG004|Overall Study|Lack of Efficacy|7|||
170412317|NCT00542386|615849257|FG005|Overall Study|Lack of Efficacy|31|||
170412318|NCT00542386|615849252|FG000|Overall Study|Physician Decision|1|||
170412319|NCT00542386|615849253|FG001|Overall Study|Physician Decision|0|||
170412320|NCT00542386|615849254|FG002|Overall Study|Physician Decision|0|||
170412321|NCT00542386|615849255|FG003|Overall Study|Physician Decision|1|||
170412322|NCT00542386|615849256|FG004|Overall Study|Physician Decision|0|||
170412323|NCT00542386|615849257|FG005|Overall Study|Physician Decision|0|||
170412324|NCT00542386|615849252|FG000|Overall Study|Protocol Violation|0|||
170412325|NCT00542386|615849253|FG001|Overall Study|Protocol Violation|0|||
170412326|NCT00542386|615849254|FG002|Overall Study|Protocol Violation|1|||
170412327|NCT00542386|615849255|FG003|Overall Study|Protocol Violation|0|||
170412328|NCT00542386|615849256|FG004|Overall Study|Protocol Violation|0|||
170412329|NCT00542386|615849257|FG005|Overall Study|Protocol Violation|4|||
170412330|NCT00542386|615849252|FG000|Overall Study|Withdrawal by Subject|5|||
170412331|NCT00542386|615849253|FG001|Overall Study|Withdrawal by Subject|8|||
170412332|NCT00542386|615849254|FG002|Overall Study|Withdrawal by Subject|10|||
170412333|NCT00542386|615849255|FG003|Overall Study|Withdrawal by Subject|11|||
170412334|NCT00542386|615849256|FG004|Overall Study|Withdrawal by Subject|15|||
170412335|NCT00542386|615849257|FG005|Overall Study|Withdrawal by Subject|7|||
170412336|NCT00542386|615849252|FG000|Overall Study|Other Reasons|4|||
170412337|NCT00542386|615849253|FG001|Overall Study|Other Reasons|1|||
170412338|NCT00542386|615849254|FG002|Overall Study|Other Reasons|4|||
170412339|NCT00542386|615849255|FG003|Overall Study|Other Reasons|3|||
170768180|NCT01393119|617157376|FG001|Overall Study|Lack of Efficacy|0|||
170768181|NCT01393119|617157377|FG002|Overall Study|Lack of Efficacy|2|||
170522366|NCT00116688|616258132|FG001|Overall Study|Lost to Follow-up|0|||
170522367|NCT00116688|616258131|FG000|Overall Study|Death|15|||
170522368|NCT00116688|616258132|FG001|Overall Study|Death|0|||
170522369|NCT00116688|616258131|FG000|Overall Study|Protocol-specified criteria|3|||
170522370|NCT00116688|616258132|FG001|Overall Study|Protocol-specified criteria|0|||
170522371|NCT00116688|616258131|FG000|Overall Study|Pregnancy|1|||
170522372|NCT00116688|616258132|FG001|Overall Study|Pregnancy|0|||
170522373|NCT00116688|616258131|FG000|Overall Study|Other|11|||
170522374|NCT00116688|616258132|FG001|Overall Study|Other|0|||
170522375|NCT01775670|616258135|FG000|Overall Study|Lost to Follow-up|1|||
170522376|NCT01775670|616258136|FG001|Overall Study|Lost to Follow-up|1|||
170522377|NCT01298700|616258137|FG000|Overall Study|Adverse Event|50|||
170522378|NCT01298700|616258138|FG001|Overall Study|Adverse Event|51|||
170522379|NCT01298700|616258137|FG000|Overall Study|Lack of Efficacy|9|||
170522380|NCT01298700|616258138|FG001|Overall Study|Lack of Efficacy|14|||
170522381|NCT01298700|616258137|FG000|Overall Study|Lost to Follow-up|5|||
170522382|NCT01298700|616258138|FG001|Overall Study|Lost to Follow-up|2|||
170522383|NCT01298700|616258137|FG000|Overall Study|Withdrawal by Subject|12|||
170522384|NCT01298700|616258138|FG001|Overall Study|Withdrawal by Subject|9|||
170522385|NCT01298700|616258137|FG000|Overall Study|Protocol Violation|6|||
170522386|NCT01298700|616258138|FG001|Overall Study|Protocol Violation|4|||
170522387|NCT01298700|616258137|FG000|Overall Study|Other Miscellaneous Reasons|16|||
170522388|NCT01298700|616258138|FG001|Overall Study|Other Miscellaneous Reasons|15|||
170522389|NCT01298700|616258137|FG000|Overall Study|Did not Receive Study Drug|3|||
170522390|NCT01298700|616258138|FG001|Overall Study|Did not Receive Study Drug|5|||
170522391|NCT01001429|616258141|FG000|Overall Study|surgery cancelled|0|||
170522392|NCT01001429|616258142|FG001|Overall Study|surgery cancelled|1|||
170522393|NCT00010257|616258143|FG000|Overall Study|Withdrawal by Subject|1|||
170522394|NCT00010257|616258144|FG001|Overall Study|Withdrawal by Subject|0|||
170522395|NCT00643760|616258145|FG000|Overall Study|Adverse Event|11|||
170522396|NCT00643760|616258146|FG001|Overall Study|Adverse Event|5|||
170522397|NCT00643760|616258147|FG002|Overall Study|Adverse Event|12|||
170522398|NCT00643760|616258148|FG003|Overall Study|Adverse Event|21|||
170522399|NCT00643760|616258149|FG004|Overall Study|Adverse Event|6|||
170522400|NCT00643760|616258145|FG000|Overall Study|Lack of Efficacy|3|||
170412340|NCT00542386|615849256|FG004|Overall Study|Other Reasons|4|||
170522401|NCT00643760|616258146|FG001|Overall Study|Lack of Efficacy|1|||
170522402|NCT00643760|616258147|FG002|Overall Study|Lack of Efficacy|0|||
170522403|NCT00643760|616258148|FG003|Overall Study|Lack of Efficacy|4|||
170522404|NCT00643760|616258149|FG004|Overall Study|Lack of Efficacy|3|||
170522405|NCT00643760|616258145|FG000|Overall Study|Protocol Violation|7|||
170522406|NCT00643760|616258146|FG001|Overall Study|Protocol Violation|6|||
170522407|NCT00643760|616258147|FG002|Overall Study|Protocol Violation|4|||
170522408|NCT00643760|616258148|FG003|Overall Study|Protocol Violation|4|||
170522409|NCT00643760|616258149|FG004|Overall Study|Protocol Violation|6|||
170522410|NCT00643760|616258145|FG000|Overall Study|Lost to Follow-up|6|||
170522411|NCT00643760|616258146|FG001|Overall Study|Lost to Follow-up|2|||
170522412|NCT00643760|616258147|FG002|Overall Study|Lost to Follow-up|1|||
170522413|NCT00643760|616258148|FG003|Overall Study|Lost to Follow-up|3|||
170522414|NCT00643760|616258149|FG004|Overall Study|Lost to Follow-up|3|||
170522415|NCT00643760|616258145|FG000|Overall Study|Investigator Discretion|0|||
170522416|NCT00643760|616258146|FG001|Overall Study|Investigator Discretion|0|||
170522417|NCT00643760|616258147|FG002|Overall Study|Investigator Discretion|0|||
170522418|NCT00643760|616258148|FG003|Overall Study|Investigator Discretion|2|||
170522419|NCT00643760|616258149|FG004|Overall Study|Investigator Discretion|0|||
170522420|NCT00643760|616258145|FG000|Overall Study|Withdrawal by Subject|3|||
170522421|NCT00643760|616258146|FG001|Overall Study|Withdrawal by Subject|1|||
170412341|NCT00542386|615849257|FG005|Overall Study|Other Reasons|2|||
170412342|NCT01006707|615849258|FG000|Study Session 1|Lost to Follow-up|2|||
170412343|NCT01006707|615849259|FG001|Study Session 1|Lost to Follow-up|0|||
170412344|NCT01006707|615849260|FG002|Study Session 1|Lost to Follow-up|0|||
170412345|NCT01006707|615849258|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
170412346|NCT01006707|615849259|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
170412347|NCT01006707|615849260|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
170412348|NCT00760383|615849261|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
170412349|NCT00760383|615849262|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
170522422|NCT00643760|616258147|FG002|Overall Study|Withdrawal by Subject|2|||
170412350|NCT03465891|615849264|FG000|Overall Study|Withdrawal by Subject|0|||
170522423|NCT00643760|616258148|FG003|Overall Study|Withdrawal by Subject|4|||
170522424|NCT00643760|616258149|FG004|Overall Study|Withdrawal by Subject|1|||
170522425|NCT02063672|616258150|FG000|Overall Study|Ongoing Follow-up|27|||
170522426|NCT02063672|616258151|FG001|Overall Study|Ongoing Follow-up|14|||
170522427|NCT02063672|616258150|FG000|Overall Study|Death|5|||
170522428|NCT02063672|616258151|FG001|Overall Study|Death|3|||
170522429|NCT02063672|616258150|FG000|Overall Study|Lost to Follow-up|1|||
170522430|NCT02063672|616258151|FG001|Overall Study|Lost to Follow-up|3|||
170522431|NCT02063672|616258150|FG000|Overall Study|Withdrawal by Subject|2|||
170522432|NCT02063672|616258151|FG001|Overall Study|Withdrawal by Subject|2|||
170522433|NCT00789321|616258152|FG000|Overall Study|Adverse Event|0|||
170870727|NCT02229539|617539003|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
170870728|NCT02229539|617539004|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
170870729|NCT02229539|617539005|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
170870730|NCT02229539|617539003|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
170870731|NCT02229539|617539004|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
170870732|NCT02229539|617539005|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
170870733|NCT02229539|617539003|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
170870734|NCT02229539|617539004|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
170870735|NCT02229539|617539005|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
170870736|NCT03441334|617539006|FG000|Overall Study|Withdrawal by Subject|1|||
170870737|NCT03441334|617539007|FG001|Overall Study|Withdrawal by Subject|0|||
170870738|NCT00682448|617539014|FG000|Overall Study|Adverse Event|1|||
170870739|NCT00682448|617539015|FG001|Overall Study|Adverse Event|2|||
170870740|NCT00682448|617539014|FG000|Overall Study|Lack of Efficacy|1|||
170870741|NCT00682448|617539015|FG001|Overall Study|Lack of Efficacy|0|||
170870742|NCT00682448|617539014|FG000|Overall Study|Lost to Follow-up|1|||
170870743|NCT00682448|617539015|FG001|Overall Study|Lost to Follow-up|3|||
170870744|NCT00682448|617539014|FG000|Overall Study|Pregnancy|0|||
170870745|NCT00682448|617539015|FG001|Overall Study|Pregnancy|1|||
170870746|NCT00682448|617539014|FG000|Overall Study|Withdrawal by Subject|2|||
170870747|NCT00682448|617539015|FG001|Overall Study|Withdrawal by Subject|0|||
170870748|NCT00268437|617539016|FG000|Overall Study|Ineligible|1|||
170870749|NCT03688880|617539023|FG000|Overall Study|Withdrawal by Subject|0|||
170870750|NCT03688880|617539024|FG001|Overall Study|Withdrawal by Subject|2|||
170870751|NCT03688880|617539023|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
170870752|NCT03688880|617539024|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
170870753|NCT03688880|617539023|FG000|Overall Study|Lost to Follow-up|4|||
170870754|NCT03688880|617539024|FG001|Overall Study|Lost to Follow-up|7|||
170870755|NCT03688880|617539023|FG000|Overall Study|Adverse Event|0|||
170870756|NCT03688880|617539024|FG001|Overall Study|Adverse Event|2|||
170522434|NCT00789321|616258153|FG001|Overall Study|Adverse Event|1|||
170522435|NCT01965327|616258154|FG000|Overall Study|Physician Decision|2|||
170522436|NCT00104052|616258155|FG000|Overall Study|Adverse Event|1|||
170522437|NCT00104052|616258155|FG000|Overall Study|Lack of Efficacy|26|||
170522438|NCT00104052|616258155|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
170522439|NCT01162343|616258156|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
170522440|NCT01162343|616258156|FG000|Overall Study|Refused psychiatrist assessment|12|||
170522441|NCT03652818|616258157|FG000|Overall Study|Adverse Event|1|||
170522442|NCT03652818|616258158|FG001|Overall Study|Adverse Event|0|||
170522443|NCT03652818|616258159|FG002|Overall Study|Adverse Event|0|||
170522444|NCT03652818|616258160|FG003|Overall Study|Adverse Event|0|||
170522445|NCT03652818|616258161|FG004|Overall Study|Adverse Event|0|||
170522446|NCT03652818|616258157|FG000|Overall Study|Physician Decision|1|||
170522447|NCT03652818|616258158|FG001|Overall Study|Physician Decision|0|||
170522448|NCT03652818|616258159|FG002|Overall Study|Physician Decision|0|||
170522449|NCT03652818|616258160|FG003|Overall Study|Physician Decision|0|||
170522450|NCT03652818|616258161|FG004|Overall Study|Physician Decision|0|||
170522451|NCT03652818|616258157|FG000|Overall Study|Lost to Follow-up|0|||
170522452|NCT03652818|616258158|FG001|Overall Study|Lost to Follow-up|1|||
170522453|NCT03652818|616258159|FG002|Overall Study|Lost to Follow-up|2|||
170522454|NCT03652818|616258160|FG003|Overall Study|Lost to Follow-up|1|||
170522455|NCT03652818|616258161|FG004|Overall Study|Lost to Follow-up|1|||
170522456|NCT01831427|616258166|FG000|Overall Study|Adverse Event|0|||
170522457|NCT01831427|616258167|FG001|Overall Study|Adverse Event|1|||
170522458|NCT01831427|616258168|FG002|Overall Study|Adverse Event|0|||
170522459|NCT01831427|616258169|FG003|Overall Study|Adverse Event|0|||
170522460|NCT01831427|616258170|FG004|Overall Study|Adverse Event|0|||
170522461|NCT01831427|616258171|FG005|Overall Study|Adverse Event|1|||
170522462|NCT01831427|616258172|FG006|Overall Study|Adverse Event|0|||
170522463|NCT01831427|616258173|FG007|Overall Study|Adverse Event|1|||
170522464|NCT01831427|616258174|FG008|Overall Study|Adverse Event|0|||
170522465|NCT01831427|616258175|FG009|Overall Study|Adverse Event|0|||
170522466|NCT01831427|616258176|FG010|Overall Study|Adverse Event|2|||
170870757|NCT03688880|617539023|FG000|Overall Study|Device deficiencies|0|||
170870758|NCT03688880|617539024|FG001|Overall Study|Device deficiencies|2|||
170522467|NCT01831427|616258166|FG000|Overall Study|Investigator's Discretion|0|||
170522468|NCT01831427|616258167|FG001|Overall Study|Investigator's Discretion|0|||
170522469|NCT01831427|616258168|FG002|Overall Study|Investigator's Discretion|0|||
170522470|NCT01831427|616258169|FG003|Overall Study|Investigator's Discretion|1|||
170522471|NCT01831427|616258170|FG004|Overall Study|Investigator's Discretion|0|||
170522472|NCT01831427|616258171|FG005|Overall Study|Investigator's Discretion|0|||
170870759|NCT03688880|617539023|FG000|Overall Study|Other|10|||
170870760|NCT03688880|617539024|FG001|Overall Study|Other|16|||
170870761|NCT01183143|617539025|FG000|Overall Study|Protocol Violation|115|||
170870762|NCT01183143|617539025|FG000|Overall Study|Withdrawal by Subject|19|||
170870763|NCT01183143|617539025|FG000|Overall Study|Subject Questionnaires not returned|5|||
170870764|NCT01183143|617539025|FG000|Overall Study|Subjects enrolled, but not treated|11|||
170768182|NCT01393119|617157378|FG003|Overall Study|Lack of Efficacy|1|||
170768183|NCT01393119|617157375|FG000|Overall Study|Protocol Violation|0|||
170768184|NCT01393119|617157376|FG001|Overall Study|Protocol Violation|0|||
170768185|NCT01393119|617157377|FG002|Overall Study|Protocol Violation|1|||
170768186|NCT01393119|617157378|FG003|Overall Study|Protocol Violation|0|||
170768187|NCT01393119|617157375|FG000|Overall Study|Death|0|||
170768188|NCT01393119|617157376|FG001|Overall Study|Death|0|||
170768189|NCT01393119|617157377|FG002|Overall Study|Death|0|||
170768190|NCT01393119|617157378|FG003|Overall Study|Death|1|||
170768191|NCT01393119|617157375|FG000|Overall Study|Randomized but Not treated|1|||
170768192|NCT01393119|617157376|FG001|Overall Study|Randomized but Not treated|0|||
170768193|NCT01393119|617157377|FG002|Overall Study|Randomized but Not treated|1|||
170768194|NCT01393119|617157378|FG003|Overall Study|Randomized but Not treated|1|||
170768195|NCT01393119|617157375|FG000|Overall Study|Sponsor Termination of Study|11|||
170768196|NCT01393119|617157376|FG001|Overall Study|Sponsor Termination of Study|12|||
170768197|NCT01393119|617157377|FG002|Overall Study|Sponsor Termination of Study|9|||
170768198|NCT01393119|617157378|FG003|Overall Study|Sponsor Termination of Study|12|||
170768199|NCT04860258|617157379|FG000|Overall Study|Withdrawal by Subject|0|||
170768200|NCT04860258|617157380|FG001|Overall Study|Withdrawal by Subject|0|||
170768201|NCT04860258|617157381|FG002|Overall Study|Withdrawal by Subject|4|||
170768202|NCT04860258|617157382|FG003|Overall Study|Withdrawal by Subject|1|||
170768203|NCT04860258|617157383|FG004|Overall Study|Withdrawal by Subject|4|||
170768204|NCT04860258|617157384|FG005|Overall Study|Withdrawal by Subject|1|||
170768205|NCT04860258|617157385|FG006|Overall Study|Withdrawal by Subject|0|||
170768206|NCT01580293|617157386|FG000|Part A_Main Trial|Adverse Event|0|||
170768207|NCT01580293|617157387|FG001|Part A_Main Trial|Adverse Event|2|||
170768208|NCT01580293|617157388|FG002|Part A_Main Trial|Adverse Event|0|||
170768209|NCT01580293|617157386|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
170768210|NCT01580293|617157387|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
170768211|NCT01580293|617157388|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
170768212|NCT01580293|617157386|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
170768213|NCT01580293|617157387|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
170768214|NCT01580293|617157388|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
170768215|NCT01580293|617157386|FG000|Part A_Extension|Adverse Event|0|||
170768216|NCT01580293|617157387|FG001|Part A_Extension|Adverse Event|2|||
170768217|NCT01580293|617157388|FG002|Part A_Extension|Adverse Event|0|||
170768218|NCT01580293|617157386|FG000|Part A_Extension|Withdrawal by Subject|0|||
170768219|NCT01580293|617157387|FG001|Part A_Extension|Withdrawal by Subject|3|||
170768220|NCT01580293|617157388|FG002|Part A_Extension|Withdrawal by Subject|0|||
170768221|NCT01580293|617157386|FG000|Part A_Extension|Lost to Follow-up|0|||
170768222|NCT01580293|617157387|FG001|Part A_Extension|Lost to Follow-up|1|||
170768223|NCT01580293|617157388|FG002|Part A_Extension|Lost to Follow-up|0|||
170768224|NCT01580293|617157386|FG000|Part A_Extension|Other Reason|0|||
170768225|NCT01580293|617157387|FG001|Part A_Extension|Other Reason|1|||
170768226|NCT01580293|617157388|FG002|Part A_Extension|Other Reason|0|||
170768227|NCT01580293|617157386|FG000|Part A_Extension|Completed Japan only|0|||
170768228|NCT01580293|617157387|FG001|Part A_Extension|Completed Japan only|5|||
170768229|NCT01580293|617157388|FG002|Part A_Extension|Completed Japan only|0|||
170768230|NCT01580293|617157386|FG000|Part B|Withdrawal by Subject|0|||
170768231|NCT01580293|617157387|FG001|Part B|Withdrawal by Subject|0|||
170768232|NCT01580293|617157388|FG002|Part B|Withdrawal by Subject|1|||
170768233|NCT01580293|617157386|FG000|Part B|Other reason|0|||
170768234|NCT01580293|617157387|FG001|Part B|Other reason|0|||
170768235|NCT01580293|617157388|FG002|Part B|Other reason|1|||
170768236|NCT01400776|617157389|FG000|Overall Study|Adverse Event|7|||
170768237|NCT01400776|617157390|FG001|Overall Study|Adverse Event|2|||
170768238|NCT01400776|617157391|FG002|Overall Study|Adverse Event|9|||
170768239|NCT01400776|617157392|FG003|Overall Study|Adverse Event|2|||
170768240|NCT01400776|617157389|FG000|Overall Study|Lost to Follow-up|1|||
170768241|NCT01400776|617157390|FG001|Overall Study|Lost to Follow-up|0|||
170768242|NCT01400776|617157391|FG002|Overall Study|Lost to Follow-up|4|||
170768243|NCT01400776|617157392|FG003|Overall Study|Lost to Follow-up|1|||
170768244|NCT01400776|617157389|FG000|Overall Study|Withdrew Consent|4|||
170870765|NCT02553265|617539026|FG000|Enrollment|Death|0|||
170870766|NCT02553265|617539027|FG001|Enrollment|Death|0|||
170870767|NCT02553265|617539028|FG002|Enrollment|Death|1|||
170870768|NCT02553265|617539026|FG000|First Intervention (28 Days)|Adverse Event|1|||
170870769|NCT02553265|617539027|FG001|First Intervention (28 Days)|Adverse Event|0|||
170870770|NCT02553265|617539028|FG002|First Intervention (28 Days)|Adverse Event|0|||
170870771|NCT02553265|617539026|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
170870772|NCT02553265|617539027|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
170768245|NCT01400776|617157390|FG001|Overall Study|Withdrew Consent|2|||
170768246|NCT01400776|617157391|FG002|Overall Study|Withdrew Consent|6|||
170870773|NCT02553265|617539028|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
170870774|NCT02553265|617539026|FG000|Second Intervention (28 Days)|Adverse Event|1|||
170768247|NCT01400776|617157392|FG003|Overall Study|Withdrew Consent|1|||
170768248|NCT01400776|617157389|FG000|Overall Study|Protocol Deviation|6|||
170768249|NCT01400776|617157390|FG001|Overall Study|Protocol Deviation|1|||
170412351|NCT03465891|615849265|FG001|Overall Study|Withdrawal by Subject|1|||
170412352|NCT03465891|615849264|FG000|Overall Study|Disease progression|1|||
170412353|NCT03465891|615849265|FG001|Overall Study|Disease progression|0|||
170412354|NCT02737306|615849266|FG000|Overall Study|Adverse Event|3|||
170412355|NCT02737306|615849267|FG001|Overall Study|Adverse Event|0|||
170412356|NCT02737306|615849266|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
170412357|NCT02737306|615849267|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
170412358|NCT05034731|615849268|FG000|Overall Study|Screen fail|1|||
170412359|NCT05034731|615849269|FG001|Overall Study|Screen fail|1|||
170412360|NCT01725451|615849275|FG000|Period 1|Withdrawal by Subject|1|||
170412361|NCT01725451|615849276|FG001|Period 1|Withdrawal by Subject|0|||
170412362|NCT01725451|615849277|FG002|Period 1|Withdrawal by Subject|0|||
170412363|NCT01725451|615849278|FG003|Period 1|Withdrawal by Subject|0|||
170412364|NCT01725451|615849275|FG000|Washout From Period 3|Protocol Violation|0|||
170412365|NCT01725451|615849276|FG001|Washout From Period 3|Protocol Violation|0|||
170412366|NCT01725451|615849277|FG002|Washout From Period 3|Protocol Violation|1|||
170412367|NCT01725451|615849278|FG003|Washout From Period 3|Protocol Violation|0|||
170412368|NCT01725451|615849275|FG000|Washout From Period 3|Adverse Event|0|||
170412369|NCT01725451|615849276|FG001|Washout From Period 3|Adverse Event|1|||
170412370|NCT01725451|615849277|FG002|Washout From Period 3|Adverse Event|0|||
170412371|NCT01725451|615849278|FG003|Washout From Period 3|Adverse Event|0|||
170412372|NCT01725451|615849275|FG000|Period 4|Adverse Event|0|||
170412373|NCT01725451|615849276|FG001|Period 4|Adverse Event|0|||
170412374|NCT01725451|615849277|FG002|Period 4|Adverse Event|1|||
170412375|NCT01725451|615849278|FG003|Period 4|Adverse Event|0|||
170412376|NCT00358826|615849279|FG000|Core Study|Adverse Event|1|||
170412377|NCT00358826|615849280|FG001|Core Study|Adverse Event|3|||
170412378|NCT00358826|615849281|FG002|Core Study|Adverse Event|1|||
170412379|NCT00358826|615849282|FG003|Core Study|Adverse Event|1|||
170412380|NCT00358826|615849283|FG004|Core Study|Adverse Event|0|||
170412381|NCT00358826|615849284|FG005|Core Study|Adverse Event|0|||
170412382|NCT00358826|615849285|FG006|Core Study|Adverse Event|0|||
170412383|NCT00358826|615849286|FG007|Core Study|Adverse Event|0|||
170412384|NCT00358826|615849279|FG000|Core Study|Withdrawal by Subject|2|||
170412385|NCT00358826|615849280|FG001|Core Study|Withdrawal by Subject|2|||
170412386|NCT00358826|615849281|FG002|Core Study|Withdrawal by Subject|0|||
170412387|NCT00358826|615849282|FG003|Core Study|Withdrawal by Subject|0|||
170412388|NCT00358826|615849283|FG004|Core Study|Withdrawal by Subject|0|||
170412389|NCT00358826|615849284|FG005|Core Study|Withdrawal by Subject|0|||
170522473|NCT01831427|616258172|FG006|Overall Study|Investigator's Discretion|0|||
170768250|NCT01400776|617157391|FG002|Overall Study|Protocol Deviation|5|||
170768251|NCT01400776|617157392|FG003|Overall Study|Protocol Deviation|2|||
170768252|NCT01400776|617157389|FG000|Overall Study|Reason not Specified|3|||
170768253|NCT01400776|617157390|FG001|Overall Study|Reason not Specified|0|||
170768254|NCT01400776|617157391|FG002|Overall Study|Reason not Specified|4|||
170768255|NCT01400776|617157392|FG003|Overall Study|Reason not Specified|3|||
170768256|NCT00423098|617157393|FG000|Overall Study|Adverse Event|1|||
170768257|NCT00423098|617157394|FG001|Overall Study|Adverse Event|2|||
170768258|NCT00423098|617157393|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170768259|NCT00423098|617157394|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170768260|NCT00423098|617157393|FG000|Overall Study|Administrative problems|0|||
170768261|NCT00423098|617157394|FG001|Overall Study|Administrative problems|1|||
170768262|NCT00423098|617157393|FG000|Overall Study|Death|2|||
170768263|NCT00423098|617157394|FG001|Overall Study|Death|0|||
170768264|NCT01426269|617157401|FG000|Period 1: 12 Weeks|Adverse Event|5|||
170768265|NCT01426269|617157402|FG001|Period 1: 12 Weeks|Adverse Event|0|||
170768266|NCT01426269|617157403|FG002|Period 1: 12 Weeks|Adverse Event|0|||
170768267|NCT01426269|617157401|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
170768268|NCT01426269|617157402|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
170768269|NCT01426269|617157403|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
170768270|NCT01426269|617157401|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
170768271|NCT01426269|617157402|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
170768272|NCT01426269|617157403|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
170768273|NCT01426269|617157401|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
170768274|NCT01426269|617157402|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
170768275|NCT01426269|617157403|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
170870775|NCT02553265|617539027|FG001|Second Intervention (28 Days)|Adverse Event|0|||
170412390|NCT00358826|615849285|FG006|Core Study|Withdrawal by Subject|0|||
170412391|NCT00358826|615849286|FG007|Core Study|Withdrawal by Subject|0|||
170412392|NCT00358826|615849279|FG000|Core Study|Lost to Follow-up|0|||
170412393|NCT00358826|615849280|FG001|Core Study|Lost to Follow-up|0|||
170412394|NCT00358826|615849281|FG002|Core Study|Lost to Follow-up|0|||
170412395|NCT00358826|615849282|FG003|Core Study|Lost to Follow-up|1|||
170412396|NCT00358826|615849283|FG004|Core Study|Lost to Follow-up|0|||
170522474|NCT01831427|616258173|FG007|Overall Study|Investigator's Discretion|0|||
170768276|NCT01426269|617157401|FG000|Period 1: 12 Weeks|Pregnancy|1|||
170768277|NCT01426269|617157402|FG001|Period 1: 12 Weeks|Pregnancy|0|||
170768278|NCT01426269|617157403|FG002|Period 1: 12 Weeks|Pregnancy|0|||
170768279|NCT01426269|617157401|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
170522475|NCT01831427|616258174|FG008|Overall Study|Investigator's Discretion|0|||
170522476|NCT01831427|616258175|FG009|Overall Study|Investigator's Discretion|0|||
170522477|NCT01831427|616258176|FG010|Overall Study|Investigator's Discretion|0|||
170522478|NCT01831427|616258166|FG000|Overall Study|Withdrew Consent|0|||
170522479|NCT01831427|616258167|FG001|Overall Study|Withdrew Consent|0|||
170522480|NCT01831427|616258168|FG002|Overall Study|Withdrew Consent|0|||
170522481|NCT01831427|616258169|FG003|Overall Study|Withdrew Consent|0|||
170522482|NCT01831427|616258170|FG004|Overall Study|Withdrew Consent|0|||
170522483|NCT01831427|616258171|FG005|Overall Study|Withdrew Consent|0|||
170522484|NCT01831427|616258172|FG006|Overall Study|Withdrew Consent|2|||
170522485|NCT01831427|616258173|FG007|Overall Study|Withdrew Consent|0|||
170522486|NCT01831427|616258174|FG008|Overall Study|Withdrew Consent|0|||
170522487|NCT01831427|616258175|FG009|Overall Study|Withdrew Consent|1|||
170522488|NCT01831427|616258176|FG010|Overall Study|Withdrew Consent|1|||
170522489|NCT01248455|616258177|FG000|Overall Study|switched to alternate treatment|1|||
170768280|NCT01426269|617157402|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
170768281|NCT01426269|617157403|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
170768282|NCT01426269|617157401|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
170768283|NCT01426269|617157402|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
170768284|NCT01426269|617157403|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
170768285|NCT01426269|617157401|FG000|Period 2: 40 Weeks|Adverse Event|0|||
170768286|NCT01426269|617157402|FG001|Period 2: 40 Weeks|Adverse Event|1|||
170768287|NCT01426269|617157403|FG002|Period 2: 40 Weeks|Adverse Event|2|||
170768288|NCT01426269|617157401|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
170768289|NCT01426269|617157402|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
170768290|NCT01426269|617157403|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
170768291|NCT01426269|617157401|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
170768292|NCT01426269|617157402|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
170768293|NCT01426269|617157403|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
170768294|NCT01426269|617157401|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
170768295|NCT01426269|617157402|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
170768296|NCT01426269|617157403|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
170768297|NCT01426269|617157401|FG000|Period 2: 40 Weeks|Site closed|0|||
170768298|NCT01426269|617157402|FG001|Period 2: 40 Weeks|Site closed|6|||
170768299|NCT01426269|617157403|FG002|Period 2: 40 Weeks|Site closed|5|||
170768300|NCT01426269|617157401|FG000|Period 2: 40 Weeks|Relapsed|0|||
170768301|NCT01426269|617157402|FG001|Period 2: 40 Weeks|Relapsed|9|||
170768302|NCT01426269|617157403|FG002|Period 2: 40 Weeks|Relapsed|18|||
170768303|NCT01171625|617157404|FG000|Overall Study|On-Protocol|67|||
170768304|NCT01171625|617157404|FG000|Overall Study|Death|38|||
170768305|NCT01171625|617157404|FG000|Overall Study|Withdrawal by Subject|31|||
170768306|NCT01171625|617157404|FG000|Overall Study|Explanted|10|||
170768307|NCT01171625|617157404|FG000|Overall Study|Lost to Follow-up|5|||
170768308|NCT01171625|617157404|FG000|Overall Study|Patient received valve-in-valve|3|||
170768309|NCT01171625|617157404|FG000|Overall Study|Other|1|||
170768310|NCT01171625|617157404|FG000|Overall Study|Consented but did not receive device|25|||
170768311|NCT00419094|617157408|FG000|Overall Study|Adverse Event|3|||
170768312|NCT00419094|617157409|FG001|Overall Study|Adverse Event|7|||
170768313|NCT00419094|617157408|FG000|Overall Study|Lack of Efficacy|1|||
170768314|NCT00419094|617157409|FG001|Overall Study|Lack of Efficacy|0|||
170768315|NCT00419094|617157408|FG000|Overall Study|Lost to Follow-up|0|||
170768316|NCT00419094|617157409|FG001|Overall Study|Lost to Follow-up|2|||
170768317|NCT00419094|617157408|FG000|Overall Study|Protocol Violation|1|||
170768318|NCT00419094|617157409|FG001|Overall Study|Protocol Violation|14|||
170768319|NCT00419094|617157408|FG000|Overall Study|Withdrawal of consent|1|||
170768320|NCT00419094|617157409|FG001|Overall Study|Withdrawal of consent|5|||
170768321|NCT00419094|617157408|FG000|Overall Study|Other: Error determining exit criteria|1|||
170768322|NCT00419094|617157409|FG001|Overall Study|Other: Error determining exit criteria|0|||
170768323|NCT00419094|617157408|FG000|Overall Study|Other: Patient non-compliant|0|||
170768324|NCT00419094|617157409|FG001|Overall Study|Other: Patient non-compliant|1|||
170768325|NCT00419094|617157408|FG000|Overall Study|Other: No contact for extended period|0|||
170768326|NCT00419094|617157409|FG001|Overall Study|Other: No contact for extended period|1|||
170768327|NCT00799396|617157410|FG000|Clopidogrel Treatment|Adverse Event|6|||
170768328|NCT00799396|617157410|FG000|Clopidogrel Treatment|Physician Decision|5|||
170768329|NCT00799396|617157410|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
170768330|NCT00799396|617157410|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
170768331|NCT00799396|617157410|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
170768332|NCT00807144|617157411|FG000|Overall Study|Lost to Follow-up|0|||
170768333|NCT00807144|617157412|FG001|Overall Study|Lost to Follow-up|1|||
170768334|NCT01337635|617157413|FG000|Overall Study|Lost to Follow-up|0|||
170522490|NCT02735980|616258178|FG000|Overall Study|Adverse Event|0|||
170522491|NCT02735980|616258179|FG001|Overall Study|Adverse Event|4|||
170522492|NCT02735980|616258180|FG002|Overall Study|Adverse Event|1|||
170768335|NCT01337635|617157414|FG001|Overall Study|Lost to Follow-up|1|||
170768336|NCT02696707|617157417|FG000|Per Protocol Population|Physician Decision|2|||
170768337|NCT02696707|617157418|FG001|Per Protocol Population|Physician Decision|1|||
170870776|NCT02553265|617539028|FG002|Second Intervention (28 Days)|Adverse Event|0|||
170870777|NCT02553265|617539026|FG000|Third Intervention (28 Days)|Adverse Event|1|||
170870778|NCT02553265|617539027|FG001|Third Intervention (28 Days)|Adverse Event|0|||
170870779|NCT02553265|617539028|FG002|Third Intervention (28 Days)|Adverse Event|0|||
170870780|NCT02553265|617539026|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
170870781|NCT02553265|617539027|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
170870782|NCT02553265|617539028|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
170870783|NCT01022996|617539031|FG000|Overall Study|Adverse Event|14|||
170870784|NCT01022996|617539031|FG000|Overall Study|Withdrawal by Subject|3|||
170870785|NCT01022996|617539031|FG000|Overall Study|Lost to Follow-up|1|||
170870786|NCT01022996|617539031|FG000|Overall Study|Administrative problems|6|||
170870787|NCT01022996|617539031|FG000|Overall Study|Disease Progression|32|||
170870788|NCT01022996|617539031|FG000|Overall Study|Protocol Violation|1|||
170870789|NCT02767323|617539032|FG000|Overall Study|Withdrawal by Subject|17|||
170870790|NCT02767323|617539033|FG001|Overall Study|Withdrawal by Subject|5|||
170870791|NCT02767323|617539034|FG002|Overall Study|Withdrawal by Subject|13|||
170870792|NCT02767323|617539035|FG003|Overall Study|Withdrawal by Subject|0|||
170870793|NCT02767323|617539032|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
170870794|NCT02767323|617539033|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
170870795|NCT02767323|617539034|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
170870796|NCT02767323|617539035|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
170870797|NCT00419120|617539036|FG000|Long Term Follow up Period|study ongoing|10|||
170870798|NCT00710879|617539037|FG000|Overall Study|Lost to Follow-up|2|||
170870799|NCT00710879|617539038|FG001|Overall Study|Lost to Follow-up|1|||
170870800|NCT00710879|617539037|FG000|Overall Study|Protocol Violation|0|||
170870801|NCT00710879|617539038|FG001|Overall Study|Protocol Violation|3|||
170870802|NCT02667275|617539043|FG000|Overall Study|Protocol Violation|11|||
170870803|NCT02667275|617539044|FG001|Overall Study|Protocol Violation|7|||
170870804|NCT02667275|617539043|FG000|Overall Study|Lost to Follow-up|0|||
170870805|NCT02667275|617539044|FG001|Overall Study|Lost to Follow-up|2|||
170870806|NCT02667275|617539043|FG000|Overall Study|Withdrawal by Subject|0|||
170412397|NCT00358826|615849284|FG005|Core Study|Lost to Follow-up|0|||
170412398|NCT00358826|615849285|FG006|Core Study|Lost to Follow-up|0|||
170412399|NCT00358826|615849286|FG007|Core Study|Lost to Follow-up|0|||
170412400|NCT00358826|615849279|FG000|Core Study|Physician Decision|0|||
170412401|NCT00358826|615849280|FG001|Core Study|Physician Decision|0|||
170412402|NCT00358826|615849281|FG002|Core Study|Physician Decision|1|||
170412403|NCT00358826|615849282|FG003|Core Study|Physician Decision|0|||
170412404|NCT00358826|615849283|FG004|Core Study|Physician Decision|0|||
170412405|NCT00358826|615849284|FG005|Core Study|Physician Decision|0|||
170412406|NCT00358826|615849285|FG006|Core Study|Physician Decision|0|||
170412407|NCT00358826|615849286|FG007|Core Study|Physician Decision|0|||
170412408|NCT00358826|615849279|FG000|MDCT Substudy|Adverse Event|0|||
170412409|NCT00358826|615849280|FG001|MDCT Substudy|Adverse Event|0|||
170412410|NCT00358826|615849281|FG002|MDCT Substudy|Adverse Event|0|||
170412411|NCT00358826|615849282|FG003|MDCT Substudy|Adverse Event|0|||
170412412|NCT00358826|615849283|FG004|MDCT Substudy|Adverse Event|1|||
170412413|NCT00358826|615849284|FG005|MDCT Substudy|Adverse Event|0|||
170412414|NCT00358826|615849285|FG006|MDCT Substudy|Adverse Event|0|||
170412415|NCT00358826|615849286|FG007|MDCT Substudy|Adverse Event|0|||
170412416|NCT00358826|615849279|FG000|MDCT Substudy|Lost to Follow-up|0|||
170412417|NCT00358826|615849280|FG001|MDCT Substudy|Lost to Follow-up|0|||
170412418|NCT00358826|615849281|FG002|MDCT Substudy|Lost to Follow-up|0|||
170412419|NCT00358826|615849282|FG003|MDCT Substudy|Lost to Follow-up|0|||
170412420|NCT00358826|615849283|FG004|MDCT Substudy|Lost to Follow-up|0|||
170412421|NCT00358826|615849284|FG005|MDCT Substudy|Lost to Follow-up|1|||
170412422|NCT00358826|615849285|FG006|MDCT Substudy|Lost to Follow-up|0|||
170412423|NCT00358826|615849286|FG007|MDCT Substudy|Lost to Follow-up|0|||
170412424|NCT00358826|615849279|FG000|MDCT Substudy|Withdrawal by Subject|0|||
170412425|NCT00358826|615849280|FG001|MDCT Substudy|Withdrawal by Subject|0|||
170412426|NCT00358826|615849281|FG002|MDCT Substudy|Withdrawal by Subject|0|||
170412427|NCT00358826|615849282|FG003|MDCT Substudy|Withdrawal by Subject|0|||
170412428|NCT00358826|615849283|FG004|MDCT Substudy|Withdrawal by Subject|0|||
170870807|NCT02667275|617539044|FG001|Overall Study|Withdrawal by Subject|5|||
170870808|NCT02667275|617539043|FG000|Overall Study|Discontinued early without completing|0|||
170412429|NCT00358826|615849284|FG005|MDCT Substudy|Withdrawal by Subject|1|||
170870809|NCT02667275|617539044|FG001|Overall Study|Discontinued early without completing|1|||
170870810|NCT01848288|617539045|FG000|Overall Study|Death|1|||
170870811|NCT01848288|617539045|FG000|Overall Study|Protocol Violation|1|||
170412430|NCT00358826|615849285|FG006|MDCT Substudy|Withdrawal by Subject|0|||
170412431|NCT00358826|615849286|FG007|MDCT Substudy|Withdrawal by Subject|0|||
170412432|NCT01851590|615849287|FG000|Overall Study|Withdrawal by Subject|0|||
170412433|NCT01851590|615849288|FG001|Overall Study|Withdrawal by Subject|0|||
170412434|NCT01851590|615849289|FG002|Overall Study|Withdrawal by Subject|1|||
170412435|NCT01851590|615849287|FG000|Overall Study|Adverse Event|0|||
170412436|NCT01851590|615849288|FG001|Overall Study|Adverse Event|0|||
170522493|NCT02735980|616258178|FG000|Overall Study|Death|5|||
170522494|NCT02735980|616258179|FG001|Overall Study|Death|4|||
170522495|NCT02735980|616258180|FG002|Overall Study|Death|0|||
170522496|NCT02735980|616258178|FG000|Overall Study|Physician Decision|3|||
170522497|NCT02735980|616258179|FG001|Overall Study|Physician Decision|1|||
170522498|NCT02735980|616258180|FG002|Overall Study|Physician Decision|0|||
170522499|NCT02735980|616258178|FG000|Overall Study|Screen failure|1|||
170522500|NCT02735980|616258179|FG001|Overall Study|Screen failure|0|||
170522501|NCT02735980|616258180|FG002|Overall Study|Screen failure|0|||
170522502|NCT02735980|616258178|FG000|Overall Study|Withdrawal by Subject|1|||
170522503|NCT02735980|616258179|FG001|Overall Study|Withdrawal by Subject|2|||
170522504|NCT02735980|616258180|FG002|Overall Study|Withdrawal by Subject|0|||
170522505|NCT01854697|616258181|FG000|Overall Study|Adverse Event|1|||
170522506|NCT01854697|616258182|FG001|Overall Study|Adverse Event|0|||
170522507|NCT01854697|616258183|FG002|Overall Study|Adverse Event|0|||
170522508|NCT01854697|616258184|FG003|Overall Study|Adverse Event|0|||
170522509|NCT01854697|616258185|FG004|Overall Study|Adverse Event|1|||
170522510|NCT01854697|616258181|FG000|Overall Study|Lost to Follow-up|4|||
170522511|NCT01854697|616258182|FG001|Overall Study|Lost to Follow-up|1|||
170522512|NCT01854697|616258183|FG002|Overall Study|Lost to Follow-up|1|||
170522513|NCT01854697|616258184|FG003|Overall Study|Lost to Follow-up|2|||
170522514|NCT01854697|616258185|FG004|Overall Study|Lost to Follow-up|0|||
170522515|NCT01854697|616258181|FG000|Overall Study|To enter another AbbVie study|1|||
170522516|NCT01854697|616258182|FG001|Overall Study|To enter another AbbVie study|0|||
170522517|NCT01854697|616258183|FG002|Overall Study|To enter another AbbVie study|0|||
170522518|NCT01854697|616258184|FG003|Overall Study|To enter another AbbVie study|0|||
170522519|NCT01854697|616258185|FG004|Overall Study|To enter another AbbVie study|1|||
170522520|NCT01854697|616258181|FG000|Overall Study|Withdrew Consent|0|||
170522521|NCT01854697|616258182|FG001|Overall Study|Withdrew Consent|1|||
170522522|NCT01854697|616258183|FG002|Overall Study|Withdrew Consent|0|||
170522523|NCT01854697|616258184|FG003|Overall Study|Withdrew Consent|1|||
170522524|NCT01854697|616258185|FG004|Overall Study|Withdrew Consent|0|||
170522525|NCT01854697|616258181|FG000|Overall Study|Other|0|||
170522526|NCT01854697|616258182|FG001|Overall Study|Other|1|||
170522527|NCT01854697|616258183|FG002|Overall Study|Other|1|||
170522528|NCT01854697|616258184|FG003|Overall Study|Other|0|||
170522529|NCT01854697|616258185|FG004|Overall Study|Other|0|||
170522530|NCT00917124|616258186|FG000|Overall Study|Protocol Violation|4|||
170768338|NCT02696707|617157417|FG000|Per Protocol Population|Participant Decision|0|||
170768339|NCT02696707|617157418|FG001|Per Protocol Population|Participant Decision|2|||
170768340|NCT02696707|617157417|FG000|Completed Study as Planned|Reason = LVEF|2|||
170768341|NCT02696707|617157418|FG001|Completed Study as Planned|Reason = LVEF|2|||
170768342|NCT02696707|617157417|FG000|Completed Study as Planned|Protocol Violation|2|||
170768343|NCT02696707|617157418|FG001|Completed Study as Planned|Protocol Violation|6|||
170768344|NCT02696707|617157417|FG000|Completed Study as Planned|Metastatic disease|3|||
170768345|NCT02696707|617157418|FG001|Completed Study as Planned|Metastatic disease|0|||
170768346|NCT02696707|617157417|FG000|Completed Study as Planned|Location|1|||
170768347|NCT02696707|617157418|FG001|Completed Study as Planned|Location|1|||
170768348|NCT05526248|617157419|FG000|Overall Study|Lost to Follow-up|1|||
170768349|NCT05526248|617157419|FG000|Overall Study|Adverse Event|2|||
170768350|NCT05526248|617157419|FG000|Overall Study|Withdrawal by Subject|1|||
170768351|NCT03823300|617157422|FG000|Overall Study|Withdrawal by Subject|16|||
170768352|NCT03823300|617157423|FG001|Overall Study|Withdrawal by Subject|22|||
170768353|NCT03823300|617157422|FG000|Overall Study|Death|10|||
170768354|NCT03823300|617157423|FG001|Overall Study|Death|14|||
170768355|NCT03823300|617157422|FG000|Overall Study|Adverse Event|3|||
170522531|NCT00917124|616258187|FG001|Overall Study|Protocol Violation|6|||
170522532|NCT01783743|616258192|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
170522533|NCT01783743|616258193|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
170522534|NCT01783743|616258192|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
170522535|NCT01783743|616258193|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
170522536|NCT01783743|616258192|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
170522537|NCT01783743|616258193|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
170522538|NCT02771275|616258194|FG000|Overall Study|Reoperation|3|||
170522539|NCT02771275|616258194|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
170522540|NCT05556148|616258197|FG000|Overall Study|Early Termination|29|||
170522541|NCT05556148|616258197|FG000|Overall Study|Baseline Tasks Expired|4|||
170522542|NCT05556148|616258197|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
170522543|NCT05556148|616258197|FG000|Overall Study|No Longer Wished to Participate|1|||
170522544|NCT05556148|616258197|FG000|Overall Study|Bacterial Conjunctivitis|1|||
170522545|NCT02869789|616258198|FG000|Overall Study|Disease progression|184|||
170768356|NCT03823300|617157423|FG001|Overall Study|Adverse Event|5|||
170768357|NCT03823300|617157422|FG000|Overall Study|Physician Decision|1|||
170768358|NCT03823300|617157423|FG001|Overall Study|Physician Decision|7|||
170768359|NCT03823300|617157422|FG000|Overall Study|Lost to Follow-up|1|||
170768360|NCT03823300|617157423|FG001|Overall Study|Lost to Follow-up|3|||
170522546|NCT02869789|616258199|FG001|Overall Study|Disease progression|109|||
170522547|NCT02869789|616258200|FG002|Overall Study|Disease progression|260|||
170522548|NCT02869789|616258201|FG003|Overall Study|Disease progression|19|||
170522549|NCT02869789|616258198|FG000|Overall Study|Study drug toxicity|90|||
170522550|NCT02869789|616258199|FG001|Overall Study|Study drug toxicity|32|||
170522551|NCT02869789|616258200|FG002|Overall Study|Study drug toxicity|55|||
170522552|NCT02869789|616258201|FG003|Overall Study|Study drug toxicity|14|||
170522553|NCT02869789|616258198|FG000|Overall Study|Death|7|||
170522554|NCT02869789|616258199|FG001|Overall Study|Death|3|||
170522555|NCT02869789|616258200|FG002|Overall Study|Death|5|||
170522556|NCT02869789|616258201|FG003|Overall Study|Death|1|||
170522557|NCT02869789|616258198|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
170522558|NCT02869789|616258199|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
170522559|NCT02869789|616258200|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
170522560|NCT02869789|616258201|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
170522561|NCT02869789|616258198|FG000|Overall Study|Participant request to discontinue study treatment|10|||
170522562|NCT02869789|616258199|FG001|Overall Study|Participant request to discontinue study treatment|5|||
170522563|NCT02869789|616258200|FG002|Overall Study|Participant request to discontinue study treatment|5|||
170522564|NCT02869789|616258201|FG003|Overall Study|Participant request to discontinue study treatment|3|||
170522565|NCT02869789|616258198|FG000|Overall Study|Withdrawal by Subject|5|||
170522566|NCT02869789|616258199|FG001|Overall Study|Withdrawal by Subject|2|||
170522567|NCT02869789|616258200|FG002|Overall Study|Withdrawal by Subject|7|||
170522568|NCT02869789|616258201|FG003|Overall Study|Withdrawal by Subject|2|||
170522569|NCT02869789|616258198|FG000|Overall Study|Lost to Follow-up|0|||
170522570|NCT02869789|616258199|FG001|Overall Study|Lost to Follow-up|0|||
170522571|NCT02869789|616258200|FG002|Overall Study|Lost to Follow-up|2|||
170522572|NCT02869789|616258201|FG003|Overall Study|Lost to Follow-up|0|||
170522573|NCT02869789|616258198|FG000|Overall Study|Maximum clinical benefit|5|||
170522574|NCT02869789|616258199|FG001|Overall Study|Maximum clinical benefit|2|||
170522575|NCT02869789|616258200|FG002|Overall Study|Maximum clinical benefit|1|||
170522576|NCT02869789|616258201|FG003|Overall Study|Maximum clinical benefit|0|||
170522577|NCT02869789|616258198|FG000|Overall Study|Poor/Non-compliance|0|||
170522578|NCT02869789|616258199|FG001|Overall Study|Poor/Non-compliance|2|||
170522579|NCT02869789|616258200|FG002|Overall Study|Poor/Non-compliance|1|||
170522580|NCT02869789|616258201|FG003|Overall Study|Poor/Non-compliance|0|||
170522581|NCT02869789|616258198|FG000|Overall Study|Participant no longer meets study criteria|0|||
170522582|NCT02869789|616258199|FG001|Overall Study|Participant no longer meets study criteria|1|||
170522583|NCT02869789|616258200|FG002|Overall Study|Participant no longer meets study criteria|1|||
170522584|NCT02869789|616258201|FG003|Overall Study|Participant no longer meets study criteria|0|||
170522585|NCT02869789|616258198|FG000|Overall Study|Administrative reason by sponsor|0|||
170522586|NCT02869789|616258199|FG001|Overall Study|Administrative reason by sponsor|0|||
170522587|NCT02869789|616258200|FG002|Overall Study|Administrative reason by sponsor|1|||
170522588|NCT02869789|616258201|FG003|Overall Study|Administrative reason by sponsor|0|||
170522589|NCT02869789|616258198|FG000|Overall Study|Other reasons|4|||
170522590|NCT02869789|616258199|FG001|Overall Study|Other reasons|8|||
170522591|NCT02869789|616258200|FG002|Overall Study|Other reasons|6|||
170522592|NCT02869789|616258201|FG003|Overall Study|Other reasons|0|||
170522593|NCT00379899|616258203|FG000|Overall Study|Adverse Event|7|||
170522594|NCT00379899|616258204|FG001|Overall Study|Adverse Event|3|||
170522595|NCT00379899|616258203|FG000|Overall Study|Death|10|||
170768361|NCT03823300|617157422|FG000|Overall Study|Protocol Violation|1|||
170768362|NCT03823300|617157423|FG001|Overall Study|Protocol Violation|1|||
170768363|NCT03823300|617157422|FG000|Overall Study|Lack of Efficacy|1|||
170768364|NCT03823300|617157423|FG001|Overall Study|Lack of Efficacy|1|||
170768365|NCT03823300|617157422|FG000|Overall Study|Not Eligible|0|||
170768366|NCT03823300|617157423|FG001|Overall Study|Not Eligible|1|||
170768367|NCT03823300|617157422|FG000|Overall Study|Other|1|||
170768368|NCT03823300|617157423|FG001|Overall Study|Other|0|||
170768369|NCT03804918|617157426|FG000|Overall Study|Participant did not use the app|1|||
170768370|NCT02393716|617157434|FG000|Overall Study|Death|29|||
170768371|NCT02393716|617157434|FG000|Overall Study|Withdrawal by Subject|8|||
170768372|NCT02393716|617157434|FG000|Overall Study|Device Explanted|8|||
170768373|NCT02393716|617157434|FG000|Overall Study|Missed visit|16|||
170768374|NCT03939819|617157435|FG000|Overall Study|Death|2|||
170870812|NCT01848288|617539045|FG000|Overall Study|Withdrawal by Subject|1|||
170870813|NCT01007032|617539046|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
170522596|NCT00379899|616258204|FG001|Overall Study|Death|10|||
170522597|NCT00379899|616258203|FG000|Overall Study|Lost to Follow-up|2|||
170522598|NCT00379899|616258204|FG001|Overall Study|Lost to Follow-up|4|||
170522599|NCT00379899|616258203|FG000|Overall Study|Physician Decision|3|||
170522600|NCT00379899|616258204|FG001|Overall Study|Physician Decision|4|||
170768375|NCT03939819|617157436|FG001|Overall Study|Death|0|||
170768376|NCT01194154|617157439|FG000|Overall Study|Adverse Event|12|||
170768377|NCT01194154|617157440|FG001|Overall Study|Adverse Event|7|||
170768378|NCT01194154|617157439|FG000|Overall Study|Lost to Follow-up|2|||
170768379|NCT01194154|617157440|FG001|Overall Study|Lost to Follow-up|3|||
170768380|NCT01194154|617157439|FG000|Overall Study|Protocol Violation|0|||
170768381|NCT01194154|617157440|FG001|Overall Study|Protocol Violation|1|||
170768382|NCT01194154|617157439|FG000|Overall Study|Withdrawal by Subject|5|||
170768383|NCT01194154|617157440|FG001|Overall Study|Withdrawal by Subject|6|||
170768384|NCT01194154|617157439|FG000|Overall Study|Blood pressure increase|5|||
170768385|NCT01194154|617157440|FG001|Overall Study|Blood pressure increase|3|||
170768386|NCT01194154|617157439|FG000|Overall Study|Hemoglobin decrease|0|||
170768387|NCT01194154|617157440|FG001|Overall Study|Hemoglobin decrease|1|||
170768388|NCT01194154|617157439|FG000|Overall Study|Hemoglobin increase|12|||
170768389|NCT01194154|617157440|FG001|Overall Study|Hemoglobin increase|3|||
170768390|NCT01194154|617157439|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
170768391|NCT01194154|617157440|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
170768392|NCT01194154|617157439|FG000|Overall Study|Treatment with prohibited medication|4|||
170768393|NCT01194154|617157440|FG001|Overall Study|Treatment with prohibited medication|5|||
170768394|NCT01194154|617157439|FG000|Overall Study|Other|4|||
170768395|NCT01194154|617157440|FG001|Overall Study|Other|0|||
170768396|NCT01194154|617157439|FG000|Overall Study|Did not receive study medication|2|||
170768397|NCT01194154|617157440|FG001|Overall Study|Did not receive study medication|4|||
170768398|NCT01505881|617157441|FG000|Overall Study|Adverse Event|0|||
170768399|NCT01505881|617157442|FG001|Overall Study|Adverse Event|1|||
170768400|NCT01505881|617157441|FG000|Overall Study|Lost to Follow-up|2|||
170768401|NCT01505881|617157442|FG001|Overall Study|Lost to Follow-up|0|||
170768402|NCT01505881|617157441|FG000|Overall Study|Withdrawal by Subject|2|||
170768403|NCT01505881|617157442|FG001|Overall Study|Withdrawal by Subject|0|||
170768404|NCT00842257|617157443|FG000|Overall Study|Adverse Event|1|||
170768405|NCT01147341|617157444|FG000|Double Blind Period|Lack of Efficacy|1|||
170768406|NCT01147341|617157445|FG001|Double Blind Period|Lack of Efficacy|1|||
170768407|NCT01147341|617157444|FG000|Double Blind Period|Withdrawal by Subject|0|||
170768408|NCT01147341|617157445|FG001|Double Blind Period|Withdrawal by Subject|1|||
170768409|NCT01147341|617157444|FG000|Open Label Period|Lack of Efficacy|3|||
170768410|NCT01147341|617157445|FG001|Open Label Period|Lack of Efficacy|0|||
170768411|NCT01147341|617157444|FG000|Open Label Period|Subject moved|1|||
170768412|NCT01147341|617157445|FG001|Open Label Period|Subject moved|0|||
170768413|NCT02314117|617157446|FG000|Overall Study|Lost to Follow-up|9|||
170768414|NCT02314117|617157447|FG001|Overall Study|Lost to Follow-up|14|||
170768415|NCT02314117|617157446|FG000|Overall Study|Withdrawal by Subject|3|||
170768416|NCT02314117|617157447|FG001|Overall Study|Withdrawal by Subject|2|||
170768417|NCT00909363|617157448|FG000|Overall Study|Withdrawal by Subject|1|||
170768418|NCT00909363|617157449|FG001|Overall Study|Withdrawal by Subject|0|||
170768419|NCT00909363|617157450|FG002|Overall Study|Withdrawal by Subject|0|||
170768420|NCT00909363|617157448|FG000|Overall Study|Lack of Efficacy|1|||
170768421|NCT00909363|617157449|FG001|Overall Study|Lack of Efficacy|0|||
170768422|NCT00909363|617157450|FG002|Overall Study|Lack of Efficacy|0|||
170768423|NCT00922207|617157455|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
170768424|NCT00922207|617157456|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
170768425|NCT00922207|617157457|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
170768426|NCT00922207|617157455|FG000|Overall Study|Insufficient Therapeutic Response|0|||
170768427|NCT00922207|617157456|FG001|Overall Study|Insufficient Therapeutic Response|0|||
170768428|NCT00922207|617157457|FG002|Overall Study|Insufficient Therapeutic Response|1|||
170768429|NCT00922207|617157455|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
170768430|NCT00922207|617157456|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
170768431|NCT00922207|617157457|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
170768432|NCT00922207|617157455|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
170768433|NCT00922207|617157456|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
170768434|NCT00922207|617157457|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
170768435|NCT00922207|617157455|FG000|Overall Study|Withdrew Consent|2|||
170768436|NCT00922207|617157456|FG001|Overall Study|Withdrew Consent|5|||
170768437|NCT00922207|617157457|FG002|Overall Study|Withdrew Consent|2|||
170768438|NCT00922207|617157455|FG000|Overall Study|Abnormality of Laboratory Test|0|||
170768439|NCT00922207|617157456|FG001|Overall Study|Abnormality of Laboratory Test|1|||
170768440|NCT00922207|617157457|FG002|Overall Study|Abnormality of Laboratory Test|1|||
170768441|NCT03515304|617157462|FG000|Overall Study|Lost to Follow-up|0|||
170768442|NCT03515304|617157463|FG001|Overall Study|Lost to Follow-up|3|||
170768443|NCT03383146|617157468|FG000|Overall Study|Screen Failure|1|||
170768444|NCT03383146|617157469|FG001|Overall Study|Screen Failure|0|||
170768445|NCT03383146|617157468|FG000|Overall Study|Adverse Event|6|||
170768446|NCT03383146|617157469|FG001|Overall Study|Adverse Event|18|||
170768447|NCT03383146|617157468|FG000|Overall Study|Lack of Efficacy|0|||
170768448|NCT03383146|617157469|FG001|Overall Study|Lack of Efficacy|3|||
170768449|NCT03383146|617157468|FG000|Overall Study|Withdrawal by Subject|20|||
170768450|NCT03383146|617157469|FG001|Overall Study|Withdrawal by Subject|36|||
170768451|NCT03383146|617157468|FG000|Overall Study|Lost to Follow-up|5|||
170768452|NCT03383146|617157469|FG001|Overall Study|Lost to Follow-up|15|||
170768453|NCT03383146|617157468|FG000|Overall Study|Death|0|||
170768454|NCT03383146|617157469|FG001|Overall Study|Death|2|||
170768455|NCT03383146|617157468|FG000|Overall Study|Physician Decision|0|||
170768456|NCT03383146|617157469|FG001|Overall Study|Physician Decision|1|||
170870814|NCT01007032|617539047|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
170870815|NCT01007032|617539048|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
170870816|NCT01007032|617539049|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
170870817|NCT01007032|617539046|FG000|Overall Study|Withdrawal by Subject|0|||
170870818|NCT01007032|617539047|FG001|Overall Study|Withdrawal by Subject|0|||
170870819|NCT01007032|617539048|FG002|Overall Study|Withdrawal by Subject|0|||
170870820|NCT01007032|617539049|FG003|Overall Study|Withdrawal by Subject|1|||
170870821|NCT03383289|617539055|FG000|Overall Study|Death|83|||
170870822|NCT03383289|617539056|FG001|Overall Study|Death|78|||
170870823|NCT03383289|617539055|FG000|Overall Study|discharge from facility|84|||
170870824|NCT03383289|617539056|FG001|Overall Study|discharge from facility|84|||
170870825|NCT03383289|617539055|FG000|Overall Study|Withdrawal by Subject|4|||
170870826|NCT03383289|617539056|FG001|Overall Study|Withdrawal by Subject|1|||
170870827|NCT01195090|617539058|FG000|Overall Study|Adverse Event|1|||
170870828|NCT01195090|617539059|FG001|Overall Study|Adverse Event|2|||
170870829|NCT01195090|617539058|FG000|Overall Study|Lost to Follow-up|2|||
170870830|NCT01195090|617539059|FG001|Overall Study|Lost to Follow-up|2|||
170870831|NCT01195090|617539058|FG000|Overall Study|Protocol Violation|3|||
170870832|NCT01195090|617539059|FG001|Overall Study|Protocol Violation|4|||
170870833|NCT03945591|617539060|FG000|Overall Study|Participant not transplanted|1|||
170870834|NCT03945591|617539060|FG000|Overall Study|Change in treatment plan|3|||
170870835|NCT03945591|617539060|FG000|Overall Study|Adverse Event|1|||
170870836|NCT00058552|617539061|FG000|Overall Study|Died prior to receiving treatment|4|||
170870837|NCT00058552|617539062|FG001|Overall Study|Died prior to receiving treatment|2|||
170870838|NCT00058552|617539061|FG000|Overall Study|Disease progression|52|||
170522601|NCT00379899|616258203|FG000|Overall Study|Withdrawal by Subject|5|||
170522602|NCT00379899|616258204|FG001|Overall Study|Withdrawal by Subject|5|||
170522603|NCT00379899|616258203|FG000|Overall Study|Ineligibility determined|0|||
170522604|NCT00379899|616258204|FG001|Overall Study|Ineligibility determined|1|||
170522605|NCT00379899|616258203|FG000|Overall Study|Noncompliance|1|||
170768457|NCT03383146|617157468|FG000|Overall Study|Protocol Deviation|1|||
170768458|NCT03383146|617157469|FG001|Overall Study|Protocol Deviation|8|||
170768459|NCT03383146|617157468|FG000|Overall Study|Study Terminated by the Sponsor|48|||
170768460|NCT03383146|617157469|FG001|Overall Study|Study Terminated by the Sponsor|95|||
170768461|NCT03383146|617157468|FG000|Overall Study|Reason not Specified|4|||
170768462|NCT03383146|617157469|FG001|Overall Study|Reason not Specified|6|||
170768463|NCT01317420|617157471|FG000|Overall Study|Progressive disease according to RECIST|2|||
170768464|NCT01317420|617157472|FG001|Overall Study|Progressive disease according to RECIST|3|||
170768465|NCT01317420|617157473|FG002|Overall Study|Progressive disease according to RECIST|3|||
170768466|NCT01317420|617157474|FG003|Overall Study|Progressive disease according to RECIST|3|||
170768467|NCT01317420|617157475|FG004|Overall Study|Progressive disease according to RECIST|3|||
170768468|NCT01317420|617157476|FG005|Overall Study|Progressive disease according to RECIST|3|||
170768469|NCT01317420|617157477|FG006|Overall Study|Progressive disease according to RECIST|3|||
170768470|NCT01317420|617157478|FG007|Overall Study|Progressive disease according to RECIST|3|||
170768471|NCT01317420|617157479|FG008|Overall Study|Progressive disease according to RECIST|3|||
170768472|NCT01317420|617157480|FG009|Overall Study|Progressive disease according to RECIST|2|||
170768473|NCT01317420|617157481|FG010|Overall Study|Progressive disease according to RECIST|3|||
170768474|NCT01317420|617157482|FG011|Overall Study|Progressive disease according to RECIST|11|||
170768475|NCT01317420|617157483|FG012|Overall Study|Progressive disease according to RECIST|16|||
170768476|NCT01317420|617157471|FG000|Overall Study|Other adverse event|1|||
170768477|NCT01317420|617157472|FG001|Overall Study|Other adverse event|0|||
170768478|NCT01317420|617157473|FG002|Overall Study|Other adverse event|0|||
170768479|NCT01317420|617157474|FG003|Overall Study|Other adverse event|0|||
170768480|NCT01317420|617157475|FG004|Overall Study|Other adverse event|0|||
170768481|NCT01317420|617157476|FG005|Overall Study|Other adverse event|0|||
170768482|NCT01317420|617157477|FG006|Overall Study|Other adverse event|0|||
170768483|NCT01317420|617157478|FG007|Overall Study|Other adverse event|0|||
170768484|NCT01317420|617157479|FG008|Overall Study|Other adverse event|0|||
170768485|NCT01317420|617157480|FG009|Overall Study|Other adverse event|0|||
170768486|NCT01317420|617157481|FG010|Overall Study|Other adverse event|0|||
170768487|NCT01317420|617157482|FG011|Overall Study|Other adverse event|0|||
170768488|NCT01317420|617157483|FG012|Overall Study|Other adverse event|2|||
170768489|NCT01317420|617157471|FG000|Overall Study|Non-compliant with protocol|0|||
170768490|NCT01317420|617157472|FG001|Overall Study|Non-compliant with protocol|0|||
170768491|NCT01317420|617157473|FG002|Overall Study|Non-compliant with protocol|0|||
170522606|NCT00379899|616258204|FG001|Overall Study|Noncompliance|1|||
170768492|NCT01317420|617157474|FG003|Overall Study|Non-compliant with protocol|0|||
170768493|NCT01317420|617157475|FG004|Overall Study|Non-compliant with protocol|0|||
170768494|NCT01317420|617157476|FG005|Overall Study|Non-compliant with protocol|0|||
170768495|NCT01317420|617157477|FG006|Overall Study|Non-compliant with protocol|0|||
170870839|NCT00058552|617539062|FG001|Overall Study|Disease progression|44|||
170522607|NCT00379899|616258203|FG000|Overall Study|Parathyroidectomy|0|||
170522608|NCT00379899|616258204|FG001|Overall Study|Parathyroidectomy|2|||
170870840|NCT00058552|617539061|FG000|Overall Study|Adverse Event|4|||
170632177|NCT01134055|616664544|FG005|Overall Study|Physician Decision|0|||
170768496|NCT01317420|617157478|FG007|Overall Study|Non-compliant with protocol|0|||
170768497|NCT01317420|617157479|FG008|Overall Study|Non-compliant with protocol|0|||
170768498|NCT01317420|617157480|FG009|Overall Study|Non-compliant with protocol|0|||
170768499|NCT01317420|617157481|FG010|Overall Study|Non-compliant with protocol|0|||
170768500|NCT01317420|617157482|FG011|Overall Study|Non-compliant with protocol|0|||
170768501|NCT01317420|617157483|FG012|Overall Study|Non-compliant with protocol|1|||
170768502|NCT01317420|617157471|FG000|Overall Study|Refused to cont. taking trial medication|0|||
170768503|NCT01317420|617157472|FG001|Overall Study|Refused to cont. taking trial medication|0|||
170768504|NCT01317420|617157473|FG002|Overall Study|Refused to cont. taking trial medication|0|||
170768505|NCT01317420|617157474|FG003|Overall Study|Refused to cont. taking trial medication|0|||
170768506|NCT01317420|617157475|FG004|Overall Study|Refused to cont. taking trial medication|0|||
170768507|NCT01317420|617157476|FG005|Overall Study|Refused to cont. taking trial medication|0|||
170768508|NCT01317420|617157477|FG006|Overall Study|Refused to cont. taking trial medication|0|||
170768509|NCT01317420|617157478|FG007|Overall Study|Refused to cont. taking trial medication|0|||
170768510|NCT01317420|617157479|FG008|Overall Study|Refused to cont. taking trial medication|0|||
170768511|NCT01317420|617157480|FG009|Overall Study|Refused to cont. taking trial medication|0|||
170768512|NCT01317420|617157481|FG010|Overall Study|Refused to cont. taking trial medication|0|||
170768513|NCT01317420|617157482|FG011|Overall Study|Refused to cont. taking trial medication|0|||
170768514|NCT01317420|617157483|FG012|Overall Study|Refused to cont. taking trial medication|1|||
170768515|NCT01317420|617157471|FG000|Overall Study|Reason other than those specified|0|||
170768516|NCT01317420|617157472|FG001|Overall Study|Reason other than those specified|0|||
170768517|NCT01317420|617157473|FG002|Overall Study|Reason other than those specified|0|||
170768518|NCT01317420|617157474|FG003|Overall Study|Reason other than those specified|0|||
170768519|NCT01317420|617157475|FG004|Overall Study|Reason other than those specified|0|||
170768520|NCT01317420|617157476|FG005|Overall Study|Reason other than those specified|0|||
170768521|NCT01317420|617157477|FG006|Overall Study|Reason other than those specified|0|||
170768522|NCT01317420|617157478|FG007|Overall Study|Reason other than those specified|0|||
170768523|NCT01317420|617157479|FG008|Overall Study|Reason other than those specified|0|||
170768524|NCT01317420|617157480|FG009|Overall Study|Reason other than those specified|1|||
170768525|NCT01317420|617157481|FG010|Overall Study|Reason other than those specified|0|||
170768526|NCT01317420|617157482|FG011|Overall Study|Reason other than those specified|0|||
170768527|NCT01317420|617157483|FG012|Overall Study|Reason other than those specified|0|||
170768528|NCT04210180|617157484|FG000|Overall Study|Withdrawal by Subject|2|||
170768529|NCT05190419|617157485|FG000|Overall Study|Lack of Efficacy|8|||
170768530|NCT05190419|617157486|FG001|Overall Study|Lack of Efficacy|0|||
170768531|NCT05190419|617157487|FG002|Overall Study|Lack of Efficacy|1|||
170768532|NCT05190419|617157488|FG003|Overall Study|Lack of Efficacy|0|||
170768533|NCT05190419|617157485|FG000|Overall Study|Withdrawal by Subject|7|||
170768534|NCT05190419|617157486|FG001|Overall Study|Withdrawal by Subject|1|||
170768535|NCT05190419|617157487|FG002|Overall Study|Withdrawal by Subject|2|||
170768536|NCT05190419|617157488|FG003|Overall Study|Withdrawal by Subject|2|||
170768537|NCT05190419|617157485|FG000|Overall Study|Adverse Event|2|||
170768538|NCT05190419|617157486|FG001|Overall Study|Adverse Event|10|||
170768539|NCT05190419|617157487|FG002|Overall Study|Adverse Event|11|||
170768540|NCT05190419|617157488|FG003|Overall Study|Adverse Event|21|||
170768541|NCT05190419|617157485|FG000|Overall Study|Lost to Follow-up|1|||
170768542|NCT05190419|617157486|FG001|Overall Study|Lost to Follow-up|2|||
170768543|NCT05190419|617157487|FG002|Overall Study|Lost to Follow-up|3|||
170768544|NCT05190419|617157488|FG003|Overall Study|Lost to Follow-up|1|||
170412437|NCT01851590|615849289|FG002|Overall Study|Adverse Event|2|||
170412438|NCT01851590|615849287|FG000|Overall Study|Lack of Efficacy|0|||
170412439|NCT01851590|615849288|FG001|Overall Study|Lack of Efficacy|1|||
170412440|NCT01851590|615849289|FG002|Overall Study|Lack of Efficacy|0|||
170412441|NCT00696709|615849291|FG000|Overall Study|Withdrawal by Subject|1|||
170412442|NCT00696709|615849292|FG001|Overall Study|Withdrawal by Subject|2|||
170412443|NCT00696709|615849293|FG002|Overall Study|Withdrawal by Subject|1|||
170412444|NCT00696709|615849294|FG003|Overall Study|Withdrawal by Subject|4|||
170412445|NCT00696709|615849295|FG004|Overall Study|Withdrawal by Subject|3|||
170412446|NCT00696709|615849291|FG000|Overall Study|Protocol Violation|1|||
170412447|NCT00696709|615849292|FG001|Overall Study|Protocol Violation|0|||
170412448|NCT00696709|615849293|FG002|Overall Study|Protocol Violation|0|||
170412449|NCT00696709|615849294|FG003|Overall Study|Protocol Violation|0|||
170412450|NCT00696709|615849295|FG004|Overall Study|Protocol Violation|0|||
170768545|NCT05190419|617157485|FG000|Overall Study|Other|1|||
170768546|NCT05190419|617157486|FG001|Overall Study|Other|1|||
170768547|NCT05190419|617157487|FG002|Overall Study|Other|0|||
170768548|NCT05190419|617157488|FG003|Overall Study|Other|3|||
170412451|NCT00696709|615849291|FG000|Overall Study|Lost to Follow-up|1|||
170412452|NCT00696709|615849292|FG001|Overall Study|Lost to Follow-up|1|||
170768549|NCT00367055|617157489|FG000|Overall Study|Adverse Event|6|||
170768550|NCT00367055|617157490|FG001|Overall Study|Adverse Event|3|||
170768551|NCT00367055|617157489|FG000|Overall Study|Patient's Willing|3|||
170768552|NCT00367055|617157490|FG001|Overall Study|Patient's Willing|2|||
170768553|NCT00367055|617157489|FG000|Overall Study|Lack of Efficacy|1|||
170412453|NCT00696709|615849293|FG002|Overall Study|Lost to Follow-up|0|||
170870841|NCT00058552|617539062|FG001|Overall Study|Adverse Event|2|||
170870842|NCT00058552|617539061|FG000|Overall Study|Withdrawal by Subject|3|||
170870843|NCT00058552|617539062|FG001|Overall Study|Withdrawal by Subject|5|||
170870844|NCT00058552|617539061|FG000|Overall Study|Physician Decision|2|||
170870845|NCT00058552|617539062|FG001|Overall Study|Physician Decision|5|||
170870846|NCT00058552|617539061|FG000|Overall Study|Clinical disease progression|0|||
170870847|NCT00058552|617539062|FG001|Overall Study|Clinical disease progression|4|||
170870848|NCT00359021|617539063|FG000|Overall Study|Adverse Event|26|||
170870849|NCT00359021|617539064|FG001|Overall Study|Adverse Event|8|||
170870850|NCT00359021|617539063|FG000|Overall Study|Subject Non-Compliant|1|||
170870851|NCT00359021|617539064|FG001|Overall Study|Subject Non-Compliant|2|||
170870852|NCT00359021|617539063|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
170870853|NCT00359021|617539064|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
170870854|NCT00359021|617539063|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
170870855|NCT00359021|617539064|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
170870856|NCT00359021|617539063|FG000|Overall Study|Withdrawal by Subject|2|||
170870857|NCT00359021|617539064|FG001|Overall Study|Withdrawal by Subject|9|||
170870858|NCT00359021|617539063|FG000|Overall Study|Lost to Follow-up|1|||
170870859|NCT00359021|617539064|FG001|Overall Study|Lost to Follow-up|0|||
170870860|NCT00359021|617539063|FG000|Overall Study|Other|4|||
170870861|NCT00359021|617539064|FG001|Overall Study|Other|1|||
170870862|NCT00359021|617539063|FG000|Overall Study|Pregnancy|1|||
170870863|NCT00359021|617539064|FG001|Overall Study|Pregnancy|0|||
170870864|NCT03198520|617539069|FG000|Overall Study|Physician Decision|2|||
170870865|NCT03198520|617539069|FG000|Overall Study|Protocol Violation|2|||
170870866|NCT03198520|617539069|FG000|Overall Study|Withdrawal by Subject|1|||
170870867|NCT03198520|617539069|FG000|Overall Study|Study Ended|1|||
170870868|NCT02316340|617539070|FG000|First Progression|Clinical progression|2|||
170870869|NCT02316340|617539071|FG001|First Progression|Clinical progression|1|||
170870870|NCT02316340|617539070|FG000|First Progression|Withdrawal by Subject|1|||
170870871|NCT02316340|617539071|FG001|First Progression|Withdrawal by Subject|0|||
170870872|NCT02665052|617539075|FG000|Overall Study|Lost to Follow-up|1|||
170870873|NCT02665052|617539076|FG001|Overall Study|Lost to Follow-up|0|||
170870874|NCT02665052|617539077|FG002|Overall Study|Lost to Follow-up|0|||
170870875|NCT02665052|617539078|FG003|Overall Study|Lost to Follow-up|0|||
170870876|NCT02665052|617539075|FG000|Overall Study|Withdrawal by Subject|1|||
170870877|NCT02665052|617539076|FG001|Overall Study|Withdrawal by Subject|1|||
170870878|NCT02665052|617539077|FG002|Overall Study|Withdrawal by Subject|0|||
170870879|NCT02665052|617539078|FG003|Overall Study|Withdrawal by Subject|5|||
170870880|NCT02665052|617539075|FG000|Overall Study|Adverse Event|1|||
170870881|NCT02665052|617539076|FG001|Overall Study|Adverse Event|1|||
170870882|NCT02665052|617539077|FG002|Overall Study|Adverse Event|0|||
170870883|NCT02665052|617539078|FG003|Overall Study|Adverse Event|0|||
170870884|NCT02234284|617539079|FG000|Overall Study|Death|4|||
170870885|NCT02234284|617539080|FG001|Overall Study|Death|2|||
170870886|NCT02234284|617539079|FG000|Overall Study|Withdrawal by Subject|1|||
170870887|NCT02234284|617539080|FG001|Overall Study|Withdrawal by Subject|0|||
170870888|NCT02234284|617539079|FG000|Overall Study|Lost to Follow-up|20|||
170870889|NCT02234284|617539080|FG001|Overall Study|Lost to Follow-up|7|||
170870890|NCT03023059|617539085|FG000|Overall Study|Withdrawal by Subject|5|||
170870891|NCT01118325|617539086|FG000|Overall Study|Adverse Event|1|||
170870892|NCT01118325|617539087|FG001|Overall Study|Adverse Event|0|||
170870893|NCT01118325|617539088|FG002|Overall Study|Adverse Event|1|||
170870894|NCT00536809|617539089|FG000|Phase II|Adverse Event|1|||
170870895|NCT00536809|617539089|FG000|Phase II|Referred for surgical resection|1|||
170870896|NCT03334409|617539090|FG000|Overall Study|Did not meet inclusion criteria|1|||
170870897|NCT03334409|617539091|FG001|Overall Study|Did not meet inclusion criteria|0|||
170870898|NCT01241552|617539096|FG000|Overall Study|Lack of Efficacy|1|||
170870899|NCT01241552|617539097|FG001|Overall Study|Lack of Efficacy|0|||
170870900|NCT01241552|617539098|FG002|Overall Study|Lack of Efficacy|0|||
170870901|NCT01241552|617539099|FG003|Overall Study|Lack of Efficacy|0|||
170412454|NCT00696709|615849294|FG003|Overall Study|Lost to Follow-up|0|||
170412455|NCT00696709|615849295|FG004|Overall Study|Lost to Follow-up|0|||
170412456|NCT00696709|615849291|FG000|Overall Study|Adverse Event|0|||
170412457|NCT00696709|615849292|FG001|Overall Study|Adverse Event|0|||
170412458|NCT00696709|615849293|FG002|Overall Study|Adverse Event|0|||
170412459|NCT00696709|615849294|FG003|Overall Study|Adverse Event|1|||
170412460|NCT00696709|615849295|FG004|Overall Study|Adverse Event|0|||
170412461|NCT00310856|615849296|FG000|Overall Study|Withdrawal by Subject|2|||
170412462|NCT00310856|615849297|FG001|Overall Study|Withdrawal by Subject|2|||
170870902|NCT01241552|617539096|FG000|Overall Study|Death|26|||
170870903|NCT01241552|617539097|FG001|Overall Study|Death|30|||
170870904|NCT01241552|617539098|FG002|Overall Study|Death|20|||
170870905|NCT01241552|617539099|FG003|Overall Study|Death|25|||
170870906|NCT01241552|617539096|FG000|Overall Study|Adverse Event|1|||
170870907|NCT01241552|617539097|FG001|Overall Study|Adverse Event|1|||
170870908|NCT01241552|617539098|FG002|Overall Study|Adverse Event|0|||
170870909|NCT01241552|617539099|FG003|Overall Study|Adverse Event|0|||
170870910|NCT01241552|617539096|FG000|Overall Study|Technical Problems|2|||
170522609|NCT00379899|616258203|FG000|Overall Study|Renal transplantation|5|||
170522610|NCT00379899|616258204|FG001|Overall Study|Renal transplantation|4|||
170522611|NCT00379899|616258203|FG000|Overall Study|Coronary artery bypass graft|1|||
170522612|NCT00379899|616258204|FG001|Overall Study|Coronary artery bypass graft|1|||
170522613|NCT00379899|616258203|FG000|Overall Study|Other protocol-specified criteria|3|||
170522614|NCT00379899|616258204|FG001|Overall Study|Other protocol-specified criteria|4|||
170768554|NCT00367055|617157490|FG001|Overall Study|Lack of Efficacy|2|||
170768555|NCT00367055|617157489|FG000|Overall Study|Lost to Follow-up|1|||
170768556|NCT00367055|617157490|FG001|Overall Study|Lost to Follow-up|1|||
170768557|NCT00367055|617157489|FG000|Overall Study|Protocol Violation|0|||
170768558|NCT00367055|617157490|FG001|Overall Study|Protocol Violation|1|||
170768559|NCT00367055|617157489|FG000|Overall Study|Stopping Criterion Met|0|||
170768560|NCT00367055|617157490|FG001|Overall Study|Stopping Criterion Met|1|||
170768561|NCT00367055|617157489|FG000|Overall Study|Participant Living too Far from Hospital|0|||
170768562|NCT00367055|617157490|FG001|Overall Study|Participant Living too Far from Hospital|1|||
170768563|NCT04707313|617157491|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
170768564|NCT04707313|617157492|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
170768565|NCT04707313|617157493|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
170768566|NCT04707313|617157494|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
170768567|NCT04707313|617157495|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
170768568|NCT04707313|617157496|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
170768569|NCT04707313|617157497|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
170768570|NCT04707313|617157498|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
170768571|NCT04707313|617157499|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
170768572|NCT04707313|617157500|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
170768573|NCT04707313|617157501|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
170768574|NCT04707313|617157502|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
170768575|NCT04707313|617157503|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
170768576|NCT04707313|617157491|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
170768577|NCT04707313|617157492|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
170768578|NCT04707313|617157493|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768579|NCT04707313|617157494|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768580|NCT04707313|617157495|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
170768581|NCT04707313|617157496|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768582|NCT04707313|617157497|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768583|NCT04707313|617157498|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768584|NCT04707313|617157499|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768585|NCT04707313|617157500|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768586|NCT04707313|617157501|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768587|NCT04707313|617157502|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768588|NCT04707313|617157503|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
170768589|NCT04707313|617157491|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
170768590|NCT04707313|617157492|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
170768591|NCT04707313|617157493|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
170768592|NCT04707313|617157494|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
170768593|NCT04707313|617157495|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
170768594|NCT04707313|617157496|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
170768595|NCT04707313|617157497|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
170768596|NCT04707313|617157498|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
170768597|NCT04707313|617157499|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
170768598|NCT04707313|617157500|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
170768599|NCT04707313|617157501|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
170768600|NCT04707313|617157502|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
170768601|NCT04707313|617157503|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
170768602|NCT04707313|617157491|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170768603|NCT04707313|617157492|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
170768604|NCT04707313|617157493|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
170768605|NCT04707313|617157494|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170768606|NCT04707313|617157495|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
170768607|NCT04707313|617157496|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170768608|NCT04707313|617157497|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170522615|NCT00379899|616258203|FG000|Overall Study|Other|3|||
170522616|NCT00379899|616258204|FG001|Overall Study|Other|1|||
170522617|NCT00673257|616258205|FG000|Overall Study|Withdrawal by Subject|4|||
170768609|NCT04707313|617157498|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170768610|NCT04707313|617157499|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170768611|NCT04707313|617157500|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170632178|NCT01134055|616664545|FG006|Overall Study|Physician Decision|1|||
170870911|NCT01241552|617539097|FG001|Overall Study|Technical Problems|0|||
170870912|NCT01241552|617539098|FG002|Overall Study|Technical Problems|2|||
170870913|NCT01241552|617539099|FG003|Overall Study|Technical Problems|2|||
170870914|NCT01241552|617539096|FG000|Overall Study|Progressive Disease|0|||
170870915|NCT01241552|617539097|FG001|Overall Study|Progressive Disease|0|||
170870916|NCT01241552|617539098|FG002|Overall Study|Progressive Disease|1|||
170870917|NCT01241552|617539099|FG003|Overall Study|Progressive Disease|2|||
170870918|NCT01241552|617539096|FG000|Overall Study|Protocol Violation|0|||
170870919|NCT01241552|617539097|FG001|Overall Study|Protocol Violation|2|||
170870920|NCT01241552|617539098|FG002|Overall Study|Protocol Violation|6|||
170870921|NCT01241552|617539099|FG003|Overall Study|Protocol Violation|1|||
170870922|NCT01241552|617539096|FG000|Overall Study|Withdrawal by Subject|7|||
170870923|NCT01241552|617539097|FG001|Overall Study|Withdrawal by Subject|15|||
170870924|NCT01241552|617539098|FG002|Overall Study|Withdrawal by Subject|14|||
170870925|NCT01241552|617539099|FG003|Overall Study|Withdrawal by Subject|15|||
170870926|NCT01241552|617539096|FG000|Overall Study|Physician Decision|2|||
170870927|NCT01241552|617539097|FG001|Overall Study|Physician Decision|4|||
170870928|NCT01241552|617539098|FG002|Overall Study|Physician Decision|2|||
170870929|NCT01241552|617539099|FG003|Overall Study|Physician Decision|3|||
170870930|NCT01241552|617539096|FG000|Overall Study|Lost to Follow-up|2|||
170870931|NCT01241552|617539097|FG001|Overall Study|Lost to Follow-up|11|||
170870932|NCT01241552|617539098|FG002|Overall Study|Lost to Follow-up|15|||
170870933|NCT01241552|617539099|FG003|Overall Study|Lost to Follow-up|16|||
170870934|NCT02606461|617539105|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
170870935|NCT02606461|617539106|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
170870936|NCT02606461|617539107|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
170870937|NCT02606461|617539108|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
170870938|NCT02606461|617539109|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
170870939|NCT02606461|617539110|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
170870940|NCT01303965|617539111|FG000|Overall Study|Adverse Event|1|||
170870941|NCT01303965|617539112|FG001|Overall Study|Adverse Event|1|||
170870942|NCT01303965|617539111|FG000|Overall Study|Death|0|||
170870943|NCT01303965|617539112|FG001|Overall Study|Death|3|||
170870944|NCT01303965|617539111|FG000|Overall Study|Withdrawal by Subject|1|||
170870945|NCT01303965|617539112|FG001|Overall Study|Withdrawal by Subject|0|||
170870946|NCT01303965|617539111|FG000|Overall Study|Disease Progression|1|||
170870947|NCT01303965|617539112|FG001|Overall Study|Disease Progression|6|||
170870948|NCT01287364|617539113|FG000|Overall Study|Adverse Event|0|||
170870949|NCT01287364|617539114|FG001|Overall Study|Adverse Event|3|||
170870950|NCT01287364|617539113|FG000|Overall Study|Protocol Violation|5|||
170870951|NCT01287364|617539114|FG001|Overall Study|Protocol Violation|5|||
170870952|NCT01287364|617539113|FG000|Overall Study|Other Reason|4|||
170870953|NCT01287364|617539114|FG001|Overall Study|Other Reason|2|||
170870954|NCT00574288|617539118|FG000|Overall Study|Adverse Event|2|||
170870955|NCT00574288|617539119|FG001|Overall Study|Adverse Event|0|||
170870956|NCT00574288|617539120|FG002|Overall Study|Adverse Event|0|||
170870957|NCT00574288|617539121|FG003|Overall Study|Adverse Event|0|||
170870958|NCT00574288|617539122|FG004|Overall Study|Adverse Event|1|||
170870959|NCT00574288|617539123|FG005|Overall Study|Adverse Event|0|||
170870960|NCT00574288|617539124|FG006|Overall Study|Adverse Event|0|||
170870961|NCT00574288|617539118|FG000|Overall Study|Death|0|||
170870962|NCT00574288|617539119|FG001|Overall Study|Death|0|||
170870963|NCT00574288|617539120|FG002|Overall Study|Death|0|||
170870964|NCT00574288|617539121|FG003|Overall Study|Death|0|||
170870965|NCT00574288|617539122|FG004|Overall Study|Death|0|||
170870966|NCT00574288|617539123|FG005|Overall Study|Death|25|||
170870967|NCT00574288|617539124|FG006|Overall Study|Death|21|||
170870968|NCT00574288|617539118|FG000|Overall Study|Lost to Follow-up|0|||
170870969|NCT00574288|617539119|FG001|Overall Study|Lost to Follow-up|0|||
170870970|NCT00574288|617539120|FG002|Overall Study|Lost to Follow-up|0|||
170870971|NCT00574288|617539121|FG003|Overall Study|Lost to Follow-up|0|||
170870972|NCT00574288|617539122|FG004|Overall Study|Lost to Follow-up|0|||
170870973|NCT00574288|617539123|FG005|Overall Study|Lost to Follow-up|1|||
170870974|NCT00574288|617539124|FG006|Overall Study|Lost to Follow-up|2|||
170870975|NCT00574288|617539118|FG000|Overall Study|Study Terminated By Sponsor|0|||
170870976|NCT00574288|617539119|FG001|Overall Study|Study Terminated By Sponsor|0|||
170870977|NCT00574288|617539120|FG002|Overall Study|Study Terminated By Sponsor|0|||
170870978|NCT00574288|617539121|FG003|Overall Study|Study Terminated By Sponsor|0|||
170870979|NCT00574288|617539122|FG004|Overall Study|Study Terminated By Sponsor|0|||
170870980|NCT00574288|617539123|FG005|Overall Study|Study Terminated By Sponsor|0|||
170870981|NCT00574288|617539124|FG006|Overall Study|Study Terminated By Sponsor|5|||
170870982|NCT00574288|617539118|FG000|Overall Study|Progressive Disease|17|||
170870983|NCT00574288|617539119|FG001|Overall Study|Progressive Disease|2|||
170870984|NCT00574288|617539120|FG002|Overall Study|Progressive Disease|3|||
170870985|NCT00574288|617539121|FG003|Overall Study|Progressive Disease|2|||
170870986|NCT00574288|617539122|FG004|Overall Study|Progressive Disease|1|||
170870987|NCT00574288|617539123|FG005|Overall Study|Progressive Disease|0|||
170870988|NCT00574288|617539124|FG006|Overall Study|Progressive Disease|0|||
170870989|NCT00574288|617539118|FG000|Overall Study|Other|1|||
170522618|NCT00673257|616258205|FG000|Overall Study|Unable to obtain specimen|1|||
170522619|NCT02111174|616258212|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
170522620|NCT02111174|616258213|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
170522621|NCT02111174|616258212|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
170870990|NCT00574288|617539119|FG001|Overall Study|Other|1|||
170870991|NCT00574288|617539120|FG002|Overall Study|Other|0|||
170870992|NCT00574288|617539121|FG003|Overall Study|Other|0|||
170870993|NCT00574288|617539122|FG004|Overall Study|Other|0|||
170870994|NCT00574288|617539123|FG005|Overall Study|Other|0|||
170870995|NCT00574288|617539124|FG006|Overall Study|Other|0|||
170870996|NCT00757003|617539130|FG000|Overall Study|Death|33|||
170870997|NCT00757003|617539130|FG000|Overall Study|Lost to Follow-up|9|||
170870998|NCT00757003|617539130|FG000|Overall Study|Withdrawal by Subject|4|||
170870999|NCT00757003|617539130|FG000|Overall Study|Surgically explanted|2|||
170871000|NCT00757003|617539130|FG000|Overall Study|Not implanted|1|||
170871001|NCT04246801|617539131|FG000|Overall Study|Adverse Event|1|||
170871002|NCT04246801|617539132|FG001|Overall Study|Adverse Event|1|||
170871003|NCT04246801|617539131|FG000|Overall Study|Protocol Violation|1|||
170871004|NCT04246801|617539132|FG001|Overall Study|Protocol Violation|1|||
170871005|NCT04246801|617539131|FG000|Overall Study|Lack of Efficacy|0|||
170871006|NCT04246801|617539132|FG001|Overall Study|Lack of Efficacy|2|||
170871007|NCT04246801|617539131|FG000|Overall Study|Lost to Follow-up|1|||
170871008|NCT04246801|617539132|FG001|Overall Study|Lost to Follow-up|1|||
170871009|NCT04246801|617539131|FG000|Overall Study|Withdrawal by Subject|2|||
170871010|NCT04246801|617539132|FG001|Overall Study|Withdrawal by Subject|1|||
170871011|NCT00175877|617539133|FG000|Overall Study|Adverse Event|136|||
170871012|NCT00175877|617539133|FG000|Overall Study|Withdrawal by Subject|141|||
170871013|NCT00175877|617539133|FG000|Overall Study|Lost to Follow-up|9|||
170871014|NCT00175877|617539133|FG000|Overall Study|Lack of Efficacy|26|||
170871015|NCT00175877|617539133|FG000|Overall Study|Protocol Violation|15|||
170871016|NCT00175877|617539133|FG000|Overall Study|Other Reason|20|||
170871017|NCT00175877|617539133|FG000|Overall Study|AE & Other|1|||
170871018|NCT00175877|617539133|FG000|Overall Study|Withdrawal by subject & Other|1|||
170871019|NCT04166383|617539136|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
170871020|NCT04166383|617539136|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
170871021|NCT04166383|617539136|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
170871022|NCT03044886|617539137|FG000|Overall Study|Lost to Follow-up|15|||
170871023|NCT03044886|617539138|FG001|Overall Study|Lost to Follow-up|10|||
170871024|NCT03044886|617539139|FG002|Overall Study|Lost to Follow-up|12|||
170871025|NCT02054325|617539142|FG000|Overall Study|Lost to Follow-up|8|||
170871026|NCT02054325|617539143|FG001|Overall Study|Lost to Follow-up|5|||
170871027|NCT03785678|617539144|FG000|Overall Study|Death|44|||
170871028|NCT03785678|617539145|FG001|Overall Study|Death|42|||
170871029|NCT03785678|617539144|FG000|Overall Study|Lost to Follow-up|4|||
170871030|NCT03785678|617539145|FG001|Overall Study|Lost to Follow-up|2|||
170871031|NCT03785678|617539144|FG000|Overall Study|Physician Decision|0|||
170871032|NCT03785678|617539145|FG001|Overall Study|Physician Decision|2|||
170871033|NCT03785678|617539144|FG000|Overall Study|Withdrawal by Subject|5|||
170871034|NCT03785678|617539145|FG001|Overall Study|Withdrawal by Subject|3|||
170871035|NCT01159912|617539146|FG000|Overall Study|Adverse Event|2|||
170871036|NCT01159912|617539147|FG001|Overall Study|Adverse Event|2|||
170871037|NCT01159912|617539148|FG002|Overall Study|Adverse Event|3|||
170871038|NCT01159912|617539146|FG000|Overall Study|Lack of Efficacy|23|||
170871039|NCT01159912|617539147|FG001|Overall Study|Lack of Efficacy|15|||
170871040|NCT01159912|617539148|FG002|Overall Study|Lack of Efficacy|14|||
170871041|NCT01159912|617539146|FG000|Overall Study|Protocol Violation|1|||
170871042|NCT01159912|617539147|FG001|Overall Study|Protocol Violation|2|||
170522622|NCT02111174|616258213|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
170522623|NCT02111174|616258212|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
170522624|NCT02111174|616258213|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
170522625|NCT02111174|616258212|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
170522626|NCT02111174|616258213|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
170522627|NCT00792909|616258218|FG000|Overall Study|Withdrawal by Subject|0|||
170522628|NCT00792909|616258219|FG001|Overall Study|Withdrawal by Subject|1|||
170522629|NCT00792909|616258220|FG002|Overall Study|Withdrawal by Subject|0|||
170871043|NCT01159912|617539148|FG002|Overall Study|Protocol Violation|3|||
170871044|NCT01159912|617539146|FG000|Overall Study|Lost to Follow-up|4|||
170871045|NCT01159912|617539147|FG001|Overall Study|Lost to Follow-up|0|||
170871046|NCT01159912|617539148|FG002|Overall Study|Lost to Follow-up|0|||
170871047|NCT01159912|617539146|FG000|Overall Study|Physician Decision|0|||
170871048|NCT01159912|617539147|FG001|Overall Study|Physician Decision|0|||
170871049|NCT01159912|617539148|FG002|Overall Study|Physician Decision|3|||
170871050|NCT01159912|617539146|FG000|Overall Study|Withdrawal by Subject|10|||
170871051|NCT01159912|617539147|FG001|Overall Study|Withdrawal by Subject|3|||
170871052|NCT01159912|617539148|FG002|Overall Study|Withdrawal by Subject|3|||
170871053|NCT02374021|617539150|FG000|Overall Study|Adverse Event|1|||
170871054|NCT02374021|617539151|FG001|Overall Study|Adverse Event|0|||
170871055|NCT02374021|617539150|FG000|Overall Study|Lost to Follow-up|3|||
170871056|NCT02374021|617539151|FG001|Overall Study|Lost to Follow-up|2|||
170871057|NCT02374021|617539150|FG000|Overall Study|Physician Decision|0|||
170871058|NCT02374021|617539151|FG001|Overall Study|Physician Decision|3|||
170871059|NCT02374021|617539150|FG000|Overall Study|Withdrawal by Subject|6|||
170871060|NCT02374021|617539151|FG001|Overall Study|Withdrawal by Subject|5|||
170871061|NCT02374021|617539150|FG000|Overall Study|Poor Adherence|0|||
170871062|NCT02374021|617539151|FG001|Overall Study|Poor Adherence|1|||
170871063|NCT02374021|617539150|FG000|Overall Study|Scan protocol not followed|0|||
170871064|NCT02374021|617539151|FG001|Overall Study|Scan protocol not followed|1|||
170871065|NCT02374021|617539150|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
170871066|NCT02374021|617539151|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
170871067|NCT01444456|617539153|FG000|Overall Study|Withdrawal by Subject|21|||
170871068|NCT01444456|617539153|FG000|Overall Study|Physician Decision|9|||
170871069|NCT01444456|617539153|FG000|Overall Study|Lost to Follow-up|37|||
170871070|NCT01444456|617539153|FG000|Overall Study|Death|73|||
170871071|NCT01444456|617539153|FG000|Overall Study|Ineligibility determined|23|||
170871072|NCT01444456|617539153|FG000|Overall Study|Other|18|||
170871073|NCT01444456|617539153|FG000|Overall Study|Not treated|104|||
170871074|NCT01704287|617541531|FG000|Initial Treatment Period|Death|139|||
170871075|NCT01704287|617541532|FG001|Initial Treatment Period|Death|129|||
170871076|NCT01704287|617541533|FG002|Initial Treatment Period|Death|71|||
170871077|NCT01704287|617541534|FG003|Initial Treatment Period|Death|0|||
170871078|NCT01704287|617541535|FG004|Initial Treatment Period|Death|0|||
170871079|NCT01704287|617541531|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
170871080|NCT01704287|617541532|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
170871081|NCT01704287|617541533|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
170871082|NCT01704287|617541534|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
170871083|NCT01704287|617541535|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
170871084|NCT01704287|617541531|FG000|Initial Treatment Period|Lost to Follow-up|5|||
170871085|NCT01704287|617541532|FG001|Initial Treatment Period|Lost to Follow-up|3|||
170871086|NCT01704287|617541533|FG002|Initial Treatment Period|Lost to Follow-up|0|||
170871087|NCT01704287|617541534|FG003|Initial Treatment Period|Lost to Follow-up|0|||
170871088|NCT01704287|617541535|FG004|Initial Treatment Period|Lost to Follow-up|0|||
170871089|NCT01704287|617541531|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
170871090|NCT01704287|617541532|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
170871091|NCT01704287|617541533|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
170871092|NCT01704287|617541534|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
170871093|NCT01704287|617541535|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
170871094|NCT01704287|617541531|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
170871095|NCT01704287|617541532|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
170871096|NCT01704287|617541533|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
170871097|NCT01704287|617541534|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
170871098|NCT01704287|617541535|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
170871099|NCT01704287|617541531|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
170871100|NCT01704287|617541532|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
170871101|NCT01704287|617541533|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
170871102|NCT01704287|617541534|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
170871103|NCT01704287|617541535|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
170871104|NCT01704287|617541531|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
170871105|NCT01704287|617541532|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
170871106|NCT01704287|617541533|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
170871107|NCT01704287|617541534|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
170871108|NCT01704287|617541535|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
170871109|NCT03713034|617541536|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
170871110|NCT03713034|617541537|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
170871111|NCT02615470|617541538|FG000|Overall Study|Lost to Follow-up|21|||
170871112|NCT02615470|617541539|FG001|Overall Study|Lost to Follow-up|32|||
170871113|NCT04490395|617541541|FG000|Overall Study|Lost to Follow-up|0|||
170871114|NCT04490395|617541542|FG001|Overall Study|Lost to Follow-up|1|||
170871115|NCT00938717|617541543|FG000|Overall Study|Adverse Event|10|||
170871116|NCT00938717|617541544|FG001|Overall Study|Adverse Event|41|||
170871117|NCT00938717|617541543|FG000|Overall Study|Protocol Violation|11|||
170871118|NCT00938717|617541544|FG001|Overall Study|Protocol Violation|8|||
170871119|NCT00938717|617541543|FG000|Overall Study|Withdrawal by Subject|26|||
170871120|NCT00938717|617541544|FG001|Overall Study|Withdrawal by Subject|24|||
170871121|NCT00938717|617541543|FG000|Overall Study|Lost to Follow-up|13|||
170871122|NCT00938717|617541544|FG001|Overall Study|Lost to Follow-up|18|||
170871123|NCT00938717|617541543|FG000|Overall Study|Lack of Efficacy|33|||
170871124|NCT00938717|617541544|FG001|Overall Study|Lack of Efficacy|15|||
170871125|NCT00938717|617541543|FG000|Overall Study|Other reason|5|||
170871126|NCT00938717|617541544|FG001|Overall Study|Other reason|2|||
170871127|NCT01809132|617541545|FG000|Overall Study|Withdrawal by Subject|0|||
170768612|NCT04707313|617157501|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170768613|NCT04707313|617157502|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170768614|NCT04707313|617157503|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
170768615|NCT04707313|617157491|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
170768616|NCT04707313|617157492|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
170768617|NCT04707313|617157493|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
170768618|NCT04707313|617157494|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
170768619|NCT04707313|617157495|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
170768620|NCT04707313|617157496|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
170768621|NCT04707313|617157497|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
170768622|NCT04707313|617157498|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
170768623|NCT04707313|617157499|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
170768624|NCT04707313|617157500|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
170768625|NCT04707313|617157501|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
170768626|NCT04707313|617157502|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
170768627|NCT04707313|617157503|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
170768628|NCT04707313|617157491|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
170768629|NCT04707313|617157492|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768630|NCT04707313|617157493|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768631|NCT04707313|617157494|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768632|NCT04707313|617157495|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768633|NCT04707313|617157496|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
170768634|NCT04707313|617157497|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
170768635|NCT04707313|617157498|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
170768636|NCT04707313|617157499|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768637|NCT04707313|617157500|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768638|NCT04707313|617157501|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768639|NCT04707313|617157502|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768640|NCT04707313|617157503|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
170768641|NCT04707313|617157491|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
170768642|NCT04707313|617157492|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
170768643|NCT04707313|617157493|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
170768644|NCT04707313|617157494|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
170768645|NCT04707313|617157495|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
170768646|NCT04707313|617157496|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
170768647|NCT04707313|617157497|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
170768648|NCT04707313|617157498|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
170768649|NCT04707313|617157499|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
170768650|NCT04707313|617157500|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
170768651|NCT04707313|617157501|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
170768652|NCT04707313|617157502|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
170768653|NCT04707313|617157503|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
170768654|NCT04707313|617157491|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768655|NCT04707313|617157492|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768656|NCT04707313|617157493|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
170768657|NCT04707313|617157494|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768658|NCT04707313|617157495|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768659|NCT04707313|617157496|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768660|NCT04707313|617157497|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768661|NCT04707313|617157498|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
170768662|NCT04707313|617157499|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768663|NCT04707313|617157500|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768664|NCT04707313|617157501|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768665|NCT04707313|617157502|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768666|NCT04707313|617157503|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
170768667|NCT04707313|617157491|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170768668|NCT04707313|617157492|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170768669|NCT04707313|617157493|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170768670|NCT04707313|617157494|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170768671|NCT04707313|617157495|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170871128|NCT01809132|617541546|FG001|Overall Study|Withdrawal by Subject|0|||
170768672|NCT04707313|617157496|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170768673|NCT04707313|617157497|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170768674|NCT04707313|617157498|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170412463|NCT00310856|615849298|FG002|Overall Study|Withdrawal by Subject|2|||
170412464|NCT00310856|615849296|FG000|Overall Study|Lost to Follow-up|1|||
170412465|NCT00310856|615849297|FG001|Overall Study|Lost to Follow-up|2|||
170412466|NCT00310856|615849298|FG002|Overall Study|Lost to Follow-up|6|||
170768675|NCT04707313|617157499|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170768676|NCT04707313|617157500|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
170768677|NCT04707313|617157501|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
170768678|NCT04707313|617157502|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
170768679|NCT04707313|617157503|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
170768680|NCT04707313|617157491|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768681|NCT04707313|617157492|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768682|NCT04707313|617157493|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768683|NCT04707313|617157494|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768684|NCT04707313|617157495|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768685|NCT04707313|617157496|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768686|NCT04707313|617157497|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768687|NCT04707313|617157498|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768688|NCT04707313|617157499|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768689|NCT04707313|617157500|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
170768690|NCT04707313|617157501|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
170768691|NCT04707313|617157502|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
170768692|NCT04707313|617157503|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
170768693|NCT04707313|617157491|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768694|NCT04707313|617157492|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768695|NCT04707313|617157493|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768696|NCT04707313|617157494|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768697|NCT04707313|617157495|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768698|NCT04707313|617157496|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768699|NCT04707313|617157497|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768700|NCT04707313|617157498|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768701|NCT04707313|617157499|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
170768702|NCT04707313|617157500|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
170768703|NCT04707313|617157501|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
170768704|NCT04707313|617157502|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
170768705|NCT04707313|617157503|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
170768706|NCT04707313|617157491|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768707|NCT04707313|617157492|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768708|NCT04707313|617157493|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768709|NCT04707313|617157494|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768710|NCT04707313|617157495|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768711|NCT04707313|617157496|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768712|NCT04707313|617157497|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768713|NCT04707313|617157498|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768714|NCT04707313|617157499|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768715|NCT04707313|617157500|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768716|NCT04707313|617157501|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
170768717|NCT04707313|617157502|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
170768718|NCT04707313|617157503|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
170768719|NCT04707313|617157491|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768720|NCT04707313|617157492|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768721|NCT04707313|617157493|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768722|NCT04707313|617157494|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768723|NCT04707313|617157495|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768724|NCT04707313|617157496|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768725|NCT04707313|617157497|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768726|NCT04707313|617157498|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768727|NCT04707313|617157499|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768728|NCT04707313|617157500|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
170768729|NCT04707313|617157501|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
170768730|NCT04707313|617157502|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768731|NCT04707313|617157503|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
170768732|NCT04707313|617157491|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768733|NCT04707313|617157492|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768734|NCT04707313|617157493|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768735|NCT04707313|617157494|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768736|NCT04707313|617157495|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768737|NCT04707313|617157496|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768738|NCT04707313|617157497|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768739|NCT04707313|617157498|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768740|NCT04707313|617157499|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
170768741|NCT04707313|617157500|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
170768742|NCT04707313|617157501|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
170768743|NCT04707313|617157502|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
170768744|NCT04707313|617157503|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
170522630|NCT01497067|616258222|FG000|Overall Study|Lost to Follow-up|56|||
170522631|NCT01497067|616258222|FG000|Overall Study|Adverse Event|3|||
170522632|NCT01497067|616258222|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
170522633|NCT01497067|616258222|FG000|Overall Study|Other|13|||
170522634|NCT03430856|616258224|FG000|Overall Study|Adverse Event|0|||
170522635|NCT03430856|616258225|FG001|Overall Study|Adverse Event|1|||
170522636|NCT03430856|616258226|FG002|Overall Study|Adverse Event|0|||
170522637|NCT03430856|616258224|FG000|Overall Study|Rescue criteria|1|||
170522638|NCT03430856|616258225|FG001|Overall Study|Rescue criteria|1|||
170522639|NCT03430856|616258226|FG002|Overall Study|Rescue criteria|0|||
170522640|NCT03430856|616258224|FG000|Overall Study|Voluntary withdrawal of consent|1|||
170522641|NCT03430856|616258225|FG001|Overall Study|Voluntary withdrawal of consent|1|||
170522642|NCT03430856|616258226|FG002|Overall Study|Voluntary withdrawal of consent|1|||
170522643|NCT02812186|616260103|FG000|Period 1|Post randomization screen failure|5|||
170522644|NCT02812186|616260104|FG001|Period 1|Post randomization screen failure|9|||
170522645|NCT02812186|616260103|FG000|Period 1|nonevaluable data sets|6|||
170522646|NCT02812186|616260104|FG001|Period 1|nonevaluable data sets|6|||
170522647|NCT03353792|616260111|FG000|Overall Study|Lost to Follow-up|1|||
170522648|NCT03353792|616260112|FG001|Overall Study|Lost to Follow-up|0|||
170522649|NCT03353792|616260111|FG000|Overall Study|Participant Unable to Manage Device|1|||
170522650|NCT03353792|616260112|FG001|Overall Study|Participant Unable to Manage Device|0|||
170522651|NCT01294423|616260113|FG000|Overall Study|Adverse Event|1|||
170522652|NCT01294423|616260114|FG001|Overall Study|Adverse Event|2|||
170522653|NCT01294423|616260115|FG002|Overall Study|Adverse Event|3|||
170522654|NCT01294423|616260113|FG000|Overall Study|Withdrawal by Subject|1|||
170522655|NCT01294423|616260114|FG001|Overall Study|Withdrawal by Subject|2|||
170522656|NCT01294423|616260115|FG002|Overall Study|Withdrawal by Subject|2|||
170522657|NCT01294423|616260113|FG000|Overall Study|subject no longer meets study criteria|2|||
170522658|NCT01294423|616260114|FG001|Overall Study|subject no longer meets study criteria|5|||
170522659|NCT01294423|616260115|FG002|Overall Study|subject no longer meets study criteria|2|||
170522660|NCT01294423|616260113|FG000|Overall Study|poor/non-compliance|1|||
170522661|NCT01294423|616260114|FG001|Overall Study|poor/non-compliance|0|||
170522662|NCT01294423|616260115|FG002|Overall Study|poor/non-compliance|1|||
170768745|NCT01227707|617157504|FG000|Overall Study|Adverse Event|10|||
170768746|NCT01227707|617157504|FG000|Overall Study|Progression of disease|3|||
170768747|NCT01227707|617157504|FG000|Overall Study|Withdrawal by Subject|1|||
170768748|NCT01227707|617157504|FG000|Overall Study|Patient non-compliance|3|||
170768749|NCT01227707|617157504|FG000|Overall Study|Medical decision|6|||
170768750|NCT01227707|617157504|FG000|Overall Study|Death|1|||
170768751|NCT02459899|617157505|FG000|Overall Study|Adverse Event|1|||
170768752|NCT02459899|617157506|FG001|Overall Study|Adverse Event|1|||
170768753|NCT02459899|617157507|FG002|Overall Study|Adverse Event|0|||
170768754|NCT02459899|617157508|FG003|Overall Study|Adverse Event|0|||
170768755|NCT02459899|617157505|FG000|Overall Study|Lost to Follow-up|1|||
170768756|NCT02459899|617157506|FG001|Overall Study|Lost to Follow-up|2|||
170768757|NCT02459899|617157507|FG002|Overall Study|Lost to Follow-up|0|||
170768758|NCT02459899|617157508|FG003|Overall Study|Lost to Follow-up|1|||
170768759|NCT02459899|617157505|FG000|Overall Study|Non-compliance with the treatment|0|||
170768760|NCT02459899|617157506|FG001|Overall Study|Non-compliance with the treatment|0|||
170768761|NCT02459899|617157507|FG002|Overall Study|Non-compliance with the treatment|0|||
170768762|NCT02459899|617157508|FG003|Overall Study|Non-compliance with the treatment|1|||
170768763|NCT02459899|617157505|FG000|Overall Study|Withdrawal by Subject|1|||
170768764|NCT02459899|617157506|FG001|Overall Study|Withdrawal by Subject|3|||
170768765|NCT02459899|617157507|FG002|Overall Study|Withdrawal by Subject|0|||
170768766|NCT02459899|617157508|FG003|Overall Study|Withdrawal by Subject|0|||
170768767|NCT02739035|617157509|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
170768768|NCT02739035|617157510|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
170768769|NCT02739035|617157509|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
170768770|NCT02739035|617157510|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
170768771|NCT02739035|617157509|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
170768772|NCT02739035|617157510|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
170768773|NCT02739035|617157509|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
170768774|NCT02739035|617157510|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
170768775|NCT04446117|617157514|FG000|Overall Study|No Study Treatment Given|4|||
170768776|NCT04446117|617157515|FG001|Overall Study|No Study Treatment Given|3|||
170768777|NCT04446117|617157514|FG000|Overall Study|Radiographic Disease Progression|132|||
170768778|NCT04446117|617157515|FG001|Overall Study|Radiographic Disease Progression|158|||
170768779|NCT04446117|617157514|FG000|Overall Study|Adverse Event|79|||
170768780|NCT04446117|617157515|FG001|Overall Study|Adverse Event|43|||
170768781|NCT04446117|617157514|FG000|Overall Study|Lack of Clinical Benefit|1|||
170768782|NCT04446117|617157515|FG001|Overall Study|Lack of Clinical Benefit|1|||
170522663|NCT01241279|616260116|FG000|Overall Study|Lost to Follow-up|0|||
170522664|NCT01241279|616260117|FG001|Overall Study|Lost to Follow-up|1|||
170768783|NCT04446117|617157514|FG000|Overall Study|Withdrawal by Subject|24|||
170768784|NCT04446117|617157515|FG001|Overall Study|Withdrawal by Subject|22|||
170522665|NCT01699750|616260120|FG000|Overall Study|Withdrew Consent|0|||
170522666|NCT01699750|616260121|FG001|Overall Study|Withdrew Consent|1|||
170768785|NCT04446117|617157514|FG000|Overall Study|Lost to Follow-up|0|||
170768786|NCT04446117|617157515|FG001|Overall Study|Lost to Follow-up|3|||
170768787|NCT04446117|617157514|FG000|Overall Study|Miscellaneous|26|||
170768788|NCT04446117|617157515|FG001|Overall Study|Miscellaneous|36|||
170768789|NCT04446117|617157514|FG000|Overall Study|Missing Data/Data not yet Received|1|||
170768790|NCT04446117|617157515|FG001|Overall Study|Missing Data/Data not yet Received|0|||
170768791|NCT03586544|617157518|FG000|First Intervention|Adverse Event|0|||
170768792|NCT03586544|617157519|FG001|First Intervention|Adverse Event|1|||
170768793|NCT03586544|617157518|FG000|Second Intervention|Withdrawal by Subject|0|||
170768794|NCT03586544|617157519|FG001|Second Intervention|Withdrawal by Subject|1|||
170768795|NCT00712166|617157520|FG000|Overall Study|Noncompliance|0|||
170768796|NCT00712166|617157521|FG001|Overall Study|Noncompliance|1|||
170768797|NCT00688519|617157524|FG000|Overall Study|Adverse Event|2|||
170768798|NCT00688519|617157525|FG001|Overall Study|Adverse Event|3|||
170768799|NCT00688519|617157524|FG000|Overall Study|Lost to Follow-up|3|||
170768800|NCT00688519|617157525|FG001|Overall Study|Lost to Follow-up|3|||
170768801|NCT00688519|617157524|FG000|Overall Study|Lack of Efficacy|3|||
170768802|NCT00688519|617157525|FG001|Overall Study|Lack of Efficacy|1|||
170768803|NCT00688519|617157524|FG000|Overall Study|Withdrawal by Subject|7|||
170768804|NCT00688519|617157525|FG001|Overall Study|Withdrawal by Subject|6|||
170768805|NCT00688519|617157524|FG000|Overall Study|Prohibited medication|1|||
170768806|NCT00688519|617157525|FG001|Overall Study|Prohibited medication|0|||
170768807|NCT00688519|617157524|FG000|Overall Study|Non-compliance|0|||
170768808|NCT00688519|617157525|FG001|Overall Study|Non-compliance|1|||
170768809|NCT00688519|617157524|FG000|Overall Study|Subject moved out of state|1|||
170412467|NCT00310856|615849296|FG000|Overall Study|Inappropriate enrollment|1|||
170412468|NCT00310856|615849297|FG001|Overall Study|Inappropriate enrollment|1|||
170412469|NCT00310856|615849298|FG002|Overall Study|Inappropriate enrollment|0|||
170412470|NCT00310856|615849296|FG000|Overall Study|Unable to classify|1|||
170412471|NCT00310856|615849297|FG001|Overall Study|Unable to classify|0|||
170412472|NCT00310856|615849298|FG002|Overall Study|Unable to classify|0|||
170412473|NCT01306253|615849299|FG000|Overall Study|Lost to Follow-up|1|||
170412474|NCT01306253|615849300|FG001|Overall Study|Lost to Follow-up|1|||
170412475|NCT01261325|615849301|FG000|Overall Study|Lack of Efficacy|1|||
170412476|NCT01261325|615849302|FG001|Overall Study|Lack of Efficacy|1|||
170412477|NCT01261325|615849303|FG002|Overall Study|Lack of Efficacy|0|||
170412478|NCT01261325|615849301|FG000|Overall Study|Withdrawal by Subject|2|||
170412479|NCT01261325|615849302|FG001|Overall Study|Withdrawal by Subject|2|||
170412480|NCT01261325|615849303|FG002|Overall Study|Withdrawal by Subject|4|||
170412481|NCT01261325|615849301|FG000|Overall Study|SAE, non-fatal|1|||
170412482|NCT01261325|615849302|FG001|Overall Study|SAE, non-fatal|5|||
170412483|NCT01261325|615849303|FG002|Overall Study|SAE, non-fatal|1|||
170412484|NCT01261325|615849301|FG000|Overall Study|AE, non-serious non-fatal|9|||
170412485|NCT01261325|615849302|FG001|Overall Study|AE, non-serious non-fatal|15|||
170412486|NCT01261325|615849303|FG002|Overall Study|AE, non-serious non-fatal|13|||
170412487|NCT01261325|615849301|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
170412488|NCT01261325|615849302|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
170412489|NCT01261325|615849303|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
170412490|NCT01261325|615849301|FG000|Overall Study|Non Compliance|2|||
170412491|NCT01261325|615849302|FG001|Overall Study|Non Compliance|0|||
170412492|NCT01261325|615849303|FG002|Overall Study|Non Compliance|0|||
170412493|NCT01261325|615849301|FG000|Overall Study|Patient Randomized by Mistake|0|||
170412494|NCT01261325|615849302|FG001|Overall Study|Patient Randomized by Mistake|1|||
170412495|NCT01261325|615849303|FG002|Overall Study|Patient Randomized by Mistake|0|||
170412496|NCT01261325|615849301|FG000|Overall Study|Erroneously Randomized|1|||
170412497|NCT01261325|615849302|FG001|Overall Study|Erroneously Randomized|0|||
170412498|NCT01261325|615849303|FG002|Overall Study|Erroneously Randomized|0|||
170412499|NCT01261325|615849301|FG000|Overall Study|Screen Failure|1|||
170412500|NCT01261325|615849302|FG001|Overall Study|Screen Failure|0|||
170522667|NCT01699750|616260120|FG000|Overall Study|Other|0|||
170522668|NCT01699750|616260121|FG001|Overall Study|Other|2|||
170768810|NCT00688519|617157525|FG001|Overall Study|Subject moved out of state|0|||
170768811|NCT00688519|617157524|FG000|Overall Study|Investigator decision|1|||
170768812|NCT00688519|617157525|FG001|Overall Study|Investigator decision|0|||
170768813|NCT00688519|617157524|FG000|Overall Study|Subject moved out of area|1|||
170768814|NCT00688519|617157525|FG001|Overall Study|Subject moved out of area|0|||
170768815|NCT00688519|617157524|FG000|Overall Study|Pregnancy|0|||
170412501|NCT01261325|615849303|FG002|Overall Study|Screen Failure|0|||
170412502|NCT01261325|615849301|FG000|Overall Study|Randomized in Error|0|||
170412503|NCT01261325|615849302|FG001|Overall Study|Randomized in Error|0|||
170412504|NCT01261325|615849303|FG002|Overall Study|Randomized in Error|1|||
170412505|NCT01261325|615849301|FG000|Overall Study|Protocol Violation|0|||
170768816|NCT00688519|617157525|FG001|Overall Study|Pregnancy|1|||
170412506|NCT01261325|615849302|FG001|Overall Study|Protocol Violation|3|||
170768817|NCT02754479|617157526|FG000|Overall Study|Lost to Follow-up|1|||
170768818|NCT01063517|617157529|FG000|Overall Study|Consent withdrawal|1|||
170412507|NCT01261325|615849303|FG002|Overall Study|Protocol Violation|1|||
170522669|NCT01484951|616260122|FG000|Overall Study|Adverse Event|3|||
170871129|NCT01809132|617541547|FG002|Overall Study|Withdrawal by Subject|1|||
170871130|NCT03349775|617541548|FG000|Overall Study|Side Effects|1|||
170871131|NCT03349775|617541549|FG001|Overall Study|Side Effects|2|||
170871132|NCT03349775|617541548|FG000|Overall Study|Withdrawal by Subject|1|||
170871133|NCT03349775|617541549|FG001|Overall Study|Withdrawal by Subject|1|||
170871134|NCT03349775|617541548|FG000|Overall Study|No primary outcome measurements|0|||
170871135|NCT03349775|617541549|FG001|Overall Study|No primary outcome measurements|1|||
170871136|NCT03593850|617541557|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
170871137|NCT03593850|617541558|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
170871138|NCT00003895|617541559|FG000|Overall Study|Adverse Event|4|||
170871139|NCT00003895|617541560|FG001|Overall Study|Adverse Event|0|||
170871140|NCT00003895|617541559|FG000|Overall Study|Lack of Efficacy|1|||
170871141|NCT00003895|617541560|FG001|Overall Study|Lack of Efficacy|1|||
170871142|NCT00003895|617541559|FG000|Overall Study|Patient Vacation|2|||
170871143|NCT00003895|617541560|FG001|Overall Study|Patient Vacation|0|||
170871144|NCT00003895|617541559|FG000|Overall Study|Withdrawal by Subject|0|||
170871145|NCT00003895|617541560|FG001|Overall Study|Withdrawal by Subject|3|||
170871146|NCT01380730|617541561|FG000|Overall Study|Death|0|||
170871147|NCT01380730|617541562|FG001|Overall Study|Death|0|||
170871148|NCT01380730|617541563|FG002|Overall Study|Death|0|||
170871149|NCT01380730|617541564|FG003|Overall Study|Death|0|||
170871150|NCT01380730|617541565|FG004|Overall Study|Death|1|||
170871151|NCT01380730|617541566|FG005|Overall Study|Death|0|||
170871152|NCT01380730|617541567|FG006|Overall Study|Death|0|||
170871153|NCT01380730|617541568|FG007|Overall Study|Death|0|||
170871154|NCT00467779|617541572|FG000|Stage 1|Adverse Event|1|||
170871155|NCT00467779|617541573|FG001|Stage 1|Adverse Event|0|||
170871156|NCT00467779|617541574|FG002|Stage 1|Adverse Event|0|||
170871157|NCT00467779|617541575|FG003|Stage 1|Adverse Event|0|||
170871158|NCT00467779|617541576|FG004|Stage 1|Adverse Event|0|||
170871159|NCT00467779|617541577|FG005|Stage 1|Adverse Event|1|||
170871160|NCT00467779|617541578|FG006|Stage 1|Adverse Event|2|||
170871161|NCT00467779|617541579|FG007|Stage 1|Adverse Event|1|||
170871162|NCT00467779|617541580|FG008|Stage 1|Adverse Event|0|||
170871163|NCT00467779|617541581|FG009|Stage 1|Adverse Event|0|||
170871164|NCT00467779|617541582|FG010|Stage 1|Adverse Event|0|||
170871165|NCT00467779|617541583|FG011|Stage 1|Adverse Event|0|||
170871166|NCT00467779|617541584|FG012|Stage 1|Adverse Event|0|||
170871167|NCT00467779|617541585|FG013|Stage 1|Adverse Event|0|||
170871168|NCT00467779|617541586|FG014|Stage 1|Adverse Event|0|||
170871169|NCT00467779|617541572|FG000|Stage 1|Disease Progression|2|||
170871170|NCT00467779|617541573|FG001|Stage 1|Disease Progression|2|||
170871171|NCT00467779|617541574|FG002|Stage 1|Disease Progression|2|||
170871172|NCT00467779|617541575|FG003|Stage 1|Disease Progression|3|||
170871173|NCT00467779|617541576|FG004|Stage 1|Disease Progression|2|||
170871174|NCT00467779|617541577|FG005|Stage 1|Disease Progression|2|||
170871175|NCT00467779|617541578|FG006|Stage 1|Disease Progression|4|||
170871176|NCT00467779|617541579|FG007|Stage 1|Disease Progression|5|||
170871177|NCT00467779|617541580|FG008|Stage 1|Disease Progression|0|||
170871178|NCT00467779|617541581|FG009|Stage 1|Disease Progression|0|||
170871179|NCT00467779|617541582|FG010|Stage 1|Disease Progression|0|||
170871180|NCT00467779|617541583|FG011|Stage 1|Disease Progression|0|||
170871181|NCT00467779|617541584|FG012|Stage 1|Disease Progression|0|||
170871182|NCT00467779|617541585|FG013|Stage 1|Disease Progression|0|||
170871183|NCT00467779|617541586|FG014|Stage 1|Disease Progression|0|||
170871184|NCT00467779|617541572|FG000|Stage 1|Unspecified Reason|1|||
170871185|NCT00467779|617541573|FG001|Stage 1|Unspecified Reason|0|||
170871186|NCT00467779|617541574|FG002|Stage 1|Unspecified Reason|1|||
170871187|NCT00467779|617541575|FG003|Stage 1|Unspecified Reason|0|||
170871188|NCT00467779|617541576|FG004|Stage 1|Unspecified Reason|1|||
170871189|NCT00467779|617541577|FG005|Stage 1|Unspecified Reason|2|||
170871190|NCT00467779|617541578|FG006|Stage 1|Unspecified Reason|0|||
170871191|NCT00467779|617541579|FG007|Stage 1|Unspecified Reason|0|||
170871192|NCT00467779|617541580|FG008|Stage 1|Unspecified Reason|0|||
170871193|NCT00467779|617541581|FG009|Stage 1|Unspecified Reason|0|||
170871194|NCT00467779|617541582|FG010|Stage 1|Unspecified Reason|0|||
170871195|NCT00467779|617541583|FG011|Stage 1|Unspecified Reason|0|||
170871196|NCT00467779|617541584|FG012|Stage 1|Unspecified Reason|0|||
170871197|NCT00467779|617541585|FG013|Stage 1|Unspecified Reason|0|||
170871198|NCT00467779|617541586|FG014|Stage 1|Unspecified Reason|0|||
170871199|NCT00467779|617541572|FG000|Stage 1|Physician Decision|0|||
170871200|NCT00467779|617541573|FG001|Stage 1|Physician Decision|1|||
170871201|NCT00467779|617541574|FG002|Stage 1|Physician Decision|0|||
170871202|NCT00467779|617541575|FG003|Stage 1|Physician Decision|0|||
170871203|NCT00467779|617541576|FG004|Stage 1|Physician Decision|0|||
170871204|NCT00467779|617541577|FG005|Stage 1|Physician Decision|0|||
170871205|NCT00467779|617541578|FG006|Stage 1|Physician Decision|0|||
170871206|NCT00467779|617541579|FG007|Stage 1|Physician Decision|0|||
170871207|NCT00467779|617541580|FG008|Stage 1|Physician Decision|0|||
170871208|NCT00467779|617541581|FG009|Stage 1|Physician Decision|0|||
170871209|NCT00467779|617541582|FG010|Stage 1|Physician Decision|0|||
170871210|NCT00467779|617541583|FG011|Stage 1|Physician Decision|0|||
170871211|NCT00467779|617541584|FG012|Stage 1|Physician Decision|0|||
170871212|NCT00467779|617541585|FG013|Stage 1|Physician Decision|0|||
170871213|NCT00467779|617541586|FG014|Stage 1|Physician Decision|0|||
170871214|NCT00467779|617541572|FG000|Stage 1|Withdrawal by Subject|0|||
170871215|NCT00467779|617541573|FG001|Stage 1|Withdrawal by Subject|0|||
170871216|NCT00467779|617541574|FG002|Stage 1|Withdrawal by Subject|0|||
170871217|NCT00467779|617541575|FG003|Stage 1|Withdrawal by Subject|0|||
170871218|NCT00467779|617541576|FG004|Stage 1|Withdrawal by Subject|0|||
170871219|NCT00467779|617541577|FG005|Stage 1|Withdrawal by Subject|0|||
170522670|NCT01484951|616260122|FG000|Overall Study|Personal Reasons|1|||
170522671|NCT01484951|616260122|FG000|Overall Study|Non-Compliance|1|||
170522672|NCT02452047|616260123|FG000|Overall Study|Adverse Event|0|||
170522673|NCT02452047|616260124|FG001|Overall Study|Adverse Event|1|||
170522674|NCT02452047|616260125|FG002|Overall Study|Adverse Event|1|||
170522675|NCT02452047|616260123|FG000|Overall Study|Death|1|||
170522676|NCT02452047|616260124|FG001|Overall Study|Death|3|||
170522677|NCT02452047|616260125|FG002|Overall Study|Death|1|||
170522678|NCT02452047|616260123|FG000|Overall Study|Physician Decision|1|||
170522679|NCT02452047|616260124|FG001|Overall Study|Physician Decision|0|||
170522680|NCT02452047|616260125|FG002|Overall Study|Physician Decision|0|||
170522681|NCT02452047|616260123|FG000|Overall Study|Lost to Follow-up|1|||
170522682|NCT02452047|616260124|FG001|Overall Study|Lost to Follow-up|1|||
170522683|NCT02452047|616260125|FG002|Overall Study|Lost to Follow-up|0|||
170522684|NCT02452047|616260123|FG000|Overall Study|Withdrawal by Subject|1|||
170522685|NCT02452047|616260124|FG001|Overall Study|Withdrawal by Subject|0|||
170522686|NCT02452047|616260125|FG002|Overall Study|Withdrawal by Subject|0|||
170522687|NCT01171898|616260127|FG000|Overall Study|Death|0|||
170522688|NCT01171898|616260128|FG001|Overall Study|Death|0|||
170522689|NCT01171898|616260129|FG002|Overall Study|Death|2|||
170522690|NCT01171898|616260130|FG003|Overall Study|Death|0|||
170522691|NCT01171898|616260127|FG000|Overall Study|Lost to Follow-up|0|||
170522692|NCT01171898|616260128|FG001|Overall Study|Lost to Follow-up|1|||
170522693|NCT01171898|616260129|FG002|Overall Study|Lost to Follow-up|1|||
170522694|NCT01171898|616260130|FG003|Overall Study|Lost to Follow-up|1|||
170522695|NCT01171898|616260127|FG000|Overall Study|Withdrawal by Subject|1|||
170522696|NCT01171898|616260128|FG001|Overall Study|Withdrawal by Subject|4|||
170522697|NCT01171898|616260129|FG002|Overall Study|Withdrawal by Subject|6|||
170522698|NCT01171898|616260130|FG003|Overall Study|Withdrawal by Subject|3|||
170522699|NCT01171898|616260127|FG000|Overall Study|Terminated by Sponsor|1|||
170522700|NCT01171898|616260128|FG001|Overall Study|Terminated by Sponsor|0|||
170522701|NCT01171898|616260129|FG002|Overall Study|Terminated by Sponsor|0|||
170522702|NCT01171898|616260130|FG003|Overall Study|Terminated by Sponsor|0|||
170522703|NCT01171898|616260127|FG000|Overall Study|Ongoing|1|||
170522704|NCT01171898|616260128|FG001|Overall Study|Ongoing|9|||
170522705|NCT01171898|616260129|FG002|Overall Study|Ongoing|3|||
170522706|NCT01171898|616260130|FG003|Overall Study|Ongoing|0|||
170522707|NCT01171898|616260127|FG000|Overall Study|Other|1|||
170768819|NCT01063517|617157530|FG001|Overall Study|Consent withdrawal|0|||
170768820|NCT01063517|617157529|FG000|Overall Study|Study reached data cut-off|19|||
170768821|NCT01063517|617157530|FG001|Overall Study|Study reached data cut-off|7|||
170768822|NCT01063517|617157529|FG000|Overall Study|Lost to Follow-up|4|||
170768823|NCT01063517|617157530|FG001|Overall Study|Lost to Follow-up|3|||
170768824|NCT01063517|617157529|FG000|Overall Study|Withdrawal by Subject|1|||
170768825|NCT01063517|617157530|FG001|Overall Study|Withdrawal by Subject|2|||
170768826|NCT01063517|617157529|FG000|Overall Study|Death|33|||
170768827|NCT01063517|617157530|FG001|Overall Study|Death|48|||
170768828|NCT02974634|617159460|FG000|Overall Study|Advanced disease|12|||
170768829|NCT02974634|617159461|FG001|Overall Study|Advanced disease|3|||
170768830|NCT02974634|617159460|FG000|Overall Study|Noncompliance|3|||
170768831|NCT02974634|617159461|FG001|Overall Study|Noncompliance|7|||
170768832|NCT02974634|617159460|FG000|Overall Study|intervention technology related issues|5|||
170768833|NCT02974634|617159461|FG001|Overall Study|intervention technology related issues|0|||
170768834|NCT02974634|617159460|FG000|Overall Study|Death|8|||
170768835|NCT02974634|617159461|FG001|Overall Study|Death|11|||
170768836|NCT05011396|617159462|FG000|Overall Study|Lost to Follow-up|3|||
170768837|NCT05011396|617159463|FG001|Overall Study|Lost to Follow-up|1|||
170768838|NCT05011396|617159462|FG000|Overall Study|Withdrawal by Subject|0|||
170768839|NCT05011396|617159463|FG001|Overall Study|Withdrawal by Subject|1|||
170768840|NCT05011396|617159462|FG000|Overall Study|Positive Drug Screen|0|||
170768841|NCT05011396|617159463|FG001|Overall Study|Positive Drug Screen|1|||
170768842|NCT06001177|617159466|FG000|Treatment Phase|Adverse Event|1|||
170768843|NCT06001177|617159467|FG001|Treatment Phase|Adverse Event|0|||
170871220|NCT00467779|617541578|FG006|Stage 1|Withdrawal by Subject|1|||
170871221|NCT00467779|617541579|FG007|Stage 1|Withdrawal by Subject|1|||
170871222|NCT00467779|617541580|FG008|Stage 1|Withdrawal by Subject|0|||
170522708|NCT01171898|616260128|FG001|Overall Study|Other|5|||
170522709|NCT01171898|616260129|FG002|Overall Study|Other|0|||
170522710|NCT01171898|616260130|FG003|Overall Study|Other|2|||
170768844|NCT06001177|617159466|FG000|Treatment Phase|Withdrawal by Subject|1|||
170871223|NCT00467779|617541581|FG009|Stage 1|Withdrawal by Subject|0|||
170768845|NCT06001177|617159467|FG001|Treatment Phase|Withdrawal by Subject|0|||
170768846|NCT06001177|617159466|FG000|Observation Phase|Adverse Event|1|||
170768847|NCT06001177|617159467|FG001|Observation Phase|Adverse Event|1|||
170768848|NCT06001177|617159466|FG000|Observation Phase|Withdrawal by Subject|0|||
170768849|NCT06001177|617159467|FG001|Observation Phase|Withdrawal by Subject|1|||
170768850|NCT00711958|617159468|FG000|Overall Study|Withdrawal by Subject|6|||
170768851|NCT00711958|617159469|FG001|Overall Study|Withdrawal by Subject|8|||
170768852|NCT00711958|617159468|FG000|Overall Study|Lack of Efficacy|3|||
170768853|NCT00711958|617159469|FG001|Overall Study|Lack of Efficacy|1|||
170768854|NCT00711958|617159468|FG000|Overall Study|Clinical deterioration|1|||
170768855|NCT00711958|617159469|FG001|Overall Study|Clinical deterioration|0|||
170768856|NCT00711958|617159468|FG000|Overall Study|Adverse Event|9|||
170768857|NCT00711958|617159469|FG001|Overall Study|Adverse Event|7|||
170768858|NCT00711958|617159468|FG000|Overall Study|Protocol Violation|1|||
170768859|NCT00711958|617159469|FG001|Overall Study|Protocol Violation|0|||
170768860|NCT00711958|617159468|FG000|Overall Study|Lost to Follow-up|2|||
170768861|NCT00711958|617159469|FG001|Overall Study|Lost to Follow-up|2|||
170768862|NCT00711958|617159468|FG000|Overall Study|Death|10|||
170768863|NCT00711958|617159469|FG001|Overall Study|Death|5|||
170768864|NCT00711958|617159468|FG000|Overall Study|Progression of disease|1|||
170768865|NCT00711958|617159469|FG001|Overall Study|Progression of disease|0|||
170768866|NCT02383472|617159470|FG000|Overall Study|Withdrawal by Subject|1|||
170768867|NCT02383472|617159471|FG001|Overall Study|Withdrawal by Subject|1|||
170768868|NCT02013830|617159472|FG000|Overall Study|Adverse Event|3|||
170768869|NCT02013830|617159472|FG000|Overall Study|Death|1|||
170768870|NCT02013830|617159472|FG000|Overall Study|Insufficient therapeutic response|25|||
170768871|NCT02013830|617159472|FG000|Overall Study|Refused treatment|1|||
170768872|NCT01111526|617159473|FG000|Overall Study|GVHD Disease Progression|0|||
170768873|NCT01111526|617159474|FG001|Overall Study|GVHD Disease Progression|1|||
170768874|NCT01111526|617159475|FG002|Overall Study|GVHD Disease Progression|2|||
170768875|NCT02015546|617159476|FG000|Overall Study|Withdrawal by Subject|1|||
170768876|NCT02015546|617159477|FG001|Overall Study|Withdrawal by Subject|1|||
170768877|NCT02015546|617159478|FG002|Overall Study|Withdrawal by Subject|1|||
170768878|NCT02015546|617159476|FG000|Overall Study|Screem Failure|2|||
170768879|NCT02015546|617159477|FG001|Overall Study|Screem Failure|1|||
170768880|NCT02015546|617159478|FG002|Overall Study|Screem Failure|3|||
170768881|NCT04424641|617159479|FG000|Overall Study|Death|1|||
170768882|NCT04424641|617159480|FG001|Overall Study|Death|2|||
170768883|NCT04424641|617159481|FG002|Overall Study|Death|3|||
170768884|NCT04424641|617159482|FG003|Overall Study|Death|0|||
170412508|NCT01261325|615849301|FG000|Overall Study|Lost to Follow-up|0|||
170412509|NCT01261325|615849302|FG001|Overall Study|Lost to Follow-up|1|||
170412510|NCT01261325|615849303|FG002|Overall Study|Lost to Follow-up|3|||
170412511|NCT01261325|615849301|FG000|Overall Study|AE, serious fatal|0|||
170412512|NCT01261325|615849302|FG001|Overall Study|AE, serious fatal|0|||
170412513|NCT01261325|615849303|FG002|Overall Study|AE, serious fatal|2|||
170412514|NCT03760510|615849304|FG000|Overall Study|Not ventilated for 24 hours|105|||
170412515|NCT03760510|615849305|FG001|Overall Study|Not ventilated for 24 hours|97|||
170412516|NCT00871728|615849306|FG000|Overall Study|Adverse Event|1|||
170412517|NCT00871728|615849306|FG000|Overall Study|Protocol Violation|7|||
170412518|NCT00871728|615849306|FG000|Overall Study|Lost to Follow-up|2|||
170412519|NCT00871728|615849306|FG000|Overall Study|Failed to Visit Hospital|4|||
170412520|NCT00871728|615849306|FG000|Overall Study|Participant Non-compliance|1|||
170522711|NCT03191799|616260131|FG000|Overall Study|Withdrawal by Subject|4|||
170768885|NCT04424641|617159483|FG004|Overall Study|Death|3|||
170768886|NCT04424641|617159484|FG005|Overall Study|Death|0|||
170768887|NCT04424641|617159485|FG006|Overall Study|Death|1|||
170768888|NCT04424641|617159486|FG007|Overall Study|Death|2|||
170768889|NCT04424641|617159479|FG000|Overall Study|Sponsor decision|0|||
170768890|NCT04424641|617159480|FG001|Overall Study|Sponsor decision|2|||
170768891|NCT04424641|617159481|FG002|Overall Study|Sponsor decision|3|||
170768892|NCT04424641|617159482|FG003|Overall Study|Sponsor decision|7|||
170768893|NCT04424641|617159483|FG004|Overall Study|Sponsor decision|2|||
170768894|NCT04424641|617159484|FG005|Overall Study|Sponsor decision|2|||
170871224|NCT00467779|617541582|FG010|Stage 1|Withdrawal by Subject|0|||
170768895|NCT04424641|617159485|FG006|Overall Study|Sponsor decision|3|||
170768896|NCT04424641|617159486|FG007|Overall Study|Sponsor decision|4|||
170768897|NCT04424641|617159479|FG000|Overall Study|Withdrawal by Subject|0|||
170768898|NCT04424641|617159480|FG001|Overall Study|Withdrawal by Subject|0|||
170768899|NCT04424641|617159481|FG002|Overall Study|Withdrawal by Subject|0|||
170768900|NCT04424641|617159482|FG003|Overall Study|Withdrawal by Subject|0|||
170768901|NCT04424641|617159483|FG004|Overall Study|Withdrawal by Subject|1|||
170768902|NCT04424641|617159484|FG005|Overall Study|Withdrawal by Subject|0|||
170768903|NCT04424641|617159485|FG006|Overall Study|Withdrawal by Subject|0|||
170768904|NCT04424641|617159486|FG007|Overall Study|Withdrawal by Subject|0|||
170768905|NCT04424641|617159479|FG000|Overall Study|Other|0|||
170871225|NCT00467779|617541583|FG011|Stage 1|Withdrawal by Subject|0|||
170412521|NCT00871728|615849306|FG000|Overall Study|Withdrawal of Informed Consent|5|||
170768906|NCT04424641|617159480|FG001|Overall Study|Other|0|||
170768907|NCT04424641|617159481|FG002|Overall Study|Other|1|||
170768908|NCT04424641|617159482|FG003|Overall Study|Other|0|||
170768909|NCT04424641|617159483|FG004|Overall Study|Other|0|||
170768910|NCT04424641|617159484|FG005|Overall Study|Other|0|||
170768911|NCT04424641|617159485|FG006|Overall Study|Other|0|||
170768912|NCT04424641|617159486|FG007|Overall Study|Other|0|||
170768913|NCT05855655|617159489|FG000|Overall Study|Withdrawal by Subject|0|||
170768914|NCT05855655|617159490|FG001|Overall Study|Withdrawal by Subject|1|||
170768915|NCT05855655|617159489|FG000|Overall Study|Lost to Follow-up|4|||
170768916|NCT05855655|617159490|FG001|Overall Study|Lost to Follow-up|0|||
170768917|NCT01113931|617159497|FG000|Overall Study|Adverse Event|2|||
170768918|NCT01113931|617159498|FG001|Overall Study|Adverse Event|2|||
170768919|NCT01113931|617159497|FG000|Overall Study|Physician Decision|0|||
170768920|NCT01113931|617159498|FG001|Overall Study|Physician Decision|2|||
170768921|NCT01113931|617159497|FG000|Overall Study|Lost to Follow-up|12|||
170768922|NCT01113931|617159498|FG001|Overall Study|Lost to Follow-up|9|||
170768923|NCT01113931|617159497|FG000|Overall Study|Various|2|||
170768924|NCT01113931|617159498|FG001|Overall Study|Various|4|||
170768925|NCT01113931|617159497|FG000|Overall Study|Withdrawal by Subject|3|||
170768926|NCT01113931|617159498|FG001|Overall Study|Withdrawal by Subject|0|||
170768927|NCT01307267|617159499|FG000|Overall Study|Death|4|||
170768928|NCT01307267|617159500|FG001|Overall Study|Death|3|||
170768929|NCT01307267|617159501|FG002|Overall Study|Death|5|||
170768930|NCT01307267|617159502|FG003|Overall Study|Death|3|||
170768931|NCT01307267|617159503|FG004|Overall Study|Death|1|||
170768932|NCT01307267|617159504|FG005|Overall Study|Death|26|||
170768933|NCT01307267|617159505|FG006|Overall Study|Death|2|||
170768934|NCT01307267|617159506|FG007|Overall Study|Death|2|||
170768935|NCT01307267|617159507|FG008|Overall Study|Death|21|||
170768936|NCT01307267|617159508|FG009|Overall Study|Death|2|||
170768937|NCT01307267|617159509|FG010|Overall Study|Death|3|||
170768938|NCT01307267|617159510|FG011|Overall Study|Death|9|||
170768939|NCT01307267|617159511|FG012|Overall Study|Death|0|||
170768940|NCT01307267|617159512|FG013|Overall Study|Death|0|||
170412522|NCT04147715|615849307|FG000|Overall Study|Adverse Event|0|||
170412523|NCT04147715|615849308|FG001|Overall Study|Adverse Event|0|||
170412524|NCT04147715|615849309|FG002|Overall Study|Adverse Event|0|||
170412525|NCT04147715|615849310|FG003|Overall Study|Adverse Event|0|||
170412526|NCT04147715|615849311|FG004|Overall Study|Adverse Event|0|||
170412527|NCT04147715|615849312|FG005|Overall Study|Adverse Event|0|||
170412528|NCT04147715|615849313|FG006|Overall Study|Adverse Event|0|||
170412529|NCT04147715|615849314|FG007|Overall Study|Adverse Event|2|||
170412530|NCT04147715|615849315|FG008|Overall Study|Adverse Event|1|||
170412531|NCT04147715|615849316|FG009|Overall Study|Adverse Event|0|||
170412532|NCT04147715|615849317|FG010|Overall Study|Adverse Event|0|||
170412533|NCT04147715|615849318|FG011|Overall Study|Adverse Event|0|||
170412534|NCT02717611|615849326|FG000|Overall Study|Death|13|||
170412535|NCT02717611|615849326|FG000|Overall Study|Withdrawal by Subject|6|||
170412536|NCT02717611|615849326|FG000|Overall Study|Active, not recruiting|40|||
170412537|NCT02717611|615849326|FG000|Overall Study|Complicating disease|1|||
170412538|NCT05182606|615849329|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
170412539|NCT02669264|615849334|FG000|Overall Study|Death|5|||
170412540|NCT02669264|615849335|FG001|Overall Study|Death|5|||
170412541|NCT02669264|615849336|FG002|Overall Study|Death|3|||
170412542|NCT02669264|615849337|FG003|Overall Study|Death|3|||
170412543|NCT02669264|615849338|FG004|Overall Study|Death|3|||
170412544|NCT02669264|615849339|FG005|Overall Study|Death|6|||
170412545|NCT02669264|615849340|FG006|Overall Study|Death|3|||
170412546|NCT02669264|615849334|FG000|Overall Study|Withdrawal by Subject|0|||
170412547|NCT02669264|615849335|FG001|Overall Study|Withdrawal by Subject|1|||
170412548|NCT02669264|615849336|FG002|Overall Study|Withdrawal by Subject|0|||
170412549|NCT02669264|615849337|FG003|Overall Study|Withdrawal by Subject|0|||
170412550|NCT02669264|615849338|FG004|Overall Study|Withdrawal by Subject|1|||
170412551|NCT02669264|615849339|FG005|Overall Study|Withdrawal by Subject|0|||
170412552|NCT02669264|615849340|FG006|Overall Study|Withdrawal by Subject|0|||
170412553|NCT02669264|615849334|FG000|Overall Study|Lost to Follow-up|0|||
170412554|NCT02669264|615849335|FG001|Overall Study|Lost to Follow-up|0|||
170412555|NCT02669264|615849336|FG002|Overall Study|Lost to Follow-up|0|||
170412556|NCT02669264|615849337|FG003|Overall Study|Lost to Follow-up|0|||
170412557|NCT02669264|615849338|FG004|Overall Study|Lost to Follow-up|1|||
170412558|NCT02669264|615849339|FG005|Overall Study|Lost to Follow-up|0|||
170412559|NCT02669264|615849340|FG006|Overall Study|Lost to Follow-up|0|||
170412560|NCT02669264|615849334|FG000|Overall Study|Miscellaneous|0|||
170412561|NCT02669264|615849335|FG001|Overall Study|Miscellaneous|0|||
170412562|NCT02669264|615849336|FG002|Overall Study|Miscellaneous|0|||
170412563|NCT02669264|615849337|FG003|Overall Study|Miscellaneous|0|||
170768941|NCT01307267|617159513|FG014|Overall Study|Death|0|||
170768942|NCT01307267|617159514|FG015|Overall Study|Death|0|||
170768943|NCT01307267|617159515|FG016|Overall Study|Death|1|||
170768944|NCT01307267|617159516|FG017|Overall Study|Death|1|||
170768945|NCT01307267|617159517|FG018|Overall Study|Death|2|||
170768946|NCT01307267|617159518|FG019|Overall Study|Death|8|||
170768947|NCT01307267|617159519|FG020|Overall Study|Death|1|||
170871226|NCT00467779|617541584|FG012|Stage 1|Withdrawal by Subject|0|||
170871227|NCT00467779|617541585|FG013|Stage 1|Withdrawal by Subject|0|||
170871228|NCT00467779|617541586|FG014|Stage 1|Withdrawal by Subject|0|||
170871229|NCT00467779|617541572|FG000|Stage 1A|Adverse Event|0|||
170871230|NCT00467779|617541573|FG001|Stage 1A|Adverse Event|0|||
170871231|NCT00467779|617541574|FG002|Stage 1A|Adverse Event|0|||
170871232|NCT00467779|617541575|FG003|Stage 1A|Adverse Event|0|||
170871233|NCT00467779|617541576|FG004|Stage 1A|Adverse Event|0|||
170871234|NCT00467779|617541577|FG005|Stage 1A|Adverse Event|0|||
170871235|NCT00467779|617541578|FG006|Stage 1A|Adverse Event|0|||
170871236|NCT00467779|617541579|FG007|Stage 1A|Adverse Event|0|||
170871237|NCT00467779|617541580|FG008|Stage 1A|Adverse Event|0|||
170871238|NCT00467779|617541581|FG009|Stage 1A|Adverse Event|0|||
170871239|NCT00467779|617541582|FG010|Stage 1A|Adverse Event|0|||
170871240|NCT00467779|617541583|FG011|Stage 1A|Adverse Event|0|||
170871241|NCT00467779|617541584|FG012|Stage 1A|Adverse Event|1|||
170871242|NCT00467779|617541585|FG013|Stage 1A|Adverse Event|0|||
170871243|NCT00467779|617541586|FG014|Stage 1A|Adverse Event|0|||
170871244|NCT00467779|617541572|FG000|Stage 1A|Death|0|||
170871245|NCT00467779|617541573|FG001|Stage 1A|Death|0|||
170871246|NCT00467779|617541574|FG002|Stage 1A|Death|0|||
170871247|NCT00467779|617541575|FG003|Stage 1A|Death|0|||
170871248|NCT00467779|617541576|FG004|Stage 1A|Death|0|||
170871249|NCT00467779|617541577|FG005|Stage 1A|Death|0|||
170871250|NCT00467779|617541578|FG006|Stage 1A|Death|0|||
170871251|NCT00467779|617541579|FG007|Stage 1A|Death|0|||
170871252|NCT00467779|617541580|FG008|Stage 1A|Death|0|||
170871253|NCT00467779|617541581|FG009|Stage 1A|Death|0|||
170871254|NCT00467779|617541582|FG010|Stage 1A|Death|0|||
170871255|NCT00467779|617541583|FG011|Stage 1A|Death|1|||
170871256|NCT00467779|617541584|FG012|Stage 1A|Death|1|||
170871257|NCT00467779|617541585|FG013|Stage 1A|Death|0|||
170871258|NCT00467779|617541586|FG014|Stage 1A|Death|0|||
170871259|NCT00467779|617541572|FG000|Stage 1A|Disease Progression|0|||
170871260|NCT00467779|617541573|FG001|Stage 1A|Disease Progression|0|||
170871261|NCT00467779|617541574|FG002|Stage 1A|Disease Progression|0|||
170871262|NCT00467779|617541575|FG003|Stage 1A|Disease Progression|0|||
170871263|NCT00467779|617541576|FG004|Stage 1A|Disease Progression|0|||
170871264|NCT00467779|617541577|FG005|Stage 1A|Disease Progression|0|||
170871265|NCT00467779|617541578|FG006|Stage 1A|Disease Progression|0|||
170871266|NCT00467779|617541579|FG007|Stage 1A|Disease Progression|0|||
170871267|NCT00467779|617541580|FG008|Stage 1A|Disease Progression|0|||
170871268|NCT00467779|617541581|FG009|Stage 1A|Disease Progression|2|||
170871269|NCT00467779|617541582|FG010|Stage 1A|Disease Progression|2|||
170871270|NCT00467779|617541583|FG011|Stage 1A|Disease Progression|5|||
170871271|NCT00467779|617541584|FG012|Stage 1A|Disease Progression|2|||
170871272|NCT00467779|617541585|FG013|Stage 1A|Disease Progression|0|||
170871273|NCT00467779|617541586|FG014|Stage 1A|Disease Progression|0|||
170871274|NCT00467779|617541572|FG000|Stage 1A|Physician Decision|0|||
170871275|NCT00467779|617541573|FG001|Stage 1A|Physician Decision|0|||
170871276|NCT00467779|617541574|FG002|Stage 1A|Physician Decision|0|||
170871277|NCT00467779|617541575|FG003|Stage 1A|Physician Decision|0|||
170871278|NCT00467779|617541576|FG004|Stage 1A|Physician Decision|0|||
170871279|NCT00467779|617541577|FG005|Stage 1A|Physician Decision|0|||
170871280|NCT00467779|617541578|FG006|Stage 1A|Physician Decision|0|||
170871281|NCT00467779|617541579|FG007|Stage 1A|Physician Decision|0|||
170871282|NCT00467779|617541580|FG008|Stage 1A|Physician Decision|0|||
170871283|NCT00467779|617541581|FG009|Stage 1A|Physician Decision|1|||
170871284|NCT00467779|617541582|FG010|Stage 1A|Physician Decision|0|||
170871285|NCT00467779|617541583|FG011|Stage 1A|Physician Decision|0|||
170871286|NCT00467779|617541584|FG012|Stage 1A|Physician Decision|0|||
170871287|NCT00467779|617541585|FG013|Stage 1A|Physician Decision|0|||
170871288|NCT00467779|617541586|FG014|Stage 1A|Physician Decision|0|||
170871289|NCT00467779|617541572|FG000|Stage 1A|Withdrawal by Subject|0|||
170871290|NCT00467779|617541573|FG001|Stage 1A|Withdrawal by Subject|0|||
170871291|NCT00467779|617541574|FG002|Stage 1A|Withdrawal by Subject|0|||
170871292|NCT00467779|617541575|FG003|Stage 1A|Withdrawal by Subject|0|||
170871293|NCT00467779|617541576|FG004|Stage 1A|Withdrawal by Subject|0|||
170871294|NCT00467779|617541577|FG005|Stage 1A|Withdrawal by Subject|0|||
170871295|NCT00467779|617541578|FG006|Stage 1A|Withdrawal by Subject|0|||
170871296|NCT00467779|617541579|FG007|Stage 1A|Withdrawal by Subject|0|||
170871297|NCT00467779|617541580|FG008|Stage 1A|Withdrawal by Subject|0|||
170871298|NCT00467779|617541581|FG009|Stage 1A|Withdrawal by Subject|0|||
170871299|NCT00467779|617541582|FG010|Stage 1A|Withdrawal by Subject|1|||
170871300|NCT00467779|617541583|FG011|Stage 1A|Withdrawal by Subject|1|||
170871301|NCT00467779|617541584|FG012|Stage 1A|Withdrawal by Subject|1|||
170871302|NCT00467779|617541585|FG013|Stage 1A|Withdrawal by Subject|0|||
170871303|NCT00467779|617541586|FG014|Stage 1A|Withdrawal by Subject|0|||
170871304|NCT00467779|617541572|FG000|Stage 1A|Unspecified Reason|0|||
170871305|NCT00467779|617541573|FG001|Stage 1A|Unspecified Reason|0|||
170871306|NCT00467779|617541574|FG002|Stage 1A|Unspecified Reason|0|||
170871307|NCT00467779|617541575|FG003|Stage 1A|Unspecified Reason|0|||
170871308|NCT00467779|617541576|FG004|Stage 1A|Unspecified Reason|0|||
170871309|NCT00467779|617541577|FG005|Stage 1A|Unspecified Reason|0|||
170871310|NCT00467779|617541578|FG006|Stage 1A|Unspecified Reason|0|||
170871311|NCT00467779|617541579|FG007|Stage 1A|Unspecified Reason|0|||
170871312|NCT00467779|617541580|FG008|Stage 1A|Unspecified Reason|0|||
170871313|NCT00467779|617541581|FG009|Stage 1A|Unspecified Reason|0|||
170871314|NCT00467779|617541582|FG010|Stage 1A|Unspecified Reason|0|||
170871315|NCT00467779|617541583|FG011|Stage 1A|Unspecified Reason|1|||
170871316|NCT00467779|617541584|FG012|Stage 1A|Unspecified Reason|1|||
170871317|NCT00467779|617541585|FG013|Stage 1A|Unspecified Reason|0|||
170871318|NCT00467779|617541586|FG014|Stage 1A|Unspecified Reason|0|||
170871319|NCT00467779|617541572|FG000|Stage 2|Adverse Event|0|||
170871320|NCT00467779|617541573|FG001|Stage 2|Adverse Event|0|||
170871321|NCT00467779|617541574|FG002|Stage 2|Adverse Event|0|||
170871322|NCT00467779|617541575|FG003|Stage 2|Adverse Event|0|||
170871323|NCT00467779|617541576|FG004|Stage 2|Adverse Event|0|||
170871324|NCT00467779|617541577|FG005|Stage 2|Adverse Event|0|||
170871325|NCT00467779|617541578|FG006|Stage 2|Adverse Event|0|||
170871326|NCT00467779|617541579|FG007|Stage 2|Adverse Event|0|||
170871327|NCT00467779|617541580|FG008|Stage 2|Adverse Event|1|||
170871328|NCT00467779|617541581|FG009|Stage 2|Adverse Event|0|||
170871329|NCT00467779|617541582|FG010|Stage 2|Adverse Event|0|||
170871330|NCT00467779|617541583|FG011|Stage 2|Adverse Event|0|||
170871331|NCT00467779|617541584|FG012|Stage 2|Adverse Event|0|||
170871332|NCT00467779|617541585|FG013|Stage 2|Adverse Event|0|||
170871333|NCT00467779|617541586|FG014|Stage 2|Adverse Event|0|||
170871334|NCT00467779|617541572|FG000|Stage 2|Death|0|||
170871335|NCT00467779|617541573|FG001|Stage 2|Death|0|||
170871336|NCT00467779|617541574|FG002|Stage 2|Death|0|||
170871337|NCT00467779|617541575|FG003|Stage 2|Death|0|||
170871338|NCT00467779|617541576|FG004|Stage 2|Death|0|||
170871339|NCT00467779|617541577|FG005|Stage 2|Death|0|||
170871340|NCT00467779|617541578|FG006|Stage 2|Death|0|||
170871341|NCT00467779|617541579|FG007|Stage 2|Death|0|||
170871342|NCT00467779|617541580|FG008|Stage 2|Death|1|||
170871343|NCT00467779|617541581|FG009|Stage 2|Death|0|||
170871344|NCT00467779|617541582|FG010|Stage 2|Death|0|||
170871345|NCT00467779|617541583|FG011|Stage 2|Death|0|||
170871346|NCT00467779|617541584|FG012|Stage 2|Death|0|||
170871347|NCT00467779|617541585|FG013|Stage 2|Death|0|||
170871348|NCT00467779|617541586|FG014|Stage 2|Death|0|||
170871349|NCT00467779|617541572|FG000|Stage 2|Disease Progression|0|||
170871350|NCT00467779|617541573|FG001|Stage 2|Disease Progression|0|||
170871351|NCT00467779|617541574|FG002|Stage 2|Disease Progression|0|||
170871352|NCT00467779|617541575|FG003|Stage 2|Disease Progression|0|||
170871353|NCT00467779|617541576|FG004|Stage 2|Disease Progression|0|||
170412564|NCT02669264|615849338|FG004|Overall Study|Miscellaneous|0|||
170412565|NCT02669264|615849339|FG005|Overall Study|Miscellaneous|0|||
170412566|NCT02669264|615849340|FG006|Overall Study|Miscellaneous|2|||
170412567|NCT01861522|615849341|FG000|Overall Study|Adverse Event|1|||
170412568|NCT01861522|615849342|FG001|Overall Study|Adverse Event|0|||
170412569|NCT01861522|615849341|FG000|Overall Study|Withdrawal by Subject|2|||
170412570|NCT01861522|615849342|FG001|Overall Study|Withdrawal by Subject|0|||
170412571|NCT04128696|615849345|FG000|Overall Study|Lost to Follow-up|3|||
170412572|NCT04128696|615849346|FG001|Overall Study|Lost to Follow-up|7|||
170412573|NCT04128696|615849345|FG000|Overall Study|Withdrawal by Subject|12|||
170412574|NCT04128696|615849346|FG001|Overall Study|Withdrawal by Subject|11|||
170412575|NCT04128696|615849345|FG000|Overall Study|Study Closed/Terminated|26|||
170412576|NCT04128696|615849346|FG001|Overall Study|Study Closed/Terminated|38|||
170412577|NCT04128696|615849345|FG000|Overall Study|Physician Decision|2|||
170412578|NCT04128696|615849346|FG001|Overall Study|Physician Decision|3|||
170412579|NCT00289458|615849358|FG000|Overall Study|Death|1|||
170412580|NCT00289458|615849359|FG001|Overall Study|Death|0|||
170412581|NCT00289458|615849360|FG002|Overall Study|Death|0|||
170412582|NCT00289458|615849358|FG000|Overall Study|Physician Decision|3|||
170871354|NCT00467779|617541577|FG005|Stage 2|Disease Progression|0|||
170871355|NCT00467779|617541578|FG006|Stage 2|Disease Progression|0|||
170871356|NCT00467779|617541579|FG007|Stage 2|Disease Progression|0|||
170412583|NCT00289458|615849359|FG001|Overall Study|Physician Decision|4|||
170412584|NCT00289458|615849360|FG002|Overall Study|Physician Decision|2|||
170412585|NCT00289458|615849358|FG000|Overall Study|Withdrawal by Subject|2|||
170412586|NCT00289458|615849359|FG001|Overall Study|Withdrawal by Subject|2|||
170412587|NCT00289458|615849360|FG002|Overall Study|Withdrawal by Subject|4|||
170871357|NCT00467779|617541580|FG008|Stage 2|Disease Progression|16|||
170871358|NCT00467779|617541581|FG009|Stage 2|Disease Progression|0|||
170871359|NCT00467779|617541582|FG010|Stage 2|Disease Progression|0|||
170412588|NCT04274192|615849361|FG000|Overall Study|Protocol Violation|1|||
170412589|NCT04274192|615849362|FG001|Overall Study|Protocol Violation|0|||
170412590|NCT07174544|615849363|FG000|Overall Study|Lost to Follow-up|43|||
170871360|NCT00467779|617541583|FG011|Stage 2|Disease Progression|0|||
170871361|NCT00467779|617541584|FG012|Stage 2|Disease Progression|0|||
170871362|NCT00467779|617541585|FG013|Stage 2|Disease Progression|0|||
170871363|NCT00467779|617541586|FG014|Stage 2|Disease Progression|0|||
170871364|NCT00467779|617541572|FG000|Stage 2|Unspecified Reason|0|||
170871365|NCT00467779|617541573|FG001|Stage 2|Unspecified Reason|0|||
170871366|NCT00467779|617541574|FG002|Stage 2|Unspecified Reason|0|||
170871367|NCT00467779|617541575|FG003|Stage 2|Unspecified Reason|0|||
170522712|NCT03191799|616260131|FG000|Overall Study|Physician Decision|2|||
170522713|NCT03191799|616260131|FG000|Overall Study|Lost to Follow-up|1|||
170522714|NCT03191799|616260131|FG000|Overall Study|Death|2|||
170522715|NCT03322293|616260144|FG000|Overall Study|Lost to Follow-up|0|||
170522716|NCT03322293|616260145|FG001|Overall Study|Lost to Follow-up|0|||
170522717|NCT03322293|616260146|FG002|Overall Study|Lost to Follow-up|1|||
170768948|NCT01307267|617159520|FG021|Overall Study|Death|2|||
170768949|NCT01307267|617159521|FG022|Overall Study|Death|2|||
170768950|NCT01307267|617159499|FG000|Overall Study|Lost to Follow-up|0|||
170768951|NCT01307267|617159500|FG001|Overall Study|Lost to Follow-up|0|||
170768952|NCT01307267|617159501|FG002|Overall Study|Lost to Follow-up|0|||
170768953|NCT01307267|617159502|FG003|Overall Study|Lost to Follow-up|0|||
170768954|NCT01307267|617159503|FG004|Overall Study|Lost to Follow-up|0|||
170768955|NCT01307267|617159504|FG005|Overall Study|Lost to Follow-up|7|||
170768956|NCT01307267|617159505|FG006|Overall Study|Lost to Follow-up|0|||
170768957|NCT01307267|617159506|FG007|Overall Study|Lost to Follow-up|0|||
170768958|NCT01307267|617159507|FG008|Overall Study|Lost to Follow-up|1|||
170768959|NCT01307267|617159508|FG009|Overall Study|Lost to Follow-up|2|||
170768960|NCT01307267|617159509|FG010|Overall Study|Lost to Follow-up|1|||
170768961|NCT01307267|617159510|FG011|Overall Study|Lost to Follow-up|0|||
170768962|NCT01307267|617159511|FG012|Overall Study|Lost to Follow-up|0|||
170768963|NCT01307267|617159512|FG013|Overall Study|Lost to Follow-up|0|||
170768964|NCT01307267|617159513|FG014|Overall Study|Lost to Follow-up|0|||
170768965|NCT01307267|617159514|FG015|Overall Study|Lost to Follow-up|0|||
170768966|NCT01307267|617159515|FG016|Overall Study|Lost to Follow-up|0|||
170768967|NCT01307267|617159516|FG017|Overall Study|Lost to Follow-up|0|||
170768968|NCT01307267|617159517|FG018|Overall Study|Lost to Follow-up|0|||
170768969|NCT01307267|617159518|FG019|Overall Study|Lost to Follow-up|2|||
170768970|NCT01307267|617159519|FG020|Overall Study|Lost to Follow-up|0|||
170768971|NCT01307267|617159520|FG021|Overall Study|Lost to Follow-up|0|||
170768972|NCT01307267|617159521|FG022|Overall Study|Lost to Follow-up|0|||
170768973|NCT01307267|617159499|FG000|Overall Study|Withdrawal by Subject|0|||
170768974|NCT01307267|617159500|FG001|Overall Study|Withdrawal by Subject|0|||
170768975|NCT01307267|617159501|FG002|Overall Study|Withdrawal by Subject|0|||
170768976|NCT01307267|617159502|FG003|Overall Study|Withdrawal by Subject|0|||
170768977|NCT01307267|617159503|FG004|Overall Study|Withdrawal by Subject|0|||
170768978|NCT01307267|617159504|FG005|Overall Study|Withdrawal by Subject|1|||
170768979|NCT01307267|617159505|FG006|Overall Study|Withdrawal by Subject|0|||
170768980|NCT01307267|617159506|FG007|Overall Study|Withdrawal by Subject|1|||
170768981|NCT01307267|617159507|FG008|Overall Study|Withdrawal by Subject|5|||
170768982|NCT01307267|617159508|FG009|Overall Study|Withdrawal by Subject|1|||
170768983|NCT01307267|617159509|FG010|Overall Study|Withdrawal by Subject|1|||
170768984|NCT01307267|617159510|FG011|Overall Study|Withdrawal by Subject|1|||
170768985|NCT01307267|617159511|FG012|Overall Study|Withdrawal by Subject|0|||
170768986|NCT01307267|617159512|FG013|Overall Study|Withdrawal by Subject|0|||
170768987|NCT01307267|617159513|FG014|Overall Study|Withdrawal by Subject|0|||
170768988|NCT01307267|617159514|FG015|Overall Study|Withdrawal by Subject|0|||
170768989|NCT01307267|617159515|FG016|Overall Study|Withdrawal by Subject|0|||
170768990|NCT01307267|617159516|FG017|Overall Study|Withdrawal by Subject|0|||
170768991|NCT01307267|617159517|FG018|Overall Study|Withdrawal by Subject|0|||
170768992|NCT01307267|617159518|FG019|Overall Study|Withdrawal by Subject|3|||
170768993|NCT01307267|617159519|FG020|Overall Study|Withdrawal by Subject|0|||
170768994|NCT01307267|617159520|FG021|Overall Study|Withdrawal by Subject|0|||
170768995|NCT01307267|617159521|FG022|Overall Study|Withdrawal by Subject|0|||
170768996|NCT01307267|617159499|FG000|Overall Study|Other|0|||
170768997|NCT01307267|617159500|FG001|Overall Study|Other|0|||
170768998|NCT01307267|617159501|FG002|Overall Study|Other|0|||
170768999|NCT01307267|617159502|FG003|Overall Study|Other|0|||
170769000|NCT01307267|617159503|FG004|Overall Study|Other|0|||
170769001|NCT01307267|617159504|FG005|Overall Study|Other|7|||
170522718|NCT01239797|616260149|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
170522719|NCT01239797|616260150|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
170522720|NCT01239797|616260149|FG000|Randomized Participants|Participant withdrew consent|1|||
170769002|NCT01307267|617159505|FG006|Overall Study|Other|0|||
170769003|NCT01307267|617159506|FG007|Overall Study|Other|1|||
170769004|NCT01307267|617159507|FG008|Overall Study|Other|3|||
170769005|NCT01307267|617159508|FG009|Overall Study|Other|0|||
170769006|NCT01307267|617159509|FG010|Overall Study|Other|1|||
170769007|NCT01307267|617159510|FG011|Overall Study|Other|1|||
170769008|NCT01307267|617159511|FG012|Overall Study|Other|1|||
170769009|NCT01307267|617159512|FG013|Overall Study|Other|0|||
170769010|NCT01307267|617159513|FG014|Overall Study|Other|2|||
170769011|NCT01307267|617159514|FG015|Overall Study|Other|1|||
170769012|NCT01307267|617159515|FG016|Overall Study|Other|0|||
170769013|NCT01307267|617159516|FG017|Overall Study|Other|0|||
170769014|NCT01307267|617159517|FG018|Overall Study|Other|0|||
170769015|NCT01307267|617159518|FG019|Overall Study|Other|19|||
170769016|NCT01307267|617159519|FG020|Overall Study|Other|2|||
170769017|NCT01307267|617159520|FG021|Overall Study|Other|3|||
170769018|NCT01307267|617159521|FG022|Overall Study|Other|2|||
170769019|NCT04956575|617159522|FG000|Overall Study|Death|1|||
170769020|NCT04956575|617159523|FG001|Overall Study|Death|0|||
170769021|NCT04956575|617159524|FG002|Overall Study|Death|0|||
170769022|NCT04956575|617159525|FG003|Overall Study|Death|0|||
170769023|NCT04956575|617159526|FG004|Overall Study|Death|0|||
170769024|NCT04956575|617159527|FG005|Overall Study|Death|0|||
170769025|NCT04956575|617159528|FG006|Overall Study|Death|0|||
170769026|NCT04956575|617159529|FG007|Overall Study|Death|1|||
170769027|NCT04956575|617159530|FG008|Overall Study|Death|0|||
170769028|NCT04956575|617159531|FG009|Overall Study|Death|1|||
170769029|NCT04956575|617159532|FG010|Overall Study|Death|0|||
170769030|NCT04956575|617159533|FG011|Overall Study|Death|0|||
170769031|NCT04956575|617159522|FG000|Overall Study|Lost to Follow-up|3|||
170769032|NCT04956575|617159523|FG001|Overall Study|Lost to Follow-up|4|||
170769033|NCT04956575|617159524|FG002|Overall Study|Lost to Follow-up|2|||
170769034|NCT04956575|617159525|FG003|Overall Study|Lost to Follow-up|3|||
170769035|NCT04956575|617159526|FG004|Overall Study|Lost to Follow-up|1|||
170769036|NCT04956575|617159527|FG005|Overall Study|Lost to Follow-up|10|||
170769037|NCT04956575|617159528|FG006|Overall Study|Lost to Follow-up|11|||
170769038|NCT04956575|617159529|FG007|Overall Study|Lost to Follow-up|7|||
170769039|NCT04956575|617159530|FG008|Overall Study|Lost to Follow-up|4|||
170769040|NCT04956575|617159531|FG009|Overall Study|Lost to Follow-up|2|||
170769041|NCT04956575|617159532|FG010|Overall Study|Lost to Follow-up|3|||
170769042|NCT04956575|617159533|FG011|Overall Study|Lost to Follow-up|8|||
170769043|NCT04956575|617159522|FG000|Overall Study|Withdrawal by Subject|1|||
170769044|NCT04956575|617159523|FG001|Overall Study|Withdrawal by Subject|2|||
170769045|NCT04956575|617159524|FG002|Overall Study|Withdrawal by Subject|1|||
170769046|NCT04956575|617159525|FG003|Overall Study|Withdrawal by Subject|4|||
170769047|NCT04956575|617159526|FG004|Overall Study|Withdrawal by Subject|2|||
170769048|NCT04956575|617159527|FG005|Overall Study|Withdrawal by Subject|8|||
170769049|NCT04956575|617159528|FG006|Overall Study|Withdrawal by Subject|5|||
170769050|NCT04956575|617159529|FG007|Overall Study|Withdrawal by Subject|1|||
170769051|NCT04956575|617159530|FG008|Overall Study|Withdrawal by Subject|1|||
170769052|NCT04956575|617159531|FG009|Overall Study|Withdrawal by Subject|0|||
170769053|NCT04956575|617159532|FG010|Overall Study|Withdrawal by Subject|3|||
170769054|NCT04956575|617159533|FG011|Overall Study|Withdrawal by Subject|1|||
170769055|NCT03593876|617159534|FG000|Overall Study|Withdrawal by Subject|1|||
170769056|NCT03593876|617159534|FG000|Overall Study|Discharged home before intervention completion|2|||
170769057|NCT03287622|617159535|FG000|Overall Study|Withdrawal by Subject|1|||
170769058|NCT03287622|617159536|FG001|Overall Study|Withdrawal by Subject|0|||
170769059|NCT03287622|617159535|FG000|Overall Study|Lost to Follow-up|27|||
170769060|NCT03287622|617159536|FG001|Overall Study|Lost to Follow-up|15|||
170769061|NCT03287622|617159535|FG000|Overall Study|No prescripion after surgery|28|||
170769062|NCT03287622|617159536|FG001|Overall Study|No prescripion after surgery|31|||
170769063|NCT03287622|617159535|FG000|Overall Study|prolonged Length of stay|2|||
170769064|NCT03287622|617159536|FG001|Overall Study|prolonged Length of stay|0|||
170769065|NCT03287622|617159535|FG000|Overall Study|surgery related|0|||
170769066|NCT03287622|617159536|FG001|Overall Study|surgery related|2|||
170769067|NCT01616654|617159540|FG000|Overall Study|Lack of Efficacy|1|||
170769068|NCT01616654|617159541|FG001|Overall Study|Lack of Efficacy|0|||
170769069|NCT01616654|617159542|FG002|Overall Study|Lack of Efficacy|0|||
170769070|NCT01616654|617159543|FG003|Overall Study|Lack of Efficacy|0|||
170769071|NCT01616654|617159544|FG004|Overall Study|Lack of Efficacy|1|||
170769072|NCT01616654|617159540|FG000|Overall Study|Adverse Event|0|||
170769073|NCT01616654|617159541|FG001|Overall Study|Adverse Event|1|||
170769074|NCT01616654|617159542|FG002|Overall Study|Adverse Event|2|||
170769075|NCT01616654|617159543|FG003|Overall Study|Adverse Event|1|||
170769076|NCT01616654|617159544|FG004|Overall Study|Adverse Event|0|||
170769077|NCT01616654|617159540|FG000|Overall Study|Withdrawal by Subject|2|||
170769078|NCT01616654|617159541|FG001|Overall Study|Withdrawal by Subject|2|||
170769079|NCT01616654|617159542|FG002|Overall Study|Withdrawal by Subject|3|||
170769080|NCT01616654|617159543|FG003|Overall Study|Withdrawal by Subject|1|||
170769081|NCT01616654|617159544|FG004|Overall Study|Withdrawal by Subject|5|||
170769082|NCT01616654|617159540|FG000|Overall Study|Protocol Violation|0|||
170769083|NCT01616654|617159541|FG001|Overall Study|Protocol Violation|5|||
170769084|NCT01616654|617159542|FG002|Overall Study|Protocol Violation|2|||
170769085|NCT01616654|617159543|FG003|Overall Study|Protocol Violation|4|||
170769086|NCT01616654|617159544|FG004|Overall Study|Protocol Violation|4|||
170769087|NCT01616654|617159540|FG000|Overall Study|Lost to Follow-up|1|||
170769088|NCT01616654|617159541|FG001|Overall Study|Lost to Follow-up|0|||
170769089|NCT01616654|617159542|FG002|Overall Study|Lost to Follow-up|3|||
170769090|NCT01616654|617159543|FG003|Overall Study|Lost to Follow-up|2|||
170769091|NCT01616654|617159544|FG004|Overall Study|Lost to Follow-up|1|||
170769092|NCT01616654|617159540|FG000|Overall Study|Pregnancy|1|||
170769093|NCT01616654|617159541|FG001|Overall Study|Pregnancy|0|||
170769094|NCT01616654|617159542|FG002|Overall Study|Pregnancy|0|||
170769095|NCT01616654|617159543|FG003|Overall Study|Pregnancy|0|||
170769096|NCT01616654|617159544|FG004|Overall Study|Pregnancy|1|||
170769097|NCT05309668|617159545|FG000|Overall Study|Ongoing at data cut-off|14|||
170769098|NCT05309668|617159546|FG001|Overall Study|Ongoing at data cut-off|17|||
170871368|NCT00467779|617541576|FG004|Stage 2|Unspecified Reason|0|||
170871369|NCT00467779|617541577|FG005|Stage 2|Unspecified Reason|0|||
170871370|NCT00467779|617541578|FG006|Stage 2|Unspecified Reason|0|||
170871371|NCT00467779|617541579|FG007|Stage 2|Unspecified Reason|0|||
170871372|NCT00467779|617541580|FG008|Stage 2|Unspecified Reason|3|||
170871373|NCT00467779|617541581|FG009|Stage 2|Unspecified Reason|0|||
170871374|NCT00467779|617541582|FG010|Stage 2|Unspecified Reason|0|||
170871375|NCT00467779|617541583|FG011|Stage 2|Unspecified Reason|0|||
170871376|NCT00467779|617541584|FG012|Stage 2|Unspecified Reason|0|||
170871377|NCT00467779|617541585|FG013|Stage 2|Unspecified Reason|0|||
170871378|NCT00467779|617541586|FG014|Stage 2|Unspecified Reason|0|||
170871379|NCT00467779|617541572|FG000|Stage 2A|Adverse Event|0|||
170871380|NCT00467779|617541573|FG001|Stage 2A|Adverse Event|0|||
170871381|NCT00467779|617541574|FG002|Stage 2A|Adverse Event|0|||
170871382|NCT00467779|617541575|FG003|Stage 2A|Adverse Event|0|||
170871383|NCT00467779|617541576|FG004|Stage 2A|Adverse Event|0|||
170871384|NCT00467779|617541577|FG005|Stage 2A|Adverse Event|0|||
170871385|NCT00467779|617541578|FG006|Stage 2A|Adverse Event|0|||
170871386|NCT00467779|617541579|FG007|Stage 2A|Adverse Event|0|||
170871387|NCT00467779|617541580|FG008|Stage 2A|Adverse Event|0|||
170871388|NCT00467779|617541581|FG009|Stage 2A|Adverse Event|0|||
170871389|NCT00467779|617541582|FG010|Stage 2A|Adverse Event|0|||
170871390|NCT00467779|617541583|FG011|Stage 2A|Adverse Event|0|||
170871391|NCT00467779|617541584|FG012|Stage 2A|Adverse Event|0|||
170871392|NCT00467779|617541585|FG013|Stage 2A|Adverse Event|2|||
170871393|NCT00467779|617541586|FG014|Stage 2A|Adverse Event|0|||
170871394|NCT00467779|617541572|FG000|Stage 2A|Death|0|||
170871395|NCT00467779|617541573|FG001|Stage 2A|Death|0|||
170871396|NCT00467779|617541574|FG002|Stage 2A|Death|0|||
170871397|NCT00467779|617541575|FG003|Stage 2A|Death|0|||
170871398|NCT00467779|617541576|FG004|Stage 2A|Death|0|||
170871399|NCT00467779|617541577|FG005|Stage 2A|Death|0|||
170871400|NCT00467779|617541578|FG006|Stage 2A|Death|0|||
170871401|NCT00467779|617541579|FG007|Stage 2A|Death|0|||
170871402|NCT00467779|617541580|FG008|Stage 2A|Death|0|||
170871403|NCT00467779|617541581|FG009|Stage 2A|Death|0|||
170871404|NCT00467779|617541582|FG010|Stage 2A|Death|0|||
170871405|NCT00467779|617541583|FG011|Stage 2A|Death|0|||
170871406|NCT00467779|617541584|FG012|Stage 2A|Death|0|||
170522721|NCT01239797|616260150|FG001|Randomized Participants|Participant withdrew consent|7|||
170522722|NCT01239797|616260149|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
170522723|NCT01239797|616260150|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
170522724|NCT01239797|616260149|FG000|Treated Participants|Disease progression|185|||
170522725|NCT01239797|616260150|FG001|Treated Participants|Disease progression|185|||
170522726|NCT01239797|616260149|FG000|Treated Participants|Study drug toxicity|39|||
170522727|NCT01239797|616260150|FG001|Treated Participants|Study drug toxicity|45|||
170522728|NCT01239797|616260149|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
170522729|NCT01239797|616260150|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
170522730|NCT01239797|616260149|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
170522731|NCT01239797|616260150|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
170522732|NCT01239797|616260149|FG000|Treated Participants|Administrative reason by sponsor|13|||
170522733|NCT01239797|616260150|FG001|Treated Participants|Administrative reason by sponsor|4|||
170522734|NCT01239797|616260149|FG000|Treated Participants|Other reasons|14|||
170522735|NCT01239797|616260150|FG001|Treated Participants|Other reasons|14|||
170522736|NCT01239797|616260149|FG000|Treated Participants|Participant withdrew consent|6|||
170522737|NCT01239797|616260150|FG001|Treated Participants|Participant withdrew consent|11|||
170522738|NCT01239797|616260149|FG000|Treated Participants|Death|1|||
170522739|NCT01239797|616260150|FG001|Treated Participants|Death|1|||
170522740|NCT01239797|616260149|FG000|Treated Participants|Participant no longer meets study criteria|1|||
170522741|NCT01239797|616260150|FG001|Treated Participants|Participant no longer meets study criteria|1|||
170522742|NCT01239797|616260149|FG000|Treated Participants|Poor/non-compliance|0|||
170522743|NCT01239797|616260150|FG001|Treated Participants|Poor/non-compliance|1|||
170522744|NCT00853762|616260151|FG000|Overall Study|Premature Termination|16|||
170522745|NCT00853762|616260152|FG001|Overall Study|Premature Termination|15|||
170871407|NCT00467779|617541585|FG013|Stage 2A|Death|1|||
170871408|NCT00467779|617541586|FG014|Stage 2A|Death|0|||
170871409|NCT00467779|617541572|FG000|Stage 2A|Disease Progression|0|||
170871410|NCT00467779|617541573|FG001|Stage 2A|Disease Progression|0|||
170871411|NCT00467779|617541574|FG002|Stage 2A|Disease Progression|0|||
170871412|NCT00467779|617541575|FG003|Stage 2A|Disease Progression|0|||
170522746|NCT00853762|616260153|FG002|Overall Study|Premature Termination|14|||
170871413|NCT00467779|617541576|FG004|Stage 2A|Disease Progression|0|||
170871414|NCT00467779|617541577|FG005|Stage 2A|Disease Progression|0|||
170871415|NCT00467779|617541578|FG006|Stage 2A|Disease Progression|0|||
170871416|NCT00467779|617541579|FG007|Stage 2A|Disease Progression|0|||
170871417|NCT00467779|617541580|FG008|Stage 2A|Disease Progression|0|||
170871418|NCT00467779|617541581|FG009|Stage 2A|Disease Progression|0|||
170871419|NCT00467779|617541582|FG010|Stage 2A|Disease Progression|0|||
170871420|NCT00467779|617541583|FG011|Stage 2A|Disease Progression|0|||
170871421|NCT00467779|617541584|FG012|Stage 2A|Disease Progression|0|||
170522747|NCT00853762|616260154|FG003|Overall Study|Premature Termination|21|||
170522748|NCT00853762|616260151|FG000|Overall Study|Protocol Violation|0|||
170522749|NCT00853762|616260152|FG001|Overall Study|Protocol Violation|0|||
170522750|NCT00853762|616260153|FG002|Overall Study|Protocol Violation|0|||
170769099|NCT05309668|617159547|FG002|Overall Study|Ongoing at data cut-off|4|||
170871422|NCT00467779|617541585|FG013|Stage 2A|Disease Progression|10|||
170769100|NCT02057692|617159551|FG000|Overall Study|Adverse Event|1|||
170769101|NCT02057692|617159552|FG001|Overall Study|Adverse Event|0|||
170769102|NCT02057692|617159553|FG002|Overall Study|Adverse Event|0|||
170769103|NCT02057692|617159554|FG003|Overall Study|Adverse Event|0|||
170769104|NCT02057692|617159551|FG000|Overall Study|Lost to Follow-up|0|||
170769105|NCT02057692|617159552|FG001|Overall Study|Lost to Follow-up|0|||
170769106|NCT02057692|617159553|FG002|Overall Study|Lost to Follow-up|0|||
170769107|NCT02057692|617159554|FG003|Overall Study|Lost to Follow-up|1|||
170769108|NCT00071799|617159555|FG000|Overall Study|Adverse Event|19|||
170769109|NCT00071799|617159556|FG001|Overall Study|Adverse Event|10|||
170769110|NCT00071799|617159555|FG000|Overall Study|Protocol Violation|1|||
170769111|NCT00071799|617159556|FG001|Overall Study|Protocol Violation|7|||
170769112|NCT00071799|617159555|FG000|Overall Study|Lost to Follow-up|1|||
170769113|NCT00071799|617159556|FG001|Overall Study|Lost to Follow-up|1|||
170769114|NCT00071799|617159555|FG000|Overall Study|Withdrawal by Subject|15|||
170769115|NCT00071799|617159556|FG001|Overall Study|Withdrawal by Subject|37|||
170769116|NCT00071799|617159555|FG000|Overall Study|Physician Decision|0|||
170769117|NCT00071799|617159556|FG001|Overall Study|Physician Decision|2|||
170769118|NCT00071799|617159555|FG000|Overall Study|Lack of Efficacy|11|||
170769119|NCT00071799|617159556|FG001|Overall Study|Lack of Efficacy|18|||
170769120|NCT00071799|617159555|FG000|Overall Study|Disease Progression|23|||
170769121|NCT00071799|617159556|FG001|Overall Study|Disease Progression|20|||
170769122|NCT00071799|617159555|FG000|Overall Study|Different Central+Local Pathology Review|0|||
170769123|NCT00071799|617159556|FG001|Overall Study|Different Central+Local Pathology Review|1|||
170769124|NCT00071799|617159555|FG000|Overall Study|Not Documented|0|||
170769125|NCT00071799|617159556|FG001|Overall Study|Not Documented|2|||
170769126|NCT00814346|617159559|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
170769127|NCT00814346|617159560|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
170769128|NCT00814346|617159559|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
170769129|NCT00814346|617159560|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
170769130|NCT00814346|617159559|FG000|Open Phase (17 Months)|Adverse Event|5|||
170769131|NCT00814346|617159560|FG001|Open Phase (17 Months)|Adverse Event|0|||
170769132|NCT00814346|617159559|FG000|Open Phase (17 Months)|Consent|2|||
170769133|NCT00814346|617159560|FG001|Open Phase (17 Months)|Consent|0|||
170769134|NCT00814346|617159559|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
170769135|NCT00814346|617159560|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
170769136|NCT00814346|617159559|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
170769137|NCT00814346|617159560|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
170769138|NCT01241292|617159565|FG000|Overall Study|Administrative Reason by Sponsor|1|||
170769139|NCT01241292|617159566|FG001|Overall Study|Administrative Reason by Sponsor|0|||
170769140|NCT01241292|617159565|FG000|Overall Study|Disease Progression|2|||
170769141|NCT01241292|617159566|FG001|Overall Study|Disease Progression|0|||
170769142|NCT01241292|617159565|FG000|Overall Study|Study Drug Toxicity|0|||
170769143|NCT01241292|617159566|FG001|Overall Study|Study Drug Toxicity|1|||
170769144|NCT01241292|617159565|FG000|Overall Study|Participant Discontinued Treatment|0|||
170769145|NCT01241292|617159566|FG001|Overall Study|Participant Discontinued Treatment|2|||
170769146|NCT01565928|617159567|FG000|Overall Study|Adverse Event|3|||
170769147|NCT01565928|617159567|FG000|Overall Study|Other|3|||
170769148|NCT01565928|617159567|FG000|Overall Study|Progressive Disease|13|||
170769149|NCT01565928|617159567|FG000|Overall Study|Withdrawal by Subject|1|||
170871423|NCT00467779|617541586|FG014|Stage 2A|Disease Progression|0|||
170522751|NCT00853762|616260154|FG003|Overall Study|Protocol Violation|1|||
170769150|NCT01565928|617159567|FG000|Overall Study|Death|2|||
170769151|NCT01191788|617159573|FG000|Overall Study|Lost to Follow-up|21|||
170769152|NCT01191788|617159574|FG001|Overall Study|Lost to Follow-up|22|||
170769153|NCT03621761|617159575|FG000|Overall Study|Lost to Follow-up|1|||
170769154|NCT03621761|617159576|FG001|Overall Study|Lost to Follow-up|1|||
170769155|NCT03621761|617159577|FG002|Overall Study|Lost to Follow-up|2|||
170769156|NCT03621761|617159575|FG000|Overall Study|Withdrawal by Subject|2|||
170769157|NCT03621761|617159576|FG001|Overall Study|Withdrawal by Subject|1|||
170769158|NCT03621761|617159577|FG002|Overall Study|Withdrawal by Subject|1|||
170769159|NCT03621761|617159575|FG000|Overall Study|Became Ineligible|0|||
170769160|NCT03621761|617159576|FG001|Overall Study|Became Ineligible|2|||
170769161|NCT03621761|617159577|FG002|Overall Study|Became Ineligible|0|||
170769162|NCT01901276|617159583|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
170769163|NCT01901276|617159584|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
170769164|NCT05641311|617159588|FG000|Dosing Period 1|Adverse Event|1|||
170769165|NCT05641311|617159589|FG001|Dosing Period 1|Adverse Event|0|||
170769166|NCT02705586|617159592|FG000|Overall Study|Health Issues|2|||
170769167|NCT02705586|617159592|FG000|Overall Study|Transportation Difficulties|5|||
170769168|NCT02705586|617159592|FG000|Overall Study|Vacation/Planned Absence|1|||
170769169|NCT03482011|617159598|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
170769170|NCT03482011|617159599|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
170769171|NCT03482011|617159600|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
170769172|NCT03482011|617159601|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
170769173|NCT03482011|617159602|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
170769174|NCT03482011|617159603|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
170769175|NCT03482011|617159604|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
170769176|NCT03482011|617159605|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
170769177|NCT03482011|617159598|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
170769178|NCT03482011|617159599|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
170769179|NCT03482011|617159600|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170769180|NCT03482011|617159601|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170769181|NCT03482011|617159602|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170769182|NCT03482011|617159603|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170769183|NCT03482011|617159604|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170769184|NCT03482011|617159605|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170769185|NCT03482011|617159598|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
170769186|NCT03482011|617159599|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
170769187|NCT03482011|617159600|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
170769188|NCT03482011|617159601|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
170769189|NCT03482011|617159602|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
170769190|NCT03482011|617159603|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
170769191|NCT03482011|617159604|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
170769192|NCT03482011|617159605|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
170769193|NCT03482011|617159598|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
170769194|NCT03482011|617159599|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
170769195|NCT03482011|617159600|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
170769196|NCT03482011|617159601|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
170769197|NCT03482011|617159602|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
170769198|NCT03482011|617159603|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
170769199|NCT03482011|617159604|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
170769200|NCT03482011|617159605|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
170769201|NCT03482011|617159598|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
170769202|NCT03482011|617159599|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
170769203|NCT03482011|617159600|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170769204|NCT03482011|617159601|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170769205|NCT03482011|617159602|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170769206|NCT03482011|617159603|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170769207|NCT03482011|617159604|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170769208|NCT03482011|617159605|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170769209|NCT03482011|617159598|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
170769210|NCT03482011|617159599|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
170769211|NCT03482011|617159600|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
170769212|NCT03482011|617159601|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
170769213|NCT03482011|617159602|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
170769214|NCT03482011|617159603|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
170769215|NCT03482011|617159604|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
170769216|NCT03482011|617159605|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
170769217|NCT03482011|617159598|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
170769218|NCT03482011|617159599|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
170769219|NCT03482011|617159600|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
170769220|NCT03482011|617159601|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
170769221|NCT03482011|617159602|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
170769222|NCT03482011|617159603|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
170769223|NCT03482011|617159604|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
170769224|NCT03482011|617159605|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
170769225|NCT03482011|617159598|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170769226|NCT03482011|617159599|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170412591|NCT07174544|615849364|FG001|Overall Study|Lost to Follow-up|15|||
170412592|NCT00135707|615850416|FG000|Overall Study|Lost to Follow-up|94|||
170412593|NCT00135707|615850417|FG001|Overall Study|Lost to Follow-up|89|||
170412594|NCT00135707|615850416|FG000|Overall Study|Withdrawal by Subject|0|||
170412595|NCT00135707|615850417|FG001|Overall Study|Withdrawal by Subject|1|||
170769227|NCT03482011|617159600|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170769228|NCT03482011|617159601|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170769229|NCT03482011|617159602|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
170769230|NCT03482011|617159603|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170769231|NCT03482011|617159604|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170769232|NCT03482011|617159605|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
170769233|NCT03482011|617159598|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
170769234|NCT03482011|617159599|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
170769235|NCT03482011|617159600|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
170522752|NCT00853762|616260151|FG000|Overall Study|Withdrawal by Subject|0|||
170522753|NCT00853762|616260152|FG001|Overall Study|Withdrawal by Subject|0|||
170522754|NCT00853762|616260153|FG002|Overall Study|Withdrawal by Subject|1|||
170522755|NCT00853762|616260154|FG003|Overall Study|Withdrawal by Subject|0|||
170522756|NCT00853762|616260151|FG000|Overall Study|Other|0|||
170522757|NCT00853762|616260152|FG001|Overall Study|Other|2|||
170522758|NCT00853762|616260153|FG002|Overall Study|Other|0|||
170769236|NCT03482011|617159601|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
170769237|NCT03482011|617159602|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
170769238|NCT03482011|617159603|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
170769239|NCT03482011|617159604|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
170769240|NCT03482011|617159605|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
170769241|NCT03482011|617159598|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170769242|NCT03482011|617159599|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170769243|NCT03482011|617159600|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170769244|NCT03482011|617159601|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
170769245|NCT03482011|617159602|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
170769246|NCT03482011|617159603|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
170769247|NCT03482011|617159604|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
170769248|NCT03482011|617159605|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
170769249|NCT03482011|617159598|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170769250|NCT03482011|617159599|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170769251|NCT03482011|617159600|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170769252|NCT03482011|617159601|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
170769253|NCT03482011|617159602|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170769254|NCT03482011|617159603|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
170769255|NCT03482011|617159604|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
170769256|NCT03482011|617159605|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
170769257|NCT03482011|617159598|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
170769258|NCT03482011|617159599|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
170769259|NCT03482011|617159600|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
170769260|NCT03482011|617159601|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
170769261|NCT03482011|617159602|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
170769262|NCT03482011|617159603|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
170769263|NCT03482011|617159604|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
170769264|NCT03482011|617159605|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
170769265|NCT03482011|617159598|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
170769266|NCT03482011|617159599|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
170769267|NCT03482011|617159600|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
170769268|NCT03482011|617159601|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
170769269|NCT03482011|617159602|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
170769270|NCT03482011|617159603|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
170769271|NCT03482011|617159604|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
170769272|NCT03482011|617159605|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
170769273|NCT03482011|617159598|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
170769274|NCT03482011|617159599|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
170769275|NCT03482011|617159600|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
170769276|NCT03482011|617159601|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
170769277|NCT03482011|617159602|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
170769278|NCT03482011|617159603|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
170769279|NCT03482011|617159604|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
170769280|NCT03482011|617159605|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
170769281|NCT03482011|617159598|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
170769282|NCT03482011|617159599|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
170769283|NCT03482011|617159600|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
170769284|NCT03482011|617159601|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
170769285|NCT03482011|617159602|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
170769286|NCT03482011|617159603|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
170769287|NCT03482011|617159604|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
170769288|NCT03482011|617159605|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
170769289|NCT00468052|617159606|FG000|Overall Study|Protocol Violation|7|||
170769290|NCT00468052|617159607|FG001|Overall Study|Protocol Violation|8|||
170769291|NCT01595061|617159608|FG000|Overall Study|Never Treated|3|||
170769292|NCT01595061|617159608|FG000|Overall Study|Inadequate Pathology|1|||
170769293|NCT00324038|617159618|FG000|Overall Study|Adverse Event|38|||
170769294|NCT00324038|617159619|FG001|Overall Study|Adverse Event|23|||
170871424|NCT00467779|617541572|FG000|Stage 2A|Unspecified Reason|0|||
170871425|NCT00467779|617541573|FG001|Stage 2A|Unspecified Reason|0|||
170871426|NCT00467779|617541574|FG002|Stage 2A|Unspecified Reason|0|||
170522759|NCT00853762|616260154|FG003|Overall Study|Other|0|||
170522760|NCT00853762|616260151|FG000|Overall Study|Randomised but not Treated|0|||
170522761|NCT00853762|616260152|FG001|Overall Study|Randomised but not Treated|2|||
170871427|NCT00467779|617541575|FG003|Stage 2A|Unspecified Reason|0|||
170871428|NCT00467779|617541576|FG004|Stage 2A|Unspecified Reason|0|||
170871429|NCT00467779|617541577|FG005|Stage 2A|Unspecified Reason|0|||
170871430|NCT00467779|617541578|FG006|Stage 2A|Unspecified Reason|0|||
170871431|NCT00467779|617541579|FG007|Stage 2A|Unspecified Reason|0|||
170871432|NCT00467779|617541580|FG008|Stage 2A|Unspecified Reason|0|||
170871433|NCT00467779|617541581|FG009|Stage 2A|Unspecified Reason|0|||
170871434|NCT00467779|617541582|FG010|Stage 2A|Unspecified Reason|0|||
170871435|NCT00467779|617541583|FG011|Stage 2A|Unspecified Reason|0|||
170871436|NCT00467779|617541584|FG012|Stage 2A|Unspecified Reason|0|||
170871437|NCT00467779|617541585|FG013|Stage 2A|Unspecified Reason|7|||
170871438|NCT00467779|617541586|FG014|Stage 2A|Unspecified Reason|0|||
170871439|NCT00467779|617541572|FG000|Stage 2A|Withdrawal by Subject|0|||
170769295|NCT00324038|617159618|FG000|Overall Study|Lack of Efficacy|5|||
170769296|NCT00324038|617159619|FG001|Overall Study|Lack of Efficacy|13|||
170769297|NCT00324038|617159618|FG000|Overall Study|Lost to Follow-up|0|||
170769298|NCT00324038|617159619|FG001|Overall Study|Lost to Follow-up|2|||
170769299|NCT00324038|617159618|FG000|Overall Study|Other|6|||
170769300|NCT00324038|617159619|FG001|Overall Study|Other|13|||
170769301|NCT02770248|617159620|FG000|Overall Study|Adverse Event|0|||
170769302|NCT02770248|617159621|FG001|Overall Study|Adverse Event|1|||
170769303|NCT02770248|617159620|FG000|Overall Study|Randomized in error, prior to treatment|0|||
170769304|NCT02770248|617159621|FG001|Overall Study|Randomized in error, prior to treatment|1|||
170769305|NCT00361283|617159623|FG000|Overall Study|Lost to Follow-up|27|||
170769306|NCT00961636|617159626|FG000|Overall Study|Adverse Event|35|||
170769307|NCT00961636|617159627|FG001|Overall Study|Adverse Event|54|||
170769308|NCT00961636|617159628|FG002|Overall Study|Adverse Event|13|||
170769309|NCT00961636|617159626|FG000|Overall Study|Flushing Symptoms|29|||
170769310|NCT00961636|617159627|FG001|Overall Study|Flushing Symptoms|46|||
170769311|NCT00961636|617159628|FG002|Overall Study|Flushing Symptoms|3|||
170769312|NCT00961636|617159626|FG000|Overall Study|Lost to Follow-up|2|||
170769313|NCT00961636|617159627|FG001|Overall Study|Lost to Follow-up|3|||
170769314|NCT00961636|617159628|FG002|Overall Study|Lost to Follow-up|1|||
170769315|NCT00961636|617159626|FG000|Overall Study|Physician Decision|3|||
170769316|NCT00961636|617159627|FG001|Overall Study|Physician Decision|1|||
170769317|NCT00961636|617159628|FG002|Overall Study|Physician Decision|1|||
170769318|NCT00961636|617159626|FG000|Overall Study|Protocol Violation|9|||
170769319|NCT00961636|617159627|FG001|Overall Study|Protocol Violation|5|||
170769320|NCT00961636|617159628|FG002|Overall Study|Protocol Violation|1|||
170769321|NCT00961636|617159626|FG000|Overall Study|Withdrawal by Subject|29|||
170769322|NCT00961636|617159627|FG001|Overall Study|Withdrawal by Subject|22|||
170769323|NCT00961636|617159628|FG002|Overall Study|Withdrawal by Subject|13|||
170769324|NCT00387465|617159629|FG000|Overall Study|Withdrawal by Subject|0|||
170769325|NCT00387465|617159630|FG001|Overall Study|Withdrawal by Subject|1|||
170769326|NCT00387465|617159631|FG002|Overall Study|Withdrawal by Subject|0|||
170769327|NCT02486588|617159633|FG000|Overall Study|Randomized in error- ineligible|738|||
170769328|NCT02486588|617159634|FG001|Overall Study|Randomized in error- ineligible|750|||
170769329|NCT02486588|617159635|FG002|Overall Study|Randomized in error- ineligible|755|||
170769330|NCT02486588|617159636|FG003|Overall Study|Randomized in error- ineligible|738|||
170769331|NCT02486588|617159637|FG004|Overall Study|Randomized in error- ineligible|746|||
170769332|NCT02486588|617159638|FG005|Overall Study|Randomized in error- ineligible|746|||
170769333|NCT00573833|617159644|FG000|Overall Study|Not Treated|2|||
170769334|NCT06269640|617160661|FG000|Overall Study|Death|1|||
170769335|NCT01613716|617160664|FG000|Overall Study|screen failures|3|||
170769336|NCT01613716|617160664|FG000|Overall Study|Lost to Follow-up|4|||
170769337|NCT02296424|617160665|FG000|Part 1|New therapy for study indication|0|||
170769338|NCT02296424|617160666|FG001|Part 1|New therapy for study indication|1|||
170769339|NCT02296424|617160667|FG002|Part 1|New therapy for study indication|0|||
170769340|NCT02296424|617160668|FG003|Part 1|New therapy for study indication|0|||
170769341|NCT02296424|617160665|FG000|Part 1|Protocol Violation|0|||
170769342|NCT02296424|617160666|FG001|Part 1|Protocol Violation|1|||
170769343|NCT02296424|617160667|FG002|Part 1|Protocol Violation|0|||
170871440|NCT00467779|617541573|FG001|Stage 2A|Withdrawal by Subject|0|||
170769344|NCT02296424|617160668|FG003|Part 1|Protocol Violation|0|||
170769345|NCT02296424|617160665|FG000|Part 1|Withdrawal by Subject|0|||
170769346|NCT02296424|617160666|FG001|Part 1|Withdrawal by Subject|2|||
170769347|NCT02296424|617160667|FG002|Part 1|Withdrawal by Subject|0|||
170769348|NCT02296424|617160668|FG003|Part 1|Withdrawal by Subject|0|||
170769349|NCT02296424|617160665|FG000|Part 1|Study terminated by sponsor|0|||
170769350|NCT02296424|617160666|FG001|Part 1|Study terminated by sponsor|1|||
170769351|NCT02296424|617160667|FG002|Part 1|Study terminated by sponsor|0|||
170769352|NCT02296424|617160668|FG003|Part 1|Study terminated by sponsor|0|||
170769353|NCT02296424|617160665|FG000|Part 1|Adverse Event|2|||
170769354|NCT02296424|617160666|FG001|Part 1|Adverse Event|11|||
170769355|NCT02296424|617160667|FG002|Part 1|Adverse Event|0|||
170769356|NCT02296424|617160668|FG003|Part 1|Adverse Event|0|||
170871441|NCT00467779|617541574|FG002|Stage 2A|Withdrawal by Subject|0|||
170871442|NCT00467779|617541575|FG003|Stage 2A|Withdrawal by Subject|0|||
170871443|NCT00467779|617541576|FG004|Stage 2A|Withdrawal by Subject|0|||
170871444|NCT00467779|617541577|FG005|Stage 2A|Withdrawal by Subject|0|||
170522762|NCT00853762|616260153|FG002|Overall Study|Randomised but not Treated|2|||
170522763|NCT00853762|616260154|FG003|Overall Study|Randomised but not Treated|0|||
170522764|NCT02631941|616260159|FG000|Overall Study|Physician Decision|0|||
170769357|NCT02296424|617160665|FG000|Part 1|Lack of Efficacy|5|||
170769358|NCT02296424|617160666|FG001|Part 1|Lack of Efficacy|17|||
170769359|NCT02296424|617160667|FG002|Part 1|Lack of Efficacy|0|||
170769360|NCT02296424|617160668|FG003|Part 1|Lack of Efficacy|0|||
170769361|NCT02296424|617160665|FG000|Part 1|16 directly started part II|16|||
170769362|NCT02296424|617160666|FG001|Part 1|16 directly started part II|0|||
170769363|NCT02296424|617160667|FG002|Part 1|16 directly started part II|0|||
170769364|NCT02296424|617160668|FG003|Part 1|16 directly started part II|0|||
170769365|NCT02296424|617160665|FG000|Part 2|Lack of Efficacy|0|||
170769366|NCT02296424|617160666|FG001|Part 2|Lack of Efficacy|0|||
170769367|NCT02296424|617160667|FG002|Part 2|Lack of Efficacy|1|||
170769368|NCT02296424|617160668|FG003|Part 2|Lack of Efficacy|0|||
170769369|NCT02296424|617160665|FG000|Part 2|Adverse Event|0|||
170769370|NCT02296424|617160666|FG001|Part 2|Adverse Event|0|||
170769371|NCT02296424|617160667|FG002|Part 2|Adverse Event|1|||
170769372|NCT02296424|617160668|FG003|Part 2|Adverse Event|0|||
170769373|NCT02296424|617160665|FG000|Part 2|Lost to Follow-up|0|||
170769374|NCT02296424|617160666|FG001|Part 2|Lost to Follow-up|0|||
170769375|NCT02296424|617160667|FG002|Part 2|Lost to Follow-up|1|||
170769376|NCT02296424|617160668|FG003|Part 2|Lost to Follow-up|0|||
170769377|NCT00743444|617160669|FG000|First Intervention|Catheter placement problems|0|||
170769378|NCT00743444|617160670|FG001|First Intervention|Catheter placement problems|1|||
170769379|NCT00743444|617160669|FG000|Washout Period|Adverse Event|0|||
170769380|NCT00743444|617160670|FG001|Washout Period|Adverse Event|1|||
170769381|NCT06119113|617160675|FG000|Overall Study|Lost to Follow-up|15|||
170769382|NCT06119113|617160676|FG001|Overall Study|Lost to Follow-up|13|||
170769383|NCT06119113|617160677|FG002|Overall Study|Lost to Follow-up|21|||
170769384|NCT00854906|617160678|FG000|Overall Study|One person had no ocular history|1|||
170769385|NCT05136443|617160679|FG000|Overall Study|Lost to Follow-up|2|||
170769386|NCT05136443|617160679|FG000|Overall Study|Adverse Event|2|||
170769387|NCT01145885|617160680|FG000|Overall Study|Progressive Disease|7|||
170769388|NCT03460756|617160684|FG000|Overall Study|Adverse Event|0|||
170769389|NCT03460756|617160685|FG001|Overall Study|Adverse Event|0|||
170769390|NCT03460756|617160686|FG002|Overall Study|Adverse Event|0|||
170769391|NCT03460756|617160687|FG003|Overall Study|Adverse Event|1|||
170769392|NCT03460756|617160684|FG000|Overall Study|Lack of Efficacy|0|||
170769393|NCT03460756|617160685|FG001|Overall Study|Lack of Efficacy|0|||
170769394|NCT03460756|617160686|FG002|Overall Study|Lack of Efficacy|0|||
170769395|NCT03460756|617160687|FG003|Overall Study|Lack of Efficacy|2|||
170769396|NCT03460756|617160684|FG000|Overall Study|Lost to Follow-up|0|||
170769397|NCT03460756|617160685|FG001|Overall Study|Lost to Follow-up|1|||
170769398|NCT03460756|617160686|FG002|Overall Study|Lost to Follow-up|2|||
170769399|NCT03460756|617160687|FG003|Overall Study|Lost to Follow-up|1|||
170769400|NCT03460756|617160684|FG000|Overall Study|Pregnancy|0|||
170769401|NCT03460756|617160685|FG001|Overall Study|Pregnancy|0|||
170769402|NCT03460756|617160686|FG002|Overall Study|Pregnancy|0|||
170769403|NCT03460756|617160687|FG003|Overall Study|Pregnancy|1|||
170769404|NCT03460756|617160684|FG000|Overall Study|Protocol Violation|0|||
170769405|NCT03460756|617160685|FG001|Overall Study|Protocol Violation|0|||
170769406|NCT03460756|617160686|FG002|Overall Study|Protocol Violation|0|||
170769407|NCT03460756|617160687|FG003|Overall Study|Protocol Violation|1|||
170769408|NCT03460756|617160684|FG000|Overall Study|Withdrawal by Subject|0|||
170769409|NCT03460756|617160685|FG001|Overall Study|Withdrawal by Subject|4|||
170769410|NCT03460756|617160686|FG002|Overall Study|Withdrawal by Subject|7|||
170769411|NCT03460756|617160687|FG003|Overall Study|Withdrawal by Subject|3|||
170769412|NCT02441036|617160688|FG000|Overall Study|No tissue resected|0|||
170769413|NCT02441036|617160689|FG001|Overall Study|No tissue resected|1|||
170769414|NCT02441036|617160690|FG002|Overall Study|No tissue resected|0|||
170769415|NCT02441036|617160691|FG003|Overall Study|No tissue resected|1|||
170769416|NCT02441036|617160692|FG004|Overall Study|No tissue resected|0|||
170769417|NCT00723450|617160695|FG000|Open-Label Phase|Adverse Event|26|||
170769418|NCT00723450|617160696|FG001|Open-Label Phase|Adverse Event|0|||
170769419|NCT00723450|617160697|FG002|Open-Label Phase|Adverse Event|0|||
170769420|NCT00723450|617160695|FG000|Open-Label Phase|Lack of Efficacy|18|||
170769421|NCT00723450|617160696|FG001|Open-Label Phase|Lack of Efficacy|0|||
170769422|NCT00723450|617160697|FG002|Open-Label Phase|Lack of Efficacy|0|||
170769423|NCT00723450|617160695|FG000|Open-Label Phase|Protocol Violation|35|||
170769424|NCT00723450|617160696|FG001|Open-Label Phase|Protocol Violation|0|||
170522765|NCT02631941|616260160|FG001|Overall Study|Physician Decision|1|||
170769425|NCT00723450|617160697|FG002|Open-Label Phase|Protocol Violation|0|||
170769426|NCT00723450|617160695|FG000|Open-Label Phase|Lost to Follow-up|7|||
170769427|NCT00723450|617160696|FG001|Open-Label Phase|Lost to Follow-up|0|||
170769428|NCT00723450|617160697|FG002|Open-Label Phase|Lost to Follow-up|0|||
170522766|NCT02631941|616260161|FG002|Overall Study|Physician Decision|0|||
170522767|NCT02631941|616260162|FG003|Overall Study|Physician Decision|0|||
170769429|NCT00723450|617160695|FG000|Open-Label Phase|Physician Decision|2|||
170769430|NCT00723450|617160696|FG001|Open-Label Phase|Physician Decision|0|||
170769431|NCT00723450|617160697|FG002|Open-Label Phase|Physician Decision|0|||
170522768|NCT02631941|616260163|FG004|Overall Study|Physician Decision|0|||
170522769|NCT02631941|616260164|FG005|Overall Study|Physician Decision|0|||
170522770|NCT02631941|616260165|FG006|Overall Study|Physician Decision|0|||
170522771|NCT02631941|616260166|FG007|Overall Study|Physician Decision|0|||
170522772|NCT02631941|616260167|FG008|Overall Study|Physician Decision|0|||
170522773|NCT02631941|616260168|FG009|Overall Study|Physician Decision|0|||
170522774|NCT02631941|616260159|FG000|Overall Study|Adverse Event|0|||
170522775|NCT02631941|616260160|FG001|Overall Study|Adverse Event|1|||
170522776|NCT02631941|616260161|FG002|Overall Study|Adverse Event|0|||
170522777|NCT02631941|616260162|FG003|Overall Study|Adverse Event|0|||
170522778|NCT02631941|616260163|FG004|Overall Study|Adverse Event|0|||
170522779|NCT02631941|616260164|FG005|Overall Study|Adverse Event|0|||
170522780|NCT02631941|616260165|FG006|Overall Study|Adverse Event|0|||
170522781|NCT02631941|616260166|FG007|Overall Study|Adverse Event|0|||
170522782|NCT02631941|616260167|FG008|Overall Study|Adverse Event|0|||
170522783|NCT02631941|616260168|FG009|Overall Study|Adverse Event|0|||
170522784|NCT02631941|616260159|FG000|Overall Study|Withdrawal by Subject|0|||
170522785|NCT02631941|616260160|FG001|Overall Study|Withdrawal by Subject|0|||
170769432|NCT00723450|617160695|FG000|Open-Label Phase|Withdrawal by Subject|37|||
170769433|NCT00723450|617160696|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170769434|NCT00723450|617160697|FG002|Open-Label Phase|Withdrawal by Subject|0|||
170769435|NCT00723450|617160695|FG000|Randomized Phase|Adverse Event|0|||
170769436|NCT00723450|617160696|FG001|Randomized Phase|Adverse Event|26|||
170769437|NCT00723450|617160697|FG002|Randomized Phase|Adverse Event|17|||
170769438|NCT00723450|617160695|FG000|Randomized Phase|Lack of Efficacy|0|||
170769439|NCT00723450|617160696|FG001|Randomized Phase|Lack of Efficacy|11|||
170769440|NCT00723450|617160697|FG002|Randomized Phase|Lack of Efficacy|11|||
170769441|NCT00723450|617160695|FG000|Randomized Phase|Protocol Violation|0|||
170769442|NCT00723450|617160696|FG001|Randomized Phase|Protocol Violation|9|||
170769443|NCT00723450|617160697|FG002|Randomized Phase|Protocol Violation|13|||
170769444|NCT00723450|617160695|FG000|Randomized Phase|Lost to Follow-up|0|||
170769445|NCT00723450|617160696|FG001|Randomized Phase|Lost to Follow-up|2|||
170769446|NCT00723450|617160697|FG002|Randomized Phase|Lost to Follow-up|3|||
170769447|NCT00723450|617160695|FG000|Randomized Phase|Physician Decision|0|||
170769448|NCT00723450|617160696|FG001|Randomized Phase|Physician Decision|3|||
170769449|NCT00723450|617160697|FG002|Randomized Phase|Physician Decision|1|||
170769450|NCT00723450|617160695|FG000|Randomized Phase|Withdrawal by Subject|0|||
170769451|NCT00723450|617160696|FG001|Randomized Phase|Withdrawal by Subject|14|||
170769452|NCT00723450|617160697|FG002|Randomized Phase|Withdrawal by Subject|22|||
170769453|NCT00117286|617160698|FG000|Overall Study|Adverse Event|12|||
170769454|NCT00117286|617160699|FG001|Overall Study|Adverse Event|6|||
170769455|NCT00117286|617160698|FG000|Overall Study|Lost to Follow-up|2|||
170769456|NCT00117286|617160699|FG001|Overall Study|Lost to Follow-up|0|||
170769457|NCT00117286|617160698|FG000|Overall Study|Protocol Violation|3|||
170769458|NCT00117286|617160699|FG001|Overall Study|Protocol Violation|3|||
170769459|NCT00117286|617160698|FG000|Overall Study|Withdrawal by Subject|6|||
170769460|NCT00117286|617160699|FG001|Overall Study|Withdrawal by Subject|2|||
170769461|NCT00117286|617160698|FG000|Overall Study|Physician Decision|3|||
170769462|NCT00117286|617160699|FG001|Overall Study|Physician Decision|7|||
170769463|NCT00117286|617160698|FG000|Overall Study|Lack of Efficacy|2|||
170769464|NCT00117286|617160699|FG001|Overall Study|Lack of Efficacy|1|||
170769465|NCT00117286|617160698|FG000|Overall Study|Research site closing|0|||
170769466|NCT00117286|617160699|FG001|Overall Study|Research site closing|2|||
170769467|NCT02045836|617160710|FG000|Overall Study|Adverse Event|4|||
170769468|NCT02045836|617160711|FG001|Overall Study|Adverse Event|4|||
170769469|NCT02045836|617160710|FG000|Overall Study|Withdrawal by Subject|1|||
170769470|NCT02045836|617160711|FG001|Overall Study|Withdrawal by Subject|1|||
170769471|NCT02045836|617160710|FG000|Overall Study|Lost to Follow-up|4|||
170769472|NCT02045836|617160711|FG001|Overall Study|Lost to Follow-up|7|||
170769473|NCT02045836|617160710|FG000|Overall Study|Migrated from study area|0|||
170769474|NCT02045836|617160711|FG001|Overall Study|Migrated from study area|2|||
170769475|NCT03920215|617160712|FG000|Overall Study|Lost to Follow-up|1|||
170769476|NCT03920215|617160713|FG001|Overall Study|Lost to Follow-up|2|||
170769477|NCT03920215|617160714|FG002|Overall Study|Lost to Follow-up|0|||
170769478|NCT03920215|617160715|FG003|Overall Study|Lost to Follow-up|0|||
170769479|NCT03920215|617160712|FG000|Overall Study|Death|0|||
170769480|NCT03920215|617160713|FG001|Overall Study|Death|0|||
170769481|NCT03920215|617160714|FG002|Overall Study|Death|0|||
170522786|NCT02631941|616260161|FG002|Overall Study|Withdrawal by Subject|0|||
170522787|NCT02631941|616260162|FG003|Overall Study|Withdrawal by Subject|0|||
170522788|NCT02631941|616260163|FG004|Overall Study|Withdrawal by Subject|1|||
170769482|NCT03920215|617160715|FG003|Overall Study|Death|1|||
170871445|NCT00467779|617541578|FG006|Stage 2A|Withdrawal by Subject|0|||
170522789|NCT02631941|616260164|FG005|Overall Study|Withdrawal by Subject|0|||
170769483|NCT02425111|617160716|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
170769484|NCT02425111|617160716|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
170769485|NCT02425111|617160716|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
170769486|NCT02425111|617160716|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
170871446|NCT00467779|617541579|FG007|Stage 2A|Withdrawal by Subject|0|||
170769487|NCT02425111|617160716|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
170769488|NCT02425111|617160716|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
170769489|NCT00585533|617160717|FG000|Overall Study|objective or symptomatic progression|9|||
170769490|NCT02547922|617160718|FG000|Overall Study|Withdrawal by Subject|9|||
170769491|NCT02547922|617160719|FG001|Overall Study|Withdrawal by Subject|6|||
170769492|NCT02547922|617160720|FG002|Overall Study|Withdrawal by Subject|10|||
170769493|NCT02547922|617160718|FG000|Overall Study|Adverse Event|3|||
170769494|NCT02547922|617160719|FG001|Overall Study|Adverse Event|1|||
170769495|NCT02547922|617160720|FG002|Overall Study|Adverse Event|2|||
170769496|NCT02547922|617160718|FG000|Overall Study|Lost to Follow-up|1|||
170769497|NCT02547922|617160719|FG001|Overall Study|Lost to Follow-up|0|||
170769498|NCT02547922|617160720|FG002|Overall Study|Lost to Follow-up|0|||
170769499|NCT02547922|617160718|FG000|Overall Study|Lack of Efficacy|5|||
170769500|NCT02547922|617160719|FG001|Overall Study|Lack of Efficacy|7|||
170769501|NCT02547922|617160720|FG002|Overall Study|Lack of Efficacy|4|||
170769502|NCT02547922|617160718|FG000|Overall Study|Death|1|||
170769503|NCT02547922|617160719|FG001|Overall Study|Death|0|||
170769504|NCT02547922|617160720|FG002|Overall Study|Death|0|||
170769505|NCT02547922|617160718|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
170769506|NCT02547922|617160719|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
170769507|NCT02547922|617160720|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
170769508|NCT02547922|617160718|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
170769509|NCT02547922|617160719|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
170769510|NCT02547922|617160720|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
170769511|NCT02547922|617160718|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
170769512|NCT02547922|617160719|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
170769513|NCT02547922|617160720|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
170769514|NCT02547922|617160718|FG000|Overall Study|Physician Decision|2|||
170769515|NCT02547922|617160719|FG001|Overall Study|Physician Decision|1|||
170769516|NCT02547922|617160720|FG002|Overall Study|Physician Decision|2|||
170769517|NCT02547922|617160718|FG000|Overall Study|Patients did not receive IP|1|||
170769518|NCT02547922|617160719|FG001|Overall Study|Patients did not receive IP|1|||
170769519|NCT02547922|617160720|FG002|Overall Study|Patients did not receive IP|0|||
170769520|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
170769521|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
170769522|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
170769523|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
170769524|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
170769525|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
170769526|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
170769527|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
170769528|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
170769529|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
170769530|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
170769531|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
170769532|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
170769533|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
170769534|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
170769535|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
170769536|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
170769537|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
170769538|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
170769539|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
170769540|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
170769541|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
170769542|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
170769543|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
170769544|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
170769545|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
170769546|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
170769547|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
170769548|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
170769549|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
170769550|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
170769551|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
170871447|NCT00467779|617541580|FG008|Stage 2A|Withdrawal by Subject|0|||
170871448|NCT00467779|617541581|FG009|Stage 2A|Withdrawal by Subject|0|||
170769552|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
170871449|NCT00467779|617541582|FG010|Stage 2A|Withdrawal by Subject|0|||
170871450|NCT00467779|617541583|FG011|Stage 2A|Withdrawal by Subject|0|||
170522790|NCT02631941|616260165|FG006|Overall Study|Withdrawal by Subject|0|||
170522791|NCT02631941|616260166|FG007|Overall Study|Withdrawal by Subject|1|||
170522792|NCT02631941|616260167|FG008|Overall Study|Withdrawal by Subject|0|||
170522793|NCT02631941|616260168|FG009|Overall Study|Withdrawal by Subject|0|||
170522794|NCT02631941|616260159|FG000|Overall Study|Lost to Follow-up|0|||
170522795|NCT02631941|616260160|FG001|Overall Study|Lost to Follow-up|0|||
170522796|NCT02631941|616260161|FG002|Overall Study|Lost to Follow-up|0|||
170522797|NCT02631941|616260162|FG003|Overall Study|Lost to Follow-up|0|||
170522798|NCT02631941|616260163|FG004|Overall Study|Lost to Follow-up|0|||
170522799|NCT02631941|616260164|FG005|Overall Study|Lost to Follow-up|0|||
170522800|NCT02631941|616260165|FG006|Overall Study|Lost to Follow-up|0|||
170522801|NCT02631941|616260166|FG007|Overall Study|Lost to Follow-up|0|||
170522802|NCT02631941|616260167|FG008|Overall Study|Lost to Follow-up|1|||
170522803|NCT02631941|616260168|FG009|Overall Study|Lost to Follow-up|0|||
170522804|NCT03933449|616260169|FG000|Overall Study|Adverse Event|6|||
170522805|NCT03933449|616260170|FG001|Overall Study|Adverse Event|4|||
170522806|NCT03933449|616260169|FG000|Overall Study|Death|55|||
170522807|NCT03933449|616260170|FG001|Overall Study|Death|57|||
170522808|NCT03933449|616260169|FG000|Overall Study|Sponsor Decision|1|||
170522809|NCT03933449|616260170|FG001|Overall Study|Sponsor Decision|0|||
170522810|NCT02087774|616260171|FG000|Overall Study|Were absent day of data collection|8|||
170522811|NCT02087774|616260172|FG001|Overall Study|Were absent day of data collection|20|||
170522812|NCT00719901|616260173|FG000|Overall Study|Adverse Event|5|||
170522813|NCT00719901|616260173|FG000|Overall Study|Withdrawal by Subject|1|||
170522814|NCT00719901|616260173|FG000|Overall Study|Alternate Treatment|1|||
170522815|NCT00719901|616260173|FG000|Overall Study|Disease Progression|3|||
170522816|NCT00719901|616260173|FG000|Overall Study|Availability of Study Drug|1|||
170522817|NCT04456686|616260174|FG000|Overall Study|Adverse Event|2|||
170522818|NCT04456686|616260175|FG001|Overall Study|Adverse Event|1|||
170522819|NCT04456686|616260174|FG000|Overall Study|Lack of Efficacy|3|||
170522820|NCT04456686|616260175|FG001|Overall Study|Lack of Efficacy|1|||
170522821|NCT04456686|616260174|FG000|Overall Study|Withdrew consent|3|||
170522822|NCT04456686|616260175|FG001|Overall Study|Withdrew consent|1|||
170522823|NCT04456686|616260174|FG000|Overall Study|Physician Decision|2|||
170522824|NCT04456686|616260175|FG001|Overall Study|Physician Decision|2|||
170522825|NCT04456686|616260174|FG000|Overall Study|Withdrawal by Subject|5|||
170522826|NCT04456686|616260175|FG001|Overall Study|Withdrawal by Subject|1|||
170522827|NCT04456686|616260174|FG000|Overall Study|Protocol Violation|0|||
170522828|NCT04456686|616260175|FG001|Overall Study|Protocol Violation|1|||
170522829|NCT00243919|616260176|FG000|Overall Study|Death|3|||
170769553|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
170769554|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
170769555|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
170769556|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
170769557|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
170769558|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
170769559|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
170769560|NCT02709655|617160721|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
170769561|NCT02709655|617160722|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
170769562|NCT02709655|617160723|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
170769563|NCT02709655|617160724|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
170769564|NCT02709655|617160725|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
170769565|NCT02709655|617160721|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
170769566|NCT02709655|617160722|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
170769567|NCT02709655|617160723|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
170769568|NCT02709655|617160724|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
170769569|NCT02709655|617160725|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
170769570|NCT02709655|617160721|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
170769571|NCT02709655|617160722|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
170522830|NCT00243919|616260177|FG001|Overall Study|Death|4|||
170522831|NCT00243919|616260178|FG002|Overall Study|Death|6|||
170522832|NCT00243919|616260176|FG000|Overall Study|Withdrawal by Subject|6|||
170769572|NCT02709655|617160723|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
170522833|NCT00243919|616260177|FG001|Overall Study|Withdrawal by Subject|6|||
170522834|NCT00243919|616260178|FG002|Overall Study|Withdrawal by Subject|2|||
170522835|NCT00243919|616260176|FG000|Overall Study|Lost to Follow-up|6|||
170522836|NCT00243919|616260177|FG001|Overall Study|Lost to Follow-up|7|||
170522837|NCT00243919|616260178|FG002|Overall Study|Lost to Follow-up|3|||
170522838|NCT00243919|616260176|FG000|Overall Study|Administrative Error|1|||
170522839|NCT00243919|616260177|FG001|Overall Study|Administrative Error|0|||
170522840|NCT00243919|616260178|FG002|Overall Study|Administrative Error|0|||
170522841|NCT00243919|616260176|FG000|Overall Study|Physician Decision|1|||
170769573|NCT02709655|617160724|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
170522842|NCT00243919|616260177|FG001|Overall Study|Physician Decision|1|||
170769574|NCT02709655|617160725|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
170871451|NCT00467779|617541584|FG012|Stage 2A|Withdrawal by Subject|0|||
170769575|NCT02709655|617160721|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
170769576|NCT02709655|617160722|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
170769577|NCT02709655|617160723|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
170769578|NCT02709655|617160724|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
170769579|NCT02709655|617160725|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
170769580|NCT02709655|617160721|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
170769581|NCT02709655|617160722|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
170769582|NCT02709655|617160723|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
170769583|NCT02709655|617160724|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
170769584|NCT02709655|617160725|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
170769585|NCT02709655|617160721|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
170769586|NCT02709655|617160722|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
170769587|NCT02709655|617160723|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
170769588|NCT02709655|617160724|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
170769589|NCT02709655|617160725|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
170769590|NCT02709655|617160721|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
170769591|NCT02709655|617160722|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
170769592|NCT02709655|617160723|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
170769593|NCT02709655|617160724|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
170769594|NCT02709655|617160725|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
170769595|NCT02709655|617160721|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
170769596|NCT02709655|617160722|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
170769597|NCT02709655|617160723|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
170769598|NCT02709655|617160724|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
170769599|NCT02709655|617160725|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
170769600|NCT00843882|617160728|FG000|Step 1|Lack of Efficacy|14|||
170769601|NCT00843882|617160729|FG001|Step 1|Lack of Efficacy|10|||
170769602|NCT00843882|617160730|FG002|Step 1|Lack of Efficacy|21|||
170769603|NCT00843882|617160728|FG000|Step 1|Adverse Event|8|||
170769604|NCT00843882|617160729|FG001|Step 1|Adverse Event|17|||
170769605|NCT00843882|617160730|FG002|Step 1|Adverse Event|20|||
170769606|NCT00843882|617160728|FG000|Step 1|Death|1|||
170769607|NCT00843882|617160729|FG001|Step 1|Death|2|||
170769608|NCT00843882|617160730|FG002|Step 1|Death|4|||
170769609|NCT00843882|617160728|FG000|Step 1|Withdrawal by Subject|6|||
170769610|NCT00843882|617160729|FG001|Step 1|Withdrawal by Subject|12|||
170769611|NCT00843882|617160730|FG002|Step 1|Withdrawal by Subject|9|||
170769612|NCT00843882|617160728|FG000|Step 1|Physician Decision|0|||
170769613|NCT00843882|617160729|FG001|Step 1|Physician Decision|5|||
170769614|NCT00843882|617160730|FG002|Step 1|Physician Decision|1|||
170769615|NCT00843882|617160728|FG000|Step 1|Patient and physician's decision|0|||
170769616|NCT00843882|617160729|FG001|Step 1|Patient and physician's decision|0|||
170769617|NCT00843882|617160730|FG002|Step 1|Patient and physician's decision|1|||
170769618|NCT00843882|617160728|FG000|Step 1|Other complicating disease|1|||
170769619|NCT00843882|617160729|FG001|Step 1|Other complicating disease|3|||
170769620|NCT00843882|617160730|FG002|Step 1|Other complicating disease|4|||
170769621|NCT00843882|617160728|FG000|Step 1|Alternative therapy|0|||
170769622|NCT00843882|617160729|FG001|Step 1|Alternative therapy|1|||
170769623|NCT00843882|617160730|FG002|Step 1|Alternative therapy|1|||
170412596|NCT00135707|615850416|FG000|Overall Study|Institutional review board request|1|||
170412597|NCT00135707|615850417|FG001|Overall Study|Institutional review board request|0|||
170412598|NCT00576901|615850421|FG000|Overall Study|Withdrawal by Subject|1|||
170412599|NCT00576901|615850421|FG000|Overall Study|Disease course|1|||
170412600|NCT00576901|615850421|FG000|Overall Study|Protocol Violation|1|||
170412601|NCT00812253|615850422|FG000|Overall Study|Withdrawal by Subject|3|||
170412602|NCT00812253|615850423|FG001|Overall Study|Withdrawal by Subject|2|||
170412603|NCT00812253|615850422|FG000|Overall Study|Protocol Violation|1|||
170412604|NCT00812253|615850423|FG001|Overall Study|Protocol Violation|1|||
170412605|NCT00812253|615850422|FG000|Overall Study|Lost to Follow-up|2|||
170412606|NCT00812253|615850423|FG001|Overall Study|Lost to Follow-up|0|||
170412607|NCT03361423|615850429|FG000|Overall Study|Withdrawal by Subject|4|||
170412608|NCT03361423|615850430|FG001|Overall Study|Withdrawal by Subject|3|||
170769624|NCT00843882|617160728|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
170769625|NCT00843882|617160729|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
170412609|NCT03361423|615850429|FG000|Overall Study|Did not treat|19|||
170412610|NCT03361423|615850430|FG001|Overall Study|Did not treat|18|||
170412611|NCT03361423|615850429|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
170412612|NCT03361423|615850430|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
170769626|NCT00843882|617160730|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
170412613|NCT03361423|615850429|FG000|Overall Study|Missing data|4|||
170769627|NCT00843882|617160728|FG000|Step 1|Off treatment reason unknown|0|||
170769628|NCT00843882|617160729|FG001|Step 1|Off treatment reason unknown|1|||
170769629|NCT00843882|617160730|FG002|Step 1|Off treatment reason unknown|4|||
170769630|NCT00843882|617160728|FG000|Step 1|Never started treatment|2|||
170769631|NCT00843882|617160729|FG001|Step 1|Never started treatment|0|||
170871452|NCT00467779|617541585|FG013|Stage 2A|Withdrawal by Subject|1|||
170871453|NCT00467779|617541586|FG014|Stage 2A|Withdrawal by Subject|0|||
170871454|NCT00467779|617541572|FG000|Stage 3|Adverse Event|0|||
170871455|NCT00467779|617541573|FG001|Stage 3|Adverse Event|0|||
170871456|NCT00467779|617541574|FG002|Stage 3|Adverse Event|0|||
170871457|NCT00467779|617541575|FG003|Stage 3|Adverse Event|0|||
170871458|NCT00467779|617541576|FG004|Stage 3|Adverse Event|0|||
170871459|NCT00467779|617541577|FG005|Stage 3|Adverse Event|0|||
170871460|NCT00467779|617541578|FG006|Stage 3|Adverse Event|0|||
170871461|NCT00467779|617541579|FG007|Stage 3|Adverse Event|0|||
170871462|NCT00467779|617541580|FG008|Stage 3|Adverse Event|0|||
170871463|NCT00467779|617541581|FG009|Stage 3|Adverse Event|0|||
170871464|NCT00467779|617541582|FG010|Stage 3|Adverse Event|0|||
170871465|NCT00467779|617541583|FG011|Stage 3|Adverse Event|0|||
170871466|NCT00467779|617541584|FG012|Stage 3|Adverse Event|0|||
170871467|NCT00467779|617541585|FG013|Stage 3|Adverse Event|0|||
170871468|NCT00467779|617541586|FG014|Stage 3|Adverse Event|2|||
170871469|NCT00467779|617541572|FG000|Stage 3|Death|0|||
170871470|NCT00467779|617541573|FG001|Stage 3|Death|0|||
170871471|NCT00467779|617541574|FG002|Stage 3|Death|0|||
170871472|NCT00467779|617541575|FG003|Stage 3|Death|0|||
170871473|NCT00467779|617541576|FG004|Stage 3|Death|0|||
170871474|NCT00467779|617541577|FG005|Stage 3|Death|0|||
170871475|NCT00467779|617541578|FG006|Stage 3|Death|0|||
170871476|NCT00467779|617541579|FG007|Stage 3|Death|0|||
170871477|NCT00467779|617541580|FG008|Stage 3|Death|0|||
170871478|NCT00467779|617541581|FG009|Stage 3|Death|0|||
170871479|NCT00467779|617541582|FG010|Stage 3|Death|0|||
170871480|NCT00467779|617541583|FG011|Stage 3|Death|0|||
170871481|NCT00467779|617541584|FG012|Stage 3|Death|0|||
170871482|NCT00467779|617541585|FG013|Stage 3|Death|0|||
170871483|NCT00467779|617541586|FG014|Stage 3|Death|1|||
170871484|NCT00467779|617541572|FG000|Stage 3|Disease Progression|0|||
170871485|NCT00467779|617541573|FG001|Stage 3|Disease Progression|0|||
170871486|NCT00467779|617541574|FG002|Stage 3|Disease Progression|0|||
170871487|NCT00467779|617541575|FG003|Stage 3|Disease Progression|0|||
170871488|NCT00467779|617541576|FG004|Stage 3|Disease Progression|0|||
170871489|NCT00467779|617541577|FG005|Stage 3|Disease Progression|0|||
170871490|NCT00467779|617541578|FG006|Stage 3|Disease Progression|0|||
170871491|NCT00467779|617541579|FG007|Stage 3|Disease Progression|0|||
170871492|NCT00467779|617541580|FG008|Stage 3|Disease Progression|0|||
170871493|NCT00467779|617541581|FG009|Stage 3|Disease Progression|0|||
170871494|NCT00467779|617541582|FG010|Stage 3|Disease Progression|0|||
170871495|NCT00467779|617541583|FG011|Stage 3|Disease Progression|0|||
170871496|NCT00467779|617541584|FG012|Stage 3|Disease Progression|0|||
170871497|NCT00467779|617541585|FG013|Stage 3|Disease Progression|0|||
170871498|NCT00467779|617541586|FG014|Stage 3|Disease Progression|9|||
170871499|NCT00467779|617541572|FG000|Stage 3|Unspecified Reason|0|||
170871500|NCT00467779|617541573|FG001|Stage 3|Unspecified Reason|0|||
170871501|NCT00467779|617541574|FG002|Stage 3|Unspecified Reason|0|||
170871502|NCT00467779|617541575|FG003|Stage 3|Unspecified Reason|0|||
170871503|NCT00467779|617541576|FG004|Stage 3|Unspecified Reason|0|||
170871504|NCT00467779|617541577|FG005|Stage 3|Unspecified Reason|0|||
170871505|NCT00467779|617541578|FG006|Stage 3|Unspecified Reason|0|||
170871506|NCT00467779|617541579|FG007|Stage 3|Unspecified Reason|0|||
170871507|NCT00467779|617541580|FG008|Stage 3|Unspecified Reason|0|||
170522843|NCT00243919|616260178|FG002|Overall Study|Physician Decision|0|||
170522844|NCT02059239|616260179|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
170522845|NCT02059239|616260180|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
170522846|NCT02059239|616260179|FG000|Overall Study|Physician Decision|1|||
170522847|NCT02059239|616260180|FG001|Overall Study|Physician Decision|0|||
170871508|NCT00467779|617541581|FG009|Stage 3|Unspecified Reason|0|||
170871509|NCT00467779|617541582|FG010|Stage 3|Unspecified Reason|0|||
170871510|NCT00467779|617541583|FG011|Stage 3|Unspecified Reason|0|||
170871511|NCT00467779|617541584|FG012|Stage 3|Unspecified Reason|0|||
170871512|NCT00467779|617541585|FG013|Stage 3|Unspecified Reason|0|||
170871513|NCT00467779|617541586|FG014|Stage 3|Unspecified Reason|5|||
170871514|NCT01509079|617541587|FG000|Overall Study|Lack of Efficacy|0|||
170871515|NCT01509079|617541588|FG001|Overall Study|Lack of Efficacy|2|||
170871516|NCT01509079|617541587|FG000|Overall Study|started an excluded medication|0|||
170871517|NCT01509079|617541588|FG001|Overall Study|started an excluded medication|1|||
170871518|NCT05111041|617541591|FG000|Overall Study|Lost to Follow-up|6|||
170522848|NCT01268267|616260181|FG000|Overall Study|Protocol Violation|1|||
170871519|NCT05111041|617541592|FG001|Overall Study|Lost to Follow-up|7|||
170871520|NCT05111041|617541591|FG000|Overall Study|Withdrawal by Subject|1|||
170871521|NCT05111041|617541592|FG001|Overall Study|Withdrawal by Subject|0|||
170871522|NCT01179672|617541593|FG000|Overall Study|Adverse Event|17|||
170871523|NCT01179672|617541594|FG001|Overall Study|Adverse Event|8|||
170871524|NCT01179672|617541593|FG000|Overall Study|Withdrawal by Subject|10|||
170871525|NCT01179672|617541594|FG001|Overall Study|Withdrawal by Subject|12|||
170871526|NCT01179672|617541593|FG000|Overall Study|Entry Criteria Not Met|0|||
170871527|NCT01179672|617541594|FG001|Overall Study|Entry Criteria Not Met|2|||
170871528|NCT01179672|617541593|FG000|Overall Study|Lost to Follow-up|0|||
170871529|NCT01179672|617541594|FG001|Overall Study|Lost to Follow-up|1|||
170871530|NCT01179672|617541593|FG000|Overall Study|Protocol Violation|2|||
170871531|NCT01179672|617541594|FG001|Overall Study|Protocol Violation|2|||
170871532|NCT01179672|617541593|FG000|Overall Study|Physician Decision|1|||
170412614|NCT03361423|615850430|FG001|Overall Study|Missing data|1|||
170412615|NCT01336894|615850431|FG000|Follow-up|Study terminated prematurely|2|||
170769632|NCT00843882|617160730|FG002|Step 1|Never started treatment|0|||
170769633|NCT00843882|617160728|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
170769634|NCT00843882|617160729|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
170769635|NCT00843882|617160730|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
170769636|NCT00843882|617160728|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
170769637|NCT00843882|617160729|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
170769638|NCT00843882|617160730|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
170769639|NCT00843882|617160728|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
170769640|NCT00843882|617160729|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
170769641|NCT00843882|617160730|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
170769642|NCT00843882|617160728|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
170769643|NCT00843882|617160729|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
170769644|NCT00843882|617160730|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
170769645|NCT00843882|617160728|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
170769646|NCT00843882|617160729|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
170769647|NCT00843882|617160730|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
170769648|NCT00843882|617160728|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
170769649|NCT00843882|617160729|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
170769650|NCT00843882|617160730|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
170769651|NCT00843882|617160728|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
170769652|NCT00843882|617160729|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
170769653|NCT00843882|617160730|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
170769654|NCT02248480|617160731|FG000|Overall Study|Lack of Efficacy|4|||
170769655|NCT02248480|617160732|FG001|Overall Study|Lack of Efficacy|6|||
170769656|NCT02248480|617160731|FG000|Overall Study|Adverse Event|11|||
170769657|NCT02248480|617160732|FG001|Overall Study|Adverse Event|2|||
170769658|NCT02248480|617160731|FG000|Overall Study|Withdrawal by Subject|2|||
170769659|NCT02248480|617160732|FG001|Overall Study|Withdrawal by Subject|4|||
170769660|NCT02248480|617160731|FG000|Overall Study|Entry Criteria Not Met|0|||
170769661|NCT02248480|617160732|FG001|Overall Study|Entry Criteria Not Met|1|||
170769662|NCT02248480|617160731|FG000|Overall Study|Other:Physician Decision|0|||
170769663|NCT02248480|617160732|FG001|Overall Study|Other:Physician Decision|1|||
170769664|NCT00630786|617160733|FG000|Overall Study|Physician Decision|0|||
170769665|NCT00630786|617160734|FG001|Overall Study|Physician Decision|0|||
170769666|NCT00630786|617160735|FG002|Overall Study|Physician Decision|1|||
170769667|NCT00630786|617160733|FG000|Overall Study|Withdrawal by Subject|0|||
170769668|NCT00630786|617160734|FG001|Overall Study|Withdrawal by Subject|1|||
170769669|NCT00630786|617160735|FG002|Overall Study|Withdrawal by Subject|1|||
170769670|NCT00630786|617160733|FG000|Overall Study|Lost to Follow-up|0|||
170769671|NCT00630786|617160734|FG001|Overall Study|Lost to Follow-up|1|||
170769672|NCT00630786|617160735|FG002|Overall Study|Lost to Follow-up|0|||
170769673|NCT00630786|617160733|FG000|Overall Study|Other|1|||
170769674|NCT00630786|617160734|FG001|Overall Study|Other|0|||
170769675|NCT00630786|617160735|FG002|Overall Study|Other|0|||
170769676|NCT01837641|617160736|FG000|Overall Study|Sponsor decision|1|||
170769677|NCT01837641|617160737|FG001|Overall Study|Sponsor decision|0|||
170769678|NCT01837641|617160738|FG002|Overall Study|Sponsor decision|0|||
170769679|NCT01837641|617160739|FG003|Overall Study|Sponsor decision|0|||
170769680|NCT01837641|617160740|FG004|Overall Study|Sponsor decision|0|||
170769681|NCT01837641|617160741|FG005|Overall Study|Sponsor decision|1|||
170769682|NCT01837641|617160742|FG006|Overall Study|Sponsor decision|0|||
170769683|NCT01837641|617160743|FG007|Overall Study|Sponsor decision|0|||
170769684|NCT01837641|617160736|FG000|Overall Study|Adverse Event|0|||
170769685|NCT01837641|617160737|FG001|Overall Study|Adverse Event|0|||
170769686|NCT01837641|617160738|FG002|Overall Study|Adverse Event|0|||
170769687|NCT01837641|617160739|FG003|Overall Study|Adverse Event|0|||
170769688|NCT01837641|617160740|FG004|Overall Study|Adverse Event|0|||
170769689|NCT01837641|617160741|FG005|Overall Study|Adverse Event|1|||
170769690|NCT01837641|617160742|FG006|Overall Study|Adverse Event|0|||
170769691|NCT01837641|617160743|FG007|Overall Study|Adverse Event|0|||
170769692|NCT01837641|617160736|FG000|Overall Study|Withdrawal by Subject|0|||
170412616|NCT01336894|615850432|FG001|Follow-up|Study terminated prematurely|7|||
170412617|NCT00622908|615850433|FG000|Overall Study|Protocol Violation|1|||
170412618|NCT00622908|615850434|FG001|Overall Study|Protocol Violation|0|||
170412619|NCT00622908|615850433|FG000|Overall Study|Adverse Event|0|||
170412620|NCT00622908|615850434|FG001|Overall Study|Adverse Event|1|||
170769693|NCT01837641|617160737|FG001|Overall Study|Withdrawal by Subject|0|||
170769694|NCT01837641|617160738|FG002|Overall Study|Withdrawal by Subject|0|||
170769695|NCT01837641|617160739|FG003|Overall Study|Withdrawal by Subject|0|||
170769696|NCT01837641|617160740|FG004|Overall Study|Withdrawal by Subject|1|||
170769697|NCT01837641|617160741|FG005|Overall Study|Withdrawal by Subject|0|||
170522849|NCT01418339|616260182|FG000|Overall Study|Adverse Event|5|||
170522850|NCT01418339|616260183|FG001|Overall Study|Adverse Event|2|||
170522851|NCT01418339|616260182|FG000|Overall Study|Subject Withdrew Consent|1|||
170522852|NCT01418339|616260183|FG001|Overall Study|Subject Withdrew Consent|2|||
170522853|NCT01418339|616260182|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
170522854|NCT01418339|616260183|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
170522855|NCT02219685|616260184|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
170522856|NCT02219685|616260185|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
170522857|NCT02219685|616260184|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
170522858|NCT02219685|616260185|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
170522859|NCT00230048|616260186|FG000|Overall Study|Lost to Follow-up|13|||
170522860|NCT00230048|616260187|FG001|Overall Study|Lost to Follow-up|18|||
170522861|NCT00297648|616260188|FG000|Overall Study|Adverse Event|13|||
170522862|NCT00297648|616260188|FG000|Overall Study|Lack of Efficacy|18|||
170522863|NCT00297648|616260188|FG000|Overall Study|Lost to Follow-up|1|||
170522864|NCT00297648|616260188|FG000|Overall Study|Withdrawal by Subject|3|||
170522865|NCT00297648|616260188|FG000|Overall Study|Other: Incompliance|1|||
170522866|NCT01529606|616260189|FG000|Overall Study|Lost to Follow-up|21|||
170522867|NCT01529606|616260190|FG001|Overall Study|Lost to Follow-up|18|||
170522868|NCT01746862|616260191|FG000|Overall Study|Withdrawal by Subject|1|||
170522869|NCT01746862|616260192|FG001|Overall Study|Withdrawal by Subject|1|||
170769698|NCT01837641|617160742|FG006|Overall Study|Withdrawal by Subject|1|||
170769699|NCT01837641|617160743|FG007|Overall Study|Withdrawal by Subject|0|||
170769700|NCT02551055|617160744|FG000|Overall Study|Death|2|||
170769701|NCT02551055|617160745|FG001|Overall Study|Death|4|||
170769702|NCT02551055|617160746|FG002|Overall Study|Death|2|||
170769703|NCT02551055|617160747|FG003|Overall Study|Death|2|||
170769704|NCT02551055|617160748|FG004|Overall Study|Death|2|||
170769705|NCT02551055|617160749|FG005|Overall Study|Death|1|||
170769706|NCT02551055|617160750|FG006|Overall Study|Death|2|||
170769707|NCT02551055|617160751|FG007|Overall Study|Death|0|||
170769708|NCT02551055|617160744|FG000|Overall Study|Study Terminated by Sponsor|1|||
170769709|NCT02551055|617160745|FG001|Overall Study|Study Terminated by Sponsor|1|||
170769710|NCT02551055|617160746|FG002|Overall Study|Study Terminated by Sponsor|0|||
170769711|NCT02551055|617160747|FG003|Overall Study|Study Terminated by Sponsor|2|||
170769712|NCT02551055|617160748|FG004|Overall Study|Study Terminated by Sponsor|2|||
170769713|NCT02551055|617160749|FG005|Overall Study|Study Terminated by Sponsor|0|||
170769714|NCT02551055|617160750|FG006|Overall Study|Study Terminated by Sponsor|0|||
170769715|NCT02551055|617160751|FG007|Overall Study|Study Terminated by Sponsor|0|||
170769716|NCT02551055|617160744|FG000|Overall Study|Withdrawal by Subject|1|||
170769717|NCT02551055|617160745|FG001|Overall Study|Withdrawal by Subject|1|||
170769718|NCT02551055|617160746|FG002|Overall Study|Withdrawal by Subject|0|||
170769719|NCT02551055|617160747|FG003|Overall Study|Withdrawal by Subject|1|||
170769720|NCT02551055|617160748|FG004|Overall Study|Withdrawal by Subject|2|||
170769721|NCT02551055|617160749|FG005|Overall Study|Withdrawal by Subject|0|||
170769722|NCT02551055|617160750|FG006|Overall Study|Withdrawal by Subject|0|||
170769723|NCT02551055|617160751|FG007|Overall Study|Withdrawal by Subject|0|||
170769724|NCT02551055|617160744|FG000|Overall Study|Reason not specified|0|||
170769725|NCT02551055|617160745|FG001|Overall Study|Reason not specified|0|||
170769726|NCT02551055|617160746|FG002|Overall Study|Reason not specified|0|||
170769727|NCT02551055|617160747|FG003|Overall Study|Reason not specified|0|||
170769728|NCT02551055|617160748|FG004|Overall Study|Reason not specified|1|||
170769729|NCT02551055|617160749|FG005|Overall Study|Reason not specified|0|||
170769730|NCT02551055|617160750|FG006|Overall Study|Reason not specified|1|||
170769731|NCT02551055|617160751|FG007|Overall Study|Reason not specified|0|||
170769732|NCT01713946|617160752|FG000|Overall Study|Death|0|||
170769733|NCT01713946|617160753|FG001|Overall Study|Death|2|||
170769734|NCT01713946|617160754|FG002|Overall Study|Death|2|||
170769735|NCT01713946|617160752|FG000|Overall Study|Adverse Event|19|||
170769736|NCT01713946|617160753|FG001|Overall Study|Adverse Event|14|||
170769737|NCT01713946|617160754|FG002|Overall Study|Adverse Event|13|||
170769738|NCT01713946|617160752|FG000|Overall Study|Withdrawal by Subject|12|||
170769739|NCT01713946|617160753|FG001|Overall Study|Withdrawal by Subject|12|||
170522870|NCT01746862|616260191|FG000|Overall Study|Protocol Violation|1|||
170522871|NCT01746862|616260192|FG001|Overall Study|Protocol Violation|0|||
170522872|NCT01746862|616260191|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
170522873|NCT01746862|616260192|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
170522874|NCT01746862|616260191|FG000|Overall Study|Entered puberty during the study|1|||
170769740|NCT01713946|617160754|FG002|Overall Study|Withdrawal by Subject|8|||
170769741|NCT01713946|617160752|FG000|Overall Study|Lack of Efficacy|8|||
170769742|NCT01713946|617160753|FG001|Overall Study|Lack of Efficacy|8|||
170769743|NCT01713946|617160754|FG002|Overall Study|Lack of Efficacy|14|||
170522875|NCT01746862|616260192|FG001|Overall Study|Entered puberty during the study|0|||
170769744|NCT01713946|617160752|FG000|Overall Study|Protocol Violation|2|||
170769745|NCT01713946|617160753|FG001|Overall Study|Protocol Violation|4|||
170769746|NCT01713946|617160754|FG002|Overall Study|Protocol Violation|1|||
170769747|NCT01713946|617160752|FG000|Overall Study|Lost to Follow-up|0|||
170769748|NCT01713946|617160753|FG001|Overall Study|Lost to Follow-up|0|||
170769749|NCT01713946|617160754|FG002|Overall Study|Lost to Follow-up|1|||
170769750|NCT01713946|617160752|FG000|Overall Study|Administrative problems|1|||
170769751|NCT01713946|617160753|FG001|Overall Study|Administrative problems|0|||
170769752|NCT01713946|617160754|FG002|Overall Study|Administrative problems|0|||
170769753|NCT01713946|617160752|FG000|Overall Study|Did not continue in Ext|0|||
170769754|NCT01713946|617160753|FG001|Overall Study|Did not continue in Ext|3|||
170769755|NCT01713946|617160754|FG002|Overall Study|Did not continue in Ext|0|||
170769756|NCT01713946|617160752|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
170769757|NCT01713946|617160753|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
170769758|NCT01713946|617160754|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
170769759|NCT01713946|617160752|FG000|Overall Study|Patients never switched to everolimus|0|||
170769760|NCT01713946|617160753|FG001|Overall Study|Patients never switched to everolimus|0|||
170769761|NCT01713946|617160754|FG002|Overall Study|Patients never switched to everolimus|5|||
170769762|NCT05052983|617160755|FG000|Overall Study|Lack of Efficacy|3|||
170769763|NCT05052983|617160756|FG001|Overall Study|Lack of Efficacy|12|||
170769764|NCT05052983|617160755|FG000|Overall Study|Adverse Event|1|||
170769765|NCT05052983|617160756|FG001|Overall Study|Adverse Event|0|||
170769766|NCT04493242|617160757|FG000|Overall Study|Death|10|||
170769767|NCT04493242|617160758|FG001|Overall Study|Death|14|||
170769768|NCT04493242|617160759|FG002|Overall Study|Death|16|||
170769769|NCT04493242|617160757|FG000|Overall Study|Lost to Follow-up|1|||
170769770|NCT04493242|617160758|FG001|Overall Study|Lost to Follow-up|1|||
170769771|NCT04493242|617160759|FG002|Overall Study|Lost to Follow-up|0|||
170769772|NCT04493242|617160757|FG000|Overall Study|Withdrawal by Subject|1|||
170769773|NCT04493242|617160758|FG001|Overall Study|Withdrawal by Subject|0|||
170769774|NCT04493242|617160759|FG002|Overall Study|Withdrawal by Subject|0|||
170769775|NCT04493242|617160757|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
170769776|NCT04493242|617160758|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
170769777|NCT04493242|617160759|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
170769778|NCT04493242|617160757|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
170769779|NCT04493242|617160758|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
170769780|NCT04493242|617160759|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
170769781|NCT02544152|617162602|FG000|Overall Study|Adverse Event|0|||
170769782|NCT02544152|617162603|FG001|Overall Study|Adverse Event|4|||
170769783|NCT02544152|617162602|FG000|Overall Study|Withdrawal by Subject|0|||
170769784|NCT02544152|617162603|FG001|Overall Study|Withdrawal by Subject|3|||
170769785|NCT02544152|617162602|FG000|Overall Study|Other|1|||
170769786|NCT02544152|617162603|FG001|Overall Study|Other|0|||
170769787|NCT05876949|617162604|FG000|Overall Study|Withdrawal by Subject|1|||
170769788|NCT05876949|617162605|FG001|Overall Study|Withdrawal by Subject|3|||
170769789|NCT05876949|617162604|FG000|Overall Study|Physician Decision|0|||
170769790|NCT05876949|617162605|FG001|Overall Study|Physician Decision|2|||
170769791|NCT05876949|617162604|FG000|Overall Study|Death|0|||
170769792|NCT05876949|617162605|FG001|Overall Study|Death|1|||
170769793|NCT05764161|617162606|FG000|12-week DBVC Period|Lack of Efficacy|2|||
170769794|NCT05764161|617162607|FG001|12-week DBVC Period|Lack of Efficacy|1|||
170769795|NCT05764161|617162606|FG000|12-week DBVC Period|Lost to Follow-up|0|||
170769796|NCT05764161|617162607|FG001|12-week DBVC Period|Lost to Follow-up|2|||
170769797|NCT05764161|617162606|FG000|12-week DBVC Period|Protocol Violation|2|||
170769798|NCT05764161|617162607|FG001|12-week DBVC Period|Protocol Violation|4|||
170769799|NCT05764161|617162606|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
170769800|NCT05764161|617162607|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
170769801|NCT05764161|617162606|FG000|40-week OLE Period|Lack of Efficacy|0|||
170769802|NCT05764161|617162607|FG001|40-week OLE Period|Lack of Efficacy|1|||
170769803|NCT05764161|617162606|FG000|40-week OLE Period|Lost to Follow-up|1|||
170769804|NCT05764161|617162607|FG001|40-week OLE Period|Lost to Follow-up|4|||
170769805|NCT05764161|617162606|FG000|40-week OLE Period|Withdrawal by Subject|2|||
170769806|NCT05764161|617162607|FG001|40-week OLE Period|Withdrawal by Subject|7|||
170769807|NCT05764161|617162606|FG000|40-week OLE Period|Extended Travel|0|||
170769808|NCT05764161|617162607|FG001|40-week OLE Period|Extended Travel|1|||
170769809|NCT05764161|617162606|FG000|40-week OLE Period|Ongoing|66|||
170769810|NCT05764161|617162607|FG001|40-week OLE Period|Ongoing|59|||
170769811|NCT03034915|617162614|FG000|Overall Study|Adverse Event|29|||
170769812|NCT03034915|617162615|FG001|Overall Study|Adverse Event|32|||
170769813|NCT03034915|617162616|FG002|Overall Study|Adverse Event|22|||
170632179|NCT03345784|616664548|FG000|Overall Study|Withdrawal by Subject|2|||
170769814|NCT03034915|617162614|FG000|Overall Study|Lost to Follow-up|5|||
170769815|NCT03034915|617162615|FG001|Overall Study|Lost to Follow-up|13|||
170769816|NCT03034915|617162616|FG002|Overall Study|Lost to Follow-up|3|||
170412621|NCT00622908|615850433|FG000|Overall Study|Lack of Efficacy|1|||
170769817|NCT03034915|617162614|FG000|Overall Study|Withdrawal by Subject|29|||
170769818|NCT03034915|617162615|FG001|Overall Study|Withdrawal by Subject|46|||
170769819|NCT03034915|617162616|FG002|Overall Study|Withdrawal by Subject|41|||
170769820|NCT03034915|617162614|FG000|Overall Study|Protocol Deviation|2|||
170871533|NCT01179672|617541594|FG001|Overall Study|Physician Decision|1|||
170871534|NCT02428855|617541595|FG000|Overall Study|Withdrawal by Subject|2|||
170871535|NCT02319668|617541596|FG000|Overall Study|Other (Not specified)|0|||
170871536|NCT02319668|617541597|FG001|Overall Study|Other (Not specified)|2|||
170871537|NCT01161043|617541598|FG000|Overall Study|Withdrawal by Subject|3|||
170871538|NCT01670539|617541599|FG000|Overall Study|Death|3|||
170871539|NCT01670539|617541600|FG001|Overall Study|Death|5|||
170871540|NCT01670539|617541599|FG000|Overall Study|Withdrawal by Subject|3|||
170871541|NCT01670539|617541600|FG001|Overall Study|Withdrawal by Subject|0|||
170871542|NCT05418673|617541601|FG000|Overall Study|Study Terminated by Sponsor|2|||
170871543|NCT05418673|617541602|FG001|Overall Study|Study Terminated by Sponsor|4|||
170871544|NCT05418673|617541601|FG000|Overall Study|Lost to Follow-up|1|||
170871545|NCT05418673|617541602|FG001|Overall Study|Lost to Follow-up|0|||
170871546|NCT02164929|617541603|FG000|Overall Study|Converted to open procedure|1|||
170871547|NCT02164929|617541604|FG001|Overall Study|Converted to open procedure|0|||
170871548|NCT02164929|617541605|FG002|Overall Study|Converted to open procedure|0|||
170871549|NCT02164929|617541606|FG003|Overall Study|Converted to open procedure|2|||
170871550|NCT02164929|617541603|FG000|Overall Study|Failed regional block|0|||
170871551|NCT02164929|617541604|FG001|Overall Study|Failed regional block|0|||
170871552|NCT02164929|617541605|FG002|Overall Study|Failed regional block|1|||
170871553|NCT02164929|617541606|FG003|Overall Study|Failed regional block|0|||
170871554|NCT00365456|617541607|FG000|Trial Period I (12 Months)|Adverse Event|84|||
170871555|NCT00365456|617541608|FG001|Trial Period I (12 Months)|Adverse Event|0|||
170871556|NCT00365456|617541607|FG000|Trial Period I (12 Months)|Non-compliance|3|||
170871557|NCT00365456|617541608|FG001|Trial Period I (12 Months)|Non-compliance|0|||
170871558|NCT00365456|617541607|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
170871559|NCT00365456|617541608|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
170871560|NCT00365456|617541607|FG000|Trial Period I (12 Months)|Other|11|||
170871561|NCT00365456|617541608|FG001|Trial Period I (12 Months)|Other|0|||
170871562|NCT00365456|617541607|FG000|Trial Period II (12 Months)|Adverse Event|0|||
170871563|NCT00365456|617541608|FG001|Trial Period II (12 Months)|Adverse Event|6|||
170871564|NCT00365456|617541607|FG000|Trial Period II (12 Months)|Non-compliance|0|||
170871565|NCT00365456|617541608|FG001|Trial Period II (12 Months)|Non-compliance|2|||
170871566|NCT00365456|617541607|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
170871567|NCT00365456|617541608|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
170871568|NCT00365456|617541607|FG000|Trial Period II (12 Months)|Other|0|||
170871569|NCT00365456|617541608|FG001|Trial Period II (12 Months)|Other|1|||
170871570|NCT00365456|617541607|FG000|Trial Period III (12 Months)|Adverse Event|13|||
170871571|NCT00365456|617541608|FG001|Trial Period III (12 Months)|Adverse Event|3|||
170871572|NCT00365456|617541607|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
170871573|NCT00365456|617541608|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
170871574|NCT00365456|617541607|FG000|Trial Period III (12 Months)|Other|1|||
170871575|NCT00365456|617541608|FG001|Trial Period III (12 Months)|Other|1|||
170632180|NCT03345784|616664549|FG001|Overall Study|Withdrawal by Subject|1|||
170632181|NCT00538902|616664550|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
170871576|NCT01986920|617541609|FG000|A- 101 25%|Withdrawal by Subject|1|||
170871577|NCT01986920|617541610|FG001|A- 101 25%|Withdrawal by Subject|0|||
170871578|NCT01986920|617541611|FG002|A- 101 25%|Withdrawal by Subject|0|||
170871579|NCT01986920|617541612|FG003|A- 101 25%|Withdrawal by Subject|0|||
170871580|NCT01986920|617541609|FG000|A-101 32.5%|Withdrawal by Subject|0|||
170871581|NCT01986920|617541610|FG001|A-101 32.5%|Withdrawal by Subject|1|||
170871582|NCT01986920|617541611|FG002|A-101 32.5%|Withdrawal by Subject|0|||
170871583|NCT01986920|617541612|FG003|A-101 32.5%|Withdrawal by Subject|0|||
170871584|NCT01986920|617541609|FG000|A-101 40%|Withdrawal by Subject|0|||
170871585|NCT01986920|617541610|FG001|A-101 40%|Withdrawal by Subject|0|||
170871586|NCT01986920|617541611|FG002|A-101 40%|Withdrawal by Subject|1|||
170871587|NCT01986920|617541612|FG003|A-101 40%|Withdrawal by Subject|0|||
170871588|NCT01986920|617541609|FG000|Placebo|Withdrawal by Subject|0|||
170871589|NCT01986920|617541610|FG001|Placebo|Withdrawal by Subject|0|||
170871590|NCT01986920|617541611|FG002|Placebo|Withdrawal by Subject|0|||
170871591|NCT01986920|617541612|FG003|Placebo|Withdrawal by Subject|1|||
170871592|NCT04754802|617541613|FG000|Overall Study|Lost to Follow-up|0|||
170871593|NCT04754802|617541614|FG001|Overall Study|Lost to Follow-up|2|||
170871594|NCT04754802|617541613|FG000|Overall Study|Withdrawal by Subject|2|||
170871595|NCT04754802|617541614|FG001|Overall Study|Withdrawal by Subject|0|||
170871596|NCT00233363|617541618|FG000|Overall Study|Adverse Event|1|||
170871597|NCT00233363|617541619|FG001|Overall Study|Adverse Event|2|||
170871598|NCT00233363|617541618|FG000|Overall Study|Lack of Efficacy|0|||
170871599|NCT00233363|617541619|FG001|Overall Study|Lack of Efficacy|2|||
170871600|NCT00233363|617541618|FG000|Overall Study|Withdrawal by Subject|1|||
170871601|NCT00233363|617541619|FG001|Overall Study|Withdrawal by Subject|1|||
170871602|NCT00233363|617541618|FG000|Overall Study|Aggravation of complication|1|||
170871603|NCT00233363|617541619|FG001|Overall Study|Aggravation of complication|0|||
170871604|NCT01526551|617541622|FG000|Overall Study|Lack of returned parental consent form|424|||
170871605|NCT00874770|617541623|FG000|Overall Study|Lack of Efficacy|2|||
170871606|NCT00874770|617541624|FG001|Overall Study|Lack of Efficacy|0|||
170871607|NCT00874770|617541625|FG002|Overall Study|Lack of Efficacy|0|||
170769821|NCT03034915|617162615|FG001|Overall Study|Protocol Deviation|14|||
170769822|NCT03034915|617162616|FG002|Overall Study|Protocol Deviation|7|||
170769823|NCT03034915|617162614|FG000|Overall Study|Lack of Efficacy|8|||
170769824|NCT03034915|617162615|FG001|Overall Study|Lack of Efficacy|16|||
170769825|NCT03034915|617162616|FG002|Overall Study|Lack of Efficacy|18|||
170769826|NCT03034915|617162614|FG000|Overall Study|Site closed|2|||
170769827|NCT03034915|617162615|FG001|Overall Study|Site closed|2|||
170769828|NCT03034915|617162616|FG002|Overall Study|Site closed|4|||
170769829|NCT03034915|617162614|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
170769830|NCT03034915|617162615|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
170769831|NCT03034915|617162616|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
170769832|NCT03034915|617162614|FG000|Overall Study|Physician Decision|1|||
170769833|NCT03034915|617162615|FG001|Overall Study|Physician Decision|5|||
170769834|NCT03034915|617162616|FG002|Overall Study|Physician Decision|2|||
170769835|NCT03861767|617162617|FG000|Overall Study|Withdrawal by Subject|2|||
170769836|NCT03861767|617162618|FG001|Overall Study|Withdrawal by Subject|1|||
170769837|NCT03861767|617162619|FG002|Overall Study|Withdrawal by Subject|0|||
170769838|NCT03861767|617162620|FG003|Overall Study|Withdrawal by Subject|5|||
170769839|NCT03861767|617162621|FG004|Overall Study|Withdrawal by Subject|2|||
170871608|NCT00874770|617541626|FG003|Overall Study|Lack of Efficacy|2|||
170871609|NCT00874770|617541623|FG000|Overall Study|Adverse Event|1|||
170871610|NCT00874770|617541624|FG001|Overall Study|Adverse Event|1|||
170871611|NCT00874770|617541625|FG002|Overall Study|Adverse Event|4|||
170871612|NCT00874770|617541626|FG003|Overall Study|Adverse Event|2|||
170871613|NCT00874770|617541623|FG000|Overall Study|Lost to Follow-up|1|||
170412622|NCT00622908|615850434|FG001|Overall Study|Lack of Efficacy|7|||
170412623|NCT00622908|615850433|FG000|Overall Study|Lost to Follow-up|1|||
170412624|NCT00622908|615850434|FG001|Overall Study|Lost to Follow-up|0|||
170412625|NCT00622908|615850433|FG000|Overall Study|Refusal|0|||
170412626|NCT00622908|615850434|FG001|Overall Study|Refusal|1|||
170412627|NCT00622908|615850433|FG000|Overall Study|Termination by study sponser|0|||
170412628|NCT00622908|615850434|FG001|Overall Study|Termination by study sponser|1|||
170412629|NCT01166568|615850435|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
170412630|NCT01166568|615850436|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
170412631|NCT01166568|615850437|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
170412632|NCT01166568|615850435|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
170412633|NCT01166568|615850436|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
170412634|NCT01166568|615850437|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
170412635|NCT01166568|615850435|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
170412636|NCT01166568|615850436|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
170412637|NCT01166568|615850437|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
170412638|NCT00321711|615850441|FG000|Part A|Adverse Event|3|||
170412639|NCT00321711|615850442|FG001|Part A|Adverse Event|3|||
170412640|NCT00321711|615850443|FG002|Part A|Adverse Event|2|||
170412641|NCT00321711|615850444|FG003|Part A|Adverse Event|0|||
170412642|NCT00321711|615850445|FG004|Part A|Adverse Event|0|||
170412643|NCT00321711|615850441|FG000|Part A|Withdrawal by Subject|1|||
170412644|NCT00321711|615850442|FG001|Part A|Withdrawal by Subject|1|||
170412645|NCT00321711|615850443|FG002|Part A|Withdrawal by Subject|1|||
170412646|NCT00321711|615850444|FG003|Part A|Withdrawal by Subject|0|||
170412647|NCT00321711|615850445|FG004|Part A|Withdrawal by Subject|0|||
170412648|NCT00321711|615850441|FG000|Part A|Disease progression|0|||
170412649|NCT00321711|615850442|FG001|Part A|Disease progression|1|||
170412650|NCT00321711|615850443|FG002|Part A|Disease progression|0|||
170412651|NCT00321711|615850444|FG003|Part A|Disease progression|0|||
170412652|NCT00321711|615850445|FG004|Part A|Disease progression|0|||
170412653|NCT00321711|615850441|FG000|Part A|Requirement for alternative therapy|0|||
170412654|NCT00321711|615850442|FG001|Part A|Requirement for alternative therapy|2|||
170412655|NCT00321711|615850443|FG002|Part A|Requirement for alternative therapy|1|||
170412656|NCT00321711|615850444|FG003|Part A|Requirement for alternative therapy|0|||
170412657|NCT00321711|615850445|FG004|Part A|Requirement for alternative therapy|0|||
170412658|NCT00321711|615850441|FG000|Part A|Physician Decision|0|||
170412659|NCT00321711|615850442|FG001|Part A|Physician Decision|1|||
170412660|NCT00321711|615850443|FG002|Part A|Physician Decision|3|||
170412661|NCT00321711|615850444|FG003|Part A|Physician Decision|0|||
170412662|NCT00321711|615850445|FG004|Part A|Physician Decision|0|||
170412663|NCT00321711|615850441|FG000|Part A|Other|1|||
170412664|NCT00321711|615850442|FG001|Part A|Other|2|||
170412665|NCT00321711|615850443|FG002|Part A|Other|3|||
170412666|NCT00321711|615850444|FG003|Part A|Other|0|||
170412667|NCT00321711|615850445|FG004|Part A|Other|0|||
170412668|NCT00321711|615850441|FG000|Part A|Protocol deviation|0|||
170412669|NCT00321711|615850442|FG001|Part A|Protocol deviation|0|||
170412670|NCT00321711|615850443|FG002|Part A|Protocol deviation|1|||
170412671|NCT00321711|615850444|FG003|Part A|Protocol deviation|0|||
170412672|NCT00321711|615850445|FG004|Part A|Protocol deviation|0|||
170412673|NCT00321711|615850441|FG000|Part B|Noncompliance|0|||
170871614|NCT00874770|617541624|FG001|Overall Study|Lost to Follow-up|0|||
170871615|NCT00874770|617541625|FG002|Overall Study|Lost to Follow-up|0|||
170412674|NCT00321711|615850442|FG001|Part B|Noncompliance|0|||
170769840|NCT03861767|617162622|FG005|Overall Study|Withdrawal by Subject|1|||
170769841|NCT03861767|617162623|FG006|Overall Study|Withdrawal by Subject|3|||
170769842|NCT03861767|617162624|FG007|Overall Study|Withdrawal by Subject|1|||
170769843|NCT03861767|617162625|FG008|Overall Study|Withdrawal by Subject|0|||
170769844|NCT03861767|617162626|FG009|Overall Study|Withdrawal by Subject|5|||
170769845|NCT00346333|617162627|FG000|Overall Study|Death|1|||
170769846|NCT00346333|617162628|FG001|Overall Study|Death|0|||
170769847|NCT00346333|617162627|FG000|Overall Study|unwilling or unable to continue|4|||
170769848|NCT00346333|617162628|FG001|Overall Study|unwilling or unable to continue|8|||
170769849|NCT00424762|617162629|FG000|Overall Study|Withdrawal by Subject|18|||
170769850|NCT00424762|617162630|FG001|Overall Study|Withdrawal by Subject|19|||
170769851|NCT00424762|617162629|FG000|Overall Study|Lost to Follow-up|2|||
170769852|NCT00424762|617162630|FG001|Overall Study|Lost to Follow-up|3|||
170769853|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
170769854|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
170769855|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
170769856|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
170769857|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
170769858|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
170769859|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
170769860|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
170769861|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
170769862|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
170769863|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
170769864|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
170769865|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
170769866|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
170769867|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
170769868|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
170769869|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
170769870|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
170769871|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
170769872|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
170769873|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
170769874|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
170412675|NCT00321711|615850443|FG002|Part B|Noncompliance|0|||
170412676|NCT00321711|615850444|FG003|Part B|Noncompliance|0|||
170412677|NCT00321711|615850445|FG004|Part B|Noncompliance|1|||
170412678|NCT00321711|615850441|FG000|Part B|Adverse Event|0|||
170412679|NCT00321711|615850442|FG001|Part B|Adverse Event|0|||
170412680|NCT00321711|615850443|FG002|Part B|Adverse Event|0|||
170412681|NCT00321711|615850444|FG003|Part B|Adverse Event|2|||
170412682|NCT00321711|615850445|FG004|Part B|Adverse Event|1|||
170412683|NCT00321711|615850441|FG000|Part B|Disease progression|0|||
170412684|NCT00321711|615850442|FG001|Part B|Disease progression|0|||
170412685|NCT00321711|615850443|FG002|Part B|Disease progression|0|||
170412686|NCT00321711|615850444|FG003|Part B|Disease progression|1|||
170412687|NCT00321711|615850445|FG004|Part B|Disease progression|0|||
170412688|NCT00321711|615850441|FG000|Part B|Physician Decision|0|||
170412689|NCT00321711|615850442|FG001|Part B|Physician Decision|0|||
170412690|NCT00321711|615850443|FG002|Part B|Physician Decision|0|||
170412691|NCT00321711|615850444|FG003|Part B|Physician Decision|1|||
170412692|NCT00321711|615850445|FG004|Part B|Physician Decision|2|||
170412693|NCT00321711|615850441|FG000|Part B|Death|0|||
170412694|NCT00321711|615850442|FG001|Part B|Death|0|||
170412695|NCT00321711|615850443|FG002|Part B|Death|0|||
170412696|NCT00321711|615850444|FG003|Part B|Death|2|||
170412697|NCT00321711|615850445|FG004|Part B|Death|1|||
170412698|NCT00146770|615850450|FG000|Overall Study|Adverse Event|2|||
170412699|NCT00146770|615850451|FG001|Overall Study|Adverse Event|0|||
170412700|NCT00146770|615850450|FG000|Overall Study|Pregnancy|1|||
170412701|NCT00146770|615850451|FG001|Overall Study|Pregnancy|0|||
170412702|NCT00146770|615850450|FG000|Overall Study|Withdrawal by Subject|2|||
170412703|NCT00146770|615850451|FG001|Overall Study|Withdrawal by Subject|0|||
170412704|NCT02668302|615850452|FG000|Overall Study|Withdrawal by Subject|1|||
170412705|NCT02668302|615850453|FG001|Overall Study|Withdrawal by Subject|0|||
170412706|NCT00616928|615850458|FG000|Overall Study|Adverse Event|6|||
170412707|NCT00616928|615850459|FG001|Overall Study|Adverse Event|3|||
170412708|NCT00616928|615850460|FG002|Overall Study|Adverse Event|2|||
170412709|NCT00616928|615850461|FG003|Overall Study|Adverse Event|2|||
170412710|NCT00616928|615850458|FG000|Overall Study|Other|51|||
170412711|NCT00616928|615850459|FG001|Overall Study|Other|8|||
170412712|NCT00616928|615850460|FG002|Overall Study|Other|15|||
170412713|NCT00616928|615850461|FG003|Overall Study|Other|5|||
170412714|NCT00616928|615850458|FG000|Overall Study|Lost to Follow-up|5|||
170412715|NCT00616928|615850459|FG001|Overall Study|Lost to Follow-up|7|||
170769875|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
170769876|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
170769877|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
170769878|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
170769879|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
170769880|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
170769881|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
170769882|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
170769883|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
170769884|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
170769885|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
170769886|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
170769887|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
170769888|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
170769889|NCT03593213|617162631|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
170769890|NCT03593213|617162632|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
170769891|NCT03593213|617162633|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
170769892|NCT03593213|617162634|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
170769893|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
170769894|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
170769895|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
170769896|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
170769897|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
170769898|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
170769899|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
170769900|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
170769901|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
170769902|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
170769903|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
170769904|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
170769905|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
170769906|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
170769907|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
170769908|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
170769909|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
170769910|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
170769911|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
170769912|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
170769913|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
170769914|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
170769915|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
170769916|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
170769917|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
170769918|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
170769919|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
170769920|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
170769921|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
170769922|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
170769923|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
170769924|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
170769925|NCT03593213|617162631|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
170769926|NCT03593213|617162632|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
170769927|NCT03593213|617162633|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
170769928|NCT03593213|617162634|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
170769929|NCT00189202|617162636|FG000|Overall Study|Physician Decision|5|||
170769930|NCT02950558|617162641|FG000|Overall Study|Lost to Follow-up|2|||
170769931|NCT02950558|617162642|FG001|Overall Study|Lost to Follow-up|0|||
170769932|NCT01135511|617162648|FG000|Overall Study|Adverse Event|0|||
170769933|NCT01135511|617162649|FG001|Overall Study|Adverse Event|1|||
170769934|NCT01135511|617162650|FG002|Overall Study|Adverse Event|2|||
170769935|NCT01135511|617162651|FG003|Overall Study|Adverse Event|0|||
170769936|NCT01135511|617162652|FG004|Overall Study|Adverse Event|0|||
170522876|NCT00731822|616260198|FG000|Overall Study|Adverse Event|2|||
170522877|NCT00731822|616260199|FG001|Overall Study|Adverse Event|1|||
170522878|NCT00731822|616260198|FG000|Overall Study|Protocol Violation|1|||
170522879|NCT00731822|616260199|FG001|Overall Study|Protocol Violation|0|||
170522880|NCT00731822|616260198|FG000|Overall Study|Lost to Follow-up|1|||
170522881|NCT00731822|616260199|FG001|Overall Study|Lost to Follow-up|0|||
170522882|NCT04073303|616260200|FG000|Overall Study|Adverse Event|0|||
170769937|NCT01135511|617162653|FG005|Overall Study|Adverse Event|1|||
170769938|NCT01135511|617162654|FG006|Overall Study|Adverse Event|0|||
170769939|NCT01135511|617162655|FG007|Overall Study|Adverse Event|1|||
170769940|NCT01135511|617162656|FG008|Overall Study|Adverse Event|0|||
170769941|NCT01135511|617162648|FG000|Overall Study|Lack of Efficacy|0|||
170769942|NCT01135511|617162649|FG001|Overall Study|Lack of Efficacy|1|||
170769943|NCT01135511|617162650|FG002|Overall Study|Lack of Efficacy|1|||
170769944|NCT01135511|617162651|FG003|Overall Study|Lack of Efficacy|2|||
170769945|NCT01135511|617162652|FG004|Overall Study|Lack of Efficacy|0|||
170769946|NCT01135511|617162653|FG005|Overall Study|Lack of Efficacy|0|||
170769947|NCT01135511|617162654|FG006|Overall Study|Lack of Efficacy|0|||
170769948|NCT01135511|617162655|FG007|Overall Study|Lack of Efficacy|0|||
170769949|NCT01135511|617162656|FG008|Overall Study|Lack of Efficacy|0|||
170769950|NCT01135511|617162648|FG000|Overall Study|Protocol Violation|0|||
170769951|NCT01135511|617162649|FG001|Overall Study|Protocol Violation|0|||
170769952|NCT01135511|617162650|FG002|Overall Study|Protocol Violation|3|||
170769953|NCT01135511|617162651|FG003|Overall Study|Protocol Violation|0|||
170769954|NCT01135511|617162652|FG004|Overall Study|Protocol Violation|0|||
170769955|NCT01135511|617162653|FG005|Overall Study|Protocol Violation|0|||
170769956|NCT01135511|617162654|FG006|Overall Study|Protocol Violation|0|||
170769957|NCT01135511|617162655|FG007|Overall Study|Protocol Violation|0|||
170769958|NCT01135511|617162656|FG008|Overall Study|Protocol Violation|0|||
170769959|NCT01135511|617162648|FG000|Overall Study|Pregnancy|0|||
170769960|NCT01135511|617162649|FG001|Overall Study|Pregnancy|0|||
170769961|NCT01135511|617162650|FG002|Overall Study|Pregnancy|0|||
170769962|NCT01135511|617162651|FG003|Overall Study|Pregnancy|1|||
170769963|NCT01135511|617162652|FG004|Overall Study|Pregnancy|0|||
170769964|NCT01135511|617162653|FG005|Overall Study|Pregnancy|0|||
170769965|NCT01135511|617162654|FG006|Overall Study|Pregnancy|0|||
170769966|NCT01135511|617162655|FG007|Overall Study|Pregnancy|0|||
170769967|NCT01135511|617162656|FG008|Overall Study|Pregnancy|0|||
170769968|NCT01135511|617162648|FG000|Overall Study|could not visit the clinic|0|||
170769969|NCT01135511|617162649|FG001|Overall Study|could not visit the clinic|1|||
170769970|NCT01135511|617162650|FG002|Overall Study|could not visit the clinic|2|||
170769971|NCT01135511|617162651|FG003|Overall Study|could not visit the clinic|0|||
170769972|NCT01135511|617162652|FG004|Overall Study|could not visit the clinic|0|||
170769973|NCT01135511|617162653|FG005|Overall Study|could not visit the clinic|0|||
170769974|NCT01135511|617162654|FG006|Overall Study|could not visit the clinic|0|||
170769975|NCT01135511|617162655|FG007|Overall Study|could not visit the clinic|0|||
170769976|NCT01135511|617162656|FG008|Overall Study|could not visit the clinic|0|||
170769977|NCT01135511|617162648|FG000|Overall Study|noncompliance with study drug taken|0|||
170769978|NCT01135511|617162649|FG001|Overall Study|noncompliance with study drug taken|0|||
170769979|NCT01135511|617162650|FG002|Overall Study|noncompliance with study drug taken|0|||
170769980|NCT01135511|617162651|FG003|Overall Study|noncompliance with study drug taken|0|||
170769981|NCT01135511|617162652|FG004|Overall Study|noncompliance with study drug taken|1|||
170769982|NCT01135511|617162653|FG005|Overall Study|noncompliance with study drug taken|0|||
170769983|NCT01135511|617162654|FG006|Overall Study|noncompliance with study drug taken|0|||
170769984|NCT01135511|617162655|FG007|Overall Study|noncompliance with study drug taken|0|||
170769985|NCT01135511|617162656|FG008|Overall Study|noncompliance with study drug taken|0|||
170769986|NCT01135511|617162648|FG000|Overall Study|Withdrawal by Subject|0|||
170769987|NCT01135511|617162649|FG001|Overall Study|Withdrawal by Subject|0|||
170769988|NCT01135511|617162650|FG002|Overall Study|Withdrawal by Subject|0|||
170522883|NCT04073303|616260201|FG001|Overall Study|Adverse Event|2|||
170522884|NCT04073303|616260200|FG000|Overall Study|Withdrawal by Subject|16|||
170522885|NCT04073303|616260201|FG001|Overall Study|Withdrawal by Subject|36|||
170769989|NCT01135511|617162651|FG003|Overall Study|Withdrawal by Subject|0|||
170522886|NCT04073303|616260200|FG000|Overall Study|Lost to Follow-up|6|||
170522887|NCT04073303|616260201|FG001|Overall Study|Lost to Follow-up|1|||
170522888|NCT04073303|616260200|FG000|Overall Study|Protocol Deviation|0|||
170769990|NCT01135511|617162652|FG004|Overall Study|Withdrawal by Subject|0|||
170769991|NCT01135511|617162653|FG005|Overall Study|Withdrawal by Subject|0|||
170769992|NCT01135511|617162654|FG006|Overall Study|Withdrawal by Subject|1|||
170769993|NCT01135511|617162655|FG007|Overall Study|Withdrawal by Subject|0|||
170769994|NCT01135511|617162656|FG008|Overall Study|Withdrawal by Subject|1|||
170769995|NCT00356265|617162669|FG000|Overall Study|Withdrawal by Subject|0|||
170769996|NCT00356265|617162670|FG001|Overall Study|Withdrawal by Subject|0|||
170769997|NCT00356265|617162671|FG002|Overall Study|Withdrawal by Subject|1|||
170769998|NCT00102063|617162672|FG000|Overall Study|Lack of Efficacy|5|||
170522889|NCT04073303|616260201|FG001|Overall Study|Protocol Deviation|4|||
170769999|NCT00102063|617162673|FG001|Overall Study|Lack of Efficacy|1|||
170770000|NCT00102063|617162674|FG002|Overall Study|Lack of Efficacy|1|||
170770001|NCT00102063|617162672|FG000|Overall Study|Adverse Event|7|||
170770002|NCT00102063|617162673|FG001|Overall Study|Adverse Event|4|||
170770003|NCT00102063|617162674|FG002|Overall Study|Adverse Event|2|||
170412716|NCT00616928|615850460|FG002|Overall Study|Lost to Follow-up|0|||
170770004|NCT00102063|617162672|FG000|Overall Study|Withdrawal by Subject|4|||
170770005|NCT00102063|617162673|FG001|Overall Study|Withdrawal by Subject|12|||
170770006|NCT00102063|617162674|FG002|Overall Study|Withdrawal by Subject|5|||
170770007|NCT00102063|617162672|FG000|Overall Study|Lost to Follow-up|0|||
170770008|NCT00102063|617162673|FG001|Overall Study|Lost to Follow-up|0|||
170770009|NCT00102063|617162674|FG002|Overall Study|Lost to Follow-up|1|||
170770010|NCT00102063|617162672|FG000|Overall Study|Protocol Violation|0|||
170770011|NCT00102063|617162673|FG001|Overall Study|Protocol Violation|1|||
170770012|NCT00102063|617162674|FG002|Overall Study|Protocol Violation|1|||
170770013|NCT00857649|617162675|FG000|Overall Study|Adverse Event|15|||
170770014|NCT00857649|617162676|FG001|Overall Study|Adverse Event|10|||
170770015|NCT00857649|617162675|FG000|Overall Study|Non-compliance|1|||
170770016|NCT00857649|617162676|FG001|Overall Study|Non-compliance|1|||
170770017|NCT00857649|617162675|FG000|Overall Study|Protocol Violation|2|||
170770018|NCT00857649|617162676|FG001|Overall Study|Protocol Violation|2|||
170770019|NCT00857649|617162675|FG000|Overall Study|Withdrawal of Consent|10|||
170770020|NCT00857649|617162676|FG001|Overall Study|Withdrawal of Consent|7|||
170770021|NCT00857649|617162675|FG000|Overall Study|Nursing Home Placement|2|||
170770022|NCT00857649|617162676|FG001|Overall Study|Nursing Home Placement|9|||
170770023|NCT00857649|617162675|FG000|Overall Study|Other Reasons|1|||
170770024|NCT00857649|617162676|FG001|Overall Study|Other Reasons|3|||
170871616|NCT00874770|617541626|FG003|Overall Study|Lost to Follow-up|1|||
170871617|NCT00874770|617541623|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
170871618|NCT00874770|617541624|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
170412717|NCT00616928|615850461|FG003|Overall Study|Lost to Follow-up|0|||
170412718|NCT02619682|615850466|FG000|Overall Study|Withdrawal by Subject|3|||
170412719|NCT02619682|615850466|FG000|Overall Study|Lack of Efficacy|8|||
170412720|NCT02619682|615850466|FG000|Overall Study|new secondary cancer|1|||
170412721|NCT02619682|615850466|FG000|Overall Study|post surgery complications|2|||
170412722|NCT03611309|615850467|FG000|Overall Study|Lost to Follow-up|16|||
170412723|NCT03611309|615850468|FG001|Overall Study|Lost to Follow-up|8|||
170412724|NCT03611309|615850467|FG000|Overall Study|Withdrawal by Subject|5|||
170412725|NCT03611309|615850468|FG001|Overall Study|Withdrawal by Subject|5|||
170412726|NCT03611309|615850467|FG000|Overall Study|Physician Decision|0|||
170412727|NCT03611309|615850468|FG001|Overall Study|Physician Decision|2|||
170412728|NCT03280537|615850505|FG000|Overall Study|Withdrawal by Subject|2|||
170412729|NCT03280537|615850506|FG001|Overall Study|Withdrawal by Subject|4|||
170412730|NCT03083132|615850507|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
170412731|NCT03083132|615850508|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
170412732|NCT03083132|615850507|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
170412733|NCT03083132|615850508|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
170412734|NCT03083132|615850507|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
170412735|NCT03083132|615850508|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
170412736|NCT03996005|615850511|FG000|Overall Study|Withdrawal by Subject|1|||
170412737|NCT04680052|615851856|FG000|Overall Study|Ongoing|244|||
170412738|NCT04680052|615851857|FG001|Overall Study|Ongoing|229|||
170412739|NCT04680052|615851858|FG002|Overall Study|Ongoing|39|||
170412740|NCT04680052|615851859|FG003|Overall Study|Ongoing|46|||
170412741|NCT04680052|615851856|FG000|Overall Study|Death|15|||
170412742|NCT04680052|615851857|FG001|Overall Study|Death|22|||
170412743|NCT04680052|615851858|FG002|Overall Study|Death|7|||
170412744|NCT04680052|615851859|FG003|Overall Study|Death|1|||
170412745|NCT04680052|615851856|FG000|Overall Study|Lost to Follow-up|3|||
170412746|NCT04680052|615851857|FG001|Overall Study|Lost to Follow-up|2|||
170412747|NCT04680052|615851858|FG002|Overall Study|Lost to Follow-up|0|||
170412748|NCT04680052|615851859|FG003|Overall Study|Lost to Follow-up|1|||
170412749|NCT04680052|615851856|FG000|Overall Study|Withdrawal by Subject|11|||
170412750|NCT04680052|615851857|FG001|Overall Study|Withdrawal by Subject|19|||
170412751|NCT04680052|615851858|FG002|Overall Study|Withdrawal by Subject|7|||
170412752|NCT04680052|615851859|FG003|Overall Study|Withdrawal by Subject|5|||
170770025|NCT04697628|617162682|FG000|Overall Study|Withdrawal by Subject|17|||
170412753|NCT04680052|615851856|FG000|Overall Study|Missing|0|||
170412754|NCT04680052|615851857|FG001|Overall Study|Missing|1|||
170412755|NCT04680052|615851858|FG002|Overall Study|Missing|0|||
170412756|NCT04680052|615851859|FG003|Overall Study|Missing|0|||
170770026|NCT04697628|617162683|FG001|Overall Study|Withdrawal by Subject|23|||
170770027|NCT04697628|617162682|FG000|Overall Study|Lost to Follow-up|0|||
170412757|NCT04680052|615851856|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
170412758|NCT04680052|615851857|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
170412759|NCT04680052|615851858|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
170412760|NCT04680052|615851859|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
170412761|NCT04680052|615851856|FG000|Overall Study|Physician Decision|0|||
170770028|NCT04697628|617162683|FG001|Overall Study|Lost to Follow-up|4|||
170871619|NCT00874770|617541625|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
170871620|NCT00874770|617541626|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
170871621|NCT05215262|617541627|FG000|Overall Study|Lost to Follow-up|12|||
170871622|NCT05215262|617541628|FG001|Overall Study|Lost to Follow-up|0|||
170871623|NCT04880447|617541630|FG000|Overall Study|No vaccination information|1|||
170871624|NCT04880447|617541630|FG000|Overall Study|No adverse event information (missing information)|1|||
170871625|NCT04880447|617541630|FG000|Overall Study|Disease not covered in this study|35|||
170871626|NCT00718549|617541631|FG000|Induction Phase|Disease Progression|1|||
170871627|NCT00718549|617541632|FG001|Induction Phase|Disease Progression|0|||
170871628|NCT00718549|617541633|FG002|Induction Phase|Disease Progression|0|||
170871629|NCT00718549|617541631|FG000|Induction Phase|Eligibility Criteria Violation|2|||
170871630|NCT00718549|617541632|FG001|Induction Phase|Eligibility Criteria Violation|0|||
170871631|NCT00718549|617541633|FG002|Induction Phase|Eligibility Criteria Violation|0|||
170871632|NCT00718549|617541631|FG000|Induction Phase|Early Termination - No Additional Info|59|||
170871633|NCT00718549|617541632|FG001|Induction Phase|Early Termination - No Additional Info|0|||
170871634|NCT00718549|617541633|FG002|Induction Phase|Early Termination - No Additional Info|0|||
170871635|NCT00718549|617541631|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
170871636|NCT00718549|617541632|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
170871637|NCT00718549|617541633|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
170871638|NCT00718549|617541631|FG000|Maintenance/ Observation Phase|Death|0|||
170871639|NCT00718549|617541632|FG001|Maintenance/ Observation Phase|Death|1|||
170871640|NCT00718549|617541633|FG002|Maintenance/ Observation Phase|Death|2|||
170871641|NCT00718549|617541631|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
170871642|NCT00718549|617541632|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
170871643|NCT00718549|617541633|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
170871644|NCT00718549|617541631|FG000|Maintenance/ Observation Phase|Progression|0|||
170871645|NCT00718549|617541632|FG001|Maintenance/ Observation Phase|Progression|5|||
170871646|NCT00718549|617541633|FG002|Maintenance/ Observation Phase|Progression|14|||
170871647|NCT00718549|617541631|FG000|Maintenance/ Observation Phase|Relapse|0|||
170871648|NCT00718549|617541632|FG001|Maintenance/ Observation Phase|Relapse|3|||
170871649|NCT00718549|617541633|FG002|Maintenance/ Observation Phase|Relapse|2|||
170871650|NCT01353508|617541634|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
170871651|NCT01353508|617541635|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
170871652|NCT01353508|617541636|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
170871653|NCT01353508|617541637|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
170871654|NCT01353508|617541634|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
170871655|NCT01353508|617541635|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
170871656|NCT01353508|617541636|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
170871657|NCT01353508|617541637|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
170871658|NCT01576172|617541638|FG000|Overall Study|Ineligible|2|||
170871659|NCT01576172|617541639|FG001|Overall Study|Ineligible|1|||
170871660|NCT01576172|617541638|FG000|Overall Study|Withdrawal by Subject|2|||
170871661|NCT01576172|617541639|FG001|Overall Study|Withdrawal by Subject|0|||
170871662|NCT01576172|617541638|FG000|Overall Study|Insurance issue|1|||
170871663|NCT01576172|617541639|FG001|Overall Study|Insurance issue|0|||
170871664|NCT02092350|617541644|FG000|Overall Study|Adverse Event|0|||
170871665|NCT02092350|617541645|FG001|Overall Study|Adverse Event|3|||
170871666|NCT02092350|617541644|FG000|Overall Study|Death|2|||
170871667|NCT02092350|617541645|FG001|Overall Study|Death|5|||
170871668|NCT02092350|617541644|FG000|Overall Study|Lost to Follow-up|3|||
170871669|NCT02092350|617541645|FG001|Overall Study|Lost to Follow-up|1|||
170871670|NCT02092350|617541644|FG000|Overall Study|Protocol Violation|1|||
170871671|NCT02092350|617541645|FG001|Overall Study|Protocol Violation|0|||
170871672|NCT02092350|617541644|FG000|Overall Study|Physician Decision|1|||
170871673|NCT02092350|617541645|FG001|Overall Study|Physician Decision|1|||
170871674|NCT02092350|617541644|FG000|Overall Study|Screen Failure|1|||
170871675|NCT02092350|617541645|FG001|Overall Study|Screen Failure|0|||
170871676|NCT02092350|617541644|FG000|Overall Study|Withdrawal by Subject|2|||
170871677|NCT02092350|617541645|FG001|Overall Study|Withdrawal by Subject|2|||
170871678|NCT00239226|617541646|FG000|Overall Study|permAF during stabilization period|0|||
170871679|NCT00239226|617541647|FG001|Overall Study|permAF during stabilization period|0|||
170871680|NCT00239226|617541648|FG002|Overall Study|permAF during stabilization period|0|||
170871681|NCT00239226|617541649|FG003|Overall Study|permAF during stabilization period|3|||
170871682|NCT00239226|617541646|FG000|Overall Study|Lost to Follow-up|1|||
170412762|NCT04680052|615851857|FG001|Overall Study|Physician Decision|1|||
170412763|NCT04680052|615851858|FG002|Overall Study|Physician Decision|0|||
170412764|NCT04680052|615851859|FG003|Overall Study|Physician Decision|0|||
170412765|NCT01673009|615851866|FG000|Overall Study|Physician Decision|5|||
170412766|NCT01673009|615851866|FG000|Overall Study|Withdrawal by Subject|8|||
170871683|NCT00239226|617541647|FG001|Overall Study|Lost to Follow-up|0|||
170412767|NCT00755326|615851868|FG000|Overall Study|Lost to Follow-up|2|||
170412768|NCT00755326|615851869|FG001|Overall Study|Lost to Follow-up|3|||
170412769|NCT02173704|615851873|FG000|Overall Study|Adverse Event|1|||
170522890|NCT04073303|616260200|FG000|Overall Study|Other|1|||
170522891|NCT04073303|616260201|FG001|Overall Study|Other|1|||
170522892|NCT03258593|616260202|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
170522893|NCT03258593|616260203|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
170522894|NCT03258593|616260204|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
170522895|NCT03258593|616260205|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
170522896|NCT03258593|616260202|FG000|Run-In Maintenance Phase|Disease progression|3|||
170522897|NCT03258593|616260203|FG001|Run-In Maintenance Phase|Disease progression|0|||
170522898|NCT03258593|616260204|FG002|Run-In Maintenance Phase|Disease progression|0|||
170522899|NCT03258593|616260205|FG003|Run-In Maintenance Phase|Disease progression|0|||
170522900|NCT03258593|616260202|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
170522901|NCT03258593|616260203|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
170522902|NCT03258593|616260204|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
170522903|NCT03258593|616260205|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
170522904|NCT03258593|616260202|FG000|Expansion Maintenance Phase|Physician Decision|0|||
170522905|NCT03258593|616260203|FG001|Expansion Maintenance Phase|Physician Decision|1|||
170522906|NCT03258593|616260204|FG002|Expansion Maintenance Phase|Physician Decision|0|||
170522907|NCT03258593|616260205|FG003|Expansion Maintenance Phase|Physician Decision|0|||
170522908|NCT00983372|616260209|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
170522909|NCT00983372|616260209|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
170522910|NCT00983372|616260209|FG000|Diltiazem ER Alone|Adverse Event|1|||
170522911|NCT05635045|616260210|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
170770029|NCT04697628|617162682|FG000|Overall Study|On-going in study|122|||
170770030|NCT04697628|617162683|FG001|Overall Study|On-going in study|91|||
170770031|NCT03388632|617162686|FG000|Triplet C|Clinical progression|0|||
170770032|NCT03388632|617162687|FG001|Triplet C|Clinical progression|0|||
170770033|NCT03388632|617162688|FG002|Triplet C|Clinical progression|0|||
170770034|NCT03388632|617162689|FG003|Triplet C|Clinical progression|0|||
170770035|NCT03388632|617162690|FG004|Triplet C|Clinical progression|1|||
170770036|NCT03388632|617162691|FG005|Triplet C|Clinical progression|0|||
170871684|NCT00239226|617541648|FG002|Overall Study|Lost to Follow-up|1|||
170871685|NCT00239226|617541649|FG003|Overall Study|Lost to Follow-up|0|||
170871686|NCT00962390|617541652|FG000|Overall Study|Adverse Event|0|||
170871687|NCT00962390|617541653|FG001|Overall Study|Adverse Event|0|||
170871688|NCT00962390|617541654|FG002|Overall Study|Adverse Event|3|||
170412770|NCT02173704|615851874|FG001|Overall Study|Adverse Event|0|||
170412771|NCT02173704|615851873|FG000|Overall Study|Lost to Follow-up|1|||
170412772|NCT02173704|615851874|FG001|Overall Study|Lost to Follow-up|0|||
170412773|NCT02173704|615851873|FG000|Overall Study|Other|1|||
170412774|NCT02173704|615851874|FG001|Overall Study|Other|0|||
170412775|NCT02173704|615851873|FG000|Overall Study|Protocol Violation|1|||
170412776|NCT02173704|615851874|FG001|Overall Study|Protocol Violation|0|||
170412777|NCT02173704|615851873|FG000|Overall Study|Withdrawal by Subject|9|||
170412778|NCT02173704|615851874|FG001|Overall Study|Withdrawal by Subject|4|||
170412779|NCT02909673|615851886|FG000|Overall Study|Did not meet inclusion criteria|129|||
170412780|NCT02909673|615851887|FG001|Overall Study|Did not meet inclusion criteria|29|||
170412781|NCT02909673|615851886|FG000|Overall Study|Surveys lost by scanner|95|||
170412782|NCT02909673|615851887|FG001|Overall Study|Surveys lost by scanner|2|||
170412783|NCT02909673|615851886|FG000|Overall Study|Tracking info missing|0|||
170412784|NCT02909673|615851887|FG001|Overall Study|Tracking info missing|5|||
170412785|NCT01689974|615851888|FG000|Overall Study|Termination of Study|5|||
170412786|NCT01689974|615851889|FG001|Overall Study|Termination of Study|5|||
170412787|NCT00384033|615851890|FG000|Overall Study|Adverse Event|10|||
170412788|NCT00384033|615851891|FG001|Overall Study|Adverse Event|8|||
170412789|NCT00384033|615851892|FG002|Overall Study|Adverse Event|11|||
170412790|NCT00384033|615851893|FG003|Overall Study|Adverse Event|20|||
170412791|NCT00384033|615851890|FG000|Overall Study|Failed to return|1|||
170412792|NCT00384033|615851891|FG001|Overall Study|Failed to return|3|||
170412793|NCT00384033|615851892|FG002|Overall Study|Failed to return|2|||
170412794|NCT00384033|615851893|FG003|Overall Study|Failed to return|2|||
170412795|NCT00384033|615851890|FG000|Overall Study|Physician Decision|1|||
170412796|NCT00384033|615851891|FG001|Overall Study|Physician Decision|0|||
170412797|NCT00384033|615851892|FG002|Overall Study|Physician Decision|0|||
170412798|NCT00384033|615851893|FG003|Overall Study|Physician Decision|0|||
170412799|NCT00384033|615851890|FG000|Overall Study|Lost to Follow-up|6|||
170412800|NCT00384033|615851891|FG001|Overall Study|Lost to Follow-up|12|||
170412801|NCT00384033|615851892|FG002|Overall Study|Lost to Follow-up|7|||
170412802|NCT00384033|615851893|FG003|Overall Study|Lost to Follow-up|7|||
170412803|NCT00384033|615851890|FG000|Overall Study|Other|2|||
170412804|NCT00384033|615851891|FG001|Overall Study|Other|0|||
170412805|NCT00384033|615851892|FG002|Overall Study|Other|0|||
170412806|NCT00384033|615851893|FG003|Overall Study|Other|0|||
170412807|NCT00384033|615851890|FG000|Overall Study|Protocol Violation|5|||
170412808|NCT00384033|615851891|FG001|Overall Study|Protocol Violation|0|||
170522912|NCT05635045|616260211|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
170770037|NCT03388632|617162692|FG006|Triplet C|Clinical progression|0|||
170770038|NCT03388632|617162693|FG007|Triplet C|Clinical progression|0|||
170871689|NCT00962390|617541655|FG003|Overall Study|Adverse Event|1|||
170871690|NCT00962390|617541652|FG000|Overall Study|Lost to Follow-up|2|||
170871691|NCT00962390|617541653|FG001|Overall Study|Lost to Follow-up|2|||
170871692|NCT00962390|617541654|FG002|Overall Study|Lost to Follow-up|0|||
170871693|NCT00962390|617541655|FG003|Overall Study|Lost to Follow-up|0|||
170871694|NCT00962390|617541652|FG000|Overall Study|Protocol Violation|1|||
170871695|NCT00962390|617541653|FG001|Overall Study|Protocol Violation|0|||
170871696|NCT00962390|617541654|FG002|Overall Study|Protocol Violation|0|||
170871697|NCT00962390|617541655|FG003|Overall Study|Protocol Violation|0|||
170871698|NCT00962390|617541652|FG000|Overall Study|Withdrawal by Subject|1|||
170871699|NCT00962390|617541653|FG001|Overall Study|Withdrawal by Subject|1|||
170871700|NCT00962390|617541654|FG002|Overall Study|Withdrawal by Subject|1|||
170871701|NCT00962390|617541655|FG003|Overall Study|Withdrawal by Subject|0|||
170871702|NCT02613884|617541658|FG000|Overall Study|Death|1|||
170871703|NCT02613884|617541658|FG000|Overall Study|Lost to Follow-up|1|||
170871704|NCT03492554|617541665|FG000|Overall Study|Protocol Violation|0|||
170871705|NCT03492554|617541666|FG001|Overall Study|Protocol Violation|14|||
170871706|NCT00736034|617541667|FG000|Overall Study|Adverse Event|2|||
170871707|NCT02361944|617541670|FG000|Overall Study|surgery cancellation|0|||
170871708|NCT02361944|617541671|FG001|Overall Study|surgery cancellation|1|||
170871709|NCT03123250|617541672|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
170871710|NCT00773136|617541699|FG000|Overall Study|Physician Decision|2|||
170871711|NCT00199836|617541702|FG000|Overall Study|Progressive Disease|5|||
170871712|NCT00199836|617541702|FG000|Overall Study|Death|1|||
170871713|NCT03044249|617541707|FG000|Overall Study|Adverse Event|4|||
170871714|NCT03044249|617541708|FG001|Overall Study|Adverse Event|9|||
170871715|NCT03044249|617541707|FG000|Overall Study|Lost to Follow-up|1|||
170871716|NCT03044249|617541708|FG001|Overall Study|Lost to Follow-up|0|||
170412809|NCT00384033|615851892|FG002|Overall Study|Protocol Violation|5|||
170412810|NCT00384033|615851893|FG003|Overall Study|Protocol Violation|6|||
170412811|NCT00384033|615851890|FG000|Overall Study|Withdrawal by Subject|6|||
170412812|NCT00384033|615851891|FG001|Overall Study|Withdrawal by Subject|2|||
170412813|NCT00384033|615851892|FG002|Overall Study|Withdrawal by Subject|5|||
170412814|NCT00384033|615851893|FG003|Overall Study|Withdrawal by Subject|2|||
170412815|NCT00384033|615851890|FG000|Overall Study|Lack of Efficacy|7|||
170412816|NCT00384033|615851891|FG001|Overall Study|Lack of Efficacy|3|||
170412817|NCT00384033|615851892|FG002|Overall Study|Lack of Efficacy|3|||
170412818|NCT00384033|615851893|FG003|Overall Study|Lack of Efficacy|1|||
170412819|NCT00384033|615851890|FG000|Overall Study|Randomized but not treated|3|||
170412820|NCT00384033|615851891|FG001|Overall Study|Randomized but not treated|7|||
170412821|NCT00384033|615851892|FG002|Overall Study|Randomized but not treated|10|||
170412822|NCT00384033|615851893|FG003|Overall Study|Randomized but not treated|2|||
170412823|NCT02985151|615851894|FG000|Original Randomization|Withdrawal by Subject|0|||
170412824|NCT02985151|615851895|FG001|Original Randomization|Withdrawal by Subject|1|||
170412825|NCT00783796|615851896|FG000|Overall Study|Did not receive any stent|4|||
170412826|NCT00783796|615851896|FG000|Overall Study|Received non-XIENCE V stent|1|||
170412827|NCT00783796|615851896|FG000|Overall Study|Received commercial XIENCE V stent|1|||
170412828|NCT01829477|615851901|FG000|Overall Study|Study Terminated by Sponsor|15|||
170412829|NCT01829477|615851902|FG001|Overall Study|Study Terminated by Sponsor|15|||
170412830|NCT01829477|615851901|FG000|Overall Study|Withdrawal by Subject|1|||
170412831|NCT01829477|615851902|FG001|Overall Study|Withdrawal by Subject|0|||
170412832|NCT01215942|615851905|FG000|Treatment Period|Adverse Event|15|||
170412833|NCT01215942|615851906|FG001|Treatment Period|Adverse Event|26|||
170412834|NCT01215942|615851905|FG000|Treatment Period|Death|2|||
170412835|NCT01215942|615851906|FG001|Treatment Period|Death|4|||
170412836|NCT01215942|615851905|FG000|Treatment Period|Lack of Efficacy|23|||
170412837|NCT01215942|615851906|FG001|Treatment Period|Lack of Efficacy|62|||
170412838|NCT01215942|615851905|FG000|Treatment Period|Lost to Follow-up|3|||
170412839|NCT01215942|615851906|FG001|Treatment Period|Lost to Follow-up|4|||
170412840|NCT01215942|615851905|FG000|Treatment Period|Withdrawal by Subject|17|||
170412841|NCT01215942|615851906|FG001|Treatment Period|Withdrawal by Subject|40|||
170412842|NCT01215942|615851905|FG000|Treatment Period|Physician Decision|5|||
170412843|NCT01215942|615851906|FG001|Treatment Period|Physician Decision|5|||
170412844|NCT01215942|615851905|FG000|Treatment Period|Protocol Violation|0|||
170412845|NCT01215942|615851906|FG001|Treatment Period|Protocol Violation|1|||
170412846|NCT01215942|615851905|FG000|Treatment Period|Sponsor Decision|349|||
170412847|NCT01215942|615851906|FG001|Treatment Period|Sponsor Decision|530|||
170412848|NCT01215942|615851905|FG000|Post-Treatment Follow-Up Period|Death|0|||
170412849|NCT01215942|615851906|FG001|Post-Treatment Follow-Up Period|Death|1|||
170412850|NCT01215942|615851905|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
170412851|NCT01215942|615851906|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
170412852|NCT01215942|615851905|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
170412853|NCT01215942|615851906|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
170412854|NCT01215942|615851905|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
170412855|NCT01215942|615851906|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
170522913|NCT05635045|616260212|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
170522914|NCT05635045|616260213|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
170522915|NCT04464707|616260214|FG000|Overall Study|Adverse Event|1|||
170522916|NCT04464707|616260215|FG001|Overall Study|Adverse Event|0|||
170522917|NCT04464707|616260216|FG002|Overall Study|Adverse Event|0|||
170522918|NCT04464707|616260214|FG000|Overall Study|Withdrawal by Subject|0|||
170522919|NCT04464707|616260215|FG001|Overall Study|Withdrawal by Subject|0|||
170522920|NCT04464707|616260216|FG002|Overall Study|Withdrawal by Subject|2|||
170522921|NCT04464707|616260214|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170522922|NCT04464707|616260215|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170522923|NCT04464707|616260216|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170522924|NCT04464707|616260214|FG000|Overall Study|Protocol Deviation|1|||
170522925|NCT04464707|616260215|FG001|Overall Study|Protocol Deviation|0|||
170522926|NCT04464707|616260216|FG002|Overall Study|Protocol Deviation|0|||
170522927|NCT04464707|616260214|FG000|Overall Study|Lost to Follow-up|2|||
170522928|NCT04464707|616260215|FG001|Overall Study|Lost to Follow-up|0|||
170522929|NCT04464707|616260216|FG002|Overall Study|Lost to Follow-up|1|||
170522930|NCT01158261|616260221|FG000|Overall Study|Lost to Follow-up|9|||
170522931|NCT01158261|616260221|FG000|Overall Study|Death|7|||
170522932|NCT01158261|616260221|FG000|Overall Study|Withdrawal by Subject|1|||
170522933|NCT03143101|616260222|FG000|Overall Study|Withdrawal by Subject|0|||
170522934|NCT03143101|616260223|FG001|Overall Study|Withdrawal by Subject|1|||
170522935|NCT03143101|616260224|FG002|Overall Study|Withdrawal by Subject|0|||
170522936|NCT03143101|616260222|FG000|Overall Study|Lost to Follow-up|2|||
170522937|NCT03143101|616260223|FG001|Overall Study|Lost to Follow-up|2|||
170522938|NCT03143101|616260224|FG002|Overall Study|Lost to Follow-up|0|||
170522939|NCT05227118|616260225|FG000|Overall Study|Adverse Event|0|||
170522940|NCT05227118|616260226|FG001|Overall Study|Adverse Event|0|||
170522941|NCT05227118|616260227|FG002|Overall Study|Adverse Event|1|||
170522942|NCT05227118|616260228|FG003|Overall Study|Adverse Event|0|||
170522943|NCT05227118|616260225|FG000|Overall Study|Withdrawal by Subject|0|||
170522944|NCT05227118|616260226|FG001|Overall Study|Withdrawal by Subject|0|||
170522945|NCT05227118|616260227|FG002|Overall Study|Withdrawal by Subject|2|||
170522946|NCT05227118|616260228|FG003|Overall Study|Withdrawal by Subject|0|||
170522947|NCT01435759|616260229|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
170522948|NCT01435759|616260230|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
170522949|NCT01435759|616260231|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
170522950|NCT01435759|616260232|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
170522951|NCT01435759|616260233|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
170522952|NCT01435759|616260234|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
170522953|NCT01435759|616260229|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
170522954|NCT01435759|616260230|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
170522955|NCT01435759|616260231|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
170522956|NCT01435759|616260232|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
170522957|NCT01435759|616260233|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
170522958|NCT01435759|616260234|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
170522959|NCT01435759|616260229|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
170522960|NCT01435759|616260230|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
170522961|NCT01435759|616260231|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
170522962|NCT01435759|616260232|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
170522963|NCT01435759|616260233|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
170522964|NCT01435759|616260234|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
170522965|NCT01435759|616260229|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
170522966|NCT01435759|616260230|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
170522967|NCT01435759|616260231|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
170522968|NCT01435759|616260232|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
170871717|NCT03044249|617541707|FG000|Overall Study|Non-compliance with Study Drug|1|||
170871718|NCT03044249|617541708|FG001|Overall Study|Non-compliance with Study Drug|0|||
170871719|NCT03044249|617541707|FG000|Overall Study|Study Terminated by Sponsor|2|||
170871720|NCT03044249|617541708|FG001|Overall Study|Study Terminated by Sponsor|0|||
170871721|NCT03044249|617541707|FG000|Overall Study|Withdrawal by Subject|2|||
170871722|NCT03044249|617541708|FG001|Overall Study|Withdrawal by Subject|5|||
170871723|NCT00955279|617541709|FG000|Overall Study|Other|0|||
170871724|NCT00955279|617541710|FG001|Overall Study|Other|0|||
170871725|NCT00955279|617541711|FG002|Overall Study|Other|3|||
170522969|NCT01435759|616260233|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
170522970|NCT01435759|616260234|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
170522971|NCT01435759|616260229|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
170871726|NCT00955279|617541709|FG000|Overall Study|Death|1|||
170871727|NCT00955279|617541710|FG001|Overall Study|Death|1|||
170871728|NCT00955279|617541711|FG002|Overall Study|Death|1|||
170522972|NCT01435759|616260230|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
170871729|NCT00955279|617541709|FG000|Overall Study|Lost to Follow-up|0|||
170871730|NCT00955279|617541710|FG001|Overall Study|Lost to Follow-up|3|||
170871731|NCT00955279|617541711|FG002|Overall Study|Lost to Follow-up|1|||
170871732|NCT00955279|617541709|FG000|Overall Study|Withdrawal by Subject|2|||
170871733|NCT00955279|617541710|FG001|Overall Study|Withdrawal by Subject|0|||
170871734|NCT00955279|617541711|FG002|Overall Study|Withdrawal by Subject|3|||
170871735|NCT02663271|617541712|FG000|Overall Study|Withdrawal by Subject|5|||
170871736|NCT02663271|617541712|FG000|Overall Study|Lack of Efficacy|1|||
170871737|NCT00617604|617541713|FG000|Overall Study|Death|2|||
170871738|NCT00617604|617541714|FG001|Overall Study|Death|1|||
170871739|NCT00617604|617541713|FG000|Overall Study|Lost to Follow-up|1|||
170871740|NCT00617604|617541714|FG001|Overall Study|Lost to Follow-up|0|||
170871741|NCT00617604|617541713|FG000|Overall Study|Miscellaneous Reasons|8|||
170871742|NCT00617604|617541714|FG001|Overall Study|Miscellaneous Reasons|10|||
170871743|NCT00617604|617541713|FG000|Overall Study|Withdrawal by Subject|4|||
170871744|NCT00617604|617541714|FG001|Overall Study|Withdrawal by Subject|6|||
170871745|NCT00617604|617541713|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
170871746|NCT00617604|617541714|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
170871747|NCT00732251|617541715|FG000|Overall Study|Lost to Follow-up|3|||
170871748|NCT00732251|617541715|FG000|Overall Study|Withdrawal by Subject|3|||
170871749|NCT00732251|617541715|FG000|Overall Study|Early Term due to Site Closure|1|||
170871750|NCT04029961|617541716|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
170871751|NCT04029961|617541717|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
170871752|NCT04029961|617541716|FG000|Overall Study|Change in Treatment Course|0|||
170871753|NCT04029961|617541717|FG001|Overall Study|Change in Treatment Course|1|||
170871754|NCT02684279|617541720|FG000|Overall Study|Adverse Event|87|||
170871755|NCT02684279|617541720|FG000|Overall Study|Lack of Efficacy|4|||
170871756|NCT02684279|617541720|FG000|Overall Study|Lost to Follow-up|61|||
170871757|NCT02684279|617541720|FG000|Overall Study|Protocol Violation|6|||
170871758|NCT02684279|617541720|FG000|Overall Study|Pregnancy|8|||
170871759|NCT02684279|617541720|FG000|Overall Study|Withdrawal by Subject|92|||
170871760|NCT02684279|617541720|FG000|Overall Study|non-compliance with study drug|9|||
170871761|NCT02684279|617541720|FG000|Overall Study|non compliance with study visits|2|||
170871762|NCT02684279|617541720|FG000|Overall Study|subject to have surgery|1|||
170871763|NCT02684279|617541720|FG000|Overall Study|family emergency|1|||
170871764|NCT02684279|617541720|FG000|Overall Study|Site closures|7|||
170871765|NCT02684279|617541720|FG000|Overall Study|Physician Decision|1|||
170871766|NCT03184077|617541721|FG000|Overall Study|Lost to Follow-up|21|||
170871767|NCT03184077|617541722|FG001|Overall Study|Lost to Follow-up|21|||
170871768|NCT04136184|617541723|FG000|Overall Study|Lost to Follow-up|0|||
170871769|NCT04136184|617541724|FG001|Overall Study|Lost to Follow-up|3|||
170871770|NCT04136184|617541723|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
170871771|NCT04136184|617541724|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
170871772|NCT03318978|617541725|FG000|Overall Study|Withdrawal by Subject|1|||
170871773|NCT03007979|617541728|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
170871774|NCT03734016|617541729|FG000|Overall Study|Sponsor Ended Study|225|||
170871775|NCT03734016|617541730|FG001|Overall Study|Sponsor Ended Study|200|||
170871776|NCT03734016|617541729|FG000|Overall Study|Death|69|||
170871777|NCT03734016|617541730|FG001|Overall Study|Death|83|||
170871778|NCT03734016|617541729|FG000|Overall Study|Withdrawal by Subject|21|||
170871779|NCT03734016|617541730|FG001|Overall Study|Withdrawal by Subject|27|||
170871780|NCT03734016|617541729|FG000|Overall Study|Physician Decision|1|||
170871781|NCT03734016|617541730|FG001|Overall Study|Physician Decision|12|||
170871782|NCT03734016|617541729|FG000|Overall Study|Lost to Follow-up|6|||
170871783|NCT03734016|617541730|FG001|Overall Study|Lost to Follow-up|2|||
170871784|NCT03734016|617541729|FG000|Overall Study|Miscellaneous|5|||
170871785|NCT03734016|617541730|FG001|Overall Study|Miscellaneous|1|||
170871786|NCT01298518|617541731|FG000|Overall Study|Withdrawal by Subject|0|||
170871787|NCT01298518|617541732|FG001|Overall Study|Withdrawal by Subject|0|||
170871788|NCT01298518|617541733|FG002|Overall Study|Withdrawal by Subject|1|||
170871789|NCT02273726|617541734|FG000|Overall Study|Death|70|||
170871790|NCT02273726|617541735|FG001|Overall Study|Death|62|||
170871791|NCT02273726|617541734|FG000|Overall Study|Withdrawal by Subject|41|||
170871792|NCT02273726|617541735|FG001|Overall Study|Withdrawal by Subject|29|||
170871793|NCT02273726|617541734|FG000|Overall Study|Kidney transplant|31|||
170871794|NCT02273726|617541735|FG001|Overall Study|Kidney transplant|39|||
170871795|NCT02273726|617541734|FG000|Overall Study|Physician Decision|30|||
170412856|NCT01215942|615851905|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
170412857|NCT01215942|615851906|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
170871796|NCT02273726|617541735|FG001|Overall Study|Physician Decision|15|||
170871797|NCT02273726|617541734|FG000|Overall Study|Adverse Event|27|||
170871798|NCT02273726|617541735|FG001|Overall Study|Adverse Event|9|||
170871799|NCT02273726|617541734|FG000|Overall Study|Lost to Follow-up|6|||
170871800|NCT02273726|617541735|FG001|Overall Study|Lost to Follow-up|3|||
170871801|NCT02273726|617541734|FG000|Overall Study|Lack of Efficacy|6|||
170871802|NCT02273726|617541735|FG001|Overall Study|Lack of Efficacy|1|||
170871803|NCT02273726|617541734|FG000|Overall Study|Protocol Violation|4|||
170871804|NCT02273726|617541735|FG001|Overall Study|Protocol Violation|0|||
170871805|NCT02273726|617541734|FG000|Overall Study|Other than specified|28|||
170871806|NCT02273726|617541735|FG001|Overall Study|Other than specified|30|||
170871807|NCT03697720|617542995|FG000|Overall Study|Lost to Follow-up|7|||
170871808|NCT00382720|617542999|FG000|Overall Study|Adverse Event|21|||
170871809|NCT00382720|617543000|FG001|Overall Study|Adverse Event|23|||
170871810|NCT00382720|617543001|FG002|Overall Study|Adverse Event|15|||
170871811|NCT00382720|617542999|FG000|Overall Study|Protocol Violation|2|||
170871812|NCT00382720|617543000|FG001|Overall Study|Protocol Violation|5|||
170871813|NCT00382720|617543001|FG002|Overall Study|Protocol Violation|1|||
170871814|NCT00382720|617542999|FG000|Overall Study|Death|0|||
170871815|NCT00382720|617543000|FG001|Overall Study|Death|1|||
170871816|NCT00382720|617543001|FG002|Overall Study|Death|2|||
170871817|NCT00382720|617542999|FG000|Overall Study|Progressive disease|37|||
170871818|NCT00382720|617543000|FG001|Overall Study|Progressive disease|28|||
170871819|NCT00382720|617543001|FG002|Overall Study|Progressive disease|38|||
170871820|NCT00382720|617542999|FG000|Overall Study|Withdrew consent|1|||
170871821|NCT00382720|617543000|FG001|Overall Study|Withdrew consent|1|||
170871822|NCT00382720|617543001|FG002|Overall Study|Withdrew consent|2|||
170871823|NCT00382720|617542999|FG000|Overall Study|Withdrawal by Subject|11|||
170871824|NCT00382720|617543000|FG001|Overall Study|Withdrawal by Subject|20|||
170871825|NCT00382720|617543001|FG002|Overall Study|Withdrawal by Subject|12|||
170871826|NCT00382720|617542999|FG000|Overall Study|Surgery|1|||
170871827|NCT00382720|617543000|FG001|Overall Study|Surgery|1|||
170871828|NCT00382720|617543001|FG002|Overall Study|Surgery|4|||
170871829|NCT00382720|617542999|FG000|Overall Study|Patient did not receive study medication|1|||
170871830|NCT00382720|617543000|FG001|Overall Study|Patient did not receive study medication|1|||
170871831|NCT00382720|617543001|FG002|Overall Study|Patient did not receive study medication|4|||
170871832|NCT00382720|617542999|FG000|Overall Study|Clinically progressive disease|0|||
170871833|NCT00382720|617543000|FG001|Overall Study|Clinically progressive disease|1|||
170871834|NCT00382720|617543001|FG002|Overall Study|Clinically progressive disease|0|||
170871835|NCT00382720|617542999|FG000|Overall Study|Good prognosis|0|||
170871836|NCT00382720|617543000|FG001|Overall Study|Good prognosis|1|||
170871837|NCT00382720|617543001|FG002|Overall Study|Good prognosis|0|||
170871838|NCT00382720|617542999|FG000|Overall Study|Investigator/Clinical decision|5|||
170871839|NCT00382720|617543000|FG001|Overall Study|Investigator/Clinical decision|6|||
170871840|NCT00382720|617543001|FG002|Overall Study|Investigator/Clinical decision|6|||
170871841|NCT00382720|617542999|FG000|Overall Study|Discontinued at end of study|0|||
170871842|NCT00382720|617543000|FG001|Overall Study|Discontinued at end of study|1|||
170871843|NCT00382720|617543001|FG002|Overall Study|Discontinued at end of study|2|||
170871844|NCT02737852|617543004|FG000|Overall Study|Withdrawal by Subject|2|||
170871845|NCT01717287|617543005|FG000|Overall Study|Lost to Follow-up|0|||
170871846|NCT01717287|617543006|FG001|Overall Study|Lost to Follow-up|2|||
170871847|NCT01717287|617543005|FG000|Overall Study|Protocol Violation|0|||
170871848|NCT01717287|617543006|FG001|Overall Study|Protocol Violation|1|||
170871849|NCT00880555|617543007|FG000|Overall Study|Physician Decision|0|||
170871850|NCT00880555|617543008|FG001|Overall Study|Physician Decision|8|||
170871851|NCT00880555|617543009|FG002|Overall Study|Physician Decision|0|||
170871852|NCT00880555|617543010|FG003|Overall Study|Physician Decision|2|||
170871853|NCT00880555|617543011|FG004|Overall Study|Physician Decision|1|||
170871854|NCT00880555|617543012|FG005|Overall Study|Physician Decision|0|||
170871855|NCT00880555|617543007|FG000|Overall Study|Withdrawal by Subject|1|||
170871856|NCT00880555|617543008|FG001|Overall Study|Withdrawal by Subject|1|||
170871857|NCT00880555|617543009|FG002|Overall Study|Withdrawal by Subject|0|||
170871858|NCT00880555|617543010|FG003|Overall Study|Withdrawal by Subject|0|||
170871859|NCT00880555|617543011|FG004|Overall Study|Withdrawal by Subject|0|||
170871860|NCT00880555|617543012|FG005|Overall Study|Withdrawal by Subject|0|||
170871861|NCT00880555|617543007|FG000|Overall Study|Lack of resources (hired rater)|9|||
170871862|NCT00880555|617543008|FG001|Overall Study|Lack of resources (hired rater)|7|||
170871863|NCT00880555|617543009|FG002|Overall Study|Lack of resources (hired rater)|5|||
170871864|NCT00880555|617543010|FG003|Overall Study|Lack of resources (hired rater)|0|||
170871865|NCT00880555|617543011|FG004|Overall Study|Lack of resources (hired rater)|0|||
170871866|NCT00880555|617543012|FG005|Overall Study|Lack of resources (hired rater)|0|||
170871867|NCT00880555|617543007|FG000|Overall Study|Death|0|||
170871868|NCT00880555|617543008|FG001|Overall Study|Death|0|||
170871869|NCT00880555|617543009|FG002|Overall Study|Death|0|||
170871870|NCT00880555|617543010|FG003|Overall Study|Death|0|||
170871871|NCT00880555|617543011|FG004|Overall Study|Death|0|||
170871872|NCT00880555|617543012|FG005|Overall Study|Death|1|||
170871873|NCT00880555|617543007|FG000|Overall Study|Lost to Follow-up|0|||
170871874|NCT00880555|617543008|FG001|Overall Study|Lost to Follow-up|1|||
170871875|NCT00880555|617543009|FG002|Overall Study|Lost to Follow-up|0|||
170871876|NCT00880555|617543010|FG003|Overall Study|Lost to Follow-up|0|||
170412858|NCT02752776|615851907|FG000|Overall Study|Adverse Event|15|||
170871877|NCT00880555|617543011|FG004|Overall Study|Lost to Follow-up|0|||
170412859|NCT02752776|615851908|FG001|Overall Study|Adverse Event|23|||
170412860|NCT02752776|615851909|FG002|Overall Study|Adverse Event|11|||
170412861|NCT02752776|615851907|FG000|Overall Study|Lack of Efficacy|2|||
170871878|NCT00880555|617543012|FG005|Overall Study|Lost to Follow-up|0|||
170871879|NCT00388505|617543020|FG000|Overall Study|Adverse Event or Death|43|||
170871880|NCT00388505|617543021|FG001|Overall Study|Adverse Event or Death|17|||
170871881|NCT00388505|617543020|FG000|Overall Study|Withdrawal by Subject|24|||
170871882|NCT00388505|617543021|FG001|Overall Study|Withdrawal by Subject|9|||
170871883|NCT00388505|617543020|FG000|Overall Study|Lost to Follow-up|5|||
170871884|NCT00388505|617543021|FG001|Overall Study|Lost to Follow-up|3|||
170871885|NCT00388505|617543020|FG000|Overall Study|Inappropriate Enrollment|0|||
170871886|NCT00388505|617543021|FG001|Overall Study|Inappropriate Enrollment|1|||
170871887|NCT00388505|617543020|FG000|Overall Study|Administrative Reason|1|||
170871888|NCT00388505|617543021|FG001|Overall Study|Administrative Reason|0|||
170871889|NCT00388505|617543020|FG000|Overall Study|Protocol Violation|6|||
170871890|NCT00388505|617543021|FG001|Overall Study|Protocol Violation|5|||
170871891|NCT00388505|617543020|FG000|Overall Study|Unable to classify|4|||
170871892|NCT00388505|617543021|FG001|Overall Study|Unable to classify|3|||
170871893|NCT02573870|617543025|FG000|Overall Study|Adverse Event|0|||
170871894|NCT02573870|617543026|FG001|Overall Study|Adverse Event|2|||
170871895|NCT02573870|617543025|FG000|Overall Study|Lack of Efficacy|0|||
170871896|NCT02573870|617543026|FG001|Overall Study|Lack of Efficacy|1|||
170871897|NCT02573870|617543025|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
170871898|NCT02573870|617543026|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
170871899|NCT02573870|617543025|FG000|Overall Study|Lost to Follow-up|0|||
170871900|NCT02573870|617543026|FG001|Overall Study|Lost to Follow-up|1|||
170871901|NCT02573870|617543025|FG000|Overall Study|Other: Fail to Meet Visit|0|||
170871902|NCT02573870|617543026|FG001|Overall Study|Other: Fail to Meet Visit|2|||
170871903|NCT01227187|617543027|FG000|Overall Study|Physician Decision|0|||
170871904|NCT01227187|617543028|FG001|Overall Study|Physician Decision|0|||
170871905|NCT01227187|617543029|FG002|Overall Study|Physician Decision|0|||
170871906|NCT01227187|617543030|FG003|Overall Study|Physician Decision|1|||
170871907|NCT01756040|617543031|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
170871908|NCT01756040|617543031|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
170871909|NCT01756040|617543031|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
170871910|NCT02081534|617543036|FG000|Overall Study|Adverse Event|5|||
170871911|NCT02081534|617543037|FG001|Overall Study|Adverse Event|4|||
170871912|NCT02081534|617543038|FG002|Overall Study|Adverse Event|3|||
170871913|NCT02081534|617543039|FG003|Overall Study|Adverse Event|10|||
170871914|NCT02081534|617543040|FG004|Overall Study|Adverse Event|2|||
170871915|NCT02081534|617543041|FG005|Overall Study|Adverse Event|8|||
170871916|NCT02081534|617543042|FG006|Overall Study|Adverse Event|2|||
170871917|NCT02081534|617543036|FG000|Overall Study|Withdrawal by Subject|0|||
170871918|NCT02081534|617543037|FG001|Overall Study|Withdrawal by Subject|1|||
170871919|NCT02081534|617543038|FG002|Overall Study|Withdrawal by Subject|1|||
170871920|NCT02081534|617543039|FG003|Overall Study|Withdrawal by Subject|1|||
170871921|NCT02081534|617543040|FG004|Overall Study|Withdrawal by Subject|1|||
170871922|NCT02081534|617543041|FG005|Overall Study|Withdrawal by Subject|0|||
170871923|NCT02081534|617543042|FG006|Overall Study|Withdrawal by Subject|1|||
170871924|NCT02081534|617543036|FG000|Overall Study|Protocol Violation|0|||
170871925|NCT02081534|617543037|FG001|Overall Study|Protocol Violation|3|||
170871926|NCT02081534|617543038|FG002|Overall Study|Protocol Violation|0|||
170871927|NCT02081534|617543039|FG003|Overall Study|Protocol Violation|0|||
170871928|NCT02081534|617543040|FG004|Overall Study|Protocol Violation|0|||
170871929|NCT02081534|617543041|FG005|Overall Study|Protocol Violation|0|||
170871930|NCT02081534|617543042|FG006|Overall Study|Protocol Violation|1|||
170871931|NCT02081534|617543036|FG000|Overall Study|Lost to Follow-up|0|||
170871932|NCT02081534|617543037|FG001|Overall Study|Lost to Follow-up|0|||
170871933|NCT02081534|617543038|FG002|Overall Study|Lost to Follow-up|0|||
170871934|NCT02081534|617543039|FG003|Overall Study|Lost to Follow-up|2|||
170871935|NCT02081534|617543040|FG004|Overall Study|Lost to Follow-up|1|||
170871936|NCT02081534|617543041|FG005|Overall Study|Lost to Follow-up|1|||
170871937|NCT02081534|617543042|FG006|Overall Study|Lost to Follow-up|0|||
170522973|NCT01435759|616260231|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
170522974|NCT01435759|616260232|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
170522975|NCT01435759|616260233|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
170522976|NCT01435759|616260234|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
170871938|NCT01274715|617543043|FG000|Overall Study|Lost to Follow-up|1|||
170871939|NCT01274715|617543043|FG000|Overall Study|After consent, met exclusion criteria.|1|||
170871940|NCT01274715|617543043|FG000|Overall Study|After consent, met exclusion criteria.|1|||
170871941|NCT01274715|617543043|FG000|Overall Study|After consent, met exclusion criteria.|1|||
170871942|NCT04479436|617543046|FG000|Overall Study|Progressive disease|26|||
170871943|NCT04479436|617543047|FG001|Overall Study|Progressive disease|1|||
170871944|NCT04479436|617543046|FG000|Overall Study|Adverse Event|6|||
170871945|NCT04479436|617543047|FG001|Overall Study|Adverse Event|0|||
170871946|NCT04479436|617543046|FG000|Overall Study|Withdrawal by Subject|5|||
170522977|NCT01435759|616260229|FG000|Antidepressant Lead-in Phase|Other|119|||
170871947|NCT04479436|617543047|FG001|Overall Study|Withdrawal by Subject|0|||
170871948|NCT04479436|617543046|FG000|Overall Study|Clinical progression|1|||
170871949|NCT04479436|617543047|FG001|Overall Study|Clinical progression|0|||
170522978|NCT01435759|616260230|FG001|Antidepressant Lead-in Phase|Other|0|||
170522979|NCT01435759|616260231|FG002|Antidepressant Lead-in Phase|Other|0|||
170522980|NCT01435759|616260232|FG003|Antidepressant Lead-in Phase|Other|0|||
170522981|NCT01435759|616260233|FG004|Antidepressant Lead-in Phase|Other|0|||
170522982|NCT01435759|616260234|FG005|Antidepressant Lead-in Phase|Other|0|||
170522983|NCT01435759|616260229|FG000|Double-blind Phase|Adverse Event|7|||
170522984|NCT01435759|616260230|FG001|Double-blind Phase|Adverse Event|0|||
170522985|NCT01435759|616260231|FG002|Double-blind Phase|Adverse Event|1|||
170522986|NCT01435759|616260232|FG003|Double-blind Phase|Adverse Event|1|||
170522987|NCT01435759|616260233|FG004|Double-blind Phase|Adverse Event|1|||
170522988|NCT01435759|616260234|FG005|Double-blind Phase|Adverse Event|3|||
170522989|NCT01435759|616260229|FG000|Double-blind Phase|Protocol Violation|2|||
170522990|NCT01435759|616260230|FG001|Double-blind Phase|Protocol Violation|0|||
170522991|NCT01435759|616260231|FG002|Double-blind Phase|Protocol Violation|1|||
170522992|NCT01435759|616260232|FG003|Double-blind Phase|Protocol Violation|2|||
170522993|NCT01435759|616260233|FG004|Double-blind Phase|Protocol Violation|0|||
170522994|NCT01435759|616260234|FG005|Double-blind Phase|Protocol Violation|1|||
170522995|NCT01435759|616260229|FG000|Double-blind Phase|Withdrawal by Subject|17|||
170522996|NCT01435759|616260230|FG001|Double-blind Phase|Withdrawal by Subject|4|||
170522997|NCT01435759|616260231|FG002|Double-blind Phase|Withdrawal by Subject|3|||
170522998|NCT01435759|616260232|FG003|Double-blind Phase|Withdrawal by Subject|4|||
170522999|NCT01435759|616260233|FG004|Double-blind Phase|Withdrawal by Subject|2|||
170523000|NCT01435759|616260234|FG005|Double-blind Phase|Withdrawal by Subject|2|||
170523001|NCT01435759|616260229|FG000|Double-blind Phase|Lost to Follow-up|31|||
170523002|NCT01435759|616260230|FG001|Double-blind Phase|Lost to Follow-up|1|||
170523003|NCT01435759|616260231|FG002|Double-blind Phase|Lost to Follow-up|2|||
170523004|NCT01435759|616260232|FG003|Double-blind Phase|Lost to Follow-up|0|||
170523005|NCT01435759|616260233|FG004|Double-blind Phase|Lost to Follow-up|3|||
170523006|NCT01435759|616260234|FG005|Double-blind Phase|Lost to Follow-up|3|||
170523007|NCT01435759|616260229|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
170523008|NCT01435759|616260230|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
170523009|NCT01435759|616260231|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
170523010|NCT01435759|616260232|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
170523011|NCT01435759|616260233|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
170523012|NCT01435759|616260234|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
170523013|NCT01435759|616260229|FG000|Double-blind Phase|Other|8|||
170523014|NCT01435759|616260230|FG001|Double-blind Phase|Other|2|||
170523015|NCT01435759|616260231|FG002|Double-blind Phase|Other|0|||
170523016|NCT01435759|616260232|FG003|Double-blind Phase|Other|2|||
170523017|NCT01435759|616260233|FG004|Double-blind Phase|Other|0|||
170871950|NCT04479436|617543046|FG000|Overall Study|Physician Decision|1|||
170871951|NCT04479436|617543047|FG001|Overall Study|Physician Decision|0|||
170871952|NCT01841749|617543049|FG000|Overall Study|Protocol Violation|1|||
170871953|NCT01480284|617543057|FG000|Overall Study|Withdrawal by Subject|2|||
170871954|NCT01480284|617543058|FG001|Overall Study|Withdrawal by Subject|0|||
170871955|NCT01480284|617543057|FG000|Overall Study|Adverse Event|1|||
170871956|NCT01480284|617543058|FG001|Overall Study|Adverse Event|0|||
170871957|NCT01480284|617543057|FG000|Overall Study|Study closed/terminated|3|||
170871958|NCT01480284|617543058|FG001|Overall Study|Study closed/terminated|0|||
170871959|NCT01480284|617543057|FG000|Overall Study|Lost to Follow-up|1|||
170871960|NCT01480284|617543058|FG001|Overall Study|Lost to Follow-up|0|||
170871961|NCT01480284|617543057|FG000|Overall Study|Physician Decision|1|||
170871962|NCT01480284|617543058|FG001|Overall Study|Physician Decision|0|||
170871963|NCT02357134|617543059|FG000|Overall Study|Lost to Follow-up|1|||
170871964|NCT02357134|617543060|FG001|Overall Study|Lost to Follow-up|0|||
170871965|NCT02357134|617543061|FG002|Overall Study|Lost to Follow-up|0|||
170871966|NCT02357134|617543062|FG003|Overall Study|Lost to Follow-up|0|||
170871967|NCT02716675|617543064|FG000|Overall Study|Death|2|||
170871968|NCT02716675|617543065|FG001|Overall Study|Death|3|||
170871969|NCT02716675|617543066|FG002|Overall Study|Death|0|||
170871970|NCT02716675|617543064|FG000|Overall Study|Physician Decision|2|||
170871971|NCT02716675|617543065|FG001|Overall Study|Physician Decision|1|||
170871972|NCT02716675|617543066|FG002|Overall Study|Physician Decision|1|||
170871973|NCT02716675|617543064|FG000|Overall Study|Lost to Follow-up|100|||
170523018|NCT01435759|616260234|FG005|Double-blind Phase|Other|0|||
170523019|NCT01601496|616260238|FG000|Overall Study|Physician Decision|1|||
170523020|NCT01601496|616260238|FG000|Overall Study|Withdrawal by Subject|1|||
170523021|NCT01601496|616260238|FG000|Overall Study|Lost to Follow-up|6|||
170523022|NCT01601496|616260238|FG000|Overall Study|Death|4|||
170523023|NCT01601496|616260238|FG000|Overall Study|Other: patient refusal to continue|3|||
170523024|NCT00227539|616260239|FG000|Overall Study|Protocol Violation|1|||
170523025|NCT04552132|616260243|FG000|Overall Study|Lost to Follow-up|4|||
170523026|NCT04552132|616260244|FG001|Overall Study|Lost to Follow-up|3|||
170523027|NCT04552132|616260243|FG000|Overall Study|Protocol Violation|1|||
170523028|NCT04552132|616260244|FG001|Overall Study|Protocol Violation|0|||
170871974|NCT02716675|617543065|FG001|Overall Study|Lost to Follow-up|87|||
170871975|NCT02716675|617543066|FG002|Overall Study|Lost to Follow-up|99|||
170871976|NCT02716675|617543064|FG000|Overall Study|Withdrawal by Subject|22|||
170523029|NCT04157088|616260246|FG000|Overall Study|Study terminated by sponsor|23|||
170523030|NCT04157088|616260246|FG000|Overall Study|Withdrawal by Subject|4|||
170523031|NCT04157088|616260246|FG000|Overall Study|Lost to Follow-up|2|||
170523032|NCT04157088|616260246|FG000|Overall Study|Death|1|||
170523033|NCT01705977|616260247|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
170523034|NCT01705977|616260248|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
170523035|NCT01705977|616260247|FG000|Treatment Period (Year 1)|Adverse Event|57|||
170523036|NCT01705977|616260248|FG001|Treatment Period (Year 1)|Adverse Event|49|||
170523037|NCT01705977|616260247|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
170523038|NCT01705977|616260248|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
170523039|NCT01705977|616260247|FG000|Treatment Period (Year 1)|Site closure|3|||
170523040|NCT01705977|616260248|FG001|Treatment Period (Year 1)|Site closure|2|||
170523041|NCT01705977|616260247|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
170523042|NCT01705977|616260248|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
170523043|NCT01705977|616260247|FG000|Treatment Period (Year 1)|Physician Decision|48|||
170523044|NCT01705977|616260248|FG001|Treatment Period (Year 1)|Physician Decision|38|||
170523045|NCT01705977|616260247|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
170523046|NCT01705977|616260248|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
170523047|NCT01705977|616260247|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
170523048|NCT01705977|616260248|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
170523049|NCT01705977|616260247|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
170523050|NCT01705977|616260248|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
170523051|NCT01705977|616260247|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
170523052|NCT01705977|616260248|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
170523053|NCT01705977|616260247|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
170523054|NCT01705977|616260248|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
170523055|NCT01705977|616260247|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
170523056|NCT01705977|616260248|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
170523057|NCT00248651|616260249|FG000|Overall Study|Withdrawal by Subject|28|||
170770039|NCT03388632|617162694|FG008|Triplet C|Clinical progression|0|||
170770040|NCT03388632|617162686|FG000|Triplet C|42-day lapse in tx|0|||
170770041|NCT03388632|617162687|FG001|Triplet C|42-day lapse in tx|0|||
170770042|NCT03388632|617162688|FG002|Triplet C|42-day lapse in tx|0|||
170770043|NCT03388632|617162689|FG003|Triplet C|42-day lapse in tx|0|||
170770044|NCT03388632|617162690|FG004|Triplet C|42-day lapse in tx|1|||
170770045|NCT03388632|617162691|FG005|Triplet C|42-day lapse in tx|0|||
170770046|NCT03388632|617162692|FG006|Triplet C|42-day lapse in tx|0|||
170770047|NCT03388632|617162693|FG007|Triplet C|42-day lapse in tx|0|||
170770048|NCT03388632|617162694|FG008|Triplet C|42-day lapse in tx|0|||
170770049|NCT03388632|617162686|FG000|Triplet C|Adverse Event|0|||
170770050|NCT03388632|617162687|FG001|Triplet C|Adverse Event|0|||
170770051|NCT03388632|617162688|FG002|Triplet C|Adverse Event|0|||
170770052|NCT03388632|617162689|FG003|Triplet C|Adverse Event|0|||
170770053|NCT03388632|617162690|FG004|Triplet C|Adverse Event|0|||
170770054|NCT03388632|617162691|FG005|Triplet C|Adverse Event|0|||
170770055|NCT03388632|617162692|FG006|Triplet C|Adverse Event|0|||
170770056|NCT03388632|617162693|FG007|Triplet C|Adverse Event|0|||
170770057|NCT03388632|617162694|FG008|Triplet C|Adverse Event|1|||
170770058|NCT03388632|617162686|FG000|Triplet C|Switched to alternative treatment|0|||
170770059|NCT03388632|617162687|FG001|Triplet C|Switched to alternative treatment|0|||
170770060|NCT03388632|617162688|FG002|Triplet C|Switched to alternative treatment|0|||
170770061|NCT03388632|617162689|FG003|Triplet C|Switched to alternative treatment|0|||
170770062|NCT03388632|617162690|FG004|Triplet C|Switched to alternative treatment|0|||
170770063|NCT03388632|617162691|FG005|Triplet C|Switched to alternative treatment|0|||
170770064|NCT03388632|617162692|FG006|Triplet C|Switched to alternative treatment|0|||
170770065|NCT03388632|617162693|FG007|Triplet C|Switched to alternative treatment|1|||
170770066|NCT03388632|617162694|FG008|Triplet C|Switched to alternative treatment|0|||
170770067|NCT03388632|617162686|FG000|Triplet C|Participant choice|0|||
170770068|NCT03388632|617162687|FG001|Triplet C|Participant choice|0|||
170770069|NCT03388632|617162688|FG002|Triplet C|Participant choice|0|||
170770070|NCT03388632|617162689|FG003|Triplet C|Participant choice|0|||
170770071|NCT03388632|617162690|FG004|Triplet C|Participant choice|0|||
170770072|NCT03388632|617162691|FG005|Triplet C|Participant choice|1|||
170770073|NCT03388632|617162692|FG006|Triplet C|Participant choice|0|||
170770074|NCT03388632|617162693|FG007|Triplet C|Participant choice|0|||
170770075|NCT03388632|617162694|FG008|Triplet C|Participant choice|0|||
170770076|NCT01579916|617162699|FG000|Overall Study|Lost to Follow-up|6|||
170770077|NCT01579916|617162700|FG001|Overall Study|Lost to Follow-up|1|||
170770078|NCT01579916|617162699|FG000|Overall Study|Withdrawal by Subject|1|||
170770079|NCT01579916|617162700|FG001|Overall Study|Withdrawal by Subject|1|||
170523058|NCT00248651|616260250|FG001|Overall Study|Withdrawal by Subject|40|||
170523059|NCT00248651|616260251|FG002|Overall Study|Withdrawal by Subject|32|||
170632182|NCT00538902|616664551|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
170770080|NCT01579916|617162699|FG000|Overall Study|Death|1|||
170770081|NCT01579916|617162700|FG001|Overall Study|Death|0|||
170871977|NCT02716675|617543065|FG001|Overall Study|Withdrawal by Subject|25|||
170523060|NCT01275144|616260254|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
170523061|NCT01275144|616260255|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
170523062|NCT00828113|616260256|FG000|Overall Study|Withdrawal by Subject|27|||
170523063|NCT00828113|616260257|FG001|Overall Study|Withdrawal by Subject|26|||
170523064|NCT00828113|616260256|FG000|Overall Study|Lost to Follow-up|3|||
170523065|NCT00828113|616260257|FG001|Overall Study|Lost to Follow-up|5|||
170523066|NCT01365130|616260258|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
170523067|NCT05067972|616260259|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
170523068|NCT05067972|616260260|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
170523069|NCT05067972|616260261|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
170523070|NCT05067972|616260262|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
170523071|NCT05067972|616260263|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
170523072|NCT05067972|616260264|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
170523073|NCT05067972|616260265|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
170523074|NCT05067972|616260259|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
170523075|NCT05067972|616260260|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
170523076|NCT05067972|616260261|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
170523077|NCT05067972|616260262|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
170523078|NCT05067972|616260263|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
170523079|NCT05067972|616260264|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
170523080|NCT05067972|616260265|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
170523081|NCT05067972|616260259|FG000|Part 1: Treatment|Progressive Disease|3|||
170523082|NCT05067972|616260260|FG001|Part 1: Treatment|Progressive Disease|3|||
170523083|NCT05067972|616260261|FG002|Part 1: Treatment|Progressive Disease|4|||
170523084|NCT05067972|616260262|FG003|Part 1: Treatment|Progressive Disease|2|||
170523085|NCT05067972|616260263|FG004|Part 1: Treatment|Progressive Disease|3|||
170523086|NCT05067972|616260264|FG005|Part 1: Treatment|Progressive Disease|0|||
170523087|NCT05067972|616260265|FG006|Part 1: Treatment|Progressive Disease|2|||
170523088|NCT05067972|616260259|FG000|Part 1: Treatment|Physician Decision|0|||
170523089|NCT05067972|616260260|FG001|Part 1: Treatment|Physician Decision|0|||
170523090|NCT05067972|616260261|FG002|Part 1: Treatment|Physician Decision|0|||
170523091|NCT05067972|616260262|FG003|Part 1: Treatment|Physician Decision|1|||
170523092|NCT05067972|616260263|FG004|Part 1: Treatment|Physician Decision|0|||
170523093|NCT05067972|616260264|FG005|Part 1: Treatment|Physician Decision|0|||
170523094|NCT05067972|616260265|FG006|Part 1: Treatment|Physician Decision|0|||
170523095|NCT05067972|616260259|FG000|Part 1: Treatment|Death|0|||
170523096|NCT05067972|616260260|FG001|Part 1: Treatment|Death|0|||
170770082|NCT03264456|617162703|FG000|Overall Study|Withdrawal by Subject|3|||
170770083|NCT03264456|617162703|FG000|Overall Study|Lost to Follow-up|1|||
170770084|NCT01123083|617162712|FG000|Overall Study|Investigator recommendation|1|||
170770085|NCT01123083|617162713|FG001|Overall Study|Investigator recommendation|1|||
170770086|NCT01123083|617162712|FG000|Overall Study|Administrative reasons|0|||
170770087|NCT01123083|617162713|FG001|Overall Study|Administrative reasons|4|||
170770088|NCT01123083|617162712|FG000|Overall Study|Lost to Follow-up|2|||
170770089|NCT01123083|617162713|FG001|Overall Study|Lost to Follow-up|6|||
170770090|NCT01123083|617162712|FG000|Overall Study|Adverse Event|1|||
170770091|NCT01123083|617162713|FG001|Overall Study|Adverse Event|0|||
170770092|NCT01123083|617162712|FG000|Overall Study|Withdrew for another reason not covered|0|||
170770093|NCT01123083|617162713|FG001|Overall Study|Withdrew for another reason not covered|1|||
170770094|NCT01123083|617162712|FG000|Overall Study|Participant/legal representative request|7|||
170770095|NCT01123083|617162713|FG001|Overall Study|Participant/legal representative request|3|||
170770096|NCT00617201|617162714|FG000|Overall Study|Lost to Follow-up|9|||
170770097|NCT00617201|617162715|FG001|Overall Study|Lost to Follow-up|13|||
170770098|NCT00546871|617162716|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
170770099|NCT00546871|617162717|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
170770100|NCT00546871|617162716|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
170770101|NCT00546871|617162717|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
170770102|NCT00546871|617162716|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
170770103|NCT00546871|617162717|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
170770104|NCT00546871|617162716|FG000|Study Extension Period|Protocol Violation|1|||
170770105|NCT00546871|617162717|FG001|Study Extension Period|Protocol Violation|0|||
170770106|NCT00546871|617162716|FG000|Study Extension Period|Withdrawal by Subject|0|||
170770107|NCT00546871|617162717|FG001|Study Extension Period|Withdrawal by Subject|1|||
170770108|NCT02106442|617162719|FG000|Overall Study|Case Report Forms Uncollected|7|||
170770109|NCT02106442|617162719|FG000|Overall Study|Protocol Deviation|30|||
170770110|NCT05850520|617162721|FG000|Overall Study|Withdrawal by Subject|8|||
170770111|NCT05850520|617162722|FG001|Overall Study|Withdrawal by Subject|8|||
170770112|NCT05850520|617162723|FG002|Overall Study|Withdrawal by Subject|16|||
170770113|NCT05850520|617162721|FG000|Overall Study|Lost to Follow-up|2|||
170770114|NCT05850520|617162722|FG001|Overall Study|Lost to Follow-up|2|||
170770115|NCT05850520|617162723|FG002|Overall Study|Lost to Follow-up|2|||
170770116|NCT05850520|617162721|FG000|Overall Study|Death|2|||
170770117|NCT05850520|617162722|FG001|Overall Study|Death|2|||
170770118|NCT05850520|617162723|FG002|Overall Study|Death|3|||
170523097|NCT05067972|616260261|FG002|Part 1: Treatment|Death|0|||
170523098|NCT05067972|616260262|FG003|Part 1: Treatment|Death|2|||
170523099|NCT05067972|616260263|FG004|Part 1: Treatment|Death|0|||
170523100|NCT05067972|616260264|FG005|Part 1: Treatment|Death|0|||
170523101|NCT05067972|616260265|FG006|Part 1: Treatment|Death|0|||
170523102|NCT05067972|616260259|FG000|Part 1: Treatment|Adverse Event|0|||
170523103|NCT05067972|616260260|FG001|Part 1: Treatment|Adverse Event|0|||
170523104|NCT05067972|616260261|FG002|Part 1: Treatment|Adverse Event|0|||
170523105|NCT05067972|616260262|FG003|Part 1: Treatment|Adverse Event|0|||
170523106|NCT05067972|616260263|FG004|Part 1: Treatment|Adverse Event|0|||
170523107|NCT05067972|616260264|FG005|Part 1: Treatment|Adverse Event|2|||
170523108|NCT05067972|616260265|FG006|Part 1: Treatment|Adverse Event|1|||
170523109|NCT05067972|616260259|FG000|Part 1: Follow-up|Adverse Event|0|||
170523110|NCT05067972|616260260|FG001|Part 1: Follow-up|Adverse Event|0|||
170523111|NCT05067972|616260261|FG002|Part 1: Follow-up|Adverse Event|0|||
170523112|NCT05067972|616260262|FG003|Part 1: Follow-up|Adverse Event|0|||
170523113|NCT05067972|616260263|FG004|Part 1: Follow-up|Adverse Event|0|||
170523114|NCT05067972|616260264|FG005|Part 1: Follow-up|Adverse Event|1|||
170523115|NCT05067972|616260265|FG006|Part 1: Follow-up|Adverse Event|0|||
170523116|NCT05067972|616260259|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
170523117|NCT05067972|616260260|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
170523118|NCT05067972|616260261|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
170523119|NCT05067972|616260262|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
170523120|NCT05067972|616260263|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
170523121|NCT05067972|616260264|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
170523122|NCT05067972|616260265|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
170523123|NCT05067972|616260259|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
170523124|NCT05067972|616260260|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
170770119|NCT05850520|617162721|FG000|Overall Study|Adverse Event|2|||
170770120|NCT05850520|617162722|FG001|Overall Study|Adverse Event|0|||
170770121|NCT05850520|617162723|FG002|Overall Study|Adverse Event|1|||
170770122|NCT05850520|617162721|FG000|Overall Study|Physician Decision|0|||
170770123|NCT05850520|617162722|FG001|Overall Study|Physician Decision|1|||
170770124|NCT05850520|617162723|FG002|Overall Study|Physician Decision|0|||
170770125|NCT05850520|617162721|FG000|Overall Study|Protocol deviation|0|||
170770126|NCT05850520|617162722|FG001|Overall Study|Protocol deviation|0|||
170770127|NCT05850520|617162723|FG002|Overall Study|Protocol deviation|1|||
170770128|NCT05850520|617162721|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
170770129|NCT05850520|617162722|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
170770130|NCT05850520|617162723|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
170770131|NCT03889925|617163669|FG000|Overall Study|Lost to Follow-up|11|||
170770132|NCT03889925|617163670|FG001|Overall Study|Lost to Follow-up|10|||
170770133|NCT05777785|617163671|FG000|Overall Study|Withdrawal by Subject|5|||
170770134|NCT05777785|617163671|FG000|Overall Study|Lost to Follow-up|1|||
170770135|NCT05644444|617163672|FG000|Tolerance Phase|Adverse Event|0|||
170770136|NCT05644444|617163673|FG001|Tolerance Phase|Adverse Event|2|||
170770137|NCT05644444|617163672|FG000|Treatment Phase|Adverse Event|0|||
170770138|NCT05644444|617163673|FG001|Treatment Phase|Adverse Event|2|||
170770139|NCT03723616|617163675|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
170770140|NCT03723616|617163676|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
170770141|NCT03723616|617163677|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
170770142|NCT03723616|617163678|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
170770143|NCT03723616|617163679|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
170770144|NCT03723616|617163680|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
170770145|NCT01188655|617163681|FG000|Overall Study|Lack of Efficacy|1|||
170770146|NCT01188655|617163681|FG000|Overall Study|Lost to Follow-up|1|||
170770147|NCT01188655|617163681|FG000|Overall Study|Other|11|||
170770148|NCT00493649|617163682|FG000|Overall Study|Adverse Event|44|||
170770149|NCT00493649|617163682|FG000|Overall Study|Patient Request|21|||
170770150|NCT00493649|617163682|FG000|Overall Study|Investigator Request|2|||
170770151|NCT00493649|617163682|FG000|Overall Study|Disease Progression|1|||
170770152|NCT00493649|617163682|FG000|Overall Study|Lost to Follow-up|1|||
170770153|NCT00493649|617163682|FG000|Overall Study|Other|13|||
170770154|NCT00925899|617163685|FG000|Part 1|Death|1|||
170770155|NCT00925899|617163686|FG001|Part 1|Death|2|||
170770156|NCT00925899|617163685|FG000|Part 1|Withdrawal by Subject|10|||
170770157|NCT00925899|617163686|FG001|Part 1|Withdrawal by Subject|9|||
170770158|NCT00683696|617163687|FG000|Overall Study|Withdrawn due to study closure|337|||
170770159|NCT00683696|617163688|FG001|Overall Study|Withdrawn due to study closure|338|||
170770160|NCT00683696|617163687|FG000|Overall Study|Withdrawn prior to study closure|13|||
170770161|NCT00683696|617163688|FG001|Overall Study|Withdrawn prior to study closure|28|||
170770162|NCT00683696|617163687|FG000|Overall Study|Lost to Follow-up|5|||
170770163|NCT00683696|617163688|FG001|Overall Study|Lost to Follow-up|6|||
170523125|NCT05067972|616260261|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
170523126|NCT05067972|616260262|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
170523127|NCT05067972|616260263|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
170523128|NCT05067972|616260264|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
170523129|NCT05067972|616260265|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
170523130|NCT05067972|616260259|FG000|Part 1: Follow-up|Physician Decision|0|||
170871978|NCT02716675|617543066|FG002|Overall Study|Withdrawal by Subject|20|||
170871979|NCT02716675|617543064|FG000|Overall Study|Protocol Violation|0|||
170523131|NCT05067972|616260260|FG001|Part 1: Follow-up|Physician Decision|0|||
170523132|NCT05067972|616260261|FG002|Part 1: Follow-up|Physician Decision|0|||
170523133|NCT05067972|616260262|FG003|Part 1: Follow-up|Physician Decision|1|||
170523134|NCT05067972|616260263|FG004|Part 1: Follow-up|Physician Decision|0|||
170523135|NCT05067972|616260264|FG005|Part 1: Follow-up|Physician Decision|0|||
170871980|NCT02716675|617543065|FG001|Overall Study|Protocol Violation|3|||
170871981|NCT02716675|617543066|FG002|Overall Study|Protocol Violation|1|||
170871982|NCT02716675|617543064|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
170871983|NCT02716675|617543065|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
170871984|NCT02716675|617543066|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
170871985|NCT02716675|617543064|FG000|Overall Study|Other|38|||
170871986|NCT02716675|617543065|FG001|Overall Study|Other|47|||
170871987|NCT02716675|617543066|FG002|Overall Study|Other|48|||
170871988|NCT00290290|617543071|FG000|Overall Study|Death|3|||
170871989|NCT00290290|617543072|FG001|Overall Study|Death|4|||
170871990|NCT00290290|617543071|FG000|Overall Study|Withdrawal by Subject|2|||
170871991|NCT00290290|617543072|FG001|Overall Study|Withdrawal by Subject|2|||
170871992|NCT00290290|617543071|FG000|Overall Study|Underwent clean surgical procedure|13|||
170871993|NCT00290290|617543072|FG001|Overall Study|Underwent clean surgical procedure|12|||
170871994|NCT03374995|617543075|FG000|Overall Study|Withdrawal by Subject|0|||
170871995|NCT03374995|617543076|FG001|Overall Study|Withdrawal by Subject|1|||
170871996|NCT01383096|617543079|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
170871997|NCT01383096|617543080|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
170871998|NCT01383096|617543081|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
170871999|NCT01383096|617543079|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
170872000|NCT01383096|617543080|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
170872001|NCT01383096|617543081|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
170872002|NCT01383096|617543079|FG000|Third Intervention (8 Days)|Elevated AST|0|||
170872003|NCT01383096|617543080|FG001|Third Intervention (8 Days)|Elevated AST|1|||
170872004|NCT01383096|617543081|FG002|Third Intervention (8 Days)|Elevated AST|0|||
170872005|NCT01383096|617543079|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
170872006|NCT01383096|617543080|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
170872007|NCT01383096|617543081|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
170872008|NCT01383096|617543079|FG000|Third Intervention (8 Days)|Adverse Event|1|||
170872009|NCT01383096|617543080|FG001|Third Intervention (8 Days)|Adverse Event|0|||
170872010|NCT01383096|617543081|FG002|Third Intervention (8 Days)|Adverse Event|0|||
170872011|NCT01383096|617543079|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
170872012|NCT01383096|617543080|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
170523136|NCT05067972|616260265|FG006|Part 1: Follow-up|Physician Decision|0|||
170523137|NCT05067972|616260259|FG000|Part 1: Follow-up|Death|1|||
170523138|NCT05067972|616260260|FG001|Part 1: Follow-up|Death|2|||
170523139|NCT05067972|616260261|FG002|Part 1: Follow-up|Death|1|||
170523140|NCT05067972|616260262|FG003|Part 1: Follow-up|Death|0|||
170523141|NCT05067972|616260263|FG004|Part 1: Follow-up|Death|1|||
170523142|NCT05067972|616260264|FG005|Part 1: Follow-up|Death|0|||
170523143|NCT05067972|616260265|FG006|Part 1: Follow-up|Death|1|||
170523144|NCT04391842|616260267|FG000|Overall Study|Withdrawal by Subject|2|||
170523145|NCT00810199|616260268|FG000|Overall Study|Adverse Event|24|||
170523146|NCT00810199|616260269|FG001|Overall Study|Adverse Event|26|||
170523147|NCT00810199|616260268|FG000|Overall Study|Death|4|||
170872013|NCT01383096|617543081|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
170872014|NCT01383096|617543079|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
170872015|NCT01383096|617543080|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
170872016|NCT01383096|617543081|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
170872017|NCT01383096|617543079|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
170523148|NCT00810199|616260269|FG001|Overall Study|Death|6|||
170523149|NCT00810199|616260268|FG000|Overall Study|Withdrew consent|9|||
170523150|NCT00810199|616260269|FG001|Overall Study|Withdrew consent|12|||
170523151|NCT00810199|616260268|FG000|Overall Study|Insufficient therapeutic response|5|||
170523152|NCT00810199|616260269|FG001|Overall Study|Insufficient therapeutic response|14|||
170872018|NCT01383096|617543080|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
170523153|NCT00810199|616260268|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
170523154|NCT00810199|616260269|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
170872019|NCT01383096|617543081|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
170770164|NCT00683696|617163687|FG000|Overall Study|Vital status follow-up only|3|||
170770165|NCT00683696|617163688|FG001|Overall Study|Vital status follow-up only|3|||
170770166|NCT00683696|617163687|FG000|Overall Study|Death|46|||
170770167|NCT00683696|617163688|FG001|Overall Study|Death|30|||
170770168|NCT00089544|617163689|FG000|Overall Study|Ineligible|1|||
170770169|NCT00089544|617163690|FG001|Overall Study|Ineligible|0|||
170770170|NCT03648762|617163696|FG000|Overall Study|Lost to Follow-up|1|||
170770171|NCT03648762|617163697|FG001|Overall Study|Lost to Follow-up|2|||
170770172|NCT03648762|617163698|FG002|Overall Study|Lost to Follow-up|0|||
170770173|NCT03648762|617163696|FG000|Overall Study|Withdrawal by Subject|5|||
170770174|NCT03648762|617163697|FG001|Overall Study|Withdrawal by Subject|2|||
170770175|NCT03648762|617163698|FG002|Overall Study|Withdrawal by Subject|1|||
170770176|NCT01662336|617163708|FG000|Overall Study|Adverse Event|1|||
170770177|NCT01662336|617163708|FG000|Overall Study|No longer on LPV/r|30|||
170770178|NCT01662336|617163708|FG000|Overall Study|Other|29|||
170770179|NCT01662336|617163708|FG000|Overall Study|Withdrawal by Subject|6|||
170770180|NCT02189252|617163709|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
170770181|NCT02189252|617163710|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
170770182|NCT02189252|617163711|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
170770183|NCT02189252|617163712|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
170770184|NCT02189252|617163709|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
170770185|NCT02189252|617163710|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
170770186|NCT02189252|617163711|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
170770187|NCT02189252|617163712|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
170770188|NCT00566735|617163713|FG000|Overall Study|Withdrawal by Subject|0|||
170770189|NCT00566735|617163714|FG001|Overall Study|Withdrawal by Subject|1|||
170770190|NCT00566735|617163713|FG000|Overall Study|Refused neuropsychological testing|2|||
170770191|NCT00566735|617163714|FG001|Overall Study|Refused neuropsychological testing|5|||
170770192|NCT00566735|617163713|FG000|Overall Study|Switched into a manic episode|0|||
170770193|NCT00566735|617163714|FG001|Overall Study|Switched into a manic episode|1|||
170770194|NCT04603924|617163715|FG000|Overall Study|Not Dosed|2|||
170770195|NCT04603924|617163716|FG001|Overall Study|Not Dosed|1|||
170770196|NCT04603924|617163715|FG000|Overall Study|Withdrawal by Subject|6|||
170770197|NCT04603924|617163716|FG001|Overall Study|Withdrawal by Subject|6|||
170770198|NCT04603924|617163715|FG000|Overall Study|Adverse Event|2|||
170770199|NCT04603924|617163716|FG001|Overall Study|Adverse Event|2|||
170770200|NCT00686855|617163717|FG000|Overall Study|Lost to Follow-up|1|||
170770201|NCT00686855|617163718|FG001|Overall Study|Lost to Follow-up|0|||
170770202|NCT00686855|617163717|FG000|Overall Study|Progressive GVHD|0|||
170770203|NCT00686855|617163718|FG001|Overall Study|Progressive GVHD|1|||
170770204|NCT00818454|617163725|FG000|Treatment Period 1|Adverse Event|0|||
170770205|NCT00818454|617163726|FG001|Treatment Period 1|Adverse Event|1|||
170770206|NCT00818454|617163727|FG002|Treatment Period 1|Adverse Event|0|||
170770207|NCT00818454|617163728|FG003|Treatment Period 1|Adverse Event|0|||
170770208|NCT00818454|617163725|FG000|Treatment Period 1|Other|3|||
170770209|NCT00818454|617163726|FG001|Treatment Period 1|Other|0|||
170770210|NCT00818454|617163727|FG002|Treatment Period 1|Other|0|||
170770211|NCT00818454|617163728|FG003|Treatment Period 1|Other|0|||
170770212|NCT00818454|617163725|FG000|Washout Period of 1 Week|Adverse Event|1|||
170770213|NCT00818454|617163726|FG001|Washout Period of 1 Week|Adverse Event|1|||
170770214|NCT00818454|617163727|FG002|Washout Period of 1 Week|Adverse Event|0|||
170770215|NCT00818454|617163728|FG003|Washout Period of 1 Week|Adverse Event|0|||
170770216|NCT00818454|617163725|FG000|Washout Period of 1 Week|Protocol Violation|2|||
170770217|NCT00818454|617163726|FG001|Washout Period of 1 Week|Protocol Violation|0|||
170770218|NCT00818454|617163727|FG002|Washout Period of 1 Week|Protocol Violation|0|||
170770219|NCT00818454|617163728|FG003|Washout Period of 1 Week|Protocol Violation|0|||
170770220|NCT00818454|617163725|FG000|Washout Period of 1 Week|Other|1|||
170770221|NCT00818454|617163726|FG001|Washout Period of 1 Week|Other|2|||
170770222|NCT00818454|617163727|FG002|Washout Period of 1 Week|Other|0|||
170770223|NCT00818454|617163728|FG003|Washout Period of 1 Week|Other|0|||
170770224|NCT00818454|617163725|FG000|Treatment Period 2|Other|2|||
170770225|NCT00818454|617163726|FG001|Treatment Period 2|Other|1|||
170770226|NCT00818454|617163727|FG002|Treatment Period 2|Other|0|||
170770227|NCT00818454|617163728|FG003|Treatment Period 2|Other|0|||
170872020|NCT01383096|617543079|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
170872021|NCT01383096|617543080|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
170770228|NCT00818454|617163725|FG000|Treatment Period 3|Adverse Event|0|||
170770229|NCT00818454|617163726|FG001|Treatment Period 3|Adverse Event|0|||
170770230|NCT00818454|617163727|FG002|Treatment Period 3|Adverse Event|0|||
170770231|NCT00818454|617163728|FG003|Treatment Period 3|Adverse Event|1|||
170770232|NCT00414544|617163729|FG000|Overall Study|Lost to Follow-up|14|||
170770233|NCT01765543|617163736|FG000|Overall Study|Death|1|||
170770234|NCT01765543|617163736|FG000|Overall Study|Withdrawal by Subject|2|||
170770235|NCT03454529|617163737|FG000|Overall Study|Did not receive treatment|6|||
170770236|NCT03454529|617163737|FG000|Overall Study|Received < 80% doses|1|||
170770237|NCT01040689|617163742|FG000|Overall Study|Adverse Event|0|||
170770238|NCT01040689|617163743|FG001|Overall Study|Adverse Event|0|||
170770239|NCT01040689|617163744|FG002|Overall Study|Adverse Event|2|||
170523155|NCT00810199|616260268|FG000|Overall Study|Administrative/Other|5|||
170523156|NCT00810199|616260269|FG001|Overall Study|Administrative/Other|6|||
170523157|NCT00810199|616260268|FG000|Overall Study|Protocol Violation|2|||
170770240|NCT01040689|617163745|FG003|Overall Study|Adverse Event|4|||
170770241|NCT01040689|617163742|FG000|Overall Study|Lack of Efficacy|0|||
170770242|NCT01040689|617163743|FG001|Overall Study|Lack of Efficacy|0|||
170770243|NCT01040689|617163744|FG002|Overall Study|Lack of Efficacy|1|||
170770244|NCT01040689|617163745|FG003|Overall Study|Lack of Efficacy|0|||
170770245|NCT01040689|617163742|FG000|Overall Study|Lost to Follow-up|1|||
170770246|NCT01040689|617163743|FG001|Overall Study|Lost to Follow-up|0|||
170770247|NCT01040689|617163744|FG002|Overall Study|Lost to Follow-up|0|||
170770248|NCT01040689|617163745|FG003|Overall Study|Lost to Follow-up|0|||
170770249|NCT01040689|617163742|FG000|Overall Study|Withdrawal by Subject|2|||
170770250|NCT01040689|617163743|FG001|Overall Study|Withdrawal by Subject|1|||
170770251|NCT01040689|617163744|FG002|Overall Study|Withdrawal by Subject|1|||
170770252|NCT01040689|617163745|FG003|Overall Study|Withdrawal by Subject|0|||
170770253|NCT01040689|617163742|FG000|Overall Study|Other reasons not listed above|0|||
170770254|NCT01040689|617163743|FG001|Overall Study|Other reasons not listed above|1|||
170770255|NCT01040689|617163744|FG002|Overall Study|Other reasons not listed above|0|||
170770256|NCT01040689|617163745|FG003|Overall Study|Other reasons not listed above|0|||
170770257|NCT03718767|617163749|FG000|Overall Study|Declined to participate (before treatment started)|0|||
170770258|NCT03718767|617163750|FG001|Overall Study|Declined to participate (before treatment started)|0|||
170770259|NCT03718767|617163751|FG002|Overall Study|Declined to participate (before treatment started)|7|||
170770260|NCT03718767|617163749|FG000|Overall Study|Ineligible|0|||
170770261|NCT03718767|617163750|FG001|Overall Study|Ineligible|0|||
170770262|NCT03718767|617163751|FG002|Overall Study|Ineligible|17|||
170770263|NCT00507689|617163752|FG000|Pre-Randomization Period|Adverse Event|1|||
170770264|NCT00507689|617163753|FG001|Pre-Randomization Period|Adverse Event|0|||
170770265|NCT00507689|617163752|FG000|Pre-Randomization Period|Physician Decision|1|||
170770266|NCT00507689|617163753|FG001|Pre-Randomization Period|Physician Decision|0|||
170770267|NCT00507689|617163752|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
170770268|NCT00507689|617163753|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
170770269|NCT00507689|617163752|FG000|Randomized Period|Adverse Event|1|||
170770270|NCT00507689|617163753|FG001|Randomized Period|Adverse Event|1|||
170770271|NCT00507689|617163752|FG000|Randomized Period|Withdrawal by Subject|0|||
170770272|NCT00507689|617163753|FG001|Randomized Period|Withdrawal by Subject|1|||
170770273|NCT03184558|617163756|FG000|Overall Study|Withdrawal by Subject|2|||
170770274|NCT03184558|617163756|FG000|Overall Study|Death|16|||
170770275|NCT03184558|617163756|FG000|Overall Study|Lost to Follow-up|2|||
170770276|NCT03184558|617163756|FG000|Overall Study|Other|9|||
170770277|NCT05299606|617163757|FG000|Overall Study|Death|1|||
170770278|NCT01391130|617163758|FG000|Overall Study|Withdrawal by Subject|3|||
170770279|NCT01391130|617163759|FG001|Overall Study|Withdrawal by Subject|2|||
170770280|NCT01391130|617163758|FG000|Overall Study|Physician Decision|2|||
170770281|NCT01391130|617163759|FG001|Overall Study|Physician Decision|3|||
170770282|NCT01391130|617163758|FG000|Overall Study|Did not Receive Drug|1|||
170770283|NCT01391130|617163759|FG001|Overall Study|Did not Receive Drug|1|||
170770284|NCT02537522|617163760|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
170770285|NCT02537522|617163761|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
170770286|NCT02537522|617163762|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
170770287|NCT02537522|617163763|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
170770288|NCT02537522|617163760|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
170770289|NCT02537522|617163761|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
170770290|NCT02537522|617163762|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
170770291|NCT02537522|617163763|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
170770292|NCT02537522|617163760|FG000|Phase I - Contralateral|incorrect randomization|0|||
170770293|NCT02537522|617163761|FG001|Phase I - Contralateral|incorrect randomization|1|||
170770294|NCT02537522|617163762|FG002|Phase I - Contralateral|incorrect randomization|0|||
170770295|NCT02537522|617163763|FG003|Phase I - Contralateral|incorrect randomization|0|||
170770296|NCT02537522|617163760|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
170523158|NCT00810199|616260269|FG001|Overall Study|Protocol Violation|6|||
170523159|NCT00810199|616260268|FG000|Overall Study|Failure to return|1|||
170770297|NCT02537522|617163761|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
170770298|NCT02537522|617163762|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
170770299|NCT02537522|617163763|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
170770300|NCT02537522|617163760|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
170770301|NCT02537522|617163761|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
170770302|NCT02537522|617163762|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
170872022|NCT01383096|617543081|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
170523160|NCT00810199|616260269|FG001|Overall Study|Failure to return|4|||
170770303|NCT02537522|617163763|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
170872023|NCT01383096|617543079|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
170523161|NCT00810199|616260268|FG000|Overall Study|Did not receive study drug|2|||
170872024|NCT01383096|617543080|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
170523162|NCT00810199|616260269|FG001|Overall Study|Did not receive study drug|1|||
170523163|NCT00992017|616260270|FG000|Overall Study|Lost to Follow-up|2|||
170770304|NCT02798835|617163764|FG000|Overall Study|Protocol Violation|0|||
170770305|NCT02798835|617163765|FG001|Overall Study|Protocol Violation|0|||
170770306|NCT02798835|617163766|FG002|Overall Study|Protocol Violation|3|||
170770307|NCT00588770|617163767|FG000|Overall Study|Disease progression|85|||
170770308|NCT00588770|617163768|FG001|Overall Study|Disease progression|68|||
170770309|NCT00588770|617163767|FG000|Overall Study|Adverse Event|29|||
170770310|NCT00588770|617163768|FG001|Overall Study|Adverse Event|58|||
170770311|NCT00588770|617163767|FG000|Overall Study|Death|13|||
170770312|NCT00588770|617163768|FG001|Overall Study|Death|22|||
170770313|NCT00588770|617163767|FG000|Overall Study|Withdrawal by Subject|15|||
170770314|NCT00588770|617163768|FG001|Overall Study|Withdrawal by Subject|25|||
170770315|NCT00588770|617163767|FG000|Overall Study|Alternative therapy|2|||
170770316|NCT00588770|617163768|FG001|Overall Study|Alternative therapy|4|||
170770317|NCT00588770|617163767|FG000|Overall Study|Other complicating disease|3|||
170770318|NCT00588770|617163768|FG001|Overall Study|Other complicating disease|2|||
170770319|NCT00588770|617163767|FG000|Overall Study|Not start protocol therapy|0|||
170770320|NCT00588770|617163768|FG001|Overall Study|Not start protocol therapy|9|||
170770321|NCT00588770|617163767|FG000|Overall Study|Lack of Efficacy|8|||
170770322|NCT00588770|617163768|FG001|Overall Study|Lack of Efficacy|10|||
170770323|NCT00588770|617163767|FG000|Overall Study|Physician discretion|2|||
170770324|NCT00588770|617163768|FG001|Overall Study|Physician discretion|0|||
170770325|NCT00588770|617163767|FG000|Overall Study|Patient non-compliance|2|||
170770326|NCT00588770|617163768|FG001|Overall Study|Patient non-compliance|2|||
170770327|NCT04177394|617163769|FG000|Overall Study|Death|16|||
170770328|NCT04177394|617163769|FG000|Overall Study|Withdrawal by Subject|19|||
170770329|NCT04177394|617163769|FG000|Overall Study|Missed visits|61|||
170770330|NCT04177394|617163769|FG000|Overall Study|Expected Visits|15|||
170770331|NCT02517307|617163770|FG000|Overall Study|Withdrawal by Subject|1|||
170770332|NCT02517307|617163771|FG001|Overall Study|Withdrawal by Subject|0|||
170770333|NCT02517307|617163772|FG002|Overall Study|Withdrawal by Subject|1|||
170770334|NCT02517307|617163773|FG003|Overall Study|Withdrawal by Subject|0|||
170770335|NCT02517307|617163770|FG000|Overall Study|Protocol Violation|0|||
170770336|NCT02517307|617163771|FG001|Overall Study|Protocol Violation|0|||
170770337|NCT02517307|617163772|FG002|Overall Study|Protocol Violation|1|||
170770338|NCT02517307|617163773|FG003|Overall Study|Protocol Violation|1|||
170770339|NCT02115282|617163774|FG000|Overall Study|Disease progression during treatment|216|||
170770340|NCT02115282|617163775|FG001|Overall Study|Disease progression during treatment|229|||
170770341|NCT02115282|617163774|FG000|Overall Study|Adverse Event|49|||
170770342|NCT02115282|617163775|FG001|Overall Study|Adverse Event|23|||
170770343|NCT02115282|617163774|FG000|Overall Study|Death|1|||
170770344|NCT02115282|617163775|FG001|Overall Study|Death|3|||
170770345|NCT02115282|617163774|FG000|Overall Study|Alternative therapy|1|||
170770346|NCT02115282|617163775|FG001|Overall Study|Alternative therapy|1|||
170770347|NCT02115282|617163774|FG000|Overall Study|Complicating disease|0|||
170770348|NCT02115282|617163775|FG001|Overall Study|Complicating disease|3|||
170770349|NCT02115282|617163774|FG000|Overall Study|Withdrawal by Subject|12|||
170770350|NCT02115282|617163775|FG001|Overall Study|Withdrawal by Subject|10|||
170770351|NCT02115282|617163774|FG000|Overall Study|Symptomatic progression/deterioration|7|||
170770352|NCT02115282|617163775|FG001|Overall Study|Symptomatic progression/deterioration|18|||
170770353|NCT02115282|617163774|FG000|Overall Study|Non-compliance|5|||
170770354|NCT02115282|617163775|FG001|Overall Study|Non-compliance|1|||
170770355|NCT02115282|617163774|FG000|Overall Study|Protocol Violation|2|||
170770356|NCT02115282|617163775|FG001|Overall Study|Protocol Violation|2|||
170770357|NCT02115282|617163774|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
170770358|NCT02115282|617163775|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
170770359|NCT02115282|617163774|FG000|Overall Study|Not start protocol therapy|9|||
170770360|NCT02115282|617163775|FG001|Overall Study|Not start protocol therapy|10|||
170770361|NCT00256243|617163776|FG000|Overall Study|Lost to Follow-up|2|||
170770362|NCT00256243|617163776|FG000|Overall Study|Death|7|||
170770363|NCT00256243|617163776|FG000|Overall Study|Not treated|1|||
170770364|NCT01582269|617163779|FG000|Overall Study|Withdrawal by Subject|1|||
170770365|NCT01582269|617163780|FG001|Overall Study|Withdrawal by Subject|0|||
170770366|NCT01582269|617163781|FG002|Overall Study|Withdrawal by Subject|0|||
170770367|NCT00997386|617163784|FG000|Overall Study|Death|7|||
170770368|NCT05797155|617163785|FG000|Overall Study|Lost to Follow-up|33|||
170770369|NCT05797155|617163786|FG001|Overall Study|Lost to Follow-up|12|||
170523164|NCT00992017|616260270|FG000|Overall Study|Withdrawal by Subject|2|||
170770370|NCT03762668|617164631|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
170770371|NCT03762668|617164632|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
170770372|NCT00768664|617164633|FG000|Overall Study|Death|57|||
170770373|NCT00768664|617164633|FG000|Overall Study|Lost to Follow-up|2|||
170770374|NCT00768664|617164633|FG000|Overall Study|Other|9|||
170770375|NCT00768664|617164633|FG000|Overall Study|Participant refused|1|||
170770376|NCT02731755|617164634|FG000|First Intervention|Withdrawal by Subject|0|||
170770377|NCT02731755|617164635|FG001|First Intervention|Withdrawal by Subject|2|||
170523165|NCT00992017|616260270|FG000|Overall Study|Unable to get to clinic|5|||
170523166|NCT00992017|616260270|FG000|Overall Study|Not adhere to study requirements|1|||
170523167|NCT01691378|616260271|FG000|Overall Study|Withdrawal by Subject|2|||
170523168|NCT01691378|616260272|FG001|Overall Study|Withdrawal by Subject|0|||
170523169|NCT01691378|616260271|FG000|Overall Study|Lost to Follow-up|5|||
170872025|NCT01383096|617543081|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
170872026|NCT01383096|617543079|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
170872027|NCT01383096|617543080|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
170872028|NCT01383096|617543081|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
170872029|NCT01211535|617543082|FG000|Overall Study|Adverse Event|0|||
170872030|NCT01211535|617543083|FG001|Overall Study|Adverse Event|1|||
170872031|NCT02490475|617543084|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
170872032|NCT02490475|617543085|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
170872033|NCT02490475|617543086|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
170872034|NCT02490475|617543087|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
170872035|NCT02490475|617543084|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
170872036|NCT02490475|617543085|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
170872037|NCT02490475|617543086|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
170872038|NCT02490475|617543087|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
170872039|NCT02490475|617543084|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
170872040|NCT02490475|617543085|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
170872041|NCT02490475|617543086|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
170872042|NCT02490475|617543087|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
170872043|NCT02490475|617543084|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
170872044|NCT02490475|617543085|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
170872045|NCT02490475|617543086|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
170872046|NCT02490475|617543087|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
170872047|NCT02490475|617543084|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
170872048|NCT02490475|617543085|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
170872049|NCT02490475|617543086|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
170872050|NCT02490475|617543087|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
170872051|NCT02490475|617543084|FG000|Period 2: Extension Phase|Refused Treatment|0|||
170872052|NCT02490475|617543085|FG001|Period 2: Extension Phase|Refused Treatment|0|||
170872053|NCT02490475|617543086|FG002|Period 2: Extension Phase|Refused Treatment|0|||
170872054|NCT02490475|617543087|FG003|Period 2: Extension Phase|Refused Treatment|1|||
170872055|NCT02490475|617543084|FG000|Period 2: Extension Phase|Adverse Event|0|||
170872056|NCT02490475|617543085|FG001|Period 2: Extension Phase|Adverse Event|0|||
170872057|NCT02490475|617543086|FG002|Period 2: Extension Phase|Adverse Event|1|||
170872058|NCT02490475|617543087|FG003|Period 2: Extension Phase|Adverse Event|0|||
170872059|NCT00616434|617543092|FG000|Overall Study|Adverse Event|5|||
170872060|NCT00616434|617543093|FG001|Overall Study|Adverse Event|2|||
170872061|NCT00616434|617543092|FG000|Overall Study|Physician Decision|0|||
170872062|NCT00616434|617543093|FG001|Overall Study|Physician Decision|4|||
170872063|NCT00616434|617543092|FG000|Overall Study|Withdrawal by Subject|1|||
170872064|NCT00616434|617543093|FG001|Overall Study|Withdrawal by Subject|1|||
170872065|NCT00616434|617543092|FG000|Overall Study|Protocol deviation|0|||
170872066|NCT00616434|617543093|FG001|Overall Study|Protocol deviation|1|||
170872067|NCT00914927|617543094|FG000|Overall Study|Adverse Event|0|||
170872068|NCT00914927|617543095|FG001|Overall Study|Adverse Event|0|||
170872069|NCT00914927|617543096|FG002|Overall Study|Adverse Event|0|||
170872070|NCT00914927|617543097|FG003|Overall Study|Adverse Event|0|||
170872071|NCT00914927|617543098|FG004|Overall Study|Adverse Event|1|||
170872072|NCT00914927|617543099|FG005|Overall Study|Adverse Event|0|||
170872073|NCT00914927|617543100|FG006|Overall Study|Adverse Event|0|||
170872074|NCT00914927|617543094|FG000|Overall Study|Withdrawal by Subject|0|||
170872075|NCT00914927|617543095|FG001|Overall Study|Withdrawal by Subject|1|||
170872076|NCT00914927|617543096|FG002|Overall Study|Withdrawal by Subject|0|||
170872077|NCT00914927|617543097|FG003|Overall Study|Withdrawal by Subject|1|||
170872078|NCT00914927|617543098|FG004|Overall Study|Withdrawal by Subject|0|||
170872079|NCT00914927|617543099|FG005|Overall Study|Withdrawal by Subject|0|||
170872080|NCT00914927|617543100|FG006|Overall Study|Withdrawal by Subject|0|||
170872081|NCT00914927|617543094|FG000|Overall Study|Lost to Follow-up|0|||
170872082|NCT00914927|617543095|FG001|Overall Study|Lost to Follow-up|0|||
170872083|NCT00914927|617543096|FG002|Overall Study|Lost to Follow-up|0|||
170872084|NCT00914927|617543097|FG003|Overall Study|Lost to Follow-up|1|||
170872085|NCT00914927|617543098|FG004|Overall Study|Lost to Follow-up|0|||
170872086|NCT00914927|617543099|FG005|Overall Study|Lost to Follow-up|0|||
170872087|NCT00914927|617543100|FG006|Overall Study|Lost to Follow-up|0|||
170523170|NCT01691378|616260272|FG001|Overall Study|Lost to Follow-up|2|||
170872088|NCT00914927|617543094|FG000|Overall Study|Administrative/Other|2|||
170872089|NCT00914927|617543095|FG001|Overall Study|Administrative/Other|1|||
170872090|NCT00914927|617543096|FG002|Overall Study|Administrative/Other|0|||
170872091|NCT00914927|617543097|FG003|Overall Study|Administrative/Other|0|||
170523171|NCT00808067|616260273|FG000|Overall Study|Major/minor bleed|30|||
170523172|NCT00808067|616260274|FG001|Overall Study|Major/minor bleed|44|||
170523173|NCT00808067|616260273|FG000|Overall Study|Outcome event - other|33|||
170523174|NCT00808067|616260274|FG001|Overall Study|Outcome event - other|25|||
170523175|NCT00808067|616260273|FG000|Overall Study|Adverse Event|111|||
170523176|NCT00808067|616260274|FG001|Overall Study|Adverse Event|121|||
170523177|NCT00808067|616260273|FG000|Overall Study|Hospitalization (not including surgery)|18|||
170523178|NCT00808067|616260274|FG001|Overall Study|Hospitalization (not including surgery)|17|||
170523179|NCT00808067|616260273|FG000|Overall Study|Hospitalization due to surgery|37|||
170523180|NCT00808067|616260274|FG001|Overall Study|Hospitalization due to surgery|40|||
170523181|NCT00808067|616260273|FG000|Overall Study|Reduced creatinine clearance|53|||
170523182|NCT00808067|616260274|FG001|Overall Study|Reduced creatinine clearance|55|||
170523183|NCT00808067|616260273|FG000|Overall Study|Elevated LFT results|7|||
170523184|NCT00808067|616260274|FG001|Overall Study|Elevated LFT results|3|||
170523185|NCT00808067|616260273|FG000|Overall Study|Patient refused to take study medication|65|||
170523186|NCT00808067|616260274|FG001|Overall Study|Patient refused to take study medication|76|||
170523187|NCT00808067|616260273|FG000|Overall Study|Missing|1|||
170523188|NCT00808067|616260274|FG001|Overall Study|Missing|0|||
170523189|NCT00808067|616260273|FG000|Overall Study|Death|1|||
170523190|NCT00808067|616260274|FG001|Overall Study|Death|1|||
170523191|NCT00808067|616260273|FG000|Overall Study|Procedure|6|||
170523192|NCT00808067|616260274|FG001|Overall Study|Procedure|7|||
170523193|NCT00808067|616260273|FG000|Overall Study|Withdrawal by Subject|21|||
170523194|NCT00808067|616260274|FG001|Overall Study|Withdrawal by Subject|25|||
170523195|NCT00808067|616260273|FG000|Overall Study|Site closed|4|||
170523196|NCT00808067|616260274|FG001|Overall Study|Site closed|3|||
170523197|NCT00808067|616260273|FG000|Overall Study|Physician Decision|47|||
170523198|NCT00808067|616260274|FG001|Overall Study|Physician Decision|38|||
170523199|NCT00808067|616260273|FG000|Overall Study|Protocol Violation|3|||
170523200|NCT00808067|616260274|FG001|Overall Study|Protocol Violation|11|||
170523201|NCT00808067|616260273|FG000|Overall Study|Patient elected|7|||
170523202|NCT00808067|616260274|FG001|Overall Study|Patient elected|9|||
170523203|NCT00808067|616260273|FG000|Overall Study|Site closed for cause|19|||
170523204|NCT00808067|616260274|FG001|Overall Study|Site closed for cause|19|||
170523205|NCT00808067|616260273|FG000|Overall Study|Other reason not defined above|5|||
170523206|NCT00808067|616260274|FG001|Overall Study|Other reason not defined above|5|||
170523207|NCT00808067|616260273|FG000|Overall Study|Excluded from analysis|13|||
170523208|NCT00808067|616260274|FG001|Overall Study|Excluded from analysis|19|||
170523209|NCT00969228|616260279|FG000|Overall Study|Adverse Event|1|||
170523210|NCT00969228|616260280|FG001|Overall Study|Adverse Event|0|||
170523211|NCT00969228|616260279|FG000|Overall Study|Withdrawal by Subject|4|||
170523212|NCT00969228|616260280|FG001|Overall Study|Withdrawal by Subject|0|||
170523213|NCT00969228|616260279|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
170523214|NCT00969228|616260280|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
170523215|NCT04877990|616260283|FG000|Treatment|Other reasons|3|||
170523216|NCT04877990|616260284|FG001|Treatment|Other reasons|1|||
170523217|NCT04877990|616260283|FG000|Treatment|Administrative reasons by sponsor|17|||
170523218|NCT04877990|616260284|FG001|Treatment|Administrative reasons by sponsor|33|||
170770378|NCT00465816|617164636|FG000|Overall Study|Lost to Follow-up|0|||
170770379|NCT00465816|617164637|FG001|Overall Study|Lost to Follow-up|0|||
170770380|NCT00465816|617164638|FG002|Overall Study|Lost to Follow-up|2|||
170770381|NCT01185561|617164639|FG000|Overall Study|Lost to Follow-up|0|||
170770382|NCT01185561|617164640|FG001|Overall Study|Lost to Follow-up|4|||
170770383|NCT01185561|617164639|FG000|Overall Study|Withdrawal by Subject|2|||
170770384|NCT01185561|617164640|FG001|Overall Study|Withdrawal by Subject|8|||
170770385|NCT02755805|617164641|FG000|Overall Study|Lost to Follow-up|1|||
170770386|NCT02755805|617164642|FG001|Overall Study|Lost to Follow-up|2|||
170770387|NCT02755805|617164641|FG000|Overall Study|Refused assessments|1|||
170770388|NCT02755805|617164642|FG001|Overall Study|Refused assessments|0|||
170770389|NCT02755805|617164641|FG000|Overall Study|Withdrawal by Subject|0|||
170770390|NCT02755805|617164642|FG001|Overall Study|Withdrawal by Subject|2|||
170770391|NCT00494442|617164650|FG000|Overall Study|Death|1|||
170770392|NCT00494442|617164651|FG001|Overall Study|Death|1|||
170770393|NCT00494442|617164650|FG000|Overall Study|Lack of Efficacy|16|||
170770394|NCT00494442|617164651|FG001|Overall Study|Lack of Efficacy|10|||
170770395|NCT00494442|617164650|FG000|Overall Study|Adverse Event|0|||
170523219|NCT04877990|616260283|FG000|Treatment|Withdrawal by Subject|2|||
170523220|NCT04877990|616260284|FG001|Treatment|Withdrawal by Subject|6|||
170523221|NCT04877990|616260283|FG000|Treatment|Adverse Event|2|||
170523222|NCT04877990|616260284|FG001|Treatment|Adverse Event|1|||
170523223|NCT01619878|616260286|FG000|6 Week Follow-up Phase|Adverse Event|1|||
170523224|NCT01619878|616260286|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
170523225|NCT01619878|616260286|FG000|Follow-up at 12 Months of Age|Death|2|||
170523226|NCT01817075|616260287|FG000|Overall Study|Adverse Event|7|||
170770396|NCT00494442|617164651|FG001|Overall Study|Adverse Event|2|||
170770397|NCT00494442|617164650|FG000|Overall Study|Physician Decision|0|||
170770398|NCT00494442|617164651|FG001|Overall Study|Physician Decision|1|||
170872092|NCT00914927|617543098|FG004|Overall Study|Administrative/Other|1|||
170872093|NCT00914927|617543099|FG005|Overall Study|Administrative/Other|0|||
170872094|NCT00914927|617543100|FG006|Overall Study|Administrative/Other|0|||
170872095|NCT00041080|617543101|FG000|Overall Study|Adverse Event|21|||
170872096|NCT00041080|617543102|FG001|Overall Study|Adverse Event|1|||
170872097|NCT00041080|617543101|FG000|Overall Study|Withdrawal by Subject|6|||
170872098|NCT00041080|617543102|FG001|Overall Study|Withdrawal by Subject|6|||
170872099|NCT00041080|617543101|FG000|Overall Study|Concommitant Illness/Other|1|||
170872100|NCT00041080|617543102|FG001|Overall Study|Concommitant Illness/Other|2|||
170872101|NCT00041080|617543101|FG000|Overall Study|Did not start therapy|1|||
170872102|NCT00041080|617543102|FG001|Overall Study|Did not start therapy|1|||
170872103|NCT00041080|617543101|FG000|Overall Study|Ineligible|1|||
170872104|NCT00041080|617543102|FG001|Overall Study|Ineligible|0|||
170872105|NCT04353596|617543103|FG000|Overall Study|Protocol Violation|4|||
170872106|NCT04353596|617543104|FG001|Overall Study|Protocol Violation|4|||
170872107|NCT04353596|617543103|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
170872108|NCT04353596|617543104|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
170872109|NCT01236573|617543105|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
170872110|NCT01236573|617543106|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
170872111|NCT01236573|617543107|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
170872112|NCT01236573|617543108|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
170872113|NCT01236573|617543109|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
170872114|NCT01236573|617543110|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
170872115|NCT01236573|617543111|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
170872116|NCT01236573|617543112|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
170872117|NCT01236573|617543113|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
170872118|NCT01236573|617543114|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
170872119|NCT01236573|617543115|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
170872120|NCT01236573|617543105|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872121|NCT01236573|617543106|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872122|NCT01236573|617543107|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872123|NCT01236573|617543108|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872124|NCT01236573|617543109|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872125|NCT01236573|617543110|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872126|NCT01236573|617543111|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872127|NCT01236573|617543112|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872128|NCT01236573|617543113|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
170872129|NCT01236573|617543114|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872130|NCT01236573|617543115|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
170872131|NCT01236573|617543105|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872132|NCT01236573|617543106|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872133|NCT01236573|617543107|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872134|NCT01236573|617543108|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872135|NCT01236573|617543109|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872136|NCT01236573|617543110|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872137|NCT01236573|617543111|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872138|NCT01236573|617543112|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872139|NCT01236573|617543113|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872140|NCT01236573|617543114|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
170872141|NCT01236573|617543115|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
170872142|NCT00701090|617543120|FG000|Overall Study|Adverse Event|11|||
170872143|NCT00701090|617543121|FG001|Overall Study|Adverse Event|2|||
170872144|NCT00701090|617543120|FG000|Overall Study|Death|0|||
170872145|NCT00701090|617543121|FG001|Overall Study|Death|1|||
170872146|NCT00701090|617543120|FG000|Overall Study|Lack of Efficacy|5|||
170872147|NCT00701090|617543121|FG001|Overall Study|Lack of Efficacy|4|||
170872148|NCT00701090|617543120|FG000|Overall Study|Lost to Follow-up|9|||
170872149|NCT00701090|617543121|FG001|Overall Study|Lost to Follow-up|9|||
170872150|NCT00701090|617543120|FG000|Overall Study|Physician Decision|3|||
170872151|NCT00701090|617543121|FG001|Overall Study|Physician Decision|4|||
170872152|NCT00701090|617543120|FG000|Overall Study|Protocol Violation|2|||
170872153|NCT00701090|617543121|FG001|Overall Study|Protocol Violation|3|||
170872154|NCT00701090|617543120|FG000|Overall Study|Withdrawal by Subject|11|||
170872155|NCT00701090|617543121|FG001|Overall Study|Withdrawal by Subject|16|||
170872156|NCT00701090|617543120|FG000|Overall Study|Other|7|||
170872157|NCT00701090|617543121|FG001|Overall Study|Other|12|||
170872158|NCT00873366|617543122|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
170872159|NCT00873366|617543122|FG000|Overall Study|Off tamoxifen due to side effects|2|||
170872160|NCT00873366|617543122|FG000|Overall Study|Refused to continue DM-BT testing|3|||
170872161|NCT02170779|617543131|FG000|Overall Study|Withdrawal by Subject|1|||
170872162|NCT02170779|617543132|FG001|Overall Study|Withdrawal by Subject|0|||
170523227|NCT01817075|616260288|FG001|Overall Study|Adverse Event|5|||
170523228|NCT01817075|616260287|FG000|Overall Study|Physician Decision|9|||
170523229|NCT01817075|616260288|FG001|Overall Study|Physician Decision|12|||
170523230|NCT01817075|616260287|FG000|Overall Study|Withdrawal by Subject|31|||
170523231|NCT01817075|616260288|FG001|Overall Study|Withdrawal by Subject|15|||
170523232|NCT01817075|616260287|FG000|Overall Study|Received Sorafenib after enrollment|0|||
170523233|NCT01817075|616260288|FG001|Overall Study|Received Sorafenib after enrollment|1|||
170523234|NCT01817075|616260287|FG000|Overall Study|Ineligible|0|||
170523235|NCT01817075|616260288|FG001|Overall Study|Ineligible|2|||
170523236|NCT00565604|616260292|FG000|Overall Study|Failure to treat|2|||
170523237|NCT00565604|616260292|FG000|Overall Study|Lost to Follow-up|2|||
170523238|NCT01496976|616261768|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
170523239|NCT04579380|616261769|FG000|Overall Study|Death|9|||
170523240|NCT04579380|616261770|FG001|Overall Study|Death|22|||
170523241|NCT04579380|616261771|FG002|Overall Study|Death|22|||
170523242|NCT04579380|616261772|FG003|Overall Study|Death|17|||
170523243|NCT04579380|616261773|FG004|Overall Study|Death|6|||
170523244|NCT04579380|616261774|FG005|Overall Study|Death|21|||
170523245|NCT04579380|616261775|FG006|Overall Study|Death|10|||
170523246|NCT04579380|616261776|FG007|Overall Study|Death|11|||
170523247|NCT04579380|616261777|FG008|Overall Study|Death|25|||
170523248|NCT04579380|616261769|FG000|Overall Study|Withdrawal by Subject|0|||
170523249|NCT04579380|616261770|FG001|Overall Study|Withdrawal by Subject|3|||
170523250|NCT04579380|616261771|FG002|Overall Study|Withdrawal by Subject|4|||
170523251|NCT04579380|616261772|FG003|Overall Study|Withdrawal by Subject|0|||
170523252|NCT04579380|616261773|FG004|Overall Study|Withdrawal by Subject|1|||
170523253|NCT04579380|616261774|FG005|Overall Study|Withdrawal by Subject|2|||
170523254|NCT04579380|616261775|FG006|Overall Study|Withdrawal by Subject|0|||
170523255|NCT04579380|616261776|FG007|Overall Study|Withdrawal by Subject|1|||
170523256|NCT04579380|616261777|FG008|Overall Study|Withdrawal by Subject|2|||
170523257|NCT04579380|616261769|FG000|Overall Study|Ongoing|2|||
170523258|NCT04579380|616261770|FG001|Overall Study|Ongoing|6|||
170523259|NCT04579380|616261771|FG002|Overall Study|Ongoing|4|||
170523260|NCT04579380|616261772|FG003|Overall Study|Ongoing|8|||
170523261|NCT04579380|616261773|FG004|Overall Study|Ongoing|5|||
170523262|NCT04579380|616261774|FG005|Overall Study|Ongoing|8|||
170523263|NCT04579380|616261775|FG006|Overall Study|Ongoing|3|||
170523264|NCT04579380|616261776|FG007|Overall Study|Ongoing|19|||
170523265|NCT04579380|616261777|FG008|Overall Study|Ongoing|6|||
170523266|NCT01868646|616261783|FG000|Overall Study|Do not meet inclusion criteria|3|||
170523267|NCT01868646|616261784|FG001|Overall Study|Do not meet inclusion criteria|5|||
170523268|NCT01249417|616261785|FG000|Randomised Population|Study treatment not received|0|||
170523269|NCT01249417|616261786|FG001|Randomised Population|Study treatment not received|0|||
170523270|NCT01249417|616261787|FG002|Randomised Population|Study treatment not received|2|||
170523271|NCT01249417|616261785|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
170523272|NCT01249417|616261786|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
170523273|NCT01249417|616261787|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
170523274|NCT01249417|616261785|FG000|Treatment Phase - ITT Population|Other|0|||
170523275|NCT01249417|616261786|FG001|Treatment Phase - ITT Population|Other|0|||
170523276|NCT01249417|616261787|FG002|Treatment Phase - ITT Population|Other|1|||
170523277|NCT01249417|616261785|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
170523278|NCT01249417|616261786|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
170523279|NCT01249417|616261787|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
170523280|NCT01249417|616261785|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
170523281|NCT01249417|616261786|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
170523282|NCT01249417|616261787|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
170523283|NCT01249417|616261785|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
170523284|NCT01249417|616261786|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
170523285|NCT01249417|616261787|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
170523286|NCT03102762|616261788|FG000|Overall Study|Lost to Follow-up|1|||
170523287|NCT03102762|616261789|FG001|Overall Study|Lost to Follow-up|0|||
170523288|NCT03074695|616261790|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
170523289|NCT03074695|616261791|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
170523290|NCT03074695|616261790|FG000|Overall Study|Research staff not available|1|||
170523291|NCT03074695|616261791|FG001|Overall Study|Research staff not available|2|||
170523292|NCT03074695|616261790|FG000|Overall Study|Did not receive neuraxial block|2|||
170523293|NCT03074695|616261791|FG001|Overall Study|Did not receive neuraxial block|2|||
170523294|NCT00902577|616261792|FG000|Overall Study|Withdrawal by Subject|6|||
170523295|NCT00902577|616261792|FG000|Overall Study|FMISO production failure|2|||
170523296|NCT00468585|616261793|FG000|Overall Study|Patient not treated|1|||
170523297|NCT00468585|616261794|FG001|Overall Study|Patient not treated|0|||
170523298|NCT00468585|616261795|FG002|Overall Study|Patient not treated|1|||
170523299|NCT00468585|616261796|FG003|Overall Study|Patient not treated|0|||
170523300|NCT00468585|616261793|FG000|Overall Study|Patient found to be ineligible|0|||
170523301|NCT00468585|616261794|FG001|Overall Study|Patient found to be ineligible|0|||
170523302|NCT00468585|616261795|FG002|Overall Study|Patient found to be ineligible|1|||
170523303|NCT00468585|616261796|FG003|Overall Study|Patient found to be ineligible|0|||
170523304|NCT00468585|616261793|FG000|Overall Study|Adverse Event|0|||
170523305|NCT00468585|616261794|FG001|Overall Study|Adverse Event|0|||
170523306|NCT00468585|616261795|FG002|Overall Study|Adverse Event|1|||
170523307|NCT00468585|616261796|FG003|Overall Study|Adverse Event|0|||
170523308|NCT00468585|616261793|FG000|Overall Study|Withdrawal by Subject|0|||
170523309|NCT00468585|616261794|FG001|Overall Study|Withdrawal by Subject|0|||
170523310|NCT00468585|616261795|FG002|Overall Study|Withdrawal by Subject|2|||
170523311|NCT00468585|616261796|FG003|Overall Study|Withdrawal by Subject|1|||
170523312|NCT01232790|616261797|FG000|Randomization|Withdrawal by Subject|2|||
170523313|NCT01232790|616261798|FG001|Randomization|Withdrawal by Subject|0|||
170523314|NCT01232790|616261797|FG000|Randomization|Protocol Violation|0|||
170523315|NCT01232790|616261798|FG001|Randomization|Protocol Violation|1|||
170523316|NCT01232790|616261797|FG000|Randomization|Physician Decision|0|||
170523317|NCT01232790|616261798|FG001|Randomization|Physician Decision|1|||
170523318|NCT01232790|616261797|FG000|Initial Assessment|Withdrawal by Subject|0|||
170523319|NCT01232790|616261798|FG001|Initial Assessment|Withdrawal by Subject|1|||
170523320|NCT01232790|616261797|FG000|First Crossover|Withdrawal by Subject|1|||
170523321|NCT01232790|616261798|FG001|First Crossover|Withdrawal by Subject|0|||
170523322|NCT01232790|616261797|FG000|Second Crossover|Withdrawal by Subject|1|||
170523323|NCT01232790|616261798|FG001|Second Crossover|Withdrawal by Subject|2|||
170523324|NCT03769649|616261799|FG000|Overall Study|Lost to Follow-up|4|||
170523325|NCT00083915|616261800|FG000|Overall Study|Death|6|||
170523326|NCT00083915|616261801|FG001|Overall Study|Death|3|||
170523327|NCT00083915|616261800|FG000|Overall Study|Physician Decision|11|||
170523328|NCT00083915|616261801|FG001|Overall Study|Physician Decision|6|||
170523329|NCT00083915|616261800|FG000|Overall Study|Withdrawal by Subject|8|||
170523330|NCT00083915|616261801|FG001|Overall Study|Withdrawal by Subject|3|||
170523331|NCT00083915|616261800|FG000|Overall Study|disease progression|18|||
170523332|NCT00083915|616261801|FG001|Overall Study|disease progression|23|||
170523333|NCT00083915|616261800|FG000|Overall Study|Failure to collect|3|||
170523334|NCT00083915|616261801|FG001|Overall Study|Failure to collect|0|||
170523335|NCT00083915|616261800|FG000|Overall Study|No response|3|||
170523336|NCT00083915|616261801|FG001|Overall Study|No response|1|||
170523337|NCT00083915|616261800|FG000|Overall Study|Insurance issues|1|||
170523338|NCT00083915|616261801|FG001|Overall Study|Insurance issues|1|||
170523339|NCT02000921|616261807|FG000|Overall Study|Withdrawal by Subject|3|||
170523340|NCT02000921|616261808|FG001|Overall Study|Withdrawal by Subject|10|||
170523341|NCT02000921|616261809|FG002|Overall Study|Withdrawal by Subject|5|||
170523342|NCT02000921|616261807|FG000|Overall Study|Lost to Follow-up|2|||
170523343|NCT02000921|616261808|FG001|Overall Study|Lost to Follow-up|4|||
170523344|NCT02000921|616261809|FG002|Overall Study|Lost to Follow-up|5|||
170523345|NCT02000921|616261807|FG000|Overall Study|Physician Decision|0|||
170523346|NCT02000921|616261808|FG001|Overall Study|Physician Decision|2|||
170523347|NCT02000921|616261809|FG002|Overall Study|Physician Decision|0|||
170523348|NCT03722576|616261814|FG000|Overall Study|Withdrawal by Subject|3|||
170523349|NCT03722576|616261814|FG000|Overall Study|Adverse Event|2|||
170523350|NCT03722576|616261814|FG000|Overall Study|Physician Decision|1|||
170523351|NCT03722576|616261814|FG000|Overall Study|Lost to Follow-up|1|||
170523352|NCT01408706|616261819|FG000|Overall Study|Physician Decision|1|||
170523353|NCT01408706|616261820|FG001|Overall Study|Physician Decision|0|||
170770399|NCT00494442|617164650|FG000|Overall Study|Non-compliance|0|||
170770400|NCT00494442|617164651|FG001|Overall Study|Non-compliance|1|||
170770401|NCT00494442|617164650|FG000|Overall Study|Intercurrent illness|0|||
170770402|NCT00494442|617164651|FG001|Overall Study|Intercurrent illness|1|||
170770403|NCT01831791|617164654|FG000|Overall Study|Withdrawal by Subject|10|||
170770404|NCT03061474|617164656|FG000|Overall Study|Adverse Event|2|||
170770405|NCT03061474|617164657|FG001|Overall Study|Adverse Event|0|||
170770406|NCT03061474|617164656|FG000|Overall Study|Safety Risk|0|||
170770407|NCT03061474|617164657|FG001|Overall Study|Safety Risk|1|||
170770408|NCT03061474|617164656|FG000|Overall Study|Participant unwilling or unable to participate|0|||
170523354|NCT02048722|616261824|FG000|2 Cycles of Treatment|Adverse Event|2|||
170523355|NCT02048722|616261824|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
170523356|NCT02048722|616261824|FG000|2 Cycles of Treatment|Progressive Disease|2|||
170523357|NCT02048722|616261824|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
170523358|NCT02048722|616261824|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
170523359|NCT02048722|616261824|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
170523360|NCT03575702|616261825|FG000|Overall Study|Withdrawal by Subject|1|||
170523361|NCT03575702|616261826|FG001|Overall Study|Withdrawal by Subject|1|||
170770409|NCT03061474|617164657|FG001|Overall Study|Participant unwilling or unable to participate|2|||
170770410|NCT03061474|617164656|FG000|Overall Study|Lost to Follow-up|0|||
170523362|NCT03575702|616261825|FG000|Overall Study|Lost to Follow-up|1|||
170523363|NCT03575702|616261826|FG001|Overall Study|Lost to Follow-up|2|||
170770411|NCT03061474|617164657|FG001|Overall Study|Lost to Follow-up|1|||
170770412|NCT03024606|617164673|FG000|Overall Study|Withdrawal by Subject|9|||
170770413|NCT03024606|617164674|FG001|Overall Study|Withdrawal by Subject|10|||
170523364|NCT03575702|616261825|FG000|Overall Study|Protocol Violation|0|||
170523365|NCT03575702|616261826|FG001|Overall Study|Protocol Violation|1|||
170523366|NCT03575702|616261825|FG000|Overall Study|Patient non compliance|4|||
170523367|NCT03575702|616261826|FG001|Overall Study|Patient non compliance|0|||
170523368|NCT00705757|616261827|FG000|Overall Study|Lack of Efficacy|5|||
170523369|NCT00705757|616261828|FG001|Overall Study|Lack of Efficacy|1|||
170523370|NCT00705757|616261829|FG002|Overall Study|Lack of Efficacy|3|||
170523371|NCT00705757|616261827|FG000|Overall Study|Lost to Follow-up|7|||
170523372|NCT00705757|616261828|FG001|Overall Study|Lost to Follow-up|6|||
170523373|NCT00705757|616261829|FG002|Overall Study|Lost to Follow-up|6|||
170523374|NCT00705757|616261827|FG000|Overall Study|Withdrawal by Subject|1|||
170523375|NCT00705757|616261828|FG001|Overall Study|Withdrawal by Subject|1|||
170523376|NCT00705757|616261829|FG002|Overall Study|Withdrawal by Subject|2|||
170523377|NCT02127658|616261830|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
170523378|NCT02127658|616261831|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
170523379|NCT02127658|616261830|FG000|Overall Study|Withdrawal by Subject|0|||
170523380|NCT02127658|616261831|FG001|Overall Study|Withdrawal by Subject|2|||
170523381|NCT02127658|616261830|FG000|Overall Study|Physician Decision|0|||
170523382|NCT02127658|616261831|FG001|Overall Study|Physician Decision|1|||
170523383|NCT05559905|616261832|FG000|Overall Study|Withdrawal by Subject|1|||
170523384|NCT05559905|616261833|FG001|Overall Study|Withdrawal by Subject|0|||
170523385|NCT05559905|616261834|FG002|Overall Study|Withdrawal by Subject|0|||
170523386|NCT05559905|616261832|FG000|Overall Study|Not Reported|1|||
170523387|NCT05559905|616261833|FG001|Overall Study|Not Reported|0|||
170523388|NCT05559905|616261834|FG002|Overall Study|Not Reported|0|||
170523389|NCT05696392|616261835|FG000|Overall Study|Lost to Follow-up|3|||
170872163|NCT02170779|617543131|FG000|Overall Study|Lost to Follow-up|0|||
170412862|NCT02752776|615851908|FG001|Overall Study|Lack of Efficacy|6|||
170412863|NCT02752776|615851909|FG002|Overall Study|Lack of Efficacy|14|||
170412864|NCT02752776|615851907|FG000|Overall Study|Lost to Follow-up|11|||
170412865|NCT02752776|615851908|FG001|Overall Study|Lost to Follow-up|12|||
170412866|NCT02752776|615851909|FG002|Overall Study|Lost to Follow-up|4|||
170412867|NCT02752776|615851907|FG000|Overall Study|Non-compliance with study treatment|0|||
170412868|NCT02752776|615851908|FG001|Overall Study|Non-compliance with study treatment|0|||
170412869|NCT02752776|615851909|FG002|Overall Study|Non-compliance with study treatment|1|||
170412870|NCT02752776|615851907|FG000|Overall Study|Physician Decision|2|||
170412871|NCT02752776|615851908|FG001|Overall Study|Physician Decision|6|||
170412872|NCT02752776|615851909|FG002|Overall Study|Physician Decision|2|||
170412873|NCT02752776|615851907|FG000|Overall Study|Pregnancy|1|||
170412874|NCT02752776|615851908|FG001|Overall Study|Pregnancy|6|||
170412875|NCT02752776|615851909|FG002|Overall Study|Pregnancy|3|||
170412876|NCT02752776|615851907|FG000|Overall Study|Protocol Violation|10|||
170412877|NCT02752776|615851908|FG001|Overall Study|Protocol Violation|13|||
170412878|NCT02752776|615851909|FG002|Overall Study|Protocol Violation|6|||
170412879|NCT02752776|615851907|FG000|Overall Study|Subject/guardian decision|8|||
170412880|NCT02752776|615851908|FG001|Overall Study|Subject/guardian decision|6|||
170412881|NCT02752776|615851909|FG002|Overall Study|Subject/guardian decision|4|||
170412882|NCT02752776|615851907|FG000|Overall Study|Death|0|||
170412883|NCT02752776|615851908|FG001|Overall Study|Death|0|||
170412884|NCT02752776|615851909|FG002|Overall Study|Death|1|||
170412885|NCT02752776|615851907|FG000|Overall Study|Withdrawal by Subject|3|||
170412886|NCT02752776|615851908|FG001|Overall Study|Withdrawal by Subject|4|||
170412887|NCT02752776|615851909|FG002|Overall Study|Withdrawal by Subject|2|||
170412888|NCT03937466|615851910|FG000|Overall Study|not eligbile after the 2-week diary|9|||
170412889|NCT03937466|615851910|FG000|Overall Study|never returned their diary|6|||
170412890|NCT03937466|615851910|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
170412891|NCT03937466|615851910|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
170412892|NCT00818623|615851911|FG000|Overall Study|Adverse Event|1|||
170412893|NCT00818623|615851912|FG001|Overall Study|Adverse Event|0|||
170412894|NCT00818623|615851913|FG002|Overall Study|Adverse Event|1|||
170412895|NCT00818623|615851914|FG003|Overall Study|Adverse Event|0|||
170412896|NCT00818623|615851915|FG004|Overall Study|Adverse Event|0|||
170412897|NCT00818623|615851916|FG005|Overall Study|Adverse Event|1|||
170412898|NCT00818623|615851917|FG006|Overall Study|Adverse Event|0|||
170412899|NCT00818623|615851918|FG007|Overall Study|Adverse Event|0|||
170412900|NCT00818623|615851911|FG000|Overall Study|Bad prostate specific antigen response|0|||
170412901|NCT00818623|615851912|FG001|Overall Study|Bad prostate specific antigen response|3|||
170412902|NCT00818623|615851913|FG002|Overall Study|Bad prostate specific antigen response|2|||
170412903|NCT00818623|615851914|FG003|Overall Study|Bad prostate specific antigen response|5|||
170412904|NCT00818623|615851915|FG004|Overall Study|Bad prostate specific antigen response|0|||
170412905|NCT00818623|615851916|FG005|Overall Study|Bad prostate specific antigen response|1|||
170412906|NCT00818623|615851917|FG006|Overall Study|Bad prostate specific antigen response|0|||
170412907|NCT00818623|615851918|FG007|Overall Study|Bad prostate specific antigen response|0|||
170412908|NCT00818623|615851911|FG000|Overall Study|Withdrawal by Subject|0|||
170412909|NCT00818623|615851912|FG001|Overall Study|Withdrawal by Subject|1|||
170412910|NCT00818623|615851913|FG002|Overall Study|Withdrawal by Subject|1|||
170523390|NCT05696392|616261835|FG000|Overall Study|Protocol Violation|1|||
170523391|NCT05696392|616261835|FG000|Overall Study|Withdrawal by Subject|1|||
170523392|NCT05276973|616261840|FG000|Overall Study|Treated and DLT unevaluable|1|||
170523393|NCT05276973|616261841|FG001|Overall Study|Treated and DLT unevaluable|1|||
170523394|NCT05276973|616261842|FG002|Overall Study|Treated and DLT unevaluable|0|||
170523395|NCT03180736|616261843|FG000|Overall Study|Adverse Event|3|||
170523396|NCT03180736|616261844|FG001|Overall Study|Adverse Event|4|||
170523397|NCT03180736|616261843|FG000|Overall Study|Death|10|||
170523398|NCT03180736|616261844|FG001|Overall Study|Death|7|||
170523399|NCT03180736|616261843|FG000|Overall Study|Withdrawal by Subject|5|||
170523400|NCT03180736|616261844|FG001|Overall Study|Withdrawal by Subject|12|||
170523401|NCT03180736|616261843|FG000|Overall Study|Lost to Follow-up|1|||
170523402|NCT03180736|616261844|FG001|Overall Study|Lost to Follow-up|0|||
170523403|NCT03180736|616261843|FG000|Overall Study|Lack of Efficacy|66|||
170523404|NCT03180736|616261844|FG001|Overall Study|Lack of Efficacy|87|||
170523405|NCT03180736|616261843|FG000|Overall Study|Physician Decision|4|||
170523406|NCT03180736|616261844|FG001|Overall Study|Physician Decision|7|||
170523407|NCT03180736|616261843|FG000|Overall Study|randomized but not treated|2|||
170523408|NCT03180736|616261844|FG001|Overall Study|randomized but not treated|3|||
170523409|NCT04144322|616261845|FG000|Overall Study|Lack of Efficacy|2|||
170523410|NCT04144322|616261846|FG001|Overall Study|Lack of Efficacy|2|||
170523411|NCT02277028|616261847|FG000|Overall Study|Lost to Follow-up|1|||
170523412|NCT02277028|616261848|FG001|Overall Study|Lost to Follow-up|0|||
170523413|NCT02277028|616261847|FG000|Overall Study|Withdrawal by Subject|0|||
170523414|NCT02277028|616261848|FG001|Overall Study|Withdrawal by Subject|1|||
170523415|NCT02718911|616261849|FG000|Overall Study|Adverse Event|0|||
170523416|NCT02718911|616261850|FG001|Overall Study|Adverse Event|0|||
170523417|NCT02718911|616261851|FG002|Overall Study|Adverse Event|0|||
170523418|NCT02718911|616261852|FG003|Overall Study|Adverse Event|0|||
170523419|NCT02718911|616261853|FG004|Overall Study|Adverse Event|0|||
170523420|NCT02718911|616261854|FG005|Overall Study|Adverse Event|0|||
170523421|NCT02718911|616261855|FG006|Overall Study|Adverse Event|0|||
170523422|NCT02718911|616261856|FG007|Overall Study|Adverse Event|0|||
170523423|NCT02718911|616261857|FG008|Overall Study|Adverse Event|0|||
170523424|NCT02718911|616261858|FG009|Overall Study|Adverse Event|2|||
170523425|NCT02718911|616261849|FG000|Overall Study|Death|2|||
170523426|NCT02718911|616261850|FG001|Overall Study|Death|3|||
170523427|NCT02718911|616261851|FG002|Overall Study|Death|1|||
170523428|NCT02718911|616261852|FG003|Overall Study|Death|0|||
170523429|NCT02718911|616261853|FG004|Overall Study|Death|1|||
170523430|NCT02718911|616261854|FG005|Overall Study|Death|3|||
170523431|NCT02718911|616261855|FG006|Overall Study|Death|1|||
170523432|NCT02718911|616261856|FG007|Overall Study|Death|1|||
170523433|NCT02718911|616261857|FG008|Overall Study|Death|4|||
170523434|NCT02718911|616261858|FG009|Overall Study|Death|3|||
170523435|NCT02718911|616261849|FG000|Overall Study|Lost to Follow-up|0|||
170523436|NCT02718911|616261850|FG001|Overall Study|Lost to Follow-up|0|||
170523437|NCT02718911|616261851|FG002|Overall Study|Lost to Follow-up|0|||
170523438|NCT02718911|616261852|FG003|Overall Study|Lost to Follow-up|0|||
170523439|NCT02718911|616261853|FG004|Overall Study|Lost to Follow-up|0|||
170523440|NCT02718911|616261854|FG005|Overall Study|Lost to Follow-up|0|||
170523441|NCT02718911|616261855|FG006|Overall Study|Lost to Follow-up|0|||
170523442|NCT02718911|616261856|FG007|Overall Study|Lost to Follow-up|0|||
170523443|NCT02718911|616261857|FG008|Overall Study|Lost to Follow-up|1|||
170523444|NCT02718911|616261858|FG009|Overall Study|Lost to Follow-up|0|||
170523445|NCT02718911|616261849|FG000|Overall Study|Physician Decision|2|||
170523446|NCT02718911|616261850|FG001|Overall Study|Physician Decision|0|||
170523447|NCT02718911|616261851|FG002|Overall Study|Physician Decision|1|||
170523448|NCT02718911|616261852|FG003|Overall Study|Physician Decision|1|||
170523449|NCT02718911|616261853|FG004|Overall Study|Physician Decision|0|||
170523450|NCT02718911|616261854|FG005|Overall Study|Physician Decision|0|||
170523451|NCT02718911|616261855|FG006|Overall Study|Physician Decision|0|||
170523452|NCT02718911|616261856|FG007|Overall Study|Physician Decision|1|||
170523453|NCT02718911|616261857|FG008|Overall Study|Physician Decision|2|||
170523454|NCT02718911|616261858|FG009|Overall Study|Physician Decision|1|||
170523455|NCT02718911|616261849|FG000|Overall Study|Withdrawal by Subject|0|||
170523456|NCT02718911|616261850|FG001|Overall Study|Withdrawal by Subject|0|||
170523457|NCT02718911|616261851|FG002|Overall Study|Withdrawal by Subject|0|||
170523458|NCT02718911|616261852|FG003|Overall Study|Withdrawal by Subject|0|||
170523459|NCT02718911|616261853|FG004|Overall Study|Withdrawal by Subject|1|||
170523460|NCT02718911|616261854|FG005|Overall Study|Withdrawal by Subject|0|||
170523461|NCT02718911|616261855|FG006|Overall Study|Withdrawal by Subject|0|||
170523462|NCT02718911|616261856|FG007|Overall Study|Withdrawal by Subject|0|||
170523463|NCT02718911|616261857|FG008|Overall Study|Withdrawal by Subject|1|||
170523464|NCT02718911|616261858|FG009|Overall Study|Withdrawal by Subject|4|||
170523465|NCT02718911|616261849|FG000|Overall Study|Reason Not Collected|0|||
170770414|NCT02200770|617164675|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
170523466|NCT02718911|616261850|FG001|Overall Study|Reason Not Collected|0|||
170523467|NCT02718911|616261851|FG002|Overall Study|Reason Not Collected|1|||
170523468|NCT02718911|616261852|FG003|Overall Study|Reason Not Collected|0|||
170523469|NCT02718911|616261853|FG004|Overall Study|Reason Not Collected|0|||
170523470|NCT02718911|616261854|FG005|Overall Study|Reason Not Collected|0|||
170523471|NCT02718911|616261855|FG006|Overall Study|Reason Not Collected|2|||
170523472|NCT02718911|616261856|FG007|Overall Study|Reason Not Collected|1|||
170523473|NCT02718911|616261857|FG008|Overall Study|Reason Not Collected|4|||
170523474|NCT02718911|616261858|FG009|Overall Study|Reason Not Collected|9|||
170523475|NCT04817332|616261859|FG000|Overall Study|Lost to Follow-up|3|||
170523476|NCT04817332|616261860|FG001|Overall Study|Lost to Follow-up|3|||
170523477|NCT04817332|616261859|FG000|Overall Study|Protocol Violation|2|||
170523478|NCT04817332|616261860|FG001|Overall Study|Protocol Violation|0|||
170523479|NCT01867008|616261864|FG000|Overall Study|Withdrawal by Subject|1|||
170523480|NCT05457257|616261871|FG000|Overall Study|Withdrawal by Subject|0|||
170523481|NCT05457257|616261872|FG001|Overall Study|Withdrawal by Subject|2|||
170523482|NCT05457257|616261871|FG000|Overall Study|Death|10|||
170523483|NCT05457257|616261872|FG001|Overall Study|Death|3|||
170523484|NCT05457257|616261871|FG000|Overall Study|Ongoing|19|||
170523485|NCT05457257|616261872|FG001|Overall Study|Ongoing|9|||
170523486|NCT02131064|616261873|FG000|Overall Study|Death|5|||
170523487|NCT02131064|616261874|FG001|Overall Study|Death|6|||
170523488|NCT02131064|616261873|FG000|Overall Study|Lost to Follow-up|4|||
170523489|NCT02131064|616261874|FG001|Overall Study|Lost to Follow-up|8|||
170523490|NCT02131064|616261873|FG000|Overall Study|Withdrawal by Subject|14|||
170523491|NCT02131064|616261874|FG001|Overall Study|Withdrawal by Subject|18|||
170523492|NCT02131064|616261873|FG000|Overall Study|Other|2|||
170523493|NCT02131064|616261874|FG001|Overall Study|Other|2|||
170523494|NCT03126786|616261877|FG000|Overall Study|Adverse Event|3|||
170523495|NCT03126786|616261878|FG001|Overall Study|Adverse Event|0|||
170523496|NCT03126786|616261877|FG000|Overall Study|Lost to Follow-up|0|||
170523497|NCT03126786|616261878|FG001|Overall Study|Lost to Follow-up|1|||
170523498|NCT03126786|616261877|FG000|Overall Study|Withdrawal by Subject|3|||
170523499|NCT03126786|616261878|FG001|Overall Study|Withdrawal by Subject|1|||
170523500|NCT03243305|616261879|FG000|Overall Study|Lost to Follow-up|250|||
170523501|NCT03243305|616261879|FG000|Overall Study|Withdrawal by Subject|170|||
170523502|NCT03243305|616261879|FG000|Overall Study|Pregnancy|104|||
170523503|NCT03243305|616261879|FG000|Overall Study|Non-Compliance with Study Drug|38|||
170523504|NCT03243305|616261879|FG000|Overall Study|Adverse Event|23|||
170523505|NCT03243305|616261879|FG000|Overall Study|No sexually active|26|||
170523506|NCT03243305|616261879|FG000|Overall Study|Physician Decision|22|||
170523507|NCT03243305|616261879|FG000|Overall Study|Protocol Violation|22|||
170523508|NCT03243305|616261879|FG000|Overall Study|Study method no longer primary method|12|||
170523509|NCT03243305|616261879|FG000|Overall Study|Study Terminated by Sponsor|1|||
170523510|NCT03243305|616261879|FG000|Overall Study|Early terminations|267|||
170523511|NCT01585246|616261880|FG000|Overall Study|Lost to Follow-up|0|||
170523512|NCT01585246|616261881|FG001|Overall Study|Lost to Follow-up|0|||
170523513|NCT01585246|616261882|FG002|Overall Study|Lost to Follow-up|2|||
170523514|NCT01585246|616261883|FG003|Overall Study|Lost to Follow-up|1|||
170523515|NCT01585246|616261884|FG004|Overall Study|Lost to Follow-up|0|||
170523516|NCT01585246|616261880|FG000|Overall Study|Protocol Violation|0|||
170523517|NCT01585246|616261881|FG001|Overall Study|Protocol Violation|0|||
170523518|NCT01585246|616261882|FG002|Overall Study|Protocol Violation|0|||
170523519|NCT01585246|616261883|FG003|Overall Study|Protocol Violation|0|||
170523520|NCT01585246|616261884|FG004|Overall Study|Protocol Violation|1|||
170523521|NCT01585246|616261880|FG000|Overall Study|Withdrawal by Subject|0|||
170523522|NCT01585246|616261881|FG001|Overall Study|Withdrawal by Subject|0|||
170523523|NCT01585246|616261882|FG002|Overall Study|Withdrawal by Subject|1|||
170523524|NCT01585246|616261883|FG003|Overall Study|Withdrawal by Subject|2|||
170523525|NCT01585246|616261884|FG004|Overall Study|Withdrawal by Subject|1|||
170523526|NCT01585246|616261880|FG000|Overall Study|Other|0|||
170523527|NCT01585246|616261881|FG001|Overall Study|Other|1|||
170523528|NCT01585246|616261882|FG002|Overall Study|Other|1|||
170523529|NCT01585246|616261883|FG003|Overall Study|Other|1|||
170523530|NCT01585246|616261884|FG004|Overall Study|Other|0|||
170523531|NCT00570401|616261889|FG000|Overall Study|Adverse Event|2|||
170523532|NCT01710020|616261890|FG000|Period 1|Protocol Violation|1|||
170523533|NCT00427908|616261891|FG000|Primary Phase|Lost to Follow-up|4|||
170523534|NCT00427908|616261892|FG001|Primary Phase|Lost to Follow-up|0|||
170523535|NCT00427908|616261893|FG002|Primary Phase|Lost to Follow-up|2|||
170523536|NCT00427908|616261894|FG003|Primary Phase|Lost to Follow-up|0|||
170523537|NCT00427908|616261891|FG000|Primary Phase|Withdrawal by Subject|1|||
170523538|NCT00427908|616261892|FG001|Primary Phase|Withdrawal by Subject|2|||
170523539|NCT00427908|616261893|FG002|Primary Phase|Withdrawal by Subject|1|||
170523540|NCT00427908|616261894|FG003|Primary Phase|Withdrawal by Subject|0|||
170523541|NCT00427908|616261891|FG000|Primary Phase|Adverse Event|0|||
170523542|NCT00427908|616261892|FG001|Primary Phase|Adverse Event|1|||
170523543|NCT00427908|616261893|FG002|Primary Phase|Adverse Event|0|||
170523544|NCT00427908|616261894|FG003|Primary Phase|Adverse Event|0|||
170523545|NCT01764841|616261895|FG000|Overall Study|Logistical Difficulties|0|||
170523546|NCT01764841|616261896|FG001|Overall Study|Logistical Difficulties|1|||
170523547|NCT01764841|616261897|FG002|Overall Study|Logistical Difficulties|0|||
170770415|NCT02200770|617164676|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
170770416|NCT02200770|617164675|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
170770417|NCT02200770|617164676|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
170770418|NCT02200770|617164675|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
170770419|NCT02200770|617164676|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
170770420|NCT02200770|617164675|FG000|Randomized-controlled Period (RCP)|Other|1|||
170412911|NCT00818623|615851914|FG003|Overall Study|Withdrawal by Subject|0|||
170412912|NCT00818623|615851915|FG004|Overall Study|Withdrawal by Subject|0|||
170412913|NCT00818623|615851916|FG005|Overall Study|Withdrawal by Subject|1|||
170412914|NCT00818623|615851917|FG006|Overall Study|Withdrawal by Subject|1|||
170412915|NCT00818623|615851918|FG007|Overall Study|Withdrawal by Subject|1|||
170412916|NCT00818623|615851911|FG000|Overall Study|Protocol Violation|1|||
170412917|NCT00818623|615851912|FG001|Overall Study|Protocol Violation|0|||
170412918|NCT00818623|615851913|FG002|Overall Study|Protocol Violation|0|||
170412919|NCT00818623|615851914|FG003|Overall Study|Protocol Violation|0|||
170412920|NCT00818623|615851915|FG004|Overall Study|Protocol Violation|1|||
170412921|NCT00818623|615851916|FG005|Overall Study|Protocol Violation|0|||
170412922|NCT00818623|615851917|FG006|Overall Study|Protocol Violation|1|||
170412923|NCT00818623|615851918|FG007|Overall Study|Protocol Violation|0|||
170412924|NCT00818623|615851911|FG000|Overall Study|Need of additional treatment|0|||
170412925|NCT00818623|615851912|FG001|Overall Study|Need of additional treatment|0|||
170412926|NCT00818623|615851913|FG002|Overall Study|Need of additional treatment|0|||
170412927|NCT00818623|615851914|FG003|Overall Study|Need of additional treatment|0|||
170412928|NCT00818623|615851915|FG004|Overall Study|Need of additional treatment|1|||
170412929|NCT00818623|615851916|FG005|Overall Study|Need of additional treatment|0|||
170412930|NCT00818623|615851917|FG006|Overall Study|Need of additional treatment|0|||
170412931|NCT00818623|615851918|FG007|Overall Study|Need of additional treatment|0|||
170412932|NCT00818623|615851911|FG000|Overall Study|Lack of trial drug at site|0|||
170412933|NCT00818623|615851912|FG001|Overall Study|Lack of trial drug at site|0|||
170412934|NCT00818623|615851913|FG002|Overall Study|Lack of trial drug at site|0|||
170412935|NCT00818623|615851914|FG003|Overall Study|Lack of trial drug at site|0|||
170412936|NCT00818623|615851915|FG004|Overall Study|Lack of trial drug at site|2|||
170412937|NCT00818623|615851916|FG005|Overall Study|Lack of trial drug at site|0|||
170412938|NCT00818623|615851917|FG006|Overall Study|Lack of trial drug at site|1|||
170412939|NCT00818623|615851918|FG007|Overall Study|Lack of trial drug at site|0|||
170412940|NCT00818623|615851911|FG000|Overall Study|Disease progression|0|||
170412941|NCT00818623|615851912|FG001|Overall Study|Disease progression|0|||
170412942|NCT00818623|615851913|FG002|Overall Study|Disease progression|0|||
170412943|NCT00818623|615851914|FG003|Overall Study|Disease progression|0|||
170412944|NCT00818623|615851915|FG004|Overall Study|Disease progression|0|||
170412945|NCT00818623|615851916|FG005|Overall Study|Disease progression|0|||
170412946|NCT00818623|615851917|FG006|Overall Study|Disease progression|1|||
170412947|NCT00818623|615851918|FG007|Overall Study|Disease progression|0|||
170412948|NCT03500484|615851919|FG000|Overall Study|Adverse Event|2|||
170412949|NCT03500484|615851920|FG001|Overall Study|Adverse Event|0|||
170412950|NCT03500484|615851919|FG000|Overall Study|Physician Decision|1|||
170412951|NCT03500484|615851920|FG001|Overall Study|Physician Decision|0|||
170412952|NCT03500484|615851919|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
170412953|NCT03500484|615851920|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
170412954|NCT00903383|615851921|FG000|Overall Study|Adverse Event|1|||
170412955|NCT00903383|615851922|FG001|Overall Study|Adverse Event|2|||
170412956|NCT00903383|615851923|FG002|Overall Study|Adverse Event|3|||
170412957|NCT00903383|615851924|FG003|Overall Study|Adverse Event|1|||
170412958|NCT00903383|615851921|FG000|Overall Study|Physician Decision|1|||
170412959|NCT00903383|615851922|FG001|Overall Study|Physician Decision|2|||
170412960|NCT00903383|615851923|FG002|Overall Study|Physician Decision|0|||
170412961|NCT00903383|615851924|FG003|Overall Study|Physician Decision|0|||
170412962|NCT00903383|615851921|FG000|Overall Study|Lost to Follow-up|0|||
170412963|NCT00903383|615851922|FG001|Overall Study|Lost to Follow-up|0|||
170412964|NCT00903383|615851923|FG002|Overall Study|Lost to Follow-up|0|||
170412965|NCT00903383|615851924|FG003|Overall Study|Lost to Follow-up|1|||
170412966|NCT00903383|615851921|FG000|Overall Study|Decision of Sponsor|1|||
170412967|NCT00903383|615851922|FG001|Overall Study|Decision of Sponsor|0|||
170412968|NCT00903383|615851923|FG002|Overall Study|Decision of Sponsor|0|||
170412969|NCT00903383|615851924|FG003|Overall Study|Decision of Sponsor|0|||
170412970|NCT00903383|615851921|FG000|Overall Study|Withdrawal by Subject|4|||
170412971|NCT00903383|615851922|FG001|Overall Study|Withdrawal by Subject|1|||
170412972|NCT00903383|615851923|FG002|Overall Study|Withdrawal by Subject|0|||
170523548|NCT01764841|616261898|FG003|Overall Study|Logistical Difficulties|0|||
170770421|NCT02200770|617164676|FG001|Randomized-controlled Period (RCP)|Other|2|||
170770422|NCT02200770|617164675|FG000|Open-label Period (OLP)|Adverse Event|1|||
170770423|NCT02200770|617164676|FG001|Open-label Period (OLP)|Adverse Event|2|||
170412973|NCT00903383|615851924|FG003|Overall Study|Withdrawal by Subject|2|||
170412974|NCT00903383|615851921|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
170412975|NCT00903383|615851922|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
170523549|NCT01764841|616261895|FG000|Overall Study|Death|3|||
170872164|NCT02170779|617543132|FG001|Overall Study|Lost to Follow-up|1|||
170872165|NCT02678416|617543133|FG000|Part 1|Withdrawal by Subject|1|||
170872166|NCT02678416|617543133|FG000|Part 2|Adverse Event|2|||
170872167|NCT02678416|617543133|FG000|Part 2|Withdrawal by Subject|1|||
170872168|NCT02463071|617543142|FG000|Overall Study|Adverse Event|3|||
170872169|NCT02463071|617543143|FG001|Overall Study|Adverse Event|5|||
170872170|NCT02463071|617543144|FG002|Overall Study|Adverse Event|1|||
170872171|NCT02463071|617543142|FG000|Overall Study|Death|1|||
170872172|NCT02463071|617543143|FG001|Overall Study|Death|0|||
170872173|NCT02463071|617543144|FG002|Overall Study|Death|0|||
170872174|NCT02463071|617543142|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
170872175|NCT02463071|617543143|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170872176|NCT02463071|617543144|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
170412976|NCT00903383|615851923|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
170412977|NCT00903383|615851924|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
170412978|NCT00903383|615851921|FG000|Overall Study|Patient Decision|0|||
170412979|NCT00903383|615851922|FG001|Overall Study|Patient Decision|0|||
170412980|NCT00903383|615851923|FG002|Overall Study|Patient Decision|0|||
170412981|NCT00903383|615851924|FG003|Overall Study|Patient Decision|1|||
170412982|NCT02015793|615851932|FG000|Overall Study|Adverse Event|3|||
170412983|NCT02015793|615851933|FG001|Overall Study|Adverse Event|3|||
170412984|NCT02015793|615851932|FG000|Overall Study|Withdrawal by Subject|1|||
170412985|NCT02015793|615851933|FG001|Overall Study|Withdrawal by Subject|1|||
170412986|NCT01709383|615851940|FG000|Overall Study|Lost to Follow-up|1|||
170412987|NCT01709383|615851941|FG001|Overall Study|Lost to Follow-up|0|||
170412988|NCT01484028|615851942|FG000|Period 1|Lost to Follow-up|0|||
170412989|NCT01484028|615851943|FG001|Period 1|Lost to Follow-up|1|||
170412990|NCT01484028|615851944|FG002|Period 1|Lost to Follow-up|0|||
170412991|NCT01484028|615851945|FG003|Period 1|Lost to Follow-up|0|||
170412992|NCT01484028|615851942|FG000|Period 1|Non-Compliance to Protocol|0|||
170412993|NCT01484028|615851943|FG001|Period 1|Non-Compliance to Protocol|1|||
170412994|NCT01484028|615851944|FG002|Period 1|Non-Compliance to Protocol|0|||
170412995|NCT01484028|615851945|FG003|Period 1|Non-Compliance to Protocol|1|||
170412996|NCT01484028|615851942|FG000|Period 1|Lens Discomfort|0|||
170412997|NCT01484028|615851943|FG001|Period 1|Lens Discomfort|1|||
170412998|NCT01484028|615851944|FG002|Period 1|Lens Discomfort|0|||
170412999|NCT01484028|615851945|FG003|Period 1|Lens Discomfort|0|||
170413000|NCT02826603|615851957|FG000|Overall Study|Adverse Event|17|||
170413001|NCT02826603|615851958|FG001|Overall Study|Adverse Event|9|||
170413002|NCT02826603|615851957|FG000|Overall Study|Lack of Efficacy|4|||
170413003|NCT02826603|615851958|FG001|Overall Study|Lack of Efficacy|9|||
170413004|NCT02826603|615851957|FG000|Overall Study|Lost to Follow-up|13|||
170413005|NCT02826603|615851958|FG001|Overall Study|Lost to Follow-up|12|||
170413006|NCT02826603|615851957|FG000|Overall Study|Noncompliance with treatment|0|||
170413007|NCT02826603|615851958|FG001|Overall Study|Noncompliance with treatment|2|||
170413008|NCT02826603|615851957|FG000|Overall Study|Physician Decision|1|||
170413009|NCT02826603|615851958|FG001|Overall Study|Physician Decision|7|||
170413010|NCT02826603|615851957|FG000|Overall Study|Pregnancy|1|||
170413011|NCT02826603|615851958|FG001|Overall Study|Pregnancy|2|||
170413012|NCT02826603|615851957|FG000|Overall Study|Protocol Violation|3|||
170413013|NCT02826603|615851958|FG001|Overall Study|Protocol Violation|3|||
170413014|NCT02826603|615851957|FG000|Overall Study|Withdrawal by Subject|20|||
170413015|NCT02826603|615851958|FG001|Overall Study|Withdrawal by Subject|19|||
170413016|NCT02826603|615851957|FG000|Overall Study|Death|2|||
170413017|NCT02826603|615851958|FG001|Overall Study|Death|0|||
170413018|NCT02826603|615851957|FG000|Overall Study|New therapy for study indication|0|||
170413019|NCT02826603|615851958|FG001|Overall Study|New therapy for study indication|1|||
170413020|NCT00583596|615851959|FG000|Overall Study|Lost to Follow-up|110|||
170413021|NCT00583596|615851959|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
170413022|NCT00583596|615851959|FG000|Overall Study|Death|2|||
170413023|NCT00583596|615851959|FG000|Overall Study|Withdrawal by Subject|6|||
170413024|NCT00583596|615851959|FG000|Overall Study|Lost to Follow-up|94|||
170413025|NCT00583596|615851959|FG000|Overall Study|Data not complete|1|||
170413026|NCT00583596|615851959|FG000|Overall Study|Not consented|15|||
170523550|NCT01764841|616261896|FG001|Overall Study|Death|0|||
170523551|NCT01764841|616261897|FG002|Overall Study|Death|1|||
170523552|NCT01764841|616261898|FG003|Overall Study|Death|4|||
170523553|NCT01764841|616261895|FG000|Overall Study|No Follow Up|1|||
170523554|NCT01764841|616261896|FG001|Overall Study|No Follow Up|0|||
170523555|NCT01764841|616261897|FG002|Overall Study|No Follow Up|1|||
170523556|NCT01764841|616261898|FG003|Overall Study|No Follow Up|0|||
170523557|NCT01764841|616261895|FG000|Overall Study|Protocol Violation|0|||
170523558|NCT01764841|616261896|FG001|Overall Study|Protocol Violation|1|||
170523559|NCT01764841|616261897|FG002|Overall Study|Protocol Violation|0|||
170523560|NCT01764841|616261898|FG003|Overall Study|Protocol Violation|0|||
170872177|NCT02463071|617543142|FG000|Overall Study|Reason not specified|7|||
170872178|NCT02463071|617543143|FG001|Overall Study|Reason not specified|9|||
170413027|NCT00583596|615851959|FG000|Overall Study|Outside f-up window|26|||
170413028|NCT03558997|615851960|FG000|Overall Study|Adverse Event|0|||
170872179|NCT02463071|617543144|FG002|Overall Study|Reason not specified|4|||
170523561|NCT01764841|616261895|FG000|Overall Study|Withdrawal by Subject|16|||
170523562|NCT01764841|616261896|FG001|Overall Study|Withdrawal by Subject|24|||
170523563|NCT01764841|616261897|FG002|Overall Study|Withdrawal by Subject|11|||
170523564|NCT01764841|616261898|FG003|Overall Study|Withdrawal by Subject|15|||
170523565|NCT01764841|616261895|FG000|Overall Study|Lost to Follow-up|3|||
170523566|NCT01764841|616261896|FG001|Overall Study|Lost to Follow-up|0|||
170523567|NCT01764841|616261897|FG002|Overall Study|Lost to Follow-up|1|||
170523568|NCT01764841|616261898|FG003|Overall Study|Lost to Follow-up|0|||
170523569|NCT02115607|616261901|FG000|Overall Study|Withdrawal by Subject|1|||
170523570|NCT04863872|616261904|FG000|Overall Study|Withdrawal by Subject|4|||
170523571|NCT04863872|616261905|FG001|Overall Study|Withdrawal by Subject|15|||
170523572|NCT04863872|616261904|FG000|Overall Study|Death|5|||
170523573|NCT04863872|616261905|FG001|Overall Study|Death|2|||
170523574|NCT04863872|616261904|FG000|Overall Study|Lost to Follow-up|2|||
170523575|NCT04863872|616261905|FG001|Overall Study|Lost to Follow-up|1|||
170523576|NCT04782180|616261906|FG000|Overall Study|Withdrawal by Subject|2|||
170523577|NCT04782180|616261906|FG000|Overall Study|Lost to Follow-up|2|||
170523578|NCT00549549|616261907|FG000|Overall Study|Adverse Event|5|||
170523579|NCT00549549|616261908|FG001|Overall Study|Adverse Event|3|||
170523580|NCT00549549|616261909|FG002|Overall Study|Adverse Event|1|||
170523581|NCT00549549|616261910|FG003|Overall Study|Adverse Event|9|||
170523582|NCT00549549|616261907|FG000|Overall Study|Lack of Efficacy|9|||
170523583|NCT00549549|616261908|FG001|Overall Study|Lack of Efficacy|6|||
170523584|NCT00549549|616261909|FG002|Overall Study|Lack of Efficacy|4|||
170523585|NCT00549549|616261910|FG003|Overall Study|Lack of Efficacy|2|||
170523586|NCT00549549|616261907|FG000|Overall Study|Lost to Follow-up|1|||
170523587|NCT00549549|616261908|FG001|Overall Study|Lost to Follow-up|0|||
170523588|NCT00549549|616261909|FG002|Overall Study|Lost to Follow-up|1|||
170523589|NCT00549549|616261910|FG003|Overall Study|Lost to Follow-up|2|||
170523590|NCT00549549|616261907|FG000|Overall Study|Withdrawal by Subject|0|||
170523591|NCT00549549|616261908|FG001|Overall Study|Withdrawal by Subject|4|||
170523592|NCT00549549|616261909|FG002|Overall Study|Withdrawal by Subject|1|||
170523593|NCT00549549|616261910|FG003|Overall Study|Withdrawal by Subject|0|||
170523594|NCT00549549|616261907|FG000|Overall Study|Other|9|||
170523595|NCT00549549|616261908|FG001|Overall Study|Other|9|||
170523596|NCT00549549|616261909|FG002|Overall Study|Other|9|||
170523597|NCT00549549|616261910|FG003|Overall Study|Other|11|||
170523598|NCT00549549|616261907|FG000|Overall Study|Randomized but not treated|0|||
170523599|NCT00549549|616261908|FG001|Overall Study|Randomized but not treated|0|||
170523600|NCT00549549|616261909|FG002|Overall Study|Randomized but not treated|1|||
170523601|NCT00549549|616261910|FG003|Overall Study|Randomized but not treated|1|||
170523602|NCT00689338|616261911|FG000|Overall Study|Death|65|||
170523603|NCT00689338|616261911|FG000|Overall Study|Adverse Event|13|||
170523604|NCT00689338|616261911|FG000|Overall Study|Insufficient Clinical Response|1|||
170523605|NCT00689338|616261911|FG000|Overall Study|Lack of Efficacy|6|||
170770424|NCT02200770|617164675|FG000|Open-label Period (OLP)|Death|1|||
170770425|NCT02200770|617164676|FG001|Open-label Period (OLP)|Death|2|||
170770426|NCT02200770|617164675|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
170770427|NCT02200770|617164676|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
170770428|NCT02200770|617164675|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
170770429|NCT02200770|617164676|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
170770430|NCT02200770|617164675|FG000|Open-label Period (OLP)|Other|6|||
170770431|NCT02200770|617164676|FG001|Open-label Period (OLP)|Other|15|||
170770432|NCT00959946|617164678|FG000|Overall Study|Adverse Event|0|||
170770433|NCT00959946|617164679|FG001|Overall Study|Adverse Event|0|||
170770434|NCT00959946|617164680|FG002|Overall Study|Adverse Event|2|||
170770435|NCT00959946|617164681|FG003|Overall Study|Adverse Event|1|||
170770436|NCT00959946|617164682|FG004|Overall Study|Adverse Event|0|||
170770437|NCT00959946|617164683|FG005|Overall Study|Adverse Event|1|||
170770438|NCT00959946|617164684|FG006|Overall Study|Adverse Event|0|||
170770439|NCT00959946|617164685|FG007|Overall Study|Adverse Event|0|||
170770440|NCT00959946|617164678|FG000|Overall Study|Death|0|||
170770441|NCT00959946|617164679|FG001|Overall Study|Death|0|||
170523606|NCT00689338|616261911|FG000|Overall Study|Other|8|||
170523607|NCT00689338|616261911|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
170523608|NCT00689338|616261911|FG000|Overall Study|Lost to Follow-up|5|||
170523609|NCT00689338|616261911|FG000|Overall Study|Withdrawal by Subject|3|||
170770442|NCT00959946|617164680|FG002|Overall Study|Death|0|||
170770443|NCT00959946|617164681|FG003|Overall Study|Death|0|||
170770444|NCT00959946|617164682|FG004|Overall Study|Death|0|||
170770445|NCT00959946|617164683|FG005|Overall Study|Death|1|||
170770446|NCT00959946|617164684|FG006|Overall Study|Death|0|||
170523610|NCT00689338|616261911|FG000|Overall Study|Protocol Violation|15|||
170523611|NCT04235504|616261912|FG000|Study Phase|Withdrawal by Subject|5|||
170523612|NCT04235504|616261913|FG001|Study Phase|Withdrawal by Subject|2|||
170523613|NCT04235504|616261914|FG002|Study Phase|Withdrawal by Subject|0|||
170523614|NCT04235504|616261915|FG003|Study Phase|Withdrawal by Subject|0|||
170523615|NCT04235504|616261912|FG000|Continuation Phase|Withdrawal by Subject|0|||
170770447|NCT00959946|617164685|FG007|Overall Study|Death|0|||
170770448|NCT00959946|617164678|FG000|Overall Study|Disease Progression|2|||
170872180|NCT02463071|617543142|FG000|Overall Study|Protocol Violation|0|||
170872181|NCT02463071|617543143|FG001|Overall Study|Protocol Violation|2|||
170872182|NCT02463071|617543144|FG002|Overall Study|Protocol Violation|0|||
170872183|NCT02463071|617543142|FG000|Overall Study|Lost to Follow-up|0|||
170872184|NCT02463071|617543143|FG001|Overall Study|Lost to Follow-up|0|||
170872185|NCT02463071|617543144|FG002|Overall Study|Lost to Follow-up|1|||
170872186|NCT02003014|617543148|FG000|Overall Study|Case report forms uncollected|9|||
170872187|NCT02003014|617543148|FG000|Overall Study|Treatment started after contract period|1|||
170872188|NCT02003014|617543148|FG000|Overall Study|Patient did not visit the study site|5|||
170872189|NCT02003014|617543148|FG000|Overall Study|Investigator's transfer|4|||
170872190|NCT01624259|617543149|FG000|Overall Study|Adverse Event|18|||
170872191|NCT01624259|617543150|FG001|Overall Study|Adverse Event|18|||
170872192|NCT01624259|617543149|FG000|Overall Study|Protocol Violation|1|||
170872193|NCT01624259|617543150|FG001|Overall Study|Protocol Violation|2|||
170872194|NCT01624259|617543149|FG000|Overall Study|Withdrawal by Subject|5|||
170872195|NCT01624259|617543150|FG001|Overall Study|Withdrawal by Subject|7|||
170872196|NCT01624259|617543149|FG000|Overall Study|Physician Decision|1|||
170872197|NCT01624259|617543150|FG001|Overall Study|Physician Decision|1|||
170872198|NCT01624259|617543149|FG000|Overall Study|Lost to Follow-up|2|||
170872199|NCT01624259|617543150|FG001|Overall Study|Lost to Follow-up|3|||
170413029|NCT03558997|615851961|FG001|Overall Study|Adverse Event|2|||
170413030|NCT03558997|615851962|FG002|Overall Study|Adverse Event|5|||
170413031|NCT03558997|615851963|FG003|Overall Study|Adverse Event|1|||
170413032|NCT03558997|615851960|FG000|Overall Study|Physician Decision|0|||
170413033|NCT03558997|615851961|FG001|Overall Study|Physician Decision|0|||
170413034|NCT03558997|615851962|FG002|Overall Study|Physician Decision|1|||
170413035|NCT03558997|615851963|FG003|Overall Study|Physician Decision|0|||
170413036|NCT03558997|615851960|FG000|Overall Study|Withdrawal by Subject|1|||
170413037|NCT03558997|615851961|FG001|Overall Study|Withdrawal by Subject|0|||
170413038|NCT03558997|615851962|FG002|Overall Study|Withdrawal by Subject|1|||
170413039|NCT03558997|615851963|FG003|Overall Study|Withdrawal by Subject|1|||
170413040|NCT03558997|615851960|FG000|Overall Study|Lost to Follow-up|0|||
170413041|NCT03558997|615851961|FG001|Overall Study|Lost to Follow-up|0|||
170413042|NCT03558997|615851962|FG002|Overall Study|Lost to Follow-up|1|||
170413043|NCT03558997|615851963|FG003|Overall Study|Lost to Follow-up|0|||
170413044|NCT00526890|615851964|FG000|Overall Study|Adverse Event|2|||
170413045|NCT00500682|615851965|FG000|Overall Study|Adverse Event|37|||
170413046|NCT00500682|615851966|FG001|Overall Study|Adverse Event|29|||
170413047|NCT00500682|615851965|FG000|Overall Study|Death|25|||
170413048|NCT00500682|615851966|FG001|Overall Study|Death|16|||
170413049|NCT00500682|615851965|FG000|Overall Study|Lost to Follow-up|11|||
170413050|NCT00500682|615851966|FG001|Overall Study|Lost to Follow-up|11|||
170413051|NCT00500682|615851965|FG000|Overall Study|Physician Decision|6|||
170413052|NCT00500682|615851966|FG001|Overall Study|Physician Decision|10|||
170413053|NCT00500682|615851965|FG000|Overall Study|Pregnancy|2|||
170413054|NCT00500682|615851966|FG001|Overall Study|Pregnancy|0|||
170413055|NCT00500682|615851965|FG000|Overall Study|Protocol Violation|1|||
170413056|NCT00500682|615851966|FG001|Overall Study|Protocol Violation|3|||
170413057|NCT00500682|615851965|FG000|Overall Study|Withdrawal by Subject|80|||
170413058|NCT00500682|615851966|FG001|Overall Study|Withdrawal by Subject|74|||
170413059|NCT00500682|615851965|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
170413060|NCT00500682|615851966|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
170413061|NCT01995058|615851967|FG000|Overall Study|Sponsor Decision to terminate study|14|||
170413062|NCT01995058|615851968|FG001|Overall Study|Sponsor Decision to terminate study|12|||
170413063|NCT01995058|615851969|FG002|Overall Study|Sponsor Decision to terminate study|12|||
170413064|NCT01995058|615851970|FG003|Overall Study|Sponsor Decision to terminate study|10|||
170413065|NCT01995058|615851967|FG000|Overall Study|Progressive Disease|0|||
170413066|NCT01995058|615851968|FG001|Overall Study|Progressive Disease|1|||
170413067|NCT01995058|615851969|FG002|Overall Study|Progressive Disease|1|||
170413068|NCT01995058|615851970|FG003|Overall Study|Progressive Disease|1|||
170413069|NCT01995058|615851967|FG000|Overall Study|Adverse Event|0|||
170413070|NCT01995058|615851968|FG001|Overall Study|Adverse Event|0|||
170413071|NCT01995058|615851969|FG002|Overall Study|Adverse Event|0|||
170413072|NCT01995058|615851970|FG003|Overall Study|Adverse Event|1|||
170413073|NCT01995058|615851967|FG000|Overall Study|Lack of Efficacy|0|||
170413074|NCT01995058|615851968|FG001|Overall Study|Lack of Efficacy|0|||
170413075|NCT01995058|615851969|FG002|Overall Study|Lack of Efficacy|0|||
170413076|NCT01995058|615851970|FG003|Overall Study|Lack of Efficacy|1|||
170413077|NCT01995058|615851967|FG000|Overall Study|No Treatment Given|0|||
170413078|NCT01995058|615851968|FG001|Overall Study|No Treatment Given|0|||
170413079|NCT01995058|615851969|FG002|Overall Study|No Treatment Given|0|||
170413080|NCT01995058|615851970|FG003|Overall Study|No Treatment Given|1|||
170413081|NCT01588106|615851975|FG000|Overall Study|Withdrawal by Subject|5|||
170413082|NCT01588106|615851976|FG001|Overall Study|Withdrawal by Subject|4|||
170413083|NCT02995837|615851977|FG000|Overall Study|Lost to Follow-up|9|||
170413084|NCT02995837|615851978|FG001|Overall Study|Lost to Follow-up|8|||
170413085|NCT03118739|615851979|FG000|Overall Study|Physician Decision|0|||
170413086|NCT03118739|615851980|FG001|Overall Study|Physician Decision|1|||
170413087|NCT03118739|615851979|FG000|Overall Study|Withdrawal by Subject|5|||
170523616|NCT04235504|616261913|FG001|Continuation Phase|Withdrawal by Subject|4|||
170523617|NCT04235504|616261914|FG002|Continuation Phase|Withdrawal by Subject|0|||
170523618|NCT04235504|616261915|FG003|Continuation Phase|Withdrawal by Subject|0|||
170523619|NCT04235504|616261912|FG000|Continuation Phase|Adverse Event|0|||
170523620|NCT04235504|616261913|FG001|Continuation Phase|Adverse Event|1|||
170523621|NCT04235504|616261914|FG002|Continuation Phase|Adverse Event|0|||
170523622|NCT04235504|616261915|FG003|Continuation Phase|Adverse Event|0|||
170523623|NCT04235504|616261912|FG000|Continuation Phase|Physician Decision|1|||
170523624|NCT04235504|616261913|FG001|Continuation Phase|Physician Decision|2|||
170523625|NCT04235504|616261914|FG002|Continuation Phase|Physician Decision|1|||
170523626|NCT04235504|616261915|FG003|Continuation Phase|Physician Decision|0|||
170523627|NCT03811821|616261923|FG000|Overall Study|Adverse Event|1|||
170523628|NCT03811821|616261924|FG001|Overall Study|Adverse Event|1|||
170523629|NCT03811821|616261923|FG000|Overall Study|Withdrawal by Subject|5|||
170523630|NCT03811821|616261924|FG001|Overall Study|Withdrawal by Subject|4|||
170523631|NCT03811821|616261923|FG000|Overall Study|Lost to Follow-up|2|||
170523632|NCT03811821|616261924|FG001|Overall Study|Lost to Follow-up|2|||
170523633|NCT03811821|616261923|FG000|Overall Study|Contraindication for treatment|0|||
170523634|NCT03811821|616261924|FG001|Overall Study|Contraindication for treatment|1|||
170523635|NCT03811821|616261923|FG000|Overall Study|Tolerability|0|||
170523636|NCT03811821|616261924|FG001|Overall Study|Tolerability|3|||
170523637|NCT03811821|616261923|FG000|Overall Study|Comorbidities|0|||
170523638|NCT03811821|616261924|FG001|Overall Study|Comorbidities|2|||
170523639|NCT04888494|616261928|FG000|Overall Study|Lost to Follow-up|2|||
170523640|NCT04888494|616261929|FG001|Overall Study|Lost to Follow-up|3|||
170523641|NCT04888494|616261928|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
170523642|NCT04888494|616261929|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
170523643|NCT01921517|616263504|FG000|Overall Study|Lost to Follow-up|5|||
170523644|NCT01921517|616263505|FG001|Overall Study|Lost to Follow-up|0|||
170523645|NCT01921517|616263504|FG000|Overall Study|Newly diagnosed health concern|2|||
170523646|NCT01921517|616263505|FG001|Overall Study|Newly diagnosed health concern|0|||
170523647|NCT01921517|616263504|FG000|Overall Study|Physician Decision|0|||
170523648|NCT01921517|616263505|FG001|Overall Study|Physician Decision|2|||
170523649|NCT01921517|616263504|FG000|Overall Study|Withdrawal by Subject|7|||
170523650|NCT01921517|616263505|FG001|Overall Study|Withdrawal by Subject|3|||
170523651|NCT01921517|616263504|FG000|Overall Study|Subject missed final imaging|1|||
170523652|NCT01921517|616263505|FG001|Overall Study|Subject missed final imaging|4|||
170523653|NCT01130272|616263511|FG000|Overall Study|Adverse Event|2|||
170523654|NCT01130272|616263512|FG001|Overall Study|Adverse Event|5|||
170523655|NCT01130272|616263513|FG002|Overall Study|Adverse Event|6|||
170523656|NCT01130272|616263514|FG003|Overall Study|Adverse Event|22|||
170523657|NCT01130272|616263515|FG004|Overall Study|Adverse Event|7|||
170523658|NCT01130272|616263511|FG000|Overall Study|IVRS-confirmed constipation|0|||
170523659|NCT01130272|616263512|FG001|Overall Study|IVRS-confirmed constipation|1|||
170523660|NCT01130272|616263513|FG002|Overall Study|IVRS-confirmed constipation|1|||
170523661|NCT01130272|616263514|FG003|Overall Study|IVRS-confirmed constipation|2|||
170523662|NCT01130272|616263515|FG004|Overall Study|IVRS-confirmed constipation|0|||
170523663|NCT01130272|616263511|FG000|Overall Study|Rescue medications due to diarrhea|3|||
170523664|NCT01130272|616263512|FG001|Overall Study|Rescue medications due to diarrhea|5|||
170523665|NCT01130272|616263513|FG002|Overall Study|Rescue medications due to diarrhea|8|||
170523666|NCT01130272|616263514|FG003|Overall Study|Rescue medications due to diarrhea|8|||
170523667|NCT01130272|616263515|FG004|Overall Study|Rescue medications due to diarrhea|6|||
170523668|NCT01130272|616263511|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
170523669|NCT01130272|616263512|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
170523670|NCT01130272|616263513|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
170523671|NCT01130272|616263514|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
170523672|NCT01130272|616263515|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
170523673|NCT01130272|616263511|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
170523674|NCT01130272|616263512|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
170523675|NCT01130272|616263513|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
170523676|NCT01130272|616263514|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
170770449|NCT00959946|617164679|FG001|Overall Study|Disease Progression|4|||
170770450|NCT00959946|617164680|FG002|Overall Study|Disease Progression|2|||
170770451|NCT00959946|617164681|FG003|Overall Study|Disease Progression|4|||
170770452|NCT00959946|617164682|FG004|Overall Study|Disease Progression|4|||
170770453|NCT00959946|617164683|FG005|Overall Study|Disease Progression|6|||
170770454|NCT00959946|617164684|FG006|Overall Study|Disease Progression|2|||
170770455|NCT00959946|617164685|FG007|Overall Study|Disease Progression|2|||
170770456|NCT00959946|617164678|FG000|Overall Study|Withdrawal by Subject|0|||
170770457|NCT00959946|617164679|FG001|Overall Study|Withdrawal by Subject|0|||
170770458|NCT00959946|617164680|FG002|Overall Study|Withdrawal by Subject|0|||
170770459|NCT00959946|617164681|FG003|Overall Study|Withdrawal by Subject|0|||
170770460|NCT00959946|617164682|FG004|Overall Study|Withdrawal by Subject|0|||
170770461|NCT00959946|617164683|FG005|Overall Study|Withdrawal by Subject|1|||
170523677|NCT01130272|616263515|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
170523678|NCT01130272|616263511|FG000|Overall Study|Protocol Violation|0|||
170523679|NCT01130272|616263512|FG001|Overall Study|Protocol Violation|0|||
170523680|NCT01130272|616263513|FG002|Overall Study|Protocol Violation|3|||
170523681|NCT01130272|616263514|FG003|Overall Study|Protocol Violation|5|||
170523682|NCT01130272|616263515|FG004|Overall Study|Protocol Violation|5|||
170523683|NCT01130272|616263511|FG000|Overall Study|Lost to Follow-up|4|||
170770462|NCT00959946|617164684|FG006|Overall Study|Withdrawal by Subject|0|||
170770463|NCT00959946|617164685|FG007|Overall Study|Withdrawal by Subject|0|||
170770464|NCT01837966|617164689|FG000|Overall Study|Withdrawal by Subject|2|||
170770465|NCT01837966|617164690|FG001|Overall Study|Withdrawal by Subject|1|||
170770466|NCT01179334|617164693|FG000|Treatment Period|Adverse Event|1|||
170770467|NCT01179334|617164694|FG001|Treatment Period|Adverse Event|0|||
170770468|NCT01179334|617164693|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
170770469|NCT01179334|617164694|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
170770470|NCT01179334|617164693|FG000|Long-term Extension (LTE) Period|Death|3|||
170770471|NCT01179334|617164694|FG001|Long-term Extension (LTE) Period|Death|0|||
170770472|NCT01179334|617164693|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
170770473|NCT01179334|617164694|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
170770474|NCT00834834|617164696|FG000|Overall Study|Withdrawal by Subject|4|||
170770475|NCT00834834|617164697|FG001|Overall Study|Withdrawal by Subject|3|||
170770476|NCT06129045|617164698|FG000|Overall Study|Lost to Follow-up|1|||
170770477|NCT06129045|617164699|FG001|Overall Study|Lost to Follow-up|1|||
170770478|NCT06129045|617164700|FG002|Overall Study|Lost to Follow-up|4|||
170770479|NCT06218251|617164701|FG000|Overall Study|Lost to Follow-up|4|||
170770480|NCT03070483|617164702|FG000|Overall Study|Lost to Follow-up|2|||
170770481|NCT02031471|617164703|FG000|24 Week Treatment Period|Adverse Event|6|||
170770482|NCT02031471|617164703|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
170770483|NCT02031471|617164703|FG000|24 Week Treatment Period|Protocol Violation|1|||
170770484|NCT02031471|617164703|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
170770485|NCT02031471|617164703|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
170770486|NCT02031471|617164703|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
170770487|NCT02031471|617164703|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
170770488|NCT00026312|617164712|FG000|Overall Study|Adverse Event|0|||
170770489|NCT00026312|617164713|FG001|Overall Study|Adverse Event|32|||
170770490|NCT00026312|617164712|FG000|Overall Study|Death|1|||
170770491|NCT00026312|617164713|FG001|Overall Study|Death|7|||
170770492|NCT00026312|617164712|FG000|Overall Study|Lack of Efficacy|19|||
170770493|NCT00026312|617164713|FG001|Overall Study|Lack of Efficacy|114|||
170770494|NCT00026312|617164712|FG000|Overall Study|Lost to Follow-up|0|||
170770495|NCT00026312|617164713|FG001|Overall Study|Lost to Follow-up|5|||
170770496|NCT00026312|617164712|FG000|Overall Study|Physician Decision|1|||
170770497|NCT00026312|617164713|FG001|Overall Study|Physician Decision|37|||
170770498|NCT00026312|617164712|FG000|Overall Study|Protocol Violation|0|||
170770499|NCT00026312|617164713|FG001|Overall Study|Protocol Violation|3|||
170770500|NCT00026312|617164712|FG000|Overall Study|Withdrawal by Subject|1|||
170770501|NCT00026312|617164713|FG001|Overall Study|Withdrawal by Subject|6|||
170770502|NCT00026312|617164712|FG000|Overall Study|Ineligible|4|||
170770503|NCT00026312|617164713|FG001|Overall Study|Ineligible|5|||
170770504|NCT00026312|617164712|FG000|Overall Study|Entry onto another COG study|0|||
170770505|NCT00026312|617164713|FG001|Overall Study|Entry onto another COG study|1|||
170770506|NCT00026312|617164712|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
170770507|NCT00026312|617164713|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
170770508|NCT01170026|617165718|FG000|Overall Study|Lost to Follow-up|4|||
170770509|NCT01170026|617165719|FG001|Overall Study|Lost to Follow-up|2|||
170770510|NCT03785782|617165727|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
170770511|NCT03785782|617165728|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
170770512|NCT03785782|617165727|FG000|Overall Study|Withdrawal by Subject|1|||
170770513|NCT03785782|617165728|FG001|Overall Study|Withdrawal by Subject|1|||
170872200|NCT01624259|617543149|FG000|Overall Study|Abnormal laboratory measure|3|||
170872201|NCT01624259|617543150|FG001|Overall Study|Abnormal laboratory measure|0|||
170872202|NCT01979835|617543151|FG000|Primary Outcome SA Measurment|failed insertion|18|||
170872203|NCT01979835|617543151|FG000|Follow-up|Lost to Follow-up|32|||
170872204|NCT02322125|617544702|FG000|Overall Study|Withdrawal by Subject|2|||
170770514|NCT03785782|617165727|FG000|Overall Study|insufficient image quality.|3|||
170770515|NCT03785782|617165728|FG001|Overall Study|insufficient image quality.|0|||
170770516|NCT04817670|617165729|FG000|Overall Study|Withdrawal by Subject|1|||
170770517|NCT04817670|617165730|FG001|Overall Study|Withdrawal by Subject|0|||
170770518|NCT04817670|617165731|FG002|Overall Study|Withdrawal by Subject|0|||
170770519|NCT04817670|617165732|FG003|Overall Study|Withdrawal by Subject|0|||
170770520|NCT04817670|617165733|FG004|Overall Study|Withdrawal by Subject|0|||
170770521|NCT04817670|617165729|FG000|Overall Study|Lost to Follow-up|0|||
170872205|NCT04096274|617544709|FG000|Phase I|Lost to Follow-up|5|||
170872206|NCT04096274|617544710|FG001|Phase I|Lost to Follow-up|5|||
170523684|NCT01130272|616263512|FG001|Overall Study|Lost to Follow-up|3|||
170523685|NCT01130272|616263513|FG002|Overall Study|Lost to Follow-up|4|||
170523686|NCT01130272|616263514|FG003|Overall Study|Lost to Follow-up|7|||
170523687|NCT01130272|616263515|FG004|Overall Study|Lost to Follow-up|6|||
170523688|NCT01130272|616263511|FG000|Overall Study|Withdrawal by Subject|4|||
170523689|NCT01130272|616263512|FG001|Overall Study|Withdrawal by Subject|11|||
170523690|NCT01130272|616263513|FG002|Overall Study|Withdrawal by Subject|10|||
170523691|NCT01130272|616263514|FG003|Overall Study|Withdrawal by Subject|9|||
170523692|NCT01130272|616263515|FG004|Overall Study|Withdrawal by Subject|8|||
170523693|NCT01130272|616263511|FG000|Overall Study|Physician Decision|1|||
170523694|NCT01130272|616263512|FG001|Overall Study|Physician Decision|1|||
170523695|NCT01130272|616263513|FG002|Overall Study|Physician Decision|0|||
170523696|NCT01130272|616263514|FG003|Overall Study|Physician Decision|1|||
170523697|NCT01130272|616263515|FG004|Overall Study|Physician Decision|2|||
170523698|NCT01130272|616263511|FG000|Overall Study|Sponsor decision|6|||
170523699|NCT01130272|616263512|FG001|Overall Study|Sponsor decision|15|||
170523700|NCT01130272|616263513|FG002|Overall Study|Sponsor decision|16|||
170523701|NCT01130272|616263514|FG003|Overall Study|Sponsor decision|13|||
170523702|NCT01130272|616263515|FG004|Overall Study|Sponsor decision|16|||
170523703|NCT01130272|616263511|FG000|Overall Study|Study arm discontinued|38|||
170523704|NCT01130272|616263512|FG001|Overall Study|Study arm discontinued|0|||
170523705|NCT01130272|616263513|FG002|Overall Study|Study arm discontinued|0|||
170523706|NCT01130272|616263514|FG003|Overall Study|Study arm discontinued|0|||
170523707|NCT01130272|616263515|FG004|Overall Study|Study arm discontinued|0|||
170523708|NCT00641056|616263516|FG000|Overall Study|Adverse Event|12|||
170523709|NCT00641056|616263517|FG001|Overall Study|Adverse Event|2|||
170523710|NCT00641056|616263516|FG000|Overall Study|Lost to Follow-up|2|||
170523711|NCT00641056|616263517|FG001|Overall Study|Lost to Follow-up|1|||
170523712|NCT00641056|616263516|FG000|Overall Study|Physician Decision|3|||
170523713|NCT00641056|616263517|FG001|Overall Study|Physician Decision|1|||
170523714|NCT00641056|616263516|FG000|Overall Study|Protocol Violation|2|||
170523715|NCT00641056|616263517|FG001|Overall Study|Protocol Violation|0|||
170523716|NCT00641056|616263516|FG000|Overall Study|Entry Criteria Not Met|3|||
170523717|NCT00641056|616263517|FG001|Overall Study|Entry Criteria Not Met|0|||
170523718|NCT00641056|616263516|FG000|Overall Study|Subject Decision|6|||
170523719|NCT00641056|616263517|FG001|Overall Study|Subject Decision|19|||
170523720|NCT00641056|616263516|FG000|Overall Study|Sponsor Decision|1|||
170523721|NCT00641056|616263517|FG001|Overall Study|Sponsor Decision|2|||
170523722|NCT01811732|616263521|FG000|Overall Study|Lost to Follow-up|24|||
170523723|NCT01811732|616263522|FG001|Overall Study|Lost to Follow-up|30|||
170523724|NCT01811732|616263521|FG000|Overall Study|Withdrawal by Subject|16|||
170523725|NCT01811732|616263522|FG001|Overall Study|Withdrawal by Subject|10|||
170523726|NCT01811732|616263521|FG000|Overall Study|Adverse Event|3|||
170523727|NCT01811732|616263522|FG001|Overall Study|Adverse Event|9|||
170523728|NCT01811732|616263521|FG000|Overall Study|Lack of Efficacy|3|||
170523729|NCT01811732|616263522|FG001|Overall Study|Lack of Efficacy|1|||
170523730|NCT01811732|616263521|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
170523731|NCT01811732|616263522|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
170523732|NCT01811732|616263521|FG000|Overall Study|Physician Decision|2|||
170523733|NCT01811732|616263522|FG001|Overall Study|Physician Decision|0|||
170523734|NCT01811732|616263521|FG000|Overall Study|Death|1|||
170523735|NCT01811732|616263522|FG001|Overall Study|Death|1|||
170523736|NCT01811732|616263521|FG000|Overall Study|Insufficient venous access|0|||
170523737|NCT01811732|616263522|FG001|Overall Study|Insufficient venous access|1|||
170523738|NCT01811732|616263521|FG000|Overall Study|Protocol Violation|0|||
170523739|NCT01811732|616263522|FG001|Overall Study|Protocol Violation|1|||
170523740|NCT01811732|616263521|FG000|Overall Study|Subject incarcerated|1|||
170523741|NCT01811732|616263522|FG001|Overall Study|Subject incarcerated|2|||
170523742|NCT01811732|616263521|FG000|Overall Study|Admitted to another facility|1|||
170523743|NCT01811732|616263522|FG001|Overall Study|Admitted to another facility|0|||
170523744|NCT01811732|616263521|FG000|Overall Study|Correct study drug not available on site|1|||
170523745|NCT01811732|616263522|FG001|Overall Study|Correct study drug not available on site|0|||
170770522|NCT04817670|617165730|FG001|Overall Study|Lost to Follow-up|0|||
170523746|NCT00896493|616263523|FG000|Overall Study|Early disease relapse|3|||
170523747|NCT00536510|616263526|FG000|Overall Study|Adverse Event|27|||
170523748|NCT00536510|616263527|FG001|Overall Study|Adverse Event|4|||
170523749|NCT00536510|616263526|FG000|Overall Study|Lost to Follow-up|11|||
170523750|NCT00536510|616263527|FG001|Overall Study|Lost to Follow-up|8|||
170523751|NCT00536510|616263526|FG000|Overall Study|Protocol Violation|4|||
170523752|NCT00536510|616263527|FG001|Overall Study|Protocol Violation|5|||
170770523|NCT04817670|617165731|FG002|Overall Study|Lost to Follow-up|1|||
170523753|NCT00536510|616263526|FG000|Overall Study|Withdrawal by Subject|16|||
170523754|NCT00536510|616263527|FG001|Overall Study|Withdrawal by Subject|9|||
170523755|NCT00536510|616263526|FG000|Overall Study|Flushing with Product|20|||
170523756|NCT00536510|616263527|FG001|Overall Study|Flushing with Product|0|||
170523757|NCT00536510|616263526|FG000|Overall Study|Laboratory Adverse Event|2|||
170523758|NCT00536510|616263527|FG001|Overall Study|Laboratory Adverse Event|1|||
170523759|NCT00536510|616263526|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
170770524|NCT04817670|617165732|FG003|Overall Study|Lost to Follow-up|0|||
170523760|NCT00536510|616263527|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
170523761|NCT02035553|616263528|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
170523762|NCT02035553|616263529|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
170523763|NCT02035553|616263528|FG000|Overall Study|Adverse Event|10|||
170523764|NCT02035553|616263529|FG001|Overall Study|Adverse Event|6|||
170523765|NCT02035553|616263528|FG000|Overall Study|Physician Decision|3|||
170523766|NCT02035553|616263529|FG001|Overall Study|Physician Decision|2|||
170523767|NCT02035553|616263528|FG000|Overall Study|Lack of Efficacy|1|||
170523768|NCT02035553|616263529|FG001|Overall Study|Lack of Efficacy|1|||
170523769|NCT02035553|616263528|FG000|Overall Study|Withdrawal by Subject|4|||
170523770|NCT02035553|616263529|FG001|Overall Study|Withdrawal by Subject|7|||
170523771|NCT02035553|616263528|FG000|Overall Study|Non-compliance with Study Drug|0|||
170523772|NCT02035553|616263529|FG001|Overall Study|Non-compliance with Study Drug|1|||
170523773|NCT02035553|616263528|FG000|Overall Study|Lost to Follow-up|0|||
170523774|NCT02035553|616263529|FG001|Overall Study|Lost to Follow-up|1|||
170523775|NCT02035553|616263528|FG000|Overall Study|Other Reason|0|||
170523776|NCT02035553|616263529|FG001|Overall Study|Other Reason|4|||
170523777|NCT01117870|616263530|FG000|Overall Study|Inability to place needle|1|||
170523778|NCT01117870|616263531|FG001|Overall Study|Inability to place needle|0|||
170523779|NCT01309386|616263532|FG000|Overall Study|Other|2|||
170523780|NCT01309386|616263533|FG001|Overall Study|Other|0|||
170523781|NCT01309386|616263532|FG000|Overall Study|Withdrawal by Subject|2|||
170523782|NCT01309386|616263533|FG001|Overall Study|Withdrawal by Subject|0|||
170523783|NCT01309386|616263532|FG000|Overall Study|Progressive disease|9|||
170523784|NCT01309386|616263533|FG001|Overall Study|Progressive disease|11|||
170523785|NCT01309386|616263532|FG000|Overall Study|Physician Decision|1|||
170523786|NCT01309386|616263533|FG001|Overall Study|Physician Decision|1|||
170523787|NCT01309386|616263532|FG000|Overall Study|Lack of Efficacy|3|||
170523788|NCT01309386|616263533|FG001|Overall Study|Lack of Efficacy|1|||
170523789|NCT01309386|616263532|FG000|Overall Study|Adverse Event|5|||
170523790|NCT01309386|616263533|FG001|Overall Study|Adverse Event|8|||
170523791|NCT02062437|616263534|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
170523792|NCT02062437|616263534|FG000|Overall Study|Patient not available for the 2y visit|18|||
170523793|NCT02062437|616263534|FG000|Overall Study|Death|2|||
170523794|NCT02062437|616263534|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
170523795|NCT01674725|616263535|FG000|Overall Study|Adverse Event|1|||
170523796|NCT01674725|616263536|FG001|Overall Study|Adverse Event|0|||
170523797|NCT01674725|616263535|FG000|Overall Study|Did not receive study drug|1|||
170523798|NCT01674725|616263536|FG001|Overall Study|Did not receive study drug|0|||
170523799|NCT01674725|616263535|FG000|Overall Study|Withdrawal by Subject|1|||
170523800|NCT01674725|616263536|FG001|Overall Study|Withdrawal by Subject|0|||
170523801|NCT01674725|616263535|FG000|Overall Study|Lost to Follow-up|0|||
170523802|NCT01674725|616263536|FG001|Overall Study|Lost to Follow-up|1|||
170523803|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
170523804|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
170523805|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
170872207|NCT04096274|617544709|FG000|Phase II|Lost to Follow-up|11|||
170872208|NCT04096274|617544710|FG001|Phase II|Lost to Follow-up|11|||
170872209|NCT04179734|617544713|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
170872210|NCT04179734|617544714|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
170872211|NCT04179734|617544713|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
170872212|NCT04179734|617544714|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
170872213|NCT04024228|617544720|FG000|Overall Study|Adverse Event|1|||
170872214|NCT04024228|617544721|FG001|Overall Study|Adverse Event|0|||
170872215|NCT04024228|617544720|FG000|Overall Study|Protocol Deviation|0|||
170872216|NCT04024228|617544721|FG001|Overall Study|Protocol Deviation|2|||
170872217|NCT04024228|617544720|FG000|Overall Study|Withdrawal by Subject|3|||
170872218|NCT04024228|617544721|FG001|Overall Study|Withdrawal by Subject|4|||
170523806|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
170523807|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
170872219|NCT02982590|617544722|FG000|Overall Study|Lost to Follow-up|0|||
170872220|NCT02982590|617544723|FG001|Overall Study|Lost to Follow-up|1|||
170872221|NCT02982590|617544722|FG000|Overall Study|Death|4|||
170872222|NCT02982590|617544723|FG001|Overall Study|Death|0|||
170872223|NCT04196803|617544727|FG000|Overall Study|Withdrawal by Subject|1|||
170872224|NCT04196803|617544728|FG001|Overall Study|Withdrawal by Subject|3|||
170872225|NCT04196803|617544727|FG000|Overall Study|Adverse Event|4|||
170523808|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
170523809|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
170523810|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
170872226|NCT04196803|617544728|FG001|Overall Study|Adverse Event|2|||
170523811|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
170523812|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
170872227|NCT04196803|617544727|FG000|Overall Study|Lost to Follow-up|0|||
170523813|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
170523814|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
170523815|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
170523816|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
170523817|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
170523818|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
170523819|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
170523820|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
170523821|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
170523822|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
170523823|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
170523824|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
170523825|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
170523826|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
170523827|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
170523828|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
170523829|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
170523830|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
170523831|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
170523832|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
170523833|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
170523834|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
170523835|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
170523836|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
170523837|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
170523838|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
170523839|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
170523840|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
170523841|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
170523842|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
170523843|NCT02709746|616263537|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
170523844|NCT02709746|616263538|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
170523845|NCT02709746|616263539|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
170523846|NCT02709746|616263540|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
170523847|NCT02709746|616263541|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
170523848|NCT02709746|616263537|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
170523849|NCT02709746|616263538|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
170523850|NCT02709746|616263539|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
170523851|NCT02709746|616263540|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
170523852|NCT02709746|616263541|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
170770525|NCT04817670|617165733|FG004|Overall Study|Lost to Follow-up|0|||
170770526|NCT02320123|617165741|FG000|Overall Study|Lost to Follow-up|4|||
170770527|NCT02320123|617165742|FG001|Overall Study|Lost to Follow-up|6|||
170770528|NCT02320123|617165741|FG000|Overall Study|Death|6|||
170770529|NCT02320123|617165742|FG001|Overall Study|Death|5|||
170770530|NCT04480827|617165743|FG000|Overall Study|Adverse Event|0|||
170770531|NCT04480827|617165744|FG001|Overall Study|Adverse Event|0|||
170770532|NCT04480827|617165745|FG002|Overall Study|Adverse Event|0|||
170770533|NCT04480827|617165746|FG003|Overall Study|Adverse Event|0|||
170770534|NCT04480827|617165747|FG004|Overall Study|Adverse Event|0|||
170770535|NCT04480827|617165748|FG005|Overall Study|Adverse Event|1|||
170770536|NCT04480827|617165749|FG006|Overall Study|Adverse Event|0|||
170770537|NCT02139046|617165750|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
170770538|NCT02139046|617165751|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
170770539|NCT02139046|617165752|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
170770540|NCT02139046|617165753|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
170770541|NCT02139046|617165754|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
170770542|NCT02139046|617165750|FG000|Overall Study|Major Protocol Deviation|9|||
170770543|NCT02139046|617165751|FG001|Overall Study|Major Protocol Deviation|10|||
170770544|NCT02139046|617165752|FG002|Overall Study|Major Protocol Deviation|16|||
170770545|NCT02139046|617165753|FG003|Overall Study|Major Protocol Deviation|12|||
170770546|NCT02139046|617165754|FG004|Overall Study|Major Protocol Deviation|6|||
170770547|NCT02139046|617165750|FG000|Overall Study|Lost to Follow-up|13|||
170770548|NCT02139046|617165751|FG001|Overall Study|Lost to Follow-up|16|||
170770549|NCT02139046|617165752|FG002|Overall Study|Lost to Follow-up|16|||
170872228|NCT04196803|617544728|FG001|Overall Study|Lost to Follow-up|1|||
170872229|NCT01168973|617544729|FG000|Overall Study|Progressive Disease|341|||
170523853|NCT02709746|616263537|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
170523854|NCT02709746|616263538|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
170523855|NCT02709746|616263539|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
170523856|NCT02709746|616263540|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
170523857|NCT02709746|616263541|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
170523858|NCT02709746|616263537|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
170523859|NCT02709746|616263538|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
170523860|NCT02709746|616263539|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
170523861|NCT02709746|616263540|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
170523862|NCT02709746|616263541|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
170523863|NCT02709746|616263537|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
170523864|NCT02709746|616263538|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
170523865|NCT02709746|616263539|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
170523866|NCT02709746|616263540|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
170523867|NCT02709746|616263541|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
170523868|NCT02709746|616263537|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
170523869|NCT02709746|616263538|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
170523870|NCT02709746|616263539|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
170523871|NCT02709746|616263540|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
170523872|NCT02709746|616263541|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
170523873|NCT02709746|616263537|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
170523874|NCT02709746|616263538|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
170523875|NCT02709746|616263539|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
170523876|NCT02709746|616263540|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
170523877|NCT02709746|616263541|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
170523878|NCT02709746|616263537|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
170770550|NCT02139046|617165753|FG003|Overall Study|Lost to Follow-up|18|||
170770551|NCT02139046|617165754|FG004|Overall Study|Lost to Follow-up|13|||
170770552|NCT02139046|617165750|FG000|Overall Study|Voluntary Withdrawal|20|||
170770553|NCT02139046|617165751|FG001|Overall Study|Voluntary Withdrawal|8|||
170770554|NCT02139046|617165752|FG002|Overall Study|Voluntary Withdrawal|10|||
170770555|NCT02139046|617165753|FG003|Overall Study|Voluntary Withdrawal|15|||
170770556|NCT02139046|617165754|FG004|Overall Study|Voluntary Withdrawal|16|||
170770557|NCT02139046|617165750|FG000|Overall Study|Lack of Efficacy|0|||
170770558|NCT02139046|617165751|FG001|Overall Study|Lack of Efficacy|1|||
170770559|NCT02139046|617165752|FG002|Overall Study|Lack of Efficacy|2|||
170770560|NCT02139046|617165753|FG003|Overall Study|Lack of Efficacy|1|||
170770561|NCT02139046|617165754|FG004|Overall Study|Lack of Efficacy|2|||
170770562|NCT02139046|617165750|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
170770563|NCT02139046|617165751|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
170770564|NCT02139046|617165752|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
170770565|NCT02139046|617165753|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
170770566|NCT02139046|617165754|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
170770567|NCT02139046|617165750|FG000|Overall Study|Other Miscellaneous Reasons|10|||
170770568|NCT02139046|617165751|FG001|Overall Study|Other Miscellaneous Reasons|9|||
170770569|NCT02139046|617165752|FG002|Overall Study|Other Miscellaneous Reasons|4|||
170770570|NCT02139046|617165753|FG003|Overall Study|Other Miscellaneous Reasons|9|||
170770571|NCT02139046|617165754|FG004|Overall Study|Other Miscellaneous Reasons|12|||
170770572|NCT01571596|617165755|FG000|Overall Study|Adverse Event|2|||
170770573|NCT01571596|617165756|FG001|Overall Study|Adverse Event|0|||
170770574|NCT01571596|617165757|FG002|Overall Study|Adverse Event|0|||
170770575|NCT01571596|617165755|FG000|Overall Study|Study Terminated by the Sponsor|0|||
170770576|NCT01571596|617165756|FG001|Overall Study|Study Terminated by the Sponsor|1|||
170770577|NCT01571596|617165757|FG002|Overall Study|Study Terminated by the Sponsor|1|||
170872230|NCT01168973|617544730|FG001|Overall Study|Progressive Disease|429|||
170872231|NCT01168973|617544729|FG000|Overall Study|Adverse Event|94|||
170872232|NCT01168973|617544730|FG001|Overall Study|Adverse Event|55|||
170872233|NCT01168973|617544729|FG000|Overall Study|Withdrawal by Subject|90|||
170872234|NCT01168973|617544730|FG001|Overall Study|Withdrawal by Subject|53|||
170523879|NCT02709746|616263538|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
170632183|NCT00538902|616664552|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
170770578|NCT01254019|617165764|FG000|Overall Study|Adverse Event|0|||
170770579|NCT01254019|617165765|FG001|Overall Study|Adverse Event|2|||
170770580|NCT01254019|617165764|FG000|Overall Study|Protocol Violation|1|||
170770581|NCT01254019|617165765|FG001|Overall Study|Protocol Violation|0|||
170770582|NCT01254019|617165764|FG000|Overall Study|Withdrawal by Subject|0|||
170770583|NCT01254019|617165765|FG001|Overall Study|Withdrawal by Subject|2|||
170770584|NCT00845832|617165766|FG000|Treatment Period|Adverse Event|0|||
170770585|NCT00845832|617165767|FG001|Treatment Period|Adverse Event|2|||
170770586|NCT00845832|617165768|FG002|Treatment Period|Adverse Event|0|||
170872235|NCT01168973|617544729|FG000|Overall Study|Death|42|||
170872236|NCT01168973|617544730|FG001|Overall Study|Death|45|||
170872237|NCT01168973|617544729|FG000|Overall Study|Physician Decision|37|||
170872238|NCT01168973|617544730|FG001|Overall Study|Physician Decision|19|||
170872239|NCT01168973|617544729|FG000|Overall Study|Sponsor Decision|2|||
170872240|NCT01168973|617544730|FG001|Overall Study|Sponsor Decision|1|||
170872241|NCT01168973|617544729|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
170872242|NCT01168973|617544730|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
170872243|NCT05092919|617544732|FG000|Overall Study|Lost to Follow-up|7|||
170872244|NCT05092919|617544732|FG000|Overall Study|Withdrawal by Subject|2|||
170872245|NCT01942148|617544738|FG000|Overall Study|Adverse Event|4|||
170872246|NCT01942148|617544738|FG000|Overall Study|Lack of Efficacy|2|||
170872247|NCT01942148|617544738|FG000|Overall Study|Physician Decision|11|||
170872248|NCT01942148|617544738|FG000|Overall Study|Protocol Violation|1|||
170872249|NCT01942148|617544738|FG000|Overall Study|Withdrawal by Subject|8|||
170872250|NCT01942148|617544738|FG000|Overall Study|Use of the prohibition medicine|1|||
170872251|NCT02248259|617544739|FG000|Treatment Period 1|Adverse Event|0|||
170872252|NCT02248259|617544740|FG001|Treatment Period 1|Adverse Event|0|||
170523880|NCT02709746|616263539|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
170523881|NCT02709746|616263540|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
170523882|NCT02709746|616263541|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
170523883|NCT02709746|616263537|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
170523884|NCT02709746|616263538|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
170523885|NCT02709746|616263539|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
170523886|NCT02709746|616263540|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
170523887|NCT02709746|616263541|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
170523888|NCT00001566|616263548|FG000|Overall Study|patients' choice to discontinue protocol|3|||
170523889|NCT00001566|616263548|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
170523890|NCT00001566|616263548|FG000|Overall Study|Death|13|||
170523891|NCT00001566|616263548|FG000|Overall Study|Lost to Follow-up|1|||
170523892|NCT00001566|616263548|FG000|Overall Study|unable to complete initial apheresis|1|||
170523893|NCT01319565|616263549|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
170523894|NCT01319565|616263550|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
170523895|NCT01319565|616263551|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
170523896|NCT00113607|616263552|FG000|Overall Study|Adverse Event|40|||
170523897|NCT00113607|616263553|FG001|Overall Study|Adverse Event|71|||
170523898|NCT00113607|616263552|FG000|Overall Study|Death|8|||
170523899|NCT00113607|616263553|FG001|Overall Study|Death|8|||
170523900|NCT00113607|616263552|FG000|Overall Study|Withdrawal by Subject|50|||
170523901|NCT00113607|616263553|FG001|Overall Study|Withdrawal by Subject|58|||
170523902|NCT00113607|616263552|FG000|Overall Study|Lost to Follow-up|0|||
170523903|NCT00113607|616263553|FG001|Overall Study|Lost to Follow-up|2|||
170523904|NCT00113607|616263552|FG000|Overall Study|Disease Progression|180|||
170523905|NCT00113607|616263553|FG001|Overall Study|Disease Progression|142|||
170523906|NCT00113607|616263552|FG000|Overall Study|Complete Response (Confirmed)|14|||
170523907|NCT00113607|616263553|FG001|Overall Study|Complete Response (Confirmed)|24|||
170523908|NCT00113607|616263552|FG000|Overall Study|Other|43|||
170523909|NCT00113607|616263553|FG001|Overall Study|Other|32|||
170523910|NCT00888654|616263554|FG000|Overall Study|Problems swallowing oral meds.|1|||
170523911|NCT00888654|616263554|FG000|Overall Study|Not enough oral meds before surgery|3|||
170523912|NCT00888654|616263554|FG000|Overall Study|Surgery aborted|2|||
170523913|NCT00888654|616263554|FG000|Overall Study|Withdrawal by Subject|1|||
170523914|NCT00888654|616263554|FG000|Overall Study|Inelig. due to contraindication of med|1|||
170523915|NCT00888654|616263554|FG000|Overall Study|Change in surg date|1|||
170523916|NCT00888654|616263554|FG000|Overall Study|Stopped meds due to headaches|1|||
170523917|NCT00490035|616263564|FG000|Overall Study|AE, non-serious non-fatal|3|||
170523918|NCT00490035|616263565|FG001|Overall Study|AE, non-serious non-fatal|4|||
170523919|NCT00490035|616263566|FG002|Overall Study|AE, non-serious non-fatal|4|||
170523920|NCT00490035|616263567|FG003|Overall Study|AE, non-serious non-fatal|5|||
170523921|NCT00490035|616263564|FG000|Overall Study|Lost to Follow-up|2|||
170523922|NCT00490035|616263565|FG001|Overall Study|Lost to Follow-up|0|||
170523923|NCT00490035|616263566|FG002|Overall Study|Lost to Follow-up|1|||
170523924|NCT00490035|616263567|FG003|Overall Study|Lost to Follow-up|0|||
170523925|NCT00490035|616263564|FG000|Overall Study|Withdrawal by Subject|2|||
170523926|NCT00490035|616263565|FG001|Overall Study|Withdrawal by Subject|1|||
170523927|NCT00490035|616263566|FG002|Overall Study|Withdrawal by Subject|1|||
170523928|NCT00490035|616263567|FG003|Overall Study|Withdrawal by Subject|0|||
170523929|NCT00490035|616263564|FG000|Overall Study|Other reason|0|||
170523930|NCT00490035|616263565|FG001|Overall Study|Other reason|1|||
170523931|NCT00490035|616263566|FG002|Overall Study|Other reason|3|||
170523932|NCT00490035|616263567|FG003|Overall Study|Other reason|1|||
170872253|NCT02248259|617544741|FG002|Treatment Period 1|Adverse Event|1|||
170872254|NCT02248259|617544742|FG003|Treatment Period 1|Adverse Event|0|||
170872255|NCT02807480|617544747|FG000|Overall Study|Withdrawal by Subject|14|||
170872256|NCT02807480|617544748|FG001|Overall Study|Withdrawal by Subject|10|||
170523933|NCT00490035|616263564|FG000|Overall Study|AE, serious fatal|1|||
170523934|NCT00490035|616263565|FG001|Overall Study|AE, serious fatal|0|||
170523935|NCT00490035|616263566|FG002|Overall Study|AE, serious fatal|0|||
170523936|NCT00490035|616263567|FG003|Overall Study|AE, serious fatal|0|||
170523937|NCT00490035|616263564|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
170523938|NCT00490035|616263565|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
170523939|NCT00490035|616263566|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
170523940|NCT00490035|616263567|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
170523941|NCT00490035|616263564|FG000|Overall Study|AE of unknown type|0|||
170523942|NCT00490035|616263565|FG001|Overall Study|AE of unknown type|0|||
170523943|NCT00490035|616263566|FG002|Overall Study|AE of unknown type|2|||
170523944|NCT00490035|616263567|FG003|Overall Study|AE of unknown type|0|||
170523945|NCT03834493|616263578|FG000|Overall Study|Participants Ongoing|311|||
170523946|NCT03834493|616263579|FG001|Overall Study|Participants Ongoing|324|||
170523947|NCT03834493|616263578|FG000|Overall Study|Withdrawal by Subject|20|||
170523948|NCT03834493|616263579|FG001|Overall Study|Withdrawal by Subject|17|||
170523949|NCT03834493|616263578|FG000|Overall Study|Physician Decision|1|||
170523950|NCT03834493|616263579|FG001|Overall Study|Physician Decision|0|||
170523951|NCT03834493|616263578|FG000|Overall Study|Death|289|||
170523952|NCT03834493|616263579|FG001|Overall Study|Death|282|||
170523953|NCT05953363|616263580|FG000|Overall Study|Screen Failure|2|||
170523954|NCT05953363|616263580|FG000|Overall Study|Withdrawal by Subject|3|||
170523955|NCT05953363|616263580|FG000|Overall Study|Surgery cancelled|2|||
170523956|NCT05953363|616263580|FG000|Overall Study|Adverse Event|1|||
170523957|NCT04003103|616263582|FG000|Overall Study|Death|1|||
170523958|NCT04003103|616263583|FG001|Overall Study|Death|0|||
170523959|NCT04003103|616263584|FG002|Overall Study|Death|0|||
170523960|NCT04003103|616263582|FG000|Overall Study|Lost to Follow-up|4|||
170523961|NCT04003103|616263583|FG001|Overall Study|Lost to Follow-up|3|||
170523962|NCT04003103|616263584|FG002|Overall Study|Lost to Follow-up|2|||
170523963|NCT04003103|616263582|FG000|Overall Study|Withdrawal by Subject|10|||
170523964|NCT04003103|616263583|FG001|Overall Study|Withdrawal by Subject|1|||
170523965|NCT04003103|616263584|FG002|Overall Study|Withdrawal by Subject|1|||
170523966|NCT04003103|616263582|FG000|Overall Study|Status not recorded|0|||
170523967|NCT04003103|616263583|FG001|Overall Study|Status not recorded|2|||
170523968|NCT04003103|616263584|FG002|Overall Study|Status not recorded|0|||
170523969|NCT00871234|616263598|FG000|Overall Study|Adverse Event|2|||
170523970|NCT00871234|616263598|FG000|Overall Study|Lost to Follow-up|3|||
170523971|NCT03389620|616263599|FG000|Overall Study|Lost to Follow-up|5|||
170523972|NCT03389620|616263600|FG001|Overall Study|Lost to Follow-up|1|||
170523973|NCT02155699|616263601|FG000|Overall Study|Withdrawal by Subject|0|||
170523974|NCT02155699|616263602|FG001|Overall Study|Withdrawal by Subject|3|||
170523975|NCT02155699|616263603|FG002|Overall Study|Withdrawal by Subject|6|||
170523976|NCT02155699|616263604|FG003|Overall Study|Withdrawal by Subject|1|||
170523977|NCT02155699|616263601|FG000|Overall Study|Lost to Follow-up|0|||
170523978|NCT02155699|616263602|FG001|Overall Study|Lost to Follow-up|0|||
170523979|NCT02155699|616263603|FG002|Overall Study|Lost to Follow-up|0|||
170523980|NCT02155699|616263604|FG003|Overall Study|Lost to Follow-up|3|||
170523981|NCT02155699|616263601|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
170523982|NCT02155699|616263602|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
170523983|NCT02155699|616263603|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
170523984|NCT02155699|616263604|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
170523985|NCT05547386|616263605|FG000|Overall Study|Withdrawal by Subject|7|||
170523986|NCT05852353|616263606|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
170523987|NCT05852353|616263606|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
170523988|NCT05852353|616263606|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
170523989|NCT05852353|616263606|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
170523990|NCT01005745|616263607|FG000|Overall Study|No TIL growth|1|||
170523991|NCT01005745|616263607|FG000|Overall Study|Disease progressed during TIL growth|3|||
170523992|NCT01005745|616263607|FG000|Overall Study|Death prior to treatment|1|||
170523993|NCT01005745|616263607|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
170523994|NCT06077773|616263608|FG000|Overall Study|Withdrawal by Subject|1|||
170523995|NCT06077773|616263609|FG001|Overall Study|Withdrawal by Subject|0|||
170523996|NCT06077773|616263610|FG002|Overall Study|Withdrawal by Subject|1|||
170523997|NCT06077773|616263608|FG000|Overall Study|Lost to Follow-up|0|||
170523998|NCT06077773|616263609|FG001|Overall Study|Lost to Follow-up|1|||
170523999|NCT06077773|616263610|FG002|Overall Study|Lost to Follow-up|0|||
170524000|NCT06077773|616263608|FG000|Overall Study|Adverse Event|0|||
170524001|NCT06077773|616263609|FG001|Overall Study|Adverse Event|0|||
170524002|NCT06077773|616263610|FG002|Overall Study|Adverse Event|2|||
170524003|NCT03834506|616263611|FG000|Overall Study|Death|336|||
170524004|NCT03834506|616263612|FG001|Overall Study|Death|326|||
170524005|NCT03834506|616263611|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170524006|NCT03834506|616263612|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170524007|NCT03834506|616263611|FG000|Overall Study|Withdrawal by Subject|10|||
170524008|NCT03834506|616263612|FG001|Overall Study|Withdrawal by Subject|8|||
170524009|NCT03834506|616263611|FG000|Overall Study|Sponsor decision|165|||
170524010|NCT03834506|616263612|FG001|Overall Study|Sponsor decision|178|||
170524011|NCT03834506|616263611|FG000|Overall Study|Physician Decision|3|||
170524012|NCT03834506|616263612|FG001|Overall Study|Physician Decision|1|||
170524013|NCT03834506|616263611|FG000|Overall Study|Lost to Follow-up|0|||
170524014|NCT03834506|616263612|FG001|Overall Study|Lost to Follow-up|1|||
170524015|NCT05115630|616263613|FG000|Overall Study|Due to COVID19|1|||
170524016|NCT05115630|616263613|FG000|Overall Study|Due to Bacteremia|1|||
170524017|NCT05115630|616263613|FG000|Overall Study|Due to viral infection|1|||
170524018|NCT02287038|616263614|FG000|Overall Study|Stopped attending appointments|3|||
170524019|NCT02287038|616263615|FG001|Overall Study|Stopped attending appointments|2|||
170524020|NCT02287038|616263614|FG000|Overall Study|Anxiety after starting medication|0|||
170524021|NCT02287038|616263615|FG001|Overall Study|Anxiety after starting medication|1|||
170524022|NCT02287038|616263614|FG000|Overall Study|Nausea after starting medication|1|||
170524023|NCT02287038|616263615|FG001|Overall Study|Nausea after starting medication|0|||
170524024|NCT02287038|616263614|FG000|Overall Study|Abnormal ECG after starting medication|1|||
170524025|NCT02287038|616263615|FG001|Overall Study|Abnormal ECG after starting medication|0|||
170524026|NCT02573259|616263624|FG000|Overall Study|Death|1|||
170524027|NCT02573259|616263625|FG001|Overall Study|Death|6|||
170524028|NCT02573259|616263626|FG002|Overall Study|Death|5|||
170524029|NCT02573259|616263627|FG003|Overall Study|Death|6|||
170524030|NCT02573259|616263628|FG004|Overall Study|Death|9|||
170524031|NCT02573259|616263629|FG005|Overall Study|Death|32|||
170524032|NCT02573259|616263630|FG006|Overall Study|Death|21|||
170524033|NCT02573259|616263624|FG000|Overall Study|Lost to Follow-up|0|||
170524034|NCT02573259|616263625|FG001|Overall Study|Lost to Follow-up|0|||
170524035|NCT02573259|616263626|FG002|Overall Study|Lost to Follow-up|0|||
170524036|NCT02573259|616263627|FG003|Overall Study|Lost to Follow-up|0|||
170524037|NCT02573259|616263628|FG004|Overall Study|Lost to Follow-up|0|||
170524038|NCT02573259|616263629|FG005|Overall Study|Lost to Follow-up|2|||
170524039|NCT02573259|616263630|FG006|Overall Study|Lost to Follow-up|1|||
170524040|NCT02573259|616263624|FG000|Overall Study|Participant refused further follow-up|0|||
170524041|NCT02573259|616263625|FG001|Overall Study|Participant refused further follow-up|2|||
170524042|NCT02573259|616263626|FG002|Overall Study|Participant refused further follow-up|1|||
170524043|NCT02573259|616263627|FG003|Overall Study|Participant refused further follow-up|0|||
170524044|NCT02573259|616263628|FG004|Overall Study|Participant refused further follow-up|3|||
170524045|NCT02573259|616263629|FG005|Overall Study|Participant refused further follow-up|20|||
170524046|NCT02573259|616263630|FG006|Overall Study|Participant refused further follow-up|7|||
170524047|NCT02573259|616263624|FG000|Overall Study|Other|0|||
170524048|NCT02573259|616263625|FG001|Overall Study|Other|0|||
170524049|NCT02573259|616263626|FG002|Overall Study|Other|0|||
170524050|NCT02573259|616263627|FG003|Overall Study|Other|0|||
170524051|NCT02573259|616263628|FG004|Overall Study|Other|1|||
170524052|NCT02573259|616263629|FG005|Overall Study|Other|4|||
170524053|NCT02573259|616263630|FG006|Overall Study|Other|5|||
170524054|NCT00751140|616263631|FG000|Overall Study|benign angioma excluded from analysis|1|||
170524055|NCT01628848|616263632|FG000|Overall Study|Adverse Event|9|||
170524056|NCT01628848|616263633|FG001|Overall Study|Adverse Event|7|||
170524057|NCT01628848|616263632|FG000|Overall Study|Lack of Efficacy|0|||
170524058|NCT01628848|616263633|FG001|Overall Study|Lack of Efficacy|4|||
170524059|NCT01628848|616263632|FG000|Overall Study|Withdrawal by Subject|0|||
170524060|NCT01628848|616263633|FG001|Overall Study|Withdrawal by Subject|2|||
170524061|NCT01628848|616263632|FG000|Overall Study|Physician Decision|3|||
170524062|NCT01628848|616263633|FG001|Overall Study|Physician Decision|1|||
170524063|NCT03311945|616263638|FG000|Overall Study|Adverse Event|2|||
170524064|NCT03311945|616263638|FG000|Overall Study|Lack of Efficacy|1|||
170524065|NCT01107925|616263639|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
170770587|NCT00845832|617165766|FG000|Treatment Period|Protocol Violation|1|||
170770588|NCT00845832|617165767|FG001|Treatment Period|Protocol Violation|1|||
170770589|NCT00845832|617165768|FG002|Treatment Period|Protocol Violation|0|||
170770590|NCT00845832|617165766|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
170632184|NCT00538902|616664550|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
170770591|NCT00845832|617165767|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
170770592|NCT00845832|617165768|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
170524066|NCT01107925|616263640|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
170524067|NCT01107925|616263641|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
170524068|NCT01107925|616263642|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
170524069|NCT01107925|616263643|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
170524070|NCT01107925|616263644|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
170524071|NCT01107925|616263639|FG000|Period 2|Withdrawal by Subject|0|||
170770593|NCT00845832|617165766|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
170524072|NCT01107925|616263640|FG001|Period 2|Withdrawal by Subject|1|||
170524073|NCT01107925|616263641|FG002|Period 2|Withdrawal by Subject|0|||
170524074|NCT01107925|616263642|FG003|Period 2|Withdrawal by Subject|0|||
170872257|NCT02163187|617544749|FG000|Overall Study|Device removed|1|||
170872258|NCT02163187|617544750|FG001|Overall Study|Device removed|0|||
170872259|NCT02163187|617544749|FG000|Overall Study|Progressive disease|1|||
170872260|NCT02163187|617544750|FG001|Overall Study|Progressive disease|0|||
170872261|NCT02369848|617544751|FG000|Overall Study|Death|1|||
170872262|NCT02369848|617544751|FG000|Overall Study|Withdrawal by Subject|2|||
170872263|NCT02369848|617544751|FG000|Overall Study|Lost to Follow-up|1|||
170872264|NCT04854434|617544752|FG000|Overall Study|Death|1|||
170872265|NCT04854434|617544753|FG001|Overall Study|Death|3|||
170872266|NCT04854434|617544754|FG002|Overall Study|Death|4|||
170872267|NCT04854434|617544752|FG000|Overall Study|Study Terminated by Sponsor|2|||
170872268|NCT04854434|617544753|FG001|Overall Study|Study Terminated by Sponsor|0|||
170872269|NCT04854434|617544754|FG002|Overall Study|Study Terminated by Sponsor|0|||
170872270|NCT04854434|617544752|FG000|Overall Study|Other|1|||
170872271|NCT04854434|617544753|FG001|Overall Study|Other|1|||
170872272|NCT04854434|617544754|FG002|Overall Study|Other|0|||
170872273|NCT03281668|617544755|FG000|Overall Study|Physician Decision|1|||
170872274|NCT03281668|617544755|FG000|Overall Study|scheduling conflict, family circumstance|2|||
170872275|NCT03281668|617544755|FG000|Overall Study|Withdrawal by Subject|4|||
170872276|NCT03281668|617544755|FG000|Overall Study|Lost to Follow-up|1|||
170872277|NCT01543152|617544756|FG000|Overall Study|Withdrawal by Subject|0|||
170872278|NCT01543152|617544757|FG001|Overall Study|Withdrawal by Subject|2|||
170872279|NCT01543152|617544758|FG002|Overall Study|Withdrawal by Subject|0|||
170872280|NCT01543152|617544759|FG003|Overall Study|Withdrawal by Subject|0|||
170872281|NCT01543152|617544760|FG004|Overall Study|Withdrawal by Subject|0|||
170872282|NCT02053168|617544763|FG000|Overall Study|Withdrawal by Subject|1|||
170872283|NCT02053168|617544763|FG000|Overall Study|Physician Decision|1|||
170872284|NCT02053168|617544763|FG000|Overall Study|Lost to Follow-up|1|||
170872285|NCT02687542|617544765|FG000|Overall Study|Medication error without associated AEs|0|||
170524075|NCT01107925|616263643|FG004|Period 2|Withdrawal by Subject|0|||
170524076|NCT01107925|616263644|FG005|Period 2|Withdrawal by Subject|1|||
170524077|NCT03839394|616263645|FG000|Overall Study|Lost to Follow-up|6|||
170524078|NCT03839394|616263646|FG001|Overall Study|Lost to Follow-up|8|||
170524079|NCT03839394|616263645|FG000|Overall Study|Withdrawal by Subject|0|||
170524080|NCT03839394|616263646|FG001|Overall Study|Withdrawal by Subject|2|||
170524081|NCT02895295|616263647|FG000|Overall Study|Survey Non-response|71|||
170524082|NCT02895295|616263648|FG001|Overall Study|Survey Non-response|94|||
170524083|NCT02895295|616263649|FG002|Overall Study|Survey Non-response|92|||
170524084|NCT01945944|616263652|FG000|Overall Study|Adverse Event|0|||
170524085|NCT01945944|616263653|FG001|Overall Study|Adverse Event|2|||
170524086|NCT01945944|616263652|FG000|Overall Study|Physician Decision|1|||
170524087|NCT01945944|616263653|FG001|Overall Study|Physician Decision|0|||
170524088|NCT01945944|616263652|FG000|Overall Study|Withdrawal by Subject|0|||
170524089|NCT01945944|616263653|FG001|Overall Study|Withdrawal by Subject|1|||
170524090|NCT04376515|616263656|FG000|Overall Study|Found to have been vaccinated before study start|6|||
170524091|NCT04376515|616263657|FG001|Overall Study|Found to have been vaccinated before study start|6|||
170524092|NCT03433898|616263660|FG000|Overall Study|Progressive disease|6|||
170524093|NCT03433898|616263661|FG001|Overall Study|Progressive disease|3|||
170524094|NCT03433898|616263662|FG002|Overall Study|Progressive disease|3|||
170524095|NCT03433898|616263663|FG003|Overall Study|Progressive disease|2|||
170524096|NCT03433898|616263664|FG004|Overall Study|Progressive disease|30|||
170524097|NCT03433898|616263665|FG005|Overall Study|Progressive disease|29|||
170524098|NCT03433898|616263666|FG006|Overall Study|Progressive disease|17|||
170524099|NCT03433898|616263667|FG007|Overall Study|Progressive disease|30|||
170524100|NCT03433898|616263660|FG000|Overall Study|Not treated|1|||
170524101|NCT03433898|616263661|FG001|Overall Study|Not treated|0|||
170524102|NCT03433898|616263662|FG002|Overall Study|Not treated|0|||
170524103|NCT03433898|616263663|FG003|Overall Study|Not treated|0|||
170524104|NCT03433898|616263664|FG004|Overall Study|Not treated|1|||
170524105|NCT03433898|616263665|FG005|Overall Study|Not treated|0|||
170524106|NCT03433898|616263666|FG006|Overall Study|Not treated|0|||
170524107|NCT03433898|616263667|FG007|Overall Study|Not treated|0|||
170524108|NCT03433898|616263660|FG000|Overall Study|Death|0|||
170524109|NCT03433898|616263661|FG001|Overall Study|Death|0|||
170524110|NCT03433898|616263662|FG002|Overall Study|Death|0|||
170524111|NCT03433898|616263663|FG003|Overall Study|Death|0|||
170524112|NCT03433898|616263664|FG004|Overall Study|Death|0|||
170524113|NCT03433898|616263665|FG005|Overall Study|Death|0|||
170524114|NCT03433898|616263666|FG006|Overall Study|Death|1|||
170872286|NCT02687542|617544766|FG001|Overall Study|Medication error without associated AEs|0|||
170872287|NCT02687542|617544767|FG002|Overall Study|Medication error without associated AEs|0|||
170872288|NCT02687542|617544768|FG003|Overall Study|Medication error without associated AEs|0|||
170872289|NCT02687542|617544769|FG004|Overall Study|Medication error without associated AEs|1|||
170524115|NCT03433898|616263667|FG007|Overall Study|Death|1|||
170524116|NCT03433898|616263660|FG000|Overall Study|Withdrawal by Subject|0|||
170524117|NCT03433898|616263661|FG001|Overall Study|Withdrawal by Subject|0|||
170524118|NCT03433898|616263662|FG002|Overall Study|Withdrawal by Subject|0|||
170524119|NCT03433898|616263663|FG003|Overall Study|Withdrawal by Subject|0|||
170524120|NCT03433898|616263664|FG004|Overall Study|Withdrawal by Subject|2|||
170770594|NCT00845832|617165767|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
170770595|NCT00845832|617165768|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
170770596|NCT03520413|617165769|FG000|Overall Study|Lost to Follow-up|1|||
170770597|NCT03520413|617165770|FG001|Overall Study|Lost to Follow-up|1|||
170770598|NCT03520413|617165769|FG000|Overall Study|Withdrawal by Subject|1|||
170770599|NCT03520413|617165770|FG001|Overall Study|Withdrawal by Subject|2|||
170770600|NCT03520413|617165769|FG000|Overall Study|Death|0|||
170770601|NCT03520413|617165770|FG001|Overall Study|Death|1|||
170770602|NCT03520413|617165769|FG000|Overall Study|Physician Decision|3|||
170770603|NCT03520413|617165770|FG001|Overall Study|Physician Decision|3|||
170770604|NCT03520413|617165769|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
170770605|NCT03520413|617165770|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
170770606|NCT00869323|617165771|FG000|Maintenance Therapy|concurrent illness|1|||
170770607|NCT00638963|617165772|FG000|Overall Study|Withdrawal by Subject|1|||
170770608|NCT00638963|617165773|FG001|Overall Study|Withdrawal by Subject|0|||
170770609|NCT01692938|617165774|FG000|Overall Study|Protocol Deviation|1|||
170770610|NCT01692938|617165775|FG001|Overall Study|Protocol Deviation|1|||
170770611|NCT01692938|617165774|FG000|Overall Study|Study completed prior to site completion|3|||
170770612|NCT01692938|617165775|FG001|Overall Study|Study completed prior to site completion|3|||
170770613|NCT02957136|617165777|FG000|Overall Study|Withdrawal by Subject|2|||
170770614|NCT02957136|617165778|FG001|Overall Study|Withdrawal by Subject|1|||
170770615|NCT00712335|617165779|FG000|Overall Study|Withdrawal by Subject|0|||
170770616|NCT00712335|617165780|FG001|Overall Study|Withdrawal by Subject|7|||
170770617|NCT00712335|617165781|FG002|Overall Study|Withdrawal by Subject|2|||
170770618|NCT00712335|617165782|FG003|Overall Study|Withdrawal by Subject|3|||
170770619|NCT00712335|617165783|FG004|Overall Study|Withdrawal by Subject|0|||
170770620|NCT00712335|617165779|FG000|Overall Study|Lost to Follow-up|2|||
170770621|NCT00712335|617165780|FG001|Overall Study|Lost to Follow-up|5|||
170770622|NCT00712335|617165781|FG002|Overall Study|Lost to Follow-up|0|||
170770623|NCT00712335|617165782|FG003|Overall Study|Lost to Follow-up|1|||
170770624|NCT00712335|617165783|FG004|Overall Study|Lost to Follow-up|0|||
170770625|NCT00712335|617165779|FG000|Overall Study|Protocol Violation|1|||
170770626|NCT00712335|617165780|FG001|Overall Study|Protocol Violation|2|||
170770627|NCT00712335|617165781|FG002|Overall Study|Protocol Violation|1|||
170770628|NCT00712335|617165782|FG003|Overall Study|Protocol Violation|0|||
170770629|NCT00712335|617165783|FG004|Overall Study|Protocol Violation|0|||
170770630|NCT00712335|617165779|FG000|Overall Study|Lack of Efficacy|0|||
170770631|NCT00712335|617165780|FG001|Overall Study|Lack of Efficacy|0|||
170770632|NCT00712335|617165781|FG002|Overall Study|Lack of Efficacy|1|||
170770633|NCT00712335|617165782|FG003|Overall Study|Lack of Efficacy|1|||
170770634|NCT00712335|617165783|FG004|Overall Study|Lack of Efficacy|0|||
170770635|NCT00712335|617165779|FG000|Overall Study|Other Reason|0|||
170770636|NCT00712335|617165780|FG001|Overall Study|Other Reason|3|||
170770637|NCT00712335|617165781|FG002|Overall Study|Other Reason|1|||
170770638|NCT00712335|617165782|FG003|Overall Study|Other Reason|0|||
170770639|NCT00712335|617165783|FG004|Overall Study|Other Reason|0|||
170770640|NCT03401112|617165784|FG000|Overall Study|Adverse Event|1|||
170770641|NCT03401112|617165785|FG001|Overall Study|Adverse Event|2|||
170770642|NCT03401112|617165786|FG002|Overall Study|Adverse Event|3|||
170770643|NCT03401112|617165787|FG003|Overall Study|Adverse Event|2|||
170770644|NCT03401112|617165788|FG004|Overall Study|Adverse Event|0|||
170524121|NCT03433898|616263665|FG005|Overall Study|Withdrawal by Subject|0|||
170524122|NCT03433898|616263666|FG006|Overall Study|Withdrawal by Subject|0|||
170524123|NCT03433898|616263667|FG007|Overall Study|Withdrawal by Subject|0|||
170524124|NCT03433898|616263660|FG000|Overall Study|Adverse Event|0|||
170524125|NCT03433898|616263661|FG001|Overall Study|Adverse Event|0|||
170524126|NCT03433898|616263662|FG002|Overall Study|Adverse Event|0|||
170524127|NCT03433898|616263663|FG003|Overall Study|Adverse Event|0|||
170770645|NCT03401112|617165784|FG000|Overall Study|Lost to Follow-up|1|||
170770646|NCT03401112|617165785|FG001|Overall Study|Lost to Follow-up|0|||
170770647|NCT03401112|617165786|FG002|Overall Study|Lost to Follow-up|0|||
170770648|NCT03401112|617165787|FG003|Overall Study|Lost to Follow-up|0|||
170770649|NCT03401112|617165788|FG004|Overall Study|Lost to Follow-up|0|||
170770650|NCT03401112|617165784|FG000|Overall Study|Noncompliance|1|||
170770651|NCT03401112|617165785|FG001|Overall Study|Noncompliance|2|||
170770652|NCT03401112|617165786|FG002|Overall Study|Noncompliance|3|||
170770653|NCT03401112|617165787|FG003|Overall Study|Noncompliance|0|||
170770654|NCT03401112|617165788|FG004|Overall Study|Noncompliance|0|||
170770655|NCT03401112|617165784|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
170770656|NCT03401112|617165785|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
170770657|NCT03401112|617165786|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
170770658|NCT03401112|617165787|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
170770659|NCT03401112|617165788|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
170524128|NCT03433898|616263664|FG004|Overall Study|Adverse Event|0|||
170770660|NCT03401112|617165784|FG000|Overall Study|Withdrawal by Subject|0|||
170770661|NCT03401112|617165785|FG001|Overall Study|Withdrawal by Subject|3|||
170770662|NCT03401112|617165786|FG002|Overall Study|Withdrawal by Subject|2|||
170872290|NCT02687542|617544765|FG000|Overall Study|Lost to Follow-up|0|||
170524129|NCT03433898|616263665|FG005|Overall Study|Adverse Event|5|||
170524130|NCT03433898|616263666|FG006|Overall Study|Adverse Event|2|||
170524131|NCT03433898|616263667|FG007|Overall Study|Adverse Event|2|||
170524132|NCT03433898|616263660|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
170524133|NCT03433898|616263661|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
170524134|NCT03433898|616263662|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
170524135|NCT03433898|616263663|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
170524136|NCT03433898|616263664|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
170524137|NCT03433898|616263665|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
170524138|NCT03433898|616263666|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
170524139|NCT03433898|616263667|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
170524140|NCT04113694|616265636|FG000|Overall Study|Adverse Event|2|||
170524141|NCT04113694|616265636|FG000|Overall Study|Lost to Follow-up|2|||
170524142|NCT04113694|616265636|FG000|Overall Study|Withdrawal by Subject|6|||
170524143|NCT04113694|616265636|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
170524144|NCT05630196|616265637|FG000|Overall Study|Adverse Event|2|||
170524145|NCT05630196|616265638|FG001|Overall Study|Adverse Event|1|||
170524146|NCT05630196|616265637|FG000|Overall Study|Lost to Follow-up|1|||
170524147|NCT05630196|616265638|FG001|Overall Study|Lost to Follow-up|1|||
170524148|NCT05630196|616265637|FG000|Overall Study|Protocol Violation|2|||
170524149|NCT05630196|616265638|FG001|Overall Study|Protocol Violation|3|||
170524150|NCT05630196|616265637|FG000|Overall Study|Physician Decision|1|||
170524151|NCT05630196|616265638|FG001|Overall Study|Physician Decision|0|||
170524152|NCT05630196|616265637|FG000|Overall Study|Withdrawal by Subject|3|||
170524153|NCT05630196|616265638|FG001|Overall Study|Withdrawal by Subject|4|||
170524154|NCT04070989|616265639|FG000|Overall Study|Death|1|||
170524155|NCT04070989|616265640|FG001|Overall Study|Death|0|||
170524156|NCT04070989|616265641|FG002|Overall Study|Death|0|||
170524157|NCT04070989|616265639|FG000|Overall Study|Study Terminated by Sponsor|7|||
170524158|NCT04070989|616265640|FG001|Overall Study|Study Terminated by Sponsor|8|||
170524159|NCT04070989|616265641|FG002|Overall Study|Study Terminated by Sponsor|23|||
170524160|NCT04070989|616265639|FG000|Overall Study|Withdrawal by Subject|0|||
170524161|NCT04070989|616265640|FG001|Overall Study|Withdrawal by Subject|1|||
170524162|NCT04070989|616265641|FG002|Overall Study|Withdrawal by Subject|0|||
170524163|NCT04070989|616265639|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
170524164|NCT04070989|616265640|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
170524165|NCT04070989|616265641|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
170524166|NCT04070989|616265639|FG000|Overall Study|Other|1|||
170524167|NCT04070989|616265640|FG001|Overall Study|Other|1|||
170524168|NCT04070989|616265641|FG002|Overall Study|Other|0|||
170524169|NCT06088784|616265642|FG000|Overall Study|Adverse Event|0|||
170524170|NCT06088784|616265643|FG001|Overall Study|Adverse Event|0|||
170524171|NCT06088784|616265644|FG002|Overall Study|Adverse Event|0|||
170524172|NCT06088784|616265645|FG003|Overall Study|Adverse Event|0|||
170524173|NCT06088784|616265646|FG004|Overall Study|Adverse Event|0|||
170524174|NCT06088784|616265647|FG005|Overall Study|Adverse Event|0|||
170524175|NCT06088784|616265648|FG006|Overall Study|Adverse Event|3|||
170524176|NCT06088784|616265649|FG007|Overall Study|Adverse Event|0|||
170524177|NCT06088784|616265650|FG008|Overall Study|Adverse Event|0|||
170524178|NCT06088784|616265651|FG009|Overall Study|Adverse Event|0|||
170524179|NCT06088784|616265652|FG010|Overall Study|Adverse Event|0|||
170524180|NCT06088784|616265653|FG011|Overall Study|Adverse Event|0|||
170524181|NCT06088784|616265642|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524182|NCT06088784|616265643|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524183|NCT06088784|616265644|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524184|NCT06088784|616265645|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524185|NCT06088784|616265646|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170770663|NCT03401112|617165787|FG003|Overall Study|Withdrawal by Subject|1|||
170770664|NCT03401112|617165788|FG004|Overall Study|Withdrawal by Subject|0|||
170770665|NCT03401112|617165784|FG000|Overall Study|Physician Decision|0|||
170770666|NCT03401112|617165785|FG001|Overall Study|Physician Decision|0|||
170770667|NCT03401112|617165786|FG002|Overall Study|Physician Decision|0|||
170524186|NCT06088784|616265647|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524187|NCT06088784|616265648|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
170524188|NCT06088784|616265649|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524189|NCT06088784|616265650|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524190|NCT06088784|616265651|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524191|NCT06088784|616265652|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524192|NCT06088784|616265653|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
170524193|NCT03256578|616265654|FG000|Overall Study|Excluded Post Randomization|66|||
170524194|NCT03256578|616265655|FG001|Overall Study|Excluded Post Randomization|56|||
170524195|NCT00922636|616265656|FG000|Overall Study|Adverse Event|3|||
170524196|NCT00922636|616265657|FG001|Overall Study|Adverse Event|3|||
170524197|NCT00922636|616265658|FG002|Overall Study|Adverse Event|2|||
170524198|NCT00922636|616265659|FG003|Overall Study|Adverse Event|3|||
170770668|NCT03401112|617165787|FG003|Overall Study|Physician Decision|2|||
170524199|NCT00922636|616265660|FG004|Overall Study|Adverse Event|2|||
170524200|NCT00922636|616265656|FG000|Overall Study|Lack of Efficacy|1|||
170524201|NCT00922636|616265657|FG001|Overall Study|Lack of Efficacy|7|||
170524202|NCT00922636|616265658|FG002|Overall Study|Lack of Efficacy|3|||
170524203|NCT00922636|616265659|FG003|Overall Study|Lack of Efficacy|2|||
170524204|NCT00922636|616265660|FG004|Overall Study|Lack of Efficacy|4|||
170524205|NCT00922636|616265656|FG000|Overall Study|Sponsor Decision|0|||
170524206|NCT00922636|616265657|FG001|Overall Study|Sponsor Decision|0|||
170524207|NCT00922636|616265658|FG002|Overall Study|Sponsor Decision|2|||
170524208|NCT00922636|616265659|FG003|Overall Study|Sponsor Decision|0|||
170524209|NCT00922636|616265660|FG004|Overall Study|Sponsor Decision|0|||
170524210|NCT00922636|616265656|FG000|Overall Study|Withdrawal by Subject|0|||
170524211|NCT00922636|616265657|FG001|Overall Study|Withdrawal by Subject|0|||
170524212|NCT00922636|616265658|FG002|Overall Study|Withdrawal by Subject|5|||
170524213|NCT00922636|616265659|FG003|Overall Study|Withdrawal by Subject|2|||
170524214|NCT00922636|616265660|FG004|Overall Study|Withdrawal by Subject|4|||
170524215|NCT00922636|616265656|FG000|Overall Study|Protocol Violation|0|||
170524216|NCT00922636|616265657|FG001|Overall Study|Protocol Violation|0|||
170524217|NCT00922636|616265658|FG002|Overall Study|Protocol Violation|2|||
170524218|NCT00922636|616265659|FG003|Overall Study|Protocol Violation|2|||
170524219|NCT00922636|616265660|FG004|Overall Study|Protocol Violation|0|||
170770669|NCT03401112|617165788|FG004|Overall Study|Physician Decision|0|||
170770670|NCT03401112|617165784|FG000|Overall Study|Study was Terminated by Sponsor|0|||
170770671|NCT03401112|617165785|FG001|Overall Study|Study was Terminated by Sponsor|0|||
170770672|NCT03401112|617165786|FG002|Overall Study|Study was Terminated by Sponsor|0|||
170770673|NCT03401112|617165787|FG003|Overall Study|Study was Terminated by Sponsor|1|||
170770674|NCT03401112|617165788|FG004|Overall Study|Study was Terminated by Sponsor|0|||
170770675|NCT03401112|617165784|FG000|Overall Study|Day 1 Assessment not Done|1|||
170770676|NCT03401112|617165785|FG001|Overall Study|Day 1 Assessment not Done|0|||
170770677|NCT03401112|617165786|FG002|Overall Study|Day 1 Assessment not Done|0|||
170770678|NCT03401112|617165787|FG003|Overall Study|Day 1 Assessment not Done|0|||
170770679|NCT03401112|617165788|FG004|Overall Study|Day 1 Assessment not Done|0|||
170770680|NCT03401112|617165784|FG000|Overall Study|Not Dosed|0|||
170770681|NCT03401112|617165785|FG001|Overall Study|Not Dosed|0|||
170770682|NCT03401112|617165786|FG002|Overall Study|Not Dosed|1|||
170770683|NCT03401112|617165787|FG003|Overall Study|Not Dosed|0|||
170770684|NCT03401112|617165788|FG004|Overall Study|Not Dosed|0|||
170770685|NCT03401112|617165784|FG000|Overall Study|Missed Clinical Visit|0|||
170770686|NCT03401112|617165785|FG001|Overall Study|Missed Clinical Visit|0|||
170770687|NCT03401112|617165786|FG002|Overall Study|Missed Clinical Visit|1|||
170770688|NCT03401112|617165787|FG003|Overall Study|Missed Clinical Visit|0|||
170770689|NCT03401112|617165788|FG004|Overall Study|Missed Clinical Visit|0|||
170413088|NCT03118739|615851980|FG001|Overall Study|Withdrawal by Subject|3|||
170413089|NCT03118739|615851979|FG000|Overall Study|Lost to Follow-up|2|||
170524220|NCT00922636|616265656|FG000|Overall Study|Entry Criteria Not Met|0|||
170524221|NCT00922636|616265657|FG001|Overall Study|Entry Criteria Not Met|0|||
170524222|NCT00922636|616265658|FG002|Overall Study|Entry Criteria Not Met|1|||
170524223|NCT00922636|616265659|FG003|Overall Study|Entry Criteria Not Met|1|||
170524224|NCT00922636|616265660|FG004|Overall Study|Entry Criteria Not Met|0|||
170524225|NCT00922636|616265656|FG000|Overall Study|Parent/Caregiver Decision|2|||
170524226|NCT00922636|616265657|FG001|Overall Study|Parent/Caregiver Decision|4|||
170524227|NCT00922636|616265658|FG002|Overall Study|Parent/Caregiver Decision|3|||
170524228|NCT00922636|616265659|FG003|Overall Study|Parent/Caregiver Decision|5|||
170524229|NCT00922636|616265660|FG004|Overall Study|Parent/Caregiver Decision|2|||
170413090|NCT03118739|615851980|FG001|Overall Study|Lost to Follow-up|0|||
170413091|NCT01326026|615851983|FG000|Overall Study|Adverse Event|4|||
170413092|NCT01326026|615851984|FG001|Overall Study|Adverse Event|3|||
170413093|NCT01326026|615851983|FG000|Overall Study|Withdrawal Criteria|5|||
170413094|NCT01326026|615851984|FG001|Overall Study|Withdrawal Criteria|7|||
170413095|NCT01326026|615851983|FG000|Overall Study|Other|3|||
170413096|NCT01326026|615851984|FG001|Overall Study|Other|3|||
170524230|NCT00922636|616265656|FG000|Overall Study|Lost to Follow-up|1|||
170524231|NCT00922636|616265657|FG001|Overall Study|Lost to Follow-up|2|||
170524232|NCT00922636|616265658|FG002|Overall Study|Lost to Follow-up|2|||
170524233|NCT00922636|616265659|FG003|Overall Study|Lost to Follow-up|2|||
170770690|NCT03401112|617165784|FG000|Overall Study|Missed Doses|0|||
170770691|NCT03401112|617165785|FG001|Overall Study|Missed Doses|0|||
170524234|NCT00922636|616265660|FG004|Overall Study|Lost to Follow-up|4|||
170524235|NCT02308046|616265661|FG000|Overall Study|Negative yeast culture at Baseline|32|||
170524236|NCT02308046|616265662|FG001|Overall Study|Negative yeast culture at Baseline|33|||
170524237|NCT02308046|616265661|FG000|Overall Study|Positive for STD at Baseline|1|||
170524238|NCT02308046|616265662|FG001|Overall Study|Positive for STD at Baseline|2|||
170524239|NCT02308046|616265661|FG000|Overall Study|Lost to Follow-up|1|||
170770692|NCT03401112|617165786|FG002|Overall Study|Missed Doses|1|||
170770693|NCT03401112|617165787|FG003|Overall Study|Missed Doses|0|||
170770694|NCT03401112|617165788|FG004|Overall Study|Missed Doses|0|||
170770695|NCT03475316|617165789|FG000|6 Month Intervention|Adverse Event|2|||
170524240|NCT02308046|616265662|FG001|Overall Study|Lost to Follow-up|3|||
170524241|NCT02224625|616265668|FG000|Irritation|Adverse Event|6|||
170524242|NCT02224625|616265668|FG000|Sensitization|Adverse Event|55|||
170524243|NCT01573000|616265669|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
170524244|NCT01573000|616265670|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
170524245|NCT01573000|616265669|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
170872291|NCT02687542|617544766|FG001|Overall Study|Lost to Follow-up|0|||
170872292|NCT02687542|617544767|FG002|Overall Study|Lost to Follow-up|0|||
170872293|NCT02687542|617544768|FG003|Overall Study|Lost to Follow-up|0|||
170872294|NCT02687542|617544769|FG004|Overall Study|Lost to Follow-up|1|||
170872295|NCT02687542|617544765|FG000|Overall Study|Protocol Violation|0|||
170872296|NCT02687542|617544766|FG001|Overall Study|Protocol Violation|1|||
170872297|NCT02687542|617544767|FG002|Overall Study|Protocol Violation|0|||
170872298|NCT02687542|617544768|FG003|Overall Study|Protocol Violation|0|||
170872299|NCT02687542|617544769|FG004|Overall Study|Protocol Violation|0|||
170872300|NCT02687542|617544765|FG000|Overall Study|Other|5|||
170872301|NCT02687542|617544766|FG001|Overall Study|Other|9|||
170872302|NCT02687542|617544767|FG002|Overall Study|Other|10|||
170872303|NCT02687542|617544768|FG003|Overall Study|Other|6|||
170872304|NCT02687542|617544769|FG004|Overall Study|Other|5|||
170872305|NCT02687542|617544765|FG000|Overall Study|Adverse Event|3|||
170872306|NCT02687542|617544766|FG001|Overall Study|Adverse Event|1|||
170872307|NCT02687542|617544767|FG002|Overall Study|Adverse Event|3|||
170872308|NCT02687542|617544768|FG003|Overall Study|Adverse Event|2|||
170872309|NCT02687542|617544769|FG004|Overall Study|Adverse Event|9|||
170872310|NCT02687542|617544765|FG000|Overall Study|Withdrawal by Subject|0|||
170524246|NCT01573000|616265670|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
170524247|NCT01573000|616265669|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
170524248|NCT01573000|616265670|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
170524249|NCT01573000|616265669|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
170524250|NCT01573000|616265670|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
170524251|NCT01573000|616265669|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
170524252|NCT01573000|616265670|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
170524253|NCT01573000|616265669|FG000|Crossover Phase|Lack of Efficacy|0|||
170524254|NCT01573000|616265670|FG001|Crossover Phase|Lack of Efficacy|13|||
170524255|NCT01573000|616265669|FG000|Crossover Phase|Lost to Follow-up|0|||
170524256|NCT01573000|616265670|FG001|Crossover Phase|Lost to Follow-up|2|||
170524257|NCT01573000|616265669|FG000|Crossover Phase|Death|0|||
170524258|NCT01573000|616265670|FG001|Crossover Phase|Death|3|||
170524259|NCT01573000|616265669|FG000|Long-Term Follow-Up|Death|3|||
170524260|NCT01573000|616265670|FG001|Long-Term Follow-Up|Death|0|||
170524261|NCT01573000|616265669|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
170524262|NCT01573000|616265670|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
170524263|NCT03342001|616265676|FG000|Overall Study|Adverse Event|1|||
170524264|NCT03342001|616265676|FG000|Overall Study|Lost to Follow-up|1|||
170524265|NCT01384877|616265680|FG000|Treatment 2|Lost to Follow-up|2|||
170524266|NCT01384877|616265681|FG001|Treatment 2|Lost to Follow-up|2|||
170524267|NCT03964207|616265682|FG000|First Treatment|Withdrawal by Subject|1|||
170524268|NCT03964207|616265683|FG001|First Treatment|Withdrawal by Subject|2|||
170524269|NCT03964207|616265682|FG000|First Treatment|Protocol Violation|1|||
170524270|NCT03964207|616265683|FG001|First Treatment|Protocol Violation|0|||
170524271|NCT03964207|616265682|FG000|First Treatment|Lost to Follow-up|1|||
170524272|NCT03964207|616265683|FG001|First Treatment|Lost to Follow-up|0|||
170524273|NCT03964207|616265682|FG000|Second Treatment|Lost to Follow-up|0|||
170524274|NCT03964207|616265683|FG001|Second Treatment|Lost to Follow-up|1|||
170524275|NCT03964207|616265682|FG000|Second Treatment|Adverse Event|1|||
170524276|NCT03964207|616265683|FG001|Second Treatment|Adverse Event|2|||
170524277|NCT01930539|616265694|FG000|Overall Study|Withdrawal by Subject|2|||
170524278|NCT01930539|616265695|FG001|Overall Study|Withdrawal by Subject|2|||
170524279|NCT00830219|616265696|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
170524280|NCT00830219|616265697|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
170872311|NCT02687542|617544766|FG001|Overall Study|Withdrawal by Subject|1|||
170524281|NCT01548404|616265698|FG000|Overall Study|Adverse Event|3|||
170524282|NCT01548404|616265699|FG001|Overall Study|Adverse Event|1|||
170524283|NCT01548404|616265698|FG000|Overall Study|Physician Decision|2|||
170872312|NCT02687542|617544767|FG002|Overall Study|Withdrawal by Subject|1|||
170872313|NCT02687542|617544768|FG003|Overall Study|Withdrawal by Subject|2|||
170872314|NCT02687542|617544769|FG004|Overall Study|Withdrawal by Subject|4|||
170872315|NCT01838616|617544770|FG000|Titration Period|Adverse Event|18|||
170872316|NCT01838616|617544771|FG001|Titration Period|Adverse Event|48|||
170872317|NCT01838616|617544770|FG000|Titration Period|Lack of Efficacy|5|||
170872318|NCT01838616|617544771|FG001|Titration Period|Lack of Efficacy|12|||
170524284|NCT01548404|616265699|FG001|Overall Study|Physician Decision|1|||
170524285|NCT01548404|616265698|FG000|Overall Study|Inadequate response to study treatment|23|||
170524286|NCT01548404|616265699|FG001|Overall Study|Inadequate response to study treatment|7|||
170872319|NCT01838616|617544770|FG000|Titration Period|Withdrawal by Subject|5|||
170872320|NCT01838616|617544771|FG001|Titration Period|Withdrawal by Subject|5|||
170770696|NCT03475316|617165790|FG001|6 Month Intervention|Adverse Event|1|||
170770697|NCT03475316|617165789|FG000|6 Month Intervention|Withdrawal by Subject|2|||
170770698|NCT03475316|617165790|FG001|6 Month Intervention|Withdrawal by Subject|0|||
170770699|NCT03475316|617165789|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
170770700|NCT03475316|617165790|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
170413097|NCT04317053|615851988|FG000|Overall Study|Withdrawn (screen failure)|4|||
170413098|NCT04317053|615851989|FG001|Overall Study|Withdrawn (screen failure)|2|||
170413099|NCT01022112|615851990|FG000|Overall Study|Adverse Event|1|||
170413100|NCT01022112|615851991|FG001|Overall Study|Adverse Event|2|||
170413101|NCT01022112|615851992|FG002|Overall Study|Adverse Event|0|||
170413102|NCT01022112|615851993|FG003|Overall Study|Adverse Event|1|||
170413103|NCT01022112|615851994|FG004|Overall Study|Adverse Event|0|||
170413104|NCT01022112|615851990|FG000|Overall Study|Lack of Efficacy|1|||
170413105|NCT01022112|615851991|FG001|Overall Study|Lack of Efficacy|0|||
170413106|NCT01022112|615851992|FG002|Overall Study|Lack of Efficacy|0|||
170413107|NCT01022112|615851993|FG003|Overall Study|Lack of Efficacy|0|||
170413108|NCT01022112|615851994|FG004|Overall Study|Lack of Efficacy|1|||
170413109|NCT01022112|615851990|FG000|Overall Study|Physician Decision|0|||
170413110|NCT01022112|615851991|FG001|Overall Study|Physician Decision|0|||
170413111|NCT01022112|615851992|FG002|Overall Study|Physician Decision|1|||
170413112|NCT01022112|615851993|FG003|Overall Study|Physician Decision|0|||
170413113|NCT01022112|615851994|FG004|Overall Study|Physician Decision|1|||
170413114|NCT01022112|615851990|FG000|Overall Study|Withdrawal by Subject|0|||
170413115|NCT01022112|615851991|FG001|Overall Study|Withdrawal by Subject|1|||
170413116|NCT01022112|615851992|FG002|Overall Study|Withdrawal by Subject|2|||
170413117|NCT01022112|615851993|FG003|Overall Study|Withdrawal by Subject|2|||
170413118|NCT01022112|615851994|FG004|Overall Study|Withdrawal by Subject|1|||
170413119|NCT01022112|615851990|FG000|Overall Study|Fasting plasma glucose level increased|1|||
170413120|NCT01022112|615851991|FG001|Overall Study|Fasting plasma glucose level increased|0|||
170413121|NCT01022112|615851992|FG002|Overall Study|Fasting plasma glucose level increased|0|||
170413122|NCT01022112|615851993|FG003|Overall Study|Fasting plasma glucose level increased|0|||
170413123|NCT01022112|615851994|FG004|Overall Study|Fasting plasma glucose level increased|7|||
170413124|NCT00759148|615853313|FG000|Overall Study|Adverse Event|1|||
170413125|NCT00759148|615853314|FG001|Overall Study|Adverse Event|6|||
170413126|NCT00759148|615853313|FG000|Overall Study|Withdrawal by Subject|3|||
170413127|NCT00759148|615853314|FG001|Overall Study|Withdrawal by Subject|7|||
170413128|NCT00759148|615853313|FG000|Overall Study|Lost to Follow-up|3|||
170413129|NCT00759148|615853314|FG001|Overall Study|Lost to Follow-up|9|||
170413130|NCT00759148|615853313|FG000|Overall Study|Treatment Failure|6|||
170413131|NCT00759148|615853314|FG001|Overall Study|Treatment Failure|10|||
170413132|NCT00759148|615853313|FG000|Overall Study|Reason not given|1|||
170413133|NCT00759148|615853314|FG001|Overall Study|Reason not given|0|||
170413134|NCT01073020|615853315|FG000|Overall Study|Withdrawal by Subject|6|||
170413135|NCT01073020|615853316|FG001|Overall Study|Withdrawal by Subject|4|||
170413136|NCT01073020|615853317|FG002|Overall Study|Withdrawal by Subject|1|||
170413137|NCT01073020|615853318|FG003|Overall Study|Withdrawal by Subject|2|||
170413138|NCT01073020|615853315|FG000|Overall Study|Physician Decision|1|||
170413139|NCT01073020|615853316|FG001|Overall Study|Physician Decision|0|||
170413140|NCT01073020|615853317|FG002|Overall Study|Physician Decision|2|||
170413141|NCT01073020|615853318|FG003|Overall Study|Physician Decision|0|||
170413142|NCT01073020|615853315|FG000|Overall Study|Death|0|||
170413143|NCT01073020|615853316|FG001|Overall Study|Death|1|||
170413144|NCT01073020|615853317|FG002|Overall Study|Death|0|||
170413145|NCT01073020|615853318|FG003|Overall Study|Death|0|||
170413146|NCT00094302|615853321|FG000|Overall Study|Lost to Follow-up|43|||
170413147|NCT00094302|615853322|FG001|Overall Study|Lost to Follow-up|41|||
170413148|NCT00094302|615853321|FG000|Overall Study|Physician Decision|5|||
170413149|NCT00094302|615853322|FG001|Overall Study|Physician Decision|8|||
170413150|NCT00094302|615853321|FG000|Overall Study|Withdrawal by Subject|103|||
170413151|NCT00094302|615853322|FG001|Overall Study|Withdrawal by Subject|111|||
170413152|NCT00094302|615853321|FG000|Overall Study|Death|266|||
170770701|NCT03475316|617165789|FG000|9 Months|Study stopped due to COVID pandemic|3|||
170413153|NCT00094302|615853322|FG001|Overall Study|Death|246|||
170413154|NCT03329027|615853325|FG000|Overall Study|Lost to Follow-up|1|||
170413155|NCT03329027|615853326|FG001|Overall Study|Lost to Follow-up|0|||
170413156|NCT03329027|615853327|FG002|Overall Study|Lost to Follow-up|1|||
170413157|NCT03329027|615853325|FG000|Overall Study|Protocol Violation|9|||
170413158|NCT03329027|615853326|FG001|Overall Study|Protocol Violation|5|||
170413159|NCT03329027|615853327|FG002|Overall Study|Protocol Violation|7|||
170413160|NCT02761980|615853330|FG000|Overall Study|Adverse Event|4|||
170413161|NCT02761980|615853331|FG001|Overall Study|Adverse Event|6|||
170413162|NCT02761980|615853332|FG002|Overall Study|Adverse Event|5|||
170770702|NCT03475316|617165790|FG001|9 Months|Study stopped due to COVID pandemic|4|||
170770703|NCT02204982|617165793|FG000|Overall Study|Patient ineligible-medical monitor|1|||
170770704|NCT02204982|617165794|FG001|Overall Study|Patient ineligible-medical monitor|0|||
170413163|NCT02761980|615853333|FG003|Overall Study|Adverse Event|6|||
170413164|NCT02761980|615853330|FG000|Overall Study|Withdrawal by Subject|0|||
170524287|NCT01548404|616265698|FG000|Overall Study|Lost to Follow-up|2|||
170524288|NCT01548404|616265699|FG001|Overall Study|Lost to Follow-up|0|||
170524289|NCT01548404|616265698|FG000|Overall Study|Withdrawal by Subject|0|||
170524290|NCT01548404|616265699|FG001|Overall Study|Withdrawal by Subject|3|||
170524291|NCT01548404|616265698|FG000|Overall Study|Other than specified above|0|||
170524292|NCT01548404|616265699|FG001|Overall Study|Other than specified above|2|||
170524293|NCT00239720|616265700|FG000|Overall Study|Adverse Event|1|||
170524294|NCT00239720|616265701|FG001|Overall Study|Adverse Event|0|||
170524295|NCT00239720|616265700|FG000|Overall Study|Lost to Follow-up|0|||
170524296|NCT00239720|616265701|FG001|Overall Study|Lost to Follow-up|1|||
170524297|NCT01405560|616265704|FG000|Overall Study|Physician Decision|1|||
170524298|NCT04040439|616265707|FG000|Overall Study|Invalid registration|11|||
170524299|NCT04040439|616265707|FG000|Overall Study|No IC* on publication of study results|2|||
170524300|NCT00426270|616265708|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
170524301|NCT00426270|616265708|FG000|Overall Study|Adverse Event|5|||
170524302|NCT01450813|616265709|FG000|Overall Study|Physician Decision|1|||
170524303|NCT01450813|616265710|FG001|Overall Study|Physician Decision|1|||
170524304|NCT01450813|616265711|FG002|Overall Study|Physician Decision|0|||
170524305|NCT01450813|616265712|FG003|Overall Study|Physician Decision|3|||
170524306|NCT00752089|616265715|FG000|Overall Study|Adverse Event|1|||
170524307|NCT00752089|616265715|FG000|Overall Study|Protocol Deviation|2|||
170524308|NCT00752089|616265715|FG000|Overall Study|Could not attend visit 9|1|||
170524309|NCT00752089|616265715|FG000|Overall Study|Not capable of wearing partial denture|1|||
170524310|NCT00752089|616265715|FG000|Overall Study|Cannot continue the study|1|||
170524311|NCT01774981|616265716|FG000|Overall Study|Adverse Event|0|||
170524312|NCT01774981|616265717|FG001|Overall Study|Adverse Event|0|||
170524313|NCT01774981|616265718|FG002|Overall Study|Adverse Event|0|||
170524314|NCT01774981|616265719|FG003|Overall Study|Adverse Event|0|||
170524315|NCT01774981|616265720|FG004|Overall Study|Adverse Event|0|||
170524316|NCT01774981|616265721|FG005|Overall Study|Adverse Event|1|||
170524317|NCT01774981|616265722|FG006|Overall Study|Adverse Event|0|||
170524318|NCT01774981|616265723|FG007|Overall Study|Adverse Event|0|||
170524319|NCT01774981|616265716|FG000|Overall Study|Withdrawal by Subject|0|||
170524320|NCT01774981|616265717|FG001|Overall Study|Withdrawal by Subject|0|||
170524321|NCT01774981|616265718|FG002|Overall Study|Withdrawal by Subject|0|||
170524322|NCT01774981|616265719|FG003|Overall Study|Withdrawal by Subject|0|||
170524323|NCT01774981|616265720|FG004|Overall Study|Withdrawal by Subject|0|||
170524324|NCT01774981|616265721|FG005|Overall Study|Withdrawal by Subject|0|||
170524325|NCT01774981|616265722|FG006|Overall Study|Withdrawal by Subject|0|||
170524326|NCT01774981|616265723|FG007|Overall Study|Withdrawal by Subject|1|||
170524327|NCT01774981|616265716|FG000|Overall Study|Death|0|||
170524328|NCT01774981|616265717|FG001|Overall Study|Death|0|||
170524329|NCT01774981|616265718|FG002|Overall Study|Death|0|||
170524330|NCT01774981|616265719|FG003|Overall Study|Death|0|||
170524331|NCT01774981|616265720|FG004|Overall Study|Death|1|||
170524332|NCT01774981|616265721|FG005|Overall Study|Death|0|||
170524333|NCT01774981|616265722|FG006|Overall Study|Death|0|||
170524334|NCT01774981|616265723|FG007|Overall Study|Death|0|||
170524335|NCT01324102|616265724|FG000|Overall Study|illness|1|||
170524336|NCT01324102|616265725|FG001|Overall Study|illness|6|||
170524337|NCT00728494|616265726|FG000|Overall Study|Adverse Event|7|||
170524338|NCT00728494|616265727|FG001|Overall Study|Adverse Event|0|||
170524339|NCT00728494|616265726|FG000|Overall Study|Withdrawal by Subject|0|||
170524340|NCT00728494|616265727|FG001|Overall Study|Withdrawal by Subject|2|||
170770705|NCT02204982|617165793|FG000|Overall Study|Withdrawal by Subject|1|||
170770706|NCT02204982|617165794|FG001|Overall Study|Withdrawal by Subject|0|||
170770707|NCT02204982|617165793|FG000|Overall Study|Adverse Event|1|||
170770708|NCT02204982|617165794|FG001|Overall Study|Adverse Event|0|||
170770709|NCT02204982|617165793|FG000|Overall Study|Adverse Event and Investigator decision|1|||
170770710|NCT02204982|617165794|FG001|Overall Study|Adverse Event and Investigator decision|0|||
170770711|NCT02204982|617165793|FG000|Overall Study|Physician Decision|0|||
170770712|NCT02204982|617165794|FG001|Overall Study|Physician Decision|2|||
170770713|NCT02204982|617165793|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
170770714|NCT02204982|617165794|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
170770715|NCT02204982|617165793|FG000|Overall Study|Termination of Study bySponsor|0|||
170770716|NCT02204982|617165794|FG001|Overall Study|Termination of Study bySponsor|1|||
170770717|NCT01968226|617165796|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
170770718|NCT03654768|617165798|FG000|Overall Study|Adverse Event|1|||
170770719|NCT03654768|617165799|FG001|Overall Study|Adverse Event|6|||
170872321|NCT01838616|617544770|FG000|Titration Period|Technical problems|1|||
170524341|NCT00728494|616265726|FG000|Overall Study|Lack of Efficacy|2|||
170524342|NCT00728494|616265727|FG001|Overall Study|Lack of Efficacy|4|||
170524343|NCT00728494|616265726|FG000|Overall Study|No data available|0|||
170524344|NCT00728494|616265727|FG001|Overall Study|No data available|1|||
170524345|NCT01290718|616265732|FG000|Overall Study|Early termination of the study|4|||
170524346|NCT00975416|616265733|FG000|Overall Study|early discharge from tx|3|||
170524347|NCT00975416|616265734|FG001|Overall Study|early discharge from tx|5|||
170524348|NCT02858401|616265738|FG000|Overall Study|Withdrew Consent|0|||
170524349|NCT02858401|616265739|FG001|Overall Study|Withdrew Consent|0|||
170524350|NCT02858401|616265740|FG002|Overall Study|Withdrew Consent|0|||
170524351|NCT02858401|616265741|FG003|Overall Study|Withdrew Consent|0|||
170524352|NCT02858401|616265742|FG004|Overall Study|Withdrew Consent|0|||
170524353|NCT02858401|616265743|FG005|Overall Study|Withdrew Consent|1|||
170524354|NCT02858401|616265744|FG006|Overall Study|Withdrew Consent|0|||
170524355|NCT02858401|616265738|FG000|Overall Study|Lost to Follow-up|0|||
170524356|NCT02858401|616265739|FG001|Overall Study|Lost to Follow-up|1|||
170524357|NCT02858401|616265740|FG002|Overall Study|Lost to Follow-up|0|||
170524358|NCT02858401|616265741|FG003|Overall Study|Lost to Follow-up|0|||
170524359|NCT02858401|616265742|FG004|Overall Study|Lost to Follow-up|0|||
170524360|NCT02858401|616265743|FG005|Overall Study|Lost to Follow-up|0|||
170524361|NCT02858401|616265744|FG006|Overall Study|Lost to Follow-up|0|||
170524362|NCT01184872|616265745|FG000|Overall Study|Adverse Event|3|||
170524363|NCT01184872|616265746|FG001|Overall Study|Adverse Event|4|||
170524364|NCT01184872|616265745|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
170524365|NCT01184872|616265746|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170524366|NCT01184872|616265745|FG000|Overall Study|Withdrawal by Subject|2|||
170524367|NCT01184872|616265746|FG001|Overall Study|Withdrawal by Subject|0|||
170524368|NCT01184872|616265745|FG000|Overall Study|Lost to Follow-up|0|||
170524369|NCT01184872|616265746|FG001|Overall Study|Lost to Follow-up|1|||
170524370|NCT01184872|616265745|FG000|Overall Study|Administrative problems|1|||
170524371|NCT01184872|616265746|FG001|Overall Study|Administrative problems|1|||
170524372|NCT01184872|616265745|FG000|Overall Study|Protocol deviation|1|||
170524373|NCT01184872|616265746|FG001|Overall Study|Protocol deviation|0|||
170524374|NCT02456727|616265753|FG000|Overall Study|Lost to Follow-up|63|||
170524375|NCT02456727|616265754|FG001|Overall Study|Lost to Follow-up|65|||
170524376|NCT02456727|616265753|FG000|Overall Study|Death|2|||
170524377|NCT02456727|616265754|FG001|Overall Study|Death|1|||
170524378|NCT02456727|616265753|FG000|Overall Study|Withdrawal by Subject|1|||
170524379|NCT02456727|616265754|FG001|Overall Study|Withdrawal by Subject|10|||
170524380|NCT02456727|616265753|FG000|Overall Study|Never Initiated Treatment|43|||
170770720|NCT03654768|617165798|FG000|Overall Study|Loss of response|2|||
170770721|NCT03654768|617165799|FG001|Overall Study|Loss of response|2|||
170770722|NCT03654768|617165798|FG000|Overall Study|Non-compliance|0|||
170770723|NCT03654768|617165799|FG001|Overall Study|Non-compliance|1|||
170770724|NCT03654768|617165798|FG000|Overall Study|Refusal not related to toxicity|1|||
170770725|NCT03654768|617165799|FG001|Overall Study|Refusal not related to toxicity|5|||
170770726|NCT03654768|617165798|FG000|Overall Study|Did not receive protocol therapy|1|||
170770727|NCT03654768|617165799|FG001|Overall Study|Did not receive protocol therapy|1|||
170770728|NCT05323734|617165800|FG000|Overall Study|Adverse Event|5|||
170770729|NCT05323734|617165801|FG001|Overall Study|Adverse Event|2|||
170770730|NCT05323734|617165800|FG000|Overall Study|Physician Decision|1|||
170770731|NCT05323734|617165801|FG001|Overall Study|Physician Decision|0|||
170770732|NCT05323734|617165800|FG000|Overall Study|Lack of Efficacy|1|||
170770733|NCT05323734|617165801|FG001|Overall Study|Lack of Efficacy|2|||
170770734|NCT05323734|617165800|FG000|Overall Study|Withdrawal by Subject|2|||
170770735|NCT05323734|617165801|FG001|Overall Study|Withdrawal by Subject|0|||
170770736|NCT05323734|617165800|FG000|Overall Study|Participant Withdrawn Due|0|||
170770737|NCT05323734|617165801|FG001|Overall Study|Participant Withdrawn Due|1|||
170770738|NCT00732381|617165809|FG000|Overall Study|Adverse Event|1|||
170770739|NCT00732381|617165810|FG001|Overall Study|Adverse Event|0|||
170770740|NCT00732381|617165809|FG000|Overall Study|Treatment Failure|1|||
170770741|NCT00732381|617165810|FG001|Overall Study|Treatment Failure|1|||
170770742|NCT01390402|617165811|FG000|Overall Study|Death|1|||
170770743|NCT01390402|617165811|FG000|Overall Study|Disease Progression|4|||
170770744|NCT01350804|617165812|FG000|Core Study|Withdrawal by Subject|11|||
170770745|NCT01350804|617165813|FG001|Core Study|Withdrawal by Subject|17|||
170770746|NCT01350804|617165814|FG002|Core Study|Withdrawal by Subject|16|||
170770747|NCT01350804|617165815|FG003|Core Study|Withdrawal by Subject|7|||
170770748|NCT01350804|617165812|FG000|Core Study|Study terminated by Sponsor|0|||
170524381|NCT02456727|616265754|FG001|Overall Study|Never Initiated Treatment|30|||
170524382|NCT02446691|616265755|FG000|Overall Study|Withdrawal by Subject|2|||
170524383|NCT02446691|616265755|FG000|Overall Study|Lost to Follow-up|8|||
170524384|NCT02446691|616265755|FG000|Overall Study|Protocol Violation|1|||
170524385|NCT00192114|616265756|FG000|Overall Study|Objective Tumor Progression|19|||
170770749|NCT01350804|617165813|FG001|Core Study|Study terminated by Sponsor|0|||
170770750|NCT01350804|617165814|FG002|Core Study|Study terminated by Sponsor|0|||
170770751|NCT01350804|617165815|FG003|Core Study|Study terminated by Sponsor|2|||
170770752|NCT01350804|617165812|FG000|Core Study|Protocol deviation|1|||
170770753|NCT01350804|617165813|FG001|Core Study|Protocol deviation|0|||
170770754|NCT01350804|617165814|FG002|Core Study|Protocol deviation|1|||
170770755|NCT01350804|617165815|FG003|Core Study|Protocol deviation|0|||
170770756|NCT01350804|617165812|FG000|Core Study|Physician Decision|1|||
170524386|NCT00192114|616265756|FG000|Overall Study|Adverse Event|2|||
170524387|NCT00192114|616265756|FG000|Overall Study|Clinical Progression|2|||
170524388|NCT00192114|616265756|FG000|Overall Study|Death|1|||
170524389|NCT00492297|616265757|FG000|Treatment|Death|2|||
170524390|NCT00492297|616265757|FG000|Treatment|Study terminated by sponsor|3|||
170872322|NCT01838616|617544771|FG001|Titration Period|Technical problems|0|||
170872323|NCT01838616|617544770|FG000|Titration Period|Other|1|||
170872324|NCT01838616|617544771|FG001|Titration Period|Other|0|||
170872325|NCT01838616|617544770|FG000|Titration Period|Protocol Violation|0|||
170872326|NCT01838616|617544771|FG001|Titration Period|Protocol Violation|1|||
170872327|NCT01838616|617544770|FG000|Continuation Period|Lack of Efficacy|3|||
170872328|NCT01838616|617544771|FG001|Continuation Period|Lack of Efficacy|5|||
170872329|NCT01838616|617544770|FG000|Continuation Period|Adverse Event|8|||
170872330|NCT01838616|617544771|FG001|Continuation Period|Adverse Event|4|||
170872331|NCT01838616|617544770|FG000|Continuation Period|Protocol Violation|2|||
170872332|NCT01838616|617544771|FG001|Continuation Period|Protocol Violation|0|||
170872333|NCT01838616|617544770|FG000|Continuation Period|Lost to Follow-up|1|||
170872334|NCT01838616|617544771|FG001|Continuation Period|Lost to Follow-up|0|||
170872335|NCT01838616|617544770|FG000|Continuation Period|Withdrawal by Subject|0|||
170872336|NCT01838616|617544771|FG001|Continuation Period|Withdrawal by Subject|4|||
170872337|NCT01838616|617544770|FG000|Continuation Period|Technical problems|0|||
170872338|NCT01838616|617544771|FG001|Continuation Period|Technical problems|1|||
170872339|NCT01838616|617544770|FG000|Pick-up Arm|Lack of Efficacy|4|||
170872340|NCT01838616|617544771|FG001|Pick-up Arm|Lack of Efficacy|0|||
170872341|NCT01838616|617544770|FG000|Pick-up Arm|Adverse Event|9|||
170524391|NCT00492297|616265757|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
170524392|NCT00492297|616265757|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
170524393|NCT00492297|616265757|FG000|Survival Only Follow-up|Death|46|||
170524394|NCT00492297|616265757|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
170524395|NCT00492297|616265757|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
170524396|NCT01222104|616265758|FG000|Overall Study|Lost to Follow-up|37|||
170524397|NCT01222104|616265758|FG000|Overall Study|Death|10|||
170524398|NCT03885908|616265761|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
170524399|NCT03885908|616265762|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
170524400|NCT03885908|616265761|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
170524401|NCT03885908|616265762|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
170524402|NCT03885908|616265761|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
170524403|NCT03885908|616265762|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
170524404|NCT03885908|616265761|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
170524405|NCT03885908|616265762|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
170524406|NCT02204917|616265763|FG000|Overall Study|Protocol Violation|1|||
170524407|NCT03669549|616265764|FG000|Overall Study|Adverse Event|4|||
170524408|NCT03669549|616265764|FG000|Overall Study|Withdrawal by Subject|1|||
170524409|NCT03669549|616265764|FG000|Overall Study|Study terminated by the Sponsor|1|||
170524410|NCT03903172|616265768|FG000|Overall Study|screen fail|4|||
170524411|NCT03903172|616265769|FG001|Overall Study|screen fail|1|||
170524412|NCT01619865|616265770|FG000|Overall Study|Adverse Event|1|||
170524413|NCT01619865|616265770|FG000|Overall Study|Death|2|||
170524414|NCT01619865|616265770|FG000|Overall Study|subject not able to comply|1|||
170524415|NCT03586050|616265771|FG000|Overall Study|Death|3|||
170524416|NCT03586050|616265771|FG000|Overall Study|Withdrawal by Subject|2|||
170524417|NCT04202497|616265772|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
170524418|NCT04202497|616265773|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
170524419|NCT04202497|616265774|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
170524420|NCT04202497|616265775|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
170524421|NCT04344301|616265776|FG000|Overall Study|Withdrawal by Subject|1|||
170524422|NCT04344301|616265777|FG001|Overall Study|Withdrawal by Subject|0|||
170524423|NCT04344301|616265776|FG000|Overall Study|Death|0|||
170524424|NCT04344301|616265777|FG001|Overall Study|Death|1|||
170524425|NCT00072410|616265778|FG000|Overall Study|Progressive disease|0|||
170524426|NCT00072410|616265779|FG001|Overall Study|Progressive disease|3|||
170524427|NCT00846586|616265782|FG000|Overall Study|Adverse Event|20|||
170524428|NCT00846586|616265783|FG001|Overall Study|Adverse Event|10|||
170524429|NCT00846586|616265782|FG000|Overall Study|Subject withdrew consent|8|||
170524430|NCT00846586|616265783|FG001|Overall Study|Subject withdrew consent|10|||
170524431|NCT00846586|616265782|FG000|Overall Study|Administrative problems|5|||
170872342|NCT01838616|617544771|FG001|Pick-up Arm|Adverse Event|0|||
170872343|NCT01838616|617544770|FG000|Pick-up Arm|Withdrawal by Subject|1|||
170524432|NCT00846586|616265783|FG001|Overall Study|Administrative problems|4|||
170872344|NCT01838616|617544771|FG001|Pick-up Arm|Withdrawal by Subject|0|||
170872345|NCT01838616|617544770|FG000|Pick-up Arm|Technical problems|1|||
170872346|NCT01838616|617544771|FG001|Pick-up Arm|Technical problems|0|||
170524433|NCT00846586|616265782|FG000|Overall Study|Death|2|||
170524434|NCT00846586|616265783|FG001|Overall Study|Death|0|||
170524435|NCT00846586|616265782|FG000|Overall Study|Protocol deviation|2|||
170524436|NCT00846586|616265783|FG001|Overall Study|Protocol deviation|6|||
170872347|NCT01858532|617544772|FG000|Overall Study|Adverse Event|58|||
170872348|NCT01858532|617544773|FG001|Overall Study|Adverse Event|50|||
170872349|NCT01858532|617544774|FG002|Overall Study|Adverse Event|23|||
170413165|NCT02761980|615853331|FG001|Overall Study|Withdrawal by Subject|1|||
170413166|NCT02761980|615853332|FG002|Overall Study|Withdrawal by Subject|0|||
170413167|NCT02761980|615853333|FG003|Overall Study|Withdrawal by Subject|0|||
170413168|NCT02761980|615853330|FG000|Overall Study|Other|0|||
170413169|NCT02761980|615853331|FG001|Overall Study|Other|0|||
170413170|NCT02761980|615853332|FG002|Overall Study|Other|1|||
170413171|NCT02761980|615853333|FG003|Overall Study|Other|0|||
170413172|NCT00101582|615853336|FG000|Overall Study|Ineligibility determined|0|||
170413173|NCT00101582|615853337|FG001|Overall Study|Ineligibility determined|1|||
170770757|NCT01350804|617165813|FG001|Core Study|Physician Decision|0|||
170770758|NCT01350804|617165814|FG002|Core Study|Physician Decision|1|||
170770759|NCT01350804|617165815|FG003|Core Study|Physician Decision|3|||
170770760|NCT01350804|617165812|FG000|Core Study|Lost to Follow-up|3|||
170413174|NCT00101582|615853336|FG000|Overall Study|Adverse Event|1|||
170413175|NCT00101582|615853337|FG001|Overall Study|Adverse Event|4|||
170413176|NCT00101582|615853336|FG000|Overall Study|Withdrawal by Subject|6|||
170413177|NCT00101582|615853337|FG001|Overall Study|Withdrawal by Subject|4|||
170413178|NCT00101582|615853336|FG000|Overall Study|Physician Decision|1|||
170413179|NCT00101582|615853337|FG001|Overall Study|Physician Decision|0|||
170413180|NCT00101582|615853336|FG000|Overall Study|Death|3|||
170413181|NCT00101582|615853337|FG001|Overall Study|Death|5|||
170770761|NCT01350804|617165813|FG001|Core Study|Lost to Follow-up|0|||
170770762|NCT01350804|617165814|FG002|Core Study|Lost to Follow-up|2|||
170770763|NCT01350804|617165815|FG003|Core Study|Lost to Follow-up|1|||
170770764|NCT01350804|617165812|FG000|Core Study|Lack of Efficacy|16|||
170770765|NCT01350804|617165813|FG001|Core Study|Lack of Efficacy|19|||
170770766|NCT01350804|617165814|FG002|Core Study|Lack of Efficacy|18|||
170770767|NCT01350804|617165815|FG003|Core Study|Lack of Efficacy|5|||
170770768|NCT01350804|617165812|FG000|Core Study|Death|1|||
170770769|NCT01350804|617165813|FG001|Core Study|Death|1|||
170413182|NCT00101582|615853336|FG000|Overall Study|Other|0|||
170413183|NCT00101582|615853337|FG001|Overall Study|Other|1|||
170413184|NCT01907087|615853338|FG000|Overall Study|Withdrawal by Subject|1|||
170413185|NCT01919190|615853340|FG000|Overall Study|Intra-op findings, etc.|3|||
170524437|NCT00846586|616265782|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170524438|NCT00846586|616265783|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170524439|NCT00846586|616265782|FG000|Overall Study|Lost to Follow-up|1|||
170524440|NCT00846586|616265783|FG001|Overall Study|Lost to Follow-up|4|||
170524441|NCT00846586|616265782|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170524442|NCT00846586|616265783|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170524443|NCT01939314|616265784|FG000|Overall Study|Withdrawal by Subject|3|||
170524444|NCT01939314|616265785|FG001|Overall Study|Withdrawal by Subject|1|||
170524445|NCT01939314|616265784|FG000|Overall Study|Protocol Violation|1|||
170524446|NCT01939314|616265785|FG001|Overall Study|Protocol Violation|0|||
170524447|NCT01939314|616265784|FG000|Overall Study|Pregnancy|0|||
170524448|NCT01939314|616265785|FG001|Overall Study|Pregnancy|1|||
170524449|NCT01939314|616265784|FG000|Overall Study|Lost to Follow-up|5|||
170524450|NCT01939314|616265785|FG001|Overall Study|Lost to Follow-up|6|||
170770770|NCT01350804|617165814|FG002|Core Study|Death|1|||
170770771|NCT01350804|617165815|FG003|Core Study|Death|0|||
170770772|NCT01350804|617165812|FG000|Core Study|Adverse Event|8|||
170770773|NCT01350804|617165813|FG001|Core Study|Adverse Event|10|||
170770774|NCT01350804|617165814|FG002|Core Study|Adverse Event|8|||
170770775|NCT01350804|617165815|FG003|Core Study|Adverse Event|8|||
170770776|NCT01350804|617165812|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
170770777|NCT01350804|617165813|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
170770778|NCT01350804|617165814|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
170770779|NCT01350804|617165815|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
170770780|NCT01350804|617165812|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
170770781|NCT01350804|617165813|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
170770782|NCT01350804|617165814|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
170770783|NCT01350804|617165815|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
170524451|NCT00735007|616265786|FG000|Overall Study|Adverse Event|4|||
170524452|NCT00735007|616265786|FG000|Overall Study|Protocol Violation|1|||
170524453|NCT01883895|616265790|FG000|Overall Study|Lost to Follow-up|2|||
170524454|NCT01395810|616265794|FG000|Overall Study|Adverse Event|0|||
170770784|NCT01350804|617165812|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
170770785|NCT01350804|617165813|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
170770786|NCT01350804|617165814|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
170770787|NCT01350804|617165815|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
170413186|NCT01919190|615853341|FG001|Overall Study|Intra-op findings, etc.|0|||
170413187|NCT01767597|615853342|FG000|Overall Study|Incomplete intervention|3|||
170413188|NCT01767597|615853343|FG001|Overall Study|Incomplete intervention|1|||
170524455|NCT01395810|616265795|FG001|Overall Study|Adverse Event|1|||
170524456|NCT01395810|616265796|FG002|Overall Study|Adverse Event|0|||
170770788|NCT01350804|617165812|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
170770789|NCT01350804|617165813|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
170770790|NCT01350804|617165814|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
170524457|NCT01395810|616265797|FG003|Overall Study|Adverse Event|0|||
170524458|NCT01395810|616265794|FG000|Overall Study|Lack of Efficacy|0|||
170524459|NCT01395810|616265795|FG001|Overall Study|Lack of Efficacy|1|||
170524460|NCT01395810|616265796|FG002|Overall Study|Lack of Efficacy|0|||
170524461|NCT01395810|616265797|FG003|Overall Study|Lack of Efficacy|0|||
170524462|NCT01395810|616265794|FG000|Overall Study|Withdrawal criteria|0|||
170524463|NCT01395810|616265795|FG001|Overall Study|Withdrawal criteria|2|||
170524464|NCT01395810|616265796|FG002|Overall Study|Withdrawal criteria|0|||
170524465|NCT01395810|616265797|FG003|Overall Study|Withdrawal criteria|0|||
170524466|NCT01395810|616265794|FG000|Overall Study|Unclassified|2|||
170524467|NCT01395810|616265795|FG001|Overall Study|Unclassified|0|||
170524468|NCT01395810|616265796|FG002|Overall Study|Unclassified|0|||
170524469|NCT01395810|616265797|FG003|Overall Study|Unclassified|0|||
170524470|NCT00434252|616267892|FG000|Overall Study|Lack of Efficacy|50|||
170524471|NCT00434252|616267893|FG001|Overall Study|Lack of Efficacy|100|||
170524472|NCT00434252|616267892|FG000|Overall Study|Adverse Event|6|||
170524473|NCT00434252|616267893|FG001|Overall Study|Adverse Event|13|||
170524474|NCT00434252|616267892|FG000|Overall Study|Death|1|||
170524475|NCT00434252|616267893|FG001|Overall Study|Death|2|||
170524476|NCT00434252|616267892|FG000|Overall Study|Lost to Follow-up|0|||
170524477|NCT00434252|616267893|FG001|Overall Study|Lost to Follow-up|1|||
170524478|NCT00434252|616267892|FG000|Overall Study|Physician Decision|4|||
170524479|NCT00434252|616267893|FG001|Overall Study|Physician Decision|8|||
170524480|NCT00434252|616267892|FG000|Overall Study|Withdrawal by Subject|3|||
170524481|NCT00434252|616267893|FG001|Overall Study|Withdrawal by Subject|7|||
170524482|NCT01655901|616267896|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
170524483|NCT01655901|616267897|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
170524484|NCT01655901|616267898|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
170524485|NCT01655901|616267899|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
170524486|NCT01655901|616267900|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
170524487|NCT01655901|616267901|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
170524488|NCT00870727|616267902|FG000|Overall Study|Lost to Follow-up|0|||
170524489|NCT00870727|616267903|FG001|Overall Study|Lost to Follow-up|1|||
170524490|NCT00870727|616267902|FG000|Overall Study|Lack of Efficacy|1|||
170524491|NCT00870727|616267903|FG001|Overall Study|Lack of Efficacy|3|||
170524492|NCT00870727|616267902|FG000|Overall Study|Adverse Event|0|||
170524493|NCT00870727|616267903|FG001|Overall Study|Adverse Event|1|||
170524494|NCT00557466|616267904|FG000|Overall Study|Adverse Event|3|||
170524495|NCT00557466|616267905|FG001|Overall Study|Adverse Event|1|||
170524496|NCT00557466|616267906|FG002|Overall Study|Adverse Event|4|||
170524497|NCT00557466|616267907|FG003|Overall Study|Adverse Event|1|||
170524498|NCT00557466|616267908|FG004|Overall Study|Adverse Event|2|||
170524499|NCT00557466|616267909|FG005|Overall Study|Adverse Event|4|||
170524500|NCT00557466|616267904|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170524501|NCT00557466|616267905|FG001|Overall Study|Abnormal laboratory value(s)|2|||
170524502|NCT00557466|616267906|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170524503|NCT00557466|616267907|FG003|Overall Study|Abnormal laboratory value(s)|0|||
170524504|NCT00557466|616267908|FG004|Overall Study|Abnormal laboratory value(s)|0|||
170524505|NCT00557466|616267909|FG005|Overall Study|Abnormal laboratory value(s)|0|||
170524506|NCT00557466|616267904|FG000|Overall Study|Protocol deviation|0|||
170524507|NCT00557466|616267905|FG001|Overall Study|Protocol deviation|1|||
170524508|NCT00557466|616267906|FG002|Overall Study|Protocol deviation|0|||
170524509|NCT00557466|616267907|FG003|Overall Study|Protocol deviation|2|||
170524510|NCT00557466|616267908|FG004|Overall Study|Protocol deviation|0|||
170524511|NCT00557466|616267909|FG005|Overall Study|Protocol deviation|0|||
170524512|NCT00557466|616267904|FG000|Overall Study|Subject withdrew consent|0|||
170524513|NCT00557466|616267905|FG001|Overall Study|Subject withdrew consent|0|||
170524514|NCT00557466|616267906|FG002|Overall Study|Subject withdrew consent|0|||
170524515|NCT00557466|616267907|FG003|Overall Study|Subject withdrew consent|0|||
170524516|NCT00557466|616267908|FG004|Overall Study|Subject withdrew consent|1|||
170524517|NCT00557466|616267909|FG005|Overall Study|Subject withdrew consent|2|||
170524518|NCT00557466|616267904|FG000|Overall Study|Administrative problems|0|||
170524519|NCT00557466|616267905|FG001|Overall Study|Administrative problems|1|||
170872350|NCT01858532|617544775|FG003|Overall Study|Adverse Event|28|||
170872351|NCT01858532|617544772|FG000|Overall Study|Withdrew consent|71|||
170524520|NCT00557466|616267906|FG002|Overall Study|Administrative problems|1|||
170872352|NCT01858532|617544773|FG001|Overall Study|Withdrew consent|93|||
170872353|NCT01858532|617544774|FG002|Overall Study|Withdrew consent|46|||
170524521|NCT00557466|616267907|FG003|Overall Study|Administrative problems|0|||
170524522|NCT00557466|616267908|FG004|Overall Study|Administrative problems|0|||
170524523|NCT00557466|616267909|FG005|Overall Study|Administrative problems|0|||
170524524|NCT00557466|616267904|FG000|Overall Study|Abnormal test procedure results|0|||
170524525|NCT00557466|616267905|FG001|Overall Study|Abnormal test procedure results|0|||
170524526|NCT00557466|616267906|FG002|Overall Study|Abnormal test procedure results|1|||
170524527|NCT00557466|616267907|FG003|Overall Study|Abnormal test procedure results|0|||
170524528|NCT00557466|616267908|FG004|Overall Study|Abnormal test procedure results|0|||
170524529|NCT00557466|616267909|FG005|Overall Study|Abnormal test procedure results|0|||
170524530|NCT00557466|616267904|FG000|Overall Study|Lost to Follow-up|0|||
170524531|NCT00557466|616267905|FG001|Overall Study|Lost to Follow-up|0|||
170524532|NCT00557466|616267906|FG002|Overall Study|Lost to Follow-up|0|||
170524533|NCT00557466|616267907|FG003|Overall Study|Lost to Follow-up|1|||
170524534|NCT00557466|616267908|FG004|Overall Study|Lost to Follow-up|0|||
170524535|NCT00557466|616267909|FG005|Overall Study|Lost to Follow-up|0|||
170524536|NCT01712516|616267910|FG000|Overall Study|Technical problems|0|||
170524537|NCT01712516|616267911|FG001|Overall Study|Technical problems|0|||
170524538|NCT01712516|616267912|FG002|Overall Study|Technical problems|0|||
170524539|NCT01712516|616267913|FG003|Overall Study|Technical problems|2|||
170524540|NCT01712516|616267910|FG000|Overall Study|Lost to Follow-up|0|||
170524541|NCT01712516|616267911|FG001|Overall Study|Lost to Follow-up|0|||
170524542|NCT01712516|616267912|FG002|Overall Study|Lost to Follow-up|2|||
170524543|NCT01712516|616267913|FG003|Overall Study|Lost to Follow-up|1|||
170524544|NCT01712516|616267910|FG000|Overall Study|Death|0|||
170524545|NCT01712516|616267911|FG001|Overall Study|Death|1|||
170524546|NCT01712516|616267912|FG002|Overall Study|Death|0|||
170524547|NCT01712516|616267913|FG003|Overall Study|Death|0|||
170524548|NCT01712516|616267910|FG000|Overall Study|Protocol deviation|1|||
170524549|NCT01712516|616267911|FG001|Overall Study|Protocol deviation|0|||
170524550|NCT01712516|616267912|FG002|Overall Study|Protocol deviation|1|||
170524551|NCT01712516|616267913|FG003|Overall Study|Protocol deviation|0|||
170524552|NCT01712516|616267910|FG000|Overall Study|Physician Decision|2|||
170524553|NCT01712516|616267911|FG001|Overall Study|Physician Decision|0|||
170524554|NCT01712516|616267912|FG002|Overall Study|Physician Decision|0|||
170524555|NCT01712516|616267913|FG003|Overall Study|Physician Decision|1|||
170524556|NCT01712516|616267910|FG000|Overall Study|Withdrawal by Subject|3|||
170524557|NCT01712516|616267911|FG001|Overall Study|Withdrawal by Subject|9|||
170524558|NCT01712516|616267912|FG002|Overall Study|Withdrawal by Subject|3|||
170524559|NCT01712516|616267913|FG003|Overall Study|Withdrawal by Subject|9|||
170524560|NCT05428436|616267914|FG000|Period 1 - 2 washout|Adverse Event|1|||
170524561|NCT05428436|616267915|FG001|Period 1 - 2 washout|Adverse Event|0|||
170524562|NCT05428436|616267916|FG002|Period 1 - 2 washout|Adverse Event|0|||
170524563|NCT01251952|616267921|FG000|Overall Study|Adverse Event|1|||
170524564|NCT00496769|616267922|FG000|Double Blind|>=1 reason assigned per patient|558|||
170524565|NCT00496769|616267923|FG001|Double Blind|>=1 reason assigned per patient|649|||
170524566|NCT00496769|616267924|FG002|Double Blind|>=1 reason assigned per patient|0|||
170524567|NCT00496769|616267922|FG000|Open Label|>=1 reason assigned per patient|0|||
170524568|NCT00496769|616267923|FG001|Open Label|>=1 reason assigned per patient|0|||
170524569|NCT00496769|616267924|FG002|Open Label|>=1 reason assigned per patient|1011|||
170524570|NCT02810418|616267925|FG000|Arm A Dose Escalation|Adverse Event|2|||
170524571|NCT02810418|616267926|FG001|Arm A Dose Escalation|Adverse Event|1|||
170413189|NCT01767597|615853342|FG000|Overall Study|Withdrawal by Subject|1|||
170413190|NCT01767597|615853343|FG001|Overall Study|Withdrawal by Subject|0|||
170413191|NCT05342753|615853344|FG000|Overall Study|Withdrawal by Subject|6|||
170413192|NCT05342753|615853344|FG000|Overall Study|Lost to Follow-up|1|||
170413193|NCT00614055|615853346|FG000|Overall Study|Adverse Event|1|||
170413194|NCT00614055|615853347|FG001|Overall Study|Adverse Event|0|||
170413195|NCT00614055|615853348|FG002|Overall Study|Adverse Event|0|||
170413196|NCT00614055|615853346|FG000|Overall Study|Protocol Violation|2|||
170413197|NCT00614055|615853347|FG001|Overall Study|Protocol Violation|2|||
170413198|NCT00614055|615853348|FG002|Overall Study|Protocol Violation|1|||
170413199|NCT00614055|615853346|FG000|Overall Study|Lack of Efficacy|0|||
170413200|NCT00614055|615853347|FG001|Overall Study|Lack of Efficacy|0|||
170413201|NCT00614055|615853348|FG002|Overall Study|Lack of Efficacy|2|||
170413202|NCT00614055|615853346|FG000|Overall Study|Unclassified|1|||
170413203|NCT00614055|615853347|FG001|Overall Study|Unclassified|4|||
170413204|NCT00614055|615853348|FG002|Overall Study|Unclassified|2|||
170413205|NCT04583579|615853349|FG000|Overall Study|Lost to Follow-up|4|||
170413206|NCT05590585|615853352|FG000|Overall Study|Lost to Follow-up|3|||
170413207|NCT05590585|615853352|FG000|Overall Study|Withdrawal by Subject|1|||
170413208|NCT02623959|615853353|FG000|Overall Study|Progression|0|||
170413209|NCT02623959|615853354|FG001|Overall Study|Progression|1|||
170413210|NCT03093454|615853359|FG000|Overall Study|Withdrawal by Subject|1|||
170413211|NCT03093454|615853360|FG001|Overall Study|Withdrawal by Subject|1|||
170413212|NCT03093454|615853359|FG000|Overall Study|Scheduling conflict|3|||
170413213|NCT03093454|615853360|FG001|Overall Study|Scheduling conflict|1|||
170413214|NCT03093454|615853359|FG000|Overall Study|Physician Decision|2|||
170413215|NCT03093454|615853360|FG001|Overall Study|Physician Decision|1|||
170524572|NCT02810418|616267927|FG002|Arm A Dose Escalation|Adverse Event|0|||
170524573|NCT02810418|616267928|FG003|Arm A Dose Escalation|Adverse Event|0|||
170524574|NCT02810418|616267929|FG004|Arm A Dose Escalation|Adverse Event|0|||
170524575|NCT02810418|616267930|FG005|Arm A Dose Escalation|Adverse Event|0|||
170524576|NCT02810418|616267931|FG006|Arm A Dose Escalation|Adverse Event|0|||
170524577|NCT02810418|616267925|FG000|Dose Expansion|Adverse Event|0|||
170524578|NCT02810418|616267926|FG001|Dose Expansion|Adverse Event|1|||
170524579|NCT02810418|616267927|FG002|Dose Expansion|Adverse Event|1|||
170524580|NCT02810418|616267928|FG003|Dose Expansion|Adverse Event|0|||
170413216|NCT02524379|615853365|FG000|Overall Study|Death|1|||
170524581|NCT02810418|616267929|FG004|Dose Expansion|Adverse Event|0|||
170524582|NCT02810418|616267930|FG005|Dose Expansion|Adverse Event|0|||
170524583|NCT02810418|616267931|FG006|Dose Expansion|Adverse Event|0|||
170524584|NCT02810418|616267925|FG000|Dose Expansion|Physician Decision|0|||
170524585|NCT02810418|616267926|FG001|Dose Expansion|Physician Decision|0|||
170524586|NCT02810418|616267927|FG002|Dose Expansion|Physician Decision|2|||
170524587|NCT02810418|616267928|FG003|Dose Expansion|Physician Decision|0|||
170524588|NCT02810418|616267929|FG004|Dose Expansion|Physician Decision|0|||
170524589|NCT02810418|616267930|FG005|Dose Expansion|Physician Decision|0|||
170524590|NCT02810418|616267931|FG006|Dose Expansion|Physician Decision|0|||
170524591|NCT02810418|616267925|FG000|Arm B Dose Escalation|Adverse Event|0|||
170524592|NCT02810418|616267926|FG001|Arm B Dose Escalation|Adverse Event|0|||
170524593|NCT02810418|616267927|FG002|Arm B Dose Escalation|Adverse Event|0|||
170524594|NCT02810418|616267928|FG003|Arm B Dose Escalation|Adverse Event|0|||
170524595|NCT02810418|616267929|FG004|Arm B Dose Escalation|Adverse Event|1|||
170524596|NCT02810418|616267930|FG005|Arm B Dose Escalation|Adverse Event|2|||
170524597|NCT02810418|616267931|FG006|Arm B Dose Escalation|Adverse Event|0|||
170524598|NCT01181167|616267932|FG000|Overall Study|Adverse Event|11|||
170524599|NCT01181167|616267933|FG001|Overall Study|Adverse Event|21|||
170524600|NCT01181167|616267932|FG000|Overall Study|Lost to Follow-up|1|||
170524601|NCT01181167|616267933|FG001|Overall Study|Lost to Follow-up|0|||
170524602|NCT01181167|616267932|FG000|Overall Study|Physician Decision|2|||
170524603|NCT01181167|616267933|FG001|Overall Study|Physician Decision|3|||
170524604|NCT01181167|616267932|FG000|Overall Study|Protocol Violation|3|||
170524605|NCT01181167|616267933|FG001|Overall Study|Protocol Violation|0|||
170524606|NCT01181167|616267932|FG000|Overall Study|Withdrawal by Subject|6|||
170524607|NCT01181167|616267933|FG001|Overall Study|Withdrawal by Subject|8|||
170524608|NCT00473083|616267936|FG000|Overall Study|Adverse Event|1|||
170524609|NCT00473083|616267937|FG001|Overall Study|Adverse Event|0|||
170524610|NCT00473083|616267938|FG002|Overall Study|Adverse Event|0|||
170524611|NCT02915835|616267939|FG000|Overall Study|Physician Decision|1|||
170524612|NCT02915835|616267940|FG001|Overall Study|Physician Decision|0|||
170524613|NCT02915835|616267939|FG000|Overall Study|Withdrawal by Subject|0|||
170524614|NCT02915835|616267940|FG001|Overall Study|Withdrawal by Subject|1|||
170524615|NCT03426345|616267941|FG000|Overall Study|Adverse Event|4|||
170524616|NCT03426345|616267942|FG001|Overall Study|Adverse Event|4|||
170524617|NCT03426345|616267941|FG000|Overall Study|Lack of Efficacy|1|||
170524618|NCT03426345|616267942|FG001|Overall Study|Lack of Efficacy|0|||
170524619|NCT03426345|616267941|FG000|Overall Study|Withdrawal by Subject|5|||
170524620|NCT03426345|616267942|FG001|Overall Study|Withdrawal by Subject|6|||
170524621|NCT03426345|616267941|FG000|Overall Study|Lost to Follow-up|3|||
170524622|NCT03426345|616267942|FG001|Overall Study|Lost to Follow-up|1|||
170524623|NCT03426345|616267941|FG000|Overall Study|Protocol Deviation|3|||
170524624|NCT03426345|616267942|FG001|Overall Study|Protocol Deviation|4|||
170524625|NCT03426345|616267941|FG000|Overall Study|Reason Not Specified|1|||
170524626|NCT03426345|616267942|FG001|Overall Study|Reason Not Specified|2|||
170524627|NCT03426345|616267941|FG000|Overall Study|Missing Completion Status|1|||
170524628|NCT03426345|616267942|FG001|Overall Study|Missing Completion Status|0|||
170524629|NCT00433836|616267943|FG000|Overall Study|Adverse Event|7|||
170524630|NCT00433836|616267944|FG001|Overall Study|Adverse Event|0|||
170524631|NCT00433836|616267943|FG000|Overall Study|Lost to Follow-up|3|||
170524632|NCT00433836|616267944|FG001|Overall Study|Lost to Follow-up|0|||
170770791|NCT01350804|617165815|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
170770792|NCT01350804|617165812|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
170770793|NCT01350804|617165813|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
170770794|NCT01350804|617165814|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
170770795|NCT01350804|617165815|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
170770796|NCT01350804|617165812|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
170770797|NCT01350804|617165813|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
170770798|NCT01350804|617165814|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
170524633|NCT00433836|616267943|FG000|Overall Study|Withdrawal by Subject|2|||
170524634|NCT00433836|616267944|FG001|Overall Study|Withdrawal by Subject|1|||
170524635|NCT00433836|616267943|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170524636|NCT00433836|616267944|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170524637|NCT00433836|616267943|FG000|Overall Study|Protocol Violation|0|||
170524638|NCT00433836|616267944|FG001|Overall Study|Protocol Violation|2|||
170524639|NCT00433836|616267943|FG000|Overall Study|Condition no longer requires study drug|0|||
170770799|NCT01350804|617165815|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
170770800|NCT02611037|617165816|FG000|Overall Study|Withdrawal prior to treatment|2|||
170770801|NCT02611037|617165817|FG001|Overall Study|Withdrawal prior to treatment|0|||
170770802|NCT04411056|617167201|FG000|Overall Study|surgery cancelled|1|||
170524640|NCT00433836|616267944|FG001|Overall Study|Condition no longer requires study drug|1|||
170770803|NCT04411056|617167202|FG001|Overall Study|surgery cancelled|0|||
170524641|NCT00433836|616267943|FG000|Overall Study|Abnormal laboratory values|0|||
170524642|NCT00433836|616267944|FG001|Overall Study|Abnormal laboratory values|1|||
170524643|NCT00748241|616267945|FG000|Overall Study|Implant failure|1|||
170524644|NCT00748241|616267945|FG000|Overall Study|Lost to Follow-up|5|||
170770804|NCT04411056|617167201|FG000|Overall Study|Equipment problem during intubation|0|||
170770805|NCT04411056|617167202|FG001|Overall Study|Equipment problem during intubation|1|||
170770806|NCT00304031|617167207|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
170770807|NCT00304031|617167208|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
170770808|NCT00304031|617167209|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
170770809|NCT00304031|617167207|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
170770810|NCT00304031|617167208|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
170770811|NCT00304031|617167209|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
170770812|NCT00304031|617167207|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
170770813|NCT00304031|617167208|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
170770814|NCT00304031|617167209|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
170770815|NCT00304031|617167207|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
170770816|NCT00304031|617167208|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
170770817|NCT00304031|617167209|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
170770818|NCT00304031|617167207|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
170770819|NCT00304031|617167208|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
170770820|NCT00304031|617167209|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
170770821|NCT00304031|617167207|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
170770822|NCT00304031|617167208|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
170770823|NCT00304031|617167209|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
170770824|NCT00304031|617167207|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
170770825|NCT00304031|617167208|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
170770826|NCT00304031|617167209|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
170770827|NCT00304031|617167207|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
170770828|NCT00304031|617167208|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
170872354|NCT01858532|617544775|FG003|Overall Study|Withdrew consent|27|||
170413217|NCT01829464|615853366|FG000|Overall Study|Adverse Event|1|||
170413218|NCT01829464|615853367|FG001|Overall Study|Adverse Event|0|||
170413219|NCT01829464|615853368|FG002|Overall Study|Adverse Event|0|||
170413220|NCT01829464|615853366|FG000|Overall Study|Lost to Follow-up|0|||
170413221|NCT01829464|615853367|FG001|Overall Study|Lost to Follow-up|0|||
170413222|NCT01829464|615853368|FG002|Overall Study|Lost to Follow-up|1|||
170413223|NCT01829464|615853366|FG000|Overall Study|Withdrawal by Subject|2|||
170413224|NCT01829464|615853367|FG001|Overall Study|Withdrawal by Subject|0|||
170413225|NCT01829464|615853368|FG002|Overall Study|Withdrawal by Subject|0|||
170413226|NCT01829464|615853366|FG000|Overall Study|Study terminated by sponsor|25|||
170413227|NCT01829464|615853367|FG001|Overall Study|Study terminated by sponsor|28|||
170413228|NCT01829464|615853368|FG002|Overall Study|Study terminated by sponsor|25|||
170413229|NCT01829464|615853366|FG000|Overall Study|Lack of Efficacy|0|||
170413230|NCT01829464|615853367|FG001|Overall Study|Lack of Efficacy|1|||
170413231|NCT01829464|615853368|FG002|Overall Study|Lack of Efficacy|0|||
170413232|NCT00635778|615853373|FG000|Overall Study|Adverse Event|1|||
170413233|NCT00635778|615853374|FG001|Overall Study|Adverse Event|0|||
170413234|NCT00635778|615853375|FG002|Overall Study|Adverse Event|0|||
170413235|NCT00635778|615853376|FG003|Overall Study|Adverse Event|3|||
170413236|NCT00635778|615853377|FG004|Overall Study|Adverse Event|3|||
170413237|NCT00635778|615853378|FG005|Overall Study|Adverse Event|6|||
170413238|NCT00635778|615853379|FG006|Overall Study|Adverse Event|1|||
170413239|NCT00635778|615853373|FG000|Overall Study|Withdrawal by Subject|0|||
170413240|NCT00635778|615853374|FG001|Overall Study|Withdrawal by Subject|0|||
170413241|NCT00635778|615853375|FG002|Overall Study|Withdrawal by Subject|0|||
170413242|NCT00635778|615853376|FG003|Overall Study|Withdrawal by Subject|1|||
170413243|NCT00635778|615853377|FG004|Overall Study|Withdrawal by Subject|0|||
170413244|NCT00635778|615853378|FG005|Overall Study|Withdrawal by Subject|1|||
170413245|NCT00635778|615853379|FG006|Overall Study|Withdrawal by Subject|1|||
170413246|NCT00635778|615853373|FG000|Overall Study|Progressive disease|0|||
170413247|NCT00635778|615853374|FG001|Overall Study|Progressive disease|3|||
170413248|NCT00635778|615853375|FG002|Overall Study|Progressive disease|3|||
170413249|NCT00635778|615853376|FG003|Overall Study|Progressive disease|4|||
170413250|NCT00635778|615853377|FG004|Overall Study|Progressive disease|5|||
170413251|NCT00635778|615853378|FG005|Overall Study|Progressive disease|14|||
170413252|NCT00635778|615853379|FG006|Overall Study|Progressive disease|4|||
170413253|NCT01884025|615853380|FG000|Overall Study|Lost to Follow-up|3|||
170413254|NCT01884025|615853381|FG001|Overall Study|Lost to Follow-up|4|||
170413255|NCT01338636|615853383|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
170413256|NCT02854436|615853384|FG000|Overall Study|Adverse Event|1|||
170413257|NCT02854436|615853384|FG000|Overall Study|Death|208|||
170413258|NCT02854436|615853384|FG000|Overall Study|Lost to Follow-up|5|||
170413259|NCT02854436|615853384|FG000|Overall Study|Withdrawal by Subject|24|||
170413260|NCT02854436|615853384|FG000|Overall Study|Other|45|||
170413261|NCT02854436|615853384|FG000|Overall Study|Physician Decision|6|||
170413262|NCT00662025|615853385|FG000|Overall Study|Objective progression or relapse|51|||
170413263|NCT00662025|615853385|FG000|Overall Study|Adverse Event|7|||
170524645|NCT00748241|616267945|FG000|Overall Study|Death|2|||
170524646|NCT01240382|616267946|FG000|Overall Study|Adverse Event|2|||
170524647|NCT01240382|616267947|FG001|Overall Study|Adverse Event|1|||
170524648|NCT01240382|616267946|FG000|Overall Study|Lack of Efficacy|0|||
170524649|NCT01240382|616267947|FG001|Overall Study|Lack of Efficacy|2|||
170524650|NCT01240382|616267946|FG000|Overall Study|Fear of adverse events|0|||
170524651|NCT01240382|616267947|FG001|Overall Study|Fear of adverse events|1|||
170524652|NCT02643693|616267948|FG000|Overall Study|Physician Decision|0|||
170524653|NCT02643693|616267949|FG001|Overall Study|Physician Decision|1|||
170524654|NCT02643693|616267950|FG002|Overall Study|Physician Decision|0|||
170524655|NCT02643693|616267951|FG003|Overall Study|Physician Decision|0|||
170524656|NCT02643693|616267952|FG004|Overall Study|Physician Decision|0|||
170524657|NCT02643693|616267953|FG005|Overall Study|Physician Decision|0|||
170524658|NCT02643693|616267948|FG000|Overall Study|Withdrawal by Subject|0|||
170524659|NCT02643693|616267949|FG001|Overall Study|Withdrawal by Subject|1|||
170524660|NCT02643693|616267950|FG002|Overall Study|Withdrawal by Subject|0|||
170524661|NCT02643693|616267951|FG003|Overall Study|Withdrawal by Subject|0|||
170524662|NCT02643693|616267952|FG004|Overall Study|Withdrawal by Subject|0|||
170524663|NCT02643693|616267953|FG005|Overall Study|Withdrawal by Subject|0|||
170524664|NCT02643693|616267948|FG000|Overall Study|Protocol Adherence Issues|2|||
170524665|NCT02643693|616267949|FG001|Overall Study|Protocol Adherence Issues|0|||
170524666|NCT02643693|616267950|FG002|Overall Study|Protocol Adherence Issues|1|||
170524667|NCT02643693|616267951|FG003|Overall Study|Protocol Adherence Issues|0|||
170524668|NCT02643693|616267952|FG004|Overall Study|Protocol Adherence Issues|0|||
170524669|NCT02643693|616267953|FG005|Overall Study|Protocol Adherence Issues|1|||
170770829|NCT00304031|617167209|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
170770830|NCT00304031|617167207|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
170770831|NCT00304031|617167208|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
170770832|NCT00304031|617167209|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
170770833|NCT02396316|617167213|FG000|Overall Study|Physician Decision|1|||
170770834|NCT02396316|617167214|FG001|Overall Study|Physician Decision|0|||
170770835|NCT02396316|617167213|FG000|Overall Study|Progressive disease|6|||
170770836|NCT02396316|617167214|FG001|Overall Study|Progressive disease|3|||
170770837|NCT02396316|617167213|FG000|Overall Study|Protocol Violation|0|||
170770838|NCT02396316|617167214|FG001|Overall Study|Protocol Violation|1|||
170770839|NCT02396316|617167213|FG000|Overall Study|Treatment unblinded|0|||
170770840|NCT02396316|617167214|FG001|Overall Study|Treatment unblinded|1|||
170770841|NCT01823536|617167215|FG000|Overall Study|Lost to Follow-up|1|||
170770842|NCT01823536|617167216|FG001|Overall Study|Lost to Follow-up|0|||
170770843|NCT01823536|617167217|FG002|Overall Study|Lost to Follow-up|0|||
170770844|NCT01823536|617167218|FG003|Overall Study|Lost to Follow-up|1|||
170770845|NCT01823536|617167219|FG004|Overall Study|Lost to Follow-up|1|||
170770846|NCT01823536|617167220|FG005|Overall Study|Lost to Follow-up|0|||
170770847|NCT01823536|617167215|FG000|Overall Study|Protocol Violation|0|||
170413264|NCT00662025|615853385|FG000|Overall Study|Withdrawal by Subject|1|||
170413265|NCT00662025|615853385|FG000|Overall Study|Results of other clinical study|2|||
170770848|NCT01823536|617167216|FG001|Overall Study|Protocol Violation|1|||
170770849|NCT01823536|617167217|FG002|Overall Study|Protocol Violation|0|||
170413266|NCT00662025|615853385|FG000|Overall Study|Target lesion cannot be evaluated|1|||
170413267|NCT00662025|615853385|FG000|Overall Study|Domestic circumstances|1|||
170413268|NCT02035137|615853386|FG000|Overall Study|Physician Decision|0|||
170413269|NCT02035137|615853387|FG001|Overall Study|Physician Decision|0|||
170413270|NCT02035137|615853388|FG002|Overall Study|Physician Decision|1|||
170413271|NCT02035137|615853386|FG000|Overall Study|Withdrawal by Subject|0|||
170413272|NCT02035137|615853387|FG001|Overall Study|Withdrawal by Subject|1|||
170413273|NCT02035137|615853388|FG002|Overall Study|Withdrawal by Subject|2|||
170413274|NCT02035137|615853386|FG000|Overall Study|Ineligible|0|||
170413275|NCT02035137|615853387|FG001|Overall Study|Ineligible|1|||
170413276|NCT02035137|615853388|FG002|Overall Study|Ineligible|2|||
170413277|NCT02035137|615853386|FG000|Overall Study|Disease progression prior to treatment start|2|||
170413278|NCT02035137|615853387|FG001|Overall Study|Disease progression prior to treatment start|0|||
170413279|NCT02035137|615853388|FG002|Overall Study|Disease progression prior to treatment start|0|||
170413280|NCT02843074|615853403|FG000|Overall Study|Withdrawal by Subject|5|||
170413281|NCT02843074|615853403|FG000|Overall Study|Progressive disease|1|||
170413282|NCT02843074|615853403|FG000|Overall Study|Physician Decision|1|||
170413283|NCT02843074|615853403|FG000|Overall Study|Lost to Follow-up|1|||
170413284|NCT02843074|615853403|FG000|Overall Study|Death|9|||
170413285|NCT03521999|615853404|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
170413286|NCT03521999|615853405|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
170413287|NCT03521999|615853404|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
170524670|NCT00909844|616267954|FG000|Overall Study|Adverse Event|1|||
170524671|NCT00909844|616267954|FG000|Overall Study|Withdrawal by Subject|1|||
170524672|NCT00909844|616267954|FG000|Overall Study|Lost to Follow-up|2|||
170524673|NCT00698815|616267955|FG000|Overall Study|Death|1|||
170524674|NCT00698815|616267956|FG001|Overall Study|Death|2|||
170770850|NCT01823536|617167218|FG003|Overall Study|Protocol Violation|0|||
170770851|NCT01823536|617167219|FG004|Overall Study|Protocol Violation|0|||
170770852|NCT01823536|617167220|FG005|Overall Study|Protocol Violation|0|||
170770853|NCT01823536|617167215|FG000|Overall Study|Withdrawal by Subject|1|||
170413288|NCT03521999|615853405|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
170413289|NCT03521999|615853404|FG000|Completed 3 Month Follow up|Death|0|||
170413290|NCT03521999|615853405|FG001|Completed 3 Month Follow up|Death|1|||
170413291|NCT03521999|615853404|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
170413292|NCT03521999|615853405|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
170413293|NCT00543439|615853411|FG000|Period 1|Adverse Event|0|||
170413294|NCT00543439|615853412|FG001|Period 1|Adverse Event|2|||
170413295|NCT00543439|615853413|FG002|Period 1|Adverse Event|1|||
170413296|NCT00543439|615853411|FG000|Period 1|Withdrawal by Subject|1|||
170413297|NCT00543439|615853412|FG001|Period 1|Withdrawal by Subject|1|||
170413298|NCT00543439|615853413|FG002|Period 1|Withdrawal by Subject|0|||
170413299|NCT00543439|615853411|FG000|Period 1|Physician Decision|0|||
170770854|NCT01823536|617167216|FG001|Overall Study|Withdrawal by Subject|1|||
170770855|NCT01823536|617167217|FG002|Overall Study|Withdrawal by Subject|0|||
170770856|NCT01823536|617167218|FG003|Overall Study|Withdrawal by Subject|0|||
170770857|NCT01823536|617167219|FG004|Overall Study|Withdrawal by Subject|0|||
170770858|NCT01823536|617167220|FG005|Overall Study|Withdrawal by Subject|0|||
170770859|NCT01823536|617167215|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
170770860|NCT01823536|617167216|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
170770861|NCT01823536|617167217|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
170770862|NCT01823536|617167218|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
170770863|NCT01823536|617167219|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
170770864|NCT01823536|617167220|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
170770865|NCT01823536|617167215|FG000|Overall Study|Met exclusion criterion No 6|0|||
170413300|NCT00543439|615853412|FG001|Period 1|Physician Decision|0|||
170413301|NCT00543439|615853413|FG002|Period 1|Physician Decision|1|||
170413302|NCT00543439|615853411|FG000|Period 2|Protocol Violation|1|||
170413303|NCT00543439|615853412|FG001|Period 2|Protocol Violation|0|||
170413304|NCT00543439|615853413|FG002|Period 2|Protocol Violation|1|||
170413305|NCT00543439|615853411|FG000|Period 2|Adverse Event|0|||
170413306|NCT00543439|615853412|FG001|Period 2|Adverse Event|1|||
170413307|NCT00543439|615853413|FG002|Period 2|Adverse Event|1|||
170413308|NCT01211769|615853414|FG000|Overall Study|Lost to Follow-up|7|||
170770866|NCT01823536|617167216|FG001|Overall Study|Met exclusion criterion No 6|0|||
170770867|NCT01823536|617167217|FG002|Overall Study|Met exclusion criterion No 6|0|||
170770868|NCT01823536|617167218|FG003|Overall Study|Met exclusion criterion No 6|1|||
170770869|NCT01823536|617167219|FG004|Overall Study|Met exclusion criterion No 6|0|||
170770870|NCT01823536|617167220|FG005|Overall Study|Met exclusion criterion No 6|0|||
170770871|NCT01823536|617167215|FG000|Overall Study|Subject moved out of the state|0|||
170770872|NCT01823536|617167216|FG001|Overall Study|Subject moved out of the state|0|||
170770873|NCT01823536|617167217|FG002|Overall Study|Subject moved out of the state|0|||
170770874|NCT01823536|617167218|FG003|Overall Study|Subject moved out of the state|0|||
170770875|NCT01823536|617167219|FG004|Overall Study|Subject moved out of the state|1|||
170770876|NCT01823536|617167220|FG005|Overall Study|Subject moved out of the state|0|||
170770877|NCT00840177|617167221|FG000|Overall Study|Adverse Event|5|||
170770878|NCT00840177|617167222|FG001|Overall Study|Adverse Event|1|||
170770879|NCT00840177|617167223|FG002|Overall Study|Adverse Event|1|||
170770880|NCT00840177|617167221|FG000|Overall Study|Refusal unrelated to adverse events|1|||
170770881|NCT00840177|617167222|FG001|Overall Study|Refusal unrelated to adverse events|0|||
170770882|NCT00840177|617167223|FG002|Overall Study|Refusal unrelated to adverse events|1|||
170770883|NCT00840177|617167221|FG000|Overall Study|Progression/relapse|2|||
170770884|NCT00840177|617167222|FG001|Overall Study|Progression/relapse|0|||
170770885|NCT00840177|617167223|FG002|Overall Study|Progression/relapse|0|||
170413309|NCT01211769|615853415|FG001|Overall Study|Lost to Follow-up|9|||
170413310|NCT01211769|615853416|FG002|Overall Study|Lost to Follow-up|5|||
170413311|NCT01211769|615853417|FG003|Overall Study|Lost to Follow-up|9|||
170413312|NCT01211769|615853414|FG000|Overall Study|Physician Decision|2|||
170413313|NCT01211769|615853415|FG001|Overall Study|Physician Decision|0|||
170524675|NCT00698815|616267957|FG002|Overall Study|Death|4|||
170524676|NCT00698815|616267955|FG000|Overall Study|Withdrawal by Subject|6|||
170524677|NCT00698815|616267956|FG001|Overall Study|Withdrawal by Subject|3|||
170413314|NCT01211769|615853416|FG002|Overall Study|Physician Decision|2|||
170413315|NCT01211769|615853417|FG003|Overall Study|Physician Decision|1|||
170413316|NCT01211769|615853414|FG000|Overall Study|Adverse Event|0|||
170413317|NCT01211769|615853415|FG001|Overall Study|Adverse Event|1|||
170413318|NCT01211769|615853416|FG002|Overall Study|Adverse Event|1|||
170770886|NCT00840177|617167221|FG000|Overall Study|Death|4|||
170413319|NCT01211769|615853417|FG003|Overall Study|Adverse Event|1|||
170413320|NCT03212170|615853420|FG000|Overall Study|Withdrawal by Subject|1|||
170413321|NCT01937364|615853421|FG000|Overall Study|Adverse Event|2|||
170413322|NCT01937364|615853422|FG001|Overall Study|Adverse Event|1|||
170413323|NCT03264066|615853426|FG000|Overall Study|Adverse Event|1|||
170413324|NCT03264066|615853427|FG001|Overall Study|Adverse Event|1|||
170413325|NCT03264066|615853428|FG002|Overall Study|Adverse Event|0|||
170770887|NCT00840177|617167222|FG001|Overall Study|Death|5|||
170524678|NCT00698815|616267957|FG002|Overall Study|Withdrawal by Subject|2|||
170524679|NCT00698815|616267955|FG000|Overall Study|MD discretion|2|||
170524680|NCT00698815|616267956|FG001|Overall Study|MD discretion|7|||
170524681|NCT00698815|616267957|FG002|Overall Study|MD discretion|2|||
170524682|NCT00698815|616267955|FG000|Overall Study|Did not receive protocol treatment|1|||
170524683|NCT00698815|616267956|FG001|Overall Study|Did not receive protocol treatment|2|||
170524684|NCT00698815|616267957|FG002|Overall Study|Did not receive protocol treatment|2|||
170524685|NCT02974868|616267958|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
170524686|NCT02974868|616267959|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
170524687|NCT02974868|616267960|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
170524688|NCT02974868|616267961|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
170524689|NCT02974868|616267958|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
170524690|NCT02974868|616267959|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
170524691|NCT02974868|616267960|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
170524692|NCT02974868|616267961|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
170524693|NCT02974868|616267958|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
170524694|NCT02974868|616267959|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
170524695|NCT02974868|616267960|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
170524696|NCT02974868|616267961|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
170524697|NCT02974868|616267958|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
170524698|NCT02974868|616267959|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
170524699|NCT02974868|616267960|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
170524700|NCT02974868|616267961|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
170524701|NCT00706004|616267962|FG000|Overall Study|Did not meet eligibility criteria|2|||
170524702|NCT02674516|616267963|FG000|Overall Study|Lost to Follow-up|3|||
170524703|NCT02674516|616267964|FG001|Overall Study|Lost to Follow-up|0|||
170524704|NCT02674516|616267963|FG000|Overall Study|Protocol Violation|0|||
170524705|NCT02674516|616267964|FG001|Overall Study|Protocol Violation|4|||
170524706|NCT02674516|616267963|FG000|Overall Study|Knowledge of study hypothesis|1|||
170524707|NCT02674516|616267964|FG001|Overall Study|Knowledge of study hypothesis|0|||
170524708|NCT01064479|616267965|FG000|Overall Study|Death|10|||
170524709|NCT01064479|616267966|FG001|Overall Study|Death|11|||
170524710|NCT01064479|616267965|FG000|Overall Study|Withdrawal by Subject|2|||
170524711|NCT01064479|616267966|FG001|Overall Study|Withdrawal by Subject|2|||
170524712|NCT01064479|616267965|FG000|Overall Study|Disease progression|1|||
170524713|NCT01064479|616267966|FG001|Overall Study|Disease progression|1|||
170524714|NCT01064479|616267965|FG000|Overall Study|Toxicity|1|||
170524715|NCT01064479|616267966|FG001|Overall Study|Toxicity|1|||
170524716|NCT01064479|616267965|FG000|Overall Study|Other|1|||
170524717|NCT01064479|616267966|FG001|Overall Study|Other|2|||
170524718|NCT00749398|616267970|FG000|Overall Study|Lack of Efficacy|7|||
170524719|NCT00749398|616267970|FG000|Overall Study|Adverse Event|4|||
170524720|NCT00749398|616267970|FG000|Overall Study|Serious adverse event|11|||
170524721|NCT00749398|616267970|FG000|Overall Study|Withdrawal by Subject|17|||
170524722|NCT00749398|616267970|FG000|Overall Study|Lost to Follow-up|11|||
170524723|NCT00749398|616267970|FG000|Overall Study|Reason not specified|2|||
170524724|NCT00749398|616267970|FG000|Overall Study|Unknown reason|1|||
170524725|NCT01663402|616267979|FG000|Overall Study|Randomized but not treated|19|||
170524726|NCT01663402|616267980|FG001|Overall Study|Randomized but not treated|11|||
170524727|NCT01663402|616267979|FG000|Overall Study|Adverse Event|347|||
170524728|NCT01663402|616267980|FG001|Overall Study|Adverse Event|362|||
170524729|NCT01663402|616267979|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
170524730|NCT01663402|616267980|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
170524731|NCT01663402|616267979|FG000|Overall Study|Poor compliance to protocol|529|||
170524732|NCT01663402|616267980|FG001|Overall Study|Poor compliance to protocol|454|||
170524733|NCT01663402|616267979|FG000|Overall Study|Physician Decision|77|||
170872355|NCT01858532|617544772|FG000|Overall Study|Lost to Follow-up|17|||
170872356|NCT01858532|617544773|FG001|Overall Study|Lost to Follow-up|26|||
170872357|NCT01858532|617544774|FG002|Overall Study|Lost to Follow-up|11|||
170872358|NCT01858532|617544775|FG003|Overall Study|Lost to Follow-up|14|||
170872359|NCT01858532|617544772|FG000|Overall Study|Deterioration of medical status|3|||
170524734|NCT01663402|616267980|FG001|Overall Study|Physician Decision|62|||
170524735|NCT01663402|616267979|FG000|Overall Study|Site terminated by sponsor|1|||
170524736|NCT01663402|616267980|FG001|Overall Study|Site terminated by sponsor|3|||
170524737|NCT01663402|616267979|FG000|Overall Study|Participant moved|139|||
170524738|NCT01663402|616267980|FG001|Overall Study|Participant moved|104|||
170524739|NCT01663402|616267979|FG000|Overall Study|Withdrawal by Subject|118|||
170524740|NCT01663402|616267980|FG001|Overall Study|Withdrawal by Subject|91|||
170524741|NCT01663402|616267979|FG000|Overall Study|Related to study drug administration|96|||
170524742|NCT01663402|616267980|FG001|Overall Study|Related to study drug administration|105|||
170524743|NCT01663402|616267979|FG000|Overall Study|Lost to Follow-up|17|||
170524744|NCT01663402|616267980|FG001|Overall Study|Lost to Follow-up|15|||
170524745|NCT01663402|616267979|FG000|Overall Study|Other than specified above|172|||
170524746|NCT01663402|616267980|FG001|Overall Study|Other than specified above|147|||
170413326|NCT03264066|615853429|FG003|Overall Study|Adverse Event|0|||
170413327|NCT03264066|615853430|FG004|Overall Study|Adverse Event|0|||
170413328|NCT03264066|615853431|FG005|Overall Study|Adverse Event|0|||
170413329|NCT03264066|615853426|FG000|Overall Study|Death|12|||
170413330|NCT03264066|615853427|FG001|Overall Study|Death|12|||
170413331|NCT03264066|615853428|FG002|Overall Study|Death|8|||
170413332|NCT03264066|615853429|FG003|Overall Study|Death|10|||
170413333|NCT03264066|615853430|FG004|Overall Study|Death|6|||
170413334|NCT03264066|615853431|FG005|Overall Study|Death|1|||
170413335|NCT03264066|615853426|FG000|Overall Study|Lost to Follow-up|1|||
170413336|NCT03264066|615853427|FG001|Overall Study|Lost to Follow-up|0|||
170413337|NCT03264066|615853428|FG002|Overall Study|Lost to Follow-up|0|||
170413338|NCT03264066|615853429|FG003|Overall Study|Lost to Follow-up|0|||
170413339|NCT03264066|615853430|FG004|Overall Study|Lost to Follow-up|0|||
170413340|NCT03264066|615853431|FG005|Overall Study|Lost to Follow-up|0|||
170413341|NCT03264066|615853426|FG000|Overall Study|Progressive Disease|0|||
170413342|NCT03264066|615853427|FG001|Overall Study|Progressive Disease|2|||
170413343|NCT03264066|615853428|FG002|Overall Study|Progressive Disease|1|||
170413344|NCT03264066|615853429|FG003|Overall Study|Progressive Disease|0|||
170413345|NCT03264066|615853430|FG004|Overall Study|Progressive Disease|0|||
170413346|NCT03264066|615853431|FG005|Overall Study|Progressive Disease|0|||
170413347|NCT03264066|615853426|FG000|Overall Study|Study Terminated by Sponsor|5|||
170413348|NCT03264066|615853427|FG001|Overall Study|Study Terminated by Sponsor|5|||
170413349|NCT03264066|615853428|FG002|Overall Study|Study Terminated by Sponsor|8|||
170413350|NCT03264066|615853429|FG003|Overall Study|Study Terminated by Sponsor|5|||
170413351|NCT03264066|615853430|FG004|Overall Study|Study Terminated by Sponsor|1|||
170413352|NCT03264066|615853431|FG005|Overall Study|Study Terminated by Sponsor|2|||
170413353|NCT03264066|615853426|FG000|Overall Study|Withdrawal by Subject|1|||
170413354|NCT03264066|615853427|FG001|Overall Study|Withdrawal by Subject|0|||
170413355|NCT03264066|615853428|FG002|Overall Study|Withdrawal by Subject|0|||
170413356|NCT03264066|615853429|FG003|Overall Study|Withdrawal by Subject|5|||
170413357|NCT03264066|615853430|FG004|Overall Study|Withdrawal by Subject|0|||
170413358|NCT03264066|615853431|FG005|Overall Study|Withdrawal by Subject|0|||
170413359|NCT01193517|615853436|FG000|Overall Study|Early Progression|1|||
170413360|NCT01193517|615853437|FG001|Overall Study|Early Progression|0|||
170413361|NCT01193517|615853438|FG002|Overall Study|Early Progression|0|||
170413362|NCT02115256|615853441|FG000|Overall Study|Withdrawal by Subject|0|||
170413363|NCT02115256|615853442|FG001|Overall Study|Withdrawal by Subject|1|||
170413364|NCT02427607|615853444|FG000|Overall Study|Withdrawal by Subject|1|||
170413365|NCT01789320|615853445|FG000|Overall Study|Re-enrolled into study|1|||
170413366|NCT01789320|615853445|FG000|Overall Study|Lost to Follow-up|1|||
170413367|NCT00905489|615853446|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
170413368|NCT00905489|615853446|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
170413369|NCT00905489|615853446|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
170413370|NCT01859702|615853461|FG000|Overall Study|Protocol deviation|3|||
170413371|NCT01859702|615853461|FG000|Overall Study|Adverse Event|2|||
170413372|NCT00929708|615853462|FG000|Overall Study|Protocol Violation|2|||
170413373|NCT00929708|615853463|FG001|Overall Study|Protocol Violation|1|||
170413374|NCT00929708|615853464|FG002|Overall Study|Protocol Violation|1|||
170413375|NCT00929708|615853465|FG003|Overall Study|Protocol Violation|1|||
170413376|NCT00929708|615853466|FG004|Overall Study|Protocol Violation|1|||
170413377|NCT00929708|615853462|FG000|Overall Study|Withdrawal by Subject|2|||
170413378|NCT00929708|615853463|FG001|Overall Study|Withdrawal by Subject|0|||
170413379|NCT00929708|615853464|FG002|Overall Study|Withdrawal by Subject|0|||
170413380|NCT00929708|615853465|FG003|Overall Study|Withdrawal by Subject|2|||
170413381|NCT00929708|615853466|FG004|Overall Study|Withdrawal by Subject|1|||
170413382|NCT00929708|615853462|FG000|Overall Study|Adverse Event|0|||
170413383|NCT00929708|615853463|FG001|Overall Study|Adverse Event|0|||
170413384|NCT00929708|615853464|FG002|Overall Study|Adverse Event|0|||
170413385|NCT00929708|615853465|FG003|Overall Study|Adverse Event|0|||
170413386|NCT00929708|615853466|FG004|Overall Study|Adverse Event|3|||
170413387|NCT00929708|615853462|FG000|Overall Study|Physician Decision|0|||
170413388|NCT00929708|615853463|FG001|Overall Study|Physician Decision|2|||
170413389|NCT00929708|615853464|FG002|Overall Study|Physician Decision|2|||
170413390|NCT00929708|615853465|FG003|Overall Study|Physician Decision|2|||
170413391|NCT00929708|615853466|FG004|Overall Study|Physician Decision|1|||
170413392|NCT00929708|615853462|FG000|Overall Study|Lost to Follow-up|0|||
170413393|NCT00929708|615853463|FG001|Overall Study|Lost to Follow-up|0|||
170413394|NCT00929708|615853464|FG002|Overall Study|Lost to Follow-up|0|||
170413395|NCT00929708|615853465|FG003|Overall Study|Lost to Follow-up|1|||
170413396|NCT00929708|615853466|FG004|Overall Study|Lost to Follow-up|0|||
170413397|NCT00772382|615853467|FG000|Overall Study|Adverse Event|19|||
170413398|NCT00772382|615853467|FG000|Overall Study|Death|6|||
170413399|NCT00772382|615853467|FG000|Overall Study|Lack of Efficacy|4|||
170413400|NCT00772382|615853467|FG000|Overall Study|Physician Decision|5|||
170413401|NCT00772382|615853467|FG000|Overall Study|Protocol Violation|1|||
170413402|NCT00772382|615853467|FG000|Overall Study|Withdrawal by Subject|10|||
170413403|NCT00772382|615853467|FG000|Overall Study|Other Reasons|10|||
170413404|NCT05440097|615854382|FG000|Overall Study|Withdrawal by Subject|154|||
170413405|NCT05440097|615854382|FG000|Overall Study|Death|2|||
170413406|NCT05440097|615854382|FG000|Overall Study|Physician Decision|2|||
170413407|NCT05440097|615854382|FG000|Overall Study|Lost to Follow-up|56|||
170413408|NCT05440097|615854382|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
170413409|NCT02081599|615854383|FG000|Period 1：Double-blind Period|Adverse Event|3|||
170413410|NCT02081599|615854384|FG001|Period 1：Double-blind Period|Adverse Event|0|||
170413411|NCT02081599|615854383|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
170413412|NCT02081599|615854384|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
170413413|NCT02081599|615854383|FG000|Period 1：Double-blind Period|Physician Decision|1|||
170413414|NCT02081599|615854384|FG001|Period 1：Double-blind Period|Physician Decision|0|||
170413415|NCT02081599|615854383|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
170413416|NCT02081599|615854384|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
170413417|NCT02081599|615854383|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
170413418|NCT02081599|615854384|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
170413419|NCT02081599|615854383|FG000|Period 1：Double-blind Period|stopping criteria|1|||
170413420|NCT02081599|615854384|FG001|Period 1：Double-blind Period|stopping criteria|0|||
170413421|NCT02081599|615854383|FG000|Period 2：Open-label Period|Adverse Event|1|||
170413422|NCT02081599|615854384|FG001|Period 2：Open-label Period|Adverse Event|0|||
170413423|NCT02081599|615854383|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
170413424|NCT02081599|615854384|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
170413425|NCT02081599|615854383|FG000|Period 2：Open-label Period|Physician Decision|1|||
170413426|NCT02081599|615854384|FG001|Period 2：Open-label Period|Physician Decision|0|||
170413427|NCT02081599|615854383|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
170413428|NCT02081599|615854384|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
170413429|NCT00836927|615854397|FG000|Overall Study|Progressive disease|2|||
170413430|NCT00836927|615854398|FG001|Overall Study|Progressive disease|0|||
170413431|NCT00836927|615854399|FG002|Overall Study|Progressive disease|0|||
170413432|NCT00836927|615854400|FG003|Overall Study|Progressive disease|1|||
170413433|NCT00836927|615854401|FG004|Overall Study|Progressive disease|1|||
170413434|NCT00836927|615854397|FG000|Overall Study|Withdrawal by Subject|1|||
170413435|NCT00836927|615854398|FG001|Overall Study|Withdrawal by Subject|0|||
170413436|NCT00836927|615854399|FG002|Overall Study|Withdrawal by Subject|0|||
170413437|NCT00836927|615854400|FG003|Overall Study|Withdrawal by Subject|0|||
170413438|NCT00836927|615854401|FG004|Overall Study|Withdrawal by Subject|0|||
170413439|NCT02006706|615854409|FG000|Overall Study|Lost to Follow-up|1|||
170413440|NCT04161144|615854410|FG000|Overall Study|Withdrawal by Subject|0|||
170413441|NCT04161144|615854411|FG001|Overall Study|Withdrawal by Subject|1|||
170413442|NCT04161144|615854410|FG000|Overall Study|Protocol Violation|1|||
170413443|NCT04161144|615854411|FG001|Overall Study|Protocol Violation|0|||
170413444|NCT02848599|615854414|FG000|Overall Study|Protocol Violation|7|||
170413445|NCT02848599|615854415|FG001|Overall Study|Protocol Violation|9|||
170413446|NCT04700449|615854416|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
170413447|NCT04700449|615854417|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
170413448|NCT04700449|615854418|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
170413449|NCT04700449|615854419|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
170413450|NCT04700449|615854416|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
170413451|NCT04700449|615854417|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
170413452|NCT04700449|615854418|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
170413453|NCT04700449|615854419|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
170413454|NCT04700449|615854416|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
170413455|NCT04700449|615854417|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
170413456|NCT04700449|615854418|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
170413457|NCT04700449|615854419|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
170413458|NCT04700449|615854416|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
170413459|NCT04700449|615854417|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
170413460|NCT04700449|615854418|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
170413461|NCT04700449|615854419|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
170413462|NCT04700449|615854416|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
170413463|NCT04700449|615854417|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
170413464|NCT04700449|615854418|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
170413465|NCT04700449|615854419|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
170413466|NCT04700449|615854416|FG000|Stage 1: Double-Blind Period|Other|0|||
170413467|NCT04700449|615854417|FG001|Stage 1: Double-Blind Period|Other|0|||
170413468|NCT04700449|615854418|FG002|Stage 1: Double-Blind Period|Other|1|||
170413469|NCT04700449|615854419|FG003|Stage 1: Double-Blind Period|Other|0|||
170413470|NCT04700449|615854416|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
170413471|NCT04700449|615854417|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
170413472|NCT04700449|615854418|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
170413473|NCT04700449|615854419|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
170413474|NCT04700449|615854416|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
170413475|NCT04700449|615854417|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
170413476|NCT04700449|615854418|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
170413477|NCT04700449|615854419|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
170524747|NCT01545388|616267983|FG000|Overall Study|Adverse Event|2|||
170524748|NCT01545388|616267984|FG001|Overall Study|Adverse Event|4|||
170524749|NCT01545388|616267985|FG002|Overall Study|Adverse Event|1|||
170524750|NCT01545388|616267983|FG000|Overall Study|Lack of Efficacy|3|||
170524751|NCT01545388|616267984|FG001|Overall Study|Lack of Efficacy|2|||
170524752|NCT01545388|616267985|FG002|Overall Study|Lack of Efficacy|5|||
170524753|NCT01545388|616267983|FG000|Overall Study|Participant moved or relocated|1|||
170524754|NCT01545388|616267984|FG001|Overall Study|Participant moved or relocated|0|||
170524755|NCT01545388|616267985|FG002|Overall Study|Participant moved or relocated|0|||
170524756|NCT01545388|616267983|FG000|Overall Study|Withdrawal by Subject|1|||
170524757|NCT01545388|616267984|FG001|Overall Study|Withdrawal by Subject|4|||
170524758|NCT01545388|616267985|FG002|Overall Study|Withdrawal by Subject|2|||
170524759|NCT01545388|616267983|FG000|Overall Study|Other|1|||
170524760|NCT01545388|616267984|FG001|Overall Study|Other|1|||
170524761|NCT01545388|616267985|FG002|Overall Study|Other|0|||
170524762|NCT01900444|616267989|FG000|Overall Study|Protocol Violation|2|||
170524763|NCT01900444|616267989|FG000|Overall Study|Lost to Follow-up|1|||
170524764|NCT00072384|616267990|FG000|Overall Study|Physician Decision|1|||
170524765|NCT00072384|616267990|FG000|Overall Study|Ineligible|8|||
170524766|NCT01825200|616267991|FG000|Overall Study|Lost to Follow-up|5|||
170524767|NCT01825200|616267992|FG001|Overall Study|Lost to Follow-up|6|||
170524768|NCT01825200|616267991|FG000|Overall Study|Withdrawal by Subject|0|||
170524769|NCT01825200|616267992|FG001|Overall Study|Withdrawal by Subject|1|||
170524770|NCT01255163|616267993|FG000|Overall Study|Withdrawal by Subject|1|||
170524771|NCT01255163|616267994|FG001|Overall Study|Withdrawal by Subject|0|||
170524772|NCT01255163|616267993|FG000|Overall Study|Lost to Follow-up|2|||
170524773|NCT01255163|616267994|FG001|Overall Study|Lost to Follow-up|0|||
170524774|NCT01255163|616267993|FG000|Overall Study|Adverse Event|0|||
170524775|NCT01255163|616267994|FG001|Overall Study|Adverse Event|2|||
170524776|NCT01255163|616267993|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
170524777|NCT01255163|616267994|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
170524778|NCT04219189|616267998|FG000|Overall Study|Withdrawal by Subject|1|||
170524779|NCT04219189|616267999|FG001|Overall Study|Withdrawal by Subject|2|||
170524780|NCT04219189|616267998|FG000|Overall Study|Protocol Violation|0|||
170524781|NCT04219189|616267999|FG001|Overall Study|Protocol Violation|1|||
170524782|NCT04219189|616267998|FG000|Overall Study|Lost to Follow-up|0|||
170524783|NCT04219189|616267999|FG001|Overall Study|Lost to Follow-up|1|||
170524784|NCT04219189|616267998|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
170524785|NCT04219189|616267999|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
170524786|NCT05817669|616268001|FG000|Overall Study|Prohibited medication used|1|||
170524787|NCT05817669|616268002|FG001|Overall Study|Prohibited medication used|2|||
170524788|NCT05817669|616268001|FG000|Overall Study|Adverse Event|1|||
170524789|NCT05817669|616268002|FG001|Overall Study|Adverse Event|0|||
170524790|NCT05817669|616268001|FG000|Overall Study|Withdrawal by Subject|1|||
170524791|NCT05817669|616268002|FG001|Overall Study|Withdrawal by Subject|2|||
170524792|NCT03292016|616268003|FG000|Second Washout|Adverse Event|0|||
170524793|NCT03292016|616268004|FG001|Second Washout|Adverse Event|1|||
170524794|NCT03292016|616268005|FG002|Second Washout|Adverse Event|0|||
170524795|NCT03292016|616268006|FG003|Second Washout|Adverse Event|0|||
170524796|NCT03292016|616268007|FG004|Second Washout|Adverse Event|0|||
170524797|NCT03292016|616268008|FG005|Second Washout|Adverse Event|0|||
170524798|NCT01802385|616268010|FG000|Overall Study|Death|106|||
170524799|NCT01802385|616268011|FG001|Overall Study|Death|120|||
170524800|NCT01172873|616268013|FG000|Overall Study|Withdrawal by Subject|3|||
170524801|NCT01172873|616268014|FG001|Overall Study|Withdrawal by Subject|2|||
170524802|NCT00338741|616268016|FG000|Overall Study|Lost to Follow-up|2|||
170524803|NCT00338741|616268017|FG001|Overall Study|Lost to Follow-up|0|||
170524804|NCT01534273|616268018|FG000|Period 1|Physician Decision|0|||
170524805|NCT01534273|616268019|FG001|Period 1|Physician Decision|0|||
170524806|NCT01534273|616268020|FG002|Period 1|Physician Decision|0|||
170524807|NCT01534273|616268021|FG003|Period 1|Physician Decision|1|||
170524808|NCT01534273|616268022|FG004|Period 1|Physician Decision|0|||
170524809|NCT01534273|616268023|FG005|Period 1|Physician Decision|0|||
170524810|NCT01534273|616268024|FG006|Period 1|Physician Decision|0|||
170524811|NCT01494818|616268027|FG000|Overall Study|Relocation|1|||
170524812|NCT01494818|616268028|FG001|Overall Study|Relocation|2|||
170524813|NCT01494818|616268027|FG000|Overall Study|Lost to Follow-up|1|||
170524814|NCT01494818|616268028|FG001|Overall Study|Lost to Follow-up|0|||
170524815|NCT04831138|616268029|FG000|Overall Study|Lost to Follow-up|2|||
170524816|NCT04831138|616268030|FG001|Overall Study|Lost to Follow-up|0|||
170524817|NCT00593918|616268031|FG000|Overall Study|Withdrawal by Subject|5|||
170524818|NCT00593918|616268032|FG001|Overall Study|Withdrawal by Subject|24|||
170524819|NCT02688933|616268043|FG000|Overall Study|Adverse Event|3|||
170524820|NCT02688933|616268044|FG001|Overall Study|Adverse Event|1|||
170524821|NCT02688933|616268043|FG000|Overall Study|Lack of Efficacy|2|||
170524822|NCT02688933|616268044|FG001|Overall Study|Lack of Efficacy|2|||
170524823|NCT02688933|616268043|FG000|Overall Study|Poor compliance to protocol|7|||
170524824|NCT02688933|616268044|FG001|Overall Study|Poor compliance to protocol|4|||
170524825|NCT02688933|616268043|FG000|Overall Study|Hypoglycemia|2|||
170524826|NCT02688933|616268044|FG001|Overall Study|Hypoglycemia|0|||
170524827|NCT02688933|616268043|FG000|Overall Study|Other than Specified|14|||
170524828|NCT02688933|616268044|FG001|Overall Study|Other than Specified|25|||
170524829|NCT02688933|616268043|FG000|Overall Study|Lost to Follow-up|1|||
170524830|NCT02688933|616268044|FG001|Overall Study|Lost to Follow-up|5|||
170872360|NCT01858532|617544773|FG001|Overall Study|Deterioration of medical status|4|||
170872361|NCT01858532|617544774|FG002|Overall Study|Deterioration of medical status|3|||
170872362|NCT01858532|617544775|FG003|Overall Study|Deterioration of medical status|7|||
170872363|NCT01858532|617544772|FG000|Overall Study|Investigator request|3|||
170872364|NCT01858532|617544773|FG001|Overall Study|Investigator request|4|||
170872365|NCT01858532|617544774|FG002|Overall Study|Investigator request|2|||
170872366|NCT01858532|617544775|FG003|Overall Study|Investigator request|6|||
170872367|NCT01858532|617544772|FG000|Overall Study|Other, not specified|29|||
170872368|NCT01858532|617544773|FG001|Overall Study|Other, not specified|15|||
170872369|NCT01858532|617544774|FG002|Overall Study|Other, not specified|13|||
170872370|NCT01858532|617544775|FG003|Overall Study|Other, not specified|11|||
170872371|NCT01566773|617544777|FG000|Overall Study|Protocol specified criteria|4|||
170872372|NCT01566773|617544777|FG000|Overall Study|Protocol Violation|4|||
170872373|NCT01566773|617544777|FG000|Overall Study|Withdrawal by Subject|9|||
170872374|NCT01566773|617544777|FG000|Overall Study|Administrative reason|1|||
170872375|NCT01566773|617544777|FG000|Overall Study|Adverse Event|10|||
170872376|NCT01566773|617544777|FG000|Overall Study|Physician Decision|2|||
170872377|NCT00762892|617544778|FG000|Overall Study|Lost to Follow-up|2|||
170872378|NCT00762892|617544779|FG001|Overall Study|Lost to Follow-up|5|||
170872379|NCT00762892|617544778|FG000|Overall Study|Withdrawal by Subject|0|||
170872380|NCT00762892|617544779|FG001|Overall Study|Withdrawal by Subject|1|||
170872381|NCT00762892|617544778|FG000|Overall Study|Death|1|||
170872382|NCT00762892|617544779|FG001|Overall Study|Death|0|||
170872383|NCT00762892|617544778|FG000|Overall Study|Pregnancy|1|||
170872384|NCT00762892|617544779|FG001|Overall Study|Pregnancy|0|||
170872385|NCT00762892|617544778|FG000|Overall Study|Incarceration|1|||
170872386|NCT00762892|617544779|FG001|Overall Study|Incarceration|0|||
170872387|NCT01735279|617544780|FG000|Overall Study|Lost to Follow-up|11|||
170872388|NCT01735279|617544781|FG001|Overall Study|Lost to Follow-up|8|||
170872389|NCT04784897|617544786|FG000|Overall Study|Death|4|||
170872390|NCT04784897|617544787|FG001|Overall Study|Death|2|||
170872391|NCT04784897|617544788|FG002|Overall Study|Death|1|||
170872392|NCT04784897|617544786|FG000|Overall Study|Withdrawal by Subject|0|||
170872393|NCT04784897|617544787|FG001|Overall Study|Withdrawal by Subject|0|||
170872394|NCT04784897|617544788|FG002|Overall Study|Withdrawal by Subject|1|||
170872395|NCT01994382|617544789|FG000|Overall Study|Informed consent withdrawn|0|||
170524831|NCT03509467|616268045|FG000|Overall Study|Withdrawal by Subject|5|||
170872396|NCT01994382|617544790|FG001|Overall Study|Informed consent withdrawn|0|||
170872397|NCT01994382|617544791|FG002|Overall Study|Informed consent withdrawn|0|||
170872398|NCT01994382|617544792|FG003|Overall Study|Informed consent withdrawn|0|||
170872399|NCT01994382|617544793|FG004|Overall Study|Informed consent withdrawn|0|||
170872400|NCT01994382|617544794|FG005|Overall Study|Informed consent withdrawn|0|||
170872401|NCT01994382|617544795|FG006|Overall Study|Informed consent withdrawn|1|||
170872402|NCT01994382|617544796|FG007|Overall Study|Informed consent withdrawn|0|||
170872403|NCT01994382|617544797|FG008|Overall Study|Informed consent withdrawn|0|||
170872404|NCT01994382|617544798|FG009|Overall Study|Informed consent withdrawn|0|||
170872405|NCT01994382|617544799|FG010|Overall Study|Informed consent withdrawn|0|||
170872406|NCT01994382|617544800|FG011|Overall Study|Informed consent withdrawn|0|||
170872407|NCT01994382|617544801|FG012|Overall Study|Informed consent withdrawn|0|||
170872408|NCT01994382|617544802|FG013|Overall Study|Informed consent withdrawn|0|||
170872409|NCT01994382|617544803|FG014|Overall Study|Informed consent withdrawn|0|||
170872410|NCT01994382|617544804|FG015|Overall Study|Informed consent withdrawn|0|||
170524832|NCT03509467|616268046|FG001|Overall Study|Withdrawal by Subject|1|||
170524833|NCT03509467|616268047|FG002|Overall Study|Withdrawal by Subject|6|||
170524834|NCT03509467|616268048|FG003|Overall Study|Withdrawal by Subject|7|||
170524835|NCT03509467|616268049|FG004|Overall Study|Withdrawal by Subject|10|||
170872411|NCT01994382|617544805|FG016|Overall Study|Informed consent withdrawn|0|||
170524836|NCT03509467|616268050|FG005|Overall Study|Withdrawal by Subject|10|||
170524837|NCT03509467|616268051|FG006|Overall Study|Withdrawal by Subject|10|||
170872412|NCT01994382|617544789|FG000|Overall Study|Progressive disease|3|||
170872413|NCT01994382|617544790|FG001|Overall Study|Progressive disease|4|||
170872414|NCT01994382|617544791|FG002|Overall Study|Progressive disease|4|||
170872415|NCT01994382|617544792|FG003|Overall Study|Progressive disease|3|||
170872416|NCT01994382|617544793|FG004|Overall Study|Progressive disease|2|||
170872417|NCT01994382|617544794|FG005|Overall Study|Progressive disease|3|||
170872418|NCT01994382|617544795|FG006|Overall Study|Progressive disease|3|||
170872419|NCT01994382|617544796|FG007|Overall Study|Progressive disease|6|||
170872420|NCT01994382|617544797|FG008|Overall Study|Progressive disease|2|||
170872421|NCT01994382|617544798|FG009|Overall Study|Progressive disease|2|||
170872422|NCT01994382|617544799|FG010|Overall Study|Progressive disease|13|||
170872423|NCT01994382|617544800|FG011|Overall Study|Progressive disease|8|||
170872424|NCT01994382|617544801|FG012|Overall Study|Progressive disease|7|||
170413478|NCT04700449|615854416|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
170524838|NCT03509467|616268052|FG007|Overall Study|Withdrawal by Subject|10|||
170524839|NCT03509467|616268045|FG000|Overall Study|Death|0|||
170524840|NCT03509467|616268046|FG001|Overall Study|Death|0|||
170524841|NCT03509467|616268047|FG002|Overall Study|Death|2|||
170770888|NCT00840177|617167223|FG002|Overall Study|Death|5|||
170770889|NCT00840177|617167221|FG000|Overall Study|not protocol specified|6|||
170770890|NCT00840177|617167222|FG001|Overall Study|not protocol specified|3|||
170770891|NCT00840177|617167223|FG002|Overall Study|not protocol specified|0|||
170770892|NCT00840177|617167221|FG000|Overall Study|Ineligible|0|||
170770893|NCT00840177|617167222|FG001|Overall Study|Ineligible|0|||
170413479|NCT04700449|615854417|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
170413480|NCT04700449|615854418|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
170413481|NCT04700449|615854419|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
170413482|NCT04700449|615854416|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
170413483|NCT04700449|615854417|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
170413484|NCT04700449|615854418|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
170413485|NCT04700449|615854419|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
170413486|NCT04700449|615854416|FG000|Stage 2 Sub-study 1|Other|1|||
170413487|NCT04700449|615854417|FG001|Stage 2 Sub-study 1|Other|2|||
170413488|NCT04700449|615854418|FG002|Stage 2 Sub-study 1|Other|0|||
170413489|NCT04700449|615854419|FG003|Stage 2 Sub-study 1|Other|0|||
170413490|NCT04700449|615854416|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
170413491|NCT04700449|615854417|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
170413492|NCT04700449|615854418|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
170413493|NCT04700449|615854419|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
170413494|NCT04700449|615854416|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
170413495|NCT04700449|615854417|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
170413496|NCT04700449|615854418|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
170413497|NCT04700449|615854419|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
170413498|NCT04700449|615854416|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
170413499|NCT04700449|615854417|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
170413500|NCT04700449|615854418|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
170413501|NCT04700449|615854419|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
170413502|NCT04700449|615854416|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
170413503|NCT04700449|615854417|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
170413504|NCT04700449|615854418|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
170413505|NCT04700449|615854419|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
170413506|NCT04700449|615854416|FG000|Stage 2 Sub-study 2|Other|0|||
170413507|NCT04700449|615854417|FG001|Stage 2 Sub-study 2|Other|0|||
170413508|NCT04700449|615854418|FG002|Stage 2 Sub-study 2|Other|0|||
170413509|NCT04700449|615854419|FG003|Stage 2 Sub-study 2|Other|5|||
170413510|NCT00356200|615854420|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
170413511|NCT00356200|615854421|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
170413512|NCT00356200|615854420|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
170413513|NCT00356200|615854421|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
170413514|NCT03679741|615854422|FG000|Period 1|No longer meet eligibility criteria|1|||
170413515|NCT03679741|615854423|FG001|Period 1|No longer meet eligibility criteria|0|||
170413516|NCT03679741|615854422|FG000|Period 1|Lost to Follow-up|0|||
170413517|NCT03679741|615854423|FG001|Period 1|Lost to Follow-up|1|||
170413518|NCT03679741|615854422|FG000|Period 1|Adverse Event|1|||
170413519|NCT03679741|615854423|FG001|Period 1|Adverse Event|1|||
170413520|NCT03679741|615854422|FG000|Period 1|Withdrawal by Subject|0|||
170413521|NCT03679741|615854423|FG001|Period 1|Withdrawal by Subject|1|||
170413522|NCT03679741|615854422|FG000|Period 2|Adverse Event|2|||
170413523|NCT03679741|615854423|FG001|Period 2|Adverse Event|1|||
170413524|NCT03679741|615854422|FG000|Period 2|Withdrawal by Subject|1|||
170413525|NCT03679741|615854423|FG001|Period 2|Withdrawal by Subject|1|||
170413526|NCT01000337|615854424|FG000|Overall Study|Lost to Follow-up|4|||
170413527|NCT01000337|615854425|FG001|Overall Study|Lost to Follow-up|3|||
170413528|NCT02385526|615854426|FG000|Overall Study|Withdrawal by Subject|0|||
170413529|NCT02385526|615854427|FG001|Overall Study|Withdrawal by Subject|2|||
170413530|NCT02385526|615854428|FG002|Overall Study|Withdrawal by Subject|0|||
170413531|NCT02385526|615854426|FG000|Overall Study|Lost to Follow-up|0|||
170413532|NCT02385526|615854427|FG001|Overall Study|Lost to Follow-up|1|||
170413533|NCT02385526|615854428|FG002|Overall Study|Lost to Follow-up|0|||
170413534|NCT02385526|615854426|FG000|Overall Study|Physician Decision|1|||
170413535|NCT02385526|615854427|FG001|Overall Study|Physician Decision|0|||
170413536|NCT02385526|615854428|FG002|Overall Study|Physician Decision|0|||
170413537|NCT02385526|615854426|FG000|Overall Study|Protocol Violation|1|||
170413538|NCT02385526|615854427|FG001|Overall Study|Protocol Violation|0|||
170413539|NCT02385526|615854428|FG002|Overall Study|Protocol Violation|0|||
170413540|NCT01700621|615854430|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
170413541|NCT01700621|615854431|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
170413542|NCT01700621|615854430|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
170413543|NCT01700621|615854431|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
170413544|NCT01700621|615854430|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
170524842|NCT03509467|616268048|FG003|Overall Study|Death|2|||
170770894|NCT00840177|617167223|FG002|Overall Study|Ineligible|3|||
170524843|NCT03509467|616268049|FG004|Overall Study|Death|1|||
170524844|NCT03509467|616268050|FG005|Overall Study|Death|0|||
170524845|NCT03509467|616268051|FG006|Overall Study|Death|1|||
170524846|NCT03509467|616268052|FG007|Overall Study|Death|0|||
170524847|NCT03509467|616268045|FG000|Overall Study|Proxy Withdrawal|0|||
170524848|NCT03509467|616268046|FG001|Overall Study|Proxy Withdrawal|0|||
170524849|NCT03509467|616268047|FG002|Overall Study|Proxy Withdrawal|0|||
170524850|NCT03509467|616268048|FG003|Overall Study|Proxy Withdrawal|0|||
170524851|NCT03509467|616268049|FG004|Overall Study|Proxy Withdrawal|0|||
170524852|NCT03509467|616268050|FG005|Overall Study|Proxy Withdrawal|0|||
170524853|NCT03509467|616268051|FG006|Overall Study|Proxy Withdrawal|0|||
170524854|NCT03509467|616268052|FG007|Overall Study|Proxy Withdrawal|1|||
170524855|NCT06110754|616268055|FG000|Overall Study|Withdrawal by Subject|0|||
170524856|NCT06110754|616268056|FG001|Overall Study|Withdrawal by Subject|0|||
170524857|NCT06110754|616268057|FG002|Overall Study|Withdrawal by Subject|1|||
170524858|NCT06110754|616268058|FG003|Overall Study|Withdrawal by Subject|0|||
170524859|NCT04577794|616268059|FG000|Overall Study|Adverse Event|1|||
170524860|NCT04577794|616268060|FG001|Overall Study|Adverse Event|1|||
170524861|NCT03160716|616268066|FG000|Overall Study|Lost to Follow-up|1|||
170524862|NCT02667301|616268067|FG000|Overall Study|Adverse Event|1|||
170524863|NCT02667301|616268067|FG000|Overall Study|Lack of Efficacy|1|||
170524864|NCT05069259|616268069|FG000|Overall Study|Withdrawal by Subject|1|||
170524865|NCT05069259|616268069|FG000|Overall Study|Sponsor decision|1|||
170524866|NCT04802161|616268070|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
170524867|NCT04802161|616268071|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
170524868|NCT04802161|616268072|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
170524869|NCT04802161|616268073|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
170524870|NCT04802161|616268070|FG000|Overall Study|Clinical Instability|0|||
170524871|NCT04802161|616268071|FG001|Overall Study|Clinical Instability|0|||
170524872|NCT04802161|616268072|FG002|Overall Study|Clinical Instability|1|||
170524873|NCT04802161|616268073|FG003|Overall Study|Clinical Instability|0|||
170524874|NCT04802161|616268070|FG000|Overall Study|Adverse Event|0|||
170524875|NCT04802161|616268071|FG001|Overall Study|Adverse Event|0|||
170524876|NCT04802161|616268072|FG002|Overall Study|Adverse Event|1|||
170524877|NCT04802161|616268073|FG003|Overall Study|Adverse Event|0|||
170524878|NCT04802161|616268070|FG000|Overall Study|Death|0|||
170524879|NCT04802161|616268071|FG001|Overall Study|Death|0|||
170524880|NCT04802161|616268072|FG002|Overall Study|Death|1|||
170524881|NCT04802161|616268073|FG003|Overall Study|Death|0|||
170524882|NCT02873689|616269956|FG000|Overall Study|Lack of Efficacy|1|||
170524883|NCT02873689|616269957|FG001|Overall Study|Lack of Efficacy|0|||
170524884|NCT02873689|616269956|FG000|Overall Study|Withdrawal by Subject|2|||
170524885|NCT02873689|616269957|FG001|Overall Study|Withdrawal by Subject|2|||
170524886|NCT02873689|616269956|FG000|Overall Study|Protocol Violation|1|||
170524887|NCT02873689|616269957|FG001|Overall Study|Protocol Violation|0|||
170524888|NCT02873689|616269956|FG000|Overall Study|Adverse Event|2|||
170524889|NCT02873689|616269957|FG001|Overall Study|Adverse Event|2|||
170524890|NCT02873689|616269956|FG000|Overall Study|Randomized but not Treated|1|||
170524891|NCT02873689|616269957|FG001|Overall Study|Randomized but not Treated|1|||
170524892|NCT00350545|616269958|FG000|Overall Study|Withdrawal by Subject|2|||
170524893|NCT02337764|616269962|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
170524894|NCT02337764|616269962|FG000|Overall Study|Voluntary Withdrawal|12|||
170524895|NCT02337764|616269962|FG000|Overall Study|Lack of Efficacy|2|||
170524896|NCT03103503|616269967|FG000|Overall Study|Death|64|||
170524897|NCT03103503|616269967|FG000|Overall Study|Physician Decision|57|||
170524898|NCT03103503|616269967|FG000|Overall Study|Withdrawal by Subject|10|||
170524899|NCT03103503|616269967|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
170524900|NCT03103503|616269967|FG000|Overall Study|Lost to Follow-up|3|||
170524901|NCT03103503|616269967|FG000|Overall Study|Study Closure|757|||
170524902|NCT01433159|616269969|FG000|Overall Study|Adverse Event|1|||
170524903|NCT01433159|616269970|FG001|Overall Study|Adverse Event|0|||
170524904|NCT01433159|616269969|FG000|Overall Study|Physician Decision|1|||
170524905|NCT01433159|616269970|FG001|Overall Study|Physician Decision|0|||
170524906|NCT01433159|616269969|FG000|Overall Study|Protocol Violation|0|||
170524907|NCT01433159|616269970|FG001|Overall Study|Protocol Violation|1|||
170524908|NCT01100853|616269971|FG000|Overall Study|Lost to Follow-up|11|||
170524909|NCT01100853|616269972|FG001|Overall Study|Lost to Follow-up|6|||
170524910|NCT01100853|616269971|FG000|Overall Study|Received <4 study injections|10|||
170524911|NCT01100853|616269972|FG001|Overall Study|Received <4 study injections|13|||
170524912|NCT01100853|616269971|FG000|Overall Study|Withdrawal by Subject|6|||
170524913|NCT01100853|616269972|FG001|Overall Study|Withdrawal by Subject|4|||
170524914|NCT04161391|616269973|FG000|Overall Study|Adverse Event|0|||
170524915|NCT04161391|616269974|FG001|Overall Study|Adverse Event|1|||
170524916|NCT04161391|616269975|FG002|Overall Study|Adverse Event|0|||
170524917|NCT04161391|616269976|FG003|Overall Study|Adverse Event|1|||
170524918|NCT04161391|616269977|FG004|Overall Study|Adverse Event|0|||
170524919|NCT04161391|616269978|FG005|Overall Study|Adverse Event|0|||
170524920|NCT04161391|616269979|FG006|Overall Study|Adverse Event|0|||
170524921|NCT04161391|616269980|FG007|Overall Study|Adverse Event|3|||
170770895|NCT00840177|617167221|FG000|Overall Study|Did not start treatment|0|||
170770896|NCT00840177|617167222|FG001|Overall Study|Did not start treatment|0|||
170770897|NCT00840177|617167223|FG002|Overall Study|Did not start treatment|1|||
170770898|NCT00722046|617167224|FG000|Overall Study|Adverse Event|0|||
170770899|NCT00722046|617167225|FG001|Overall Study|Adverse Event|1|||
170770900|NCT00722046|617167226|FG002|Overall Study|Adverse Event|2|||
170770901|NCT00722046|617167227|FG003|Overall Study|Adverse Event|1|||
170770902|NCT00722046|617167228|FG004|Overall Study|Adverse Event|2|||
170770903|NCT00722046|617167229|FG005|Overall Study|Adverse Event|1|||
170770904|NCT00722046|617167230|FG006|Overall Study|Adverse Event|0|||
170770905|NCT00722046|617167224|FG000|Overall Study|Death|0|||
170770906|NCT00722046|617167225|FG001|Overall Study|Death|1|||
170770907|NCT00722046|617167226|FG002|Overall Study|Death|0|||
170770908|NCT00722046|617167227|FG003|Overall Study|Death|0|||
170770909|NCT00722046|617167228|FG004|Overall Study|Death|0|||
170770910|NCT00722046|617167229|FG005|Overall Study|Death|0|||
170770911|NCT00722046|617167230|FG006|Overall Study|Death|2|||
170770912|NCT00722046|617167224|FG000|Overall Study|Protocol Violation|1|||
170770913|NCT00722046|617167225|FG001|Overall Study|Protocol Violation|0|||
170770914|NCT00722046|617167226|FG002|Overall Study|Protocol Violation|0|||
170770915|NCT00722046|617167227|FG003|Overall Study|Protocol Violation|0|||
170770916|NCT00722046|617167228|FG004|Overall Study|Protocol Violation|0|||
170770917|NCT00722046|617167229|FG005|Overall Study|Protocol Violation|1|||
170770918|NCT00722046|617167230|FG006|Overall Study|Protocol Violation|0|||
170770919|NCT00722046|617167224|FG000|Overall Study|Withdrawal by Subject|3|||
170770920|NCT00722046|617167225|FG001|Overall Study|Withdrawal by Subject|3|||
170770921|NCT00722046|617167226|FG002|Overall Study|Withdrawal by Subject|4|||
170770922|NCT00722046|617167227|FG003|Overall Study|Withdrawal by Subject|4|||
170770923|NCT00722046|617167228|FG004|Overall Study|Withdrawal by Subject|4|||
170770924|NCT00722046|617167229|FG005|Overall Study|Withdrawal by Subject|7|||
170770925|NCT00722046|617167230|FG006|Overall Study|Withdrawal by Subject|3|||
170770926|NCT00722046|617167224|FG000|Overall Study|Randomized, but not treated|1|||
170770927|NCT00722046|617167225|FG001|Overall Study|Randomized, but not treated|1|||
170770928|NCT00722046|617167226|FG002|Overall Study|Randomized, but not treated|0|||
170770929|NCT00722046|617167227|FG003|Overall Study|Randomized, but not treated|2|||
170770930|NCT00722046|617167228|FG004|Overall Study|Randomized, but not treated|0|||
170770931|NCT00722046|617167229|FG005|Overall Study|Randomized, but not treated|0|||
170770932|NCT00722046|617167230|FG006|Overall Study|Randomized, but not treated|0|||
170770933|NCT00722046|617167224|FG000|Overall Study|Other|0|||
170770934|NCT00722046|617167225|FG001|Overall Study|Other|0|||
170770935|NCT00722046|617167226|FG002|Overall Study|Other|1|||
170770936|NCT00722046|617167227|FG003|Overall Study|Other|1|||
170770937|NCT00722046|617167228|FG004|Overall Study|Other|3|||
170770938|NCT00722046|617167229|FG005|Overall Study|Other|2|||
170770939|NCT00722046|617167230|FG006|Overall Study|Other|1|||
170770940|NCT00516321|617167231|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
170770941|NCT00516321|617167232|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
170770942|NCT00516321|617167233|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
170770943|NCT00516321|617167231|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
170770944|NCT00516321|617167232|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
170770945|NCT00516321|617167233|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
170770946|NCT00516321|617167231|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
170770947|NCT00516321|617167232|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
170770948|NCT00516321|617167233|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
170770949|NCT00516321|617167231|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
170770950|NCT00516321|617167232|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
170770951|NCT00516321|617167233|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
170770952|NCT00516321|617167231|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
170770953|NCT00516321|617167232|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
170770954|NCT00516321|617167233|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
170770955|NCT00516321|617167231|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
170770956|NCT00516321|617167232|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
170770957|NCT00516321|617167233|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
170770958|NCT00516321|617167231|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
170770959|NCT00516321|617167232|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
170770960|NCT00516321|617167233|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
170770961|NCT00516321|617167231|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
170770962|NCT00516321|617167232|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
170770963|NCT00516321|617167233|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
170770964|NCT00516321|617167231|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
170770965|NCT00516321|617167232|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
170770966|NCT00516321|617167233|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
170770967|NCT00516321|617167231|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
170524922|NCT04161391|616269981|FG008|Overall Study|Adverse Event|0|||
170524923|NCT04161391|616269973|FG000|Overall Study|Death|0|||
170524924|NCT04161391|616269974|FG001|Overall Study|Death|0|||
170524925|NCT04161391|616269975|FG002|Overall Study|Death|0|||
170524926|NCT04161391|616269976|FG003|Overall Study|Death|0|||
170524927|NCT04161391|616269977|FG004|Overall Study|Death|0|||
170524928|NCT04161391|616269978|FG005|Overall Study|Death|0|||
170524929|NCT04161391|616269979|FG006|Overall Study|Death|0|||
170524930|NCT04161391|616269980|FG007|Overall Study|Death|1|||
170524931|NCT04161391|616269981|FG008|Overall Study|Death|0|||
170524932|NCT04161391|616269973|FG000|Overall Study|Physician Decision|0|||
170524933|NCT04161391|616269974|FG001|Overall Study|Physician Decision|0|||
170524934|NCT04161391|616269975|FG002|Overall Study|Physician Decision|1|||
170524935|NCT04161391|616269976|FG003|Overall Study|Physician Decision|2|||
170524936|NCT04161391|616269977|FG004|Overall Study|Physician Decision|0|||
170524937|NCT04161391|616269978|FG005|Overall Study|Physician Decision|0|||
170524938|NCT04161391|616269979|FG006|Overall Study|Physician Decision|2|||
170524939|NCT04161391|616269980|FG007|Overall Study|Physician Decision|0|||
170524940|NCT04161391|616269981|FG008|Overall Study|Physician Decision|0|||
170524941|NCT04161391|616269973|FG000|Overall Study|Progressive Disease|4|||
170524942|NCT04161391|616269974|FG001|Overall Study|Progressive Disease|3|||
170524943|NCT04161391|616269975|FG002|Overall Study|Progressive Disease|3|||
170524944|NCT04161391|616269976|FG003|Overall Study|Progressive Disease|5|||
170524945|NCT04161391|616269977|FG004|Overall Study|Progressive Disease|3|||
170524946|NCT04161391|616269978|FG005|Overall Study|Progressive Disease|3|||
170524947|NCT04161391|616269979|FG006|Overall Study|Progressive Disease|5|||
170524948|NCT04161391|616269980|FG007|Overall Study|Progressive Disease|2|||
170524949|NCT04161391|616269981|FG008|Overall Study|Progressive Disease|2|||
170524950|NCT00744939|616269982|FG000|Overall Study|Withdrawal by Subject|9|||
170524951|NCT00744939|616269982|FG000|Overall Study|Protocol Violation|13|||
170524952|NCT00744939|616269982|FG000|Overall Study|Death|24|||
170524953|NCT00744939|616269982|FG000|Overall Study|distance|4|||
170524954|NCT00744939|616269982|FG000|Overall Study|Lost to Follow-up|12|||
170524955|NCT00744939|616269982|FG000|Overall Study|Medical history exclusionary|1|||
170524956|NCT00744939|616269982|FG000|Overall Study|Did not receive Magnevist|7|||
170524957|NCT00744939|616269982|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
170770968|NCT00516321|617167232|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
170413545|NCT01700621|615854431|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
170413546|NCT03349333|615854432|FG000|Overall Study|Progression of Disease|36|||
170413547|NCT03349333|615854432|FG000|Overall Study|Adverse Event|11|||
170413548|NCT03349333|615854432|FG000|Overall Study|Other|6|||
170413549|NCT03349333|615854432|FG000|Overall Study|Withdrawal by Subject|5|||
170413550|NCT03349333|615854432|FG000|Overall Study|Conditions interfere with participation|2|||
170413551|NCT03349333|615854432|FG000|Overall Study|Physician Decision|2|||
170413552|NCT03349333|615854432|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
170413553|NCT03349333|615854432|FG000|Overall Study|Patients in treatment less than 24 month|8|||
170413554|NCT02162758|615854433|FG000|Overall Study|Study termination|0|||
170413555|NCT02162758|615854434|FG001|Overall Study|Study termination|1|||
170413556|NCT02540356|615854435|FG000|Overall Study|Terminated due to disease progression|1|||
170413557|NCT02540356|615854436|FG001|Overall Study|Terminated due to disease progression|0|||
170413558|NCT02795104|615854437|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
170413559|NCT02795104|615854438|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
170413560|NCT02795104|615854439|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
170413561|NCT02795104|615854437|FG000|Overall Study|Withdrawal by Subject|0|||
170413562|NCT02795104|615854438|FG001|Overall Study|Withdrawal by Subject|2|||
170413563|NCT02795104|615854439|FG002|Overall Study|Withdrawal by Subject|0|||
170413564|NCT02795104|615854437|FG000|Overall Study|Lost to Follow-up|0|||
170413565|NCT02795104|615854438|FG001|Overall Study|Lost to Follow-up|0|||
170413566|NCT02795104|615854439|FG002|Overall Study|Lost to Follow-up|1|||
170413567|NCT00948675|615854440|FG000|Overall Study|Lost to Follow-up|1|||
170413568|NCT00948675|615854441|FG001|Overall Study|Lost to Follow-up|0|||
170413569|NCT00684671|615854445|FG000|Overall Study|Adverse Event|1|||
170413570|NCT00684671|615854446|FG001|Overall Study|Adverse Event|0|||
170413571|NCT00684671|615854447|FG002|Overall Study|Adverse Event|0|||
170413572|NCT00684671|615854445|FG000|Overall Study|Lost to Follow-up|1|||
170413573|NCT00684671|615854446|FG001|Overall Study|Lost to Follow-up|0|||
170413574|NCT00684671|615854447|FG002|Overall Study|Lost to Follow-up|0|||
170413575|NCT00684671|615854445|FG000|Overall Study|Alcoholic dependance|1|||
170413576|NCT00684671|615854446|FG001|Overall Study|Alcoholic dependance|0|||
170413577|NCT00684671|615854447|FG002|Overall Study|Alcoholic dependance|0|||
170413578|NCT04128007|615854448|FG000|Overall Study|Withdrawal by Subject|9|||
170413579|NCT04128007|615854449|FG001|Overall Study|Withdrawal by Subject|6|||
170413580|NCT04128007|615854448|FG000|Overall Study|Protocol Violation|1|||
170413581|NCT04128007|615854449|FG001|Overall Study|Protocol Violation|0|||
170413582|NCT04128007|615854448|FG000|Overall Study|Lost to Follow-up|8|||
170524958|NCT00744939|616269982|FG000|Overall Study|coma|1|||
170524959|NCT00744939|616269982|FG000|Overall Study|incorrect race|1|||
170524960|NCT02914834|616269984|FG000|Overall Study|Study halted due to COVID|1|||
170872425|NCT01994382|617544802|FG013|Overall Study|Progressive disease|3|||
170872426|NCT01994382|617544803|FG014|Overall Study|Progressive disease|6|||
170872427|NCT01994382|617544804|FG015|Overall Study|Progressive disease|44|||
170872428|NCT01994382|617544805|FG016|Overall Study|Progressive disease|28|||
170872429|NCT01994382|617544789|FG000|Overall Study|Physician Decision|0|||
170872430|NCT01994382|617544790|FG001|Overall Study|Physician Decision|1|||
170872431|NCT01994382|617544791|FG002|Overall Study|Physician Decision|0|||
170872432|NCT01994382|617544792|FG003|Overall Study|Physician Decision|0|||
170872433|NCT01994382|617544793|FG004|Overall Study|Physician Decision|0|||
170872434|NCT01994382|617544794|FG005|Overall Study|Physician Decision|0|||
170872435|NCT01994382|617544795|FG006|Overall Study|Physician Decision|0|||
170872436|NCT01994382|617544796|FG007|Overall Study|Physician Decision|0|||
170632185|NCT00538902|616664551|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
170632186|NCT00538902|616664552|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
170632187|NCT00538902|616664550|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
170770969|NCT00516321|617167233|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
170770970|NCT00516321|617167231|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
170770971|NCT00516321|617167232|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
170770972|NCT00516321|617167233|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
170770973|NCT02271854|617167235|FG000|Overall Study|Withdrawal by Subject|2|||
170770974|NCT02271854|617167235|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
170770975|NCT02271854|617167235|FG000|Overall Study|Lost to Follow-up|1|||
170770976|NCT01308567|617167236|FG000|Overall Study|Lost to Follow-up|2|||
170770977|NCT01308567|617167237|FG001|Overall Study|Lost to Follow-up|4|||
170770978|NCT01308567|617167238|FG002|Overall Study|Lost to Follow-up|4|||
170770979|NCT01582100|617167241|FG000|Overall Study|Adverse Event|1|||
170770980|NCT01582100|617167241|FG000|Overall Study|Withdrawal by Subject|1|||
170770981|NCT00585052|617167244|FG000|Overall Study|Withdrawal by Subject|1|||
170770982|NCT02616900|617167245|FG000|Overall Study|Lack of Efficacy|7|||
170770983|NCT02616900|617167245|FG000|Overall Study|Lost to Follow-up|2|||
170770984|NCT02616900|617167245|FG000|Overall Study|Protocol Violation|5|||
170770985|NCT02616900|617167245|FG000|Overall Study|Withdrawal by Subject|3|||
170770986|NCT02616900|617167245|FG000|Overall Study|Incomplete data|6|||
170770987|NCT04425863|617167246|FG000|Overall Study|Death|0|||
170770988|NCT04425863|617167247|FG001|Overall Study|Death|0|||
170770989|NCT04425863|617167248|FG002|Overall Study|Death|1|||
170770990|NCT03691428|617167250|FG000|Overall Study|Withdrawal by Subject|6|||
170770991|NCT03691428|617167251|FG001|Overall Study|Withdrawal by Subject|8|||
170770992|NCT01460290|617167252|FG000|Overall Study|Adverse Event|3|||
170770993|NCT01460290|617167252|FG000|Overall Study|Elevated liver function|1|||
170770994|NCT02527148|617167253|FG000|Overall Study|Did not receive study intervention|1|||
170770995|NCT02527148|617167254|FG001|Overall Study|Did not receive study intervention|0|||
170770996|NCT00869258|617167261|FG000|Overall Study|Physician Decision|1|||
170770997|NCT00346151|617167262|FG000|Overall Study|Withdrawal by Subject|3|||
170770998|NCT00463788|617167265|FG000|Overall Study|Progressive Disease|86|||
170770999|NCT00463788|617167266|FG001|Overall Study|Progressive Disease|42|||
170771000|NCT00463788|617167265|FG000|Overall Study|Adverse Event|6|||
170771001|NCT00463788|617167266|FG001|Overall Study|Adverse Event|2|||
170771002|NCT00463788|617167265|FG000|Overall Study|Withdrawal by Subject|6|||
170771003|NCT00463788|617167266|FG001|Overall Study|Withdrawal by Subject|2|||
170771004|NCT00463788|617167265|FG000|Overall Study|Death|4|||
170771005|NCT00463788|617167266|FG001|Overall Study|Death|3|||
170771006|NCT00463788|617167265|FG000|Overall Study|Symptomatic Deterioration|2|||
170771007|NCT00463788|617167266|FG001|Overall Study|Symptomatic Deterioration|3|||
170771008|NCT00463788|617167265|FG000|Overall Study|Lost to Follow-up|1|||
170771009|NCT00463788|617167266|FG001|Overall Study|Lost to Follow-up|0|||
170771010|NCT00463788|617167265|FG000|Overall Study|Protocol Violation|0|||
170771011|NCT00463788|617167266|FG001|Overall Study|Protocol Violation|1|||
170771012|NCT00463788|617167265|FG000|Overall Study|Other|3|||
170771013|NCT00463788|617167266|FG001|Overall Study|Other|0|||
170771014|NCT00463788|617167265|FG000|Overall Study|Randomized but not treated|1|||
170771015|NCT00463788|617167266|FG001|Overall Study|Randomized but not treated|1|||
170771016|NCT00360698|617167267|FG000|Run-In|Physician Decision|0|||
170771017|NCT00360698|617167268|FG001|Run-In|Physician Decision|1|||
170771018|NCT00360698|617167267|FG000|Run-In|Withdrawal by Subject|0|||
170872437|NCT01994382|617544797|FG008|Overall Study|Physician Decision|0|||
170872438|NCT01994382|617544798|FG009|Overall Study|Physician Decision|0|||
170872439|NCT01994382|617544799|FG010|Overall Study|Physician Decision|3|||
170872440|NCT01994382|617544800|FG011|Overall Study|Physician Decision|1|||
170872441|NCT01994382|617544801|FG012|Overall Study|Physician Decision|1|||
170413583|NCT04128007|615854449|FG001|Overall Study|Lost to Follow-up|7|||
170413584|NCT04128007|615854448|FG000|Overall Study|Adverse Event|5|||
170413585|NCT04128007|615854449|FG001|Overall Study|Adverse Event|2|||
170413586|NCT04128007|615854448|FG000|Overall Study|Not reported|0|||
170413587|NCT04128007|615854449|FG001|Overall Study|Not reported|2|||
170413588|NCT00320593|615854450|FG000|Overall Study|Lost to Follow-up|3|||
170413589|NCT00320593|615854451|FG001|Overall Study|Lost to Follow-up|0|||
170413590|NCT00320593|615854450|FG000|Overall Study|Moved to another state|1|||
170872442|NCT01994382|617544802|FG013|Overall Study|Physician Decision|0|||
170872443|NCT01994382|617544803|FG014|Overall Study|Physician Decision|1|||
170872444|NCT01994382|617544804|FG015|Overall Study|Physician Decision|4|||
170872445|NCT01994382|617544805|FG016|Overall Study|Physician Decision|2|||
170872446|NCT01994382|617544789|FG000|Overall Study|Death|0|||
170872447|NCT01994382|617544790|FG001|Overall Study|Death|0|||
170872448|NCT01994382|617544791|FG002|Overall Study|Death|0|||
170872449|NCT01994382|617544792|FG003|Overall Study|Death|0|||
170872450|NCT01994382|617544793|FG004|Overall Study|Death|1|||
170872451|NCT01994382|617544794|FG005|Overall Study|Death|0|||
170771019|NCT00360698|617167268|FG001|Run-In|Withdrawal by Subject|2|||
170771020|NCT00360698|617167267|FG000|Run-In|Non compliance with treatment procedure|0|||
170771021|NCT00360698|617167268|FG001|Run-In|Non compliance with treatment procedure|1|||
170771022|NCT00360698|617167267|FG000|Run-In|Sponsor request|0|||
170771023|NCT00360698|617167268|FG001|Run-In|Sponsor request|2|||
170771024|NCT00360698|617167267|FG000|Run-In|Patient did not meet inclusion criteria|0|||
170771025|NCT00360698|617167268|FG001|Run-In|Patient did not meet inclusion criteria|1|||
170771026|NCT00360698|617167267|FG000|Run-In|Patient personal reasons|0|||
170771027|NCT00360698|617167268|FG001|Run-In|Patient personal reasons|2|||
170771028|NCT00360698|617167267|FG000|Run-In|Need of insulin with meals|0|||
170771029|NCT00360698|617167268|FG001|Run-In|Need of insulin with meals|1|||
170771030|NCT00360698|617167267|FG000|Treatment Period|Non compliance with treatment procedure|1|||
170771031|NCT00360698|617167268|FG001|Treatment Period|Non compliance with treatment procedure|0|||
170872452|NCT01994382|617544795|FG006|Overall Study|Death|0|||
170872453|NCT01994382|617544796|FG007|Overall Study|Death|0|||
170872454|NCT01994382|617544797|FG008|Overall Study|Death|1|||
170872455|NCT01994382|617544798|FG009|Overall Study|Death|1|||
170872456|NCT01994382|617544799|FG010|Overall Study|Death|0|||
170872457|NCT01994382|617544800|FG011|Overall Study|Death|0|||
170872458|NCT01994382|617544801|FG012|Overall Study|Death|0|||
170872459|NCT01994382|617544802|FG013|Overall Study|Death|0|||
170872460|NCT01994382|617544803|FG014|Overall Study|Death|0|||
170872461|NCT01994382|617544804|FG015|Overall Study|Death|1|||
170872462|NCT01994382|617544805|FG016|Overall Study|Death|0|||
170872463|NCT01994382|617544789|FG000|Overall Study|Adverse Event|0|||
170872464|NCT01994382|617544790|FG001|Overall Study|Adverse Event|1|||
170872465|NCT01994382|617544791|FG002|Overall Study|Adverse Event|2|||
170872466|NCT01994382|617544792|FG003|Overall Study|Adverse Event|0|||
170872467|NCT01994382|617544793|FG004|Overall Study|Adverse Event|0|||
170872468|NCT01994382|617544794|FG005|Overall Study|Adverse Event|0|||
170872469|NCT01994382|617544795|FG006|Overall Study|Adverse Event|0|||
170872470|NCT01994382|617544796|FG007|Overall Study|Adverse Event|0|||
170872471|NCT01994382|617544797|FG008|Overall Study|Adverse Event|0|||
170872472|NCT01994382|617544798|FG009|Overall Study|Adverse Event|0|||
170872473|NCT01994382|617544799|FG010|Overall Study|Adverse Event|15|||
170872474|NCT01994382|617544800|FG011|Overall Study|Adverse Event|2|||
170872475|NCT01994382|617544801|FG012|Overall Study|Adverse Event|7|||
170872476|NCT01994382|617544802|FG013|Overall Study|Adverse Event|3|||
170872477|NCT01994382|617544803|FG014|Overall Study|Adverse Event|17|||
170872478|NCT01994382|617544804|FG015|Overall Study|Adverse Event|6|||
170872479|NCT01994382|617544805|FG016|Overall Study|Adverse Event|3|||
170413591|NCT00320593|615854451|FG001|Overall Study|Moved to another state|0|||
170413592|NCT00320593|615854450|FG000|Overall Study|Withdrawal by Subject|2|||
170413593|NCT00320593|615854451|FG001|Overall Study|Withdrawal by Subject|1|||
170413594|NCT00320593|615854450|FG000|Overall Study|Withdrawal by clinical center|1|||
170413595|NCT00320593|615854451|FG001|Overall Study|Withdrawal by clinical center|0|||
170413596|NCT01076166|615854452|FG000|Overall Study|Adverse Event|3|||
170413597|NCT01076166|615854452|FG000|Overall Study|Symptoms improved/resolved|6|||
170413598|NCT02110706|615854455|FG000|Overall Study|Adverse Event|2|||
170413599|NCT02110706|615854456|FG001|Overall Study|Adverse Event|3|||
170413600|NCT02110706|615854455|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
170413601|NCT02110706|615854456|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
170413602|NCT02087059|615854457|FG000|Overall Study|Disease Progression|1|||
170413603|NCT02087059|615854457|FG000|Overall Study|Adverse Event|5|||
170413604|NCT02087059|615854457|FG000|Overall Study|Lost to Follow-up|1|||
170413605|NCT01564758|615854459|FG000|Overall Study|Death|8|||
170413606|NCT01564758|615854459|FG000|Overall Study|Adverse Event|3|||
170413607|NCT01564758|615854459|FG000|Overall Study|Other|3|||
170413608|NCT01227668|615854460|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
170413609|NCT01227668|615854461|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
170413610|NCT01227668|615854460|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
170771032|NCT00360698|617167267|FG000|Treatment Period|Early termination by error|0|||
170872480|NCT01994382|617544789|FG000|Overall Study|Other than specified|0|||
170872481|NCT01994382|617544790|FG001|Overall Study|Other than specified|0|||
170872482|NCT01994382|617544791|FG002|Overall Study|Other than specified|0|||
170872483|NCT01994382|617544792|FG003|Overall Study|Other than specified|0|||
170872484|NCT01994382|617544793|FG004|Overall Study|Other than specified|0|||
170872485|NCT01994382|617544794|FG005|Overall Study|Other than specified|0|||
170872486|NCT01994382|617544795|FG006|Overall Study|Other than specified|0|||
170524961|NCT02914834|616269985|FG001|Overall Study|Study halted due to COVID|1|||
170524962|NCT02914834|616269984|FG000|Overall Study|1 subject withdrew|0|||
170524963|NCT02914834|616269985|FG001|Overall Study|1 subject withdrew|1|||
170524964|NCT01122173|616269986|FG000|Overall Study|Lost to Follow-up|3|||
170524965|NCT01122173|616269986|FG000|Overall Study|Withdrawal by Subject|3|||
170524966|NCT01122173|616269986|FG000|Overall Study|Left study for other reasons|3|||
170524967|NCT02666222|616269988|FG000|Overall Study|Death|2|||
170771033|NCT00360698|617167268|FG001|Treatment Period|Early termination by error|1|||
170771034|NCT04530747|617167277|FG000|Overall Study|Withdrawal by Subject|1|||
170771035|NCT04530747|617167278|FG001|Overall Study|Withdrawal by Subject|0|||
170771036|NCT05283395|617167280|FG000|Overall Study|Adverse Event|4|||
170771037|NCT05283395|617167281|FG001|Overall Study|Adverse Event|4|||
170771038|NCT05283395|617167282|FG002|Overall Study|Adverse Event|0|||
170771039|NCT05283395|617167280|FG000|Overall Study|Patient Lost to Follow-Up|0|||
170771040|NCT05283395|617167281|FG001|Overall Study|Patient Lost to Follow-Up|0|||
170771041|NCT05283395|617167282|FG002|Overall Study|Patient Lost to Follow-Up|1|||
170771042|NCT05283395|617167280|FG000|Overall Study|Patient Withdrawal|2|||
170771043|NCT05283395|617167281|FG001|Overall Study|Patient Withdrawal|4|||
170771044|NCT05283395|617167282|FG002|Overall Study|Patient Withdrawal|2|||
170771045|NCT05283395|617167280|FG000|Overall Study|Investigator Decision|1|||
170771046|NCT05283395|617167281|FG001|Overall Study|Investigator Decision|0|||
170771047|NCT05283395|617167282|FG002|Overall Study|Investigator Decision|1|||
170771048|NCT05283395|617167280|FG000|Overall Study|Enrolled in error|0|||
170771049|NCT05283395|617167281|FG001|Overall Study|Enrolled in error|0|||
170771050|NCT05283395|617167282|FG002|Overall Study|Enrolled in error|1|||
170771051|NCT01264679|617167283|FG000|Overall Study|Participation in Another Clinical Trial|1|||
170771052|NCT01264679|617167283|FG000|Overall Study|Physician Decision|1|||
170771053|NCT01264679|617167283|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
170771054|NCT01264679|617167283|FG000|Overall Study|Withdrawal by Subject|1|||
170771055|NCT00529789|617167286|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
170771056|NCT00529789|617167286|FG000|Study Period II/III|Adverse Event|3|||
170771057|NCT00529789|617167286|FG000|Study Period II/III|Lack of Efficacy|2|||
170771058|NCT00529789|617167286|FG000|Study Period II/III|Withdrawal by Subject|1|||
170771059|NCT00529789|617167286|FG000|Study Period II/III|Protocol Violation|3|||
170771060|NCT00529789|617167286|FG000|Study Period II/III|Physician Decision|3|||
170771061|NCT00529789|617167286|FG000|Study Period II/III|Lost to Follow-up|3|||
170771062|NCT00529789|617167286|FG000|Study Period IV|Parent/Caregiver Decision|1|||
170771063|NCT00529789|617167286|FG000|Study Period IV|Adverse Event|1|||
170771064|NCT00529789|617167286|FG000|Study Period IV|Lack of Efficacy|1|||
170771065|NCT00529789|617167286|FG000|Study Period IV|Lost to Follow-up|3|||
170771066|NCT03194958|617167287|FG000|Overall Study|Death|0|||
170771067|NCT03194958|617167288|FG001|Overall Study|Death|1|||
170771068|NCT03194958|617167289|FG002|Overall Study|Death|1|||
170771069|NCT03194958|617167290|FG003|Overall Study|Death|1|||
170771070|NCT03194958|617167287|FG000|Overall Study|Withdrawal by Subject|24|||
170771071|NCT03194958|617167288|FG001|Overall Study|Withdrawal by Subject|27|||
170771072|NCT03194958|617167289|FG002|Overall Study|Withdrawal by Subject|7|||
170771073|NCT03194958|617167290|FG003|Overall Study|Withdrawal by Subject|22|||
170771074|NCT03194958|617167287|FG000|Overall Study|Lost to Follow-up|168|||
170771075|NCT03194958|617167288|FG001|Overall Study|Lost to Follow-up|196|||
170771076|NCT03194958|617167289|FG002|Overall Study|Lost to Follow-up|174|||
170771077|NCT03194958|617167290|FG003|Overall Study|Lost to Follow-up|186|||
170771078|NCT00457743|617167291|FG000|Overall Study|Adverse Event|0|||
170771079|NCT00457743|617167292|FG001|Overall Study|Adverse Event|4|||
170771080|NCT00457743|617167293|FG002|Overall Study|Adverse Event|0|||
170771081|NCT00457743|617167291|FG000|Overall Study|Lack of Efficacy|3|||
170771082|NCT00457743|617167292|FG001|Overall Study|Lack of Efficacy|23|||
170771083|NCT00457743|617167293|FG002|Overall Study|Lack of Efficacy|3|||
170771084|NCT00566527|617167294|FG000|Overall Study|Reason not provided|3|||
170771085|NCT00566527|617167295|FG001|Overall Study|Reason not provided|11|||
170771086|NCT00566527|617167296|FG002|Overall Study|Reason not provided|10|||
170872487|NCT01994382|617544796|FG007|Overall Study|Other than specified|0|||
170524968|NCT03504917|616269990|FG000|Blinded Treatment Period|Protocol Violation|1|||
170771087|NCT00566527|617167294|FG000|Overall Study|Adverse Event|2|||
170771088|NCT00566527|617167295|FG001|Overall Study|Adverse Event|0|||
170771089|NCT00566527|617167296|FG002|Overall Study|Adverse Event|1|||
170771090|NCT00566527|617167294|FG000|Overall Study|Physician Decision|3|||
170771091|NCT00566527|617167295|FG001|Overall Study|Physician Decision|8|||
170524969|NCT03504917|616269991|FG001|Blinded Treatment Period|Protocol Violation|0|||
170524970|NCT03504917|616269990|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
170771092|NCT00566527|617167296|FG002|Overall Study|Physician Decision|20|||
170771093|NCT00566527|617167294|FG000|Overall Study|Lost to Follow-up|3|||
170771094|NCT00566527|617167295|FG001|Overall Study|Lost to Follow-up|4|||
170771095|NCT00566527|617167296|FG002|Overall Study|Lost to Follow-up|4|||
170771096|NCT00566527|617167294|FG000|Overall Study|Withdrawal by Subject|6|||
170771097|NCT00566527|617167295|FG001|Overall Study|Withdrawal by Subject|43|||
170771098|NCT00566527|617167296|FG002|Overall Study|Withdrawal by Subject|43|||
170771099|NCT01202955|617167297|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
170524971|NCT03504917|616269991|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
170524972|NCT03504917|616269990|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
170524973|NCT03504917|616269991|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
170524974|NCT03504917|616269990|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
170524975|NCT03504917|616269991|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
170524976|NCT03504917|616269990|FG000|Blinded Treatment Period|Adverse Event|4|||
170524977|NCT03504917|616269991|FG001|Blinded Treatment Period|Adverse Event|4|||
170771100|NCT01202955|617167298|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
170771101|NCT04975308|617167306|FG000|Overall Study|Withdrawal by Subject|6|||
170524978|NCT03504917|616269990|FG000|Blinded Treatment Period|Physician Decision|1|||
170524979|NCT03504917|616269991|FG001|Blinded Treatment Period|Physician Decision|0|||
170524980|NCT03504917|616269990|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
170524981|NCT03504917|616269991|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
170524982|NCT03504917|616269990|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
170524983|NCT03504917|616269991|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
170524984|NCT03504917|616269990|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
170524985|NCT03504917|616269991|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
170524986|NCT03504917|616269990|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
170524987|NCT03504917|616269991|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
170524988|NCT03504917|616269990|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
170524989|NCT03504917|616269991|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
170524990|NCT03504917|616269990|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
170524991|NCT03504917|616269991|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
170524992|NCT03504917|616269990|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
170524993|NCT03504917|616269991|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
170524994|NCT03504917|616269990|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
170524995|NCT03504917|616269991|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
170524996|NCT03504917|616269990|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
170524997|NCT03504917|616269991|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
170524998|NCT03504917|616269990|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
170524999|NCT03504917|616269991|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
170525000|NCT06058390|616269992|FG000|Overall Study|Lost to Follow-up|0|||
170525001|NCT06058390|616269993|FG001|Overall Study|Lost to Follow-up|0|||
170525002|NCT06058390|616269994|FG002|Overall Study|Lost to Follow-up|2|||
170525003|NCT06058390|616269995|FG003|Overall Study|Lost to Follow-up|1|||
170525004|NCT06058390|616269992|FG000|Overall Study|Physician Decision|0|||
170525005|NCT06058390|616269993|FG001|Overall Study|Physician Decision|0|||
170525006|NCT06058390|616269994|FG002|Overall Study|Physician Decision|0|||
170525007|NCT06058390|616269995|FG003|Overall Study|Physician Decision|1|||
170632188|NCT00538902|616664551|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
170632189|NCT00538902|616664552|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
170632190|NCT00538902|616664550|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
170632191|NCT00538902|616664551|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
170413611|NCT01227668|615854461|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
170413612|NCT01227668|615854460|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
170413613|NCT01227668|615854461|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
170413614|NCT01227668|615854460|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
170413615|NCT01227668|615854461|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
170413616|NCT01227668|615854460|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
170413617|NCT01227668|615854461|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
170413618|NCT01227668|615854460|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
170413619|NCT01227668|615854461|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
170413620|NCT01227668|615854460|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
170413621|NCT01227668|615854461|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
170632192|NCT00538902|616664552|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
170632193|NCT00538902|616664550|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
170632194|NCT00538902|616664551|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
170632195|NCT00538902|616664552|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
170632196|NCT00538902|616664550|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
170771102|NCT04975308|617167307|FG001|Overall Study|Withdrawal by Subject|16|||
170771103|NCT04975308|617167308|FG002|Overall Study|Withdrawal by Subject|6|||
170771104|NCT04975308|617167306|FG000|Overall Study|Physician Decision|0|||
170771105|NCT04975308|617167307|FG001|Overall Study|Physician Decision|3|||
170771106|NCT04975308|617167308|FG002|Overall Study|Physician Decision|1|||
170771107|NCT04975308|617167306|FG000|Overall Study|Adverse Event|10|||
170771108|NCT04975308|617167307|FG001|Overall Study|Adverse Event|1|||
170771109|NCT04975308|617167308|FG002|Overall Study|Adverse Event|12|||
170413622|NCT01227668|615854460|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
170525008|NCT06058390|616269992|FG000|Overall Study|Participants did not receive any study intervention|0|||
170525009|NCT06058390|616269993|FG001|Overall Study|Participants did not receive any study intervention|0|||
170525010|NCT06058390|616269994|FG002|Overall Study|Participants did not receive any study intervention|0|||
170525011|NCT06058390|616269995|FG003|Overall Study|Participants did not receive any study intervention|1|||
170525012|NCT03863353|616269996|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
170525013|NCT03863353|616269997|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
170525014|NCT02495389|616269998|FG000|Overall Study|Withdrawal by Subject|40|||
170525015|NCT04079790|616270002|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
170525016|NCT04079790|616270003|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
170525017|NCT04079790|616270004|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
170525018|NCT04079790|616270005|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
170525019|NCT04079790|616270002|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
170525020|NCT04079790|616270003|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
170525021|NCT04079790|616270004|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
170525022|NCT04079790|616270005|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
170525023|NCT04079790|616270002|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
170525024|NCT04079790|616270003|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
170525025|NCT04079790|616270004|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
170525026|NCT04079790|616270005|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
170525027|NCT01924533|616270006|FG000|Overall Study|Death|181|||
170525028|NCT01924533|616270007|FG001|Overall Study|Death|200|||
170525029|NCT01924533|616270006|FG000|Overall Study|Lost to Follow-up|0|||
170525030|NCT01924533|616270007|FG001|Overall Study|Lost to Follow-up|1|||
170525031|NCT01924533|616270006|FG000|Overall Study|Withdrawal by Subject|7|||
170525032|NCT01924533|616270007|FG001|Overall Study|Withdrawal by Subject|3|||
170525033|NCT01924533|616270006|FG000|Overall Study|Other Eligibility criteria|1|||
170771110|NCT04975308|617167306|FG000|Overall Study|On study treatment (Ongoing)|65|||
170771111|NCT04975308|617167307|FG001|Overall Study|On study treatment (Ongoing)|43|||
170771112|NCT04975308|617167308|FG002|Overall Study|On study treatment (Ongoing)|75|||
170771113|NCT04975308|617167306|FG000|Overall Study|Protocol Deviation|4|||
170771114|NCT04975308|617167307|FG001|Overall Study|Protocol Deviation|3|||
170771115|NCT04975308|617167308|FG002|Overall Study|Protocol Deviation|2|||
170771116|NCT00468910|617167309|FG000|Overall Study|Lost to Follow-up|2|||
170771117|NCT00468910|617167310|FG001|Overall Study|Lost to Follow-up|1|||
170771118|NCT00468910|617167309|FG000|Overall Study|Withdrawal by Subject|2|||
170771119|NCT00468910|617167310|FG001|Overall Study|Withdrawal by Subject|1|||
170771120|NCT00468910|617167309|FG000|Overall Study|Medical Contraindication|0|||
170771121|NCT00468910|617167310|FG001|Overall Study|Medical Contraindication|1|||
170771122|NCT01909778|617167311|FG000|Overall Study|failed screening|1|||
170771123|NCT01943916|617167312|FG000|Overall Study|Technically invalid images|10|||
170771124|NCT01943916|617167312|FG000|Overall Study|Enrollment Failure|23|||
170771125|NCT01943916|617167312|FG000|Overall Study|Pilot Phase exclusion|100|||
170771126|NCT01943916|617167312|FG000|Overall Study|Quality Assurance Reader Fail|130|||
170771127|NCT01943916|617167312|FG000|Overall Study|Technical Failure|39|||
170771128|NCT01943916|617167312|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
170771129|NCT01943916|617167312|FG000|Overall Study|No Truth Panel Review|38|||
170771130|NCT01943916|617167312|FG000|Overall Study|Protocol Deviation|1|||
170771131|NCT00919763|617167313|FG000|Overall Study|Adverse Event|7|||
170771132|NCT00919763|617167314|FG001|Overall Study|Adverse Event|1|||
170771133|NCT00919763|617167313|FG000|Overall Study|Lost to Follow-up|1|||
170771134|NCT00919763|617167314|FG001|Overall Study|Lost to Follow-up|0|||
170771135|NCT00919763|617167313|FG000|Overall Study|Protocol Violation|1|||
170771136|NCT00919763|617167314|FG001|Overall Study|Protocol Violation|1|||
170771137|NCT00919763|617167313|FG000|Overall Study|Withdrawal by Subject|3|||
170771138|NCT00919763|617167314|FG001|Overall Study|Withdrawal by Subject|1|||
170771139|NCT00919763|617167313|FG000|Overall Study|Non-compliance|0|||
170771140|NCT00919763|617167314|FG001|Overall Study|Non-compliance|1|||
170771141|NCT00547118|617167315|FG000|Overall Study|Did not qualify prior to starting drug|1|||
170525034|NCT01924533|616270007|FG001|Overall Study|Other Eligibility criteria|1|||
170525035|NCT03585270|616270010|FG000|Overall Study|Withdrawal by Subject|2|||
170525036|NCT03585270|616270011|FG001|Overall Study|Withdrawal by Subject|6|||
170771142|NCT00547118|617167316|FG001|Overall Study|Did not qualify prior to starting drug|1|||
170771143|NCT00547118|617167315|FG000|Overall Study|Study suspended|7|||
170771144|NCT00547118|617167316|FG001|Overall Study|Study suspended|8|||
170771145|NCT01595321|617167317|FG000|Overall Study|Adverse Event|1|||
170771146|NCT01595321|617167318|FG001|Overall Study|Adverse Event|1|||
170771147|NCT01595321|617167319|FG002|Overall Study|Adverse Event|1|||
170771148|NCT01595321|617167317|FG000|Overall Study|Lack of Efficacy|0|||
170771149|NCT01595321|617167318|FG001|Overall Study|Lack of Efficacy|0|||
170771150|NCT01595321|617167319|FG002|Overall Study|Lack of Efficacy|4|||
170771151|NCT00373529|617167320|FG000|Overall Study|Physician Decision|19|||
170771152|NCT00373529|617167320|FG000|Overall Study|Withdrawal by Subject|7|||
170771153|NCT00373529|617167320|FG000|Overall Study|Adverse Event|7|||
170771154|NCT00373529|617167320|FG000|Overall Study|Treatment failure|36|||
170872488|NCT01994382|617544797|FG008|Overall Study|Other than specified|0|||
170872489|NCT01994382|617544798|FG009|Overall Study|Other than specified|0|||
170872490|NCT01994382|617544799|FG010|Overall Study|Other than specified|2|||
170872491|NCT01994382|617544800|FG011|Overall Study|Other than specified|0|||
170872492|NCT01994382|617544801|FG012|Overall Study|Other than specified|2|||
170872493|NCT01994382|617544802|FG013|Overall Study|Other than specified|0|||
170872494|NCT01994382|617544803|FG014|Overall Study|Other than specified|0|||
170872495|NCT01994382|617544804|FG015|Overall Study|Other than specified|4|||
170872496|NCT01994382|617544805|FG016|Overall Study|Other than specified|4|||
170872497|NCT01994382|617544789|FG000|Overall Study|Withdrawal by Subject|0|||
170872498|NCT01994382|617544790|FG001|Overall Study|Withdrawal by Subject|0|||
170872499|NCT01994382|617544791|FG002|Overall Study|Withdrawal by Subject|0|||
170872500|NCT01994382|617544792|FG003|Overall Study|Withdrawal by Subject|0|||
170872501|NCT01994382|617544793|FG004|Overall Study|Withdrawal by Subject|0|||
170872502|NCT01994382|617544794|FG005|Overall Study|Withdrawal by Subject|0|||
170872503|NCT01994382|617544795|FG006|Overall Study|Withdrawal by Subject|0|||
170872504|NCT01994382|617544796|FG007|Overall Study|Withdrawal by Subject|0|||
170872505|NCT01994382|617544797|FG008|Overall Study|Withdrawal by Subject|0|||
170872506|NCT01994382|617544798|FG009|Overall Study|Withdrawal by Subject|0|||
170872507|NCT01994382|617544799|FG010|Overall Study|Withdrawal by Subject|6|||
170872508|NCT01994382|617544800|FG011|Overall Study|Withdrawal by Subject|0|||
170872509|NCT01994382|617544801|FG012|Overall Study|Withdrawal by Subject|2|||
170872510|NCT01994382|617544802|FG013|Overall Study|Withdrawal by Subject|0|||
170872511|NCT01994382|617544803|FG014|Overall Study|Withdrawal by Subject|4|||
170872512|NCT01994382|617544804|FG015|Overall Study|Withdrawal by Subject|3|||
170872513|NCT01994382|617544805|FG016|Overall Study|Withdrawal by Subject|0|||
170872514|NCT01994382|617544789|FG000|Overall Study|Lost to Follow-up|0|||
170872515|NCT01994382|617544790|FG001|Overall Study|Lost to Follow-up|0|||
170872516|NCT01994382|617544791|FG002|Overall Study|Lost to Follow-up|0|||
170872517|NCT01994382|617544792|FG003|Overall Study|Lost to Follow-up|0|||
170872518|NCT01994382|617544793|FG004|Overall Study|Lost to Follow-up|0|||
170872519|NCT01994382|617544794|FG005|Overall Study|Lost to Follow-up|0|||
170872520|NCT01994382|617544795|FG006|Overall Study|Lost to Follow-up|0|||
170872521|NCT01994382|617544796|FG007|Overall Study|Lost to Follow-up|0|||
170872522|NCT01994382|617544797|FG008|Overall Study|Lost to Follow-up|0|||
170872523|NCT01994382|617544798|FG009|Overall Study|Lost to Follow-up|0|||
170872524|NCT01994382|617544799|FG010|Overall Study|Lost to Follow-up|1|||
170872525|NCT01994382|617544800|FG011|Overall Study|Lost to Follow-up|0|||
170525037|NCT03585270|616270010|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
170525038|NCT03585270|616270011|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
170525039|NCT03585270|616270010|FG000|Overall Study|Adverse Event|5|||
170525040|NCT03585270|616270011|FG001|Overall Study|Adverse Event|2|||
170525041|NCT03585270|616270010|FG000|Overall Study|Lost to Follow-up|1|||
170525042|NCT03585270|616270011|FG001|Overall Study|Lost to Follow-up|4|||
170771155|NCT00373529|617167320|FG000|Overall Study|Disease recurrence|10|||
170771156|NCT00373529|617167320|FG000|Overall Study|Death|16|||
170771157|NCT00373529|617167320|FG000|Overall Study|Need for treatment prohibited by study|1|||
170771158|NCT00373529|617167320|FG000|Overall Study|Other|8|||
170771159|NCT00373529|617167320|FG000|Overall Study|Failed independent confirmation of AML|3|||
170771160|NCT00373529|617167320|FG000|Overall Study|Consent violation|1|||
170771161|NCT04795752|617167321|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
170771162|NCT04795752|617167322|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
170771163|NCT04795752|617167321|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
170771164|NCT04795752|617167322|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
170771165|NCT04795752|617167321|FG000|Primary Endpoint Phase|Physician Decision|2|||
170771166|NCT04795752|617167322|FG001|Primary Endpoint Phase|Physician Decision|0|||
170771167|NCT04795752|617167321|FG000|Primary Endpoint Phase|Other|4|||
170771168|NCT04795752|617167322|FG001|Primary Endpoint Phase|Other|1|||
170771169|NCT04795752|617167321|FG000|Primary Endpoint Phase|Protocol Violation|1|||
170771170|NCT04795752|617167322|FG001|Primary Endpoint Phase|Protocol Violation|0|||
170771171|NCT04795752|617167321|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
170771172|NCT04795752|617167322|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
170771173|NCT04795752|617167321|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
170771174|NCT04795752|617167322|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
170771175|NCT04795752|617167321|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
170771176|NCT04795752|617167322|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
170771177|NCT04795752|617167321|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
170771178|NCT04795752|617167322|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
170771179|NCT04795752|617167321|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
170771180|NCT04795752|617167322|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
170771181|NCT00792948|617167323|FG000|Overall Study|Adverse Event|6|||
170771182|NCT00792948|617167323|FG000|Overall Study|Death|4|||
170771183|NCT00792948|617167323|FG000|Overall Study|Withdrawal by Subject|3|||
170771184|NCT00792948|617167323|FG000|Overall Study|Ineligible|2|||
170771185|NCT00792948|617167323|FG000|Overall Study|Insurance denial - not treated|1|||
170872526|NCT01994382|617544801|FG012|Overall Study|Lost to Follow-up|0|||
170872527|NCT01994382|617544802|FG013|Overall Study|Lost to Follow-up|0|||
170872528|NCT01994382|617544803|FG014|Overall Study|Lost to Follow-up|0|||
170872529|NCT01994382|617544804|FG015|Overall Study|Lost to Follow-up|0|||
170872530|NCT01994382|617544805|FG016|Overall Study|Lost to Follow-up|0|||
170872531|NCT01994382|617544789|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872532|NCT01994382|617544790|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872533|NCT01994382|617544791|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872534|NCT01994382|617544792|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872535|NCT01994382|617544793|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872536|NCT01994382|617544794|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872537|NCT01994382|617544795|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872538|NCT01994382|617544796|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872539|NCT01994382|617544797|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872540|NCT01994382|617544798|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170413623|NCT01227668|615854461|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
170413624|NCT01227668|615854460|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
170413625|NCT01227668|615854461|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
170413626|NCT01227668|615854460|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
170413627|NCT01227668|615854461|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
170413628|NCT01227668|615854460|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
170413629|NCT01227668|615854461|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
170413630|NCT01227668|615854460|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
170413631|NCT01227668|615854461|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
170413632|NCT04317599|615854462|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
170413633|NCT04317599|615854462|FG000|Overall Study|treatment outside standard of care|4|||
170413634|NCT00947427|615854463|FG000|Overall Study|Withdrawal by Subject|1|||
170413635|NCT00947427|615854464|FG001|Overall Study|Withdrawal by Subject|3|||
170413636|NCT00947427|615854463|FG000|Overall Study|Protocol Violation|0|||
170413637|NCT00947427|615854464|FG001|Overall Study|Protocol Violation|1|||
170413638|NCT00249821|615854465|FG000|Overall Study|Technical problem|0|||
170413639|NCT00249821|615854466|FG001|Overall Study|Technical problem|1|||
170413640|NCT03199274|615854468|FG000|Overall Study|Withdrawal by Subject|4|||
170413641|NCT03199274|615854469|FG001|Overall Study|Withdrawal by Subject|0|||
170413642|NCT03199274|615854468|FG000|Overall Study|Lost to Follow-up|0|||
170413643|NCT03199274|615854469|FG001|Overall Study|Lost to Follow-up|1|||
170413644|NCT03199274|615854468|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
170413645|NCT03199274|615854469|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
170413646|NCT00385541|615854472|FG000|Overall Study|severe pain, clinician requested unblind|0|||
170413647|NCT00385541|615854473|FG001|Overall Study|severe pain, clinician requested unblind|1|||
170413648|NCT01893138|615854474|FG000|Double-Blind Period|Withdrawal by Subject|1|||
170413649|NCT01893138|615854475|FG001|Double-Blind Period|Withdrawal by Subject|1|||
170413650|NCT01893138|615854474|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
170413651|NCT01893138|615854475|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
170413652|NCT01893138|615854474|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
170413653|NCT01893138|615854475|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
170413654|NCT01893138|615854474|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
170413655|NCT01893138|615854475|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
170413656|NCT01893138|615854474|FG000|Open Label - Unblinded Period|Adverse Event|1|||
170413657|NCT01893138|615854475|FG001|Open Label - Unblinded Period|Adverse Event|0|||
170413658|NCT04567615|615854476|FG000|Randomization|Participant withdrew consent|1|||
170413659|NCT04567615|615854477|FG001|Randomization|Participant withdrew consent|0|||
170413660|NCT04567615|615854478|FG002|Randomization|Participant withdrew consent|0|||
170413661|NCT04567615|615854476|FG000|Randomization|Adverse event unrelated to study drug|0|||
170413662|NCT04567615|615854477|FG001|Randomization|Adverse event unrelated to study drug|1|||
170413663|NCT04567615|615854478|FG002|Randomization|Adverse event unrelated to study drug|0|||
170413664|NCT04567615|615854476|FG000|Treatment Period|Participant Withdrew Consent|2|||
170413665|NCT04567615|615854477|FG001|Treatment Period|Participant Withdrew Consent|5|||
170413666|NCT04567615|615854478|FG002|Treatment Period|Participant Withdrew Consent|1|||
170413667|NCT04567615|615854476|FG000|Treatment Period|Death|1|||
170413668|NCT04567615|615854477|FG001|Treatment Period|Death|2|||
170413669|NCT04567615|615854478|FG002|Treatment Period|Death|0|||
170413670|NCT04567615|615854476|FG000|Treatment Period|Lost to Follow-up|0|||
170413671|NCT04567615|615854477|FG001|Treatment Period|Lost to Follow-up|1|||
170525043|NCT03585270|616270010|FG000|Overall Study|Death|5|||
170525044|NCT03585270|616270011|FG001|Overall Study|Death|3|||
170525045|NCT03585270|616270010|FG000|Overall Study|Other reasons|2|||
170525046|NCT03585270|616270011|FG001|Overall Study|Other reasons|2|||
170525047|NCT03810183|616270012|FG000|Overall Study|Study terminated by Sponsor|2|||
170525048|NCT03810183|616270013|FG001|Overall Study|Study terminated by Sponsor|1|||
170525049|NCT01701674|616270014|FG000|Overall Study|Unable to safely complete treatment|1|||
170525050|NCT00323063|616270015|FG000|Overall Study|Adverse Event|1|||
170525051|NCT00323063|616270016|FG001|Overall Study|Adverse Event|0|||
170525052|NCT00323063|616270015|FG000|Overall Study|brain mets discovered prior to treatment|1|||
170525053|NCT00323063|616270016|FG001|Overall Study|brain mets discovered prior to treatment|0|||
170525054|NCT03055936|616270017|FG000|Overall Study|Adverse Event|0|||
170525055|NCT03055936|616270018|FG001|Overall Study|Adverse Event|1|||
170525056|NCT03055936|616270019|FG002|Overall Study|Adverse Event|1|||
170525057|NCT03055936|616270020|FG003|Overall Study|Adverse Event|1|||
170525058|NCT03055936|616270017|FG000|Overall Study|Personal reason|2|||
170525059|NCT03055936|616270018|FG001|Overall Study|Personal reason|0|||
170525060|NCT03055936|616270019|FG002|Overall Study|Personal reason|1|||
170525061|NCT03055936|616270020|FG003|Overall Study|Personal reason|0|||
170525062|NCT03904693|616270021|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
170525063|NCT03904693|616270022|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
170525064|NCT03904693|616270023|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
170525065|NCT03904693|616270024|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
170525066|NCT03904693|616270025|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
170525067|NCT03904693|616270026|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
170525068|NCT03904693|616270021|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170525069|NCT03904693|616270022|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170525070|NCT03904693|616270023|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
170525071|NCT03904693|616270024|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170525072|NCT03904693|616270025|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170525073|NCT03904693|616270026|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170525074|NCT03904693|616270021|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
170525075|NCT03904693|616270022|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
170525076|NCT03904693|616270023|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
170525077|NCT03904693|616270024|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
170525078|NCT03904693|616270025|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
170525079|NCT03904693|616270026|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
170525080|NCT03904693|616270021|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
170525081|NCT03904693|616270022|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
170525082|NCT03904693|616270023|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
170525083|NCT03904693|616270024|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
170525084|NCT03904693|616270025|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
170525085|NCT03904693|616270026|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
170525086|NCT03904693|616270021|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
170525087|NCT03904693|616270022|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
170525088|NCT03904693|616270023|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
170525089|NCT03904693|616270024|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
170525090|NCT03904693|616270025|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
170525091|NCT03904693|616270026|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
170525092|NCT03904693|616270021|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
170525093|NCT03904693|616270022|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
170525094|NCT03904693|616270023|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
170525095|NCT03904693|616270024|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
170525096|NCT03904693|616270025|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
170525097|NCT03904693|616270026|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
170525098|NCT03904693|616270021|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
170525099|NCT03904693|616270022|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
170525100|NCT03904693|616270023|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
170525101|NCT03904693|616270024|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
170525102|NCT03904693|616270025|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
170525103|NCT03904693|616270026|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
170525104|NCT03904693|616270021|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
170525105|NCT03904693|616270022|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
170771186|NCT00792948|617167323|FG000|Overall Study|Physician Decision|11|||
170771187|NCT00792948|617167323|FG000|Overall Study|Protocol Violation|1|||
170771188|NCT04623008|617168356|FG000|Baseline to T2|Withdrawal by Subject|4|||
170771189|NCT04623008|617168357|FG001|Baseline to T2|Withdrawal by Subject|2|||
170771190|NCT04623008|617168356|FG000|Baseline to T3|Withdrawal by Subject|4|||
170413672|NCT04567615|615854478|FG002|Treatment Period|Lost to Follow-up|0|||
170413673|NCT04567615|615854476|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170413674|NCT04567615|615854477|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
170413675|NCT04567615|615854478|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170413676|NCT04567615|615854476|FG000|Treatment Period|Disease Progression|85|||
170413677|NCT04567615|615854477|FG001|Treatment Period|Disease Progression|63|||
170413678|NCT04567615|615854478|FG002|Treatment Period|Disease Progression|16|||
170413679|NCT04567615|615854476|FG000|Treatment Period|Study Drug Toxicity|3|||
170413680|NCT04567615|615854477|FG001|Treatment Period|Study Drug Toxicity|10|||
170413681|NCT04567615|615854478|FG002|Treatment Period|Study Drug Toxicity|4|||
170413682|NCT04567615|615854476|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
170413683|NCT04567615|615854477|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
170413684|NCT04567615|615854478|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
170413685|NCT04567615|615854476|FG000|Treatment Period|Other Reasons|1|||
170413686|NCT04567615|615854477|FG001|Treatment Period|Other Reasons|2|||
170413687|NCT04567615|615854478|FG002|Treatment Period|Other Reasons|0|||
170413688|NCT04567615|615854476|FG000|Treatment Period|Still On-going Treatment|21|||
170413689|NCT04567615|615854477|FG001|Treatment Period|Still On-going Treatment|22|||
170413690|NCT04567615|615854478|FG002|Treatment Period|Still On-going Treatment|2|||
170413691|NCT02146430|615855997|FG000|Overall Study|Protocol Violation|5|||
170413692|NCT02146430|615855998|FG001|Overall Study|Protocol Violation|4|||
170413693|NCT02146430|615855999|FG002|Overall Study|Protocol Violation|8|||
170413694|NCT02146430|615856000|FG003|Overall Study|Protocol Violation|6|||
170413695|NCT02146430|615855997|FG000|Overall Study|Lack of Efficacy|13|||
170413696|NCT02146430|615855998|FG001|Overall Study|Lack of Efficacy|11|||
170413697|NCT02146430|615855999|FG002|Overall Study|Lack of Efficacy|8|||
170413698|NCT02146430|615856000|FG003|Overall Study|Lack of Efficacy|5|||
170771191|NCT04623008|617168357|FG001|Baseline to T3|Withdrawal by Subject|2|||
170771192|NCT03122886|617168369|FG000|Overall Study|Withdrawal by Subject|1|||
170771193|NCT03122886|617168370|FG001|Overall Study|Withdrawal by Subject|2|||
170771194|NCT04688450|617168379|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
170771195|NCT04688450|617168379|FG000|Overall Study|Withdrawal by Subject|1|||
170771196|NCT02544074|617168380|FG000|Overall Study|Withdrawal by Subject|0|||
170771197|NCT02544074|617168381|FG001|Overall Study|Withdrawal by Subject|1|||
170771198|NCT02544074|617168382|FG002|Overall Study|Withdrawal by Subject|0|||
170771199|NCT02544074|617168383|FG003|Overall Study|Withdrawal by Subject|0|||
170771200|NCT02544074|617168384|FG004|Overall Study|Withdrawal by Subject|0|||
170771201|NCT02544074|617168385|FG005|Overall Study|Withdrawal by Subject|0|||
170771202|NCT02544074|617168386|FG006|Overall Study|Withdrawal by Subject|0|||
170771203|NCT02544074|617168387|FG007|Overall Study|Withdrawal by Subject|0|||
170771204|NCT02544074|617168388|FG008|Overall Study|Withdrawal by Subject|0|||
170771205|NCT02544074|617168389|FG009|Overall Study|Withdrawal by Subject|0|||
170771206|NCT02544074|617168390|FG010|Overall Study|Withdrawal by Subject|0|||
170771207|NCT02544074|617168391|FG011|Overall Study|Withdrawal by Subject|0|||
170771208|NCT02544074|617168392|FG012|Overall Study|Withdrawal by Subject|0|||
170771209|NCT02544074|617168393|FG013|Overall Study|Withdrawal by Subject|0|||
170771210|NCT02544074|617168394|FG014|Overall Study|Withdrawal by Subject|0|||
170771211|NCT02544074|617168395|FG015|Overall Study|Withdrawal by Subject|0|||
170771212|NCT02544074|617168396|FG016|Overall Study|Withdrawal by Subject|0|||
170771213|NCT02544074|617168397|FG017|Overall Study|Withdrawal by Subject|0|||
170771214|NCT02544074|617168398|FG018|Overall Study|Withdrawal by Subject|0|||
170771215|NCT02544074|617168399|FG019|Overall Study|Withdrawal by Subject|0|||
170771216|NCT02544074|617168400|FG020|Overall Study|Withdrawal by Subject|0|||
170771217|NCT02544074|617168380|FG000|Overall Study|Tablet error|0|||
170771218|NCT02544074|617168381|FG001|Overall Study|Tablet error|0|||
170771219|NCT02544074|617168382|FG002|Overall Study|Tablet error|0|||
170771220|NCT02544074|617168383|FG003|Overall Study|Tablet error|0|||
170771221|NCT02544074|617168384|FG004|Overall Study|Tablet error|0|||
170771222|NCT02544074|617168385|FG005|Overall Study|Tablet error|1|||
170771223|NCT02544074|617168386|FG006|Overall Study|Tablet error|0|||
170771224|NCT02544074|617168387|FG007|Overall Study|Tablet error|0|||
170771225|NCT02544074|617168388|FG008|Overall Study|Tablet error|0|||
170771226|NCT02544074|617168389|FG009|Overall Study|Tablet error|1|||
170771227|NCT02544074|617168390|FG010|Overall Study|Tablet error|0|||
170771228|NCT02544074|617168391|FG011|Overall Study|Tablet error|0|||
170413699|NCT02146430|615855997|FG000|Overall Study|Adverse Event|20|||
170413700|NCT02146430|615855998|FG001|Overall Study|Adverse Event|40|||
170413701|NCT02146430|615855999|FG002|Overall Study|Adverse Event|32|||
170771229|NCT02544074|617168392|FG012|Overall Study|Tablet error|0|||
170771230|NCT02544074|617168393|FG013|Overall Study|Tablet error|0|||
170771231|NCT02544074|617168394|FG014|Overall Study|Tablet error|0|||
170771232|NCT02544074|617168395|FG015|Overall Study|Tablet error|0|||
170771233|NCT02544074|617168396|FG016|Overall Study|Tablet error|0|||
170413702|NCT02146430|615856000|FG003|Overall Study|Adverse Event|49|||
170413703|NCT02146430|615855997|FG000|Overall Study|Reason missing or not reported|2|||
170413704|NCT02146430|615855998|FG001|Overall Study|Reason missing or not reported|3|||
170525106|NCT03904693|616270023|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
170525107|NCT03904693|616270024|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
170525108|NCT03904693|616270025|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
170525109|NCT03904693|616270026|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
170525110|NCT03904693|616270021|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
170525111|NCT03904693|616270022|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
170525112|NCT03904693|616270023|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
170525113|NCT03904693|616270024|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
170525114|NCT03904693|616270025|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
170525115|NCT03904693|616270026|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
170525116|NCT03904693|616270021|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
170525117|NCT03904693|616270022|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
170525118|NCT03904693|616270023|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
170525119|NCT03904693|616270024|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
170525120|NCT03904693|616270025|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
170525121|NCT03904693|616270026|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
170525122|NCT03904693|616270021|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
170525123|NCT03904693|616270022|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
170525124|NCT03904693|616270023|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
170525125|NCT03904693|616270024|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
170525126|NCT03904693|616270025|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
170525127|NCT03904693|616270026|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
170525128|NCT05518539|616270033|FG000|Overall Study|Lost to Follow-up|6|||
170525129|NCT04613518|616270038|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
170525130|NCT04613518|616270039|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
170525131|NCT04613518|616270040|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
170525132|NCT04613518|616270038|FG000|Double-Blind Treatment Period|Adverse Event|2|||
170525133|NCT04613518|616270039|FG001|Double-Blind Treatment Period|Adverse Event|0|||
170525134|NCT04613518|616270040|FG002|Double-Blind Treatment Period|Adverse Event|1|||
170525135|NCT04613518|616270038|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
170525136|NCT04613518|616270039|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
170525137|NCT04613518|616270040|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
170525138|NCT04613518|616270038|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
170525139|NCT04613518|616270039|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
170525140|NCT04613518|616270040|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
170525141|NCT04613518|616270038|FG000|Double-Blind Treatment Period|Other Reasons|2|||
170525142|NCT04613518|616270039|FG001|Double-Blind Treatment Period|Other Reasons|0|||
170525143|NCT04613518|616270040|FG002|Double-Blind Treatment Period|Other Reasons|0|||
170525144|NCT04613518|616270038|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
170525145|NCT04613518|616270039|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
170525146|NCT04613518|616270040|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
170525147|NCT04613518|616270038|FG000|Open-Label Treatment Period|Adverse Event|1|||
170525148|NCT04613518|616270039|FG001|Open-Label Treatment Period|Adverse Event|0|||
170525149|NCT04613518|616270040|FG002|Open-Label Treatment Period|Adverse Event|3|||
170525150|NCT04613518|616270038|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
170525151|NCT04613518|616270039|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
170525152|NCT04613518|616270040|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
170525153|NCT04613518|616270038|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
170525154|NCT04613518|616270039|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
170525155|NCT04613518|616270040|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
170525156|NCT04613518|616270038|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
170632197|NCT00538902|616664551|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
170771234|NCT02544074|617168397|FG017|Overall Study|Tablet error|0|||
170771235|NCT02544074|617168398|FG018|Overall Study|Tablet error|0|||
170771236|NCT02544074|617168399|FG019|Overall Study|Tablet error|0|||
170771237|NCT02544074|617168400|FG020|Overall Study|Tablet error|0|||
170771238|NCT01780298|617168405|FG000|Overall Study|Physician Decision|1|||
170771239|NCT01780298|617168406|FG001|Overall Study|Physician Decision|5|||
170771240|NCT01780298|617168407|FG002|Overall Study|Physician Decision|1|||
170771241|NCT01780298|617168408|FG003|Overall Study|Physician Decision|1|||
170771242|NCT01780298|617168405|FG000|Overall Study|Subject not matched|1|||
170771243|NCT01780298|617168406|FG001|Overall Study|Subject not matched|0|||
170771244|NCT01780298|617168407|FG002|Overall Study|Subject not matched|1|||
170771245|NCT01780298|617168408|FG003|Overall Study|Subject not matched|0|||
170771246|NCT01780298|617168405|FG000|Overall Study|Adverse Event|0|||
170771247|NCT01780298|617168406|FG001|Overall Study|Adverse Event|0|||
170771248|NCT01780298|617168407|FG002|Overall Study|Adverse Event|2|||
170525157|NCT04613518|616270039|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
170525158|NCT04613518|616270040|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
170525159|NCT04613518|616270038|FG000|Open-Label Treatment Period|Other reasons|1|||
170525160|NCT04613518|616270039|FG001|Open-Label Treatment Period|Other reasons|0|||
170525161|NCT04613518|616270040|FG002|Open-Label Treatment Period|Other reasons|0|||
170525162|NCT03589807|616270041|FG000|Overall Study|Lost to Follow-up|0|||
170525163|NCT03589807|616270042|FG001|Overall Study|Lost to Follow-up|2|||
170525164|NCT03589807|616270043|FG002|Overall Study|Lost to Follow-up|2|||
170525165|NCT03589807|616270044|FG003|Overall Study|Lost to Follow-up|3|||
170525166|NCT03589807|616270045|FG004|Overall Study|Lost to Follow-up|1|||
170525167|NCT03589807|616270046|FG005|Overall Study|Lost to Follow-up|1|||
170525168|NCT03589807|616270041|FG000|Overall Study|Withdrawal by Subject|0|||
170525169|NCT03589807|616270042|FG001|Overall Study|Withdrawal by Subject|5|||
170525170|NCT03589807|616270043|FG002|Overall Study|Withdrawal by Subject|0|||
170525171|NCT03589807|616270044|FG003|Overall Study|Withdrawal by Subject|0|||
170525172|NCT03589807|616270045|FG004|Overall Study|Withdrawal by Subject|0|||
170525173|NCT03589807|616270046|FG005|Overall Study|Withdrawal by Subject|0|||
170525174|NCT03589807|616270041|FG000|Overall Study|Protocol Violation|0|||
170525175|NCT03589807|616270042|FG001|Overall Study|Protocol Violation|0|||
170525176|NCT03589807|616270043|FG002|Overall Study|Protocol Violation|0|||
170525177|NCT03589807|616270044|FG003|Overall Study|Protocol Violation|1|||
170525178|NCT03589807|616270045|FG004|Overall Study|Protocol Violation|0|||
170525179|NCT03589807|616270046|FG005|Overall Study|Protocol Violation|0|||
170525180|NCT03589807|616270041|FG000|Overall Study|Enrolled but treatment not administered|0|||
170525181|NCT03589807|616270042|FG001|Overall Study|Enrolled but treatment not administered|0|||
170525182|NCT03589807|616270043|FG002|Overall Study|Enrolled but treatment not administered|0|||
170525183|NCT03589807|616270044|FG003|Overall Study|Enrolled but treatment not administered|0|||
170525184|NCT03589807|616270045|FG004|Overall Study|Enrolled but treatment not administered|1|||
170525185|NCT03589807|616270046|FG005|Overall Study|Enrolled but treatment not administered|0|||
170525186|NCT01076543|616270047|FG000|Overall Study|Withdrawal by Subject|2|||
170525187|NCT01076543|616270048|FG001|Overall Study|Withdrawal by Subject|0|||
170525188|NCT01076543|616270049|FG002|Overall Study|Withdrawal by Subject|0|||
170525189|NCT01076543|616270050|FG003|Overall Study|Withdrawal by Subject|0|||
170525190|NCT01076543|616270051|FG004|Overall Study|Withdrawal by Subject|0|||
170525191|NCT01076543|616270052|FG005|Overall Study|Withdrawal by Subject|0|||
170525192|NCT01211145|616270053|FG000|Overall Study|Reason not specified|3|||
170525193|NCT01211145|616270054|FG001|Overall Study|Reason not specified|2|||
170525194|NCT01211145|616270055|FG002|Overall Study|Reason not specified|2|||
170525195|NCT01211145|616270056|FG003|Overall Study|Reason not specified|1|||
170525196|NCT01211145|616270053|FG000|Overall Study|Lost to Follow-up|3|||
170525197|NCT01211145|616270054|FG001|Overall Study|Lost to Follow-up|2|||
170525198|NCT01211145|616270055|FG002|Overall Study|Lost to Follow-up|1|||
170525199|NCT01211145|616270056|FG003|Overall Study|Lost to Follow-up|2|||
170525200|NCT01211145|616270053|FG000|Overall Study|Study-specific withdrawal criteria|1|||
170525201|NCT01211145|616270054|FG001|Overall Study|Study-specific withdrawal criteria|0|||
170525202|NCT01211145|616270055|FG002|Overall Study|Study-specific withdrawal criteria|0|||
170525203|NCT01211145|616270056|FG003|Overall Study|Study-specific withdrawal criteria|0|||
170525204|NCT01211145|616270053|FG000|Overall Study|Severe noncompliance to protocol|1|||
170525205|NCT01211145|616270054|FG001|Overall Study|Severe noncompliance to protocol|0|||
170525206|NCT01211145|616270055|FG002|Overall Study|Severe noncompliance to protocol|0|||
170771249|NCT01780298|617168408|FG003|Overall Study|Adverse Event|0|||
170771250|NCT03613740|617168415|FG000|Overall Study|Lost to Follow-up|1|||
170771251|NCT03613740|617168416|FG001|Overall Study|Lost to Follow-up|1|||
170771252|NCT01318382|617168419|FG000|Overall Study|Physician Decision|2|||
170771253|NCT01318382|617168419|FG000|Overall Study|Device Malfunction|10|||
170771254|NCT01318382|617168419|FG000|Overall Study|Protocol Violation|1|||
170771255|NCT01599104|617168422|FG000|Overall Study|Withdrawal by Subject|1|||
170771256|NCT01599104|617168423|FG001|Overall Study|Withdrawal by Subject|1|||
170771257|NCT01599104|617168424|FG002|Overall Study|Withdrawal by Subject|2|||
170771258|NCT01599104|617168422|FG000|Overall Study|Technical Problems|1|||
170771259|NCT01599104|617168423|FG001|Overall Study|Technical Problems|0|||
170771260|NCT01599104|617168424|FG002|Overall Study|Technical Problems|0|||
170771261|NCT01599104|617168422|FG000|Overall Study|Physician Decision|3|||
170771262|NCT01599104|617168423|FG001|Overall Study|Physician Decision|2|||
170771263|NCT01599104|617168424|FG002|Overall Study|Physician Decision|2|||
170525207|NCT01211145|616270056|FG003|Overall Study|Severe noncompliance to protocol|0|||
170525208|NCT01211145|616270053|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
170525209|NCT01211145|616270054|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
170525210|NCT01211145|616270055|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
170525211|NCT01211145|616270056|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
170525212|NCT01211145|616270053|FG000|Overall Study|Patient decision|2|||
170525213|NCT01211145|616270054|FG001|Overall Study|Patient decision|1|||
170525214|NCT01211145|616270055|FG002|Overall Study|Patient decision|0|||
170525215|NCT01211145|616270056|FG003|Overall Study|Patient decision|2|||
170525216|NCT00791999|616270057|FG000|Overall Study|Protocol planed withdrawal|14|||
170771264|NCT01599104|617168422|FG000|Overall Study|Non-compliance with study treatment|0|||
170771265|NCT01599104|617168423|FG001|Overall Study|Non-compliance with study treatment|1|||
170771266|NCT01599104|617168424|FG002|Overall Study|Non-compliance with study treatment|0|||
170771267|NCT01599104|617168422|FG000|Overall Study|Lack of Efficacy|4|||
170771268|NCT01599104|617168423|FG001|Overall Study|Lack of Efficacy|4|||
170771269|NCT01599104|617168424|FG002|Overall Study|Lack of Efficacy|10|||
170771270|NCT01599104|617168422|FG000|Overall Study|Adverse Event|7|||
170771271|NCT01599104|617168423|FG001|Overall Study|Adverse Event|6|||
170771272|NCT01599104|617168424|FG002|Overall Study|Adverse Event|12|||
170872541|NCT01994382|617544799|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
170872542|NCT01994382|617544800|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872543|NCT01994382|617544801|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
170872544|NCT01994382|617544802|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872545|NCT01994382|617544803|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
170872546|NCT01994382|617544804|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
170872547|NCT01994382|617544805|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
170872548|NCT01994382|617544789|FG000|Overall Study|Protocol violation/noncompliance|0|||
170872549|NCT01994382|617544790|FG001|Overall Study|Protocol violation/noncompliance|0|||
170872550|NCT01994382|617544791|FG002|Overall Study|Protocol violation/noncompliance|0|||
170872551|NCT01994382|617544792|FG003|Overall Study|Protocol violation/noncompliance|0|||
170872552|NCT01994382|617544793|FG004|Overall Study|Protocol violation/noncompliance|0|||
170872553|NCT01994382|617544794|FG005|Overall Study|Protocol violation/noncompliance|0|||
170872554|NCT01994382|617544795|FG006|Overall Study|Protocol violation/noncompliance|0|||
170872555|NCT01994382|617544796|FG007|Overall Study|Protocol violation/noncompliance|0|||
170872556|NCT01994382|617544797|FG008|Overall Study|Protocol violation/noncompliance|0|||
170872557|NCT01994382|617544798|FG009|Overall Study|Protocol violation/noncompliance|0|||
170872558|NCT01994382|617544799|FG010|Overall Study|Protocol violation/noncompliance|0|||
170872559|NCT01994382|617544800|FG011|Overall Study|Protocol violation/noncompliance|1|||
170872560|NCT01994382|617544801|FG012|Overall Study|Protocol violation/noncompliance|0|||
170872561|NCT01994382|617544802|FG013|Overall Study|Protocol violation/noncompliance|0|||
170872562|NCT01994382|617544803|FG014|Overall Study|Protocol violation/noncompliance|0|||
170872563|NCT01994382|617544804|FG015|Overall Study|Protocol violation/noncompliance|0|||
170872564|NCT01994382|617544805|FG016|Overall Study|Protocol violation/noncompliance|2|||
170872565|NCT01994382|617544789|FG000|Overall Study|Rolled over to Phase 2a|0|||
170872566|NCT01994382|617544790|FG001|Overall Study|Rolled over to Phase 2a|0|||
170872567|NCT01994382|617544791|FG002|Overall Study|Rolled over to Phase 2a|1|||
170872568|NCT01994382|617544792|FG003|Overall Study|Rolled over to Phase 2a|0|||
170872569|NCT01994382|617544793|FG004|Overall Study|Rolled over to Phase 2a|0|||
170872570|NCT01994382|617544794|FG005|Overall Study|Rolled over to Phase 2a|0|||
170872571|NCT01994382|617544795|FG006|Overall Study|Rolled over to Phase 2a|0|||
170872572|NCT01994382|617544796|FG007|Overall Study|Rolled over to Phase 2a|0|||
170872573|NCT01994382|617544797|FG008|Overall Study|Rolled over to Phase 2a|0|||
170872574|NCT01994382|617544798|FG009|Overall Study|Rolled over to Phase 2a|2|||
170872575|NCT01994382|617544799|FG010|Overall Study|Rolled over to Phase 2a|0|||
170872576|NCT01994382|617544800|FG011|Overall Study|Rolled over to Phase 2a|0|||
170872577|NCT01994382|617544801|FG012|Overall Study|Rolled over to Phase 2a|0|||
170872578|NCT01994382|617544802|FG013|Overall Study|Rolled over to Phase 2a|0|||
170872579|NCT01994382|617544803|FG014|Overall Study|Rolled over to Phase 2a|0|||
170872580|NCT01994382|617544804|FG015|Overall Study|Rolled over to Phase 2a|0|||
170872581|NCT01994382|617544805|FG016|Overall Study|Rolled over to Phase 2a|0|||
170872582|NCT04667377|617544806|FG000|Dose Escalation Period|Other not specified below|3|||
170872583|NCT04667377|617544807|FG001|Dose Escalation Period|Other not specified below|3|||
170872584|NCT04667377|617544808|FG002|Dose Escalation Period|Other not specified below|2|||
170872585|NCT04667377|617544809|FG003|Dose Escalation Period|Other not specified below|1|||
170872586|NCT04667377|617544810|FG004|Dose Escalation Period|Other not specified below|3|||
170872587|NCT04667377|617544806|FG000|Dose Escalation Period|Protocol Violation|2|||
170872588|NCT04667377|617544807|FG001|Dose Escalation Period|Protocol Violation|2|||
170872589|NCT04667377|617544808|FG002|Dose Escalation Period|Protocol Violation|0|||
170872590|NCT04667377|617544809|FG003|Dose Escalation Period|Protocol Violation|2|||
170872591|NCT04667377|617544810|FG004|Dose Escalation Period|Protocol Violation|1|||
170872592|NCT04667377|617544806|FG000|Dose Escalation Period|Burden of study procedures|2|||
170872593|NCT04667377|617544807|FG001|Dose Escalation Period|Burden of study procedures|1|||
170872594|NCT04667377|617544808|FG002|Dose Escalation Period|Burden of study procedures|1|||
170872595|NCT04667377|617544809|FG003|Dose Escalation Period|Burden of study procedures|1|||
170872596|NCT04667377|617544810|FG004|Dose Escalation Period|Burden of study procedures|5|||
170872597|NCT04667377|617544806|FG000|Dose Escalation Period|Change of residence|0|||
170872598|NCT04667377|617544807|FG001|Dose Escalation Period|Change of residence|0|||
170872599|NCT04667377|617544808|FG002|Dose Escalation Period|Change of residence|1|||
170872600|NCT04667377|617544809|FG003|Dose Escalation Period|Change of residence|0|||
170872601|NCT04667377|617544810|FG004|Dose Escalation Period|Change of residence|0|||
170872602|NCT04667377|617544806|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
170872603|NCT04667377|617544807|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
170872604|NCT04667377|617544808|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
170872605|NCT04667377|617544809|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
170872606|NCT04667377|617544810|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
170872607|NCT04667377|617544806|FG000|Dose Escalation Period|Adverse Event|9|||
170872608|NCT04667377|617544807|FG001|Dose Escalation Period|Adverse Event|10|||
170872609|NCT04667377|617544808|FG002|Dose Escalation Period|Adverse Event|12|||
170872610|NCT04667377|617544809|FG003|Dose Escalation Period|Adverse Event|17|||
170872611|NCT04667377|617544810|FG004|Dose Escalation Period|Adverse Event|3|||
170872612|NCT04667377|617544806|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
170872613|NCT04667377|617544807|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
170872614|NCT04667377|617544808|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
170413705|NCT02146430|615855999|FG002|Overall Study|Reason missing or not reported|4|||
170413706|NCT02146430|615856000|FG003|Overall Study|Reason missing or not reported|5|||
170413707|NCT02146430|615855997|FG000|Overall Study|Withdrawal by Subject|27|||
170413708|NCT02146430|615855998|FG001|Overall Study|Withdrawal by Subject|29|||
170413709|NCT02146430|615855999|FG002|Overall Study|Withdrawal by Subject|30|||
170413710|NCT02146430|615856000|FG003|Overall Study|Withdrawal by Subject|34|||
170413711|NCT03312530|615856001|FG000|Overall Study|Death|5|||
170413712|NCT03312530|615856002|FG001|Overall Study|Death|5|||
170413713|NCT03312530|615856003|FG002|Overall Study|Death|4|||
170413714|NCT03312530|615856004|FG003|Overall Study|Death|10|||
170413715|NCT03312530|615856005|FG004|Overall Study|Death|8|||
170413716|NCT03312530|615856001|FG000|Overall Study|Lost to Follow-up|0|||
170413717|NCT03312530|615856002|FG001|Overall Study|Lost to Follow-up|0|||
170413718|NCT03312530|615856003|FG002|Overall Study|Lost to Follow-up|0|||
170413719|NCT03312530|615856004|FG003|Overall Study|Lost to Follow-up|1|||
170413720|NCT03312530|615856005|FG004|Overall Study|Lost to Follow-up|0|||
170413721|NCT03312530|615856001|FG000|Overall Study|Participant in another sponsor study.|0|||
170413722|NCT03312530|615856002|FG001|Overall Study|Participant in another sponsor study.|0|||
170413723|NCT03312530|615856003|FG002|Overall Study|Participant in another sponsor study.|0|||
170413724|NCT03312530|615856004|FG003|Overall Study|Participant in another sponsor study.|1|||
170413725|NCT03312530|615856005|FG004|Overall Study|Participant in another sponsor study.|0|||
170413726|NCT03312530|615856001|FG000|Overall Study|Study terminated by sponsor|1|||
170413727|NCT03312530|615856002|FG001|Overall Study|Study terminated by sponsor|0|||
170413728|NCT03312530|615856003|FG002|Overall Study|Study terminated by sponsor|2|||
170413729|NCT03312530|615856004|FG003|Overall Study|Study terminated by sponsor|3|||
170413730|NCT03312530|615856005|FG004|Overall Study|Study terminated by sponsor|7|||
170413731|NCT03312530|615856001|FG000|Overall Study|Withdrawal by Subject|0|||
170413732|NCT03312530|615856002|FG001|Overall Study|Withdrawal by Subject|1|||
170413733|NCT03312530|615856003|FG002|Overall Study|Withdrawal by Subject|0|||
170413734|NCT03312530|615856004|FG003|Overall Study|Withdrawal by Subject|0|||
170413735|NCT03312530|615856005|FG004|Overall Study|Withdrawal by Subject|0|||
170413736|NCT03312530|615856001|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
170413737|NCT03312530|615856002|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
170413738|NCT03312530|615856003|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
170413739|NCT03312530|615856004|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
170413740|NCT03312530|615856005|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
170413741|NCT03093324|615856006|FG000|Overall Study|Adverse Event|4|||
170413742|NCT03093324|615856007|FG001|Overall Study|Adverse Event|15|||
170413743|NCT03093324|615856006|FG000|Overall Study|Lost to Follow-up|1|||
170413744|NCT03093324|615856007|FG001|Overall Study|Lost to Follow-up|0|||
170413745|NCT03093324|615856006|FG000|Overall Study|Protocol Deviation|2|||
170413746|NCT03093324|615856007|FG001|Overall Study|Protocol Deviation|2|||
170413747|NCT03093324|615856006|FG000|Overall Study|Withdrawal by Subject|2|||
170413748|NCT03093324|615856007|FG001|Overall Study|Withdrawal by Subject|2|||
170413749|NCT04471935|615856009|FG000|Overall Study|Withdrawal by Subject|1|||
170413750|NCT04471935|615856009|FG000|Overall Study|Deemed ineligible to participate|1|||
170413751|NCT02116803|615856010|FG000|Overall Study|Adverse Event|2|||
170413752|NCT02116803|615856011|FG001|Overall Study|Adverse Event|1|||
170413753|NCT02116803|615856010|FG000|Overall Study|Physician Decision|1|||
170413754|NCT02116803|615856011|FG001|Overall Study|Physician Decision|0|||
170413755|NCT02116803|615856010|FG000|Overall Study|Progressive disease|4|||
170413756|NCT02116803|615856011|FG001|Overall Study|Progressive disease|0|||
170413757|NCT02116803|615856010|FG000|Overall Study|Study terminated by sponsor|2|||
170413758|NCT02116803|615856011|FG001|Overall Study|Study terminated by sponsor|1|||
170413759|NCT02116803|615856010|FG000|Overall Study|Death|1|||
170413760|NCT02116803|615856011|FG001|Overall Study|Death|0|||
170413761|NCT01399736|615856012|FG000|Overall Study|Withdrawal by Subject|4|||
170872615|NCT04667377|617544809|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
170413762|NCT01399736|615856013|FG001|Overall Study|Withdrawal by Subject|2|||
170525217|NCT00791999|616270058|FG001|Overall Study|Protocol planed withdrawal|11|||
170525218|NCT00791999|616270059|FG002|Overall Study|Protocol planed withdrawal|11|||
170525219|NCT00791999|616270060|FG003|Overall Study|Protocol planed withdrawal|45|||
170525220|NCT00791999|616270057|FG000|Overall Study|Withdrawal by Subject|0|||
170525221|NCT00791999|616270058|FG001|Overall Study|Withdrawal by Subject|1|||
170525222|NCT00791999|616270059|FG002|Overall Study|Withdrawal by Subject|0|||
170525223|NCT00791999|616270060|FG003|Overall Study|Withdrawal by Subject|2|||
170525224|NCT00791999|616270057|FG000|Overall Study|Protocol Violation|3|||
170525225|NCT00791999|616270058|FG001|Overall Study|Protocol Violation|0|||
170525226|NCT00791999|616270059|FG002|Overall Study|Protocol Violation|1|||
170525227|NCT00791999|616270060|FG003|Overall Study|Protocol Violation|0|||
170525228|NCT00791999|616270057|FG000|Overall Study|Adverse Event|3|||
170525229|NCT00791999|616270058|FG001|Overall Study|Adverse Event|3|||
170525230|NCT00791999|616270059|FG002|Overall Study|Adverse Event|7|||
170525231|NCT00791999|616270060|FG003|Overall Study|Adverse Event|3|||
170525232|NCT00791999|616270057|FG000|Overall Study|Lack of Efficacy|0|||
170525233|NCT00791999|616270058|FG001|Overall Study|Lack of Efficacy|1|||
170525234|NCT00791999|616270059|FG002|Overall Study|Lack of Efficacy|0|||
170525235|NCT00791999|616270060|FG003|Overall Study|Lack of Efficacy|2|||
170525236|NCT00791999|616270057|FG000|Overall Study|Reason other than those above|1|||
170525237|NCT00791999|616270058|FG001|Overall Study|Reason other than those above|0|||
170525238|NCT00791999|616270059|FG002|Overall Study|Reason other than those above|1|||
170525239|NCT00791999|616270060|FG003|Overall Study|Reason other than those above|0|||
170525240|NCT02998151|616270068|FG000|Overall Study|Withdrawal by Subject|3|||
170525241|NCT02998151|616270068|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
170525242|NCT02998151|616270068|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
170525243|NCT04460326|616270069|FG000|Completed at Least 4 Meals|Early discharge|5|||
170525244|NCT04460326|616270070|FG001|Completed at Least 4 Meals|Early discharge|5|||
170525245|NCT04460326|616270069|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
170525246|NCT04460326|616270070|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
170525247|NCT04460326|616270069|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
170525248|NCT04460326|616270070|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
170525249|NCT04460326|616270069|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
170525250|NCT04460326|616270070|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
170525251|NCT04460326|616270069|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
170525252|NCT04460326|616270070|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
170525253|NCT04460326|616270069|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
170525254|NCT04460326|616270070|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
170525255|NCT00875810|616270077|FG000|Overall Study|Withdrawal by Subject|1|||
170525256|NCT00875810|616270077|FG000|Overall Study|Physician Decision|3|||
170525257|NCT00875810|616270077|FG000|Overall Study|Lost to Follow-up|39|||
170525258|NCT00875810|616270077|FG000|Overall Study|Patient enroled but not implanted|2|||
170525259|NCT00875810|616270077|FG000|Overall Study|Device explanted|1|||
170525260|NCT01789047|616270080|FG000|Overall Study|Adverse Event|3|||
170525261|NCT01789047|616270081|FG001|Overall Study|Adverse Event|2|||
170525262|NCT01789047|616270080|FG000|Overall Study|Withdrawal by Subject|1|||
170525263|NCT01789047|616270081|FG001|Overall Study|Withdrawal by Subject|2|||
170525264|NCT03644017|616270082|FG000|Overall Study|Access Abandonment|5|||
170525265|NCT03644017|616270082|FG000|Overall Study|Kidney Transplant|2|||
170525266|NCT01204671|616270083|FG000|Overall Study|Adverse Event|4|||
170525267|NCT01204671|616270084|FG001|Overall Study|Adverse Event|3|||
170525268|NCT01204671|616270085|FG002|Overall Study|Adverse Event|3|||
170525269|NCT01204671|616270086|FG003|Overall Study|Adverse Event|3|||
170525270|NCT01204671|616270087|FG004|Overall Study|Adverse Event|1|||
170525271|NCT01204671|616270083|FG000|Overall Study|Withdrawal by Subject|2|||
170771273|NCT00309907|617168431|FG000|Overall Study|Death|4|||
170771274|NCT00309907|617168431|FG000|Overall Study|Physician Decision|1|||
170771275|NCT00309907|617168431|FG000|Overall Study|Ineligible|11|||
170771276|NCT00309907|617168431|FG000|Overall Study|Major infectious event|4|||
170771277|NCT01190007|617168432|FG000|Overall Study|Withdrawal by Subject|4|||
170771278|NCT01190007|617168432|FG000|Overall Study|Adverse Event|8|||
170771279|NCT01190007|617168432|FG000|Overall Study|Difficulty of visit for complications|1|||
170771280|NCT01190007|617168432|FG000|Overall Study|Participant was arrested|1|||
170525272|NCT01204671|616270084|FG001|Overall Study|Withdrawal by Subject|3|||
170525273|NCT01204671|616270085|FG002|Overall Study|Withdrawal by Subject|4|||
170525274|NCT01204671|616270086|FG003|Overall Study|Withdrawal by Subject|5|||
170525275|NCT01204671|616270087|FG004|Overall Study|Withdrawal by Subject|3|||
170525276|NCT01204671|616270083|FG000|Overall Study|Lost to Follow-up|7|||
170525277|NCT01204671|616270084|FG001|Overall Study|Lost to Follow-up|8|||
170525278|NCT01204671|616270085|FG002|Overall Study|Lost to Follow-up|6|||
170525279|NCT01204671|616270086|FG003|Overall Study|Lost to Follow-up|4|||
170525280|NCT01204671|616270087|FG004|Overall Study|Lost to Follow-up|0|||
170525281|NCT01204671|616270083|FG000|Overall Study|Unknown Completion Status|1|||
170525282|NCT01204671|616270084|FG001|Overall Study|Unknown Completion Status|1|||
170872616|NCT04667377|617544810|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
170413763|NCT01399736|615856012|FG000|Overall Study|Lost to Follow-up|0|||
170413764|NCT01399736|615856013|FG001|Overall Study|Lost to Follow-up|2|||
170413765|NCT01654380|615856014|FG000|Part B, Period 1|Physician Decision|0|||
170413766|NCT01654380|615856015|FG001|Part B, Period 1|Physician Decision|0|||
170413767|NCT01654380|615856016|FG002|Part B, Period 1|Physician Decision|1|||
170413768|NCT01654380|615856017|FG003|Part B, Period 1|Physician Decision|0|||
170413769|NCT02985957|615856023|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170413770|NCT02985957|615856024|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170413771|NCT02985957|615856025|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170413772|NCT02985957|615856026|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170413773|NCT02985957|615856027|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
170413774|NCT02985957|615856028|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170413775|NCT02985957|615856029|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170413776|NCT02985957|615856023|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
170413777|NCT02985957|615856024|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
170413778|NCT02985957|615856025|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
170413779|NCT02985957|615856026|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
170413780|NCT02985957|615856027|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
170413781|NCT02985957|615856028|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
170413782|NCT02985957|615856029|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
170413783|NCT02985957|615856023|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
170413784|NCT02985957|615856024|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
170413785|NCT02985957|615856025|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
170413786|NCT02985957|615856026|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
170413787|NCT02985957|615856027|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
170413788|NCT02985957|615856028|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
170413789|NCT02985957|615856029|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
170413790|NCT02985957|615856023|FG000|Treatment Period|Death|0|||
170413791|NCT02985957|615856024|FG001|Treatment Period|Death|0|||
170413792|NCT02985957|615856025|FG002|Treatment Period|Death|0|||
170413793|NCT02985957|615856026|FG003|Treatment Period|Death|0|||
170413794|NCT02985957|615856027|FG004|Treatment Period|Death|1|||
170413795|NCT02985957|615856028|FG005|Treatment Period|Death|0|||
170413796|NCT02985957|615856029|FG006|Treatment Period|Death|0|||
170413797|NCT02985957|615856023|FG000|Treatment Period|Participant withdrew consent|0|||
170413798|NCT02985957|615856024|FG001|Treatment Period|Participant withdrew consent|0|||
170413799|NCT02985957|615856025|FG002|Treatment Period|Participant withdrew consent|0|||
170413800|NCT02985957|615856026|FG003|Treatment Period|Participant withdrew consent|1|||
170413801|NCT02985957|615856027|FG004|Treatment Period|Participant withdrew consent|3|||
170413802|NCT02985957|615856028|FG005|Treatment Period|Participant withdrew consent|0|||
170413803|NCT02985957|615856029|FG006|Treatment Period|Participant withdrew consent|1|||
170413804|NCT02985957|615856023|FG000|Treatment Period|Lost to Follow-up|0|||
170413805|NCT02985957|615856024|FG001|Treatment Period|Lost to Follow-up|0|||
170413806|NCT02985957|615856025|FG002|Treatment Period|Lost to Follow-up|0|||
170413807|NCT02985957|615856026|FG003|Treatment Period|Lost to Follow-up|0|||
170413808|NCT02985957|615856027|FG004|Treatment Period|Lost to Follow-up|1|||
170413809|NCT02985957|615856028|FG005|Treatment Period|Lost to Follow-up|0|||
170413810|NCT02985957|615856029|FG006|Treatment Period|Lost to Follow-up|0|||
170413811|NCT02985957|615856023|FG000|Treatment Period|Other reasons|0|||
170413812|NCT02985957|615856024|FG001|Treatment Period|Other reasons|0|||
170413813|NCT02985957|615856025|FG002|Treatment Period|Other reasons|1|||
170413814|NCT02985957|615856026|FG003|Treatment Period|Other reasons|3|||
170413815|NCT02985957|615856027|FG004|Treatment Period|Other reasons|5|||
170413816|NCT02985957|615856028|FG005|Treatment Period|Other reasons|0|||
170413817|NCT02985957|615856029|FG006|Treatment Period|Other reasons|1|||
170413818|NCT02985957|615856023|FG000|Treatment Period|Not reported|0|||
170413819|NCT02985957|615856024|FG001|Treatment Period|Not reported|2|||
170413820|NCT02985957|615856025|FG002|Treatment Period|Not reported|2|||
170413821|NCT02985957|615856026|FG003|Treatment Period|Not reported|5|||
170413822|NCT02985957|615856027|FG004|Treatment Period|Not reported|0|||
170413823|NCT02985957|615856028|FG005|Treatment Period|Not reported|0|||
170413824|NCT02985957|615856029|FG006|Treatment Period|Not reported|0|||
170413825|NCT02985957|615856023|FG000|Treatment Period|Maximum clinical benefit|0|||
170413826|NCT02985957|615856024|FG001|Treatment Period|Maximum clinical benefit|0|||
170413827|NCT02985957|615856025|FG002|Treatment Period|Maximum clinical benefit|1|||
170413828|NCT02985957|615856026|FG003|Treatment Period|Maximum clinical benefit|1|||
170413829|NCT02985957|615856027|FG004|Treatment Period|Maximum clinical benefit|0|||
170413830|NCT02985957|615856028|FG005|Treatment Period|Maximum clinical benefit|0|||
170413831|NCT02985957|615856029|FG006|Treatment Period|Maximum clinical benefit|2|||
170413832|NCT02985957|615856023|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
170413833|NCT02985957|615856024|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
170872617|NCT04667377|617544806|FG000|Dose Escalation Period|Not treated|1|||
170771281|NCT01641198|617168434|FG000|After 12 Months of Function|Lost to Follow-up|3|||
170771282|NCT01641198|617168435|FG001|After 12 Months of Function|Lost to Follow-up|2|||
170771283|NCT01641198|617168436|FG002|After 12 Months of Function|Lost to Follow-up|2|||
170771284|NCT01641198|617168434|FG000|After 12 Months of Function|Protocol Violation|1|||
170413834|NCT02985957|615856025|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
170413835|NCT02985957|615856026|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
170413836|NCT02985957|615856027|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
170413837|NCT02985957|615856028|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
170413838|NCT02985957|615856029|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
170413839|NCT02985957|615856023|FG000|Treatment Period|Study drug toxicity|1|||
170413840|NCT02985957|615856024|FG001|Treatment Period|Study drug toxicity|23|||
170413841|NCT02985957|615856025|FG002|Treatment Period|Study drug toxicity|20|||
170413842|NCT02985957|615856026|FG003|Treatment Period|Study drug toxicity|12|||
170413843|NCT02985957|615856027|FG004|Treatment Period|Study drug toxicity|20|||
170413844|NCT02985957|615856028|FG005|Treatment Period|Study drug toxicity|3|||
170413845|NCT02985957|615856029|FG006|Treatment Period|Study drug toxicity|5|||
170413846|NCT02985957|615856023|FG000|Treatment Period|Disease progression|0|||
170413847|NCT02985957|615856024|FG001|Treatment Period|Disease progression|16|||
170413848|NCT02985957|615856025|FG002|Treatment Period|Disease progression|20|||
170413849|NCT02985957|615856026|FG003|Treatment Period|Disease progression|40|||
170413850|NCT02985957|615856027|FG004|Treatment Period|Disease progression|29|||
170413851|NCT02985957|615856028|FG005|Treatment Period|Disease progression|11|||
170413852|NCT02985957|615856029|FG006|Treatment Period|Disease progression|28|||
170413853|NCT02985957|615856023|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
170413854|NCT02985957|615856024|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
170413855|NCT02985957|615856025|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
170413856|NCT02985957|615856026|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
170413857|NCT02985957|615856027|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
170413858|NCT02985957|615856028|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
170413859|NCT02985957|615856029|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
170413860|NCT02985957|615856023|FG000|Treatment Period|Poor/Non-Compliance|0|||
170413861|NCT02985957|615856024|FG001|Treatment Period|Poor/Non-Compliance|0|||
170413862|NCT02985957|615856025|FG002|Treatment Period|Poor/Non-Compliance|0|||
170413863|NCT02985957|615856026|FG003|Treatment Period|Poor/Non-Compliance|0|||
170413864|NCT02985957|615856027|FG004|Treatment Period|Poor/Non-Compliance|1|||
170413865|NCT02985957|615856028|FG005|Treatment Period|Poor/Non-Compliance|1|||
170413866|NCT02985957|615856029|FG006|Treatment Period|Poor/Non-Compliance|0|||
170413867|NCT00998881|615856030|FG000|Overall Study|Adverse Event|2|||
170413868|NCT00998881|615856031|FG001|Overall Study|Adverse Event|2|||
170413869|NCT00998881|615856030|FG000|Overall Study|Lack of Efficacy|1|||
170413870|NCT00998881|615856031|FG001|Overall Study|Lack of Efficacy|0|||
170413871|NCT00998881|615856030|FG000|Overall Study|Physician Decision|3|||
170413872|NCT00998881|615856031|FG001|Overall Study|Physician Decision|0|||
170413873|NCT00998881|615856030|FG000|Overall Study|Withdrawal by Subject|1|||
170413874|NCT00998881|615856031|FG001|Overall Study|Withdrawal by Subject|0|||
170413875|NCT00998881|615856030|FG000|Overall Study|Personal matter|1|||
170413876|NCT00998881|615856031|FG001|Overall Study|Personal matter|0|||
170413877|NCT01716754|615856032|FG000|Overall Study|Death|0|||
170413878|NCT01716754|615856033|FG001|Overall Study|Death|0|||
170413879|NCT01716754|615856034|FG002|Overall Study|Death|0|||
170413880|NCT01716754|615856035|FG003|Overall Study|Death|1|||
170413881|NCT01716754|615856032|FG000|Overall Study|Protocol deviation|0|||
170413882|NCT01716754|615856033|FG001|Overall Study|Protocol deviation|2|||
170413883|NCT01716754|615856034|FG002|Overall Study|Protocol deviation|7|||
170413884|NCT01716754|615856035|FG003|Overall Study|Protocol deviation|2|||
170413885|NCT01716754|615856032|FG000|Overall Study|Non-compliance with study treatment|0|||
170413886|NCT01716754|615856033|FG001|Overall Study|Non-compliance with study treatment|0|||
170413887|NCT01716754|615856034|FG002|Overall Study|Non-compliance with study treatment|1|||
170413888|NCT01716754|615856035|FG003|Overall Study|Non-compliance with study treatment|0|||
170413889|NCT01716754|615856032|FG000|Overall Study|Physician Decision|1|||
170413890|NCT01716754|615856033|FG001|Overall Study|Physician Decision|0|||
170413891|NCT01716754|615856034|FG002|Overall Study|Physician Decision|0|||
170413892|NCT01716754|615856035|FG003|Overall Study|Physician Decision|0|||
170413893|NCT01716754|615856032|FG000|Overall Study|Lost to Follow-up|1|||
170413894|NCT01716754|615856033|FG001|Overall Study|Lost to Follow-up|0|||
170413895|NCT01716754|615856034|FG002|Overall Study|Lost to Follow-up|0|||
170413896|NCT01716754|615856035|FG003|Overall Study|Lost to Follow-up|1|||
170413897|NCT01716754|615856032|FG000|Overall Study|Adverse Event|4|||
170413898|NCT01716754|615856033|FG001|Overall Study|Adverse Event|2|||
170413899|NCT01716754|615856034|FG002|Overall Study|Adverse Event|2|||
170413900|NCT01716754|615856035|FG003|Overall Study|Adverse Event|1|||
170771285|NCT01641198|617168435|FG001|After 12 Months of Function|Protocol Violation|0|||
170771286|NCT01641198|617168436|FG002|After 12 Months of Function|Protocol Violation|0|||
170771287|NCT01641198|617168434|FG000|After 12 Months of Function|Adverse Event|0|||
170525283|NCT01204671|616270085|FG002|Overall Study|Unknown Completion Status|0|||
170525284|NCT01204671|616270086|FG003|Overall Study|Unknown Completion Status|0|||
170525285|NCT01204671|616270087|FG004|Overall Study|Unknown Completion Status|0|||
170525286|NCT01204671|616270083|FG000|Overall Study|Physician Decision|0|||
170525287|NCT01204671|616270084|FG001|Overall Study|Physician Decision|0|||
170525288|NCT01204671|616270085|FG002|Overall Study|Physician Decision|0|||
170525289|NCT01204671|616270086|FG003|Overall Study|Physician Decision|1|||
170525290|NCT01204671|616270087|FG004|Overall Study|Physician Decision|0|||
170525291|NCT02175225|616270088|FG000|Overall Study|Withdrawal by Subject|1|||
170525292|NCT02175225|616270089|FG001|Overall Study|Withdrawal by Subject|2|||
170525293|NCT02175225|616270088|FG000|Overall Study|Lost to Follow-up|6|||
170525294|NCT02175225|616270089|FG001|Overall Study|Lost to Follow-up|7|||
170525295|NCT02175225|616270088|FG000|Overall Study|Study drug not administered|1|||
170525296|NCT02175225|616270089|FG001|Overall Study|Study drug not administered|2|||
170525297|NCT02340000|616270090|FG000|Time Period 1|Withdrawal by Subject|6|||
170525298|NCT02340000|616270091|FG001|Time Period 1|Withdrawal by Subject|8|||
170525299|NCT02340000|616270090|FG000|Time Period 1|Lost to Follow-up|6|||
170525300|NCT02340000|616270091|FG001|Time Period 1|Lost to Follow-up|7|||
170525301|NCT02340000|616270090|FG000|Time Period 2|Withdrawal by Subject|9|||
170525302|NCT02340000|616270091|FG001|Time Period 2|Withdrawal by Subject|7|||
170525303|NCT02340000|616270090|FG000|Time Period 2|Lost to Follow-up|10|||
170525304|NCT02340000|616270091|FG001|Time Period 2|Lost to Follow-up|8|||
170525305|NCT02104895|616270092|FG000|Overall Study|Withdrawal by Subject|0|||
170525306|NCT02104895|616270093|FG001|Overall Study|Withdrawal by Subject|14|||
170525307|NCT03106077|616270094|FG000|Overall Study|Screen Failure|94|||
170525308|NCT03106077|616270095|FG001|Overall Study|Screen Failure|0|||
170525309|NCT02668640|616270096|FG000|Overall Study|Lost to Follow-up|13|||
170525310|NCT02668640|616270096|FG000|Overall Study|Other, not specified|1|||
170525311|NCT04414787|616270100|FG000|Overall Study|Patient Death|18|||
170525312|NCT04414787|616270101|FG001|Overall Study|Patient Death|18|||
170525313|NCT04414787|616270102|FG002|Overall Study|Patient Death|15|||
170525314|NCT04414787|616270103|FG003|Overall Study|Patient Death|15|||
170525315|NCT04414787|616270100|FG000|Overall Study|Patient Hospitalization|1|||
170525316|NCT04414787|616270101|FG001|Overall Study|Patient Hospitalization|1|||
170525317|NCT04414787|616270102|FG002|Overall Study|Patient Hospitalization|2|||
170525318|NCT04414787|616270103|FG003|Overall Study|Patient Hospitalization|2|||
170525319|NCT04414787|616270100|FG000|Overall Study|Lost to Follow-up|7|||
170525320|NCT04414787|616270101|FG001|Overall Study|Lost to Follow-up|7|||
170525321|NCT04414787|616270102|FG002|Overall Study|Lost to Follow-up|5|||
170525322|NCT04414787|616270103|FG003|Overall Study|Lost to Follow-up|5|||
170525323|NCT04414787|616270100|FG000|Overall Study|Residence in post-acute care facility|3|||
170525324|NCT04414787|616270101|FG001|Overall Study|Residence in post-acute care facility|3|||
170525325|NCT04414787|616270102|FG002|Overall Study|Residence in post-acute care facility|5|||
170525326|NCT04414787|616270103|FG003|Overall Study|Residence in post-acute care facility|5|||
170525327|NCT05093933|616270104|FG000|Overall Study|Death|372|||
170525328|NCT05093933|616270105|FG001|Overall Study|Death|434|||
170525329|NCT05093933|616270104|FG000|Overall Study|Lost to Follow-up|13|||
170525330|NCT05093933|616270105|FG001|Overall Study|Lost to Follow-up|16|||
170525331|NCT05093933|616270104|FG000|Overall Study|Physician Decision|0|||
170525332|NCT05093933|616270105|FG001|Overall Study|Physician Decision|2|||
170525333|NCT05093933|616270104|FG000|Overall Study|Sponsor Decision|1|||
170525334|NCT05093933|616270105|FG001|Overall Study|Sponsor Decision|3|||
170525335|NCT05093933|616270104|FG000|Overall Study|Withdrawal by Guardian|1|||
170525336|NCT05093933|616270105|FG001|Overall Study|Withdrawal by Guardian|1|||
170525337|NCT05093933|616270104|FG000|Overall Study|Withdrawal by Subject|18|||
170525338|NCT05093933|616270105|FG001|Overall Study|Withdrawal by Subject|25|||
170525339|NCT00919633|616270108|FG000|Overall Study|Adverse Event|1|||
170525340|NCT00919633|616270109|FG001|Overall Study|Adverse Event|9|||
170525341|NCT00919633|616270110|FG002|Overall Study|Adverse Event|12|||
170525342|NCT00919633|616270111|FG003|Overall Study|Adverse Event|10|||
170525343|NCT00919633|616270108|FG000|Overall Study|Death|0|||
170525344|NCT00919633|616270109|FG001|Overall Study|Death|0|||
170525345|NCT00919633|616270110|FG002|Overall Study|Death|2|||
170525346|NCT00919633|616270111|FG003|Overall Study|Death|0|||
170525347|NCT00919633|616270108|FG000|Overall Study|Lack of Efficacy|17|||
170525348|NCT00919633|616270109|FG001|Overall Study|Lack of Efficacy|3|||
170525349|NCT00919633|616270110|FG002|Overall Study|Lack of Efficacy|2|||
170525350|NCT00919633|616270111|FG003|Overall Study|Lack of Efficacy|3|||
170525351|NCT00919633|616270108|FG000|Overall Study|Withdrawal by Subject|1|||
170525352|NCT00919633|616270109|FG001|Overall Study|Withdrawal by Subject|2|||
170525353|NCT00919633|616270110|FG002|Overall Study|Withdrawal by Subject|4|||
170525354|NCT00919633|616270111|FG003|Overall Study|Withdrawal by Subject|3|||
170525355|NCT00919633|616270108|FG000|Overall Study|Lost to Follow-up|3|||
170771288|NCT01641198|617168435|FG001|After 12 Months of Function|Adverse Event|1|||
170771289|NCT01641198|617168436|FG002|After 12 Months of Function|Adverse Event|0|||
170771290|NCT01641198|617168434|FG000|After 24 Months of Function|Lost to Follow-up|4|||
170771291|NCT01641198|617168435|FG001|After 24 Months of Function|Lost to Follow-up|9|||
170525356|NCT00919633|616270109|FG001|Overall Study|Lost to Follow-up|1|||
170872618|NCT04667377|617544807|FG001|Dose Escalation Period|Not treated|0|||
170872619|NCT04667377|617544808|FG002|Dose Escalation Period|Not treated|0|||
170872620|NCT04667377|617544809|FG003|Dose Escalation Period|Not treated|0|||
170872621|NCT04667377|617544810|FG004|Dose Escalation Period|Not treated|0|||
170872622|NCT04667377|617544806|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
170872623|NCT04667377|617544807|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
170872624|NCT04667377|617544808|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
170872625|NCT04667377|617544809|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
170872626|NCT04667377|617544810|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
170872627|NCT04667377|617544806|FG000|Dose Escalation Period|Lost to Follow-up|0|||
170872628|NCT04667377|617544807|FG001|Dose Escalation Period|Lost to Follow-up|1|||
170872629|NCT04667377|617544808|FG002|Dose Escalation Period|Lost to Follow-up|0|||
170872630|NCT04667377|617544809|FG003|Dose Escalation Period|Lost to Follow-up|0|||
170872631|NCT04667377|617544810|FG004|Dose Escalation Period|Lost to Follow-up|0|||
170872632|NCT04667377|617544806|FG000|Maintenance Period|Perceived lack of efficacy|0|||
170872633|NCT04667377|617544807|FG001|Maintenance Period|Perceived lack of efficacy|2|||
170872634|NCT04667377|617544808|FG002|Maintenance Period|Perceived lack of efficacy|1|||
170872635|NCT04667377|617544809|FG003|Maintenance Period|Perceived lack of efficacy|0|||
170872636|NCT04667377|617544810|FG004|Maintenance Period|Perceived lack of efficacy|1|||
170872637|NCT04667377|617544806|FG000|Maintenance Period|Adverse Event|2|||
170872638|NCT04667377|617544807|FG001|Maintenance Period|Adverse Event|8|||
170413901|NCT01716754|615856032|FG000|Overall Study|Withdrawal by Subject|5|||
170413902|NCT01716754|615856033|FG001|Overall Study|Withdrawal by Subject|0|||
170413903|NCT01716754|615856034|FG002|Overall Study|Withdrawal by Subject|4|||
170413904|NCT01716754|615856035|FG003|Overall Study|Withdrawal by Subject|3|||
170413905|NCT00481247|615856036|FG000|Overall Study|Death|0|||
170413906|NCT00481247|615856037|FG001|Overall Study|Death|1|||
170413907|NCT00481247|615856036|FG000|Overall Study|Disease progression|18|||
170413908|NCT00481247|615856037|FG001|Overall Study|Disease progression|22|||
170413909|NCT00481247|615856036|FG000|Overall Study|Intolerance|42|||
170413910|NCT00481247|615856037|FG001|Overall Study|Intolerance|17|||
170413911|NCT00481247|615856036|FG000|Overall Study|Treatment failure|10|||
170413912|NCT00481247|615856037|FG001|Overall Study|Treatment failure|14|||
170413913|NCT00481247|615856036|FG000|Overall Study|AE unrelated to study drug|13|||
170413914|NCT00481247|615856037|FG001|Overall Study|AE unrelated to study drug|4|||
170413915|NCT00481247|615856036|FG000|Overall Study|Withdrawal by Subject|8|||
170413916|NCT00481247|615856037|FG001|Overall Study|Withdrawal by Subject|13|||
170413917|NCT00481247|615856036|FG000|Overall Study|Pregnancy|2|||
170413918|NCT00481247|615856037|FG001|Overall Study|Pregnancy|1|||
170413919|NCT00481247|615856036|FG000|Overall Study|Lost to Follow-up|1|||
170413920|NCT00481247|615856037|FG001|Overall Study|Lost to Follow-up|2|||
170413921|NCT00481247|615856036|FG000|Overall Study|Poor compliance/noncompliance|1|||
170413922|NCT00481247|615856037|FG001|Overall Study|Poor compliance/noncompliance|7|||
170413923|NCT00481247|615856036|FG000|Overall Study|Administrative reason by sponsor|157|||
170413924|NCT00481247|615856037|FG001|Overall Study|Administrative reason by sponsor|162|||
170413925|NCT00481247|615856036|FG000|Overall Study|Varied|6|||
170413926|NCT00481247|615856037|FG001|Overall Study|Varied|15|||
170413927|NCT00481247|615856036|FG000|Overall Study|Did not receive treatment|1|||
170413928|NCT00481247|615856037|FG001|Overall Study|Did not receive treatment|2|||
170413929|NCT02970669|615856055|FG000|Double-blind Period|Adverse Event|4|||
170413930|NCT02970669|615856056|FG001|Double-blind Period|Adverse Event|0|||
170413931|NCT02970669|615856055|FG000|Double-blind Period|Death|1|||
170413932|NCT02970669|615856056|FG001|Double-blind Period|Death|0|||
170413933|NCT02970669|615856055|FG000|Double-blind Period|Study terminated by sponsor|1|||
170413934|NCT02970669|615856056|FG001|Double-blind Period|Study terminated by sponsor|2|||
170413935|NCT02970669|615856055|FG000|Double-blind Period|Physician Decision|0|||
170413936|NCT02970669|615856056|FG001|Double-blind Period|Physician Decision|2|||
170413937|NCT02970669|615856055|FG000|Double-blind Period|Withdrawal by Subject|2|||
170413938|NCT02970669|615856056|FG001|Double-blind Period|Withdrawal by Subject|2|||
170413939|NCT02970669|615856055|FG000|Open-label Period|Withdrawal by Subject|2|||
170525357|NCT00919633|616270110|FG002|Overall Study|Lost to Follow-up|0|||
170872639|NCT04667377|617544808|FG002|Maintenance Period|Adverse Event|5|||
170872640|NCT04667377|617544809|FG003|Maintenance Period|Adverse Event|4|||
170872641|NCT04667377|617544810|FG004|Maintenance Period|Adverse Event|1|||
170872642|NCT04667377|617544806|FG000|Maintenance Period|Adverse event: COVID infection|0|||
170413940|NCT02970669|615856056|FG001|Open-label Period|Withdrawal by Subject|2|||
170413941|NCT02970669|615856055|FG000|Open-label Period|Adverse Event|1|||
170413942|NCT02970669|615856056|FG001|Open-label Period|Adverse Event|0|||
170525358|NCT00919633|616270111|FG003|Overall Study|Lost to Follow-up|2|||
170413943|NCT02970669|615856055|FG000|Open-label Period|Physician Decision|1|||
170413944|NCT02970669|615856056|FG001|Open-label Period|Physician Decision|0|||
170413945|NCT00876733|615856057|FG000|Overall Study|Adverse Event|34|||
170413946|NCT00876733|615856058|FG001|Overall Study|Adverse Event|20|||
170413947|NCT00876733|615856059|FG002|Overall Study|Adverse Event|10|||
170413948|NCT00876733|615856060|FG003|Overall Study|Adverse Event|3|||
170413949|NCT00876733|615856057|FG000|Overall Study|Lack of Efficacy|17|||
170413950|NCT00876733|615856058|FG001|Overall Study|Lack of Efficacy|9|||
170525359|NCT00919633|616270108|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
170525360|NCT00919633|616270109|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
170525361|NCT00919633|616270110|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
170525362|NCT00919633|616270111|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
170525363|NCT00919633|616270108|FG000|Overall Study|Protocol Violation|0|||
170525364|NCT00919633|616270109|FG001|Overall Study|Protocol Violation|0|||
170525365|NCT00919633|616270110|FG002|Overall Study|Protocol Violation|0|||
170525366|NCT00919633|616270111|FG003|Overall Study|Protocol Violation|1|||
170525367|NCT00919633|616270108|FG000|Overall Study|Physician Decision|0|||
170413951|NCT00876733|615856059|FG002|Overall Study|Lack of Efficacy|10|||
170413952|NCT00876733|615856060|FG003|Overall Study|Lack of Efficacy|1|||
170413953|NCT00876733|615856057|FG000|Overall Study|Lost to Follow-up|26|||
170413954|NCT00876733|615856058|FG001|Overall Study|Lost to Follow-up|10|||
170771292|NCT01641198|617168436|FG002|After 24 Months of Function|Lost to Follow-up|6|||
170771293|NCT01641198|617168434|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
170771294|NCT01641198|617168435|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
170771295|NCT01641198|617168436|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
170771296|NCT01641198|617168434|FG000|At 15-20 Years of Function|Death|1|||
170413955|NCT00876733|615856059|FG002|Overall Study|Lost to Follow-up|3|||
170413956|NCT00876733|615856060|FG003|Overall Study|Lost to Follow-up|2|||
170413957|NCT00876733|615856057|FG000|Overall Study|Data not available|14|||
170413958|NCT00876733|615856058|FG001|Overall Study|Data not available|3|||
170413959|NCT00876733|615856059|FG002|Overall Study|Data not available|7|||
170413960|NCT00876733|615856060|FG003|Overall Study|Data not available|1|||
170413961|NCT02611752|615856063|FG000|Overall Study|Adverse Event|0|||
170413962|NCT02611752|615856064|FG001|Overall Study|Adverse Event|1|||
170413963|NCT01186978|615856065|FG000|Overall Study|Withdrawal by Subject|1|||
170413964|NCT04281485|615856066|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
170413965|NCT04281485|615856067|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
170413966|NCT04281485|615856066|FG000|Overall Study|Ongoing (Safety data collection)|10|||
170413967|NCT04281485|615856067|FG001|Overall Study|Ongoing (Safety data collection)|5|||
170413968|NCT04182204|615856068|FG000|Safety Run-in|Lost to Follow-up|1|||
170413969|NCT04182204|615856069|FG001|Safety Run-in|Lost to Follow-up|0|||
170413970|NCT04182204|615856070|FG002|Safety Run-in|Lost to Follow-up|0|||
170413971|NCT04182204|615856068|FG000|Safety Run-in|Withdrawal by Subject|2|||
170413972|NCT04182204|615856069|FG001|Safety Run-in|Withdrawal by Subject|0|||
170413973|NCT04182204|615856070|FG002|Safety Run-in|Withdrawal by Subject|0|||
170413974|NCT04182204|615856068|FG000|Safety Run-in|Death|7|||
170413975|NCT04182204|615856069|FG001|Safety Run-in|Death|0|||
170413976|NCT04182204|615856070|FG002|Safety Run-in|Death|0|||
170413977|NCT04182204|615856068|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
170413978|NCT04182204|615856069|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
170413979|NCT04182204|615856070|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
170413980|NCT04182204|615856068|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
170413981|NCT04182204|615856069|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
170413982|NCT04182204|615856070|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
170413983|NCT04182204|615856068|FG000|Randomized Controlled Trial|Death|0|||
170632198|NCT00538902|616664552|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
170771297|NCT01641198|617168435|FG001|At 15-20 Years of Function|Death|0|||
170771298|NCT01641198|617168436|FG002|At 15-20 Years of Function|Death|1|||
170771299|NCT01075217|617168437|FG000|Overall Study|Adverse Event|1|||
170771300|NCT01075217|617168438|FG001|Overall Study|Adverse Event|1|||
170771301|NCT01075217|617168437|FG000|Overall Study|Physician Decision|1|||
170771302|NCT01075217|617168438|FG001|Overall Study|Physician Decision|0|||
170771303|NCT02880241|617168439|FG000|Overall Study|Lack of Efficacy|1|||
170771304|NCT02880241|617168440|FG001|Overall Study|Lack of Efficacy|0|||
170771305|NCT02880241|617168441|FG002|Overall Study|Lack of Efficacy|0|||
170771306|NCT02880241|617168442|FG003|Overall Study|Lack of Efficacy|0|||
170771307|NCT02880241|617168443|FG004|Overall Study|Lack of Efficacy|0|||
170771308|NCT02880241|617168444|FG005|Overall Study|Lack of Efficacy|0|||
170413984|NCT04182204|615856069|FG001|Randomized Controlled Trial|Death|83|||
170413985|NCT04182204|615856070|FG002|Randomized Controlled Trial|Death|66|||
170771309|NCT02448446|617168445|FG000|Overall Study|Withdrawal by Subject|1|||
170771310|NCT02448446|617168446|FG001|Overall Study|Withdrawal by Subject|0|||
170771311|NCT01369498|617168447|FG000|Overall Study|Lack of Efficacy|9|||
170872643|NCT04667377|617544807|FG001|Maintenance Period|Adverse event: COVID infection|1|||
170872644|NCT04667377|617544808|FG002|Maintenance Period|Adverse event: COVID infection|0|||
170872645|NCT04667377|617544809|FG003|Maintenance Period|Adverse event: COVID infection|0|||
170413986|NCT03933202|615856071|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
170413987|NCT03933202|615856072|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
170413988|NCT03933202|615856071|FG000|Overall Study|Participant transferred care|1|||
170413989|NCT03933202|615856072|FG001|Overall Study|Participant transferred care|0|||
170413990|NCT03933202|615856071|FG000|Overall Study|Site research department closing|1|||
170413991|NCT03933202|615856072|FG001|Overall Study|Site research department closing|0|||
170525368|NCT00919633|616270109|FG001|Overall Study|Physician Decision|0|||
170771312|NCT01369498|617168448|FG001|Overall Study|Lack of Efficacy|9|||
170771313|NCT01369498|617168449|FG002|Overall Study|Lack of Efficacy|1|||
170771314|NCT01369498|617168450|FG003|Overall Study|Lack of Efficacy|3|||
170771315|NCT01369498|617168447|FG000|Overall Study|Adverse Event|1|||
170771316|NCT01369498|617168448|FG001|Overall Study|Adverse Event|2|||
170771317|NCT01369498|617168449|FG002|Overall Study|Adverse Event|0|||
170771318|NCT01369498|617168450|FG003|Overall Study|Adverse Event|1|||
170872646|NCT04667377|617544810|FG004|Maintenance Period|Adverse event: COVID infection|0|||
170872647|NCT04667377|617544806|FG000|Maintenance Period|COVID-related|0|||
170872648|NCT04667377|617544807|FG001|Maintenance Period|COVID-related|0|||
170872649|NCT04667377|617544808|FG002|Maintenance Period|COVID-related|1|||
170872650|NCT04667377|617544809|FG003|Maintenance Period|COVID-related|1|||
170872651|NCT04667377|617544810|FG004|Maintenance Period|COVID-related|0|||
170872652|NCT04667377|617544806|FG000|Maintenance Period|Protocol Violation|1|||
170872653|NCT04667377|617544807|FG001|Maintenance Period|Protocol Violation|0|||
170872654|NCT04667377|617544808|FG002|Maintenance Period|Protocol Violation|0|||
170413992|NCT03933202|615856071|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
170413993|NCT03933202|615856072|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
170413994|NCT03933202|615856071|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
170413995|NCT03933202|615856072|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
170413996|NCT03933202|615856071|FG000|Overall Study|Participant changed primary neurology provider|1|||
170413997|NCT03933202|615856072|FG001|Overall Study|Participant changed primary neurology provider|0|||
170413998|NCT03933202|615856071|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
170413999|NCT03933202|615856072|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
170414000|NCT03933202|615856071|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
170414001|NCT03933202|615856072|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
170414002|NCT03933202|615856071|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
170414003|NCT03933202|615856072|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
170414004|NCT03933202|615856071|FG000|Overall Study|Missed visit|0|||
170414005|NCT03933202|615856072|FG001|Overall Study|Missed visit|1|||
170414006|NCT03933202|615856071|FG000|Overall Study|Investigator decision|4|||
170414007|NCT03933202|615856072|FG001|Overall Study|Investigator decision|0|||
170414008|NCT03933202|615856071|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
170414009|NCT03933202|615856072|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
170414010|NCT03933202|615856071|FG000|Overall Study|Withdrawal by Subject|10|||
170414011|NCT03933202|615856072|FG001|Overall Study|Withdrawal by Subject|8|||
170414012|NCT03933202|615856071|FG000|Overall Study|Death|2|||
170414013|NCT03933202|615856072|FG001|Overall Study|Death|0|||
170414014|NCT03933202|615856071|FG000|Overall Study|Progressive disease|0|||
170414015|NCT03933202|615856072|FG001|Overall Study|Progressive disease|3|||
170414016|NCT03933202|615856071|FG000|Overall Study|Protocol non-compliance|6|||
170414017|NCT03933202|615856072|FG001|Overall Study|Protocol non-compliance|3|||
170414018|NCT03933202|615856071|FG000|Overall Study|Lost to Follow-up|16|||
170414019|NCT03933202|615856072|FG001|Overall Study|Lost to Follow-up|8|||
170414020|NCT03933202|615856071|FG000|Overall Study|Adverse Event|3|||
170414021|NCT03933202|615856072|FG001|Overall Study|Adverse Event|0|||
170414022|NCT05476679|615856075|FG000|Overall Study|Withdrawal by Subject|0|||
170414023|NCT05476679|615856076|FG001|Overall Study|Withdrawal by Subject|0|||
170414024|NCT05476679|615856077|FG002|Overall Study|Withdrawal by Subject|0|||
170414025|NCT05476679|615856078|FG003|Overall Study|Withdrawal by Subject|1|||
170414026|NCT05476679|615856079|FG004|Overall Study|Withdrawal by Subject|0|||
170414027|NCT05476679|615856075|FG000|Overall Study|Lost to Follow-up|0|||
170414028|NCT05476679|615856076|FG001|Overall Study|Lost to Follow-up|0|||
170414029|NCT05476679|615856077|FG002|Overall Study|Lost to Follow-up|0|||
170414030|NCT05476679|615856078|FG003|Overall Study|Lost to Follow-up|1|||
170414031|NCT05476679|615856079|FG004|Overall Study|Lost to Follow-up|0|||
170414032|NCT01214330|615856080|FG000|Overall Study|Withdrawal by Subject|2|||
170414033|NCT01214330|615856080|FG000|Overall Study|Withdrawal by Subject|2|||
170414034|NCT01348542|615856081|FG000|Overall Study|Withdrawal by Subject|3|||
170414035|NCT01348542|615856082|FG001|Overall Study|Withdrawal by Subject|0|||
170414036|NCT00686036|615856087|FG000|Overall Study|Adverse Event|3|||
170414037|NCT00686036|615856088|FG001|Overall Study|Adverse Event|0|||
170414038|NCT00686036|615856087|FG000|Overall Study|Withdrawal by Subject|3|||
170414039|NCT00686036|615856088|FG001|Overall Study|Withdrawal by Subject|1|||
170414040|NCT00686036|615856087|FG000|Overall Study|Study terminated by AstraZeneca|2|||
170771319|NCT01369498|617168447|FG000|Overall Study|Withdrawal of Consent|0|||
170872655|NCT04667377|617544809|FG003|Maintenance Period|Protocol Violation|0|||
170414041|NCT00686036|615856088|FG001|Overall Study|Study terminated by AstraZeneca|1|||
170414042|NCT00686036|615856087|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
170414043|NCT00686036|615856088|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
170414044|NCT00686036|615856087|FG000|Overall Study|Other reasons not identified|0|||
170771320|NCT01369498|617168448|FG001|Overall Study|Withdrawal of Consent|1|||
170771321|NCT01369498|617168449|FG002|Overall Study|Withdrawal of Consent|1|||
170414045|NCT00686036|615856088|FG001|Overall Study|Other reasons not identified|4|||
170414046|NCT01411995|615856089|FG000|Overall Study|Failed IUD insertion|0|||
170414047|NCT01411995|615856090|FG001|Overall Study|Failed IUD insertion|1|||
170414048|NCT05658523|615856091|FG000|Baseline|No blood draw|1|||
170414049|NCT05658523|615856092|FG001|Baseline|No blood draw|0|||
170414050|NCT05658523|615856093|FG002|Baseline|No blood draw|0|||
170414051|NCT05658523|615856091|FG000|28 Days|Lost to Follow-up|1|||
170414052|NCT05658523|615856092|FG001|28 Days|Lost to Follow-up|0|||
170414053|NCT05658523|615856093|FG002|28 Days|Lost to Follow-up|0|||
170414054|NCT05658523|615856091|FG000|28 Days|Withdrawal by Subject|1|||
170414055|NCT05658523|615856092|FG001|28 Days|Withdrawal by Subject|1|||
170414056|NCT05658523|615856093|FG002|28 Days|Withdrawal by Subject|0|||
170414057|NCT05658523|615856091|FG000|28 Days|Visit missed|0|||
170414058|NCT05658523|615856092|FG001|28 Days|Visit missed|4|||
170414059|NCT05658523|615856093|FG002|28 Days|Visit missed|0|||
170414060|NCT05658523|615856091|FG000|6 Months|Lost to Follow-up|1|||
170414061|NCT05658523|615856092|FG001|6 Months|Lost to Follow-up|7|||
170414062|NCT05658523|615856093|FG002|6 Months|Lost to Follow-up|2|||
170414063|NCT05658523|615856091|FG000|6 Months|Withdrawal by Subject|1|||
170414064|NCT05658523|615856092|FG001|6 Months|Withdrawal by Subject|3|||
170414065|NCT05658523|615856093|FG002|6 Months|Withdrawal by Subject|4|||
170414066|NCT05658523|615856091|FG000|6 Months|Visit missed|5|||
170414067|NCT05658523|615856092|FG001|6 Months|Visit missed|7|||
170414068|NCT05658523|615856093|FG002|6 Months|Visit missed|0|||
170414069|NCT05658523|615856091|FG000|6 Months|No blood draw|0|||
170414070|NCT05658523|615856092|FG001|6 Months|No blood draw|0|||
170414071|NCT05658523|615856093|FG002|6 Months|No blood draw|1|||
170414072|NCT05658523|615856091|FG000|12 Months|Lost to Follow-up|2|||
170414073|NCT05658523|615856092|FG001|12 Months|Lost to Follow-up|6|||
170414074|NCT05658523|615856093|FG002|12 Months|Lost to Follow-up|3|||
170414075|NCT05658523|615856091|FG000|12 Months|Withdrawal by Subject|4|||
170414076|NCT05658523|615856092|FG001|12 Months|Withdrawal by Subject|4|||
170414077|NCT05658523|615856093|FG002|12 Months|Withdrawal by Subject|2|||
170414078|NCT05658523|615856091|FG000|12 Months|Visit missed|4|||
170414079|NCT05658523|615856092|FG001|12 Months|Visit missed|8|||
170414080|NCT05658523|615856093|FG002|12 Months|Visit missed|8|||
170414081|NCT05658523|615856091|FG000|18 Months|Lost to Follow-up|5|||
170414082|NCT05658523|615856092|FG001|18 Months|Lost to Follow-up|8|||
170414083|NCT05658523|615856093|FG002|18 Months|Lost to Follow-up|2|||
170414084|NCT05658523|615856091|FG000|18 Months|Withdrawal by Subject|17|||
170414085|NCT05658523|615856092|FG001|18 Months|Withdrawal by Subject|9|||
170414086|NCT05658523|615856093|FG002|18 Months|Withdrawal by Subject|16|||
170414087|NCT05658523|615856091|FG000|18 Months|Visit missed|12|||
170414088|NCT05658523|615856092|FG001|18 Months|Visit missed|14|||
170414089|NCT05658523|615856093|FG002|18 Months|Visit missed|6|||
170414090|NCT00467584|615856096|FG000|Overall Study|Withdrawal by Subject|4|||
170414091|NCT00467584|615856097|FG001|Overall Study|Withdrawal by Subject|5|||
170414092|NCT00467584|615856098|FG002|Overall Study|Withdrawal by Subject|1|||
170632199|NCT00538902|616664550|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
170632200|NCT00538902|616664551|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
170632201|NCT00538902|616664552|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
170632202|NCT00538902|616664550|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
170632203|NCT00538902|616664551|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
170632204|NCT00538902|616664552|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
170632205|NCT04596267|616664553|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
170632206|NCT04596267|616664554|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
170632207|NCT04596267|616664553|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
170632208|NCT04596267|616664554|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
170632209|NCT01967940|616664555|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
170632210|NCT01967940|616664556|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
170632211|NCT01967940|616664557|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
170632212|NCT01967940|616664558|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
170632213|NCT01967940|616664555|FG000|Part 2|Adverse Event|0|||
170771322|NCT01369498|617168450|FG003|Overall Study|Withdrawal of Consent|1|||
170771323|NCT01369498|617168447|FG000|Overall Study|Death|0|||
170414093|NCT03387098|615856103|FG000|Overall Study|progressive disease|1|||
170414094|NCT03387098|615856103|FG000|Overall Study|Withdrawal by Subject|2|||
170414095|NCT03387098|615856103|FG000|Overall Study|study terminated by sponsor|1|||
170414096|NCT00814320|615856104|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
170414097|NCT00814320|615856105|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
170414098|NCT00814320|615856104|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
170414099|NCT00814320|615856105|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
170414100|NCT00814320|615856104|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
170414101|NCT00814320|615856105|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
170414102|NCT00814320|615856104|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
170414103|NCT00814320|615856105|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
170414104|NCT00814320|615856104|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
170771324|NCT01369498|617168448|FG001|Overall Study|Death|0|||
170771325|NCT01369498|617168449|FG002|Overall Study|Death|1|||
170771326|NCT01369498|617168450|FG003|Overall Study|Death|0|||
170771327|NCT01369498|617168447|FG000|Overall Study|Investigator's Discretion|1|||
170771328|NCT01369498|617168448|FG001|Overall Study|Investigator's Discretion|0|||
170771329|NCT01369498|617168449|FG002|Overall Study|Investigator's Discretion|1|||
170771330|NCT01369498|617168450|FG003|Overall Study|Investigator's Discretion|3|||
170771331|NCT01369498|617168447|FG000|Overall Study|Unknown Reason|1|||
170771332|NCT01369498|617168448|FG001|Overall Study|Unknown Reason|0|||
170414105|NCT00814320|615856105|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
170414106|NCT00814320|615856104|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
170414107|NCT00814320|615856105|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
170414108|NCT00814320|615856104|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
170414109|NCT00814320|615856105|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
170414110|NCT00814320|615856104|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
170414111|NCT00814320|615856105|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
170414112|NCT00814320|615856104|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
170414113|NCT00814320|615856105|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
170414114|NCT00814320|615856104|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
170414115|NCT00814320|615856105|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
170414116|NCT03730103|615856106|FG000|Overall Study|Did not meet inclusion criteria|0|||
170414117|NCT03730103|615856107|FG001|Overall Study|Did not meet inclusion criteria|5|||
170414118|NCT02308111|615856108|FG000|Overall Study|Adverse Event|31|||
170414119|NCT02308111|615856109|FG001|Overall Study|Adverse Event|19|||
170414120|NCT02308111|615856108|FG000|Overall Study|Death|9|||
170414121|NCT02308111|615856109|FG001|Overall Study|Death|6|||
170771333|NCT01369498|617168449|FG002|Overall Study|Unknown Reason|11|||
170771334|NCT01369498|617168450|FG003|Overall Study|Unknown Reason|6|||
170771335|NCT01369498|617168447|FG000|Overall Study|Disease Progression|0|||
170414122|NCT02308111|615856108|FG000|Overall Study|Lost to Follow-up|2|||
170414123|NCT02308111|615856109|FG001|Overall Study|Lost to Follow-up|7|||
170414124|NCT02308111|615856108|FG000|Overall Study|Physician Decision|6|||
170414125|NCT02308111|615856109|FG001|Overall Study|Physician Decision|17|||
170414126|NCT02308111|615856108|FG000|Overall Study|Protocol Violation|0|||
170414127|NCT02308111|615856109|FG001|Overall Study|Protocol Violation|1|||
170414128|NCT02308111|615856108|FG000|Overall Study|Withdrawal by Subject|28|||
170414129|NCT02308111|615856109|FG001|Overall Study|Withdrawal by Subject|38|||
170771336|NCT01369498|617168448|FG001|Overall Study|Disease Progression|0|||
170771337|NCT01369498|617168449|FG002|Overall Study|Disease Progression|0|||
170771338|NCT01369498|617168450|FG003|Overall Study|Disease Progression|1|||
170771339|NCT03260140|617168451|FG000|Overall Study|Death|4|||
170771340|NCT03260140|617168452|FG001|Overall Study|Death|1|||
170771341|NCT03260140|617168451|FG000|Overall Study|Withdrawal by Subject|1|||
170771342|NCT03260140|617168452|FG001|Overall Study|Withdrawal by Subject|4|||
170771343|NCT00439569|617168453|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
170771344|NCT00439569|617168453|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
170771345|NCT00439569|617168453|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
170771346|NCT01444417|617168454|FG000|Overall Study|Ineligibility Determined|0|||
170771347|NCT01444417|617168455|FG001|Overall Study|Ineligibility Determined|1|||
170771348|NCT01444417|617168454|FG000|Overall Study|Withdrawal by Subject|2|||
170771349|NCT01444417|617168455|FG001|Overall Study|Withdrawal by Subject|0|||
170771350|NCT02755116|617168456|FG000|Overall Study|surgery converted to open, pt admitted|3|||
170771351|NCT02755116|617168457|FG001|Overall Study|surgery converted to open, pt admitted|1|||
170771352|NCT01124734|617168461|FG000|Overall Study|Disease progression|13|||
170414130|NCT02308111|615856108|FG000|Overall Study|Study Terminated by Sponsor|72|||
170414131|NCT02308111|615856109|FG001|Overall Study|Study Terminated by Sponsor|61|||
170414132|NCT02308111|615856108|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
170414133|NCT02308111|615856109|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
170414134|NCT02308111|615856108|FG000|Overall Study|Site Closure|3|||
170414135|NCT02308111|615856109|FG001|Overall Study|Site Closure|3|||
170414136|NCT02308111|615856108|FG000|Overall Study|Non-compliance with Study Drug|3|||
170414137|NCT02308111|615856109|FG001|Overall Study|Non-compliance with Study Drug|1|||
170414138|NCT02308111|615856108|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
170414139|NCT02308111|615856109|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
170771353|NCT01124734|617168461|FG000|Overall Study|Adverse Event|1|||
170771354|NCT01124734|617168461|FG000|Overall Study|Withdrawal by Subject|1|||
170771355|NCT01124734|617168461|FG000|Overall Study|Elected for alternative treatment|2|||
170771356|NCT03292913|617168462|FG000|Overall Study|Death|9|||
170771357|NCT03292913|617168463|FG001|Overall Study|Death|3|||
170771358|NCT03292913|617168462|FG000|Overall Study|Lost to Follow-up|49|||
170414140|NCT02308111|615856108|FG000|Overall Study|Liver Transplant|3|||
170414141|NCT02308111|615856109|FG001|Overall Study|Liver Transplant|3|||
170414142|NCT02308111|615856108|FG000|Overall Study|Liver Transplant Waitlist|2|||
170414143|NCT02308111|615856109|FG001|Overall Study|Liver Transplant Waitlist|2|||
170525369|NCT00919633|616270110|FG002|Overall Study|Physician Decision|0|||
170771359|NCT03292913|617168463|FG001|Overall Study|Lost to Follow-up|49|||
170872656|NCT04667377|617544810|FG004|Maintenance Period|Protocol Violation|1|||
170872657|NCT04667377|617544806|FG000|Maintenance Period|Burden of study procedures|1|||
170872658|NCT04667377|617544807|FG001|Maintenance Period|Burden of study procedures|2|||
170872659|NCT04667377|617544808|FG002|Maintenance Period|Burden of study procedures|0|||
170872660|NCT04667377|617544809|FG003|Maintenance Period|Burden of study procedures|1|||
170872661|NCT04667377|617544810|FG004|Maintenance Period|Burden of study procedures|0|||
170872662|NCT04667377|617544806|FG000|Maintenance Period|Change of residence|0|||
170872663|NCT04667377|617544807|FG001|Maintenance Period|Change of residence|1|||
170872664|NCT04667377|617544808|FG002|Maintenance Period|Change of residence|0|||
170872665|NCT04667377|617544809|FG003|Maintenance Period|Change of residence|0|||
170872666|NCT04667377|617544810|FG004|Maintenance Period|Change of residence|1|||
170872667|NCT04667377|617544806|FG000|Maintenance Period|Missing|1|||
170872668|NCT04667377|617544807|FG001|Maintenance Period|Missing|0|||
170872669|NCT04667377|617544808|FG002|Maintenance Period|Missing|0|||
170872670|NCT04667377|617544809|FG003|Maintenance Period|Missing|0|||
170872671|NCT04667377|617544810|FG004|Maintenance Period|Missing|0|||
170872672|NCT04667377|617544806|FG000|Maintenance Period|Other than listed above|2|||
170525370|NCT00919633|616270111|FG003|Overall Study|Physician Decision|1|||
170525371|NCT00919633|616270108|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
170525372|NCT00919633|616270109|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
170525373|NCT00919633|616270110|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
170525374|NCT00919633|616270111|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
170525375|NCT00919633|616270108|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
170525376|NCT00919633|616270109|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
170525377|NCT00919633|616270110|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
170525378|NCT00919633|616270111|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
170525379|NCT02579629|616271931|FG000|Overall Study|Withdrawal by Subject|0|||
170525380|NCT02579629|616271932|FG001|Overall Study|Withdrawal by Subject|1|||
170525381|NCT02579629|616271933|FG002|Overall Study|Withdrawal by Subject|0|||
170525382|NCT02579629|616271931|FG000|Overall Study|Screen Failure|2|||
170525383|NCT02579629|616271932|FG001|Overall Study|Screen Failure|0|||
170525384|NCT02579629|616271933|FG002|Overall Study|Screen Failure|2|||
170525385|NCT01190891|616271934|FG000|Overall Study|Protocol Violation|1|||
170525386|NCT01190891|616271935|FG001|Overall Study|Protocol Violation|0|||
170525387|NCT01190891|616271934|FG000|Overall Study|Withdrawal by Subject|5|||
170525388|NCT01190891|616271935|FG001|Overall Study|Withdrawal by Subject|0|||
170525389|NCT00301834|616271936|FG000|Overall Study|Death|1|||
170525390|NCT02737358|616271937|FG000|Overall Study|Withdrawal by Subject|7|||
170525391|NCT02737358|616271938|FG001|Overall Study|Withdrawal by Subject|12|||
170525392|NCT02737358|616271937|FG000|Overall Study|Lost to Follow-up|2|||
170525393|NCT02737358|616271938|FG001|Overall Study|Lost to Follow-up|3|||
170525394|NCT01739335|616271940|FG000|Overall Study|Lost to Follow-up|7|||
170525395|NCT01739335|616271941|FG001|Overall Study|Lost to Follow-up|4|||
170525396|NCT01739335|616271940|FG000|Overall Study|Ineligible patient randomized|0|||
170525397|NCT01739335|616271941|FG001|Overall Study|Ineligible patient randomized|1|||
170525398|NCT00183430|616271942|FG000|Overall Study|Adverse Event|1|||
170525399|NCT00183430|616271943|FG001|Overall Study|Adverse Event|0|||
170525400|NCT00183430|616271942|FG000|Overall Study|Lost to Follow-up|3|||
170525401|NCT00183430|616271943|FG001|Overall Study|Lost to Follow-up|0|||
170525402|NCT00183430|616271942|FG000|Overall Study|did not meet inclusion criteria|1|||
170525403|NCT00183430|616271943|FG001|Overall Study|did not meet inclusion criteria|0|||
170525404|NCT00183430|616271942|FG000|Overall Study|Withdrawal by Subject|1|||
170525405|NCT00183430|616271943|FG001|Overall Study|Withdrawal by Subject|0|||
170525406|NCT02014272|616271949|FG000|Intervention Period 1|Withdrawal by Subject|1|||
170525407|NCT02014272|616271950|FG001|Intervention Period 1|Withdrawal by Subject|0|||
170525408|NCT02014272|616271949|FG000|Intervention Period 1|Adverse Event|0|||
170525409|NCT02014272|616271950|FG001|Intervention Period 1|Adverse Event|1|||
170525410|NCT01863771|616271951|FG000|Induction Phase|Adverse Event|9|||
170525411|NCT01863771|616271952|FG001|Induction Phase|Adverse Event|0|||
170525412|NCT01863771|616271953|FG002|Induction Phase|Adverse Event|0|||
170872673|NCT04667377|617544807|FG001|Maintenance Period|Other than listed above|0|||
170872674|NCT04667377|617544808|FG002|Maintenance Period|Other than listed above|3|||
170525413|NCT01863771|616271954|FG003|Induction Phase|Adverse Event|0|||
170525414|NCT01863771|616271951|FG000|Induction Phase|Lack of Efficacy|10|||
170632214|NCT01967940|616664556|FG001|Part 2|Adverse Event|0|||
170632215|NCT01967940|616664557|FG002|Part 2|Adverse Event|0|||
170872675|NCT04667377|617544809|FG003|Maintenance Period|Other than listed above|2|||
170872676|NCT04667377|617544810|FG004|Maintenance Period|Other than listed above|6|||
170872677|NCT04667377|617544806|FG000|Maintenance Period|Withdrawal by Subject|0|||
170632216|NCT01967940|616664558|FG003|Part 2|Adverse Event|1|||
170872678|NCT04667377|617544807|FG001|Maintenance Period|Withdrawal by Subject|1|||
170525415|NCT01863771|616271952|FG001|Induction Phase|Lack of Efficacy|0|||
170525416|NCT01863771|616271953|FG002|Induction Phase|Lack of Efficacy|0|||
170525417|NCT01863771|616271954|FG003|Induction Phase|Lack of Efficacy|0|||
170525418|NCT01863771|616271951|FG000|Induction Phase|Withdrawal by Subject|2|||
170525419|NCT01863771|616271952|FG001|Induction Phase|Withdrawal by Subject|0|||
170525420|NCT01863771|616271953|FG002|Induction Phase|Withdrawal by Subject|0|||
170525421|NCT01863771|616271954|FG003|Induction Phase|Withdrawal by Subject|0|||
170525422|NCT01863771|616271951|FG000|Maintenance Phase|Adverse Event|0|||
170525423|NCT01863771|616271952|FG001|Maintenance Phase|Adverse Event|0|||
170525424|NCT01863771|616271953|FG002|Maintenance Phase|Adverse Event|1|||
170525425|NCT01863771|616271954|FG003|Maintenance Phase|Adverse Event|1|||
170525426|NCT01863771|616271951|FG000|Maintenance Phase|Lack of Efficacy|0|||
170525427|NCT01863771|616271952|FG001|Maintenance Phase|Lack of Efficacy|3|||
170525428|NCT01863771|616271953|FG002|Maintenance Phase|Lack of Efficacy|7|||
170525429|NCT01863771|616271954|FG003|Maintenance Phase|Lack of Efficacy|38|||
170525430|NCT01863771|616271951|FG000|Maintenance Phase|Physician Decision|0|||
170525431|NCT01863771|616271952|FG001|Maintenance Phase|Physician Decision|0|||
170525432|NCT01863771|616271953|FG002|Maintenance Phase|Physician Decision|2|||
170525433|NCT01863771|616271954|FG003|Maintenance Phase|Physician Decision|1|||
170525434|NCT01863771|616271951|FG000|Maintenance Phase|Pregnancy|0|||
170525435|NCT01863771|616271952|FG001|Maintenance Phase|Pregnancy|1|||
170525436|NCT01863771|616271953|FG002|Maintenance Phase|Pregnancy|0|||
170525437|NCT01863771|616271954|FG003|Maintenance Phase|Pregnancy|0|||
170525438|NCT01863771|616271951|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170525439|NCT01863771|616271952|FG001|Maintenance Phase|Withdrawal by Subject|1|||
170525440|NCT01863771|616271953|FG002|Maintenance Phase|Withdrawal by Subject|2|||
170525441|NCT01863771|616271954|FG003|Maintenance Phase|Withdrawal by Subject|3|||
170525442|NCT00883181|616271955|FG000|Overall Study|Hematological Adverse Event|26|||
170525443|NCT00883181|616271955|FG000|Overall Study|Non-hematological Adverse Event|55|||
170525444|NCT00883181|616271955|FG000|Overall Study|Disease Progression|94|||
170525445|NCT00883181|616271955|FG000|Overall Study|Administrative Reason|24|||
170525446|NCT00883181|616271955|FG000|Overall Study|Withdrawal by Subject|4|||
170525447|NCT00883181|616271955|FG000|Overall Study|Death|31|||
170525448|NCT00883181|616271955|FG000|Overall Study|Other|38|||
170525449|NCT00883181|616271955|FG000|Overall Study|Protocol Deviation|3|||
170525450|NCT00883181|616271955|FG000|Overall Study|Noncompliance|3|||
170525451|NCT01218308|616271956|FG000|Overall Study|Adverse Event|1|||
170525452|NCT01218308|616271957|FG001|Overall Study|Adverse Event|2|||
170525453|NCT01218308|616271956|FG000|Overall Study|Protocol Violation|0|||
170525454|NCT01218308|616271957|FG001|Overall Study|Protocol Violation|2|||
170525455|NCT01218308|616271956|FG000|Overall Study|Withdrawal by Subject|61|||
170525456|NCT01218308|616271957|FG001|Overall Study|Withdrawal by Subject|64|||
170525457|NCT01218308|616271956|FG000|Overall Study|Lost to Follow-up|27|||
170525458|NCT01218308|616271957|FG001|Overall Study|Lost to Follow-up|31|||
170525459|NCT01218308|616271956|FG000|Overall Study|Other|14|||
170525460|NCT01218308|616271957|FG001|Overall Study|Other|21|||
170525461|NCT03238417|616271961|FG000|Overall|non-response|955|||
170525462|NCT03238417|616271962|FG001|Overall|non-response|1920|||
170525463|NCT03238417|616271961|FG000|Overall|partial completion|48|||
170525464|NCT03238417|616271962|FG001|Overall|partial completion|68|||
170525465|NCT03238417|616271961|FG000|Baseline|Partial completion|17|||
170525466|NCT03238417|616271962|FG001|Baseline|Partial completion|48|||
170525467|NCT03238417|616271961|FG000|Baseline|non-response|372|||
170525468|NCT03238417|616271962|FG001|Baseline|non-response|669|||
170525469|NCT03238417|616271961|FG000|12-month|non-response|296|||
170525470|NCT03238417|616271962|FG001|12-month|non-response|669|||
170525471|NCT03238417|616271961|FG000|12-month|partial completion|23|||
170525472|NCT03238417|616271962|FG001|12-month|partial completion|37|||
170525473|NCT03238417|616271961|FG000|24-month|non-response|287|||
170525474|NCT03238417|616271962|FG001|24-month|non-response|594|||
170525475|NCT03238417|616271961|FG000|24-month|partial completion|8|||
170525476|NCT03238417|616271962|FG001|24-month|partial completion|31|||
170525477|NCT01774591|616271974|FG000|Overall Study|Physician Decision|1|||
170525478|NCT01774591|616271975|FG001|Overall Study|Physician Decision|1|||
170525479|NCT01774591|616271974|FG000|Overall Study|Withdrawal by Subject|0|||
170525480|NCT01774591|616271975|FG001|Overall Study|Withdrawal by Subject|1|||
170525481|NCT01774591|616271974|FG000|Overall Study|Adverse Event|0|||
170771360|NCT03292913|617168462|FG000|Overall Study|Withdrawal by Subject|2|||
170771361|NCT03292913|617168463|FG001|Overall Study|Withdrawal by Subject|0|||
170525482|NCT01774591|616271975|FG001|Overall Study|Adverse Event|2|||
170525483|NCT01474486|616271976|FG000|Overall Study|Death|2|||
170525484|NCT01474486|616271976|FG000|Overall Study|Withdrawal by Subject|4|||
170525485|NCT01474486|616271976|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
170525486|NCT04275336|616271977|FG000|Overall Study|First venipuncture failed|4|||
170525487|NCT04275336|616271978|FG001|Overall Study|First venipuncture failed|6|||
170525488|NCT04275336|616271979|FG002|Overall Study|First venipuncture failed|5|||
170525489|NCT04275336|616271977|FG000|Overall Study|Unscheduled venipuncture|9|||
170525490|NCT04275336|616271978|FG001|Overall Study|Unscheduled venipuncture|13|||
170525491|NCT04275336|616271979|FG002|Overall Study|Unscheduled venipuncture|7|||
170525492|NCT04275336|616271977|FG000|Overall Study|Failed specimen of saliva|4|||
170525493|NCT04275336|616271978|FG001|Overall Study|Failed specimen of saliva|3|||
170771362|NCT03292913|617168462|FG000|Overall Study|Clinic closed due to COVID|22|||
170525494|NCT04275336|616271979|FG002|Overall Study|Failed specimen of saliva|4|||
170414144|NCT02308111|615856108|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
170414145|NCT02308111|615856109|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
170414146|NCT01688037|615856111|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
170414147|NCT01688037|615856112|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
170414148|NCT01688037|615856113|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
170414149|NCT01688037|615856111|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
170414150|NCT01688037|615856112|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
170414151|NCT01688037|615856113|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
170414152|NCT01688037|615856111|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
170414153|NCT01688037|615856112|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
170414154|NCT01688037|615856113|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
170414155|NCT01688037|615856111|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
170414156|NCT01688037|615856112|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
170414157|NCT01688037|615856113|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
170414158|NCT01688037|615856111|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
170414159|NCT01688037|615856112|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
170414160|NCT01688037|615856113|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
170414161|NCT01688037|615856111|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
170414162|NCT01688037|615856112|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
170414163|NCT01688037|615856113|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
170414164|NCT01688037|615856111|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
170414165|NCT01688037|615856112|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
170414166|NCT01688037|615856113|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
170414167|NCT01688037|615856111|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
170414168|NCT01688037|615856112|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
170414169|NCT01688037|615856113|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
170414170|NCT01688037|615856111|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
170414171|NCT01688037|615856112|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
170414172|NCT01688037|615856113|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
170414173|NCT01688037|615856111|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
170414174|NCT01688037|615856112|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
170414175|NCT01688037|615856113|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
170414176|NCT01618305|615856114|FG000|Overall Study|Death|0|||
170414177|NCT01618305|615856115|FG001|Overall Study|Death|1|||
170414178|NCT01618305|615856114|FG000|Overall Study|Lost to Follow-up|11|||
170414179|NCT01618305|615856115|FG001|Overall Study|Lost to Follow-up|7|||
170414180|NCT01618305|615856114|FG000|Overall Study|Protocol Violation|1|||
170414181|NCT01618305|615856115|FG001|Overall Study|Protocol Violation|0|||
170414182|NCT01618305|615856114|FG000|Overall Study|Withdrawal by Subject|3|||
170414183|NCT01618305|615856115|FG001|Overall Study|Withdrawal by Subject|2|||
170414184|NCT04071769|615856116|FG000|Overall Study|Lost to Follow-up|3|||
170414185|NCT04071769|615856116|FG000|Overall Study|Physician Decision|2|||
170414186|NCT04071769|615856116|FG000|Overall Study|Withdrawal by Subject|8|||
170414187|NCT05431686|615856117|FG000|Overall Study|unable to schedule|10|||
170414188|NCT02102490|615856118|FG000|Overall Study|Death|6|||
170414189|NCT02102490|615856118|FG000|Overall Study|Lost to Follow-up|1|||
170414190|NCT01890707|615856119|FG000|Overall Study|Lost to Follow-up|1|||
170414191|NCT01890707|615856120|FG001|Overall Study|Lost to Follow-up|1|||
170414192|NCT02154529|615856121|FG000|Overall Study|Death|1|||
170414193|NCT02154529|615856122|FG001|Overall Study|Death|1|||
170414194|NCT02154529|615856123|FG002|Overall Study|Death|5|||
170414195|NCT02154529|615856124|FG003|Overall Study|Death|1|||
170414196|NCT02154529|615856121|FG000|Overall Study|Termination of study by sponsor|2|||
170414197|NCT02154529|615856122|FG001|Overall Study|Termination of study by sponsor|2|||
170414198|NCT02154529|615856123|FG002|Overall Study|Termination of study by sponsor|3|||
170414199|NCT02154529|615856124|FG003|Overall Study|Termination of study by sponsor|1|||
170414200|NCT02154529|615856121|FG000|Overall Study|Lost to Follow-up|1|||
170414201|NCT02154529|615856122|FG001|Overall Study|Lost to Follow-up|0|||
170414202|NCT02154529|615856123|FG002|Overall Study|Lost to Follow-up|0|||
170414203|NCT02154529|615856124|FG003|Overall Study|Lost to Follow-up|0|||
170414204|NCT02178709|615857153|FG000|Overall Study|Adverse Event|5|||
170414205|NCT02178709|615857153|FG000|Overall Study|Death|2|||
170414206|NCT02178709|615857153|FG000|Overall Study|Withdrawal by Subject|2|||
170414207|NCT02178709|615857153|FG000|Overall Study|Physician Decision|2|||
170414208|NCT02178709|615857153|FG000|Overall Study|Disease Progression|5|||
170414209|NCT02192905|615857155|FG000|Overall Study|Lost to Follow-up|1|||
170414210|NCT01691859|615857156|FG000|Overall Study|Adverse Event|19|||
170414211|NCT01691859|615857156|FG000|Overall Study|Lack of Efficacy|11|||
170414212|NCT01691859|615857156|FG000|Overall Study|Protocol Violation|4|||
170414213|NCT01691859|615857156|FG000|Overall Study|Product commercially available|221|||
170414214|NCT01691859|615857156|FG000|Overall Study|Study closed/terminated|50|||
170414215|NCT01691859|615857156|FG000|Overall Study|Lost to Follow-up|5|||
170414216|NCT01691859|615857156|FG000|Overall Study|Physician Decision|6|||
170525495|NCT05002972|616271981|FG000|Overall Study|Withdrawal by Subject|2|||
170525496|NCT01664091|616271982|FG000|Overall Study|Death|1|||
170525497|NCT01664091|616271982|FG000|Overall Study|Disease Progression|2|||
170525498|NCT01664091|616271982|FG000|Overall Study|Lost to Follow-up|2|||
170525499|NCT01664091|616271982|FG000|Overall Study|Withdrawal by Subject|1|||
170525500|NCT02053493|616271983|FG000|Overall Study|Withdrawal by Subject|1|||
170525501|NCT02053493|616271984|FG001|Overall Study|Withdrawal by Subject|1|||
170525502|NCT00617357|616271985|FG000|Overall Study|Lost to Follow-up|7|||
170525503|NCT00617357|616271985|FG000|Overall Study|Death|5|||
170525504|NCT00617357|616271985|FG000|Overall Study|insurance concerns|2|||
170525505|NCT00617357|616271985|FG000|Overall Study|Withdrawal by Subject|1|||
170525506|NCT00617357|616271985|FG000|Overall Study|Physician Decision|1|||
170525507|NCT01103323|616271990|FG000|Without/Before Drug Switch|Adverse Event|50|||
170525508|NCT01103323|616271991|FG001|Without/Before Drug Switch|Adverse Event|7|||
170525509|NCT01103323|616271990|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
170525510|NCT01103323|616271991|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
170525511|NCT01103323|616271990|FG000|Without/Before Drug Switch|Protocol Violation|2|||
170525512|NCT01103323|616271991|FG001|Without/Before Drug Switch|Protocol Violation|0|||
170525513|NCT01103323|616271990|FG000|Without/Before Drug Switch|Physician Decision|2|||
170525514|NCT01103323|616271991|FG001|Without/Before Drug Switch|Physician Decision|0|||
170525515|NCT01103323|616271990|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
170525516|NCT01103323|616271991|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
170525517|NCT01103323|616271990|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
170525518|NCT01103323|616271991|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
170525519|NCT01103323|616271990|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
170525520|NCT01103323|616271991|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
170525521|NCT03797898|616272000|FG000|Overall Study|Lost to Follow-up|60|||
170525522|NCT03797898|616272001|FG001|Overall Study|Lost to Follow-up|69|||
170525523|NCT03797898|616272000|FG000|Overall Study|Withdrawal by Subject|9|||
170525524|NCT03797898|616272001|FG001|Overall Study|Withdrawal by Subject|7|||
170525525|NCT03797898|616272000|FG000|Overall Study|Became ineligible|5|||
170525526|NCT03797898|616272001|FG001|Overall Study|Became ineligible|2|||
170525527|NCT00086190|616272002|FG000|Overall Study|Adverse Event|6|||
170525528|NCT00086190|616272003|FG001|Overall Study|Adverse Event|2|||
170525529|NCT00086190|616272004|FG002|Overall Study|Adverse Event|2|||
170525530|NCT00086190|616272002|FG000|Overall Study|Withdrawal by Subject|0|||
170525531|NCT00086190|616272003|FG001|Overall Study|Withdrawal by Subject|2|||
170525532|NCT00086190|616272004|FG002|Overall Study|Withdrawal by Subject|2|||
170525533|NCT00086190|616272002|FG000|Overall Study|Protocol Violation|1|||
170525534|NCT00086190|616272003|FG001|Overall Study|Protocol Violation|0|||
170525535|NCT00086190|616272004|FG002|Overall Study|Protocol Violation|0|||
170525536|NCT00086190|616272002|FG000|Overall Study|Moved|1|||
170525537|NCT00086190|616272003|FG001|Overall Study|Moved|0|||
170525538|NCT00086190|616272004|FG002|Overall Study|Moved|0|||
170525539|NCT00086190|616272002|FG000|Overall Study|Worsening depression|0|||
170525540|NCT00086190|616272003|FG001|Overall Study|Worsening depression|0|||
170525541|NCT00086190|616272004|FG002|Overall Study|Worsening depression|2|||
170525542|NCT00249834|616272005|FG000|Overall Study|Ovarian stimulation failed|1|||
170525543|NCT00249834|616272006|FG001|Overall Study|Ovarian stimulation failed|0|||
170525544|NCT00249834|616272007|FG002|Overall Study|Ovarian stimulation failed|0|||
170525545|NCT00249834|616272008|FG003|Overall Study|Ovarian stimulation failed|0|||
170525546|NCT00249834|616272009|FG004|Overall Study|Ovarian stimulation failed|0|||
170525547|NCT00249834|616272010|FG005|Overall Study|Ovarian stimulation failed|0|||
170525548|NCT00249834|616272011|FG006|Overall Study|Ovarian stimulation failed|0|||
170525549|NCT00249834|616272012|FG007|Overall Study|Ovarian stimulation failed|0|||
170525550|NCT00249834|616272005|FG000|Overall Study|Failure of down-regulation|0|||
170525551|NCT00249834|616272006|FG001|Overall Study|Failure of down-regulation|0|||
170525552|NCT00249834|616272007|FG002|Overall Study|Failure of down-regulation|0|||
170525553|NCT00249834|616272008|FG003|Overall Study|Failure of down-regulation|0|||
170525554|NCT00249834|616272009|FG004|Overall Study|Failure of down-regulation|0|||
170525555|NCT00249834|616272010|FG005|Overall Study|Failure of down-regulation|0|||
170525556|NCT00249834|616272011|FG006|Overall Study|Failure of down-regulation|1|||
170525557|NCT00249834|616272012|FG007|Overall Study|Failure of down-regulation|0|||
170525558|NCT00249834|616272005|FG000|Overall Study|Protocol Violation|0|||
170525559|NCT00249834|616272006|FG001|Overall Study|Protocol Violation|19|||
170525560|NCT00249834|616272007|FG002|Overall Study|Protocol Violation|14|||
170525561|NCT00249834|616272008|FG003|Overall Study|Protocol Violation|8|||
170771363|NCT03292913|617168463|FG001|Overall Study|Clinic closed due to COVID|36|||
170771364|NCT02423798|617168466|FG000|Overall Study|Withdrawal by Subject|3|||
170525562|NCT00249834|616272009|FG004|Overall Study|Protocol Violation|5|||
170525563|NCT00249834|616272010|FG005|Overall Study|Protocol Violation|2|||
170525564|NCT00249834|616272011|FG006|Overall Study|Protocol Violation|0|||
170525565|NCT00249834|616272012|FG007|Overall Study|Protocol Violation|0|||
170525566|NCT04275973|616272015|FG000|Overall Study|Withdrawal by Subject|2|||
170525567|NCT04275973|616272016|FG001|Overall Study|Withdrawal by Subject|1|||
170525568|NCT03528551|616272020|FG000|Overall Study|Lost to Follow-up|0|||
170525569|NCT03528551|616272021|FG001|Overall Study|Lost to Follow-up|1|||
170525570|NCT03528551|616272022|FG002|Overall Study|Lost to Follow-up|0|||
170525571|NCT03528551|616272020|FG000|Overall Study|Transferred to other arm/group|2|||
170525572|NCT03528551|616272021|FG001|Overall Study|Transferred to other arm/group|3|||
170525573|NCT03528551|616272022|FG002|Overall Study|Transferred to other arm/group|0|||
170525574|NCT03528551|616272020|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170525575|NCT03528551|616272021|FG001|Overall Study|Withdrawal by parent/guardian|5|||
170525576|NCT03528551|616272022|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170525577|NCT03528551|616272020|FG000|Overall Study|Protocol Violation|0|||
170525578|NCT03528551|616272021|FG001|Overall Study|Protocol Violation|3|||
170525579|NCT03528551|616272022|FG002|Overall Study|Protocol Violation|0|||
170525580|NCT03528551|616272020|FG000|Overall Study|Withdrawal by Subject|0|||
170872679|NCT04667377|617544808|FG002|Maintenance Period|Withdrawal by Subject|0|||
170872680|NCT04667377|617544809|FG003|Maintenance Period|Withdrawal by Subject|0|||
170872681|NCT04667377|617544810|FG004|Maintenance Period|Withdrawal by Subject|0|||
170872682|NCT04667377|617544806|FG000|Maintenance Period|Lost to Follow-up|1|||
170872683|NCT04667377|617544807|FG001|Maintenance Period|Lost to Follow-up|0|||
170872684|NCT04667377|617544808|FG002|Maintenance Period|Lost to Follow-up|1|||
170872685|NCT04667377|617544809|FG003|Maintenance Period|Lost to Follow-up|0|||
170872686|NCT04667377|617544810|FG004|Maintenance Period|Lost to Follow-up|1|||
170872687|NCT05525689|617544812|FG000|Overall Study|Lost to Follow-up|1|||
170872688|NCT05525689|617544813|FG001|Overall Study|Lost to Follow-up|0|||
170872689|NCT01671111|617544816|FG000|Overall Study|Adverse Event|2|||
170872690|NCT01671111|617544816|FG000|Overall Study|Lack of Efficacy|1|||
170872691|NCT01671111|617544816|FG000|Overall Study|Withdrawal by Subject|2|||
170872692|NCT01671111|617544816|FG000|Overall Study|Physician Decision|1|||
170872693|NCT01671111|617544816|FG000|Overall Study|Other|24|||
170872694|NCT04556136|617544821|FG000|Overall Study|Lost to Follow-up|6|||
170872695|NCT04556136|617544822|FG001|Overall Study|Lost to Follow-up|6|||
170872696|NCT04556136|617544821|FG000|Overall Study|Physician Decision|2|||
170872697|NCT04556136|617544822|FG001|Overall Study|Physician Decision|1|||
170872698|NCT04556136|617544821|FG000|Overall Study|Withdrawal by Subject|2|||
170872699|NCT04556136|617544822|FG001|Overall Study|Withdrawal by Subject|1|||
170872700|NCT00935272|617544825|FG000|Overall Study|Lost to Follow-up|10|||
170872701|NCT00935272|617544826|FG001|Overall Study|Lost to Follow-up|3|||
170872702|NCT00935272|617544825|FG000|Overall Study|Withdrawal by Subject|8|||
170872703|NCT00935272|617544826|FG001|Overall Study|Withdrawal by Subject|2|||
170872704|NCT00935272|617544825|FG000|Overall Study|Physician Decision|1|||
170872705|NCT00935272|617544826|FG001|Overall Study|Physician Decision|0|||
170872706|NCT00935272|617544825|FG000|Overall Study|Protocol Violation|0|||
170872707|NCT00935272|617544826|FG001|Overall Study|Protocol Violation|1|||
170872708|NCT01221727|617544827|FG000|Overall Study|Physician Decision|2|||
170414217|NCT01691859|615857156|FG000|Overall Study|Withdrawal by Subject|31|||
170414218|NCT04820842|615857157|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
170414219|NCT04820842|615857158|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
170414220|NCT04820842|615857159|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
170414221|NCT04820842|615857160|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
170414222|NCT04820842|615857161|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
170414223|NCT04820842|615857162|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
170414224|NCT04820842|615857163|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
170414225|NCT04820842|615857157|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
170414226|NCT04820842|615857158|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
170414227|NCT04820842|615857159|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
170414228|NCT04820842|615857160|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170414229|NCT04820842|615857161|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170414230|NCT04820842|615857162|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170414231|NCT04820842|615857163|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170414232|NCT04820842|615857157|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
170414233|NCT04820842|615857158|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
170414234|NCT04820842|615857159|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
170414235|NCT04820842|615857160|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
170414236|NCT04820842|615857161|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
170414237|NCT04820842|615857162|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
170414238|NCT04820842|615857163|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
170414239|NCT04820842|615857157|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170414240|NCT04820842|615857158|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170872709|NCT01221727|617544828|FG001|Overall Study|Physician Decision|0|||
170771365|NCT01063972|617168467|FG000|Overall Study|Death|12|||
170771366|NCT01063972|617168468|FG001|Overall Study|Death|11|||
170771367|NCT01063972|617168467|FG000|Overall Study|Incarcerated|2|||
170771368|NCT01063972|617168468|FG001|Overall Study|Incarcerated|1|||
170771369|NCT01510717|617168469|FG000|Overall Study|Adverse Event|1|||
170771370|NCT01510717|617168470|FG001|Overall Study|Adverse Event|2|||
170771371|NCT01510717|617168469|FG000|Overall Study|Death|1|||
170771372|NCT01510717|617168470|FG001|Overall Study|Death|0|||
170771373|NCT01510717|617168469|FG000|Overall Study|Lost to Follow-up|0|||
170771374|NCT01510717|617168470|FG001|Overall Study|Lost to Follow-up|1|||
170771375|NCT01510717|617168469|FG000|Overall Study|Withdrawal by Subject|0|||
170771376|NCT01510717|617168470|FG001|Overall Study|Withdrawal by Subject|2|||
170771377|NCT00424645|617168474|FG000|Overall Study|Death|1|||
170771378|NCT00424645|617168475|FG001|Overall Study|Death|0|||
170771379|NCT02555215|617168476|FG000|Overall Study|Other|1|||
170771380|NCT02555215|617168476|FG000|Overall Study|Investigator Decision|2|||
170414241|NCT04820842|615857159|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170414242|NCT04820842|615857160|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
170414243|NCT04820842|615857161|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170414244|NCT04820842|615857162|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
170414245|NCT04820842|615857163|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
170414246|NCT06041646|615857171|FG000|Overall Study|Withdrawal by Subject|1|||
170414247|NCT02918162|615857172|FG000|Overall Study|Withdrawal by Subject|1|||
170414248|NCT02918162|615857172|FG000|Overall Study|Omental Disease|1|||
170414249|NCT03209570|615857173|FG000|Overall Study|Death|1|||
170414250|NCT03209570|615857174|FG001|Overall Study|Death|0|||
170414251|NCT03209570|615857173|FG000|Overall Study|Incomplete Data|8|||
170414252|NCT03209570|615857174|FG001|Overall Study|Incomplete Data|10|||
170414253|NCT03209570|615857173|FG000|Overall Study|Protocol Violation|1|||
170414254|NCT03209570|615857174|FG001|Overall Study|Protocol Violation|0|||
170414255|NCT03209570|615857173|FG000|Overall Study|Withdrawal by Subject|0|||
170414256|NCT03209570|615857174|FG001|Overall Study|Withdrawal by Subject|3|||
170414257|NCT02227862|615857176|FG000|Overall Study|Protocol Violation|7|||
170414258|NCT02227862|615857177|FG001|Overall Study|Protocol Violation|9|||
170414259|NCT02227862|615857176|FG000|Overall Study|Other|0|||
170414260|NCT02227862|615857177|FG001|Overall Study|Other|2|||
170414261|NCT02227862|615857176|FG000|Overall Study|Adverse Event|4|||
170414262|NCT02227862|615857177|FG001|Overall Study|Adverse Event|3|||
170414263|NCT02227862|615857176|FG000|Overall Study|Withdrawal by Subject|7|||
170414264|NCT02227862|615857177|FG001|Overall Study|Withdrawal by Subject|6|||
170414265|NCT02227862|615857176|FG000|Overall Study|Lost to Follow-up|1|||
170414266|NCT02227862|615857177|FG001|Overall Study|Lost to Follow-up|2|||
170414267|NCT04956666|615857178|FG000|Overall Study|Adverse Event|18|||
170414268|NCT04956666|615857178|FG000|Overall Study|Physician Decision|5|||
170414269|NCT01333033|615857179|FG000|Overall Study|Ineligible|0|||
170414270|NCT01333033|615857180|FG001|Overall Study|Ineligible|0|||
170414271|NCT01333033|615857181|FG002|Overall Study|Ineligible|0|||
170414272|NCT01333033|615857182|FG003|Overall Study|Ineligible|0|||
170414273|NCT01333033|615857183|FG004|Overall Study|Ineligible|6|||
170414274|NCT01333033|615857184|FG005|Overall Study|Ineligible|8|||
170414275|NCT01333033|615857179|FG000|Overall Study|Withdrawal by Subject|0|||
170414276|NCT01333033|615857180|FG001|Overall Study|Withdrawal by Subject|0|||
170414277|NCT01333033|615857181|FG002|Overall Study|Withdrawal by Subject|0|||
170414278|NCT01333033|615857182|FG003|Overall Study|Withdrawal by Subject|0|||
170414279|NCT01333033|615857183|FG004|Overall Study|Withdrawal by Subject|4|||
170414280|NCT01333033|615857184|FG005|Overall Study|Withdrawal by Subject|2|||
170414281|NCT01333033|615857179|FG000|Overall Study|PET inevaluable|0|||
170414282|NCT01333033|615857180|FG001|Overall Study|PET inevaluable|0|||
170414283|NCT01333033|615857181|FG002|Overall Study|PET inevaluable|0|||
170414284|NCT01333033|615857182|FG003|Overall Study|PET inevaluable|0|||
170414285|NCT01333033|615857183|FG004|Overall Study|PET inevaluable|2|||
170414286|NCT01333033|615857184|FG005|Overall Study|PET inevaluable|4|||
170414287|NCT01333033|615857179|FG000|Overall Study|Adverse Event|0|||
170414288|NCT01333033|615857180|FG001|Overall Study|Adverse Event|0|||
170414289|NCT01333033|615857181|FG002|Overall Study|Adverse Event|0|||
170414290|NCT01333033|615857182|FG003|Overall Study|Adverse Event|0|||
170414291|NCT01333033|615857183|FG004|Overall Study|Adverse Event|2|||
170414292|NCT01333033|615857184|FG005|Overall Study|Adverse Event|1|||
170414293|NCT01333033|615857179|FG000|Overall Study|Progression|0|||
170414294|NCT01333033|615857180|FG001|Overall Study|Progression|0|||
170771381|NCT00159783|617168479|FG000|Overall Study|Adverse Event|5|||
170771382|NCT00159783|617168480|FG001|Overall Study|Adverse Event|7|||
170771383|NCT00159783|617168481|FG002|Overall Study|Adverse Event|9|||
170414295|NCT01333033|615857181|FG002|Overall Study|Progression|0|||
170771384|NCT00159783|617168479|FG000|Overall Study|Lack of Efficacy|1|||
170771385|NCT00159783|617168480|FG001|Overall Study|Lack of Efficacy|2|||
170771386|NCT00159783|617168481|FG002|Overall Study|Lack of Efficacy|3|||
170414296|NCT01333033|615857182|FG003|Overall Study|Progression|0|||
170414297|NCT01333033|615857183|FG004|Overall Study|Progression|0|||
170414298|NCT01333033|615857184|FG005|Overall Study|Progression|1|||
170414299|NCT01333033|615857179|FG000|Overall Study|MD Decision|0|||
170414300|NCT01333033|615857180|FG001|Overall Study|MD Decision|0|||
170414301|NCT01333033|615857181|FG002|Overall Study|MD Decision|0|||
170414302|NCT01333033|615857182|FG003|Overall Study|MD Decision|0|||
170414303|NCT01333033|615857183|FG004|Overall Study|MD Decision|0|||
170414304|NCT01333033|615857184|FG005|Overall Study|MD Decision|2|||
170414305|NCT03305055|615857185|FG000|Overall Study|Withdrawal by Subject|0|||
170414306|NCT03305055|615857186|FG001|Overall Study|Withdrawal by Subject|1|||
170414307|NCT03305055|615857185|FG000|Overall Study|Adverse Event|1|||
170414308|NCT03305055|615857186|FG001|Overall Study|Adverse Event|1|||
170414309|NCT01816477|615857187|FG000|Overall Study|Withdrawal by Subject|13|||
170414310|NCT01816477|615857188|FG001|Overall Study|Withdrawal by Subject|1|||
170414311|NCT01816477|615857187|FG000|Overall Study|Unable to tolerate catheter placement|3|||
170414312|NCT01816477|615857188|FG001|Overall Study|Unable to tolerate catheter placement|0|||
170414313|NCT03213210|615857189|FG000|Overall Study|Lost to Follow-up|2|||
170414314|NCT03213210|615857189|FG000|Overall Study|Study termination|3|||
170414315|NCT06331156|615857190|FG000|Overall Study|Adverse Event|1|||
170414316|NCT06331156|615857191|FG001|Overall Study|Adverse Event|0|||
170414317|NCT06331156|615857190|FG000|Overall Study|Lost to Follow-up|1|||
170414318|NCT06331156|615857191|FG001|Overall Study|Lost to Follow-up|0|||
170414319|NCT06331156|615857190|FG000|Overall Study|Migrated / Moved from the study area|4|||
170414320|NCT06331156|615857191|FG001|Overall Study|Migrated / Moved from the study area|3|||
170414321|NCT06331156|615857190|FG000|Overall Study|Other|7|||
170414322|NCT06331156|615857191|FG001|Overall Study|Other|0|||
170414323|NCT06331156|615857190|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
170414324|NCT06331156|615857191|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
170414325|NCT05845645|615857192|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414326|NCT05845645|615857193|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414327|NCT05845645|615857194|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
170414328|NCT05845645|615857195|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414329|NCT05845645|615857196|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414330|NCT05845645|615857197|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414331|NCT05845645|615857198|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414332|NCT05845645|615857199|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414333|NCT05845645|615857200|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414334|NCT05845645|615857201|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414335|NCT05845645|615857202|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414336|NCT05845645|615857203|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
170414337|NCT05845645|615857192|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414338|NCT05845645|615857193|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414339|NCT05845645|615857194|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414340|NCT05845645|615857195|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414341|NCT05845645|615857196|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414342|NCT05845645|615857197|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414343|NCT05845645|615857198|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414344|NCT05845645|615857199|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414345|NCT05845645|615857200|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414346|NCT05845645|615857201|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
170414347|NCT05845645|615857202|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414348|NCT05845645|615857203|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
170414349|NCT02978326|615857207|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
170414350|NCT02978326|615857208|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
170414351|NCT02978326|615857209|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
170414352|NCT02978326|615857207|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
170414353|NCT02978326|615857208|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
170414354|NCT02978326|615857209|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
170414355|NCT02978326|615857207|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
170414356|NCT02978326|615857208|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
170414357|NCT02978326|615857209|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
170632217|NCT01967940|616664555|FG000|Part 2|Unknown Reason|0|||
170632218|NCT01967940|616664556|FG001|Part 2|Unknown Reason|0|||
170632219|NCT01967940|616664557|FG002|Part 2|Unknown Reason|0|||
170414358|NCT02978326|615857207|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
170414359|NCT02978326|615857208|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
170414360|NCT02978326|615857209|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
170414361|NCT00278512|615857213|FG000|Overall Study|Death|1|||
170414362|NCT00278512|615857214|FG001|Overall Study|Death|0|||
170414363|NCT02974153|615857215|FG000|Overall Study|Adverse Event|6|||
170632220|NCT01967940|616664558|FG003|Part 2|Unknown Reason|1|||
170414364|NCT02974153|615857216|FG001|Overall Study|Adverse Event|0|||
170414365|NCT02974153|615857217|FG002|Overall Study|Adverse Event|1|||
170414366|NCT02974153|615857215|FG000|Overall Study|Lack of Efficacy|6|||
170414367|NCT02974153|615857216|FG001|Overall Study|Lack of Efficacy|5|||
170414368|NCT02974153|615857217|FG002|Overall Study|Lack of Efficacy|10|||
170414369|NCT02974153|615857215|FG000|Overall Study|Lost to Follow-up|9|||
170414370|NCT02974153|615857216|FG001|Overall Study|Lost to Follow-up|10|||
170414371|NCT02974153|615857217|FG002|Overall Study|Lost to Follow-up|17|||
170414372|NCT02974153|615857215|FG000|Overall Study|Physician Decision|0|||
170414373|NCT02974153|615857216|FG001|Overall Study|Physician Decision|2|||
170414374|NCT02974153|615857217|FG002|Overall Study|Physician Decision|1|||
170771387|NCT00159783|617168479|FG000|Overall Study|Withdrawal by Subject|7|||
170771388|NCT00159783|617168480|FG001|Overall Study|Withdrawal by Subject|11|||
170771389|NCT00159783|617168481|FG002|Overall Study|Withdrawal by Subject|12|||
170771390|NCT00159783|617168479|FG000|Overall Study|Lost to Follow-up|6|||
170771391|NCT00159783|617168480|FG001|Overall Study|Lost to Follow-up|5|||
170771392|NCT00159783|617168481|FG002|Overall Study|Lost to Follow-up|11|||
170414375|NCT02974153|615857215|FG000|Overall Study|Withdrawal by Subject|9|||
170414376|NCT02974153|615857216|FG001|Overall Study|Withdrawal by Subject|16|||
170414377|NCT02974153|615857217|FG002|Overall Study|Withdrawal by Subject|11|||
170414378|NCT02974153|615857215|FG000|Overall Study|Study Burden|8|||
170414379|NCT02974153|615857216|FG001|Overall Study|Study Burden|7|||
170414380|NCT02974153|615857217|FG002|Overall Study|Study Burden|3|||
170414381|NCT02974153|615857215|FG000|Overall Study|Other|14|||
170414382|NCT02974153|615857216|FG001|Overall Study|Other|8|||
170414383|NCT02974153|615857217|FG002|Overall Study|Other|7|||
170414384|NCT01620177|615857218|FG000|Overall Study|Failure at Screening Visit|43|||
170414385|NCT01620177|615857218|FG000|Overall Study|Withdrawal by Subject|26|||
170414386|NCT01620177|615857218|FG000|Overall Study|Lost to Follow-up|7|||
170414387|NCT01620177|615857218|FG000|Overall Study|Physician Decision|2|||
170414388|NCT01620177|615857218|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
170414389|NCT02521948|615857219|FG000|Overall Study|Adverse Event|2|||
170414390|NCT02521948|615857219|FG000|Overall Study|Death|4|||
170414391|NCT02521948|615857219|FG000|Overall Study|Lost to Follow-up|1|||
170414392|NCT02521948|615857219|FG000|Overall Study|Did not attend one or both follow-ups|6|||
170414393|NCT00423800|615857220|FG000|Overall Study|Protocol Violation|0|||
170414394|NCT00423800|615857221|FG001|Overall Study|Protocol Violation|1|||
170414395|NCT02292238|615857222|FG000|Overall Study|Protocol Violation|1|||
170414396|NCT02292238|615857223|FG001|Overall Study|Protocol Violation|2|||
170414397|NCT02292238|615857222|FG000|Overall Study|Withdrawal by Subject|2|||
170414398|NCT02292238|615857223|FG001|Overall Study|Withdrawal by Subject|1|||
170414399|NCT02292238|615857222|FG000|Overall Study|Lost to Follow-up|1|||
170414400|NCT02292238|615857223|FG001|Overall Study|Lost to Follow-up|0|||
170414401|NCT02292238|615857222|FG000|Overall Study|Physician Decision|0|||
170414402|NCT02292238|615857223|FG001|Overall Study|Physician Decision|1|||
170414403|NCT02829918|615857228|FG000|Overall Study|Death|2|||
170414404|NCT02829918|615857228|FG000|Overall Study|Withdrawal by Subject|4|||
170414405|NCT02829918|615857228|FG000|Overall Study|Adverse Event|1|||
170414406|NCT02829918|615857228|FG000|Overall Study|Progression|1|||
170414407|NCT00491504|615857231|FG000|Overall Study|Adverse Event|0|||
170414408|NCT00491504|615857232|FG001|Overall Study|Adverse Event|1|||
170414409|NCT00491504|615857233|FG002|Overall Study|Adverse Event|0|||
170414410|NCT00491504|615857234|FG003|Overall Study|Adverse Event|0|||
170414411|NCT00491504|615857231|FG000|Overall Study|Withdrawal by Subject|0|||
170414412|NCT00491504|615857232|FG001|Overall Study|Withdrawal by Subject|0|||
170414413|NCT00491504|615857233|FG002|Overall Study|Withdrawal by Subject|1|||
170414414|NCT00491504|615857234|FG003|Overall Study|Withdrawal by Subject|2|||
170414415|NCT00491504|615857231|FG000|Overall Study|Protocol Violation|0|||
170414416|NCT00491504|615857232|FG001|Overall Study|Protocol Violation|0|||
170414417|NCT00491504|615857233|FG002|Overall Study|Protocol Violation|3|||
170414418|NCT00491504|615857234|FG003|Overall Study|Protocol Violation|2|||
170414419|NCT00619385|615857235|FG000|Overall Study|Adverse Event|0|||
170414420|NCT00619385|615857236|FG001|Overall Study|Adverse Event|0|||
170771393|NCT00159783|617168479|FG000|Overall Study|Other|0|||
170771394|NCT00159783|617168480|FG001|Overall Study|Other|2|||
170771395|NCT00159783|617168481|FG002|Overall Study|Other|4|||
170771396|NCT00305695|617168484|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
170414421|NCT00619385|615857237|FG002|Overall Study|Adverse Event|3|||
170414422|NCT00619385|615857235|FG000|Overall Study|Other|1|||
170414423|NCT00619385|615857236|FG001|Overall Study|Other|2|||
170771397|NCT00305695|617168485|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
170414424|NCT00619385|615857237|FG002|Overall Study|Other|1|||
170414425|NCT02041702|615857242|FG000|Overall Study|Lost to Follow-up|1|||
170414426|NCT02041702|615857243|FG001|Overall Study|Lost to Follow-up|6|||
170414427|NCT02041702|615857242|FG000|Overall Study|Death|4|||
170414428|NCT02041702|615857243|FG001|Overall Study|Death|0|||
170414429|NCT02041702|615857242|FG000|Overall Study|Withdrawal by Subject|4|||
170414430|NCT02041702|615857243|FG001|Overall Study|Withdrawal by Subject|3|||
170414431|NCT02041702|615857242|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
170771398|NCT00305695|617168484|FG000|Overall Study|Did not have baseline scan|1|||
170872710|NCT01221727|617544827|FG000|Overall Study|Withdrawal by Subject|1|||
170525581|NCT03528551|616272021|FG001|Overall Study|Withdrawal by Subject|7|||
170525582|NCT03528551|616272022|FG002|Overall Study|Withdrawal by Subject|0|||
170525583|NCT03044314|616272026|FG000|Overall Study|Physician Decision|2|||
170525584|NCT03044314|616272026|FG000|Overall Study|Withdrawal by Subject|1|||
170525585|NCT03044314|616272026|FG000|Overall Study|Connector tubing not available|1|||
170525586|NCT01316224|616272027|FG000|Overall Study|Protocol Violation|3|||
170525587|NCT01316224|616272027|FG000|Overall Study|Adverse Event|3|||
170525588|NCT01316224|616272027|FG000|Overall Study|Lack of Efficacy|1|||
170525589|NCT01316224|616272027|FG000|Overall Study|Withdrawal by Subject|1|||
170525590|NCT01316224|616272027|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
170525591|NCT01316224|616272027|FG000|Overall Study|Other|1|||
170525592|NCT00264147|616272028|FG000|Treatment I Period|Adverse Event|3|||
170525593|NCT00264147|616272029|FG001|Treatment I Period|Adverse Event|6|||
170525594|NCT00264147|616272030|FG002|Treatment I Period|Adverse Event|3|||
170525595|NCT00264147|616272031|FG003|Treatment I Period|Adverse Event|5|||
170525596|NCT00264147|616272032|FG004|Treatment I Period|Adverse Event|7|||
170525597|NCT00264147|616272033|FG005|Treatment I Period|Adverse Event|0|||
170525598|NCT00264147|616272028|FG000|Treatment I Period|Laboratory Adverse Event|0|||
170525599|NCT00264147|616272029|FG001|Treatment I Period|Laboratory Adverse Event|0|||
170525600|NCT00264147|616272030|FG002|Treatment I Period|Laboratory Adverse Event|0|||
170525601|NCT00264147|616272031|FG003|Treatment I Period|Laboratory Adverse Event|1|||
170525602|NCT00264147|616272032|FG004|Treatment I Period|Laboratory Adverse Event|0|||
170525603|NCT00264147|616272033|FG005|Treatment I Period|Laboratory Adverse Event|0|||
170525604|NCT00264147|616272028|FG000|Treatment I Period|Lack of Efficacy|6|||
170525605|NCT00264147|616272029|FG001|Treatment I Period|Lack of Efficacy|2|||
170525606|NCT00264147|616272030|FG002|Treatment I Period|Lack of Efficacy|8|||
170525607|NCT00264147|616272031|FG003|Treatment I Period|Lack of Efficacy|0|||
170525608|NCT00264147|616272032|FG004|Treatment I Period|Lack of Efficacy|1|||
170525609|NCT00264147|616272033|FG005|Treatment I Period|Lack of Efficacy|0|||
170525610|NCT00264147|616272028|FG000|Treatment I Period|Lost to Follow-up|1|||
170525611|NCT00264147|616272029|FG001|Treatment I Period|Lost to Follow-up|0|||
170525612|NCT00264147|616272030|FG002|Treatment I Period|Lost to Follow-up|0|||
170525613|NCT00264147|616272031|FG003|Treatment I Period|Lost to Follow-up|1|||
170525614|NCT00264147|616272032|FG004|Treatment I Period|Lost to Follow-up|1|||
170525615|NCT00264147|616272033|FG005|Treatment I Period|Lost to Follow-up|0|||
170525616|NCT00264147|616272028|FG000|Treatment I Period|Protocol Violation|2|||
170525617|NCT00264147|616272029|FG001|Treatment I Period|Protocol Violation|2|||
170525618|NCT00264147|616272030|FG002|Treatment I Period|Protocol Violation|0|||
170525619|NCT00264147|616272031|FG003|Treatment I Period|Protocol Violation|0|||
170525620|NCT00264147|616272032|FG004|Treatment I Period|Protocol Violation|0|||
170525621|NCT00264147|616272033|FG005|Treatment I Period|Protocol Violation|0|||
170525622|NCT00264147|616272028|FG000|Treatment I Period|Withdrawal by Subject|2|||
170525623|NCT00264147|616272029|FG001|Treatment I Period|Withdrawal by Subject|0|||
170525624|NCT00264147|616272030|FG002|Treatment I Period|Withdrawal by Subject|0|||
170771399|NCT00305695|617168485|FG001|Overall Study|Did not have baseline scan|1|||
170771400|NCT03189524|617170383|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
170771401|NCT03189524|617170384|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
170771402|NCT03189524|617170385|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
170771403|NCT03189524|617170383|FG000|Overall Study|Death|2|||
170771404|NCT03189524|617170384|FG001|Overall Study|Death|2|||
170771405|NCT03189524|617170385|FG002|Overall Study|Death|1|||
170525625|NCT00264147|616272031|FG003|Treatment I Period|Withdrawal by Subject|2|||
170525626|NCT00264147|616272032|FG004|Treatment I Period|Withdrawal by Subject|2|||
170525627|NCT00264147|616272033|FG005|Treatment I Period|Withdrawal by Subject|0|||
170525628|NCT00264147|616272028|FG000|Treatment I Period|Patient out of town for an extended time|0|||
170525629|NCT00264147|616272029|FG001|Treatment I Period|Patient out of town for an extended time|1|||
170525630|NCT00264147|616272030|FG002|Treatment I Period|Patient out of town for an extended time|0|||
170872711|NCT01221727|617544828|FG001|Overall Study|Withdrawal by Subject|1|||
170872712|NCT01252810|617544853|FG000|Overall Study|Withdrawal by Subject|4|||
170872713|NCT01252810|617544854|FG001|Overall Study|Withdrawal by Subject|1|||
170872714|NCT01252810|617544853|FG000|Overall Study|Lost to Follow-up|0|||
170872715|NCT01252810|617544854|FG001|Overall Study|Lost to Follow-up|1|||
170872716|NCT01252810|617544853|FG000|Overall Study|Physician Decision|2|||
170872717|NCT01252810|617544854|FG001|Overall Study|Physician Decision|1|||
170872718|NCT01252810|617544853|FG000|Overall Study|Various reasons|8|||
170872719|NCT01252810|617544854|FG001|Overall Study|Various reasons|0|||
170872720|NCT02811549|617544855|FG000|Overall Study|Lost to Follow-up|1|||
170872721|NCT02811549|617544855|FG000|Overall Study|Withdrawal by Subject|3|||
170872722|NCT02811549|617544855|FG000|Overall Study|Subject screen failed|4|||
170872723|NCT02811549|617544855|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
170872724|NCT00688155|617544856|FG000|Overall Study|Withdrawal by Subject|2|||
170632221|NCT03995368|616664559|FG000|Overall Study|Lost to Follow-up|1|||
170525631|NCT00264147|616272031|FG003|Treatment I Period|Patient out of town for an extended time|0|||
170525632|NCT00264147|616272032|FG004|Treatment I Period|Patient out of town for an extended time|0|||
170525633|NCT00264147|616272033|FG005|Treatment I Period|Patient out of town for an extended time|0|||
170525634|NCT00264147|616272028|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
170525635|NCT00264147|616272029|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
170525636|NCT00264147|616272030|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
170525637|NCT00264147|616272031|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
170525638|NCT00264147|616272032|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
170525639|NCT00264147|616272033|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
170525640|NCT00264147|616272028|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
170525641|NCT00264147|616272029|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
170525642|NCT00264147|616272030|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
170525643|NCT00264147|616272031|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
170525644|NCT00264147|616272032|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
170525645|NCT00264147|616272033|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
170525646|NCT00264147|616272028|FG000|Treatment II Period|Adverse Event|0|||
170525647|NCT00264147|616272029|FG001|Treatment II Period|Adverse Event|0|||
170525648|NCT00264147|616272030|FG002|Treatment II Period|Adverse Event|0|||
170525649|NCT00264147|616272031|FG003|Treatment II Period|Adverse Event|0|||
170525650|NCT00264147|616272032|FG004|Treatment II Period|Adverse Event|9|||
170525651|NCT00264147|616272033|FG005|Treatment II Period|Adverse Event|9|||
170525652|NCT00264147|616272028|FG000|Treatment II Period|Laboratory Adverse Event|0|||
170525653|NCT00264147|616272029|FG001|Treatment II Period|Laboratory Adverse Event|0|||
170525654|NCT00264147|616272030|FG002|Treatment II Period|Laboratory Adverse Event|0|||
170525655|NCT00264147|616272031|FG003|Treatment II Period|Laboratory Adverse Event|0|||
170525656|NCT00264147|616272032|FG004|Treatment II Period|Laboratory Adverse Event|0|||
170525657|NCT00264147|616272033|FG005|Treatment II Period|Laboratory Adverse Event|1|||
170525658|NCT00264147|616272028|FG000|Treatment II Period|Lack of Efficacy|0|||
170525659|NCT00264147|616272029|FG001|Treatment II Period|Lack of Efficacy|0|||
170525660|NCT00264147|616272030|FG002|Treatment II Period|Lack of Efficacy|0|||
170525661|NCT00264147|616272031|FG003|Treatment II Period|Lack of Efficacy|0|||
170525662|NCT00264147|616272032|FG004|Treatment II Period|Lack of Efficacy|20|||
170525663|NCT00264147|616272033|FG005|Treatment II Period|Lack of Efficacy|19|||
170525664|NCT00264147|616272028|FG000|Treatment II Period|Lost to Follow-up|0|||
170525665|NCT00264147|616272029|FG001|Treatment II Period|Lost to Follow-up|0|||
170525666|NCT00264147|616272030|FG002|Treatment II Period|Lost to Follow-up|0|||
170525667|NCT00264147|616272031|FG003|Treatment II Period|Lost to Follow-up|0|||
170525668|NCT00264147|616272032|FG004|Treatment II Period|Lost to Follow-up|1|||
170525669|NCT00264147|616272033|FG005|Treatment II Period|Lost to Follow-up|1|||
170525670|NCT00264147|616272028|FG000|Treatment II Period|Withdrawal by Subject|0|||
170525671|NCT00264147|616272029|FG001|Treatment II Period|Withdrawal by Subject|0|||
170525672|NCT00264147|616272030|FG002|Treatment II Period|Withdrawal by Subject|0|||
170525673|NCT00264147|616272031|FG003|Treatment II Period|Withdrawal by Subject|0|||
170525674|NCT00264147|616272032|FG004|Treatment II Period|Withdrawal by Subject|3|||
170525675|NCT00264147|616272033|FG005|Treatment II Period|Withdrawal by Subject|2|||
170525676|NCT00264147|616272028|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
170525677|NCT00264147|616272029|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
170525678|NCT00264147|616272030|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
170525679|NCT00264147|616272031|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
170525680|NCT00264147|616272032|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
170525681|NCT00264147|616272033|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
170525682|NCT03234465|616272034|FG000|Overall Study|Adverse Event|4|||
170525683|NCT03234465|616272035|FG001|Overall Study|Adverse Event|2|||
170525684|NCT03234465|616272034|FG000|Overall Study|Death|0|||
170525685|NCT03234465|616272035|FG001|Overall Study|Death|1|||
170525686|NCT03234465|616272034|FG000|Overall Study|Lost to Follow-up|1|||
170525687|NCT03234465|616272035|FG001|Overall Study|Lost to Follow-up|1|||
170525688|NCT03234465|616272034|FG000|Overall Study|Withdrawal by Subject|12|||
170525689|NCT03234465|616272035|FG001|Overall Study|Withdrawal by Subject|27|||
170771406|NCT03189524|617170383|FG000|Overall Study|Lost to Follow-up|1|||
170771407|NCT03189524|617170384|FG001|Overall Study|Lost to Follow-up|0|||
170771408|NCT03189524|617170385|FG002|Overall Study|Lost to Follow-up|8|||
170771409|NCT03189524|617170383|FG000|Overall Study|Withdrawal by Subject|1|||
170771410|NCT03189524|617170384|FG001|Overall Study|Withdrawal by Subject|1|||
170771411|NCT03189524|617170385|FG002|Overall Study|Withdrawal by Subject|3|||
170771412|NCT03189524|617170383|FG000|Overall Study|Progressive Disease|0|||
170771413|NCT03189524|617170384|FG001|Overall Study|Progressive Disease|2|||
170525690|NCT03234465|616272034|FG000|Overall Study|Symptomatic deterioration|0|||
170525691|NCT03234465|616272035|FG001|Overall Study|Symptomatic deterioration|1|||
170525692|NCT03234465|616272034|FG000|Overall Study|Non-compliance|2|||
170525693|NCT03234465|616272035|FG001|Overall Study|Non-compliance|0|||
170771414|NCT03189524|617170385|FG002|Overall Study|Progressive Disease|0|||
170806903|NCT03697603|617301664|FG001|Overall Study|Withdrawal by Subject|1|||
170525694|NCT03234465|616272034|FG000|Overall Study|Other|14|||
170525695|NCT03234465|616272035|FG001|Overall Study|Other|8|||
170525696|NCT02563899|616272038|FG000|Overall Study|Protocol Violation|1|||
170525697|NCT02563899|616272039|FG001|Overall Study|Protocol Violation|0|||
170525698|NCT02563899|616272040|FG002|Overall Study|Protocol Violation|0|||
170525699|NCT02563899|616272041|FG003|Overall Study|Protocol Violation|0|||
170525700|NCT02563899|616272038|FG000|Overall Study|Withdrawal by Subject|0|||
170525701|NCT02563899|616272039|FG001|Overall Study|Withdrawal by Subject|0|||
170525702|NCT02563899|616272040|FG002|Overall Study|Withdrawal by Subject|1|||
170525703|NCT02563899|616272041|FG003|Overall Study|Withdrawal by Subject|0|||
170525704|NCT01190813|616272044|FG000|Overall Study|Lost to Follow-up|1|||
170525705|NCT01190813|616272045|FG001|Overall Study|Lost to Follow-up|2|||
170525706|NCT01190813|616272044|FG000|Overall Study|Withdrawal by Subject|2|||
170525707|NCT01190813|616272045|FG001|Overall Study|Withdrawal by Subject|1|||
170525708|NCT01190813|616272044|FG000|Overall Study|Refused study treatment after randomized|1|||
170525709|NCT01190813|616272045|FG001|Overall Study|Refused study treatment after randomized|0|||
170525710|NCT01190813|616272044|FG000|Overall Study|Adverse Event|0|||
170525711|NCT01190813|616272045|FG001|Overall Study|Adverse Event|1|||
170525712|NCT02532283|616272052|FG000|Overall Study|Adverse Event|0|||
170525713|NCT02532283|616272053|FG001|Overall Study|Adverse Event|1|||
170525714|NCT02532283|616272052|FG000|Overall Study|Death|1|||
170525715|NCT02532283|616272053|FG001|Overall Study|Death|0|||
170525716|NCT02532283|616272052|FG000|Overall Study|Lost to Follow-up|0|||
170525717|NCT02532283|616272053|FG001|Overall Study|Lost to Follow-up|1|||
170525718|NCT02532283|616272052|FG000|Overall Study|Withdrawal by Subject|8|||
170525719|NCT02532283|616272053|FG001|Overall Study|Withdrawal by Subject|3|||
170525720|NCT04037358|616272054|FG000|Overall Study|Patient withdrew before intervention|1|||
170525721|NCT04037358|616272055|FG001|Overall Study|Patient withdrew before intervention|0|||
170525722|NCT01526785|616272066|FG000|Overall Study|Study Terminated by Sponsor|8|||
170525723|NCT01526785|616272066|FG000|Overall Study|Death|2|||
170525724|NCT01526785|616272066|FG000|Overall Study|Physician Decision|1|||
170525725|NCT01526785|616272066|FG000|Overall Study|Withdrawal by Subject|2|||
170525726|NCT01949142|616272067|FG000|Overall Study|Withdrawal of consent|1|||
170525727|NCT01949142|616272068|FG001|Overall Study|Withdrawal of consent|0|||
170525728|NCT01949142|616272067|FG000|Overall Study|Lost to Follow-up|1|||
170525729|NCT01949142|616272068|FG001|Overall Study|Lost to Follow-up|1|||
170525730|NCT01949142|616272067|FG000|Overall Study|Parent changed their mind|1|||
170525731|NCT01949142|616272068|FG001|Overall Study|Parent changed their mind|0|||
170525732|NCT01121263|616272069|FG000|Overall Study|Death|3|||
170525733|NCT01121263|616272070|FG001|Overall Study|Death|2|||
170525734|NCT01121263|616272069|FG000|Overall Study|Lost to Follow-up|22|||
170525735|NCT01121263|616272070|FG001|Overall Study|Lost to Follow-up|12|||
170525736|NCT01121263|616272069|FG000|Overall Study|Withdrawal by Subject|0|||
170525737|NCT01121263|616272070|FG001|Overall Study|Withdrawal by Subject|1|||
170525738|NCT05027815|616272073|FG000|Overall Study|Death|2|||
170525739|NCT05027815|616272074|FG001|Overall Study|Death|1|||
170525740|NCT00447902|616272081|FG000|Overall Study|Adverse Event|0|||
170525741|NCT00447902|616272082|FG001|Overall Study|Adverse Event|3|||
170771415|NCT05672667|617170392|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
170771416|NCT04250883|617170393|FG000|Overall Study|Lost to Follow-up|1|||
170771417|NCT04250883|617170394|FG001|Overall Study|Lost to Follow-up|0|||
170771418|NCT02763319|617170400|FG000|Overall Study|Adverse Event|12|||
170771419|NCT02763319|617170401|FG001|Overall Study|Adverse Event|3|||
170771420|NCT02763319|617170400|FG000|Overall Study|Death|123|||
170771421|NCT02763319|617170401|FG001|Overall Study|Death|123|||
170771422|NCT02763319|617170400|FG000|Overall Study|Lost to Follow-up|6|||
170771423|NCT02763319|617170401|FG001|Overall Study|Lost to Follow-up|7|||
170771424|NCT02763319|617170400|FG000|Overall Study|Noncompliance with Study Drug|2|||
170771425|NCT02763319|617170401|FG001|Overall Study|Noncompliance with Study Drug|0|||
170771426|NCT02763319|617170400|FG000|Overall Study|"Captured as Other in Database"|29|||
170771427|NCT02763319|617170401|FG001|Overall Study|"Captured as Other in Database"|34|||
170771428|NCT02763319|617170400|FG000|Overall Study|Physician Decision|1|||
170771429|NCT02763319|617170401|FG001|Overall Study|Physician Decision|7|||
170771430|NCT02763319|617170400|FG000|Overall Study|Progressive Disease|24|||
170771431|NCT02763319|617170401|FG001|Overall Study|Progressive Disease|27|||
170525742|NCT00447902|616272081|FG000|Overall Study|Protocol Violation|1|||
170525743|NCT00447902|616272082|FG001|Overall Study|Protocol Violation|0|||
170525744|NCT00447902|616272081|FG000|Overall Study|Withdrawal by Subject|0|||
170525745|NCT00447902|616272082|FG001|Overall Study|Withdrawal by Subject|1|||
170525746|NCT00447902|616272081|FG000|Overall Study|included patients who discontinued|1|||
170771432|NCT02763319|617170400|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
170771433|NCT02763319|617170401|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
170525747|NCT00447902|616272082|FG001|Overall Study|included patients who discontinued|1|||
170525748|NCT00447902|616272081|FG000|Overall Study|Lack of Efficacy|2|||
170525749|NCT00447902|616272082|FG001|Overall Study|Lack of Efficacy|1|||
170525750|NCT00352118|616273987|FG000|Overall Study|Physician Decision|4|||
170525751|NCT02997163|616273988|FG000|Overall Study|Adverse Event|1|||
170414432|NCT02041702|615857243|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
170414433|NCT02041702|615857242|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
170414434|NCT02041702|615857243|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
170414435|NCT00203307|615857244|FG000|First Intervention|Adverse Event|2|||
170414436|NCT00203307|615857245|FG001|First Intervention|Adverse Event|0|||
170771434|NCT02763319|617170400|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
170771435|NCT02763319|617170401|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
170771436|NCT02763319|617170400|FG000|Overall Study|Withdrawal by Subject|26|||
170771437|NCT02763319|617170401|FG001|Overall Study|Withdrawal by Subject|25|||
170771438|NCT01693120|617170402|FG000|Enrollment|Lost to Follow-up|1|||
170771439|NCT01693120|617170402|FG000|Enrollment|Withdrawal by Subject|10|||
170771440|NCT01693120|617170402|FG000|Enrollment|Protocol Violation|46|||
170771441|NCT01693120|617170402|FG000|Enrollment|Physician Decision|3|||
170771442|NCT01693120|617170402|FG000|Enrollment|Adverse Event|1|||
170771443|NCT01693120|617170402|FG000|Enrollment|Study closed|8|||
170771444|NCT01693120|617170402|FG000|Enrollment|Other|1|||
170771445|NCT01693120|617170402|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
170771446|NCT01693120|617170402|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
170771447|NCT01693120|617170402|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
170771448|NCT01693120|617170402|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
170771449|NCT01693120|617170402|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
170771450|NCT03936660|617170403|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
170771451|NCT03936660|617170404|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
170771452|NCT00925587|617170413|FG000|Overall Study|Protocol Specified Criteria|6|||
170771453|NCT00925587|617170414|FG001|Overall Study|Protocol Specified Criteria|6|||
170771454|NCT00925587|617170413|FG000|Overall Study|Physician Decision|4|||
170414437|NCT00656019|615857249|FG000|Overall Study|Not Eligible|10|||
170414438|NCT00656019|615857250|FG001|Overall Study|Not Eligible|0|||
170414439|NCT00656019|615857251|FG002|Overall Study|Not Eligible|0|||
170414440|NCT00656019|615857252|FG003|Overall Study|Not Eligible|0|||
170414441|NCT00656019|615857249|FG000|Overall Study|Withdrawal by Subject|2|||
170414442|NCT00656019|615857250|FG001|Overall Study|Withdrawal by Subject|0|||
170414443|NCT00656019|615857251|FG002|Overall Study|Withdrawal by Subject|0|||
170414444|NCT00656019|615857252|FG003|Overall Study|Withdrawal by Subject|0|||
170414445|NCT00656019|615857249|FG000|Overall Study|Lost to Follow-up|2|||
170414446|NCT00656019|615857250|FG001|Overall Study|Lost to Follow-up|1|||
170525752|NCT02997163|616273989|FG001|Overall Study|Adverse Event|0|||
170525753|NCT02997163|616273990|FG002|Overall Study|Adverse Event|0|||
170525754|NCT02997163|616273991|FG003|Overall Study|Adverse Event|1|||
170525755|NCT02990000|616273992|FG000|Overall Study|Failed to provide data beyond baseline|36|||
170525756|NCT02990000|616273993|FG001|Overall Study|Failed to provide data beyond baseline|34|||
170525757|NCT00737048|616274009|FG000|Overall Study|Physician Decision|0|||
170525758|NCT00737048|616274010|FG001|Overall Study|Physician Decision|0|||
170525759|NCT00737048|616274011|FG002|Overall Study|Physician Decision|1|||
170525760|NCT00737048|616274009|FG000|Overall Study|Adverse Event|0|||
170525761|NCT00737048|616274010|FG001|Overall Study|Adverse Event|1|||
170525762|NCT00737048|616274011|FG002|Overall Study|Adverse Event|0|||
170525763|NCT00737048|616274009|FG000|Overall Study|Worsening of the symptoms|3|||
170525764|NCT00737048|616274010|FG001|Overall Study|Worsening of the symptoms|5|||
170525765|NCT00737048|616274011|FG002|Overall Study|Worsening of the symptoms|3|||
170525766|NCT00785356|616274014|FG000|Overall Study|Study prematurely terminated|8|||
170525767|NCT02089347|616274015|FG000|Overall Study|Protocol Violation|1|||
170525768|NCT02089347|616274016|FG001|Overall Study|Protocol Violation|0|||
170525769|NCT03712280|616274020|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
170525770|NCT03712280|616274021|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
170525771|NCT03712280|616274022|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
170525772|NCT03712280|616274023|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
170525773|NCT03712280|616274020|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
170525774|NCT03712280|616274021|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
170525775|NCT03712280|616274022|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
170525776|NCT03712280|616274023|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
170525777|NCT03712280|616274020|FG000|Overall Study|Adverse Event|0|||
170525778|NCT03712280|616274021|FG001|Overall Study|Adverse Event|0|||
170525779|NCT03712280|616274022|FG002|Overall Study|Adverse Event|1|||
170525780|NCT03712280|616274023|FG003|Overall Study|Adverse Event|0|||
170525781|NCT00106002|616274026|FG000|Overall Study|Did not take any study drug|1|||
170525782|NCT00106002|616274026|FG000|Overall Study|Ineligible after Registration|1|||
170771455|NCT00925587|617170414|FG001|Overall Study|Physician Decision|1|||
170414447|NCT00656019|615857251|FG002|Overall Study|Lost to Follow-up|0|||
170414448|NCT00656019|615857252|FG003|Overall Study|Lost to Follow-up|0|||
170632222|NCT03995368|616664560|FG001|Overall Study|Lost to Follow-up|4|||
170771456|NCT00925587|617170413|FG000|Overall Study|Protocol Violation|6|||
170414449|NCT02789111|615857253|FG000|Overall Study|Withdrawal by Subject|1|||
170771457|NCT00925587|617170414|FG001|Overall Study|Protocol Violation|4|||
170872725|NCT00688155|617544857|FG001|Overall Study|Withdrawal by Subject|2|||
170872726|NCT00688155|617544858|FG002|Overall Study|Withdrawal by Subject|1|||
170872727|NCT00688155|617544859|FG003|Overall Study|Withdrawal by Subject|1|||
170872728|NCT00445224|617544862|FG000|Specific Exercises|Withdrawal by Subject|3|||
170872729|NCT00445224|617544863|FG001|Specific Exercises|Withdrawal by Subject|3|||
170872730|NCT00445224|617544862|FG000|Specific Exercises|Withdrawal by Subject|1|||
170872731|NCT00445224|617544863|FG001|Specific Exercises|Withdrawal by Subject|0|||
170872732|NCT00667823|617544869|FG000|Overall Study|Lost to Follow-up|5|||
170414450|NCT02789111|615857254|FG001|Overall Study|Withdrawal by Subject|4|||
170525783|NCT01249131|616274029|FG000|Washout Period of 10 Days|Adverse Event|0|||
170525784|NCT01249131|616274030|FG001|Washout Period of 10 Days|Adverse Event|0|||
170525785|NCT01249131|616274031|FG002|Washout Period of 10 Days|Adverse Event|0|||
170525786|NCT01249131|616274032|FG003|Washout Period of 10 Days|Adverse Event|0|||
170525787|NCT01249131|616274033|FG004|Washout Period of 10 Days|Adverse Event|1|||
170525788|NCT01249131|616274034|FG005|Washout Period of 10 Days|Adverse Event|0|||
170525789|NCT01245101|616274035|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
170525790|NCT01245101|616274036|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
170525791|NCT01245101|616274035|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
170525792|NCT01245101|616274036|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
170525793|NCT01245101|616274035|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
170525794|NCT01245101|616274036|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
170525795|NCT01225549|616274037|FG000|Period 4 - Washout|Disallowed medication|0|||
170525796|NCT01225549|616274038|FG001|Period 4 - Washout|Disallowed medication|1|||
170525797|NCT01225549|616274039|FG002|Period 4 - Washout|Disallowed medication|0|||
170525798|NCT01225549|616274040|FG003|Period 4 - Washout|Disallowed medication|0|||
170525799|NCT01225549|616274041|FG004|Period 4 - Washout|Disallowed medication|0|||
170525800|NCT01225549|616274042|FG005|Period 4 - Washout|Disallowed medication|0|||
170525801|NCT01225549|616274043|FG006|Period 4 - Washout|Disallowed medication|0|||
170414451|NCT01488578|615857255|FG000|Overall Study|Protocol Violation|1836|||
170414452|NCT03271528|615857258|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
170414453|NCT03271528|615857259|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
170414454|NCT03271528|615857258|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
170414455|NCT03271528|615857259|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
170414456|NCT03271528|615857258|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
170414457|NCT03271528|615857259|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
170414458|NCT03271528|615857258|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
170414459|NCT03271528|615857259|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
170414460|NCT03271528|615857258|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
170414461|NCT03271528|615857259|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
170414462|NCT03271528|615857258|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
170414463|NCT03271528|615857259|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
170414464|NCT03271528|615857258|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
170414465|NCT03271528|615857259|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
170414466|NCT01533428|615857260|FG000|Overall Study|Adverse Event|0|||
170414467|NCT01533428|615857261|FG001|Overall Study|Adverse Event|1|||
170414468|NCT01533428|615857260|FG000|Overall Study|Lost to Follow-up|2|||
170414469|NCT01533428|615857261|FG001|Overall Study|Lost to Follow-up|1|||
170414470|NCT01533428|615857260|FG000|Overall Study|Withdrawal by Subject|7|||
170414471|NCT01533428|615857261|FG001|Overall Study|Withdrawal by Subject|6|||
170414472|NCT03977584|615857266|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
170414473|NCT03977584|615857267|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
170414474|NCT03977584|615857268|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
170414475|NCT02666430|615857279|FG000|Period 1|Lost to Follow-up|1|||
170414476|NCT02666430|615857280|FG001|Period 1|Lost to Follow-up|0|||
170414477|NCT02666430|615857279|FG000|Period 1|Adverse Event|0|||
170414478|NCT02666430|615857280|FG001|Period 1|Adverse Event|1|||
170414479|NCT02666430|615857279|FG000|Period 2|Withdrawal by Subject|1|||
170414480|NCT02666430|615857280|FG001|Period 2|Withdrawal by Subject|4|||
170414481|NCT02666430|615857279|FG000|Period 3|Lost to Follow-up|1|||
170414482|NCT02666430|615857280|FG001|Period 3|Lost to Follow-up|0|||
170414483|NCT00859469|615857281|FG000|Overall Study|Adverse Event|2|||
170414484|NCT00859469|615857281|FG000|Overall Study|Lack of Efficacy|9|||
170414485|NCT00859469|615857281|FG000|Overall Study|Withdrawal by Subject|1|||
170414486|NCT00859469|615857281|FG000|Overall Study|Death|16|||
170414487|NCT00663871|615857282|FG000|Overall Study|Lost to Follow-up|5|||
170414488|NCT00663871|615857283|FG001|Overall Study|Lost to Follow-up|5|||
170414489|NCT00663871|615857282|FG000|Overall Study|Withdrawal by Subject|5|||
170872733|NCT00667823|617544869|FG000|Overall Study|Adverse Event|7|||
170414490|NCT00663871|615857283|FG001|Overall Study|Withdrawal by Subject|2|||
170525802|NCT01225549|616274044|FG007|Period 4 - Washout|Disallowed medication|0|||
170525803|NCT01225549|616274045|FG008|Period 4 - Washout|Disallowed medication|0|||
170872734|NCT00667823|617544869|FG000|Overall Study|Death|182|||
170872735|NCT00667823|617544869|FG000|Overall Study|Withdrawal by Subject|12|||
170414491|NCT00582309|615857284|FG000|Overall Study|Protocol Violation|0|||
170414492|NCT00582309|615857285|FG001|Overall Study|Protocol Violation|0|||
170414493|NCT00582309|615857286|FG002|Overall Study|Protocol Violation|2|||
170414494|NCT03922477|615857287|FG000|Overall Study|Death|9|||
170414495|NCT03922477|615857287|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
170414496|NCT03922477|615857287|FG000|Overall Study|Physician Decision|1|||
170414497|NCT03922477|615857287|FG000|Overall Study|Withdrawal by Subject|2|||
170414498|NCT00862979|615858819|FG000|Overall Study|Adverse Event|6|||
170414499|NCT00862979|615858820|FG001|Overall Study|Adverse Event|3|||
170414500|NCT00862979|615858819|FG000|Overall Study|Protocol Violation|0|||
170414501|NCT00862979|615858820|FG001|Overall Study|Protocol Violation|1|||
170414502|NCT00862979|615858819|FG000|Overall Study|Patient withdrew consent|2|||
170414503|NCT00862979|615858820|FG001|Overall Study|Patient withdrew consent|1|||
170414504|NCT00862979|615858819|FG000|Overall Study|Administrative problems|0|||
170414505|NCT00862979|615858820|FG001|Overall Study|Administrative problems|1|||
170414506|NCT00862979|615858819|FG000|Overall Study|Death|0|||
170414507|NCT00862979|615858820|FG001|Overall Study|Death|1|||
170414508|NCT02688400|615858823|FG000|Overall Study|Protocol Violation|2|||
170414509|NCT02688400|615858824|FG001|Overall Study|Protocol Violation|5|||
170414510|NCT02688400|615858823|FG000|Overall Study|Lack of Efficacy|7|||
170414511|NCT02688400|615858824|FG001|Overall Study|Lack of Efficacy|7|||
170414512|NCT02688400|615858823|FG000|Overall Study|Adverse Event|21|||
170414513|NCT02688400|615858824|FG001|Overall Study|Adverse Event|12|||
170414514|NCT02688400|615858823|FG000|Overall Study|Withdrawal by Subject|15|||
170414515|NCT02688400|615858824|FG001|Overall Study|Withdrawal by Subject|13|||
170414516|NCT02688400|615858823|FG000|Overall Study|No study medication intake|1|||
170414517|NCT02688400|615858824|FG001|Overall Study|No study medication intake|4|||
170414518|NCT02688400|615858823|FG000|Overall Study|Lost to Follow-up|0|||
170414519|NCT02688400|615858824|FG001|Overall Study|Lost to Follow-up|3|||
170414520|NCT02336737|615858828|FG000|Overall Study|Withdrawal by Subject|5|||
170414521|NCT02336737|615858828|FG000|Overall Study|Physician Decision|8|||
170414522|NCT02228382|615858829|FG000|Overall Study|Death|5|||
170414523|NCT02228382|615858830|FG001|Overall Study|Death|7|||
170414524|NCT02228382|615858831|FG002|Overall Study|Death|5|||
170414525|NCT02228382|615858832|FG003|Overall Study|Death|0|||
170414526|NCT02228382|615858833|FG004|Overall Study|Death|2|||
170414527|NCT02228382|615858829|FG000|Overall Study|Participant refused further follow-up|0|||
170414528|NCT02228382|615858830|FG001|Overall Study|Participant refused further follow-up|0|||
170414529|NCT02228382|615858831|FG002|Overall Study|Participant refused further follow-up|1|||
170414530|NCT02228382|615858832|FG003|Overall Study|Participant refused further follow-up|0|||
170414531|NCT02228382|615858833|FG004|Overall Study|Participant refused further follow-up|0|||
170414532|NCT02228382|615858829|FG000|Overall Study|Study terminated by sponsor|3|||
170414533|NCT02228382|615858830|FG001|Overall Study|Study terminated by sponsor|5|||
170414534|NCT02228382|615858831|FG002|Overall Study|Study terminated by sponsor|7|||
170414535|NCT02228382|615858832|FG003|Overall Study|Study terminated by sponsor|0|||
170414536|NCT02228382|615858833|FG004|Overall Study|Study terminated by sponsor|0|||
170414537|NCT02228382|615858829|FG000|Overall Study|Lost to Follow-up|0|||
170414538|NCT02228382|615858830|FG001|Overall Study|Lost to Follow-up|0|||
170414539|NCT02228382|615858831|FG002|Overall Study|Lost to Follow-up|3|||
170414540|NCT02228382|615858832|FG003|Overall Study|Lost to Follow-up|1|||
170414541|NCT02228382|615858833|FG004|Overall Study|Lost to Follow-up|0|||
170414542|NCT02228382|615858829|FG000|Overall Study|Withdrawal by Subject|0|||
170414543|NCT02228382|615858830|FG001|Overall Study|Withdrawal by Subject|3|||
170414544|NCT02228382|615858831|FG002|Overall Study|Withdrawal by Subject|2|||
170414545|NCT02228382|615858832|FG003|Overall Study|Withdrawal by Subject|1|||
170414546|NCT02228382|615858833|FG004|Overall Study|Withdrawal by Subject|0|||
170414547|NCT02228382|615858829|FG000|Overall Study|Other|2|||
170414548|NCT02228382|615858830|FG001|Overall Study|Other|3|||
170414549|NCT02228382|615858831|FG002|Overall Study|Other|3|||
170414550|NCT02228382|615858832|FG003|Overall Study|Other|0|||
170414551|NCT02228382|615858833|FG004|Overall Study|Other|0|||
170414552|NCT02396381|615858835|FG000|Overall Study|Adverse Event|3|||
170525804|NCT01225549|616274046|FG009|Period 4 - Washout|Disallowed medication|0|||
170414553|NCT02396381|615858836|FG001|Overall Study|Adverse Event|2|||
170414554|NCT02396381|615858835|FG000|Overall Study|Withdrawal by Subject|33|||
170414555|NCT02396381|615858836|FG001|Overall Study|Withdrawal by Subject|24|||
170414556|NCT02396381|615858835|FG000|Overall Study|Lost to Follow-up|49|||
170414557|NCT02396381|615858836|FG001|Overall Study|Lost to Follow-up|31|||
170414558|NCT02396381|615858835|FG000|Overall Study|Protocol Violation|1|||
170525805|NCT01225549|616274037|FG000|Period 6 - Washout|Disallowed medication|0|||
170414559|NCT02396381|615858836|FG001|Overall Study|Protocol Violation|0|||
170414560|NCT02396381|615858835|FG000|Overall Study|Site terminated by sponsor|7|||
170414561|NCT02396381|615858836|FG001|Overall Study|Site terminated by sponsor|8|||
170414562|NCT02396381|615858835|FG000|Overall Study|Physician Decision|5|||
170414563|NCT02396381|615858836|FG001|Overall Study|Physician Decision|5|||
170414564|NCT02396381|615858835|FG000|Overall Study|Pregnancy|2|||
170414565|NCT02396381|615858836|FG001|Overall Study|Pregnancy|0|||
170414566|NCT02396381|615858835|FG000|Overall Study|Non-compliance with study procedures|1|||
170771458|NCT00925587|617170413|FG000|Overall Study|Withdrawal by Subject|9|||
170771459|NCT00925587|617170414|FG001|Overall Study|Withdrawal by Subject|6|||
170771460|NCT00925587|617170413|FG000|Overall Study|Death|5|||
170771461|NCT00925587|617170414|FG001|Overall Study|Death|5|||
170771462|NCT00925587|617170413|FG000|Overall Study|Adverse Event|6|||
170771463|NCT00925587|617170414|FG001|Overall Study|Adverse Event|2|||
170771464|NCT00925587|617170413|FG000|Overall Study|Lost to Follow-up|0|||
170771465|NCT00925587|617170414|FG001|Overall Study|Lost to Follow-up|1|||
170872736|NCT00667823|617544869|FG000|Overall Study|Other|8|||
170872737|NCT00667823|617544869|FG000|Overall Study|Missing (completion page missing)|2|||
170872738|NCT00457015|617546427|FG000|Overall Study|Left study site against medical advice|0|||
170872739|NCT00457015|617546428|FG001|Overall Study|Left study site against medical advice|1|||
170872740|NCT04042740|617546429|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
170872741|NCT04042740|617546429|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
170872742|NCT01490450|617546431|FG000|Period 1|Lack of Efficacy|2|||
170414567|NCT02396381|615858836|FG001|Overall Study|Non-compliance with study procedures|0|||
170414568|NCT02396381|615858835|FG000|Overall Study|Moved out of town/state|1|||
170414569|NCT02396381|615858836|FG001|Overall Study|Moved out of town/state|3|||
170414570|NCT02396381|615858835|FG000|Overall Study|Could not complete visit|1|||
170414571|NCT02396381|615858836|FG001|Overall Study|Could not complete visit|0|||
170414572|NCT02396381|615858835|FG000|Overall Study|Possible conflict of interest|1|||
170414573|NCT02396381|615858836|FG001|Overall Study|Possible conflict of interest|0|||
170414574|NCT02396381|615858835|FG000|Overall Study|Randomization/Screening Error|3|||
170414575|NCT02396381|615858836|FG001|Overall Study|Randomization/Screening Error|1|||
170414576|NCT00275002|615858838|FG000|Overall Study|Death|1|||
170414577|NCT00275002|615858839|FG001|Overall Study|Death|0|||
170414578|NCT00275002|615858838|FG000|Overall Study|Disease progression|21|||
170414579|NCT00275002|615858839|FG001|Overall Study|Disease progression|15|||
170414580|NCT00275002|615858838|FG000|Overall Study|Adverse Event|0|||
170414581|NCT00275002|615858839|FG001|Overall Study|Adverse Event|1|||
170414582|NCT00395226|615858840|FG000|Overall Study|Adverse Event|4|||
170414583|NCT00395226|615858841|FG001|Overall Study|Adverse Event|3|||
170414584|NCT00395226|615858840|FG000|Overall Study|Withdrawal by Subject|0|||
170414585|NCT00395226|615858841|FG001|Overall Study|Withdrawal by Subject|1|||
170414586|NCT00395226|615858840|FG000|Overall Study|Lost to Follow-up|0|||
170414587|NCT00395226|615858841|FG001|Overall Study|Lost to Follow-up|1|||
170414588|NCT00287118|615858842|FG000|Overall Study|Adverse Event|30|||
170414589|NCT00287118|615858842|FG000|Overall Study|Death|1|||
170414590|NCT00287118|615858842|FG000|Overall Study|Lack of Efficacy|11|||
170414591|NCT00287118|615858842|FG000|Overall Study|Lost to Follow-up|1|||
170414592|NCT00287118|615858842|FG000|Overall Study|Protocol Violation|2|||
170414593|NCT00287118|615858842|FG000|Overall Study|Other|7|||
170414594|NCT02655237|615858845|FG000|Overall Study|Adverse Event|10|||
170414595|NCT02655237|615858846|FG001|Overall Study|Adverse Event|7|||
170414596|NCT02655237|615858845|FG000|Overall Study|Protocol Deviation|2|||
170414597|NCT02655237|615858846|FG001|Overall Study|Protocol Deviation|0|||
170414598|NCT02655237|615858845|FG000|Overall Study|Withdrawal by Participant|1|||
170414599|NCT02655237|615858846|FG001|Overall Study|Withdrawal by Participant|2|||
170414600|NCT02655237|615858845|FG000|Overall Study|Lack of Efficacy|0|||
170414601|NCT02655237|615858846|FG001|Overall Study|Lack of Efficacy|1|||
170414602|NCT02655237|615858845|FG000|Overall Study|Recovery Leading to Surgery|2|||
170414603|NCT02655237|615858846|FG001|Overall Study|Recovery Leading to Surgery|1|||
170414604|NCT02655237|615858845|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
170414605|NCT02655237|615858846|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
170414606|NCT02655237|615858845|FG000|Overall Study|Randomized but Not Treated|1|||
170414607|NCT02655237|615858846|FG001|Overall Study|Randomized but Not Treated|0|||
170414608|NCT00113490|615858847|FG000|Overall Study|Withdrawal by Subject|1|||
170414609|NCT00113490|615858848|FG001|Overall Study|Withdrawal by Subject|3|||
170414610|NCT00113490|615858847|FG000|Overall Study|Lost to Follow-up|1|||
170414611|NCT00113490|615858848|FG001|Overall Study|Lost to Follow-up|0|||
170414612|NCT00819247|615858849|FG000|Overall Study|Adverse Event|0|||
170771466|NCT01460446|617170420|FG000|Overall Study|Non-compliance|2|||
170771467|NCT01460446|617170421|FG001|Overall Study|Non-compliance|9|||
170872743|NCT01490450|617546432|FG001|Period 1|Lack of Efficacy|0|||
170872744|NCT01490450|617546433|FG002|Period 1|Lack of Efficacy|3|||
170414613|NCT00819247|615858850|FG001|Overall Study|Adverse Event|5|||
170414614|NCT00819247|615858851|FG002|Overall Study|Adverse Event|3|||
170414615|NCT00819247|615858849|FG000|Overall Study|Insufficient testosterone response|5|||
170414616|NCT00819247|615858850|FG001|Overall Study|Insufficient testosterone response|8|||
170414617|NCT00819247|615858851|FG002|Overall Study|Insufficient testosterone response|10|||
170414618|NCT00819247|615858849|FG000|Overall Study|Withdrawal by Subject|1|||
170414619|NCT00819247|615858850|FG001|Overall Study|Withdrawal by Subject|0|||
170414620|NCT00819247|615858851|FG002|Overall Study|Withdrawal by Subject|0|||
170414621|NCT00819247|615858849|FG000|Overall Study|Protocol Violation|1|||
170771468|NCT01460446|617170420|FG000|Overall Study|Consent Withdrawn|0|||
170771469|NCT01460446|617170421|FG001|Overall Study|Consent Withdrawn|4|||
170771470|NCT01460446|617170420|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
170525806|NCT01225549|616274038|FG001|Period 6 - Washout|Disallowed medication|0|||
170525807|NCT01225549|616274039|FG002|Period 6 - Washout|Disallowed medication|0|||
170525808|NCT01225549|616274040|FG003|Period 6 - Washout|Disallowed medication|1|||
170525809|NCT01225549|616274041|FG004|Period 6 - Washout|Disallowed medication|0|||
170525810|NCT01225549|616274042|FG005|Period 6 - Washout|Disallowed medication|0|||
170525811|NCT01225549|616274043|FG006|Period 6 - Washout|Disallowed medication|0|||
170525812|NCT01225549|616274044|FG007|Period 6 - Washout|Disallowed medication|0|||
170525813|NCT01225549|616274045|FG008|Period 6 - Washout|Disallowed medication|0|||
170525814|NCT01225549|616274046|FG009|Period 6 - Washout|Disallowed medication|0|||
170525815|NCT02265510|616274049|FG000|Overall Study|Withdrawal by Subject|1|||
170525816|NCT02265510|616274050|FG001|Overall Study|Withdrawal by Subject|1|||
170525817|NCT02265510|616274051|FG002|Overall Study|Withdrawal by Subject|2|||
170525818|NCT02265510|616274052|FG003|Overall Study|Withdrawal by Subject|1|||
170525819|NCT02265510|616274053|FG004|Overall Study|Withdrawal by Subject|0|||
170525820|NCT02265510|616274054|FG005|Overall Study|Withdrawal by Subject|2|||
170525821|NCT02265510|616274055|FG006|Overall Study|Withdrawal by Subject|0|||
170525822|NCT02265510|616274056|FG007|Overall Study|Withdrawal by Subject|2|||
170525823|NCT02265510|616274057|FG008|Overall Study|Withdrawal by Subject|0|||
170525824|NCT02265510|616274058|FG009|Overall Study|Withdrawal by Subject|0|||
170525825|NCT02265510|616274059|FG010|Overall Study|Withdrawal by Subject|0|||
170525826|NCT02265510|616274060|FG011|Overall Study|Withdrawal by Subject|0|||
170525827|NCT02265510|616274061|FG012|Overall Study|Withdrawal by Subject|1|||
170525828|NCT02265510|616274062|FG013|Overall Study|Withdrawal by Subject|0|||
170525829|NCT02265510|616274049|FG000|Overall Study|Disease Progression|0|||
170771471|NCT01460446|617170421|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
170771472|NCT01460446|617170420|FG000|Overall Study|Surgery/Illness|1|||
170771473|NCT01460446|617170421|FG001|Overall Study|Surgery/Illness|1|||
170771474|NCT01460446|617170420|FG000|Overall Study|Pregnancy|1|||
170771475|NCT01460446|617170421|FG001|Overall Study|Pregnancy|0|||
170771476|NCT01460446|617170420|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
170771477|NCT01460446|617170421|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
170771478|NCT00714714|617170422|FG000|Overall Study|Adverse Event|1|||
170771479|NCT03644849|617170429|FG000|Overall Study|Lost to Follow-up|1|||
170771480|NCT03644849|617170430|FG001|Overall Study|Lost to Follow-up|3|||
170771481|NCT02564744|617170431|FG000|Overall Study|Investigator decision|0|||
170771482|NCT02564744|617170432|FG001|Overall Study|Investigator decision|0|||
170771483|NCT02564744|617170433|FG002|Overall Study|Investigator decision|0|||
170771484|NCT02564744|617170434|FG003|Overall Study|Investigator decision|0|||
170771485|NCT02564744|617170435|FG004|Overall Study|Investigator decision|1|||
170771486|NCT02564744|617170431|FG000|Overall Study|Death|10|||
170771487|NCT02564744|617170432|FG001|Overall Study|Death|5|||
170771488|NCT02564744|617170433|FG002|Overall Study|Death|4|||
170771489|NCT02564744|617170434|FG003|Overall Study|Death|16|||
170771490|NCT02564744|617170435|FG004|Overall Study|Death|16|||
170771491|NCT02564744|617170431|FG000|Overall Study|End of study Page Missing|0|||
170771492|NCT02564744|617170432|FG001|Overall Study|End of study Page Missing|0|||
170771493|NCT02564744|617170433|FG002|Overall Study|End of study Page Missing|3|||
170771494|NCT02564744|617170434|FG003|Overall Study|End of study Page Missing|3|||
170771495|NCT02564744|617170435|FG004|Overall Study|End of study Page Missing|0|||
170771496|NCT02564744|617170431|FG000|Overall Study|Subject Withdrew Consent|1|||
170771497|NCT02564744|617170432|FG001|Overall Study|Subject Withdrew Consent|1|||
170771498|NCT02564744|617170433|FG002|Overall Study|Subject Withdrew Consent|1|||
170771499|NCT02564744|617170434|FG003|Overall Study|Subject Withdrew Consent|0|||
170771500|NCT02564744|617170435|FG004|Overall Study|Subject Withdrew Consent|2|||
170771501|NCT02564744|617170431|FG000|Overall Study|Lost to Follow-up|0|||
170872745|NCT01490450|617546434|FG003|Period 1|Lack of Efficacy|0|||
170872746|NCT01490450|617546431|FG000|Period 1|Adverse Event|0|||
170525830|NCT02265510|616274050|FG001|Overall Study|Disease Progression|1|||
170525831|NCT02265510|616274051|FG002|Overall Study|Disease Progression|2|||
170525832|NCT02265510|616274052|FG003|Overall Study|Disease Progression|1|||
170525833|NCT02265510|616274053|FG004|Overall Study|Disease Progression|1|||
170525834|NCT02265510|616274054|FG005|Overall Study|Disease Progression|0|||
170525835|NCT02265510|616274055|FG006|Overall Study|Disease Progression|0|||
170525836|NCT02265510|616274056|FG007|Overall Study|Disease Progression|0|||
170525837|NCT02265510|616274057|FG008|Overall Study|Disease Progression|0|||
170525838|NCT02265510|616274058|FG009|Overall Study|Disease Progression|0|||
170771502|NCT02564744|617170432|FG001|Overall Study|Lost to Follow-up|1|||
170771503|NCT02564744|617170433|FG002|Overall Study|Lost to Follow-up|0|||
170525839|NCT02265510|616274059|FG010|Overall Study|Disease Progression|0|||
170525840|NCT02265510|616274060|FG011|Overall Study|Disease Progression|0|||
170525841|NCT02265510|616274061|FG012|Overall Study|Disease Progression|0|||
170525842|NCT02265510|616274062|FG013|Overall Study|Disease Progression|0|||
170771504|NCT02564744|617170434|FG003|Overall Study|Lost to Follow-up|0|||
170771505|NCT02564744|617170435|FG004|Overall Study|Lost to Follow-up|1|||
170771506|NCT02564744|617170431|FG000|Overall Study|Reason not specified|1|||
170771507|NCT02564744|617170432|FG001|Overall Study|Reason not specified|0|||
170771508|NCT02564744|617170433|FG002|Overall Study|Reason not specified|0|||
170771509|NCT02564744|617170434|FG003|Overall Study|Reason not specified|0|||
170525843|NCT02265510|616274049|FG000|Overall Study|Death|2|||
170525844|NCT02265510|616274050|FG001|Overall Study|Death|0|||
170525845|NCT02265510|616274051|FG002|Overall Study|Death|2|||
170525846|NCT02265510|616274052|FG003|Overall Study|Death|2|||
170525847|NCT02265510|616274053|FG004|Overall Study|Death|1|||
170525848|NCT02265510|616274054|FG005|Overall Study|Death|3|||
170525849|NCT02265510|616274055|FG006|Overall Study|Death|2|||
170525850|NCT02265510|616274056|FG007|Overall Study|Death|1|||
170525851|NCT02265510|616274057|FG008|Overall Study|Death|3|||
170525852|NCT02265510|616274058|FG009|Overall Study|Death|3|||
170525853|NCT02265510|616274059|FG010|Overall Study|Death|4|||
170525854|NCT02265510|616274060|FG011|Overall Study|Death|12|||
170525855|NCT02265510|616274061|FG012|Overall Study|Death|7|||
170525856|NCT02265510|616274062|FG013|Overall Study|Death|6|||
170525857|NCT02265510|616274049|FG000|Overall Study|Lost to Follow-up|0|||
170525858|NCT02265510|616274050|FG001|Overall Study|Lost to Follow-up|0|||
170525859|NCT02265510|616274051|FG002|Overall Study|Lost to Follow-up|0|||
170525860|NCT02265510|616274052|FG003|Overall Study|Lost to Follow-up|0|||
170525861|NCT02265510|616274053|FG004|Overall Study|Lost to Follow-up|1|||
170525862|NCT02265510|616274054|FG005|Overall Study|Lost to Follow-up|0|||
170525863|NCT02265510|616274055|FG006|Overall Study|Lost to Follow-up|0|||
170525864|NCT02265510|616274056|FG007|Overall Study|Lost to Follow-up|0|||
170525865|NCT02265510|616274057|FG008|Overall Study|Lost to Follow-up|0|||
170525866|NCT02265510|616274058|FG009|Overall Study|Lost to Follow-up|2|||
170525867|NCT02265510|616274059|FG010|Overall Study|Lost to Follow-up|0|||
170525868|NCT02265510|616274060|FG011|Overall Study|Lost to Follow-up|0|||
170771510|NCT02564744|617170435|FG004|Overall Study|Reason not specified|0|||
170771511|NCT02675244|617170443|FG000|Overall Study|Death|9|||
170771512|NCT02675244|617170444|FG001|Overall Study|Death|6|||
170771513|NCT02675244|617170443|FG000|Overall Study|Withdrawal by Subject|3|||
170771514|NCT02675244|617170444|FG001|Overall Study|Withdrawal by Subject|6|||
170771515|NCT02675244|617170443|FG000|Overall Study|Lost to Follow-up|1|||
170771516|NCT02675244|617170444|FG001|Overall Study|Lost to Follow-up|1|||
170771517|NCT02675244|617170443|FG000|Overall Study|Ongoing at 2 Years|190|||
170771518|NCT02675244|617170444|FG001|Overall Study|Ongoing at 2 Years|185|||
170771519|NCT01177670|617170446|FG000|Overall Study|Study Terminated|115|||
170771520|NCT01177670|617170446|FG000|Overall Study|Physician Decision|50|||
170771521|NCT01177670|617170446|FG000|Overall Study|Withdrawal by Subject|4|||
170771522|NCT00979992|617170447|FG000|Overall Study|Ineligible - inadequate pathology|1|||
170771523|NCT00979992|617170447|FG000|Overall Study|Ineligible - wrong cell type|2|||
170771524|NCT00979992|617170447|FG000|Overall Study|Refused - Never Treated|2|||
170771525|NCT00494780|617170449|FG000|Overall Study|Adverse Event|1|||
170771526|NCT00494780|617170450|FG001|Overall Study|Adverse Event|0|||
170771527|NCT00494780|617170449|FG000|Overall Study|Withdrew before Dosed|0|||
170771528|NCT00494780|617170450|FG001|Overall Study|Withdrew before Dosed|1|||
170771529|NCT00494780|617170449|FG000|Overall Study|Progression of Study Disease|7|||
170771530|NCT00494780|617170450|FG001|Overall Study|Progression of Study Disease|8|||
170771531|NCT00494780|617170449|FG000|Overall Study|New Treatment|2|||
170771532|NCT00494780|617170450|FG001|Overall Study|New Treatment|2|||
170771533|NCT00494780|617170449|FG000|Overall Study|Non-compliance|1|||
170771534|NCT00494780|617170450|FG001|Overall Study|Non-compliance|0|||
170771535|NCT00494780|617170449|FG000|Overall Study|Residual Tumour Mass|0|||
170771536|NCT00494780|617170450|FG001|Overall Study|Residual Tumour Mass|1|||
170771537|NCT00494780|617170449|FG000|Overall Study|Insurance Issues|0|||
170771538|NCT00494780|617170450|FG001|Overall Study|Insurance Issues|1|||
170771539|NCT02888080|617170451|FG000|Overall Study|Subject / Guardian decision|1|||
170771540|NCT02888080|617170452|FG001|Overall Study|Subject / Guardian decision|3|||
170872747|NCT01490450|617546432|FG001|Period 1|Adverse Event|0|||
170525869|NCT02265510|616274061|FG012|Overall Study|Lost to Follow-up|0|||
170525870|NCT02265510|616274062|FG013|Overall Study|Lost to Follow-up|2|||
170525871|NCT02265510|616274049|FG000|Overall Study|Other|0|||
170525872|NCT02265510|616274050|FG001|Overall Study|Other|1|||
170525873|NCT02265510|616274051|FG002|Overall Study|Other|0|||
170525874|NCT02265510|616274052|FG003|Overall Study|Other|0|||
170525875|NCT02265510|616274053|FG004|Overall Study|Other|0|||
170525876|NCT02265510|616274054|FG005|Overall Study|Other|0|||
170525877|NCT02265510|616274055|FG006|Overall Study|Other|0|||
170525878|NCT02265510|616274056|FG007|Overall Study|Other|0|||
170525879|NCT02265510|616274057|FG008|Overall Study|Other|0|||
170771541|NCT02888080|617170451|FG000|Overall Study|New Therapy for study indication|1|||
170771542|NCT02888080|617170452|FG001|Overall Study|New Therapy for study indication|0|||
170771543|NCT02888080|617170451|FG000|Overall Study|Lack of Efficacy|0|||
170525880|NCT02265510|616274058|FG009|Overall Study|Other|0|||
170771544|NCT02888080|617170452|FG001|Overall Study|Lack of Efficacy|1|||
170771545|NCT02888080|617170451|FG000|Overall Study|Adverse Event|0|||
170771546|NCT02888080|617170452|FG001|Overall Study|Adverse Event|1|||
170525881|NCT02265510|616274059|FG010|Overall Study|Other|0|||
170525882|NCT02265510|616274060|FG011|Overall Study|Other|0|||
170525883|NCT02265510|616274061|FG012|Overall Study|Other|0|||
170525884|NCT02265510|616274062|FG013|Overall Study|Other|0|||
170525885|NCT02265510|616274049|FG000|Overall Study|Study Terminated by Sponsor|0|||
170771547|NCT00980330|617170454|FG000|Overall Study|Adverse Event|0|||
170525886|NCT02265510|616274050|FG001|Overall Study|Study Terminated by Sponsor|0|||
170525887|NCT02265510|616274051|FG002|Overall Study|Study Terminated by Sponsor|0|||
170525888|NCT02265510|616274052|FG003|Overall Study|Study Terminated by Sponsor|0|||
170525889|NCT02265510|616274053|FG004|Overall Study|Study Terminated by Sponsor|0|||
170525890|NCT02265510|616274054|FG005|Overall Study|Study Terminated by Sponsor|1|||
170525891|NCT02265510|616274055|FG006|Overall Study|Study Terminated by Sponsor|1|||
170525892|NCT02265510|616274056|FG007|Overall Study|Study Terminated by Sponsor|1|||
170525893|NCT02265510|616274057|FG008|Overall Study|Study Terminated by Sponsor|1|||
170525894|NCT02265510|616274058|FG009|Overall Study|Study Terminated by Sponsor|2|||
170525895|NCT02265510|616274059|FG010|Overall Study|Study Terminated by Sponsor|1|||
170525896|NCT02265510|616274060|FG011|Overall Study|Study Terminated by Sponsor|4|||
170525897|NCT02265510|616274061|FG012|Overall Study|Study Terminated by Sponsor|1|||
170525898|NCT02265510|616274062|FG013|Overall Study|Study Terminated by Sponsor|2|||
170525899|NCT03093181|616274065|FG000|Overall Study|Withdrawal by Subject|2|||
170525900|NCT03093181|616274066|FG001|Overall Study|Withdrawal by Subject|1|||
170525901|NCT03093181|616274067|FG002|Overall Study|Withdrawal by Subject|2|||
170525902|NCT03093181|616274065|FG000|Overall Study|Other (Not specified)|1|||
170525903|NCT03093181|616274066|FG001|Overall Study|Other (Not specified)|0|||
170525904|NCT03093181|616274067|FG002|Overall Study|Other (Not specified)|0|||
170525905|NCT03093181|616274065|FG000|Overall Study|Adverse Event|0|||
170525906|NCT03093181|616274066|FG001|Overall Study|Adverse Event|1|||
170525907|NCT03093181|616274067|FG002|Overall Study|Adverse Event|0|||
170525908|NCT03093181|616274065|FG000|Overall Study|Other (Protocol violation)|0|||
170525909|NCT03093181|616274066|FG001|Overall Study|Other (Protocol violation)|0|||
170525910|NCT03093181|616274067|FG002|Overall Study|Other (Protocol violation)|1|||
170525911|NCT04076917|616274068|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
170525912|NCT04076917|616274068|FG000|Overall Study|Study closure|13|||
170525913|NCT04076917|616274068|FG000|Overall Study|Physician Decision|3|||
170525914|NCT04076917|616274068|FG000|Overall Study|Death|1|||
170525915|NCT04076917|616274068|FG000|Overall Study|Lost to Follow-up|1|||
170525916|NCT04076917|616274068|FG000|Overall Study|Withdrawal by Subject|1|||
170525917|NCT04076917|616274068|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
170525918|NCT04210986|616274069|FG000|Overall Study|Lost to Follow-up|5|||
170525919|NCT04210986|616274070|FG001|Overall Study|Lost to Follow-up|2|||
170525920|NCT04210986|616274069|FG000|Overall Study|Withdrawal by Subject|3|||
170525921|NCT04210986|616274070|FG001|Overall Study|Withdrawal by Subject|1|||
170525922|NCT04210986|616274069|FG000|Overall Study|Protocol Violation|1|||
170525923|NCT04210986|616274070|FG001|Overall Study|Protocol Violation|1|||
170525924|NCT04210986|616274069|FG000|Overall Study|Physician Decision|0|||
170525925|NCT04210986|616274070|FG001|Overall Study|Physician Decision|1|||
170525926|NCT02378662|616274071|FG000|Overall Study|Early Discontinuation|2|||
170525927|NCT02378662|616274072|FG001|Overall Study|Early Discontinuation|0|||
170525928|NCT01159574|616274073|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
170525929|NCT01159574|616274073|FG000|Treatment Phase|Adverse Event|3|||
170525930|NCT01159574|616274073|FG000|Treatment Phase|Death|6|||
170525931|NCT01159574|616274073|FG000|Treatment Phase|Physician Decision|2|||
170525932|NCT01159574|616274073|FG000|Treatment Phase|Withdrawal by Subject|7|||
170525933|NCT01159574|616274073|FG000|Treatment Phase|still on treatment|2|||
170525934|NCT01159574|616274073|FG000|Follow Up Phase|Lost to Follow-up|2|||
170525935|NCT01159574|616274073|FG000|Follow Up Phase|still being followed for overall surviva|18|||
170525936|NCT00630916|616274076|FG000|Overall Study|Death|110|||
170525937|NCT00630916|616274076|FG000|Overall Study|Explant|8|||
170525938|NCT00630916|616274076|FG000|Overall Study|Lost to Follow-up|5|||
170525939|NCT00630916|616274076|FG000|Overall Study|Withdrawal by Subject|30|||
170525940|NCT00630916|616274076|FG000|Overall Study|Protocol Violation|7|||
170525941|NCT00630916|616274076|FG000|Overall Study|Physician Decision|47|||
170525942|NCT00630916|616274076|FG000|Overall Study|Lack of Efficacy|3|||
170525943|NCT00324155|616274077|FG000|Enrolled and Randomized|No longer met study criteria|3|||
170525944|NCT00324155|616274078|FG001|Enrolled and Randomized|No longer met study criteria|0|||
170525945|NCT00324155|616274077|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
170525946|NCT00324155|616274078|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
170525947|NCT00324155|616274077|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
170525948|NCT00324155|616274078|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
170525949|NCT00324155|616274077|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
170771548|NCT00980330|617170455|FG001|Overall Study|Adverse Event|0|||
170771549|NCT00980330|617170456|FG002|Overall Study|Adverse Event|0|||
170771550|NCT00980330|617170457|FG003|Overall Study|Adverse Event|1|||
170771551|NCT00980330|617170458|FG004|Overall Study|Adverse Event|0|||
170525950|NCT00324155|616274078|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
170525951|NCT00324155|616274077|FG000|Received Treatment in Induction Phase|Death|8|||
170525952|NCT00324155|616274078|FG001|Received Treatment in Induction Phase|Death|15|||
170525953|NCT00324155|616274077|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
170525954|NCT00324155|616274078|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
170525955|NCT00324155|616274077|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
170771552|NCT00980330|617170459|FG005|Overall Study|Adverse Event|0|||
170771553|NCT00980330|617170460|FG006|Overall Study|Adverse Event|0|||
170771554|NCT00980330|617170454|FG000|Overall Study|Lost to Follow-up|1|||
170771555|NCT00980330|617170455|FG001|Overall Study|Lost to Follow-up|1|||
170414622|NCT00819247|615858850|FG001|Overall Study|Protocol Violation|0|||
170414623|NCT00819247|615858851|FG002|Overall Study|Protocol Violation|1|||
170414624|NCT00819247|615858849|FG000|Overall Study|Mistakenly withdrawn|0|||
170414625|NCT00819247|615858850|FG001|Overall Study|Mistakenly withdrawn|1|||
170414626|NCT00819247|615858851|FG002|Overall Study|Mistakenly withdrawn|0|||
170414627|NCT00819247|615858849|FG000|Overall Study|Bad prostate-specific antigen response|3|||
170414628|NCT00819247|615858850|FG001|Overall Study|Bad prostate-specific antigen response|2|||
170414629|NCT00819247|615858851|FG002|Overall Study|Bad prostate-specific antigen response|0|||
170414630|NCT00819247|615858849|FG000|Overall Study|Other|1|||
170414631|NCT00819247|615858850|FG001|Overall Study|Other|0|||
170414632|NCT00819247|615858851|FG002|Overall Study|Other|0|||
170414633|NCT03335371|615858852|FG000|Overall Study|Lost to Follow-up|0|||
170414634|NCT03335371|615858853|FG001|Overall Study|Lost to Follow-up|0|||
170414635|NCT03335371|615858854|FG002|Overall Study|Lost to Follow-up|0|||
170414636|NCT03335371|615858855|FG003|Overall Study|Lost to Follow-up|0|||
170414637|NCT03335371|615858856|FG004|Overall Study|Lost to Follow-up|1|||
170414638|NCT03335371|615858852|FG000|Overall Study|Withdrawal by Subject|0|||
170414639|NCT03335371|615858853|FG001|Overall Study|Withdrawal by Subject|0|||
170414640|NCT03335371|615858854|FG002|Overall Study|Withdrawal by Subject|0|||
170414641|NCT03335371|615858855|FG003|Overall Study|Withdrawal by Subject|0|||
170414642|NCT03335371|615858856|FG004|Overall Study|Withdrawal by Subject|1|||
170414643|NCT03335371|615858852|FG000|Overall Study|Randomization Error|0|||
170414644|NCT03335371|615858853|FG001|Overall Study|Randomization Error|0|||
170414645|NCT03335371|615858854|FG002|Overall Study|Randomization Error|1|||
170414646|NCT03335371|615858855|FG003|Overall Study|Randomization Error|0|||
170414647|NCT03335371|615858856|FG004|Overall Study|Randomization Error|0|||
170414648|NCT04652453|615858859|FG000|Overall Study|Death|8|||
170414649|NCT04652453|615858860|FG001|Overall Study|Death|2|||
170414650|NCT04652453|615858861|FG002|Overall Study|Death|0|||
170414651|NCT04652453|615858859|FG000|Overall Study|Hospice|5|||
170414652|NCT04652453|615858860|FG001|Overall Study|Hospice|5|||
170414653|NCT04652453|615858861|FG002|Overall Study|Hospice|0|||
170414654|NCT04652453|615858859|FG000|Overall Study|Withdrawal by Subject|2|||
170771556|NCT00980330|617170456|FG002|Overall Study|Lost to Follow-up|4|||
170771557|NCT00980330|617170457|FG003|Overall Study|Lost to Follow-up|2|||
170771558|NCT00980330|617170458|FG004|Overall Study|Lost to Follow-up|1|||
170771559|NCT00980330|617170459|FG005|Overall Study|Lost to Follow-up|1|||
170771560|NCT00980330|617170460|FG006|Overall Study|Lost to Follow-up|2|||
170872748|NCT01490450|617546433|FG002|Period 1|Adverse Event|0|||
170872749|NCT01490450|617546434|FG003|Period 1|Adverse Event|5|||
170872750|NCT01490450|617546431|FG000|Period 1|Request to discontinue treatment|1|||
170872751|NCT01490450|617546432|FG001|Period 1|Request to discontinue treatment|0|||
170872752|NCT01490450|617546433|FG002|Period 1|Request to discontinue treatment|0|||
170872753|NCT01490450|617546434|FG003|Period 1|Request to discontinue treatment|0|||
170872754|NCT01490450|617546431|FG000|Period 1|Withdrawal by Subject|0|||
170872755|NCT01490450|617546432|FG001|Period 1|Withdrawal by Subject|0|||
170872756|NCT01490450|617546433|FG002|Period 1|Withdrawal by Subject|0|||
170872757|NCT01490450|617546434|FG003|Period 1|Withdrawal by Subject|3|||
170872758|NCT01490450|617546431|FG000|Period 1|No longer met study criteria|0|||
170872759|NCT01490450|617546432|FG001|Period 1|No longer met study criteria|1|||
170872760|NCT01490450|617546433|FG002|Period 1|No longer met study criteria|1|||
170872761|NCT01490450|617546434|FG003|Period 1|No longer met study criteria|0|||
170872762|NCT01490450|617546431|FG000|Period 2|Lack of Efficacy|0|||
170872763|NCT01490450|617546432|FG001|Period 2|Lack of Efficacy|0|||
170872764|NCT01490450|617546433|FG002|Period 2|Lack of Efficacy|0|||
170872765|NCT01490450|617546434|FG003|Period 2|Lack of Efficacy|1|||
170872766|NCT01490450|617546431|FG000|Period 2|Adverse Event|1|||
170872767|NCT01490450|617546432|FG001|Period 2|Adverse Event|1|||
170872768|NCT01490450|617546433|FG002|Period 2|Adverse Event|0|||
170872769|NCT01490450|617546434|FG003|Period 2|Adverse Event|1|||
170872770|NCT01490450|617546431|FG000|Period 2|Withdrawal by Subject|1|||
170872771|NCT01490450|617546432|FG001|Period 2|Withdrawal by Subject|0|||
170872772|NCT01490450|617546433|FG002|Period 2|Withdrawal by Subject|0|||
170872773|NCT01490450|617546434|FG003|Period 2|Withdrawal by Subject|0|||
170872774|NCT01490450|617546431|FG000|Period 2|Lost to Follow-up|0|||
170872775|NCT01490450|617546432|FG001|Period 2|Lost to Follow-up|0|||
170872776|NCT01490450|617546433|FG002|Period 2|Lost to Follow-up|0|||
170414655|NCT04652453|615858860|FG001|Overall Study|Withdrawal by Subject|0|||
170414656|NCT04652453|615858861|FG002|Overall Study|Withdrawal by Subject|0|||
170414657|NCT02192099|615858862|FG000|Overall Study|Adverse Event|1|||
170414658|NCT02192099|615858862|FG000|Overall Study|Lost to Follow-up|2|||
170414659|NCT02192099|615858862|FG000|Overall Study|Physician Decision|1|||
170414660|NCT02192099|615858862|FG000|Overall Study|Pregnancy|1|||
170414661|NCT02192099|615858862|FG000|Overall Study|Protocol Violation|8|||
170771561|NCT00980330|617170454|FG000|Overall Study|Withdrawal by Subject|2|||
170872777|NCT01490450|617546434|FG003|Period 2|Lost to Follow-up|2|||
170525956|NCT00324155|616274078|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
170525957|NCT00324155|616274077|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
170525958|NCT00324155|616274078|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
170525959|NCT00324155|616274077|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
170525960|NCT00324155|616274078|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
170525961|NCT00324155|616274077|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
170525962|NCT00324155|616274078|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
170525963|NCT00324155|616274077|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
170525964|NCT00324155|616274078|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
170525965|NCT00324155|616274077|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
170525966|NCT00324155|616274078|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
170525967|NCT00324155|616274077|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
170525968|NCT00324155|616274078|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
170525969|NCT00324155|616274077|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
170525970|NCT00324155|616274078|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
170525971|NCT00324155|616274077|FG000|Follow-up Phase|On-going participants still on drug|11|||
170525972|NCT00324155|616274078|FG001|Follow-up Phase|On-going participants still on drug|6|||
170525973|NCT00390689|616274079|FG000|Overall Study|Adverse Event|2|||
170525974|NCT00390689|616274080|FG001|Overall Study|Adverse Event|5|||
170525975|NCT00390689|616274081|FG002|Overall Study|Adverse Event|2|||
170525976|NCT00390689|616274079|FG000|Overall Study|Lack of Efficacy|0|||
170525977|NCT00390689|616274080|FG001|Overall Study|Lack of Efficacy|0|||
170525978|NCT00390689|616274081|FG002|Overall Study|Lack of Efficacy|1|||
170525979|NCT00390689|616274079|FG000|Overall Study|Protocol Violation|1|||
170525980|NCT00390689|616274080|FG001|Overall Study|Protocol Violation|0|||
170525981|NCT00390689|616274081|FG002|Overall Study|Protocol Violation|0|||
170525982|NCT00390689|616274079|FG000|Overall Study|Investigator's judgement|2|||
170525983|NCT00390689|616274080|FG001|Overall Study|Investigator's judgement|0|||
170525984|NCT00390689|616274081|FG002|Overall Study|Investigator's judgement|0|||
170525985|NCT01253161|616274082|FG000|Overall Study|Adverse Event|1|||
170525986|NCT05412134|616274084|FG000|Overall Study|Lost to Follow-up|2|||
170525987|NCT05412134|616274085|FG001|Overall Study|Lost to Follow-up|0|||
170525988|NCT03167242|616274092|FG000|Overall Study|Patient/Guardian Decision|0|||
170525989|NCT03167242|616274093|FG001|Overall Study|Patient/Guardian Decision|1|||
170525990|NCT03167242|616274094|FG002|Overall Study|Patient/Guardian Decision|2|||
170525991|NCT03167242|616274095|FG003|Overall Study|Patient/Guardian Decision|1|||
170525992|NCT03167242|616274096|FG004|Overall Study|Patient/Guardian Decision|1|||
170525993|NCT03167242|616274097|FG005|Overall Study|Patient/Guardian Decision|1|||
170525994|NCT03167242|616274098|FG006|Overall Study|Patient/Guardian Decision|0|||
170525995|NCT03167242|616274099|FG007|Overall Study|Patient/Guardian Decision|0|||
170525996|NCT03167242|616274100|FG008|Overall Study|Patient/Guardian Decision|0|||
170525997|NCT03167242|616274101|FG009|Overall Study|Patient/Guardian Decision|0|||
170525998|NCT03167242|616274102|FG010|Overall Study|Patient/Guardian Decision|1|||
170525999|NCT03167242|616274103|FG011|Overall Study|Patient/Guardian Decision|0|||
170526000|NCT03167242|616274092|FG000|Overall Study|Lost to Follow-up|0|||
170526001|NCT03167242|616274093|FG001|Overall Study|Lost to Follow-up|0|||
170526002|NCT03167242|616274094|FG002|Overall Study|Lost to Follow-up|1|||
170526003|NCT03167242|616274095|FG003|Overall Study|Lost to Follow-up|0|||
170526004|NCT03167242|616274096|FG004|Overall Study|Lost to Follow-up|0|||
170526005|NCT03167242|616274097|FG005|Overall Study|Lost to Follow-up|1|||
170526006|NCT03167242|616274098|FG006|Overall Study|Lost to Follow-up|2|||
170526007|NCT03167242|616274099|FG007|Overall Study|Lost to Follow-up|1|||
170526008|NCT03167242|616274100|FG008|Overall Study|Lost to Follow-up|0|||
170526009|NCT03167242|616274101|FG009|Overall Study|Lost to Follow-up|0|||
170632223|NCT03995368|616664561|FG002|Overall Study|Lost to Follow-up|1|||
170771562|NCT00980330|617170455|FG001|Overall Study|Withdrawal by Subject|4|||
170771563|NCT00980330|617170456|FG002|Overall Study|Withdrawal by Subject|4|||
170771564|NCT00980330|617170457|FG003|Overall Study|Withdrawal by Subject|1|||
170771565|NCT00980330|617170458|FG004|Overall Study|Withdrawal by Subject|3|||
170771566|NCT00980330|617170459|FG005|Overall Study|Withdrawal by Subject|2|||
170771567|NCT00980330|617170460|FG006|Overall Study|Withdrawal by Subject|5|||
170771568|NCT00980330|617170454|FG000|Overall Study|(not specified)|2|||
170771569|NCT00980330|617170455|FG001|Overall Study|(not specified)|0|||
170771570|NCT00980330|617170456|FG002|Overall Study|(not specified)|0|||
170771571|NCT00980330|617170457|FG003|Overall Study|(not specified)|1|||
170771572|NCT00980330|617170458|FG004|Overall Study|(not specified)|1|||
170872778|NCT01462435|617546435|FG000|Overall Study|Lack of Efficacy|1|||
170526010|NCT03167242|616274102|FG010|Overall Study|Lost to Follow-up|1|||
170526011|NCT03167242|616274103|FG011|Overall Study|Lost to Follow-up|1|||
170526012|NCT03167242|616274092|FG000|Overall Study|Reason not provided|0|||
170526013|NCT03167242|616274093|FG001|Overall Study|Reason not provided|0|||
170526014|NCT03167242|616274094|FG002|Overall Study|Reason not provided|0|||
170526015|NCT03167242|616274095|FG003|Overall Study|Reason not provided|0|||
170771573|NCT00980330|617170459|FG005|Overall Study|(not specified)|1|||
170771574|NCT00980330|617170460|FG006|Overall Study|(not specified)|0|||
170771575|NCT05001945|617170465|FG000|Overall Study|Adverse Event|0|||
170771576|NCT05001945|617170466|FG001|Overall Study|Adverse Event|0|||
170771577|NCT05001945|617170467|FG002|Overall Study|Adverse Event|0|||
170771578|NCT05001945|617170468|FG003|Overall Study|Adverse Event|1|||
170771579|NCT05001945|617170469|FG004|Overall Study|Adverse Event|0|||
170414662|NCT02192099|615858862|FG000|Overall Study|Study Terminated by Sponsor|32|||
170414663|NCT02192099|615858862|FG000|Overall Study|Withdrawal by Subject|11|||
170414664|NCT02192099|615858862|FG000|Overall Study|Miscellaneous Reasons|5|||
170414665|NCT02649231|615858866|FG000|Overall Study|Adverse Event|0|||
170414666|NCT02649231|615858867|FG001|Overall Study|Adverse Event|0|||
170414667|NCT02649231|615858868|FG002|Overall Study|Adverse Event|0|||
170414668|NCT02649231|615858869|FG003|Overall Study|Adverse Event|1|||
170414669|NCT02649231|615858866|FG000|Overall Study|Lost to Follow-up|2|||
170414670|NCT02649231|615858867|FG001|Overall Study|Lost to Follow-up|1|||
170414671|NCT02649231|615858868|FG002|Overall Study|Lost to Follow-up|1|||
170414672|NCT02649231|615858869|FG003|Overall Study|Lost to Follow-up|0|||
170414673|NCT02649231|615858866|FG000|Overall Study|Withdrawal by Subject|0|||
170414674|NCT02649231|615858867|FG001|Overall Study|Withdrawal by Subject|1|||
170414675|NCT02649231|615858868|FG002|Overall Study|Withdrawal by Subject|0|||
170414676|NCT02649231|615858869|FG003|Overall Study|Withdrawal by Subject|1|||
170414677|NCT02649231|615858866|FG000|Overall Study|Protocol Violation|2|||
170414678|NCT02649231|615858867|FG001|Overall Study|Protocol Violation|1|||
170414679|NCT02649231|615858868|FG002|Overall Study|Protocol Violation|1|||
170414680|NCT02649231|615858869|FG003|Overall Study|Protocol Violation|0|||
170414681|NCT00437281|615858870|FG000|Overall Study|Adverse Event|0|||
170414682|NCT00437281|615858871|FG001|Overall Study|Adverse Event|0|||
170414683|NCT00437281|615858872|FG002|Overall Study|Adverse Event|0|||
170414684|NCT00437281|615858873|FG003|Overall Study|Adverse Event|1|||
170414685|NCT00437281|615858874|FG004|Overall Study|Adverse Event|0|||
170414686|NCT00437281|615858875|FG005|Overall Study|Adverse Event|1|||
170414687|NCT00437281|615858876|FG006|Overall Study|Adverse Event|0|||
170414688|NCT00437281|615858877|FG007|Overall Study|Adverse Event|0|||
170414689|NCT00437281|615858878|FG008|Overall Study|Adverse Event|0|||
170414690|NCT00437281|615858879|FG009|Overall Study|Adverse Event|1|||
170414691|NCT00437281|615858880|FG010|Overall Study|Adverse Event|0|||
170414692|NCT00437281|615858881|FG011|Overall Study|Adverse Event|0|||
170414693|NCT00437281|615858882|FG012|Overall Study|Adverse Event|0|||
170414694|NCT00437281|615858883|FG013|Overall Study|Adverse Event|1|||
170414695|NCT00437281|615858884|FG014|Overall Study|Adverse Event|1|||
170414696|NCT00437281|615858885|FG015|Overall Study|Adverse Event|0|||
170414697|NCT00437281|615858886|FG016|Overall Study|Adverse Event|0|||
170414698|NCT00437281|615858887|FG017|Overall Study|Adverse Event|0|||
170414699|NCT00437281|615858888|FG018|Overall Study|Adverse Event|1|||
170414700|NCT00437281|615858889|FG019|Overall Study|Adverse Event|0|||
170414701|NCT00437281|615858870|FG000|Overall Study|Lost to Follow-up|0|||
170414702|NCT00437281|615858871|FG001|Overall Study|Lost to Follow-up|0|||
170414703|NCT00437281|615858872|FG002|Overall Study|Lost to Follow-up|0|||
170414704|NCT00437281|615858873|FG003|Overall Study|Lost to Follow-up|0|||
170414705|NCT00437281|615858874|FG004|Overall Study|Lost to Follow-up|0|||
170414706|NCT00437281|615858875|FG005|Overall Study|Lost to Follow-up|0|||
170414707|NCT00437281|615858876|FG006|Overall Study|Lost to Follow-up|0|||
170414708|NCT00437281|615858877|FG007|Overall Study|Lost to Follow-up|0|||
170414709|NCT00437281|615858878|FG008|Overall Study|Lost to Follow-up|0|||
170414710|NCT00437281|615858879|FG009|Overall Study|Lost to Follow-up|0|||
170414711|NCT00437281|615858880|FG010|Overall Study|Lost to Follow-up|0|||
170414712|NCT00437281|615858881|FG011|Overall Study|Lost to Follow-up|0|||
170414713|NCT00437281|615858882|FG012|Overall Study|Lost to Follow-up|0|||
170414714|NCT00437281|615858883|FG013|Overall Study|Lost to Follow-up|0|||
170414715|NCT00437281|615858884|FG014|Overall Study|Lost to Follow-up|0|||
170414716|NCT00437281|615858885|FG015|Overall Study|Lost to Follow-up|0|||
170771580|NCT05001945|617170470|FG005|Overall Study|Adverse Event|0|||
170771581|NCT05001945|617170471|FG006|Overall Study|Adverse Event|0|||
170771582|NCT05001945|617170472|FG007|Overall Study|Adverse Event|0|||
170771583|NCT05001945|617170465|FG000|Overall Study|Lost to Follow-up|0|||
170414717|NCT00437281|615858886|FG016|Overall Study|Lost to Follow-up|0|||
170771584|NCT05001945|617170466|FG001|Overall Study|Lost to Follow-up|1|||
170414718|NCT00437281|615858887|FG017|Overall Study|Lost to Follow-up|0|||
170771585|NCT05001945|617170467|FG002|Overall Study|Lost to Follow-up|1|||
170414719|NCT00437281|615858888|FG018|Overall Study|Lost to Follow-up|0|||
170414720|NCT00437281|615858889|FG019|Overall Study|Lost to Follow-up|1|||
170414721|NCT05876091|615858890|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
170414722|NCT00628212|615858891|FG000|Overall Study|Adverse Event|2|||
170414723|NCT00628212|615858892|FG001|Overall Study|Adverse Event|0|||
170414724|NCT00628212|615858893|FG002|Overall Study|Adverse Event|1|||
170414725|NCT00628212|615858894|FG003|Overall Study|Adverse Event|2|||
170414726|NCT00628212|615858891|FG000|Overall Study|Physician Decision|1|||
170414727|NCT00628212|615858892|FG001|Overall Study|Physician Decision|1|||
170414728|NCT00628212|615858893|FG002|Overall Study|Physician Decision|2|||
170414729|NCT00628212|615858894|FG003|Overall Study|Physician Decision|3|||
170414730|NCT02482571|615858895|FG000|Overall Study|Adverse Event|1|||
170414731|NCT02482571|615858895|FG000|Overall Study|Scanner or Respiract failure|3|||
170414732|NCT02482571|615858895|FG000|Overall Study|Withdrawal by Subject|4|||
170414733|NCT00753714|615858896|FG000|Overall Study|Lack of Efficacy|21|||
170414734|NCT00753714|615858897|FG001|Overall Study|Lack of Efficacy|34|||
170414735|NCT00753714|615858896|FG000|Overall Study|Adverse Event|26|||
170414736|NCT00753714|615858897|FG001|Overall Study|Adverse Event|18|||
170414737|NCT00753714|615858896|FG000|Overall Study|Protocol Violation|1|||
170414738|NCT00753714|615858897|FG001|Overall Study|Protocol Violation|0|||
170414739|NCT00753714|615858896|FG000|Overall Study|Lost to Follow-up|0|||
170414740|NCT00753714|615858897|FG001|Overall Study|Lost to Follow-up|1|||
170414741|NCT00753714|615858896|FG000|Overall Study|Withdrawal by Subject|2|||
170414742|NCT00753714|615858897|FG001|Overall Study|Withdrawal by Subject|1|||
170414743|NCT00753714|615858896|FG000|Overall Study|Death|3|||
170414744|NCT00753714|615858897|FG001|Overall Study|Death|3|||
170414745|NCT00753714|615858896|FG000|Overall Study|Other|7|||
170414746|NCT00753714|615858897|FG001|Overall Study|Other|5|||
170414747|NCT04000009|615858898|FG000|Overall Study|Adverse Event|13|||
170414748|NCT04000009|615858898|FG000|Overall Study|Lack of Efficacy|7|||
170414749|NCT04000009|615858898|FG000|Overall Study|Lost to Follow-up|8|||
170414750|NCT04000009|615858898|FG000|Overall Study|Noncompliance with study drug|4|||
170414751|NCT04000009|615858898|FG000|Overall Study|Physician Decision|1|||
170414752|NCT04000009|615858898|FG000|Overall Study|Use of prohibited medication|3|||
170414753|NCT04000009|615858898|FG000|Overall Study|Pregnancy|1|||
170414754|NCT04000009|615858898|FG000|Overall Study|Withdrawal by Subject|22|||
170414755|NCT04000009|615858898|FG000|Overall Study|Study terminated by sponsor|98|||
170414756|NCT04000009|615858898|FG000|Overall Study|Not further specified|8|||
170414757|NCT01754259|615858900|FG000|Overall Study|Withdrawal by Subject|2|||
170414758|NCT01754259|615858901|FG001|Overall Study|Withdrawal by Subject|4|||
170414759|NCT01754259|615858900|FG000|Overall Study|Adverse Event|3|||
170414760|NCT01754259|615858901|FG001|Overall Study|Adverse Event|1|||
170414761|NCT01754259|615858900|FG000|Overall Study|Lost to Follow-up|0|||
170414762|NCT01754259|615858901|FG001|Overall Study|Lost to Follow-up|1|||
170414763|NCT00673790|615858902|FG000|Overall Study|Adverse Event|23|||
170414764|NCT00673790|615858903|FG001|Overall Study|Adverse Event|14|||
170414765|NCT00673790|615858904|FG002|Overall Study|Adverse Event|2|||
170414766|NCT00673790|615858902|FG000|Overall Study|Lack of Efficacy|2|||
170414767|NCT00673790|615858903|FG001|Overall Study|Lack of Efficacy|2|||
170414768|NCT00673790|615858904|FG002|Overall Study|Lack of Efficacy|2|||
170414769|NCT00673790|615858902|FG000|Overall Study|Protocol Violation|6|||
170414770|NCT00673790|615858903|FG001|Overall Study|Protocol Violation|9|||
170414771|NCT00673790|615858904|FG002|Overall Study|Protocol Violation|1|||
170414772|NCT00673790|615858902|FG000|Overall Study|Withdrawal by Subject|7|||
170414773|NCT00673790|615858903|FG001|Overall Study|Withdrawal by Subject|4|||
170414774|NCT00673790|615858904|FG002|Overall Study|Withdrawal by Subject|1|||
170414775|NCT00673790|615858902|FG000|Overall Study|Lost to Follow-up|6|||
170414776|NCT00673790|615858903|FG001|Overall Study|Lost to Follow-up|6|||
170414777|NCT00673790|615858904|FG002|Overall Study|Lost to Follow-up|5|||
170414778|NCT00673790|615858902|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
170414779|NCT00673790|615858903|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
170414780|NCT00673790|615858904|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
170414781|NCT00673790|615858902|FG000|Overall Study|Poor compliance|1|||
170414782|NCT00673790|615858903|FG001|Overall Study|Poor compliance|0|||
170414783|NCT00673790|615858904|FG002|Overall Study|Poor compliance|0|||
170414784|NCT00673790|615858902|FG000|Overall Study|Participated in two Nebivolol studies|0|||
170414785|NCT00673790|615858903|FG001|Overall Study|Participated in two Nebivolol studies|0|||
170414786|NCT00673790|615858904|FG002|Overall Study|Participated in two Nebivolol studies|1|||
170414787|NCT00673790|615858902|FG000|Overall Study|Unconfirmed pregnancy|0|||
170414788|NCT00673790|615858903|FG001|Overall Study|Unconfirmed pregnancy|1|||
170414789|NCT00673790|615858904|FG002|Overall Study|Unconfirmed pregnancy|0|||
170414790|NCT00673790|615858902|FG000|Overall Study|Randomization criteria not met|0|||
170414791|NCT00673790|615858903|FG001|Overall Study|Randomization criteria not met|1|||
170414792|NCT00673790|615858904|FG002|Overall Study|Randomization criteria not met|0|||
170632224|NCT03995368|616664559|FG000|Overall Study|Did not meet inclusion criteria|1|||
170632225|NCT03995368|616664560|FG001|Overall Study|Did not meet inclusion criteria|6|||
170632226|NCT03995368|616664561|FG002|Overall Study|Did not meet inclusion criteria|3|||
170632227|NCT03995368|616664559|FG000|Overall Study|Withdrawal by Subject|0|||
170632228|NCT03995368|616664560|FG001|Overall Study|Withdrawal by Subject|1|||
170632229|NCT03995368|616664561|FG002|Overall Study|Withdrawal by Subject|1|||
170632230|NCT04825678|616664565|FG000|Overall Study|Decision by Sponsor|2|||
170414801|NCT04471428|615858907|FG000|Overall Study|Withdrawal by Subject|29|||
170414802|NCT04471428|615858908|FG001|Overall Study|Withdrawal by Subject|4|||
170414803|NCT04471428|615858907|FG000|Overall Study|Physician Decision|0|||
170414804|NCT04471428|615858908|FG001|Overall Study|Physician Decision|1|||
170414805|NCT04471428|615858907|FG000|Overall Study|Reason Not Specified|0|||
170414806|NCT04471428|615858908|FG001|Overall Study|Reason Not Specified|2|||
170414807|NCT04471428|615858907|FG000|Overall Study|Death|131|||
170414808|NCT04471428|615858908|FG001|Overall Study|Death|147|||
170414809|NCT04471428|615858907|FG000|Overall Study|Lost to Follow-up|0|||
170414810|NCT04471428|615858908|FG001|Overall Study|Lost to Follow-up|3|||
170414811|NCT04471428|615858907|FG000|Overall Study|Study Terminated by Sponsor|20|||
170414812|NCT04471428|615858908|FG001|Overall Study|Study Terminated by Sponsor|29|||
170414813|NCT03290079|615858909|FG000|Overall Study|Death|2|||
170414814|NCT03828461|615858910|FG000|Overall Study|Lost to Follow-up|1|||
170414815|NCT03828461|615858910|FG000|Overall Study|Withdrawal by Subject|3|||
170414816|NCT01565083|615858914|FG000|Overall Study|Withdrawal by Subject|6|||
170414817|NCT01565083|615858915|FG001|Overall Study|Withdrawal by Subject|4|||
170414818|NCT01565083|615858914|FG000|Overall Study|Lost to Follow-up|2|||
170414819|NCT01565083|615858915|FG001|Overall Study|Lost to Follow-up|7|||
170414820|NCT01565083|615858914|FG000|Overall Study|Death|22|||
170414821|NCT01565083|615858915|FG001|Overall Study|Death|23|||
170414822|NCT01565083|615858914|FG000|Overall Study|Other|3|||
170414823|NCT01565083|615858915|FG001|Overall Study|Other|5|||
170414824|NCT01960816|615858916|FG000|Overall Study|Lost to Follow-up|1|||
170414825|NCT01309919|615858934|FG000|Overall Study|Did not receive a postpartum IUD|17|||
170414826|NCT01309919|615858935|FG001|Overall Study|Did not receive a postpartum IUD|48|||
170414827|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
170414828|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
170414829|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
170414830|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
170414831|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
170414832|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
170414833|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
170414834|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
170414835|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
170414836|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
170414837|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
170414838|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
170414839|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
170414840|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
170414841|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
170414842|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
170414843|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
170414844|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
170414845|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
170414846|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
170414847|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
170414848|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
170414849|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
170414850|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
170414851|NCT00455533|615858936|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
170414852|NCT00455533|615858937|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
170414853|NCT00455533|615858938|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
170414854|NCT00455533|615858936|FG000|Period Two: Randomized Period|Death|0|||
170414855|NCT00455533|615858937|FG001|Period Two: Randomized Period|Death|0|||
170414856|NCT00455533|615858938|FG002|Period Two: Randomized Period|Death|3|||
170414857|NCT00455533|615858936|FG000|Period Two: Randomized Period|Disease Progression|0|||
170414858|NCT00455533|615858937|FG001|Period Two: Randomized Period|Disease Progression|1|||
170414859|NCT00455533|615858938|FG002|Period Two: Randomized Period|Disease Progression|1|||
170414860|NCT00455533|615858936|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
170414861|NCT00455533|615858937|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
170414862|NCT00455533|615858938|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
170414863|NCT00455533|615858936|FG000|Period Two: Randomized Period|Other - need reasons|0|||
170414864|NCT00455533|615858937|FG001|Period Two: Randomized Period|Other - need reasons|1|||
170414865|NCT00455533|615858938|FG002|Period Two: Randomized Period|Other - need reasons|0|||
170414866|NCT00455533|615858936|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
170414867|NCT00455533|615858937|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
170414868|NCT00455533|615858938|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
170632231|NCT04825678|616664566|FG001|Overall Study|Decision by Sponsor|3|||
170632232|NCT04825678|616664565|FG000|Overall Study|Withdrawal of Consent From Study|7|||
170632233|NCT04825678|616664566|FG001|Overall Study|Withdrawal of Consent From Study|9|||
170632234|NCT04825678|616664565|FG000|Overall Study|Lost to Follow-up|3|||
170632235|NCT04825678|616664566|FG001|Overall Study|Lost to Follow-up|4|||
170632236|NCT04825678|616664565|FG000|Overall Study|Never Received Investigational Product|1|||
170632237|NCT04825678|616664566|FG001|Overall Study|Never Received Investigational Product|1|||
170632238|NCT02594124|616664569|FG000|Overall Study|Adverse Event|0|||
170632239|NCT02594124|616664570|FG001|Overall Study|Adverse Event|5|||
170526016|NCT03167242|616274096|FG004|Overall Study|Reason not provided|0|||
170526017|NCT03167242|616274097|FG005|Overall Study|Reason not provided|0|||
170526018|NCT03167242|616274098|FG006|Overall Study|Reason not provided|0|||
170526019|NCT03167242|616274099|FG007|Overall Study|Reason not provided|0|||
170526020|NCT03167242|616274100|FG008|Overall Study|Reason not provided|1|||
170526021|NCT03167242|616274101|FG009|Overall Study|Reason not provided|0|||
170526022|NCT03167242|616274102|FG010|Overall Study|Reason not provided|0|||
170526023|NCT03167242|616274103|FG011|Overall Study|Reason not provided|0|||
170526024|NCT03444584|616274104|FG000|Overall Study|Withdrawal by Subject|0|||
170526025|NCT03444584|616274105|FG001|Overall Study|Withdrawal by Subject|1|||
170526026|NCT03444584|616274104|FG000|Overall Study|Other|0|||
170526027|NCT03444584|616274105|FG001|Overall Study|Other|1|||
170526028|NCT03786380|616274106|FG000|Overall Study|Adverse Event|1|||
170526029|NCT03786380|616274107|FG001|Overall Study|Adverse Event|0|||
170526030|NCT03786380|616274108|FG002|Overall Study|Adverse Event|0|||
170526031|NCT03786380|616274109|FG003|Overall Study|Adverse Event|3|||
170526032|NCT03786380|616274110|FG004|Overall Study|Adverse Event|1|||
170526033|NCT03786380|616274106|FG000|Overall Study|Lack of Efficacy|0|||
170526034|NCT03786380|616274107|FG001|Overall Study|Lack of Efficacy|0|||
170526035|NCT03786380|616274108|FG002|Overall Study|Lack of Efficacy|0|||
170526036|NCT03786380|616274109|FG003|Overall Study|Lack of Efficacy|0|||
170526037|NCT03786380|616274110|FG004|Overall Study|Lack of Efficacy|1|||
170526038|NCT03786380|616274106|FG000|Overall Study|Withdrawal by Subject|1|||
170526039|NCT03786380|616274107|FG001|Overall Study|Withdrawal by Subject|2|||
170526040|NCT03786380|616274108|FG002|Overall Study|Withdrawal by Subject|2|||
170526041|NCT03786380|616274109|FG003|Overall Study|Withdrawal by Subject|1|||
170526042|NCT03786380|616274110|FG004|Overall Study|Withdrawal by Subject|2|||
170526043|NCT03786380|616274106|FG000|Overall Study|Lost to Follow-up|3|||
170526044|NCT03786380|616274107|FG001|Overall Study|Lost to Follow-up|0|||
170526045|NCT03786380|616274108|FG002|Overall Study|Lost to Follow-up|1|||
170526046|NCT03786380|616274109|FG003|Overall Study|Lost to Follow-up|2|||
170526047|NCT03786380|616274110|FG004|Overall Study|Lost to Follow-up|0|||
170526048|NCT03786380|616274106|FG000|Overall Study|Physician Decision|0|||
170526049|NCT03786380|616274107|FG001|Overall Study|Physician Decision|0|||
170526050|NCT03786380|616274108|FG002|Overall Study|Physician Decision|1|||
170526051|NCT03786380|616274109|FG003|Overall Study|Physician Decision|0|||
170526052|NCT03786380|616274110|FG004|Overall Study|Physician Decision|0|||
170526053|NCT03786380|616274106|FG000|Overall Study|Study Terminated by the Sponsor|30|||
170526054|NCT03786380|616274107|FG001|Overall Study|Study Terminated by the Sponsor|20|||
170526055|NCT03786380|616274108|FG002|Overall Study|Study Terminated by the Sponsor|50|||
170872779|NCT01462435|617546436|FG001|Overall Study|Lack of Efficacy|0|||
170872780|NCT01462435|617546437|FG002|Overall Study|Lack of Efficacy|0|||
170872781|NCT01462435|617546438|FG003|Overall Study|Lack of Efficacy|3|||
170872782|NCT01462435|617546435|FG000|Overall Study|Physician Decision|0|||
170872783|NCT01462435|617546436|FG001|Overall Study|Physician Decision|0|||
170872784|NCT01462435|617546437|FG002|Overall Study|Physician Decision|1|||
170872785|NCT01462435|617546438|FG003|Overall Study|Physician Decision|0|||
170872786|NCT01462435|617546435|FG000|Overall Study|Withdrawal by Subject|0|||
170872787|NCT01462435|617546436|FG001|Overall Study|Withdrawal by Subject|0|||
170872788|NCT01462435|617546437|FG002|Overall Study|Withdrawal by Subject|0|||
170872789|NCT01462435|617546438|FG003|Overall Study|Withdrawal by Subject|1|||
170872790|NCT01462435|617546435|FG000|Overall Study|Lost to Follow-up|0|||
170872791|NCT01462435|617546436|FG001|Overall Study|Lost to Follow-up|0|||
170872792|NCT01462435|617546437|FG002|Overall Study|Lost to Follow-up|0|||
170872793|NCT01462435|617546438|FG003|Overall Study|Lost to Follow-up|1|||
170872794|NCT00096785|617546443|FG000|Overall Study|Lost to Follow-up|1|||
170872795|NCT00096785|617546444|FG001|Overall Study|Lost to Follow-up|0|||
170872796|NCT00096785|617546443|FG000|Overall Study|Withdrawal by Subject|0|||
170872797|NCT00096785|617546444|FG001|Overall Study|Withdrawal by Subject|1|||
170872798|NCT00096785|617546443|FG000|Overall Study|Relocated|1|||
170872799|NCT00096785|617546444|FG001|Overall Study|Relocated|0|||
170872800|NCT00257725|617546445|FG000|Overall Study|Adverse Event|3|||
170872801|NCT00514514|617546446|FG000|Pre-phase|Death|10|||
170872802|NCT00514514|617546447|FG001|Pre-phase|Death|0|||
170526056|NCT03786380|616274109|FG003|Overall Study|Study Terminated by the Sponsor|57|||
170526057|NCT03786380|616274110|FG004|Overall Study|Study Terminated by the Sponsor|23|||
170872803|NCT00514514|617546448|FG002|Pre-phase|Death|0|||
170872804|NCT00514514|617546446|FG000|Pre-phase|administrative problems|2|||
170872805|NCT00514514|617546447|FG001|Pre-phase|administrative problems|0|||
170872806|NCT00514514|617546448|FG002|Pre-phase|administrative problems|0|||
170526058|NCT03786380|616274106|FG000|Overall Study|Reason Not Specified|0|||
170526059|NCT03786380|616274107|FG001|Overall Study|Reason Not Specified|0|||
170526060|NCT03786380|616274108|FG002|Overall Study|Reason Not Specified|0|||
170526061|NCT03786380|616274109|FG003|Overall Study|Reason Not Specified|0|||
170526062|NCT03786380|616274110|FG004|Overall Study|Reason Not Specified|1|||
170526063|NCT03327324|616274111|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526064|NCT03327324|616274112|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
170872807|NCT00514514|617546446|FG000|Pre-phase|Protocol Violation|6|||
170632240|NCT02594124|616664571|FG002|Overall Study|Adverse Event|8|||
170632241|NCT02594124|616664572|FG003|Overall Study|Adverse Event|1|||
170632242|NCT02594124|616664573|FG004|Overall Study|Adverse Event|0|||
170632243|NCT02594124|616664574|FG005|Overall Study|Adverse Event|0|||
170632244|NCT02594124|616664575|FG006|Overall Study|Adverse Event|2|||
170632245|NCT02594124|616664576|FG007|Overall Study|Adverse Event|2|||
170632246|NCT02594124|616664577|FG008|Overall Study|Adverse Event|0|||
170632247|NCT02594124|616664569|FG000|Overall Study|Withdrawal by Subject|2|||
170632248|NCT02594124|616664570|FG001|Overall Study|Withdrawal by Subject|3|||
170632249|NCT02594124|616664571|FG002|Overall Study|Withdrawal by Subject|5|||
170632250|NCT02594124|616664572|FG003|Overall Study|Withdrawal by Subject|1|||
170632251|NCT02594124|616664573|FG004|Overall Study|Withdrawal by Subject|8|||
170632252|NCT02594124|616664574|FG005|Overall Study|Withdrawal by Subject|4|||
170632253|NCT02594124|616664575|FG006|Overall Study|Withdrawal by Subject|13|||
170632254|NCT02594124|616664576|FG007|Overall Study|Withdrawal by Subject|19|||
170632255|NCT02594124|616664577|FG008|Overall Study|Withdrawal by Subject|0|||
170632256|NCT02594124|616664569|FG000|Overall Study|Physician Decision|0|||
170632257|NCT02594124|616664570|FG001|Overall Study|Physician Decision|2|||
170632258|NCT02594124|616664571|FG002|Overall Study|Physician Decision|0|||
170632259|NCT02594124|616664572|FG003|Overall Study|Physician Decision|0|||
170632260|NCT02594124|616664573|FG004|Overall Study|Physician Decision|0|||
170632261|NCT02594124|616664574|FG005|Overall Study|Physician Decision|0|||
170632262|NCT02594124|616664575|FG006|Overall Study|Physician Decision|0|||
170632263|NCT02594124|616664576|FG007|Overall Study|Physician Decision|1|||
170632264|NCT02594124|616664577|FG008|Overall Study|Physician Decision|0|||
170632265|NCT02594124|616664569|FG000|Overall Study|Commercial drug|0|||
170632266|NCT02594124|616664570|FG001|Overall Study|Commercial drug|1|||
170632267|NCT02594124|616664571|FG002|Overall Study|Commercial drug|6|||
170632268|NCT02594124|616664572|FG003|Overall Study|Commercial drug|3|||
170632269|NCT02594124|616664573|FG004|Overall Study|Commercial drug|0|||
170632270|NCT02594124|616664574|FG005|Overall Study|Commercial drug|0|||
170632271|NCT02594124|616664575|FG006|Overall Study|Commercial drug|7|||
170632272|NCT02594124|616664576|FG007|Overall Study|Commercial drug|11|||
170632273|NCT02594124|616664577|FG008|Overall Study|Commercial drug|2|||
170632274|NCT02594124|616664569|FG000|Overall Study|Reason Not Specified|1|||
170632275|NCT02594124|616664570|FG001|Overall Study|Reason Not Specified|3|||
170632276|NCT02594124|616664571|FG002|Overall Study|Reason Not Specified|4|||
170632277|NCT02594124|616664572|FG003|Overall Study|Reason Not Specified|0|||
170632278|NCT02594124|616664573|FG004|Overall Study|Reason Not Specified|0|||
170632279|NCT02594124|616664574|FG005|Overall Study|Reason Not Specified|1|||
170632280|NCT02594124|616664575|FG006|Overall Study|Reason Not Specified|1|||
170632281|NCT02594124|616664576|FG007|Overall Study|Reason Not Specified|6|||
170632282|NCT02594124|616664577|FG008|Overall Study|Reason Not Specified|1|||
170632283|NCT02202759|616666589|FG000|Overall Study|Study Terminated by Sponsor|3|||
170632284|NCT02202759|616666590|FG001|Overall Study|Study Terminated by Sponsor|3|||
170632285|NCT02202759|616666591|FG002|Overall Study|Study Terminated by Sponsor|3|||
170632286|NCT02202759|616666589|FG000|Overall Study|Withdrawal by Subject|2|||
170632287|NCT02202759|616666590|FG001|Overall Study|Withdrawal by Subject|1|||
170632288|NCT02202759|616666591|FG002|Overall Study|Withdrawal by Subject|1|||
170632289|NCT02202759|616666589|FG000|Overall Study|Reason not Specified|4|||
170632290|NCT02202759|616666590|FG001|Overall Study|Reason not Specified|11|||
170632291|NCT02202759|616666591|FG002|Overall Study|Reason not Specified|10|||
170632292|NCT04953728|616666592|FG000|Overall Study|Withdrawal by Subject|3|||
170632293|NCT04953728|616666592|FG000|Overall Study|Physician Decision|1|||
170632294|NCT01772316|616666596|FG000|Overall Study|Serious adverse event|1|||
170632295|NCT01772316|616666596|FG000|Overall Study|Inform consent withdrawn|1|||
170632296|NCT01772316|616666596|FG000|Overall Study|Withdrawn by sponsor decision|5|||
170632297|NCT03349034|616666597|FG000|Overall Study|catheters dislodged during transport|2|||
170632298|NCT03349034|616666598|FG001|Overall Study|catheters dislodged during transport|0|||
170632299|NCT03349034|616666597|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
170872808|NCT00514514|617546447|FG001|Pre-phase|Protocol Violation|0|||
170632300|NCT03349034|616666598|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
170632301|NCT03349034|616666597|FG000|Overall Study|soft tissue flap used|1|||
170632302|NCT03349034|616666598|FG001|Overall Study|soft tissue flap used|0|||
170632303|NCT03349034|616666597|FG000|Overall Study|Other|0|||
170632304|NCT03349034|616666598|FG001|Overall Study|Other|1|||
170872809|NCT00514514|617546448|FG002|Pre-phase|Protocol Violation|0|||
170632305|NCT02453321|616666599|FG000|Overall Study|Weakness|1|||
170632306|NCT02453321|616666600|FG001|Overall Study|Weakness|1|||
170632307|NCT02453321|616666601|FG002|Overall Study|Weakness|2|||
170632308|NCT02453321|616666599|FG000|Overall Study|Deep Venous Thrombosis|0|||
170632309|NCT02453321|616666600|FG001|Overall Study|Deep Venous Thrombosis|1|||
170632310|NCT02453321|616666601|FG002|Overall Study|Deep Venous Thrombosis|0|||
170632311|NCT01244893|616666602|FG000|Baseline|Protocol Violation|0|||
170632312|NCT01244893|616666603|FG001|Baseline|Protocol Violation|1|||
170632313|NCT01244893|616666602|FG000|1-Week Follow Up|Lost to Follow-up|1|||
170632314|NCT01244893|616666603|FG001|1-Week Follow Up|Lost to Follow-up|0|||
170632315|NCT04555616|616666604|FG000|Overall Study|Death|1|||
170632316|NCT04555616|616666605|FG001|Overall Study|Death|0|||
170632317|NCT04555616|616666606|FG002|Overall Study|Death|1|||
170632318|NCT04555616|616666604|FG000|Overall Study|Withdrawal by Subject|2|||
170632319|NCT04555616|616666605|FG001|Overall Study|Withdrawal by Subject|1|||
170632320|NCT04555616|616666606|FG002|Overall Study|Withdrawal by Subject|0|||
170632321|NCT01002339|616666609|FG000|Overall Study|Withdrawal by Subject|0|||
170632322|NCT01002339|616666610|FG001|Overall Study|Withdrawal by Subject|1|||
170632323|NCT01002339|616666611|FG002|Overall Study|Withdrawal by Subject|0|||
170632324|NCT01002339|616666609|FG000|Overall Study|Incorrect treatment assignment|0|||
170632325|NCT01002339|616666610|FG001|Overall Study|Incorrect treatment assignment|0|||
170632326|NCT01002339|616666611|FG002|Overall Study|Incorrect treatment assignment|1|||
170632327|NCT01002339|616666609|FG000|Overall Study|Protocol Violation|0|||
170632328|NCT01002339|616666610|FG001|Overall Study|Protocol Violation|0|||
170632329|NCT01002339|616666611|FG002|Overall Study|Protocol Violation|2|||
170632330|NCT01002339|616666609|FG000|Overall Study|Lung cancer detected before transplant|0|||
170632331|NCT01002339|616666610|FG001|Overall Study|Lung cancer detected before transplant|0|||
170632332|NCT01002339|616666611|FG002|Overall Study|Lung cancer detected before transplant|1|||
170632333|NCT01002339|616666609|FG000|Overall Study|Randomized. Not transplanted|0|||
170632334|NCT01002339|616666610|FG001|Overall Study|Randomized. Not transplanted|0|||
170632335|NCT01002339|616666611|FG002|Overall Study|Randomized. Not transplanted|1|||
170632336|NCT02215252|616666612|FG000|Overall Study|Adverse Event|1|||
170632337|NCT02215252|616666613|FG001|Overall Study|Adverse Event|5|||
170632338|NCT02215252|616666614|FG002|Overall Study|Adverse Event|2|||
170632339|NCT02215252|616666612|FG000|Overall Study|Lost to Follow-up|0|||
170632340|NCT02215252|616666613|FG001|Overall Study|Lost to Follow-up|0|||
170632341|NCT02215252|616666614|FG002|Overall Study|Lost to Follow-up|1|||
170632342|NCT02215252|616666612|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
170632343|NCT02215252|616666613|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
170632344|NCT02215252|616666614|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
170632345|NCT02215252|616666612|FG000|Overall Study|Protocol Violation|0|||
170632346|NCT02215252|616666613|FG001|Overall Study|Protocol Violation|1|||
170632347|NCT02215252|616666614|FG002|Overall Study|Protocol Violation|0|||
170632348|NCT02215252|616666612|FG000|Overall Study|Withdrawal by Subject|1|||
170632349|NCT02215252|616666613|FG001|Overall Study|Withdrawal by Subject|0|||
170632350|NCT02215252|616666614|FG002|Overall Study|Withdrawal by Subject|0|||
170632351|NCT02215252|616666612|FG000|Overall Study|Other|0|||
170632352|NCT02215252|616666613|FG001|Overall Study|Other|1|||
170632353|NCT02215252|616666614|FG002|Overall Study|Other|1|||
170632354|NCT00892099|616666615|FG000|Overall Study|Death|1|||
170632355|NCT00892099|616666616|FG001|Overall Study|Death|0|||
170632356|NCT00892099|616666617|FG002|Overall Study|Death|1|||
170632357|NCT00892099|616666615|FG000|Overall Study|Adverse Event|1|||
170632358|NCT00892099|616666616|FG001|Overall Study|Adverse Event|0|||
170632359|NCT00892099|616666617|FG002|Overall Study|Adverse Event|0|||
170632360|NCT00892099|616666615|FG000|Overall Study|replocated|1|||
170632361|NCT00892099|616666616|FG001|Overall Study|replocated|0|||
170632362|NCT00892099|616666617|FG002|Overall Study|replocated|2|||
170632363|NCT00892099|616666615|FG000|Overall Study|Prolonged hospitalization|1|||
170632364|NCT00892099|616666616|FG001|Overall Study|Prolonged hospitalization|0|||
170632365|NCT00892099|616666617|FG002|Overall Study|Prolonged hospitalization|1|||
170632366|NCT00892099|616666615|FG000|Overall Study|no further details|1|||
170632367|NCT00892099|616666616|FG001|Overall Study|no further details|0|||
170632368|NCT00892099|616666617|FG002|Overall Study|no further details|1|||
170632369|NCT00892099|616666615|FG000|Overall Study|kidney function recovered|0|||
170632370|NCT00892099|616666616|FG001|Overall Study|kidney function recovered|1|||
170632371|NCT00892099|616666617|FG002|Overall Study|kidney function recovered|0|||
170632372|NCT00892099|616666615|FG000|Overall Study|investigator decision|0|||
170632373|NCT00892099|616666616|FG001|Overall Study|investigator decision|0|||
170632374|NCT00892099|616666617|FG002|Overall Study|investigator decision|1|||
170632375|NCT00892099|616666615|FG000|Overall Study|Lost to Follow-up|0|||
170414869|NCT00455533|615858936|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
170632376|NCT00892099|616666616|FG001|Overall Study|Lost to Follow-up|0|||
170632377|NCT00892099|616666617|FG002|Overall Study|Lost to Follow-up|1|||
170632378|NCT02796170|616666618|FG000|Overall Study|Lost to Follow-up|3|||
170632379|NCT02796170|616666619|FG001|Overall Study|Lost to Follow-up|0|||
170632380|NCT00665652|616666623|FG000|Overall Study|Adverse Event|4|||
170632381|NCT00665652|616666623|FG000|Overall Study|Death|1|||
170632382|NCT00665652|616666623|FG000|Overall Study|No longer met inclusion criteria.|1|||
170632383|NCT00930046|616666624|FG000|Overall Study|Wound catheter malfunctioned|1|||
170632384|NCT00930046|616666625|FG001|Overall Study|Wound catheter malfunctioned|2|||
170632385|NCT01055197|616666632|FG000|Overall Study|Protocol Violation|7|||
170632386|NCT01055197|616666633|FG001|Overall Study|Protocol Violation|2|||
170632387|NCT01055197|616666632|FG000|Overall Study|Withdrawal by Subject|2|||
170632388|NCT01055197|616666633|FG001|Overall Study|Withdrawal by Subject|0|||
170632389|NCT01454102|616666634|FG000|Overall Study|Continuing in the treatment period|0|||
170632390|NCT01454102|616666635|FG001|Overall Study|Continuing in the treatment period|0|||
170632391|NCT01454102|616666636|FG002|Overall Study|Continuing in the treatment period|0|||
170632392|NCT01454102|616666637|FG003|Overall Study|Continuing in the treatment period|0|||
170632393|NCT01454102|616666638|FG004|Overall Study|Continuing in the treatment period|3|||
170632394|NCT01454102|616666639|FG005|Overall Study|Continuing in the treatment period|3|||
170632395|NCT01454102|616666640|FG006|Overall Study|Continuing in the treatment period|2|||
170632396|NCT01454102|616666641|FG007|Overall Study|Continuing in the treatment period|0|||
170632397|NCT01454102|616666642|FG008|Overall Study|Continuing in the treatment period|1|||
170632398|NCT01454102|616666643|FG009|Overall Study|Continuing in the treatment period|0|||
170632399|NCT01454102|616666644|FG010|Overall Study|Continuing in the treatment period|0|||
170632400|NCT01454102|616666645|FG011|Overall Study|Continuing in the treatment period|4|||
170632401|NCT01454102|616666646|FG012|Overall Study|Continuing in the treatment period|7|||
170632402|NCT01454102|616666647|FG013|Overall Study|Continuing in the treatment period|4|||
170632403|NCT01454102|616666648|FG014|Overall Study|Continuing in the treatment period|3|||
170632404|NCT01454102|616666649|FG015|Overall Study|Continuing in the treatment period|1|||
170632405|NCT03131570|616666650|FG000|Overall Study|Adverse Event|1|||
170632406|NCT03131570|616666651|FG001|Overall Study|Adverse Event|0|||
170632407|NCT01782378|616666654|FG000|First Series|Lost to Follow-up|7|||
170632408|NCT01782378|616666655|FG001|First Series|Lost to Follow-up|8|||
170632409|NCT01782378|616666654|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
170632410|NCT01782378|616666655|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
170632411|NCT01782378|616666654|FG000|Second Series|Lost to Follow-up|8|||
170632412|NCT01782378|616666655|FG001|Second Series|Lost to Follow-up|7|||
170632413|NCT01782378|616666654|FG000|Second Series|Did not choose to complete S2 Optional|18|||
170632414|NCT01782378|616666655|FG001|Second Series|Did not choose to complete S2 Optional|0|||
170632415|NCT00705016|616666656|FG000|Overall Study|Adverse Event|6|||
170632416|NCT00705016|616666657|FG001|Overall Study|Adverse Event|11|||
170632417|NCT00705016|616666658|FG002|Overall Study|Adverse Event|10|||
170632418|NCT00705016|616666656|FG000|Overall Study|Death|5|||
170632419|NCT00705016|616666657|FG001|Overall Study|Death|7|||
170632420|NCT00705016|616666658|FG002|Overall Study|Death|5|||
170632421|NCT00705016|616666656|FG000|Overall Study|Protocol Violation|0|||
170632422|NCT00705016|616666657|FG001|Overall Study|Protocol Violation|1|||
170632423|NCT00705016|616666658|FG002|Overall Study|Protocol Violation|1|||
170632424|NCT00705016|616666656|FG000|Overall Study|Withdrawal by Subject|4|||
170632425|NCT00705016|616666657|FG001|Overall Study|Withdrawal by Subject|3|||
170632426|NCT00705016|616666658|FG002|Overall Study|Withdrawal by Subject|2|||
170632427|NCT00705016|616666656|FG000|Overall Study|Progressive Disease|33|||
170632428|NCT00705016|616666657|FG001|Overall Study|Progressive Disease|29|||
170632429|NCT00705016|616666658|FG002|Overall Study|Progressive Disease|33|||
170632430|NCT00705016|616666656|FG000|Overall Study|Symptomatic Deterioration|3|||
170632431|NCT00705016|616666657|FG001|Overall Study|Symptomatic Deterioration|1|||
170632432|NCT00705016|616666658|FG002|Overall Study|Symptomatic Deterioration|1|||
170632433|NCT00705016|616666656|FG000|Overall Study|Other|9|||
170632434|NCT00705016|616666657|FG001|Overall Study|Other|6|||
170632435|NCT00705016|616666658|FG002|Overall Study|Other|6|||
170632436|NCT00071058|616666659|FG000|Overall Study|brain tumor-removed from study|1|||
170632437|NCT00942604|616666662|FG000|Overall Study|Protocol Violation|1|||
170632438|NCT00942604|616666663|FG001|Overall Study|Protocol Violation|1|||
170632439|NCT00942604|616666662|FG000|Overall Study|Adverse Event|0|||
170632440|NCT00942604|616666663|FG001|Overall Study|Adverse Event|1|||
170632441|NCT00942604|616666662|FG000|Overall Study|Withdrawal by Subject|0|||
170632442|NCT00942604|616666663|FG001|Overall Study|Withdrawal by Subject|1|||
170632443|NCT00942604|616666662|FG000|Overall Study|Patient relocation|1|||
170632444|NCT00942604|616666663|FG001|Overall Study|Patient relocation|1|||
170632445|NCT03592186|616666666|FG000|Overall Study|Withdrawal by Subject|1|||
170632446|NCT03592186|616666667|FG001|Overall Study|Withdrawal by Subject|0|||
170632447|NCT03592186|616666666|FG000|Overall Study|Lost to Follow-up|16|||
170632448|NCT03592186|616666667|FG001|Overall Study|Lost to Follow-up|11|||
170632449|NCT03755934|616666670|FG000|Overall Study|Adverse Event|4|||
170632450|NCT03755934|616666671|FG001|Overall Study|Adverse Event|1|||
170632451|NCT03755934|616666672|FG002|Overall Study|Adverse Event|1|||
170632452|NCT03755934|616666673|FG003|Overall Study|Adverse Event|3|||
170632453|NCT03755934|616666670|FG000|Overall Study|Physician Decision|2|||
170632454|NCT03755934|616666671|FG001|Overall Study|Physician Decision|0|||
170632455|NCT03755934|616666672|FG002|Overall Study|Physician Decision|0|||
170632456|NCT03755934|616666673|FG003|Overall Study|Physician Decision|1|||
170632457|NCT03755934|616666670|FG000|Overall Study|Withdrawal by Subject|5|||
170632458|NCT03755934|616666671|FG001|Overall Study|Withdrawal by Subject|0|||
170632459|NCT03755934|616666672|FG002|Overall Study|Withdrawal by Subject|0|||
170632460|NCT03755934|616666673|FG003|Overall Study|Withdrawal by Subject|1|||
170632461|NCT03755934|616666670|FG000|Overall Study|Other|3|||
170632462|NCT03755934|616666671|FG001|Overall Study|Other|1|||
170632463|NCT03755934|616666672|FG002|Overall Study|Other|3|||
170632464|NCT03755934|616666673|FG003|Overall Study|Other|1|||
170632465|NCT04634253|616666676|FG000|Overall Study|Adverse Event|1|||
170771586|NCT05001945|617170468|FG003|Overall Study|Lost to Follow-up|2|||
170414870|NCT00455533|615858937|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
170526065|NCT03327324|616274113|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526066|NCT03327324|616274114|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
170526067|NCT03327324|616274115|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526068|NCT03327324|616274116|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
170526069|NCT03327324|616274111|FG000|Baseline (Month 0-Month 3)|Refused|0|||
170526070|NCT03327324|616274112|FG001|Baseline (Month 0-Month 3)|Refused|0|||
170526071|NCT03327324|616274113|FG002|Baseline (Month 0-Month 3)|Refused|0|||
170526072|NCT03327324|616274114|FG003|Baseline (Month 0-Month 3)|Refused|0|||
170526073|NCT03327324|616274115|FG004|Baseline (Month 0-Month 3)|Refused|1|||
170526074|NCT03327324|616274116|FG005|Baseline (Month 0-Month 3)|Refused|0|||
170526075|NCT03327324|616274111|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
170526076|NCT03327324|616274112|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
170526077|NCT03327324|616274113|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
170526078|NCT03327324|616274114|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
170526079|NCT03327324|616274115|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
170526080|NCT03327324|616274116|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
170526081|NCT03327324|616274111|FG000|Baseline (Month 0-Month 3)|Death|0|||
170526082|NCT03327324|616274112|FG001|Baseline (Month 0-Month 3)|Death|0|||
170526083|NCT03327324|616274113|FG002|Baseline (Month 0-Month 3)|Death|0|||
170526084|NCT03327324|616274114|FG003|Baseline (Month 0-Month 3)|Death|0|||
170526085|NCT03327324|616274115|FG004|Baseline (Month 0-Month 3)|Death|1|||
170526086|NCT03327324|616274116|FG005|Baseline (Month 0-Month 3)|Death|0|||
170526087|NCT03327324|616274111|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526088|NCT03327324|616274112|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526089|NCT03327324|616274113|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526090|NCT03327324|616274114|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526091|NCT03327324|616274115|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526092|NCT03327324|616274116|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
170526093|NCT03327324|616274111|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526094|NCT03327324|616274112|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526095|NCT03327324|616274113|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
170526096|NCT03327324|616274114|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526097|NCT03327324|616274115|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526098|NCT03327324|616274116|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526099|NCT03327324|616274111|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
170771587|NCT05001945|617170469|FG004|Overall Study|Lost to Follow-up|0|||
170771588|NCT05001945|617170470|FG005|Overall Study|Lost to Follow-up|1|||
170526100|NCT03327324|616274112|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
170771589|NCT05001945|617170471|FG006|Overall Study|Lost to Follow-up|0|||
170771590|NCT05001945|617170472|FG007|Overall Study|Lost to Follow-up|0|||
170771591|NCT05001945|617170465|FG000|Overall Study|Protocol Violation|1|||
170771592|NCT05001945|617170466|FG001|Overall Study|Protocol Violation|0|||
170771593|NCT05001945|617170467|FG002|Overall Study|Protocol Violation|1|||
170771594|NCT05001945|617170468|FG003|Overall Study|Protocol Violation|1|||
170771595|NCT05001945|617170469|FG004|Overall Study|Protocol Violation|0|||
170771596|NCT05001945|617170470|FG005|Overall Study|Protocol Violation|1|||
170771597|NCT05001945|617170471|FG006|Overall Study|Protocol Violation|0|||
170771598|NCT05001945|617170472|FG007|Overall Study|Protocol Violation|0|||
170771599|NCT05001945|617170465|FG000|Overall Study|Withdrawal by Subject|0|||
170771600|NCT05001945|617170466|FG001|Overall Study|Withdrawal by Subject|0|||
170771601|NCT05001945|617170467|FG002|Overall Study|Withdrawal by Subject|0|||
170771602|NCT05001945|617170468|FG003|Overall Study|Withdrawal by Subject|1|||
170771603|NCT05001945|617170469|FG004|Overall Study|Withdrawal by Subject|1|||
170771604|NCT05001945|617170470|FG005|Overall Study|Withdrawal by Subject|1|||
170771605|NCT05001945|617170471|FG006|Overall Study|Withdrawal by Subject|0|||
170872810|NCT00514514|617546446|FG000|Pre-phase|condition no longer requires study drug|7|||
170526101|NCT03327324|616274113|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
170526102|NCT03327324|616274114|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
170526103|NCT03327324|616274115|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
170526104|NCT03327324|616274116|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
170771606|NCT05001945|617170472|FG007|Overall Study|Withdrawal by Subject|1|||
170771607|NCT05001945|617170465|FG000|Overall Study|Not specified by Investigator|0|||
170771608|NCT05001945|617170466|FG001|Overall Study|Not specified by Investigator|3|||
170771609|NCT05001945|617170467|FG002|Overall Study|Not specified by Investigator|0|||
170771610|NCT05001945|617170468|FG003|Overall Study|Not specified by Investigator|0|||
170771611|NCT05001945|617170469|FG004|Overall Study|Not specified by Investigator|1|||
170771612|NCT05001945|617170470|FG005|Overall Study|Not specified by Investigator|0|||
170771613|NCT05001945|617170471|FG006|Overall Study|Not specified by Investigator|0|||
170771614|NCT05001945|617170472|FG007|Overall Study|Not specified by Investigator|0|||
170771615|NCT02214160|617170481|FG000|Overall Study|Withdrawal by Subject|1|||
170771616|NCT02214160|617170482|FG001|Overall Study|Withdrawal by Subject|0|||
170771617|NCT02214160|617170483|FG002|Overall Study|Withdrawal by Subject|6|||
170771618|NCT02214160|617170481|FG000|Overall Study|Death|2|||
170771619|NCT02214160|617170482|FG001|Overall Study|Death|2|||
170771620|NCT02214160|617170483|FG002|Overall Study|Death|1|||
170771621|NCT02214160|617170481|FG000|Overall Study|Subject Non-Compliance|0|||
170771622|NCT02214160|617170482|FG001|Overall Study|Subject Non-Compliance|3|||
170771623|NCT02214160|617170483|FG002|Overall Study|Subject Non-Compliance|1|||
170771624|NCT02214160|617170481|FG000|Overall Study|Adverse Event|0|||
170771625|NCT02214160|617170482|FG001|Overall Study|Adverse Event|1|||
170771626|NCT02214160|617170483|FG002|Overall Study|Adverse Event|1|||
170771627|NCT02214160|617170481|FG000|Overall Study|Sponsor Decision|0|||
170771628|NCT02214160|617170482|FG001|Overall Study|Sponsor Decision|2|||
170771629|NCT02214160|617170483|FG002|Overall Study|Sponsor Decision|0|||
170771630|NCT02214160|617170481|FG000|Overall Study|Protocol Violation|1|||
170771631|NCT02214160|617170482|FG001|Overall Study|Protocol Violation|0|||
170771632|NCT02214160|617170483|FG002|Overall Study|Protocol Violation|0|||
170771633|NCT02214160|617170481|FG000|Overall Study|Physician Decision|0|||
170771634|NCT02214160|617170482|FG001|Overall Study|Physician Decision|0|||
170771635|NCT02214160|617170483|FG002|Overall Study|Physician Decision|1|||
170771636|NCT03531840|617170488|FG000|Overall Study|Death on study|3|||
170771637|NCT03531840|617170489|FG001|Overall Study|Death on study|2|||
170771638|NCT03531840|617170490|FG002|Overall Study|Death on study|1|||
170771639|NCT03531840|617170491|FG003|Overall Study|Death on study|2|||
170771640|NCT03531840|617170488|FG000|Overall Study|Death during follow up|2|||
170771641|NCT03531840|617170489|FG001|Overall Study|Death during follow up|3|||
170771642|NCT03531840|617170490|FG002|Overall Study|Death during follow up|4|||
170771643|NCT03531840|617170491|FG003|Overall Study|Death during follow up|1|||
170771644|NCT02115139|617170492|FG000|Overall Study|Protocol Violation|1|||
170771645|NCT02115139|617170492|FG000|Overall Study|treatment discontinuation|6|||
170771646|NCT01152190|617170493|FG000|Overall Study|Adverse Event|2|||
170771647|NCT01152190|617170494|FG001|Overall Study|Adverse Event|4|||
170771648|NCT01152190|617170493|FG000|Overall Study|Death|1|||
170771649|NCT01152190|617170494|FG001|Overall Study|Death|0|||
170771650|NCT01152190|617170493|FG000|Overall Study|Protocol Violation|1|||
170771651|NCT01152190|617170494|FG001|Overall Study|Protocol Violation|1|||
170771652|NCT01152190|617170493|FG000|Overall Study|Withdrawal by Subject|1|||
170771653|NCT01152190|617170494|FG001|Overall Study|Withdrawal by Subject|3|||
170771654|NCT00442117|617170495|FG000|Overall Study|Adverse Event|3|||
170771655|NCT00442117|617170496|FG001|Overall Study|Adverse Event|2|||
170771656|NCT00442117|617170495|FG000|Overall Study|Lack of Efficacy|2|||
170771657|NCT00442117|617170496|FG001|Overall Study|Lack of Efficacy|6|||
170771658|NCT00442117|617170495|FG000|Overall Study|Lost to Follow-up|1|||
170771659|NCT00442117|617170496|FG001|Overall Study|Lost to Follow-up|2|||
170771660|NCT00442117|617170495|FG000|Overall Study|Withdrawal by Subject|2|||
170771661|NCT00442117|617170496|FG001|Overall Study|Withdrawal by Subject|2|||
170771662|NCT00442117|617170495|FG000|Overall Study|Major Deviation|25|||
170771663|NCT00442117|617170496|FG001|Overall Study|Major Deviation|20|||
170771664|NCT00442117|617170495|FG000|Overall Study|Non compliance with protocol|3|||
170771665|NCT00442117|617170496|FG001|Overall Study|Non compliance with protocol|5|||
170771666|NCT00442117|617170495|FG000|Overall Study|Met Withdrawal Criteria|2|||
170771667|NCT00442117|617170496|FG001|Overall Study|Met Withdrawal Criteria|1|||
170771668|NCT01585558|617170505|FG000|Overall Study|Withdrawal by Subject|4|||
170771669|NCT01585558|617170506|FG001|Overall Study|Withdrawal by Subject|5|||
170771670|NCT01585558|617170507|FG002|Overall Study|Withdrawal by Subject|8|||
170771671|NCT01585558|617170505|FG000|Overall Study|Lost to Follow-up|2|||
170771672|NCT01585558|617170506|FG001|Overall Study|Lost to Follow-up|0|||
170771673|NCT01585558|617170507|FG002|Overall Study|Lost to Follow-up|3|||
170771674|NCT01585558|617170505|FG000|Overall Study|Adverse Event|3|||
170771675|NCT01585558|617170506|FG001|Overall Study|Adverse Event|4|||
170771676|NCT01585558|617170507|FG002|Overall Study|Adverse Event|1|||
170771677|NCT01585558|617170505|FG000|Overall Study|Protocol Violation|4|||
170771678|NCT01585558|617170506|FG001|Overall Study|Protocol Violation|3|||
170771679|NCT01585558|617170507|FG002|Overall Study|Protocol Violation|2|||
170771680|NCT01585558|617170505|FG000|Overall Study|Lack of Efficacy|0|||
170771681|NCT01585558|617170506|FG001|Overall Study|Lack of Efficacy|0|||
170771682|NCT01585558|617170507|FG002|Overall Study|Lack of Efficacy|1|||
170771683|NCT00841035|617170508|FG000|Phase 1 Overall Study|Physician Decision|13|||
170771684|NCT00433199|617170513|FG000|Double-Blind Period|Adverse Event|0|||
170771685|NCT00433199|617170514|FG001|Double-Blind Period|Adverse Event|25|||
170771686|NCT00433199|617170513|FG000|Double-Blind Period|Lack of Efficacy|0|||
170872811|NCT00514514|617546447|FG001|Pre-phase|condition no longer requires study drug|0|||
170872812|NCT00514514|617546448|FG002|Pre-phase|condition no longer requires study drug|0|||
170872813|NCT00514514|617546446|FG000|Pre-phase|abnormal test procedure results|15|||
170872814|NCT00514514|617546447|FG001|Pre-phase|abnormal test procedure results|0|||
170872815|NCT00514514|617546448|FG002|Pre-phase|abnormal test procedure results|0|||
170872816|NCT00514514|617546446|FG000|Pre-phase|Lost to Follow-up|2|||
170872817|NCT00514514|617546447|FG001|Pre-phase|Lost to Follow-up|0|||
170872818|NCT00514514|617546448|FG002|Pre-phase|Lost to Follow-up|0|||
170872819|NCT00514514|617546446|FG000|Pre-phase|abnormal lab values|23|||
170872820|NCT00514514|617546447|FG001|Pre-phase|abnormal lab values|0|||
170872821|NCT00514514|617546448|FG002|Pre-phase|abnormal lab values|0|||
170872822|NCT00514514|617546446|FG000|Pre-phase|Lack of Efficacy|35|||
170872823|NCT00514514|617546447|FG001|Pre-phase|Lack of Efficacy|0|||
170872824|NCT00514514|617546448|FG002|Pre-phase|Lack of Efficacy|0|||
170872825|NCT00514514|617546446|FG000|Pre-phase|Adverse Event|137|||
170872826|NCT00514514|617546447|FG001|Pre-phase|Adverse Event|0|||
170872827|NCT00514514|617546448|FG002|Pre-phase|Adverse Event|0|||
170872828|NCT00514514|617546446|FG000|Pre-phase|Withdrawal by Subject|66|||
170872829|NCT00514514|617546447|FG001|Pre-phase|Withdrawal by Subject|0|||
170872830|NCT00514514|617546448|FG002|Pre-phase|Withdrawal by Subject|0|||
170872831|NCT00514514|617546446|FG000|Randomized - 9 Month|Death|3|||
170872832|NCT00514514|617546447|FG001|Randomized - 9 Month|Death|2|||
170872833|NCT00514514|617546448|FG002|Randomized - 9 Month|Death|2|||
170872834|NCT00514514|617546446|FG000|Randomized - 9 Month|Administrative problems|1|||
170872835|NCT00514514|617546447|FG001|Randomized - 9 Month|Administrative problems|1|||
170872836|NCT00514514|617546448|FG002|Randomized - 9 Month|Administrative problems|2|||
170872837|NCT00514514|617546446|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
170872838|NCT00514514|617546447|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
170872839|NCT00514514|617546448|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
170771687|NCT00433199|617170514|FG001|Double-Blind Period|Lack of Efficacy|2|||
170771688|NCT00433199|617170513|FG000|Double-Blind Period|Lost to Follow-up|2|||
170771689|NCT00433199|617170514|FG001|Double-Blind Period|Lost to Follow-up|5|||
170771690|NCT00433199|617170513|FG000|Double-Blind Period|Withdrawal by Subject|8|||
170771691|NCT00433199|617170514|FG001|Double-Blind Period|Withdrawal by Subject|19|||
170771692|NCT00433199|617170513|FG000|Double-Blind Period|Protocol Violation|1|||
170771693|NCT00433199|617170514|FG001|Double-Blind Period|Protocol Violation|10|||
170771694|NCT00433199|617170513|FG000|Double-Blind Period|Administrative|1|||
170771695|NCT00433199|617170514|FG001|Double-Blind Period|Administrative|5|||
170771696|NCT00433199|617170513|FG000|Open-Label Period|Adverse Event|0|||
170771697|NCT00433199|617170514|FG001|Open-Label Period|Adverse Event|19|||
170771698|NCT00433199|617170513|FG000|Open-Label Period|Lack of Efficacy|0|||
170771699|NCT00433199|617170514|FG001|Open-Label Period|Lack of Efficacy|2|||
170771700|NCT00433199|617170513|FG000|Open-Label Period|Lost to Follow-up|0|||
170771701|NCT00433199|617170514|FG001|Open-Label Period|Lost to Follow-up|3|||
170771702|NCT00433199|617170513|FG000|Open-Label Period|Withdrawal by Subject|0|||
170771703|NCT00433199|617170514|FG001|Open-Label Period|Withdrawal by Subject|7|||
170771704|NCT00433199|617170513|FG000|Open-Label Period|Protocol Violation|0|||
170771705|NCT00433199|617170514|FG001|Open-Label Period|Protocol Violation|2|||
170771706|NCT00433199|617170513|FG000|Open-Label Period|Administrative|0|||
170771707|NCT00433199|617170514|FG001|Open-Label Period|Administrative|1|||
170771708|NCT00357097|617170515|FG000|Overall Study|Did not meet inclusion criteria|5|||
170771709|NCT00357097|617170516|FG001|Overall Study|Did not meet inclusion criteria|3|||
170771710|NCT00357097|617170515|FG000|Overall Study|Adverse Event|34|||
170771711|NCT00357097|617170516|FG001|Overall Study|Adverse Event|6|||
170771712|NCT00357097|617170515|FG000|Overall Study|Withdrawal by Subject|8|||
170771713|NCT00357097|617170516|FG001|Overall Study|Withdrawal by Subject|7|||
170771714|NCT00357097|617170515|FG000|Overall Study|Non-compliance|1|||
170771715|NCT00357097|617170516|FG001|Overall Study|Non-compliance|2|||
170771716|NCT00357097|617170515|FG000|Overall Study|Lack of Efficacy|2|||
170872840|NCT00514514|617546446|FG000|Randomized - 9 Month|Protocol Violation|1|||
170872841|NCT00514514|617546447|FG001|Randomized - 9 Month|Protocol Violation|1|||
170872842|NCT00514514|617546448|FG002|Randomized - 9 Month|Protocol Violation|0|||
170872843|NCT00514514|617546446|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
170872844|NCT00514514|617546447|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
170771717|NCT00357097|617170516|FG001|Overall Study|Lack of Efficacy|8|||
170771718|NCT00357097|617170515|FG000|Overall Study|Met Exclusion Criteria|3|||
170771719|NCT00357097|617170516|FG001|Overall Study|Met Exclusion Criteria|1|||
170771720|NCT00357097|617170515|FG000|Overall Study|Other|1|||
170872845|NCT00514514|617546448|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
170872846|NCT00514514|617546446|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
170872847|NCT00514514|617546447|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
170872848|NCT00514514|617546448|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
170872849|NCT00514514|617546446|FG000|Randomized - 9 Month|Adverse Event|25|||
170872850|NCT00514514|617546447|FG001|Randomized - 9 Month|Adverse Event|44|||
170771721|NCT00357097|617170516|FG001|Overall Study|Other|1|||
170771722|NCT00357097|617170515|FG000|Overall Study|Increase of RLS Symptoms|0|||
170771723|NCT00357097|617170516|FG001|Overall Study|Increase of RLS Symptoms|1|||
170771724|NCT00658996|617170517|FG000|First Intervention|Positive slit lamp finding|1|||
170872851|NCT00514514|617546448|FG002|Randomized - 9 Month|Adverse Event|27|||
170872852|NCT00514514|617546446|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
170872853|NCT00514514|617546447|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
170872854|NCT00514514|617546448|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
170872855|NCT00514514|617546446|FG000|Extension - 4 Years|Lost to Follow-up|12|||
170872856|NCT00514514|617546447|FG001|Extension - 4 Years|Lost to Follow-up|10|||
170872857|NCT00514514|617546448|FG002|Extension - 4 Years|Lost to Follow-up|9|||
170872858|NCT00514514|617546446|FG000|Extension - 4 Years|Administrative problems|3|||
170872859|NCT00514514|617546447|FG001|Extension - 4 Years|Administrative problems|1|||
170872860|NCT00514514|617546448|FG002|Extension - 4 Years|Administrative problems|1|||
170872861|NCT00514514|617546446|FG000|Extension - 4 Years|Death|8|||
170872862|NCT00514514|617546447|FG001|Extension - 4 Years|Death|3|||
170872863|NCT00514514|617546448|FG002|Extension - 4 Years|Death|6|||
170872864|NCT00514514|617546446|FG000|Extension - 4 Years|Adverse Event|9|||
170872865|NCT00514514|617546447|FG001|Extension - 4 Years|Adverse Event|6|||
170872866|NCT00514514|617546448|FG002|Extension - 4 Years|Adverse Event|3|||
170872867|NCT00833053|617546451|FG000|Overall Study|Adverse Event|4|||
170872868|NCT00833053|617546452|FG001|Overall Study|Adverse Event|0|||
170872869|NCT00833053|617546451|FG000|Overall Study|Treatment Failure|3|||
170872870|NCT00833053|617546452|FG001|Overall Study|Treatment Failure|1|||
170872871|NCT00833053|617546451|FG000|Overall Study|Withdrawal by Subject|0|||
170872872|NCT00833053|617546452|FG001|Overall Study|Withdrawal by Subject|1|||
170872873|NCT00833053|617546451|FG000|Overall Study|Protocol Violation|2|||
170872874|NCT00833053|617546452|FG001|Overall Study|Protocol Violation|1|||
170872875|NCT00957528|617546457|FG000|Overall Study|Protocol Violation|0|||
170872876|NCT00957528|617546458|FG001|Overall Study|Protocol Violation|1|||
170872877|NCT00957528|617546459|FG002|Overall Study|Protocol Violation|0|||
170872878|NCT00957528|617546457|FG000|Overall Study|Withdrawal by Subject|0|||
170872879|NCT00957528|617546458|FG001|Overall Study|Withdrawal by Subject|0|||
170872880|NCT00957528|617546459|FG002|Overall Study|Withdrawal by Subject|1|||
170872881|NCT00677820|617546462|FG000|Overall Study|Lost to Follow-up|1|||
170872882|NCT00677820|617546463|FG001|Overall Study|Lost to Follow-up|0|||
170771725|NCT00658996|617170518|FG001|First Intervention|Positive slit lamp finding|0|||
170771726|NCT00658996|617170517|FG000|First Intervention|Lack of lenses|0|||
170771727|NCT00658996|617170518|FG001|First Intervention|Lack of lenses|1|||
170771728|NCT00658996|617170517|FG000|Crossover Period|Physician Decision|1|||
170771729|NCT00658996|617170518|FG001|Crossover Period|Physician Decision|0|||
170771730|NCT00658996|617170517|FG000|Crossover Period|Ineligible|1|||
170771731|NCT00658996|617170518|FG001|Crossover Period|Ineligible|1|||
170771732|NCT00658996|617170517|FG000|Second Intervention|Developed a stye on upper lid|1|||
170771733|NCT00658996|617170518|FG001|Second Intervention|Developed a stye on upper lid|0|||
170771734|NCT00658996|617170517|FG000|Second Intervention|Positive slit lamp finding|0|||
170771735|NCT00658996|617170518|FG001|Second Intervention|Positive slit lamp finding|1|||
170771736|NCT02994654|617170525|FG000|Overall Study|Lost to Follow-up|1|||
170771737|NCT03603717|617170528|FG000|Overall Study|Lost to Follow-up|20|||
170771738|NCT03603717|617170529|FG001|Overall Study|Lost to Follow-up|20|||
170771739|NCT03603717|617170528|FG000|Overall Study|Withdrawal by Subject|16|||
170771740|NCT03603717|617170529|FG001|Overall Study|Withdrawal by Subject|10|||
170771741|NCT01810263|617170530|FG000|Overall Study|Lost to Follow-up|8|||
170771742|NCT01810263|617170531|FG001|Overall Study|Lost to Follow-up|7|||
170771743|NCT00457691|617170532|FG000|Overall Study|Adverse Event|4|||
170771744|NCT00457691|617170533|FG001|Overall Study|Adverse Event|1|||
170771745|NCT00457691|617170532|FG000|Overall Study|Death|163|||
170771746|NCT00457691|617170533|FG001|Overall Study|Death|148|||
170771747|NCT00457691|617170532|FG000|Overall Study|Protocol Violation|1|||
170771748|NCT00457691|617170533|FG001|Overall Study|Protocol Violation|3|||
170771749|NCT00457691|617170532|FG000|Overall Study|Lost to Follow-up|23|||
170771750|NCT00457691|617170533|FG001|Overall Study|Lost to Follow-up|14|||
170771751|NCT00457691|617170532|FG000|Overall Study|Study terminated by Sponsor|1|||
170872883|NCT00066742|617546466|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
170872884|NCT00066742|617546466|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
170872885|NCT00066742|617546466|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
170872886|NCT00066742|617546466|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
170771752|NCT00457691|617170533|FG001|Overall Study|Study terminated by Sponsor|1|||
170771753|NCT00457691|617170532|FG000|Overall Study|Subject refused (reason other than AE)|14|||
170771754|NCT00457691|617170533|FG001|Overall Study|Subject refused (reason other than AE)|19|||
170872887|NCT00066742|617546466|FG000|Induction Chemoradiotherapy|Ineligible|3|||
170872888|NCT00066742|617546466|FG000|Consolidation Chemotherapy|not protocol specified|1|||
170872889|NCT00066742|617546466|FG000|Consolidation Chemotherapy|Ineligible|2|||
170872890|NCT00294060|617546469|FG000|Overall Study|Death|225|||
170872891|NCT00294060|617546469|FG000|Overall Study|Other|59|||
170872892|NCT00294060|617546469|FG000|Overall Study|Lost to Follow-up|55|||
170771755|NCT00457691|617170532|FG000|Overall Study|Disease progression, study terminated|180|||
170771756|NCT00457691|617170533|FG001|Overall Study|Disease progression, study terminated|196|||
170872893|NCT00294060|617546469|FG000|Overall Study|Withdrawal by Subject|11|||
170872894|NCT00294060|617546469|FG000|Overall Study|Physician Decision|797|||
170872895|NCT00294060|617546469|FG000|Overall Study|Medical condition|3|||
170872896|NCT00294060|617546469|FG000|Overall Study|Device explanted/not replaced|23|||
170872897|NCT00806195|617546470|FG000|Overall Study|Death|6|||
170872898|NCT00806195|617546471|FG001|Overall Study|Death|0|||
170872899|NCT00806195|617546472|FG002|Overall Study|Death|1|||
170872900|NCT00806195|617546473|FG003|Overall Study|Death|0|||
170872901|NCT00806195|617546470|FG000|Overall Study|Adverse Event|25|||
170872902|NCT00806195|617546471|FG001|Overall Study|Adverse Event|5|||
170872903|NCT00806195|617546472|FG002|Overall Study|Adverse Event|11|||
170872904|NCT00806195|617546473|FG003|Overall Study|Adverse Event|2|||
170872905|NCT00806195|617546470|FG000|Overall Study|Withdrawal by Subject|119|||
170872906|NCT00806195|617546471|FG001|Overall Study|Withdrawal by Subject|31|||
170872907|NCT00806195|617546472|FG002|Overall Study|Withdrawal by Subject|76|||
170872908|NCT00806195|617546473|FG003|Overall Study|Withdrawal by Subject|35|||
170872909|NCT00806195|617546470|FG000|Overall Study|Lost to Follow-up|217|||
170872910|NCT00806195|617546471|FG001|Overall Study|Lost to Follow-up|66|||
170872911|NCT00806195|617546472|FG002|Overall Study|Lost to Follow-up|90|||
170872912|NCT00806195|617546473|FG003|Overall Study|Lost to Follow-up|34|||
170872913|NCT00806195|617546470|FG000|Overall Study|Inappropriate Enrollment|0|||
170872914|NCT00806195|617546471|FG001|Overall Study|Inappropriate Enrollment|1|||
170872915|NCT00806195|617546472|FG002|Overall Study|Inappropriate Enrollment|0|||
170872916|NCT00806195|617546473|FG003|Overall Study|Inappropriate Enrollment|0|||
170872917|NCT00806195|617546470|FG000|Overall Study|Administrative Reason|113|||
170872918|NCT00806195|617546471|FG001|Overall Study|Administrative Reason|35|||
170872919|NCT00806195|617546472|FG002|Overall Study|Administrative Reason|66|||
170872920|NCT00806195|617546473|FG003|Overall Study|Administrative Reason|26|||
170872921|NCT00806195|617546470|FG000|Overall Study|Protocol Violation|34|||
170872922|NCT00806195|617546471|FG001|Overall Study|Protocol Violation|24|||
170872923|NCT00806195|617546472|FG002|Overall Study|Protocol Violation|26|||
170872924|NCT00806195|617546473|FG003|Overall Study|Protocol Violation|9|||
170872925|NCT00187096|617546476|FG000|Overall Study|unacceptable toxicity|0|||
170872926|NCT00187096|617546477|FG001|Overall Study|unacceptable toxicity|0|||
170872927|NCT00187096|617546478|FG002|Overall Study|unacceptable toxicity|1|||
170872928|NCT01911442|617546481|FG000|Overall Study|Adverse Event|2|||
170872929|NCT01911442|617546482|FG001|Overall Study|Adverse Event|2|||
170872930|NCT01911442|617546483|FG002|Overall Study|Adverse Event|4|||
170872931|NCT01911442|617546481|FG000|Overall Study|Lack of Efficacy|1|||
170872932|NCT01911442|617546482|FG001|Overall Study|Lack of Efficacy|1|||
170872933|NCT01911442|617546483|FG002|Overall Study|Lack of Efficacy|1|||
170872934|NCT01911442|617546481|FG000|Overall Study|Lost to Follow-up|2|||
170872935|NCT01911442|617546482|FG001|Overall Study|Lost to Follow-up|0|||
170872936|NCT01911442|617546483|FG002|Overall Study|Lost to Follow-up|1|||
170872937|NCT01911442|617546481|FG000|Overall Study|Withdrawal by Subject|1|||
170872938|NCT01911442|617546482|FG001|Overall Study|Withdrawal by Subject|0|||
170872939|NCT01911442|617546483|FG002|Overall Study|Withdrawal by Subject|6|||
170872940|NCT01911442|617546481|FG000|Overall Study|Mother's Work Schedule|0|||
170872941|NCT01911442|617546482|FG001|Overall Study|Mother's Work Schedule|1|||
170872942|NCT01911442|617546483|FG002|Overall Study|Mother's Work Schedule|0|||
170872943|NCT01519934|617546484|FG000|Overall Study|Lost to Follow-up|3|||
170872944|NCT00971178|617546485|FG000|Overall Study|Lost to Follow-up|2|||
170872945|NCT00971178|617546486|FG001|Overall Study|Lost to Follow-up|2|||
170872946|NCT00971178|617546487|FG002|Overall Study|Lost to Follow-up|2|||
170872947|NCT00714285|617546489|FG000|Overall Study|Lost to Follow-up|0|||
170872948|NCT00714285|617546490|FG001|Overall Study|Lost to Follow-up|2|||
170872949|NCT00714285|617546491|FG002|Overall Study|Lost to Follow-up|0|||
170872950|NCT00714285|617546492|FG003|Overall Study|Lost to Follow-up|1|||
170872951|NCT00714285|617546489|FG000|Overall Study|Migrated/moved from study area|0|||
170872952|NCT00714285|617546490|FG001|Overall Study|Migrated/moved from study area|1|||
170872953|NCT00714285|617546491|FG002|Overall Study|Migrated/moved from study area|0|||
170872954|NCT00714285|617546492|FG003|Overall Study|Migrated/moved from study area|0|||
170872955|NCT02138617|617546493|FG000|Overall Study|Death|1|||
170872956|NCT02138617|617546494|FG001|Overall Study|Death|2|||
170872957|NCT02138617|617546495|FG002|Overall Study|Death|2|||
170872958|NCT02138617|617546493|FG000|Overall Study|Adverse Event|8|||
170632466|NCT04634253|616666677|FG001|Overall Study|Adverse Event|1|||
170872959|NCT02138617|617546494|FG001|Overall Study|Adverse Event|5|||
170872960|NCT02138617|617546495|FG002|Overall Study|Adverse Event|2|||
170872961|NCT02138617|617546493|FG000|Overall Study|Disease Progression|20|||
170872962|NCT02138617|617546494|FG001|Overall Study|Disease Progression|13|||
170872963|NCT02138617|617546495|FG002|Overall Study|Disease Progression|4|||
170632467|NCT04634253|616666678|FG002|Overall Study|Adverse Event|0|||
170632468|NCT04634253|616666676|FG000|Overall Study|Physician Decision|0|||
170632469|NCT04634253|616666677|FG001|Overall Study|Physician Decision|1|||
170872964|NCT02138617|617546493|FG000|Overall Study|Withdrawal by Subject|7|||
170872965|NCT02138617|617546494|FG001|Overall Study|Withdrawal by Subject|10|||
170632470|NCT04634253|616666678|FG002|Overall Study|Physician Decision|0|||
170872966|NCT02138617|617546495|FG002|Overall Study|Withdrawal by Subject|2|||
170872967|NCT02138617|617546493|FG000|Overall Study|other complicating disease|0|||
170872968|NCT02138617|617546494|FG001|Overall Study|other complicating disease|2|||
170526105|NCT03327324|616274111|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
170526106|NCT03327324|616274112|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
170526107|NCT03327324|616274113|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
170526108|NCT03327324|616274114|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
170526109|NCT03327324|616274115|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
170526110|NCT03327324|616274116|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
170526111|NCT03327324|616274111|FG000|Intervention (Month 3-Month 6)|Death|1|||
170526112|NCT03327324|616274112|FG001|Intervention (Month 3-Month 6)|Death|0|||
170526113|NCT03327324|616274113|FG002|Intervention (Month 3-Month 6)|Death|1|||
170526114|NCT03327324|616274114|FG003|Intervention (Month 3-Month 6)|Death|1|||
170526115|NCT03327324|616274115|FG004|Intervention (Month 3-Month 6)|Death|1|||
170526116|NCT03327324|616274116|FG005|Intervention (Month 3-Month 6)|Death|0|||
170526117|NCT03327324|616274111|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526118|NCT03327324|616274112|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526119|NCT03327324|616274113|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526120|NCT03327324|616274114|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526121|NCT03327324|616274115|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526122|NCT03327324|616274116|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
170632471|NCT04634253|616666676|FG000|Overall Study|Withdrawal by Subject|1|||
170771757|NCT02079844|617170534|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
170771758|NCT02079844|617170535|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
170771759|NCT02079844|617170536|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
170771760|NCT02079844|617170534|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
170771761|NCT02079844|617170535|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
170771762|NCT02079844|617170536|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
170771763|NCT05985044|617171981|FG000|Overall Study|Death|6|||
170771764|NCT05985044|617171981|FG000|Overall Study|Lost to Follow-up|4|||
170771765|NCT05985044|617171981|FG000|Overall Study|Incapacitation|3|||
170771766|NCT05985044|617171981|FG000|Overall Study|Withdrawal by Subject|2|||
170771767|NCT02279095|617171983|FG000|Overall Study|Non-Compliance|1|||
170771768|NCT02279095|617171983|FG000|Overall Study|Withdrawal by Subject|8|||
170771769|NCT02279095|617171983|FG000|Overall Study|Adverse Event|2|||
170771770|NCT02279095|617171983|FG000|Overall Study|Other|7|||
170771771|NCT02279095|617171983|FG000|Overall Study|Lost to Follow-up|1|||
170771772|NCT05938413|617171984|FG000|Overall Study|Lost to Follow-up|1|||
170771773|NCT05938413|617171985|FG001|Overall Study|Lost to Follow-up|7|||
170771774|NCT05938413|617171984|FG000|Overall Study|Withdrawal by Subject|1|||
170771775|NCT05938413|617171985|FG001|Overall Study|Withdrawal by Subject|1|||
170771776|NCT03312907|617171986|FG000|Overall Study|Adverse Event|1|||
170771777|NCT03312907|617171987|FG001|Overall Study|Adverse Event|6|||
170771778|NCT03312907|617171988|FG002|Overall Study|Adverse Event|1|||
170771779|NCT03312907|617171986|FG000|Overall Study|Protocol Violation|2|||
170771780|NCT03312907|617171987|FG001|Overall Study|Protocol Violation|3|||
170771781|NCT03312907|617171988|FG002|Overall Study|Protocol Violation|4|||
170771782|NCT03312907|617171986|FG000|Overall Study|Lost to Follow-up|2|||
170771783|NCT03312907|617171987|FG001|Overall Study|Lost to Follow-up|3|||
170771784|NCT03312907|617171988|FG002|Overall Study|Lost to Follow-up|2|||
170771785|NCT03312907|617171986|FG000|Overall Study|Physician Decision|3|||
170771786|NCT03312907|617171987|FG001|Overall Study|Physician Decision|4|||
170771787|NCT03312907|617171988|FG002|Overall Study|Physician Decision|2|||
170771788|NCT03312907|617171986|FG000|Overall Study|Withdrawal by Subject|9|||
170771789|NCT03312907|617171987|FG001|Overall Study|Withdrawal by Subject|14|||
170771790|NCT03312907|617171988|FG002|Overall Study|Withdrawal by Subject|10|||
170771791|NCT03481777|617171992|FG000|Overall Study|Withdrawal by Subject|36|||
170771792|NCT03481777|617171993|FG001|Overall Study|Withdrawal by Subject|31|||
170771793|NCT03481777|617171992|FG000|Overall Study|Non stroke = non target population|277|||
170771794|NCT03481777|617171993|FG001|Overall Study|Non stroke = non target population|254|||
170771795|NCT03073941|617171994|FG000|Overall Study|Received non-study device intraoperatively|0|||
170771796|NCT03073941|617171995|FG001|Overall Study|Received non-study device intraoperatively|2|||
170771797|NCT03073941|617171994|FG000|Overall Study|Death|1|||
170771798|NCT03073941|617171995|FG001|Overall Study|Death|0|||
170771799|NCT03073941|617171994|FG000|Overall Study|Withdrawal by Subject|1|||
170771800|NCT03073941|617171995|FG001|Overall Study|Withdrawal by Subject|3|||
170771801|NCT03073941|617171994|FG000|Overall Study|Lost to Follow-up|5|||
170771802|NCT03073941|617171995|FG001|Overall Study|Lost to Follow-up|4|||
170771803|NCT03073941|617171994|FG000|Overall Study|Adverse Event|4|||
170771804|NCT03073941|617171995|FG001|Overall Study|Adverse Event|2|||
170872969|NCT02138617|617546495|FG002|Overall Study|other complicating disease|0|||
170872970|NCT02138617|617546493|FG000|Overall Study|Protocol Violation|1|||
170771805|NCT03073941|617171994|FG000|Overall Study|Met an exclusion criterion|0|||
170771806|NCT03073941|617171995|FG001|Overall Study|Met an exclusion criterion|1|||
170771807|NCT01078116|617171998|FG000|Overall Study|Lost to Follow-up|17|||
170526123|NCT03327324|616274111|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
170526124|NCT03327324|616274112|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526125|NCT03327324|616274113|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526126|NCT03327324|616274114|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526127|NCT03327324|616274115|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526128|NCT03327324|616274116|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
170526129|NCT03327324|616274111|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
170526130|NCT03327324|616274112|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
170526131|NCT03327324|616274113|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
170526132|NCT03327324|616274114|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
170526133|NCT03327324|616274115|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
170526134|NCT03327324|616274116|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
170526135|NCT03327324|616274111|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
170526136|NCT03327324|616274112|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
170526137|NCT03327324|616274113|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
170526138|NCT03327324|616274114|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
170526139|NCT03327324|616274115|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
170526140|NCT03327324|616274116|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
170526141|NCT03327324|616274111|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526142|NCT03327324|616274112|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526143|NCT03327324|616274113|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526144|NCT03327324|616274114|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
170526145|NCT03327324|616274115|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
170526146|NCT03327324|616274116|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
170526147|NCT03327324|616274111|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
170526148|NCT03327324|616274112|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
170526149|NCT03327324|616274113|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
170526150|NCT03327324|616274114|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
170526151|NCT03327324|616274115|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
170526152|NCT03327324|616274116|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
170526153|NCT03327324|616274111|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
170526154|NCT03327324|616274112|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
170526155|NCT03327324|616274113|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
170526156|NCT03327324|616274114|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
170526157|NCT03327324|616274115|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
170526158|NCT03327324|616274116|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
170526159|NCT00372424|616274117|FG000|Overall Study|Adverse Event|2|||
170526160|NCT00372424|616274117|FG000|Overall Study|Withdrawal by Subject|1|||
170526161|NCT00372424|616274117|FG000|Overall Study|Death|1|||
170526162|NCT00372424|616274117|FG000|Overall Study|Objective Progression or Relapse|14|||
170526163|NCT00372424|616274117|FG000|Overall Study|Other|7|||
170526164|NCT00372424|616274117|FG000|Overall Study|Enrolled, Not Treated|1|||
170526165|NCT01673178|616274127|FG000|Overall Study|Lost to Follow-up|0|||
170526166|NCT01673178|616274128|FG001|Overall Study|Lost to Follow-up|1|||
170526167|NCT01673178|616274129|FG002|Overall Study|Lost to Follow-up|0|||
170526168|NCT01673178|616274130|FG003|Overall Study|Lost to Follow-up|0|||
170526169|NCT01673178|616274131|FG004|Overall Study|Lost to Follow-up|0|||
170526170|NCT01673178|616274127|FG000|Overall Study|Withdrawal by Subject|0|||
170526171|NCT01673178|616274128|FG001|Overall Study|Withdrawal by Subject|0|||
170526172|NCT01673178|616274129|FG002|Overall Study|Withdrawal by Subject|1|||
170771808|NCT01078116|617171998|FG000|Overall Study|Adverse Event|5|||
170771809|NCT01078116|617171998|FG000|Overall Study|Withdrawal by Subject|8|||
170771810|NCT01078116|617171998|FG000|Overall Study|Lack of effectiveness|15|||
170771811|NCT01078116|617171998|FG000|Overall Study|Case report form not completed|3|||
170771812|NCT02499159|617171999|FG000|Randomization|Protocol Violation|1|||
170771813|NCT02499159|617172000|FG001|Randomization|Protocol Violation|1|||
170771814|NCT02499159|617171999|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
170771815|NCT02499159|617172000|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
170771816|NCT02499159|617171999|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
170771817|NCT02499159|617172000|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
170872971|NCT02138617|617546494|FG001|Overall Study|Protocol Violation|0|||
170872972|NCT02138617|617546495|FG002|Overall Study|Protocol Violation|0|||
170872973|NCT02138617|617546493|FG000|Overall Study|Physician Decision|7|||
170526173|NCT01673178|616274130|FG003|Overall Study|Withdrawal by Subject|4|||
170526174|NCT01673178|616274131|FG004|Overall Study|Withdrawal by Subject|2|||
170526175|NCT01673178|616274127|FG000|Overall Study|Protocol Violation|1|||
170771818|NCT02499159|617171999|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
170771819|NCT02499159|617172000|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
170771820|NCT02499159|617171999|FG000|30-Day Follow-Up Phone Call|Other|1|||
170771821|NCT02499159|617172000|FG001|30-Day Follow-Up Phone Call|Other|0|||
170771822|NCT02242487|617172001|FG000|Overall Study|Adverse Event|13|||
170771823|NCT02242487|617172002|FG001|Overall Study|Adverse Event|15|||
170771824|NCT02242487|617172001|FG000|Overall Study|Lack of Efficacy|4|||
170771825|NCT02242487|617172002|FG001|Overall Study|Lack of Efficacy|6|||
170771826|NCT02242487|617172001|FG000|Overall Study|Protocol Violation|2|||
170771827|NCT02242487|617172002|FG001|Overall Study|Protocol Violation|0|||
170771828|NCT02242487|617172001|FG000|Overall Study|Lost to Follow-up|2|||
170771829|NCT02242487|617172002|FG001|Overall Study|Lost to Follow-up|1|||
170771830|NCT02242487|617172001|FG000|Overall Study|Other - Miscellaneous|4|||
170771831|NCT02242487|617172002|FG001|Overall Study|Other - Miscellaneous|6|||
170771832|NCT02242487|617172001|FG000|Overall Study|Withdrawal by Subject|37|||
170771833|NCT02242487|617172002|FG001|Overall Study|Withdrawal by Subject|19|||
170771834|NCT01599793|617172003|FG000|Overall Study|Adverse Event|2|||
170771835|NCT02613871|617172006|FG000|Overall Study|Death|2|||
170771836|NCT02613871|617172006|FG000|Overall Study|Withdrew Consent|1|||
170771837|NCT01636687|617172007|FG000|Induction Period|Withdrawal by Subject|1|||
170771838|NCT01636687|617172008|FG001|Induction Period|Withdrawal by Subject|0|||
170771839|NCT01636687|617172009|FG002|Induction Period|Withdrawal by Subject|0|||
170771840|NCT01636687|617172010|FG003|Induction Period|Withdrawal by Subject|0|||
170771841|NCT01636687|617172011|FG004|Induction Period|Withdrawal by Subject|0|||
170771842|NCT01636687|617172007|FG000|Induction Period|Adverse Event|1|||
170771843|NCT01636687|617172008|FG001|Induction Period|Adverse Event|0|||
170771844|NCT01636687|617172009|FG002|Induction Period|Adverse Event|0|||
170771845|NCT01636687|617172010|FG003|Induction Period|Adverse Event|0|||
170771846|NCT01636687|617172011|FG004|Induction Period|Adverse Event|1|||
170771847|NCT01636687|617172007|FG000|Induction Period|Lack of Efficacy|0|||
170771848|NCT01636687|617172008|FG001|Induction Period|Lack of Efficacy|0|||
170771849|NCT01636687|617172009|FG002|Induction Period|Lack of Efficacy|0|||
170771850|NCT01636687|617172010|FG003|Induction Period|Lack of Efficacy|0|||
170771851|NCT01636687|617172011|FG004|Induction Period|Lack of Efficacy|1|||
170771852|NCT01636687|617172007|FG000|Induction Period|Physician Decision|1|||
170771853|NCT01636687|617172008|FG001|Induction Period|Physician Decision|0|||
170771854|NCT01636687|617172009|FG002|Induction Period|Physician Decision|0|||
170771855|NCT01636687|617172010|FG003|Induction Period|Physician Decision|0|||
170771856|NCT01636687|617172011|FG004|Induction Period|Physician Decision|0|||
170771857|NCT01636687|617172007|FG000|Maintenance Period|Withdrawal by Subject|2|||
170771858|NCT01636687|617172008|FG001|Maintenance Period|Withdrawal by Subject|0|||
170771859|NCT01636687|617172009|FG002|Maintenance Period|Withdrawal by Subject|2|||
170771860|NCT01636687|617172010|FG003|Maintenance Period|Withdrawal by Subject|0|||
170771861|NCT01636687|617172011|FG004|Maintenance Period|Withdrawal by Subject|0|||
170771862|NCT01636687|617172007|FG000|Maintenance Period|Adverse Event|1|||
170771863|NCT01636687|617172008|FG001|Maintenance Period|Adverse Event|0|||
170771864|NCT01636687|617172009|FG002|Maintenance Period|Adverse Event|0|||
170771865|NCT01636687|617172010|FG003|Maintenance Period|Adverse Event|0|||
170771866|NCT01636687|617172011|FG004|Maintenance Period|Adverse Event|0|||
170771867|NCT01636687|617172007|FG000|Maintenance Period|Lack of Efficacy|4|||
170771868|NCT01636687|617172008|FG001|Maintenance Period|Lack of Efficacy|1|||
170771869|NCT01636687|617172009|FG002|Maintenance Period|Lack of Efficacy|0|||
170771870|NCT01636687|617172010|FG003|Maintenance Period|Lack of Efficacy|0|||
170771871|NCT01636687|617172011|FG004|Maintenance Period|Lack of Efficacy|0|||
170771872|NCT01636687|617172007|FG000|Maintenance Period|Lost to Follow-up|1|||
170771873|NCT01636687|617172008|FG001|Maintenance Period|Lost to Follow-up|1|||
170771874|NCT01636687|617172009|FG002|Maintenance Period|Lost to Follow-up|0|||
170771875|NCT01636687|617172010|FG003|Maintenance Period|Lost to Follow-up|0|||
170771876|NCT01636687|617172011|FG004|Maintenance Period|Lost to Follow-up|1|||
170771877|NCT01636687|617172007|FG000|Maintenance Period|Physician Decision|0|||
170771878|NCT01636687|617172008|FG001|Maintenance Period|Physician Decision|0|||
170771879|NCT01636687|617172009|FG002|Maintenance Period|Physician Decision|0|||
170771880|NCT01636687|617172010|FG003|Maintenance Period|Physician Decision|0|||
170771881|NCT01636687|617172011|FG004|Maintenance Period|Physician Decision|1|||
170526176|NCT01673178|616274128|FG001|Overall Study|Protocol Violation|1|||
170771882|NCT01636687|617172007|FG000|Extension Period|technical problems|0|||
170771883|NCT01636687|617172008|FG001|Extension Period|technical problems|1|||
170526177|NCT01673178|616274129|FG002|Overall Study|Protocol Violation|0|||
170771884|NCT01636687|617172009|FG002|Extension Period|technical problems|2|||
170771885|NCT01636687|617172010|FG003|Extension Period|technical problems|1|||
170771886|NCT01636687|617172011|FG004|Extension Period|technical problems|0|||
170771887|NCT01636687|617172007|FG000|Extension Period|Adverse Event|4|||
170771888|NCT01636687|617172008|FG001|Extension Period|Adverse Event|3|||
170526178|NCT01673178|616274130|FG003|Overall Study|Protocol Violation|1|||
170771889|NCT01636687|617172009|FG002|Extension Period|Adverse Event|2|||
170771890|NCT01636687|617172010|FG003|Extension Period|Adverse Event|1|||
170771891|NCT01636687|617172011|FG004|Extension Period|Adverse Event|0|||
170771892|NCT01636687|617172007|FG000|Extension Period|Lack of Efficacy|7|||
170771893|NCT01636687|617172008|FG001|Extension Period|Lack of Efficacy|0|||
170771894|NCT01636687|617172009|FG002|Extension Period|Lack of Efficacy|2|||
170771895|NCT01636687|617172010|FG003|Extension Period|Lack of Efficacy|1|||
170771896|NCT01636687|617172011|FG004|Extension Period|Lack of Efficacy|0|||
170771897|NCT01636687|617172007|FG000|Extension Period|Lost to Follow-up|1|||
170771898|NCT01636687|617172008|FG001|Extension Period|Lost to Follow-up|0|||
170771899|NCT01636687|617172009|FG002|Extension Period|Lost to Follow-up|1|||
170771900|NCT01636687|617172010|FG003|Extension Period|Lost to Follow-up|0|||
170771901|NCT01636687|617172011|FG004|Extension Period|Lost to Follow-up|0|||
170771902|NCT01636687|617172007|FG000|Extension Period|Physician Decision|1|||
170771903|NCT01636687|617172008|FG001|Extension Period|Physician Decision|0|||
170771904|NCT01636687|617172009|FG002|Extension Period|Physician Decision|0|||
170771905|NCT01636687|617172010|FG003|Extension Period|Physician Decision|1|||
170771906|NCT01636687|617172011|FG004|Extension Period|Physician Decision|0|||
170771907|NCT01636687|617172007|FG000|Extension Period|study terminated by sponsor|33|||
170771908|NCT01636687|617172008|FG001|Extension Period|study terminated by sponsor|50|||
170771909|NCT01636687|617172009|FG002|Extension Period|study terminated by sponsor|17|||
170771910|NCT01636687|617172010|FG003|Extension Period|study terminated by sponsor|23|||
170771911|NCT01636687|617172011|FG004|Extension Period|study terminated by sponsor|0|||
170771912|NCT01636687|617172007|FG000|Extension Period|Withdrawal by Subject|1|||
170771913|NCT01636687|617172008|FG001|Extension Period|Withdrawal by Subject|0|||
170771914|NCT01636687|617172009|FG002|Extension Period|Withdrawal by Subject|1|||
170771915|NCT01636687|617172010|FG003|Extension Period|Withdrawal by Subject|1|||
170771916|NCT01636687|617172011|FG004|Extension Period|Withdrawal by Subject|0|||
170771917|NCT01636687|617172007|FG000|Follow-up Period|Withdrawal by Subject|1|||
170771918|NCT01636687|617172008|FG001|Follow-up Period|Withdrawal by Subject|0|||
170771919|NCT01636687|617172009|FG002|Follow-up Period|Withdrawal by Subject|0|||
170771920|NCT01636687|617172010|FG003|Follow-up Period|Withdrawal by Subject|0|||
170771921|NCT01636687|617172011|FG004|Follow-up Period|Withdrawal by Subject|1|||
170771922|NCT02594735|617172014|FG000|Overall Study|Adverse Event|1|||
170771923|NCT04054635|617172021|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
170771924|NCT04054635|617172022|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
170771925|NCT04054635|617172023|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
170771926|NCT04054635|617172021|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
170771927|NCT04054635|617172022|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
170771928|NCT04054635|617172023|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
170771929|NCT03737240|617172024|FG000|Overall Study|Lost to Follow-up|16|||
170771930|NCT03737240|617172025|FG001|Overall Study|Lost to Follow-up|15|||
170771931|NCT05082935|617172027|FG000|Overall Study|Lost to Follow-up|549|||
170771932|NCT05082935|617172028|FG001|Overall Study|Lost to Follow-up|631|||
170771933|NCT05082935|617172027|FG000|Overall Study|Withdrawal by Subject|27|||
170771934|NCT05082935|617172028|FG001|Overall Study|Withdrawal by Subject|58|||
170771935|NCT02423291|617172030|FG000|Overall Study|Lack of Efficacy|14|||
170771936|NCT02423291|617172030|FG000|Overall Study|Adverse Event|1|||
170771937|NCT03950622|617172031|FG000|Overall Study|Withdrawal by Subject|1|||
170771938|NCT03950622|617172032|FG001|Overall Study|Withdrawal by Subject|0|||
170771939|NCT03950622|617172031|FG000|Overall Study|Protocol Deviation|0|||
170771940|NCT03950622|617172032|FG001|Overall Study|Protocol Deviation|1|||
170771941|NCT03950622|617172031|FG000|Overall Study|Physician Decision|1|||
170771942|NCT03950622|617172032|FG001|Overall Study|Physician Decision|0|||
170771943|NCT03950622|617172031|FG000|Overall Study|Lost to Follow-up|5|||
170771944|NCT03950622|617172032|FG001|Overall Study|Lost to Follow-up|5|||
170771945|NCT03950622|617172031|FG000|Overall Study|Death|1|||
170771946|NCT03950622|617172032|FG001|Overall Study|Death|1|||
170771947|NCT01430611|617172035|FG000|Overall Study|Adverse Event|0|||
170771948|NCT01430611|617172036|FG001|Overall Study|Adverse Event|1|||
170771949|NCT01430611|617172035|FG000|Overall Study|Protocol Violation|1|||
170771950|NCT01430611|617172036|FG001|Overall Study|Protocol Violation|0|||
170771951|NCT01430611|617172035|FG000|Overall Study|Lost to Follow-up|1|||
170771952|NCT01430611|617172036|FG001|Overall Study|Lost to Follow-up|0|||
170771953|NCT01430611|617172035|FG000|Overall Study|Withdrawal by Subject|15|||
170771954|NCT01430611|617172036|FG001|Overall Study|Withdrawal by Subject|14|||
170771955|NCT02928224|617172037|FG000|Overall Study|Lost to Follow-up|1|||
170771956|NCT02928224|617172038|FG001|Overall Study|Lost to Follow-up|1|||
170771957|NCT02928224|617172039|FG002|Overall Study|Lost to Follow-up|3|||
170771958|NCT02928224|617172040|FG003|Overall Study|Lost to Follow-up|0|||
170526179|NCT01673178|616274131|FG004|Overall Study|Protocol Violation|0|||
170771959|NCT02928224|617172037|FG000|Overall Study|Death|30|||
170771960|NCT02928224|617172038|FG001|Overall Study|Death|209|||
170771961|NCT02928224|617172039|FG002|Overall Study|Death|193|||
170771962|NCT02928224|617172040|FG003|Overall Study|Death|198|||
170771963|NCT02928224|617172037|FG000|Overall Study|Withdrawal by Subject|0|||
170771964|NCT02928224|617172038|FG001|Overall Study|Withdrawal by Subject|3|||
170771965|NCT02928224|617172039|FG002|Overall Study|Withdrawal by Subject|7|||
170526180|NCT01673178|616274127|FG000|Overall Study|Adverse Event|1|||
170526181|NCT01673178|616274128|FG001|Overall Study|Adverse Event|0|||
170526182|NCT01673178|616274129|FG002|Overall Study|Adverse Event|0|||
170526183|NCT01673178|616274130|FG003|Overall Study|Adverse Event|2|||
170526184|NCT01673178|616274131|FG004|Overall Study|Adverse Event|0|||
170526185|NCT01673178|616274127|FG000|Overall Study|Other|1|||
170526186|NCT01673178|616274128|FG001|Overall Study|Other|0|||
170526187|NCT01673178|616274129|FG002|Overall Study|Other|2|||
170526188|NCT01673178|616274130|FG003|Overall Study|Other|1|||
170526189|NCT01673178|616274131|FG004|Overall Study|Other|0|||
170526190|NCT05502302|616274132|FG000|Overall Study|Lost to Follow-up|6|||
170526191|NCT05502302|616274132|FG000|Overall Study|Death|2|||
170526192|NCT00577317|616274139|FG000|Overall Study|Study Terminated|0|||
170526193|NCT00577317|616274140|FG001|Overall Study|Study Terminated|2|||
170526194|NCT03372798|616274141|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
170526195|NCT03372798|616274142|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
170526196|NCT03372798|616274141|FG000|Overall Study|Failure of imaging probe|0|||
170526197|NCT03372798|616274142|FG001|Overall Study|Failure of imaging probe|1|||
170526198|NCT02283658|616274144|FG000|Overall Study|Withdrawal by Subject|1|||
170771966|NCT02928224|617172040|FG003|Overall Study|Withdrawal by Subject|20|||
170771967|NCT02928224|617172037|FG000|Overall Study|Study participation terminated by sponsor|3|||
170771968|NCT02928224|617172038|FG001|Overall Study|Study participation terminated by sponsor|8|||
170771969|NCT02928224|617172039|FG002|Overall Study|Study participation terminated by sponsor|12|||
170771970|NCT02928224|617172040|FG003|Overall Study|Study participation terminated by sponsor|3|||
170771971|NCT02928224|617172037|FG000|Overall Study|Other|3|||
170771972|NCT02928224|617172038|FG001|Overall Study|Other|3|||
170771973|NCT02928224|617172039|FG002|Overall Study|Other|5|||
170771974|NCT02928224|617172040|FG003|Overall Study|Other|0|||
170771975|NCT02538107|617172041|FG000|Overall Study|Did not receive any Mircera dose|11|||
170771976|NCT02538107|617172041|FG000|Overall Study|Missing|5|||
170771977|NCT02538107|617172041|FG000|Overall Study|Necessity of dialysis|20|||
170771978|NCT02538107|617172041|FG000|Overall Study|Administration of other ESA|11|||
170771979|NCT02538107|617172041|FG000|Overall Study|No further treatment necessary|18|||
170771980|NCT02538107|617172041|FG000|Overall Study|Withdrawal by Subject|17|||
170771981|NCT02538107|617172041|FG000|Overall Study|Death|4|||
170771982|NCT02538107|617172041|FG000|Overall Study|Administrative reason|5|||
170771983|NCT02538107|617172041|FG000|Overall Study|Adverse Event|4|||
170771984|NCT02538107|617172041|FG000|Overall Study|Surgery|1|||
170771985|NCT02538107|617172041|FG000|Overall Study|Other|7|||
170771986|NCT02538107|617172041|FG000|Overall Study|Not recorded|7|||
170771987|NCT01278394|617172042|FG000|Overall Study|Lost to Follow-up|1|||
170771988|NCT00546754|617172043|FG000|Overall Study|Serious Adverse Event|1|||
170771989|NCT00546754|617172044|FG001|Overall Study|Serious Adverse Event|1|||
170771990|NCT00546754|617172043|FG000|Overall Study|Adverse Event|11|||
170771991|NCT00546754|617172044|FG001|Overall Study|Adverse Event|16|||
170771992|NCT00546754|617172043|FG000|Overall Study|Lack of Efficacy|1|||
170771993|NCT00546754|617172044|FG001|Overall Study|Lack of Efficacy|1|||
170771994|NCT00546754|617172043|FG000|Overall Study|Lost to Follow-up|9|||
170771995|NCT00546754|617172044|FG001|Overall Study|Lost to Follow-up|15|||
170771996|NCT00546754|617172043|FG000|Overall Study|Protocol Violation|3|||
170771997|NCT00546754|617172044|FG001|Overall Study|Protocol Violation|0|||
170771998|NCT00546754|617172043|FG000|Overall Study|Withdrawal by Subject|6|||
170771999|NCT00546754|617172044|FG001|Overall Study|Withdrawal by Subject|7|||
170772000|NCT00546754|617172043|FG000|Overall Study|Dyspnea|1|||
170772001|NCT00546754|617172044|FG001|Overall Study|Dyspnea|0|||
170772002|NCT00546754|617172043|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
170772003|NCT00546754|617172044|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
170772004|NCT00546754|617172043|FG000|Overall Study|Hip Replacement|1|||
170772005|NCT00546754|617172044|FG001|Overall Study|Hip Replacement|0|||
170772006|NCT00546754|617172043|FG000|Overall Study|Suicide|1|||
170772007|NCT00546754|617172044|FG001|Overall Study|Suicide|0|||
170772008|NCT00546754|617172043|FG000|Overall Study|Missing Cooperation|1|||
170772009|NCT00546754|617172044|FG001|Overall Study|Missing Cooperation|0|||
170772010|NCT00546754|617172043|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
170772011|NCT00546754|617172044|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
170526199|NCT01687218|616274145|FG000|Overall Study|Withdrawal by Subject|2|||
170772012|NCT00546754|617172043|FG000|Overall Study|Patient's Decision|0|||
170772013|NCT00546754|617172044|FG001|Overall Study|Patient's Decision|1|||
170772014|NCT00546754|617172043|FG000|Overall Study|Missing|14|||
170772015|NCT00546754|617172044|FG001|Overall Study|Missing|7|||
170772016|NCT01576484|617172045|FG000|Overall Study|Adverse Event|1|||
170772017|NCT01576484|617172046|FG001|Overall Study|Adverse Event|1|||
170526200|NCT01687218|616274146|FG001|Overall Study|Withdrawal by Subject|3|||
170772018|NCT01576484|617172045|FG000|Overall Study|Protocol Violation|0|||
170772019|NCT01576484|617172046|FG001|Overall Study|Protocol Violation|2|||
170772020|NCT01576484|617172045|FG000|Overall Study|Sponsor Decision|2|||
170772021|NCT01576484|617172046|FG001|Overall Study|Sponsor Decision|8|||
170772022|NCT01576484|617172045|FG000|Overall Study|Withdrawal by Subject|0|||
170772023|NCT01576484|617172046|FG001|Overall Study|Withdrawal by Subject|3|||
170872974|NCT02138617|617546494|FG001|Overall Study|Physician Decision|6|||
170872975|NCT02138617|617546495|FG002|Overall Study|Physician Decision|0|||
170872976|NCT02138617|617546493|FG000|Overall Study|financial reason|0|||
170872977|NCT02138617|617546494|FG001|Overall Study|financial reason|1|||
170872978|NCT02138617|617546495|FG002|Overall Study|financial reason|0|||
170872979|NCT02138617|617546493|FG000|Overall Study|other therapy|3|||
170872980|NCT02138617|617546494|FG001|Overall Study|other therapy|4|||
170872981|NCT02138617|617546495|FG002|Overall Study|other therapy|0|||
170526201|NCT01687218|616274147|FG002|Overall Study|Withdrawal by Subject|0|||
170872982|NCT01490814|617546501|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
170872983|NCT01490814|617546502|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
170872984|NCT01490814|617546501|FG000|Overall Study|Physician Decision|1|||
170872985|NCT01490814|617546502|FG001|Overall Study|Physician Decision|0|||
170872986|NCT01490814|617546501|FG000|Overall Study|Withdrawal by Subject|0|||
170872987|NCT01490814|617546502|FG001|Overall Study|Withdrawal by Subject|5|||
170872988|NCT01537198|617546503|FG000|Overall Study|RSV infection|2|||
170872989|NCT01537198|617546503|FG000|Overall Study|Adverse Event|4|||
170872990|NCT01537198|617546503|FG000|Overall Study|No Further Visits to the Clinic|37|||
170872991|NCT01537198|617546503|FG000|Overall Study|Other|111|||
170872992|NCT01231659|617546504|FG000|Overall Study|Adverse Event|9|||
170872993|NCT01231659|617546504|FG000|Overall Study|Disease Progression|48|||
170872994|NCT01231659|617546504|FG000|Overall Study|Death|2|||
170872995|NCT01231659|617546504|FG000|Overall Study|Patient refused to complete study visit|1|||
170872996|NCT01231659|617546504|FG000|Overall Study|Other protocol defined criteria|12|||
170872997|NCT00496730|617546511|FG000|Overall Study|Lost to Follow-up|4|||
170872998|NCT00496730|617546512|FG001|Overall Study|Lost to Follow-up|3|||
170872999|NCT00496730|617546511|FG000|Overall Study|Withdrawal by Subject|2|||
170873000|NCT00496730|617546512|FG001|Overall Study|Withdrawal by Subject|2|||
170873001|NCT00113074|617546516|FG000|Overall Study|Lost to Follow-up|10|||
170873002|NCT00113074|617546517|FG001|Overall Study|Lost to Follow-up|10|||
170873003|NCT00113074|617546518|FG002|Overall Study|Lost to Follow-up|14|||
170873004|NCT03680911|617546519|FG000|At Home Treatment|Study Termination|3|||
170873005|NCT03680911|617546520|FG001|At Home Treatment|Study Termination|0|||
170873006|NCT03680911|617546519|FG000|At Home Treatment|Lost to Follow-up|0|||
170873007|NCT03680911|617546520|FG001|At Home Treatment|Lost to Follow-up|1|||
170873008|NCT03680911|617546519|FG000|At Home Treatment|Withdrawal by Subject|0|||
170873009|NCT03680911|617546520|FG001|At Home Treatment|Withdrawal by Subject|2|||
170873010|NCT03680911|617546519|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
170873011|NCT03680911|617546520|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
170873012|NCT03962738|617546523|FG000|Overall Study|Protocol Deviation|3|||
170873013|NCT03962738|617546524|FG001|Overall Study|Protocol Deviation|0|||
170873014|NCT03962738|617546525|FG002|Overall Study|Protocol Deviation|1|||
170873015|NCT03962738|617546526|FG003|Overall Study|Protocol Deviation|1|||
170873016|NCT03962738|617546523|FG000|Overall Study|Withdrawal by Subject|4|||
170873017|NCT03962738|617546524|FG001|Overall Study|Withdrawal by Subject|0|||
170873018|NCT03962738|617546525|FG002|Overall Study|Withdrawal by Subject|0|||
170873019|NCT03962738|617546526|FG003|Overall Study|Withdrawal by Subject|0|||
170873020|NCT03962738|617546523|FG000|Overall Study|Lost to Follow-up|0|||
170873021|NCT03962738|617546524|FG001|Overall Study|Lost to Follow-up|0|||
170873022|NCT03962738|617546525|FG002|Overall Study|Lost to Follow-up|1|||
170873023|NCT03962738|617546526|FG003|Overall Study|Lost to Follow-up|0|||
170873024|NCT00509067|617546527|FG000|Overall Study|Lost to Follow-up|1|||
170873025|NCT00509067|617546528|FG001|Overall Study|Lost to Follow-up|1|||
170873026|NCT00509067|617546527|FG000|Overall Study|Adverse Event|3|||
170873027|NCT00509067|617546528|FG001|Overall Study|Adverse Event|1|||
170873028|NCT00509067|617546527|FG000|Overall Study|Protocol Violation|0|||
170873029|NCT00509067|617546528|FG001|Overall Study|Protocol Violation|3|||
170873030|NCT00760669|617546530|FG000|Overall Study|Not assessed for overall improvement|18|||
170873031|NCT00760669|617546530|FG000|Overall Study|Participants missing efficacy assessment|6|||
170873032|NCT00760669|617546530|FG000|Overall Study|Participants with overlapping cases|1|||
170873033|NCT00760669|617546530|FG000|Overall Study|Took drug before entering in contract|5|||
170873034|NCT00117598|617546531|FG000|Prior to Treatment Cross Over|Death|40|||
170873035|NCT00117598|617546532|FG001|Prior to Treatment Cross Over|Death|41|||
170873036|NCT00117598|617546533|FG002|Prior to Treatment Cross Over|Death|37|||
170873037|NCT00117598|617546534|FG003|Prior to Treatment Cross Over|Death|0|||
170873038|NCT00117598|617546535|FG004|Prior to Treatment Cross Over|Death|0|||
170873039|NCT00117598|617546531|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
170873040|NCT00117598|617546532|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
170873041|NCT00117598|617546533|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
170873042|NCT00117598|617546534|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
170873043|NCT00117598|617546535|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
170873044|NCT00117598|617546531|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
170873045|NCT00117598|617546532|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
170873046|NCT00117598|617546533|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
170526202|NCT01687218|616274148|FG003|Overall Study|Withdrawal by Subject|1|||
170526203|NCT01687218|616274149|FG004|Overall Study|Withdrawal by Subject|1|||
170772024|NCT01576484|617172045|FG000|Overall Study|Other|2|||
170772025|NCT01576484|617172046|FG001|Overall Study|Other|5|||
170772026|NCT00258895|617172053|FG000|Overall Study|Lost to Follow-up|3|||
170772027|NCT00258895|617172054|FG001|Overall Study|Lost to Follow-up|1|||
170772028|NCT00258895|617172053|FG000|Overall Study|Protocol Violation|6|||
170772029|NCT00258895|617172054|FG001|Overall Study|Protocol Violation|2|||
170772030|NCT00258895|617172053|FG000|Overall Study|Withdrawal by Subject|1|||
170772031|NCT00258895|617172054|FG001|Overall Study|Withdrawal by Subject|0|||
170772032|NCT00958633|617172057|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
170772033|NCT00958633|617172058|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
170772034|NCT00958633|617172059|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
170772035|NCT00958633|617172057|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
170772036|NCT00958633|617172058|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
170772037|NCT00958633|617172059|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
170772038|NCT00958633|617172057|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
170772039|NCT00958633|617172058|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
170772040|NCT00958633|617172059|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
170772041|NCT00958633|617172057|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
170772042|NCT00958633|617172058|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
170772043|NCT00958633|617172059|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
170772044|NCT00958633|617172057|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
170772045|NCT00958633|617172058|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
170772046|NCT00958633|617172059|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
170772047|NCT00958633|617172057|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
170772048|NCT00958633|617172058|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
170772049|NCT00958633|617172059|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
170873047|NCT00117598|617546534|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
170873048|NCT00117598|617546535|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
170873049|NCT00117598|617546531|FG000|Prior to Treatment Cross Over|Other|15|||
170873050|NCT00117598|617546532|FG001|Prior to Treatment Cross Over|Other|9|||
170873051|NCT00117598|617546533|FG002|Prior to Treatment Cross Over|Other|9|||
170873052|NCT00117598|617546534|FG003|Prior to Treatment Cross Over|Other|0|||
170873053|NCT00117598|617546535|FG004|Prior to Treatment Cross Over|Other|0|||
170873054|NCT00117598|617546531|FG000|After Treament Cross Over|Death|0|||
170873055|NCT00117598|617546532|FG001|After Treament Cross Over|Death|0|||
170873056|NCT00117598|617546533|FG002|After Treament Cross Over|Death|0|||
170873057|NCT00117598|617546534|FG003|After Treament Cross Over|Death|1|||
170873058|NCT00117598|617546535|FG004|After Treament Cross Over|Death|2|||
170873059|NCT00117598|617546531|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
170873060|NCT00117598|617546532|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
170873061|NCT00117598|617546533|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
170873062|NCT00117598|617546534|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
170873063|NCT00117598|617546535|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
170873064|NCT00117598|617546531|FG000|After Treament Cross Over|Other|0|||
170873065|NCT00117598|617546532|FG001|After Treament Cross Over|Other|0|||
170873066|NCT00117598|617546533|FG002|After Treament Cross Over|Other|0|||
170873067|NCT00117598|617546534|FG003|After Treament Cross Over|Other|1|||
170873068|NCT00117598|617546535|FG004|After Treament Cross Over|Other|2|||
170873069|NCT01235793|617546536|FG000|Overall Study|Death|6|||
170873070|NCT00545064|617546537|FG000|Overall Study|Lost to Follow-up|3|||
170873071|NCT00545064|617546537|FG000|Overall Study|Withdrawal by Subject|2|||
170873072|NCT00545064|617546537|FG000|Overall Study|did not complete course of treatment|1|||
170873073|NCT00545064|617546537|FG000|Overall Study|cancel all appointments, no rebooking|1|||
170873074|NCT00545064|617546537|FG000|Overall Study|inclement weather|1|||
170873075|NCT02456662|617546542|FG000|Overall Study|Lost to Follow-up|2|||
170873076|NCT02456662|617546543|FG001|Overall Study|Lost to Follow-up|1|||
170873077|NCT00504153|617546544|FG000|Overall Study|Withdrawal by Subject|1|||
170873078|NCT00504153|617546544|FG000|Overall Study|Adverse Event|4|||
170873079|NCT00504153|617546544|FG000|Overall Study|Death|1|||
170873080|NCT00074581|617546548|FG000|Overall Study|Death|15|||
170873081|NCT00074581|617546549|FG001|Overall Study|Death|16|||
170873082|NCT00074581|617546548|FG000|Overall Study|Withdrawal by Subject|50|||
170873083|NCT00074581|617546549|FG001|Overall Study|Withdrawal by Subject|49|||
170873084|NCT00074581|617546548|FG000|Overall Study|Unable to adhere to visit schedule|13|||
170772050|NCT00958633|617172057|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
170772051|NCT00958633|617172058|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
170772052|NCT00958633|617172059|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
170772053|NCT00094575|617172065|FG000|Overall Study|Death|146|||
170873085|NCT00074581|617546549|FG001|Overall Study|Unable to adhere to visit schedule|14|||
170873086|NCT00074581|617546548|FG000|Overall Study|Relocated|14|||
170873087|NCT00074581|617546549|FG001|Overall Study|Relocated|9|||
170873088|NCT00074581|617546548|FG000|Overall Study|Were withdrawn by investigator|5|||
170873089|NCT00074581|617546549|FG001|Overall Study|Were withdrawn by investigator|2|||
170873090|NCT00074581|617546548|FG000|Overall Study|Lost to Follow-up|16|||
170632472|NCT04634253|616666677|FG001|Overall Study|Withdrawal by Subject|0|||
170632473|NCT04634253|616666678|FG002|Overall Study|Withdrawal by Subject|3|||
170632474|NCT01721044|616666679|FG000|Treatment Period|Adverse Event|7|||
170632475|NCT01721044|616666680|FG001|Treatment Period|Adverse Event|7|||
170632476|NCT01721044|616666681|FG002|Treatment Period|Adverse Event|10|||
170632477|NCT01721044|616666679|FG000|Treatment Period|Death|0|||
170632478|NCT01721044|616666680|FG001|Treatment Period|Death|0|||
170632479|NCT01721044|616666681|FG002|Treatment Period|Death|1|||
170632480|NCT01721044|616666679|FG000|Treatment Period|Lack of Efficacy|16|||
170632481|NCT01721044|616666680|FG001|Treatment Period|Lack of Efficacy|4|||
170632482|NCT01721044|616666681|FG002|Treatment Period|Lack of Efficacy|4|||
170632483|NCT01721044|616666679|FG000|Treatment Period|Lost to Follow-up|0|||
170632484|NCT01721044|616666680|FG001|Treatment Period|Lost to Follow-up|0|||
170632485|NCT01721044|616666681|FG002|Treatment Period|Lost to Follow-up|1|||
170632486|NCT01721044|616666679|FG000|Treatment Period|Physician Decision|1|||
170632487|NCT01721044|616666680|FG001|Treatment Period|Physician Decision|0|||
170772054|NCT00094575|617172066|FG001|Overall Study|Death|146|||
170772055|NCT00794118|617172067|FG000|Overall Study|Lost to Follow-up|16|||
170772056|NCT00794118|617172067|FG000|Overall Study|Withdrawal by Subject|9|||
170772057|NCT00794118|617172067|FG000|Overall Study|Changed hospital center|2|||
170772058|NCT00837616|617172068|FG000|Overall Study|Withdrawal by Subject|0|||
170772059|NCT00837616|617172069|FG001|Overall Study|Withdrawal by Subject|1|||
170772060|NCT03512756|617172076|FG000|Part 1|Death|23|||
170772061|NCT03512756|617172077|FG001|Part 1|Death|18|||
170772062|NCT03512756|617172078|FG002|Part 1|Death|0|||
170772063|NCT03512756|617172079|FG003|Part 1|Death|0|||
170772064|NCT03512756|617172076|FG000|Part 1|Lost to Follow-up|0|||
170772065|NCT03512756|617172077|FG001|Part 1|Lost to Follow-up|3|||
170772066|NCT03512756|617172078|FG002|Part 1|Lost to Follow-up|0|||
170772067|NCT03512756|617172079|FG003|Part 1|Lost to Follow-up|0|||
170772068|NCT03512756|617172076|FG000|Part 1|Physician Decision|0|||
170772069|NCT03512756|617172077|FG001|Part 1|Physician Decision|1|||
170772070|NCT03512756|617172078|FG002|Part 1|Physician Decision|0|||
170772071|NCT03512756|617172079|FG003|Part 1|Physician Decision|0|||
170772072|NCT03512756|617172076|FG000|Part 1|Withdrawal by Subject|2|||
170772073|NCT03512756|617172077|FG001|Part 1|Withdrawal by Subject|2|||
170772074|NCT03512756|617172078|FG002|Part 1|Withdrawal by Subject|0|||
170772075|NCT03512756|617172079|FG003|Part 1|Withdrawal by Subject|0|||
170772076|NCT03512756|617172076|FG000|Part 2|Death|0|||
170772077|NCT03512756|617172077|FG001|Part 2|Death|0|||
170772078|NCT03512756|617172078|FG002|Part 2|Death|32|||
170772079|NCT03512756|617172079|FG003|Part 2|Death|21|||
170772080|NCT03512756|617172076|FG000|Part 2|Lost to Follow-up|0|||
170772081|NCT03512756|617172077|FG001|Part 2|Lost to Follow-up|0|||
170772082|NCT03512756|617172078|FG002|Part 2|Lost to Follow-up|1|||
170772083|NCT03512756|617172079|FG003|Part 2|Lost to Follow-up|0|||
170772084|NCT03512756|617172076|FG000|Part 2|Physician Decision|0|||
170772085|NCT03512756|617172077|FG001|Part 2|Physician Decision|0|||
170772086|NCT03512756|617172078|FG002|Part 2|Physician Decision|2|||
170772087|NCT03512756|617172079|FG003|Part 2|Physician Decision|4|||
170772088|NCT03512756|617172076|FG000|Part 2|Study Terminated by Sponsor|0|||
170772089|NCT03512756|617172077|FG001|Part 2|Study Terminated by Sponsor|0|||
170772090|NCT03512756|617172078|FG002|Part 2|Study Terminated by Sponsor|2|||
170772091|NCT03512756|617172079|FG003|Part 2|Study Terminated by Sponsor|6|||
170772092|NCT03512756|617172076|FG000|Part 2|Protocol Violation|0|||
170772093|NCT03512756|617172077|FG001|Part 2|Protocol Violation|0|||
170772094|NCT03512756|617172078|FG002|Part 2|Protocol Violation|1|||
170772095|NCT03512756|617172079|FG003|Part 2|Protocol Violation|0|||
170772096|NCT03512756|617172076|FG000|Part 2|Withdrawal by Subject|0|||
170772097|NCT03512756|617172077|FG001|Part 2|Withdrawal by Subject|0|||
170772098|NCT03512756|617172078|FG002|Part 2|Withdrawal by Subject|3|||
170772099|NCT03512756|617172079|FG003|Part 2|Withdrawal by Subject|9|||
170772100|NCT01121549|617172080|FG000|Overall Study|Adverse Event|10|||
170772101|NCT01121549|617172080|FG000|Overall Study|Lack of Efficacy|11|||
170772102|NCT01121549|617172080|FG000|Overall Study|Lost to Follow-up|12|||
170772103|NCT01121549|617172080|FG000|Overall Study|Did not meet entrance criteria|9|||
170632488|NCT01721044|616666681|FG002|Treatment Period|Physician Decision|2|||
170632489|NCT01721044|616666679|FG000|Treatment Period|Protocol Violation|1|||
170632490|NCT01721044|616666680|FG001|Treatment Period|Protocol Violation|0|||
170632491|NCT01721044|616666681|FG002|Treatment Period|Protocol Violation|0|||
170632492|NCT01721044|616666679|FG000|Treatment Period|Withdrawal by Subject|7|||
170772104|NCT01121549|617172080|FG000|Overall Study|Study terminated by sponsor|197|||
170772105|NCT01121549|617172080|FG000|Overall Study|Pregnancy|1|||
170772106|NCT01121549|617172080|FG000|Overall Study|Protocol Violation|33|||
170772107|NCT01121549|617172080|FG000|Overall Study|Withdrawal by Subject|16|||
170772108|NCT01121549|617172080|FG000|Overall Study|Other|58|||
170772109|NCT00203411|617172081|FG000|Follow-up|Progressive Disease|4|||
170772110|NCT04725890|617173418|FG000|Overall Study|Lost to Follow-up|2|||
170632493|NCT01721044|616666680|FG001|Treatment Period|Withdrawal by Subject|6|||
170772111|NCT04725890|617173418|FG000|Overall Study|Withdrawal by Subject|3|||
170772112|NCT04725890|617173418|FG000|Overall Study|Physician Decision|1|||
170772113|NCT03873779|617173432|FG000|Overall Study|Withdrawal by Subject|1|||
170772114|NCT02581215|617173433|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
170772115|NCT02581215|617173434|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
170772116|NCT02581215|617173433|FG000|Overall Study|Eligibility Criteria Not Met|0|||
170772117|NCT02581215|617173434|FG001|Overall Study|Eligibility Criteria Not Met|1|||
170772118|NCT03289039|617173436|FG000|Overall Study|Withdrawal by Subject|0|||
170772119|NCT03289039|617173437|FG001|Overall Study|Withdrawal by Subject|1|||
170772120|NCT03289039|617173436|FG000|Overall Study|Became ineligible prior to treatment start|0|||
170772121|NCT03289039|617173437|FG001|Overall Study|Became ineligible prior to treatment start|1|||
170772122|NCT03289039|617173436|FG000|Overall Study|progressed before treatment start|1|||
170772123|NCT03289039|617173437|FG001|Overall Study|progressed before treatment start|0|||
170772124|NCT02918279|617173459|FG000|Overall Study|Lost to Follow-up|3|||
170772125|NCT02918279|617173460|FG001|Overall Study|Lost to Follow-up|6|||
170772126|NCT02918279|617173459|FG000|Overall Study|Withdrawal by Subject|5|||
170772127|NCT02918279|617173460|FG001|Overall Study|Withdrawal by Subject|15|||
170772128|NCT02918279|617173459|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170772129|NCT02918279|617173460|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170772130|NCT02918279|617173459|FG000|Overall Study|Other|3|||
170772131|NCT02918279|617173460|FG001|Overall Study|Other|1|||
170772132|NCT01140048|617173461|FG000|Overall Study|Physician Decision|1|||
170772133|NCT01140048|617173461|FG000|Overall Study|Withdrawal by Subject|13|||
170772134|NCT01140048|617173461|FG000|Overall Study|Lost to Follow-up|31|||
170772135|NCT00636207|617173462|FG000|Overall Study|Adverse Event|1|||
170772136|NCT00636207|617173463|FG001|Overall Study|Adverse Event|0|||
170772137|NCT00636207|617173464|FG002|Overall Study|Adverse Event|0|||
170772138|NCT00636207|617173465|FG003|Overall Study|Adverse Event|0|||
170772139|NCT00636207|617173466|FG004|Overall Study|Adverse Event|0|||
170772140|NCT00636207|617173467|FG005|Overall Study|Adverse Event|0|||
170772141|NCT00636207|617173468|FG006|Overall Study|Adverse Event|0|||
170772142|NCT00636207|617173462|FG000|Overall Study|Withdrawal by Subject|0|||
170772143|NCT00636207|617173463|FG001|Overall Study|Withdrawal by Subject|1|||
170772144|NCT00636207|617173464|FG002|Overall Study|Withdrawal by Subject|0|||
170772145|NCT00636207|617173465|FG003|Overall Study|Withdrawal by Subject|0|||
170772146|NCT00636207|617173466|FG004|Overall Study|Withdrawal by Subject|1|||
170772147|NCT00636207|617173467|FG005|Overall Study|Withdrawal by Subject|0|||
170772148|NCT00636207|617173468|FG006|Overall Study|Withdrawal by Subject|0|||
170772149|NCT00666276|617173469|FG000|Overall Study|Protocol Violation|34|||
170772150|NCT01039688|617173470|FG000|Overall Study|Adverse Event|38|||
170772151|NCT01039688|617173471|FG001|Overall Study|Adverse Event|39|||
170772152|NCT01039688|617173472|FG002|Overall Study|Adverse Event|24|||
170772153|NCT01039688|617173470|FG000|Overall Study|Lack of Efficacy|20|||
170772154|NCT01039688|617173471|FG001|Overall Study|Lack of Efficacy|11|||
170772155|NCT01039688|617173472|FG002|Overall Study|Lack of Efficacy|26|||
170772156|NCT01039688|617173470|FG000|Overall Study|Lost to Follow-up|11|||
170772157|NCT01039688|617173471|FG001|Overall Study|Lost to Follow-up|9|||
170873091|NCT00074581|617546549|FG001|Overall Study|Lost to Follow-up|11|||
170873092|NCT00074581|617546548|FG000|Overall Study|Ended relationship w. index participant|117|||
170632494|NCT01721044|616666681|FG002|Treatment Period|Withdrawal by Subject|1|||
170632495|NCT00904982|616666683|FG000|Overall Study|Withdrawal by Subject|2|||
170632496|NCT00904982|616666684|FG001|Overall Study|Withdrawal by Subject|0|||
170632497|NCT00904982|616666685|FG002|Overall Study|Withdrawal by Subject|0|||
170632498|NCT00904982|616666686|FG003|Overall Study|Withdrawal by Subject|0|||
170632499|NCT01499355|616666688|FG000|Run-In Period|Study Termination|15|||
170632500|NCT01499355|616666689|FG001|Run-In Period|Study Termination|0|||
170632501|NCT01499355|616666690|FG002|Run-In Period|Study Termination|0|||
170632502|NCT01499355|616666691|FG003|Run-In Period|Study Termination|0|||
170632503|NCT01499355|616666688|FG000|Run-In Period|Other|3|||
170873093|NCT00074581|617546549|FG001|Overall Study|Ended relationship w. index participant|106|||
170873094|NCT00074581|617546548|FG000|Overall Study|Other|14|||
170873095|NCT00074581|617546549|FG001|Overall Study|Other|19|||
170873096|NCT01770912|617546550|FG000|Overall Study|Lost to Follow-up|2|||
170873097|NCT01770912|617546551|FG001|Overall Study|Lost to Follow-up|0|||
170873098|NCT01708291|617546552|FG000|Overall Study|fighting|2|||
170873099|NCT01708291|617546553|FG001|Overall Study|fighting|1|||
170873100|NCT03250832|617546554|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
170873101|NCT03250832|617546555|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
170873102|NCT03250832|617546556|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
170873103|NCT03250832|617546557|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
170632504|NCT01499355|616666689|FG001|Run-In Period|Other|0|||
170632505|NCT01499355|616666690|FG002|Run-In Period|Other|0|||
170772158|NCT01039688|617173472|FG002|Overall Study|Lost to Follow-up|5|||
170772159|NCT01039688|617173470|FG000|Overall Study|Other|13|||
170772160|NCT01039688|617173471|FG001|Overall Study|Other|25|||
170772161|NCT01039688|617173472|FG002|Overall Study|Other|12|||
170873104|NCT03250832|617546558|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
170632506|NCT01499355|616666691|FG003|Run-In Period|Other|0|||
170772162|NCT01039688|617173470|FG000|Overall Study|Withdrawal by Subject|23|||
170772163|NCT01039688|617173471|FG001|Overall Study|Withdrawal by Subject|27|||
170772164|NCT01039688|617173472|FG002|Overall Study|Withdrawal by Subject|13|||
170873105|NCT03250832|617546559|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
170873106|NCT03250832|617546560|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
170873107|NCT03250832|617546561|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
170873108|NCT03250832|617546562|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
170873109|NCT03250832|617546563|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
170873110|NCT03250832|617546564|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
170873111|NCT03250832|617546565|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
170873112|NCT03250832|617546554|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
170873113|NCT03250832|617546555|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
170873114|NCT03250832|617546556|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
170873115|NCT03250832|617546557|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
170873116|NCT03250832|617546558|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
170873117|NCT03250832|617546559|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
170873118|NCT03250832|617546560|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
170873119|NCT03250832|617546561|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
170873120|NCT03250832|617546562|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
170873121|NCT03250832|617546563|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
170873122|NCT03250832|617546564|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
170873123|NCT03250832|617546565|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
170873124|NCT03250832|617546554|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873125|NCT03250832|617546555|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873126|NCT03250832|617546556|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
170873127|NCT03250832|617546557|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873128|NCT03250832|617546558|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873129|NCT03250832|617546559|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873130|NCT03250832|617546560|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873131|NCT03250832|617546561|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873132|NCT03250832|617546562|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873133|NCT03250832|617546563|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873134|NCT03250832|617546564|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873135|NCT03250832|617546565|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
170873136|NCT03250832|617546554|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873137|NCT03250832|617546555|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873138|NCT03250832|617546556|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873139|NCT03250832|617546557|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873140|NCT03250832|617546558|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873141|NCT03250832|617546559|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873142|NCT03250832|617546560|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873143|NCT03250832|617546561|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
170873144|NCT03250832|617546562|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873145|NCT03250832|617546563|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873146|NCT03250832|617546564|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873147|NCT03250832|617546565|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
170873148|NCT03250832|617546554|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873149|NCT03250832|617546555|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873150|NCT03250832|617546556|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873151|NCT03250832|617546557|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873152|NCT03250832|617546558|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873153|NCT03250832|617546559|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873154|NCT03250832|617546560|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873155|NCT03250832|617546561|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
170873156|NCT03250832|617546562|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873157|NCT03250832|617546563|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873158|NCT03250832|617546564|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873159|NCT03250832|617546565|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
170873160|NCT03250832|617546554|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873161|NCT03250832|617546555|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873162|NCT03250832|617546556|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873163|NCT03250832|617546557|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873164|NCT03250832|617546558|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873165|NCT03250832|617546559|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170526204|NCT01687218|616274150|FG005|Overall Study|Withdrawal by Subject|0|||
170772165|NCT01039688|617173470|FG000|Overall Study|Death|2|||
170772166|NCT01039688|617173471|FG001|Overall Study|Death|0|||
170772167|NCT01039688|617173472|FG002|Overall Study|Death|0|||
170772168|NCT03844269|617173478|FG000|Overall Study|Withdrawal pre-intervention|1|||
170772169|NCT03844269|617173478|FG000|Overall Study|Did not complete the intervention|2|||
170772170|NCT00101010|617173484|FG000|Overall Study|Physician Decision|1|||
170772171|NCT00364013|617173487|FG000|Overall Study|Ineligibility determined|4|||
170772172|NCT00364013|617173488|FG001|Overall Study|Ineligibility determined|2|||
170772173|NCT00364013|617173487|FG000|Overall Study|Adverse Event|4|||
170772174|NCT00364013|617173488|FG001|Overall Study|Adverse Event|3|||
170772175|NCT00364013|617173487|FG000|Overall Study|Withdrawal by Subject|13|||
170772176|NCT00364013|617173488|FG001|Overall Study|Withdrawal by Subject|18|||
170772177|NCT00364013|617173487|FG000|Overall Study|Physician Decision|3|||
170772178|NCT00364013|617173488|FG001|Overall Study|Physician Decision|3|||
170772179|NCT00364013|617173487|FG000|Overall Study|Lost to Follow-up|10|||
170772180|NCT00364013|617173488|FG001|Overall Study|Lost to Follow-up|3|||
170772181|NCT00364013|617173487|FG000|Overall Study|Protocol-specified criteria|6|||
170772182|NCT00364013|617173488|FG001|Overall Study|Protocol-specified criteria|6|||
170772183|NCT00364013|617173487|FG000|Overall Study|Other|41|||
170772184|NCT00364013|617173488|FG001|Overall Study|Other|47|||
170772185|NCT00364013|617173487|FG000|Overall Study|Ongoing|20|||
170772186|NCT00364013|617173488|FG001|Overall Study|Ongoing|13|||
170772187|NCT00891930|617173489|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
170772188|NCT00891930|617173489|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
170772189|NCT00891930|617173489|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
170772190|NCT00891930|617173489|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
170772191|NCT00891930|617173489|FG000|Part 2 Panitumumab + AMG479|Death|30|||
170772192|NCT02512965|617173493|FG000|Overall Study|Withdrawal by Subject|0|||
170772193|NCT02512965|617173494|FG001|Overall Study|Withdrawal by Subject|4|||
170772194|NCT02570711|617173495|FG000|Overall Study|Death|1|||
170772195|NCT02570711|617173496|FG001|Overall Study|Death|0|||
170772196|NCT02570711|617173495|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
170772197|NCT02570711|617173496|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
170772198|NCT00545077|617173498|FG000|Overall Study|Treatment not received|5|||
170772199|NCT00545077|617173499|FG001|Overall Study|Treatment not received|1|||
170772200|NCT00545077|617173498|FG000|Overall Study|Disease Progression|131|||
170772201|NCT00545077|617173499|FG001|Overall Study|Disease Progression|98|||
170772202|NCT00545077|617173498|FG000|Overall Study|Withdrawal by Subject|3|||
170772203|NCT00545077|617173499|FG001|Overall Study|Withdrawal by Subject|14|||
170772204|NCT00545077|617173498|FG000|Overall Study|Physician Decision|6|||
170772205|NCT00545077|617173499|FG001|Overall Study|Physician Decision|3|||
170772206|NCT00545077|617173498|FG000|Overall Study|Lost to Follow-up|2|||
170772207|NCT00545077|617173499|FG001|Overall Study|Lost to Follow-up|0|||
170772208|NCT00545077|617173498|FG000|Overall Study|Protocol Violation|1|||
170772209|NCT00545077|617173499|FG001|Overall Study|Protocol Violation|0|||
170772210|NCT00545077|617173498|FG000|Overall Study|Adverse Event|0|||
170772211|NCT00545077|617173499|FG001|Overall Study|Adverse Event|31|||
170772212|NCT00545077|617173498|FG000|Overall Study|Death|0|||
170772213|NCT00545077|617173499|FG001|Overall Study|Death|8|||
170772214|NCT02202499|617173500|FG000|Overall Study|Cancer diagnosis|0|||
170772215|NCT02202499|617173501|FG001|Overall Study|Cancer diagnosis|0|||
170772216|NCT02202499|617173502|FG002|Overall Study|Cancer diagnosis|1|||
170772217|NCT02202499|617173500|FG000|Overall Study|Moved from area|0|||
170772218|NCT02202499|617173501|FG001|Overall Study|Moved from area|0|||
170772219|NCT02202499|617173502|FG002|Overall Study|Moved from area|1|||
170772220|NCT02202499|617173500|FG000|Overall Study|Declined before randomization|1|||
170873166|NCT03250832|617546560|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170526205|NCT01687218|616274145|FG000|Overall Study|Relocated, no follow-up planned|1|||
170526206|NCT01687218|616274146|FG001|Overall Study|Relocated, no follow-up planned|0|||
170526207|NCT01687218|616274147|FG002|Overall Study|Relocated, no follow-up planned|1|||
170526208|NCT01687218|616274148|FG003|Overall Study|Relocated, no follow-up planned|1|||
170526209|NCT01687218|616274149|FG004|Overall Study|Relocated, no follow-up planned|0|||
170526210|NCT01687218|616274150|FG005|Overall Study|Relocated, no follow-up planned|0|||
170526211|NCT03608826|616274151|FG000|Overall Study|Death|3|||
170526212|NCT03608826|616274151|FG000|Overall Study|Heart Transplant|3|||
170526213|NCT03608826|616274151|FG000|Overall Study|Physician Decision|4|||
170526214|NCT00887484|616274166|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
170772221|NCT02202499|617173501|FG001|Overall Study|Declined before randomization|0|||
170772222|NCT02202499|617173502|FG002|Overall Study|Declined before randomization|0|||
170772223|NCT02202499|617173500|FG000|Overall Study|Auto accident|1|||
170772224|NCT02202499|617173501|FG001|Overall Study|Auto accident|0|||
170772225|NCT02202499|617173502|FG002|Overall Study|Auto accident|0|||
170772226|NCT00535145|617173503|FG000|Phase I|Adverse Event|3|||
170772227|NCT00535145|617173503|FG000|Phase I|Lost to Follow-up|7|||
170772228|NCT00535145|617173503|FG000|Phase I|Withdrawal by Subject|6|||
170772229|NCT00535145|617173503|FG000|Phase I|(eligibility)|8|||
170772230|NCT00535145|617173503|FG000|Phase I|(protocol violation)|1|||
170772231|NCT00535145|617173503|FG000|Phase I|(PI decision)|1|||
170873167|NCT03250832|617546561|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
170873168|NCT03250832|617546562|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873169|NCT03250832|617546563|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873170|NCT03250832|617546564|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873171|NCT03250832|617546565|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
170873172|NCT03250832|617546554|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873173|NCT03250832|617546555|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873174|NCT03250832|617546556|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873175|NCT03250832|617546557|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873176|NCT03250832|617546558|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873177|NCT03250832|617546559|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873178|NCT03250832|617546560|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873179|NCT03250832|617546561|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
170873180|NCT03250832|617546562|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873181|NCT03250832|617546563|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873182|NCT03250832|617546564|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873183|NCT03250832|617546565|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
170873184|NCT03250832|617546554|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873185|NCT03250832|617546555|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873186|NCT03250832|617546556|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873187|NCT03250832|617546557|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873188|NCT03250832|617546558|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873189|NCT03250832|617546559|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873190|NCT03250832|617546560|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873191|NCT03250832|617546561|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
170873192|NCT03250832|617546562|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873193|NCT03250832|617546563|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873194|NCT03250832|617546564|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
170873195|NCT03250832|617546565|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
170526215|NCT00887484|616274166|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
170526216|NCT00887484|616274166|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
170526217|NCT03122171|616274167|FG000|Overall Study|Withdrawal by Subject|1|||
170772232|NCT00535145|617173503|FG000|Phase I|(diagnosis)|3|||
170873196|NCT03250832|617546554|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
170772233|NCT00535145|617173503|FG000|Phase II|Adverse Event|2|||
170873197|NCT03250832|617546555|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
170873198|NCT03250832|617546556|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
170873199|NCT03250832|617546557|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
170873200|NCT03250832|617546558|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
170873201|NCT03250832|617546559|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
170873202|NCT03250832|617546560|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
170772234|NCT00535145|617173503|FG000|Phase II|Lack of Efficacy|1|||
170772235|NCT00535145|617173503|FG000|Phase II|Lost to Follow-up|5|||
170772236|NCT00535145|617173503|FG000|Phase II|Withdrawal by Subject|5|||
170772237|NCT00535145|617173503|FG000|Phase II|Subject non-compliance|2|||
170772238|NCT02471755|617173504|FG000|Overall Study|Withdrawal by Subject|1|||
170772239|NCT02471755|617173505|FG001|Overall Study|Withdrawal by Subject|0|||
170772240|NCT02471755|617173504|FG000|Overall Study|Lost to Follow-up|0|||
170772241|NCT02471755|617173505|FG001|Overall Study|Lost to Follow-up|1|||
170772242|NCT04740164|617173506|FG000|Overall Study|Lack of Efficacy|4|||
170772243|NCT04740164|617173507|FG001|Overall Study|Lack of Efficacy|0|||
170772244|NCT04740164|617173506|FG000|Overall Study|Physician Decision|3|||
170772245|NCT04740164|617173507|FG001|Overall Study|Physician Decision|3|||
170772246|NCT04523714|617173510|FG000|Overall Study|Death|3|||
170772247|NCT04523714|617173511|FG001|Overall Study|Death|7|||
170772248|NCT04523714|617173512|FG002|Overall Study|Death|7|||
170772249|NCT04523714|617173510|FG000|Overall Study|Withdrawal by Subject|43|||
170772250|NCT04523714|617173511|FG001|Overall Study|Withdrawal by Subject|45|||
170772251|NCT04523714|617173512|FG002|Overall Study|Withdrawal by Subject|16|||
170772252|NCT04523714|617173510|FG000|Overall Study|Randomized in error|0|||
170772253|NCT04523714|617173511|FG001|Overall Study|Randomized in error|0|||
170772254|NCT04523714|617173512|FG002|Overall Study|Randomized in error|2|||
170772255|NCT02971748|617173513|FG000|Overall Study|Adverse Event|12|||
170772256|NCT02971748|617173513|FG000|Overall Study|Withdrawal by Subject|1|||
170772257|NCT02971748|617173513|FG000|Overall Study|Financial issue|2|||
170772258|NCT02971748|617173513|FG000|Overall Study|Clinical progression|8|||
170772259|NCT02389517|617173514|FG000|Overall Study|Withdrawal by Subject|3|||
170772260|NCT02389517|617173515|FG001|Overall Study|Withdrawal by Subject|2|||
170772261|NCT02389517|617173514|FG000|Overall Study|Adverse Event|3|||
170873203|NCT03250832|617546561|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
170873204|NCT03250832|617546562|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
170873205|NCT03250832|617546563|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
170873206|NCT03250832|617546564|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
170873207|NCT03250832|617546565|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
170873208|NCT03250832|617546554|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873209|NCT03250832|617546555|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873210|NCT03250832|617546556|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873211|NCT03250832|617546557|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873212|NCT03250832|617546558|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873213|NCT03250832|617546559|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873214|NCT03250832|617546560|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873215|NCT03250832|617546561|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873216|NCT03250832|617546562|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
170873217|NCT03250832|617546563|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
170873218|NCT03250832|617546564|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873219|NCT03250832|617546565|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
170873220|NCT03250832|617546554|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873221|NCT03250832|617546555|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873222|NCT03250832|617546556|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873223|NCT03250832|617546557|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873224|NCT03250832|617546558|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873225|NCT03250832|617546559|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873226|NCT03250832|617546560|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873227|NCT03250832|617546561|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873228|NCT03250832|617546562|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
170873229|NCT03250832|617546563|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
170873230|NCT03250832|617546564|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873231|NCT03250832|617546565|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
170873232|NCT03250832|617546554|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873233|NCT03250832|617546555|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873234|NCT03250832|617546556|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873235|NCT03250832|617546557|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873236|NCT03250832|617546558|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873237|NCT03250832|617546559|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873238|NCT03250832|617546560|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873239|NCT03250832|617546561|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873240|NCT03250832|617546562|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873241|NCT03250832|617546563|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873242|NCT03250832|617546564|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
170873243|NCT03250832|617546565|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
170873244|NCT02303704|617546566|FG000|Overall Study|Protocol Violation|5|||
170873245|NCT02303704|617546567|FG001|Overall Study|Protocol Violation|9|||
170873246|NCT04411628|617546569|FG000|Overall Study|Withdrawal by Subject|1|||
170873247|NCT04411628|617546570|FG001|Overall Study|Withdrawal by Subject|1|||
170873248|NCT04411628|617546571|FG002|Overall Study|Withdrawal by Subject|2|||
170873249|NCT04411628|617546572|FG003|Overall Study|Withdrawal by Subject|0|||
170873250|NCT04411628|617546569|FG000|Overall Study|Lost to Follow-up|0|||
170873251|NCT04411628|617546570|FG001|Overall Study|Lost to Follow-up|1|||
170873252|NCT04411628|617546571|FG002|Overall Study|Lost to Follow-up|0|||
170873253|NCT04411628|617546572|FG003|Overall Study|Lost to Follow-up|0|||
170873254|NCT00805025|617546573|FG000|Overall Study|Screened but not enrolled/treated|42|||
170873255|NCT00805025|617546573|FG000|Overall Study|Adverse Event|4|||
170873256|NCT00805025|617546573|FG000|Overall Study|Withdrawal by Subject|2|||
170873257|NCT00805025|617546573|FG000|Overall Study|Physician Decision|1|||
170873258|NCT00932425|617546574|FG000|Overall Study|Lost to Follow-up|0|||
170873259|NCT00932425|617546575|FG001|Overall Study|Lost to Follow-up|1|||
170873260|NCT00932425|617546574|FG000|Overall Study|Withdrawal by Subject|0|||
170873261|NCT00932425|617546575|FG001|Overall Study|Withdrawal by Subject|1|||
170873262|NCT04360551|617548107|FG000|Overall Study|Withdrawal by Subject|1|||
170873263|NCT04360551|617548108|FG001|Overall Study|Withdrawal by Subject|0|||
170873264|NCT03496012|617548112|FG000|Overall Study|Withdrawal by Subject|2|||
170873265|NCT03496012|617548113|FG001|Overall Study|Withdrawal by Subject|0|||
170873266|NCT03496012|617548114|FG002|Overall Study|Withdrawal by Subject|2|||
170873267|NCT03496012|617548112|FG000|Overall Study|Adverse Event|0|||
170873268|NCT03496012|617548113|FG001|Overall Study|Adverse Event|0|||
170873269|NCT03496012|617548114|FG002|Overall Study|Adverse Event|1|||
170873270|NCT03496012|617548112|FG000|Overall Study|Reason Not Specified|2|||
170873271|NCT03496012|617548113|FG001|Overall Study|Reason Not Specified|0|||
170873272|NCT03496012|617548114|FG002|Overall Study|Reason Not Specified|1|||
170873273|NCT00574145|617548115|FG000|Overall Study|Withdrawal by Subject|2|||
170873274|NCT00574145|617548116|FG001|Overall Study|Withdrawal by Subject|1|||
170873275|NCT03227471|617548117|FG000|Overall Study|Withdrawal by Subject|0|||
170873276|NCT03227471|617548118|FG001|Overall Study|Withdrawal by Subject|0|||
170873277|NCT03227471|617548119|FG002|Overall Study|Withdrawal by Subject|0|||
170873278|NCT03227471|617548120|FG003|Overall Study|Withdrawal by Subject|0|||
170873279|NCT03227471|617548121|FG004|Overall Study|Withdrawal by Subject|1|||
170873280|NCT03227471|617548122|FG005|Overall Study|Withdrawal by Subject|0|||
170873281|NCT03227471|617548123|FG006|Overall Study|Withdrawal by Subject|0|||
170873282|NCT03227471|617548124|FG007|Overall Study|Withdrawal by Subject|0|||
170873283|NCT03227471|617548125|FG008|Overall Study|Withdrawal by Subject|0|||
170873284|NCT03227471|617548126|FG009|Overall Study|Withdrawal by Subject|0|||
170873285|NCT03227471|617548127|FG010|Overall Study|Withdrawal by Subject|0|||
170873286|NCT03227471|617548128|FG011|Overall Study|Withdrawal by Subject|0|||
170873287|NCT03227471|617548129|FG012|Overall Study|Withdrawal by Subject|1|||
170873288|NCT03227471|617548130|FG013|Overall Study|Withdrawal by Subject|0|||
170873289|NCT03227471|617548131|FG014|Overall Study|Withdrawal by Subject|0|||
170873290|NCT03227471|617548117|FG000|Overall Study|Randomized, Never Dosed|0|||
170873291|NCT03227471|617548118|FG001|Overall Study|Randomized, Never Dosed|0|||
170873292|NCT03227471|617548119|FG002|Overall Study|Randomized, Never Dosed|0|||
170873293|NCT03227471|617548120|FG003|Overall Study|Randomized, Never Dosed|0|||
170873294|NCT03227471|617548121|FG004|Overall Study|Randomized, Never Dosed|0|||
170873295|NCT03227471|617548122|FG005|Overall Study|Randomized, Never Dosed|0|||
170873296|NCT03227471|617548123|FG006|Overall Study|Randomized, Never Dosed|0|||
170873297|NCT03227471|617548124|FG007|Overall Study|Randomized, Never Dosed|0|||
170873298|NCT03227471|617548125|FG008|Overall Study|Randomized, Never Dosed|0|||
170873299|NCT03227471|617548126|FG009|Overall Study|Randomized, Never Dosed|0|||
170873300|NCT03227471|617548127|FG010|Overall Study|Randomized, Never Dosed|0|||
170873301|NCT03227471|617548128|FG011|Overall Study|Randomized, Never Dosed|0|||
170873302|NCT03227471|617548129|FG012|Overall Study|Randomized, Never Dosed|0|||
170873303|NCT03227471|617548130|FG013|Overall Study|Randomized, Never Dosed|0|||
170873304|NCT03227471|617548131|FG014|Overall Study|Randomized, Never Dosed|1|||
170873305|NCT00736255|617548133|FG000|Overall Study|Adverse Event|1|||
170873306|NCT00736255|617548134|FG001|Overall Study|Adverse Event|0|||
170873307|NCT00736255|617548133|FG000|Overall Study|Physician Decision|1|||
170873308|NCT00736255|617548134|FG001|Overall Study|Physician Decision|0|||
170873309|NCT00736255|617548133|FG000|Overall Study|Non-compliance|1|||
170873310|NCT00736255|617548134|FG001|Overall Study|Non-compliance|1|||
170873311|NCT01251653|617548136|FG000|Overall Study|Progressive Disease|1|||
170873312|NCT01251653|617548137|FG001|Overall Study|Progressive Disease|7|||
170873313|NCT01251653|617548138|FG002|Overall Study|Progressive Disease|16|||
170873314|NCT01251653|617548139|FG003|Overall Study|Progressive Disease|4|||
170873315|NCT01251653|617548140|FG004|Overall Study|Progressive Disease|0|||
170873316|NCT01251653|617548141|FG005|Overall Study|Progressive Disease|17|||
170873317|NCT01251653|617548142|FG006|Overall Study|Progressive Disease|14|||
170873318|NCT01251653|617548143|FG007|Overall Study|Progressive Disease|7|||
170873319|NCT01251653|617548144|FG008|Overall Study|Progressive Disease|5|||
170873320|NCT01251653|617548136|FG000|Overall Study|Dose-limiting toxicity|0|||
170873321|NCT01251653|617548137|FG001|Overall Study|Dose-limiting toxicity|1|||
170873322|NCT01251653|617548138|FG002|Overall Study|Dose-limiting toxicity|1|||
170873323|NCT01251653|617548139|FG003|Overall Study|Dose-limiting toxicity|1|||
170873324|NCT01251653|617548140|FG004|Overall Study|Dose-limiting toxicity|0|||
170873325|NCT01251653|617548141|FG005|Overall Study|Dose-limiting toxicity|0|||
170873326|NCT01251653|617548142|FG006|Overall Study|Dose-limiting toxicity|2|||
170873327|NCT01251653|617548143|FG007|Overall Study|Dose-limiting toxicity|0|||
170873328|NCT01251653|617548144|FG008|Overall Study|Dose-limiting toxicity|0|||
170873329|NCT01251653|617548136|FG000|Overall Study|Adverse Event|1|||
170873330|NCT01251653|617548137|FG001|Overall Study|Adverse Event|0|||
170873331|NCT01251653|617548138|FG002|Overall Study|Adverse Event|2|||
170873332|NCT01251653|617548139|FG003|Overall Study|Adverse Event|1|||
170873333|NCT01251653|617548140|FG004|Overall Study|Adverse Event|1|||
170873334|NCT01251653|617548141|FG005|Overall Study|Adverse Event|0|||
170873335|NCT01251653|617548142|FG006|Overall Study|Adverse Event|2|||
170873336|NCT01251653|617548143|FG007|Overall Study|Adverse Event|2|||
170873337|NCT01251653|617548144|FG008|Overall Study|Adverse Event|1|||
170873338|NCT01251653|617548136|FG000|Overall Study|Withdrawal by Subject|1|||
170873339|NCT01251653|617548137|FG001|Overall Study|Withdrawal by Subject|0|||
170873340|NCT01251653|617548138|FG002|Overall Study|Withdrawal by Subject|1|||
170873341|NCT01251653|617548139|FG003|Overall Study|Withdrawal by Subject|0|||
170873342|NCT01251653|617548140|FG004|Overall Study|Withdrawal by Subject|1|||
170873343|NCT01251653|617548141|FG005|Overall Study|Withdrawal by Subject|1|||
170873344|NCT01251653|617548142|FG006|Overall Study|Withdrawal by Subject|0|||
170873345|NCT01251653|617548143|FG007|Overall Study|Withdrawal by Subject|1|||
170873346|NCT01251653|617548144|FG008|Overall Study|Withdrawal by Subject|0|||
170873347|NCT01251653|617548136|FG000|Overall Study|Other reason not mentioned above|0|||
170873348|NCT01251653|617548137|FG001|Overall Study|Other reason not mentioned above|0|||
170873349|NCT01251653|617548138|FG002|Overall Study|Other reason not mentioned above|0|||
170873350|NCT01251653|617548139|FG003|Overall Study|Other reason not mentioned above|0|||
170873351|NCT01251653|617548140|FG004|Overall Study|Other reason not mentioned above|0|||
170873352|NCT01251653|617548141|FG005|Overall Study|Other reason not mentioned above|0|||
170873353|NCT01251653|617548142|FG006|Overall Study|Other reason not mentioned above|0|||
170873354|NCT01251653|617548143|FG007|Overall Study|Other reason not mentioned above|2|||
170873355|NCT01251653|617548144|FG008|Overall Study|Other reason not mentioned above|0|||
170873356|NCT01524198|617548145|FG000|Overall Study|Protocol Violation|8|||
170873357|NCT01524198|617548146|FG001|Overall Study|Protocol Violation|6|||
170873358|NCT01524198|617548145|FG000|Overall Study|Withdrawal by Subject|15|||
170873359|NCT01524198|617548146|FG001|Overall Study|Withdrawal by Subject|10|||
170873360|NCT02232802|617548147|FG000|Period 1|Sponsor request|1|||
170873361|NCT02232802|617548148|FG001|Period 1|Sponsor request|0|||
170873362|NCT02232802|617548147|FG000|Period 1|Adverse Event|1|||
170873363|NCT02232802|617548148|FG001|Period 1|Adverse Event|1|||
170873364|NCT00885703|617548149|FG000|Overall Study|Death|9|||
170873365|NCT00885703|617548150|FG001|Overall Study|Death|7|||
170873366|NCT00885703|617548151|FG002|Overall Study|Death|8|||
170873367|NCT00885703|617548152|FG003|Overall Study|Death|7|||
170873368|NCT00885703|617548153|FG004|Overall Study|Death|7|||
170873369|NCT00885703|617548154|FG005|Overall Study|Death|8|||
170873370|NCT00885703|617548155|FG006|Overall Study|Death|4|||
170873371|NCT00885703|617548149|FG000|Overall Study|Lost to Follow-up|0|||
170873372|NCT00885703|617548150|FG001|Overall Study|Lost to Follow-up|0|||
170772262|NCT02389517|617173515|FG001|Overall Study|Adverse Event|1|||
170772263|NCT02389517|617173514|FG000|Overall Study|Physician Decision|0|||
170772264|NCT02389517|617173515|FG001|Overall Study|Physician Decision|1|||
170772265|NCT02389517|617173514|FG000|Overall Study|Progressive disease|0|||
170772266|NCT02389517|617173515|FG001|Overall Study|Progressive disease|1|||
170772267|NCT01208662|617173516|FG000|Induction and Consolidation|Disease Progression|23|||
170772268|NCT01208662|617173517|FG001|Induction and Consolidation|Disease Progression|13|||
170772269|NCT01208662|617173518|FG002|Induction and Consolidation|Disease Progression|0|||
170772270|NCT01208662|617173516|FG000|Induction and Consolidation|Adverse Event|16|||
170772271|NCT01208662|617173517|FG001|Induction and Consolidation|Adverse Event|18|||
170772272|NCT01208662|617173518|FG002|Induction and Consolidation|Adverse Event|2|||
170772273|NCT01208662|617173516|FG000|Induction and Consolidation|MD or Participant Decision|16|||
170772274|NCT01208662|617173517|FG001|Induction and Consolidation|MD or Participant Decision|34|||
170772275|NCT01208662|617173518|FG002|Induction and Consolidation|MD or Participant Decision|4|||
170772276|NCT01208662|617173516|FG000|Induction and Consolidation|Death|1|||
170772277|NCT01208662|617173517|FG001|Induction and Consolidation|Death|3|||
170772278|NCT01208662|617173518|FG002|Induction and Consolidation|Death|1|||
170772279|NCT01208662|617173516|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
170772280|NCT01208662|617173517|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
170772281|NCT01208662|617173518|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
170772282|NCT01208662|617173516|FG000|Maintenance|Disease Progression|156|||
170772283|NCT01208662|617173517|FG001|Maintenance|Disease Progression|102|||
170772284|NCT01208662|617173518|FG002|Maintenance|Disease Progression|0|||
170772285|NCT01208662|617173516|FG000|Maintenance|Adverse Event|12|||
170772286|NCT01208662|617173517|FG001|Maintenance|Adverse Event|28|||
170772287|NCT01208662|617173518|FG002|Maintenance|Adverse Event|0|||
170772288|NCT01208662|617173516|FG000|Maintenance|MD or Participant Decision|24|||
170772289|NCT01208662|617173517|FG001|Maintenance|MD or Participant Decision|36|||
170772290|NCT01208662|617173518|FG002|Maintenance|MD or Participant Decision|0|||
170873373|NCT00885703|617548151|FG002|Overall Study|Lost to Follow-up|1|||
170873374|NCT00885703|617548152|FG003|Overall Study|Lost to Follow-up|0|||
170873375|NCT00885703|617548153|FG004|Overall Study|Lost to Follow-up|0|||
170873376|NCT00885703|617548154|FG005|Overall Study|Lost to Follow-up|1|||
170873377|NCT00885703|617548155|FG006|Overall Study|Lost to Follow-up|0|||
170873378|NCT00885703|617548149|FG000|Overall Study|Withdrawal by Subject|0|||
170873379|NCT00885703|617548150|FG001|Overall Study|Withdrawal by Subject|0|||
170873380|NCT00885703|617548151|FG002|Overall Study|Withdrawal by Subject|0|||
170873381|NCT00885703|617548152|FG003|Overall Study|Withdrawal by Subject|1|||
170873382|NCT00885703|617548153|FG004|Overall Study|Withdrawal by Subject|3|||
170873383|NCT00885703|617548154|FG005|Overall Study|Withdrawal by Subject|1|||
170873384|NCT00885703|617548155|FG006|Overall Study|Withdrawal by Subject|1|||
170873385|NCT00885703|617548149|FG000|Overall Study|Ineligible (no CM)|1|||
170772291|NCT01208662|617173516|FG000|Maintenance|Death|0|||
170772292|NCT01208662|617173517|FG001|Maintenance|Death|3|||
170772293|NCT01208662|617173518|FG002|Maintenance|Death|0|||
170772294|NCT01208662|617173516|FG000|Maintenance|Discontinued for other reasons|21|||
170772295|NCT01208662|617173517|FG001|Maintenance|Discontinued for other reasons|31|||
170873386|NCT00885703|617548150|FG001|Overall Study|Ineligible (no CM)|3|||
170873387|NCT00885703|617548151|FG002|Overall Study|Ineligible (no CM)|2|||
170873388|NCT00885703|617548152|FG003|Overall Study|Ineligible (no CM)|1|||
170873389|NCT00885703|617548153|FG004|Overall Study|Ineligible (no CM)|2|||
170414871|NCT00455533|615858938|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
170873390|NCT00885703|617548154|FG005|Overall Study|Ineligible (no CM)|3|||
170873391|NCT00885703|617548155|FG006|Overall Study|Ineligible (no CM)|1|||
170772296|NCT01208662|617173518|FG002|Maintenance|Discontinued for other reasons|0|||
170772297|NCT01208662|617173516|FG000|Maintenance|Still on Treatment|78|||
170772298|NCT01208662|617173517|FG001|Maintenance|Still on Treatment|89|||
170772299|NCT01208662|617173518|FG002|Maintenance|Still on Treatment|0|||
170772300|NCT01597258|617173520|FG000|Overall Study|No Drug Administration|1|||
170526218|NCT02700048|616274168|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
170772301|NCT04789408|617173521|FG000|Overall Study|Death|4|||
170772302|NCT04789408|617173522|FG001|Overall Study|Death|3|||
170772303|NCT04789408|617173523|FG002|Overall Study|Death|6|||
170772304|NCT04789408|617173521|FG000|Overall Study|Did not meet eligibility criteria|1|||
170772305|NCT04789408|617173522|FG001|Overall Study|Did not meet eligibility criteria|0|||
170772306|NCT04789408|617173523|FG002|Overall Study|Did not meet eligibility criteria|0|||
170772307|NCT04789408|617173521|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
170772308|NCT04789408|617173522|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
170772309|NCT04789408|617173523|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
170772310|NCT03473340|617173524|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
170772311|NCT03473340|617173525|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
170772312|NCT03473340|617173524|FG000|Overall Study|Withdrawal by Subject|1|||
170772313|NCT03473340|617173525|FG001|Overall Study|Withdrawal by Subject|0|||
170772314|NCT03473340|617173524|FG000|Overall Study|Lost to Follow-up|1|||
170772315|NCT03473340|617173525|FG001|Overall Study|Lost to Follow-up|2|||
170772316|NCT01420549|617173526|FG000|Overall Study|Adverse Event|1|||
170772317|NCT01420549|617173527|FG001|Overall Study|Adverse Event|1|||
170772318|NCT01420549|617173526|FG000|Overall Study|Lost to Follow-up|2|||
170772319|NCT01420549|617173527|FG001|Overall Study|Lost to Follow-up|2|||
170772320|NCT01420549|617173526|FG000|Overall Study|Protocol Violation|0|||
170772321|NCT01420549|617173527|FG001|Overall Study|Protocol Violation|1|||
170772322|NCT01420549|617173526|FG000|Overall Study|Non-adherence to medication|4|||
170772323|NCT01420549|617173527|FG001|Overall Study|Non-adherence to medication|1|||
170772324|NCT03394885|617173528|FG000|Overall Study|Adverse Event|4|||
170772325|NCT03394885|617173528|FG000|Overall Study|Lack of Efficacy|1|||
170772326|NCT03394885|617173528|FG000|Overall Study|Physician Decision|1|||
170772327|NCT03394885|617173528|FG000|Overall Study|Withdrawal by Subject|8|||
170772328|NCT03394885|617173528|FG000|Overall Study|Alternative Therapy|1|||
170772329|NCT04980755|617173529|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
170772330|NCT04980755|617173529|FG000|Body Reprogramming Courses|Work commitment|2|||
170772331|NCT04980755|617173529|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
170772332|NCT04980755|617173529|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
170772333|NCT01212991|617173530|FG000|Double-blind|Lost to Follow-up|8|||
170772334|NCT01212991|617173531|FG001|Double-blind|Lost to Follow-up|4|||
170772335|NCT01212991|617173532|FG002|Double-blind|Lost to Follow-up|0|||
170772336|NCT01212991|617173530|FG000|Double-blind|Death|699|||
170772337|NCT01212991|617173531|FG001|Double-blind|Death|550|||
170772338|NCT01212991|617173532|FG002|Double-blind|Death|0|||
170772339|NCT01212991|617173530|FG000|Double-blind|Withdrawal by Subject|16|||
170772340|NCT01212991|617173531|FG001|Double-blind|Withdrawal by Subject|19|||
170772341|NCT01212991|617173532|FG002|Double-blind|Withdrawal by Subject|0|||
170772342|NCT01212991|617173530|FG000|Double-blind|Other|7|||
170772343|NCT01212991|617173531|FG001|Double-blind|Other|0|||
170772344|NCT01212991|617173532|FG002|Double-blind|Other|0|||
170772345|NCT01212991|617173530|FG000|Double-blind|Sponsor decision|142|||
170772346|NCT01212991|617173531|FG001|Double-blind|Sponsor decision|38|||
170772347|NCT01212991|617173532|FG002|Double-blind|Sponsor decision|0|||
170772348|NCT01212991|617173530|FG000|Open-label|Death|0|||
170772349|NCT01212991|617173531|FG001|Open-label|Death|0|||
170772350|NCT01212991|617173532|FG002|Open-label|Death|166|||
170772351|NCT01212991|617173530|FG000|Open-label|Lost to Follow-up|0|||
170772352|NCT01212991|617173531|FG001|Open-label|Lost to Follow-up|0|||
170772353|NCT01212991|617173532|FG002|Open-label|Lost to Follow-up|5|||
170772354|NCT01212991|617173530|FG000|Open-label|Withdrawal by Subject|0|||
170772355|NCT01212991|617173531|FG001|Open-label|Withdrawal by Subject|0|||
170772356|NCT01212991|617173532|FG002|Open-label|Withdrawal by Subject|7|||
170772357|NCT01212991|617173530|FG000|Open-label|Sponsor decision|0|||
170772358|NCT01212991|617173531|FG001|Open-label|Sponsor decision|0|||
170526219|NCT02700048|616274169|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
170526220|NCT01274533|616274170|FG000|Overall Study|Withdrawal by Subject|1|||
170526221|NCT01274533|616274170|FG000|Overall Study|Non-compliance|1|||
170526222|NCT01274533|616274170|FG000|Overall Study|Disease progression|2|||
170772359|NCT01212991|617173532|FG002|Open-label|Sponsor decision|53|||
170772360|NCT01212991|617173530|FG000|Open-label|Other|0|||
170772361|NCT01212991|617173531|FG001|Open-label|Other|0|||
170772362|NCT01212991|617173532|FG002|Open-label|Other|3|||
170772363|NCT06602466|617173538|FG000|Overall Study|Adverse Event|2|||
170772364|NCT06602466|617173539|FG001|Overall Study|Adverse Event|0|||
170772365|NCT06602466|617173538|FG000|Overall Study|Lost to Follow-up|1|||
170772366|NCT06602466|617173539|FG001|Overall Study|Lost to Follow-up|3|||
170772367|NCT06602466|617173538|FG000|Overall Study|Withdrawal by Subject|1|||
170526223|NCT02008526|616274171|FG000|Overall Study|Death|0|||
170526224|NCT02008526|616274172|FG001|Overall Study|Death|2|||
170526225|NCT02008526|616274173|FG002|Overall Study|Death|1|||
170526226|NCT02008526|616274171|FG000|Overall Study|Withdrawal by Subject|3|||
170526227|NCT02008526|616274172|FG001|Overall Study|Withdrawal by Subject|3|||
170526228|NCT02008526|616274173|FG002|Overall Study|Withdrawal by Subject|2|||
170526229|NCT02008526|616274171|FG000|Overall Study|Lost to Follow-up|5|||
170526230|NCT02008526|616274172|FG001|Overall Study|Lost to Follow-up|9|||
170526231|NCT02008526|616274173|FG002|Overall Study|Lost to Follow-up|6|||
170526232|NCT02669849|616275374|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
170526233|NCT02669849|616275375|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
170526234|NCT02669849|616275376|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
170526235|NCT02669849|616275374|FG000|Overall Study|Lost to Follow-up|1|||
170526236|NCT02669849|616275375|FG001|Overall Study|Lost to Follow-up|0|||
170526237|NCT02669849|616275376|FG002|Overall Study|Lost to Follow-up|3|||
170526238|NCT02669849|616275374|FG000|Overall Study|Death|1|||
170526239|NCT02669849|616275375|FG001|Overall Study|Death|1|||
170526240|NCT02669849|616275376|FG002|Overall Study|Death|2|||
170526241|NCT02669849|616275374|FG000|Overall Study|Study terminated by sponsor|16|||
170526242|NCT02669849|616275375|FG001|Overall Study|Study terminated by sponsor|1|||
170526243|NCT02669849|616275376|FG002|Overall Study|Study terminated by sponsor|14|||
170526244|NCT02669849|616275374|FG000|Overall Study|Other|0|||
170526245|NCT02669849|616275375|FG001|Overall Study|Other|0|||
170526246|NCT02669849|616275376|FG002|Overall Study|Other|2|||
170526247|NCT03408899|616275377|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
170526248|NCT04745351|616275378|FG000|Overall Study|Death|51|||
170526249|NCT04745351|616275379|FG001|Overall Study|Death|25|||
170526250|NCT04745351|616275378|FG000|Overall Study|Lost to Follow-up|9|||
170526251|NCT04745351|616275379|FG001|Overall Study|Lost to Follow-up|3|||
170526252|NCT04745351|616275378|FG000|Overall Study|Randomized but Never Treated|3|||
170526253|NCT04745351|616275379|FG001|Overall Study|Randomized but Never Treated|3|||
170526254|NCT04745351|616275378|FG000|Overall Study|Adverse Event|4|||
170772368|NCT06602466|617173539|FG001|Overall Study|Withdrawal by Subject|0|||
170526255|NCT04745351|616275379|FG001|Overall Study|Adverse Event|0|||
170526256|NCT04745351|616275378|FG000|Overall Study|Withdrew Consent|1|||
170526257|NCT04745351|616275379|FG001|Overall Study|Withdrew Consent|2|||
170526258|NCT04745351|616275378|FG000|Overall Study|Investigator's Discretion|2|||
170526259|NCT04745351|616275379|FG001|Overall Study|Investigator's Discretion|0|||
170526260|NCT04745351|616275378|FG000|Overall Study|Protocol Violation|1|||
170526261|NCT04745351|616275379|FG001|Overall Study|Protocol Violation|0|||
170526262|NCT03499795|616275380|FG000|Overall Study|Adverse Event|1|||
170526263|NCT03499795|616275380|FG000|Overall Study|Lost to Follow-up|1|||
170526264|NCT03636256|616275381|FG000|Overall Study|Lost to Follow-up|3|||
170526265|NCT03636256|616275382|FG001|Overall Study|Lost to Follow-up|0|||
170526266|NCT03636256|616275383|FG002|Overall Study|Lost to Follow-up|2|||
170526267|NCT03636256|616275384|FG003|Overall Study|Lost to Follow-up|1|||
170526268|NCT03636256|616275385|FG004|Overall Study|Lost to Follow-up|0|||
170526269|NCT03636256|616275386|FG005|Overall Study|Lost to Follow-up|4|||
170772369|NCT02300298|617174585|FG000|Disposition for Nintedanib|Progressive disease|10|||
170772370|NCT02300298|617174586|FG001|Disposition for Nintedanib|Progressive disease|0|||
170772371|NCT02300298|617174585|FG000|Disposition for Docetaxel|Progressive disease|0|||
170772372|NCT02300298|617174586|FG001|Disposition for Docetaxel|Progressive disease|6|||
170772373|NCT02300298|617174585|FG000|Disposition for Docetaxel|other adverse event|0|||
170772374|NCT02300298|617174586|FG001|Disposition for Docetaxel|other adverse event|4|||
170772375|NCT00774397|617174587|FG000|Overall Study|Adverse Event|1|||
170772376|NCT00774397|617174588|FG001|Overall Study|Adverse Event|3|||
170772377|NCT00774397|617174589|FG002|Overall Study|Adverse Event|16|||
170772378|NCT00774397|617174590|FG003|Overall Study|Adverse Event|8|||
170772379|NCT00774397|617174591|FG004|Overall Study|Adverse Event|8|||
170772380|NCT00774397|617174592|FG005|Overall Study|Adverse Event|3|||
170772381|NCT00774397|617174593|FG006|Overall Study|Adverse Event|16|||
170772382|NCT00774397|617174587|FG000|Overall Study|Lack of Efficacy|11|||
170772383|NCT00774397|617174588|FG001|Overall Study|Lack of Efficacy|4|||
170772384|NCT00774397|617174589|FG002|Overall Study|Lack of Efficacy|5|||
170526270|NCT03636256|616275387|FG006|Overall Study|Lost to Follow-up|2|||
170526271|NCT03636256|616275388|FG007|Overall Study|Lost to Follow-up|0|||
170526272|NCT03636256|616275389|FG008|Overall Study|Lost to Follow-up|4|||
170526273|NCT03636256|616275381|FG000|Overall Study|Withdrawal by Subject|0|||
170526274|NCT03636256|616275382|FG001|Overall Study|Withdrawal by Subject|0|||
170772385|NCT00774397|617174590|FG003|Overall Study|Lack of Efficacy|3|||
170772386|NCT00774397|617174591|FG004|Overall Study|Lack of Efficacy|27|||
170873392|NCT00937937|617548158|FG000|Overall Study|Adverse Event|6|||
170526275|NCT03636256|616275383|FG002|Overall Study|Withdrawal by Subject|0|||
170526276|NCT03636256|616275384|FG003|Overall Study|Withdrawal by Subject|0|||
170526277|NCT03636256|616275385|FG004|Overall Study|Withdrawal by Subject|0|||
170526278|NCT03636256|616275386|FG005|Overall Study|Withdrawal by Subject|0|||
170526279|NCT03636256|616275387|FG006|Overall Study|Withdrawal by Subject|0|||
170772387|NCT00774397|617174592|FG005|Overall Study|Lack of Efficacy|15|||
170772388|NCT00774397|617174593|FG006|Overall Study|Lack of Efficacy|9|||
170772389|NCT00774397|617174587|FG000|Overall Study|Protocol Violation|0|||
170772390|NCT00774397|617174588|FG001|Overall Study|Protocol Violation|1|||
170772391|NCT00774397|617174589|FG002|Overall Study|Protocol Violation|3|||
170772392|NCT00774397|617174590|FG003|Overall Study|Protocol Violation|1|||
170772393|NCT00774397|617174591|FG004|Overall Study|Protocol Violation|2|||
170772394|NCT00774397|617174592|FG005|Overall Study|Protocol Violation|1|||
170772395|NCT00774397|617174593|FG006|Overall Study|Protocol Violation|0|||
170772396|NCT00774397|617174587|FG000|Overall Study|Lost to Follow-up|0|||
170772397|NCT00774397|617174588|FG001|Overall Study|Lost to Follow-up|1|||
170772398|NCT00774397|617174589|FG002|Overall Study|Lost to Follow-up|1|||
170772399|NCT00774397|617174590|FG003|Overall Study|Lost to Follow-up|1|||
170772400|NCT00774397|617174591|FG004|Overall Study|Lost to Follow-up|0|||
170772401|NCT00774397|617174592|FG005|Overall Study|Lost to Follow-up|1|||
170772402|NCT00774397|617174593|FG006|Overall Study|Lost to Follow-up|0|||
170772403|NCT00774397|617174587|FG000|Overall Study|Refused to continue trial medication|1|||
170772404|NCT00774397|617174588|FG001|Overall Study|Refused to continue trial medication|3|||
170772405|NCT00774397|617174589|FG002|Overall Study|Refused to continue trial medication|2|||
170772406|NCT00774397|617174590|FG003|Overall Study|Refused to continue trial medication|2|||
170772407|NCT00774397|617174591|FG004|Overall Study|Refused to continue trial medication|6|||
170772408|NCT00774397|617174592|FG005|Overall Study|Refused to continue trial medication|2|||
170772409|NCT00774397|617174593|FG006|Overall Study|Refused to continue trial medication|3|||
170772410|NCT00774397|617174587|FG000|Overall Study|Not treated|0|||
170772411|NCT00774397|617174588|FG001|Overall Study|Not treated|0|||
170772412|NCT00774397|617174589|FG002|Overall Study|Not treated|0|||
170772413|NCT00774397|617174590|FG003|Overall Study|Not treated|0|||
170873393|NCT00937937|617548158|FG000|Overall Study|Withdrawal by Subject|2|||
170873394|NCT00937937|617548158|FG000|Overall Study|Progression/relapse|61|||
170526280|NCT03636256|616275388|FG007|Overall Study|Withdrawal by Subject|0|||
170526281|NCT03636256|616275389|FG008|Overall Study|Withdrawal by Subject|1|||
170526282|NCT02337491|616275392|FG000|Overall Study|Death|1|||
170526283|NCT02337491|616275393|FG001|Overall Study|Death|1|||
170526284|NCT02337491|616275392|FG000|Overall Study|Adverse Event|0|||
170526285|NCT02337491|616275393|FG001|Overall Study|Adverse Event|1|||
170526286|NCT02337491|616275392|FG000|Overall Study|Withdrawal by Subject|3|||
170526287|NCT02337491|616275393|FG001|Overall Study|Withdrawal by Subject|0|||
170526288|NCT02337491|616275392|FG000|Overall Study|Progressive Disease|44|||
170526289|NCT02337491|616275393|FG001|Overall Study|Progressive Disease|28|||
170526290|NCT02337491|616275392|FG000|Overall Study|On Treatment|2|||
170526291|NCT02337491|616275393|FG001|Overall Study|On Treatment|0|||
170526292|NCT00723229|616275394|FG000|First Intervention|Lost to Follow-up|7|||
170526293|NCT00723229|616275395|FG001|First Intervention|Lost to Follow-up|3|||
170526294|NCT01432951|616275396|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
170526295|NCT02900352|616275397|FG000|Overall Study|Lost to Follow-up|28|||
170526296|NCT02900352|616275398|FG001|Overall Study|Lost to Follow-up|17|||
170526297|NCT00960193|616275399|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
170526298|NCT00386334|616275400|FG000|Double Blind Period|Adverse Event|9|||
170526299|NCT00386334|616275401|FG001|Double Blind Period|Adverse Event|14|||
170526300|NCT00386334|616275400|FG000|Double Blind Period|Protocol Violation|1|||
170526301|NCT00386334|616275401|FG001|Double Blind Period|Protocol Violation|1|||
170526302|NCT00386334|616275400|FG000|Double Blind Period|Withdrawal by Subject|9|||
170526303|NCT00386334|616275401|FG001|Double Blind Period|Withdrawal by Subject|13|||
170526304|NCT00386334|616275400|FG000|Double Blind Period|Lack of Efficacy|20|||
170526305|NCT00386334|616275401|FG001|Double Blind Period|Lack of Efficacy|11|||
170526306|NCT00386334|616275400|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
170526307|NCT00386334|616275401|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
170526308|NCT00386334|616275400|FG000|Double Blind Period|Other|3|||
170526309|NCT00386334|616275401|FG001|Double Blind Period|Other|3|||
170526310|NCT00386334|616275400|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
170526311|NCT00386334|616275401|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
170526312|NCT05222880|616275403|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
170526313|NCT05222880|616275403|FG000|Overall Study|Withdrew Consent during Study|1|||
170526314|NCT05222880|616275403|FG000|Overall Study|COVID-19 Related|1|||
170526315|NCT05401565|616275404|FG000|Overall Study|Lost to Follow-up|1|||
170526316|NCT05401565|616275405|FG001|Overall Study|Lost to Follow-up|0|||
170526317|NCT05401565|616275404|FG000|Overall Study|Adverse Event|2|||
170526318|NCT05401565|616275405|FG001|Overall Study|Adverse Event|0|||
170526319|NCT01077323|616275410|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
170526320|NCT01077323|616275411|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
170526321|NCT01077323|616275412|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
170526322|NCT01077323|616275410|FG000|Overall Study|Dispensing of drug in baseline period|0|||
170526323|NCT01077323|616275411|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
170526324|NCT01077323|616275412|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
170526325|NCT01077323|616275410|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
170772414|NCT00774397|617174591|FG004|Overall Study|Not treated|1|||
170772415|NCT00774397|617174592|FG005|Overall Study|Not treated|0|||
170772416|NCT00774397|617174593|FG006|Overall Study|Not treated|1|||
170526326|NCT01077323|616275411|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
170772417|NCT00774397|617174587|FG000|Overall Study|Other than those stated above|1|||
170772418|NCT00774397|617174588|FG001|Overall Study|Other than those stated above|1|||
170772419|NCT00774397|617174589|FG002|Overall Study|Other than those stated above|3|||
170772420|NCT00774397|617174590|FG003|Overall Study|Other than those stated above|2|||
170772421|NCT00774397|617174591|FG004|Overall Study|Other than those stated above|2|||
170772422|NCT00774397|617174592|FG005|Overall Study|Other than those stated above|0|||
170772423|NCT00774397|617174593|FG006|Overall Study|Other than those stated above|1|||
170772424|NCT02652442|617174594|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
170772425|NCT02252042|617174595|FG000|Overall Study|Adverse Event|9|||
170772426|NCT02252042|617174596|FG001|Overall Study|Adverse Event|6|||
170772427|NCT02252042|617174595|FG000|Overall Study|Death|209|||
170772428|NCT02252042|617174596|FG001|Overall Study|Death|217|||
170772429|NCT02252042|617174595|FG000|Overall Study|Physician Decision|0|||
170772430|NCT02252042|617174596|FG001|Overall Study|Physician Decision|2|||
170772431|NCT02252042|617174595|FG000|Overall Study|Transferred to Extension Study|7|||
170772432|NCT02252042|617174596|FG001|Overall Study|Transferred to Extension Study|1|||
170772433|NCT02252042|617174595|FG000|Overall Study|Did Not Continue on Extension Study|7|||
170772434|NCT02252042|617174596|FG001|Overall Study|Did Not Continue on Extension Study|2|||
170526327|NCT01077323|616275412|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
170526328|NCT02984982|616275413|FG000|Overall Study|Adverse Event|2|||
170526329|NCT02984982|616275414|FG001|Overall Study|Adverse Event|5|||
170772435|NCT02252042|617174595|FG000|Overall Study|Withdrawal by Subject|15|||
170772436|NCT02252042|617174596|FG001|Overall Study|Withdrawal by Subject|20|||
170772437|NCT02593149|617174597|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
170772438|NCT02593149|617174598|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
170772439|NCT02593149|617174597|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
170772440|NCT02593149|617174598|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
170772441|NCT05755711|617174599|FG000|Overall Study|Death|8|||
170772442|NCT05755711|617174599|FG000|Overall Study|Withdrawal by Subject|2|||
170772443|NCT03740009|617174606|FG000|Overall Study|Physician Decision|9|||
170772444|NCT03740009|617174606|FG000|Overall Study|Lost to Follow-up|1|||
170772445|NCT03756571|617174609|FG000|Overall Study|Lost to Follow-up|1|||
170772446|NCT03756571|617174610|FG001|Overall Study|Lost to Follow-up|1|||
170772447|NCT02379819|617174611|FG000|Overall Study|Withdrawal by Subject|10|||
170772448|NCT02379819|617174611|FG000|Overall Study|Death|2|||
170772449|NCT02379819|617174611|FG000|Overall Study|Lack of Efficacy|1|||
170772450|NCT02379819|617174611|FG000|Overall Study|Lost to Follow-up|1|||
170772451|NCT03752151|617174612|FG000|Overall Study|Withdrawal by Subject|1|||
170772452|NCT03752151|617174612|FG000|Overall Study|Protocol Violation|1|||
170772453|NCT00529516|617174613|FG000|Overall Study|Adverse Event|2|||
170772454|NCT00529516|617174614|FG001|Overall Study|Adverse Event|1|||
170772455|NCT00529516|617174615|FG002|Overall Study|Adverse Event|0|||
170772456|NCT00529516|617174613|FG000|Overall Study|Withdrawal by Subject|1|||
170772457|NCT00529516|617174614|FG001|Overall Study|Withdrawal by Subject|1|||
170772458|NCT00529516|617174615|FG002|Overall Study|Withdrawal by Subject|0|||
170772459|NCT00529516|617174613|FG000|Overall Study|Lost to Follow-up|0|||
170772460|NCT00529516|617174614|FG001|Overall Study|Lost to Follow-up|0|||
170772461|NCT00529516|617174615|FG002|Overall Study|Lost to Follow-up|1|||
170772462|NCT04056624|617174616|FG000|Overall Study|Withdrawal by Subject|0|||
170772463|NCT04056624|617174617|FG001|Overall Study|Withdrawal by Subject|0|||
170772464|NCT04056624|617174618|FG002|Overall Study|Withdrawal by Subject|1|||
170772465|NCT04056624|617174616|FG000|Overall Study|Protocol Violation|1|||
170772466|NCT04056624|617174617|FG001|Overall Study|Protocol Violation|2|||
170873395|NCT00937937|617548158|FG000|Overall Study|Death|1|||
170873396|NCT00937937|617548158|FG000|Overall Study|Other|2|||
170873397|NCT00404820|617548159|FG000|Overall Study|Adverse Event|4|||
170873398|NCT00404820|617548160|FG001|Overall Study|Adverse Event|16|||
170526330|NCT02984982|616275413|FG000|Overall Study|Poor Compliance to Protocol|4|||
170526331|NCT02984982|616275414|FG001|Overall Study|Poor Compliance to Protocol|4|||
170526332|NCT02984982|616275413|FG000|Overall Study|Withdrawal by Subject|2|||
170526333|NCT02984982|616275414|FG001|Overall Study|Withdrawal by Subject|0|||
170526334|NCT02984982|616275413|FG000|Overall Study|Randomized but not treated|0|||
170526335|NCT02984982|616275414|FG001|Overall Study|Randomized but not treated|1|||
170526336|NCT02153918|616275415|FG000|Overall Study|Refused further treatment|1|||
170526337|NCT02144701|616275416|FG000|Overall Study|development of relapse, GVHD or death|9|||
170526338|NCT02144701|616275417|FG001|Overall Study|development of relapse, GVHD or death|3|||
170526339|NCT02616783|616275418|FG000|Overall Study|Randomized but Not Treated|1|||
170526340|NCT02616783|616275419|FG001|Overall Study|Randomized but Not Treated|0|||
170772467|NCT04056624|617174618|FG002|Overall Study|Protocol Violation|0|||
170772468|NCT02267824|617174619|FG000|Overall Study|Pregnancy|1|||
170772469|NCT02267824|617174620|FG001|Overall Study|Pregnancy|1|||
170772470|NCT02267824|617174619|FG000|Overall Study|Lost to Follow-up|4|||
170772471|NCT02267824|617174620|FG001|Overall Study|Lost to Follow-up|0|||
170772472|NCT02267824|617174619|FG000|Overall Study|Protocol Violation|3|||
170772473|NCT02267824|617174620|FG001|Overall Study|Protocol Violation|0|||
170873399|NCT00404820|617548159|FG000|Overall Study|Withdrawal by Subject|5|||
170873400|NCT00404820|617548160|FG001|Overall Study|Withdrawal by Subject|3|||
170873401|NCT00404820|617548159|FG000|Overall Study|Lost to Follow-up|7|||
170873402|NCT00404820|617548160|FG001|Overall Study|Lost to Follow-up|3|||
170873403|NCT00404820|617548159|FG000|Overall Study|Administrative problems|2|||
170873404|NCT00404820|617548160|FG001|Overall Study|Administrative problems|0|||
170873405|NCT00404820|617548159|FG000|Overall Study|Death|1|||
170873406|NCT00404820|617548160|FG001|Overall Study|Death|0|||
170873407|NCT00404820|617548159|FG000|Overall Study|Other|0|||
170873408|NCT00404820|617548160|FG001|Overall Study|Other|2|||
170873409|NCT03785925|617548161|FG000|Overall Study|Withdrawal by Subject|15|||
170873410|NCT03785925|617548161|FG000|Overall Study|Lost to Follow-up|1|||
170873411|NCT02236520|617548164|FG000|Overall Study|Physician Decision|0|||
170873412|NCT02236520|617548165|FG001|Overall Study|Physician Decision|5|||
170873413|NCT02236520|617548166|FG002|Overall Study|Physician Decision|0|||
170873414|NCT02236520|617548167|FG003|Overall Study|Physician Decision|0|||
170873415|NCT02236520|617548164|FG000|Overall Study|Withdrawal by Subject|1|||
170873416|NCT02236520|617548165|FG001|Overall Study|Withdrawal by Subject|0|||
170873417|NCT02236520|617548166|FG002|Overall Study|Withdrawal by Subject|0|||
170873418|NCT02236520|617548167|FG003|Overall Study|Withdrawal by Subject|1|||
170873419|NCT02236520|617548164|FG000|Overall Study|Pregnancy|1|||
170414872|NCT00095199|615858939|FG000|Overall Study|Adverse Event|40|||
170414873|NCT00095199|615858940|FG001|Overall Study|Adverse Event|22|||
170414874|NCT00095199|615858941|FG002|Overall Study|Adverse Event|26|||
170414875|NCT00095199|615858942|FG003|Overall Study|Adverse Event|11|||
170414876|NCT00095199|615858939|FG000|Overall Study|Progressive disease|213|||
170414877|NCT00095199|615858940|FG001|Overall Study|Progressive disease|179|||
170414878|NCT00095199|615858941|FG002|Overall Study|Progressive disease|105|||
170414879|NCT00095199|615858942|FG003|Overall Study|Progressive disease|98|||
170414880|NCT00095199|615858939|FG000|Overall Study|Death|10|||
170414881|NCT00095199|615858940|FG001|Overall Study|Death|6|||
170414882|NCT00095199|615858941|FG002|Overall Study|Death|11|||
170414883|NCT00095199|615858942|FG003|Overall Study|Death|9|||
170414884|NCT00095199|615858939|FG000|Overall Study|Withdrawal by Subject|21|||
170414885|NCT00095199|615858940|FG001|Overall Study|Withdrawal by Subject|16|||
170414886|NCT00095199|615858941|FG002|Overall Study|Withdrawal by Subject|13|||
170414887|NCT00095199|615858942|FG003|Overall Study|Withdrawal by Subject|22|||
170414888|NCT00095199|615858939|FG000|Overall Study|Protocol Violation|4|||
170414889|NCT00095199|615858940|FG001|Overall Study|Protocol Violation|4|||
170414890|NCT00095199|615858941|FG002|Overall Study|Protocol Violation|2|||
170414891|NCT00095199|615858942|FG003|Overall Study|Protocol Violation|0|||
170414892|NCT00095199|615858939|FG000|Overall Study|Liver function test results elevated|0|||
170526341|NCT02616783|616275418|FG000|Overall Study|Adverse Event|1|||
170526342|NCT02616783|616275419|FG001|Overall Study|Adverse Event|0|||
170526343|NCT02616783|616275418|FG000|Overall Study|Death|1|||
170526344|NCT02616783|616275419|FG001|Overall Study|Death|0|||
170526345|NCT02616783|616275418|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170526346|NCT02616783|616275419|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170526347|NCT02616783|616275418|FG000|Overall Study|Protocol Violation|1|||
170526348|NCT02616783|616275419|FG001|Overall Study|Protocol Violation|1|||
170526349|NCT02616783|616275418|FG000|Overall Study|Withdrew Consent|1|||
170526350|NCT02616783|616275419|FG001|Overall Study|Withdrew Consent|1|||
170526351|NCT00467519|616275420|FG000|Overall Study|Protocol Violation|8|||
170526352|NCT00467519|616275421|FG001|Overall Study|Protocol Violation|4|||
170526353|NCT00467519|616275420|FG000|Overall Study|Lost to Follow-up|2|||
170526354|NCT00467519|616275421|FG001|Overall Study|Lost to Follow-up|9|||
170526355|NCT00467519|616275420|FG000|Overall Study|Withdrawal by Subject|4|||
170526356|NCT00467519|616275421|FG001|Overall Study|Withdrawal by Subject|10|||
170526357|NCT01791985|616275422|FG000|Overall Study|Adverse Event|7|||
170526358|NCT01791985|616275422|FG000|Overall Study|Withdrawal by Subject|1|||
170526359|NCT00485069|616275430|FG000|Overall Study|Adverse Event|10|||
170526360|NCT00485069|616275431|FG001|Overall Study|Adverse Event|4|||
170526361|NCT00485069|616275430|FG000|Overall Study|Lack of Efficacy|2|||
170526362|NCT00485069|616275431|FG001|Overall Study|Lack of Efficacy|1|||
170526363|NCT00485069|616275430|FG000|Overall Study|Protocol Violation|0|||
170526364|NCT00485069|616275431|FG001|Overall Study|Protocol Violation|1|||
170526365|NCT00485069|616275430|FG000|Overall Study|Withdrawal by Subject|6|||
170526366|NCT00485069|616275431|FG001|Overall Study|Withdrawal by Subject|6|||
170873420|NCT02236520|617548165|FG001|Overall Study|Pregnancy|0|||
170873421|NCT02236520|617548166|FG002|Overall Study|Pregnancy|0|||
170873422|NCT02236520|617548167|FG003|Overall Study|Pregnancy|0|||
170414893|NCT00095199|615858940|FG001|Overall Study|Liver function test results elevated|0|||
170414894|NCT00095199|615858941|FG002|Overall Study|Liver function test results elevated|1|||
170414895|NCT00095199|615858942|FG003|Overall Study|Liver function test results elevated|1|||
170414896|NCT00095199|615858939|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
170414897|NCT00095199|615858940|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
170526367|NCT03118934|616275432|FG000|Overall Study|Adverse Event|0|||
170526368|NCT03118934|616275433|FG001|Overall Study|Adverse Event|0|||
170526369|NCT03118934|616275434|FG002|Overall Study|Adverse Event|0|||
170873423|NCT02234479|617548168|FG000|Overall Study|Withdrawal by Subject|1|||
170772474|NCT02267824|617174619|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
170772475|NCT02267824|617174620|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
170772476|NCT00939510|617174621|FG000|Overall Study|Withdrawal by Subject|1|||
170772477|NCT05411393|617174622|FG000|Overall Study|Illness or loss of interest|2|||
170772478|NCT05411393|617174623|FG001|Overall Study|Illness or loss of interest|0|||
170772479|NCT05411393|617174622|FG000|Overall Study|Withdrawal by Subject|1|||
170772480|NCT05411393|617174623|FG001|Overall Study|Withdrawal by Subject|0|||
170772481|NCT05411393|617174622|FG000|Overall Study|Lost to Follow-up|3|||
170772482|NCT05411393|617174623|FG001|Overall Study|Lost to Follow-up|2|||
170772483|NCT04588428|617174626|FG000|Overall Study|Withdrawal by Subject|0|||
170772484|NCT04588428|617174627|FG001|Overall Study|Withdrawal by Subject|0|||
170772485|NCT04588428|617174628|FG002|Overall Study|Withdrawal by Subject|1|||
170772486|NCT04588428|617174629|FG003|Overall Study|Withdrawal by Subject|0|||
170772487|NCT04588428|617174630|FG004|Overall Study|Withdrawal by Subject|0|||
170772488|NCT04588428|617174631|FG005|Overall Study|Withdrawal by Subject|1|||
170772489|NCT04588428|617174632|FG006|Overall Study|Withdrawal by Subject|0|||
170772490|NCT04588428|617174633|FG007|Overall Study|Withdrawal by Subject|0|||
170772491|NCT04588428|617174634|FG008|Overall Study|Withdrawal by Subject|0|||
170772492|NCT04588428|617174626|FG000|Overall Study|Protocol Deviation|0|||
170772493|NCT04588428|617174627|FG001|Overall Study|Protocol Deviation|0|||
170772494|NCT04588428|617174628|FG002|Overall Study|Protocol Deviation|2|||
170772495|NCT04588428|617174629|FG003|Overall Study|Protocol Deviation|0|||
170772496|NCT04588428|617174630|FG004|Overall Study|Protocol Deviation|0|||
170772497|NCT04588428|617174631|FG005|Overall Study|Protocol Deviation|0|||
170772498|NCT04588428|617174632|FG006|Overall Study|Protocol Deviation|0|||
170772499|NCT04588428|617174633|FG007|Overall Study|Protocol Deviation|0|||
170772500|NCT04588428|617174634|FG008|Overall Study|Protocol Deviation|0|||
170772501|NCT04588428|617174626|FG000|Overall Study|Reason Not Specified|0|||
170772502|NCT04588428|617174627|FG001|Overall Study|Reason Not Specified|0|||
170772503|NCT04588428|617174628|FG002|Overall Study|Reason Not Specified|0|||
170772504|NCT04588428|617174629|FG003|Overall Study|Reason Not Specified|1|||
170772505|NCT04588428|617174630|FG004|Overall Study|Reason Not Specified|0|||
170772506|NCT04588428|617174631|FG005|Overall Study|Reason Not Specified|0|||
170772507|NCT04588428|617174632|FG006|Overall Study|Reason Not Specified|0|||
170772508|NCT04588428|617174633|FG007|Overall Study|Reason Not Specified|0|||
170772509|NCT04588428|617174634|FG008|Overall Study|Reason Not Specified|0|||
170772510|NCT04050293|617174635|FG000|Overall Study|Lost to Follow-up|1|||
170772511|NCT04050293|617174636|FG001|Overall Study|Lost to Follow-up|2|||
170772512|NCT04050293|617174635|FG000|Overall Study|Withdrawal by Subject|2|||
170772513|NCT04050293|617174636|FG001|Overall Study|Withdrawal by Subject|0|||
170772514|NCT05763576|617174637|FG000|Overall Study|Study Terminated by Sponsor|0|||
170772515|NCT05763576|617174638|FG001|Overall Study|Study Terminated by Sponsor|0|||
170772516|NCT05763576|617174639|FG002|Overall Study|Study Terminated by Sponsor|0|||
170772517|NCT05763576|617174640|FG003|Overall Study|Study Terminated by Sponsor|0|||
170772518|NCT05763576|617174641|FG004|Overall Study|Study Terminated by Sponsor|0|||
170772519|NCT05763576|617174642|FG005|Overall Study|Study Terminated by Sponsor|0|||
170772520|NCT05763576|617174643|FG006|Overall Study|Study Terminated by Sponsor|0|||
170772521|NCT05763576|617174644|FG007|Overall Study|Study Terminated by Sponsor|2|||
170772522|NCT05763576|617174645|FG008|Overall Study|Study Terminated by Sponsor|6|||
170772523|NCT05763576|617174637|FG000|Overall Study|Withdrawal by Subject|0|||
170772524|NCT05763576|617174638|FG001|Overall Study|Withdrawal by Subject|0|||
170772525|NCT05763576|617174639|FG002|Overall Study|Withdrawal by Subject|0|||
170772526|NCT05763576|617174640|FG003|Overall Study|Withdrawal by Subject|0|||
170772527|NCT05763576|617174641|FG004|Overall Study|Withdrawal by Subject|0|||
170772528|NCT05763576|617174642|FG005|Overall Study|Withdrawal by Subject|1|||
170772529|NCT05763576|617174643|FG006|Overall Study|Withdrawal by Subject|0|||
170772530|NCT05763576|617174644|FG007|Overall Study|Withdrawal by Subject|0|||
170772531|NCT05763576|617174645|FG008|Overall Study|Withdrawal by Subject|0|||
170772532|NCT04818671|617174646|FG000|Overall Study|Withdrawal by Subject|16|||
170772533|NCT04818671|617174646|FG000|Overall Study|Adverse Event|5|||
170772534|NCT04818671|617174646|FG000|Overall Study|Lack of Efficacy|5|||
170772535|NCT04818671|617174646|FG000|Overall Study|Death|4|||
170772536|NCT04818671|617174646|FG000|Overall Study|Physician Decision|4|||
170772537|NCT04818671|617174646|FG000|Overall Study|Requires Prohibited Medication|4|||
170772538|NCT04818671|617174646|FG000|Overall Study|Lost to Follow-up|2|||
170772539|NCT04818671|617174646|FG000|Overall Study|Approved Drug Available for Indication|1|||
170772540|NCT04818671|617174646|FG000|Overall Study|Sponsor Request|1|||
170772541|NCT04625413|617174648|FG000|Overall Study|Hospice|2|||
170772542|NCT04625413|617174648|FG000|Overall Study|Distress|1|||
170772543|NCT04625413|617174648|FG000|Overall Study|Not feeling well|1|||
170772544|NCT04564339|617174649|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
170772545|NCT04564339|617174650|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
170772546|NCT04564339|617174651|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
170772547|NCT04564339|617174652|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
170772548|NCT04564339|617174649|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
170772549|NCT04564339|617174650|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170772550|NCT04564339|617174651|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170772551|NCT04564339|617174652|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170772552|NCT04564339|617174649|FG000|Extension Period (Week 26 to Week 50)|Physician Decision|1|||
170772553|NCT04564339|617174650|FG001|Extension Period (Week 26 to Week 50)|Physician Decision|0|||
170772554|NCT04564339|617174651|FG002|Extension Period (Week 26 to Week 50)|Physician Decision|1|||
170772555|NCT04564339|617174652|FG003|Extension Period (Week 26 to Week 50)|Physician Decision|0|||
170772556|NCT04564339|617174649|FG000|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|1|||
170772557|NCT04564339|617174650|FG001|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
170772558|NCT04564339|617174651|FG002|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
170772559|NCT04564339|617174652|FG003|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
170772560|NCT04564339|617174649|FG000|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
170772561|NCT04564339|617174650|FG001|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|1|||
170772562|NCT04564339|617174651|FG002|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
170772563|NCT04564339|617174652|FG003|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
170772564|NCT03237481|617175453|FG000|Overall Study|Lost to Follow-up|1|||
170772565|NCT03237481|617175454|FG001|Overall Study|Lost to Follow-up|0|||
170772566|NCT03237481|617175455|FG002|Overall Study|Lost to Follow-up|0|||
170772567|NCT03237481|617175453|FG000|Overall Study|Protocol Violation|1|||
170772568|NCT03237481|617175454|FG001|Overall Study|Protocol Violation|0|||
170772569|NCT03237481|617175455|FG002|Overall Study|Protocol Violation|0|||
170772570|NCT03237481|617175453|FG000|Overall Study|Withdrawal by Subject|3|||
170772571|NCT03237481|617175454|FG001|Overall Study|Withdrawal by Subject|2|||
170772572|NCT03237481|617175455|FG002|Overall Study|Withdrawal by Subject|1|||
170772573|NCT04714320|617175456|FG000|Overall Study|Voluntary Withdrawal|4|||
170772574|NCT04714320|617175457|FG001|Overall Study|Voluntary Withdrawal|1|||
170772575|NCT04714320|617175458|FG002|Overall Study|Voluntary Withdrawal|2|||
170772576|NCT04714320|617175456|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
170772577|NCT04714320|617175457|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
170772578|NCT04714320|617175458|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
170772579|NCT04714320|617175456|FG000|Overall Study|Reason Not Specified|1|||
170772580|NCT04714320|617175457|FG001|Overall Study|Reason Not Specified|3|||
170772581|NCT04714320|617175458|FG002|Overall Study|Reason Not Specified|3|||
170772582|NCT04755660|617175463|FG000|Overall Study|Lost to Follow-up|1|||
170772583|NCT04755660|617175464|FG001|Overall Study|Lost to Follow-up|1|||
170772584|NCT04755660|617175465|FG002|Overall Study|Lost to Follow-up|0|||
170772585|NCT04755660|617175463|FG000|Overall Study|Withdrawal by Subject|0|||
170772586|NCT04755660|617175464|FG001|Overall Study|Withdrawal by Subject|1|||
170772587|NCT04755660|617175465|FG002|Overall Study|Withdrawal by Subject|1|||
170772588|NCT04755660|617175463|FG000|Overall Study|Physician Decision|0|||
170772589|NCT04755660|617175464|FG001|Overall Study|Physician Decision|0|||
170772590|NCT04755660|617175465|FG002|Overall Study|Physician Decision|1|||
170772591|NCT04279574|617175469|FG000|Overall Study|Death|1|||
170772592|NCT04279574|617175470|FG001|Overall Study|Death|0|||
170772593|NCT04279574|617175469|FG000|Overall Study|lost restoration, tooth fracture|1|||
170772594|NCT04279574|617175470|FG001|Overall Study|lost restoration, tooth fracture|0|||
170772595|NCT04279574|617175469|FG000|Overall Study|Lost to Follow-up|0|||
170772596|NCT04279574|617175470|FG001|Overall Study|Lost to Follow-up|1|||
170772597|NCT04252586|617175472|FG000|Overall Study|Withdrawal by parent/guardian|3|||
170772598|NCT04252586|617175472|FG000|Overall Study|Adverse Event|1|||
170772599|NCT04252586|617175472|FG000|Overall Study|Death|2|||
170772600|NCT04252586|617175472|FG000|Overall Study|Study terminated by sponsor|4|||
170772601|NCT04252586|617175472|FG000|Overall Study|Sponsor request|10|||
170772602|NCT04252586|617175472|FG000|Overall Study|Did not complete treatment period|1|||
170772603|NCT00232180|617175473|FG000|Double-blind (DB) Phase|Death|186|||
170772604|NCT00232180|617175474|FG001|Double-blind (DB) Phase|Death|222|||
170772605|NCT00232180|617175475|FG002|Double-blind (DB) Phase|Death|0|||
170772606|NCT00232180|617175473|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
170772607|NCT00232180|617175474|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
170772608|NCT00232180|617175475|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
170772609|NCT00232180|617175473|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
170772610|NCT00232180|617175474|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
170772611|NCT00232180|617175475|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
170772612|NCT00232180|617175473|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
170772613|NCT00232180|617175474|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
170772614|NCT00232180|617175475|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
170772615|NCT00232180|617175473|FG000|Double-blind (DB) Phase|Adverse Event|83|||
170772616|NCT00232180|617175474|FG001|Double-blind (DB) Phase|Adverse Event|100|||
170772617|NCT00232180|617175475|FG002|Double-blind (DB) Phase|Adverse Event|0|||
170772618|NCT00232180|617175473|FG000|Double-blind (DB) Phase|Other|70|||
170772619|NCT00232180|617175474|FG001|Double-blind (DB) Phase|Other|75|||
170873424|NCT02234479|617548169|FG001|Overall Study|Withdrawal by Subject|3|||
170632507|NCT01499355|616666688|FG000|Run-In Period|Death|2|||
170873425|NCT02285920|617548170|FG000|Overall Study|Kidney transplantation|2|||
170873426|NCT02285920|617548171|FG001|Overall Study|Kidney transplantation|2|||
170873427|NCT02285920|617548172|FG002|Overall Study|Kidney transplantation|2|||
170873428|NCT02285920|617548173|FG003|Overall Study|Kidney transplantation|0|||
170873429|NCT02285920|617548170|FG000|Overall Study|Change to peritoneal dialysis|0|||
170873430|NCT02285920|617548171|FG001|Overall Study|Change to peritoneal dialysis|0|||
170873431|NCT02285920|617548172|FG002|Overall Study|Change to peritoneal dialysis|1|||
170873432|NCT02285920|617548173|FG003|Overall Study|Change to peritoneal dialysis|0|||
170873433|NCT02285920|617548170|FG000|Overall Study|Transfer to non-participating unit|0|||
170873434|NCT02285920|617548171|FG001|Overall Study|Transfer to non-participating unit|1|||
170873435|NCT02285920|617548172|FG002|Overall Study|Transfer to non-participating unit|0|||
170873436|NCT02285920|617548173|FG003|Overall Study|Transfer to non-participating unit|0|||
170873437|NCT02285920|617548170|FG000|Overall Study|Dialysis discontinuation|0|||
170873438|NCT02285920|617548171|FG001|Overall Study|Dialysis discontinuation|1|||
170873439|NCT02285920|617548172|FG002|Overall Study|Dialysis discontinuation|0|||
170873440|NCT02285920|617548173|FG003|Overall Study|Dialysis discontinuation|0|||
170873441|NCT02285920|617548170|FG000|Overall Study|Death|2|||
170873442|NCT02285920|617548171|FG001|Overall Study|Death|0|||
170873443|NCT02285920|617548172|FG002|Overall Study|Death|2|||
170873444|NCT02285920|617548173|FG003|Overall Study|Death|1|||
170873445|NCT02865018|617548174|FG000|Overall Study|Withdrawal by Subject|1|||
170873446|NCT00139776|617548181|FG000|Period I|Did not enter Period II|575|||
170873447|NCT00139776|617548182|FG001|Period I|Did not enter Period II|0|||
170873448|NCT00139776|617548183|FG002|Period I|Did not enter Period II|0|||
170873449|NCT00139776|617548184|FG003|Period I|Did not enter Period II|0|||
170873450|NCT00139776|617548181|FG000|Period II|Not Randomized into Period III|0|||
170873451|NCT00139776|617548182|FG001|Period II|Not Randomized into Period III|322|||
170873452|NCT00139776|617548183|FG002|Period II|Not Randomized into Period III|0|||
170873453|NCT00139776|617548184|FG003|Period II|Not Randomized into Period III|0|||
170873454|NCT00139776|617548181|FG000|Period III|Adverse Event|0|||
170873455|NCT00139776|617548182|FG001|Period III|Adverse Event|0|||
170873456|NCT00139776|617548183|FG002|Period III|Adverse Event|22|||
170873457|NCT00139776|617548184|FG003|Period III|Adverse Event|23|||
170873458|NCT00139776|617548181|FG000|Period III|Other|0|||
170873459|NCT00139776|617548182|FG001|Period III|Other|0|||
170873460|NCT00139776|617548183|FG002|Period III|Other|23|||
170873461|NCT00139776|617548184|FG003|Period III|Other|34|||
170873462|NCT00139776|617548181|FG000|Period III|Lack of Efficacy|0|||
170873463|NCT00139776|617548182|FG001|Period III|Lack of Efficacy|0|||
170873464|NCT00139776|617548183|FG002|Period III|Lack of Efficacy|10|||
170873465|NCT00139776|617548184|FG003|Period III|Lack of Efficacy|24|||
170873466|NCT00139776|617548181|FG000|Period III|Lost to Follow-up|0|||
170873467|NCT00139776|617548182|FG001|Period III|Lost to Follow-up|0|||
170873468|NCT00139776|617548183|FG002|Period III|Lost to Follow-up|5|||
170873469|NCT00139776|617548184|FG003|Period III|Lost to Follow-up|4|||
170873470|NCT00139776|617548181|FG000|Period III|Withdrawal by Subject|0|||
170873471|NCT00139776|617548182|FG001|Period III|Withdrawal by Subject|0|||
170873472|NCT00139776|617548183|FG002|Period III|Withdrawal by Subject|16|||
170873473|NCT00139776|617548184|FG003|Period III|Withdrawal by Subject|21|||
170414898|NCT00095199|615858941|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
170414899|NCT00095199|615858942|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
170414900|NCT00095199|615858939|FG000|Overall Study|Physician Decision|5|||
170772620|NCT00232180|617175475|FG002|Double-blind (DB) Phase|Other|0|||
170772621|NCT00232180|617175473|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
170772622|NCT00232180|617175474|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
170772623|NCT00232180|617175475|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
170772624|NCT00232180|617175473|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
170772625|NCT00232180|617175474|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
170772626|NCT00232180|617175475|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
170772627|NCT00232180|617175473|FG000|Open Label Phase|Death|0|||
170772628|NCT00232180|617175474|FG001|Open Label Phase|Death|0|||
170772629|NCT00232180|617175475|FG002|Open Label Phase|Death|48|||
170772630|NCT00232180|617175473|FG000|Open Label Phase|Lost to Follow-up|0|||
170772631|NCT00232180|617175474|FG001|Open Label Phase|Lost to Follow-up|0|||
170873474|NCT02161575|617548198|FG000|Overall Study|Protocol Violation|8|||
170873475|NCT02161575|617548198|FG000|Overall Study|Lack of Efficacy|1|||
170873476|NCT02161575|617548198|FG000|Overall Study|Adverse Event|2|||
170873477|NCT00326209|617548199|FG000|Overall Study|Adverse Event|28|||
170873478|NCT00326209|617548199|FG000|Overall Study|Withdrawal by Subject|22|||
170873479|NCT00326209|617548199|FG000|Overall Study|Lack of Efficacy|31|||
170873480|NCT00326209|617548199|FG000|Overall Study|Lost to Follow-up|18|||
170873481|NCT00326209|617548199|FG000|Overall Study|Participant non-compliant|6|||
170873482|NCT00326209|617548199|FG000|Overall Study|Sponsor closed study|173|||
170873483|NCT00326209|617548199|FG000|Overall Study|Prohibited medication use|1|||
170873484|NCT00326209|617548199|FG000|Overall Study|Violation of entry criteria|1|||
170873485|NCT00326209|617548199|FG000|Overall Study|Withdrawn in error|1|||
170873486|NCT00326209|617548199|FG000|Overall Study|Pregnancy|1|||
170873487|NCT01478360|617548204|FG000|Overall Study|Lost to Follow-up|1|||
170772632|NCT00232180|617175475|FG002|Open Label Phase|Lost to Follow-up|5|||
170772633|NCT00232180|617175473|FG000|Open Label Phase|Protocol Violation|0|||
170772634|NCT00232180|617175474|FG001|Open Label Phase|Protocol Violation|0|||
170772635|NCT00232180|617175475|FG002|Open Label Phase|Protocol Violation|3|||
170772636|NCT00232180|617175473|FG000|Open Label Phase|Study terminated by sponsor|0|||
170772637|NCT00232180|617175474|FG001|Open Label Phase|Study terminated by sponsor|0|||
170772638|NCT00232180|617175475|FG002|Open Label Phase|Study terminated by sponsor|3|||
170772639|NCT00232180|617175473|FG000|Open Label Phase|Withdrawal by Subject|0|||
170772640|NCT00232180|617175474|FG001|Open Label Phase|Withdrawal by Subject|0|||
170772641|NCT00232180|617175475|FG002|Open Label Phase|Withdrawal by Subject|37|||
170772642|NCT00232180|617175473|FG000|Open Label Phase|Other|0|||
170772643|NCT00232180|617175474|FG001|Open Label Phase|Other|0|||
170772644|NCT00232180|617175475|FG002|Open Label Phase|Other|16|||
170772645|NCT00232180|617175473|FG000|Open Label Phase|Adverse Event|0|||
170772646|NCT00232180|617175474|FG001|Open Label Phase|Adverse Event|0|||
170772647|NCT00232180|617175475|FG002|Open Label Phase|Adverse Event|25|||
170772648|NCT00232180|617175473|FG000|Open Label Phase|Laboratory abnormality|0|||
170772649|NCT00232180|617175474|FG001|Open Label Phase|Laboratory abnormality|0|||
170772650|NCT00232180|617175475|FG002|Open Label Phase|Laboratory abnormality|10|||
170772651|NCT00232180|617175473|FG000|Open Label Phase|Randomized but not treated|0|||
170772652|NCT00232180|617175474|FG001|Open Label Phase|Randomized but not treated|0|||
170772653|NCT00232180|617175475|FG002|Open Label Phase|Randomized but not treated|1|||
170772654|NCT02748317|617175476|FG000|Overall Study|Withdrawal by Subject|14|||
170772655|NCT02748317|617175476|FG000|Overall Study|Lost to Follow-up|8|||
170772656|NCT02748317|617175476|FG000|Overall Study|Death|1|||
170772657|NCT03452189|617175477|FG000|First Intervention (3 Months)|Adverse Event|1|||
170772658|NCT03452189|617175478|FG001|First Intervention (3 Months)|Adverse Event|0|||
170772659|NCT03452189|617175477|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
170772660|NCT03452189|617175478|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
170772661|NCT02724592|617175479|FG000|Overall Study|Lost to Follow-up|4|||
170772662|NCT02724592|617175480|FG001|Overall Study|Lost to Follow-up|1|||
170772663|NCT00434304|617175481|FG000|Overall Study|Adverse Event|14|||
170772664|NCT00434304|617175481|FG000|Overall Study|Lack of Efficacy|2|||
170772665|NCT00434304|617175481|FG000|Overall Study|Withdrawal by Subject|4|||
170772666|NCT01951170|617175483|FG000|Overall Study|Investigator decision|1|||
170772667|NCT01972724|617175486|FG000|Double-Blind|Rescue Criteria Met|1|||
170772668|NCT01972724|617175487|FG001|Double-Blind|Rescue Criteria Met|0|||
170772669|NCT01972724|617175488|FG002|Double-Blind|Rescue Criteria Met|0|||
170772670|NCT01972724|617175486|FG000|Double-Blind|Adverse Event|1|||
170772671|NCT01972724|617175487|FG001|Double-Blind|Adverse Event|0|||
170772672|NCT01972724|617175488|FG002|Double-Blind|Adverse Event|0|||
170772673|NCT01972724|617175486|FG000|Double-Blind|Withdrawal of Consent|2|||
170772674|NCT01972724|617175487|FG001|Double-Blind|Withdrawal of Consent|1|||
170772675|NCT01972724|617175488|FG002|Double-Blind|Withdrawal of Consent|0|||
170772676|NCT01972724|617175486|FG000|Double-Blind|Significant Protocol Deviation|5|||
170772677|NCT01972724|617175487|FG001|Double-Blind|Significant Protocol Deviation|8|||
170772678|NCT01972724|617175488|FG002|Double-Blind|Significant Protocol Deviation|0|||
170772679|NCT01972724|617175486|FG000|Open-Label|Withdrew Consent|0|||
170772680|NCT01972724|617175487|FG001|Open-Label|Withdrew Consent|0|||
170772681|NCT01972724|617175488|FG002|Open-Label|Withdrew Consent|3|||
170772682|NCT01972724|617175486|FG000|Open-Label|Significant Protocol Deviation|0|||
170772683|NCT01972724|617175487|FG001|Open-Label|Significant Protocol Deviation|0|||
170772684|NCT01972724|617175488|FG002|Open-Label|Significant Protocol Deviation|2|||
170772685|NCT02765100|617175489|FG000|Overall Study|subject found ineligible after baseline|1|||
170772686|NCT02765100|617175490|FG001|Overall Study|subject found ineligible after baseline|1|||
170772687|NCT02765100|617175489|FG000|Overall Study|Lost to Follow-up|0|||
170772688|NCT02765100|617175490|FG001|Overall Study|Lost to Follow-up|1|||
170772689|NCT00835770|617175506|FG000|Overall Study|MS Relapse|17|||
170772690|NCT00835770|617175507|FG001|Overall Study|MS Relapse|23|||
170772691|NCT00835770|617175506|FG000|Overall Study|MS Progression|14|||
170772692|NCT00835770|617175507|FG001|Overall Study|MS Progression|9|||
170772693|NCT00835770|617175506|FG000|Overall Study|Adverse Event|113|||
170772694|NCT00835770|617175507|FG001|Overall Study|Adverse Event|124|||
170772695|NCT00835770|617175506|FG000|Overall Study|Lost to Follow-up|22|||
170772696|NCT00835770|617175507|FG001|Overall Study|Lost to Follow-up|19|||
170772697|NCT00835770|617175506|FG000|Overall Study|Consent Withdrawn|144|||
170772698|NCT00835770|617175507|FG001|Overall Study|Consent Withdrawn|156|||
170772699|NCT00835770|617175506|FG000|Overall Study|Investigator Decision|42|||
170772700|NCT00835770|617175507|FG001|Overall Study|Investigator Decision|42|||
170772701|NCT00835770|617175506|FG000|Overall Study|Participant Non-Compliance|11|||
170772702|NCT00835770|617175507|FG001|Overall Study|Participant Non-Compliance|9|||
170772703|NCT00835770|617175506|FG000|Overall Study|Death|4|||
170772704|NCT00835770|617175507|FG001|Overall Study|Death|6|||
170772705|NCT00835770|617175506|FG000|Overall Study|Other|115|||
170772706|NCT00835770|617175507|FG001|Overall Study|Other|104|||
170772707|NCT00835770|617175506|FG000|Overall Study|Other|2|||
170772708|NCT00835770|617175507|FG001|Overall Study|Other|1|||
170873488|NCT01478360|617548205|FG001|Overall Study|Lost to Follow-up|0|||
170873489|NCT01478360|617548204|FG000|Overall Study|Adverse Event|0|||
170873490|NCT01478360|617548205|FG001|Overall Study|Adverse Event|1|||
170873491|NCT01478360|617548204|FG000|Overall Study|Administrative problems|1|||
170873492|NCT01478360|617548205|FG001|Overall Study|Administrative problems|2|||
170873493|NCT03716050|617548209|FG000|Overall Study|Lost to Follow-up|0|||
170873494|NCT03716050|617548210|FG001|Overall Study|Lost to Follow-up|0|||
170873495|NCT03716050|617548211|FG002|Overall Study|Lost to Follow-up|1|||
170873496|NCT03716050|617548212|FG003|Overall Study|Lost to Follow-up|0|||
170873497|NCT03716050|617548213|FG004|Overall Study|Lost to Follow-up|0|||
170873498|NCT03716050|617548214|FG005|Overall Study|Lost to Follow-up|0|||
170873499|NCT03716050|617548215|FG006|Overall Study|Lost to Follow-up|0|||
170873500|NCT03716050|617548216|FG007|Overall Study|Lost to Follow-up|0|||
170873501|NCT03716050|617548209|FG000|Overall Study|Physician Decision|0|||
170873502|NCT03716050|617548210|FG001|Overall Study|Physician Decision|0|||
170873503|NCT03716050|617548211|FG002|Overall Study|Physician Decision|0|||
170873504|NCT03716050|617548212|FG003|Overall Study|Physician Decision|1|||
170873505|NCT03716050|617548213|FG004|Overall Study|Physician Decision|0|||
170873506|NCT03716050|617548214|FG005|Overall Study|Physician Decision|0|||
170873507|NCT03716050|617548215|FG006|Overall Study|Physician Decision|0|||
170873508|NCT03716050|617548216|FG007|Overall Study|Physician Decision|0|||
170873509|NCT03716050|617548209|FG000|Overall Study|Protocol Violation|0|||
170873510|NCT03716050|617548210|FG001|Overall Study|Protocol Violation|0|||
170873511|NCT03716050|617548211|FG002|Overall Study|Protocol Violation|0|||
170873512|NCT03716050|617548212|FG003|Overall Study|Protocol Violation|1|||
170873513|NCT03716050|617548213|FG004|Overall Study|Protocol Violation|0|||
170873514|NCT03716050|617548214|FG005|Overall Study|Protocol Violation|0|||
170873515|NCT03716050|617548215|FG006|Overall Study|Protocol Violation|0|||
170873516|NCT03716050|617548216|FG007|Overall Study|Protocol Violation|2|||
170873517|NCT04340557|617548217|FG000|Overall Study|Transferred to ICU and/or death|1|||
170873518|NCT04340557|617548218|FG001|Overall Study|Transferred to ICU and/or death|2|||
170873519|NCT01010633|617548223|FG000|Overall Study|Adverse Event|1|||
170873520|NCT01010633|617548224|FG001|Overall Study|Adverse Event|1|||
170772709|NCT01254188|617175513|FG000|Overall Study|Disease Progression|6|||
170772710|NCT01254188|617175513|FG000|Overall Study|Protocol Violation|6|||
170772711|NCT01254188|617175513|FG000|Overall Study|Pregnancy|2|||
170772712|NCT01254188|617175513|FG000|Overall Study|Death|4|||
170772713|NCT01254188|617175513|FG000|Overall Study|Lost to Follow-up|5|||
170772714|NCT01254188|617175513|FG000|Overall Study|Withdrawal by Subject|7|||
170772715|NCT01254188|617175513|FG000|Overall Study|Adverse Event|43|||
170772716|NCT01254188|617175513|FG000|Overall Study|per investigator discretion|20|||
170772717|NCT01061151|617175514|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
170772718|NCT01061151|617175515|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
170772719|NCT01061151|617175516|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
170772720|NCT01061151|617175517|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
170772721|NCT01061151|617175514|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
170772722|NCT01061151|617175515|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
170772723|NCT01061151|617175516|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
170772724|NCT01061151|617175517|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
170772725|NCT01061151|617175514|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
170772726|NCT01061151|617175515|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
170772727|NCT01061151|617175516|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
170772728|NCT01061151|617175517|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
170772729|NCT01061151|617175514|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
170772730|NCT01061151|617175515|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
170772731|NCT01061151|617175516|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
170772732|NCT01061151|617175517|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
170772733|NCT01061151|617175514|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
170772734|NCT01061151|617175515|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
170772735|NCT01061151|617175516|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
170772736|NCT01061151|617175517|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
170772737|NCT01061151|617175514|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
170772738|NCT01061151|617175515|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
170772739|NCT01061151|617175516|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
170772740|NCT01061151|617175517|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
170772741|NCT01061151|617175514|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
170873521|NCT01010633|617548223|FG000|Overall Study|Protocol Violation|1|||
170873522|NCT01010633|617548224|FG001|Overall Study|Protocol Violation|2|||
170873523|NCT01010633|617548223|FG000|Overall Study|Withdrawal by Subject|2|||
170873524|NCT01010633|617548224|FG001|Overall Study|Withdrawal by Subject|1|||
170873525|NCT01010633|617548223|FG000|Overall Study|Investigator decision|0|||
170873526|NCT01010633|617548224|FG001|Overall Study|Investigator decision|1|||
170873527|NCT02941926|617548225|FG000|Core Phase|Progressive disease|1109|||
170873528|NCT02941926|617548225|FG000|Core Phase|Adverse Event|504|||
170873529|NCT02941926|617548225|FG000|Core Phase|Subject/guardian decision|127|||
170873530|NCT02941926|617548225|FG000|Core Phase|Physician Decision|112|||
170873531|NCT02941926|617548225|FG000|Core Phase|Death|46|||
170873532|NCT02941926|617548225|FG000|Core Phase|Protocol deviation|34|||
170873533|NCT02941926|617548225|FG000|Core Phase|Lost to Follow-up|8|||
170873534|NCT02941926|617548225|FG000|Core Phase|Technical problems|5|||
170873535|NCT02941926|617548225|FG000|Extension Phase|Physician Decision|155|||
170873536|NCT02941926|617548225|FG000|Extension Phase|Progressive disease|115|||
170873537|NCT02941926|617548225|FG000|Extension Phase|Adverse Event|13|||
170873538|NCT02941926|617548225|FG000|Extension Phase|Subject/Guardian decision|12|||
170873539|NCT02941926|617548225|FG000|Extension Phase|Death|6|||
170873540|NCT00097773|617548226|FG000|Overall Study|Lost to Follow-up|2|||
170873541|NCT00097773|617548227|FG001|Overall Study|Lost to Follow-up|2|||
170873542|NCT00097773|617548228|FG002|Overall Study|Lost to Follow-up|0|||
170873543|NCT00097773|617548229|FG003|Overall Study|Lost to Follow-up|1|||
170873544|NCT00097773|617548226|FG000|Overall Study|Physician Decision|2|||
170873545|NCT00097773|617548227|FG001|Overall Study|Physician Decision|2|||
170873546|NCT00097773|617548228|FG002|Overall Study|Physician Decision|3|||
170873547|NCT00097773|617548229|FG003|Overall Study|Physician Decision|1|||
170873548|NCT00097773|617548226|FG000|Overall Study|Withdrawal by Subject|3|||
170873549|NCT00097773|617548227|FG001|Overall Study|Withdrawal by Subject|3|||
170873550|NCT00097773|617548228|FG002|Overall Study|Withdrawal by Subject|3|||
170873551|NCT00097773|617548229|FG003|Overall Study|Withdrawal by Subject|1|||
170873552|NCT00097773|617548226|FG000|Overall Study|Adverse Event|0|||
170873553|NCT00097773|617548227|FG001|Overall Study|Adverse Event|1|||
170873554|NCT00097773|617548228|FG002|Overall Study|Adverse Event|0|||
170873555|NCT00097773|617548229|FG003|Overall Study|Adverse Event|0|||
170873556|NCT00097773|617548226|FG000|Overall Study|Other|1|||
170873557|NCT00097773|617548227|FG001|Overall Study|Other|0|||
170873558|NCT00097773|617548228|FG002|Overall Study|Other|2|||
170873559|NCT00097773|617548229|FG003|Overall Study|Other|0|||
170873560|NCT01009034|617548230|FG000|Overall Study|Lost to Follow-up|2|||
170873561|NCT01009034|617548230|FG000|Overall Study|Withdrawal by Subject|2|||
170873562|NCT01494350|617548231|FG000|Overall Study|Worsening of lesion|1|||
170873563|NCT02790138|617548232|FG000|Overall Study|Adverse Event|5|||
170873564|NCT02790138|617548233|FG001|Overall Study|Adverse Event|2|||
170873565|NCT02790138|617548232|FG000|Overall Study|Significant Protocol Deviation|0|||
170873566|NCT02790138|617548233|FG001|Overall Study|Significant Protocol Deviation|1|||
170873567|NCT02790138|617548232|FG000|Overall Study|Lost to Follow-up|1|||
170772742|NCT01061151|617175515|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
170772743|NCT01061151|617175516|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
170772744|NCT01061151|617175517|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
170772745|NCT01061151|617175514|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
170772746|NCT01061151|617175515|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
170772747|NCT01061151|617175516|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
170772748|NCT01061151|617175517|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
170772749|NCT01061151|617175514|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
170772750|NCT01061151|617175515|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
170772751|NCT01061151|617175516|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
170772752|NCT01061151|617175517|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
170772753|NCT01061151|617175514|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
170772754|NCT01061151|617175515|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
170772755|NCT01061151|617175516|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
170772756|NCT01061151|617175517|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
170772757|NCT01061151|617175514|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
170772758|NCT01061151|617175515|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
170772759|NCT01061151|617175516|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
170772760|NCT01061151|617175517|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
170772761|NCT01061151|617175514|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
170772762|NCT01061151|617175515|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
170772763|NCT01061151|617175516|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
170772764|NCT01061151|617175517|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
170772765|NCT01061151|617175514|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
170772766|NCT01061151|617175515|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
170772767|NCT01061151|617175516|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
170772768|NCT01061151|617175517|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
170772769|NCT01061151|617175514|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
170772770|NCT01061151|617175515|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
170873568|NCT02790138|617548233|FG001|Overall Study|Lost to Follow-up|0|||
170873569|NCT02790138|617548232|FG000|Overall Study|Voluntary Withdrawal|8|||
170873570|NCT02790138|617548233|FG001|Overall Study|Voluntary Withdrawal|9|||
170873571|NCT02790138|617548232|FG000|Overall Study|Lack of Efficacy|6|||
170526370|NCT03118934|616275435|FG003|Overall Study|Adverse Event|0|||
170772771|NCT01061151|617175516|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
170772772|NCT01061151|617175517|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
170772773|NCT01061151|617175514|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
170772774|NCT01061151|617175515|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
170772775|NCT01061151|617175516|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
170772776|NCT01061151|617175517|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
170772777|NCT03829722|617175524|FG000|Overall Study|Adverse Event|1|||
170772778|NCT03829722|617175524|FG000|Overall Study|Withdrawal by Subject|7|||
170772779|NCT03829722|617175524|FG000|Overall Study|Physician Decision|5|||
170772780|NCT01546753|617175529|FG000|Overall Study|anxiety|1|||
170772781|NCT01546753|617175530|FG001|Overall Study|anxiety|1|||
170772782|NCT01546753|617175529|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
170772783|NCT01546753|617175530|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
170772784|NCT04118088|617175533|FG000|Overall Study|Study Terminated by Sponsor|38|||
170772785|NCT04118088|617175533|FG000|Overall Study|Lost to Follow-up|2|||
170772786|NCT04118088|617175533|FG000|Overall Study|Withdrawal by Subject|1|||
170772787|NCT04118088|617175533|FG000|Overall Study|Reason Not Specified|1|||
170772788|NCT00880594|617175537|FG000|Overall Study|Subject did not initiate desipramine therapy|5|||
170772789|NCT00880594|617175538|FG001|Overall Study|Subject did not initiate desipramine therapy|4|||
170772790|NCT03299166|617175541|FG000|Overall Study|Adverse Event|9|||
170772791|NCT03299166|617175542|FG001|Overall Study|Adverse Event|4|||
170772792|NCT03299166|617175541|FG000|Overall Study|Withdrawal by Subject|6|||
170772793|NCT03299166|617175542|FG001|Overall Study|Withdrawal by Subject|5|||
170772794|NCT03299166|617175541|FG000|Overall Study|Physician Decision|1|||
170772795|NCT03299166|617175542|FG001|Overall Study|Physician Decision|1|||
170772796|NCT03299166|617175541|FG000|Overall Study|Sponsor Decision|3|||
170772797|NCT03299166|617175542|FG001|Overall Study|Sponsor Decision|0|||
170772798|NCT03299166|617175541|FG000|Overall Study|Lost to Follow-up|2|||
170772799|NCT03299166|617175542|FG001|Overall Study|Lost to Follow-up|4|||
170772800|NCT03299166|617175541|FG000|Overall Study|Randomization Error|0|||
170772801|NCT03299166|617175542|FG001|Overall Study|Randomization Error|1|||
170772802|NCT03299166|617175541|FG000|Overall Study|Subject unable to return due to COVID|1|||
170772803|NCT03299166|617175542|FG001|Overall Study|Subject unable to return due to COVID|0|||
170772804|NCT03299166|617175541|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
170772805|NCT03299166|617175542|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
170772806|NCT04165317|617177326|FG000|Treatment Phase|Adverse Event|131|||
170772807|NCT04165317|617177327|FG001|Treatment Phase|Adverse Event|89|||
170772808|NCT04165317|617177328|FG002|Treatment Phase|Adverse Event|37|||
170772809|NCT04165317|617177329|FG003|Treatment Phase|Adverse Event|0|||
170772810|NCT04165317|617177330|FG004|Treatment Phase|Adverse Event|2|||
170772811|NCT04165317|617177326|FG000|Treatment Phase|Death|8|||
170772812|NCT04165317|617177327|FG001|Treatment Phase|Death|8|||
170772813|NCT04165317|617177328|FG002|Treatment Phase|Death|6|||
170772814|NCT04165317|617177329|FG003|Treatment Phase|Death|0|||
170772815|NCT04165317|617177330|FG004|Treatment Phase|Death|0|||
170772816|NCT04165317|617177326|FG000|Treatment Phase|Lack of Efficacy|32|||
170772817|NCT04165317|617177327|FG001|Treatment Phase|Lack of Efficacy|50|||
170772818|NCT04165317|617177328|FG002|Treatment Phase|Lack of Efficacy|54|||
170772819|NCT04165317|617177329|FG003|Treatment Phase|Lack of Efficacy|3|||
170772820|NCT04165317|617177330|FG004|Treatment Phase|Lack of Efficacy|2|||
170772821|NCT04165317|617177326|FG000|Treatment Phase|Lost to Follow-up|3|||
170772822|NCT04165317|617177327|FG001|Treatment Phase|Lost to Follow-up|0|||
170772823|NCT04165317|617177328|FG002|Treatment Phase|Lost to Follow-up|2|||
170772824|NCT04165317|617177329|FG003|Treatment Phase|Lost to Follow-up|0|||
170772825|NCT04165317|617177330|FG004|Treatment Phase|Lost to Follow-up|0|||
170772826|NCT04165317|617177326|FG000|Treatment Phase|Withdrawal by Subject|41|||
170772827|NCT04165317|617177327|FG001|Treatment Phase|Withdrawal by Subject|26|||
170772828|NCT04165317|617177328|FG002|Treatment Phase|Withdrawal by Subject|29|||
170772829|NCT04165317|617177329|FG003|Treatment Phase|Withdrawal by Subject|1|||
170772830|NCT04165317|617177330|FG004|Treatment Phase|Withdrawal by Subject|0|||
170772831|NCT04165317|617177326|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
170772832|NCT04165317|617177327|FG001|Treatment Phase|Global Deterioration of Health Status|2|||
170772833|NCT04165317|617177328|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
170772834|NCT04165317|617177329|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
170772835|NCT04165317|617177330|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
170772836|NCT04165317|617177326|FG000|Treatment Phase|Other|14|||
170772837|NCT04165317|617177327|FG001|Treatment Phase|Other|13|||
170772838|NCT04165317|617177328|FG002|Treatment Phase|Other|18|||
170772839|NCT04165317|617177329|FG003|Treatment Phase|Other|0|||
170772840|NCT04165317|617177330|FG004|Treatment Phase|Other|0|||
170772841|NCT04165317|617177326|FG000|Treatment Phase|Randomized, not treated|2|||
170772842|NCT04165317|617177327|FG001|Treatment Phase|Randomized, not treated|4|||
170772843|NCT04165317|617177328|FG002|Treatment Phase|Randomized, not treated|2|||
170772844|NCT04165317|617177329|FG003|Treatment Phase|Randomized, not treated|0|||
170772845|NCT04165317|617177330|FG004|Treatment Phase|Randomized, not treated|0|||
170873572|NCT02790138|617548233|FG001|Overall Study|Lack of Efficacy|7|||
170873573|NCT02790138|617548232|FG000|Overall Study|Reason not Specified|1|||
170873574|NCT02790138|617548233|FG001|Overall Study|Reason not Specified|0|||
170873575|NCT00474708|617548234|FG000|Overall Study|Lack of Efficacy|11|||
170873576|NCT00474708|617548235|FG001|Overall Study|Lack of Efficacy|5|||
170873577|NCT00474708|617548234|FG000|Overall Study|Suicide ideation/behavior|0|||
170772846|NCT04165317|617177326|FG000|Follow up Phase|Death|23|||
170772847|NCT04165317|617177327|FG001|Follow up Phase|Death|20|||
170772848|NCT04165317|617177328|FG002|Follow up Phase|Death|23|||
170772849|NCT04165317|617177329|FG003|Follow up Phase|Death|0|||
170772850|NCT04165317|617177330|FG004|Follow up Phase|Death|0|||
170772851|NCT04165317|617177326|FG000|Follow up Phase|Lost to Follow-up|4|||
170772852|NCT04165317|617177327|FG001|Follow up Phase|Lost to Follow-up|6|||
170772853|NCT04165317|617177328|FG002|Follow up Phase|Lost to Follow-up|1|||
170772854|NCT04165317|617177329|FG003|Follow up Phase|Lost to Follow-up|0|||
170772855|NCT04165317|617177330|FG004|Follow up Phase|Lost to Follow-up|0|||
170772856|NCT04165317|617177326|FG000|Follow up Phase|Withdrawal by Subject|12|||
170772857|NCT04165317|617177327|FG001|Follow up Phase|Withdrawal by Subject|27|||
170772858|NCT04165317|617177328|FG002|Follow up Phase|Withdrawal by Subject|21|||
170772859|NCT04165317|617177329|FG003|Follow up Phase|Withdrawal by Subject|0|||
170772860|NCT04165317|617177330|FG004|Follow up Phase|Withdrawal by Subject|0|||
170772861|NCT04165317|617177326|FG000|Follow up Phase|Ongoing|280|||
170772862|NCT04165317|617177327|FG001|Follow up Phase|Ongoing|277|||
170772863|NCT04165317|617177328|FG002|Follow up Phase|Ongoing|289|||
170772864|NCT04165317|617177329|FG003|Follow up Phase|Ongoing|0|||
170772865|NCT04165317|617177330|FG004|Follow up Phase|Ongoing|0|||
170772866|NCT04165317|617177326|FG000|Follow up Phase|Other|0|||
170772867|NCT04165317|617177327|FG001|Follow up Phase|Other|0|||
170772868|NCT04165317|617177328|FG002|Follow up Phase|Other|0|||
170772869|NCT04165317|617177329|FG003|Follow up Phase|Other|5|||
170772870|NCT04165317|617177330|FG004|Follow up Phase|Other|7|||
170772871|NCT01353313|617177331|FG000|Overall Study|Lost to Follow-up|22|||
170772872|NCT01353313|617177332|FG001|Overall Study|Lost to Follow-up|23|||
170772873|NCT01353313|617177331|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
170772874|NCT01353313|617177332|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
170772875|NCT04524390|617177333|FG000|Double Blind|Consent Withdrawal by subject|2|||
170772876|NCT04524390|617177334|FG001|Double Blind|Consent Withdrawal by subject|1|||
170772877|NCT04524390|617177335|FG002|Double Blind|Consent Withdrawal by subject|0|||
170772878|NCT04524390|617177333|FG000|Double Blind|Adverse Event|5|||
170772879|NCT04524390|617177334|FG001|Double Blind|Adverse Event|3|||
170772880|NCT04524390|617177335|FG002|Double Blind|Adverse Event|0|||
170772881|NCT04524390|617177333|FG000|Double Blind|Liver Transplant|5|||
170772882|NCT04524390|617177334|FG001|Double Blind|Liver Transplant|6|||
170772883|NCT04524390|617177335|FG002|Double Blind|Liver Transplant|0|||
170772884|NCT04524390|617177333|FG000|Double Blind|Disease Progression|0|||
170772885|NCT04524390|617177334|FG001|Double Blind|Disease Progression|1|||
170772886|NCT04524390|617177335|FG002|Double Blind|Disease Progression|0|||
170772887|NCT04524390|617177333|FG000|Open-Label|Drug interruption criteria|0|||
170772888|NCT04524390|617177334|FG001|Open-Label|Drug interruption criteria|0|||
170772889|NCT04524390|617177335|FG002|Open-Label|Drug interruption criteria|1|||
170772890|NCT04524390|617177333|FG000|Open-Label|Liver Transplant|0|||
170772891|NCT04524390|617177334|FG001|Open-Label|Liver Transplant|0|||
170772892|NCT04524390|617177335|FG002|Open-Label|Liver Transplant|1|||
170772893|NCT04524390|617177333|FG000|Open-Label|Disease Progression|0|||
170772894|NCT04524390|617177334|FG001|Open-Label|Disease Progression|0|||
170772895|NCT04524390|617177335|FG002|Open-Label|Disease Progression|1|||
170772896|NCT04524390|617177333|FG000|Open-Label|Adverse Event|0|||
170772897|NCT04524390|617177334|FG001|Open-Label|Adverse Event|0|||
170772898|NCT04524390|617177335|FG002|Open-Label|Adverse Event|3|||
170772899|NCT04524390|617177333|FG000|Open-Label|Study Termination by sponsor|0|||
170772900|NCT04524390|617177334|FG001|Open-Label|Study Termination by sponsor|0|||
170772901|NCT04524390|617177335|FG002|Open-Label|Study Termination by sponsor|45|||
170772902|NCT04153565|617177336|FG000|Overall Study|Death|13|||
170772903|NCT01875848|617177339|FG000|Overall Study|Withdrawal by Subject|2|||
170772904|NCT01875848|617177340|FG001|Overall Study|Withdrawal by Subject|0|||
170772905|NCT02407249|617177341|FG000|Overall Study|Did not complete 12-month follow-up|13|||
170772906|NCT02407249|617177341|FG000|Overall Study|Not treated|13|||
170772907|NCT01391832|617177342|FG000|Overall Study|Withdrawal by Subject|21|||
170772908|NCT01391832|617177343|FG001|Overall Study|Withdrawal by Subject|22|||
170772909|NCT01391832|617177342|FG000|Overall Study|Lost to Follow-up|0|||
170873578|NCT00474708|617548235|FG001|Overall Study|Suicide ideation/behavior|1|||
170873579|NCT00474708|617548234|FG000|Overall Study|Withdrawal by Subject|7|||
170772910|NCT01391832|617177343|FG001|Overall Study|Lost to Follow-up|1|||
170772911|NCT03345901|617177347|FG000|Overall Study|The study was terminated|18|||
170772912|NCT05262738|617177348|FG000|Overall Study|Withdrawal by Subject|1|||
170772913|NCT05262738|617177349|FG001|Overall Study|Withdrawal by Subject|0|||
170772914|NCT01424397|617177352|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772915|NCT01424397|617177353|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772916|NCT01424397|617177354|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
170772917|NCT01424397|617177355|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772918|NCT01424397|617177356|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772919|NCT01424397|617177357|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772920|NCT01424397|617177358|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772921|NCT01424397|617177359|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772922|NCT01424397|617177360|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772923|NCT01424397|617177361|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772924|NCT01424397|617177362|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772925|NCT01424397|617177363|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
170772926|NCT02767765|617177364|FG000|Overall Study|Adverse Event|4|||
170772927|NCT02767765|617177364|FG000|Overall Study|Death|1|||
170772928|NCT02767765|617177364|FG000|Overall Study|Insufficient response|1|||
170772929|NCT02767765|617177364|FG000|Overall Study|Lost to Follow-up|2|||
170772930|NCT02767765|617177364|FG000|Overall Study|Investigator decision|1|||
170772931|NCT02767765|617177364|FG000|Overall Study|Non-Compliance|1|||
170772932|NCT02767765|617177364|FG000|Overall Study|Withdrawal by Subject|1|||
170772933|NCT00277355|617177366|FG000|Overall Study|Withdrawal by Subject|3|||
170772934|NCT00277355|617177367|FG001|Overall Study|Withdrawal by Subject|3|||
170772935|NCT00277355|617177366|FG000|Overall Study|Lost to Follow-up|2|||
170772936|NCT00277355|617177367|FG001|Overall Study|Lost to Follow-up|2|||
170772937|NCT00277355|617177366|FG000|Overall Study|Adverse Event|5|||
170772938|NCT00277355|617177367|FG001|Overall Study|Adverse Event|0|||
170772939|NCT00277355|617177366|FG000|Overall Study|Death|3|||
170772940|NCT00277355|617177367|FG001|Overall Study|Death|0|||
170772941|NCT00277355|617177366|FG000|Overall Study|Physician Decision|1|||
170772942|NCT00277355|617177367|FG001|Overall Study|Physician Decision|0|||
170772943|NCT02597920|617177368|FG000|Overall Study|Worsening of other pre-existing disease|0|||
170772944|NCT02597920|617177369|FG001|Overall Study|Worsening of other pre-existing disease|1|||
170772945|NCT02597920|617177370|FG002|Overall Study|Worsening of other pre-existing disease|0|||
170772946|NCT02597920|617177368|FG000|Overall Study|Other adverse event|20|||
170772947|NCT02597920|617177369|FG001|Overall Study|Other adverse event|30|||
170772948|NCT02597920|617177370|FG002|Overall Study|Other adverse event|0|||
170772949|NCT02597920|617177368|FG000|Overall Study|Lost to Follow-up|7|||
170772950|NCT02597920|617177369|FG001|Overall Study|Lost to Follow-up|9|||
170772951|NCT02597920|617177370|FG002|Overall Study|Lost to Follow-up|0|||
170772952|NCT02597920|617177368|FG000|Overall Study|Refuse to continue in the study|3|||
170772953|NCT02597920|617177369|FG001|Overall Study|Refuse to continue in the study|13|||
170772954|NCT02597920|617177370|FG002|Overall Study|Refuse to continue in the study|1|||
170772955|NCT02597920|617177368|FG000|Overall Study|Other than specified|10|||
170772956|NCT02597920|617177369|FG001|Overall Study|Other than specified|31|||
170772957|NCT02597920|617177370|FG002|Overall Study|Other than specified|5|||
170772958|NCT02597920|617177368|FG000|Overall Study|Other|1|||
170772959|NCT02597920|617177369|FG001|Overall Study|Other|0|||
170772960|NCT02597920|617177370|FG002|Overall Study|Other|0|||
170772961|NCT00642850|617177374|FG000|Overall Study|Death|7|||
170772962|NCT00642850|617177374|FG000|Overall Study|Adverse Event|2|||
170772963|NCT00642850|617177374|FG000|Overall Study|Lack of Efficacy|1|||
170772964|NCT00642850|617177374|FG000|Overall Study|Protocol Violation|2|||
170772965|NCT00642850|617177374|FG000|Overall Study|Kidney transplantation|8|||
170772966|NCT00642850|617177374|FG000|Overall Study|Blood transfusion|6|||
170772967|NCT00642850|617177374|FG000|Overall Study|Other reasons|7|||
170772968|NCT04532528|617177377|FG000|Overall Study|Adverse Event|12|||
170772969|NCT04532528|617177378|FG001|Overall Study|Adverse Event|17|||
170772970|NCT04532528|617177377|FG000|Overall Study|Withdrawal of consent|16|||
170772971|NCT04532528|617177378|FG001|Overall Study|Withdrawal of consent|17|||
170772972|NCT04532528|617177377|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
170772973|NCT04532528|617177378|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
170772974|NCT04532528|617177377|FG000|Overall Study|Lost to Follow-up|69|||
170772975|NCT04532528|617177378|FG001|Overall Study|Lost to Follow-up|68|||
170772976|NCT04532528|617177377|FG000|Overall Study|Administrative problems|12|||
170772977|NCT04532528|617177378|FG001|Overall Study|Administrative problems|14|||
170772978|NCT04532528|617177377|FG000|Overall Study|Death|3|||
170772979|NCT04532528|617177378|FG001|Overall Study|Death|3|||
170772980|NCT04532528|617177377|FG000|Overall Study|Other|38|||
170772981|NCT04532528|617177378|FG001|Overall Study|Other|46|||
170772982|NCT00244855|617177383|FG000|Overall Study|Withdrawal by Subject|0|||
170772983|NCT00244855|617177384|FG001|Overall Study|Withdrawal by Subject|1|||
170772984|NCT00668863|617177385|FG000|Overall Study|Objective Progression or Relapse|42|||
170772985|NCT00668863|617177385|FG000|Overall Study|Adverse Event|13|||
170772986|NCT00668863|617177385|FG000|Overall Study|Study Terminated by Sponsor|8|||
170772987|NCT00668863|617177385|FG000|Overall Study|Global Deterioration of Health Status|4|||
170772988|NCT00668863|617177385|FG000|Overall Study|Withdrawal by Subject|1|||
170772989|NCT00668863|617177385|FG000|Overall Study|Surgery|1|||
170772990|NCT00668863|617177385|FG000|Overall Study|Subject's work scheduling problem|1|||
170772991|NCT00668863|617177385|FG000|Overall Study|Physician Decision|1|||
170772992|NCT00665444|617177386|FG000|Overall Study|Physician Decision|1|||
170772993|NCT00665444|617177386|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
170772994|NCT01068743|617177387|FG000|Period 3|Adverse Event|0|||
170772995|NCT01068743|617177388|FG001|Period 3|Adverse Event|1|||
170772996|NCT01068743|617177389|FG002|Period 3|Adverse Event|0|||
170772997|NCT01068743|617177390|FG003|Period 3|Adverse Event|0|||
170772998|NCT00293293|617177391|FG000|Overall Study|Withdrawal by Subject|1|||
170772999|NCT00293293|617177392|FG001|Overall Study|Withdrawal by Subject|1|||
170773000|NCT00293293|617177391|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
170773001|NCT00293293|617177392|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
170773002|NCT00293293|617177391|FG000|Overall Study|Patient discontinued chemotherapy|0|||
170773003|NCT00293293|617177392|FG001|Overall Study|Patient discontinued chemotherapy|1|||
170773004|NCT01414738|617177393|FG000|Overall Study|Death|26|||
170773005|NCT01414738|617177393|FG000|Overall Study|Refused testing|5|||
170773006|NCT01414738|617177393|FG000|Overall Study|Lost to Follow-up|2|||
170773007|NCT01414738|617177393|FG000|Overall Study|Refused, disease progression|8|||
170773008|NCT01414738|617177393|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
170773009|NCT01266122|617177394|FG000|Overall Study|Lost to Follow-up|6|||
170773010|NCT01266122|617177395|FG001|Overall Study|Lost to Follow-up|6|||
170773011|NCT00703820|617177399|FG000|Overall Study|Adverse Event|12|||
170773012|NCT00703820|617177400|FG001|Overall Study|Adverse Event|17|||
170773013|NCT00703820|617177399|FG000|Overall Study|Death|5|||
170773014|NCT00703820|617177400|FG001|Overall Study|Death|0|||
170773015|NCT00703820|617177399|FG000|Overall Study|Lack of Efficacy|11|||
170773016|NCT00703820|617177400|FG001|Overall Study|Lack of Efficacy|11|||
170773017|NCT00703820|617177399|FG000|Overall Study|Received non-protocol therapy|1|||
170773018|NCT00703820|617177400|FG001|Overall Study|Received non-protocol therapy|0|||
170773019|NCT00703820|617177399|FG000|Overall Study|Physician Decision|4|||
170773020|NCT00703820|617177400|FG001|Overall Study|Physician Decision|5|||
170773021|NCT00703820|617177399|FG000|Overall Study|Withdrawal by Subject|2|||
170773022|NCT00703820|617177400|FG001|Overall Study|Withdrawal by Subject|1|||
170773023|NCT01007396|617177401|FG000|Overall Study|Lost to Follow-up|47|||
170773024|NCT03451721|617177402|FG000|Overall Study|Death|1|||
170773025|NCT03076515|617177403|FG000|Overall Study|DMC decision based on interim analysis|25|||
170773026|NCT03076515|617177404|FG001|Overall Study|DMC decision based on interim analysis|29|||
170773027|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
170773028|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
170773029|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
170773030|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
170773031|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
170773032|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
170773033|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
170773034|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
170773035|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
170773036|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
170773037|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
170773038|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
170773039|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
170773040|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
170773041|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
170773042|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
170773043|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
170773044|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
170773045|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
170773046|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
170773047|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
170773048|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
170773049|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
170773050|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
170773051|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
170773052|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
170773053|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
170773054|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
170773055|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
170773056|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
170773057|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
170632508|NCT01499355|616666689|FG001|Run-In Period|Death|0|||
170773058|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
170773059|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
170773060|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
170773061|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
170773062|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
170773063|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
170773064|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
170773065|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
170773066|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
170773067|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
170773068|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
170773069|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
170773070|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
170773071|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
170773072|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
170773073|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
170773074|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
170773075|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
170773076|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
170773077|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
170773078|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
170773079|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
170773080|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
170773081|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
170773082|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
170773083|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
170773084|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
170773085|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
170773086|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
170773087|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
170773088|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
170773089|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
170773090|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
170773091|NCT03903822|617177406|FG000|Treatment Phase (6 Weeks)|Other|2|||
170773092|NCT03903822|617177407|FG001|Treatment Phase (6 Weeks)|Other|1|||
170773093|NCT03903822|617177408|FG002|Treatment Phase (6 Weeks)|Other|0|||
170773094|NCT03903822|617177409|FG003|Treatment Phase (6 Weeks)|Other|0|||
170773095|NCT03903822|617177410|FG004|Treatment Phase (6 Weeks)|Other|1|||
170773096|NCT03903822|617177411|FG005|Treatment Phase (6 Weeks)|Other|1|||
170773097|NCT03903822|617177412|FG006|Treatment Phase (6 Weeks)|Other|0|||
170773098|NCT03903822|617177413|FG007|Treatment Phase (6 Weeks)|Other|0|||
170773099|NCT03903822|617177406|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
170773100|NCT03903822|617177407|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
170773101|NCT03903822|617177408|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
170773102|NCT03903822|617177409|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
170773103|NCT03903822|617177410|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
170773104|NCT03903822|617177411|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
170773105|NCT03903822|617177412|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
170773106|NCT03903822|617177413|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
170773107|NCT03903822|617177406|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
170773108|NCT03903822|617177407|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
170773109|NCT03903822|617177408|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
170773110|NCT03903822|617177409|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
170773111|NCT03903822|617177410|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
170773112|NCT03903822|617177411|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
170773113|NCT03903822|617177412|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
170773114|NCT03903822|617177413|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
170773115|NCT03903822|617177406|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
170773116|NCT03903822|617177407|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
170773117|NCT03903822|617177408|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
170773118|NCT03903822|617177409|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
170773119|NCT03903822|617177410|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
170773120|NCT03903822|617177411|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
170773121|NCT03903822|617177412|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
170773122|NCT03903822|617177413|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
170773123|NCT03903822|617177406|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
170773124|NCT03903822|617177407|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
170773125|NCT03903822|617177408|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
170773126|NCT03903822|617177409|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
170773127|NCT03903822|617177410|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
170773128|NCT03903822|617177411|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
170773129|NCT03903822|617177412|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
170873580|NCT00474708|617548235|FG001|Overall Study|Withdrawal by Subject|0|||
170873581|NCT00474708|617548234|FG000|Overall Study|Lack of compliance|12|||
170873582|NCT00474708|617548235|FG001|Overall Study|Lack of compliance|4|||
170873583|NCT00474708|617548234|FG000|Overall Study|Lost to Follow-up|18|||
170873584|NCT00474708|617548235|FG001|Overall Study|Lost to Follow-up|9|||
170873585|NCT00474708|617548234|FG000|Overall Study|Physician Decision|9|||
170873586|NCT00474708|617548235|FG001|Overall Study|Physician Decision|6|||
170873587|NCT03700320|617548236|FG000|Overall Study|Adverse Event|5|||
170873588|NCT03700320|617548237|FG001|Overall Study|Adverse Event|31|||
170873589|NCT03700320|617548236|FG000|Overall Study|Lack of Efficacy|2|||
170873590|NCT03700320|617548237|FG001|Overall Study|Lack of Efficacy|5|||
170873591|NCT03700320|617548236|FG000|Overall Study|Withdrawal by Subject|29|||
170873592|NCT03700320|617548237|FG001|Overall Study|Withdrawal by Subject|75|||
170873593|NCT03700320|617548236|FG000|Overall Study|Lost to Follow-up|16|||
170873594|NCT03700320|617548237|FG001|Overall Study|Lost to Follow-up|23|||
170873595|NCT03700320|617548236|FG000|Overall Study|Pregnancy|2|||
170873596|NCT03700320|617548237|FG001|Overall Study|Pregnancy|4|||
170873597|NCT03700320|617548236|FG000|Overall Study|Protocol Deviation|7|||
170873598|NCT03700320|617548237|FG001|Overall Study|Protocol Deviation|31|||
170873599|NCT03700320|617548236|FG000|Overall Study|Non-compliance with Study Drug|1|||
170873600|NCT03700320|617548237|FG001|Overall Study|Non-compliance with Study Drug|3|||
170873601|NCT03700320|617548236|FG000|Overall Study|Reason not Specified|0|||
170873602|NCT03700320|617548237|FG001|Overall Study|Reason not Specified|1|||
170873603|NCT04305275|617548238|FG000|Overall Study|Adverse Event|4|||
170873604|NCT04305275|617548239|FG001|Overall Study|Adverse Event|0|||
170873605|NCT04305275|617548238|FG000|Overall Study|Lost to Follow-up|1|||
170873606|NCT04305275|617548239|FG001|Overall Study|Lost to Follow-up|1|||
170873607|NCT04305275|617548238|FG000|Overall Study|Withdrawal by Participant|8|||
170873608|NCT04305275|617548239|FG001|Overall Study|Withdrawal by Participant|1|||
170873609|NCT03061175|617548243|FG000|Baseline|Participant was deemed ineligible|1|||
170873610|NCT03061175|617548244|FG001|Baseline|Participant was deemed ineligible|0|||
170873611|NCT03061175|617548243|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
170873612|NCT03061175|617548244|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
170873613|NCT03061175|617548243|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
170873614|NCT03061175|617548244|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
170873615|NCT03061175|617548243|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
170873616|NCT03061175|617548244|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
170873617|NCT02243865|617548245|FG000|Overall Study|Protocol Violation|1|||
170873618|NCT02243865|617548246|FG001|Overall Study|Protocol Violation|3|||
170773130|NCT03903822|617177413|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
170773131|NCT03903822|617177406|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
170773132|NCT03903822|617177407|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
170773133|NCT03903822|617177408|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
170773134|NCT03903822|617177409|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
170773135|NCT03903822|617177410|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
170773136|NCT03903822|617177411|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
170773137|NCT03903822|617177412|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
170773138|NCT03903822|617177413|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
170773139|NCT03903822|617177406|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
170773140|NCT03903822|617177407|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
170773141|NCT03903822|617177408|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
170773142|NCT03903822|617177409|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
170773143|NCT03903822|617177410|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
170773144|NCT03903822|617177411|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
170773145|NCT03903822|617177412|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
170773146|NCT03903822|617177413|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
170773147|NCT03903822|617177406|FG000|Follow up Phase (4 Weeks)|Other|1|||
170773148|NCT03903822|617177407|FG001|Follow up Phase (4 Weeks)|Other|1|||
170773149|NCT03903822|617177408|FG002|Follow up Phase (4 Weeks)|Other|0|||
170773150|NCT03903822|617177409|FG003|Follow up Phase (4 Weeks)|Other|0|||
170773151|NCT03903822|617177410|FG004|Follow up Phase (4 Weeks)|Other|0|||
170773152|NCT03903822|617177411|FG005|Follow up Phase (4 Weeks)|Other|0|||
170773153|NCT03903822|617177412|FG006|Follow up Phase (4 Weeks)|Other|0|||
170773154|NCT03903822|617177413|FG007|Follow up Phase (4 Weeks)|Other|0|||
170773155|NCT01792830|617177417|FG000|Overall Study|Withdrawal by Subject|22|||
170773156|NCT01792830|617177418|FG001|Overall Study|Withdrawal by Subject|0|||
170526371|NCT03118934|616275436|FG004|Overall Study|Adverse Event|0|||
170773157|NCT01792830|617177419|FG002|Overall Study|Withdrawal by Subject|0|||
170773158|NCT01792830|617177420|FG003|Overall Study|Withdrawal by Subject|2|||
170873619|NCT02243865|617548245|FG000|Overall Study|Lost to Follow-up|1|||
170873620|NCT02243865|617548246|FG001|Overall Study|Lost to Follow-up|1|||
170873621|NCT02243865|617548245|FG000|Overall Study|Withdrawal by Subject|1|||
170873622|NCT02243865|617548246|FG001|Overall Study|Withdrawal by Subject|0|||
170526372|NCT03118934|616275437|FG005|Overall Study|Adverse Event|1|||
170873623|NCT02243865|617548245|FG000|Overall Study|Adverse Event|1|||
170873624|NCT02243865|617548246|FG001|Overall Study|Adverse Event|1|||
170873625|NCT03654976|617548247|FG000|Overall Study|Withdrawal by Subject|12|||
170873626|NCT03654976|617548248|FG001|Overall Study|Withdrawal by Subject|11|||
170873627|NCT03654976|617548247|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
170873628|NCT03654976|617548248|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
170873629|NCT03654976|617548247|FG000|Overall Study|Adverse Event|5|||
170873630|NCT03654976|617548248|FG001|Overall Study|Adverse Event|0|||
170873631|NCT03654976|617548247|FG000|Overall Study|Lost to Follow-up|2|||
170873632|NCT03654976|617548248|FG001|Overall Study|Lost to Follow-up|0|||
170873633|NCT03654976|617548247|FG000|Overall Study|Lack of Efficacy|0|||
170873634|NCT03654976|617548248|FG001|Overall Study|Lack of Efficacy|1|||
170873635|NCT03098836|617548249|FG000|Overall Study|Adverse Event|1|||
170873636|NCT03098836|617548250|FG001|Overall Study|Adverse Event|3|||
170873637|NCT03098836|617548249|FG000|Overall Study|Lack of Efficacy|30|||
170873638|NCT03098836|617548250|FG001|Overall Study|Lack of Efficacy|15|||
170873639|NCT03098836|617548249|FG000|Overall Study|Physician Decision|2|||
170873640|NCT03098836|617548250|FG001|Overall Study|Physician Decision|1|||
170873641|NCT03098836|617548249|FG000|Overall Study|Withdrawal by Subject|3|||
170873642|NCT03098836|617548250|FG001|Overall Study|Withdrawal by Subject|2|||
170873643|NCT01660451|617548251|FG000|Overall Study|Protocol Violation|0|||
170873644|NCT01660451|617548252|FG001|Overall Study|Protocol Violation|1|||
170873645|NCT01660451|617548253|FG002|Overall Study|Protocol Violation|1|||
170773159|NCT01792830|617177421|FG004|Overall Study|Withdrawal by Subject|1|||
170773160|NCT01792830|617177422|FG005|Overall Study|Withdrawal by Subject|1|||
170773161|NCT01792830|617177423|FG006|Overall Study|Withdrawal by Subject|1|||
170773162|NCT01792830|617177424|FG007|Overall Study|Withdrawal by Subject|1|||
170773163|NCT01792830|617177425|FG008|Overall Study|Withdrawal by Subject|7|||
170773164|NCT01792830|617177426|FG009|Overall Study|Withdrawal by Subject|0|||
170773165|NCT01792830|617177427|FG010|Overall Study|Withdrawal by Subject|2|||
170773166|NCT01792830|617177417|FG000|Overall Study|Death|3|||
170773167|NCT01792830|617177418|FG001|Overall Study|Death|0|||
170773168|NCT01792830|617177419|FG002|Overall Study|Death|0|||
170773169|NCT01792830|617177420|FG003|Overall Study|Death|1|||
170773170|NCT01792830|617177421|FG004|Overall Study|Death|0|||
170773171|NCT01792830|617177422|FG005|Overall Study|Death|0|||
170773172|NCT01792830|617177423|FG006|Overall Study|Death|1|||
170773173|NCT01792830|617177424|FG007|Overall Study|Death|0|||
170773174|NCT01792830|617177425|FG008|Overall Study|Death|1|||
170773175|NCT01792830|617177426|FG009|Overall Study|Death|0|||
170773176|NCT01792830|617177427|FG010|Overall Study|Death|1|||
170773177|NCT01792830|617177417|FG000|Overall Study|Adverse Event|0|||
170773178|NCT01792830|617177418|FG001|Overall Study|Adverse Event|0|||
170773179|NCT01792830|617177419|FG002|Overall Study|Adverse Event|0|||
170773180|NCT01792830|617177420|FG003|Overall Study|Adverse Event|0|||
170773181|NCT01792830|617177421|FG004|Overall Study|Adverse Event|0|||
170773182|NCT01792830|617177422|FG005|Overall Study|Adverse Event|0|||
170773183|NCT01792830|617177423|FG006|Overall Study|Adverse Event|0|||
170773184|NCT01792830|617177424|FG007|Overall Study|Adverse Event|0|||
170773185|NCT01792830|617177425|FG008|Overall Study|Adverse Event|1|||
170773186|NCT01792830|617177426|FG009|Overall Study|Adverse Event|0|||
170773187|NCT01792830|617177427|FG010|Overall Study|Adverse Event|0|||
170773188|NCT05510245|617177443|FG000|Overall Study|Withdrawal by Subject|1|||
170773189|NCT05510245|617177444|FG001|Overall Study|Withdrawal by Subject|0|||
170773190|NCT05510245|617177445|FG002|Overall Study|Withdrawal by Subject|0|||
170773191|NCT04305405|617177447|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170773192|NCT04305405|617177448|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170773193|NCT00206375|617177449|FG000|Overall Study|Lost to Follow-up|1|||
170773194|NCT00206375|617177450|FG001|Overall Study|Lost to Follow-up|0|||
170873646|NCT01660451|617548251|FG000|Overall Study|AE not associated with clinical disease progression|13|||
170873647|NCT01660451|617548252|FG001|Overall Study|AE not associated with clinical disease progression|10|||
170873648|NCT01660451|617548253|FG002|Overall Study|AE not associated with clinical disease progression|40|||
170873649|NCT01660451|617548251|FG000|Overall Study|AE associated with clinical disease progression|1|||
170873650|NCT01660451|617548252|FG001|Overall Study|AE associated with clinical disease progression|3|||
170773195|NCT00206375|617177451|FG002|Overall Study|Lost to Follow-up|0|||
170873651|NCT01660451|617548253|FG002|Overall Study|AE associated with clinical disease progression|11|||
170873652|NCT01660451|617548251|FG000|Overall Study|Sponsor Decision|0|||
170873653|NCT01660451|617548252|FG001|Overall Study|Sponsor Decision|0|||
170873654|NCT01660451|617548253|FG002|Overall Study|Sponsor Decision|1|||
170873655|NCT01660451|617548251|FG000|Overall Study|Protocol Deviation|0|||
170773196|NCT00206375|617177449|FG000|Overall Study|Withdrawal by Subject|2|||
170773197|NCT00206375|617177450|FG001|Overall Study|Withdrawal by Subject|1|||
170773198|NCT00206375|617177451|FG002|Overall Study|Withdrawal by Subject|3|||
170773199|NCT00206375|617177449|FG000|Overall Study|Study terminated due to lack of funds|0|||
170773200|NCT00206375|617177450|FG001|Overall Study|Study terminated due to lack of funds|1|||
170873656|NCT01660451|617548252|FG001|Overall Study|Protocol Deviation|0|||
170773201|NCT00206375|617177451|FG002|Overall Study|Study terminated due to lack of funds|1|||
170873657|NCT01660451|617548253|FG002|Overall Study|Protocol Deviation|1|||
170873658|NCT01660451|617548251|FG000|Overall Study|Physician Decision|1|||
170873659|NCT01660451|617548252|FG001|Overall Study|Physician Decision|2|||
170873660|NCT01660451|617548253|FG002|Overall Study|Physician Decision|5|||
170873661|NCT01660451|617548251|FG000|Overall Study|Withdrawal by Subject|1|||
170873662|NCT01660451|617548252|FG001|Overall Study|Withdrawal by Subject|1|||
170873663|NCT01660451|617548253|FG002|Overall Study|Withdrawal by Subject|20|||
170873664|NCT01660451|617548251|FG000|Overall Study|Trial closure.|0|||
170873665|NCT01660451|617548252|FG001|Overall Study|Trial closure.|0|||
170873666|NCT01660451|617548253|FG002|Overall Study|Trial closure.|1|||
170873667|NCT01660451|617548251|FG000|Overall Study|Switching to other therapy|0|||
170873668|NCT01660451|617548252|FG001|Overall Study|Switching to other therapy|1|||
170873669|NCT01660451|617548253|FG002|Overall Study|Switching to other therapy|1|||
170873670|NCT01660451|617548251|FG000|Overall Study|Progressive disease - clinical progression|4|||
170873671|NCT01660451|617548252|FG001|Overall Study|Progressive disease - clinical progression|10|||
170873672|NCT01660451|617548253|FG002|Overall Study|Progressive disease - clinical progression|9|||
170873673|NCT01660451|617548251|FG000|Overall Study|Progressive disease - radiological progression|12|||
170873674|NCT01660451|617548252|FG001|Overall Study|Progressive disease - radiological progression|23|||
170873675|NCT01660451|617548253|FG002|Overall Study|Progressive disease - radiological progression|50|||
170873676|NCT01660451|617548251|FG000|Overall Study|Death|1|||
170873677|NCT01660451|617548252|FG001|Overall Study|Death|0|||
170873678|NCT01660451|617548253|FG002|Overall Study|Death|1|||
170873679|NCT01660451|617548251|FG000|Overall Study|Other|0|||
170873680|NCT01660451|617548252|FG001|Overall Study|Other|0|||
170873681|NCT01660451|617548253|FG002|Overall Study|Other|1|||
170873682|NCT05093322|617548254|FG000|Overall Study|Death|6|||
170873683|NCT05093322|617548255|FG001|Overall Study|Death|2|||
170873684|NCT05093322|617548254|FG000|Overall Study|Other|4|||
170873685|NCT05093322|617548255|FG001|Overall Study|Other|1|||
170873686|NCT00898443|617548256|FG000|Overall Study|Withdrawal by Subject|1|||
170873687|NCT00898443|617548257|FG001|Overall Study|Withdrawal by Subject|0|||
170873688|NCT01034540|617548259|FG000|Overall Study|Adverse Event|0|||
170873689|NCT01034540|617548260|FG001|Overall Study|Adverse Event|1|||
170873690|NCT03805750|617548264|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
170873691|NCT03805750|617548265|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
170873692|NCT00698997|617548269|FG000|Overall Study|Lost to Follow-up|3|||
170873693|NCT00698997|617548270|FG001|Overall Study|Lost to Follow-up|0|||
170873694|NCT00698997|617548269|FG000|Overall Study|Withdrawal by Subject|7|||
170873695|NCT00698997|617548270|FG001|Overall Study|Withdrawal by Subject|27|||
170873696|NCT01889238|617548273|FG000|Overall Study|Death|1|||
170873697|NCT01889238|617548273|FG000|Overall Study|Withdrawal by Subject|1|||
170873698|NCT01889238|617548273|FG000|Overall Study|Adverse Event|6|||
170873699|NCT01889238|617548273|FG000|Overall Study|Disease Progression|104|||
170873700|NCT01889238|617548273|FG000|Overall Study|Other|6|||
170873701|NCT02844816|617548274|FG000|Overall Study|No protocol treatment received|5|||
170873702|NCT02844816|617548275|FG001|Overall Study|No protocol treatment received|1|||
170873703|NCT02844816|617548274|FG000|Overall Study|Ineligible|22|||
170873704|NCT02844816|617548275|FG001|Overall Study|Ineligible|15|||
170873705|NCT02844816|617548274|FG000|Overall Study|Participant refusal|5|||
170873706|NCT02844816|617548275|FG001|Overall Study|Participant refusal|5|||
170873707|NCT02844816|617548274|FG000|Overall Study|Adverse Event|5|||
170873708|NCT02844816|617548275|FG001|Overall Study|Adverse Event|4|||
170873709|NCT02844816|617548274|FG000|Overall Study|Death|0|||
170873710|NCT02844816|617548275|FG001|Overall Study|Death|1|||
170873711|NCT02844816|617548274|FG000|Overall Study|Disease progression/recurrence|50|||
170873712|NCT02844816|617548275|FG001|Overall Study|Disease progression/recurrence|24|||
170873713|NCT02844816|617548274|FG000|Overall Study|Physician Decision|1|||
170873714|NCT02844816|617548275|FG001|Overall Study|Physician Decision|1|||
170873715|NCT01200238|617548279|FG000|Overall Study|Adverse Event|2|||
170414901|NCT00095199|615858940|FG001|Overall Study|Physician Decision|6|||
170414902|NCT00095199|615858941|FG002|Overall Study|Physician Decision|1|||
170414903|NCT00095199|615858942|FG003|Overall Study|Physician Decision|1|||
170414904|NCT00095199|615858939|FG000|Overall Study|Not eligible|1|||
170414905|NCT00095199|615858940|FG001|Overall Study|Not eligible|7|||
170414906|NCT00095199|615858941|FG002|Overall Study|Not eligible|0|||
170414907|NCT00095199|615858942|FG003|Overall Study|Not eligible|1|||
170414908|NCT00095199|615858939|FG000|Overall Study|Started Palliative Radiotherapy|1|||
170414909|NCT00095199|615858940|FG001|Overall Study|Started Palliative Radiotherapy|0|||
170873716|NCT01200238|617548280|FG001|Overall Study|Adverse Event|1|||
170873717|NCT01200238|617548279|FG000|Overall Study|Progressive Disease|5|||
170873718|NCT01200238|617548280|FG001|Overall Study|Progressive Disease|8|||
170873719|NCT01200238|617548279|FG000|Overall Study|Withdrawal by Subject|0|||
170873720|NCT01200238|617548280|FG001|Overall Study|Withdrawal by Subject|1|||
170873721|NCT02717754|617548281|FG000|Overall Study|Incorrect Infusion Duration|0|||
170873722|NCT02717754|617548282|FG001|Overall Study|Incorrect Infusion Duration|0|||
170873723|NCT02717754|617548283|FG002|Overall Study|Incorrect Infusion Duration|0|||
170873724|NCT02717754|617548284|FG003|Overall Study|Incorrect Infusion Duration|10|||
170873725|NCT02717754|617548285|FG004|Overall Study|Incorrect Infusion Duration|20|||
170873726|NCT02717754|617548286|FG005|Overall Study|Incorrect Infusion Duration|20|||
170873727|NCT00482703|617548287|FG000|Overall Study|Poor compliance|1|||
170873728|NCT00482703|617548288|FG001|Overall Study|Poor compliance|0|||
170873729|NCT05050318|617549896|FG000|Overall Study|Protocol Deviation|1|||
170873730|NCT05050318|617549897|FG001|Overall Study|Protocol Deviation|0|||
170873731|NCT05050318|617549898|FG002|Overall Study|Protocol Deviation|0|||
170873732|NCT04183790|617549905|FG000|Overall Study|Participants did not rollover to Part B|12|||
170873733|NCT04183790|617549906|FG001|Overall Study|Participants did not rollover to Part B|0|||
170873734|NCT04183790|617549905|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
170873735|NCT04183790|617549906|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
170873736|NCT04183790|617549905|FG000|Overall Study|Commercial drug is available for participant|6|||
170873737|NCT04183790|617549906|FG001|Overall Study|Commercial drug is available for participant|0|||
170873738|NCT04183790|617549905|FG000|Overall Study|Adverse Event|1|||
170873739|NCT04183790|617549906|FG001|Overall Study|Adverse Event|0|||
170873740|NCT04183790|617549905|FG000|Overall Study|Not enrolled in 107 study|0|||
170873741|NCT04183790|617549906|FG001|Overall Study|Not enrolled in 107 study|2|||
170873742|NCT02833974|617549908|FG000|Overall Study|Lost to Follow-up|1|||
170873743|NCT02833974|617549909|FG001|Overall Study|Lost to Follow-up|0|||
170873744|NCT02833974|617549908|FG000|Overall Study|Adverse Event|0|||
170873745|NCT02833974|617549909|FG001|Overall Study|Adverse Event|3|||
170873746|NCT04419610|617549910|FG000|Overall Study|Withdrawal by Subject|3|||
170873747|NCT04419610|617549911|FG001|Overall Study|Withdrawal by Subject|1|||
170873748|NCT04419610|617549910|FG000|Overall Study|Adverse Event|1|||
170873749|NCT04419610|617549911|FG001|Overall Study|Adverse Event|0|||
170873750|NCT04419610|617549910|FG000|Overall Study|discharged early|1|||
170873751|NCT04419610|617549911|FG001|Overall Study|discharged early|1|||
170873752|NCT01439282|617549912|FG000|Overall Study|Adverse Event|5|||
170873753|NCT01439282|617549913|FG001|Overall Study|Adverse Event|0|||
170873754|NCT01439282|617549912|FG000|Overall Study|Withdrawal by Subject|2|||
170873755|NCT01439282|617549913|FG001|Overall Study|Withdrawal by Subject|0|||
170873756|NCT01439282|617549912|FG000|Overall Study|Other|1|||
170873757|NCT01439282|617549913|FG001|Overall Study|Other|1|||
170873758|NCT03670953|617549918|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
170873759|NCT03670953|617549919|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
170873760|NCT03670953|617549920|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
170873761|NCT03670953|617549921|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
170873762|NCT03670953|617549918|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
170873763|NCT03670953|617549919|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
170873764|NCT03670953|617549920|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
170873765|NCT03670953|617549921|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
170873766|NCT03670953|617549918|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
170873767|NCT03670953|617549919|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
170873768|NCT03670953|617549920|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
170873769|NCT03670953|617549921|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
170873770|NCT03670953|617549918|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
170873771|NCT03670953|617549919|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
170873772|NCT03670953|617549920|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
170873773|NCT03670953|617549921|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
170873774|NCT03670953|617549918|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
170873775|NCT03670953|617549919|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
170873776|NCT03670953|617549920|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
170873777|NCT03670953|617549921|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
170873778|NCT03670953|617549918|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
170414910|NCT00095199|615858941|FG002|Overall Study|Started Palliative Radiotherapy|0|||
170414911|NCT00095199|615858942|FG003|Overall Study|Started Palliative Radiotherapy|0|||
170873779|NCT03670953|617549919|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
170873780|NCT03670953|617549920|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
170873781|NCT03670953|617549921|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
170873782|NCT03670953|617549918|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
170414912|NCT00095199|615858939|FG000|Overall Study|Started radiotherapy regimen|0|||
170414913|NCT00095199|615858940|FG001|Overall Study|Started radiotherapy regimen|1|||
170414914|NCT00095199|615858941|FG002|Overall Study|Started radiotherapy regimen|0|||
170414915|NCT00095199|615858942|FG003|Overall Study|Started radiotherapy regimen|0|||
170414916|NCT00095199|615858939|FG000|Overall Study|Primary tumor removed in other surgery|0|||
170526373|NCT03118934|616275432|FG000|Overall Study|Physician Decision|0|||
170526374|NCT03118934|616275433|FG001|Overall Study|Physician Decision|0|||
170526375|NCT03118934|616275434|FG002|Overall Study|Physician Decision|0|||
170873783|NCT03670953|617549919|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
170873784|NCT03670953|617549920|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
170873785|NCT03670953|617549921|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
170414917|NCT00095199|615858940|FG001|Overall Study|Primary tumor removed in other surgery|1|||
170414918|NCT00095199|615858941|FG002|Overall Study|Primary tumor removed in other surgery|0|||
170526376|NCT03118934|616275435|FG003|Overall Study|Physician Decision|0|||
170873786|NCT03670953|617549918|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
170873787|NCT03670953|617549919|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
170873788|NCT03670953|617549920|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
170873789|NCT03670953|617549921|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
170873790|NCT03670953|617549918|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
170873791|NCT03670953|617549919|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
170873792|NCT03670953|617549920|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
170873793|NCT03670953|617549921|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
170873794|NCT03670953|617549918|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
170873795|NCT03670953|617549919|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
170873796|NCT03670953|617549920|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
170873797|NCT03670953|617549921|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
170873798|NCT03670953|617549918|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
170873799|NCT03670953|617549919|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
170873800|NCT03670953|617549920|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
170873801|NCT03670953|617549921|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
170873802|NCT03670953|617549918|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
170873803|NCT03670953|617549919|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
170873804|NCT03670953|617549920|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
170873805|NCT03670953|617549921|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
170873806|NCT03670953|617549918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
170873807|NCT03670953|617549919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
170873808|NCT03670953|617549920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
170873809|NCT03670953|617549921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
170873810|NCT03670953|617549918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
170873811|NCT03670953|617549919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
170873812|NCT03670953|617549920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
170873813|NCT03670953|617549921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
170873814|NCT03670953|617549918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
170873815|NCT03670953|617549919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
170873816|NCT03670953|617549920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
170873817|NCT03670953|617549921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
170873818|NCT03670953|617549918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
170873819|NCT03670953|617549919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
170873820|NCT03670953|617549920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
170873821|NCT03670953|617549921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
170873822|NCT03670953|617549918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
170873823|NCT03670953|617549919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
170873824|NCT03670953|617549920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
170873825|NCT03670953|617549921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
170873826|NCT03670953|617549918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
170873827|NCT03670953|617549919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
170873828|NCT03670953|617549920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
170873829|NCT03670953|617549921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
170873830|NCT00054704|617549922|FG000|Overall Study|Lack of Efficacy|2|||
170873831|NCT00054704|617549923|FG001|Overall Study|Lack of Efficacy|3|||
170873832|NCT00054704|617549922|FG000|Overall Study|Adverse Event|3|||
170873833|NCT00054704|617549923|FG001|Overall Study|Adverse Event|1|||
170873834|NCT00054704|617549922|FG000|Overall Study|Lost to Follow-up|0|||
170873835|NCT00054704|617549923|FG001|Overall Study|Lost to Follow-up|1|||
170873836|NCT00362414|617549926|FG000|Overall Study|Death|2|||
170873837|NCT00362414|617549926|FG000|Overall Study|Adverse Event|1|||
170873838|NCT01469182|617549927|FG000|Overall Study|Adverse Event|21|||
170873839|NCT01469182|617549928|FG001|Overall Study|Adverse Event|3|||
170873840|NCT01469182|617549927|FG000|Overall Study|Lost to Follow-up|3|||
170873841|NCT01469182|617549928|FG001|Overall Study|Lost to Follow-up|0|||
170873842|NCT01469182|617549927|FG000|Overall Study|Withdrawal by Subject|4|||
170873843|NCT01469182|617549928|FG001|Overall Study|Withdrawal by Subject|1|||
170873844|NCT01469182|617549927|FG000|Overall Study|Protocol Violation|4|||
170873845|NCT01469182|617549928|FG001|Overall Study|Protocol Violation|2|||
170873846|NCT01469182|617549927|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
170873847|NCT01469182|617549928|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
170873848|NCT00636675|617549929|FG000|Overall Study|Lost to Follow-up|121|||
170873849|NCT00636675|617549930|FG001|Overall Study|Lost to Follow-up|31|||
170873850|NCT00636675|617549929|FG000|Overall Study|Withdrawal by Subject|19|||
170873851|NCT00636675|617549930|FG001|Overall Study|Withdrawal by Subject|10|||
170873852|NCT02187471|617549931|FG000|Overall Study|Protocol Violation|4|||
170873853|NCT02187471|617549932|FG001|Overall Study|Protocol Violation|5|||
170873854|NCT02187471|617549933|FG002|Overall Study|Protocol Violation|4|||
170873855|NCT02187471|617549934|FG003|Overall Study|Protocol Violation|4|||
170873856|NCT02187471|617549931|FG000|Overall Study|Missing|0|||
170873857|NCT02187471|617549932|FG001|Overall Study|Missing|0|||
170873858|NCT02187471|617549933|FG002|Overall Study|Missing|0|||
170873859|NCT02187471|617549934|FG003|Overall Study|Missing|1|||
170873860|NCT02187471|617549931|FG000|Overall Study|Lack of Efficacy|18|||
170873861|NCT02187471|617549932|FG001|Overall Study|Lack of Efficacy|9|||
170873862|NCT02187471|617549933|FG002|Overall Study|Lack of Efficacy|13|||
170873863|NCT02187471|617549934|FG003|Overall Study|Lack of Efficacy|11|||
170873864|NCT02187471|617549931|FG000|Overall Study|Adverse Event|24|||
170873865|NCT02187471|617549932|FG001|Overall Study|Adverse Event|34|||
170873866|NCT02187471|617549933|FG002|Overall Study|Adverse Event|44|||
170873867|NCT02187471|617549934|FG003|Overall Study|Adverse Event|36|||
170873868|NCT02187471|617549931|FG000|Overall Study|Withdrawal by Subject|23|||
170873869|NCT02187471|617549932|FG001|Overall Study|Withdrawal by Subject|29|||
170873870|NCT02187471|617549933|FG002|Overall Study|Withdrawal by Subject|22|||
170873871|NCT02187471|617549934|FG003|Overall Study|Withdrawal by Subject|24|||
170873872|NCT02187471|617549931|FG000|Overall Study|Other|7|||
170873873|NCT02187471|617549932|FG001|Overall Study|Other|5|||
170873874|NCT02187471|617549933|FG002|Overall Study|Other|3|||
170873875|NCT02187471|617549934|FG003|Overall Study|Other|4|||
170873876|NCT01785160|617549935|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
170873877|NCT01785160|617549935|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
170873878|NCT00916357|617549936|FG000|Period 1|Withdrawal by Subject|1|||
170873879|NCT00916357|617549937|FG001|Period 1|Withdrawal by Subject|0|||
170873880|NCT00916357|617549938|FG002|Period 1|Withdrawal by Subject|0|||
170873881|NCT00916357|617549939|FG003|Period 1|Withdrawal by Subject|0|||
170414919|NCT00095199|615858942|FG003|Overall Study|Primary tumor removed in other surgery|0|||
170414920|NCT00095199|615858939|FG000|Overall Study|Data inadvertently lost by site|1|||
170414921|NCT00095199|615858940|FG001|Overall Study|Data inadvertently lost by site|0|||
170414922|NCT00095199|615858941|FG002|Overall Study|Data inadvertently lost by site|0|||
170414923|NCT00095199|615858942|FG003|Overall Study|Data inadvertently lost by site|0|||
170414924|NCT03896490|615858943|FG000|Overall Study|Withdrawal by Subject|1|||
170414925|NCT03896490|615858944|FG001|Overall Study|Withdrawal by Subject|1|||
170414926|NCT01736553|615858951|FG000|Overall Study|Death|12|||
170414927|NCT01736553|615858952|FG001|Overall Study|Death|0|||
170414928|NCT01736553|615858951|FG000|Overall Study|Withdrawal by Subject|5|||
170414929|NCT01736553|615858952|FG001|Overall Study|Withdrawal by Subject|2|||
170773202|NCT01787760|617177457|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
170773203|NCT01787760|617177458|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
170773204|NCT01787760|617177459|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
170773205|NCT01787760|617177457|FG000|Overall Study|Decompensated on left exotropia|0|||
170773206|NCT01787760|617177458|FG001|Overall Study|Decompensated on left exotropia|0|||
170773207|NCT01787760|617177459|FG002|Overall Study|Decompensated on left exotropia|1|||
170773208|NCT01787760|617177457|FG000|Overall Study|Dryness|0|||
170773209|NCT01787760|617177458|FG001|Overall Study|Dryness|1|||
170773210|NCT01787760|617177459|FG002|Overall Study|Dryness|0|||
170773211|NCT01787760|617177457|FG000|Overall Study|Relocation|1|||
170773212|NCT01787760|617177458|FG001|Overall Study|Relocation|1|||
170773213|NCT01787760|617177459|FG002|Overall Study|Relocation|0|||
170773214|NCT01787760|617177457|FG000|Overall Study|Lens discomfort|3|||
170773215|NCT01787760|617177458|FG001|Overall Study|Lens discomfort|0|||
170773216|NCT01787760|617177459|FG002|Overall Study|Lens discomfort|0|||
170773217|NCT01787760|617177457|FG000|Overall Study|Lens handling difficulty|1|||
170773218|NCT01787760|617177458|FG001|Overall Study|Lens handling difficulty|2|||
170773219|NCT01787760|617177459|FG002|Overall Study|Lens handling difficulty|0|||
170773220|NCT01787760|617177457|FG000|Overall Study|Protocol Violation|6|||
170773221|NCT01787760|617177458|FG001|Overall Study|Protocol Violation|0|||
170773222|NCT01787760|617177459|FG002|Overall Study|Protocol Violation|1|||
170773223|NCT01787760|617177457|FG000|Overall Study|Withdrawal by Subject|5|||
170773224|NCT01787760|617177458|FG001|Overall Study|Withdrawal by Subject|1|||
170773225|NCT01787760|617177459|FG002|Overall Study|Withdrawal by Subject|2|||
170773226|NCT01787760|617177457|FG000|Overall Study|Lost to Follow-up|1|||
170773227|NCT01787760|617177458|FG001|Overall Study|Lost to Follow-up|0|||
170773228|NCT01787760|617177459|FG002|Overall Study|Lost to Follow-up|1|||
170773229|NCT01787760|617177457|FG000|Overall Study|Stroke|1|||
170773230|NCT01787760|617177458|FG001|Overall Study|Stroke|0|||
170773231|NCT01787760|617177459|FG002|Overall Study|Stroke|0|||
170773232|NCT01787760|617177457|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
170873882|NCT00916357|617549940|FG004|Period 1|Withdrawal by Subject|0|||
170773233|NCT01787760|617177458|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
170773234|NCT01787760|617177459|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
170773235|NCT01787760|617177457|FG000|Overall Study|Unsatisfactory physiological response|2|||
170773236|NCT01787760|617177458|FG001|Overall Study|Unsatisfactory physiological response|4|||
170873883|NCT00916357|617549941|FG005|Period 1|Withdrawal by Subject|0|||
170873884|NCT00916357|617549936|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
170873885|NCT00916357|617549937|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
170873886|NCT00916357|617549938|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
170873887|NCT00916357|617549939|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
170773237|NCT01787760|617177459|FG002|Overall Study|Unsatisfactory physiological response|0|||
170773238|NCT01787760|617177457|FG000|Overall Study|Unsatisfactory visual response|1|||
170773239|NCT01787760|617177458|FG001|Overall Study|Unsatisfactory visual response|1|||
170773240|NCT01787760|617177459|FG002|Overall Study|Unsatisfactory visual response|0|||
170773241|NCT01787760|617177457|FG000|Overall Study|Near vision blur|1|||
170773242|NCT01787760|617177458|FG001|Overall Study|Near vision blur|0|||
170773243|NCT01787760|617177459|FG002|Overall Study|Near vision blur|0|||
170773244|NCT05070247|617177460|FG000|Overall Study|Death|1|||
170773245|NCT05070247|617177461|FG001|Overall Study|Death|1|||
170773246|NCT05070247|617177462|FG002|Overall Study|Death|1|||
170773247|NCT05070247|617177463|FG003|Overall Study|Death|1|||
170773248|NCT05070247|617177464|FG004|Overall Study|Death|0|||
170773249|NCT05070247|617177465|FG005|Overall Study|Death|2|||
170773250|NCT05070247|617177466|FG006|Overall Study|Death|0|||
170773251|NCT05070247|617177467|FG007|Overall Study|Death|0|||
170773252|NCT05070247|617177468|FG008|Overall Study|Death|2|||
170773253|NCT05070247|617177469|FG009|Overall Study|Death|1|||
170773254|NCT05070247|617177470|FG010|Overall Study|Death|2|||
170773255|NCT05070247|617177471|FG011|Overall Study|Death|2|||
170773256|NCT05070247|617177472|FG012|Overall Study|Death|1|||
170773257|NCT05070247|617177473|FG013|Overall Study|Death|0|||
170773258|NCT05070247|617177474|FG014|Overall Study|Death|0|||
170773259|NCT05070247|617177460|FG000|Overall Study|Withdrawal by Subject|1|||
170773260|NCT05070247|617177461|FG001|Overall Study|Withdrawal by Subject|1|||
170773261|NCT05070247|617177462|FG002|Overall Study|Withdrawal by Subject|1|||
170773262|NCT05070247|617177463|FG003|Overall Study|Withdrawal by Subject|1|||
170773263|NCT05070247|617177464|FG004|Overall Study|Withdrawal by Subject|0|||
170773264|NCT05070247|617177465|FG005|Overall Study|Withdrawal by Subject|4|||
170773265|NCT05070247|617177466|FG006|Overall Study|Withdrawal by Subject|0|||
170773266|NCT05070247|617177467|FG007|Overall Study|Withdrawal by Subject|1|||
170773267|NCT05070247|617177468|FG008|Overall Study|Withdrawal by Subject|2|||
170773268|NCT05070247|617177469|FG009|Overall Study|Withdrawal by Subject|1|||
170773269|NCT05070247|617177470|FG010|Overall Study|Withdrawal by Subject|0|||
170773270|NCT05070247|617177471|FG011|Overall Study|Withdrawal by Subject|0|||
170773271|NCT05070247|617177472|FG012|Overall Study|Withdrawal by Subject|3|||
170773272|NCT05070247|617177473|FG013|Overall Study|Withdrawal by Subject|4|||
170773273|NCT05070247|617177474|FG014|Overall Study|Withdrawal by Subject|0|||
170773274|NCT05070247|617177460|FG000|Overall Study|Reason Not Specified|0|||
170773275|NCT05070247|617177461|FG001|Overall Study|Reason Not Specified|0|||
170773276|NCT05070247|617177462|FG002|Overall Study|Reason Not Specified|2|||
170773277|NCT05070247|617177463|FG003|Overall Study|Reason Not Specified|0|||
170773278|NCT05070247|617177464|FG004|Overall Study|Reason Not Specified|0|||
170773279|NCT05070247|617177465|FG005|Overall Study|Reason Not Specified|0|||
170773280|NCT05070247|617177466|FG006|Overall Study|Reason Not Specified|1|||
170773281|NCT05070247|617177467|FG007|Overall Study|Reason Not Specified|1|||
170773282|NCT05070247|617177468|FG008|Overall Study|Reason Not Specified|1|||
170773283|NCT05070247|617177469|FG009|Overall Study|Reason Not Specified|1|||
170773284|NCT05070247|617177470|FG010|Overall Study|Reason Not Specified|2|||
170773285|NCT05070247|617177471|FG011|Overall Study|Reason Not Specified|2|||
170773286|NCT05070247|617177472|FG012|Overall Study|Reason Not Specified|2|||
170773287|NCT05070247|617177473|FG013|Overall Study|Reason Not Specified|0|||
170773288|NCT05070247|617177474|FG014|Overall Study|Reason Not Specified|0|||
170773289|NCT04201834|617178613|FG000|Overall Study|Screen fail|1|||
170773290|NCT05386238|617178614|FG000|Overall Study|Lost to Follow-up|3|||
170773291|NCT05386238|617178615|FG001|Overall Study|Lost to Follow-up|2|||
170773292|NCT05386238|617178614|FG000|Overall Study|Withdrawal by Subject|0|||
170773293|NCT05386238|617178615|FG001|Overall Study|Withdrawal by Subject|1|||
170773294|NCT01631214|617178619|FG000|Overall Study|Withdrawal by Subject|276|||
170773295|NCT01631214|617178620|FG001|Overall Study|Withdrawal by Subject|290|||
170773296|NCT01631214|617178619|FG000|Overall Study|Death|113|||
170773297|NCT01631214|617178620|FG001|Overall Study|Death|106|||
170773298|NCT01631214|617178619|FG000|Overall Study|Lost to Follow-up|54|||
170773299|NCT01631214|617178620|FG001|Overall Study|Lost to Follow-up|40|||
170773300|NCT01631214|617178619|FG000|Overall Study|Adverse Event|45|||
170773301|NCT01631214|617178620|FG001|Overall Study|Adverse Event|45|||
170773302|NCT01631214|617178619|FG000|Overall Study|Other|22|||
170773303|NCT01631214|617178620|FG001|Overall Study|Other|19|||
170773304|NCT01631214|617178619|FG000|Overall Study|Noncompliance|16|||
170773305|NCT01631214|617178620|FG001|Overall Study|Noncompliance|15|||
170773306|NCT01631214|617178619|FG000|Overall Study|Requirement for Alternative Therapy|8|||
170773307|NCT01631214|617178620|FG001|Overall Study|Requirement for Alternative Therapy|3|||
170773308|NCT01631214|617178619|FG000|Overall Study|Protocol Deviation|4|||
170773309|NCT01631214|617178620|FG001|Overall Study|Protocol Deviation|3|||
170773310|NCT01631214|617178619|FG000|Overall Study|Ineligibility determined|5|||
170773311|NCT01631214|617178620|FG001|Overall Study|Ineligibility determined|2|||
170773312|NCT01631214|617178619|FG000|Overall Study|Administrative Decision|1|||
170773313|NCT01631214|617178620|FG001|Overall Study|Administrative Decision|0|||
170773314|NCT03575052|617178621|FG000|Overall Study|Adverse Event|6|||
170414930|NCT01736553|615858951|FG000|Overall Study|Lost to Follow-up|2|||
170414931|NCT01736553|615858952|FG001|Overall Study|Lost to Follow-up|2|||
170414932|NCT01896297|615858953|FG000|Overall Study|Died in post treatment phase|1|||
170414933|NCT02415959|615858954|FG000|Overall Study|Adverse Event|0|||
170414934|NCT02415959|615858955|FG001|Overall Study|Adverse Event|1|||
170414935|NCT02415959|615858956|FG002|Overall Study|Adverse Event|0|||
170773315|NCT03575052|617178622|FG001|Overall Study|Adverse Event|10|||
170773316|NCT03575052|617178621|FG000|Overall Study|Not further specified|5|||
170773317|NCT03575052|617178622|FG001|Overall Study|Not further specified|7|||
170773318|NCT03575052|617178621|FG000|Overall Study|Withdrawal by Subject|5|||
170773319|NCT03575052|617178622|FG001|Overall Study|Withdrawal by Subject|6|||
170773320|NCT03575052|617178621|FG000|Overall Study|Lost to Follow-up|3|||
170773321|NCT03575052|617178622|FG001|Overall Study|Lost to Follow-up|0|||
170773322|NCT03575052|617178621|FG000|Overall Study|Death|2|||
170773323|NCT03575052|617178622|FG001|Overall Study|Death|1|||
170773324|NCT03575052|617178621|FG000|Overall Study|Lack of Efficacy|2|||
170773325|NCT03575052|617178622|FG001|Overall Study|Lack of Efficacy|1|||
170773326|NCT03575052|617178621|FG000|Overall Study|Study drug noncompliance|1|||
170773327|NCT03575052|617178622|FG001|Overall Study|Study drug noncompliance|2|||
170773328|NCT03575052|617178621|FG000|Overall Study|Protocol Violation|0|||
170773329|NCT03575052|617178622|FG001|Overall Study|Protocol Violation|2|||
170773330|NCT03575052|617178621|FG000|Overall Study|Physician Decision|1|||
170773331|NCT03575052|617178622|FG001|Overall Study|Physician Decision|0|||
170773332|NCT05288283|617178632|FG000|Overall Study|Study Terminated Early|1|||
170773333|NCT05288283|617178633|FG001|Overall Study|Study Terminated Early|1|||
170773334|NCT02411084|617178634|FG000|Overall Study|Lack of Efficacy|6|||
170773335|NCT02411084|617178635|FG001|Overall Study|Lack of Efficacy|3|||
170773336|NCT02411084|617178634|FG000|Overall Study|Death|5|||
170773337|NCT02411084|617178635|FG001|Overall Study|Death|4|||
170773338|NCT02411084|617178634|FG000|Overall Study|Adverse Event|2|||
170773339|NCT02411084|617178635|FG001|Overall Study|Adverse Event|1|||
170773340|NCT02411084|617178634|FG000|Overall Study|Other reasons|0|||
170773341|NCT02411084|617178635|FG001|Overall Study|Other reasons|5|||
170773342|NCT02647905|617178639|FG000|Overall Study|Lost to Follow-up|1|||
170773343|NCT02647905|617178639|FG000|Overall Study|Withdrawal by Subject|2|||
170773344|NCT00077675|617178640|FG000|Overall Study|Adverse Event|1|||
170773345|NCT00077675|617178641|FG001|Overall Study|Adverse Event|2|||
170773346|NCT00077675|617178640|FG000|Overall Study|Lost to Follow-up|6|||
170773347|NCT00077675|617178641|FG001|Overall Study|Lost to Follow-up|3|||
170773348|NCT00077675|617178640|FG000|Overall Study|Withdrawal by Subject|1|||
170773349|NCT00077675|617178641|FG001|Overall Study|Withdrawal by Subject|0|||
170773350|NCT00077675|617178640|FG000|Overall Study|Other|0|||
170773351|NCT00077675|617178641|FG001|Overall Study|Other|1|||
170773352|NCT00077675|617178640|FG000|Overall Study|Never received study treatment|3|||
170773353|NCT00077675|617178641|FG001|Overall Study|Never received study treatment|3|||
170773354|NCT02601820|617178642|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
170773355|NCT02601820|617178642|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
170773356|NCT02601820|617178642|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
170773357|NCT02601820|617178642|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
170414936|NCT02415959|615858957|FG003|Overall Study|Adverse Event|0|||
170414937|NCT02415959|615858958|FG004|Overall Study|Adverse Event|0|||
170414938|NCT02415959|615858954|FG000|Overall Study|Protocol Violation|0|||
170414939|NCT02415959|615858955|FG001|Overall Study|Protocol Violation|0|||
170773358|NCT01185782|617178646|FG000|Overall Study|Adverse Event|0|||
170773359|NCT01185782|617178647|FG001|Overall Study|Adverse Event|1|||
170773360|NCT01185782|617178646|FG000|Overall Study|Protocol Violation|1|||
170773361|NCT01185782|617178647|FG001|Overall Study|Protocol Violation|0|||
170773362|NCT01185782|617178646|FG000|Overall Study|Poor Response to Treatment|3|||
170773363|NCT01185782|617178647|FG001|Overall Study|Poor Response to Treatment|1|||
170773364|NCT01185782|617178646|FG000|Overall Study|Other|2|||
170414940|NCT02415959|615858956|FG002|Overall Study|Protocol Violation|0|||
170414941|NCT02415959|615858957|FG003|Overall Study|Protocol Violation|1|||
170414942|NCT02415959|615858958|FG004|Overall Study|Protocol Violation|0|||
170414943|NCT00003782|615858959|FG000|Overall Study|No follow up data|30|||
170773365|NCT01185782|617178647|FG001|Overall Study|Other|5|||
170773366|NCT01185782|617178646|FG000|Overall Study|Randomized but not treated|0|||
170773367|NCT01185782|617178647|FG001|Overall Study|Randomized but not treated|4|||
170773368|NCT02507752|617178648|FG000|Overall Study|Adverse Event|1|||
170773369|NCT02507752|617178648|FG000|Overall Study|Protocol Violation|6|||
170773370|NCT02507752|617178648|FG000|Overall Study|Lost to Follow-up|7|||
170773371|NCT02507752|617178648|FG000|Overall Study|Infusion reaction at first infusion|1|||
170773372|NCT02507752|617178648|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
170773373|NCT02507752|617178648|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
170773374|NCT00960141|617178649|FG000|Overall Study|Adverse Event|4|||
170773375|NCT00960141|617178650|FG001|Overall Study|Adverse Event|8|||
170773376|NCT00960141|617178651|FG002|Overall Study|Adverse Event|2|||
170773377|NCT00960141|617178649|FG000|Overall Study|Lack of Efficacy|3|||
170773378|NCT00960141|617178650|FG001|Overall Study|Lack of Efficacy|4|||
170773379|NCT00960141|617178651|FG002|Overall Study|Lack of Efficacy|2|||
170632509|NCT01499355|616666690|FG002|Run-In Period|Death|0|||
170773380|NCT00960141|617178649|FG000|Overall Study|Lost to Follow-up|1|||
170773381|NCT00960141|617178650|FG001|Overall Study|Lost to Follow-up|0|||
170773382|NCT00960141|617178651|FG002|Overall Study|Lost to Follow-up|0|||
170773383|NCT00960141|617178649|FG000|Overall Study|Protocol Violation|1|||
170773384|NCT00960141|617178650|FG001|Overall Study|Protocol Violation|3|||
170773385|NCT00960141|617178651|FG002|Overall Study|Protocol Violation|2|||
170773386|NCT00960141|617178649|FG000|Overall Study|Withdrawal by Subject|1|||
170773387|NCT00960141|617178650|FG001|Overall Study|Withdrawal by Subject|2|||
170773388|NCT00960141|617178651|FG002|Overall Study|Withdrawal by Subject|1|||
170773389|NCT00296036|617178654|FG000|Overall Study|Withdrawal by Subject|1|||
170773390|NCT00296036|617178655|FG001|Overall Study|Withdrawal by Subject|0|||
170773391|NCT00296036|617178656|FG002|Overall Study|Withdrawal by Subject|2|||
170773392|NCT00296036|617178657|FG003|Overall Study|Withdrawal by Subject|1|||
170773393|NCT00296036|617178658|FG004|Overall Study|Withdrawal by Subject|2|||
170773394|NCT00296036|617178659|FG005|Overall Study|Withdrawal by Subject|1|||
170773395|NCT00296036|617178654|FG000|Overall Study|Protocol Violation|0|||
170773396|NCT00296036|617178655|FG001|Overall Study|Protocol Violation|0|||
170773397|NCT00296036|617178656|FG002|Overall Study|Protocol Violation|0|||
170773398|NCT00296036|617178657|FG003|Overall Study|Protocol Violation|0|||
170773399|NCT00296036|617178658|FG004|Overall Study|Protocol Violation|0|||
170773400|NCT00296036|617178659|FG005|Overall Study|Protocol Violation|3|||
170773401|NCT03823911|617178666|FG000|Overall Study|Lost to Follow-up|1|||
170773402|NCT03823911|617178667|FG001|Overall Study|Lost to Follow-up|5|||
170773403|NCT03823911|617178668|FG002|Overall Study|Lost to Follow-up|2|||
170773404|NCT03823911|617178666|FG000|Overall Study|Did not meet eligibility criteria|13|||
170773405|NCT03823911|617178667|FG001|Overall Study|Did not meet eligibility criteria|7|||
170773406|NCT03823911|617178668|FG002|Overall Study|Did not meet eligibility criteria|4|||
170773407|NCT03823911|617178666|FG000|Overall Study|Death|0|||
170773408|NCT03823911|617178667|FG001|Overall Study|Death|1|||
170773409|NCT03823911|617178668|FG002|Overall Study|Death|0|||
170773410|NCT01832480|617178669|FG000|Overall Study|Lost to Follow-up|33|||
170773411|NCT01832480|617178670|FG001|Overall Study|Lost to Follow-up|30|||
170773412|NCT01832480|617178669|FG000|Overall Study|Withdrawal by Subject|0|||
170773413|NCT01832480|617178670|FG001|Overall Study|Withdrawal by Subject|2|||
170773414|NCT01832480|617178669|FG000|Overall Study|post randomization ineligible|8|||
170773415|NCT01832480|617178670|FG001|Overall Study|post randomization ineligible|10|||
170773416|NCT03764475|617178673|FG000|Overall Study|Adverse Event|11|||
170773417|NCT03764475|617178674|FG001|Overall Study|Adverse Event|2|||
170773418|NCT03764475|617178673|FG000|Overall Study|Lost to Follow-up|24|||
170773419|NCT03764475|617178674|FG001|Overall Study|Lost to Follow-up|10|||
170773420|NCT03764475|617178673|FG000|Overall Study|Withdrawal by Subject|26|||
170773421|NCT03764475|617178674|FG001|Overall Study|Withdrawal by Subject|10|||
170773422|NCT03764475|617178673|FG000|Overall Study|Lack of Efficacy|3|||
170773423|NCT03764475|617178674|FG001|Overall Study|Lack of Efficacy|0|||
170773424|NCT03764475|617178673|FG000|Overall Study|COVID-19 Disruption|2|||
170773425|NCT03764475|617178674|FG001|Overall Study|COVID-19 Disruption|0|||
170773426|NCT00580866|617178675|FG000|Overall Study|Lost to Follow-up|2|||
170773427|NCT00580866|617178676|FG001|Overall Study|Lost to Follow-up|2|||
170773428|NCT02261467|617178677|FG000|Overall Study|Enrolled in Error|1|||
170773429|NCT02261467|617178678|FG001|Overall Study|Enrolled in Error|0|||
170773430|NCT02261467|617178677|FG000|Overall Study|Protocol Violation|0|||
170773431|NCT02261467|617178678|FG001|Overall Study|Protocol Violation|1|||
170773432|NCT02261467|617178677|FG000|Overall Study|Personal Reasons|17|||
170773433|NCT02261467|617178678|FG001|Overall Study|Personal Reasons|22|||
170773434|NCT02261467|617178677|FG000|Overall Study|Lost to Follow-up|2|||
170773435|NCT02261467|617178678|FG001|Overall Study|Lost to Follow-up|13|||
170773436|NCT02261467|617178677|FG000|Overall Study|Adverse Event|1|||
170773437|NCT02261467|617178678|FG001|Overall Study|Adverse Event|1|||
170773438|NCT02477605|617178679|FG000|Overall Study|Discontinued prior to treatment|1|||
170773439|NCT02477605|617178680|FG001|Overall Study|Discontinued prior to treatment|0|||
170773440|NCT02477605|617178679|FG000|Overall Study|Lost to Follow-up|0|||
170773441|NCT02477605|617178680|FG001|Overall Study|Lost to Follow-up|2|||
170773442|NCT02477605|617178679|FG000|Overall Study|Withdrawal by Subject|0|||
170773443|NCT02477605|617178680|FG001|Overall Study|Withdrawal by Subject|1|||
170773444|NCT02477605|617178679|FG000|Overall Study|Administered gas during surgery|0|||
170773445|NCT02477605|617178680|FG001|Overall Study|Administered gas during surgery|1|||
170773446|NCT03144674|617178687|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
170773447|NCT03144674|617178688|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
170773448|NCT03144674|617178689|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
170773449|NCT03144674|617178690|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
170773450|NCT03144674|617178687|FG000|Overall Study|Death|3|||
170773451|NCT03144674|617178688|FG001|Overall Study|Death|2|||
170773452|NCT03144674|617178689|FG002|Overall Study|Death|6|||
170773453|NCT03144674|617178690|FG003|Overall Study|Death|24|||
170773454|NCT03144674|617178687|FG000|Overall Study|Lost to Follow-up|0|||
170773455|NCT03144674|617178688|FG001|Overall Study|Lost to Follow-up|1|||
170773456|NCT03144674|617178689|FG002|Overall Study|Lost to Follow-up|0|||
170873888|NCT00916357|617549940|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
170873889|NCT00916357|617549941|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
170873890|NCT01033734|617549942|FG000|Overall Study|Withdrawal by Subject|1|||
170873891|NCT01101438|617549943|FG000|Overall Study|Withdrawal by Subject|8|||
170873892|NCT01101438|617549944|FG001|Overall Study|Withdrawal by Subject|9|||
170873893|NCT03810781|617549945|FG000|Overall Study|COVID shut down|2|||
170873894|NCT00709111|617549946|FG000|Overall Study|Withdrawal by Subject|1|||
170873895|NCT00709111|617549946|FG000|Overall Study|Unable to attend clinic visits|1|||
170873896|NCT00915772|617549949|FG000|Overall Study|Adverse Event|12|||
170873897|NCT00915772|617549950|FG001|Overall Study|Adverse Event|13|||
170873898|NCT00915772|617549951|FG002|Overall Study|Adverse Event|11|||
170873899|NCT00915772|617549949|FG000|Overall Study|Protocol Violation|4|||
170873900|NCT00915772|617549950|FG001|Overall Study|Protocol Violation|1|||
170873901|NCT00915772|617549951|FG002|Overall Study|Protocol Violation|2|||
170873902|NCT00915772|617549949|FG000|Overall Study|Lost to Follow-up|1|||
170873903|NCT00915772|617549950|FG001|Overall Study|Lost to Follow-up|2|||
170873904|NCT00915772|617549951|FG002|Overall Study|Lost to Follow-up|2|||
170873905|NCT00915772|617549949|FG000|Overall Study|Lack of Efficacy|9|||
170873906|NCT00915772|617549950|FG001|Overall Study|Lack of Efficacy|15|||
170873907|NCT00915772|617549951|FG002|Overall Study|Lack of Efficacy|3|||
170873908|NCT00915772|617549949|FG000|Overall Study|Refused to continue trial medication|6|||
170873909|NCT00915772|617549950|FG001|Overall Study|Refused to continue trial medication|8|||
170873910|NCT00915772|617549951|FG002|Overall Study|Refused to continue trial medication|4|||
170873911|NCT00915772|617549949|FG000|Overall Study|Any other reason|4|||
170873912|NCT00915772|617549950|FG001|Overall Study|Any other reason|7|||
170873913|NCT00915772|617549951|FG002|Overall Study|Any other reason|7|||
170873914|NCT01365039|617549952|FG000|Overall Study|Study related symptoms and complaints|1|||
170873915|NCT01365039|617549953|FG001|Overall Study|Study related symptoms and complaints|0|||
170873916|NCT03677596|617549960|FG000|Overall Study|Adverse Event|0|||
170873917|NCT03677596|617549961|FG001|Overall Study|Adverse Event|1|||
170873918|NCT03677596|617549960|FG000|Overall Study|Death|10|||
170873919|NCT03677596|617549961|FG001|Overall Study|Death|6|||
170873920|NCT03677596|617549960|FG000|Overall Study|Lost to Follow-up|0|||
170873921|NCT03677596|617549961|FG001|Overall Study|Lost to Follow-up|1|||
170873922|NCT03677596|617549960|FG000|Overall Study|Progressive Disease|8|||
170873923|NCT03677596|617549961|FG001|Overall Study|Progressive Disease|8|||
170873924|NCT03677596|617549960|FG000|Overall Study|Withdrawal by Subject|3|||
170873925|NCT03677596|617549961|FG001|Overall Study|Withdrawal by Subject|0|||
170873926|NCT03677596|617549960|FG000|Overall Study|Disease Relapse|2|||
170873927|NCT03677596|617549961|FG001|Overall Study|Disease Relapse|2|||
170873928|NCT03677596|617549960|FG000|Overall Study|Other|0|||
170873929|NCT03677596|617549961|FG001|Overall Study|Other|1|||
170873930|NCT00922480|617549968|FG000|Main Study|Protocol Violation|3|||
170873931|NCT00922480|617549969|FG001|Main Study|Protocol Violation|6|||
170873932|NCT00922480|617549968|FG000|Main Study|Adverse Event|6|||
170873933|NCT00922480|617549969|FG001|Main Study|Adverse Event|7|||
170873934|NCT00922480|617549968|FG000|Main Study|Lack of Efficacy|3|||
170873935|NCT00922480|617549969|FG001|Main Study|Lack of Efficacy|0|||
170873936|NCT00922480|617549968|FG000|Main Study|Withdrawal by Subject|20|||
170873937|NCT00922480|617549969|FG001|Main Study|Withdrawal by Subject|15|||
170873938|NCT00922480|617549968|FG000|Main Study|Lost to Follow-up|5|||
170873939|NCT00922480|617549969|FG001|Main Study|Lost to Follow-up|0|||
170873940|NCT00922480|617549968|FG000|Main Study|Physician Decision|0|||
170632510|NCT01499355|616666691|FG003|Run-In Period|Death|0|||
170632511|NCT01499355|616666688|FG000|Run-In Period|Investigator Decision|2|||
170873941|NCT00922480|617549969|FG001|Main Study|Physician Decision|1|||
170873942|NCT00922480|617549968|FG000|Extension Study|Protocol Violation|3|||
170873943|NCT00922480|617549969|FG001|Extension Study|Protocol Violation|0|||
170873944|NCT00922480|617549968|FG000|Extension Study|Adverse Event|1|||
170873945|NCT00922480|617549969|FG001|Extension Study|Adverse Event|1|||
170873946|NCT00922480|617549968|FG000|Extension Study|Withdrawal by Subject|1|||
170873947|NCT00922480|617549969|FG001|Extension Study|Withdrawal by Subject|1|||
170873948|NCT00922480|617549968|FG000|Extension Study|Others|0|||
170873949|NCT00922480|617549969|FG001|Extension Study|Others|1|||
170873950|NCT01131676|617549974|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
170873951|NCT01131676|617549975|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
170873952|NCT01131676|617549976|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
170873953|NCT01131676|617549974|FG000|Discontinuation From Treatment|Not treated|4|||
170873954|NCT01131676|617549975|FG001|Discontinuation From Treatment|Not treated|2|||
170873955|NCT01131676|617549976|FG002|Discontinuation From Treatment|Not treated|2|||
170873956|NCT01131676|617549974|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
170873957|NCT01131676|617549975|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
170873958|NCT01131676|617549976|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
170873959|NCT01131676|617549974|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
170873960|NCT01131676|617549975|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
170873961|NCT01131676|617549976|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
170873962|NCT01131676|617549974|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
170873963|NCT01131676|617549975|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
170873964|NCT01131676|617549976|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
170873965|NCT01131676|617549974|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
170873966|NCT01131676|617549975|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
170873967|NCT01131676|617549976|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
170873968|NCT01131676|617549974|FG000|Discontinuation From Treatment|Other than those specified|162|||
170873969|NCT01131676|617549975|FG001|Discontinuation From Treatment|Other than those specified|142|||
170873970|NCT01131676|617549976|FG002|Discontinuation From Treatment|Other than those specified|125|||
170873971|NCT01131676|617549974|FG000|Discontinuation From Treatment|Adverse Event|303|||
170873972|NCT01131676|617549975|FG001|Discontinuation From Treatment|Adverse Event|267|||
170873973|NCT01131676|617549976|FG002|Discontinuation From Treatment|Adverse Event|273|||
170873974|NCT01131676|617549974|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
170873975|NCT01131676|617549975|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
170873976|NCT01131676|617549976|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
170873977|NCT01131676|617549974|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
170873978|NCT01131676|617549975|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
170873979|NCT01131676|617549976|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
170873980|NCT01131676|617549974|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
170873981|NCT01131676|617549975|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
170873982|NCT01131676|617549976|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
170873983|NCT01131676|617549974|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
170873984|NCT01131676|617549975|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
170873985|NCT01131676|617549976|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
170873986|NCT01131676|617549974|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
170873987|NCT01131676|617549975|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
170873988|NCT01131676|617549976|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
170873989|NCT01131676|617549974|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
170873990|NCT01131676|617549975|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
170873991|NCT01131676|617549976|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
170873992|NCT01970488|617549977|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
170873993|NCT01970488|617549978|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
170873994|NCT01970488|617549979|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
170873995|NCT01970488|617549980|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
170873996|NCT01970488|617549981|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
170873997|NCT01970488|617549977|FG000|Part 1: Through Week 16|Protocol Violation|1|||
170873998|NCT01970488|617549978|FG001|Part 1: Through Week 16|Protocol Violation|2|||
170873999|NCT01970488|617549979|FG002|Part 1: Through Week 16|Protocol Violation|0|||
170874000|NCT01970488|617549980|FG003|Part 1: Through Week 16|Protocol Violation|0|||
170874001|NCT01970488|617549981|FG004|Part 1: Through Week 16|Protocol Violation|0|||
170874002|NCT01970488|617549977|FG000|Part 1: Through Week 16|Adverse Event|6|||
170874003|NCT01970488|617549978|FG001|Part 1: Through Week 16|Adverse Event|5|||
170874004|NCT01970488|617549979|FG002|Part 1: Through Week 16|Adverse Event|0|||
170874005|NCT01970488|617549980|FG003|Part 1: Through Week 16|Adverse Event|0|||
170874006|NCT01970488|617549981|FG004|Part 1: Through Week 16|Adverse Event|0|||
170874007|NCT01970488|617549977|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
170874008|NCT01970488|617549978|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
170874009|NCT01970488|617549979|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
170874010|NCT01970488|617549980|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
170874011|NCT01970488|617549981|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
170874012|NCT01970488|617549977|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
170874013|NCT01970488|617549978|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
170874014|NCT01970488|617549979|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
170874015|NCT01970488|617549980|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
170874016|NCT01970488|617549981|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
170874017|NCT01970488|617549977|FG000|Part 2: Post Week 16|Physician Decision|0|||
170874018|NCT01970488|617549978|FG001|Part 2: Post Week 16|Physician Decision|0|||
170874019|NCT01970488|617549979|FG002|Part 2: Post Week 16|Physician Decision|0|||
170874020|NCT01970488|617549980|FG003|Part 2: Post Week 16|Physician Decision|0|||
170874021|NCT01970488|617549981|FG004|Part 2: Post Week 16|Physician Decision|1|||
170874022|NCT01970488|617549977|FG000|Part 2: Post Week 16|Non-compliance|0|||
170874023|NCT01970488|617549978|FG001|Part 2: Post Week 16|Non-compliance|0|||
170874024|NCT01970488|617549979|FG002|Part 2: Post Week 16|Non-compliance|1|||
170874025|NCT01970488|617549980|FG003|Part 2: Post Week 16|Non-compliance|0|||
170874026|NCT01970488|617549981|FG004|Part 2: Post Week 16|Non-compliance|0|||
170874027|NCT01970488|617549977|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
170773457|NCT03144674|617178690|FG003|Overall Study|Lost to Follow-up|4|||
170773458|NCT03144674|617178687|FG000|Overall Study|Withdrawal by Participant|0|||
170773459|NCT03144674|617178688|FG001|Overall Study|Withdrawal by Participant|0|||
170773460|NCT03144674|617178689|FG002|Overall Study|Withdrawal by Participant|2|||
170773461|NCT03144674|617178690|FG003|Overall Study|Withdrawal by Participant|6|||
170773462|NCT03144674|617178687|FG000|Overall Study|Discharged from the Trust|0|||
170773463|NCT03144674|617178688|FG001|Overall Study|Discharged from the Trust|0|||
170773464|NCT03144674|617178689|FG002|Overall Study|Discharged from the Trust|1|||
170773465|NCT03144674|617178690|FG003|Overall Study|Discharged from the Trust|0|||
170773466|NCT03144674|617178687|FG000|Overall Study|Exclusion Criteria Met|0|||
170773467|NCT03144674|617178688|FG001|Overall Study|Exclusion Criteria Met|0|||
170773468|NCT03144674|617178689|FG002|Overall Study|Exclusion Criteria Met|1|||
170773469|NCT03144674|617178690|FG003|Overall Study|Exclusion Criteria Met|0|||
170773470|NCT03144674|617178687|FG000|Overall Study|Changed Physicians|0|||
170773471|NCT03144674|617178688|FG001|Overall Study|Changed Physicians|0|||
170773472|NCT03144674|617178689|FG002|Overall Study|Changed Physicians|0|||
170773473|NCT03144674|617178690|FG003|Overall Study|Changed Physicians|1|||
170773474|NCT03144674|617178687|FG000|Overall Study|Removed for Safety|0|||
170773475|NCT03144674|617178688|FG001|Overall Study|Removed for Safety|0|||
170773476|NCT03144674|617178689|FG002|Overall Study|Removed for Safety|0|||
170773477|NCT03144674|617178690|FG003|Overall Study|Removed for Safety|1|||
170773478|NCT03144674|617178687|FG000|Overall Study|Site Closed|0|||
170773479|NCT03144674|617178688|FG001|Overall Study|Site Closed|0|||
170773480|NCT03144674|617178689|FG002|Overall Study|Site Closed|0|||
170773481|NCT03144674|617178690|FG003|Overall Study|Site Closed|1|||
170773482|NCT03144674|617178687|FG000|Overall Study|Histological Criteria Not Met|0|||
170773483|NCT03144674|617178688|FG001|Overall Study|Histological Criteria Not Met|0|||
170773484|NCT03144674|617178689|FG002|Overall Study|Histological Criteria Not Met|0|||
170773485|NCT03144674|617178690|FG003|Overall Study|Histological Criteria Not Met|1|||
170773486|NCT03144674|617178687|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
170773487|NCT03144674|617178688|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
170773488|NCT03144674|617178689|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
170773489|NCT03144674|617178690|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
170773490|NCT03144674|617178687|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
170773491|NCT03144674|617178688|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
170773492|NCT03144674|617178689|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
170773493|NCT03144674|617178690|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
170773494|NCT01373346|617178693|FG000|Overall Study|Death|1|||
170773495|NCT01198028|617178696|FG000|Overall Study|Adverse Event|5|||
170773496|NCT01198028|617178696|FG000|Overall Study|Death|3|||
170773497|NCT01198028|617178696|FG000|Overall Study|Physician Decision|2|||
170773498|NCT01395758|617178697|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
170773499|NCT01395758|617178698|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
170773500|NCT01395758|617178699|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
170773501|NCT02674750|617178703|FG000|Overall Study|Death|4|||
170773502|NCT02674750|617178704|FG001|Overall Study|Death|5|||
170773503|NCT02674750|617178705|FG002|Overall Study|Death|8|||
170773504|NCT02674750|617178703|FG000|Overall Study|Lost to Follow-up|0|||
170773505|NCT02674750|617178704|FG001|Overall Study|Lost to Follow-up|8|||
170773506|NCT02674750|617178705|FG002|Overall Study|Lost to Follow-up|0|||
170773507|NCT02674750|617178703|FG000|Overall Study|Lack of Efficacy|1|||
170773508|NCT02674750|617178704|FG001|Overall Study|Lack of Efficacy|17|||
170773509|NCT02674750|617178705|FG002|Overall Study|Lack of Efficacy|3|||
170773510|NCT02674750|617178703|FG000|Overall Study|Withdrawal by Subject|0|||
170773511|NCT02674750|617178704|FG001|Overall Study|Withdrawal by Subject|7|||
170773512|NCT02674750|617178705|FG002|Overall Study|Withdrawal by Subject|1|||
170773513|NCT02674750|617178703|FG000|Overall Study|Other|0|||
170773514|NCT02674750|617178704|FG001|Overall Study|Other|8|||
170773515|NCT02674750|617178705|FG002|Overall Study|Other|0|||
170773516|NCT01685606|617178708|FG000|Overall Study|Withdrawal by Subject|1|||
170773517|NCT00736853|617178709|FG000|Open-Label Period|Physician Decision|2|||
170773518|NCT00736853|617178710|FG001|Open-Label Period|Physician Decision|0|||
170773519|NCT00736853|617178711|FG002|Open-Label Period|Physician Decision|0|||
170773520|NCT00736853|617178709|FG000|Open-Label Period|Adverse Event|31|||
170773521|NCT00736853|617178710|FG001|Open-Label Period|Adverse Event|0|||
170773522|NCT00736853|617178711|FG002|Open-Label Period|Adverse Event|0|||
170773523|NCT00736853|617178709|FG000|Open-Label Period|Withdrawal by Subject|16|||
170773524|NCT00736853|617178710|FG001|Open-Label Period|Withdrawal by Subject|0|||
170773525|NCT00736853|617178711|FG002|Open-Label Period|Withdrawal by Subject|0|||
170773526|NCT00736853|617178709|FG000|Open-Label Period|Started but not treated|42|||
170773527|NCT00736853|617178710|FG001|Open-Label Period|Started but not treated|0|||
170773528|NCT00736853|617178711|FG002|Open-Label Period|Started but not treated|0|||
170773529|NCT00736853|617178709|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
170773530|NCT00736853|617178710|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
170773531|NCT00736853|617178711|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
170773532|NCT00736853|617178709|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
170874028|NCT01970488|617549978|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
170874029|NCT01970488|617549979|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
170874030|NCT01970488|617549980|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
170874031|NCT01970488|617549981|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
170874032|NCT01970488|617549977|FG000|Part 2: Post Week 16|Adverse Event|0|||
170874033|NCT01970488|617549978|FG001|Part 2: Post Week 16|Adverse Event|0|||
170874034|NCT01970488|617549979|FG002|Part 2: Post Week 16|Adverse Event|5|||
170874035|NCT01970488|617549980|FG003|Part 2: Post Week 16|Adverse Event|1|||
170874036|NCT01970488|617549981|FG004|Part 2: Post Week 16|Adverse Event|1|||
170874037|NCT01970488|617549977|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
170874038|NCT01970488|617549978|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
170874039|NCT01970488|617549979|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
170874040|NCT01970488|617549980|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
170874041|NCT01970488|617549981|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
170874042|NCT01970488|617549977|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
170773533|NCT00736853|617178710|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
170874043|NCT01970488|617549978|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
170874044|NCT01970488|617549979|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
170874045|NCT01970488|617549980|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
170773534|NCT00736853|617178711|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
170773535|NCT00736853|617178709|FG000|Double-Blind Period|Lack of Efficacy|0|||
170773536|NCT00736853|617178710|FG001|Double-Blind Period|Lack of Efficacy|19|||
170773537|NCT00736853|617178711|FG002|Double-Blind Period|Lack of Efficacy|42|||
170773538|NCT00736853|617178709|FG000|Double-Blind Period|Adverse Event|0|||
170773539|NCT00736853|617178710|FG001|Double-Blind Period|Adverse Event|3|||
170773540|NCT00736853|617178711|FG002|Double-Blind Period|Adverse Event|2|||
170773541|NCT00736853|617178709|FG000|Double-Blind Period|Withdrawal by Subject|0|||
170773542|NCT00736853|617178710|FG001|Double-Blind Period|Withdrawal by Subject|1|||
170773543|NCT00736853|617178711|FG002|Double-Blind Period|Withdrawal by Subject|4|||
170773544|NCT00736853|617178709|FG000|Double-Blind Period|Ineligible to participate the study|0|||
170773545|NCT00736853|617178710|FG001|Double-Blind Period|Ineligible to participate the study|1|||
170773546|NCT00736853|617178711|FG002|Double-Blind Period|Ineligible to participate the study|0|||
170773547|NCT01353963|617178712|FG000|Overall Study|Adverse Event|2|||
170773548|NCT01415349|617178713|FG000|Treatment Period 1|Adverse Event|0|||
170773549|NCT01415349|617178714|FG001|Treatment Period 1|Adverse Event|1|||
170773550|NCT01415349|617178713|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170773551|NCT01415349|617178714|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170773552|NCT01764464|617178717|FG000|First Intervention|Withdrawal by Subject|1|||
170773553|NCT01764464|617178718|FG001|First Intervention|Withdrawal by Subject|0|||
170773554|NCT01764464|617178717|FG000|First Intervention|Lost to Follow-up|1|||
170773555|NCT01764464|617178718|FG001|First Intervention|Lost to Follow-up|0|||
170773556|NCT01764464|617178717|FG000|First Intervention|Adverse Event|0|||
170773557|NCT01764464|617178718|FG001|First Intervention|Adverse Event|2|||
170773558|NCT01764464|617178717|FG000|First Intervention|did not receive study drug|0|||
170773559|NCT01764464|617178718|FG001|First Intervention|did not receive study drug|1|||
170773560|NCT01764464|617178717|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
170773561|NCT01764464|617178718|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
170773562|NCT02531113|617178724|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
170773563|NCT02531113|617178724|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
170773564|NCT02531113|617178724|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
170773565|NCT02531113|617178724|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
170773566|NCT02531113|617178724|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
170773567|NCT02531113|617178724|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
170773568|NCT02531113|617178724|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
170773569|NCT02531113|617178724|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
170773570|NCT04814186|617181050|FG000|Treatment Phase|Adverse Event|1|||
170874046|NCT01970488|617549981|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
170874047|NCT01816061|617549982|FG000|Overall Study|Lost to Follow-up|13|||
170773571|NCT04814186|617181050|FG000|Treatment Phase|Death|6|||
170773572|NCT04814186|617181050|FG000|Treatment Phase|Withdrawal by Subject|2|||
170773573|NCT04814186|617181050|FG000|Treatment Phase|Other|1|||
170773574|NCT04814186|617181050|FG000|Follow-Up Phase|Adverse Event|1|||
170773575|NCT04814186|617181050|FG000|Follow-Up Phase|Death|6|||
170773576|NCT04814186|617181050|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
170773577|NCT04814186|617181050|FG000|Follow-Up Phase|Other|1|||
170773578|NCT03422276|617181068|FG000|Overall Study|Withdrawal by Subject|21|||
170874048|NCT01816061|617549983|FG001|Overall Study|Lost to Follow-up|24|||
170874049|NCT02114268|617549984|FG000|Overall Study|Lost to Follow-up|4|||
170874050|NCT02114268|617549985|FG001|Overall Study|Lost to Follow-up|1|||
170874051|NCT02114268|617549986|FG002|Overall Study|Lost to Follow-up|1|||
170874052|NCT02114268|617549987|FG003|Overall Study|Lost to Follow-up|0|||
170874053|NCT02114268|617549988|FG004|Overall Study|Lost to Follow-up|0|||
170874054|NCT02114268|617549989|FG005|Overall Study|Lost to Follow-up|2|||
170874055|NCT02114268|617549984|FG000|Overall Study|Withdrawal by Subject|1|||
170874056|NCT02114268|617549985|FG001|Overall Study|Withdrawal by Subject|0|||
170874057|NCT02114268|617549986|FG002|Overall Study|Withdrawal by Subject|0|||
170874058|NCT02114268|617549987|FG003|Overall Study|Withdrawal by Subject|0|||
170874059|NCT02114268|617549988|FG004|Overall Study|Withdrawal by Subject|0|||
170874060|NCT02114268|617549989|FG005|Overall Study|Withdrawal by Subject|1|||
170874061|NCT02114268|617549984|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
170773579|NCT03422276|617181069|FG001|Overall Study|Withdrawal by Subject|25|||
170773580|NCT03422276|617181070|FG002|Overall Study|Withdrawal by Subject|14|||
170773581|NCT03422276|617181071|FG003|Overall Study|Withdrawal by Subject|16|||
170773582|NCT03422276|617181068|FG000|Overall Study|Death|14|||
170773583|NCT03422276|617181069|FG001|Overall Study|Death|21|||
170773584|NCT03422276|617181070|FG002|Overall Study|Death|3|||
170773585|NCT03422276|617181071|FG003|Overall Study|Death|1|||
170773586|NCT03422276|617181068|FG000|Overall Study|Discontinued, ineligible|4|||
170773587|NCT03422276|617181069|FG001|Overall Study|Discontinued, ineligible|3|||
170773588|NCT03422276|617181070|FG002|Overall Study|Discontinued, ineligible|0|||
170773589|NCT03422276|617181071|FG003|Overall Study|Discontinued, ineligible|0|||
170773590|NCT03422276|617181068|FG000|Overall Study|Lost to Follow-up|15|||
170773591|NCT03422276|617181069|FG001|Overall Study|Lost to Follow-up|8|||
170773592|NCT03422276|617181070|FG002|Overall Study|Lost to Follow-up|13|||
170773593|NCT03422276|617181071|FG003|Overall Study|Lost to Follow-up|4|||
170773594|NCT03422276|617181068|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
170773595|NCT03422276|617181069|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
170773596|NCT03422276|617181070|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
170773597|NCT03422276|617181071|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
170773598|NCT03422276|617181068|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
170773599|NCT03422276|617181069|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
170773600|NCT03422276|617181070|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
170773601|NCT03422276|617181071|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
170773602|NCT03422276|617181068|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
170773603|NCT03422276|617181069|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
170773604|NCT03422276|617181070|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
170773605|NCT03422276|617181071|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
170773606|NCT03422276|617181068|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
170773607|NCT03422276|617181069|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
170773608|NCT03422276|617181070|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
170773609|NCT03422276|617181071|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
170773610|NCT03422276|617181068|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
170773611|NCT03422276|617181069|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
170773612|NCT03422276|617181070|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
170773613|NCT03422276|617181071|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
170773614|NCT05194917|617181072|FG000|Overall Study|Lost to Follow-up|7|||
170773615|NCT05194917|617181073|FG001|Overall Study|Lost to Follow-up|5|||
170773616|NCT05194917|617181074|FG002|Overall Study|Lost to Follow-up|6|||
170773617|NCT05194917|617181075|FG003|Overall Study|Lost to Follow-up|5|||
170773618|NCT04941287|617181081|FG000|Overall Study|Rapid decline before starting treatment|3|||
170773619|NCT04941287|617181082|FG001|Overall Study|Rapid decline before starting treatment|1|||
170773620|NCT02980276|617181083|FG000|Overall Study|Withdrawal by Subject|4|||
170773621|NCT02980276|617181084|FG001|Overall Study|Withdrawal by Subject|4|||
170773622|NCT02980276|617181083|FG000|Overall Study|Physician Decision|0|||
170773623|NCT02980276|617181084|FG001|Overall Study|Physician Decision|1|||
170773624|NCT02980276|617181083|FG000|Overall Study|Lost to Follow-up|18|||
170773625|NCT02980276|617181084|FG001|Overall Study|Lost to Follow-up|18|||
170773626|NCT02980276|617181083|FG000|Overall Study|Death|1|||
170773627|NCT02980276|617181084|FG001|Overall Study|Death|0|||
170773628|NCT02980276|617181083|FG000|Overall Study|Miscellaneous other|10|||
170874062|NCT02114268|617549985|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
170526377|NCT03118934|616275436|FG004|Overall Study|Physician Decision|0|||
170773629|NCT02980276|617181084|FG001|Overall Study|Miscellaneous other|4|||
170773630|NCT01998984|617181089|FG000|Overall Study|Adverse Event|0|||
170874063|NCT02114268|617549986|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
170874064|NCT02114268|617549987|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
170874065|NCT02114268|617549988|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
170526378|NCT03118934|616275437|FG005|Overall Study|Physician Decision|1|||
170874066|NCT02114268|617549989|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
170874067|NCT01075412|617549990|FG000|Overall Study|Withdrawal by Subject|0|||
170874068|NCT01075412|617549991|FG001|Overall Study|Withdrawal by Subject|1|||
170874069|NCT00702325|617550003|FG000|Overall Study|Adverse Event|1|||
170874070|NCT00702325|617550004|FG001|Overall Study|Adverse Event|0|||
170874071|NCT00702325|617550003|FG000|Overall Study|Withdrawal by Subject|7|||
170874072|NCT00702325|617550004|FG001|Overall Study|Withdrawal by Subject|7|||
170874073|NCT00702325|617550003|FG000|Overall Study|Lost to Follow-up|3|||
170874074|NCT00702325|617550004|FG001|Overall Study|Lost to Follow-up|4|||
170874075|NCT00702325|617550003|FG000|Overall Study|Incorrect enrollment|5|||
170874076|NCT00702325|617550004|FG001|Overall Study|Incorrect enrollment|7|||
170874077|NCT00702325|617550003|FG000|Overall Study|Developed study discontinuation criteria|18|||
170874078|NCT00702325|617550004|FG001|Overall Study|Developed study discontinuation criteria|28|||
170874079|NCT00702325|617550003|FG000|Overall Study|Severe noncompliance to protocol|3|||
170874080|NCT00702325|617550004|FG001|Overall Study|Severe noncompliance to protocol|3|||
170874081|NCT00702325|617550003|FG000|Overall Study|Termination due to lab results|1|||
170874082|NCT00702325|617550004|FG001|Overall Study|Termination due to lab results|0|||
170874083|NCT00702325|617550003|FG000|Overall Study|Didn't follow study medication dosage|0|||
170874084|NCT00702325|617550004|FG001|Overall Study|Didn't follow study medication dosage|2|||
170874085|NCT00702325|617550003|FG000|Overall Study|Withdrew consent|0|||
170874086|NCT00702325|617550004|FG001|Overall Study|Withdrew consent|1|||
170874087|NCT00702325|617550003|FG000|Overall Study|Incorrectly Discontinued|0|||
170874088|NCT00702325|617550004|FG001|Overall Study|Incorrectly Discontinued|1|||
170874089|NCT01022502|617550007|FG000|Overall Study|Adverse Event|1|||
170874090|NCT01022502|617550007|FG000|Overall Study|employment related reasons|1|||
170874091|NCT01022502|617550007|FG000|Overall Study|Withdrawal by Subject|1|||
170874092|NCT00529451|617550009|FG000|Overall Study|Subject withdrew consent|16|||
170874093|NCT00529451|617550010|FG001|Overall Study|Subject withdrew consent|21|||
170874094|NCT00529451|617550011|FG002|Overall Study|Subject withdrew consent|13|||
170874095|NCT00529451|617550012|FG003|Overall Study|Subject withdrew consent|12|||
170874096|NCT00529451|617550009|FG000|Overall Study|Adverse Event|9|||
170874097|NCT00529451|617550010|FG001|Overall Study|Adverse Event|16|||
170874098|NCT00529451|617550011|FG002|Overall Study|Adverse Event|14|||
170874099|NCT00529451|617550012|FG003|Overall Study|Adverse Event|8|||
170874100|NCT00529451|617550009|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
170874101|NCT00529451|617550010|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
170874102|NCT00529451|617550011|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
170874103|NCT00529451|617550012|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
170874104|NCT00529451|617550009|FG000|Overall Study|Lost to Follow-up|4|||
170874105|NCT00529451|617550010|FG001|Overall Study|Lost to Follow-up|7|||
170874106|NCT00529451|617550011|FG002|Overall Study|Lost to Follow-up|4|||
170874107|NCT00529451|617550012|FG003|Overall Study|Lost to Follow-up|4|||
170874108|NCT00529451|617550009|FG000|Overall Study|Protocol deviation|1|||
170874109|NCT00529451|617550010|FG001|Overall Study|Protocol deviation|1|||
170874110|NCT00529451|617550011|FG002|Overall Study|Protocol deviation|4|||
170874111|NCT00529451|617550012|FG003|Overall Study|Protocol deviation|1|||
170874112|NCT00529451|617550009|FG000|Overall Study|Administrative problems|1|||
170874113|NCT00529451|617550010|FG001|Overall Study|Administrative problems|1|||
170874114|NCT00529451|617550011|FG002|Overall Study|Administrative problems|0|||
170874115|NCT00529451|617550012|FG003|Overall Study|Administrative problems|2|||
170874116|NCT01289821|617550013|FG000|Treatment Period|Withdrawal by Subject|1|||
170874117|NCT01289821|617550013|FG000|Treatment Period|Physician Decision|3|||
170874118|NCT01289821|617550013|FG000|Treatment Period|Adverse Event|4|||
170874119|NCT01289821|617550013|FG000|Treatment Period|Radiological Progression|43|||
170874120|NCT01289821|617550013|FG000|Treatment Period|Clinical Progression|2|||
170874121|NCT01289821|617550013|FG000|Treatment Period|Therapeutic procedure required|1|||
170874122|NCT01289821|617550013|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
170874123|NCT01289821|617550013|FG000|Safety Follow-up Period|Protocol Violation|3|||
170874124|NCT01289821|617550013|FG000|Safety Follow-up Period|Unspecified reason|1|||
170874125|NCT01289821|617550013|FG000|Survival Follow-up Period|Protocol Violation|1|||
170874126|NCT01289821|617550013|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
170874127|NCT01289821|617550013|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
170414944|NCT00003782|615858960|FG001|Overall Study|No follow up data|31|||
170414945|NCT00003782|615858961|FG002|Overall Study|No follow up data|26|||
170874128|NCT03986866|617550022|FG000|Overall Study|Withdrawal by Subject|0|||
170874129|NCT03986866|617550023|FG001|Overall Study|Withdrawal by Subject|3|||
170874130|NCT03986866|617550022|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
170874131|NCT03986866|617550023|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
170874132|NCT04688775|617550026|FG000|Placebo-controlled Period|Randomized, not treated|1|||
170874133|NCT04688775|617550027|FG001|Placebo-controlled Period|Randomized, not treated|1|||
170874134|NCT04688775|617550028|FG002|Placebo-controlled Period|Randomized, not treated|0|||
170874135|NCT04688775|617550029|FG003|Placebo-controlled Period|Randomized, not treated|0|||
170414946|NCT00669955|615858964|FG000|Overall Study|Adverse Event|3|||
170773631|NCT01998984|617181090|FG001|Overall Study|Adverse Event|0|||
170773632|NCT01998984|617181091|FG002|Overall Study|Adverse Event|0|||
170773633|NCT01998984|617181092|FG003|Overall Study|Adverse Event|1|||
170773634|NCT01998984|617181089|FG000|Overall Study|Lost to Follow-up|0|||
170773635|NCT01998984|617181090|FG001|Overall Study|Lost to Follow-up|1|||
170773636|NCT01998984|617181091|FG002|Overall Study|Lost to Follow-up|0|||
170773637|NCT01998984|617181092|FG003|Overall Study|Lost to Follow-up|1|||
170773638|NCT01998984|617181089|FG000|Overall Study|Withdrawal by Subject|0|||
170773639|NCT01998984|617181090|FG001|Overall Study|Withdrawal by Subject|0|||
170773640|NCT01998984|617181091|FG002|Overall Study|Withdrawal by Subject|1|||
170773641|NCT01998984|617181092|FG003|Overall Study|Withdrawal by Subject|0|||
170773642|NCT01998984|617181089|FG000|Overall Study|Other|0|||
170773643|NCT01998984|617181090|FG001|Overall Study|Other|0|||
170773644|NCT01998984|617181091|FG002|Overall Study|Other|0|||
170773645|NCT01998984|617181092|FG003|Overall Study|Other|1|||
170773646|NCT04188379|617181093|FG000|Overall Study|Withdrawal by Subject|10|||
170773647|NCT04188379|617181094|FG001|Overall Study|Withdrawal by Subject|3|||
170773648|NCT04188379|617181093|FG000|Overall Study|Physician Decision|0|||
170773649|NCT04188379|617181094|FG001|Overall Study|Physician Decision|1|||
170773650|NCT04188379|617181093|FG000|Overall Study|Adverse Event|3|||
170773651|NCT04188379|617181094|FG001|Overall Study|Adverse Event|1|||
170773652|NCT04188379|617181093|FG000|Overall Study|Pregnancy|1|||
170773653|NCT04188379|617181094|FG001|Overall Study|Pregnancy|0|||
170773654|NCT04188379|617181093|FG000|Overall Study|Lack of Efficacy|8|||
170773655|NCT04188379|617181094|FG001|Overall Study|Lack of Efficacy|5|||
170773656|NCT04188379|617181093|FG000|Overall Study|Other|0|||
170773657|NCT04188379|617181094|FG001|Overall Study|Other|3|||
170773658|NCT03112174|617181096|FG000|Overall Study|Withdrawal by Subject|3|||
170773659|NCT03112174|617181097|FG001|Overall Study|Withdrawal by Subject|0|||
170773660|NCT03112174|617181098|FG002|Overall Study|Withdrawal by Subject|11|||
170773661|NCT03112174|617181099|FG003|Overall Study|Withdrawal by Subject|9|||
170773662|NCT03112174|617181100|FG004|Overall Study|Withdrawal by Subject|7|||
170773663|NCT03112174|617181096|FG000|Overall Study|Lost to Follow-up|1|||
170773664|NCT03112174|617181097|FG001|Overall Study|Lost to Follow-up|1|||
170773665|NCT03112174|617181098|FG002|Overall Study|Lost to Follow-up|2|||
170773666|NCT03112174|617181099|FG003|Overall Study|Lost to Follow-up|3|||
170773667|NCT03112174|617181100|FG004|Overall Study|Lost to Follow-up|2|||
170773668|NCT03112174|617181096|FG000|Overall Study|Death|8|||
170773669|NCT03112174|617181097|FG001|Overall Study|Death|3|||
170773670|NCT03112174|617181098|FG002|Overall Study|Death|67|||
170773671|NCT03112174|617181099|FG003|Overall Study|Death|73|||
170773672|NCT03112174|617181100|FG004|Overall Study|Death|18|||
170874136|NCT04688775|617550026|FG000|Placebo-controlled Period|Adverse Event|2|||
170874137|NCT04688775|617550027|FG001|Placebo-controlled Period|Adverse Event|0|||
170874138|NCT04688775|617550028|FG002|Placebo-controlled Period|Adverse Event|0|||
170874139|NCT04688775|617550029|FG003|Placebo-controlled Period|Adverse Event|0|||
170874140|NCT04688775|617550026|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
170874141|NCT04688775|617550027|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
170773673|NCT03112174|617181096|FG000|Overall Study|Other, Not Specified|1|||
170773674|NCT03112174|617181097|FG001|Overall Study|Other, Not Specified|0|||
170773675|NCT03112174|617181098|FG002|Overall Study|Other, Not Specified|1|||
170773676|NCT03112174|617181099|FG003|Overall Study|Other, Not Specified|2|||
170773677|NCT03112174|617181100|FG004|Overall Study|Other, Not Specified|0|||
170773678|NCT04425629|617181101|FG000|Overall Study|Adverse Event|0|||
170874142|NCT04688775|617550028|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
170414947|NCT00669955|615858965|FG001|Overall Study|Adverse Event|5|||
170773679|NCT04425629|617181102|FG001|Overall Study|Adverse Event|0|||
170773680|NCT04425629|617181103|FG002|Overall Study|Adverse Event|0|||
170773681|NCT04425629|617181104|FG003|Overall Study|Adverse Event|0|||
170773682|NCT04425629|617181105|FG004|Overall Study|Adverse Event|1|||
170773683|NCT04425629|617181106|FG005|Overall Study|Adverse Event|0|||
170773684|NCT04425629|617181107|FG006|Overall Study|Adverse Event|0|||
170414948|NCT00669955|615858964|FG000|Overall Study|Death|0|||
170414949|NCT00669955|615858965|FG001|Overall Study|Death|1|||
170773685|NCT04425629|617181108|FG007|Overall Study|Adverse Event|0|||
170773686|NCT04425629|617181109|FG008|Overall Study|Adverse Event|0|||
170773687|NCT04425629|617181110|FG009|Overall Study|Adverse Event|3|||
170773688|NCT04425629|617181111|FG010|Overall Study|Adverse Event|2|||
170773689|NCT04425629|617181112|FG011|Overall Study|Adverse Event|1|||
170773690|NCT04425629|617181113|FG012|Overall Study|Adverse Event|1|||
170773691|NCT04425629|617181114|FG013|Overall Study|Adverse Event|0|||
170773692|NCT04425629|617181115|FG014|Overall Study|Adverse Event|0|||
170773693|NCT04425629|617181116|FG015|Overall Study|Adverse Event|0|||
170773694|NCT04425629|617181117|FG016|Overall Study|Adverse Event|0|||
170773695|NCT04425629|617181118|FG017|Overall Study|Adverse Event|0|||
170414950|NCT00669955|615858964|FG000|Overall Study|Withdrawal by Subject|2|||
170773696|NCT04425629|617181119|FG018|Overall Study|Adverse Event|0|||
170773697|NCT04425629|617181101|FG000|Overall Study|Lost to Follow-up|1|||
170773698|NCT04425629|617181102|FG001|Overall Study|Lost to Follow-up|3|||
170874143|NCT04688775|617550029|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
170874144|NCT04688775|617550026|FG000|Placebo-controlled Period|Protocol Violation|0|||
170874145|NCT04688775|617550027|FG001|Placebo-controlled Period|Protocol Violation|1|||
170874146|NCT04688775|617550028|FG002|Placebo-controlled Period|Protocol Violation|0|||
170874147|NCT04688775|617550029|FG003|Placebo-controlled Period|Protocol Violation|0|||
170874148|NCT04688775|617550026|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
170874149|NCT04688775|617550027|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
170874150|NCT04688775|617550028|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
170874151|NCT04688775|617550029|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
170874152|NCT04688775|617550026|FG000|Placebo-controlled Period|Other reasons|0|||
170874153|NCT04688775|617550027|FG001|Placebo-controlled Period|Other reasons|1|||
170874154|NCT04688775|617550028|FG002|Placebo-controlled Period|Other reasons|0|||
170874155|NCT04688775|617550029|FG003|Placebo-controlled Period|Other reasons|0|||
170874156|NCT04688775|617550026|FG000|Delayed Start Period|Adverse Event|0|||
170874157|NCT04688775|617550027|FG001|Delayed Start Period|Adverse Event|0|||
170874158|NCT04688775|617550028|FG002|Delayed Start Period|Adverse Event|1|||
170874159|NCT04688775|617550029|FG003|Delayed Start Period|Adverse Event|0|||
170874160|NCT04688775|617550026|FG000|Delayed Start Period|Lack of Efficacy|0|||
170874161|NCT04688775|617550027|FG001|Delayed Start Period|Lack of Efficacy|0|||
170874162|NCT04688775|617550028|FG002|Delayed Start Period|Lack of Efficacy|0|||
170874163|NCT04688775|617550029|FG003|Delayed Start Period|Lack of Efficacy|3|||
170874164|NCT04688775|617550026|FG000|Delayed Start Period|Withdrawal by Subject|0|||
170874165|NCT04688775|617550027|FG001|Delayed Start Period|Withdrawal by Subject|0|||
170874166|NCT04688775|617550028|FG002|Delayed Start Period|Withdrawal by Subject|2|||
170874167|NCT04688775|617550029|FG003|Delayed Start Period|Withdrawal by Subject|4|||
170874168|NCT04688775|617550026|FG000|Delayed Start Period|Lost to Follow-up|0|||
170874169|NCT04688775|617550027|FG001|Delayed Start Period|Lost to Follow-up|0|||
170874170|NCT04688775|617550028|FG002|Delayed Start Period|Lost to Follow-up|2|||
170874171|NCT04688775|617550029|FG003|Delayed Start Period|Lost to Follow-up|1|||
170874172|NCT04688775|617550026|FG000|Delayed Start Period|other reasons|0|||
170874173|NCT04688775|617550027|FG001|Delayed Start Period|other reasons|0|||
170874174|NCT04688775|617550028|FG002|Delayed Start Period|other reasons|1|||
170874175|NCT04688775|617550029|FG003|Delayed Start Period|other reasons|0|||
170874176|NCT01721876|617550030|FG000|Overall Study|Not treated|1|||
170874177|NCT01721876|617550031|FG001|Overall Study|Not treated|4|||
170874178|NCT01721876|617550030|FG000|Overall Study|Disease progression / relapse|123|||
170874179|NCT01721876|617550031|FG001|Overall Study|Disease progression / relapse|156|||
170874180|NCT01721876|617550030|FG000|Overall Study|Death|6|||
170874181|NCT01721876|617550031|FG001|Overall Study|Death|13|||
170874182|NCT01721876|617550030|FG000|Overall Study|Adverse Event|41|||
170874183|NCT01721876|617550031|FG001|Overall Study|Adverse Event|165|||
170874184|NCT01721876|617550030|FG000|Overall Study|Protocol Violation|2|||
170874185|NCT01721876|617550031|FG001|Overall Study|Protocol Violation|1|||
170874186|NCT01721876|617550030|FG000|Overall Study|Withdrawal by Subject|15|||
170874187|NCT01721876|617550031|FG001|Overall Study|Withdrawal by Subject|38|||
170874188|NCT01721876|617550030|FG000|Overall Study|Reason not listed|34|||
170874189|NCT01721876|617550031|FG001|Overall Study|Reason not listed|63|||
170874190|NCT01721876|617550030|FG000|Overall Study|Sponsor terminated trial|0|||
170874191|NCT01721876|617550031|FG001|Overall Study|Sponsor terminated trial|4|||
170874192|NCT01428661|617550035|FG000|Double-Masked Phase|Protocol Violation|9|||
170874193|NCT01428661|617550036|FG001|Double-Masked Phase|Protocol Violation|4|||
170874194|NCT01428661|617550037|FG002|Double-Masked Phase|Protocol Violation|0|||
170874195|NCT01428661|617550035|FG000|Double-Masked Phase|Adverse Event|13|||
170874196|NCT01428661|617550036|FG001|Double-Masked Phase|Adverse Event|4|||
170874197|NCT01428661|617550037|FG002|Double-Masked Phase|Adverse Event|0|||
170874198|NCT01428661|617550035|FG000|Double-Masked Phase|Lost to Follow-up|14|||
170874199|NCT01428661|617550036|FG001|Double-Masked Phase|Lost to Follow-up|14|||
170874200|NCT01428661|617550037|FG002|Double-Masked Phase|Lost to Follow-up|0|||
170874201|NCT01428661|617550035|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
170874202|NCT01428661|617550036|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
170874203|NCT01428661|617550037|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
170874204|NCT01428661|617550035|FG000|Double-Masked Phase|Lack of Efficacy|2|||
170874205|NCT01428661|617550036|FG001|Double-Masked Phase|Lack of Efficacy|1|||
170874206|NCT01428661|617550037|FG002|Double-Masked Phase|Lack of Efficacy|0|||
170874207|NCT01428661|617550035|FG000|Double-Masked Phase|*Various|1|||
170874208|NCT01428661|617550036|FG001|Double-Masked Phase|*Various|6|||
170526379|NCT03118934|616275432|FG000|Overall Study|Discontinued prior to exposure|0|||
170874209|NCT01428661|617550037|FG002|Double-Masked Phase|*Various|0|||
170874210|NCT01428661|617550035|FG000|Open Label Extension|Protocol Violation|0|||
170526380|NCT03118934|616275433|FG001|Overall Study|Discontinued prior to exposure|1|||
170874211|NCT01428661|617550036|FG001|Open Label Extension|Protocol Violation|0|||
170874212|NCT01428661|617550037|FG002|Open Label Extension|Protocol Violation|9|||
170874213|NCT01428661|617550035|FG000|Open Label Extension|Adverse Event|0|||
170874214|NCT01428661|617550036|FG001|Open Label Extension|Adverse Event|0|||
170874215|NCT01428661|617550037|FG002|Open Label Extension|Adverse Event|15|||
170874216|NCT01428661|617550035|FG000|Open Label Extension|Lost to Follow-up|0|||
170773699|NCT04425629|617181103|FG002|Overall Study|Lost to Follow-up|1|||
170773700|NCT04425629|617181104|FG003|Overall Study|Lost to Follow-up|7|||
170773701|NCT04425629|617181105|FG004|Overall Study|Lost to Follow-up|1|||
170773702|NCT04425629|617181106|FG005|Overall Study|Lost to Follow-up|2|||
170773703|NCT04425629|617181107|FG006|Overall Study|Lost to Follow-up|1|||
170773704|NCT04425629|617181108|FG007|Overall Study|Lost to Follow-up|0|||
170773705|NCT04425629|617181109|FG008|Overall Study|Lost to Follow-up|1|||
170773706|NCT04425629|617181110|FG009|Overall Study|Lost to Follow-up|64|||
170773707|NCT04425629|617181111|FG010|Overall Study|Lost to Follow-up|70|||
170773708|NCT04425629|617181112|FG011|Overall Study|Lost to Follow-up|98|||
170773709|NCT04425629|617181113|FG012|Overall Study|Lost to Follow-up|30|||
170773710|NCT04425629|617181114|FG013|Overall Study|Lost to Follow-up|0|||
170773711|NCT04425629|617181115|FG014|Overall Study|Lost to Follow-up|5|||
170773712|NCT04425629|617181116|FG015|Overall Study|Lost to Follow-up|4|||
170773713|NCT04425629|617181117|FG016|Overall Study|Lost to Follow-up|0|||
170773714|NCT04425629|617181118|FG017|Overall Study|Lost to Follow-up|3|||
170773715|NCT04425629|617181119|FG018|Overall Study|Lost to Follow-up|1|||
170773716|NCT04425629|617181101|FG000|Overall Study|Subject Decision|0|||
170773717|NCT04425629|617181102|FG001|Overall Study|Subject Decision|2|||
170773718|NCT04425629|617181103|FG002|Overall Study|Subject Decision|1|||
170773719|NCT04425629|617181104|FG003|Overall Study|Subject Decision|3|||
170773720|NCT04425629|617181105|FG004|Overall Study|Subject Decision|6|||
170773721|NCT04425629|617181106|FG005|Overall Study|Subject Decision|6|||
170773722|NCT04425629|617181107|FG006|Overall Study|Subject Decision|3|||
170773723|NCT04425629|617181108|FG007|Overall Study|Subject Decision|3|||
170773724|NCT04425629|617181109|FG008|Overall Study|Subject Decision|1|||
170773725|NCT04425629|617181110|FG009|Overall Study|Subject Decision|70|||
170773726|NCT04425629|617181111|FG010|Overall Study|Subject Decision|95|||
170773727|NCT04425629|617181112|FG011|Overall Study|Subject Decision|124|||
170773728|NCT04425629|617181113|FG012|Overall Study|Subject Decision|25|||
170773729|NCT04425629|617181114|FG013|Overall Study|Subject Decision|0|||
170773730|NCT04425629|617181115|FG014|Overall Study|Subject Decision|1|||
170773731|NCT04425629|617181116|FG015|Overall Study|Subject Decision|4|||
170773732|NCT04425629|617181117|FG016|Overall Study|Subject Decision|1|||
170773733|NCT04425629|617181118|FG017|Overall Study|Subject Decision|0|||
170773734|NCT04425629|617181119|FG018|Overall Study|Subject Decision|2|||
170773735|NCT04425629|617181101|FG000|Overall Study|Death|0|||
170773736|NCT04425629|617181102|FG001|Overall Study|Death|0|||
170773737|NCT04425629|617181103|FG002|Overall Study|Death|0|||
170773738|NCT04425629|617181104|FG003|Overall Study|Death|0|||
170773739|NCT04425629|617181105|FG004|Overall Study|Death|0|||
170773740|NCT04425629|617181106|FG005|Overall Study|Death|0|||
170773741|NCT04425629|617181107|FG006|Overall Study|Death|0|||
170773742|NCT04425629|617181108|FG007|Overall Study|Death|0|||
170773743|NCT04425629|617181109|FG008|Overall Study|Death|0|||
170773744|NCT04425629|617181110|FG009|Overall Study|Death|11|||
170773745|NCT04425629|617181111|FG010|Overall Study|Death|2|||
170773746|NCT04425629|617181112|FG011|Overall Study|Death|4|||
170773747|NCT04425629|617181113|FG012|Overall Study|Death|0|||
170773748|NCT04425629|617181114|FG013|Overall Study|Death|0|||
170773749|NCT04425629|617181115|FG014|Overall Study|Death|0|||
170773750|NCT04425629|617181116|FG015|Overall Study|Death|0|||
170773751|NCT04425629|617181117|FG016|Overall Study|Death|0|||
170773752|NCT04425629|617181118|FG017|Overall Study|Death|0|||
170773753|NCT04425629|617181119|FG018|Overall Study|Death|0|||
170773754|NCT04425629|617181101|FG000|Overall Study|Sponsor Request|0|||
170773755|NCT04425629|617181102|FG001|Overall Study|Sponsor Request|0|||
170526381|NCT03118934|616275434|FG002|Overall Study|Discontinued prior to exposure|1|||
170526382|NCT03118934|616275435|FG003|Overall Study|Discontinued prior to exposure|1|||
170526383|NCT03118934|616275436|FG004|Overall Study|Discontinued prior to exposure|2|||
170526384|NCT03118934|616275437|FG005|Overall Study|Discontinued prior to exposure|0|||
170773756|NCT04425629|617181103|FG002|Overall Study|Sponsor Request|0|||
170773757|NCT04425629|617181104|FG003|Overall Study|Sponsor Request|2|||
170773758|NCT04425629|617181105|FG004|Overall Study|Sponsor Request|2|||
170773759|NCT04425629|617181106|FG005|Overall Study|Sponsor Request|2|||
170773760|NCT04425629|617181107|FG006|Overall Study|Sponsor Request|1|||
170773761|NCT04425629|617181108|FG007|Overall Study|Sponsor Request|0|||
170773762|NCT04425629|617181109|FG008|Overall Study|Sponsor Request|0|||
170773763|NCT04425629|617181110|FG009|Overall Study|Sponsor Request|9|||
170773764|NCT04425629|617181111|FG010|Overall Study|Sponsor Request|9|||
170773765|NCT04425629|617181112|FG011|Overall Study|Sponsor Request|10|||
170773766|NCT04425629|617181113|FG012|Overall Study|Sponsor Request|8|||
170773767|NCT04425629|617181114|FG013|Overall Study|Sponsor Request|0|||
170773768|NCT04425629|617181115|FG014|Overall Study|Sponsor Request|0|||
170773769|NCT04425629|617181116|FG015|Overall Study|Sponsor Request|1|||
170773770|NCT04425629|617181117|FG016|Overall Study|Sponsor Request|0|||
170773771|NCT04425629|617181118|FG017|Overall Study|Sponsor Request|0|||
170773772|NCT04425629|617181119|FG018|Overall Study|Sponsor Request|0|||
170773773|NCT04425629|617181101|FG000|Overall Study|Physician Decision|0|||
170773774|NCT04425629|617181102|FG001|Overall Study|Physician Decision|0|||
170773775|NCT04425629|617181103|FG002|Overall Study|Physician Decision|0|||
170773776|NCT04425629|617181104|FG003|Overall Study|Physician Decision|0|||
170773777|NCT04425629|617181105|FG004|Overall Study|Physician Decision|0|||
170773778|NCT04425629|617181106|FG005|Overall Study|Physician Decision|0|||
170773779|NCT04425629|617181107|FG006|Overall Study|Physician Decision|0|||
170773780|NCT04425629|617181108|FG007|Overall Study|Physician Decision|0|||
170773781|NCT04425629|617181109|FG008|Overall Study|Physician Decision|0|||
170773782|NCT04425629|617181110|FG009|Overall Study|Physician Decision|4|||
170773783|NCT04425629|617181111|FG010|Overall Study|Physician Decision|3|||
170773784|NCT04425629|617181112|FG011|Overall Study|Physician Decision|5|||
170773785|NCT04425629|617181113|FG012|Overall Study|Physician Decision|1|||
170773786|NCT04425629|617181114|FG013|Overall Study|Physician Decision|0|||
170773787|NCT04425629|617181115|FG014|Overall Study|Physician Decision|0|||
170773788|NCT04425629|617181116|FG015|Overall Study|Physician Decision|1|||
170773789|NCT04425629|617181117|FG016|Overall Study|Physician Decision|0|||
170773790|NCT04425629|617181118|FG017|Overall Study|Physician Decision|0|||
170773791|NCT04425629|617181119|FG018|Overall Study|Physician Decision|0|||
170773792|NCT04425629|617181101|FG000|Overall Study|Lack of Efficacy|0|||
170773793|NCT04425629|617181102|FG001|Overall Study|Lack of Efficacy|0|||
170773794|NCT04425629|617181103|FG002|Overall Study|Lack of Efficacy|0|||
170773795|NCT04425629|617181104|FG003|Overall Study|Lack of Efficacy|0|||
170773796|NCT04425629|617181105|FG004|Overall Study|Lack of Efficacy|0|||
170773797|NCT04425629|617181106|FG005|Overall Study|Lack of Efficacy|0|||
170773798|NCT04425629|617181107|FG006|Overall Study|Lack of Efficacy|0|||
170773799|NCT04425629|617181108|FG007|Overall Study|Lack of Efficacy|0|||
170773800|NCT04425629|617181109|FG008|Overall Study|Lack of Efficacy|0|||
170773801|NCT04425629|617181110|FG009|Overall Study|Lack of Efficacy|0|||
170773802|NCT04425629|617181111|FG010|Overall Study|Lack of Efficacy|1|||
170773803|NCT04425629|617181112|FG011|Overall Study|Lack of Efficacy|0|||
170773804|NCT04425629|617181113|FG012|Overall Study|Lack of Efficacy|0|||
170773805|NCT04425629|617181114|FG013|Overall Study|Lack of Efficacy|0|||
170773806|NCT04425629|617181115|FG014|Overall Study|Lack of Efficacy|0|||
170773807|NCT04425629|617181116|FG015|Overall Study|Lack of Efficacy|0|||
170773808|NCT04425629|617181117|FG016|Overall Study|Lack of Efficacy|0|||
170773809|NCT04425629|617181118|FG017|Overall Study|Lack of Efficacy|0|||
170773810|NCT04425629|617181119|FG018|Overall Study|Lack of Efficacy|0|||
170773811|NCT01149369|617181120|FG000|Overall Study|Adverse Event|6|||
170773812|NCT01149369|617181121|FG001|Overall Study|Adverse Event|3|||
170773813|NCT04723394|617181136|FG000|Overall Study|Adverse Event|0|||
170773814|NCT04723394|617181137|FG001|Overall Study|Adverse Event|3|||
170773815|NCT04723394|617181136|FG000|Overall Study|Death|8|||
170773816|NCT04723394|617181137|FG001|Overall Study|Death|8|||
170773817|NCT04723394|617181136|FG000|Overall Study|Lost to Follow-up|20|||
170773818|NCT04723394|617181137|FG001|Overall Study|Lost to Follow-up|17|||
170773819|NCT04723394|617181136|FG000|Overall Study|Physician Decision|1|||
170773820|NCT04723394|617181137|FG001|Overall Study|Physician Decision|0|||
170773821|NCT04723394|617181136|FG000|Overall Study|Withdrawal by Subject|20|||
170773822|NCT04723394|617181137|FG001|Overall Study|Withdrawal by Subject|34|||
170773823|NCT04723394|617181136|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
170773824|NCT04723394|617181137|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
170773825|NCT00371787|617181138|FG000|Overall Study|Withdrawal by Subject|3|||
170773826|NCT00371787|617181139|FG001|Overall Study|Withdrawal by Subject|1|||
170773827|NCT02529995|617181146|FG000|Part A|Ongoing Study at Data Cut-off|14|||
170773828|NCT02529995|617181147|FG001|Part A|Ongoing Study at Data Cut-off|16|||
170773829|NCT02529995|617181146|FG000|Part A|Discontinued Study|1|||
170773830|NCT02529995|617181147|FG001|Part A|Discontinued Study|0|||
170773831|NCT02529995|617181146|FG000|Part B|Ongoing Study at Data Cut-off|0|||
170773832|NCT02529995|617181147|FG001|Part B|Ongoing Study at Data Cut-off|7|||
170773833|NCT02529995|617181146|FG000|Part B|Discontinued Study|6|||
170773834|NCT02529995|617181147|FG001|Part B|Discontinued Study|5|||
170773835|NCT02706717|617181148|FG000|Overall Study|Withdrawal by Subject|1|||
170773836|NCT02706717|617181149|FG001|Overall Study|Withdrawal by Subject|8|||
170773837|NCT02706717|617181148|FG000|Overall Study|Lost to Follow-up|0|||
170773838|NCT02706717|617181149|FG001|Overall Study|Lost to Follow-up|1|||
170773839|NCT02706717|617181148|FG000|Overall Study|Physician Decision|0|||
170773840|NCT02706717|617181149|FG001|Overall Study|Physician Decision|1|||
170414951|NCT00669955|615858965|FG001|Overall Study|Withdrawal by Subject|3|||
170773841|NCT02706717|617181148|FG000|Overall Study|Death|0|||
170773842|NCT02706717|617181149|FG001|Overall Study|Death|1|||
170773843|NCT00444600|617181150|FG000|Overall Study|Death|7|||
170773844|NCT00444600|617181151|FG001|Overall Study|Death|5|||
170773845|NCT00444600|617181152|FG002|Overall Study|Death|3|||
170773846|NCT00444600|617181153|FG003|Overall Study|Death|2|||
170773847|NCT00444600|617181150|FG000|Overall Study|Dropped|11|||
170414952|NCT00669955|615858964|FG000|Overall Study|Lost to Follow-up|5|||
170773848|NCT00444600|617181151|FG001|Overall Study|Dropped|11|||
170773849|NCT00444600|617181152|FG002|Overall Study|Dropped|7|||
170773850|NCT00444600|617181153|FG003|Overall Study|Dropped|7|||
170773851|NCT00444600|617181150|FG000|Overall Study|Missed visit|1|||
170773852|NCT00444600|617181151|FG001|Overall Study|Missed visit|0|||
170773853|NCT00444600|617181152|FG002|Overall Study|Missed visit|0|||
170773854|NCT00444600|617181153|FG003|Overall Study|Missed visit|1|||
170773855|NCT00106080|617181154|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
170773856|NCT00106080|617181155|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
170773857|NCT01236001|617181156|FG000|Overall Study|Adverse Event|5|||
170773858|NCT01236001|617181157|FG001|Overall Study|Adverse Event|14|||
170773859|NCT01236001|617181156|FG000|Overall Study|Lack of Efficacy|6|||
170773860|NCT01236001|617181157|FG001|Overall Study|Lack of Efficacy|6|||
170773861|NCT01236001|617181156|FG000|Overall Study|Lost to Follow-up|6|||
170773862|NCT01236001|617181157|FG001|Overall Study|Lost to Follow-up|1|||
170773863|NCT01236001|617181156|FG000|Overall Study|Incompliance|1|||
170773864|NCT01236001|617181157|FG001|Overall Study|Incompliance|0|||
170773865|NCT01236001|617181156|FG000|Overall Study|Planned Visit After End of Study|0|||
170773866|NCT01236001|617181157|FG001|Overall Study|Planned Visit After End of Study|1|||
170773867|NCT02988817|617181158|FG000|Overall Study|Withdrawal by Subject|1|||
170773868|NCT02988817|617181159|FG001|Overall Study|Withdrawal by Subject|0|||
170773869|NCT02988817|617181160|FG002|Overall Study|Withdrawal by Subject|0|||
170773870|NCT02988817|617181161|FG003|Overall Study|Withdrawal by Subject|1|||
170773871|NCT02988817|617181162|FG004|Overall Study|Withdrawal by Subject|3|||
170773872|NCT02988817|617181163|FG005|Overall Study|Withdrawal by Subject|1|||
170773873|NCT02988817|617181164|FG006|Overall Study|Withdrawal by Subject|2|||
170773874|NCT02988817|617181165|FG007|Overall Study|Withdrawal by Subject|1|||
170773875|NCT02988817|617181166|FG008|Overall Study|Withdrawal by Subject|1|||
170773876|NCT02988817|617181167|FG009|Overall Study|Withdrawal by Subject|1|||
170773877|NCT02988817|617181168|FG010|Overall Study|Withdrawal by Subject|1|||
170773878|NCT02988817|617181169|FG011|Overall Study|Withdrawal by Subject|12|||
170773879|NCT02988817|617181170|FG012|Overall Study|Withdrawal by Subject|6|||
170773880|NCT02988817|617181171|FG013|Overall Study|Withdrawal by Subject|6|||
170773881|NCT02988817|617181172|FG014|Overall Study|Withdrawal by Subject|4|||
170773882|NCT02988817|617181173|FG015|Overall Study|Withdrawal by Subject|5|||
170773883|NCT02988817|617181174|FG016|Overall Study|Withdrawal by Subject|4|||
170773884|NCT02988817|617181175|FG017|Overall Study|Withdrawal by Subject|11|||
170773885|NCT02988817|617181176|FG018|Overall Study|Withdrawal by Subject|4|||
170773886|NCT02988817|617181177|FG019|Overall Study|Withdrawal by Subject|2|||
170773887|NCT02988817|617181158|FG000|Overall Study|Death|0|||
170773888|NCT02988817|617181159|FG001|Overall Study|Death|1|||
170773889|NCT02988817|617181160|FG002|Overall Study|Death|3|||
170773890|NCT02988817|617181161|FG003|Overall Study|Death|1|||
170773891|NCT02988817|617181162|FG004|Overall Study|Death|6|||
170773892|NCT02988817|617181163|FG005|Overall Study|Death|10|||
170773893|NCT02988817|617181164|FG006|Overall Study|Death|1|||
170773894|NCT02988817|617181165|FG007|Overall Study|Death|2|||
170773895|NCT02988817|617181166|FG008|Overall Study|Death|1|||
170773896|NCT02988817|617181167|FG009|Overall Study|Death|5|||
170773897|NCT02988817|617181168|FG010|Overall Study|Death|1|||
170773898|NCT02988817|617181169|FG011|Overall Study|Death|8|||
170773899|NCT02988817|617181170|FG012|Overall Study|Death|9|||
170773900|NCT02988817|617181171|FG013|Overall Study|Death|17|||
170874217|NCT01428661|617550036|FG001|Open Label Extension|Lost to Follow-up|0|||
170874218|NCT01428661|617550037|FG002|Open Label Extension|Lost to Follow-up|38|||
170874219|NCT01428661|617550035|FG000|Open Label Extension|Withdrawal by Subject|0|||
170874220|NCT01428661|617550036|FG001|Open Label Extension|Withdrawal by Subject|0|||
170874221|NCT01428661|617550037|FG002|Open Label Extension|Withdrawal by Subject|49|||
170874222|NCT01428661|617550035|FG000|Open Label Extension|Lack of Efficacy|0|||
170874223|NCT01428661|617550036|FG001|Open Label Extension|Lack of Efficacy|0|||
170874224|NCT01428661|617550037|FG002|Open Label Extension|Lack of Efficacy|24|||
170874225|NCT01428661|617550035|FG000|Open Label Extension|**Various|0|||
170874226|NCT01428661|617550036|FG001|Open Label Extension|**Various|0|||
170874227|NCT01428661|617550037|FG002|Open Label Extension|**Various|185|||
170874228|NCT00282295|617550038|FG000|Overall Study|Adverse Event|0|||
170874229|NCT00282295|617550039|FG001|Overall Study|Adverse Event|1|||
170874230|NCT00282295|617550040|FG002|Overall Study|Adverse Event|0|||
170414953|NCT00669955|615858965|FG001|Overall Study|Lost to Follow-up|7|||
170414954|NCT00669955|615858964|FG000|Overall Study|Protocol Violation|2|||
170773901|NCT02988817|617181172|FG014|Overall Study|Death|18|||
170773902|NCT02988817|617181173|FG015|Overall Study|Death|30|||
170773903|NCT02988817|617181174|FG016|Overall Study|Death|17|||
170773904|NCT02988817|617181175|FG017|Overall Study|Death|38|||
170773905|NCT02988817|617181176|FG018|Overall Study|Death|14|||
170773906|NCT02988817|617181177|FG019|Overall Study|Death|16|||
170773907|NCT02988817|617181158|FG000|Overall Study|Other|0|||
170414955|NCT00669955|615858965|FG001|Overall Study|Protocol Violation|7|||
170773908|NCT02988817|617181159|FG001|Overall Study|Other|0|||
170773909|NCT02988817|617181160|FG002|Overall Study|Other|0|||
170773910|NCT02988817|617181161|FG003|Overall Study|Other|1|||
170773911|NCT02988817|617181162|FG004|Overall Study|Other|1|||
170773912|NCT02988817|617181163|FG005|Overall Study|Other|0|||
170773913|NCT02988817|617181164|FG006|Overall Study|Other|0|||
170773914|NCT02988817|617181165|FG007|Overall Study|Other|0|||
170874231|NCT00282295|617550038|FG000|Overall Study|Serious Adverse Events|0|||
170874232|NCT00282295|617550039|FG001|Overall Study|Serious Adverse Events|0|||
170874233|NCT00282295|617550040|FG002|Overall Study|Serious Adverse Events|1|||
170874234|NCT00282295|617550038|FG000|Overall Study|Protocol Violation|0|||
170874235|NCT00282295|617550039|FG001|Overall Study|Protocol Violation|2|||
170874236|NCT00282295|617550040|FG002|Overall Study|Protocol Violation|1|||
170874237|NCT00282295|617550038|FG000|Overall Study|Withdrawal by Subject|2|||
170874238|NCT00282295|617550039|FG001|Overall Study|Withdrawal by Subject|6|||
170874239|NCT00282295|617550040|FG002|Overall Study|Withdrawal by Subject|4|||
170874240|NCT00282295|617550038|FG000|Overall Study|Lost to Follow-up|1|||
170874241|NCT00282295|617550039|FG001|Overall Study|Lost to Follow-up|7|||
170874242|NCT00282295|617550040|FG002|Overall Study|Lost to Follow-up|2|||
170874243|NCT00282295|617550038|FG000|Overall Study|Other|0|||
170874244|NCT00282295|617550039|FG001|Overall Study|Other|1|||
170874245|NCT00282295|617550040|FG002|Overall Study|Other|0|||
170874246|NCT04376827|617550042|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
170874247|NCT04376827|617550043|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
170874248|NCT04376827|617550042|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
170874249|NCT04376827|617550043|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
170874250|NCT04376827|617550042|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
170874251|NCT04376827|617550043|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
170874252|NCT04376827|617550042|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
170874253|NCT04376827|617550043|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
170874254|NCT04376827|617550042|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
170874255|NCT04376827|617550043|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
170874256|NCT00346073|617551529|FG000|Overall Study|Serious Adverse Event|2|||
170874257|NCT00346073|617551530|FG001|Overall Study|Serious Adverse Event|0|||
170874258|NCT00346073|617551529|FG000|Overall Study|Lost to Follow-up|39|||
170874259|NCT00346073|617551530|FG001|Overall Study|Lost to Follow-up|24|||
170874260|NCT00980200|617551531|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
170874261|NCT00980200|617551532|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
170874262|NCT00980200|617551533|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
170874263|NCT00980200|617551534|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
170874264|NCT00980200|617551535|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
170874265|NCT00980200|617551531|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
170874266|NCT00980200|617551532|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
170874267|NCT00980200|617551533|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
170874268|NCT00980200|617551534|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
170874269|NCT00980200|617551535|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
170874270|NCT03197493|617551536|FG000|Overall Study|Withdrawal by Subject|5|||
170874271|NCT00176605|617551540|FG000|Overall Study|Withdrawal by Subject|2|||
170874272|NCT02318667|617551542|FG000|Overall Study|Adverse Event|1|||
170874273|NCT02318667|617551542|FG000|Overall Study|Lack of Efficacy|6|||
170874274|NCT02318667|617551542|FG000|Overall Study|Protocol Violation|2|||
170874275|NCT02289742|617551556|FG000|First Wear Period|Adverse event prior to treatment|0|||
170874276|NCT02289742|617551557|FG001|First Wear Period|Adverse event prior to treatment|1|||
170874277|NCT02289742|617551558|FG002|First Wear Period|Adverse event prior to treatment|0|||
170874278|NCT02289742|617551559|FG003|First Wear Period|Adverse event prior to treatment|0|||
170874279|NCT02289742|617551556|FG000|First Wear Period|Adverse Event|0|||
170874280|NCT02289742|617551557|FG001|First Wear Period|Adverse Event|0|||
170874281|NCT02289742|617551558|FG002|First Wear Period|Adverse Event|1|||
170874282|NCT02289742|617551559|FG003|First Wear Period|Adverse Event|0|||
170874283|NCT02289742|617551556|FG000|First Wear Period|Other prior to treatment|0|||
170874284|NCT02289742|617551557|FG001|First Wear Period|Other prior to treatment|0|||
170874285|NCT02289742|617551558|FG002|First Wear Period|Other prior to treatment|0|||
170874286|NCT02289742|617551559|FG003|First Wear Period|Other prior to treatment|1|||
170874287|NCT02289742|617551556|FG000|Third Wear Period|Adverse Event|0|||
170874288|NCT02289742|617551557|FG001|Third Wear Period|Adverse Event|1|||
170874289|NCT02289742|617551558|FG002|Third Wear Period|Adverse Event|0|||
170874290|NCT02289742|617551559|FG003|Third Wear Period|Adverse Event|0|||
170874291|NCT02289742|617551556|FG000|Third Wear Period|Reason not given|0|||
170874292|NCT02289742|617551557|FG001|Third Wear Period|Reason not given|0|||
170874293|NCT02289742|617551558|FG002|Third Wear Period|Reason not given|0|||
170874294|NCT02289742|617551559|FG003|Third Wear Period|Reason not given|1|||
170874295|NCT03807349|617551560|FG000|Overall Study|Early Study Termination|9|||
170874296|NCT00549939|617551561|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
170874297|NCT00549939|617551562|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
170874298|NCT00549939|617551563|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
170874299|NCT00549939|617551561|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
170874300|NCT00549939|617551562|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
170874301|NCT00549939|617551563|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
170874302|NCT00549939|617551561|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
170874303|NCT00549939|617551562|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
170874304|NCT00549939|617551563|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
170632512|NCT01499355|616666689|FG001|Run-In Period|Investigator Decision|0|||
170773915|NCT02988817|617181166|FG008|Overall Study|Other|0|||
170773916|NCT02988817|617181167|FG009|Overall Study|Other|0|||
170773917|NCT02988817|617181168|FG010|Overall Study|Other|0|||
170773918|NCT02988817|617181169|FG011|Overall Study|Other|0|||
170773919|NCT02988817|617181170|FG012|Overall Study|Other|0|||
170773920|NCT02988817|617181171|FG013|Overall Study|Other|0|||
170773921|NCT02988817|617181172|FG014|Overall Study|Other|0|||
170773922|NCT02988817|617181173|FG015|Overall Study|Other|1|||
170773923|NCT02988817|617181174|FG016|Overall Study|Other|0|||
170773924|NCT02988817|617181175|FG017|Overall Study|Other|0|||
170773925|NCT02988817|617181176|FG018|Overall Study|Other|0|||
170773926|NCT02988817|617181177|FG019|Overall Study|Other|0|||
170773927|NCT02988817|617181158|FG000|Overall Study|Lost to Follow-up|0|||
170773928|NCT02988817|617181159|FG001|Overall Study|Lost to Follow-up|0|||
170773929|NCT02988817|617181160|FG002|Overall Study|Lost to Follow-up|0|||
170773930|NCT02988817|617181161|FG003|Overall Study|Lost to Follow-up|0|||
170773931|NCT02988817|617181162|FG004|Overall Study|Lost to Follow-up|0|||
170773932|NCT02988817|617181163|FG005|Overall Study|Lost to Follow-up|0|||
170773933|NCT02988817|617181164|FG006|Overall Study|Lost to Follow-up|0|||
170773934|NCT02988817|617181165|FG007|Overall Study|Lost to Follow-up|0|||
170773935|NCT02988817|617181166|FG008|Overall Study|Lost to Follow-up|1|||
170773936|NCT02988817|617181167|FG009|Overall Study|Lost to Follow-up|0|||
170773937|NCT02988817|617181168|FG010|Overall Study|Lost to Follow-up|1|||
170773938|NCT02988817|617181169|FG011|Overall Study|Lost to Follow-up|1|||
170773939|NCT02988817|617181170|FG012|Overall Study|Lost to Follow-up|0|||
170773940|NCT02988817|617181171|FG013|Overall Study|Lost to Follow-up|0|||
170773941|NCT02988817|617181172|FG014|Overall Study|Lost to Follow-up|1|||
170773942|NCT02988817|617181173|FG015|Overall Study|Lost to Follow-up|1|||
170773943|NCT02988817|617181174|FG016|Overall Study|Lost to Follow-up|2|||
170773944|NCT02988817|617181175|FG017|Overall Study|Lost to Follow-up|3|||
170773945|NCT02988817|617181176|FG018|Overall Study|Lost to Follow-up|0|||
170773946|NCT02988817|617181177|FG019|Overall Study|Lost to Follow-up|0|||
170773947|NCT02988817|617181158|FG000|Overall Study|Sponsor decision|0|||
170773948|NCT02988817|617181159|FG001|Overall Study|Sponsor decision|0|||
170773949|NCT02988817|617181160|FG002|Overall Study|Sponsor decision|0|||
170773950|NCT02988817|617181161|FG003|Overall Study|Sponsor decision|0|||
170773951|NCT02988817|617181162|FG004|Overall Study|Sponsor decision|0|||
170773952|NCT02988817|617181163|FG005|Overall Study|Sponsor decision|0|||
170773953|NCT02988817|617181164|FG006|Overall Study|Sponsor decision|0|||
170773954|NCT02988817|617181165|FG007|Overall Study|Sponsor decision|0|||
170773955|NCT02988817|617181166|FG008|Overall Study|Sponsor decision|0|||
170773956|NCT02988817|617181167|FG009|Overall Study|Sponsor decision|0|||
170773957|NCT02988817|617181168|FG010|Overall Study|Sponsor decision|0|||
170773958|NCT02988817|617181169|FG011|Overall Study|Sponsor decision|1|||
170773959|NCT02988817|617181170|FG012|Overall Study|Sponsor decision|1|||
170773960|NCT02988817|617181171|FG013|Overall Study|Sponsor decision|2|||
170773961|NCT02988817|617181172|FG014|Overall Study|Sponsor decision|2|||
170773962|NCT02988817|617181173|FG015|Overall Study|Sponsor decision|6|||
170773963|NCT02988817|617181174|FG016|Overall Study|Sponsor decision|2|||
170773964|NCT02988817|617181175|FG017|Overall Study|Sponsor decision|3|||
170773965|NCT02988817|617181176|FG018|Overall Study|Sponsor decision|2|||
170773966|NCT02988817|617181177|FG019|Overall Study|Sponsor decision|7|||
170773967|NCT02988817|617181158|FG000|Overall Study|Physician Decision|0|||
170773968|NCT02988817|617181159|FG001|Overall Study|Physician Decision|0|||
170773969|NCT02988817|617181160|FG002|Overall Study|Physician Decision|0|||
170773970|NCT02988817|617181161|FG003|Overall Study|Physician Decision|0|||
170773971|NCT02988817|617181162|FG004|Overall Study|Physician Decision|0|||
170773972|NCT02988817|617181163|FG005|Overall Study|Physician Decision|0|||
170773973|NCT02988817|617181164|FG006|Overall Study|Physician Decision|0|||
170773974|NCT02988817|617181165|FG007|Overall Study|Physician Decision|0|||
170773975|NCT02988817|617181166|FG008|Overall Study|Physician Decision|0|||
170773976|NCT02988817|617181167|FG009|Overall Study|Physician Decision|0|||
170773977|NCT02988817|617181168|FG010|Overall Study|Physician Decision|0|||
170773978|NCT02988817|617181169|FG011|Overall Study|Physician Decision|0|||
170773979|NCT02988817|617181170|FG012|Overall Study|Physician Decision|0|||
170773980|NCT02988817|617181171|FG013|Overall Study|Physician Decision|0|||
170773981|NCT02988817|617181172|FG014|Overall Study|Physician Decision|0|||
170773982|NCT02988817|617181173|FG015|Overall Study|Physician Decision|1|||
170773983|NCT02988817|617181174|FG016|Overall Study|Physician Decision|0|||
170773984|NCT02988817|617181175|FG017|Overall Study|Physician Decision|0|||
170773985|NCT02988817|617181176|FG018|Overall Study|Physician Decision|1|||
170773986|NCT02988817|617181177|FG019|Overall Study|Physician Decision|1|||
170773987|NCT02092116|617181188|FG000|Overall Study|Withdrawal by Subject|0|||
170773988|NCT02092116|617181189|FG001|Overall Study|Withdrawal by Subject|3|||
170773989|NCT02092116|617181188|FG000|Overall Study|Adverse Event|0|||
170773990|NCT02092116|617181189|FG001|Overall Study|Adverse Event|1|||
170773991|NCT03036813|617181194|FG000|Overall Study|Adverse Event|6|||
170773992|NCT03036813|617181195|FG001|Overall Study|Adverse Event|11|||
170773993|NCT03036813|617181196|FG002|Overall Study|Adverse Event|6|||
170773994|NCT03036813|617181194|FG000|Overall Study|Withdrawal by Subject|12|||
170773995|NCT03036813|617181195|FG001|Overall Study|Withdrawal by Subject|6|||
170874305|NCT00549939|617551561|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
170874306|NCT00549939|617551562|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
170874307|NCT00549939|617551563|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
170874308|NCT00549939|617551561|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
170874309|NCT00549939|617551562|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
170874310|NCT00549939|617551563|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
170874311|NCT00549939|617551561|FG000|40-week Open Label Treatment Period|Other|0|||
170874312|NCT00549939|617551562|FG001|40-week Open Label Treatment Period|Other|1|||
170874313|NCT00549939|617551563|FG002|40-week Open Label Treatment Period|Other|4|||
170874314|NCT01360554|617551564|FG000|Overall Study|Death|359|||
170874315|NCT01360554|617551565|FG001|Overall Study|Death|371|||
170874316|NCT01360554|617551564|FG000|Overall Study|Lost to Follow-up|4|||
170874317|NCT01360554|617551565|FG001|Overall Study|Lost to Follow-up|4|||
170874318|NCT01360554|617551564|FG000|Overall Study|Withdrawal by Subject|23|||
170874319|NCT01360554|617551565|FG001|Overall Study|Withdrawal by Subject|24|||
170874320|NCT01360554|617551564|FG000|Overall Study|Study terminated by sponsor|49|||
170874321|NCT01360554|617551565|FG001|Overall Study|Study terminated by sponsor|37|||
170874322|NCT01360554|617551564|FG000|Overall Study|Other, not specified|1|||
170414956|NCT00669955|615858964|FG000|Overall Study|Investigator Sponsor Judgement|0|||
170414957|NCT00669955|615858965|FG001|Overall Study|Investigator Sponsor Judgement|1|||
170773996|NCT03036813|617181196|FG002|Overall Study|Withdrawal by Subject|10|||
170773997|NCT03036813|617181194|FG000|Overall Study|Lost to Follow-up|1|||
170773998|NCT03036813|617181195|FG001|Overall Study|Lost to Follow-up|1|||
170773999|NCT03036813|617181196|FG002|Overall Study|Lost to Follow-up|0|||
170774000|NCT03036813|617181194|FG000|Overall Study|Physician Decision|2|||
170774001|NCT03036813|617181195|FG001|Overall Study|Physician Decision|1|||
170774002|NCT03036813|617181196|FG002|Overall Study|Physician Decision|1|||
170774003|NCT03036813|617181194|FG000|Overall Study|Non-Compliance|1|||
170774004|NCT03036813|617181195|FG001|Overall Study|Non-Compliance|5|||
170774005|NCT03036813|617181196|FG002|Overall Study|Non-Compliance|3|||
170774006|NCT03036813|617181194|FG000|Overall Study|Pregnancy|0|||
170774007|NCT03036813|617181195|FG001|Overall Study|Pregnancy|0|||
170774008|NCT03036813|617181196|FG002|Overall Study|Pregnancy|1|||
170774009|NCT03036813|617181194|FG000|Overall Study|Other|0|||
170774010|NCT03036813|617181195|FG001|Overall Study|Other|3|||
170774011|NCT03036813|617181196|FG002|Overall Study|Other|5|||
170774012|NCT01102231|617181197|FG000|Overall Study|Protocol Violation|3|||
170774013|NCT01102231|617181197|FG000|Overall Study|Lack of Efficacy|2|||
170774014|NCT01102231|617181197|FG000|Overall Study|Death|2|||
170774015|NCT01102231|617181197|FG000|Overall Study|Adverse Event|3|||
170774016|NCT01102231|617181197|FG000|Overall Study|Withdrawal by Subject|1|||
170774017|NCT01102231|617181197|FG000|Overall Study|Did not received the treatment|4|||
170774018|NCT01236560|617181198|FG000|Overall Study|Adverse Event|0|||
170774019|NCT01236560|617181199|FG001|Overall Study|Adverse Event|2|||
170774020|NCT01236560|617181200|FG002|Overall Study|Adverse Event|1|||
170774021|NCT01236560|617181201|FG003|Overall Study|Adverse Event|3|||
170774022|NCT01236560|617181202|FG004|Overall Study|Adverse Event|0|||
170774023|NCT01236560|617181203|FG005|Overall Study|Adverse Event|0|||
170774024|NCT01236560|617181198|FG000|Overall Study|Death|0|||
170774025|NCT01236560|617181199|FG001|Overall Study|Death|1|||
170774026|NCT01236560|617181200|FG002|Overall Study|Death|0|||
170774027|NCT01236560|617181201|FG003|Overall Study|Death|1|||
170774028|NCT01236560|617181202|FG004|Overall Study|Death|0|||
170774029|NCT01236560|617181203|FG005|Overall Study|Death|0|||
170774030|NCT01236560|617181198|FG000|Overall Study|Lost to Follow-up|0|||
170774031|NCT01236560|617181199|FG001|Overall Study|Lost to Follow-up|1|||
170774032|NCT01236560|617181200|FG002|Overall Study|Lost to Follow-up|1|||
170774033|NCT01236560|617181201|FG003|Overall Study|Lost to Follow-up|0|||
170774034|NCT01236560|617181202|FG004|Overall Study|Lost to Follow-up|0|||
170774035|NCT01236560|617181203|FG005|Overall Study|Lost to Follow-up|0|||
170774036|NCT01236560|617181198|FG000|Overall Study|Physician Decision|0|||
170774037|NCT01236560|617181199|FG001|Overall Study|Physician Decision|1|||
170774038|NCT01236560|617181200|FG002|Overall Study|Physician Decision|8|||
170774039|NCT01236560|617181201|FG003|Overall Study|Physician Decision|0|||
170774040|NCT01236560|617181202|FG004|Overall Study|Physician Decision|0|||
170774041|NCT01236560|617181203|FG005|Overall Study|Physician Decision|0|||
170774042|NCT01236560|617181198|FG000|Overall Study|Withdrawal by Subject|0|||
170774043|NCT01236560|617181199|FG001|Overall Study|Withdrawal by Subject|0|||
170874323|NCT01360554|617551565|FG001|Overall Study|Other, not specified|0|||
170874324|NCT01360554|617551564|FG000|Overall Study|Randomized but not treated.|3|||
170874325|NCT01360554|617551565|FG001|Overall Study|Randomized but not treated.|3|||
170774044|NCT01236560|617181200|FG002|Overall Study|Withdrawal by Subject|1|||
170774045|NCT01236560|617181201|FG003|Overall Study|Withdrawal by Subject|2|||
170774046|NCT01236560|617181202|FG004|Overall Study|Withdrawal by Subject|0|||
170774047|NCT01236560|617181203|FG005|Overall Study|Withdrawal by Subject|0|||
170774048|NCT01236560|617181198|FG000|Overall Study|Progressive disease|5|||
170774049|NCT01236560|617181199|FG001|Overall Study|Progressive disease|19|||
170774050|NCT01236560|617181200|FG002|Overall Study|Progressive disease|9|||
170774051|NCT01236560|617181201|FG003|Overall Study|Progressive disease|16|||
170774052|NCT01236560|617181202|FG004|Overall Study|Progressive disease|0|||
170774053|NCT01236560|617181203|FG005|Overall Study|Progressive disease|0|||
170774054|NCT05274217|617181210|FG000|Overall Study|Study terminated.|11|||
170774055|NCT05274217|617181211|FG001|Overall Study|Study terminated.|0|||
170774056|NCT00396084|617181212|FG000|Overall Study|Adverse Event|0|||
170774057|NCT00396084|617181213|FG001|Overall Study|Adverse Event|0|||
170774058|NCT00396084|617181214|FG002|Overall Study|Adverse Event|0|||
170774059|NCT00396084|617181215|FG003|Overall Study|Adverse Event|0|||
170774060|NCT00396084|617181216|FG004|Overall Study|Adverse Event|1|||
170774061|NCT00396084|617181217|FG005|Overall Study|Adverse Event|2|||
170774062|NCT00396084|617181212|FG000|Overall Study|Withdrawal by Subject|0|||
170774063|NCT00396084|617181213|FG001|Overall Study|Withdrawal by Subject|0|||
170774064|NCT00396084|617181214|FG002|Overall Study|Withdrawal by Subject|0|||
170774065|NCT00396084|617181215|FG003|Overall Study|Withdrawal by Subject|1|||
170774066|NCT00396084|617181216|FG004|Overall Study|Withdrawal by Subject|0|||
170774067|NCT00396084|617181217|FG005|Overall Study|Withdrawal by Subject|0|||
170774068|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
170774069|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
170774070|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
170774071|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
170774072|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
170774073|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
170774074|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
170774075|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
170774076|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
170774077|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
170774078|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
170774079|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
170774080|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
170774081|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
170774082|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
170774083|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
170774084|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
170774085|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
170774086|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
170774087|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
170774088|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
170774089|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
170774090|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
170774091|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
170774092|NCT00311363|617181218|FG000|24-Week Single-Blind Treatment Period|Death|1|||
170774093|NCT00311363|617181219|FG001|24-Week Single-Blind Treatment Period|Death|0|||
170774094|NCT00311363|617181220|FG002|24-Week Single-Blind Treatment Period|Death|0|||
170774095|NCT00311363|617181218|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
170774096|NCT00311363|617181219|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
170774097|NCT00311363|617181220|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
170774098|NCT00311363|617181218|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
170774099|NCT00311363|617181219|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
170774100|NCT00311363|617181220|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
170774101|NCT00311363|617181218|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
170774102|NCT00311363|617181219|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
170774103|NCT00311363|617181220|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
170774104|NCT00311363|617181218|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
170774105|NCT00311363|617181219|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
170774106|NCT00311363|617181220|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
170774107|NCT00311363|617181218|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
170774108|NCT00311363|617181219|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
170774109|NCT00311363|617181220|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
170774110|NCT00311363|617181218|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
170774111|NCT00311363|617181219|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
170774112|NCT00311363|617181220|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
170774113|NCT04009577|617181223|FG000|Core Study|Adverse Event|1|||
170774114|NCT04009577|617181224|FG001|Core Study|Adverse Event|0|||
170774115|NCT04009577|617181225|FG002|Core Study|Adverse Event|2|||
170774116|NCT04009577|617181226|FG003|Core Study|Adverse Event|4|||
170774117|NCT04009577|617181223|FG000|Core Study|Withdrawal by Subject|0|||
170774118|NCT04009577|617181224|FG001|Core Study|Withdrawal by Subject|0|||
170774119|NCT04009577|617181225|FG002|Core Study|Withdrawal by Subject|2|||
170774120|NCT04009577|617181226|FG003|Core Study|Withdrawal by Subject|0|||
170774121|NCT04009577|617181223|FG000|Core Study|Other|0|||
170774122|NCT04009577|617181224|FG001|Core Study|Other|0|||
170774123|NCT04009577|617181225|FG002|Core Study|Other|0|||
170774124|NCT04009577|617181226|FG003|Core Study|Other|1|||
170774125|NCT04009577|617181223|FG000|Extension Phase|Adverse Event|0|||
170774126|NCT04009577|617181224|FG001|Extension Phase|Adverse Event|0|||
170774127|NCT04009577|617181225|FG002|Extension Phase|Adverse Event|0|||
170774128|NCT04009577|617181226|FG003|Extension Phase|Adverse Event|1|||
170774129|NCT04009577|617181223|FG000|Extension Phase|Inadequate therapeutic effect|0|||
170774130|NCT04009577|617181224|FG001|Extension Phase|Inadequate therapeutic effect|0|||
170774131|NCT04009577|617181225|FG002|Extension Phase|Inadequate therapeutic effect|1|||
170774132|NCT04009577|617181226|FG003|Extension Phase|Inadequate therapeutic effect|0|||
170774133|NCT04009577|617181223|FG000|Extension Phase|Withdrawal by Subject|0|||
170774134|NCT04009577|617181224|FG001|Extension Phase|Withdrawal by Subject|0|||
170774135|NCT04009577|617181225|FG002|Extension Phase|Withdrawal by Subject|1|||
170774136|NCT04009577|617181226|FG003|Extension Phase|Withdrawal by Subject|0|||
170774137|NCT04009577|617181223|FG000|Extension Phase|Not Treated|0|||
170774138|NCT04009577|617181224|FG001|Extension Phase|Not Treated|0|||
170774139|NCT04009577|617181225|FG002|Extension Phase|Not Treated|2|||
170774140|NCT04009577|617181226|FG003|Extension Phase|Not Treated|0|||
170774141|NCT01697969|617181227|FG000|Overall Study|Did not meet inc/exc criteria|3|||
170774142|NCT03485950|617181229|FG000|Overall Study|Adverse Event|1|||
170774143|NCT03485950|617181230|FG001|Overall Study|Adverse Event|0|||
170774144|NCT03485950|617181229|FG000|Overall Study|Death|3|||
170774145|NCT03485950|617181230|FG001|Overall Study|Death|2|||
170774146|NCT03485950|617181229|FG000|Overall Study|Withdrawal by Subject|3|||
170774147|NCT03485950|617181230|FG001|Overall Study|Withdrawal by Subject|0|||
170774148|NCT04556981|617181232|FG000|Overall Study|Death|0|||
170774149|NCT04556981|617181233|FG001|Overall Study|Death|1|||
170774150|NCT04556981|617181232|FG000|Overall Study|Lost to Follow-up|2|||
170774151|NCT04556981|617181233|FG001|Overall Study|Lost to Follow-up|11|||
170774152|NCT04556981|617181232|FG000|Overall Study|Moved from the study area|1|||
170774153|NCT04556981|617181233|FG001|Overall Study|Moved from the study area|4|||
170774154|NCT04556981|617181232|FG000|Overall Study|Withdrawal by Subject|2|||
170774155|NCT04556981|617181233|FG001|Overall Study|Withdrawal by Subject|2|||
170774156|NCT04556981|617181232|FG000|Overall Study|Other|2|||
170774157|NCT04556981|617181233|FG001|Overall Study|Other|1|||
170774158|NCT00529659|617181234|FG000|Overall Study|Adverse Event|8|||
170774159|NCT00529659|617181235|FG001|Overall Study|Adverse Event|7|||
170774160|NCT00529659|617181234|FG000|Overall Study|Lost to Follow-up|0|||
170774161|NCT00529659|617181235|FG001|Overall Study|Lost to Follow-up|2|||
170774162|NCT00529659|617181234|FG000|Overall Study|Physician Decision|0|||
170774163|NCT00529659|617181235|FG001|Overall Study|Physician Decision|2|||
170774164|NCT00529659|617181234|FG000|Overall Study|Protocol Violation|2|||
170774165|NCT00529659|617181235|FG001|Overall Study|Protocol Violation|6|||
170774166|NCT00529659|617181234|FG000|Overall Study|Withdrawal by Subject|1|||
170774167|NCT00529659|617181235|FG001|Overall Study|Withdrawal by Subject|6|||
170774168|NCT02139943|617181240|FG000|Overall Study|Adverse Event|0|||
170774169|NCT02139943|617181241|FG001|Overall Study|Adverse Event|1|||
170774170|NCT02139943|617181242|FG002|Overall Study|Adverse Event|2|||
170874326|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
170874327|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
170874328|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
170874329|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
170874330|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
170874331|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
170874332|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
170414958|NCT00669955|615858964|FG000|Overall Study|not compliant with study drug/visit|2|||
170774171|NCT02139943|617181240|FG000|Overall Study|Lost to Follow-up|3|||
170774172|NCT02139943|617181241|FG001|Overall Study|Lost to Follow-up|2|||
170774173|NCT02139943|617181242|FG002|Overall Study|Lost to Follow-up|2|||
170414959|NCT00669955|615858965|FG001|Overall Study|not compliant with study drug/visit|3|||
170414960|NCT03495869|615858966|FG000|Overall Study|Lost to Follow-up|4|||
170774174|NCT02139943|617181240|FG000|Overall Study|Withdrawal by Subject|4|||
170774175|NCT02139943|617181241|FG001|Overall Study|Withdrawal by Subject|3|||
170774176|NCT02139943|617181242|FG002|Overall Study|Withdrawal by Subject|0|||
170774177|NCT02139943|617181240|FG000|Overall Study|Other|0|||
170774178|NCT02139943|617181241|FG001|Overall Study|Other|0|||
170874333|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
170414961|NCT03495869|615858967|FG001|Overall Study|Lost to Follow-up|17|||
170774179|NCT02139943|617181242|FG002|Overall Study|Other|1|||
170774180|NCT02139943|617181240|FG000|Overall Study|Participant wishes to discontinue|2|||
170774181|NCT02139943|617181241|FG001|Overall Study|Participant wishes to discontinue|0|||
170774182|NCT02139943|617181242|FG002|Overall Study|Participant wishes to discontinue|0|||
170774183|NCT02139943|617181240|FG000|Overall Study|Participant in Poor Compliance|1|||
170774184|NCT02139943|617181241|FG001|Overall Study|Participant in Poor Compliance|0|||
170774185|NCT02139943|617181242|FG002|Overall Study|Participant in Poor Compliance|1|||
170774186|NCT02139943|617181240|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
170774187|NCT02139943|617181241|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
170774188|NCT02139943|617181242|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
170774189|NCT01041417|617181243|FG000|Overall Study|Adverse Event|5|||
170774190|NCT01041417|617181244|FG001|Overall Study|Adverse Event|2|||
170774191|NCT01041417|617181243|FG000|Overall Study|Lost to Follow-up|1|||
170774192|NCT01041417|617181244|FG001|Overall Study|Lost to Follow-up|1|||
170774193|NCT01041417|617181243|FG000|Overall Study|Death|1|||
170774194|NCT01041417|617181244|FG001|Overall Study|Death|0|||
170774195|NCT02918071|617181247|FG000|Overall Study|Withdrawal by Subject|2|||
170774196|NCT02918071|617181247|FG000|Overall Study|Lost to Follow-up|1|||
170774197|NCT01616459|617181249|FG000|Overall Study|Adverse Event|1|||
170774198|NCT01616459|617181250|FG001|Overall Study|Adverse Event|1|||
170774199|NCT01616459|617181251|FG002|Overall Study|Adverse Event|2|||
170774200|NCT01616459|617181252|FG003|Overall Study|Adverse Event|0|||
170774201|NCT01616459|617181249|FG000|Overall Study|Lost to Follow-up|1|||
170774202|NCT01616459|617181250|FG001|Overall Study|Lost to Follow-up|11|||
170774203|NCT01616459|617181251|FG002|Overall Study|Lost to Follow-up|3|||
170774204|NCT01616459|617181252|FG003|Overall Study|Lost to Follow-up|2|||
170774205|NCT01616459|617181249|FG000|Overall Study|Protocol Violation|0|||
170774206|NCT01616459|617181250|FG001|Overall Study|Protocol Violation|0|||
170774207|NCT01616459|617181251|FG002|Overall Study|Protocol Violation|0|||
170774208|NCT01616459|617181252|FG003|Overall Study|Protocol Violation|2|||
170774209|NCT01616459|617181249|FG000|Overall Study|Withdrawal by Subject|2|||
170774210|NCT01616459|617181250|FG001|Overall Study|Withdrawal by Subject|4|||
170774211|NCT01616459|617181251|FG002|Overall Study|Withdrawal by Subject|4|||
170774212|NCT01616459|617181252|FG003|Overall Study|Withdrawal by Subject|4|||
170774213|NCT01616459|617181249|FG000|Overall Study|Other reason|0|||
170774214|NCT01616459|617181250|FG001|Overall Study|Other reason|1|||
170774215|NCT01616459|617181251|FG002|Overall Study|Other reason|1|||
170774216|NCT01616459|617181252|FG003|Overall Study|Other reason|0|||
170774217|NCT00632424|617181262|FG000|Overall Study|Disease Progression|17|||
170774218|NCT00632424|617181262|FG000|Overall Study|Study Drug Toxicity|1|||
170774219|NCT00801983|617181263|FG000|Period 1|Lost to Follow-up|2|||
170774220|NCT00801983|617181264|FG001|Period 1|Lost to Follow-up|0|||
170774221|NCT00801983|617181263|FG000|Period 1|Withdrawal by Subject|2|||
170774222|NCT00801983|617181264|FG001|Period 1|Withdrawal by Subject|8|||
170774223|NCT00801983|617181263|FG000|Period 2|Withdrawal by Subject|2|||
170774224|NCT00801983|617181264|FG001|Period 2|Withdrawal by Subject|1|||
170806904|NCT03697603|617301665|FG002|Overall Study|Withdrawal by Subject|1|||
170806905|NCT03697603|617301663|FG000|Overall Study|Protocol Violation|0|||
170806906|NCT03697603|617301664|FG001|Overall Study|Protocol Violation|0|||
170806907|NCT03697603|617301665|FG002|Overall Study|Protocol Violation|1|||
170806908|NCT01683409|617301666|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
170806909|NCT01683409|617301667|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
170806910|NCT01683409|617301668|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
170806911|NCT01683409|617301669|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
170806912|NCT01683409|617301670|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
170806913|NCT01683409|617301666|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
170806914|NCT01683409|617301667|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
170806915|NCT01683409|617301668|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
170806916|NCT01683409|617301669|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
170806917|NCT01683409|617301670|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
170806918|NCT01683409|617301666|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
170806919|NCT01683409|617301667|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
170806920|NCT01683409|617301668|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
170806921|NCT01683409|617301669|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
170806922|NCT01683409|617301670|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
170806923|NCT01683409|617301666|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
170806924|NCT01683409|617301667|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
170806925|NCT01683409|617301668|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
170806926|NCT01683409|617301669|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
170806927|NCT01683409|617301670|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
170806928|NCT01683409|617301666|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
170806929|NCT01683409|617301667|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
170806930|NCT01683409|617301668|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
170526385|NCT03217591|616275448|FG000|Overall Study|Adverse Event|1|||
170806931|NCT01683409|617301669|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
170806932|NCT01683409|617301670|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
170806933|NCT01683409|617301666|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
170806934|NCT01683409|617301667|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
170806935|NCT01683409|617301668|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
170806936|NCT01683409|617301669|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
170806937|NCT01683409|617301670|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
170806938|NCT01683409|617301666|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
170874334|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
170874335|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
170874336|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
170874337|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
170874338|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
170874339|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
170874340|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
170874341|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
170874342|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
170874343|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
170874344|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
170874345|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
170874346|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
170874347|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
170874348|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
170874349|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
170874350|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
170874351|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
170874352|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
170874353|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
170874354|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
170874355|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
170874356|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
170874357|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
170874358|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
170874359|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
170874360|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
170874361|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
170874362|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
170874363|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
170874364|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
170874365|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
170874366|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
170874367|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
170874368|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
170874369|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
170874370|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
170874371|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
170874372|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
170874373|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
170874374|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
170874375|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
170874376|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
170874377|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
170874378|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
170874379|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
170874380|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
170874381|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
170874382|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
170874383|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
170874384|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
170874385|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
170874386|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
170874387|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
170874388|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
170874389|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
170874390|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
170874391|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
170874392|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
170874393|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
170874394|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
170632513|NCT01499355|616666690|FG002|Run-In Period|Investigator Decision|0|||
170874395|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
170874396|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
170874397|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
170874398|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
170874399|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
170874400|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
170874401|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
170874402|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
170874403|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
170874404|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
170874405|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
170874406|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
170874407|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
170874408|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
170874409|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
170874410|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
170874411|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
170874412|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
170874413|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
170874414|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
170874415|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
170874416|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
170874417|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
170874418|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
170874419|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
170874420|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
170874421|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
170874422|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
170874423|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
170874424|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
170874425|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
170874426|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
170874427|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
170874428|NCT00111800|617551566|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
170874429|NCT00111800|617551567|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
170874430|NCT00111800|617551568|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
170874431|NCT00111800|617551569|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
170874432|NCT00111800|617551570|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
170874433|NCT00111800|617551571|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
170874434|NCT00111800|617551566|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
170874435|NCT00111800|617551567|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
170874436|NCT00111800|617551568|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
170874437|NCT00111800|617551569|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
170874438|NCT00111800|617551570|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
170874439|NCT00111800|617551571|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
170874440|NCT00111800|617551566|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
170874441|NCT00111800|617551567|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
170874442|NCT00111800|617551568|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
170874443|NCT00111800|617551569|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
170874444|NCT00111800|617551570|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
170874445|NCT00111800|617551571|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
170874446|NCT00111800|617551566|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
170874447|NCT00111800|617551567|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
170874448|NCT00111800|617551568|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
170874449|NCT00111800|617551569|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
170874450|NCT00111800|617551570|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
170874451|NCT00111800|617551571|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
170874452|NCT00111800|617551566|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
170874453|NCT00111800|617551567|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
170874454|NCT00111800|617551568|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
170874455|NCT00111800|617551569|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
170414962|NCT03495869|615858968|FG002|Overall Study|Lost to Follow-up|8|||
170526386|NCT03217591|616275449|FG001|Overall Study|Adverse Event|2|||
170774225|NCT03783026|617183089|FG000|Treatment Phase|Adverse Event|15|||
170774226|NCT03783026|617183089|FG000|Treatment Phase|Lack of Efficacy|11|||
170774227|NCT03783026|617183089|FG000|Treatment Phase|Withdrawal by Subject|6|||
170774228|NCT03783026|617183089|FG000|Treatment Phase|Lost to Follow-up|2|||
170774229|NCT03783026|617183089|FG000|Treatment Phase|Protocol Deviation|8|||
170774230|NCT03783026|617183089|FG000|Treatment Phase|Did Not Receive Treatment|1|||
170774231|NCT03783026|617183089|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
170774232|NCT03960463|617183096|FG000|Overall Study|Withdrawal by Subject|2|||
170774233|NCT03960463|617183097|FG001|Overall Study|Withdrawal by Subject|0|||
170774234|NCT04043455|617183098|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
170774235|NCT04043455|617183099|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
170774236|NCT04043455|617183100|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
170774237|NCT04043455|617183101|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
170774238|NCT04043455|617183102|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
170774239|NCT04043455|617183103|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
170774240|NCT04043455|617183098|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
170774241|NCT04043455|617183099|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
170774242|NCT04043455|617183100|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
170774243|NCT04043455|617183101|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
170774244|NCT04043455|617183102|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
170774245|NCT04043455|617183103|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
170774246|NCT04043455|617183098|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
170774247|NCT04043455|617183099|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
170774248|NCT04043455|617183100|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
170774249|NCT04043455|617183101|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
170774250|NCT04043455|617183102|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
170774251|NCT04043455|617183103|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
170774252|NCT04043455|617183098|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
170774253|NCT04043455|617183099|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
170774254|NCT04043455|617183100|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
170774255|NCT04043455|617183101|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
170774256|NCT04043455|617183102|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
170774257|NCT04043455|617183103|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
170774258|NCT04043455|617183098|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
170774259|NCT04043455|617183099|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
170774260|NCT04043455|617183100|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
170774261|NCT04043455|617183101|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
170774262|NCT04043455|617183102|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
170774263|NCT04043455|617183103|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
170774264|NCT04043455|617183098|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
170774265|NCT04043455|617183099|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
170774266|NCT04043455|617183100|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
170774267|NCT04043455|617183101|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
170774268|NCT04043455|617183102|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
170774269|NCT04043455|617183103|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
170774270|NCT04043455|617183098|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
170774271|NCT04043455|617183099|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
170774272|NCT04043455|617183100|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
170774273|NCT04043455|617183101|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
170774274|NCT04043455|617183102|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
170774275|NCT04043455|617183103|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
170774276|NCT04043455|617183098|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
170774277|NCT04043455|617183099|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
170774278|NCT04043455|617183100|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
170774279|NCT04043455|617183101|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
170774280|NCT04043455|617183102|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
170774281|NCT04043455|617183103|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
170774282|NCT04043455|617183098|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
170774283|NCT04043455|617183099|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
170774284|NCT04043455|617183100|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
170774285|NCT04043455|617183101|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
170774286|NCT04043455|617183102|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
170874456|NCT00111800|617551570|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
170874457|NCT00111800|617551571|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
170874458|NCT00111800|617551566|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
170874459|NCT00111800|617551567|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
170874460|NCT00111800|617551568|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
170874461|NCT00111800|617551569|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
170874462|NCT00111800|617551570|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
170874463|NCT00111800|617551571|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
170874464|NCT00111800|617551566|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
170874465|NCT00111800|617551567|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
170874466|NCT00111800|617551568|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
170874467|NCT00111800|617551569|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
170874468|NCT00111800|617551570|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
170874469|NCT00111800|617551571|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
170874470|NCT00111800|617551566|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
170874471|NCT00111800|617551567|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
170874472|NCT00111800|617551568|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
170874473|NCT00111800|617551569|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
170874474|NCT00111800|617551570|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
170874475|NCT00111800|617551571|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
170874476|NCT00111800|617551566|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
170874477|NCT00111800|617551567|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
170874478|NCT00111800|617551568|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
170874479|NCT00111800|617551569|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
170874480|NCT00111800|617551570|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
170874481|NCT00111800|617551571|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
170874482|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
170874483|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
170874484|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
170874485|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
170874486|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
170874487|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
170874488|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
170874489|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
170874490|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
170874491|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
170874492|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
170874493|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
170874494|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
170874495|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
170874496|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
170874497|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
170874498|NCT00094770|617551572|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
170874499|NCT00094770|617551573|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
170874500|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
170874501|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
170874502|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
170874503|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
170874504|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
170874505|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
170874506|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
170874507|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
170874508|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
170874509|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
170874510|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
170874511|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
170874512|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
170874513|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
170874514|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
170874515|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
170874516|NCT00094770|617551572|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
170874517|NCT00094770|617551573|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
170874518|NCT02752035|617551574|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
170874519|NCT02752035|617551575|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
170874520|NCT02752035|617551576|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
170874521|NCT02752035|617551577|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
170874522|NCT02752035|617551574|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
170874523|NCT02752035|617551575|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
170874524|NCT02752035|617551576|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
170874525|NCT02752035|617551577|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
170874526|NCT02752035|617551574|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
170874527|NCT02752035|617551575|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
170874528|NCT02752035|617551576|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
170874529|NCT02752035|617551577|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
170874530|NCT02752035|617551574|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
170874531|NCT02752035|617551575|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
170874532|NCT02752035|617551576|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
170874533|NCT02752035|617551577|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
170874534|NCT02752035|617551574|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
170874535|NCT02752035|617551575|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
170874536|NCT02752035|617551576|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
170874537|NCT02752035|617551577|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
170874538|NCT02752035|617551574|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
170874539|NCT02752035|617551575|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
170874540|NCT02752035|617551576|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
170874541|NCT02752035|617551577|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
170874542|NCT02752035|617551574|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
170874543|NCT02752035|617551575|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
170874544|NCT02752035|617551576|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
170874545|NCT02752035|617551577|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
170874546|NCT02752035|617551574|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
170874547|NCT02752035|617551575|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
170874548|NCT02752035|617551576|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
170874549|NCT02752035|617551577|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
170874550|NCT02752035|617551574|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
170874551|NCT02752035|617551575|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
170874552|NCT02752035|617551576|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
170874553|NCT02752035|617551577|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
170874554|NCT02752035|617551574|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
170874555|NCT02752035|617551575|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
170874556|NCT02752035|617551576|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
170874557|NCT02752035|617551577|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
170874558|NCT02752035|617551574|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
170874559|NCT02752035|617551575|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
170874560|NCT02752035|617551576|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
170874561|NCT02752035|617551577|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
170874562|NCT02752035|617551574|FG000|Randomization: Approximately 3 Years|Death|0|||
170874563|NCT02752035|617551575|FG001|Randomization: Approximately 3 Years|Death|25|||
170874564|NCT02752035|617551576|FG002|Randomization: Approximately 3 Years|Death|13|||
170874565|NCT02752035|617551577|FG003|Randomization: Approximately 3 Years|Death|4|||
170874566|NCT02752035|617551574|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
170874567|NCT02752035|617551575|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
170874568|NCT02752035|617551576|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
170874569|NCT02752035|617551577|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
170874570|NCT02752035|617551574|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
170874571|NCT02752035|617551575|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
170874572|NCT02752035|617551576|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
170874573|NCT02752035|617551577|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
170874574|NCT02752035|617551574|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
170874575|NCT02752035|617551575|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
170874576|NCT02752035|617551576|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
170874577|NCT02752035|617551577|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
170874578|NCT02752035|617551574|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
170874579|NCT02752035|617551575|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
170874580|NCT02752035|617551576|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
170874581|NCT02752035|617551577|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
170874582|NCT02752035|617551574|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
170874583|NCT02752035|617551575|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
170874584|NCT02752035|617551576|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
170874585|NCT02752035|617551577|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
170874586|NCT02343159|617551582|FG000|Overall Study|Early Study Termination|16|||
170874587|NCT02343159|617551583|FG001|Overall Study|Early Study Termination|19|||
170874588|NCT02343159|617551584|FG002|Overall Study|Early Study Termination|23|||
170774287|NCT04043455|617183103|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
170774288|NCT04043455|617183098|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
170774289|NCT04043455|617183099|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
170774290|NCT04043455|617183100|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
170774291|NCT04043455|617183101|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
170774292|NCT04043455|617183102|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
170774293|NCT04043455|617183103|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
170774294|NCT04043455|617183098|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
170774295|NCT04043455|617183099|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
170774296|NCT04043455|617183100|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
170774297|NCT04043455|617183101|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
170774298|NCT04043455|617183102|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
170774299|NCT04043455|617183103|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
170774300|NCT04922021|617183104|FG000|Overall Study|Withdrawal by Subject|4|||
170774301|NCT04922021|617183105|FG001|Overall Study|Withdrawal by Subject|10|||
170774302|NCT04922021|617183104|FG000|Overall Study|Adverse Event|2|||
170774303|NCT04922021|617183105|FG001|Overall Study|Adverse Event|2|||
170774304|NCT04922021|617183104|FG000|Overall Study|Lack of Efficacy|0|||
170774305|NCT04922021|617183105|FG001|Overall Study|Lack of Efficacy|1|||
170774306|NCT04922021|617183104|FG000|Overall Study|Multiple reasons|1|||
170774307|NCT04922021|617183105|FG001|Overall Study|Multiple reasons|0|||
170774308|NCT04842500|617183106|FG000|Overall Study|Withdrawal by Subject|4|||
170774309|NCT04842500|617183107|FG001|Overall Study|Withdrawal by Subject|1|||
170774310|NCT04842500|617183108|FG002|Overall Study|Withdrawal by Subject|2|||
170774311|NCT04842500|617183109|FG003|Overall Study|Withdrawal by Subject|3|||
170774312|NCT04842500|617183106|FG000|Overall Study|Protocol Violation|1|||
170774313|NCT04842500|617183107|FG001|Overall Study|Protocol Violation|0|||
170774314|NCT04842500|617183108|FG002|Overall Study|Protocol Violation|0|||
170774315|NCT04842500|617183109|FG003|Overall Study|Protocol Violation|1|||
170774316|NCT04139668|617183110|FG000|Overall Study|Withdrawal by Subject|1|||
170774317|NCT02652260|617183111|FG000|Base Study|Pregnancy|0|||
170774318|NCT02652260|617183112|FG001|Base Study|Pregnancy|1|||
170774319|NCT02652260|617183111|FG000|Base Study|Withdrawal by Subject|0|||
170774320|NCT02652260|617183112|FG001|Base Study|Withdrawal by Subject|1|||
170774321|NCT02652260|617183111|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
170774322|NCT02652260|617183112|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
170774323|NCT02652260|617183111|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
170774324|NCT02652260|617183112|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
170774325|NCT02652260|617183111|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
170774326|NCT02652260|617183112|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
170774327|NCT02652260|617183111|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
170774328|NCT02652260|617183112|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
170774329|NCT02652260|617183111|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
170774330|NCT02652260|617183112|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
170774331|NCT02652260|617183111|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
170774332|NCT02652260|617183112|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
170774333|NCT02652260|617183111|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
170774334|NCT02652260|617183112|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
170774335|NCT02652260|617183111|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
170774336|NCT02652260|617183112|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
170774337|NCT02652260|617183111|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
170774338|NCT02652260|617183112|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
170774339|NCT02652260|617183111|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
170774340|NCT02652260|617183112|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
170774341|NCT02652260|617183111|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
170774342|NCT02652260|617183112|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
170774343|NCT02652260|617183111|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
170774344|NCT02652260|617183112|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
170774345|NCT02824029|617183118|FG000|Overall Study|Didn't receive treatment|2|||
170774346|NCT02824029|617183118|FG000|Overall Study|Patient decision to discontinue treatment|3|||
170774347|NCT02824029|617183118|FG000|Overall Study|Non-compliant|5|||
170774348|NCT02824029|617183118|FG000|Overall Study|Progression of disease|15|||
170414963|NCT03495869|615858969|FG003|Overall Study|Lost to Follow-up|14|||
170414964|NCT03495869|615858966|FG000|Overall Study|Withdrawal by Subject|0|||
170414965|NCT03495869|615858967|FG001|Overall Study|Withdrawal by Subject|3|||
170774349|NCT02824029|617183118|FG000|Overall Study|Inadequate response to therapy|2|||
170774350|NCT02824029|617183118|FG000|Overall Study|Possible progression per treating physician|1|||
170774351|NCT03088813|617183119|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
170774352|NCT03088813|617183120|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
170774353|NCT03088813|617183121|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
170874589|NCT02343159|617551582|FG000|Overall Study|Physician Decision|2|||
170874590|NCT02343159|617551583|FG001|Overall Study|Physician Decision|0|||
170874591|NCT02343159|617551584|FG002|Overall Study|Physician Decision|1|||
170874592|NCT02343159|617551582|FG000|Overall Study|Withdrawal by Subject|3|||
170874593|NCT02343159|617551583|FG001|Overall Study|Withdrawal by Subject|0|||
170874594|NCT02343159|617551584|FG002|Overall Study|Withdrawal by Subject|2|||
170874595|NCT02343159|617551582|FG000|Overall Study|Lost to Follow-up|0|||
170874596|NCT02343159|617551583|FG001|Overall Study|Lost to Follow-up|2|||
170874597|NCT02343159|617551584|FG002|Overall Study|Lost to Follow-up|2|||
170874598|NCT02343159|617551582|FG000|Overall Study|Adverse Event|4|||
170874599|NCT02343159|617551583|FG001|Overall Study|Adverse Event|4|||
170874600|NCT02343159|617551584|FG002|Overall Study|Adverse Event|2|||
170874601|NCT02343159|617551582|FG000|Overall Study|Sponsor Decision|0|||
170874602|NCT02343159|617551583|FG001|Overall Study|Sponsor Decision|1|||
170874603|NCT02343159|617551584|FG002|Overall Study|Sponsor Decision|0|||
170874604|NCT02343159|617551582|FG000|Overall Study|Enrollment Error|1|||
170874605|NCT02343159|617551583|FG001|Overall Study|Enrollment Error|0|||
170874606|NCT02343159|617551584|FG002|Overall Study|Enrollment Error|0|||
170874607|NCT03199040|617551589|FG000|Overall Study|Lack of Efficacy|2|||
170874608|NCT03199040|617551590|FG001|Overall Study|Lack of Efficacy|0|||
170526387|NCT03217591|616275450|FG002|Overall Study|Adverse Event|6|||
170774354|NCT03088813|617183122|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
170774355|NCT03088813|617183119|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
170774356|NCT03088813|617183120|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
170774357|NCT03088813|617183121|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
170774358|NCT03088813|617183122|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
170774359|NCT03088813|617183119|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
170774360|NCT03088813|617183120|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
170774361|NCT03088813|617183121|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
170774362|NCT03088813|617183122|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
170774363|NCT03088813|617183119|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
170774364|NCT03088813|617183120|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
170774365|NCT03088813|617183121|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
170774366|NCT03088813|617183122|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
170774367|NCT03088813|617183119|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
170774368|NCT03088813|617183120|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
170774369|NCT03088813|617183121|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
170774370|NCT03088813|617183122|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
170774371|NCT03088813|617183119|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
170774372|NCT03088813|617183120|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
170774373|NCT03088813|617183121|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
170774374|NCT03088813|617183122|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
170774375|NCT03088813|617183119|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
170774376|NCT03088813|617183120|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
170774377|NCT03088813|617183121|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
170774378|NCT03088813|617183122|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
170774379|NCT02152137|617183123|FG000|Overall Study|Withdrawal by Subject|1|||
170774380|NCT02152137|617183123|FG000|Overall Study|Originally assigned to Arm B|3|||
170774381|NCT04440176|617183124|FG000|Overall Study|Withdrawal by Subject|5|||
170774382|NCT04440176|617183125|FG001|Overall Study|Withdrawal by Subject|3|||
170774383|NCT04440176|617183124|FG000|Overall Study|Withdrawal by parent/guardian|4|||
170774384|NCT04440176|617183125|FG001|Overall Study|Withdrawal by parent/guardian|5|||
170774385|NCT04440176|617183124|FG000|Overall Study|Adverse Event|2|||
170774386|NCT04440176|617183125|FG001|Overall Study|Adverse Event|6|||
170774387|NCT04440176|617183124|FG000|Overall Study|Lost to Follow-up|22|||
170774388|NCT04440176|617183125|FG001|Overall Study|Lost to Follow-up|23|||
170774389|NCT04440176|617183124|FG000|Overall Study|Medication error without associated adverse event|0|||
170774390|NCT04440176|617183125|FG001|Overall Study|Medication error without associated adverse event|1|||
170774391|NCT04440176|617183124|FG000|Overall Study|No longer met eligibility criteria|7|||
170774392|NCT04440176|617183125|FG001|Overall Study|No longer met eligibility criteria|1|||
170774393|NCT04440176|617183124|FG000|Overall Study|Other|1|||
170774394|NCT04440176|617183125|FG001|Overall Study|Other|2|||
170774395|NCT04440176|617183124|FG000|Overall Study|Protocol deviation|6|||
170774396|NCT04440176|617183125|FG001|Overall Study|Protocol deviation|8|||
170774397|NCT04440176|617183124|FG000|Overall Study|Randomized but not vaccinated|6|||
170774398|NCT04440176|617183125|FG001|Overall Study|Randomized but not vaccinated|3|||
170774399|NCT02991807|617183126|FG000|Overall Study|Withdrawal by Subject|2|||
170874609|NCT03199040|617551589|FG000|Overall Study|Withdrawal by Subject|2|||
170874610|NCT03199040|617551590|FG001|Overall Study|Withdrawal by Subject|0|||
170874611|NCT03199040|617551589|FG000|Overall Study|Adverse Event|0|||
170874612|NCT03199040|617551590|FG001|Overall Study|Adverse Event|1|||
170874613|NCT03199040|617551589|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
170874614|NCT03199040|617551590|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
170874615|NCT01786603|617551591|FG000|Overall Study|Death|5|||
170874616|NCT01786603|617551592|FG001|Overall Study|Death|1|||
170874617|NCT01786603|617551591|FG000|Overall Study|Adverse Event|6|||
170874618|NCT01786603|617551592|FG001|Overall Study|Adverse Event|2|||
170874619|NCT01786603|617551591|FG000|Overall Study|Physician decision to withdraw|6|||
170874620|NCT01786603|617551592|FG001|Overall Study|Physician decision to withdraw|7|||
170874621|NCT01786603|617551591|FG000|Overall Study|Lost to Follow-up|1|||
170874622|NCT01786603|617551592|FG001|Overall Study|Lost to Follow-up|2|||
170874623|NCT01226459|617551593|FG000|Overall Study|Adverse Event|2|||
170874624|NCT01226459|617551594|FG001|Overall Study|Adverse Event|8|||
170874625|NCT01226459|617551593|FG000|Overall Study|Protocol Violation|4|||
170874626|NCT01226459|617551594|FG001|Overall Study|Protocol Violation|3|||
170874627|NCT01226459|617551593|FG000|Overall Study|Withdrawal by Subject|10|||
170874628|NCT01226459|617551594|FG001|Overall Study|Withdrawal by Subject|13|||
170874629|NCT01226459|617551593|FG000|Overall Study|Lost to Follow-up|4|||
170874630|NCT01226459|617551594|FG001|Overall Study|Lost to Follow-up|8|||
170874631|NCT01226459|617551593|FG000|Overall Study|Pregnancy|1|||
170874632|NCT01226459|617551594|FG001|Overall Study|Pregnancy|0|||
170874633|NCT01092143|617551600|FG000|Overall Study|Adverse Event|10|||
170874634|NCT01092143|617551601|FG001|Overall Study|Adverse Event|5|||
170874635|NCT01092143|617551602|FG002|Overall Study|Adverse Event|1|||
170874636|NCT01092143|617551603|FG003|Overall Study|Adverse Event|4|||
170874637|NCT01092143|617551604|FG004|Overall Study|Adverse Event|3|||
170874638|NCT01092143|617551600|FG000|Overall Study|Lost to Follow-up|1|||
170874639|NCT01092143|617551601|FG001|Overall Study|Lost to Follow-up|0|||
170874640|NCT01092143|617551602|FG002|Overall Study|Lost to Follow-up|1|||
170874641|NCT01092143|617551603|FG003|Overall Study|Lost to Follow-up|0|||
170874642|NCT01092143|617551604|FG004|Overall Study|Lost to Follow-up|0|||
170874643|NCT01092143|617551600|FG000|Overall Study|Consent withdrawn|2|||
170874644|NCT01092143|617551601|FG001|Overall Study|Consent withdrawn|1|||
170874645|NCT01092143|617551602|FG002|Overall Study|Consent withdrawn|0|||
170874646|NCT01092143|617551603|FG003|Overall Study|Consent withdrawn|1|||
170874647|NCT01092143|617551604|FG004|Overall Study|Consent withdrawn|3|||
170874648|NCT01092143|617551600|FG000|Overall Study|Not treated|0|||
170874649|NCT01092143|617551601|FG001|Overall Study|Not treated|0|||
170874650|NCT01092143|617551602|FG002|Overall Study|Not treated|1|||
170874651|NCT01092143|617551603|FG003|Overall Study|Not treated|0|||
170874652|NCT01092143|617551604|FG004|Overall Study|Not treated|0|||
170874653|NCT01092143|617551600|FG000|Overall Study|did not reversibility criteria|0|||
170874654|NCT01092143|617551601|FG001|Overall Study|did not reversibility criteria|0|||
170874655|NCT01092143|617551602|FG002|Overall Study|did not reversibility criteria|1|||
170874656|NCT01092143|617551603|FG003|Overall Study|did not reversibility criteria|0|||
170874657|NCT01092143|617551604|FG004|Overall Study|did not reversibility criteria|0|||
170874658|NCT01092143|617551600|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
170874659|NCT01092143|617551601|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
170874660|NCT01092143|617551602|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
170874661|NCT01092143|617551603|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
170874662|NCT01092143|617551604|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
170874663|NCT01092143|617551600|FG000|Overall Study|Ineligible patient|1|||
170874664|NCT01092143|617551601|FG001|Overall Study|Ineligible patient|0|||
170874665|NCT01092143|617551602|FG002|Overall Study|Ineligible patient|0|||
170874666|NCT01092143|617551603|FG003|Overall Study|Ineligible patient|0|||
170874667|NCT01092143|617551604|FG004|Overall Study|Ineligible patient|0|||
170874668|NCT01092143|617551600|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
170874669|NCT01092143|617551601|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
170874670|NCT01092143|617551602|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
170874671|NCT01092143|617551603|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
170874672|NCT01092143|617551604|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
170874673|NCT01092143|617551600|FG000|Overall Study|Patient travel|0|||
170874674|NCT01092143|617551601|FG001|Overall Study|Patient travel|0|||
170874675|NCT01092143|617551602|FG002|Overall Study|Patient travel|0|||
170874676|NCT01092143|617551603|FG003|Overall Study|Patient travel|0|||
170874677|NCT01092143|617551604|FG004|Overall Study|Patient travel|1|||
170874678|NCT01092143|617551600|FG000|Overall Study|Non compliance with study medication|0|||
170874679|NCT01092143|617551601|FG001|Overall Study|Non compliance with study medication|0|||
170874680|NCT01092143|617551602|FG002|Overall Study|Non compliance with study medication|0|||
170874681|NCT01092143|617551603|FG003|Overall Study|Non compliance with study medication|0|||
170874682|NCT01092143|617551604|FG004|Overall Study|Non compliance with study medication|1|||
170874683|NCT01092143|617551600|FG000|Overall Study|Randomized by mistake|0|||
170874684|NCT01092143|617551601|FG001|Overall Study|Randomized by mistake|0|||
170874685|NCT01092143|617551602|FG002|Overall Study|Randomized by mistake|0|||
170874686|NCT01092143|617551603|FG003|Overall Study|Randomized by mistake|1|||
170874687|NCT01092143|617551604|FG004|Overall Study|Randomized by mistake|0|||
170874688|NCT01092143|617551600|FG000|Overall Study|Pregnancy|0|||
170874689|NCT01092143|617551601|FG001|Overall Study|Pregnancy|0|||
170874690|NCT01092143|617551602|FG002|Overall Study|Pregnancy|0|||
170874691|NCT01092143|617551603|FG003|Overall Study|Pregnancy|1|||
170874692|NCT01092143|617551604|FG004|Overall Study|Pregnancy|0|||
170874693|NCT01843972|617551608|FG000|Overall Study|Withdrawal by Subject|0|||
170874694|NCT01843972|617551609|FG001|Overall Study|Withdrawal by Subject|0|||
170874695|NCT01843972|617551610|FG002|Overall Study|Withdrawal by Subject|0|||
170874696|NCT01843972|617551611|FG003|Overall Study|Withdrawal by Subject|0|||
170874697|NCT01843972|617551612|FG004|Overall Study|Withdrawal by Subject|1|||
170874698|NCT01843972|617551613|FG005|Overall Study|Withdrawal by Subject|0|||
170874699|NCT01843972|617551614|FG006|Overall Study|Withdrawal by Subject|0|||
170874700|NCT01843972|617551615|FG007|Overall Study|Withdrawal by Subject|0|||
170874701|NCT01843972|617551616|FG008|Overall Study|Withdrawal by Subject|0|||
170874702|NCT01843972|617551617|FG009|Overall Study|Withdrawal by Subject|0|||
170874703|NCT01854645|617551623|FG000|Overall Study|Protocol-Specified Criteria|13|||
170874704|NCT01854645|617551624|FG001|Overall Study|Protocol-Specified Criteria|10|||
170874705|NCT01854645|617551625|FG002|Overall Study|Protocol-Specified Criteria|8|||
170874706|NCT01854645|617551626|FG003|Overall Study|Protocol-Specified Criteria|5|||
170874707|NCT01854645|617551627|FG004|Overall Study|Protocol-Specified Criteria|7|||
170874708|NCT01854645|617551623|FG000|Overall Study|Administrative Reasons / Missing|0|||
170874709|NCT01854645|617551624|FG001|Overall Study|Administrative Reasons / Missing|0|||
170874710|NCT01854645|617551625|FG002|Overall Study|Administrative Reasons / Missing|0|||
170874711|NCT01854645|617551626|FG003|Overall Study|Administrative Reasons / Missing|1|||
170874712|NCT01854645|617551627|FG004|Overall Study|Administrative Reasons / Missing|1|||
170874713|NCT01854645|617551623|FG000|Overall Study|Protocol Violation|3|||
170874714|NCT01854645|617551624|FG001|Overall Study|Protocol Violation|0|||
170874715|NCT01854645|617551625|FG002|Overall Study|Protocol Violation|5|||
170874716|NCT01854645|617551626|FG003|Overall Study|Protocol Violation|4|||
170874717|NCT01854645|617551627|FG004|Overall Study|Protocol Violation|1|||
170874718|NCT01854645|617551623|FG000|Overall Study|Lost to Follow-up|10|||
170874719|NCT01854645|617551624|FG001|Overall Study|Lost to Follow-up|7|||
170874720|NCT01854645|617551625|FG002|Overall Study|Lost to Follow-up|8|||
170874721|NCT01854645|617551626|FG003|Overall Study|Lost to Follow-up|5|||
170874722|NCT01854645|617551627|FG004|Overall Study|Lost to Follow-up|0|||
170874723|NCT01854645|617551623|FG000|Overall Study|Physician Decision|1|||
170874724|NCT01854645|617551624|FG001|Overall Study|Physician Decision|5|||
170874725|NCT01854645|617551625|FG002|Overall Study|Physician Decision|3|||
170874726|NCT01854645|617551626|FG003|Overall Study|Physician Decision|3|||
170874727|NCT01854645|617551627|FG004|Overall Study|Physician Decision|7|||
170874728|NCT01854645|617551623|FG000|Overall Study|Withdrawal by Subject|31|||
170874729|NCT01854645|617551624|FG001|Overall Study|Withdrawal by Subject|41|||
170874730|NCT01854645|617551625|FG002|Overall Study|Withdrawal by Subject|30|||
170874731|NCT01854645|617551626|FG003|Overall Study|Withdrawal by Subject|21|||
170874732|NCT01854645|617551627|FG004|Overall Study|Withdrawal by Subject|24|||
170874733|NCT01854645|617551623|FG000|Overall Study|Lack of Efficacy|7|||
170874734|NCT01854645|617551624|FG001|Overall Study|Lack of Efficacy|12|||
170874735|NCT01854645|617551625|FG002|Overall Study|Lack of Efficacy|9|||
170874736|NCT01854645|617551626|FG003|Overall Study|Lack of Efficacy|3|||
170874737|NCT01854645|617551627|FG004|Overall Study|Lack of Efficacy|9|||
170874738|NCT01854645|617551623|FG000|Overall Study|Adverse Event|33|||
170874739|NCT01854645|617551624|FG001|Overall Study|Adverse Event|31|||
170874740|NCT01854645|617551625|FG002|Overall Study|Adverse Event|19|||
170874741|NCT01854645|617551626|FG003|Overall Study|Adverse Event|20|||
170874742|NCT01854645|617551627|FG004|Overall Study|Adverse Event|11|||
170874743|NCT05293743|617551628|FG000|Overall Study|Withdrawal by Subject|1|||
170874744|NCT05293743|617551629|FG001|Overall Study|Withdrawal by Subject|0|||
170874745|NCT00427349|617551632|FG000|Overall Study|Lack of Efficacy|23|||
170874746|NCT00427349|617551632|FG000|Overall Study|Adverse Event|14|||
170874747|NCT00427349|617551632|FG000|Overall Study|Death|1|||
170874748|NCT00427349|617551632|FG000|Overall Study|Withdrawal by Subject|3|||
170874749|NCT00427349|617551632|FG000|Overall Study|Alternative therapy|1|||
170874750|NCT00427349|617551632|FG000|Overall Study|Other|2|||
170874751|NCT00427349|617551632|FG000|Overall Study|Ineligible|1|||
170874752|NCT00427349|617551632|FG000|Overall Study|Never started therapy|1|||
170874753|NCT00475722|617551633|FG000|Overall Study|Withdrawal by Subject|12|||
170874754|NCT00475722|617551634|FG001|Overall Study|Withdrawal by Subject|12|||
170874755|NCT00475722|617551633|FG000|Overall Study|Protocol Violation|3|||
170874756|NCT00475722|617551634|FG001|Overall Study|Protocol Violation|0|||
170874757|NCT00493220|617551635|FG000|Third Intervention|Withdrawal by Subject|1|||
170874758|NCT00493220|617551636|FG001|Third Intervention|Withdrawal by Subject|0|||
170874759|NCT00493220|617551637|FG002|Third Intervention|Withdrawal by Subject|0|||
170874760|NCT00493220|617551638|FG003|Third Intervention|Withdrawal by Subject|0|||
170874761|NCT00493220|617551639|FG004|Third Intervention|Withdrawal by Subject|0|||
170874762|NCT00493220|617551640|FG005|Third Intervention|Withdrawal by Subject|0|||
170874763|NCT02625233|617551641|FG000|Overall Study|Adverse Event|2|||
170874764|NCT02625233|617551642|FG001|Overall Study|Adverse Event|0|||
170874765|NCT00916279|617551643|FG000|Overall Study|Death|2|||
170874766|NCT00916279|617551643|FG000|Overall Study|Lost to Follow-up|2|||
170874767|NCT00310804|617551644|FG000|Overall Study|Lost to Follow-up|2|||
170874768|NCT00310804|617551645|FG001|Overall Study|Lost to Follow-up|0|||
170874769|NCT00310804|617551644|FG000|Overall Study|Withdrawal by Subject|3|||
170874770|NCT00310804|617551645|FG001|Overall Study|Withdrawal by Subject|0|||
170874771|NCT00290186|617551655|FG000|Overall Study|Adverse Event|1|||
170874772|NCT00290186|617551656|FG001|Overall Study|Adverse Event|1|||
170874773|NCT00290186|617551655|FG000|Overall Study|Lost to Follow-up|3|||
170874774|NCT00290186|617551656|FG001|Overall Study|Lost to Follow-up|2|||
170874775|NCT00290186|617551655|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
170874776|NCT00290186|617551656|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
170874777|NCT00290186|617551655|FG000|Overall Study|Withdrawal by Subject|0|||
170874778|NCT00290186|617551656|FG001|Overall Study|Withdrawal by Subject|1|||
170874779|NCT00807742|617551657|FG000|Overall Study|Death|9|||
170874780|NCT00807742|617551658|FG001|Overall Study|Death|2|||
170874781|NCT00807742|617551657|FG000|Overall Study|Withdrawal by Subject|2|||
170874782|NCT00807742|617551658|FG001|Overall Study|Withdrawal by Subject|1|||
170874783|NCT00807742|617551657|FG000|Overall Study|Lost to Follow-up|35|||
170874784|NCT00807742|617551658|FG001|Overall Study|Lost to Follow-up|51|||
170874785|NCT00609986|617551660|FG000|Overall Study|Did not receive transplant or treatment|8|||
170874786|NCT00609986|617551661|FG001|Overall Study|Did not receive transplant or treatment|3|||
170874787|NCT04814823|617551664|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
170874788|NCT01877915|617551665|FG000|Overall Study|Lost to Follow-up|10|||
170874789|NCT01877915|617551666|FG001|Overall Study|Lost to Follow-up|9|||
170874790|NCT01877915|617551665|FG000|Overall Study|Withdrawal by Subject|42|||
170874791|NCT01877915|617551666|FG001|Overall Study|Withdrawal by Subject|55|||
170874792|NCT01877915|617551665|FG000|Overall Study|Other|2|||
170874793|NCT01877915|617551666|FG001|Overall Study|Other|4|||
170874794|NCT05678257|617551671|FG000|Overall Study|Withdrawal by Subject|2|||
170874795|NCT05678257|617551672|FG001|Overall Study|Withdrawal by Subject|0|||
170874796|NCT05678257|617551673|FG002|Overall Study|Withdrawal by Subject|5|||
170874797|NCT05678257|617551671|FG000|Overall Study|Physician Decision|1|||
170874798|NCT05678257|617551672|FG001|Overall Study|Physician Decision|0|||
170874799|NCT05678257|617551673|FG002|Overall Study|Physician Decision|1|||
170874800|NCT05678257|617551671|FG000|Overall Study|Adverse Event|1|||
170874801|NCT05678257|617551672|FG001|Overall Study|Adverse Event|3|||
170874802|NCT05678257|617551673|FG002|Overall Study|Adverse Event|1|||
170874803|NCT05678257|617551671|FG000|Overall Study|Progressive disease|11|||
170874804|NCT05678257|617551672|FG001|Overall Study|Progressive disease|18|||
170874805|NCT05678257|617551673|FG002|Overall Study|Progressive disease|7|||
170874806|NCT05678257|617551671|FG000|Overall Study|No longer clinically benefitting|2|||
170874807|NCT05678257|617551672|FG001|Overall Study|No longer clinically benefitting|1|||
170874808|NCT05678257|617551673|FG002|Overall Study|No longer clinically benefitting|0|||
170874809|NCT05678257|617551671|FG000|Overall Study|Sponsor decision|5|||
170874810|NCT05678257|617551672|FG001|Overall Study|Sponsor decision|9|||
170874811|NCT05678257|617551673|FG002|Overall Study|Sponsor decision|8|||
170874812|NCT05678257|617551671|FG000|Overall Study|Protocol Violation|0|||
170874813|NCT05678257|617551672|FG001|Overall Study|Protocol Violation|0|||
170874814|NCT05678257|617551673|FG002|Overall Study|Protocol Violation|1|||
170874815|NCT05678257|617551671|FG000|Overall Study|Patient non-compliance|0|||
170874816|NCT05678257|617551672|FG001|Overall Study|Patient non-compliance|0|||
170874817|NCT05678257|617551673|FG002|Overall Study|Patient non-compliance|3|||
170874818|NCT01045798|617551674|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
170874819|NCT01045798|617551675|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
170874820|NCT01045798|617551674|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
170874821|NCT01045798|617551675|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
170874822|NCT01045798|617551674|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
170874823|NCT01045798|617551675|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
170874824|NCT01045798|617551674|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
170874825|NCT01045798|617551675|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
170874826|NCT01449461|617551676|FG000|Overall Study|Adverse Event|0|||
170874827|NCT01449461|617551677|FG001|Overall Study|Adverse Event|3|||
170874828|NCT01449461|617551678|FG002|Overall Study|Adverse Event|2|||
170874829|NCT01449461|617551679|FG003|Overall Study|Adverse Event|3|||
170874830|NCT01449461|617551680|FG004|Overall Study|Adverse Event|4|||
170874831|NCT01449461|617551681|FG005|Overall Study|Adverse Event|4|||
170874832|NCT01449461|617551676|FG000|Overall Study|Death|0|||
170874833|NCT01449461|617551677|FG001|Overall Study|Death|2|||
170414966|NCT03495869|615858968|FG002|Overall Study|Withdrawal by Subject|0|||
170414967|NCT03495869|615858969|FG003|Overall Study|Withdrawal by Subject|3|||
170874834|NCT01449461|617551678|FG002|Overall Study|Death|0|||
170874835|NCT01449461|617551679|FG003|Overall Study|Death|0|||
170874836|NCT01449461|617551680|FG004|Overall Study|Death|7|||
170874837|NCT01449461|617551681|FG005|Overall Study|Death|1|||
170874838|NCT01449461|617551676|FG000|Overall Study|Physician Decision|0|||
170874839|NCT01449461|617551677|FG001|Overall Study|Physician Decision|1|||
170874840|NCT01449461|617551678|FG002|Overall Study|Physician Decision|0|||
170874841|NCT01449461|617551679|FG003|Overall Study|Physician Decision|4|||
170414968|NCT03495869|615858966|FG000|Overall Study|Dropped from study|0|||
170874842|NCT01449461|617551680|FG004|Overall Study|Physician Decision|1|||
170874843|NCT01449461|617551681|FG005|Overall Study|Physician Decision|0|||
170874844|NCT01449461|617551676|FG000|Overall Study|Documented Progressive Disease|4|||
170874845|NCT01449461|617551677|FG001|Overall Study|Documented Progressive Disease|7|||
170874846|NCT01449461|617551678|FG002|Overall Study|Documented Progressive Disease|14|||
170874847|NCT01449461|617551679|FG003|Overall Study|Documented Progressive Disease|15|||
170874848|NCT01449461|617551680|FG004|Overall Study|Documented Progressive Disease|24|||
170874849|NCT01449461|617551681|FG005|Overall Study|Documented Progressive Disease|5|||
170874850|NCT01449461|617551676|FG000|Overall Study|Clinical Progressive Disease|2|||
170874851|NCT01449461|617551677|FG001|Overall Study|Clinical Progressive Disease|2|||
170874852|NCT01449461|617551678|FG002|Overall Study|Clinical Progressive Disease|0|||
170874853|NCT01449461|617551679|FG003|Overall Study|Clinical Progressive Disease|3|||
170874854|NCT01449461|617551680|FG004|Overall Study|Clinical Progressive Disease|4|||
170874855|NCT01449461|617551681|FG005|Overall Study|Clinical Progressive Disease|2|||
170874856|NCT01449461|617551676|FG000|Overall Study|Protocol Violation|0|||
170874857|NCT01449461|617551677|FG001|Overall Study|Protocol Violation|0|||
170874858|NCT01449461|617551678|FG002|Overall Study|Protocol Violation|0|||
170874859|NCT01449461|617551679|FG003|Overall Study|Protocol Violation|1|||
170874860|NCT01449461|617551680|FG004|Overall Study|Protocol Violation|0|||
170874861|NCT01449461|617551681|FG005|Overall Study|Protocol Violation|0|||
170874862|NCT01449461|617551676|FG000|Overall Study|Site Terminated by Sponsor|0|||
170874863|NCT01449461|617551677|FG001|Overall Study|Site Terminated by Sponsor|1|||
170874864|NCT01449461|617551678|FG002|Overall Study|Site Terminated by Sponsor|2|||
170874865|NCT01449461|617551679|FG003|Overall Study|Site Terminated by Sponsor|3|||
170874866|NCT01449461|617551680|FG004|Overall Study|Site Terminated by Sponsor|4|||
170874867|NCT01449461|617551681|FG005|Overall Study|Site Terminated by Sponsor|1|||
170874868|NCT01449461|617551676|FG000|Overall Study|Withdrawal by Subject|0|||
170874869|NCT01449461|617551677|FG001|Overall Study|Withdrawal by Subject|1|||
170874870|NCT01449461|617551678|FG002|Overall Study|Withdrawal by Subject|0|||
170874871|NCT01449461|617551679|FG003|Overall Study|Withdrawal by Subject|0|||
170874872|NCT01449461|617551680|FG004|Overall Study|Withdrawal by Subject|2|||
170874873|NCT01449461|617551681|FG005|Overall Study|Withdrawal by Subject|1|||
170874874|NCT01449461|617551676|FG000|Overall Study|Reason not Specified|0|||
170874875|NCT01449461|617551677|FG001|Overall Study|Reason not Specified|1|||
170874876|NCT01449461|617551678|FG002|Overall Study|Reason not Specified|0|||
170874877|NCT01449461|617551679|FG003|Overall Study|Reason not Specified|3|||
170874878|NCT01449461|617551680|FG004|Overall Study|Reason not Specified|2|||
170874879|NCT01449461|617551681|FG005|Overall Study|Reason not Specified|1|||
170874880|NCT02269787|617551683|FG000|Overall Study|Lost to Follow-up|20|||
170874881|NCT02269787|617551684|FG001|Overall Study|Lost to Follow-up|6|||
170874882|NCT02269787|617551683|FG000|Overall Study|Death|2|||
170874883|NCT02269787|617551684|FG001|Overall Study|Death|3|||
170874884|NCT02269787|617551683|FG000|Overall Study|Incapacitated|0|||
170874885|NCT02269787|617551684|FG001|Overall Study|Incapacitated|1|||
170874886|NCT00798135|617551685|FG000|Overall Study|Disease progression, relapse|11|||
170874887|NCT00798135|617551685|FG000|Overall Study|Disease progression, refractory|1|||
170874888|NCT00798135|617551685|FG000|Overall Study|Physician Decision|1|||
170874889|NCT02228720|617551686|FG000|Open Label - Day 30|Lost to Follow-up|1|||
170874890|NCT01401842|617551687|FG000|Overall Study|Withdrawal by Subject|3|||
170874891|NCT01401842|617551688|FG001|Overall Study|Withdrawal by Subject|2|||
170874892|NCT01401842|617551687|FG000|Overall Study|academic reason|4|||
170874893|NCT01401842|617551688|FG001|Overall Study|academic reason|1|||
170874894|NCT01401842|617551687|FG000|Overall Study|changed companies|20|||
170874895|NCT01401842|617551688|FG001|Overall Study|changed companies|34|||
170874896|NCT01401842|617551687|FG000|Overall Study|discharged from US Army|3|||
170874897|NCT01401842|617551688|FG001|Overall Study|discharged from US Army|4|||
170874898|NCT01401842|617551687|FG000|Overall Study|invalid follow-up strength data|1|||
170874899|NCT01401842|617551688|FG001|Overall Study|invalid follow-up strength data|4|||
170874900|NCT01401842|617551687|FG000|Overall Study|on profile|9|||
170874901|NCT01401842|617551688|FG001|Overall Study|on profile|5|||
170874902|NCT01401842|617551687|FG000|Overall Study|other/unknown|28|||
170874903|NCT01401842|617551688|FG001|Overall Study|other/unknown|17|||
170874904|NCT06156215|617551689|FG000|Overall Study|Withdrawal by Subject|2|||
170874905|NCT06156215|617551690|FG001|Overall Study|Withdrawal by Subject|4|||
170874906|NCT06156215|617551691|FG002|Overall Study|Withdrawal by Subject|4|||
170874907|NCT06156215|617551692|FG003|Overall Study|Withdrawal by Subject|0|||
170874908|NCT06156215|617551693|FG004|Overall Study|Withdrawal by Subject|2|||
170874909|NCT06156215|617551694|FG005|Overall Study|Withdrawal by Subject|2|||
170874910|NCT06156215|617551689|FG000|Overall Study|Left ED without completing study|9|||
170874911|NCT06156215|617551690|FG001|Overall Study|Left ED without completing study|3|||
170874912|NCT06156215|617551691|FG002|Overall Study|Left ED without completing study|9|||
170874913|NCT06156215|617551692|FG003|Overall Study|Left ED without completing study|0|||
170874914|NCT06156215|617551693|FG004|Overall Study|Left ED without completing study|8|||
170874915|NCT06156215|617551694|FG005|Overall Study|Left ED without completing study|16|||
170874916|NCT06156215|617551689|FG000|Overall Study|Physician Decision|1|||
170874917|NCT06156215|617551690|FG001|Overall Study|Physician Decision|0|||
170874918|NCT06156215|617551691|FG002|Overall Study|Physician Decision|0|||
170874919|NCT06156215|617551692|FG003|Overall Study|Physician Decision|0|||
170874920|NCT06156215|617551693|FG004|Overall Study|Physician Decision|0|||
170632514|NCT01499355|616666691|FG003|Run-In Period|Investigator Decision|0|||
170774400|NCT02991807|617183127|FG001|Overall Study|Withdrawal by Subject|1|||
170774401|NCT02991807|617183126|FG000|Overall Study|Physician Decision|0|||
170774402|NCT02991807|617183127|FG001|Overall Study|Physician Decision|1|||
170774403|NCT02991807|617183126|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
170774404|NCT02991807|617183127|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
170774405|NCT02566902|617183128|FG000|Overall Study|Protocol Violation|2|||
170774406|NCT02566902|617183129|FG001|Overall Study|Protocol Violation|1|||
170774407|NCT01622868|617183130|FG000|Overall Study|Protocol Violation|7|||
170774408|NCT01622868|617183131|FG001|Overall Study|Protocol Violation|0|||
170774409|NCT03285763|617183132|FG000|Overall Study|Death|470|||
170774410|NCT03285763|617183132|FG000|Overall Study|Lost to Follow-up|18|||
170774411|NCT03285763|617183132|FG000|Overall Study|Physician Decision|2|||
170774412|NCT03285763|617183132|FG000|Overall Study|Study Terminated By Sponsor|79|||
170774413|NCT03285763|617183132|FG000|Overall Study|Withdrawal by Subject|33|||
170774414|NCT03624972|617183133|FG000|Overall Study|Lost to Follow-up|2|||
170774415|NCT03624972|617183134|FG001|Overall Study|Lost to Follow-up|0|||
170774416|NCT03624972|617183135|FG002|Overall Study|Lost to Follow-up|0|||
170774417|NCT03624972|617183133|FG000|Overall Study|Withdrawal by Subject|0|||
170774418|NCT03624972|617183134|FG001|Overall Study|Withdrawal by Subject|2|||
170774419|NCT03624972|617183135|FG002|Overall Study|Withdrawal by Subject|0|||
170774420|NCT00610649|617183138|FG000|Overall Study|Adverse Event|1|||
170774421|NCT00610649|617183139|FG001|Overall Study|Adverse Event|0|||
170774422|NCT00610649|617183140|FG002|Overall Study|Adverse Event|0|||
170774423|NCT00610649|617183141|FG003|Overall Study|Adverse Event|0|||
170774424|NCT00610649|617183142|FG004|Overall Study|Adverse Event|0|||
170774425|NCT00610649|617183143|FG005|Overall Study|Adverse Event|0|||
170774426|NCT00610649|617183144|FG006|Overall Study|Adverse Event|0|||
170774427|NCT00610649|617183145|FG007|Overall Study|Adverse Event|0|||
170774428|NCT00610649|617183146|FG008|Overall Study|Adverse Event|0|||
170774429|NCT00610649|617183147|FG009|Overall Study|Adverse Event|0|||
170774430|NCT00610649|617183148|FG010|Overall Study|Adverse Event|1|||
170774431|NCT00610649|617183138|FG000|Overall Study|Family Emergency|0|||
170774432|NCT00610649|617183139|FG001|Overall Study|Family Emergency|1|||
170774433|NCT00610649|617183140|FG002|Overall Study|Family Emergency|0|||
170774434|NCT00610649|617183141|FG003|Overall Study|Family Emergency|0|||
170774435|NCT00610649|617183142|FG004|Overall Study|Family Emergency|0|||
170774436|NCT00610649|617183143|FG005|Overall Study|Family Emergency|0|||
170774437|NCT00610649|617183144|FG006|Overall Study|Family Emergency|0|||
170774438|NCT00610649|617183145|FG007|Overall Study|Family Emergency|0|||
170774439|NCT00610649|617183146|FG008|Overall Study|Family Emergency|0|||
170774440|NCT00610649|617183147|FG009|Overall Study|Family Emergency|0|||
170774441|NCT00610649|617183148|FG010|Overall Study|Family Emergency|0|||
170774442|NCT00610649|617183138|FG000|Overall Study|Withdrawal by Subject|0|||
170774443|NCT00610649|617183139|FG001|Overall Study|Withdrawal by Subject|0|||
170774444|NCT00610649|617183140|FG002|Overall Study|Withdrawal by Subject|0|||
170774445|NCT00610649|617183141|FG003|Overall Study|Withdrawal by Subject|0|||
170774446|NCT00610649|617183142|FG004|Overall Study|Withdrawal by Subject|0|||
170774447|NCT00610649|617183143|FG005|Overall Study|Withdrawal by Subject|0|||
170774448|NCT00610649|617183144|FG006|Overall Study|Withdrawal by Subject|0|||
170774449|NCT00610649|617183145|FG007|Overall Study|Withdrawal by Subject|0|||
170774450|NCT00610649|617183146|FG008|Overall Study|Withdrawal by Subject|0|||
170774451|NCT00610649|617183147|FG009|Overall Study|Withdrawal by Subject|1|||
170774452|NCT00610649|617183148|FG010|Overall Study|Withdrawal by Subject|0|||
170774453|NCT04259450|617183152|FG000|Overall Study|Adverse event/ Toxicity|0|||
170774454|NCT04259450|617183153|FG001|Overall Study|Adverse event/ Toxicity|3|||
170774455|NCT04259450|617183154|FG002|Overall Study|Adverse event/ Toxicity|0|||
170774456|NCT04259450|617183155|FG003|Overall Study|Adverse event/ Toxicity|1|||
170774457|NCT04259450|617183156|FG004|Overall Study|Adverse event/ Toxicity|0|||
170774458|NCT04259450|617183157|FG005|Overall Study|Adverse event/ Toxicity|0|||
170774459|NCT04259450|617183158|FG006|Overall Study|Adverse event/ Toxicity|0|||
170774460|NCT04259450|617183159|FG007|Overall Study|Adverse event/ Toxicity|1|||
170774461|NCT04259450|617183160|FG008|Overall Study|Adverse event/ Toxicity|0|||
170774462|NCT04259450|617183161|FG009|Overall Study|Adverse event/ Toxicity|3|||
170774463|NCT04259450|617183152|FG000|Overall Study|Disease progression|2|||
170774464|NCT04259450|617183153|FG001|Overall Study|Disease progression|3|||
170774465|NCT04259450|617183154|FG002|Overall Study|Disease progression|4|||
170774466|NCT04259450|617183155|FG003|Overall Study|Disease progression|4|||
170774467|NCT04259450|617183156|FG004|Overall Study|Disease progression|6|||
170774468|NCT04259450|617183157|FG005|Overall Study|Disease progression|6|||
170774469|NCT04259450|617183158|FG006|Overall Study|Disease progression|6|||
170774470|NCT04259450|617183159|FG007|Overall Study|Disease progression|15|||
170774471|NCT04259450|617183160|FG008|Overall Study|Disease progression|6|||
170774472|NCT04259450|617183161|FG009|Overall Study|Disease progression|18|||
170774473|NCT04259450|617183152|FG000|Overall Study|Death|0|||
170774474|NCT04259450|617183153|FG001|Overall Study|Death|0|||
170774475|NCT04259450|617183154|FG002|Overall Study|Death|0|||
170774476|NCT04259450|617183155|FG003|Overall Study|Death|0|||
170774477|NCT04259450|617183156|FG004|Overall Study|Death|0|||
170774478|NCT04259450|617183157|FG005|Overall Study|Death|0|||
170774479|NCT04259450|617183158|FG006|Overall Study|Death|0|||
170774480|NCT04259450|617183159|FG007|Overall Study|Death|1|||
170774481|NCT04259450|617183160|FG008|Overall Study|Death|1|||
170774482|NCT04259450|617183161|FG009|Overall Study|Death|0|||
170774483|NCT04259450|617183152|FG000|Overall Study|Withdrawal by Subject|0|||
170774484|NCT04259450|617183153|FG001|Overall Study|Withdrawal by Subject|0|||
170774485|NCT04259450|617183154|FG002|Overall Study|Withdrawal by Subject|0|||
170774486|NCT04259450|617183155|FG003|Overall Study|Withdrawal by Subject|0|||
170774487|NCT04259450|617183156|FG004|Overall Study|Withdrawal by Subject|0|||
170774488|NCT04259450|617183157|FG005|Overall Study|Withdrawal by Subject|0|||
170774489|NCT04259450|617183158|FG006|Overall Study|Withdrawal by Subject|0|||
170774490|NCT04259450|617183159|FG007|Overall Study|Withdrawal by Subject|1|||
170774491|NCT04259450|617183160|FG008|Overall Study|Withdrawal by Subject|0|||
170774492|NCT04259450|617183161|FG009|Overall Study|Withdrawal by Subject|0|||
170774493|NCT04259450|617183152|FG000|Overall Study|Other than listed|0|||
170774494|NCT04259450|617183153|FG001|Overall Study|Other than listed|0|||
170774495|NCT04259450|617183154|FG002|Overall Study|Other than listed|0|||
170774496|NCT04259450|617183155|FG003|Overall Study|Other than listed|0|||
170774497|NCT04259450|617183156|FG004|Overall Study|Other than listed|0|||
170774498|NCT04259450|617183157|FG005|Overall Study|Other than listed|0|||
170774499|NCT04259450|617183158|FG006|Overall Study|Other than listed|0|||
170774500|NCT04259450|617183159|FG007|Overall Study|Other than listed|1|||
170774501|NCT04259450|617183160|FG008|Overall Study|Other than listed|1|||
170774502|NCT04259450|617183161|FG009|Overall Study|Other than listed|2|||
170774503|NCT00332241|617183162|FG000|Overall Study|Lack of Efficacy|6|||
170774504|NCT00332241|617183163|FG001|Overall Study|Lack of Efficacy|1|||
170774505|NCT00332241|617183162|FG000|Overall Study|Adverse Event|3|||
170774506|NCT00332241|617183163|FG001|Overall Study|Adverse Event|5|||
170774507|NCT00332241|617183162|FG000|Overall Study|Withdrawal by Subject|2|||
170774508|NCT00332241|617183163|FG001|Overall Study|Withdrawal by Subject|1|||
170774509|NCT00332241|617183162|FG000|Overall Study|Lost to Follow-up|4|||
170774510|NCT00332241|617183163|FG001|Overall Study|Lost to Follow-up|1|||
170774511|NCT00542789|617183164|FG000|Overall Study|Adverse Event|18|||
170774512|NCT00542789|617183165|FG001|Overall Study|Adverse Event|17|||
170774513|NCT00542789|617183164|FG000|Overall Study|Withdrawal by Subject|7|||
170774514|NCT00542789|617183165|FG001|Overall Study|Withdrawal by Subject|3|||
170774515|NCT00542789|617183164|FG000|Overall Study|Protocol Violation|8|||
170774516|NCT00542789|617183165|FG001|Overall Study|Protocol Violation|1|||
170774517|NCT00542789|617183164|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
170774518|NCT00542789|617183165|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
170774519|NCT02584829|617183167|FG000|Overall Study|Physician Decision|1|||
170774520|NCT02584829|617183168|FG001|Overall Study|Physician Decision|0|||
170774521|NCT02584829|617183167|FG000|Overall Study|Withdrawal by Subject|0|||
170774522|NCT02584829|617183168|FG001|Overall Study|Withdrawal by Subject|1|||
170774523|NCT02584829|617183167|FG000|Overall Study|Progressive Disease|0|||
170774524|NCT02584829|617183168|FG001|Overall Study|Progressive Disease|3|||
170774525|NCT02374463|617183170|FG000|Overall Study|Withdrawal by Subject|3|||
170874921|NCT06156215|617551694|FG005|Overall Study|Physician Decision|0|||
170874922|NCT06156215|617551689|FG000|Overall Study|Became or found ineligible|2|||
170874923|NCT06156215|617551690|FG001|Overall Study|Became or found ineligible|0|||
170874924|NCT06156215|617551691|FG002|Overall Study|Became or found ineligible|2|||
170874925|NCT06156215|617551692|FG003|Overall Study|Became or found ineligible|0|||
170874926|NCT06156215|617551693|FG004|Overall Study|Became or found ineligible|1|||
170874927|NCT06156215|617551694|FG005|Overall Study|Became or found ineligible|2|||
170874928|NCT02982954|617552741|FG000|Overall Study|Death|55|||
170874929|NCT02982954|617552742|FG001|Overall Study|Death|29|||
170874930|NCT02982954|617552743|FG002|Overall Study|Death|15|||
170874931|NCT02982954|617552744|FG003|Overall Study|Death|20|||
170874932|NCT02982954|617552741|FG000|Overall Study|Lost to Follow-up|2|||
170874933|NCT02982954|617552742|FG001|Overall Study|Lost to Follow-up|1|||
170874934|NCT02982954|617552743|FG002|Overall Study|Lost to Follow-up|0|||
170874935|NCT02982954|617552744|FG003|Overall Study|Lost to Follow-up|0|||
170774526|NCT02374463|617183171|FG001|Overall Study|Withdrawal by Subject|3|||
170774527|NCT00446459|617183173|FG000|8 Months|Protocol Violation|12|||
170774528|NCT00446459|617183173|FG000|12 Months|Protocol Violation|4|||
170774529|NCT00446459|617183173|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
170774530|NCT00858117|617183177|FG000|Treatment on Study|Adverse Event|2|||
170774531|NCT00858117|617183177|FG000|Follow up for 5 Years|Death|4|||
170874936|NCT02982954|617552741|FG000|Overall Study|Participant withdrew consent|7|||
170774532|NCT00858117|617183177|FG000|Follow up for 5 Years|No further data collected for study|9|||
170774533|NCT04759833|617183179|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
170774534|NCT04759833|617183180|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
170774535|NCT04759833|617183181|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
170874937|NCT02982954|617552742|FG001|Overall Study|Participant withdrew consent|5|||
170774536|NCT04759833|617183182|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
170774537|NCT04759833|617183183|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
170774538|NCT04759833|617183179|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
170774539|NCT04759833|617183180|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
170774540|NCT04759833|617183181|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
170774541|NCT04759833|617183182|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
170774542|NCT04759833|617183183|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
170774543|NCT04759833|617183179|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
170774544|NCT04759833|617183180|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
170774545|NCT04759833|617183181|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
170774546|NCT04759833|617183182|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
170774547|NCT04759833|617183183|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
170774548|NCT04759833|617183179|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
170774549|NCT04759833|617183180|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
170774550|NCT04759833|617183181|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
170774551|NCT04759833|617183182|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
170774552|NCT04759833|617183183|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
170774553|NCT04759833|617183179|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
170774554|NCT04759833|617183180|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
170774555|NCT04759833|617183181|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
170774556|NCT04759833|617183182|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
170774557|NCT04759833|617183183|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
170774558|NCT04759833|617183179|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
170774559|NCT04759833|617183180|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
170774560|NCT04759833|617183181|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
170774561|NCT04759833|617183182|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
170774562|NCT04759833|617183183|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
170774563|NCT04759833|617183179|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
170774564|NCT04759833|617183180|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
170774565|NCT04759833|617183181|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
170774566|NCT04759833|617183182|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
170774567|NCT04759833|617183183|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
170774568|NCT04759833|617183179|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
170774569|NCT04759833|617183180|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
170774570|NCT04759833|617183181|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
170774571|NCT04759833|617183182|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
170774572|NCT04759833|617183183|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
170774573|NCT04759833|617183179|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
170774574|NCT04759833|617183180|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
170774575|NCT04759833|617183181|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
170774576|NCT04759833|617183182|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
170774577|NCT04759833|617183183|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
170774578|NCT04759833|617183179|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
170774579|NCT04759833|617183180|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
170774580|NCT04759833|617183181|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
170774581|NCT04759833|617183182|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
170774582|NCT04759833|617183183|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
170774583|NCT04759833|617183179|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
170774584|NCT04759833|617183180|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
170774585|NCT04759833|617183181|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
170774586|NCT04759833|617183182|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
170774587|NCT04759833|617183183|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
170774588|NCT04759833|617183179|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
170774589|NCT04759833|617183180|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
170774590|NCT04759833|617183181|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
170774591|NCT04759833|617183182|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
170774592|NCT04759833|617183183|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
170774593|NCT04759833|617183179|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
170774594|NCT04759833|617183180|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
170774595|NCT04759833|617183181|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
170774596|NCT04759833|617183182|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
170774597|NCT04759833|617183183|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
170774598|NCT00508924|617183184|FG000|Overall Study|Protocol Violation|0|||
170774599|NCT00508924|617183185|FG001|Overall Study|Protocol Violation|0|||
170774600|NCT00508924|617183186|FG002|Overall Study|Protocol Violation|1|||
170774601|NCT00508924|617183187|FG003|Overall Study|Protocol Violation|1|||
170774602|NCT00630058|617183189|FG000|Overall Study|Adverse Event|1|||
170774603|NCT00630058|617183190|FG001|Overall Study|Adverse Event|1|||
170774604|NCT00630058|617183189|FG000|Overall Study|Withdrawal by Subject|0|||
170774605|NCT00630058|617183190|FG001|Overall Study|Withdrawal by Subject|1|||
170774606|NCT00630058|617183189|FG000|Overall Study|stopping criteria|3|||
170774607|NCT00630058|617183190|FG001|Overall Study|stopping criteria|2|||
170774608|NCT05132478|617183193|FG000|Overall Study|did not complete survey after consent|1|||
170774609|NCT05132478|617183194|FG001|Overall Study|did not complete survey after consent|1|||
170774610|NCT05132478|617183193|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
170774611|NCT05132478|617183194|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
170774612|NCT00421889|617183195|FG000|Overall Study|Adverse Event|1|||
170774613|NCT00421889|617183196|FG001|Overall Study|Adverse Event|0|||
170774614|NCT00421889|617183197|FG002|Overall Study|Adverse Event|1|||
170774615|NCT00421889|617183198|FG003|Overall Study|Adverse Event|1|||
170774616|NCT00421889|617183199|FG004|Overall Study|Adverse Event|1|||
170774617|NCT00421889|617183200|FG005|Overall Study|Adverse Event|4|||
170774618|NCT00421889|617183201|FG006|Overall Study|Adverse Event|1|||
170774619|NCT00421889|617183202|FG007|Overall Study|Adverse Event|0|||
170774620|NCT00421889|617183203|FG008|Overall Study|Adverse Event|2|||
170774621|NCT00421889|617183195|FG000|Overall Study|Withdrawal by Subject|1|||
170774622|NCT00421889|617183196|FG001|Overall Study|Withdrawal by Subject|3|||
170774623|NCT00421889|617183197|FG002|Overall Study|Withdrawal by Subject|0|||
170774624|NCT00421889|617183198|FG003|Overall Study|Withdrawal by Subject|0|||
170774625|NCT00421889|617183199|FG004|Overall Study|Withdrawal by Subject|2|||
170774626|NCT00421889|617183200|FG005|Overall Study|Withdrawal by Subject|0|||
170774627|NCT00421889|617183201|FG006|Overall Study|Withdrawal by Subject|0|||
170774628|NCT00421889|617183202|FG007|Overall Study|Withdrawal by Subject|0|||
170774629|NCT00421889|617183203|FG008|Overall Study|Withdrawal by Subject|0|||
170774630|NCT00421889|617183195|FG000|Overall Study|Death|0|||
170774631|NCT00421889|617183196|FG001|Overall Study|Death|0|||
170774632|NCT00421889|617183197|FG002|Overall Study|Death|0|||
170774633|NCT00421889|617183198|FG003|Overall Study|Death|0|||
170774634|NCT00421889|617183199|FG004|Overall Study|Death|1|||
170774635|NCT00421889|617183200|FG005|Overall Study|Death|1|||
170774636|NCT00421889|617183201|FG006|Overall Study|Death|0|||
170774637|NCT00421889|617183202|FG007|Overall Study|Death|0|||
170774638|NCT00421889|617183203|FG008|Overall Study|Death|0|||
170774639|NCT00421889|617183195|FG000|Overall Study|Progressive disease|3|||
170774640|NCT00421889|617183196|FG001|Overall Study|Progressive disease|2|||
170774641|NCT00421889|617183197|FG002|Overall Study|Progressive disease|2|||
170774642|NCT00421889|617183198|FG003|Overall Study|Progressive disease|3|||
170774643|NCT00421889|617183199|FG004|Overall Study|Progressive disease|2|||
170774644|NCT00421889|617183200|FG005|Overall Study|Progressive disease|21|||
170774645|NCT00421889|617183201|FG006|Overall Study|Progressive disease|3|||
170774646|NCT00421889|617183202|FG007|Overall Study|Progressive disease|1|||
170774647|NCT00421889|617183203|FG008|Overall Study|Progressive disease|5|||
170774648|NCT00421889|617183195|FG000|Overall Study|Patient/Investigator request|0|||
170774649|NCT00421889|617183196|FG001|Overall Study|Patient/Investigator request|0|||
170774650|NCT00421889|617183197|FG002|Overall Study|Patient/Investigator request|0|||
170774651|NCT00421889|617183198|FG003|Overall Study|Patient/Investigator request|0|||
170774652|NCT00421889|617183199|FG004|Overall Study|Patient/Investigator request|0|||
170774653|NCT00421889|617183200|FG005|Overall Study|Patient/Investigator request|9|||
170774654|NCT00421889|617183201|FG006|Overall Study|Patient/Investigator request|0|||
170774655|NCT00421889|617183202|FG007|Overall Study|Patient/Investigator request|1|||
170774656|NCT00421889|617183203|FG008|Overall Study|Patient/Investigator request|3|||
170774657|NCT00421889|617183195|FG000|Overall Study|Lost to Follow-up|0|||
170774658|NCT00421889|617183196|FG001|Overall Study|Lost to Follow-up|0|||
170774659|NCT00421889|617183197|FG002|Overall Study|Lost to Follow-up|0|||
170774660|NCT00421889|617183198|FG003|Overall Study|Lost to Follow-up|0|||
170774661|NCT00421889|617183199|FG004|Overall Study|Lost to Follow-up|0|||
170774662|NCT00421889|617183200|FG005|Overall Study|Lost to Follow-up|0|||
170774663|NCT00421889|617183201|FG006|Overall Study|Lost to Follow-up|0|||
170774664|NCT00421889|617183202|FG007|Overall Study|Lost to Follow-up|0|||
170774665|NCT00421889|617183203|FG008|Overall Study|Lost to Follow-up|1|||
170774666|NCT00111813|617183204|FG000|Overall Study|Adverse Event|1|||
170874938|NCT02982954|617552743|FG002|Overall Study|Participant withdrew consent|1|||
170774667|NCT00111813|617183205|FG001|Overall Study|Adverse Event|2|||
170774668|NCT00111813|617183206|FG002|Overall Study|Adverse Event|4|||
170774669|NCT00111813|617183207|FG003|Overall Study|Adverse Event|2|||
170774670|NCT00111813|617183208|FG004|Overall Study|Adverse Event|2|||
170774671|NCT00111813|617183209|FG005|Overall Study|Adverse Event|2|||
170774672|NCT00111813|617183204|FG000|Overall Study|Progressive disease|2|||
170774673|NCT00111813|617183205|FG001|Overall Study|Progressive disease|1|||
170774674|NCT00111813|617183206|FG002|Overall Study|Progressive disease|5|||
170874939|NCT02982954|617552744|FG003|Overall Study|Participant withdrew consent|1|||
170874940|NCT02982954|617552741|FG000|Overall Study|Other reasons|42|||
170874941|NCT02982954|617552742|FG001|Overall Study|Other reasons|17|||
170874942|NCT02982954|617552743|FG002|Overall Study|Other reasons|12|||
170874943|NCT02982954|617552744|FG003|Overall Study|Other reasons|3|||
170874944|NCT02982954|617552741|FG000|Overall Study|Premature site closure|0|||
170874945|NCT02982954|617552742|FG001|Overall Study|Premature site closure|0|||
170874946|NCT02982954|617552743|FG002|Overall Study|Premature site closure|0|||
170874947|NCT02982954|617552744|FG003|Overall Study|Premature site closure|1|||
170874948|NCT03668600|617552751|FG000|Overall Study|Study Terminated by the Sponsor|157|||
170874949|NCT03668600|617552751|FG000|Overall Study|Protocol Violation|1|||
170874950|NCT03668600|617552751|FG000|Overall Study|Pregnancy|1|||
170874951|NCT03668600|617552751|FG000|Overall Study|Lost to Follow-up|7|||
170874952|NCT03668600|617552751|FG000|Overall Study|Withdrawal by Subject|56|||
170874953|NCT03668600|617552751|FG000|Overall Study|Lack of Efficacy|7|||
170874954|NCT03668600|617552751|FG000|Overall Study|Adverse Event|1|||
170874955|NCT01263483|617552753|FG000|Overall Study|Adverse Event|4|||
170874956|NCT01263483|617552754|FG001|Overall Study|Adverse Event|0|||
170874957|NCT01263483|617552755|FG002|Overall Study|Adverse Event|3|||
170874958|NCT01263483|617552753|FG000|Overall Study|Withdrawal by Subject|1|||
170874959|NCT01263483|617552754|FG001|Overall Study|Withdrawal by Subject|0|||
170874960|NCT01263483|617552755|FG002|Overall Study|Withdrawal by Subject|0|||
170874961|NCT01263483|617552753|FG000|Overall Study|Lack of Efficacy|2|||
170874962|NCT01263483|617552754|FG001|Overall Study|Lack of Efficacy|0|||
170874963|NCT01263483|617552755|FG002|Overall Study|Lack of Efficacy|0|||
170874964|NCT01263483|617552753|FG000|Overall Study|Protocol Violation|0|||
170874965|NCT01263483|617552754|FG001|Overall Study|Protocol Violation|1|||
170874966|NCT01263483|617552755|FG002|Overall Study|Protocol Violation|1|||
170874967|NCT01263483|617552753|FG000|Overall Study|Participant Unavailability|0|||
170874968|NCT01263483|617552754|FG001|Overall Study|Participant Unavailability|1|||
170874969|NCT01263483|617552755|FG002|Overall Study|Participant Unavailability|1|||
170874970|NCT02577406|617552759|FG000|Randomized Period|Death|1|||
170874971|NCT02577406|617552760|FG001|Randomized Period|Death|0|||
170874972|NCT02577406|617552759|FG000|Randomized Period|Other reasons|0|||
170874973|NCT02577406|617552760|FG001|Randomized Period|Other reasons|20|||
170874974|NCT02577406|617552759|FG000|Treatment Period|Death|38|||
170874975|NCT02577406|617552760|FG001|Treatment Period|Death|23|||
170874976|NCT02577406|617552759|FG000|Treatment Period|Adverse Event|17|||
170874977|NCT02577406|617552760|FG001|Treatment Period|Adverse Event|12|||
170874978|NCT02577406|617552759|FG000|Treatment Period|Progressive Disease|53|||
170874979|NCT02577406|617552760|FG001|Treatment Period|Progressive Disease|37|||
170874980|NCT02577406|617552759|FG000|Treatment Period|Withdrawal by Subject|10|||
170874981|NCT02577406|617552760|FG001|Treatment Period|Withdrawal by Subject|24|||
170874982|NCT02577406|617552759|FG000|Treatment Period|Lost to Follow-up|0|||
170874983|NCT02577406|617552760|FG001|Treatment Period|Lost to Follow-up|1|||
170874984|NCT02577406|617552759|FG000|Treatment Period|Transition to commercially available treatment|1|||
170874985|NCT02577406|617552760|FG001|Treatment Period|Transition to commercially available treatment|1|||
170874986|NCT02577406|617552759|FG000|Treatment Period|Physician Decision|1|||
170874987|NCT02577406|617552760|FG001|Treatment Period|Physician Decision|0|||
170874988|NCT02577406|617552759|FG000|Treatment Period|Disease Relapse|28|||
170874989|NCT02577406|617552760|FG001|Treatment Period|Disease Relapse|1|||
170874990|NCT02577406|617552759|FG000|Treatment Period|Protocol Violation|0|||
170874991|NCT02577406|617552760|FG001|Treatment Period|Protocol Violation|1|||
170874992|NCT02577406|617552759|FG000|Treatment Period|Other Reasons|3|||
170874993|NCT02577406|617552760|FG001|Treatment Period|Other Reasons|39|||
170874994|NCT02577406|617552759|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
170874995|NCT02577406|617552760|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
170874996|NCT02566577|617552761|FG000|Overall Study|Withdrawal by Subject|1|||
170874997|NCT02566577|617552762|FG001|Overall Study|Withdrawal by Subject|1|||
170874998|NCT02566577|617552761|FG000|Overall Study|Equipment failure|1|||
170874999|NCT02566577|617552762|FG001|Overall Study|Equipment failure|1|||
170875000|NCT02566577|617552761|FG000|Overall Study|Physical limitation|1|||
170875001|NCT02566577|617552762|FG001|Overall Study|Physical limitation|0|||
170875002|NCT04206605|617552767|FG000|Overall Study|Adverse Event|0|||
170875003|NCT04206605|617552768|FG001|Overall Study|Adverse Event|1|||
170875004|NCT04206605|617552767|FG000|Overall Study|Withdrawal by Subject|1|||
170875005|NCT04206605|617552768|FG001|Overall Study|Withdrawal by Subject|0|||
170875006|NCT03418129|617552775|FG000|Overall Study|Lost to Follow-up|11|||
170875007|NCT03418129|617552776|FG001|Overall Study|Lost to Follow-up|20|||
170875008|NCT03418129|617552777|FG002|Overall Study|Lost to Follow-up|15|||
170526388|NCT03217591|616275448|FG000|Overall Study|Withdrawal by Subject|0|||
170875009|NCT03418129|617552775|FG000|Overall Study|Withdrawal by Subject|3|||
170875010|NCT03418129|617552776|FG001|Overall Study|Withdrawal by Subject|6|||
170875011|NCT03418129|617552777|FG002|Overall Study|Withdrawal by Subject|4|||
170875012|NCT04810689|617552781|FG000|Overall Study|Withdrawal by Subject|0|||
170875013|NCT04810689|617552782|FG001|Overall Study|Withdrawal by Subject|1|||
170875014|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
170875015|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
170875016|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
170875017|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
170875018|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
170875019|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
170875020|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
170875021|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
170875022|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
170875023|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
170875024|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
170875025|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
170875026|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
170875027|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
170875028|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
170875029|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
170875030|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
170875031|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
170875032|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
170875033|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
170875034|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
170774675|NCT00111813|617183207|FG003|Overall Study|Progressive disease|3|||
170774676|NCT00111813|617183208|FG004|Overall Study|Progressive disease|4|||
170774677|NCT00111813|617183209|FG005|Overall Study|Progressive disease|3|||
170774678|NCT00111813|617183204|FG000|Overall Study|Lack of Efficacy|0|||
170774679|NCT00111813|617183205|FG001|Overall Study|Lack of Efficacy|0|||
170774680|NCT00111813|617183206|FG002|Overall Study|Lack of Efficacy|0|||
170774681|NCT00111813|617183207|FG003|Overall Study|Lack of Efficacy|0|||
170774682|NCT00111813|617183208|FG004|Overall Study|Lack of Efficacy|0|||
170774683|NCT00111813|617183209|FG005|Overall Study|Lack of Efficacy|1|||
170774684|NCT00111813|617183204|FG000|Overall Study|Other|0|||
170774685|NCT00111813|617183205|FG001|Overall Study|Other|0|||
170774686|NCT00111813|617183206|FG002|Overall Study|Other|1|||
170774687|NCT00111813|617183207|FG003|Overall Study|Other|0|||
170774688|NCT00111813|617183208|FG004|Overall Study|Other|0|||
170774689|NCT00111813|617183209|FG005|Overall Study|Other|0|||
170774690|NCT03051165|617183210|FG000|Overall Study|Withdrawal by Subject|1|||
170774691|NCT03051165|617183210|FG000|Overall Study|Early termination of study|12|||
170774692|NCT00761605|617183211|FG000|Overall Study|Adverse Event|26|||
170774693|NCT00761605|617183211|FG000|Overall Study|Death|2|||
170774694|NCT00761605|617183211|FG000|Overall Study|Lack of Efficacy|26|||
170774695|NCT00761605|617183211|FG000|Overall Study|Lost to Follow-up|29|||
170774696|NCT00761605|617183211|FG000|Overall Study|Withdrawal by Subject|37|||
170774697|NCT00761605|617183211|FG000|Overall Study|Other|21|||
170774698|NCT03074331|617183212|FG000|Overall Study|Enrolled but Not Treated|1|||
170774699|NCT03074331|617183212|FG000|Overall Study|Lost to Follow-up|5|||
170774700|NCT03074331|617183212|FG000|Overall Study|Withdrew Consent|1|||
170774701|NCT00350792|617183214|FG000|Overall Study|Adverse Event|11|||
170774702|NCT00350792|617183214|FG000|Overall Study|Death from Study Disease|1|||
170774703|NCT00350792|617183214|FG000|Overall Study|Death from Study Drug Toxicity|1|||
170774704|NCT00350792|617183214|FG000|Overall Study|Death Not Study Drug Related|2|||
170774705|NCT00350792|617183214|FG000|Overall Study|Protocol Violation|1|||
170774706|NCT00350792|617183214|FG000|Overall Study|Withdrawal by Subject|4|||
170774707|NCT00350792|617183214|FG000|Overall Study|Physician Decision|2|||
170774708|NCT00350792|617183214|FG000|Overall Study|Lack of Efficacy|11|||
170774709|NCT00174382|617183215|FG000|Overall Study|Death|2|||
170774710|NCT00174382|617183215|FG000|Overall Study|Adverse Event|19|||
170774711|NCT00174382|617183215|FG000|Overall Study|Withdrawal by Subject|6|||
170774712|NCT00174382|617183215|FG000|Overall Study|Protocol Violation|3|||
170774713|NCT00174382|617183215|FG000|Overall Study|Arrived early for last visit in error|1|||
170774714|NCT00174382|617183215|FG000|Overall Study|Subject felt pill not effective enough|1|||
170774715|NCT00174382|617183215|FG000|Overall Study|Lost to Follow-up|1|||
170774716|NCT00785512|617183218|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
170774717|NCT00785512|617183219|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
170774718|NCT00785512|617183218|FG000|Overall Study|Adverse Event|0|||
170774719|NCT00785512|617183219|FG001|Overall Study|Adverse Event|0|||
170774720|NCT00785512|617183218|FG000|Overall Study|Lack of Efficacy|0|||
170774721|NCT00785512|617183219|FG001|Overall Study|Lack of Efficacy|2|||
170774722|NCT00785512|617183218|FG000|Overall Study|Withdrawal by Subject|0|||
170774723|NCT00785512|617183219|FG001|Overall Study|Withdrawal by Subject|1|||
170774724|NCT00785512|617183218|FG000|Overall Study|Lost to Follow-up|3|||
170774725|NCT00785512|617183219|FG001|Overall Study|Lost to Follow-up|0|||
170774726|NCT00785512|617183218|FG000|Overall Study|Precedure Refused|0|||
170774727|NCT00785512|617183219|FG001|Overall Study|Precedure Refused|0|||
170774728|NCT00785512|617183218|FG000|Overall Study|IVRS Programing Error|0|||
170774729|NCT00785512|617183219|FG001|Overall Study|IVRS Programing Error|0|||
170774730|NCT00785512|617183218|FG000|Overall Study|Physician Decision|0|||
170875035|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
170875036|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
170875037|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
170875038|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Death|2|||
170875039|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Death|1|||
170875040|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Death|0|||
170875041|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Death|0|||
170875042|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
170875043|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
170875044|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
170875045|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
170875046|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
170875047|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
170875048|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
170875049|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
170875050|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
170875051|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
170875052|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
170875053|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
170875054|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
170875055|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
170875056|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
170875057|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
170875058|NCT01940471|617552783|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
170875059|NCT01940471|617552784|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
170774731|NCT00785512|617183219|FG001|Overall Study|Physician Decision|0|||
170774732|NCT00785512|617183218|FG000|Overall Study|Lack of compliance|0|||
170774733|NCT00785512|617183219|FG001|Overall Study|Lack of compliance|1|||
170774734|NCT03684044|617183224|FG000|Overall Study|Adverse Event|3|||
170774735|NCT03684044|617183225|FG001|Overall Study|Adverse Event|0|||
170774736|NCT03684044|617183224|FG000|Overall Study|Death|4|||
170774737|NCT03684044|617183225|FG001|Overall Study|Death|7|||
170774738|NCT03684044|617183224|FG000|Overall Study|Lost to Follow-up|3|||
170774739|NCT03684044|617183225|FG001|Overall Study|Lost to Follow-up|2|||
170774740|NCT03684044|617183224|FG000|Overall Study|Patient Not Available|0|||
170774741|NCT03684044|617183225|FG001|Overall Study|Patient Not Available|2|||
170774742|NCT03684044|617183224|FG000|Overall Study|Physician Decision|1|||
170774743|NCT03684044|617183225|FG001|Overall Study|Physician Decision|0|||
170774744|NCT03684044|617183224|FG000|Overall Study|Withdrawal by Subject|11|||
170774745|NCT03684044|617183225|FG001|Overall Study|Withdrawal by Subject|9|||
170774746|NCT03703336|617183226|FG000|Overall Study|Parent withdrew consent|29|||
170774747|NCT03703336|617183227|FG001|Overall Study|Parent withdrew consent|8|||
170774748|NCT03703336|617183226|FG000|Overall Study|Migration|3|||
170774749|NCT03703336|617183227|FG001|Overall Study|Migration|3|||
170774750|NCT03703336|617183226|FG000|Overall Study|Protocol Violation|3|||
170774751|NCT03703336|617183227|FG001|Overall Study|Protocol Violation|1|||
170774752|NCT03703336|617183226|FG000|Overall Study|Physician Decision|2|||
170774753|NCT03703336|617183227|FG001|Overall Study|Physician Decision|0|||
170774754|NCT03703336|617183226|FG000|Overall Study|Adverse Event|0|||
170774755|NCT03703336|617183227|FG001|Overall Study|Adverse Event|2|||
170774756|NCT03703336|617183226|FG000|Overall Study|Lost to Follow-up|1|||
170774757|NCT03703336|617183227|FG001|Overall Study|Lost to Follow-up|0|||
170774758|NCT00595413|617183228|FG000|Overall Study|Adverse Event|0|||
170774759|NCT00595413|617183229|FG001|Overall Study|Adverse Event|2|||
170774760|NCT00595413|617183230|FG002|Overall Study|Adverse Event|1|||
170774761|NCT00595413|617183231|FG003|Overall Study|Adverse Event|1|||
170774762|NCT00595413|617183228|FG000|Overall Study|Lost to Follow-up|2|||
170774763|NCT00595413|617183229|FG001|Overall Study|Lost to Follow-up|2|||
170774764|NCT00595413|617183230|FG002|Overall Study|Lost to Follow-up|1|||
170774765|NCT00595413|617183231|FG003|Overall Study|Lost to Follow-up|3|||
170774766|NCT00595413|617183228|FG000|Overall Study|Death|0|||
170774767|NCT00595413|617183229|FG001|Overall Study|Death|0|||
170875060|NCT01940471|617552785|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
170774768|NCT00595413|617183230|FG002|Overall Study|Death|1|||
170774769|NCT00595413|617183231|FG003|Overall Study|Death|0|||
170774770|NCT00595413|617183228|FG000|Overall Study|Other|5|||
170774771|NCT00595413|617183229|FG001|Overall Study|Other|1|||
170774772|NCT00595413|617183230|FG002|Overall Study|Other|5|||
170774773|NCT00595413|617183231|FG003|Overall Study|Other|0|||
170774774|NCT04629950|617183234|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
170774775|NCT04629950|617183235|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
170875061|NCT01940471|617552786|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
170774776|NCT04629950|617183236|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
170774777|NCT04629950|617183237|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
170774778|NCT04629950|617183234|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
170774779|NCT04629950|617183235|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
170774780|NCT04629950|617183236|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
170774781|NCT04629950|617183237|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
170774782|NCT04629950|617183234|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
170774783|NCT04629950|617183235|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
170774784|NCT04629950|617183236|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
170774785|NCT04629950|617183237|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
170774786|NCT04629950|617183234|FG000|Extension Study|Withdrawal by Subject|0|||
170774787|NCT04629950|617183235|FG001|Extension Study|Withdrawal by Subject|0|||
170774788|NCT04629950|617183236|FG002|Extension Study|Withdrawal by Subject|1|||
170774789|NCT04629950|617183237|FG003|Extension Study|Withdrawal by Subject|0|||
170774790|NCT04629950|617183234|FG000|Extension Study|Adverse Event|0|||
170774791|NCT04629950|617183235|FG001|Extension Study|Adverse Event|0|||
170774792|NCT04629950|617183236|FG002|Extension Study|Adverse Event|0|||
170774793|NCT04629950|617183237|FG003|Extension Study|Adverse Event|1|||
170774794|NCT03233633|617183238|FG000|Overall Study|Adverse Event|2|||
170774795|NCT03233633|617183238|FG000|Overall Study|Less Than 3 Days of Data|6|||
170774796|NCT05061693|617183239|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
170774797|NCT05061693|617183240|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
170774798|NCT05061693|617183241|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
170774799|NCT05061693|617183242|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774800|NCT05061693|617183243|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774801|NCT05061693|617183244|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774802|NCT05061693|617183245|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774803|NCT05061693|617183246|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774804|NCT05061693|617183247|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774805|NCT05061693|617183248|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774806|NCT05061693|617183249|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774807|NCT05061693|617183250|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
170774808|NCT05061693|617183239|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
170774809|NCT05061693|617183240|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
170774810|NCT05061693|617183241|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
170774811|NCT05061693|617183242|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
170774812|NCT05061693|617183243|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
170774813|NCT05061693|617183244|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
170774814|NCT05061693|617183245|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
170774815|NCT05061693|617183246|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
170774816|NCT05061693|617183247|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
170774817|NCT05061693|617183248|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
170774818|NCT05061693|617183249|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
170774819|NCT05061693|617183250|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
170774820|NCT05061693|617183239|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
170774821|NCT05061693|617183240|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774822|NCT05061693|617183241|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774823|NCT05061693|617183242|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774824|NCT05061693|617183243|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774825|NCT05061693|617183244|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774826|NCT05061693|617183245|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774827|NCT05061693|617183246|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774828|NCT05061693|617183247|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774829|NCT05061693|617183248|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774830|NCT05061693|617183249|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774831|NCT05061693|617183250|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
170774832|NCT05061693|617183239|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774833|NCT05061693|617183240|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774834|NCT05061693|617183241|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
170774835|NCT05061693|617183242|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774836|NCT05061693|617183243|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774837|NCT05061693|617183244|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170875062|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
170875063|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
170774838|NCT05061693|617183245|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774839|NCT05061693|617183246|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774840|NCT05061693|617183247|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774841|NCT05061693|617183248|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774842|NCT05061693|617183249|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170875064|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
170774843|NCT05061693|617183250|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
170774844|NCT05061693|617183239|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
170875065|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
170875066|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
170875067|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
170875068|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
170875069|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
170875070|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
170875071|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
170875072|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
170875073|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
170875074|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
170875075|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
170875076|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
170875077|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
170875078|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
170875079|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
170875080|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
170875081|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
170875082|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
170875083|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
170875084|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
170875085|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
170875086|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
170875087|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
170875088|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
170774845|NCT05061693|617183240|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
170774846|NCT05061693|617183241|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
170774847|NCT05061693|617183242|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
170774848|NCT05061693|617183243|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
170774849|NCT05061693|617183244|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
170774850|NCT05061693|617183245|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
170774851|NCT05061693|617183246|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
170774852|NCT05061693|617183247|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
170774853|NCT05061693|617183248|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
170774854|NCT05061693|617183249|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
170774855|NCT05061693|617183250|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
170774856|NCT05061693|617183239|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
170774857|NCT05061693|617183240|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
170774858|NCT05061693|617183241|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
170774859|NCT05061693|617183242|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
170774860|NCT05061693|617183243|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
170774861|NCT05061693|617183244|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
170774862|NCT05061693|617183245|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
170774863|NCT05061693|617183246|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
170774864|NCT05061693|617183247|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
170774865|NCT05061693|617183248|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
170774866|NCT05061693|617183249|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
170774867|NCT05061693|617183250|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
170774868|NCT05061693|617183239|FG000|24-week Extension Period|Adverse Event|0|||
170774869|NCT05061693|617183240|FG001|24-week Extension Period|Adverse Event|0|||
170774870|NCT05061693|617183241|FG002|24-week Extension Period|Adverse Event|0|||
170774871|NCT05061693|617183242|FG003|24-week Extension Period|Adverse Event|0|||
170774872|NCT05061693|617183243|FG004|24-week Extension Period|Adverse Event|0|||
170774873|NCT05061693|617183244|FG005|24-week Extension Period|Adverse Event|0|||
170774874|NCT05061693|617183245|FG006|24-week Extension Period|Adverse Event|0|||
170774875|NCT05061693|617183246|FG007|24-week Extension Period|Adverse Event|2|||
170774876|NCT05061693|617183247|FG008|24-week Extension Period|Adverse Event|2|||
170774877|NCT05061693|617183248|FG009|24-week Extension Period|Adverse Event|0|||
170774878|NCT05061693|617183249|FG010|24-week Extension Period|Adverse Event|1|||
170774879|NCT05061693|617183250|FG011|24-week Extension Period|Adverse Event|3|||
170526389|NCT03217591|616275449|FG001|Overall Study|Withdrawal by Subject|1|||
170526390|NCT03217591|616275450|FG002|Overall Study|Withdrawal by Subject|3|||
170526391|NCT03217591|616275448|FG000|Overall Study|Lost to Follow-up|1|||
170875089|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
170875090|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
170875091|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
170875092|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
170875093|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
170875094|NCT01940471|617552783|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
170875095|NCT01940471|617552784|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
170875096|NCT01940471|617552785|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
170875097|NCT01940471|617552786|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
170875098|NCT01536951|617552787|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
170875099|NCT01536951|617552788|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
170875100|NCT01536951|617552789|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
170875101|NCT01536951|617552790|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
170875102|NCT01536951|617552791|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
170875103|NCT01536951|617552792|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
170875104|NCT01536951|617552793|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
170875105|NCT01536951|617552794|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
170875106|NCT01536951|617552795|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
170875107|NCT01536951|617552787|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
170875108|NCT01536951|617552788|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
170875109|NCT01536951|617552789|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
170875110|NCT01536951|617552790|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
170875111|NCT01536951|617552791|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
170875112|NCT01536951|617552792|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
170875113|NCT01536951|617552793|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
170875114|NCT01536951|617552794|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
170875115|NCT01536951|617552795|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
170875116|NCT01506960|617552798|FG000|Overall Study|Did not meet angiographic criteria|47|||
170875117|NCT01817751|617552799|FG000|Overall Study|Physician Decision|1|||
170875118|NCT00545402|617552800|FG000|Overall Study|Discontinuation of treatment|17|||
170875119|NCT00545402|617552801|FG001|Overall Study|Discontinuation of treatment|9|||
170875120|NCT00545402|617552800|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
170875121|NCT00545402|617552801|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
170875122|NCT00545402|617552800|FG000|Overall Study|Death|5|||
170875123|NCT00545402|617552801|FG001|Overall Study|Death|7|||
170875124|NCT00545402|617552800|FG000|Overall Study|Graft loss|2|||
170875125|NCT00545402|617552801|FG001|Overall Study|Graft loss|4|||
170875126|NCT00545402|617552800|FG000|Overall Study|Withdrawal by Subject|0|||
170875127|NCT00545402|617552801|FG001|Overall Study|Withdrawal by Subject|1|||
170774880|NCT05061693|617183239|FG000|24-week Extension Period|Lack of Efficacy|0|||
170774881|NCT05061693|617183240|FG001|24-week Extension Period|Lack of Efficacy|0|||
170774882|NCT05061693|617183241|FG002|24-week Extension Period|Lack of Efficacy|0|||
170875128|NCT00545402|617552800|FG000|Overall Study|Protocol Violation|1|||
170875129|NCT00545402|617552801|FG001|Overall Study|Protocol Violation|0|||
170875130|NCT00545402|617552800|FG000|Overall Study|Reason not specified|1|||
170774883|NCT05061693|617183242|FG003|24-week Extension Period|Lack of Efficacy|0|||
170774884|NCT05061693|617183243|FG004|24-week Extension Period|Lack of Efficacy|0|||
170774885|NCT05061693|617183244|FG005|24-week Extension Period|Lack of Efficacy|0|||
170774886|NCT05061693|617183245|FG006|24-week Extension Period|Lack of Efficacy|0|||
170774887|NCT05061693|617183246|FG007|24-week Extension Period|Lack of Efficacy|0|||
170774888|NCT05061693|617183247|FG008|24-week Extension Period|Lack of Efficacy|0|||
170774889|NCT05061693|617183248|FG009|24-week Extension Period|Lack of Efficacy|0|||
170774890|NCT05061693|617183249|FG010|24-week Extension Period|Lack of Efficacy|2|||
170774891|NCT05061693|617183250|FG011|24-week Extension Period|Lack of Efficacy|0|||
170774892|NCT05061693|617183239|FG000|24-week Extension Period|Lost to Follow-up|0|||
170774893|NCT05061693|617183240|FG001|24-week Extension Period|Lost to Follow-up|0|||
170774894|NCT05061693|617183241|FG002|24-week Extension Period|Lost to Follow-up|0|||
170774895|NCT05061693|617183242|FG003|24-week Extension Period|Lost to Follow-up|0|||
170774896|NCT05061693|617183243|FG004|24-week Extension Period|Lost to Follow-up|0|||
170774897|NCT05061693|617183244|FG005|24-week Extension Period|Lost to Follow-up|0|||
170774898|NCT05061693|617183245|FG006|24-week Extension Period|Lost to Follow-up|1|||
170774899|NCT05061693|617183246|FG007|24-week Extension Period|Lost to Follow-up|0|||
170875131|NCT00545402|617552801|FG001|Overall Study|Reason not specified|1|||
170875132|NCT00397033|617552802|FG000|Overall Study|Adverse Event|7|||
170875133|NCT00397033|617552803|FG001|Overall Study|Adverse Event|10|||
170875134|NCT00397033|617552804|FG002|Overall Study|Adverse Event|4|||
170774900|NCT05061693|617183247|FG008|24-week Extension Period|Lost to Follow-up|1|||
170774901|NCT05061693|617183248|FG009|24-week Extension Period|Lost to Follow-up|1|||
170875135|NCT00397033|617552802|FG000|Overall Study|Lack of Efficacy|22|||
170875136|NCT00397033|617552803|FG001|Overall Study|Lack of Efficacy|12|||
170774902|NCT05061693|617183249|FG010|24-week Extension Period|Lost to Follow-up|0|||
170774903|NCT05061693|617183250|FG011|24-week Extension Period|Lost to Follow-up|0|||
170774904|NCT05061693|617183239|FG000|24-week Extension Period|Withdrawal by Subject|0|||
170774905|NCT05061693|617183240|FG001|24-week Extension Period|Withdrawal by Subject|0|||
170774906|NCT05061693|617183241|FG002|24-week Extension Period|Withdrawal by Subject|0|||
170774907|NCT05061693|617183242|FG003|24-week Extension Period|Withdrawal by Subject|0|||
170774908|NCT05061693|617183243|FG004|24-week Extension Period|Withdrawal by Subject|0|||
170774909|NCT05061693|617183244|FG005|24-week Extension Period|Withdrawal by Subject|0|||
170774910|NCT05061693|617183245|FG006|24-week Extension Period|Withdrawal by Subject|0|||
170774911|NCT05061693|617183246|FG007|24-week Extension Period|Withdrawal by Subject|0|||
170774912|NCT05061693|617183247|FG008|24-week Extension Period|Withdrawal by Subject|1|||
170774913|NCT05061693|617183248|FG009|24-week Extension Period|Withdrawal by Subject|2|||
170774914|NCT05061693|617183249|FG010|24-week Extension Period|Withdrawal by Subject|2|||
170774915|NCT05061693|617183250|FG011|24-week Extension Period|Withdrawal by Subject|1|||
170774916|NCT05061693|617183239|FG000|24-week Extension Period|Sponsor Decision|0|||
170774917|NCT05061693|617183240|FG001|24-week Extension Period|Sponsor Decision|0|||
170774918|NCT05061693|617183241|FG002|24-week Extension Period|Sponsor Decision|0|||
170774919|NCT05061693|617183242|FG003|24-week Extension Period|Sponsor Decision|0|||
170774920|NCT05061693|617183243|FG004|24-week Extension Period|Sponsor Decision|0|||
170774921|NCT05061693|617183244|FG005|24-week Extension Period|Sponsor Decision|0|||
170774922|NCT05061693|617183245|FG006|24-week Extension Period|Sponsor Decision|0|||
170774923|NCT05061693|617183246|FG007|24-week Extension Period|Sponsor Decision|1|||
170774924|NCT05061693|617183247|FG008|24-week Extension Period|Sponsor Decision|0|||
170774925|NCT05061693|617183248|FG009|24-week Extension Period|Sponsor Decision|0|||
170774926|NCT05061693|617183249|FG010|24-week Extension Period|Sponsor Decision|0|||
170774927|NCT05061693|617183250|FG011|24-week Extension Period|Sponsor Decision|0|||
170774928|NCT05061693|617183239|FG000|24-week Extension Period|Site Closure|0|||
170774929|NCT05061693|617183240|FG001|24-week Extension Period|Site Closure|0|||
170774930|NCT05061693|617183241|FG002|24-week Extension Period|Site Closure|0|||
170774931|NCT05061693|617183242|FG003|24-week Extension Period|Site Closure|0|||
170774932|NCT05061693|617183243|FG004|24-week Extension Period|Site Closure|0|||
170774933|NCT05061693|617183244|FG005|24-week Extension Period|Site Closure|0|||
170774934|NCT05061693|617183245|FG006|24-week Extension Period|Site Closure|0|||
170774935|NCT05061693|617183246|FG007|24-week Extension Period|Site Closure|0|||
170774936|NCT05061693|617183247|FG008|24-week Extension Period|Site Closure|1|||
170774937|NCT05061693|617183248|FG009|24-week Extension Period|Site Closure|0|||
170774938|NCT05061693|617183249|FG010|24-week Extension Period|Site Closure|0|||
170774939|NCT05061693|617183250|FG011|24-week Extension Period|Site Closure|1|||
170774940|NCT01943799|617183251|FG000|Overall Study|Lost to Follow-up|0|||
170774941|NCT01943799|617183252|FG001|Overall Study|Lost to Follow-up|1|||
170774942|NCT01943799|617183253|FG002|Overall Study|Lost to Follow-up|1|||
170774943|NCT01943799|617183254|FG003|Overall Study|Lost to Follow-up|0|||
170774944|NCT01943799|617183251|FG000|Overall Study|Protocol Violation|1|||
170774945|NCT01943799|617183252|FG001|Overall Study|Protocol Violation|0|||
170774946|NCT01943799|617183253|FG002|Overall Study|Protocol Violation|0|||
170774947|NCT01943799|617183254|FG003|Overall Study|Protocol Violation|0|||
170774948|NCT01943799|617183251|FG000|Overall Study|Withdrawal by Subject|4|||
170774949|NCT01943799|617183252|FG001|Overall Study|Withdrawal by Subject|2|||
170774950|NCT01943799|617183253|FG002|Overall Study|Withdrawal by Subject|1|||
170774951|NCT01943799|617183254|FG003|Overall Study|Withdrawal by Subject|0|||
170774952|NCT03811574|617183255|FG000|Overall Study|Withdrawal by Subject|2|||
170774953|NCT03811574|617183256|FG001|Overall Study|Withdrawal by Subject|4|||
170774954|NCT03811574|617183257|FG002|Overall Study|Withdrawal by Subject|0|||
170774955|NCT02568683|617183259|FG000|Overall Study|Death|0|||
170774956|NCT02568683|617183260|FG001|Overall Study|Death|2|||
170774957|NCT02568683|617183259|FG000|Overall Study|Withdrew Consent|1|||
170774958|NCT02568683|617183260|FG001|Overall Study|Withdrew Consent|0|||
170774959|NCT02568683|617183259|FG000|Overall Study|Study Terminated By Sponsor|5|||
170774960|NCT02568683|617183260|FG001|Overall Study|Study Terminated By Sponsor|2|||
170774961|NCT01561989|617183263|FG000|Overall Study|accural target not met.|5|||
170774962|NCT01561989|617183264|FG001|Overall Study|accural target not met.|6|||
170774963|NCT01853748|617184602|FG000|Allocation|Withdrawal by Subject|1|||
170875137|NCT00397033|617552804|FG002|Overall Study|Lack of Efficacy|9|||
170875138|NCT00397033|617552802|FG000|Overall Study|Lost to Follow-up|3|||
170526392|NCT03217591|616275449|FG001|Overall Study|Lost to Follow-up|0|||
170526393|NCT03217591|616275450|FG002|Overall Study|Lost to Follow-up|0|||
170774964|NCT01853748|617184603|FG001|Allocation|Withdrawal by Subject|13|||
170774965|NCT01853748|617184602|FG000|Allocation|not sufficient to receive intervention|0|||
170774966|NCT01853748|617184603|FG001|Allocation|not sufficient to receive intervention|1|||
170774967|NCT01853748|617184602|FG000|Follow-Up|Withdrawal by Subject|7|||
170774968|NCT01853748|617184603|FG001|Follow-Up|Withdrawal by Subject|6|||
170774969|NCT01853748|617184602|FG000|Follow-Up|Adverse Event|67|||
170774970|NCT01853748|617184603|FG001|Follow-Up|Adverse Event|7|||
170774971|NCT01853748|617184602|FG000|Follow-Up|not available for data collection|16|||
170875139|NCT00397033|617552803|FG001|Overall Study|Lost to Follow-up|3|||
170875140|NCT00397033|617552804|FG002|Overall Study|Lost to Follow-up|3|||
170875141|NCT00397033|617552802|FG000|Overall Study|Withdrawal by Subject|12|||
170875142|NCT00397033|617552803|FG001|Overall Study|Withdrawal by Subject|7|||
170875143|NCT00397033|617552804|FG002|Overall Study|Withdrawal by Subject|5|||
170875144|NCT00397033|617552802|FG000|Overall Study|Other|0|||
170875145|NCT00397033|617552803|FG001|Overall Study|Other|5|||
170875146|NCT00397033|617552804|FG002|Overall Study|Other|2|||
170875147|NCT00382018|617552805|FG000|Overall Study|Progression|0|||
170875148|NCT00382018|617552806|FG001|Overall Study|Progression|136|||
170875149|NCT00382018|617552807|FG002|Overall Study|Progression|51|||
170875150|NCT00382018|617552808|FG003|Overall Study|Progression|43|||
170875151|NCT00382018|617552805|FG000|Overall Study|Death|0|||
170875152|NCT00382018|617552806|FG001|Overall Study|Death|9|||
170875153|NCT00382018|617552807|FG002|Overall Study|Death|7|||
170875154|NCT00382018|617552808|FG003|Overall Study|Death|11|||
170875155|NCT00382018|617552805|FG000|Overall Study|Withdrawal by Subject|0|||
170875156|NCT00382018|617552806|FG001|Overall Study|Withdrawal by Subject|4|||
170875157|NCT00382018|617552807|FG002|Overall Study|Withdrawal by Subject|3|||
170875158|NCT00382018|617552808|FG003|Overall Study|Withdrawal by Subject|4|||
170875159|NCT00382018|617552805|FG000|Overall Study|Other, not protocol specified|0|||
170875160|NCT00382018|617552806|FG001|Overall Study|Other, not protocol specified|16|||
170875161|NCT00382018|617552807|FG002|Overall Study|Other, not protocol specified|3|||
170875162|NCT00382018|617552808|FG003|Overall Study|Other, not protocol specified|1|||
170875163|NCT01977820|617552813|FG000|Overall Study|Sponsor terminated the study|1|||
170875164|NCT01977820|617552814|FG001|Overall Study|Sponsor terminated the study|1|||
170875165|NCT05082376|617552817|FG000|Overall Study|Lost to Follow-up|2|||
170875166|NCT02568475|617552818|FG000|Overall Study|Lost to Follow-up|40|||
170875167|NCT02568475|617552819|FG001|Overall Study|Lost to Follow-up|39|||
170875168|NCT02568475|617552818|FG000|Overall Study|Withdrawal by Subject|2|||
170875169|NCT02568475|617552819|FG001|Overall Study|Withdrawal by Subject|0|||
170875170|NCT02568475|617552818|FG000|Overall Study|Discharged home|4|||
170875171|NCT02568475|617552819|FG001|Overall Study|Discharged home|4|||
170875172|NCT02568475|617552818|FG000|Overall Study|Short-term: Discharge location unknown|4|||
170875173|NCT02568475|617552819|FG001|Overall Study|Short-term: Discharge location unknown|0|||
170875174|NCT02568475|617552818|FG000|Overall Study|Transferred to another facility|1|||
170875175|NCT02568475|617552819|FG001|Overall Study|Transferred to another facility|0|||
170875176|NCT00262522|617552820|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
170875177|NCT00262522|617552821|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
170414969|NCT03495869|615858967|FG001|Overall Study|Dropped from study|7|||
170414970|NCT03495869|615858968|FG002|Overall Study|Dropped from study|2|||
170414971|NCT03495869|615858969|FG003|Overall Study|Dropped from study|4|||
170414972|NCT01301833|615858970|FG000|Overall Study|Adverse Event|7|||
170414973|NCT01301833|615858971|FG001|Overall Study|Adverse Event|5|||
170414974|NCT01301833|615858972|FG002|Overall Study|Adverse Event|5|||
170414975|NCT01301833|615858973|FG003|Overall Study|Adverse Event|5|||
170414976|NCT01301833|615858970|FG000|Overall Study|Lack of Efficacy|1|||
170526394|NCT03217591|616275448|FG000|Overall Study|Protocol Violation|1|||
170526395|NCT03217591|616275449|FG001|Overall Study|Protocol Violation|0|||
170526396|NCT03217591|616275450|FG002|Overall Study|Protocol Violation|1|||
170526397|NCT04249427|616275454|FG000|Overall Study|Adverse Event|3|||
170526398|NCT04249427|616275455|FG001|Overall Study|Adverse Event|1|||
170526399|NCT04249427|616275454|FG000|Overall Study|Lack of Efficacy|0|||
170526400|NCT04249427|616275455|FG001|Overall Study|Lack of Efficacy|1|||
170526401|NCT04249427|616275454|FG000|Overall Study|Withdrawal by Subject|1|||
170526402|NCT04249427|616275455|FG001|Overall Study|Withdrawal by Subject|2|||
170526403|NCT01091246|616275456|FG000|Overall Study|Lost to Follow-up|23|||
170526404|NCT01091246|616275457|FG001|Overall Study|Lost to Follow-up|11|||
170526405|NCT01091246|616275458|FG002|Overall Study|Lost to Follow-up|7|||
170526406|NCT01091246|616275456|FG000|Overall Study|Adverse Event|1|||
170526407|NCT01091246|616275457|FG001|Overall Study|Adverse Event|0|||
170526408|NCT01091246|616275458|FG002|Overall Study|Adverse Event|1|||
170526409|NCT01091246|616275456|FG000|Overall Study|Withdrawal by Subject|9|||
170526410|NCT01091246|616275457|FG001|Overall Study|Withdrawal by Subject|5|||
170875178|NCT00262522|617552822|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
170875179|NCT00262522|617552823|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
170875180|NCT00262522|617552820|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
170875181|NCT00262522|617552821|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
170875182|NCT00262522|617552822|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
170414977|NCT01301833|615858971|FG001|Overall Study|Lack of Efficacy|1|||
170414978|NCT01301833|615858972|FG002|Overall Study|Lack of Efficacy|0|||
170414979|NCT01301833|615858973|FG003|Overall Study|Lack of Efficacy|0|||
170414980|NCT01301833|615858970|FG000|Overall Study|Physician Decision|3|||
170526411|NCT01091246|616275458|FG002|Overall Study|Withdrawal by Subject|4|||
170526412|NCT01091246|616275456|FG000|Overall Study|Subject not dosed|2|||
170526413|NCT01091246|616275457|FG001|Overall Study|Subject not dosed|0|||
170875183|NCT00262522|617552823|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
170875184|NCT00262522|617552820|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
170875185|NCT00262522|617552821|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
170875186|NCT00262522|617552822|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
170875187|NCT00262522|617552823|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
170875188|NCT00262522|617552820|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
170875189|NCT00262522|617552821|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
170875190|NCT00262522|617552822|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
170875191|NCT00262522|617552823|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
170875192|NCT00262522|617552820|FG000|Study Start Through 8 Weeks|Death|1|||
170875193|NCT00262522|617552821|FG001|Study Start Through 8 Weeks|Death|0|||
170875194|NCT00262522|617552822|FG002|Study Start Through 8 Weeks|Death|0|||
170875195|NCT00262522|617552823|FG003|Study Start Through 8 Weeks|Death|0|||
170875196|NCT00262522|617552820|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
170875197|NCT00262522|617552821|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
170875198|NCT00262522|617552822|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
170875199|NCT00262522|617552823|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
170875200|NCT00262522|617552820|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
170875201|NCT00262522|617552821|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
170875202|NCT00262522|617552822|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
170875203|NCT00262522|617552823|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
170875204|NCT00262522|617552820|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
170875205|NCT00262522|617552821|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
170875206|NCT00262522|617552822|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
170875207|NCT00262522|617552823|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
170875208|NCT00262522|617552820|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
170875209|NCT00262522|617552821|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
170875210|NCT00262522|617552822|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
170875211|NCT00262522|617552823|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
170875212|NCT00262522|617552820|FG000|Study Start Through 48 Weeks|Death|2|||
170875213|NCT00262522|617552821|FG001|Study Start Through 48 Weeks|Death|0|||
170875214|NCT00262522|617552822|FG002|Study Start Through 48 Weeks|Death|1|||
170875215|NCT00262522|617552823|FG003|Study Start Through 48 Weeks|Death|0|||
170875216|NCT00262522|617552820|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
170875217|NCT00262522|617552821|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
170875218|NCT00262522|617552822|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
170875219|NCT00262522|617552823|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
170875220|NCT00262522|617552820|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
170875221|NCT00262522|617552821|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
170875222|NCT00262522|617552822|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
170875223|NCT00262522|617552823|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
170875224|NCT00262522|617552820|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
170875225|NCT00262522|617552821|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
170414981|NCT01301833|615858971|FG001|Overall Study|Physician Decision|1|||
170414982|NCT01301833|615858972|FG002|Overall Study|Physician Decision|1|||
170414983|NCT01301833|615858973|FG003|Overall Study|Physician Decision|0|||
170414984|NCT01301833|615858970|FG000|Overall Study|Withdrawal by Subject|3|||
170414985|NCT01301833|615858971|FG001|Overall Study|Withdrawal by Subject|1|||
170414986|NCT01301833|615858972|FG002|Overall Study|Withdrawal by Subject|1|||
170414987|NCT01301833|615858973|FG003|Overall Study|Withdrawal by Subject|2|||
170414988|NCT01301833|615858970|FG000|Overall Study|Personal matter|1|||
170414989|NCT01301833|615858971|FG001|Overall Study|Personal matter|0|||
170414990|NCT01301833|615858972|FG002|Overall Study|Personal matter|0|||
170414991|NCT01301833|615858973|FG003|Overall Study|Personal matter|0|||
170414992|NCT05328375|615860376|FG000|Overall Study|Withdrawal by Subject|0|||
170414993|NCT05328375|615860377|FG001|Overall Study|Withdrawal by Subject|1|||
170414994|NCT01402908|615860378|FG000|Overall Study|Withdrawal by Subject|30|||
170414995|NCT01402908|615860379|FG001|Overall Study|Withdrawal by Subject|17|||
170875226|NCT00262522|617552822|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
170875227|NCT00262522|617552823|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
170875228|NCT00262522|617552820|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
170875229|NCT00262522|617552821|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
170414996|NCT01402908|615860378|FG000|Overall Study|Lost to Follow-up|3|||
170414997|NCT01402908|615860379|FG001|Overall Study|Lost to Follow-up|1|||
170414998|NCT01402908|615860378|FG000|Overall Study|Physician Decision|1|||
170875230|NCT00262522|617552822|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
170875231|NCT00262522|617552823|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
170875232|NCT00262522|617552820|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
170875233|NCT00262522|617552821|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
170875234|NCT00262522|617552822|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
170875235|NCT00262522|617552823|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
170875236|NCT00262522|617552820|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
170875237|NCT00262522|617552821|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
170875238|NCT00262522|617552822|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
170875239|NCT00262522|617552823|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
170875240|NCT00262522|617552820|FG000|Study Start Through 96 Weeks|Death|2|||
170875241|NCT00262522|617552821|FG001|Study Start Through 96 Weeks|Death|0|||
170875242|NCT00262522|617552822|FG002|Study Start Through 96 Weeks|Death|2|||
170875243|NCT00262522|617552823|FG003|Study Start Through 96 Weeks|Death|0|||
170875244|NCT00262522|617552820|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
170875245|NCT00262522|617552821|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
170875246|NCT00262522|617552822|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
170875247|NCT00262522|617552823|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
170875248|NCT00262522|617552820|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
170875249|NCT00262522|617552821|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
170875250|NCT00262522|617552822|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
170875251|NCT00262522|617552823|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
170875252|NCT04085523|617552824|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
170875253|NCT04085523|617552825|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
170875254|NCT04085523|617552826|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
170875255|NCT04085523|617552827|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
170875256|NCT04085523|617552828|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
170875257|NCT04085523|617552829|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
170875258|NCT04722042|617552832|FG000|Overall Study|Withdrawal by Subject|2|||
170875259|NCT04722042|617552833|FG001|Overall Study|Withdrawal by Subject|1|||
170875260|NCT04722042|617552834|FG002|Overall Study|Withdrawal by Subject|0|||
170875261|NCT05314517|617552835|FG000|Double-blind Period|Adverse Event|4|||
170875262|NCT05314517|617552836|FG001|Double-blind Period|Adverse Event|0|||
170875263|NCT05314517|617552837|FG002|Double-blind Period|Adverse Event|0|||
170875264|NCT05314517|617552838|FG003|Double-blind Period|Adverse Event|0|||
170875265|NCT05314517|617552835|FG000|Double-blind Period|Noncompliance|0|||
170875266|NCT05314517|617552836|FG001|Double-blind Period|Noncompliance|1|||
170875267|NCT05314517|617552837|FG002|Double-blind Period|Noncompliance|0|||
170875268|NCT05314517|617552838|FG003|Double-blind Period|Noncompliance|0|||
170875269|NCT05314517|617552835|FG000|Double-blind Period|Randomized, not treated|1|||
170875270|NCT05314517|617552836|FG001|Double-blind Period|Randomized, not treated|0|||
170875271|NCT05314517|617552837|FG002|Double-blind Period|Randomized, not treated|0|||
170875272|NCT05314517|617552838|FG003|Double-blind Period|Randomized, not treated|0|||
170875273|NCT05314517|617552835|FG000|Open-label Extension|Adverse Event|0|||
170875274|NCT05314517|617552836|FG001|Open-label Extension|Adverse Event|0|||
170875275|NCT05314517|617552837|FG002|Open-label Extension|Adverse Event|1|||
170875276|NCT05314517|617552838|FG003|Open-label Extension|Adverse Event|2|||
170875277|NCT05314517|617552835|FG000|Open-label Extension|Investigator decision|0|||
170875278|NCT05314517|617552836|FG001|Open-label Extension|Investigator decision|0|||
170875279|NCT05314517|617552837|FG002|Open-label Extension|Investigator decision|1|||
170875280|NCT05314517|617552838|FG003|Open-label Extension|Investigator decision|0|||
170875281|NCT05314517|617552835|FG000|Open-label Extension|Lost to Follow-up|0|||
170875282|NCT05314517|617552836|FG001|Open-label Extension|Lost to Follow-up|0|||
170875283|NCT05314517|617552837|FG002|Open-label Extension|Lost to Follow-up|0|||
170875284|NCT05314517|617552838|FG003|Open-label Extension|Lost to Follow-up|1|||
170875285|NCT05314517|617552835|FG000|Open-label Extension|Withdrawal by Subject|0|||
170875286|NCT05314517|617552836|FG001|Open-label Extension|Withdrawal by Subject|0|||
170875287|NCT05314517|617552837|FG002|Open-label Extension|Withdrawal by Subject|1|||
170875288|NCT05314517|617552838|FG003|Open-label Extension|Withdrawal by Subject|2|||
170875289|NCT05314517|617552835|FG000|Open-label Extension|Use of prohibited medication|0|||
170875290|NCT05314517|617552836|FG001|Open-label Extension|Use of prohibited medication|0|||
170414999|NCT01402908|615860379|FG001|Overall Study|Physician Decision|0|||
170875291|NCT05314517|617552837|FG002|Open-label Extension|Use of prohibited medication|1|||
170875292|NCT05314517|617552838|FG003|Open-label Extension|Use of prohibited medication|0|||
170875293|NCT05314517|617552835|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
170875294|NCT05314517|617552836|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
170875295|NCT05314517|617552837|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
170875296|NCT05314517|617552838|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
170875297|NCT04969276|617552839|FG000|Overall Study|Protocol Deviation|0|||
170415000|NCT01739790|615860380|FG000|Overall Study|Early Trial Termination|2|||
170415001|NCT01739790|615860381|FG001|Overall Study|Early Trial Termination|4|||
170774972|NCT01853748|617184603|FG001|Follow-Up|not available for data collection|4|||
170774973|NCT02916706|617184614|FG000|Overall Study|Adverse Event|0|||
170774974|NCT02916706|617184615|FG001|Overall Study|Adverse Event|1|||
170774975|NCT02916706|617184614|FG000|Overall Study|Lost to Follow-up|0|||
170774976|NCT02916706|617184615|FG001|Overall Study|Lost to Follow-up|1|||
170774977|NCT02916706|617184614|FG000|Overall Study|Physician Decision|1|||
170774978|NCT02916706|617184615|FG001|Overall Study|Physician Decision|0|||
170774979|NCT02916706|617184614|FG000|Overall Study|Protocol Violation|3|||
170774980|NCT02916706|617184615|FG001|Overall Study|Protocol Violation|1|||
170774981|NCT02916706|617184614|FG000|Overall Study|Withdrawal by Subject|6|||
170774982|NCT02916706|617184615|FG001|Overall Study|Withdrawal by Subject|9|||
170774983|NCT02916706|617184614|FG000|Overall Study|Other|5|||
170774984|NCT02916706|617184615|FG001|Overall Study|Other|19|||
170774985|NCT04300647|617184617|FG000|Pre-Crossover|Death|19|||
170774986|NCT04300647|617184618|FG001|Pre-Crossover|Death|58|||
170774987|NCT04300647|617184619|FG002|Pre-Crossover|Death|0|||
170774988|NCT04300647|617184617|FG000|Pre-Crossover|Lost to Follow-up|0|||
170774989|NCT04300647|617184618|FG001|Pre-Crossover|Lost to Follow-up|3|||
170774990|NCT04300647|617184619|FG002|Pre-Crossover|Lost to Follow-up|0|||
170774991|NCT04300647|617184617|FG000|Pre-Crossover|Withdrawal by Subject|2|||
170774992|NCT04300647|617184618|FG001|Pre-Crossover|Withdrawal by Subject|4|||
170774993|NCT04300647|617184619|FG002|Pre-Crossover|Withdrawal by Subject|0|||
170774994|NCT04300647|617184617|FG000|Pre-Crossover|On-going in Study|24|||
170774995|NCT04300647|617184618|FG001|Pre-Crossover|On-going in Study|61|||
170774996|NCT04300647|617184619|FG002|Pre-Crossover|On-going in Study|0|||
170774997|NCT04300647|617184617|FG000|Post-Crossover|Death|0|||
170774998|NCT04300647|617184618|FG001|Post-Crossover|Death|0|||
170774999|NCT04300647|617184619|FG002|Post-Crossover|Death|3|||
170775000|NCT04300647|617184617|FG000|Post-Crossover|Lost to Follow-up|0|||
170775001|NCT04300647|617184618|FG001|Post-Crossover|Lost to Follow-up|0|||
170775002|NCT04300647|617184619|FG002|Post-Crossover|Lost to Follow-up|1|||
170775003|NCT04300647|617184617|FG000|Post-Crossover|Withdrawal by Subject|0|||
170775004|NCT04300647|617184618|FG001|Post-Crossover|Withdrawal by Subject|0|||
170775005|NCT04300647|617184619|FG002|Post-Crossover|Withdrawal by Subject|1|||
170775006|NCT04300647|617184617|FG000|Post-Crossover|On-going in Study|0|||
170775007|NCT04300647|617184618|FG001|Post-Crossover|On-going in Study|0|||
170775008|NCT04300647|617184619|FG002|Post-Crossover|On-going in Study|8|||
170775009|NCT04878354|617184624|FG000|Overall Study|Adverse Event|4|||
170775010|NCT04878354|617184625|FG001|Overall Study|Adverse Event|13|||
170775011|NCT04878354|617184624|FG000|Overall Study|Withdrawal by Subject|14|||
170775012|NCT04878354|617184625|FG001|Overall Study|Withdrawal by Subject|12|||
170775013|NCT04878354|617184624|FG000|Overall Study|Lost to Follow-up|4|||
170775014|NCT04878354|617184625|FG001|Overall Study|Lost to Follow-up|1|||
170775015|NCT04878354|617184624|FG000|Overall Study|Lack of Efficacy|1|||
170775016|NCT04878354|617184625|FG001|Overall Study|Lack of Efficacy|0|||
170775017|NCT04878354|617184624|FG000|Overall Study|Protocol Violation|0|||
170775018|NCT04878354|617184625|FG001|Overall Study|Protocol Violation|1|||
170775019|NCT04878354|617184624|FG000|Overall Study|"Reason stated as other in CRF"|2|||
170775020|NCT04878354|617184625|FG001|Overall Study|"Reason stated as other in CRF"|3|||
170775021|NCT03358875|617184626|FG000|Overall Study|Death|409|||
170775022|NCT03358875|617184627|FG001|Overall Study|Death|223|||
170775023|NCT03358875|617184626|FG000|Overall Study|Study Closed by Sponsor|66|||
170775024|NCT03358875|617184627|FG001|Overall Study|Study Closed by Sponsor|29|||
170775025|NCT03358875|617184626|FG000|Overall Study|Withdrawal by Subject|13|||
170775026|NCT03358875|617184627|FG001|Overall Study|Withdrawal by Subject|16|||
170775027|NCT03358875|617184626|FG000|Overall Study|Lost to Follow-up|13|||
170775028|NCT03358875|617184627|FG001|Overall Study|Lost to Follow-up|2|||
170775029|NCT03358875|617184626|FG000|Overall Study|Miscellaneous|33|||
170775030|NCT03358875|617184627|FG001|Overall Study|Miscellaneous|0|||
170775031|NCT03358875|617184626|FG000|Overall Study|Remained on Study|1|||
170775032|NCT03358875|617184627|FG001|Overall Study|Remained on Study|0|||
170775033|NCT01903811|617184632|FG000|Overall Study|No measurable disease|1|||
170775034|NCT01903811|617184633|FG001|Overall Study|No measurable disease|1|||
170875298|NCT04969276|617552840|FG001|Overall Study|Protocol Deviation|1|||
170775035|NCT01903811|617184632|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
170775036|NCT01903811|617184633|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
170775037|NCT01903811|617184632|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
170775038|NCT01903811|617184633|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
170775039|NCT01903811|617184632|FG000|Overall Study|Withdrawal by Subject|0|||
170775040|NCT01903811|617184633|FG001|Overall Study|Withdrawal by Subject|1|||
170775041|NCT02932579|617184645|FG000|Overall Study|Withdrawal by Subject|4|||
170775042|NCT02932579|617184646|FG001|Overall Study|Withdrawal by Subject|1|||
170775043|NCT00978042|617184648|FG000|Initial Treatment Period|Treated in Error|0|||
170775044|NCT00978042|617184649|FG001|Initial Treatment Period|Treated in Error|3|||
170775045|NCT00978042|617184648|FG000|Initial Treatment Period|Ineligibility|1|||
170775046|NCT00978042|617184649|FG001|Initial Treatment Period|Ineligibility|0|||
170775047|NCT00978042|617184648|FG000|Initial Treatment Period|Lost to Follow-up|21|||
170775048|NCT00978042|617184649|FG001|Initial Treatment Period|Lost to Follow-up|3|||
170875299|NCT04969276|617552841|FG002|Overall Study|Protocol Deviation|0|||
170875300|NCT04969276|617552839|FG000|Overall Study|Withdrawal by Subject|1|||
170875301|NCT04969276|617552840|FG001|Overall Study|Withdrawal by Subject|10|||
170875302|NCT04969276|617552841|FG002|Overall Study|Withdrawal by Subject|0|||
170875303|NCT04969276|617552839|FG000|Overall Study|Lost to Follow-up|0|||
170875304|NCT04969276|617552840|FG001|Overall Study|Lost to Follow-up|1|||
170875305|NCT04969276|617552841|FG002|Overall Study|Lost to Follow-up|0|||
170875306|NCT02592018|617552847|FG000|Overall Study|Adverse Event|1|||
170875307|NCT02592018|617552847|FG000|Overall Study|Lost to Follow-up|1|||
170875308|NCT02710136|617552850|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
170875309|NCT02710136|617552851|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
170875310|NCT03337542|617552857|FG000|Overall Study|Withdrew Consent|17|||
170875311|NCT03337542|617552857|FG000|Overall Study|Allergic Adverse Event|1|||
170875312|NCT03337542|617552857|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
170875313|NCT03337542|617552857|FG000|Overall Study|Lost to Follow-up|1|||
170875314|NCT03337542|617552857|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
170875315|NCT04198623|617554425|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
170875316|NCT04259411|617554426|FG000|Overall Study|Death|1|||
170875317|NCT04259411|617554426|FG000|Overall Study|Missed visit|2|||
170875318|NCT00766038|617554429|FG000|Overall Study|Lost to Follow-up|15|||
170875319|NCT00766038|617554430|FG001|Overall Study|Lost to Follow-up|14|||
170875320|NCT00449670|617554431|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
170875321|NCT00449670|617554432|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
170875322|NCT00449670|617554431|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
170875323|NCT00449670|617554432|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
170875324|NCT00449670|617554431|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
170875325|NCT00449670|617554432|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
170875326|NCT00449670|617554431|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
170875327|NCT00449670|617554432|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
170875328|NCT00449670|617554431|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
170875329|NCT00449670|617554432|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
170875330|NCT00449670|617554431|FG000|Booster Phase (Study no.109873)|Other|0|||
170875331|NCT00449670|617554432|FG001|Booster Phase (Study no.109873)|Other|2|||
170875332|NCT00847145|617554436|FG000|Overall Study|AE or Death|0|||
170875333|NCT00847145|617554437|FG001|Overall Study|AE or Death|1|||
170875334|NCT00847145|617554438|FG002|Overall Study|AE or Death|1|||
170875335|NCT00847145|617554439|FG003|Overall Study|AE or Death|0|||
170875336|NCT00847145|617554440|FG004|Overall Study|AE or Death|0|||
170875337|NCT00847145|617554441|FG005|Overall Study|AE or Death|0|||
170875338|NCT00847145|617554442|FG006|Overall Study|AE or Death|0|||
170875339|NCT00847145|617554443|FG007|Overall Study|AE or Death|0|||
170875340|NCT00847145|617554436|FG000|Overall Study|Withdrawal by Subject|3|||
170875341|NCT00847145|617554437|FG001|Overall Study|Withdrawal by Subject|4|||
170875342|NCT00847145|617554438|FG002|Overall Study|Withdrawal by Subject|6|||
170875343|NCT00847145|617554439|FG003|Overall Study|Withdrawal by Subject|1|||
170875344|NCT00847145|617554440|FG004|Overall Study|Withdrawal by Subject|0|||
170875345|NCT00847145|617554441|FG005|Overall Study|Withdrawal by Subject|0|||
170875346|NCT00847145|617554442|FG006|Overall Study|Withdrawal by Subject|1|||
170875347|NCT00847145|617554443|FG007|Overall Study|Withdrawal by Subject|1|||
170875348|NCT00847145|617554436|FG000|Overall Study|Lost to Follow-up|3|||
170875349|NCT00847145|617554437|FG001|Overall Study|Lost to Follow-up|1|||
170875350|NCT00847145|617554438|FG002|Overall Study|Lost to Follow-up|1|||
170875351|NCT00847145|617554439|FG003|Overall Study|Lost to Follow-up|0|||
170875352|NCT00847145|617554440|FG004|Overall Study|Lost to Follow-up|4|||
170875353|NCT00847145|617554441|FG005|Overall Study|Lost to Follow-up|4|||
170875354|NCT00847145|617554442|FG006|Overall Study|Lost to Follow-up|8|||
170875355|NCT00847145|617554443|FG007|Overall Study|Lost to Follow-up|2|||
170875356|NCT00847145|617554436|FG000|Overall Study|Inappropriate enrollment|0|||
170875357|NCT00847145|617554437|FG001|Overall Study|Inappropriate enrollment|0|||
170875358|NCT00847145|617554438|FG002|Overall Study|Inappropriate enrollment|0|||
170875359|NCT00847145|617554439|FG003|Overall Study|Inappropriate enrollment|0|||
170875360|NCT00847145|617554440|FG004|Overall Study|Inappropriate enrollment|1|||
170875361|NCT00847145|617554441|FG005|Overall Study|Inappropriate enrollment|0|||
170875362|NCT00847145|617554442|FG006|Overall Study|Inappropriate enrollment|0|||
170875363|NCT00847145|617554443|FG007|Overall Study|Inappropriate enrollment|0|||
170875364|NCT00847145|617554436|FG000|Overall Study|Protocol Violation|0|||
170875365|NCT00847145|617554437|FG001|Overall Study|Protocol Violation|0|||
170875366|NCT00847145|617554438|FG002|Overall Study|Protocol Violation|3|||
170875367|NCT00847145|617554439|FG003|Overall Study|Protocol Violation|0|||
170875368|NCT00847145|617554440|FG004|Overall Study|Protocol Violation|1|||
170875369|NCT00847145|617554441|FG005|Overall Study|Protocol Violation|0|||
170526414|NCT01091246|616275458|FG002|Overall Study|Subject not dosed|1|||
170875370|NCT00847145|617554442|FG006|Overall Study|Protocol Violation|0|||
170526415|NCT02895347|616275459|FG000|Overall Study|Withdrawal by Subject|3|||
170875371|NCT00847145|617554443|FG007|Overall Study|Protocol Violation|1|||
170875372|NCT01502709|617554445|FG000|Overall Study|Lost to Follow-up|4|||
170775049|NCT00978042|617184648|FG000|Initial Treatment Period|Adverse Event|2|||
170775050|NCT00978042|617184649|FG001|Initial Treatment Period|Adverse Event|0|||
170775051|NCT00978042|617184648|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
170775052|NCT00978042|617184649|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
170775053|NCT00978042|617184648|FG000|Initial Treatment Period|Consent withdrawn|22|||
170775054|NCT00978042|617184649|FG001|Initial Treatment Period|Consent withdrawn|9|||
170775055|NCT00978042|617184648|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
170775056|NCT00978042|617184649|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
170775057|NCT01839331|617184650|FG000|Overall Study|Early Termination|3|||
170775058|NCT01839331|617184651|FG001|Overall Study|Early Termination|0|||
170775059|NCT01839331|617184652|FG002|Overall Study|Early Termination|1|||
170775060|NCT01839331|617184653|FG003|Overall Study|Early Termination|2|||
170775061|NCT01839331|617184650|FG000|Overall Study|Protocol Violation|1|||
170775062|NCT01839331|617184651|FG001|Overall Study|Protocol Violation|6|||
170775063|NCT01839331|617184652|FG002|Overall Study|Protocol Violation|4|||
170775064|NCT01839331|617184653|FG003|Overall Study|Protocol Violation|3|||
170775065|NCT00818246|617184654|FG000|Overall Study|Impossible to match pictures|5|||
170775066|NCT04788641|617184655|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
170775067|NCT04788641|617184656|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
170775068|NCT04788641|617184657|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
170775069|NCT04788641|617184658|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
170775070|NCT04788641|617184655|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
170775071|NCT04788641|617184656|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
170775072|NCT04788641|617184657|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
170775073|NCT04788641|617184658|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
170775074|NCT04788641|617184655|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
170775075|NCT04788641|617184656|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
170775076|NCT04788641|617184657|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
170775077|NCT04788641|617184658|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
170775078|NCT01290341|617184659|FG000|Overall Study|Protocol Violation|7|||
170775079|NCT01290341|617184660|FG001|Overall Study|Protocol Violation|3|||
170775080|NCT01290341|617184659|FG000|Overall Study|Adverse Event|1|||
170775081|NCT01290341|617184660|FG001|Overall Study|Adverse Event|0|||
170775082|NCT01290341|617184659|FG000|Overall Study|Lost to Follow-up|21|||
170775083|NCT01290341|617184660|FG001|Overall Study|Lost to Follow-up|10|||
170775084|NCT01290341|617184659|FG000|Overall Study|Withdrawal by Subject|19|||
170775085|NCT01290341|617184660|FG001|Overall Study|Withdrawal by Subject|5|||
170775086|NCT01290341|617184659|FG000|Overall Study|Negative baseline culture and others|44|||
170775087|NCT01290341|617184660|FG001|Overall Study|Negative baseline culture and others|11|||
170775088|NCT01198145|617184668|FG000|Overall Study|Withdrawal by Subject|1|||
170775089|NCT01198145|617184669|FG001|Overall Study|Withdrawal by Subject|1|||
170775090|NCT00781274|617184670|FG000|Overall Study|Withdrawal by Subject|2|||
170775091|NCT00603954|617184672|FG000|Overall Study|Protocol Violation|1|||
170775092|NCT00603954|617184673|FG001|Overall Study|Protocol Violation|2|||
170775093|NCT04594759|617184674|FG000|Overall Study|Lost to Follow-up|3|||
170775094|NCT02708108|617184675|FG000|Overall Study|Death|1|||
170775095|NCT02708108|617184676|FG001|Overall Study|Death|2|||
170775096|NCT02708108|617184675|FG000|Overall Study|Regimen change|1|||
170775097|NCT02708108|617184676|FG001|Overall Study|Regimen change|0|||
170775098|NCT02708108|617184675|FG000|Overall Study|No MRD and no imaging available|0|||
170775099|NCT02708108|617184676|FG001|Overall Study|No MRD and no imaging available|1|||
170775100|NCT01565148|617184683|FG000|Overall Study|Withdrawal by Subject|1|||
170775101|NCT01565148|617184684|FG001|Overall Study|Withdrawal by Subject|1|||
170775102|NCT01565148|617184685|FG002|Overall Study|Withdrawal by Subject|1|||
170775103|NCT01565148|617184686|FG003|Overall Study|Withdrawal by Subject|2|||
170775104|NCT01565148|617184683|FG000|Overall Study|Lost to Follow-up|4|||
170775105|NCT01565148|617184684|FG001|Overall Study|Lost to Follow-up|4|||
170775106|NCT01565148|617184685|FG002|Overall Study|Lost to Follow-up|0|||
170775107|NCT01565148|617184686|FG003|Overall Study|Lost to Follow-up|3|||
170775108|NCT01565148|617184683|FG000|Overall Study|Rescue Therapy|8|||
170775109|NCT01565148|617184684|FG001|Overall Study|Rescue Therapy|5|||
170775110|NCT01565148|617184685|FG002|Overall Study|Rescue Therapy|5|||
170775111|NCT01565148|617184686|FG003|Overall Study|Rescue Therapy|8|||
170775112|NCT01565148|617184683|FG000|Overall Study|Death|0|||
170775113|NCT01565148|617184684|FG001|Overall Study|Death|0|||
170775114|NCT01565148|617184685|FG002|Overall Study|Death|1|||
170775115|NCT01565148|617184686|FG003|Overall Study|Death|0|||
170775116|NCT01565148|617184683|FG000|Overall Study|Physician Decision|2|||
170775117|NCT01565148|617184684|FG001|Overall Study|Physician Decision|5|||
170775118|NCT01565148|617184685|FG002|Overall Study|Physician Decision|0|||
170775119|NCT01565148|617184686|FG003|Overall Study|Physician Decision|0|||
170775120|NCT01759771|617184687|FG000|Overall Study|Withdrawal by Subject|1|||
170775121|NCT01759771|617184688|FG001|Overall Study|Withdrawal by Subject|1|||
170775122|NCT03887650|617184689|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
170775123|NCT03887650|617184690|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
170875373|NCT01502709|617554446|FG001|Overall Study|Lost to Follow-up|0|||
170875374|NCT03703882|617554447|FG000|Overall Study|Adverse Event|1|||
170875375|NCT03703882|617554448|FG001|Overall Study|Adverse Event|0|||
170875376|NCT03703882|617554447|FG000|Overall Study|Lost to Follow-up|0|||
170875377|NCT03703882|617554448|FG001|Overall Study|Lost to Follow-up|2|||
170875378|NCT03703882|617554447|FG000|Overall Study|Non-compliance with study drug|0|||
170875379|NCT03703882|617554448|FG001|Overall Study|Non-compliance with study drug|1|||
170875380|NCT03703882|617554447|FG000|Overall Study|Physician Decision|0|||
170875381|NCT03703882|617554448|FG001|Overall Study|Physician Decision|1|||
170875382|NCT03703882|617554447|FG000|Overall Study|Progressive disease|1|||
170875383|NCT03703882|617554448|FG001|Overall Study|Progressive disease|0|||
170875384|NCT03703882|617554447|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170875385|NCT03703882|617554448|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170875386|NCT03703882|617554447|FG000|Overall Study|Starting another treatment|0|||
170875387|NCT03703882|617554448|FG001|Overall Study|Starting another treatment|1|||
170875388|NCT03703882|617554447|FG000|Overall Study|noncompliance with study procedures|0|||
170875389|NCT03703882|617554448|FG001|Overall Study|noncompliance with study procedures|1|||
170875390|NCT01617460|617554449|FG000|Overall Study|Adverse Event|10|||
170875391|NCT01617460|617554449|FG000|Overall Study|Physician Decision|16|||
170875392|NCT01617460|617554449|FG000|Overall Study|Protocol Violation|5|||
170875393|NCT01617460|617554449|FG000|Overall Study|Withdrawal by Subject|9|||
170875394|NCT02966509|617554456|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
170875395|NCT02966509|617554457|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
170875396|NCT02966509|617554456|FG000|Baseline Satisfaction Survey|Death|0|||
170875397|NCT02966509|617554457|FG001|Baseline Satisfaction Survey|Death|1|||
170875398|NCT02966509|617554456|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
170875399|NCT02966509|617554457|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
170875400|NCT02966509|617554456|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
170875401|NCT02966509|617554457|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
170875402|NCT02966509|617554456|FG000|6 Month Satisfaction Decision Survey|Death|22|||
170875403|NCT02966509|617554457|FG001|6 Month Satisfaction Decision Survey|Death|25|||
170875404|NCT02966509|617554456|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
170875405|NCT02966509|617554457|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
170875406|NCT02966509|617554456|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
170875407|NCT02966509|617554457|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
170875408|NCT02966509|617554456|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
170875409|NCT02966509|617554457|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
170875410|NCT02966509|617554456|FG000|6 Month Satisfaction Survey|Death|36|||
170875411|NCT02966509|617554457|FG001|6 Month Satisfaction Survey|Death|33|||
170875412|NCT02966509|617554456|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
170875413|NCT02966509|617554457|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
170875414|NCT02966509|617554456|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
170875415|NCT02966509|617554457|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
170875416|NCT02966509|617554456|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
170875417|NCT02966509|617554457|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
170875418|NCT02966509|617554456|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
170875419|NCT02966509|617554457|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
170875420|NCT02966509|617554456|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
170875421|NCT02966509|617554457|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
170875422|NCT02263079|617554459|FG000|Overall Study|Physician Decision|1|||
170875423|NCT02263079|617554460|FG001|Overall Study|Physician Decision|0|||
170875424|NCT02263079|617554461|FG002|Overall Study|Physician Decision|0|||
170875425|NCT02263079|617554459|FG000|Overall Study|Withdrawal by Subject|2|||
170875426|NCT02263079|617554460|FG001|Overall Study|Withdrawal by Subject|8|||
170875427|NCT02263079|617554461|FG002|Overall Study|Withdrawal by Subject|0|||
170875428|NCT02603120|617554462|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
170875429|NCT02603120|617554463|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
170875430|NCT02603120|617554462|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
170875431|NCT02603120|617554463|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
170875432|NCT02603120|617554462|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
170875433|NCT02603120|617554463|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
170875434|NCT02603120|617554462|FG000|Double-Blind Treatment Phase|Death|2|||
170875435|NCT02603120|617554463|FG001|Double-Blind Treatment Phase|Death|0|||
170875436|NCT02603120|617554462|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
170875437|NCT02603120|617554463|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
170875438|NCT02603120|617554462|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
170875439|NCT02603120|617554463|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
170875440|NCT02603120|617554462|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
170875441|NCT02603120|617554463|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
170875442|NCT02603120|617554462|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
170875443|NCT02603120|617554463|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
170875444|NCT02603120|617554462|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
170875445|NCT02603120|617554463|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
170875446|NCT02603120|617554462|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
170875447|NCT02603120|617554463|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
170875448|NCT02603120|617554462|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
170875449|NCT02603120|617554463|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
170875450|NCT02603120|617554462|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
170875451|NCT02603120|617554463|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
170875452|NCT02603120|617554462|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
170875453|NCT02603120|617554463|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
170875454|NCT02603120|617554462|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
170875455|NCT02603120|617554463|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
170875456|NCT00402649|617554464|FG000|Overall Study|Lost to Follow-up|1|||
170875457|NCT00402649|617554464|FG000|Overall Study|Withdrawal by Subject|1|||
170875458|NCT01321710|617554470|FG000|Overall Study|Lost to Follow-up|4|||
170875459|NCT01321710|617554471|FG001|Overall Study|Lost to Follow-up|5|||
170875460|NCT01321710|617554472|FG002|Overall Study|Lost to Follow-up|0|||
170875461|NCT01761292|617554473|FG000|Part 1|Adverse Event|1|||
170875462|NCT01761292|617554473|FG000|Part 1|not receiving treatment in Part 1|1|||
170875463|NCT01761292|617554473|FG000|Extension 1|Withdrawal by Subject|1|||
170875464|NCT00840086|617554474|FG000|Overall Study|Adverse Event|1|||
170875465|NCT00840086|617554474|FG000|Overall Study|Protocol Violation|2|||
170875466|NCT00840086|617554474|FG000|Overall Study|Lost to Follow-up|1|||
170875467|NCT03332498|617554475|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
170875468|NCT03332498|617554476|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
170875469|NCT03332498|617554477|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
170875470|NCT05611671|617554482|FG000|Overall Study|Adverse Event|1|||
170875471|NCT05611671|617554483|FG001|Overall Study|Adverse Event|1|||
170875472|NCT05611671|617554484|FG002|Overall Study|Adverse Event|0|||
170875473|NCT05611671|617554485|FG003|Overall Study|Adverse Event|1|||
170875474|NCT05611671|617554482|FG000|Overall Study|Lack of Efficacy|1|||
170875475|NCT05611671|617554483|FG001|Overall Study|Lack of Efficacy|0|||
170875476|NCT05611671|617554484|FG002|Overall Study|Lack of Efficacy|1|||
170875477|NCT05611671|617554485|FG003|Overall Study|Lack of Efficacy|2|||
170875478|NCT05611671|617554482|FG000|Overall Study|Lost to Follow-up|0|||
170875479|NCT05611671|617554483|FG001|Overall Study|Lost to Follow-up|0|||
170875480|NCT05611671|617554484|FG002|Overall Study|Lost to Follow-up|0|||
170875481|NCT05611671|617554485|FG003|Overall Study|Lost to Follow-up|1|||
170875482|NCT05611671|617554482|FG000|Overall Study|Protocol Violation|0|||
170875483|NCT05611671|617554483|FG001|Overall Study|Protocol Violation|1|||
170875484|NCT05611671|617554484|FG002|Overall Study|Protocol Violation|0|||
170875485|NCT05611671|617554485|FG003|Overall Study|Protocol Violation|0|||
170875486|NCT05611671|617554482|FG000|Overall Study|Withdrawal by Subject|2|||
170875487|NCT05611671|617554483|FG001|Overall Study|Withdrawal by Subject|1|||
170875488|NCT05611671|617554484|FG002|Overall Study|Withdrawal by Subject|2|||
170875489|NCT05611671|617554485|FG003|Overall Study|Withdrawal by Subject|1|||
170875490|NCT00253643|617554488|FG000|Overall Study|Withdrawal by Subject|0|||
170875491|NCT00253643|617554489|FG001|Overall Study|Withdrawal by Subject|0|||
170875492|NCT00253643|617554490|FG002|Overall Study|Withdrawal by Subject|1|||
170875493|NCT00253643|617554491|FG003|Overall Study|Withdrawal by Subject|1|||
170875494|NCT00253643|617554488|FG000|Overall Study|Non-Compliance|0|||
170875495|NCT00253643|617554489|FG001|Overall Study|Non-Compliance|0|||
170875496|NCT00253643|617554490|FG002|Overall Study|Non-Compliance|0|||
170875497|NCT00253643|617554491|FG003|Overall Study|Non-Compliance|2|||
170875498|NCT02113436|617554496|FG000|Period 1: 8 Weeks|Adverse Event|1|||
170875499|NCT02113436|617554497|FG001|Period 1: 8 Weeks|Adverse Event|0|||
170875500|NCT02113436|617554498|FG002|Period 1: 8 Weeks|Adverse Event|0|||
170875501|NCT02113436|617554499|FG003|Period 1: 8 Weeks|Adverse Event|0|||
170875502|NCT02113436|617554496|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
170875503|NCT02113436|617554497|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
170875504|NCT02113436|617554498|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
170875505|NCT02113436|617554499|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
170875506|NCT02113436|617554496|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
170875507|NCT02113436|617554497|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
170875508|NCT02113436|617554498|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
170526416|NCT02895347|616275460|FG001|Overall Study|Withdrawal by Subject|1|||
170875509|NCT02113436|617554499|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
170875510|NCT02113436|617554496|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
170875511|NCT02113436|617554497|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
170875512|NCT02113436|617554498|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
170875513|NCT02113436|617554499|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
170875514|NCT02113436|617554496|FG000|Period 2: 16 Weeks|Adverse Event|0|||
170875515|NCT02113436|617554497|FG001|Period 2: 16 Weeks|Adverse Event|0|||
170526417|NCT00369343|616275467|FG000|Double-blind Phase|Adverse Event|19|||
170526418|NCT00369343|616275468|FG001|Double-blind Phase|Adverse Event|4|||
170875516|NCT02113436|617554498|FG002|Period 2: 16 Weeks|Adverse Event|4|||
170875517|NCT02113436|617554499|FG003|Period 2: 16 Weeks|Adverse Event|5|||
170875518|NCT02113436|617554496|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
170875519|NCT02113436|617554497|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
170875520|NCT02113436|617554498|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
170875521|NCT02113436|617554499|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
170875522|NCT02113436|617554496|FG000|Period 2: 16 Weeks|Physician Decision|0|||
170875523|NCT02113436|617554497|FG001|Period 2: 16 Weeks|Physician Decision|0|||
170875524|NCT02113436|617554498|FG002|Period 2: 16 Weeks|Physician Decision|2|||
170875525|NCT02113436|617554499|FG003|Period 2: 16 Weeks|Physician Decision|0|||
170875526|NCT02113436|617554496|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
170875527|NCT02113436|617554497|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
170875528|NCT02113436|617554498|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
170875529|NCT02113436|617554499|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
170875530|NCT00424749|617554500|FG000|Overall Study|Withdrawal by Subject|1|||
170875531|NCT04109222|617554501|FG000|Overall Study|Adverse Event|1|||
170875532|NCT04109222|617554502|FG001|Overall Study|Adverse Event|0|||
170875533|NCT04109222|617554503|FG002|Overall Study|Adverse Event|0|||
170875534|NCT05374525|617554506|FG000|Overall Study|Adverse Event|5|||
170875535|NCT05374525|617554507|FG001|Overall Study|Adverse Event|6|||
170875536|NCT05374525|617554506|FG000|Overall Study|Lost to Follow-up|3|||
170875537|NCT05374525|617554507|FG001|Overall Study|Lost to Follow-up|3|||
170875538|NCT05374525|617554506|FG000|Overall Study|Physician Decision|2|||
170875539|NCT05374525|617554507|FG001|Overall Study|Physician Decision|2|||
170875540|NCT05374525|617554506|FG000|Overall Study|Withdrawal by Subject|26|||
170875541|NCT05374525|617554507|FG001|Overall Study|Withdrawal by Subject|8|||
170875542|NCT01111851|617554511|FG000|Overall Study|All planned PET scans were not obtained.|2|||
170875543|NCT01111851|617554512|FG001|Overall Study|All planned PET scans were not obtained.|0|||
170875544|NCT05500274|617554513|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
170875545|NCT05500274|617554514|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
170875546|NCT05500274|617554513|FG000|Overall Study|Lost to Follow-up|76|||
170875547|NCT05500274|617554514|FG001|Overall Study|Lost to Follow-up|51|||
170875548|NCT05807464|617554517|FG000|Overall Study|Adverse Event|1|||
170875549|NCT04451161|617554520|FG000|Overall Study|Lost to Follow-up|28|||
170875550|NCT04451161|617554521|FG001|Overall Study|Lost to Follow-up|37|||
170875551|NCT04451161|617554522|FG002|Overall Study|Lost to Follow-up|22|||
170875552|NCT04451161|617554523|FG003|Overall Study|Lost to Follow-up|13|||
170875553|NCT04451161|617554524|FG004|Overall Study|Lost to Follow-up|11|||
170875554|NCT04451161|617554525|FG005|Overall Study|Lost to Follow-up|14|||
170875555|NCT04451161|617554520|FG000|Overall Study|Withdrawal by Subject|3|||
170875556|NCT04451161|617554521|FG001|Overall Study|Withdrawal by Subject|0|||
170875557|NCT04451161|617554522|FG002|Overall Study|Withdrawal by Subject|0|||
170875558|NCT04451161|617554523|FG003|Overall Study|Withdrawal by Subject|0|||
170875559|NCT04451161|617554524|FG004|Overall Study|Withdrawal by Subject|2|||
170875560|NCT04451161|617554525|FG005|Overall Study|Withdrawal by Subject|4|||
170875561|NCT01349101|617554526|FG000|Overall Study|Disease Progression|1|||
170875562|NCT01349101|617554527|FG001|Overall Study|Disease Progression|1|||
170875563|NCT01349101|617554526|FG000|Overall Study|Death|3|||
170875564|NCT01349101|617554527|FG001|Overall Study|Death|8|||
170875565|NCT00003702|617554534|FG000|Overall Study|Ineligible cell types|2|||
170875566|NCT00003702|617554535|FG001|Overall Study|Ineligible cell types|2|||
170875567|NCT00003702|617554534|FG000|Overall Study|Did not meet criteria for persistence|8|||
170875568|NCT00003702|617554535|FG001|Overall Study|Did not meet criteria for persistence|5|||
170875569|NCT00003702|617554534|FG000|Overall Study|WHO score > 6|2|||
170875570|NCT00003702|617554535|FG001|Overall Study|WHO score > 6|1|||
170875571|NCT00003702|617554534|FG000|Overall Study|Inadequate documentation of disease|1|||
170875572|NCT00003702|617554535|FG001|Overall Study|Inadequate documentation of disease|3|||
170875573|NCT04037748|617554538|FG000|Treatment Period 1|Withdrawal by Subject|3|||
170875574|NCT04037748|617554539|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170875575|NCT04037748|617554538|FG000|Treatment Period 1|Adverse Event|1|||
170875576|NCT04037748|617554539|FG001|Treatment Period 1|Adverse Event|1|||
170875577|NCT04037748|617554538|FG000|Treatment Period 1|Protocol Violation|4|||
170875578|NCT04037748|617554539|FG001|Treatment Period 1|Protocol Violation|5|||
170875579|NCT04037748|617554538|FG000|Treatment Period 2|Adverse Event|0|||
170415002|NCT01893905|615860382|FG000|Overall Study|Withdrawal by Subject|1|||
170415003|NCT01893905|615860383|FG001|Overall Study|Withdrawal by Subject|0|||
170875580|NCT04037748|617554539|FG001|Treatment Period 2|Adverse Event|1|||
170875581|NCT04037748|617554538|FG000|Treatment Period 2|Protocol Violation|2|||
170875582|NCT04037748|617554539|FG001|Treatment Period 2|Protocol Violation|0|||
170875583|NCT03519867|617554542|FG000|Overall Study|Adverse Event|1|||
170875584|NCT03519867|617554543|FG001|Overall Study|Adverse Event|1|||
170415004|NCT01893905|615860382|FG000|Overall Study|Adverse Event|9|||
170415005|NCT01893905|615860383|FG001|Overall Study|Adverse Event|3|||
170415006|NCT01893905|615860382|FG000|Overall Study|Lack of Efficacy|5|||
170875585|NCT03519867|617554544|FG002|Overall Study|Adverse Event|0|||
170875586|NCT03519867|617554545|FG003|Overall Study|Adverse Event|0|||
170526419|NCT00369343|616275467|FG000|Double-blind Phase|Failed to return|2|||
170526420|NCT00369343|616275468|FG001|Double-blind Phase|Failed to return|0|||
170526421|NCT00369343|616275467|FG000|Double-blind Phase|Lost to Follow-up|9|||
170526422|NCT00369343|616275468|FG001|Double-blind Phase|Lost to Follow-up|2|||
170526423|NCT00369343|616275467|FG000|Double-blind Phase|Protocol Violation|2|||
170775124|NCT03887650|617184689|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
170775125|NCT03887650|617184690|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
170775126|NCT03887650|617184689|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
170775127|NCT03887650|617184690|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
170775128|NCT04200365|617184691|FG000|Overall Study|Adverse Event|2|||
170775129|NCT04200365|617184691|FG000|Overall Study|Progressive Disease|4|||
170775130|NCT04200365|617184691|FG000|Overall Study|Lack of Efficacy|1|||
170775131|NCT04200365|617184691|FG000|Overall Study|Study Closure|4|||
170775132|NCT01499199|617184692|FG000|Overall Study|Adverse Event|1|||
170775133|NCT01499199|617184692|FG000|Overall Study|Lack of Efficacy|1|||
170775134|NCT01199705|617184693|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
170775135|NCT01692730|617184699|FG000|Overall Study|Lost to Follow-up|225|||
170775136|NCT01692730|617184700|FG001|Overall Study|Lost to Follow-up|227|||
170775137|NCT01199575|617184701|FG000|Overall Study|Withdrawal by Subject|5|||
170775138|NCT00933400|617184702|FG000|Overall Study|Withdrawal by Subject|21|||
170775139|NCT00933400|617184703|FG001|Overall Study|Withdrawal by Subject|1|||
170775140|NCT01849055|617184704|FG000|Overall Study|Withdrawal by Subject|0|||
170775141|NCT01849055|617184705|FG001|Overall Study|Withdrawal by Subject|0|||
170775142|NCT01849055|617184706|FG002|Overall Study|Withdrawal by Subject|1|||
170775143|NCT01849055|617184707|FG003|Overall Study|Withdrawal by Subject|0|||
170775144|NCT01849055|617184708|FG004|Overall Study|Withdrawal by Subject|0|||
170775145|NCT01849055|617184709|FG005|Overall Study|Withdrawal by Subject|0|||
170775146|NCT01239316|617184710|FG000|Overall Study|Progression/Relapse|11|||
170775147|NCT01239316|617184710|FG000|Overall Study|Adverse Event|1|||
170775148|NCT00223795|617184712|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
170775149|NCT00223795|617184713|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
170775150|NCT00223795|617184712|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
170775151|NCT00223795|617184713|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
170775152|NCT00704184|617184714|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
170775153|NCT00704184|617184715|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
170775154|NCT00704184|617184716|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
170775155|NCT00704184|617184717|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
170775156|NCT00704184|617184718|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
170775157|NCT00704184|617184714|FG000|Open-Label Treatment|Adverse Event|0|||
170775158|NCT00704184|617184715|FG001|Open-Label Treatment|Adverse Event|0|||
170775159|NCT00704184|617184716|FG002|Open-Label Treatment|Adverse Event|2|||
170775160|NCT00704184|617184717|FG003|Open-Label Treatment|Adverse Event|0|||
170775161|NCT00704184|617184718|FG004|Open-Label Treatment|Adverse Event|1|||
170775162|NCT00704184|617184714|FG000|Open-Label Treatment|Lack of Efficacy|0|||
170775163|NCT00704184|617184715|FG001|Open-Label Treatment|Lack of Efficacy|2|||
170775164|NCT00704184|617184716|FG002|Open-Label Treatment|Lack of Efficacy|2|||
170775165|NCT00704184|617184717|FG003|Open-Label Treatment|Lack of Efficacy|2|||
170775166|NCT00704184|617184718|FG004|Open-Label Treatment|Lack of Efficacy|1|||
170775167|NCT00704184|617184714|FG000|Open-Label Treatment|Physician Decision|0|||
170775168|NCT00704184|617184715|FG001|Open-Label Treatment|Physician Decision|0|||
170775169|NCT00704184|617184716|FG002|Open-Label Treatment|Physician Decision|0|||
170775170|NCT00704184|617184717|FG003|Open-Label Treatment|Physician Decision|0|||
170775171|NCT00704184|617184718|FG004|Open-Label Treatment|Physician Decision|1|||
170775172|NCT00704184|617184714|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
170775173|NCT00704184|617184715|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
170775174|NCT00704184|617184716|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
170775175|NCT00704184|617184717|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
170775176|NCT00704184|617184718|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
170775177|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
170775178|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
170775179|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
170775180|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
170775181|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
170775182|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
170526424|NCT00369343|616275468|FG001|Double-blind Phase|Protocol Violation|0|||
170775183|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
170775184|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
170775185|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
170775186|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
170775187|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
170526425|NCT00369343|616275467|FG000|Double-blind Phase|Withdrawal by Subject|8|||
170875587|NCT03519867|617554546|FG004|Overall Study|Adverse Event|0|||
170875588|NCT03519867|617554547|FG005|Overall Study|Adverse Event|0|||
170875589|NCT03519867|617554548|FG006|Overall Study|Adverse Event|0|||
170875590|NCT03519867|617554549|FG007|Overall Study|Adverse Event|0|||
170875591|NCT03519867|617554550|FG008|Overall Study|Adverse Event|0|||
170875592|NCT03519867|617554551|FG009|Overall Study|Adverse Event|0|||
170875593|NCT03519867|617554542|FG000|Overall Study|Protocol Violation|0|||
170875594|NCT03519867|617554543|FG001|Overall Study|Protocol Violation|0|||
170875595|NCT03519867|617554544|FG002|Overall Study|Protocol Violation|0|||
170875596|NCT03519867|617554545|FG003|Overall Study|Protocol Violation|0|||
170875597|NCT03519867|617554546|FG004|Overall Study|Protocol Violation|0|||
170875598|NCT03519867|617554547|FG005|Overall Study|Protocol Violation|1|||
170875599|NCT03519867|617554548|FG006|Overall Study|Protocol Violation|0|||
170875600|NCT03519867|617554549|FG007|Overall Study|Protocol Violation|0|||
170875601|NCT03519867|617554550|FG008|Overall Study|Protocol Violation|0|||
170875602|NCT03519867|617554551|FG009|Overall Study|Protocol Violation|0|||
170875603|NCT03519867|617554542|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875604|NCT03519867|617554543|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875605|NCT03519867|617554544|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875606|NCT03519867|617554545|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875607|NCT03519867|617554546|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875608|NCT03519867|617554547|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875609|NCT03519867|617554548|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
170875610|NCT03519867|617554549|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875611|NCT03519867|617554550|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875612|NCT03519867|617554551|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
170875613|NCT03519867|617554542|FG000|Overall Study|Admin. of other reversal agent|1|||
170875614|NCT03519867|617554543|FG001|Overall Study|Admin. of other reversal agent|1|||
170875615|NCT03519867|617554544|FG002|Overall Study|Admin. of other reversal agent|0|||
170875616|NCT03519867|617554545|FG003|Overall Study|Admin. of other reversal agent|0|||
170875617|NCT03519867|617554546|FG004|Overall Study|Admin. of other reversal agent|0|||
170875618|NCT03519867|617554547|FG005|Overall Study|Admin. of other reversal agent|1|||
170875619|NCT03519867|617554548|FG006|Overall Study|Admin. of other reversal agent|0|||
170875620|NCT03519867|617554549|FG007|Overall Study|Admin. of other reversal agent|0|||
170875621|NCT03519867|617554550|FG008|Overall Study|Admin. of other reversal agent|0|||
170875622|NCT03519867|617554551|FG009|Overall Study|Admin. of other reversal agent|0|||
170875623|NCT03519867|617554542|FG000|Overall Study|Reason not provided|1|||
170875624|NCT03519867|617554543|FG001|Overall Study|Reason not provided|1|||
170875625|NCT03519867|617554544|FG002|Overall Study|Reason not provided|1|||
170875626|NCT03519867|617554545|FG003|Overall Study|Reason not provided|1|||
170875627|NCT03519867|617554546|FG004|Overall Study|Reason not provided|0|||
170875628|NCT03519867|617554547|FG005|Overall Study|Reason not provided|1|||
170875629|NCT03519867|617554548|FG006|Overall Study|Reason not provided|0|||
170875630|NCT03519867|617554549|FG007|Overall Study|Reason not provided|1|||
170875631|NCT03519867|617554550|FG008|Overall Study|Reason not provided|1|||
170875632|NCT03519867|617554551|FG009|Overall Study|Reason not provided|0|||
170875633|NCT01846624|617554552|FG000|Overall Study|Died during induction, no midostaurin|1|||
170875634|NCT04702737|617554553|FG000|Overall Study|Decision by Sponsor|1|||
170875635|NCT04702737|617554553|FG000|Overall Study|Withdrawal of Consent from Study|3|||
170875636|NCT04702737|617554553|FG000|Overall Study|Lost to Follow-up|1|||
170875637|NCT04702737|617554553|FG000|Overall Study|Death|35|||
170875638|NCT01202279|617554554|FG000|Overall Study|Adverse Event|8|||
170875639|NCT01202279|617554555|FG001|Overall Study|Adverse Event|6|||
170875640|NCT01202279|617554554|FG000|Overall Study|Withdrawal by Subject|13|||
170875641|NCT01202279|617554555|FG001|Overall Study|Withdrawal by Subject|10|||
170875642|NCT01202279|617554554|FG000|Overall Study|Physician Decision|0|||
170875643|NCT01202279|617554555|FG001|Overall Study|Physician Decision|1|||
170415007|NCT01893905|615860383|FG001|Overall Study|Lack of Efficacy|7|||
170415008|NCT01893905|615860382|FG000|Overall Study|Lost to Follow-up|1|||
170415009|NCT01893905|615860383|FG001|Overall Study|Lost to Follow-up|0|||
170415010|NCT01893905|615860382|FG000|Overall Study|Protocol Violation|6|||
170415011|NCT01893905|615860383|FG001|Overall Study|Protocol Violation|1|||
170415012|NCT01893905|615860382|FG000|Overall Study|Lack of adherence to treatment|2|||
170415013|NCT01893905|615860383|FG001|Overall Study|Lack of adherence to treatment|0|||
170415014|NCT01893905|615860382|FG000|Overall Study|Other reason|1|||
170875644|NCT01202279|617554554|FG000|Overall Study|Lost to Follow-up|10|||
170875645|NCT01202279|617554555|FG001|Overall Study|Lost to Follow-up|7|||
170875646|NCT01202279|617554554|FG000|Overall Study|Protocol Violation|1|||
170875647|NCT01202279|617554555|FG001|Overall Study|Protocol Violation|1|||
170415015|NCT01893905|615860383|FG001|Overall Study|Other reason|3|||
170415016|NCT00278200|615860385|FG000|Overall Study|Death|1|||
170415017|NCT00278200|615860386|FG001|Overall Study|Death|3|||
170875648|NCT01202279|617554554|FG000|Overall Study|study compliance|5|||
170875649|NCT01202279|617554555|FG001|Overall Study|study compliance|2|||
170875650|NCT02047253|617554556|FG000|Overall Study|Lost to Follow-up|8|||
170875651|NCT03574753|617554557|FG000|Overall Study|Adverse Event|3|||
170875652|NCT03574753|617554557|FG000|Overall Study|Progression/relapse|19|||
170875653|NCT03574753|617554557|FG000|Overall Study|Death|1|||
170875654|NCT01984164|617554558|FG000|Overall Study|Withdrawal by Subject|4|||
170875655|NCT01984164|617554559|FG001|Overall Study|Withdrawal by Subject|3|||
170875656|NCT01984164|617554558|FG000|Overall Study|Adverse Event|5|||
170875657|NCT01984164|617554559|FG001|Overall Study|Adverse Event|19|||
170875658|NCT01984164|617554558|FG000|Overall Study|Lost to Follow-up|1|||
170875659|NCT01984164|617554559|FG001|Overall Study|Lost to Follow-up|3|||
170875660|NCT03472924|617554560|FG000|Overall Study|Adverse Event|1|||
170875661|NCT03472924|617554561|FG001|Overall Study|Adverse Event|0|||
170875662|NCT02109562|617554567|FG000|Overall Study|Insufficient clinical response|2|||
170875663|NCT02109562|617554568|FG001|Overall Study|Insufficient clinical response|0|||
170875664|NCT02109562|617554569|FG002|Overall Study|Insufficient clinical response|4|||
170875665|NCT02109562|617554567|FG000|Overall Study|Adverse Event|0|||
170875666|NCT02109562|617554568|FG001|Overall Study|Adverse Event|2|||
170875667|NCT02109562|617554569|FG002|Overall Study|Adverse Event|3|||
170875668|NCT02109562|617554567|FG000|Overall Study|Lost to Follow-up|1|||
170875669|NCT02109562|617554568|FG001|Overall Study|Lost to Follow-up|0|||
170875670|NCT02109562|617554569|FG002|Overall Study|Lost to Follow-up|1|||
170875671|NCT02109562|617554567|FG000|Overall Study|Protocol Violation|0|||
170875672|NCT02109562|617554568|FG001|Overall Study|Protocol Violation|3|||
170875673|NCT02109562|617554569|FG002|Overall Study|Protocol Violation|1|||
170875674|NCT02109562|617554567|FG000|Overall Study|Withdrawal by Subject|20|||
170875675|NCT02109562|617554568|FG001|Overall Study|Withdrawal by Subject|25|||
170875676|NCT02109562|617554569|FG002|Overall Study|Withdrawal by Subject|21|||
170875677|NCT02109562|617554567|FG000|Overall Study|Physician Decision|3|||
170875678|NCT02109562|617554568|FG001|Overall Study|Physician Decision|4|||
170875679|NCT02109562|617554569|FG002|Overall Study|Physician Decision|5|||
170875680|NCT04425720|617554570|FG000|Overall Study|Withdrawal by Subject|0|||
170875681|NCT04425720|617554571|FG001|Overall Study|Withdrawal by Subject|20|||
170875682|NCT02044133|617554572|FG000|Overall Study|Lost to Follow-up|1|||
170875683|NCT02044133|617554573|FG001|Overall Study|Lost to Follow-up|1|||
170875684|NCT02044133|617554572|FG000|Overall Study|Death|1|||
170875685|NCT02044133|617554573|FG001|Overall Study|Death|0|||
170875686|NCT02044133|617554572|FG000|Overall Study|Release|3|||
170875687|NCT02044133|617554573|FG001|Overall Study|Release|4|||
170875688|NCT02044133|617554572|FG000|Overall Study|Transfer|1|||
170875689|NCT02044133|617554573|FG001|Overall Study|Transfer|0|||
170875690|NCT02044133|617554572|FG000|Overall Study|refusal of blood sampling|0|||
170875691|NCT02044133|617554573|FG001|Overall Study|refusal of blood sampling|1|||
170875692|NCT05318937|617554576|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170875693|NCT05318937|617554577|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170875694|NCT05318937|617554576|FG000|Overall Study|Lost to Follow-up|0|||
170875695|NCT05318937|617554577|FG001|Overall Study|Lost to Follow-up|1|||
170875696|NCT05318937|617554576|FG000|Overall Study|Withdrawal by Subject|0|||
170875697|NCT05318937|617554577|FG001|Overall Study|Withdrawal by Subject|2|||
170875698|NCT05318937|617554576|FG000|Overall Study|Protocol Violation|0|||
170875699|NCT05318937|617554577|FG001|Overall Study|Protocol Violation|1|||
170875700|NCT02046096|617554585|FG000|Overall Study|Death|28|||
170875701|NCT02046096|617554586|FG001|Overall Study|Death|45|||
170875702|NCT02046096|617554585|FG000|Overall Study|Lost to Follow-up|9|||
170875703|NCT02046096|617554586|FG001|Overall Study|Lost to Follow-up|20|||
170875704|NCT02046096|617554585|FG000|Overall Study|Withdrawal by Subject|5|||
170875705|NCT02046096|617554586|FG001|Overall Study|Withdrawal by Subject|17|||
170875706|NCT02046096|617554585|FG000|Overall Study|Other endpoint|2|||
170875707|NCT02046096|617554586|FG001|Overall Study|Other endpoint|19|||
170875708|NCT03520959|617554587|FG000|Overall Study|Study terminated by Sponsor|0|||
170875709|NCT03520959|617554588|FG001|Overall Study|Study terminated by Sponsor|1|||
170875710|NCT00853749|617554589|FG000|Overall Study|Lost to Follow-up|0|||
170875711|NCT00853749|617554590|FG001|Overall Study|Lost to Follow-up|1|||
170875712|NCT03828292|617554593|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
170875713|NCT03828292|617554594|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
170875714|NCT03828292|617554595|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
170875715|NCT03828292|617554596|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
170875716|NCT03828292|617554597|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
170526426|NCT00369343|616275468|FG001|Double-blind Phase|Withdrawal by Subject|6|||
170875717|NCT03828292|617554598|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
170875718|NCT03828292|617554593|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
170875719|NCT03828292|617554594|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
170875720|NCT03828292|617554595|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
170875721|NCT03828292|617554596|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
170875722|NCT03828292|617554597|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
170875723|NCT03828292|617554598|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
170875724|NCT03828292|617554593|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
170875725|NCT03828292|617554594|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
170875726|NCT03828292|617554595|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
170875727|NCT03828292|617554596|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
170875728|NCT03828292|617554597|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
170875729|NCT03828292|617554598|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
170875730|NCT03828292|617554593|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
170875731|NCT03828292|617554594|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
170875732|NCT03828292|617554595|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
170875733|NCT03828292|617554596|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
170875734|NCT03828292|617554597|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
170875735|NCT03828292|617554598|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
170875736|NCT03828292|617554593|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
170875737|NCT03828292|617554594|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
170875738|NCT03828292|617554595|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
170875739|NCT03828292|617554596|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
170875740|NCT03828292|617554597|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
170875741|NCT03828292|617554598|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
170875742|NCT00430482|617554599|FG000|Completed Treatment|Insufficient Treatment|7|||
170875743|NCT00430482|617554600|FG001|Completed Treatment|Insufficient Treatment|11|||
170875744|NCT00390546|617556127|FG000|Overall Study|Renal impairment|1|||
170875745|NCT00390546|617556128|FG001|Overall Study|Renal impairment|0|||
170875746|NCT00390546|617556127|FG000|Overall Study|Physician Decision|5|||
170875747|NCT00390546|617556128|FG001|Overall Study|Physician Decision|5|||
170875748|NCT02463409|617556129|FG000|Overall Study|Withdrawal by Subject|1|||
170875749|NCT02463409|617556129|FG000|Overall Study|Screen failure|1|||
170875750|NCT01308008|617556130|FG000|4 Weeks|Illness, disinterest, time|9|||
170875751|NCT01308008|617556131|FG001|4 Weeks|Illness, disinterest, time|2|||
170775188|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
170775189|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
170775190|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
170875752|NCT03577730|617556132|FG000|Overall Study|Physician Decision|3|||
170875753|NCT03577730|617556133|FG001|Overall Study|Physician Decision|1|||
170875754|NCT03577730|617556132|FG000|Overall Study|Did not receive allocated intervention|1|||
170875755|NCT03577730|617556133|FG001|Overall Study|Did not receive allocated intervention|0|||
170875756|NCT01444742|617556134|FG000|Overall Study|Death|1|||
170875757|NCT02187172|617556135|FG000|Overall Study|Lost to Follow-up|1|||
170875758|NCT02187172|617556136|FG001|Overall Study|Lost to Follow-up|2|||
170875759|NCT02187172|617556135|FG000|Overall Study|Lack of Efficacy|1|||
170875760|NCT02187172|617556136|FG001|Overall Study|Lack of Efficacy|2|||
170875761|NCT02187172|617556135|FG000|Overall Study|Adverse Event|0|||
170875762|NCT02187172|617556136|FG001|Overall Study|Adverse Event|1|||
170875763|NCT02187172|617556135|FG000|Overall Study|Physician Decision|1|||
170875764|NCT02187172|617556136|FG001|Overall Study|Physician Decision|1|||
170875765|NCT02830880|617556142|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
170415018|NCT00278200|615860385|FG000|Overall Study|Physician Decision|0|||
170415019|NCT00278200|615860386|FG001|Overall Study|Physician Decision|1|||
170415020|NCT01691508|615860387|FG000|Overall Study|Adverse Event|3|||
170775191|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
170775192|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
170775193|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
170775194|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
170775195|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
170775196|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
170775197|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
170775198|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
170775199|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
170775200|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
170775201|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
170875766|NCT02830880|617556142|FG000|Overall Study|Death|1|||
170875767|NCT02830880|617556142|FG000|Overall Study|Physician Decision|1|||
170875768|NCT01368536|617556145|FG000|Overall Study|Adverse Event|5|||
170875769|NCT01368536|617556146|FG001|Overall Study|Adverse Event|6|||
170875770|NCT01368536|617556147|FG002|Overall Study|Adverse Event|8|||
170875771|NCT01368536|617556145|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170875772|NCT01368536|617556146|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170415021|NCT01691508|615860388|FG001|Overall Study|Adverse Event|3|||
170415022|NCT01691508|615860387|FG000|Overall Study|Withdrawal by Subject|1|||
170415023|NCT01691508|615860388|FG001|Overall Study|Withdrawal by Subject|0|||
170415024|NCT01296932|615860389|FG000|Overall Study|Dose limiting toxicity|0|||
170875773|NCT01368536|617556147|FG002|Overall Study|Abnormal laboratory value(s)|2|||
170875774|NCT01368536|617556145|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170875775|NCT01368536|617556146|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170526427|NCT00369343|616275467|FG000|Double-blind Phase|Lack of Efficacy|0|||
170415025|NCT01296932|615860390|FG001|Overall Study|Dose limiting toxicity|0|||
170415026|NCT01296932|615860391|FG002|Overall Study|Dose limiting toxicity|0|||
170775202|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
170775203|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
170775204|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
170775205|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
170775206|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
170775207|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
170775208|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
170775209|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
170775210|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
170775211|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
170775212|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
170775213|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
170775214|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
170775215|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
170775216|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
170775217|NCT02409667|617184724|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
170775218|NCT02409667|617184725|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
170775219|NCT02409667|617184726|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
170775220|NCT02409667|617184727|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
170775221|NCT02409667|617184728|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
170775222|NCT02409667|617184724|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
170775223|NCT02409667|617184725|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
170775224|NCT02409667|617184726|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
170775225|NCT02409667|617184727|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
170775226|NCT02409667|617184728|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
170775227|NCT02409667|617184724|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
170775228|NCT02409667|617184725|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
170775229|NCT02409667|617184726|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
170775230|NCT02409667|617184727|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
170775231|NCT02409667|617184728|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
170775232|NCT02409667|617184724|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
170775233|NCT02409667|617184725|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
170775234|NCT02409667|617184726|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
170775235|NCT02409667|617184727|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
170775236|NCT02409667|617184728|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
170775237|NCT02409667|617184724|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
170775238|NCT02409667|617184725|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
170775239|NCT02409667|617184726|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
170775240|NCT02409667|617184727|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
170775241|NCT02409667|617184728|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
170775242|NCT02409667|617184724|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
170775243|NCT02409667|617184725|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
170775244|NCT02409667|617184726|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
170775245|NCT02409667|617184727|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
170775246|NCT02409667|617184728|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
170775247|NCT02409667|617184724|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
170775248|NCT02409667|617184725|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
170775249|NCT02409667|617184726|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
170775250|NCT02409667|617184727|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
170775251|NCT02409667|617184728|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
170775252|NCT02409667|617184724|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
170775253|NCT02409667|617184725|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
170775254|NCT02409667|617184726|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
170775255|NCT02409667|617184727|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
170775256|NCT02409667|617184728|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
170775257|NCT01925339|617184729|FG000|Overall Study|Adverse Event|2|||
170775258|NCT01925339|617184730|FG001|Overall Study|Adverse Event|0|||
170775259|NCT00411216|617184731|FG000|Overall Study|Ten participants were entered into the c|0|||
170775260|NCT00411216|617184732|FG001|Overall Study|Ten participants were entered into the c|2|||
170775261|NCT05505045|617186944|FG000|Overall Study|Withdrawal by Subject|2|||
170775262|NCT05505045|617186945|FG001|Overall Study|Withdrawal by Subject|1|||
170775263|NCT01643070|617186946|FG000|Overall Study|Withdrawal by Subject|3|||
170775264|NCT01643070|617186947|FG001|Overall Study|Withdrawal by Subject|1|||
170775265|NCT01643070|617186946|FG000|Overall Study|Death|1|||
170775266|NCT01643070|617186947|FG001|Overall Study|Death|0|||
170775267|NCT01643070|617186946|FG000|Overall Study|Pregressive disease|0|||
170775268|NCT01643070|617186947|FG001|Overall Study|Pregressive disease|2|||
170775269|NCT00780416|617186948|FG000|Overall Study|Physician Decision|3|||
170775270|NCT00780416|617186949|FG001|Overall Study|Physician Decision|3|||
170775271|NCT00780416|617186948|FG000|Overall Study|Protocol Violation|1|||
170775272|NCT00780416|617186949|FG001|Overall Study|Protocol Violation|0|||
170415027|NCT01296932|615860392|FG003|Overall Study|Dose limiting toxicity|0|||
170415028|NCT01296932|615860393|FG004|Overall Study|Dose limiting toxicity|0|||
170415029|NCT01296932|615860394|FG005|Overall Study|Dose limiting toxicity|0|||
170415030|NCT01296932|615860395|FG006|Overall Study|Dose limiting toxicity|1|||
170415031|NCT01296932|615860396|FG007|Overall Study|Dose limiting toxicity|0|||
170415032|NCT01296932|615860397|FG008|Overall Study|Dose limiting toxicity|1|||
170775273|NCT00780416|617186948|FG000|Overall Study|Withdrawal by Subject|8|||
170775274|NCT00780416|617186949|FG001|Overall Study|Withdrawal by Subject|6|||
170775275|NCT03025789|617186950|FG000|Overall Study|Lack of Efficacy|6|||
170775276|NCT03025789|617186951|FG001|Overall Study|Lack of Efficacy|1|||
170775277|NCT03025789|617186950|FG000|Overall Study|Death|1|||
170775278|NCT03025789|617186951|FG001|Overall Study|Death|0|||
170775279|NCT03025789|617186950|FG000|Overall Study|Withdrawal by Subject|0|||
170775280|NCT03025789|617186951|FG001|Overall Study|Withdrawal by Subject|2|||
170775281|NCT03554265|617186952|FG000|Overall Study|Withdrawal by Subject|2|||
170775282|NCT03554265|617186953|FG001|Overall Study|Withdrawal by Subject|2|||
170775283|NCT03554265|617186954|FG002|Overall Study|Withdrawal by Subject|3|||
170775284|NCT03554265|617186952|FG000|Overall Study|Physician Decision|0|||
170775285|NCT03554265|617186953|FG001|Overall Study|Physician Decision|0|||
170775286|NCT03554265|617186954|FG002|Overall Study|Physician Decision|1|||
170775287|NCT02723955|617186955|FG000|Escalation Phase|Death|1|||
170775288|NCT02723955|617186956|FG001|Escalation Phase|Death|1|||
170775289|NCT02723955|617186957|FG002|Escalation Phase|Death|2|||
170775290|NCT02723955|617186958|FG003|Escalation Phase|Death|7|||
170775291|NCT02723955|617186959|FG004|Escalation Phase|Death|18|||
170775292|NCT02723955|617186960|FG005|Escalation Phase|Death|17|||
170775293|NCT02723955|617186961|FG006|Escalation Phase|Death|11|||
170775294|NCT02723955|617186962|FG007|Escalation Phase|Death|21|||
170775295|NCT02723955|617186963|FG008|Escalation Phase|Death|3|||
170775296|NCT02723955|617186964|FG009|Escalation Phase|Death|0|||
170775297|NCT02723955|617186965|FG010|Escalation Phase|Death|0|||
170775298|NCT02723955|617186966|FG011|Escalation Phase|Death|0|||
170775299|NCT02723955|617186967|FG012|Escalation Phase|Death|2|||
170775300|NCT02723955|617186968|FG013|Escalation Phase|Death|4|||
170775301|NCT02723955|617186969|FG014|Escalation Phase|Death|5|||
170775302|NCT02723955|617186970|FG015|Escalation Phase|Death|6|||
170775303|NCT02723955|617186971|FG016|Escalation Phase|Death|6|||
170775304|NCT02723955|617186972|FG017|Escalation Phase|Death|7|||
170775305|NCT02723955|617186973|FG018|Escalation Phase|Death|1|||
170775306|NCT02723955|617186974|FG019|Escalation Phase|Death|3|||
170775307|NCT02723955|617186975|FG020|Escalation Phase|Death|13|||
170775308|NCT02723955|617186976|FG021|Escalation Phase|Death|3|||
170775309|NCT02723955|617186977|FG022|Escalation Phase|Death|2|||
170775310|NCT02723955|617186978|FG023|Escalation Phase|Death|4|||
170775311|NCT02723955|617186979|FG024|Escalation Phase|Death|31|||
170775312|NCT02723955|617186980|FG025|Escalation Phase|Death|7|||
170775313|NCT02723955|617186981|FG026|Escalation Phase|Death|13|||
170775314|NCT02723955|617186982|FG027|Escalation Phase|Death|0|||
170775315|NCT02723955|617186983|FG028|Escalation Phase|Death|1|||
170775316|NCT02723955|617186984|FG029|Escalation Phase|Death|0|||
170775317|NCT02723955|617186985|FG030|Escalation Phase|Death|0|||
170775318|NCT02723955|617186986|FG031|Escalation Phase|Death|0|||
170775319|NCT02723955|617186987|FG032|Escalation Phase|Death|0|||
170775320|NCT02723955|617186988|FG033|Escalation Phase|Death|0|||
170775321|NCT02723955|617186989|FG034|Escalation Phase|Death|0|||
170415033|NCT01296932|615860389|FG000|Overall Study|Progressive disease|2|||
170415034|NCT01296932|615860390|FG001|Overall Study|Progressive disease|0|||
170415035|NCT01296932|615860391|FG002|Overall Study|Progressive disease|1|||
170415036|NCT01296932|615860392|FG003|Overall Study|Progressive disease|1|||
170775322|NCT02723955|617186990|FG035|Escalation Phase|Death|0|||
170775323|NCT02723955|617186991|FG036|Escalation Phase|Death|0|||
170775324|NCT02723955|617186992|FG037|Escalation Phase|Death|0|||
170775325|NCT02723955|617186993|FG038|Escalation Phase|Death|0|||
170775326|NCT02723955|617186994|FG039|Escalation Phase|Death|0|||
170775327|NCT02723955|617186995|FG040|Escalation Phase|Death|0|||
170775328|NCT02723955|617186996|FG041|Escalation Phase|Death|0|||
170775329|NCT02723955|617186997|FG042|Escalation Phase|Death|0|||
170775330|NCT02723955|617186955|FG000|Escalation Phase|Lost to Follow-up|0|||
170775331|NCT02723955|617186956|FG001|Escalation Phase|Lost to Follow-up|0|||
170415037|NCT01296932|615860393|FG004|Overall Study|Progressive disease|2|||
170775332|NCT02723955|617186957|FG002|Escalation Phase|Lost to Follow-up|0|||
170775333|NCT02723955|617186958|FG003|Escalation Phase|Lost to Follow-up|0|||
170415038|NCT01296932|615860394|FG005|Overall Study|Progressive disease|3|||
170775334|NCT02723955|617186959|FG004|Escalation Phase|Lost to Follow-up|0|||
170775335|NCT02723955|617186960|FG005|Escalation Phase|Lost to Follow-up|2|||
170775336|NCT02723955|617186961|FG006|Escalation Phase|Lost to Follow-up|1|||
170775337|NCT02723955|617186962|FG007|Escalation Phase|Lost to Follow-up|1|||
170775338|NCT02723955|617186963|FG008|Escalation Phase|Lost to Follow-up|1|||
170775339|NCT02723955|617186964|FG009|Escalation Phase|Lost to Follow-up|0|||
170775340|NCT02723955|617186965|FG010|Escalation Phase|Lost to Follow-up|0|||
170775341|NCT02723955|617186966|FG011|Escalation Phase|Lost to Follow-up|0|||
170775342|NCT02723955|617186967|FG012|Escalation Phase|Lost to Follow-up|1|||
170775343|NCT02723955|617186968|FG013|Escalation Phase|Lost to Follow-up|0|||
170775344|NCT02723955|617186969|FG014|Escalation Phase|Lost to Follow-up|0|||
170775345|NCT02723955|617186970|FG015|Escalation Phase|Lost to Follow-up|0|||
170775346|NCT02723955|617186971|FG016|Escalation Phase|Lost to Follow-up|1|||
170775347|NCT02723955|617186972|FG017|Escalation Phase|Lost to Follow-up|2|||
170775348|NCT02723955|617186973|FG018|Escalation Phase|Lost to Follow-up|0|||
170775349|NCT02723955|617186974|FG019|Escalation Phase|Lost to Follow-up|1|||
170775350|NCT02723955|617186975|FG020|Escalation Phase|Lost to Follow-up|2|||
170775351|NCT02723955|617186976|FG021|Escalation Phase|Lost to Follow-up|1|||
170775352|NCT02723955|617186977|FG022|Escalation Phase|Lost to Follow-up|0|||
170775353|NCT02723955|617186978|FG023|Escalation Phase|Lost to Follow-up|0|||
170775354|NCT02723955|617186979|FG024|Escalation Phase|Lost to Follow-up|1|||
170775355|NCT02723955|617186980|FG025|Escalation Phase|Lost to Follow-up|1|||
170775356|NCT02723955|617186981|FG026|Escalation Phase|Lost to Follow-up|3|||
170775357|NCT02723955|617186982|FG027|Escalation Phase|Lost to Follow-up|0|||
170775358|NCT02723955|617186983|FG028|Escalation Phase|Lost to Follow-up|1|||
170775359|NCT02723955|617186984|FG029|Escalation Phase|Lost to Follow-up|0|||
170775360|NCT02723955|617186985|FG030|Escalation Phase|Lost to Follow-up|0|||
170775361|NCT02723955|617186986|FG031|Escalation Phase|Lost to Follow-up|0|||
170775362|NCT02723955|617186987|FG032|Escalation Phase|Lost to Follow-up|0|||
170775363|NCT02723955|617186988|FG033|Escalation Phase|Lost to Follow-up|0|||
170775364|NCT02723955|617186989|FG034|Escalation Phase|Lost to Follow-up|0|||
170775365|NCT02723955|617186990|FG035|Escalation Phase|Lost to Follow-up|0|||
170775366|NCT02723955|617186991|FG036|Escalation Phase|Lost to Follow-up|0|||
170775367|NCT02723955|617186992|FG037|Escalation Phase|Lost to Follow-up|0|||
170775368|NCT02723955|617186993|FG038|Escalation Phase|Lost to Follow-up|0|||
170775369|NCT02723955|617186994|FG039|Escalation Phase|Lost to Follow-up|0|||
170775370|NCT02723955|617186995|FG040|Escalation Phase|Lost to Follow-up|0|||
170775371|NCT02723955|617186996|FG041|Escalation Phase|Lost to Follow-up|0|||
170775372|NCT02723955|617186997|FG042|Escalation Phase|Lost to Follow-up|0|||
170775373|NCT02723955|617186955|FG000|Escalation Phase|Physician Decision|0|||
170775374|NCT02723955|617186956|FG001|Escalation Phase|Physician Decision|0|||
170775375|NCT02723955|617186957|FG002|Escalation Phase|Physician Decision|0|||
170775376|NCT02723955|617186958|FG003|Escalation Phase|Physician Decision|0|||
170775377|NCT02723955|617186959|FG004|Escalation Phase|Physician Decision|0|||
170775378|NCT02723955|617186960|FG005|Escalation Phase|Physician Decision|2|||
170775379|NCT02723955|617186961|FG006|Escalation Phase|Physician Decision|0|||
170775380|NCT02723955|617186962|FG007|Escalation Phase|Physician Decision|0|||
170775381|NCT02723955|617186963|FG008|Escalation Phase|Physician Decision|0|||
170775382|NCT02723955|617186964|FG009|Escalation Phase|Physician Decision|0|||
170775383|NCT02723955|617186965|FG010|Escalation Phase|Physician Decision|0|||
170775384|NCT02723955|617186966|FG011|Escalation Phase|Physician Decision|0|||
170775385|NCT02723955|617186967|FG012|Escalation Phase|Physician Decision|0|||
170775386|NCT02723955|617186968|FG013|Escalation Phase|Physician Decision|0|||
170775387|NCT02723955|617186969|FG014|Escalation Phase|Physician Decision|0|||
170775388|NCT02723955|617186970|FG015|Escalation Phase|Physician Decision|0|||
170775389|NCT02723955|617186971|FG016|Escalation Phase|Physician Decision|0|||
170775390|NCT02723955|617186972|FG017|Escalation Phase|Physician Decision|0|||
170775391|NCT02723955|617186973|FG018|Escalation Phase|Physician Decision|0|||
170775392|NCT02723955|617186974|FG019|Escalation Phase|Physician Decision|0|||
170775393|NCT02723955|617186975|FG020|Escalation Phase|Physician Decision|0|||
170775394|NCT02723955|617186976|FG021|Escalation Phase|Physician Decision|0|||
170775395|NCT02723955|617186977|FG022|Escalation Phase|Physician Decision|0|||
170775396|NCT02723955|617186978|FG023|Escalation Phase|Physician Decision|0|||
170775397|NCT02723955|617186979|FG024|Escalation Phase|Physician Decision|0|||
170775398|NCT02723955|617186980|FG025|Escalation Phase|Physician Decision|0|||
170775399|NCT02723955|617186981|FG026|Escalation Phase|Physician Decision|2|||
170775400|NCT02723955|617186982|FG027|Escalation Phase|Physician Decision|0|||
170775401|NCT02723955|617186983|FG028|Escalation Phase|Physician Decision|0|||
170775402|NCT02723955|617186984|FG029|Escalation Phase|Physician Decision|0|||
170775403|NCT02723955|617186985|FG030|Escalation Phase|Physician Decision|0|||
170775404|NCT02723955|617186986|FG031|Escalation Phase|Physician Decision|0|||
170775405|NCT02723955|617186987|FG032|Escalation Phase|Physician Decision|0|||
170775406|NCT02723955|617186988|FG033|Escalation Phase|Physician Decision|0|||
170775407|NCT02723955|617186989|FG034|Escalation Phase|Physician Decision|0|||
170775408|NCT02723955|617186990|FG035|Escalation Phase|Physician Decision|0|||
170775409|NCT02723955|617186991|FG036|Escalation Phase|Physician Decision|0|||
170775410|NCT02723955|617186992|FG037|Escalation Phase|Physician Decision|0|||
170775411|NCT02723955|617186993|FG038|Escalation Phase|Physician Decision|0|||
170775412|NCT02723955|617186994|FG039|Escalation Phase|Physician Decision|0|||
170775413|NCT02723955|617186995|FG040|Escalation Phase|Physician Decision|0|||
170775414|NCT02723955|617186996|FG041|Escalation Phase|Physician Decision|0|||
170775415|NCT02723955|617186997|FG042|Escalation Phase|Physician Decision|0|||
170775416|NCT02723955|617186955|FG000|Escalation Phase|Withdrawal by Subject|0|||
170775417|NCT02723955|617186956|FG001|Escalation Phase|Withdrawal by Subject|0|||
170775418|NCT02723955|617186957|FG002|Escalation Phase|Withdrawal by Subject|0|||
170775419|NCT02723955|617186958|FG003|Escalation Phase|Withdrawal by Subject|0|||
170775420|NCT02723955|617186959|FG004|Escalation Phase|Withdrawal by Subject|1|||
170775421|NCT02723955|617186960|FG005|Escalation Phase|Withdrawal by Subject|1|||
170775422|NCT02723955|617186961|FG006|Escalation Phase|Withdrawal by Subject|1|||
170775423|NCT02723955|617186962|FG007|Escalation Phase|Withdrawal by Subject|1|||
170775424|NCT02723955|617186963|FG008|Escalation Phase|Withdrawal by Subject|0|||
170775425|NCT02723955|617186964|FG009|Escalation Phase|Withdrawal by Subject|0|||
170775426|NCT02723955|617186965|FG010|Escalation Phase|Withdrawal by Subject|0|||
170775427|NCT02723955|617186966|FG011|Escalation Phase|Withdrawal by Subject|0|||
170775428|NCT02723955|617186967|FG012|Escalation Phase|Withdrawal by Subject|1|||
170775429|NCT02723955|617186968|FG013|Escalation Phase|Withdrawal by Subject|0|||
170775430|NCT02723955|617186969|FG014|Escalation Phase|Withdrawal by Subject|0|||
170775431|NCT02723955|617186970|FG015|Escalation Phase|Withdrawal by Subject|0|||
170775432|NCT02723955|617186971|FG016|Escalation Phase|Withdrawal by Subject|1|||
170775433|NCT02723955|617186972|FG017|Escalation Phase|Withdrawal by Subject|0|||
170775434|NCT02723955|617186973|FG018|Escalation Phase|Withdrawal by Subject|0|||
170775435|NCT02723955|617186974|FG019|Escalation Phase|Withdrawal by Subject|0|||
170775436|NCT02723955|617186975|FG020|Escalation Phase|Withdrawal by Subject|0|||
170775437|NCT02723955|617186976|FG021|Escalation Phase|Withdrawal by Subject|0|||
170775438|NCT02723955|617186977|FG022|Escalation Phase|Withdrawal by Subject|0|||
170775439|NCT02723955|617186978|FG023|Escalation Phase|Withdrawal by Subject|2|||
170775440|NCT02723955|617186979|FG024|Escalation Phase|Withdrawal by Subject|0|||
170775441|NCT02723955|617186980|FG025|Escalation Phase|Withdrawal by Subject|1|||
170775442|NCT02723955|617186981|FG026|Escalation Phase|Withdrawal by Subject|0|||
170775443|NCT02723955|617186982|FG027|Escalation Phase|Withdrawal by Subject|0|||
170775444|NCT02723955|617186983|FG028|Escalation Phase|Withdrawal by Subject|1|||
170775445|NCT02723955|617186984|FG029|Escalation Phase|Withdrawal by Subject|0|||
170775446|NCT02723955|617186985|FG030|Escalation Phase|Withdrawal by Subject|0|||
170775447|NCT02723955|617186986|FG031|Escalation Phase|Withdrawal by Subject|0|||
170775448|NCT02723955|617186987|FG032|Escalation Phase|Withdrawal by Subject|0|||
170775449|NCT02723955|617186988|FG033|Escalation Phase|Withdrawal by Subject|0|||
170775450|NCT02723955|617186989|FG034|Escalation Phase|Withdrawal by Subject|0|||
170775451|NCT02723955|617186990|FG035|Escalation Phase|Withdrawal by Subject|0|||
170775452|NCT02723955|617186991|FG036|Escalation Phase|Withdrawal by Subject|0|||
170775453|NCT02723955|617186992|FG037|Escalation Phase|Withdrawal by Subject|0|||
170775454|NCT02723955|617186993|FG038|Escalation Phase|Withdrawal by Subject|0|||
170775455|NCT02723955|617186994|FG039|Escalation Phase|Withdrawal by Subject|0|||
170775456|NCT02723955|617186995|FG040|Escalation Phase|Withdrawal by Subject|0|||
170775457|NCT02723955|617186996|FG041|Escalation Phase|Withdrawal by Subject|0|||
170775458|NCT02723955|617186997|FG042|Escalation Phase|Withdrawal by Subject|0|||
170775459|NCT02723955|617186955|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775460|NCT02723955|617186956|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775461|NCT02723955|617186957|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775462|NCT02723955|617186958|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775463|NCT02723955|617186959|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
170775464|NCT02723955|617186960|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
170775465|NCT02723955|617186961|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
170775466|NCT02723955|617186962|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
170775467|NCT02723955|617186963|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
170775468|NCT02723955|617186964|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775469|NCT02723955|617186965|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775470|NCT02723955|617186966|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775471|NCT02723955|617186967|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775472|NCT02723955|617186968|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775473|NCT02723955|617186969|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775474|NCT02723955|617186970|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775475|NCT02723955|617186971|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775476|NCT02723955|617186972|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775477|NCT02723955|617186973|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775478|NCT02723955|617186974|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170875776|NCT01368536|617556147|FG002|Overall Study|Abnormal test procedure result(s)|1|||
170875777|NCT01368536|617556145|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
170875778|NCT01368536|617556146|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170875779|NCT01368536|617556147|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
170875780|NCT01368536|617556145|FG000|Overall Study|No longer required study medication|0|||
170875781|NCT01368536|617556146|FG001|Overall Study|No longer required study medication|0|||
170875782|NCT01368536|617556147|FG002|Overall Study|No longer required study medication|1|||
170875783|NCT01368536|617556145|FG000|Overall Study|Withdrawal by Subject|2|||
170875784|NCT01368536|617556146|FG001|Overall Study|Withdrawal by Subject|5|||
170875785|NCT01368536|617556147|FG002|Overall Study|Withdrawal by Subject|4|||
170875786|NCT01368536|617556145|FG000|Overall Study|Lost to Follow-up|3|||
170875787|NCT01368536|617556146|FG001|Overall Study|Lost to Follow-up|3|||
170875788|NCT01368536|617556147|FG002|Overall Study|Lost to Follow-up|5|||
170526428|NCT00369343|616275468|FG001|Double-blind Phase|Lack of Efficacy|4|||
170526429|NCT00369343|616275467|FG000|Double-blind Phase|Protocol deviation|4|||
170526430|NCT00369343|616275468|FG001|Double-blind Phase|Protocol deviation|0|||
170875789|NCT01368536|617556145|FG000|Overall Study|Administrative problems|34|||
170875790|NCT01368536|617556146|FG001|Overall Study|Administrative problems|39|||
170875791|NCT01368536|617556147|FG002|Overall Study|Administrative problems|35|||
170875792|NCT01368536|617556145|FG000|Overall Study|Protocol deviation|0|||
170875793|NCT01368536|617556146|FG001|Overall Study|Protocol deviation|3|||
170875794|NCT01368536|617556147|FG002|Overall Study|Protocol deviation|1|||
170875795|NCT01148537|617556150|FG000|Overall Study|Withdrawal by Subject|1|||
170875796|NCT01148537|617556151|FG001|Overall Study|Withdrawal by Subject|0|||
170875797|NCT01148537|617556152|FG002|Overall Study|Withdrawal by Subject|2|||
170875798|NCT01148537|617556150|FG000|Overall Study|Adverse Event|2|||
170875799|NCT01148537|617556151|FG001|Overall Study|Adverse Event|0|||
170875800|NCT01148537|617556152|FG002|Overall Study|Adverse Event|1|||
170875801|NCT01555151|617556153|FG000|Overall Study|Withdrawal by Subject|6|||
170875802|NCT01555151|617556154|FG001|Overall Study|Withdrawal by Subject|2|||
170875803|NCT01555151|617556155|FG002|Overall Study|Withdrawal by Subject|0|||
170875804|NCT01555151|617556156|FG003|Overall Study|Withdrawal by Subject|2|||
170875805|NCT01555151|617556153|FG000|Overall Study|Administrative|3|||
170875806|NCT01555151|617556154|FG001|Overall Study|Administrative|1|||
170875807|NCT01555151|617556155|FG002|Overall Study|Administrative|2|||
170875808|NCT01555151|617556156|FG003|Overall Study|Administrative|0|||
170875809|NCT01555151|617556153|FG000|Overall Study|Protocol Violation|3|||
170875810|NCT01555151|617556154|FG001|Overall Study|Protocol Violation|3|||
170875811|NCT01555151|617556155|FG002|Overall Study|Protocol Violation|3|||
170875812|NCT01555151|617556156|FG003|Overall Study|Protocol Violation|5|||
170875813|NCT01555151|617556153|FG000|Overall Study|Adverse Event|1|||
170875814|NCT01555151|617556154|FG001|Overall Study|Adverse Event|2|||
170875815|NCT01555151|617556155|FG002|Overall Study|Adverse Event|1|||
170875816|NCT01555151|617556156|FG003|Overall Study|Adverse Event|2|||
170875817|NCT01555151|617556153|FG000|Overall Study|Lost to Follow-up|0|||
170875818|NCT01555151|617556154|FG001|Overall Study|Lost to Follow-up|0|||
170875819|NCT01555151|617556155|FG002|Overall Study|Lost to Follow-up|0|||
170875820|NCT01555151|617556156|FG003|Overall Study|Lost to Follow-up|1|||
170875821|NCT03596866|617556157|FG000|Overall Study|Site terminated by Sponsor|64|||
170875822|NCT03596866|617556158|FG001|Overall Study|Site terminated by Sponsor|65|||
170875823|NCT03596866|617556157|FG000|Overall Study|Death|37|||
170875824|NCT03596866|617556158|FG001|Overall Study|Death|24|||
170875825|NCT03596866|617556157|FG000|Overall Study|Withdrawal by Subject|4|||
170875826|NCT03596866|617556158|FG001|Overall Study|Withdrawal by Subject|6|||
170875827|NCT03596866|617556157|FG000|Overall Study|Missing|0|||
170875828|NCT03596866|617556158|FG001|Overall Study|Missing|6|||
170875829|NCT03596866|617556157|FG000|Overall Study|Lost to Follow-up|2|||
170875830|NCT03596866|617556158|FG001|Overall Study|Lost to Follow-up|3|||
170875831|NCT03596866|617556157|FG000|Overall Study|Protocol Violation|1|||
170875832|NCT03596866|617556158|FG001|Overall Study|Protocol Violation|0|||
170875833|NCT03596866|617556157|FG000|Overall Study|Reason Not Specified|14|||
170875834|NCT03596866|617556158|FG001|Overall Study|Reason Not Specified|13|||
170875835|NCT01961349|617556159|FG000|Overall Study|Withdrawal by Subject|1|||
170875836|NCT01961349|617556160|FG001|Overall Study|Withdrawal by Subject|4|||
170875837|NCT01961349|617556161|FG002|Overall Study|Withdrawal by Subject|0|||
170875838|NCT01961349|617556159|FG000|Overall Study|Adverse Event|0|||
170875839|NCT01961349|617556160|FG001|Overall Study|Adverse Event|0|||
170875840|NCT01961349|617556161|FG002|Overall Study|Adverse Event|1|||
170526431|NCT00369343|616275467|FG000|Open-label Phase|Adverse Event|19|||
170526432|NCT00369343|616275468|FG001|Open-label Phase|Adverse Event|7|||
170526433|NCT00369343|616275467|FG000|Open-label Phase|Failed to return|4|||
170875841|NCT01961349|617556159|FG000|Overall Study|registration error, personal reason etc|2|||
170875842|NCT01961349|617556160|FG001|Overall Study|registration error, personal reason etc|2|||
170875843|NCT01961349|617556161|FG002|Overall Study|registration error, personal reason etc|1|||
170875844|NCT04770532|617556162|FG000|Overall Study|Withdrawal by Subject|0|||
170875845|NCT04770532|617556163|FG001|Overall Study|Withdrawal by Subject|3|||
170875846|NCT04770532|617556162|FG000|Overall Study|Physician Decision|1|||
170875847|NCT04770532|617556163|FG001|Overall Study|Physician Decision|0|||
170875848|NCT04770532|617556162|FG000|Overall Study|Death|2|||
170875849|NCT04770532|617556163|FG001|Overall Study|Death|2|||
170875850|NCT00596947|617556167|FG000|Overall Study|study halted due to low enrollment|5|||
170875851|NCT00596947|617556168|FG001|Overall Study|study halted due to low enrollment|3|||
170775479|NCT02723955|617186975|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775480|NCT02723955|617186976|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775481|NCT02723955|617186977|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775482|NCT02723955|617186978|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775483|NCT02723955|617186979|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775484|NCT02723955|617186980|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775485|NCT02723955|617186981|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170526434|NCT00369343|616275468|FG001|Open-label Phase|Failed to return|0|||
170775486|NCT02723955|617186982|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775487|NCT02723955|617186983|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775488|NCT02723955|617186984|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775489|NCT02723955|617186985|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775490|NCT02723955|617186986|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775491|NCT02723955|617186987|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775492|NCT02723955|617186988|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775493|NCT02723955|617186989|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775494|NCT02723955|617186990|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775495|NCT02723955|617186991|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775496|NCT02723955|617186992|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775497|NCT02723955|617186993|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775498|NCT02723955|617186994|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775499|NCT02723955|617186995|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775500|NCT02723955|617186996|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775501|NCT02723955|617186997|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
170775502|NCT02723955|617186955|FG000|Escalation Phase|Site Closed|0|||
170775503|NCT02723955|617186956|FG001|Escalation Phase|Site Closed|0|||
170775504|NCT02723955|617186957|FG002|Escalation Phase|Site Closed|0|||
170775505|NCT02723955|617186958|FG003|Escalation Phase|Site Closed|0|||
170775506|NCT02723955|617186959|FG004|Escalation Phase|Site Closed|0|||
170775507|NCT02723955|617186960|FG005|Escalation Phase|Site Closed|0|||
170775508|NCT02723955|617186961|FG006|Escalation Phase|Site Closed|0|||
170775509|NCT02723955|617186962|FG007|Escalation Phase|Site Closed|0|||
170775510|NCT02723955|617186963|FG008|Escalation Phase|Site Closed|0|||
170775511|NCT02723955|617186964|FG009|Escalation Phase|Site Closed|0|||
170775512|NCT02723955|617186965|FG010|Escalation Phase|Site Closed|0|||
170775513|NCT02723955|617186966|FG011|Escalation Phase|Site Closed|0|||
170775514|NCT02723955|617186967|FG012|Escalation Phase|Site Closed|0|||
170775515|NCT02723955|617186968|FG013|Escalation Phase|Site Closed|0|||
170775516|NCT02723955|617186969|FG014|Escalation Phase|Site Closed|0|||
170775517|NCT02723955|617186970|FG015|Escalation Phase|Site Closed|1|||
170775518|NCT02723955|617186971|FG016|Escalation Phase|Site Closed|0|||
170775519|NCT02723955|617186972|FG017|Escalation Phase|Site Closed|2|||
170775520|NCT02723955|617186973|FG018|Escalation Phase|Site Closed|0|||
170775521|NCT02723955|617186974|FG019|Escalation Phase|Site Closed|0|||
170775522|NCT02723955|617186975|FG020|Escalation Phase|Site Closed|1|||
170775523|NCT02723955|617186976|FG021|Escalation Phase|Site Closed|0|||
170775524|NCT02723955|617186977|FG022|Escalation Phase|Site Closed|0|||
170775525|NCT02723955|617186978|FG023|Escalation Phase|Site Closed|0|||
170775526|NCT02723955|617186979|FG024|Escalation Phase|Site Closed|3|||
170775527|NCT02723955|617186980|FG025|Escalation Phase|Site Closed|1|||
170875852|NCT00596947|617556167|FG000|Overall Study|Lost to Follow-up|1|||
170875853|NCT00596947|617556168|FG001|Overall Study|Lost to Follow-up|0|||
170875854|NCT03000179|617556169|FG000|Overall Study|Lost to Follow-up|2|||
170526435|NCT00369343|616275467|FG000|Open-label Phase|Physician Decision|2|||
170526436|NCT00369343|616275468|FG001|Open-label Phase|Physician Decision|0|||
170526437|NCT00369343|616275467|FG000|Open-label Phase|Lost to Follow-up|5|||
170526438|NCT00369343|616275468|FG001|Open-label Phase|Lost to Follow-up|3|||
170526439|NCT00369343|616275467|FG000|Open-label Phase|inadvertently reported study completers|3|||
170526440|NCT00369343|616275468|FG001|Open-label Phase|inadvertently reported study completers|2|||
170526441|NCT00369343|616275467|FG000|Open-label Phase|Protocol Violation|1|||
170775528|NCT02723955|617186981|FG026|Escalation Phase|Site Closed|3|||
170775529|NCT02723955|617186982|FG027|Escalation Phase|Site Closed|1|||
170775530|NCT02723955|617186983|FG028|Escalation Phase|Site Closed|1|||
170875855|NCT00271596|617556170|FG000|Overall Study|Protocol Violation|1|||
170875856|NCT00271596|617556171|FG001|Overall Study|Protocol Violation|0|||
170875857|NCT00271596|617556170|FG000|Overall Study|Withdrawal by Subject|0|||
170875858|NCT00271596|617556171|FG001|Overall Study|Withdrawal by Subject|1|||
170875859|NCT04707157|617556172|FG000|Overall Study|Adverse Event|12|||
170875860|NCT04707157|617556173|FG001|Overall Study|Adverse Event|3|||
170875861|NCT04707157|617556172|FG000|Overall Study|Lost to Follow-up|2|||
170875862|NCT04707157|617556173|FG001|Overall Study|Lost to Follow-up|0|||
170875863|NCT04707157|617556172|FG000|Overall Study|Sponsor's decision|1|||
170875864|NCT04707157|617556173|FG001|Overall Study|Sponsor's decision|0|||
170875865|NCT04707157|617556172|FG000|Overall Study|Physician Decision|8|||
170875866|NCT04707157|617556173|FG001|Overall Study|Physician Decision|5|||
170875867|NCT04707157|617556172|FG000|Overall Study|Protocol Deviation|1|||
170875868|NCT04707157|617556173|FG001|Overall Study|Protocol Deviation|0|||
170875869|NCT04707157|617556172|FG000|Overall Study|Withdrawal by Subject|1|||
170875870|NCT04707157|617556173|FG001|Overall Study|Withdrawal by Subject|1|||
170875871|NCT02969915|617556174|FG000|Overall Study|Death|104|||
170875872|NCT02969915|617556175|FG001|Overall Study|Death|125|||
170875873|NCT02969915|617556174|FG000|Overall Study|Lost to Follow-up|108|||
170875874|NCT02969915|617556175|FG001|Overall Study|Lost to Follow-up|112|||
170875875|NCT02969915|617556174|FG000|Overall Study|Censored due to COVID-19|481|||
170875876|NCT02969915|617556175|FG001|Overall Study|Censored due to COVID-19|471|||
170875877|NCT03625687|617556177|FG000|Overall Study|Death|1|||
170875878|NCT00073528|617556178|FG000|Overall Study|Death|488|||
170875879|NCT00073528|617556179|FG001|Overall Study|Death|473|||
170875880|NCT00073528|617556178|FG000|Overall Study|Lost to Follow-up|52|||
170875881|NCT00073528|617556179|FG001|Overall Study|Lost to Follow-up|45|||
170875882|NCT00073528|617556178|FG000|Overall Study|Withdrawal by Subject|50|||
170875883|NCT00073528|617556179|FG001|Overall Study|Withdrawal by Subject|45|||
170875884|NCT00073528|617556178|FG000|Overall Study|Study terminated by Sponsor|10|||
170875885|NCT00073528|617556179|FG001|Overall Study|Study terminated by Sponsor|29|||
170875886|NCT00073528|617556178|FG000|Overall Study|Other|18|||
170875887|NCT00073528|617556179|FG001|Overall Study|Other|19|||
170875888|NCT00073528|617556178|FG000|Overall Study|Other|9|||
170875889|NCT00073528|617556179|FG001|Overall Study|Other|12|||
170875890|NCT00073528|617556178|FG000|Overall Study|Protocol Violation|3|||
170875891|NCT00073528|617556179|FG001|Overall Study|Protocol Violation|5|||
170875892|NCT03086057|617556184|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
170875893|NCT03086057|617556185|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
170875894|NCT03086057|617556186|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
170875895|NCT03086057|617556187|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
170875896|NCT03086057|617556184|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
170875897|NCT03086057|617556185|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
170875898|NCT03086057|617556186|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
170875899|NCT03086057|617556187|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
170875900|NCT03086057|617556184|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
170875901|NCT03086057|617556185|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
170875902|NCT03086057|617556186|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
170875903|NCT03086057|617556187|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
170875904|NCT03086057|617556184|FG000|Stage 1: PrEP Uptake|Death|1|||
170875905|NCT03086057|617556185|FG001|Stage 1: PrEP Uptake|Death|0|||
170875906|NCT03086057|617556186|FG002|Stage 1: PrEP Uptake|Death|0|||
170875907|NCT03086057|617556187|FG003|Stage 1: PrEP Uptake|Death|0|||
170875908|NCT03086057|617556184|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
170875909|NCT03086057|617556185|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
170875910|NCT03086057|617556186|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
170875911|NCT03086057|617556187|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
170875912|NCT03086057|617556184|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
170875913|NCT03086057|617556185|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
170875914|NCT03086057|617556186|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
170875915|NCT03086057|617556187|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
170875916|NCT03086057|617556184|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
170875917|NCT03086057|617556185|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
170875918|NCT03086057|617556186|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
170875919|NCT03086057|617556187|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
170526442|NCT00369343|616275468|FG001|Open-label Phase|Protocol Violation|3|||
170875920|NCT00843518|617556188|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
170875921|NCT00843518|617556189|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
170875922|NCT00843518|617556188|FG000|Period 2 (Double-blind Treatment)|Death|0|||
170875923|NCT00843518|617556189|FG001|Period 2 (Double-blind Treatment)|Death|1|||
170875924|NCT00843518|617556188|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
170875925|NCT00843518|617556189|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
170875926|NCT00843518|617556188|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
170875927|NCT00843518|617556189|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
170875928|NCT00843518|617556188|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
170875929|NCT00843518|617556189|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
170875930|NCT00843518|617556188|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
170875931|NCT00843518|617556189|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
170875932|NCT00843518|617556188|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
170875933|NCT00843518|617556189|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
170875934|NCT00243386|617556190|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
170875935|NCT00243386|617556191|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
170875936|NCT00243386|617556192|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
170875937|NCT00243386|617556190|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
170875938|NCT00243386|617556191|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
170875939|NCT00243386|617556192|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
170875940|NCT00243386|617556190|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
170875941|NCT00243386|617556191|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
170875942|NCT00243386|617556192|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
170875943|NCT00243386|617556190|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
170875944|NCT00243386|617556191|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
170875945|NCT00243386|617556192|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
170875946|NCT00243386|617556190|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
170875947|NCT00243386|617556191|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
170875948|NCT00243386|617556192|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
170875949|NCT00243386|617556190|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
170875950|NCT00243386|617556191|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
170875951|NCT00243386|617556192|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
170875952|NCT00243386|617556190|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
170875953|NCT00243386|617556191|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
170875954|NCT00243386|617556192|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
170875955|NCT00243386|617556190|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
170875956|NCT00243386|617556191|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
170875957|NCT00243386|617556192|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
170875958|NCT04995055|617556193|FG000|Period 1|COVID-19 Related|1|||
170875959|NCT04995055|617556194|FG001|Period 1|COVID-19 Related|0|||
170875960|NCT04995055|617556193|FG000|Period 1|Withdrawal by Subject|0|||
170415039|NCT01296932|615860395|FG006|Overall Study|Progressive disease|1|||
170415040|NCT01296932|615860396|FG007|Overall Study|Progressive disease|0|||
170775531|NCT02723955|617186984|FG029|Escalation Phase|Site Closed|0|||
170775532|NCT02723955|617186985|FG030|Escalation Phase|Site Closed|0|||
170775533|NCT02723955|617186986|FG031|Escalation Phase|Site Closed|0|||
170775534|NCT02723955|617186987|FG032|Escalation Phase|Site Closed|0|||
170775535|NCT02723955|617186988|FG033|Escalation Phase|Site Closed|0|||
170775536|NCT02723955|617186989|FG034|Escalation Phase|Site Closed|0|||
170775537|NCT02723955|617186990|FG035|Escalation Phase|Site Closed|0|||
170775538|NCT02723955|617186991|FG036|Escalation Phase|Site Closed|0|||
170775539|NCT02723955|617186992|FG037|Escalation Phase|Site Closed|0|||
170775540|NCT02723955|617186993|FG038|Escalation Phase|Site Closed|0|||
170775541|NCT02723955|617186994|FG039|Escalation Phase|Site Closed|0|||
170775542|NCT02723955|617186995|FG040|Escalation Phase|Site Closed|0|||
170775543|NCT02723955|617186996|FG041|Escalation Phase|Site Closed|0|||
170775544|NCT02723955|617186997|FG042|Escalation Phase|Site Closed|0|||
170775545|NCT02723955|617186955|FG000|Expansion Phase|Death|0|||
170775546|NCT02723955|617186956|FG001|Expansion Phase|Death|0|||
170775547|NCT02723955|617186957|FG002|Expansion Phase|Death|0|||
170775548|NCT02723955|617186958|FG003|Expansion Phase|Death|0|||
170775549|NCT02723955|617186959|FG004|Expansion Phase|Death|0|||
170775550|NCT02723955|617186960|FG005|Expansion Phase|Death|0|||
170775551|NCT02723955|617186961|FG006|Expansion Phase|Death|0|||
170775552|NCT02723955|617186962|FG007|Expansion Phase|Death|0|||
170775553|NCT02723955|617186963|FG008|Expansion Phase|Death|0|||
170775554|NCT02723955|617186964|FG009|Expansion Phase|Death|25|||
170775555|NCT02723955|617186965|FG010|Expansion Phase|Death|69|||
170775556|NCT02723955|617186966|FG011|Expansion Phase|Death|48|||
170775557|NCT02723955|617186967|FG012|Expansion Phase|Death|0|||
170775558|NCT02723955|617186968|FG013|Expansion Phase|Death|0|||
170775559|NCT02723955|617186969|FG014|Expansion Phase|Death|0|||
170775560|NCT02723955|617186970|FG015|Expansion Phase|Death|0|||
170415041|NCT01296932|615860397|FG008|Overall Study|Progressive disease|0|||
170415042|NCT01296932|615860389|FG000|Overall Study|Withdrawal by Subject|0|||
170415043|NCT01296932|615860390|FG001|Overall Study|Withdrawal by Subject|0|||
170775561|NCT02723955|617186971|FG016|Expansion Phase|Death|0|||
170775562|NCT02723955|617186972|FG017|Expansion Phase|Death|0|||
170775563|NCT02723955|617186973|FG018|Expansion Phase|Death|0|||
170775564|NCT02723955|617186974|FG019|Expansion Phase|Death|0|||
170775565|NCT02723955|617186975|FG020|Expansion Phase|Death|0|||
170775566|NCT02723955|617186976|FG021|Expansion Phase|Death|0|||
170775567|NCT02723955|617186977|FG022|Expansion Phase|Death|0|||
170775568|NCT02723955|617186978|FG023|Expansion Phase|Death|0|||
170775569|NCT02723955|617186979|FG024|Expansion Phase|Death|0|||
170775570|NCT02723955|617186980|FG025|Expansion Phase|Death|0|||
170775571|NCT02723955|617186981|FG026|Expansion Phase|Death|0|||
170775572|NCT02723955|617186982|FG027|Expansion Phase|Death|0|||
170775573|NCT02723955|617186983|FG028|Expansion Phase|Death|0|||
170775574|NCT02723955|617186984|FG029|Expansion Phase|Death|12|||
170775575|NCT02723955|617186985|FG030|Expansion Phase|Death|202|||
170775576|NCT02723955|617186986|FG031|Expansion Phase|Death|31|||
170775577|NCT02723955|617186987|FG032|Expansion Phase|Death|17|||
170775578|NCT02723955|617186988|FG033|Expansion Phase|Death|2|||
170775579|NCT02723955|617186989|FG034|Expansion Phase|Death|3|||
170775580|NCT02723955|617186990|FG035|Expansion Phase|Death|3|||
170775581|NCT02723955|617186991|FG036|Expansion Phase|Death|1|||
170775582|NCT02723955|617186992|FG037|Expansion Phase|Death|0|||
170775583|NCT02723955|617186993|FG038|Expansion Phase|Death|0|||
170775584|NCT02723955|617186994|FG039|Expansion Phase|Death|0|||
170775585|NCT02723955|617186995|FG040|Expansion Phase|Death|0|||
170775586|NCT02723955|617186996|FG041|Expansion Phase|Death|0|||
170775587|NCT02723955|617186997|FG042|Expansion Phase|Death|0|||
170775588|NCT02723955|617186955|FG000|Expansion Phase|Lost to Follow-up|0|||
170775589|NCT02723955|617186956|FG001|Expansion Phase|Lost to Follow-up|0|||
170775590|NCT02723955|617186957|FG002|Expansion Phase|Lost to Follow-up|0|||
170775591|NCT02723955|617186958|FG003|Expansion Phase|Lost to Follow-up|0|||
170775592|NCT02723955|617186959|FG004|Expansion Phase|Lost to Follow-up|0|||
170775593|NCT02723955|617186960|FG005|Expansion Phase|Lost to Follow-up|0|||
170775594|NCT02723955|617186961|FG006|Expansion Phase|Lost to Follow-up|0|||
170775595|NCT02723955|617186962|FG007|Expansion Phase|Lost to Follow-up|0|||
170775596|NCT02723955|617186963|FG008|Expansion Phase|Lost to Follow-up|0|||
170775597|NCT02723955|617186964|FG009|Expansion Phase|Lost to Follow-up|0|||
170775598|NCT02723955|617186965|FG010|Expansion Phase|Lost to Follow-up|4|||
170775599|NCT02723955|617186966|FG011|Expansion Phase|Lost to Follow-up|1|||
170775600|NCT02723955|617186967|FG012|Expansion Phase|Lost to Follow-up|0|||
170775601|NCT02723955|617186968|FG013|Expansion Phase|Lost to Follow-up|0|||
170775602|NCT02723955|617186969|FG014|Expansion Phase|Lost to Follow-up|0|||
170775603|NCT02723955|617186970|FG015|Expansion Phase|Lost to Follow-up|0|||
170775604|NCT02723955|617186971|FG016|Expansion Phase|Lost to Follow-up|0|||
170775605|NCT02723955|617186972|FG017|Expansion Phase|Lost to Follow-up|0|||
170775606|NCT02723955|617186973|FG018|Expansion Phase|Lost to Follow-up|0|||
170775607|NCT02723955|617186974|FG019|Expansion Phase|Lost to Follow-up|0|||
170775608|NCT02723955|617186975|FG020|Expansion Phase|Lost to Follow-up|0|||
170775609|NCT02723955|617186976|FG021|Expansion Phase|Lost to Follow-up|0|||
170775610|NCT02723955|617186977|FG022|Expansion Phase|Lost to Follow-up|0|||
170775611|NCT02723955|617186978|FG023|Expansion Phase|Lost to Follow-up|0|||
170775612|NCT02723955|617186979|FG024|Expansion Phase|Lost to Follow-up|0|||
170775613|NCT02723955|617186980|FG025|Expansion Phase|Lost to Follow-up|0|||
170775614|NCT02723955|617186981|FG026|Expansion Phase|Lost to Follow-up|0|||
170775615|NCT02723955|617186982|FG027|Expansion Phase|Lost to Follow-up|0|||
170775616|NCT02723955|617186983|FG028|Expansion Phase|Lost to Follow-up|0|||
170775617|NCT02723955|617186984|FG029|Expansion Phase|Lost to Follow-up|1|||
170775618|NCT02723955|617186985|FG030|Expansion Phase|Lost to Follow-up|19|||
170775619|NCT02723955|617186986|FG031|Expansion Phase|Lost to Follow-up|2|||
170775620|NCT02723955|617186987|FG032|Expansion Phase|Lost to Follow-up|1|||
170775621|NCT02723955|617186988|FG033|Expansion Phase|Lost to Follow-up|0|||
170775622|NCT02723955|617186989|FG034|Expansion Phase|Lost to Follow-up|0|||
170775623|NCT02723955|617186990|FG035|Expansion Phase|Lost to Follow-up|0|||
170775624|NCT02723955|617186991|FG036|Expansion Phase|Lost to Follow-up|0|||
170775625|NCT02723955|617186992|FG037|Expansion Phase|Lost to Follow-up|0|||
170775626|NCT02723955|617186993|FG038|Expansion Phase|Lost to Follow-up|0|||
170775627|NCT02723955|617186994|FG039|Expansion Phase|Lost to Follow-up|0|||
170775628|NCT02723955|617186995|FG040|Expansion Phase|Lost to Follow-up|0|||
170775629|NCT02723955|617186996|FG041|Expansion Phase|Lost to Follow-up|0|||
170775630|NCT02723955|617186997|FG042|Expansion Phase|Lost to Follow-up|0|||
170775631|NCT02723955|617186955|FG000|Expansion Phase|Physician Decision|0|||
170775632|NCT02723955|617186956|FG001|Expansion Phase|Physician Decision|0|||
170775633|NCT02723955|617186957|FG002|Expansion Phase|Physician Decision|0|||
170775634|NCT02723955|617186958|FG003|Expansion Phase|Physician Decision|0|||
170775635|NCT02723955|617186959|FG004|Expansion Phase|Physician Decision|0|||
170775636|NCT02723955|617186960|FG005|Expansion Phase|Physician Decision|0|||
170775637|NCT02723955|617186961|FG006|Expansion Phase|Physician Decision|0|||
170775638|NCT02723955|617186962|FG007|Expansion Phase|Physician Decision|0|||
170775639|NCT02723955|617186963|FG008|Expansion Phase|Physician Decision|0|||
170875961|NCT04995055|617556194|FG001|Period 1|Withdrawal by Subject|1|||
170875962|NCT04995055|617556193|FG000|Period 1|Subject discontinued due to timing|4|||
170875963|NCT04995055|617556194|FG001|Period 1|Subject discontinued due to timing|4|||
170775640|NCT02723955|617186964|FG009|Expansion Phase|Physician Decision|0|||
170775641|NCT02723955|617186965|FG010|Expansion Phase|Physician Decision|0|||
170775642|NCT02723955|617186966|FG011|Expansion Phase|Physician Decision|0|||
170775643|NCT02723955|617186967|FG012|Expansion Phase|Physician Decision|0|||
170775644|NCT02723955|617186968|FG013|Expansion Phase|Physician Decision|0|||
170775645|NCT02723955|617186969|FG014|Expansion Phase|Physician Decision|0|||
170775646|NCT02723955|617186970|FG015|Expansion Phase|Physician Decision|0|||
170775647|NCT02723955|617186971|FG016|Expansion Phase|Physician Decision|0|||
170775648|NCT02723955|617186972|FG017|Expansion Phase|Physician Decision|0|||
170775649|NCT02723955|617186973|FG018|Expansion Phase|Physician Decision|0|||
170875964|NCT00974675|617556195|FG000|Overall Study|Adverse Event|2|||
170775650|NCT02723955|617186974|FG019|Expansion Phase|Physician Decision|0|||
170775651|NCT02723955|617186975|FG020|Expansion Phase|Physician Decision|0|||
170775652|NCT02723955|617186976|FG021|Expansion Phase|Physician Decision|0|||
170775653|NCT02723955|617186977|FG022|Expansion Phase|Physician Decision|0|||
170775654|NCT02723955|617186978|FG023|Expansion Phase|Physician Decision|0|||
170775655|NCT02723955|617186979|FG024|Expansion Phase|Physician Decision|0|||
170775656|NCT02723955|617186980|FG025|Expansion Phase|Physician Decision|0|||
170775657|NCT02723955|617186981|FG026|Expansion Phase|Physician Decision|0|||
170775658|NCT02723955|617186982|FG027|Expansion Phase|Physician Decision|0|||
170775659|NCT02723955|617186983|FG028|Expansion Phase|Physician Decision|0|||
170775660|NCT02723955|617186984|FG029|Expansion Phase|Physician Decision|0|||
170775661|NCT02723955|617186985|FG030|Expansion Phase|Physician Decision|1|||
170775662|NCT02723955|617186986|FG031|Expansion Phase|Physician Decision|1|||
170775663|NCT02723955|617186987|FG032|Expansion Phase|Physician Decision|0|||
170775664|NCT02723955|617186988|FG033|Expansion Phase|Physician Decision|0|||
170775665|NCT02723955|617186989|FG034|Expansion Phase|Physician Decision|0|||
170775666|NCT02723955|617186990|FG035|Expansion Phase|Physician Decision|0|||
170775667|NCT02723955|617186991|FG036|Expansion Phase|Physician Decision|0|||
170775668|NCT02723955|617186992|FG037|Expansion Phase|Physician Decision|0|||
170775669|NCT02723955|617186993|FG038|Expansion Phase|Physician Decision|0|||
170775670|NCT02723955|617186994|FG039|Expansion Phase|Physician Decision|0|||
170775671|NCT02723955|617186995|FG040|Expansion Phase|Physician Decision|0|||
170775672|NCT02723955|617186996|FG041|Expansion Phase|Physician Decision|0|||
170775673|NCT02723955|617186997|FG042|Expansion Phase|Physician Decision|0|||
170775674|NCT02723955|617186955|FG000|Expansion Phase|Withdrawal by Subject|0|||
170775675|NCT02723955|617186956|FG001|Expansion Phase|Withdrawal by Subject|0|||
170775676|NCT02723955|617186957|FG002|Expansion Phase|Withdrawal by Subject|0|||
170775677|NCT02723955|617186958|FG003|Expansion Phase|Withdrawal by Subject|0|||
170775678|NCT02723955|617186959|FG004|Expansion Phase|Withdrawal by Subject|0|||
170775679|NCT02723955|617186960|FG005|Expansion Phase|Withdrawal by Subject|0|||
170775680|NCT02723955|617186961|FG006|Expansion Phase|Withdrawal by Subject|0|||
170775681|NCT02723955|617186962|FG007|Expansion Phase|Withdrawal by Subject|0|||
170775682|NCT02723955|617186963|FG008|Expansion Phase|Withdrawal by Subject|0|||
170775683|NCT02723955|617186964|FG009|Expansion Phase|Withdrawal by Subject|2|||
170775684|NCT02723955|617186965|FG010|Expansion Phase|Withdrawal by Subject|1|||
170775685|NCT02723955|617186966|FG011|Expansion Phase|Withdrawal by Subject|0|||
170775686|NCT02723955|617186967|FG012|Expansion Phase|Withdrawal by Subject|0|||
170775687|NCT02723955|617186968|FG013|Expansion Phase|Withdrawal by Subject|0|||
170775688|NCT02723955|617186969|FG014|Expansion Phase|Withdrawal by Subject|0|||
170775689|NCT02723955|617186970|FG015|Expansion Phase|Withdrawal by Subject|0|||
170775690|NCT02723955|617186971|FG016|Expansion Phase|Withdrawal by Subject|0|||
170775691|NCT02723955|617186972|FG017|Expansion Phase|Withdrawal by Subject|0|||
170775692|NCT02723955|617186973|FG018|Expansion Phase|Withdrawal by Subject|0|||
170775693|NCT02723955|617186974|FG019|Expansion Phase|Withdrawal by Subject|0|||
170775694|NCT02723955|617186975|FG020|Expansion Phase|Withdrawal by Subject|0|||
170775695|NCT02723955|617186976|FG021|Expansion Phase|Withdrawal by Subject|0|||
170775696|NCT02723955|617186977|FG022|Expansion Phase|Withdrawal by Subject|0|||
170775697|NCT02723955|617186978|FG023|Expansion Phase|Withdrawal by Subject|0|||
170775698|NCT02723955|617186979|FG024|Expansion Phase|Withdrawal by Subject|0|||
170775699|NCT02723955|617186980|FG025|Expansion Phase|Withdrawal by Subject|0|||
170775700|NCT02723955|617186981|FG026|Expansion Phase|Withdrawal by Subject|0|||
170775701|NCT02723955|617186982|FG027|Expansion Phase|Withdrawal by Subject|0|||
170775702|NCT02723955|617186983|FG028|Expansion Phase|Withdrawal by Subject|0|||
170775703|NCT02723955|617186984|FG029|Expansion Phase|Withdrawal by Subject|0|||
170775704|NCT02723955|617186985|FG030|Expansion Phase|Withdrawal by Subject|8|||
170775705|NCT02723955|617186986|FG031|Expansion Phase|Withdrawal by Subject|4|||
170775706|NCT02723955|617186987|FG032|Expansion Phase|Withdrawal by Subject|0|||
170775707|NCT02723955|617186988|FG033|Expansion Phase|Withdrawal by Subject|0|||
170875965|NCT00974675|617556196|FG001|Overall Study|Adverse Event|1|||
170875966|NCT00974675|617556197|FG002|Overall Study|Adverse Event|1|||
170775708|NCT02723955|617186989|FG034|Expansion Phase|Withdrawal by Subject|0|||
170775709|NCT02723955|617186990|FG035|Expansion Phase|Withdrawal by Subject|1|||
170775710|NCT02723955|617186991|FG036|Expansion Phase|Withdrawal by Subject|0|||
170775711|NCT02723955|617186992|FG037|Expansion Phase|Withdrawal by Subject|0|||
170775712|NCT02723955|617186993|FG038|Expansion Phase|Withdrawal by Subject|0|||
170875967|NCT00974675|617556198|FG003|Overall Study|Adverse Event|1|||
170875968|NCT00974675|617556195|FG000|Overall Study|Physician Decision|0|||
170415044|NCT01296932|615860391|FG002|Overall Study|Withdrawal by Subject|1|||
170415045|NCT01296932|615860392|FG003|Overall Study|Withdrawal by Subject|1|||
170415046|NCT01296932|615860393|FG004|Overall Study|Withdrawal by Subject|0|||
170415047|NCT01296932|615860394|FG005|Overall Study|Withdrawal by Subject|0|||
170415048|NCT01296932|615860395|FG006|Overall Study|Withdrawal by Subject|3|||
170415049|NCT01296932|615860396|FG007|Overall Study|Withdrawal by Subject|0|||
170415050|NCT01296932|615860397|FG008|Overall Study|Withdrawal by Subject|0|||
170415051|NCT01296932|615860389|FG000|Overall Study|Adverse Event|1|||
170526443|NCT00369343|616275467|FG000|Open-label Phase|Withdrawal by Subject|15|||
170526444|NCT00369343|616275468|FG001|Open-label Phase|Withdrawal by Subject|6|||
170526445|NCT00369343|616275467|FG000|Open-label Phase|Lack of Efficacy|4|||
170526446|NCT00369343|616275468|FG001|Open-label Phase|Lack of Efficacy|3|||
170526447|NCT00369343|616275467|FG000|Open-label Phase|Lack of continuance tolerability|3|||
170526448|NCT00369343|616275468|FG001|Open-label Phase|Lack of continuance tolerability|4|||
170775713|NCT02723955|617186994|FG039|Expansion Phase|Withdrawal by Subject|0|||
170775714|NCT02723955|617186995|FG040|Expansion Phase|Withdrawal by Subject|0|||
170775715|NCT02723955|617186996|FG041|Expansion Phase|Withdrawal by Subject|0|||
170775716|NCT02723955|617186997|FG042|Expansion Phase|Withdrawal by Subject|0|||
170775717|NCT02723955|617186955|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775718|NCT02723955|617186956|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775719|NCT02723955|617186957|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775720|NCT02723955|617186958|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775721|NCT02723955|617186959|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775722|NCT02723955|617186960|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775723|NCT02723955|617186961|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775724|NCT02723955|617186962|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775725|NCT02723955|617186963|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775726|NCT02723955|617186964|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
170775727|NCT02723955|617186965|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
170775728|NCT02723955|617186966|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
170775729|NCT02723955|617186967|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775730|NCT02723955|617186968|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775731|NCT02723955|617186969|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775732|NCT02723955|617186970|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775733|NCT02723955|617186971|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775734|NCT02723955|617186972|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775735|NCT02723955|617186973|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775736|NCT02723955|617186974|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775737|NCT02723955|617186975|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775738|NCT02723955|617186976|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775739|NCT02723955|617186977|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775740|NCT02723955|617186978|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775741|NCT02723955|617186979|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775742|NCT02723955|617186980|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775743|NCT02723955|617186981|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775744|NCT02723955|617186982|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775745|NCT02723955|617186983|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775746|NCT02723955|617186984|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775747|NCT02723955|617186985|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
170775748|NCT02723955|617186986|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775749|NCT02723955|617186987|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775750|NCT02723955|617186988|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775751|NCT02723955|617186989|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775752|NCT02723955|617186990|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775753|NCT02723955|617186991|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775754|NCT02723955|617186992|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775755|NCT02723955|617186993|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775756|NCT02723955|617186994|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170875969|NCT00974675|617556196|FG001|Overall Study|Physician Decision|0|||
170875970|NCT00974675|617556197|FG002|Overall Study|Physician Decision|1|||
170526449|NCT00369343|616275467|FG000|Open-label Phase|did not take study drug|1|||
170526450|NCT00369343|616275468|FG001|Open-label Phase|did not take study drug|2|||
170526451|NCT01305564|616275471|FG000|Overall Study|Death|21|||
170526452|NCT01305564|616275471|FG000|Overall Study|Lost to Follow-up|12|||
170526453|NCT01305564|616275471|FG000|Overall Study|Withdrawal by Subject|1|||
170526454|NCT01305564|616275471|FG000|Overall Study|Physician Decision|3|||
170526455|NCT01973218|616275472|FG000|Overall Study|Adverse Event|1|||
170526456|NCT01973218|616275473|FG001|Overall Study|Adverse Event|0|||
170775757|NCT02723955|617186995|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775758|NCT02723955|617186996|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775759|NCT02723955|617186997|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
170775760|NCT02723955|617186955|FG000|Expansion Phase|Site Closed|0|||
170775761|NCT02723955|617186956|FG001|Expansion Phase|Site Closed|0|||
170775762|NCT02723955|617186957|FG002|Expansion Phase|Site Closed|0|||
170775763|NCT02723955|617186958|FG003|Expansion Phase|Site Closed|0|||
170775764|NCT02723955|617186959|FG004|Expansion Phase|Site Closed|0|||
170775765|NCT02723955|617186960|FG005|Expansion Phase|Site Closed|0|||
170775766|NCT02723955|617186961|FG006|Expansion Phase|Site Closed|0|||
170775767|NCT02723955|617186962|FG007|Expansion Phase|Site Closed|0|||
170775768|NCT02723955|617186963|FG008|Expansion Phase|Site Closed|0|||
170775769|NCT02723955|617186964|FG009|Expansion Phase|Site Closed|1|||
170775770|NCT02723955|617186965|FG010|Expansion Phase|Site Closed|2|||
170775771|NCT02723955|617186966|FG011|Expansion Phase|Site Closed|6|||
170775772|NCT02723955|617186967|FG012|Expansion Phase|Site Closed|0|||
170775773|NCT02723955|617186968|FG013|Expansion Phase|Site Closed|0|||
170775774|NCT02723955|617186969|FG014|Expansion Phase|Site Closed|0|||
170775775|NCT02723955|617186970|FG015|Expansion Phase|Site Closed|0|||
170775776|NCT02723955|617186971|FG016|Expansion Phase|Site Closed|0|||
170775777|NCT02723955|617186972|FG017|Expansion Phase|Site Closed|0|||
170775778|NCT02723955|617186973|FG018|Expansion Phase|Site Closed|0|||
170775779|NCT02723955|617186974|FG019|Expansion Phase|Site Closed|0|||
170775780|NCT02723955|617186975|FG020|Expansion Phase|Site Closed|0|||
170775781|NCT02723955|617186976|FG021|Expansion Phase|Site Closed|0|||
170775782|NCT02723955|617186977|FG022|Expansion Phase|Site Closed|0|||
170775783|NCT02723955|617186978|FG023|Expansion Phase|Site Closed|0|||
170775784|NCT02723955|617186979|FG024|Expansion Phase|Site Closed|0|||
170775785|NCT02723955|617186980|FG025|Expansion Phase|Site Closed|0|||
170775786|NCT02723955|617186981|FG026|Expansion Phase|Site Closed|0|||
170775787|NCT02723955|617186982|FG027|Expansion Phase|Site Closed|0|||
170775788|NCT02723955|617186983|FG028|Expansion Phase|Site Closed|0|||
170775789|NCT02723955|617186984|FG029|Expansion Phase|Site Closed|0|||
170775790|NCT02723955|617186985|FG030|Expansion Phase|Site Closed|8|||
170775791|NCT02723955|617186986|FG031|Expansion Phase|Site Closed|4|||
170775792|NCT02723955|617186987|FG032|Expansion Phase|Site Closed|2|||
170775793|NCT02723955|617186988|FG033|Expansion Phase|Site Closed|2|||
170775794|NCT02723955|617186989|FG034|Expansion Phase|Site Closed|0|||
170775795|NCT02723955|617186990|FG035|Expansion Phase|Site Closed|0|||
170775796|NCT02723955|617186991|FG036|Expansion Phase|Site Closed|0|||
170775797|NCT02723955|617186992|FG037|Expansion Phase|Site Closed|0|||
170775798|NCT02723955|617186993|FG038|Expansion Phase|Site Closed|0|||
170775799|NCT02723955|617186994|FG039|Expansion Phase|Site Closed|0|||
170775800|NCT02723955|617186995|FG040|Expansion Phase|Site Closed|0|||
170775801|NCT02723955|617186996|FG041|Expansion Phase|Site Closed|0|||
170775802|NCT02723955|617186997|FG042|Expansion Phase|Site Closed|0|||
170775803|NCT02723955|617186955|FG000|Crossover/ Re-treatment Phase|Death|0|||
170775804|NCT02723955|617186956|FG001|Crossover/ Re-treatment Phase|Death|0|||
170775805|NCT02723955|617186957|FG002|Crossover/ Re-treatment Phase|Death|0|||
170775806|NCT02723955|617186958|FG003|Crossover/ Re-treatment Phase|Death|0|||
170775807|NCT02723955|617186959|FG004|Crossover/ Re-treatment Phase|Death|0|||
170775808|NCT02723955|617186960|FG005|Crossover/ Re-treatment Phase|Death|0|||
170775809|NCT02723955|617186961|FG006|Crossover/ Re-treatment Phase|Death|0|||
170775810|NCT02723955|617186962|FG007|Crossover/ Re-treatment Phase|Death|0|||
170775811|NCT02723955|617186963|FG008|Crossover/ Re-treatment Phase|Death|0|||
170775812|NCT02723955|617186964|FG009|Crossover/ Re-treatment Phase|Death|0|||
170775813|NCT02723955|617186965|FG010|Crossover/ Re-treatment Phase|Death|0|||
170775814|NCT02723955|617186966|FG011|Crossover/ Re-treatment Phase|Death|0|||
170775815|NCT02723955|617186967|FG012|Crossover/ Re-treatment Phase|Death|0|||
170775816|NCT02723955|617186968|FG013|Crossover/ Re-treatment Phase|Death|0|||
170775817|NCT02723955|617186969|FG014|Crossover/ Re-treatment Phase|Death|0|||
170775818|NCT02723955|617186970|FG015|Crossover/ Re-treatment Phase|Death|0|||
170775819|NCT02723955|617186971|FG016|Crossover/ Re-treatment Phase|Death|0|||
170775820|NCT02723955|617186972|FG017|Crossover/ Re-treatment Phase|Death|0|||
170775821|NCT02723955|617186973|FG018|Crossover/ Re-treatment Phase|Death|0|||
170775822|NCT02723955|617186974|FG019|Crossover/ Re-treatment Phase|Death|0|||
170775823|NCT02723955|617186975|FG020|Crossover/ Re-treatment Phase|Death|0|||
170775824|NCT02723955|617186976|FG021|Crossover/ Re-treatment Phase|Death|0|||
170775825|NCT02723955|617186977|FG022|Crossover/ Re-treatment Phase|Death|0|||
170775826|NCT02723955|617186978|FG023|Crossover/ Re-treatment Phase|Death|0|||
170775827|NCT02723955|617186979|FG024|Crossover/ Re-treatment Phase|Death|0|||
170775828|NCT02723955|617186980|FG025|Crossover/ Re-treatment Phase|Death|0|||
170775829|NCT02723955|617186981|FG026|Crossover/ Re-treatment Phase|Death|0|||
170775830|NCT02723955|617186982|FG027|Crossover/ Re-treatment Phase|Death|0|||
170875971|NCT00974675|617556198|FG003|Overall Study|Physician Decision|0|||
170875972|NCT00974675|617556195|FG000|Overall Study|Participant on holiday; unable to attend|0|||
170875973|NCT00974675|617556196|FG001|Overall Study|Participant on holiday; unable to attend|0|||
170875974|NCT00974675|617556197|FG002|Overall Study|Participant on holiday; unable to attend|0|||
170875975|NCT00974675|617556198|FG003|Overall Study|Participant on holiday; unable to attend|1|||
170875976|NCT01358760|617556199|FG000|Overall Study|Adverse Event|3|||
170875977|NCT01358760|617556200|FG001|Overall Study|Adverse Event|4|||
170875978|NCT01358760|617556201|FG002|Overall Study|Adverse Event|3|||
170875979|NCT01358760|617556199|FG000|Overall Study|Lost to Follow-up|1|||
170875980|NCT01358760|617556200|FG001|Overall Study|Lost to Follow-up|1|||
170875981|NCT01358760|617556201|FG002|Overall Study|Lost to Follow-up|3|||
170875982|NCT01358760|617556199|FG000|Overall Study|Withdrawal by Subject|5|||
170875983|NCT01358760|617556200|FG001|Overall Study|Withdrawal by Subject|3|||
170875984|NCT01358760|617556201|FG002|Overall Study|Withdrawal by Subject|2|||
170875985|NCT01358760|617556199|FG000|Overall Study|Physician Decision|1|||
170875986|NCT01358760|617556200|FG001|Overall Study|Physician Decision|0|||
170875987|NCT01358760|617556201|FG002|Overall Study|Physician Decision|1|||
170875988|NCT01358760|617556199|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
170875989|NCT01358760|617556200|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
170875990|NCT01358760|617556201|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
170875991|NCT04695392|617556202|FG000|Overall Study|Withdrawn by parent/guardian|0|||
170875992|NCT04695392|617556203|FG001|Overall Study|Withdrawn by parent/guardian|1|||
170875993|NCT04695392|617556202|FG000|Overall Study|Withdrawn by physician|0|||
170526457|NCT01973218|616275472|FG000|Overall Study|Withdrawal by Subject|1|||
170526458|NCT01973218|616275473|FG001|Overall Study|Withdrawal by Subject|0|||
170526459|NCT02247466|616275474|FG000|Overall Study|Procedure changed to open surgery|0|||
170526460|NCT02247466|616275475|FG001|Overall Study|Procedure changed to open surgery|3|||
170526461|NCT00492726|616275476|FG000|Overall Study|Adverse Event|10|||
170526462|NCT00492726|616275477|FG001|Overall Study|Adverse Event|6|||
170526463|NCT00492726|616275476|FG000|Overall Study|Death|7|||
170526464|NCT00492726|616275477|FG001|Overall Study|Death|2|||
170875994|NCT04695392|617556203|FG001|Overall Study|Withdrawn by physician|1|||
170875995|NCT00555477|617556206|FG000|Overall Study|Adverse Event|0|||
170875996|NCT00555477|617556207|FG001|Overall Study|Adverse Event|9|||
170875997|NCT00555477|617556206|FG000|Overall Study|Withdrawal by Subject|1|||
170875998|NCT00555477|617556207|FG001|Overall Study|Withdrawal by Subject|2|||
170875999|NCT00555477|617556206|FG000|Overall Study|Physician Decision|1|||
170876000|NCT00555477|617556207|FG001|Overall Study|Physician Decision|2|||
170876001|NCT00450723|617556208|FG000|Overall Study|Physician Decision|5|||
170876002|NCT01721057|617556209|FG000|Treatment Period|Withdrawal by Subject|11|||
170876003|NCT01721057|617556210|FG001|Treatment Period|Withdrawal by Subject|5|||
170526465|NCT00492726|616275476|FG000|Overall Study|Lack of Efficacy|0|||
170526466|NCT00492726|616275477|FG001|Overall Study|Lack of Efficacy|2|||
170526467|NCT00492726|616275476|FG000|Overall Study|Lost to Follow-up|27|||
170526468|NCT00492726|616275477|FG001|Overall Study|Lost to Follow-up|19|||
170632515|NCT01499355|616666688|FG000|Run-In Period|Consent Withdrawn|1|||
170632516|NCT01499355|616666689|FG001|Run-In Period|Consent Withdrawn|0|||
170632517|NCT01499355|616666690|FG002|Run-In Period|Consent Withdrawn|0|||
170876004|NCT01721057|617556211|FG002|Treatment Period|Withdrawal by Subject|8|||
170876005|NCT01721057|617556212|FG003|Treatment Period|Withdrawal by Subject|0|||
170876006|NCT01721057|617556213|FG004|Treatment Period|Withdrawal by Subject|0|||
170876007|NCT01721057|617556214|FG005|Treatment Period|Withdrawal by Subject|0|||
170876008|NCT01721057|617556215|FG006|Treatment Period|Withdrawal by Subject|0|||
170876009|NCT01721057|617556209|FG000|Treatment Period|Adverse Event|7|||
170876010|NCT01721057|617556210|FG001|Treatment Period|Adverse Event|10|||
170876011|NCT01721057|617556211|FG002|Treatment Period|Adverse Event|12|||
170876012|NCT01721057|617556212|FG003|Treatment Period|Adverse Event|0|||
170876013|NCT01721057|617556213|FG004|Treatment Period|Adverse Event|0|||
170876014|NCT01721057|617556214|FG005|Treatment Period|Adverse Event|0|||
170876015|NCT01721057|617556215|FG006|Treatment Period|Adverse Event|0|||
170876016|NCT01721057|617556209|FG000|Treatment Period|Lack of Efficacy|7|||
170632518|NCT01499355|616666691|FG003|Run-In Period|Consent Withdrawn|0|||
170876017|NCT01721057|617556210|FG001|Treatment Period|Lack of Efficacy|3|||
170876018|NCT01721057|617556211|FG002|Treatment Period|Lack of Efficacy|0|||
170876019|NCT01721057|617556212|FG003|Treatment Period|Lack of Efficacy|0|||
170876020|NCT01721057|617556213|FG004|Treatment Period|Lack of Efficacy|0|||
170876021|NCT01721057|617556214|FG005|Treatment Period|Lack of Efficacy|0|||
170876022|NCT01721057|617556215|FG006|Treatment Period|Lack of Efficacy|0|||
170632519|NCT01499355|616666688|FG000|Run-In Period|Adverse Event|8|||
170876023|NCT01721057|617556209|FG000|Treatment Period|Lost to Follow-up|1|||
170876024|NCT01721057|617556210|FG001|Treatment Period|Lost to Follow-up|0|||
170876025|NCT01721057|617556211|FG002|Treatment Period|Lost to Follow-up|0|||
170876026|NCT01721057|617556212|FG003|Treatment Period|Lost to Follow-up|0|||
170876027|NCT01721057|617556213|FG004|Treatment Period|Lost to Follow-up|0|||
170876028|NCT01721057|617556214|FG005|Treatment Period|Lost to Follow-up|0|||
170526469|NCT00492726|616275476|FG000|Overall Study|Physician Decision|0|||
170526470|NCT00492726|616275477|FG001|Overall Study|Physician Decision|1|||
170876029|NCT01721057|617556215|FG006|Treatment Period|Lost to Follow-up|0|||
170876030|NCT01721057|617556209|FG000|Treatment Period|Physician Decision|0|||
170876031|NCT01721057|617556210|FG001|Treatment Period|Physician Decision|1|||
170876032|NCT01721057|617556211|FG002|Treatment Period|Physician Decision|3|||
170876033|NCT01721057|617556212|FG003|Treatment Period|Physician Decision|0|||
170876034|NCT01721057|617556213|FG004|Treatment Period|Physician Decision|0|||
170876035|NCT01721057|617556214|FG005|Treatment Period|Physician Decision|0|||
170876036|NCT01721057|617556215|FG006|Treatment Period|Physician Decision|0|||
170876037|NCT01721057|617556209|FG000|Treatment Period|Death|2|||
170775831|NCT02723955|617186983|FG028|Crossover/ Re-treatment Phase|Death|0|||
170876038|NCT01721057|617556210|FG001|Treatment Period|Death|0|||
170876039|NCT01721057|617556211|FG002|Treatment Period|Death|0|||
170876040|NCT01721057|617556212|FG003|Treatment Period|Death|0|||
170876041|NCT01721057|617556213|FG004|Treatment Period|Death|0|||
170876042|NCT01721057|617556214|FG005|Treatment Period|Death|0|||
170876043|NCT01721057|617556215|FG006|Treatment Period|Death|0|||
170876044|NCT01721057|617556209|FG000|Rescue Period|Adverse Event|0|||
170876045|NCT01721057|617556210|FG001|Rescue Period|Adverse Event|0|||
170876046|NCT01721057|617556211|FG002|Rescue Period|Adverse Event|0|||
170876047|NCT01721057|617556212|FG003|Rescue Period|Adverse Event|1|||
170876048|NCT01721057|617556213|FG004|Rescue Period|Adverse Event|0|||
170876049|NCT01721057|617556214|FG005|Rescue Period|Adverse Event|0|||
170876050|NCT01721057|617556215|FG006|Rescue Period|Adverse Event|0|||
170876051|NCT01721057|617556209|FG000|Rescue Period|Lack of Efficacy|0|||
170876052|NCT01721057|617556210|FG001|Rescue Period|Lack of Efficacy|0|||
170876053|NCT01721057|617556211|FG002|Rescue Period|Lack of Efficacy|0|||
170876054|NCT01721057|617556212|FG003|Rescue Period|Lack of Efficacy|2|||
170876055|NCT01721057|617556213|FG004|Rescue Period|Lack of Efficacy|0|||
170775832|NCT02723955|617186984|FG029|Crossover/ Re-treatment Phase|Death|0|||
170775833|NCT02723955|617186985|FG030|Crossover/ Re-treatment Phase|Death|0|||
170775834|NCT02723955|617186986|FG031|Crossover/ Re-treatment Phase|Death|0|||
170775835|NCT02723955|617186987|FG032|Crossover/ Re-treatment Phase|Death|0|||
170775836|NCT02723955|617186988|FG033|Crossover/ Re-treatment Phase|Death|0|||
170775837|NCT02723955|617186989|FG034|Crossover/ Re-treatment Phase|Death|0|||
170775838|NCT02723955|617186990|FG035|Crossover/ Re-treatment Phase|Death|0|||
170775839|NCT02723955|617186991|FG036|Crossover/ Re-treatment Phase|Death|0|||
170775840|NCT02723955|617186992|FG037|Crossover/ Re-treatment Phase|Death|1|||
170775841|NCT02723955|617186993|FG038|Crossover/ Re-treatment Phase|Death|14|||
170775842|NCT02723955|617186994|FG039|Crossover/ Re-treatment Phase|Death|32|||
170775843|NCT02723955|617186995|FG040|Crossover/ Re-treatment Phase|Death|2|||
170775844|NCT02723955|617186996|FG041|Crossover/ Re-treatment Phase|Death|1|||
170775845|NCT02723955|617186997|FG042|Crossover/ Re-treatment Phase|Death|0|||
170775846|NCT02723955|617186955|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775847|NCT02723955|617186956|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775848|NCT02723955|617186957|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775849|NCT02723955|617186958|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775850|NCT02723955|617186959|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775851|NCT02723955|617186960|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775852|NCT02723955|617186961|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775853|NCT02723955|617186962|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775854|NCT02723955|617186963|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775855|NCT02723955|617186964|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775856|NCT02723955|617186965|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775857|NCT02723955|617186966|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775858|NCT02723955|617186967|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775859|NCT02723955|617186968|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775860|NCT02723955|617186969|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775861|NCT02723955|617186970|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775862|NCT02723955|617186971|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775863|NCT02723955|617186972|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775864|NCT02723955|617186973|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775865|NCT02723955|617186974|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775866|NCT02723955|617186975|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170876056|NCT01721057|617556214|FG005|Rescue Period|Lack of Efficacy|0|||
170876057|NCT01721057|617556215|FG006|Rescue Period|Lack of Efficacy|0|||
170876058|NCT02546765|617556219|FG000|Overall Study|Withdrawal by Subject|0|||
170775867|NCT02723955|617186976|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775868|NCT02723955|617186977|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775869|NCT02723955|617186978|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170876059|NCT02546765|617556220|FG001|Overall Study|Withdrawal by Subject|1|||
170876060|NCT02546765|617556221|FG002|Overall Study|Withdrawal by Subject|0|||
170876061|NCT02546765|617556222|FG003|Overall Study|Withdrawal by Subject|0|||
170876062|NCT02064920|617556225|FG000|Overall Study|Adverse Event|0|||
170876063|NCT02064920|617556226|FG001|Overall Study|Adverse Event|4|||
170876064|NCT02064920|617556225|FG000|Overall Study|Physician Decision|0|||
170775870|NCT02723955|617186979|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775871|NCT02723955|617186980|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775872|NCT02723955|617186981|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775873|NCT02723955|617186982|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775874|NCT02723955|617186983|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775875|NCT02723955|617186984|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775876|NCT02723955|617186985|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775877|NCT02723955|617186986|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775878|NCT02723955|617186987|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775879|NCT02723955|617186988|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775880|NCT02723955|617186989|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775881|NCT02723955|617186990|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775882|NCT02723955|617186991|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775883|NCT02723955|617186992|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775884|NCT02723955|617186993|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775885|NCT02723955|617186994|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
170775886|NCT02723955|617186995|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775887|NCT02723955|617186996|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775888|NCT02723955|617186997|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
170775889|NCT02723955|617186955|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775890|NCT02723955|617186956|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775891|NCT02723955|617186957|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775892|NCT02723955|617186958|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775893|NCT02723955|617186959|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775894|NCT02723955|617186960|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775895|NCT02723955|617186961|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775896|NCT02723955|617186962|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775897|NCT02723955|617186963|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775898|NCT02723955|617186964|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775899|NCT02723955|617186965|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775900|NCT02723955|617186966|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775901|NCT02723955|617186967|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775902|NCT02723955|617186968|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775903|NCT02723955|617186969|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775904|NCT02723955|617186970|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775905|NCT02723955|617186971|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775906|NCT02723955|617186972|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775907|NCT02723955|617186973|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775908|NCT02723955|617186974|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775909|NCT02723955|617186975|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775910|NCT02723955|617186976|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775911|NCT02723955|617186977|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775912|NCT02723955|617186978|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775913|NCT02723955|617186979|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775914|NCT02723955|617186980|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775915|NCT02723955|617186981|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775916|NCT02723955|617186982|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775917|NCT02723955|617186983|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775918|NCT02723955|617186984|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775919|NCT02723955|617186985|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775920|NCT02723955|617186986|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775921|NCT02723955|617186987|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775922|NCT02723955|617186988|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775923|NCT02723955|617186989|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775924|NCT02723955|617186990|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775925|NCT02723955|617186991|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775926|NCT02723955|617186992|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775927|NCT02723955|617186993|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
170775928|NCT02723955|617186994|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
170775929|NCT02723955|617186995|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775930|NCT02723955|617186996|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
170775931|NCT02723955|617186997|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
170775932|NCT02723955|617186955|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
170415052|NCT01296932|615860390|FG001|Overall Study|Adverse Event|1|||
170415053|NCT01296932|615860391|FG002|Overall Study|Adverse Event|1|||
170415054|NCT01296932|615860392|FG003|Overall Study|Adverse Event|2|||
170415055|NCT01296932|615860393|FG004|Overall Study|Adverse Event|1|||
170415056|NCT01296932|615860394|FG005|Overall Study|Adverse Event|0|||
170415057|NCT01296932|615860395|FG006|Overall Study|Adverse Event|0|||
170415058|NCT01296932|615860396|FG007|Overall Study|Adverse Event|0|||
170415059|NCT01296932|615860397|FG008|Overall Study|Adverse Event|1|||
170632520|NCT01499355|616666689|FG001|Run-In Period|Adverse Event|0|||
170775933|NCT02723955|617186956|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
170775934|NCT02723955|617186957|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
170775935|NCT02723955|617186958|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
170775936|NCT02723955|617186959|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
170775937|NCT02723955|617186960|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
170775938|NCT02723955|617186961|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
170775939|NCT02723955|617186962|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
170775940|NCT02723955|617186963|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
170775941|NCT02723955|617186964|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
170775942|NCT02723955|617186965|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
170775943|NCT02723955|617186966|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
170775944|NCT02723955|617186967|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
170775945|NCT02723955|617186968|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
170775946|NCT02723955|617186969|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
170775947|NCT02723955|617186970|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
170775948|NCT02723955|617186971|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
170775949|NCT02723955|617186972|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
170775950|NCT02723955|617186973|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
170775951|NCT02723955|617186974|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
170775952|NCT02723955|617186975|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
170775953|NCT02723955|617186976|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
170775954|NCT02723955|617186977|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
170775955|NCT02723955|617186978|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
170775956|NCT02723955|617186979|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
170775957|NCT02723955|617186980|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
170775958|NCT02723955|617186981|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
170775959|NCT02723955|617186982|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
170775960|NCT02723955|617186983|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
170775961|NCT02723955|617186984|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
170775962|NCT02723955|617186985|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
170775963|NCT02723955|617186986|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
170775964|NCT02723955|617186987|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
170775965|NCT02723955|617186988|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
170775966|NCT02723955|617186989|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
170775967|NCT02723955|617186990|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
170775968|NCT02723955|617186991|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
170775969|NCT02723955|617186992|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
170775970|NCT02723955|617186993|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
170775971|NCT02723955|617186994|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
170775972|NCT02723955|617186995|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
170775973|NCT02723955|617186996|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
170775974|NCT02723955|617186997|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
170775975|NCT05056246|617186998|FG000|Overall Study|Adverse Event|0|||
170775976|NCT05056246|617186999|FG001|Overall Study|Adverse Event|0|||
170775977|NCT05056246|617187000|FG002|Overall Study|Adverse Event|0|||
170775978|NCT05056246|617187001|FG003|Overall Study|Adverse Event|0|||
170775979|NCT05056246|617187002|FG004|Overall Study|Adverse Event|1|||
170775980|NCT05056246|617186998|FG000|Overall Study|Lost to Follow-up|0|||
170775981|NCT05056246|617186999|FG001|Overall Study|Lost to Follow-up|0|||
170775982|NCT05056246|617187000|FG002|Overall Study|Lost to Follow-up|0|||
170775983|NCT05056246|617187001|FG003|Overall Study|Lost to Follow-up|2|||
170775984|NCT05056246|617187002|FG004|Overall Study|Lost to Follow-up|0|||
170775985|NCT05056246|617186998|FG000|Overall Study|Withdrawal by Subject|0|||
170775986|NCT05056246|617186999|FG001|Overall Study|Withdrawal by Subject|1|||
170775987|NCT05056246|617187000|FG002|Overall Study|Withdrawal by Subject|0|||
170775988|NCT05056246|617187001|FG003|Overall Study|Withdrawal by Subject|0|||
170775989|NCT05056246|617187002|FG004|Overall Study|Withdrawal by Subject|0|||
170775990|NCT04907474|617187003|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
170775991|NCT04907474|617187004|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
170775992|NCT05057897|617187005|FG000|Overall Study|Site closure|2|||
170775993|NCT05057897|617187006|FG001|Overall Study|Site closure|2|||
170775994|NCT05057897|617187005|FG000|Overall Study|Death|1|||
170775995|NCT05057897|617187006|FG001|Overall Study|Death|0|||
170775996|NCT04337372|617187009|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
170775997|NCT04337372|617187010|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
170775998|NCT04337372|617187011|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
170775999|NCT04337372|617187012|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
170776000|NCT04337372|617187009|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
170776001|NCT04337372|617187010|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
170776002|NCT04337372|617187011|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
170776003|NCT04337372|617187012|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
170776004|NCT04337372|617187009|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
170776005|NCT04337372|617187010|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
170776006|NCT04337372|617187011|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
170876065|NCT02064920|617556226|FG001|Overall Study|Physician Decision|1|||
170876066|NCT02064920|617556225|FG000|Overall Study|Technical Problems|0|||
170876067|NCT02064920|617556226|FG001|Overall Study|Technical Problems|1|||
170876068|NCT02064920|617556225|FG000|Overall Study|Withdrawal by Subject|1|||
170876069|NCT02064920|617556226|FG001|Overall Study|Withdrawal by Subject|3|||
170876070|NCT00943579|617556229|FG000|Overall Study|Adverse Event|4|||
170876071|NCT00943579|617556230|FG001|Overall Study|Adverse Event|3|||
170876072|NCT00943579|617556229|FG000|Overall Study|Lack of Efficacy|2|||
170876073|NCT00943579|617556230|FG001|Overall Study|Lack of Efficacy|2|||
170876074|NCT03996876|617556235|FG000|Overall Study|Incomplete Data|2|||
170876075|NCT03996876|617556236|FG001|Overall Study|Incomplete Data|4|||
170876076|NCT00121108|617556237|FG000|Overall Study|Lost to Follow-up|10|||
170776007|NCT04337372|617187012|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
170776008|NCT04337372|617187009|FG000|Day 2: EEG Measures|Protocol Violation|6|||
170776009|NCT04337372|617187010|FG001|Day 2: EEG Measures|Protocol Violation|6|||
170776010|NCT04337372|617187011|FG002|Day 2: EEG Measures|Protocol Violation|5|||
170776011|NCT04337372|617187012|FG003|Day 2: EEG Measures|Protocol Violation|17|||
170776012|NCT03990649|617187019|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
170776013|NCT03990649|617187020|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
170776014|NCT03990649|617187021|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
170776015|NCT03990649|617187019|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
170776016|NCT03990649|617187020|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
170776017|NCT03990649|617187021|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
170776018|NCT03990649|617187019|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
170776019|NCT03990649|617187020|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
170776020|NCT03990649|617187021|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
170776021|NCT03990649|617187019|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
170776022|NCT03990649|617187020|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
170776023|NCT03990649|617187021|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
170776024|NCT03990649|617187019|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
170776025|NCT03990649|617187020|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
170776026|NCT03990649|617187021|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
170776027|NCT03990649|617187019|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
170776028|NCT03990649|617187020|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
170776029|NCT03990649|617187021|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
170776030|NCT03990649|617187019|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
170776031|NCT03990649|617187020|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
170776032|NCT03990649|617187021|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
170776033|NCT04512482|617187024|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
170776034|NCT04512482|617187025|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
170776035|NCT00391898|617187027|FG000|Overall Study|Adverse Event|3|||
170776036|NCT00391898|617187028|FG001|Overall Study|Adverse Event|0|||
170776037|NCT00391898|617187027|FG000|Overall Study|Other|8|||
170776038|NCT00391898|617187028|FG001|Overall Study|Other|10|||
170776039|NCT02549170|617187029|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
170776040|NCT02549170|617187030|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
170776041|NCT02549170|617187031|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
170776042|NCT02549170|617187032|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
170776043|NCT02549170|617187033|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
170776044|NCT02549170|617187029|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
170776045|NCT02549170|617187030|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
170776046|NCT02549170|617187031|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
170776047|NCT02549170|617187032|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
170776048|NCT02549170|617187033|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
170776049|NCT02549170|617187029|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
170776050|NCT02549170|617187030|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
170776051|NCT02549170|617187031|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
170776052|NCT02549170|617187032|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
170776053|NCT02549170|617187033|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
170776054|NCT02121002|617187035|FG000|Overall Study|Physician Decision|2|||
170776055|NCT02121002|617187036|FG001|Overall Study|Physician Decision|0|||
170776056|NCT02121002|617187037|FG002|Overall Study|Physician Decision|0|||
170876077|NCT00121108|617556238|FG001|Overall Study|Lost to Follow-up|22|||
170876078|NCT00121108|617556237|FG000|Overall Study|Withdrawal by Subject|106|||
170776057|NCT02121002|617187035|FG000|Overall Study|Withdrawal by Subject|3|||
170876079|NCT00121108|617556238|FG001|Overall Study|Withdrawal by Subject|195|||
170876080|NCT00121108|617556237|FG000|Overall Study|Death|5|||
170776058|NCT02121002|617187036|FG001|Overall Study|Withdrawal by Subject|1|||
170776059|NCT02121002|617187037|FG002|Overall Study|Withdrawal by Subject|4|||
170776060|NCT02121002|617187035|FG000|Overall Study|Protocol Violation|1|||
170776061|NCT02121002|617187036|FG001|Overall Study|Protocol Violation|2|||
170776062|NCT02121002|617187037|FG002|Overall Study|Protocol Violation|4|||
170776063|NCT02121002|617187035|FG000|Overall Study|Concomitant therapy|0|||
170776064|NCT02121002|617187036|FG001|Overall Study|Concomitant therapy|1|||
170776065|NCT02121002|617187037|FG002|Overall Study|Concomitant therapy|1|||
170776066|NCT02121002|617187035|FG000|Overall Study|Others|1|||
170776067|NCT02121002|617187036|FG001|Overall Study|Others|0|||
170776068|NCT02121002|617187037|FG002|Overall Study|Others|1|||
170776069|NCT02590432|617187038|FG000|Open-label Treatment Period|Adverse Event|97|||
170776070|NCT02590432|617187039|FG001|Open-label Treatment Period|Adverse Event|79|||
170776071|NCT02590432|617187040|FG002|Open-label Treatment Period|Adverse Event|0|||
170776072|NCT02590432|617187041|FG003|Open-label Treatment Period|Adverse Event|0|||
170776073|NCT02590432|617187042|FG004|Open-label Treatment Period|Adverse Event|0|||
170776074|NCT02590432|617187043|FG005|Open-label Treatment Period|Adverse Event|0|||
170776075|NCT02590432|617187044|FG006|Open-label Treatment Period|Adverse Event|0|||
170776076|NCT02590432|617187045|FG007|Open-label Treatment Period|Adverse Event|0|||
170776077|NCT02590432|617187046|FG008|Open-label Treatment Period|Adverse Event|0|||
170776078|NCT02590432|617187038|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
170776079|NCT02590432|617187039|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
170776080|NCT02590432|617187040|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
170776081|NCT02590432|617187041|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
170776082|NCT02590432|617187042|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
170776083|NCT02590432|617187043|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
170776084|NCT02590432|617187044|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
170776085|NCT02590432|617187045|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
170776086|NCT02590432|617187046|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
170776087|NCT02590432|617187038|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
170776088|NCT02590432|617187039|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
170776089|NCT02590432|617187040|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
170776090|NCT02590432|617187041|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
170776091|NCT02590432|617187042|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
170776092|NCT02590432|617187043|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
170776093|NCT02590432|617187044|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
170776094|NCT02590432|617187045|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
170776095|NCT02590432|617187046|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
170776096|NCT02590432|617187038|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
170776097|NCT02590432|617187039|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
170776098|NCT02590432|617187040|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
170776099|NCT02590432|617187041|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
170776100|NCT02590432|617187042|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
170776101|NCT02590432|617187043|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
170776102|NCT02590432|617187044|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
170776103|NCT02590432|617187045|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
170776104|NCT02590432|617187046|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
170776105|NCT02590432|617187038|FG000|Open-label Treatment Period|Protocol Violation|10|||
170776106|NCT02590432|617187039|FG001|Open-label Treatment Period|Protocol Violation|4|||
170776107|NCT02590432|617187040|FG002|Open-label Treatment Period|Protocol Violation|0|||
170776108|NCT02590432|617187041|FG003|Open-label Treatment Period|Protocol Violation|0|||
170776109|NCT02590432|617187042|FG004|Open-label Treatment Period|Protocol Violation|0|||
170776110|NCT02590432|617187043|FG005|Open-label Treatment Period|Protocol Violation|0|||
170776111|NCT02590432|617187044|FG006|Open-label Treatment Period|Protocol Violation|0|||
170776112|NCT02590432|617187045|FG007|Open-label Treatment Period|Protocol Violation|0|||
170776113|NCT02590432|617187046|FG008|Open-label Treatment Period|Protocol Violation|0|||
170776114|NCT02590432|617187038|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
170776115|NCT02590432|617187039|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
170776116|NCT02590432|617187040|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
170776117|NCT02590432|617187041|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
170776118|NCT02590432|617187042|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
170776119|NCT02590432|617187043|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
170776120|NCT02590432|617187044|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
170776121|NCT02590432|617187045|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
170776122|NCT02590432|617187046|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
170776123|NCT02590432|617187038|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
170776124|NCT02590432|617187039|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
170776125|NCT02590432|617187040|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
170776126|NCT02590432|617187041|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
170776127|NCT02590432|617187042|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
170876081|NCT00121108|617556238|FG001|Overall Study|Death|8|||
170876082|NCT02581202|617556243|FG000|Overall Study|Lack of Efficacy|2|||
170876083|NCT02581202|617556243|FG000|Overall Study|Withdrawal by Subject|4|||
170876084|NCT02581202|617556243|FG000|Overall Study|Lost to Follow-up|5|||
170876085|NCT02581202|617556243|FG000|Overall Study|Pregnancy|3|||
170876086|NCT05937165|617556253|FG000|Overall Study|Withdrawal by Subject|0|||
170876087|NCT05937165|617556254|FG001|Overall Study|Withdrawal by Subject|1|||
170876088|NCT00666458|617557015|FG000|Overall Study|Adverse Event|8|||
170876089|NCT00666458|617557016|FG001|Overall Study|Adverse Event|7|||
170876090|NCT00666458|617557015|FG000|Overall Study|Withdrawal by Subject|5|||
170876091|NCT00666458|617557016|FG001|Overall Study|Withdrawal by Subject|4|||
170876092|NCT00666458|617557015|FG000|Overall Study|Lost to Follow-up|0|||
170876093|NCT00666458|617557016|FG001|Overall Study|Lost to Follow-up|3|||
170876094|NCT00666458|617557015|FG000|Overall Study|Administrative reason by sponsor|1|||
170876095|NCT00666458|617557016|FG001|Overall Study|Administrative reason by sponsor|1|||
170876096|NCT00666458|617557015|FG000|Overall Study|Incorrect enrollment|7|||
170876097|NCT00666458|617557016|FG001|Overall Study|Incorrect enrollment|1|||
170876098|NCT00666458|617557015|FG000|Overall Study|Study specific discontinuation criteria|14|||
170876099|NCT00666458|617557016|FG001|Overall Study|Study specific discontinuation criteria|7|||
170876100|NCT00666458|617557015|FG000|Overall Study|Severe non-compliance to the protocol|1|||
170876101|NCT00666458|617557016|FG001|Overall Study|Severe non-compliance to the protocol|1|||
170876102|NCT00666458|617557015|FG000|Overall Study|Safety reasons|1|||
170876103|NCT00666458|617557016|FG001|Overall Study|Safety reasons|0|||
170876104|NCT00666458|617557015|FG000|Overall Study|Medical history of anemia|1|||
170876105|NCT00666458|617557016|FG001|Overall Study|Medical history of anemia|0|||
170876106|NCT00516048|617557017|FG000|Overall Study|Death|0|||
170876107|NCT00516048|617557018|FG001|Overall Study|Death|0|||
170876108|NCT00516048|617557019|FG002|Overall Study|Death|1|||
170876109|NCT00516048|617557017|FG000|Overall Study|Subject Decision|0|||
170876110|NCT00516048|617557018|FG001|Overall Study|Subject Decision|2|||
170876111|NCT00516048|617557019|FG002|Overall Study|Subject Decision|0|||
170876112|NCT01486927|617557026|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
170876113|NCT01486927|617557026|FG000|Overall Study|Physician Decision|1|||
170876114|NCT01486927|617557026|FG000|Overall Study|50 Exposure days not reached|2|||
170876115|NCT01486927|617557026|FG000|Overall Study|Withdrawal by Subject|8|||
170876116|NCT01486927|617557026|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
170876117|NCT03810911|617557027|FG000|Overall Study|Death|1|||
170876118|NCT03810911|617557028|FG001|Overall Study|Death|1|||
170876119|NCT03810911|617557027|FG000|Overall Study|Withdrawal by Subject|1|||
170876120|NCT03810911|617557028|FG001|Overall Study|Withdrawal by Subject|1|||
170876121|NCT00827606|617557038|FG000|Overall Study|Protocol Violation|4|||
170876122|NCT00827606|617557039|FG001|Overall Study|Protocol Violation|3|||
170876123|NCT00827606|617557038|FG000|Overall Study|Lost to Follow-up|3|||
170876124|NCT00827606|617557039|FG001|Overall Study|Lost to Follow-up|1|||
170876125|NCT00827606|617557038|FG000|Overall Study|Withdrawal by Subject|7|||
170876126|NCT00827606|617557039|FG001|Overall Study|Withdrawal by Subject|6|||
170876127|NCT00827606|617557038|FG000|Overall Study|Pregnancy|0|||
170876128|NCT00827606|617557039|FG001|Overall Study|Pregnancy|1|||
170876129|NCT00827606|617557038|FG000|Overall Study|Other|5|||
170876130|NCT00827606|617557039|FG001|Overall Study|Other|13|||
170876131|NCT00827606|617557038|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
170876132|NCT00827606|617557039|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
170876133|NCT00827606|617557038|FG000|Overall Study|Adverse Event|4|||
170876134|NCT00827606|617557039|FG001|Overall Study|Adverse Event|2|||
170876135|NCT00133991|617557044|FG000|Overall Study|Death|4|||
170876136|NCT03002155|617557045|FG000|Overall Study|Lost to Follow-up|1|||
170876137|NCT03002155|617557046|FG001|Overall Study|Lost to Follow-up|2|||
170876138|NCT03002155|617557045|FG000|Overall Study|Withdrawal by Subject|1|||
170876139|NCT03002155|617557046|FG001|Overall Study|Withdrawal by Subject|0|||
170876140|NCT03002155|617557045|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
170876141|NCT03002155|617557046|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
170876142|NCT00545298|617557047|FG000|Overall Study|Issues with Standard of Care|2|||
170876143|NCT00545298|617557048|FG001|Overall Study|Issues with Standard of Care|0|||
170876144|NCT00545298|617557049|FG002|Overall Study|Issues with Standard of Care|1|||
170876145|NCT01087775|617557053|FG000|Overall Study|failed inclusion criteria|2|||
170876146|NCT01378858|617557056|FG000|Overall Study|Withdrawal by Subject|4|||
170876147|NCT01378858|617557057|FG001|Overall Study|Withdrawal by Subject|4|||
170876148|NCT02664272|617557058|FG000|Overall Study|Fluoroscopic images not made available|2|||
170876149|NCT00825162|617557059|FG000|Overall Study|Withdrawal by Subject|11|||
170876150|NCT00825162|617557060|FG001|Overall Study|Withdrawal by Subject|13|||
170876151|NCT00825162|617557061|FG002|Overall Study|Withdrawal by Subject|3|||
170876152|NCT00825162|617557059|FG000|Overall Study|Lost to Follow-up|9|||
170876153|NCT00825162|617557060|FG001|Overall Study|Lost to Follow-up|6|||
170876154|NCT00825162|617557061|FG002|Overall Study|Lost to Follow-up|3|||
170876155|NCT00825162|617557059|FG000|Overall Study|Physician Decision|2|||
170876156|NCT00825162|617557060|FG001|Overall Study|Physician Decision|0|||
170876157|NCT00825162|617557061|FG002|Overall Study|Physician Decision|0|||
170876158|NCT00825162|617557059|FG000|Overall Study|Move away from the study area|1|||
170876159|NCT00825162|617557060|FG001|Overall Study|Move away from the study area|0|||
170876160|NCT00825162|617557061|FG002|Overall Study|Move away from the study area|0|||
170876161|NCT00825162|617557059|FG000|Overall Study|Unable to attend the study visit|5|||
170876162|NCT00825162|617557060|FG001|Overall Study|Unable to attend the study visit|2|||
170876163|NCT00825162|617557061|FG002|Overall Study|Unable to attend the study visit|0|||
170876164|NCT03073980|617557068|FG000|Overall Study|Lost to Follow-up|10|||
170876165|NCT03073980|617557069|FG001|Overall Study|Lost to Follow-up|2|||
170876166|NCT03073980|617557070|FG002|Overall Study|Lost to Follow-up|9|||
170876167|NCT03073980|617557068|FG000|Overall Study|No post-procedure data|0|||
170876168|NCT03073980|617557069|FG001|Overall Study|No post-procedure data|0|||
170876169|NCT03073980|617557070|FG002|Overall Study|No post-procedure data|2|||
170876170|NCT04066491|617557076|FG000|Overall Study|Randomized, not treated|0|||
170876171|NCT04066491|617557077|FG001|Overall Study|Randomized, not treated|0|||
170876172|NCT04066491|617557078|FG002|Overall Study|Randomized, not treated|2|||
170876173|NCT00418665|617557083|FG000|Treatment Period|Ineligibility determined|1|||
170876174|NCT00418665|617557084|FG001|Treatment Period|Ineligibility determined|1|||
170876175|NCT00418665|617557085|FG002|Treatment Period|Ineligibility determined|0|||
170876176|NCT00418665|617557083|FG000|Treatment Period|Adverse Event|2|||
170876177|NCT00418665|617557084|FG001|Treatment Period|Adverse Event|2|||
170876178|NCT00418665|617557085|FG002|Treatment Period|Adverse Event|0|||
170876179|NCT00418665|617557083|FG000|Treatment Period|Withdrawal by Subject|0|||
170876180|NCT00418665|617557084|FG001|Treatment Period|Withdrawal by Subject|3|||
170876181|NCT00418665|617557085|FG002|Treatment Period|Withdrawal by Subject|1|||
170876182|NCT00418665|617557083|FG000|Treatment Period|Requirement for alternative therapy|1|||
170876183|NCT00418665|617557084|FG001|Treatment Period|Requirement for alternative therapy|0|||
170876184|NCT00418665|617557085|FG002|Treatment Period|Requirement for alternative therapy|0|||
170876185|NCT00418665|617557083|FG000|Treatment Period|Physician Decision|1|||
170876186|NCT00418665|617557084|FG001|Treatment Period|Physician Decision|0|||
170876187|NCT00418665|617557085|FG002|Treatment Period|Physician Decision|3|||
170876188|NCT00418665|617557083|FG000|Treatment Extension|Adverse Event|1|||
170876189|NCT00418665|617557084|FG001|Treatment Extension|Adverse Event|0|||
170876190|NCT00418665|617557085|FG002|Treatment Extension|Adverse Event|0|||
170876191|NCT00418665|617557083|FG000|Treatment Extension|Withdrawal by Subject|1|||
170876192|NCT00418665|617557084|FG001|Treatment Extension|Withdrawal by Subject|0|||
170876193|NCT00418665|617557085|FG002|Treatment Extension|Withdrawal by Subject|0|||
170876194|NCT00418665|617557083|FG000|Treatment Extension|Requirement for alternative therapy|2|||
170876195|NCT00418665|617557084|FG001|Treatment Extension|Requirement for alternative therapy|2|||
170876196|NCT00418665|617557085|FG002|Treatment Extension|Requirement for alternative therapy|0|||
170876197|NCT00418665|617557083|FG000|Treatment Extension|Physician Decision|2|||
170876198|NCT00418665|617557084|FG001|Treatment Extension|Physician Decision|2|||
170876199|NCT00418665|617557085|FG002|Treatment Extension|Physician Decision|1|||
170876200|NCT00418665|617557083|FG000|Treatment Extension|Death|0|||
170876201|NCT00418665|617557084|FG001|Treatment Extension|Death|0|||
170876202|NCT00418665|617557085|FG002|Treatment Extension|Death|1|||
170876203|NCT01293968|617557086|FG000|Overall Study|non-cooperation|3|||
170876204|NCT01293968|617557087|FG001|Overall Study|non-cooperation|3|||
170876205|NCT01133379|617557088|FG000|Overall Study|Withdrawal by Subject|0|||
170876206|NCT01133379|617557089|FG001|Overall Study|Withdrawal by Subject|1|||
170876207|NCT01133379|617557090|FG002|Overall Study|Withdrawal by Subject|1|||
170876208|NCT01133379|617557088|FG000|Overall Study|Lost to Follow-up|1|||
170876209|NCT01133379|617557089|FG001|Overall Study|Lost to Follow-up|1|||
170876210|NCT01133379|617557090|FG002|Overall Study|Lost to Follow-up|1|||
170876211|NCT00687440|617557091|FG000|Overall Study|Adverse Event|3|||
170876212|NCT00687440|617557091|FG000|Overall Study|Lost to Follow-up|3|||
170876213|NCT00687440|617557091|FG000|Overall Study|Lack of Efficacy|2|||
170876214|NCT00687440|617557091|FG000|Overall Study|Death|2|||
170876215|NCT00687440|617557091|FG000|Overall Study|Other|1|||
170876216|NCT00687440|617557091|FG000|Overall Study|Missing|1|||
170876217|NCT01392677|617557092|FG000|Overall Study|Adverse Event|3|||
170876218|NCT01392677|617557093|FG001|Overall Study|Adverse Event|1|||
170876219|NCT01392677|617557092|FG000|Overall Study|Withdrawal by Subject|0|||
170876220|NCT01392677|617557093|FG001|Overall Study|Withdrawal by Subject|2|||
170876221|NCT01392677|617557092|FG000|Overall Study|Incorrect enrollment|2|||
170876222|NCT01392677|617557093|FG001|Overall Study|Incorrect enrollment|3|||
170876223|NCT01392677|617557092|FG000|Overall Study|Other reason|3|||
170876224|NCT01392677|617557093|FG001|Overall Study|Other reason|2|||
170876225|NCT01380379|617557096|FG000|Overall Study|Pregnancy|1|||
170876226|NCT01357577|617557097|FG000|Overall Study|Lost to Follow-up|20|||
170876227|NCT01357577|617557098|FG001|Overall Study|Lost to Follow-up|16|||
170876228|NCT01357577|617557097|FG000|Overall Study|Withdrawal by Subject|16|||
170876229|NCT01357577|617557098|FG001|Overall Study|Withdrawal by Subject|8|||
170876230|NCT01357577|617557097|FG000|Overall Study|look at data in database?|1|||
170876231|NCT01357577|617557098|FG001|Overall Study|look at data in database?|2|||
170876232|NCT05493280|617557099|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
170876233|NCT05493280|617557100|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
170876234|NCT00583024|617557101|FG000|Overall Study|Lost to Follow-up|4|||
170876235|NCT00075400|617558564|FG000|Overall Study|Ineligible: wrong primary|1|||
170876236|NCT00075400|617558564|FG000|Overall Study|Never treated|2|||
170876237|NCT02222207|617558565|FG000|Overall Study|Death|1|||
170876238|NCT02222207|617558565|FG000|Overall Study|Other reasons|2|||
170876239|NCT02222207|617558565|FG000|Overall Study|Adverse Event|1|||
170876240|NCT01429584|617558569|FG000|Overall Study|Withdrawal by Subject|1|||
170876241|NCT01429584|617558570|FG001|Overall Study|Withdrawal by Subject|0|||
170876242|NCT01429584|617558569|FG000|Overall Study|Protocol Violation|0|||
170876243|NCT01429584|617558570|FG001|Overall Study|Protocol Violation|1|||
170876244|NCT00750698|617558571|FG000|Overall Study|Withdrawal by Subject|1|||
170876245|NCT00750698|617558572|FG001|Overall Study|Withdrawal by Subject|0|||
170876246|NCT00750698|617558571|FG000|Overall Study|Progressive disease|5|||
170876247|NCT00750698|617558572|FG001|Overall Study|Progressive disease|2|||
170876248|NCT02554019|617558575|FG000|Overall Study|Withdrawal by Subject|1|||
170876249|NCT02554019|617558576|FG001|Overall Study|Withdrawal by Subject|0|||
170876250|NCT02554019|617558577|FG002|Overall Study|Withdrawal by Subject|2|||
170876251|NCT02554019|617558575|FG000|Overall Study|Adverse Event|1|||
170876252|NCT02554019|617558576|FG001|Overall Study|Adverse Event|0|||
170876253|NCT02554019|617558577|FG002|Overall Study|Adverse Event|0|||
170876254|NCT01417195|617558578|FG000|Overall Study|Stimulation failure|1|||
170876255|NCT01417195|617558579|FG001|Overall Study|Stimulation failure|0|||
170415060|NCT01296932|615860389|FG000|Overall Study|Investigator decision|0|||
170632521|NCT01499355|616666690|FG002|Run-In Period|Adverse Event|0|||
170632522|NCT01499355|616666691|FG003|Run-In Period|Adverse Event|0|||
170632523|NCT01499355|616666688|FG000|Double-Blind Period|Adverse Event|0|||
170632524|NCT01499355|616666689|FG001|Double-Blind Period|Adverse Event|2|||
170632525|NCT01499355|616666690|FG002|Double-Blind Period|Adverse Event|3|||
170632526|NCT01499355|616666691|FG003|Double-Blind Period|Adverse Event|2|||
170632527|NCT01499355|616666688|FG000|Double-Blind Period|Study Termination|0|||
170632528|NCT01499355|616666689|FG001|Double-Blind Period|Study Termination|18|||
170632529|NCT01499355|616666690|FG002|Double-Blind Period|Study Termination|16|||
170632530|NCT01499355|616666691|FG003|Double-Blind Period|Study Termination|14|||
170632531|NCT01499355|616666688|FG000|Double-Blind Period|Other|0|||
170632532|NCT01499355|616666689|FG001|Double-Blind Period|Other|1|||
170632533|NCT01499355|616666690|FG002|Double-Blind Period|Other|2|||
170632534|NCT01499355|616666691|FG003|Double-Blind Period|Other|2|||
170632535|NCT01499355|616666688|FG000|Double-Blind Period|Death|0|||
170632536|NCT01499355|616666689|FG001|Double-Blind Period|Death|1|||
170632537|NCT01499355|616666690|FG002|Double-Blind Period|Death|0|||
170632538|NCT01499355|616666691|FG003|Double-Blind Period|Death|0|||
170632539|NCT01499355|616666688|FG000|Double-Blind Period|Investigator Decision|0|||
170632540|NCT01499355|616666689|FG001|Double-Blind Period|Investigator Decision|0|||
170632541|NCT01499355|616666690|FG002|Double-Blind Period|Investigator Decision|3|||
170632542|NCT01499355|616666691|FG003|Double-Blind Period|Investigator Decision|3|||
170632543|NCT01499355|616666688|FG000|Double-Blind Period|Consent Withdrawn|0|||
170632544|NCT01499355|616666689|FG001|Double-Blind Period|Consent Withdrawn|0|||
170632545|NCT01499355|616666690|FG002|Double-Blind Period|Consent Withdrawn|1|||
170632546|NCT01499355|616666691|FG003|Double-Blind Period|Consent Withdrawn|2|||
170632547|NCT01499355|616666688|FG000|Double-Blind Period|Lost to Follow-up|0|||
170632548|NCT01499355|616666689|FG001|Double-Blind Period|Lost to Follow-up|1|||
170632549|NCT01499355|616666690|FG002|Double-Blind Period|Lost to Follow-up|0|||
170632550|NCT01499355|616666691|FG003|Double-Blind Period|Lost to Follow-up|0|||
170632551|NCT02072668|616666692|FG000|Second Intervention|Lost to Follow-up|1|||
170632552|NCT02072668|616666693|FG001|Second Intervention|Lost to Follow-up|0|||
170632553|NCT01353898|616666694|FG000|Overall Study|Study site terminated|0|||
170632554|NCT01353898|616666695|FG001|Overall Study|Study site terminated|0|||
170632555|NCT01353898|616666696|FG002|Overall Study|Study site terminated|0|||
170632556|NCT01353898|616666697|FG003|Overall Study|Study site terminated|0|||
170632557|NCT01353898|616666698|FG004|Overall Study|Study site terminated|0|||
170632558|NCT01353898|616666699|FG005|Overall Study|Study site terminated|1|||
170632559|NCT02668653|616666700|FG000|Overall Study|Refractory disease|41|||
170632560|NCT02668653|616666701|FG001|Overall Study|Refractory disease|70|||
170632561|NCT02668653|616666700|FG000|Overall Study|Relapse|44|||
170632562|NCT02668653|616666701|FG001|Overall Study|Relapse|65|||
170632563|NCT02668653|616666700|FG000|Overall Study|Adverse Event|58|||
170632564|NCT02668653|616666701|FG001|Overall Study|Adverse Event|23|||
170632565|NCT02668653|616666700|FG000|Overall Study|Subject decision to stop study drug|25|||
170632566|NCT02668653|616666701|FG001|Overall Study|Subject decision to stop study drug|23|||
170632567|NCT02668653|616666700|FG000|Overall Study|Other reasons not specified|16|||
170876256|NCT01417195|617558578|FG000|Overall Study|No embryos for transfer|0|||
170415061|NCT01296932|615860390|FG001|Overall Study|Investigator decision|1|||
170632568|NCT02668653|616666701|FG001|Overall Study|Other reasons not specified|11|||
170632569|NCT02668653|616666700|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
170632570|NCT02668653|616666701|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
170632571|NCT02668653|616666700|FG000|Overall Study|Investigator decision|10|||
170876257|NCT01417195|617558579|FG001|Overall Study|No embryos for transfer|1|||
170876258|NCT01417195|617558578|FG000|Overall Study|No transfer due to risk of OHSS|1|||
170632572|NCT02668653|616666701|FG001|Overall Study|Investigator decision|7|||
170632573|NCT02668653|616666700|FG000|Overall Study|Failure to meet continuation criteria|5|||
170632574|NCT02668653|616666701|FG001|Overall Study|Failure to meet continuation criteria|12|||
170632575|NCT02668653|616666700|FG000|Overall Study|Lost to Follow-up|1|||
170876259|NCT01417195|617558579|FG001|Overall Study|No transfer due to risk of OHSS|0|||
170876260|NCT01417195|617558578|FG000|Overall Study|No transfer due to elevated progesterone|1|||
170876261|NCT01417195|617558579|FG001|Overall Study|No transfer due to elevated progesterone|0|||
170876262|NCT02325219|617558580|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
170876263|NCT02325219|617558581|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
170876264|NCT02325219|617558582|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
170876265|NCT02325219|617558583|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
170876266|NCT02325219|617558584|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
170876267|NCT02325219|617558580|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
170876268|NCT02325219|617558581|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
170876269|NCT02325219|617558582|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170876270|NCT02325219|617558583|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170876271|NCT02325219|617558584|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170876272|NCT02325219|617558580|FG000|Controlled Period (Week 0 - 16)|Other|0|||
170876273|NCT02325219|617558581|FG001|Controlled Period (Week 0 - 16)|Other|0|||
170876274|NCT02325219|617558582|FG002|Controlled Period (Week 0 - 16)|Other|1|||
170876275|NCT02325219|617558583|FG003|Controlled Period (Week 0 - 16)|Other|0|||
170876276|NCT02325219|617558584|FG004|Controlled Period (Week 0 - 16)|Other|0|||
170876277|NCT02325219|617558580|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
170876278|NCT02325219|617558581|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
170876279|NCT02325219|617558582|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
170876280|NCT02325219|617558583|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
170876281|NCT02325219|617558584|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
170876282|NCT02325219|617558580|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
170876283|NCT02325219|617558581|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
170876284|NCT02325219|617558582|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
170876285|NCT02325219|617558583|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
170876286|NCT02325219|617558584|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
170876287|NCT02325219|617558580|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
170876288|NCT02325219|617558581|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
170876289|NCT02325219|617558582|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
170876290|NCT02325219|617558583|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
170876291|NCT02325219|617558584|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
170876292|NCT04766021|617558585|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
170876293|NCT04766021|617558585|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
170876294|NCT02535715|617558588|FG000|Overall Study|Withdrawal by Subject|0|||
170876295|NCT02535715|617558589|FG001|Overall Study|Withdrawal by Subject|0|||
170876296|NCT02535715|617558590|FG002|Overall Study|Withdrawal by Subject|1|||
170876297|NCT00909181|617558591|FG000|Overall Study|Lost to Follow-up|39|||
170876298|NCT00909181|617558592|FG001|Overall Study|Lost to Follow-up|18|||
170876299|NCT00909181|617558593|FG002|Overall Study|Lost to Follow-up|33|||
170876300|NCT02349048|617558594|FG000|Overall Study|Withdrawal by Subject|4|||
170876301|NCT02349048|617558595|FG001|Overall Study|Withdrawal by Subject|0|||
170876302|NCT02349048|617558594|FG000|Overall Study|Lost to Follow-up|1|||
170876303|NCT02349048|617558595|FG001|Overall Study|Lost to Follow-up|0|||
170876304|NCT03709654|617558596|FG000|Overall Study|Lost to Follow-up|1|||
170876305|NCT03709654|617558597|FG001|Overall Study|Lost to Follow-up|1|||
170876306|NCT03709654|617558596|FG000|Overall Study|Withdrawal by Subject|1|||
170876307|NCT03709654|617558597|FG001|Overall Study|Withdrawal by Subject|1|||
170876308|NCT03709654|617558596|FG000|Overall Study|Adverse Event|1|||
170876309|NCT03709654|617558597|FG001|Overall Study|Adverse Event|0|||
170876310|NCT01040351|617558598|FG000|Overall Study|poor ovarian response|1|||
170876311|NCT01040351|617558599|FG001|Overall Study|poor ovarian response|2|||
170876312|NCT01431274|617558602|FG000|Overall Study|Adverse Event|51|||
170876313|NCT01431274|617558603|FG001|Overall Study|Adverse Event|37|||
170876314|NCT01431274|617558604|FG002|Overall Study|Adverse Event|43|||
170876315|NCT01431274|617558605|FG003|Overall Study|Adverse Event|30|||
170876316|NCT01431274|617558606|FG004|Overall Study|Adverse Event|37|||
170876317|NCT01431274|617558602|FG000|Overall Study|Consent withdrawn not due to AE|29|||
170876318|NCT01431274|617558603|FG001|Overall Study|Consent withdrawn not due to AE|20|||
170876319|NCT01431274|617558604|FG002|Overall Study|Consent withdrawn not due to AE|17|||
170876320|NCT01431274|617558605|FG003|Overall Study|Consent withdrawn not due to AE|20|||
170876321|NCT01431274|617558606|FG004|Overall Study|Consent withdrawn not due to AE|11|||
170876322|NCT01431274|617558602|FG000|Overall Study|Non compliant with protocol|5|||
170876323|NCT01431274|617558603|FG001|Overall Study|Non compliant with protocol|8|||
170632576|NCT02668653|616666701|FG001|Overall Study|Lost to Follow-up|0|||
170876324|NCT01431274|617558604|FG002|Overall Study|Non compliant with protocol|4|||
170876325|NCT01431274|617558605|FG003|Overall Study|Non compliant with protocol|4|||
170876326|NCT01431274|617558606|FG004|Overall Study|Non compliant with protocol|4|||
170876327|NCT01431274|617558602|FG000|Overall Study|Lost to Follow-up|6|||
170876328|NCT01431274|617558603|FG001|Overall Study|Lost to Follow-up|7|||
170876329|NCT01431274|617558604|FG002|Overall Study|Lost to Follow-up|1|||
170876330|NCT01431274|617558605|FG003|Overall Study|Lost to Follow-up|4|||
170876331|NCT01431274|617558606|FG004|Overall Study|Lost to Follow-up|0|||
170876332|NCT01431274|617558602|FG000|Overall Study|Other reason not stated above|6|||
170876333|NCT01431274|617558603|FG001|Overall Study|Other reason not stated above|5|||
170876334|NCT01431274|617558604|FG002|Overall Study|Other reason not stated above|7|||
170876335|NCT01431274|617558605|FG003|Overall Study|Other reason not stated above|2|||
170876336|NCT01431274|617558606|FG004|Overall Study|Other reason not stated above|4|||
170876337|NCT01069172|617558607|FG000|Overall Study|Withdrawal by Subject|1|||
170876338|NCT01069172|617558608|FG001|Overall Study|Withdrawal by Subject|0|||
170876339|NCT02184195|617558611|FG000|Overall Study|Patient decision|5|||
170876340|NCT02184195|617558612|FG001|Overall Study|Patient decision|2|||
170876341|NCT02184195|617558611|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170876342|NCT02184195|617558612|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170876343|NCT02184195|617558611|FG000|Overall Study|Death|67|||
170876344|NCT02184195|617558612|FG001|Overall Study|Death|44|||
170876345|NCT02184195|617558611|FG000|Overall Study|Lost to Follow-up|1|||
170876346|NCT02184195|617558612|FG001|Overall Study|Lost to Follow-up|5|||
170876347|NCT02184195|617558611|FG000|Overall Study|Other|0|||
170876348|NCT02184195|617558612|FG001|Overall Study|Other|3|||
170876349|NCT00916149|617558613|FG000|Overall Study|Lost to Follow-up|3|||
170876350|NCT00916149|617558614|FG001|Overall Study|Lost to Follow-up|2|||
170876351|NCT00916149|617558615|FG002|Overall Study|Lost to Follow-up|0|||
170876352|NCT00916149|617558613|FG000|Overall Study|Unable to place scalp EEG leads|1|||
170876353|NCT00916149|617558614|FG001|Overall Study|Unable to place scalp EEG leads|0|||
170876354|NCT00916149|617558615|FG002|Overall Study|Unable to place scalp EEG leads|0|||
170876355|NCT00841568|617558616|FG000|Overall Study|Adverse Event|1|||
170876356|NCT00841568|617558616|FG000|Overall Study|Death|1|||
170876357|NCT00841568|617558616|FG000|Overall Study|Withdrawal by Subject|2|||
170876358|NCT00841568|617558616|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
170876359|NCT00978029|617558617|FG000|Overall Study|Adverse Event|1|||
170876360|NCT00978029|617558618|FG001|Overall Study|Adverse Event|2|||
170876361|NCT00978029|617558619|FG002|Overall Study|Adverse Event|5|||
170876362|NCT00978029|617558617|FG000|Overall Study|Withdrawal by Subject|0|||
170876363|NCT00978029|617558618|FG001|Overall Study|Withdrawal by Subject|0|||
170876364|NCT00978029|617558619|FG002|Overall Study|Withdrawal by Subject|1|||
170876365|NCT00978029|617558617|FG000|Overall Study|Protocol Violation|0|||
170876366|NCT00978029|617558618|FG001|Overall Study|Protocol Violation|1|||
170876367|NCT00978029|617558619|FG002|Overall Study|Protocol Violation|0|||
170876368|NCT02016820|617558627|FG000|Overall Study|Lost to Follow-up|2|||
170876369|NCT02016820|617558628|FG001|Overall Study|Lost to Follow-up|4|||
170876370|NCT00258674|617558629|FG000|Overall Study|Death|32|||
170876371|NCT00258674|617558630|FG001|Overall Study|Death|53|||
170876372|NCT00258674|617558631|FG002|Overall Study|Death|34|||
170876373|NCT03710486|617558633|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
170876374|NCT03710486|617558634|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
170876375|NCT03710486|617558633|FG000|Overall Study|Missing|0|||
170876376|NCT03710486|617558634|FG001|Overall Study|Missing|2|||
170876377|NCT01987960|617558635|FG000|Period 1|Adverse Event|24|||
170415062|NCT01296932|615860391|FG002|Overall Study|Investigator decision|0|||
170415063|NCT01296932|615860392|FG003|Overall Study|Investigator decision|1|||
170415064|NCT01296932|615860393|FG004|Overall Study|Investigator decision|0|||
170415065|NCT01296932|615860394|FG005|Overall Study|Investigator decision|0|||
170415066|NCT01296932|615860395|FG006|Overall Study|Investigator decision|1|||
170415067|NCT01296932|615860396|FG007|Overall Study|Investigator decision|0|||
170415068|NCT01296932|615860397|FG008|Overall Study|Investigator decision|1|||
170415069|NCT01296932|615860389|FG000|Overall Study|No clinical benefit anymore|0|||
170415070|NCT01296932|615860390|FG001|Overall Study|No clinical benefit anymore|1|||
170415071|NCT01296932|615860391|FG002|Overall Study|No clinical benefit anymore|0|||
170526471|NCT00492726|616275476|FG000|Overall Study|Withdrawal by Subject|6|||
170526472|NCT00492726|616275477|FG001|Overall Study|Withdrawal by Subject|3|||
170876378|NCT01987960|617558636|FG001|Period 1|Adverse Event|0|||
170876379|NCT01987960|617558637|FG002|Period 1|Adverse Event|0|||
170876380|NCT01987960|617558638|FG003|Period 1|Adverse Event|0|||
170876381|NCT01987960|617558635|FG000|Period 1|Lack of Efficacy|4|||
170876382|NCT01987960|617558636|FG001|Period 1|Lack of Efficacy|0|||
170876383|NCT01987960|617558637|FG002|Period 1|Lack of Efficacy|0|||
170415072|NCT01296932|615860392|FG003|Overall Study|No clinical benefit anymore|0|||
170876384|NCT01987960|617558638|FG003|Period 1|Lack of Efficacy|0|||
170876385|NCT01987960|617558635|FG000|Period 1|Non-compliance with IMP|6|||
170876386|NCT01987960|617558636|FG001|Period 1|Non-compliance with IMP|0|||
170876387|NCT01987960|617558637|FG002|Period 1|Non-compliance with IMP|0|||
170876388|NCT01987960|617558638|FG003|Period 1|Non-compliance with IMP|0|||
170876389|NCT01987960|617558635|FG000|Period 1|Protocol Violation|12|||
170876390|NCT01987960|617558636|FG001|Period 1|Protocol Violation|0|||
170876391|NCT01987960|617558637|FG002|Period 1|Protocol Violation|0|||
170876392|NCT01987960|617558638|FG003|Period 1|Protocol Violation|0|||
170876393|NCT01987960|617558635|FG000|Period 1|Withdrawal by Subject|21|||
170876394|NCT01987960|617558636|FG001|Period 1|Withdrawal by Subject|0|||
170876395|NCT01987960|617558637|FG002|Period 1|Withdrawal by Subject|0|||
170876396|NCT01987960|617558638|FG003|Period 1|Withdrawal by Subject|0|||
170876397|NCT01987960|617558635|FG000|Period 1|Lost to Follow-up|40|||
170876398|NCT01987960|617558636|FG001|Period 1|Lost to Follow-up|0|||
170876399|NCT01987960|617558637|FG002|Period 1|Lost to Follow-up|0|||
170876400|NCT01987960|617558638|FG003|Period 1|Lost to Follow-up|0|||
170876401|NCT01987960|617558635|FG000|Period 1|administrative or other reason|75|||
170876402|NCT01987960|617558636|FG001|Period 1|administrative or other reason|0|||
170876403|NCT01987960|617558637|FG002|Period 1|administrative or other reason|0|||
170876404|NCT01987960|617558638|FG003|Period 1|administrative or other reason|0|||
170876405|NCT01987960|617558635|FG000|Period 1|Withdrawal of consent before treatment|4|||
170876406|NCT01987960|617558636|FG001|Period 1|Withdrawal of consent before treatment|0|||
170876407|NCT01987960|617558637|FG002|Period 1|Withdrawal of consent before treatment|0|||
170876408|NCT01987960|617558638|FG003|Period 1|Withdrawal of consent before treatment|0|||
170876409|NCT01987960|617558635|FG000|Period 2|Adverse Event|0|||
170876410|NCT01987960|617558636|FG001|Period 2|Adverse Event|0|||
170876411|NCT01987960|617558637|FG002|Period 2|Adverse Event|1|||
170876412|NCT01987960|617558638|FG003|Period 2|Adverse Event|0|||
170876413|NCT01987960|617558635|FG000|Period 2|Withdrawal by Subject|0|||
170876414|NCT01987960|617558636|FG001|Period 2|Withdrawal by Subject|0|||
170876415|NCT01987960|617558637|FG002|Period 2|Withdrawal by Subject|1|||
170876416|NCT01987960|617558638|FG003|Period 2|Withdrawal by Subject|0|||
170876417|NCT01987960|617558635|FG000|Period 2|Administrative or other reason|0|||
170876418|NCT01987960|617558636|FG001|Period 2|Administrative or other reason|5|||
170876419|NCT01987960|617558637|FG002|Period 2|Administrative or other reason|7|||
170876420|NCT01987960|617558638|FG003|Period 2|Administrative or other reason|0|||
170876421|NCT01987960|617558635|FG000|Period 3|Adverse Event|0|||
170876422|NCT01987960|617558636|FG001|Period 3|Adverse Event|0|||
170876423|NCT01987960|617558637|FG002|Period 3|Adverse Event|0|||
170876424|NCT01987960|617558638|FG003|Period 3|Adverse Event|7|||
170876425|NCT01987960|617558635|FG000|Period 3|Non-compliance with IMP|0|||
170876426|NCT01987960|617558636|FG001|Period 3|Non-compliance with IMP|0|||
170876427|NCT01987960|617558637|FG002|Period 3|Non-compliance with IMP|0|||
170876428|NCT01987960|617558638|FG003|Period 3|Non-compliance with IMP|1|||
170876429|NCT01987960|617558635|FG000|Period 3|Protocol Violation|0|||
170876430|NCT01987960|617558636|FG001|Period 3|Protocol Violation|0|||
170876431|NCT01987960|617558637|FG002|Period 3|Protocol Violation|0|||
170876432|NCT01987960|617558638|FG003|Period 3|Protocol Violation|6|||
170876433|NCT01987960|617558635|FG000|Period 3|Withdrawal by Subject|0|||
170876434|NCT01987960|617558636|FG001|Period 3|Withdrawal by Subject|0|||
170876435|NCT01987960|617558637|FG002|Period 3|Withdrawal by Subject|0|||
170876436|NCT01987960|617558638|FG003|Period 3|Withdrawal by Subject|9|||
170876437|NCT01987960|617558635|FG000|Period 3|Lost to Follow-up|0|||
170876438|NCT01987960|617558636|FG001|Period 3|Lost to Follow-up|0|||
170876439|NCT01987960|617558637|FG002|Period 3|Lost to Follow-up|0|||
170876440|NCT01987960|617558638|FG003|Period 3|Lost to Follow-up|5|||
170876441|NCT01987960|617558635|FG000|Period 3|Administrative or other reason|0|||
170876442|NCT01987960|617558636|FG001|Period 3|Administrative or other reason|0|||
170876443|NCT01987960|617558637|FG002|Period 3|Administrative or other reason|0|||
170876444|NCT01987960|617558638|FG003|Period 3|Administrative or other reason|43|||
170876445|NCT01177683|617558640|FG000|Study Treatment|Disease Progressions during treatment|2|||
170876446|NCT01177683|617558641|FG001|Study Treatment|Disease Progressions during treatment|0|||
170876447|NCT01177683|617558642|FG002|Study Treatment|Disease Progressions during treatment|3|||
170876448|NCT01177683|617558640|FG000|Study Treatment|Adverse Event|0|||
170876449|NCT01177683|617558641|FG001|Study Treatment|Adverse Event|1|||
170876450|NCT01177683|617558642|FG002|Study Treatment|Adverse Event|12|||
170876451|NCT01177683|617558640|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
170876452|NCT01177683|617558641|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
170415073|NCT01296932|615860393|FG004|Overall Study|No clinical benefit anymore|0|||
170876453|NCT01177683|617558642|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
170876454|NCT01177683|617558640|FG000|Study Treatment|Alternative therapy|0|||
170876455|NCT01177683|617558641|FG001|Study Treatment|Alternative therapy|0|||
170876456|NCT01177683|617558642|FG002|Study Treatment|Alternative therapy|4|||
170876457|NCT01177683|617558640|FG000|Study Treatment|Physician Decision|1|||
170876458|NCT01177683|617558641|FG001|Study Treatment|Physician Decision|0|||
170876459|NCT01177683|617558642|FG002|Study Treatment|Physician Decision|1|||
170415074|NCT01296932|615860394|FG005|Overall Study|No clinical benefit anymore|0|||
170876460|NCT01177683|617558640|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
170876461|NCT01177683|617558641|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
170876462|NCT01177683|617558642|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
170876463|NCT01177683|617558640|FG000|Study Treatment|Symptomatic Deterioration|0|||
170876464|NCT01177683|617558641|FG001|Study Treatment|Symptomatic Deterioration|0|||
170415075|NCT01296932|615860395|FG006|Overall Study|No clinical benefit anymore|0|||
170526473|NCT00492726|616275476|FG000|Overall Study|Non compliant with study medication|0|||
170526474|NCT00492726|616275477|FG001|Overall Study|Non compliant with study medication|3|||
170526475|NCT04386902|616275478|FG000|Overall Study|Withdrawal by Subject|5|||
170526476|NCT04386902|616275478|FG000|Overall Study|Technical problems in the recording|5|||
170526477|NCT02322749|616275483|FG000|Period 2|Adverse Event|0|||
170526478|NCT02322749|616275484|FG001|Period 2|Adverse Event|0|||
170526479|NCT02322749|616275485|FG002|Period 2|Adverse Event|0|||
170526480|NCT02322749|616275486|FG003|Period 2|Adverse Event|1|||
170526481|NCT02322749|616275487|FG004|Period 2|Adverse Event|0|||
170526482|NCT02322749|616275488|FG005|Period 2|Adverse Event|0|||
170526483|NCT02322749|616275483|FG000|Period 2|Withdrawal by Subject|0|||
170526484|NCT02322749|616275484|FG001|Period 2|Withdrawal by Subject|0|||
170526485|NCT02322749|616275485|FG002|Period 2|Withdrawal by Subject|0|||
170526486|NCT02322749|616275486|FG003|Period 2|Withdrawal by Subject|1|||
170526487|NCT02322749|616275487|FG004|Period 2|Withdrawal by Subject|0|||
170526488|NCT02322749|616275488|FG005|Period 2|Withdrawal by Subject|0|||
170526489|NCT02322749|616275483|FG000|Period 3|Withdrawal by Subject|0|||
170526490|NCT02322749|616275484|FG001|Period 3|Withdrawal by Subject|0|||
170526491|NCT02322749|616275485|FG002|Period 3|Withdrawal by Subject|1|||
170526492|NCT02322749|616275486|FG003|Period 3|Withdrawal by Subject|0|||
170526493|NCT02322749|616275487|FG004|Period 3|Withdrawal by Subject|0|||
170526494|NCT02322749|616275488|FG005|Period 3|Withdrawal by Subject|0|||
170526495|NCT03630393|616277064|FG000|Overall Study|Death|1|||
170526496|NCT03630393|616277065|FG001|Overall Study|Death|0|||
170526497|NCT04635839|616277066|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
170526498|NCT04635839|616277067|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
170526499|NCT02870868|616277068|FG000|Overall Study|Withdrawal by Subject|2|||
170526500|NCT02870868|616277069|FG001|Overall Study|Withdrawal by Subject|1|||
170526501|NCT00499122|616277071|FG000|Overall Study|Withdrawal by Subject|2|||
170526502|NCT00288912|616277072|FG000|Overall Study|Developed exclusion criterion|4|||
170526503|NCT00288912|616277073|FG001|Overall Study|Developed exclusion criterion|6|||
170526504|NCT00288912|616277074|FG002|Overall Study|Developed exclusion criterion|7|||
170526505|NCT00288912|616277072|FG000|Overall Study|Lost to Follow-up|9|||
170526506|NCT00288912|616277073|FG001|Overall Study|Lost to Follow-up|6|||
170526507|NCT00288912|616277074|FG002|Overall Study|Lost to Follow-up|9|||
170526508|NCT00288912|616277072|FG000|Overall Study|Withdrawal by Subject|4|||
170526509|NCT00288912|616277073|FG001|Overall Study|Withdrawal by Subject|5|||
170526510|NCT00288912|616277074|FG002|Overall Study|Withdrawal by Subject|12|||
170526511|NCT00607893|616277075|FG000|Overall Study|Lost to Follow-up|4|||
170526512|NCT00607893|616277076|FG001|Overall Study|Lost to Follow-up|0|||
170526513|NCT00607893|616277075|FG000|Overall Study|withdrew due to loss of interest|0|||
170526514|NCT00607893|616277076|FG001|Overall Study|withdrew due to loss of interest|1|||
170526515|NCT00607893|616277075|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
170526516|NCT00607893|616277076|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
170526517|NCT00607893|616277075|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
170526518|NCT00607893|616277076|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
170526519|NCT00607893|616277075|FG000|Overall Study|Declined to be treated|1|||
170526520|NCT00607893|616277076|FG001|Overall Study|Declined to be treated|0|||
170526521|NCT00607893|616277075|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
170526522|NCT00607893|616277076|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
170526523|NCT00977197|616277079|FG000|Overall Study|Withdrawal by Subject|3|||
170526524|NCT00977197|616277080|FG001|Overall Study|Withdrawal by Subject|4|||
170776128|NCT02590432|617187043|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
170776129|NCT02590432|617187044|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
170776130|NCT02590432|617187045|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
170776131|NCT02590432|617187046|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
170776132|NCT02590432|617187038|FG000|Double-blind Treatment Period|Adverse Event|0|||
170776133|NCT02590432|617187039|FG001|Double-blind Treatment Period|Adverse Event|0|||
170776134|NCT02590432|617187040|FG002|Double-blind Treatment Period|Adverse Event|14|||
170776135|NCT02590432|617187041|FG003|Double-blind Treatment Period|Adverse Event|12|||
170776136|NCT02590432|617187042|FG004|Double-blind Treatment Period|Adverse Event|6|||
170776137|NCT02590432|617187043|FG005|Double-blind Treatment Period|Adverse Event|22|||
170776138|NCT02590432|617187044|FG006|Double-blind Treatment Period|Adverse Event|20|||
170526525|NCT00977197|616277079|FG000|Overall Study|Adverse Event|3|||
170526526|NCT00977197|616277080|FG001|Overall Study|Adverse Event|1|||
170526527|NCT00977197|616277079|FG000|Overall Study|Lack of Efficacy|1|||
170526528|NCT00977197|616277080|FG001|Overall Study|Lack of Efficacy|0|||
170526529|NCT00977197|616277079|FG000|Overall Study|Lost to Follow-up|1|||
170526530|NCT00977197|616277080|FG001|Overall Study|Lost to Follow-up|3|||
170526531|NCT00977197|616277079|FG000|Overall Study|Nonadherence|1|||
170526532|NCT00977197|616277080|FG001|Overall Study|Nonadherence|1|||
170776139|NCT02590432|617187045|FG007|Double-blind Treatment Period|Adverse Event|0|||
170876465|NCT01177683|617558642|FG002|Study Treatment|Symptomatic Deterioration|1|||
170876466|NCT01177683|617558640|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
170526533|NCT03530293|616277083|FG000|Pre-randomization|Adverse Event|12|||
170526534|NCT03530293|616277084|FG001|Pre-randomization|Adverse Event|0|||
170526535|NCT03530293|616277085|FG002|Pre-randomization|Adverse Event|0|||
170526536|NCT03530293|616277083|FG000|Pre-randomization|Protocol Violation|2|||
170526537|NCT03530293|616277084|FG001|Pre-randomization|Protocol Violation|0|||
170526538|NCT03530293|616277085|FG002|Pre-randomization|Protocol Violation|0|||
170526539|NCT03530293|616277083|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
170526540|NCT03530293|616277084|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
170526541|NCT03530293|616277085|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
170526542|NCT03530293|616277083|FG000|Pre-randomization|Withdrawal by Subject|5|||
170526543|NCT03530293|616277084|FG001|Pre-randomization|Withdrawal by Subject|0|||
170526544|NCT03530293|616277085|FG002|Pre-randomization|Withdrawal by Subject|0|||
170526545|NCT03530293|616277083|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
170526546|NCT03530293|616277084|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
170526547|NCT03530293|616277085|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
170526548|NCT03530293|616277083|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
170526549|NCT03530293|616277084|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
170526550|NCT03530293|616277085|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
170526551|NCT03530293|616277083|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
170526552|NCT03530293|616277084|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
170526553|NCT03530293|616277085|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
170526554|NCT03530293|616277083|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
170526555|NCT03530293|616277084|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
170526556|NCT03530293|616277085|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
170526557|NCT03530293|616277083|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
170526558|NCT03530293|616277084|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
170526559|NCT03530293|616277085|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
170526560|NCT00250588|616277088|FG000|Overall Study|Withdrawal by Subject|3|||
170776140|NCT02590432|617187046|FG008|Double-blind Treatment Period|Adverse Event|0|||
170776141|NCT02590432|617187038|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
170776142|NCT02590432|617187039|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
170776143|NCT02590432|617187040|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
170776144|NCT02590432|617187041|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
170776145|NCT02590432|617187042|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
170776146|NCT02590432|617187043|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
170776147|NCT02590432|617187044|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
170776148|NCT02590432|617187045|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
170776149|NCT02590432|617187046|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
170776150|NCT02590432|617187038|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
170776151|NCT02590432|617187039|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
170776152|NCT02590432|617187040|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
170776153|NCT02590432|617187041|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
170776154|NCT02590432|617187042|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
170776155|NCT02590432|617187043|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
170776156|NCT02590432|617187044|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
170776157|NCT02590432|617187045|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
170776158|NCT02590432|617187046|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
170776159|NCT02590432|617187038|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
170776160|NCT02590432|617187039|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
170776161|NCT02590432|617187040|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
170776162|NCT02590432|617187041|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
170776163|NCT02590432|617187042|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
170776164|NCT02590432|617187043|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
170776165|NCT02590432|617187044|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
170776166|NCT02590432|617187045|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
170776167|NCT02590432|617187046|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
170776168|NCT02590432|617187038|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
170776169|NCT02590432|617187039|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
170776170|NCT02590432|617187040|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
170776171|NCT02590432|617187041|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
170776172|NCT02590432|617187042|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
170776173|NCT02590432|617187043|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
170776174|NCT02590432|617187044|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
170776175|NCT02590432|617187045|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
170776176|NCT02590432|617187046|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
170776177|NCT02590432|617187038|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
170526561|NCT00250588|616277089|FG001|Overall Study|Withdrawal by Subject|6|||
170632577|NCT02668653|616666700|FG000|Overall Study|Pregnancy|0|||
170876467|NCT01177683|617558641|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
170876468|NCT01177683|617558642|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
170876469|NCT01177683|617558640|FG000|Follow up|Patient lost to follow up|0|||
170876470|NCT01177683|617558641|FG001|Follow up|Patient lost to follow up|0|||
170876471|NCT01177683|617558642|FG002|Follow up|Patient lost to follow up|2|||
170876472|NCT01177683|617558640|FG000|Follow up|Death|2|||
170876473|NCT01177683|617558641|FG001|Follow up|Death|1|||
170876474|NCT01177683|617558642|FG002|Follow up|Death|7|||
170876475|NCT01177683|617558640|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
170876476|NCT01177683|617558641|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
170876477|NCT01177683|617558642|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
170876478|NCT00789880|617558643|FG000|Overall Study|Adverse Event|0|||
170876479|NCT00789880|617558644|FG001|Overall Study|Adverse Event|0|||
170876480|NCT00789880|617558645|FG002|Overall Study|Adverse Event|0|||
170876481|NCT00789880|617558646|FG003|Overall Study|Adverse Event|0|||
170876482|NCT00789880|617558647|FG004|Overall Study|Adverse Event|1|||
170876483|NCT00789880|617558648|FG005|Overall Study|Adverse Event|0|||
170876484|NCT00789880|617558643|FG000|Overall Study|Protocol Violation|0|||
170876485|NCT00789880|617558644|FG001|Overall Study|Protocol Violation|1|||
170876486|NCT00789880|617558645|FG002|Overall Study|Protocol Violation|0|||
170876487|NCT00789880|617558646|FG003|Overall Study|Protocol Violation|1|||
170876488|NCT00789880|617558647|FG004|Overall Study|Protocol Violation|0|||
170876489|NCT00789880|617558648|FG005|Overall Study|Protocol Violation|0|||
170876490|NCT00789880|617558643|FG000|Overall Study|Withdrawal by Subject|1|||
170876491|NCT00789880|617558644|FG001|Overall Study|Withdrawal by Subject|0|||
170876492|NCT00789880|617558645|FG002|Overall Study|Withdrawal by Subject|0|||
170876493|NCT00789880|617558646|FG003|Overall Study|Withdrawal by Subject|0|||
170526562|NCT00250588|616277090|FG002|Overall Study|Withdrawal by Subject|0|||
170876494|NCT00789880|617558647|FG004|Overall Study|Withdrawal by Subject|2|||
170876495|NCT00789880|617558648|FG005|Overall Study|Withdrawal by Subject|0|||
170876496|NCT01131520|617558650|FG000|Overall Study|Computer problem|1|||
170876497|NCT01131520|617558651|FG001|Overall Study|Computer problem|0|||
170876498|NCT01131520|617558650|FG000|Overall Study|Counselor not available|0|||
170876499|NCT01131520|617558651|FG001|Overall Study|Counselor not available|3|||
170876500|NCT01131520|617558650|FG000|Overall Study|Subject changed history after enrollment|0|||
170876501|NCT01131520|617558651|FG001|Overall Study|Subject changed history after enrollment|1|||
170876502|NCT01147744|617558652|FG000|Overall Study|Protocol Violation|1|||
170876503|NCT01147744|617558653|FG001|Overall Study|Protocol Violation|0|||
170876504|NCT01147744|617558654|FG002|Overall Study|Protocol Violation|1|||
170876505|NCT01147744|617558655|FG003|Overall Study|Protocol Violation|0|||
170876506|NCT01147744|617558656|FG004|Overall Study|Protocol Violation|1|||
170526563|NCT00250588|616277088|FG000|Overall Study|Lost to Follow-up|6|||
170526564|NCT00250588|616277089|FG001|Overall Study|Lost to Follow-up|13|||
170526565|NCT00250588|616277090|FG002|Overall Study|Lost to Follow-up|13|||
170526566|NCT02662569|616277094|FG000|Overall Study|Withdrawal by Subject|6|||
170526567|NCT02662569|616277095|FG001|Overall Study|Withdrawal by Subject|1|||
170526568|NCT02662569|616277096|FG002|Overall Study|Withdrawal by Subject|6|||
170526569|NCT02662569|616277097|FG003|Overall Study|Withdrawal by Subject|4|||
170526570|NCT02662569|616277094|FG000|Overall Study|Lost to Follow-up|1|||
170526571|NCT02662569|616277095|FG001|Overall Study|Lost to Follow-up|0|||
170526572|NCT02662569|616277096|FG002|Overall Study|Lost to Follow-up|0|||
170526573|NCT02662569|616277097|FG003|Overall Study|Lost to Follow-up|0|||
170526574|NCT01603277|616277098|FG000|Overall Study|Adverse Event|1|||
170526575|NCT01603277|616277099|FG001|Overall Study|Adverse Event|2|||
170526576|NCT01603277|616277098|FG000|Overall Study|Physician Decision|0|||
170526577|NCT01603277|616277099|FG001|Overall Study|Physician Decision|1|||
170526578|NCT01603277|616277098|FG000|Overall Study|Protocol Violation|6|||
170526579|NCT01603277|616277099|FG001|Overall Study|Protocol Violation|10|||
170526580|NCT01603277|616277098|FG000|Overall Study|Withdrawal by Subject|5|||
170526581|NCT01603277|616277099|FG001|Overall Study|Withdrawal by Subject|4|||
170526582|NCT01603277|616277098|FG000|Overall Study|Non-Compliance|2|||
170876507|NCT01147744|617558657|FG005|Overall Study|Protocol Violation|3|||
170876508|NCT01147744|617558658|FG006|Overall Study|Protocol Violation|1|||
170876509|NCT01147744|617558652|FG000|Overall Study|Physician Decision|0|||
170876510|NCT01147744|617558653|FG001|Overall Study|Physician Decision|1|||
170876511|NCT01147744|617558654|FG002|Overall Study|Physician Decision|1|||
170526583|NCT01603277|616277099|FG001|Overall Study|Non-Compliance|1|||
170526584|NCT01701245|616277102|FG000|Overall Study|Protocol Violation|1|||
170526585|NCT01701245|616277103|FG001|Overall Study|Protocol Violation|3|||
170632578|NCT02668653|616666701|FG001|Overall Study|Pregnancy|1|||
170876512|NCT01147744|617558655|FG003|Overall Study|Physician Decision|0|||
170876513|NCT01147744|617558656|FG004|Overall Study|Physician Decision|0|||
170876514|NCT01147744|617558657|FG005|Overall Study|Physician Decision|0|||
170876515|NCT01147744|617558658|FG006|Overall Study|Physician Decision|1|||
170876516|NCT01147744|617558652|FG000|Overall Study|Lack of Efficacy|11|||
170876517|NCT01147744|617558653|FG001|Overall Study|Lack of Efficacy|11|||
170632579|NCT02668653|616666700|FG000|Overall Study|Death|0|||
170415076|NCT01296932|615860396|FG007|Overall Study|No clinical benefit anymore|0|||
170415077|NCT01296932|615860397|FG008|Overall Study|No clinical benefit anymore|0|||
170415078|NCT01296932|615860389|FG000|Overall Study|Physician Decision|0|||
170415079|NCT01296932|615860390|FG001|Overall Study|Physician Decision|0|||
170415080|NCT01296932|615860391|FG002|Overall Study|Physician Decision|1|||
170415081|NCT01296932|615860392|FG003|Overall Study|Physician Decision|0|||
170415082|NCT01296932|615860393|FG004|Overall Study|Physician Decision|0|||
170415083|NCT01296932|615860394|FG005|Overall Study|Physician Decision|0|||
170415084|NCT01296932|615860395|FG006|Overall Study|Physician Decision|0|||
170415085|NCT01296932|615860396|FG007|Overall Study|Physician Decision|0|||
170415086|NCT01296932|615860397|FG008|Overall Study|Physician Decision|0|||
170415087|NCT01296932|615860389|FG000|Overall Study|IV problems, administration not possible|0|||
170415088|NCT01296932|615860390|FG001|Overall Study|IV problems, administration not possible|0|||
170415089|NCT01296932|615860391|FG002|Overall Study|IV problems, administration not possible|1|||
170415090|NCT01296932|615860392|FG003|Overall Study|IV problems, administration not possible|0|||
170415091|NCT01296932|615860393|FG004|Overall Study|IV problems, administration not possible|0|||
170415092|NCT01296932|615860394|FG005|Overall Study|IV problems, administration not possible|0|||
170415093|NCT01296932|615860395|FG006|Overall Study|IV problems, administration not possible|0|||
170415094|NCT01296932|615860396|FG007|Overall Study|IV problems, administration not possible|0|||
170415095|NCT01296932|615860397|FG008|Overall Study|IV problems, administration not possible|0|||
170415096|NCT01296932|615860389|FG000|Overall Study|per protocol|0|||
170415097|NCT01296932|615860390|FG001|Overall Study|per protocol|0|||
170415098|NCT01296932|615860391|FG002|Overall Study|per protocol|1|||
170415099|NCT01296932|615860392|FG003|Overall Study|per protocol|1|||
170415100|NCT01296932|615860393|FG004|Overall Study|per protocol|0|||
170415101|NCT01296932|615860394|FG005|Overall Study|per protocol|0|||
170415102|NCT01296932|615860395|FG006|Overall Study|per protocol|0|||
170415103|NCT01296932|615860396|FG007|Overall Study|per protocol|0|||
170415104|NCT01296932|615860397|FG008|Overall Study|per protocol|0|||
170415105|NCT01296932|615860389|FG000|Overall Study|Low benefit and too many side effects|0|||
170415106|NCT01296932|615860390|FG001|Overall Study|Low benefit and too many side effects|0|||
170415107|NCT01296932|615860391|FG002|Overall Study|Low benefit and too many side effects|0|||
170415108|NCT01296932|615860392|FG003|Overall Study|Low benefit and too many side effects|0|||
170415109|NCT01296932|615860393|FG004|Overall Study|Low benefit and too many side effects|0|||
170415110|NCT01296932|615860394|FG005|Overall Study|Low benefit and too many side effects|0|||
170415111|NCT01296932|615860395|FG006|Overall Study|Low benefit and too many side effects|0|||
170415112|NCT01296932|615860396|FG007|Overall Study|Low benefit and too many side effects|1|||
170415113|NCT01296932|615860397|FG008|Overall Study|Low benefit and too many side effects|0|||
170415114|NCT01296932|615860389|FG000|Overall Study|No adequate treatment response|0|||
170415115|NCT01296932|615860390|FG001|Overall Study|No adequate treatment response|0|||
170415116|NCT01296932|615860391|FG002|Overall Study|No adequate treatment response|0|||
170415117|NCT01296932|615860392|FG003|Overall Study|No adequate treatment response|0|||
170415118|NCT01296932|615860393|FG004|Overall Study|No adequate treatment response|0|||
170415119|NCT01296932|615860394|FG005|Overall Study|No adequate treatment response|0|||
170415120|NCT01296932|615860395|FG006|Overall Study|No adequate treatment response|0|||
170415121|NCT01296932|615860396|FG007|Overall Study|No adequate treatment response|1|||
170415122|NCT01296932|615860397|FG008|Overall Study|No adequate treatment response|0|||
170415123|NCT01296932|615860389|FG000|Overall Study|Dosage already reduced, AE still present|0|||
170415124|NCT01296932|615860390|FG001|Overall Study|Dosage already reduced, AE still present|0|||
170415125|NCT01296932|615860391|FG002|Overall Study|Dosage already reduced, AE still present|0|||
170415126|NCT01296932|615860392|FG003|Overall Study|Dosage already reduced, AE still present|0|||
170415127|NCT01296932|615860393|FG004|Overall Study|Dosage already reduced, AE still present|0|||
170415128|NCT01296932|615860394|FG005|Overall Study|Dosage already reduced, AE still present|0|||
170415129|NCT01296932|615860395|FG006|Overall Study|Dosage already reduced, AE still present|0|||
170415130|NCT01296932|615860396|FG007|Overall Study|Dosage already reduced, AE still present|0|||
170415131|NCT01296932|615860397|FG008|Overall Study|Dosage already reduced, AE still present|1|||
170415132|NCT05568225|615860399|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
170415133|NCT05568225|615860400|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
170415134|NCT05568225|615860401|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
170415135|NCT05568225|615860399|FG000|Primary Treatment Period|Physician Decision|0|||
170415136|NCT05568225|615860400|FG001|Primary Treatment Period|Physician Decision|1|||
170415137|NCT05568225|615860401|FG002|Primary Treatment Period|Physician Decision|0|||
170415138|NCT05568225|615860399|FG000|Primary Treatment Period|Disease progression|0|||
170415139|NCT05568225|615860400|FG001|Primary Treatment Period|Disease progression|1|||
170415140|NCT05568225|615860401|FG002|Primary Treatment Period|Disease progression|0|||
170415141|NCT05568225|615860399|FG000|Primary Treatment Period|Lack of Efficacy|0|||
170415142|NCT05568225|615860400|FG001|Primary Treatment Period|Lack of Efficacy|1|||
170415143|NCT05568225|615860401|FG002|Primary Treatment Period|Lack of Efficacy|0|||
170415144|NCT05568225|615860399|FG000|Primary Treatment Period|Withdrawal of conset|1|||
170632580|NCT02668653|616666701|FG001|Overall Study|Death|1|||
170632581|NCT02420821|616666703|FG000|Overall Study|Lost to Follow-up|6|||
170415145|NCT05568225|615860400|FG001|Primary Treatment Period|Withdrawal of conset|0|||
170415146|NCT05568225|615860401|FG002|Primary Treatment Period|Withdrawal of conset|4|||
170415147|NCT05568225|615860399|FG000|Primary Treatment Period|Adverse Event|1|||
170415148|NCT05568225|615860400|FG001|Primary Treatment Period|Adverse Event|0|||
170415149|NCT05568225|615860401|FG002|Primary Treatment Period|Adverse Event|0|||
170415150|NCT05568225|615860399|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
170415151|NCT05568225|615860400|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
170415152|NCT05568225|615860401|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
170415153|NCT05568225|615860399|FG000|Extension Treatment Period|Protocol Violation|0|||
170415154|NCT05568225|615860400|FG001|Extension Treatment Period|Protocol Violation|0|||
170415155|NCT05568225|615860401|FG002|Extension Treatment Period|Protocol Violation|1|||
170415156|NCT05568225|615860399|FG000|Extension Treatment Period|Lack of Efficacy|0|||
170415157|NCT05568225|615860400|FG001|Extension Treatment Period|Lack of Efficacy|0|||
170415158|NCT05568225|615860401|FG002|Extension Treatment Period|Lack of Efficacy|1|||
170415159|NCT01027143|615860404|FG000|Overall Study|Lost to Follow-up|9|||
170415160|NCT01027143|615860405|FG001|Overall Study|Lost to Follow-up|4|||
170415161|NCT02637557|615860412|FG000|Overall Study|Adverse Event|3|||
170415162|NCT02637557|615860413|FG001|Overall Study|Adverse Event|1|||
170415163|NCT02637557|615860414|FG002|Overall Study|Adverse Event|3|||
170415164|NCT02637557|615860415|FG003|Overall Study|Adverse Event|3|||
170415165|NCT02637557|615860412|FG000|Overall Study|Lost to Follow-up|1|||
170415166|NCT02637557|615860413|FG001|Overall Study|Lost to Follow-up|1|||
170415167|NCT02637557|615860414|FG002|Overall Study|Lost to Follow-up|0|||
170415168|NCT02637557|615860415|FG003|Overall Study|Lost to Follow-up|1|||
170415169|NCT02637557|615860412|FG000|Overall Study|Physician Decision|1|||
170415170|NCT02637557|615860413|FG001|Overall Study|Physician Decision|0|||
170415171|NCT02637557|615860414|FG002|Overall Study|Physician Decision|0|||
170415172|NCT02637557|615860415|FG003|Overall Study|Physician Decision|0|||
170415173|NCT02637557|615860412|FG000|Overall Study|Protocol Violation|2|||
170415174|NCT02637557|615860413|FG001|Overall Study|Protocol Violation|0|||
170415175|NCT02637557|615860414|FG002|Overall Study|Protocol Violation|2|||
170415176|NCT02637557|615860415|FG003|Overall Study|Protocol Violation|1|||
170415177|NCT02637557|615860412|FG000|Overall Study|Withdrawal by Subject|1|||
170415178|NCT02637557|615860413|FG001|Overall Study|Withdrawal by Subject|3|||
170415179|NCT02637557|615860414|FG002|Overall Study|Withdrawal by Subject|4|||
170415180|NCT02637557|615860415|FG003|Overall Study|Withdrawal by Subject|2|||
170415181|NCT03519256|615860416|FG000|Overall Study|Disease recurrence|4|||
170415182|NCT03519256|615860417|FG001|Overall Study|Disease recurrence|4|||
170415183|NCT03519256|615860418|FG002|Overall Study|Disease recurrence|5|||
170415184|NCT03519256|615860419|FG003|Overall Study|Disease recurrence|2|||
170415185|NCT03519256|615860416|FG000|Overall Study|Study drug toxicity|0|||
170415186|NCT03519256|615860417|FG001|Overall Study|Study drug toxicity|2|||
170415187|NCT03519256|615860418|FG002|Overall Study|Study drug toxicity|5|||
170415188|NCT03519256|615860419|FG003|Overall Study|Study drug toxicity|2|||
170415189|NCT03519256|615860416|FG000|Overall Study|Adverse event unrelated to study drug|0|||
170415190|NCT03519256|615860417|FG001|Overall Study|Adverse event unrelated to study drug|1|||
170415191|NCT03519256|615860418|FG002|Overall Study|Adverse event unrelated to study drug|1|||
170415192|NCT03519256|615860419|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170415193|NCT03519256|615860416|FG000|Overall Study|Participant request to discontinue study treatment|0|||
170415194|NCT03519256|615860417|FG001|Overall Study|Participant request to discontinue study treatment|0|||
170415195|NCT03519256|615860418|FG002|Overall Study|Participant request to discontinue study treatment|0|||
170415196|NCT03519256|615860419|FG003|Overall Study|Participant request to discontinue study treatment|2|||
170415197|NCT03519256|615860416|FG000|Overall Study|Other reasons|0|||
170415198|NCT03519256|615860417|FG001|Overall Study|Other reasons|0|||
170415199|NCT03519256|615860418|FG002|Overall Study|Other reasons|2|||
170415200|NCT03519256|615860419|FG003|Overall Study|Other reasons|0|||
170415201|NCT03519256|615860416|FG000|Overall Study|Disease progression|6|||
170415202|NCT03519256|615860417|FG001|Overall Study|Disease progression|3|||
170415203|NCT03519256|615860418|FG002|Overall Study|Disease progression|2|||
170415204|NCT03519256|615860419|FG003|Overall Study|Disease progression|1|||
170415205|NCT03519256|615860416|FG000|Overall Study|Lost to Follow-up|0|||
170415206|NCT03519256|615860417|FG001|Overall Study|Lost to Follow-up|1|||
170415207|NCT03519256|615860418|FG002|Overall Study|Lost to Follow-up|0|||
170415208|NCT03519256|615860419|FG003|Overall Study|Lost to Follow-up|0|||
170415209|NCT02207231|615860420|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
170415210|NCT02207231|615860421|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
170415211|NCT02207231|615860422|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
170632582|NCT02420821|616666704|FG001|Overall Study|Lost to Follow-up|6|||
170632583|NCT02420821|616666703|FG000|Overall Study|Non-compliance|0|||
170415212|NCT02207231|615860423|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
170415213|NCT02207231|615860420|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
170415214|NCT02207231|615860421|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
170415215|NCT02207231|615860422|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
170415216|NCT02207231|615860423|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
170632584|NCT02420821|616666704|FG001|Overall Study|Non-compliance|2|||
170632585|NCT02420821|616666703|FG000|Overall Study|Physician Decision|6|||
170632586|NCT02420821|616666704|FG001|Overall Study|Physician Decision|2|||
170632587|NCT02420821|616666703|FG000|Overall Study|Withdrawal by Subject|32|||
170632588|NCT02420821|616666704|FG001|Overall Study|Withdrawal by Subject|25|||
170632589|NCT02420821|616666703|FG000|Overall Study|Death|270|||
170632590|NCT02420821|616666704|FG001|Overall Study|Death|263|||
170632591|NCT02420821|616666703|FG000|Overall Study|Study Terminated By Sponsor|145|||
170632592|NCT02420821|616666704|FG001|Overall Study|Study Terminated By Sponsor|149|||
170415217|NCT02207231|615860420|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
170415218|NCT02207231|615860421|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
170415219|NCT02207231|615860422|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
170415220|NCT02207231|615860423|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
170415221|NCT02207231|615860420|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
170415222|NCT02207231|615860421|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
170415223|NCT02207231|615860422|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
170415224|NCT02207231|615860423|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
170415225|NCT02207231|615860420|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
170415226|NCT02207231|615860421|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
170415227|NCT02207231|615860422|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
170415228|NCT02207231|615860423|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
170415229|NCT02207231|615860420|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
170415230|NCT02207231|615860421|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
170415231|NCT02207231|615860422|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
170415232|NCT02207231|615860423|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
170415233|NCT02207231|615860420|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
170415234|NCT02207231|615860421|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
170415235|NCT02207231|615860422|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
170415236|NCT02207231|615860423|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
170415237|NCT02207231|615860420|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
170415238|NCT02207231|615860421|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
170415239|NCT02207231|615860422|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
170415240|NCT02207231|615860423|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
170415241|NCT02207231|615860420|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
170415242|NCT02207231|615860421|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
170415243|NCT02207231|615860422|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
170415244|NCT02207231|615860423|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
170415245|NCT02207231|615860420|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
170415246|NCT02207231|615860421|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
170415247|NCT02207231|615860422|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
170415248|NCT02207231|615860423|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
170415249|NCT02207231|615860420|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
170415250|NCT02207231|615860421|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
170415251|NCT02207231|615860422|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
170415252|NCT02207231|615860423|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
170415253|NCT02207231|615860420|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
170415254|NCT02207231|615860421|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
170415255|NCT02207231|615860422|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
170415256|NCT02207231|615860423|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
170415257|NCT02207231|615860420|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
170415258|NCT02207231|615860421|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
170415259|NCT02207231|615860422|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
170415260|NCT02207231|615860423|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
170415261|NCT02207231|615860420|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
170415262|NCT02207231|615860421|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
170415263|NCT02207231|615860422|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
170415264|NCT02207231|615860423|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
170415265|NCT02207231|615860420|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
170415266|NCT02207231|615860421|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
170415267|NCT02207231|615860422|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
170415268|NCT02207231|615860423|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
170415269|NCT02207231|615860420|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
170415270|NCT02207231|615860421|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
170415271|NCT02207231|615860422|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
170415272|NCT02207231|615860423|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
170415273|NCT02207231|615860420|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
170415274|NCT02207231|615860421|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
170876518|NCT01147744|617558654|FG002|Overall Study|Lack of Efficacy|9|||
170876519|NCT01147744|617558655|FG003|Overall Study|Lack of Efficacy|11|||
170876520|NCT01147744|617558656|FG004|Overall Study|Lack of Efficacy|13|||
170876521|NCT01147744|617558657|FG005|Overall Study|Lack of Efficacy|8|||
170876522|NCT01147744|617558658|FG006|Overall Study|Lack of Efficacy|7|||
170876523|NCT01147744|617558652|FG000|Overall Study|Adverse Event|1|||
170876524|NCT01147744|617558653|FG001|Overall Study|Adverse Event|2|||
170876525|NCT01147744|617558654|FG002|Overall Study|Adverse Event|3|||
170876526|NCT01147744|617558655|FG003|Overall Study|Adverse Event|0|||
170876527|NCT01147744|617558656|FG004|Overall Study|Adverse Event|2|||
170876528|NCT01147744|617558657|FG005|Overall Study|Adverse Event|1|||
170876529|NCT01147744|617558658|FG006|Overall Study|Adverse Event|2|||
170876530|NCT01147744|617558652|FG000|Overall Study|Withdrawal by Subject|8|||
170876531|NCT01147744|617558653|FG001|Overall Study|Withdrawal by Subject|4|||
170876532|NCT01147744|617558654|FG002|Overall Study|Withdrawal by Subject|2|||
170876533|NCT01147744|617558655|FG003|Overall Study|Withdrawal by Subject|2|||
170876534|NCT01147744|617558656|FG004|Overall Study|Withdrawal by Subject|2|||
170876535|NCT01147744|617558657|FG005|Overall Study|Withdrawal by Subject|5|||
170876536|NCT01147744|617558658|FG006|Overall Study|Withdrawal by Subject|2|||
170876537|NCT01147744|617558652|FG000|Overall Study|Lost to Follow-up|0|||
170876538|NCT01147744|617558653|FG001|Overall Study|Lost to Follow-up|1|||
170876539|NCT01147744|617558654|FG002|Overall Study|Lost to Follow-up|0|||
170876540|NCT01147744|617558655|FG003|Overall Study|Lost to Follow-up|0|||
170876541|NCT01147744|617558656|FG004|Overall Study|Lost to Follow-up|0|||
170876542|NCT01147744|617558657|FG005|Overall Study|Lost to Follow-up|0|||
170876543|NCT01147744|617558658|FG006|Overall Study|Lost to Follow-up|0|||
170876544|NCT01147744|617558652|FG000|Overall Study|Sponsor decision to amend protocol|7|||
170876545|NCT01147744|617558653|FG001|Overall Study|Sponsor decision to amend protocol|4|||
170876546|NCT01147744|617558654|FG002|Overall Study|Sponsor decision to amend protocol|2|||
170876547|NCT01147744|617558655|FG003|Overall Study|Sponsor decision to amend protocol|5|||
170876548|NCT01147744|617558656|FG004|Overall Study|Sponsor decision to amend protocol|7|||
170876549|NCT01147744|617558657|FG005|Overall Study|Sponsor decision to amend protocol|2|||
170876550|NCT01147744|617558658|FG006|Overall Study|Sponsor decision to amend protocol|6|||
170876551|NCT01147744|617558652|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
170876552|NCT01147744|617558653|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
170876553|NCT01147744|617558654|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
170876554|NCT01147744|617558655|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
170876555|NCT01147744|617558656|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
170876556|NCT01147744|617558657|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
170876557|NCT01147744|617558658|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
170876558|NCT01342484|617558660|FG000|Overall Study|Other Reasons|1|||
170876559|NCT01342484|617558661|FG001|Overall Study|Other Reasons|0|||
170876560|NCT01342484|617558662|FG002|Overall Study|Other Reasons|0|||
170876561|NCT01342484|617558660|FG000|Overall Study|Protocol Violation|0|||
170876562|NCT01342484|617558661|FG001|Overall Study|Protocol Violation|0|||
170876563|NCT01342484|617558662|FG002|Overall Study|Protocol Violation|1|||
170876564|NCT01342484|617558660|FG000|Overall Study|Withdrawal by Subject|1|||
170876565|NCT01342484|617558661|FG001|Overall Study|Withdrawal by Subject|0|||
170876566|NCT01342484|617558662|FG002|Overall Study|Withdrawal by Subject|0|||
170876567|NCT03302975|617558664|FG000|Overall Study|Lost to Follow-up|4|||
170776178|NCT02590432|617187039|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
170776179|NCT02590432|617187040|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
170776180|NCT02590432|617187041|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
170776181|NCT02590432|617187042|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
170776182|NCT02590432|617187043|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
170776183|NCT02590432|617187044|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
170776184|NCT02590432|617187045|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
170876568|NCT01436084|617558665|FG000|Overall Study|Disease Progression|2|||
170876569|NCT01436084|617558665|FG000|Overall Study|Withdrawal by Subject|1|||
170876570|NCT01436084|617558665|FG000|Overall Study|Early Closure of Study|1|||
170876571|NCT00432042|617558666|FG000|Overall Study|Protocol Violation|2|||
170876572|NCT00432042|617558667|FG001|Overall Study|Protocol Violation|0|||
170876573|NCT00432042|617558668|FG002|Overall Study|Protocol Violation|0|||
170876574|NCT00432042|617558666|FG000|Overall Study|Withdrawal by Subject|0|||
170876575|NCT00432042|617558667|FG001|Overall Study|Withdrawal by Subject|0|||
170876576|NCT00432042|617558668|FG002|Overall Study|Withdrawal by Subject|2|||
170876577|NCT00432042|617558666|FG000|Overall Study|Lost to Follow-up|5|||
170876578|NCT00432042|617558667|FG001|Overall Study|Lost to Follow-up|1|||
170876579|NCT00432042|617558668|FG002|Overall Study|Lost to Follow-up|0|||
170876580|NCT01744665|617558669|FG000|Monitoring Phase|Adverse Event|4|||
170876581|NCT01744665|617558669|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
170876582|NCT01744665|617558669|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
170876583|NCT01744665|617558669|FG000|Monitoring Phase|Withdrawal by Subject|5|||
170876584|NCT01744665|617558669|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
170876585|NCT01744665|617558669|FG000|Consolidation Phase|Adverse Event|2|||
170876586|NCT01744665|617558669|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
170876587|NCT01744665|617558669|FG000|Consolidation Phase|Withdrawal by Subject|4|||
170876588|NCT01744665|617558669|FG000|Consolidation Phase|Administrative problems|9|||
170876589|NCT01744665|617558669|FG000|Re-initiation Phase|Administrative problems|10|||
170876590|NCT01744665|617558669|FG000|Re-initiation Phase|Adverse Event|1|||
170526586|NCT01701245|616277102|FG000|Overall Study|Did not complete the open label period|11|||
170526587|NCT01701245|616277103|FG001|Overall Study|Did not complete the open label period|12|||
170526588|NCT01787552|616277110|FG000|Overall Study|Withdrawal by Subject|2|||
170526589|NCT01787552|616277111|FG001|Overall Study|Withdrawal by Subject|0|||
170526590|NCT01787552|616277112|FG002|Overall Study|Withdrawal by Subject|0|||
170526591|NCT01787552|616277113|FG003|Overall Study|Withdrawal by Subject|4|||
170526592|NCT01787552|616277110|FG000|Overall Study|Physician Decision|2|||
170526593|NCT01787552|616277111|FG001|Overall Study|Physician Decision|2|||
170526594|NCT01787552|616277112|FG002|Overall Study|Physician Decision|1|||
170526595|NCT01787552|616277113|FG003|Overall Study|Physician Decision|2|||
170876591|NCT01744665|617558669|FG000|Re-initiation Phase|No longer required treatment|1|||
170876592|NCT01744665|617558669|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
170876593|NCT03159091|617558670|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
170876594|NCT03159091|617558671|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
170876595|NCT03159091|617558670|FG000|Overall Study|Patient has taken no dose of study drug|0|||
170876596|NCT03159091|617558671|FG001|Overall Study|Patient has taken no dose of study drug|1|||
170876597|NCT05998148|617558675|FG000|Allocation|Did not attend any appointments|1|||
170876598|NCT05998148|617558676|FG001|Allocation|Did not attend any appointments|4|||
170876599|NCT05998148|617558675|FG000|Follow-Up|Lost to Follow-up|1|||
170876600|NCT05998148|617558676|FG001|Follow-Up|Lost to Follow-up|2|||
170876601|NCT05998148|617558675|FG000|Follow-Up|Change in insurance|1|||
170876602|NCT05998148|617558676|FG001|Follow-Up|Change in insurance|1|||
170876603|NCT02090413|617558679|FG000|Overall Study|Adverse Event|11|||
170876604|NCT02090413|617558680|FG001|Overall Study|Adverse Event|15|||
170876605|NCT02090413|617558681|FG002|Overall Study|Adverse Event|20|||
170876606|NCT02090413|617558679|FG000|Overall Study|Flushing event|2|||
170876607|NCT02090413|617558680|FG001|Overall Study|Flushing event|0|||
170876608|NCT02090413|617558681|FG002|Overall Study|Flushing event|1|||
170876609|NCT02090413|617558679|FG000|Overall Study|Withdrawal by Subject|2|||
170876610|NCT02090413|617558680|FG001|Overall Study|Withdrawal by Subject|2|||
170876611|NCT02090413|617558681|FG002|Overall Study|Withdrawal by Subject|2|||
170876612|NCT02090413|617558679|FG000|Overall Study|Investigator Decision|1|||
170876613|NCT02090413|617558680|FG001|Overall Study|Investigator Decision|1|||
170876614|NCT02090413|617558681|FG002|Overall Study|Investigator Decision|0|||
170876615|NCT02090413|617558679|FG000|Overall Study|Other|2|||
170876616|NCT02090413|617558680|FG001|Overall Study|Other|1|||
170876617|NCT02090413|617558681|FG002|Overall Study|Other|0|||
170876618|NCT02090413|617558679|FG000|Overall Study|Lost to Follow-up|1|||
170876619|NCT02090413|617558680|FG001|Overall Study|Lost to Follow-up|1|||
170876620|NCT02090413|617558681|FG002|Overall Study|Lost to Follow-up|0|||
170876621|NCT03834519|617558683|FG000|Overall Study|Lost to Follow-up|2|||
170876622|NCT03834519|617558684|FG001|Overall Study|Lost to Follow-up|1|||
170876623|NCT03834519|617558683|FG000|Overall Study|Withdrawal by Subject|5|||
170876624|NCT03834519|617558684|FG001|Overall Study|Withdrawal by Subject|8|||
170876625|NCT03834519|617558683|FG000|Overall Study|Death|368|||
170876626|NCT03834519|617558684|FG001|Overall Study|Death|174|||
170876627|NCT03834519|617558683|FG000|Overall Study|Physician Decision|5|||
170876628|NCT03834519|617558684|FG001|Overall Study|Physician Decision|1|||
170876629|NCT03834519|617558683|FG000|Overall Study|Sponsor decision|149|||
170876630|NCT03834519|617558684|FG001|Overall Study|Sponsor decision|80|||
170876631|NCT04506086|617558685|FG000|Overall Study|Withdrawal by Subject|2|||
170876632|NCT01538628|617558686|FG000|Overall Study|Withdrawal by Subject|1|||
170526596|NCT01787552|616277110|FG000|Overall Study|Death|0|||
170526597|NCT01787552|616277111|FG001|Overall Study|Death|0|||
170526598|NCT01787552|616277112|FG002|Overall Study|Death|0|||
170526599|NCT01787552|616277113|FG003|Overall Study|Death|1|||
170526600|NCT01787552|616277110|FG000|Overall Study|Adverse Event|2|||
170876633|NCT01538628|617558687|FG001|Overall Study|Withdrawal by Subject|1|||
170876634|NCT01538628|617558686|FG000|Overall Study|Lost to Follow-up|0|||
170876635|NCT01538628|617558687|FG001|Overall Study|Lost to Follow-up|1|||
170876636|NCT03080883|617558688|FG000|Overall Study|Withdrawal by Subject|11|||
170876637|NCT03080883|617558689|FG001|Overall Study|Withdrawal by Subject|15|||
170876638|NCT03080883|617558688|FG000|Overall Study|Adverse Event|22|||
170526601|NCT01787552|616277111|FG001|Overall Study|Adverse Event|5|||
170526602|NCT01787552|616277112|FG002|Overall Study|Adverse Event|2|||
170526603|NCT01787552|616277113|FG003|Overall Study|Adverse Event|16|||
170876639|NCT03080883|617558689|FG001|Overall Study|Adverse Event|22|||
170876640|NCT03080883|617558688|FG000|Overall Study|Alternative Therapy|0|||
170876641|NCT03080883|617558689|FG001|Overall Study|Alternative Therapy|3|||
170876642|NCT03080883|617558688|FG000|Overall Study|Other Complicating Disease|9|||
170876643|NCT03080883|617558689|FG001|Overall Study|Other Complicating Disease|5|||
170876644|NCT03080883|617558688|FG000|Overall Study|Death|21|||
170876645|NCT03080883|617558689|FG001|Overall Study|Death|16|||
170876646|NCT03080883|617558688|FG000|Overall Study|Physician Decision|2|||
170526604|NCT01787552|616277110|FG000|Overall Study|Study terminated by Sponsor|0|||
170776185|NCT02590432|617187046|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
170776186|NCT02590432|617187038|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
170776187|NCT02590432|617187039|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
170776188|NCT02590432|617187040|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
170776189|NCT02590432|617187041|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
170776190|NCT02590432|617187042|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
170776191|NCT02590432|617187043|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
170776192|NCT02590432|617187044|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
170776193|NCT02590432|617187045|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
170776194|NCT02590432|617187046|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
170776195|NCT02590432|617187038|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
170776196|NCT02590432|617187039|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
170776197|NCT02590432|617187040|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
170776198|NCT02590432|617187041|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
170776199|NCT02590432|617187042|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
170776200|NCT02590432|617187043|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
170776201|NCT02590432|617187044|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
170776202|NCT02590432|617187045|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
170776203|NCT02590432|617187046|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
170776204|NCT02590432|617187038|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
170776205|NCT02590432|617187039|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
170776206|NCT02590432|617187040|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
170776207|NCT02590432|617187041|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
170776208|NCT02590432|617187042|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
170776209|NCT02590432|617187043|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
170776210|NCT02590432|617187044|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
170776211|NCT02590432|617187045|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
170776212|NCT02590432|617187046|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
170776213|NCT02590432|617187038|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
170776214|NCT02590432|617187039|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
170776215|NCT02590432|617187040|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
170776216|NCT02590432|617187041|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
170776217|NCT02590432|617187042|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
170776218|NCT02590432|617187043|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
170776219|NCT02590432|617187044|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
170776220|NCT02590432|617187045|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
170776221|NCT02590432|617187046|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
170776222|NCT02590432|617187038|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
170776223|NCT02590432|617187039|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
170776224|NCT02590432|617187040|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
170776225|NCT02590432|617187041|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
170776226|NCT02590432|617187042|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
170776227|NCT02590432|617187043|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
170776228|NCT02590432|617187044|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
170776229|NCT02590432|617187045|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
170776230|NCT02590432|617187046|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
170776231|NCT02590432|617187038|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
170776232|NCT02590432|617187039|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
170776233|NCT02590432|617187040|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
170876647|NCT03080883|617558689|FG001|Overall Study|Physician Decision|2|||
170526605|NCT01787552|616277111|FG001|Overall Study|Study terminated by Sponsor|0|||
170526606|NCT01787552|616277112|FG002|Overall Study|Study terminated by Sponsor|1|||
170526607|NCT01787552|616277113|FG003|Overall Study|Study terminated by Sponsor|3|||
170526608|NCT01787552|616277110|FG000|Overall Study|Progressive Disease|2|||
170526609|NCT01787552|616277111|FG001|Overall Study|Progressive Disease|2|||
170526610|NCT01787552|616277112|FG002|Overall Study|Progressive Disease|1|||
170526611|NCT01787552|616277113|FG003|Overall Study|Progressive Disease|1|||
170526612|NCT02295644|616277114|FG000|Overall Study|Did not meet inclusion criterion|0|||
170526613|NCT02295644|616277115|FG001|Overall Study|Did not meet inclusion criterion|0|||
170526614|NCT02295644|616277116|FG002|Overall Study|Did not meet inclusion criterion|1|||
170526615|NCT02295644|616277117|FG003|Overall Study|Did not meet inclusion criterion|2|||
170526616|NCT02147626|616277118|FG000|Overall Study|Lost to Follow-up|4|||
170526617|NCT02147626|616277119|FG001|Overall Study|Lost to Follow-up|4|||
170776234|NCT02590432|617187041|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
170776235|NCT02590432|617187042|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
170776236|NCT02590432|617187043|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
170776237|NCT02590432|617187044|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
170776238|NCT02590432|617187045|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
170776239|NCT02590432|617187046|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
170776240|NCT00409838|617187047|FG000|Short-term Period|Adverse Event|0|||
170776241|NCT00409838|617187048|FG001|Short-term Period|Adverse Event|1|||
170776242|NCT00409838|617187047|FG000|Short-term Period|Lost to Follow-up|0|||
170776243|NCT00409838|617187048|FG001|Short-term Period|Lost to Follow-up|1|||
170776244|NCT00409838|617187047|FG000|Short-term Period|Withdrawal by Subject|2|||
170776245|NCT00409838|617187048|FG001|Short-term Period|Withdrawal by Subject|3|||
170776246|NCT00409838|617187047|FG000|Short-term Period|Never Treated|1|||
170776247|NCT00409838|617187048|FG001|Short-term Period|Never Treated|0|||
170776248|NCT00409838|617187047|FG000|Long-term Extension Period|Adverse Event|10|||
170776249|NCT00409838|617187048|FG001|Long-term Extension Period|Adverse Event|0|||
170776250|NCT00409838|617187047|FG000|Long-term Extension Period|Death|1|||
170776251|NCT00409838|617187048|FG001|Long-term Extension Period|Death|0|||
170776252|NCT00409838|617187047|FG000|Long-term Extension Period|Lack of Efficacy|2|||
170776253|NCT00409838|617187048|FG001|Long-term Extension Period|Lack of Efficacy|0|||
170776254|NCT00409838|617187047|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
170776255|NCT00409838|617187048|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
170776256|NCT00409838|617187047|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
170776257|NCT00409838|617187048|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
170776258|NCT00409838|617187047|FG000|Long-term Extension Period|Pregnancy|1|||
170776259|NCT00409838|617187048|FG001|Long-term Extension Period|Pregnancy|0|||
170776260|NCT03283371|617187050|FG000|Placebo-controlled|Adverse Event|1|||
170776261|NCT03283371|617187051|FG001|Placebo-controlled|Adverse Event|1|||
170776262|NCT03283371|617187052|FG002|Placebo-controlled|Adverse Event|0|||
170776263|NCT03283371|617187053|FG003|Placebo-controlled|Adverse Event|0|||
170776264|NCT03283371|617187050|FG000|Placebo-controlled|Lack of Efficacy|1|||
170776265|NCT03283371|617187051|FG001|Placebo-controlled|Lack of Efficacy|0|||
170776266|NCT03283371|617187052|FG002|Placebo-controlled|Lack of Efficacy|0|||
170776267|NCT03283371|617187053|FG003|Placebo-controlled|Lack of Efficacy|0|||
170776268|NCT03283371|617187050|FG000|Placebo-controlled|Withdrawal by Subject|1|||
170776269|NCT03283371|617187051|FG001|Placebo-controlled|Withdrawal by Subject|1|||
170776270|NCT03283371|617187052|FG002|Placebo-controlled|Withdrawal by Subject|0|||
170776271|NCT03283371|617187053|FG003|Placebo-controlled|Withdrawal by Subject|0|||
170776272|NCT03283371|617187050|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
170776273|NCT03283371|617187051|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
170776274|NCT03283371|617187052|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
170776275|NCT03283371|617187053|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
170776276|NCT03283371|617187050|FG000|Open-label Phase|Adverse Event|0|||
170776277|NCT03283371|617187051|FG001|Open-label Phase|Adverse Event|0|||
170776278|NCT03283371|617187052|FG002|Open-label Phase|Adverse Event|2|||
170776279|NCT03283371|617187053|FG003|Open-label Phase|Adverse Event|0|||
170776280|NCT03283371|617187050|FG000|Open-label Phase|Withdrawal by Subject|0|||
170776281|NCT03283371|617187051|FG001|Open-label Phase|Withdrawal by Subject|0|||
170776282|NCT03283371|617187052|FG002|Open-label Phase|Withdrawal by Subject|1|||
170776283|NCT03283371|617187053|FG003|Open-label Phase|Withdrawal by Subject|0|||
170776284|NCT03283371|617187050|FG000|Open-label Phase|Other|0|||
170776285|NCT03283371|617187051|FG001|Open-label Phase|Other|0|||
170776286|NCT03283371|617187052|FG002|Open-label Phase|Other|1|||
170776287|NCT03283371|617187053|FG003|Open-label Phase|Other|1|||
170776288|NCT03403413|617187057|FG000|Overall Study|Lack of Efficacy|2|||
170776289|NCT02924064|617187058|FG000|Overall Study|Adverse Event|2|||
170776290|NCT02924064|617187059|FG001|Overall Study|Adverse Event|2|||
170776291|NCT02924064|617187058|FG000|Overall Study|Lost to Follow-up|0|||
170776292|NCT02924064|617187059|FG001|Overall Study|Lost to Follow-up|2|||
170776293|NCT02924064|617187058|FG000|Overall Study|Physician Decision|0|||
170776294|NCT02924064|617187059|FG001|Overall Study|Physician Decision|2|||
170776295|NCT02924064|617187058|FG000|Overall Study|Protocol Violation|1|||
170776296|NCT02924064|617187059|FG001|Overall Study|Protocol Violation|3|||
170776297|NCT02924064|617187058|FG000|Overall Study|Withdrawal by Subject|4|||
170776298|NCT02924064|617187059|FG001|Overall Study|Withdrawal by Subject|5|||
170776299|NCT02924064|617187058|FG000|Overall Study|Other|17|||
170776300|NCT02924064|617187059|FG001|Overall Study|Other|29|||
170776301|NCT00529100|617187062|FG000|Overall Study|Adverse Event|0|||
170776302|NCT00529100|617187063|FG001|Overall Study|Adverse Event|5|||
170776303|NCT00529100|617187062|FG000|Overall Study|Protocol Violation|0|||
170776304|NCT00529100|617187063|FG001|Overall Study|Protocol Violation|1|||
170776305|NCT00529100|617187062|FG000|Overall Study|Progressive Disease|0|||
170776306|NCT00529100|617187063|FG001|Overall Study|Progressive Disease|1|||
170776307|NCT00529100|617187062|FG000|Overall Study|Withdrawal by Subject|0|||
170776308|NCT00529100|617187063|FG001|Overall Study|Withdrawal by Subject|1|||
170876648|NCT03080883|617558688|FG000|Overall Study|Disease Progression|2|||
170876649|NCT03080883|617558689|FG001|Overall Study|Disease Progression|8|||
170876650|NCT03080883|617558688|FG000|Overall Study|Lost to Follow-up|1|||
170876651|NCT03080883|617558689|FG001|Overall Study|Lost to Follow-up|1|||
170876652|NCT04649255|617560295|FG000|Overall Study|Death|9|||
170876653|NCT04649255|617560295|FG000|Overall Study|Withdrawal by Subject|1|||
170876654|NCT00388973|617560296|FG000|Overall Study|Adverse Event|16|||
170876655|NCT00388973|617560297|FG001|Overall Study|Adverse Event|6|||
170876656|NCT00388973|617560296|FG000|Overall Study|Lack of Efficacy|1|||
170876657|NCT00388973|617560297|FG001|Overall Study|Lack of Efficacy|12|||
170876658|NCT00388973|617560296|FG000|Overall Study|Protocol Violation|3|||
170876659|NCT00388973|617560297|FG001|Overall Study|Protocol Violation|0|||
170876660|NCT00388973|617560296|FG000|Overall Study|Withdrawal by Subject|14|||
170876661|NCT00388973|617560297|FG001|Overall Study|Withdrawal by Subject|17|||
170876662|NCT00388973|617560296|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
170526618|NCT02147626|616277118|FG000|Overall Study|Pregnancy|1|||
170526619|NCT02147626|616277119|FG001|Overall Study|Pregnancy|2|||
170526620|NCT02147626|616277118|FG000|Overall Study|Withdrawal by Subject|0|||
170526621|NCT02147626|616277119|FG001|Overall Study|Withdrawal by Subject|1|||
170526622|NCT03101020|616277120|FG000|Overall Study|Lack of time to participate|1|||
170526623|NCT03101020|616277121|FG001|Overall Study|Lack of time to participate|0|||
170526624|NCT03101020|616277120|FG000|Overall Study|Ran over by a car|0|||
170526625|NCT03101020|616277121|FG001|Overall Study|Ran over by a car|1|||
170526626|NCT03101020|616277120|FG000|Overall Study|Withdrawal by Subject|0|||
170526627|NCT03101020|616277121|FG001|Overall Study|Withdrawal by Subject|2|||
170526628|NCT00423046|616277125|FG000|Overall Study|Other|340|||
170526629|NCT00423046|616277126|FG001|Overall Study|Other|345|||
170526630|NCT01909804|616277127|FG000|Overall Study|Randomized but Never Treated|0|||
170526631|NCT01909804|616277128|FG001|Overall Study|Randomized but Never Treated|0|||
170526632|NCT01909804|616277129|FG002|Overall Study|Randomized but Never Treated|0|||
170526633|NCT01909804|616277130|FG003|Overall Study|Randomized but Never Treated|0|||
170526634|NCT01909804|616277131|FG004|Overall Study|Randomized but Never Treated|0|||
170526635|NCT01909804|616277132|FG005|Overall Study|Randomized but Never Treated|0|||
170526636|NCT01909804|616277133|FG006|Overall Study|Randomized but Never Treated|1|||
170526637|NCT01909804|616277134|FG007|Overall Study|Randomized but Never Treated|0|||
170526638|NCT01909804|616277135|FG008|Overall Study|Randomized but Never Treated|0|||
170526639|NCT01909804|616277136|FG009|Overall Study|Randomized but Never Treated|0|||
170526640|NCT01909804|616277137|FG010|Overall Study|Randomized but Never Treated|0|||
170526641|NCT01909804|616277138|FG011|Overall Study|Randomized but Never Treated|1|||
170526642|NCT01909804|616277127|FG000|Overall Study|Death|0|||
170526643|NCT01909804|616277128|FG001|Overall Study|Death|0|||
170526644|NCT01909804|616277129|FG002|Overall Study|Death|0|||
170526645|NCT01909804|616277130|FG003|Overall Study|Death|0|||
170526646|NCT01909804|616277131|FG004|Overall Study|Death|0|||
170526647|NCT01909804|616277132|FG005|Overall Study|Death|0|||
170526648|NCT01909804|616277133|FG006|Overall Study|Death|0|||
170526649|NCT01909804|616277134|FG007|Overall Study|Death|0|||
170526650|NCT01909804|616277135|FG008|Overall Study|Death|0|||
170526651|NCT01909804|616277136|FG009|Overall Study|Death|0|||
170526652|NCT01909804|616277137|FG010|Overall Study|Death|1|||
170526653|NCT01909804|616277138|FG011|Overall Study|Death|0|||
170526654|NCT01909804|616277127|FG000|Overall Study|Lack of Efficacy|4|||
170526655|NCT01909804|616277128|FG001|Overall Study|Lack of Efficacy|1|||
170526656|NCT01909804|616277129|FG002|Overall Study|Lack of Efficacy|0|||
170526657|NCT01909804|616277130|FG003|Overall Study|Lack of Efficacy|0|||
170526658|NCT01909804|616277131|FG004|Overall Study|Lack of Efficacy|7|||
170526659|NCT01909804|616277132|FG005|Overall Study|Lack of Efficacy|3|||
170526660|NCT01909804|616277133|FG006|Overall Study|Lack of Efficacy|1|||
170526661|NCT01909804|616277134|FG007|Overall Study|Lack of Efficacy|1|||
170526662|NCT01909804|616277135|FG008|Overall Study|Lack of Efficacy|0|||
170876663|NCT00388973|617560297|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
170876664|NCT00388973|617560296|FG000|Overall Study|Did not complete 61 days of treatment|5|||
170876665|NCT00388973|617560297|FG001|Overall Study|Did not complete 61 days of treatment|4|||
170876666|NCT00388973|617560296|FG000|Overall Study|Left region|0|||
170526663|NCT01909804|616277136|FG009|Overall Study|Lack of Efficacy|1|||
170526664|NCT01909804|616277137|FG010|Overall Study|Lack of Efficacy|0|||
170526665|NCT01909804|616277138|FG011|Overall Study|Lack of Efficacy|1|||
170526666|NCT01909804|616277127|FG000|Overall Study|Withdrew Consent|0|||
170526667|NCT01909804|616277128|FG001|Overall Study|Withdrew Consent|0|||
170526668|NCT01909804|616277129|FG002|Overall Study|Withdrew Consent|0|||
170632593|NCT02420821|616666703|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
170876667|NCT00388973|617560297|FG001|Overall Study|Left region|1|||
170876668|NCT00388973|617560296|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
170876669|NCT00388973|617560297|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
170526669|NCT01909804|616277130|FG003|Overall Study|Withdrew Consent|0|||
170526670|NCT01909804|616277131|FG004|Overall Study|Withdrew Consent|1|||
170526671|NCT01909804|616277132|FG005|Overall Study|Withdrew Consent|1|||
170526672|NCT01909804|616277133|FG006|Overall Study|Withdrew Consent|0|||
170526673|NCT01909804|616277134|FG007|Overall Study|Withdrew Consent|0|||
170526674|NCT01909804|616277135|FG008|Overall Study|Withdrew Consent|0|||
170526675|NCT01909804|616277136|FG009|Overall Study|Withdrew Consent|0|||
170526676|NCT01909804|616277137|FG010|Overall Study|Withdrew Consent|0|||
170526677|NCT01909804|616277138|FG011|Overall Study|Withdrew Consent|0|||
170526678|NCT01909804|616277127|FG000|Overall Study|Protocol Violation|0|||
170526679|NCT01909804|616277128|FG001|Overall Study|Protocol Violation|0|||
170526680|NCT01909804|616277129|FG002|Overall Study|Protocol Violation|0|||
170526681|NCT01909804|616277130|FG003|Overall Study|Protocol Violation|0|||
170526682|NCT01909804|616277131|FG004|Overall Study|Protocol Violation|0|||
170526683|NCT01909804|616277132|FG005|Overall Study|Protocol Violation|0|||
170526684|NCT01909804|616277133|FG006|Overall Study|Protocol Violation|0|||
170526685|NCT01909804|616277134|FG007|Overall Study|Protocol Violation|0|||
170526686|NCT01909804|616277135|FG008|Overall Study|Protocol Violation|0|||
170526687|NCT01909804|616277136|FG009|Overall Study|Protocol Violation|0|||
170526688|NCT01909804|616277137|FG010|Overall Study|Protocol Violation|0|||
170526689|NCT01909804|616277138|FG011|Overall Study|Protocol Violation|1|||
170876670|NCT00307151|617560298|FG000|Overall Study|Death|4|||
170876671|NCT00307151|617560299|FG001|Overall Study|Death|3|||
170876672|NCT00307151|617560300|FG002|Overall Study|Death|10|||
170876673|NCT00307151|617560301|FG003|Overall Study|Death|3|||
170876674|NCT00307151|617560298|FG000|Overall Study|Severe debilitation, unable to continue|1|||
170876675|NCT00307151|617560299|FG001|Overall Study|Severe debilitation, unable to continue|0|||
170876676|NCT00307151|617560300|FG002|Overall Study|Severe debilitation, unable to continue|0|||
170876677|NCT00307151|617560301|FG003|Overall Study|Severe debilitation, unable to continue|0|||
170876678|NCT00307151|617560298|FG000|Overall Study|Subject unable to get to clinic|1|||
170876679|NCT00307151|617560299|FG001|Overall Study|Subject unable to get to clinic|0|||
170876680|NCT00307151|617560300|FG002|Overall Study|Subject unable to get to clinic|6|||
170876681|NCT00307151|617560301|FG003|Overall Study|Subject unable to get to clinic|2|||
170876682|NCT00307151|617560298|FG000|Overall Study|Withdrew consent|0|||
170876683|NCT00307151|617560299|FG001|Overall Study|Withdrew consent|1|||
170876684|NCT00307151|617560300|FG002|Overall Study|Withdrew consent|1|||
170876685|NCT00307151|617560301|FG003|Overall Study|Withdrew consent|3|||
170876686|NCT00307151|617560298|FG000|Overall Study|Not willing to adhere to study reqs|2|||
170876687|NCT00307151|617560299|FG001|Overall Study|Not willing to adhere to study reqs|0|||
170526690|NCT01038687|616277139|FG000|Overall Study|Adverse Event|0|||
170526691|NCT01038687|616277140|FG001|Overall Study|Adverse Event|2|||
170526692|NCT01038687|616277141|FG002|Overall Study|Adverse Event|1|||
170526693|NCT02783911|616277142|FG000|Overall Study|Lost to Follow-up|3|||
170526694|NCT02783911|616277143|FG001|Overall Study|Lost to Follow-up|32|||
170526695|NCT02314728|616277144|FG000|Overall Study|Protocol Violation|1|||
170526696|NCT02314728|616277145|FG001|Overall Study|Protocol Violation|0|||
170526697|NCT02314728|616277144|FG000|Overall Study|Lost to Follow-up|0|||
170526698|NCT02314728|616277145|FG001|Overall Study|Lost to Follow-up|1|||
170526699|NCT03080935|616277146|FG000|Overall Study|Death|34|||
170526700|NCT03080935|616277147|FG001|Overall Study|Death|50|||
170526701|NCT03080935|616277146|FG000|Overall Study|Lost to Follow-up|5|||
170526702|NCT03080935|616277147|FG001|Overall Study|Lost to Follow-up|4|||
170876688|NCT00307151|617560300|FG002|Overall Study|Not willing to adhere to study reqs|2|||
170876689|NCT00307151|617560301|FG003|Overall Study|Not willing to adhere to study reqs|2|||
170876690|NCT00307151|617560298|FG000|Overall Study|Clinic unable to contact subject|3|||
170876691|NCT00307151|617560299|FG001|Overall Study|Clinic unable to contact subject|3|||
170876692|NCT00307151|617560300|FG002|Overall Study|Clinic unable to contact subject|1|||
170876693|NCT00307151|617560301|FG003|Overall Study|Clinic unable to contact subject|1|||
170526703|NCT03080935|616277146|FG000|Overall Study|Withdrawal by Subject|11|||
170526704|NCT03080935|616277147|FG001|Overall Study|Withdrawal by Subject|15|||
170526705|NCT01614470|616277149|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
170526706|NCT01614470|616277150|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
170526707|NCT01614470|616277151|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
170876694|NCT01652885|617560310|FG000|Overall Study|Adverse Event|1|||
170876695|NCT03723707|617560312|FG000|Overall Study|Death|32|||
170876696|NCT03723707|617560313|FG001|Overall Study|Death|32|||
170876697|NCT03723707|617560312|FG000|Overall Study|Admitted to long term care|12|||
170876698|NCT03723707|617560313|FG001|Overall Study|Admitted to long term care|12|||
170526708|NCT01614470|616277149|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
170526709|NCT01614470|616277150|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
170526710|NCT01614470|616277151|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
170526711|NCT03902613|616277152|FG000|Overall Study|Physician Decision|1|||
170526712|NCT00069264|616277155|FG000|Overall Study|Adverse Event|3|||
170526713|NCT00069264|616277155|FG000|Overall Study|Progressive Disease|23|||
170632594|NCT02420821|616666704|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
170876699|NCT03723707|617560312|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
170526714|NCT00069264|616277155|FG000|Overall Study|Withdrawal by Subject|3|||
170526715|NCT00069264|616277155|FG000|Overall Study|Discon Therapy|3|||
170526716|NCT04622969|616277156|FG000|Overall Study|Withdrawal by Subject|2|||
170876700|NCT03723707|617560313|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
170876701|NCT03723707|617560312|FG000|Overall Study|Lost to Follow-up|40|||
170526717|NCT04622969|616277157|FG001|Overall Study|Withdrawal by Subject|3|||
170526718|NCT03886272|616277160|FG000|Period 1|Withdrawal by Subject|0|||
170526719|NCT03886272|616277161|FG001|Period 1|Withdrawal by Subject|0|||
170526720|NCT03886272|616277162|FG002|Period 1|Withdrawal by Subject|0|||
170526721|NCT03886272|616277163|FG003|Period 1|Withdrawal by Subject|0|||
170526722|NCT03886272|616277164|FG004|Period 1|Withdrawal by Subject|0|||
170526723|NCT03886272|616277165|FG005|Period 1|Withdrawal by Subject|1|||
170526724|NCT03886272|616277166|FG006|Period 1|Withdrawal by Subject|0|||
170526725|NCT03177148|616277167|FG000|Overall Study|Lost to Follow-up|50|||
170526726|NCT03177148|616277168|FG001|Overall Study|Lost to Follow-up|1|||
170526727|NCT03177148|616277167|FG000|Overall Study|Death|1|||
170526728|NCT03177148|616277168|FG001|Overall Study|Death|0|||
170526729|NCT01676012|616277170|FG000|Overall Study|Adverse Event|2|||
170526730|NCT01676012|616277170|FG000|Overall Study|incomplete set of videos|1|||
170526731|NCT02848664|616277173|FG000|Overall Study|Withdrawal by Subject|2|||
170526732|NCT02848664|616277173|FG000|Overall Study|Adverse Event|1|||
170526733|NCT02848664|616277173|FG000|Overall Study|no assistance for device training|1|||
170526734|NCT02849080|616277174|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
170526735|NCT02849080|616277175|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
170526736|NCT02849080|616277176|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
170526737|NCT02849080|616277177|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
170526738|NCT02849080|616277174|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
170526739|NCT02849080|616277175|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
170526740|NCT02849080|616277176|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
170526741|NCT02849080|616277177|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
170526742|NCT02849080|616277174|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
170526743|NCT02849080|616277175|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
170526744|NCT02849080|616277176|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
170526745|NCT02849080|616277177|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
170526746|NCT02849080|616277174|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
170526747|NCT02849080|616277175|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
170526748|NCT02849080|616277176|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
170526749|NCT02849080|616277177|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
170526750|NCT02849080|616277174|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
170526751|NCT02849080|616277175|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
170876702|NCT03723707|617560313|FG001|Overall Study|Lost to Follow-up|22|||
170876703|NCT03723707|617560312|FG000|Overall Study|Discontinued after study closure|24|||
170876704|NCT03723707|617560313|FG001|Overall Study|Discontinued after study closure|12|||
170876705|NCT00075023|617560319|FG000|Pilot Study|Physician Decision|1|||
170876706|NCT00075023|617560320|FG001|Pilot Study|Physician Decision|2|||
170876707|NCT00075023|617560319|FG000|Pilot Study|Withdrawal by Subject|1|||
170876708|NCT00075023|617560320|FG001|Pilot Study|Withdrawal by Subject|0|||
170876709|NCT04342871|617560321|FG000|Overall Study|Death|4|||
170876710|NCT04342871|617560321|FG000|Overall Study|Clinical deterioration/illness progression|2|||
170876711|NCT04342871|617560321|FG000|Overall Study|Did not complete baseline assessments|5|||
170876712|NCT04342871|617560321|FG000|Overall Study|Lost to Follow-up|13|||
170876713|NCT04682405|617560323|FG000|Overall Study|Adverse Event|0|||
170876714|NCT04682405|617560324|FG001|Overall Study|Adverse Event|1|||
170876715|NCT01999465|617560325|FG000|Overall Study|Lost to Follow-up|0|||
170876716|NCT01999465|617560326|FG001|Overall Study|Lost to Follow-up|2|||
170876717|NCT01999465|617560325|FG000|Overall Study|Protocol Violation|0|||
170876718|NCT01999465|617560326|FG001|Overall Study|Protocol Violation|1|||
170876719|NCT02347098|617560328|FG000|Overall Study|Death|1|||
170876720|NCT02347098|617560329|FG001|Overall Study|Death|0|||
170876721|NCT02347098|617560328|FG000|Overall Study|Withdrawal by Subject|1|||
170876722|NCT02347098|617560329|FG001|Overall Study|Withdrawal by Subject|0|||
170876723|NCT02347098|617560328|FG000|Overall Study|Lost to Follow-up|2|||
170876724|NCT02347098|617560329|FG001|Overall Study|Lost to Follow-up|2|||
170876725|NCT02347098|617560328|FG000|Overall Study|Refuse Follow-up Visit|1|||
170876726|NCT02347098|617560329|FG001|Overall Study|Refuse Follow-up Visit|5|||
170876727|NCT02347098|617560328|FG000|Overall Study|no visit due to illness|2|||
170526752|NCT02849080|616277176|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
170526753|NCT02849080|616277177|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
170526754|NCT02849080|616277174|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
170526755|NCT02849080|616277175|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
170526756|NCT02849080|616277176|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
170876728|NCT02347098|617560329|FG001|Overall Study|no visit due to illness|1|||
170876729|NCT04640272|617560330|FG000|Overall Study|Subject moved out of area|1|||
170526757|NCT02849080|616277177|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
170526758|NCT01819727|616277180|FG000|Overall Study|Adverse Event|8|||
170526759|NCT01819727|616277181|FG001|Overall Study|Adverse Event|9|||
170876730|NCT00880399|617560334|FG000|Overall Study|Adverse Event|4|||
170526760|NCT01819727|616277180|FG000|Overall Study|Death|1|||
170526761|NCT01819727|616277181|FG001|Overall Study|Death|0|||
170526762|NCT01819727|616277180|FG000|Overall Study|Lost to Follow-up|1|||
170526763|NCT01819727|616277181|FG001|Overall Study|Lost to Follow-up|1|||
170526764|NCT01819727|616277180|FG000|Overall Study|Physician Decision|3|||
170526765|NCT01819727|616277181|FG001|Overall Study|Physician Decision|2|||
170526766|NCT01819727|616277180|FG000|Overall Study|Pregnancy|1|||
170526767|NCT01819727|616277181|FG001|Overall Study|Pregnancy|0|||
170776309|NCT00529100|617187062|FG000|Overall Study|Participant Ineligibility|0|||
170776310|NCT00529100|617187063|FG001|Overall Study|Participant Ineligibility|1|||
170776311|NCT05524454|617187065|FG000|Overall Study|Withdrawal by Subject|1|||
170776312|NCT00807937|617187066|FG000|Overall Study|Adverse Event|12|||
170776313|NCT00807937|617187067|FG001|Overall Study|Adverse Event|12|||
170776314|NCT00807937|617187068|FG002|Overall Study|Adverse Event|5|||
170776315|NCT00807937|617187069|FG003|Overall Study|Adverse Event|4|||
170776316|NCT00807937|617187066|FG000|Overall Study|Protocol Violation|4|||
170776317|NCT00807937|617187067|FG001|Overall Study|Protocol Violation|5|||
170776318|NCT00807937|617187068|FG002|Overall Study|Protocol Violation|3|||
170776319|NCT00807937|617187069|FG003|Overall Study|Protocol Violation|3|||
170776320|NCT00807937|617187066|FG000|Overall Study|Withdrawal by Subject|5|||
170776321|NCT00807937|617187067|FG001|Overall Study|Withdrawal by Subject|4|||
170776322|NCT00807937|617187068|FG002|Overall Study|Withdrawal by Subject|1|||
170776323|NCT00807937|617187069|FG003|Overall Study|Withdrawal by Subject|4|||
170776324|NCT00807937|617187066|FG000|Overall Study|Lost to Follow-up|4|||
170776325|NCT00807937|617187067|FG001|Overall Study|Lost to Follow-up|0|||
170776326|NCT00807937|617187068|FG002|Overall Study|Lost to Follow-up|2|||
170776327|NCT00807937|617187069|FG003|Overall Study|Lost to Follow-up|1|||
170776328|NCT00807937|617187066|FG000|Overall Study|Lack of Efficacy|0|||
170776329|NCT00807937|617187067|FG001|Overall Study|Lack of Efficacy|0|||
170776330|NCT00807937|617187068|FG002|Overall Study|Lack of Efficacy|1|||
170776331|NCT00807937|617187069|FG003|Overall Study|Lack of Efficacy|2|||
170776332|NCT00807937|617187066|FG000|Overall Study|Intake of prohibited medicine|0|||
170776333|NCT00807937|617187067|FG001|Overall Study|Intake of prohibited medicine|0|||
170776334|NCT00807937|617187068|FG002|Overall Study|Intake of prohibited medicine|2|||
170776335|NCT00807937|617187069|FG003|Overall Study|Intake of prohibited medicine|0|||
170776336|NCT00807937|617187066|FG000|Overall Study|All other reasons (not provided)|2|||
170776337|NCT00807937|617187067|FG001|Overall Study|All other reasons (not provided)|4|||
170776338|NCT00807937|617187068|FG002|Overall Study|All other reasons (not provided)|0|||
170776339|NCT00807937|617187069|FG003|Overall Study|All other reasons (not provided)|1|||
170526768|NCT01819727|616277180|FG000|Overall Study|Protocol Violation|0|||
170526769|NCT01819727|616277181|FG001|Overall Study|Protocol Violation|2|||
170526770|NCT01819727|616277180|FG000|Overall Study|Study Terminated by Sponsor|0|||
170526771|NCT01819727|616277181|FG001|Overall Study|Study Terminated by Sponsor|1|||
170526772|NCT01819727|616277180|FG000|Overall Study|Withdrawal by Subject|6|||
170526773|NCT01819727|616277181|FG001|Overall Study|Withdrawal by Subject|11|||
170526774|NCT01819727|616277180|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
170526775|NCT01819727|616277181|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
170526776|NCT01819727|616277180|FG000|Overall Study|Quit due to lack of health benifits|0|||
170526777|NCT01819727|616277181|FG001|Overall Study|Quit due to lack of health benifits|1|||
170526778|NCT02155985|616277182|FG000|Overall Study|Withdrawal by Subject|0|||
170526779|NCT02155985|616277183|FG001|Overall Study|Withdrawal by Subject|0|||
170526780|NCT02155985|616277184|FG002|Overall Study|Withdrawal by Subject|1|||
170526781|NCT02155985|616277182|FG000|Overall Study|Lost to Follow-up|1|||
170526782|NCT02155985|616277183|FG001|Overall Study|Lost to Follow-up|0|||
170526783|NCT02155985|616277184|FG002|Overall Study|Lost to Follow-up|0|||
170526784|NCT00732069|616277189|FG000|Washout After First Study Drug|Adverse Event|1|||
170526785|NCT00732069|616277190|FG001|Washout After First Study Drug|Adverse Event|0|||
170526786|NCT00732069|616277191|FG002|Washout After First Study Drug|Adverse Event|0|||
170526787|NCT00732069|616277192|FG003|Washout After First Study Drug|Adverse Event|0|||
170526788|NCT00732069|616277193|FG004|Washout After First Study Drug|Adverse Event|0|||
170526789|NCT00732069|616277194|FG005|Washout After First Study Drug|Adverse Event|0|||
170526790|NCT00402727|616277195|FG000|Overall Study|Adverse Event|10|||
170526791|NCT00402727|616277196|FG001|Overall Study|Adverse Event|6|||
170526792|NCT00402727|616277195|FG000|Overall Study|Death|1|||
170526793|NCT00402727|616277196|FG001|Overall Study|Death|0|||
170526794|NCT00402727|616277195|FG000|Overall Study|Lack of Efficacy|1|||
170526795|NCT00402727|616277196|FG001|Overall Study|Lack of Efficacy|3|||
170526796|NCT00402727|616277195|FG000|Overall Study|Lost to Follow-up|24|||
170526797|NCT00402727|616277196|FG001|Overall Study|Lost to Follow-up|11|||
170526798|NCT00402727|616277195|FG000|Overall Study|Physician Decision|1|||
170526799|NCT00402727|616277196|FG001|Overall Study|Physician Decision|1|||
170526800|NCT00402727|616277195|FG000|Overall Study|Protocol Violation|0|||
170526801|NCT00402727|616277196|FG001|Overall Study|Protocol Violation|4|||
170526802|NCT00402727|616277195|FG000|Overall Study|Withdrawal by Subject|3|||
170526803|NCT00402727|616277196|FG001|Overall Study|Withdrawal by Subject|7|||
170526804|NCT00402727|616277195|FG000|Overall Study|supply problems|2|||
170776340|NCT04982315|617187070|FG000|Overall Study|Death|1|||
170776341|NCT04982315|617187071|FG001|Overall Study|Death|0|||
170526805|NCT00402727|616277196|FG001|Overall Study|supply problems|1|||
170526806|NCT00402727|616277195|FG000|Overall Study|non-compliance|0|||
170526807|NCT00402727|616277196|FG001|Overall Study|non-compliance|1|||
170526808|NCT04794751|616277198|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
170526809|NCT04794751|616277199|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
170526810|NCT04794751|616277198|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
170526811|NCT04794751|616277199|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
170526812|NCT04794751|616277198|FG000|Period 1|Protocol Violation|0|||
170526813|NCT04794751|616277199|FG001|Period 1|Protocol Violation|2|||
170526814|NCT04794751|616277198|FG000|Period 1|Withdrawal by Subject|0|||
170526815|NCT04794751|616277199|FG001|Period 1|Withdrawal by Subject|1|||
170526816|NCT04794751|616277198|FG000|Period 2|Withdrawal by Subject|0|||
170526817|NCT04794751|616277199|FG001|Period 2|Withdrawal by Subject|1|||
170526818|NCT04794751|616277198|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
170526819|NCT04794751|616277199|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
170526820|NCT04794751|616277198|FG000|Period 2|Protocol Violation|1|||
170526821|NCT04794751|616277199|FG001|Period 2|Protocol Violation|0|||
170526822|NCT01405898|616277202|FG000|Overall Study|Withdrawal by Subject|2|||
170526823|NCT01405898|616277203|FG001|Overall Study|Withdrawal by Subject|2|||
170526824|NCT03139552|616277207|FG000|Overall Study|unable to attend tasting due to schedule|3|||
170526825|NCT00780975|616277214|FG000|Overall Study|Progressive disease|3|||
170876731|NCT00880399|617560335|FG001|Overall Study|Adverse Event|6|||
170876732|NCT00880399|617560336|FG002|Overall Study|Adverse Event|5|||
170526826|NCT00780975|616277214|FG000|Overall Study|Toxicity|5|||
170526827|NCT01061606|616277219|FG000|Overall Study|Adverse Event|1|||
170526828|NCT01061606|616277219|FG000|Overall Study|Death|1|||
170526829|NCT01061606|616277219|FG000|Overall Study|Disease Progression|4|||
170526830|NCT01061606|616277219|FG000|Overall Study|alternative therapy|2|||
170526831|NCT03669588|616277234|FG000|Overall Study|Adverse Event|1|||
170526832|NCT03669588|616277235|FG001|Overall Study|Adverse Event|0|||
170526833|NCT03669588|616277234|FG000|Overall Study|Physician Decision|0|||
170526834|NCT03669588|616277235|FG001|Overall Study|Physician Decision|1|||
170526835|NCT03669588|616277234|FG000|Overall Study|Protocol Violation|1|||
170526836|NCT03669588|616277235|FG001|Overall Study|Protocol Violation|0|||
170526837|NCT03669588|616277234|FG000|Overall Study|Sponsor Decision|1|||
170526838|NCT03669588|616277235|FG001|Overall Study|Sponsor Decision|1|||
170526839|NCT03669588|616277234|FG000|Overall Study|Withdrawal by Subject|1|||
170526840|NCT03669588|616277235|FG001|Overall Study|Withdrawal by Subject|4|||
170526841|NCT03669588|616277234|FG000|Overall Study|Rescue Therapy Needed|0|||
170526842|NCT03669588|616277235|FG001|Overall Study|Rescue Therapy Needed|1|||
170526843|NCT00073918|616277237|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
170526844|NCT00073918|616277237|FG000|Overall Study|Rapid disease progression|2|||
170526845|NCT00073918|616277237|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
170526846|NCT02033759|616277238|FG000|Overall Study|Withdrawal by Subject|2|||
170526847|NCT02033759|616277239|FG001|Overall Study|Withdrawal by Subject|1|||
170526848|NCT02033759|616277238|FG000|Overall Study|Protocol Violation|1|||
170526849|NCT02033759|616277239|FG001|Overall Study|Protocol Violation|1|||
170526850|NCT02034006|616279071|FG000|Overall Study|Withdrawal by Subject|7|||
170526851|NCT02034006|616279071|FG000|Overall Study|Lost to Follow-up|5|||
170876733|NCT00880399|617560334|FG000|Overall Study|Lack of Efficacy|1|||
170876734|NCT00880399|617560335|FG001|Overall Study|Lack of Efficacy|4|||
170876735|NCT00880399|617560336|FG002|Overall Study|Lack of Efficacy|2|||
170876736|NCT00880399|617560334|FG000|Overall Study|Protocol Violation|4|||
170876737|NCT00880399|617560335|FG001|Overall Study|Protocol Violation|4|||
170876738|NCT00880399|617560336|FG002|Overall Study|Protocol Violation|6|||
170876739|NCT00880399|617560334|FG000|Overall Study|Study closed/terminated|3|||
170876740|NCT00880399|617560335|FG001|Overall Study|Study closed/terminated|7|||
170415275|NCT02207231|615860422|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
170415276|NCT02207231|615860423|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
170415277|NCT02207231|615860420|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
170415278|NCT02207231|615860421|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
170415279|NCT02207231|615860422|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
170415280|NCT02207231|615860423|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
170415281|NCT02207231|615860420|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
170415282|NCT02207231|615860421|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
170526852|NCT02034006|616279071|FG000|Overall Study|Death|1|||
170526853|NCT02034006|616279071|FG000|Overall Study|Pregnancy|1|||
170526854|NCT00750269|616279081|FG000|Overall Study|Protocol Violation|0|||
170526855|NCT00750269|616279082|FG001|Overall Study|Protocol Violation|1|||
170526856|NCT00750269|616279083|FG002|Overall Study|Protocol Violation|1|||
170526857|NCT00750269|616279084|FG003|Overall Study|Protocol Violation|2|||
170526858|NCT00750269|616279085|FG004|Overall Study|Protocol Violation|4|||
170526859|NCT00750269|616279081|FG000|Overall Study|Withdrawal by Subject|0|||
170526860|NCT00750269|616279082|FG001|Overall Study|Withdrawal by Subject|0|||
170876741|NCT00880399|617560336|FG002|Overall Study|Study closed/terminated|4|||
170415283|NCT02207231|615860422|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
170415284|NCT02207231|615860423|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
170415285|NCT02207231|615860420|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
170415286|NCT02207231|615860421|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
170415287|NCT02207231|615860422|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
170776342|NCT04982315|617187072|FG002|Overall Study|Death|1|||
170776343|NCT04982315|617187070|FG000|Overall Study|Lack of Efficacy|0|||
170415288|NCT02207231|615860423|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
170415289|NCT02207231|615860420|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
170415290|NCT02207231|615860421|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
170415291|NCT02207231|615860422|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
170415292|NCT02207231|615860423|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
170776344|NCT04982315|617187071|FG001|Overall Study|Lack of Efficacy|0|||
170776345|NCT04982315|617187072|FG002|Overall Study|Lack of Efficacy|2|||
170776346|NCT04982315|617187070|FG000|Overall Study|Withdrawal by Subject|24|||
170776347|NCT04982315|617187071|FG001|Overall Study|Withdrawal by Subject|1|||
170776348|NCT04982315|617187072|FG002|Overall Study|Withdrawal by Subject|2|||
170415293|NCT05218655|615860424|FG000|Overall Study|Adverse Event|6|||
170415294|NCT05218655|615860424|FG000|Overall Study|Sponsor's decision|85|||
170415295|NCT05218655|615860424|FG000|Overall Study|Death|1|||
170415296|NCT05218655|615860424|FG000|Overall Study|Lost to Follow-up|3|||
170415297|NCT05218655|615860424|FG000|Overall Study|Withdrawal by Subject|3|||
170415298|NCT05218655|615860424|FG000|Overall Study|Other than specified|3|||
170415299|NCT00421174|615860425|FG000|Overall Study|Withdrawal by Subject|0|||
170415300|NCT00421174|615860426|FG001|Overall Study|Withdrawal by Subject|1|||
170415301|NCT00421174|615860425|FG000|Overall Study|Ineligible due to infection|2|||
170415302|NCT00421174|615860426|FG001|Overall Study|Ineligible due to infection|0|||
170415303|NCT00992407|615860427|FG000|Overall Study|Protocol Violation|2|||
170415304|NCT00992407|615860428|FG001|Overall Study|Protocol Violation|1|||
170415305|NCT00992407|615860427|FG000|Overall Study|Lost to Follow-up|3|||
170415306|NCT00992407|615860428|FG001|Overall Study|Lost to Follow-up|3|||
170415307|NCT00992407|615860427|FG000|Overall Study|Adverse Event|3|||
170415308|NCT00992407|615860428|FG001|Overall Study|Adverse Event|2|||
170415309|NCT00992407|615860427|FG000|Overall Study|protocol Violation & Adverse events|2|||
170415310|NCT00992407|615860428|FG001|Overall Study|protocol Violation & Adverse events|4|||
170415311|NCT00992407|615860427|FG000|Overall Study|Other|2|||
170415312|NCT00992407|615860428|FG001|Overall Study|Other|0|||
170415313|NCT00992407|615860427|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
170415314|NCT00992407|615860428|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
170415315|NCT00992407|615860427|FG000|Overall Study|Study medication not administered|17|||
170415316|NCT00992407|615860428|FG001|Overall Study|Study medication not administered|13|||
170415317|NCT03738332|615860431|FG000|Overall Study|Withdrawal by Subject|1|||
170415318|NCT01521559|615860432|FG000|Overall Study|Adverse Event|0|||
170415319|NCT01521559|615860433|FG001|Overall Study|Adverse Event|4|||
170415320|NCT01521559|615860432|FG000|Overall Study|Death|1|||
170415321|NCT01521559|615860433|FG001|Overall Study|Death|0|||
170415322|NCT01521559|615860432|FG000|Overall Study|Withdrawal by Subject|9|||
170415323|NCT01521559|615860433|FG001|Overall Study|Withdrawal by Subject|11|||
170415324|NCT01521559|615860432|FG000|Overall Study|Lost to Follow-up|3|||
170415325|NCT01521559|615860433|FG001|Overall Study|Lost to Follow-up|1|||
170415326|NCT01521559|615860432|FG000|Overall Study|Protocol Violation|1|||
170415327|NCT01521559|615860433|FG001|Overall Study|Protocol Violation|0|||
170415328|NCT01521559|615860432|FG000|Overall Study|Other|1|||
170415329|NCT01521559|615860433|FG001|Overall Study|Other|2|||
170415330|NCT02309099|615860434|FG000|Overall Study|Adverse Event|2|||
170415331|NCT02309099|615860435|FG001|Overall Study|Adverse Event|0|||
170415332|NCT02819362|615860436|FG000|Overall Study|On-site MRI could not be performed|70|||
170415333|NCT00576381|615860437|FG000|Overall Study|Reoperation|3|||
170415334|NCT00576381|615860437|FG000|Overall Study|Adverse Event|4|||
170415335|NCT02324465|615860441|FG000|Overall Study|device failure|0|||
170632595|NCT02420821|616666703|FG000|Overall Study|Adverse Event|0|||
170776349|NCT04982315|617187070|FG000|Overall Study|Dealing with health/life issues|3|||
170776350|NCT04982315|617187071|FG001|Overall Study|Dealing with health/life issues|4|||
170415336|NCT02324465|615860442|FG001|Overall Study|device failure|1|||
170415337|NCT01631864|615860443|FG000|Overall Study|Withdrawal by Subject|0|||
170415338|NCT01631864|615860444|FG001|Overall Study|Withdrawal by Subject|1|||
170415339|NCT01631864|615860443|FG000|Overall Study|Adverse Event|2|||
170415340|NCT01631864|615860444|FG001|Overall Study|Adverse Event|3|||
170415341|NCT01031537|615860445|FG000|Overall Study|medical reasons not related to study|3|||
170415342|NCT01031537|615860445|FG000|Overall Study|Lack of Efficacy|1|||
170415343|NCT01031537|615860445|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
170415344|NCT01031537|615860445|FG000|Overall Study|moved, met exclusion criteria|10|||
170415345|NCT01031537|615860445|FG000|Overall Study|Withdrawal by Subject|5|||
170415346|NCT01031537|615860445|FG000|Overall Study|PI removal, no longer met eligibility|12|||
170415347|NCT02153398|615860452|FG000|Overall Study|Withdrawal by Subject|1|||
170415348|NCT02153398|615860453|FG001|Overall Study|Withdrawal by Subject|0|||
170632596|NCT02420821|616666704|FG001|Overall Study|Adverse Event|1|||
170526861|NCT00750269|616279083|FG002|Overall Study|Withdrawal by Subject|2|||
170526862|NCT00750269|616279084|FG003|Overall Study|Withdrawal by Subject|2|||
170526863|NCT00750269|616279085|FG004|Overall Study|Withdrawal by Subject|2|||
170526864|NCT00750269|616279081|FG000|Overall Study|Physician Decision|0|||
170526865|NCT00750269|616279082|FG001|Overall Study|Physician Decision|0|||
170526866|NCT00750269|616279083|FG002|Overall Study|Physician Decision|0|||
170526867|NCT00750269|616279084|FG003|Overall Study|Physician Decision|0|||
170526868|NCT00750269|616279085|FG004|Overall Study|Physician Decision|2|||
170526869|NCT00750269|616279081|FG000|Overall Study|Patient too large for positioning|0|||
170526870|NCT00750269|616279082|FG001|Overall Study|Patient too large for positioning|0|||
170526871|NCT00750269|616279083|FG002|Overall Study|Patient too large for positioning|1|||
170526872|NCT00750269|616279084|FG003|Overall Study|Patient too large for positioning|0|||
170526873|NCT00750269|616279085|FG004|Overall Study|Patient too large for positioning|0|||
170876742|NCT00880399|617560334|FG000|Overall Study|Lost to Follow-up|8|||
170876743|NCT00880399|617560335|FG001|Overall Study|Lost to Follow-up|5|||
170876744|NCT00880399|617560336|FG002|Overall Study|Lost to Follow-up|3|||
170876745|NCT00880399|617560334|FG000|Overall Study|Physician Decision|5|||
170876746|NCT00880399|617560335|FG001|Overall Study|Physician Decision|0|||
170876747|NCT00880399|617560336|FG002|Overall Study|Physician Decision|3|||
170876748|NCT00880399|617560334|FG000|Overall Study|Withdrawal by Subject|6|||
170876749|NCT00880399|617560335|FG001|Overall Study|Withdrawal by Subject|3|||
170876750|NCT00880399|617560336|FG002|Overall Study|Withdrawal by Subject|3|||
170876751|NCT02181816|617560337|FG000|Overall Study|Case Report Forms Uncollected|38|||
170876752|NCT02181816|617560337|FG000|Overall Study|Protocol Deviation|21|||
170876753|NCT04353284|617560338|FG000|Overall Study|Adverse Event|1|||
170876754|NCT04353284|617560339|FG001|Overall Study|Adverse Event|1|||
170876755|NCT04353284|617560338|FG000|Overall Study|Lost to Follow-up|1|||
170876756|NCT04353284|617560339|FG001|Overall Study|Lost to Follow-up|0|||
170876757|NCT03179891|617560344|FG000|First Intervention|Withdrawal by Subject|1|||
170876758|NCT03179891|617560345|FG001|First Intervention|Withdrawal by Subject|1|||
170876759|NCT03179891|617560344|FG000|First Intervention|Unspecified reason|1|||
170876760|NCT03179891|617560345|FG001|First Intervention|Unspecified reason|0|||
170876761|NCT03179891|617560344|FG000|First Intervention|Protocol Violation|0|||
170876762|NCT03179891|617560345|FG001|First Intervention|Protocol Violation|1|||
170876763|NCT00530894|617560347|FG000|Overall Study|Death|84|||
170876764|NCT00530894|617560348|FG001|Overall Study|Death|89|||
170876765|NCT00530894|617560349|FG002|Overall Study|Death|55|||
170876766|NCT00530894|617560350|FG003|Overall Study|Death|89|||
170876767|NCT00530894|617560347|FG000|Overall Study|Lost to Follow-up|1|||
170876768|NCT00530894|617560348|FG001|Overall Study|Lost to Follow-up|3|||
170876769|NCT00530894|617560349|FG002|Overall Study|Lost to Follow-up|0|||
170876770|NCT00530894|617560350|FG003|Overall Study|Lost to Follow-up|0|||
170876771|NCT00530894|617560347|FG000|Overall Study|Withdrawal by Subject|1|||
170876772|NCT00530894|617560348|FG001|Overall Study|Withdrawal by Subject|23|||
170876773|NCT00530894|617560349|FG002|Overall Study|Withdrawal by Subject|0|||
170876774|NCT00530894|617560350|FG003|Overall Study|Withdrawal by Subject|5|||
170876775|NCT00530894|617560347|FG000|Overall Study|Alive and censored prior to 1 year|2|||
170876776|NCT00530894|617560348|FG001|Overall Study|Alive and censored prior to 1 year|0|||
170876777|NCT00530894|617560349|FG002|Overall Study|Alive and censored prior to 1 year|0|||
170876778|NCT00530894|617560350|FG003|Overall Study|Alive and censored prior to 1 year|0|||
170876779|NCT00383084|617560351|FG000|Overall Study|Withdrawal by Subject|12|||
170876780|NCT00383084|617560352|FG001|Overall Study|Withdrawal by Subject|10|||
170876781|NCT01230242|617560353|FG000|Overall Study|Physician Decision|2|||
170876782|NCT01230242|617560353|FG000|Overall Study|Withdrawal by Subject|1|||
170876783|NCT02256540|617560354|FG000|Overall Study|Withdrawal by Subject|0|||
170876784|NCT02256540|617560355|FG001|Overall Study|Withdrawal by Subject|1|||
170876785|NCT02256540|617560356|FG002|Overall Study|Withdrawal by Subject|1|||
170876786|NCT02256540|617560354|FG000|Overall Study|Back pain preventing exercise|0|||
170526874|NCT00750269|616279081|FG000|Overall Study|Site error|0|||
170526875|NCT00750269|616279082|FG001|Overall Study|Site error|0|||
170876787|NCT02256540|617560355|FG001|Overall Study|Back pain preventing exercise|0|||
170526876|NCT00750269|616279083|FG002|Overall Study|Site error|0|||
170526877|NCT00750269|616279084|FG003|Overall Study|Site error|1|||
170526878|NCT00750269|616279085|FG004|Overall Study|Site error|0|||
170526879|NCT00750269|616279081|FG000|Overall Study|SBRT plan could not be drawn|0|||
170526880|NCT00750269|616279082|FG001|Overall Study|SBRT plan could not be drawn|0|||
170526881|NCT00750269|616279083|FG002|Overall Study|SBRT plan could not be drawn|0|||
170526882|NCT00750269|616279084|FG003|Overall Study|SBRT plan could not be drawn|0|||
170876788|NCT02256540|617560356|FG002|Overall Study|Back pain preventing exercise|1|||
170876789|NCT01648790|617560357|FG000|Treatment 3|Withdrawal by Subject|0|||
170876790|NCT01648790|617560358|FG001|Treatment 3|Withdrawal by Subject|0|||
170526883|NCT00750269|616279085|FG004|Overall Study|SBRT plan could not be drawn|1|||
170876791|NCT01648790|617560359|FG002|Treatment 3|Withdrawal by Subject|0|||
170876792|NCT01648790|617560360|FG003|Treatment 3|Withdrawal by Subject|1|||
170876793|NCT01648790|617560361|FG004|Treatment 3|Withdrawal by Subject|0|||
170876794|NCT02969187|617560362|FG000|Overall Study|Physician Decision|12|||
170876795|NCT02969187|617560363|FG001|Overall Study|Physician Decision|13|||
170876796|NCT01438489|617560367|FG000|Overall Study|Lost to Follow-up|4|||
170876797|NCT01438489|617560368|FG001|Overall Study|Lost to Follow-up|2|||
170876798|NCT01438489|617560369|FG002|Overall Study|Lost to Follow-up|2|||
170876799|NCT01438489|617560367|FG000|Overall Study|Withdrawal by Subject|11|||
170876800|NCT01438489|617560368|FG001|Overall Study|Withdrawal by Subject|3|||
170876801|NCT01438489|617560369|FG002|Overall Study|Withdrawal by Subject|8|||
170876802|NCT01438489|617560367|FG000|Overall Study|Death|0|||
170876803|NCT01438489|617560368|FG001|Overall Study|Death|0|||
170876804|NCT01438489|617560369|FG002|Overall Study|Death|1|||
170876805|NCT01438489|617560367|FG000|Overall Study|Sponsor decision|4|||
170876806|NCT01438489|617560368|FG001|Overall Study|Sponsor decision|1|||
170876807|NCT01438489|617560369|FG002|Overall Study|Sponsor decision|4|||
170876808|NCT01438489|617560367|FG000|Overall Study|Subject choice/Subject moved|2|||
170876809|NCT01438489|617560368|FG001|Overall Study|Subject choice/Subject moved|1|||
170876810|NCT01438489|617560369|FG002|Overall Study|Subject choice/Subject moved|1|||
170876811|NCT01438489|617560367|FG000|Overall Study|Investigator decision|0|||
170876812|NCT01438489|617560368|FG001|Overall Study|Investigator decision|1|||
170876813|NCT01438489|617560369|FG002|Overall Study|Investigator decision|0|||
170876814|NCT01438489|617560367|FG000|Overall Study|AE/SAEs|2|||
170876815|NCT01438489|617560368|FG001|Overall Study|AE/SAEs|1|||
170876816|NCT01438489|617560369|FG002|Overall Study|AE/SAEs|1|||
170876817|NCT01438489|617560367|FG000|Overall Study|Received prohibited medication|1|||
170876818|NCT01438489|617560368|FG001|Overall Study|Received prohibited medication|0|||
170876819|NCT01438489|617560369|FG002|Overall Study|Received prohibited medication|0|||
170876820|NCT01438489|617560367|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
170876821|NCT01438489|617560368|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
170876822|NCT01438489|617560369|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
170876823|NCT01438489|617560367|FG000|Overall Study|Inadequate venous access|0|||
170776351|NCT04982315|617187072|FG002|Overall Study|Dealing with health/life issues|7|||
170776352|NCT04982315|617187070|FG000|Overall Study|Privacy concerns|1|||
170526884|NCT00750269|616279081|FG000|Overall Study|Fiducials could not be placed|0|||
170526885|NCT00750269|616279082|FG001|Overall Study|Fiducials could not be placed|0|||
170776353|NCT04982315|617187071|FG001|Overall Study|Privacy concerns|0|||
170776354|NCT04982315|617187072|FG002|Overall Study|Privacy concerns|0|||
170776355|NCT04982315|617187070|FG000|Overall Study|Withdrawal by research team|0|||
170776356|NCT04982315|617187071|FG001|Overall Study|Withdrawal by research team|0|||
170776357|NCT04982315|617187072|FG002|Overall Study|Withdrawal by research team|1|||
170776358|NCT00780910|617187073|FG000|Overall Study|Adverse Event|2|||
170776359|NCT02574455|617187078|FG000|Overall Study|Death|197|||
170776360|NCT02574455|617187079|FG001|Overall Study|Death|210|||
170776361|NCT02574455|617187078|FG000|Overall Study|Withdrawal of Consent|11|||
170776362|NCT02574455|617187079|FG001|Overall Study|Withdrawal of Consent|28|||
170776363|NCT02574455|617187078|FG000|Overall Study|Lost to Follow-up|4|||
170776364|NCT02574455|617187079|FG001|Overall Study|Lost to Follow-up|4|||
170776365|NCT02574455|617187078|FG000|Overall Study|Sponsor's Decision|55|||
170776366|NCT02574455|617187079|FG001|Overall Study|Sponsor's Decision|20|||
170776367|NCT02528188|617187080|FG000|Overall Study|Adverse Event|23|||
170776368|NCT02528188|617187081|FG001|Overall Study|Adverse Event|22|||
170776369|NCT02528188|617187082|FG002|Overall Study|Adverse Event|8|||
170776370|NCT02528188|617187080|FG000|Overall Study|Protocol Violation|4|||
170776371|NCT02528188|617187081|FG001|Overall Study|Protocol Violation|6|||
170776372|NCT02528188|617187082|FG002|Overall Study|Protocol Violation|4|||
170776373|NCT02528188|617187080|FG000|Overall Study|Lack of Efficacy|19|||
170776374|NCT02528188|617187081|FG001|Overall Study|Lack of Efficacy|21|||
170776375|NCT02528188|617187082|FG002|Overall Study|Lack of Efficacy|22|||
170776376|NCT02528188|617187080|FG000|Overall Study|Withdrawal by Subject|97|||
170776377|NCT02528188|617187081|FG001|Overall Study|Withdrawal by Subject|104|||
170776378|NCT02528188|617187082|FG002|Overall Study|Withdrawal by Subject|100|||
170776379|NCT02528188|617187080|FG000|Overall Study|Lost to Follow-up|25|||
170776380|NCT02528188|617187081|FG001|Overall Study|Lost to Follow-up|21|||
170776381|NCT02528188|617187082|FG002|Overall Study|Lost to Follow-up|31|||
170776382|NCT02528188|617187080|FG000|Overall Study|Death|4|||
170776383|NCT02528188|617187081|FG001|Overall Study|Death|4|||
170776384|NCT02528188|617187082|FG002|Overall Study|Death|0|||
170876824|NCT01438489|617560368|FG001|Overall Study|Inadequate venous access|2|||
170876825|NCT01438489|617560369|FG002|Overall Study|Inadequate venous access|0|||
170776385|NCT02528188|617187080|FG000|Overall Study|Other|89|||
170776386|NCT02528188|617187081|FG001|Overall Study|Other|91|||
170876826|NCT00766532|617560370|FG000|Overall Study|Protocol Violation|2|||
170776387|NCT02528188|617187082|FG002|Overall Study|Other|74|||
170776388|NCT02528188|617187080|FG000|Overall Study|Randomized but not treated|6|||
170776389|NCT02528188|617187081|FG001|Overall Study|Randomized but not treated|7|||
170776390|NCT02528188|617187082|FG002|Overall Study|Randomized but not treated|12|||
170776391|NCT01170962|617187084|FG000|Treatment Period|Lack of Efficacy|96|||
170876827|NCT03923426|617560371|FG000|Overall Study|Other|19|||
170876828|NCT03923426|617560371|FG000|Overall Study|Lost to Follow-up|16|||
170876829|NCT03923426|617560371|FG000|Overall Study|Death|107|||
170776392|NCT01170962|617187085|FG001|Treatment Period|Lack of Efficacy|91|||
170526886|NCT00750269|616279083|FG002|Overall Study|Fiducials could not be placed|0|||
170526887|NCT00750269|616279084|FG003|Overall Study|Fiducials could not be placed|0|||
170526888|NCT00750269|616279085|FG004|Overall Study|Fiducials could not be placed|1|||
170526889|NCT01898078|616279086|FG000|Overall Study|Progressive Disease|1|||
170526890|NCT01898078|616279087|FG001|Overall Study|Progressive Disease|5|||
170526891|NCT01898078|616279086|FG000|Overall Study|Adverse Event|2|||
170526892|NCT01898078|616279087|FG001|Overall Study|Adverse Event|1|||
170526893|NCT01898078|616279086|FG000|Overall Study|Withdrawal by Subject|1|||
170526894|NCT01898078|616279087|FG001|Overall Study|Withdrawal by Subject|1|||
170415349|NCT02153398|615860454|FG002|Overall Study|Withdrawal by Subject|0|||
170526895|NCT01898078|616279086|FG000|Overall Study|Symptomatic Deterioration|2|||
170526896|NCT01898078|616279087|FG001|Overall Study|Symptomatic Deterioration|0|||
170526897|NCT01898078|616279086|FG000|Overall Study|Reason not Specified|0|||
170526898|NCT01898078|616279087|FG001|Overall Study|Reason not Specified|1|||
170526899|NCT00606008|616279088|FG000|Overall Study|Adverse Event|1|||
170526900|NCT00606008|616279088|FG000|Overall Study|Withdrawal by Subject|4|||
170526901|NCT02426684|616279089|FG000|Overall Study|Physician Decision|1|||
170526902|NCT03736967|616279090|FG000|Overall Study|Withdrawal by Subject|26|||
170876830|NCT03923426|617560371|FG000|Overall Study|Incomplete response to question|13|||
170876831|NCT02159729|617560373|FG000|Overall Study|Adverse Event|0|||
170876832|NCT02159729|617560374|FG001|Overall Study|Adverse Event|1|||
170876833|NCT02159729|617560373|FG000|Overall Study|Subject's Request|13|||
170876834|NCT02159729|617560374|FG001|Overall Study|Subject's Request|10|||
170876835|NCT02159729|617560373|FG000|Overall Study|Lost to Follow-up|24|||
170876836|NCT02159729|617560374|FG001|Overall Study|Lost to Follow-up|9|||
170876837|NCT02159729|617560373|FG000|Overall Study|Non compliance|2|||
170876838|NCT02159729|617560374|FG001|Overall Study|Non compliance|0|||
170876839|NCT02159729|617560373|FG000|Overall Study|Other Unspecified|3|||
170876840|NCT02159729|617560374|FG001|Overall Study|Other Unspecified|1|||
170876841|NCT01476475|617560375|FG000|Overall Study|Adverse Event|6|||
170876842|NCT01476475|617560376|FG001|Overall Study|Adverse Event|0|||
170876843|NCT01476475|617560375|FG000|Overall Study|Poor compliance to protocol|1|||
170876844|NCT01476475|617560376|FG001|Overall Study|Poor compliance to protocol|1|||
170876845|NCT01476475|617560375|FG000|Overall Study|Other reasons|4|||
170876846|NCT01476475|617560376|FG001|Overall Study|Other reasons|2|||
170876847|NCT02636582|617560381|FG000|Overall Study|Surgical Pathology|1|||
170876848|NCT02636582|617560382|FG001|Overall Study|Surgical Pathology|0|||
170415350|NCT02153398|615860455|FG003|Overall Study|Withdrawal by Subject|0|||
170415351|NCT02153398|615860456|FG004|Overall Study|Withdrawal by Subject|0|||
170415352|NCT02153398|615860452|FG000|Overall Study|Adverse Event|0|||
170415353|NCT02153398|615860453|FG001|Overall Study|Adverse Event|0|||
170415354|NCT02153398|615860454|FG002|Overall Study|Adverse Event|1|||
170415355|NCT02153398|615860455|FG003|Overall Study|Adverse Event|1|||
170415356|NCT02153398|615860456|FG004|Overall Study|Adverse Event|0|||
170415357|NCT02204371|615860457|FG000|Overall Study|Adverse Event|1|||
170415358|NCT00337571|615860461|FG000|Overall Study|Lack of Efficacy|3|||
170415359|NCT00337571|615860462|FG001|Overall Study|Lack of Efficacy|0|||
170415360|NCT00337571|615860463|FG002|Overall Study|Lack of Efficacy|0|||
170415361|NCT00337571|615860464|FG003|Overall Study|Lack of Efficacy|0|||
170415362|NCT00337571|615860461|FG000|Overall Study|Adverse Event|4|||
170415363|NCT00337571|615860462|FG001|Overall Study|Adverse Event|5|||
170415364|NCT00337571|615860463|FG002|Overall Study|Adverse Event|8|||
170415365|NCT00337571|615860464|FG003|Overall Study|Adverse Event|4|||
170415366|NCT00337571|615860461|FG000|Overall Study|Withdrawal by Subject|2|||
170415367|NCT00337571|615860462|FG001|Overall Study|Withdrawal by Subject|2|||
170415368|NCT00337571|615860463|FG002|Overall Study|Withdrawal by Subject|1|||
170415369|NCT00337571|615860464|FG003|Overall Study|Withdrawal by Subject|0|||
170415370|NCT00337571|615860461|FG000|Overall Study|Lost to Follow-up|3|||
170415371|NCT00337571|615860462|FG001|Overall Study|Lost to Follow-up|1|||
170415372|NCT00337571|615860463|FG002|Overall Study|Lost to Follow-up|0|||
170526903|NCT03736967|616279091|FG001|Overall Study|Withdrawal by Subject|25|||
170632597|NCT02420821|616666703|FG000|Overall Study|Protinuria|0|||
170415373|NCT00337571|615860464|FG003|Overall Study|Lost to Follow-up|1|||
170415374|NCT00337571|615860461|FG000|Overall Study|Poor/noncompliance|1|||
170415375|NCT00337571|615860462|FG001|Overall Study|Poor/noncompliance|1|||
170526904|NCT03736967|616279092|FG002|Overall Study|Withdrawal by Subject|23|||
170526905|NCT03736967|616279093|FG003|Overall Study|Withdrawal by Subject|26|||
170526906|NCT03736967|616279090|FG000|Overall Study|Lost to Follow-up|3|||
170876849|NCT03719690|617560384|FG000|Overall Study|Withdrawal by Subject|5|||
170876850|NCT03719690|617560385|FG001|Overall Study|Withdrawal by Subject|10|||
170876851|NCT03719690|617560384|FG000|Overall Study|Death|40|||
170876852|NCT03719690|617560385|FG001|Overall Study|Death|149|||
170415376|NCT00337571|615860463|FG002|Overall Study|Poor/noncompliance|1|||
170415377|NCT00337571|615860464|FG003|Overall Study|Poor/noncompliance|1|||
170415378|NCT00337571|615860461|FG000|Overall Study|No longer met study criteria|1|||
170415379|NCT00337571|615860462|FG001|Overall Study|No longer met study criteria|0|||
170415380|NCT00337571|615860463|FG002|Overall Study|No longer met study criteria|0|||
170415381|NCT00337571|615860464|FG003|Overall Study|No longer met study criteria|0|||
170876853|NCT03719690|617560384|FG000|Overall Study|Miscellaneous|12|||
170876854|NCT03719690|617560385|FG001|Overall Study|Miscellaneous|56|||
170876855|NCT03719690|617560384|FG000|Overall Study|Lost to Follow-up|2|||
170876856|NCT03719690|617560385|FG001|Overall Study|Lost to Follow-up|18|||
170876857|NCT03719690|617560384|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
170876858|NCT03719690|617560385|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
170876859|NCT00573430|617560386|FG000|Overall Study|Incorrect enrollment of randomization|0|||
170876860|NCT00573430|617560387|FG001|Overall Study|Incorrect enrollment of randomization|4|||
170876861|NCT00573430|617560388|FG002|Overall Study|Incorrect enrollment of randomization|3|||
170876862|NCT00573430|617560386|FG000|Overall Study|Adverse Event|0|||
170876863|NCT00573430|617560387|FG001|Overall Study|Adverse Event|0|||
170876864|NCT00573430|617560388|FG002|Overall Study|Adverse Event|2|||
170876865|NCT00573430|617560386|FG000|Overall Study|Withdrawal by Subject|1|||
170876866|NCT00573430|617560387|FG001|Overall Study|Withdrawal by Subject|0|||
170876867|NCT00573430|617560388|FG002|Overall Study|Withdrawal by Subject|1|||
170876868|NCT00573430|617560386|FG000|Overall Study|Protocol Violation|0|||
170876869|NCT00573430|617560387|FG001|Overall Study|Protocol Violation|1|||
170876870|NCT00573430|617560388|FG002|Overall Study|Protocol Violation|1|||
170876871|NCT00573430|617560386|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170876872|NCT00573430|617560387|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170876873|NCT00573430|617560388|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
170876874|NCT01372384|617560390|FG000|Overall Study|Progression of disease|3|||
170876875|NCT01278745|617560394|FG000|Overall Study|Death|2|||
170876876|NCT01278745|617560395|FG001|Overall Study|Death|5|||
170876877|NCT01278745|617560396|FG002|Overall Study|Death|7|||
170876878|NCT01278745|617560397|FG003|Overall Study|Death|0|||
170876879|NCT01278745|617560394|FG000|Overall Study|Physician Decision|1|||
170876880|NCT01278745|617560395|FG001|Overall Study|Physician Decision|0|||
170415382|NCT00337571|615860461|FG000|Overall Study|High Potassium level|0|||
170415383|NCT00337571|615860462|FG001|Overall Study|High Potassium level|0|||
170415384|NCT00337571|615860463|FG002|Overall Study|High Potassium level|0|||
170415385|NCT00337571|615860464|FG003|Overall Study|High Potassium level|1|||
170415386|NCT04543136|615860467|FG000|Overall Study|Withdrawal by Subject|0|||
170415387|NCT04543136|615860468|FG001|Overall Study|Withdrawal by Subject|1|||
170415388|NCT04543136|615860469|FG002|Overall Study|Withdrawal by Subject|0|||
170415389|NCT04543136|615860470|FG003|Overall Study|Withdrawal by Subject|1|||
170415390|NCT04543136|615860471|FG004|Overall Study|Withdrawal by Subject|0|||
170415391|NCT04543136|615860472|FG005|Overall Study|Withdrawal by Subject|0|||
170415392|NCT00536575|615860473|FG000|Overall Study|Withdrawal by Subject|1|||
170415393|NCT00536575|615860473|FG000|Overall Study|Death|1|||
170415394|NCT00638157|615860479|FG000|Overall Study|Adverse Event|0|||
170415395|NCT00638157|615860480|FG001|Overall Study|Adverse Event|1|||
170415396|NCT00638157|615860479|FG000|Overall Study|Clinical (symptomatic) failure|1|||
170415397|NCT00638157|615860480|FG001|Overall Study|Clinical (symptomatic) failure|1|||
170415398|NCT00638157|615860479|FG000|Overall Study|Microbiological failure|1|||
170415399|NCT00638157|615860480|FG001|Overall Study|Microbiological failure|0|||
170415400|NCT00638157|615860479|FG000|Overall Study|Lost to Follow-up|1|||
170415401|NCT00638157|615860480|FG001|Overall Study|Lost to Follow-up|0|||
170415402|NCT00638157|615860479|FG000|Overall Study|Physician Decision|1|||
170415403|NCT00638157|615860480|FG001|Overall Study|Physician Decision|0|||
170415404|NCT00638157|615860479|FG000|Overall Study|Other|1|||
170415405|NCT00638157|615860480|FG001|Overall Study|Other|2|||
170415406|NCT00638157|615860479|FG000|Overall Study|Randomized, not treated|2|||
170415407|NCT00638157|615860480|FG001|Overall Study|Randomized, not treated|0|||
170415408|NCT03495986|615860481|FG000|Overall Study|Physician Decision|1|||
170415409|NCT03495986|615860482|FG001|Overall Study|Physician Decision|0|||
170415410|NCT03495986|615860481|FG000|Overall Study|Withdrawal by Subject|1|||
170415411|NCT03495986|615860482|FG001|Overall Study|Withdrawal by Subject|1|||
170415412|NCT03495986|615860481|FG000|Overall Study|Withdrawal by Subject|1|||
170415413|NCT03495986|615860482|FG001|Overall Study|Withdrawal by Subject|0|||
170415414|NCT01118728|615860483|FG000|Overall Study|Adverse Event|17|||
170526907|NCT03736967|616279091|FG001|Overall Study|Lost to Follow-up|2|||
170526908|NCT03736967|616279092|FG002|Overall Study|Lost to Follow-up|1|||
170876881|NCT01278745|617560396|FG002|Overall Study|Physician Decision|0|||
170526909|NCT03736967|616279093|FG003|Overall Study|Lost to Follow-up|1|||
170876882|NCT01278745|617560397|FG003|Overall Study|Physician Decision|9|||
170876883|NCT01278745|617560394|FG000|Overall Study|Withdrawal by Subject|1|||
170876884|NCT01278745|617560395|FG001|Overall Study|Withdrawal by Subject|1|||
170876885|NCT01278745|617560396|FG002|Overall Study|Withdrawal by Subject|5|||
170876886|NCT01278745|617560397|FG003|Overall Study|Withdrawal by Subject|1|||
170415415|NCT01118728|615860483|FG000|Overall Study|Lack of Efficacy|27|||
170415416|NCT01118728|615860483|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
170415417|NCT01118728|615860483|FG000|Overall Study|Withdrawal by Subject|3|||
170415418|NCT01118728|615860483|FG000|Overall Study|Lost to Follow-up|4|||
170415419|NCT03131999|615860486|FG000|Overall Study|Withdrawal by Subject|0|||
170415420|NCT03131999|615860487|FG001|Overall Study|Withdrawal by Subject|1|||
170415421|NCT02260492|615860488|FG000|Overall Study|Adverse Event|6|||
170526910|NCT03736967|616279090|FG000|Overall Study|Physician Decision|1|||
170876887|NCT01278745|617560394|FG000|Overall Study|Sponsor Decision|1|||
170876888|NCT01278745|617560395|FG001|Overall Study|Sponsor Decision|0|||
170526911|NCT03736967|616279091|FG001|Overall Study|Physician Decision|0|||
170876889|NCT01278745|617560396|FG002|Overall Study|Sponsor Decision|62|||
170876890|NCT01278745|617560397|FG003|Overall Study|Sponsor Decision|6|||
170876891|NCT01278745|617560394|FG000|Overall Study|Ineligible|0|||
170876892|NCT01278745|617560395|FG001|Overall Study|Ineligible|0|||
170876893|NCT01278745|617560396|FG002|Overall Study|Ineligible|42|||
170876894|NCT01278745|617560397|FG003|Overall Study|Ineligible|61|||
170876895|NCT01278745|617560394|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
170876896|NCT01278745|617560395|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
170876897|NCT01278745|617560396|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
170876898|NCT01278745|617560397|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
170876899|NCT00441974|617560398|FG000|Overall Study|Adverse Event|6|||
170876900|NCT00441974|617560398|FG000|Overall Study|Consent Withdrawn|35|||
170876901|NCT00441974|617560398|FG000|Overall Study|Lost to Follow-up|80|||
170876902|NCT00441974|617560398|FG000|Overall Study|Protocol Violation|7|||
170876903|NCT05895552|617560399|FG000|Overall Study|Adverse Event|2|||
170876904|NCT05895552|617560400|FG001|Overall Study|Adverse Event|2|||
170876905|NCT05895552|617560401|FG002|Overall Study|Adverse Event|1|||
170876906|NCT05895552|617560399|FG000|Overall Study|Lost to Follow-up|0|||
170876907|NCT05895552|617560400|FG001|Overall Study|Lost to Follow-up|1|||
170876908|NCT05895552|617560401|FG002|Overall Study|Lost to Follow-up|0|||
170876909|NCT05895552|617560399|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170876910|NCT05895552|617560400|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170876911|NCT05895552|617560401|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170876912|NCT05895552|617560399|FG000|Overall Study|Protocol Deviation|0|||
170876913|NCT05895552|617560400|FG001|Overall Study|Protocol Deviation|0|||
170876914|NCT05895552|617560401|FG002|Overall Study|Protocol Deviation|2|||
170876915|NCT05895552|617560399|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
170526912|NCT03736967|616279092|FG002|Overall Study|Physician Decision|0|||
170526913|NCT03736967|616279093|FG003|Overall Study|Physician Decision|1|||
170526914|NCT03736967|616279090|FG000|Overall Study|Adverse Event|0|||
170526915|NCT03736967|616279091|FG001|Overall Study|Adverse Event|1|||
170526916|NCT03736967|616279092|FG002|Overall Study|Adverse Event|0|||
170876916|NCT05895552|617560400|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
170876917|NCT05895552|617560401|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
170876918|NCT05895552|617560399|FG000|Overall Study|Withdrawal by Subject|2|||
170876919|NCT05895552|617560400|FG001|Overall Study|Withdrawal by Subject|2|||
170876920|NCT05895552|617560401|FG002|Overall Study|Withdrawal by Subject|4|||
170876921|NCT02576444|617560409|FG000|Overall Study|Death|1|||
170876922|NCT02576444|617560410|FG001|Overall Study|Death|1|||
170876923|NCT02576444|617560411|FG002|Overall Study|Death|0|||
170876924|NCT02576444|617560412|FG003|Overall Study|Death|0|||
170876925|NCT02576444|617560409|FG000|Overall Study|Withdrawal by Subject|0|||
170876926|NCT02576444|617560410|FG001|Overall Study|Withdrawal by Subject|0|||
170876927|NCT02576444|617560411|FG002|Overall Study|Withdrawal by Subject|2|||
170876928|NCT02576444|617560412|FG003|Overall Study|Withdrawal by Subject|0|||
170876929|NCT02576444|617560409|FG000|Overall Study|Adverse Event|0|||
170876930|NCT02576444|617560410|FG001|Overall Study|Adverse Event|0|||
170876931|NCT02576444|617560411|FG002|Overall Study|Adverse Event|1|||
170876932|NCT02576444|617560412|FG003|Overall Study|Adverse Event|0|||
170876933|NCT02576444|617560409|FG000|Overall Study|Physician Decision|0|||
170876934|NCT02576444|617560410|FG001|Overall Study|Physician Decision|0|||
170876935|NCT02576444|617560411|FG002|Overall Study|Physician Decision|1|||
170876936|NCT02576444|617560412|FG003|Overall Study|Physician Decision|0|||
170876937|NCT01843842|617560416|FG000|Overall Study|Do not meet inclusion criteria|1|||
170876938|NCT01843842|617560417|FG001|Overall Study|Do not meet inclusion criteria|1|||
170876939|NCT01376778|617560418|FG000|Overall Study|Lost to Follow-up|3|||
170876940|NCT01376778|617560419|FG001|Overall Study|Lost to Follow-up|2|||
170876941|NCT00454857|617560420|FG000|Overall Study|Withdrawal by Subject|15|||
170876942|NCT00454857|617560420|FG000|Overall Study|Lost to Follow-up|16|||
170876943|NCT00454857|617560420|FG000|Overall Study|Noncompliance|6|||
170876944|NCT00454857|617560420|FG000|Overall Study|Death|5|||
170526917|NCT03736967|616279093|FG003|Overall Study|Adverse Event|1|||
170526918|NCT03736967|616279090|FG000|Overall Study|Death|0|||
170526919|NCT03736967|616279091|FG001|Overall Study|Death|0|||
170876945|NCT00454857|617560420|FG000|Overall Study|Other|11|||
170876946|NCT00454857|617560420|FG000|Overall Study|Reason unknown|1|||
170876947|NCT00829179|617560421|FG000|Overall Study|Withdrawal by Subject|1|||
170876948|NCT00632099|617560422|FG000|Overall Study|Lost to Follow-up|3|||
170876949|NCT00632099|617560423|FG001|Overall Study|Lost to Follow-up|3|||
170526920|NCT03736967|616279092|FG002|Overall Study|Death|0|||
170876950|NCT03374189|617560431|FG000|Overall Study|Lost to Follow-up|1|||
170876951|NCT03374189|617560432|FG001|Overall Study|Lost to Follow-up|0|||
170876952|NCT01356407|617560433|FG000|Overall Study|Lost to Follow-up|2|||
170526921|NCT03736967|616279093|FG003|Overall Study|Death|1|||
170876953|NCT01356407|617560434|FG001|Overall Study|Lost to Follow-up|0|||
170776393|NCT01170962|617187086|FG002|Treatment Period|Lack of Efficacy|7|||
170776394|NCT01170962|617187084|FG000|Treatment Period|Adverse Event|11|||
170776395|NCT01170962|617187085|FG001|Treatment Period|Adverse Event|12|||
170776396|NCT01170962|617187086|FG002|Treatment Period|Adverse Event|3|||
170776397|NCT01170962|617187084|FG000|Treatment Period|Withdrawal by Subject|2|||
170776398|NCT01170962|617187085|FG001|Treatment Period|Withdrawal by Subject|1|||
170776399|NCT01170962|617187086|FG002|Treatment Period|Withdrawal by Subject|0|||
170776400|NCT01170962|617187084|FG000|Treatment Period|Lost to Follow-up|1|||
170776401|NCT01170962|617187085|FG001|Treatment Period|Lost to Follow-up|1|||
170776402|NCT01170962|617187086|FG002|Treatment Period|Lost to Follow-up|1|||
170776403|NCT01170962|617187084|FG000|Treatment Period|Participant no longer meets criteria|0|||
170776404|NCT01170962|617187085|FG001|Treatment Period|Participant no longer meets criteria|1|||
170776405|NCT01170962|617187086|FG002|Treatment Period|Participant no longer meets criteria|0|||
170776406|NCT01170962|617187084|FG000|Treatment Period|Request to discontinue treatment|7|||
170776407|NCT01170962|617187085|FG001|Treatment Period|Request to discontinue treatment|3|||
170776408|NCT01170962|617187086|FG002|Treatment Period|Request to discontinue treatment|1|||
170776409|NCT01170962|617187084|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
170776410|NCT01170962|617187085|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
170776411|NCT01170962|617187086|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
170776412|NCT01170962|617187084|FG000|Follow up Period|Withdrawal by Subject|14|||
170776413|NCT01170962|617187085|FG001|Follow up Period|Withdrawal by Subject|10|||
170776414|NCT01170962|617187086|FG002|Follow up Period|Withdrawal by Subject|2|||
170776415|NCT01170962|617187084|FG000|Follow up Period|Lost to Follow-up|13|||
170776416|NCT01170962|617187085|FG001|Follow up Period|Lost to Follow-up|8|||
170776417|NCT01170962|617187086|FG002|Follow up Period|Lost to Follow-up|1|||
170876954|NCT01356407|617560433|FG000|Overall Study|Patient Withdrew Consent|2|||
170415422|NCT02260492|615860489|FG001|Overall Study|Adverse Event|1|||
170776418|NCT01170962|617187084|FG000|Follow up Period|Death|2|||
170776419|NCT01170962|617187085|FG001|Follow up Period|Death|2|||
170776420|NCT01170962|617187086|FG002|Follow up Period|Death|0|||
170776421|NCT01170962|617187084|FG000|Follow up Period|Others|10|||
170776422|NCT01170962|617187085|FG001|Follow up Period|Others|7|||
170776423|NCT01170962|617187086|FG002|Follow up Period|Others|3|||
170776424|NCT00716859|617187091|FG000|Overall Study|Adverse Event|4|||
170776425|NCT00716859|617187092|FG001|Overall Study|Adverse Event|1|||
170776426|NCT00716859|617187091|FG000|Overall Study|Lack of Efficacy|3|||
170776427|NCT00716859|617187092|FG001|Overall Study|Lack of Efficacy|0|||
170776428|NCT00716859|617187091|FG000|Overall Study|Withdrawal by Subject|1|||
170776429|NCT00716859|617187092|FG001|Overall Study|Withdrawal by Subject|3|||
170776430|NCT00716859|617187091|FG000|Overall Study|Not treated|1|||
170776431|NCT00716859|617187092|FG001|Overall Study|Not treated|1|||
170776432|NCT02178098|617187093|FG000|Overall Study|Withdrawal by Subject|0|||
170776433|NCT02178098|617187094|FG001|Overall Study|Withdrawal by Subject|6|||
170876955|NCT01356407|617560434|FG001|Overall Study|Patient Withdrew Consent|1|||
170876956|NCT01356407|617560433|FG000|Overall Study|Could not afford IMP administration|0|||
170876957|NCT01356407|617560434|FG001|Overall Study|Could not afford IMP administration|1|||
170876958|NCT01356407|617560433|FG000|Overall Study|Not complete Endoscopy|2|||
170876959|NCT01356407|617560434|FG001|Overall Study|Not complete Endoscopy|2|||
170415423|NCT02260492|615860490|FG002|Overall Study|Adverse Event|2|||
170415424|NCT02260492|615860488|FG000|Overall Study|Death|0|||
170415425|NCT02260492|615860489|FG001|Overall Study|Death|1|||
170415426|NCT02260492|615860490|FG002|Overall Study|Death|0|||
170415427|NCT02260492|615860488|FG000|Overall Study|Lost to Follow-up|12|||
170415428|NCT02260492|615860489|FG001|Overall Study|Lost to Follow-up|9|||
170415429|NCT02260492|615860490|FG002|Overall Study|Lost to Follow-up|0|||
170415430|NCT02260492|615860488|FG000|Overall Study|Physician Decision|2|||
170415431|NCT02260492|615860489|FG001|Overall Study|Physician Decision|0|||
170415432|NCT02260492|615860490|FG002|Overall Study|Physician Decision|1|||
170415433|NCT02260492|615860488|FG000|Overall Study|Withdrawal by Subject|3|||
170415434|NCT02260492|615860489|FG001|Overall Study|Withdrawal by Subject|2|||
170415435|NCT02260492|615860490|FG002|Overall Study|Withdrawal by Subject|2|||
170415436|NCT04634409|615860499|FG000|Overall Study|Death|0|||
170415437|NCT04634409|615860500|FG001|Overall Study|Death|0|||
170415438|NCT04634409|615860501|FG002|Overall Study|Death|0|||
170415439|NCT04634409|615860502|FG003|Overall Study|Death|0|||
170415440|NCT04634409|615860503|FG004|Overall Study|Death|0|||
170415441|NCT04634409|615860504|FG005|Overall Study|Death|0|||
170415442|NCT04634409|615860505|FG006|Overall Study|Death|0|||
170415443|NCT04634409|615860506|FG007|Overall Study|Death|0|||
170415444|NCT04634409|615860507|FG008|Overall Study|Death|0|||
170415445|NCT04634409|615860508|FG009|Overall Study|Death|0|||
170415446|NCT04634409|615860509|FG010|Overall Study|Death|1|||
170776434|NCT02178098|617187093|FG000|Overall Study|Adverse Event|1|||
170776435|NCT02178098|617187094|FG001|Overall Study|Adverse Event|2|||
170776436|NCT02178098|617187093|FG000|Overall Study|Protocol Violation|1|||
170776437|NCT02178098|617187094|FG001|Overall Study|Protocol Violation|1|||
170776438|NCT02178098|617187093|FG000|Overall Study|Lost to Follow-up|0|||
170776439|NCT02178098|617187094|FG001|Overall Study|Lost to Follow-up|1|||
170776440|NCT02178098|617187093|FG000|Overall Study|Sponsor Request|1|||
170876960|NCT01197521|617560437|FG000|Overall Study|Not reported|24|||
170876961|NCT01197521|617560438|FG001|Overall Study|Not reported|25|||
170876962|NCT01197521|617560439|FG002|Overall Study|Not reported|21|||
170776441|NCT02178098|617187094|FG001|Overall Study|Sponsor Request|0|||
170776442|NCT02178098|617187093|FG000|Overall Study|Other|2|||
170776443|NCT02178098|617187094|FG001|Overall Study|Other|2|||
170776444|NCT04992390|617187103|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
170776445|NCT04992390|617187104|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
170776446|NCT04992390|617187105|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
170776447|NCT04992390|617187103|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
170776448|NCT04992390|617187104|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
170776449|NCT04992390|617187105|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
170776450|NCT04992390|617187103|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
170776451|NCT04992390|617187104|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
170776452|NCT04992390|617187105|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
170776453|NCT04992390|617187103|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
170776454|NCT04992390|617187104|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
170776455|NCT04992390|617187105|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
170776456|NCT04992390|617187103|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
170776457|NCT04992390|617187104|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
170776458|NCT04992390|617187105|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
170776459|NCT04992390|617187103|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
170776460|NCT04992390|617187104|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
170776461|NCT04992390|617187105|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
170776462|NCT04992390|617187103|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
170776463|NCT04992390|617187104|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
170776464|NCT04992390|617187105|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
170776465|NCT04992390|617187103|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
170776466|NCT04992390|617187104|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
170876963|NCT01197521|617560437|FG000|Overall Study|Enrolment in long term extension|42|||
170876964|NCT01197521|617560438|FG001|Overall Study|Enrolment in long term extension|36|||
170415447|NCT04634409|615860510|FG011|Overall Study|Death|0|||
170415448|NCT04634409|615860511|FG012|Overall Study|Death|1|||
170415449|NCT04634409|615860512|FG013|Overall Study|Death|0|||
170776467|NCT04992390|617187105|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
170876965|NCT01197521|617560439|FG002|Overall Study|Enrolment in long term extension|87|||
170876966|NCT01197521|617560437|FG000|Overall Study|Severe non-compliance to protocol|1|||
170415450|NCT04634409|615860513|FG014|Overall Study|Death|0|||
170415451|NCT04634409|615860514|FG015|Overall Study|Death|0|||
170415452|NCT04634409|615860515|FG016|Overall Study|Death|0|||
170415453|NCT04634409|615860516|FG017|Overall Study|Death|0|||
170415454|NCT04634409|615860517|FG018|Overall Study|Death|0|||
170415455|NCT04634409|615860518|FG019|Overall Study|Death|0|||
170415456|NCT04634409|615860519|FG020|Overall Study|Death|0|||
170415457|NCT04634409|615860520|FG021|Overall Study|Death|0|||
170415458|NCT04634409|615860521|FG022|Overall Study|Death|0|||
170415459|NCT04634409|615860522|FG023|Overall Study|Death|0|||
170415460|NCT04634409|615860523|FG024|Overall Study|Death|0|||
170415461|NCT04634409|615860524|FG025|Overall Study|Death|0|||
170415462|NCT04634409|615860525|FG026|Overall Study|Death|0|||
170415463|NCT04634409|615860499|FG000|Overall Study|Adverse Event|0|||
170415464|NCT04634409|615860500|FG001|Overall Study|Adverse Event|0|||
170415465|NCT04634409|615860501|FG002|Overall Study|Adverse Event|1|||
170415466|NCT04634409|615860502|FG003|Overall Study|Adverse Event|0|||
170415467|NCT04634409|615860503|FG004|Overall Study|Adverse Event|0|||
170415468|NCT04634409|615860504|FG005|Overall Study|Adverse Event|1|||
170415469|NCT04634409|615860505|FG006|Overall Study|Adverse Event|0|||
170415470|NCT04634409|615860506|FG007|Overall Study|Adverse Event|0|||
170415471|NCT04634409|615860507|FG008|Overall Study|Adverse Event|0|||
170415472|NCT04634409|615860508|FG009|Overall Study|Adverse Event|0|||
170415473|NCT04634409|615860509|FG010|Overall Study|Adverse Event|0|||
170415474|NCT04634409|615860510|FG011|Overall Study|Adverse Event|0|||
170415475|NCT04634409|615860511|FG012|Overall Study|Adverse Event|0|||
170415476|NCT04634409|615860512|FG013|Overall Study|Adverse Event|0|||
170415477|NCT04634409|615860513|FG014|Overall Study|Adverse Event|0|||
170415478|NCT04634409|615860514|FG015|Overall Study|Adverse Event|0|||
170415479|NCT04634409|615860515|FG016|Overall Study|Adverse Event|0|||
170415480|NCT04634409|615860516|FG017|Overall Study|Adverse Event|0|||
170415481|NCT04634409|615860517|FG018|Overall Study|Adverse Event|0|||
170415482|NCT04634409|615860518|FG019|Overall Study|Adverse Event|0|||
170415483|NCT04634409|615860519|FG020|Overall Study|Adverse Event|0|||
170415484|NCT04634409|615860520|FG021|Overall Study|Adverse Event|0|||
170415485|NCT04634409|615860521|FG022|Overall Study|Adverse Event|0|||
170415486|NCT04634409|615860522|FG023|Overall Study|Adverse Event|0|||
170415487|NCT04634409|615860523|FG024|Overall Study|Adverse Event|0|||
170776468|NCT04992390|617187103|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
170776469|NCT04992390|617187104|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
170526922|NCT03736967|616279090|FG000|Overall Study|Randomized but never treated|1|||
170526923|NCT03736967|616279091|FG001|Overall Study|Randomized but never treated|0|||
170526924|NCT03736967|616279092|FG002|Overall Study|Randomized but never treated|0|||
170526925|NCT03736967|616279093|FG003|Overall Study|Randomized but never treated|0|||
170526926|NCT02369653|616279094|FG000|Overall Study|Lost to Follow-up|0|||
170526927|NCT02369653|616279095|FG001|Overall Study|Lost to Follow-up|1|||
170526928|NCT02369653|616279094|FG000|Overall Study|Administrative reason by sponsor|0|||
170526929|NCT02369653|616279095|FG001|Overall Study|Administrative reason by sponsor|1|||
170526930|NCT02369653|616279094|FG000|Overall Study|Death|1|||
170526931|NCT02369653|616279095|FG001|Overall Study|Death|2|||
170526932|NCT02369653|616279094|FG000|Overall Study|Participant withdrew consent|13|||
170526933|NCT02369653|616279095|FG001|Overall Study|Participant withdrew consent|3|||
170526934|NCT01458587|616279096|FG000|Overall Study|Withdrawal by Subject|1|||
170526935|NCT01458587|616279097|FG001|Overall Study|Withdrawal by Subject|0|||
170526936|NCT04748718|616279101|FG000|Overall Study|Lost to Follow-up|50|||
170526937|NCT00316004|616279102|FG000|Overall Study|Subject was not given study fluid.|14|||
170526938|NCT00316004|616279103|FG001|Overall Study|Subject was not given study fluid.|14|||
170526939|NCT00316004|616279104|FG002|Overall Study|Subject was not given study fluid.|21|||
170526940|NCT01118299|616279105|FG000|Overall Study|Death|7|||
170526941|NCT01118299|616279106|FG001|Overall Study|Death|5|||
170526942|NCT01118299|616279105|FG000|Overall Study|Withdrawal by Subject|8|||
170526943|NCT01118299|616279106|FG001|Overall Study|Withdrawal by Subject|8|||
170526944|NCT01118299|616279105|FG000|Overall Study|Lost to Follow-up|2|||
170526945|NCT01118299|616279106|FG001|Overall Study|Lost to Follow-up|1|||
170526946|NCT01118299|616279105|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
170526947|NCT01118299|616279106|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
170526948|NCT05379920|616279114|FG000|Overall Study|Lost to Follow-up|0|||
170526949|NCT05379920|616279115|FG001|Overall Study|Lost to Follow-up|5|||
170526950|NCT05379920|616279116|FG002|Overall Study|Lost to Follow-up|0|||
170526951|NCT05379920|616279117|FG003|Overall Study|Lost to Follow-up|0|||
170526952|NCT01004614|616279121|FG000|Washout|Withdrawal by Subject|0|||
170526953|NCT01004614|616279122|FG001|Washout|Withdrawal by Subject|1|||
170526954|NCT01004614|616279123|FG002|Washout|Withdrawal by Subject|0|||
170415488|NCT04634409|615860524|FG025|Overall Study|Adverse Event|0|||
170415489|NCT04634409|615860525|FG026|Overall Study|Adverse Event|0|||
170415490|NCT04634409|615860499|FG000|Overall Study|Lost to Follow-up|3|||
170415491|NCT04634409|615860500|FG001|Overall Study|Lost to Follow-up|1|||
170415492|NCT04634409|615860501|FG002|Overall Study|Lost to Follow-up|1|||
170415493|NCT04634409|615860502|FG003|Overall Study|Lost to Follow-up|3|||
170415494|NCT04634409|615860503|FG004|Overall Study|Lost to Follow-up|1|||
170415495|NCT04634409|615860504|FG005|Overall Study|Lost to Follow-up|1|||
170415496|NCT04634409|615860505|FG006|Overall Study|Lost to Follow-up|1|||
170415497|NCT04634409|615860506|FG007|Overall Study|Lost to Follow-up|3|||
170415498|NCT04634409|615860507|FG008|Overall Study|Lost to Follow-up|3|||
170415499|NCT04634409|615860508|FG009|Overall Study|Lost to Follow-up|11|||
170415500|NCT04634409|615860509|FG010|Overall Study|Lost to Follow-up|8|||
170415501|NCT04634409|615860510|FG011|Overall Study|Lost to Follow-up|15|||
170415502|NCT04634409|615860511|FG012|Overall Study|Lost to Follow-up|3|||
170415503|NCT04634409|615860512|FG013|Overall Study|Lost to Follow-up|2|||
170415504|NCT04634409|615860513|FG014|Overall Study|Lost to Follow-up|7|||
170415505|NCT04634409|615860514|FG015|Overall Study|Lost to Follow-up|0|||
170415506|NCT04634409|615860515|FG016|Overall Study|Lost to Follow-up|0|||
170415507|NCT04634409|615860516|FG017|Overall Study|Lost to Follow-up|0|||
170415508|NCT04634409|615860517|FG018|Overall Study|Lost to Follow-up|0|||
170415509|NCT04634409|615860518|FG019|Overall Study|Lost to Follow-up|0|||
170415510|NCT04634409|615860519|FG020|Overall Study|Lost to Follow-up|0|||
170415511|NCT04634409|615860520|FG021|Overall Study|Lost to Follow-up|0|||
170415512|NCT04634409|615860521|FG022|Overall Study|Lost to Follow-up|0|||
170415513|NCT04634409|615860522|FG023|Overall Study|Lost to Follow-up|0|||
170526955|NCT01004614|616279124|FG003|Washout|Withdrawal by Subject|0|||
170526956|NCT02530385|616279125|FG000|Overall Study|Withdrawal by Subject|0|||
170526957|NCT02530385|616279126|FG001|Overall Study|Withdrawal by Subject|1|||
170526958|NCT01569022|616279128|FG000|First Intervention|Lost to Follow-up|2|||
170526959|NCT01569022|616279129|FG001|First Intervention|Lost to Follow-up|1|||
170526960|NCT01569022|616279128|FG000|Second Intervention|Lost to Follow-up|2|||
170526961|NCT01569022|616279129|FG001|Second Intervention|Lost to Follow-up|2|||
170526962|NCT00116142|616279134|FG000|Overall Study|Adverse Event|8|||
170526963|NCT00116142|616279135|FG001|Overall Study|Adverse Event|7|||
170526964|NCT00116142|616279134|FG000|Overall Study|Protocol Violation|2|||
170526965|NCT00116142|616279135|FG001|Overall Study|Protocol Violation|1|||
170526966|NCT00116142|616279134|FG000|Overall Study|Withdrawal by Subject|5|||
170526967|NCT00116142|616279135|FG001|Overall Study|Withdrawal by Subject|5|||
170526968|NCT00116142|616279134|FG000|Overall Study|Physician Decision|3|||
170415514|NCT04634409|615860523|FG024|Overall Study|Lost to Follow-up|0|||
170415515|NCT04634409|615860524|FG025|Overall Study|Lost to Follow-up|0|||
170415516|NCT04634409|615860525|FG026|Overall Study|Lost to Follow-up|0|||
170415517|NCT04634409|615860499|FG000|Overall Study|Withdrawal by Subject|3|||
170415518|NCT04634409|615860500|FG001|Overall Study|Withdrawal by Subject|1|||
170876967|NCT01197521|617560438|FG001|Overall Study|Severe non-compliance to protocol|3|||
170876968|NCT01197521|617560439|FG002|Overall Study|Severe non-compliance to protocol|3|||
170876969|NCT01197521|617560437|FG000|Overall Study|Lack of therapeutic response|2|||
170876970|NCT01197521|617560438|FG001|Overall Study|Lack of therapeutic response|3|||
170876971|NCT01197521|617560439|FG002|Overall Study|Lack of therapeutic response|4|||
170876972|NCT01197521|617560437|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
170876973|NCT01197521|617560438|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
170876974|NCT01197521|617560439|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
170876975|NCT01197521|617560437|FG000|Overall Study|Lost to Follow-up|3|||
170876976|NCT01197521|617560438|FG001|Overall Study|Lost to Follow-up|2|||
170876977|NCT01197521|617560439|FG002|Overall Study|Lost to Follow-up|2|||
170876978|NCT01197521|617560437|FG000|Overall Study|Adverse Event|25|||
170876979|NCT01197521|617560438|FG001|Overall Study|Adverse Event|28|||
170876980|NCT01197521|617560439|FG002|Overall Study|Adverse Event|24|||
170876981|NCT01517893|617560440|FG000|Overall Study|Withdrawal by Subject|3|||
170876982|NCT01517893|617560441|FG001|Overall Study|Withdrawal by Subject|0|||
170876983|NCT01309659|617560442|FG000|Overall Study|Protocol Violation|0|||
170876984|NCT01309659|617560443|FG001|Overall Study|Protocol Violation|1|||
170876985|NCT03462576|617560444|FG000|Overall Study|Protocol Violation|5|||
170876986|NCT03462576|617560445|FG001|Overall Study|Protocol Violation|11|||
170876987|NCT03462576|617560446|FG002|Overall Study|Protocol Violation|7|||
170876988|NCT03462576|617560444|FG000|Overall Study|Device Malfunction|0|||
170876989|NCT03462576|617560445|FG001|Overall Study|Device Malfunction|0|||
170876990|NCT03462576|617560446|FG002|Overall Study|Device Malfunction|1|||
170876991|NCT02018822|617560447|FG000|Overall Study|filling replaced by crown|0|||
170876992|NCT02018822|617560448|FG001|Overall Study|filling replaced by crown|1|||
170876993|NCT02018822|617560449|FG002|Overall Study|filling replaced by crown|0|||
170876994|NCT02018822|617560447|FG000|Overall Study|Physician Decision|0|||
170876995|NCT02018822|617560448|FG001|Overall Study|Physician Decision|1|||
170876996|NCT02018822|617560449|FG002|Overall Study|Physician Decision|1|||
170876997|NCT02018822|617560447|FG000|Overall Study|Lost to Follow-up|6|||
170876998|NCT02018822|617560448|FG001|Overall Study|Lost to Follow-up|6|||
170876999|NCT02018822|617560449|FG002|Overall Study|Lost to Follow-up|5|||
170877000|NCT00715026|617560450|FG000|Overall Study|Withdrawal by Subject|5|||
170877001|NCT00715026|617560450|FG000|Overall Study|Lost to Follow-up|3|||
170877002|NCT00715026|617560450|FG000|Overall Study|Protocol Violation|1|||
170877003|NCT00715026|617560450|FG000|Overall Study|Surgery done on non-study consented hip|1|||
170877004|NCT04232553|617560456|FG000|Overall Study|Adverse Event|3|||
170877005|NCT04232553|617560457|FG001|Overall Study|Adverse Event|2|||
170877006|NCT04232553|617560458|FG002|Overall Study|Adverse Event|1|||
170877007|NCT04232553|617560459|FG003|Overall Study|Adverse Event|2|||
170415519|NCT04634409|615860501|FG002|Overall Study|Withdrawal by Subject|6|||
170415520|NCT04634409|615860502|FG003|Overall Study|Withdrawal by Subject|4|||
170415521|NCT04634409|615860503|FG004|Overall Study|Withdrawal by Subject|2|||
170415522|NCT04634409|615860504|FG005|Overall Study|Withdrawal by Subject|0|||
170415523|NCT04634409|615860505|FG006|Overall Study|Withdrawal by Subject|0|||
170415524|NCT04634409|615860506|FG007|Overall Study|Withdrawal by Subject|2|||
170415525|NCT04634409|615860507|FG008|Overall Study|Withdrawal by Subject|3|||
170415526|NCT04634409|615860508|FG009|Overall Study|Withdrawal by Subject|2|||
170415527|NCT04634409|615860509|FG010|Overall Study|Withdrawal by Subject|3|||
170415528|NCT04634409|615860510|FG011|Overall Study|Withdrawal by Subject|2|||
170415529|NCT04634409|615860511|FG012|Overall Study|Withdrawal by Subject|2|||
170415530|NCT04634409|615860512|FG013|Overall Study|Withdrawal by Subject|1|||
170415531|NCT04634409|615860513|FG014|Overall Study|Withdrawal by Subject|5|||
170415532|NCT04634409|615860514|FG015|Overall Study|Withdrawal by Subject|0|||
170415533|NCT04634409|615860515|FG016|Overall Study|Withdrawal by Subject|0|||
170415534|NCT04634409|615860516|FG017|Overall Study|Withdrawal by Subject|1|||
170415535|NCT04634409|615860517|FG018|Overall Study|Withdrawal by Subject|0|||
170415536|NCT04634409|615860518|FG019|Overall Study|Withdrawal by Subject|0|||
170415537|NCT04634409|615860519|FG020|Overall Study|Withdrawal by Subject|0|||
170415538|NCT04634409|615860520|FG021|Overall Study|Withdrawal by Subject|0|||
170415539|NCT04634409|615860521|FG022|Overall Study|Withdrawal by Subject|0|||
170415540|NCT04634409|615860522|FG023|Overall Study|Withdrawal by Subject|1|||
170415541|NCT04634409|615860523|FG024|Overall Study|Withdrawal by Subject|0|||
170877008|NCT04232553|617560460|FG004|Overall Study|Adverse Event|1|||
170877009|NCT04232553|617560461|FG005|Overall Study|Adverse Event|1|||
170877010|NCT04232553|617560462|FG006|Overall Study|Adverse Event|0|||
170877011|NCT04232553|617560463|FG007|Overall Study|Adverse Event|0|||
170877012|NCT04232553|617560464|FG008|Overall Study|Adverse Event|0|||
170877013|NCT04232553|617560456|FG000|Overall Study|Death|0|||
170877014|NCT04232553|617560457|FG001|Overall Study|Death|1|||
170877015|NCT04232553|617560458|FG002|Overall Study|Death|0|||
170877016|NCT04232553|617560459|FG003|Overall Study|Death|1|||
170877017|NCT04232553|617560460|FG004|Overall Study|Death|0|||
170415542|NCT04634409|615860524|FG025|Overall Study|Withdrawal by Subject|0|||
170877018|NCT04232553|617560461|FG005|Overall Study|Death|0|||
170877019|NCT04232553|617560462|FG006|Overall Study|Death|0|||
170526969|NCT00116142|616279135|FG001|Overall Study|Physician Decision|1|||
170526970|NCT00116142|616279134|FG000|Overall Study|Delayed Radiation Therapy|1|||
170526971|NCT00116142|616279135|FG001|Overall Study|Delayed Radiation Therapy|0|||
170526972|NCT00116142|616279134|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
170526973|NCT00116142|616279135|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
170526974|NCT00116142|616279134|FG000|Overall Study|Patient stopped due to depression|0|||
170526975|NCT00116142|616279135|FG001|Overall Study|Patient stopped due to depression|1|||
170526976|NCT00116142|616279134|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
170526977|NCT00116142|616279135|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
170526978|NCT00116142|616279134|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
170526979|NCT00116142|616279135|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
170526980|NCT00116142|616279134|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
170526981|NCT00116142|616279135|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
170526982|NCT00644059|616279136|FG000|Overall Study|Lost to Follow-up|37|||
170776470|NCT04992390|617187105|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
170776471|NCT04992390|617187103|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
170776472|NCT04992390|617187104|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
170776473|NCT04992390|617187105|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
170776474|NCT04992390|617187103|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
170776475|NCT04992390|617187104|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
170776476|NCT04992390|617187105|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
170776477|NCT04992390|617187103|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
170776478|NCT04992390|617187104|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
170776479|NCT04992390|617187105|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
170776480|NCT04992390|617187103|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
170776481|NCT04992390|617187104|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
170776482|NCT04992390|617187105|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
170776483|NCT04992390|617187103|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
170776484|NCT04992390|617187104|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
170776485|NCT04992390|617187105|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
170776486|NCT04992390|617187103|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
170776487|NCT04992390|617187104|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
170776488|NCT04992390|617187105|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
170776489|NCT04992390|617187103|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
170776490|NCT04992390|617187104|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
170776491|NCT04992390|617187105|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
170776492|NCT02769858|617187110|FG000|Overall Study|Withdrawal by Subject|2|||
170776493|NCT04939246|617187111|FG000|After Treatment|Death|4|||
170776494|NCT04939246|617187111|FG000|After Treatment|Lost to Follow-up|1|||
170776495|NCT04939246|617187111|FG000|After Treatment|Discharged to hospice|2|||
170776496|NCT04999085|617188642|FG000|Overall Study|Death|1|||
170776497|NCT04540913|617188661|FG000|Overall Study|Withdrawal by Subject|14|||
170776498|NCT04540913|617188662|FG001|Overall Study|Withdrawal by Subject|3|||
170776499|NCT05613205|617188663|FG000|Overall Study|Lost to Follow-up|0|||
170776500|NCT05613205|617188664|FG001|Overall Study|Lost to Follow-up|0|||
170776501|NCT05613205|617188665|FG002|Overall Study|Lost to Follow-up|1|||
170776502|NCT05613205|617188666|FG003|Overall Study|Lost to Follow-up|1|||
170776503|NCT05613205|617188667|FG004|Overall Study|Lost to Follow-up|0|||
170776504|NCT05613205|617188663|FG000|Overall Study|Withdrawal by Subject|0|||
170776505|NCT05613205|617188664|FG001|Overall Study|Withdrawal by Subject|0|||
170776506|NCT05613205|617188665|FG002|Overall Study|Withdrawal by Subject|1|||
170776507|NCT05613205|617188666|FG003|Overall Study|Withdrawal by Subject|1|||
170776508|NCT05613205|617188667|FG004|Overall Study|Withdrawal by Subject|0|||
170776509|NCT03602014|617188668|FG000|Overall Study|Lost to Follow-up|2|||
170776510|NCT03602014|617188669|FG001|Overall Study|Lost to Follow-up|0|||
170776511|NCT03602014|617188670|FG002|Overall Study|Lost to Follow-up|0|||
170776512|NCT03584516|617188676|FG000|Part 1|Death|2|||
170776513|NCT03584516|617188677|FG001|Part 1|Death|3|||
170776514|NCT03584516|617188678|FG002|Part 1|Death|0|||
170776515|NCT03584516|617188679|FG003|Part 1|Death|0|||
170877020|NCT04232553|617560463|FG007|Overall Study|Death|0|||
170526983|NCT00644059|616279137|FG001|Overall Study|Lost to Follow-up|34|||
170526984|NCT00644059|616279138|FG002|Overall Study|Lost to Follow-up|16|||
170526985|NCT00644059|616279136|FG000|Overall Study|Withdrawal by Subject|52|||
170526986|NCT00644059|616279137|FG001|Overall Study|Withdrawal by Subject|60|||
170776516|NCT03584516|617188680|FG004|Part 1|Death|0|||
170776517|NCT03584516|617188681|FG005|Part 1|Death|0|||
170776518|NCT03584516|617188676|FG000|Part 1|Withdrawal by Subject|2|||
170776519|NCT03584516|617188677|FG001|Part 1|Withdrawal by Subject|0|||
170776520|NCT03584516|617188678|FG002|Part 1|Withdrawal by Subject|0|||
170776521|NCT03584516|617188679|FG003|Part 1|Withdrawal by Subject|0|||
170776522|NCT03584516|617188680|FG004|Part 1|Withdrawal by Subject|0|||
170526987|NCT00644059|616279138|FG002|Overall Study|Withdrawal by Subject|30|||
170526988|NCT00644059|616279136|FG000|Overall Study|Adverse Event|8|||
170526989|NCT00644059|616279137|FG001|Overall Study|Adverse Event|5|||
170526990|NCT00644059|616279138|FG002|Overall Study|Adverse Event|1|||
170526991|NCT00644059|616279136|FG000|Overall Study|Inappropriate Enrollment|1|||
170526992|NCT00644059|616279137|FG001|Overall Study|Inappropriate Enrollment|3|||
170526993|NCT00644059|616279138|FG002|Overall Study|Inappropriate Enrollment|0|||
170526994|NCT00644059|616279136|FG000|Overall Study|Protocol Deviation/violation|20|||
170526995|NCT00644059|616279137|FG001|Overall Study|Protocol Deviation/violation|19|||
170526996|NCT00644059|616279138|FG002|Overall Study|Protocol Deviation/violation|15|||
170526997|NCT00644059|616279136|FG000|Overall Study|Unable to classify|6|||
170526998|NCT00644059|616279137|FG001|Overall Study|Unable to classify|2|||
170526999|NCT00644059|616279138|FG002|Overall Study|Unable to classify|3|||
170527000|NCT02133508|616279139|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
170527001|NCT02133508|616279139|FG000|Overall Study|Death|12|||
170527002|NCT02133508|616279139|FG000|Overall Study|Lost to Follow-up|2|||
170527003|NCT01302899|616279144|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
170527004|NCT01302899|616279145|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
170527005|NCT01302899|616279144|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
170527006|NCT01302899|616279145|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
170527007|NCT03451071|616279146|FG000|First Vaccine|Withdrawal by Subject|1|||
170527008|NCT03451071|616279146|FG000|Second Vaccine|Lost to Follow-up|19|||
170527009|NCT03451071|616279146|FG000|Third Vaccine|Lost to Follow-up|22|||
170527010|NCT03451071|616279146|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
170527011|NCT03482024|616279148|FG000|Overall Study|Physician Decision|1|||
170527012|NCT03482024|616279149|FG001|Overall Study|Physician Decision|0|||
170527013|NCT03482024|616279150|FG002|Overall Study|Physician Decision|0|||
170527014|NCT03482024|616279151|FG003|Overall Study|Physician Decision|0|||
170527015|NCT03482024|616279152|FG004|Overall Study|Physician Decision|0|||
170527016|NCT02497469|616279153|FG000|Overall Study|Randomized but not Treated|0|||
170527017|NCT02497469|616279154|FG001|Overall Study|Randomized but not Treated|2|||
170527018|NCT02497469|616279153|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
170527019|NCT02497469|616279154|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
170527020|NCT02497469|616279153|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
170527021|NCT02497469|616279154|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
170527022|NCT02497469|616279153|FG000|Overall Study|Significant Protocol Deviation|4|||
170527023|NCT02497469|616279154|FG001|Overall Study|Significant Protocol Deviation|5|||
170527024|NCT02497469|616279153|FG000|Overall Study|Lost to Follow-up|14|||
170527025|NCT02497469|616279154|FG001|Overall Study|Lost to Follow-up|4|||
170527026|NCT02497469|616279153|FG000|Overall Study|Voluntary Withdrawal|39|||
170527027|NCT02497469|616279154|FG001|Overall Study|Voluntary Withdrawal|41|||
170527028|NCT02497469|616279153|FG000|Overall Study|Pregnancy|1|||
170527029|NCT02497469|616279154|FG001|Overall Study|Pregnancy|1|||
170527030|NCT02497469|616279153|FG000|Overall Study|Lack of Efficacy|86|||
170527031|NCT02497469|616279154|FG001|Overall Study|Lack of Efficacy|40|||
170527032|NCT02497469|616279153|FG000|Overall Study|Reason not Specified|6|||
170527033|NCT02497469|616279154|FG001|Overall Study|Reason not Specified|6|||
170527034|NCT03558516|616279159|FG000|Overall Study|Protocol Violation|2|||
170527035|NCT03558516|616279160|FG001|Overall Study|Protocol Violation|2|||
170527036|NCT02714153|616279161|FG000|Overall Study|Death|1|||
170527037|NCT00686972|616279162|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
170527038|NCT01901185|616279163|FG000|Overall Study|Withdrawal by Subject|2|||
170527039|NCT02065557|616279164|FG000|Induction Period|Withdrawal by Subject|2|||
170527040|NCT02065557|616279165|FG001|Induction Period|Withdrawal by Subject|1|||
170527041|NCT02065557|616279166|FG002|Induction Period|Withdrawal by Subject|0|||
170527042|NCT02065557|616279167|FG003|Induction Period|Withdrawal by Subject|0|||
170527043|NCT02065557|616279168|FG004|Induction Period|Withdrawal by Subject|0|||
170527044|NCT02065557|616279169|FG005|Induction Period|Withdrawal by Subject|0|||
170527045|NCT02065557|616279164|FG000|Induction Period|Lack of Efficacy|2|||
170527046|NCT02065557|616279165|FG001|Induction Period|Lack of Efficacy|1|||
170527047|NCT02065557|616279166|FG002|Induction Period|Lack of Efficacy|1|||
170527048|NCT02065557|616279167|FG003|Induction Period|Lack of Efficacy|0|||
170527049|NCT02065557|616279168|FG004|Induction Period|Lack of Efficacy|0|||
170527050|NCT02065557|616279169|FG005|Induction Period|Lack of Efficacy|0|||
170527051|NCT02065557|616279164|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
170527052|NCT02065557|616279165|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
170527053|NCT02065557|616279166|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
170527054|NCT02065557|616279167|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
170527055|NCT02065557|616279168|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
170527056|NCT02065557|616279169|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
170527057|NCT02065557|616279164|FG000|Induction Period|Non-Responder at Week 8|4|||
170527058|NCT02065557|616279165|FG001|Induction Period|Non-Responder at Week 8|4|||
170527059|NCT02065557|616279166|FG002|Induction Period|Non-Responder at Week 8|0|||
170527060|NCT02065557|616279167|FG003|Induction Period|Non-Responder at Week 8|0|||
170527061|NCT02065557|616279168|FG004|Induction Period|Non-Responder at Week 8|0|||
170632598|NCT02420821|616666704|FG001|Overall Study|Protinuria|1|||
170877021|NCT04232553|617560464|FG008|Overall Study|Death|0|||
170415543|NCT04634409|615860525|FG026|Overall Study|Withdrawal by Subject|0|||
170415544|NCT04634409|615860499|FG000|Overall Study|Other - As reported by Investigator|1|||
170415545|NCT04634409|615860500|FG001|Overall Study|Other - As reported by Investigator|0|||
170877022|NCT04232553|617560456|FG000|Overall Study|Lack of Efficacy|0|||
170415546|NCT04634409|615860501|FG002|Overall Study|Other - As reported by Investigator|0|||
170415547|NCT04634409|615860502|FG003|Overall Study|Other - As reported by Investigator|0|||
170415548|NCT04634409|615860503|FG004|Overall Study|Other - As reported by Investigator|0|||
170415549|NCT04634409|615860504|FG005|Overall Study|Other - As reported by Investigator|0|||
170415550|NCT04634409|615860505|FG006|Overall Study|Other - As reported by Investigator|0|||
170415551|NCT04634409|615860506|FG007|Overall Study|Other - As reported by Investigator|6|||
170415552|NCT04634409|615860507|FG008|Overall Study|Other - As reported by Investigator|4|||
170415553|NCT04634409|615860508|FG009|Overall Study|Other - As reported by Investigator|0|||
170415554|NCT04634409|615860509|FG010|Overall Study|Other - As reported by Investigator|1|||
170415555|NCT04634409|615860510|FG011|Overall Study|Other - As reported by Investigator|2|||
170415556|NCT04634409|615860511|FG012|Overall Study|Other - As reported by Investigator|2|||
170415557|NCT04634409|615860512|FG013|Overall Study|Other - As reported by Investigator|1|||
170415558|NCT04634409|615860513|FG014|Overall Study|Other - As reported by Investigator|0|||
170415559|NCT04634409|615860514|FG015|Overall Study|Other - As reported by Investigator|0|||
170415560|NCT04634409|615860515|FG016|Overall Study|Other - As reported by Investigator|0|||
170415561|NCT04634409|615860516|FG017|Overall Study|Other - As reported by Investigator|0|||
170527062|NCT02065557|616279169|FG005|Induction Period|Non-Responder at Week 8|0|||
170527063|NCT02065557|616279164|FG000|Induction Period|Adverse Event|1|||
170877023|NCT04232553|617560457|FG001|Overall Study|Lack of Efficacy|2|||
170877024|NCT04232553|617560458|FG002|Overall Study|Lack of Efficacy|0|||
170877025|NCT04232553|617560459|FG003|Overall Study|Lack of Efficacy|0|||
170877026|NCT04232553|617560460|FG004|Overall Study|Lack of Efficacy|0|||
170877027|NCT04232553|617560461|FG005|Overall Study|Lack of Efficacy|0|||
170877028|NCT04232553|617560462|FG006|Overall Study|Lack of Efficacy|0|||
170877029|NCT04232553|617560463|FG007|Overall Study|Lack of Efficacy|0|||
170877030|NCT04232553|617560464|FG008|Overall Study|Lack of Efficacy|1|||
170877031|NCT04232553|617560456|FG000|Overall Study|Lost to Follow-up|0|||
170877032|NCT04232553|617560457|FG001|Overall Study|Lost to Follow-up|1|||
170877033|NCT04232553|617560458|FG002|Overall Study|Lost to Follow-up|0|||
170877034|NCT04232553|617560459|FG003|Overall Study|Lost to Follow-up|0|||
170877035|NCT04232553|617560460|FG004|Overall Study|Lost to Follow-up|1|||
170877036|NCT04232553|617560461|FG005|Overall Study|Lost to Follow-up|0|||
170877037|NCT04232553|617560462|FG006|Overall Study|Lost to Follow-up|0|||
170877038|NCT04232553|617560463|FG007|Overall Study|Lost to Follow-up|0|||
170877039|NCT04232553|617560464|FG008|Overall Study|Lost to Follow-up|1|||
170877040|NCT04232553|617560456|FG000|Overall Study|Other - As reported by the investigator|0|||
170877041|NCT04232553|617560457|FG001|Overall Study|Other - As reported by the investigator|1|||
170877042|NCT04232553|617560458|FG002|Overall Study|Other - As reported by the investigator|0|||
170877043|NCT04232553|617560459|FG003|Overall Study|Other - As reported by the investigator|0|||
170877044|NCT04232553|617560460|FG004|Overall Study|Other - As reported by the investigator|0|||
170877045|NCT04232553|617560461|FG005|Overall Study|Other - As reported by the investigator|0|||
170877046|NCT04232553|617560462|FG006|Overall Study|Other - As reported by the investigator|0|||
170877047|NCT04232553|617560463|FG007|Overall Study|Other - As reported by the investigator|0|||
170877048|NCT04232553|617560464|FG008|Overall Study|Other - As reported by the investigator|0|||
170877049|NCT04232553|617560456|FG000|Overall Study|Physician Decision|1|||
170877050|NCT04232553|617560457|FG001|Overall Study|Physician Decision|1|||
170877051|NCT04232553|617560458|FG002|Overall Study|Physician Decision|0|||
170877052|NCT04232553|617560459|FG003|Overall Study|Physician Decision|0|||
170877053|NCT04232553|617560460|FG004|Overall Study|Physician Decision|1|||
170877054|NCT04232553|617560461|FG005|Overall Study|Physician Decision|0|||
170877055|NCT04232553|617560462|FG006|Overall Study|Physician Decision|0|||
170877056|NCT04232553|617560463|FG007|Overall Study|Physician Decision|0|||
170877057|NCT04232553|617560464|FG008|Overall Study|Physician Decision|0|||
170877058|NCT04232553|617560456|FG000|Overall Study|Pregnancy|1|||
170877059|NCT04232553|617560457|FG001|Overall Study|Pregnancy|0|||
170415562|NCT04634409|615860517|FG018|Overall Study|Other - As reported by Investigator|0|||
170415563|NCT04634409|615860518|FG019|Overall Study|Other - As reported by Investigator|0|||
170415564|NCT04634409|615860519|FG020|Overall Study|Other - As reported by Investigator|0|||
170415565|NCT04634409|615860520|FG021|Overall Study|Other - As reported by Investigator|0|||
170527064|NCT02065557|616279165|FG001|Induction Period|Adverse Event|1|||
170877060|NCT04232553|617560458|FG002|Overall Study|Pregnancy|0|||
170877061|NCT04232553|617560459|FG003|Overall Study|Pregnancy|0|||
170877062|NCT04232553|617560460|FG004|Overall Study|Pregnancy|0|||
170877063|NCT04232553|617560461|FG005|Overall Study|Pregnancy|0|||
170877064|NCT04232553|617560462|FG006|Overall Study|Pregnancy|0|||
170877065|NCT04232553|617560463|FG007|Overall Study|Pregnancy|0|||
170877066|NCT04232553|617560464|FG008|Overall Study|Pregnancy|0|||
170877067|NCT04232553|617560456|FG000|Overall Study|Withdrawal by Subject|7|||
170877068|NCT04232553|617560457|FG001|Overall Study|Withdrawal by Subject|5|||
170877069|NCT04232553|617560458|FG002|Overall Study|Withdrawal by Subject|0|||
170877070|NCT04232553|617560459|FG003|Overall Study|Withdrawal by Subject|0|||
170776523|NCT03584516|617188681|FG005|Part 1|Withdrawal by Subject|0|||
170776524|NCT03584516|617188676|FG000|Part 1|Lost to Follow-up|1|||
170776525|NCT03584516|617188677|FG001|Part 1|Lost to Follow-up|0|||
170776526|NCT03584516|617188678|FG002|Part 1|Lost to Follow-up|0|||
170776527|NCT03584516|617188679|FG003|Part 1|Lost to Follow-up|0|||
170776528|NCT03584516|617188680|FG004|Part 1|Lost to Follow-up|0|||
170415566|NCT04634409|615860521|FG022|Overall Study|Other - As reported by Investigator|0|||
170415567|NCT04634409|615860522|FG023|Overall Study|Other - As reported by Investigator|0|||
170415568|NCT04634409|615860523|FG024|Overall Study|Other - As reported by Investigator|0|||
170415569|NCT04634409|615860524|FG025|Overall Study|Other - As reported by Investigator|0|||
170415570|NCT04634409|615860525|FG026|Overall Study|Other - As reported by Investigator|0|||
170415571|NCT03708211|615860526|FG000|Overall Study|Progressive Disease|10|||
170415572|NCT03708211|615860527|FG001|Overall Study|Progressive Disease|7|||
170415573|NCT03708211|615860526|FG000|Overall Study|Withdrawal by Subject|0|||
170415574|NCT03708211|615860527|FG001|Overall Study|Withdrawal by Subject|1|||
170415575|NCT03708211|615860526|FG000|Overall Study|Other|2|||
170415576|NCT03708211|615860527|FG001|Overall Study|Other|0|||
170415577|NCT00462982|615860538|FG000|Overall Study|Adverse Event|1|||
170415578|NCT00462982|615860538|FG000|Overall Study|Patient Not Treated|2|||
170415579|NCT04849988|615862007|FG000|Overall Study|Lack of Efficacy|3|||
170415580|NCT04849988|615862008|FG001|Overall Study|Lack of Efficacy|4|||
170415581|NCT04849988|615862009|FG002|Overall Study|Lack of Efficacy|1|||
170415582|NCT04849988|615862010|FG003|Overall Study|Lack of Efficacy|4|||
170415583|NCT04849988|615862007|FG000|Overall Study|Other reasons|1|||
170415584|NCT04849988|615862008|FG001|Overall Study|Other reasons|2|||
170415585|NCT04849988|615862009|FG002|Overall Study|Other reasons|2|||
170415586|NCT04849988|615862010|FG003|Overall Study|Other reasons|1|||
170415587|NCT03471078|615862011|FG000|Overall Study|Withdrawal by Subject|9|||
170415588|NCT03471078|615862012|FG001|Overall Study|Withdrawal by Subject|1|||
170415589|NCT03471078|615862011|FG000|Overall Study|Adverse Event|4|||
170415590|NCT03471078|615862012|FG001|Overall Study|Adverse Event|1|||
170415591|NCT03471078|615862011|FG000|Overall Study|Physician Decision|3|||
170415592|NCT03471078|615862012|FG001|Overall Study|Physician Decision|2|||
170415593|NCT03471078|615862011|FG000|Overall Study|Death|2|||
170415594|NCT03471078|615862012|FG001|Overall Study|Death|0|||
170415595|NCT03471078|615862011|FG000|Overall Study|Other|3|||
170415596|NCT03471078|615862012|FG001|Overall Study|Other|2|||
170415597|NCT02473640|615862022|FG000|Treatment Period 1|Adverse Event|1|||
170415598|NCT02710123|615862029|FG000|Overall Study|Lost to Follow-up|3|||
170415599|NCT02710123|615862030|FG001|Overall Study|Lost to Follow-up|4|||
170415600|NCT02710123|615862029|FG000|Overall Study|Withdrawal by Subject|1|||
170415601|NCT02710123|615862030|FG001|Overall Study|Withdrawal by Subject|1|||
170415602|NCT02710123|615862029|FG000|Overall Study|Illness unrelated to study intervention|1|||
170415603|NCT02710123|615862030|FG001|Overall Study|Illness unrelated to study intervention|0|||
170415604|NCT05381948|615862031|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
170415605|NCT05381948|615862032|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
170415606|NCT05381948|615862033|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
170415607|NCT05381948|615862031|FG000|Overall Study|Adverse Event: Non-ocular|0|||
170415608|NCT05381948|615862032|FG001|Overall Study|Adverse Event: Non-ocular|1|||
170415609|NCT05381948|615862033|FG002|Overall Study|Adverse Event: Non-ocular|0|||
170415610|NCT05381948|615862031|FG000|Overall Study|Lost to Follow-up|1|||
170415611|NCT05381948|615862032|FG001|Overall Study|Lost to Follow-up|0|||
170415612|NCT05381948|615862033|FG002|Overall Study|Lost to Follow-up|0|||
170415613|NCT05381948|615862031|FG000|Overall Study|Protocol Deviation|0|||
170415614|NCT05381948|615862032|FG001|Overall Study|Protocol Deviation|2|||
170415615|NCT05381948|615862033|FG002|Overall Study|Protocol Deviation|0|||
170415616|NCT05381948|615862031|FG000|Overall Study|Withdrawal by Subject|1|||
170415617|NCT05381948|615862032|FG001|Overall Study|Withdrawal by Subject|0|||
170415618|NCT05381948|615862033|FG002|Overall Study|Withdrawal by Subject|1|||
170415619|NCT05381948|615862031|FG000|Overall Study|Death|0|||
170415620|NCT05381948|615862032|FG001|Overall Study|Death|2|||
170415621|NCT05381948|615862033|FG002|Overall Study|Death|0|||
170415622|NCT05381948|615862031|FG000|Overall Study|Discontinued study without receiving study drug|0|||
170415623|NCT05381948|615862032|FG001|Overall Study|Discontinued study without receiving study drug|0|||
170415624|NCT05381948|615862033|FG002|Overall Study|Discontinued study without receiving study drug|1|||
170415625|NCT04471207|615862034|FG000|Overall Study|Lost to Follow-up|4|||
170415626|NCT04471207|615862035|FG001|Overall Study|Lost to Follow-up|1|||
170776529|NCT03584516|617188681|FG005|Part 1|Lost to Follow-up|0|||
170776530|NCT03584516|617188676|FG000|Part 1|Study Terminated by Sponsor|0|||
170415627|NCT04471207|615862034|FG000|Overall Study|Medication Contraindication|0|||
170415628|NCT04471207|615862035|FG001|Overall Study|Medication Contraindication|1|||
170415629|NCT04471207|615862034|FG000|Overall Study|Loss of Interest|2|||
170415630|NCT04471207|615862035|FG001|Overall Study|Loss of Interest|1|||
170415631|NCT04471207|615862034|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
170415632|NCT04471207|615862035|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
170776531|NCT03584516|617188677|FG001|Part 1|Study Terminated by Sponsor|2|||
170415633|NCT04471207|615862034|FG000|Overall Study|Scheduling Conflicts|3|||
170415634|NCT04471207|615862035|FG001|Overall Study|Scheduling Conflicts|1|||
170527065|NCT02065557|616279166|FG002|Induction Period|Adverse Event|0|||
170527066|NCT02065557|616279167|FG003|Induction Period|Adverse Event|0|||
170527067|NCT02065557|616279168|FG004|Induction Period|Adverse Event|0|||
170527068|NCT02065557|616279169|FG005|Induction Period|Adverse Event|0|||
170527069|NCT02065557|616279164|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
170527070|NCT02065557|616279165|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
170527071|NCT02065557|616279166|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
170527072|NCT02065557|616279167|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
170527073|NCT02065557|616279168|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
170527074|NCT02065557|616279169|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
170527075|NCT02065557|616279164|FG000|Maintenance Period|Withdrawal by Subject|0|||
170527076|NCT02065557|616279165|FG001|Maintenance Period|Withdrawal by Subject|0|||
170527077|NCT02065557|616279166|FG002|Maintenance Period|Withdrawal by Subject|0|||
170527078|NCT02065557|616279167|FG003|Maintenance Period|Withdrawal by Subject|0|||
170527079|NCT02065557|616279168|FG004|Maintenance Period|Withdrawal by Subject|2|||
170527080|NCT02065557|616279169|FG005|Maintenance Period|Withdrawal by Subject|1|||
170527081|NCT02065557|616279164|FG000|Maintenance Period|Lack of Efficacy|0|||
170527082|NCT02065557|616279165|FG001|Maintenance Period|Lack of Efficacy|0|||
170527083|NCT02065557|616279166|FG002|Maintenance Period|Lack of Efficacy|0|||
170527084|NCT02065557|616279167|FG003|Maintenance Period|Lack of Efficacy|0|||
170527085|NCT02065557|616279168|FG004|Maintenance Period|Lack of Efficacy|5|||
170527086|NCT02065557|616279169|FG005|Maintenance Period|Lack of Efficacy|2|||
170527087|NCT02065557|616279164|FG000|Maintenance Period|Subject Non-Compliance|0|||
170527088|NCT02065557|616279165|FG001|Maintenance Period|Subject Non-Compliance|0|||
170527089|NCT02065557|616279166|FG002|Maintenance Period|Subject Non-Compliance|0|||
170527090|NCT02065557|616279167|FG003|Maintenance Period|Subject Non-Compliance|0|||
170527091|NCT02065557|616279168|FG004|Maintenance Period|Subject Non-Compliance|0|||
170527092|NCT02065557|616279169|FG005|Maintenance Period|Subject Non-Compliance|1|||
170527093|NCT01462942|616279170|FG000|Overall Study|Adverse Event|7|||
170527094|NCT01462942|616279171|FG001|Overall Study|Adverse Event|12|||
170527095|NCT01462942|616279172|FG002|Overall Study|Adverse Event|10|||
170527096|NCT01462942|616279173|FG003|Overall Study|Adverse Event|11|||
170527097|NCT01462942|616279174|FG004|Overall Study|Adverse Event|11|||
170527098|NCT01462942|616279170|FG000|Overall Study|Other, including COPD exacerbation|3|||
170527099|NCT01462942|616279171|FG001|Overall Study|Other, including COPD exacerbation|5|||
170527100|NCT01462942|616279172|FG002|Overall Study|Other, including COPD exacerbation|2|||
170527101|NCT01462942|616279173|FG003|Overall Study|Other, including COPD exacerbation|8|||
170527102|NCT01462942|616279174|FG004|Overall Study|Other, including COPD exacerbation|5|||
170527103|NCT01462942|616279170|FG000|Overall Study|Withdrawal by Subject|14|||
170527104|NCT01462942|616279171|FG001|Overall Study|Withdrawal by Subject|10|||
170527105|NCT01462942|616279172|FG002|Overall Study|Withdrawal by Subject|14|||
170527106|NCT01462942|616279173|FG003|Overall Study|Withdrawal by Subject|16|||
170527107|NCT01462942|616279174|FG004|Overall Study|Withdrawal by Subject|19|||
170527108|NCT01462942|616279170|FG000|Overall Study|Lack of Efficacy|6|||
170527109|NCT01462942|616279171|FG001|Overall Study|Lack of Efficacy|0|||
170527110|NCT01462942|616279172|FG002|Overall Study|Lack of Efficacy|4|||
170527111|NCT01462942|616279173|FG003|Overall Study|Lack of Efficacy|5|||
170527112|NCT01462942|616279174|FG004|Overall Study|Lack of Efficacy|3|||
170527113|NCT01462942|616279170|FG000|Overall Study|Lost to Follow-up|0|||
170527114|NCT01462942|616279171|FG001|Overall Study|Lost to Follow-up|1|||
170527115|NCT01462942|616279172|FG002|Overall Study|Lost to Follow-up|1|||
170527116|NCT01462942|616279173|FG003|Overall Study|Lost to Follow-up|1|||
170527117|NCT01462942|616279174|FG004|Overall Study|Lost to Follow-up|1|||
170527118|NCT01462942|616279170|FG000|Overall Study|Protocol Violation|4|||
170527119|NCT01462942|616279171|FG001|Overall Study|Protocol Violation|6|||
170527120|NCT01462942|616279172|FG002|Overall Study|Protocol Violation|9|||
170527121|NCT01462942|616279173|FG003|Overall Study|Protocol Violation|9|||
170527122|NCT01462942|616279174|FG004|Overall Study|Protocol Violation|6|||
170527123|NCT04465422|616279190|FG000|Overall Study|Lost to Follow-up|0|||
170527124|NCT04465422|616279191|FG001|Overall Study|Lost to Follow-up|2|||
170527125|NCT04467515|616279197|FG000|Overall Study|Lost to Follow-up|1|||
170877071|NCT04232553|617560460|FG004|Overall Study|Withdrawal by Subject|2|||
170877072|NCT04232553|617560461|FG005|Overall Study|Withdrawal by Subject|2|||
170527126|NCT04467515|616279198|FG001|Overall Study|Lost to Follow-up|0|||
170527127|NCT04467515|616279199|FG002|Overall Study|Lost to Follow-up|0|||
170527128|NCT04467515|616279197|FG000|Overall Study|Withdrawal by Subject|1|||
170527129|NCT04467515|616279198|FG001|Overall Study|Withdrawal by Subject|0|||
170527130|NCT04467515|616279199|FG002|Overall Study|Withdrawal by Subject|1|||
170527131|NCT04467515|616279197|FG000|Overall Study|Progressive Disease|0|||
170527132|NCT04467515|616279198|FG001|Overall Study|Progressive Disease|1|||
170527133|NCT04467515|616279199|FG002|Overall Study|Progressive Disease|3|||
170527134|NCT04467515|616279197|FG000|Overall Study|Death|0|||
170527135|NCT04467515|616279198|FG001|Overall Study|Death|1|||
170527136|NCT04467515|616279199|FG002|Overall Study|Death|0|||
170527137|NCT01419314|616279201|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
170527138|NCT01419314|616279202|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
170527139|NCT01419314|616279201|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
170527140|NCT01419314|616279202|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
170527141|NCT01419314|616279201|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
170527142|NCT01419314|616279202|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
170527143|NCT00449163|616279203|FG000|Overall Study|Physician Decision|3|||
170527144|NCT03368807|616279204|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
170527145|NCT03368807|616279204|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
170527146|NCT03368807|616279204|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
170527147|NCT03368807|616279204|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
170527148|NCT01118052|616279205|FG000|Overall Study|Never treated|2|||
170527149|NCT00843492|616279207|FG000|Overall Study|Adverse Event|0|||
170527150|NCT00843492|616279208|FG001|Overall Study|Adverse Event|3|||
170527151|NCT00843492|616279207|FG000|Overall Study|Lost to Follow-up|4|||
170527152|NCT00843492|616279208|FG001|Overall Study|Lost to Follow-up|4|||
170527153|NCT00843492|616279207|FG000|Overall Study|Withdrawal by Subject|0|||
170527154|NCT00843492|616279208|FG001|Overall Study|Withdrawal by Subject|4|||
170527155|NCT00843492|616279207|FG000|Overall Study|Immobilization Stopped|1|||
170527156|NCT00843492|616279208|FG001|Overall Study|Immobilization Stopped|0|||
170527157|NCT00843492|616279207|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
170527158|NCT00843492|616279208|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
170527159|NCT00843492|616279207|FG000|Overall Study|Orthopedic Surgery|0|||
170527160|NCT00843492|616279208|FG001|Overall Study|Orthopedic Surgery|2|||
170527161|NCT00843492|616279207|FG000|Overall Study|Visit Not Performed|1|||
170527162|NCT00843492|616279208|FG001|Overall Study|Visit Not Performed|0|||
170527163|NCT00843492|616279207|FG000|Overall Study|Deep-vein Thrombosis|1|||
170527164|NCT00843492|616279208|FG001|Overall Study|Deep-vein Thrombosis|0|||
170527165|NCT00794664|616279209|FG000|Treatment Period|Withdrawal by Subject|0|||
170527166|NCT00794664|616279210|FG001|Treatment Period|Withdrawal by Subject|2|||
170527167|NCT00794664|616279209|FG000|Treatment Period|Protocol non-compliance|0|||
170527168|NCT00794664|616279210|FG001|Treatment Period|Protocol non-compliance|1|||
170527169|NCT00794664|616279209|FG000|Treatment Period|Other|0|||
170527170|NCT00794664|616279210|FG001|Treatment Period|Other|1|||
170527171|NCT00794664|616279209|FG000|Treatment Period|Adverse Event|1|||
170527172|NCT00794664|616279210|FG001|Treatment Period|Adverse Event|8|||
170527173|NCT00794664|616279209|FG000|Follow-up Period|Other|1|||
170527174|NCT00794664|616279210|FG001|Follow-up Period|Other|2|||
170527175|NCT00794664|616279209|FG000|Follow-up Period|Withdrawal by Subject|0|||
170527176|NCT00794664|616279210|FG001|Follow-up Period|Withdrawal by Subject|2|||
170527177|NCT00794664|616279209|FG000|Follow-up Period|Protocol non-compliance|0|||
170527178|NCT00794664|616279210|FG001|Follow-up Period|Protocol non-compliance|1|||
170527179|NCT02557399|616279215|FG000|Overall Study|Adverse Event|6|||
170527180|NCT02557399|616279216|FG001|Overall Study|Adverse Event|5|||
170527181|NCT02557399|616279215|FG000|Overall Study|Protocol Violation|0|||
170527182|NCT02557399|616279216|FG001|Overall Study|Protocol Violation|1|||
170527183|NCT02557399|616279215|FG000|Overall Study|Protocol-defined stopping criteria|0|||
170527184|NCT02557399|616279216|FG001|Overall Study|Protocol-defined stopping criteria|1|||
170527185|NCT02557399|616279215|FG000|Overall Study|Withdrawal by Subject|1|||
170527186|NCT02557399|616279216|FG001|Overall Study|Withdrawal by Subject|1|||
170527187|NCT00960804|616279217|FG000|Overall Study|Adverse Event|1|||
170527188|NCT00960804|616279218|FG001|Overall Study|Adverse Event|0|||
170527189|NCT00960804|616279219|FG002|Overall Study|Adverse Event|0|||
170527190|NCT00960804|616279217|FG000|Overall Study|Withdrawal by Subject|1|||
170527191|NCT00960804|616279218|FG001|Overall Study|Withdrawal by Subject|0|||
170527192|NCT00960804|616279219|FG002|Overall Study|Withdrawal by Subject|0|||
170527193|NCT00960804|616279217|FG000|Overall Study|Study terminated by the sponsor|5|||
170527194|NCT00960804|616279218|FG001|Overall Study|Study terminated by the sponsor|4|||
170527195|NCT00960804|616279219|FG002|Overall Study|Study terminated by the sponsor|10|||
170527196|NCT02007720|616279220|FG000|Overall Study|Withdrawal by Subject|9|||
170527197|NCT02007720|616279221|FG001|Overall Study|Withdrawal by Subject|11|||
170527198|NCT02007720|616279220|FG000|Overall Study|study terminated by sponsor|58|||
170527199|NCT02007720|616279221|FG001|Overall Study|study terminated by sponsor|54|||
170527200|NCT02007720|616279220|FG000|Overall Study|technical problem|4|||
170527201|NCT02007720|616279221|FG001|Overall Study|technical problem|2|||
170527202|NCT02007720|616279220|FG000|Overall Study|patient followd less than 165 days|11|||
170527203|NCT02007720|616279221|FG001|Overall Study|patient followd less than 165 days|5|||
170527204|NCT03810456|616279223|FG000|Treatment|Urgent Family Matters|3|||
170527205|NCT03810456|616279224|FG001|Treatment|Urgent Family Matters|0|||
170527206|NCT03810456|616279225|FG002|Treatment|Urgent Family Matters|0|||
170527207|NCT03810456|616279223|FG000|Treatment|Scheduling Conflicts|0|||
170527208|NCT03810456|616279224|FG001|Treatment|Scheduling Conflicts|11|||
170527209|NCT03810456|616279225|FG002|Treatment|Scheduling Conflicts|0|||
170527210|NCT03810456|616279223|FG000|Treatment|No Longer Interested|0|||
170527211|NCT03810456|616279224|FG001|Treatment|No Longer Interested|12|||
170527212|NCT03810456|616279225|FG002|Treatment|No Longer Interested|0|||
170527213|NCT03810456|616279223|FG000|Treatment|Transportation Issues|0|||
170527214|NCT03810456|616279224|FG001|Treatment|Transportation Issues|1|||
170527215|NCT03810456|616279225|FG002|Treatment|Transportation Issues|0|||
170527216|NCT03810456|616279223|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
170527217|NCT03810456|616279224|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
170527218|NCT03810456|616279225|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
170527219|NCT03810456|616279223|FG000|1 Month Follow-Up|Relocated to Different State|1|||
170527220|NCT03810456|616279224|FG001|1 Month Follow-Up|Relocated to Different State|0|||
170527221|NCT03810456|616279225|FG002|1 Month Follow-Up|Relocated to Different State|1|||
170527222|NCT03810456|616279223|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
170527223|NCT03810456|616279224|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
170527224|NCT03810456|616279225|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
170527225|NCT03810456|616279223|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
170527226|NCT03810456|616279224|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
170527227|NCT03810456|616279225|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
170527228|NCT03810456|616279223|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
170527229|NCT03810456|616279224|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
170527230|NCT03810456|616279225|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
170527231|NCT03810456|616279223|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
170527232|NCT03810456|616279224|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
170527233|NCT03810456|616279225|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
170527234|NCT03810456|616279223|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
170527235|NCT03810456|616279224|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
170527236|NCT03810456|616279225|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
170527237|NCT00490919|616279226|FG000|Open-label Run-in Period|Adverse Event|239|||
170527238|NCT00490919|616279227|FG001|Open-label Run-in Period|Adverse Event|0|||
170527239|NCT00490919|616279228|FG002|Open-label Run-in Period|Adverse Event|0|||
170527240|NCT00490919|616279226|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
170527241|NCT00490919|616279227|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
170527242|NCT00490919|616279228|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
170527243|NCT00490919|616279226|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
170527244|NCT00490919|616279227|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
170527245|NCT00490919|616279228|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
170527246|NCT00490919|616279226|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
170527247|NCT00490919|616279227|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
170527248|NCT00490919|616279228|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
170527249|NCT00490919|616279226|FG000|Open-label Run-in Period|Administrative|40|||
170527250|NCT00490919|616279227|FG001|Open-label Run-in Period|Administrative|0|||
170527251|NCT00490919|616279228|FG002|Open-label Run-in Period|Administrative|0|||
170527252|NCT00490919|616279226|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
170527253|NCT00490919|616279227|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
170527254|NCT00490919|616279228|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
170527255|NCT00490919|616279226|FG000|Double-blind Phase|Adverse Event|0|||
170527256|NCT00490919|616279227|FG001|Double-blind Phase|Adverse Event|40|||
170527257|NCT00490919|616279228|FG002|Double-blind Phase|Adverse Event|20|||
170527258|NCT00490919|616279226|FG000|Double-blind Phase|Withdrawal by Subject|0|||
170527259|NCT00490919|616279227|FG001|Double-blind Phase|Withdrawal by Subject|10|||
170527260|NCT00490919|616279228|FG002|Double-blind Phase|Withdrawal by Subject|11|||
170527261|NCT00490919|616279226|FG000|Double-blind Phase|Lost to Follow-up|0|||
170527262|NCT00490919|616279227|FG001|Double-blind Phase|Lost to Follow-up|8|||
170527263|NCT00490919|616279228|FG002|Double-blind Phase|Lost to Follow-up|11|||
170527264|NCT00490919|616279226|FG000|Double-blind Phase|Lack of Efficacy|0|||
170527265|NCT00490919|616279227|FG001|Double-blind Phase|Lack of Efficacy|22|||
170527266|NCT00490919|616279228|FG002|Double-blind Phase|Lack of Efficacy|36|||
170527267|NCT00490919|616279226|FG000|Double-blind Phase|Administrative|0|||
170527268|NCT00490919|616279227|FG001|Double-blind Phase|Administrative|6|||
170527269|NCT00490919|616279228|FG002|Double-blind Phase|Administrative|6|||
170527270|NCT02100124|616279231|FG000|Overall Study|Lost to Follow-up|5|||
170527271|NCT02100124|616279232|FG001|Overall Study|Lost to Follow-up|11|||
170527272|NCT02100124|616279233|FG002|Overall Study|Lost to Follow-up|3|||
170527273|NCT02100124|616279231|FG000|Overall Study|Withdrawal by Subject|1|||
170527274|NCT02100124|616279232|FG001|Overall Study|Withdrawal by Subject|0|||
170527275|NCT02100124|616279233|FG002|Overall Study|Withdrawal by Subject|0|||
170527276|NCT04350827|616279235|FG000|Overall Study|Lost to Follow-up|1|||
170527277|NCT04350827|616279236|FG001|Overall Study|Lost to Follow-up|2|||
170527278|NCT04265261|616279237|FG000|Overall Study|Adverse Event|2|||
170527279|NCT04265261|616279238|FG001|Overall Study|Adverse Event|0|||
170527280|NCT04265261|616279239|FG002|Overall Study|Adverse Event|0|||
170527281|NCT04265261|616279237|FG000|Overall Study|Death|1|||
170527282|NCT04265261|616279238|FG001|Overall Study|Death|0|||
170527283|NCT04265261|616279239|FG002|Overall Study|Death|0|||
170527284|NCT04265261|616279237|FG000|Overall Study|Lost to Follow-up|4|||
170527285|NCT04265261|616279238|FG001|Overall Study|Lost to Follow-up|1|||
170527286|NCT04265261|616279239|FG002|Overall Study|Lost to Follow-up|3|||
170527287|NCT04265261|616279237|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170527288|NCT04265261|616279238|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170527289|NCT04265261|616279239|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170527290|NCT04265261|616279237|FG000|Overall Study|Physician Decision|0|||
170527291|NCT04265261|616279238|FG001|Overall Study|Physician Decision|0|||
170415635|NCT04471207|615862034|FG000|Overall Study|Physician Decision|1|||
170415636|NCT04471207|615862035|FG001|Overall Study|Physician Decision|0|||
170415637|NCT04471207|615862034|FG000|Overall Study|Unwilling to Use System|0|||
170415638|NCT04471207|615862035|FG001|Overall Study|Unwilling to Use System|1|||
170415639|NCT02750761|615862052|FG000|Overall Study|Lost to Follow-up|0|||
170415640|NCT02750761|615862053|FG001|Overall Study|Lost to Follow-up|0|||
170415641|NCT02750761|615862054|FG002|Overall Study|Lost to Follow-up|1|||
170415642|NCT02750761|615862055|FG003|Overall Study|Lost to Follow-up|0|||
170415643|NCT02750761|615862056|FG004|Overall Study|Lost to Follow-up|0|||
170415644|NCT02750761|615862057|FG005|Overall Study|Lost to Follow-up|0|||
170415645|NCT05014204|615862059|FG000|Overall Study|Withdrawal by Subject|1|||
170415646|NCT05014204|615862059|FG000|Overall Study|Physician Decision|1|||
170415647|NCT01966042|615862063|FG000|Overall Study|Death|2|||
170415648|NCT00698685|615862064|FG000|Overall Study|Sister withdrew as donor|1|||
170415649|NCT00698685|615862064|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
170415650|NCT04670068|615862065|FG000|Overall Study|Progressive Disease|1|||
170415651|NCT04670068|615862066|FG001|Overall Study|Progressive Disease|1|||
170415652|NCT04670068|615862065|FG000|Overall Study|Withdrawal by Subject|1|||
170415653|NCT04670068|615862066|FG001|Overall Study|Withdrawal by Subject|0|||
170415654|NCT04684524|615862067|FG000|Overall Study|Other|2|||
170415655|NCT04684524|615862068|FG001|Overall Study|Other|0|||
170415656|NCT04684524|615862067|FG000|Overall Study|Withdrawal by Subject|5|||
170415657|NCT04684524|615862068|FG001|Overall Study|Withdrawal by Subject|3|||
170415658|NCT04684524|615862067|FG000|Overall Study|Adverse Event|1|||
170415659|NCT04684524|615862068|FG001|Overall Study|Adverse Event|1|||
170415660|NCT00601354|615862069|FG000|Overall Study|Lost to Follow-up|4|||
170415661|NCT00601354|615862070|FG001|Overall Study|Lost to Follow-up|5|||
170415662|NCT03402893|615862073|FG000|Overall Study|Withdrawal by Subject|1|||
170415663|NCT04799158|615862074|FG000|Run-In Period|Adverse Event|6|||
170415664|NCT04799158|615862075|FG001|Run-In Period|Adverse Event|0|||
170415665|NCT04799158|615862076|FG002|Run-In Period|Adverse Event|0|||
170415666|NCT04799158|615862077|FG003|Run-In Period|Adverse Event|0|||
170415667|NCT04799158|615862078|FG004|Run-In Period|Adverse Event|0|||
170415668|NCT04799158|615862074|FG000|Run-In Period|Lost to Follow-up|4|||
170415669|NCT04799158|615862075|FG001|Run-In Period|Lost to Follow-up|0|||
170415670|NCT04799158|615862076|FG002|Run-In Period|Lost to Follow-up|0|||
170415671|NCT04799158|615862077|FG003|Run-In Period|Lost to Follow-up|0|||
170415672|NCT04799158|615862078|FG004|Run-In Period|Lost to Follow-up|0|||
170415673|NCT04799158|615862074|FG000|Run-In Period|Significant Protocol Deviation|1|||
170415674|NCT04799158|615862075|FG001|Run-In Period|Significant Protocol Deviation|0|||
170415675|NCT04799158|615862076|FG002|Run-In Period|Significant Protocol Deviation|0|||
170415676|NCT04799158|615862077|FG003|Run-In Period|Significant Protocol Deviation|0|||
170415677|NCT04799158|615862078|FG004|Run-In Period|Significant Protocol Deviation|0|||
170415678|NCT04799158|615862074|FG000|Run-In Period|Withdrawal by Subject|11|||
170415679|NCT04799158|615862075|FG001|Run-In Period|Withdrawal by Subject|0|||
170415680|NCT04799158|615862076|FG002|Run-In Period|Withdrawal by Subject|0|||
170415681|NCT04799158|615862077|FG003|Run-In Period|Withdrawal by Subject|0|||
170415682|NCT04799158|615862078|FG004|Run-In Period|Withdrawal by Subject|0|||
170415683|NCT04799158|615862074|FG000|Run-In Period|Miscellaneous|3|||
170415684|NCT04799158|615862075|FG001|Run-In Period|Miscellaneous|0|||
170415685|NCT04799158|615862076|FG002|Run-In Period|Miscellaneous|0|||
170415686|NCT04799158|615862077|FG003|Run-In Period|Miscellaneous|0|||
170415687|NCT04799158|615862078|FG004|Run-In Period|Miscellaneous|0|||
170415688|NCT04799158|615862074|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
170415689|NCT04799158|615862075|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
170415690|NCT04799158|615862076|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
170415691|NCT04799158|615862077|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
170415692|NCT04799158|615862078|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
170415693|NCT04799158|615862074|FG000|On-Demand Treatment Period|Adverse Event|0|||
170415694|NCT04799158|615862075|FG001|On-Demand Treatment Period|Adverse Event|1|||
170415695|NCT04799158|615862076|FG002|On-Demand Treatment Period|Adverse Event|0|||
170415696|NCT04799158|615862077|FG003|On-Demand Treatment Period|Adverse Event|0|||
170415697|NCT04799158|615862078|FG004|On-Demand Treatment Period|Adverse Event|1|||
170415698|NCT04799158|615862074|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
170415699|NCT04799158|615862075|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
170415700|NCT04799158|615862076|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
170415701|NCT04799158|615862077|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
170415702|NCT04799158|615862078|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
170415703|NCT04799158|615862074|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
170415704|NCT04799158|615862075|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
170415705|NCT04799158|615862076|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
170415706|NCT04799158|615862077|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
170415707|NCT04799158|615862078|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
170415708|NCT04799158|615862074|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
170415709|NCT04799158|615862075|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
170527292|NCT04265261|616279239|FG002|Overall Study|Physician Decision|1|||
170527293|NCT04265261|616279237|FG000|Overall Study|Protocol Deviation|0|||
170527294|NCT04265261|616279238|FG001|Overall Study|Protocol Deviation|2|||
170527295|NCT04265261|616279239|FG002|Overall Study|Protocol Deviation|0|||
170527296|NCT04265261|616279237|FG000|Overall Study|Withdrawal by Subject|2|||
170527297|NCT04265261|616279238|FG001|Overall Study|Withdrawal by Subject|1|||
170527298|NCT04265261|616279239|FG002|Overall Study|Withdrawal by Subject|4|||
170527299|NCT03861039|616280608|FG000|Overall Study|Adverse Event|2|||
170527300|NCT03861039|616280609|FG001|Overall Study|Adverse Event|5|||
170527301|NCT03861039|616280610|FG002|Overall Study|Adverse Event|11|||
170527302|NCT03861039|616280608|FG000|Overall Study|Withdrawal by Subject|1|||
170527303|NCT03861039|616280609|FG001|Overall Study|Withdrawal by Subject|3|||
170527304|NCT03861039|616280610|FG002|Overall Study|Withdrawal by Subject|4|||
170527305|NCT01113749|616280611|FG000|Overall Study|Lost to Follow-up|1|||
170527306|NCT01113749|616280612|FG001|Overall Study|Lost to Follow-up|2|||
170527307|NCT03427892|616280613|FG000|Overall Study|Lost to Follow-up|2|||
170527308|NCT02934178|616280614|FG000|Received Vaccination 2|Death|0|||
170527309|NCT02934178|616280615|FG001|Received Vaccination 2|Death|1|||
170527310|NCT02934178|616280614|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
170527311|NCT02934178|616280615|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
170527312|NCT00161213|616280625|FG000|Overall Study|Withdrawal by Subject|1|||
170527313|NCT00161213|616280625|FG000|Overall Study|Evaluable for toxicity but not response|1|||
170527314|NCT00266708|616280630|FG000|Overall Study|No renal function|1|||
170527315|NCT00266708|616280631|FG001|Overall Study|No renal function|1|||
170527316|NCT00266708|616280630|FG000|Overall Study|Refused biopsy|3|||
170527317|NCT00266708|616280631|FG001|Overall Study|Refused biopsy|6|||
170527318|NCT00266708|616280630|FG000|Overall Study|Asthma|0|||
170527319|NCT00266708|616280631|FG001|Overall Study|Asthma|2|||
170527320|NCT01926028|616280632|FG000|Overall Study|Lost to Follow-up|7|||
170527321|NCT01926028|616280633|FG001|Overall Study|Lost to Follow-up|6|||
170527322|NCT01926028|616280634|FG002|Overall Study|Lost to Follow-up|0|||
170527323|NCT01926028|616280632|FG000|Overall Study|Physician Decision|1|||
170527324|NCT01926028|616280633|FG001|Overall Study|Physician Decision|5|||
170527325|NCT01926028|616280634|FG002|Overall Study|Physician Decision|0|||
170527326|NCT01926028|616280632|FG000|Overall Study|Withdrawal by Subject|9|||
170527327|NCT01926028|616280633|FG001|Overall Study|Withdrawal by Subject|9|||
170527328|NCT01926028|616280634|FG002|Overall Study|Withdrawal by Subject|2|||
170527329|NCT01926028|616280632|FG000|Overall Study|Non compliance or other reasons|4|||
170527330|NCT01926028|616280633|FG001|Overall Study|Non compliance or other reasons|2|||
170527331|NCT01926028|616280634|FG002|Overall Study|Non compliance or other reasons|0|||
170527332|NCT00703534|616280635|FG000|Overall Study|Adverse Event|14|||
170776532|NCT03584516|617188678|FG002|Part 1|Study Terminated by Sponsor|0|||
170776533|NCT03584516|617188679|FG003|Part 1|Study Terminated by Sponsor|0|||
170776534|NCT03584516|617188680|FG004|Part 1|Study Terminated by Sponsor|0|||
170776535|NCT03584516|617188681|FG005|Part 1|Study Terminated by Sponsor|0|||
170776536|NCT03584516|617188676|FG000|Part 1 Expansion|Death|0|||
170776537|NCT03584516|617188677|FG001|Part 1 Expansion|Death|0|||
170776538|NCT03584516|617188678|FG002|Part 1 Expansion|Death|9|||
170776539|NCT03584516|617188679|FG003|Part 1 Expansion|Death|8|||
170776540|NCT03584516|617188680|FG004|Part 1 Expansion|Death|4|||
170776541|NCT03584516|617188681|FG005|Part 1 Expansion|Death|5|||
170776542|NCT03584516|617188676|FG000|Part 1 Expansion|Lost to Follow-up|0|||
170776543|NCT03584516|617188677|FG001|Part 1 Expansion|Lost to Follow-up|0|||
170776544|NCT03584516|617188678|FG002|Part 1 Expansion|Lost to Follow-up|0|||
170776545|NCT03584516|617188679|FG003|Part 1 Expansion|Lost to Follow-up|1|||
170776546|NCT03584516|617188680|FG004|Part 1 Expansion|Lost to Follow-up|0|||
170776547|NCT03584516|617188681|FG005|Part 1 Expansion|Lost to Follow-up|0|||
170776548|NCT03584516|617188676|FG000|Part 1 Expansion|Physician Decision|0|||
170776549|NCT03584516|617188677|FG001|Part 1 Expansion|Physician Decision|0|||
170776550|NCT03584516|617188678|FG002|Part 1 Expansion|Physician Decision|4|||
170776551|NCT03584516|617188679|FG003|Part 1 Expansion|Physician Decision|3|||
170415710|NCT04799158|615862076|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
170415711|NCT04799158|615862077|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
170415712|NCT04799158|615862078|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
170415713|NCT04799158|615862074|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
170415714|NCT04799158|615862075|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
170415715|NCT04799158|615862076|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
170415716|NCT04799158|615862077|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
170415717|NCT04799158|615862078|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
170415718|NCT04799158|615862074|FG000|On-Demand Treatment Period|Miscellaneous|0|||
170415719|NCT04799158|615862075|FG001|On-Demand Treatment Period|Miscellaneous|0|||
170415720|NCT04799158|615862076|FG002|On-Demand Treatment Period|Miscellaneous|0|||
170415721|NCT04799158|615862077|FG003|On-Demand Treatment Period|Miscellaneous|0|||
170415722|NCT04799158|615862078|FG004|On-Demand Treatment Period|Miscellaneous|1|||
170527333|NCT00703534|616280636|FG001|Overall Study|Adverse Event|3|||
170527334|NCT00703534|616280635|FG000|Overall Study|Withdrawal by Subject|8|||
170776552|NCT03584516|617188680|FG004|Part 1 Expansion|Physician Decision|2|||
170527335|NCT00703534|616280636|FG001|Overall Study|Withdrawal by Subject|7|||
170527336|NCT00703534|616280635|FG000|Overall Study|Incorrect Enrollment|6|||
170527337|NCT00703534|616280636|FG001|Overall Study|Incorrect Enrollment|6|||
170527338|NCT00703534|616280635|FG000|Overall Study|Lost to Follow-up|1|||
170527339|NCT00703534|616280636|FG001|Overall Study|Lost to Follow-up|4|||
170527340|NCT00703534|616280635|FG000|Overall Study|Severe Non Compliance|1|||
170527341|NCT00703534|616280636|FG001|Overall Study|Severe Non Compliance|5|||
170527342|NCT00427934|616280637|FG000|Overall Study|Adverse Event|1|||
170527343|NCT00427934|616280638|FG001|Overall Study|Adverse Event|0|||
170527344|NCT00427934|616280639|FG002|Overall Study|Adverse Event|5|||
170527345|NCT00427934|616280640|FG003|Overall Study|Adverse Event|4|||
170527346|NCT00427934|616280637|FG000|Overall Study|Lack of Efficacy|0|||
170527347|NCT00427934|616280638|FG001|Overall Study|Lack of Efficacy|0|||
170527348|NCT00427934|616280639|FG002|Overall Study|Lack of Efficacy|5|||
170527349|NCT00427934|616280640|FG003|Overall Study|Lack of Efficacy|2|||
170527350|NCT00427934|616280637|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
170527351|NCT00427934|616280638|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
170527352|NCT00427934|616280639|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
170527353|NCT00427934|616280640|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
170527354|NCT00427934|616280637|FG000|Overall Study|Other|0|||
170527355|NCT00427934|616280638|FG001|Overall Study|Other|0|||
170527356|NCT00427934|616280639|FG002|Overall Study|Other|11|||
170527357|NCT00427934|616280640|FG003|Overall Study|Other|5|||
170527358|NCT00427934|616280637|FG000|Overall Study|Withdrawal by Subject|0|||
170527359|NCT00427934|616280638|FG001|Overall Study|Withdrawal by Subject|0|||
170527360|NCT00427934|616280639|FG002|Overall Study|Withdrawal by Subject|1|||
170527361|NCT00427934|616280640|FG003|Overall Study|Withdrawal by Subject|3|||
170527362|NCT02351934|616280641|FG000|Allocation|POD weight<pre-op weight|3|||
170527363|NCT02351934|616280642|FG001|Allocation|POD weight<pre-op weight|0|||
170527364|NCT02351934|616280641|FG000|Allocation|Hypotension preventing administration|2|||
170527365|NCT02351934|616280642|FG001|Allocation|Hypotension preventing administration|0|||
170527366|NCT02351934|616280641|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
170527367|NCT02351934|616280642|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
170527368|NCT02351934|616280641|FG000|Follow-Up|POD weight<pre-op weight|3|||
170527369|NCT02351934|616280642|FG001|Follow-Up|POD weight<pre-op weight|0|||
170527370|NCT02351934|616280641|FG000|Follow-Up|Acute Kidney Injury|1|||
170527371|NCT02351934|616280642|FG001|Follow-Up|Acute Kidney Injury|0|||
170527372|NCT02351934|616280641|FG000|Follow-Up|Early dismissal|3|||
170527373|NCT02351934|616280642|FG001|Follow-Up|Early dismissal|0|||
170527374|NCT02351934|616280641|FG000|Follow-Up|Hypotension|3|||
170527375|NCT02351934|616280642|FG001|Follow-Up|Hypotension|0|||
170527376|NCT02351934|616280641|FG000|Follow-Up|No documentation|2|||
170527377|NCT02351934|616280642|FG001|Follow-Up|No documentation|0|||
170527378|NCT02351934|616280641|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
170527379|NCT02351934|616280642|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
170527380|NCT02351934|616280641|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
170527381|NCT02351934|616280642|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
170527382|NCT03312738|616280643|FG000|Overall Study|Progressive disease|58|||
170527383|NCT03312738|616280644|FG001|Overall Study|Progressive disease|67|||
170527384|NCT03312738|616280643|FG000|Overall Study|Patient/guardian decision|13|||
170527385|NCT03312738|616280644|FG001|Overall Study|Patient/guardian decision|5|||
170527386|NCT03312738|616280643|FG000|Overall Study|Adverse Event|5|||
170527387|NCT03312738|616280644|FG001|Overall Study|Adverse Event|3|||
170527388|NCT03312738|616280643|FG000|Overall Study|Protocol deviation|2|||
170527389|NCT03312738|616280644|FG001|Overall Study|Protocol deviation|0|||
170776553|NCT03584516|617188681|FG005|Part 1 Expansion|Physician Decision|3|||
170776554|NCT03584516|617188676|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
170776555|NCT03584516|617188677|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
170776556|NCT03584516|617188678|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
170776557|NCT03584516|617188679|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
170776558|NCT03584516|617188680|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
170776559|NCT03584516|617188681|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
170776560|NCT03584516|617188676|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
170877073|NCT04232553|617560462|FG006|Overall Study|Withdrawal by Subject|0|||
170877074|NCT04232553|617560463|FG007|Overall Study|Withdrawal by Subject|2|||
170877075|NCT04232553|617560464|FG008|Overall Study|Withdrawal by Subject|0|||
170527390|NCT03312738|616280643|FG000|Overall Study|Technical problems|0|||
170527391|NCT03312738|616280644|FG001|Overall Study|Technical problems|1|||
170527392|NCT03312738|616280643|FG000|Overall Study|Physician Decision|2|||
170527393|NCT03312738|616280644|FG001|Overall Study|Physician Decision|3|||
170527394|NCT02466399|616280653|FG000|Overall Study|Adverse Event|1|||
170527395|NCT02466399|616280654|FG001|Overall Study|Adverse Event|0|||
170877076|NCT00711425|617560465|FG000|Overall Study|Protocol Violation|1|||
170877077|NCT00711425|617560465|FG000|Overall Study|Death|2|||
170527396|NCT02466399|616280653|FG000|Overall Study|Early exit due to family emergency|1|||
170527397|NCT02466399|616280654|FG001|Overall Study|Early exit due to family emergency|0|||
170527398|NCT04539275|616280655|FG000|Overall Study|Death|2|||
170877078|NCT00711425|617560465|FG000|Overall Study|Lost to Follow-up|1|||
170877079|NCT05248295|617560466|FG000|Overall Study|found ineligible|4|||
170877080|NCT05248295|617560467|FG001|Overall Study|found ineligible|1|||
170877081|NCT05248295|617560466|FG000|Overall Study|Withdrawal by Subject|0|||
170877082|NCT05248295|617560467|FG001|Overall Study|Withdrawal by Subject|1|||
170877083|NCT05248295|617560466|FG000|Overall Study|Data loss: audio recording error|1|||
170877084|NCT05248295|617560467|FG001|Overall Study|Data loss: audio recording error|1|||
170877085|NCT06608368|617560468|FG000|Overall Study|Family Emergency|0|||
170877086|NCT06608368|617560469|FG001|Overall Study|Family Emergency|1|||
170527399|NCT04539275|616280656|FG001|Overall Study|Death|4|||
170527400|NCT04539275|616280655|FG000|Overall Study|Lost to Follow-up|1|||
170527401|NCT04539275|616280656|FG001|Overall Study|Lost to Follow-up|1|||
170527402|NCT04539275|616280655|FG000|Overall Study|Withdrawal by Subject|3|||
170527403|NCT04539275|616280656|FG001|Overall Study|Withdrawal by Subject|0|||
170527404|NCT01799941|616280661|FG000|Overall Study|Adverse Event|34|||
170527405|NCT01799941|616280661|FG000|Overall Study|Withdrawal by Subject|21|||
170527406|NCT01799941|616280661|FG000|Overall Study|Death|2|||
170527407|NCT01799941|616280661|FG000|Overall Study|Investigator Decision|4|||
170527408|NCT01799941|616280661|FG000|Overall Study|Lack of Efficacy|3|||
170527409|NCT01799941|616280661|FG000|Overall Study|Lost to Follow-up|17|||
170527410|NCT01799941|616280661|FG000|Overall Study|Other|15|||
170527411|NCT01715831|616280669|FG000|Overall Study|Adverse Event|1|||
170527412|NCT00547339|616280670|FG000|Overall Study|Physician Decision|0|||
170527413|NCT00547339|616280671|FG001|Overall Study|Physician Decision|0|||
170527414|NCT00547339|616280672|FG002|Overall Study|Physician Decision|1|||
170527415|NCT00547339|616280673|FG003|Overall Study|Physician Decision|0|||
170527416|NCT01603602|616280674|FG000|Overall Study|Adverse Event|1|||
170527417|NCT01603602|616280675|FG001|Overall Study|Adverse Event|0|||
170527418|NCT01603602|616280676|FG002|Overall Study|Adverse Event|0|||
170527419|NCT01603602|616280674|FG000|Overall Study|Personal Reasons|1|||
170527420|NCT01603602|616280675|FG001|Overall Study|Personal Reasons|0|||
170527421|NCT01603602|616280676|FG002|Overall Study|Personal Reasons|1|||
170527422|NCT02665117|616280677|FG000|Overall Study|Physician Decision|1|||
170527423|NCT02665117|616280678|FG001|Overall Study|Physician Decision|0|||
170527424|NCT00095979|616280685|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
170527425|NCT01483118|616280686|FG000|Overall Study|Lost to Follow-up|12|||
170527426|NCT01483118|616280687|FG001|Overall Study|Lost to Follow-up|16|||
170527427|NCT01178294|616280688|FG000|Overall Study|Adverse Event|4|||
170527428|NCT01178294|616280688|FG000|Overall Study|Lost to Follow-up|2|||
170527429|NCT01178294|616280688|FG000|Overall Study|Lack of Efficacy|1|||
170527430|NCT01178294|616280688|FG000|Overall Study|Death|1|||
170527431|NCT01178294|616280688|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
170527432|NCT01178294|616280688|FG000|Overall Study|Subject status is terminal|1|||
170527433|NCT01178294|616280688|FG000|Overall Study|Completion status could not be verified|1|||
170527434|NCT02783066|616280689|FG000|Overall Study|Withdrawal by Subject|13|||
170527435|NCT02785939|616280696|FG000|Overall Study|Progression|25|||
170527436|NCT02785939|616280697|FG001|Overall Study|Progression|8|||
170527437|NCT02785939|616280696|FG000|Overall Study|Adverse Event|3|||
170527438|NCT02785939|616280697|FG001|Overall Study|Adverse Event|1|||
170527439|NCT02785939|616280696|FG000|Overall Study|Death|1|||
170527440|NCT02785939|616280697|FG001|Overall Study|Death|0|||
170527441|NCT02785939|616280696|FG000|Overall Study|Refusal|1|||
170527442|NCT02785939|616280697|FG001|Overall Study|Refusal|0|||
170527443|NCT02785939|616280696|FG000|Overall Study|Deteriorating health|1|||
170527444|NCT02785939|616280697|FG001|Overall Study|Deteriorating health|0|||
170527445|NCT02785939|616280696|FG000|Overall Study|Not protocol specified|0|||
170527446|NCT02785939|616280697|FG001|Overall Study|Not protocol specified|1|||
170527447|NCT01299584|616280705|FG000|Overall Study|Protocol Violation|9|||
170527448|NCT00572832|616280706|FG000|Overall Study|Lost to Follow-up|0|||
170527449|NCT00572832|616280707|FG001|Overall Study|Lost to Follow-up|11|||
170877087|NCT06608368|617560470|FG002|Overall Study|Family Emergency|0|||
170877088|NCT06608368|617560468|FG000|Overall Study|Scheduling Issues|0|||
170877089|NCT06608368|617560469|FG001|Overall Study|Scheduling Issues|1|||
170877090|NCT06608368|617560470|FG002|Overall Study|Scheduling Issues|0|||
170877091|NCT03977974|617560471|FG000|Period 2|Adverse Event|0|||
170527450|NCT00572832|616280706|FG000|Overall Study|Pregnancy|0|||
170527451|NCT00572832|616280707|FG001|Overall Study|Pregnancy|1|||
170527452|NCT01604785|616280715|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
170527453|NCT01604785|616280716|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
170527454|NCT05214118|616280721|FG000|Overall Study|Lost to Follow-up|0|||
170527455|NCT05214118|616280722|FG001|Overall Study|Lost to Follow-up|2|||
170527456|NCT05214118|616280721|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
170527457|NCT05214118|616280722|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
170527458|NCT05214118|616280721|FG000|Overall Study|moved|1|||
170527459|NCT05214118|616280722|FG001|Overall Study|moved|0|||
170877092|NCT03977974|617560472|FG001|Period 2|Adverse Event|0|||
170877093|NCT03977974|617560473|FG002|Period 2|Adverse Event|0|||
170877094|NCT03977974|617560474|FG003|Period 2|Adverse Event|0|||
170527460|NCT02175121|616280723|FG000|Overall Study|Lack of Efficacy|1|||
170527461|NCT02175121|616280724|FG001|Overall Study|Lack of Efficacy|0|||
170527462|NCT02175121|616280725|FG002|Overall Study|Lack of Efficacy|0|||
170527463|NCT02175121|616280726|FG003|Overall Study|Lack of Efficacy|0|||
170527464|NCT02175121|616280727|FG004|Overall Study|Lack of Efficacy|0|||
170527465|NCT02175121|616280723|FG000|Overall Study|Lost to Follow-up|0|||
170527466|NCT02175121|616280724|FG001|Overall Study|Lost to Follow-up|1|||
170527467|NCT02175121|616280725|FG002|Overall Study|Lost to Follow-up|0|||
170527468|NCT02175121|616280726|FG003|Overall Study|Lost to Follow-up|1|||
170527469|NCT02175121|616280727|FG004|Overall Study|Lost to Follow-up|0|||
170527470|NCT02175121|616280723|FG000|Overall Study|Personal emergency|0|||
170527471|NCT02175121|616280724|FG001|Overall Study|Personal emergency|0|||
170527472|NCT02175121|616280725|FG002|Overall Study|Personal emergency|0|||
170527473|NCT02175121|616280726|FG003|Overall Study|Personal emergency|0|||
170527474|NCT02175121|616280727|FG004|Overall Study|Personal emergency|1|||
170527475|NCT02175121|616280723|FG000|Overall Study|Schedule conflict|0|||
170527476|NCT02175121|616280724|FG001|Overall Study|Schedule conflict|0|||
170527477|NCT02175121|616280725|FG002|Overall Study|Schedule conflict|1|||
170527478|NCT02175121|616280726|FG003|Overall Study|Schedule conflict|0|||
170527479|NCT02175121|616280727|FG004|Overall Study|Schedule conflict|0|||
170527480|NCT02175121|616280723|FG000|Overall Study|Time issues|0|||
170527481|NCT02175121|616280724|FG001|Overall Study|Time issues|0|||
170527482|NCT02175121|616280725|FG002|Overall Study|Time issues|1|||
170527483|NCT02175121|616280726|FG003|Overall Study|Time issues|0|||
170527484|NCT02175121|616280727|FG004|Overall Study|Time issues|0|||
170527485|NCT03014206|616280728|FG000|Overall Study|Registration Violation|12|||
170527486|NCT00931632|616280729|FG000|Overall Study|Withdrawal by Subject|2|||
170527487|NCT00931632|616280730|FG001|Overall Study|Withdrawal by Subject|3|||
170527488|NCT00931632|616280729|FG000|Overall Study|Adverse Event|19|||
170527489|NCT00931632|616280730|FG001|Overall Study|Adverse Event|15|||
170527490|NCT00606307|616280733|FG000|Overall Study|Adverse Event|2|||
170527491|NCT00606307|616280733|FG000|Overall Study|Withdrawal by Subject|2|||
170527492|NCT00606307|616280733|FG000|Overall Study|Disease progression|6|||
170527493|NCT00606307|616280733|FG000|Overall Study|QTc prolongation|1|||
170527494|NCT04356937|616280734|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
170527495|NCT04356937|616280735|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
170527496|NCT00807365|616280736|FG000|Overall Study|Study Terminated|5|||
170527497|NCT04821830|616280737|FG000|Overall Study|Withdrawal by Subject|1|||
170527498|NCT04821830|616280738|FG001|Overall Study|Withdrawal by Subject|0|||
170527499|NCT05399680|616282856|FG000|Overall Study|Lost to Follow-up|1|||
170527500|NCT05399680|616282857|FG001|Overall Study|Lost to Follow-up|0|||
170527501|NCT05399680|616282856|FG000|Overall Study|Death|0|||
170527502|NCT05399680|616282857|FG001|Overall Study|Death|1|||
170527503|NCT03737994|616282861|FG000|Overall Study|Withdrawal by Subject|0|||
170527504|NCT03737994|616282862|FG001|Overall Study|Withdrawal by Subject|0|||
170527505|NCT03737994|616282863|FG002|Overall Study|Withdrawal by Subject|0|||
170527506|NCT03737994|616282864|FG003|Overall Study|Withdrawal by Subject|0|||
170527507|NCT03737994|616282865|FG004|Overall Study|Withdrawal by Subject|0|||
170527508|NCT03737994|616282866|FG005|Overall Study|Withdrawal by Subject|0|||
170527509|NCT03737994|616282867|FG006|Overall Study|Withdrawal by Subject|1|||
170527510|NCT00720278|616282868|FG000|Overall Study|Adverse Event|5|||
170527511|NCT00720278|616282869|FG001|Overall Study|Adverse Event|3|||
170527512|NCT00720278|616282870|FG002|Overall Study|Adverse Event|4|||
170527513|NCT00720278|616282868|FG000|Overall Study|Withdrawal by Subject|0|||
170527514|NCT00720278|616282869|FG001|Overall Study|Withdrawal by Subject|1|||
170527515|NCT00720278|616282870|FG002|Overall Study|Withdrawal by Subject|0|||
170527516|NCT00720278|616282868|FG000|Overall Study|Lost to Follow-up|0|||
170527517|NCT00720278|616282869|FG001|Overall Study|Lost to Follow-up|0|||
170776561|NCT03584516|617188677|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
170776562|NCT03584516|617188678|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
170776563|NCT03584516|617188679|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
170776564|NCT03584516|617188680|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
170776565|NCT03584516|617188681|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
170527518|NCT00720278|616282870|FG002|Overall Study|Lost to Follow-up|1|||
170527519|NCT00720278|616282868|FG000|Overall Study|Non-compliance|1|||
170527520|NCT00720278|616282869|FG001|Overall Study|Non-compliance|0|||
170776566|NCT03584516|617188676|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
170776567|NCT03584516|617188677|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
170776568|NCT03584516|617188678|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
170527521|NCT00720278|616282870|FG002|Overall Study|Non-compliance|0|||
170527522|NCT00720278|616282868|FG000|Overall Study|eligibility criteria violation|1|||
170527523|NCT00720278|616282869|FG001|Overall Study|eligibility criteria violation|0|||
170527524|NCT00720278|616282870|FG002|Overall Study|eligibility criteria violation|1|||
170527525|NCT01075048|616282872|FG000|Overall Study|Death|4|||
170527526|NCT01075048|616282873|FG001|Overall Study|Death|17|||
170527527|NCT01075048|616282874|FG002|Overall Study|Death|12|||
170527528|NCT01075048|616282872|FG000|Overall Study|Start of other or new therapy|4|||
170527529|NCT01075048|616282873|FG001|Overall Study|Start of other or new therapy|36|||
170527530|NCT01075048|616282874|FG002|Overall Study|Start of other or new therapy|46|||
170527531|NCT01075048|616282872|FG000|Overall Study|Withdrawal by Subject|1|||
170527532|NCT01075048|616282873|FG001|Overall Study|Withdrawal by Subject|6|||
170527533|NCT01075048|616282874|FG002|Overall Study|Withdrawal by Subject|3|||
170527534|NCT01075048|616282872|FG000|Overall Study|Lost to Follow-up|0|||
170527535|NCT01075048|616282873|FG001|Overall Study|Lost to Follow-up|1|||
170527536|NCT01075048|616282874|FG002|Overall Study|Lost to Follow-up|1|||
170527537|NCT03944616|616282875|FG000|Overall Study|Lost to Follow-up|0|||
170527538|NCT03944616|616282876|FG001|Overall Study|Lost to Follow-up|2|||
170527539|NCT00997334|616282877|FG000|Overall Study|still on therapy|12|||
170527540|NCT00997334|616282877|FG000|Overall Study|Adverse Event|3|||
170527541|NCT00997334|616282877|FG000|Overall Study|Patient non-compliance|1|||
170527542|NCT00997334|616282877|FG000|Overall Study|Withdrawal by Subject|3|||
170527543|NCT00997334|616282877|FG000|Overall Study|Death|2|||
170527544|NCT00997334|616282877|FG000|Overall Study|Urgent Palliative Care|2|||
170527545|NCT00997334|616282877|FG000|Overall Study|No lesion amenable|1|||
170527546|NCT00997334|616282877|FG000|Overall Study|Ineligible|1|||
170527547|NCT01079780|616282879|FG000|Overall Study|Disease progression|43|||
170527548|NCT01079780|616282880|FG001|Overall Study|Disease progression|7|||
170527549|NCT01079780|616282881|FG002|Overall Study|Disease progression|31|||
170527550|NCT01079780|616282879|FG000|Overall Study|Adverse Event|13|||
170527551|NCT01079780|616282880|FG001|Overall Study|Adverse Event|5|||
170527552|NCT01079780|616282881|FG002|Overall Study|Adverse Event|7|||
170527553|NCT01079780|616282879|FG000|Overall Study|Death|2|||
170527554|NCT01079780|616282880|FG001|Overall Study|Death|0|||
170527555|NCT01079780|616282881|FG002|Overall Study|Death|2|||
170527556|NCT01079780|616282879|FG000|Overall Study|Withdrawal by Subject|6|||
170527557|NCT01079780|616282880|FG001|Overall Study|Withdrawal by Subject|4|||
170527558|NCT01079780|616282881|FG002|Overall Study|Withdrawal by Subject|4|||
170527559|NCT01079780|616282879|FG000|Overall Study|Alternative therapy|2|||
170527560|NCT01079780|616282880|FG001|Overall Study|Alternative therapy|0|||
170527561|NCT01079780|616282881|FG002|Overall Study|Alternative therapy|2|||
170527562|NCT01079780|616282879|FG000|Overall Study|Physician Decision|1|||
170527563|NCT01079780|616282880|FG001|Overall Study|Physician Decision|0|||
170527564|NCT01079780|616282881|FG002|Overall Study|Physician Decision|1|||
170527565|NCT01079780|616282879|FG000|Overall Study|Error made in lesion measurement|1|||
170527566|NCT01079780|616282880|FG001|Overall Study|Error made in lesion measurement|0|||
170527567|NCT01079780|616282881|FG002|Overall Study|Error made in lesion measurement|0|||
170527568|NCT01079780|616282879|FG000|Overall Study|Patient had surgery|1|||
170527569|NCT01079780|616282880|FG001|Overall Study|Patient had surgery|0|||
170527570|NCT01079780|616282881|FG002|Overall Study|Patient had surgery|0|||
170527571|NCT01079780|616282879|FG000|Overall Study|Treatment cycle delay|0|||
170527572|NCT01079780|616282880|FG001|Overall Study|Treatment cycle delay|0|||
170527573|NCT01079780|616282881|FG002|Overall Study|Treatment cycle delay|1|||
170527574|NCT01079780|616282879|FG000|Overall Study|Never started treatment|1|||
170527575|NCT01079780|616282880|FG001|Overall Study|Never started treatment|0|||
170527576|NCT01079780|616282881|FG002|Overall Study|Never started treatment|2|||
170527577|NCT00551369|616282882|FG000|Overall Study|Protocol Violation|5|||
170527578|NCT00551369|616282882|FG000|Overall Study|Withdrawal by Subject|1|||
170527579|NCT00551369|616282882|FG000|Overall Study|Not treated per protocol and re|1|||
170527580|NCT02051296|616282885|FG000|Overall Study|Lost to Follow-up|1|||
170527581|NCT02051296|616282886|FG001|Overall Study|Lost to Follow-up|2|||
170527582|NCT02051296|616282885|FG000|Overall Study|withdraw prior to treatment|7|||
170527583|NCT02051296|616282886|FG001|Overall Study|withdraw prior to treatment|7|||
170527584|NCT01663623|616282891|FG000|Overall Study|Adverse Event|3|||
170527585|NCT01663623|616282892|FG001|Overall Study|Adverse Event|7|||
170527586|NCT01663623|616282891|FG000|Overall Study|Lack of Efficacy|5|||
170527587|NCT01663623|616282892|FG001|Overall Study|Lack of Efficacy|6|||
170527588|NCT01663623|616282891|FG000|Overall Study|Protocol Violation|0|||
170527589|NCT01663623|616282892|FG001|Overall Study|Protocol Violation|1|||
170527590|NCT01663623|616282891|FG000|Overall Study|Other-Study closed/terminated|1|||
170527591|NCT01663623|616282892|FG001|Overall Study|Other-Study closed/terminated|1|||
170527592|NCT01663623|616282891|FG000|Overall Study|Physician Decision|1|||
170527593|NCT01663623|616282892|FG001|Overall Study|Physician Decision|4|||
170527594|NCT01663623|616282891|FG000|Overall Study|Withdrawal by Subject|2|||
170527595|NCT01663623|616282892|FG001|Overall Study|Withdrawal by Subject|1|||
170527596|NCT02251275|616282893|FG000|Overall Study|Adverse Event|23|||
170527597|NCT02251275|616282894|FG001|Overall Study|Adverse Event|60|||
170527598|NCT02251275|616282895|FG002|Overall Study|Adverse Event|28|||
170776569|NCT03584516|617188679|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
170776570|NCT03584516|617188680|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
170776571|NCT03584516|617188681|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
170527599|NCT02251275|616282896|FG003|Overall Study|Adverse Event|0|||
170527600|NCT02251275|616282897|FG004|Overall Study|Adverse Event|0|||
170527601|NCT02251275|616282893|FG000|Overall Study|Lost to Follow-up|5|||
170527602|NCT02251275|616282894|FG001|Overall Study|Lost to Follow-up|6|||
170527603|NCT02251275|616282895|FG002|Overall Study|Lost to Follow-up|4|||
170527604|NCT02251275|616282896|FG003|Overall Study|Lost to Follow-up|0|||
170527605|NCT02251275|616282897|FG004|Overall Study|Lost to Follow-up|0|||
170527606|NCT02251275|616282893|FG000|Overall Study|Physician Decision|19|||
170527607|NCT02251275|616282894|FG001|Overall Study|Physician Decision|30|||
170527608|NCT02251275|616282895|FG002|Overall Study|Physician Decision|26|||
170527609|NCT02251275|616282896|FG003|Overall Study|Physician Decision|0|||
170527610|NCT02251275|616282897|FG004|Overall Study|Physician Decision|1|||
170527611|NCT02251275|616282893|FG000|Overall Study|Protocol Deviation|0|||
170527612|NCT02251275|616282894|FG001|Overall Study|Protocol Deviation|0|||
170527613|NCT02251275|616282895|FG002|Overall Study|Protocol Deviation|1|||
170527614|NCT02251275|616282896|FG003|Overall Study|Protocol Deviation|0|||
170527615|NCT02251275|616282897|FG004|Overall Study|Protocol Deviation|0|||
170527616|NCT02251275|616282893|FG000|Overall Study|Withdrawal by Subject|25|||
170527617|NCT02251275|616282894|FG001|Overall Study|Withdrawal by Subject|51|||
170527618|NCT02251275|616282895|FG002|Overall Study|Withdrawal by Subject|35|||
170527619|NCT02251275|616282896|FG003|Overall Study|Withdrawal by Subject|1|||
170527620|NCT02251275|616282897|FG004|Overall Study|Withdrawal by Subject|0|||
170527621|NCT00827567|616282899|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
170527622|NCT02152007|616282900|FG000|Overall Study|Withdrawal by Subject|1|||
170527623|NCT02834975|616282905|FG000|Overall Study|Physician Decision|2|||
170527624|NCT02834975|616282905|FG000|Overall Study|Adverse Event|1|||
170527625|NCT02834975|616282905|FG000|Overall Study|Withdrawal by Subject|1|||
170527626|NCT02834975|616282905|FG000|Overall Study|Lack of Efficacy|1|||
170527627|NCT03363906|616282906|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
170527628|NCT03363906|616282907|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
170527629|NCT03363906|616282906|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
170527630|NCT03363906|616282907|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
170527631|NCT03363906|616282906|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
170527632|NCT03363906|616282907|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
170527633|NCT03363906|616282906|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
170527634|NCT03363906|616282907|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
170527635|NCT00676143|616282908|FG000|Overall Study|Adverse Event|34|||
170527636|NCT00676143|616282909|FG001|Overall Study|Adverse Event|60|||
170527637|NCT00676143|616282908|FG000|Overall Study|Death|4|||
170527638|NCT00676143|616282909|FG001|Overall Study|Death|4|||
170527639|NCT00676143|616282908|FG000|Overall Study|Lack of Efficacy|0|||
170776572|NCT03584516|617188676|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
170877095|NCT03977974|617560475|FG004|Period 2|Adverse Event|1|||
170415723|NCT03740165|615862079|FG000|Overall Study|Death|232|||
170415724|NCT03740165|615862080|FG001|Overall Study|Death|242|||
170415725|NCT03740165|615862081|FG002|Overall Study|Death|229|||
170415726|NCT03740165|615862079|FG000|Overall Study|Lost to Follow-up|0|||
170415727|NCT03740165|615862080|FG001|Overall Study|Lost to Follow-up|0|||
170415728|NCT03740165|615862081|FG002|Overall Study|Lost to Follow-up|1|||
170415729|NCT03740165|615862079|FG000|Overall Study|Withdrawal by Subject|7|||
170415730|NCT03740165|615862080|FG001|Overall Study|Withdrawal by Subject|4|||
170415731|NCT03740165|615862081|FG002|Overall Study|Withdrawal by Subject|3|||
170415732|NCT03740165|615862079|FG000|Overall Study|Ongoing in Study|216|||
170415733|NCT03740165|615862080|FG001|Overall Study|Ongoing in Study|212|||
170415734|NCT03740165|615862081|FG002|Overall Study|Ongoing in Study|221|||
170415735|NCT03049618|615862082|FG000|Overall Study|Death|1|||
170415736|NCT03049618|615862083|FG001|Overall Study|Death|0|||
170415737|NCT03049618|615862082|FG000|Overall Study|Lack of Efficacy|1|||
170415738|NCT03049618|615862083|FG001|Overall Study|Lack of Efficacy|2|||
170415739|NCT00936975|615862084|FG000|Overall Study|Withdrawal by Subject|1|||
170415740|NCT00936975|615862084|FG000|Overall Study|Disease progression|3|||
170415741|NCT00936975|615862084|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
170415742|NCT00926289|615862087|FG000|Overall Study|Adverse Event|9|||
170415743|NCT00926289|615862088|FG001|Overall Study|Adverse Event|11|||
170415744|NCT00926289|615862087|FG000|Overall Study|Protocol Violation|8|||
170415745|NCT00926289|615862088|FG001|Overall Study|Protocol Violation|12|||
170415746|NCT00926289|615862087|FG000|Overall Study|Lost to Follow-up|3|||
170415747|NCT00926289|615862088|FG001|Overall Study|Lost to Follow-up|6|||
170415748|NCT00926289|615862087|FG000|Overall Study|Withdrawal by Subject|4|||
170415749|NCT00926289|615862088|FG001|Overall Study|Withdrawal by Subject|4|||
170415750|NCT00926289|615862087|FG000|Overall Study|Other|1|||
170415751|NCT00926289|615862088|FG001|Overall Study|Other|3|||
170415752|NCT04104646|615862089|FG000|Overall Study|Withdrawal by Subject|1|||
170415753|NCT04104646|615862090|FG001|Overall Study|Withdrawal by Subject|1|||
170415754|NCT04104646|615862089|FG000|Overall Study|Lost to Follow-up|1|||
170415755|NCT04104646|615862090|FG001|Overall Study|Lost to Follow-up|0|||
170415756|NCT04104646|615862089|FG000|Overall Study|Physician Decision|2|||
170415757|NCT04104646|615862090|FG001|Overall Study|Physician Decision|0|||
170527640|NCT00676143|616282909|FG001|Overall Study|Lack of Efficacy|6|||
170527641|NCT00676143|616282908|FG000|Overall Study|Lost to Follow-up|0|||
170527642|NCT00676143|616282909|FG001|Overall Study|Lost to Follow-up|13|||
170415758|NCT01199601|615862091|FG000|Overall Study|Lost to Follow-up|47|||
170415759|NCT01199601|615862092|FG001|Overall Study|Lost to Follow-up|66|||
170415760|NCT01199601|615862091|FG000|Overall Study|Withdrawal by Subject|15|||
170527643|NCT00676143|616282908|FG000|Overall Study|Physician Decision|5|||
170527644|NCT00676143|616282909|FG001|Overall Study|Physician Decision|8|||
170527645|NCT00676143|616282908|FG000|Overall Study|Protocol Violation|4|||
170527646|NCT00676143|616282909|FG001|Overall Study|Protocol Violation|8|||
170527647|NCT00676143|616282908|FG000|Overall Study|Withdrawal by Subject|24|||
170527648|NCT00676143|616282909|FG001|Overall Study|Withdrawal by Subject|42|||
170527649|NCT00676143|616282908|FG000|Overall Study|Discontinuation of study by sponsor|65|||
170527650|NCT00676143|616282909|FG001|Overall Study|Discontinuation of study by sponsor|88|||
170527651|NCT00676143|616282908|FG000|Overall Study|Failed to return|2|||
170415761|NCT01199601|615862092|FG001|Overall Study|Withdrawal by Subject|3|||
170415762|NCT01199601|615862091|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
170415763|NCT01199601|615862092|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
170415764|NCT03276975|615862093|FG000|Overall Study|Withdrawal by Subject|1|||
170415765|NCT03276975|615862094|FG001|Overall Study|Withdrawal by Subject|0|||
170415766|NCT01446913|615862098|FG000|Overall Study|Significant illness|1|||
170415767|NCT01446913|615862099|FG001|Overall Study|Significant illness|1|||
170415768|NCT01446913|615862100|FG002|Overall Study|Significant illness|1|||
170415769|NCT01446913|615862098|FG000|Overall Study|Withdrawal by Subject|5|||
170415770|NCT01446913|615862099|FG001|Overall Study|Withdrawal by Subject|3|||
170415771|NCT01446913|615862100|FG002|Overall Study|Withdrawal by Subject|5|||
170415772|NCT01446913|615862098|FG000|Overall Study|Physician Decision|0|||
170415773|NCT01446913|615862099|FG001|Overall Study|Physician Decision|0|||
170415774|NCT01446913|615862100|FG002|Overall Study|Physician Decision|2|||
170415775|NCT01446913|615862098|FG000|Overall Study|Lost to Follow-up|3|||
170415776|NCT01446913|615862099|FG001|Overall Study|Lost to Follow-up|5|||
170415777|NCT01446913|615862100|FG002|Overall Study|Lost to Follow-up|3|||
170415778|NCT01485536|615862101|FG000|Overall Study|Withdrawal by Subject|3|||
170415779|NCT01485536|615862101|FG000|Overall Study|Adverse Event|1|||
170415780|NCT00717756|615862102|FG000|Overall Study|Withdrawal by Subject|1|||
170415781|NCT01364870|615862103|FG000|Overall Study|Withdrawal by Subject|13|||
170415782|NCT01364870|615862104|FG001|Overall Study|Withdrawal by Subject|24|||
170415783|NCT01364870|615862105|FG002|Overall Study|Withdrawal by Subject|10|||
170415784|NCT01364870|615862103|FG000|Overall Study|Adverse Event|8|||
170415785|NCT01364870|615862104|FG001|Overall Study|Adverse Event|6|||
170415786|NCT01364870|615862105|FG002|Overall Study|Adverse Event|4|||
170415787|NCT01364870|615862103|FG000|Overall Study|Protocol Violation|1|||
170415788|NCT01364870|615862104|FG001|Overall Study|Protocol Violation|0|||
170415789|NCT01364870|615862105|FG002|Overall Study|Protocol Violation|0|||
170415790|NCT01873859|615862106|FG000|Overall Study|Withdrawal by Subject|0|||
170415791|NCT01873859|615862107|FG001|Overall Study|Withdrawal by Subject|4|||
170415792|NCT00601484|615862108|FG000|Overall Study|Adverse Event|0|||
170415793|NCT00601484|615862109|FG001|Overall Study|Adverse Event|1|||
170415794|NCT00601484|615862108|FG000|Overall Study|Lost to Follow-up|4|||
170415795|NCT00601484|615862109|FG001|Overall Study|Lost to Follow-up|3|||
170415796|NCT00601484|615862108|FG000|Overall Study|Lack of Efficacy|0|||
170415797|NCT00601484|615862109|FG001|Overall Study|Lack of Efficacy|2|||
170415798|NCT00601484|615862108|FG000|Overall Study|Withdrawal by Subject|1|||
170415799|NCT00601484|615862109|FG001|Overall Study|Withdrawal by Subject|1|||
170415800|NCT00601484|615862108|FG000|Overall Study|Randomized, but not treated|0|||
170415801|NCT00601484|615862109|FG001|Overall Study|Randomized, but not treated|1|||
170415802|NCT03504852|615862110|FG000|Overall Study|Withdrawal of informed consent|2|||
170415803|NCT03504852|615862111|FG001|Overall Study|Withdrawal of informed consent|1|||
170415804|NCT03504852|615862112|FG002|Overall Study|Withdrawal of informed consent|0|||
170415805|NCT03504852|615862110|FG000|Overall Study|Withdrawal by Subject|5|||
170415806|NCT03504852|615862111|FG001|Overall Study|Withdrawal by Subject|5|||
170415807|NCT03504852|615862112|FG002|Overall Study|Withdrawal by Subject|1|||
170415808|NCT03504852|615862110|FG000|Overall Study|Lost to Follow-up|4|||
170415809|NCT03504852|615862111|FG001|Overall Study|Lost to Follow-up|1|||
170415810|NCT03504852|615862112|FG002|Overall Study|Lost to Follow-up|0|||
170415811|NCT03504852|615862110|FG000|Overall Study|New therapy for study indication|1|||
170415812|NCT03504852|615862111|FG001|Overall Study|New therapy for study indication|0|||
170415813|NCT03504852|615862112|FG002|Overall Study|New therapy for study indication|0|||
170415814|NCT03504852|615862110|FG000|Overall Study|Lack of Efficacy|1|||
170415815|NCT03504852|615862111|FG001|Overall Study|Lack of Efficacy|2|||
170415816|NCT03504852|615862112|FG002|Overall Study|Lack of Efficacy|0|||
170415817|NCT03504852|615862110|FG000|Overall Study|Death|0|||
170415818|NCT03504852|615862111|FG001|Overall Study|Death|1|||
170415819|NCT03504852|615862112|FG002|Overall Study|Death|0|||
170415820|NCT03504852|615862110|FG000|Overall Study|Adverse Event|4|||
170415821|NCT03504852|615862111|FG001|Overall Study|Adverse Event|8|||
170415822|NCT03504852|615862112|FG002|Overall Study|Adverse Event|2|||
170415823|NCT00745251|615862113|FG000|Overall Study|Adverse Event|1|||
170415824|NCT00745251|615862114|FG001|Overall Study|Adverse Event|2|||
170415825|NCT00745251|615862113|FG000|Overall Study|Withdrawal by Subject|1|||
170415826|NCT00745251|615862114|FG001|Overall Study|Withdrawal by Subject|1|||
170415827|NCT02928848|615862115|FG000|Arm 2|Withdrawal by Subject|1|||
170415828|NCT02928848|615862116|FG001|Arm 2|Withdrawal by Subject|0|||
170415829|NCT03850509|615862117|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
170415830|NCT03850509|615862118|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
170776573|NCT03584516|617188677|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
170776574|NCT03584516|617188678|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
170776575|NCT03584516|617188679|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
170776576|NCT03584516|617188680|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
170776577|NCT03584516|617188681|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
170776578|NCT05846646|617188682|FG000|Overall Study|Physician Decision|1|||
170776579|NCT05846646|617188683|FG001|Overall Study|Physician Decision|0|||
170776580|NCT05846646|617188684|FG002|Overall Study|Physician Decision|0|||
170415831|NCT03095352|615862123|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
170415832|NCT03095352|615862124|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
170415833|NCT03111147|615862125|FG000|Overall Study|Lost to Follow-up|2|||
170415834|NCT03111147|615862126|FG001|Overall Study|Lost to Follow-up|5|||
170415835|NCT03111147|615862125|FG000|Overall Study|Withdrawal by Subject|4|||
170415836|NCT03111147|615862126|FG001|Overall Study|Withdrawal by Subject|3|||
170415837|NCT03111147|615862125|FG000|Overall Study|Protocol Violation|2|||
170415838|NCT03111147|615862126|FG001|Overall Study|Protocol Violation|1|||
170415839|NCT03111147|615862125|FG000|Overall Study|Death|1|||
170415840|NCT03111147|615862126|FG001|Overall Study|Death|1|||
170415841|NCT01463683|615862127|FG000|Overall Study|Adverse Event|2|||
170415842|NCT01463683|615862128|FG001|Overall Study|Adverse Event|0|||
170415843|NCT01463683|615862129|FG002|Overall Study|Adverse Event|0|||
170415844|NCT01463683|615862127|FG000|Overall Study|Lost to Follow-up|10|||
170415845|NCT01463683|615862128|FG001|Overall Study|Lost to Follow-up|9|||
170415846|NCT01463683|615862129|FG002|Overall Study|Lost to Follow-up|7|||
170415847|NCT01463683|615862127|FG000|Overall Study|Physician Decision|0|||
170415848|NCT01463683|615862128|FG001|Overall Study|Physician Decision|3|||
170415849|NCT01463683|615862129|FG002|Overall Study|Physician Decision|1|||
170415850|NCT01463683|615862127|FG000|Overall Study|Pregnancy|2|||
170415851|NCT01463683|615862128|FG001|Overall Study|Pregnancy|2|||
170415852|NCT01463683|615862129|FG002|Overall Study|Pregnancy|1|||
170415853|NCT01463683|615862127|FG000|Overall Study|Withdrawal by Subject|5|||
170415854|NCT01463683|615862128|FG001|Overall Study|Withdrawal by Subject|17|||
170415855|NCT01463683|615862129|FG002|Overall Study|Withdrawal by Subject|2|||
170415856|NCT03384745|615862132|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
170415857|NCT03384745|615862133|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
170415858|NCT03384745|615862134|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
170415859|NCT03384745|615862135|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
170415860|NCT03384745|615862136|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
170415861|NCT03384745|615862137|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
170415862|NCT03384745|615862132|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
170415863|NCT03384745|615862133|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
170776581|NCT05846646|617188682|FG000|Overall Study|Lack of Efficacy|1|||
170415864|NCT03384745|615862134|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
170415865|NCT03384745|615862135|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
170415866|NCT03384745|615862136|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
170415867|NCT03384745|615862137|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
170776582|NCT05846646|617188683|FG001|Overall Study|Lack of Efficacy|1|||
170776583|NCT05846646|617188684|FG002|Overall Study|Lack of Efficacy|0|||
170527652|NCT00676143|616282909|FG001|Overall Study|Failed to return|1|||
170527653|NCT00676143|616282908|FG000|Overall Study|Loss of caregiver|5|||
170527654|NCT00676143|616282909|FG001|Overall Study|Loss of caregiver|3|||
170527655|NCT00676143|616282908|FG000|Overall Study|Other|11|||
170527656|NCT00676143|616282909|FG001|Overall Study|Other|20|||
170527657|NCT00676143|616282908|FG000|Overall Study|Participant participation unknown|1|||
170527658|NCT00676143|616282909|FG001|Overall Study|Participant participation unknown|4|||
170527659|NCT00676143|616282908|FG000|Overall Study|Vasogenic edema recurrence|1|||
170527660|NCT00676143|616282909|FG001|Overall Study|Vasogenic edema recurrence|3|||
170527661|NCT00929669|616282910|FG000|Overall Study|elevated glucose levels|1|||
170527662|NCT00472420|616282911|FG000|Induction Treatment Period|Physician Decision|9|||
170527663|NCT00472420|616282911|FG000|Induction Treatment Period|Adverse Event|3|||
170527664|NCT00472420|616282911|FG000|Induction Treatment Period|Non-compliance|1|||
170527665|NCT00472420|616282911|FG000|Induction Treatment Period|Death|3|||
170527666|NCT00472420|616282911|FG000|Follow-up Period|Death|5|||
170527667|NCT00472420|616282911|FG000|Follow-up Period|Physician Decision|9|||
170527668|NCT00472420|616282911|FG000|Follow-up Period|Lost to Follow-up|2|||
170527669|NCT00472420|616282911|FG000|Follow-up Period|Protocol Violation|1|||
170527670|NCT01200355|616282913|FG000|Overall Study|Death|7|||
170527671|NCT01200355|616282914|FG001|Overall Study|Death|2|||
170527672|NCT01281306|616282915|FG000|Overall Study|Lack of Efficacy|0|||
170527673|NCT01281306|616282916|FG001|Overall Study|Lack of Efficacy|1|||
170527674|NCT01281306|616282917|FG002|Overall Study|Lack of Efficacy|3|||
170527675|NCT01281306|616282918|FG003|Overall Study|Lack of Efficacy|0|||
170527676|NCT01281306|616282919|FG004|Overall Study|Lack of Efficacy|2|||
170527677|NCT01281306|616282920|FG005|Overall Study|Lack of Efficacy|0|||
170527678|NCT01281306|616282921|FG006|Overall Study|Lack of Efficacy|1|||
170527679|NCT01281306|616282915|FG000|Overall Study|Withdrawal by Subject|1|||
170527680|NCT01281306|616282916|FG001|Overall Study|Withdrawal by Subject|0|||
170527681|NCT01281306|616282917|FG002|Overall Study|Withdrawal by Subject|2|||
170527682|NCT01281306|616282918|FG003|Overall Study|Withdrawal by Subject|4|||
170527683|NCT01281306|616282919|FG004|Overall Study|Withdrawal by Subject|1|||
170527684|NCT01281306|616282920|FG005|Overall Study|Withdrawal by Subject|3|||
170527685|NCT01281306|616282921|FG006|Overall Study|Withdrawal by Subject|1|||
170527686|NCT01281306|616282915|FG000|Overall Study|Protocol deviation|0|||
170527687|NCT01281306|616282916|FG001|Overall Study|Protocol deviation|1|||
170527688|NCT01281306|616282917|FG002|Overall Study|Protocol deviation|1|||
170527689|NCT01281306|616282918|FG003|Overall Study|Protocol deviation|1|||
170527690|NCT01281306|616282919|FG004|Overall Study|Protocol deviation|1|||
170527691|NCT01281306|616282920|FG005|Overall Study|Protocol deviation|0|||
170527692|NCT01281306|616282921|FG006|Overall Study|Protocol deviation|0|||
170527693|NCT01281306|616282915|FG000|Overall Study|Condition no longer requires study drug|1|||
170527694|NCT01281306|616282916|FG001|Overall Study|Condition no longer requires study drug|0|||
170527695|NCT01281306|616282917|FG002|Overall Study|Condition no longer requires study drug|0|||
170527696|NCT01281306|616282918|FG003|Overall Study|Condition no longer requires study drug|0|||
170527697|NCT01281306|616282919|FG004|Overall Study|Condition no longer requires study drug|0|||
170527698|NCT01281306|616282920|FG005|Overall Study|Condition no longer requires study drug|1|||
170527699|NCT01281306|616282921|FG006|Overall Study|Condition no longer requires study drug|1|||
170527700|NCT01281306|616282915|FG000|Overall Study|Lost to Follow-up|1|||
170527701|NCT01281306|616282916|FG001|Overall Study|Lost to Follow-up|0|||
170776584|NCT05846646|617188682|FG000|Overall Study|Early Study Termination|1|||
170776585|NCT05846646|617188683|FG001|Overall Study|Early Study Termination|2|||
170776586|NCT05846646|617188684|FG002|Overall Study|Early Study Termination|0|||
170776587|NCT05773313|617188689|FG000|Overall Study|Lost to Follow-up|3|||
170776588|NCT03050814|617188690|FG000|Overall Study|Screen failures|0|||
170776589|NCT03050814|617188691|FG001|Overall Study|Screen failures|0|||
170776590|NCT03050814|617188692|FG002|Overall Study|Screen failures|4|||
170776591|NCT05137236|617188693|FG000|Part A|Other than Specified|1|||
170776592|NCT05137236|617188694|FG001|Part A|Other than Specified|0|||
170776593|NCT05137236|617188695|FG002|Part A|Other than Specified|0|||
170776594|NCT05137236|617188696|FG003|Part A|Other than Specified|0|||
170776595|NCT05137236|617188697|FG004|Part A|Other than Specified|0|||
170776596|NCT05137236|617188698|FG005|Part A|Other than Specified|0|||
170527702|NCT01281306|616282917|FG002|Overall Study|Lost to Follow-up|0|||
170527703|NCT01281306|616282918|FG003|Overall Study|Lost to Follow-up|2|||
170527704|NCT01281306|616282919|FG004|Overall Study|Lost to Follow-up|0|||
170527705|NCT01281306|616282920|FG005|Overall Study|Lost to Follow-up|0|||
170527706|NCT01281306|616282921|FG006|Overall Study|Lost to Follow-up|1|||
170527707|NCT01281306|616282915|FG000|Overall Study|Death|1|||
170776597|NCT05137236|617188699|FG006|Part A|Other than Specified|0|||
170527708|NCT01281306|616282916|FG001|Overall Study|Death|0|||
170527709|NCT01281306|616282917|FG002|Overall Study|Death|0|||
170527710|NCT01281306|616282918|FG003|Overall Study|Death|0|||
170527711|NCT01281306|616282919|FG004|Overall Study|Death|0|||
170527712|NCT01281306|616282920|FG005|Overall Study|Death|0|||
170527713|NCT01281306|616282921|FG006|Overall Study|Death|0|||
170527714|NCT01281306|616282915|FG000|Overall Study|Adverse Event|3|||
170527715|NCT01281306|616282916|FG001|Overall Study|Adverse Event|2|||
170527716|NCT01281306|616282917|FG002|Overall Study|Adverse Event|2|||
170527717|NCT01281306|616282918|FG003|Overall Study|Adverse Event|3|||
170527718|NCT01281306|616282919|FG004|Overall Study|Adverse Event|5|||
170527719|NCT01281306|616282920|FG005|Overall Study|Adverse Event|3|||
170527720|NCT01281306|616282921|FG006|Overall Study|Adverse Event|3|||
170776598|NCT05137236|617188700|FG007|Part A|Other than Specified|0|||
170776599|NCT05137236|617188693|FG000|Part A|Withdrawal by Subject|0|||
170776600|NCT05137236|617188694|FG001|Part A|Withdrawal by Subject|4|||
170776601|NCT05137236|617188695|FG002|Part A|Withdrawal by Subject|1|||
170776602|NCT05137236|617188696|FG003|Part A|Withdrawal by Subject|1|||
170776603|NCT05137236|617188697|FG004|Part A|Withdrawal by Subject|3|||
170776604|NCT05137236|617188698|FG005|Part A|Withdrawal by Subject|2|||
170776605|NCT05137236|617188699|FG006|Part A|Withdrawal by Subject|0|||
170776606|NCT05137236|617188700|FG007|Part A|Withdrawal by Subject|0|||
170776607|NCT05137236|617188693|FG000|Part A|Lost to Follow-up|5|||
170776608|NCT05137236|617188694|FG001|Part A|Lost to Follow-up|7|||
170776609|NCT05137236|617188695|FG002|Part A|Lost to Follow-up|1|||
170776610|NCT05137236|617188696|FG003|Part A|Lost to Follow-up|3|||
170776611|NCT05137236|617188697|FG004|Part A|Lost to Follow-up|3|||
170776612|NCT05137236|617188698|FG005|Part A|Lost to Follow-up|8|||
170776613|NCT05137236|617188699|FG006|Part A|Lost to Follow-up|0|||
170776614|NCT05137236|617188700|FG007|Part A|Lost to Follow-up|0|||
170776615|NCT05137236|617188693|FG000|Part B|Withdrawal by Subject|0|||
170776616|NCT05137236|617188694|FG001|Part B|Withdrawal by Subject|0|||
170776617|NCT05137236|617188695|FG002|Part B|Withdrawal by Subject|0|||
170776618|NCT05137236|617188696|FG003|Part B|Withdrawal by Subject|0|||
170776619|NCT05137236|617188697|FG004|Part B|Withdrawal by Subject|0|||
170776620|NCT05137236|617188698|FG005|Part B|Withdrawal by Subject|0|||
170776621|NCT05137236|617188699|FG006|Part B|Withdrawal by Subject|0|||
170776622|NCT05137236|617188700|FG007|Part B|Withdrawal by Subject|2|||
170776623|NCT05137236|617188693|FG000|Part B|Lost to Follow-up|0|||
170776624|NCT05137236|617188694|FG001|Part B|Lost to Follow-up|0|||
170776625|NCT05137236|617188695|FG002|Part B|Lost to Follow-up|0|||
170776626|NCT05137236|617188696|FG003|Part B|Lost to Follow-up|0|||
170776627|NCT05137236|617188697|FG004|Part B|Lost to Follow-up|0|||
170776628|NCT05137236|617188698|FG005|Part B|Lost to Follow-up|0|||
170776629|NCT05137236|617188699|FG006|Part B|Lost to Follow-up|5|||
170776630|NCT05137236|617188700|FG007|Part B|Lost to Follow-up|5|||
170776631|NCT05137236|617188693|FG000|Part B|Death|0|||
170776632|NCT05137236|617188694|FG001|Part B|Death|0|||
170776633|NCT05137236|617188695|FG002|Part B|Death|0|||
170776634|NCT05137236|617188696|FG003|Part B|Death|0|||
170776635|NCT05137236|617188697|FG004|Part B|Death|0|||
170776636|NCT05137236|617188698|FG005|Part B|Death|0|||
170776637|NCT05137236|617188699|FG006|Part B|Death|0|||
170776638|NCT05137236|617188700|FG007|Part B|Death|2|||
170776639|NCT00402246|617188701|FG000|Overall Study|Death|62|||
170776640|NCT00402246|617188702|FG001|Overall Study|Death|58|||
170776641|NCT00402246|617188701|FG000|Overall Study|Lost to Follow-up|20|||
170776642|NCT00402246|617188702|FG001|Overall Study|Lost to Follow-up|28|||
170776643|NCT00402246|617188701|FG000|Overall Study|Withdrawal by Subject|72|||
170776644|NCT00402246|617188702|FG001|Overall Study|Withdrawal by Subject|87|||
170776645|NCT00402246|617188701|FG000|Overall Study|Physician Decision|24|||
170776646|NCT00402246|617188702|FG001|Overall Study|Physician Decision|26|||
170776647|NCT00402246|617188701|FG000|Overall Study|Protocol Violation|25|||
170776648|NCT00402246|617188702|FG001|Overall Study|Protocol Violation|24|||
170776649|NCT00402246|617188701|FG000|Overall Study|Missed Final Visit|1|||
170776650|NCT00402246|617188702|FG001|Overall Study|Missed Final Visit|2|||
170776651|NCT00402246|617188701|FG000|Overall Study|Insurance Issues|2|||
170776652|NCT00402246|617188702|FG001|Overall Study|Insurance Issues|1|||
170527721|NCT01281306|616282915|FG000|Overall Study|Randomized in error|1|||
170776653|NCT00402246|617188701|FG000|Overall Study|Heart Transplant|0|||
170776654|NCT00402246|617188702|FG001|Overall Study|Heart Transplant|1|||
170776655|NCT00402246|617188701|FG000|Overall Study|Patient's device explanted|6|||
170776656|NCT00402246|617188702|FG001|Overall Study|Patient's device explanted|2|||
170776657|NCT00402246|617188701|FG000|Overall Study|Center Closure|5|||
170776658|NCT00402246|617188702|FG001|Overall Study|Center Closure|3|||
170776659|NCT00402246|617188701|FG000|Overall Study|Deterioriating Condition|3|||
170776660|NCT00402246|617188702|FG001|Overall Study|Deterioriating Condition|2|||
170877096|NCT03977974|617560476|FG005|Period 2|Adverse Event|0|||
170877097|NCT03977974|617560477|FG006|Period 2|Adverse Event|0|||
170527722|NCT01281306|616282916|FG001|Overall Study|Randomized in error|0|||
170776661|NCT00431834|617188707|FG000|Overall Study|Withdrawal by Subject|7|||
170776662|NCT00431834|617188707|FG000|Overall Study|Death|3|||
170776663|NCT00431834|617188707|FG000|Overall Study|Missed Endpoint Visit|2|||
170527723|NCT01281306|616282917|FG002|Overall Study|Randomized in error|0|||
170776664|NCT00431834|617188707|FG000|Overall Study|Lost to Follow-up|1|||
170776665|NCT01471691|617188708|FG000|Overall Study|Lack of Efficacy|0|||
170776666|NCT01471691|617188709|FG001|Overall Study|Lack of Efficacy|1|||
170776667|NCT02622568|617188712|FG000|Overall Study|Lost to Follow-up|5|||
170776668|NCT02622568|617188713|FG001|Overall Study|Lost to Follow-up|5|||
170776669|NCT02015520|617188714|FG000|Overall Study|Lack of Efficacy|1|||
170776670|NCT02015520|617188715|FG001|Overall Study|Lack of Efficacy|0|||
170776671|NCT02015520|617188716|FG002|Overall Study|Lack of Efficacy|3|||
170776672|NCT02015520|617188717|FG003|Overall Study|Lack of Efficacy|2|||
170776673|NCT02015520|617188714|FG000|Overall Study|Adverse Event|0|||
170776674|NCT02015520|617188715|FG001|Overall Study|Adverse Event|0|||
170776675|NCT02015520|617188716|FG002|Overall Study|Adverse Event|0|||
170776676|NCT02015520|617188717|FG003|Overall Study|Adverse Event|1|||
170776677|NCT02015520|617188714|FG000|Overall Study|Withdrawal by Subject|2|||
170776678|NCT02015520|617188715|FG001|Overall Study|Withdrawal by Subject|2|||
170776679|NCT02015520|617188716|FG002|Overall Study|Withdrawal by Subject|1|||
170776680|NCT02015520|617188717|FG003|Overall Study|Withdrawal by Subject|0|||
170776681|NCT02015520|617188714|FG000|Overall Study|Death|1|||
170776682|NCT02015520|617188715|FG001|Overall Study|Death|0|||
170776683|NCT02015520|617188716|FG002|Overall Study|Death|0|||
170776684|NCT02015520|617188717|FG003|Overall Study|Death|0|||
170776685|NCT02015520|617188714|FG000|Overall Study|Lost to Follow-up|0|||
170776686|NCT02015520|617188715|FG001|Overall Study|Lost to Follow-up|0|||
170776687|NCT02015520|617188716|FG002|Overall Study|Lost to Follow-up|1|||
170776688|NCT02015520|617188717|FG003|Overall Study|Lost to Follow-up|0|||
170776689|NCT02015520|617188714|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
170776690|NCT02015520|617188715|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
170776691|NCT02015520|617188716|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
170776692|NCT02015520|617188717|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
170776693|NCT02015520|617188714|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
170776694|NCT02015520|617188715|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
170776695|NCT02015520|617188716|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
170776696|NCT02015520|617188717|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
170776697|NCT05489484|617188724|FG000|Overall Study|withdrawn|1|||
170776698|NCT01610297|617188727|FG000|Overall Study|Lost to Follow-up|1|||
170776699|NCT01250769|617188728|FG000|Overall Study|Withdrawal by Subject|0|||
170776700|NCT01250769|617188729|FG001|Overall Study|Withdrawal by Subject|1|||
170776701|NCT01250769|617188730|FG002|Overall Study|Withdrawal by Subject|1|||
170776702|NCT01250769|617188731|FG003|Overall Study|Withdrawal by Subject|0|||
170776703|NCT01250769|617188728|FG000|Overall Study|Adverse Event|0|||
170415868|NCT03384745|615862132|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
170415869|NCT03384745|615862133|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
170415870|NCT03384745|615862134|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
170415871|NCT03384745|615862135|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
170415872|NCT03384745|615862136|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
170415873|NCT03384745|615862137|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
170415874|NCT03384745|615862132|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
170415875|NCT03384745|615862133|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
170415876|NCT03384745|615862134|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
170415877|NCT03384745|615862135|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
170415878|NCT03384745|615862136|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
170415879|NCT03384745|615862137|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
170415880|NCT03384745|615862132|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
170415881|NCT03384745|615862133|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
170415882|NCT03384745|615862134|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
170415883|NCT03384745|615862135|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
170415884|NCT03384745|615862136|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
170415885|NCT03384745|615862137|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
170415886|NCT03384745|615862132|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
170415887|NCT03384745|615862133|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
170415888|NCT03384745|615862134|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
170415889|NCT03384745|615862135|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
170415890|NCT03384745|615862136|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
170415891|NCT03384745|615862137|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
170776704|NCT01250769|617188729|FG001|Overall Study|Adverse Event|0|||
170776705|NCT01250769|617188730|FG002|Overall Study|Adverse Event|1|||
170776706|NCT01250769|617188731|FG003|Overall Study|Adverse Event|0|||
170776707|NCT01985334|617188732|FG000|Overall Study|Administrative problems|1|||
170776708|NCT01985334|617188733|FG001|Overall Study|Administrative problems|1|||
170776709|NCT01985334|617188734|FG002|Overall Study|Administrative problems|0|||
170776710|NCT01985334|617188735|FG003|Overall Study|Administrative problems|2|||
170776711|NCT01985334|617188736|FG004|Overall Study|Administrative problems|0|||
170776712|NCT01985334|617188737|FG005|Overall Study|Administrative problems|1|||
170776713|NCT01985334|617188738|FG006|Overall Study|Administrative problems|1|||
170776714|NCT01985334|617188739|FG007|Overall Study|Administrative problems|3|||
170415892|NCT03384745|615862132|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
170415893|NCT03384745|615862133|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
170527724|NCT01281306|616282918|FG003|Overall Study|Randomized in error|1|||
170527725|NCT01281306|616282919|FG004|Overall Study|Randomized in error|0|||
170527726|NCT01281306|616282920|FG005|Overall Study|Randomized in error|0|||
170527727|NCT01281306|616282921|FG006|Overall Study|Randomized in error|0|||
170527728|NCT00368550|616282922|FG000|Overall Study|Adverse Event|7|||
170527729|NCT00368550|616282923|FG001|Overall Study|Adverse Event|4|||
170527730|NCT00368550|616282922|FG000|Overall Study|Lack of Efficacy|4|||
170527731|NCT00368550|616282923|FG001|Overall Study|Lack of Efficacy|9|||
170527732|NCT00368550|616282922|FG000|Overall Study|Withdrawal by Subject|17|||
170527733|NCT00368550|616282923|FG001|Overall Study|Withdrawal by Subject|10|||
170527734|NCT02737722|616282924|FG000|Overall Study|Physician Decision|0|||
170527735|NCT02737722|616282925|FG001|Overall Study|Physician Decision|0|||
170527736|NCT02737722|616282926|FG002|Overall Study|Physician Decision|1|||
170527737|NCT02737722|616282927|FG003|Overall Study|Physician Decision|0|||
170527738|NCT01026493|616282928|FG000|Overall Study|Protocol Violation|0|||
170527739|NCT01026493|616282929|FG001|Overall Study|Protocol Violation|1|||
170527740|NCT01026493|616282930|FG002|Overall Study|Protocol Violation|0|||
170527741|NCT01026493|616282931|FG003|Overall Study|Protocol Violation|0|||
170527742|NCT01026493|616282932|FG004|Overall Study|Protocol Violation|2|||
170527743|NCT01026493|616282933|FG005|Overall Study|Protocol Violation|3|||
170527744|NCT01026493|616282934|FG006|Overall Study|Protocol Violation|4|||
170527745|NCT01026493|616282935|FG007|Overall Study|Protocol Violation|1|||
170527746|NCT03154086|616282940|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527747|NCT03154086|616282941|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527748|NCT03154086|616282942|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527749|NCT03154086|616282943|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
170527750|NCT03154086|616282944|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527751|NCT03154086|616282945|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527752|NCT03154086|616282946|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527753|NCT03154086|616282947|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527754|NCT03154086|616282948|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527755|NCT03154086|616282949|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527756|NCT03154086|616282950|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527757|NCT03154086|616282951|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527758|NCT03154086|616282952|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527759|NCT03154086|616282953|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170527760|NCT03154086|616282954|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
170776715|NCT01985334|617188732|FG000|Overall Study|Death|1|||
170776716|NCT01985334|617188733|FG001|Overall Study|Death|0|||
170776717|NCT01985334|617188734|FG002|Overall Study|Death|0|||
170776718|NCT01985334|617188735|FG003|Overall Study|Death|3|||
170776719|NCT01985334|617188736|FG004|Overall Study|Death|0|||
170776720|NCT01985334|617188737|FG005|Overall Study|Death|0|||
170776721|NCT01985334|617188738|FG006|Overall Study|Death|1|||
170776722|NCT01985334|617188739|FG007|Overall Study|Death|2|||
170776723|NCT01985334|617188732|FG000|Overall Study|Worsening of disease|0|||
170776724|NCT01985334|617188733|FG001|Overall Study|Worsening of disease|0|||
170776725|NCT01985334|617188734|FG002|Overall Study|Worsening of disease|0|||
170776726|NCT01985334|617188735|FG003|Overall Study|Worsening of disease|1|||
170776727|NCT01985334|617188736|FG004|Overall Study|Worsening of disease|0|||
170776728|NCT01985334|617188737|FG005|Overall Study|Worsening of disease|3|||
170776729|NCT01985334|617188738|FG006|Overall Study|Worsening of disease|0|||
170776730|NCT01985334|617188739|FG007|Overall Study|Worsening of disease|1|||
170415894|NCT03384745|615862134|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
170415895|NCT03384745|615862135|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
170415896|NCT03384745|615862136|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
170415897|NCT03384745|615862137|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
170415898|NCT03384745|615862132|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
170415899|NCT03384745|615862133|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
170415900|NCT03384745|615862134|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
170415901|NCT03384745|615862135|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
170415902|NCT03384745|615862136|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
170415903|NCT03384745|615862137|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
170415904|NCT03384745|615862132|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
170527761|NCT03154086|616282940|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527762|NCT03154086|616282941|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
170776731|NCT01985334|617188732|FG000|Overall Study|Other|2|||
170776732|NCT01985334|617188733|FG001|Overall Study|Other|9|||
170776733|NCT01985334|617188734|FG002|Overall Study|Other|7|||
170776734|NCT01985334|617188735|FG003|Overall Study|Other|17|||
170776735|NCT01985334|617188736|FG004|Overall Study|Other|4|||
170776736|NCT01985334|617188737|FG005|Overall Study|Other|8|||
170776737|NCT01985334|617188738|FG006|Overall Study|Other|4|||
170776738|NCT01985334|617188739|FG007|Overall Study|Other|7|||
170776739|NCT01985334|617188732|FG000|Overall Study|Protocol deviation|6|||
170415905|NCT03384745|615862133|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
170415906|NCT03384745|615862134|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
170415907|NCT03384745|615862135|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
170415908|NCT03384745|615862136|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
170415909|NCT03384745|615862137|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
170415910|NCT03384745|615862132|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
170415911|NCT03384745|615862133|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
170415912|NCT03384745|615862134|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
170415913|NCT03384745|615862135|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
170415914|NCT03384745|615862136|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
170415915|NCT03384745|615862137|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
170415916|NCT03384745|615862132|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
170415917|NCT03384745|615862133|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
170415918|NCT03384745|615862134|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
170415919|NCT03384745|615862135|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
170415920|NCT03384745|615862136|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
170415921|NCT03384745|615862137|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
170415922|NCT01058421|615862138|FG000|1 Month Outcomes|Death|10|||
170415923|NCT01058421|615862139|FG001|1 Month Outcomes|Death|6|||
170415924|NCT01058421|615862138|FG000|1 Month Outcomes|Lost to Follow-up|8|||
170415925|NCT01058421|615862139|FG001|1 Month Outcomes|Lost to Follow-up|7|||
170415926|NCT01058421|615862138|FG000|1 Month Outcomes|Remained in Hospital|5|||
170415927|NCT01058421|615862139|FG001|1 Month Outcomes|Remained in Hospital|12|||
170415928|NCT01058421|615862138|FG000|1 Month Outcomes|Remained in Other Facility|16|||
170415929|NCT01058421|615862139|FG001|1 Month Outcomes|Remained in Other Facility|17|||
170415930|NCT01058421|615862138|FG000|3 Month Outcomes|Death|3|||
170415931|NCT01058421|615862139|FG001|3 Month Outcomes|Death|5|||
170415932|NCT01058421|615862138|FG000|3 Month Outcomes|Lost to Follow-up|12|||
170415933|NCT01058421|615862139|FG001|3 Month Outcomes|Lost to Follow-up|11|||
170415934|NCT01058421|615862138|FG000|3 Month Outcomes|Remained in Hospital|0|||
170415935|NCT01058421|615862139|FG001|3 Month Outcomes|Remained in Hospital|2|||
170415936|NCT01058421|615862138|FG000|3 Month Outcomes|Remained in Other Facility|5|||
170415937|NCT01058421|615862139|FG001|3 Month Outcomes|Remained in Other Facility|8|||
170415938|NCT01058421|615862138|FG000|6 Month Outcomes|Death|2|||
170415939|NCT01058421|615862139|FG001|6 Month Outcomes|Death|2|||
170415940|NCT01058421|615862138|FG000|6 Month Outcomes|Lost to Follow-up|16|||
170415941|NCT01058421|615862139|FG001|6 Month Outcomes|Lost to Follow-up|21|||
170415942|NCT01058421|615862138|FG000|6 Month Outcomes|Remained in Other Facility|1|||
170415943|NCT01058421|615862139|FG001|6 Month Outcomes|Remained in Other Facility|3|||
170415944|NCT02779855|615862140|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
170415945|NCT02779855|615862141|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
170415946|NCT02779855|615862142|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
170415947|NCT00319449|615862151|FG000|Overall Study|Subject did not wish to continue|1|||
170415948|NCT00319449|615862152|FG001|Overall Study|Subject did not wish to continue|0|||
170415949|NCT00319449|615862151|FG000|Overall Study|Noncompliance with the protocol|1|||
170415950|NCT00319449|615862152|FG001|Overall Study|Noncompliance with the protocol|0|||
170415951|NCT01497938|615862153|FG000|Overall Study|Adverse Event|0|||
170415952|NCT01497938|615862154|FG001|Overall Study|Adverse Event|1|||
170415953|NCT01497938|615862153|FG000|Overall Study|Physician Decision|0|||
170415954|NCT01497938|615862154|FG001|Overall Study|Physician Decision|1|||
170415955|NCT01497938|615862153|FG000|Overall Study|Withdrawal by Subject|4|||
170415956|NCT01497938|615862154|FG001|Overall Study|Withdrawal by Subject|0|||
170415957|NCT01497938|615862153|FG000|Overall Study|Device Violation|1|||
170415958|NCT01497938|615862154|FG001|Overall Study|Device Violation|0|||
170527763|NCT03154086|616282942|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527764|NCT03154086|616282943|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527765|NCT03154086|616282944|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527766|NCT03154086|616282945|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527767|NCT03154086|616282946|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527768|NCT03154086|616282947|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527769|NCT03154086|616282948|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527770|NCT03154086|616282949|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527771|NCT03154086|616282950|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527772|NCT03154086|616282951|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527773|NCT03154086|616282952|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527774|NCT03154086|616282953|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527775|NCT03154086|616282954|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
170527776|NCT03154086|616282940|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527777|NCT03154086|616282941|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527778|NCT03154086|616282942|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
170527779|NCT03154086|616282943|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170776740|NCT01985334|617188733|FG001|Overall Study|Protocol deviation|31|||
170776741|NCT01985334|617188734|FG002|Overall Study|Protocol deviation|25|||
170776742|NCT01985334|617188735|FG003|Overall Study|Protocol deviation|84|||
170776743|NCT01985334|617188736|FG004|Overall Study|Protocol deviation|17|||
170776744|NCT01985334|617188737|FG005|Overall Study|Protocol deviation|47|||
170776745|NCT01985334|617188738|FG006|Overall Study|Protocol deviation|15|||
170776746|NCT01985334|617188739|FG007|Overall Study|Protocol deviation|42|||
170776747|NCT01985334|617188732|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
170776748|NCT01985334|617188733|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
170776749|NCT01985334|617188734|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
170415959|NCT00365352|615862155|FG000|Overall Study|Adverse Event|6|||
170415960|NCT00365352|615862156|FG001|Overall Study|Adverse Event|7|||
170415961|NCT00365352|615862157|FG002|Overall Study|Adverse Event|8|||
170415962|NCT00365352|615862155|FG000|Overall Study|Participant Withdrew Consent|8|||
170415963|NCT00365352|615862156|FG001|Overall Study|Participant Withdrew Consent|3|||
170415964|NCT00365352|615862157|FG002|Overall Study|Participant Withdrew Consent|4|||
170776750|NCT01985334|617188735|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
170776751|NCT01985334|617188736|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
170776752|NCT01985334|617188737|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
170776753|NCT01985334|617188738|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
170776754|NCT01985334|617188739|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
170776755|NCT01985334|617188732|FG000|Overall Study|Subject withdrawal of consent|3|||
170776756|NCT01985334|617188733|FG001|Overall Study|Subject withdrawal of consent|6|||
170776757|NCT01985334|617188734|FG002|Overall Study|Subject withdrawal of consent|2|||
170776758|NCT01985334|617188735|FG003|Overall Study|Subject withdrawal of consent|28|||
170776759|NCT01985334|617188736|FG004|Overall Study|Subject withdrawal of consent|4|||
170776760|NCT01985334|617188737|FG005|Overall Study|Subject withdrawal of consent|19|||
170776761|NCT01985334|617188738|FG006|Overall Study|Subject withdrawal of consent|0|||
170776762|NCT01985334|617188739|FG007|Overall Study|Subject withdrawal of consent|20|||
170776763|NCT01985334|617188732|FG000|Overall Study|Adverse Event|0|||
170776764|NCT01985334|617188733|FG001|Overall Study|Adverse Event|8|||
170776765|NCT01985334|617188734|FG002|Overall Study|Adverse Event|2|||
170776766|NCT01985334|617188735|FG003|Overall Study|Adverse Event|26|||
170776767|NCT01985334|617188736|FG004|Overall Study|Adverse Event|3|||
170776768|NCT01985334|617188737|FG005|Overall Study|Adverse Event|18|||
170776769|NCT01985334|617188738|FG006|Overall Study|Adverse Event|3|||
170776770|NCT01985334|617188739|FG007|Overall Study|Adverse Event|15|||
170776771|NCT01985334|617188732|FG000|Overall Study|Other|4|||
170776772|NCT01985334|617188733|FG001|Overall Study|Other|2|||
170776773|NCT01985334|617188734|FG002|Overall Study|Other|3|||
170776774|NCT01985334|617188735|FG003|Overall Study|Other|10|||
170776775|NCT01985334|617188736|FG004|Overall Study|Other|1|||
170776776|NCT01985334|617188737|FG005|Overall Study|Other|6|||
170776777|NCT01985334|617188738|FG006|Overall Study|Other|2|||
170415965|NCT00365352|615862155|FG000|Overall Study|Lack of Efficacy|3|||
170415966|NCT00365352|615862156|FG001|Overall Study|Lack of Efficacy|0|||
170415967|NCT00365352|615862157|FG002|Overall Study|Lack of Efficacy|0|||
170415968|NCT00365352|615862155|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
170415969|NCT00365352|615862156|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
170415970|NCT00365352|615862157|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
170415971|NCT00365352|615862155|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
170415972|NCT00365352|615862156|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
170415973|NCT00365352|615862157|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
170415974|NCT00365352|615862155|FG000|Overall Study|Lost to Follow-up|1|||
170415975|NCT00365352|615862156|FG001|Overall Study|Lost to Follow-up|1|||
170415976|NCT00365352|615862157|FG002|Overall Study|Lost to Follow-up|0|||
170415977|NCT00365352|615862155|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
170776778|NCT01985334|617188739|FG007|Overall Study|Other|2|||
170776779|NCT01985334|617188732|FG000|Overall Study|Medication non-compliance|0|||
170776780|NCT01985334|617188733|FG001|Overall Study|Medication non-compliance|4|||
170776781|NCT01985334|617188734|FG002|Overall Study|Medication non-compliance|1|||
170776782|NCT01985334|617188735|FG003|Overall Study|Medication non-compliance|6|||
170776783|NCT01985334|617188736|FG004|Overall Study|Medication non-compliance|2|||
170776784|NCT01985334|617188737|FG005|Overall Study|Medication non-compliance|3|||
170776785|NCT01985334|617188738|FG006|Overall Study|Medication non-compliance|1|||
170776786|NCT01985334|617188739|FG007|Overall Study|Medication non-compliance|3|||
170776787|NCT01985334|617188732|FG000|Overall Study|Use of prohibited treatment|1|||
170776788|NCT01985334|617188733|FG001|Overall Study|Use of prohibited treatment|4|||
170776789|NCT01985334|617188734|FG002|Overall Study|Use of prohibited treatment|1|||
170776790|NCT01985334|617188735|FG003|Overall Study|Use of prohibited treatment|2|||
170776791|NCT01985334|617188736|FG004|Overall Study|Use of prohibited treatment|1|||
170776792|NCT01985334|617188737|FG005|Overall Study|Use of prohibited treatment|6|||
170776793|NCT01985334|617188738|FG006|Overall Study|Use of prohibited treatment|2|||
170776794|NCT01985334|617188739|FG007|Overall Study|Use of prohibited treatment|0|||
170776795|NCT01985334|617188732|FG000|Overall Study|Investigator decision|0|||
170527780|NCT03154086|616282944|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527781|NCT03154086|616282945|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527782|NCT03154086|616282946|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527783|NCT03154086|616282947|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527784|NCT03154086|616282948|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527785|NCT03154086|616282949|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527786|NCT03154086|616282950|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527787|NCT03154086|616282951|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527788|NCT03154086|616282952|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527789|NCT03154086|616282953|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527790|NCT03154086|616282954|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
170527791|NCT03154086|616282940|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
170527792|NCT03154086|616282941|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527793|NCT03154086|616282942|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170776796|NCT01985334|617188733|FG001|Overall Study|Investigator decision|3|||
170776797|NCT01985334|617188734|FG002|Overall Study|Investigator decision|0|||
170527794|NCT03154086|616282943|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527795|NCT03154086|616282944|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527796|NCT03154086|616282945|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527797|NCT03154086|616282946|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527798|NCT03154086|616282947|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527799|NCT03154086|616282948|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527800|NCT03154086|616282949|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527801|NCT03154086|616282950|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527802|NCT03154086|616282951|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527803|NCT03154086|616282952|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527804|NCT03154086|616282953|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527805|NCT03154086|616282954|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
170527806|NCT03154086|616282940|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527807|NCT03154086|616282941|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527808|NCT03154086|616282942|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527809|NCT03154086|616282943|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527810|NCT03154086|616282944|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527811|NCT03154086|616282945|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527812|NCT03154086|616282946|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527813|NCT03154086|616282947|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527814|NCT03154086|616282948|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
170527815|NCT03154086|616282949|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527816|NCT03154086|616282950|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527817|NCT03154086|616282951|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527818|NCT03154086|616282952|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527819|NCT03154086|616282953|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527820|NCT03154086|616282954|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
170527821|NCT03154086|616282940|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527822|NCT03154086|616282941|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527823|NCT03154086|616282942|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527824|NCT03154086|616282943|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527825|NCT03154086|616282944|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527826|NCT03154086|616282945|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527827|NCT03154086|616282946|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527828|NCT03154086|616282947|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
170776798|NCT01985334|617188735|FG003|Overall Study|Investigator decision|7|||
170527829|NCT03154086|616282948|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527830|NCT03154086|616282949|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527831|NCT03154086|616282950|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527832|NCT03154086|616282951|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527833|NCT03154086|616282952|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527834|NCT03154086|616282953|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527835|NCT03154086|616282954|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
170527836|NCT03154086|616282940|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
170527837|NCT03154086|616282941|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
170527838|NCT03154086|616282942|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
170776799|NCT01985334|617188736|FG004|Overall Study|Investigator decision|1|||
170776800|NCT01985334|617188737|FG005|Overall Study|Investigator decision|1|||
170776801|NCT01985334|617188738|FG006|Overall Study|Investigator decision|0|||
170776802|NCT01985334|617188739|FG007|Overall Study|Investigator decision|4|||
170415978|NCT00365352|615862156|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
170415979|NCT00365352|615862157|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
170415980|NCT02683187|615862158|FG000|Overall Study|Failed IV access|3|||
170415981|NCT02683187|615862158|FG000|Overall Study|Withdrawal by Subject|5|||
170415982|NCT03626857|615862159|FG000|Overall Study|Adverse Event|9|||
170415983|NCT03626857|615862160|FG001|Overall Study|Adverse Event|7|||
170415984|NCT03626857|615862159|FG000|Overall Study|Lost to Follow-up|8|||
170415985|NCT03626857|615862160|FG001|Overall Study|Lost to Follow-up|8|||
170415986|NCT03626857|615862159|FG000|Overall Study|Withdrawal by Subject|2|||
170415987|NCT03626857|615862160|FG001|Overall Study|Withdrawal by Subject|2|||
170415988|NCT03626857|615862159|FG000|Overall Study|Protocol Violation|1|||
170415989|NCT03626857|615862160|FG001|Overall Study|Protocol Violation|3|||
170415990|NCT05665595|615863441|FG000|Overall Study|Ongoing|692|||
170415991|NCT05665595|615863442|FG001|Overall Study|Ongoing|698|||
170415992|NCT05665595|615863441|FG000|Overall Study|Withdrawal by Subject|2|||
170415993|NCT05665595|615863442|FG001|Overall Study|Withdrawal by Subject|2|||
170415994|NCT05665595|615863441|FG000|Overall Study|Lost to Follow-up|1|||
170415995|NCT05665595|615863442|FG001|Overall Study|Lost to Follow-up|0|||
170415996|NCT05665595|615863441|FG000|Overall Study|Death|6|||
170415997|NCT05665595|615863442|FG001|Overall Study|Death|1|||
170415998|NCT05514119|615863443|FG000|Overall Study|Ineligible due to disease progression|1|||
170415999|NCT02946385|615863444|FG000|Overall Study|Lost to Follow-up|0|||
170416000|NCT02946385|615863445|FG001|Overall Study|Lost to Follow-up|0|||
170416001|NCT02946385|615863446|FG002|Overall Study|Lost to Follow-up|3|||
170416002|NCT02946385|615863447|FG003|Overall Study|Lost to Follow-up|0|||
170416003|NCT02946385|615863448|FG004|Overall Study|Lost to Follow-up|2|||
170416004|NCT02946385|615863449|FG005|Overall Study|Lost to Follow-up|1|||
170416005|NCT02785913|615863450|FG000|Overall Study|Adverse Event|5|||
170416006|NCT02785913|615863450|FG000|Overall Study|Death|2|||
170416007|NCT02785913|615863450|FG000|Overall Study|Progression|18|||
170416008|NCT02785913|615863450|FG000|Overall Study|Not protocol specified|1|||
170416009|NCT01929109|615863453|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
170416010|NCT01929109|615863454|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
170416011|NCT01929109|615863455|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
170416012|NCT01929109|615863456|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
170416013|NCT01929109|615863457|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
170416014|NCT00076102|615863458|FG000|Overall Study|Clinical progression|1|||
170416015|NCT00076102|615863458|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
170416016|NCT00076102|615863458|FG000|Overall Study|plexiform neurofibroma surgery|1|||
170416017|NCT00076102|615863458|FG000|Overall Study|refusal of further therapy|2|||
170416018|NCT02180711|615863464|FG000|Overall Study|Death|0|||
170416019|NCT02180711|615863465|FG001|Overall Study|Death|1|||
170416020|NCT02180711|615863466|FG002|Overall Study|Death|0|||
170416021|NCT02180711|615863467|FG003|Overall Study|Death|0|||
170416022|NCT02180711|615863468|FG004|Overall Study|Death|7|||
170416023|NCT02180711|615863469|FG005|Overall Study|Death|0|||
170416024|NCT02180711|615863470|FG006|Overall Study|Death|1|||
170416025|NCT02180711|615863471|FG007|Overall Study|Death|3|||
170416026|NCT02180711|615863464|FG000|Overall Study|Lost to Follow-up|0|||
170416027|NCT02180711|615863465|FG001|Overall Study|Lost to Follow-up|1|||
170416028|NCT02180711|615863466|FG002|Overall Study|Lost to Follow-up|0|||
170416029|NCT02180711|615863467|FG003|Overall Study|Lost to Follow-up|0|||
170416030|NCT02180711|615863468|FG004|Overall Study|Lost to Follow-up|1|||
170416031|NCT02180711|615863469|FG005|Overall Study|Lost to Follow-up|1|||
170416032|NCT02180711|615863470|FG006|Overall Study|Lost to Follow-up|0|||
170416033|NCT02180711|615863471|FG007|Overall Study|Lost to Follow-up|3|||
170416034|NCT02180711|615863464|FG000|Overall Study|Withdrawal by Subject|2|||
170416035|NCT02180711|615863465|FG001|Overall Study|Withdrawal by Subject|1|||
170416036|NCT02180711|615863466|FG002|Overall Study|Withdrawal by Subject|0|||
170416037|NCT02180711|615863467|FG003|Overall Study|Withdrawal by Subject|4|||
170416038|NCT02180711|615863468|FG004|Overall Study|Withdrawal by Subject|3|||
170416039|NCT02180711|615863469|FG005|Overall Study|Withdrawal by Subject|0|||
170416040|NCT02180711|615863470|FG006|Overall Study|Withdrawal by Subject|3|||
170416041|NCT02180711|615863471|FG007|Overall Study|Withdrawal by Subject|2|||
170776803|NCT01985334|617188732|FG000|Overall Study|Lost to Follow-up|0|||
170416042|NCT02180711|615863464|FG000|Overall Study|- Disease Progression|0|||
170416043|NCT02180711|615863465|FG001|Overall Study|- Disease Progression|1|||
170416044|NCT02180711|615863466|FG002|Overall Study|- Disease Progression|0|||
170416045|NCT02180711|615863467|FG003|Overall Study|- Disease Progression|0|||
170416046|NCT02180711|615863468|FG004|Overall Study|- Disease Progression|0|||
170416047|NCT02180711|615863469|FG005|Overall Study|- Disease Progression|0|||
170416048|NCT02180711|615863470|FG006|Overall Study|- Disease Progression|0|||
170416049|NCT02180711|615863471|FG007|Overall Study|- Disease Progression|0|||
170416050|NCT02180711|615863464|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
170416051|NCT02180711|615863465|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
170416052|NCT02180711|615863466|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
170416053|NCT02180711|615863467|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
170416054|NCT02180711|615863468|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
170416055|NCT02180711|615863469|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
170416056|NCT02180711|615863470|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
170416057|NCT02180711|615863471|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
170416058|NCT02180711|615863464|FG000|Overall Study|- Study Terminated by Sponsor|2|||
170416059|NCT02180711|615863465|FG001|Overall Study|- Study Terminated by Sponsor|3|||
170416060|NCT02180711|615863466|FG002|Overall Study|- Study Terminated by Sponsor|0|||
170416061|NCT02180711|615863467|FG003|Overall Study|- Study Terminated by Sponsor|5|||
170416062|NCT02180711|615863468|FG004|Overall Study|- Study Terminated by Sponsor|32|||
170416063|NCT02180711|615863469|FG005|Overall Study|- Study Terminated by Sponsor|0|||
170416064|NCT02180711|615863470|FG006|Overall Study|- Study Terminated by Sponsor|4|||
170416065|NCT02180711|615863471|FG007|Overall Study|- Study Terminated by Sponsor|13|||
170416066|NCT02180711|615863464|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
170416067|NCT02180711|615863465|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
170416068|NCT02180711|615863466|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
170416069|NCT02180711|615863467|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
170416070|NCT02180711|615863468|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
170416071|NCT02180711|615863469|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
170416072|NCT02180711|615863470|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
170416073|NCT02180711|615863471|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
170416074|NCT02180711|615863464|FG000|Overall Study|- Other|1|||
170416075|NCT02180711|615863465|FG001|Overall Study|- Other|0|||
170416076|NCT02180711|615863466|FG002|Overall Study|- Other|0|||
170416077|NCT02180711|615863467|FG003|Overall Study|- Other|1|||
170416078|NCT02180711|615863468|FG004|Overall Study|- Other|0|||
170416079|NCT02180711|615863469|FG005|Overall Study|- Other|0|||
170416080|NCT02180711|615863470|FG006|Overall Study|- Other|0|||
170416081|NCT02180711|615863471|FG007|Overall Study|- Other|0|||
170416082|NCT01545076|615863484|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
170416083|NCT01545076|615863485|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
170416084|NCT01545076|615863486|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
170416085|NCT01545076|615863487|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
170416086|NCT01545076|615863488|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
170416087|NCT01545076|615863484|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
170416088|NCT01545076|615863485|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
170416089|NCT01545076|615863486|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
170416090|NCT01545076|615863487|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
170416091|NCT01545076|615863488|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
170416092|NCT01545076|615863484|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
170416093|NCT01545076|615863485|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
170416094|NCT01545076|615863486|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
170416095|NCT01545076|615863487|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
170416096|NCT01545076|615863488|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
170416097|NCT01545076|615863484|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
170416098|NCT01545076|615863485|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
170416099|NCT01545076|615863486|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
170416100|NCT01545076|615863487|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
170416101|NCT01545076|615863488|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
170416102|NCT01545076|615863484|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
170416103|NCT01545076|615863485|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
170416104|NCT01545076|615863486|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
170416105|NCT01545076|615863487|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
170416106|NCT01545076|615863488|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
170416107|NCT01545076|615863484|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
170416108|NCT01545076|615863485|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
170416109|NCT01545076|615863486|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
170416110|NCT01545076|615863487|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
170416111|NCT01545076|615863488|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
170416112|NCT01545076|615863484|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
170416113|NCT01545076|615863485|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
170416114|NCT01545076|615863486|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
170416115|NCT01545076|615863487|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
170416116|NCT01545076|615863488|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
170416117|NCT01545076|615863484|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
170416118|NCT01545076|615863485|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
170416119|NCT01545076|615863486|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
170416120|NCT01545076|615863487|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
170416121|NCT01545076|615863488|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
170632599|NCT02420821|616666703|FG000|Overall Study|Progressive Disease|1|||
170527839|NCT03154086|616282943|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
170527840|NCT03154086|616282944|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
170527841|NCT03154086|616282945|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
170527842|NCT03154086|616282946|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
170527843|NCT03154086|616282947|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
170527844|NCT03154086|616282948|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
170527845|NCT03154086|616282949|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
170527846|NCT03154086|616282950|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
170527847|NCT03154086|616282951|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
170527848|NCT03154086|616282952|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
170527849|NCT03154086|616282953|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
170527850|NCT03154086|616282954|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
170527851|NCT03555149|616282955|FG000|Overall Study|Death|18|||
170527852|NCT03555149|616282956|FG001|Overall Study|Death|15|||
170527853|NCT03555149|616282957|FG002|Overall Study|Death|15|||
170527854|NCT03555149|616282958|FG003|Overall Study|Death|4|||
170527855|NCT03555149|616282959|FG004|Overall Study|Death|4|||
170527856|NCT03555149|616282960|FG005|Overall Study|Death|11|||
170527857|NCT03555149|616282961|FG006|Overall Study|Death|12|||
170527858|NCT03555149|616282962|FG007|Overall Study|Death|1|||
170527859|NCT03555149|616282955|FG000|Overall Study|Lost to Follow-up|1|||
170527860|NCT03555149|616282956|FG001|Overall Study|Lost to Follow-up|0|||
170527861|NCT03555149|616282957|FG002|Overall Study|Lost to Follow-up|0|||
170527862|NCT03555149|616282958|FG003|Overall Study|Lost to Follow-up|0|||
170527863|NCT03555149|616282959|FG004|Overall Study|Lost to Follow-up|0|||
170527864|NCT03555149|616282960|FG005|Overall Study|Lost to Follow-up|1|||
170527865|NCT03555149|616282961|FG006|Overall Study|Lost to Follow-up|0|||
170527866|NCT03555149|616282962|FG007|Overall Study|Lost to Follow-up|0|||
170527867|NCT03555149|616282955|FG000|Overall Study|Physician Decision|1|||
170527868|NCT03555149|616282956|FG001|Overall Study|Physician Decision|0|||
170527869|NCT03555149|616282957|FG002|Overall Study|Physician Decision|0|||
170527870|NCT03555149|616282958|FG003|Overall Study|Physician Decision|0|||
170527871|NCT03555149|616282959|FG004|Overall Study|Physician Decision|0|||
170527872|NCT03555149|616282960|FG005|Overall Study|Physician Decision|0|||
170527873|NCT03555149|616282961|FG006|Overall Study|Physician Decision|0|||
170527874|NCT03555149|616282962|FG007|Overall Study|Physician Decision|0|||
170527875|NCT03555149|616282955|FG000|Overall Study|Study Terminated By Sponsor|1|||
170527876|NCT03555149|616282956|FG001|Overall Study|Study Terminated By Sponsor|0|||
170527877|NCT03555149|616282957|FG002|Overall Study|Study Terminated By Sponsor|0|||
170527878|NCT03555149|616282958|FG003|Overall Study|Study Terminated By Sponsor|0|||
170527879|NCT03555149|616282959|FG004|Overall Study|Study Terminated By Sponsor|0|||
170527880|NCT03555149|616282960|FG005|Overall Study|Study Terminated By Sponsor|2|||
170527881|NCT03555149|616282961|FG006|Overall Study|Study Terminated By Sponsor|3|||
170527882|NCT03555149|616282962|FG007|Overall Study|Study Terminated By Sponsor|1|||
170527883|NCT03555149|616282955|FG000|Overall Study|Withdrawal by Subject|3|||
170527884|NCT03555149|616282956|FG001|Overall Study|Withdrawal by Subject|0|||
170527885|NCT03555149|616282957|FG002|Overall Study|Withdrawal by Subject|0|||
170776804|NCT01985334|617188733|FG001|Overall Study|Lost to Follow-up|2|||
170776805|NCT01985334|617188734|FG002|Overall Study|Lost to Follow-up|0|||
170776806|NCT01985334|617188735|FG003|Overall Study|Lost to Follow-up|3|||
170776807|NCT01985334|617188736|FG004|Overall Study|Lost to Follow-up|1|||
170776808|NCT01985334|617188737|FG005|Overall Study|Lost to Follow-up|4|||
170776809|NCT01985334|617188738|FG006|Overall Study|Lost to Follow-up|0|||
170776810|NCT01985334|617188739|FG007|Overall Study|Lost to Follow-up|3|||
170527886|NCT03555149|616282958|FG003|Overall Study|Withdrawal by Subject|2|||
170527887|NCT03555149|616282959|FG004|Overall Study|Withdrawal by Subject|0|||
170527888|NCT03555149|616282960|FG005|Overall Study|Withdrawal by Subject|1|||
170527889|NCT03555149|616282961|FG006|Overall Study|Withdrawal by Subject|0|||
170527890|NCT03555149|616282962|FG007|Overall Study|Withdrawal by Subject|0|||
170527891|NCT01776554|616282963|FG000|Overall Study|Adverse Event|1|||
170527892|NCT01776554|616282964|FG001|Overall Study|Adverse Event|0|||
170527893|NCT01776554|616282963|FG000|Overall Study|Withdrawal by Subject|3|||
170527894|NCT01776554|616282964|FG001|Overall Study|Withdrawal by Subject|8|||
170527895|NCT01776554|616282963|FG000|Overall Study|Lost to Follow-up|6|||
170527896|NCT01776554|616282964|FG001|Overall Study|Lost to Follow-up|9|||
170527897|NCT01776554|616282963|FG000|Overall Study|Administrative Reason|2|||
170527898|NCT01776554|616282964|FG001|Overall Study|Administrative Reason|5|||
170527899|NCT01776554|616282963|FG000|Overall Study|Protocol Violation|1|||
170527900|NCT01776554|616282964|FG001|Overall Study|Protocol Violation|0|||
170527901|NCT01776554|616282963|FG000|Overall Study|Unclassified|4|||
170527902|NCT01776554|616282964|FG001|Overall Study|Unclassified|1|||
170527903|NCT01041859|616282965|FG000|Open-Label Titration|Adverse Event|69|||
170527904|NCT01041859|616282966|FG001|Open-Label Titration|Adverse Event|0|||
170527905|NCT01041859|616282967|FG002|Open-Label Titration|Adverse Event|0|||
170527906|NCT01041859|616282965|FG000|Open-Label Titration|Lack of Efficacy|3|||
170527907|NCT01041859|616282966|FG001|Open-Label Titration|Lack of Efficacy|0|||
170776811|NCT04191499|617188744|FG000|Overall Study|Adverse Event|1|||
170776812|NCT04191499|617188745|FG001|Overall Study|Adverse Event|0|||
170776813|NCT04191499|617188744|FG000|Overall Study|Death|42|||
170416122|NCT01545076|615863484|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
170416123|NCT01545076|615863485|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
170416124|NCT01545076|615863486|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
170416125|NCT01545076|615863487|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
170416126|NCT01545076|615863488|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
170416127|NCT05456529|615863489|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
170416128|NCT05456529|615863489|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
170416129|NCT05456529|615863489|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
170416130|NCT05456529|615863489|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
170416131|NCT05456529|615863489|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
170416132|NCT05456529|615863489|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
170416133|NCT05456529|615863489|FG000|44-week Long-term Safety Period|Physician Decision|2|||
170416134|NCT05456529|615863489|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
170416135|NCT05456529|615863489|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
170416136|NCT05456529|615863489|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
170416137|NCT05456529|615863489|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
170416138|NCT00797108|615863490|FG000|Overall Study|Adverse Event|1|||
170416139|NCT00797108|615863491|FG001|Overall Study|Adverse Event|0|||
170416140|NCT00797108|615863492|FG002|Overall Study|Adverse Event|3|||
170416141|NCT00797108|615863490|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
170416142|NCT00797108|615863491|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
170416143|NCT00797108|615863492|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
170416144|NCT00797108|615863490|FG000|Overall Study|Global Deterioration of Health Status|0|||
170416145|NCT00797108|615863491|FG001|Overall Study|Global Deterioration of Health Status|1|||
170416146|NCT00797108|615863492|FG002|Overall Study|Global Deterioration of Health Status|0|||
170416147|NCT00797108|615863490|FG000|Overall Study|Lack of Efficacy|1|||
170416148|NCT00797108|615863491|FG001|Overall Study|Lack of Efficacy|0|||
170416149|NCT00797108|615863492|FG002|Overall Study|Lack of Efficacy|1|||
170416150|NCT00797108|615863490|FG000|Overall Study|Other|0|||
170416151|NCT00797108|615863491|FG001|Overall Study|Other|0|||
170416152|NCT00797108|615863492|FG002|Overall Study|Other|2|||
170416153|NCT00797108|615863490|FG000|Overall Study|Randomized but not Treated|2|||
170416154|NCT00797108|615863491|FG001|Overall Study|Randomized but not Treated|0|||
170416155|NCT00797108|615863492|FG002|Overall Study|Randomized but not Treated|0|||
170416156|NCT00520741|615863493|FG000|Overall Study|Adverse Event|16|||
170416157|NCT00520741|615863494|FG001|Overall Study|Adverse Event|56|||
170416158|NCT00520741|615863493|FG000|Overall Study|Lack of Efficacy|11|||
170416159|NCT00520741|615863494|FG001|Overall Study|Lack of Efficacy|30|||
170416160|NCT00520741|615863493|FG000|Overall Study|Withdrawal by Subject|0|||
170416161|NCT00520741|615863494|FG001|Overall Study|Withdrawal by Subject|11|||
170416162|NCT00520741|615863493|FG000|Overall Study|Protocol Violation|2|||
170416163|NCT00520741|615863494|FG001|Overall Study|Protocol Violation|15|||
170416164|NCT00520741|615863493|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
170416165|NCT00520741|615863494|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
170416166|NCT00520741|615863493|FG000|Overall Study|Lost to Follow-up|4|||
170416167|NCT00520741|615863494|FG001|Overall Study|Lost to Follow-up|4|||
170416168|NCT00520741|615863493|FG000|Overall Study|Other reasons for premature termination|0|||
170416169|NCT00520741|615863494|FG001|Overall Study|Other reasons for premature termination|6|||
170416170|NCT04373434|615863495|FG000|Overall Study|Lost to Follow-up|37|||
170416171|NCT04373434|615863496|FG001|Overall Study|Lost to Follow-up|32|||
170416172|NCT04373434|615863495|FG000|Overall Study|Refused at 9 months|1|||
170416173|NCT04373434|615863496|FG001|Overall Study|Refused at 9 months|2|||
170416174|NCT04373434|615863495|FG000|Overall Study|Refused at 4 months|7|||
170416175|NCT04373434|615863496|FG001|Overall Study|Refused at 4 months|3|||
170416176|NCT04373434|615863495|FG000|Overall Study|Excluded|2|||
170416177|NCT04373434|615863496|FG001|Overall Study|Excluded|0|||
170416178|NCT00527423|615863497|FG000|Overall Study|Protocol Violation|1|||
170416179|NCT00527423|615863497|FG000|Overall Study|Adverse Event|5|||
170416180|NCT00527423|615863497|FG000|Overall Study|Physician Decision|4|||
170416181|NCT00527423|615863497|FG000|Overall Study|Withdrawal by Subject|10|||
170416182|NCT00527423|615863497|FG000|Overall Study|Lost to Follow-up|4|||
170416183|NCT00527423|615863497|FG000|Overall Study|OTHER|4|||
170416184|NCT00527423|615863497|FG000|Overall Study|Death|9|||
170416185|NCT03702621|615863498|FG000|Overall Study|Physician Decision|6|||
170416186|NCT03702621|615863499|FG001|Overall Study|Physician Decision|6|||
170416187|NCT01860976|615863503|FG000|Blinded Treatment|Adverse Event|1|||
170416188|NCT01860976|615863504|FG001|Blinded Treatment|Adverse Event|3|||
170416189|NCT01860976|615863503|FG000|Blinded Treatment|Lack of Efficacy|5|||
170416190|NCT01860976|615863504|FG001|Blinded Treatment|Lack of Efficacy|12|||
170416191|NCT01860976|615863503|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
170416192|NCT01860976|615863504|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
170416193|NCT01860976|615863503|FG000|Blinded Treatment|Withdrawal by Subject|3|||
170416194|NCT01860976|615863504|FG001|Blinded Treatment|Withdrawal by Subject|5|||
170527908|NCT01041859|616282967|FG002|Open-Label Titration|Lack of Efficacy|0|||
170527909|NCT01041859|616282965|FG000|Open-Label Titration|Lost to Follow-up|1|||
170527910|NCT01041859|616282966|FG001|Open-Label Titration|Lost to Follow-up|0|||
170527911|NCT01041859|616282967|FG002|Open-Label Titration|Lost to Follow-up|0|||
170527912|NCT01041859|616282965|FG000|Open-Label Titration|Physician Decision|1|||
170527913|NCT01041859|616282966|FG001|Open-Label Titration|Physician Decision|0|||
170527914|NCT01041859|616282967|FG002|Open-Label Titration|Physician Decision|0|||
170527915|NCT01041859|616282965|FG000|Open-Label Titration|Protocol Violation|1|||
170527916|NCT01041859|616282966|FG001|Open-Label Titration|Protocol Violation|0|||
170527917|NCT01041859|616282967|FG002|Open-Label Titration|Protocol Violation|0|||
170527918|NCT01041859|616282965|FG000|Open-Label Titration|Other|7|||
170527919|NCT01041859|616282966|FG001|Open-Label Titration|Other|0|||
170527920|NCT01041859|616282967|FG002|Open-Label Titration|Other|0|||
170527921|NCT01041859|616282965|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
170527922|NCT01041859|616282966|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
170527923|NCT01041859|616282967|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
170527924|NCT01041859|616282965|FG000|Open-Label Titration|Withdrawal by Subject|11|||
170527925|NCT01041859|616282966|FG001|Open-Label Titration|Withdrawal by Subject|0|||
170527926|NCT01041859|616282967|FG002|Open-Label Titration|Withdrawal by Subject|0|||
170527927|NCT01041859|616282965|FG000|Double-Blind Maintenance|Adverse Event|0|||
170527928|NCT01041859|616282966|FG001|Double-Blind Maintenance|Adverse Event|23|||
170527929|NCT01041859|616282967|FG002|Double-Blind Maintenance|Adverse Event|13|||
170527930|NCT01041859|616282965|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
170527931|NCT01041859|616282966|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
170527932|NCT01041859|616282967|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
170527933|NCT01041859|616282965|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
170527934|NCT01041859|616282966|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
170527935|NCT01041859|616282967|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
170527936|NCT01041859|616282965|FG000|Double-Blind Maintenance|Physician Decision|0|||
170527937|NCT01041859|616282966|FG001|Double-Blind Maintenance|Physician Decision|2|||
170527938|NCT01041859|616282967|FG002|Double-Blind Maintenance|Physician Decision|1|||
170527939|NCT01041859|616282965|FG000|Double-Blind Maintenance|Protocol Violation|0|||
170527940|NCT01041859|616282966|FG001|Double-Blind Maintenance|Protocol Violation|1|||
170527941|NCT01041859|616282967|FG002|Double-Blind Maintenance|Protocol Violation|3|||
170527942|NCT01041859|616282965|FG000|Double-Blind Maintenance|Other|0|||
170527943|NCT01041859|616282966|FG001|Double-Blind Maintenance|Other|6|||
170527944|NCT01041859|616282967|FG002|Double-Blind Maintenance|Other|2|||
170527945|NCT01041859|616282965|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
170527946|NCT01041859|616282966|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
170527947|NCT01041859|616282967|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
170527948|NCT01041859|616282965|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
170527949|NCT01041859|616282966|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
170527950|NCT01041859|616282967|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
170527951|NCT02027025|616282972|FG000|Overall Study|Adverse Event|0|||
170527952|NCT02027025|616282973|FG001|Overall Study|Adverse Event|1|||
170527953|NCT02027025|616282974|FG002|Overall Study|Adverse Event|1|||
170527954|NCT02027025|616282972|FG000|Overall Study|Protocol Violation|1|||
170527955|NCT02027025|616282973|FG001|Overall Study|Protocol Violation|0|||
170527956|NCT02027025|616282974|FG002|Overall Study|Protocol Violation|0|||
170527957|NCT02027025|616282972|FG000|Overall Study|Lost to Follow-up|0|||
170527958|NCT02027025|616282973|FG001|Overall Study|Lost to Follow-up|2|||
170527959|NCT02027025|616282974|FG002|Overall Study|Lost to Follow-up|0|||
170527960|NCT02027025|616282972|FG000|Overall Study|Withdrawal by Subject|0|||
170527961|NCT02027025|616282973|FG001|Overall Study|Withdrawal by Subject|1|||
170527962|NCT02027025|616282974|FG002|Overall Study|Withdrawal by Subject|0|||
170527963|NCT02027025|616282972|FG000|Overall Study|Sponsor's decision|0|||
170527964|NCT02027025|616282973|FG001|Overall Study|Sponsor's decision|1|||
170527965|NCT02027025|616282974|FG002|Overall Study|Sponsor's decision|0|||
170527966|NCT04798027|616282975|FG000|Overall Study|Protocol Violation|0|||
170527967|NCT04798027|616282976|FG001|Overall Study|Protocol Violation|0|||
170527968|NCT04798027|616282977|FG002|Overall Study|Protocol Violation|0|||
170527969|NCT04798027|616282978|FG003|Overall Study|Protocol Violation|0|||
170527970|NCT04798027|616282979|FG004|Overall Study|Protocol Violation|1|||
170527971|NCT04798027|616282980|FG005|Overall Study|Protocol Violation|0|||
170527972|NCT04798027|616282981|FG006|Overall Study|Protocol Violation|0|||
170527973|NCT04798027|616282982|FG007|Overall Study|Protocol Violation|1|||
170527974|NCT04798027|616282983|FG008|Overall Study|Protocol Violation|0|||
170527975|NCT04798027|616282975|FG000|Overall Study|Withdrawal by Subject|1|||
170527976|NCT04798027|616282976|FG001|Overall Study|Withdrawal by Subject|0|||
170527977|NCT04798027|616282977|FG002|Overall Study|Withdrawal by Subject|1|||
170527978|NCT04798027|616282978|FG003|Overall Study|Withdrawal by Subject|1|||
170527979|NCT04798027|616282979|FG004|Overall Study|Withdrawal by Subject|1|||
170527980|NCT04798027|616282980|FG005|Overall Study|Withdrawal by Subject|1|||
170527981|NCT04798027|616282981|FG006|Overall Study|Withdrawal by Subject|3|||
170527982|NCT04798027|616282982|FG007|Overall Study|Withdrawal by Subject|2|||
170527983|NCT04798027|616282983|FG008|Overall Study|Withdrawal by Subject|2|||
170527984|NCT04798027|616282975|FG000|Overall Study|Lost to Follow-up|1|||
170527985|NCT04798027|616282976|FG001|Overall Study|Lost to Follow-up|3|||
170527986|NCT04798027|616282977|FG002|Overall Study|Lost to Follow-up|0|||
170527987|NCT04798027|616282978|FG003|Overall Study|Lost to Follow-up|0|||
170527988|NCT04798027|616282979|FG004|Overall Study|Lost to Follow-up|0|||
170527989|NCT04798027|616282980|FG005|Overall Study|Lost to Follow-up|1|||
170527990|NCT04798027|616282981|FG006|Overall Study|Lost to Follow-up|0|||
170527991|NCT04798027|616282982|FG007|Overall Study|Lost to Follow-up|0|||
170527992|NCT04798027|616282983|FG008|Overall Study|Lost to Follow-up|1|||
170527993|NCT04798027|616282975|FG000|Overall Study|Withdrawal by Sponsor|8|||
170527994|NCT04798027|616282976|FG001|Overall Study|Withdrawal by Sponsor|22|||
170527995|NCT04798027|616282977|FG002|Overall Study|Withdrawal by Sponsor|9|||
170527996|NCT04798027|616282978|FG003|Overall Study|Withdrawal by Sponsor|26|||
170527997|NCT04798027|616282979|FG004|Overall Study|Withdrawal by Sponsor|24|||
170527998|NCT04798027|616282980|FG005|Overall Study|Withdrawal by Sponsor|11|||
170527999|NCT04798027|616282981|FG006|Overall Study|Withdrawal by Sponsor|25|||
170528000|NCT04798027|616282982|FG007|Overall Study|Withdrawal by Sponsor|26|||
170528001|NCT04798027|616282983|FG008|Overall Study|Withdrawal by Sponsor|11|||
170528002|NCT02949947|616282986|FG000|Overall Study|Non Compliance|0|||
170528003|NCT02949947|616282987|FG001|Overall Study|Non Compliance|1|||
170528004|NCT02949947|616282986|FG000|Overall Study|Insurance change|1|||
170528005|NCT02949947|616282987|FG001|Overall Study|Insurance change|0|||
170528006|NCT00720499|616282988|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
170528007|NCT00720499|616282989|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
170528008|NCT00720499|616282988|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
170528009|NCT00720499|616282989|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
170528010|NCT00720499|616282988|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
170528011|NCT00720499|616282989|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
170528012|NCT01100502|616282992|FG000|Overall Study|Withdrawal by Subject|18|||
170528013|NCT01100502|616282993|FG001|Overall Study|Withdrawal by Subject|25|||
170528014|NCT01100502|616282992|FG000|Overall Study|Lost to Follow-up|13|||
170528015|NCT01100502|616282993|FG001|Overall Study|Lost to Follow-up|28|||
170528016|NCT01100502|616282992|FG000|Overall Study|Site request to end participation in study|0|||
170528017|NCT01100502|616282993|FG001|Overall Study|Site request to end participation in study|1|||
170528018|NCT01100502|616282992|FG000|Overall Study|Death|45|||
170528019|NCT01100502|616282993|FG001|Overall Study|Death|40|||
170528020|NCT00828711|616282994|FG000|Overall Study|Lost to Follow-up|1|||
170528021|NCT00828711|616282995|FG001|Overall Study|Lost to Follow-up|0|||
170528022|NCT00828711|616282996|FG002|Overall Study|Lost to Follow-up|0|||
170528023|NCT01326871|616282997|FG000|Overall Study|Major surgery|0|||
170528024|NCT01326871|616282998|FG001|Overall Study|Major surgery|1|||
170528025|NCT01326871|616282999|FG002|Overall Study|Major surgery|0|||
170528026|NCT01326871|616282997|FG000|Overall Study|SAE and death|0|||
170528027|NCT01326871|616282998|FG001|Overall Study|SAE and death|2|||
170528028|NCT01326871|616282999|FG002|Overall Study|SAE and death|0|||
170528029|NCT01326871|616282997|FG000|Overall Study|Physician decision and decreased performance status|0|||
170528030|NCT01326871|616282998|FG001|Overall Study|Physician decision and decreased performance status|1|||
170528031|NCT01326871|616282999|FG002|Overall Study|Physician decision and decreased performance status|0|||
170528032|NCT01326871|616282997|FG000|Overall Study|Disease progression|0|||
170528033|NCT01326871|616282998|FG001|Overall Study|Disease progression|11|||
170776814|NCT04191499|617188745|FG001|Overall Study|Death|55|||
170776815|NCT04191499|617188744|FG000|Overall Study|Lost to Follow-up|4|||
170776816|NCT04191499|617188745|FG001|Overall Study|Lost to Follow-up|1|||
170776817|NCT04191499|617188744|FG000|Overall Study|Physician Decision|1|||
170776818|NCT04191499|617188745|FG001|Overall Study|Physician Decision|0|||
170776819|NCT04191499|617188744|FG000|Overall Study|Progressive Disease|1|||
170776820|NCT04191499|617188745|FG001|Overall Study|Progressive Disease|0|||
170776821|NCT04191499|617188744|FG000|Overall Study|Symptomatic Deterioration|1|||
170776822|NCT04191499|617188745|FG001|Overall Study|Symptomatic Deterioration|0|||
170776823|NCT04191499|617188744|FG000|Overall Study|Withdrawal by Subject|7|||
170877098|NCT03977974|617560478|FG007|Period 2|Adverse Event|0|||
170776824|NCT04191499|617188745|FG001|Overall Study|Withdrawal by Subject|11|||
170776825|NCT04191499|617188744|FG000|Overall Study|Ongoing in the study|104|||
170776826|NCT04191499|617188745|FG001|Overall Study|Ongoing in the study|97|||
170528034|NCT01326871|616282999|FG002|Overall Study|Disease progression|5|||
170528035|NCT01326871|616282997|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
170528036|NCT01326871|616282998|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
170528037|NCT01326871|616282999|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
170528038|NCT01326871|616282997|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
170528039|NCT01326871|616282998|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
170528040|NCT01326871|616282999|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
170528041|NCT01326871|616282997|FG000|Overall Study|Withdrawal by Subject|0|||
170528042|NCT01326871|616282998|FG001|Overall Study|Withdrawal by Subject|1|||
170776827|NCT03951805|617188746|FG000|Overall Study|Adverse Event|1|||
170528043|NCT01326871|616282999|FG002|Overall Study|Withdrawal by Subject|0|||
170776828|NCT03951805|617188747|FG001|Overall Study|Adverse Event|0|||
170776829|NCT03951805|617188748|FG002|Overall Study|Adverse Event|0|||
170776830|NCT03951805|617188749|FG003|Overall Study|Adverse Event|0|||
170776831|NCT05999435|617188750|FG000|Overall Study|Adverse Event|1|||
170776832|NCT05999435|617188751|FG001|Overall Study|Adverse Event|0|||
170776833|NCT05999435|617188752|FG002|Overall Study|Adverse Event|0|||
170776834|NCT05999435|617188750|FG000|Overall Study|Withdrawal by Subject|2|||
170776835|NCT05999435|617188751|FG001|Overall Study|Withdrawal by Subject|1|||
170776836|NCT05999435|617188752|FG002|Overall Study|Withdrawal by Subject|0|||
170776837|NCT00970359|617188758|FG000|Overall Study|Not Treated|4|||
170776838|NCT05368831|617188761|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
170776839|NCT03565315|617188762|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
170776840|NCT03565315|617188763|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
170776841|NCT03565315|617188764|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
170776842|NCT03565315|617188765|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
170776843|NCT01083316|617188766|FG000|Overall Study|Adverse Event|2|||
170776844|NCT01083316|617188766|FG000|Overall Study|Withdrawal by Subject|1|||
170776845|NCT02321514|617188767|FG000|Overall Study|Death|15|||
170776846|NCT02321514|617188767|FG000|Overall Study|Missed Visit|7|||
170776847|NCT02321514|617188767|FG000|Overall Study|Study Exit|3|||
170776848|NCT03942042|617188768|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
170776849|NCT03942042|617188769|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
170776850|NCT03942042|617188768|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
170776851|NCT03942042|617188769|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
170776852|NCT02299375|617188772|FG000|Overall Study|Adverse Event, serious fatal|1|||
170776853|NCT02299375|617188773|FG001|Overall Study|Adverse Event, serious fatal|3|||
170776854|NCT02299375|617188772|FG000|Overall Study|Adverse Event, non-fatal|8|||
170776855|NCT02299375|617188773|FG001|Overall Study|Adverse Event, non-fatal|9|||
170776856|NCT02299375|617188772|FG000|Overall Study|Lack of Efficacy|1|||
170776857|NCT02299375|617188773|FG001|Overall Study|Lack of Efficacy|3|||
170776858|NCT02299375|617188772|FG000|Overall Study|Protocol Violation|1|||
170776859|NCT02299375|617188773|FG001|Overall Study|Protocol Violation|3|||
170776860|NCT02299375|617188772|FG000|Overall Study|Other: Met stopping criteria|1|||
170776861|NCT02299375|617188773|FG001|Overall Study|Other: Met stopping criteria|0|||
170776862|NCT02299375|617188772|FG000|Overall Study|Other: Study closed/terminated|66|||
170776863|NCT02299375|617188773|FG001|Overall Study|Other: Study closed/terminated|55|||
170776864|NCT02299375|617188772|FG000|Overall Study|Lost to Follow-up|0|||
170776865|NCT02299375|617188773|FG001|Overall Study|Lost to Follow-up|2|||
170776866|NCT02299375|617188772|FG000|Overall Study|Physician Decision|1|||
170776867|NCT02299375|617188773|FG001|Overall Study|Physician Decision|1|||
170776868|NCT02299375|617188772|FG000|Overall Study|Withdrawal by Subject|1|||
170776869|NCT02299375|617188773|FG001|Overall Study|Withdrawal by Subject|4|||
170776870|NCT01109524|617188776|FG000|Overall Study|Disease Progression|29|||
170776871|NCT01109524|617188776|FG000|Overall Study|Study Drug toxicity|6|||
170776872|NCT01109524|617188776|FG000|Overall Study|Adverse Event|4|||
170776873|NCT01109524|617188776|FG000|Overall Study|Withdrawal by Subject|2|||
170776874|NCT01109524|617188776|FG000|Overall Study|Maximum clinical benefit|3|||
170776875|NCT01109524|617188776|FG000|Overall Study|Death|2|||
170776876|NCT01109524|617188776|FG000|Overall Study|No longer meets criteria|2|||
170776877|NCT01109524|617188776|FG000|Overall Study|Participant requested to end treatment|4|||
170776878|NCT01109524|617188776|FG000|Overall Study|Other|5|||
170776879|NCT01205048|617188777|FG000|Overall Study|Withdrawal by Subject|14|||
170776880|NCT01205048|617188777|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
170776881|NCT01205048|617188777|FG000|Overall Study|Lost to Follow-up|4|||
170776882|NCT01205048|617188777|FG000|Overall Study|Other|2|||
170877099|NCT03977974|617560479|FG008|Period 2|Adverse Event|0|||
170776883|NCT00823472|617188778|FG000|Overall Study|Physician Decision|24|||
170776884|NCT00823472|617188779|FG001|Overall Study|Physician Decision|28|||
170776885|NCT03671811|617188786|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
170776886|NCT03671811|617188787|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
170776887|NCT04578106|617188788|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
170776888|NCT06938230|617188789|FG000|Overall Study|Lost to Follow-up|56|||
170776889|NCT06938230|617188790|FG001|Overall Study|Lost to Follow-up|18|||
170776890|NCT02118961|617190177|FG000|Overall Study|Withdrawal by Subject|1|||
170776891|NCT02118961|617190178|FG001|Overall Study|Withdrawal by Subject|0|||
170776892|NCT03103321|617190179|FG000|Overall Study|Protocol Violation|1|||
170776893|NCT03103321|617190180|FG001|Overall Study|Protocol Violation|1|||
170776894|NCT03103321|617190181|FG002|Overall Study|Protocol Violation|1|||
170776895|NCT03103321|617190182|FG003|Overall Study|Protocol Violation|0|||
170776896|NCT01898494|617190188|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
170528044|NCT01326871|616282997|FG000|Overall Study|DLT|0|||
170776897|NCT01898494|617190189|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
170776898|NCT01898494|617190190|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
170776899|NCT01898494|617190191|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
170776900|NCT01898494|617190192|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
170776901|NCT01898494|617190188|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
170776902|NCT01898494|617190189|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
170416195|NCT01860976|615863503|FG000|Blinded Treatment|Subject no longer met criteria|1|||
170416196|NCT01860976|615863504|FG001|Blinded Treatment|Subject no longer met criteria|0|||
170416197|NCT01860976|615863503|FG000|Blinded Treatment|Entered Open-Label in error|0|||
170416198|NCT01860976|615863504|FG001|Blinded Treatment|Entered Open-Label in error|1|||
170416199|NCT01860976|615863503|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
170416200|NCT01860976|615863504|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
170416201|NCT01860976|615863503|FG000|Open-Label|Adverse Event|2|||
170416202|NCT01860976|615863504|FG001|Open-Label|Adverse Event|4|||
170416203|NCT01860976|615863503|FG000|Open-Label|Lack of Efficacy|16|||
170416204|NCT01860976|615863504|FG001|Open-Label|Lack of Efficacy|8|||
170416205|NCT01860976|615863503|FG000|Open-Label|Lost to Follow-up|1|||
170416206|NCT01860976|615863504|FG001|Open-Label|Lost to Follow-up|2|||
170416207|NCT01860976|615863503|FG000|Open-Label|Subject request discontinue treatment|4|||
170416208|NCT01860976|615863504|FG001|Open-Label|Subject request discontinue treatment|3|||
170416209|NCT01860976|615863503|FG000|Open-Label|Withdrawal by Subject|4|||
170416210|NCT01860976|615863504|FG001|Open-Label|Withdrawal by Subject|1|||
170416211|NCT01860976|615863503|FG000|Open-Label|Other Reasons|1|||
170416212|NCT01860976|615863504|FG001|Open-Label|Other Reasons|1|||
170416213|NCT01860976|615863503|FG000|Long Term Extension|Adverse Event|4|||
170416214|NCT01860976|615863504|FG001|Long Term Extension|Adverse Event|0|||
170416215|NCT01860976|615863503|FG000|Long Term Extension|Lack of Efficacy|2|||
170416216|NCT01860976|615863504|FG001|Long Term Extension|Lack of Efficacy|0|||
170416217|NCT01860976|615863503|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
170416218|NCT01860976|615863504|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
170416219|NCT01860976|615863503|FG000|Long Term Extension|Lost to Follow-up|2|||
170416220|NCT01860976|615863504|FG001|Long Term Extension|Lost to Follow-up|0|||
170416221|NCT01860976|615863503|FG000|Long Term Extension|subject withdrew consent|7|||
170416222|NCT01860976|615863504|FG001|Long Term Extension|subject withdrew consent|0|||
170416223|NCT00419926|615863505|FG000|Overall Study|Withdrawal by Subject|7|||
170416224|NCT00419926|615863506|FG001|Overall Study|Withdrawal by Subject|3|||
170416225|NCT00419926|615863505|FG000|Overall Study|Administrative Problem|4|||
170416226|NCT00419926|615863506|FG001|Overall Study|Administrative Problem|4|||
170416227|NCT00419926|615863505|FG000|Overall Study|Lost to Follow-up|1|||
170416228|NCT00419926|615863506|FG001|Overall Study|Lost to Follow-up|2|||
170416229|NCT00419926|615863505|FG000|Overall Study|Death|2|||
170416230|NCT00419926|615863506|FG001|Overall Study|Death|1|||
170416231|NCT02402166|615863508|FG000|Overall Study|Adverse Event|2|||
170416232|NCT02402166|615863508|FG000|Overall Study|Withdrawal by Subject|2|||
170416233|NCT02402166|615863508|FG000|Overall Study|Lost to Follow-up|1|||
170416234|NCT00810368|615863509|FG000|Overall Study|Lost to Follow-up|4|||
170416235|NCT00810368|615863510|FG001|Overall Study|Lost to Follow-up|2|||
170416236|NCT00810368|615863509|FG000|Overall Study|Lack of Efficacy|2|||
170416237|NCT00810368|615863510|FG001|Overall Study|Lack of Efficacy|0|||
170416238|NCT01424722|615863514|FG000|Overall Study|Sponsor terminated investigation|2258|||
170416239|NCT01781286|615863517|FG000|Overall Study|Lost to Follow-up|0|||
170416240|NCT01781286|615863518|FG001|Overall Study|Lost to Follow-up|0|||
170416241|NCT01781286|615863519|FG002|Overall Study|Lost to Follow-up|0|||
170416242|NCT01781286|615863520|FG003|Overall Study|Lost to Follow-up|0|||
170416243|NCT01781286|615863521|FG004|Overall Study|Lost to Follow-up|0|||
170416244|NCT01781286|615863522|FG005|Overall Study|Lost to Follow-up|1|||
170416245|NCT01781286|615863517|FG000|Overall Study|Time Constraints|2|||
170416246|NCT01781286|615863518|FG001|Overall Study|Time Constraints|0|||
170416247|NCT01781286|615863519|FG002|Overall Study|Time Constraints|2|||
170416248|NCT01781286|615863520|FG003|Overall Study|Time Constraints|0|||
170416249|NCT01781286|615863521|FG004|Overall Study|Time Constraints|0|||
170416250|NCT01781286|615863522|FG005|Overall Study|Time Constraints|0|||
170416251|NCT01781286|615863517|FG000|Overall Study|Noncompliance|0|||
170416252|NCT01781286|615863518|FG001|Overall Study|Noncompliance|0|||
170416253|NCT01781286|615863519|FG002|Overall Study|Noncompliance|0|||
170416254|NCT01781286|615863520|FG003|Overall Study|Noncompliance|1|||
170416255|NCT01781286|615863521|FG004|Overall Study|Noncompliance|0|||
170416256|NCT01781286|615863522|FG005|Overall Study|Noncompliance|0|||
170416257|NCT00995410|615863523|FG000|Overall Study|Adverse Event|51|||
170416258|NCT00995410|615863523|FG000|Overall Study|Withdrawal by Subject|7|||
170416259|NCT00995410|615863523|FG000|Overall Study|Lost to Follow-up|2|||
170416260|NCT00995410|615863523|FG000|Overall Study|Misc|28|||
170776903|NCT01898494|617190190|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
170416261|NCT03267264|615863524|FG000|Overall Study|Withdrawal by Subject|1|||
170416262|NCT03267264|615863525|FG001|Overall Study|Withdrawal by Subject|0|||
170416263|NCT03267264|615863526|FG002|Overall Study|Withdrawal by Subject|2|||
170416264|NCT03267264|615863527|FG003|Overall Study|Withdrawal by Subject|4|||
170416265|NCT02224391|615863528|FG000|Overall Study|Lost to Follow-up|26|||
170416266|NCT02224391|615863529|FG001|Overall Study|Lost to Follow-up|19|||
170416267|NCT02224391|615863528|FG000|Overall Study|Withdrawal by Subject|6|||
170416268|NCT02224391|615863529|FG001|Overall Study|Withdrawal by Subject|5|||
170416269|NCT02492958|615863530|FG000|Overall Study|Withdrawal by Subject|0|||
170416270|NCT02492958|615863531|FG001|Overall Study|Withdrawal by Subject|0|||
170416271|NCT02492958|615863532|FG002|Overall Study|Withdrawal by Subject|1|||
170416272|NCT02492958|615863533|FG003|Overall Study|Withdrawal by Subject|0|||
170416273|NCT02492958|615863530|FG000|Overall Study|Adverse Event|1|||
170416274|NCT02492958|615863531|FG001|Overall Study|Adverse Event|0|||
170416275|NCT02492958|615863532|FG002|Overall Study|Adverse Event|1|||
170416276|NCT02492958|615863533|FG003|Overall Study|Adverse Event|0|||
170416277|NCT03522948|615863534|FG000|Overall Study|Lost to Follow-up|1|||
170416278|NCT02187042|615863536|FG000|Overall Study|Death|1|||
170416279|NCT02187042|615863537|FG001|Overall Study|Death|1|||
170416280|NCT02187042|615863536|FG000|Overall Study|Toxicity|6|||
170416281|NCT02187042|615863537|FG001|Overall Study|Toxicity|5|||
170416282|NCT02187042|615863536|FG000|Overall Study|Participant choice|1|||
170416283|NCT02187042|615863537|FG001|Overall Study|Participant choice|0|||
170416284|NCT02187042|615863536|FG000|Overall Study|Doctor choice|1|||
170416285|NCT02187042|615863537|FG001|Overall Study|Doctor choice|0|||
170416286|NCT02187042|615863536|FG000|Overall Study|Progressive disease|4|||
170416287|NCT02187042|615863537|FG001|Overall Study|Progressive disease|8|||
170416288|NCT01325207|615863539|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
170416289|NCT01325207|615863540|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
170416290|NCT01325207|615863541|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
170416291|NCT01325207|615863542|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
170416292|NCT01325207|615863543|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
170416293|NCT01325207|615863544|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
170416294|NCT01325207|615863539|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
170416295|NCT01325207|615863540|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
170416296|NCT01325207|615863541|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
170416297|NCT01325207|615863542|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
170416298|NCT01325207|615863543|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
170416299|NCT01325207|615863544|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
170416300|NCT01325207|615863539|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
170416301|NCT01325207|615863540|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
170416302|NCT01325207|615863541|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
170416303|NCT01325207|615863542|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
170416304|NCT01325207|615863543|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
170416305|NCT01325207|615863544|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
170416306|NCT01325207|615863539|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
170416307|NCT01325207|615863540|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
170416308|NCT01325207|615863541|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
170416309|NCT01325207|615863542|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
170416310|NCT01325207|615863543|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
170416311|NCT01325207|615863544|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
170416312|NCT01325207|615863539|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
170416313|NCT01325207|615863540|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
170416314|NCT01325207|615863541|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
170416315|NCT01325207|615863542|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
170416316|NCT01325207|615863543|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
170416317|NCT01325207|615863544|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
170416318|NCT01325207|615863539|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
170416319|NCT01325207|615863540|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
170416320|NCT01325207|615863541|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
170416321|NCT01325207|615863542|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
170416322|NCT01325207|615863543|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
170416323|NCT01325207|615863544|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
170416324|NCT01325207|615863539|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
170416325|NCT01325207|615863540|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
170416326|NCT01325207|615863541|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
170416327|NCT01325207|615863542|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
170416328|NCT01325207|615863543|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
170416329|NCT01325207|615863544|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
170776904|NCT01898494|617190191|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
170776905|NCT01898494|617190192|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
170776906|NCT01898494|617190188|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
170776907|NCT01898494|617190189|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
170776908|NCT01898494|617190190|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
170776909|NCT01898494|617190191|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
170528045|NCT01326871|616282998|FG001|Overall Study|DLT|2|||
170528046|NCT01326871|616282999|FG002|Overall Study|DLT|0|||
170528047|NCT01326871|616282997|FG000|Overall Study|SAE, disease progression and subject decision|0|||
170528048|NCT01326871|616282998|FG001|Overall Study|SAE, disease progression and subject decision|1|||
170528049|NCT01326871|616282999|FG002|Overall Study|SAE, disease progression and subject decision|0|||
170528050|NCT01326871|616282997|FG000|Overall Study|Death|0|||
170528051|NCT01326871|616282998|FG001|Overall Study|Death|1|||
170528052|NCT01326871|616282999|FG002|Overall Study|Death|0|||
170528053|NCT01326871|616282997|FG000|Overall Study|Other|0|||
170528054|NCT01326871|616282998|FG001|Overall Study|Other|3|||
170528055|NCT01326871|616282999|FG002|Overall Study|Other|0|||
170528056|NCT01326871|616282997|FG000|Overall Study|SAE and disease progression|0|||
170528057|NCT01326871|616282998|FG001|Overall Study|SAE and disease progression|0|||
170528058|NCT01326871|616282999|FG002|Overall Study|SAE and disease progression|1|||
170528059|NCT01326871|616282997|FG000|Overall Study|SAE and physician decision|0|||
170528060|NCT01326871|616282998|FG001|Overall Study|SAE and physician decision|0|||
170528061|NCT01326871|616282999|FG002|Overall Study|SAE and physician decision|1|||
170528062|NCT01326871|616282997|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
170528063|NCT01326871|616282998|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
170528064|NCT01326871|616282999|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
170528065|NCT01326871|616282997|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
170528066|NCT01326871|616282998|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
170528067|NCT01326871|616282999|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
170528068|NCT01326871|616282997|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
170528069|NCT01326871|616282998|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
170528070|NCT01326871|616282999|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
170528071|NCT01326871|616282997|FG000|Overall Study|Physician Decision|0|||
170528072|NCT01326871|616282998|FG001|Overall Study|Physician Decision|0|||
170528073|NCT01326871|616282999|FG002|Overall Study|Physician Decision|1|||
170528074|NCT01326871|616282997|FG000|Overall Study|SAE|0|||
170528075|NCT01326871|616282998|FG001|Overall Study|SAE|0|||
170528076|NCT01326871|616282999|FG002|Overall Study|SAE|1|||
170528077|NCT01326871|616282997|FG000|Overall Study|Disease progression and death|0|||
170528078|NCT01326871|616282998|FG001|Overall Study|Disease progression and death|0|||
170528079|NCT01326871|616282999|FG002|Overall Study|Disease progression and death|1|||
170528080|NCT01326871|616282997|FG000|Overall Study|Subject decision|0|||
170528081|NCT01326871|616282998|FG001|Overall Study|Subject decision|0|||
170528082|NCT01326871|616282999|FG002|Overall Study|Subject decision|1|||
170528083|NCT00251758|616283000|FG000|Overall Study|Adverse Event|7|||
170528084|NCT00251758|616283001|FG001|Overall Study|Adverse Event|9|||
170528085|NCT00251758|616283002|FG002|Overall Study|Adverse Event|11|||
170528086|NCT00251758|616283000|FG000|Overall Study|Lost to Follow-up|4|||
170528087|NCT00251758|616283001|FG001|Overall Study|Lost to Follow-up|2|||
170528088|NCT00251758|616283002|FG002|Overall Study|Lost to Follow-up|5|||
170528089|NCT00251758|616283000|FG000|Overall Study|Withdrawal by Subject|13|||
170528090|NCT00251758|616283001|FG001|Overall Study|Withdrawal by Subject|7|||
170528091|NCT00251758|616283002|FG002|Overall Study|Withdrawal by Subject|3|||
170528092|NCT00251758|616283000|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
170528093|NCT00251758|616283001|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
170528094|NCT00251758|616283002|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
170528095|NCT00251758|616283000|FG000|Overall Study|Lack of Efficacy|3|||
170528096|NCT00251758|616283001|FG001|Overall Study|Lack of Efficacy|0|||
170528097|NCT00251758|616283002|FG002|Overall Study|Lack of Efficacy|0|||
170528098|NCT00251758|616283000|FG000|Overall Study|Noncompliant|0|||
170528099|NCT00251758|616283001|FG001|Overall Study|Noncompliant|2|||
170528100|NCT00251758|616283002|FG002|Overall Study|Noncompliant|2|||
170528101|NCT00251758|616283000|FG000|Overall Study|Pregnancy|0|||
170528102|NCT00251758|616283001|FG001|Overall Study|Pregnancy|1|||
170528103|NCT00251758|616283002|FG002|Overall Study|Pregnancy|0|||
170528104|NCT00251758|616283000|FG000|Overall Study|Per Subject Request|0|||
170528105|NCT00251758|616283001|FG001|Overall Study|Per Subject Request|0|||
170528106|NCT00251758|616283002|FG002|Overall Study|Per Subject Request|1|||
170528107|NCT00251758|616283000|FG000|Overall Study|Per Investigator Request|1|||
170528108|NCT00251758|616283001|FG001|Overall Study|Per Investigator Request|0|||
170528109|NCT00251758|616283002|FG002|Overall Study|Per Investigator Request|0|||
170528110|NCT01387269|616283006|FG000|Overall Study|Death|38|||
170528111|NCT01387269|616283007|FG001|Overall Study|Death|20|||
170528112|NCT01387269|616283006|FG000|Overall Study|Other|8|||
170528113|NCT01387269|616283007|FG001|Overall Study|Other|7|||
170528114|NCT01387269|616283006|FG000|Overall Study|Unrelated AE|12|||
170528115|NCT01387269|616283007|FG001|Overall Study|Unrelated AE|3|||
170528116|NCT01387269|616283006|FG000|Overall Study|Withdrawal by patient|32|||
170528117|NCT01387269|616283007|FG001|Overall Study|Withdrawal by patient|10|||
170528118|NCT01387269|616283006|FG000|Overall Study|Study drug-related AE|1|||
170528119|NCT01387269|616283007|FG001|Overall Study|Study drug-related AE|0|||
170416330|NCT00708422|615863545|FG000|Overall Study|Adverse Event|3|||
170416331|NCT00708422|615863546|FG001|Overall Study|Adverse Event|1|||
170416332|NCT00708422|615863545|FG000|Overall Study|Withdrawal by Subject|1|||
170416333|NCT00708422|615863546|FG001|Overall Study|Withdrawal by Subject|0|||
170416334|NCT01254409|615863547|FG000|Overall Study|Adverse Event|0|||
170416335|NCT01254409|615863548|FG001|Overall Study|Adverse Event|1|||
170416336|NCT01254409|615863549|FG002|Overall Study|Adverse Event|0|||
170416337|NCT01254409|615863550|FG003|Overall Study|Adverse Event|0|||
170416338|NCT04309474|615863552|FG000|Overall Study|Randomized but not treated|0|||
170416339|NCT04309474|615863553|FG001|Overall Study|Randomized but not treated|2|||
170416340|NCT04309474|615863552|FG000|Overall Study|Adverse Event|4|||
170416341|NCT04309474|615863553|FG001|Overall Study|Adverse Event|1|||
170416342|NCT04309474|615863552|FG000|Overall Study|Withdrawal by Subject|6|||
170416343|NCT04309474|615863553|FG001|Overall Study|Withdrawal by Subject|9|||
170416344|NCT04309474|615863552|FG000|Overall Study|Lost to Follow-up|1|||
170416345|NCT04309474|615863553|FG001|Overall Study|Lost to Follow-up|2|||
170416346|NCT04309474|615863552|FG000|Overall Study|Not disclosed|10|||
170416347|NCT04309474|615863553|FG001|Overall Study|Not disclosed|6|||
170416348|NCT01498484|615863557|FG000|Overall Study|Death|6|||
170416349|NCT01498484|615863558|FG001|Overall Study|Death|3|||
170416350|NCT01498484|615863559|FG002|Overall Study|Death|1|||
170416351|NCT01498484|615863560|FG003|Overall Study|Death|1|||
170416352|NCT01498484|615863561|FG004|Overall Study|Death|0|||
170416353|NCT01498484|615863562|FG005|Overall Study|Death|0|||
170528120|NCT01387269|616283006|FG000|Overall Study|Lost to Follow-up|1|||
170528121|NCT01387269|616283007|FG001|Overall Study|Lost to Follow-up|0|||
170528122|NCT01200329|616283010|FG000|Overall Study|Lack of financial coverage|2|||
170528123|NCT01200329|616283010|FG000|Overall Study|Progressive disease|1|||
170528124|NCT03642990|616283017|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
170528125|NCT03642990|616283017|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
170416354|NCT01498484|615863563|FG006|Overall Study|Death|10|||
170416355|NCT01498484|615863564|FG007|Overall Study|Death|1|||
170416356|NCT01498484|615863565|FG008|Overall Study|Death|0|||
170528126|NCT00721799|616283019|FG000|Overall Study|Withdrawal by Subject|7|||
170528127|NCT00721799|616283019|FG000|Overall Study|withdraw by subject after scan 1|1|||
170528128|NCT05158140|616283020|FG000|Overall Study|Death|0|||
170528129|NCT05158140|616283021|FG001|Overall Study|Death|0|||
170528130|NCT05158140|616283022|FG002|Overall Study|Death|0|||
170528131|NCT05158140|616283023|FG003|Overall Study|Death|1|||
170528132|NCT05158140|616283020|FG000|Overall Study|Lost to Follow-up|3|||
170528133|NCT05158140|616283021|FG001|Overall Study|Lost to Follow-up|6|||
170528134|NCT05158140|616283022|FG002|Overall Study|Lost to Follow-up|4|||
170528135|NCT05158140|616283023|FG003|Overall Study|Lost to Follow-up|3|||
170528136|NCT05158140|616283020|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170528137|NCT05158140|616283021|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170528138|NCT05158140|616283022|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
170528139|NCT05158140|616283023|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170528140|NCT05158140|616283020|FG000|Overall Study|Withdrawal by Subject|3|||
170528141|NCT05158140|616283021|FG001|Overall Study|Withdrawal by Subject|7|||
170528142|NCT05158140|616283022|FG002|Overall Study|Withdrawal by Subject|3|||
170528143|NCT05158140|616283023|FG003|Overall Study|Withdrawal by Subject|7|||
170528144|NCT01441973|616283024|FG000|Overall Study|Disease progression|8|||
170528145|NCT01441973|616283025|FG001|Overall Study|Disease progression|6|||
170528146|NCT01441973|616283024|FG000|Overall Study|Adverse event unrelated to study drug|3|||
170528147|NCT01441973|616283025|FG001|Overall Study|Adverse event unrelated to study drug|2|||
170528148|NCT01441973|616283024|FG000|Overall Study|Participant request to discontinue|1|||
170528149|NCT01441973|616283025|FG001|Overall Study|Participant request to discontinue|1|||
170528150|NCT01441973|616283024|FG000|Overall Study|Poor compliance/noncompliance|0|||
170528151|NCT01441973|616283025|FG001|Overall Study|Poor compliance/noncompliance|1|||
170528152|NCT01441973|616283024|FG000|Overall Study|Administrative reason by sponsor|3|||
170528153|NCT01441973|616283025|FG001|Overall Study|Administrative reason by sponsor|5|||
170528154|NCT01441973|616283024|FG000|Overall Study|Participant withdrew consent|0|||
170528155|NCT01441973|616283025|FG001|Overall Study|Participant withdrew consent|1|||
170528156|NCT00617279|616283026|FG000|Overall Study|Study terminated by Sponsor|10|||
170528157|NCT00617279|616283027|FG001|Overall Study|Study terminated by Sponsor|15|||
170528158|NCT00617279|616283026|FG000|Overall Study|Graft abandonment|2|||
170528159|NCT00617279|616283027|FG001|Overall Study|Graft abandonment|0|||
170528160|NCT00617279|616283026|FG000|Overall Study|Lost to Follow-up|1|||
170528161|NCT00617279|616283027|FG001|Overall Study|Lost to Follow-up|0|||
170528162|NCT00617279|616283026|FG000|Overall Study|Death|1|||
170528163|NCT00617279|616283027|FG001|Overall Study|Death|2|||
170528164|NCT01814007|616283028|FG000|Overall Study|Withdrawal by Subject|1|||
170416357|NCT01498484|615863557|FG000|Overall Study|Physician Decision|3|||
170416358|NCT01498484|615863558|FG001|Overall Study|Physician Decision|2|||
170416359|NCT01498484|615863559|FG002|Overall Study|Physician Decision|1|||
170416360|NCT01498484|615863560|FG003|Overall Study|Physician Decision|1|||
170528165|NCT01274351|616283030|FG000|Overall Study|Lost to Follow-up|1|||
170632600|NCT02420821|616666704|FG001|Overall Study|Progressive Disease|1|||
170776910|NCT01898494|617190192|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
170776911|NCT01898494|617190188|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
170776912|NCT01898494|617190189|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
170776913|NCT01898494|617190190|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
170776914|NCT01898494|617190191|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
170776915|NCT01898494|617190192|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
170776916|NCT01898494|617190188|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
170776917|NCT01898494|617190189|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
170776918|NCT01898494|617190190|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
170776919|NCT01898494|617190191|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
170776920|NCT01898494|617190192|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
170776921|NCT01898494|617190188|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
170416361|NCT01498484|615863561|FG004|Overall Study|Physician Decision|0|||
170632601|NCT02420821|616666703|FG000|Overall Study|Disease Progression|0|||
170632602|NCT02420821|616666704|FG001|Overall Study|Disease Progression|1|||
170632603|NCT02420821|616666703|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
170632604|NCT02420821|616666704|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
170632605|NCT00926237|616666705|FG000|Overall Study|Withdrawal by Subject|2|||
170776922|NCT01898494|617190189|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
170416362|NCT01498484|615863562|FG005|Overall Study|Physician Decision|0|||
170416363|NCT01498484|615863563|FG006|Overall Study|Physician Decision|8|||
170416364|NCT01498484|615863564|FG007|Overall Study|Physician Decision|13|||
170416365|NCT01498484|615863565|FG008|Overall Study|Physician Decision|1|||
170416366|NCT01498484|615863557|FG000|Overall Study|Adverse Event|0|||
170416367|NCT01498484|615863558|FG001|Overall Study|Adverse Event|0|||
170416368|NCT01498484|615863559|FG002|Overall Study|Adverse Event|0|||
170416369|NCT01498484|615863560|FG003|Overall Study|Adverse Event|0|||
170416370|NCT01498484|615863561|FG004|Overall Study|Adverse Event|0|||
170416371|NCT01498484|615863562|FG005|Overall Study|Adverse Event|1|||
170416372|NCT01498484|615863563|FG006|Overall Study|Adverse Event|0|||
170416373|NCT01498484|615863564|FG007|Overall Study|Adverse Event|0|||
170416374|NCT01498484|615863565|FG008|Overall Study|Adverse Event|0|||
170416375|NCT01498484|615863557|FG000|Overall Study|Withdrawal by Subject|0|||
170416376|NCT01498484|615863558|FG001|Overall Study|Withdrawal by Subject|0|||
170416377|NCT01498484|615863559|FG002|Overall Study|Withdrawal by Subject|0|||
170416378|NCT01498484|615863560|FG003|Overall Study|Withdrawal by Subject|1|||
170416379|NCT01498484|615863561|FG004|Overall Study|Withdrawal by Subject|0|||
170416380|NCT01498484|615863562|FG005|Overall Study|Withdrawal by Subject|0|||
170416381|NCT01498484|615863563|FG006|Overall Study|Withdrawal by Subject|1|||
170416382|NCT01498484|615863564|FG007|Overall Study|Withdrawal by Subject|0|||
170416383|NCT01498484|615863565|FG008|Overall Study|Withdrawal by Subject|0|||
170416384|NCT01498484|615863557|FG000|Overall Study|Other|5|||
170416385|NCT01498484|615863558|FG001|Overall Study|Other|2|||
170416386|NCT01498484|615863559|FG002|Overall Study|Other|0|||
170416387|NCT01498484|615863560|FG003|Overall Study|Other|0|||
170416388|NCT01498484|615863561|FG004|Overall Study|Other|1|||
170416389|NCT01498484|615863562|FG005|Overall Study|Other|0|||
170416390|NCT01498484|615863563|FG006|Overall Study|Other|3|||
170416391|NCT01498484|615863564|FG007|Overall Study|Other|0|||
170416392|NCT01498484|615863565|FG008|Overall Study|Other|1|||
170416393|NCT00319956|615863566|FG000|Overall Study|Death|20|||
170416394|NCT00319956|615863567|FG001|Overall Study|Death|24|||
170416395|NCT02607800|615863568|FG000|Overall Study|Lost to Follow-up|7|||
170416396|NCT02607800|615863569|FG001|Overall Study|Lost to Follow-up|10|||
170416397|NCT02607800|615863568|FG000|Overall Study|Withdrew Consent|2|||
170416398|NCT02607800|615863569|FG001|Overall Study|Withdrew Consent|0|||
170416399|NCT02607800|615863568|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
170416400|NCT02607800|615863569|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
170416401|NCT01656889|615863570|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
170416402|NCT01656889|615863571|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
170416403|NCT01656889|615863570|FG000|Treatment Period, 12 Weeks|Death|0|||
170416404|NCT01656889|615863571|FG001|Treatment Period, 12 Weeks|Death|1|||
170416405|NCT01656889|615863570|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
170416406|NCT01656889|615863571|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
170416407|NCT01656889|615863570|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
170416408|NCT01656889|615863571|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
170416409|NCT01656889|615863570|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
170416410|NCT01656889|615863571|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
170416411|NCT01656889|615863570|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
170416412|NCT01656889|615863571|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
170416413|NCT01656889|615863570|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
170416414|NCT01656889|615863571|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
170416415|NCT01656889|615863570|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
170416416|NCT01656889|615863571|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
170416417|NCT01656889|615863570|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
170877100|NCT03977974|617560480|FG009|Period 2|Adverse Event|0|||
170416418|NCT01656889|615863571|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
170416419|NCT01656889|615863570|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
170416420|NCT01656889|615863571|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
170416421|NCT02486796|615863572|FG000|Overall Study|Withdrawal by Subject|1|||
170416422|NCT02486796|615863573|FG001|Overall Study|Withdrawal by Subject|1|||
170416423|NCT02486796|615863572|FG000|Overall Study|Physician Decision|1|||
170416424|NCT02486796|615863573|FG001|Overall Study|Physician Decision|0|||
170416425|NCT01185288|615863574|FG000|Overall Study|Adverse Event|7|||
170416426|NCT01185288|615863575|FG001|Overall Study|Adverse Event|6|||
170416427|NCT01185288|615863574|FG000|Overall Study|Withdrawal by Subject|6|||
170416428|NCT01185288|615863575|FG001|Overall Study|Withdrawal by Subject|4|||
170416429|NCT01185288|615863574|FG000|Overall Study|Lost to Follow-up|2|||
170416430|NCT01185288|615863575|FG001|Overall Study|Lost to Follow-up|5|||
170416431|NCT01185288|615863574|FG000|Overall Study|Lack of Efficacy|2|||
170416432|NCT01185288|615863575|FG001|Overall Study|Lack of Efficacy|0|||
170416433|NCT01185288|615863574|FG000|Overall Study|Investigator discretion|1|||
170416434|NCT01185288|615863575|FG001|Overall Study|Investigator discretion|0|||
170416435|NCT01185288|615863574|FG000|Overall Study|Did not meet inclusion criteria|1|||
170416436|NCT01185288|615863575|FG001|Overall Study|Did not meet inclusion criteria|0|||
170416437|NCT01185288|615863574|FG000|Overall Study|Noncompliance|0|||
170416438|NCT01185288|615863575|FG001|Overall Study|Noncompliance|1|||
170416439|NCT01202747|615863576|FG000|Overall Study|Withdrawal by Subject|1|||
170416440|NCT00679783|615863577|FG000|Overall Study|Adverse Event|0|||
170416441|NCT00679783|615863578|FG001|Overall Study|Adverse Event|0|||
170416442|NCT00679783|615863579|FG002|Overall Study|Adverse Event|0|||
170416443|NCT00679783|615863580|FG003|Overall Study|Adverse Event|3|||
170416444|NCT00679783|615863581|FG004|Overall Study|Adverse Event|0|||
170416445|NCT00679783|615863582|FG005|Overall Study|Adverse Event|0|||
170416446|NCT00679783|615863583|FG006|Overall Study|Adverse Event|1|||
170416447|NCT00679783|615863577|FG000|Overall Study|Lack of Efficacy|0|||
170416448|NCT00679783|615863578|FG001|Overall Study|Lack of Efficacy|1|||
170416449|NCT00679783|615863579|FG002|Overall Study|Lack of Efficacy|0|||
170416450|NCT00679783|615863580|FG003|Overall Study|Lack of Efficacy|2|||
170416451|NCT00679783|615863581|FG004|Overall Study|Lack of Efficacy|0|||
170416452|NCT00679783|615863582|FG005|Overall Study|Lack of Efficacy|0|||
170416453|NCT00679783|615863583|FG006|Overall Study|Lack of Efficacy|0|||
170416454|NCT00679783|615863577|FG000|Overall Study|Withdrawal by Subject|0|||
170416455|NCT00679783|615863578|FG001|Overall Study|Withdrawal by Subject|0|||
170416456|NCT00679783|615863579|FG002|Overall Study|Withdrawal by Subject|1|||
170416457|NCT00679783|615863580|FG003|Overall Study|Withdrawal by Subject|1|||
170416458|NCT00679783|615863581|FG004|Overall Study|Withdrawal by Subject|0|||
170416459|NCT00679783|615863582|FG005|Overall Study|Withdrawal by Subject|0|||
170416460|NCT00679783|615863583|FG006|Overall Study|Withdrawal by Subject|0|||
170416461|NCT00679783|615863577|FG000|Overall Study|Not Captured|0|||
170416462|NCT00679783|615863578|FG001|Overall Study|Not Captured|0|||
170416463|NCT00679783|615863579|FG002|Overall Study|Not Captured|0|||
170416464|NCT00679783|615863580|FG003|Overall Study|Not Captured|5|||
170416465|NCT00679783|615863581|FG004|Overall Study|Not Captured|0|||
170416466|NCT00679783|615863582|FG005|Overall Study|Not Captured|0|||
170416467|NCT00679783|615863583|FG006|Overall Study|Not Captured|0|||
170416468|NCT00679783|615863577|FG000|Overall Study|Ongoing at data cut-off|2|||
170416469|NCT00679783|615863578|FG001|Overall Study|Ongoing at data cut-off|2|||
170416470|NCT00679783|615863579|FG002|Overall Study|Ongoing at data cut-off|0|||
170416471|NCT00679783|615863580|FG003|Overall Study|Ongoing at data cut-off|9|||
170416472|NCT00679783|615863581|FG004|Overall Study|Ongoing at data cut-off|1|||
170416473|NCT00679783|615863582|FG005|Overall Study|Ongoing at data cut-off|0|||
170416474|NCT00679783|615863583|FG006|Overall Study|Ongoing at data cut-off|0|||
170416475|NCT02626949|615863586|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
170416476|NCT02626949|615863587|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
170416477|NCT02626949|615863586|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
170416478|NCT02626949|615863587|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
170416479|NCT02626949|615863586|FG000|Enrolled|Lost to Follow-up|7|||
170416480|NCT02626949|615863587|FG001|Enrolled|Lost to Follow-up|6|||
170416481|NCT02626949|615863586|FG000|Enrolled|Withdrawal by Subject|3|||
170416482|NCT02626949|615863587|FG001|Enrolled|Withdrawal by Subject|2|||
170416483|NCT02984683|615863591|FG000|Overall Study|Adverse Event|3|||
170416484|NCT02984683|615863592|FG001|Overall Study|Adverse Event|3|||
170877101|NCT03977974|617560481|FG010|Period 2|Adverse Event|0|||
170416485|NCT02984683|615863591|FG000|Overall Study|Withdrawal by Subject|1|||
170416486|NCT02984683|615863592|FG001|Overall Study|Withdrawal by Subject|0|||
170416487|NCT02984683|615863591|FG000|Overall Study|Disease progression|7|||
170416488|NCT02984683|615863592|FG001|Overall Study|Disease progression|9|||
170416489|NCT01546987|615865535|FG000|Overall Study|Protocol Violation|3|||
170416490|NCT01546987|615865536|FG001|Overall Study|Protocol Violation|4|||
170416491|NCT02518113|615865537|FG000|Overall Study|Adverse Event|1|||
170416492|NCT02518113|615865538|FG001|Overall Study|Adverse Event|0|||
170528166|NCT01274351|616283030|FG000|Overall Study|patient not compliant with the protocol|1|||
170528167|NCT01274351|616283030|FG000|Overall Study|Pregnancy|1|||
170528168|NCT01274351|616283030|FG000|Overall Study|Death|2|||
170528169|NCT01274351|616283030|FG000|Overall Study|Withdrawal by Subject|3|||
170528170|NCT01274351|616283030|FG000|Overall Study|Adverse Event|8|||
170528171|NCT01274351|616283030|FG000|Overall Study|progression of disease|3|||
170528172|NCT01274351|616283030|FG000|Overall Study|hospitalization|1|||
170528173|NCT01296412|616283033|FG000|Overall Study|Adverse Event|8|||
170528174|NCT01296412|616283034|FG001|Overall Study|Adverse Event|29|||
170528175|NCT01296412|616283033|FG000|Overall Study|Lack of Efficacy|1|||
170528176|NCT01296412|616283034|FG001|Overall Study|Lack of Efficacy|0|||
170528177|NCT01296412|616283033|FG000|Overall Study|Lost to Follow-up|10|||
170528178|NCT01296412|616283034|FG001|Overall Study|Lost to Follow-up|7|||
170528179|NCT01296412|616283033|FG000|Overall Study|Non-compliance with study drug|1|||
170528180|NCT01296412|616283034|FG001|Overall Study|Non-compliance with study drug|2|||
170528181|NCT01296412|616283033|FG000|Overall Study|Other reason not specified|20|||
170528182|NCT01296412|616283034|FG001|Overall Study|Other reason not specified|15|||
170528183|NCT01296412|616283033|FG000|Overall Study|Physician Decision|1|||
170528184|NCT01296412|616283034|FG001|Overall Study|Physician Decision|3|||
170528185|NCT01296412|616283033|FG000|Overall Study|Pregnancy|0|||
170528186|NCT01296412|616283034|FG001|Overall Study|Pregnancy|1|||
170528187|NCT01296412|616283033|FG000|Overall Study|Withdrawal by Subject|10|||
170528188|NCT01296412|616283034|FG001|Overall Study|Withdrawal by Subject|13|||
170528189|NCT02160626|616283035|FG000|Overall Study|Adverse Event|1|||
170528190|NCT02160626|616283036|FG001|Overall Study|Adverse Event|0|||
170528191|NCT02160626|616283037|FG002|Overall Study|Adverse Event|0|||
170528192|NCT02160626|616283035|FG000|Overall Study|Schedule not conducive to study visits|0|||
170528193|NCT02160626|616283036|FG001|Overall Study|Schedule not conducive to study visits|0|||
170528194|NCT02160626|616283037|FG002|Overall Study|Schedule not conducive to study visits|1|||
170528195|NCT02160626|616283035|FG000|Overall Study|Withdrawal by Subject|0|||
170528196|NCT02160626|616283036|FG001|Overall Study|Withdrawal by Subject|1|||
170528197|NCT02160626|616283037|FG002|Overall Study|Withdrawal by Subject|0|||
170528198|NCT04239924|616283040|FG000|Overall Study|Lost to Follow-up|2|||
170528199|NCT04194814|616283041|FG000|Overall Study|Physician Decision|3|||
170528200|NCT04194814|616283042|FG001|Overall Study|Physician Decision|0|||
170528201|NCT04194814|616283041|FG000|Overall Study|Withdrawal by Subject|0|||
170528202|NCT04194814|616283042|FG001|Overall Study|Withdrawal by Subject|2|||
170528203|NCT03255187|616285070|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
170528204|NCT03255187|616285071|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
170528205|NCT03255187|616285070|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
170528206|NCT03255187|616285071|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
170528207|NCT00408499|616285073|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
170528208|NCT00408499|616285074|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
170528209|NCT00408499|616285075|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
170528210|NCT00408499|616285076|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
170528211|NCT00408499|616285077|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
170528212|NCT00408499|616285073|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
170528213|NCT00408499|616285074|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
170528214|NCT00408499|616285075|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
170528215|NCT00408499|616285076|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
170528216|NCT00408499|616285077|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
170528217|NCT00408499|616285073|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
170528218|NCT00408499|616285074|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
170528219|NCT00408499|616285075|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
170528220|NCT00408499|616285076|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
170528221|NCT00408499|616285077|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
170528222|NCT00408499|616285073|FG000|Phase II- MTD Expansion|Adverse Event|0|||
170528223|NCT00408499|616285074|FG001|Phase II- MTD Expansion|Adverse Event|0|||
170528224|NCT00408499|616285075|FG002|Phase II- MTD Expansion|Adverse Event|0|||
170528225|NCT00408499|616285076|FG003|Phase II- MTD Expansion|Adverse Event|0|||
170528226|NCT00408499|616285077|FG004|Phase II- MTD Expansion|Adverse Event|9|||
170528227|NCT00408499|616285073|FG000|Phase II- MTD Expansion|Death|0|||
170528228|NCT00408499|616285074|FG001|Phase II- MTD Expansion|Death|0|||
170528229|NCT00408499|616285075|FG002|Phase II- MTD Expansion|Death|0|||
170528230|NCT00408499|616285076|FG003|Phase II- MTD Expansion|Death|0|||
170528231|NCT00408499|616285077|FG004|Phase II- MTD Expansion|Death|2|||
170528232|NCT00408499|616285073|FG000|Phase II- MTD Expansion|Physician Decision|0|||
170528233|NCT00408499|616285074|FG001|Phase II- MTD Expansion|Physician Decision|0|||
170528234|NCT00408499|616285075|FG002|Phase II- MTD Expansion|Physician Decision|0|||
170528235|NCT00408499|616285076|FG003|Phase II- MTD Expansion|Physician Decision|0|||
170528236|NCT00408499|616285077|FG004|Phase II- MTD Expansion|Physician Decision|1|||
170528237|NCT00408499|616285073|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
170528238|NCT00408499|616285074|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
170528239|NCT00408499|616285075|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
170776923|NCT01898494|617190190|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
170776924|NCT01898494|617190191|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
170776925|NCT01898494|617190192|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
170416493|NCT02518113|615865539|FG002|Overall Study|Adverse Event|1|||
170416494|NCT02518113|615865540|FG003|Overall Study|Adverse Event|0|||
170416495|NCT02518113|615865537|FG000|Overall Study|Death|1|||
170416496|NCT02518113|615865538|FG001|Overall Study|Death|2|||
170416497|NCT02518113|615865539|FG002|Overall Study|Death|0|||
170416498|NCT02518113|615865540|FG003|Overall Study|Death|0|||
170416499|NCT02518113|615865537|FG000|Overall Study|Physician Decision|0|||
170416500|NCT02518113|615865538|FG001|Overall Study|Physician Decision|1|||
170416501|NCT02518113|615865539|FG002|Overall Study|Physician Decision|0|||
170416502|NCT02518113|615865540|FG003|Overall Study|Physician Decision|0|||
170416503|NCT02518113|615865537|FG000|Overall Study|Progressive Disease|1|||
170416504|NCT02518113|615865538|FG001|Overall Study|Progressive Disease|2|||
170416505|NCT02518113|615865539|FG002|Overall Study|Progressive Disease|3|||
170416506|NCT02518113|615865540|FG003|Overall Study|Progressive Disease|0|||
170416507|NCT02270736|615865541|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
170416508|NCT02270736|615865542|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
170416509|NCT02270736|615865543|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
170416510|NCT02270736|615865544|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
170416511|NCT02270736|615865545|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
170416512|NCT02270736|615865541|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
170416513|NCT02270736|615865542|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
170416514|NCT02270736|615865543|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
170416515|NCT02270736|615865544|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
170416516|NCT02270736|615865545|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
170416517|NCT02270736|615865541|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
170416518|NCT02270736|615865542|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
170416519|NCT02270736|615865543|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
170416520|NCT02270736|615865544|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
170416521|NCT02270736|615865545|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
170416522|NCT02270736|615865541|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
170416523|NCT02270736|615865542|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
170416524|NCT02270736|615865543|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
170416525|NCT02270736|615865544|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
170416526|NCT02270736|615865545|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
170416527|NCT02270736|615865541|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
170416528|NCT02270736|615865542|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
170416529|NCT02270736|615865543|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
170416530|NCT02270736|615865544|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
170416531|NCT02270736|615865545|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
170416532|NCT02270736|615865541|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
170416533|NCT02270736|615865542|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
170416534|NCT02270736|615865543|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
170416535|NCT02270736|615865544|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
170416536|NCT02270736|615865545|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
170416537|NCT02270736|615865541|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
170416538|NCT02270736|615865542|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
170416539|NCT02270736|615865543|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
170416540|NCT02270736|615865544|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
170416541|NCT02270736|615865545|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
170416542|NCT02270736|615865541|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
170416543|NCT02270736|615865542|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
170416544|NCT02270736|615865543|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
170416545|NCT02270736|615865544|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
170416546|NCT02270736|615865545|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
170416547|NCT02270736|615865541|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
170416548|NCT02270736|615865542|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
170416549|NCT02270736|615865543|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
170416550|NCT02270736|615865544|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
170416551|NCT02270736|615865545|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
170416552|NCT00262600|615865546|FG000|Overall Study|Lost to Follow-up|17|||
170416553|NCT00262600|615865547|FG001|Overall Study|Lost to Follow-up|31|||
170416554|NCT00262600|615865548|FG002|Overall Study|Lost to Follow-up|41|||
170416555|NCT00262600|615865546|FG000|Overall Study|Withdrawal by Subject|128|||
170416556|NCT00262600|615865547|FG001|Overall Study|Withdrawal by Subject|145|||
170416557|NCT00262600|615865548|FG002|Overall Study|Withdrawal by Subject|139|||
170416558|NCT00262600|615865546|FG000|Overall Study|Not Treated|32|||
170776926|NCT01898494|617190188|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
170776927|NCT01898494|617190189|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
170776928|NCT01898494|617190190|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
170528240|NCT00408499|616285076|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
170528241|NCT00408499|616285077|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
170528242|NCT00408499|616285073|FG000|Phase II- MTD Expansion|treatment delay|0|||
170528243|NCT00408499|616285074|FG001|Phase II- MTD Expansion|treatment delay|0|||
170528244|NCT00408499|616285075|FG002|Phase II- MTD Expansion|treatment delay|0|||
170528245|NCT00408499|616285076|FG003|Phase II- MTD Expansion|treatment delay|0|||
170528246|NCT00408499|616285077|FG004|Phase II- MTD Expansion|treatment delay|3|||
170528247|NCT01586195|616285082|FG000|Overall Study|Death|11|||
170528248|NCT01586195|616285082|FG000|Overall Study|Withdrawal of Consent|5|||
170528249|NCT01586195|616285082|FG000|Overall Study|Started new anti-melanoma therapy|1|||
170528250|NCT01586195|616285082|FG000|Overall Study|Reason not specified|9|||
170528251|NCT01287936|616285083|FG000|Overall Study|Lost to Follow-up|0|||
170528252|NCT01287936|616285084|FG001|Overall Study|Lost to Follow-up|1|||
170528253|NCT01287936|616285085|FG002|Overall Study|Lost to Follow-up|1|||
170528254|NCT01855958|616285086|FG000|Overall Study|Withdrawal by Subject|1|||
170528255|NCT01855958|616285087|FG001|Overall Study|Withdrawal by Subject|0|||
170528256|NCT00296244|616285088|FG000|Overall Study|Underwent retransplant|0|||
170528257|NCT00296244|616285089|FG001|Overall Study|Underwent retransplant|1|||
170528258|NCT02791269|616285091|FG000|Overall Study|Lost to Follow-up|0|||
170528259|NCT02791269|616285092|FG001|Overall Study|Lost to Follow-up|1|||
170528260|NCT02683109|616285093|FG000|Overall Study|Adverse Event|1|||
170528261|NCT02683109|616285094|FG001|Overall Study|Adverse Event|0|||
170528262|NCT01125930|616285095|FG000|Overall Study|Adverse Event|0|||
170528263|NCT01125930|616285096|FG001|Overall Study|Adverse Event|1|||
170528264|NCT01125930|616285095|FG000|Overall Study|Withdrawal by Subject|1|||
170528265|NCT01125930|616285096|FG001|Overall Study|Withdrawal by Subject|6|||
170528266|NCT01125930|616285095|FG000|Overall Study|Protocol Violation|0|||
170528267|NCT01125930|616285096|FG001|Overall Study|Protocol Violation|1|||
170528268|NCT01125930|616285095|FG000|Overall Study|Lost to Follow-up|0|||
170528269|NCT01125930|616285096|FG001|Overall Study|Lost to Follow-up|2|||
170528270|NCT03617588|616285101|FG000|Overall Study|Withdrawal by Subject|1|||
170528271|NCT03617588|616285102|FG001|Overall Study|Withdrawal by Subject|0|||
170528272|NCT03261401|616285105|FG000|Overall Study|Withdrawal by Subject|0|||
170528273|NCT03261401|616285106|FG001|Overall Study|Withdrawal by Subject|0|||
170528274|NCT03261401|616285107|FG002|Overall Study|Withdrawal by Subject|0|||
170528275|NCT03261401|616285108|FG003|Overall Study|Withdrawal by Subject|0|||
170528276|NCT03261401|616285109|FG004|Overall Study|Withdrawal by Subject|0|||
170528277|NCT03261401|616285110|FG005|Overall Study|Withdrawal by Subject|1|||
170528278|NCT03261401|616285111|FG006|Overall Study|Withdrawal by Subject|0|||
170528279|NCT03261401|616285112|FG007|Overall Study|Withdrawal by Subject|0|||
170528280|NCT03261401|616285113|FG008|Overall Study|Withdrawal by Subject|0|||
170528281|NCT03261401|616285114|FG009|Overall Study|Withdrawal by Subject|0|||
170528282|NCT03261401|616285115|FG010|Overall Study|Withdrawal by Subject|0|||
170528283|NCT03261401|616285116|FG011|Overall Study|Withdrawal by Subject|0|||
170528284|NCT03261401|616285117|FG012|Overall Study|Withdrawal by Subject|0|||
170528285|NCT03261401|616285105|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
170528286|NCT03261401|616285106|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
170528287|NCT03261401|616285107|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
170528288|NCT03261401|616285108|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
170528289|NCT03261401|616285109|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
170528290|NCT03261401|616285110|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
170528291|NCT03261401|616285111|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
170528292|NCT03261401|616285112|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
170528293|NCT03261401|616285113|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
170528294|NCT03261401|616285114|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
170528295|NCT03261401|616285115|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
170528296|NCT03261401|616285116|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
170528297|NCT03261401|616285117|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
170528298|NCT00900562|616285118|FG000|Overall Study|Progressive disease|9|||
170528299|NCT00900562|616285119|FG001|Overall Study|Progressive disease|5|||
170528300|NCT00900562|616285118|FG000|Overall Study|Toxicity|1|||
170528301|NCT00900562|616285119|FG001|Overall Study|Toxicity|0|||
170528302|NCT00900562|616285118|FG000|Overall Study|Death|1|||
170528303|NCT00900562|616285119|FG001|Overall Study|Death|1|||
170528304|NCT00900562|616285118|FG000|Overall Study|Withdrawal by Subject|0|||
170528305|NCT00900562|616285119|FG001|Overall Study|Withdrawal by Subject|1|||
170528306|NCT00900562|616285118|FG000|Overall Study|Unrelated adverse event|1|||
170528307|NCT00900562|616285119|FG001|Overall Study|Unrelated adverse event|0|||
170528308|NCT01715298|616285120|FG000|Overall Study|Lost to Follow-up|0|||
170528309|NCT01715298|616285121|FG001|Overall Study|Lost to Follow-up|2|||
170528310|NCT01715298|616285120|FG000|Overall Study|Patient/guardian decision|7|||
170528311|NCT01715298|616285121|FG001|Overall Study|Patient/guardian decision|9|||
170528312|NCT02419807|616285122|FG000|Overall Study|Withdrawal by Subject|4|||
170528313|NCT02419807|616285122|FG000|Overall Study|Physician Decision|1|||
170528314|NCT02419807|616285122|FG000|Overall Study|Protocol Violation|5|||
170528315|NCT01935089|616285125|FG000|Overall Study|Adverse Event|2|||
170528316|NCT01935089|616285125|FG000|Overall Study|Withdrawal by Subject|1|||
170528317|NCT00958074|616285126|FG000|Overall Study|Withdrawal by Subject|0|||
170528318|NCT00958074|616285127|FG001|Overall Study|Withdrawal by Subject|1|||
170528319|NCT00915525|616285128|FG000|Overall Study|Protocol Violation|9|||
170528320|NCT00915525|616285129|FG001|Overall Study|Protocol Violation|4|||
170528321|NCT00915525|616285128|FG000|Overall Study|Withdrawal by Subject|59|||
170528322|NCT00915525|616285129|FG001|Overall Study|Withdrawal by Subject|21|||
170528323|NCT00915525|616285128|FG000|Overall Study|Lost to Follow-up|27|||
170528324|NCT00915525|616285129|FG001|Overall Study|Lost to Follow-up|16|||
170528325|NCT00915525|616285128|FG000|Overall Study|Pregnancy|2|||
170528326|NCT00915525|616285129|FG001|Overall Study|Pregnancy|0|||
170528327|NCT00915525|616285128|FG000|Overall Study|Lack of Efficacy|15|||
170528328|NCT00915525|616285129|FG001|Overall Study|Lack of Efficacy|32|||
170528329|NCT00915525|616285128|FG000|Overall Study|Adverse Event|29|||
170528330|NCT00915525|616285129|FG001|Overall Study|Adverse Event|13|||
170528331|NCT00915525|616285128|FG000|Overall Study|Missing|12|||
170528332|NCT00915525|616285129|FG001|Overall Study|Missing|1|||
170528333|NCT00915525|616285128|FG000|Overall Study|Other Reason|35|||
170528334|NCT00915525|616285129|FG001|Overall Study|Other Reason|12|||
170528335|NCT00915525|616285128|FG000|Overall Study|Site Closed|27|||
170528336|NCT00915525|616285129|FG001|Overall Study|Site Closed|9|||
170528337|NCT00915525|616285128|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
170528338|NCT00915525|616285129|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
170528339|NCT00915525|616285128|FG000|Overall Study|Study Burden|28|||
170528340|NCT00915525|616285129|FG001|Overall Study|Study Burden|12|||
170528341|NCT00915525|616285128|FG000|Overall Study|Non-Compliance|3|||
170528342|NCT00915525|616285129|FG001|Overall Study|Non-Compliance|1|||
170528343|NCT00915525|616285128|FG000|Overall Study|Patient Moved|15|||
170528344|NCT00915525|616285129|FG001|Overall Study|Patient Moved|9|||
170528345|NCT00941928|616285130|FG000|Overall Study|Withdrawal by Subject|1|||
170528346|NCT00941928|616285130|FG000|Overall Study|Disease Progression|1|||
170528347|NCT02300610|616285131|FG000|Overall Study|Withdrawal by Subject|1|||
170528348|NCT02300610|616285132|FG001|Overall Study|Withdrawal by Subject|0|||
170528349|NCT02300610|616285133|FG002|Overall Study|Withdrawal by Subject|1|||
170528350|NCT01829347|616285134|FG000|VTI-210|Death|5|||
170528351|NCT01829347|616285135|FG001|VTI-210|Death|3|||
170528352|NCT01829347|616285134|FG000|VTI-210|Withdrawal by Subject|1|||
170528353|NCT01829347|616285135|FG001|VTI-210|Withdrawal by Subject|0|||
170528354|NCT01829347|616285134|FG000|VTI-210E|Death|2|||
170528355|NCT01829347|616285135|FG001|VTI-210E|Death|1|||
170528356|NCT01829347|616285134|FG000|VTI-210E|Study terminated prematurely|1|||
170528357|NCT01829347|616285135|FG001|VTI-210E|Study terminated prematurely|5|||
170528358|NCT03435055|616285136|FG000|Screening|Physician Decision|2|||
170528359|NCT03435055|616285136|FG000|Received Intervention|Did not complete nitrous administration|3|||
170528360|NCT01668797|616285144|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
170528361|NCT01668797|616285145|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
170528362|NCT01668797|616285146|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
170528363|NCT01668797|616285147|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
170528364|NCT01668797|616285144|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
170528365|NCT01668797|616285145|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
170776929|NCT01898494|617190191|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
170776930|NCT01898494|617190192|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
170776931|NCT01898494|617190188|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
170776932|NCT01898494|617190189|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
170776933|NCT01898494|617190190|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
170776934|NCT01898494|617190191|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
170528366|NCT01668797|616285146|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
170528367|NCT01668797|616285147|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
170528368|NCT01668797|616285144|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
170528369|NCT01668797|616285145|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
170528370|NCT01668797|616285146|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
170528371|NCT01668797|616285147|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
170528372|NCT01668797|616285144|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
170528373|NCT01668797|616285145|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
170528374|NCT01668797|616285146|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
170528375|NCT01668797|616285147|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
170528376|NCT01668797|616285144|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
170528377|NCT01668797|616285145|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
170528378|NCT01668797|616285146|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
170528379|NCT01668797|616285147|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
170528380|NCT01668797|616285144|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
170528381|NCT01668797|616285145|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
170528382|NCT01668797|616285146|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
170528383|NCT01668797|616285147|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
170528384|NCT01668797|616285144|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
170528385|NCT01668797|616285145|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
170528386|NCT01668797|616285146|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
170528387|NCT01668797|616285147|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
170528388|NCT01668797|616285144|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
170528389|NCT01668797|616285145|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
170528390|NCT01668797|616285146|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
170528391|NCT01668797|616285147|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
170528392|NCT01668797|616285144|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
170528393|NCT01668797|616285145|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
170528394|NCT01668797|616285146|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
170528395|NCT01668797|616285147|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
170528396|NCT01668797|616285144|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
170528397|NCT01668797|616285145|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
170528398|NCT01668797|616285146|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
170528399|NCT01668797|616285147|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
170528400|NCT01668797|616285144|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
170528401|NCT01668797|616285145|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
170528402|NCT01668797|616285146|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
170528403|NCT01668797|616285147|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
170528404|NCT01668797|616285144|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
170528405|NCT01668797|616285145|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
170528406|NCT01668797|616285146|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
170528407|NCT01668797|616285147|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
170528408|NCT01668797|616285144|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
170528409|NCT01668797|616285145|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
170528410|NCT01668797|616285146|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
170528411|NCT01668797|616285147|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
170528412|NCT01668797|616285144|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
170528413|NCT01668797|616285145|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
170528414|NCT01668797|616285146|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
170528415|NCT01668797|616285147|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
170528416|NCT01668797|616285144|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
170528417|NCT01668797|616285145|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
170528418|NCT01668797|616285146|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
170528419|NCT01668797|616285147|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
170528420|NCT01668797|616285144|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
170528421|NCT01668797|616285145|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
170528422|NCT01668797|616285146|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
170528423|NCT01668797|616285147|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
170528424|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
170528425|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
170528426|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
170528427|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
170528428|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
170528429|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
170528430|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
170528431|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
170528432|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
170528433|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
170528434|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
170528435|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
170528436|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
170528437|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
170528438|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
170528439|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
170528440|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
170528441|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
170528442|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
170528443|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
170528444|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
170528445|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
170877102|NCT03977974|617560482|FG011|Period 2|Adverse Event|0|||
170528446|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
170528447|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
170528448|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
170528449|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
170528450|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
170528451|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
170528452|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
170528453|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
170528454|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
170528455|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
170528456|NCT01668797|616285144|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
170528457|NCT01668797|616285145|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
170528458|NCT01668797|616285146|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
170528459|NCT01668797|616285147|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
170528460|NCT00671749|616285148|FG000|Overall Study|Adverse Event|2|||
170528461|NCT00671749|616285148|FG000|Overall Study|Withdrawal by Subject|4|||
170528462|NCT00671749|616285148|FG000|Overall Study|Protocol Violation|1|||
170528463|NCT00671749|616285148|FG000|Overall Study|Lost to Follow-up|1|||
170528464|NCT02515227|616285149|FG000|Overall Study|Adverse Event|0|||
170528465|NCT02515227|616285150|FG001|Overall Study|Adverse Event|2|||
170528466|NCT02515227|616285149|FG000|Overall Study|Progressive disease|2|||
170528467|NCT02515227|616285150|FG001|Overall Study|Progressive disease|9|||
170528468|NCT02111083|616285151|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
170528469|NCT02111083|616285152|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
170528470|NCT01259245|616285155|FG000|Overall Study|Withdrawal by Subject|27|||
170528471|NCT01259245|616285156|FG001|Overall Study|Withdrawal by Subject|24|||
170528472|NCT01259245|616285155|FG000|Overall Study|Death|1|||
170528473|NCT01259245|616285156|FG001|Overall Study|Death|2|||
170528474|NCT03937778|616285159|FG000|Overall Study|Withdrawal by Subject|1|||
170528475|NCT03937778|616285159|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
170528476|NCT03502798|616285163|FG000|Overall Study|equipment failure|0|||
170528477|NCT03502798|616285164|FG001|Overall Study|equipment failure|7|||
170528478|NCT01027845|616285169|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
170528479|NCT01027845|616285170|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
170528480|NCT01027845|616285171|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
170528481|NCT01027845|616285172|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
170528482|NCT01027845|616285169|FG000|Primary Vaccination Phase|Adverse Event|1|||
170528483|NCT01027845|616285170|FG001|Primary Vaccination Phase|Adverse Event|0|||
170528484|NCT01027845|616285171|FG002|Primary Vaccination Phase|Adverse Event|0|||
170528485|NCT01027845|616285172|FG003|Primary Vaccination Phase|Adverse Event|0|||
170528486|NCT01027845|616285169|FG000|Primary Vaccination Phase|Protocol Violation|1|||
170528487|NCT01027845|616285170|FG001|Primary Vaccination Phase|Protocol Violation|0|||
170528488|NCT01027845|616285171|FG002|Primary Vaccination Phase|Protocol Violation|0|||
170528489|NCT01027845|616285172|FG003|Primary Vaccination Phase|Protocol Violation|0|||
170528490|NCT01027845|616285169|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
170528491|NCT01027845|616285170|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
170528492|NCT01027845|616285171|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
170528493|NCT01027845|616285172|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
170528494|NCT01027845|616285169|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
170528495|NCT01027845|616285170|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
170528496|NCT01027845|616285171|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
170528497|NCT01027845|616285172|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
170528498|NCT01027845|616285169|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
170528499|NCT01027845|616285170|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
170528500|NCT01027845|616285171|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
170528501|NCT01027845|616285172|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
170528502|NCT01401322|616285173|FG000|Overall Study|Withdrawal by Subject|1|||
170528503|NCT01401322|616285173|FG000|Overall Study|Physician Decision|1|||
170528504|NCT02410629|616285177|FG000|Overall Study|Family cannot commit to the study|2|||
170528505|NCT02410629|616285178|FG001|Overall Study|Family cannot commit to the study|1|||
170528506|NCT02410629|616285177|FG000|Overall Study|Subject returned to work|1|||
170528507|NCT02410629|616285178|FG001|Overall Study|Subject returned to work|0|||
170528508|NCT02410629|616285177|FG000|Overall Study|Subject moved back to home country|0|||
170528509|NCT02410629|616285178|FG001|Overall Study|Subject moved back to home country|1|||
170528510|NCT02410629|616285177|FG000|Overall Study|Subject underwent heart surgery|0|||
170528511|NCT02410629|616285178|FG001|Overall Study|Subject underwent heart surgery|1|||
170528512|NCT01670292|616285179|FG000|Overall Study|Lost to Follow-up|14|||
170528513|NCT00087178|616285180|FG000|Overall Study|No follow up data|5|||
170528514|NCT00087178|616285181|FG001|Overall Study|No follow up data|15|||
170528515|NCT00087178|616285180|FG000|Overall Study|No clinical assessment|1|||
170528516|NCT00087178|616285181|FG001|Overall Study|No clinical assessment|2|||
170528517|NCT00087178|616285180|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
170528518|NCT00087178|616285181|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
170528519|NCT02722967|616285184|FG000|Overall Study|Adverse Event|1|||
170528520|NCT02722967|616285185|FG001|Overall Study|Adverse Event|0|||
170528521|NCT02722967|616285186|FG002|Overall Study|Adverse Event|0|||
170528522|NCT02722967|616285184|FG000|Overall Study|Lost to Follow-up|0|||
170528523|NCT02722967|616285185|FG001|Overall Study|Lost to Follow-up|1|||
170528524|NCT02722967|616285186|FG002|Overall Study|Lost to Follow-up|0|||
170528525|NCT02722967|616285184|FG000|Overall Study|Non-compliance with patch wearing|2|||
170528526|NCT02722967|616285185|FG001|Overall Study|Non-compliance with patch wearing|1|||
170632606|NCT00926237|616666706|FG001|Overall Study|Withdrawal by Subject|1|||
170632607|NCT04119414|616666707|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
170528527|NCT02722967|616285186|FG002|Overall Study|Non-compliance with patch wearing|1|||
170528528|NCT02722967|616285184|FG000|Overall Study|Withdrawal by Subject|1|||
170528529|NCT02722967|616285185|FG001|Overall Study|Withdrawal by Subject|0|||
170528530|NCT02722967|616285186|FG002|Overall Study|Withdrawal by Subject|1|||
170528531|NCT02722967|616285184|FG000|Overall Study|Physician Decision|1|||
170528532|NCT02722967|616285185|FG001|Overall Study|Physician Decision|0|||
170528533|NCT02722967|616285186|FG002|Overall Study|Physician Decision|0|||
170528534|NCT02722967|616285184|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
170528535|NCT02722967|616285185|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
170528536|NCT02722967|616285186|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
170528537|NCT04142242|616285187|FG000|Stage I|Non-compliance with the protocol|1|||
170528538|NCT04142242|616285188|FG001|Stage I|Non-compliance with the protocol|0|||
170528539|NCT04142242|616285189|FG002|Stage I|Non-compliance with the protocol|0|||
170528540|NCT04142242|616285190|FG003|Stage I|Non-compliance with the protocol|0|||
170528541|NCT04142242|616285191|FG004|Stage I|Non-compliance with the protocol|0|||
170528542|NCT04142242|616285192|FG005|Stage I|Non-compliance with the protocol|1|||
170528543|NCT04142242|616285187|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
170528544|NCT04142242|616285188|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
170528545|NCT04142242|616285189|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
170528546|NCT04142242|616285190|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
170528547|NCT04142242|616285191|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
170528548|NCT04142242|616285192|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
170528549|NCT04142242|616285187|FG000|Stage II|Non-compliance with the protocol|0|||
170528550|NCT04142242|616285188|FG001|Stage II|Non-compliance with the protocol|0|||
170528551|NCT04142242|616285189|FG002|Stage II|Non-compliance with the protocol|0|||
170528552|NCT04142242|616285190|FG003|Stage II|Non-compliance with the protocol|2|||
170528553|NCT04142242|616285191|FG004|Stage II|Non-compliance with the protocol|0|||
170528554|NCT04142242|616285192|FG005|Stage II|Non-compliance with the protocol|0|||
170528555|NCT04142242|616285187|FG000|Stage II|Lost to Follow-up|0|||
170528556|NCT04142242|616285188|FG001|Stage II|Lost to Follow-up|0|||
170528557|NCT04142242|616285189|FG002|Stage II|Lost to Follow-up|1|||
170528558|NCT04142242|616285190|FG003|Stage II|Lost to Follow-up|2|||
170528559|NCT04142242|616285191|FG004|Stage II|Lost to Follow-up|0|||
170528560|NCT04142242|616285192|FG005|Stage II|Lost to Follow-up|0|||
170528561|NCT04142242|616285187|FG000|Stage II|Withdrawal by Subject|0|||
170528562|NCT04142242|616285188|FG001|Stage II|Withdrawal by Subject|0|||
170528563|NCT04142242|616285189|FG002|Stage II|Withdrawal by Subject|5|||
170528564|NCT04142242|616285190|FG003|Stage II|Withdrawal by Subject|9|||
170528565|NCT04142242|616285191|FG004|Stage II|Withdrawal by Subject|0|||
170528566|NCT04142242|616285192|FG005|Stage II|Withdrawal by Subject|0|||
170528567|NCT00846053|616285195|FG000|Overall Study|Physician Decision|3|||
170528568|NCT00846053|616285196|FG001|Overall Study|Physician Decision|0|||
170528569|NCT01123655|616285197|FG000|Overall Study|Medication for RA had to be changed|1|||
170528570|NCT01123655|616285198|FG001|Overall Study|Medication for RA had to be changed|0|||
170528571|NCT01123655|616285199|FG002|Overall Study|Medication for RA had to be changed|0|||
170528572|NCT01123655|616285197|FG000|Overall Study|new illness|0|||
170528573|NCT01123655|616285198|FG001|Overall Study|new illness|1|||
170528574|NCT01123655|616285199|FG002|Overall Study|new illness|0|||
170528575|NCT01123655|616285197|FG000|Overall Study|began prohibitive drug|0|||
170528576|NCT01123655|616285198|FG001|Overall Study|began prohibitive drug|0|||
170528577|NCT01123655|616285199|FG002|Overall Study|began prohibitive drug|1|||
170528578|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
170528579|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
170528580|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
170528581|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
170528582|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
170528583|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
170528584|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
170528585|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
170528586|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
170528587|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
170528588|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
170528589|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
170528590|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
170528591|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
170528592|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
170528593|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
170528594|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
170528595|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
170528596|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
170528597|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
170528598|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
170528599|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
170528600|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
170528601|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
170528602|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
170528603|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
170528604|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
170528605|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
170528606|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
170528607|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
170528608|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
170528609|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
170528610|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
170528611|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
170528612|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
170528613|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
170528614|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
170528615|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
170528616|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
170528617|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
170528618|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
170528619|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
170528620|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
170528621|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
170528622|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
170528623|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
170528624|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
170528625|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
170528626|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
170528627|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
170528628|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
170528629|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
170528630|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
170528631|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
170528632|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
170528633|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
170528634|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
170528635|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
170528636|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
170528637|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
170528638|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
170528639|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
170776935|NCT01898494|617190192|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
170776936|NCT01898494|617190188|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
170776937|NCT01898494|617190189|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
170776938|NCT01898494|617190190|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
170776939|NCT01898494|617190191|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
170776940|NCT01898494|617190192|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
170776941|NCT01898494|617190188|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
170776942|NCT01898494|617190189|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
170776943|NCT01898494|617190190|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
170776944|NCT01898494|617190191|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
170776945|NCT01898494|617190192|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
170776946|NCT01898494|617190188|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
170877103|NCT03977974|617560483|FG012|Period 2|Adverse Event|0|||
170877104|NCT00597753|617560484|FG000|Overall Study|Adverse Event|6|||
170877105|NCT00597753|617560485|FG001|Overall Study|Adverse Event|2|||
170632608|NCT01352793|616666715|FG000|Overall Study|Lost to Follow-up|289|||
170877106|NCT00597753|617560484|FG000|Overall Study|Death|55|||
170877107|NCT00597753|617560485|FG001|Overall Study|Death|29|||
170877108|NCT00597753|617560484|FG000|Overall Study|Lack of Efficacy|2|||
170877109|NCT00597753|617560485|FG001|Overall Study|Lack of Efficacy|0|||
170877110|NCT00597753|617560484|FG000|Overall Study|Lost to Follow-up|10|||
170877111|NCT00597753|617560485|FG001|Overall Study|Lost to Follow-up|3|||
170877112|NCT00597753|617560484|FG000|Overall Study|Physician Decision|5|||
170877113|NCT00597753|617560485|FG001|Overall Study|Physician Decision|1|||
170877114|NCT00597753|617560484|FG000|Overall Study|Pregnancy|1|||
170877115|NCT00597753|617560485|FG001|Overall Study|Pregnancy|0|||
170877116|NCT00597753|617560484|FG000|Overall Study|Withdrawal by Subject|35|||
170877117|NCT00597753|617560485|FG001|Overall Study|Withdrawal by Subject|12|||
170416559|NCT00262600|615865547|FG001|Overall Study|Not Treated|17|||
170877118|NCT00597753|617560484|FG000|Overall Study|Discontinued Dialysis|0|||
170877119|NCT00597753|617560485|FG001|Overall Study|Discontinued Dialysis|1|||
170877120|NCT00597753|617560484|FG000|Overall Study|Never dosed|2|||
170877121|NCT00597753|617560485|FG001|Overall Study|Never dosed|0|||
170877122|NCT00597753|617560484|FG000|Overall Study|Noncompliance|2|||
170877123|NCT00597753|617560485|FG001|Overall Study|Noncompliance|1|||
170877124|NCT00597753|617560484|FG000|Overall Study|Relocation|17|||
170877125|NCT00597753|617560485|FG001|Overall Study|Relocation|6|||
170877126|NCT00597753|617560484|FG000|Overall Study|Renal transplant|10|||
170877127|NCT00597753|617560485|FG001|Overall Study|Renal transplant|3|||
170877128|NCT00597753|617560484|FG000|Overall Study|Site closed by sponsor|19|||
170877129|NCT00597753|617560485|FG001|Overall Study|Site closed by sponsor|7|||
170877130|NCT00597753|617560484|FG000|Overall Study|Site elected to close|2|||
170877131|NCT00597753|617560485|FG001|Overall Study|Site elected to close|4|||
170416560|NCT00262600|615865548|FG002|Overall Study|Not Treated|24|||
170416561|NCT00262600|615865546|FG000|Overall Study|Other|58|||
170416562|NCT00262600|615865547|FG001|Overall Study|Other|59|||
170416563|NCT00262600|615865548|FG002|Overall Study|Other|62|||
170416564|NCT00561730|615865551|FG000|Overall Study|Adverse Event|2|||
170416565|NCT00561730|615865551|FG000|Overall Study|Handling of the drug|1|||
170416566|NCT00561730|615865551|FG000|Overall Study|Lost to Follow-up|5|||
170416567|NCT00561730|615865551|FG000|Overall Study|Not specified reasons|1|||
170416568|NCT03194464|615865554|FG000|Overall Study|data not usable|2|||
170416569|NCT03103100|615865555|FG000|Overall Study|Adverse Event|1|||
170416570|NCT03103100|615865556|FG001|Overall Study|Adverse Event|0|||
170416571|NCT03103100|615865557|FG002|Overall Study|Adverse Event|0|||
170416572|NCT03103100|615865555|FG000|Overall Study|Physician Decision|1|||
170416573|NCT03103100|615865556|FG001|Overall Study|Physician Decision|0|||
170416574|NCT03103100|615865557|FG002|Overall Study|Physician Decision|2|||
170416575|NCT00623103|615865558|FG000|Overall Study|Adverse Event|70|||
170416576|NCT00623103|615865559|FG001|Overall Study|Adverse Event|60|||
170416577|NCT00623103|615865558|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170416578|NCT00623103|615865559|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
170416579|NCT00623103|615865558|FG000|Overall Study|Withdrawal by Subject|18|||
170416580|NCT00623103|615865559|FG001|Overall Study|Withdrawal by Subject|24|||
170416581|NCT00623103|615865558|FG000|Overall Study|Lost to Follow-up|4|||
170416582|NCT00623103|615865559|FG001|Overall Study|Lost to Follow-up|1|||
170416583|NCT00623103|615865558|FG000|Overall Study|Administrative problems|2|||
170416584|NCT00623103|615865559|FG001|Overall Study|Administrative problems|4|||
170416585|NCT00623103|615865558|FG000|Overall Study|Death|11|||
170416586|NCT00623103|615865559|FG001|Overall Study|Death|11|||
170416587|NCT00623103|615865558|FG000|Overall Study|Protocol deviation|2|||
170416588|NCT00623103|615865559|FG001|Overall Study|Protocol deviation|1|||
170416589|NCT03594123|615865561|FG000|Overall Study|Lost to Follow-up|0|||
170416590|NCT03594123|615865562|FG001|Overall Study|Lost to Follow-up|1|||
170416591|NCT03594123|615865561|FG000|Overall Study|Adverse Event|8|||
170416592|NCT03594123|615865562|FG001|Overall Study|Adverse Event|5|||
170416593|NCT03594123|615865561|FG000|Overall Study|Site Terminated by Sponsor|4|||
170416594|NCT03594123|615865562|FG001|Overall Study|Site Terminated by Sponsor|1|||
170416595|NCT03594123|615865561|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
170416596|NCT03594123|615865562|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
170877132|NCT02953340|617562084|FG000|Overall Study|Death|0|||
170877133|NCT02953340|617562085|FG001|Overall Study|Death|1|||
170877134|NCT02953340|617562084|FG000|Overall Study|Investigator Decision|3|||
170877135|NCT02953340|617562085|FG001|Overall Study|Investigator Decision|3|||
170877136|NCT02953340|617562084|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
170877137|NCT02953340|617562085|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
170877138|NCT02953340|617562084|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
170416597|NCT03594123|615865561|FG000|Overall Study|Lack of Efficacy|1|||
170416598|NCT03594123|615865562|FG001|Overall Study|Lack of Efficacy|0|||
170416599|NCT03594123|615865561|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
170416600|NCT03594123|615865562|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
170877139|NCT02953340|617562085|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
170877140|NCT02953340|617562084|FG000|Overall Study|Withdrawal by Subject|9|||
170877141|NCT02953340|617562085|FG001|Overall Study|Withdrawal by Subject|9|||
170877142|NCT02953340|617562084|FG000|Overall Study|Sponsor decision|0|||
170877143|NCT02953340|617562085|FG001|Overall Study|Sponsor decision|2|||
170877144|NCT02953340|617562084|FG000|Overall Study|Lost to Follow-up|3|||
170877145|NCT02953340|617562085|FG001|Overall Study|Lost to Follow-up|2|||
170877146|NCT02953340|617562084|FG000|Overall Study|Reason not specified|2|||
170877147|NCT02953340|617562085|FG001|Overall Study|Reason not specified|2|||
170877148|NCT02700412|617562089|FG000|Overall Study|Adverse Event|6|||
170877149|NCT02700412|617562089|FG000|Overall Study|Death|1|||
170877150|NCT02700412|617562089|FG000|Overall Study|Lack of Efficacy|19|||
170877151|NCT02700412|617562089|FG000|Overall Study|Protocol Violation|5|||
170877152|NCT02700412|617562089|FG000|Overall Study|Withdrawal by Subject|2|||
170877153|NCT00928889|617562090|FG000|Overall Study|Lost to Follow-up|3|||
170877154|NCT00928889|617562091|FG001|Overall Study|Lost to Follow-up|1|||
170877155|NCT00928889|617562090|FG000|Overall Study|Protocol Violation|0|||
170877156|NCT00928889|617562091|FG001|Overall Study|Protocol Violation|1|||
170877157|NCT00928889|617562090|FG000|Overall Study|Adverse Event|1|||
170877158|NCT00928889|617562091|FG001|Overall Study|Adverse Event|0|||
170877159|NCT00928889|617562090|FG000|Overall Study|Other|1|||
170877160|NCT00928889|617562091|FG001|Overall Study|Other|0|||
170877161|NCT04416555|617562093|FG000|Overall Study|Withdrawal by Subject|0|||
170877162|NCT04416555|617562094|FG001|Overall Study|Withdrawal by Subject|3|||
170877163|NCT00530270|617562095|FG000|Overall Study|Protocol Violation|1|||
170877164|NCT00530270|617562096|FG001|Overall Study|Protocol Violation|0|||
170877165|NCT01923285|617562103|FG000|Overall Study|Withdrawal by Subject|7|||
170877166|NCT01923285|617562104|FG001|Overall Study|Withdrawal by Subject|6|||
170877167|NCT02375724|617562105|FG000|Overall Study|Lack of Efficacy|1|||
170877168|NCT02375724|617562106|FG001|Overall Study|Lack of Efficacy|1|||
170877169|NCT02375724|617562105|FG000|Overall Study|Withdrawal by Subject|1|||
170877170|NCT02375724|617562106|FG001|Overall Study|Withdrawal by Subject|1|||
170877171|NCT02375724|617562105|FG000|Overall Study|Lost to Follow-up|1|||
170877172|NCT02375724|617562106|FG001|Overall Study|Lost to Follow-up|0|||
170877173|NCT02375724|617562105|FG000|Overall Study|Protocol Violation|1|||
170877174|NCT02375724|617562106|FG001|Overall Study|Protocol Violation|0|||
170877175|NCT02375724|617562105|FG000|Overall Study|Adverse Event|2|||
170877176|NCT02375724|617562106|FG001|Overall Study|Adverse Event|4|||
170877177|NCT03201458|617562107|FG000|Overall Study|No longer eligible|2|||
170877178|NCT03201458|617562108|FG001|Overall Study|No longer eligible|5|||
170877179|NCT03201458|617562107|FG000|Overall Study|Health event before starting|1|||
170877180|NCT03201458|617562108|FG001|Overall Study|Health event before starting|0|||
170877181|NCT03201458|617562107|FG000|Overall Study|Physician Decision|1|||
170877182|NCT03201458|617562108|FG001|Overall Study|Physician Decision|0|||
170877183|NCT03962101|617562109|FG000|Overall Study|Adverse Event|1|||
170877184|NCT03962101|617562109|FG000|Overall Study|Physician Decision|2|||
170877185|NCT03962101|617562109|FG000|Overall Study|Not related to medical events|1|||
170877186|NCT00750737|617562116|FG000|Overall Study|Withdrawal by Subject|3|||
170877187|NCT00750737|617562117|FG001|Overall Study|Withdrawal by Subject|3|||
170877188|NCT00865904|617562120|FG000|Overall Study|Randomized but not Treated|2|||
170877189|NCT00865904|617562121|FG001|Overall Study|Randomized but not Treated|0|||
170776947|NCT01898494|617190189|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
170776948|NCT01898494|617190190|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
170776949|NCT01898494|617190191|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
170776950|NCT01898494|617190192|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
170776951|NCT01898494|617190188|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
170776952|NCT01898494|617190189|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
170776953|NCT01898494|617190190|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
170776954|NCT01898494|617190191|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
170776955|NCT01898494|617190192|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
170776956|NCT01898494|617190188|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
170776957|NCT01898494|617190189|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
170776958|NCT01898494|617190190|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
170776959|NCT01898494|617190191|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
170776960|NCT01898494|617190192|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
170877190|NCT00865904|617562122|FG002|Overall Study|Randomized but not Treated|0|||
170877191|NCT00865904|617562123|FG003|Overall Study|Randomized but not Treated|1|||
170877192|NCT00865904|617562124|FG004|Overall Study|Randomized but not Treated|1|||
170877193|NCT04607148|617562127|FG000|Overall Study|Withdrawal by Subject|0|||
170632609|NCT01352793|616666716|FG001|Overall Study|Lost to Follow-up|125|||
170776961|NCT01898494|617190188|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
170877194|NCT04607148|617562128|FG001|Overall Study|Withdrawal by Subject|4|||
170877195|NCT04607148|617562129|FG002|Overall Study|Withdrawal by Subject|2|||
170877196|NCT04607148|617562130|FG003|Overall Study|Withdrawal by Subject|8|||
170877197|NCT04607148|617562127|FG000|Overall Study|Study Terminated by Sponsor|14|||
170776962|NCT01898494|617190189|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
170877198|NCT04607148|617562128|FG001|Overall Study|Study Terminated by Sponsor|59|||
170877199|NCT04607148|617562129|FG002|Overall Study|Study Terminated by Sponsor|9|||
170877200|NCT04607148|617562130|FG003|Overall Study|Study Terminated by Sponsor|39|||
170877201|NCT04607148|617562127|FG000|Overall Study|Sponsor Decision|0|||
170877202|NCT04607148|617562128|FG001|Overall Study|Sponsor Decision|0|||
170877203|NCT04607148|617562129|FG002|Overall Study|Sponsor Decision|1|||
170877204|NCT04607148|617562130|FG003|Overall Study|Sponsor Decision|0|||
170877205|NCT04607148|617562127|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170877206|NCT04607148|617562128|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170877207|NCT04607148|617562129|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170877208|NCT04607148|617562130|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170877209|NCT04607148|617562127|FG000|Overall Study|Lost to Follow-up|0|||
170877210|NCT04607148|617562128|FG001|Overall Study|Lost to Follow-up|2|||
170416601|NCT03365375|615865563|FG000|Overall Study|Withdrawal by Subject|0|||
170416602|NCT03365375|615865564|FG001|Overall Study|Withdrawal by Subject|1|||
170416603|NCT03365375|615865563|FG000|Overall Study|Lost to Follow-up|0|||
170416604|NCT03365375|615865564|FG001|Overall Study|Lost to Follow-up|4|||
170416605|NCT02483975|615865565|FG000|Overall Study|Adverse Event|0|||
170416606|NCT02483975|615865566|FG001|Overall Study|Adverse Event|1|||
170416607|NCT02483975|615865565|FG000|Overall Study|Lost to Follow-up|0|||
170416608|NCT02483975|615865566|FG001|Overall Study|Lost to Follow-up|1|||
170416609|NCT02483975|615865565|FG000|Overall Study|Physician Decision|2|||
170416610|NCT02483975|615865566|FG001|Overall Study|Physician Decision|0|||
170416611|NCT02166697|615865567|FG000|Overall Study|Protocol Violation|347|||
170416612|NCT02684578|615865571|FG000|Overall Study|Withdrawal by Subject|10|||
170416613|NCT02684578|615865572|FG001|Overall Study|Withdrawal by Subject|7|||
170416614|NCT02684578|615865571|FG000|Overall Study|Lost to Follow-up|0|||
170416615|NCT02684578|615865572|FG001|Overall Study|Lost to Follow-up|3|||
170416616|NCT02684578|615865571|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
170416617|NCT02684578|615865572|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
170416618|NCT02684578|615865571|FG000|Overall Study|Missing follow-up data|0|||
170416619|NCT02684578|615865572|FG001|Overall Study|Missing follow-up data|1|||
170416620|NCT00626925|615865575|FG000|Overall Study|Lost to Follow-up|1|||
170416621|NCT00626925|615865576|FG001|Overall Study|Lost to Follow-up|2|||
170416622|NCT00626925|615865575|FG000|Overall Study|relapse|1|||
170416623|NCT00626925|615865576|FG001|Overall Study|relapse|0|||
170416624|NCT00626925|615865575|FG000|Overall Study|Adverse effect|6|||
170416625|NCT00626925|615865576|FG001|Overall Study|Adverse effect|2|||
170416626|NCT00626925|615865575|FG000|Overall Study|Lack of Efficacy|1|||
170416627|NCT00626925|615865576|FG001|Overall Study|Lack of Efficacy|4|||
170416628|NCT00626925|615865575|FG000|Overall Study|Time constraints|3|||
170416629|NCT00626925|615865576|FG001|Overall Study|Time constraints|1|||
170416630|NCT00625807|615865579|FG000|Overall Study|schedule conflict|2|||
170416631|NCT00625807|615865580|FG001|Overall Study|schedule conflict|8|||
170416632|NCT01802879|615865581|FG000|Overall Study|Administrative problems|2|||
170416633|NCT01802879|615865581|FG000|Overall Study|Disease progression|6|||
170416634|NCT02236130|615865589|FG000|Overall Study|Lost to Follow-up|7|||
170416635|NCT02236130|615865590|FG001|Overall Study|Lost to Follow-up|12|||
170416636|NCT00108732|615865591|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
170416637|NCT00108732|615865591|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
170416638|NCT00108732|615865591|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
170416639|NCT00108732|615865591|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
170416640|NCT00108732|615865591|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
170416641|NCT00108732|615865591|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
170416642|NCT00108732|615865591|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
170416643|NCT01766921|615865594|FG000|Overall Study|Administrative Reason|5|||
170416644|NCT01766921|615865595|FG001|Overall Study|Administrative Reason|5|||
170416645|NCT01766921|615865594|FG000|Overall Study|Death|1|||
170416646|NCT01766921|615865595|FG001|Overall Study|Death|1|||
170416647|NCT01766921|615865594|FG000|Overall Study|Lost to Follow-up|1|||
170416648|NCT01766921|615865595|FG001|Overall Study|Lost to Follow-up|3|||
170416649|NCT01766921|615865594|FG000|Overall Study|Unclassified|2|||
170416650|NCT01766921|615865595|FG001|Overall Study|Unclassified|2|||
170416651|NCT01766921|615865594|FG000|Overall Study|Protocol Violation|1|||
170416652|NCT01766921|615865595|FG001|Overall Study|Protocol Violation|1|||
170416653|NCT01766921|615865594|FG000|Overall Study|Withdrawal by Subject|14|||
170528640|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
170528641|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
170877211|NCT04607148|617562129|FG002|Overall Study|Lost to Follow-up|0|||
170877212|NCT04607148|617562130|FG003|Overall Study|Lost to Follow-up|0|||
170416654|NCT01766921|615865595|FG001|Overall Study|Withdrawal by Subject|5|||
170877213|NCT04607148|617562127|FG000|Overall Study|Death|0|||
170416655|NCT01946165|615865596|FG000|Overall Study|Physician Decision|2|||
170416656|NCT01946165|615865597|FG001|Overall Study|Physician Decision|0|||
170416657|NCT01946165|615865596|FG000|Overall Study|Withdrawal by Subject|0|||
170416658|NCT01946165|615865597|FG001|Overall Study|Withdrawal by Subject|2|||
170416659|NCT01901055|615865598|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
170416660|NCT01901055|615865599|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
170528642|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
170528643|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
170528644|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
170528645|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
170528646|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
170528647|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
170528648|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
170528649|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
170528650|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
170528651|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
170528652|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
170528653|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
170528654|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
170528655|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
170528656|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
170528657|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
170528658|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
170528659|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
170528660|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
170528661|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
170528662|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
170528663|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
170528664|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
170528665|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
170528666|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
170528667|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
170528668|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
170528669|NCT01791595|616285202|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
170528670|NCT01791595|616285203|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
170528671|NCT01791595|616285204|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
170528672|NCT01791595|616285205|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
170528673|NCT01791595|616285206|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
170528674|NCT01791595|616285207|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
170528675|NCT01791595|616285208|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
170528676|NCT01791595|616285202|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
170528677|NCT01791595|616285203|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
170528678|NCT01791595|616285204|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
170528679|NCT01791595|616285205|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
170528680|NCT01791595|616285206|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
170528681|NCT01791595|616285207|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
170528682|NCT01791595|616285208|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
170528683|NCT01791595|616285202|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
170528684|NCT01791595|616285203|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
170528685|NCT01791595|616285204|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
170528686|NCT01791595|616285205|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
170416661|NCT01901055|615865598|FG000|Randomization But Not Titrated|Physician Decision|0|||
170416662|NCT01901055|615865599|FG001|Randomization But Not Titrated|Physician Decision|1|||
170528687|NCT01791595|616285206|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
170528688|NCT01791595|616285207|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
170528689|NCT01791595|616285208|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
170528690|NCT01791595|616285202|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
170528691|NCT01791595|616285203|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
170528692|NCT01791595|616285204|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
170528693|NCT01791595|616285205|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
170528694|NCT01791595|616285206|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
170416663|NCT01901055|615865598|FG000|Started Protocol to Week 6|Physician Decision|2|||
170416664|NCT01901055|615865599|FG001|Started Protocol to Week 6|Physician Decision|1|||
170416665|NCT01901055|615865598|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
170416666|NCT01901055|615865599|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
170416667|NCT01901055|615865598|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
170416668|NCT01901055|615865599|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
170416669|NCT01901055|615865598|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
170416670|NCT01901055|615865599|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
170528695|NCT01791595|616285207|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
170528696|NCT01791595|616285208|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
170528697|NCT01791595|616285202|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
170528698|NCT01791595|616285203|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
170528699|NCT01791595|616285204|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
170528700|NCT01791595|616285205|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
170528701|NCT01791595|616285206|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
170528702|NCT01791595|616285207|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
170528703|NCT01791595|616285208|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
170528704|NCT06494761|616285209|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
170528705|NCT06494761|616285209|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
170528706|NCT03210714|616285210|FG000|Overall Study|Adverse Event|6|||
170528707|NCT03210714|616285210|FG000|Overall Study|Physician Decision|1|||
170528708|NCT03210714|616285210|FG000|Overall Study|Progressive disease|11|||
170528709|NCT03210714|616285210|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
170528710|NCT00803179|616285211|FG000|Overall Study|Lost to Follow-up|3|||
170528711|NCT04609514|616285212|FG000|Overall Study|Lost to Follow-up|5|||
170528712|NCT04609514|616285213|FG001|Overall Study|Lost to Follow-up|4|||
170528713|NCT04609514|616285212|FG000|Overall Study|Withdrawal by PI|0|||
170528714|NCT04609514|616285213|FG001|Overall Study|Withdrawal by PI|2|||
170528715|NCT01618968|616285215|FG000|Overall Study|Adverse Event|1|||
170528716|NCT01618968|616285216|FG001|Overall Study|Adverse Event|0|||
170528717|NCT01618968|616285217|FG002|Overall Study|Adverse Event|0|||
170528718|NCT01618968|616285218|FG003|Overall Study|Adverse Event|0|||
170528719|NCT01618968|616285215|FG000|Overall Study|Death|0|||
170528720|NCT01618968|616285216|FG001|Overall Study|Death|0|||
170528721|NCT01618968|616285217|FG002|Overall Study|Death|0|||
170528722|NCT01618968|616285218|FG003|Overall Study|Death|1|||
170528723|NCT03883386|616285219|FG000|First Assignment|Lost to Follow-up|1|||
170528724|NCT03883386|616285220|FG001|First Assignment|Lost to Follow-up|0|||
170528725|NCT03883386|616285219|FG000|First Assignment|Withdrawal by Subject|1|||
170528726|NCT03883386|616285220|FG001|First Assignment|Withdrawal by Subject|1|||
170528727|NCT02230891|616285223|FG000|Baseline|Did not meet inclusion|0|||
170528728|NCT02230891|616285224|FG001|Baseline|Did not meet inclusion|1|||
170528729|NCT02230891|616285225|FG002|Baseline|Did not meet inclusion|1|||
170528730|NCT02230891|616285223|FG000|2 Week|Withdrawal by Subject|2|||
170528731|NCT02230891|616285224|FG001|2 Week|Withdrawal by Subject|2|||
170528732|NCT02230891|616285225|FG002|2 Week|Withdrawal by Subject|0|||
170528733|NCT02230891|616285223|FG000|2 Week|Consent withdrawn|1|||
170528734|NCT02230891|616285224|FG001|2 Week|Consent withdrawn|0|||
170528735|NCT02230891|616285225|FG002|2 Week|Consent withdrawn|0|||
170528736|NCT02230891|616285223|FG000|6 Month|Withdrawal by Subject|1|||
170528737|NCT02230891|616285224|FG001|6 Month|Withdrawal by Subject|1|||
170528738|NCT02230891|616285225|FG002|6 Month|Withdrawal by Subject|1|||
170528739|NCT02230891|616285223|FG000|6 Month|Physician Decision|0|||
170528740|NCT02230891|616285224|FG001|6 Month|Physician Decision|2|||
170528741|NCT02230891|616285225|FG002|6 Month|Physician Decision|0|||
170528742|NCT02230891|616285223|FG000|12 Month|Death|1|||
170528743|NCT02230891|616285224|FG001|12 Month|Death|0|||
170528744|NCT02230891|616285225|FG002|12 Month|Death|0|||
170528745|NCT02230891|616285223|FG000|12 Month|Lost to Follow-up|0|||
170528746|NCT02230891|616285224|FG001|12 Month|Lost to Follow-up|1|||
170528747|NCT02230891|616285225|FG002|12 Month|Lost to Follow-up|0|||
170528748|NCT02230891|616285223|FG000|12 Month|Withdrawal by Subject|0|||
170528749|NCT02230891|616285224|FG001|12 Month|Withdrawal by Subject|2|||
170528750|NCT02230891|616285225|FG002|12 Month|Withdrawal by Subject|0|||
170528751|NCT02230891|616285223|FG000|18 Month End of Study|Death|0|||
170528752|NCT02230891|616285224|FG001|18 Month End of Study|Death|0|||
170528753|NCT02230891|616285225|FG002|18 Month End of Study|Death|1|||
170528754|NCT02230891|616285223|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
170528755|NCT02230891|616285224|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
170528756|NCT02230891|616285225|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
170528757|NCT00094445|616285226|FG000|Overall Study|Withdrawal by Subject|3|||
170528758|NCT00094445|616285226|FG000|Overall Study|Lost to Follow-up|1|||
170528759|NCT00094445|616285226|FG000|Overall Study|Progressive Disease|2|||
170528760|NCT01265498|616285234|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
170528761|NCT01265498|616285235|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
170528762|NCT04158219|616285236|FG000|Overall Study|Lost to Follow-up|1|||
170528763|NCT01324947|616285241|FG000|Overall Study|Adverse Event|7|||
170528764|NCT01324947|616285241|FG000|Overall Study|Death|10|||
170528765|NCT01324947|616285241|FG000|Overall Study|Other|3|||
170528766|NCT01324947|616285241|FG000|Overall Study|Progressive Disease|50|||
170528767|NCT01324947|616285241|FG000|Overall Study|Withdrawal by Subject|3|||
170528768|NCT01324947|616285241|FG000|Overall Study|1 discontinued before starting drug|1|||
170528769|NCT02659865|616286940|FG000|Period 1|Withdrawal by Subject|1|||
170528770|NCT02659865|616286941|FG001|Period 1|Withdrawal by Subject|0|||
170528771|NCT02659865|616286942|FG002|Period 1|Withdrawal by Subject|0|||
170528772|NCT02659865|616286943|FG003|Period 1|Withdrawal by Subject|0|||
170528773|NCT02659865|616286944|FG004|Period 1|Withdrawal by Subject|0|||
170528774|NCT02659865|616286940|FG000|Period 1|Adverse Event|0|||
170528775|NCT02659865|616286941|FG001|Period 1|Adverse Event|0|||
170528776|NCT02659865|616286942|FG002|Period 1|Adverse Event|0|||
170528777|NCT02659865|616286943|FG003|Period 1|Adverse Event|0|||
170528778|NCT02659865|616286944|FG004|Period 1|Adverse Event|1|||
170528779|NCT01288430|616286945|FG000|Part 1|Progressive disease|2|||
170528780|NCT01288430|616286946|FG001|Part 1|Progressive disease|1|||
170528781|NCT01288430|616286947|FG002|Part 1|Progressive disease|1|||
170528782|NCT01288430|616286948|FG003|Part 1|Progressive disease|6|||
170528783|NCT01288430|616286949|FG004|Part 1|Progressive disease|2|||
170528784|NCT01288430|616286950|FG005|Part 1|Progressive disease|4|||
170528785|NCT01288430|616286951|FG006|Part 1|Progressive disease|2|||
170528786|NCT01288430|616286952|FG007|Part 1|Progressive disease|0|||
170528787|NCT01288430|616286953|FG008|Part 1|Progressive disease|0|||
170528788|NCT01288430|616286954|FG009|Part 1|Progressive disease|0|||
170528789|NCT01288430|616286945|FG000|Part 1|Clinical disease progression|0|||
170528790|NCT01288430|616286946|FG001|Part 1|Clinical disease progression|0|||
170528791|NCT01288430|616286947|FG002|Part 1|Clinical disease progression|1|||
170528792|NCT01288430|616286948|FG003|Part 1|Clinical disease progression|0|||
170528793|NCT01288430|616286949|FG004|Part 1|Clinical disease progression|0|||
170528794|NCT01288430|616286950|FG005|Part 1|Clinical disease progression|2|||
170528795|NCT01288430|616286951|FG006|Part 1|Clinical disease progression|2|||
170528796|NCT01288430|616286952|FG007|Part 1|Clinical disease progression|0|||
170528797|NCT01288430|616286953|FG008|Part 1|Clinical disease progression|0|||
170528798|NCT01288430|616286954|FG009|Part 1|Clinical disease progression|0|||
170528799|NCT01288430|616286945|FG000|Part 1|Death due to disease progression|0|||
170528800|NCT01288430|616286946|FG001|Part 1|Death due to disease progression|0|||
170528801|NCT01288430|616286947|FG002|Part 1|Death due to disease progression|0|||
170528802|NCT01288430|616286948|FG003|Part 1|Death due to disease progression|0|||
170528803|NCT01288430|616286949|FG004|Part 1|Death due to disease progression|1|||
170528804|NCT01288430|616286950|FG005|Part 1|Death due to disease progression|0|||
170528805|NCT01288430|616286951|FG006|Part 1|Death due to disease progression|0|||
170528806|NCT01288430|616286952|FG007|Part 1|Death due to disease progression|0|||
170528807|NCT01288430|616286953|FG008|Part 1|Death due to disease progression|0|||
170528808|NCT01288430|616286954|FG009|Part 1|Death due to disease progression|0|||
170528809|NCT01288430|616286945|FG000|Part 1|Adverse Event|0|||
170528810|NCT01288430|616286946|FG001|Part 1|Adverse Event|0|||
170528811|NCT01288430|616286947|FG002|Part 1|Adverse Event|3|||
170528812|NCT01288430|616286948|FG003|Part 1|Adverse Event|1|||
170528813|NCT01288430|616286949|FG004|Part 1|Adverse Event|0|||
170528814|NCT01288430|616286950|FG005|Part 1|Adverse Event|0|||
170528815|NCT01288430|616286951|FG006|Part 1|Adverse Event|2|||
170528816|NCT01288430|616286952|FG007|Part 1|Adverse Event|0|||
170528817|NCT01288430|616286953|FG008|Part 1|Adverse Event|0|||
170528818|NCT01288430|616286954|FG009|Part 1|Adverse Event|0|||
170528819|NCT01288430|616286945|FG000|Part 1|Other|0|||
170528820|NCT01288430|616286946|FG001|Part 1|Other|2|||
170528821|NCT01288430|616286947|FG002|Part 1|Other|0|||
170528822|NCT01288430|616286948|FG003|Part 1|Other|0|||
170528823|NCT01288430|616286949|FG004|Part 1|Other|0|||
170528824|NCT01288430|616286950|FG005|Part 1|Other|0|||
170528825|NCT01288430|616286951|FG006|Part 1|Other|1|||
170528826|NCT01288430|616286952|FG007|Part 1|Other|0|||
170528827|NCT01288430|616286953|FG008|Part 1|Other|0|||
170528828|NCT01288430|616286954|FG009|Part 1|Other|0|||
170528829|NCT01288430|616286945|FG000|Part 2|Progressive disease|0|||
170528830|NCT01288430|616286946|FG001|Part 2|Progressive disease|0|||
170528831|NCT01288430|616286947|FG002|Part 2|Progressive disease|0|||
170528832|NCT01288430|616286948|FG003|Part 2|Progressive disease|0|||
170528833|NCT01288430|616286949|FG004|Part 2|Progressive disease|0|||
170528834|NCT01288430|616286950|FG005|Part 2|Progressive disease|0|||
170528835|NCT01288430|616286951|FG006|Part 2|Progressive disease|0|||
170528836|NCT01288430|616286952|FG007|Part 2|Progressive disease|8|||
170877214|NCT04607148|617562128|FG001|Overall Study|Death|3|||
170877215|NCT04607148|617562129|FG002|Overall Study|Death|0|||
170528837|NCT01288430|616286953|FG008|Part 2|Progressive disease|7|||
170528838|NCT01288430|616286954|FG009|Part 2|Progressive disease|2|||
170528839|NCT01288430|616286945|FG000|Part 2|Clinical disease progression|0|||
170528840|NCT01288430|616286946|FG001|Part 2|Clinical disease progression|0|||
170528841|NCT01288430|616286947|FG002|Part 2|Clinical disease progression|0|||
170528842|NCT01288430|616286948|FG003|Part 2|Clinical disease progression|0|||
170528843|NCT01288430|616286949|FG004|Part 2|Clinical disease progression|0|||
170528844|NCT01288430|616286950|FG005|Part 2|Clinical disease progression|0|||
170528845|NCT01288430|616286951|FG006|Part 2|Clinical disease progression|0|||
170528846|NCT01288430|616286952|FG007|Part 2|Clinical disease progression|2|||
170528847|NCT01288430|616286953|FG008|Part 2|Clinical disease progression|0|||
170528848|NCT01288430|616286954|FG009|Part 2|Clinical disease progression|0|||
170528849|NCT01288430|616286945|FG000|Part 2|Withdrawal by Subject|0|||
170528850|NCT01288430|616286946|FG001|Part 2|Withdrawal by Subject|0|||
170528851|NCT01288430|616286947|FG002|Part 2|Withdrawal by Subject|0|||
170528852|NCT01288430|616286948|FG003|Part 2|Withdrawal by Subject|0|||
170528853|NCT01288430|616286949|FG004|Part 2|Withdrawal by Subject|0|||
170528854|NCT01288430|616286950|FG005|Part 2|Withdrawal by Subject|0|||
170528855|NCT01288430|616286951|FG006|Part 2|Withdrawal by Subject|0|||
170528856|NCT01288430|616286952|FG007|Part 2|Withdrawal by Subject|1|||
170528857|NCT01288430|616286953|FG008|Part 2|Withdrawal by Subject|4|||
170528858|NCT01288430|616286954|FG009|Part 2|Withdrawal by Subject|0|||
170528859|NCT01288430|616286945|FG000|Part 2|Adverse Event|0|||
170528860|NCT01288430|616286946|FG001|Part 2|Adverse Event|0|||
170528861|NCT01288430|616286947|FG002|Part 2|Adverse Event|0|||
170528862|NCT01288430|616286948|FG003|Part 2|Adverse Event|0|||
170528863|NCT01288430|616286949|FG004|Part 2|Adverse Event|0|||
170528864|NCT01288430|616286950|FG005|Part 2|Adverse Event|0|||
170528865|NCT01288430|616286951|FG006|Part 2|Adverse Event|0|||
170528866|NCT01288430|616286952|FG007|Part 2|Adverse Event|1|||
170528867|NCT01288430|616286953|FG008|Part 2|Adverse Event|1|||
170528868|NCT01288430|616286954|FG009|Part 2|Adverse Event|0|||
170776963|NCT01898494|617190190|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
170776964|NCT01898494|617190191|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
170776965|NCT01898494|617190192|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
170776966|NCT02819843|617190195|FG000|Overall Study|Disease progression before RT|0|||
170776967|NCT02819843|617190196|FG001|Overall Study|Disease progression before RT|1|||
170776968|NCT04732494|617190197|FG000|Overall Study|Death|39|||
170776969|NCT04732494|617190198|FG001|Overall Study|Death|36|||
170776970|NCT04732494|617190197|FG000|Overall Study|Study Closed by Sponsor|20|||
170776971|NCT04732494|617190198|FG001|Overall Study|Study Closed by Sponsor|15|||
170776972|NCT04732494|617190197|FG000|Overall Study|Withdrawal by Subject|2|||
170776973|NCT04732494|617190198|FG001|Overall Study|Withdrawal by Subject|7|||
170776974|NCT04732494|617190197|FG000|Overall Study|Lost to Follow-up|1|||
170776975|NCT04732494|617190198|FG001|Overall Study|Lost to Follow-up|5|||
170776976|NCT03055858|617190199|FG000|Overall Study|Death|9|||
170776977|NCT03055858|617190199|FG000|Overall Study|Withdrawal by Subject|11|||
170776978|NCT03055858|617190199|FG000|Overall Study|Lost to Follow-up|6|||
170776979|NCT03055858|617190199|FG000|Overall Study|Missed Follow-Up Visits|18|||
170776980|NCT00670046|617190209|FG000|Overall Study|Lost to Follow-up|1|||
170776981|NCT00670046|617190210|FG001|Overall Study|Lost to Follow-up|1|||
170776982|NCT00670046|617190209|FG000|Overall Study|Withdrawal by Subject|0|||
170776983|NCT00670046|617190210|FG001|Overall Study|Withdrawal by Subject|1|||
170776984|NCT05760313|617190211|FG000|Overall Study|Withdrawal by Subject|0|||
170776985|NCT05760313|617190212|FG001|Overall Study|Withdrawal by Subject|0|||
170776986|NCT05760313|617190213|FG002|Overall Study|Withdrawal by Subject|1|||
170776987|NCT05760313|617190211|FG000|Overall Study|Other|1|||
170776988|NCT05760313|617190212|FG001|Overall Study|Other|0|||
170776989|NCT05760313|617190213|FG002|Overall Study|Other|0|||
170776990|NCT00956007|617190214|FG000|Overall Study|Protocol Violation|27|||
170776991|NCT00956007|617190215|FG001|Overall Study|Protocol Violation|23|||
170776992|NCT05228470|617190218|FG000|Overall Study|Death|6|||
170776993|NCT05228470|617190219|FG001|Overall Study|Death|11|||
170776994|NCT05228470|617190218|FG000|Overall Study|Withdrawal by Subject|1|||
170776995|NCT05228470|617190219|FG001|Overall Study|Withdrawal by Subject|8|||
170776996|NCT05228470|617190218|FG000|Overall Study|Ongoing|1|||
170776997|NCT05228470|617190219|FG001|Overall Study|Ongoing|11|||
170776998|NCT03885037|617190220|FG000|Overall Study|Protocol Violation|16|||
170877216|NCT04607148|617562130|FG003|Overall Study|Death|1|||
170877217|NCT04607148|617562127|FG000|Overall Study|Adverse Event|0|||
170528869|NCT01288430|616286945|FG000|Part 2|Other|0|||
170528870|NCT01288430|616286946|FG001|Part 2|Other|0|||
170776999|NCT01492686|617190221|FG000|Double-blind Phase|Adverse Event|0|||
170777000|NCT01492686|617190222|FG001|Double-blind Phase|Adverse Event|2|||
170777001|NCT01492686|617190221|FG000|Double-blind Phase|Physician Decision|0|||
170777002|NCT01492686|617190222|FG001|Double-blind Phase|Physician Decision|1|||
170777003|NCT01492686|617190221|FG000|Double-blind Phase|Withdrawal by Subject|0|||
170777004|NCT01492686|617190222|FG001|Double-blind Phase|Withdrawal by Subject|2|||
170777005|NCT01492686|617190221|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
170777006|NCT01492686|617190222|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
170777007|NCT01492686|617190221|FG000|Open-label Phase|Adverse Event|1|||
170777008|NCT01492686|617190222|FG001|Open-label Phase|Adverse Event|2|||
170777009|NCT01492686|617190221|FG000|Open-label Phase|Physician Decision|1|||
170777010|NCT01492686|617190222|FG001|Open-label Phase|Physician Decision|0|||
170777011|NCT01492686|617190221|FG000|Open-label Phase|Withdrawal by Subject|6|||
170777012|NCT01492686|617190222|FG001|Open-label Phase|Withdrawal by Subject|7|||
170777013|NCT01492686|617190221|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
170777014|NCT01492686|617190222|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
170777015|NCT03314987|617190225|FG000|Overall Study|Lost to Follow-up|13|||
170777016|NCT03314987|617190226|FG001|Overall Study|Lost to Follow-up|13|||
170777017|NCT02992925|617190227|FG000|Cohort 2|Physician Decision|0|||
170777018|NCT02992925|617190228|FG001|Cohort 2|Physician Decision|0|||
170777019|NCT02992925|617190229|FG002|Cohort 2|Physician Decision|1|||
170777020|NCT02992925|617190230|FG003|Cohort 2|Physician Decision|0|||
170777021|NCT02992925|617190227|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
170528871|NCT01288430|616286947|FG002|Part 2|Other|0|||
170528872|NCT01288430|616286948|FG003|Part 2|Other|0|||
170528873|NCT01288430|616286949|FG004|Part 2|Other|0|||
170528874|NCT01288430|616286950|FG005|Part 2|Other|0|||
170528875|NCT01288430|616286951|FG006|Part 2|Other|0|||
170528876|NCT01288430|616286952|FG007|Part 2|Other|0|||
170528877|NCT01288430|616286953|FG008|Part 2|Other|0|||
170528878|NCT01288430|616286954|FG009|Part 2|Other|1|||
170528879|NCT00959751|616286955|FG000|Overall Study|Lost to Follow-up|2|||
170528880|NCT00959751|616286956|FG001|Overall Study|Lost to Follow-up|3|||
170528881|NCT00959751|616286955|FG000|Overall Study|Consent Withdrawn|0|||
170528882|NCT00959751|616286956|FG001|Overall Study|Consent Withdrawn|1|||
170528883|NCT00959751|616286955|FG000|Overall Study|Non-compliance to Study Procedures|0|||
170528884|NCT00959751|616286956|FG001|Overall Study|Non-compliance to Study Procedures|1|||
170528885|NCT00959751|616286955|FG000|Overall Study|No migraine headache without aura|7|||
170528886|NCT00959751|616286956|FG001|Overall Study|No migraine headache without aura|7|||
170528887|NCT00368251|616286957|FG000|Overall Study|SAE, non-fatal|1|||
170528888|NCT00368251|616286958|FG001|Overall Study|SAE, non-fatal|0|||
170528889|NCT00368251|616286959|FG002|Overall Study|SAE, non-fatal|0|||
170528890|NCT00368251|616286957|FG000|Overall Study|AE, non-serious non-fatal|0|||
170528891|NCT00368251|616286958|FG001|Overall Study|AE, non-serious non-fatal|0|||
170528892|NCT00368251|616286959|FG002|Overall Study|AE, non-serious non-fatal|1|||
170528893|NCT00076570|616286960|FG000|Overall Study|Drug intolerance|8|||
170528894|NCT00076570|616286961|FG001|Overall Study|Drug intolerance|8|||
170528895|NCT00761319|616286962|FG000|Overall Study|Protocol Violation|21|||
170528896|NCT00761319|616286963|FG001|Overall Study|Protocol Violation|14|||
170528897|NCT00761319|616286962|FG000|Overall Study|Adverse Event|11|||
170528898|NCT00761319|616286963|FG001|Overall Study|Adverse Event|7|||
170528899|NCT00761319|616286962|FG000|Overall Study|Withdrawal by Subject|8|||
170528900|NCT00761319|616286963|FG001|Overall Study|Withdrawal by Subject|7|||
170528901|NCT00761319|616286962|FG000|Overall Study|Noncompliance|4|||
170528902|NCT00761319|616286963|FG001|Overall Study|Noncompliance|3|||
170528903|NCT00761319|616286962|FG000|Overall Study|Lost to Follow-up|1|||
170528904|NCT00761319|616286963|FG001|Overall Study|Lost to Follow-up|1|||
170528905|NCT00761319|616286962|FG000|Overall Study|Nonspecified|2|||
170528906|NCT00761319|616286963|FG001|Overall Study|Nonspecified|2|||
170528907|NCT00761319|616286962|FG000|Overall Study|Missing|1|||
170528908|NCT00761319|616286963|FG001|Overall Study|Missing|0|||
170528909|NCT01373164|616286964|FG000|Overall Study|Lost to Follow-up|0|||
170528910|NCT01373164|616286965|FG001|Overall Study|Lost to Follow-up|0|||
170528911|NCT01373164|616286966|FG002|Overall Study|Lost to Follow-up|1|||
170528912|NCT01373164|616286967|FG003|Overall Study|Lost to Follow-up|2|||
170528913|NCT01373164|616286968|FG004|Overall Study|Lost to Follow-up|0|||
170528914|NCT01373164|616286964|FG000|Overall Study|Withdrawal by Subject|0|||
170528915|NCT01373164|616286965|FG001|Overall Study|Withdrawal by Subject|1|||
170528916|NCT01373164|616286966|FG002|Overall Study|Withdrawal by Subject|0|||
170528917|NCT01373164|616286967|FG003|Overall Study|Withdrawal by Subject|10|||
170528918|NCT01373164|616286968|FG004|Overall Study|Withdrawal by Subject|2|||
170528919|NCT03587636|616286969|FG000|Overall Study|Lost to Follow-up|2|||
170528920|NCT03587636|616286970|FG001|Overall Study|Lost to Follow-up|5|||
170777022|NCT02992925|617190228|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
170777023|NCT02992925|617190229|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
170777024|NCT02992925|617190230|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
170777025|NCT05552963|617190231|FG000|Overall Study|Lost to Follow-up|1|||
170777026|NCT05552963|617190231|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
170528921|NCT01587885|616286971|FG000|Treatment Period 1|Failure to Return|0|||
170528922|NCT01587885|616286972|FG001|Treatment Period 1|Failure to Return|1|||
170528923|NCT01587885|616286971|FG000|Treatment Period 1|Protocol Violation|0|||
170528924|NCT01587885|616286972|FG001|Treatment Period 1|Protocol Violation|2|||
170528925|NCT01006629|616286973|FG000|Overall Study|Adverse Event|1|||
170528926|NCT01006629|616286973|FG000|Overall Study|Parent refused to continue participation|1|||
170528927|NCT01006629|616286973|FG000|Overall Study|Parent unable to perform site visit|4|||
170528928|NCT01499511|616286974|FG000|Overall Study|Death|1|||
170528929|NCT01499511|616286975|FG001|Overall Study|Death|0|||
170528930|NCT01065818|616286976|FG000|Overall Study|Withdrawal by Subject|1|||
170528931|NCT01065818|616286976|FG000|Overall Study|Not a candidate for surgery|1|||
170528932|NCT04459338|616286979|FG000|Overall Study|Loss of IV during study|1|||
170528933|NCT04459338|616286980|FG001|Overall Study|Loss of IV during study|0|||
170528934|NCT03157089|616286981|FG000|Overall Study|Treated only with pembrolizumab|1|||
170528935|NCT03157089|616286982|FG001|Overall Study|Treated only with pembrolizumab|0|||
170528936|NCT03157089|616286981|FG000|Overall Study|Adverse Event|5|||
170528937|NCT03157089|616286982|FG001|Overall Study|Adverse Event|4|||
170528938|NCT03157089|616286981|FG000|Overall Study|Progressive disease|6|||
170528939|NCT03157089|616286982|FG001|Overall Study|Progressive disease|8|||
170528940|NCT02932943|616286983|FG000|Overall Study|Lost to Follow-up|0|||
170528941|NCT02932943|616286984|FG001|Overall Study|Lost to Follow-up|2|||
170777027|NCT01534494|617190234|FG000|Overall Study|Withdrawal by Subject|1|||
170777028|NCT00802464|617190235|FG000|Month 0 - Month 8|Adverse Event|0|||
170777029|NCT00802464|617190236|FG001|Month 0 - Month 8|Adverse Event|1|||
170528942|NCT02932943|616286983|FG000|Overall Study|Adverse Event|2|||
170528943|NCT02932943|616286984|FG001|Overall Study|Adverse Event|2|||
170528944|NCT02932943|616286983|FG000|Overall Study|Withdrawal by Subject|3|||
170528945|NCT02932943|616286984|FG001|Overall Study|Withdrawal by Subject|3|||
170528946|NCT00784875|616286985|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
170528947|NCT00784875|616286986|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
170528948|NCT00784875|616286987|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
170528949|NCT00784875|616286988|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
170528950|NCT00784875|616286985|FG000|Period A - Baseline|Adverse Event|0|||
170528951|NCT00784875|616286986|FG001|Period A - Baseline|Adverse Event|0|||
170528952|NCT00784875|616286987|FG002|Period A - Baseline|Adverse Event|0|||
170528953|NCT00784875|616286988|FG003|Period A - Baseline|Adverse Event|8|||
170528954|NCT00784875|616286985|FG000|Period A - Baseline|Protocol Violation|0|||
170528955|NCT00784875|616286986|FG001|Period A - Baseline|Protocol Violation|0|||
170528956|NCT00784875|616286987|FG002|Period A - Baseline|Protocol Violation|0|||
170528957|NCT00784875|616286988|FG003|Period A - Baseline|Protocol Violation|25|||
170528958|NCT00784875|616286985|FG000|Period A - Baseline|Withdrawal by Subject|0|||
170528959|NCT00784875|616286986|FG001|Period A - Baseline|Withdrawal by Subject|0|||
170528960|NCT00784875|616286987|FG002|Period A - Baseline|Withdrawal by Subject|0|||
170528961|NCT00784875|616286988|FG003|Period A - Baseline|Withdrawal by Subject|27|||
170528962|NCT00784875|616286985|FG000|Period A - Baseline|Physician Decision|0|||
170528963|NCT00784875|616286986|FG001|Period A - Baseline|Physician Decision|0|||
170528964|NCT00784875|616286987|FG002|Period A - Baseline|Physician Decision|0|||
170528965|NCT00784875|616286988|FG003|Period A - Baseline|Physician Decision|2|||
170528966|NCT00784875|616286985|FG000|Period A - Baseline|Sponsor Decision|0|||
170528967|NCT00784875|616286986|FG001|Period A - Baseline|Sponsor Decision|0|||
170528968|NCT00784875|616286987|FG002|Period A - Baseline|Sponsor Decision|0|||
170528969|NCT00784875|616286988|FG003|Period A - Baseline|Sponsor Decision|113|||
170528970|NCT00784875|616286985|FG000|Period A - Baseline|Lost to Follow-up|0|||
170528971|NCT00784875|616286986|FG001|Period A - Baseline|Lost to Follow-up|0|||
170528972|NCT00784875|616286987|FG002|Period A - Baseline|Lost to Follow-up|0|||
170528973|NCT00784875|616286988|FG003|Period A - Baseline|Lost to Follow-up|2|||
170528974|NCT00784875|616286985|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
170528975|NCT00784875|616286986|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
170528976|NCT00784875|616286987|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
170528977|NCT00784875|616286988|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
170528978|NCT00784875|616286985|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
170528979|NCT00784875|616286986|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
170528980|NCT00784875|616286987|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
170528981|NCT00784875|616286988|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
170528982|NCT00784875|616286985|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
170528983|NCT00784875|616286986|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
170528984|NCT00784875|616286987|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
170528985|NCT00784875|616286988|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
170528986|NCT00784875|616286985|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
170528987|NCT00784875|616286986|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
170528988|NCT00784875|616286987|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
170528989|NCT00784875|616286988|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
170528990|NCT00784875|616286985|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
170528991|NCT00784875|616286986|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
170528992|NCT00784875|616286987|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
170528993|NCT00784875|616286988|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
170528994|NCT00784875|616286985|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
170528995|NCT00784875|616286986|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
170528996|NCT00784875|616286987|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
170528997|NCT00784875|616286988|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
170528998|NCT00784875|616286985|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
170528999|NCT00784875|616286986|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
170529000|NCT00784875|616286987|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
170529001|NCT00784875|616286988|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
170529002|NCT00784875|616286985|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
170529003|NCT00784875|616286986|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
170529004|NCT00784875|616286987|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
170529005|NCT00784875|616286988|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
170529006|NCT00784875|616286985|FG000|Period C|Adverse Event|1|||
170529007|NCT00784875|616286986|FG001|Period C|Adverse Event|0|||
170529008|NCT00784875|616286987|FG002|Period C|Adverse Event|4|||
170529009|NCT00784875|616286988|FG003|Period C|Adverse Event|2|||
170529010|NCT00784875|616286985|FG000|Period C|Protocol Violation|0|||
170529011|NCT00784875|616286986|FG001|Period C|Protocol Violation|0|||
170777030|NCT00802464|617190237|FG002|Month 0 - Month 8|Adverse Event|1|||
170777031|NCT00802464|617190238|FG003|Month 0 - Month 8|Adverse Event|2|||
170777032|NCT00802464|617190235|FG000|Month 0 - Month 8|Protocol Violation|0|||
170777033|NCT00802464|617190236|FG001|Month 0 - Month 8|Protocol Violation|0|||
170777034|NCT00802464|617190237|FG002|Month 0 - Month 8|Protocol Violation|1|||
170777035|NCT00802464|617190238|FG003|Month 0 - Month 8|Protocol Violation|0|||
170777036|NCT00802464|617190235|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
170777037|NCT00802464|617190236|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
170777038|NCT00802464|617190237|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
170777039|NCT00802464|617190238|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
170777040|NCT00802464|617190235|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
170777041|NCT00802464|617190236|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
170529012|NCT00784875|616286987|FG002|Period C|Protocol Violation|1|||
170529013|NCT00784875|616286988|FG003|Period C|Protocol Violation|2|||
170529014|NCT00784875|616286985|FG000|Period C|Lack of Efficacy|0|||
170529015|NCT00784875|616286986|FG001|Period C|Lack of Efficacy|0|||
170529016|NCT00784875|616286987|FG002|Period C|Lack of Efficacy|1|||
170529017|NCT00784875|616286988|FG003|Period C|Lack of Efficacy|0|||
170529018|NCT00784875|616286985|FG000|Period C|Withdrawal by Subject|1|||
170529019|NCT00784875|616286986|FG001|Period C|Withdrawal by Subject|1|||
170529020|NCT00784875|616286987|FG002|Period C|Withdrawal by Subject|2|||
170529021|NCT00784875|616286988|FG003|Period C|Withdrawal by Subject|0|||
170529022|NCT00784875|616286985|FG000|Period C|Physician Decision|0|||
170529023|NCT00784875|616286986|FG001|Period C|Physician Decision|0|||
170529024|NCT00784875|616286987|FG002|Period C|Physician Decision|1|||
170529025|NCT00784875|616286988|FG003|Period C|Physician Decision|1|||
170529026|NCT00784875|616286985|FG000|Period C|Sponsor Decision|5|||
170777042|NCT00802464|617190237|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
170777043|NCT00802464|617190238|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
170777044|NCT00802464|617190235|FG000|Month 0 - Month 8|Other|0|||
170777045|NCT00802464|617190236|FG001|Month 0 - Month 8|Other|0|||
170777046|NCT00802464|617190237|FG002|Month 0 - Month 8|Other|1|||
170777047|NCT00802464|617190238|FG003|Month 0 - Month 8|Other|0|||
170777048|NCT00802464|617190235|FG000|Month 8 - Month 14|Adverse Event|0|||
170777049|NCT00802464|617190236|FG001|Month 8 - Month 14|Adverse Event|1|||
170777050|NCT00802464|617190237|FG002|Month 8 - Month 14|Adverse Event|0|||
170777051|NCT00802464|617190238|FG003|Month 8 - Month 14|Adverse Event|0|||
170777052|NCT00802464|617190235|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
170777053|NCT00802464|617190236|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
170777054|NCT00802464|617190237|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
170777055|NCT00802464|617190238|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
170777056|NCT00802464|617190235|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
170777057|NCT00802464|617190236|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
170777058|NCT00802464|617190237|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
170777059|NCT00802464|617190238|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
170777060|NCT01808339|617190239|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
170777061|NCT01808339|617190240|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
170777062|NCT01808339|617190241|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
170777063|NCT01808339|617190242|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
170777064|NCT01808339|617190243|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
170777065|NCT01808339|617190244|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
170529027|NCT00784875|616286986|FG001|Period C|Sponsor Decision|5|||
170529028|NCT00784875|616286987|FG002|Period C|Sponsor Decision|4|||
170529029|NCT00784875|616286988|FG003|Period C|Sponsor Decision|2|||
170529030|NCT00784875|616286985|FG000|Period D|Adverse Event|0|||
170529031|NCT00784875|616286986|FG001|Period D|Adverse Event|2|||
170529032|NCT00784875|616286987|FG002|Period D|Adverse Event|2|||
170529033|NCT00784875|616286988|FG003|Period D|Adverse Event|0|||
170529034|NCT00784875|616286985|FG000|Period D|Protocol Violation|1|||
170529035|NCT00784875|616286986|FG001|Period D|Protocol Violation|0|||
170529036|NCT00784875|616286987|FG002|Period D|Protocol Violation|0|||
170529037|NCT00784875|616286988|FG003|Period D|Protocol Violation|0|||
170529038|NCT00784875|616286985|FG000|Period D|Withdrawal by Subject|2|||
170777066|NCT01808339|617190239|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170777067|NCT01808339|617190240|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170777068|NCT01808339|617190241|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170777069|NCT01808339|617190242|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170777070|NCT01808339|617190243|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170777071|NCT01808339|617190244|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170777072|NCT01808339|617190239|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
170777073|NCT01808339|617190240|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
170777074|NCT01808339|617190241|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
170777075|NCT01808339|617190242|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
170777076|NCT01808339|617190243|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
170777077|NCT01808339|617190244|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
170777078|NCT01939899|617190247|FG000|Lead-in Dose Finding Phase|Death|0|||
170777079|NCT01939899|617190248|FG001|Lead-in Dose Finding Phase|Death|3|||
170777080|NCT01939899|617190249|FG002|Lead-in Dose Finding Phase|Death|1|||
170877218|NCT04607148|617562128|FG001|Overall Study|Adverse Event|1|||
170877219|NCT04607148|617562129|FG002|Overall Study|Adverse Event|0|||
170877220|NCT04607148|617562130|FG003|Overall Study|Adverse Event|0|||
170877221|NCT00589420|617562131|FG000|Overall Study|screen failure|1|||
170877222|NCT04744207|617562134|FG000|Treatment|Withdrawal by Subject|2|||
170877223|NCT04744207|617562135|FG001|Treatment|Withdrawal by Subject|0|||
170877224|NCT04744207|617562134|FG000|Treatment|Adverse Event|1|||
170877225|NCT04744207|617562135|FG001|Treatment|Adverse Event|2|||
170877226|NCT00808236|617562137|FG000|Overall Study|Was not resuscitated|50|||
170877227|NCT00808236|617562138|FG001|Overall Study|Was not resuscitated|56|||
170877228|NCT00808236|617562137|FG000|Overall Study|Pre-defined exclusion|13|||
170877229|NCT00808236|617562138|FG001|Overall Study|Pre-defined exclusion|3|||
170877230|NCT00808236|617562137|FG000|Overall Study|Lost to Follow-up|1|||
170877231|NCT00808236|617562138|FG001|Overall Study|Lost to Follow-up|1|||
170877232|NCT00808236|617562137|FG000|Overall Study|Physician Decision|0|||
170877233|NCT00808236|617562138|FG001|Overall Study|Physician Decision|1|||
170877234|NCT00808236|617562137|FG000|Overall Study|Death|18|||
170877235|NCT00808236|617562138|FG001|Overall Study|Death|30|||
170877236|NCT02230384|617562139|FG000|Phase 1|Lost to Follow-up|1|||
170877237|NCT02230384|617562140|FG001|Phase 1|Lost to Follow-up|0|||
170877238|NCT02230384|617562139|FG000|Phase 1|Physician Decision|0|||
170877239|NCT02230384|617562140|FG001|Phase 1|Physician Decision|1|||
170877240|NCT02230384|617562139|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
170877241|NCT02230384|617562140|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
170877242|NCT02230384|617562139|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
170877243|NCT02230384|617562140|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
170877244|NCT02230384|617562139|FG000|Phase 2 - Switch|Adverse Event|2|||
170877245|NCT02230384|617562140|FG001|Phase 2 - Switch|Adverse Event|0|||
170877246|NCT01251367|617562147|FG000|Overall Study|Protocol Violation|1|||
170877247|NCT01251367|617562147|FG000|Overall Study|Lack of Efficacy|2|||
170877248|NCT01251367|617562147|FG000|Overall Study|Adverse Event|19|||
170877249|NCT01251367|617562147|FG000|Overall Study|Withdrawal by Subject|36|||
170877250|NCT01251367|617562147|FG000|Overall Study|Lost to Follow-up|5|||
170877251|NCT01251367|617562147|FG000|Overall Study|Subject Required Alternative Treatment|7|||
170877252|NCT01251367|617562147|FG000|Overall Study|No Study Drug Available|1|||
170877253|NCT01251367|617562147|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
170877254|NCT01251367|617562147|FG000|Overall Study|End of Study Visit Performed in Error|1|||
170877255|NCT02424253|617562148|FG000|Overall Study|Other, unspecified|1|||
170877256|NCT02424253|617562149|FG001|Overall Study|Other, unspecified|0|||
170877257|NCT02424253|617562148|FG000|Overall Study|Compliance problems|1|||
170416671|NCT01901055|615865598|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
170416672|NCT01901055|615865599|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
170416673|NCT01901055|615865598|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
170416674|NCT01901055|615865599|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
170416675|NCT01901055|615865598|FG000|Week 24|Withdrawal by Subject|13|||
170416676|NCT01901055|615865599|FG001|Week 24|Withdrawal by Subject|19|||
170416677|NCT01901055|615865598|FG000|Week 24|Physician Decision|1|||
170416678|NCT01901055|615865599|FG001|Week 24|Physician Decision|0|||
170416679|NCT01901055|615865598|FG000|Week 36|Withdrawal by Subject|0|||
170416680|NCT01901055|615865599|FG001|Week 36|Withdrawal by Subject|5|||
170416681|NCT01659567|615865602|FG000|Overall Study|Lack of Efficacy|22|||
170416682|NCT01659567|615865602|FG000|Overall Study|Switched to Pegferon|6|||
170416683|NCT01659567|615865602|FG000|Overall Study|Adverse Event|12|||
170416684|NCT01659567|615865602|FG000|Overall Study|Good result at early stage of treatment|5|||
170416685|NCT01659567|615865602|FG000|Overall Study|Withdrawal by Subject|64|||
170416686|NCT01659567|615865602|FG000|Overall Study|Progression of the main disease|1|||
170416687|NCT01659567|615865602|FG000|Overall Study|Other|13|||
170416688|NCT03019965|615865603|FG000|Overall Study|Withdrawal by Subject|1|||
170416689|NCT03019965|615865604|FG001|Overall Study|Withdrawal by Subject|0|||
170416690|NCT03019965|615865603|FG000|Overall Study|Protocol Violation|1|||
170416691|NCT03019965|615865604|FG001|Overall Study|Protocol Violation|3|||
170416692|NCT03019965|615865603|FG000|Overall Study|viral or fungal infection|3|||
170416693|NCT03019965|615865604|FG001|Overall Study|viral or fungal infection|4|||
170416694|NCT03019965|615865603|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
170632610|NCT01352793|616666715|FG000|Overall Study|Withdrawal by Subject|120|||
170877258|NCT02424253|617562149|FG001|Overall Study|Compliance problems|0|||
170877259|NCT02424253|617562148|FG000|Overall Study|Physician Decision|2|||
170877260|NCT02424253|617562149|FG001|Overall Study|Physician Decision|0|||
170877261|NCT02424253|617562148|FG000|Overall Study|Lack of Efficacy|0|||
170416695|NCT03019965|615865604|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
170877262|NCT02424253|617562149|FG001|Overall Study|Lack of Efficacy|7|||
170877263|NCT02424253|617562148|FG000|Overall Study|Adverse Event|2|||
170877264|NCT02424253|617562149|FG001|Overall Study|Adverse Event|0|||
170877265|NCT02424253|617562148|FG000|Overall Study|Consent withdrawn by subject|4|||
170416696|NCT03019965|615865603|FG000|Overall Study|Physician Decision|1|||
170416697|NCT03019965|615865604|FG001|Overall Study|Physician Decision|1|||
170877266|NCT02424253|617562149|FG001|Overall Study|Consent withdrawn by subject|1|||
170877267|NCT02424253|617562148|FG000|Overall Study|Lost to Follow-up|1|||
170877268|NCT02424253|617562149|FG001|Overall Study|Lost to Follow-up|1|||
170877269|NCT00884273|617562150|FG000|Overall Study|Adverse Event|0|||
170877270|NCT00884273|617562151|FG001|Overall Study|Adverse Event|2|||
170877271|NCT00884273|617562150|FG000|Overall Study|Protocol Violation|1|||
170877272|NCT00884273|617562151|FG001|Overall Study|Protocol Violation|3|||
170877273|NCT00884273|617562150|FG000|Overall Study|Practical reasons|1|||
170877274|NCT00884273|617562151|FG001|Overall Study|Practical reasons|0|||
170877275|NCT02973087|617562156|FG000|Overall Study|Withdrawal by Subject|2|||
170877276|NCT02973087|617562157|FG001|Overall Study|Withdrawal by Subject|1|||
170877277|NCT02973087|617562156|FG000|Overall Study|Adverse Event|1|||
170877278|NCT02973087|617562157|FG001|Overall Study|Adverse Event|0|||
170877279|NCT02973087|617562156|FG000|Overall Study|other|1|||
170877280|NCT02973087|617562157|FG001|Overall Study|other|1|||
170877281|NCT00578136|617562158|FG000|Overall Study|Not given intervention|1|||
170877282|NCT00578136|617562159|FG001|Overall Study|Not given intervention|1|||
170529039|NCT00784875|616286986|FG001|Period D|Withdrawal by Subject|0|||
170529040|NCT00784875|616286987|FG002|Period D|Withdrawal by Subject|2|||
170529041|NCT00784875|616286988|FG003|Period D|Withdrawal by Subject|0|||
170777081|NCT01939899|617190250|FG003|Lead-in Dose Finding Phase|Death|0|||
170777082|NCT01939899|617190251|FG004|Lead-in Dose Finding Phase|Death|0|||
170777083|NCT01939899|617190247|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
170777084|NCT01939899|617190248|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
170777085|NCT01939899|617190249|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
170777086|NCT01939899|617190250|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
170777087|NCT01939899|617190251|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
170777088|NCT01939899|617190247|FG000|Lead-in Dose Finding Phase|Other|0|||
170777089|NCT01939899|617190248|FG001|Lead-in Dose Finding Phase|Other|0|||
170777090|NCT01939899|617190249|FG002|Lead-in Dose Finding Phase|Other|1|||
170777091|NCT01939899|617190250|FG003|Lead-in Dose Finding Phase|Other|0|||
170777092|NCT01939899|617190251|FG004|Lead-in Dose Finding Phase|Other|0|||
170777093|NCT01939899|617190247|FG000|Phase 2|Withdrawal by Subject|0|||
170777094|NCT01939899|617190248|FG001|Phase 2|Withdrawal by Subject|0|||
170777095|NCT01939899|617190249|FG002|Phase 2|Withdrawal by Subject|0|||
170777096|NCT01939899|617190250|FG003|Phase 2|Withdrawal by Subject|2|||
170777097|NCT01939899|617190251|FG004|Phase 2|Withdrawal by Subject|0|||
170777098|NCT01939899|617190247|FG000|Phase 2|Disease Progression|0|||
170777099|NCT01939899|617190248|FG001|Phase 2|Disease Progression|0|||
170777100|NCT01939899|617190249|FG002|Phase 2|Disease Progression|0|||
170777101|NCT01939899|617190250|FG003|Phase 2|Disease Progression|9|||
170777102|NCT01939899|617190251|FG004|Phase 2|Disease Progression|1|||
170777103|NCT05529979|617190254|FG000|Overall Study|Lost to Follow-up|6|||
170777104|NCT05529979|617190254|FG000|Overall Study|Physician Decision|1|||
170777105|NCT05529979|617190254|FG000|Overall Study|non-feasibility cases|4|||
170777106|NCT05529979|617190254|FG000|Overall Study|Lack of Efficacy|3|||
170777107|NCT05529979|617190254|FG000|Overall Study|ablation not performed|1|||
170777108|NCT00093015|617190255|FG000|Overall Study|Withdrawal by Subject|194|||
170777109|NCT00093015|617190256|FG001|Overall Study|Withdrawal by Subject|171|||
170777110|NCT00093015|617190255|FG000|Overall Study|Lost to Follow-up|96|||
170777111|NCT00093015|617190256|FG001|Overall Study|Lost to Follow-up|108|||
170777112|NCT00093015|617190255|FG000|Overall Study|Death|375|||
170777113|NCT00093015|617190256|FG001|Overall Study|Death|385|||
170777114|NCT04872738|617190257|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
170777115|NCT04872738|617190258|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
170877283|NCT06347731|617562160|FG000|Overall Study|Death|1|||
170877284|NCT06347731|617562160|FG000|Overall Study|Protocol Violation|1|||
170877285|NCT06347731|617562160|FG000|Overall Study|Withdrawal by Subject|2|||
170416698|NCT01179919|615865607|FG000|Overall Study|Protocol Violation|1|||
170416699|NCT01179919|615865607|FG000|Overall Study|Adverse Event|1|||
170416700|NCT01915732|615865608|FG000|Overall Study|Withdrawal by Subject|18|||
170416701|NCT01915732|615865609|FG001|Overall Study|Withdrawal by Subject|18|||
170416702|NCT01915732|615865608|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
170416703|NCT01915732|615865609|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
170416704|NCT01915732|615865608|FG000|Overall Study|Adverse Event|12|||
170416705|NCT01915732|615865609|FG001|Overall Study|Adverse Event|4|||
170416706|NCT01915732|615865608|FG000|Overall Study|Protocol Violation|5|||
170416707|NCT01915732|615865609|FG001|Overall Study|Protocol Violation|5|||
170416708|NCT01915732|615865608|FG000|Overall Study|Lack of Efficacy|6|||
170416709|NCT01915732|615865609|FG001|Overall Study|Lack of Efficacy|11|||
170416710|NCT01915732|615865608|FG000|Overall Study|Lost to Follow-up|22|||
170416711|NCT01915732|615865609|FG001|Overall Study|Lost to Follow-up|26|||
170416712|NCT01915732|615865608|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
170416713|NCT01915732|615865609|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
170416714|NCT01915732|615865608|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
170416715|NCT01915732|615865609|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
170777116|NCT05054725|617190261|FG000|Overall Study|Withdrawal by Subject|3|||
170877286|NCT01279850|617562161|FG000|Overall Study|Protocol Violation|50|||
170529042|NCT00784875|616286985|FG000|Period D|Physician Decision|0|||
170529043|NCT00784875|616286986|FG001|Period D|Physician Decision|1|||
170529044|NCT00784875|616286987|FG002|Period D|Physician Decision|0|||
170529045|NCT00784875|616286988|FG003|Period D|Physician Decision|0|||
170529046|NCT00784875|616286985|FG000|Period D|Sponsor Decision|1|||
170529047|NCT00784875|616286986|FG001|Period D|Sponsor Decision|1|||
170529048|NCT00784875|616286987|FG002|Period D|Sponsor Decision|1|||
170529049|NCT00784875|616286988|FG003|Period D|Sponsor Decision|0|||
170529050|NCT00784875|616286985|FG000|Period D|Lost to Follow-up|1|||
170529051|NCT00784875|616286986|FG001|Period D|Lost to Follow-up|0|||
170529052|NCT00784875|616286987|FG002|Period D|Lost to Follow-up|1|||
170877287|NCT01279850|617562161|FG000|Overall Study|No Drug Administration Information|7|||
170877288|NCT01279850|617562161|FG000|Overall Study|No Visit After Treatment|34|||
170877289|NCT01840579|617562170|FG000|Overall Study|Status not recorded|0|||
170877290|NCT01840579|617562171|FG001|Overall Study|Status not recorded|0|||
170877291|NCT01840579|617562172|FG002|Overall Study|Status not recorded|2|||
170877292|NCT01840579|617562173|FG003|Overall Study|Status not recorded|3|||
170877293|NCT01840579|617562174|FG004|Overall Study|Status not recorded|4|||
170877294|NCT01840579|617562175|FG005|Overall Study|Status not recorded|3|||
170877295|NCT01840579|617562176|FG006|Overall Study|Status not recorded|0|||
170529053|NCT00784875|616286988|FG003|Period D|Lost to Follow-up|1|||
170877296|NCT01840579|617562177|FG007|Overall Study|Status not recorded|3|||
170877297|NCT01840579|617562178|FG008|Overall Study|Status not recorded|3|||
170877298|NCT01840579|617562179|FG009|Overall Study|Status not recorded|3|||
170877299|NCT01840579|617562170|FG000|Overall Study|Progressive disease|3|||
170877300|NCT01840579|617562171|FG001|Overall Study|Progressive disease|5|||
170877301|NCT01840579|617562172|FG002|Overall Study|Progressive disease|0|||
170877302|NCT01840579|617562173|FG003|Overall Study|Progressive disease|0|||
170877303|NCT01840579|617562174|FG004|Overall Study|Progressive disease|0|||
170877304|NCT01840579|617562175|FG005|Overall Study|Progressive disease|0|||
170877305|NCT01840579|617562176|FG006|Overall Study|Progressive disease|0|||
170877306|NCT01840579|617562177|FG007|Overall Study|Progressive disease|0|||
170877307|NCT01840579|617562178|FG008|Overall Study|Progressive disease|0|||
170877308|NCT01840579|617562179|FG009|Overall Study|Progressive disease|0|||
170877309|NCT01840579|617562170|FG000|Overall Study|Ongoing in study|0|||
170877310|NCT01840579|617562171|FG001|Overall Study|Ongoing in study|1|||
170877311|NCT01840579|617562172|FG002|Overall Study|Ongoing in study|0|||
170877312|NCT01840579|617562173|FG003|Overall Study|Ongoing in study|0|||
170877313|NCT01840579|617562174|FG004|Overall Study|Ongoing in study|0|||
170877314|NCT01840579|617562175|FG005|Overall Study|Ongoing in study|0|||
170877315|NCT01840579|617562176|FG006|Overall Study|Ongoing in study|0|||
170877316|NCT01840579|617562177|FG007|Overall Study|Ongoing in study|0|||
170877317|NCT01840579|617562178|FG008|Overall Study|Ongoing in study|0|||
170877318|NCT01840579|617562179|FG009|Overall Study|Ongoing in study|0|||
170877319|NCT01840579|617562170|FG000|Overall Study|Death|0|||
170877320|NCT01840579|617562171|FG001|Overall Study|Death|0|||
170877321|NCT01840579|617562172|FG002|Overall Study|Death|0|||
170877322|NCT01840579|617562173|FG003|Overall Study|Death|0|||
170877323|NCT01840579|617562174|FG004|Overall Study|Death|0|||
170877324|NCT01840579|617562175|FG005|Overall Study|Death|1|||
170877325|NCT01840579|617562176|FG006|Overall Study|Death|0|||
170877326|NCT01840579|617562177|FG007|Overall Study|Death|0|||
170877327|NCT01840579|617562178|FG008|Overall Study|Death|0|||
170877328|NCT01840579|617562179|FG009|Overall Study|Death|0|||
170877329|NCT01840579|617562170|FG000|Overall Study|Adverse Event|0|||
170529054|NCT00853385|616286989|FG000|Overall Study|Death|0|||
170529055|NCT00853385|616286990|FG001|Overall Study|Death|0|||
170529056|NCT00853385|616286991|FG002|Overall Study|Death|0|||
170529057|NCT00853385|616286992|FG003|Overall Study|Death|0|||
170529058|NCT00853385|616286993|FG004|Overall Study|Death|1|||
170529059|NCT00853385|616286989|FG000|Overall Study|Adverse Event|24|||
170877330|NCT01840579|617562171|FG001|Overall Study|Adverse Event|1|||
170529060|NCT00853385|616286990|FG001|Overall Study|Adverse Event|24|||
170877331|NCT01840579|617562172|FG002|Overall Study|Adverse Event|0|||
170877332|NCT01840579|617562173|FG003|Overall Study|Adverse Event|0|||
170877333|NCT01840579|617562174|FG004|Overall Study|Adverse Event|0|||
170529061|NCT00853385|616286991|FG002|Overall Study|Adverse Event|2|||
170529062|NCT00853385|616286992|FG003|Overall Study|Adverse Event|5|||
170529063|NCT00853385|616286993|FG004|Overall Study|Adverse Event|22|||
170529064|NCT00853385|616286989|FG000|Overall Study|Lack of Efficacy|6|||
170529065|NCT00853385|616286990|FG001|Overall Study|Lack of Efficacy|7|||
170529066|NCT00853385|616286991|FG002|Overall Study|Lack of Efficacy|3|||
170529067|NCT00853385|616286992|FG003|Overall Study|Lack of Efficacy|3|||
170877334|NCT01840579|617562175|FG005|Overall Study|Adverse Event|0|||
170877335|NCT01840579|617562176|FG006|Overall Study|Adverse Event|0|||
170877336|NCT01840579|617562177|FG007|Overall Study|Adverse Event|0|||
170877337|NCT01840579|617562178|FG008|Overall Study|Adverse Event|0|||
170529068|NCT00853385|616286993|FG004|Overall Study|Lack of Efficacy|6|||
170529069|NCT00853385|616286989|FG000|Overall Study|Lost to Follow-up|2|||
170529070|NCT00853385|616286990|FG001|Overall Study|Lost to Follow-up|1|||
170877338|NCT01840579|617562179|FG009|Overall Study|Adverse Event|0|||
170877339|NCT01840579|617562170|FG000|Overall Study|Follow-up ended by Sponsor|0|||
170877340|NCT01840579|617562171|FG001|Overall Study|Follow-up ended by Sponsor|0|||
170877341|NCT01840579|617562172|FG002|Overall Study|Follow-up ended by Sponsor|0|||
170877342|NCT01840579|617562173|FG003|Overall Study|Follow-up ended by Sponsor|0|||
170877343|NCT01840579|617562174|FG004|Overall Study|Follow-up ended by Sponsor|0|||
170877344|NCT01840579|617562175|FG005|Overall Study|Follow-up ended by Sponsor|0|||
170877345|NCT01840579|617562176|FG006|Overall Study|Follow-up ended by Sponsor|2|||
170877346|NCT01840579|617562177|FG007|Overall Study|Follow-up ended by Sponsor|0|||
170877347|NCT01840579|617562178|FG008|Overall Study|Follow-up ended by Sponsor|0|||
170416716|NCT01915732|615865608|FG000|Overall Study|Drug Release Error|1|||
170416717|NCT01915732|615865609|FG001|Overall Study|Drug Release Error|0|||
170416718|NCT01915732|615865608|FG000|Overall Study|Recovered|1|||
170416719|NCT01915732|615865609|FG001|Overall Study|Recovered|0|||
170416720|NCT01915732|615865608|FG000|Overall Study|Pregnancy|1|||
170416721|NCT01915732|615865609|FG001|Overall Study|Pregnancy|0|||
170416722|NCT01915732|615865608|FG000|Overall Study|Poor Perceived Efficacy|1|||
170416723|NCT01915732|615865609|FG001|Overall Study|Poor Perceived Efficacy|0|||
170416724|NCT01915732|615865608|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
170416725|NCT01915732|615865609|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
170416726|NCT01915732|615865608|FG000|Overall Study|Got Well|0|||
170416727|NCT01915732|615865609|FG001|Overall Study|Got Well|1|||
170416728|NCT01915732|615865608|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
170416729|NCT01915732|615865609|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
170416730|NCT01915732|615865608|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
170416731|NCT01915732|615865609|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
170416732|NCT01915732|615865608|FG000|Overall Study|Job Transfer|0|||
170416733|NCT01915732|615865609|FG001|Overall Study|Job Transfer|1|||
170416734|NCT01915732|615865608|FG000|Overall Study|Improper Facial Procedure|0|||
170416735|NCT01915732|615865609|FG001|Overall Study|Improper Facial Procedure|1|||
170416736|NCT01915732|615865608|FG000|Overall Study|Poor Conscious Effect|0|||
170416737|NCT01915732|615865609|FG001|Overall Study|Poor Conscious Effect|1|||
170416738|NCT01890915|615865611|FG000|Overall Study|Adverse Event|1|||
170416739|NCT01890915|615865612|FG001|Overall Study|Adverse Event|0|||
170416740|NCT01890915|615865611|FG000|Overall Study|Protocol Violation|2|||
170416741|NCT01890915|615865612|FG001|Overall Study|Protocol Violation|0|||
170416742|NCT01890915|615865611|FG000|Overall Study|Equipment Malfunction|0|||
170416743|NCT01890915|615865612|FG001|Overall Study|Equipment Malfunction|1|||
170416744|NCT00635154|615865618|FG000|Overall Study|Alternative Treatment|8|||
170416745|NCT00635154|615865618|FG000|Overall Study|Other|4|||
170416746|NCT00635154|615865618|FG000|Overall Study|Still on treatment|21|||
170416747|NCT02114697|615865619|FG000|Overall Study|Study terminated|5|||
170416748|NCT02114697|615865620|FG001|Overall Study|Study terminated|4|||
170416749|NCT01513148|615865621|FG000|Overall Study|Protocol Violation|2|||
170416750|NCT01513148|615865622|FG001|Overall Study|Protocol Violation|2|||
170416751|NCT00424489|615865623|FG000|Overall Study|Death|3|||
170416752|NCT01984242|615865624|FG000|Overall Study|Death|52|||
170416753|NCT01984242|615865625|FG001|Overall Study|Death|50|||
170416754|NCT01984242|615865626|FG002|Overall Study|Death|52|||
170416755|NCT01984242|615865624|FG000|Overall Study|Withdrawal by Subject|5|||
170416756|NCT01984242|615865625|FG001|Overall Study|Withdrawal by Subject|3|||
170416757|NCT01984242|615865626|FG002|Overall Study|Withdrawal by Subject|10|||
170416758|NCT01984242|615865624|FG000|Overall Study|Physician Decision|0|||
170416759|NCT01984242|615865625|FG001|Overall Study|Physician Decision|0|||
170416760|NCT01984242|615865626|FG002|Overall Study|Physician Decision|1|||
170416761|NCT01984242|615865624|FG000|Overall Study|Lost to Follow-up|4|||
170416762|NCT01984242|615865625|FG001|Overall Study|Lost to Follow-up|0|||
170416763|NCT01984242|615865626|FG002|Overall Study|Lost to Follow-up|3|||
170416764|NCT01984242|615865624|FG000|Overall Study|Sponsor Decision|1|||
170416765|NCT01984242|615865625|FG001|Overall Study|Sponsor Decision|0|||
170416766|NCT01984242|615865626|FG002|Overall Study|Sponsor Decision|0|||
170416767|NCT01984242|615865624|FG000|Overall Study|Non-Compliance|1|||
170416768|NCT01984242|615865625|FG001|Overall Study|Non-Compliance|0|||
170416769|NCT01984242|615865626|FG002|Overall Study|Non-Compliance|0|||
170416770|NCT01984242|615865624|FG000|Overall Study|Study terminated by Sponsor|38|||
170529071|NCT00853385|616286991|FG002|Overall Study|Lost to Follow-up|0|||
170877348|NCT01840579|617562179|FG009|Overall Study|Follow-up ended by Sponsor|0|||
170877349|NCT02437864|617562182|FG000|Overall Study|Protocol Violation|4|||
170416771|NCT01984242|615865625|FG001|Overall Study|Study terminated by Sponsor|50|||
170416772|NCT01984242|615865626|FG002|Overall Study|Study terminated by Sponsor|34|||
170416773|NCT01984242|615865624|FG000|Overall Study|Disease Progression|0|||
170416774|NCT01984242|615865625|FG001|Overall Study|Disease Progression|0|||
170416775|NCT01984242|615865626|FG002|Overall Study|Disease Progression|1|||
170416776|NCT02660242|615865632|FG000|Glucose Tabs|Lost to Follow-up|1|||
170416777|NCT02660242|615865632|FG000|Glucagon Injection|Lost to Follow-up|1|||
170416778|NCT02246478|615865633|FG000|Multiple-dose Phase|Protocol Violation|1|||
170416779|NCT02246478|615865634|FG001|Multiple-dose Phase|Protocol Violation|0|||
170877350|NCT02437864|617562183|FG001|Overall Study|Protocol Violation|0|||
170416780|NCT02246478|615865635|FG002|Multiple-dose Phase|Protocol Violation|0|||
170416781|NCT02246478|615865636|FG003|Multiple-dose Phase|Protocol Violation|1|||
170877351|NCT00645593|617562186|FG000|Overall Study|Later found to be ineligible|1|||
170877352|NCT00645593|617562187|FG001|Overall Study|Later found to be ineligible|0|||
170877353|NCT00492752|617562188|FG000|Double Blind Treatment|Death|13|||
170877354|NCT00492752|617562189|FG001|Double Blind Treatment|Death|0|||
170877355|NCT00492752|617562190|FG002|Double Blind Treatment|Death|2|||
170877356|NCT00492752|617562191|FG003|Double Blind Treatment|Death|0|||
170877357|NCT00492752|617562188|FG000|Double Blind Treatment|Adverse Event|1|||
170877358|NCT00492752|617562189|FG001|Double Blind Treatment|Adverse Event|0|||
170877359|NCT00492752|617562190|FG002|Double Blind Treatment|Adverse Event|0|||
170877360|NCT00492752|617562191|FG003|Double Blind Treatment|Adverse Event|0|||
170877361|NCT00492752|617562188|FG000|Double Blind Treatment|Protocol Violation|0|||
170877362|NCT00492752|617562189|FG001|Double Blind Treatment|Protocol Violation|0|||
170877363|NCT00492752|617562190|FG002|Double Blind Treatment|Protocol Violation|1|||
170877364|NCT00492752|617562191|FG003|Double Blind Treatment|Protocol Violation|0|||
170877365|NCT00492752|617562188|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
170877366|NCT00492752|617562189|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
170877367|NCT00492752|617562190|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
170877368|NCT00492752|617562191|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
170877369|NCT00492752|617562188|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
170877370|NCT00492752|617562189|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
170877371|NCT00492752|617562190|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
170877372|NCT00492752|617562191|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
170877373|NCT00492752|617562188|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
170877374|NCT00492752|617562189|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
170877375|NCT00492752|617562190|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
170877376|NCT00492752|617562191|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
170877377|NCT00492752|617562188|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
170877378|NCT00492752|617562189|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
170877379|NCT00492752|617562190|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
170877380|NCT00492752|617562191|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
170877381|NCT00492752|617562188|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
170877382|NCT00492752|617562189|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
170877383|NCT00492752|617562190|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
170877384|NCT00492752|617562191|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
170877385|NCT00492752|617562188|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
170877386|NCT00492752|617562189|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
170877387|NCT00492752|617562190|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
170416782|NCT00386009|615865639|FG000|Overall Study|Adverse Event|0|||
170416783|NCT00386009|615865640|FG001|Overall Study|Adverse Event|2|||
170416784|NCT00386009|615865639|FG000|Overall Study|Death|1|||
170416785|NCT00386009|615865640|FG001|Overall Study|Death|0|||
170416786|NCT00386009|615865639|FG000|Overall Study|Entry Criteria Not Met|0|||
170416787|NCT00386009|615865640|FG001|Overall Study|Entry Criteria Not Met|2|||
170416788|NCT00386009|615865639|FG000|Overall Study|Lost to Follow-up|1|||
170416789|NCT00386009|615865640|FG001|Overall Study|Lost to Follow-up|1|||
170416790|NCT00386009|615865639|FG000|Overall Study|Protocol Violation|1|||
170416791|NCT00386009|615865640|FG001|Overall Study|Protocol Violation|0|||
170416792|NCT00386009|615865639|FG000|Overall Study|Sponsor Decision|1|||
170416793|NCT00386009|615865640|FG001|Overall Study|Sponsor Decision|1|||
170416794|NCT00386009|615865639|FG000|Overall Study|Withdrawal by Subject|5|||
170416795|NCT00386009|615865640|FG001|Overall Study|Withdrawal by Subject|4|||
170416796|NCT01089647|615865643|FG000|Overall Study|Lost to Follow-up|2|||
170416797|NCT01089647|615865644|FG001|Overall Study|Lost to Follow-up|2|||
170416798|NCT01089647|615865643|FG000|Overall Study|Withdrawal by Subject|2|||
170416799|NCT01089647|615865644|FG001|Overall Study|Withdrawal by Subject|1|||
170416800|NCT01089647|615865643|FG000|Overall Study|Adverse Event|0|||
170416801|NCT01089647|615865644|FG001|Overall Study|Adverse Event|1|||
170416802|NCT01531205|615865645|FG000|Overall Study|Did not proceed to surgery|1|||
170416803|NCT01626079|615865650|FG000|Overall Study|Death|167|||
170416804|NCT01626079|615865651|FG001|Overall Study|Death|192|||
170416805|NCT01626079|615865652|FG002|Overall Study|Death|39|||
170416806|NCT01626079|615865650|FG000|Overall Study|Withdrawal by Subject|23|||
170416807|NCT01626079|615865651|FG001|Overall Study|Withdrawal by Subject|37|||
170416808|NCT01626079|615865652|FG002|Overall Study|Withdrawal by Subject|5|||
170416809|NCT01626079|615865650|FG000|Overall Study|Lost to Follow-up|7|||
170416810|NCT01626079|615865651|FG001|Overall Study|Lost to Follow-up|4|||
170416811|NCT01626079|615865652|FG002|Overall Study|Lost to Follow-up|2|||
170416812|NCT01626079|615865650|FG000|Overall Study|Missed Visits|1|||
170632611|NCT01352793|616666716|FG001|Overall Study|Withdrawal by Subject|55|||
170416813|NCT01626079|615865651|FG001|Overall Study|Missed Visits|4|||
170416814|NCT01626079|615865652|FG002|Overall Study|Missed Visits|6|||
170416815|NCT02549495|615865655|FG000|Overall Study|Death|2|||
170529072|NCT00853385|616286992|FG003|Overall Study|Lost to Follow-up|0|||
170529073|NCT00853385|616286993|FG004|Overall Study|Lost to Follow-up|0|||
170529074|NCT00853385|616286989|FG000|Overall Study|Withdrawal by Subject|4|||
170877388|NCT00492752|617562191|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
170877389|NCT00492752|617562188|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
170877390|NCT00492752|617562189|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
170877391|NCT00492752|617562190|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
170877392|NCT00492752|617562191|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
170877393|NCT00492752|617562188|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
170877394|NCT00492752|617562189|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
170877395|NCT00492752|617562190|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
170877396|NCT00492752|617562191|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
170877397|NCT03803059|617562194|FG000|Overall Study|Protocol Violation|2|||
170877398|NCT03803059|617562194|FG000|Overall Study|Lost to Follow-up|1|||
170877399|NCT04013529|617562195|FG000|Overall Study|Withdrawal by Subject|1|||
170877400|NCT04013529|617562196|FG001|Overall Study|Withdrawal by Subject|1|||
170877401|NCT03116698|617562199|FG000|Overall Study|Adverse Event|1|||
170877402|NCT03116698|617562200|FG001|Overall Study|Adverse Event|1|||
170877403|NCT03116698|617562201|FG002|Overall Study|Adverse Event|1|||
170877404|NCT03116698|617562202|FG003|Overall Study|Adverse Event|0|||
170877405|NCT03116698|617562199|FG000|Overall Study|Withdrawal by Subject|1|||
170877406|NCT03116698|617562200|FG001|Overall Study|Withdrawal by Subject|4|||
170416816|NCT02549495|615865655|FG000|Overall Study|Withdrawal by Subject|5|||
170416817|NCT02549495|615865655|FG000|Overall Study|Physician Decision|22|||
170416818|NCT02549495|615865655|FG000|Overall Study|Lost to Follow-up|6|||
170416819|NCT02549495|615865655|FG000|Overall Study|Protocol Violation|6|||
170416820|NCT01862328|615865658|FG000|Overall Study|Progressive Disease|3|||
170416821|NCT01862328|615865659|FG001|Overall Study|Progressive Disease|11|||
170416822|NCT01862328|615865660|FG002|Overall Study|Progressive Disease|5|||
170416823|NCT01862328|615865661|FG003|Overall Study|Progressive Disease|6|||
170416824|NCT01862328|615865662|FG004|Overall Study|Progressive Disease|7|||
170416825|NCT01862328|615865663|FG005|Overall Study|Progressive Disease|4|||
170416826|NCT01862328|615865664|FG006|Overall Study|Progressive Disease|3|||
170416827|NCT01862328|615865658|FG000|Overall Study|Adverse Event|0|||
170416828|NCT01862328|615865659|FG001|Overall Study|Adverse Event|4|||
170416829|NCT01862328|615865660|FG002|Overall Study|Adverse Event|0|||
170416830|NCT01862328|615865661|FG003|Overall Study|Adverse Event|1|||
170416831|NCT01862328|615865662|FG004|Overall Study|Adverse Event|0|||
170416832|NCT01862328|615865663|FG005|Overall Study|Adverse Event|2|||
170416833|NCT01862328|615865664|FG006|Overall Study|Adverse Event|4|||
170416834|NCT01862328|615865658|FG000|Overall Study|Other|0|||
170416835|NCT01862328|615865659|FG001|Overall Study|Other|2|||
170416836|NCT01862328|615865660|FG002|Overall Study|Other|1|||
170416837|NCT01862328|615865661|FG003|Overall Study|Other|0|||
170416838|NCT01862328|615865662|FG004|Overall Study|Other|4|||
170416839|NCT01862328|615865663|FG005|Overall Study|Other|0|||
170416840|NCT01862328|615865664|FG006|Overall Study|Other|1|||
170416841|NCT01862328|615865658|FG000|Overall Study|Withdrawal by Subject|1|||
170416842|NCT01862328|615865659|FG001|Overall Study|Withdrawal by Subject|1|||
170416843|NCT01862328|615865660|FG002|Overall Study|Withdrawal by Subject|0|||
170416844|NCT01862328|615865661|FG003|Overall Study|Withdrawal by Subject|0|||
170416845|NCT01862328|615865662|FG004|Overall Study|Withdrawal by Subject|1|||
170416846|NCT01862328|615865663|FG005|Overall Study|Withdrawal by Subject|1|||
170416847|NCT01862328|615865664|FG006|Overall Study|Withdrawal by Subject|1|||
170416848|NCT01862328|615865658|FG000|Overall Study|Symptomatic Deterioration|0|||
170416849|NCT01862328|615865659|FG001|Overall Study|Symptomatic Deterioration|0|||
170416850|NCT01862328|615865660|FG002|Overall Study|Symptomatic Deterioration|0|||
170416851|NCT01862328|615865661|FG003|Overall Study|Symptomatic Deterioration|0|||
170416852|NCT01862328|615865662|FG004|Overall Study|Symptomatic Deterioration|0|||
170416853|NCT01862328|615865663|FG005|Overall Study|Symptomatic Deterioration|0|||
170416854|NCT01862328|615865664|FG006|Overall Study|Symptomatic Deterioration|1|||
170416855|NCT04333095|615865665|FG000|Overall Study|Protocol Violation|4|||
170416856|NCT04333095|615865666|FG001|Overall Study|Protocol Violation|0|||
170416857|NCT04333095|615865665|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
170416858|NCT04333095|615865666|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
170416859|NCT04333095|615865665|FG000|Overall Study|Mini Sternotomy|4|||
170416860|NCT04333095|615865666|FG001|Overall Study|Mini Sternotomy|5|||
170416861|NCT04347239|615865667|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
170416862|NCT04347239|615865668|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
170416863|NCT04347239|615865669|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
170416864|NCT04347239|615865667|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
170416865|NCT04347239|615865668|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
170529075|NCT00853385|616286990|FG001|Overall Study|Withdrawal by Subject|2|||
170529076|NCT00853385|616286991|FG002|Overall Study|Withdrawal by Subject|0|||
170529077|NCT00853385|616286992|FG003|Overall Study|Withdrawal by Subject|1|||
170529078|NCT00853385|616286993|FG004|Overall Study|Withdrawal by Subject|1|||
170529079|NCT00853385|616286989|FG000|Overall Study|Other|18|||
170529080|NCT00853385|616286990|FG001|Overall Study|Other|9|||
170529081|NCT00853385|616286991|FG002|Overall Study|Other|4|||
170529082|NCT00853385|616286992|FG003|Overall Study|Other|4|||
170529083|NCT00853385|616286993|FG004|Overall Study|Other|12|||
170529084|NCT00577408|616286998|FG000|Overall Study|Stopped attending study visits|9|||
170529085|NCT00577408|616286999|FG001|Overall Study|Stopped attending study visits|11|||
170777117|NCT05054725|617190262|FG001|Overall Study|Withdrawal by Subject|4|||
170777118|NCT05054725|617190261|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
170777119|NCT05054725|617190262|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
170777120|NCT05054725|617190261|FG000|Overall Study|Death|1|||
170777121|NCT05054725|617190262|FG001|Overall Study|Death|21|||
170777122|NCT05054725|617190261|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
170777123|NCT05054725|617190262|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
170777124|NCT05054725|617190261|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
170777125|NCT05054725|617190262|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
170777126|NCT05054725|617190261|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
170777127|NCT05054725|617190262|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
170777128|NCT05054725|617190261|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
170777129|NCT05054725|617190262|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
170777130|NCT05054725|617190261|FG000|Overall Study|Physician discretion due to subject progression|0|||
170777131|NCT05054725|617190262|FG001|Overall Study|Physician discretion due to subject progression|1|||
170777132|NCT03674411|617190263|FG000|Overall Study|Non-treatment|4|||
170777133|NCT03674411|617190264|FG001|Overall Study|Non-treatment|0|||
170777134|NCT04705480|617190271|FG000|Overall Study|Withdrawal by Subject|1|||
170777135|NCT04705480|617190272|FG001|Overall Study|Withdrawal by Subject|0|||
170777136|NCT04705480|617190273|FG002|Overall Study|Withdrawal by Subject|1|||
170777137|NCT04705480|617190271|FG000|Overall Study|Protocol Violation|2|||
170777138|NCT04705480|617190272|FG001|Overall Study|Protocol Violation|0|||
170777139|NCT04705480|617190273|FG002|Overall Study|Protocol Violation|2|||
170777140|NCT04705480|617190271|FG000|Overall Study|Decision to discharge before intervention|2|||
170777141|NCT04705480|617190272|FG001|Overall Study|Decision to discharge before intervention|0|||
170777142|NCT04705480|617190273|FG002|Overall Study|Decision to discharge before intervention|0|||
170777143|NCT00861692|617190274|FG000|Overall Study|Death|6|||
170777144|NCT06429163|617190275|FG000|Overall Study|uterine fibroid type 7|1|||
170777145|NCT06429163|617190276|FG001|Overall Study|uterine fibroid type 7|1|||
170777146|NCT06429163|617190277|FG002|Overall Study|uterine fibroid type 7|1|||
170777147|NCT06429163|617190275|FG000|Overall Study|severe adhesions|1|||
170777148|NCT06429163|617190276|FG001|Overall Study|severe adhesions|2|||
170777149|NCT06429163|617190277|FG002|Overall Study|severe adhesions|1|||
170777150|NCT06429163|617190275|FG000|Overall Study|conversion to laparotomy|0|||
170777151|NCT06429163|617190276|FG001|Overall Study|conversion to laparotomy|1|||
170777152|NCT06429163|617190277|FG002|Overall Study|conversion to laparotomy|0|||
170777153|NCT06429163|617190275|FG000|Overall Study|concomitant procedure|1|||
170777154|NCT06429163|617190276|FG001|Overall Study|concomitant procedure|0|||
170777155|NCT06429163|617190277|FG002|Overall Study|concomitant procedure|0|||
170777156|NCT04970654|617190278|FG000|Overall Study|Withdrawal by parents/guardian|1|||
170777157|NCT04970654|617190279|FG001|Overall Study|Withdrawal by parents/guardian|2|||
170777158|NCT04970654|617190278|FG000|Overall Study|Unclassified|2|||
170777159|NCT04970654|617190279|FG001|Overall Study|Unclassified|1|||
170777160|NCT04970654|617190278|FG000|Overall Study|Lost to Follow-up|1|||
170777161|NCT04970654|617190279|FG001|Overall Study|Lost to Follow-up|0|||
170777162|NCT02238483|617190280|FG000|Overall Study|Withdrawal by Subject|2|||
170777163|NCT02238483|617190281|FG001|Overall Study|Withdrawal by Subject|7|||
170777164|NCT02238483|617190280|FG000|Overall Study|Lost to Follow-up|1|||
170777165|NCT02238483|617190281|FG001|Overall Study|Lost to Follow-up|1|||
170777166|NCT02238483|617190280|FG000|Overall Study|Protocol Violation|1|||
170777167|NCT02238483|617190281|FG001|Overall Study|Protocol Violation|2|||
170777168|NCT02238483|617190280|FG000|Overall Study|Death|1|||
170777169|NCT02238483|617190281|FG001|Overall Study|Death|0|||
170777170|NCT02238483|617190280|FG000|Overall Study|Adverse Event|7|||
170777171|NCT02238483|617190281|FG001|Overall Study|Adverse Event|3|||
170777172|NCT02238483|617190280|FG000|Overall Study|Withdrawn due to physician decision|1|||
170777173|NCT02238483|617190281|FG001|Overall Study|Withdrawn due to physician decision|0|||
170777174|NCT02238483|617190280|FG000|Overall Study|Completion status not recorded|1|||
170777175|NCT02238483|617190281|FG001|Overall Study|Completion status not recorded|1|||
170777176|NCT02238483|617190280|FG000|Overall Study|Illness in family member|1|||
170777177|NCT02238483|617190281|FG001|Overall Study|Illness in family member|0|||
170529086|NCT00577408|616286998|FG000|Overall Study|Continued opioid use|3|||
170529087|NCT00577408|616286999|FG001|Overall Study|Continued opioid use|2|||
170777178|NCT04929483|617190282|FG000|Main Study (24 Weeks)|Adverse Event|1|||
170777179|NCT04929483|617190283|FG001|Main Study (24 Weeks)|Adverse Event|6|||
170777180|NCT04929483|617190284|FG002|Main Study (24 Weeks)|Adverse Event|2|||
170777181|NCT04929483|617190285|FG003|Main Study (24 Weeks)|Adverse Event|1|||
170777182|NCT04929483|617190286|FG004|Main Study (24 Weeks)|Adverse Event|0|||
170777183|NCT04929483|617190287|FG005|Main Study (24 Weeks)|Adverse Event|0|||
170777184|NCT04929483|617190282|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
170777185|NCT04929483|617190283|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
170777186|NCT04929483|617190284|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
170777187|NCT04929483|617190285|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
170777188|NCT04929483|617190286|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
170777189|NCT04929483|617190287|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
170777190|NCT04929483|617190282|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
170777191|NCT04929483|617190283|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
170777192|NCT04929483|617190284|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
170777193|NCT04929483|617190285|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
170777194|NCT04929483|617190286|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
170777195|NCT04929483|617190287|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
170777196|NCT04929483|617190282|FG000|Main Study (24 Weeks)|Physician Decision|0|||
170777197|NCT04929483|617190283|FG001|Main Study (24 Weeks)|Physician Decision|2|||
170777198|NCT04929483|617190284|FG002|Main Study (24 Weeks)|Physician Decision|0|||
170777199|NCT04929483|617190285|FG003|Main Study (24 Weeks)|Physician Decision|0|||
170777200|NCT04929483|617190286|FG004|Main Study (24 Weeks)|Physician Decision|0|||
170777201|NCT04929483|617190287|FG005|Main Study (24 Weeks)|Physician Decision|0|||
170777202|NCT04929483|617190282|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
170777203|NCT04929483|617190283|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
170777204|NCT04929483|617190284|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
170777205|NCT04929483|617190285|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
170777206|NCT04929483|617190286|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
170777207|NCT04929483|617190287|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
170777208|NCT04929483|617190282|FG000|Main Study (24 Weeks)|Randomized in error|0|||
170777209|NCT04929483|617190283|FG001|Main Study (24 Weeks)|Randomized in error|1|||
170777210|NCT04929483|617190284|FG002|Main Study (24 Weeks)|Randomized in error|0|||
170777211|NCT04929483|617190285|FG003|Main Study (24 Weeks)|Randomized in error|2|||
170777212|NCT04929483|617190286|FG004|Main Study (24 Weeks)|Randomized in error|0|||
170777213|NCT04929483|617190287|FG005|Main Study (24 Weeks)|Randomized in error|0|||
170777214|NCT04929483|617190282|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
170777215|NCT04929483|617190283|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
170777216|NCT04929483|617190284|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
170777217|NCT04929483|617190285|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
170777218|NCT04929483|617190286|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
170777219|NCT04929483|617190287|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
170777220|NCT04929483|617190282|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
170777221|NCT04929483|617190283|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
170777222|NCT04929483|617190284|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
170777223|NCT04929483|617190285|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
170777224|NCT04929483|617190286|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
170777225|NCT04929483|617190287|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
170777226|NCT04929483|617190282|FG000|Extension Study (24 Weeks)|Other than specified|1|||
170777227|NCT04929483|617190283|FG001|Extension Study (24 Weeks)|Other than specified|0|||
170777228|NCT04929483|617190284|FG002|Extension Study (24 Weeks)|Other than specified|1|||
170777229|NCT04929483|617190285|FG003|Extension Study (24 Weeks)|Other than specified|0|||
170777230|NCT04929483|617190286|FG004|Extension Study (24 Weeks)|Other than specified|1|||
170777231|NCT04929483|617190287|FG005|Extension Study (24 Weeks)|Other than specified|0|||
170777232|NCT04929483|617190282|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
170777233|NCT04929483|617190283|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
170777234|NCT04929483|617190284|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
170777235|NCT04929483|617190285|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
170777236|NCT04929483|617190286|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
170416866|NCT04347239|615865669|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
170777237|NCT04929483|617190287|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
170416867|NCT00306384|615865671|FG000|Overall Study|Adverse Event|103|||
170416868|NCT00306384|615865672|FG001|Overall Study|Adverse Event|87|||
170416869|NCT00306384|615865673|FG002|Overall Study|Adverse Event|40|||
170777238|NCT01626885|617190288|FG000|Overall Study|Adverse Event|8|||
170777239|NCT01626885|617190288|FG000|Overall Study|Withdrawal by Subject|4|||
170416870|NCT00306384|615865671|FG000|Overall Study|Major protocol deviation|43|||
170777240|NCT04083781|617190295|FG000|Main Part|Physician Decision|0|||
170777241|NCT04083781|617190296|FG001|Main Part|Physician Decision|1|||
170777242|NCT04083781|617190297|FG002|Main Part|Physician Decision|2|||
170777243|NCT04083781|617190298|FG003|Main Part|Physician Decision|0|||
170777244|NCT04083781|617190295|FG000|Main Part|Death|1|||
170777245|NCT04083781|617190296|FG001|Main Part|Death|3|||
170777246|NCT04083781|617190297|FG002|Main Part|Death|1|||
170777247|NCT04083781|617190298|FG003|Main Part|Death|0|||
170529088|NCT00577408|616286998|FG000|Overall Study|Non-compliance with study meds|0|||
170529089|NCT00577408|616286999|FG001|Overall Study|Non-compliance with study meds|3|||
170529090|NCT00577408|616286998|FG000|Overall Study|Refused Oral Naltrexone|0|||
170529091|NCT00577408|616286999|FG001|Overall Study|Refused Oral Naltrexone|1|||
170529092|NCT00577408|616286998|FG000|Overall Study|Moved out of state|0|||
170529093|NCT00577408|616286999|FG001|Overall Study|Moved out of state|1|||
170529094|NCT00577408|616286998|FG000|Overall Study|Scheduling Issues|0|||
170529095|NCT00577408|616286999|FG001|Overall Study|Scheduling Issues|3|||
170529096|NCT00577408|616286998|FG000|Overall Study|Death|0|||
170529097|NCT00577408|616286999|FG001|Overall Study|Death|1|||
170529098|NCT00577408|616286998|FG000|Overall Study|Psychiatric hospitalization|0|||
170529099|NCT00577408|616286999|FG001|Overall Study|Psychiatric hospitalization|1|||
170529100|NCT03817528|616287000|FG000|Overall Study|Withdrawal by Subject|1|||
170529101|NCT03817528|616287000|FG000|Overall Study|Adverse Event|2|||
170529102|NCT02732639|616287003|FG000|Overall Study|Lost to Follow-up|1|||
170529103|NCT00706797|616287006|FG000|Overall Study|Lack of Efficacy|3|||
170529104|NCT00706797|616287007|FG001|Overall Study|Lack of Efficacy|0|||
170529105|NCT00706797|616287006|FG000|Overall Study|Adverse Event|0|||
170529106|NCT00706797|616287007|FG001|Overall Study|Adverse Event|3|||
170529107|NCT00706797|616287006|FG000|Overall Study|Withdrawal by Subject|8|||
170529108|NCT00706797|616287007|FG001|Overall Study|Withdrawal by Subject|1|||
170529109|NCT00706797|616287006|FG000|Overall Study|Death|1|||
170529110|NCT00706797|616287007|FG001|Overall Study|Death|0|||
170529111|NCT00706797|616287006|FG000|Overall Study|Discontinuation of study by sponsor|52|||
170529112|NCT00706797|616287007|FG001|Overall Study|Discontinuation of study by sponsor|63|||
170529113|NCT00706797|616287006|FG000|Overall Study|Protocol Violation|3|||
170529114|NCT00706797|616287007|FG001|Overall Study|Protocol Violation|2|||
170529115|NCT00706797|616287006|FG000|Overall Study|Lost to Follow-up|1|||
170529116|NCT00706797|616287007|FG001|Overall Study|Lost to Follow-up|2|||
170529117|NCT00706797|616287006|FG000|Overall Study|Other|1|||
170529118|NCT00706797|616287007|FG001|Overall Study|Other|0|||
170529119|NCT00485303|616287009|FG000|Overall Study|Adverse Event|5|||
170529120|NCT00485303|616287009|FG000|Overall Study|Progressive Disease|44|||
170529121|NCT00485303|616287009|FG000|Overall Study|Other|3|||
170529122|NCT00485303|616287009|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
170529123|NCT00485303|616287009|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
170529124|NCT03451045|616287010|FG000|Overall Study|Lack of Efficacy|3|||
170529125|NCT03451045|616287011|FG001|Overall Study|Lack of Efficacy|2|||
170529126|NCT03451045|616287012|FG002|Overall Study|Lack of Efficacy|2|||
170529127|NCT03451045|616287010|FG000|Overall Study|Physician Decision|1|||
170529128|NCT03451045|616287011|FG001|Overall Study|Physician Decision|1|||
170529129|NCT03451045|616287012|FG002|Overall Study|Physician Decision|1|||
170529130|NCT03451045|616287010|FG000|Overall Study|Withdrawal by Subject|4|||
170529131|NCT03451045|616287011|FG001|Overall Study|Withdrawal by Subject|0|||
170529132|NCT03451045|616287012|FG002|Overall Study|Withdrawal by Subject|5|||
170529133|NCT03451045|616287010|FG000|Overall Study|Pregnancy|0|||
170529134|NCT03451045|616287011|FG001|Overall Study|Pregnancy|0|||
170529135|NCT03451045|616287012|FG002|Overall Study|Pregnancy|2|||
170529136|NCT03451045|616287010|FG000|Overall Study|Adverse Event|7|||
170529137|NCT03451045|616287011|FG001|Overall Study|Adverse Event|1|||
170529138|NCT03451045|616287012|FG002|Overall Study|Adverse Event|3|||
170529139|NCT03451045|616287010|FG000|Overall Study|Non-compliance with study|2|||
170529140|NCT03451045|616287011|FG001|Overall Study|Non-compliance with study|0|||
170529141|NCT03451045|616287012|FG002|Overall Study|Non-compliance with study|1|||
170529142|NCT03451045|616287010|FG000|Overall Study|any other reason|10|||
170529143|NCT03451045|616287011|FG001|Overall Study|any other reason|2|||
170529144|NCT03451045|616287012|FG002|Overall Study|any other reason|13|||
170529145|NCT00863707|616287013|FG000|Overall Study|Randomized, but drug not received|4|||
170529146|NCT00863707|616287014|FG001|Overall Study|Randomized, but drug not received|3|||
170529147|NCT00830128|616287015|FG000|Overall Study|Adverse Event|5|||
170529148|NCT00830128|616287015|FG000|Overall Study|Lack of Efficacy|7|||
170529149|NCT00830128|616287015|FG000|Overall Study|Protocol Violation|1|||
170529150|NCT00830128|616287015|FG000|Overall Study|Withdrawal by Subject|2|||
170529151|NCT00830128|616287015|FG000|Overall Study|Family obligation|1|||
170529152|NCT00830128|616287015|FG000|Overall Study|Relocation|1|||
170529153|NCT00830128|616287015|FG000|Overall Study|Work obligation|1|||
170529154|NCT00830128|616287015|FG000|Overall Study|Operating a vehicle|1|||
170529155|NCT03040726|616287033|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
170529156|NCT03040726|616287034|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
170529157|NCT03040726|616287033|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
170529158|NCT03040726|616287034|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
170529159|NCT03040726|616287033|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
170529160|NCT03040726|616287034|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
170529161|NCT03040726|616287033|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
170529162|NCT03040726|616287034|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
170632612|NCT01352793|616666715|FG000|Overall Study|Protocol Violation|44|||
170416871|NCT00306384|615865672|FG001|Overall Study|Major protocol deviation|51|||
170416872|NCT00306384|615865673|FG002|Overall Study|Major protocol deviation|18|||
170416873|NCT00306384|615865671|FG000|Overall Study|Lost to Follow-up|57|||
170416874|NCT00306384|615865672|FG001|Overall Study|Lost to Follow-up|41|||
170416875|NCT00306384|615865673|FG002|Overall Study|Lost to Follow-up|35|||
170416876|NCT00306384|615865671|FG000|Overall Study|Voluntary withdrawal|199|||
170416877|NCT00306384|615865672|FG001|Overall Study|Voluntary withdrawal|187|||
170416878|NCT00306384|615865673|FG002|Overall Study|Voluntary withdrawal|91|||
170416879|NCT00306384|615865671|FG000|Overall Study|Study termination|1|||
170416880|NCT00306384|615865672|FG001|Overall Study|Study termination|0|||
170416881|NCT00306384|615865673|FG002|Overall Study|Study termination|1|||
170416882|NCT00306384|615865671|FG000|Overall Study|Pregnancy|3|||
170416883|NCT00306384|615865672|FG001|Overall Study|Pregnancy|1|||
170416884|NCT00306384|615865673|FG002|Overall Study|Pregnancy|1|||
170416885|NCT00306384|615865671|FG000|Overall Study|Lack of Efficacy|26|||
170416886|NCT00306384|615865672|FG001|Overall Study|Lack of Efficacy|40|||
170416887|NCT00306384|615865673|FG002|Overall Study|Lack of Efficacy|38|||
170416888|NCT00306384|615865671|FG000|Overall Study|Investigator discretion|28|||
170416889|NCT00306384|615865672|FG001|Overall Study|Investigator discretion|31|||
170416890|NCT00306384|615865673|FG002|Overall Study|Investigator discretion|21|||
170416891|NCT00306384|615865671|FG000|Overall Study|Other|80|||
170416892|NCT00306384|615865672|FG001|Overall Study|Other|70|||
170416893|NCT00306384|615865673|FG002|Overall Study|Other|32|||
170416894|NCT00306384|615865671|FG000|Overall Study|Site closure|2|||
170416895|NCT00306384|615865672|FG001|Overall Study|Site closure|0|||
170416896|NCT00306384|615865673|FG002|Overall Study|Site closure|0|||
170416897|NCT02275364|615865674|FG000|Period 1|Withdrawal by Subject|1|||
170416898|NCT02275364|615865675|FG001|Period 1|Withdrawal by Subject|0|||
170416899|NCT02275364|615865674|FG000|Period 1|Other reason|1|||
170416900|NCT02275364|615865675|FG001|Period 1|Other reason|0|||
170416901|NCT03184441|615865676|FG000|Overall Study|Withdrawal by Subject|1|||
170416902|NCT00969332|615865679|FG000|Overall Study|Physician Decision|8|||
170416903|NCT00969332|615865679|FG000|Overall Study|Withdrawal by Subject|3|||
170416904|NCT00576199|615865680|FG000|Overall Study|Adverse Event|12|||
170416905|NCT00576199|615865680|FG000|Overall Study|Insufficient Therapeutic Response|14|||
170416906|NCT00576199|615865680|FG000|Overall Study|Refused Treatment|2|||
170416907|NCT00576199|615865680|FG000|Overall Study|Reason Unspecified|2|||
170416908|NCT01052116|615867504|FG000|Overall Study|Lost to Follow-up|11|||
170416909|NCT01052116|615867505|FG001|Overall Study|Lost to Follow-up|17|||
170416910|NCT01052116|615867504|FG000|Overall Study|Withdrawal by Subject|3|||
170416911|NCT01052116|615867505|FG001|Overall Study|Withdrawal by Subject|6|||
170416912|NCT01052116|615867504|FG000|Overall Study|Spirometry not performed|0|||
170416913|NCT01052116|615867505|FG001|Overall Study|Spirometry not performed|4|||
170416914|NCT00444145|615867506|FG000|Overall Study|Withdrawal by Subject|2|||
170416915|NCT00444145|615867506|FG000|Overall Study|Lost to Follow-up|1|||
170416916|NCT00444145|615867506|FG000|Overall Study|non-compliant|11|||
170416917|NCT00444145|615867506|FG000|Overall Study|Screen Failures|5|||
170416918|NCT02581345|615867507|FG000|Part 1: up to Week 16|Adverse Event|3|||
170416919|NCT02581345|615867508|FG001|Part 1: up to Week 16|Adverse Event|8|||
170416920|NCT02581345|615867509|FG002|Part 1: up to Week 16|Adverse Event|0|||
170416921|NCT02581345|615867510|FG003|Part 1: up to Week 16|Adverse Event|0|||
170416922|NCT02581345|615867507|FG000|Part 1: up to Week 16|Physician Decision|2|||
170416923|NCT02581345|615867508|FG001|Part 1: up to Week 16|Physician Decision|4|||
170416924|NCT02581345|615867509|FG002|Part 1: up to Week 16|Physician Decision|0|||
170416925|NCT02581345|615867510|FG003|Part 1: up to Week 16|Physician Decision|0|||
170416926|NCT02581345|615867507|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
170416927|NCT02581345|615867508|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
170416928|NCT02581345|615867509|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
170416929|NCT02581345|615867510|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
170416930|NCT02581345|615867507|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
170416931|NCT02581345|615867508|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
170416932|NCT02581345|615867509|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
170416933|NCT02581345|615867510|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
170416934|NCT02581345|615867507|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
170416935|NCT02581345|615867508|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
170416936|NCT02581345|615867509|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
170416937|NCT02581345|615867510|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
170416938|NCT02581345|615867507|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
170416939|NCT02581345|615867508|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
170416940|NCT02581345|615867509|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
170416941|NCT02581345|615867510|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
170416942|NCT02581345|615867507|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
170416943|NCT02581345|615867508|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
170416944|NCT02581345|615867509|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
170416945|NCT02581345|615867510|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
170416946|NCT02581345|615867507|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
170416947|NCT02581345|615867508|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
170529163|NCT03040726|616287033|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
170529164|NCT03040726|616287034|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
170529165|NCT01218802|616287037|FG000|Overall Study|Lost to Follow-up|5|||
170529166|NCT01218802|616287038|FG001|Overall Study|Lost to Follow-up|6|||
170529167|NCT01218802|616287037|FG000|Overall Study|Withdrawal by Subject|3|||
170529168|NCT01218802|616287038|FG001|Overall Study|Withdrawal by Subject|10|||
170529169|NCT01218802|616287037|FG000|Overall Study|Adverse Event|0|||
170529170|NCT01218802|616287038|FG001|Overall Study|Adverse Event|2|||
170529171|NCT01218802|616287037|FG000|Overall Study|Incarcerated|2|||
170529172|NCT01218802|616287038|FG001|Overall Study|Incarcerated|0|||
170529173|NCT00062166|616287039|FG000|Overall Study|Withdrawal by Subject|6|||
170529174|NCT05063448|616287040|FG000|Overall Study|Withdrawal by Subject|1|||
170529175|NCT02475369|616287044|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
170529176|NCT02475369|616287045|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
170529177|NCT00885118|616287051|FG000|Overall Study|Adverse Event|1|||
170529178|NCT00885118|616287052|FG001|Overall Study|Adverse Event|0|||
170529179|NCT00885118|616287053|FG002|Overall Study|Adverse Event|0|||
170529180|NCT00885118|616287054|FG003|Overall Study|Adverse Event|0|||
170529181|NCT00885118|616287055|FG004|Overall Study|Adverse Event|0|||
170529182|NCT00885118|616287051|FG000|Overall Study|Withdrawal by Subject|0|||
170529183|NCT00885118|616287052|FG001|Overall Study|Withdrawal by Subject|0|||
170529184|NCT00885118|616287053|FG002|Overall Study|Withdrawal by Subject|0|||
170529185|NCT00885118|616287054|FG003|Overall Study|Withdrawal by Subject|0|||
170529186|NCT00885118|616287055|FG004|Overall Study|Withdrawal by Subject|1|||
170529187|NCT00885118|616287051|FG000|Overall Study|Other reason not defined above|0|||
170529188|NCT00885118|616287052|FG001|Overall Study|Other reason not defined above|0|||
170529189|NCT00885118|616287053|FG002|Overall Study|Other reason not defined above|1|||
170529190|NCT00885118|616287054|FG003|Overall Study|Other reason not defined above|0|||
170529191|NCT00885118|616287055|FG004|Overall Study|Other reason not defined above|0|||
170529192|NCT01677741|616287062|FG000|Overall Study|Death|0|||
170529193|NCT01677741|616287063|FG001|Overall Study|Death|0|||
170529194|NCT01677741|616287064|FG002|Overall Study|Death|0|||
170529195|NCT01677741|616287065|FG003|Overall Study|Death|1|||
170529196|NCT01677741|616287066|FG004|Overall Study|Death|0|||
170529197|NCT01677741|616287067|FG005|Overall Study|Death|1|||
170529198|NCT01677741|616287068|FG006|Overall Study|Death|0|||
170529199|NCT01677741|616287069|FG007|Overall Study|Death|0|||
170529200|NCT01677741|616287062|FG000|Overall Study|Withdrawal by Subject|2|||
170529201|NCT01677741|616287063|FG001|Overall Study|Withdrawal by Subject|7|||
170529202|NCT01677741|616287064|FG002|Overall Study|Withdrawal by Subject|5|||
170529203|NCT01677741|616287065|FG003|Overall Study|Withdrawal by Subject|4|||
170529204|NCT01677741|616287066|FG004|Overall Study|Withdrawal by Subject|11|||
170529205|NCT01677741|616287067|FG005|Overall Study|Withdrawal by Subject|20|||
170529206|NCT01677741|616287068|FG006|Overall Study|Withdrawal by Subject|4|||
170529207|NCT01677741|616287069|FG007|Overall Study|Withdrawal by Subject|2|||
170529208|NCT01677741|616287062|FG000|Overall Study|Enrolled in a rollover study|0|||
170529209|NCT01677741|616287063|FG001|Overall Study|Enrolled in a rollover study|3|||
170529210|NCT01677741|616287064|FG002|Overall Study|Enrolled in a rollover study|2|||
170529211|NCT01677741|616287065|FG003|Overall Study|Enrolled in a rollover study|1|||
170529212|NCT01677741|616287066|FG004|Overall Study|Enrolled in a rollover study|6|||
170529213|NCT01677741|616287067|FG005|Overall Study|Enrolled in a rollover study|6|||
170529214|NCT01677741|616287068|FG006|Overall Study|Enrolled in a rollover study|7|||
170529215|NCT01677741|616287069|FG007|Overall Study|Enrolled in a rollover study|0|||
170529216|NCT01677741|616287062|FG000|Overall Study|Progressive disease|1|||
170529217|NCT01677741|616287063|FG001|Overall Study|Progressive disease|0|||
170529218|NCT01677741|616287064|FG002|Overall Study|Progressive disease|1|||
170529219|NCT01677741|616287065|FG003|Overall Study|Progressive disease|0|||
170529220|NCT01677741|616287066|FG004|Overall Study|Progressive disease|0|||
170529221|NCT01677741|616287067|FG005|Overall Study|Progressive disease|1|||
170529222|NCT01677741|616287068|FG006|Overall Study|Progressive disease|0|||
170529223|NCT01677741|616287069|FG007|Overall Study|Progressive disease|0|||
170529224|NCT02404545|616287073|FG000|Overall Study|Sponsor Termination|6|||
170529225|NCT02404545|616287074|FG001|Overall Study|Sponsor Termination|6|||
170529226|NCT03641508|616287075|FG000|First Injection|Lost to Follow-up|2|||
170529227|NCT03641508|616287076|FG001|First Injection|Lost to Follow-up|0|||
170529228|NCT03087058|616287077|FG000|Overall Study|Withdrawal by Subject|2|||
170529229|NCT03087058|616287078|FG001|Overall Study|Withdrawal by Subject|0|||
170529230|NCT03087058|616287079|FG002|Overall Study|Withdrawal by Subject|0|||
170529231|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
170529232|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
170529233|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
170529234|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
170529235|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
170529236|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
170529237|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
170529238|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
170529239|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
170529240|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
170529241|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
170529242|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
170529243|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
170529244|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
170529245|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
170529246|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
170529247|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
170529248|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
170529249|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
170529250|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
170529251|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
170529252|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
170529253|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
170529254|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
170529255|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
170529256|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
170529257|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
170529258|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
170777248|NCT04083781|617190295|FG000|Main Part|Withdrawal by Subject|5|||
170777249|NCT04083781|617190296|FG001|Main Part|Withdrawal by Subject|2|||
170777250|NCT04083781|617190297|FG002|Main Part|Withdrawal by Subject|3|||
170777251|NCT04083781|617190298|FG003|Main Part|Withdrawal by Subject|7|||
170777252|NCT04083781|617190295|FG000|Extension Part|Physician Decision|0|||
170777253|NCT04083781|617190296|FG001|Extension Part|Physician Decision|0|||
170777254|NCT04083781|617190297|FG002|Extension Part|Physician Decision|0|||
170777255|NCT04083781|617190298|FG003|Extension Part|Physician Decision|1|||
170777256|NCT04083781|617190295|FG000|Extension Part|Death|0|||
170777257|NCT04083781|617190296|FG001|Extension Part|Death|1|||
170777258|NCT04083781|617190297|FG002|Extension Part|Death|0|||
170777259|NCT04083781|617190298|FG003|Extension Part|Death|1|||
170777260|NCT04083781|617190295|FG000|Extension Part|Withdrawal by Subject|0|||
170777261|NCT04083781|617190296|FG001|Extension Part|Withdrawal by Subject|1|||
170777262|NCT04083781|617190297|FG002|Extension Part|Withdrawal by Subject|0|||
170777263|NCT04083781|617190298|FG003|Extension Part|Withdrawal by Subject|0|||
170777264|NCT04083781|617190295|FG000|Extension Part|Ongoing|13|||
170777265|NCT04083781|617190296|FG001|Extension Part|Ongoing|25|||
170777266|NCT04083781|617190297|FG002|Extension Part|Ongoing|15|||
170777267|NCT04083781|617190298|FG003|Extension Part|Ongoing|51|||
170777268|NCT01143337|617190299|FG000|Overall Study|Adverse Event|3|||
170777269|NCT01143337|617190300|FG001|Overall Study|Adverse Event|9|||
170777270|NCT01143337|617190301|FG002|Overall Study|Adverse Event|5|||
170777271|NCT01143337|617190299|FG000|Overall Study|Lack of Efficacy|6|||
170777272|NCT01143337|617190300|FG001|Overall Study|Lack of Efficacy|2|||
170777273|NCT01143337|617190301|FG002|Overall Study|Lack of Efficacy|1|||
170777274|NCT01143337|617190299|FG000|Overall Study|Protocol Violation|1|||
170777275|NCT01143337|617190300|FG001|Overall Study|Protocol Violation|0|||
170777276|NCT01143337|617190301|FG002|Overall Study|Protocol Violation|0|||
170777277|NCT01143337|617190299|FG000|Overall Study|Withdrawal by Subject|0|||
170777278|NCT01143337|617190300|FG001|Overall Study|Withdrawal by Subject|0|||
170777279|NCT01143337|617190301|FG002|Overall Study|Withdrawal by Subject|1|||
170777280|NCT01143337|617190299|FG000|Overall Study|Other reason|0|||
170777281|NCT01143337|617190300|FG001|Overall Study|Other reason|0|||
170777282|NCT01143337|617190301|FG002|Overall Study|Other reason|5|||
170777283|NCT01466192|617190302|FG000|Overall Study|Physician Decision|1|||
170777284|NCT01466192|617190302|FG000|Overall Study|Withdrawal by Subject|3|||
170777285|NCT00591214|617190305|FG000|Overall Study|Physician Decision|7|||
170777286|NCT00591214|617190305|FG000|Overall Study|Withdrawal by Subject|1|||
170777287|NCT01251354|617190307|FG000|Overall Study|Adverse Event|1|||
170777288|NCT01251354|617190307|FG000|Overall Study|Investigator's Decision|1|||
170777289|NCT01251354|617190307|FG000|Overall Study|Disease Progression|4|||
170777290|NCT03481660|617192048|FG000|Overall Study|Adverse Event|5|||
170777291|NCT03481660|617192049|FG001|Overall Study|Adverse Event|4|||
170777292|NCT03481660|617192048|FG000|Overall Study|Death|13|||
170777293|NCT03481660|617192049|FG001|Overall Study|Death|9|||
170777294|NCT03481660|617192048|FG000|Overall Study|Lost to Follow-up|2|||
170777295|NCT03481660|617192049|FG001|Overall Study|Lost to Follow-up|2|||
170777296|NCT03481660|617192048|FG000|Overall Study|Physician Decision|2|||
170777297|NCT03481660|617192049|FG001|Overall Study|Physician Decision|3|||
170777298|NCT03481660|617192048|FG000|Overall Study|Withdrawal by Subject|14|||
170777299|NCT03481660|617192049|FG001|Overall Study|Withdrawal by Subject|7|||
170777300|NCT04310735|617192050|FG000|Overall Study|Withdrawal by Subject|1|||
170777301|NCT04310735|617192051|FG001|Overall Study|Withdrawal by Subject|3|||
170877407|NCT03116698|617562201|FG002|Overall Study|Withdrawal by Subject|5|||
170877408|NCT03116698|617562202|FG003|Overall Study|Withdrawal by Subject|2|||
170877409|NCT03116698|617562199|FG000|Overall Study|Lost to Follow-up|2|||
170877410|NCT03116698|617562200|FG001|Overall Study|Lost to Follow-up|0|||
170877411|NCT03116698|617562201|FG002|Overall Study|Lost to Follow-up|0|||
170877412|NCT03116698|617562202|FG003|Overall Study|Lost to Follow-up|0|||
170877413|NCT03116698|617562199|FG000|Overall Study|Physician Decision|1|||
170877414|NCT03116698|617562200|FG001|Overall Study|Physician Decision|1|||
170877415|NCT03116698|617562201|FG002|Overall Study|Physician Decision|0|||
170877416|NCT03116698|617562202|FG003|Overall Study|Physician Decision|0|||
170877417|NCT03116698|617562199|FG000|Overall Study|Protocol Violation|1|||
170877418|NCT03116698|617562200|FG001|Overall Study|Protocol Violation|0|||
170877419|NCT03116698|617562201|FG002|Overall Study|Protocol Violation|0|||
170877420|NCT03116698|617562202|FG003|Overall Study|Protocol Violation|0|||
170877421|NCT03116698|617562199|FG000|Overall Study|Death|0|||
170877422|NCT03116698|617562200|FG001|Overall Study|Death|0|||
170877423|NCT03116698|617562201|FG002|Overall Study|Death|2|||
170877424|NCT03116698|617562202|FG003|Overall Study|Death|0|||
170877425|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
170877426|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
170877427|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
170877428|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
170877429|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
170416948|NCT02581345|615867509|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
170416949|NCT02581345|615867510|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
170416950|NCT02581345|615867507|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
170416951|NCT02581345|615867508|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
170416952|NCT02581345|615867509|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
170416953|NCT02581345|615867510|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
170416954|NCT02581345|615867507|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
170416955|NCT02581345|615867508|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
170416956|NCT02581345|615867509|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
170416957|NCT02581345|615867510|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
170416958|NCT02581345|615867507|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
170416959|NCT02581345|615867508|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
170416960|NCT02581345|615867509|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
170416961|NCT02581345|615867510|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
170416962|NCT02581345|615867507|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
170416963|NCT02581345|615867508|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
170416964|NCT02581345|615867509|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
170416965|NCT02581345|615867510|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
170416966|NCT01768858|615867511|FG000|Overall Study|Lost to Follow-up|9|||
170416967|NCT01768858|615867511|FG000|Overall Study|Lack of Efficacy|8|||
170416968|NCT01768858|615867511|FG000|Overall Study|Serious Adverse Event|1|||
170416969|NCT01768858|615867511|FG000|Overall Study|Participant moved to Germany|1|||
170416970|NCT01768858|615867511|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
170416971|NCT01768858|615867511|FG000|Overall Study|Exanthema|1|||
170777302|NCT04310735|617192052|FG002|Overall Study|Withdrawal by Subject|8|||
170777303|NCT04310735|617192050|FG000|Overall Study|Equipment malfunction|0|||
170777304|NCT04310735|617192051|FG001|Overall Study|Equipment malfunction|1|||
170777305|NCT04310735|617192052|FG002|Overall Study|Equipment malfunction|0|||
170777306|NCT03012841|617192053|FG000|Overall Study|Protocol Violation|0|||
170777307|NCT03012841|617192054|FG001|Overall Study|Protocol Violation|10|||
170777308|NCT03012841|617192053|FG000|Overall Study|Lost to Follow-up|6|||
170777309|NCT03012841|617192054|FG001|Overall Study|Lost to Follow-up|1|||
170777310|NCT03012841|617192053|FG000|Overall Study|Withdrawal by Subject|6|||
170777311|NCT03012841|617192054|FG001|Overall Study|Withdrawal by Subject|0|||
170777312|NCT03012841|617192053|FG000|Overall Study|Unable to complete 12 month visit|6|||
170777313|NCT03012841|617192054|FG001|Overall Study|Unable to complete 12 month visit|0|||
170777314|NCT03012841|617192053|FG000|Overall Study|Subject relocation|1|||
170777315|NCT03012841|617192054|FG001|Overall Study|Subject relocation|0|||
170777316|NCT03012841|617192053|FG000|Overall Study|Seasonal winter travel|1|||
170777317|NCT03012841|617192054|FG001|Overall Study|Seasonal winter travel|0|||
170777318|NCT03012841|617192053|FG000|Overall Study|Physician Decision|0|||
170777319|NCT03012841|617192054|FG001|Overall Study|Physician Decision|2|||
170777320|NCT03012841|617192053|FG000|Overall Study|No ablation performed|0|||
170777321|NCT03012841|617192054|FG001|Overall Study|No ablation performed|2|||
170777322|NCT03012841|617192053|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
170777323|NCT03012841|617192054|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
170777324|NCT03012841|617192053|FG000|Overall Study|Insurance change|0|||
170777325|NCT03012841|617192054|FG001|Overall Study|Insurance change|1|||
170777326|NCT05696080|617192055|FG000|Overall Study|Lost to Follow-up|2|||
170877430|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
170877431|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
170877432|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
170877433|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to death|4|||
170877434|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to death|3|||
170416972|NCT01768858|615867511|FG000|Overall Study|Withdrawal by Subject|1|||
170416973|NCT03480425|615867513|FG000|Overall Study|Force transducer technical failure|1|||
170416974|NCT02924038|615867516|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
170416975|NCT02924038|615867517|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
170416976|NCT02395822|615867518|FG000|Overall Study|Withdrawal by Subject|1|||
170416977|NCT02395822|615867518|FG000|Overall Study|Death|1|||
170416978|NCT03292653|615867520|FG000|Overall Study|Adverse Event|0|||
170416979|NCT03292653|615867521|FG001|Overall Study|Adverse Event|0|||
170416980|NCT03292653|615867522|FG002|Overall Study|Adverse Event|1|||
170416981|NCT03292653|615867520|FG000|Overall Study|Did not Receive Treatment|1|||
170416982|NCT03292653|615867521|FG001|Overall Study|Did not Receive Treatment|0|||
170416983|NCT03292653|615867522|FG002|Overall Study|Did not Receive Treatment|0|||
170416984|NCT04720664|615867523|FG000|Overall Study|Adverse Event|2|||
170416985|NCT04720664|615867523|FG000|Overall Study|Lack of Efficacy|9|||
170416986|NCT01290263|615867525|FG000|Overall Study|Adverse Event|0|||
170416987|NCT01290263|615867526|FG001|Overall Study|Adverse Event|0|||
170416988|NCT01290263|615867527|FG002|Overall Study|Adverse Event|0|||
170416989|NCT01290263|615867528|FG003|Overall Study|Adverse Event|1|||
170416990|NCT01290263|615867529|FG004|Overall Study|Adverse Event|1|||
170416991|NCT01290263|615867525|FG000|Overall Study|Lack of Efficacy|8|||
170416992|NCT01290263|615867526|FG001|Overall Study|Lack of Efficacy|2|||
170416993|NCT01290263|615867527|FG002|Overall Study|Lack of Efficacy|7|||
170416994|NCT01290263|615867528|FG003|Overall Study|Lack of Efficacy|24|||
170416995|NCT01290263|615867529|FG004|Overall Study|Lack of Efficacy|33|||
170416996|NCT01290263|615867525|FG000|Overall Study|Withdrawal by Subject|3|||
170416997|NCT01290263|615867526|FG001|Overall Study|Withdrawal by Subject|1|||
170416998|NCT01290263|615867527|FG002|Overall Study|Withdrawal by Subject|0|||
170416999|NCT01290263|615867528|FG003|Overall Study|Withdrawal by Subject|1|||
170417000|NCT01290263|615867529|FG004|Overall Study|Withdrawal by Subject|2|||
170417001|NCT01290263|615867525|FG000|Overall Study|Participant Non-Compliance|0|||
170417002|NCT01290263|615867526|FG001|Overall Study|Participant Non-Compliance|0|||
170417003|NCT01290263|615867527|FG002|Overall Study|Participant Non-Compliance|0|||
170417004|NCT01290263|615867528|FG003|Overall Study|Participant Non-Compliance|1|||
170417005|NCT01290263|615867529|FG004|Overall Study|Participant Non-Compliance|1|||
170417006|NCT00502775|615867530|FG000|Overall Study|Adverse Event|1|||
170417007|NCT00502775|615867531|FG001|Overall Study|Adverse Event|2|||
170417008|NCT00502775|615867532|FG002|Overall Study|Adverse Event|1|||
170417009|NCT00502775|615867530|FG000|Overall Study|Protocol Violation|1|||
170417010|NCT00502775|615867531|FG001|Overall Study|Protocol Violation|5|||
170417011|NCT00502775|615867532|FG002|Overall Study|Protocol Violation|2|||
170417012|NCT00502775|615867530|FG000|Overall Study|Withdrawal by Subject|1|||
170417013|NCT00502775|615867531|FG001|Overall Study|Withdrawal by Subject|1|||
170417014|NCT00502775|615867532|FG002|Overall Study|Withdrawal by Subject|2|||
170417015|NCT00502775|615867530|FG000|Overall Study|Sponsor Terminated Study|1|||
170417016|NCT00502775|615867531|FG001|Overall Study|Sponsor Terminated Study|0|||
170417017|NCT00502775|615867532|FG002|Overall Study|Sponsor Terminated Study|1|||
170417018|NCT00502775|615867530|FG000|Overall Study|Non-compliance with eDiary|4|||
170417019|NCT00502775|615867531|FG001|Overall Study|Non-compliance with eDiary|1|||
170417020|NCT00502775|615867532|FG002|Overall Study|Non-compliance with eDiary|1|||
170417021|NCT00502775|615867530|FG000|Overall Study|Subject unable to swallow capsule|1|||
170417022|NCT00502775|615867531|FG001|Overall Study|Subject unable to swallow capsule|0|||
170417023|NCT00502775|615867532|FG002|Overall Study|Subject unable to swallow capsule|1|||
170417024|NCT00502775|615867530|FG000|Overall Study|Logpad compliance <80%|1|||
170417025|NCT00502775|615867531|FG001|Overall Study|Logpad compliance <80%|0|||
170417026|NCT00502775|615867532|FG002|Overall Study|Logpad compliance <80%|0|||
170417027|NCT00502775|615867530|FG000|Overall Study|Randomized in error|0|||
170417028|NCT00502775|615867531|FG001|Overall Study|Randomized in error|1|||
170417029|NCT00502775|615867532|FG002|Overall Study|Randomized in error|1|||
170417030|NCT00502775|615867530|FG000|Overall Study|Non-compliance|0|||
170417031|NCT00502775|615867531|FG001|Overall Study|Non-compliance|2|||
170417032|NCT00502775|615867532|FG002|Overall Study|Non-compliance|2|||
170417033|NCT00502775|615867530|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
170417034|NCT00502775|615867531|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
170417035|NCT00502775|615867532|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
170529259|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
170417036|NCT00502775|615867530|FG000|Overall Study|Declining pollen counts|0|||
170417037|NCT00502775|615867531|FG001|Overall Study|Declining pollen counts|1|||
170417038|NCT00502775|615867532|FG002|Overall Study|Declining pollen counts|1|||
170877435|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
170417039|NCT00502775|615867530|FG000|Overall Study|Subject in jail|0|||
170417040|NCT00502775|615867531|FG001|Overall Study|Subject in jail|1|||
170417041|NCT00502775|615867532|FG002|Overall Study|Subject in jail|0|||
170417042|NCT00502775|615867530|FG000|Overall Study|Subject took disallowed drug|0|||
170417043|NCT00502775|615867531|FG001|Overall Study|Subject took disallowed drug|0|||
170417044|NCT00502775|615867532|FG002|Overall Study|Subject took disallowed drug|1|||
170417045|NCT02016300|615867535|FG000|Overall Study|Lost to Follow-up|0|||
170417046|NCT02016300|615867536|FG001|Overall Study|Lost to Follow-up|3|||
170417047|NCT06165744|615867541|FG000|Overall Study|Non device-related adverse event|1|||
170417048|NCT02132247|615867542|FG000|Overall Study|Protocol Violation|1|||
170417049|NCT02132247|615867543|FG001|Overall Study|Protocol Violation|0|||
170417050|NCT00436007|615867548|FG000|Overall Study|Withdrawal by Subject|5|||
170417051|NCT00436007|615867549|FG001|Overall Study|Withdrawal by Subject|3|||
170417052|NCT00436007|615867550|FG002|Overall Study|Withdrawal by Subject|4|||
170417053|NCT00436007|615867548|FG000|Overall Study|Lost to Follow-up|14|||
170417054|NCT00436007|615867549|FG001|Overall Study|Lost to Follow-up|10|||
170417055|NCT00436007|615867550|FG002|Overall Study|Lost to Follow-up|13|||
170417056|NCT00436007|615867548|FG000|Overall Study|Physician Decision|0|||
170417057|NCT00436007|615867549|FG001|Overall Study|Physician Decision|0|||
170417058|NCT00436007|615867550|FG002|Overall Study|Physician Decision|2|||
170417059|NCT00436007|615867548|FG000|Overall Study|Death|0|||
170417060|NCT00436007|615867549|FG001|Overall Study|Death|1|||
170417061|NCT00436007|615867550|FG002|Overall Study|Death|3|||
170417062|NCT00436007|615867548|FG000|Overall Study|Other|0|||
170417063|NCT00436007|615867549|FG001|Overall Study|Other|0|||
170417064|NCT00436007|615867550|FG002|Overall Study|Other|1|||
170417065|NCT02374918|615867551|FG000|Overall Study|Protocol Violation|2|||
170417066|NCT02374918|615867552|FG001|Overall Study|Protocol Violation|0|||
170417067|NCT02374918|615867553|FG002|Overall Study|Protocol Violation|2|||
170417068|NCT02374918|615867554|FG003|Overall Study|Protocol Violation|1|||
170417069|NCT02374918|615867551|FG000|Overall Study|Withdrawal by Subject|1|||
170417070|NCT02374918|615867552|FG001|Overall Study|Withdrawal by Subject|1|||
170417071|NCT02374918|615867553|FG002|Overall Study|Withdrawal by Subject|1|||
170417072|NCT02374918|615867554|FG003|Overall Study|Withdrawal by Subject|0|||
170417073|NCT02374918|615867551|FG000|Overall Study|Lack of Efficacy|0|||
170417074|NCT02374918|615867552|FG001|Overall Study|Lack of Efficacy|0|||
170417075|NCT02374918|615867553|FG002|Overall Study|Lack of Efficacy|1|||
170417076|NCT02374918|615867554|FG003|Overall Study|Lack of Efficacy|1|||
170417077|NCT02433678|615867558|FG000|Overall Study|Lost to Follow-up|1|||
170417078|NCT02433678|615867559|FG001|Overall Study|Lost to Follow-up|2|||
170417079|NCT01506947|615867560|FG000|Overall Study|Lost to Follow-up|7|||
170417080|NCT01506947|615867560|FG000|Overall Study|Adverse Event|5|||
170417081|NCT01506947|615867560|FG000|Overall Study|Death|1|||
170417082|NCT01506947|615867560|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
170417083|NCT03803943|615867563|FG000|Overall Study|Withdrawal by Subject|2|||
170529260|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
170877436|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
170877437|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
170877438|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
170877439|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
170877440|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
170877441|NCT02258451|617562203|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
170877442|NCT02258451|617562204|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
170877443|NCT02258451|617562203|FG000|Overall Study|Other reason|1|||
170877444|NCT02258451|617562204|FG001|Overall Study|Other reason|1|||
170877445|NCT02258451|617562203|FG000|Overall Study|Never treated|2|||
170877446|NCT02258451|617562204|FG001|Overall Study|Never treated|3|||
170877447|NCT04490018|617562210|FG000|Overall Study|Protocol Violation|0|||
170877448|NCT04490018|617562211|FG001|Overall Study|Protocol Violation|2|||
170877449|NCT04490018|617562212|FG002|Overall Study|Protocol Violation|1|||
170877450|NCT04490018|617562210|FG000|Overall Study|Lost to Follow-up|2|||
170417084|NCT03803943|615867564|FG001|Overall Study|Withdrawal by Subject|2|||
170417085|NCT03803943|615867565|FG002|Overall Study|Withdrawal by Subject|2|||
170417086|NCT03803943|615867566|FG003|Overall Study|Withdrawal by Subject|2|||
170417087|NCT00818883|615867567|FG000|Overall Study|Adverse Event|28|||
170417088|NCT00818883|615867568|FG001|Overall Study|Adverse Event|19|||
170417089|NCT00818883|615867567|FG000|Overall Study|Protocol Violation|2|||
170417090|NCT00818883|615867568|FG001|Overall Study|Protocol Violation|2|||
170417091|NCT00818883|615867567|FG000|Overall Study|Lost to Follow-up|3|||
170417092|NCT00818883|615867568|FG001|Overall Study|Lost to Follow-up|2|||
170417093|NCT00818883|615867567|FG000|Overall Study|Withdrawal by Subject|16|||
170417094|NCT00818883|615867568|FG001|Overall Study|Withdrawal by Subject|14|||
170417095|NCT00818883|615867567|FG000|Overall Study|Lack of Efficacy|0|||
170632613|NCT01352793|616666716|FG001|Overall Study|Protocol Violation|23|||
170417096|NCT00818883|615867568|FG001|Overall Study|Lack of Efficacy|2|||
170529261|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
170529262|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
170529263|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
170529264|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
170529265|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
170529266|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
170529267|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
170529268|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
170529269|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
170529270|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
170529271|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
170529272|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
170529273|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
170529274|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
170529275|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
170529276|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
170529277|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
170529278|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
170529279|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
170529280|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
170529281|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
170529282|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
170529283|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
170529284|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
170529285|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
170529286|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
170529287|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
170529288|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
170529289|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
170529290|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
170529291|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
170529292|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
170529293|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
170529294|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
170632614|NCT01352793|616666715|FG000|Overall Study|Adverse Event|44|||
170777327|NCT05696080|617192056|FG001|Overall Study|Lost to Follow-up|1|||
170777328|NCT05696080|617192055|FG000|Overall Study|Physician Decision|1|||
170777329|NCT05696080|617192056|FG001|Overall Study|Physician Decision|0|||
170777330|NCT05696080|617192055|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170777331|NCT05696080|617192056|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170777332|NCT05696080|617192055|FG000|Overall Study|Withdrawal by Subject|12|||
170777333|NCT05696080|617192056|FG001|Overall Study|Withdrawal by Subject|0|||
170777334|NCT03954184|617192057|FG000|Overall Study|Lost to Follow-up|500|||
170777335|NCT03954184|617192058|FG001|Overall Study|Lost to Follow-up|0|||
170777336|NCT03398200|617192059|FG000|Overall Study|Withdrawal by Subject|0|||
170777337|NCT03398200|617192060|FG001|Overall Study|Withdrawal by Subject|1|||
170777338|NCT04065048|617192061|FG000|Overall Study|Withdrawal by Subject|1|||
170777339|NCT04065048|617192062|FG001|Overall Study|Withdrawal by Subject|2|||
170777340|NCT04065048|617192063|FG002|Overall Study|Withdrawal by Subject|1|||
170777341|NCT04065048|617192064|FG003|Overall Study|Withdrawal by Subject|1|||
170777342|NCT04065048|617192061|FG000|Overall Study|Adverse Event|1|||
170777343|NCT04065048|617192062|FG001|Overall Study|Adverse Event|0|||
170777344|NCT04065048|617192063|FG002|Overall Study|Adverse Event|1|||
170777345|NCT04065048|617192064|FG003|Overall Study|Adverse Event|0|||
170777346|NCT03397108|617192065|FG000|Overall Study|Lost to Follow-up|15|||
170777347|NCT03397108|617192066|FG001|Overall Study|Lost to Follow-up|0|||
170777348|NCT03397108|617192065|FG000|Overall Study|Insufficient milk production|3|||
170777349|NCT03397108|617192066|FG001|Overall Study|Insufficient milk production|2|||
170777350|NCT03397108|617192065|FG000|Overall Study|Withdrawal by Subject|2|||
170777351|NCT03397108|617192066|FG001|Overall Study|Withdrawal by Subject|0|||
170777352|NCT05096819|617192069|FG000|Overall Study|Withdrawal by Subject|3|||
170777353|NCT05096819|617192070|FG001|Overall Study|Withdrawal by Subject|0|||
170777354|NCT05307978|617192071|FG000|Overall Study|Lost to Follow-up|0|||
170777355|NCT05307978|617192072|FG001|Overall Study|Lost to Follow-up|1|||
170777356|NCT05307978|617192073|FG002|Overall Study|Lost to Follow-up|0|||
170777357|NCT05307978|617192074|FG003|Overall Study|Lost to Follow-up|4|||
170777358|NCT05307978|617192075|FG004|Overall Study|Lost to Follow-up|0|||
170777359|NCT05307978|617192076|FG005|Overall Study|Lost to Follow-up|0|||
170417097|NCT00818883|615867567|FG000|Overall Study|Other|2|||
170417098|NCT00818883|615867568|FG001|Overall Study|Other|7|||
170417099|NCT01505530|615867569|FG000|Overall Study|Progressive Disease|19|||
170417100|NCT01505530|615867570|FG001|Overall Study|Progressive Disease|17|||
170417101|NCT01505530|615867571|FG002|Overall Study|Progressive Disease|18|||
170417102|NCT01505530|615867569|FG000|Overall Study|Adverse Event|1|||
170417103|NCT01505530|615867570|FG001|Overall Study|Adverse Event|1|||
170417104|NCT01505530|615867571|FG002|Overall Study|Adverse Event|0|||
170417105|NCT01505530|615867569|FG000|Overall Study|Withdrawal by Subject|7|||
170417106|NCT01505530|615867570|FG001|Overall Study|Withdrawal by Subject|8|||
170417107|NCT01505530|615867571|FG002|Overall Study|Withdrawal by Subject|6|||
170417108|NCT01505530|615867569|FG000|Overall Study|Physician Decision|6|||
170417109|NCT01505530|615867570|FG001|Overall Study|Physician Decision|2|||
170417110|NCT01505530|615867571|FG002|Overall Study|Physician Decision|5|||
170417111|NCT01505530|615867569|FG000|Overall Study|Sponsor Decision|1|||
170417112|NCT01505530|615867570|FG001|Overall Study|Sponsor Decision|8|||
170777360|NCT05307978|617192077|FG006|Overall Study|Lost to Follow-up|1|||
170777361|NCT03324984|617192078|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
170777362|NCT03324984|617192079|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
170777363|NCT04607044|617192080|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
170777364|NCT04607044|617192080|FG000|Overall Study|Adverse Event|1|||
170777365|NCT04607044|617192080|FG000|Overall Study|Did not receive study device|3|||
170777366|NCT04607044|617192080|FG000|Overall Study|Death|1|||
170777367|NCT05403801|617192081|FG000|Overall Study|Withdrawal by Subject|2|||
170777368|NCT04527146|617192082|FG000|Overall Study|Withdrawal by Subject|12|||
170777369|NCT04527146|617192083|FG001|Overall Study|Withdrawal by Subject|15|||
170777370|NCT04527146|617192084|FG002|Overall Study|Withdrawal by Subject|7|||
170777371|NCT04527146|617192085|FG003|Overall Study|Withdrawal by Subject|16|||
170777372|NCT04527146|617192082|FG000|Overall Study|Lost to Follow-up|13|||
170777373|NCT04527146|617192083|FG001|Overall Study|Lost to Follow-up|9|||
170777374|NCT04527146|617192084|FG002|Overall Study|Lost to Follow-up|16|||
170777375|NCT04527146|617192085|FG003|Overall Study|Lost to Follow-up|13|||
170777376|NCT04527146|617192082|FG000|Overall Study|Death|0|||
170777377|NCT04527146|617192083|FG001|Overall Study|Death|1|||
170777378|NCT04527146|617192084|FG002|Overall Study|Death|1|||
170777379|NCT04527146|617192085|FG003|Overall Study|Death|0|||
170777380|NCT04527146|617192082|FG000|Overall Study|Adverse Event|0|||
170777381|NCT04527146|617192083|FG001|Overall Study|Adverse Event|0|||
170777382|NCT04527146|617192084|FG002|Overall Study|Adverse Event|1|||
170777383|NCT04527146|617192085|FG003|Overall Study|Adverse Event|0|||
170777384|NCT04527146|617192082|FG000|Overall Study|Ineligible after randomization|2|||
170777385|NCT04527146|617192083|FG001|Overall Study|Ineligible after randomization|0|||
170777386|NCT04527146|617192084|FG002|Overall Study|Ineligible after randomization|2|||
170777387|NCT04527146|617192085|FG003|Overall Study|Ineligible after randomization|2|||
170777388|NCT04527146|617192082|FG000|Overall Study|Moved to a different group|6|||
170777389|NCT04527146|617192083|FG001|Overall Study|Moved to a different group|3|||
170777390|NCT04527146|617192084|FG002|Overall Study|Moved to a different group|0|||
170777391|NCT04527146|617192085|FG003|Overall Study|Moved to a different group|2|||
170777392|NCT05510232|617192086|FG000|Overall Study|Withdrawal by Subject|2|||
170777393|NCT05510232|617192087|FG001|Overall Study|Withdrawal by Subject|7|||
170777394|NCT05510232|617192088|FG002|Overall Study|Withdrawal by Subject|6|||
170777395|NCT04883645|617192098|FG000|Overall Study|Death|1|||
170777396|NCT06194214|617192100|FG000|Overall Study|Adverse Event|1|||
170777397|NCT06375421|617192101|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
170777398|NCT06375421|617192102|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
170777399|NCT06375421|617192103|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
170777400|NCT06375421|617192104|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
170777401|NCT05136404|617192105|FG000|Period 1|Adverse Event|0|||
170777402|NCT05136404|617192106|FG001|Period 1|Adverse Event|1|||
170777403|NCT05136404|617192107|FG002|Period 1|Adverse Event|1|||
170777404|NCT05136404|617192105|FG000|Period 2|Inappropriate Behavior|0|||
170777405|NCT05136404|617192106|FG001|Period 2|Inappropriate Behavior|0|||
170777406|NCT05136404|617192107|FG002|Period 2|Inappropriate Behavior|1|||
170777407|NCT05136404|617192105|FG000|Period 3|Adverse Event|0|||
170777408|NCT05136404|617192106|FG001|Period 3|Adverse Event|0|||
170777409|NCT05136404|617192107|FG002|Period 3|Adverse Event|1|||
170777410|NCT05986565|617192108|FG000|Overall Study|Lost to Follow-up|8|||
170777411|NCT05986565|617192109|FG001|Overall Study|Lost to Follow-up|3|||
170777412|NCT05986565|617192108|FG000|Overall Study|Withdrawal by Subject|0|||
170777413|NCT05986565|617192109|FG001|Overall Study|Withdrawal by Subject|1|||
170777414|NCT01854385|617192111|FG000|Pre-Treatment|Withdrawal by Subject|4|||
170777415|NCT01854385|617192111|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
170777416|NCT01854385|617192111|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
170777417|NCT01854385|617192111|FG000|Pre-Treatment|Unable to come for study visits|1|||
170777418|NCT01854385|617192111|FG000|Treatment|Lost to Follow-up|1|||
170777419|NCT00415519|617192112|FG000|Overall Study|Adverse Event|1|||
170777420|NCT00415519|617192113|FG001|Overall Study|Adverse Event|0|||
170877451|NCT04490018|617562211|FG001|Overall Study|Lost to Follow-up|2|||
170529295|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
170529296|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
170529297|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
170529298|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
170529299|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
170529300|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
170529301|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
170529302|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
170529303|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
170529304|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
170529305|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
170529306|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
170529307|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
170529308|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
170529309|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
170529310|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
170529311|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
170529312|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
170529313|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
170529314|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
170529315|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
170529316|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
170529317|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
170529318|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
170529319|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
170529320|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
170529321|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
170529322|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
170529323|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
170529324|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
170529325|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
170529326|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
170529327|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
170529328|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
170529329|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
170529330|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
170529331|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
170529332|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
170529333|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
170529334|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
170529335|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
170529336|NCT02717195|616287080|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
170529337|NCT02717195|616287081|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
170529338|NCT02717195|616287082|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
170529339|NCT02717195|616287083|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
170529340|NCT02717195|616287084|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
170529341|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
170529342|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
170529343|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
170529344|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
170529345|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
170529346|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
170529347|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
170877452|NCT04490018|617562212|FG002|Overall Study|Lost to Follow-up|0|||
170529348|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
170529349|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
170529350|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
170529351|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
170529352|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
170529353|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
170529354|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
170529355|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
170529356|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
170529357|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
170529358|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
170529359|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
170529360|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
170529361|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
170529362|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
170777421|NCT00415519|617192112|FG000|Overall Study|Withdrawal by Subject|2|||
170777422|NCT00415519|617192113|FG001|Overall Study|Withdrawal by Subject|0|||
170777423|NCT00415519|617192112|FG000|Overall Study|Patient's convenience|1|||
170777424|NCT00415519|617192113|FG001|Overall Study|Patient's convenience|0|||
170777425|NCT04163718|617192114|FG000|Overall Study|Study terminated|12|||
170777426|NCT02462759|617192118|FG000|Part 1: Double Blind|Death|1|||
170777427|NCT02462759|617192119|FG001|Part 1: Double Blind|Death|0|||
170777428|NCT02462759|617192120|FG002|Part 1: Double Blind|Death|0|||
170777429|NCT04704284|617192127|FG000|Overall Study|Withdrawal by Subject|1|||
170777430|NCT02252172|617192130|FG000|Overall Study|Lost to Follow-up|9|||
170777431|NCT02252172|617192131|FG001|Overall Study|Lost to Follow-up|6|||
170777432|NCT02252172|617192130|FG000|Overall Study|Death|218|||
170777433|NCT02252172|617192131|FG001|Overall Study|Death|175|||
170777434|NCT02252172|617192130|FG000|Overall Study|Withdrawal by Subject|20|||
170777435|NCT02252172|617192131|FG001|Overall Study|Withdrawal by Subject|15|||
170777436|NCT02252172|617192130|FG000|Overall Study|Physician Decision|0|||
170777437|NCT02252172|617192131|FG001|Overall Study|Physician Decision|1|||
170777438|NCT02252172|617192130|FG000|Overall Study|End of data collection|122|||
170777439|NCT02252172|617192131|FG001|Overall Study|End of data collection|170|||
170777440|NCT02252172|617192130|FG000|Overall Study|Site closure|0|||
170777441|NCT02252172|617192131|FG001|Overall Study|Site closure|1|||
170777442|NCT05575076|617192132|FG000|Overall Study|Adverse Event|24|||
170777443|NCT05575076|617192132|FG000|Overall Study|Death|7|||
170777444|NCT05575076|617192132|FG000|Overall Study|Lost to Follow-up|16|||
170777445|NCT05575076|617192132|FG000|Overall Study|Non-Compliance|3|||
170777446|NCT05575076|617192132|FG000|Overall Study|Physician Decision|6|||
170777447|NCT05575076|617192132|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
170777448|NCT05575076|617192132|FG000|Overall Study|Withdrawal by Subject|71|||
170777449|NCT05575076|617192132|FG000|Overall Study|Study Terminated by Sponsor|630|||
170777450|NCT05575076|617192132|FG000|Overall Study|Other|17|||
170777451|NCT03447249|617192144|FG000|Overall Study|Adverse Event|1|||
170777452|NCT03447249|617192145|FG001|Overall Study|Adverse Event|0|||
170777453|NCT03447249|617192144|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
170777454|NCT03447249|617192145|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
170777455|NCT03447249|617192144|FG000|Overall Study|Other|3|||
170777456|NCT03447249|617192145|FG001|Overall Study|Other|0|||
170777457|NCT01248936|617192146|FG000|Overall Study|Sponsor Decision|259|||
170777458|NCT01248936|617192146|FG000|Overall Study|Progression of Disease|50|||
170777459|NCT01248936|617192146|FG000|Overall Study|Death|26|||
170777460|NCT01248936|617192146|FG000|Overall Study|Withdrawal of Consent|20|||
170777461|NCT01248936|617192146|FG000|Overall Study|Adverse Event|8|||
170777462|NCT01248936|617192146|FG000|Overall Study|Lost to Follow-up|7|||
170777463|NCT01248936|617192146|FG000|Overall Study|Refused Treatment|1|||
170777464|NCT01248936|617192146|FG000|Overall Study|Other reason|3|||
170777465|NCT01426412|617192147|FG000|Overall Study|Withdrawal by Subject|1|||
170777466|NCT01426412|617192148|FG001|Overall Study|Withdrawal by Subject|0|||
170777467|NCT01426412|617192149|FG002|Overall Study|Withdrawal by Subject|0|||
170777468|NCT01426412|617192150|FG003|Overall Study|Withdrawal by Subject|0|||
170777469|NCT01426412|617192151|FG004|Overall Study|Withdrawal by Subject|1|||
170777470|NCT01426412|617192152|FG005|Overall Study|Withdrawal by Subject|0|||
170777471|NCT01426412|617192153|FG006|Overall Study|Withdrawal by Subject|0|||
170777472|NCT01426412|617192154|FG007|Overall Study|Withdrawal by Subject|3|||
170777473|NCT01426412|617192155|FG008|Overall Study|Withdrawal by Subject|1|||
170777474|NCT02376790|617192156|FG000|Overall Study|Withdrawal by Subject|43|||
170777475|NCT02376790|617192157|FG001|Overall Study|Withdrawal by Subject|36|||
170777476|NCT02376790|617192158|FG002|Overall Study|Withdrawal by Subject|37|||
170777477|NCT02376790|617192156|FG000|Overall Study|Decision by Sponsor|2|||
170632615|NCT01352793|616666716|FG001|Overall Study|Adverse Event|10|||
170777478|NCT02376790|617192157|FG001|Overall Study|Decision by Sponsor|1|||
170777479|NCT02376790|617192158|FG002|Overall Study|Decision by Sponsor|4|||
170777480|NCT02376790|617192156|FG000|Overall Study|Lost to Follow-up|15|||
170777481|NCT02376790|617192157|FG001|Overall Study|Lost to Follow-up|10|||
170777482|NCT02376790|617192158|FG002|Overall Study|Lost to Follow-up|12|||
170777483|NCT00988858|617192159|FG000|Overall Study|Adverse Event|7|||
170777484|NCT00988858|617192159|FG000|Overall Study|Death|1|||
170777485|NCT00988858|617192159|FG000|Overall Study|Physician Decision|1|||
170777486|NCT00988858|617192159|FG000|Overall Study|Sponsor Decision|1|||
170777487|NCT03930420|617192160|FG000|Overall Study|Withdrawal by Subject|7|||
170777488|NCT03930420|617192161|FG001|Overall Study|Withdrawal by Subject|9|||
170777489|NCT00609336|617192162|FG000|Overall Study|Protocol Violation|3|||
170877453|NCT04490018|617562210|FG000|Overall Study|Withdrawal by Subject|2|||
170877454|NCT04490018|617562211|FG001|Overall Study|Withdrawal by Subject|1|||
170877455|NCT04490018|617562212|FG002|Overall Study|Withdrawal by Subject|0|||
170417113|NCT01505530|615867571|FG002|Overall Study|Sponsor Decision|7|||
170417114|NCT01505530|615867569|FG000|Overall Study|Death|7|||
170417115|NCT01505530|615867570|FG001|Overall Study|Death|6|||
170417116|NCT01505530|615867571|FG002|Overall Study|Death|5|||
170417117|NCT01505530|615867569|FG000|Overall Study|entry criteria not met|0|||
170417118|NCT01505530|615867570|FG001|Overall Study|entry criteria not met|1|||
170417119|NCT01505530|615867571|FG002|Overall Study|entry criteria not met|0|||
170417120|NCT00973700|615867572|FG000|Overall Study|Withdrawal by Subject|2|||
170417121|NCT00973700|615867573|FG001|Overall Study|Withdrawal by Subject|2|||
170417122|NCT00973700|615867574|FG002|Overall Study|Withdrawal by Subject|8|||
170417123|NCT00973700|615867575|FG003|Overall Study|Withdrawal by Subject|4|||
170417124|NCT00973700|615867576|FG004|Overall Study|Withdrawal by Subject|4|||
170417125|NCT00973700|615867572|FG000|Overall Study|Lost to Follow-up|5|||
170417126|NCT00973700|615867573|FG001|Overall Study|Lost to Follow-up|0|||
170417127|NCT00973700|615867574|FG002|Overall Study|Lost to Follow-up|1|||
170417128|NCT00973700|615867575|FG003|Overall Study|Lost to Follow-up|8|||
170417129|NCT00973700|615867576|FG004|Overall Study|Lost to Follow-up|5|||
170417130|NCT00973700|615867572|FG000|Overall Study|Inappropriate enrolment|0|||
170417131|NCT00973700|615867573|FG001|Overall Study|Inappropriate enrolment|0|||
170417132|NCT00973700|615867574|FG002|Overall Study|Inappropriate enrolment|0|||
170417133|NCT00973700|615867575|FG003|Overall Study|Inappropriate enrolment|4|||
170417134|NCT00973700|615867576|FG004|Overall Study|Inappropriate enrolment|0|||
170417135|NCT00973700|615867572|FG000|Overall Study|Unable to Classify|0|||
170417136|NCT00973700|615867573|FG001|Overall Study|Unable to Classify|0|||
170417137|NCT00973700|615867574|FG002|Overall Study|Unable to Classify|1|||
170417138|NCT00973700|615867575|FG003|Overall Study|Unable to Classify|2|||
170417139|NCT00973700|615867576|FG004|Overall Study|Unable to Classify|1|||
170417140|NCT00266409|615867577|FG000|Overall Study|Lack of Efficacy|2|||
170417141|NCT00266409|615867578|FG001|Overall Study|Lack of Efficacy|6|||
170417142|NCT00266409|615867579|FG002|Overall Study|Lack of Efficacy|1|||
170417143|NCT00266409|615867580|FG003|Overall Study|Lack of Efficacy|2|||
170417144|NCT00266409|615867577|FG000|Overall Study|Adverse Event|7|||
170417145|NCT00266409|615867578|FG001|Overall Study|Adverse Event|2|||
170417146|NCT00266409|615867579|FG002|Overall Study|Adverse Event|1|||
170417147|NCT00266409|615867580|FG003|Overall Study|Adverse Event|1|||
170417148|NCT00266409|615867577|FG000|Overall Study|Lost to Follow-up|18|||
170417149|NCT00266409|615867578|FG001|Overall Study|Lost to Follow-up|21|||
170417150|NCT00266409|615867579|FG002|Overall Study|Lost to Follow-up|6|||
170417151|NCT00266409|615867580|FG003|Overall Study|Lost to Follow-up|8|||
170417152|NCT00266409|615867577|FG000|Overall Study|Withdrawal by Subject|6|||
170417153|NCT00266409|615867578|FG001|Overall Study|Withdrawal by Subject|10|||
170417154|NCT00266409|615867579|FG002|Overall Study|Withdrawal by Subject|3|||
170417155|NCT00266409|615867580|FG003|Overall Study|Withdrawal by Subject|9|||
170417156|NCT00266409|615867577|FG000|Overall Study|Protocol Violation|5|||
170417157|NCT00266409|615867578|FG001|Overall Study|Protocol Violation|3|||
170417158|NCT00266409|615867579|FG002|Overall Study|Protocol Violation|4|||
170417159|NCT00266409|615867580|FG003|Overall Study|Protocol Violation|2|||
170417160|NCT00266409|615867577|FG000|Overall Study|Other|7|||
170417161|NCT00266409|615867578|FG001|Overall Study|Other|4|||
170417162|NCT00266409|615867579|FG002|Overall Study|Other|2|||
170417163|NCT00266409|615867580|FG003|Overall Study|Other|0|||
170417164|NCT02796664|615867585|FG000|Overall Study|Withdrawal by Subject|0|||
170417165|NCT02796664|615867586|FG001|Overall Study|Withdrawal by Subject|3|||
170417166|NCT02796664|615867585|FG000|Overall Study|Noncompliance|1|||
170417167|NCT02796664|615867586|FG001|Overall Study|Noncompliance|1|||
170417168|NCT02796664|615867585|FG000|Overall Study|Death|0|||
170417169|NCT02796664|615867586|FG001|Overall Study|Death|1|||
170417170|NCT00865709|615867592|FG000|Treatment|Adverse Event|9|||
170417171|NCT00865709|615867593|FG001|Treatment|Adverse Event|6|||
170417172|NCT00865709|615867592|FG000|Treatment|Withdrawal by Subject|10|||
170417173|NCT00865709|615867593|FG001|Treatment|Withdrawal by Subject|7|||
170417174|NCT00865709|615867592|FG000|Treatment|Physician Decision|3|||
170417175|NCT00865709|615867593|FG001|Treatment|Physician Decision|2|||
170417176|NCT00865709|615867592|FG000|Treatment|Surgery|8|||
170417177|NCT00865709|615867593|FG001|Treatment|Surgery|3|||
170417178|NCT02153736|615867596|FG000|Overall Study|Lost to Follow-up|1|||
170417179|NCT02153736|615867597|FG001|Overall Study|Lost to Follow-up|0|||
170417180|NCT02153736|615867596|FG000|Overall Study|Medical status change made ineligible|1|||
170417181|NCT02153736|615867597|FG001|Overall Study|Medical status change made ineligible|0|||
170417182|NCT02153736|615867596|FG000|Overall Study|Death|0|||
170417183|NCT02153736|615867597|FG001|Overall Study|Death|1|||
170417184|NCT02153736|615867596|FG000|Overall Study|Withdrawal by Subject|0|||
170417185|NCT02153736|615867597|FG001|Overall Study|Withdrawal by Subject|1|||
170417186|NCT05030753|615867600|FG000|9-week|Lost to Follow-up|10|||
170417187|NCT05030753|615867601|FG001|9-week|Lost to Follow-up|7|||
170417188|NCT05030753|615867600|FG000|9-week|Withdrawal by Subject|1|||
170417189|NCT05030753|615867601|FG001|9-week|Withdrawal by Subject|0|||
170529363|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
170529364|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
170529365|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
170529366|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
170529367|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
170529368|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
170529369|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
170529370|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
170529371|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
170529372|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
170529373|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
170529374|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
170632616|NCT01352793|616666715|FG000|Overall Study|Physician Decision|1|||
170777490|NCT00609336|617192162|FG000|Overall Study|Death|1|||
170777491|NCT00609336|617192162|FG000|Overall Study|LA or Met at Surgery|9|||
170777492|NCT00567489|617192163|FG000|Overall Study|Adverse Event|6|||
170777493|NCT00567489|617192164|FG001|Overall Study|Adverse Event|14|||
170777494|NCT00567489|617192163|FG000|Overall Study|Physician Decision|0|||
170777495|NCT00567489|617192164|FG001|Overall Study|Physician Decision|4|||
170777496|NCT00567489|617192163|FG000|Overall Study|Withdrawal by Subject|0|||
170777497|NCT00567489|617192164|FG001|Overall Study|Withdrawal by Subject|2|||
170777498|NCT00567489|617192163|FG000|Overall Study|Renal Transplantation|0|||
170777499|NCT00567489|617192164|FG001|Overall Study|Renal Transplantation|3|||
170777500|NCT00567489|617192163|FG000|Overall Study|Other|1|||
170777501|NCT00567489|617192164|FG001|Overall Study|Other|0|||
170777502|NCT05600283|617192165|FG000|Overall Study|Withdrawal by Subject|3|||
170777503|NCT05600283|617192166|FG001|Overall Study|Withdrawal by Subject|8|||
170777504|NCT05600283|617192165|FG000|Overall Study|Invalid Vaginal Swab|2|||
170777505|NCT05600283|617192166|FG001|Overall Study|Invalid Vaginal Swab|2|||
170777506|NCT05600283|617192165|FG000|Overall Study|Missing Clinician Collection|3|||
170777507|NCT05600283|617192166|FG001|Overall Study|Missing Clinician Collection|6|||
170777508|NCT05600283|617192165|FG000|Overall Study|Screen Failure|1|||
170777509|NCT05600283|617192166|FG001|Overall Study|Screen Failure|2|||
170777510|NCT05600283|617192165|FG000|Overall Study|Sample Lost in Transit|1|||
170777511|NCT05600283|617192166|FG001|Overall Study|Sample Lost in Transit|0|||
170777512|NCT01388361|617192167|FG000|Overall Study|Adverse Event|0|||
170777513|NCT01388361|617192168|FG001|Overall Study|Adverse Event|5|||
170777514|NCT01388361|617192169|FG002|Overall Study|Adverse Event|1|||
170777515|NCT01388361|617192167|FG000|Overall Study|Protocol Violation|0|||
170777516|NCT01388361|617192168|FG001|Overall Study|Protocol Violation|0|||
170777517|NCT01388361|617192169|FG002|Overall Study|Protocol Violation|2|||
170777518|NCT01388361|617192167|FG000|Overall Study|Withdrawal criteria|12|||
170777519|NCT01388361|617192168|FG001|Overall Study|Withdrawal criteria|7|||
170777520|NCT01388361|617192169|FG002|Overall Study|Withdrawal criteria|10|||
170777521|NCT01388361|617192167|FG000|Overall Study|Unclassified|0|||
170777522|NCT01388361|617192168|FG001|Overall Study|Unclassified|0|||
170777523|NCT01388361|617192169|FG002|Overall Study|Unclassified|1|||
170777524|NCT01061671|617192170|FG000|Overall Study|Withdrawal by Subject|16|||
170777525|NCT01061671|617192171|FG001|Overall Study|Withdrawal by Subject|20|||
170777526|NCT01061671|617192170|FG000|Overall Study|Lost to Follow-up|3|||
170777527|NCT01061671|617192171|FG001|Overall Study|Lost to Follow-up|5|||
170777528|NCT01061671|617192170|FG000|Overall Study|Death|28|||
170777529|NCT01061671|617192171|FG001|Overall Study|Death|30|||
170777530|NCT00068601|617192172|FG000|Overall Study|Ineligible|11|||
170777531|NCT00068601|617192173|FG001|Overall Study|Ineligible|13|||
170777532|NCT00068601|617192172|FG000|Overall Study|Not evaluable: withdrew consent|5|||
170777533|NCT00068601|617192173|FG001|Overall Study|Not evaluable: withdrew consent|4|||
170777534|NCT00068601|617192172|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
170777535|NCT00068601|617192173|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
170777536|NCT00068601|617192172|FG000|Overall Study|Death|11|||
170777537|NCT00068601|617192173|FG001|Overall Study|Death|3|||
170777538|NCT00068601|617192172|FG000|Overall Study|Lost to Follow-up|3|||
170777539|NCT00068601|617192173|FG001|Overall Study|Lost to Follow-up|2|||
170777540|NCT00068601|617192172|FG000|Overall Study|Missing primary outcome data|30|||
170777541|NCT00068601|617192173|FG001|Overall Study|Missing primary outcome data|34|||
170777542|NCT02468128|617192178|FG000|Overall Study|Protocol Violation|6|||
170777543|NCT02468128|617192179|FG001|Overall Study|Protocol Violation|6|||
170777544|NCT00440011|617192183|FG000|Overall Study|Adverse Event|2|||
170777545|NCT00440011|617192184|FG001|Overall Study|Adverse Event|0|||
170777546|NCT00440011|617192183|FG000|Overall Study|Lost to Follow-up|0|||
170777547|NCT00440011|617192184|FG001|Overall Study|Lost to Follow-up|2|||
170777548|NCT00440011|617192183|FG000|Overall Study|Protocol Violation|1|||
170777549|NCT00440011|617192184|FG001|Overall Study|Protocol Violation|1|||
170777550|NCT00440011|617192183|FG000|Overall Study|Withdrawal by Subject|1|||
170777551|NCT00440011|617192184|FG001|Overall Study|Withdrawal by Subject|0|||
170777552|NCT00331136|617192190|FG000|Overall Study|Adverse Event|3|||
170777553|NCT00331136|617192191|FG001|Overall Study|Adverse Event|5|||
170777554|NCT00331136|617192192|FG002|Overall Study|Adverse Event|0|||
170777555|NCT00331136|617192193|FG003|Overall Study|Adverse Event|1|||
170777556|NCT00331136|617192190|FG000|Overall Study|Withdrawal by Subject|0|||
170777557|NCT00331136|617192191|FG001|Overall Study|Withdrawal by Subject|1|||
170777558|NCT00331136|617192192|FG002|Overall Study|Withdrawal by Subject|0|||
170777559|NCT00331136|617192193|FG003|Overall Study|Withdrawal by Subject|0|||
170777560|NCT00331136|617192190|FG000|Overall Study|Lost to Follow-up|0|||
170777561|NCT00331136|617192191|FG001|Overall Study|Lost to Follow-up|1|||
170777562|NCT00331136|617192192|FG002|Overall Study|Lost to Follow-up|0|||
170777563|NCT00331136|617192193|FG003|Overall Study|Lost to Follow-up|0|||
170777564|NCT00331136|617192190|FG000|Overall Study|Protocol Violation|1|||
170777565|NCT00331136|617192191|FG001|Overall Study|Protocol Violation|0|||
170777566|NCT00331136|617192192|FG002|Overall Study|Protocol Violation|0|||
170777567|NCT00331136|617192193|FG003|Overall Study|Protocol Violation|0|||
170777568|NCT00331136|617192190|FG000|Overall Study|Not treated|1|||
170777569|NCT00331136|617192191|FG001|Overall Study|Not treated|0|||
170777570|NCT00331136|617192192|FG002|Overall Study|Not treated|0|||
170777571|NCT00331136|617192193|FG003|Overall Study|Not treated|0|||
170777572|NCT00419341|617192194|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
170777573|NCT00419341|617192194|FG000|Wash in/Wash Out Period|Adverse Event|2|||
170777574|NCT00419341|617192194|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
170777575|NCT00419341|617192194|FG000|Efficacy Period|Withdrawal by Subject|6|||
170777576|NCT00419341|617192194|FG000|Efficacy Period|Protocol Violation|1|||
170777577|NCT00419341|617192194|FG000|Efficacy Period|Lost to Follow-up|1|||
170777578|NCT00419341|617192194|FG000|Efficacy Period|Non-compliance|1|||
170777579|NCT00419341|617192194|FG000|Efficacy Period|Termination of study site|1|||
170777580|NCT04166058|617192195|FG000|Overall Study|Adverse Event|1|||
170777581|NCT04166058|617192196|FG001|Overall Study|Adverse Event|1|||
170777582|NCT04166058|617192197|FG002|Overall Study|Adverse Event|0|||
170777583|NCT04166058|617192198|FG003|Overall Study|Adverse Event|0|||
170777584|NCT04166058|617192195|FG000|Overall Study|Withdrawal by Subject|4|||
170777585|NCT04166058|617192196|FG001|Overall Study|Withdrawal by Subject|4|||
170777586|NCT04166058|617192197|FG002|Overall Study|Withdrawal by Subject|1|||
170777587|NCT04166058|617192198|FG003|Overall Study|Withdrawal by Subject|10|||
170777588|NCT04166058|617192195|FG000|Overall Study|Lost to Follow-up|9|||
170777589|NCT04166058|617192196|FG001|Overall Study|Lost to Follow-up|2|||
170777590|NCT04166058|617192197|FG002|Overall Study|Lost to Follow-up|1|||
170777591|NCT04166058|617192198|FG003|Overall Study|Lost to Follow-up|1|||
170777592|NCT04166058|617192195|FG000|Overall Study|Pregnancy|1|||
170777593|NCT04166058|617192196|FG001|Overall Study|Pregnancy|0|||
170777594|NCT04166058|617192197|FG002|Overall Study|Pregnancy|0|||
170777595|NCT04166058|617192198|FG003|Overall Study|Pregnancy|0|||
170777596|NCT04166058|617192195|FG000|Overall Study|Physician Decision|2|||
170777597|NCT04166058|617192196|FG001|Overall Study|Physician Decision|0|||
170777598|NCT04166058|617192197|FG002|Overall Study|Physician Decision|0|||
170777599|NCT04166058|617192198|FG003|Overall Study|Physician Decision|2|||
170777600|NCT04166058|617192195|FG000|Overall Study|Protocol Violation|1|||
170777601|NCT04166058|617192196|FG001|Overall Study|Protocol Violation|0|||
170777602|NCT04166058|617192197|FG002|Overall Study|Protocol Violation|0|||
170777603|NCT04166058|617192198|FG003|Overall Study|Protocol Violation|0|||
170777604|NCT04166058|617192195|FG000|Overall Study|Lack of Efficacy|2|||
170777605|NCT04166058|617192196|FG001|Overall Study|Lack of Efficacy|0|||
170777606|NCT04166058|617192197|FG002|Overall Study|Lack of Efficacy|0|||
170777607|NCT04166058|617192198|FG003|Overall Study|Lack of Efficacy|0|||
170777608|NCT04166058|617192195|FG000|Overall Study|Other|1|||
170777609|NCT04166058|617192196|FG001|Overall Study|Other|0|||
170777610|NCT04166058|617192197|FG002|Overall Study|Other|0|||
170777611|NCT04166058|617192198|FG003|Overall Study|Other|1|||
170777612|NCT04166058|617192195|FG000|Overall Study|Non-compliance with study drug|0|||
170777613|NCT04166058|617192196|FG001|Overall Study|Non-compliance with study drug|0|||
170777614|NCT04166058|617192197|FG002|Overall Study|Non-compliance with study drug|0|||
170777615|NCT04166058|617192198|FG003|Overall Study|Non-compliance with study drug|2|||
170777616|NCT02998528|617192199|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
170777617|NCT02998528|617192200|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
170777618|NCT02998528|617192201|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
170777619|NCT02998528|617192199|FG000|Randomization Period|Participant withdrew consent|0|||
170877456|NCT04490018|617562210|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170877457|NCT04490018|617562211|FG001|Overall Study|Withdrawal by parent/guardian|3|||
170877458|NCT04490018|617562212|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170877459|NCT00517751|617562213|FG000|Overall Study|Death|3|||
170877460|NCT00517751|617562213|FG000|Overall Study|Withdrawal by Subject|37|||
170877461|NCT00517751|617562213|FG000|Overall Study|Lost to Follow-up|4|||
170877462|NCT00517751|617562213|FG000|Overall Study|patient not over due|6|||
170877463|NCT00517751|617562213|FG000|Overall Study|Patient not due for visit|76|||
170877464|NCT00517751|617562213|FG000|Overall Study|Missing|3|||
170877465|NCT02321930|617562214|FG000|Overall Study|Lost to Follow-up|1|||
170877466|NCT00820950|617562217|FG000|Overall Study|Scheduling Conflict|0|||
170877467|NCT00820950|617562218|FG001|Overall Study|Scheduling Conflict|0|||
170877468|NCT00820950|617562219|FG002|Overall Study|Scheduling Conflict|0|||
170877469|NCT00820950|617562220|FG003|Overall Study|Scheduling Conflict|0|||
170877470|NCT00820950|617562221|FG004|Overall Study|Scheduling Conflict|0|||
170877471|NCT00820950|617562222|FG005|Overall Study|Scheduling Conflict|0|||
170877472|NCT00820950|617562223|FG006|Overall Study|Scheduling Conflict|1|||
170877473|NCT00820950|617562224|FG007|Overall Study|Scheduling Conflict|1|||
170877474|NCT00820950|617562225|FG008|Overall Study|Scheduling Conflict|0|||
170877475|NCT00820950|617562226|FG009|Overall Study|Scheduling Conflict|0|||
170877476|NCT00820950|617562217|FG000|Overall Study|Protocol Violation|1|||
170877477|NCT00820950|617562218|FG001|Overall Study|Protocol Violation|1|||
170877478|NCT00820950|617562219|FG002|Overall Study|Protocol Violation|0|||
170877479|NCT00820950|617562220|FG003|Overall Study|Protocol Violation|0|||
170877480|NCT00820950|617562221|FG004|Overall Study|Protocol Violation|0|||
170877481|NCT00820950|617562222|FG005|Overall Study|Protocol Violation|0|||
170877482|NCT00820950|617562223|FG006|Overall Study|Protocol Violation|0|||
170877483|NCT00820950|617562224|FG007|Overall Study|Protocol Violation|0|||
170877484|NCT00820950|617562225|FG008|Overall Study|Protocol Violation|0|||
170877485|NCT00820950|617562226|FG009|Overall Study|Protocol Violation|0|||
170877486|NCT04050982|617562232|FG000|Overall Study|Did not meet eligibility criteria|0|||
170877487|NCT04050982|617562233|FG001|Overall Study|Did not meet eligibility criteria|1|||
170877488|NCT04050982|617562234|FG002|Overall Study|Did not meet eligibility criteria|0|||
170877489|NCT04050982|617562232|FG000|Overall Study|Withdrawal by Subject|1|||
170877490|NCT04050982|617562233|FG001|Overall Study|Withdrawal by Subject|0|||
170877491|NCT04050982|617562234|FG002|Overall Study|Withdrawal by Subject|0|||
170877492|NCT04050982|617562232|FG000|Overall Study|Unable to enroll on platform|1|||
170877493|NCT04050982|617562233|FG001|Overall Study|Unable to enroll on platform|0|||
170877494|NCT04050982|617562234|FG002|Overall Study|Unable to enroll on platform|0|||
170877495|NCT03557281|617563912|FG000|Overall Study|Investigator discretion|0|||
170877496|NCT03557281|617563913|FG001|Overall Study|Investigator discretion|0|||
170877497|NCT03557281|617563914|FG002|Overall Study|Investigator discretion|1|||
170877498|NCT03557281|617563915|FG003|Overall Study|Investigator discretion|0|||
170877499|NCT03557281|617563916|FG004|Overall Study|Investigator discretion|0|||
170877500|NCT03557281|617563912|FG000|Overall Study|Withdrawal by Subject|0|||
170877501|NCT03557281|617563913|FG001|Overall Study|Withdrawal by Subject|1|||
170877502|NCT03557281|617563914|FG002|Overall Study|Withdrawal by Subject|1|||
170877503|NCT03557281|617563915|FG003|Overall Study|Withdrawal by Subject|1|||
170877504|NCT03557281|617563916|FG004|Overall Study|Withdrawal by Subject|2|||
170877505|NCT03557281|617563912|FG000|Overall Study|Randomized, but did not receive treatment|0|||
170877506|NCT03557281|617563913|FG001|Overall Study|Randomized, but did not receive treatment|0|||
170877507|NCT03557281|617563914|FG002|Overall Study|Randomized, but did not receive treatment|0|||
170877508|NCT03557281|617563915|FG003|Overall Study|Randomized, but did not receive treatment|0|||
170877509|NCT03557281|617563916|FG004|Overall Study|Randomized, but did not receive treatment|1|||
170877510|NCT01199042|617563917|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
170877511|NCT01199042|617563917|FG000|At Home (3 Months)|Lost to Follow-up|1|||
170877512|NCT03357731|617563918|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
170877513|NCT03357731|617563919|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
170877514|NCT03357731|617563920|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
170877515|NCT03357731|617563921|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
170877516|NCT03357731|617563922|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
170877517|NCT03357731|617563923|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
170877518|NCT03357731|617563918|FG000|Overall Study|Acute bradycardia and hypotension|0|||
170877519|NCT03357731|617563919|FG001|Overall Study|Acute bradycardia and hypotension|0|||
170877520|NCT03357731|617563920|FG002|Overall Study|Acute bradycardia and hypotension|0|||
170877521|NCT03357731|617563921|FG003|Overall Study|Acute bradycardia and hypotension|1|||
170877522|NCT03357731|617563922|FG004|Overall Study|Acute bradycardia and hypotension|0|||
170877523|NCT03357731|617563923|FG005|Overall Study|Acute bradycardia and hypotension|0|||
170877524|NCT03357731|617563918|FG000|Overall Study|Adverse Event|0|||
170877525|NCT03357731|617563919|FG001|Overall Study|Adverse Event|0|||
170877526|NCT03357731|617563920|FG002|Overall Study|Adverse Event|0|||
170877527|NCT03357731|617563921|FG003|Overall Study|Adverse Event|0|||
170877528|NCT03357731|617563922|FG004|Overall Study|Adverse Event|0|||
170877529|NCT03357731|617563923|FG005|Overall Study|Adverse Event|1|||
170877530|NCT03357731|617563918|FG000|Overall Study|Hypotension|0|||
170529375|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
170529376|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
170529377|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
170529378|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
170529379|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
170529380|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
170529381|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
170529382|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
170529383|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
170529384|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
170529385|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
170529386|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
170529387|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
170529388|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
170529389|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
170529390|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
170529391|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
170529392|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
170529393|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
170529394|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
170529395|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
170529396|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
170529397|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
170529398|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
170529399|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
170529400|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
170529401|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
170529402|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
170529403|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
170529404|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
170529405|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
170529406|NCT02717195|616287080|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
170529407|NCT02717195|616287081|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
170529408|NCT02717195|616287082|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
170529409|NCT02717195|616287083|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
170529410|NCT02717195|616287084|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
170529411|NCT02078817|616287087|FG000|Overall Study|Withdrawal by Subject|1|||
170529412|NCT00769561|616287093|FG000|Overall Study|Withdrawal by Subject|2|||
170529413|NCT00769561|616287094|FG001|Overall Study|Withdrawal by Subject|2|||
170529414|NCT00769561|616287093|FG000|Overall Study|Lost to Follow-up|1|||
170529415|NCT00769561|616287094|FG001|Overall Study|Lost to Follow-up|3|||
170529416|NCT01149655|616287095|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
170529417|NCT01149655|616287096|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
170529418|NCT01149655|616287097|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
170529419|NCT01149655|616287098|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
170529420|NCT01149655|616287095|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
170529421|NCT01149655|616287096|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
170529422|NCT01149655|616287097|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
170529423|NCT01149655|616287098|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
170529424|NCT01149655|616287095|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
170529425|NCT01149655|616287096|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
170529426|NCT01149655|616287097|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
170529427|NCT01149655|616287098|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
170529428|NCT01149655|616287095|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
170529429|NCT01149655|616287096|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
170529430|NCT01149655|616287097|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
170529431|NCT01149655|616287098|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
170529432|NCT01149655|616287095|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
170529433|NCT01149655|616287096|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
170529434|NCT01149655|616287097|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
170529435|NCT01149655|616287098|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
170529436|NCT01149655|616287095|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
170529437|NCT01149655|616287096|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
170529438|NCT01149655|616287097|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
170529439|NCT01149655|616287098|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
170529440|NCT01149655|616287095|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
170417190|NCT05030753|615867600|FG000|9-week|Excluded from analysis due to missing covariates|2|||
170417191|NCT05030753|615867601|FG001|9-week|Excluded from analysis due to missing covariates|1|||
170417192|NCT05030753|615867600|FG000|6-month post intervention|Lost to Follow-up|5|||
170417193|NCT05030753|615867601|FG001|6-month post intervention|Lost to Follow-up|4|||
170417194|NCT05030753|615867600|FG000|6-month post intervention|Withdrawal by Subject|4|||
170417195|NCT05030753|615867601|FG001|6-month post intervention|Withdrawal by Subject|0|||
170417196|NCT05030753|615867600|FG000|18-month post intervention|Lost to Follow-up|3|||
170417197|NCT05030753|615867601|FG001|18-month post intervention|Lost to Follow-up|1|||
170417198|NCT00720122|615867604|FG000|Overall Study|Lost to Follow-up|1|||
170417199|NCT00720122|615867604|FG000|Overall Study|Physician Decision|1|||
170417200|NCT00720122|615867604|FG000|Overall Study|Withdrawal by Subject|7|||
170417201|NCT03072459|615867605|FG000|Overall Study|Device revised/removed|1|||
170417202|NCT03072459|615867605|FG000|Overall Study|Subject not able to return|1|||
170417203|NCT00329602|615867606|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
170417204|NCT00329602|615867607|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
170417205|NCT00329602|615867608|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
170417206|NCT00329602|615867606|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
170417207|NCT00329602|615867607|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
170417208|NCT00329602|615867608|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
170417209|NCT00329602|615867606|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
170417210|NCT00329602|615867607|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
170417211|NCT00329602|615867608|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
170417212|NCT00329602|615867606|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
170417213|NCT00329602|615867607|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
170417214|NCT00329602|615867608|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
170417215|NCT00329602|615867606|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
170632617|NCT01352793|616666716|FG001|Overall Study|Physician Decision|0|||
170777620|NCT02998528|617192200|FG001|Randomization Period|Participant withdrew consent|3|||
170777621|NCT02998528|617192201|FG002|Randomization Period|Participant withdrew consent|0|||
170777622|NCT02998528|617192199|FG000|Randomization Period|Participant no longer meets study criteria|1|||
170777623|NCT02998528|617192200|FG001|Randomization Period|Participant no longer meets study criteria|3|||
170777624|NCT02998528|617192201|FG002|Randomization Period|Participant no longer meets study criteria|2|||
170777625|NCT02998528|617192199|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
170777626|NCT02998528|617192200|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
170777627|NCT02998528|617192201|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
170777628|NCT02998528|617192199|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
170777629|NCT02998528|617192200|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
170777630|NCT02998528|617192201|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
170777631|NCT02998528|617192199|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
170777632|NCT02998528|617192200|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
170777633|NCT02998528|617192201|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
170777634|NCT02998528|617192199|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
170777635|NCT02998528|617192200|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
170777636|NCT02998528|617192201|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
170777637|NCT02998528|617192199|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
170777638|NCT02998528|617192200|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
170777639|NCT02998528|617192201|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
170777640|NCT02998528|617192199|FG000|Neoadjuvant Treatment Period|Death|1|||
170777641|NCT02998528|617192200|FG001|Neoadjuvant Treatment Period|Death|0|||
170777642|NCT02998528|617192201|FG002|Neoadjuvant Treatment Period|Death|0|||
170777643|NCT02998528|617192199|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
170777644|NCT02998528|617192200|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
170777645|NCT02998528|617192201|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
170777646|NCT02998528|617192199|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
170777647|NCT02998528|617192200|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
170777648|NCT02998528|617192201|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
170777649|NCT02998528|617192199|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
170777650|NCT02998528|617192200|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
170777651|NCT02998528|617192201|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
170777652|NCT02998528|617192199|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
170777653|NCT02998528|617192200|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
170777654|NCT02998528|617192201|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
170777655|NCT02998528|617192199|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
170777656|NCT02998528|617192200|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
170777657|NCT02998528|617192201|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
170529441|NCT01149655|616287096|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
170529442|NCT01149655|616287097|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
170529443|NCT01149655|616287098|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
170529444|NCT01149655|616287095|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
170529445|NCT01149655|616287096|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
170529446|NCT01149655|616287097|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
170529447|NCT01149655|616287098|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
170529448|NCT01149655|616287095|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
170529449|NCT01149655|616287096|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
170529450|NCT01149655|616287097|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
170877531|NCT03357731|617563919|FG001|Overall Study|Hypotension|0|||
170877532|NCT03357731|617563920|FG002|Overall Study|Hypotension|1|||
170877533|NCT03357731|617563921|FG003|Overall Study|Hypotension|1|||
170877534|NCT03357731|617563922|FG004|Overall Study|Hypotension|0|||
170877535|NCT03357731|617563923|FG005|Overall Study|Hypotension|0|||
170877536|NCT03357731|617563918|FG000|Overall Study|Lost to Follow-up|0|||
170877537|NCT03357731|617563919|FG001|Overall Study|Lost to Follow-up|0|||
170877538|NCT03357731|617563920|FG002|Overall Study|Lost to Follow-up|0|||
170877539|NCT03357731|617563921|FG003|Overall Study|Lost to Follow-up|1|||
170877540|NCT03357731|617563922|FG004|Overall Study|Lost to Follow-up|0|||
170877541|NCT03357731|617563923|FG005|Overall Study|Lost to Follow-up|0|||
170877542|NCT01773109|617563924|FG000|Overall Study|Symptomatic Progression|2|||
170877543|NCT01773109|617563924|FG000|Overall Study|Death|1|||
170877544|NCT01239342|617563925|FG000|Overall Study|Adverse Event|1|||
170877545|NCT01239342|617563926|FG001|Overall Study|Adverse Event|0|||
170877546|NCT01239342|617563925|FG000|Overall Study|Withdrawal by Subject|1|||
170877547|NCT01239342|617563926|FG001|Overall Study|Withdrawal by Subject|5|||
170877548|NCT01239342|617563925|FG000|Overall Study|Reason Unknown|1|||
170877549|NCT01239342|617563926|FG001|Overall Study|Reason Unknown|1|||
170877550|NCT02918864|617563927|FG000|Overall Study|Withdrawal by Subject|1|||
170877551|NCT02918864|617563928|FG001|Overall Study|Withdrawal by Subject|1|||
170877552|NCT02918864|617563927|FG000|Overall Study|Lost to Follow-up|3|||
170877553|NCT02918864|617563928|FG001|Overall Study|Lost to Follow-up|2|||
170877554|NCT00003535|617563929|FG000|Overall Study|Not evaluable|5|||
170877555|NCT01849874|617563930|FG000|Overall Study|Death|89|||
170877556|NCT01849874|617563931|FG001|Overall Study|Death|42|||
170877557|NCT01849874|617563930|FG000|Overall Study|Withdrawal by Subject|17|||
170877558|NCT01849874|617563931|FG001|Overall Study|Withdrawal by Subject|16|||
170877559|NCT01849874|617563930|FG000|Overall Study|Lost to Follow-up|3|||
170877560|NCT01849874|617563931|FG001|Overall Study|Lost to Follow-up|2|||
170877561|NCT01849874|617563930|FG000|Overall Study|Study Termination By Sponsor|93|||
170877562|NCT01849874|617563931|FG001|Overall Study|Study Termination By Sponsor|48|||
170877563|NCT01849874|617563930|FG000|Overall Study|Completed as per protocol amendment 6|3|||
170877564|NCT01849874|617563931|FG001|Overall Study|Completed as per protocol amendment 6|0|||
170877565|NCT01849874|617563930|FG000|Overall Study|Physician Decision|7|||
170877566|NCT01849874|617563931|FG001|Overall Study|Physician Decision|1|||
170877567|NCT01849874|617563930|FG000|Overall Study|Other|16|||
170877568|NCT01849874|617563931|FG001|Overall Study|Other|4|||
170877569|NCT01918007|617563932|FG000|Overall Study|Baseline oximetry not acceptable|11|||
170877570|NCT01918007|617563933|FG001|Overall Study|Baseline oximetry not acceptable|7|||
170877571|NCT01918007|617563932|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
170877572|NCT01918007|617563933|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
170417216|NCT00329602|615867607|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
170417217|NCT00329602|615867608|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
170417218|NCT00329602|615867606|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
170417219|NCT00329602|615867607|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
170417220|NCT00329602|615867608|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
170417221|NCT02579096|615867609|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
170417222|NCT02579096|615867610|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
170417223|NCT02579096|615867609|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
170417224|NCT02579096|615867610|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
170417225|NCT02579096|615867609|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
170417226|NCT02579096|615867610|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
170417227|NCT02579096|615867609|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
170417228|NCT02579096|615867610|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
170529451|NCT01149655|616287098|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
170877573|NCT01918007|617563932|FG000|Overall Study|Lost to Follow-up|4|||
170877574|NCT01918007|617563933|FG001|Overall Study|Lost to Follow-up|7|||
170877575|NCT01140451|617563935|FG000|Overall Study|Withdrawal by Subject|26|||
170877576|NCT01140451|617563936|FG001|Overall Study|Withdrawal by Subject|33|||
170877577|NCT01140451|617563935|FG000|Overall Study|Adverse Event|2|||
170877578|NCT01140451|617563936|FG001|Overall Study|Adverse Event|6|||
170877579|NCT01140451|617563935|FG000|Overall Study|Physician Decision|5|||
170877580|NCT01140451|617563936|FG001|Overall Study|Physician Decision|3|||
170877581|NCT01140451|617563935|FG000|Overall Study|Lost to Follow-up|2|||
170877582|NCT01140451|617563936|FG001|Overall Study|Lost to Follow-up|0|||
170877583|NCT01140451|617563935|FG000|Overall Study|Participants Planning Pregnancy|3|||
170877584|NCT01140451|617563936|FG001|Overall Study|Participants Planning Pregnancy|0|||
170877585|NCT00783094|617563939|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
170877586|NCT00783094|617563940|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
170877587|NCT00783094|617563941|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
170877588|NCT00783094|617563939|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
170877589|NCT00783094|617563940|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
170877590|NCT00783094|617563941|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
170877591|NCT00783094|617563939|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
170877592|NCT00783094|617563940|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
170877593|NCT00783094|617563941|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
170877594|NCT00783094|617563939|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
170877595|NCT00783094|617563940|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
170877596|NCT00783094|617563941|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
170877597|NCT00783094|617563939|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
170877598|NCT00783094|617563940|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
170877599|NCT00783094|617563941|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
170417229|NCT02579096|615867609|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
170417230|NCT02579096|615867610|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
170417231|NCT02579096|615867609|FG000|Phase 2, Weeks 25 - 48|Death|2|||
170417232|NCT02579096|615867610|FG001|Phase 2, Weeks 25 - 48|Death|4|||
170417233|NCT02579096|615867609|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
170417234|NCT02579096|615867610|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
170417235|NCT02579096|615867609|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
170417236|NCT02579096|615867610|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
170417237|NCT02579096|615867609|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
170417238|NCT02579096|615867610|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
170417239|NCT02579096|615867609|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
170417240|NCT02579096|615867610|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
170417241|NCT02579096|615867609|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
170417242|NCT02579096|615867610|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
170417243|NCT02579096|615867609|FG000|Phase 3, Weeks 49 - 72|Death|3|||
170417244|NCT02579096|615867610|FG001|Phase 3, Weeks 49 - 72|Death|2|||
170417245|NCT02579096|615867609|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
170417246|NCT02579096|615867610|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
170417247|NCT02579096|615867609|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
170417248|NCT02579096|615867610|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
170417249|NCT02579096|615867609|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
170417250|NCT02579096|615867610|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
170417251|NCT02579096|615867609|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
170417252|NCT02579096|615867610|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
170417253|NCT02579096|615867609|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
170417254|NCT02579096|615867610|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
170417255|NCT02579096|615867609|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
170417256|NCT02579096|615867610|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
170417257|NCT02097121|615867615|FG000|Overall Study|Other, not specified|4|||
170417258|NCT02097121|615867616|FG001|Overall Study|Other, not specified|2|||
170417259|NCT02097121|615867617|FG002|Overall Study|Other, not specified|3|||
170417260|NCT02097121|615867615|FG000|Overall Study|Lack of Efficacy|2|||
170417261|NCT02097121|615867616|FG001|Overall Study|Lack of Efficacy|1|||
170417262|NCT02097121|615867617|FG002|Overall Study|Lack of Efficacy|3|||
170417263|NCT02097121|615867615|FG000|Overall Study|Withdrawal by Subject|0|||
170417264|NCT02097121|615867616|FG001|Overall Study|Withdrawal by Subject|1|||
170417265|NCT02097121|615867617|FG002|Overall Study|Withdrawal by Subject|2|||
170417266|NCT02097121|615867615|FG000|Overall Study|Adverse Event|0|||
170417267|NCT02097121|615867616|FG001|Overall Study|Adverse Event|1|||
170417268|NCT02097121|615867617|FG002|Overall Study|Adverse Event|0|||
170417269|NCT02097121|615867615|FG000|Overall Study|Lost to Follow-up|1|||
170417270|NCT02097121|615867616|FG001|Overall Study|Lost to Follow-up|1|||
170417271|NCT02097121|615867617|FG002|Overall Study|Lost to Follow-up|2|||
170417272|NCT03066999|615867618|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
170417273|NCT03066999|615867619|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
170417274|NCT00510510|615867620|FG000|Overall Study|Adverse Event|4|||
170417275|NCT00510510|615867621|FG001|Overall Study|Adverse Event|3|||
170417276|NCT00510510|615867622|FG002|Overall Study|Adverse Event|6|||
170417277|NCT00510510|615867620|FG000|Overall Study|Lack of Efficacy|0|||
170417278|NCT00510510|615867621|FG001|Overall Study|Lack of Efficacy|1|||
170417279|NCT00510510|615867622|FG002|Overall Study|Lack of Efficacy|1|||
170417280|NCT00510510|615867620|FG000|Overall Study|Subjects no longer requires study drug|0|||
170417281|NCT00510510|615867621|FG001|Overall Study|Subjects no longer requires study drug|0|||
170529452|NCT01149655|616287095|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
170529453|NCT01149655|616287096|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
170529454|NCT01149655|616287097|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
170529455|NCT01149655|616287098|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
170529456|NCT01149655|616287095|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
170529457|NCT01149655|616287096|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
170529458|NCT01149655|616287097|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
170529459|NCT01149655|616287098|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
170529460|NCT01149655|616287095|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
170529461|NCT01149655|616287096|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
170529462|NCT01149655|616287097|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
170529463|NCT01149655|616287098|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
170529464|NCT01149655|616287095|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
170529465|NCT01149655|616287096|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
170529466|NCT01149655|616287097|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
170529467|NCT01149655|616287098|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
170529468|NCT01149655|616287095|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
170529469|NCT01149655|616287096|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
170529470|NCT01149655|616287097|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
170529471|NCT01149655|616287098|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
170529472|NCT01149655|616287095|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
170529473|NCT01149655|616287096|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
170529474|NCT01149655|616287097|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
170529475|NCT01149655|616287098|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
170529476|NCT01149655|616287095|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
170529477|NCT01149655|616287096|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
170529478|NCT01149655|616287097|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
170529479|NCT01149655|616287098|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
170529480|NCT00921024|616287104|FG000|Overall Study|Lost to Follow-up|2|||
170529481|NCT00921024|616287105|FG001|Overall Study|Lost to Follow-up|0|||
170529482|NCT00921024|616287104|FG000|Overall Study|Received concomittant therapy|2|||
170529483|NCT00921024|616287105|FG001|Overall Study|Received concomittant therapy|0|||
170529484|NCT00921024|616287104|FG000|Overall Study|Withdrawal by Subject|0|||
170529485|NCT00921024|616287105|FG001|Overall Study|Withdrawal by Subject|3|||
170529486|NCT03675308|616288349|FG000|Overall Study|Adverse Event|3|||
170529487|NCT03675308|616288350|FG001|Overall Study|Adverse Event|2|||
170529488|NCT03675308|616288349|FG000|Overall Study|Withdrawal by Subject|6|||
170529489|NCT03675308|616288350|FG001|Overall Study|Withdrawal by Subject|4|||
170529490|NCT03675308|616288349|FG000|Overall Study|Lost to Follow-up|3|||
170529491|NCT03675308|616288350|FG001|Overall Study|Lost to Follow-up|0|||
170529492|NCT03675308|616288349|FG000|Overall Study|Lack of Efficacy|1|||
170529493|NCT03675308|616288350|FG001|Overall Study|Lack of Efficacy|1|||
170529494|NCT03675308|616288349|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
170529495|NCT03675308|616288350|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
170529496|NCT03675308|616288349|FG000|Overall Study|Other|0|||
170529497|NCT03675308|616288350|FG001|Overall Study|Other|1|||
170529498|NCT02325414|616288354|FG000|Overall Study|Withdrawal by Subject|3|||
170529499|NCT02325414|616288355|FG001|Overall Study|Withdrawal by Subject|1|||
170529500|NCT02325414|616288354|FG000|Overall Study|Lost to Follow-up|5|||
170529501|NCT02325414|616288355|FG001|Overall Study|Lost to Follow-up|5|||
170529502|NCT05722522|616288356|FG000|Overall Study|Adverse Event|0|||
170529503|NCT05722522|616288357|FG001|Overall Study|Adverse Event|1|||
170529504|NCT00961064|616288359|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
170529505|NCT00961064|616288359|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
170529506|NCT00961064|616288359|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
170529507|NCT00961064|616288359|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
170529508|NCT00961064|616288359|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
170529509|NCT00961064|616288359|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
170529510|NCT00961064|616288359|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
170529511|NCT00961064|616288359|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
170777658|NCT02998528|617192199|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
170777659|NCT02998528|617192200|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
170777660|NCT02998528|617192201|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
170777661|NCT03570892|617192209|FG000|Overall Study|Death|51|||
170777662|NCT03570892|617192210|FG001|Overall Study|Death|45|||
170529512|NCT00089648|616288362|FG000|Overall Study|Adverse Event|7|||
170529513|NCT00089648|616288362|FG000|Overall Study|Withdrawal by Subject|1|||
170777663|NCT03570892|617192209|FG000|Overall Study|Subject decision|5|||
170529514|NCT00089648|616288362|FG000|Overall Study|Lack of Efficacy|33|||
170529515|NCT01516216|616288367|FG000|Overall Study|Adverse Event|2|||
170529516|NCT01516216|616288368|FG001|Overall Study|Adverse Event|4|||
170529517|NCT01516216|616288367|FG000|Overall Study|Disease Progression|38|||
170529518|NCT01516216|616288368|FG001|Overall Study|Disease Progression|34|||
170529519|NCT01516216|616288367|FG000|Overall Study|Withdrawal by Subject|9|||
170529520|NCT01516216|616288368|FG001|Overall Study|Withdrawal by Subject|11|||
170529521|NCT01516216|616288367|FG000|Overall Study|Potentially Curative Resection|6|||
170529522|NCT01516216|616288368|FG001|Overall Study|Potentially Curative Resection|12|||
170529523|NCT01516216|616288367|FG000|Overall Study|Nonadherence|2|||
170529524|NCT01516216|616288368|FG001|Overall Study|Nonadherence|3|||
170529525|NCT01516216|616288367|FG000|Overall Study|Physician Decision|6|||
170529526|NCT01516216|616288368|FG001|Overall Study|Physician Decision|3|||
170529527|NCT01516216|616288367|FG000|Overall Study|Prolonged Treatment Delay|5|||
170529528|NCT01516216|616288368|FG001|Overall Study|Prolonged Treatment Delay|1|||
170529529|NCT01516216|616288367|FG000|Overall Study|Intercurrent Illness|1|||
170529530|NCT01516216|616288368|FG001|Overall Study|Intercurrent Illness|0|||
170529531|NCT01516216|616288367|FG000|Overall Study|Death|1|||
170529532|NCT01516216|616288368|FG001|Overall Study|Death|1|||
170529533|NCT03098979|616288369|FG000|Overall Study|Adverse Event|1|||
170529534|NCT03098979|616288370|FG001|Overall Study|Adverse Event|0|||
170529535|NCT03098979|616288371|FG002|Overall Study|Adverse Event|1|||
170529536|NCT03098979|616288372|FG003|Overall Study|Adverse Event|4|||
170529537|NCT03098979|616288373|FG004|Overall Study|Adverse Event|6|||
170529538|NCT03098979|616288374|FG005|Overall Study|Adverse Event|1|||
170529539|NCT03098979|616288369|FG000|Overall Study|Withdrawal by Subject|2|||
170529540|NCT03098979|616288370|FG001|Overall Study|Withdrawal by Subject|1|||
170529541|NCT03098979|616288371|FG002|Overall Study|Withdrawal by Subject|1|||
170529542|NCT03098979|616288372|FG003|Overall Study|Withdrawal by Subject|1|||
170529543|NCT03098979|616288373|FG004|Overall Study|Withdrawal by Subject|2|||
170529544|NCT03098979|616288374|FG005|Overall Study|Withdrawal by Subject|1|||
170529545|NCT03098979|616288369|FG000|Overall Study|Death|1|||
170529546|NCT03098979|616288370|FG001|Overall Study|Death|0|||
170529547|NCT03098979|616288371|FG002|Overall Study|Death|2|||
170529548|NCT03098979|616288372|FG003|Overall Study|Death|0|||
170529549|NCT03098979|616288373|FG004|Overall Study|Death|1|||
170529550|NCT03098979|616288374|FG005|Overall Study|Death|0|||
170529551|NCT03098979|616288369|FG000|Overall Study|Physician Decision|2|||
170529552|NCT03098979|616288370|FG001|Overall Study|Physician Decision|1|||
170529553|NCT03098979|616288371|FG002|Overall Study|Physician Decision|0|||
170529554|NCT03098979|616288372|FG003|Overall Study|Physician Decision|0|||
170529555|NCT03098979|616288373|FG004|Overall Study|Physician Decision|0|||
170529556|NCT03098979|616288374|FG005|Overall Study|Physician Decision|0|||
170529557|NCT03098979|616288369|FG000|Overall Study|Non-compliance|0|||
170529558|NCT03098979|616288370|FG001|Overall Study|Non-compliance|0|||
170529559|NCT03098979|616288371|FG002|Overall Study|Non-compliance|0|||
170529560|NCT03098979|616288372|FG003|Overall Study|Non-compliance|0|||
170529561|NCT03098979|616288373|FG004|Overall Study|Non-compliance|0|||
170529562|NCT03098979|616288374|FG005|Overall Study|Non-compliance|1|||
170529563|NCT03098979|616288369|FG000|Overall Study|Protocol Violation|0|||
170529564|NCT03098979|616288370|FG001|Overall Study|Protocol Violation|0|||
170529565|NCT03098979|616288371|FG002|Overall Study|Protocol Violation|0|||
170529566|NCT03098979|616288372|FG003|Overall Study|Protocol Violation|0|||
170529567|NCT03098979|616288373|FG004|Overall Study|Protocol Violation|0|||
170529568|NCT03098979|616288374|FG005|Overall Study|Protocol Violation|1|||
170529569|NCT02058095|616288375|FG000|Overall Study|Adverse Event|1|||
170529570|NCT02058095|616288376|FG001|Overall Study|Adverse Event|0|||
170529571|NCT00998946|616288379|FG000|Overall Study|Lost to Follow-up|1|||
170529572|NCT00998946|616288379|FG000|Overall Study|Withdrawal by Subject|1|||
170529573|NCT00998946|616288379|FG000|Overall Study|Death|2|||
170529574|NCT00998946|616288379|FG000|Overall Study|Reason Unspecified|3|||
170529575|NCT00998946|616288379|FG000|Overall Study|Enrolled but not Dosed|2|||
170529576|NCT00726453|616288381|FG000|Primary Enrollment Group|Death|18|||
170529577|NCT00726453|616288382|FG001|Primary Enrollment Group|Death|0|||
170529578|NCT00726453|616288381|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
170529579|NCT00726453|616288382|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
170529580|NCT00726453|616288381|FG000|38 mm Length Group|Death|0|||
170529581|NCT00726453|616288382|FG001|38 mm Length Group|Death|3|||
170632618|NCT01352793|616666715|FG000|Overall Study|Pregnancy|26|||
170632619|NCT01352793|616666716|FG001|Overall Study|Pregnancy|8|||
170529582|NCT01588509|616288385|FG000|Overall Study|Lost to Follow-up|1|||
170529583|NCT01588509|616288386|FG001|Overall Study|Lost to Follow-up|0|||
170529584|NCT00393367|616288387|FG000|Overall Study|Protocol Violation|2|||
170529585|NCT00393367|616288388|FG001|Overall Study|Protocol Violation|5|||
170529586|NCT00393367|616288387|FG000|Overall Study|Withdrawal by Subject|0|||
170529587|NCT00393367|616288388|FG001|Overall Study|Withdrawal by Subject|2|||
170529588|NCT03248037|616288389|FG000|Overall Study|Withdrawal by Subject|6|||
170529589|NCT03248037|616288390|FG001|Overall Study|Withdrawal by Subject|9|||
170529590|NCT03248037|616288389|FG000|Overall Study|Adverse Event|15|||
170529591|NCT03248037|616288390|FG001|Overall Study|Adverse Event|0|||
170529592|NCT02765035|616288395|FG000|First Intervention (90 Days)|Adverse Event|1|||
170529593|NCT02765035|616288396|FG001|First Intervention (90 Days)|Adverse Event|1|||
170632620|NCT01352793|616666715|FG000|Overall Study|Other|25|||
170877600|NCT00783094|617563939|FG000|Open-Label Extension Period|Adverse Event|12|||
170877601|NCT00783094|617563940|FG001|Open-Label Extension Period|Adverse Event|7|||
170877602|NCT00783094|617563941|FG002|Open-Label Extension Period|Adverse Event|16|||
170417282|NCT00510510|615867622|FG002|Overall Study|Subjects no longer requires study drug|2|||
170417283|NCT00510510|615867620|FG000|Overall Study|Withdrawal by Subject|1|||
170417284|NCT00510510|615867621|FG001|Overall Study|Withdrawal by Subject|2|||
170417285|NCT00510510|615867622|FG002|Overall Study|Withdrawal by Subject|3|||
170417286|NCT00510510|615867620|FG000|Overall Study|Lost to Follow-up|0|||
170417287|NCT00510510|615867621|FG001|Overall Study|Lost to Follow-up|0|||
170417288|NCT00510510|615867622|FG002|Overall Study|Lost to Follow-up|1|||
170417289|NCT00510510|615867620|FG000|Overall Study|Protocol Violation|0|||
170417290|NCT00510510|615867621|FG001|Overall Study|Protocol Violation|3|||
170417291|NCT00510510|615867622|FG002|Overall Study|Protocol Violation|4|||
170417292|NCT03595657|615867623|FG000|Overall Study|Adverse Event|14|||
170417293|NCT03595657|615867623|FG000|Overall Study|Death|1|||
170417294|NCT03595657|615867623|FG000|Overall Study|Lack of Efficacy|40|||
170417295|NCT03595657|615867623|FG000|Overall Study|Withdrawal by Subject|10|||
170417296|NCT03595657|615867623|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
170417297|NCT03595657|615867623|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
170417298|NCT01066052|615867624|FG000|Overall Study|Enrolled But Not Treated|3|||
170417299|NCT01066052|615867625|FG001|Overall Study|Enrolled But Not Treated|0|||
170417300|NCT01361126|615867626|FG000|Overall Study|Sponsor decision|0|||
170417301|NCT01361126|615867627|FG001|Overall Study|Sponsor decision|2|||
170417302|NCT02994056|615867628|FG000|Overall Study|Death|8|||
170417303|NCT02994056|615867628|FG000|Overall Study|Withdrew Consent|1|||
170417304|NCT01200394|615867629|FG000|Overall Study|Adverse Event|0|||
170417305|NCT01200394|615867630|FG001|Overall Study|Adverse Event|14|||
170417306|NCT01200394|615867629|FG000|Overall Study|Death|1|||
170417307|NCT01200394|615867630|FG001|Overall Study|Death|0|||
170417308|NCT01200394|615867629|FG000|Overall Study|Lost to Follow-up|0|||
170417309|NCT01200394|615867630|FG001|Overall Study|Lost to Follow-up|1|||
170417310|NCT01200394|615867629|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
170417311|NCT01200394|615867630|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
170417312|NCT01200394|615867629|FG000|Overall Study|Protocol Violation|0|||
170417313|NCT01200394|615867630|FG001|Overall Study|Protocol Violation|3|||
170417314|NCT01200394|615867629|FG000|Overall Study|Withdrawal by Subject|0|||
170417315|NCT01200394|615867630|FG001|Overall Study|Withdrawal by Subject|5|||
170417316|NCT01200394|615867629|FG000|Overall Study|Other|0|||
170417317|NCT01200394|615867630|FG001|Overall Study|Other|1|||
170417318|NCT02729896|615867631|FG000|Overall Study|Death|0|||
170417319|NCT02729896|615867632|FG001|Overall Study|Death|2|||
170417320|NCT02729896|615867633|FG002|Overall Study|Death|13|||
170417321|NCT02729896|615867631|FG000|Overall Study|Lost to Follow-up|0|||
170417322|NCT02729896|615867632|FG001|Overall Study|Lost to Follow-up|2|||
170417323|NCT02729896|615867633|FG002|Overall Study|Lost to Follow-up|3|||
170417324|NCT02729896|615867631|FG000|Overall Study|Other|0|||
170417325|NCT02729896|615867632|FG001|Overall Study|Other|2|||
170417326|NCT02729896|615867633|FG002|Overall Study|Other|0|||
170417327|NCT02729896|615867631|FG000|Overall Study|Physician Decision|1|||
170417328|NCT02729896|615867632|FG001|Overall Study|Physician Decision|2|||
170417329|NCT02729896|615867633|FG002|Overall Study|Physician Decision|3|||
170417330|NCT02729896|615867631|FG000|Overall Study|Progressive Disease|0|||
170417331|NCT02729896|615867632|FG001|Overall Study|Progressive Disease|1|||
170417332|NCT02729896|615867633|FG002|Overall Study|Progressive Disease|0|||
170417333|NCT02729896|615867631|FG000|Overall Study|Withdrawal by Subject|1|||
170417334|NCT02729896|615867632|FG001|Overall Study|Withdrawal by Subject|0|||
170417335|NCT02729896|615867633|FG002|Overall Study|Withdrawal by Subject|3|||
170417336|NCT01835145|615867634|FG000|Overall Study|Ineligible prior to treatment|1|||
170417337|NCT01835145|615867635|FG001|Overall Study|Ineligible prior to treatment|0|||
170417338|NCT02199509|615867636|FG000|Overall Study|Suicidal Ideation|0|||
170417339|NCT02199509|615867637|FG001|Overall Study|Suicidal Ideation|1|||
170417340|NCT02199509|615867636|FG000|Overall Study|Misunderstood titration schedule|1|||
170417341|NCT02199509|615867637|FG001|Overall Study|Misunderstood titration schedule|0|||
170417342|NCT04094870|615867638|FG000|Overall Study|Lost to Follow-up|1|||
170417343|NCT04094870|615867639|FG001|Overall Study|Lost to Follow-up|1|||
170417344|NCT01658943|615867644|FG000|Overall Study|Adverse Event|6|||
170877603|NCT00783094|617563939|FG000|Open-Label Extension Period|Death|0|||
170417345|NCT01658943|615867645|FG001|Overall Study|Adverse Event|13|||
170417346|NCT01658943|615867644|FG000|Overall Study|Withdrawal by Subject|9|||
170417347|NCT01658943|615867645|FG001|Overall Study|Withdrawal by Subject|2|||
170417348|NCT01658943|615867644|FG000|Overall Study|Progression/Relapse|39|||
170417349|NCT01658943|615867645|FG001|Overall Study|Progression/Relapse|40|||
170417350|NCT01658943|615867644|FG000|Overall Study|Death|4|||
170417351|NCT01658943|615867645|FG001|Overall Study|Death|2|||
170417352|NCT01658943|615867644|FG000|Overall Study|not protocol specified|4|||
170417353|NCT01658943|615867645|FG001|Overall Study|not protocol specified|1|||
170417354|NCT01658943|615867644|FG000|Overall Study|Not eligible|7|||
170417355|NCT01658943|615867645|FG001|Overall Study|Not eligible|9|||
170417356|NCT01658943|615867644|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
170529594|NCT02765035|616288395|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
170529595|NCT02765035|616288396|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
170529596|NCT03895086|616288399|FG000|Overall Study|Early termination study|1|||
170529597|NCT03895086|616288400|FG001|Overall Study|Early termination study|0|||
170529598|NCT04649359|616288401|FG000|Overall Study|Withdrawal by Subject|7|||
170529599|NCT04649359|616288402|FG001|Overall Study|Withdrawal by Subject|7|||
170529600|NCT04649359|616288401|FG000|Overall Study|Death|41|||
170529601|NCT04649359|616288402|FG001|Overall Study|Death|26|||
170529602|NCT04649359|616288401|FG000|Overall Study|Ongoing in the study|75|||
170529603|NCT04649359|616288402|FG001|Overall Study|Ongoing in the study|31|||
170529604|NCT03307174|616288403|FG000|Overall Study|Unplanned ICU Administrion|5|||
170529605|NCT03307174|616288404|FG001|Overall Study|Unplanned ICU Administrion|3|||
170529606|NCT03307174|616288403|FG000|Overall Study|Aborted Surgery|1|||
170529607|NCT03307174|616288404|FG001|Overall Study|Aborted Surgery|2|||
170529608|NCT03307174|616288403|FG000|Overall Study|Hypotension|6|||
170529609|NCT03307174|616288404|FG001|Overall Study|Hypotension|0|||
170529610|NCT03307174|616288403|FG000|Overall Study|Nonfunctional epidural|1|||
170529611|NCT03307174|616288404|FG001|Overall Study|Nonfunctional epidural|1|||
170529612|NCT03307174|616288403|FG000|Overall Study|Planned epidural removal|1|||
170529613|NCT03307174|616288404|FG001|Overall Study|Planned epidural removal|0|||
170529614|NCT03307174|616288403|FG000|Overall Study|Intrathecal catheter placement|0|||
170529615|NCT03307174|616288404|FG001|Overall Study|Intrathecal catheter placement|1|||
170529616|NCT01192815|616288408|FG000|Overall Study|Withdrawal by Subject|1|||
170529617|NCT01192815|616288408|FG000|Overall Study|Lack of Efficacy|1|||
170529618|NCT01142336|616288409|FG000|Overall Study|Adverse Event|1|||
170529619|NCT01142336|616288410|FG001|Overall Study|Adverse Event|1|||
170529620|NCT01142336|616288409|FG000|Overall Study|Lost to Follow-up|0|||
170529621|NCT01142336|616288410|FG001|Overall Study|Lost to Follow-up|1|||
170529622|NCT02029417|616288411|FG000|Overall Study|Death|1|||
170529623|NCT02029417|616288411|FG000|Overall Study|Adverse Event|1|||
170529624|NCT00471497|616288421|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
170529625|NCT00471497|616288422|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
170529626|NCT00471497|616288423|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
170529627|NCT00471497|616288421|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
170529628|NCT00471497|616288422|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
170529629|NCT00471497|616288423|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
170529630|NCT00471497|616288421|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
170529631|NCT00471497|616288422|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
170529632|NCT00471497|616288423|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
170529633|NCT00471497|616288421|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
170529634|NCT00471497|616288422|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
170529635|NCT00471497|616288423|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
170529636|NCT00471497|616288421|FG000|Core Treatment Phase|Lost to Follow-up|6|||
170529637|NCT00471497|616288422|FG001|Core Treatment Phase|Lost to Follow-up|6|||
170529638|NCT00471497|616288423|FG002|Core Treatment Phase|Lost to Follow-up|3|||
170877604|NCT00783094|617563940|FG001|Open-Label Extension Period|Death|0|||
170877605|NCT00783094|617563941|FG002|Open-Label Extension Period|Death|1|||
170877606|NCT00783094|617563939|FG000|Open-Label Extension Period|Protocol Violation|4|||
170877607|NCT00783094|617563940|FG001|Open-Label Extension Period|Protocol Violation|5|||
170877608|NCT00783094|617563941|FG002|Open-Label Extension Period|Protocol Violation|7|||
170877609|NCT00783094|617563939|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
170877610|NCT00783094|617563940|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
170877611|NCT00783094|617563941|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
170877612|NCT00783094|617563939|FG000|Open-Label Extension Period|Physician Decision|4|||
170877613|NCT00783094|617563940|FG001|Open-Label Extension Period|Physician Decision|2|||
170877614|NCT00783094|617563941|FG002|Open-Label Extension Period|Physician Decision|3|||
170529639|NCT00471497|616288421|FG000|Core Treatment Phase|Death|3|||
170529640|NCT00471497|616288422|FG001|Core Treatment Phase|Death|9|||
170529641|NCT00471497|616288423|FG002|Core Treatment Phase|Death|3|||
170529642|NCT00471497|616288421|FG000|Core Treatment Phase|Disease Progression|10|||
170529643|NCT00471497|616288422|FG001|Core Treatment Phase|Disease Progression|2|||
170529644|NCT00471497|616288423|FG002|Core Treatment Phase|Disease Progression|4|||
170529645|NCT00471497|616288421|FG000|Core Treatment Phase|Protocol Violation|6|||
170877615|NCT00783094|617563939|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
170877616|NCT00783094|617563940|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
170877617|NCT00783094|617563941|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
170877618|NCT01324232|617563942|FG000|Overall Study|Protocol Violation|0|||
170877619|NCT01324232|617563943|FG001|Overall Study|Protocol Violation|0|||
170877620|NCT01324232|617563944|FG002|Overall Study|Protocol Violation|0|||
170877621|NCT01324232|617563945|FG003|Overall Study|Protocol Violation|2|||
170877622|NCT01324232|617563942|FG000|Overall Study|Missing|0|||
170529646|NCT00471497|616288422|FG001|Core Treatment Phase|Protocol Violation|15|||
170529647|NCT00471497|616288423|FG002|Core Treatment Phase|Protocol Violation|11|||
170529648|NCT00471497|616288421|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
170632621|NCT01352793|616666716|FG001|Overall Study|Other|7|||
170529649|NCT00471497|616288422|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
170529650|NCT00471497|616288423|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
170529651|NCT00471497|616288421|FG000|Core Treatment Phase|Administrative problems|14|||
170529652|NCT00471497|616288422|FG001|Core Treatment Phase|Administrative problems|14|||
170529653|NCT00471497|616288423|FG002|Core Treatment Phase|Administrative problems|12|||
170529654|NCT00471497|616288421|FG000|Core Treatment Phase|Adverse Event|43|||
170529655|NCT00471497|616288422|FG001|Core Treatment Phase|Adverse Event|53|||
170529656|NCT00471497|616288423|FG002|Core Treatment Phase|Adverse Event|89|||
170529657|NCT00471497|616288421|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
170529658|NCT00471497|616288422|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
170529659|NCT00471497|616288423|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
170529660|NCT00471497|616288421|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
170529661|NCT00471497|616288422|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
170529662|NCT00471497|616288423|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
170529663|NCT00471497|616288421|FG000|Extension Phase|Adverse Event|9|||
170529664|NCT00471497|616288422|FG001|Extension Phase|Adverse Event|5|||
170529665|NCT00471497|616288423|FG002|Extension Phase|Adverse Event|1|||
170529666|NCT00471497|616288421|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
170529667|NCT00471497|616288422|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
170529668|NCT00471497|616288423|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
170529669|NCT00471497|616288421|FG000|Extension Phase|Withdrawal by Subject|3|||
170529670|NCT00471497|616288422|FG001|Extension Phase|Withdrawal by Subject|1|||
170529671|NCT00471497|616288423|FG002|Extension Phase|Withdrawal by Subject|0|||
170529672|NCT00471497|616288421|FG000|Extension Phase|Lost to Follow-up|2|||
170529673|NCT00471497|616288422|FG001|Extension Phase|Lost to Follow-up|0|||
170529674|NCT00471497|616288423|FG002|Extension Phase|Lost to Follow-up|0|||
170529675|NCT00471497|616288421|FG000|Extension Phase|Death|1|||
170529676|NCT00471497|616288422|FG001|Extension Phase|Death|0|||
170529677|NCT00471497|616288423|FG002|Extension Phase|Death|0|||
170529678|NCT00471497|616288421|FG000|Extension Phase|Disease progression|2|||
170529679|NCT00471497|616288422|FG001|Extension Phase|Disease progression|0|||
170529680|NCT00471497|616288423|FG002|Extension Phase|Disease progression|0|||
170529681|NCT00471497|616288421|FG000|Extension Phase|Protocol Violation|2|||
170529682|NCT00471497|616288422|FG001|Extension Phase|Protocol Violation|2|||
170529683|NCT00471497|616288423|FG002|Extension Phase|Protocol Violation|0|||
170529684|NCT03329885|616288424|FG000|Overall Study|Sponsor discontinued the study early|0|||
170529685|NCT03329885|616288425|FG001|Overall Study|Sponsor discontinued the study early|0|||
170529686|NCT03329885|616288426|FG002|Overall Study|Sponsor discontinued the study early|0|||
170529687|NCT03329885|616288427|FG003|Overall Study|Sponsor discontinued the study early|0|||
170529688|NCT03329885|616288428|FG004|Overall Study|Sponsor discontinued the study early|0|||
170529689|NCT03329885|616288429|FG005|Overall Study|Sponsor discontinued the study early|0|||
170529690|NCT03329885|616288430|FG006|Overall Study|Sponsor discontinued the study early|1|||
170529691|NCT03329885|616288431|FG007|Overall Study|Sponsor discontinued the study early|1|||
170529692|NCT03329885|616288432|FG008|Overall Study|Sponsor discontinued the study early|0|||
170529693|NCT04004000|616288433|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
170529694|NCT04865289|616288434|FG000|Overall Study|Death|34|||
170529695|NCT04865289|616288435|FG001|Overall Study|Death|25|||
170529696|NCT04865289|616288434|FG000|Overall Study|Physician Decision|27|||
170529697|NCT04865289|616288435|FG001|Overall Study|Physician Decision|27|||
170529698|NCT04865289|616288434|FG000|Overall Study|Sponsor Decision|11|||
170529699|NCT04865289|616288435|FG001|Overall Study|Sponsor Decision|1|||
170529700|NCT04865289|616288434|FG000|Overall Study|Withdrawal by Subject|2|||
170529701|NCT04865289|616288435|FG001|Overall Study|Withdrawal by Subject|3|||
170529702|NCT03104374|616288436|FG000|Period 1|Adverse Event|7|||
170529703|NCT03104374|616288437|FG001|Period 1|Adverse Event|7|||
170529704|NCT03104374|616288438|FG002|Period 1|Adverse Event|12|||
170529705|NCT03104374|616288439|FG003|Period 1|Adverse Event|14|||
170529706|NCT03104374|616288436|FG000|Period 1|Withdrawal by Subject|18|||
170529707|NCT03104374|616288437|FG001|Period 1|Withdrawal by Subject|9|||
170529708|NCT03104374|616288438|FG002|Period 1|Withdrawal by Subject|10|||
170529709|NCT03104374|616288439|FG003|Period 1|Withdrawal by Subject|17|||
170529710|NCT03104374|616288436|FG000|Period 1|Lost to Follow-up|4|||
170529711|NCT03104374|616288437|FG001|Period 1|Lost to Follow-up|4|||
170529712|NCT03104374|616288438|FG002|Period 1|Lost to Follow-up|6|||
170529713|NCT03104374|616288439|FG003|Period 1|Lost to Follow-up|8|||
170777664|NCT03570892|617192210|FG001|Overall Study|Subject decision|3|||
170529714|NCT03104374|616288436|FG000|Period 1|Lack of Efficacy|6|||
170529715|NCT03104374|616288437|FG001|Period 1|Lack of Efficacy|7|||
170529716|NCT03104374|616288438|FG002|Period 1|Lack of Efficacy|12|||
170777665|NCT03570892|617192209|FG000|Overall Study|Protocol Violation|1|||
170777666|NCT03570892|617192210|FG001|Overall Study|Protocol Violation|4|||
170777667|NCT03570892|617192209|FG000|Overall Study|Physician Decision|0|||
170777668|NCT03570892|617192210|FG001|Overall Study|Physician Decision|2|||
170529717|NCT03104374|616288439|FG003|Period 1|Lack of Efficacy|6|||
170529718|NCT03104374|616288436|FG000|Period 1|Other|2|||
170529719|NCT03104374|616288437|FG001|Period 1|Other|2|||
170529720|NCT03104374|616288438|FG002|Period 1|Other|4|||
170529721|NCT03104374|616288439|FG003|Period 1|Other|7|||
170529722|NCT03104374|616288436|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
170529723|NCT03104374|616288437|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
170529724|NCT03104374|616288438|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
170529725|NCT03104374|616288439|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
170529726|NCT03104374|616288436|FG000|Period 2|Adverse Event|4|||
170529727|NCT03104374|616288437|FG001|Period 2|Adverse Event|7|||
170529728|NCT03104374|616288438|FG002|Period 2|Adverse Event|10|||
170529729|NCT03104374|616288439|FG003|Period 2|Adverse Event|10|||
170529730|NCT03104374|616288436|FG000|Period 2|Withdrawal by Subject|3|||
170529731|NCT03104374|616288437|FG001|Period 2|Withdrawal by Subject|7|||
170529732|NCT03104374|616288438|FG002|Period 2|Withdrawal by Subject|13|||
170529733|NCT03104374|616288439|FG003|Period 2|Withdrawal by Subject|16|||
170529734|NCT03104374|616288436|FG000|Period 2|Lost to Follow-up|2|||
170529735|NCT03104374|616288437|FG001|Period 2|Lost to Follow-up|2|||
170529736|NCT03104374|616288438|FG002|Period 2|Lost to Follow-up|3|||
170529737|NCT03104374|616288439|FG003|Period 2|Lost to Follow-up|5|||
170529738|NCT03104374|616288436|FG000|Period 2|Lack of Efficacy|2|||
170529739|NCT03104374|616288437|FG001|Period 2|Lack of Efficacy|4|||
170529740|NCT03104374|616288438|FG002|Period 2|Lack of Efficacy|7|||
170529741|NCT03104374|616288439|FG003|Period 2|Lack of Efficacy|4|||
170529742|NCT03104374|616288436|FG000|Period 2|COVID-19 Infection|0|||
170529743|NCT03104374|616288437|FG001|Period 2|COVID-19 Infection|0|||
170529744|NCT03104374|616288438|FG002|Period 2|COVID-19 Infection|1|||
170529745|NCT03104374|616288439|FG003|Period 2|COVID-19 Infection|0|||
170529746|NCT03104374|616288436|FG000|Period 2|Other|3|||
170529747|NCT03104374|616288437|FG001|Period 2|Other|2|||
170529748|NCT03104374|616288438|FG002|Period 2|Other|2|||
170529749|NCT03104374|616288439|FG003|Period 2|Other|4|||
170529750|NCT02121210|616288440|FG000|Overall Study|Adverse Event|5|||
170529751|NCT02121210|616288441|FG001|Overall Study|Adverse Event|7|||
170529752|NCT02121210|616288440|FG000|Overall Study|Lack of Efficacy|2|||
170529753|NCT02121210|616288441|FG001|Overall Study|Lack of Efficacy|0|||
170529754|NCT02121210|616288440|FG000|Overall Study|Other than specified above|0|||
170529755|NCT02121210|616288441|FG001|Overall Study|Other than specified above|2|||
170529756|NCT01232283|616288444|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
170529757|NCT01232283|616288445|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
170529758|NCT01232283|616288446|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
170529759|NCT01232283|616288447|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
170529760|NCT01232283|616288448|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
170529761|NCT01232283|616288449|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
170529762|NCT01232283|616288450|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
170529763|NCT01232283|616288451|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
170529764|NCT01232283|616288452|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
170529765|NCT01232283|616288453|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
170529766|NCT01232283|616288444|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
170529767|NCT01232283|616288445|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
170529768|NCT01232283|616288446|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170529769|NCT01232283|616288447|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170529770|NCT01232283|616288448|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170529771|NCT01232283|616288449|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170529772|NCT01232283|616288450|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170529773|NCT01232283|616288451|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170777669|NCT05028582|617192211|FG000|Overall Study|Lost to Follow-up|11|||
170777670|NCT05028582|617192212|FG001|Overall Study|Lost to Follow-up|9|||
170777671|NCT05028582|617192211|FG000|Overall Study|Withdrawal by Subject|9|||
170777672|NCT05028582|617192212|FG001|Overall Study|Withdrawal by Subject|10|||
170777673|NCT05028582|617192211|FG000|Overall Study|Adverse Event|5|||
170777674|NCT05028582|617192212|FG001|Overall Study|Adverse Event|2|||
170777675|NCT05028582|617192211|FG000|Overall Study|Miscellaneous|3|||
170777676|NCT05028582|617192212|FG001|Overall Study|Miscellaneous|2|||
170777677|NCT05028582|617192211|FG000|Overall Study|Lack of Efficacy|3|||
170777678|NCT05028582|617192212|FG001|Overall Study|Lack of Efficacy|1|||
170777679|NCT05028582|617192211|FG000|Overall Study|Physician Decision|0|||
170777680|NCT05028582|617192212|FG001|Overall Study|Physician Decision|1|||
170777681|NCT03891758|617192213|FG000|Overall Study|Adverse Event|2|||
170777682|NCT03891758|617192214|FG001|Overall Study|Adverse Event|0|||
170529774|NCT01232283|616288452|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170529775|NCT01232283|616288453|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170529776|NCT01232283|616288444|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
170529777|NCT01232283|616288445|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170777683|NCT03891758|617192213|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170777684|NCT03891758|617192214|FG001|Overall Study|Withdrawal by parent/guardian|2|||
170777685|NCT02791230|617193922|FG000|Overall Study|Adverse Event|10|||
170777686|NCT02791230|617193923|FG001|Overall Study|Adverse Event|9|||
170777687|NCT02791230|617193924|FG002|Overall Study|Adverse Event|66|||
170777688|NCT02791230|617193922|FG000|Overall Study|Death|38|||
170777689|NCT02791230|617193923|FG001|Overall Study|Death|25|||
170777690|NCT02791230|617193924|FG002|Overall Study|Death|184|||
170777691|NCT02791230|617193922|FG000|Overall Study|Lack of Efficacy|1|||
170777692|NCT02791230|617193923|FG001|Overall Study|Lack of Efficacy|0|||
170777693|NCT02791230|617193924|FG002|Overall Study|Lack of Efficacy|3|||
170877623|NCT01324232|617563943|FG001|Overall Study|Missing|0|||
170877624|NCT01324232|617563944|FG002|Overall Study|Missing|1|||
170877625|NCT01324232|617563945|FG003|Overall Study|Missing|0|||
170877626|NCT01324232|617563942|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
170877627|NCT01324232|617563943|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
170877628|NCT01324232|617563944|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
170877629|NCT01324232|617563945|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
170877630|NCT01324232|617563942|FG000|Overall Study|Lack of Efficacy|2|||
170417357|NCT01658943|615867645|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
170877631|NCT01324232|617563943|FG001|Overall Study|Lack of Efficacy|1|||
170877632|NCT01324232|617563944|FG002|Overall Study|Lack of Efficacy|2|||
170877633|NCT01324232|617563945|FG003|Overall Study|Lack of Efficacy|2|||
170877634|NCT01324232|617563942|FG000|Overall Study|Participant Refused Medication|0|||
170877635|NCT01324232|617563943|FG001|Overall Study|Participant Refused Medication|1|||
170877636|NCT01324232|617563944|FG002|Overall Study|Participant Refused Medication|0|||
170877637|NCT01324232|617563945|FG003|Overall Study|Participant Refused Medication|0|||
170777694|NCT02791230|617193922|FG000|Overall Study|Lost to Follow-up|0|||
170777695|NCT02791230|617193923|FG001|Overall Study|Lost to Follow-up|0|||
170777696|NCT02791230|617193924|FG002|Overall Study|Lost to Follow-up|10|||
170777697|NCT02791230|617193922|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
170777698|NCT02791230|617193923|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
170777699|NCT02791230|617193924|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
170777700|NCT02791230|617193922|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
170777701|NCT02791230|617193923|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
170777702|NCT02791230|617193924|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
170777703|NCT02791230|617193922|FG000|Overall Study|Study sites terminated by sponsor|1|||
170417358|NCT02742181|615867646|FG000|Overall Study|Physician Decision|1|||
170417359|NCT02742181|615867647|FG001|Overall Study|Physician Decision|0|||
170417360|NCT04947579|615867649|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
170417361|NCT04947579|615867650|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
170417362|NCT04947579|615867651|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
170417363|NCT04947579|615867652|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
170417364|NCT04947579|615867653|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
170417365|NCT04947579|615867654|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
170417366|NCT04947579|615867649|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
170417367|NCT04947579|615867650|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
170417368|NCT04947579|615867651|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
170417369|NCT04947579|615867652|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
170417370|NCT04947579|615867653|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
170417371|NCT04947579|615867654|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
170417372|NCT04947579|615867649|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
170417373|NCT04947579|615867650|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
170417374|NCT04947579|615867651|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
170417375|NCT04947579|615867652|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
170417376|NCT04947579|615867653|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
170417377|NCT04947579|615867654|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
170417378|NCT04947579|615867649|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
170417379|NCT04947579|615867650|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
170417380|NCT04947579|615867651|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
170417381|NCT04947579|615867652|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
170417382|NCT04947579|615867653|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
170417383|NCT04947579|615867654|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
170417384|NCT04947579|615867649|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
170632622|NCT01352793|616666715|FG000|Overall Study|Medication error|2|||
170777704|NCT02791230|617193923|FG001|Overall Study|Study sites terminated by sponsor|0|||
170777705|NCT02791230|617193924|FG002|Overall Study|Study sites terminated by sponsor|5|||
170777706|NCT02791230|617193922|FG000|Overall Study|Other|9|||
170877638|NCT01324232|617563942|FG000|Overall Study|Intercurrent illness|0|||
170877639|NCT01324232|617563943|FG001|Overall Study|Intercurrent illness|0|||
170877640|NCT01324232|617563944|FG002|Overall Study|Intercurrent illness|0|||
170877641|NCT01324232|617563945|FG003|Overall Study|Intercurrent illness|1|||
170877642|NCT01324232|617563942|FG000|Overall Study|Adverse Event|2|||
170877643|NCT01324232|617563943|FG001|Overall Study|Adverse Event|5|||
170877644|NCT01324232|617563944|FG002|Overall Study|Adverse Event|6|||
170877645|NCT01324232|617563945|FG003|Overall Study|Adverse Event|6|||
170877646|NCT01324232|617563942|FG000|Overall Study|Withdrawal by Subject|0|||
170877647|NCT01324232|617563943|FG001|Overall Study|Withdrawal by Subject|3|||
170877648|NCT01324232|617563944|FG002|Overall Study|Withdrawal by Subject|4|||
170877649|NCT01324232|617563945|FG003|Overall Study|Withdrawal by Subject|0|||
170877650|NCT01324232|617563942|FG000|Overall Study|Lost to Follow-up|1|||
170877651|NCT01324232|617563943|FG001|Overall Study|Lost to Follow-up|0|||
170877652|NCT01324232|617563944|FG002|Overall Study|Lost to Follow-up|0|||
170877653|NCT01324232|617563945|FG003|Overall Study|Lost to Follow-up|0|||
170877654|NCT02513329|617563946|FG000|Overall Study|Lost to Follow-up|5|||
170877655|NCT02513329|617563947|FG001|Overall Study|Lost to Follow-up|2|||
170877656|NCT04206020|617563948|FG000|Overall Study|Adverse Event|1|||
170877657|NCT04206020|617563949|FG001|Overall Study|Adverse Event|4|||
170877658|NCT04206020|617563948|FG000|Overall Study|Protocol Violation|2|||
170877659|NCT04206020|617563949|FG001|Overall Study|Protocol Violation|0|||
170877660|NCT04206020|617563948|FG000|Overall Study|Withdrawal by Subject|2|||
170877661|NCT04206020|617563949|FG001|Overall Study|Withdrawal by Subject|0|||
170417385|NCT04947579|615867650|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
170417386|NCT04947579|615867651|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
170417387|NCT04947579|615867652|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
170417388|NCT04947579|615867653|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
170417389|NCT04947579|615867654|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
170417390|NCT04947579|615867649|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
170417391|NCT04947579|615867650|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
170417392|NCT04947579|615867651|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
170417393|NCT04947579|615867652|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
170417394|NCT04947579|615867653|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
170417395|NCT04947579|615867654|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
170417396|NCT04947579|615867649|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
170417397|NCT04947579|615867650|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
170417398|NCT04947579|615867651|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
170417399|NCT04947579|615867652|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
170417400|NCT04947579|615867653|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
170417401|NCT04947579|615867654|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
170417402|NCT04947579|615867649|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
170417403|NCT04947579|615867650|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
170417404|NCT04947579|615867651|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
170417405|NCT04947579|615867652|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
170417406|NCT04947579|615867653|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
170417407|NCT04947579|615867654|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
170417408|NCT04947579|615867649|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
170417409|NCT04947579|615867650|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
170417410|NCT04947579|615867651|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
170417411|NCT04947579|615867652|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
170417412|NCT04947579|615867653|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
170417413|NCT04947579|615867654|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
170417414|NCT04947579|615867649|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
170417415|NCT04947579|615867650|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
170417416|NCT04947579|615867651|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
170417417|NCT04947579|615867652|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
170417418|NCT04947579|615867653|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
170417419|NCT04947579|615867654|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
170417420|NCT04947579|615867649|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
170417421|NCT04947579|615867650|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
170417422|NCT04947579|615867651|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
170417423|NCT04947579|615867652|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
170417424|NCT04947579|615867653|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
170417425|NCT04947579|615867654|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
170877662|NCT04206020|617563948|FG000|Overall Study|Lost to Follow-up|2|||
170877663|NCT04206020|617563949|FG001|Overall Study|Lost to Follow-up|0|||
170877664|NCT04206020|617563948|FG000|Overall Study|Pregnancy|0|||
170877665|NCT04206020|617563949|FG001|Overall Study|Pregnancy|1|||
170877666|NCT04206020|617563948|FG000|Overall Study|Unable to attend visits|1|||
170877667|NCT04206020|617563949|FG001|Overall Study|Unable to attend visits|2|||
170877668|NCT01146873|617563950|FG000|Overall Study|Transfer out|0|||
170877669|NCT01146873|617563951|FG001|Overall Study|Transfer out|6|||
170877670|NCT04712110|617563954|FG000|Overall Study|Lost to Follow-up|0|||
170877671|NCT04712110|617563955|FG001|Overall Study|Lost to Follow-up|1|||
170877672|NCT04712110|617563954|FG000|Overall Study|Withdrawal by Subject|0|||
170877673|NCT04712110|617563955|FG001|Overall Study|Withdrawal by Subject|4|||
170877674|NCT04712110|617563954|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
170877675|NCT04712110|617563955|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
170877676|NCT02055820|617563958|FG000|Phase I: Dose-Finding|Death|1|||
170877677|NCT02055820|617563959|FG001|Phase I: Dose-Finding|Death|0|||
170877678|NCT02055820|617563960|FG002|Phase I: Dose-Finding|Death|1|||
170417426|NCT01298570|615869269|FG000|Overall Study|Disease progression, relapse during acti|64|||
170417427|NCT01298570|615869270|FG001|Overall Study|Disease progression, relapse during acti|40|||
170417428|NCT01298570|615869269|FG000|Overall Study|Adverse Event|20|||
170417429|NCT01298570|615869270|FG001|Overall Study|Adverse Event|2|||
170417430|NCT01298570|615869269|FG000|Overall Study|Withdrawal by Subject|21|||
170417431|NCT01298570|615869270|FG001|Overall Study|Withdrawal by Subject|6|||
170417432|NCT01298570|615869269|FG000|Overall Study|Treatment delay > 4 weeks|4|||
170417433|NCT01298570|615869270|FG001|Overall Study|Treatment delay > 4 weeks|5|||
170417434|NCT01298570|615869269|FG000|Overall Study|Physician Decision|4|||
170417435|NCT01298570|615869270|FG001|Overall Study|Physician Decision|2|||
170417436|NCT01298570|615869269|FG000|Overall Study|Other complicating disease|2|||
170417437|NCT01298570|615869270|FG001|Overall Study|Other complicating disease|1|||
170417438|NCT01298570|615869269|FG000|Overall Study|Surgery|2|||
170417439|NCT01298570|615869270|FG001|Overall Study|Surgery|1|||
170417440|NCT01298570|615869269|FG000|Overall Study|Symptomatic progression/deterioration|3|||
170417441|NCT01298570|615869270|FG001|Overall Study|Symptomatic progression/deterioration|2|||
170417442|NCT01298570|615869269|FG000|Overall Study|Death|0|||
170777707|NCT02791230|617193923|FG001|Overall Study|Other|1|||
170777708|NCT02791230|617193924|FG002|Overall Study|Other|28|||
170777709|NCT02791230|617193922|FG000|Overall Study|Protocol Violation|0|||
170777710|NCT02791230|617193923|FG001|Overall Study|Protocol Violation|0|||
170777711|NCT02791230|617193924|FG002|Overall Study|Protocol Violation|4|||
170777712|NCT02791230|617193922|FG000|Overall Study|Withdrawal by Subject|24|||
170777713|NCT02791230|617193923|FG001|Overall Study|Withdrawal by Subject|13|||
170777714|NCT02791230|617193924|FG002|Overall Study|Withdrawal by Subject|172|||
170877679|NCT02055820|617563961|FG003|Phase I: Dose-Finding|Death|2|||
170877680|NCT02055820|617563962|FG004|Phase I: Dose-Finding|Death|0|||
170877681|NCT02055820|617563963|FG005|Phase I: Dose-Finding|Death|1|||
170877682|NCT02055820|617563964|FG006|Phase I: Dose-Finding|Death|1|||
170417443|NCT01298570|615869270|FG001|Overall Study|Death|1|||
170877683|NCT02055820|617563965|FG007|Phase I: Dose-Finding|Death|0|||
170877684|NCT02055820|617563966|FG008|Phase I: Dose-Finding|Death|0|||
170877685|NCT02055820|617563967|FG009|Phase I: Dose-Finding|Death|0|||
170877686|NCT02055820|617563958|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877687|NCT02055820|617563959|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877688|NCT02055820|617563960|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877689|NCT02055820|617563961|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877690|NCT02055820|617563962|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877691|NCT02055820|617563963|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
170877692|NCT02055820|617563964|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877693|NCT02055820|617563965|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877694|NCT02055820|617563966|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877695|NCT02055820|617563967|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
170877696|NCT02055820|617563958|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
170877697|NCT02055820|617563959|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
170877698|NCT02055820|617563960|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
170877699|NCT02055820|617563961|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
170877700|NCT02055820|617563962|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
170877701|NCT02055820|617563963|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
170877702|NCT02055820|617563964|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
170877703|NCT02055820|617563965|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
170877704|NCT02055820|617563966|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
170877705|NCT02055820|617563967|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
170877706|NCT02055820|617563958|FG000|Phase II: Expansion|Death|0|||
170877707|NCT02055820|617563959|FG001|Phase II: Expansion|Death|0|||
170877708|NCT02055820|617563960|FG002|Phase II: Expansion|Death|0|||
170877709|NCT02055820|617563961|FG003|Phase II: Expansion|Death|0|||
170777715|NCT02791230|617193922|FG000|Overall Study|Enrolled but not treated|0|||
170777716|NCT02791230|617193923|FG001|Overall Study|Enrolled but not treated|0|||
170777717|NCT02791230|617193924|FG002|Overall Study|Enrolled but not treated|5|||
170877710|NCT02055820|617563962|FG004|Phase II: Expansion|Death|33|||
170877711|NCT02055820|617563963|FG005|Phase II: Expansion|Death|0|||
170877712|NCT02055820|617563964|FG006|Phase II: Expansion|Death|0|||
170877713|NCT02055820|617563965|FG007|Phase II: Expansion|Death|0|||
170877714|NCT02055820|617563966|FG008|Phase II: Expansion|Death|0|||
170877715|NCT02055820|617563967|FG009|Phase II: Expansion|Death|0|||
170877716|NCT02055820|617563958|FG000|Phase II: Expansion|Lost to Follow-up|0|||
170877717|NCT02055820|617563959|FG001|Phase II: Expansion|Lost to Follow-up|0|||
170877718|NCT02055820|617563960|FG002|Phase II: Expansion|Lost to Follow-up|0|||
170877719|NCT02055820|617563961|FG003|Phase II: Expansion|Lost to Follow-up|0|||
170529778|NCT01232283|616288446|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170529779|NCT01232283|616288447|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170529780|NCT01232283|616288448|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170529781|NCT01232283|616288449|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170529782|NCT01232283|616288450|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170529783|NCT01232283|616288451|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170529784|NCT01232283|616288452|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170529785|NCT01232283|616288453|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
170529786|NCT01232283|616288444|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
170529787|NCT01232283|616288445|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
170529788|NCT01232283|616288446|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170529789|NCT01232283|616288447|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170529790|NCT01232283|616288448|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170529791|NCT01232283|616288449|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170877720|NCT02055820|617563962|FG004|Phase II: Expansion|Lost to Follow-up|4|||
170529792|NCT01232283|616288450|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170529793|NCT01232283|616288451|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170529794|NCT01232283|616288452|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170529795|NCT01232283|616288453|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170529796|NCT01232283|616288444|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
170529797|NCT01232283|616288445|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
170529798|NCT01232283|616288446|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
170529799|NCT01232283|616288447|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
170529800|NCT01232283|616288448|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
170529801|NCT01232283|616288449|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
170529802|NCT01232283|616288450|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
170529803|NCT01232283|616288451|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
170529804|NCT01232283|616288452|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
170529805|NCT01232283|616288453|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
170529806|NCT01232283|616288444|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
170529807|NCT01232283|616288445|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
170529808|NCT01232283|616288446|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
170529809|NCT01232283|616288447|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
170529810|NCT01232283|616288448|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
170529811|NCT01232283|616288449|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
170529812|NCT01232283|616288450|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
170529813|NCT01232283|616288451|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
170529814|NCT01232283|616288452|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
170529815|NCT01232283|616288453|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
170529816|NCT01232283|616288444|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
170529817|NCT01232283|616288445|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
170529818|NCT01232283|616288446|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
170529819|NCT01232283|616288447|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
170529820|NCT01232283|616288448|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
170529821|NCT01232283|616288449|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
170529822|NCT01232283|616288450|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
170529823|NCT01232283|616288451|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
170529824|NCT01232283|616288452|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
170529825|NCT01232283|616288453|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
170529826|NCT01232283|616288444|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
170529827|NCT01232283|616288445|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
170529828|NCT01232283|616288446|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
170529829|NCT01232283|616288447|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
170529830|NCT01232283|616288448|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
170529831|NCT01232283|616288449|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
170529832|NCT01232283|616288450|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
170877721|NCT02055820|617563963|FG005|Phase II: Expansion|Lost to Follow-up|0|||
170877722|NCT02055820|617563964|FG006|Phase II: Expansion|Lost to Follow-up|0|||
170529833|NCT01232283|616288451|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
170529834|NCT01232283|616288452|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
170877723|NCT02055820|617563965|FG007|Phase II: Expansion|Lost to Follow-up|0|||
170877724|NCT02055820|617563966|FG008|Phase II: Expansion|Lost to Follow-up|0|||
170529835|NCT01232283|616288453|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
170529836|NCT01232283|616288444|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
170529837|NCT01232283|616288445|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
170529838|NCT01232283|616288446|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
170529839|NCT01232283|616288447|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
170529840|NCT01232283|616288448|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
170529841|NCT01232283|616288449|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
170529842|NCT01232283|616288450|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
170529843|NCT01232283|616288451|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
170529844|NCT01232283|616288452|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
170529845|NCT01232283|616288453|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
170529846|NCT01232283|616288444|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529847|NCT01232283|616288445|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529848|NCT01232283|616288446|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
170529849|NCT01232283|616288447|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529850|NCT01232283|616288448|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529851|NCT01232283|616288449|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529852|NCT01232283|616288450|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529853|NCT01232283|616288451|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529854|NCT01232283|616288452|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529855|NCT01232283|616288453|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
170529856|NCT01232283|616288444|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
170529857|NCT01232283|616288445|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
170529858|NCT01232283|616288446|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
170529859|NCT01232283|616288447|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
170529860|NCT01232283|616288448|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
170529861|NCT01232283|616288449|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
170529862|NCT01232283|616288450|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
170529863|NCT01232283|616288451|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
170417444|NCT01298570|615869269|FG000|Overall Study|Ineligibility|0|||
170417445|NCT01298570|615869270|FG001|Overall Study|Ineligibility|1|||
170417446|NCT01781637|615869272|FG000|Overall Study|Adverse Event|1|||
170417447|NCT01781637|615869273|FG001|Overall Study|Adverse Event|0|||
170417448|NCT01781637|615869272|FG000|Overall Study|Lack of Efficacy|2|||
170417449|NCT01781637|615869273|FG001|Overall Study|Lack of Efficacy|6|||
170417450|NCT01781637|615869272|FG000|Overall Study|Withdrawal by Subject|1|||
170417451|NCT01781637|615869273|FG001|Overall Study|Withdrawal by Subject|0|||
170417452|NCT02637232|615869274|FG000|Overall Study|Lost to Follow-up|42|||
170417453|NCT02637232|615869274|FG000|Overall Study|Adverse Event|11|||
170417454|NCT02637232|615869274|FG000|Overall Study|patient 's decision|2|||
170417455|NCT02999178|615869275|FG000|Overall Study|Adverse Event|85|||
170417456|NCT02999178|615869276|FG001|Overall Study|Adverse Event|62|||
170417457|NCT02999178|615869275|FG000|Overall Study|Protocol Violation|1|||
170417458|NCT02999178|615869276|FG001|Overall Study|Protocol Violation|2|||
170417459|NCT02999178|615869275|FG000|Overall Study|Lost to Follow-up|0|||
170417460|NCT02999178|615869276|FG001|Overall Study|Lost to Follow-up|2|||
170417461|NCT02999178|615869275|FG000|Overall Study|Withdrawal by Subject|21|||
170417462|NCT02999178|615869276|FG001|Overall Study|Withdrawal by Subject|21|||
170417463|NCT02999178|615869275|FG000|Overall Study|Other reason not defined above|7|||
170417464|NCT02999178|615869276|FG001|Overall Study|Other reason not defined above|13|||
170417465|NCT00863746|615869279|FG000|Treatment|Not treated|4|||
170417466|NCT00863746|615869280|FG001|Treatment|Not treated|2|||
170877725|NCT02055820|617563967|FG009|Phase II: Expansion|Lost to Follow-up|0|||
170877726|NCT02055820|617563958|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
170417467|NCT00863746|615869279|FG000|Treatment|Adverse Event|41|||
170417468|NCT00863746|615869280|FG001|Treatment|Adverse Event|16|||
170417469|NCT00863746|615869279|FG000|Treatment|non-compliant with study medication|4|||
170417470|NCT00863746|615869280|FG001|Treatment|non-compliant with study medication|0|||
170417471|NCT00863746|615869279|FG000|Treatment|Consent withdrawn|15|||
170417472|NCT00863746|615869280|FG001|Treatment|Consent withdrawn|14|||
170417473|NCT00863746|615869279|FG000|Treatment|Lost to Follow-up|1|||
170417474|NCT00863746|615869280|FG001|Treatment|Lost to Follow-up|0|||
170417475|NCT00863746|615869279|FG000|Treatment|Protocol Violation|5|||
170417476|NCT00863746|615869280|FG001|Treatment|Protocol Violation|3|||
170417477|NCT00863746|615869279|FG000|Treatment|Other|1|||
170417478|NCT00863746|615869280|FG001|Treatment|Other|0|||
170417479|NCT00863746|615869279|FG000|Survival Follow up|Death|244|||
170417480|NCT00863746|615869280|FG001|Survival Follow up|Death|271|||
170417481|NCT00863746|615869279|FG000|Survival Follow up|Lost to Follow-up|2|||
170417482|NCT00863746|615869280|FG001|Survival Follow up|Lost to Follow-up|1|||
170417483|NCT00863746|615869279|FG000|Survival Follow up|Consent Withdrawn|7|||
170417484|NCT00863746|615869280|FG001|Survival Follow up|Consent Withdrawn|8|||
170417485|NCT05301751|615869283|FG000|Overall Study|Withdrawal by Subject|0|||
170417486|NCT05301751|615869284|FG001|Overall Study|Withdrawal by Subject|0|||
170417487|NCT05301751|615869285|FG002|Overall Study|Withdrawal by Subject|1|||
170417488|NCT05301751|615869286|FG003|Overall Study|Withdrawal by Subject|0|||
170417489|NCT00920140|615869291|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
170417490|NCT00920140|615869292|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
170417491|NCT00920140|615869293|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
170417492|NCT00920140|615869294|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
170417493|NCT00920140|615869295|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
170417494|NCT00920140|615869291|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
170417495|NCT00920140|615869292|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
170417496|NCT00920140|615869293|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
170417497|NCT00920140|615869294|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
170417498|NCT00920140|615869295|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
170417499|NCT00920140|615869291|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170417500|NCT00920140|615869292|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
170417501|NCT00920140|615869293|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170417502|NCT00920140|615869294|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170417503|NCT00920140|615869295|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170417504|NCT00920140|615869291|FG000|Phase 2|Adverse Event|0|||
170417505|NCT00920140|615869292|FG001|Phase 2|Adverse Event|0|||
170417506|NCT00920140|615869293|FG002|Phase 2|Adverse Event|14|||
170417507|NCT00920140|615869294|FG003|Phase 2|Adverse Event|2|||
170417508|NCT00920140|615869295|FG004|Phase 2|Adverse Event|3|||
170632623|NCT01352793|616666716|FG001|Overall Study|Medication error|2|||
170777718|NCT05075408|617193925|FG000|Overall Study|Withdrawal by Subject|5|||
170777719|NCT05075408|617193926|FG001|Overall Study|Withdrawal by Subject|3|||
170777720|NCT05075408|617193927|FG002|Overall Study|Withdrawal by Subject|4|||
170777721|NCT05075408|617193925|FG000|Overall Study|Adverse Event|5|||
170777722|NCT05075408|617193926|FG001|Overall Study|Adverse Event|7|||
170777723|NCT05075408|617193927|FG002|Overall Study|Adverse Event|8|||
170777724|NCT05075408|617193925|FG000|Overall Study|Protocol Violation|0|||
170777725|NCT05075408|617193926|FG001|Overall Study|Protocol Violation|1|||
170777726|NCT05075408|617193927|FG002|Overall Study|Protocol Violation|0|||
170777727|NCT05075408|617193925|FG000|Overall Study|Lost to Follow-up|2|||
170777728|NCT05075408|617193926|FG001|Overall Study|Lost to Follow-up|1|||
170777729|NCT05075408|617193927|FG002|Overall Study|Lost to Follow-up|1|||
170777730|NCT05075408|617193925|FG000|Overall Study|Physician Decision|1|||
170777731|NCT05075408|617193926|FG001|Overall Study|Physician Decision|0|||
170777732|NCT05075408|617193927|FG002|Overall Study|Physician Decision|0|||
170777733|NCT05075408|617193925|FG000|Overall Study|Other-unspecified|3|||
170777734|NCT05075408|617193926|FG001|Overall Study|Other-unspecified|2|||
170777735|NCT05075408|617193927|FG002|Overall Study|Other-unspecified|0|||
170777736|NCT03416023|617193928|FG000|Overall Study|Exclusion criteria failure|1|||
170417509|NCT00920140|615869291|FG000|Phase 2|Lack of Efficacy|0|||
170417510|NCT00920140|615869292|FG001|Phase 2|Lack of Efficacy|0|||
170417511|NCT00920140|615869293|FG002|Phase 2|Lack of Efficacy|29|||
170417512|NCT00920140|615869294|FG003|Phase 2|Lack of Efficacy|14|||
170417513|NCT00920140|615869295|FG004|Phase 2|Lack of Efficacy|5|||
170777737|NCT03416023|617193928|FG000|Overall Study|Withdrawal by Subject|6|||
170777738|NCT03416023|617193928|FG000|Overall Study|Explanted|7|||
170777739|NCT03416023|617193928|FG000|Overall Study|Physician Decision|1|||
170777740|NCT03416023|617193928|FG000|Overall Study|Lost to Follow-up|1|||
170417514|NCT00920140|615869291|FG000|Phase 2|Lost to Follow-up|0|||
170417515|NCT00920140|615869292|FG001|Phase 2|Lost to Follow-up|0|||
170417516|NCT00920140|615869293|FG002|Phase 2|Lost to Follow-up|0|||
170417517|NCT00920140|615869294|FG003|Phase 2|Lost to Follow-up|1|||
170777741|NCT03416023|617193928|FG000|Overall Study|Death|1|||
170777742|NCT03651895|617193929|FG000|First Drug Assignment|Adverse Event|4|||
170417518|NCT00920140|615869295|FG004|Phase 2|Lost to Follow-up|0|||
170417519|NCT00920140|615869291|FG000|Phase 2|Physician Decision|0|||
170417520|NCT00920140|615869292|FG001|Phase 2|Physician Decision|0|||
170417521|NCT00920140|615869293|FG002|Phase 2|Physician Decision|3|||
170417522|NCT00920140|615869294|FG003|Phase 2|Physician Decision|3|||
170417523|NCT00920140|615869295|FG004|Phase 2|Physician Decision|2|||
170417524|NCT00920140|615869291|FG000|Phase 2|Withdrawal by Subject|0|||
170417525|NCT00920140|615869292|FG001|Phase 2|Withdrawal by Subject|0|||
170417526|NCT00920140|615869293|FG002|Phase 2|Withdrawal by Subject|4|||
170417527|NCT00920140|615869294|FG003|Phase 2|Withdrawal by Subject|2|||
170417528|NCT00920140|615869295|FG004|Phase 2|Withdrawal by Subject|1|||
170417529|NCT03331042|615869297|FG000|Overall Study|Protocol Violation|1|||
170417530|NCT03331042|615869298|FG001|Overall Study|Protocol Violation|0|||
170417531|NCT03331042|615869299|FG002|Overall Study|Protocol Violation|0|||
170417532|NCT03331042|615869300|FG003|Overall Study|Protocol Violation|0|||
170417533|NCT03331042|615869297|FG000|Overall Study|Physician Decision|0|||
170417534|NCT03331042|615869298|FG001|Overall Study|Physician Decision|0|||
170417535|NCT03331042|615869299|FG002|Overall Study|Physician Decision|1|||
170417536|NCT03331042|615869300|FG003|Overall Study|Physician Decision|0|||
170417537|NCT03331042|615869297|FG000|Overall Study|Lost to Follow-up|0|||
170417538|NCT03331042|615869298|FG001|Overall Study|Lost to Follow-up|0|||
170417539|NCT03331042|615869299|FG002|Overall Study|Lost to Follow-up|0|||
170417540|NCT03331042|615869300|FG003|Overall Study|Lost to Follow-up|1|||
170417541|NCT01400425|615869303|FG000|Overall Study|Withdrawal by Subject|10|||
170417542|NCT04557124|615869305|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
170417543|NCT04557124|615869306|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
170417544|NCT04557124|615869305|FG000|Mid-point (1 Month)|Missed testing|5|||
170417545|NCT04557124|615869306|FG001|Mid-point (1 Month)|Missed testing|4|||
170417546|NCT04557124|615869305|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
170417547|NCT04557124|615869306|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
170417548|NCT04557124|615869305|FG000|Post-testing (2 Months)|Missed testing|1|||
170417549|NCT04557124|615869306|FG001|Post-testing (2 Months)|Missed testing|5|||
170417550|NCT04557124|615869305|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
170417551|NCT04557124|615869306|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
170417552|NCT04557124|615869305|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
170417553|NCT04557124|615869306|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
170417554|NCT00442936|615869307|FG000|Overall Study|Protocol Violation|1|||
170417555|NCT00442936|615869308|FG001|Overall Study|Protocol Violation|0|||
170417556|NCT00442936|615869309|FG002|Overall Study|Protocol Violation|1|||
170417557|NCT00442936|615869310|FG003|Overall Study|Protocol Violation|1|||
170417558|NCT02460159|615869317|FG000|Overall Study|Adverse Event|4|||
170417559|NCT02460159|615869318|FG001|Overall Study|Adverse Event|1|||
170417560|NCT02460159|615869317|FG000|Overall Study|Withdrawal by Subject|2|||
170417561|NCT02460159|615869318|FG001|Overall Study|Withdrawal by Subject|0|||
170417562|NCT00243932|615869321|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
170417563|NCT00243932|615869322|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
170417564|NCT00243932|615869323|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
170417565|NCT00084084|615869324|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
170417566|NCT00084084|615869324|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
170417567|NCT01047345|615869325|FG000|Base Study|Adverse Event|3|||
170417568|NCT01047345|615869326|FG001|Base Study|Adverse Event|0|||
170417569|NCT01047345|615869327|FG002|Base Study|Adverse Event|0|||
170417570|NCT01047345|615869325|FG000|Base Study|Lost to Follow-up|4|||
170417571|NCT01047345|615869326|FG001|Base Study|Lost to Follow-up|1|||
170417572|NCT01047345|615869327|FG002|Base Study|Lost to Follow-up|0|||
170417573|NCT01047345|615869325|FG000|Base Study|Protocol Violation|3|||
170417574|NCT01047345|615869326|FG001|Base Study|Protocol Violation|1|||
170417575|NCT01047345|615869327|FG002|Base Study|Protocol Violation|0|||
170417576|NCT01047345|615869325|FG000|Base Study|Withdrawal by Subject|12|||
170417577|NCT01047345|615869326|FG001|Base Study|Withdrawal by Subject|4|||
170417578|NCT01047345|615869327|FG002|Base Study|Withdrawal by Subject|0|||
170529864|NCT01232283|616288452|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
170529865|NCT01232283|616288453|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
170417579|NCT01047345|615869325|FG000|Extension|Withdrawal by Subject|0|||
170417580|NCT01047345|615869326|FG001|Extension|Withdrawal by Subject|0|||
170417581|NCT01047345|615869327|FG002|Extension|Withdrawal by Subject|1|||
170417582|NCT01047345|615869325|FG000|Extension|Lost to Follow-up|0|||
170417583|NCT01047345|615869326|FG001|Extension|Lost to Follow-up|0|||
170417584|NCT01047345|615869327|FG002|Extension|Lost to Follow-up|5|||
170417585|NCT00712010|615869328|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
170417586|NCT01974895|615869343|FG000|Overall Study|Protocol Violation|1|||
170417587|NCT01974895|615869344|FG001|Overall Study|Protocol Violation|0|||
170417588|NCT01974895|615869343|FG000|Overall Study|Lost to Follow-up|4|||
170417589|NCT01974895|615869344|FG001|Overall Study|Lost to Follow-up|6|||
170417590|NCT01974895|615869343|FG000|Overall Study|Withdrawal by Subject|0|||
170417591|NCT01974895|615869344|FG001|Overall Study|Withdrawal by Subject|1|||
170417592|NCT01974895|615869343|FG000|Overall Study|Other (Missed Visit)|1|||
170417593|NCT01974895|615869344|FG001|Overall Study|Other (Missed Visit)|0|||
170417594|NCT01974895|615869343|FG000|Overall Study|Other (Reason unknown)|9|||
170417595|NCT01974895|615869344|FG001|Overall Study|Other (Reason unknown)|8|||
170417596|NCT00449150|615869345|FG000|Overall Study|Adverse Event|11|||
170417597|NCT00449150|615869346|FG001|Overall Study|Adverse Event|18|||
170417598|NCT00449150|615869347|FG002|Overall Study|Adverse Event|9|||
170417599|NCT00449150|615869345|FG000|Overall Study|Lack of Efficacy|1|||
170417600|NCT00449150|615869346|FG001|Overall Study|Lack of Efficacy|2|||
170417601|NCT00449150|615869347|FG002|Overall Study|Lack of Efficacy|2|||
170417602|NCT00449150|615869345|FG000|Overall Study|Other|16|||
170417603|NCT00449150|615869346|FG001|Overall Study|Other|13|||
170417604|NCT00449150|615869347|FG002|Overall Study|Other|14|||
170417605|NCT00449150|615869345|FG000|Overall Study|Withdrawal by Subject|17|||
170417606|NCT00449150|615869346|FG001|Overall Study|Withdrawal by Subject|18|||
170417607|NCT00449150|615869347|FG002|Overall Study|Withdrawal by Subject|21|||
170417608|NCT00449150|615869345|FG000|Overall Study|Protocol Violation|1|||
170417609|NCT00449150|615869346|FG001|Overall Study|Protocol Violation|2|||
170417610|NCT00449150|615869347|FG002|Overall Study|Protocol Violation|1|||
170417611|NCT03552757|615869349|FG000|Overall Study|Withdrawal by Subject|10|||
170417612|NCT03552757|615869350|FG001|Overall Study|Withdrawal by Subject|5|||
170417613|NCT03552757|615869351|FG002|Overall Study|Withdrawal by Subject|12|||
170417614|NCT03552757|615869349|FG000|Overall Study|Lost to Follow-up|2|||
170417615|NCT03552757|615869350|FG001|Overall Study|Lost to Follow-up|7|||
170417616|NCT03552757|615869351|FG002|Overall Study|Lost to Follow-up|7|||
170417617|NCT03552757|615869349|FG000|Overall Study|Death|1|||
170417618|NCT03552757|615869350|FG001|Overall Study|Death|1|||
170417619|NCT03552757|615869351|FG002|Overall Study|Death|1|||
170417620|NCT00860405|615869352|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
170417621|NCT00860405|615869353|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
170417622|NCT00995553|615869354|FG000|Overall Study|Withdrawal by Subject|2|||
170417623|NCT00995553|615869355|FG001|Overall Study|Withdrawal by Subject|6|||
170417624|NCT00927810|615869356|FG000|Overall Study|Withdrawal by Subject|0|||
170417625|NCT00927810|615869357|FG001|Overall Study|Withdrawal by Subject|3|||
170417626|NCT00927810|615869358|FG002|Overall Study|Withdrawal by Subject|0|||
170417627|NCT00927810|615869359|FG003|Overall Study|Withdrawal by Subject|1|||
170417628|NCT00927810|615869356|FG000|Overall Study|Lost to Follow-up|0|||
170417629|NCT00927810|615869357|FG001|Overall Study|Lost to Follow-up|2|||
170417630|NCT00927810|615869358|FG002|Overall Study|Lost to Follow-up|1|||
170417631|NCT00927810|615869359|FG003|Overall Study|Lost to Follow-up|1|||
170417632|NCT00927810|615869356|FG000|Overall Study|Death|0|||
170417633|NCT00927810|615869357|FG001|Overall Study|Death|2|||
170417634|NCT00927810|615869358|FG002|Overall Study|Death|0|||
170417635|NCT00927810|615869359|FG003|Overall Study|Death|0|||
170417636|NCT00927810|615869356|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170417637|NCT00927810|615869357|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170417638|NCT00927810|615869358|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170417639|NCT00927810|615869359|FG003|Overall Study|Abnormal laboratory value(s)|0|||
170417640|NCT00198029|615869362|FG000|Overall Study|Withdrawal by Subject|4|||
170417641|NCT02465567|615869363|FG000|Overall Study|Adverse Event|118|||
170417642|NCT02465567|615869364|FG001|Overall Study|Adverse Event|113|||
170417643|NCT02465567|615869365|FG002|Overall Study|Adverse Event|147|||
170417644|NCT02465567|615869366|FG003|Overall Study|Adverse Event|138|||
170417645|NCT02465567|615869363|FG000|Overall Study|Lack of Efficacy|103|||
170417646|NCT02465567|615869364|FG001|Overall Study|Lack of Efficacy|102|||
170417647|NCT02465567|615869365|FG002|Overall Study|Lack of Efficacy|171|||
170417648|NCT02465567|615869366|FG003|Overall Study|Lack of Efficacy|135|||
170417649|NCT02465567|615869363|FG000|Overall Study|Withdrawal by Subject|104|||
170417650|NCT02465567|615869364|FG001|Overall Study|Withdrawal by Subject|94|||
170417651|NCT02465567|615869365|FG002|Overall Study|Withdrawal by Subject|123|||
170417652|NCT02465567|615869366|FG003|Overall Study|Withdrawal by Subject|130|||
170417653|NCT02465567|615869363|FG000|Overall Study|Physician Decision|23|||
170417654|NCT02465567|615869364|FG001|Overall Study|Physician Decision|33|||
170417655|NCT02465567|615869365|FG002|Overall Study|Physician Decision|38|||
170417656|NCT02465567|615869366|FG003|Overall Study|Physician Decision|28|||
170417657|NCT02465567|615869363|FG000|Overall Study|Major Protocol Deviation|24|||
170417658|NCT02465567|615869364|FG001|Overall Study|Major Protocol Deviation|26|||
170529866|NCT01232283|616288444|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
170529867|NCT01232283|616288445|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
170529868|NCT01232283|616288446|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
170529869|NCT01232283|616288447|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
170529870|NCT01232283|616288448|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
170529871|NCT01232283|616288449|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
170529872|NCT01232283|616288450|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
170529873|NCT01232283|616288451|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
170529874|NCT01232283|616288452|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
170417659|NCT02465567|615869365|FG002|Overall Study|Major Protocol Deviation|22|||
170417660|NCT02465567|615869366|FG003|Overall Study|Major Protocol Deviation|25|||
170417661|NCT02465567|615869363|FG000|Overall Study|Lost to Follow-up|25|||
170417662|NCT02465567|615869364|FG001|Overall Study|Lost to Follow-up|21|||
170417663|NCT02465567|615869365|FG002|Overall Study|Lost to Follow-up|19|||
170417664|NCT02465567|615869366|FG003|Overall Study|Lost to Follow-up|15|||
170417665|NCT02465567|615869363|FG000|Overall Study|Protocol Specified Criteria|20|||
170417666|NCT02465567|615869364|FG001|Overall Study|Protocol Specified Criteria|10|||
170417667|NCT02465567|615869365|FG002|Overall Study|Protocol Specified Criteria|9|||
170417668|NCT02465567|615869366|FG003|Overall Study|Protocol Specified Criteria|12|||
170417669|NCT02465567|615869363|FG000|Overall Study|Administrative Reasons|12|||
170417670|NCT02465567|615869364|FG001|Overall Study|Administrative Reasons|9|||
170417671|NCT02465567|615869365|FG002|Overall Study|Administrative Reasons|11|||
170417672|NCT02465567|615869366|FG003|Overall Study|Administrative Reasons|5|||
170417673|NCT02465567|615869363|FG000|Overall Study|Randomized but not treated|1|||
170417674|NCT02465567|615869364|FG001|Overall Study|Randomized but not treated|5|||
170417675|NCT02465567|615869365|FG002|Overall Study|Randomized but not treated|4|||
170417676|NCT02465567|615869366|FG003|Overall Study|Randomized but not treated|5|||
170417677|NCT02465567|615869363|FG000|Overall Study|enrolled in >1 studies|18|||
170417678|NCT02465567|615869364|FG001|Overall Study|enrolled in >1 studies|11|||
170417679|NCT02465567|615869365|FG002|Overall Study|enrolled in >1 studies|19|||
170417680|NCT02465567|615869366|FG003|Overall Study|enrolled in >1 studies|15|||
170417681|NCT02465567|615869363|FG000|Overall Study|missing PI Signature|1|||
170417682|NCT02465567|615869364|FG001|Overall Study|missing PI Signature|0|||
170417683|NCT02465567|615869365|FG002|Overall Study|missing PI Signature|0|||
170417684|NCT02465567|615869366|FG003|Overall Study|missing PI Signature|0|||
170417685|NCT02001558|615869367|FG000|Overall Study|Lost to Follow-up|8|||
170417686|NCT02001558|615869368|FG001|Overall Study|Lost to Follow-up|14|||
170417687|NCT00950807|615869371|FG000|Treatment Period 1|Lack of Efficacy|1|||
170417688|NCT00950807|615869372|FG001|Treatment Period 1|Lack of Efficacy|0|||
170417689|NCT00950807|615869373|FG002|Treatment Period 1|Lack of Efficacy|0|||
170417690|NCT00950807|615869374|FG003|Treatment Period 1|Lack of Efficacy|0|||
170417691|NCT00950807|615869375|FG004|Treatment Period 1|Lack of Efficacy|0|||
170417692|NCT00950807|615869376|FG005|Treatment Period 1|Lack of Efficacy|1|||
170417693|NCT00950807|615869377|FG006|Treatment Period 1|Lack of Efficacy|0|||
170417694|NCT00950807|615869378|FG007|Treatment Period 1|Lack of Efficacy|0|||
170417695|NCT00950807|615869379|FG008|Treatment Period 1|Lack of Efficacy|0|||
170417696|NCT00950807|615869380|FG009|Treatment Period 1|Lack of Efficacy|0|||
170417697|NCT00950807|615869371|FG000|Treatment Period 1|Protocol Violation|1|||
170417698|NCT00950807|615869372|FG001|Treatment Period 1|Protocol Violation|0|||
170417699|NCT00950807|615869373|FG002|Treatment Period 1|Protocol Violation|0|||
170417700|NCT00950807|615869374|FG003|Treatment Period 1|Protocol Violation|0|||
170417701|NCT00950807|615869375|FG004|Treatment Period 1|Protocol Violation|0|||
170417702|NCT00950807|615869376|FG005|Treatment Period 1|Protocol Violation|0|||
170417703|NCT00950807|615869377|FG006|Treatment Period 1|Protocol Violation|0|||
170417704|NCT00950807|615869378|FG007|Treatment Period 1|Protocol Violation|0|||
170417705|NCT00950807|615869379|FG008|Treatment Period 1|Protocol Violation|0|||
170417706|NCT00950807|615869380|FG009|Treatment Period 1|Protocol Violation|0|||
170417707|NCT00950807|615869371|FG000|Treatment Period 1|Lost to Follow-up|0|||
170417708|NCT00950807|615869372|FG001|Treatment Period 1|Lost to Follow-up|0|||
170417709|NCT00950807|615869373|FG002|Treatment Period 1|Lost to Follow-up|1|||
170417710|NCT00950807|615869374|FG003|Treatment Period 1|Lost to Follow-up|0|||
170417711|NCT00950807|615869375|FG004|Treatment Period 1|Lost to Follow-up|0|||
170417712|NCT00950807|615869376|FG005|Treatment Period 1|Lost to Follow-up|0|||
170417713|NCT00950807|615869377|FG006|Treatment Period 1|Lost to Follow-up|0|||
170417714|NCT00950807|615869378|FG007|Treatment Period 1|Lost to Follow-up|0|||
170417715|NCT00950807|615869379|FG008|Treatment Period 1|Lost to Follow-up|0|||
170417716|NCT00950807|615869380|FG009|Treatment Period 1|Lost to Follow-up|0|||
170417717|NCT00950807|615869371|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170417718|NCT00950807|615869372|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170417719|NCT00950807|615869373|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170417720|NCT00950807|615869374|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170417721|NCT00950807|615869375|FG004|Treatment Period 1|Withdrawal by Subject|1|||
170417722|NCT00950807|615869376|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170417723|NCT00950807|615869377|FG006|Treatment Period 1|Withdrawal by Subject|0|||
170417724|NCT00950807|615869378|FG007|Treatment Period 1|Withdrawal by Subject|0|||
170417725|NCT00950807|615869379|FG008|Treatment Period 1|Withdrawal by Subject|1|||
170417726|NCT00950807|615869380|FG009|Treatment Period 1|Withdrawal by Subject|0|||
170417727|NCT00950807|615869371|FG000|Treatment Period 1|Adverse Event|0|||
170417728|NCT00950807|615869372|FG001|Treatment Period 1|Adverse Event|0|||
170417729|NCT00950807|615869373|FG002|Treatment Period 1|Adverse Event|0|||
170417730|NCT00950807|615869374|FG003|Treatment Period 1|Adverse Event|0|||
170777743|NCT03651895|617193930|FG001|First Drug Assignment|Adverse Event|5|||
170417731|NCT00950807|615869375|FG004|Treatment Period 1|Adverse Event|0|||
170417732|NCT00950807|615869376|FG005|Treatment Period 1|Adverse Event|1|||
170417733|NCT00950807|615869377|FG006|Treatment Period 1|Adverse Event|0|||
170417734|NCT00950807|615869378|FG007|Treatment Period 1|Adverse Event|0|||
170417735|NCT00950807|615869379|FG008|Treatment Period 1|Adverse Event|0|||
170417736|NCT00950807|615869380|FG009|Treatment Period 1|Adverse Event|0|||
170529875|NCT01232283|616288453|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
170529876|NCT01232283|616288444|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
170529877|NCT01232283|616288445|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
170529878|NCT01232283|616288446|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
170529879|NCT01232283|616288447|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
170529880|NCT01232283|616288448|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
170529881|NCT01232283|616288449|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
170529882|NCT01232283|616288450|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
170529883|NCT01232283|616288451|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
170529884|NCT01232283|616288452|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
170529885|NCT01232283|616288453|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
170529886|NCT01232283|616288444|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
170529887|NCT01232283|616288445|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
170529888|NCT01232283|616288446|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
170529889|NCT01232283|616288447|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
170529890|NCT01232283|616288448|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
170529891|NCT01232283|616288449|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
170529892|NCT01232283|616288450|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
170529893|NCT01232283|616288451|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
170529894|NCT01232283|616288452|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
170529895|NCT01232283|616288453|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
170529896|NCT01232283|616288444|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
170529897|NCT01232283|616288445|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
170529898|NCT01232283|616288446|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
170529899|NCT01232283|616288447|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
170529900|NCT01232283|616288448|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
170529901|NCT01232283|616288449|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
170529902|NCT01232283|616288450|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
170529903|NCT01232283|616288451|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
170529904|NCT01232283|616288452|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
170529905|NCT01232283|616288453|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
170529906|NCT01232283|616288444|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
170529907|NCT01232283|616288445|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
170529908|NCT01232283|616288446|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
170529909|NCT01232283|616288447|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
170529910|NCT01232283|616288448|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
170529911|NCT01232283|616288449|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
170529912|NCT01232283|616288450|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
170529913|NCT01232283|616288451|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
170529914|NCT01232283|616288452|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
170529915|NCT01232283|616288453|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
170529916|NCT01232283|616288444|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170529917|NCT01232283|616288445|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170777744|NCT03651895|617193929|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
170777745|NCT03651895|617193930|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
170777746|NCT02837510|617193931|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
170777747|NCT02837510|617193932|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
170777748|NCT02837510|617193931|FG000|Washout (2 Weeks)|Adverse Event|0|||
170777749|NCT02837510|617193932|FG001|Washout (2 Weeks)|Adverse Event|1|||
170777750|NCT02837510|617193931|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
170777751|NCT02837510|617193932|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
170777752|NCT02837510|617193931|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
170777753|NCT02837510|617193932|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
170777754|NCT02837510|617193931|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
170777755|NCT02837510|617193932|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
170777756|NCT02837510|617193931|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
170777757|NCT02837510|617193932|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
170777758|NCT05307783|617193933|FG000|Overall Study|Death|7|||
170777759|NCT05307783|617193933|FG000|Overall Study|Lost to Follow-up|4|||
170777760|NCT03460236|617193934|FG000|Overall Study|failed radiographic screening|16|||
170777761|NCT03460236|617193934|FG000|Overall Study|Withdrawal by Subject|11|||
170877727|NCT02055820|617563959|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
170877728|NCT02055820|617563960|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
170877729|NCT02055820|617563961|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
170777762|NCT04468776|617193937|FG000|Overall Study|Lost to Follow-up|4|||
170777763|NCT04468776|617193938|FG001|Overall Study|Lost to Follow-up|3|||
170529918|NCT01232283|616288446|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170529919|NCT01232283|616288447|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170529920|NCT01232283|616288448|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
170529921|NCT01232283|616288449|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170777764|NCT04468776|617193939|FG002|Overall Study|Lost to Follow-up|4|||
170777765|NCT04468776|617193937|FG000|Overall Study|Withdrawal by Subject|1|||
170777766|NCT04468776|617193938|FG001|Overall Study|Withdrawal by Subject|10|||
170777767|NCT04468776|617193939|FG002|Overall Study|Withdrawal by Subject|4|||
170777768|NCT04468776|617193937|FG000|Overall Study|Physician Decision|0|||
170777769|NCT04468776|617193938|FG001|Overall Study|Physician Decision|1|||
170777770|NCT04468776|617193939|FG002|Overall Study|Physician Decision|1|||
170777771|NCT05687903|617193940|FG000|Overall Study|Protocol Deviation|1|||
170777772|NCT05687903|617193941|FG001|Overall Study|Protocol Deviation|1|||
170777773|NCT05687903|617193942|FG002|Overall Study|Protocol Deviation|0|||
170777774|NCT05687903|617193943|FG003|Overall Study|Protocol Deviation|1|||
170777775|NCT05687903|617193944|FG004|Overall Study|Protocol Deviation|0|||
170777776|NCT04855760|617193945|FG000|Overall Study|Adverse Event|21|||
170777777|NCT04855760|617193945|FG000|Overall Study|Withdrawal by Subject|116|||
170777778|NCT04855760|617193945|FG000|Overall Study|Lack of Efficacy|21|||
170777779|NCT04855760|617193945|FG000|Overall Study|Lost to Follow-up|49|||
170777780|NCT04855760|617193945|FG000|Overall Study|Protocol Violation|2|||
170777781|NCT04855760|617193945|FG000|Overall Study|Physician Decision|5|||
170777782|NCT04855760|617193945|FG000|Overall Study|Pregnancy|1|||
170777783|NCT04855760|617193945|FG000|Overall Study|Non-Compliance with Study Drug|11|||
170777784|NCT04855760|617193945|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
170777785|NCT04855760|617193945|FG000|Overall Study|Study Completed by Sponsor|202|||
170777786|NCT04855760|617193945|FG000|Overall Study|Other|13|||
170777787|NCT04840199|617193948|FG000|Overall Study|Study Terminated by Sponsor|8|||
170777788|NCT04840199|617193949|FG001|Overall Study|Study Terminated by Sponsor|9|||
170777789|NCT04840199|617193948|FG000|Overall Study|Lost to Follow-up|0|||
170777790|NCT04840199|617193949|FG001|Overall Study|Lost to Follow-up|2|||
170777791|NCT04840199|617193948|FG000|Overall Study|Withdrawal by Subject|2|||
170777792|NCT04840199|617193949|FG001|Overall Study|Withdrawal by Subject|0|||
170777793|NCT04840199|617193948|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
170777794|NCT04840199|617193949|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
170777795|NCT04869982|617193950|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
170777796|NCT04869982|617193951|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
170777797|NCT04869982|617193950|FG000|Overall Study|Migrated / moved from the study area|1|||
170777798|NCT04869982|617193951|FG001|Overall Study|Migrated / moved from the study area|1|||
170777799|NCT04869982|617193950|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
170777800|NCT04869982|617193951|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
170777801|NCT04869982|617193950|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
170777802|NCT04869982|617193951|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
170777803|NCT04869982|617193950|FG000|Overall Study|Solicited adverse event|2|||
170777804|NCT04869982|617193951|FG001|Overall Study|Solicited adverse event|1|||
170777805|NCT04300231|617193959|FG000|Overall Study|Protocol Violation|4|||
170777806|NCT04300231|617193960|FG001|Overall Study|Protocol Violation|3|||
170777807|NCT04300231|617193961|FG002|Overall Study|Protocol Violation|0|||
170777808|NCT04300231|617193962|FG003|Overall Study|Protocol Violation|2|||
170777809|NCT05678998|617193963|FG000|Overall Study|Withdrawal by Subject|1|||
170777810|NCT05678998|617193964|FG001|Overall Study|Withdrawal by Subject|1|||
170777811|NCT05678998|617193965|FG002|Overall Study|Withdrawal by Subject|3|||
170777812|NCT05678998|617193966|FG003|Overall Study|Withdrawal by Subject|0|||
170777813|NCT05678998|617193967|FG004|Overall Study|Withdrawal by Subject|1|||
170777814|NCT05678998|617193963|FG000|Overall Study|Lost to Follow-up|0|||
170777815|NCT05678998|617193964|FG001|Overall Study|Lost to Follow-up|0|||
170777816|NCT05678998|617193965|FG002|Overall Study|Lost to Follow-up|0|||
170777817|NCT05678998|617193966|FG003|Overall Study|Lost to Follow-up|0|||
170777818|NCT05678998|617193967|FG004|Overall Study|Lost to Follow-up|1|||
170777819|NCT05678998|617193963|FG000|Overall Study|Death|0|||
170777820|NCT05678998|617193964|FG001|Overall Study|Death|0|||
170777821|NCT05678998|617193965|FG002|Overall Study|Death|0|||
170777822|NCT05678998|617193966|FG003|Overall Study|Death|3|||
170777823|NCT05678998|617193967|FG004|Overall Study|Death|4|||
170777824|NCT05678998|617193963|FG000|Overall Study|Other|0|||
170777825|NCT05678998|617193964|FG001|Overall Study|Other|0|||
170777826|NCT05678998|617193965|FG002|Overall Study|Other|0|||
170777827|NCT05678998|617193966|FG003|Overall Study|Other|2|||
170777828|NCT05678998|617193967|FG004|Overall Study|Other|1|||
170777829|NCT01443845|617193971|FG000|Overall Study|Protocol Violation|43|||
170777830|NCT01443845|617193972|FG001|Overall Study|Protocol Violation|45|||
170777831|NCT01443845|617193971|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
170777832|NCT01443845|617193972|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
170417737|NCT00950807|615869371|FG000|Washout Period 1|Lack of Efficacy|0|||
170417738|NCT00950807|615869372|FG001|Washout Period 1|Lack of Efficacy|0|||
170417739|NCT00950807|615869373|FG002|Washout Period 1|Lack of Efficacy|0|||
170417740|NCT00950807|615869374|FG003|Washout Period 1|Lack of Efficacy|0|||
170417741|NCT00950807|615869375|FG004|Washout Period 1|Lack of Efficacy|0|||
170417742|NCT00950807|615869376|FG005|Washout Period 1|Lack of Efficacy|0|||
170417743|NCT00950807|615869377|FG006|Washout Period 1|Lack of Efficacy|1|||
170417744|NCT00950807|615869378|FG007|Washout Period 1|Lack of Efficacy|0|||
170417745|NCT00950807|615869379|FG008|Washout Period 1|Lack of Efficacy|0|||
170417746|NCT00950807|615869380|FG009|Washout Period 1|Lack of Efficacy|0|||
170417747|NCT00950807|615869371|FG000|Washout Period 1|Withdrawal by Subject|0|||
170417748|NCT00950807|615869372|FG001|Washout Period 1|Withdrawal by Subject|0|||
170417749|NCT00950807|615869373|FG002|Washout Period 1|Withdrawal by Subject|0|||
170417750|NCT00950807|615869374|FG003|Washout Period 1|Withdrawal by Subject|0|||
170417751|NCT00950807|615869375|FG004|Washout Period 1|Withdrawal by Subject|0|||
170417752|NCT00950807|615869376|FG005|Washout Period 1|Withdrawal by Subject|0|||
170417753|NCT00950807|615869377|FG006|Washout Period 1|Withdrawal by Subject|0|||
170417754|NCT00950807|615869378|FG007|Washout Period 1|Withdrawal by Subject|0|||
170777833|NCT01443845|617193971|FG000|Overall Study|Deterioration in pulmonary function|1|||
170777834|NCT01443845|617193972|FG001|Overall Study|Deterioration in pulmonary function|4|||
170777835|NCT01443845|617193971|FG000|Overall Study|Lack of Efficacy|10|||
170777836|NCT01443845|617193972|FG001|Overall Study|Lack of Efficacy|5|||
170777837|NCT01443845|617193971|FG000|Overall Study|Adverse Event|64|||
170777838|NCT01443845|617193972|FG001|Overall Study|Adverse Event|138|||
170777839|NCT01443845|617193971|FG000|Overall Study|Withdrawal by Subject|63|||
170777840|NCT01443845|617193972|FG001|Overall Study|Withdrawal by Subject|67|||
170417755|NCT00950807|615869379|FG008|Washout Period 1|Withdrawal by Subject|1|||
170417756|NCT00950807|615869380|FG009|Washout Period 1|Withdrawal by Subject|0|||
170417757|NCT00950807|615869371|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
170777841|NCT01443845|617193971|FG000|Overall Study|Military Conflict - Site Terminated|20|||
170529922|NCT01232283|616288450|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170529923|NCT01232283|616288451|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170529924|NCT01232283|616288452|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170529925|NCT01232283|616288453|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
170529926|NCT01232283|616288444|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
170529927|NCT01232283|616288445|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
170529928|NCT01232283|616288446|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
170529929|NCT01232283|616288447|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
170529930|NCT01232283|616288448|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
170529931|NCT01232283|616288449|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
170529932|NCT01232283|616288450|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
170529933|NCT01232283|616288451|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
170529934|NCT01232283|616288452|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
170529935|NCT01232283|616288453|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
170529936|NCT01232283|616288444|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529937|NCT01232283|616288445|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529938|NCT01232283|616288446|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529939|NCT01232283|616288447|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529940|NCT01232283|616288448|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529941|NCT01232283|616288449|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529942|NCT01232283|616288450|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529943|NCT01232283|616288451|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
170529944|NCT01232283|616288452|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529945|NCT01232283|616288453|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
170529946|NCT01232283|616288444|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529947|NCT01232283|616288445|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529948|NCT01232283|616288446|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529949|NCT01232283|616288447|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529950|NCT01232283|616288448|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529951|NCT01232283|616288449|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
170529952|NCT01232283|616288450|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529953|NCT01232283|616288451|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529954|NCT01232283|616288452|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529955|NCT01232283|616288453|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
170529956|NCT01232283|616288444|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
170529957|NCT01232283|616288445|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
170529958|NCT01232283|616288446|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
170529959|NCT01232283|616288447|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
170529960|NCT01232283|616288448|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
170529961|NCT01232283|616288449|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
170529962|NCT01232283|616288450|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
170529963|NCT01232283|616288451|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
170529964|NCT01232283|616288452|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
170529965|NCT01232283|616288453|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
170529966|NCT01232283|616288444|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
170529967|NCT01232283|616288445|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
170529968|NCT01232283|616288446|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
170529969|NCT01232283|616288447|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
170529970|NCT01232283|616288448|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
170529971|NCT01232283|616288449|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
170529972|NCT01232283|616288450|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
170777842|NCT01443845|617193972|FG001|Overall Study|Military Conflict - Site Terminated|21|||
170777843|NCT01443845|617193971|FG000|Overall Study|Lost to Follow-up|9|||
170777844|NCT01443845|617193972|FG001|Overall Study|Lost to Follow-up|13|||
170777845|NCT01000480|617193978|FG000|Induction Phase|Adverse Event|2|||
170777846|NCT01000480|617193978|FG000|Induction Phase|Lost to Follow-up|1|||
170777847|NCT01000480|617193978|FG000|Induction Phase|Physician Decision|1|||
170777848|NCT01000480|617193978|FG000|Induction Phase|Entry Criteria Not Met|3|||
170777849|NCT01000480|617193978|FG000|Concurrent Therapy Phase|Adverse Event|4|||
170777850|NCT01000480|617193978|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
170777851|NCT01000480|617193978|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
170777852|NCT01000480|617193978|FG000|Concurrent Therapy Phase|Physician Decision|1|||
170777853|NCT01736215|617193979|FG000|Overall Study|Early termination of erythropoietin use|1|||
170777854|NCT01736215|617193979|FG000|Overall Study|Adverse Event|4|||
170777855|NCT01736215|617193979|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
170777856|NCT01736215|617193979|FG000|Overall Study|Insufficient data to perform analysis|8|||
170777857|NCT02538341|617193981|FG000|Overall Study|Lost to Follow-up|51|||
170529973|NCT01232283|616288451|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
170529974|NCT01232283|616288452|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
170529975|NCT01232283|616288453|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
170529976|NCT01232283|616288444|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
170529977|NCT01232283|616288445|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
170529978|NCT01232283|616288446|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
170529979|NCT01232283|616288447|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
170529980|NCT01232283|616288448|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
170529981|NCT01232283|616288449|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
170529982|NCT01232283|616288450|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
170529983|NCT01232283|616288451|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
170529984|NCT01232283|616288452|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
170529985|NCT01232283|616288453|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
170529986|NCT01232283|616288444|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
170529987|NCT01232283|616288445|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
170529988|NCT01232283|616288446|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
170529989|NCT01232283|616288447|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
170529990|NCT01232283|616288448|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
170529991|NCT01232283|616288449|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
170529992|NCT01232283|616288450|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
170529993|NCT01232283|616288451|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
170529994|NCT01232283|616288452|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
170529995|NCT01232283|616288453|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
170529996|NCT01232283|616288444|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
170529997|NCT01232283|616288445|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
170529998|NCT01232283|616288446|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
170529999|NCT01232283|616288447|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
170530000|NCT01232283|616288448|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
170530001|NCT01232283|616288449|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
170530002|NCT01232283|616288450|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
170530003|NCT01232283|616288451|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
170530004|NCT01232283|616288452|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
170530005|NCT01232283|616288453|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
170417758|NCT00950807|615869372|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
170417759|NCT00950807|615869373|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
170417760|NCT00950807|615869374|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
170530006|NCT01232283|616288444|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170530007|NCT01232283|616288445|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170417761|NCT00950807|615869375|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
170417762|NCT00950807|615869376|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
170417763|NCT00950807|615869377|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
170417764|NCT00950807|615869378|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
170417765|NCT00950807|615869379|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
170417766|NCT00950807|615869380|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
170417767|NCT00950807|615869371|FG000|Washout Period 1|Adverse Event|2|||
170417768|NCT00950807|615869372|FG001|Washout Period 1|Adverse Event|0|||
170417769|NCT00950807|615869373|FG002|Washout Period 1|Adverse Event|0|||
170417770|NCT00950807|615869374|FG003|Washout Period 1|Adverse Event|1|||
170417771|NCT00950807|615869375|FG004|Washout Period 1|Adverse Event|1|||
170417772|NCT00950807|615869376|FG005|Washout Period 1|Adverse Event|0|||
170417773|NCT00950807|615869377|FG006|Washout Period 1|Adverse Event|0|||
170417774|NCT00950807|615869378|FG007|Washout Period 1|Adverse Event|0|||
170417775|NCT00950807|615869379|FG008|Washout Period 1|Adverse Event|0|||
170417776|NCT00950807|615869380|FG009|Washout Period 1|Adverse Event|0|||
170417777|NCT00950807|615869371|FG000|Treatment Period 2|Lack of Efficacy|1|||
170417778|NCT00950807|615869372|FG001|Treatment Period 2|Lack of Efficacy|0|||
170417779|NCT00950807|615869373|FG002|Treatment Period 2|Lack of Efficacy|0|||
170417780|NCT00950807|615869374|FG003|Treatment Period 2|Lack of Efficacy|0|||
170417781|NCT00950807|615869375|FG004|Treatment Period 2|Lack of Efficacy|0|||
170417782|NCT00950807|615869376|FG005|Treatment Period 2|Lack of Efficacy|0|||
170417783|NCT00950807|615869377|FG006|Treatment Period 2|Lack of Efficacy|0|||
170417784|NCT00950807|615869378|FG007|Treatment Period 2|Lack of Efficacy|0|||
170417785|NCT00950807|615869379|FG008|Treatment Period 2|Lack of Efficacy|0|||
170417786|NCT00950807|615869380|FG009|Treatment Period 2|Lack of Efficacy|0|||
170417787|NCT00950807|615869371|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170417788|NCT00950807|615869372|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170417789|NCT00950807|615869373|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170417790|NCT00950807|615869374|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170417791|NCT00950807|615869375|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170417792|NCT00950807|615869376|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170417793|NCT00950807|615869377|FG006|Treatment Period 2|Withdrawal by Subject|1|||
170417794|NCT00950807|615869378|FG007|Treatment Period 2|Withdrawal by Subject|2|||
170417795|NCT00950807|615869379|FG008|Treatment Period 2|Withdrawal by Subject|0|||
170417796|NCT00950807|615869380|FG009|Treatment Period 2|Withdrawal by Subject|0|||
170417797|NCT00950807|615869371|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
170417798|NCT00950807|615869372|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417799|NCT00950807|615869373|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417800|NCT00950807|615869374|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417801|NCT00950807|615869375|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417802|NCT00950807|615869376|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417803|NCT00950807|615869377|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417804|NCT00950807|615869378|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417805|NCT00950807|615869379|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417806|NCT00950807|615869380|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170417807|NCT00950807|615869371|FG000|Treatment Period 2|Adverse Event|0|||
170417808|NCT00950807|615869372|FG001|Treatment Period 2|Adverse Event|1|||
170417809|NCT00950807|615869373|FG002|Treatment Period 2|Adverse Event|0|||
170530008|NCT01232283|616288446|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170530009|NCT01232283|616288447|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170530010|NCT01232283|616288448|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170530011|NCT01232283|616288449|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170530012|NCT01232283|616288450|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170530013|NCT01232283|616288451|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170530014|NCT01232283|616288452|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
170530015|NCT01232283|616288453|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
170530016|NCT01232283|616288444|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530017|NCT01232283|616288445|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530018|NCT01232283|616288446|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530019|NCT01232283|616288447|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530020|NCT01232283|616288448|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530021|NCT01232283|616288449|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530022|NCT01232283|616288450|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530023|NCT01232283|616288451|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530024|NCT01232283|616288452|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
170530025|NCT01232283|616288453|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
170530026|NCT01232283|616288444|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
170530027|NCT01232283|616288445|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
170530028|NCT01232283|616288446|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
170530029|NCT01232283|616288447|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
170530030|NCT01232283|616288448|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
170530031|NCT01232283|616288449|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
170530032|NCT01232283|616288450|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
170530033|NCT01232283|616288451|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
170530034|NCT01232283|616288452|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
170530035|NCT01232283|616288453|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
170530036|NCT03882918|616288458|FG000|Overall Study|Study terminated by sponsor|98|||
170530037|NCT03882918|616288458|FG000|Overall Study|Protocol Violation|1|||
170530038|NCT03882918|616288458|FG000|Overall Study|Other|9|||
170530039|NCT03882918|616288458|FG000|Overall Study|Lack of Efficacy|14|||
170530040|NCT03882918|616288458|FG000|Overall Study|Adverse Event|13|||
170530041|NCT03882918|616288458|FG000|Overall Study|Withdrawal by Subject|5|||
170530042|NCT02097823|616288459|FG000|Overall Study|Withdrawal by Subject|1|||
170530043|NCT02097823|616288460|FG001|Overall Study|Withdrawal by Subject|1|||
170530044|NCT01419535|616288461|FG000|Overall Study|could not maintain iv line|1|||
170777858|NCT02538341|617193982|FG001|Overall Study|Lost to Follow-up|46|||
170777859|NCT02538341|617193981|FG000|Overall Study|Withdrawal by Subject|3|||
170417810|NCT00950807|615869374|FG003|Treatment Period 2|Adverse Event|1|||
170417811|NCT00950807|615869375|FG004|Treatment Period 2|Adverse Event|0|||
170417812|NCT00950807|615869376|FG005|Treatment Period 2|Adverse Event|1|||
170530045|NCT01419535|616288462|FG001|Overall Study|could not maintain iv line|1|||
170530046|NCT01419535|616288461|FG000|Overall Study|Withdrawal by Subject|0|||
170530047|NCT01419535|616288462|FG001|Overall Study|Withdrawal by Subject|1|||
170530048|NCT03370172|616289736|FG000|Overall Study|Withdrawal by Subject|0|||
170417813|NCT00950807|615869377|FG006|Treatment Period 2|Adverse Event|0|||
170530049|NCT03370172|616289737|FG001|Overall Study|Withdrawal by Subject|1|||
170530050|NCT00548327|616289738|FG000|Overall Study|Adverse Event|0|||
170777860|NCT02538341|617193982|FG001|Overall Study|Withdrawal by Subject|1|||
170417814|NCT00950807|615869378|FG007|Treatment Period 2|Adverse Event|1|||
170417815|NCT00950807|615869379|FG008|Treatment Period 2|Adverse Event|0|||
170417816|NCT00950807|615869380|FG009|Treatment Period 2|Adverse Event|0|||
170417817|NCT00950807|615869371|FG000|Washout Period 2|Lack of Efficacy|1|||
170417818|NCT00950807|615869372|FG001|Washout Period 2|Lack of Efficacy|0|||
170417819|NCT00950807|615869373|FG002|Washout Period 2|Lack of Efficacy|0|||
170417820|NCT00950807|615869374|FG003|Washout Period 2|Lack of Efficacy|0|||
170417821|NCT00950807|615869375|FG004|Washout Period 2|Lack of Efficacy|0|||
170417822|NCT00950807|615869376|FG005|Washout Period 2|Lack of Efficacy|0|||
170417823|NCT00950807|615869377|FG006|Washout Period 2|Lack of Efficacy|0|||
170417824|NCT00950807|615869378|FG007|Washout Period 2|Lack of Efficacy|0|||
170417825|NCT00950807|615869379|FG008|Washout Period 2|Lack of Efficacy|0|||
170417826|NCT00950807|615869380|FG009|Washout Period 2|Lack of Efficacy|0|||
170417827|NCT00950807|615869371|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
170417828|NCT00950807|615869372|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
170417829|NCT00950807|615869373|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
170417830|NCT00950807|615869374|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
170417831|NCT00950807|615869375|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
170417832|NCT00950807|615869376|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
170417833|NCT00950807|615869377|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
170417834|NCT00950807|615869378|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
170417835|NCT00950807|615869379|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
170417836|NCT00950807|615869380|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
170417837|NCT00950807|615869371|FG000|Washout Period 2|Adverse Event|3|||
170417838|NCT00950807|615869372|FG001|Washout Period 2|Adverse Event|0|||
170417839|NCT00950807|615869373|FG002|Washout Period 2|Adverse Event|0|||
170417840|NCT00950807|615869374|FG003|Washout Period 2|Adverse Event|1|||
170417841|NCT00950807|615869375|FG004|Washout Period 2|Adverse Event|0|||
170417842|NCT00950807|615869376|FG005|Washout Period 2|Adverse Event|0|||
170417843|NCT00950807|615869377|FG006|Washout Period 2|Adverse Event|0|||
170417844|NCT00950807|615869378|FG007|Washout Period 2|Adverse Event|0|||
170417845|NCT00950807|615869379|FG008|Washout Period 2|Adverse Event|0|||
170417846|NCT00950807|615869380|FG009|Washout Period 2|Adverse Event|0|||
170417847|NCT00950807|615869371|FG000|Treatment Period 3|Withdrawal by Subject|0|||
170417848|NCT00950807|615869372|FG001|Treatment Period 3|Withdrawal by Subject|0|||
170417849|NCT00950807|615869373|FG002|Treatment Period 3|Withdrawal by Subject|0|||
170417850|NCT00950807|615869374|FG003|Treatment Period 3|Withdrawal by Subject|0|||
170417851|NCT00950807|615869375|FG004|Treatment Period 3|Withdrawal by Subject|0|||
170417852|NCT00950807|615869376|FG005|Treatment Period 3|Withdrawal by Subject|0|||
170417853|NCT00950807|615869377|FG006|Treatment Period 3|Withdrawal by Subject|0|||
170417854|NCT00950807|615869378|FG007|Treatment Period 3|Withdrawal by Subject|0|||
170417855|NCT00950807|615869379|FG008|Treatment Period 3|Withdrawal by Subject|0|||
170417856|NCT00950807|615869380|FG009|Treatment Period 3|Withdrawal by Subject|1|||
170417857|NCT00950807|615869371|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
170417858|NCT00950807|615869372|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170417859|NCT00950807|615869373|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170417860|NCT00950807|615869374|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170417861|NCT00950807|615869375|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170417862|NCT00950807|615869376|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170417863|NCT00950807|615869377|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170417864|NCT00950807|615869378|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
170417865|NCT00950807|615869379|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170417866|NCT00950807|615869380|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170417867|NCT00950807|615869371|FG000|Treatment Period 3|Adverse Event|0|||
170417868|NCT00950807|615869372|FG001|Treatment Period 3|Adverse Event|0|||
170417869|NCT00950807|615869373|FG002|Treatment Period 3|Adverse Event|0|||
170417870|NCT00950807|615869374|FG003|Treatment Period 3|Adverse Event|0|||
170417871|NCT00950807|615869375|FG004|Treatment Period 3|Adverse Event|0|||
170417872|NCT00950807|615869376|FG005|Treatment Period 3|Adverse Event|0|||
170417873|NCT00950807|615869377|FG006|Treatment Period 3|Adverse Event|1|||
170417874|NCT00950807|615869378|FG007|Treatment Period 3|Adverse Event|0|||
170417875|NCT00950807|615869379|FG008|Treatment Period 3|Adverse Event|0|||
170417876|NCT00950807|615869380|FG009|Treatment Period 3|Adverse Event|0|||
170417877|NCT00320112|615869381|FG000|Overall Study|Lost to Follow-up|3|||
170417878|NCT00320112|615869382|FG001|Overall Study|Lost to Follow-up|4|||
170417879|NCT00320112|615869381|FG000|Overall Study|Withdrawal by Subject|3|||
170417880|NCT00320112|615869382|FG001|Overall Study|Withdrawal by Subject|0|||
170632624|NCT01352793|616666715|FG000|Overall Study|Death|1|||
170417881|NCT00320112|615869381|FG000|Overall Study|Death|2|||
170417882|NCT00320112|615869382|FG001|Overall Study|Death|1|||
170417883|NCT01457053|615869383|FG000|Overall Study|Unable to undergo selected treatment|1|||
170417884|NCT01457053|615869384|FG001|Overall Study|Unable to undergo selected treatment|1|||
170417885|NCT02073643|615869385|FG000|Overall Study|Lost to Follow-up|24|||
170417886|NCT02430870|615869386|FG000|Part 2|Voluntary Withdrawal|0|||
170632625|NCT01352793|616666716|FG001|Overall Study|Death|0|||
170417887|NCT02430870|615869387|FG001|Part 2|Voluntary Withdrawal|0|||
170417888|NCT02430870|615869388|FG002|Part 2|Voluntary Withdrawal|0|||
170417889|NCT02430870|615869389|FG003|Part 2|Voluntary Withdrawal|0|||
170417890|NCT02430870|615869390|FG004|Part 2|Voluntary Withdrawal|0|||
170417891|NCT02430870|615869391|FG005|Part 2|Voluntary Withdrawal|0|||
170417892|NCT02430870|615869392|FG006|Part 2|Voluntary Withdrawal|1|||
170417893|NCT02430870|615869393|FG007|Part 2|Voluntary Withdrawal|0|||
170417894|NCT02430870|615869386|FG000|Part 2|Other Reason Not Specified|0|||
170417895|NCT02430870|615869387|FG001|Part 2|Other Reason Not Specified|0|||
170417896|NCT02430870|615869388|FG002|Part 2|Other Reason Not Specified|0|||
170417897|NCT02430870|615869389|FG003|Part 2|Other Reason Not Specified|0|||
170417898|NCT02430870|615869390|FG004|Part 2|Other Reason Not Specified|0|||
170417899|NCT02430870|615869391|FG005|Part 2|Other Reason Not Specified|0|||
170417900|NCT02430870|615869392|FG006|Part 2|Other Reason Not Specified|0|||
170417901|NCT02430870|615869393|FG007|Part 2|Other Reason Not Specified|1|||
170417902|NCT03982433|615869396|FG000|Overall Study|Lost to Follow-up|1|||
170417903|NCT00429923|615869397|FG000|Overall Study|Adverse Event|0|||
170417904|NCT00429923|615869398|FG001|Overall Study|Adverse Event|2|||
170417905|NCT00429923|615869399|FG002|Overall Study|Adverse Event|3|||
170417906|NCT00429923|615869397|FG000|Overall Study|Lack of Efficacy|4|||
170417907|NCT00429923|615869398|FG001|Overall Study|Lack of Efficacy|1|||
170417908|NCT00429923|615869399|FG002|Overall Study|Lack of Efficacy|33|||
170417909|NCT00429923|615869397|FG000|Overall Study|Lost to Follow-up|0|||
170417910|NCT00429923|615869398|FG001|Overall Study|Lost to Follow-up|0|||
170417911|NCT00429923|615869399|FG002|Overall Study|Lost to Follow-up|2|||
170417912|NCT00429923|615869397|FG000|Overall Study|Withdrew Consent|1|||
170530051|NCT00548327|616289739|FG001|Overall Study|Adverse Event|1|||
170530052|NCT01673386|616289740|FG000|Overall Study|Study terminated by sponsor|16|||
170530053|NCT01673386|616289741|FG001|Overall Study|Study terminated by sponsor|22|||
170530054|NCT01673386|616289740|FG000|Overall Study|Adverse Event|5|||
170530055|NCT01673386|616289741|FG001|Overall Study|Adverse Event|2|||
170530056|NCT01673386|616289740|FG000|Overall Study|Progressive disease|4|||
170530057|NCT01673386|616289741|FG001|Overall Study|Progressive disease|1|||
170530058|NCT01673386|616289740|FG000|Overall Study|Withdrawal by Subject|0|||
170530059|NCT01673386|616289741|FG001|Overall Study|Withdrawal by Subject|2|||
170530060|NCT00274456|616289742|FG000|Overall Study|Still on treatment|2|||
170530061|NCT00274456|616289743|FG001|Overall Study|Still on treatment|3|||
170530062|NCT00274456|616289744|FG002|Overall Study|Still on treatment|5|||
170530063|NCT00274456|616289745|FG003|Overall Study|Still on treatment|1|||
170530064|NCT00274456|616289742|FG000|Overall Study|Unacceptable toxicity|10|||
170530065|NCT00274456|616289743|FG001|Overall Study|Unacceptable toxicity|5|||
170530066|NCT00274456|616289744|FG002|Overall Study|Unacceptable toxicity|12|||
170530067|NCT00274456|616289745|FG003|Overall Study|Unacceptable toxicity|16|||
170530068|NCT00274456|616289742|FG000|Overall Study|Adverse Event|0|||
170530069|NCT00274456|616289743|FG001|Overall Study|Adverse Event|1|||
170530070|NCT00274456|616289744|FG002|Overall Study|Adverse Event|2|||
170530071|NCT00274456|616289745|FG003|Overall Study|Adverse Event|2|||
170530072|NCT00274456|616289742|FG000|Overall Study|Physician Decision|7|||
170530073|NCT00274456|616289743|FG001|Overall Study|Physician Decision|5|||
170530074|NCT00274456|616289744|FG002|Overall Study|Physician Decision|6|||
170530075|NCT00274456|616289745|FG003|Overall Study|Physician Decision|13|||
170530076|NCT00274456|616289742|FG000|Overall Study|Lost to Follow-up|0|||
170530077|NCT00274456|616289743|FG001|Overall Study|Lost to Follow-up|0|||
170530078|NCT00274456|616289744|FG002|Overall Study|Lost to Follow-up|1|||
170530079|NCT00274456|616289745|FG003|Overall Study|Lost to Follow-up|0|||
170530080|NCT00274456|616289742|FG000|Overall Study|Withdrawal by Subject|18|||
170530081|NCT00274456|616289743|FG001|Overall Study|Withdrawal by Subject|13|||
170530082|NCT00274456|616289744|FG002|Overall Study|Withdrawal by Subject|9|||
170530083|NCT00274456|616289745|FG003|Overall Study|Withdrawal by Subject|13|||
170530084|NCT00109343|616289749|FG000|Overall Study|Adverse Event|1|||
170530085|NCT00109343|616289750|FG001|Overall Study|Adverse Event|0|||
170530086|NCT00109343|616289751|FG002|Overall Study|Adverse Event|2|||
170530087|NCT00109343|616289749|FG000|Overall Study|Lack of Efficacy|1|||
170530088|NCT00109343|616289750|FG001|Overall Study|Lack of Efficacy|0|||
170530089|NCT00109343|616289751|FG002|Overall Study|Lack of Efficacy|0|||
170530090|NCT00109343|616289749|FG000|Overall Study|Lost to Follow-up|35|||
170530091|NCT00109343|616289750|FG001|Overall Study|Lost to Follow-up|20|||
170530092|NCT00109343|616289751|FG002|Overall Study|Lost to Follow-up|14|||
170530093|NCT00109343|616289749|FG000|Overall Study|Protocol Violation|1|||
170530094|NCT00109343|616289750|FG001|Overall Study|Protocol Violation|2|||
170530095|NCT00109343|616289751|FG002|Overall Study|Protocol Violation|2|||
170530096|NCT00109343|616289749|FG000|Overall Study|Withdrawal by Subject|15|||
170417913|NCT00429923|615869398|FG001|Overall Study|Withdrew Consent|0|||
170417914|NCT00429923|615869399|FG002|Overall Study|Withdrew Consent|1|||
170417915|NCT00429923|615869397|FG000|Overall Study|Early Termination|0|||
170417916|NCT00429923|615869398|FG001|Overall Study|Early Termination|1|||
170530097|NCT00109343|616289750|FG001|Overall Study|Withdrawal by Subject|11|||
170530098|NCT00109343|616289751|FG002|Overall Study|Withdrawal by Subject|10|||
170530099|NCT00109343|616289749|FG000|Overall Study|Subject Moved|6|||
170530100|NCT00109343|616289750|FG001|Overall Study|Subject Moved|2|||
170530101|NCT00109343|616289751|FG002|Overall Study|Subject Moved|1|||
170530102|NCT00109343|616289749|FG000|Overall Study|Other|5|||
170530103|NCT00109343|616289750|FG001|Overall Study|Other|2|||
170530104|NCT00109343|616289751|FG002|Overall Study|Other|1|||
170530105|NCT02194465|616289753|FG000|Overall Study|Adverse Event|6|||
170530106|NCT02194465|616289754|FG001|Overall Study|Adverse Event|1|||
170530107|NCT02194465|616289755|FG002|Overall Study|Adverse Event|4|||
170530108|NCT02194465|616289756|FG003|Overall Study|Adverse Event|4|||
170530109|NCT02194465|616289757|FG004|Overall Study|Adverse Event|4|||
170530110|NCT02194465|616289758|FG005|Overall Study|Adverse Event|2|||
170530111|NCT02194465|616289759|FG006|Overall Study|Adverse Event|0|||
170530112|NCT02194465|616289753|FG000|Overall Study|Lost to Follow-up|0|||
170530113|NCT02194465|616289754|FG001|Overall Study|Lost to Follow-up|0|||
170530114|NCT02194465|616289755|FG002|Overall Study|Lost to Follow-up|0|||
170530115|NCT02194465|616289756|FG003|Overall Study|Lost to Follow-up|1|||
170530116|NCT02194465|616289757|FG004|Overall Study|Lost to Follow-up|0|||
170530117|NCT02194465|616289758|FG005|Overall Study|Lost to Follow-up|1|||
170530118|NCT02194465|616289759|FG006|Overall Study|Lost to Follow-up|0|||
170530119|NCT02194465|616289753|FG000|Overall Study|Physician Decision|1|||
170530120|NCT02194465|616289754|FG001|Overall Study|Physician Decision|0|||
170530121|NCT02194465|616289755|FG002|Overall Study|Physician Decision|0|||
170530122|NCT02194465|616289756|FG003|Overall Study|Physician Decision|0|||
170530123|NCT02194465|616289757|FG004|Overall Study|Physician Decision|0|||
170530124|NCT02194465|616289758|FG005|Overall Study|Physician Decision|0|||
170530125|NCT02194465|616289759|FG006|Overall Study|Physician Decision|0|||
170530126|NCT02194465|616289753|FG000|Overall Study|Protocol Violation|1|||
170530127|NCT02194465|616289754|FG001|Overall Study|Protocol Violation|1|||
170530128|NCT02194465|616289755|FG002|Overall Study|Protocol Violation|2|||
170530129|NCT02194465|616289756|FG003|Overall Study|Protocol Violation|1|||
170530130|NCT02194465|616289757|FG004|Overall Study|Protocol Violation|1|||
170530131|NCT02194465|616289758|FG005|Overall Study|Protocol Violation|0|||
170530132|NCT02194465|616289759|FG006|Overall Study|Protocol Violation|0|||
170530133|NCT02194465|616289753|FG000|Overall Study|Withdrawal by Subject|1|||
170530134|NCT02194465|616289754|FG001|Overall Study|Withdrawal by Subject|3|||
170530135|NCT02194465|616289755|FG002|Overall Study|Withdrawal by Subject|1|||
170530136|NCT02194465|616289756|FG003|Overall Study|Withdrawal by Subject|2|||
170530137|NCT02194465|616289757|FG004|Overall Study|Withdrawal by Subject|2|||
170530138|NCT02194465|616289758|FG005|Overall Study|Withdrawal by Subject|1|||
170530139|NCT02194465|616289759|FG006|Overall Study|Withdrawal by Subject|2|||
170530140|NCT02194465|616289753|FG000|Overall Study|Discontinued follow-up period|0|||
170530141|NCT02194465|616289754|FG001|Overall Study|Discontinued follow-up period|2|||
170530142|NCT02194465|616289755|FG002|Overall Study|Discontinued follow-up period|1|||
170530143|NCT02194465|616289756|FG003|Overall Study|Discontinued follow-up period|0|||
170530144|NCT02194465|616289757|FG004|Overall Study|Discontinued follow-up period|2|||
170530145|NCT02194465|616289758|FG005|Overall Study|Discontinued follow-up period|0|||
170530146|NCT02194465|616289759|FG006|Overall Study|Discontinued follow-up period|0|||
170530147|NCT01408641|616289760|FG000|Overall Study|Physician Decision|1|||
170530148|NCT01408641|616289761|FG001|Overall Study|Physician Decision|0|||
170530149|NCT00576758|616289762|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
170530150|NCT00576758|616289763|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
170530151|NCT00576758|616289762|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
170530152|NCT00576758|616289763|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
170530153|NCT00576758|616289762|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
170530154|NCT00576758|616289763|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
170530155|NCT00576758|616289762|FG000|Induction Treatment Period|Death|1|||
170530156|NCT00576758|616289763|FG001|Induction Treatment Period|Death|0|||
170530157|NCT00576758|616289762|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
170530158|NCT00576758|616289763|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
170530159|NCT00576758|616289762|FG000|Induction Treatment Period|Withdrew consent|1|||
170530160|NCT00576758|616289763|FG001|Induction Treatment Period|Withdrew consent|0|||
170530161|NCT00576758|616289762|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
170777861|NCT02538341|617193981|FG000|Overall Study|Death|2|||
170530162|NCT00576758|616289763|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
170530163|NCT00576758|616289762|FG000|Extension Treatment Period|Death|1|||
170530164|NCT00576758|616289763|FG001|Extension Treatment Period|Death|1|||
170530165|NCT00576758|616289762|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
170530166|NCT00576758|616289763|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
170530167|NCT00576758|616289762|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
170530168|NCT00576758|616289763|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
170530169|NCT00576758|616289762|FG000|Extension Treatment Period|Administrative/Other|3|||
170530170|NCT00576758|616289763|FG001|Extension Treatment Period|Administrative/Other|1|||
170530171|NCT00576758|616289762|FG000|Follow-up Period|Administrative/Other|6|||
170777862|NCT02538341|617193982|FG001|Overall Study|Death|0|||
170417917|NCT00429923|615869399|FG002|Overall Study|Early Termination|0|||
170417918|NCT00984295|615869400|FG000|Overall Study|Lost to Follow-up|31|||
170417919|NCT00984295|615869401|FG001|Overall Study|Lost to Follow-up|12|||
170417920|NCT00984295|615869402|FG002|Overall Study|Lost to Follow-up|13|||
170417921|NCT00984295|615869400|FG000|Overall Study|Protocol Violation|2|||
170417922|NCT00984295|615869401|FG001|Overall Study|Protocol Violation|1|||
170417923|NCT00984295|615869402|FG002|Overall Study|Protocol Violation|4|||
170417924|NCT00984295|615869400|FG000|Overall Study|Withdrawal by Subject|18|||
170417925|NCT00984295|615869401|FG001|Overall Study|Withdrawal by Subject|9|||
170417926|NCT00984295|615869402|FG002|Overall Study|Withdrawal by Subject|12|||
170417927|NCT00984295|615869400|FG000|Overall Study|CAE - discontinued test vaccine|0|||
170417928|NCT00984295|615869401|FG001|Overall Study|CAE - discontinued test vaccine|1|||
170417929|NCT00984295|615869402|FG002|Overall Study|CAE - discontinued test vaccine|3|||
170417930|NCT00984295|615869400|FG000|Overall Study|Missed one or more blood samplings|3|||
170417931|NCT00984295|615869401|FG001|Overall Study|Missed one or more blood samplings|7|||
170417932|NCT00984295|615869402|FG002|Overall Study|Missed one or more blood samplings|2|||
170417933|NCT00984295|615869400|FG000|Overall Study|Incomplete safety follow-up|11|||
170417934|NCT00984295|615869401|FG001|Overall Study|Incomplete safety follow-up|2|||
170417935|NCT00984295|615869402|FG002|Overall Study|Incomplete safety follow-up|3|||
170417936|NCT00788957|615869404|FG000|Part 1|Death|8|||
170417937|NCT00788957|615869405|FG001|Part 1|Death|0|||
170417938|NCT00788957|615869406|FG002|Part 1|Death|0|||
170777863|NCT00621296|617193983|FG000|Overall Study|Adverse Event|2|||
170777864|NCT00621296|617193983|FG000|Overall Study|Lack of Efficacy|1|||
170777865|NCT00621296|617193983|FG000|Overall Study|Physician Decision|7|||
170777866|NCT00621296|617193983|FG000|Overall Study|Unmatch Criteria|1|||
170777867|NCT00621296|617193983|FG000|Overall Study|Stopping Criteria|3|||
170777868|NCT02692417|617193985|FG000|Overall Study|Withdrawal by Subject|5|||
170777869|NCT02692417|617193986|FG001|Overall Study|Withdrawal by Subject|1|||
170777870|NCT02692417|617193985|FG000|Overall Study|Adverse Event|1|||
170777871|NCT02692417|617193986|FG001|Overall Study|Adverse Event|0|||
170777872|NCT01551355|617194006|FG000|Overall Study|Lost to Follow-up|51|||
170777873|NCT01551355|617194007|FG001|Overall Study|Lost to Follow-up|49|||
170777874|NCT01551355|617194008|FG002|Overall Study|Lost to Follow-up|34|||
170777875|NCT01551355|617194009|FG003|Overall Study|Lost to Follow-up|24|||
170777876|NCT01551355|617194010|FG004|Overall Study|Lost to Follow-up|9|||
170777877|NCT01551355|617194011|FG005|Overall Study|Lost to Follow-up|6|||
170777878|NCT03892564|617194012|FG000|Overall Study|Withdrawal by Subject|2|||
170777879|NCT05308316|617194013|FG000|Overall Study|Withdrawal by Subject|2|||
170777880|NCT05308316|617194013|FG000|Overall Study|Physician Decision|1|||
170777881|NCT04019444|617194014|FG000|Overall Study|Withdrawal by Subject|0|||
170777882|NCT04019444|617194015|FG001|Overall Study|Withdrawal by Subject|1|||
170777883|NCT04019444|617194016|FG002|Overall Study|Withdrawal by Subject|0|||
170777884|NCT04019444|617194017|FG003|Overall Study|Withdrawal by Subject|1|||
170777885|NCT04019444|617194014|FG000|Overall Study|Solicited Event|0|||
170777886|NCT04019444|617194015|FG001|Overall Study|Solicited Event|0|||
170777887|NCT04019444|617194016|FG002|Overall Study|Solicited Event|2|||
170777888|NCT04019444|617194017|FG003|Overall Study|Solicited Event|0|||
170777889|NCT03997916|617194021|FG000|Overall Study|Protocol Violation|35|||
170777890|NCT00497198|617194022|FG000|Overall Study|Adverse Event|4|||
170777891|NCT00497198|617194023|FG001|Overall Study|Adverse Event|2|||
170777892|NCT00497198|617194022|FG000|Overall Study|Physician Decision|1|||
170777893|NCT00497198|617194023|FG001|Overall Study|Physician Decision|2|||
170777894|NCT00497198|617194022|FG000|Overall Study|Withdrawal by Subject|0|||
170777895|NCT00497198|617194023|FG001|Overall Study|Withdrawal by Subject|1|||
170777896|NCT00424463|617194026|FG000|Overall Study|Adverse Event|2|||
170777897|NCT00424463|617194027|FG001|Overall Study|Adverse Event|3|||
170777898|NCT00424463|617194028|FG002|Overall Study|Adverse Event|2|||
170877730|NCT02055820|617563962|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
170877731|NCT02055820|617563963|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
170877732|NCT02055820|617563964|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
170417939|NCT00788957|615869407|FG003|Part 1|Death|0|||
170417940|NCT00788957|615869408|FG004|Part 1|Death|0|||
170417941|NCT00788957|615869409|FG005|Part 1|Death|0|||
170417942|NCT00788957|615869404|FG000|Part 1|Lost to Follow-up|1|||
170417943|NCT00788957|615869405|FG001|Part 1|Lost to Follow-up|0|||
170417944|NCT00788957|615869406|FG002|Part 1|Lost to Follow-up|0|||
170417945|NCT00788957|615869407|FG003|Part 1|Lost to Follow-up|0|||
170417946|NCT00788957|615869408|FG004|Part 1|Lost to Follow-up|0|||
170417947|NCT00788957|615869409|FG005|Part 1|Lost to Follow-up|0|||
170417948|NCT00788957|615869404|FG000|Part 2|Withdrawal by Subject|0|||
170777899|NCT00424463|617194026|FG000|Overall Study|Physician Decision|0|||
170777900|NCT00424463|617194027|FG001|Overall Study|Physician Decision|2|||
170777901|NCT00424463|617194028|FG002|Overall Study|Physician Decision|2|||
170777902|NCT00424463|617194026|FG000|Overall Study|Withdrawal by Subject|4|||
170777903|NCT00424463|617194027|FG001|Overall Study|Withdrawal by Subject|2|||
170777904|NCT00424463|617194028|FG002|Overall Study|Withdrawal by Subject|5|||
170417949|NCT00788957|615869405|FG001|Part 2|Withdrawal by Subject|9|||
170417950|NCT00788957|615869406|FG002|Part 2|Withdrawal by Subject|5|||
170777905|NCT00424463|617194026|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
170417951|NCT00788957|615869407|FG003|Part 2|Withdrawal by Subject|3|||
170417952|NCT00788957|615869408|FG004|Part 2|Withdrawal by Subject|0|||
170417953|NCT00788957|615869409|FG005|Part 2|Withdrawal by Subject|0|||
170417954|NCT00788957|615869404|FG000|Part 2|Death|0|||
170417955|NCT00788957|615869405|FG001|Part 2|Death|32|||
170417956|NCT00788957|615869406|FG002|Part 2|Death|35|||
170417957|NCT00788957|615869407|FG003|Part 2|Death|37|||
170417958|NCT00788957|615869408|FG004|Part 2|Death|0|||
170417959|NCT00788957|615869409|FG005|Part 2|Death|0|||
170417960|NCT00788957|615869404|FG000|Part 2|Lost to Follow-up|0|||
170417961|NCT00788957|615869405|FG001|Part 2|Lost to Follow-up|0|||
170417962|NCT00788957|615869406|FG002|Part 2|Lost to Follow-up|3|||
170417963|NCT00788957|615869407|FG003|Part 2|Lost to Follow-up|0|||
170417964|NCT00788957|615869408|FG004|Part 2|Lost to Follow-up|0|||
170417965|NCT00788957|615869409|FG005|Part 2|Lost to Follow-up|0|||
170417966|NCT00788957|615869404|FG000|Part 2|On-study at time of data cut-off|0|||
170417967|NCT00788957|615869405|FG001|Part 2|On-study at time of data cut-off|1|||
170417968|NCT00788957|615869406|FG002|Part 2|On-study at time of data cut-off|1|||
170417969|NCT00788957|615869407|FG003|Part 2|On-study at time of data cut-off|1|||
170417970|NCT00788957|615869408|FG004|Part 2|On-study at time of data cut-off|0|||
170417971|NCT00788957|615869409|FG005|Part 2|On-study at time of data cut-off|0|||
170417972|NCT00788957|615869404|FG000|Part 3|Withdrawal by Subject|0|||
170417973|NCT00788957|615869405|FG001|Part 3|Withdrawal by Subject|0|||
170417974|NCT00788957|615869406|FG002|Part 3|Withdrawal by Subject|0|||
170417975|NCT00788957|615869407|FG003|Part 3|Withdrawal by Subject|0|||
170417976|NCT00788957|615869408|FG004|Part 3|Withdrawal by Subject|0|||
170417977|NCT00788957|615869409|FG005|Part 3|Withdrawal by Subject|2|||
170417978|NCT00788957|615869404|FG000|Part 3|Death|0|||
170417979|NCT00788957|615869405|FG001|Part 3|Death|0|||
170417980|NCT00788957|615869406|FG002|Part 3|Death|0|||
170417981|NCT00788957|615869407|FG003|Part 3|Death|0|||
170417982|NCT00788957|615869408|FG004|Part 3|Death|8|||
170417983|NCT00788957|615869409|FG005|Part 3|Death|8|||
170417984|NCT00788957|615869404|FG000|Part 3|On-study at time of data cut-off|0|||
170417985|NCT00788957|615869405|FG001|Part 3|On-study at time of data cut-off|0|||
170417986|NCT00788957|615869406|FG002|Part 3|On-study at time of data cut-off|0|||
170417987|NCT00788957|615869407|FG003|Part 3|On-study at time of data cut-off|0|||
170417988|NCT00788957|615869408|FG004|Part 3|On-study at time of data cut-off|1|||
170417989|NCT00788957|615869409|FG005|Part 3|On-study at time of data cut-off|0|||
170417990|NCT00662129|615869410|FG000|Overall Study|Protocol Violation|1|||
170417991|NCT00662129|615869410|FG000|Overall Study|Cancel prior to beginning treatment|1|||
170417992|NCT00662129|615869410|FG000|Overall Study|Ineligible|1|||
170417993|NCT01734772|615869419|FG000|Overall Study|Adverse Event|1|||
170417994|NCT01734772|615869420|FG001|Overall Study|Adverse Event|2|||
170417995|NCT01734772|615869419|FG000|Overall Study|Withdrawal by Subject|0|||
170417996|NCT01734772|615869420|FG001|Overall Study|Withdrawal by Subject|1|||
170417997|NCT04803357|615869423|FG000|Overall Study|Withdrawal by Subject|31|||
170417998|NCT04803357|615869424|FG001|Overall Study|Withdrawal by Subject|5|||
170417999|NCT01346410|615869425|FG000|Overall Study|Death|1|||
170418000|NCT04272801|615869426|FG000|Overall Study|Withdrawal by Subject|4|||
170418001|NCT04272801|615869426|FG000|Overall Study|Lost to Follow-up|4|||
170418002|NCT04272801|615869426|FG000|Overall Study|Ineligible|1|||
170418003|NCT00752856|615869427|FG000|Overall Study|randomized but did not do viral kinetics|0|||
170418004|NCT00752856|615869428|FG001|Overall Study|randomized but did not do viral kinetics|1|||
170418005|NCT00996736|615869429|FG000|Overall Study|Death|1|||
170777906|NCT00424463|617194027|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
170777907|NCT00424463|617194028|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
170777908|NCT00424463|617194026|FG000|Overall Study|Patient's convenience|0|||
170777909|NCT00424463|617194027|FG001|Overall Study|Patient's convenience|0|||
170777910|NCT00424463|617194028|FG002|Overall Study|Patient's convenience|1|||
170777911|NCT04434729|617194030|FG000|Overall Study|Adverse Event|1|||
170777912|NCT04434729|617194030|FG000|Overall Study|Physician Decision|1|||
170777913|NCT00975819|617194031|FG000|Overall Study|Lack of Efficacy|8|||
170777914|NCT00975819|617194031|FG000|Overall Study|Adverse Event|2|||
170418006|NCT00996736|615869430|FG001|Overall Study|Death|1|||
170418007|NCT00996736|615869429|FG000|Overall Study|Lost to Follow-up|15|||
170418008|NCT00996736|615869430|FG001|Overall Study|Lost to Follow-up|14|||
170418009|NCT00996736|615869429|FG000|Overall Study|Visit not within 3-month window|5|||
170418010|NCT00996736|615869430|FG001|Overall Study|Visit not within 3-month window|3|||
170418011|NCT02456909|615869431|FG000|Overall Study|Did not receive allocated intervention|24|||
170418012|NCT02456909|615869432|FG001|Overall Study|Did not receive allocated intervention|26|||
170418013|NCT02456909|615869431|FG000|Overall Study|Did not complete the primary outcome|0|||
170418014|NCT02456909|615869432|FG001|Overall Study|Did not complete the primary outcome|1|||
170418015|NCT02346201|615869433|FG000|Overall Study|Adverse Event|3|||
170418016|NCT02346201|615869434|FG001|Overall Study|Adverse Event|2|||
170418017|NCT02346201|615869433|FG000|Overall Study|Lost to Follow-up|1|||
170777915|NCT00975819|617194031|FG000|Overall Study|Physician Decision|2|||
170418018|NCT02346201|615869434|FG001|Overall Study|Lost to Follow-up|0|||
170418019|NCT02346201|615869433|FG000|Overall Study|Withdrawal by Subject|6|||
170418020|NCT02346201|615869434|FG001|Overall Study|Withdrawal by Subject|3|||
170418021|NCT02346201|615869433|FG000|Overall Study|Unavailable for future follow-up|0|||
170418022|NCT02346201|615869434|FG001|Overall Study|Unavailable for future follow-up|1|||
170418023|NCT02346201|615869433|FG000|Overall Study|Physician Decision|0|||
170418024|NCT02346201|615869434|FG001|Overall Study|Physician Decision|1|||
170418025|NCT02346201|615869433|FG000|Overall Study|Missed final visit|0|||
170418026|NCT02346201|615869434|FG001|Overall Study|Missed final visit|2|||
170418027|NCT01508936|615869437|FG000|Overall Study|Adverse Event|11|||
170877733|NCT02055820|617563965|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
170877734|NCT02055820|617563966|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
170877735|NCT02055820|617563967|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
170877736|NCT00631020|617563968|FG000|Overall Study|Lost to Follow-up|7|||
170877737|NCT00631020|617563968|FG000|Overall Study|Incarcerated|1|||
170418028|NCT01508936|615869438|FG001|Overall Study|Adverse Event|32|||
170418029|NCT01508936|615869437|FG000|Overall Study|Lack of Efficacy|0|||
170418030|NCT01508936|615869438|FG001|Overall Study|Lack of Efficacy|1|||
170418031|NCT01508936|615869437|FG000|Overall Study|Withdrawal by Subject|4|||
170418032|NCT01508936|615869438|FG001|Overall Study|Withdrawal by Subject|18|||
170418033|NCT01508936|615869437|FG000|Overall Study|Protocol Violation|2|||
170418034|NCT01508936|615869438|FG001|Overall Study|Protocol Violation|3|||
170418035|NCT01508936|615869437|FG000|Overall Study|Lost to Follow-up|2|||
170418036|NCT01508936|615869438|FG001|Overall Study|Lost to Follow-up|9|||
170418037|NCT01508936|615869437|FG000|Overall Study|Other|0|||
170418038|NCT01508936|615869438|FG001|Overall Study|Other|5|||
170418039|NCT01508936|615869437|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
170418040|NCT01508936|615869438|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
170418041|NCT00409578|615869439|FG000|Overall Study|Adverse Event|27|||
170418042|NCT00409578|615869440|FG001|Overall Study|Adverse Event|37|||
170418043|NCT00409578|615869441|FG002|Overall Study|Adverse Event|25|||
170418044|NCT00409578|615869442|FG003|Overall Study|Adverse Event|33|||
170418045|NCT00409578|615869439|FG000|Overall Study|Abnormal laboratory value(s)|2|||
170418046|NCT00409578|615869440|FG001|Overall Study|Abnormal laboratory value(s)|2|||
170418047|NCT00409578|615869441|FG002|Overall Study|Abnormal laboratory value(s)|2|||
170418048|NCT00409578|615869442|FG003|Overall Study|Abnormal laboratory value(s)|4|||
170418049|NCT00409578|615869439|FG000|Overall Study|Lack of Efficacy|0|||
170418050|NCT00409578|615869440|FG001|Overall Study|Lack of Efficacy|0|||
170418051|NCT00409578|615869441|FG002|Overall Study|Lack of Efficacy|0|||
170418052|NCT00409578|615869442|FG003|Overall Study|Lack of Efficacy|2|||
170418053|NCT00409578|615869439|FG000|Overall Study|Subject no longer requires study drug|0|||
170418054|NCT00409578|615869440|FG001|Overall Study|Subject no longer requires study drug|0|||
170418055|NCT00409578|615869441|FG002|Overall Study|Subject no longer requires study drug|0|||
170418056|NCT00409578|615869442|FG003|Overall Study|Subject no longer requires study drug|1|||
170418057|NCT00409578|615869439|FG000|Overall Study|Withdrawal by Subject|8|||
170418058|NCT00409578|615869440|FG001|Overall Study|Withdrawal by Subject|15|||
170418059|NCT00409578|615869441|FG002|Overall Study|Withdrawal by Subject|16|||
170418060|NCT00409578|615869442|FG003|Overall Study|Withdrawal by Subject|17|||
170418061|NCT00409578|615869439|FG000|Overall Study|Lost to Follow-up|2|||
170418062|NCT00409578|615869440|FG001|Overall Study|Lost to Follow-up|0|||
170418063|NCT00409578|615869441|FG002|Overall Study|Lost to Follow-up|2|||
170418064|NCT00409578|615869442|FG003|Overall Study|Lost to Follow-up|2|||
170418065|NCT00409578|615869439|FG000|Overall Study|Administrative problems|8|||
170418066|NCT00409578|615869440|FG001|Overall Study|Administrative problems|9|||
170418067|NCT00409578|615869441|FG002|Overall Study|Administrative problems|2|||
170418068|NCT00409578|615869442|FG003|Overall Study|Administrative problems|4|||
170418069|NCT00409578|615869439|FG000|Overall Study|Death|2|||
170418070|NCT00409578|615869440|FG001|Overall Study|Death|4|||
170418071|NCT00409578|615869441|FG002|Overall Study|Death|4|||
170418072|NCT00409578|615869442|FG003|Overall Study|Death|2|||
170418073|NCT00409578|615869439|FG000|Overall Study|Protocol Violation|3|||
170418074|NCT00409578|615869440|FG001|Overall Study|Protocol Violation|2|||
170418075|NCT00409578|615869441|FG002|Overall Study|Protocol Violation|3|||
170418076|NCT00409578|615869442|FG003|Overall Study|Protocol Violation|1|||
170418077|NCT00409578|615869439|FG000|Overall Study|Missing|0|||
170418078|NCT00409578|615869440|FG001|Overall Study|Missing|1|||
170418079|NCT00409578|615869441|FG002|Overall Study|Missing|0|||
170418080|NCT00409578|615869442|FG003|Overall Study|Missing|1|||
170418081|NCT02109133|615869443|FG000|Overall Study|Lost to Follow-up|1|||
170418082|NCT02109133|615869444|FG001|Overall Study|Lost to Follow-up|0|||
170418083|NCT02448771|615869445|FG000|Overall Study|Disease Progression|30|||
170418084|NCT02448771|615869445|FG000|Overall Study|Unacceptable Toxicity|1|||
170418085|NCT02448771|615869445|FG000|Overall Study|Physician Decision|3|||
170418086|NCT02448771|615869445|FG000|Overall Study|Started new therapy|2|||
170418087|NCT03815942|615871627|FG000|Overall Study|Withdrawal by Subject|0|||
170418088|NCT03815942|615871628|FG001|Overall Study|Withdrawal by Subject|17|||
170418089|NCT03717064|615871629|FG000|Period 2|Adverse Event|1|||
170418090|NCT02841709|615871630|FG000|5th Intervention|Adverse Event|2|||
170877738|NCT02614859|617563969|FG000|Overall Study|Physician Decision|0|||
170877739|NCT02614859|617563970|FG001|Overall Study|Physician Decision|1|||
170777916|NCT00975819|617194031|FG000|Overall Study|Withdrawal by Subject|2|||
170777917|NCT00975819|617194031|FG000|Overall Study|Protocol Violation|1|||
170777918|NCT01968109|617194032|FG000|Overall Study|DISEASE PROGRESSION|4|||
170777919|NCT01968109|617194033|FG001|Overall Study|DISEASE PROGRESSION|4|||
170777920|NCT01968109|617194034|FG002|Overall Study|DISEASE PROGRESSION|3|||
170777921|NCT01968109|617194035|FG003|Overall Study|DISEASE PROGRESSION|9|||
170777922|NCT01968109|617194036|FG004|Overall Study|DISEASE PROGRESSION|5|||
170777923|NCT01968109|617194037|FG005|Overall Study|DISEASE PROGRESSION|6|||
170777924|NCT01968109|617194038|FG006|Overall Study|DISEASE PROGRESSION|6|||
170777925|NCT01968109|617194039|FG007|Overall Study|DISEASE PROGRESSION|6|||
170777926|NCT01968109|617194040|FG008|Overall Study|DISEASE PROGRESSION|4|||
170777927|NCT01968109|617194041|FG009|Overall Study|DISEASE PROGRESSION|5|||
170777928|NCT01968109|617194042|FG010|Overall Study|DISEASE PROGRESSION|8|||
170777929|NCT01968109|617194043|FG011|Overall Study|DISEASE PROGRESSION|4|||
170777930|NCT01968109|617194044|FG012|Overall Study|DISEASE PROGRESSION|7|||
170777931|NCT01968109|617194045|FG013|Overall Study|DISEASE PROGRESSION|14|||
170777932|NCT01968109|617194046|FG014|Overall Study|DISEASE PROGRESSION|14|||
170777933|NCT01968109|617194047|FG015|Overall Study|DISEASE PROGRESSION|13|||
170777934|NCT01968109|617194048|FG016|Overall Study|DISEASE PROGRESSION|34|||
170777935|NCT01968109|617194049|FG017|Overall Study|DISEASE PROGRESSION|20|||
170777936|NCT01968109|617194050|FG018|Overall Study|DISEASE PROGRESSION|54|||
170777937|NCT01968109|617194051|FG019|Overall Study|DISEASE PROGRESSION|46|||
170777938|NCT01968109|617194052|FG020|Overall Study|DISEASE PROGRESSION|77|||
170777939|NCT01968109|617194053|FG021|Overall Study|DISEASE PROGRESSION|25|||
170777940|NCT01968109|617194054|FG022|Overall Study|DISEASE PROGRESSION|47|||
170777941|NCT01968109|617194055|FG023|Overall Study|DISEASE PROGRESSION|125|||
170777942|NCT01968109|617194056|FG024|Overall Study|DISEASE PROGRESSION|155|||
170777943|NCT01968109|617194057|FG025|Overall Study|DISEASE PROGRESSION|63|||
170777944|NCT01968109|617194058|FG026|Overall Study|DISEASE PROGRESSION|65|||
170777945|NCT01968109|617194059|FG027|Overall Study|DISEASE PROGRESSION|137|||
170777946|NCT01968109|617194060|FG028|Overall Study|DISEASE PROGRESSION|35|||
170777947|NCT01968109|617194061|FG029|Overall Study|DISEASE PROGRESSION|23|||
170777948|NCT01968109|617194062|FG030|Overall Study|DISEASE PROGRESSION|71|||
170777949|NCT01968109|617194032|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170777950|NCT01968109|617194033|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777951|NCT01968109|617194034|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777952|NCT01968109|617194035|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777953|NCT01968109|617194036|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170777954|NCT01968109|617194037|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170777955|NCT01968109|617194038|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170777956|NCT01968109|617194039|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170777957|NCT01968109|617194040|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777958|NCT01968109|617194041|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777959|NCT01968109|617194042|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777960|NCT01968109|617194043|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777961|NCT01968109|617194044|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777962|NCT01968109|617194045|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777963|NCT01968109|617194046|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777964|NCT01968109|617194047|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170777965|NCT01968109|617194048|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170418091|NCT02841709|615871631|FG001|5th Intervention|Adverse Event|0|||
170418092|NCT02841709|615871632|FG002|5th Intervention|Adverse Event|0|||
170418093|NCT02841709|615871633|FG003|5th Intervention|Adverse Event|0|||
170418094|NCT02841709|615871634|FG004|5th Intervention|Adverse Event|2|||
170418095|NCT01210001|615871635|FG000|Overall Study|Not treated|1|||
170418096|NCT01210001|615871636|FG001|Overall Study|Not treated|0|||
170418097|NCT01210001|615871637|FG002|Overall Study|Not treated|0|||
170418098|NCT01210001|615871635|FG000|Overall Study|Adverse Event|4|||
170418099|NCT01210001|615871636|FG001|Overall Study|Adverse Event|2|||
170418100|NCT01210001|615871637|FG002|Overall Study|Adverse Event|5|||
170418101|NCT01210001|615871635|FG000|Overall Study|Non compliant with protocol|2|||
170418102|NCT01210001|615871636|FG001|Overall Study|Non compliant with protocol|2|||
170418103|NCT01210001|615871637|FG002|Overall Study|Non compliant with protocol|3|||
170418104|NCT01210001|615871635|FG000|Overall Study|Lost to Follow-up|4|||
170418105|NCT01210001|615871636|FG001|Overall Study|Lost to Follow-up|3|||
170777966|NCT01968109|617194049|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170777967|NCT01968109|617194050|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
170418106|NCT01210001|615871637|FG002|Overall Study|Lost to Follow-up|2|||
170418107|NCT01210001|615871635|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
170418108|NCT01210001|615871636|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
170777968|NCT01968109|617194051|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777969|NCT01968109|617194052|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
170418109|NCT01210001|615871637|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
170418110|NCT01210001|615871635|FG000|Overall Study|Other reason not defined above|2|||
170418111|NCT01210001|615871636|FG001|Overall Study|Other reason not defined above|2|||
170418112|NCT01210001|615871637|FG002|Overall Study|Other reason not defined above|1|||
170418113|NCT00788125|615871638|FG000|Overall Study|Death|6|||
170418114|NCT01374919|615871648|FG000|Overall Study|Withdrawal by Subject|2|||
170418115|NCT03805438|615871649|FG000|Overall Study|Lack of Efficacy|1|||
170418116|NCT03805438|615871649|FG000|Overall Study|Protocol Violation|1|||
170530172|NCT00576758|616289763|FG001|Follow-up Period|Administrative/Other|8|||
170530173|NCT00576758|616289762|FG000|Follow-up Period|Death|3|||
170530174|NCT00576758|616289763|FG001|Follow-up Period|Death|3|||
170530175|NCT00576758|616289762|FG000|Follow-up Period|Insufficient therapeutic response|16|||
170530176|NCT00576758|616289763|FG001|Follow-up Period|Insufficient therapeutic response|5|||
170530177|NCT00576758|616289762|FG000|Follow-up Period|Withdrew consent|2|||
170530178|NCT00576758|616289763|FG001|Follow-up Period|Withdrew consent|1|||
170530179|NCT00715208|616289764|FG000|Overall Study|Withdrawal by Subject|1|||
170530180|NCT00715208|616289765|FG001|Overall Study|Withdrawal by Subject|1|||
170530181|NCT00715208|616289764|FG000|Overall Study|Adverse Event|0|||
170530182|NCT00715208|616289765|FG001|Overall Study|Adverse Event|6|||
170530183|NCT00715208|616289764|FG000|Overall Study|Lack of Efficacy|0|||
170530184|NCT00715208|616289765|FG001|Overall Study|Lack of Efficacy|2|||
170418117|NCT00366899|615871650|FG000|Infant Series|Withdrawal by Subject|4|||
170418118|NCT00366899|615871651|FG001|Infant Series|Withdrawal by Subject|7|||
170418119|NCT00366899|615871650|FG000|Infant Series|Protocol Violation|2|||
170418120|NCT00366899|615871651|FG001|Infant Series|Protocol Violation|1|||
170418121|NCT00366899|615871650|FG000|Infant Series|Failed to return|1|||
170418122|NCT00366899|615871651|FG001|Infant Series|Failed to return|1|||
170418123|NCT00366899|615871650|FG000|Infant Series|Lost to Follow-up|0|||
170418124|NCT00366899|615871651|FG001|Infant Series|Lost to Follow-up|2|||
170418125|NCT00366899|615871650|FG000|Infant Series|Adverse Event|0|||
170418126|NCT00366899|615871651|FG001|Infant Series|Adverse Event|1|||
170418127|NCT00366899|615871650|FG000|Infant Series|Physician Decision|1|||
170418128|NCT00366899|615871651|FG001|Infant Series|Physician Decision|0|||
170418129|NCT00366899|615871650|FG000|Infant Series|Randomized but not consented|1|||
170418130|NCT00366899|615871651|FG001|Infant Series|Randomized but not consented|0|||
170418131|NCT00366899|615871650|FG000|After Infant Series|Lost to Follow-up|4|||
170418132|NCT00366899|615871651|FG001|After Infant Series|Lost to Follow-up|3|||
170418133|NCT00366899|615871650|FG000|After Infant Series|Withdrawal by Subject|1|||
170418134|NCT00366899|615871651|FG001|After Infant Series|Withdrawal by Subject|4|||
170418135|NCT00366899|615871650|FG000|After Infant Series|Adverse Event|1|||
170418136|NCT00366899|615871651|FG001|After Infant Series|Adverse Event|2|||
170418137|NCT00366899|615871650|FG000|After Infant Series|Protocol Violation|1|||
170530185|NCT01316614|616289766|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
170777970|NCT01968109|617194053|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170777971|NCT01968109|617194054|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
170777972|NCT01968109|617194055|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
170777973|NCT01968109|617194056|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
170777974|NCT01968109|617194057|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
170777975|NCT01968109|617194058|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
170777976|NCT01968109|617194059|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
170777977|NCT01968109|617194060|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
170777978|NCT01968109|617194061|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
170777979|NCT01968109|617194062|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
170777980|NCT01968109|617194032|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
170777981|NCT01968109|617194033|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
170777982|NCT01968109|617194034|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
170777983|NCT01968109|617194035|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
170777984|NCT01968109|617194036|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
170777985|NCT01968109|617194037|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
170777986|NCT01968109|617194038|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
170777987|NCT01968109|617194039|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
170777988|NCT01968109|617194040|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
170530186|NCT01316614|616289766|FG000|Overall Study|Cytology slides not available for review|4|||
170777989|NCT01968109|617194041|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
170777990|NCT01968109|617194042|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
170777991|NCT01968109|617194043|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
170418138|NCT00366899|615871651|FG001|After Infant Series|Protocol Violation|0|||
170418139|NCT00366899|615871650|FG000|Toddler Dose|Withdrawal by Subject|1|||
170418140|NCT00366899|615871651|FG001|Toddler Dose|Withdrawal by Subject|1|||
170418141|NCT00366899|615871650|FG000|Toddler Dose|Protocol Violation|1|||
170418142|NCT00366899|615871651|FG001|Toddler Dose|Protocol Violation|0|||
170418143|NCT01619800|615871652|FG000|Overall Study|study terminated|2|||
170530187|NCT01316614|616289766|FG000|Overall Study|Cystic lesion|5|||
170777992|NCT01968109|617194044|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
170777993|NCT01968109|617194045|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
170418144|NCT01619800|615871653|FG001|Overall Study|study terminated|0|||
170777994|NCT01968109|617194046|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
170777995|NCT01968109|617194047|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
170777996|NCT01968109|617194048|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
170777997|NCT01968109|617194049|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
170777998|NCT01968109|617194050|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
170777999|NCT01968109|617194051|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
170778000|NCT01968109|617194052|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
170778001|NCT01968109|617194053|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
170778002|NCT01968109|617194054|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
170877740|NCT03548935|617563971|FG000|Overall Study|Withdrawal by Subject|26|||
170877741|NCT03548935|617563972|FG001|Overall Study|Withdrawal by Subject|17|||
170877742|NCT03548935|617563971|FG000|Overall Study|Lost to Follow-up|39|||
170877743|NCT03548935|617563972|FG001|Overall Study|Lost to Follow-up|28|||
170877744|NCT03548935|617563971|FG000|Overall Study|Death|1|||
170877745|NCT03548935|617563972|FG001|Overall Study|Death|1|||
170877746|NCT00732303|617563973|FG000|Overall Study|Study Terminated|2|||
170877747|NCT01074190|617563974|FG000|Overall Study|Emergency Cesarean Delivery|1|||
170877748|NCT01074190|617563975|FG001|Overall Study|Emergency Cesarean Delivery|2|||
170877749|NCT01074190|617563976|FG002|Overall Study|Emergency Cesarean Delivery|1|||
170877750|NCT01074190|617563974|FG000|Overall Study|Protocol Violation|2|||
170877751|NCT01074190|617563975|FG001|Overall Study|Protocol Violation|1|||
170418145|NCT00414466|615871656|FG000|Overall Study|Adverse Event|0|||
170418146|NCT00414466|615871657|FG001|Overall Study|Adverse Event|0|||
170418147|NCT00414466|615871658|FG002|Overall Study|Adverse Event|1|||
170418148|NCT00414466|615871659|FG003|Overall Study|Adverse Event|1|||
170418149|NCT00414466|615871656|FG000|Overall Study|Lack of Efficacy|1|||
170418150|NCT00414466|615871657|FG001|Overall Study|Lack of Efficacy|0|||
170418151|NCT00414466|615871658|FG002|Overall Study|Lack of Efficacy|0|||
170418152|NCT00414466|615871659|FG003|Overall Study|Lack of Efficacy|0|||
170418153|NCT00414466|615871656|FG000|Overall Study|Withdrawn by Sponsor|1|||
170418154|NCT00414466|615871657|FG001|Overall Study|Withdrawn by Sponsor|0|||
170418155|NCT00414466|615871658|FG002|Overall Study|Withdrawn by Sponsor|0|||
170418156|NCT00414466|615871659|FG003|Overall Study|Withdrawn by Sponsor|0|||
170418157|NCT04526210|615871665|FG000|Overall Study|Sponsor decision|7|||
170418158|NCT04526210|615871666|FG001|Overall Study|Sponsor decision|5|||
170418159|NCT04526210|615871665|FG000|Overall Study|Withdrawal by Subject|3|||
170418160|NCT04526210|615871666|FG001|Overall Study|Withdrawal by Subject|2|||
170418161|NCT00090857|615871667|FG000|Overall Study|Lost to Follow-up|0|||
170418162|NCT00090857|615871668|FG001|Overall Study|Lost to Follow-up|1|||
170418163|NCT00090857|615871667|FG000|Overall Study|Withdrawal by Subject|2|||
170418164|NCT00090857|615871668|FG001|Overall Study|Withdrawal by Subject|0|||
170418165|NCT00090857|615871667|FG000|Overall Study|Adverse Event|2|||
170418166|NCT00090857|615871668|FG001|Overall Study|Adverse Event|2|||
170418167|NCT05097326|615871670|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
170418168|NCT05097326|615871671|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
170418169|NCT02684344|615871673|FG000|Overall Study|Withdrawal by Subject|0|||
170418170|NCT02684344|615871674|FG001|Overall Study|Withdrawal by Subject|1|||
170418171|NCT01244126|615871675|FG000|Overall Study|Protocol Violation|3|||
170418172|NCT01244126|615871676|FG001|Overall Study|Protocol Violation|3|||
170418173|NCT01244126|615871677|FG002|Overall Study|Protocol Violation|9|||
170418174|NCT00630305|615871678|FG000|Overall Study|Withdrawal by Subject|1|||
170418175|NCT00630305|615871678|FG000|Overall Study|Inability to insert contact lens|1|||
170418176|NCT01085045|615871679|FG000|Part A|Withdrawal by Subject|4|||
170418177|NCT01085045|615871679|FG000|Part A|Adverse Event|6|||
170418178|NCT01085045|615871679|FG000|Part A|Protocol Violation|1|||
170418179|NCT01085045|615871679|FG000|Part A|Protocol Specified Criteria|7|||
170418180|NCT01085045|615871679|FG000|Part B|Withdrawal by Subject|2|||
170418181|NCT01085045|615871679|FG000|Part B|Protocol Specified Criteria|6|||
170418182|NCT01085045|615871679|FG000|Part B|Lost to Follow-up|1|||
170418183|NCT01085045|615871679|FG000|Part B|Adverse Event|6|||
170418184|NCT00433147|615871688|FG000|Overall Study|Adverse Event|0|||
170418185|NCT00433147|615871689|FG001|Overall Study|Adverse Event|1|||
170418186|NCT00433147|615871690|FG002|Overall Study|Adverse Event|0|||
170418187|NCT00433147|615871691|FG003|Overall Study|Adverse Event|0|||
170418188|NCT01882647|615871692|FG000|Overall Study|Lost to Follow-up|2|||
170418189|NCT01882647|615871693|FG001|Overall Study|Lost to Follow-up|2|||
170418190|NCT01882647|615871692|FG000|Overall Study|Withdrawal by Subject|0|||
170418191|NCT01882647|615871693|FG001|Overall Study|Withdrawal by Subject|4|||
170778003|NCT01968109|617194055|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
170877752|NCT01074190|617563976|FG002|Overall Study|Protocol Violation|0|||
170877753|NCT01074190|617563974|FG000|Overall Study|Delivered in under 90 minutes|0|||
170418192|NCT00290745|615871694|FG000|Overall Study|Withdrawal by Subject|4|||
170418193|NCT00290745|615871694|FG000|Overall Study|Physician Decision|2|||
170877754|NCT01074190|617563975|FG001|Overall Study|Delivered in under 90 minutes|2|||
170778004|NCT01968109|617194056|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
170877755|NCT01074190|617563976|FG002|Overall Study|Delivered in under 90 minutes|1|||
170418194|NCT00290745|615871694|FG000|Overall Study|Surgery after 3 months for progression|3|||
170418195|NCT00290745|615871694|FG000|Overall Study|Baseline MRI not available|3|||
170418196|NCT03499964|615871697|FG000|Overall Study|Lack of Efficacy|6|||
170418197|NCT03499964|615871698|FG001|Overall Study|Lack of Efficacy|26|||
170418198|NCT03499964|615871697|FG000|Overall Study|Adverse Event|1|||
170418199|NCT03499964|615871698|FG001|Overall Study|Adverse Event|0|||
170418200|NCT03499964|615871697|FG000|Overall Study|Death|1|||
170418201|NCT03499964|615871698|FG001|Overall Study|Death|0|||
170418202|NCT03499964|615871697|FG000|Overall Study|Withdrawal by Subject|2|||
170418203|NCT03499964|615871698|FG001|Overall Study|Withdrawal by Subject|1|||
170418204|NCT03499964|615871697|FG000|Overall Study|Lost to Follow-up|1|||
170418205|NCT03499964|615871698|FG001|Overall Study|Lost to Follow-up|0|||
170418206|NCT02497781|615871699|FG000|Overall Study|Withdrawal by Subject|2|||
170418207|NCT02497781|615871700|FG001|Overall Study|Withdrawal by Subject|0|||
170418208|NCT02497781|615871699|FG000|Overall Study|Lack of Efficacy|0|||
170418209|NCT02497781|615871700|FG001|Overall Study|Lack of Efficacy|1|||
170418210|NCT02497781|615871699|FG000|Overall Study|Randomised but not treated|1|||
170418211|NCT02497781|615871700|FG001|Overall Study|Randomised but not treated|1|||
170418212|NCT02497781|615871699|FG000|Overall Study|Lost to Follow-up|1|||
170418213|NCT02497781|615871700|FG001|Overall Study|Lost to Follow-up|1|||
170418214|NCT01193608|615871701|FG000|Overall Study|Other|0|||
170418215|NCT01193608|615871702|FG001|Overall Study|Other|1|||
170530188|NCT01316614|616289766|FG000|Overall Study|Inadequate number of passes|2|||
170530189|NCT01316614|616289766|FG000|Overall Study|Medically unstable|1|||
170530190|NCT03979313|616289767|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
170530191|NCT03979313|616289768|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
170530192|NCT03979313|616289767|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
170530193|NCT03979313|616289768|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
170530194|NCT03979313|616289767|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
170530195|NCT03979313|616289768|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
170530196|NCT03979313|616289767|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
170530197|NCT03979313|616289768|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
170530198|NCT03979313|616289767|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
170530199|NCT03979313|616289768|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
170530200|NCT03979313|616289767|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
170530201|NCT03979313|616289768|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
170418216|NCT01193608|615871703|FG002|Overall Study|Other|0|||
170418217|NCT01193608|615871704|FG003|Overall Study|Other|0|||
170418218|NCT01193608|615871705|FG004|Overall Study|Other|0|||
170418219|NCT01193608|615871706|FG005|Overall Study|Other|0|||
170418220|NCT01193608|615871701|FG000|Overall Study|Withdrawal by Subject|0|||
170418221|NCT01193608|615871702|FG001|Overall Study|Withdrawal by Subject|1|||
170418222|NCT01193608|615871703|FG002|Overall Study|Withdrawal by Subject|2|||
170418223|NCT01193608|615871704|FG003|Overall Study|Withdrawal by Subject|3|||
170418224|NCT01193608|615871705|FG004|Overall Study|Withdrawal by Subject|3|||
170418225|NCT01193608|615871706|FG005|Overall Study|Withdrawal by Subject|0|||
170418226|NCT01193608|615871701|FG000|Overall Study|Lost to Follow-up|0|||
170418227|NCT01193608|615871702|FG001|Overall Study|Lost to Follow-up|0|||
170418228|NCT01193608|615871703|FG002|Overall Study|Lost to Follow-up|0|||
170418229|NCT01193608|615871704|FG003|Overall Study|Lost to Follow-up|0|||
170418230|NCT01193608|615871705|FG004|Overall Study|Lost to Follow-up|1|||
170418231|NCT01193608|615871706|FG005|Overall Study|Lost to Follow-up|2|||
170418232|NCT01193608|615871701|FG000|Overall Study|Adverse Event|0|||
170418233|NCT01193608|615871702|FG001|Overall Study|Adverse Event|0|||
170418234|NCT01193608|615871703|FG002|Overall Study|Adverse Event|0|||
170530202|NCT03979313|616289767|FG000|All Subjects|Any Other Reason|16|||
170530203|NCT03979313|616289768|FG001|All Subjects|Any Other Reason|23|||
170530204|NCT03979313|616289767|FG000|All Subjects|Covid-19|1|||
170418235|NCT01193608|615871704|FG003|Overall Study|Adverse Event|0|||
170418236|NCT01193608|615871705|FG004|Overall Study|Adverse Event|1|||
170418237|NCT01193608|615871706|FG005|Overall Study|Adverse Event|0|||
170418238|NCT00454636|615871711|FG000|Overall Study|Adverse Event|10|||
170418239|NCT00454636|615871712|FG001|Overall Study|Adverse Event|6|||
170418240|NCT00454636|615871713|FG002|Overall Study|Adverse Event|9|||
170530205|NCT03979313|616289768|FG001|All Subjects|Covid-19|3|||
170530206|NCT03979313|616289767|FG000|All Subjects|Withdrawal by Subject|35|||
170530207|NCT03979313|616289768|FG001|All Subjects|Withdrawal by Subject|44|||
170530208|NCT03979313|616289767|FG000|All Subjects|Death|0|||
170418241|NCT00454636|615871714|FG003|Overall Study|Adverse Event|15|||
170418242|NCT00454636|615871711|FG000|Overall Study|Disease Progression|11|||
170418243|NCT00454636|615871712|FG001|Overall Study|Disease Progression|12|||
170418244|NCT00454636|615871713|FG002|Overall Study|Disease Progression|4|||
170418245|NCT00454636|615871714|FG003|Overall Study|Disease Progression|11|||
170418246|NCT00454636|615871711|FG000|Overall Study|Protocol Violation|3|||
170418247|NCT00454636|615871712|FG001|Overall Study|Protocol Violation|2|||
170418248|NCT00454636|615871713|FG002|Overall Study|Protocol Violation|3|||
170418249|NCT00454636|615871714|FG003|Overall Study|Protocol Violation|3|||
170530209|NCT03979313|616289768|FG001|All Subjects|Death|5|||
170418250|NCT00454636|615871711|FG000|Overall Study|Death|6|||
170418251|NCT00454636|615871712|FG001|Overall Study|Death|1|||
170418252|NCT00454636|615871713|FG002|Overall Study|Death|1|||
170778005|NCT01968109|617194057|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
170418253|NCT00454636|615871714|FG003|Overall Study|Death|1|||
170418254|NCT00454636|615871711|FG000|Overall Study|Patient refusal|1|||
170418255|NCT00454636|615871712|FG001|Overall Study|Patient refusal|1|||
170418256|NCT00454636|615871713|FG002|Overall Study|Patient refusal|3|||
170418257|NCT00454636|615871714|FG003|Overall Study|Patient refusal|2|||
170418258|NCT00454636|615871711|FG000|Overall Study|Lost to Follow-up|0|||
170778006|NCT01968109|617194058|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
170778007|NCT01968109|617194059|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
170778008|NCT01968109|617194060|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
170778009|NCT01968109|617194061|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
170778010|NCT01968109|617194062|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
170778011|NCT01968109|617194032|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778012|NCT01968109|617194033|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778013|NCT01968109|617194034|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778014|NCT01968109|617194035|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778015|NCT01968109|617194036|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778016|NCT01968109|617194037|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778017|NCT01968109|617194038|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778018|NCT01968109|617194039|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
170778019|NCT01968109|617194040|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778020|NCT01968109|617194041|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778021|NCT01968109|617194042|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778022|NCT01968109|617194043|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778023|NCT01968109|617194044|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778024|NCT01968109|617194045|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778025|NCT01968109|617194046|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778026|NCT01968109|617194047|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778027|NCT01968109|617194048|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778028|NCT01968109|617194049|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778029|NCT01968109|617194050|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
170778030|NCT01968109|617194051|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
170778031|NCT01968109|617194052|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
170778032|NCT01968109|617194053|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
170778033|NCT01968109|617194054|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778034|NCT01968109|617194055|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778035|NCT01968109|617194056|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
170778036|NCT01968109|617194057|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
170778037|NCT01968109|617194058|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
170778038|NCT01968109|617194059|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
170778039|NCT01968109|617194060|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
170778040|NCT01968109|617194061|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
170778041|NCT01968109|617194062|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
170778042|NCT01968109|617194032|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778043|NCT01968109|617194033|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778044|NCT01968109|617194034|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778045|NCT01968109|617194035|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778046|NCT01968109|617194036|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778047|NCT01968109|617194037|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778048|NCT01968109|617194038|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778049|NCT01968109|617194039|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778050|NCT01968109|617194040|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
170778051|NCT01968109|617194041|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
170778052|NCT01968109|617194042|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778053|NCT01968109|617194043|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
170778054|NCT01968109|617194044|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778055|NCT01968109|617194045|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
170778056|NCT01968109|617194046|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170778057|NCT01968109|617194047|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
170778058|NCT01968109|617194048|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
170778059|NCT01968109|617194049|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170418259|NCT00454636|615871712|FG001|Overall Study|Lost to Follow-up|1|||
170778060|NCT01968109|617194050|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
170778061|NCT01968109|617194051|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
170778062|NCT01968109|617194052|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
170778063|NCT01968109|617194053|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
170778064|NCT01968109|617194054|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
170778065|NCT01968109|617194055|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
170418260|NCT00454636|615871713|FG002|Overall Study|Lost to Follow-up|0|||
170418261|NCT00454636|615871714|FG003|Overall Study|Lost to Follow-up|0|||
170530210|NCT03979313|616289767|FG000|All Subjects|Lost to Follow-up|28|||
170530211|NCT03979313|616289768|FG001|All Subjects|Lost to Follow-up|61|||
170530212|NCT00420745|616289769|FG000|Overall Study|Adverse Event|2|||
170530213|NCT00420745|616289770|FG001|Overall Study|Adverse Event|2|||
170530214|NCT00420745|616289769|FG000|Overall Study|Lost to Follow-up|10|||
170530215|NCT00420745|616289770|FG001|Overall Study|Lost to Follow-up|2|||
170530216|NCT00420745|616289769|FG000|Overall Study|Protocol Violation|1|||
170530217|NCT00420745|616289770|FG001|Overall Study|Protocol Violation|0|||
170530218|NCT00420745|616289769|FG000|Overall Study|Physician Decision|1|||
170530219|NCT00420745|616289770|FG001|Overall Study|Physician Decision|1|||
170530220|NCT00420745|616289769|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
170530221|NCT00420745|616289770|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
170530222|NCT00420745|616289769|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
170530223|NCT00420745|616289770|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
170530224|NCT00423605|616289771|FG000|Overall Study|Adverse Event|129|||
170530225|NCT00423605|616289771|FG000|Overall Study|Withdrawal by Subject|36|||
170530226|NCT00423605|616289771|FG000|Overall Study|Lost to Follow-up|15|||
170530227|NCT00423605|616289771|FG000|Overall Study|Lack of Efficacy|38|||
170530228|NCT00423605|616289771|FG000|Overall Study|Sponsor Decision|3|||
170530229|NCT00423605|616289771|FG000|Overall Study|Physician Decision|8|||
170530230|NCT00423605|616289771|FG000|Overall Study|Protocol Violation|7|||
170530231|NCT00423605|616289771|FG000|Overall Study|Not one of the pre-specified options|5|||
170530232|NCT01983930|616289773|FG000|Overall Study|Withdrawal by Subject|9|||
170530233|NCT01983930|616289774|FG001|Overall Study|Withdrawal by Subject|8|||
170530234|NCT01983930|616289773|FG000|Overall Study|Adverse Event|0|||
170530235|NCT01983930|616289774|FG001|Overall Study|Adverse Event|1|||
170530236|NCT01454284|616289775|FG000|Overall Study|Adverse Event|20|||
170530237|NCT01454284|616289776|FG001|Overall Study|Adverse Event|7|||
170530238|NCT01454284|616289775|FG000|Overall Study|Death|0|||
170530239|NCT01454284|616289776|FG001|Overall Study|Death|3|||
170530240|NCT01454284|616289775|FG000|Overall Study|Lost to Follow-up|13|||
170530241|NCT01454284|616289776|FG001|Overall Study|Lost to Follow-up|8|||
170530242|NCT01454284|616289775|FG000|Overall Study|Protocol Violation|9|||
170530243|NCT01454284|616289776|FG001|Overall Study|Protocol Violation|6|||
170530244|NCT01454284|616289775|FG000|Overall Study|Withdrawal by Subject|58|||
170530245|NCT01454284|616289776|FG001|Overall Study|Withdrawal by Subject|36|||
170530246|NCT01454284|616289775|FG000|Overall Study|Physician Decision|16|||
170530247|NCT01454284|616289776|FG001|Overall Study|Physician Decision|11|||
170530248|NCT01454284|616289775|FG000|Overall Study|Sponsor Decision|0|||
170530249|NCT01454284|616289776|FG001|Overall Study|Sponsor Decision|2|||
170530250|NCT02842866|616289779|FG000|Overall Study|Serious Adverse Event|0|||
170530251|NCT02842866|616289780|FG001|Overall Study|Serious Adverse Event|1|||
170530252|NCT02842866|616289779|FG000|Overall Study|Protocol Violation|4|||
170530253|NCT02842866|616289780|FG001|Overall Study|Protocol Violation|2|||
170530254|NCT02842866|616289779|FG000|Overall Study|Lost to Follow-up|2|||
170530255|NCT02842866|616289780|FG001|Overall Study|Lost to Follow-up|0|||
170530256|NCT02842866|616289779|FG000|Overall Study|Withdrawal by Subject|1|||
170530257|NCT02842866|616289780|FG001|Overall Study|Withdrawal by Subject|0|||
170530258|NCT01432327|616289781|FG000|Posttest 3 Months|depression|3|||
170530259|NCT01432327|616289782|FG001|Posttest 3 Months|depression|0|||
170530260|NCT01432327|616289783|FG002|Posttest 3 Months|depression|0|||
170530261|NCT01432327|616289784|FG003|Posttest 3 Months|depression|0|||
170530262|NCT01432327|616289781|FG000|Posttest 3 Months|Lost to Follow-up|1|||
170530263|NCT01432327|616289782|FG001|Posttest 3 Months|Lost to Follow-up|0|||
170530264|NCT01432327|616289783|FG002|Posttest 3 Months|Lost to Follow-up|2|||
170530265|NCT01432327|616289784|FG003|Posttest 3 Months|Lost to Follow-up|1|||
170530266|NCT01432327|616289781|FG000|Posttest 3 Months|Allergic reaction|0|||
170530267|NCT01432327|616289782|FG001|Posttest 3 Months|Allergic reaction|2|||
170530268|NCT01432327|616289783|FG002|Posttest 3 Months|Allergic reaction|0|||
170530269|NCT01432327|616289784|FG003|Posttest 3 Months|Allergic reaction|0|||
170530270|NCT01432327|616289781|FG000|Posttest 6 Months|Lost to Follow-up|0|||
170530271|NCT01432327|616289782|FG001|Posttest 6 Months|Lost to Follow-up|0|||
170530272|NCT01432327|616289783|FG002|Posttest 6 Months|Lost to Follow-up|3|||
170530273|NCT01432327|616289784|FG003|Posttest 6 Months|Lost to Follow-up|2|||
170530274|NCT01432327|616289781|FG000|Posttest 6 Months|Allergic reaction|0|||
170530275|NCT01432327|616289782|FG001|Posttest 6 Months|Allergic reaction|0|||
170530276|NCT01432327|616289783|FG002|Posttest 6 Months|Allergic reaction|1|||
170530277|NCT01432327|616289784|FG003|Posttest 6 Months|Allergic reaction|0|||
170530278|NCT01432327|616289781|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
170530279|NCT01432327|616289782|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
170530280|NCT01432327|616289783|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
170530281|NCT01432327|616289784|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
170530282|NCT01432327|616289781|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
170530283|NCT01432327|616289782|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
170530284|NCT01432327|616289783|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
170530285|NCT01432327|616289784|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
170530286|NCT01432327|616289781|FG000|Posttest 1 Year|Lost to Follow-up|0|||
170418262|NCT01249664|615871715|FG000|Overall Study|Withdrawal by Subject|5|||
170418263|NCT01249664|615871716|FG001|Overall Study|Withdrawal by Subject|0|||
170418264|NCT01249664|615871715|FG000|Overall Study|Adverse Event|1|||
170418265|NCT01249664|615871716|FG001|Overall Study|Adverse Event|0|||
170418266|NCT00806156|615871717|FG000|Overall Study|Death|35|||
170418267|NCT00806156|615871718|FG001|Overall Study|Death|95|||
170418268|NCT00806156|615871717|FG000|Overall Study|Did not meet eligibility criteria|1|||
170418269|NCT00806156|615871718|FG001|Overall Study|Did not meet eligibility criteria|0|||
170418270|NCT00806156|615871717|FG000|Overall Study|Study terminated by Sponsor|2|||
170418271|NCT00806156|615871718|FG001|Overall Study|Study terminated by Sponsor|40|||
170418272|NCT00806156|615871717|FG000|Overall Study|Consent withdrawn by subject|1|||
170418273|NCT00806156|615871718|FG001|Overall Study|Consent withdrawn by subject|3|||
170418274|NCT00806156|615871717|FG000|Overall Study|Lost to Follow-up|0|||
170418275|NCT00806156|615871718|FG001|Overall Study|Lost to Follow-up|1|||
170530287|NCT01432327|616289782|FG001|Posttest 1 Year|Lost to Follow-up|0|||
170530288|NCT01432327|616289783|FG002|Posttest 1 Year|Lost to Follow-up|4|||
170530289|NCT01432327|616289784|FG003|Posttest 1 Year|Lost to Follow-up|2|||
170778066|NCT01968109|617194056|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
170877756|NCT01074190|617563974|FG000|Overall Study|Subject withdrew consent|1|||
170877757|NCT01074190|617563975|FG001|Overall Study|Subject withdrew consent|1|||
170877758|NCT01074190|617563976|FG002|Overall Study|Subject withdrew consent|1|||
170877759|NCT02919436|617563977|FG000|Overall Study|Did not undergo surgery|16|||
170877760|NCT02919436|617563978|FG001|Overall Study|Did not undergo surgery|20|||
170877761|NCT02919436|617563977|FG000|Overall Study|Enrolled before trial registration|44|||
170877762|NCT02919436|617563978|FG001|Overall Study|Enrolled before trial registration|33|||
170877763|NCT03259074|617563979|FG000|Overall Study|Adverse Event|9|||
170877764|NCT03259074|617563980|FG001|Overall Study|Adverse Event|12|||
170877765|NCT03259074|617563981|FG002|Overall Study|Adverse Event|8|||
170877766|NCT03259074|617563979|FG000|Overall Study|Death|1|||
170877767|NCT03259074|617563980|FG001|Overall Study|Death|1|||
170877768|NCT03259074|617563981|FG002|Overall Study|Death|3|||
170418276|NCT01025037|615871719|FG000|Overall Study|Adverse Event|3|||
170418277|NCT01025037|615871719|FG000|Overall Study|Lost to Follow-up|7|||
170778067|NCT01968109|617194057|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
170778068|NCT01968109|617194058|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
170778069|NCT01968109|617194059|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
170778070|NCT01968109|617194060|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
170778071|NCT01968109|617194061|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
170778072|NCT01968109|617194062|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
170778073|NCT01968109|617194032|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778074|NCT01968109|617194033|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170877769|NCT03259074|617563979|FG000|Overall Study|Lost to Follow-up|2|||
170877770|NCT03259074|617563980|FG001|Overall Study|Lost to Follow-up|4|||
170877771|NCT03259074|617563981|FG002|Overall Study|Lost to Follow-up|3|||
170530290|NCT01432327|616289781|FG000|Posttest 1 Year|Allergic reaction|0|||
170530291|NCT01432327|616289782|FG001|Posttest 1 Year|Allergic reaction|0|||
170530292|NCT01432327|616289783|FG002|Posttest 1 Year|Allergic reaction|1|||
170530293|NCT01432327|616289784|FG003|Posttest 1 Year|Allergic reaction|1|||
170530294|NCT02897349|616289785|FG000|Overall Study|Lost to Follow-up|2|||
170530295|NCT02897349|616289786|FG001|Overall Study|Lost to Follow-up|2|||
170530296|NCT02897349|616289785|FG000|Overall Study|Adverse Event|3|||
170530297|NCT02897349|616289786|FG001|Overall Study|Adverse Event|3|||
170530298|NCT02897349|616289785|FG000|Overall Study|Other than listed above|0|||
170530299|NCT02897349|616289786|FG001|Overall Study|Other than listed above|1|||
170530300|NCT03055013|616289788|FG000|Overall Study|Adverse Event|78|||
170530301|NCT03055013|616289789|FG001|Overall Study|Adverse Event|0|||
170530302|NCT03055013|616289788|FG000|Overall Study|Death|6|||
170530303|NCT03055013|616289789|FG001|Overall Study|Death|0|||
170530304|NCT03055013|616289788|FG000|Overall Study|Disease relapse|33|||
170530305|NCT03055013|616289789|FG001|Overall Study|Disease relapse|0|||
170530306|NCT03055013|616289788|FG000|Overall Study|Withdrawal by Subject|28|||
170530307|NCT03055013|616289789|FG001|Overall Study|Withdrawal by Subject|0|||
170530308|NCT03055013|616289788|FG000|Overall Study|Other complicating disease|5|||
170530309|NCT03055013|616289789|FG001|Overall Study|Other complicating disease|0|||
170530310|NCT03055013|616289788|FG000|Overall Study|Physician Decision|1|||
170530311|NCT03055013|616289789|FG001|Overall Study|Physician Decision|0|||
170877772|NCT03259074|617563979|FG000|Overall Study|New Therapy For Study Indication|1|||
170877773|NCT03259074|617563980|FG001|Overall Study|New Therapy For Study Indication|2|||
170877774|NCT03259074|617563981|FG002|Overall Study|New Therapy For Study Indication|2|||
170877775|NCT03259074|617563979|FG000|Overall Study|Physician Decision|4|||
170530312|NCT03055013|616289788|FG000|Overall Study|Benign mass/non-RCC|4|||
170530313|NCT03055013|616289789|FG001|Overall Study|Benign mass/non-RCC|0|||
170418278|NCT01025037|615871719|FG000|Overall Study|Withdrawal by Subject|1|||
170418279|NCT00770510|615871725|FG000|Overall Study|Lost to Follow-up|2|||
170530314|NCT03055013|616289788|FG000|Overall Study|Enrolled in another trial|1|||
170530315|NCT03055013|616289789|FG001|Overall Study|Enrolled in another trial|0|||
170418280|NCT00770510|615871725|FG000|Overall Study|Pregnancy|1|||
170418281|NCT00770510|615871725|FG000|Overall Study|Withdrawal by Subject|2|||
170418282|NCT00864097|615871728|FG000|Overall Study|Death|0|||
170418283|NCT00864097|615871729|FG001|Overall Study|Death|1|||
170418284|NCT00864097|615871730|FG002|Overall Study|Death|0|||
170418285|NCT00864097|615871731|FG003|Overall Study|Death|0|||
170418286|NCT00864097|615871728|FG000|Overall Study|Adverse Event|6|||
170418287|NCT00864097|615871729|FG001|Overall Study|Adverse Event|8|||
170418288|NCT00864097|615871730|FG002|Overall Study|Adverse Event|11|||
170418289|NCT00864097|615871731|FG003|Overall Study|Adverse Event|9|||
170418290|NCT00864097|615871728|FG000|Overall Study|Lack of Efficacy|9|||
170418291|NCT00864097|615871729|FG001|Overall Study|Lack of Efficacy|3|||
170418292|NCT00864097|615871730|FG002|Overall Study|Lack of Efficacy|7|||
170418293|NCT00864097|615871731|FG003|Overall Study|Lack of Efficacy|2|||
170418294|NCT00864097|615871728|FG000|Overall Study|Lost to Follow-up|0|||
170418295|NCT00864097|615871729|FG001|Overall Study|Lost to Follow-up|1|||
170418296|NCT00864097|615871730|FG002|Overall Study|Lost to Follow-up|0|||
170418297|NCT00864097|615871731|FG003|Overall Study|Lost to Follow-up|1|||
170418298|NCT00864097|615871728|FG000|Overall Study|Withdrawal by Subject|15|||
170418299|NCT00864097|615871729|FG001|Overall Study|Withdrawal by Subject|11|||
170418300|NCT00864097|615871730|FG002|Overall Study|Withdrawal by Subject|11|||
170418301|NCT00864097|615871731|FG003|Overall Study|Withdrawal by Subject|12|||
170418302|NCT00864097|615871728|FG000|Overall Study|Protocol Violation|2|||
170418303|NCT00864097|615871729|FG001|Overall Study|Protocol Violation|1|||
170418304|NCT00864097|615871730|FG002|Overall Study|Protocol Violation|0|||
170418305|NCT00864097|615871731|FG003|Overall Study|Protocol Violation|1|||
170418306|NCT00864097|615871728|FG000|Overall Study|Terminated by sponsor|105|||
170418307|NCT00864097|615871729|FG001|Overall Study|Terminated by sponsor|112|||
170418308|NCT00864097|615871730|FG002|Overall Study|Terminated by sponsor|102|||
170418309|NCT00864097|615871731|FG003|Overall Study|Terminated by sponsor|99|||
170418310|NCT00864097|615871728|FG000|Overall Study|Randomized but not treated|2|||
170418311|NCT00864097|615871729|FG001|Overall Study|Randomized but not treated|0|||
170418312|NCT00864097|615871730|FG002|Overall Study|Randomized but not treated|1|||
170418313|NCT00864097|615871731|FG003|Overall Study|Randomized but not treated|0|||
170418314|NCT00864097|615871728|FG000|Overall Study|Other|0|||
170418315|NCT00864097|615871729|FG001|Overall Study|Other|0|||
170418316|NCT00864097|615871730|FG002|Overall Study|Other|0|||
170418317|NCT00864097|615871731|FG003|Overall Study|Other|1|||
170418318|NCT04117607|615871733|FG000|Overall Study|Early Termination|0|||
170418319|NCT04117607|615871734|FG001|Overall Study|Early Termination|1|||
170418320|NCT04117607|615871735|FG002|Overall Study|Early Termination|0|||
170418321|NCT04117607|615871736|FG003|Overall Study|Early Termination|0|||
170418322|NCT04117607|615871737|FG004|Overall Study|Early Termination|0|||
170418323|NCT04117607|615871738|FG005|Overall Study|Early Termination|0|||
170418324|NCT04117607|615871739|FG006|Overall Study|Early Termination|1|||
170418325|NCT04117607|615871740|FG007|Overall Study|Early Termination|0|||
170418326|NCT04117607|615871741|FG008|Overall Study|Early Termination|0|||
170418327|NCT04117607|615871742|FG009|Overall Study|Early Termination|0|||
170418328|NCT04117607|615871743|FG010|Overall Study|Early Termination|0|||
170418329|NCT04117607|615871744|FG011|Overall Study|Early Termination|0|||
170418330|NCT04117607|615871745|FG012|Overall Study|Early Termination|0|||
170418331|NCT04117607|615871746|FG013|Overall Study|Early Termination|0|||
170418332|NCT00337077|615871748|FG000|Overall Study|Progressive disease|25|||
170418333|NCT00337077|615871749|FG001|Overall Study|Progressive disease|37|||
170418334|NCT00337077|615871750|FG002|Overall Study|Progressive disease|19|||
170418335|NCT00337077|615871748|FG000|Overall Study|Adverse Event|7|||
170418336|NCT00337077|615871749|FG001|Overall Study|Adverse Event|7|||
170418337|NCT00337077|615871750|FG002|Overall Study|Adverse Event|1|||
170418338|NCT00337077|615871748|FG000|Overall Study|Death|0|||
170418339|NCT00337077|615871749|FG001|Overall Study|Death|1|||
170418340|NCT00337077|615871750|FG002|Overall Study|Death|0|||
170418341|NCT00337077|615871748|FG000|Overall Study|Withdrawal by Subject|7|||
170418342|NCT00337077|615871749|FG001|Overall Study|Withdrawal by Subject|2|||
170418343|NCT00337077|615871750|FG002|Overall Study|Withdrawal by Subject|2|||
170418344|NCT00337077|615871748|FG000|Overall Study|Alternative therapy|1|||
170418345|NCT00337077|615871749|FG001|Overall Study|Alternative therapy|0|||
170418346|NCT00337077|615871750|FG002|Overall Study|Alternative therapy|0|||
170418347|NCT00337077|615871748|FG000|Overall Study|Physician Decision|1|||
170418348|NCT00337077|615871749|FG001|Overall Study|Physician Decision|4|||
170418349|NCT00337077|615871750|FG002|Overall Study|Physician Decision|2|||
170418350|NCT00337077|615871748|FG000|Overall Study|Never started treatment|1|||
170418351|NCT00337077|615871749|FG001|Overall Study|Never started treatment|1|||
170418352|NCT00337077|615871750|FG002|Overall Study|Never started treatment|0|||
170418353|NCT00337077|615871748|FG000|Overall Study|Ineligible|1|||
170418354|NCT00337077|615871749|FG001|Overall Study|Ineligible|1|||
170418355|NCT00337077|615871750|FG002|Overall Study|Ineligible|1|||
170418356|NCT01492400|615871756|FG000|Overall Study|Miscellaneous Reasons|2|||
170418357|NCT01492400|615871757|FG001|Overall Study|Miscellaneous Reasons|3|||
170418358|NCT01492400|615871756|FG000|Overall Study|Personal Reasons|0|||
170418359|NCT01492400|615871757|FG001|Overall Study|Personal Reasons|5|||
170418360|NCT01492400|615871756|FG000|Overall Study|Lost to Follow-up|3|||
170418361|NCT01492400|615871757|FG001|Overall Study|Lost to Follow-up|1|||
170418362|NCT01492400|615871756|FG000|Overall Study|Pregnancy|0|||
170418363|NCT01492400|615871757|FG001|Overall Study|Pregnancy|1|||
170418364|NCT01492400|615871756|FG000|Overall Study|Lack of Efficacy|1|||
170418365|NCT01492400|615871757|FG001|Overall Study|Lack of Efficacy|1|||
170418366|NCT01492400|615871756|FG000|Overall Study|Adverse Event|10|||
170418367|NCT01492400|615871757|FG001|Overall Study|Adverse Event|5|||
170418368|NCT00659607|615871758|FG000|Overall Study|No blood pressure recorded|147|||
170418369|NCT00659607|615871758|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
170418370|NCT00659607|615871758|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
170418371|NCT00659607|615871758|FG000|Overall Study|No recorded efficacy data|15|||
170418372|NCT00659607|615871758|FG000|Overall Study|Inconsistent BP measuring date|2|||
170418373|NCT01265784|615871760|FG000|Overall Study|Lost to Follow-up|5|||
170418374|NCT01265784|615871761|FG001|Overall Study|Lost to Follow-up|3|||
170418375|NCT01265784|615871762|FG002|Overall Study|Lost to Follow-up|2|||
170418376|NCT01265784|615871760|FG000|Overall Study|Withdrawal by Subject|0|||
170418377|NCT01265784|615871761|FG001|Overall Study|Withdrawal by Subject|5|||
170418378|NCT01265784|615871762|FG002|Overall Study|Withdrawal by Subject|0|||
170418379|NCT01265784|615871760|FG000|Overall Study|Physician Decision|1|||
170418380|NCT01265784|615871761|FG001|Overall Study|Physician Decision|0|||
170418381|NCT01265784|615871762|FG002|Overall Study|Physician Decision|1|||
170418382|NCT01265784|615871760|FG000|Overall Study|Adverse Event|1|||
170418383|NCT01265784|615871761|FG001|Overall Study|Adverse Event|0|||
170418384|NCT01265784|615871762|FG002|Overall Study|Adverse Event|0|||
170418385|NCT01265784|615871760|FG000|Overall Study|Death|3|||
170418386|NCT01265784|615871761|FG001|Overall Study|Death|0|||
170418387|NCT01265784|615871762|FG002|Overall Study|Death|0|||
170418388|NCT01265784|615871760|FG000|Overall Study|Protocol Violation|2|||
170418389|NCT01265784|615871761|FG001|Overall Study|Protocol Violation|0|||
170418390|NCT01265784|615871762|FG002|Overall Study|Protocol Violation|0|||
170778075|NCT01968109|617194034|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778076|NCT01968109|617194035|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778077|NCT01968109|617194036|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778078|NCT01968109|617194037|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
170418391|NCT01265784|615871760|FG000|Overall Study|Incorrectly Randomized|0|||
170418392|NCT01265784|615871761|FG001|Overall Study|Incorrectly Randomized|0|||
170418393|NCT01265784|615871762|FG002|Overall Study|Incorrectly Randomized|1|||
170418394|NCT02364557|615871763|FG000|Overall Study|Protocol Violation|3|||
170418395|NCT02364557|615871764|FG001|Overall Study|Protocol Violation|1|||
170418396|NCT04582539|615871765|FG000|Overall Study|Death|1|||
170418397|NCT04582539|615871766|FG001|Overall Study|Death|1|||
170778079|NCT01968109|617194038|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778080|NCT01968109|617194039|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778081|NCT01968109|617194040|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
170778082|NCT01968109|617194041|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778083|NCT01968109|617194042|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778084|NCT01968109|617194043|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778085|NCT01968109|617194044|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778086|NCT01968109|617194045|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778087|NCT01968109|617194046|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778088|NCT01968109|617194047|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
170418398|NCT04582539|615871767|FG002|Overall Study|Death|0|||
170418399|NCT04582539|615871768|FG003|Overall Study|Death|1|||
170418400|NCT04582539|615871769|FG004|Overall Study|Death|0|||
170418401|NCT04582539|615871765|FG000|Overall Study|Lost to Follow-up|1|||
170418402|NCT04582539|615871766|FG001|Overall Study|Lost to Follow-up|0|||
170418403|NCT04582539|615871767|FG002|Overall Study|Lost to Follow-up|0|||
170418404|NCT04582539|615871768|FG003|Overall Study|Lost to Follow-up|0|||
170418405|NCT04582539|615871769|FG004|Overall Study|Lost to Follow-up|0|||
170418406|NCT04582539|615871765|FG000|Overall Study|Study Terminated by Sponsor|1|||
170418407|NCT04582539|615871766|FG001|Overall Study|Study Terminated by Sponsor|3|||
170418408|NCT04582539|615871767|FG002|Overall Study|Study Terminated by Sponsor|2|||
170418409|NCT04582539|615871768|FG003|Overall Study|Study Terminated by Sponsor|2|||
170418410|NCT04582539|615871769|FG004|Overall Study|Study Terminated by Sponsor|3|||
170418411|NCT04582539|615871765|FG000|Overall Study|Physician Decision|0|||
170418412|NCT04582539|615871766|FG001|Overall Study|Physician Decision|1|||
170418413|NCT04582539|615871767|FG002|Overall Study|Physician Decision|0|||
170418414|NCT04582539|615871768|FG003|Overall Study|Physician Decision|0|||
170418415|NCT04582539|615871769|FG004|Overall Study|Physician Decision|0|||
170418416|NCT04582539|615871765|FG000|Overall Study|Withdrawal by Subject|1|||
170530316|NCT03055013|616289788|FG000|Overall Study|Non-protocol therapy|1|||
170778089|NCT01968109|617194048|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
170778090|NCT01968109|617194049|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
170418417|NCT04582539|615871766|FG001|Overall Study|Withdrawal by Subject|0|||
170418418|NCT04582539|615871767|FG002|Overall Study|Withdrawal by Subject|2|||
170418419|NCT04582539|615871768|FG003|Overall Study|Withdrawal by Subject|1|||
170418420|NCT04582539|615871769|FG004|Overall Study|Withdrawal by Subject|0|||
170418421|NCT04582539|615871765|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
170418422|NCT04582539|615871766|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
170418423|NCT04582539|615871767|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
170418424|NCT04582539|615871768|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
170418425|NCT04582539|615871769|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
170418426|NCT02568384|615871775|FG000|Overall Study|Mobile devices incompatible with App|2|||
170418427|NCT00117949|615871776|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
170418428|NCT00117949|615871777|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
170418429|NCT00117949|615871778|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
170418430|NCT00117949|615871779|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
170418431|NCT00117949|615871776|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
170418432|NCT00117949|615871777|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
170418433|NCT00117949|615871778|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
170418434|NCT00117949|615871779|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
170418435|NCT00117949|615871776|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
170418436|NCT00117949|615871777|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
170418437|NCT00117949|615871778|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
170418438|NCT00117949|615871779|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
170418439|NCT00117949|615871776|FG000|Overall Study|PSA increase >=10ng/mL|0|||
170418440|NCT00117949|615871777|FG001|Overall Study|PSA increase >=10ng/mL|1|||
170418441|NCT00117949|615871778|FG002|Overall Study|PSA increase >=10ng/mL|1|||
170418442|NCT00117949|615871779|FG003|Overall Study|PSA increase >=10ng/mL|0|||
170418443|NCT00117949|615871776|FG000|Overall Study|PSA reduction <=50%|0|||
170418444|NCT00117949|615871777|FG001|Overall Study|PSA reduction <=50%|2|||
170418445|NCT00117949|615871778|FG002|Overall Study|PSA reduction <=50%|2|||
170418446|NCT00117949|615871779|FG003|Overall Study|PSA reduction <=50%|4|||
170418447|NCT00117949|615871776|FG000|Overall Study|Hepatic abnormalities|0|||
170418448|NCT00117949|615871777|FG001|Overall Study|Hepatic abnormalities|1|||
170418449|NCT00117949|615871778|FG002|Overall Study|Hepatic abnormalities|0|||
170418450|NCT00117949|615871779|FG003|Overall Study|Hepatic abnormalities|1|||
170418451|NCT00796510|615871780|FG000|Overall Study|Death|1|||
170418452|NCT00796510|615871781|FG001|Overall Study|Death|0|||
170418453|NCT00796510|615871780|FG000|Overall Study|Study Terminated|2|||
170418454|NCT00796510|615871781|FG001|Overall Study|Study Terminated|0|||
170418455|NCT01867242|615871782|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
170418456|NCT01867242|615871783|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
170418457|NCT01867242|615871784|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
170418458|NCT02708277|615871785|FG000|Overall Study|Lost to Follow-up|7|||
170418459|NCT02708277|615871786|FG001|Overall Study|Lost to Follow-up|4|||
170418460|NCT02739984|615871787|FG000|Overall Study|Sponsor Decision|1|||
170418461|NCT02739984|615871788|FG001|Overall Study|Sponsor Decision|0|||
170418462|NCT02739984|615871787|FG000|Overall Study|Withdrawal by Subject|1|||
170418463|NCT02739984|615871788|FG001|Overall Study|Withdrawal by Subject|1|||
170418464|NCT02739984|615871787|FG000|Overall Study|Death|0|||
170418465|NCT02739984|615871788|FG001|Overall Study|Death|1|||
170418466|NCT02739984|615871787|FG000|Overall Study|Lost to Follow-up|3|||
170418467|NCT02739984|615871788|FG001|Overall Study|Lost to Follow-up|0|||
170418468|NCT00634179|615871798|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
170418469|NCT00767325|615871799|FG000|Overall Study|Lack of Efficacy|2|||
170418470|NCT00767325|615871799|FG000|Overall Study|Adverse Event|7|||
170418471|NCT00767325|615871799|FG000|Overall Study|Lost to Follow-up|3|||
170418472|NCT00767325|615871799|FG000|Overall Study|No longer met study criteria|2|||
170418473|NCT00767325|615871799|FG000|Overall Study|Missed visit due to family reasons|1|||
170418474|NCT03538756|615871800|FG000|Long-Term Follow-up|Adverse Event|0|||
170418475|NCT03538756|615871801|FG001|Long-Term Follow-up|Adverse Event|0|||
170418476|NCT03538756|615871802|FG002|Long-Term Follow-up|Adverse Event|6|||
170418477|NCT03538756|615871800|FG000|Long-Term Follow-up|Death|0|||
170418478|NCT03538756|615871801|FG001|Long-Term Follow-up|Death|0|||
170418479|NCT03538756|615871802|FG002|Long-Term Follow-up|Death|1|||
170418480|NCT03538756|615871800|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
170418481|NCT03538756|615871801|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
170418482|NCT03538756|615871802|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
170418483|NCT03538756|615871800|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
170418484|NCT03538756|615871801|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
170418485|NCT03538756|615871802|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
170418486|NCT03538756|615871800|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
170418487|NCT03538756|615871801|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
170418488|NCT03538756|615871802|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
170418489|NCT00679367|615871803|FG000|Overall Study|Adverse Event|7|||
170418490|NCT00679367|615871803|FG000|Overall Study|inability to swallow oral drugs|1|||
170418491|NCT00679367|615871803|FG000|Overall Study|Lack of Efficacy|3|||
170418492|NCT00679367|615871803|FG000|Overall Study|Withdrawal by Subject|1|||
170418493|NCT05200858|615871806|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
170418494|NCT05200858|615871807|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
170418495|NCT05200858|615871808|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
170418496|NCT05200858|615871809|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
170418497|NCT05771428|615873278|FG000|Overall Study|Adverse Event|0|||
170418498|NCT05771428|615873279|FG001|Overall Study|Adverse Event|1|||
170418499|NCT05771428|615873280|FG002|Overall Study|Adverse Event|1|||
170418500|NCT05771428|615873281|FG003|Overall Study|Adverse Event|1|||
170418501|NCT05771428|615873278|FG000|Overall Study|Withdrawal by Subject|3|||
170418502|NCT05771428|615873279|FG001|Overall Study|Withdrawal by Subject|2|||
170418503|NCT05771428|615873280|FG002|Overall Study|Withdrawal by Subject|1|||
170778091|NCT01968109|617194050|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
170778092|NCT01968109|617194051|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
170778093|NCT01968109|617194052|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
170778094|NCT01968109|617194053|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
170778095|NCT01968109|617194054|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778096|NCT01968109|617194055|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
170778097|NCT01968109|617194056|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
170778098|NCT01968109|617194057|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170418504|NCT05771428|615873281|FG003|Overall Study|Withdrawal by Subject|4|||
170418505|NCT05771428|615873278|FG000|Overall Study|Other|0|||
170418506|NCT05771428|615873279|FG001|Overall Study|Other|1|||
170418507|NCT05771428|615873280|FG002|Overall Study|Other|2|||
170778099|NCT01968109|617194058|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
170778100|NCT01968109|617194059|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
170778101|NCT01968109|617194060|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170778102|NCT01968109|617194061|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
170418508|NCT05771428|615873281|FG003|Overall Study|Other|1|||
170418509|NCT05771428|615873278|FG000|Overall Study|Randomized but Not Treated|0|||
170418510|NCT05771428|615873279|FG001|Overall Study|Randomized but Not Treated|0|||
170418511|NCT05771428|615873280|FG002|Overall Study|Randomized but Not Treated|1|||
170418512|NCT05771428|615873281|FG003|Overall Study|Randomized but Not Treated|0|||
170418513|NCT04025229|615873282|FG000|Overall Study|Adverse Event|1|||
170418514|NCT04025229|615873283|FG001|Overall Study|Adverse Event|0|||
170418515|NCT04025229|615873282|FG000|Overall Study|Withdrawal by Subject|0|||
170418516|NCT04025229|615873283|FG001|Overall Study|Withdrawal by Subject|2|||
170418517|NCT04025229|615873282|FG000|Overall Study|Death|0|||
170418518|NCT04025229|615873283|FG001|Overall Study|Death|1|||
170418519|NCT04025229|615873282|FG000|Overall Study|Physician Decision|0|||
170418520|NCT04025229|615873283|FG001|Overall Study|Physician Decision|1|||
170418521|NCT00419770|615873287|FG000|Overall Study|Withdrawal by Subject|5|||
170418522|NCT00419770|615873288|FG001|Overall Study|Withdrawal by Subject|1|||
170418523|NCT02742090|615873289|FG000|Overall Study|Adverse Event|10|||
170418524|NCT02742090|615873289|FG000|Overall Study|Death|3|||
170418525|NCT02742090|615873289|FG000|Overall Study|Disease Progression|25|||
170418526|NCT02742090|615873289|FG000|Overall Study|Investigator's Decision|1|||
170418527|NCT02742090|615873289|FG000|Overall Study|Lost to Follow-up|1|||
170418528|NCT02742090|615873289|FG000|Overall Study|Non-compliance with Study|1|||
170418529|NCT02742090|615873289|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
170418530|NCT02742090|615873289|FG000|Overall Study|Withdrawal by Subject|4|||
170418531|NCT02742090|615873289|FG000|Overall Study|Reason Not Specified|1|||
170418532|NCT02424188|615873292|FG000|Overall Study|Death|2|||
170418533|NCT02424188|615873293|FG001|Overall Study|Death|2|||
170418534|NCT02424188|615873292|FG000|Overall Study|Lost to Follow-up|1|||
170418535|NCT02424188|615873293|FG001|Overall Study|Lost to Follow-up|3|||
170418536|NCT02424188|615873292|FG000|Overall Study|Incarceration|1|||
170418537|NCT02424188|615873293|FG001|Overall Study|Incarceration|0|||
170418538|NCT02777528|615873299|FG000|Overall Study|Still in study|24|||
170418539|NCT02777528|615873300|FG001|Overall Study|Still in study|10|||
170418540|NCT02777528|615873301|FG002|Overall Study|Still in study|1|||
170418541|NCT02777528|615873299|FG000|Overall Study|Study Device Explanted|1|||
170418542|NCT02777528|615873300|FG001|Overall Study|Study Device Explanted|0|||
170418543|NCT02777528|615873301|FG002|Overall Study|Study Device Explanted|0|||
170418544|NCT02777528|615873299|FG000|Overall Study|Death|14|||
170418545|NCT02777528|615873300|FG001|Overall Study|Death|7|||
170418546|NCT02777528|615873301|FG002|Overall Study|Death|1|||
170418547|NCT02777528|615873299|FG000|Overall Study|Withdrawal by Subject|2|||
170778103|NCT01968109|617194062|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
170778104|NCT01968109|617194032|FG000|Overall Study|OTHER REASONS|0|||
170778105|NCT01968109|617194033|FG001|Overall Study|OTHER REASONS|0|||
170778106|NCT01968109|617194034|FG002|Overall Study|OTHER REASONS|0|||
170418548|NCT02777528|615873300|FG001|Overall Study|Withdrawal by Subject|2|||
170418549|NCT02777528|615873301|FG002|Overall Study|Withdrawal by Subject|1|||
170418550|NCT02777528|615873299|FG000|Overall Study|Physician Decision|2|||
170418551|NCT02777528|615873300|FG001|Overall Study|Physician Decision|1|||
170418552|NCT02777528|615873301|FG002|Overall Study|Physician Decision|0|||
170418553|NCT02777528|615873299|FG000|Overall Study|Lost to Follow-up|2|||
170418554|NCT02777528|615873300|FG001|Overall Study|Lost to Follow-up|0|||
170418555|NCT02777528|615873301|FG002|Overall Study|Lost to Follow-up|0|||
170418556|NCT02777528|615873299|FG000|Overall Study|Discontinued due to Other|1|||
170530317|NCT03055013|616289789|FG001|Overall Study|Non-protocol therapy|0|||
170530318|NCT03055013|616289788|FG000|Overall Study|Incompliance|1|||
170530319|NCT03055013|616289789|FG001|Overall Study|Incompliance|0|||
170530320|NCT03055013|616289788|FG000|Overall Study|Insurance issues|1|||
170530321|NCT03055013|616289789|FG001|Overall Study|Insurance issues|0|||
170530322|NCT03055013|616289788|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
170530323|NCT03055013|616289789|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
170530324|NCT03055013|616289788|FG000|Overall Study|Did not receive nivolumab|10|||
170530325|NCT03055013|616289789|FG001|Overall Study|Did not receive nivolumab|0|||
170530326|NCT03055013|616289788|FG000|Overall Study|Did not receive surgery|0|||
170530327|NCT03055013|616289789|FG001|Overall Study|Did not receive surgery|28|||
170530328|NCT00856180|616289794|FG000|Overall Study|Adverse Event|4|||
170530329|NCT00856180|616289794|FG000|Overall Study|Progressive Disease|16|||
170530330|NCT05001620|616289802|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
170632626|NCT01352793|616666715|FG000|Overall Study|Randomized but not vaccinated|8|||
170778107|NCT01968109|617194035|FG003|Overall Study|OTHER REASONS|1|||
170778108|NCT01968109|617194036|FG004|Overall Study|OTHER REASONS|0|||
170778109|NCT01968109|617194037|FG005|Overall Study|OTHER REASONS|0|||
170778110|NCT01968109|617194038|FG006|Overall Study|OTHER REASONS|0|||
170778111|NCT01968109|617194039|FG007|Overall Study|OTHER REASONS|0|||
170778112|NCT01968109|617194040|FG008|Overall Study|OTHER REASONS|0|||
170778113|NCT01968109|617194041|FG009|Overall Study|OTHER REASONS|0|||
170778114|NCT01968109|617194042|FG010|Overall Study|OTHER REASONS|0|||
170778115|NCT01968109|617194043|FG011|Overall Study|OTHER REASONS|1|||
170778116|NCT01968109|617194044|FG012|Overall Study|OTHER REASONS|0|||
170778117|NCT01968109|617194045|FG013|Overall Study|OTHER REASONS|0|||
170778118|NCT01968109|617194046|FG014|Overall Study|OTHER REASONS|1|||
170778119|NCT01968109|617194047|FG015|Overall Study|OTHER REASONS|1|||
170778120|NCT01968109|617194048|FG016|Overall Study|OTHER REASONS|1|||
170778121|NCT01968109|617194049|FG017|Overall Study|OTHER REASONS|0|||
170778122|NCT01968109|617194050|FG018|Overall Study|OTHER REASONS|0|||
170778123|NCT01968109|617194051|FG019|Overall Study|OTHER REASONS|0|||
170778124|NCT01968109|617194052|FG020|Overall Study|OTHER REASONS|0|||
170778125|NCT01968109|617194053|FG021|Overall Study|OTHER REASONS|2|||
170778126|NCT01968109|617194054|FG022|Overall Study|OTHER REASONS|0|||
170778127|NCT01968109|617194055|FG023|Overall Study|OTHER REASONS|0|||
170778128|NCT01968109|617194056|FG024|Overall Study|OTHER REASONS|3|||
170778129|NCT01968109|617194057|FG025|Overall Study|OTHER REASONS|0|||
170778130|NCT01968109|617194058|FG026|Overall Study|OTHER REASONS|3|||
170778131|NCT01968109|617194059|FG027|Overall Study|OTHER REASONS|3|||
170778132|NCT01968109|617194060|FG028|Overall Study|OTHER REASONS|6|||
170778133|NCT01968109|617194061|FG029|Overall Study|OTHER REASONS|7|||
170778134|NCT01968109|617194062|FG030|Overall Study|OTHER REASONS|3|||
170778135|NCT01968109|617194032|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778136|NCT01968109|617194033|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778137|NCT01968109|617194034|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778138|NCT01968109|617194035|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778139|NCT01968109|617194036|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778140|NCT01968109|617194037|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778141|NCT01968109|617194038|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778142|NCT01968109|617194039|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778143|NCT01968109|617194040|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778144|NCT01968109|617194041|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778145|NCT01968109|617194042|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778146|NCT01968109|617194043|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778147|NCT01968109|617194044|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778148|NCT01968109|617194045|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778149|NCT01968109|617194046|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778150|NCT01968109|617194047|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778151|NCT01968109|617194048|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
170778152|NCT01968109|617194049|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
170778153|NCT01968109|617194050|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778154|NCT01968109|617194051|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
170778155|NCT01968109|617194052|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
170778156|NCT01968109|617194053|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778157|NCT01968109|617194054|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778158|NCT01968109|617194055|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170778159|NCT01968109|617194056|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
170778160|NCT01968109|617194057|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
170530331|NCT05001620|616289803|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
170530332|NCT00819039|616289804|FG000|Overall Study|Physician Decision|1|||
170530333|NCT00819039|616289805|FG001|Overall Study|Physician Decision|0|||
170778161|NCT01968109|617194058|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
170778162|NCT01968109|617194059|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
170778163|NCT01968109|617194060|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
170778164|NCT01968109|617194061|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
170530334|NCT00819039|616289806|FG002|Overall Study|Physician Decision|1|||
170530335|NCT00819039|616289804|FG000|Overall Study|Protocol Violation|1|||
170530336|NCT00819039|616289805|FG001|Overall Study|Protocol Violation|0|||
170530337|NCT00819039|616289806|FG002|Overall Study|Protocol Violation|0|||
170530338|NCT04796415|616289807|FG000|Overall Study|not interested|12|||
170530339|NCT04796415|616289807|FG000|Overall Study|health issue|8|||
170530340|NCT04796415|616289807|FG000|Overall Study|Other|4|||
170530341|NCT04796415|616289807|FG000|Overall Study|discharged from home health service|3|||
170530342|NCT04796415|616289807|FG000|Overall Study|re-hospitalization|2|||
170530343|NCT04796415|616289807|FG000|Overall Study|moving to nursing home|1|||
170530344|NCT04796415|616289807|FG000|Overall Study|lost contact|1|||
170530345|NCT00296335|616289812|FG000|Overall Study|Recurrence|3|||
170530346|NCT00296335|616289813|FG001|Overall Study|Recurrence|51|||
170530347|NCT00296335|616289812|FG000|Overall Study|Adverse Event|17|||
170530348|NCT00296335|616289813|FG001|Overall Study|Adverse Event|27|||
170530349|NCT00296335|616289812|FG000|Overall Study|Lost to Follow-up|7|||
170530350|NCT00296335|616289813|FG001|Overall Study|Lost to Follow-up|33|||
170530351|NCT00296335|616289812|FG000|Overall Study|Physician Decision|3|||
170530352|NCT00296335|616289813|FG001|Overall Study|Physician Decision|11|||
170530353|NCT00486044|616289815|FG000|Overall Study|Withdrawal by Subject|2|||
170530354|NCT00486044|616289816|FG001|Overall Study|Withdrawal by Subject|1|||
170530355|NCT00486044|616289815|FG000|Overall Study|Adverse Event|0|||
170778165|NCT01968109|617194062|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
170778166|NCT01968109|617194032|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778167|NCT01968109|617194033|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778168|NCT01968109|617194034|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170530356|NCT00486044|616289816|FG001|Overall Study|Adverse Event|1|||
170530357|NCT00486044|616289815|FG000|Overall Study|Lost to Follow-up|0|||
170530358|NCT00486044|616289816|FG001|Overall Study|Lost to Follow-up|1|||
170530359|NCT03466346|616289817|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
170530360|NCT03466346|616289818|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
170530361|NCT03466346|616289819|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
170530362|NCT03466346|616289820|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
170530363|NCT03466346|616289821|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
170530364|NCT03466346|616289817|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
170530365|NCT03466346|616289818|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
170530366|NCT03466346|616289819|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
170530367|NCT03466346|616289820|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
170530368|NCT03466346|616289821|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
170530369|NCT03466346|616289817|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
170530370|NCT03466346|616289818|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
170530371|NCT03466346|616289819|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
170530372|NCT03466346|616289820|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
170530373|NCT03466346|616289821|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
170530374|NCT03466346|616289817|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
170530375|NCT03466346|616289818|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
170530376|NCT03466346|616289819|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
170530377|NCT03466346|616289820|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
170530378|NCT03466346|616289821|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
170530379|NCT03466346|616289817|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
170530380|NCT03466346|616289818|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
170530381|NCT03466346|616289819|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
170530382|NCT03466346|616289820|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
170530383|NCT03466346|616289821|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
170530384|NCT03466346|616289817|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
170530385|NCT03466346|616289818|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
170530386|NCT03466346|616289819|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
170530387|NCT03466346|616289820|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
170530388|NCT03466346|616289821|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
170530389|NCT03466346|616289817|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
170530390|NCT03466346|616289818|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
170530391|NCT03466346|616289819|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
170530392|NCT03466346|616289820|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
170530393|NCT03466346|616289821|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
170530394|NCT02701634|616289822|FG000|Overall Study|Adverse Event|2|||
170530395|NCT02701634|616289823|FG001|Overall Study|Adverse Event|3|||
170530396|NCT02701634|616289822|FG000|Overall Study|Death|1|||
170530397|NCT02701634|616289823|FG001|Overall Study|Death|0|||
170530398|NCT02701634|616289822|FG000|Overall Study|Investigator's Discretion|7|||
170530399|NCT02701634|616289823|FG001|Overall Study|Investigator's Discretion|4|||
170530400|NCT02701634|616289822|FG000|Overall Study|Study terminated by Sponsor|15|||
170530401|NCT02701634|616289823|FG001|Overall Study|Study terminated by Sponsor|17|||
170530402|NCT02701634|616289822|FG000|Overall Study|Withdrew Consent|6|||
170530403|NCT02701634|616289823|FG001|Overall Study|Withdrew Consent|7|||
170530404|NCT02701634|616289822|FG000|Overall Study|Randomized but not treated|1|||
170530405|NCT02701634|616289823|FG001|Overall Study|Randomized but not treated|0|||
170530406|NCT00537277|616289826|FG000|Overall Study|Adverse Event|1|||
170530407|NCT00537277|616289826|FG000|Overall Study|Lack of Efficacy|2|||
170530408|NCT00537277|616289826|FG000|Overall Study|Lost to Follow-up|12|||
170530409|NCT00537277|616289826|FG000|Overall Study|Protocol Violation|11|||
170530410|NCT00537277|616289826|FG000|Overall Study|Unclassified|4|||
170530411|NCT00537277|616289826|FG000|Overall Study|Inability to tolerate trial medication|4|||
170530412|NCT00537277|616289826|FG000|Overall Study|Non-compliance with trial procedures|15|||
170530413|NCT01692119|616289827|FG000|Overall Study|Protocol Violation|3|||
170530414|NCT01692119|616289828|FG001|Overall Study|Protocol Violation|1|||
170530415|NCT01692119|616289827|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
170530416|NCT01692119|616289828|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
170530417|NCT03620162|616289829|FG000|Overall Study|Physician Decision|4|||
170530418|NCT03620162|616289830|FG001|Overall Study|Physician Decision|0|||
170530419|NCT03620162|616289831|FG002|Overall Study|Physician Decision|1|||
170530420|NCT03620162|616289832|FG003|Overall Study|Physician Decision|0|||
170530421|NCT03620162|616289833|FG004|Overall Study|Physician Decision|2|||
170530422|NCT03620162|616289829|FG000|Overall Study|Lost to Follow-up|2|||
170530423|NCT03620162|616289830|FG001|Overall Study|Lost to Follow-up|6|||
170530424|NCT03620162|616289831|FG002|Overall Study|Lost to Follow-up|7|||
170530425|NCT03620162|616289832|FG003|Overall Study|Lost to Follow-up|3|||
170530426|NCT03620162|616289833|FG004|Overall Study|Lost to Follow-up|2|||
170530427|NCT03620162|616289829|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
170530428|NCT03620162|616289830|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
170530429|NCT03620162|616289831|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
170877776|NCT03259074|617563980|FG001|Overall Study|Physician Decision|12|||
170530430|NCT03620162|616289832|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
170530431|NCT03620162|616289833|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
170530432|NCT04009837|616289836|FG000|Overall Study|Withdrawal by Subject|5|||
170530433|NCT04009837|616289837|FG001|Overall Study|Withdrawal by Subject|4|||
170530434|NCT04009837|616289836|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
170530435|NCT04009837|616289837|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
170530436|NCT06129149|616289838|FG000|Overall Study|Death|1|||
170530437|NCT02855268|616289840|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
170530438|NCT02855268|616289841|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
170530439|NCT02855268|616289840|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
170530440|NCT02855268|616289841|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
170530441|NCT02855268|616289840|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
170778169|NCT01968109|617194035|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778170|NCT01968109|617194036|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778171|NCT01968109|617194037|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778172|NCT01968109|617194038|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778173|NCT01968109|617194039|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778174|NCT01968109|617194040|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778175|NCT01968109|617194041|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778176|NCT01968109|617194042|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778177|NCT01968109|617194043|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778178|NCT01968109|617194044|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778179|NCT01968109|617194045|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778180|NCT01968109|617194046|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778181|NCT01968109|617194047|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778182|NCT01968109|617194048|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778183|NCT01968109|617194049|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778184|NCT01968109|617194050|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778185|NCT01968109|617194051|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778186|NCT01968109|617194052|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
170778187|NCT01968109|617194053|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778188|NCT01968109|617194054|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778189|NCT01968109|617194055|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
170778190|NCT01968109|617194056|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778191|NCT01968109|617194057|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778192|NCT01968109|617194058|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778193|NCT01968109|617194059|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778194|NCT01968109|617194060|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778195|NCT01968109|617194061|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778196|NCT01968109|617194062|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
170778197|NCT01968109|617194032|FG000|Overall Study|Death|0|||
170778198|NCT01968109|617194033|FG001|Overall Study|Death|0|||
170778199|NCT01968109|617194034|FG002|Overall Study|Death|0|||
170778200|NCT01968109|617194035|FG003|Overall Study|Death|0|||
170778201|NCT01968109|617194036|FG004|Overall Study|Death|0|||
170778202|NCT01968109|617194037|FG005|Overall Study|Death|0|||
170778203|NCT01968109|617194038|FG006|Overall Study|Death|0|||
170778204|NCT01968109|617194039|FG007|Overall Study|Death|0|||
170778205|NCT01968109|617194040|FG008|Overall Study|Death|0|||
170778206|NCT01968109|617194041|FG009|Overall Study|Death|0|||
170778207|NCT01968109|617194042|FG010|Overall Study|Death|0|||
170778208|NCT01968109|617194043|FG011|Overall Study|Death|0|||
170778209|NCT01968109|617194044|FG012|Overall Study|Death|0|||
170778210|NCT01968109|617194045|FG013|Overall Study|Death|0|||
170778211|NCT01968109|617194046|FG014|Overall Study|Death|0|||
170778212|NCT01968109|617194047|FG015|Overall Study|Death|0|||
170778213|NCT01968109|617194048|FG016|Overall Study|Death|0|||
170778214|NCT01968109|617194049|FG017|Overall Study|Death|0|||
170778215|NCT01968109|617194050|FG018|Overall Study|Death|0|||
170778216|NCT01968109|617194051|FG019|Overall Study|Death|0|||
170778217|NCT01968109|617194052|FG020|Overall Study|Death|0|||
170778218|NCT01968109|617194053|FG021|Overall Study|Death|1|||
170778219|NCT01968109|617194054|FG022|Overall Study|Death|0|||
170530442|NCT02855268|616289841|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
170778220|NCT01968109|617194055|FG023|Overall Study|Death|0|||
170778221|NCT01968109|617194056|FG024|Overall Study|Death|0|||
170778222|NCT01968109|617194057|FG025|Overall Study|Death|0|||
170778223|NCT01968109|617194058|FG026|Overall Study|Death|0|||
170778224|NCT01968109|617194059|FG027|Overall Study|Death|0|||
170778225|NCT01968109|617194060|FG028|Overall Study|Death|0|||
170530443|NCT02855268|616289840|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
170530444|NCT02855268|616289841|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
170778226|NCT01968109|617194061|FG029|Overall Study|Death|0|||
170778227|NCT01968109|617194062|FG030|Overall Study|Death|1|||
170778228|NCT03899792|617194067|FG000|Phase 2|Ongoing Treatment|0|||
170530445|NCT02855268|616289840|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
170530446|NCT02855268|616289841|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
170530447|NCT02855268|616289840|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
170530448|NCT02855268|616289841|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
170530449|NCT00465517|616289844|FG000|Overall Study|Adverse Event|7|||
170530450|NCT00465517|616289845|FG001|Overall Study|Adverse Event|3|||
170530451|NCT00465517|616289844|FG000|Overall Study|Lost to Follow-up|1|||
170530452|NCT00465517|616289845|FG001|Overall Study|Lost to Follow-up|0|||
170530453|NCT00465517|616289844|FG000|Overall Study|Withdrawal by Subject|4|||
170530454|NCT00465517|616289845|FG001|Overall Study|Withdrawal by Subject|1|||
170530455|NCT01286129|616289846|FG000|Overall Study|Withdrawal by Subject|4|||
170530456|NCT01286129|616289847|FG001|Overall Study|Withdrawal by Subject|1|||
170530457|NCT01286129|616289846|FG000|Overall Study|Could not comply with study requirements|4|||
170530458|NCT01286129|616289847|FG001|Overall Study|Could not comply with study requirements|4|||
170530459|NCT00111761|616289857|FG000|Part 1|Physician Decision|0|||
170530460|NCT00111761|616289858|FG001|Part 1|Physician Decision|1|||
170530461|NCT00111761|616289857|FG000|Part 1|Death|0|||
170530462|NCT00111761|616289858|FG001|Part 1|Death|2|||
170530463|NCT00111761|616289857|FG000|Part 1|Other|0|||
170530464|NCT00111761|616289858|FG001|Part 1|Other|1|||
170530465|NCT00111761|616289857|FG000|Part 1|Withdrawal by Subject|0|||
170530466|NCT00111761|616289858|FG001|Part 1|Withdrawal by Subject|1|||
170530467|NCT00111761|616289857|FG000|Part 2|Adverse Event|1|||
170530468|NCT00111761|616289858|FG001|Part 2|Adverse Event|0|||
170530469|NCT00111761|616289857|FG000|Part 2|Physician Decision|1|||
170530470|NCT00111761|616289858|FG001|Part 2|Physician Decision|0|||
170530471|NCT00111761|616289857|FG000|Part 2|Death|1|||
170530472|NCT00111761|616289858|FG001|Part 2|Death|0|||
170530473|NCT00111761|616289857|FG000|Part 2|Disease progression|3|||
170530474|NCT00111761|616289858|FG001|Part 2|Disease progression|0|||
170530475|NCT00111761|616289857|FG000|Part 2|Protocol-specified criteria|1|||
170530476|NCT00111761|616289858|FG001|Part 2|Protocol-specified criteria|0|||
170530477|NCT00111761|616289857|FG000|Part 2|Other|1|||
170530478|NCT00111761|616289858|FG001|Part 2|Other|0|||
170530479|NCT04458922|616289859|FG000|Overall Study|Withdrawal by Subject|1|||
170530480|NCT04458922|616289860|FG001|Overall Study|Withdrawal by Subject|0|||
170530481|NCT04458922|616289861|FG002|Overall Study|Withdrawal by Subject|2|||
170530482|NCT04458922|616289859|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
170530483|NCT04458922|616289860|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
170530484|NCT04458922|616289861|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
170530485|NCT04458922|616289859|FG000|Overall Study|Adverse Event|1|||
170530486|NCT04458922|616289860|FG001|Overall Study|Adverse Event|0|||
170530487|NCT04458922|616289861|FG002|Overall Study|Adverse Event|0|||
170530488|NCT04458922|616289859|FG000|Overall Study|Started new study|0|||
170530489|NCT04458922|616289860|FG001|Overall Study|Started new study|0|||
170530490|NCT04458922|616289861|FG002|Overall Study|Started new study|1|||
170530491|NCT04458922|616289859|FG000|Overall Study|Progressive disease|6|||
170530492|NCT04458922|616289860|FG001|Overall Study|Progressive disease|8|||
170530493|NCT04458922|616289861|FG002|Overall Study|Progressive disease|2|||
170530494|NCT04458922|616289859|FG000|Overall Study|Death|1|||
170530495|NCT04458922|616289860|FG001|Overall Study|Death|0|||
170530496|NCT04458922|616289861|FG002|Overall Study|Death|2|||
170530497|NCT04458922|616289859|FG000|Overall Study|Participant started chemotherapy|0|||
170530498|NCT04458922|616289860|FG001|Overall Study|Participant started chemotherapy|1|||
170530499|NCT04458922|616289861|FG002|Overall Study|Participant started chemotherapy|0|||
170530500|NCT01991795|616289865|FG000|Overall Study|Lost to Follow-up|6|||
170530501|NCT01991795|616289866|FG001|Overall Study|Lost to Follow-up|4|||
170530502|NCT01991795|616289865|FG000|Overall Study|Withdrawal by Subject|117|||
170530503|NCT01991795|616289866|FG001|Overall Study|Withdrawal by Subject|94|||
170877777|NCT03259074|617563981|FG002|Overall Study|Physician Decision|10|||
170877778|NCT03259074|617563979|FG000|Overall Study|Pregnancy|1|||
170877779|NCT03259074|617563980|FG001|Overall Study|Pregnancy|1|||
170877780|NCT03259074|617563981|FG002|Overall Study|Pregnancy|0|||
170877781|NCT03259074|617563979|FG000|Overall Study|Progressive Disease|1|||
170877782|NCT03259074|617563980|FG001|Overall Study|Progressive Disease|0|||
170530504|NCT01991795|616289865|FG000|Overall Study|Site prematurely closed by sponsor|26|||
170530505|NCT01991795|616289866|FG001|Overall Study|Site prematurely closed by sponsor|25|||
170530506|NCT01981616|616289868|FG000|Overall Study|Adverse Event|0|||
170530507|NCT01981616|616289869|FG001|Overall Study|Adverse Event|1|||
170530508|NCT01981616|616289868|FG000|Overall Study|Protocol Violation|1|||
170530509|NCT01981616|616289869|FG001|Overall Study|Protocol Violation|0|||
170530510|NCT04030598|616289870|FG000|Overall Study|Voluntary Withdrawal|0|||
170530511|NCT04030598|616289871|FG001|Overall Study|Voluntary Withdrawal|1|||
170530512|NCT04030598|616289872|FG002|Overall Study|Voluntary Withdrawal|0|||
170530513|NCT05117060|616289875|FG000|Overall Study|Adverse Event|3|||
170530514|NCT05117060|616289876|FG001|Overall Study|Adverse Event|5|||
170530515|NCT05117060|616289877|FG002|Overall Study|Adverse Event|6|||
170530516|NCT05117060|616289878|FG003|Overall Study|Adverse Event|1|||
170877783|NCT03259074|617563981|FG002|Overall Study|Progressive Disease|0|||
170418557|NCT02777528|615873300|FG001|Overall Study|Discontinued due to Other|0|||
170418558|NCT02777528|615873301|FG002|Overall Study|Discontinued due to Other|0|||
170418559|NCT00453362|615873302|FG000|Overall Study|Adverse Event|5|||
170418560|NCT00453362|615873302|FG000|Overall Study|Death|7|||
170418561|NCT00453362|615873302|FG000|Overall Study|Physician Decision|2|||
170418562|NCT00453362|615873302|FG000|Overall Study|Withdrawal by Subject|3|||
170418563|NCT00453362|615873302|FG000|Overall Study|Progression of disease|56|||
170418564|NCT00453362|615873302|FG000|Overall Study|Screening Failure|14|||
170418565|NCT04885296|615873303|FG000|Period 1|Covid-19 Related|1|||
170418566|NCT04885296|615873304|FG001|Period 1|Covid-19 Related|0|||
170418567|NCT04885296|615873303|FG000|Period 1|Adverse Event|0|||
170418568|NCT04885296|615873304|FG001|Period 1|Adverse Event|1|||
170418569|NCT04885296|615873303|FG000|Period 1|Withdrawal by Subject|1|||
170418570|NCT04885296|615873304|FG001|Period 1|Withdrawal by Subject|1|||
170418571|NCT04885296|615873303|FG000|Period 1|Test Article No Longer Available|1|||
170418572|NCT04885296|615873304|FG001|Period 1|Test Article No Longer Available|0|||
170418573|NCT04885296|615873303|FG000|Period 1|Dispensed Study lens in Error|1|||
170418574|NCT04885296|615873304|FG001|Period 1|Dispensed Study lens in Error|0|||
170418575|NCT04885296|615873303|FG000|Period 1|Lost to Follow-up|1|||
170418576|NCT04885296|615873304|FG001|Period 1|Lost to Follow-up|0|||
170418577|NCT04885296|615873303|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
170418578|NCT04885296|615873304|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
170778229|NCT03899792|617194068|FG001|Phase 2|Ongoing Treatment|13|||
170778230|NCT03899792|617194069|FG002|Phase 2|Ongoing Treatment|14|||
170778231|NCT03899792|617194070|FG003|Phase 2|Ongoing Treatment|2|||
170778232|NCT03899792|617194067|FG000|Phase 2|Death|0|||
170778233|NCT03899792|617194068|FG001|Phase 2|Death|0|||
170778234|NCT03899792|617194069|FG002|Phase 2|Death|0|||
170778235|NCT03899792|617194070|FG003|Phase 2|Death|4|||
170778236|NCT03899792|617194067|FG000|Phase 2|Lost to Follow-up|0|||
170778237|NCT03899792|617194068|FG001|Phase 2|Lost to Follow-up|1|||
170778238|NCT03899792|617194069|FG002|Phase 2|Lost to Follow-up|1|||
170778239|NCT03899792|617194070|FG003|Phase 2|Lost to Follow-up|0|||
170778240|NCT03899792|617194067|FG000|Phase 2|Withdrawal by Subject|0|||
170778241|NCT03899792|617194068|FG001|Phase 2|Withdrawal by Subject|1|||
170778242|NCT03899792|617194069|FG002|Phase 2|Withdrawal by Subject|0|||
170778243|NCT03899792|617194070|FG003|Phase 2|Withdrawal by Subject|0|||
170778244|NCT00330681|617194071|FG000|Overall Study|Adverse Event|3|||
170778245|NCT00330681|617194072|FG001|Overall Study|Adverse Event|6|||
170778246|NCT00330681|617194071|FG000|Overall Study|Protocol Violation|0|||
170778247|NCT00330681|617194072|FG001|Overall Study|Protocol Violation|1|||
170778248|NCT00330681|617194071|FG000|Overall Study|Withdrawal by Subject|5|||
170778249|NCT00330681|617194072|FG001|Overall Study|Withdrawal by Subject|5|||
170778250|NCT00330681|617194071|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
170778251|NCT00330681|617194072|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
170778252|NCT04608045|617195545|FG000|Overall Study|Physician Decision|1|||
170778253|NCT04118452|617195546|FG000|Overall Study|Lost to Follow-up|5|||
170778254|NCT04118452|617195547|FG001|Overall Study|Lost to Follow-up|5|||
170778255|NCT04118452|617195546|FG000|Overall Study|Withdrawal by Subject|17|||
170778256|NCT04118452|617195547|FG001|Overall Study|Withdrawal by Subject|17|||
170778257|NCT05215847|617195548|FG000|Overall Study|Lost to Follow-up|1|||
170778258|NCT04847999|617195549|FG000|Overall Study|Lost to Follow-up|0|||
170778259|NCT04847999|617195550|FG001|Overall Study|Lost to Follow-up|1|||
170778260|NCT03433339|617195551|FG000|Overall Study|Lost to Follow-up|2|||
170778261|NCT03433339|617195552|FG001|Overall Study|Lost to Follow-up|0|||
170778262|NCT03433339|617195551|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
170778263|NCT03433339|617195552|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
170778264|NCT03433339|617195551|FG000|Overall Study|Withdrawal by Subject|0|||
170778265|NCT03433339|617195552|FG001|Overall Study|Withdrawal by Subject|2|||
170778266|NCT02728557|617195554|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
170778267|NCT02728557|617195555|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
170778268|NCT02728557|617195554|FG000|Overall Study|Dissatisfaction with research tasks|0|||
170418579|NCT03601637|615873308|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
170418580|NCT03601637|615873309|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
170418581|NCT03601637|615873308|FG000|Overall Study|Adverse Event|1|||
170418582|NCT03601637|615873309|FG001|Overall Study|Adverse Event|1|||
170418583|NCT03601637|615873308|FG000|Overall Study|Other|0|||
170418584|NCT03601637|615873309|FG001|Overall Study|Other|1|||
170418585|NCT01108094|615873311|FG000|Overall Study|Adverse Event|2|||
170530517|NCT05117060|616289875|FG000|Overall Study|Lost to Follow-up|0|||
170530518|NCT05117060|616289876|FG001|Overall Study|Lost to Follow-up|0|||
170530519|NCT05117060|616289877|FG002|Overall Study|Lost to Follow-up|0|||
170778269|NCT02728557|617195555|FG001|Overall Study|Dissatisfaction with research tasks|1|||
170778270|NCT02728557|617195554|FG000|Overall Study|Scheduling or change in availability|1|||
170778271|NCT02728557|617195555|FG001|Overall Study|Scheduling or change in availability|1|||
170778272|NCT01718743|617195556|FG000|Overall Study|Physician Decision|7|||
170778273|NCT01718743|617195556|FG000|Overall Study|Withdrawal by Subject|14|||
170778274|NCT01718743|617195556|FG000|Overall Study|Progressive Disease|22|||
170418586|NCT01108094|615873312|FG001|Overall Study|Adverse Event|0|||
170418587|NCT01108094|615873313|FG002|Overall Study|Adverse Event|0|||
170418588|NCT01108094|615873314|FG003|Overall Study|Adverse Event|0|||
170418589|NCT01108094|615873311|FG000|Overall Study|Withdrawal by Subject|1|||
170418590|NCT01108094|615873312|FG001|Overall Study|Withdrawal by Subject|0|||
170418591|NCT01108094|615873313|FG002|Overall Study|Withdrawal by Subject|0|||
170418592|NCT01108094|615873314|FG003|Overall Study|Withdrawal by Subject|0|||
170418593|NCT02918877|615873315|FG000|Overall Study|Withdrawal by Subject|2|||
170418594|NCT02918877|615873316|FG001|Overall Study|Withdrawal by Subject|2|||
170418595|NCT02918877|615873315|FG000|Overall Study|Surgery cancelled|1|||
170418596|NCT02918877|615873316|FG001|Overall Study|Surgery cancelled|0|||
170418597|NCT02918877|615873315|FG000|Overall Study|Physician Decision|1|||
170418598|NCT02918877|615873316|FG001|Overall Study|Physician Decision|0|||
170418599|NCT02918877|615873315|FG000|Overall Study|Received intraoperative steroids|1|||
170418600|NCT02918877|615873316|FG001|Overall Study|Received intraoperative steroids|0|||
170418601|NCT02918877|615873315|FG000|Overall Study|Unable to obtain lab samples|1|||
170418602|NCT02918877|615873316|FG001|Overall Study|Unable to obtain lab samples|0|||
170418603|NCT02918877|615873315|FG000|Overall Study|Unsafe to perform BAL|0|||
170418604|NCT02918877|615873316|FG001|Overall Study|Unsafe to perform BAL|1|||
170418605|NCT04510857|615873317|FG000|Overall Study|Withdrawal by Subject|1|||
170418606|NCT04510857|615873318|FG001|Overall Study|Withdrawal by Subject|2|||
170418607|NCT00376220|615873325|FG000|Overall Study|Lost to Follow-up|7|||
170418608|NCT00376220|615873326|FG001|Overall Study|Lost to Follow-up|10|||
170418609|NCT00376220|615873325|FG000|Overall Study|Withdrawal by Subject|3|||
170418610|NCT00376220|615873326|FG001|Overall Study|Withdrawal by Subject|2|||
170418611|NCT02564263|615873329|FG000|Overall Study|Adverse Event|31|||
170418612|NCT02564263|615873330|FG001|Overall Study|Adverse Event|29|||
170418613|NCT02564263|615873329|FG000|Overall Study|Death|270|||
170418614|NCT02564263|615873330|FG001|Overall Study|Death|262|||
170418615|NCT02564263|615873329|FG000|Overall Study|Withdrawal by Subject|4|||
170418616|NCT02564263|615873330|FG001|Overall Study|Withdrawal by Subject|19|||
170418617|NCT02564263|615873329|FG000|Overall Study|Sponsor's decision|9|||
170418618|NCT02564263|615873330|FG001|Overall Study|Sponsor's decision|4|||
170418619|NCT03311646|615873331|FG000|Overall Study|Physician Decision|1|||
170418620|NCT03311646|615873331|FG000|Overall Study|Withdrawal by Subject|5|||
170418621|NCT03311646|615873331|FG000|Overall Study|Lost to Follow-up|5|||
170418622|NCT03311646|615873331|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
170418623|NCT00531206|615873334|FG000|Overall Study|Adverse Event related|5|||
170418624|NCT00531206|615873334|FG000|Overall Study|Lack of Efficacy|2|||
170418625|NCT00531206|615873334|FG000|Overall Study|Lost to Follow-up|5|||
170418626|NCT00531206|615873334|FG000|Overall Study|including non-related adverse events|8|||
170418627|NCT02446132|615873341|FG000|Overall Study|Adverse Event|10|||
170418628|NCT02446132|615873342|FG001|Overall Study|Adverse Event|27|||
170418629|NCT02446132|615873343|FG002|Overall Study|Adverse Event|27|||
170418630|NCT02446132|615873341|FG000|Overall Study|Death|2|||
170877784|NCT03259074|617563979|FG000|Overall Study|Protocol Deviation|1|||
170877785|NCT03259074|617563980|FG001|Overall Study|Protocol Deviation|1|||
170877786|NCT03259074|617563981|FG002|Overall Study|Protocol Deviation|3|||
170877787|NCT03259074|617563979|FG000|Overall Study|Subject/Guardian Decision|13|||
170877788|NCT03259074|617563980|FG001|Overall Study|Subject/Guardian Decision|16|||
170877789|NCT03259074|617563981|FG002|Overall Study|Subject/Guardian Decision|14|||
170877790|NCT01543828|617563982|FG000|Treatment 2|Lost to Follow-up|1|||
170877791|NCT01543828|617563983|FG001|Treatment 2|Lost to Follow-up|0|||
170877792|NCT05879107|617563984|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
170877793|NCT05879107|617563985|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
170418631|NCT02446132|615873342|FG001|Overall Study|Death|13|||
170418632|NCT02446132|615873343|FG002|Overall Study|Death|10|||
170418633|NCT02446132|615873341|FG000|Overall Study|Lack of Efficacy|1|||
170418634|NCT02446132|615873342|FG001|Overall Study|Lack of Efficacy|10|||
170418635|NCT02446132|615873343|FG002|Overall Study|Lack of Efficacy|6|||
170418636|NCT02446132|615873341|FG000|Overall Study|Lost to Follow-up|2|||
170418637|NCT02446132|615873342|FG001|Overall Study|Lost to Follow-up|4|||
170418638|NCT02446132|615873343|FG002|Overall Study|Lost to Follow-up|5|||
170418639|NCT02446132|615873341|FG000|Overall Study|Non-compliance With Study Drug|2|||
170418640|NCT02446132|615873342|FG001|Overall Study|Non-compliance With Study Drug|2|||
170418641|NCT02446132|615873343|FG002|Overall Study|Non-compliance With Study Drug|3|||
170418642|NCT02446132|615873341|FG000|Overall Study|Physician Decision|1|||
170418643|NCT02446132|615873342|FG001|Overall Study|Physician Decision|8|||
170877794|NCT05879107|617563984|FG000|Overall Study|Migrated / moved from the study area|1|||
170877795|NCT05879107|617563985|FG001|Overall Study|Migrated / moved from the study area|1|||
170877796|NCT05879107|617563984|FG000|Overall Study|Lost to Follow-up|8|||
170418644|NCT02446132|615873343|FG002|Overall Study|Physician Decision|13|||
170418645|NCT02446132|615873341|FG000|Overall Study|Protocol Deviation|0|||
170418646|NCT02446132|615873342|FG001|Overall Study|Protocol Deviation|0|||
170418647|NCT02446132|615873343|FG002|Overall Study|Protocol Deviation|1|||
170418648|NCT02446132|615873341|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
170418649|NCT02446132|615873342|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
170530520|NCT05117060|616289878|FG003|Overall Study|Lost to Follow-up|1|||
170877797|NCT05879107|617563985|FG001|Overall Study|Lost to Follow-up|13|||
170877798|NCT05879107|617563984|FG000|Overall Study|Death|0|||
170877799|NCT05879107|617563985|FG001|Overall Study|Death|2|||
170877800|NCT05879107|617563984|FG000|Overall Study|Other|0|||
170418650|NCT02446132|615873343|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
170418651|NCT02446132|615873341|FG000|Overall Study|Study Terminated by Sponsor|4|||
170418652|NCT02446132|615873342|FG001|Overall Study|Study Terminated by Sponsor|35|||
170418653|NCT02446132|615873343|FG002|Overall Study|Study Terminated by Sponsor|58|||
170418654|NCT02446132|615873341|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
170418655|NCT02446132|615873342|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
170418656|NCT02446132|615873343|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
170418657|NCT02446132|615873341|FG000|Overall Study|Withdrawal by Subject|11|||
170418658|NCT02446132|615873342|FG001|Overall Study|Withdrawal by Subject|29|||
170418659|NCT02446132|615873343|FG002|Overall Study|Withdrawal by Subject|25|||
170418660|NCT02446132|615873341|FG000|Overall Study|Reason not Specified|4|||
170418661|NCT02446132|615873342|FG001|Overall Study|Reason not Specified|16|||
170418662|NCT02446132|615873343|FG002|Overall Study|Reason not Specified|10|||
170418663|NCT02446132|615873341|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
170418664|NCT02446132|615873342|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
170418665|NCT02446132|615873343|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
170418666|NCT03444038|615873345|FG000|Overall Study|Adverse Event|12|||
170418667|NCT03444038|615873345|FG000|Overall Study|Withdrawal by Subject|7|||
170418668|NCT03444038|615873345|FG000|Overall Study|Lost to Follow-up|1|||
170418669|NCT03444038|615873345|FG000|Overall Study|Physician Decision|2|||
170418670|NCT03444038|615873345|FG000|Overall Study|Lack of Efficacy|7|||
170418671|NCT02354586|615873348|FG000|Overall Study|Death|230|||
170418672|NCT02354586|615873348|FG000|Overall Study|Withdrawal by Subject|59|||
170418673|NCT02354586|615873348|FG000|Overall Study|Lost to Follow-up|11|||
170418674|NCT02354586|615873348|FG000|Overall Study|Sponsor decision|51|||
170418675|NCT02354586|615873348|FG000|Overall Study|Site closure|2|||
170418676|NCT02354586|615873348|FG000|Overall Study|Intercurrent illness|1|||
170418677|NCT02354586|615873348|FG000|Overall Study|Protocol Violation|3|||
170418678|NCT02354586|615873348|FG000|Overall Study|Physician Decision|13|||
170418679|NCT02354586|615873348|FG000|Overall Study|Lack of Efficacy|86|||
170418680|NCT02354586|615873348|FG000|Overall Study|Adverse Event|7|||
170418681|NCT00721409|615873357|FG000|Overall Study|Global deterioration of health status|2|||
170418682|NCT00721409|615873358|FG001|Overall Study|Global deterioration of health status|6|||
170418683|NCT00721409|615873359|FG002|Overall Study|Global deterioration of health status|3|||
170418684|NCT00721409|615873357|FG000|Overall Study|Death|0|||
170418685|NCT00721409|615873358|FG001|Overall Study|Death|1|||
170418686|NCT00721409|615873359|FG002|Overall Study|Death|0|||
170418687|NCT00721409|615873357|FG000|Overall Study|Randomized not Treated|0|||
170418688|NCT00721409|615873358|FG001|Overall Study|Randomized not Treated|1|||
170418689|NCT00721409|615873359|FG002|Overall Study|Randomized not Treated|4|||
170418690|NCT00721409|615873357|FG000|Overall Study|Reason not specified|1|||
170418691|NCT00721409|615873358|FG001|Overall Study|Reason not specified|0|||
170418692|NCT00721409|615873359|FG002|Overall Study|Reason not specified|2|||
170418693|NCT00721409|615873357|FG000|Overall Study|Adverse Event|0|||
170418694|NCT00721409|615873358|FG001|Overall Study|Adverse Event|13|||
170418695|NCT00721409|615873359|FG002|Overall Study|Adverse Event|2|||
170418696|NCT00721409|615873357|FG000|Overall Study|Lost to Follow-up|0|||
170418697|NCT00721409|615873358|FG001|Overall Study|Lost to Follow-up|0|||
170418698|NCT00721409|615873359|FG002|Overall Study|Lost to Follow-up|1|||
170418699|NCT00721409|615873357|FG000|Overall Study|Withdrawal by Subject|1|||
170418700|NCT00721409|615873358|FG001|Overall Study|Withdrawal by Subject|6|||
170418701|NCT00721409|615873359|FG002|Overall Study|Withdrawal by Subject|5|||
170418702|NCT00721409|615873357|FG000|Overall Study|Objective progression or relapse|8|||
170418703|NCT00721409|615873358|FG001|Overall Study|Objective progression or relapse|55|||
170418704|NCT00721409|615873359|FG002|Overall Study|Objective progression or relapse|62|||
170418705|NCT01957488|615873360|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
170418706|NCT01957488|615873361|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
170418707|NCT01957488|615873362|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
170418708|NCT01957488|615873363|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
170418709|NCT01957488|615873364|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
170418710|NCT01957488|615873365|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
170418711|NCT01957488|615873360|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
170418712|NCT01957488|615873361|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
170418713|NCT01957488|615873362|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
170418714|NCT01957488|615873363|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
170418715|NCT01957488|615873364|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
170418716|NCT01957488|615873365|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
170418717|NCT01957488|615873360|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
170418718|NCT01957488|615873361|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
170530521|NCT05117060|616289875|FG000|Overall Study|Lack of Efficacy|4|||
170530522|NCT05117060|616289876|FG001|Overall Study|Lack of Efficacy|5|||
170530523|NCT05117060|616289877|FG002|Overall Study|Lack of Efficacy|2|||
170530524|NCT05117060|616289878|FG003|Overall Study|Lack of Efficacy|6|||
170530525|NCT05117060|616289875|FG000|Overall Study|Withdrawal by Subject|8|||
170530526|NCT05117060|616289876|FG001|Overall Study|Withdrawal by Subject|5|||
170530527|NCT05117060|616289877|FG002|Overall Study|Withdrawal by Subject|5|||
170530528|NCT05117060|616289878|FG003|Overall Study|Withdrawal by Subject|6|||
170530529|NCT05117060|616289875|FG000|Overall Study|Other|2|||
170530530|NCT05117060|616289876|FG001|Overall Study|Other|1|||
170530531|NCT05117060|616289877|FG002|Overall Study|Other|3|||
170530532|NCT05117060|616289878|FG003|Overall Study|Other|1|||
170530533|NCT05079321|616289879|FG000|Overall Study|Withdrawal by Subject|2|||
170530534|NCT05079321|616289880|FG001|Overall Study|Withdrawal by Subject|2|||
170530535|NCT05079321|616289879|FG000|Overall Study|Lost to Follow-up|0|||
170530536|NCT05079321|616289880|FG001|Overall Study|Lost to Follow-up|1|||
170530537|NCT01081626|616289881|FG000|Overall Study|Dosing error|1|||
170530538|NCT01081626|616289882|FG001|Overall Study|Dosing error|1|||
170530539|NCT01081626|616289881|FG000|Overall Study|Missing Estradiol|25|||
170530540|NCT01081626|616289882|FG001|Overall Study|Missing Estradiol|28|||
170530541|NCT01081626|616289881|FG000|Overall Study|Low antral follicle count|1|||
170530542|NCT01081626|616289882|FG001|Overall Study|Low antral follicle count|0|||
170530543|NCT01081626|616289881|FG000|Overall Study|Overstimulation|0|||
170530544|NCT01081626|616289882|FG001|Overall Study|Overstimulation|1|||
170530545|NCT01081626|616289881|FG000|Overall Study|Lost to Follow-up|0|||
170530546|NCT01081626|616289882|FG001|Overall Study|Lost to Follow-up|1|||
170530547|NCT01081626|616289881|FG000|Overall Study|Other|33|||
170530548|NCT01081626|616289882|FG001|Overall Study|Other|30|||
170530549|NCT02003144|616289883|FG000|Open Label Maintenance Phase|Other than specified|2|||
170530550|NCT02003144|616289884|FG001|Open Label Maintenance Phase|Other than specified|4|||
170530551|NCT02003144|616289883|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
170530552|NCT02003144|616289884|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
170530553|NCT02003144|616289883|FG000|Open Label Maintenance Phase|Pregnancy|0|||
170530554|NCT02003144|616289884|FG001|Open Label Maintenance Phase|Pregnancy|2|||
170530555|NCT02003144|616289883|FG000|Open Label Maintenance Phase|Physician Decision|1|||
170530556|NCT02003144|616289884|FG001|Open Label Maintenance Phase|Physician Decision|1|||
170530557|NCT02003144|616289883|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
170530558|NCT02003144|616289884|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
170877801|NCT05879107|617563985|FG001|Overall Study|Other|3|||
170530559|NCT02003144|616289883|FG000|Open Label Maintenance Phase|Adverse Event|2|||
170530560|NCT02003144|616289884|FG001|Open Label Maintenance Phase|Adverse Event|1|||
170530561|NCT05965752|616289888|FG000|Overall Study|Adverse Event|0|||
170530562|NCT05965752|616289889|FG001|Overall Study|Adverse Event|1|||
170530563|NCT05965752|616289890|FG002|Overall Study|Adverse Event|0|||
170530564|NCT05965752|616289891|FG003|Overall Study|Adverse Event|1|||
170530565|NCT05965752|616289892|FG004|Overall Study|Adverse Event|3|||
170530566|NCT05965752|616289888|FG000|Overall Study|Lost to Follow-up|2|||
170530567|NCT05965752|616289889|FG001|Overall Study|Lost to Follow-up|0|||
170530568|NCT05965752|616289890|FG002|Overall Study|Lost to Follow-up|1|||
170530569|NCT05965752|616289891|FG003|Overall Study|Lost to Follow-up|1|||
170530570|NCT05965752|616289892|FG004|Overall Study|Lost to Follow-up|1|||
170530571|NCT05965752|616289888|FG000|Overall Study|Withdrawal by Subject|2|||
170530572|NCT05965752|616289889|FG001|Overall Study|Withdrawal by Subject|2|||
170877802|NCT03901079|617563986|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
170877803|NCT00804570|617563987|FG000|Overall Study|Adverse Event|14|||
170877804|NCT00804570|617563988|FG001|Overall Study|Adverse Event|7|||
170877805|NCT00804570|617563987|FG000|Overall Study|Lack of Efficacy|0|||
170877806|NCT00804570|617563988|FG001|Overall Study|Lack of Efficacy|1|||
170877807|NCT00804570|617563987|FG000|Overall Study|Lost to Follow-up|18|||
170877808|NCT00804570|617563988|FG001|Overall Study|Lost to Follow-up|21|||
170877809|NCT00804570|617563987|FG000|Overall Study|Entry criteria not met|5|||
170877810|NCT00804570|617563988|FG001|Overall Study|Entry criteria not met|5|||
170877811|NCT00804570|617563987|FG000|Overall Study|Protocol Violation|12|||
170530573|NCT05965752|616289890|FG002|Overall Study|Withdrawal by Subject|1|||
170530574|NCT05965752|616289891|FG003|Overall Study|Withdrawal by Subject|5|||
170530575|NCT05965752|616289892|FG004|Overall Study|Withdrawal by Subject|0|||
170632627|NCT01352793|616666716|FG001|Overall Study|Randomized but not vaccinated|0|||
170877812|NCT00804570|617563988|FG001|Overall Study|Protocol Violation|16|||
170877813|NCT00804570|617563987|FG000|Overall Study|Physician Decision|1|||
170530576|NCT05965752|616289888|FG000|Overall Study|Disease Relapse|1|||
170530577|NCT05965752|616289889|FG001|Overall Study|Disease Relapse|0|||
170530578|NCT05965752|616289890|FG002|Overall Study|Disease Relapse|1|||
170530579|NCT05965752|616289891|FG003|Overall Study|Disease Relapse|0|||
170530580|NCT05965752|616289892|FG004|Overall Study|Disease Relapse|0|||
170530581|NCT05965752|616289888|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
170530582|NCT05965752|616289889|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
170530583|NCT05965752|616289890|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
170530584|NCT05965752|616289891|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
170530585|NCT05965752|616289892|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
170530586|NCT05965752|616289888|FG000|Overall Study|Unable to Return for Study Visits|0|||
170530587|NCT05965752|616289889|FG001|Overall Study|Unable to Return for Study Visits|1|||
170530588|NCT05965752|616289890|FG002|Overall Study|Unable to Return for Study Visits|0|||
170530589|NCT05965752|616289891|FG003|Overall Study|Unable to Return for Study Visits|3|||
170530590|NCT05965752|616289892|FG004|Overall Study|Unable to Return for Study Visits|1|||
170530591|NCT05965752|616289888|FG000|Overall Study|Early Termination|0|||
170530592|NCT05965752|616289889|FG001|Overall Study|Early Termination|0|||
170530593|NCT05965752|616289890|FG002|Overall Study|Early Termination|1|||
170530594|NCT05965752|616289891|FG003|Overall Study|Early Termination|0|||
170530595|NCT05965752|616289892|FG004|Overall Study|Early Termination|0|||
170530596|NCT05965752|616289888|FG000|Overall Study|Reported Unwanted Symptoms|0|||
170530597|NCT05965752|616289889|FG001|Overall Study|Reported Unwanted Symptoms|0|||
170530598|NCT05965752|616289890|FG002|Overall Study|Reported Unwanted Symptoms|0|||
170530599|NCT05965752|616289891|FG003|Overall Study|Reported Unwanted Symptoms|0|||
170530600|NCT05965752|616289892|FG004|Overall Study|Reported Unwanted Symptoms|1|||
170530601|NCT05965752|616289888|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
170530602|NCT05965752|616289889|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
170530603|NCT05965752|616289890|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
170530604|NCT05965752|616289891|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
170530605|NCT05965752|616289892|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
170530606|NCT04530630|616291331|FG000|Overall Study|Physician Decision|1|||
170530607|NCT02775851|616291334|FG000|Overall Study|Adverse Event|1|||
170530608|NCT02775851|616291335|FG001|Overall Study|Adverse Event|10|||
170530609|NCT02775851|616291334|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
170530610|NCT02775851|616291335|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
170530611|NCT02775851|616291334|FG000|Overall Study|Progression/Relapse|0|||
170530612|NCT02775851|616291335|FG001|Overall Study|Progression/Relapse|4|||
170530613|NCT02775851|616291334|FG000|Overall Study|Other - Not Protocol Specified|0|||
170530614|NCT02775851|616291335|FG001|Overall Study|Other - Not Protocol Specified|7|||
170530615|NCT02775851|616291334|FG000|Overall Study|Withdrawal by Subject|1|||
170530616|NCT02775851|616291335|FG001|Overall Study|Withdrawal by Subject|0|||
170530617|NCT06125964|616291336|FG000|Overall Study|Lost to Follow-up|0|||
170530618|NCT06125964|616291337|FG001|Overall Study|Lost to Follow-up|1|||
170530619|NCT06125964|616291338|FG002|Overall Study|Lost to Follow-up|0|||
170530620|NCT06125964|616291339|FG003|Overall Study|Lost to Follow-up|0|||
170530621|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
170530622|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
170530623|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
170530624|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Death|1|||
170530625|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Death|1|||
170530626|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Death|0|||
170530627|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
170530628|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
170530629|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
170530630|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
170530631|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
170530632|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
170530633|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
170530634|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
170530635|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
170530636|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
170530637|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
170530638|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
170530639|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
170530640|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
170530641|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
170530642|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
170530643|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
170530644|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
170530645|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
170530646|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
170877814|NCT00804570|617563988|FG001|Overall Study|Physician Decision|2|||
170877815|NCT00804570|617563987|FG000|Overall Study|Sponsor decision|1|||
170877816|NCT00804570|617563988|FG001|Overall Study|Sponsor decision|4|||
170530647|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
170530648|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
170530649|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
170530650|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
170530651|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Other|10|||
170530652|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Other|4|||
170530653|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Other|0|||
170530654|NCT04006457|616291340|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
170530655|NCT04006457|616291341|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
170530656|NCT04006457|616291342|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
170530657|NCT04006457|616291340|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
170418719|NCT01957488|615873362|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
170418720|NCT01957488|615873363|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
170418721|NCT01957488|615873364|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
170418722|NCT01957488|615873365|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
170418723|NCT01957488|615873360|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
170418724|NCT01957488|615873361|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
170418725|NCT01957488|615873362|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
170418726|NCT01957488|615873363|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
170418727|NCT01957488|615873364|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
170418728|NCT01957488|615873365|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
170418729|NCT01957488|615873360|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
170418730|NCT01957488|615873361|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
170418731|NCT01957488|615873362|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
170418732|NCT01957488|615873363|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
170418733|NCT01957488|615873364|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
170418734|NCT01957488|615873365|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
170418735|NCT01957488|615873360|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
170418736|NCT01957488|615873361|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
170418737|NCT01957488|615873362|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
170418738|NCT01957488|615873363|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
170418739|NCT01957488|615873364|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
170418740|NCT01957488|615873365|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
170418741|NCT01957488|615873360|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
170418742|NCT01957488|615873361|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
170418743|NCT01957488|615873362|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
170418744|NCT01957488|615873363|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
170418745|NCT01957488|615873364|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
170418746|NCT01957488|615873365|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
170418747|NCT01957488|615873360|FG000|Test Period 2 (2 Weeks)|Other|1|||
170418748|NCT01957488|615873361|FG001|Test Period 2 (2 Weeks)|Other|0|||
170418749|NCT01957488|615873362|FG002|Test Period 2 (2 Weeks)|Other|0|||
170418750|NCT01957488|615873363|FG003|Test Period 2 (2 Weeks)|Other|0|||
170418751|NCT01957488|615873364|FG004|Test Period 2 (2 Weeks)|Other|0|||
170418752|NCT01957488|615873365|FG005|Test Period 2 (2 Weeks)|Other|0|||
170418753|NCT01957488|615873360|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
170418754|NCT01957488|615873361|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
170418755|NCT01957488|615873362|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
170418756|NCT01957488|615873363|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
170418757|NCT01957488|615873364|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
170418758|NCT01957488|615873365|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
170418759|NCT01957488|615873360|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
170418760|NCT01957488|615873361|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
170418761|NCT01957488|615873362|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
170418762|NCT01957488|615873363|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
170418763|NCT01957488|615873364|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
170418764|NCT01957488|615873365|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
170418765|NCT01957488|615873360|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
170418766|NCT01957488|615873361|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
170418767|NCT01957488|615873362|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
170418768|NCT01957488|615873363|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
170418769|NCT01957488|615873364|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
170418770|NCT01957488|615873365|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
170418771|NCT01957488|615873360|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
170418772|NCT01957488|615873361|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
170418773|NCT01957488|615873362|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
170530658|NCT04006457|616291341|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
170530659|NCT04006457|616291342|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
170778275|NCT01718743|617195556|FG000|Overall Study|Toxicity|1|||
170778276|NCT01718743|617195556|FG000|Overall Study|Malignancy|1|||
170778277|NCT03416010|617195557|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
170418774|NCT01957488|615873363|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
170418775|NCT01957488|615873364|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
170418776|NCT01957488|615873365|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
170418777|NCT01957488|615873360|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
170418778|NCT01957488|615873361|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
170418779|NCT01957488|615873362|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
170418780|NCT01957488|615873363|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
170418781|NCT01957488|615873364|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
170418782|NCT01957488|615873365|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
170418783|NCT01439165|615873366|FG000|Overall Study|Protocol Violation|3|||
170418784|NCT01439165|615873367|FG001|Overall Study|Protocol Violation|0|||
170418785|NCT01439165|615873366|FG000|Overall Study|Lost to Follow-up|11|||
170418786|NCT01439165|615873367|FG001|Overall Study|Lost to Follow-up|1|||
170418787|NCT01439165|615873366|FG000|Overall Study|Withdrawal by Subject|7|||
170418788|NCT01439165|615873367|FG001|Overall Study|Withdrawal by Subject|1|||
170418789|NCT00720096|615873368|FG000|Overall Study|Withdrawal by Subject|0|||
170418790|NCT00720096|615873369|FG001|Overall Study|Withdrawal by Subject|2|||
170418791|NCT00264797|615873370|FG000|Overall Study|Withdrawal by Subject|11|||
170418792|NCT00264797|615873371|FG001|Overall Study|Withdrawal by Subject|11|||
170418793|NCT00264797|615873370|FG000|Overall Study|Lost to Follow-up|9|||
170418794|NCT00264797|615873371|FG001|Overall Study|Lost to Follow-up|17|||
170418795|NCT00264797|615873370|FG000|Overall Study|Moved from area|3|||
170418796|NCT00264797|615873371|FG001|Overall Study|Moved from area|1|||
170418797|NCT00264797|615873370|FG000|Overall Study|Practical Problems|2|||
170418798|NCT00264797|615873371|FG001|Overall Study|Practical Problems|3|||
170418799|NCT00264797|615873370|FG000|Overall Study|Incarceration|4|||
170418800|NCT00264797|615873371|FG001|Overall Study|Incarceration|5|||
170418801|NCT00264797|615873370|FG000|Overall Study|Pressure/advice from Outsiders|1|||
170418802|NCT00264797|615873371|FG001|Overall Study|Pressure/advice from Outsiders|1|||
170418803|NCT00264797|615873370|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
170418804|NCT00264797|615873371|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
170418805|NCT00264797|615873370|FG000|Overall Study|Other|3|||
170418806|NCT00264797|615873371|FG001|Overall Study|Other|4|||
170418807|NCT03992196|615873372|FG000|Enrollment|lost to follow-up prior dosing|1|||
170418808|NCT03992196|615873373|FG001|Enrollment|lost to follow-up prior dosing|0|||
170418809|NCT03992196|615873374|FG002|Enrollment|lost to follow-up prior dosing|0|||
170418810|NCT03992196|615873372|FG000|Treatment|Protocol Violation|0|||
170418811|NCT03992196|615873373|FG001|Treatment|Protocol Violation|0|||
170418812|NCT03992196|615873374|FG002|Treatment|Protocol Violation|1|||
170418813|NCT03992196|615873372|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
170418814|NCT03992196|615873373|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
170418815|NCT03992196|615873374|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
170418816|NCT03992196|615873372|FG000|Treatment|Withdrawal due to non-compliance|0|||
170418817|NCT03992196|615873373|FG001|Treatment|Withdrawal due to non-compliance|0|||
170418818|NCT03992196|615873374|FG002|Treatment|Withdrawal due to non-compliance|1|||
170418819|NCT03992196|615873372|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
170418820|NCT03992196|615873373|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
170418821|NCT03992196|615873374|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
170418822|NCT03992196|615873372|FG000|Treatment|Withdrawal by parent/guardian|0|||
170418823|NCT03992196|615873373|FG001|Treatment|Withdrawal by parent/guardian|0|||
170418824|NCT03992196|615873374|FG002|Treatment|Withdrawal by parent/guardian|2|||
170418825|NCT00755196|615873376|FG000|Overall Study|Lost to Follow-up|1|||
170418826|NCT00755196|615873376|FG000|Overall Study|Lack of Efficiency|1|||
170418827|NCT02388763|615873377|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
170418828|NCT02388763|615873378|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
170418829|NCT02388763|615873377|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
170418830|NCT02388763|615873378|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
170418831|NCT02720510|615873379|FG000|Overall Study|Study Terminated by the sponsor|2|||
170418832|NCT02720510|615873380|FG001|Overall Study|Study Terminated by the sponsor|0|||
170418833|NCT02720510|615873379|FG000|Overall Study|Adverse Event|0|||
170418834|NCT02720510|615873380|FG001|Overall Study|Adverse Event|1|||
170418835|NCT02720510|615873379|FG000|Overall Study|Physician Decision|1|||
170418836|NCT02720510|615873380|FG001|Overall Study|Physician Decision|2|||
170418837|NCT01604850|615873381|FG000|Overall Study|Enrolled but never treated|0|||
170418838|NCT01604850|615873382|FG001|Overall Study|Enrolled but never treated|1|||
170418839|NCT01604850|615873381|FG000|Overall Study|Efficacy Failure|50|||
170418840|NCT01604850|615873382|FG001|Overall Study|Efficacy Failure|29|||
170418841|NCT01604850|615873381|FG000|Overall Study|Lost to Follow-up|1|||
170418842|NCT01604850|615873382|FG001|Overall Study|Lost to Follow-up|0|||
170418843|NCT01604850|615873381|FG000|Overall Study|Subject withdrew consent|1|||
170418844|NCT01604850|615873382|FG001|Overall Study|Subject withdrew consent|0|||
170418845|NCT01153984|615873383|FG000|Overall Study|Withdrawal by Subject|1|||
170418846|NCT01153984|615873383|FG000|Overall Study|Adverse Event|1|||
170418847|NCT01703832|615873384|FG000|Overall Study|Withdrawal by Subject|1|||
170418848|NCT01703832|615873385|FG001|Overall Study|Withdrawal by Subject|0|||
170418849|NCT05518487|615873386|FG000|Overall Study|Withdrawal by Subject|3|||
170530660|NCT04006457|616291340|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
170530661|NCT04006457|616291341|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
170530662|NCT04006457|616291342|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
170530663|NCT04006457|616291340|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
170530664|NCT04006457|616291341|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
170530665|NCT04006457|616291342|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
170530666|NCT04006457|616291340|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
170530667|NCT04006457|616291341|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
170530668|NCT04006457|616291342|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
170530669|NCT04006457|616291340|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
170530670|NCT04006457|616291341|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
170530671|NCT04006457|616291342|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
170530672|NCT04006457|616291340|FG000|Main Study: Treatment Period 2|Other|2|||
170530673|NCT04006457|616291341|FG001|Main Study: Treatment Period 2|Other|3|||
170530674|NCT04006457|616291342|FG002|Main Study: Treatment Period 2|Other|0|||
170530675|NCT04006457|616291340|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
170530676|NCT04006457|616291341|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
170530677|NCT04006457|616291342|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
170530678|NCT04006457|616291340|FG000|Main Study: Treatment Period 2|Ongoing|86|||
170530679|NCT04006457|616291341|FG001|Main Study: Treatment Period 2|Ongoing|96|||
170530680|NCT04006457|616291342|FG002|Main Study: Treatment Period 2|Ongoing|0|||
170530681|NCT04006457|616291340|FG000|Main Study Observation Period|Adverse Event|1|||
170530682|NCT04006457|616291341|FG001|Main Study Observation Period|Adverse Event|1|||
170530683|NCT04006457|616291342|FG002|Main Study Observation Period|Adverse Event|0|||
170530684|NCT04006457|616291340|FG000|Main Study Observation Period|Lost to Follow-up|0|||
170530685|NCT04006457|616291341|FG001|Main Study Observation Period|Lost to Follow-up|1|||
170530686|NCT04006457|616291342|FG002|Main Study Observation Period|Lost to Follow-up|0|||
170530687|NCT04006457|616291340|FG000|Main Study Observation Period|Pregnancy|1|||
170530688|NCT04006457|616291341|FG001|Main Study Observation Period|Pregnancy|0|||
170530689|NCT04006457|616291342|FG002|Main Study Observation Period|Pregnancy|0|||
170530690|NCT04006457|616291340|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
170530691|NCT04006457|616291341|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
170530692|NCT04006457|616291342|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
170530693|NCT04006457|616291340|FG000|Main Study Observation Period|Other|8|||
170530694|NCT04006457|616291341|FG001|Main Study Observation Period|Other|16|||
170530695|NCT04006457|616291342|FG002|Main Study Observation Period|Other|0|||
170530696|NCT04006457|616291340|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
170530697|NCT04006457|616291341|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
170530698|NCT04006457|616291342|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
170530699|NCT04006457|616291340|FG000|Main Study Observation Period|Ongoing|2|||
170530700|NCT04006457|616291341|FG001|Main Study Observation Period|Ongoing|1|||
170530701|NCT04006457|616291342|FG002|Main Study Observation Period|Ongoing|0|||
170530702|NCT04006457|616291340|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
170530703|NCT04006457|616291341|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
170530704|NCT04006457|616291342|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
170530705|NCT05918055|616291343|FG000|Phase I - Dose Level 1|Ineligible|0|||
170530706|NCT05918055|616291344|FG001|Phase I - Dose Level 1|Ineligible|0|||
170530707|NCT05918055|616291345|FG002|Phase I - Dose Level 1|Ineligible|1|||
170530708|NCT05918055|616291343|FG000|Phase I - Dose Level -1|Physician Decision|1|||
170530709|NCT05918055|616291344|FG001|Phase I - Dose Level -1|Physician Decision|0|||
170530710|NCT05918055|616291345|FG002|Phase I - Dose Level -1|Physician Decision|0|||
170418850|NCT01458405|615873394|FG000|Phase 1 (up to 12 Months)|Other|0|||
170418851|NCT01458405|615873395|FG001|Phase 1 (up to 12 Months)|Other|1|||
170418852|NCT01458405|615873396|FG002|Phase 1 (up to 12 Months)|Other|0|||
170418853|NCT01458405|615873397|FG003|Phase 1 (up to 12 Months)|Other|0|||
170418854|NCT01458405|615873394|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
170418855|NCT01458405|615873395|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
170418856|NCT01458405|615873396|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
170530711|NCT04460885|616291352|FG000|Overall Study|Withdrawal by Subject|6|||
170530712|NCT04460885|616291353|FG001|Overall Study|Withdrawal by Subject|8|||
170530713|NCT04460885|616291352|FG000|Overall Study|Site closure|1|||
170418857|NCT01458405|615873397|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
170530714|NCT04460885|616291353|FG001|Overall Study|Site closure|0|||
170530715|NCT04460885|616291352|FG000|Overall Study|Death|5|||
170530716|NCT04460885|616291353|FG001|Overall Study|Death|4|||
170530717|NCT04460885|616291352|FG000|Overall Study|Physician Decision|2|||
170418858|NCT01458405|615873394|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
170530718|NCT04460885|616291353|FG001|Overall Study|Physician Decision|1|||
170530719|NCT04460885|616291352|FG000|Overall Study|Lost to Follow-up|4|||
170530720|NCT04460885|616291353|FG001|Overall Study|Lost to Follow-up|4|||
170530721|NCT01721798|616291356|FG000|Overall Study|Death|0|||
170530722|NCT01721798|616291357|FG001|Overall Study|Death|0|||
170530723|NCT01721798|616291358|FG002|Overall Study|Death|1|||
170530724|NCT01721798|616291359|FG003|Overall Study|Death|1|||
170530725|NCT01721798|616291356|FG000|Overall Study|Lost to Follow-up|2|||
170530726|NCT01721798|616291357|FG001|Overall Study|Lost to Follow-up|2|||
170530727|NCT01721798|616291358|FG002|Overall Study|Lost to Follow-up|9|||
170530728|NCT01721798|616291359|FG003|Overall Study|Lost to Follow-up|9|||
170530729|NCT01721798|616291356|FG000|Overall Study|Pregnancy|0|||
170530730|NCT01721798|616291357|FG001|Overall Study|Pregnancy|0|||
170530731|NCT01721798|616291358|FG002|Overall Study|Pregnancy|1|||
170530732|NCT01721798|616291359|FG003|Overall Study|Pregnancy|1|||
170530733|NCT01721798|616291356|FG000|Overall Study|Withdrawal by Subject|1|||
170530734|NCT01721798|616291357|FG001|Overall Study|Withdrawal by Subject|0|||
170530735|NCT01721798|616291358|FG002|Overall Study|Withdrawal by Subject|2|||
170530736|NCT01721798|616291359|FG003|Overall Study|Withdrawal by Subject|1|||
170530737|NCT01721798|616291356|FG000|Overall Study|Not eligible for 24 month visit|1|||
170530738|NCT01721798|616291357|FG001|Overall Study|Not eligible for 24 month visit|0|||
170530739|NCT01721798|616291358|FG002|Overall Study|Not eligible for 24 month visit|8|||
170530740|NCT01721798|616291359|FG003|Overall Study|Not eligible for 24 month visit|7|||
170530741|NCT00336544|616291360|FG000|Overall Study|Lack of Efficacy|8|||
170530742|NCT00336544|616291361|FG001|Overall Study|Lack of Efficacy|5|||
170530743|NCT00336544|616291360|FG000|Overall Study|Adverse Event|4|||
170530744|NCT00336544|616291361|FG001|Overall Study|Adverse Event|9|||
170530745|NCT00336544|616291360|FG000|Overall Study|Withdrawal by Subject|4|||
170530746|NCT00336544|616291361|FG001|Overall Study|Withdrawal by Subject|3|||
170530747|NCT00336544|616291360|FG000|Overall Study|Other|3|||
170530748|NCT00336544|616291361|FG001|Overall Study|Other|5|||
170530749|NCT01648764|616291362|FG000|Overall Study|Progressive Disease|0|||
170530750|NCT01648764|616291363|FG001|Overall Study|Progressive Disease|1|||
170530751|NCT01648764|616291364|FG002|Overall Study|Progressive Disease|0|||
170530752|NCT01648764|616291365|FG003|Overall Study|Progressive Disease|0|||
170530753|NCT01648764|616291366|FG004|Overall Study|Progressive Disease|0|||
170530754|NCT01648764|616291367|FG005|Overall Study|Progressive Disease|1|||
170530755|NCT01648764|616291368|FG006|Overall Study|Progressive Disease|1|||
170530756|NCT01648764|616291369|FG007|Overall Study|Progressive Disease|0|||
170530757|NCT01648764|616291370|FG008|Overall Study|Progressive Disease|0|||
170530758|NCT01648764|616291371|FG009|Overall Study|Progressive Disease|2|||
170530759|NCT01648764|616291372|FG010|Overall Study|Progressive Disease|0|||
170530760|NCT01648764|616291373|FG011|Overall Study|Progressive Disease|1|||
170530761|NCT01648764|616291374|FG012|Overall Study|Progressive Disease|2|||
170530762|NCT01648764|616291375|FG013|Overall Study|Progressive Disease|1|||
170530763|NCT01648764|616291362|FG000|Overall Study|Adverse Event|0|||
170530764|NCT01648764|616291363|FG001|Overall Study|Adverse Event|0|||
170530765|NCT01648764|616291364|FG002|Overall Study|Adverse Event|0|||
170530766|NCT01648764|616291365|FG003|Overall Study|Adverse Event|0|||
170530767|NCT01648764|616291366|FG004|Overall Study|Adverse Event|0|||
170530768|NCT01648764|616291367|FG005|Overall Study|Adverse Event|1|||
170530769|NCT01648764|616291368|FG006|Overall Study|Adverse Event|0|||
170530770|NCT01648764|616291369|FG007|Overall Study|Adverse Event|0|||
170530771|NCT01648764|616291370|FG008|Overall Study|Adverse Event|0|||
170530772|NCT01648764|616291371|FG009|Overall Study|Adverse Event|1|||
170530773|NCT01648764|616291372|FG010|Overall Study|Adverse Event|0|||
170530774|NCT01648764|616291373|FG011|Overall Study|Adverse Event|3|||
170530775|NCT01648764|616291374|FG012|Overall Study|Adverse Event|1|||
170530776|NCT01648764|616291375|FG013|Overall Study|Adverse Event|1|||
170530777|NCT01648764|616291362|FG000|Overall Study|Death|0|||
170530778|NCT01648764|616291363|FG001|Overall Study|Death|0|||
170530779|NCT01648764|616291364|FG002|Overall Study|Death|0|||
170530780|NCT01648764|616291365|FG003|Overall Study|Death|0|||
170530781|NCT01648764|616291366|FG004|Overall Study|Death|0|||
170530782|NCT01648764|616291367|FG005|Overall Study|Death|0|||
170530783|NCT01648764|616291368|FG006|Overall Study|Death|1|||
170530784|NCT01648764|616291369|FG007|Overall Study|Death|0|||
170530785|NCT01648764|616291370|FG008|Overall Study|Death|0|||
170530786|NCT01648764|616291371|FG009|Overall Study|Death|0|||
170530787|NCT01648764|616291372|FG010|Overall Study|Death|0|||
170530788|NCT01648764|616291373|FG011|Overall Study|Death|0|||
170530789|NCT01648764|616291374|FG012|Overall Study|Death|0|||
170530790|NCT01648764|616291375|FG013|Overall Study|Death|1|||
170530791|NCT01648764|616291362|FG000|Overall Study|Withdrawal by Subject|0|||
170530792|NCT01648764|616291363|FG001|Overall Study|Withdrawal by Subject|0|||
170530793|NCT01648764|616291364|FG002|Overall Study|Withdrawal by Subject|0|||
170530794|NCT01648764|616291365|FG003|Overall Study|Withdrawal by Subject|0|||
170530795|NCT01648764|616291366|FG004|Overall Study|Withdrawal by Subject|0|||
170778278|NCT03416010|617195558|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
170530796|NCT01648764|616291367|FG005|Overall Study|Withdrawal by Subject|0|||
170530797|NCT01648764|616291368|FG006|Overall Study|Withdrawal by Subject|2|||
170530798|NCT01648764|616291369|FG007|Overall Study|Withdrawal by Subject|0|||
170530799|NCT01648764|616291370|FG008|Overall Study|Withdrawal by Subject|0|||
170530800|NCT01648764|616291371|FG009|Overall Study|Withdrawal by Subject|0|||
170530801|NCT01648764|616291372|FG010|Overall Study|Withdrawal by Subject|0|||
170530802|NCT01648764|616291373|FG011|Overall Study|Withdrawal by Subject|0|||
170530803|NCT01648764|616291374|FG012|Overall Study|Withdrawal by Subject|1|||
170530804|NCT01648764|616291375|FG013|Overall Study|Withdrawal by Subject|0|||
170530805|NCT01648764|616291362|FG000|Overall Study|Investigator Decision|0|||
170530806|NCT01648764|616291363|FG001|Overall Study|Investigator Decision|0|||
170530807|NCT01648764|616291364|FG002|Overall Study|Investigator Decision|0|||
170530808|NCT01648764|616291365|FG003|Overall Study|Investigator Decision|0|||
170530809|NCT01648764|616291366|FG004|Overall Study|Investigator Decision|0|||
170530810|NCT01648764|616291367|FG005|Overall Study|Investigator Decision|0|||
170530811|NCT01648764|616291368|FG006|Overall Study|Investigator Decision|1|||
170530812|NCT01648764|616291369|FG007|Overall Study|Investigator Decision|0|||
170530813|NCT01648764|616291370|FG008|Overall Study|Investigator Decision|0|||
170530814|NCT01648764|616291371|FG009|Overall Study|Investigator Decision|0|||
170530815|NCT01648764|616291372|FG010|Overall Study|Investigator Decision|0|||
170530816|NCT01648764|616291373|FG011|Overall Study|Investigator Decision|1|||
170530817|NCT01648764|616291374|FG012|Overall Study|Investigator Decision|0|||
170530818|NCT01648764|616291375|FG013|Overall Study|Investigator Decision|0|||
170530819|NCT03427411|616291376|FG000|Overall Study|Screen failure - platelets too low|0|||
170530820|NCT03427411|616291377|FG001|Overall Study|Screen failure - platelets too low|1|||
170530821|NCT01294046|616291378|FG000|Overall Study|Infection and surgical explant|1|||
170530822|NCT01294046|616291378|FG000|Overall Study|Eligibility criteria expanded|1|||
170530823|NCT01294046|616291378|FG000|Overall Study|Stimulation response inadqequate|1|||
170530824|NCT03183908|616291379|FG000|Overall Study|Missing Symptom Diary Data|0|||
170530825|NCT03183908|616291380|FG001|Overall Study|Missing Symptom Diary Data|2|||
170530826|NCT00656617|616291383|FG000|Overall Study|Adverse Event|1|||
170530827|NCT00656617|616291383|FG000|Overall Study|Death|2|||
170530828|NCT00656617|616291383|FG000|Overall Study|Insurance Issues|2|||
170530829|NCT00656617|616291383|FG000|Overall Study|Move to different clinical trial|2|||
170530830|NCT01712178|616291384|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
170530831|NCT01712178|616291385|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
170530832|NCT01712178|616291384|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
170530833|NCT01712178|616291385|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
170530834|NCT01712178|616291384|FG000|Overall Study|Lost to Follow-up|0|||
170530835|NCT01712178|616291385|FG001|Overall Study|Lost to Follow-up|1|||
170530836|NCT00091819|616291386|FG000|Overall Study|Adverse Event|1|||
170530837|NCT00091819|616291387|FG001|Overall Study|Adverse Event|1|||
170530838|NCT00091819|616291386|FG000|Overall Study|Death|4|||
170530839|NCT00091819|616291387|FG001|Overall Study|Death|5|||
170530840|NCT00091819|616291386|FG000|Overall Study|Lost to Follow-up|26|||
170530841|NCT00091819|616291387|FG001|Overall Study|Lost to Follow-up|23|||
170530842|NCT00091819|616291386|FG000|Overall Study|Withdrawal by Subject|5|||
170530843|NCT00091819|616291387|FG001|Overall Study|Withdrawal by Subject|8|||
170530844|NCT00091819|616291386|FG000|Overall Study|Protocol Violation|1|||
170530845|NCT00091819|616291387|FG001|Overall Study|Protocol Violation|2|||
170530846|NCT00091819|616291386|FG000|Overall Study|Other|2|||
170418859|NCT01458405|615873395|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
170418860|NCT01458405|615873396|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
170418861|NCT01458405|615873397|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
170418862|NCT01458405|615873394|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
170418863|NCT01458405|615873395|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
170418864|NCT01458405|615873396|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
170418865|NCT01458405|615873397|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
170418866|NCT01618266|615873401|FG000|Overall Study|Lost to Follow-up|9|||
170418867|NCT01618266|615873401|FG000|Overall Study|Treatment satisfaction|10|||
170418868|NCT01618266|615873401|FG000|Overall Study|Other reasons|11|||
170418869|NCT01618266|615873401|FG000|Overall Study|Lack of Efficacy|23|||
170418870|NCT01618266|615873401|FG000|Overall Study|Protocol Violation|43|||
170418871|NCT01400113|615873402|FG000|Overall Study|Withdrawal by Subject|1|||
170418872|NCT01400113|615873403|FG001|Overall Study|Withdrawal by Subject|1|||
170418873|NCT00282256|615873404|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
170418874|NCT00282256|615873404|FG000|Extension Treatment Period|Adverse Event|2|||
170418875|NCT00525590|615873409|FG000|Overall Study|Adverse Event|3|||
170418876|NCT00525590|615873409|FG000|Overall Study|Physician Decision|3|||
170530847|NCT00091819|616291387|FG001|Overall Study|Other|3|||
170530848|NCT00091819|616291386|FG000|Overall Study|Never received study treatment|3|||
170418877|NCT00525590|615873409|FG000|Overall Study|Withdrawal by Subject|16|||
170530849|NCT00091819|616291387|FG001|Overall Study|Never received study treatment|4|||
170530850|NCT04810962|616291388|FG000|Overall Study|Adverse Event|0|||
170530851|NCT04810962|616291389|FG001|Overall Study|Adverse Event|1|||
170530852|NCT04810962|616291388|FG000|Overall Study|Lost to Follow-up|2|||
170418878|NCT00525590|615873409|FG000|Overall Study|Lost to Follow-up|1|||
170418879|NCT00525590|615873409|FG000|Overall Study|Death|9|||
170530853|NCT04810962|616291389|FG001|Overall Study|Lost to Follow-up|1|||
170530854|NCT04810962|616291388|FG000|Overall Study|Physician Decision|1|||
170530855|NCT04810962|616291389|FG001|Overall Study|Physician Decision|0|||
170530856|NCT04810962|616291388|FG000|Overall Study|Withdrawal by Subject|1|||
170530857|NCT04810962|616291389|FG001|Overall Study|Withdrawal by Subject|3|||
170530858|NCT04810962|616291388|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
170530859|NCT04810962|616291389|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
170530860|NCT05911841|616291393|FG000|Induction Period|Study Terminated by Sponsor|2|||
170530861|NCT05911841|616291394|FG001|Induction Period|Study Terminated by Sponsor|0|||
170530862|NCT05911841|616291395|FG002|Induction Period|Study Terminated by Sponsor|14|||
170530863|NCT05911841|616291396|FG003|Induction Period|Study Terminated by Sponsor|6|||
170530864|NCT05911841|616291397|FG004|Induction Period|Study Terminated by Sponsor|0|||
170530865|NCT05911841|616291398|FG005|Induction Period|Study Terminated by Sponsor|0|||
170530866|NCT05911841|616291399|FG006|Induction Period|Study Terminated by Sponsor|0|||
170530867|NCT05911841|616291400|FG007|Induction Period|Study Terminated by Sponsor|0|||
170530868|NCT05911841|616291401|FG008|Induction Period|Study Terminated by Sponsor|0|||
170530869|NCT05911841|616291402|FG009|Induction Period|Study Terminated by Sponsor|0|||
170530870|NCT05911841|616291393|FG000|Induction Period|Withdrawal by Subject|4|||
170530871|NCT05911841|616291394|FG001|Induction Period|Withdrawal by Subject|3|||
170530872|NCT05911841|616291395|FG002|Induction Period|Withdrawal by Subject|4|||
170530873|NCT05911841|616291396|FG003|Induction Period|Withdrawal by Subject|6|||
170530874|NCT05911841|616291397|FG004|Induction Period|Withdrawal by Subject|0|||
170530875|NCT05911841|616291398|FG005|Induction Period|Withdrawal by Subject|0|||
170530876|NCT05911841|616291399|FG006|Induction Period|Withdrawal by Subject|0|||
170530877|NCT05911841|616291400|FG007|Induction Period|Withdrawal by Subject|0|||
170530878|NCT05911841|616291401|FG008|Induction Period|Withdrawal by Subject|0|||
170530879|NCT05911841|616291402|FG009|Induction Period|Withdrawal by Subject|0|||
170530880|NCT05911841|616291393|FG000|Induction Period|Lack of Efficacy|3|||
170530881|NCT05911841|616291394|FG001|Induction Period|Lack of Efficacy|0|||
170530882|NCT05911841|616291395|FG002|Induction Period|Lack of Efficacy|3|||
170530883|NCT05911841|616291396|FG003|Induction Period|Lack of Efficacy|3|||
170530884|NCT05911841|616291397|FG004|Induction Period|Lack of Efficacy|0|||
170530885|NCT05911841|616291398|FG005|Induction Period|Lack of Efficacy|0|||
170530886|NCT05911841|616291399|FG006|Induction Period|Lack of Efficacy|0|||
170530887|NCT05911841|616291400|FG007|Induction Period|Lack of Efficacy|0|||
170530888|NCT05911841|616291401|FG008|Induction Period|Lack of Efficacy|0|||
170530889|NCT05911841|616291402|FG009|Induction Period|Lack of Efficacy|0|||
170530890|NCT05911841|616291393|FG000|Induction Period|Adverse Event|3|||
170530891|NCT05911841|616291394|FG001|Induction Period|Adverse Event|1|||
170530892|NCT05911841|616291395|FG002|Induction Period|Adverse Event|2|||
170530893|NCT05911841|616291396|FG003|Induction Period|Adverse Event|0|||
170530894|NCT05911841|616291397|FG004|Induction Period|Adverse Event|0|||
170530895|NCT05911841|616291398|FG005|Induction Period|Adverse Event|0|||
170530896|NCT05911841|616291399|FG006|Induction Period|Adverse Event|0|||
170530897|NCT05911841|616291400|FG007|Induction Period|Adverse Event|0|||
170530898|NCT05911841|616291401|FG008|Induction Period|Adverse Event|0|||
170530899|NCT05911841|616291402|FG009|Induction Period|Adverse Event|0|||
170530900|NCT05911841|616291393|FG000|Induction Period|Assigned Treatment by Mistake|0|||
170530901|NCT05911841|616291394|FG001|Induction Period|Assigned Treatment by Mistake|1|||
170530902|NCT05911841|616291395|FG002|Induction Period|Assigned Treatment by Mistake|0|||
170530903|NCT05911841|616291396|FG003|Induction Period|Assigned Treatment by Mistake|1|||
170530904|NCT05911841|616291397|FG004|Induction Period|Assigned Treatment by Mistake|0|||
170530905|NCT05911841|616291398|FG005|Induction Period|Assigned Treatment by Mistake|0|||
170530906|NCT05911841|616291399|FG006|Induction Period|Assigned Treatment by Mistake|0|||
170530907|NCT05911841|616291400|FG007|Induction Period|Assigned Treatment by Mistake|0|||
170530908|NCT05911841|616291401|FG008|Induction Period|Assigned Treatment by Mistake|0|||
170530909|NCT05911841|616291402|FG009|Induction Period|Assigned Treatment by Mistake|0|||
170530910|NCT05911841|616291393|FG000|Induction Period|Lost to Follow-up|0|||
170530911|NCT05911841|616291394|FG001|Induction Period|Lost to Follow-up|0|||
170530912|NCT05911841|616291395|FG002|Induction Period|Lost to Follow-up|1|||
170530913|NCT05911841|616291396|FG003|Induction Period|Lost to Follow-up|1|||
170530914|NCT05911841|616291397|FG004|Induction Period|Lost to Follow-up|0|||
170530915|NCT05911841|616291398|FG005|Induction Period|Lost to Follow-up|0|||
170530916|NCT05911841|616291399|FG006|Induction Period|Lost to Follow-up|0|||
170530917|NCT05911841|616291400|FG007|Induction Period|Lost to Follow-up|0|||
170530918|NCT05911841|616291401|FG008|Induction Period|Lost to Follow-up|0|||
170632628|NCT01352793|616666715|FG000|Overall Study|No longer meets eligibility criteria|25|||
170632629|NCT01352793|616666716|FG001|Overall Study|No longer meets eligibility criteria|15|||
170632630|NCT01929317|616666723|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
170632631|NCT01929317|616666724|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
170778279|NCT03416010|617195557|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
170530919|NCT05911841|616291402|FG009|Induction Period|Lost to Follow-up|0|||
170530920|NCT05911841|616291393|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
170877817|NCT00804570|617563987|FG000|Overall Study|Withdrawal by Subject|21|||
170877818|NCT00804570|617563988|FG001|Overall Study|Withdrawal by Subject|38|||
170877819|NCT00290342|617563989|FG000|Overall Study|Other|0|||
170877820|NCT00290342|617563990|FG001|Overall Study|Other|1|||
170877821|NCT00290342|617563989|FG000|Overall Study|Withdrawal by Subject|6|||
170877822|NCT00290342|617563990|FG001|Overall Study|Withdrawal by Subject|4|||
170877823|NCT00290342|617563989|FG000|Overall Study|Lost to Follow-up|1|||
170877824|NCT00290342|617563990|FG001|Overall Study|Lost to Follow-up|0|||
170877825|NCT01056510|617563993|FG000|Overall Study|Dropout Before Start of Treatment|1|||
170877826|NCT01056510|617563994|FG001|Overall Study|Dropout Before Start of Treatment|1|||
170877827|NCT01056510|617563993|FG000|Overall Study|Withdrawal by Subject|4|||
170877828|NCT01056510|617563994|FG001|Overall Study|Withdrawal by Subject|2|||
170877829|NCT01056510|617563993|FG000|Overall Study|Death|29|||
170877830|NCT01056510|617563994|FG001|Overall Study|Death|34|||
170877831|NCT01056510|617563993|FG000|Overall Study|Noncompliance|1|||
170418880|NCT00525590|615873409|FG000|Overall Study|Other|13|||
170418881|NCT02674334|615873414|FG000|Overall Study|Lost to Follow-up|5|||
170418882|NCT02674334|615873415|FG001|Overall Study|Lost to Follow-up|3|||
170418883|NCT02674334|615873414|FG000|Overall Study|participant difficulty breathing|1|||
170418884|NCT02674334|615873415|FG001|Overall Study|participant difficulty breathing|0|||
170418885|NCT02674334|615873414|FG000|Overall Study|NIRS not recording|1|||
170418886|NCT02674334|615873415|FG001|Overall Study|NIRS not recording|0|||
170418887|NCT02636907|615873419|FG000|Autoinjector Assessment Period|Adverse Event|2|||
170418888|NCT02636907|615873419|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
170418889|NCT02636907|615873419|FG000|Extension Phase|Adverse Event|2|||
170418890|NCT02636907|615873419|FG000|Extension Phase|Withdrawal by Subject|4|||
170418891|NCT02636907|615873419|FG000|Extension Phase|Physician Decision|1|||
170418892|NCT02636907|615873419|FG000|Extension Phase|Lost to Follow-up|2|||
170418893|NCT02636907|615873419|FG000|Extension Phase|Lack of Efficacy|1|||
170418894|NCT00762086|615873420|FG000|Overall Study|Adverse Event|2|||
170418895|NCT00762086|615873421|FG001|Overall Study|Adverse Event|0|||
170418896|NCT00762086|615873420|FG000|Overall Study|Lost to Follow-up|0|||
170418897|NCT00762086|615873421|FG001|Overall Study|Lost to Follow-up|2|||
170418898|NCT00762086|615873420|FG000|Overall Study|Non compliance|1|||
170418899|NCT00762086|615873421|FG001|Overall Study|Non compliance|0|||
170418900|NCT00762086|615873420|FG000|Overall Study|Withdrawal by Subject|2|||
170418901|NCT00762086|615873421|FG001|Overall Study|Withdrawal by Subject|2|||
170418902|NCT00762086|615873420|FG000|Overall Study|Ineligible to participate in the study|1|||
170418903|NCT00762086|615873421|FG001|Overall Study|Ineligible to participate in the study|0|||
170418904|NCT00661999|615873430|FG000|Overall Study|Adverse Event|11|||
170418905|NCT00661999|615873431|FG001|Overall Study|Adverse Event|5|||
170418906|NCT00661999|615873432|FG002|Overall Study|Adverse Event|8|||
170418907|NCT00661999|615873430|FG000|Overall Study|Death|8|||
170418908|NCT00661999|615873431|FG001|Overall Study|Death|6|||
170418909|NCT00661999|615873432|FG002|Overall Study|Death|3|||
170418910|NCT00661999|615873430|FG000|Overall Study|Other Reasons|5|||
170418911|NCT00661999|615873431|FG001|Overall Study|Other Reasons|12|||
170418912|NCT00661999|615873432|FG002|Overall Study|Other Reasons|23|||
170418913|NCT00661999|615873430|FG000|Overall Study|Withdrawal by Subject|30|||
170418914|NCT00661999|615873431|FG001|Overall Study|Withdrawal by Subject|23|||
170418915|NCT00661999|615873432|FG002|Overall Study|Withdrawal by Subject|14|||
170418916|NCT00661999|615873430|FG000|Overall Study|Alternative Treatment|1|||
170418917|NCT00661999|615873431|FG001|Overall Study|Alternative Treatment|0|||
170418918|NCT00661999|615873432|FG002|Overall Study|Alternative Treatment|0|||
170418919|NCT00661999|615873430|FG000|Overall Study|Other Medical Problems|4|||
170418920|NCT00661999|615873431|FG001|Overall Study|Other Medical Problems|4|||
170418921|NCT00661999|615873432|FG002|Overall Study|Other Medical Problems|9|||
170418922|NCT01139164|615873435|FG000|Overall Study|Withdrawn prior to study start|0|||
170418923|NCT01139164|615873436|FG001|Overall Study|Withdrawn prior to study start|2|||
170418924|NCT01139164|615873437|FG002|Overall Study|Withdrawn prior to study start|0|||
170418925|NCT01790568|615873438|FG000|Overall Study|Progression prior to transplant|0|||
170418926|NCT01790568|615873439|FG001|Overall Study|Progression prior to transplant|1|||
170418927|NCT00264810|615873440|FG000|Baseline|Withdrawal by Subject|10|||
170418928|NCT00264810|615873441|FG001|Baseline|Withdrawal by Subject|10|||
170418929|NCT00264810|615873440|FG000|Baseline|Physician Decision|7|||
170418930|NCT00264810|615873441|FG001|Baseline|Physician Decision|8|||
170418931|NCT00264810|615873440|FG000|Baseline|Subject Compliance Failure|3|||
170418932|NCT00264810|615873441|FG001|Baseline|Subject Compliance Failure|3|||
170418933|NCT00264810|615873440|FG000|Baseline|Insufficient Seizure Frequency|2|||
170418934|NCT00264810|615873441|FG001|Baseline|Insufficient Seizure Frequency|2|||
170418935|NCT00264810|615873440|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
170418936|NCT00264810|615873441|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
170877832|NCT01056510|617563994|FG001|Overall Study|Noncompliance|3|||
170418937|NCT00264810|615873440|FG000|Baseline|Other|0|||
170418938|NCT00264810|615873441|FG001|Baseline|Other|1|||
170877833|NCT01056510|617563993|FG000|Overall Study|Physician Decision|4|||
170877834|NCT01056510|617563994|FG001|Overall Study|Physician Decision|5|||
170877835|NCT01056510|617563993|FG000|Overall Study|Lost to Follow-up|5|||
170877836|NCT01056510|617563994|FG001|Overall Study|Lost to Follow-up|6|||
170877837|NCT01056510|617563993|FG000|Overall Study|Other|10|||
170877838|NCT01056510|617563994|FG001|Overall Study|Other|12|||
170877839|NCT01056510|617563993|FG000|Overall Study|Missing|0|||
170877840|NCT01056510|617563994|FG001|Overall Study|Missing|1|||
170877841|NCT00912028|617563995|FG000|Overall Study|Lost to Follow-up|2|||
170877842|NCT00912028|617563996|FG001|Overall Study|Lost to Follow-up|3|||
170877843|NCT00912028|617563997|FG002|Overall Study|Lost to Follow-up|0|||
170877844|NCT00912028|617563998|FG003|Overall Study|Lost to Follow-up|1|||
170877845|NCT00912028|617563999|FG004|Overall Study|Lost to Follow-up|3|||
170877846|NCT00912028|617563995|FG000|Overall Study|Withdrawal by Subject|3|||
170877847|NCT00912028|617563996|FG001|Overall Study|Withdrawal by Subject|0|||
170877848|NCT00912028|617563997|FG002|Overall Study|Withdrawal by Subject|0|||
170877849|NCT00912028|617563998|FG003|Overall Study|Withdrawal by Subject|0|||
170877850|NCT00912028|617563999|FG004|Overall Study|Withdrawal by Subject|0|||
170877851|NCT02285998|617564000|FG000|Overall Study|Adverse Event|9|||
170877852|NCT02285998|617564001|FG001|Overall Study|Adverse Event|8|||
170877853|NCT02285998|617564000|FG000|Overall Study|Physician Decision|1|||
170877854|NCT02285998|617564001|FG001|Overall Study|Physician Decision|2|||
170877855|NCT02285998|617564000|FG000|Overall Study|Lost to Follow-up|176|||
170877856|NCT02285998|617564001|FG001|Overall Study|Lost to Follow-up|172|||
170877857|NCT02285998|617564000|FG000|Overall Study|Withdrawal by Subject|53|||
170877858|NCT02285998|617564001|FG001|Overall Study|Withdrawal by Subject|61|||
170877859|NCT02285998|617564000|FG000|Overall Study|Other Reasons|7|||
170877860|NCT02285998|617564001|FG001|Overall Study|Other Reasons|10|||
170877861|NCT02830776|617564002|FG000|Overall Study|Lost to Follow-up|1|||
170877862|NCT01793142|617564003|FG000|Overall Study|Randomized not treated|7|||
170877863|NCT00961220|617564008|FG000|Overall Study|Adverse Event|3|||
170877864|NCT00961220|617564008|FG000|Overall Study|Lack of Efficacy|1|||
170877865|NCT00961220|617564008|FG000|Overall Study|No IV access for O6BG|1|||
170877866|NCT00961220|617564008|FG000|Overall Study|O6BG no longer supplied|1|||
170877867|NCT00961220|617564008|FG000|Overall Study|Complete Response prior to 12 courses|1|||
170877868|NCT05376215|617564009|FG000|Overall Study|Withdrawal by Subject|2|||
170877869|NCT05376215|617564010|FG001|Overall Study|Withdrawal by Subject|1|||
170877870|NCT05376215|617564009|FG000|Overall Study|Lost to Follow-up|0|||
170877871|NCT05376215|617564010|FG001|Overall Study|Lost to Follow-up|1|||
170877872|NCT01301950|617564011|FG000|Overall Study|Surgery was cancelled by patient|0|||
170877873|NCT01301950|617564012|FG001|Overall Study|Surgery was cancelled by patient|1|||
170877874|NCT00942175|617564013|FG000|Overall Study|Adverse Event|2|||
170877875|NCT00942175|617564014|FG001|Overall Study|Adverse Event|1|||
170877876|NCT00942175|617564015|FG002|Overall Study|Adverse Event|0|||
170877877|NCT00942175|617564016|FG003|Overall Study|Adverse Event|0|||
170877878|NCT00942175|617564013|FG000|Overall Study|Protocol Violation|0|||
170877879|NCT00942175|617564014|FG001|Overall Study|Protocol Violation|1|||
170877880|NCT00942175|617564015|FG002|Overall Study|Protocol Violation|2|||
170877881|NCT00942175|617564016|FG003|Overall Study|Protocol Violation|0|||
170877882|NCT00942175|617564013|FG000|Overall Study|Pregnancy|0|||
170877883|NCT00942175|617564014|FG001|Overall Study|Pregnancy|0|||
170877884|NCT00942175|617564015|FG002|Overall Study|Pregnancy|0|||
170877885|NCT00942175|617564016|FG003|Overall Study|Pregnancy|1|||
170877886|NCT00942175|617564013|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
170877887|NCT00942175|617564014|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
170877888|NCT00942175|617564015|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
170877889|NCT00942175|617564016|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
170877890|NCT00942175|617564013|FG000|Overall Study|Low Platelet Count|0|||
170877891|NCT00942175|617564014|FG001|Overall Study|Low Platelet Count|2|||
170877892|NCT00942175|617564015|FG002|Overall Study|Low Platelet Count|0|||
170877893|NCT00942175|617564016|FG003|Overall Study|Low Platelet Count|0|||
170877894|NCT01066585|617564017|FG000|Overall Study|Protocol Violation|1|||
170877895|NCT01066585|617564018|FG001|Overall Study|Protocol Violation|0|||
170877896|NCT01066585|617564017|FG000|Overall Study|Withdrawal by Subject|0|||
170877897|NCT01066585|617564018|FG001|Overall Study|Withdrawal by Subject|3|||
170877898|NCT04041284|617564020|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
170877899|NCT04041284|617564021|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
170877900|NCT04041284|617564020|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
170877901|NCT04041284|617564021|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
170877902|NCT04041284|617564020|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
170877903|NCT04041284|617564021|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
170877904|NCT04041284|617564020|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
170877905|NCT04041284|617564021|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
170877906|NCT04041284|617564020|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
170877907|NCT04041284|617564021|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
170877908|NCT04041284|617564020|FG000|DB Phase (12 Weeks)|Other than specified|1|||
170877909|NCT04041284|617564021|FG001|DB Phase (12 Weeks)|Other than specified|0|||
170877910|NCT04041284|617564020|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
170877911|NCT04041284|617564021|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
170530921|NCT05911841|616291394|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
170530922|NCT05911841|616291395|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
170530923|NCT05911841|616291396|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
170530924|NCT05911841|616291397|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
170530925|NCT05911841|616291398|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
170530926|NCT05911841|616291399|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
170530927|NCT05911841|616291400|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
170530928|NCT05911841|616291401|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
170530929|NCT05911841|616291402|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
170530930|NCT05911841|616291393|FG000|Maintenance Period|Lack of Efficacy|0|||
170530931|NCT05911841|616291394|FG001|Maintenance Period|Lack of Efficacy|0|||
170530932|NCT05911841|616291395|FG002|Maintenance Period|Lack of Efficacy|0|||
170530933|NCT05911841|616291396|FG003|Maintenance Period|Lack of Efficacy|0|||
170530934|NCT05911841|616291397|FG004|Maintenance Period|Lack of Efficacy|1|||
170530935|NCT05911841|616291398|FG005|Maintenance Period|Lack of Efficacy|0|||
170530936|NCT05911841|616291399|FG006|Maintenance Period|Lack of Efficacy|1|||
170530937|NCT05911841|616291400|FG007|Maintenance Period|Lack of Efficacy|0|||
170530938|NCT05911841|616291401|FG008|Maintenance Period|Lack of Efficacy|0|||
170530939|NCT05911841|616291402|FG009|Maintenance Period|Lack of Efficacy|0|||
170530940|NCT05911841|616291393|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
170530941|NCT05911841|616291394|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
170530942|NCT05911841|616291395|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
170530943|NCT05911841|616291396|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
170530944|NCT05911841|616291397|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
170530945|NCT05911841|616291398|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
170530946|NCT05911841|616291399|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
170530947|NCT05911841|616291400|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
170530948|NCT05911841|616291401|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
170530949|NCT05911841|616291402|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
170530950|NCT05911841|616291393|FG000|Maintenance Period|Withdrawal by Subject|0|||
170530951|NCT05911841|616291394|FG001|Maintenance Period|Withdrawal by Subject|0|||
170530952|NCT05911841|616291395|FG002|Maintenance Period|Withdrawal by Subject|0|||
170530953|NCT05911841|616291396|FG003|Maintenance Period|Withdrawal by Subject|0|||
170530954|NCT05911841|616291397|FG004|Maintenance Period|Withdrawal by Subject|0|||
170530955|NCT05911841|616291398|FG005|Maintenance Period|Withdrawal by Subject|1|||
170530956|NCT05911841|616291399|FG006|Maintenance Period|Withdrawal by Subject|0|||
170530957|NCT05911841|616291400|FG007|Maintenance Period|Withdrawal by Subject|1|||
170530958|NCT05911841|616291401|FG008|Maintenance Period|Withdrawal by Subject|0|||
170530959|NCT05911841|616291402|FG009|Maintenance Period|Withdrawal by Subject|0|||
170530960|NCT05911841|616291393|FG000|Maintenance Period|Adverse Event|0|||
170530961|NCT05911841|616291394|FG001|Maintenance Period|Adverse Event|0|||
170530962|NCT05911841|616291395|FG002|Maintenance Period|Adverse Event|0|||
170530963|NCT05911841|616291396|FG003|Maintenance Period|Adverse Event|0|||
170530964|NCT05911841|616291397|FG004|Maintenance Period|Adverse Event|0|||
170530965|NCT05911841|616291398|FG005|Maintenance Period|Adverse Event|0|||
170530966|NCT05911841|616291399|FG006|Maintenance Period|Adverse Event|0|||
170530967|NCT05911841|616291400|FG007|Maintenance Period|Adverse Event|1|||
170530968|NCT05911841|616291401|FG008|Maintenance Period|Adverse Event|0|||
170530969|NCT05911841|616291402|FG009|Maintenance Period|Adverse Event|0|||
170530970|NCT05911841|616291393|FG000|Escape Period|Adverse Event|0|||
170530971|NCT05911841|616291394|FG001|Escape Period|Adverse Event|0|||
170530972|NCT05911841|616291395|FG002|Escape Period|Adverse Event|0|||
170418939|NCT00264810|615873440|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
170418940|NCT00264810|615873441|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
170418941|NCT00264810|615873440|FG000|Stimulation Optimization Period|Death|0|||
170418942|NCT00264810|615873441|FG001|Stimulation Optimization Period|Death|1|||
170418943|NCT00264810|615873440|FG000|Blinded Evaluation Period|Explant due to infection|1|||
170418944|NCT00264810|615873441|FG001|Blinded Evaluation Period|Explant due to infection|1|||
170877912|NCT04041284|617564020|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
170877913|NCT04041284|617564021|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
170877914|NCT04041284|617564020|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
170877915|NCT04041284|617564021|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
170418945|NCT00264810|615873440|FG000|Open Label Evaluation Period|Explant due to infection|1|||
170530973|NCT05911841|616291396|FG003|Escape Period|Adverse Event|0|||
170530974|NCT05911841|616291397|FG004|Escape Period|Adverse Event|0|||
170530975|NCT05911841|616291398|FG005|Escape Period|Adverse Event|0|||
170530976|NCT05911841|616291399|FG006|Escape Period|Adverse Event|0|||
170530977|NCT05911841|616291400|FG007|Escape Period|Adverse Event|0|||
170530978|NCT05911841|616291401|FG008|Escape Period|Adverse Event|0|||
170530979|NCT05911841|616291402|FG009|Escape Period|Adverse Event|1|||
170530980|NCT05911841|616291393|FG000|Escape Period|Lack of Efficacy|0|||
170530981|NCT05911841|616291394|FG001|Escape Period|Lack of Efficacy|0|||
170530982|NCT05911841|616291395|FG002|Escape Period|Lack of Efficacy|0|||
170530983|NCT05911841|616291396|FG003|Escape Period|Lack of Efficacy|0|||
170877916|NCT04041284|617564020|FG000|OL Phase (12 Weeks)|Other than specified|6|||
170877917|NCT04041284|617564021|FG001|OL Phase (12 Weeks)|Other than specified|2|||
170877918|NCT00506883|617564022|FG000|Overall Study|Lost to Follow-up|1|||
170877919|NCT00506883|617564023|FG001|Overall Study|Lost to Follow-up|1|||
170877920|NCT00506883|617564024|FG002|Overall Study|Lost to Follow-up|1|||
170877921|NCT00506883|617564022|FG000|Overall Study|Withdrawal by Subject|1|||
170877922|NCT00506883|617564023|FG001|Overall Study|Withdrawal by Subject|0|||
170877923|NCT00506883|617564024|FG002|Overall Study|Withdrawal by Subject|1|||
170877924|NCT00506883|617564022|FG000|Overall Study|Lack of Efficacy|0|||
170877925|NCT00506883|617564023|FG001|Overall Study|Lack of Efficacy|1|||
170877926|NCT00506883|617564024|FG002|Overall Study|Lack of Efficacy|1|||
170877927|NCT00506883|617564022|FG000|Overall Study|Other|5|||
170877928|NCT00506883|617564023|FG001|Overall Study|Other|1|||
170877929|NCT00506883|617564024|FG002|Overall Study|Other|1|||
170877930|NCT05419128|617564031|FG000|Overall Study|Withdrawal by Subject|1|||
170877931|NCT05419128|617564032|FG001|Overall Study|Withdrawal by Subject|1|||
170877932|NCT05419128|617564033|FG002|Overall Study|Withdrawal by Subject|0|||
170877933|NCT05419128|617564034|FG003|Overall Study|Withdrawal by Subject|1|||
170877934|NCT05419128|617564035|FG004|Overall Study|Withdrawal by Subject|1|||
170877935|NCT05419128|617564036|FG005|Overall Study|Withdrawal by Subject|0|||
170877936|NCT05419128|617564031|FG000|Overall Study|Lost to Follow-up|0|||
170877937|NCT05419128|617564032|FG001|Overall Study|Lost to Follow-up|0|||
170877938|NCT05419128|617564033|FG002|Overall Study|Lost to Follow-up|1|||
170877939|NCT05419128|617564034|FG003|Overall Study|Lost to Follow-up|0|||
170877940|NCT05419128|617564035|FG004|Overall Study|Lost to Follow-up|0|||
170877941|NCT05419128|617564036|FG005|Overall Study|Lost to Follow-up|1|||
170877942|NCT03021499|617564039|FG000|Overall Study|Adverse Event|1|||
170877943|NCT03021499|617564040|FG001|Overall Study|Adverse Event|0|||
170877944|NCT03021499|617564039|FG000|Overall Study|Death|1|||
170877945|NCT03021499|617564040|FG001|Overall Study|Death|5|||
170877946|NCT03021499|617564039|FG000|Overall Study|Lack of Efficacy|0|||
170877947|NCT03021499|617564040|FG001|Overall Study|Lack of Efficacy|1|||
170877948|NCT03021499|617564039|FG000|Overall Study|Lost to Follow-up|1|||
170877949|NCT03021499|617564040|FG001|Overall Study|Lost to Follow-up|3|||
170877950|NCT03021499|617564039|FG000|Overall Study|Physician Decision|2|||
170877951|NCT03021499|617564040|FG001|Overall Study|Physician Decision|3|||
170877952|NCT03021499|617564039|FG000|Overall Study|Pregnancy|1|||
170877953|NCT03021499|617564040|FG001|Overall Study|Pregnancy|0|||
170877954|NCT03021499|617564039|FG000|Overall Study|Withdrawal by Subject|7|||
170530984|NCT05911841|616291397|FG004|Escape Period|Lack of Efficacy|0|||
170530985|NCT05911841|616291398|FG005|Escape Period|Lack of Efficacy|0|||
170530986|NCT05911841|616291399|FG006|Escape Period|Lack of Efficacy|0|||
170877955|NCT03021499|617564040|FG001|Overall Study|Withdrawal by Subject|14|||
170877956|NCT03021499|617564039|FG000|Overall Study|Prohibited medication required|1|||
170877957|NCT03021499|617564040|FG001|Overall Study|Prohibited medication required|0|||
170877958|NCT03021499|617564039|FG000|Overall Study|Protocol non-compliance|1|||
170877959|NCT03021499|617564040|FG001|Overall Study|Protocol non-compliance|1|||
170877960|NCT03021499|617564039|FG000|Overall Study|None of the above|0|||
170877961|NCT03021499|617564040|FG001|Overall Study|None of the above|4|||
170877962|NCT03021499|617564039|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
170877963|NCT03021499|617564040|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
170877964|NCT01484977|617564041|FG000|Overall Study|Adverse Event|8|||
170877965|NCT01484977|617564041|FG000|Overall Study|Lack of Efficacy|4|||
170877966|NCT01484977|617564041|FG000|Overall Study|Protocol Violation|6|||
170877967|NCT01484977|617564041|FG000|Overall Study|Lost to Follow-up|1|||
170877968|NCT01484977|617564041|FG000|Overall Study|Withdrawal by Subject|4|||
170877969|NCT01484977|617564041|FG000|Overall Study|Subject Protocol Non-compliant|1|||
170877970|NCT01484977|617564041|FG000|Overall Study|Moving Overseas|1|||
170877971|NCT01484977|617564041|FG000|Overall Study|Low White Blood Cell Count|1|||
170877972|NCT01484977|617564041|FG000|Overall Study|Lack of Compliance|1|||
170877973|NCT00495820|617564042|FG000|Overall Study|Adverse Event|1|||
170877974|NCT00495820|617564043|FG001|Overall Study|Adverse Event|1|||
170530987|NCT05911841|616291400|FG007|Escape Period|Lack of Efficacy|0|||
170530988|NCT05911841|616291401|FG008|Escape Period|Lack of Efficacy|0|||
170530989|NCT05911841|616291402|FG009|Escape Period|Lack of Efficacy|31|||
170877975|NCT01129921|617564044|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
170877976|NCT01129921|617564045|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
170877977|NCT01129921|617564044|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
170530990|NCT05911841|616291393|FG000|Escape Period|Lost to Follow-up|0|||
170530991|NCT05911841|616291394|FG001|Escape Period|Lost to Follow-up|0|||
170877978|NCT01129921|617564045|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
170877979|NCT01129921|617564044|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
170877980|NCT01129921|617564045|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
170877981|NCT01129921|617564044|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
170877982|NCT01129921|617564045|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
170877983|NCT02988661|617564046|FG000|Overall Study|Death|2|||
170877984|NCT02988661|617564047|FG001|Overall Study|Death|18|||
170877985|NCT02988661|617564046|FG000|Overall Study|Lost to Follow-up|0|||
170877986|NCT02988661|617564047|FG001|Overall Study|Lost to Follow-up|33|||
170530992|NCT05911841|616291395|FG002|Escape Period|Lost to Follow-up|0|||
170530993|NCT05911841|616291396|FG003|Escape Period|Lost to Follow-up|0|||
170530994|NCT05911841|616291397|FG004|Escape Period|Lost to Follow-up|0|||
170530995|NCT05911841|616291398|FG005|Escape Period|Lost to Follow-up|0|||
170530996|NCT05911841|616291399|FG006|Escape Period|Lost to Follow-up|0|||
170530997|NCT05911841|616291400|FG007|Escape Period|Lost to Follow-up|0|||
170530998|NCT05911841|616291401|FG008|Escape Period|Lost to Follow-up|0|||
170530999|NCT05911841|616291402|FG009|Escape Period|Lost to Follow-up|1|||
170531000|NCT05911841|616291393|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531001|NCT05911841|616291394|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531002|NCT05911841|616291395|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531003|NCT05911841|616291396|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531004|NCT05911841|616291397|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531005|NCT05911841|616291398|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531006|NCT05911841|616291399|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531007|NCT05911841|616291400|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531008|NCT05911841|616291401|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
170531009|NCT05911841|616291402|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
170531010|NCT05911841|616291393|FG000|Escape Period|Site Terminated by Sponsor|0|||
170531011|NCT05911841|616291394|FG001|Escape Period|Site Terminated by Sponsor|0|||
170531012|NCT05911841|616291395|FG002|Escape Period|Site Terminated by Sponsor|0|||
170531013|NCT05911841|616291396|FG003|Escape Period|Site Terminated by Sponsor|0|||
170531014|NCT05911841|616291397|FG004|Escape Period|Site Terminated by Sponsor|0|||
170531015|NCT05911841|616291398|FG005|Escape Period|Site Terminated by Sponsor|0|||
170531016|NCT05911841|616291399|FG006|Escape Period|Site Terminated by Sponsor|0|||
170531017|NCT05911841|616291400|FG007|Escape Period|Site Terminated by Sponsor|0|||
170531018|NCT05911841|616291401|FG008|Escape Period|Site Terminated by Sponsor|0|||
170418946|NCT00264810|615873441|FG001|Open Label Evaluation Period|Explant due to infection|1|||
170418947|NCT00264810|615873440|FG000|Open Label Evaluation Period|Death|3|||
170418948|NCT00264810|615873441|FG001|Open Label Evaluation Period|Death|2|||
170418949|NCT00264810|615873440|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
170418950|NCT00264810|615873441|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
170418951|NCT03481309|615873443|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
170418952|NCT03481309|615873444|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
170418953|NCT03481309|615873445|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
170418954|NCT03481309|615873446|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
170418955|NCT03481309|615873447|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
170418956|NCT03481309|615873448|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
170418957|NCT01575054|615873449|FG000|Overall Study|Other Reasons|5|||
170418958|NCT01575054|615873450|FG001|Overall Study|Other Reasons|3|||
170418959|NCT01575054|615873449|FG000|Overall Study|Protocol Violation|2|||
170418960|NCT01575054|615873450|FG001|Overall Study|Protocol Violation|1|||
170418961|NCT01575054|615873449|FG000|Overall Study|Personal Reasons|10|||
170418962|NCT01575054|615873450|FG001|Overall Study|Personal Reasons|11|||
170418963|NCT01575054|615873449|FG000|Overall Study|Lost to Follow-up|3|||
170418964|NCT01575054|615873450|FG001|Overall Study|Lost to Follow-up|3|||
170418965|NCT01575054|615873449|FG000|Overall Study|Adverse Event|9|||
170418966|NCT01575054|615873450|FG001|Overall Study|Adverse Event|8|||
170418967|NCT03309956|615873453|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
170418968|NCT05037097|615875014|FG000|Overall Study|Withdrawal by Subject|0|||
170418969|NCT05037097|615875015|FG001|Overall Study|Withdrawal by Subject|1|||
170418970|NCT05037097|615875016|FG002|Overall Study|Withdrawal by Subject|0|||
170418971|NCT05037097|615875017|FG003|Overall Study|Withdrawal by Subject|1|||
170418972|NCT05037097|615875018|FG004|Overall Study|Withdrawal by Subject|0|||
170418973|NCT05037097|615875019|FG005|Overall Study|Withdrawal by Subject|2|||
170418974|NCT05037097|615875020|FG006|Overall Study|Withdrawal by Subject|0|||
170418975|NCT05037097|615875021|FG007|Overall Study|Withdrawal by Subject|0|||
170418976|NCT05037097|615875014|FG000|Overall Study|Lost to Follow-up|0|||
170418977|NCT05037097|615875015|FG001|Overall Study|Lost to Follow-up|1|||
170418978|NCT05037097|615875016|FG002|Overall Study|Lost to Follow-up|0|||
170418979|NCT05037097|615875017|FG003|Overall Study|Lost to Follow-up|0|||
170418980|NCT05037097|615875018|FG004|Overall Study|Lost to Follow-up|1|||
170531019|NCT05911841|616291402|FG009|Escape Period|Site Terminated by Sponsor|1|||
170531020|NCT05911841|616291393|FG000|Escape Period|Study Terminated by Sponsor|0|||
170418981|NCT05037097|615875019|FG005|Overall Study|Lost to Follow-up|1|||
170418982|NCT05037097|615875020|FG006|Overall Study|Lost to Follow-up|0|||
170418983|NCT05037097|615875021|FG007|Overall Study|Lost to Follow-up|0|||
170531021|NCT05911841|616291394|FG001|Escape Period|Study Terminated by Sponsor|0|||
170531022|NCT05911841|616291395|FG002|Escape Period|Study Terminated by Sponsor|0|||
170418984|NCT00745420|615875022|FG000|Overall Study|Ineligible|1|||
170418985|NCT02322047|615875023|FG000|Overall Study|Physician Decision|1|||
170418986|NCT02322047|615875024|FG001|Overall Study|Physician Decision|0|||
170418987|NCT02322047|615875025|FG002|Overall Study|Physician Decision|0|||
170877987|NCT02988661|617564046|FG000|Overall Study|Withdrawal by Subject|0|||
170877988|NCT02988661|617564047|FG001|Overall Study|Withdrawal by Subject|6|||
170877989|NCT02988661|617564046|FG000|Overall Study|Unable to complete the 18-month survey|1|||
170877990|NCT02988661|617564047|FG001|Overall Study|Unable to complete the 18-month survey|27|||
170877991|NCT00747643|617565557|FG000|Overall Study|Withdrawal by Subject|36|||
170877992|NCT00747643|617565558|FG001|Overall Study|Withdrawal by Subject|27|||
170877993|NCT01623271|617565559|FG000|Overall Study|Withdrawal by Subject|2|||
170877994|NCT03927105|617565564|FG000|Overall Study|Death|1|||
170877995|NCT03927105|617565564|FG000|Overall Study|In observation for potential re-treatment|2|||
170877996|NCT03927105|617565564|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
170877997|NCT04036708|617565565|FG000|Overall Study|Lost to Follow-up|14|||
170877998|NCT04036708|617565566|FG001|Overall Study|Lost to Follow-up|4|||
170877999|NCT04036708|617565567|FG002|Overall Study|Lost to Follow-up|14|||
170878000|NCT04036708|617565568|FG003|Overall Study|Lost to Follow-up|4|||
170878001|NCT02257372|617565573|FG000|Overall Study|Adverse Event|3|||
170878002|NCT02257372|617565574|FG001|Overall Study|Adverse Event|7|||
170878003|NCT02257372|617565573|FG000|Overall Study|Lack of Efficacy|2|||
170878004|NCT02257372|617565574|FG001|Overall Study|Lack of Efficacy|1|||
170878005|NCT02257372|617565573|FG000|Overall Study|Protocol Violation|1|||
170878006|NCT02257372|617565574|FG001|Overall Study|Protocol Violation|1|||
170878007|NCT02257372|617565573|FG000|Overall Study|Lost to Follow-up|0|||
170878008|NCT02257372|617565574|FG001|Overall Study|Lost to Follow-up|1|||
170878009|NCT02257372|617565573|FG000|Overall Study|Withdrew consent|1|||
170878010|NCT02257372|617565574|FG001|Overall Study|Withdrew consent|0|||
170878011|NCT00789529|617565575|FG000|Overall Study|Withdrawal by Subject|0|||
170878012|NCT00789529|617565576|FG001|Overall Study|Withdrawal by Subject|1|||
170878013|NCT00789529|617565575|FG000|Overall Study|Other Reason|1|||
170878014|NCT00789529|617565576|FG001|Overall Study|Other Reason|0|||
170878015|NCT02634151|617565577|FG000|Overall Study|Withdrawal by Subject|1|||
170878016|NCT02634151|617565578|FG001|Overall Study|Withdrawal by Subject|0|||
170878017|NCT02634151|617565577|FG000|Overall Study|Non-Compliance|0|||
170878018|NCT02634151|617565578|FG001|Overall Study|Non-Compliance|1|||
170878019|NCT02634151|617565577|FG000|Overall Study|Other|0|||
170878020|NCT02634151|617565578|FG001|Overall Study|Other|1|||
170878021|NCT01870401|617565579|FG000|Overall Study|Death|48|||
170878022|NCT01870401|617565580|FG001|Overall Study|Death|24|||
170878023|NCT01870401|617565579|FG000|Overall Study|Withdrawal by Subject|39|||
170878024|NCT01870401|617565580|FG001|Overall Study|Withdrawal by Subject|26|||
170878025|NCT01870401|617565579|FG000|Overall Study|Lost to Follow-up|19|||
170878026|NCT01870401|617565580|FG001|Overall Study|Lost to Follow-up|14|||
170878027|NCT01870401|617565579|FG000|Overall Study|Other|9|||
170878028|NCT01870401|617565580|FG001|Overall Study|Other|7|||
170878029|NCT01870401|617565579|FG000|Overall Study|On-going in the Study|35|||
170878030|NCT01870401|617565580|FG001|Overall Study|On-going in the Study|25|||
170878031|NCT01135498|617565583|FG000|Overall Study|Adverse Event|20|||
170878032|NCT01135498|617565583|FG000|Overall Study|Progressive disease|38|||
170878033|NCT01135498|617565583|FG000|Overall Study|Investigator judgement|25|||
170878034|NCT01135498|617565583|FG000|Overall Study|Withdrawal by Subject|4|||
170878035|NCT01135498|617565583|FG000|Overall Study|Death|1|||
170878036|NCT01135498|617565583|FG000|Overall Study|Ongoing at time of analysis|2|||
170878037|NCT02104583|617565584|FG000|Overall Study|New ICD or CRT-D implanted|2|||
170878038|NCT02104583|617565585|FG001|Overall Study|New ICD or CRT-D implanted|0|||
170878039|NCT02104583|617565586|FG002|Overall Study|New ICD or CRT-D implanted|1|||
170878040|NCT02104583|617565587|FG003|Overall Study|New ICD or CRT-D implanted|0|||
170878041|NCT02104583|617565588|FG004|Overall Study|New ICD or CRT-D implanted|0|||
170878042|NCT02104583|617565584|FG000|Overall Study|Death|2|||
170531023|NCT05911841|616291396|FG003|Escape Period|Study Terminated by Sponsor|0|||
170878043|NCT02104583|617565585|FG001|Overall Study|Death|1|||
170878044|NCT02104583|617565586|FG002|Overall Study|Death|3|||
170878045|NCT02104583|617565587|FG003|Overall Study|Death|3|||
170878046|NCT02104583|617565588|FG004|Overall Study|Death|5|||
170878047|NCT02104583|617565584|FG000|Overall Study|Subject required cardiac ablation|6|||
170878048|NCT02104583|617565585|FG001|Overall Study|Subject required cardiac ablation|4|||
170878049|NCT02104583|617565586|FG002|Overall Study|Subject required cardiac ablation|4|||
170878050|NCT02104583|617565587|FG003|Overall Study|Subject required cardiac ablation|5|||
170878051|NCT02104583|617565588|FG004|Overall Study|Subject required cardiac ablation|4|||
170878052|NCT02104583|617565584|FG000|Overall Study|Subject required prohibited medication|0|||
170878053|NCT02104583|617565585|FG001|Overall Study|Subject required prohibited medication|1|||
170531024|NCT05911841|616291397|FG004|Escape Period|Study Terminated by Sponsor|0|||
170878054|NCT02104583|617565586|FG002|Overall Study|Subject required prohibited medication|1|||
170878055|NCT02104583|617565587|FG003|Overall Study|Subject required prohibited medication|0|||
170878056|NCT02104583|617565588|FG004|Overall Study|Subject required prohibited medication|1|||
170878057|NCT02104583|617565584|FG000|Overall Study|Withdrew Consent|3|||
170878058|NCT02104583|617565585|FG001|Overall Study|Withdrew Consent|2|||
170878059|NCT02104583|617565586|FG002|Overall Study|Withdrew Consent|0|||
170418988|NCT02322047|615875026|FG003|Overall Study|Physician Decision|0|||
170418989|NCT02322047|615875023|FG000|Overall Study|Withdrawal by Subject|1|||
170418990|NCT02322047|615875024|FG001|Overall Study|Withdrawal by Subject|0|||
170418991|NCT02322047|615875025|FG002|Overall Study|Withdrawal by Subject|0|||
170418992|NCT02322047|615875026|FG003|Overall Study|Withdrawal by Subject|1|||
170418993|NCT02322047|615875023|FG000|Overall Study|Adverse Event|0|||
170418994|NCT02322047|615875024|FG001|Overall Study|Adverse Event|1|||
170418995|NCT02322047|615875025|FG002|Overall Study|Adverse Event|0|||
170418996|NCT02322047|615875026|FG003|Overall Study|Adverse Event|0|||
170418997|NCT02322047|615875023|FG000|Overall Study|Lost to Follow-up|0|||
170418998|NCT02322047|615875024|FG001|Overall Study|Lost to Follow-up|0|||
170418999|NCT02322047|615875025|FG002|Overall Study|Lost to Follow-up|1|||
170419000|NCT02322047|615875026|FG003|Overall Study|Lost to Follow-up|1|||
170419001|NCT05346055|615875034|FG000|Overall Study|Withdrawal by Subject|1|||
170419002|NCT05346055|615875034|FG000|Overall Study|Protocol Violation|1|||
170419003|NCT05346055|615875034|FG000|Overall Study|Therapist decision|1|||
170419004|NCT02532764|615875035|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
170419005|NCT02532764|615875036|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
170419006|NCT02532764|615875037|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
170419007|NCT02532764|615875038|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
170419008|NCT02532764|615875039|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
170419009|NCT02532764|615875040|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
170419010|NCT02532764|615875041|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
170419011|NCT02532764|615875042|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
170419012|NCT02532764|615875043|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
170419013|NCT02532764|615875044|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
170419014|NCT02906709|615875045|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
170419015|NCT02906709|615875046|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
170419016|NCT02906709|615875045|FG000|Phase A (Week 0 to Week 16)|Death|0|||
170419017|NCT02906709|615875046|FG001|Phase A (Week 0 to Week 16)|Death|1|||
170419018|NCT02906709|615875045|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
170419019|NCT02906709|615875046|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
170419020|NCT02906709|615875045|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
170419021|NCT02906709|615875046|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
170419022|NCT00001849|615875050|FG000|Overall Study|Death|4|||
170419023|NCT00001849|615875050|FG000|Overall Study|Lost to Follow-up|2|||
170419024|NCT00001849|615875050|FG000|Overall Study|Withdrawal by Subject|2|||
170419025|NCT00001849|615875050|FG000|Overall Study|tumor remained occult|6|||
170419026|NCT00728949|615875054|FG000|Overall Study|Adverse Event|8|||
170419027|NCT00728949|615875055|FG001|Overall Study|Adverse Event|0|||
170419028|NCT00728949|615875054|FG000|Overall Study|Withdrawal by Subject|2|||
170419029|NCT00728949|615875055|FG001|Overall Study|Withdrawal by Subject|2|||
170419030|NCT00728949|615875054|FG000|Overall Study|Abnormal Lab Results|0|||
170419031|NCT00728949|615875055|FG001|Overall Study|Abnormal Lab Results|2|||
170419032|NCT00728949|615875054|FG000|Overall Study|On treatment at cutoff date|1|||
170419033|NCT00728949|615875055|FG001|Overall Study|On treatment at cutoff date|0|||
170419034|NCT04424407|615875056|FG000|Overall Study|Withdrawal by Subject|2|||
170419035|NCT04424407|615875056|FG000|Overall Study|Lost to Follow-up|1|||
170419036|NCT00497796|615875059|FG000|Overall Study|Adverse event (not related)|9|||
170419037|NCT00497796|615875060|FG001|Overall Study|Adverse event (not related)|9|||
170419038|NCT00497796|615875059|FG000|Overall Study|Adverse event (related)|5|||
170419039|NCT00497796|615875060|FG001|Overall Study|Adverse event (related)|4|||
170419040|NCT00497796|615875059|FG000|Overall Study|CMV infection or disease treatment|30|||
170419041|NCT00497796|615875060|FG001|Overall Study|CMV infection or disease treatment|4|||
170419042|NCT00497796|615875059|FG000|Overall Study|Consent withdrawn|10|||
170419043|NCT00497796|615875060|FG001|Overall Study|Consent withdrawn|3|||
170419044|NCT00497796|615875059|FG000|Overall Study|Investigator/sponsor discretion|31|||
170419045|NCT00497796|615875060|FG001|Overall Study|Investigator/sponsor discretion|34|||
170419046|NCT00497796|615875059|FG000|Overall Study|Lost to Follow-up|0|||
170419047|NCT00497796|615875060|FG001|Overall Study|Lost to Follow-up|1|||
170419048|NCT00497796|615875059|FG000|Overall Study|Not applicable (randomized not treated)|0|||
170419049|NCT00497796|615875060|FG001|Overall Study|Not applicable (randomized not treated)|4|||
170419050|NCT02899338|615875066|FG000|Overall Study|Adverse Event|1|||
170419051|NCT02899338|615875067|FG001|Overall Study|Adverse Event|2|||
170419052|NCT02899338|615875066|FG000|Overall Study|Withdrawal by Subject|2|||
170778280|NCT03416010|617195558|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
170778281|NCT03416010|617195557|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
170419053|NCT02899338|615875067|FG001|Overall Study|Withdrawal by Subject|0|||
170419054|NCT06179108|615875068|FG000|Overall Study|Withdrawal by Subject|16|||
170419055|NCT06179108|615875069|FG001|Overall Study|Withdrawal by Subject|19|||
170419056|NCT06179108|615875070|FG002|Overall Study|Withdrawal by Subject|10|||
170419057|NCT06179108|615875071|FG003|Overall Study|Withdrawal by Subject|11|||
170419058|NCT06179108|615875068|FG000|Overall Study|Lost to Follow-up|12|||
170419059|NCT06179108|615875069|FG001|Overall Study|Lost to Follow-up|4|||
170419060|NCT06179108|615875070|FG002|Overall Study|Lost to Follow-up|1|||
170419061|NCT06179108|615875071|FG003|Overall Study|Lost to Follow-up|9|||
170419062|NCT06179108|615875068|FG000|Overall Study|Adverse Event|2|||
170419063|NCT06179108|615875069|FG001|Overall Study|Adverse Event|3|||
170419064|NCT06179108|615875070|FG002|Overall Study|Adverse Event|3|||
170419065|NCT06179108|615875071|FG003|Overall Study|Adverse Event|2|||
170419066|NCT06179108|615875068|FG000|Overall Study|Protocol Violation|0|||
170419067|NCT06179108|615875069|FG001|Overall Study|Protocol Violation|1|||
170419068|NCT06179108|615875070|FG002|Overall Study|Protocol Violation|0|||
170419069|NCT06179108|615875071|FG003|Overall Study|Protocol Violation|1|||
170419070|NCT06179108|615875068|FG000|Overall Study|Physician Decision|1|||
170419071|NCT06179108|615875069|FG001|Overall Study|Physician Decision|1|||
170419072|NCT06179108|615875070|FG002|Overall Study|Physician Decision|0|||
170419073|NCT06179108|615875071|FG003|Overall Study|Physician Decision|0|||
170419074|NCT06179108|615875068|FG000|Overall Study|Lack of Efficacy|0|||
170419075|NCT06179108|615875069|FG001|Overall Study|Lack of Efficacy|0|||
170419076|NCT06179108|615875070|FG002|Overall Study|Lack of Efficacy|0|||
170419077|NCT06179108|615875071|FG003|Overall Study|Lack of Efficacy|1|||
170419078|NCT06179108|615875068|FG000|Overall Study|Death|0|||
170419079|NCT06179108|615875069|FG001|Overall Study|Death|0|||
170419080|NCT06179108|615875070|FG002|Overall Study|Death|0|||
170419081|NCT06179108|615875071|FG003|Overall Study|Death|1|||
170419082|NCT00814463|615875076|FG000|Overall Study|Lost to Follow-up|1|||
170419083|NCT01370408|615875077|FG000|Overall Study|treatment failure|9|||
170419084|NCT02780687|615875080|FG000|Overall Study|Adverse Event|1|||
170419085|NCT02780687|615875081|FG001|Overall Study|Adverse Event|1|||
170419086|NCT02780687|615875080|FG000|Overall Study|Withdrawal by Subject|2|||
170419087|NCT02780687|615875081|FG001|Overall Study|Withdrawal by Subject|1|||
170419088|NCT02780687|615875080|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
170419089|NCT02780687|615875081|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
170419090|NCT02780687|615875080|FG000|Overall Study|progressive disease|29|||
170419091|NCT02780687|615875081|FG001|Overall Study|progressive disease|6|||
170419092|NCT02353169|615875084|FG000|Overall Study|QTc > 450 msec|1|||
170419093|NCT02353169|615875085|FG001|Overall Study|QTc > 450 msec|1|||
170419094|NCT02353169|615875086|FG002|Overall Study|QTc > 450 msec|1|||
170419095|NCT02353169|615875087|FG003|Overall Study|QTc > 450 msec|1|||
170419096|NCT02353169|615875084|FG000|Overall Study|OR team declined|2|||
170419097|NCT02353169|615875085|FG001|Overall Study|OR team declined|0|||
170419098|NCT02353169|615875086|FG002|Overall Study|OR team declined|0|||
170419099|NCT02353169|615875087|FG003|Overall Study|OR team declined|0|||
170419100|NCT02353169|615875084|FG000|Overall Study|Inhalational induction|0|||
170419101|NCT02353169|615875085|FG001|Overall Study|Inhalational induction|2|||
170419102|NCT02353169|615875086|FG002|Overall Study|Inhalational induction|0|||
170419103|NCT02353169|615875087|FG003|Overall Study|Inhalational induction|0|||
170419104|NCT02353169|615875084|FG000|Overall Study|ECG data error|0|||
170419105|NCT02353169|615875085|FG001|Overall Study|ECG data error|3|||
170419106|NCT02353169|615875086|FG002|Overall Study|ECG data error|2|||
170419107|NCT02353169|615875087|FG003|Overall Study|ECG data error|2|||
170419108|NCT02353169|615875084|FG000|Overall Study|Pre-op medication|0|||
170419109|NCT02353169|615875085|FG001|Overall Study|Pre-op medication|0|||
170419110|NCT02353169|615875086|FG002|Overall Study|Pre-op medication|1|||
170419111|NCT02353169|615875087|FG003|Overall Study|Pre-op medication|0|||
170419112|NCT00414765|615875091|FG000|Overall Study|Adverse Event|5|||
170419113|NCT00414765|615875092|FG001|Overall Study|Adverse Event|9|||
170419114|NCT00414765|615875091|FG000|Overall Study|Withdrawal by Subject|1|||
170419115|NCT00414765|615875092|FG001|Overall Study|Withdrawal by Subject|1|||
170419116|NCT00414765|615875091|FG000|Overall Study|Disease Progression|0|||
170419117|NCT00414765|615875092|FG001|Overall Study|Disease Progression|1|||
170419118|NCT05295953|615875093|FG000|Overall Study|Withdrawal by Subject|0|||
170419119|NCT05295953|615875094|FG001|Overall Study|Withdrawal by Subject|1|||
170419120|NCT03130699|615875096|FG000|Overall Study|Lost to Follow-up|34|||
170419121|NCT03130699|615875097|FG001|Overall Study|Lost to Follow-up|37|||
170419122|NCT03130699|615875098|FG002|Overall Study|Lost to Follow-up|26|||
170419123|NCT03130699|615875096|FG000|Overall Study|Withdrawal by Subject|5|||
170419124|NCT03130699|615875097|FG001|Overall Study|Withdrawal by Subject|1|||
170419125|NCT03130699|615875098|FG002|Overall Study|Withdrawal by Subject|0|||
170419126|NCT03130699|615875096|FG000|Overall Study|Withdrawal by PI|1|||
170419127|NCT03130699|615875097|FG001|Overall Study|Withdrawal by PI|2|||
170419128|NCT03130699|615875098|FG002|Overall Study|Withdrawal by PI|5|||
170419129|NCT03130699|615875096|FG000|Overall Study|Death|0|||
170419130|NCT03130699|615875097|FG001|Overall Study|Death|0|||
170419131|NCT03130699|615875098|FG002|Overall Study|Death|1|||
170419132|NCT01199861|615875099|FG000|Overall Study|Administrative problems|1|||
170419133|NCT01199861|615875100|FG001|Overall Study|Administrative problems|0|||
170419134|NCT01199861|615875099|FG000|Overall Study|Adverse Event|1|||
170419135|NCT01199861|615875100|FG001|Overall Study|Adverse Event|0|||
170419136|NCT04817891|615875101|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
170419137|NCT04817891|615875101|FG000|Overall Study|Adverse Event|1|||
170419138|NCT04817891|615875101|FG000|Overall Study|Withdrawal by Subject|1|||
170531025|NCT05911841|616291398|FG005|Escape Period|Study Terminated by Sponsor|0|||
170531026|NCT05911841|616291399|FG006|Escape Period|Study Terminated by Sponsor|0|||
170531027|NCT05911841|616291400|FG007|Escape Period|Study Terminated by Sponsor|0|||
170531028|NCT05911841|616291401|FG008|Escape Period|Study Terminated by Sponsor|0|||
170531029|NCT05911841|616291402|FG009|Escape Period|Study Terminated by Sponsor|34|||
170531030|NCT05911841|616291393|FG000|Escape Period|Withdrawal by Subject|0|||
170531031|NCT05911841|616291394|FG001|Escape Period|Withdrawal by Subject|0|||
170531032|NCT05911841|616291395|FG002|Escape Period|Withdrawal by Subject|0|||
170531033|NCT05911841|616291396|FG003|Escape Period|Withdrawal by Subject|0|||
170531034|NCT05911841|616291397|FG004|Escape Period|Withdrawal by Subject|0|||
170531035|NCT05911841|616291398|FG005|Escape Period|Withdrawal by Subject|0|||
170531036|NCT05911841|616291399|FG006|Escape Period|Withdrawal by Subject|0|||
170531037|NCT05911841|616291400|FG007|Escape Period|Withdrawal by Subject|0|||
170531038|NCT05911841|616291401|FG008|Escape Period|Withdrawal by Subject|0|||
170531039|NCT05911841|616291402|FG009|Escape Period|Withdrawal by Subject|10|||
170531040|NCT00726609|616291407|FG000|Overall Study|Adverse Event|10|||
170531041|NCT00726609|616291407|FG000|Overall Study|Withdrawal by Subject|2|||
170531042|NCT00726609|616291407|FG000|Overall Study|Lack of Efficacy|25|||
170531043|NCT00726609|616291407|FG000|Overall Study|Other|16|||
170531044|NCT00726609|616291407|FG000|Overall Study|Missing|42|||
170531045|NCT00726609|616291407|FG000|Overall Study|Other|3|||
170531046|NCT00071981|616291411|FG000|Overall Study|Lack of Efficacy|37|||
170531047|NCT00071981|616291412|FG001|Overall Study|Lack of Efficacy|29|||
170531048|NCT00071981|616291413|FG002|Overall Study|Lack of Efficacy|30|||
170531049|NCT00071981|616291414|FG003|Overall Study|Lack of Efficacy|43|||
170531050|NCT00071981|616291411|FG000|Overall Study|Adverse Event|4|||
170531051|NCT00071981|616291412|FG001|Overall Study|Adverse Event|4|||
170419139|NCT04981912|615875102|FG000|Overall Study|Physician Decision|2|||
170419140|NCT04534283|615875103|FG000|Overall Study|Physician Decision|2|||
170419141|NCT04534283|615875103|FG000|Overall Study|Withdrawal by Subject|1|||
170419142|NCT04534283|615875103|FG000|Overall Study|Disease Progression|12|||
170419143|NCT04534283|615875103|FG000|Overall Study|Adverse Event|1|||
170419144|NCT05097989|615875104|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170419145|NCT05097989|615875105|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170419146|NCT05097989|615875106|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170419147|NCT05097989|615875107|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170419148|NCT05097989|615875108|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170419149|NCT05097989|615875109|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
170419150|NCT05097989|615875110|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170419151|NCT05097989|615875111|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170419152|NCT05097989|615875112|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
170419153|NCT05097989|615875104|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
170419154|NCT05097989|615875105|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
170419155|NCT05097989|615875106|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
170419156|NCT05097989|615875107|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
170419157|NCT05097989|615875108|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
170419158|NCT05097989|615875109|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
170419159|NCT05097989|615875110|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
170419160|NCT05097989|615875111|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
170419161|NCT05097989|615875112|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
170419162|NCT05097989|615875104|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
170419163|NCT05097989|615875105|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
170419164|NCT05097989|615875106|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
170419165|NCT05097989|615875107|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
170419166|NCT05097989|615875108|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
170419167|NCT05097989|615875109|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
170419168|NCT05097989|615875110|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
170419169|NCT05097989|615875111|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
170419170|NCT05097989|615875112|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
170419171|NCT05097989|615875104|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
170419172|NCT05097989|615875105|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
170419173|NCT05097989|615875106|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
170419174|NCT05097989|615875107|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
170419175|NCT05097989|615875108|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
170531052|NCT00071981|616291413|FG002|Overall Study|Adverse Event|3|||
170531053|NCT00071981|616291414|FG003|Overall Study|Adverse Event|1|||
170531054|NCT00071981|616291411|FG000|Overall Study|Death|0|||
170531055|NCT00071981|616291412|FG001|Overall Study|Death|0|||
170531056|NCT00071981|616291413|FG002|Overall Study|Death|1|||
170531057|NCT00071981|616291414|FG003|Overall Study|Death|1|||
170531058|NCT00071981|616291411|FG000|Overall Study|Withdrawal by Subject|3|||
170778282|NCT03416010|617195558|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
170531059|NCT00071981|616291412|FG001|Overall Study|Withdrawal by Subject|1|||
170531060|NCT00071981|616291413|FG002|Overall Study|Withdrawal by Subject|0|||
170531061|NCT00071981|616291414|FG003|Overall Study|Withdrawal by Subject|0|||
170531062|NCT00071981|616291411|FG000|Overall Study|No protocol therapy|2|||
170531063|NCT00071981|616291412|FG001|Overall Study|No protocol therapy|5|||
170531064|NCT00071981|616291413|FG002|Overall Study|No protocol therapy|1|||
170531065|NCT00071981|616291414|FG003|Overall Study|No protocol therapy|0|||
170531066|NCT00071981|616291411|FG000|Overall Study|others (not specified in the study)|0|||
170531067|NCT00071981|616291412|FG001|Overall Study|others (not specified in the study)|2|||
170531068|NCT00071981|616291413|FG002|Overall Study|others (not specified in the study)|2|||
170531069|NCT00071981|616291414|FG003|Overall Study|others (not specified in the study)|0|||
170531070|NCT00262925|616291417|FG000|Overall Study|Lack of Efficacy|3|||
170531071|NCT00262925|616291417|FG000|Overall Study|Adverse Event|4|||
170531072|NCT00262925|616291417|FG000|Overall Study|Death|2|||
170531073|NCT00262925|616291417|FG000|Overall Study|alternative therapy|1|||
170531074|NCT00262925|616291417|FG000|Overall Study|Other|1|||
170531075|NCT04682301|616291418|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
170531076|NCT04682301|616291418|FG000|Overall Study|Death|2|||
170531077|NCT04220021|616291419|FG000|Overall Study|Withdrawal by Subject|11|||
170531078|NCT04220021|616291419|FG000|Overall Study|Physician Decision|2|||
170531079|NCT04220021|616291419|FG000|Overall Study|Non-study related illness|5|||
170531080|NCT01420536|616291422|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
170531081|NCT01420536|616291423|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
170531082|NCT00855218|616291426|FG000|Overall Study|Adverse Event|43|||
170778283|NCT03416010|617195557|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
170778284|NCT03416010|617195558|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
170778285|NCT03416010|617195557|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
170778286|NCT03416010|617195558|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
170778287|NCT03416010|617195557|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
170778288|NCT03416010|617195558|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
170778289|NCT03416010|617195557|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
170778290|NCT03416010|617195558|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
170778291|NCT06629454|617195565|FG000|Overall Study|Withdraw by Clinician Decision|1|||
170778292|NCT01704079|617195566|FG000|Overall Study|Withdrawal by Subject|5|||
170778293|NCT01704079|617195567|FG001|Overall Study|Withdrawal by Subject|7|||
170778294|NCT01704079|617195566|FG000|Overall Study|Lost to Follow-up|2|||
170778295|NCT01704079|617195567|FG001|Overall Study|Lost to Follow-up|5|||
170778296|NCT01704079|617195566|FG000|Overall Study|Adverse Event|4|||
170778297|NCT01704079|617195567|FG001|Overall Study|Adverse Event|7|||
170778298|NCT01704079|617195566|FG000|Overall Study|Protocol Violation|1|||
170778299|NCT01704079|617195567|FG001|Overall Study|Protocol Violation|0|||
170778300|NCT01704079|617195566|FG000|Overall Study|Subject noncompliance|2|||
170778301|NCT01704079|617195567|FG001|Overall Study|Subject noncompliance|3|||
170778302|NCT01704079|617195566|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
170778303|NCT01704079|617195567|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
170778304|NCT06023082|617195568|FG000|Overall Study|Withdrawal by Subject|2|||
170778305|NCT06023082|617195568|FG000|Overall Study|Lost to Follow-up|15|||
170778306|NCT06023082|617195568|FG000|Overall Study|Side effects|5|||
170778307|NCT04868110|617195572|FG000|Overall Study|Withdrawal by Subject|3|||
170778308|NCT04868110|617195573|FG001|Overall Study|Withdrawal by Subject|4|||
170778309|NCT02553642|617195577|FG000|Overall Study|Withdrawal by Subject|0|||
170778310|NCT02553642|617195578|FG001|Overall Study|Withdrawal by Subject|3|||
170778311|NCT02553642|617195577|FG000|Overall Study|Physician Decision|0|||
170778312|NCT02553642|617195578|FG001|Overall Study|Physician Decision|1|||
170778313|NCT02553642|617195577|FG000|Overall Study|Additional cancer dx|0|||
170778314|NCT02553642|617195578|FG001|Overall Study|Additional cancer dx|1|||
170778315|NCT02553642|617195577|FG000|Overall Study|Never started treatment|0|||
170778316|NCT02553642|617195578|FG001|Overall Study|Never started treatment|1|||
170778317|NCT01820260|617195584|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778318|NCT01820260|617195585|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778319|NCT01820260|617195586|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778320|NCT01820260|617195587|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778321|NCT01820260|617195588|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778322|NCT01820260|617195589|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778323|NCT01820260|617195590|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
170778324|NCT01820260|617195591|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778325|NCT01820260|617195592|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778326|NCT01820260|617195593|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778327|NCT01820260|617195594|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778328|NCT01820260|617195595|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170806939|NCT01683409|617301667|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
170531083|NCT00855218|616291427|FG001|Overall Study|Adverse Event|27|||
170531084|NCT00855218|616291426|FG000|Overall Study|Withdrawal by Subject|10|||
170531085|NCT00855218|616291427|FG001|Overall Study|Withdrawal by Subject|6|||
170531086|NCT00855218|616291426|FG000|Overall Study|Physician Decision|18|||
170531087|NCT00855218|616291427|FG001|Overall Study|Physician Decision|11|||
170531088|NCT00855218|616291426|FG000|Overall Study|Lost to Follow-up|0|||
170531089|NCT00855218|616291427|FG001|Overall Study|Lost to Follow-up|1|||
170531090|NCT00855218|616291426|FG000|Overall Study|Protocol Violation|5|||
170531091|NCT00855218|616291427|FG001|Overall Study|Protocol Violation|9|||
170531092|NCT00855218|616291426|FG000|Overall Study|non-compliant with study drug|3|||
170531093|NCT00855218|616291427|FG001|Overall Study|non-compliant with study drug|1|||
170531094|NCT00855218|616291426|FG000|Overall Study|patient convenience|2|||
170531095|NCT00855218|616291427|FG001|Overall Study|patient convenience|0|||
170531096|NCT00855218|616291426|FG000|Overall Study|technical problems|2|||
170531097|NCT00855218|616291427|FG001|Overall Study|technical problems|1|||
170531098|NCT00855218|616291426|FG000|Overall Study|Still treated with study medication|0|||
170531099|NCT00855218|616291427|FG001|Overall Study|Still treated with study medication|1|||
170531100|NCT00855218|616291426|FG000|Overall Study|Untreatable disease progression|54|||
170531101|NCT00855218|616291427|FG001|Overall Study|Untreatable disease progression|67|||
170531102|NCT00855218|616291426|FG000|Overall Study|Second malignancy|0|||
170531103|NCT00855218|616291427|FG001|Overall Study|Second malignancy|1|||
170531104|NCT00855218|616291426|FG000|Overall Study|Progression measurement proven|7|||
170531105|NCT00855218|616291427|FG001|Overall Study|Progression measurement proven|15|||
170531106|NCT00855218|616291426|FG000|Overall Study|Clinical endpoint reached|10|||
170531107|NCT00855218|616291427|FG001|Overall Study|Clinical endpoint reached|13|||
170531108|NCT04711005|616291428|FG000|Overall Study|Withdrawal by Subject|0|||
170531109|NCT04711005|616291429|FG001|Overall Study|Withdrawal by Subject|0|||
170531110|NCT04711005|616291430|FG002|Overall Study|Withdrawal by Subject|0|||
170531111|NCT04711005|616291431|FG003|Overall Study|Withdrawal by Subject|0|||
170531112|NCT04711005|616291432|FG004|Overall Study|Withdrawal by Subject|0|||
170531113|NCT04711005|616291433|FG005|Overall Study|Withdrawal by Subject|0|||
170531114|NCT04711005|616291434|FG006|Overall Study|Withdrawal by Subject|0|||
170531115|NCT04711005|616291435|FG007|Overall Study|Withdrawal by Subject|1|||
170531116|NCT04711005|616291436|FG008|Overall Study|Withdrawal by Subject|0|||
170531117|NCT04711005|616291437|FG009|Overall Study|Withdrawal by Subject|0|||
170531118|NCT04711005|616291428|FG000|Overall Study|Physician Decision|0|||
170531119|NCT04711005|616291429|FG001|Overall Study|Physician Decision|0|||
170531120|NCT04711005|616291430|FG002|Overall Study|Physician Decision|0|||
170531121|NCT04711005|616291431|FG003|Overall Study|Physician Decision|0|||
170531122|NCT04711005|616291432|FG004|Overall Study|Physician Decision|0|||
170531123|NCT04711005|616291433|FG005|Overall Study|Physician Decision|0|||
170531124|NCT04711005|616291434|FG006|Overall Study|Physician Decision|0|||
170531125|NCT04711005|616291435|FG007|Overall Study|Physician Decision|2|||
170531126|NCT04711005|616291436|FG008|Overall Study|Physician Decision|1|||
170531127|NCT04711005|616291437|FG009|Overall Study|Physician Decision|0|||
170531128|NCT00764790|616291440|FG000|Overall Study|Protocol Violation|0|||
170531129|NCT00764790|616291441|FG001|Overall Study|Protocol Violation|0|||
170531130|NCT00764790|616291442|FG002|Overall Study|Protocol Violation|1|||
170531131|NCT00764790|616291440|FG000|Overall Study|Withdrawal by Subject|10|||
170531132|NCT00764790|616291441|FG001|Overall Study|Withdrawal by Subject|12|||
170531133|NCT00764790|616291442|FG002|Overall Study|Withdrawal by Subject|6|||
170531134|NCT00764790|616291440|FG000|Overall Study|Lost to Follow-up|28|||
170419176|NCT05097989|615875109|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
170419177|NCT05097989|615875110|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
170419178|NCT05097989|615875111|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
170419179|NCT05097989|615875112|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
170419180|NCT05097989|615875104|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
170419181|NCT05097989|615875105|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
170419182|NCT05097989|615875106|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
170419183|NCT05097989|615875107|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
170531135|NCT00764790|616291441|FG001|Overall Study|Lost to Follow-up|29|||
170531136|NCT00764790|616291442|FG002|Overall Study|Lost to Follow-up|23|||
170531137|NCT03824561|616291443|FG000|Overall Study|Protocol Violation|19|||
170531138|NCT01773928|616291445|FG000|Overall Study|Adverse Event|0|||
170531139|NCT01773928|616291446|FG001|Overall Study|Adverse Event|0|||
170531140|NCT01773928|616291447|FG002|Overall Study|Adverse Event|0|||
170531141|NCT01773928|616291448|FG003|Overall Study|Adverse Event|0|||
170531142|NCT01773928|616291449|FG004|Overall Study|Adverse Event|0|||
170531143|NCT01773928|616291450|FG005|Overall Study|Adverse Event|0|||
170778329|NCT01820260|617195596|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170531144|NCT01773928|616291451|FG006|Overall Study|Adverse Event|0|||
170531145|NCT01773928|616291452|FG007|Overall Study|Adverse Event|1|||
170531146|NCT01773928|616291453|FG008|Overall Study|Adverse Event|0|||
170531147|NCT01773928|616291445|FG000|Overall Study|Physician Decision|0|||
170531148|NCT01773928|616291446|FG001|Overall Study|Physician Decision|0|||
170531149|NCT01773928|616291447|FG002|Overall Study|Physician Decision|0|||
170531150|NCT01773928|616291448|FG003|Overall Study|Physician Decision|1|||
170531151|NCT01773928|616291449|FG004|Overall Study|Physician Decision|0|||
170531152|NCT01773928|616291450|FG005|Overall Study|Physician Decision|0|||
170531153|NCT01773928|616291451|FG006|Overall Study|Physician Decision|0|||
170531154|NCT01773928|616291452|FG007|Overall Study|Physician Decision|0|||
170531155|NCT01773928|616291453|FG008|Overall Study|Physician Decision|0|||
170531156|NCT01773928|616291445|FG000|Overall Study|Withdrawal by Subject|5|||
170531157|NCT01773928|616291446|FG001|Overall Study|Withdrawal by Subject|4|||
170531158|NCT01773928|616291447|FG002|Overall Study|Withdrawal by Subject|4|||
170531159|NCT01773928|616291448|FG003|Overall Study|Withdrawal by Subject|4|||
170531160|NCT01773928|616291449|FG004|Overall Study|Withdrawal by Subject|7|||
170531161|NCT01773928|616291450|FG005|Overall Study|Withdrawal by Subject|1|||
170531162|NCT01773928|616291451|FG006|Overall Study|Withdrawal by Subject|0|||
170531163|NCT01773928|616291452|FG007|Overall Study|Withdrawal by Subject|0|||
170531164|NCT01773928|616291453|FG008|Overall Study|Withdrawal by Subject|1|||
170419184|NCT05097989|615875108|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
170419185|NCT05097989|615875109|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
170419186|NCT05097989|615875110|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
170419187|NCT05097989|615875111|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
170419188|NCT05097989|615875112|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
170419189|NCT05097989|615875104|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
170419190|NCT05097989|615875105|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
170419191|NCT05097989|615875106|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
170419192|NCT05097989|615875107|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
170419193|NCT05097989|615875108|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
170419194|NCT05097989|615875109|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
170419195|NCT05097989|615875110|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
170419196|NCT05097989|615875111|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
170419197|NCT05097989|615875112|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
170419198|NCT05097989|615875104|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170419199|NCT05097989|615875105|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170419200|NCT05097989|615875106|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170419201|NCT05097989|615875107|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170419202|NCT05097989|615875108|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170419203|NCT05097989|615875109|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170419204|NCT05097989|615875110|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170419205|NCT05097989|615875111|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170419206|NCT05097989|615875112|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170419207|NCT05097989|615875104|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
170419208|NCT05097989|615875105|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
170419209|NCT05097989|615875106|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
170419210|NCT05097989|615875107|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
170419211|NCT05097989|615875108|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
170419212|NCT05097989|615875109|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
170419213|NCT05097989|615875110|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
170419214|NCT05097989|615875111|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
170419215|NCT05097989|615875112|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
170419216|NCT05097989|615875104|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170419217|NCT05097989|615875105|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
170419218|NCT05097989|615875106|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170419219|NCT05097989|615875107|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
170419220|NCT05097989|615875108|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170419221|NCT05097989|615875109|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170419222|NCT05097989|615875110|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170419223|NCT05097989|615875111|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170419224|NCT05097989|615875112|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170531165|NCT01773928|616291445|FG000|Overall Study|Lost to Follow-up|0|||
170531166|NCT01773928|616291446|FG001|Overall Study|Lost to Follow-up|0|||
170531167|NCT01773928|616291447|FG002|Overall Study|Lost to Follow-up|0|||
170419225|NCT05097989|615875104|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
170419226|NCT05097989|615875105|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
170419227|NCT05097989|615875106|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
170419228|NCT05097989|615875107|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
170419229|NCT05097989|615875108|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
170419230|NCT05097989|615875109|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
170531168|NCT01773928|616291448|FG003|Overall Study|Lost to Follow-up|0|||
170531169|NCT01773928|616291449|FG004|Overall Study|Lost to Follow-up|0|||
170531170|NCT01773928|616291450|FG005|Overall Study|Lost to Follow-up|1|||
170531171|NCT01773928|616291451|FG006|Overall Study|Lost to Follow-up|0|||
170419231|NCT05097989|615875110|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
170419232|NCT05097989|615875111|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
170419233|NCT05097989|615875112|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
170419234|NCT05097989|615875104|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
170419235|NCT05097989|615875105|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
170419236|NCT05097989|615875106|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
170419237|NCT05097989|615875107|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
170419238|NCT05097989|615875108|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
170419239|NCT05097989|615875109|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
170419240|NCT05097989|615875110|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
170419241|NCT05097989|615875111|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
170419242|NCT05097989|615875112|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
170419243|NCT05097989|615875104|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
170419244|NCT05097989|615875105|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
170419245|NCT05097989|615875106|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
170419246|NCT05097989|615875107|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
170419247|NCT05097989|615875108|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
170419248|NCT05097989|615875109|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
170419249|NCT05097989|615875110|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
170419250|NCT05097989|615875111|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
170419251|NCT05097989|615875112|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
170419252|NCT05097989|615875104|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
170419253|NCT05097989|615875105|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
170419254|NCT05097989|615875106|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
170419255|NCT05097989|615875107|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
170419256|NCT05097989|615875108|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
170419257|NCT05097989|615875109|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
170419258|NCT05097989|615875110|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
170419259|NCT05097989|615875111|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
170419260|NCT05097989|615875112|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
170419261|NCT05097989|615875104|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
170419262|NCT05097989|615875105|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
170419263|NCT05097989|615875106|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
170419264|NCT05097989|615875107|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
170419265|NCT05097989|615875108|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
170419266|NCT05097989|615875109|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
170419267|NCT05097989|615875110|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
170419268|NCT05097989|615875111|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
170419269|NCT05097989|615875112|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
170419270|NCT02879643|615875118|FG000|Overall Study|Adverse Event|0|||
170419271|NCT02879643|615875119|FG001|Overall Study|Adverse Event|0|||
170419272|NCT02879643|615875120|FG002|Overall Study|Adverse Event|1|||
170419273|NCT02879643|615875121|FG003|Overall Study|Adverse Event|1|||
170419274|NCT02879643|615875122|FG004|Overall Study|Adverse Event|0|||
170419275|NCT01046253|615875123|FG000|Second Intervention|Adverse Event|0|||
170419276|NCT01046253|615875124|FG001|Second Intervention|Adverse Event|1|||
170419277|NCT01046253|615875123|FG000|Second Intervention|Protocol Violation|0|||
170419278|NCT01046253|615875124|FG001|Second Intervention|Protocol Violation|1|||
170419279|NCT05905783|615875125|FG000|Overall Study|Lost to Follow-up|12|||
170419280|NCT05905783|615875126|FG001|Overall Study|Lost to Follow-up|18|||
170419281|NCT05905783|615875125|FG000|Overall Study|Withdrawal by Subject|29|||
170419282|NCT05905783|615875126|FG001|Overall Study|Withdrawal by Subject|37|||
170419283|NCT05905783|615875125|FG000|Overall Study|Decision by sponsor|69|||
170419284|NCT05905783|615875126|FG001|Overall Study|Decision by sponsor|65|||
170419285|NCT00911859|615875127|FG000|Treatment Period|Adverse Event|3|||
170419286|NCT00911859|615875128|FG001|Treatment Period|Adverse Event|3|||
170419287|NCT00911859|615875129|FG002|Treatment Period|Adverse Event|7|||
170419288|NCT00911859|615875127|FG000|Treatment Period|Death|1|||
170419289|NCT00911859|615875128|FG001|Treatment Period|Death|3|||
170419290|NCT00911859|615875129|FG002|Treatment Period|Death|5|||
170419291|NCT00911859|615875127|FG000|Treatment Period|Lack of Efficacy|1|||
170419292|NCT00911859|615875128|FG001|Treatment Period|Lack of Efficacy|7|||
170419293|NCT00911859|615875129|FG002|Treatment Period|Lack of Efficacy|5|||
170419294|NCT00911859|615875127|FG000|Treatment Period|Physician Decision|3|||
170419295|NCT00911859|615875128|FG001|Treatment Period|Physician Decision|3|||
170419296|NCT00911859|615875129|FG002|Treatment Period|Physician Decision|3|||
170419297|NCT00911859|615875127|FG000|Treatment Period|Withdrawal by Subject|0|||
170419298|NCT00911859|615875128|FG001|Treatment Period|Withdrawal by Subject|4|||
170419299|NCT00911859|615875129|FG002|Treatment Period|Withdrawal by Subject|5|||
170419300|NCT00911859|615875127|FG000|Treatment Period|Did not receive study treatment|0|||
170531172|NCT01773928|616291452|FG007|Overall Study|Lost to Follow-up|0|||
170531173|NCT01773928|616291453|FG008|Overall Study|Lost to Follow-up|0|||
170531174|NCT01773928|616291445|FG000|Overall Study|Subject misrepresented age|0|||
170531175|NCT01773928|616291446|FG001|Overall Study|Subject misrepresented age|1|||
170419301|NCT00911859|615875128|FG001|Treatment Period|Did not receive study treatment|1|||
170419302|NCT00911859|615875129|FG002|Treatment Period|Did not receive study treatment|0|||
170419303|NCT00911859|615875127|FG000|Maintainance Period|Lack of Efficacy|0|||
170419304|NCT00911859|615875128|FG001|Maintainance Period|Lack of Efficacy|0|||
170419305|NCT00911859|615875129|FG002|Maintainance Period|Lack of Efficacy|9|||
170419306|NCT00911859|615875127|FG000|Maintainance Period|Physician Decision|0|||
170419307|NCT00911859|615875128|FG001|Maintainance Period|Physician Decision|0|||
170419308|NCT00911859|615875129|FG002|Maintainance Period|Physician Decision|9|||
170419309|NCT00911859|615875127|FG000|Maintainance Period|Withdrawal by Subject|0|||
170419310|NCT00911859|615875128|FG001|Maintainance Period|Withdrawal by Subject|0|||
170419311|NCT00911859|615875129|FG002|Maintainance Period|Withdrawal by Subject|3|||
170419312|NCT00911859|615875127|FG000|Follow-up Period|Death|5|||
170419313|NCT00911859|615875128|FG001|Follow-up Period|Death|8|||
170419314|NCT00911859|615875129|FG002|Follow-up Period|Death|10|||
170419315|NCT00911859|615875127|FG000|Follow-up Period|Lost to Follow-up|1|||
170419316|NCT00911859|615875128|FG001|Follow-up Period|Lost to Follow-up|1|||
170419317|NCT00911859|615875129|FG002|Follow-up Period|Lost to Follow-up|0|||
170419318|NCT00911859|615875127|FG000|Follow-up Period|Withdrawal by Subject|0|||
170419319|NCT00911859|615875128|FG001|Follow-up Period|Withdrawal by Subject|4|||
170419320|NCT00911859|615875129|FG002|Follow-up Period|Withdrawal by Subject|4|||
170419321|NCT00911859|615875127|FG000|Follow-up Period|Study terminated by sponsor|5|||
170419322|NCT00911859|615875128|FG001|Follow-up Period|Study terminated by sponsor|33|||
170419323|NCT00911859|615875129|FG002|Follow-up Period|Study terminated by sponsor|27|||
170419324|NCT01048333|615875130|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
170419325|NCT01048333|615875131|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
170419326|NCT01048333|615875132|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
170419327|NCT01048333|615875133|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
170419328|NCT01048333|615875134|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
170419329|NCT01048333|615875135|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
170419330|NCT03008460|615875140|FG000|Overall Study|Protocol deviation|0|||
170419331|NCT03008460|615875141|FG001|Overall Study|Protocol deviation|2|||
170419332|NCT03008460|615875140|FG000|Overall Study|Study drug not dispensed|0|||
170419333|NCT03008460|615875141|FG001|Overall Study|Study drug not dispensed|1|||
170419334|NCT03008460|615875140|FG000|Overall Study|Adverse Event|0|||
170419335|NCT03008460|615875141|FG001|Overall Study|Adverse Event|1|||
170419336|NCT03008460|615875140|FG000|Overall Study|Withdrawal by Subject|5|||
170419337|NCT03008460|615875141|FG001|Overall Study|Withdrawal by Subject|6|||
170419338|NCT03008460|615875140|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
170419339|NCT03008460|615875141|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
170419340|NCT03008460|615875140|FG000|Overall Study|End of study visit outside permitted time window|0|||
170419341|NCT03008460|615875141|FG001|Overall Study|End of study visit outside permitted time window|1|||
170419342|NCT03008460|615875140|FG000|Overall Study|Lost to Follow-up|1|||
170419343|NCT03008460|615875141|FG001|Overall Study|Lost to Follow-up|3|||
170419344|NCT02768298|615875143|FG000|Overall Study|Adverse Event|1|||
170419345|NCT02768298|615875144|FG001|Overall Study|Adverse Event|4|||
170419346|NCT02768298|615875143|FG000|Overall Study|Death|2|||
170419347|NCT02768298|615875144|FG001|Overall Study|Death|1|||
170419348|NCT02768298|615875143|FG000|Overall Study|Non-compliance with study treatment|0|||
170419349|NCT02768298|615875144|FG001|Overall Study|Non-compliance with study treatment|1|||
170419350|NCT02768298|615875143|FG000|Overall Study|Subject/guardian decision|1|||
170419351|NCT02768298|615875144|FG001|Overall Study|Subject/guardian decision|0|||
170419352|NCT02768298|615875143|FG000|Overall Study|Withdrawal of informed consent|0|||
170419353|NCT02768298|615875144|FG001|Overall Study|Withdrawal of informed consent|1|||
170419354|NCT02130466|615875145|FG000|Overall Study|Death|4|||
170419355|NCT02130466|615875146|FG001|Overall Study|Death|1|||
170419356|NCT02130466|615875147|FG002|Overall Study|Death|1|||
170419357|NCT02130466|615875148|FG003|Overall Study|Death|3|||
170419358|NCT02130466|615875149|FG004|Overall Study|Death|2|||
170419359|NCT02130466|615875150|FG005|Overall Study|Death|30|||
170419360|NCT02130466|615875151|FG006|Overall Study|Death|45|||
170419361|NCT02130466|615875152|FG007|Overall Study|Death|2|||
170419362|NCT02130466|615875153|FG008|Overall Study|Death|3|||
170419363|NCT02130466|615875154|FG009|Overall Study|Death|4|||
170419364|NCT02130466|615875155|FG010|Overall Study|Death|5|||
170419365|NCT02130466|615875156|FG011|Overall Study|Death|3|||
170419366|NCT02130466|615875157|FG012|Overall Study|Death|11|||
170419367|NCT02130466|615875158|FG013|Overall Study|Death|7|||
170419368|NCT02130466|615875145|FG000|Overall Study|Lost to Follow-up|1|||
170419369|NCT02130466|615875146|FG001|Overall Study|Lost to Follow-up|0|||
170419370|NCT02130466|615875147|FG002|Overall Study|Lost to Follow-up|0|||
170419371|NCT02130466|615875148|FG003|Overall Study|Lost to Follow-up|0|||
170419372|NCT02130466|615875149|FG004|Overall Study|Lost to Follow-up|0|||
170419373|NCT02130466|615875150|FG005|Overall Study|Lost to Follow-up|1|||
170878060|NCT02104583|617565587|FG003|Overall Study|Withdrew Consent|2|||
170531176|NCT01773928|616291447|FG002|Overall Study|Subject misrepresented age|0|||
170531177|NCT01773928|616291448|FG003|Overall Study|Subject misrepresented age|0|||
170419374|NCT02130466|615875151|FG006|Overall Study|Lost to Follow-up|0|||
170419375|NCT02130466|615875152|FG007|Overall Study|Lost to Follow-up|0|||
170419376|NCT02130466|615875153|FG008|Overall Study|Lost to Follow-up|0|||
170419377|NCT02130466|615875154|FG009|Overall Study|Lost to Follow-up|0|||
170419378|NCT02130466|615875155|FG010|Overall Study|Lost to Follow-up|0|||
170419379|NCT02130466|615875156|FG011|Overall Study|Lost to Follow-up|0|||
170419380|NCT02130466|615875157|FG012|Overall Study|Lost to Follow-up|1|||
170419381|NCT02130466|615875158|FG013|Overall Study|Lost to Follow-up|0|||
170419382|NCT02130466|615875145|FG000|Overall Study|Physician Decision|0|||
170419383|NCT02130466|615875146|FG001|Overall Study|Physician Decision|0|||
170419384|NCT02130466|615875147|FG002|Overall Study|Physician Decision|0|||
170419385|NCT02130466|615875148|FG003|Overall Study|Physician Decision|0|||
170419386|NCT02130466|615875149|FG004|Overall Study|Physician Decision|0|||
170419387|NCT02130466|615875150|FG005|Overall Study|Physician Decision|1|||
170419388|NCT02130466|615875151|FG006|Overall Study|Physician Decision|1|||
170419389|NCT02130466|615875152|FG007|Overall Study|Physician Decision|0|||
170419390|NCT02130466|615875153|FG008|Overall Study|Physician Decision|0|||
170419391|NCT02130466|615875154|FG009|Overall Study|Physician Decision|0|||
170419392|NCT02130466|615875155|FG010|Overall Study|Physician Decision|0|||
170419393|NCT02130466|615875156|FG011|Overall Study|Physician Decision|0|||
170419394|NCT02130466|615875157|FG012|Overall Study|Physician Decision|0|||
170419395|NCT02130466|615875158|FG013|Overall Study|Physician Decision|0|||
170419396|NCT02130466|615875145|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
170419397|NCT02130466|615875146|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
170419398|NCT02130466|615875147|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
170419399|NCT02130466|615875148|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
170419400|NCT02130466|615875149|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
170419401|NCT02130466|615875150|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
170419402|NCT02130466|615875151|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
170419403|NCT02130466|615875152|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
170419404|NCT02130466|615875153|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
170419405|NCT02130466|615875154|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
170419406|NCT02130466|615875155|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
170419407|NCT02130466|615875156|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
170419408|NCT02130466|615875157|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
170419409|NCT02130466|615875158|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
170419410|NCT02130466|615875145|FG000|Overall Study|Withdrawal by Subject|1|||
170419411|NCT02130466|615875146|FG001|Overall Study|Withdrawal by Subject|0|||
170419412|NCT02130466|615875147|FG002|Overall Study|Withdrawal by Subject|0|||
170419413|NCT02130466|615875148|FG003|Overall Study|Withdrawal by Subject|0|||
170419414|NCT02130466|615875149|FG004|Overall Study|Withdrawal by Subject|0|||
170419415|NCT02130466|615875150|FG005|Overall Study|Withdrawal by Subject|1|||
170419416|NCT02130466|615875151|FG006|Overall Study|Withdrawal by Subject|0|||
170419417|NCT02130466|615875152|FG007|Overall Study|Withdrawal by Subject|0|||
170419418|NCT02130466|615875153|FG008|Overall Study|Withdrawal by Subject|1|||
170419419|NCT02130466|615875154|FG009|Overall Study|Withdrawal by Subject|0|||
170419420|NCT02130466|615875155|FG010|Overall Study|Withdrawal by Subject|0|||
170419421|NCT02130466|615875156|FG011|Overall Study|Withdrawal by Subject|0|||
170419422|NCT02130466|615875157|FG012|Overall Study|Withdrawal by Subject|0|||
170419423|NCT02130466|615875158|FG013|Overall Study|Withdrawal by Subject|0|||
170419424|NCT04529109|615875159|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
170419425|NCT04529109|615875160|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
170419426|NCT01611090|615875161|FG000|Randomized Period|Lost to Follow-up|8|||
170419427|NCT01611090|615875162|FG001|Randomized Period|Lost to Follow-up|3|||
170419428|NCT01611090|615875163|FG002|Randomized Period|Lost to Follow-up|0|||
170419429|NCT01611090|615875161|FG000|Randomized Period|Withdrawal by Subject|22|||
170878061|NCT02104583|617565588|FG004|Overall Study|Withdrew Consent|1|||
170878062|NCT02104583|617565584|FG000|Overall Study|Investigator's Discretion|1|||
170878063|NCT02104583|617565585|FG001|Overall Study|Investigator's Discretion|0|||
170878064|NCT02104583|617565586|FG002|Overall Study|Investigator's Discretion|0|||
170878065|NCT02104583|617565587|FG003|Overall Study|Investigator's Discretion|0|||
170419430|NCT01611090|615875162|FG001|Randomized Period|Withdrawal by Subject|26|||
170419431|NCT01611090|615875163|FG002|Randomized Period|Withdrawal by Subject|0|||
170419432|NCT01611090|615875161|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
170419433|NCT01611090|615875162|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
170419434|NCT01611090|615875163|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
170419435|NCT01611090|615875161|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
170419436|NCT01611090|615875162|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
170531178|NCT01773928|616291449|FG004|Overall Study|Subject misrepresented age|0|||
170878066|NCT02104583|617565588|FG004|Overall Study|Investigator's Discretion|0|||
170531179|NCT01773928|616291450|FG005|Overall Study|Subject misrepresented age|0|||
170531180|NCT01773928|616291451|FG006|Overall Study|Subject misrepresented age|0|||
170531181|NCT01773928|616291452|FG007|Overall Study|Subject misrepresented age|0|||
170531182|NCT01773928|616291453|FG008|Overall Study|Subject misrepresented age|0|||
170531183|NCT01773928|616291445|FG000|Overall Study|Subject met exclusion criteria|0|||
170531184|NCT01773928|616291446|FG001|Overall Study|Subject met exclusion criteria|0|||
170531185|NCT01773928|616291447|FG002|Overall Study|Subject met exclusion criteria|0|||
170531186|NCT01773928|616291448|FG003|Overall Study|Subject met exclusion criteria|0|||
170531187|NCT01773928|616291449|FG004|Overall Study|Subject met exclusion criteria|0|||
170531188|NCT01773928|616291450|FG005|Overall Study|Subject met exclusion criteria|0|||
170531189|NCT01773928|616291451|FG006|Overall Study|Subject met exclusion criteria|0|||
170531190|NCT01773928|616291452|FG007|Overall Study|Subject met exclusion criteria|0|||
170531191|NCT01773928|616291453|FG008|Overall Study|Subject met exclusion criteria|1|||
170531192|NCT01773928|616291445|FG000|Overall Study|Randomized, had to leave, never returned|0|||
170531193|NCT01773928|616291446|FG001|Overall Study|Randomized, had to leave, never returned|0|||
170531194|NCT01773928|616291447|FG002|Overall Study|Randomized, had to leave, never returned|0|||
170531195|NCT01773928|616291448|FG003|Overall Study|Randomized, had to leave, never returned|1|||
170531196|NCT01773928|616291449|FG004|Overall Study|Randomized, had to leave, never returned|0|||
170531197|NCT01773928|616291450|FG005|Overall Study|Randomized, had to leave, never returned|0|||
170531198|NCT01773928|616291451|FG006|Overall Study|Randomized, had to leave, never returned|0|||
170531199|NCT01773928|616291452|FG007|Overall Study|Randomized, had to leave, never returned|0|||
170531200|NCT01773928|616291453|FG008|Overall Study|Randomized, had to leave, never returned|0|||
170531201|NCT01773928|616291445|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
170531202|NCT01773928|616291446|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
170531203|NCT01773928|616291447|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
170531204|NCT01773928|616291448|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
170531205|NCT01773928|616291449|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
170531206|NCT01773928|616291450|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
170531207|NCT01773928|616291451|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
170531208|NCT01773928|616291452|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
170531209|NCT01773928|616291453|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
170531210|NCT02370511|616291454|FG000|Overall Study|Death|10|||
170531211|NCT02370511|616291455|FG001|Overall Study|Death|7|||
170531212|NCT02370511|616291456|FG002|Overall Study|Death|1|||
170531213|NCT02370511|616291454|FG000|Overall Study|Withdrawal by Subject|2|||
170531214|NCT02370511|616291455|FG001|Overall Study|Withdrawal by Subject|0|||
170531215|NCT02370511|616291456|FG002|Overall Study|Withdrawal by Subject|0|||
170531216|NCT02370511|616291454|FG000|Overall Study|Lost to Follow-up|0|||
170531217|NCT02370511|616291455|FG001|Overall Study|Lost to Follow-up|4|||
170531218|NCT02370511|616291456|FG002|Overall Study|Lost to Follow-up|0|||
170531219|NCT03092752|616291457|FG000|Overall Study|Aged <40 years|14209|||
170531220|NCT03092752|616291457|FG000|Overall Study|At least one claim with T2DM|61299|||
170531221|NCT03092752|616291457|FG000|Overall Study|Having no claim of study drugs|29282|||
170531222|NCT03092752|616291457|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
170531223|NCT03092752|616291457|FG000|Overall Study|<6 month history|245900|||
170531224|NCT01652690|616291458|FG000|Overall Study|Withdrawal by Subject|16|||
170531225|NCT01652690|616291459|FG001|Overall Study|Withdrawal by Subject|4|||
170531226|NCT01652690|616291458|FG000|Overall Study|Other|8|||
170531227|NCT01652690|616291459|FG001|Overall Study|Other|9|||
170531228|NCT01652690|616291458|FG000|Overall Study|Lost to Follow-up|6|||
170531229|NCT01652690|616291459|FG001|Overall Study|Lost to Follow-up|6|||
170531230|NCT01652690|616291458|FG000|Overall Study|Death|5|||
170531231|NCT01652690|616291459|FG001|Overall Study|Death|2|||
170531232|NCT06996301|616291460|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
170531233|NCT06996301|616291461|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
170531234|NCT06996301|616291460|FG000|Overall Study|Patients with discordant diagnostic results|107|||
170531235|NCT06996301|616291461|FG001|Overall Study|Patients with discordant diagnostic results|90|||
170531236|NCT06996301|616291460|FG000|Overall Study|Lost to Follow-up|31|||
170531237|NCT06996301|616291461|FG001|Overall Study|Lost to Follow-up|56|||
170531238|NCT06996301|616291460|FG000|Overall Study|Withdrawal by Subject|12|||
170531239|NCT06996301|616291461|FG001|Overall Study|Withdrawal by Subject|7|||
170531240|NCT01884597|616291462|FG000|Overall Study|Adverse Event|0|||
170531241|NCT01884597|616291463|FG001|Overall Study|Adverse Event|0|||
170531242|NCT01884597|616291464|FG002|Overall Study|Adverse Event|1|||
170531243|NCT01884597|616291462|FG000|Overall Study|Lack of Efficacy|1|||
170531244|NCT01884597|616291463|FG001|Overall Study|Lack of Efficacy|0|||
170531245|NCT01884597|616291464|FG002|Overall Study|Lack of Efficacy|0|||
170531246|NCT01884597|616291462|FG000|Overall Study|Death|0|||
170531247|NCT01884597|616291463|FG001|Overall Study|Death|1|||
170531248|NCT01884597|616291464|FG002|Overall Study|Death|0|||
170531249|NCT02074514|616291466|FG000|Overall Study|Lack of Efficacy|3|||
170531250|NCT02074514|616291467|FG001|Overall Study|Lack of Efficacy|2|||
170531251|NCT02074514|616291466|FG000|Overall Study|Lost to Follow-up|0|||
170531252|NCT02074514|616291467|FG001|Overall Study|Lost to Follow-up|1|||
170531253|NCT02074514|616291466|FG000|Overall Study|Withdrew Consent|0|||
170531254|NCT02074514|616291467|FG001|Overall Study|Withdrew Consent|1|||
170531255|NCT00788671|616293238|FG000|Overall Study|Death|2|||
170878067|NCT02104583|617565584|FG000|Overall Study|Protocol Violation|0|||
170878068|NCT02104583|617565585|FG001|Overall Study|Protocol Violation|0|||
170878069|NCT02104583|617565586|FG002|Overall Study|Protocol Violation|1|||
170878070|NCT02104583|617565587|FG003|Overall Study|Protocol Violation|0|||
170878071|NCT02104583|617565588|FG004|Overall Study|Protocol Violation|0|||
170878072|NCT02104583|617565584|FG000|Overall Study|Adverse Event|3|||
170878073|NCT02104583|617565585|FG001|Overall Study|Adverse Event|3|||
170878074|NCT02104583|617565586|FG002|Overall Study|Adverse Event|6|||
170878075|NCT02104583|617565587|FG003|Overall Study|Adverse Event|6|||
170878076|NCT02104583|617565588|FG004|Overall Study|Adverse Event|1|||
170878077|NCT02104583|617565584|FG000|Overall Study|Lost to Follow-up|1|||
170878078|NCT02104583|617565585|FG001|Overall Study|Lost to Follow-up|0|||
170878079|NCT02104583|617565586|FG002|Overall Study|Lost to Follow-up|0|||
170878080|NCT02104583|617565587|FG003|Overall Study|Lost to Follow-up|0|||
170878081|NCT02104583|617565588|FG004|Overall Study|Lost to Follow-up|0|||
170878082|NCT02104583|617565584|FG000|Overall Study|Randomized but Never Treated|0|||
170878083|NCT02104583|617565585|FG001|Overall Study|Randomized but Never Treated|0|||
170878084|NCT02104583|617565586|FG002|Overall Study|Randomized but Never Treated|0|||
170878085|NCT02104583|617565587|FG003|Overall Study|Randomized but Never Treated|1|||
170878086|NCT02104583|617565588|FG004|Overall Study|Randomized but Never Treated|0|||
170878087|NCT01192022|617565589|FG000|Overall Study|Withdrawal of Consent|3|||
170878088|NCT01192022|617565590|FG001|Overall Study|Withdrawal of Consent|1|||
170878089|NCT01192022|617565591|FG002|Overall Study|Withdrawal of Consent|0|||
170878090|NCT01192022|617565592|FG003|Overall Study|Withdrawal of Consent|0|||
170878091|NCT01192022|617565593|FG004|Overall Study|Withdrawal of Consent|0|||
170878092|NCT01192022|617565589|FG000|Overall Study|Lost to Follow-up|4|||
170878093|NCT01192022|617565590|FG001|Overall Study|Lost to Follow-up|2|||
170878094|NCT01192022|617565591|FG002|Overall Study|Lost to Follow-up|1|||
170878095|NCT01192022|617565592|FG003|Overall Study|Lost to Follow-up|1|||
170878096|NCT01192022|617565593|FG004|Overall Study|Lost to Follow-up|0|||
170878097|NCT01192022|617565589|FG000|Overall Study|Adverse Event|1|||
170878098|NCT01192022|617565590|FG001|Overall Study|Adverse Event|0|||
170878099|NCT01192022|617565591|FG002|Overall Study|Adverse Event|0|||
170878100|NCT01192022|617565592|FG003|Overall Study|Adverse Event|0|||
170878101|NCT01192022|617565593|FG004|Overall Study|Adverse Event|0|||
170878102|NCT01192022|617565589|FG000|Overall Study|Fatal Adverse Event|4|||
170878103|NCT01192022|617565590|FG001|Overall Study|Fatal Adverse Event|6|||
170878104|NCT01192022|617565591|FG002|Overall Study|Fatal Adverse Event|0|||
170878105|NCT01192022|617565592|FG003|Overall Study|Fatal Adverse Event|0|||
170878106|NCT01192022|617565593|FG004|Overall Study|Fatal Adverse Event|1|||
170878107|NCT01192022|617565589|FG000|Overall Study|Physician withdrew-patient hardship|1|||
170878108|NCT01192022|617565590|FG001|Overall Study|Physician withdrew-patient hardship|0|||
170878109|NCT01192022|617565591|FG002|Overall Study|Physician withdrew-patient hardship|0|||
170878110|NCT01192022|617565592|FG003|Overall Study|Physician withdrew-patient hardship|0|||
170878111|NCT01192022|617565593|FG004|Overall Study|Physician withdrew-patient hardship|0|||
170878112|NCT01192022|617565589|FG000|Overall Study|Patient too sick from chemotherapy|0|||
170878113|NCT01192022|617565590|FG001|Overall Study|Patient too sick from chemotherapy|1|||
170878114|NCT01192022|617565591|FG002|Overall Study|Patient too sick from chemotherapy|0|||
170878115|NCT01192022|617565592|FG003|Overall Study|Patient too sick from chemotherapy|0|||
170878116|NCT01192022|617565593|FG004|Overall Study|Patient too sick from chemotherapy|0|||
170878117|NCT01192022|617565589|FG000|Overall Study|Patient needed surgery|0|||
170878118|NCT01192022|617565590|FG001|Overall Study|Patient needed surgery|1|||
170878119|NCT01192022|617565591|FG002|Overall Study|Patient needed surgery|0|||
170878120|NCT01192022|617565592|FG003|Overall Study|Patient needed surgery|0|||
170878121|NCT01192022|617565593|FG004|Overall Study|Patient needed surgery|0|||
170878122|NCT01192022|617565589|FG000|Overall Study|Parents did not allow all follow up|0|||
170878123|NCT01192022|617565590|FG001|Overall Study|Parents did not allow all follow up|0|||
170878124|NCT01192022|617565591|FG002|Overall Study|Parents did not allow all follow up|0|||
170878125|NCT01192022|617565592|FG003|Overall Study|Parents did not allow all follow up|1|||
170878126|NCT01192022|617565593|FG004|Overall Study|Parents did not allow all follow up|0|||
170878127|NCT01351389|617565594|FG000|Overall Study|Withdrawal by Subject|7|||
170878128|NCT01351389|617565595|FG001|Overall Study|Withdrawal by Subject|0|||
170878129|NCT01351389|617565594|FG000|Overall Study|did not complete intervention|23|||
170878130|NCT01351389|617565595|FG001|Overall Study|did not complete intervention|15|||
170878131|NCT01549275|617565597|FG000|Overall Study|Lost to Follow-up|1|||
170878132|NCT01549275|617565598|FG001|Overall Study|Lost to Follow-up|0|||
170878133|NCT01230307|617565599|FG000|Overall Study|LVAD Placement|0|||
170531256|NCT00788671|616293238|FG000|Overall Study|Unable to biopsy|1|||
170878134|NCT01230307|617565600|FG001|Overall Study|LVAD Placement|2|||
170878135|NCT04773106|617565603|FG000|Overall Study|Withdrawal by Subject|3|||
170878136|NCT04773106|617565603|FG000|Overall Study|Death|1|||
170531257|NCT00788671|616293238|FG000|Overall Study|Withdrawal by Subject|4|||
170531258|NCT00788671|616293238|FG000|Overall Study|IUD expulsed|1|||
170531259|NCT00788671|616293238|FG000|Overall Study|Lost to follow up|2|||
170531260|NCT04780659|616293239|FG000|Overall Study|Adverse event, serious fatal|3|||
170531261|NCT04780659|616293240|FG001|Overall Study|Adverse event, serious fatal|0|||
170531262|NCT04780659|616293239|FG000|Overall Study|Withdrawal by Subject|3|||
170531263|NCT04780659|616293240|FG001|Overall Study|Withdrawal by Subject|0|||
170531264|NCT04780659|616293239|FG000|Overall Study|Physician Decision|1|||
170531265|NCT04780659|616293240|FG001|Overall Study|Physician Decision|0|||
170531266|NCT04780659|616293239|FG000|Overall Study|Died in original disease|2|||
170531267|NCT04780659|616293240|FG001|Overall Study|Died in original disease|0|||
170531268|NCT04780659|616293239|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
170531269|NCT04780659|616293240|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
170531270|NCT05507437|616293241|FG000|Overall Study|Withdrawal by Subject|1|||
170531271|NCT05507437|616293242|FG001|Overall Study|Withdrawal by Subject|1|||
170531272|NCT05507437|616293241|FG000|Overall Study|Death|3|||
170531273|NCT05507437|616293242|FG001|Overall Study|Death|0|||
170531274|NCT06583096|616293243|FG000|Overall Study|Lost to Follow-up|4|||
170531275|NCT06583096|616293244|FG001|Overall Study|Lost to Follow-up|10|||
170531276|NCT06583096|616293243|FG000|Overall Study|Withdrawal by Subject|0|||
170531277|NCT06583096|616293244|FG001|Overall Study|Withdrawal by Subject|2|||
170531278|NCT05172609|616293245|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
170531279|NCT05172609|616293246|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
170531280|NCT05172609|616293245|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
170531281|NCT05172609|616293246|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
170531282|NCT05172609|616293245|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
170531283|NCT05172609|616293246|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
170531284|NCT05610605|616293249|FG000|6-month Assessment|Death|1|||
170531285|NCT05610605|616293250|FG001|6-month Assessment|Death|1|||
170531286|NCT05610605|616293249|FG000|6-month Assessment|Lost to Follow-up|20|||
170531287|NCT05610605|616293250|FG001|6-month Assessment|Lost to Follow-up|0|||
170531288|NCT05610605|616293249|FG000|6-month Assessment|Institutionalized|1|||
170531289|NCT05610605|616293250|FG001|6-month Assessment|Institutionalized|2|||
170531290|NCT05610605|616293249|FG000|12-month Assessment|Death|2|||
170531291|NCT05610605|616293250|FG001|12-month Assessment|Death|1|||
170531292|NCT05610605|616293249|FG000|12-month Assessment|Lost to Follow-up|1|||
170531293|NCT05610605|616293250|FG001|12-month Assessment|Lost to Follow-up|4|||
170531294|NCT05610605|616293249|FG000|12-month Assessment|Institutionalized|2|||
170531295|NCT05610605|616293250|FG001|12-month Assessment|Institutionalized|1|||
170531296|NCT00753519|616293251|FG000|Overall Study|Withdrawal by Subject|0|||
170531297|NCT00753519|616293252|FG001|Overall Study|Withdrawal by Subject|2|||
170531298|NCT03801252|616293254|FG000|Overall Study|Protocol Violation|1|||
170531299|NCT03801252|616293255|FG001|Overall Study|Protocol Violation|2|||
170531300|NCT00855582|616293256|FG000|Overall Study|Adverse Event|2|||
170531301|NCT00855582|616293257|FG001|Overall Study|Adverse Event|6|||
170531302|NCT00855582|616293258|FG002|Overall Study|Adverse Event|3|||
170531303|NCT00855582|616293256|FG000|Overall Study|Death|1|||
170878137|NCT00122681|617565611|FG000|Overall Study|Adverse Event|20|||
170878138|NCT00122681|617565612|FG001|Overall Study|Adverse Event|16|||
170878139|NCT00122681|617565611|FG000|Overall Study|Lost to Follow-up|1080|||
170878140|NCT00122681|617565612|FG001|Overall Study|Lost to Follow-up|1097|||
170878141|NCT00122681|617565611|FG000|Overall Study|Protocol Violation|7|||
170878142|NCT00122681|617565612|FG001|Overall Study|Protocol Violation|10|||
170878143|NCT00122681|617565611|FG000|Overall Study|Withdrawal by Subject|257|||
170531304|NCT00855582|616293257|FG001|Overall Study|Death|0|||
170531305|NCT00855582|616293258|FG002|Overall Study|Death|0|||
170531306|NCT00855582|616293256|FG000|Overall Study|Lack of Efficacy|1|||
170531307|NCT00855582|616293257|FG001|Overall Study|Lack of Efficacy|3|||
170531308|NCT00855582|616293258|FG002|Overall Study|Lack of Efficacy|8|||
170531309|NCT00855582|616293256|FG000|Overall Study|Lost to Follow-up|1|||
170531310|NCT00855582|616293257|FG001|Overall Study|Lost to Follow-up|3|||
170531311|NCT00855582|616293258|FG002|Overall Study|Lost to Follow-up|1|||
170531312|NCT00855582|616293256|FG000|Overall Study|Physician Decision|0|||
170531313|NCT00855582|616293257|FG001|Overall Study|Physician Decision|0|||
170531314|NCT00855582|616293258|FG002|Overall Study|Physician Decision|1|||
170531315|NCT00855582|616293256|FG000|Overall Study|Protocol Violation|6|||
170878144|NCT00122681|617565612|FG001|Overall Study|Withdrawal by Subject|251|||
170531316|NCT00855582|616293257|FG001|Overall Study|Protocol Violation|2|||
170878145|NCT00122681|617565611|FG000|Overall Study|Personal reasons|150|||
170878146|NCT00122681|617565612|FG001|Overall Study|Personal reasons|147|||
170878147|NCT02819635|617565614|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
170878148|NCT02819635|617565615|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
170878149|NCT02819635|617565616|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
170878150|NCT02819635|617565617|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
170878151|NCT02819635|617565618|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
170878152|NCT02819635|617565619|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
170878153|NCT02819635|617565620|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
170878154|NCT02819635|617565621|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
170878155|NCT02819635|617565622|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
170878156|NCT02819635|617565623|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
170878157|NCT02819635|617565624|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
170878158|NCT02819635|617565625|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
170878159|NCT02819635|617565614|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878160|NCT02819635|617565615|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878161|NCT02819635|617565616|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878162|NCT02819635|617565617|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878163|NCT02819635|617565618|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
170878164|NCT02819635|617565619|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
170878165|NCT02819635|617565620|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
170878166|NCT02819635|617565621|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878167|NCT02819635|617565622|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878168|NCT02819635|617565623|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878169|NCT02819635|617565624|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878170|NCT02819635|617565625|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
170878171|NCT02819635|617565614|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878172|NCT02819635|617565615|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878173|NCT02819635|617565616|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878174|NCT02819635|617565617|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878175|NCT02819635|617565618|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878176|NCT02819635|617565619|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
170878177|NCT02819635|617565620|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
170878178|NCT02819635|617565621|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878179|NCT02819635|617565622|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878180|NCT02819635|617565623|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878181|NCT02819635|617565624|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878182|NCT02819635|617565625|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
170878183|NCT02819635|617565614|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878184|NCT02819635|617565615|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878185|NCT02819635|617565616|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878186|NCT02819635|617565617|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878187|NCT02819635|617565618|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878188|NCT02819635|617565619|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878189|NCT02819635|617565620|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
170878190|NCT02819635|617565621|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878191|NCT02819635|617565622|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878192|NCT02819635|617565623|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170419437|NCT01611090|615875163|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
170419438|NCT00922779|615875164|FG000|Overall Study|Adverse Event|67|||
170419439|NCT00922779|615875164|FG000|Overall Study|Pregnancy|7|||
170419440|NCT00922779|615875164|FG000|Overall Study|Withdrawal by Subject|308|||
170419441|NCT00922779|615875164|FG000|Overall Study|Lost to Follow-up|44|||
170419442|NCT00922779|615875164|FG000|Overall Study|Other|27|||
170419443|NCT00922779|615875164|FG000|Overall Study|Missing|1874|||
170419444|NCT03968224|615875165|FG000|Overall Study|Lost to Follow-up|11|||
170419445|NCT03968224|615875166|FG001|Overall Study|Lost to Follow-up|18|||
170419446|NCT00770315|615875169|FG000|Overall Study|Adverse Event|11|||
170419447|NCT00770315|615875170|FG001|Overall Study|Adverse Event|17|||
170419448|NCT00770315|615875171|FG002|Overall Study|Adverse Event|16|||
170419449|NCT00770315|615875172|FG003|Overall Study|Adverse Event|6|||
170878193|NCT02819635|617565624|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878194|NCT02819635|617565625|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
170878195|NCT02819635|617565614|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
170878196|NCT02819635|617565615|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
170878197|NCT02819635|617565616|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
170419450|NCT00770315|615875169|FG000|Overall Study|Lost to Follow-up|9|||
170419451|NCT00770315|615875170|FG001|Overall Study|Lost to Follow-up|5|||
170419452|NCT00770315|615875171|FG002|Overall Study|Lost to Follow-up|10|||
170878198|NCT02819635|617565617|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
170878199|NCT02819635|617565618|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
170878200|NCT02819635|617565619|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
170878201|NCT02819635|617565620|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
170878202|NCT02819635|617565621|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
170878203|NCT02819635|617565622|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
170878204|NCT02819635|617565623|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
170878205|NCT02819635|617565624|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
170878206|NCT02819635|617565625|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
170878207|NCT02819635|617565614|FG000|Substudy 2, Part 2|Adverse Event|0|||
170878208|NCT02819635|617565615|FG001|Substudy 2, Part 2|Adverse Event|0|||
170878209|NCT02819635|617565616|FG002|Substudy 2, Part 2|Adverse Event|0|||
170878210|NCT02819635|617565617|FG003|Substudy 2, Part 2|Adverse Event|0|||
170878211|NCT02819635|617565618|FG004|Substudy 2, Part 2|Adverse Event|0|||
170878212|NCT02819635|617565619|FG005|Substudy 2, Part 2|Adverse Event|4|||
170878213|NCT02819635|617565620|FG006|Substudy 2, Part 2|Adverse Event|0|||
170878214|NCT02819635|617565621|FG007|Substudy 2, Part 2|Adverse Event|0|||
170878215|NCT02819635|617565622|FG008|Substudy 2, Part 2|Adverse Event|0|||
170878216|NCT02819635|617565623|FG009|Substudy 2, Part 2|Adverse Event|0|||
170878217|NCT02819635|617565624|FG010|Substudy 2, Part 2|Adverse Event|0|||
170878218|NCT02819635|617565625|FG011|Substudy 2, Part 2|Adverse Event|0|||
170878219|NCT02819635|617565614|FG000|Substudy 2, Part 2|Withdrew consent|0|||
170878220|NCT02819635|617565615|FG001|Substudy 2, Part 2|Withdrew consent|0|||
170878221|NCT02819635|617565616|FG002|Substudy 2, Part 2|Withdrew consent|0|||
170878222|NCT02819635|617565617|FG003|Substudy 2, Part 2|Withdrew consent|0|||
170878223|NCT02819635|617565618|FG004|Substudy 2, Part 2|Withdrew consent|0|||
170878224|NCT02819635|617565619|FG005|Substudy 2, Part 2|Withdrew consent|3|||
170878225|NCT02819635|617565620|FG006|Substudy 2, Part 2|Withdrew consent|1|||
170878226|NCT02819635|617565621|FG007|Substudy 2, Part 2|Withdrew consent|0|||
170878227|NCT02819635|617565622|FG008|Substudy 2, Part 2|Withdrew consent|0|||
170878228|NCT02819635|617565623|FG009|Substudy 2, Part 2|Withdrew consent|0|||
170878229|NCT02819635|617565624|FG010|Substudy 2, Part 2|Withdrew consent|0|||
170878230|NCT02819635|617565625|FG011|Substudy 2, Part 2|Withdrew consent|0|||
170878231|NCT02819635|617565614|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
170878232|NCT02819635|617565615|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
170878233|NCT02819635|617565616|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
170878234|NCT02819635|617565617|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
170878235|NCT02819635|617565618|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
170878236|NCT02819635|617565619|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
170878237|NCT02819635|617565620|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
170878238|NCT02819635|617565621|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
170878239|NCT02819635|617565622|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
170878240|NCT02819635|617565623|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
170878241|NCT02819635|617565624|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
170878242|NCT02819635|617565625|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
170878243|NCT02819635|617565614|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878244|NCT02819635|617565615|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878245|NCT02819635|617565616|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878246|NCT02819635|617565617|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878247|NCT02819635|617565618|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878248|NCT02819635|617565619|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878249|NCT02819635|617565620|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
170878250|NCT02819635|617565621|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878251|NCT02819635|617565622|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878252|NCT02819635|617565623|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878253|NCT02819635|617565624|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878254|NCT02819635|617565625|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
170878255|NCT02819635|617565614|FG000|Substudy 2, Part 2|Other, not specified|0|||
170878256|NCT02819635|617565615|FG001|Substudy 2, Part 2|Other, not specified|0|||
170419453|NCT00770315|615875172|FG003|Overall Study|Lost to Follow-up|3|||
170419454|NCT00770315|615875169|FG000|Overall Study|Withdrawal by Subject|13|||
170632632|NCT01929317|616666723|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
170878257|NCT02819635|617565616|FG002|Substudy 2, Part 2|Other, not specified|0|||
170878258|NCT02819635|617565617|FG003|Substudy 2, Part 2|Other, not specified|0|||
170878259|NCT02819635|617565618|FG004|Substudy 2, Part 2|Other, not specified|0|||
170878260|NCT02819635|617565619|FG005|Substudy 2, Part 2|Other, not specified|4|||
170878261|NCT02819635|617565620|FG006|Substudy 2, Part 2|Other, not specified|8|||
170878262|NCT02819635|617565621|FG007|Substudy 2, Part 2|Other, not specified|0|||
170878263|NCT02819635|617565622|FG008|Substudy 2, Part 2|Other, not specified|0|||
170878264|NCT02819635|617565623|FG009|Substudy 2, Part 2|Other, not specified|0|||
170878265|NCT02819635|617565624|FG010|Substudy 2, Part 2|Other, not specified|0|||
170878266|NCT02819635|617565625|FG011|Substudy 2, Part 2|Other, not specified|0|||
170878267|NCT02819635|617565614|FG000|Substudy 3|Adverse Event|0|||
170419455|NCT00770315|615875170|FG001|Overall Study|Withdrawal by Subject|17|||
170419456|NCT00770315|615875171|FG002|Overall Study|Withdrawal by Subject|24|||
170419457|NCT00770315|615875172|FG003|Overall Study|Withdrawal by Subject|20|||
170419458|NCT00770315|615875169|FG000|Overall Study|Noncompliance with Protocol|7|||
170419459|NCT00770315|615875170|FG001|Overall Study|Noncompliance with Protocol|4|||
170419460|NCT00770315|615875171|FG002|Overall Study|Noncompliance with Protocol|7|||
170419461|NCT00770315|615875172|FG003|Overall Study|Noncompliance with Protocol|9|||
170419462|NCT05067504|615875174|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
170419463|NCT05067504|615875175|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
170419464|NCT05067504|615875174|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
170419465|NCT05067504|615875175|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
170419466|NCT05067504|615875174|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
170419467|NCT05067504|615875175|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
170419468|NCT04349917|615876640|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
170419469|NCT04349917|615876641|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
170419470|NCT04349917|615876640|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
170419471|NCT04349917|615876641|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
170419472|NCT00088829|615876649|FG000|Overall Study|PI left institution and study was close|22|||
170419473|NCT02419313|615876650|FG000|First Intervention|Lost to Follow-up|2|||
170419474|NCT02419313|615876651|FG001|First Intervention|Lost to Follow-up|0|||
170419475|NCT02419313|615876650|FG000|Second Intervention|Lost to Follow-up|1|||
170419476|NCT02419313|615876651|FG001|Second Intervention|Lost to Follow-up|0|||
170419477|NCT00688064|615876655|FG000|Overall Study|Protocol Violation|0|||
170419478|NCT00688064|615876656|FG001|Overall Study|Protocol Violation|1|||
170419479|NCT00688064|615876655|FG000|Overall Study|Adverse Event|2|||
170419480|NCT00688064|615876656|FG001|Overall Study|Adverse Event|4|||
170419481|NCT00688064|615876655|FG000|Overall Study|Withdrawal by Subject|7|||
170419482|NCT00688064|615876656|FG001|Overall Study|Withdrawal by Subject|7|||
170419483|NCT00688064|615876655|FG000|Overall Study|Lost to Follow-up|10|||
170419484|NCT00688064|615876656|FG001|Overall Study|Lost to Follow-up|10|||
170419485|NCT00688064|615876655|FG000|Overall Study|Lack of Efficacy|0|||
170419486|NCT00688064|615876656|FG001|Overall Study|Lack of Efficacy|1|||
170419487|NCT00688064|615876655|FG000|Overall Study|Pregnancy|1|||
170419488|NCT00688064|615876656|FG001|Overall Study|Pregnancy|0|||
170419489|NCT00688064|615876655|FG000|Overall Study|Any other reasons|1|||
170632633|NCT01929317|616666724|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
170878268|NCT02819635|617565615|FG001|Substudy 3|Adverse Event|0|||
170878269|NCT02819635|617565616|FG002|Substudy 3|Adverse Event|0|||
170878270|NCT02819635|617565617|FG003|Substudy 3|Adverse Event|0|||
170878271|NCT02819635|617565618|FG004|Substudy 3|Adverse Event|0|||
170878272|NCT02819635|617565619|FG005|Substudy 3|Adverse Event|0|||
170878273|NCT02819635|617565620|FG006|Substudy 3|Adverse Event|0|||
170419490|NCT00688064|615876656|FG001|Overall Study|Any other reasons|3|||
170419491|NCT00524459|615876657|FG000|Overall Study|Withdrawal by Subject|1|||
170419492|NCT00524459|615876657|FG000|Overall Study|Other|1|||
170419493|NCT02428699|615876658|FG000|Washout Period 1|Screen Failure|1|||
170419494|NCT02428699|615876659|FG001|Washout Period 1|Screen Failure|2|||
170419495|NCT03127137|615876661|FG000|Overall Study|Requested sedation after consent|1|||
170419496|NCT03127137|615876662|FG001|Overall Study|Requested sedation after consent|0|||
170419497|NCT03127137|615876661|FG000|Overall Study|Malfunction in electronic data collection|1|||
170419498|NCT03127137|615876662|FG001|Overall Study|Malfunction in electronic data collection|0|||
170419499|NCT03127137|615876661|FG000|Overall Study|Post procedure testing could not be obtained|0|||
170778330|NCT01820260|617195597|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
170778331|NCT01820260|617195584|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778332|NCT01820260|617195585|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778333|NCT01820260|617195586|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778334|NCT01820260|617195587|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778335|NCT01820260|617195588|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778336|NCT01820260|617195589|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778337|NCT01820260|617195590|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778338|NCT01820260|617195591|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778339|NCT01820260|617195592|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778340|NCT01820260|617195593|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
170778341|NCT01820260|617195594|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778342|NCT01820260|617195595|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778343|NCT01820260|617195596|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778344|NCT01820260|617195597|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
170778345|NCT05444192|617195598|FG000|Overall Study|Lost to Follow-up|1|||
170778346|NCT05444192|617195599|FG001|Overall Study|Lost to Follow-up|0|||
170778347|NCT00505934|617195601|FG000|Overall Study|Adverse Event|1|||
170778348|NCT00505934|617195601|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
170778349|NCT00505934|617195601|FG000|Overall Study|Other: IV dose needed to be changed|1|||
170778350|NCT01046136|617195602|FG000|Overall Study|Withdrawal by Subject|0|||
170778351|NCT01046136|617195603|FG001|Overall Study|Withdrawal by Subject|4|||
170878274|NCT02819635|617565621|FG007|Substudy 3|Adverse Event|0|||
170878275|NCT02819635|617565622|FG008|Substudy 3|Adverse Event|32|||
170878276|NCT02819635|617565623|FG009|Substudy 3|Adverse Event|3|||
170878277|NCT02819635|617565624|FG010|Substudy 3|Adverse Event|12|||
170878278|NCT02819635|617565625|FG011|Substudy 3|Adverse Event|18|||
170878279|NCT02819635|617565614|FG000|Substudy 3|Withdrew consent|0|||
170878280|NCT02819635|617565615|FG001|Substudy 3|Withdrew consent|0|||
170878281|NCT02819635|617565616|FG002|Substudy 3|Withdrew consent|0|||
170878282|NCT02819635|617565617|FG003|Substudy 3|Withdrew consent|0|||
170878283|NCT02819635|617565618|FG004|Substudy 3|Withdrew consent|0|||
170878284|NCT02819635|617565619|FG005|Substudy 3|Withdrew consent|0|||
170419500|NCT03127137|615876662|FG001|Overall Study|Post procedure testing could not be obtained|1|||
170419501|NCT00543309|615876681|FG000|Overall Study|Physician Decision|0|||
170419502|NCT00543309|615876682|FG001|Overall Study|Physician Decision|1|||
170419503|NCT00543309|615876683|FG002|Overall Study|Physician Decision|0|||
170419504|NCT02194998|615876688|FG000|On-HCV Treatment|Did not pick up study medication|0|||
170419505|NCT02194998|615876689|FG001|On-HCV Treatment|Did not pick up study medication|1|||
170419506|NCT02194998|615876690|FG002|On-HCV Treatment|Did not pick up study medication|0|||
170419507|NCT02194998|615876691|FG003|On-HCV Treatment|Did not pick up study medication|0|||
170419508|NCT02194998|615876688|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
170419509|NCT02194998|615876689|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
170419510|NCT02194998|615876690|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
170419511|NCT02194998|615876691|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
170419512|NCT01345019|615876692|FG000|Blinded Treatment Phase|Death|147|||
170419513|NCT01345019|615876693|FG001|Blinded Treatment Phase|Death|137|||
170419514|NCT01345019|615876692|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
170419515|NCT01345019|615876693|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
170419516|NCT01345019|615876692|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
170419517|NCT01345019|615876693|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
170419518|NCT01345019|615876692|FG000|Blinded Treatment Phase|Disease Progression|12|||
170419519|NCT01345019|615876693|FG001|Blinded Treatment Phase|Disease Progression|10|||
170419520|NCT01345019|615876692|FG000|Blinded Treatment Phase|Adverse Event|6|||
170419521|NCT01345019|615876693|FG001|Blinded Treatment Phase|Adverse Event|13|||
170419522|NCT01345019|615876692|FG000|Blinded Treatment Phase|Administrative Decision|10|||
170419523|NCT01345019|615876693|FG001|Blinded Treatment Phase|Administrative Decision|8|||
170419524|NCT01345019|615876692|FG000|Blinded Treatment Phase|Noncompliance|5|||
170419525|NCT01345019|615876693|FG001|Blinded Treatment Phase|Noncompliance|3|||
170419526|NCT01345019|615876692|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
170419527|NCT01345019|615876693|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
170419528|NCT01345019|615876692|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
170419529|NCT01345019|615876693|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
170419530|NCT01345019|615876692|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
170419531|NCT01345019|615876693|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
170419532|NCT01345019|615876692|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
170419533|NCT01345019|615876693|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
170419534|NCT01345019|615876692|FG000|Open Label Treatment Phase|Death|49|||
170419535|NCT01345019|615876693|FG001|Open Label Treatment Phase|Death|48|||
170419536|NCT01345019|615876692|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
170419537|NCT01345019|615876693|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
170419538|NCT01345019|615876692|FG000|Open Label Treatment Phase|Adverse Event|30|||
170419539|NCT01345019|615876693|FG001|Open Label Treatment Phase|Adverse Event|51|||
170419540|NCT01345019|615876692|FG000|Open Label Treatment Phase|Administrative Decision|30|||
170419541|NCT01345019|615876693|FG001|Open Label Treatment Phase|Administrative Decision|15|||
170419542|NCT01345019|615876692|FG000|Open Label Treatment Phase|Disease Progression|17|||
170419543|NCT01345019|615876693|FG001|Open Label Treatment Phase|Disease Progression|18|||
170419544|NCT01345019|615876692|FG000|Open Label Treatment Phase|Noncompliance|5|||
170419545|NCT01345019|615876693|FG001|Open Label Treatment Phase|Noncompliance|4|||
170419546|NCT01345019|615876692|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
170419547|NCT01345019|615876693|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
170419548|NCT01345019|615876692|FG000|Open Label Treatment Phase|Pregnancy|1|||
170419549|NCT01345019|615876693|FG001|Open Label Treatment Phase|Pregnancy|0|||
170419550|NCT01345019|615876692|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
170419551|NCT01345019|615876693|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
170419552|NCT01345019|615876692|FG000|Open Label Treatment Phase|Protocol Violation|0|||
170419553|NCT01345019|615876693|FG001|Open Label Treatment Phase|Protocol Violation|1|||
170419554|NCT03830164|615876696|FG000|Overall Study|Adverse Event|0|||
170419555|NCT03830164|615876697|FG001|Overall Study|Adverse Event|2|||
170419556|NCT03830164|615876698|FG002|Overall Study|Adverse Event|0|||
170419557|NCT03830164|615876696|FG000|Overall Study|Lack of Efficacy|1|||
170419558|NCT03830164|615876697|FG001|Overall Study|Lack of Efficacy|5|||
170419559|NCT03830164|615876698|FG002|Overall Study|Lack of Efficacy|0|||
170419560|NCT03830164|615876696|FG000|Overall Study|Lost to Follow-up|0|||
170419561|NCT03830164|615876697|FG001|Overall Study|Lost to Follow-up|1|||
170419562|NCT03830164|615876698|FG002|Overall Study|Lost to Follow-up|0|||
170878285|NCT02819635|617565620|FG006|Substudy 3|Withdrew consent|0|||
170878286|NCT02819635|617565621|FG007|Substudy 3|Withdrew consent|0|||
170531317|NCT00855582|616293258|FG002|Overall Study|Protocol Violation|6|||
170531318|NCT00855582|616293256|FG000|Overall Study|Entry Criteria Not Met|8|||
170531319|NCT00855582|616293257|FG001|Overall Study|Entry Criteria Not Met|6|||
170531320|NCT00855582|616293258|FG002|Overall Study|Entry Criteria Not Met|3|||
170531321|NCT00855582|616293256|FG000|Overall Study|Withdrawal by Subject|7|||
170531322|NCT00855582|616293257|FG001|Overall Study|Withdrawal by Subject|4|||
170531323|NCT00855582|616293258|FG002|Overall Study|Withdrawal by Subject|8|||
170531324|NCT01732692|616293262|FG000|Overall Study|Adverse Event|0|||
170531325|NCT01732692|616293263|FG001|Overall Study|Adverse Event|1|||
170531326|NCT01027949|616293264|FG000|Overall Study|Death|174|||
170531327|NCT01027949|616293264|FG000|Overall Study|Progressive Disease|163|||
170531328|NCT01027949|616293264|FG000|Overall Study|Adverse Event|172|||
170531329|NCT01027949|616293264|FG000|Overall Study|Withdrawal by Subject|113|||
170531330|NCT01027949|616293264|FG000|Overall Study|Lost to Follow-up|17|||
170531331|NCT01027949|616293264|FG000|Overall Study|Protocol Violation|13|||
170531332|NCT01027949|616293264|FG000|Overall Study|PI Decision|8|||
170531333|NCT01027949|616293264|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
170531334|NCT01027949|616293264|FG000|Overall Study|Non-compliance with Study Procedures|7|||
170531335|NCT01027949|616293264|FG000|Overall Study|Lung Transplant|5|||
170531336|NCT01027949|616293264|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
170531337|NCT01027949|616293264|FG000|Overall Study|Use of Excluded Medication|2|||
170531338|NCT01027949|616293264|FG000|Overall Study|Patient Self-discontinuation|1|||
170531339|NCT01027949|616293264|FG000|Overall Study|Pregnancy|1|||
170531340|NCT01027949|616293264|FG000|Overall Study|Surgery|1|||
170531341|NCT02030600|616293267|FG000|Treatment Period 1|Adverse Event|5|||
170531342|NCT02030600|616293268|FG001|Treatment Period 1|Adverse Event|7|||
170531343|NCT02030600|616293267|FG000|Treatment Period 1|Lack of Efficacy|0|||
170531344|NCT02030600|616293268|FG001|Treatment Period 1|Lack of Efficacy|1|||
170531345|NCT02030600|616293267|FG000|Treatment Period 1|Lost to Follow-up|11|||
170531346|NCT02030600|616293268|FG001|Treatment Period 1|Lost to Follow-up|3|||
170531347|NCT02030600|616293267|FG000|Treatment Period 1|Protocol Violation|22|||
170531348|NCT02030600|616293268|FG001|Treatment Period 1|Protocol Violation|17|||
170531349|NCT02030600|616293267|FG000|Treatment Period 1|Withdrawal by Subject|13|||
170531350|NCT02030600|616293268|FG001|Treatment Period 1|Withdrawal by Subject|17|||
170531351|NCT02030600|616293267|FG000|Treatment Period 1|Casebook Unsigned|1|||
170531352|NCT02030600|616293268|FG001|Treatment Period 1|Casebook Unsigned|0|||
170531353|NCT02030600|616293267|FG000|Treatment Period 1|Unclassified|1|||
170531354|NCT02030600|616293268|FG001|Treatment Period 1|Unclassified|0|||
170531355|NCT02030600|616293267|FG000|Treatment Period 2|Adverse Event|4|||
170531356|NCT02030600|616293268|FG001|Treatment Period 2|Adverse Event|4|||
170531357|NCT02030600|616293267|FG000|Treatment Period 2|Lack of Efficacy|2|||
170531358|NCT02030600|616293268|FG001|Treatment Period 2|Lack of Efficacy|1|||
170531359|NCT02030600|616293267|FG000|Treatment Period 2|Lost to Follow-up|4|||
170531360|NCT02030600|616293268|FG001|Treatment Period 2|Lost to Follow-up|2|||
170531361|NCT02030600|616293267|FG000|Treatment Period 2|Protocol Violation|1|||
170531362|NCT02030600|616293268|FG001|Treatment Period 2|Protocol Violation|2|||
170531363|NCT02030600|616293267|FG000|Treatment Period 2|Withdrawal by Subject|13|||
170531364|NCT02030600|616293268|FG001|Treatment Period 2|Withdrawal by Subject|9|||
170531365|NCT02030600|616293267|FG000|Treatment Period 2|Unclassified|1|||
170531366|NCT02030600|616293268|FG001|Treatment Period 2|Unclassified|0|||
170531367|NCT01155323|616293271|FG000|First Intervention|exclusion criteria|1|||
170531368|NCT01155323|616293272|FG001|First Intervention|exclusion criteria|1|||
170531369|NCT01155323|616293271|FG000|Second Intervention|Lost to Follow-up|1|||
170531370|NCT01155323|616293272|FG001|Second Intervention|Lost to Follow-up|1|||
170531371|NCT01208051|616293275|FG000|Total Enrollment|Withdrawal by Subject|0|||
170531372|NCT01208051|616293276|FG001|Total Enrollment|Withdrawal by Subject|1|||
170531373|NCT01208051|616293277|FG002|Total Enrollment|Withdrawal by Subject|0|||
170531374|NCT01208051|616293278|FG003|Total Enrollment|Withdrawal by Subject|0|||
170531375|NCT01208051|616293279|FG004|Total Enrollment|Withdrawal by Subject|2|||
170531376|NCT01208051|616293275|FG000|Total Enrollment|Brain metastases|0|||
170531377|NCT01208051|616293276|FG001|Total Enrollment|Brain metastases|0|||
170531378|NCT01208051|616293277|FG002|Total Enrollment|Brain metastases|1|||
170632634|NCT01929317|616666723|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
170878287|NCT02819635|617565622|FG008|Substudy 3|Withdrew consent|11|||
170778352|NCT01046136|617195602|FG000|Overall Study|Physician Decision|1|||
170531379|NCT01208051|616293278|FG003|Total Enrollment|Brain metastases|0|||
170531380|NCT01208051|616293279|FG004|Total Enrollment|Brain metastases|0|||
170531381|NCT02349386|616293280|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
170531382|NCT02349386|616293281|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
170531383|NCT02349386|616293282|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
170531384|NCT02349386|616293283|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
170531385|NCT02349386|616293280|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
170778353|NCT01046136|617195603|FG001|Overall Study|Physician Decision|1|||
170778354|NCT01046136|617195602|FG000|Overall Study|Lost to Follow-up|3|||
170778355|NCT01046136|617195603|FG001|Overall Study|Lost to Follow-up|3|||
170778356|NCT02058108|617195604|FG000|Overall Study|Abnormal Laboratory Values|0|||
170778357|NCT02058108|617195605|FG001|Overall Study|Abnormal Laboratory Values|1|||
170419563|NCT03830164|615876696|FG000|Overall Study|Withdrawal by Subject|1|||
170419564|NCT03830164|615876697|FG001|Overall Study|Withdrawal by Subject|0|||
170419565|NCT03830164|615876698|FG002|Overall Study|Withdrawal by Subject|0|||
170419566|NCT02731157|615876708|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
170419567|NCT01074554|615876712|FG000|Overall Study|Adverse Event|3|||
170419568|NCT01074554|615876713|FG001|Overall Study|Adverse Event|3|||
170419569|NCT01074554|615876712|FG000|Overall Study|Lost to Follow-up|0|||
170419570|NCT01074554|615876713|FG001|Overall Study|Lost to Follow-up|1|||
170419571|NCT01856309|615876715|FG000|Overall Study|Death|4|||
170419572|NCT01856309|615876716|FG001|Overall Study|Death|6|||
170419573|NCT01856309|615876717|FG002|Overall Study|Death|11|||
170419574|NCT01856309|615876718|FG003|Overall Study|Death|6|||
170419575|NCT01856309|615876715|FG000|Overall Study|Lost to Follow-up|6|||
170419576|NCT01856309|615876716|FG001|Overall Study|Lost to Follow-up|2|||
170419577|NCT01856309|615876717|FG002|Overall Study|Lost to Follow-up|4|||
170419578|NCT01856309|615876718|FG003|Overall Study|Lost to Follow-up|8|||
170419579|NCT01856309|615876715|FG000|Overall Study|Withdrawal by Subject|11|||
170419580|NCT01856309|615876716|FG001|Overall Study|Withdrawal by Subject|13|||
170419581|NCT01856309|615876717|FG002|Overall Study|Withdrawal by Subject|28|||
170419582|NCT01856309|615876718|FG003|Overall Study|Withdrawal by Subject|26|||
170419583|NCT01856309|615876715|FG000|Overall Study|Other|227|||
170419584|NCT01856309|615876716|FG001|Overall Study|Other|225|||
170419585|NCT01856309|615876717|FG002|Overall Study|Other|447|||
170419586|NCT01856309|615876718|FG003|Overall Study|Other|469|||
170419587|NCT01856309|615876715|FG000|Overall Study|Lack of Efficacy|14|||
170419588|NCT01856309|615876716|FG001|Overall Study|Lack of Efficacy|9|||
170419589|NCT01856309|615876717|FG002|Overall Study|Lack of Efficacy|40|||
170419590|NCT01856309|615876718|FG003|Overall Study|Lack of Efficacy|25|||
170419591|NCT01856309|615876715|FG000|Overall Study|Adverse Event|31|||
170419592|NCT01856309|615876716|FG001|Overall Study|Adverse Event|31|||
170419593|NCT01856309|615876717|FG002|Overall Study|Adverse Event|55|||
170419594|NCT01856309|615876718|FG003|Overall Study|Adverse Event|65|||
170419595|NCT01856309|615876715|FG000|Overall Study|Pregnancy|0|||
170419596|NCT01856309|615876716|FG001|Overall Study|Pregnancy|0|||
170419597|NCT01856309|615876717|FG002|Overall Study|Pregnancy|0|||
170419598|NCT01856309|615876718|FG003|Overall Study|Pregnancy|1|||
170419599|NCT01856309|615876715|FG000|Overall Study|Physician Decision|6|||
170419600|NCT01856309|615876716|FG001|Overall Study|Physician Decision|1|||
170419601|NCT01856309|615876717|FG002|Overall Study|Physician Decision|6|||
170419602|NCT01856309|615876718|FG003|Overall Study|Physician Decision|8|||
170419603|NCT01856309|615876715|FG000|Overall Study|Noncompliance With Study Drug|0|||
170419604|NCT01856309|615876716|FG001|Overall Study|Noncompliance With Study Drug|1|||
170419605|NCT01856309|615876717|FG002|Overall Study|Noncompliance With Study Drug|4|||
170419606|NCT01856309|615876718|FG003|Overall Study|Noncompliance With Study Drug|1|||
170419607|NCT00832377|615876719|FG000|Overall Study|Protocol Violation|1|||
170419608|NCT00220337|615876722|FG000|Overall Study|Adverse Event|70|||
170419609|NCT00220337|615876722|FG000|Overall Study|Lack of Efficacy|17|||
170419610|NCT00220337|615876722|FG000|Overall Study|Withdrawal by Subject|68|||
170419611|NCT00220337|615876722|FG000|Overall Study|Protocol Violation|2|||
170419612|NCT00220337|615876722|FG000|Overall Study|Lost to Follow-up|5|||
170419613|NCT00220337|615876722|FG000|Overall Study|Other|12|||
170419614|NCT00220337|615876722|FG000|Overall Study|Unsatisfactory compliance|5|||
170419615|NCT01273181|615876723|FG000|Phase I, Dose 1|Study termination|1|||
170419616|NCT01273181|615876724|FG001|Phase I, Dose 1|Study termination|0|||
170419617|NCT01273181|615876725|FG002|Phase I, Dose 1|Study termination|0|||
170419618|NCT01273181|615876726|FG003|Phase I, Dose 1|Study termination|0|||
170419619|NCT01273181|615876723|FG000|Phase I, Dose 2|Death during treatment|0|||
170419620|NCT01273181|615876724|FG001|Phase I, Dose 2|Death during treatment|1|||
170419621|NCT01273181|615876725|FG002|Phase I, Dose 2|Death during treatment|0|||
170419622|NCT01273181|615876726|FG003|Phase I, Dose 2|Death during treatment|0|||
170419623|NCT01273181|615876723|FG000|Phase 2, Dose 1|Study termination|0|||
170419624|NCT01273181|615876724|FG001|Phase 2, Dose 1|Study termination|0|||
170419625|NCT01273181|615876725|FG002|Phase 2, Dose 1|Study termination|1|||
170419626|NCT01273181|615876726|FG003|Phase 2, Dose 1|Study termination|0|||
170419627|NCT01273181|615876723|FG000|Phase 2, Dose 2|Death during treatment|0|||
170419628|NCT01273181|615876724|FG001|Phase 2, Dose 2|Death during treatment|0|||
170419629|NCT01273181|615876725|FG002|Phase 2, Dose 2|Death during treatment|0|||
170419630|NCT01273181|615876726|FG003|Phase 2, Dose 2|Death during treatment|1|||
170419631|NCT03661528|615876727|FG000|Overall Study|Death|1|||
170419632|NCT03661528|615876728|FG001|Overall Study|Death|0|||
170419633|NCT03661528|615876727|FG000|Overall Study|Physician Decision|3|||
170419634|NCT03661528|615876728|FG001|Overall Study|Physician Decision|1|||
170419635|NCT03661528|615876727|FG000|Overall Study|Other than Specified|5|||
170419636|NCT03661528|615876728|FG001|Overall Study|Other than Specified|2|||
170419637|NCT03661528|615876727|FG000|Overall Study|Withdrawal by Subject|5|||
170419638|NCT03661528|615876728|FG001|Overall Study|Withdrawal by Subject|3|||
170419639|NCT03661528|615876727|FG000|Overall Study|Disease Progression|8|||
170419640|NCT03661528|615876728|FG001|Overall Study|Disease Progression|13|||
170419641|NCT03661528|615876727|FG000|Overall Study|Adverse Event|61|||
170419642|NCT03661528|615876728|FG001|Overall Study|Adverse Event|55|||
170531386|NCT02349386|616293281|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
170531387|NCT02349386|616293282|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
170531388|NCT02349386|616293283|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
170531389|NCT02349386|616293280|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
170531390|NCT02349386|616293281|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
170531391|NCT02349386|616293282|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
170531392|NCT02349386|616293283|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
170531393|NCT02349386|616293280|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
170531394|NCT02349386|616293281|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
170531395|NCT02349386|616293282|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
170531396|NCT02349386|616293283|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
170531397|NCT02349386|616293280|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
170531398|NCT02349386|616293281|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
170531399|NCT02349386|616293282|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
170531400|NCT02349386|616293283|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
170531401|NCT02349386|616293280|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
170531402|NCT02349386|616293281|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
170531403|NCT02349386|616293282|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
170531404|NCT02349386|616293283|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
170531405|NCT00973973|616293284|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
170531406|NCT00973973|616293285|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
170531407|NCT00973973|616293284|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
170531408|NCT00973973|616293285|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
170531409|NCT00973973|616293284|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
170531410|NCT00973973|616293285|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
170531411|NCT00973973|616293284|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
170531412|NCT00973973|616293285|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
170531413|NCT00973973|616293284|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
170531414|NCT00973973|616293285|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
170531415|NCT00973973|616293284|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
170531416|NCT00973973|616293285|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
170531417|NCT00973973|616293284|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
170531418|NCT00973973|616293285|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
170531419|NCT00973973|616293284|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
170531420|NCT00973973|616293285|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
170531421|NCT00973973|616293284|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
170531422|NCT00973973|616293285|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
170531423|NCT00973973|616293284|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
170531424|NCT00973973|616293285|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
170531425|NCT00973973|616293284|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
170531426|NCT00973973|616293285|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
170531427|NCT00973973|616293284|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
170531428|NCT00973973|616293285|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
170531429|NCT02471339|616293286|FG000|Overall Study|Did not provide follow-up data|2|||
170531430|NCT02471339|616293287|FG001|Overall Study|Did not provide follow-up data|0|||
170531431|NCT06057064|616293288|FG000|Overall Study|Death|2|||
170531432|NCT06057064|616293289|FG001|Overall Study|Death|0|||
170531433|NCT06057064|616293288|FG000|Overall Study|Physician Decision|1|||
170531434|NCT06057064|616293289|FG001|Overall Study|Physician Decision|0|||
170419643|NCT00486837|615876730|FG000|Overall Study|Withdrawal by Subject|1|||
170419644|NCT00486837|615876731|FG001|Overall Study|Withdrawal by Subject|0|||
170419645|NCT00486837|615876730|FG000|Overall Study|Adverse Event|1|||
170419646|NCT00486837|615876731|FG001|Overall Study|Adverse Event|1|||
170419647|NCT00486837|615876730|FG000|Overall Study|Protocol Violation|4|||
170419648|NCT00486837|615876731|FG001|Overall Study|Protocol Violation|2|||
170419649|NCT00486837|615876730|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
170419650|NCT00486837|615876731|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
170419651|NCT05694013|615876734|FG000|Overall Study|Death|6|||
170419652|NCT05694013|615876735|FG001|Overall Study|Death|2|||
170419653|NCT05694013|615876734|FG000|Overall Study|Participant Decision|0|||
170419654|NCT05694013|615876735|FG001|Overall Study|Participant Decision|1|||
170419655|NCT05694013|615876734|FG000|Overall Study|Physician Decision|1|||
170419656|NCT05694013|615876735|FG001|Overall Study|Physician Decision|0|||
170419657|NCT05694013|615876734|FG000|Overall Study|Progressive Disease|0|||
170419658|NCT05694013|615876735|FG001|Overall Study|Progressive Disease|1|||
170419659|NCT05694013|615876734|FG000|Overall Study|Study Terminated by Sponsor|12|||
170531435|NCT06057064|616293288|FG000|Overall Study|Withdrawal by Subject|1|||
170531436|NCT06057064|616293289|FG001|Overall Study|Withdrawal by Subject|1|||
170531437|NCT02832037|616293291|FG000|Overall Study|Administrative reasons|0|||
170531438|NCT02832037|616293292|FG001|Overall Study|Administrative reasons|0|||
170531439|NCT02832037|616293293|FG002|Overall Study|Administrative reasons|1|||
170531440|NCT02832037|616293294|FG003|Overall Study|Administrative reasons|0|||
170531441|NCT02832037|616293295|FG004|Overall Study|Administrative reasons|0|||
170531442|NCT02832037|616293291|FG000|Overall Study|Protocol Violation|3|||
170531443|NCT02832037|616293292|FG001|Overall Study|Protocol Violation|0|||
170531444|NCT02832037|616293293|FG002|Overall Study|Protocol Violation|4|||
170531445|NCT02832037|616293294|FG003|Overall Study|Protocol Violation|1|||
170531446|NCT02832037|616293295|FG004|Overall Study|Protocol Violation|2|||
170531447|NCT02832037|616293291|FG000|Overall Study|Lost to Follow-up|2|||
170531448|NCT02832037|616293292|FG001|Overall Study|Lost to Follow-up|0|||
170531449|NCT02832037|616293293|FG002|Overall Study|Lost to Follow-up|3|||
170531450|NCT02832037|616293294|FG003|Overall Study|Lost to Follow-up|0|||
170531451|NCT02832037|616293295|FG004|Overall Study|Lost to Follow-up|5|||
170531452|NCT02832037|616293291|FG000|Overall Study|Withdrawal by Subject|9|||
170531453|NCT02832037|616293292|FG001|Overall Study|Withdrawal by Subject|8|||
170531454|NCT02832037|616293293|FG002|Overall Study|Withdrawal by Subject|0|||
170531455|NCT02832037|616293294|FG003|Overall Study|Withdrawal by Subject|4|||
170531456|NCT02832037|616293295|FG004|Overall Study|Withdrawal by Subject|8|||
170531457|NCT02832037|616293291|FG000|Overall Study|Adverse Event|5|||
170531458|NCT02832037|616293292|FG001|Overall Study|Adverse Event|4|||
170531459|NCT02832037|616293293|FG002|Overall Study|Adverse Event|0|||
170531460|NCT02832037|616293294|FG003|Overall Study|Adverse Event|2|||
170531461|NCT02832037|616293295|FG004|Overall Study|Adverse Event|4|||
170531462|NCT04424901|616293296|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
170531463|NCT04424901|616293297|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
170531464|NCT01180777|616293298|FG000|Overall Study|Protocol Violation|6|||
170531465|NCT01180777|616293298|FG000|Overall Study|Poor lens fit|4|||
170531466|NCT01180777|616293298|FG000|Overall Study|Lost to Follow-up|1|||
170531467|NCT01180777|616293298|FG000|Overall Study|Adverse Event|1|||
170419660|NCT05694013|615876735|FG001|Overall Study|Study Terminated by Sponsor|17|||
170419661|NCT05694013|615876734|FG000|Overall Study|Withdrawal by Subject|3|||
170419662|NCT05694013|615876735|FG001|Overall Study|Withdrawal by Subject|0|||
170419663|NCT00661505|615876738|FG000|Overall Study|Adverse Event|3|||
170419664|NCT00661505|615876738|FG000|Overall Study|Protocol Violation|14|||
170419665|NCT00661505|615876738|FG000|Overall Study|Withdrawal by Subject|8|||
170419666|NCT00661505|615876738|FG000|Overall Study|Lost to Follow-up|3|||
170419667|NCT00661505|615876738|FG000|Overall Study|Other|2|||
170419668|NCT05630547|615876739|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
170419669|NCT05630547|615876740|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
170419670|NCT05630547|615876741|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
170419671|NCT05630547|615876742|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
170419672|NCT05630547|615876739|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
170419673|NCT05630547|615876740|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
170419674|NCT05630547|615876741|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
170419675|NCT05630547|615876742|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
170419676|NCT05630547|615876739|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
170419677|NCT05630547|615876740|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
170419678|NCT05630547|615876741|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
170419679|NCT05630547|615876742|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
170419680|NCT05630547|615876739|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
170419681|NCT05630547|615876740|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
170419682|NCT05630547|615876741|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
170419683|NCT05630547|615876742|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
170419684|NCT05630547|615876739|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
170419685|NCT05630547|615876740|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
170419686|NCT05630547|615876741|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
170419687|NCT05630547|615876742|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
170419688|NCT05630547|615876739|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
170419689|NCT05630547|615876740|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
170419690|NCT05630547|615876741|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
170419691|NCT05630547|615876742|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
170531468|NCT03185208|616293299|FG000|Overall Study|Did not start study medication|0|||
170531469|NCT03185208|616293300|FG001|Overall Study|Did not start study medication|3|||
170531470|NCT02765165|616293301|FG000|Treatment Period|Progressive disease|3|||
170531471|NCT02765165|616293302|FG001|Treatment Period|Progressive disease|2|||
170531472|NCT02765165|616293303|FG002|Treatment Period|Progressive disease|3|||
170632635|NCT01929317|616666724|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
170419692|NCT05630547|615876739|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
170419693|NCT05630547|615876740|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
170419694|NCT05630547|615876741|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
170419695|NCT05630547|615876742|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
170419696|NCT05630547|615876739|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
170419697|NCT05630547|615876740|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
170419698|NCT05630547|615876741|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
170419699|NCT05630547|615876742|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
170419700|NCT05630547|615876739|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
170419701|NCT05630547|615876740|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
170419702|NCT05630547|615876741|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
170419703|NCT05630547|615876742|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
170419704|NCT05630547|615876739|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
170419705|NCT05630547|615876740|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
170419706|NCT05630547|615876741|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
170419707|NCT05630547|615876742|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
170419708|NCT05956665|615876743|FG000|Overall Study|Death|1|||
170419709|NCT05956665|615876743|FG000|Overall Study|Withdrawal by Subject|1|||
170419710|NCT05049460|615876744|FG000|Overall Study|Withdrawal by Subject|2|||
170419711|NCT05049460|615876745|FG001|Overall Study|Withdrawal by Subject|2|||
170419712|NCT05049460|615876744|FG000|Overall Study|Lost to Follow-up|2|||
170419713|NCT05049460|615876745|FG001|Overall Study|Lost to Follow-up|2|||
170419714|NCT00977470|615876746|FG000|Overall Study|Lack of Efficacy|32|||
170419715|NCT00977470|615876747|FG001|Overall Study|Lack of Efficacy|30|||
170419716|NCT00977470|615876746|FG000|Overall Study|Physician Decision|2|||
170419717|NCT00977470|615876747|FG001|Overall Study|Physician Decision|0|||
170419718|NCT00977470|615876746|FG000|Overall Study|Adverse Event|1|||
170419719|NCT00977470|615876747|FG001|Overall Study|Adverse Event|2|||
170419720|NCT00977470|615876746|FG000|Overall Study|Protocol Violation|1|||
170419721|NCT00977470|615876747|FG001|Overall Study|Protocol Violation|0|||
170419722|NCT00977470|615876746|FG000|Overall Study|Withdrawal by Subject|0|||
170419723|NCT00977470|615876747|FG001|Overall Study|Withdrawal by Subject|2|||
170419724|NCT00977470|615876746|FG000|Overall Study|Death|0|||
170419725|NCT00977470|615876747|FG001|Overall Study|Death|2|||
170419726|NCT00977470|615876746|FG000|Overall Study|clinical decline|0|||
170419727|NCT00977470|615876747|FG001|Overall Study|clinical decline|1|||
170419728|NCT00977470|615876746|FG000|Overall Study|prolonged recovery post-surgery|0|||
170419729|NCT00977470|615876747|FG001|Overall Study|prolonged recovery post-surgery|1|||
170419730|NCT00977470|615876746|FG000|Overall Study|Still on-study|2|||
170419731|NCT00977470|615876747|FG001|Overall Study|Still on-study|0|||
170419732|NCT03257462|615876750|FG000|Cohort A|Lost to Follow-up|1|||
170419733|NCT03257462|615876751|FG001|Cohort A|Lost to Follow-up|0|||
170419734|NCT03257462|615876752|FG002|Cohort A|Lost to Follow-up|0|||
170419735|NCT03257462|615876753|FG003|Cohort A|Lost to Follow-up|0|||
170419736|NCT03257462|615876750|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
170419737|NCT03257462|615876751|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
170419738|NCT03257462|615876752|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
170419739|NCT03257462|615876753|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
170419740|NCT00796822|615876754|FG000|Overall Study|Lost to Follow-up|2|||
170419741|NCT00796822|615876755|FG001|Overall Study|Lost to Follow-up|0|||
170419742|NCT00796822|615876754|FG000|Overall Study|Adverse Event|1|||
170419743|NCT00796822|615876755|FG001|Overall Study|Adverse Event|0|||
170419744|NCT00368277|615876756|FG000|Overall Study|Adverse Event|33|||
170419745|NCT00368277|615876757|FG001|Overall Study|Adverse Event|49|||
170419746|NCT00368277|615876756|FG000|Overall Study|Death|2|||
170419747|NCT00368277|615876757|FG001|Overall Study|Death|1|||
170419748|NCT00368277|615876756|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
170419749|NCT00368277|615876757|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
170419750|NCT00368277|615876756|FG000|Overall Study|Protocol deviation|7|||
170419751|NCT00368277|615876757|FG001|Overall Study|Protocol deviation|0|||
170419752|NCT00368277|615876756|FG000|Overall Study|Patient withdrew consent|32|||
170419753|NCT00368277|615876757|FG001|Overall Study|Patient withdrew consent|28|||
170419754|NCT00368277|615876756|FG000|Overall Study|Lost to Follow-up|8|||
170419755|NCT00368277|615876757|FG001|Overall Study|Lost to Follow-up|6|||
170419756|NCT01974141|615876778|FG000|Overall Study|Other Reasons|28|||
170419757|NCT01974141|615876779|FG001|Overall Study|Other Reasons|18|||
170419758|NCT01974141|615876778|FG000|Overall Study|Protocol Violation|2|||
170419759|NCT01974141|615876779|FG001|Overall Study|Protocol Violation|6|||
170419760|NCT01974141|615876778|FG000|Overall Study|Personal Reasons|21|||
170419761|NCT01974141|615876779|FG001|Overall Study|Personal Reasons|20|||
170419762|NCT01974141|615876778|FG000|Overall Study|Lost to Follow-up|38|||
170419763|NCT01974141|615876779|FG001|Overall Study|Lost to Follow-up|29|||
170632636|NCT01929317|616666723|FG000|Long-term Phase|Adverse Event|5|||
170419764|NCT01974141|615876778|FG000|Overall Study|Pregnancy|3|||
170419765|NCT01974141|615876779|FG001|Overall Study|Pregnancy|3|||
170419766|NCT01974141|615876778|FG000|Overall Study|Lack of Efficacy|0|||
170531473|NCT02765165|616293304|FG003|Treatment Period|Progressive disease|3|||
170531474|NCT02765165|616293305|FG004|Treatment Period|Progressive disease|4|||
170531475|NCT02765165|616293306|FG005|Treatment Period|Progressive disease|2|||
170531476|NCT02765165|616293307|FG006|Treatment Period|Progressive disease|2|||
170531477|NCT02765165|616293301|FG000|Treatment Period|Physician Decision|0|||
170531478|NCT02765165|616293302|FG001|Treatment Period|Physician Decision|1|||
170531479|NCT02765165|616293303|FG002|Treatment Period|Physician Decision|0|||
170419767|NCT01974141|615876779|FG001|Overall Study|Lack of Efficacy|1|||
170419768|NCT01974141|615876778|FG000|Overall Study|Adverse Event|4|||
170419769|NCT01974141|615876779|FG001|Overall Study|Adverse Event|5|||
170419770|NCT04028843|615876781|FG000|Overall Study|Lost to Follow-up|32|||
170419771|NCT04028843|615876782|FG001|Overall Study|Lost to Follow-up|39|||
170419772|NCT04028843|615876781|FG000|Overall Study|Adverse Event|1|||
170419773|NCT04028843|615876782|FG001|Overall Study|Adverse Event|0|||
170419774|NCT04028843|615876781|FG000|Overall Study|Non-viable Pregnancy|0|||
170419775|NCT04028843|615876782|FG001|Overall Study|Non-viable Pregnancy|1|||
170419776|NCT04028843|615876781|FG000|Overall Study|Withdrawal by Subject|4|||
170419777|NCT04028843|615876782|FG001|Overall Study|Withdrawal by Subject|2|||
170419778|NCT05125952|615876786|FG000|Overall Study|Physician Decision|1|||
170419779|NCT02127281|615878701|FG000|Overall Study|Lost to Follow-up|1|||
170419780|NCT02127281|615878702|FG001|Overall Study|Lost to Follow-up|0|||
170419781|NCT00441467|615878703|FG000|Overall Study|Adverse Event|6|||
170419782|NCT00441467|615878703|FG000|Overall Study|Withdrawal by Subject|3|||
170419783|NCT00441467|615878703|FG000|Overall Study|Progressive disease|9|||
170419784|NCT01042522|615878705|FG000|Overall Study|Adverse Event|1|||
170419785|NCT01042522|615878706|FG001|Overall Study|Adverse Event|2|||
170419786|NCT01042522|615878705|FG000|Overall Study|Disease Progression|5|||
170419787|NCT01042522|615878706|FG001|Overall Study|Disease Progression|0|||
170419788|NCT01042522|615878705|FG000|Overall Study|Death|1|||
170419789|NCT01042522|615878706|FG001|Overall Study|Death|0|||
170419790|NCT01042522|615878705|FG000|Overall Study|Patient Refused|0|||
170419791|NCT01042522|615878706|FG001|Overall Study|Patient Refused|3|||
170419792|NCT01042522|615878705|FG000|Overall Study|Withdrawal by Subject|1|||
170419793|NCT01042522|615878706|FG001|Overall Study|Withdrawal by Subject|1|||
170419794|NCT03075761|615878707|FG000|Overall Study|Lost to Follow-up|1|||
170419795|NCT03075761|615878708|FG001|Overall Study|Lost to Follow-up|6|||
170419796|NCT01124149|615878714|FG000|Acute Phase|Withdrawal by Subject|22|||
170419797|NCT01124149|615878714|FG000|Acute Phase|Adverse Event|21|||
170419798|NCT01124149|615878714|FG000|Acute Phase|Lack of Efficacy|17|||
170419799|NCT01124149|615878714|FG000|Acute Phase|Protocol Violation|14|||
170419800|NCT01124149|615878714|FG000|Acute Phase|Lost to Follow-up|2|||
170419801|NCT01124149|615878714|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
170419802|NCT01124149|615878714|FG000|Acute Phase|Sponsor request|1|||
170419803|NCT01124149|615878714|FG000|Acute Phase|UC symptoms not ameliorated|1|||
170419804|NCT01124149|615878714|FG000|Acute Phase|Non-compliance|1|||
170419805|NCT01124149|615878714|FG000|Acute Phase|Low hemoglobin|1|||
170419806|NCT01124149|615878714|FG000|Acute Phase|Travelling to another country|1|||
170419807|NCT01124149|615878714|FG000|Acute Phase|Sponsor decision|1|||
170419808|NCT01124149|615878714|FG000|Maintenance Phase|Lack of Efficacy|40|||
170419809|NCT01124149|615878714|FG000|Maintenance Phase|Adverse Event|24|||
170419810|NCT01124149|615878714|FG000|Maintenance Phase|Lost to Follow-up|15|||
170419811|NCT01124149|615878714|FG000|Maintenance Phase|Withdrawal by Subject|10|||
170419812|NCT01124149|615878714|FG000|Maintenance Phase|Protocol Violation|5|||
170419813|NCT01124149|615878714|FG000|Maintenance Phase|Coordinator error|1|||
170419814|NCT01124149|615878714|FG000|Maintenance Phase|Non-compliance|1|||
170419815|NCT01644500|615878716|FG000|Overall Study|Adverse Event|6|||
170419816|NCT01644500|615878717|FG001|Overall Study|Adverse Event|1|||
170419817|NCT01644500|615878718|FG002|Overall Study|Adverse Event|2|||
170419818|NCT01644500|615878716|FG000|Overall Study|Death|0|||
170419819|NCT01644500|615878717|FG001|Overall Study|Death|1|||
170419820|NCT01644500|615878718|FG002|Overall Study|Death|0|||
170419821|NCT01644500|615878716|FG000|Overall Study|Lost to Follow-up|3|||
170878288|NCT02819635|617565623|FG009|Substudy 3|Withdrew consent|1|||
170878289|NCT02819635|617565624|FG010|Substudy 3|Withdrew consent|4|||
170419822|NCT01644500|615878717|FG001|Overall Study|Lost to Follow-up|8|||
170419823|NCT01644500|615878718|FG002|Overall Study|Lost to Follow-up|0|||
170531480|NCT02765165|616293304|FG003|Treatment Period|Physician Decision|0|||
170878290|NCT02819635|617565625|FG011|Substudy 3|Withdrew consent|9|||
170419824|NCT01644500|615878716|FG000|Overall Study|Protocol Violation|1|||
170419825|NCT01644500|615878717|FG001|Overall Study|Protocol Violation|1|||
170419826|NCT01644500|615878718|FG002|Overall Study|Protocol Violation|0|||
170419827|NCT01644500|615878716|FG000|Overall Study|Withdrawal by Subject|11|||
170419828|NCT01644500|615878717|FG001|Overall Study|Withdrawal by Subject|12|||
170419829|NCT01644500|615878718|FG002|Overall Study|Withdrawal by Subject|12|||
170419830|NCT01644500|615878716|FG000|Overall Study|Physician Decision|1|||
170419831|NCT01644500|615878717|FG001|Overall Study|Physician Decision|1|||
170419832|NCT01644500|615878718|FG002|Overall Study|Physician Decision|1|||
170419833|NCT00048568|615878719|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
170878291|NCT02819635|617565614|FG000|Substudy 3|Lost to Follow-up|0|||
170878292|NCT02819635|617565615|FG001|Substudy 3|Lost to Follow-up|0|||
170878293|NCT02819635|617565616|FG002|Substudy 3|Lost to Follow-up|0|||
170878294|NCT02819635|617565617|FG003|Substudy 3|Lost to Follow-up|0|||
170531481|NCT02765165|616293305|FG004|Treatment Period|Physician Decision|0|||
170531482|NCT02765165|616293306|FG005|Treatment Period|Physician Decision|0|||
170531483|NCT02765165|616293307|FG006|Treatment Period|Physician Decision|0|||
170531484|NCT02765165|616293301|FG000|Treatment Period|Adverse Event|0|||
170531485|NCT02765165|616293302|FG001|Treatment Period|Adverse Event|1|||
170531486|NCT02765165|616293303|FG002|Treatment Period|Adverse Event|0|||
170531487|NCT02765165|616293304|FG003|Treatment Period|Adverse Event|0|||
170531488|NCT02765165|616293305|FG004|Treatment Period|Adverse Event|0|||
170531489|NCT02765165|616293306|FG005|Treatment Period|Adverse Event|0|||
170531490|NCT02765165|616293307|FG006|Treatment Period|Adverse Event|0|||
170531491|NCT02765165|616293301|FG000|Treatment Period|Withdrawal by Subject|0|||
170531492|NCT02765165|616293302|FG001|Treatment Period|Withdrawal by Subject|0|||
170531493|NCT02765165|616293303|FG002|Treatment Period|Withdrawal by Subject|0|||
170531494|NCT02765165|616293304|FG003|Treatment Period|Withdrawal by Subject|0|||
170531495|NCT02765165|616293305|FG004|Treatment Period|Withdrawal by Subject|2|||
170531496|NCT02765165|616293306|FG005|Treatment Period|Withdrawal by Subject|0|||
170531497|NCT02765165|616293307|FG006|Treatment Period|Withdrawal by Subject|0|||
170531498|NCT02765165|616293301|FG000|Treatment Period|Study terminated|0|||
170531499|NCT02765165|616293302|FG001|Treatment Period|Study terminated|0|||
170531500|NCT02765165|616293303|FG002|Treatment Period|Study terminated|0|||
170531501|NCT02765165|616293304|FG003|Treatment Period|Study terminated|0|||
170531502|NCT02765165|616293305|FG004|Treatment Period|Study terminated|0|||
170531503|NCT02765165|616293306|FG005|Treatment Period|Study terminated|1|||
170531504|NCT02765165|616293307|FG006|Treatment Period|Study terminated|2|||
170531505|NCT02765165|616293301|FG000|Post-treatment Follow-up|Death|1|||
170531506|NCT02765165|616293302|FG001|Post-treatment Follow-up|Death|2|||
170531507|NCT02765165|616293303|FG002|Post-treatment Follow-up|Death|1|||
170531508|NCT02765165|616293304|FG003|Post-treatment Follow-up|Death|1|||
170531509|NCT02765165|616293305|FG004|Post-treatment Follow-up|Death|1|||
170531510|NCT02765165|616293306|FG005|Post-treatment Follow-up|Death|1|||
170531511|NCT02765165|616293307|FG006|Post-treatment Follow-up|Death|0|||
170531512|NCT02765165|616293301|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
170531513|NCT02765165|616293302|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
170531514|NCT02765165|616293303|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
170531515|NCT02765165|616293304|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
170531516|NCT02765165|616293305|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
170531517|NCT02765165|616293306|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
170531518|NCT02765165|616293307|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
170531519|NCT02765165|616293301|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
170531520|NCT02765165|616293302|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
170531521|NCT02765165|616293303|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
170531522|NCT02765165|616293304|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
170531523|NCT02765165|616293305|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
170531524|NCT02765165|616293306|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
170531525|NCT02765165|616293307|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
170531526|NCT02765165|616293301|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
170531527|NCT02765165|616293302|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
170531528|NCT02765165|616293303|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
170531529|NCT02765165|616293304|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
170531530|NCT02765165|616293305|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
170531531|NCT02765165|616293306|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
170531532|NCT02765165|616293307|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
170531533|NCT02765165|616293301|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
170531534|NCT02765165|616293302|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
170531535|NCT02765165|616293303|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
170531536|NCT02765165|616293304|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
170531537|NCT02765165|616293305|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
170531538|NCT02765165|616293306|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
170531539|NCT02765165|616293307|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
170531540|NCT02765165|616293301|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
170878295|NCT02819635|617565618|FG004|Substudy 3|Lost to Follow-up|0|||
170531541|NCT02765165|616293302|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
170531542|NCT02765165|616293303|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
170531543|NCT02765165|616293304|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
170531544|NCT02765165|616293305|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
170531545|NCT02765165|616293306|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
170531546|NCT02765165|616293307|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
170878296|NCT02819635|617565619|FG005|Substudy 3|Lost to Follow-up|0|||
170878297|NCT02819635|617565620|FG006|Substudy 3|Lost to Follow-up|0|||
170419834|NCT00048568|615878720|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
170419835|NCT00048568|615878721|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
170419836|NCT00048568|615878719|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
170419837|NCT00048568|615878720|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
170419838|NCT00048568|615878721|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
170419839|NCT00048568|615878719|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
170419840|NCT00048568|615878720|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
170419841|NCT00048568|615878721|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
170419842|NCT00048568|615878719|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
170419843|NCT00048568|615878720|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
170419844|NCT00048568|615878721|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
170419845|NCT00048568|615878719|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
170419846|NCT00048568|615878720|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
170419847|NCT00048568|615878721|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
170419848|NCT00048568|615878719|FG000|Double-Blind Period Days 170 to 365|Death|1|||
170419849|NCT00048568|615878720|FG001|Double-Blind Period Days 170 to 365|Death|1|||
170419850|NCT00048568|615878721|FG002|Double-Blind Period Days 170 to 365|Death|0|||
170419851|NCT00048568|615878719|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
170419852|NCT00048568|615878720|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
170419853|NCT00048568|615878721|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
170419854|NCT00048568|615878719|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
170419855|NCT00048568|615878720|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
170419856|NCT00048568|615878721|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
170419857|NCT00048568|615878719|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
170419858|NCT00048568|615878720|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
170419859|NCT00048568|615878721|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
170419860|NCT00048568|615878719|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
170419861|NCT00048568|615878720|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
170419862|NCT00048568|615878721|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
170419863|NCT00048568|615878719|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
170419864|NCT00048568|615878720|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
170419865|NCT00048568|615878721|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
170419866|NCT00048568|615878719|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
170419867|NCT00048568|615878720|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
170419868|NCT00048568|615878721|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
170419869|NCT00048568|615878719|FG000|Open-Label Period|Death|0|||
170419870|NCT00048568|615878720|FG001|Open-Label Period|Death|0|||
170419871|NCT00048568|615878721|FG002|Open-Label Period|Death|13|||
170419872|NCT00048568|615878719|FG000|Open-Label Period|Adverse Event|0|||
170419873|NCT00048568|615878720|FG001|Open-Label Period|Adverse Event|0|||
170419874|NCT00048568|615878721|FG002|Open-Label Period|Adverse Event|49|||
170419875|NCT00048568|615878719|FG000|Open-Label Period|Lack of Efficacy|0|||
170419876|NCT00048568|615878720|FG001|Open-Label Period|Lack of Efficacy|0|||
170419877|NCT00048568|615878721|FG002|Open-Label Period|Lack of Efficacy|32|||
170419878|NCT00048568|615878719|FG000|Open-Label Period|Withdrawal by Subject|0|||
170419879|NCT00048568|615878720|FG001|Open-Label Period|Withdrawal by Subject|0|||
170419880|NCT00048568|615878721|FG002|Open-Label Period|Withdrawal by Subject|26|||
170419881|NCT00048568|615878719|FG000|Open-Label Period|Pregnancy|0|||
170419882|NCT00048568|615878720|FG001|Open-Label Period|Pregnancy|0|||
170419883|NCT00048568|615878721|FG002|Open-Label Period|Pregnancy|5|||
170419884|NCT00048568|615878719|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
170419885|NCT00048568|615878720|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
170419886|NCT00048568|615878721|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
170419887|NCT00048568|615878719|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
170419888|NCT00048568|615878720|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
170419889|NCT00048568|615878721|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
170419890|NCT00048568|615878719|FG000|Open-Label Period|Unknown Reasons|0|||
170419891|NCT00048568|615878720|FG001|Open-Label Period|Unknown Reasons|0|||
170419892|NCT00048568|615878721|FG002|Open-Label Period|Unknown Reasons|25|||
170419893|NCT00048568|615878719|FG000|Open-Label Period|Lost to Follow-up|0|||
170419894|NCT00048568|615878720|FG001|Open-Label Period|Lost to Follow-up|0|||
170419895|NCT00048568|615878721|FG002|Open-Label Period|Lost to Follow-up|7|||
170419896|NCT04099888|615878734|FG000|Overall Study|Study terminated by sponsor|9|||
170419897|NCT04099888|615878735|FG001|Overall Study|Study terminated by sponsor|11|||
170419898|NCT04099888|615878734|FG000|Overall Study|Lost to Follow-up|1|||
170419899|NCT04099888|615878735|FG001|Overall Study|Lost to Follow-up|1|||
170419900|NCT04099888|615878734|FG000|Overall Study|Withdrawal by Subject|5|||
170419901|NCT04099888|615878735|FG001|Overall Study|Withdrawal by Subject|6|||
170419902|NCT04099888|615878734|FG000|Overall Study|Death|5|||
170419903|NCT04099888|615878735|FG001|Overall Study|Death|2|||
170419904|NCT04099888|615878734|FG000|Overall Study|Other|1|||
170419905|NCT04099888|615878735|FG001|Overall Study|Other|0|||
170878298|NCT02819635|617565621|FG007|Substudy 3|Lost to Follow-up|0|||
170878299|NCT02819635|617565622|FG008|Substudy 3|Lost to Follow-up|1|||
170878300|NCT02819635|617565623|FG009|Substudy 3|Lost to Follow-up|0|||
170878301|NCT02819635|617565624|FG010|Substudy 3|Lost to Follow-up|1|||
170878302|NCT02819635|617565625|FG011|Substudy 3|Lost to Follow-up|1|||
170878303|NCT02819635|617565614|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878304|NCT02819635|617565615|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878305|NCT02819635|617565616|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878306|NCT02819635|617565617|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878307|NCT02819635|617565618|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878308|NCT02819635|617565619|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878309|NCT02819635|617565620|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878310|NCT02819635|617565621|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878311|NCT02819635|617565622|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878312|NCT02819635|617565623|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878313|NCT02819635|617565624|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
170878314|NCT02819635|617565625|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
170878315|NCT02819635|617565614|FG000|Substudy 3|Other, not specified|0|||
170878316|NCT02819635|617565615|FG001|Substudy 3|Other, not specified|0|||
170878317|NCT02819635|617565616|FG002|Substudy 3|Other, not specified|0|||
170878318|NCT02819635|617565617|FG003|Substudy 3|Other, not specified|0|||
170878319|NCT02819635|617565618|FG004|Substudy 3|Other, not specified|0|||
170878320|NCT02819635|617565619|FG005|Substudy 3|Other, not specified|0|||
170878321|NCT02819635|617565620|FG006|Substudy 3|Other, not specified|0|||
170878322|NCT02819635|617565621|FG007|Substudy 3|Other, not specified|0|||
170878323|NCT02819635|617565622|FG008|Substudy 3|Other, not specified|202|||
170878324|NCT02819635|617565623|FG009|Substudy 3|Other, not specified|5|||
170878325|NCT02819635|617565624|FG010|Substudy 3|Other, not specified|89|||
170878326|NCT02819635|617565625|FG011|Substudy 3|Other, not specified|39|||
170878327|NCT01081912|617565626|FG000|Conversion/Titration|Adverse Event|47|||
170878328|NCT01081912|617565627|FG001|Conversion/Titration|Adverse Event|0|||
170878329|NCT01081912|617565628|FG002|Conversion/Titration|Adverse Event|0|||
170878330|NCT01081912|617565626|FG000|Conversion/Titration|Lack of Efficacy|17|||
170878331|NCT01081912|617565627|FG001|Conversion/Titration|Lack of Efficacy|0|||
170878332|NCT01081912|617565628|FG002|Conversion/Titration|Lack of Efficacy|0|||
170878333|NCT01081912|617565626|FG000|Conversion/Titration|Lost to Follow-up|5|||
170531547|NCT01206764|616293308|FG000|Overall Study|Adverse Event|20|||
170531548|NCT01206764|616293308|FG000|Overall Study|Abnormal laboratory value|2|||
170531549|NCT01206764|616293308|FG000|Overall Study|Abnormal test procedure result|1|||
170531550|NCT01206764|616293308|FG000|Overall Study|Patient withdrew consent|5|||
170531551|NCT01206764|616293308|FG000|Overall Study|Lost to Follow-up|6|||
170531552|NCT01206764|616293308|FG000|Overall Study|Death|11|||
170531553|NCT01206764|616293308|FG000|Overall Study|New cancer therapy|2|||
170531554|NCT01206764|616293308|FG000|Overall Study|Disease progression|88|||
170531555|NCT01206764|616293308|FG000|Overall Study|Protocol deviation|3|||
170531556|NCT04494646|616293309|FG000|Overall Study|Adverse Event|0|||
170531557|NCT04494646|616293310|FG001|Overall Study|Adverse Event|1|||
170531558|NCT04494646|616293309|FG000|Overall Study|Withdrawal by Subject|0|||
170531559|NCT04494646|616293310|FG001|Overall Study|Withdrawal by Subject|1|||
170531560|NCT05282823|616293311|FG000|Overall Study|Withdrawal by Subject|9|||
170531561|NCT05282823|616293311|FG000|Overall Study|Adverse Event|1|||
170531562|NCT05282823|616293311|FG000|Overall Study|did not meet protocol criteria|2|||
170531563|NCT05282823|616293311|FG000|Overall Study|Withdrawal by Subject|7|||
170531564|NCT00997893|616293312|FG000|Overall Study|Adverse Event|1|||
170531565|NCT00997893|616293313|FG001|Overall Study|Adverse Event|0|||
170531566|NCT00997893|616293314|FG002|Overall Study|Adverse Event|0|||
170531567|NCT00997893|616293312|FG000|Overall Study|Unable to meet study timelines|1|||
170531568|NCT00997893|616293313|FG001|Overall Study|Unable to meet study timelines|0|||
170531569|NCT00997893|616293314|FG002|Overall Study|Unable to meet study timelines|0|||
170878334|NCT01081912|617565627|FG001|Conversion/Titration|Lost to Follow-up|0|||
170878335|NCT01081912|617565628|FG002|Conversion/Titration|Lost to Follow-up|0|||
170878336|NCT01081912|617565626|FG000|Conversion/Titration|Physician Decision|2|||
170878337|NCT01081912|617565627|FG001|Conversion/Titration|Physician Decision|0|||
170531570|NCT00997893|616293312|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
170531571|NCT00997893|616293313|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
170531572|NCT00997893|616293314|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
170531573|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
170878338|NCT01081912|617565628|FG002|Conversion/Titration|Physician Decision|0|||
170878339|NCT01081912|617565626|FG000|Conversion/Titration|Protocol Violation|67|||
170878340|NCT01081912|617565627|FG001|Conversion/Titration|Protocol Violation|0|||
170531574|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
170531575|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
170531576|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
170878341|NCT01081912|617565628|FG002|Conversion/Titration|Protocol Violation|0|||
170878342|NCT01081912|617565626|FG000|Conversion/Titration|Withdrawal by Subject|23|||
170419906|NCT03952143|615878738|FG000|Lead-In Period|Adverse Event|2|||
170419907|NCT03952143|615878739|FG001|Lead-In Period|Adverse Event|0|||
170419908|NCT03952143|615878740|FG002|Lead-In Period|Adverse Event|0|||
170419909|NCT03952143|615878738|FG000|Lead-In Period|Lack of Efficacy|2|||
170419910|NCT03952143|615878739|FG001|Lead-In Period|Lack of Efficacy|0|||
170419911|NCT03952143|615878740|FG002|Lead-In Period|Lack of Efficacy|0|||
170419912|NCT03952143|615878738|FG000|Lead-In Period|Physician Decision|5|||
170419913|NCT03952143|615878739|FG001|Lead-In Period|Physician Decision|0|||
170419914|NCT03952143|615878740|FG002|Lead-In Period|Physician Decision|0|||
170419915|NCT03952143|615878738|FG000|Lead-In Period|Protocol Violation|5|||
170419916|NCT03952143|615878739|FG001|Lead-In Period|Protocol Violation|0|||
170419917|NCT03952143|615878740|FG002|Lead-In Period|Protocol Violation|0|||
170419918|NCT03952143|615878738|FG000|Lead-In Period|Withdrawal by Subject|19|||
170419919|NCT03952143|615878739|FG001|Lead-In Period|Withdrawal by Subject|0|||
170419920|NCT03952143|615878740|FG002|Lead-In Period|Withdrawal by Subject|0|||
170419921|NCT03952143|615878738|FG000|Treatment Period|Adverse Event|0|||
170419922|NCT03952143|615878739|FG001|Treatment Period|Adverse Event|0|||
170419923|NCT03952143|615878740|FG002|Treatment Period|Adverse Event|1|||
170419924|NCT03952143|615878738|FG000|Treatment Period|Lost to Follow-up|0|||
170419925|NCT03952143|615878739|FG001|Treatment Period|Lost to Follow-up|2|||
170419926|NCT03952143|615878740|FG002|Treatment Period|Lost to Follow-up|0|||
170419927|NCT03952143|615878738|FG000|Treatment Period|Physician Decision|0|||
170419928|NCT03952143|615878739|FG001|Treatment Period|Physician Decision|0|||
170419929|NCT03952143|615878740|FG002|Treatment Period|Physician Decision|2|||
170419930|NCT03952143|615878738|FG000|Treatment Period|Protocol Violation|0|||
170419931|NCT03952143|615878739|FG001|Treatment Period|Protocol Violation|0|||
170419932|NCT03952143|615878740|FG002|Treatment Period|Protocol Violation|1|||
170419933|NCT03952143|615878738|FG000|Treatment Period|Withdrawal by Subject|0|||
170419934|NCT03952143|615878739|FG001|Treatment Period|Withdrawal by Subject|5|||
170419935|NCT03952143|615878740|FG002|Treatment Period|Withdrawal by Subject|26|||
170419936|NCT03952143|615878738|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
170419937|NCT03952143|615878739|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
170419938|NCT03952143|615878740|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
170419939|NCT03952143|615878738|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
170419940|NCT03952143|615878739|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
170419941|NCT03952143|615878740|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
170419942|NCT01866319|615878741|FG000|Overall Study|Adverse Event|12|||
170419943|NCT01866319|615878742|FG001|Overall Study|Adverse Event|5|||
170419944|NCT01866319|615878743|FG002|Overall Study|Adverse Event|9|||
170419945|NCT01866319|615878741|FG000|Overall Study|Clinical progression|3|||
170419946|NCT01866319|615878742|FG001|Overall Study|Clinical progression|2|||
170419947|NCT01866319|615878743|FG002|Overall Study|Clinical progression|2|||
170419948|NCT01866319|615878741|FG000|Overall Study|Death|153|||
170419949|NCT01866319|615878742|FG001|Overall Study|Death|154|||
170419950|NCT01866319|615878743|FG002|Overall Study|Death|147|||
170419951|NCT01866319|615878741|FG000|Overall Study|Lost to Follow-up|6|||
170419952|NCT01866319|615878742|FG001|Overall Study|Lost to Follow-up|3|||
170419953|NCT01866319|615878743|FG002|Overall Study|Lost to Follow-up|8|||
170419954|NCT01866319|615878741|FG000|Overall Study|Physician Decision|1|||
170419955|NCT01866319|615878742|FG001|Overall Study|Physician Decision|0|||
170419956|NCT01866319|615878743|FG002|Overall Study|Physician Decision|1|||
170419957|NCT01866319|615878741|FG000|Overall Study|Protocol Violation|0|||
170419958|NCT01866319|615878742|FG001|Overall Study|Protocol Violation|0|||
170419959|NCT01866319|615878743|FG002|Overall Study|Protocol Violation|1|||
170419960|NCT01866319|615878741|FG000|Overall Study|Withdrawal by Subject|32|||
170419961|NCT01866319|615878742|FG001|Overall Study|Withdrawal by Subject|14|||
170419962|NCT01866319|615878743|FG002|Overall Study|Withdrawal by Subject|12|||
170419963|NCT01629381|615878750|FG000|Overall Study|Withdrawal by Subject|2|||
170419964|NCT01629381|615878751|FG001|Overall Study|Withdrawal by Subject|5|||
170419965|NCT06354270|615878755|FG000|Overall Study|Withdrawal by Subject|1|||
170419966|NCT06354270|615878756|FG001|Overall Study|Withdrawal by Subject|0|||
170419967|NCT03978624|615878757|FG000|Overall Study|Protocol Violation|1|||
170419968|NCT03978624|615878758|FG001|Overall Study|Protocol Violation|0|||
170419969|NCT00918567|615878765|FG000|Overall Study|Lack of Efficacy|3|||
170419970|NCT00918567|615878766|FG001|Overall Study|Lack of Efficacy|1|||
170419971|NCT00918567|615878765|FG000|Overall Study|Withdrawal by Subject|1|||
170419972|NCT00918567|615878766|FG001|Overall Study|Withdrawal by Subject|1|||
170419973|NCT00918567|615878765|FG000|Overall Study|Adverse Event|1|||
170419974|NCT00918567|615878766|FG001|Overall Study|Adverse Event|0|||
170419975|NCT00745095|615878767|FG000|Overall Study|Declined to participate|1|||
170419976|NCT00745095|615878768|FG001|Overall Study|Declined to participate|0|||
170419977|NCT00745095|615878769|FG002|Overall Study|Declined to participate|0|||
170419978|NCT00745095|615878770|FG003|Overall Study|Declined to participate|0|||
170419979|NCT00745095|615878771|FG004|Overall Study|Declined to participate|92|||
170419980|NCT00745095|615878772|FG005|Overall Study|Declined to participate|95|||
170419981|NCT00745095|615878767|FG000|Overall Study|Ineligible due to GFR criteria|0|||
170419982|NCT00745095|615878768|FG001|Overall Study|Ineligible due to GFR criteria|2|||
170531577|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
170531578|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
170531579|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
170531580|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
170531581|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
170531582|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
170531583|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
170531584|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
170531585|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
170531586|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
170531587|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
170531588|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
170531589|NCT00410163|616293315|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
170531590|NCT00410163|616293316|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
170531591|NCT00410163|616293315|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
170531592|NCT00410163|616293316|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
170531593|NCT00410163|616293315|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
170531594|NCT00410163|616293316|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
170531595|NCT00410163|616293315|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
170531596|NCT00410163|616293316|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
170531597|NCT00410163|616293315|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
170531598|NCT00410163|616293316|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
170531599|NCT00410163|616293315|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
170531600|NCT00410163|616293316|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
170531601|NCT00112957|616293317|FG000|Overall Study|Progressive disease|18|||
170531602|NCT00112957|616293317|FG000|Overall Study|Physician Decision|1|||
170531603|NCT03530696|616293319|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
170531604|NCT03530696|616293320|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
170531605|NCT05352815|616293321|FG000|Overall Study|Withdrawal by Subject|28|||
170531606|NCT05352815|616293322|FG001|Overall Study|Withdrawal by Subject|24|||
170531607|NCT05352815|616293321|FG000|Overall Study|Lost to Follow-up|4|||
170531608|NCT05352815|616293322|FG001|Overall Study|Lost to Follow-up|7|||
170531609|NCT05352815|616293321|FG000|Overall Study|Death|2|||
170531610|NCT05352815|616293322|FG001|Overall Study|Death|3|||
170531611|NCT05352815|616293321|FG000|Overall Study|Site closure|1|||
170531612|NCT05352815|616293322|FG001|Overall Study|Site closure|0|||
170531613|NCT00961415|616293326|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
170531614|NCT00961415|616293327|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
170531615|NCT00961415|616293328|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
170531616|NCT00961415|616293326|FG000|Induction Treatment Phase|Death|77|||
170531617|NCT00961415|616293327|FG001|Induction Treatment Phase|Death|0|||
170531618|NCT00961415|616293328|FG002|Induction Treatment Phase|Death|0|||
170531619|NCT00961415|616293326|FG000|Induction Treatment Phase|Protocol Violation|1|||
170531620|NCT00961415|616293327|FG001|Induction Treatment Phase|Protocol Violation|0|||
170531621|NCT00961415|616293328|FG002|Induction Treatment Phase|Protocol Violation|0|||
170531622|NCT00961415|616293326|FG000|Induction Treatment Phase|Physician Decision|2|||
170531623|NCT00961415|616293327|FG001|Induction Treatment Phase|Physician Decision|0|||
170531624|NCT00961415|616293328|FG002|Induction Treatment Phase|Physician Decision|0|||
170531625|NCT00961415|616293326|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
170531626|NCT00961415|616293327|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
170531627|NCT00961415|616293328|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
170531628|NCT00961415|616293326|FG000|Induction Treatment Phase|Other Reason|5|||
170531629|NCT00961415|616293327|FG001|Induction Treatment Phase|Other Reason|0|||
170531630|NCT00961415|616293328|FG002|Induction Treatment Phase|Other Reason|0|||
170531631|NCT00961415|616293326|FG000|Maintenance Treatment Phase|Death|0|||
170531632|NCT00961415|616293327|FG001|Maintenance Treatment Phase|Death|42|||
170531633|NCT00961415|616293328|FG002|Maintenance Treatment Phase|Death|34|||
170531634|NCT00961415|616293326|FG000|Maintenance Treatment Phase|Investigators decision|0|||
170531635|NCT00961415|616293327|FG001|Maintenance Treatment Phase|Investigators decision|2|||
170531636|NCT00961415|616293328|FG002|Maintenance Treatment Phase|Investigators decision|0|||
170531637|NCT00961415|616293326|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170531638|NCT00961415|616293327|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
170531639|NCT00961415|616293328|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
170531640|NCT00961415|616293326|FG000|Maintenance Treatment Phase|Other reason|0|||
170531641|NCT00961415|616293327|FG001|Maintenance Treatment Phase|Other reason|1|||
170531642|NCT00961415|616293328|FG002|Maintenance Treatment Phase|Other reason|3|||
170531643|NCT00226655|616293329|FG000|Overall Study|Death|13|||
170632637|NCT01929317|616666724|FG001|Long-term Phase|Adverse Event|1|||
170419983|NCT00745095|615878769|FG002|Overall Study|Ineligible due to GFR criteria|3|||
170419984|NCT00745095|615878770|FG003|Overall Study|Ineligible due to GFR criteria|3|||
170419985|NCT00745095|615878771|FG004|Overall Study|Ineligible due to GFR criteria|30|||
170419986|NCT00745095|615878772|FG005|Overall Study|Ineligible due to GFR criteria|28|||
170419987|NCT04646109|615878773|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
170419988|NCT04646109|615878774|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
170419989|NCT03283709|615878775|FG000|Overall Study|trial terminated|0|||
170419990|NCT03283709|615878776|FG001|Overall Study|trial terminated|1|||
170419991|NCT05275998|615878777|FG000|Overall Study|Adverse Event|0|||
170419992|NCT05275998|615878778|FG001|Overall Study|Adverse Event|0|||
170419993|NCT05275998|615878779|FG002|Overall Study|Adverse Event|0|||
170419994|NCT05275998|615878780|FG003|Overall Study|Adverse Event|1|||
170419995|NCT05275998|615878777|FG000|Overall Study|Withdrawal by Subject|0|||
170419996|NCT05275998|615878778|FG001|Overall Study|Withdrawal by Subject|0|||
170419997|NCT05275998|615878779|FG002|Overall Study|Withdrawal by Subject|0|||
170419998|NCT05275998|615878780|FG003|Overall Study|Withdrawal by Subject|1|||
170419999|NCT05275998|615878777|FG000|Overall Study|Physician Decision|0|||
170420000|NCT05275998|615878778|FG001|Overall Study|Physician Decision|0|||
170420001|NCT05275998|615878779|FG002|Overall Study|Physician Decision|0|||
170420002|NCT05275998|615878780|FG003|Overall Study|Physician Decision|1|||
170420003|NCT05275998|615878777|FG000|Overall Study|Protocol Violation|0|||
170420004|NCT05275998|615878778|FG001|Overall Study|Protocol Violation|0|||
170420005|NCT05275998|615878779|FG002|Overall Study|Protocol Violation|1|||
170420006|NCT05275998|615878780|FG003|Overall Study|Protocol Violation|0|||
170420007|NCT01936948|615878784|FG000|Overall Study|no 30-day follow-up data|0|||
170420008|NCT01936948|615878785|FG001|Overall Study|no 30-day follow-up data|3|||
170420009|NCT01936948|615878786|FG002|Overall Study|no 30-day follow-up data|3|||
170420010|NCT01936948|615878787|FG003|Overall Study|no 30-day follow-up data|3|||
170420011|NCT02327130|615878791|FG000|Overall Study|Discharged in less than 5 days|5|||
170420012|NCT02327130|615878791|FG000|Overall Study|Physician Decision|2|||
170420013|NCT02327130|615878791|FG000|Overall Study|Unable to provide breath sample|1|||
170420014|NCT02327130|615878791|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
170420015|NCT02327130|615878791|FG000|Overall Study|Met exclusion criteria|3|||
170420016|NCT01347710|615878793|FG000|Overall Study|Withdrawal by Subject|2|||
170420017|NCT01347710|615878793|FG000|Overall Study|Adverse Event|4|||
170420018|NCT01347710|615878793|FG000|Overall Study|Angio or SPECT not completed|18|||
170420019|NCT01347710|615878793|FG000|Overall Study|issue with vitals prior to dosing|1|||
170420020|NCT01347710|615878793|FG000|Overall Study|Lost to Follow-up|1|||
170420021|NCT01347710|615878793|FG000|Overall Study|Physician Decision|2|||
170420022|NCT01347710|615878793|FG000|Overall Study|Other|3|||
170420023|NCT00950872|615878796|FG000|Overall Study|Withdrawal by Subject|1|||
170420024|NCT00950872|615878796|FG000|Overall Study|Did not have surgery|2|||
170420025|NCT02003183|615878799|FG000|Overall Study|Lost to Follow-up|0|||
170420026|NCT02003183|615878800|FG001|Overall Study|Lost to Follow-up|2|||
170420027|NCT00406848|615878805|FG000|Overall Study|Withdrawal by Subject|27|||
170420028|NCT00406848|615878806|FG001|Overall Study|Withdrawal by Subject|22|||
170420029|NCT00406848|615878805|FG000|Overall Study|Adverse Event|38|||
170420030|NCT00406848|615878806|FG001|Overall Study|Adverse Event|7|||
170420031|NCT00406848|615878805|FG000|Overall Study|Lack of Efficacy|9|||
170420032|NCT00406848|615878806|FG001|Overall Study|Lack of Efficacy|14|||
170420033|NCT00406848|615878805|FG000|Overall Study|Protocol Violation|10|||
170420034|NCT00406848|615878806|FG001|Overall Study|Protocol Violation|6|||
170420035|NCT00406848|615878805|FG000|Overall Study|Lost to Follow-up|6|||
170420036|NCT00406848|615878806|FG001|Overall Study|Lost to Follow-up|2|||
170420037|NCT00406848|615878805|FG000|Overall Study|Physician Decision|2|||
170420038|NCT00406848|615878806|FG001|Overall Study|Physician Decision|2|||
170420039|NCT00406848|615878805|FG000|Overall Study|Sponsor Decision|1|||
170420040|NCT00406848|615878806|FG001|Overall Study|Sponsor Decision|1|||
170420041|NCT00841100|615878807|FG000|Phase 1 (28 Days)|Adverse Event|1|||
170420042|NCT00841100|615878807|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
170420043|NCT01355081|615878810|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
170420044|NCT01355081|615878811|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
170420045|NCT01355081|615878812|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
170420046|NCT01355081|615878810|FG000|Overall Study|Major Protocol Deviation|0|||
170420047|NCT01355081|615878811|FG001|Overall Study|Major Protocol Deviation|1|||
170420048|NCT01355081|615878812|FG002|Overall Study|Major Protocol Deviation|0|||
170420049|NCT01355081|615878810|FG000|Overall Study|Lost to Follow-up|0|||
170420050|NCT01355081|615878811|FG001|Overall Study|Lost to Follow-up|0|||
170420051|NCT01355081|615878812|FG002|Overall Study|Lost to Follow-up|1|||
170632638|NCT01929317|616666723|FG000|Long-term Phase|Physician Decision|3|||
170878343|NCT01081912|617565627|FG001|Conversion/Titration|Withdrawal by Subject|0|||
170420052|NCT01355081|615878810|FG000|Overall Study|Withdrawal of Consent|2|||
170420053|NCT01355081|615878811|FG001|Overall Study|Withdrawal of Consent|3|||
170420054|NCT01355081|615878812|FG002|Overall Study|Withdrawal of Consent|3|||
170420055|NCT01355081|615878810|FG000|Overall Study|Lack of Efficacy|2|||
170420056|NCT01355081|615878811|FG001|Overall Study|Lack of Efficacy|1|||
170420057|NCT01355081|615878812|FG002|Overall Study|Lack of Efficacy|1|||
170531644|NCT00226655|616293329|FG000|Overall Study|Withdrawal by Subject|15|||
170531645|NCT00226655|616293329|FG000|Overall Study|Adverse Event|35|||
170531646|NCT00226655|616293329|FG000|Overall Study|Physician Decision|6|||
170531647|NCT00226655|616293329|FG000|Overall Study|Clinical deterioration|10|||
170531648|NCT02309359|616293330|FG000|Overall Study|Adverse Event|4|||
170531649|NCT02309359|616293331|FG001|Overall Study|Adverse Event|5|||
170531650|NCT02309359|616293332|FG002|Overall Study|Adverse Event|5|||
170531651|NCT02309359|616293333|FG003|Overall Study|Adverse Event|4|||
170531652|NCT02309359|616293334|FG004|Overall Study|Adverse Event|4|||
170531653|NCT02309359|616293330|FG000|Overall Study|Death|1|||
170531654|NCT02309359|616293331|FG001|Overall Study|Death|0|||
170531655|NCT02309359|616293332|FG002|Overall Study|Death|0|||
170531656|NCT02309359|616293333|FG003|Overall Study|Death|0|||
170531657|NCT02309359|616293334|FG004|Overall Study|Death|0|||
170531658|NCT02309359|616293330|FG000|Overall Study|Withdrawal by Subject|2|||
170531659|NCT02309359|616293331|FG001|Overall Study|Withdrawal by Subject|2|||
170531660|NCT02309359|616293332|FG002|Overall Study|Withdrawal by Subject|4|||
170531661|NCT02309359|616293333|FG003|Overall Study|Withdrawal by Subject|4|||
170531662|NCT02309359|616293334|FG004|Overall Study|Withdrawal by Subject|0|||
170531663|NCT02309359|616293330|FG000|Overall Study|Lack of Efficacy|3|||
170531664|NCT02309359|616293331|FG001|Overall Study|Lack of Efficacy|1|||
170531665|NCT02309359|616293332|FG002|Overall Study|Lack of Efficacy|0|||
170531666|NCT02309359|616293333|FG003|Overall Study|Lack of Efficacy|0|||
170531667|NCT02309359|616293334|FG004|Overall Study|Lack of Efficacy|3|||
170420058|NCT01355081|615878810|FG000|Overall Study|Non Compliance with Study Medication|0|||
170420059|NCT01355081|615878811|FG001|Overall Study|Non Compliance with Study Medication|1|||
170420060|NCT01355081|615878812|FG002|Overall Study|Non Compliance with Study Medication|0|||
170420061|NCT03629249|615878813|FG000|Overall Study|Study terminated by sponsor|197|||
170420062|NCT03629249|615878814|FG001|Overall Study|Study terminated by sponsor|197|||
170420063|NCT03629249|615878815|FG002|Overall Study|Study terminated by sponsor|194|||
170420064|NCT03629249|615878813|FG000|Overall Study|Protocol deviation|0|||
170420065|NCT03629249|615878814|FG001|Overall Study|Protocol deviation|2|||
170420066|NCT03629249|615878815|FG002|Overall Study|Protocol deviation|5|||
170420067|NCT03629249|615878813|FG000|Overall Study|Subject decision|1|||
170420068|NCT03629249|615878814|FG001|Overall Study|Subject decision|1|||
170420069|NCT03629249|615878815|FG002|Overall Study|Subject decision|3|||
170420070|NCT03629249|615878813|FG000|Overall Study|Adverse Event|1|||
170420071|NCT03629249|615878814|FG001|Overall Study|Adverse Event|1|||
170420072|NCT03629249|615878815|FG002|Overall Study|Adverse Event|0|||
170420073|NCT03629249|615878813|FG000|Overall Study|Death|1|||
170420074|NCT03629249|615878814|FG001|Overall Study|Death|0|||
170420075|NCT03629249|615878815|FG002|Overall Study|Death|0|||
170420076|NCT03629249|615878813|FG000|Overall Study|Physician Decision|1|||
170420077|NCT03629249|615878814|FG001|Overall Study|Physician Decision|0|||
170420078|NCT03629249|615878815|FG002|Overall Study|Physician Decision|0|||
170420079|NCT00352690|615878816|FG000|Overall Study|Determined to be ineligible|2|||
170420080|NCT00352690|615878817|FG001|Overall Study|Determined to be ineligible|0|||
170420081|NCT02719522|615878820|FG000|Overall Study|Implant Failure|4|||
170420082|NCT02719522|615878820|FG000|Overall Study|Death|2|||
170420083|NCT02719522|615878820|FG000|Overall Study|Lost to Follow-up|5|||
170420084|NCT06096168|615878822|FG000|Overall Study|Death|30|||
170420085|NCT06096168|615878822|FG000|Overall Study|Revision|2|||
170420086|NCT01868009|615878823|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
170420087|NCT01868009|615878824|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
170420088|NCT01868009|615878823|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
170420089|NCT01868009|615878824|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
170420090|NCT01868009|615878823|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
170420091|NCT01868009|615878824|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
170420092|NCT00182091|615878825|FG000|Overall Study|Withdrawal by Subject|1|||
170420093|NCT00182091|615878826|FG001|Overall Study|Withdrawal by Subject|0|||
170420094|NCT00182091|615878827|FG002|Overall Study|Withdrawal by Subject|0|||
170420095|NCT00182091|615878828|FG003|Overall Study|Withdrawal by Subject|0|||
170420096|NCT02339909|615878829|FG000|Overall Study|Became ineligible after randomisation|89|||
170420097|NCT02339909|615878830|FG001|Overall Study|Became ineligible after randomisation|63|||
170420098|NCT02339909|615878831|FG002|Overall Study|Became ineligible after randomisation|71|||
170420099|NCT00860028|615878833|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
170420100|NCT00860028|615878834|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
170420101|NCT01592370|615878835|FG000|Overall Study|Disease Progression|62|||
170420102|NCT01592370|615878836|FG001|Overall Study|Disease Progression|16|||
170420103|NCT01592370|615878837|FG002|Overall Study|Disease Progression|52|||
170531668|NCT02309359|616293330|FG000|Overall Study|Lost to Follow-up|0|||
170531669|NCT02309359|616293331|FG001|Overall Study|Lost to Follow-up|0|||
170531670|NCT02309359|616293332|FG002|Overall Study|Lost to Follow-up|0|||
170531671|NCT02309359|616293333|FG003|Overall Study|Lost to Follow-up|1|||
170632639|NCT01929317|616666724|FG001|Long-term Phase|Physician Decision|0|||
170531672|NCT02309359|616293334|FG004|Overall Study|Lost to Follow-up|0|||
170531673|NCT02309359|616293330|FG000|Overall Study|Other|2|||
170531674|NCT02309359|616293331|FG001|Overall Study|Other|0|||
170531675|NCT02309359|616293332|FG002|Overall Study|Other|2|||
170531676|NCT02309359|616293333|FG003|Overall Study|Other|3|||
170531677|NCT02309359|616293334|FG004|Overall Study|Other|2|||
170531678|NCT05144945|616293336|FG000|Overall Study|Withdrawal by Subject|1|||
170531679|NCT05144945|616293337|FG001|Overall Study|Withdrawal by Subject|0|||
170531680|NCT05595369|616293339|FG000|Overall Study|Adverse Event|2|||
170531681|NCT05595369|616293340|FG001|Overall Study|Adverse Event|0|||
170531682|NCT05595369|616293341|FG002|Overall Study|Adverse Event|0|||
170531683|NCT05595369|616293339|FG000|Overall Study|Lost to Follow-up|11|||
170531684|NCT05595369|616293340|FG001|Overall Study|Lost to Follow-up|10|||
170531685|NCT05595369|616293341|FG002|Overall Study|Lost to Follow-up|10|||
170531686|NCT05595369|616293339|FG000|Overall Study|Physician Decision|1|||
170531687|NCT05595369|616293340|FG001|Overall Study|Physician Decision|0|||
170531688|NCT05595369|616293341|FG002|Overall Study|Physician Decision|0|||
170531689|NCT05595369|616293339|FG000|Overall Study|Withdrawal by Subject|5|||
170531690|NCT05595369|616293340|FG001|Overall Study|Withdrawal by Subject|7|||
170531691|NCT05595369|616293341|FG002|Overall Study|Withdrawal by Subject|6|||
170531692|NCT05595369|616293339|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
170531693|NCT05595369|616293340|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
170531694|NCT05595369|616293341|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
170531695|NCT05595369|616293339|FG000|Overall Study|Study Drug Non-compliance|0|||
170531696|NCT05595369|616293340|FG001|Overall Study|Study Drug Non-compliance|1|||
170531697|NCT05595369|616293341|FG002|Overall Study|Study Drug Non-compliance|0|||
170531698|NCT05595369|616293339|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
170531699|NCT05595369|616293340|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
170531700|NCT05595369|616293341|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
170531701|NCT02592824|616293342|FG000|Overall Study|Protocol Violation|5|||
170531702|NCT02592824|616293343|FG001|Overall Study|Protocol Violation|3|||
170531703|NCT02592824|616293342|FG000|Overall Study|Lost to Follow-up|2|||
170531704|NCT02592824|616293343|FG001|Overall Study|Lost to Follow-up|1|||
170531705|NCT01704261|616293344|FG000|Overall Study|Withdrawal by Subject|12|||
170531706|NCT01704261|616293345|FG001|Overall Study|Withdrawal by Subject|15|||
170531707|NCT01704261|616293344|FG000|Overall Study|Lost to Follow-up|1|||
170531708|NCT01704261|616293345|FG001|Overall Study|Lost to Follow-up|0|||
170531709|NCT02391337|616293346|FG000|6 Months Follow-up|Death|5|||
170531710|NCT02391337|616293347|FG001|6 Months Follow-up|Death|4|||
170531711|NCT02391337|616293346|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
170531712|NCT02391337|616293347|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
170531713|NCT02391337|616293346|FG000|12 Months Follow-up|Death|2|||
170531714|NCT02391337|616293347|FG001|12 Months Follow-up|Death|0|||
170531715|NCT02391337|616293346|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
170531716|NCT02391337|616293347|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
170531717|NCT02391337|616293346|FG000|12 Months Follow-up|Lost to Follow-up|0|||
170531718|NCT02391337|616293347|FG001|12 Months Follow-up|Lost to Follow-up|2|||
170531719|NCT00465179|616293351|FG000|Overall Study|Adverse Event|4|||
170531720|NCT00465179|616293351|FG000|Overall Study|Withdrawal by Subject|2|||
170531721|NCT00465179|616293351|FG000|Overall Study|Progression of Disease|47|||
170531722|NCT02867592|616293353|FG000|Overall Study|Adverse Event|3|||
170531723|NCT02867592|616293354|FG001|Overall Study|Adverse Event|0|||
170531724|NCT02867592|616293355|FG002|Overall Study|Adverse Event|2|||
170531725|NCT02867592|616293356|FG003|Overall Study|Adverse Event|1|||
170531726|NCT02867592|616293357|FG004|Overall Study|Adverse Event|1|||
170531727|NCT02867592|616293358|FG005|Overall Study|Adverse Event|5|||
170531728|NCT02867592|616293353|FG000|Overall Study|Death|0|||
170531729|NCT02867592|616293354|FG001|Overall Study|Death|0|||
170531730|NCT02867592|616293355|FG002|Overall Study|Death|0|||
170531731|NCT02867592|616293356|FG003|Overall Study|Death|1|||
170531732|NCT02867592|616293357|FG004|Overall Study|Death|0|||
170531733|NCT02867592|616293358|FG005|Overall Study|Death|1|||
170531734|NCT02867592|616293353|FG000|Overall Study|Lack of Efficacy|8|||
170531735|NCT02867592|616293354|FG001|Overall Study|Lack of Efficacy|10|||
170531736|NCT02867592|616293355|FG002|Overall Study|Lack of Efficacy|8|||
170531737|NCT02867592|616293356|FG003|Overall Study|Lack of Efficacy|8|||
170531738|NCT02867592|616293357|FG004|Overall Study|Lack of Efficacy|12|||
170531739|NCT02867592|616293358|FG005|Overall Study|Lack of Efficacy|17|||
170531740|NCT02867592|616293353|FG000|Overall Study|Physician Decision|1|||
170531741|NCT02867592|616293354|FG001|Overall Study|Physician Decision|2|||
170531742|NCT02867592|616293355|FG002|Overall Study|Physician Decision|2|||
170531743|NCT02867592|616293356|FG003|Overall Study|Physician Decision|0|||
170531744|NCT02867592|616293357|FG004|Overall Study|Physician Decision|5|||
170531745|NCT02867592|616293358|FG005|Overall Study|Physician Decision|1|||
170531746|NCT02867592|616293353|FG000|Overall Study|Protocol Violation|0|||
170531747|NCT02867592|616293354|FG001|Overall Study|Protocol Violation|0|||
170531748|NCT02867592|616293355|FG002|Overall Study|Protocol Violation|0|||
170531749|NCT02867592|616293356|FG003|Overall Study|Protocol Violation|0|||
170531750|NCT02867592|616293357|FG004|Overall Study|Protocol Violation|1|||
170531751|NCT02867592|616293358|FG005|Overall Study|Protocol Violation|1|||
170531752|NCT02867592|616293353|FG000|Overall Study|Withdrawal by Subject|0|||
170531753|NCT02867592|616293354|FG001|Overall Study|Withdrawal by Subject|1|||
170420104|NCT01592370|615878838|FG003|Overall Study|Disease Progression|3|||
170420105|NCT01592370|615878839|FG004|Overall Study|Disease Progression|3|||
170420106|NCT01592370|615878840|FG005|Overall Study|Disease Progression|31|||
170420107|NCT01592370|615878841|FG006|Overall Study|Disease Progression|14|||
170420108|NCT01592370|615878835|FG000|Overall Study|Study Drug Toxicity|14|||
170420109|NCT01592370|615878836|FG001|Overall Study|Study Drug Toxicity|3|||
170420110|NCT01592370|615878837|FG002|Overall Study|Study Drug Toxicity|0|||
170420111|NCT01592370|615878838|FG003|Overall Study|Study Drug Toxicity|0|||
170420112|NCT01592370|615878839|FG004|Overall Study|Study Drug Toxicity|0|||
170420113|NCT01592370|615878840|FG005|Overall Study|Study Drug Toxicity|0|||
170420114|NCT01592370|615878841|FG006|Overall Study|Study Drug Toxicity|1|||
170420115|NCT01592370|615878835|FG000|Overall Study|AE unrelated to study drug|4|||
170420116|NCT01592370|615878836|FG001|Overall Study|AE unrelated to study drug|3|||
170420117|NCT01592370|615878837|FG002|Overall Study|AE unrelated to study drug|0|||
170420118|NCT01592370|615878838|FG003|Overall Study|AE unrelated to study drug|0|||
170420119|NCT01592370|615878839|FG004|Overall Study|AE unrelated to study drug|0|||
170420120|NCT01592370|615878840|FG005|Overall Study|AE unrelated to study drug|0|||
170420121|NCT01592370|615878841|FG006|Overall Study|AE unrelated to study drug|1|||
170420122|NCT01592370|615878835|FG000|Overall Study|Request to discontinue study treatment|5|||
170420123|NCT01592370|615878836|FG001|Overall Study|Request to discontinue study treatment|0|||
170420124|NCT01592370|615878837|FG002|Overall Study|Request to discontinue study treatment|2|||
170420125|NCT01592370|615878838|FG003|Overall Study|Request to discontinue study treatment|0|||
170420126|NCT01592370|615878839|FG004|Overall Study|Request to discontinue study treatment|1|||
170420127|NCT01592370|615878840|FG005|Overall Study|Request to discontinue study treatment|2|||
170420128|NCT01592370|615878841|FG006|Overall Study|Request to discontinue study treatment|0|||
170420129|NCT01592370|615878835|FG000|Overall Study|Withdrew consent|1|||
170420130|NCT01592370|615878836|FG001|Overall Study|Withdrew consent|2|||
170420131|NCT01592370|615878837|FG002|Overall Study|Withdrew consent|1|||
170420132|NCT01592370|615878838|FG003|Overall Study|Withdrew consent|1|||
170420133|NCT01592370|615878839|FG004|Overall Study|Withdrew consent|0|||
170420134|NCT01592370|615878840|FG005|Overall Study|Withdrew consent|0|||
170420135|NCT01592370|615878841|FG006|Overall Study|Withdrew consent|0|||
170420136|NCT01592370|615878835|FG000|Overall Study|Maximum clinical benefit|11|||
170420137|NCT01592370|615878836|FG001|Overall Study|Maximum clinical benefit|1|||
170420138|NCT01592370|615878837|FG002|Overall Study|Maximum clinical benefit|7|||
170420139|NCT01592370|615878838|FG003|Overall Study|Maximum clinical benefit|1|||
170420140|NCT01592370|615878839|FG004|Overall Study|Maximum clinical benefit|0|||
170420141|NCT01592370|615878840|FG005|Overall Study|Maximum clinical benefit|0|||
170420142|NCT01592370|615878841|FG006|Overall Study|Maximum clinical benefit|0|||
170420143|NCT01592370|615878835|FG000|Overall Study|No longer meets study criteria|1|||
170420144|NCT01592370|615878836|FG001|Overall Study|No longer meets study criteria|0|||
170420145|NCT01592370|615878837|FG002|Overall Study|No longer meets study criteria|0|||
170420146|NCT01592370|615878838|FG003|Overall Study|No longer meets study criteria|0|||
170420147|NCT01592370|615878839|FG004|Overall Study|No longer meets study criteria|0|||
170420148|NCT01592370|615878840|FG005|Overall Study|No longer meets study criteria|0|||
170420149|NCT01592370|615878841|FG006|Overall Study|No longer meets study criteria|0|||
170420150|NCT01592370|615878835|FG000|Overall Study|Other Reasons|6|||
170420151|NCT01592370|615878836|FG001|Overall Study|Other Reasons|0|||
170420152|NCT01592370|615878837|FG002|Overall Study|Other Reasons|10|||
170420153|NCT01592370|615878838|FG003|Overall Study|Other Reasons|0|||
170420154|NCT01592370|615878839|FG004|Overall Study|Other Reasons|0|||
170420155|NCT01592370|615878840|FG005|Overall Study|Other Reasons|1|||
170420156|NCT01592370|615878841|FG006|Overall Study|Other Reasons|0|||
170420157|NCT01592370|615878835|FG000|Overall Study|Not Treated|0|||
170420158|NCT01592370|615878836|FG001|Overall Study|Not Treated|0|||
170420159|NCT01592370|615878837|FG002|Overall Study|Not Treated|0|||
170420160|NCT01592370|615878838|FG003|Overall Study|Not Treated|0|||
170420161|NCT01592370|615878839|FG004|Overall Study|Not Treated|2|||
170420162|NCT01592370|615878840|FG005|Overall Study|Not Treated|2|||
170420163|NCT01592370|615878841|FG006|Overall Study|Not Treated|0|||
170420164|NCT00979628|615878845|FG000|Overall Study|received regimen < 24 hours|7|||
170420165|NCT00979628|615878846|FG001|Overall Study|received regimen < 24 hours|6|||
170420166|NCT00979628|615878847|FG002|Overall Study|received regimen < 24 hours|5|||
170420167|NCT00979628|615878845|FG000|Overall Study|received steroids|1|||
170420168|NCT00979628|615878846|FG001|Overall Study|received steroids|1|||
170420169|NCT00979628|615878847|FG002|Overall Study|received steroids|0|||
170420170|NCT00979628|615878845|FG000|Overall Study|transferred to ICU|1|||
170420171|NCT00979628|615878846|FG001|Overall Study|transferred to ICU|2|||
170420172|NCT00979628|615878847|FG002|Overall Study|transferred to ICU|1|||
170420173|NCT02576990|615878848|FG000|Overall Study|Death|29|||
170420174|NCT02576990|615878849|FG001|Overall Study|Death|18|||
170420175|NCT02576990|615878848|FG000|Overall Study|Physician Decision|1|||
170420176|NCT02576990|615878849|FG001|Overall Study|Physician Decision|0|||
170420177|NCT02576990|615878848|FG000|Overall Study|Screen failure|2|||
170420178|NCT02576990|615878849|FG001|Overall Study|Screen failure|0|||
170420179|NCT02576990|615878848|FG000|Overall Study|Sponsor's decision|24|||
170420180|NCT02576990|615878849|FG001|Overall Study|Sponsor's decision|4|||
170420181|NCT02576990|615878848|FG000|Overall Study|Withdrawal by Subject|0|||
170420182|NCT02576990|615878849|FG001|Overall Study|Withdrawal by Subject|2|||
170420183|NCT00936390|615878850|FG000|Overall Study|Protocol Violation|21|||
170420184|NCT00936390|615878851|FG001|Overall Study|Protocol Violation|25|||
170420185|NCT00475020|615878852|FG000|Overall Study|Physician Decision|3|||
170420186|NCT00475020|615878852|FG000|Overall Study|Insurance Denial|1|||
170420187|NCT00475020|615878852|FG000|Overall Study|Donor not able to donate the last minute|1|||
170420188|NCT02688608|615878853|FG000|Overall Study|Lost to Follow-up|1|||
170420189|NCT03365947|615878854|FG000|Overall Study|Lost to Follow-up|0|||
170420190|NCT03365947|615878855|FG001|Overall Study|Lost to Follow-up|0|||
170420191|NCT03365947|615878856|FG002|Overall Study|Lost to Follow-up|0|||
170420192|NCT03365947|615878857|FG003|Overall Study|Lost to Follow-up|0|||
170420193|NCT03365947|615878858|FG004|Overall Study|Lost to Follow-up|0|||
170420194|NCT03365947|615878859|FG005|Overall Study|Lost to Follow-up|1|||
170420195|NCT03365947|615878860|FG006|Overall Study|Lost to Follow-up|0|||
170420196|NCT03365947|615878861|FG007|Overall Study|Lost to Follow-up|0|||
170420197|NCT03365947|615878862|FG008|Overall Study|Lost to Follow-up|0|||
170420198|NCT03365947|615878863|FG009|Overall Study|Lost to Follow-up|0|||
170420199|NCT03365947|615878864|FG010|Overall Study|Lost to Follow-up|0|||
170420200|NCT03365947|615878865|FG011|Overall Study|Lost to Follow-up|0|||
170420201|NCT03365947|615878866|FG012|Overall Study|Lost to Follow-up|0|||
170420202|NCT03365947|615878867|FG013|Overall Study|Lost to Follow-up|0|||
170420203|NCT03365947|615878868|FG014|Overall Study|Lost to Follow-up|0|||
170420204|NCT03365947|615878869|FG015|Overall Study|Lost to Follow-up|0|||
170420205|NCT03365947|615878870|FG016|Overall Study|Lost to Follow-up|0|||
170420206|NCT03365947|615878871|FG017|Overall Study|Lost to Follow-up|0|||
170420207|NCT03365947|615878872|FG018|Overall Study|Lost to Follow-up|0|||
170878344|NCT01081912|617565628|FG002|Conversion/Titration|Withdrawal by Subject|0|||
170878345|NCT01081912|617565626|FG000|Conversion/Titration|Non-Compliance|47|||
170878346|NCT01081912|617565627|FG001|Conversion/Titration|Non-Compliance|0|||
170878347|NCT01081912|617565628|FG002|Conversion/Titration|Non-Compliance|0|||
170878348|NCT01081912|617565626|FG000|Maintenance Treatment|Adverse Event|0|||
170878349|NCT01081912|617565627|FG001|Maintenance Treatment|Adverse Event|2|||
170878350|NCT01081912|617565628|FG002|Maintenance Treatment|Adverse Event|12|||
170878351|NCT01081912|617565626|FG000|Maintenance Treatment|Lack of Efficacy|0|||
170878352|NCT01081912|617565627|FG001|Maintenance Treatment|Lack of Efficacy|14|||
170878353|NCT01081912|617565628|FG002|Maintenance Treatment|Lack of Efficacy|64|||
170878354|NCT01081912|617565626|FG000|Maintenance Treatment|Lost to Follow-up|0|||
170878355|NCT01081912|617565627|FG001|Maintenance Treatment|Lost to Follow-up|1|||
170878356|NCT01081912|617565628|FG002|Maintenance Treatment|Lost to Follow-up|0|||
170878357|NCT01081912|617565626|FG000|Maintenance Treatment|Physician Decision|0|||
170878358|NCT01081912|617565627|FG001|Maintenance Treatment|Physician Decision|0|||
170878359|NCT01081912|617565628|FG002|Maintenance Treatment|Physician Decision|1|||
170878360|NCT01081912|617565626|FG000|Maintenance Treatment|Protocol Violation|0|||
170878361|NCT01081912|617565627|FG001|Maintenance Treatment|Protocol Violation|1|||
170878362|NCT01081912|617565628|FG002|Maintenance Treatment|Protocol Violation|2|||
170878363|NCT01081912|617565626|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
170878364|NCT01081912|617565627|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
170878365|NCT01081912|617565628|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
170878366|NCT01081912|617565626|FG000|Maintenance Treatment|Non-Compliance|0|||
170878367|NCT01081912|617565627|FG001|Maintenance Treatment|Non-Compliance|4|||
170878368|NCT01081912|617565628|FG002|Maintenance Treatment|Non-Compliance|7|||
170878369|NCT01081912|617565626|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
170878370|NCT01081912|617565627|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
170878371|NCT01081912|617565628|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
170878372|NCT01265615|617565636|FG000|Overall Study|Protocol Violation|2|||
170878373|NCT01265615|617565637|FG001|Overall Study|Protocol Violation|2|||
170878374|NCT01265615|617565638|FG002|Overall Study|Protocol Violation|4|||
170878375|NCT01265615|617565639|FG003|Overall Study|Protocol Violation|3|||
170878376|NCT01471015|617565640|FG000|Overall Study|Death|0|||
170878377|NCT01471015|617565641|FG001|Overall Study|Death|1|||
170878378|NCT01471015|617565642|FG002|Overall Study|Death|1|||
170878379|NCT04962022|617565645|FG000|Period 1|Withdrawal by Subject|1|||
170878380|NCT04962022|617565646|FG001|Period 1|Withdrawal by Subject|0|||
170878381|NCT03703102|617565648|FG000|Overall Study|Adverse Event|4|||
170878382|NCT03703102|617565649|FG001|Overall Study|Adverse Event|3|||
170878383|NCT03703102|617565650|FG002|Overall Study|Adverse Event|7|||
170878384|NCT03703102|617565651|FG003|Overall Study|Adverse Event|3|||
170878385|NCT03703102|617565652|FG004|Overall Study|Adverse Event|13|||
170878386|NCT03703102|617565648|FG000|Overall Study|Lack of Efficacy|4|||
170878387|NCT03703102|617565649|FG001|Overall Study|Lack of Efficacy|0|||
170878388|NCT03703102|617565650|FG002|Overall Study|Lack of Efficacy|1|||
170420208|NCT02518685|615878873|FG000|Overall Study|Adverse Event|29|||
170420209|NCT02518685|615878874|FG001|Overall Study|Adverse Event|1|||
170420210|NCT02518685|615878873|FG000|Overall Study|Withdrawal by Subject|10|||
170420211|NCT02518685|615878874|FG001|Overall Study|Withdrawal by Subject|3|||
170420212|NCT02518685|615878873|FG000|Overall Study|relocation, study fatigue|7|||
170420213|NCT02518685|615878874|FG001|Overall Study|relocation, study fatigue|2|||
170420214|NCT02518685|615878873|FG000|Overall Study|Pregnancy|1|||
170420215|NCT02518685|615878874|FG001|Overall Study|Pregnancy|0|||
170420216|NCT02518685|615878873|FG000|Overall Study|Physician Decision|1|||
170420217|NCT02518685|615878874|FG001|Overall Study|Physician Decision|0|||
170420218|NCT02518685|615878873|FG000|Overall Study|Lost to Follow-up|1|||
170420219|NCT02518685|615878874|FG001|Overall Study|Lost to Follow-up|4|||
170420220|NCT00993616|615878875|FG000|Overall Study|No tumor at entry|1|||
170420221|NCT00993616|615878875|FG000|Overall Study|Never treated|1|||
170420222|NCT03946449|615878876|FG000|Treatment Extension II|Rolled over to another study|0|||
170420223|NCT03946449|615878877|FG001|Treatment Extension II|Rolled over to another study|0|||
170420224|NCT03946449|615878878|FG002|Treatment Extension II|Rolled over to another study|2|||
170420225|NCT03946449|615878876|FG000|Treatment Extension II|Withdrawal by Subject|0|||
170420226|NCT03946449|615878877|FG001|Treatment Extension II|Withdrawal by Subject|0|||
170420227|NCT03946449|615878878|FG002|Treatment Extension II|Withdrawal by Subject|1|||
170420228|NCT02028715|615880491|FG000|Overall Study|Adverse Event|2|||
170420229|NCT02028715|615880492|FG001|Overall Study|Adverse Event|2|||
170420230|NCT02028715|615880491|FG000|Overall Study|Physician Decision|1|||
170420231|NCT02028715|615880492|FG001|Overall Study|Physician Decision|0|||
170420232|NCT02028715|615880491|FG000|Overall Study|Did not complete satisfaction surveys|2|||
170420233|NCT02028715|615880492|FG001|Overall Study|Did not complete satisfaction surveys|2|||
170420234|NCT01367275|615880493|FG000|Overall Study|Ineligible|1|||
170420235|NCT01367275|615880493|FG000|Overall Study|Disease Progression|2|||
170420236|NCT01648166|615880494|FG000|Overall Study|inadequate toenail samples|53|||
170420237|NCT01648166|615880495|FG001|Overall Study|inadequate toenail samples|100|||
170420238|NCT00560235|615880496|FG000|Phase 1|Discontinued|8|||
170420239|NCT00560235|615880497|FG001|Phase 1|Discontinued|0|||
170420240|NCT00560235|615880498|FG002|Phase 1|Discontinued|0|||
170420241|NCT00560235|615880496|FG000|Phase 1B|Discontinued|0|||
170420242|NCT00560235|615880497|FG001|Phase 1B|Discontinued|19|||
170420243|NCT00560235|615880498|FG002|Phase 1B|Discontinued|0|||
170420244|NCT00560235|615880496|FG000|Phase 2|Discontinued|0|||
170420245|NCT00560235|615880497|FG001|Phase 2|Discontinued|0|||
170420246|NCT00560235|615880498|FG002|Phase 2|Discontinued|96|||
170420247|NCT00560235|615880496|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
170420248|NCT00560235|615880497|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
170420249|NCT00560235|615880498|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
170420250|NCT02319148|615880502|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
170420251|NCT02319148|615880503|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
170420252|NCT02319148|615880504|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
170420253|NCT02319148|615880505|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
170420254|NCT02319148|615880502|FG000|Second Intervention Period|No longer willing to participate|0|||
170420255|NCT02319148|615880503|FG001|Second Intervention Period|No longer willing to participate|1|||
170420256|NCT02319148|615880504|FG002|Second Intervention Period|No longer willing to participate|0|||
170420257|NCT02319148|615880505|FG003|Second Intervention Period|No longer willing to participate|0|||
170420258|NCT02319148|615880502|FG000|Second Intervention Period|Other|0|||
170420259|NCT02319148|615880503|FG001|Second Intervention Period|Other|0|||
170420260|NCT02319148|615880504|FG002|Second Intervention Period|Other|0|||
170420261|NCT02319148|615880505|FG003|Second Intervention Period|Other|1|||
170420262|NCT01574248|615880506|FG000|Overall Study|Withdrawal by Subject|2|||
170420263|NCT01574248|615880507|FG001|Overall Study|Withdrawal by Subject|0|||
170420264|NCT01574248|615880506|FG000|Overall Study|Missing primary endpoint data|1|||
170420265|NCT01574248|615880507|FG001|Overall Study|Missing primary endpoint data|0|||
170420266|NCT03655106|615880510|FG000|Overall Study|Withdrawal by Subject|3|||
170420267|NCT03655106|615880511|FG001|Overall Study|Withdrawal by Subject|2|||
170420268|NCT03655106|615880510|FG000|Overall Study|Lost to Follow-up|2|||
170420269|NCT03655106|615880511|FG001|Overall Study|Lost to Follow-up|1|||
170420270|NCT03655106|615880510|FG000|Overall Study|Duplicate Enrollment|1|||
170420271|NCT03655106|615880511|FG001|Overall Study|Duplicate Enrollment|1|||
170420272|NCT03655106|615880510|FG000|Overall Study|Protocol Violation|3|||
170420273|NCT03655106|615880511|FG001|Overall Study|Protocol Violation|0|||
170420274|NCT00048048|615880512|FG000|Core Treatment|Withdrawal by Subject|0|||
170420275|NCT00048048|615880513|FG001|Core Treatment|Withdrawal by Subject|0|||
170420276|NCT00048048|615880514|FG002|Core Treatment|Withdrawal by Subject|1|||
170420277|NCT00048048|615880515|FG003|Core Treatment|Withdrawal by Subject|0|||
170420278|NCT00048048|615880516|FG004|Core Treatment|Withdrawal by Subject|0|||
170420279|NCT00048048|615880517|FG005|Core Treatment|Withdrawal by Subject|0|||
170420280|NCT00048048|615880518|FG006|Core Treatment|Withdrawal by Subject|0|||
170420281|NCT00048048|615880519|FG007|Core Treatment|Withdrawal by Subject|0|||
170420282|NCT00048048|615880520|FG008|Core Treatment|Withdrawal by Subject|0|||
170420283|NCT00048048|615880521|FG009|Core Treatment|Withdrawal by Subject|0|||
170420284|NCT00048048|615880522|FG010|Core Treatment|Withdrawal by Subject|0|||
170420285|NCT00048048|615880523|FG011|Core Treatment|Withdrawal by Subject|0|||
170420286|NCT00048048|615880512|FG000|Core Treatment|Adverse Event|0|||
170420287|NCT00048048|615880513|FG001|Core Treatment|Adverse Event|0|||
170420288|NCT00048048|615880514|FG002|Core Treatment|Adverse Event|0|||
170420289|NCT00048048|615880515|FG003|Core Treatment|Adverse Event|0|||
170420290|NCT00048048|615880516|FG004|Core Treatment|Adverse Event|0|||
170420291|NCT00048048|615880517|FG005|Core Treatment|Adverse Event|0|||
170420292|NCT00048048|615880518|FG006|Core Treatment|Adverse Event|0|||
170420293|NCT00048048|615880519|FG007|Core Treatment|Adverse Event|1|||
170420294|NCT00048048|615880520|FG008|Core Treatment|Adverse Event|0|||
170420295|NCT00048048|615880521|FG009|Core Treatment|Adverse Event|0|||
170420296|NCT00048048|615880522|FG010|Core Treatment|Adverse Event|0|||
170420297|NCT00048048|615880523|FG011|Core Treatment|Adverse Event|0|||
170420298|NCT00048048|615880512|FG000|Extension Year 1|Early withdrawals|0|||
170420299|NCT00048048|615880513|FG001|Extension Year 1|Early withdrawals|0|||
170420300|NCT00048048|615880514|FG002|Extension Year 1|Early withdrawals|0|||
170420301|NCT00048048|615880515|FG003|Extension Year 1|Early withdrawals|0|||
170420302|NCT00048048|615880516|FG004|Extension Year 1|Early withdrawals|0|||
170420303|NCT00048048|615880517|FG005|Extension Year 1|Early withdrawals|0|||
170420304|NCT00048048|615880518|FG006|Extension Year 1|Early withdrawals|0|||
170420305|NCT00048048|615880519|FG007|Extension Year 1|Early withdrawals|0|||
170420306|NCT00048048|615880520|FG008|Extension Year 1|Early withdrawals|0|||
170420307|NCT00048048|615880521|FG009|Extension Year 1|Early withdrawals|2|||
170420308|NCT00048048|615880522|FG010|Extension Year 1|Early withdrawals|2|||
170420309|NCT00048048|615880523|FG011|Extension Year 1|Early withdrawals|4|||
170420310|NCT00048048|615880512|FG000|Extension Year 2|Early withdrawals|0|||
170420311|NCT00048048|615880513|FG001|Extension Year 2|Early withdrawals|0|||
170420312|NCT00048048|615880514|FG002|Extension Year 2|Early withdrawals|0|||
170420313|NCT00048048|615880515|FG003|Extension Year 2|Early withdrawals|0|||
170420314|NCT00048048|615880516|FG004|Extension Year 2|Early withdrawals|0|||
170420315|NCT00048048|615880517|FG005|Extension Year 2|Early withdrawals|0|||
170420316|NCT00048048|615880518|FG006|Extension Year 2|Early withdrawals|0|||
170420317|NCT00048048|615880519|FG007|Extension Year 2|Early withdrawals|0|||
170420318|NCT00048048|615880520|FG008|Extension Year 2|Early withdrawals|0|||
170420319|NCT00048048|615880521|FG009|Extension Year 2|Early withdrawals|0|||
170420320|NCT00048048|615880522|FG010|Extension Year 2|Early withdrawals|4|||
170420321|NCT00048048|615880523|FG011|Extension Year 2|Early withdrawals|2|||
170420322|NCT02896361|615880524|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
170420323|NCT02896361|615880525|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
170420324|NCT02896361|615880526|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
170420325|NCT02896361|615880524|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
170420326|NCT02896361|615880525|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
170420327|NCT02896361|615880526|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
170420328|NCT03164772|615880529|FG000|Overall Study|Death|4|||
170420329|NCT03164772|615880530|FG001|Overall Study|Death|2|||
170420330|NCT03164772|615880529|FG000|Overall Study|Adverse Event|1|||
170420331|NCT03164772|615880530|FG001|Overall Study|Adverse Event|4|||
170420332|NCT03164772|615880529|FG000|Overall Study|Progressive Disease|11|||
170420333|NCT03164772|615880530|FG001|Overall Study|Progressive Disease|21|||
170420334|NCT03164772|615880529|FG000|Overall Study|Physician Decision|2|||
170420335|NCT03164772|615880530|FG001|Overall Study|Physician Decision|0|||
170420336|NCT03164772|615880529|FG000|Overall Study|Withdrawal by Subject|0|||
170420337|NCT03164772|615880530|FG001|Overall Study|Withdrawal by Subject|4|||
170420338|NCT01029353|615880531|FG000|Overall Study|Lost to Follow-up|4|||
170420339|NCT01029353|615880532|FG001|Overall Study|Lost to Follow-up|5|||
170420340|NCT01029353|615880533|FG002|Overall Study|Lost to Follow-up|5|||
170420341|NCT01029353|615880534|FG003|Overall Study|Lost to Follow-up|4|||
170420342|NCT01029353|615880531|FG000|Overall Study|Consent Withdrawn|2|||
170420343|NCT01029353|615880532|FG001|Overall Study|Consent Withdrawn|0|||
170420344|NCT01029353|615880533|FG002|Overall Study|Consent Withdrawn|0|||
170420345|NCT01029353|615880534|FG003|Overall Study|Consent Withdrawn|0|||
170531754|NCT02867592|616293355|FG002|Overall Study|Withdrawal by Subject|0|||
170420346|NCT01029353|615880531|FG000|Overall Study|Primary Outcome Indeterminate|1|||
170420347|NCT01029353|615880532|FG001|Overall Study|Primary Outcome Indeterminate|3|||
170420348|NCT01029353|615880533|FG002|Overall Study|Primary Outcome Indeterminate|2|||
170420349|NCT01029353|615880534|FG003|Overall Study|Primary Outcome Indeterminate|0|||
170420350|NCT04538170|615880537|FG000|Overall Study|Withdrawal by Subject|104|||
170420351|NCT04538170|615880538|FG001|Overall Study|Withdrawal by Subject|210|||
170420352|NCT00849901|615880541|FG000|Acute Treatment Phase|Adverse Event|9|||
170420353|NCT00849901|615880542|FG001|Acute Treatment Phase|Adverse Event|1|||
170420354|NCT00849901|615880543|FG002|Acute Treatment Phase|Adverse Event|3|||
170420355|NCT00849901|615880541|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
170420356|NCT00849901|615880542|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
170420357|NCT00849901|615880543|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
170531755|NCT02867592|616293356|FG003|Overall Study|Withdrawal by Subject|1|||
170531756|NCT02867592|616293357|FG004|Overall Study|Withdrawal by Subject|3|||
170531757|NCT02867592|616293358|FG005|Overall Study|Withdrawal by Subject|3|||
170531758|NCT02867592|616293353|FG000|Overall Study|Ineligible|1|||
170531759|NCT02867592|616293354|FG001|Overall Study|Ineligible|1|||
170531760|NCT02867592|616293355|FG002|Overall Study|Ineligible|0|||
170531761|NCT02867592|616293356|FG003|Overall Study|Ineligible|0|||
170531762|NCT02867592|616293357|FG004|Overall Study|Ineligible|2|||
170531763|NCT02867592|616293358|FG005|Overall Study|Ineligible|0|||
170531764|NCT02867592|616293353|FG000|Overall Study|No Treatment|1|||
170531765|NCT02867592|616293354|FG001|Overall Study|No Treatment|0|||
170531766|NCT02867592|616293355|FG002|Overall Study|No Treatment|0|||
170531767|NCT02867592|616293356|FG003|Overall Study|No Treatment|0|||
170531768|NCT02867592|616293357|FG004|Overall Study|No Treatment|0|||
170531769|NCT02867592|616293358|FG005|Overall Study|No Treatment|0|||
170531770|NCT02867592|616293353|FG000|Overall Study|Still on Therapy|0|||
170531771|NCT02867592|616293354|FG001|Overall Study|Still on Therapy|0|||
170531772|NCT02867592|616293355|FG002|Overall Study|Still on Therapy|0|||
170531773|NCT02867592|616293356|FG003|Overall Study|Still on Therapy|0|||
170531774|NCT02867592|616293357|FG004|Overall Study|Still on Therapy|1|||
170531775|NCT02867592|616293358|FG005|Overall Study|Still on Therapy|0|||
170531776|NCT02867592|616293353|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
170531777|NCT02867592|616293354|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
170531778|NCT02867592|616293355|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
170531779|NCT02867592|616293356|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
170531780|NCT02867592|616293357|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
170531781|NCT02867592|616293358|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
170531782|NCT02867592|616293353|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
170531783|NCT02867592|616293354|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
170531784|NCT02867592|616293355|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
170531785|NCT02867592|616293356|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
170531786|NCT02867592|616293357|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
170531787|NCT02867592|616293358|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
170531788|NCT00909870|616293359|FG000|Overall Study|Adverse Event|13|||
170531789|NCT00909870|616293360|FG001|Overall Study|Adverse Event|7|||
170531790|NCT00909870|616293359|FG000|Overall Study|Protocol Violation|1|||
170531791|NCT00909870|616293360|FG001|Overall Study|Protocol Violation|2|||
170531792|NCT00909870|616293359|FG000|Overall Study|Withdrawal by Subject|5|||
170531793|NCT00909870|616293360|FG001|Overall Study|Withdrawal by Subject|8|||
170531794|NCT00909870|616293359|FG000|Overall Study|Lost to Follow-up|3|||
170531795|NCT00909870|616293360|FG001|Overall Study|Lost to Follow-up|3|||
170531796|NCT00909870|616293359|FG000|Overall Study|Physician Decision|0|||
170531797|NCT00909870|616293360|FG001|Overall Study|Physician Decision|2|||
170531798|NCT00909870|616293359|FG000|Overall Study|Other|1|||
170531799|NCT00909870|616293360|FG001|Overall Study|Other|5|||
170531800|NCT03191552|616293369|FG000|Overall Study|Lost to Follow-up|1|||
170531801|NCT03191552|616293370|FG001|Overall Study|Lost to Follow-up|0|||
170531802|NCT03191552|616293371|FG002|Overall Study|Lost to Follow-up|0|||
170531803|NCT03191552|616293369|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
170531804|NCT03191552|616293370|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
170531805|NCT03191552|616293371|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
170531806|NCT04935879|616293372|FG000|Overall Study|Adverse Event|2|||
170531807|NCT04935879|616293373|FG001|Overall Study|Adverse Event|1|||
170531808|NCT04935879|616293372|FG000|Overall Study|Lost to Follow-up|1|||
170531809|NCT04935879|616293373|FG001|Overall Study|Lost to Follow-up|1|||
170531810|NCT04935879|616293372|FG000|Overall Study|Pregnancy|2|||
170531811|NCT04935879|616293373|FG001|Overall Study|Pregnancy|3|||
170531812|NCT04935879|616293372|FG000|Overall Study|Withdrawal by Subject|8|||
170531813|NCT04935879|616293373|FG001|Overall Study|Withdrawal by Subject|6|||
170531814|NCT04935879|616293372|FG000|Overall Study|Other|3|||
170531815|NCT04935879|616293373|FG001|Overall Study|Other|3|||
170632640|NCT01929317|616666723|FG000|Long-term Phase|Withdrawal by Subject|4|||
170632641|NCT01929317|616666724|FG001|Long-term Phase|Withdrawal by Subject|0|||
170531816|NCT03054428|616293374|FG000|Overall Study|Physician Decision|0|||
170531817|NCT03054428|616293375|FG001|Overall Study|Physician Decision|1|||
170531818|NCT03054428|616293376|FG002|Overall Study|Physician Decision|1|||
170531819|NCT03054428|616293374|FG000|Overall Study|Lack of Efficacy|3|||
170531820|NCT03054428|616293375|FG001|Overall Study|Lack of Efficacy|1|||
170531821|NCT03054428|616293376|FG002|Overall Study|Lack of Efficacy|0|||
170531822|NCT03054428|616293374|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
170531823|NCT03054428|616293375|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
170531824|NCT03054428|616293376|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
170420358|NCT00849901|615880541|FG000|Acute Treatment Phase|Protocol Violation|0|||
170420359|NCT00849901|615880542|FG001|Acute Treatment Phase|Protocol Violation|2|||
170420360|NCT00849901|615880543|FG002|Acute Treatment Phase|Protocol Violation|1|||
170420361|NCT00849901|615880541|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
170420362|NCT00849901|615880542|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
170420363|NCT00849901|615880543|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
170420364|NCT00849901|615880541|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
170420365|NCT00849901|615880542|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
170420366|NCT00849901|615880543|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
170420367|NCT00849901|615880541|FG000|Acute Treatment Phase|Physician Decision|1|||
170420368|NCT00849901|615880542|FG001|Acute Treatment Phase|Physician Decision|1|||
170420369|NCT00849901|615880543|FG002|Acute Treatment Phase|Physician Decision|1|||
170420370|NCT00849901|615880541|FG000|Acute Treatment Phase|Sponsor Decision|1|||
170420371|NCT00849901|615880542|FG001|Acute Treatment Phase|Sponsor Decision|0|||
170420372|NCT00849901|615880543|FG002|Acute Treatment Phase|Sponsor Decision|0|||
170420373|NCT00849901|615880541|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
170420374|NCT00849901|615880542|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
170420375|NCT00849901|615880543|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
170420376|NCT00849901|615880541|FG000|Extension Phase|Adverse Event|2|||
170420377|NCT00849901|615880542|FG001|Extension Phase|Adverse Event|8|||
170420378|NCT00849901|615880543|FG002|Extension Phase|Adverse Event|4|||
170420379|NCT00849901|615880541|FG000|Extension Phase|Lost to Follow-up|3|||
170420380|NCT00849901|615880542|FG001|Extension Phase|Lost to Follow-up|0|||
170420381|NCT00849901|615880543|FG002|Extension Phase|Lost to Follow-up|1|||
170420382|NCT00849901|615880541|FG000|Extension Phase|Protocol Violation|2|||
170420383|NCT00849901|615880542|FG001|Extension Phase|Protocol Violation|2|||
170420384|NCT00849901|615880543|FG002|Extension Phase|Protocol Violation|4|||
170420385|NCT00849901|615880541|FG000|Extension Phase|Withdrawal by Subject|7|||
170420386|NCT00849901|615880542|FG001|Extension Phase|Withdrawal by Subject|6|||
170420387|NCT00849901|615880543|FG002|Extension Phase|Withdrawal by Subject|3|||
170420388|NCT00849901|615880541|FG000|Extension Phase|Parent or Caregiver Decision|10|||
170420389|NCT00849901|615880542|FG001|Extension Phase|Parent or Caregiver Decision|4|||
170420390|NCT00849901|615880543|FG002|Extension Phase|Parent or Caregiver Decision|4|||
170420391|NCT00849901|615880541|FG000|Extension Phase|Physician Decision|1|||
170420392|NCT00849901|615880542|FG001|Extension Phase|Physician Decision|2|||
170420393|NCT00849901|615880543|FG002|Extension Phase|Physician Decision|0|||
170420394|NCT00849901|615880541|FG000|Extension Phase|Lack of Efficacy|2|||
170420395|NCT00849901|615880542|FG001|Extension Phase|Lack of Efficacy|4|||
170420396|NCT00849901|615880543|FG002|Extension Phase|Lack of Efficacy|1|||
170420397|NCT00262223|615880544|FG000|Treatment Phase|Withdrawal by Subject|3|||
170420398|NCT00262223|615880545|FG001|Treatment Phase|Withdrawal by Subject|6|||
170420399|NCT00262223|615880544|FG000|Treatment Phase|Adverse Event|1|||
170420400|NCT00262223|615880545|FG001|Treatment Phase|Adverse Event|2|||
170420401|NCT00262223|615880544|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
170420402|NCT00262223|615880545|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
170420403|NCT00262223|615880544|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
170420404|NCT00262223|615880545|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
170420405|NCT00262223|615880544|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
170878389|NCT03703102|617565651|FG003|Overall Study|Lack of Efficacy|4|||
170878390|NCT03703102|617565652|FG004|Overall Study|Lack of Efficacy|1|||
170878391|NCT03703102|617565648|FG000|Overall Study|Lost to Follow-up|0|||
170878392|NCT03703102|617565649|FG001|Overall Study|Lost to Follow-up|0|||
170420406|NCT00262223|615880545|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
170420407|NCT00437658|615880548|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
170420408|NCT00437658|615880549|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
170420409|NCT00437658|615880550|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
170420410|NCT00437658|615880548|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
170420411|NCT00437658|615880549|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
170420412|NCT00437658|615880550|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
170420413|NCT00437658|615880548|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
170420414|NCT00437658|615880549|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
170420415|NCT00437658|615880550|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
170420416|NCT00437658|615880548|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
170420417|NCT00437658|615880549|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
170420418|NCT00437658|615880550|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
170420419|NCT00437658|615880548|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
170420420|NCT00437658|615880549|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
170420421|NCT00437658|615880550|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
170420422|NCT00437658|615880548|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
170420423|NCT00437658|615880549|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
170420424|NCT00437658|615880550|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
170420425|NCT00437658|615880548|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
170420426|NCT00437658|615880549|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
170420427|NCT00437658|615880550|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
170420428|NCT00437658|615880548|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
170420429|NCT00437658|615880549|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
170420430|NCT00437658|615880550|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
170420431|NCT00437658|615880548|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
170420432|NCT00437658|615880549|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
170420433|NCT00437658|615880550|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
170420434|NCT00437658|615880548|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
170420435|NCT00437658|615880549|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
170420436|NCT00437658|615880550|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
170420437|NCT00437658|615880548|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
170420438|NCT00437658|615880549|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
170420439|NCT00437658|615880550|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
170420440|NCT00437658|615880548|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
170420441|NCT00437658|615880549|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
170420442|NCT00437658|615880550|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
170420443|NCT00944697|615880551|FG000|Overall Study|Withdrawal by Subject|1|||
170420444|NCT00944697|615880552|FG001|Overall Study|Withdrawal by Subject|1|||
170420445|NCT00944697|615880551|FG000|Overall Study|Adverse Event|0|||
170420446|NCT00944697|615880552|FG001|Overall Study|Adverse Event|3|||
170420447|NCT00944697|615880551|FG000|Overall Study|Administrative|1|||
170420448|NCT00944697|615880552|FG001|Overall Study|Administrative|1|||
170420449|NCT04276883|615880553|FG000|Overall Study|Withdrawal by Subject|2|||
170420450|NCT04276883|615880554|FG001|Overall Study|Withdrawal by Subject|3|||
170420451|NCT04276883|615880555|FG002|Overall Study|Withdrawal by Subject|6|||
170420452|NCT04276883|615880553|FG000|Overall Study|Lost to Follow-up|1|||
170420453|NCT04276883|615880554|FG001|Overall Study|Lost to Follow-up|3|||
170420454|NCT04276883|615880555|FG002|Overall Study|Lost to Follow-up|0|||
170420455|NCT04276883|615880553|FG000|Overall Study|Adverse Event|0|||
170420456|NCT04276883|615880554|FG001|Overall Study|Adverse Event|1|||
170420457|NCT04276883|615880555|FG002|Overall Study|Adverse Event|0|||
170420458|NCT04276883|615880553|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
170420459|NCT04276883|615880554|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
170420460|NCT04276883|615880555|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
170420461|NCT02732210|615880557|FG000|Overall Study|Site Closed|0|||
170420462|NCT02732210|615880558|FG001|Overall Study|Site Closed|11|||
170420463|NCT02732210|615880557|FG000|Overall Study|Study Ended|13|||
170420464|NCT02732210|615880558|FG001|Overall Study|Study Ended|13|||
170420465|NCT02732210|615880557|FG000|Overall Study|Withdrawal by Subject|28|||
170420466|NCT02732210|615880558|FG001|Overall Study|Withdrawal by Subject|87|||
170420467|NCT02732210|615880557|FG000|Overall Study|Lost to Follow-up|5|||
170420468|NCT02732210|615880558|FG001|Overall Study|Lost to Follow-up|57|||
170420469|NCT02732210|615880557|FG000|Overall Study|Death|4|||
170420470|NCT02732210|615880558|FG001|Overall Study|Death|15|||
170420471|NCT02732210|615880557|FG000|Overall Study|Other|35|||
170420472|NCT02732210|615880558|FG001|Overall Study|Other|103|||
170878393|NCT03703102|617565650|FG002|Overall Study|Lost to Follow-up|1|||
170878394|NCT03703102|617565651|FG003|Overall Study|Lost to Follow-up|2|||
170531825|NCT03054428|616293374|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
170531826|NCT03054428|616293375|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
170531827|NCT03054428|616293376|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
170531828|NCT03054428|616293374|FG000|Overall Study|Transitioned to OLE study|76|||
170531829|NCT03054428|616293375|FG001|Overall Study|Transitioned to OLE study|76|||
170531830|NCT03054428|616293376|FG002|Overall Study|Transitioned to OLE study|73|||
170420473|NCT02732210|615880557|FG000|Overall Study|Missing|0|||
170420474|NCT02732210|615880558|FG001|Overall Study|Missing|8|||
170420475|NCT01876706|615880559|FG000|Overall Study|BPH Intervention|9|||
170420476|NCT01876706|615880559|FG000|Overall Study|Lost to Follow-up|7|||
170420477|NCT01876706|615880559|FG000|Overall Study|Withdrawals|6|||
170531831|NCT03054428|616293374|FG000|Overall Study|Withdrawal by Subject|3|||
170531832|NCT03054428|616293375|FG001|Overall Study|Withdrawal by Subject|2|||
170531833|NCT03054428|616293376|FG002|Overall Study|Withdrawal by Subject|3|||
170531834|NCT03054428|616293374|FG000|Overall Study|Lost to Follow-up|0|||
170531835|NCT03054428|616293375|FG001|Overall Study|Lost to Follow-up|0|||
170531836|NCT03054428|616293376|FG002|Overall Study|Lost to Follow-up|1|||
170531837|NCT03533751|616293379|FG000|Overall Study|Withdrawal by Subject|12|||
170531838|NCT03533751|616293380|FG001|Overall Study|Withdrawal by Subject|6|||
170531839|NCT03533751|616293381|FG002|Overall Study|Withdrawal by Subject|11|||
170531840|NCT03533751|616293382|FG003|Overall Study|Withdrawal by Subject|9|||
170531841|NCT03533751|616293383|FG004|Overall Study|Withdrawal by Subject|10|||
170531842|NCT03533751|616293379|FG000|Overall Study|Adverse Event|4|||
170531843|NCT03533751|616293380|FG001|Overall Study|Adverse Event|7|||
170531844|NCT03533751|616293381|FG002|Overall Study|Adverse Event|2|||
170531845|NCT03533751|616293382|FG003|Overall Study|Adverse Event|4|||
170531846|NCT03533751|616293383|FG004|Overall Study|Adverse Event|5|||
170531847|NCT03533751|616293379|FG000|Overall Study|Physician Decision|0|||
170531848|NCT03533751|616293380|FG001|Overall Study|Physician Decision|2|||
170531849|NCT03533751|616293381|FG002|Overall Study|Physician Decision|1|||
170531850|NCT03533751|616293382|FG003|Overall Study|Physician Decision|2|||
170531851|NCT03533751|616293383|FG004|Overall Study|Physician Decision|1|||
170531852|NCT03533751|616293379|FG000|Overall Study|Sponsor Decision|0|||
170531853|NCT03533751|616293380|FG001|Overall Study|Sponsor Decision|0|||
170531854|NCT03533751|616293381|FG002|Overall Study|Sponsor Decision|1|||
170420478|NCT01876706|615880559|FG000|Overall Study|Death|3|||
170420479|NCT02191891|615880560|FG000|Overall Study|Withdrawal by Subject|0|||
170420480|NCT02191891|615880561|FG001|Overall Study|Withdrawal by Subject|1|||
170420481|NCT02191891|615880562|FG002|Overall Study|Withdrawal by Subject|0|||
170420482|NCT02191891|615880563|FG003|Overall Study|Withdrawal by Subject|0|||
170420483|NCT02191891|615880564|FG004|Overall Study|Withdrawal by Subject|1|||
170420484|NCT02191891|615880560|FG000|Overall Study|Adverse Event|0|||
170420485|NCT02191891|615880561|FG001|Overall Study|Adverse Event|1|||
170420486|NCT02191891|615880562|FG002|Overall Study|Adverse Event|0|||
170420487|NCT02191891|615880563|FG003|Overall Study|Adverse Event|0|||
170420488|NCT02191891|615880564|FG004|Overall Study|Adverse Event|2|||
170420489|NCT02191891|615880560|FG000|Overall Study|Disease Progression|4|||
170420490|NCT02191891|615880561|FG001|Overall Study|Disease Progression|10|||
170420491|NCT02191891|615880562|FG002|Overall Study|Disease Progression|4|||
170420492|NCT02191891|615880563|FG003|Overall Study|Disease Progression|2|||
170420493|NCT02191891|615880564|FG004|Overall Study|Disease Progression|7|||
170420494|NCT03099538|615880565|FG000|Overall Study|Lack of Efficacy|3|||
170420495|NCT02603952|615880570|FG000|Overall Study|Withdrawal by Subject|1|||
170420496|NCT02603952|615880571|FG001|Overall Study|Withdrawal by Subject|0|||
170420497|NCT02603952|615880572|FG002|Overall Study|Withdrawal by Subject|0|||
170420498|NCT02603952|615880573|FG003|Overall Study|Withdrawal by Subject|0|||
170420499|NCT02603952|615880570|FG000|Overall Study|Received oseltamivir by error|0|||
170420500|NCT02603952|615880571|FG001|Overall Study|Received oseltamivir by error|0|||
170420501|NCT02603952|615880572|FG002|Overall Study|Received oseltamivir by error|0|||
170420502|NCT02603952|615880573|FG003|Overall Study|Received oseltamivir by error|1|||
170420503|NCT00958243|615880578|FG000|Overall Study|Withdrawal by Subject|0|||
170420504|NCT00958243|615880579|FG001|Overall Study|Withdrawal by Subject|1|||
170420505|NCT00958243|615880580|FG002|Overall Study|Withdrawal by Subject|3|||
170531855|NCT03533751|616293382|FG003|Overall Study|Sponsor Decision|1|||
170531856|NCT03533751|616293383|FG004|Overall Study|Sponsor Decision|0|||
170531857|NCT03533751|616293379|FG000|Overall Study|Lost to Follow-up|3|||
170531858|NCT03533751|616293380|FG001|Overall Study|Lost to Follow-up|7|||
170531859|NCT03533751|616293381|FG002|Overall Study|Lost to Follow-up|6|||
170531860|NCT03533751|616293382|FG003|Overall Study|Lost to Follow-up|4|||
170531861|NCT03533751|616293383|FG004|Overall Study|Lost to Follow-up|3|||
170878395|NCT03703102|617565652|FG004|Overall Study|Lost to Follow-up|2|||
170531862|NCT03533751|616293379|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
170420506|NCT00958243|615880581|FG003|Overall Study|Withdrawal by Subject|1|||
170420507|NCT00958243|615880582|FG004|Overall Study|Withdrawal by Subject|1|||
170420508|NCT00958243|615880583|FG005|Overall Study|Withdrawal by Subject|5|||
170420509|NCT00958243|615880578|FG000|Overall Study|Lost to Follow-up|2|||
170420510|NCT00958243|615880579|FG001|Overall Study|Lost to Follow-up|5|||
170420511|NCT00958243|615880580|FG002|Overall Study|Lost to Follow-up|11|||
170878396|NCT03703102|617565648|FG000|Overall Study|Physician Decision|2|||
170878397|NCT03703102|617565649|FG001|Overall Study|Physician Decision|2|||
170878398|NCT03703102|617565650|FG002|Overall Study|Physician Decision|2|||
170878399|NCT03703102|617565651|FG003|Overall Study|Physician Decision|2|||
170878400|NCT03703102|617565652|FG004|Overall Study|Physician Decision|4|||
170878401|NCT03703102|617565648|FG000|Overall Study|Withdrawal by Subject|7|||
170878402|NCT03703102|617565649|FG001|Overall Study|Withdrawal by Subject|5|||
170878403|NCT03703102|617565650|FG002|Overall Study|Withdrawal by Subject|5|||
170878404|NCT03703102|617565651|FG003|Overall Study|Withdrawal by Subject|5|||
170878405|NCT03703102|617565652|FG004|Overall Study|Withdrawal by Subject|9|||
170878406|NCT03703102|617565648|FG000|Overall Study|Ineligibility|0|||
170878407|NCT03703102|617565649|FG001|Overall Study|Ineligibility|0|||
170878408|NCT03703102|617565650|FG002|Overall Study|Ineligibility|1|||
170878409|NCT03703102|617565651|FG003|Overall Study|Ineligibility|0|||
170878410|NCT03703102|617565652|FG004|Overall Study|Ineligibility|0|||
170878411|NCT03703102|617565648|FG000|Overall Study|Protocol Deviation|4|||
170878412|NCT03703102|617565649|FG001|Overall Study|Protocol Deviation|4|||
170878413|NCT03703102|617565650|FG002|Overall Study|Protocol Deviation|3|||
170878414|NCT03703102|617565651|FG003|Overall Study|Protocol Deviation|0|||
170878415|NCT03703102|617565652|FG004|Overall Study|Protocol Deviation|0|||
170878416|NCT03703102|617565648|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170878417|NCT03703102|617565649|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170878418|NCT03703102|617565650|FG002|Overall Study|Non-Compliance with Study Drug|2|||
170878419|NCT03703102|617565651|FG003|Overall Study|Non-Compliance with Study Drug|1|||
170878420|NCT03703102|617565652|FG004|Overall Study|Non-Compliance with Study Drug|4|||
170878421|NCT00053417|617565665|FG000|Overall Study|Adverse Event|1|||
170878422|NCT00053417|617565666|FG001|Overall Study|Adverse Event|0|||
170878423|NCT00053417|617565667|FG002|Overall Study|Adverse Event|1|||
170878424|NCT00053417|617565668|FG003|Overall Study|Adverse Event|5|||
170878425|NCT00053417|617565665|FG000|Overall Study|Non-Compliance|0|||
170878426|NCT00053417|617565666|FG001|Overall Study|Non-Compliance|0|||
170878427|NCT00053417|617565667|FG002|Overall Study|Non-Compliance|0|||
170878428|NCT00053417|617565668|FG003|Overall Study|Non-Compliance|1|||
170878429|NCT00053417|617565665|FG000|Overall Study|Withdrawal by Subject|0|||
170878430|NCT00053417|617565666|FG001|Overall Study|Withdrawal by Subject|1|||
170878431|NCT00053417|617565667|FG002|Overall Study|Withdrawal by Subject|0|||
170878432|NCT00053417|617565668|FG003|Overall Study|Withdrawal by Subject|0|||
170878433|NCT00053417|617565665|FG000|Overall Study|Lost to Follow-up|1|||
170878434|NCT00053417|617565666|FG001|Overall Study|Lost to Follow-up|1|||
170878435|NCT00053417|617565667|FG002|Overall Study|Lost to Follow-up|0|||
170878436|NCT00053417|617565668|FG003|Overall Study|Lost to Follow-up|0|||
170878437|NCT01820364|617565669|FG000|Part I: LGX818|Death|1|||
170878438|NCT01820364|617565670|FG001|Part I: LGX818|Death|0|||
170878439|NCT01820364|617565669|FG000|Part I: LGX818|Administrative Problems|3|||
170878440|NCT01820364|617565670|FG001|Part I: LGX818|Administrative Problems|0|||
170878441|NCT01820364|617565669|FG000|Part I: LGX818|Adverse Event|6|||
170878442|NCT01820364|617565670|FG001|Part I: LGX818|Adverse Event|0|||
170878443|NCT01820364|617565669|FG000|Part I: LGX818|Disease Progression|4|||
170878444|NCT01820364|617565670|FG001|Part I: LGX818|Disease Progression|0|||
170878445|NCT01820364|617565669|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
170878446|NCT01820364|617565670|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
170878447|NCT03029143|617565673|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
170878448|NCT03029143|617565674|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
170878449|NCT03029143|617565675|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
170878450|NCT03029143|617565673|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
170878451|NCT03029143|617565674|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
170420512|NCT00958243|615880581|FG003|Overall Study|Lost to Follow-up|2|||
170420513|NCT00958243|615880582|FG004|Overall Study|Lost to Follow-up|8|||
170420514|NCT00958243|615880583|FG005|Overall Study|Lost to Follow-up|5|||
170420515|NCT06176768|615880586|FG000|Overall Study|Adverse Event|1|||
170420516|NCT06176768|615880587|FG001|Overall Study|Adverse Event|0|||
170420517|NCT06176768|615880586|FG000|Overall Study|Assigned treatment by mistake|1|||
170420518|NCT06176768|615880587|FG001|Overall Study|Assigned treatment by mistake|0|||
170420519|NCT06176768|615880586|FG000|Overall Study|Lost to Follow-up|0|||
170420520|NCT06176768|615880587|FG001|Overall Study|Lost to Follow-up|3|||
170420521|NCT06176768|615880586|FG000|Overall Study|Physician Decision|1|||
170420522|NCT06176768|615880587|FG001|Overall Study|Physician Decision|0|||
170878452|NCT03029143|617565675|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
170878453|NCT03029143|617565673|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
170878454|NCT03029143|617565674|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
170878455|NCT03029143|617565675|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
170878456|NCT03029143|617565673|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
170878457|NCT03029143|617565674|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
170878458|NCT03029143|617565675|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
170878459|NCT03029143|617565673|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
170878460|NCT03029143|617565674|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
170420523|NCT06176768|615880586|FG000|Overall Study|Protocol deviation|3|||
170778358|NCT02058108|617195604|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
170778359|NCT02058108|617195605|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
170778360|NCT02058108|617195604|FG000|Overall Study|No longer requires study drug|0|||
170778361|NCT02058108|617195605|FG001|Overall Study|No longer requires study drug|1|||
170778362|NCT02058108|617195604|FG000|Overall Study|Withdrawal by Subject|1|||
170778363|NCT02058108|617195605|FG001|Overall Study|Withdrawal by Subject|0|||
170778364|NCT02058108|617195604|FG000|Overall Study|Administrative problems|3|||
170778365|NCT02058108|617195605|FG001|Overall Study|Administrative problems|3|||
170778366|NCT02058108|617195604|FG000|Overall Study|Protocol Violation|0|||
170778367|NCT02058108|617195605|FG001|Overall Study|Protocol Violation|1|||
170778368|NCT04110054|617195609|FG000|Overall Study|COVID-19 reason other than AE|0|||
170778369|NCT04110054|617195610|FG001|Overall Study|COVID-19 reason other than AE|0|||
170778370|NCT04110054|617195611|FG002|Overall Study|COVID-19 reason other than AE|2|||
170778371|NCT04110054|617195612|FG003|Overall Study|COVID-19 reason other than AE|0|||
170778372|NCT04110054|617195609|FG000|Overall Study|Withdrawal by Subject|0|||
170778373|NCT04110054|617195610|FG001|Overall Study|Withdrawal by Subject|3|||
170778374|NCT04110054|617195611|FG002|Overall Study|Withdrawal by Subject|2|||
170778375|NCT04110054|617195612|FG003|Overall Study|Withdrawal by Subject|0|||
170778376|NCT04110054|617195609|FG000|Overall Study|Adverse Event|1|||
170778377|NCT04110054|617195610|FG001|Overall Study|Adverse Event|1|||
170778378|NCT04110054|617195611|FG002|Overall Study|Adverse Event|4|||
170778379|NCT04110054|617195612|FG003|Overall Study|Adverse Event|3|||
170778380|NCT02101281|617195617|FG000|Overall Study|Adverse Event|0|||
170778381|NCT02101281|617195618|FG001|Overall Study|Adverse Event|1|||
170778382|NCT03655262|617195619|FG000|Overall Study|Withdrawal by Subject|0|||
170778383|NCT03655262|617195620|FG001|Overall Study|Withdrawal by Subject|0|||
170778384|NCT03655262|617195621|FG002|Overall Study|Withdrawal by Subject|1|||
170778385|NCT03733119|617195622|FG000|Overall Study|Physician Decision|2|||
170778386|NCT03733119|617195623|FG001|Overall Study|Physician Decision|1|||
170778387|NCT03733119|617195622|FG000|Overall Study|ineligible to treat per protocol|0|||
170778388|NCT03733119|617195623|FG001|Overall Study|ineligible to treat per protocol|1|||
170778389|NCT02554786|617195626|FG000|Overall Study|Subject/guardian decision|29|||
170778390|NCT02554786|617195627|FG001|Overall Study|Subject/guardian decision|17|||
170778391|NCT02554786|617195628|FG002|Overall Study|Subject/guardian decision|18|||
170778392|NCT02554786|617195629|FG003|Overall Study|Subject/guardian decision|30|||
170778393|NCT02554786|617195630|FG004|Overall Study|Subject/guardian decision|20|||
170778394|NCT02554786|617195626|FG000|Overall Study|Lost to Follow-up|4|||
170778395|NCT02554786|617195627|FG001|Overall Study|Lost to Follow-up|3|||
170778396|NCT02554786|617195628|FG002|Overall Study|Lost to Follow-up|4|||
170778397|NCT02554786|617195629|FG003|Overall Study|Lost to Follow-up|2|||
170778398|NCT02554786|617195630|FG004|Overall Study|Lost to Follow-up|2|||
170778399|NCT02554786|617195626|FG000|Overall Study|Protocol deviation|1|||
170778400|NCT02554786|617195627|FG001|Overall Study|Protocol deviation|3|||
170778401|NCT02554786|617195628|FG002|Overall Study|Protocol deviation|3|||
170778402|NCT02554786|617195629|FG003|Overall Study|Protocol deviation|4|||
170778403|NCT02554786|617195630|FG004|Overall Study|Protocol deviation|2|||
170778404|NCT02554786|617195626|FG000|Overall Study|Technical problems|1|||
170778405|NCT02554786|617195627|FG001|Overall Study|Technical problems|1|||
170778406|NCT02554786|617195628|FG002|Overall Study|Technical problems|0|||
170778407|NCT02554786|617195629|FG003|Overall Study|Technical problems|2|||
170778408|NCT02554786|617195630|FG004|Overall Study|Technical problems|1|||
170778409|NCT02554786|617195626|FG000|Overall Study|Adverse Event|0|||
170778410|NCT02554786|617195627|FG001|Overall Study|Adverse Event|0|||
170778411|NCT02554786|617195628|FG002|Overall Study|Adverse Event|0|||
170778412|NCT02554786|617195629|FG003|Overall Study|Adverse Event|0|||
170778413|NCT02554786|617195630|FG004|Overall Study|Adverse Event|2|||
170778414|NCT02554786|617195626|FG000|Overall Study|Death|0|||
170778415|NCT02554786|617195627|FG001|Overall Study|Death|0|||
170778416|NCT02554786|617195628|FG002|Overall Study|Death|0|||
170778417|NCT02554786|617195629|FG003|Overall Study|Death|1|||
170778418|NCT02554786|617195630|FG004|Overall Study|Death|0|||
170778419|NCT02554786|617195626|FG000|Overall Study|Non-compliance with study treatment|0|||
170778420|NCT02554786|617195627|FG001|Overall Study|Non-compliance with study treatment|1|||
170778421|NCT02554786|617195628|FG002|Overall Study|Non-compliance with study treatment|1|||
170778422|NCT02554786|617195629|FG003|Overall Study|Non-compliance with study treatment|0|||
170778423|NCT02554786|617195630|FG004|Overall Study|Non-compliance with study treatment|1|||
170778424|NCT02554786|617195626|FG000|Overall Study|Physician Decision|0|||
170778425|NCT02554786|617195627|FG001|Overall Study|Physician Decision|1|||
170778426|NCT02554786|617195628|FG002|Overall Study|Physician Decision|4|||
170778427|NCT02554786|617195629|FG003|Overall Study|Physician Decision|1|||
170778428|NCT02554786|617195630|FG004|Overall Study|Physician Decision|1|||
170778429|NCT02554786|617195626|FG000|Overall Study|Pregnancy|0|||
170778430|NCT02554786|617195627|FG001|Overall Study|Pregnancy|0|||
170778431|NCT02554786|617195628|FG002|Overall Study|Pregnancy|0|||
170778432|NCT02554786|617195629|FG003|Overall Study|Pregnancy|1|||
170778433|NCT02554786|617195630|FG004|Overall Study|Pregnancy|1|||
170778434|NCT01695954|617195632|FG000|Overall Study|Withdrawal by Subject|4|||
170878461|NCT03029143|617565675|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
170878462|NCT03029143|617565673|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
170878463|NCT03029143|617565674|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
170878464|NCT03029143|617565675|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
170878465|NCT03029143|617565673|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
170878466|NCT03029143|617565674|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
170878467|NCT03029143|617565675|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
170878468|NCT03029143|617565673|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170878469|NCT03029143|617565674|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170878470|NCT03029143|617565675|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
170878471|NCT03029143|617565673|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
170878472|NCT03029143|617565674|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
170878473|NCT03029143|617565675|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
170878474|NCT03029143|617565673|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
170878475|NCT03029143|617565674|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
170878476|NCT03029143|617565675|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
170878477|NCT03029143|617565673|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
170878478|NCT03029143|617565674|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
170878479|NCT03029143|617565675|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
170878480|NCT02121262|617565678|FG000|Overall Study|Adverse Event|6|||
170878481|NCT02121262|617565679|FG001|Overall Study|Adverse Event|3|||
170878482|NCT02121262|617565678|FG000|Overall Study|Lack of Efficacy|3|||
170878483|NCT02121262|617565679|FG001|Overall Study|Lack of Efficacy|0|||
170878484|NCT02121262|617565678|FG000|Overall Study|Personal Reasons|19|||
170878485|NCT02121262|617565679|FG001|Overall Study|Personal Reasons|5|||
170878486|NCT02121262|617565678|FG000|Overall Study|Protocol Violation|1|||
170878487|NCT02121262|617565679|FG001|Overall Study|Protocol Violation|1|||
170878488|NCT02121262|617565678|FG000|Overall Study|Participant Dropped-out|0|||
170878489|NCT02121262|617565679|FG001|Overall Study|Participant Dropped-out|1|||
170878490|NCT02121262|617565678|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
170878491|NCT02121262|617565679|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
170878492|NCT02121262|617565678|FG000|Overall Study|Consent Withdrawn|1|||
170878493|NCT02121262|617565679|FG001|Overall Study|Consent Withdrawn|0|||
170878494|NCT01553188|617565680|FG000|Overall Study|Patient choice|1|||
170878495|NCT01553188|617565681|FG001|Overall Study|Patient choice|0|||
170878496|NCT01553188|617565682|FG002|Overall Study|Patient choice|0|||
170878497|NCT01553188|617565683|FG003|Overall Study|Patient choice|0|||
170878498|NCT01553188|617565680|FG000|Overall Study|Intercurrent illness and adverse event|0|||
170878499|NCT01553188|617565681|FG001|Overall Study|Intercurrent illness and adverse event|1|||
170878500|NCT01553188|617565682|FG002|Overall Study|Intercurrent illness and adverse event|2|||
170878501|NCT01553188|617565683|FG003|Overall Study|Intercurrent illness and adverse event|0|||
170878502|NCT02716987|617565684|FG000|Overall Study|Ligand synthesis failure|0|||
170878503|NCT02716987|617565685|FG001|Overall Study|Ligand synthesis failure|0|||
170878504|NCT02716987|617565686|FG002|Overall Study|Ligand synthesis failure|1|||
170878505|NCT02716987|617565687|FG003|Overall Study|Ligand synthesis failure|0|||
170878506|NCT02716987|617565688|FG004|Overall Study|Ligand synthesis failure|0|||
170878507|NCT02716987|617565689|FG005|Overall Study|Ligand synthesis failure|0|||
170878508|NCT02716987|617565684|FG000|Overall Study|Withdrawal by Subject|0|||
170878509|NCT02716987|617565685|FG001|Overall Study|Withdrawal by Subject|0|||
170878510|NCT02716987|617565686|FG002|Overall Study|Withdrawal by Subject|0|||
170878511|NCT02716987|617565687|FG003|Overall Study|Withdrawal by Subject|0|||
170878512|NCT02716987|617565688|FG004|Overall Study|Withdrawal by Subject|1|||
170878513|NCT02716987|617565689|FG005|Overall Study|Withdrawal by Subject|1|||
170878514|NCT02829138|617565690|FG000|Overall Study|Withdrawal by Subject|1|||
170878515|NCT02829138|617565691|FG001|Overall Study|Withdrawal by Subject|0|||
170878516|NCT01394627|617565692|FG000|First Intervention (1 Day)|poor intravenous access|0|||
170878517|NCT01394627|617565693|FG001|First Intervention (1 Day)|poor intravenous access|1|||
170878518|NCT01394627|617565692|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
170878519|NCT01394627|617565693|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
170878520|NCT05289570|617565694|FG000|Overall Study|Physician Decision|1|||
170878521|NCT03317795|617565698|FG000|Overall Study|IUD Expulsion|1|||
170878522|NCT03317795|617565699|FG001|Overall Study|IUD Expulsion|0|||
170878523|NCT03317795|617565698|FG000|Overall Study|Lost to Follow-up|1|||
170878524|NCT03317795|617565699|FG001|Overall Study|Lost to Follow-up|3|||
170878525|NCT03317795|617565698|FG000|Overall Study|Treatment change|0|||
170878526|NCT03317795|617565699|FG001|Overall Study|Treatment change|3|||
170878527|NCT03317795|617565698|FG000|Overall Study|Intolerance of medication|0|||
170878528|NCT03317795|617565699|FG001|Overall Study|Intolerance of medication|1|||
170878529|NCT04857996|617565708|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
170878530|NCT04857996|617565709|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
170878531|NCT04857996|617565708|FG000|Overall Study|Lost to Follow-up|1|||
170878532|NCT04857996|617565709|FG001|Overall Study|Lost to Follow-up|3|||
170878533|NCT04857996|617565708|FG000|Overall Study|Site Closure|1|||
170878534|NCT04857996|617565709|FG001|Overall Study|Site Closure|0|||
170878535|NCT04857996|617565708|FG000|Overall Study|Withdrawal by Subject|1|||
170878536|NCT04857996|617565709|FG001|Overall Study|Withdrawal by Subject|0|||
170878537|NCT02484911|617567206|FG000|Overall Study|Withdrawal by Subject|2|||
170878538|NCT02484911|617567207|FG001|Overall Study|Withdrawal by Subject|1|||
170878539|NCT02484911|617567206|FG000|Overall Study|Protocol Violation|2|||
170878540|NCT02484911|617567207|FG001|Overall Study|Protocol Violation|1|||
170878541|NCT00490568|617567213|FG000|Overall Study|Adverse Event|116|||
170878542|NCT00490568|617567213|FG000|Overall Study|Lost to Follow-up|13|||
170878543|NCT00490568|617567213|FG000|Overall Study|Protocol Violation|45|||
170878544|NCT00490568|617567213|FG000|Overall Study|Withdrawal by Subject|135|||
170878545|NCT00490568|617567213|FG000|Overall Study|Still in the study at termination|974|||
170878546|NCT00490568|617567213|FG000|Overall Study|Other|1|||
170878547|NCT00490568|617567213|FG000|Overall Study|Exclusion criteria met|1|||
170878548|NCT00490568|617567213|FG000|Overall Study|Caregiver related|20|||
170878549|NCT00490568|617567213|FG000|Overall Study|Abnormal ECG|25|||
170878550|NCT00490568|617567213|FG000|Overall Study|Participant refused follow-up|9|||
170878551|NCT00490568|617567213|FG000|Overall Study|Legal representative withdrew consent|1|||
170878552|NCT00490568|617567213|FG000|Overall Study|Disease progression|4|||
170878553|NCT00490568|617567213|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
170878554|NCT00490568|617567213|FG000|Overall Study|Investigator decision|3|||
170878555|NCT00490568|617567213|FG000|Overall Study|Non-Compliance|7|||
170878556|NCT00490568|617567213|FG000|Overall Study|Efficacy related|3|||
170531863|NCT03533751|616293380|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
170531864|NCT03533751|616293381|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
170531865|NCT03533751|616293382|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
170878557|NCT00490568|617567213|FG000|Overall Study|Participant died|1|||
170878558|NCT00490568|617567213|FG000|Overall Study|Participant withdrawal due to surgery|1|||
170878559|NCT01395394|617567214|FG000|Baseline Study Visit|Protocol Violation|1|||
170878560|NCT01395394|617567215|FG001|Baseline Study Visit|Protocol Violation|0|||
170878561|NCT01395394|617567216|FG002|Baseline Study Visit|Protocol Violation|0|||
170878562|NCT01157078|617567219|FG000|Overall Study|Withdrawal by Subject|12|||
170878563|NCT01157078|617567220|FG001|Overall Study|Withdrawal by Subject|14|||
170878564|NCT01157078|617567219|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
170878565|NCT01157078|617567220|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170878566|NCT01157078|617567219|FG000|Overall Study|Adverse Event|6|||
170878567|NCT01157078|617567220|FG001|Overall Study|Adverse Event|6|||
170878568|NCT01157078|617567219|FG000|Overall Study|Severe non-compliance to protocol|2|||
170878569|NCT01157078|617567220|FG001|Overall Study|Severe non-compliance to protocol|4|||
170878570|NCT01157078|617567219|FG000|Overall Study|Condition under investigation worsened|0|||
170878571|NCT01157078|617567220|FG001|Overall Study|Condition under investigation worsened|1|||
170878572|NCT01157078|617567219|FG000|Overall Study|Lack of Efficacy|2|||
170878573|NCT01157078|617567220|FG001|Overall Study|Lack of Efficacy|0|||
170878574|NCT01157078|617567219|FG000|Overall Study|Study-specific withdrawal criteria|2|||
170878575|NCT01157078|617567220|FG001|Overall Study|Study-specific withdrawal criteria|2|||
170878576|NCT01157078|617567219|FG000|Overall Study|Lost to Follow-up|7|||
170878577|NCT01157078|617567220|FG001|Overall Study|Lost to Follow-up|5|||
170878578|NCT01157078|617567219|FG000|Overall Study|Other|2|||
170878579|NCT01157078|617567220|FG001|Overall Study|Other|4|||
170878580|NCT00522431|617567221|FG000|Overall Study|Adverse Event|5|||
170878581|NCT00522431|617567221|FG000|Overall Study|Protocol Violation|2|||
170878582|NCT00522431|617567221|FG000|Overall Study|Withdrawal by Subject|2|||
170878583|NCT00522431|617567221|FG000|Overall Study|Subject non-compliance|1|||
170878584|NCT00522431|617567221|FG000|Overall Study|Other/unknown|1|||
170878585|NCT00132132|617567224|FG000|Overall Study|Lost to Follow-up|7|||
170531866|NCT03533751|616293383|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
170531867|NCT03533751|616293379|FG000|Overall Study|Other|0|||
170531868|NCT03533751|616293380|FG001|Overall Study|Other|2|||
170531869|NCT03533751|616293381|FG002|Overall Study|Other|1|||
170878586|NCT00132132|617567225|FG001|Overall Study|Lost to Follow-up|2|||
170878587|NCT02145741|617567226|FG000|Overall Study|Progressive disease|3|||
170878588|NCT02145741|617567227|FG001|Overall Study|Progressive disease|6|||
170878589|NCT02145741|617567228|FG002|Overall Study|Progressive disease|6|||
170878590|NCT02145741|617567226|FG000|Overall Study|quality issue with the administered drug|3|||
170878591|NCT02145741|617567227|FG001|Overall Study|quality issue with the administered drug|0|||
170531870|NCT03533751|616293382|FG003|Overall Study|Other|0|||
170878592|NCT02145741|617567228|FG002|Overall Study|quality issue with the administered drug|0|||
170878593|NCT04839978|617567229|FG000|Overall Study|Lost to Follow-up|135|||
170878594|NCT04839978|617567230|FG001|Overall Study|Lost to Follow-up|147|||
170878595|NCT00129766|617567231|FG000|Overall Study|Death|3|||
170878596|NCT00129766|617567232|FG001|Overall Study|Death|8|||
170878597|NCT00129766|617567231|FG000|Overall Study|Withdrawal of consent|31|||
170878598|NCT00129766|617567232|FG001|Overall Study|Withdrawal of consent|30|||
170878599|NCT00129766|617567231|FG000|Overall Study|Lost to Follow-up|26|||
170878600|NCT00129766|617567232|FG001|Overall Study|Lost to Follow-up|21|||
170878601|NCT01349465|617567237|FG000|Overall Study|Adverse Event|1|||
170878602|NCT01349465|617567238|FG001|Overall Study|Adverse Event|0|||
170878603|NCT01349465|617567237|FG000|Overall Study|Death|3|||
170878604|NCT01349465|617567238|FG001|Overall Study|Death|0|||
170878605|NCT01349465|617567237|FG000|Overall Study|Lost to Follow-up|10|||
170878606|NCT01349465|617567238|FG001|Overall Study|Lost to Follow-up|1|||
170878607|NCT01349465|617567237|FG000|Overall Study|Withdrawal by Subject|4|||
170878608|NCT01349465|617567238|FG001|Overall Study|Withdrawal by Subject|2|||
170878609|NCT01349465|617567237|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
170878610|NCT01349465|617567238|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
170878611|NCT04329702|617567239|FG000|Overall Study|illness|3|||
170878612|NCT04329702|617567240|FG001|Overall Study|illness|4|||
170878613|NCT04329702|617567241|FG002|Overall Study|illness|0|||
170878614|NCT04329702|617567239|FG000|Overall Study|Lost to Follow-up|0|||
170878615|NCT04329702|617567240|FG001|Overall Study|Lost to Follow-up|0|||
170878616|NCT04329702|617567241|FG002|Overall Study|Lost to Follow-up|2|||
170878617|NCT04329702|617567239|FG000|Overall Study|Death|0|||
170878618|NCT04329702|617567240|FG001|Overall Study|Death|2|||
170878619|NCT04329702|617567241|FG002|Overall Study|Death|0|||
170878620|NCT00751400|617567242|FG000|Overall Study|Lost to Follow-up|10|||
170878621|NCT05440539|617567243|FG000|Overall Study|Lost to Follow-up|4|||
170878622|NCT05440539|617567244|FG001|Overall Study|Lost to Follow-up|4|||
170878623|NCT05440539|617567243|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
170878624|NCT05440539|617567244|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
170878625|NCT01732796|617567245|FG000|Overall Study|Adverse Event|16|||
170878626|NCT01732796|617567246|FG001|Overall Study|Adverse Event|16|||
170878627|NCT01732796|617567247|FG002|Overall Study|Adverse Event|4|||
170878628|NCT01732796|617567245|FG000|Overall Study|Lack of Efficacy|21|||
170878629|NCT01732796|617567246|FG001|Overall Study|Lack of Efficacy|18|||
170878630|NCT01732796|617567247|FG002|Overall Study|Lack of Efficacy|5|||
170878631|NCT01732796|617567245|FG000|Overall Study|Lost to Follow-up|2|||
170878632|NCT01732796|617567246|FG001|Overall Study|Lost to Follow-up|0|||
170878633|NCT01732796|617567247|FG002|Overall Study|Lost to Follow-up|0|||
170878634|NCT01732796|617567245|FG000|Overall Study|Withdrawal by Subject|6|||
170878635|NCT01732796|617567246|FG001|Overall Study|Withdrawal by Subject|8|||
170878636|NCT01732796|617567247|FG002|Overall Study|Withdrawal by Subject|2|||
170878637|NCT01732796|617567245|FG000|Overall Study|Other reason not defined above|1|||
170878638|NCT01732796|617567246|FG001|Overall Study|Other reason not defined above|0|||
170878639|NCT01732796|617567247|FG002|Overall Study|Other reason not defined above|2|||
170878640|NCT03370120|617567250|FG000|Overall Study|Adverse event, non-fatal|24|||
170878641|NCT03370120|617567250|FG000|Overall Study|Withdrawal by Subject|6|||
170878642|NCT03370120|617567250|FG000|Overall Study|Lost to Follow-up|1|||
170878643|NCT03370120|617567250|FG000|Overall Study|Lack of Efficacy|37|||
170878644|NCT03370120|617567250|FG000|Overall Study|Per sponsor's instructions|1|||
170878645|NCT03370120|617567250|FG000|Overall Study|Study was terminated by parent company UCB|2|||
170878646|NCT03370120|617567250|FG000|Overall Study|The study was ended by the promoter|3|||
170878647|NCT03370120|617567250|FG000|Overall Study|Discontinuation of drug development|3|||
170878648|NCT03370120|617567250|FG000|Overall Study|End of project|2|||
170878649|NCT03370120|617567250|FG000|Overall Study|Premature study closure|2|||
170878650|NCT03370120|617567250|FG000|Overall Study|Premature program termination|1|||
170878651|NCT03370120|617567250|FG000|Overall Study|Premature study termination|7|||
170878652|NCT03370120|617567250|FG000|Overall Study|Trial terminated by sponsor|2|||
170878653|NCT03370120|617567250|FG000|Overall Study|Trial discontinued by sponsor|2|||
170878654|NCT03370120|617567250|FG000|Overall Study|Study ended|15|||
170878655|NCT03370120|617567250|FG000|Overall Study|Clinical trial has been cancelled|1|||
170878656|NCT03370120|617567250|FG000|Overall Study|End of study per sponsor decision|2|||
170878657|NCT03370120|617567250|FG000|Overall Study|Promoter's decision|2|||
170878658|NCT03370120|617567250|FG000|Overall Study|The trial has been suspended|3|||
170878659|NCT03370120|617567250|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
170878660|NCT03370120|617567250|FG000|Overall Study|Early termination by order of sponsor|2|||
170878661|NCT03370120|617567250|FG000|Overall Study|Discontinuation of the study|5|||
170878662|NCT03370120|617567250|FG000|Overall Study|End of clinical trial discontinuation|1|||
170878663|NCT03370120|617567250|FG000|Overall Study|Because the clinical trial ended halfway|4|||
170878664|NCT03370120|617567250|FG000|Overall Study|Development discontinued|5|||
170420524|NCT06176768|615880587|FG001|Overall Study|Protocol deviation|1|||
170878665|NCT03370120|617567250|FG000|Overall Study|Padsenovil program closed|3|||
170878666|NCT03370120|617567250|FG000|Overall Study|End of project|2|||
170878667|NCT03370120|617567250|FG000|Overall Study|Termination of project|1|||
170878668|NCT03370120|617567250|FG000|Overall Study|The study was interrupted by sponsor|4|||
170878669|NCT03370120|617567250|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
170878670|NCT03370120|617567250|FG000|Overall Study|End of sponsor decision|1|||
170878671|NCT03370120|617567250|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
170878672|NCT03370120|617567250|FG000|Overall Study|Early termination of studies|5|||
170878673|NCT03370120|617567250|FG000|Overall Study|This study is ended early|1|||
170878674|NCT03370120|617567250|FG000|Overall Study|End of padsevonil program|2|||
170878675|NCT03370120|617567250|FG000|Overall Study|Decision of sponsor|6|||
170878676|NCT03370120|617567250|FG000|Overall Study|Asked by the sponsor|3|||
170878677|NCT03370120|617567250|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
170878678|NCT03370120|617567250|FG000|Overall Study|PI decision poor compliance from participant|1|||
170878679|NCT03370120|617567250|FG000|Overall Study|Promoter ended the study|3|||
170878680|NCT03370120|617567250|FG000|Overall Study|Premature study close by sponsor's decision|4|||
170878681|NCT03370120|617567250|FG000|Overall Study|Study terminated by sponsor|33|||
170878682|NCT03370120|617567250|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
170878683|NCT03370120|617567250|FG000|Overall Study|Sponsor decision to terminate study|63|||
170878684|NCT03370120|617567250|FG000|Overall Study|Program closure|3|||
170878685|NCT03370120|617567250|FG000|Overall Study|Study ended prematurely|1|||
170878686|NCT03370120|617567250|FG000|Overall Study|Study stopped by sponsor|2|||
170878687|NCT03370120|617567250|FG000|Overall Study|Program termination|55|||
170878688|NCT03370120|617567250|FG000|Overall Study|Sponsor decision|62|||
170878689|NCT03370120|617567250|FG000|Overall Study|Sponsor study closure|10|||
170878690|NCT02004262|617567251|FG000|Overall Study|Death|67|||
170878691|NCT02004262|617567252|FG001|Overall Study|Death|64|||
170878692|NCT02004262|617567253|FG002|Overall Study|Death|66|||
170878693|NCT02004262|617567254|FG003|Overall Study|Death|28|||
170878694|NCT02004262|617567255|FG004|Overall Study|Death|29|||
170878695|NCT02004262|617567256|FG005|Overall Study|Death|22|||
170878696|NCT02004262|617567251|FG000|Overall Study|Withdrawal by Subject|1|||
170878697|NCT02004262|617567252|FG001|Overall Study|Withdrawal by Subject|0|||
170878698|NCT02004262|617567253|FG002|Overall Study|Withdrawal by Subject|4|||
170878699|NCT02004262|617567254|FG003|Overall Study|Withdrawal by Subject|0|||
170878700|NCT02004262|617567255|FG004|Overall Study|Withdrawal by Subject|1|||
170878701|NCT02004262|617567256|FG005|Overall Study|Withdrawal by Subject|3|||
170878702|NCT02004262|617567251|FG000|Overall Study|Lost to Follow-up|1|||
170878703|NCT02004262|617567252|FG001|Overall Study|Lost to Follow-up|1|||
170878704|NCT02004262|617567253|FG002|Overall Study|Lost to Follow-up|0|||
170878705|NCT02004262|617567254|FG003|Overall Study|Lost to Follow-up|0|||
170878706|NCT02004262|617567255|FG004|Overall Study|Lost to Follow-up|0|||
170878707|NCT02004262|617567256|FG005|Overall Study|Lost to Follow-up|0|||
170878708|NCT02004262|617567251|FG000|Overall Study|Study Terminated by Sponsor|4|||
170878709|NCT02004262|617567252|FG001|Overall Study|Study Terminated by Sponsor|3|||
170878710|NCT02004262|617567253|FG002|Overall Study|Study Terminated by Sponsor|2|||
170878711|NCT02004262|617567254|FG003|Overall Study|Study Terminated by Sponsor|1|||
170878712|NCT02004262|617567255|FG004|Overall Study|Study Terminated by Sponsor|1|||
170878713|NCT02004262|617567256|FG005|Overall Study|Study Terminated by Sponsor|5|||
170878714|NCT03200366|617567257|FG000|Patient Navigation Intervention Given|Death|0|||
170878715|NCT03200366|617567258|FG001|Patient Navigation Intervention Given|Death|2|||
170878716|NCT03200366|617567259|FG002|Patient Navigation Intervention Given|Death|0|||
170878717|NCT03200366|617567257|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
170878718|NCT03200366|617567258|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
170878719|NCT03200366|617567259|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
170878720|NCT03200366|617567257|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
170878721|NCT03200366|617567258|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
170878722|NCT03200366|617567259|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
170878723|NCT03200366|617567257|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
170878724|NCT03200366|617567258|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
170878725|NCT03200366|617567259|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
170878726|NCT03200366|617567257|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
170878727|NCT03200366|617567258|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
170878728|NCT03200366|617567259|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
170878729|NCT03200366|617567257|FG000|6 Month Post-Baseline Interview|Death|1|||
170878730|NCT03200366|617567258|FG001|6 Month Post-Baseline Interview|Death|1|||
170878731|NCT03200366|617567259|FG002|6 Month Post-Baseline Interview|Death|1|||
170878732|NCT03200366|617567257|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
170878733|NCT03200366|617567258|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
170878734|NCT03200366|617567259|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
170878735|NCT03200366|617567257|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
170878736|NCT03200366|617567258|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
170878737|NCT03200366|617567259|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
170878738|NCT03200366|617567257|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
170878739|NCT03200366|617567258|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
170878740|NCT03200366|617567259|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
170878741|NCT03200366|617567257|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
170420525|NCT06176768|615880586|FG000|Overall Study|Other|1|||
170420526|NCT06176768|615880587|FG001|Overall Study|Other|0|||
170420527|NCT06176768|615880586|FG000|Overall Study|Withdrawal by Subject|6|||
170420528|NCT06176768|615880587|FG001|Overall Study|Withdrawal by Subject|9|||
170420529|NCT01395030|615880592|FG000|Overall Study|Did not complete FCH PET/CT|7|||
170420530|NCT04977336|615880595|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
170420531|NCT04977336|615880596|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
170420532|NCT04977336|615880597|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
170420533|NCT04977336|615880598|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
170420534|NCT04977336|615880599|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
170420535|NCT04977336|615880595|FG000|Overall Study|Lost to Follow-up|0|||
170420536|NCT04977336|615880596|FG001|Overall Study|Lost to Follow-up|0|||
170420537|NCT04977336|615880597|FG002|Overall Study|Lost to Follow-up|1|||
170420538|NCT04977336|615880598|FG003|Overall Study|Lost to Follow-up|0|||
170420539|NCT04977336|615880599|FG004|Overall Study|Lost to Follow-up|0|||
170420540|NCT04591626|615880603|FG000|Overall Study|Adverse Event|4|||
170420541|NCT04591626|615880604|FG001|Overall Study|Adverse Event|0|||
170420542|NCT04591626|615880603|FG000|Overall Study|Withdrawal by Subject|5|||
170420543|NCT04591626|615880604|FG001|Overall Study|Withdrawal by Subject|3|||
170420544|NCT04591626|615880603|FG000|Overall Study|Physician Decision|0|||
170420545|NCT04591626|615880604|FG001|Overall Study|Physician Decision|1|||
170420546|NCT04591626|615880603|FG000|Overall Study|Death|0|||
170420547|NCT04591626|615880604|FG001|Overall Study|Death|1|||
170420548|NCT04591626|615880603|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170420549|NCT04591626|615880604|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170420550|NCT01004172|615880605|FG000|Overall Study|Progressive Disease in CNS Only|16|||
170420551|NCT01004172|615880605|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
170420552|NCT01004172|615880605|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
170420553|NCT01004172|615880605|FG000|Overall Study|Adverse Event|1|||
170420554|NCT01004172|615880605|FG000|Overall Study|Physician Decision|1|||
170420555|NCT01004172|615880605|FG000|Overall Study|Symptomatic Deterioration|2|||
170420556|NCT01606306|615880606|FG000|Overall Study|Lack of Efficacy|2|||
170420557|NCT01606306|615880607|FG001|Overall Study|Lack of Efficacy|1|||
170420558|NCT01606306|615880608|FG002|Overall Study|Lack of Efficacy|4|||
170420559|NCT01606306|615880609|FG003|Overall Study|Lack of Efficacy|4|||
170420560|NCT01606306|615880610|FG004|Overall Study|Lack of Efficacy|1|||
170420561|NCT01606306|615880611|FG005|Overall Study|Lack of Efficacy|2|||
170420562|NCT01606306|615880606|FG000|Overall Study|Adverse Event|1|||
170420563|NCT01606306|615880607|FG001|Overall Study|Adverse Event|0|||
170420564|NCT01606306|615880608|FG002|Overall Study|Adverse Event|1|||
170420565|NCT01606306|615880609|FG003|Overall Study|Adverse Event|1|||
170420566|NCT01606306|615880610|FG004|Overall Study|Adverse Event|2|||
170420567|NCT01606306|615880611|FG005|Overall Study|Adverse Event|0|||
170420568|NCT01606306|615880606|FG000|Overall Study|Lost to Follow-up|7|||
170420569|NCT01606306|615880607|FG001|Overall Study|Lost to Follow-up|4|||
170420570|NCT01606306|615880608|FG002|Overall Study|Lost to Follow-up|5|||
170420571|NCT01606306|615880609|FG003|Overall Study|Lost to Follow-up|4|||
170420572|NCT01606306|615880610|FG004|Overall Study|Lost to Follow-up|3|||
170420573|NCT01606306|615880611|FG005|Overall Study|Lost to Follow-up|5|||
170420574|NCT01606306|615880606|FG000|Overall Study|Withdrawal by Subject|4|||
170420575|NCT01606306|615880607|FG001|Overall Study|Withdrawal by Subject|3|||
170420576|NCT01606306|615880608|FG002|Overall Study|Withdrawal by Subject|4|||
170420577|NCT01606306|615880609|FG003|Overall Study|Withdrawal by Subject|4|||
170420578|NCT01606306|615880610|FG004|Overall Study|Withdrawal by Subject|5|||
170420579|NCT01606306|615880611|FG005|Overall Study|Withdrawal by Subject|4|||
170420580|NCT01606306|615880606|FG000|Overall Study|Physician Decision|1|||
170420581|NCT01606306|615880607|FG001|Overall Study|Physician Decision|2|||
170420582|NCT01606306|615880608|FG002|Overall Study|Physician Decision|0|||
170420583|NCT01606306|615880609|FG003|Overall Study|Physician Decision|0|||
170420584|NCT01606306|615880610|FG004|Overall Study|Physician Decision|0|||
170420585|NCT01606306|615880611|FG005|Overall Study|Physician Decision|0|||
170420586|NCT00970281|615880612|FG000|Overall Study|Lack of Efficacy|1|||
170420587|NCT00970281|615880613|FG001|Overall Study|Lack of Efficacy|14|||
170420588|NCT00970281|615880612|FG000|Overall Study|Withdrawal by Subject|0|||
170420589|NCT00970281|615880613|FG001|Overall Study|Withdrawal by Subject|1|||
170420590|NCT00970281|615880612|FG000|Overall Study|Physician Decision|1|||
170420591|NCT00970281|615880613|FG001|Overall Study|Physician Decision|1|||
170420592|NCT01759290|615880618|FG000|Overall Study|Subjects withdrawn consent|5|||
170420593|NCT01759290|615880618|FG000|Overall Study|Physician Decision|2|||
170420594|NCT01759290|615880618|FG000|Overall Study|Death|17|||
170420595|NCT01759290|615880618|FG000|Overall Study|Lost to Follow-up|53|||
170420596|NCT01759290|615880618|FG000|Overall Study|Unknown reason|4|||
170420597|NCT03338972|615880619|FG000|Overall Study|Death|1|||
170420598|NCT03338972|615880620|FG001|Overall Study|Death|1|||
170420599|NCT03338972|615880621|FG002|Overall Study|Death|0|||
170420600|NCT03338972|615880622|FG003|Overall Study|Death|0|||
170420601|NCT03338972|615880619|FG000|Overall Study|Withdrawal by Subject|1|||
170420602|NCT03338972|615880620|FG001|Overall Study|Withdrawal by Subject|0|||
170420603|NCT03338972|615880621|FG002|Overall Study|Withdrawal by Subject|0|||
170420604|NCT03338972|615880622|FG003|Overall Study|Withdrawal by Subject|0|||
170420605|NCT02343120|615880623|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
170420606|NCT02343120|615880624|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
170420607|NCT02343120|615880625|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
170420608|NCT02343120|615880626|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
170420609|NCT02343120|615880627|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
170420610|NCT02343120|615880623|FG000|Part 1: Dose Escalation|Death|1|||
170420611|NCT02343120|615880624|FG001|Part 1: Dose Escalation|Death|2|||
170420612|NCT02343120|615880625|FG002|Part 1: Dose Escalation|Death|2|||
170420613|NCT02343120|615880626|FG003|Part 1: Dose Escalation|Death|2|||
170420614|NCT02343120|615880627|FG004|Part 1: Dose Escalation|Death|1|||
170420615|NCT02343120|615880623|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
170420616|NCT02343120|615880624|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
170420617|NCT02343120|615880625|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
170420618|NCT02343120|615880626|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
170420619|NCT02343120|615880627|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
170420620|NCT02343120|615880623|FG000|Part 2: Expansion|Sponsor decision|0|||
170420621|NCT02343120|615880624|FG001|Part 2: Expansion|Sponsor decision|0|||
170420622|NCT02343120|615880625|FG002|Part 2: Expansion|Sponsor decision|0|||
170878742|NCT03200366|617567258|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
170878743|NCT03200366|617567259|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
170878744|NCT03200366|617567257|FG000|9 Month Post-Baseline Interview|Death|1|||
170878745|NCT03200366|617567258|FG001|9 Month Post-Baseline Interview|Death|1|||
170878746|NCT03200366|617567259|FG002|9 Month Post-Baseline Interview|Death|1|||
170878747|NCT03200366|617567257|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
170878748|NCT03200366|617567258|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
170878749|NCT03200366|617567259|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
170878750|NCT03200366|617567257|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
170878751|NCT03200366|617567258|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
170878752|NCT03200366|617567259|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
170878753|NCT03200366|617567257|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
170878754|NCT03200366|617567258|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
170878755|NCT03200366|617567259|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
170878756|NCT00405067|617567260|FG000|Overall Study|Adverse Event|4|||
170878757|NCT00405067|617567261|FG001|Overall Study|Adverse Event|9|||
170878758|NCT00405067|617567262|FG002|Overall Study|Adverse Event|4|||
170878759|NCT00405067|617567260|FG000|Overall Study|Lost to Follow-up|0|||
170878760|NCT00405067|617567261|FG001|Overall Study|Lost to Follow-up|0|||
170878761|NCT00405067|617567262|FG002|Overall Study|Lost to Follow-up|1|||
170878762|NCT02285777|617567264|FG000|Overall Study|Withdrawal by Subject|1|||
170878763|NCT02285777|617567265|FG001|Overall Study|Withdrawal by Subject|1|||
170878764|NCT02285777|617567264|FG000|Overall Study|Lost to Follow-up|4|||
170878765|NCT02285777|617567265|FG001|Overall Study|Lost to Follow-up|2|||
170878766|NCT03287219|617567266|FG000|Overall Study|Protocol Violation|0|||
170878767|NCT03287219|617567267|FG001|Overall Study|Protocol Violation|2|||
170878768|NCT00552175|617567268|FG000|Overall Study|Lack of Efficacy|2|||
170878769|NCT00552175|617567269|FG001|Overall Study|Lack of Efficacy|0|||
170878770|NCT00552175|617567270|FG002|Overall Study|Lack of Efficacy|1|||
170878771|NCT00552175|617567268|FG000|Overall Study|Adverse Event|9|||
170878772|NCT00552175|617567269|FG001|Overall Study|Adverse Event|9|||
170878773|NCT00552175|617567270|FG002|Overall Study|Adverse Event|10|||
170878774|NCT00552175|617567268|FG000|Overall Study|Withdrawal by Subject|2|||
170878775|NCT00552175|617567269|FG001|Overall Study|Withdrawal by Subject|2|||
170878776|NCT00552175|617567270|FG002|Overall Study|Withdrawal by Subject|1|||
170878777|NCT00552175|617567268|FG000|Overall Study|Lost to Follow-up|0|||
170878778|NCT00552175|617567269|FG001|Overall Study|Lost to Follow-up|0|||
170878779|NCT00552175|617567270|FG002|Overall Study|Lost to Follow-up|1|||
170878780|NCT00552175|617567268|FG000|Overall Study|Entry Criteria Not Met|1|||
170878781|NCT00552175|617567269|FG001|Overall Study|Entry Criteria Not Met|1|||
170420623|NCT02343120|615880626|FG003|Part 2: Expansion|Sponsor decision|165|||
170878782|NCT00552175|617567270|FG002|Overall Study|Entry Criteria Not Met|0|||
170878783|NCT00552175|617567268|FG000|Overall Study|Reason Not Specified|3|||
170878784|NCT00552175|617567269|FG001|Overall Study|Reason Not Specified|1|||
170878785|NCT00552175|617567270|FG002|Overall Study|Reason Not Specified|1|||
170878786|NCT00957008|617567271|FG000|Overall Study|Withdrawal by Subject|13|||
170878787|NCT00957008|617567272|FG001|Overall Study|Withdrawal by Subject|10|||
170878788|NCT00957008|617567273|FG002|Overall Study|Withdrawal by Subject|12|||
170878789|NCT00957008|617567274|FG003|Overall Study|Withdrawal by Subject|16|||
170878790|NCT00957008|617567271|FG000|Overall Study|Lost to Follow-up|3|||
170420624|NCT02343120|615880627|FG004|Part 2: Expansion|Sponsor decision|67|||
170420625|NCT02343120|615880623|FG000|Part 2: Expansion|Death|0|||
170420626|NCT02343120|615880624|FG001|Part 2: Expansion|Death|0|||
170878791|NCT00957008|617567272|FG001|Overall Study|Lost to Follow-up|1|||
170420627|NCT02343120|615880625|FG002|Part 2: Expansion|Death|0|||
170878792|NCT00957008|617567273|FG002|Overall Study|Lost to Follow-up|3|||
170878793|NCT00957008|617567274|FG003|Overall Study|Lost to Follow-up|4|||
170878794|NCT00957008|617567271|FG000|Overall Study|Physician Decision|1|||
170878795|NCT00957008|617567272|FG001|Overall Study|Physician Decision|0|||
170878796|NCT00957008|617567273|FG002|Overall Study|Physician Decision|1|||
170878797|NCT00957008|617567274|FG003|Overall Study|Physician Decision|1|||
170878798|NCT00957008|617567271|FG000|Overall Study|Relocated; Family conflict|4|||
170878799|NCT00957008|617567272|FG001|Overall Study|Relocated; Family conflict|1|||
170878800|NCT00957008|617567273|FG002|Overall Study|Relocated; Family conflict|1|||
170878801|NCT00957008|617567274|FG003|Overall Study|Relocated; Family conflict|3|||
170878802|NCT01118351|617567275|FG000|Overall Study|Adverse Event|3|||
170878803|NCT01118351|617567275|FG000|Overall Study|Withdrawal by Subject|1|||
170878804|NCT00811135|617567276|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
170878805|NCT00811135|617567276|FG000|Overall Study|Death|3|||
170878806|NCT00811135|617567276|FG000|Overall Study|Protocol Violation|2|||
170878807|NCT00811135|617567276|FG000|Overall Study|Violation of Selection Criteria|1|||
170878808|NCT00811135|617567276|FG000|Overall Study|Refused Treatment|1|||
170878809|NCT00811135|617567276|FG000|Overall Study|Withdrawal by Subject|3|||
170878810|NCT00811135|617567276|FG000|Overall Study|Administrative/Other Unspecified|11|||
170878811|NCT00811135|617567276|FG000|Overall Study|Ongoing|59|||
170878812|NCT02192827|617567284|FG000|Overall Study|Lost to Follow-up|25|||
170878813|NCT02192827|617567285|FG001|Overall Study|Lost to Follow-up|27|||
170878814|NCT02192827|617567284|FG000|Overall Study|Given additional steroids with admission|13|||
170878815|NCT02192827|617567285|FG001|Overall Study|Given additional steroids with admission|11|||
170878816|NCT04677959|617567286|FG000|Overall Study|Adverse Event|1|||
170878817|NCT04677959|617567287|FG001|Overall Study|Adverse Event|9|||
170878818|NCT04677959|617567286|FG000|Overall Study|Withdrawal by Subject|2|||
170878819|NCT04677959|617567287|FG001|Overall Study|Withdrawal by Subject|15|||
170878820|NCT04677959|617567286|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170878821|NCT04677959|617567287|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170878822|NCT04677959|617567286|FG000|Overall Study|Non-compliance with study drug|0|||
170878823|NCT04677959|617567287|FG001|Overall Study|Non-compliance with study drug|2|||
170878824|NCT04677959|617567286|FG000|Overall Study|Protocol deviation|0|||
170878825|NCT04677959|617567287|FG001|Overall Study|Protocol deviation|11|||
170878826|NCT04677959|617567286|FG000|Overall Study|Lost to Follow-up|9|||
170878827|NCT04677959|617567287|FG001|Overall Study|Lost to Follow-up|13|||
170878828|NCT04677959|617567286|FG000|Overall Study|Other than specified|0|||
170878829|NCT04677959|617567287|FG001|Overall Study|Other than specified|8|||
170878830|NCT00283595|617567294|FG000|Overall Study|Withdrawal by Subject|1|||
170878831|NCT00283595|617567295|FG001|Overall Study|Withdrawal by Subject|2|||
170878832|NCT04718974|617567299|FG000|Overall Study|Death|0|||
170878833|NCT04718974|617567300|FG001|Overall Study|Death|2|||
170878834|NCT04718974|617567299|FG000|Overall Study|Lost to Follow-up|10|||
170878835|NCT04718974|617567300|FG001|Overall Study|Lost to Follow-up|20|||
170878836|NCT04718974|617567299|FG000|Overall Study|Transferred out|2|||
170878837|NCT04718974|617567300|FG001|Overall Study|Transferred out|4|||
170878838|NCT00845728|617567301|FG000|Overall Study|Abnormal laboratory value (s)|2|||
170878839|NCT00845728|617567302|FG001|Overall Study|Abnormal laboratory value (s)|2|||
170878840|NCT00845728|617567301|FG000|Overall Study|Patient's inability to use the device|4|||
170878841|NCT00845728|617567302|FG001|Overall Study|Patient's inability to use the device|6|||
170878842|NCT00845728|617567301|FG000|Overall Study|Abnormal test procedure result (s)|7|||
170878843|NCT00845728|617567302|FG001|Overall Study|Abnormal test procedure result (s)|2|||
170878844|NCT00845728|617567301|FG000|Overall Study|Lost to Follow-up|22|||
170878845|NCT00845728|617567302|FG001|Overall Study|Lost to Follow-up|13|||
170878846|NCT00845728|617567301|FG000|Overall Study|Death|24|||
170878847|NCT00845728|617567302|FG001|Overall Study|Death|26|||
170878848|NCT00845728|617567301|FG000|Overall Study|Administrative Problems|34|||
170878849|NCT00845728|617567302|FG001|Overall Study|Administrative Problems|26|||
170878850|NCT00845728|617567301|FG000|Overall Study|Protocol Violation|36|||
170878851|NCT00845728|617567302|FG001|Overall Study|Protocol Violation|24|||
170878852|NCT00845728|617567301|FG000|Overall Study|Lack of Efficacy|51|||
170878853|NCT00845728|617567302|FG001|Overall Study|Lack of Efficacy|39|||
170878854|NCT00845728|617567301|FG000|Overall Study|Adverse Event|101|||
170878855|NCT00845728|617567302|FG001|Overall Study|Adverse Event|96|||
170878856|NCT00845728|617567301|FG000|Overall Study|Withdrawal by Subject|105|||
170878857|NCT00845728|617567302|FG001|Overall Study|Withdrawal by Subject|108|||
170878858|NCT01389752|617567303|FG000|Study Period 1|Sponsor decision|0|||
170878859|NCT01389752|617567304|FG001|Study Period 1|Sponsor decision|2|||
170878860|NCT01389752|617567303|FG000|Study Period 2|Sponsor decision|1|||
170878861|NCT01389752|617567304|FG001|Study Period 2|Sponsor decision|0|||
170420628|NCT02343120|615880626|FG003|Part 2: Expansion|Death|74|||
170420629|NCT02343120|615880627|FG004|Part 2: Expansion|Death|17|||
170420630|NCT02343120|615880623|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
170420631|NCT02343120|615880624|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
170878862|NCT01576549|617567305|FG000|Overall Study|Sponsor Decision|2|||
170878863|NCT04081363|617567306|FG000|Overall Study|Withdrawal by Subject|1|||
170878864|NCT04081363|617567307|FG001|Overall Study|Withdrawal by Subject|0|||
170878865|NCT02409290|617567308|FG000|Overall Study|Protocol Violation|3|||
170878866|NCT02409290|617567309|FG001|Overall Study|Protocol Violation|6|||
170878867|NCT02409290|617567310|FG002|Overall Study|Protocol Violation|9|||
170878868|NCT02409290|617567311|FG003|Overall Study|Protocol Violation|4|||
170878869|NCT02409290|617567308|FG000|Overall Study|No positive culture/no baseline sample|3|||
170878870|NCT02409290|617567309|FG001|Overall Study|No positive culture/no baseline sample|9|||
170420632|NCT02343120|615880625|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
170420633|NCT02343120|615880626|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
170420634|NCT02343120|615880627|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
170420635|NCT02343120|615880623|FG000|Part 2: Expansion|Lost to Follow-up|0|||
170420636|NCT02343120|615880624|FG001|Part 2: Expansion|Lost to Follow-up|0|||
170420637|NCT02343120|615880625|FG002|Part 2: Expansion|Lost to Follow-up|0|||
170420638|NCT02343120|615880626|FG003|Part 2: Expansion|Lost to Follow-up|5|||
170420639|NCT02343120|615880627|FG004|Part 2: Expansion|Lost to Follow-up|2|||
170420640|NCT02343120|615880623|FG000|Part 2: Expansion|Other|0|||
170420641|NCT02343120|615880624|FG001|Part 2: Expansion|Other|0|||
170878871|NCT02409290|617567310|FG002|Overall Study|No positive culture/no baseline sample|6|||
170878872|NCT02409290|617567311|FG003|Overall Study|No positive culture/no baseline sample|5|||
170878873|NCT02409290|617567308|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
170878874|NCT02409290|617567309|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
170878875|NCT02409290|617567310|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
170878876|NCT02409290|617567311|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
170878877|NCT01617070|617567321|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
170878878|NCT02025907|617567322|FG000|Overall Study|Lack of Efficacy|1|||
170878879|NCT02025907|617567323|FG001|Overall Study|Lack of Efficacy|0|||
170878880|NCT02025907|617567322|FG000|Overall Study|Withdrawal by Subject|15|||
170878881|NCT02025907|617567323|FG001|Overall Study|Withdrawal by Subject|8|||
170878882|NCT02025907|617567322|FG000|Overall Study|Protocol Violation|2|||
170878883|NCT02025907|617567323|FG001|Overall Study|Protocol Violation|0|||
170878884|NCT02025907|617567322|FG000|Overall Study|Physician Decision|2|||
170878885|NCT02025907|617567323|FG001|Overall Study|Physician Decision|0|||
170878886|NCT02025907|617567322|FG000|Overall Study|Lost to Follow-up|2|||
170878887|NCT02025907|617567323|FG001|Overall Study|Lost to Follow-up|2|||
170878888|NCT02025907|617567322|FG000|Overall Study|Adverse Event|3|||
170878889|NCT02025907|617567323|FG001|Overall Study|Adverse Event|1|||
170878890|NCT02025907|617567322|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
170878891|NCT02025907|617567323|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
170878892|NCT00777101|617567324|FG000|Overall Study|Death|48|||
170878893|NCT00777101|617567325|FG001|Overall Study|Death|43|||
170878894|NCT00777101|617567324|FG000|Overall Study|Withdrawal by Subject|11|||
170878895|NCT00777101|617567325|FG001|Overall Study|Withdrawal by Subject|6|||
170878896|NCT00777101|617567324|FG000|Overall Study|Lost to Follow-up|2|||
170878897|NCT00777101|617567325|FG001|Overall Study|Lost to Follow-up|1|||
170878898|NCT00777101|617567324|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
170878899|NCT00777101|617567325|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
170878900|NCT00777101|617567324|FG000|Overall Study|Failed to Return|0|||
170878901|NCT00777101|617567325|FG001|Overall Study|Failed to Return|1|||
170878902|NCT00964743|617567329|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
170878903|NCT03631732|617567336|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
170878904|NCT03631732|617567337|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
170878905|NCT03631732|617567336|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
170878906|NCT03631732|617567337|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
170878907|NCT03631732|617567336|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
170878908|NCT03631732|617567337|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
170878909|NCT03631732|617567336|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
170878910|NCT03631732|617567337|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
170878911|NCT03631732|617567336|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
170878912|NCT03631732|617567337|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
170878913|NCT03631732|617567336|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
170878914|NCT03631732|617567337|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
170878915|NCT03631732|617567336|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
170878916|NCT03631732|617567337|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
170878917|NCT03631732|617567336|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
170878918|NCT03631732|617567337|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
170878919|NCT03631732|617567336|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
170878920|NCT03631732|617567337|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
170878921|NCT03631732|617567336|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
170878922|NCT03631732|617567337|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
170878923|NCT00886600|617567338|FG000|Double-blind Monotherapy|Adverse Event|1|||
170878924|NCT00886600|617567339|FG001|Double-blind Monotherapy|Adverse Event|1|||
170878925|NCT00886600|617567340|FG002|Double-blind Monotherapy|Adverse Event|1|||
170420642|NCT02343120|615880625|FG002|Part 2: Expansion|Other|0|||
170420643|NCT02343120|615880626|FG003|Part 2: Expansion|Other|1|||
170420644|NCT02343120|615880627|FG004|Part 2: Expansion|Other|5|||
170420645|NCT02343120|615880623|FG000|Part 2: Expansion|Adverse Event|0|||
170420646|NCT02343120|615880624|FG001|Part 2: Expansion|Adverse Event|0|||
170420647|NCT02343120|615880625|FG002|Part 2: Expansion|Adverse Event|0|||
170420648|NCT02343120|615880626|FG003|Part 2: Expansion|Adverse Event|1|||
170420649|NCT02343120|615880627|FG004|Part 2: Expansion|Adverse Event|1|||
170420650|NCT02534493|615880628|FG000|Overall Study|Lost to Follow-up|1|||
170420651|NCT02534493|615880628|FG000|Overall Study|Withdrawal by Subject|1|||
170420652|NCT01766778|615880632|FG000|Overall Study|Adverse Event|4|||
170420653|NCT01766778|615880633|FG001|Overall Study|Adverse Event|4|||
170420654|NCT01766778|615880632|FG000|Overall Study|Withdrawal by Subject|1|||
170420655|NCT01766778|615880633|FG001|Overall Study|Withdrawal by Subject|0|||
170420656|NCT02093689|615880634|FG000|Overall Study|Physician Decision|4|||
170420657|NCT02093689|615880635|FG001|Overall Study|Physician Decision|0|||
170632642|NCT01929317|616666723|FG000|Long-term Phase|Protocol Violation|1|||
170878926|NCT00886600|617567341|FG003|Double-blind Monotherapy|Adverse Event|1|||
170878927|NCT00886600|617567338|FG000|Double-blind Monotherapy|Protocol Violation|0|||
170878928|NCT00886600|617567339|FG001|Double-blind Monotherapy|Protocol Violation|0|||
170878929|NCT00886600|617567340|FG002|Double-blind Monotherapy|Protocol Violation|0|||
170878930|NCT00886600|617567341|FG003|Double-blind Monotherapy|Protocol Violation|1|||
170878931|NCT00886600|617567338|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
170878932|NCT00886600|617567339|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
170878933|NCT00886600|617567340|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
170878934|NCT00886600|617567341|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
170878935|NCT00886600|617567338|FG000|Combination Therapy Period|Adverse Event|0|||
170878936|NCT00886600|617567339|FG001|Combination Therapy Period|Adverse Event|0|||
170878937|NCT00886600|617567340|FG002|Combination Therapy Period|Adverse Event|1|||
170878938|NCT00886600|617567341|FG003|Combination Therapy Period|Adverse Event|0|||
170878939|NCT00886600|617567338|FG000|Combination Therapy Period|Protocol Violation|0|||
170878940|NCT00886600|617567339|FG001|Combination Therapy Period|Protocol Violation|0|||
170878941|NCT00886600|617567340|FG002|Combination Therapy Period|Protocol Violation|1|||
170878942|NCT00886600|617567341|FG003|Combination Therapy Period|Protocol Violation|0|||
170878943|NCT01439204|617567342|FG000|Overall Study|Withdrawal by Subject|0|||
170878944|NCT01439204|617567343|FG001|Overall Study|Withdrawal by Subject|1|||
170878945|NCT01439204|617567342|FG000|Overall Study|Lost to Follow-up|0|||
170878946|NCT01439204|617567343|FG001|Overall Study|Lost to Follow-up|2|||
170878947|NCT01439204|617567342|FG000|Overall Study|No longer meets study criteria|1|||
170878948|NCT01439204|617567343|FG001|Overall Study|No longer meets study criteria|0|||
170878949|NCT01439204|617567342|FG000|Overall Study|poor/non-compliance|3|||
170878950|NCT01439204|617567343|FG001|Overall Study|poor/non-compliance|0|||
170632643|NCT01929317|616666724|FG001|Long-term Phase|Protocol Violation|0|||
170878951|NCT02255409|617567344|FG000|Overall Study|Administrative Reason|3|||
170878952|NCT02255409|617567345|FG001|Overall Study|Administrative Reason|7|||
170420658|NCT02093689|615880636|FG002|Overall Study|Physician Decision|0|||
170420659|NCT02888171|615880642|FG000|Overall Study|Lost to Follow-up|2|||
170420660|NCT02888171|615880643|FG001|Overall Study|Lost to Follow-up|1|||
170420661|NCT02888171|615880642|FG000|Overall Study|Withdrawal by Subject|3|||
170420662|NCT02888171|615880643|FG001|Overall Study|Withdrawal by Subject|2|||
170420663|NCT02888171|615880642|FG000|Overall Study|Adverse Event|0|||
170420664|NCT02888171|615880643|FG001|Overall Study|Adverse Event|1|||
170420665|NCT04603937|615880644|FG000|Overall Study|Adverse Event|9|||
170420666|NCT04603937|615880645|FG001|Overall Study|Adverse Event|10|||
170420667|NCT04603937|615880644|FG000|Overall Study|Withdrawal by Subject|7|||
170420668|NCT04603937|615880645|FG001|Overall Study|Withdrawal by Subject|6|||
170420669|NCT04603937|615880644|FG000|Overall Study|Lost to Follow-up|5|||
170420670|NCT04603937|615880645|FG001|Overall Study|Lost to Follow-up|6|||
170420671|NCT04603937|615880644|FG000|Overall Study|Physician Decision|0|||
170420672|NCT04603937|615880645|FG001|Overall Study|Physician Decision|1|||
170420673|NCT04603937|615880644|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
170420674|NCT04603937|615880645|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
170420675|NCT01922349|615880646|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
170420676|NCT01922349|615880647|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
170420677|NCT01922349|615880648|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
170420678|NCT01922349|615880649|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
170420679|NCT05109234|615880650|FG000|Overall Study|Adverse Event|2|||
170420680|NCT05109234|615880651|FG001|Overall Study|Adverse Event|2|||
170420681|NCT05109234|615880650|FG000|Overall Study|Lack of Efficacy|5|||
170420682|NCT05109234|615880651|FG001|Overall Study|Lack of Efficacy|0|||
170420683|NCT05109234|615880650|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
170420684|NCT05109234|615880651|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
170420685|NCT05109234|615880650|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
170420686|NCT05109234|615880651|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
170420687|NCT05109234|615880650|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
170420688|NCT05109234|615880651|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
170420689|NCT05109234|615880650|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
170420690|NCT05109234|615880651|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
170420691|NCT02585258|615880652|FG000|Overall Study|Adverse Event|28|||
170420692|NCT02585258|615880653|FG001|Overall Study|Adverse Event|29|||
170420693|NCT02585258|615880652|FG000|Overall Study|Death|3|||
170420694|NCT02585258|615880653|FG001|Overall Study|Death|2|||
170420695|NCT02585258|615880652|FG000|Overall Study|Lack of Efficacy|7|||
170420696|NCT02585258|615880653|FG001|Overall Study|Lack of Efficacy|9|||
170420697|NCT02585258|615880652|FG000|Overall Study|includes covid-related access problems|42|||
170420698|NCT02585258|615880653|FG001|Overall Study|includes covid-related access problems|46|||
170420699|NCT02585258|615880652|FG000|Overall Study|Lost to Follow-up|5|||
170878953|NCT02255409|617567344|FG000|Overall Study|Withdrawal by Subject|1|||
170878954|NCT02255409|617567345|FG001|Overall Study|Withdrawal by Subject|5|||
170878955|NCT02255409|617567344|FG000|Overall Study|Lost to Follow-up|10|||
170878956|NCT02255409|617567345|FG001|Overall Study|Lost to Follow-up|19|||
170878957|NCT03917823|617567347|FG000|Overall Study|Lost to Follow-up|1|||
170878958|NCT03917823|617567348|FG001|Overall Study|Lost to Follow-up|1|||
170878959|NCT03917823|617567347|FG000|Overall Study|Withdrawal by Subject|0|||
170878960|NCT03917823|617567348|FG001|Overall Study|Withdrawal by Subject|1|||
170878961|NCT00473343|617567349|FG000|Overall Study|Adverse Event|9|||
170878962|NCT00473343|617567349|FG000|Overall Study|Lost to Follow-up|8|||
170878963|NCT00473343|617567349|FG000|Overall Study|Treatment failure|27|||
170878964|NCT00473343|617567349|FG000|Overall Study|Withdrew consent|3|||
170878965|NCT00473343|617567349|FG000|Overall Study|Other un-specified reason|3|||
170878966|NCT02290873|617567350|FG000|Overall Study|Withdrawal by Subject|0|||
170878967|NCT02290873|617567351|FG001|Overall Study|Withdrawal by Subject|1|||
170878968|NCT02290873|617567352|FG002|Overall Study|Withdrawal by Subject|1|||
170878969|NCT02290873|617567350|FG000|Overall Study|Nellcor device error|1|||
170878970|NCT02290873|617567351|FG001|Overall Study|Nellcor device error|0|||
170878971|NCT02290873|617567352|FG002|Overall Study|Nellcor device error|0|||
170878972|NCT02290873|617567350|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
170878973|NCT02290873|617567351|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
170878974|NCT02290873|617567352|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
170878975|NCT02290873|617567350|FG000|Overall Study|Protocol Violation|0|||
170878976|NCT02290873|617567351|FG001|Overall Study|Protocol Violation|0|||
170632644|NCT01929317|616666723|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
170878977|NCT02290873|617567352|FG002|Overall Study|Protocol Violation|1|||
170878978|NCT01519765|617567353|FG000|Overall Study|Adverse Event|0|||
170878979|NCT01519765|617567354|FG001|Overall Study|Adverse Event|1|||
170878980|NCT01519765|617567353|FG000|Overall Study|Lack of Efficacy|2|||
170420700|NCT02585258|615880653|FG001|Overall Study|Lost to Follow-up|2|||
170420701|NCT01451762|615882314|FG000|Overall Study|Lost to Follow-up|3|||
170420702|NCT01451762|615882315|FG001|Overall Study|Lost to Follow-up|6|||
170878981|NCT01519765|617567354|FG001|Overall Study|Lack of Efficacy|0|||
170531871|NCT03533751|616293383|FG004|Overall Study|Other|3|||
170531872|NCT06070610|616293386|FG000|Washout period|Adverse Event|1|||
170531873|NCT06070610|616293386|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
170531874|NCT01499810|616293387|FG000|Overall Study|Lost to Follow-up|10|||
170531875|NCT01499810|616293387|FG000|Overall Study|Protocol Violation|1|||
170531876|NCT01499810|616293387|FG000|Overall Study|Withdrawal by Subject|1|||
170531877|NCT00834041|616293388|FG000|Overall Study|Withdrawal by Subject|1|||
170531878|NCT00834041|616293389|FG001|Overall Study|Withdrawal by Subject|0|||
170531879|NCT00834041|616293388|FG000|Overall Study|Lost to Follow-up|0|||
170531880|NCT00834041|616293389|FG001|Overall Study|Lost to Follow-up|1|||
170531881|NCT00666237|616293392|FG000|Overall Study|Death|5|||
170531882|NCT00666237|616293393|FG001|Overall Study|Death|5|||
170531883|NCT00666237|616293392|FG000|Overall Study|Lost to Follow-up|29|||
170531884|NCT00666237|616293393|FG001|Overall Study|Lost to Follow-up|25|||
170531885|NCT02839707|616293396|FG000|Phase I|Not eligible for analysis|9|||
170531886|NCT02839707|616293397|FG001|Phase I|Not eligible for analysis|0|||
170531887|NCT02839707|616293398|FG002|Phase I|Not eligible for analysis|0|||
170531888|NCT02839707|616293396|FG000|Phase II|Not treated according to protocol|4|||
170531889|NCT02839707|616293397|FG001|Phase II|Not treated according to protocol|0|||
170531890|NCT02839707|616293398|FG002|Phase II|Not treated according to protocol|2|||
170531891|NCT02839707|616293396|FG000|Phase III|Not treated according to protocol|0|||
170531892|NCT02839707|616293397|FG001|Phase III|Not treated according to protocol|0|||
170531893|NCT02839707|616293398|FG002|Phase III|Not treated according to protocol|4|||
170531894|NCT03729362|616295291|FG000|Overall Study|Withdrawal by Subject|2|||
170531895|NCT03729362|616295292|FG001|Overall Study|Withdrawal by Subject|0|||
170531896|NCT03729362|616295291|FG000|Overall Study|Physician Decision|1|||
170878982|NCT01519765|617567353|FG000|Overall Study|Protocol Violation|1|||
170420703|NCT01451762|615882316|FG002|Overall Study|Lost to Follow-up|6|||
170420704|NCT00977106|615882327|FG000|Overall Study|Adverse Event|5|||
170420705|NCT00977106|615882328|FG001|Overall Study|Adverse Event|6|||
170420706|NCT00977106|615882327|FG000|Overall Study|Withdrawal by Subject|2|||
170420707|NCT00977106|615882328|FG001|Overall Study|Withdrawal by Subject|2|||
170420708|NCT00977106|615882327|FG000|Overall Study|Lack of Efficacy|2|||
170420709|NCT00977106|615882328|FG001|Overall Study|Lack of Efficacy|2|||
170420710|NCT00977106|615882327|FG000|Overall Study|Protocol Violation|0|||
170420711|NCT00977106|615882328|FG001|Overall Study|Protocol Violation|1|||
170420712|NCT00977106|615882327|FG000|Overall Study|Other|1|||
170420713|NCT00977106|615882328|FG001|Overall Study|Other|0|||
170420714|NCT01717976|615882339|FG000|Overall Study|Protocol Violation|0|||
170420715|NCT01717976|615882340|FG001|Overall Study|Protocol Violation|1|||
170420716|NCT04015232|615882342|FG000|Overall Study|Withdrawal by Subject|7|||
170420717|NCT04015232|615882343|FG001|Overall Study|Withdrawal by Subject|4|||
170420718|NCT04015232|615882342|FG000|Overall Study|Protocol Violation|1|||
170420719|NCT04015232|615882343|FG001|Overall Study|Protocol Violation|0|||
170420720|NCT04015232|615882342|FG000|Overall Study|Medical Grounds|3|||
170420721|NCT04015232|615882343|FG001|Overall Study|Medical Grounds|3|||
170420722|NCT01996033|615882344|FG000|Overall Study|Death|1|||
170420723|NCT01996033|615882344|FG000|Overall Study|Physician Decision|1|||
170420724|NCT01996033|615882344|FG000|Overall Study|Withdrawal by Subject|4|||
170420725|NCT01996033|615882344|FG000|Overall Study|Lost to Follow-up|3|||
170420726|NCT03227445|615882345|FG000|Period 1 (28 Days)|Adverse Event|1|||
170420727|NCT03227445|615882346|FG001|Period 1 (28 Days)|Adverse Event|2|||
170420728|NCT03227445|615882347|FG002|Period 1 (28 Days)|Adverse Event|0|||
170420729|NCT03227445|615882348|FG003|Period 1 (28 Days)|Adverse Event|1|||
170420730|NCT03227445|615882345|FG000|Period 1 (28 Days)|Protocol Violation|1|||
170420731|NCT03227445|615882346|FG001|Period 1 (28 Days)|Protocol Violation|0|||
170420732|NCT03227445|615882347|FG002|Period 1 (28 Days)|Protocol Violation|0|||
170420733|NCT03227445|615882348|FG003|Period 1 (28 Days)|Protocol Violation|0|||
170420734|NCT03227445|615882345|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
170878983|NCT01519765|617567354|FG001|Overall Study|Protocol Violation|0|||
170878984|NCT01519765|617567353|FG000|Overall Study|Withdrawal by Subject|0|||
170878985|NCT01519765|617567354|FG001|Overall Study|Withdrawal by Subject|1|||
170878986|NCT04126083|617567355|FG000|Overall Study|Withdrawal by Subject|1|||
170420735|NCT03227445|615882346|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
170420736|NCT03227445|615882347|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
170420737|NCT03227445|615882348|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
170420738|NCT03227445|615882345|FG000|Period 2 (28 Days)|Adverse Event|1|||
170420739|NCT03227445|615882346|FG001|Period 2 (28 Days)|Adverse Event|0|||
170420740|NCT03227445|615882347|FG002|Period 2 (28 Days)|Adverse Event|2|||
170420741|NCT03227445|615882348|FG003|Period 2 (28 Days)|Adverse Event|1|||
170420742|NCT03227445|615882345|FG000|Period 2 (28 Days)|Protocol Violation|0|||
170420743|NCT03227445|615882346|FG001|Period 2 (28 Days)|Protocol Violation|0|||
170531897|NCT03729362|616295292|FG001|Overall Study|Physician Decision|0|||
170531898|NCT03729362|616295291|FG000|Overall Study|COVID-19 Pandemic|1|||
170531899|NCT03729362|616295292|FG001|Overall Study|COVID-19 Pandemic|0|||
170531900|NCT03729362|616295291|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
170531901|NCT03729362|616295292|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
170878987|NCT05513625|617567359|FG000|Overall Study|Withdrawal by Subject|1|||
170420744|NCT03227445|615882347|FG002|Period 2 (28 Days)|Protocol Violation|0|||
170420745|NCT03227445|615882348|FG003|Period 2 (28 Days)|Protocol Violation|1|||
170420746|NCT03227445|615882345|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
170632645|NCT01929317|616666724|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
170632646|NCT01929317|616666723|FG000|Long-term Phase|Study Closed/Terminated|5|||
170420747|NCT03227445|615882346|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
170531902|NCT03729362|616295291|FG000|Overall Study|Adverse Event|0|||
170531903|NCT03729362|616295292|FG001|Overall Study|Adverse Event|1|||
170531904|NCT03729362|616295291|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
170531905|NCT03729362|616295292|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
170531906|NCT03405870|616295293|FG000|Overall Study|Withdrawal|1|||
170531907|NCT03405870|616295294|FG001|Overall Study|Withdrawal|0|||
170531908|NCT03405870|616295295|FG002|Overall Study|Withdrawal|1|||
170531909|NCT03405870|616295296|FG003|Overall Study|Withdrawal|0|||
170531910|NCT03405870|616295297|FG004|Overall Study|Withdrawal|0|||
170531911|NCT03405870|616295298|FG005|Overall Study|Withdrawal|0|||
170531912|NCT03405870|616295299|FG006|Overall Study|Withdrawal|1|||
170531913|NCT03405870|616295300|FG007|Overall Study|Withdrawal|0|||
170531914|NCT00042289|616295303|FG000|Overall Study|Lost to Follow-up|3|||
170531915|NCT00042289|616295304|FG001|Overall Study|Lost to Follow-up|0|||
170531916|NCT00042289|616295305|FG002|Overall Study|Lost to Follow-up|0|||
170531917|NCT00042289|616295306|FG003|Overall Study|Lost to Follow-up|1|||
170531918|NCT00042289|616295307|FG004|Overall Study|Lost to Follow-up|3|||
170531919|NCT00042289|616295308|FG005|Overall Study|Lost to Follow-up|3|||
170531920|NCT00042289|616295309|FG006|Overall Study|Lost to Follow-up|6|||
170531921|NCT00042289|616295310|FG007|Overall Study|Lost to Follow-up|1|||
170531922|NCT00042289|616295311|FG008|Overall Study|Lost to Follow-up|1|||
170531923|NCT00042289|616295312|FG009|Overall Study|Lost to Follow-up|0|||
170531924|NCT00042289|616295313|FG010|Overall Study|Lost to Follow-up|0|||
170531925|NCT00042289|616295314|FG011|Overall Study|Lost to Follow-up|0|||
170531926|NCT00042289|616295315|FG012|Overall Study|Lost to Follow-up|0|||
170531927|NCT00042289|616295316|FG013|Overall Study|Lost to Follow-up|0|||
170531928|NCT00042289|616295317|FG014|Overall Study|Lost to Follow-up|0|||
170531929|NCT00042289|616295318|FG015|Overall Study|Lost to Follow-up|1|||
170531930|NCT00042289|616295319|FG016|Overall Study|Lost to Follow-up|1|||
170531931|NCT00042289|616295320|FG017|Overall Study|Lost to Follow-up|0|||
170531932|NCT00042289|616295321|FG018|Overall Study|Lost to Follow-up|3|||
170531933|NCT00042289|616295322|FG019|Overall Study|Lost to Follow-up|2|||
170531934|NCT00042289|616295323|FG020|Overall Study|Lost to Follow-up|0|||
170531935|NCT00042289|616295324|FG021|Overall Study|Lost to Follow-up|0|||
170531936|NCT00042289|616295325|FG022|Overall Study|Lost to Follow-up|0|||
170531937|NCT00042289|616295326|FG023|Overall Study|Lost to Follow-up|0|||
170531938|NCT00042289|616295327|FG024|Overall Study|Lost to Follow-up|0|||
170531939|NCT00042289|616295328|FG025|Overall Study|Lost to Follow-up|0|||
170531940|NCT00042289|616295329|FG026|Overall Study|Lost to Follow-up|2|||
170531941|NCT00042289|616295330|FG027|Overall Study|Lost to Follow-up|2|||
170531942|NCT00042289|616295331|FG028|Overall Study|Lost to Follow-up|2|||
170531943|NCT00042289|616295332|FG029|Overall Study|Lost to Follow-up|0|||
170531944|NCT00042289|616295333|FG030|Overall Study|Lost to Follow-up|0|||
170531945|NCT00042289|616295334|FG031|Overall Study|Lost to Follow-up|2|||
170531946|NCT00042289|616295335|FG032|Overall Study|Lost to Follow-up|1|||
170531947|NCT00042289|616295336|FG033|Overall Study|Lost to Follow-up|1|||
170531948|NCT00042289|616295337|FG034|Overall Study|Lost to Follow-up|1|||
170531949|NCT00042289|616295338|FG035|Overall Study|Lost to Follow-up|2|||
170531950|NCT00042289|616295339|FG036|Overall Study|Lost to Follow-up|1|||
170531951|NCT00042289|616295340|FG037|Overall Study|Lost to Follow-up|1|||
170531952|NCT00042289|616295341|FG038|Overall Study|Lost to Follow-up|0|||
170531953|NCT00042289|616295342|FG039|Overall Study|Lost to Follow-up|5|||
170531954|NCT00042289|616295343|FG040|Overall Study|Lost to Follow-up|0|||
170531955|NCT00042289|616295344|FG041|Overall Study|Lost to Follow-up|2|||
170531956|NCT00042289|616295345|FG042|Overall Study|Lost to Follow-up|2|||
170531957|NCT00042289|616295346|FG043|Overall Study|Lost to Follow-up|0|||
170531958|NCT00042289|616295347|FG044|Overall Study|Lost to Follow-up|0|||
170531959|NCT00042289|616295348|FG045|Overall Study|Lost to Follow-up|1|||
170531960|NCT00042289|616295349|FG046|Overall Study|Lost to Follow-up|0|||
170531961|NCT00042289|616295303|FG000|Overall Study|Other reason|0|||
170531962|NCT00042289|616295304|FG001|Overall Study|Other reason|0|||
170531963|NCT00042289|616295305|FG002|Overall Study|Other reason|0|||
170531964|NCT00042289|616295306|FG003|Overall Study|Other reason|2|||
170531965|NCT00042289|616295307|FG004|Overall Study|Other reason|0|||
170531966|NCT00042289|616295308|FG005|Overall Study|Other reason|0|||
170531967|NCT00042289|616295309|FG006|Overall Study|Other reason|0|||
170531968|NCT00042289|616295310|FG007|Overall Study|Other reason|0|||
170531969|NCT00042289|616295311|FG008|Overall Study|Other reason|0|||
170632647|NCT01929317|616666724|FG001|Long-term Phase|Study Closed/Terminated|3|||
170531970|NCT00042289|616295312|FG009|Overall Study|Other reason|0|||
170531971|NCT00042289|616295313|FG010|Overall Study|Other reason|0|||
170531972|NCT00042289|616295314|FG011|Overall Study|Other reason|0|||
170531973|NCT00042289|616295315|FG012|Overall Study|Other reason|0|||
170531974|NCT00042289|616295316|FG013|Overall Study|Other reason|0|||
170531975|NCT00042289|616295317|FG014|Overall Study|Other reason|0|||
170531976|NCT00042289|616295318|FG015|Overall Study|Other reason|0|||
170531977|NCT00042289|616295319|FG016|Overall Study|Other reason|0|||
170531978|NCT00042289|616295320|FG017|Overall Study|Other reason|0|||
170531979|NCT00042289|616295321|FG018|Overall Study|Other reason|1|||
170531980|NCT00042289|616295322|FG019|Overall Study|Other reason|0|||
170531981|NCT00042289|616295323|FG020|Overall Study|Other reason|0|||
170531982|NCT00042289|616295324|FG021|Overall Study|Other reason|0|||
170531983|NCT00042289|616295325|FG022|Overall Study|Other reason|0|||
170531984|NCT00042289|616295326|FG023|Overall Study|Other reason|1|||
170531985|NCT00042289|616295327|FG024|Overall Study|Other reason|0|||
170531986|NCT00042289|616295328|FG025|Overall Study|Other reason|0|||
170531987|NCT00042289|616295329|FG026|Overall Study|Other reason|1|||
170531988|NCT00042289|616295330|FG027|Overall Study|Other reason|0|||
170531989|NCT00042289|616295331|FG028|Overall Study|Other reason|3|||
170531990|NCT00042289|616295332|FG029|Overall Study|Other reason|0|||
170531991|NCT00042289|616295333|FG030|Overall Study|Other reason|0|||
170531992|NCT00042289|616295334|FG031|Overall Study|Other reason|1|||
170531993|NCT00042289|616295335|FG032|Overall Study|Other reason|0|||
170531994|NCT00042289|616295336|FG033|Overall Study|Other reason|1|||
170531995|NCT00042289|616295337|FG034|Overall Study|Other reason|0|||
170531996|NCT00042289|616295338|FG035|Overall Study|Other reason|2|||
170531997|NCT00042289|616295339|FG036|Overall Study|Other reason|0|||
170531998|NCT00042289|616295340|FG037|Overall Study|Other reason|0|||
170531999|NCT00042289|616295341|FG038|Overall Study|Other reason|0|||
170532000|NCT00042289|616295342|FG039|Overall Study|Other reason|0|||
170532001|NCT00042289|616295343|FG040|Overall Study|Other reason|0|||
170532002|NCT00042289|616295344|FG041|Overall Study|Other reason|0|||
170532003|NCT00042289|616295345|FG042|Overall Study|Other reason|0|||
170532004|NCT00042289|616295346|FG043|Overall Study|Other reason|1|||
170532005|NCT00042289|616295347|FG044|Overall Study|Other reason|0|||
170532006|NCT00042289|616295348|FG045|Overall Study|Other reason|0|||
170532007|NCT00042289|616295349|FG046|Overall Study|Other reason|0|||
170532008|NCT00042289|616295303|FG000|Overall Study|Severe debilitation, unable to continue|0|||
170532009|NCT00042289|616295304|FG001|Overall Study|Severe debilitation, unable to continue|0|||
170532010|NCT00042289|616295305|FG002|Overall Study|Severe debilitation, unable to continue|0|||
170532011|NCT00042289|616295306|FG003|Overall Study|Severe debilitation, unable to continue|0|||
170532012|NCT00042289|616295307|FG004|Overall Study|Severe debilitation, unable to continue|0|||
170532013|NCT00042289|616295308|FG005|Overall Study|Severe debilitation, unable to continue|0|||
170532014|NCT00042289|616295309|FG006|Overall Study|Severe debilitation, unable to continue|0|||
170532015|NCT00042289|616295310|FG007|Overall Study|Severe debilitation, unable to continue|0|||
170532016|NCT00042289|616295311|FG008|Overall Study|Severe debilitation, unable to continue|0|||
170532017|NCT00042289|616295312|FG009|Overall Study|Severe debilitation, unable to continue|0|||
170532018|NCT00042289|616295313|FG010|Overall Study|Severe debilitation, unable to continue|0|||
170420748|NCT03227445|615882347|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
170420749|NCT03227445|615882348|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
170420750|NCT00365300|615882349|FG000|Open-label Phase|Adverse Event|4|||
170420751|NCT00365300|615882350|FG001|Open-label Phase|Adverse Event|0|||
170420752|NCT00365300|615882349|FG000|Open-label Phase|Failed to Return|1|||
170420753|NCT00365300|615882350|FG001|Open-label Phase|Failed to Return|0|||
170420754|NCT00365300|615882349|FG000|Open-label Phase|Physician Decision|1|||
170420755|NCT00365300|615882350|FG001|Open-label Phase|Physician Decision|0|||
170420756|NCT00365300|615882349|FG000|Open-label Phase|Noncompliance|9|||
170420757|NCT00365300|615882350|FG001|Open-label Phase|Noncompliance|0|||
170420758|NCT00365300|615882349|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
170420759|NCT00365300|615882350|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
170420760|NCT00365300|615882349|FG000|Open-label Phase|Protocol Violation|1|||
170420761|NCT00365300|615882350|FG001|Open-label Phase|Protocol Violation|0|||
170420762|NCT00365300|615882349|FG000|Open-label Phase|Lack of Efficacy|1|||
170420763|NCT00365300|615882350|FG001|Open-label Phase|Lack of Efficacy|0|||
170420764|NCT00365300|615882349|FG000|Open-label Phase|Patient skipped open label phase|1|||
170420765|NCT00365300|615882350|FG001|Open-label Phase|Patient skipped open label phase|0|||
170420766|NCT00365300|615882349|FG000|Double-blind Phase|Failed to return|1|||
170420767|NCT00365300|615882350|FG001|Double-blind Phase|Failed to return|0|||
170420768|NCT00365300|615882349|FG000|Double-blind Phase|Noncompliance|1|||
170420769|NCT00365300|615882350|FG001|Double-blind Phase|Noncompliance|1|||
170420770|NCT00365300|615882349|FG000|Double-blind Phase|Withdrawal by Subject|0|||
170532019|NCT00042289|616295314|FG011|Overall Study|Severe debilitation, unable to continue|0|||
170532020|NCT00042289|616295315|FG012|Overall Study|Severe debilitation, unable to continue|0|||
170532021|NCT00042289|616295316|FG013|Overall Study|Severe debilitation, unable to continue|0|||
170532022|NCT00042289|616295317|FG014|Overall Study|Severe debilitation, unable to continue|0|||
170532023|NCT00042289|616295318|FG015|Overall Study|Severe debilitation, unable to continue|0|||
170420771|NCT00365300|615882350|FG001|Double-blind Phase|Withdrawal by Subject|1|||
170420772|NCT00365300|615882349|FG000|Double-blind Phase|Protocol Violation|3|||
170420773|NCT00365300|615882350|FG001|Double-blind Phase|Protocol Violation|1|||
170420774|NCT00365300|615882349|FG000|Double-blind Phase|Lack of Efficacy|6|||
170420775|NCT00365300|615882350|FG001|Double-blind Phase|Lack of Efficacy|6|||
170420776|NCT02143102|615882353|FG000|Overall Study|Lost to Follow-up|11|||
170532024|NCT00042289|616295319|FG016|Overall Study|Severe debilitation, unable to continue|0|||
170532025|NCT00042289|616295320|FG017|Overall Study|Severe debilitation, unable to continue|0|||
170532026|NCT00042289|616295321|FG018|Overall Study|Severe debilitation, unable to continue|0|||
170532027|NCT00042289|616295322|FG019|Overall Study|Severe debilitation, unable to continue|0|||
170532028|NCT00042289|616295323|FG020|Overall Study|Severe debilitation, unable to continue|0|||
170532029|NCT00042289|616295324|FG021|Overall Study|Severe debilitation, unable to continue|1|||
170532030|NCT00042289|616295325|FG022|Overall Study|Severe debilitation, unable to continue|0|||
170532031|NCT00042289|616295326|FG023|Overall Study|Severe debilitation, unable to continue|1|||
170532032|NCT00042289|616295327|FG024|Overall Study|Severe debilitation, unable to continue|0|||
170532033|NCT00042289|616295328|FG025|Overall Study|Severe debilitation, unable to continue|0|||
170532034|NCT00042289|616295329|FG026|Overall Study|Severe debilitation, unable to continue|0|||
170532035|NCT00042289|616295330|FG027|Overall Study|Severe debilitation, unable to continue|1|||
170532036|NCT00042289|616295331|FG028|Overall Study|Severe debilitation, unable to continue|0|||
170532037|NCT00042289|616295332|FG029|Overall Study|Severe debilitation, unable to continue|0|||
170420777|NCT02143102|615882354|FG001|Overall Study|Lost to Follow-up|0|||
170420778|NCT00051025|615882358|FG000|Overall Study|Progressive Disease|1|||
170420779|NCT00051025|615882359|FG001|Overall Study|Progressive Disease|1|||
170420780|NCT00051025|615882358|FG000|Overall Study|Adverse Event|1|||
170420781|NCT00051025|615882359|FG001|Overall Study|Adverse Event|1|||
170420782|NCT00051025|615882358|FG000|Overall Study|Withdrawal by Subject|0|||
170420783|NCT00051025|615882359|FG001|Overall Study|Withdrawal by Subject|1|||
170420784|NCT00051025|615882358|FG000|Overall Study|Death|0|||
170420785|NCT00051025|615882359|FG001|Overall Study|Death|1|||
170420786|NCT00324168|615882360|FG000|Overall Study|Lost to Follow-up|19|||
170420787|NCT00324168|615882361|FG001|Overall Study|Lost to Follow-up|18|||
170420788|NCT00324168|615882360|FG000|Overall Study|Death|3|||
170420789|NCT00324168|615882361|FG001|Overall Study|Death|3|||
170420790|NCT00324168|615882360|FG000|Overall Study|Patient did not visit in f/u window|6|||
170420791|NCT00324168|615882361|FG001|Overall Study|Patient did not visit in f/u window|9|||
170420792|NCT01203878|615882362|FG000|Overall Study|Withdrawal by Subject|0|||
170420793|NCT01203878|615882363|FG001|Overall Study|Withdrawal by Subject|0|||
170420794|NCT01203878|615882364|FG002|Overall Study|Withdrawal by Subject|1|||
170420795|NCT01203878|615882362|FG000|Overall Study|Adverse Event|0|||
170420796|NCT01203878|615882363|FG001|Overall Study|Adverse Event|0|||
170420797|NCT01203878|615882364|FG002|Overall Study|Adverse Event|2|||
170420798|NCT02189941|615882365|FG000|Overall Study|Non-compliance|0|||
170420799|NCT02189941|615882366|FG001|Overall Study|Non-compliance|0|||
170420800|NCT02189941|615882367|FG002|Overall Study|Non-compliance|1|||
170420801|NCT01682083|615882369|FG000|Overall Study|Lost to Follow-up|11|||
170420802|NCT01682083|615882370|FG001|Overall Study|Lost to Follow-up|18|||
170420803|NCT01682083|615882369|FG000|Overall Study|Withdrawal by Subject|31|||
170420804|NCT01682083|615882370|FG001|Overall Study|Withdrawal by Subject|40|||
170420805|NCT01682083|615882369|FG000|Overall Study|Death|60|||
170420806|NCT01682083|615882370|FG001|Overall Study|Death|93|||
170420807|NCT01682083|615882369|FG000|Overall Study|Physician Decision|5|||
170420808|NCT01682083|615882370|FG001|Overall Study|Physician Decision|4|||
170420809|NCT02932878|615882372|FG000|Overall Study|Due to Lab Results|2|||
170420810|NCT02932878|615882373|FG001|Overall Study|Due to Lab Results|1|||
170532038|NCT00042289|616295333|FG030|Overall Study|Severe debilitation, unable to continue|0|||
170532039|NCT00042289|616295334|FG031|Overall Study|Severe debilitation, unable to continue|1|||
170532040|NCT00042289|616295335|FG032|Overall Study|Severe debilitation, unable to continue|1|||
170420811|NCT01918397|615882374|FG000|Overall Study|Never started treatment|2|||
170420812|NCT01918397|615882375|FG001|Overall Study|Never started treatment|1|||
170420813|NCT01918397|615882376|FG002|Overall Study|Never started treatment|0|||
170420814|NCT01918397|615882377|FG003|Overall Study|Never started treatment|0|||
170420815|NCT01918397|615882374|FG000|Overall Study|Adverse Event|1|||
170420816|NCT01918397|615882375|FG001|Overall Study|Adverse Event|1|||
170420817|NCT01918397|615882376|FG002|Overall Study|Adverse Event|1|||
170420818|NCT01918397|615882377|FG003|Overall Study|Adverse Event|0|||
170420819|NCT01918397|615882374|FG000|Overall Study|Lack of compliance|2|||
170420820|NCT01918397|615882375|FG001|Overall Study|Lack of compliance|2|||
170420821|NCT01918397|615882376|FG002|Overall Study|Lack of compliance|3|||
170420822|NCT01918397|615882377|FG003|Overall Study|Lack of compliance|0|||
170420823|NCT01918397|615882374|FG000|Overall Study|Pregnancy|0|||
170420824|NCT01918397|615882375|FG001|Overall Study|Pregnancy|1|||
170420825|NCT01918397|615882376|FG002|Overall Study|Pregnancy|0|||
170420826|NCT01918397|615882377|FG003|Overall Study|Pregnancy|0|||
170420827|NCT01918397|615882374|FG000|Overall Study|Rifampin susceptible|0|||
170420828|NCT01918397|615882375|FG001|Overall Study|Rifampin susceptible|0|||
170420829|NCT01918397|615882376|FG002|Overall Study|Rifampin susceptible|0|||
170420830|NCT01918397|615882377|FG003|Overall Study|Rifampin susceptible|2|||
170420831|NCT01918397|615882374|FG000|Overall Study|Treatment failure|0|||
170420832|NCT01918397|615882375|FG001|Overall Study|Treatment failure|0|||
170420833|NCT01918397|615882376|FG002|Overall Study|Treatment failure|0|||
170420834|NCT01918397|615882377|FG003|Overall Study|Treatment failure|1|||
170420835|NCT01918397|615882374|FG000|Overall Study|Withdrawal by Subject|3|||
170420836|NCT01918397|615882375|FG001|Overall Study|Withdrawal by Subject|2|||
170420837|NCT01918397|615882376|FG002|Overall Study|Withdrawal by Subject|1|||
170420838|NCT01918397|615882377|FG003|Overall Study|Withdrawal by Subject|1|||
170420839|NCT01918397|615882374|FG000|Overall Study|XDR at baseline|0|||
170420840|NCT01918397|615882375|FG001|Overall Study|XDR at baseline|0|||
170420841|NCT01918397|615882376|FG002|Overall Study|XDR at baseline|1|||
170420842|NCT01918397|615882377|FG003|Overall Study|XDR at baseline|0|||
170420843|NCT01918397|615882374|FG000|Overall Study|Lost to Follow-up|2|||
170420844|NCT01918397|615882375|FG001|Overall Study|Lost to Follow-up|1|||
170420845|NCT01918397|615882376|FG002|Overall Study|Lost to Follow-up|1|||
170420846|NCT01918397|615882377|FG003|Overall Study|Lost to Follow-up|1|||
170420847|NCT01918397|615882374|FG000|Overall Study|Increased QTc|1|||
170420848|NCT01918397|615882375|FG001|Overall Study|Increased QTc|0|||
170420849|NCT01918397|615882376|FG002|Overall Study|Increased QTc|0|||
170420850|NCT01918397|615882377|FG003|Overall Study|Increased QTc|1|||
170420851|NCT01918397|615882374|FG000|Overall Study|Death|0|||
170420852|NCT01918397|615882375|FG001|Overall Study|Death|0|||
170420853|NCT01918397|615882376|FG002|Overall Study|Death|1|||
170420854|NCT01918397|615882377|FG003|Overall Study|Death|0|||
170420855|NCT01918397|615882374|FG000|Overall Study|Involved in another investigative trial|0|||
170420856|NCT01918397|615882375|FG001|Overall Study|Involved in another investigative trial|0|||
170420857|NCT01918397|615882376|FG002|Overall Study|Involved in another investigative trial|0|||
170420858|NCT01918397|615882377|FG003|Overall Study|Involved in another investigative trial|1|||
170420859|NCT02152566|615882382|FG000|Overall Study|Lost to Follow-up|1|||
170420860|NCT02152566|615882382|FG000|Overall Study|Withdrawal by Subject|2|||
170420861|NCT00496964|615882383|FG000|Overall Study|Withdrawal by Subject|0|||
170420862|NCT00496964|615882384|FG001|Overall Study|Withdrawal by Subject|1|||
170420863|NCT02942264|615882385|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
170420864|NCT02942264|615882386|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
170420865|NCT02942264|615882387|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
170420866|NCT02942264|615882388|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
170420867|NCT02942264|615882389|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
170420868|NCT02942264|615882390|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
170420869|NCT02942264|615882391|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
170420870|NCT02942264|615882392|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
170420871|NCT02942264|615882393|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
170420872|NCT02942264|615882385|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
170420873|NCT02942264|615882386|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
170420874|NCT02942264|615882387|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
170420875|NCT02942264|615882388|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
170420876|NCT02942264|615882389|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
170420877|NCT02942264|615882390|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
170420878|NCT02942264|615882391|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
170420879|NCT02942264|615882392|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
170420880|NCT02942264|615882393|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
170420881|NCT01328093|615882394|FG000|Double-Blind Phase|Adverse Event|78|||
170420882|NCT01328093|615882395|FG001|Double-Blind Phase|Adverse Event|15|||
170420883|NCT01328093|615882394|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
170420884|NCT01328093|615882395|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
170420885|NCT01328093|615882394|FG000|Double-Blind Phase|Lost to Follow-up|39|||
170420886|NCT01328093|615882395|FG001|Double-Blind Phase|Lost to Follow-up|14|||
170420887|NCT01328093|615882394|FG000|Double-Blind Phase|Protocol Violation|30|||
170420888|NCT01328093|615882395|FG001|Double-Blind Phase|Protocol Violation|10|||
170420889|NCT01328093|615882394|FG000|Double-Blind Phase|Lack of Efficacy|55|||
170420890|NCT01328093|615882395|FG001|Double-Blind Phase|Lack of Efficacy|13|||
170420891|NCT01328093|615882394|FG000|Double-Blind Phase|Sponsor Decision|17|||
170420892|NCT01328093|615882395|FG001|Double-Blind Phase|Sponsor Decision|3|||
170420893|NCT01328093|615882394|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
170420894|NCT01328093|615882395|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
170420895|NCT01328093|615882394|FG000|Double-Blind Phase|Scheduling conflict|8|||
170420896|NCT01328093|615882395|FG001|Double-Blind Phase|Scheduling conflict|3|||
170420897|NCT01328093|615882394|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
170420898|NCT01328093|615882395|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
170420899|NCT01328093|615882394|FG000|Double-Blind Phase|Death|1|||
170420900|NCT01328093|615882395|FG001|Double-Blind Phase|Death|0|||
170420901|NCT01328093|615882394|FG000|Open-Label Phase|Sponsor Decision|98|||
170420902|NCT01328093|615882395|FG001|Open-Label Phase|Sponsor Decision|34|||
170420903|NCT01328093|615882394|FG000|Open-Label Phase|Protocol Violation|8|||
170420904|NCT01328093|615882395|FG001|Open-Label Phase|Protocol Violation|3|||
170420905|NCT01328093|615882394|FG000|Open-Label Phase|Lost to Follow-up|10|||
170420906|NCT01328093|615882395|FG001|Open-Label Phase|Lost to Follow-up|1|||
170420907|NCT01328093|615882394|FG000|Open-Label Phase|Adverse Event|10|||
170420908|NCT01328093|615882395|FG001|Open-Label Phase|Adverse Event|4|||
170420909|NCT01328093|615882394|FG000|Open-Label Phase|Lack of Efficacy|5|||
170420910|NCT01328093|615882395|FG001|Open-Label Phase|Lack of Efficacy|6|||
170420911|NCT01328093|615882394|FG000|Open-Label Phase|Withdrawal by Subject|4|||
170420912|NCT01328093|615882395|FG001|Open-Label Phase|Withdrawal by Subject|1|||
170420913|NCT01328093|615882394|FG000|Open-Label Phase|Scheduling conflict|2|||
170420914|NCT01328093|615882395|FG001|Open-Label Phase|Scheduling conflict|1|||
170420915|NCT01328093|615882394|FG000|Open-Label Phase|Subject is moving or has moved|2|||
170420916|NCT01328093|615882395|FG001|Open-Label Phase|Subject is moving or has moved|0|||
170420917|NCT01328093|615882394|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
170420918|NCT01328093|615882395|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
170420919|NCT03980483|615882398|FG000|Overall Study|Adverse Event|13|||
170420920|NCT03980483|615882399|FG001|Overall Study|Adverse Event|29|||
170420921|NCT03980483|615882400|FG002|Overall Study|Adverse Event|11|||
170420922|NCT03980483|615882401|FG003|Overall Study|Adverse Event|2|||
170420923|NCT03980483|615882402|FG004|Overall Study|Adverse Event|2|||
170420924|NCT03980483|615882403|FG005|Overall Study|Adverse Event|2|||
170420925|NCT03980483|615882398|FG000|Overall Study|Lack of Efficacy|7|||
170420926|NCT03980483|615882399|FG001|Overall Study|Lack of Efficacy|6|||
170420927|NCT03980483|615882400|FG002|Overall Study|Lack of Efficacy|0|||
170420928|NCT03980483|615882401|FG003|Overall Study|Lack of Efficacy|3|||
170420929|NCT03980483|615882402|FG004|Overall Study|Lack of Efficacy|1|||
170420930|NCT03980483|615882403|FG005|Overall Study|Lack of Efficacy|1|||
170420931|NCT03980483|615882398|FG000|Overall Study|Lost to Follow-up|2|||
170420932|NCT03980483|615882399|FG001|Overall Study|Lost to Follow-up|4|||
170420933|NCT03980483|615882400|FG002|Overall Study|Lost to Follow-up|2|||
170420934|NCT03980483|615882401|FG003|Overall Study|Lost to Follow-up|1|||
170420935|NCT03980483|615882402|FG004|Overall Study|Lost to Follow-up|2|||
170420936|NCT03980483|615882403|FG005|Overall Study|Lost to Follow-up|0|||
170420937|NCT03980483|615882398|FG000|Overall Study|Protocol Violation|4|||
170420938|NCT03980483|615882399|FG001|Overall Study|Protocol Violation|2|||
170420939|NCT03980483|615882400|FG002|Overall Study|Protocol Violation|1|||
170420940|NCT03980483|615882401|FG003|Overall Study|Protocol Violation|1|||
170420941|NCT03980483|615882402|FG004|Overall Study|Protocol Violation|0|||
170420942|NCT03980483|615882403|FG005|Overall Study|Protocol Violation|0|||
170420943|NCT03980483|615882398|FG000|Overall Study|Physician Decision|14|||
170420944|NCT03980483|615882399|FG001|Overall Study|Physician Decision|10|||
170420945|NCT03980483|615882400|FG002|Overall Study|Physician Decision|7|||
170420946|NCT03980483|615882401|FG003|Overall Study|Physician Decision|4|||
170420947|NCT03980483|615882402|FG004|Overall Study|Physician Decision|4|||
170420948|NCT03980483|615882403|FG005|Overall Study|Physician Decision|2|||
170420949|NCT03980483|615882398|FG000|Overall Study|Withdrawal by Subject|38|||
170420950|NCT03980483|615882399|FG001|Overall Study|Withdrawal by Subject|21|||
170420951|NCT03980483|615882400|FG002|Overall Study|Withdrawal by Subject|15|||
170420952|NCT03980483|615882401|FG003|Overall Study|Withdrawal by Subject|5|||
170420953|NCT03980483|615882402|FG004|Overall Study|Withdrawal by Subject|3|||
170420954|NCT03980483|615882403|FG005|Overall Study|Withdrawal by Subject|4|||
170420955|NCT03980483|615882398|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
170420956|NCT03980483|615882399|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
170420957|NCT03980483|615882400|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
170420958|NCT03980483|615882401|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
170420959|NCT03980483|615882402|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
170420960|NCT03980483|615882403|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
170420961|NCT03980483|615882398|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
170420962|NCT03980483|615882399|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
170420963|NCT03980483|615882400|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
170420964|NCT03980483|615882401|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
170420965|NCT03980483|615882402|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
170420966|NCT03980483|615882403|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
170420967|NCT03980483|615882398|FG000|Overall Study|Other|0|||
170420968|NCT03980483|615882399|FG001|Overall Study|Other|1|||
170420969|NCT03980483|615882400|FG002|Overall Study|Other|0|||
170420970|NCT03980483|615882401|FG003|Overall Study|Other|0|||
170420971|NCT03980483|615882402|FG004|Overall Study|Other|0|||
170420972|NCT03980483|615882403|FG005|Overall Study|Other|0|||
170420973|NCT00760266|615882404|FG000|Overall Study|Adverse Event|13|||
170420974|NCT00760266|615882405|FG001|Overall Study|Adverse Event|7|||
170420975|NCT00760266|615882404|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170420976|NCT00760266|615882405|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170420977|NCT00760266|615882404|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170420978|NCT00760266|615882405|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170420979|NCT00760266|615882404|FG000|Overall Study|Lack of Efficacy|2|||
170420980|NCT00760266|615882405|FG001|Overall Study|Lack of Efficacy|2|||
170420981|NCT00760266|615882404|FG000|Overall Study|Protocol deviation|2|||
170420982|NCT00760266|615882405|FG001|Overall Study|Protocol deviation|4|||
170420983|NCT00760266|615882404|FG000|Overall Study|Patient withdrew consent|3|||
170420984|NCT00760266|615882405|FG001|Overall Study|Patient withdrew consent|3|||
170420985|NCT00760266|615882404|FG000|Overall Study|Lost to Follow-up|2|||
170420986|NCT00760266|615882405|FG001|Overall Study|Lost to Follow-up|1|||
170420987|NCT00760266|615882404|FG000|Overall Study|Administrative Problems|0|||
170420988|NCT00760266|615882405|FG001|Overall Study|Administrative Problems|1|||
170420989|NCT01225146|615882406|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
170420990|NCT01225146|615882407|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
170420991|NCT01239121|615882408|FG000|Overall Study|Withdrawal by Subject|2|||
170420992|NCT01239121|615882409|FG001|Overall Study|Withdrawal by Subject|4|||
170420993|NCT01239121|615882410|FG002|Overall Study|Withdrawal by Subject|0|||
170420994|NCT05150964|615882411|FG000|Overall Study|Lost to Follow-up|2|||
170420995|NCT00623779|615882412|FG000|Overall Study|Adverse Event|1|||
170420996|NCT00623779|615882413|FG001|Overall Study|Adverse Event|3|||
170420997|NCT00623779|615882414|FG002|Overall Study|Adverse Event|0|||
170420998|NCT00623779|615882412|FG000|Overall Study|Criteria from CSR|2|||
170420999|NCT00623779|615882413|FG001|Overall Study|Criteria from CSR|0|||
170421000|NCT00623779|615882414|FG002|Overall Study|Criteria from CSR|1|||
170421001|NCT03657160|615882417|FG000|Overall Study|Adverse Event|5|||
170421002|NCT03657160|615882418|FG001|Overall Study|Adverse Event|6|||
170421003|NCT03657160|615882417|FG000|Overall Study|Protocol Deviation|3|||
170421004|NCT03657160|615882418|FG001|Overall Study|Protocol Deviation|0|||
170421005|NCT03657160|615882417|FG000|Overall Study|Withdrawal by Subject|18|||
170421006|NCT03657160|615882418|FG001|Overall Study|Withdrawal by Subject|16|||
170421007|NCT03657160|615882417|FG000|Overall Study|Site Termination|1|||
170421008|NCT03657160|615882418|FG001|Overall Study|Site Termination|0|||
170421009|NCT03657160|615882417|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
170421010|NCT03657160|615882418|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
170421011|NCT03657160|615882417|FG000|Overall Study|Death|33|||
170632648|NCT04322526|616666725|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
170421012|NCT03657160|615882418|FG001|Overall Study|Death|26|||
170421013|NCT03657160|615882417|FG000|Overall Study|Death (COVID-19-Related)|1|||
170421014|NCT03657160|615882418|FG001|Overall Study|Death (COVID-19-Related)|0|||
170421015|NCT03657160|615882417|FG000|Overall Study|Reason Not Specified|5|||
170421016|NCT03657160|615882418|FG001|Overall Study|Reason Not Specified|5|||
170421017|NCT03657160|615882417|FG000|Overall Study|Other (COVID-19-Related)|0|||
170421018|NCT03657160|615882418|FG001|Overall Study|Other (COVID-19-Related)|1|||
170421019|NCT00686959|615882422|FG000|Overall Study|Participants censored (no death events)|124|||
170421020|NCT00686959|615882423|FG001|Overall Study|Participants censored (no death events)|117|||
170421021|NCT00604500|615882424|FG000|Overall Study|Adverse Event|2|||
170421022|NCT00604500|615882424|FG000|Overall Study|Protocol Violation|2|||
170532041|NCT00042289|616295336|FG033|Overall Study|Severe debilitation, unable to continue|0|||
170532042|NCT00042289|616295337|FG034|Overall Study|Severe debilitation, unable to continue|0|||
170532043|NCT00042289|616295338|FG035|Overall Study|Severe debilitation, unable to continue|0|||
170532044|NCT00042289|616295339|FG036|Overall Study|Severe debilitation, unable to continue|0|||
170532045|NCT00042289|616295340|FG037|Overall Study|Severe debilitation, unable to continue|0|||
170532046|NCT00042289|616295341|FG038|Overall Study|Severe debilitation, unable to continue|0|||
170532047|NCT00042289|616295342|FG039|Overall Study|Severe debilitation, unable to continue|0|||
170532048|NCT00042289|616295343|FG040|Overall Study|Severe debilitation, unable to continue|0|||
170532049|NCT00042289|616295344|FG041|Overall Study|Severe debilitation, unable to continue|0|||
170532050|NCT00042289|616295345|FG042|Overall Study|Severe debilitation, unable to continue|0|||
170532051|NCT00042289|616295346|FG043|Overall Study|Severe debilitation, unable to continue|0|||
170532052|NCT00042289|616295347|FG044|Overall Study|Severe debilitation, unable to continue|0|||
170532053|NCT00042289|616295348|FG045|Overall Study|Severe debilitation, unable to continue|0|||
170532054|NCT00042289|616295349|FG046|Overall Study|Severe debilitation, unable to continue|0|||
170532055|NCT00042289|616295303|FG000|Overall Study|Site closed|0|||
170532056|NCT00042289|616295304|FG001|Overall Study|Site closed|0|||
170532057|NCT00042289|616295305|FG002|Overall Study|Site closed|0|||
170532058|NCT00042289|616295306|FG003|Overall Study|Site closed|0|||
170532059|NCT00042289|616295307|FG004|Overall Study|Site closed|0|||
170532060|NCT00042289|616295308|FG005|Overall Study|Site closed|0|||
170532061|NCT00042289|616295309|FG006|Overall Study|Site closed|0|||
170532062|NCT00042289|616295310|FG007|Overall Study|Site closed|0|||
170532063|NCT00042289|616295311|FG008|Overall Study|Site closed|0|||
170532064|NCT00042289|616295312|FG009|Overall Study|Site closed|0|||
170532065|NCT00042289|616295313|FG010|Overall Study|Site closed|0|||
170532066|NCT00042289|616295314|FG011|Overall Study|Site closed|0|||
170532067|NCT00042289|616295315|FG012|Overall Study|Site closed|0|||
170421023|NCT00604500|615882424|FG000|Overall Study|Treatment Failure|1|||
170421024|NCT00604500|615882424|FG000|Overall Study|Withdrawal by Subject|4|||
170421025|NCT00604500|615882424|FG000|Overall Study|Administrative|1|||
170421026|NCT00604500|615882424|FG000|Overall Study|Did not meet protocol eligibility|1|||
170421027|NCT01062256|615882429|FG000|Overall Study|Adverse Event|1|||
170421028|NCT01062256|615882430|FG001|Overall Study|Adverse Event|0|||
170421029|NCT01062256|615882431|FG002|Overall Study|Adverse Event|0|||
170421030|NCT01062256|615882429|FG000|Overall Study|Withdrawal by Subject|1|||
170421031|NCT01062256|615882430|FG001|Overall Study|Withdrawal by Subject|1|||
170421032|NCT01062256|615882431|FG002|Overall Study|Withdrawal by Subject|1|||
170421033|NCT01062256|615882429|FG000|Overall Study|Ineligible|1|||
170421034|NCT01062256|615882430|FG001|Overall Study|Ineligible|4|||
170421035|NCT01062256|615882431|FG002|Overall Study|Ineligible|3|||
170421036|NCT01062256|615882429|FG000|Overall Study|Administrative|0|||
170421037|NCT01062256|615882430|FG001|Overall Study|Administrative|2|||
170421038|NCT01062256|615882431|FG002|Overall Study|Administrative|0|||
170421039|NCT03049488|615882432|FG000|Overall Study|Lost to Follow-up|1|||
170421040|NCT03049488|615882433|FG001|Overall Study|Lost to Follow-up|1|||
170421041|NCT03049488|615882434|FG002|Overall Study|Lost to Follow-up|0|||
170421042|NCT03049488|615882435|FG003|Overall Study|Lost to Follow-up|0|||
170421043|NCT03049488|615882436|FG004|Overall Study|Lost to Follow-up|0|||
170421044|NCT03049488|615882437|FG005|Overall Study|Lost to Follow-up|0|||
170421045|NCT03049488|615882432|FG000|Overall Study|Moved from Area|1|||
170421046|NCT03049488|615882433|FG001|Overall Study|Moved from Area|0|||
170421047|NCT03049488|615882434|FG002|Overall Study|Moved from Area|0|||
170421048|NCT03049488|615882435|FG003|Overall Study|Moved from Area|1|||
170421049|NCT03049488|615882436|FG004|Overall Study|Moved from Area|1|||
170421050|NCT03049488|615882437|FG005|Overall Study|Moved from Area|0|||
170421051|NCT03049488|615882432|FG000|Overall Study|Physician Decision|0|||
170421052|NCT03049488|615882433|FG001|Overall Study|Physician Decision|1|||
170421053|NCT03049488|615882434|FG002|Overall Study|Physician Decision|0|||
170421054|NCT03049488|615882435|FG003|Overall Study|Physician Decision|0|||
170878988|NCT00754793|617567360|FG000|Overall Study|voluntary withdrawn from study|0|||
170532068|NCT00042289|616295316|FG013|Overall Study|Site closed|0|||
170532069|NCT00042289|616295317|FG014|Overall Study|Site closed|0|||
170532070|NCT00042289|616295318|FG015|Overall Study|Site closed|0|||
170532071|NCT00042289|616295319|FG016|Overall Study|Site closed|0|||
170532072|NCT00042289|616295320|FG017|Overall Study|Site closed|0|||
170421055|NCT03049488|615882436|FG004|Overall Study|Physician Decision|0|||
170421056|NCT03049488|615882437|FG005|Overall Study|Physician Decision|0|||
170421057|NCT03049488|615882432|FG000|Overall Study|Withdrawal by Subject|0|||
170532073|NCT00042289|616295321|FG018|Overall Study|Site closed|0|||
170532074|NCT00042289|616295322|FG019|Overall Study|Site closed|0|||
170421058|NCT03049488|615882433|FG001|Overall Study|Withdrawal by Subject|0|||
170421059|NCT03049488|615882434|FG002|Overall Study|Withdrawal by Subject|0|||
170532075|NCT00042289|616295323|FG020|Overall Study|Site closed|0|||
170421060|NCT03049488|615882435|FG003|Overall Study|Withdrawal by Subject|1|||
170421061|NCT03049488|615882436|FG004|Overall Study|Withdrawal by Subject|1|||
170421062|NCT03049488|615882437|FG005|Overall Study|Withdrawal by Subject|0|||
170421063|NCT02178722|615882440|FG000|Overall Study|Withdrawal by Subject|0|||
170532076|NCT00042289|616295324|FG021|Overall Study|Site closed|0|||
170421064|NCT02178722|615882441|FG001|Overall Study|Withdrawal by Subject|0|||
170421065|NCT02178722|615882442|FG002|Overall Study|Withdrawal by Subject|0|||
170421066|NCT02178722|615882443|FG003|Overall Study|Withdrawal by Subject|2|||
170421067|NCT02178722|615882444|FG004|Overall Study|Withdrawal by Subject|33|||
170421068|NCT02178722|615882440|FG000|Overall Study|Death|2|||
170421069|NCT02178722|615882441|FG001|Overall Study|Death|13|||
170421070|NCT02178722|615882442|FG002|Overall Study|Death|12|||
170421071|NCT02178722|615882443|FG003|Overall Study|Death|12|||
170421072|NCT02178722|615882444|FG004|Overall Study|Death|205|||
170421073|NCT02178722|615882440|FG000|Overall Study|Lost to Follow-up|0|||
170421074|NCT02178722|615882441|FG001|Overall Study|Lost to Follow-up|0|||
170421075|NCT02178722|615882442|FG002|Overall Study|Lost to Follow-up|0|||
170421076|NCT02178722|615882443|FG003|Overall Study|Lost to Follow-up|2|||
170421077|NCT02178722|615882444|FG004|Overall Study|Lost to Follow-up|11|||
170421078|NCT02178722|615882440|FG000|Overall Study|Study terminated by Sponsor|2|||
170421079|NCT02178722|615882441|FG001|Overall Study|Study terminated by Sponsor|7|||
170421080|NCT02178722|615882442|FG002|Overall Study|Study terminated by Sponsor|6|||
170421081|NCT02178722|615882443|FG003|Overall Study|Study terminated by Sponsor|4|||
170421082|NCT02178722|615882444|FG004|Overall Study|Study terminated by Sponsor|128|||
170421083|NCT02178722|615882440|FG000|Overall Study|Physician Decision|0|||
170421084|NCT02178722|615882441|FG001|Overall Study|Physician Decision|0|||
170421085|NCT02178722|615882442|FG002|Overall Study|Physician Decision|0|||
170421086|NCT02178722|615882443|FG003|Overall Study|Physician Decision|0|||
170421087|NCT02178722|615882444|FG004|Overall Study|Physician Decision|3|||
170421088|NCT02178722|615882440|FG000|Overall Study|Other|0|||
170421089|NCT02178722|615882441|FG001|Overall Study|Other|0|||
170421090|NCT02178722|615882442|FG002|Overall Study|Other|0|||
170421091|NCT02178722|615882443|FG003|Overall Study|Other|0|||
170421092|NCT02178722|615882444|FG004|Overall Study|Other|2|||
170421093|NCT01448057|615882445|FG000|Overall Study|Protocol Violation|3|||
170421094|NCT01448057|615882446|FG001|Overall Study|Protocol Violation|2|||
170421095|NCT01448057|615882445|FG000|Overall Study|Lost to Follow-up|3|||
170421096|NCT01448057|615882446|FG001|Overall Study|Lost to Follow-up|0|||
170421097|NCT01448057|615882445|FG000|Overall Study|Adverse Event|0|||
170421098|NCT01448057|615882446|FG001|Overall Study|Adverse Event|2|||
170421099|NCT01448057|615882445|FG000|Overall Study|Withdrawal by Subject|2|||
170421100|NCT01448057|615882446|FG001|Overall Study|Withdrawal by Subject|0|||
170421101|NCT03883906|615882448|FG000|Overall Study|Withdrawal by Subject|2|||
170421102|NCT03883906|615882448|FG000|Overall Study|Physician Decision|5|||
170421103|NCT02468778|615882449|FG000|Overall Study|Death|2|||
170421104|NCT02468778|615882450|FG001|Overall Study|Death|1|||
170421105|NCT02468778|615882451|FG002|Overall Study|Death|0|||
170421106|NCT02468778|615882449|FG000|Overall Study|Lost to Follow-up|1|||
170421107|NCT02468778|615882450|FG001|Overall Study|Lost to Follow-up|2|||
170421108|NCT02468778|615882451|FG002|Overall Study|Lost to Follow-up|2|||
170421109|NCT02468778|615882449|FG000|Overall Study|Withdrawal by Subject|0|||
170421110|NCT02468778|615882450|FG001|Overall Study|Withdrawal by Subject|1|||
170421111|NCT02468778|615882451|FG002|Overall Study|Withdrawal by Subject|1|||
170421112|NCT02458469|615882461|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
170421113|NCT02458469|615882462|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
170421114|NCT02458469|615882463|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
170421115|NCT02458469|615882464|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
170421116|NCT02458469|615882465|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
170421117|NCT02458469|615882466|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
170421118|NCT02458469|615882461|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
170421119|NCT02458469|615882462|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
170421120|NCT02458469|615882463|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
170421121|NCT02458469|615882464|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
170421122|NCT02458469|615882465|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
170421123|NCT02458469|615882466|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
170421124|NCT02458469|615882461|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
170421125|NCT02458469|615882462|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
170421126|NCT02458469|615882463|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
170421127|NCT02458469|615882464|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
170421128|NCT02458469|615882465|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
170421129|NCT02458469|615882466|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
170421130|NCT03561883|615882467|FG000|Overall Study|Adverse Event|10|||
170421131|NCT03561883|615882468|FG001|Overall Study|Adverse Event|13|||
170421132|NCT03561883|615882467|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170421133|NCT03561883|615882468|FG001|Overall Study|Non-Compliance With Study Drug|2|||
170421134|NCT03561883|615882467|FG000|Overall Study|Protocol Violation|2|||
170421135|NCT03561883|615882468|FG001|Overall Study|Protocol Violation|3|||
170421136|NCT03561883|615882467|FG000|Overall Study|Withdrawal by Subject|14|||
170421137|NCT03561883|615882468|FG001|Overall Study|Withdrawal by Subject|6|||
170421138|NCT03561883|615882467|FG000|Overall Study|Lost to Follow-up|2|||
170421139|NCT03561883|615882468|FG001|Overall Study|Lost to Follow-up|6|||
170532077|NCT00042289|616295325|FG022|Overall Study|Site closed|0|||
170421140|NCT03561883|615882467|FG000|Overall Study|Study Terminated by Sponsor|12|||
170421141|NCT03561883|615882468|FG001|Overall Study|Study Terminated by Sponsor|11|||
170421142|NCT03561883|615882467|FG000|Overall Study|Physician Decision|1|||
170421143|NCT03561883|615882468|FG001|Overall Study|Physician Decision|0|||
170421144|NCT03561883|615882467|FG000|Overall Study|Randomized by Mistake|1|||
170421145|NCT03561883|615882468|FG001|Overall Study|Randomized by Mistake|0|||
170421146|NCT03561883|615882467|FG000|Overall Study|Other, Not Specified|3|||
170421147|NCT03561883|615882468|FG001|Overall Study|Other, Not Specified|2|||
170421148|NCT01318499|615882470|FG000|Overall Study|Adverse Event|16|||
170421149|NCT01318499|615882471|FG001|Overall Study|Adverse Event|11|||
170421150|NCT01318499|615882472|FG002|Overall Study|Adverse Event|6|||
170421151|NCT01318499|615882470|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
170421152|NCT01318499|615882471|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
170421153|NCT01318499|615882472|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
170421154|NCT01318499|615882470|FG000|Overall Study|Noncompliance|2|||
170421155|NCT01318499|615882471|FG001|Overall Study|Noncompliance|3|||
170421156|NCT01318499|615882472|FG002|Overall Study|Noncompliance|0|||
170421157|NCT01318499|615882470|FG000|Overall Study|Treatment Failure|19|||
170421158|NCT01318499|615882471|FG001|Overall Study|Treatment Failure|19|||
170421159|NCT01318499|615882472|FG002|Overall Study|Treatment Failure|101|||
170421160|NCT01318499|615882470|FG000|Overall Study|Protocol Violation|2|||
170421161|NCT01318499|615882471|FG001|Overall Study|Protocol Violation|4|||
170421162|NCT01318499|615882472|FG002|Overall Study|Protocol Violation|2|||
170421163|NCT01318499|615882470|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
170421164|NCT01318499|615882471|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
170421165|NCT01318499|615882472|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
170421166|NCT01318499|615882470|FG000|Overall Study|Other|7|||
170421167|NCT01318499|615882471|FG001|Overall Study|Other|10|||
170421168|NCT01318499|615882472|FG002|Overall Study|Other|22|||
170421169|NCT05214560|615882473|FG000|Overall Study|Screening Failure|1|||
170421170|NCT05214560|615882473|FG000|Overall Study|Physician Decision|4|||
170421171|NCT05214560|615882473|FG000|Overall Study|Withdrawal by Subject|1|||
170421172|NCT05214560|615882473|FG000|Overall Study|Lost to Follow-up|2|||
170421173|NCT05214560|615882473|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
170421174|NCT05214560|615882473|FG000|Overall Study|Study physician not available for the anesthesia|3|||
170421175|NCT05214560|615882473|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
170421176|NCT05214560|615882473|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
170421177|NCT05214560|615882473|FG000|Overall Study|Surgery not performed|3|||
170421178|NCT00878995|615882477|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
170421179|NCT00878995|615882478|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
170421180|NCT02848326|615883960|FG000|Treatment Period|Adverse Event|5|||
170421181|NCT02848326|615883961|FG001|Treatment Period|Adverse Event|4|||
170421182|NCT02848326|615883962|FG002|Treatment Period|Adverse Event|11|||
170421183|NCT02848326|615883963|FG003|Treatment Period|Adverse Event|6|||
170421184|NCT02848326|615883964|FG004|Treatment Period|Adverse Event|5|||
170421185|NCT02848326|615883965|FG005|Treatment Period|Adverse Event|7|||
170421186|NCT02848326|615883960|FG000|Treatment Period|Withdrawal of Consent|20|||
170421187|NCT02848326|615883961|FG001|Treatment Period|Withdrawal of Consent|6|||
170421188|NCT02848326|615883962|FG002|Treatment Period|Withdrawal of Consent|9|||
170421189|NCT02848326|615883963|FG003|Treatment Period|Withdrawal of Consent|6|||
170421190|NCT02848326|615883964|FG004|Treatment Period|Withdrawal of Consent|9|||
170421191|NCT02848326|615883965|FG005|Treatment Period|Withdrawal of Consent|6|||
170421192|NCT02848326|615883960|FG000|Treatment Period|Lost to Follow-up|5|||
170421193|NCT02848326|615883961|FG001|Treatment Period|Lost to Follow-up|1|||
170421194|NCT02848326|615883962|FG002|Treatment Period|Lost to Follow-up|11|||
170421195|NCT02848326|615883963|FG003|Treatment Period|Lost to Follow-up|7|||
170421196|NCT02848326|615883964|FG004|Treatment Period|Lost to Follow-up|2|||
170421197|NCT02848326|615883965|FG005|Treatment Period|Lost to Follow-up|3|||
170421198|NCT02848326|615883960|FG000|Treatment Period|Pregnancy|0|||
170421199|NCT02848326|615883961|FG001|Treatment Period|Pregnancy|0|||
170421200|NCT02848326|615883962|FG002|Treatment Period|Pregnancy|1|||
170421201|NCT02848326|615883963|FG003|Treatment Period|Pregnancy|1|||
170421202|NCT02848326|615883964|FG004|Treatment Period|Pregnancy|0|||
170421203|NCT02848326|615883965|FG005|Treatment Period|Pregnancy|1|||
170421204|NCT02848326|615883960|FG000|Treatment Period|Protocol Violation|4|||
170421205|NCT02848326|615883961|FG001|Treatment Period|Protocol Violation|3|||
170421206|NCT02848326|615883962|FG002|Treatment Period|Protocol Violation|4|||
170421207|NCT02848326|615883963|FG003|Treatment Period|Protocol Violation|2|||
170421208|NCT02848326|615883964|FG004|Treatment Period|Protocol Violation|3|||
170421209|NCT02848326|615883965|FG005|Treatment Period|Protocol Violation|3|||
170421210|NCT02848326|615883960|FG000|Treatment Period|Non-compliance with Study Drug|4|||
170421211|NCT02848326|615883961|FG001|Treatment Period|Non-compliance with Study Drug|0|||
170421212|NCT02848326|615883962|FG002|Treatment Period|Non-compliance with Study Drug|0|||
170421213|NCT02848326|615883963|FG003|Treatment Period|Non-compliance with Study Drug|1|||
170421214|NCT02848326|615883964|FG004|Treatment Period|Non-compliance with Study Drug|0|||
170421215|NCT02848326|615883965|FG005|Treatment Period|Non-compliance with Study Drug|0|||
170421216|NCT02848326|615883960|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
170421217|NCT02848326|615883961|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
170421218|NCT02848326|615883962|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
170421219|NCT02848326|615883963|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
170421220|NCT02848326|615883964|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
170421221|NCT02848326|615883965|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
170421222|NCT02848326|615883960|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
170421223|NCT02848326|615883961|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
170421224|NCT02848326|615883962|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
170421225|NCT02848326|615883963|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
170421226|NCT02848326|615883964|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
170421227|NCT02848326|615883965|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
170421228|NCT01494506|615883966|FG000|Overall Study|Lack of Efficacy|77|||
170421229|NCT01494506|615883967|FG001|Overall Study|Lack of Efficacy|83|||
170421230|NCT01494506|615883968|FG002|Overall Study|Lack of Efficacy|57|||
170421231|NCT01494506|615883966|FG000|Overall Study|Adverse Event|17|||
170421232|NCT01494506|615883967|FG001|Overall Study|Adverse Event|10|||
170421233|NCT01494506|615883968|FG002|Overall Study|Adverse Event|11|||
170421234|NCT01494506|615883966|FG000|Overall Study|Death|9|||
170421235|NCT01494506|615883967|FG001|Overall Study|Death|5|||
170421236|NCT01494506|615883968|FG002|Overall Study|Death|2|||
170421237|NCT01494506|615883966|FG000|Overall Study|Physician Decision|7|||
170421238|NCT01494506|615883967|FG001|Overall Study|Physician Decision|5|||
170421239|NCT01494506|615883968|FG002|Overall Study|Physician Decision|4|||
170421240|NCT01494506|615883966|FG000|Overall Study|Withdrawal by Subject|17|||
170421241|NCT01494506|615883967|FG001|Overall Study|Withdrawal by Subject|20|||
170421242|NCT01494506|615883968|FG002|Overall Study|Withdrawal by Subject|14|||
170421243|NCT01494506|615883966|FG000|Overall Study|Clinical Deterioration|21|||
170421244|NCT01494506|615883967|FG001|Overall Study|Clinical Deterioration|17|||
170421245|NCT01494506|615883968|FG002|Overall Study|Clinical Deterioration|13|||
170421246|NCT01494506|615883966|FG000|Overall Study|Sponsor Decision|0|||
170421247|NCT01494506|615883967|FG001|Overall Study|Sponsor Decision|0|||
170421248|NCT01494506|615883968|FG002|Overall Study|Sponsor Decision|1|||
170421249|NCT01494506|615883966|FG000|Overall Study|Other|0|||
170421250|NCT01494506|615883967|FG001|Overall Study|Other|3|||
170421251|NCT01494506|615883968|FG002|Overall Study|Other|1|||
170421252|NCT02106156|615883969|FG000|Overall Study|Patient Died|19|||
170421253|NCT02106156|615883970|FG001|Overall Study|Patient Died|0|||
170421254|NCT02106156|615883971|FG002|Overall Study|Patient Died|0|||
170421255|NCT02106156|615883969|FG000|Overall Study|Lack of Tolerability|305|||
170421256|NCT02106156|615883970|FG001|Overall Study|Lack of Tolerability|3|||
170421257|NCT02106156|615883971|FG002|Overall Study|Lack of Tolerability|0|||
170421258|NCT02106156|615883969|FG000|Overall Study|Lack of Virological Response|1044|||
170421259|NCT02106156|615883970|FG001|Overall Study|Lack of Virological Response|8|||
170421260|NCT02106156|615883971|FG002|Overall Study|Lack of Virological Response|0|||
170421261|NCT02106156|615883969|FG000|Overall Study|Concomitant Disease|74|||
170421262|NCT02106156|615883970|FG001|Overall Study|Concomitant Disease|2|||
170421263|NCT02106156|615883971|FG002|Overall Study|Concomitant Disease|0|||
170421264|NCT02106156|615883969|FG000|Overall Study|Lack of Compliance|211|||
170421265|NCT02106156|615883970|FG001|Overall Study|Lack of Compliance|7|||
170421266|NCT02106156|615883971|FG002|Overall Study|Lack of Compliance|0|||
170421267|NCT02106156|615883969|FG000|Overall Study|Patients Request|307|||
170421268|NCT02106156|615883970|FG001|Overall Study|Patients Request|9|||
170421269|NCT02106156|615883971|FG002|Overall Study|Patients Request|0|||
170421270|NCT02106156|615883969|FG000|Overall Study|Lost to Follow-up|451|||
170421271|NCT02106156|615883970|FG001|Overall Study|Lost to Follow-up|8|||
170421272|NCT02106156|615883971|FG002|Overall Study|Lost to Follow-up|0|||
170421273|NCT02106156|615883969|FG000|Overall Study|Unplanned Event|82|||
170421274|NCT02106156|615883970|FG001|Overall Study|Unplanned Event|2|||
170421275|NCT02106156|615883971|FG002|Overall Study|Unplanned Event|0|||
170421276|NCT02106156|615883969|FG000|Overall Study|Change of Laboratory Parameter|10|||
170421277|NCT02106156|615883970|FG001|Overall Study|Change of Laboratory Parameter|0|||
170421278|NCT02106156|615883971|FG002|Overall Study|Change of Laboratory Parameter|0|||
170421279|NCT02106156|615883969|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
170421280|NCT02106156|615883970|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
170421281|NCT02106156|615883971|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
170421282|NCT02106156|615883969|FG000|Overall Study|Relocation/Change of Physician|40|||
170421283|NCT02106156|615883970|FG001|Overall Study|Relocation/Change of Physician|1|||
170421284|NCT02106156|615883971|FG002|Overall Study|Relocation/Change of Physician|0|||
170421285|NCT00420303|615883972|FG000|Overall Study|Serious Adverse Event|1|||
170421286|NCT00420303|615883973|FG001|Overall Study|Serious Adverse Event|0|||
170421287|NCT00420303|615883972|FG000|Overall Study|Lack of Efficacy|0|||
170421288|NCT00420303|615883973|FG001|Overall Study|Lack of Efficacy|3|||
170421289|NCT00420303|615883972|FG000|Overall Study|Physician Decision|0|||
170421290|NCT00420303|615883973|FG001|Overall Study|Physician Decision|1|||
170421291|NCT05017480|615883974|FG000|Stage 1 Study|Withdrawal by Subject|8|||
170421292|NCT05017480|615883975|FG001|Stage 1 Study|Withdrawal by Subject|6|||
170421293|NCT05017480|615883976|FG002|Stage 1 Study|Withdrawal by Subject|0|||
170421294|NCT05017480|615883977|FG003|Stage 1 Study|Withdrawal by Subject|0|||
170421295|NCT05017480|615883978|FG004|Stage 1 Study|Withdrawal by Subject|0|||
170421296|NCT05017480|615883974|FG000|Stage 1 Study|Adverse Event|1|||
170421297|NCT05017480|615883975|FG001|Stage 1 Study|Adverse Event|1|||
170421298|NCT05017480|615883976|FG002|Stage 1 Study|Adverse Event|0|||
170421299|NCT05017480|615883977|FG003|Stage 1 Study|Adverse Event|0|||
170421300|NCT05017480|615883978|FG004|Stage 1 Study|Adverse Event|0|||
170421301|NCT05017480|615883974|FG000|Stage 1 Study|Poor Compliance|1|||
170421302|NCT05017480|615883975|FG001|Stage 1 Study|Poor Compliance|1|||
170421303|NCT05017480|615883976|FG002|Stage 1 Study|Poor Compliance|0|||
170421304|NCT05017480|615883977|FG003|Stage 1 Study|Poor Compliance|0|||
170421305|NCT05017480|615883978|FG004|Stage 1 Study|Poor Compliance|0|||
170421306|NCT05017480|615883974|FG000|Stage 1 Study|Physician Decision|0|||
170421307|NCT05017480|615883975|FG001|Stage 1 Study|Physician Decision|1|||
170421308|NCT05017480|615883976|FG002|Stage 1 Study|Physician Decision|0|||
170421309|NCT05017480|615883977|FG003|Stage 1 Study|Physician Decision|0|||
170421310|NCT05017480|615883978|FG004|Stage 1 Study|Physician Decision|0|||
170421311|NCT05017480|615883974|FG000|Stage 2 Study|Withdrawal by Subject|0|||
170421312|NCT05017480|615883975|FG001|Stage 2 Study|Withdrawal by Subject|0|||
170421313|NCT05017480|615883976|FG002|Stage 2 Study|Withdrawal by Subject|6|||
170421314|NCT05017480|615883977|FG003|Stage 2 Study|Withdrawal by Subject|9|||
170421315|NCT05017480|615883978|FG004|Stage 2 Study|Withdrawal by Subject|11|||
170421316|NCT05017480|615883974|FG000|Stage 2 Study|Lost to Follow-up|0|||
170421317|NCT05017480|615883975|FG001|Stage 2 Study|Lost to Follow-up|0|||
170421318|NCT05017480|615883976|FG002|Stage 2 Study|Lost to Follow-up|0|||
170421319|NCT05017480|615883977|FG003|Stage 2 Study|Lost to Follow-up|2|||
170421320|NCT05017480|615883978|FG004|Stage 2 Study|Lost to Follow-up|1|||
170421321|NCT05017480|615883974|FG000|Stage 2 Study|Adverse Event|0|||
170421322|NCT05017480|615883975|FG001|Stage 2 Study|Adverse Event|0|||
170421323|NCT05017480|615883976|FG002|Stage 2 Study|Adverse Event|0|||
170421324|NCT05017480|615883977|FG003|Stage 2 Study|Adverse Event|1|||
170421325|NCT05017480|615883978|FG004|Stage 2 Study|Adverse Event|0|||
170421326|NCT05017480|615883974|FG000|Stage 2 Study|COVID-19|0|||
170421327|NCT05017480|615883975|FG001|Stage 2 Study|COVID-19|0|||
170421328|NCT05017480|615883976|FG002|Stage 2 Study|COVID-19|0|||
170421329|NCT05017480|615883977|FG003|Stage 2 Study|COVID-19|1|||
170421330|NCT05017480|615883978|FG004|Stage 2 Study|COVID-19|0|||
170421331|NCT05017480|615883974|FG000|Stage 2 Study|Pregnancy|0|||
170421332|NCT05017480|615883975|FG001|Stage 2 Study|Pregnancy|0|||
170421333|NCT05017480|615883976|FG002|Stage 2 Study|Pregnancy|0|||
170421334|NCT05017480|615883977|FG003|Stage 2 Study|Pregnancy|0|||
170421335|NCT05017480|615883978|FG004|Stage 2 Study|Pregnancy|1|||
170421336|NCT01136382|615883981|FG000|Overall Study|Other|8|||
170421337|NCT01136382|615883982|FG001|Overall Study|Other|3|||
170421338|NCT01136382|615883981|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
170421339|NCT01136382|615883982|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
170421340|NCT01136382|615883981|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
170421341|NCT01136382|615883982|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
170421342|NCT01136382|615883981|FG000|Overall Study|Withdrawal by Subject|4|||
170421343|NCT01136382|615883982|FG001|Overall Study|Withdrawal by Subject|1|||
170421344|NCT02311361|615883990|FG000|Overall Study|Did not receive treatment|0|||
170421345|NCT02311361|615883991|FG001|Overall Study|Did not receive treatment|1|||
170421346|NCT02311361|615883992|FG002|Overall Study|Did not receive treatment|0|||
170421347|NCT02311361|615883993|FG003|Overall Study|Did not receive treatment|1|||
170421348|NCT01725529|615883994|FG000|Overall Study|Adverse Event|1|||
170421349|NCT01725529|615883995|FG001|Overall Study|Adverse Event|0|||
170421350|NCT01725529|615883996|FG002|Overall Study|Adverse Event|0|||
170421351|NCT01725529|615883994|FG000|Overall Study|Lost to Follow-up|2|||
170421352|NCT01725529|615883995|FG001|Overall Study|Lost to Follow-up|1|||
170421353|NCT01725529|615883996|FG002|Overall Study|Lost to Follow-up|1|||
170421354|NCT01725529|615883994|FG000|Overall Study|Protocol Violation|0|||
170421355|NCT01725529|615883995|FG001|Overall Study|Protocol Violation|1|||
170421356|NCT01725529|615883996|FG002|Overall Study|Protocol Violation|1|||
170421357|NCT01725529|615883994|FG000|Overall Study|Withdrawal by Subject|12|||
170421358|NCT01725529|615883995|FG001|Overall Study|Withdrawal by Subject|14|||
170421359|NCT01725529|615883996|FG002|Overall Study|Withdrawal by Subject|8|||
170421360|NCT01941095|615884001|FG000|Overall Study|Insufficient therapeutic response|13|||
170421361|NCT01941095|615884001|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
170421362|NCT01941095|615884001|FG000|Overall Study|Adverse Event|11|||
170421363|NCT01941095|615884001|FG000|Overall Study|Physician Decision|3|||
170421364|NCT01941095|615884001|FG000|Overall Study|Withdrawal by Subject|17|||
170632649|NCT04322526|616666726|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
170632650|NCT04322526|616666725|FG000|Washout (1 Week)|Lost to Follow-up|1|||
170632651|NCT04322526|616666726|FG001|Washout (1 Week)|Lost to Follow-up|2|||
170421365|NCT01941095|615884001|FG000|Overall Study|Lost to Follow-up|10|||
170421366|NCT00485472|615884002|FG000|Overall Study|Adverse Event|8|||
170421367|NCT00485472|615884003|FG001|Overall Study|Adverse Event|5|||
170421368|NCT00485472|615884002|FG000|Overall Study|Lack of Efficacy|5|||
170421369|NCT00485472|615884003|FG001|Overall Study|Lack of Efficacy|4|||
170421370|NCT00485472|615884002|FG000|Overall Study|Withdrawal by Subject|1|||
170421371|NCT00485472|615884003|FG001|Overall Study|Withdrawal by Subject|0|||
170421372|NCT00485472|615884002|FG000|Overall Study|Protocol Violation|0|||
170421373|NCT00485472|615884003|FG001|Overall Study|Protocol Violation|1|||
170421374|NCT00485472|615884002|FG000|Overall Study|Other|2|||
170421375|NCT00485472|615884003|FG001|Overall Study|Other|1|||
170421376|NCT00485472|615884002|FG000|Overall Study|Lost to Follow-up|0|||
170421377|NCT00485472|615884003|FG001|Overall Study|Lost to Follow-up|1|||
170421378|NCT00633594|615884006|FG000|Overall Study|Adverse Event|0|||
170421379|NCT00633594|615884007|FG001|Overall Study|Adverse Event|4|||
170421380|NCT00633594|615884008|FG002|Overall Study|Adverse Event|7|||
170421381|NCT00633594|615884006|FG000|Overall Study|Death|0|||
170421382|NCT00633594|615884007|FG001|Overall Study|Death|1|||
170421383|NCT00633594|615884008|FG002|Overall Study|Death|2|||
170421384|NCT00633594|615884006|FG000|Overall Study|Disease Progression|0|||
170421385|NCT00633594|615884007|FG001|Overall Study|Disease Progression|0|||
170421386|NCT00633594|615884008|FG002|Overall Study|Disease Progression|1|||
170421387|NCT04455633|615884010|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
170421388|NCT04455633|615884011|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
170421389|NCT04455633|615884012|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
170421390|NCT04455633|615884010|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
170421391|NCT04455633|615884011|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
170421392|NCT04455633|615884012|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
170421393|NCT04455633|615884010|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
170421394|NCT04455633|615884011|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
170421395|NCT04455633|615884012|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
170421396|NCT04455633|615884010|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
170421397|NCT04455633|615884011|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
170421398|NCT04455633|615884012|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
170421399|NCT00883090|615884013|FG000|Overall Study|Sponsor's decision|1|||
170532078|NCT00042289|616295326|FG023|Overall Study|Site closed|0|||
170532079|NCT00042289|616295327|FG024|Overall Study|Site closed|0|||
170421400|NCT00883090|615884013|FG000|Overall Study|Withdrawal by Subject|1|||
170421401|NCT01492361|615884014|FG000|Overall Study|Withdrawal by Subject|281|||
170421402|NCT01492361|615884015|FG001|Overall Study|Withdrawal by Subject|297|||
170421403|NCT01492361|615884014|FG000|Overall Study|Physician Decision|12|||
170421404|NCT01492361|615884015|FG001|Overall Study|Physician Decision|12|||
170421405|NCT01492361|615884014|FG000|Overall Study|Lost to Follow-up|6|||
170421406|NCT01492361|615884015|FG001|Overall Study|Lost to Follow-up|13|||
170421407|NCT01492361|615884014|FG000|Overall Study|Other than specified above|106|||
170421408|NCT01492361|615884015|FG001|Overall Study|Other than specified above|138|||
170421409|NCT03527745|615884016|FG000|Overall Study|Lost to Follow-up|3|||
170421410|NCT03527745|615884017|FG001|Overall Study|Lost to Follow-up|6|||
170421411|NCT03527745|615884018|FG002|Overall Study|Lost to Follow-up|7|||
170421412|NCT03527745|615884019|FG003|Overall Study|Lost to Follow-up|9|||
170421413|NCT03527745|615884020|FG004|Overall Study|Lost to Follow-up|0|||
170878989|NCT00754793|617567361|FG001|Overall Study|voluntary withdrawn from study|1|||
170878990|NCT01892163|617567362|FG000|Overall Study|Death|1|||
170878991|NCT01892163|617567363|FG001|Overall Study|Death|1|||
170878992|NCT01892163|617567362|FG000|Overall Study|Lost to Follow-up|1|||
170878993|NCT01892163|617567363|FG001|Overall Study|Lost to Follow-up|0|||
170878994|NCT01585272|617567364|FG000|Overall Study|Adverse Event|22|||
170878995|NCT01585272|617567364|FG000|Overall Study|Protocol Violation|7|||
170878996|NCT01585272|617567364|FG000|Overall Study|Withdrawal by Subject|10|||
170878997|NCT02577146|617567369|FG000|Overall Study|Lost to Follow-up|8|||
170878998|NCT02577146|617567369|FG000|Overall Study|Physician Decision|3|||
170878999|NCT02577146|617567369|FG000|Overall Study|Screen Failure|17|||
170879000|NCT00278993|617567373|FG000|Overall Study|Adverse Event|24|||
170879001|NCT00278993|617567373|FG000|Overall Study|Withdrawal by Subject|5|||
170879002|NCT00278993|617567373|FG000|Overall Study|Progressive Disease|65|||
170879003|NCT00278993|617567373|FG000|Overall Study|Physician Decision|9|||
170879004|NCT00278993|617567373|FG000|Overall Study|Not Otherwise Specified|4|||
170879005|NCT00609791|617569165|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
170879006|NCT04218201|617569166|FG000|Overall Study|Death|0|||
170879007|NCT04218201|617569167|FG001|Overall Study|Death|0|||
170879008|NCT04218201|617569168|FG002|Overall Study|Death|2|||
170879009|NCT04218201|617569169|FG003|Overall Study|Death|0|||
170879010|NCT04218201|617569166|FG000|Overall Study|Unable to contact participant|4|||
170879011|NCT04218201|617569167|FG001|Overall Study|Unable to contact participant|0|||
170879012|NCT04218201|617569168|FG002|Overall Study|Unable to contact participant|3|||
170879013|NCT04218201|617569169|FG003|Overall Study|Unable to contact participant|0|||
170879014|NCT04218201|617569166|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
170879015|NCT04218201|617569167|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
170879016|NCT04218201|617569168|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
170879017|NCT04218201|617569169|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
170879018|NCT04218201|617569166|FG000|Overall Study|Withdrawal by Subject|2|||
170879019|NCT04218201|617569167|FG001|Overall Study|Withdrawal by Subject|0|||
170879020|NCT04218201|617569168|FG002|Overall Study|Withdrawal by Subject|0|||
170879021|NCT04218201|617569169|FG003|Overall Study|Withdrawal by Subject|0|||
170879022|NCT04218201|617569166|FG000|Overall Study|PCP plans to leave practice|0|||
170879023|NCT04218201|617569167|FG001|Overall Study|PCP plans to leave practice|8|||
170879024|NCT04218201|617569168|FG002|Overall Study|PCP plans to leave practice|0|||
170879025|NCT04218201|617569169|FG003|Overall Study|PCP plans to leave practice|5|||
170879026|NCT04218201|617569166|FG000|Overall Study|Reduced panel|0|||
170879027|NCT04218201|617569167|FG001|Overall Study|Reduced panel|0|||
170879028|NCT04218201|617569168|FG002|Overall Study|Reduced panel|0|||
170879029|NCT04218201|617569169|FG003|Overall Study|Reduced panel|1|||
170879030|NCT04218201|617569166|FG000|Overall Study|No longer interested in participating|0|||
170879031|NCT04218201|617569167|FG001|Overall Study|No longer interested in participating|1|||
170421414|NCT03527745|615884021|FG005|Overall Study|Lost to Follow-up|2|||
170421415|NCT03527745|615884022|FG006|Overall Study|Lost to Follow-up|3|||
170421416|NCT03527745|615884023|FG007|Overall Study|Lost to Follow-up|2|||
170421417|NCT03527745|615884024|FG008|Overall Study|Lost to Follow-up|3|||
170421418|NCT03527745|615884025|FG009|Overall Study|Lost to Follow-up|2|||
170421419|NCT03527745|615884026|FG010|Overall Study|Lost to Follow-up|1|||
170421420|NCT03527745|615884027|FG011|Overall Study|Lost to Follow-up|1|||
170421421|NCT03527745|615884028|FG012|Overall Study|Lost to Follow-up|0|||
170421422|NCT03527745|615884029|FG013|Overall Study|Lost to Follow-up|0|||
170421423|NCT03527745|615884030|FG014|Overall Study|Lost to Follow-up|0|||
170421424|NCT03527745|615884031|FG015|Overall Study|Lost to Follow-up|0|||
170421425|NCT03527745|615884032|FG016|Overall Study|Lost to Follow-up|1|||
170421426|NCT03527745|615884033|FG017|Overall Study|Lost to Follow-up|0|||
170879032|NCT04218201|617569168|FG002|Overall Study|No longer interested in participating|0|||
170421427|NCT03527745|615884034|FG018|Overall Study|Lost to Follow-up|0|||
170421428|NCT03527745|615884035|FG019|Overall Study|Lost to Follow-up|1|||
170421429|NCT03527745|615884036|FG020|Overall Study|Lost to Follow-up|1|||
170421430|NCT03527745|615884037|FG021|Overall Study|Lost to Follow-up|5|||
170421431|NCT03527745|615884038|FG022|Overall Study|Lost to Follow-up|6|||
170879033|NCT04218201|617569169|FG003|Overall Study|No longer interested in participating|0|||
170421432|NCT03527745|615884039|FG023|Overall Study|Lost to Follow-up|8|||
170421433|NCT03527745|615884040|FG024|Overall Study|Lost to Follow-up|1|||
170421434|NCT03527745|615884041|FG025|Overall Study|Lost to Follow-up|3|||
170421435|NCT01475838|615884042|FG000|Randomized Phase|Randomized but Not Treated|0|||
170421436|NCT01475838|615884043|FG001|Randomized Phase|Randomized but Not Treated|5|||
170421437|NCT01475838|615884042|FG000|Randomized Phase|Adverse Event|6|||
170421438|NCT01475838|615884043|FG001|Randomized Phase|Adverse Event|1|||
170421439|NCT01475838|615884042|FG000|Randomized Phase|Pregnancy|0|||
170421440|NCT01475838|615884043|FG001|Randomized Phase|Pregnancy|1|||
170421441|NCT01475838|615884042|FG000|Randomized Phase|Investigators Discretion|1|||
170421442|NCT01475838|615884043|FG001|Randomized Phase|Investigators Discretion|2|||
170421443|NCT01475838|615884042|FG000|Randomized Phase|Withdrew Consent|10|||
170421444|NCT01475838|615884043|FG001|Randomized Phase|Withdrew Consent|14|||
170421445|NCT01475838|615884042|FG000|Randomized Phase|Lost to Follow-up|3|||
170421446|NCT01475838|615884043|FG001|Randomized Phase|Lost to Follow-up|4|||
170421447|NCT01475838|615884042|FG000|Randomized Phase|Participant Noncompliance|1|||
170421448|NCT01475838|615884043|FG001|Randomized Phase|Participant Noncompliance|5|||
170421449|NCT01475838|615884042|FG000|Randomized Phase|Protocol Violation|9|||
170421450|NCT01475838|615884043|FG001|Randomized Phase|Protocol Violation|4|||
170421451|NCT01475838|615884042|FG000|Extension Phase|Participant Noncompliance|1|||
170421452|NCT01475838|615884043|FG001|Extension Phase|Participant Noncompliance|0|||
170421453|NCT03831048|615884044|FG000|Overall Study|Protocol Violation|9|||
170421454|NCT03831048|615884045|FG001|Overall Study|Protocol Violation|3|||
170421455|NCT03831048|615884044|FG000|Overall Study|Death|4|||
170421456|NCT03831048|615884045|FG001|Overall Study|Death|9|||
170421457|NCT03831048|615884044|FG000|Overall Study|Re-transplant|0|||
170421458|NCT03831048|615884045|FG001|Overall Study|Re-transplant|2|||
170421459|NCT03831048|615884044|FG000|Overall Study|Protocol violation and death|1|||
170421460|NCT03831048|615884045|FG001|Overall Study|Protocol violation and death|1|||
170421461|NCT00322491|615884046|FG000|Overall Study|Adverse Event|1|||
170421462|NCT00322491|615884047|FG001|Overall Study|Adverse Event|0|||
170421463|NCT00322491|615884046|FG000|Overall Study|Death|1|||
170421464|NCT00322491|615884047|FG001|Overall Study|Death|2|||
170421465|NCT01315249|615884053|FG000|Overall Study|Adverse Event|22|||
170421466|NCT01315249|615884054|FG001|Overall Study|Adverse Event|26|||
170421467|NCT01315249|615884053|FG000|Overall Study|Withdrawal by Subject|11|||
170421468|NCT01315249|615884054|FG001|Overall Study|Withdrawal by Subject|10|||
170421469|NCT01315249|615884053|FG000|Overall Study|Protocol Violation|8|||
170421470|NCT01315249|615884054|FG001|Overall Study|Protocol Violation|5|||
170421471|NCT01315249|615884053|FG000|Overall Study|Abnormal test results|1|||
170421472|NCT01315249|615884054|FG001|Overall Study|Abnormal test results|2|||
170421473|NCT01315249|615884053|FG000|Overall Study|Administrative problems|1|||
170421474|NCT01315249|615884054|FG001|Overall Study|Administrative problems|0|||
170421475|NCT01315249|615884053|FG000|Overall Study|inability to use device|1|||
170421476|NCT01315249|615884054|FG001|Overall Study|inability to use device|0|||
170421477|NCT01315249|615884053|FG000|Overall Study|Lack of Efficacy|0|||
170421478|NCT01315249|615884054|FG001|Overall Study|Lack of Efficacy|1|||
170421479|NCT01315249|615884053|FG000|Overall Study|Lost to Follow-up|0|||
170421480|NCT01315249|615884054|FG001|Overall Study|Lost to Follow-up|2|||
170421481|NCT01315249|615884053|FG000|Overall Study|Death|0|||
170421482|NCT01315249|615884054|FG001|Overall Study|Death|1|||
170421483|NCT01087970|615884055|FG000|Overall Study|Protocol Violation|2|||
170421484|NCT01991470|615884056|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
170421485|NCT01991470|615884056|FG000|Enlite 1 Period|Adverse Event|1|||
170421486|NCT01991470|615884056|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
170421487|NCT01991470|615884056|FG000|Enlite 3 Period|Lost to Follow-up|1|||
170421488|NCT01991470|615884056|FG000|Enlite 3 Period|Physician Decision|2|||
170421489|NCT01991470|615884056|FG000|Enlite 3 Period|Physician Decision|8|||
170421490|NCT01991470|615884056|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
170421491|NCT01900730|615884059|FG000|Overall Study|Withdrawal by Subject|1|||
170421492|NCT01900730|615884060|FG001|Overall Study|Withdrawal by Subject|0|||
170421493|NCT01900730|615884059|FG000|Overall Study|Screen Failure|1|||
170421494|NCT01900730|615884060|FG001|Overall Study|Screen Failure|0|||
170421495|NCT00274937|615884061|FG000|Overall Study|Physician Decision|10|||
170421496|NCT00274937|615884061|FG000|Overall Study|Withdrawal by Subject|6|||
170421497|NCT00274937|615884061|FG000|Overall Study|Progressive Disease|4|||
170421498|NCT00874237|615884064|FG000|Overall Study|Physician Decision|0|||
170421499|NCT00874237|615884065|FG001|Overall Study|Physician Decision|1|||
170421500|NCT00874237|615884066|FG002|Overall Study|Physician Decision|0|||
170421501|NCT00874237|615884067|FG003|Overall Study|Physician Decision|0|||
170421502|NCT00874237|615884068|FG004|Overall Study|Physician Decision|0|||
170421503|NCT00874237|615884069|FG005|Overall Study|Physician Decision|0|||
170421504|NCT00874237|615884064|FG000|Overall Study|Withdrawal by Subject|0|||
170421505|NCT00874237|615884065|FG001|Overall Study|Withdrawal by Subject|0|||
170421506|NCT00874237|615884066|FG002|Overall Study|Withdrawal by Subject|1|||
170421507|NCT00874237|615884067|FG003|Overall Study|Withdrawal by Subject|0|||
170421508|NCT00874237|615884068|FG004|Overall Study|Withdrawal by Subject|0|||
170421509|NCT00874237|615884069|FG005|Overall Study|Withdrawal by Subject|0|||
170421510|NCT03912337|615884074|FG000|Overall Study|Withdrawal of Consent From Study|1|||
170421511|NCT03912337|615884075|FG001|Overall Study|Withdrawal of Consent From Study|0|||
170421512|NCT03912337|615884074|FG000|Overall Study|Lost to Follow-up|1|||
170421513|NCT03912337|615884075|FG001|Overall Study|Lost to Follow-up|1|||
170421514|NCT00537030|615884077|FG000|Overall Study|Physician Decision|2|||
170421515|NCT00537030|615884077|FG000|Overall Study|Withdrawal by Subject|2|||
170421516|NCT00537030|615884077|FG000|Overall Study|≥ Grade 2 allergy|7|||
170421517|NCT00537030|615884077|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
170421518|NCT00537030|615884077|FG000|Overall Study|Ineligible|2|||
170421519|NCT00537030|615884077|FG000|Overall Study|Inevaluable|2|||
170421520|NCT00259012|615884078|FG000|Overall Study|Adverse Event|0|||
170421521|NCT00259012|615884079|FG001|Overall Study|Adverse Event|1|||
170421522|NCT00259012|615884078|FG000|Overall Study|Withdrawal by Subject|1|||
170421523|NCT00259012|615884079|FG001|Overall Study|Withdrawal by Subject|0|||
170421524|NCT00259012|615884078|FG000|Overall Study|Physician Decision|0|||
170421525|NCT00259012|615884079|FG001|Overall Study|Physician Decision|1|||
170421526|NCT00259012|615884078|FG000|Overall Study|Lost to Follow-up|0|||
170421527|NCT00259012|615884079|FG001|Overall Study|Lost to Follow-up|1|||
170421528|NCT00259012|615884078|FG000|Overall Study|Protocol Violation|1|||
170421529|NCT00259012|615884079|FG001|Overall Study|Protocol Violation|1|||
170421530|NCT00906347|615884083|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
170421531|NCT00906347|615884084|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
170421532|NCT00906347|615884083|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
170421533|NCT00906347|615884084|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
170421534|NCT00906347|615884083|FG000|Received Study Drug|Refused study drug|1|||
170421535|NCT00906347|615884084|FG001|Received Study Drug|Refused study drug|0|||
170421536|NCT00906347|615884083|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
170421537|NCT00906347|615884084|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
170421538|NCT00680121|615884092|FG000|Overall Study|Lost to Follow-up|27|||
170421539|NCT00680121|615884093|FG001|Overall Study|Lost to Follow-up|23|||
170421540|NCT01939197|615884094|FG000|Overall Study|Withdrawal by Subject|1|||
170421541|NCT01939197|615884095|FG001|Overall Study|Withdrawal by Subject|0|||
170421542|NCT01939197|615884096|FG002|Overall Study|Withdrawal by Subject|0|||
170421543|NCT01939197|615884097|FG003|Overall Study|Withdrawal by Subject|0|||
170421544|NCT01939197|615884098|FG004|Overall Study|Withdrawal by Subject|1|||
170421545|NCT01939197|615884099|FG005|Overall Study|Withdrawal by Subject|0|||
170421546|NCT01939197|615884100|FG006|Overall Study|Withdrawal by Subject|0|||
170421547|NCT01939197|615884094|FG000|Overall Study|Lost to Follow-up|0|||
170421548|NCT01939197|615884095|FG001|Overall Study|Lost to Follow-up|1|||
170421549|NCT01939197|615884096|FG002|Overall Study|Lost to Follow-up|0|||
170421550|NCT01939197|615884097|FG003|Overall Study|Lost to Follow-up|1|||
170421551|NCT01939197|615884098|FG004|Overall Study|Lost to Follow-up|3|||
170421552|NCT01939197|615884099|FG005|Overall Study|Lost to Follow-up|1|||
170421553|NCT01939197|615884100|FG006|Overall Study|Lost to Follow-up|2|||
170421554|NCT02849652|615884101|FG000|Overall Study|Lost to Follow-up|104|||
170421555|NCT02849652|615884102|FG001|Overall Study|Lost to Follow-up|35|||
170421556|NCT02849652|615884103|FG002|Overall Study|Lost to Follow-up|116|||
170421557|NCT02849652|615884104|FG003|Overall Study|Lost to Follow-up|22|||
170421558|NCT02849652|615884101|FG000|Overall Study|Withdrawal by Subject|10|||
170421559|NCT02849652|615884102|FG001|Overall Study|Withdrawal by Subject|2|||
170532080|NCT00042289|616295328|FG025|Overall Study|Site closed|0|||
170421560|NCT02849652|615884103|FG002|Overall Study|Withdrawal by Subject|8|||
170421561|NCT02849652|615884104|FG003|Overall Study|Withdrawal by Subject|4|||
170532081|NCT00042289|616295329|FG026|Overall Study|Site closed|0|||
170532082|NCT00042289|616295330|FG027|Overall Study|Site closed|0|||
170532083|NCT00042289|616295331|FG028|Overall Study|Site closed|0|||
170532084|NCT00042289|616295332|FG029|Overall Study|Site closed|0|||
170532085|NCT00042289|616295333|FG030|Overall Study|Site closed|0|||
170532086|NCT00042289|616295334|FG031|Overall Study|Site closed|3|||
170532087|NCT00042289|616295335|FG032|Overall Study|Site closed|0|||
170532088|NCT00042289|616295336|FG033|Overall Study|Site closed|0|||
170532089|NCT00042289|616295337|FG034|Overall Study|Site closed|0|||
170532090|NCT00042289|616295338|FG035|Overall Study|Site closed|0|||
170532091|NCT00042289|616295339|FG036|Overall Study|Site closed|1|||
170532092|NCT00042289|616295340|FG037|Overall Study|Site closed|0|||
170532093|NCT00042289|616295341|FG038|Overall Study|Site closed|0|||
170532094|NCT00042289|616295342|FG039|Overall Study|Site closed|0|||
170532095|NCT00042289|616295343|FG040|Overall Study|Site closed|0|||
170532096|NCT00042289|616295344|FG041|Overall Study|Site closed|0|||
170532097|NCT00042289|616295345|FG042|Overall Study|Site closed|1|||
170532098|NCT00042289|616295346|FG043|Overall Study|Site closed|0|||
170532099|NCT00042289|616295347|FG044|Overall Study|Site closed|0|||
170532100|NCT00042289|616295348|FG045|Overall Study|Site closed|0|||
170532101|NCT00042289|616295349|FG046|Overall Study|Site closed|0|||
170532102|NCT00042289|616295303|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
170532103|NCT00042289|616295304|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
170532104|NCT00042289|616295305|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
170532105|NCT00042289|616295306|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
170532106|NCT00042289|616295307|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
170532107|NCT00042289|616295308|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
170532108|NCT00042289|616295309|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
170532109|NCT00042289|616295310|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
170532110|NCT00042289|616295311|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
170532111|NCT00042289|616295312|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
170532112|NCT00042289|616295313|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
170532113|NCT00042289|616295314|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
170532114|NCT00042289|616295315|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
170532115|NCT00042289|616295316|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
170532116|NCT00042289|616295317|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
170532117|NCT00042289|616295318|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
170532118|NCT00042289|616295319|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
170532119|NCT00042289|616295320|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
170532120|NCT00042289|616295321|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
170532121|NCT00042289|616295322|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
170532122|NCT00042289|616295323|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
170532123|NCT00042289|616295324|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
170532124|NCT00042289|616295325|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
170532125|NCT00042289|616295326|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
170532126|NCT00042289|616295327|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
170532127|NCT00042289|616295328|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
170532128|NCT00042289|616295329|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
170532129|NCT00042289|616295330|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
170532130|NCT00042289|616295331|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
170532131|NCT00042289|616295332|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
170532132|NCT00042289|616295333|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
170532133|NCT00042289|616295334|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
170532134|NCT00042289|616295335|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
170532135|NCT00042289|616295336|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
170532136|NCT00042289|616295337|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
170532137|NCT00042289|616295338|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
170532138|NCT00042289|616295339|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
170532139|NCT00042289|616295340|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
170532140|NCT00042289|616295341|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
170532141|NCT00042289|616295342|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
170532142|NCT00042289|616295343|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
170532143|NCT00042289|616295344|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
170532144|NCT00042289|616295345|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
170532145|NCT00042289|616295346|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
170532146|NCT00042289|616295347|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
170532147|NCT00042289|616295348|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
170532148|NCT00042289|616295349|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
170532149|NCT00042289|616295303|FG000|Overall Study|Protocol Violation|0|||
170532150|NCT00042289|616295304|FG001|Overall Study|Protocol Violation|0|||
170532151|NCT00042289|616295305|FG002|Overall Study|Protocol Violation|0|||
170532152|NCT00042289|616295306|FG003|Overall Study|Protocol Violation|0|||
170532153|NCT00042289|616295307|FG004|Overall Study|Protocol Violation|0|||
170532154|NCT00042289|616295308|FG005|Overall Study|Protocol Violation|1|||
170532155|NCT00042289|616295309|FG006|Overall Study|Protocol Violation|0|||
170532156|NCT00042289|616295310|FG007|Overall Study|Protocol Violation|1|||
170532157|NCT00042289|616295311|FG008|Overall Study|Protocol Violation|0|||
170532158|NCT00042289|616295312|FG009|Overall Study|Protocol Violation|0|||
170532159|NCT00042289|616295313|FG010|Overall Study|Protocol Violation|0|||
170532160|NCT00042289|616295314|FG011|Overall Study|Protocol Violation|0|||
170532161|NCT00042289|616295315|FG012|Overall Study|Protocol Violation|0|||
170532162|NCT00042289|616295316|FG013|Overall Study|Protocol Violation|0|||
170532163|NCT00042289|616295317|FG014|Overall Study|Protocol Violation|0|||
170532164|NCT00042289|616295318|FG015|Overall Study|Protocol Violation|0|||
170532165|NCT00042289|616295319|FG016|Overall Study|Protocol Violation|0|||
170532166|NCT00042289|616295320|FG017|Overall Study|Protocol Violation|0|||
170532167|NCT00042289|616295321|FG018|Overall Study|Protocol Violation|0|||
170532168|NCT00042289|616295322|FG019|Overall Study|Protocol Violation|0|||
170532169|NCT00042289|616295323|FG020|Overall Study|Protocol Violation|0|||
170532170|NCT00042289|616295324|FG021|Overall Study|Protocol Violation|0|||
170532171|NCT00042289|616295325|FG022|Overall Study|Protocol Violation|0|||
170532172|NCT00042289|616295326|FG023|Overall Study|Protocol Violation|1|||
170532173|NCT00042289|616295327|FG024|Overall Study|Protocol Violation|1|||
170532174|NCT00042289|616295328|FG025|Overall Study|Protocol Violation|0|||
170532175|NCT00042289|616295329|FG026|Overall Study|Protocol Violation|2|||
170532176|NCT00042289|616295330|FG027|Overall Study|Protocol Violation|0|||
170532177|NCT00042289|616295331|FG028|Overall Study|Protocol Violation|0|||
170532178|NCT00042289|616295332|FG029|Overall Study|Protocol Violation|0|||
170532179|NCT00042289|616295333|FG030|Overall Study|Protocol Violation|1|||
170421562|NCT02545998|615884105|FG000|Overall Study|Lost to Follow-up|12|||
170421563|NCT02545998|615884106|FG001|Overall Study|Lost to Follow-up|3|||
170421564|NCT02545998|615884105|FG000|Overall Study|Withdrawal by Subject|3|||
170421565|NCT02545998|615884106|FG001|Overall Study|Withdrawal by Subject|2|||
170421566|NCT00777829|615884107|FG000|Overall Study|Withdrawal by Subject|0|||
170421567|NCT00777829|615884108|FG001|Overall Study|Withdrawal by Subject|2|||
170421568|NCT00577460|615884110|FG000|Overall Study|Adverse Event|11|||
170421569|NCT00577460|615884111|FG001|Overall Study|Adverse Event|7|||
170421570|NCT00577460|615884112|FG002|Overall Study|Adverse Event|14|||
170421571|NCT00577460|615884110|FG000|Overall Study|Protocol Violation|0|||
170421572|NCT00577460|615884111|FG001|Overall Study|Protocol Violation|1|||
170421573|NCT00577460|615884112|FG002|Overall Study|Protocol Violation|1|||
170421574|NCT00577460|615884110|FG000|Overall Study|Lost to Follow-up|0|||
170532180|NCT00042289|616295334|FG031|Overall Study|Protocol Violation|0|||
170532181|NCT00042289|616295335|FG032|Overall Study|Protocol Violation|0|||
170532182|NCT00042289|616295336|FG033|Overall Study|Protocol Violation|0|||
170532183|NCT00042289|616295337|FG034|Overall Study|Protocol Violation|0|||
170532184|NCT00042289|616295338|FG035|Overall Study|Protocol Violation|0|||
170632652|NCT00993967|616666730|FG000|Overall Study|Adverse Event|8|||
170421575|NCT00577460|615884111|FG001|Overall Study|Lost to Follow-up|3|||
170532185|NCT00042289|616295339|FG036|Overall Study|Protocol Violation|0|||
170532186|NCT00042289|616295340|FG037|Overall Study|Protocol Violation|0|||
170532187|NCT00042289|616295341|FG038|Overall Study|Protocol Violation|0|||
170532188|NCT00042289|616295342|FG039|Overall Study|Protocol Violation|0|||
170532189|NCT00042289|616295343|FG040|Overall Study|Protocol Violation|0|||
170532190|NCT00042289|616295344|FG041|Overall Study|Protocol Violation|1|||
170532191|NCT00042289|616295345|FG042|Overall Study|Protocol Violation|1|||
170532192|NCT00042289|616295346|FG043|Overall Study|Protocol Violation|1|||
170532193|NCT00042289|616295347|FG044|Overall Study|Protocol Violation|0|||
170532194|NCT00042289|616295348|FG045|Overall Study|Protocol Violation|0|||
170632653|NCT00993967|616666730|FG000|Overall Study|Death|1|||
170632654|NCT00993967|616666730|FG000|Overall Study|Lost to Follow-up|14|||
170632655|NCT00993967|616666730|FG000|Overall Study|Withdrawal by Subject|36|||
170632656|NCT00993967|616666730|FG000|Overall Study|Protocol Violation|2|||
170632657|NCT03815929|616666739|FG000|Overall Study|Lost to Follow-up|2|||
170532195|NCT00042289|616295349|FG046|Overall Study|Protocol Violation|0|||
170532196|NCT00042289|616295303|FG000|Overall Study|Withdrawal by Subject|4|||
170532197|NCT00042289|616295304|FG001|Overall Study|Withdrawal by Subject|1|||
170532198|NCT00042289|616295305|FG002|Overall Study|Withdrawal by Subject|0|||
170532199|NCT00042289|616295306|FG003|Overall Study|Withdrawal by Subject|2|||
170532200|NCT00042289|616295307|FG004|Overall Study|Withdrawal by Subject|0|||
170532201|NCT00042289|616295308|FG005|Overall Study|Withdrawal by Subject|2|||
170532202|NCT00042289|616295309|FG006|Overall Study|Withdrawal by Subject|0|||
170532203|NCT00042289|616295310|FG007|Overall Study|Withdrawal by Subject|0|||
170532204|NCT00042289|616295311|FG008|Overall Study|Withdrawal by Subject|0|||
170532205|NCT00042289|616295312|FG009|Overall Study|Withdrawal by Subject|1|||
170532206|NCT00042289|616295313|FG010|Overall Study|Withdrawal by Subject|0|||
170532207|NCT00042289|616295314|FG011|Overall Study|Withdrawal by Subject|0|||
170532208|NCT00042289|616295315|FG012|Overall Study|Withdrawal by Subject|2|||
170532209|NCT00042289|616295316|FG013|Overall Study|Withdrawal by Subject|0|||
170532210|NCT00042289|616295317|FG014|Overall Study|Withdrawal by Subject|0|||
170532211|NCT00042289|616295318|FG015|Overall Study|Withdrawal by Subject|0|||
170532212|NCT00042289|616295319|FG016|Overall Study|Withdrawal by Subject|0|||
170532213|NCT00042289|616295320|FG017|Overall Study|Withdrawal by Subject|0|||
170532214|NCT00042289|616295321|FG018|Overall Study|Withdrawal by Subject|0|||
170532215|NCT00042289|616295322|FG019|Overall Study|Withdrawal by Subject|0|||
170532216|NCT00042289|616295323|FG020|Overall Study|Withdrawal by Subject|0|||
170532217|NCT00042289|616295324|FG021|Overall Study|Withdrawal by Subject|1|||
170532218|NCT00042289|616295325|FG022|Overall Study|Withdrawal by Subject|1|||
170532219|NCT00042289|616295326|FG023|Overall Study|Withdrawal by Subject|1|||
170532220|NCT00042289|616295327|FG024|Overall Study|Withdrawal by Subject|0|||
170532221|NCT00042289|616295328|FG025|Overall Study|Withdrawal by Subject|0|||
170532222|NCT00042289|616295329|FG026|Overall Study|Withdrawal by Subject|1|||
170532223|NCT00042289|616295330|FG027|Overall Study|Withdrawal by Subject|0|||
170532224|NCT00042289|616295331|FG028|Overall Study|Withdrawal by Subject|2|||
170532225|NCT00042289|616295332|FG029|Overall Study|Withdrawal by Subject|0|||
170532226|NCT00042289|616295333|FG030|Overall Study|Withdrawal by Subject|0|||
170532227|NCT00042289|616295334|FG031|Overall Study|Withdrawal by Subject|1|||
170532228|NCT00042289|616295335|FG032|Overall Study|Withdrawal by Subject|2|||
170532229|NCT00042289|616295336|FG033|Overall Study|Withdrawal by Subject|1|||
170532230|NCT00042289|616295337|FG034|Overall Study|Withdrawal by Subject|0|||
170532231|NCT00042289|616295338|FG035|Overall Study|Withdrawal by Subject|0|||
170532232|NCT00042289|616295339|FG036|Overall Study|Withdrawal by Subject|0|||
170532233|NCT00042289|616295340|FG037|Overall Study|Withdrawal by Subject|1|||
170532234|NCT00042289|616295341|FG038|Overall Study|Withdrawal by Subject|0|||
170532235|NCT00042289|616295342|FG039|Overall Study|Withdrawal by Subject|0|||
170532236|NCT00042289|616295343|FG040|Overall Study|Withdrawal by Subject|0|||
170532237|NCT00042289|616295344|FG041|Overall Study|Withdrawal by Subject|0|||
170532238|NCT00042289|616295345|FG042|Overall Study|Withdrawal by Subject|1|||
170532239|NCT00042289|616295346|FG043|Overall Study|Withdrawal by Subject|0|||
170532240|NCT00042289|616295347|FG044|Overall Study|Withdrawal by Subject|0|||
170532241|NCT00042289|616295348|FG045|Overall Study|Withdrawal by Subject|0|||
170532242|NCT00042289|616295349|FG046|Overall Study|Withdrawal by Subject|0|||
170532243|NCT02807259|616295352|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
170532244|NCT02807259|616295353|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
170532245|NCT02807259|616295352|FG000|Midline (3 Months)|migration, refusal, not available|30|||
170532246|NCT02807259|616295353|FG001|Midline (3 Months)|migration, refusal, not available|34|||
170532247|NCT02807259|616295352|FG000|Endline (3 Months)|migration, refusal, not available|35|||
170532248|NCT02807259|616295353|FG001|Endline (3 Months)|migration, refusal, not available|87|||
170532249|NCT01171534|616295354|FG000|Overall Study|Lost to Follow-up|0|||
170532250|NCT01171534|616295355|FG001|Overall Study|Lost to Follow-up|2|||
170532251|NCT01171534|616295354|FG000|Overall Study|screen failure|0|||
170632658|NCT03815929|616666740|FG001|Overall Study|Lost to Follow-up|1|||
170532252|NCT01171534|616295355|FG001|Overall Study|screen failure|1|||
170532253|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
170532254|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
170532255|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
170532256|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
170632659|NCT03815929|616666741|FG002|Overall Study|Lost to Follow-up|0|||
170532257|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
170532258|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
170532259|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
170532260|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
170532261|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
170532262|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
170532263|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
170532264|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
170532265|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
170532266|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
170532267|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
170532268|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
170532269|NCT00849056|616295356|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
170532270|NCT00849056|616295357|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
170532271|NCT00849056|616295356|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
170532272|NCT00849056|616295357|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
170532273|NCT00849056|616295356|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
170532274|NCT00849056|616295357|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
170532275|NCT00849056|616295356|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
170532276|NCT00849056|616295357|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
170532277|NCT00849056|616295356|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
170532278|NCT00849056|616295357|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
170532279|NCT00849056|616295356|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
170532280|NCT00849056|616295357|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
170532281|NCT00849056|616295356|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
170532282|NCT00849056|616295357|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
170532283|NCT00849056|616295356|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
170532284|NCT00849056|616295357|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
170532285|NCT04588259|616295358|FG000|Run-in period|Run-in failure|0|||
170532286|NCT04588259|616295359|FG001|Run-in period|Run-in failure|23|||
170532287|NCT04588259|616295358|FG000|Run-in period|Withdrawn before randomisation|0|||
170532288|NCT04588259|616295359|FG001|Run-in period|Withdrawn before randomisation|8|||
170532289|NCT04588259|616295358|FG000|Treatment period|Withdrawal by Subject|6|||
170532290|NCT04588259|616295359|FG001|Treatment period|Withdrawal by Subject|6|||
170532291|NCT01473134|616295360|FG000|Overall Study|Lost to Follow-up|21|||
170532292|NCT01473134|616295361|FG001|Overall Study|Lost to Follow-up|13|||
170532293|NCT01473134|616295360|FG000|Overall Study|Protocol Violation|32|||
170532294|NCT01473134|616295361|FG001|Overall Study|Protocol Violation|19|||
170532295|NCT01473134|616295360|FG000|Overall Study|Withdrawal by Subject|1|||
170532296|NCT01473134|616295361|FG001|Overall Study|Withdrawal by Subject|2|||
170532297|NCT01473134|616295360|FG000|Overall Study|Death|0|||
170532298|NCT01473134|616295361|FG001|Overall Study|Death|1|||
170532299|NCT01473134|616295360|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
170532300|NCT01473134|616295361|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
170532301|NCT02100631|616295365|FG000|Overall Study|Withdrawal by Subject|1|||
170532302|NCT02100631|616295366|FG001|Overall Study|Withdrawal by Subject|0|||
170532303|NCT02100631|616295367|FG002|Overall Study|Withdrawal by Subject|0|||
170532304|NCT02100631|616295365|FG000|Overall Study|Lost to Follow-up|3|||
170532305|NCT02100631|616295366|FG001|Overall Study|Lost to Follow-up|4|||
170532306|NCT02100631|616295367|FG002|Overall Study|Lost to Follow-up|0|||
170532307|NCT02100631|616295365|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
170532308|NCT02100631|616295366|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
170532309|NCT02100631|616295367|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
170532310|NCT04476043|616295368|FG000|Overall Study|Withdrawal by Subject|1|||
170532311|NCT04476043|616295369|FG001|Overall Study|Withdrawal by Subject|3|||
170532312|NCT04476043|616295370|FG002|Overall Study|Withdrawal by Subject|4|||
170532313|NCT04476043|616295371|FG003|Overall Study|Withdrawal by Subject|1|||
170532314|NCT04476043|616295368|FG000|Overall Study|Lost to Follow-up|1|||
170532315|NCT04476043|616295369|FG001|Overall Study|Lost to Follow-up|1|||
170532316|NCT04476043|616295370|FG002|Overall Study|Lost to Follow-up|2|||
170532317|NCT04476043|616295371|FG003|Overall Study|Lost to Follow-up|1|||
170532318|NCT04476043|616295368|FG000|Overall Study|Adverse Event|2|||
170532319|NCT04476043|616295369|FG001|Overall Study|Adverse Event|0|||
170532320|NCT04476043|616295370|FG002|Overall Study|Adverse Event|1|||
170532321|NCT04476043|616295371|FG003|Overall Study|Adverse Event|0|||
170532322|NCT04476043|616295368|FG000|Overall Study|Protocol Violation|0|||
170532323|NCT04476043|616295369|FG001|Overall Study|Protocol Violation|1|||
170532324|NCT04476043|616295370|FG002|Overall Study|Protocol Violation|0|||
170532325|NCT04476043|616295371|FG003|Overall Study|Protocol Violation|0|||
170532326|NCT01140906|616295372|FG000|Overall Study|Adverse Event|7|||
170532327|NCT01140906|616295373|FG001|Overall Study|Adverse Event|10|||
170532328|NCT01140906|616295374|FG002|Overall Study|Adverse Event|17|||
170532329|NCT01140906|616295375|FG003|Overall Study|Adverse Event|7|||
170532330|NCT01140906|616295372|FG000|Overall Study|Lack of Efficacy|6|||
170532331|NCT01140906|616295373|FG001|Overall Study|Lack of Efficacy|8|||
170532332|NCT01140906|616295374|FG002|Overall Study|Lack of Efficacy|2|||
170532333|NCT01140906|616295375|FG003|Overall Study|Lack of Efficacy|1|||
170532334|NCT01140906|616295372|FG000|Overall Study|Non-compliance|0|||
170532335|NCT01140906|616295373|FG001|Overall Study|Non-compliance|1|||
170532336|NCT01140906|616295374|FG002|Overall Study|Non-compliance|0|||
170532337|NCT01140906|616295375|FG003|Overall Study|Non-compliance|1|||
170532338|NCT01140906|616295372|FG000|Overall Study|Protocol Violation|5|||
170532339|NCT01140906|616295373|FG001|Overall Study|Protocol Violation|3|||
170532340|NCT01140906|616295374|FG002|Overall Study|Protocol Violation|2|||
170532341|NCT01140906|616295375|FG003|Overall Study|Protocol Violation|1|||
170532342|NCT01140906|616295372|FG000|Overall Study|Withdrawal of consent|6|||
170532343|NCT01140906|616295373|FG001|Overall Study|Withdrawal of consent|6|||
170532344|NCT01140906|616295374|FG002|Overall Study|Withdrawal of consent|2|||
170532345|NCT01140906|616295375|FG003|Overall Study|Withdrawal of consent|2|||
170532346|NCT01140906|616295372|FG000|Overall Study|Lost to Follow-up|1|||
170532347|NCT01140906|616295373|FG001|Overall Study|Lost to Follow-up|1|||
170532348|NCT01140906|616295374|FG002|Overall Study|Lost to Follow-up|0|||
170532349|NCT01140906|616295375|FG003|Overall Study|Lost to Follow-up|2|||
170532350|NCT01140906|616295372|FG000|Overall Study|Administrative or other reason|0|||
170532351|NCT01140906|616295373|FG001|Overall Study|Administrative or other reason|5|||
170532352|NCT01140906|616295374|FG002|Overall Study|Administrative or other reason|3|||
170532353|NCT01140906|616295375|FG003|Overall Study|Administrative or other reason|2|||
170532354|NCT02469233|616295376|FG000|Overall Study|Death|1|||
170532355|NCT02469233|616295377|FG001|Overall Study|Death|1|||
170532356|NCT02469233|616295376|FG000|Overall Study|Lost to post or 6 month follow up|7|||
170532357|NCT02469233|616295377|FG001|Overall Study|Lost to post or 6 month follow up|2|||
170532358|NCT00903968|616295378|FG000|Overall Study|Adverse Event|0|||
170532359|NCT00903968|616295379|FG001|Overall Study|Adverse Event|0|||
170532360|NCT00903968|616295380|FG002|Overall Study|Adverse Event|0|||
170532361|NCT00903968|616295381|FG003|Overall Study|Adverse Event|0|||
170532362|NCT00903968|616295382|FG004|Overall Study|Adverse Event|0|||
170532363|NCT00903968|616295383|FG005|Overall Study|Adverse Event|0|||
170532364|NCT00903968|616295384|FG006|Overall Study|Adverse Event|1|||
170532365|NCT00903968|616295385|FG007|Overall Study|Adverse Event|8|||
170532366|NCT00903968|616295378|FG000|Overall Study|DLT|0|||
170532367|NCT00903968|616295379|FG001|Overall Study|DLT|0|||
170532368|NCT00903968|616295380|FG002|Overall Study|DLT|0|||
170532369|NCT00903968|616295381|FG003|Overall Study|DLT|0|||
170532370|NCT00903968|616295382|FG004|Overall Study|DLT|0|||
170532371|NCT00903968|616295383|FG005|Overall Study|DLT|0|||
170532372|NCT00903968|616295384|FG006|Overall Study|DLT|2|||
170532373|NCT00903968|616295385|FG007|Overall Study|DLT|0|||
170532374|NCT00903968|616295378|FG000|Overall Study|Withdrawal by Subject|1|||
170532375|NCT00903968|616295379|FG001|Overall Study|Withdrawal by Subject|0|||
170532376|NCT00903968|616295380|FG002|Overall Study|Withdrawal by Subject|1|||
170532377|NCT00903968|616295381|FG003|Overall Study|Withdrawal by Subject|0|||
170532378|NCT00903968|616295382|FG004|Overall Study|Withdrawal by Subject|1|||
170532379|NCT00903968|616295383|FG005|Overall Study|Withdrawal by Subject|1|||
170532380|NCT00903968|616295384|FG006|Overall Study|Withdrawal by Subject|0|||
170532381|NCT00903968|616295385|FG007|Overall Study|Withdrawal by Subject|4|||
170532382|NCT00903968|616295378|FG000|Overall Study|Non-Compliance|0|||
170532383|NCT00903968|616295379|FG001|Overall Study|Non-Compliance|0|||
170532384|NCT00903968|616295380|FG002|Overall Study|Non-Compliance|0|||
170532385|NCT00903968|616295381|FG003|Overall Study|Non-Compliance|0|||
170532386|NCT00903968|616295382|FG004|Overall Study|Non-Compliance|0|||
170532387|NCT00903968|616295383|FG005|Overall Study|Non-Compliance|1|||
170532388|NCT00903968|616295384|FG006|Overall Study|Non-Compliance|0|||
170532389|NCT00903968|616295385|FG007|Overall Study|Non-Compliance|0|||
170532390|NCT00903968|616295378|FG000|Overall Study|Physician Decision|0|||
170532391|NCT00903968|616295379|FG001|Overall Study|Physician Decision|0|||
170532392|NCT00903968|616295380|FG002|Overall Study|Physician Decision|0|||
170532393|NCT00903968|616295381|FG003|Overall Study|Physician Decision|0|||
170532394|NCT00903968|616295382|FG004|Overall Study|Physician Decision|0|||
170532395|NCT00903968|616295383|FG005|Overall Study|Physician Decision|1|||
170532396|NCT00903968|616295384|FG006|Overall Study|Physician Decision|0|||
170532397|NCT00903968|616295385|FG007|Overall Study|Physician Decision|0|||
170532398|NCT00903968|616295378|FG000|Overall Study|Progressive Disease|2|||
170632660|NCT03815929|616666739|FG000|Overall Study|Physician Decision|2|||
170879034|NCT04129528|617569170|FG000|Overall Study|Adverse Event|1|||
170532399|NCT00903968|616295379|FG001|Overall Study|Progressive Disease|3|||
170532400|NCT00903968|616295380|FG002|Overall Study|Progressive Disease|2|||
170532401|NCT00903968|616295381|FG003|Overall Study|Progressive Disease|3|||
170532402|NCT00903968|616295382|FG004|Overall Study|Progressive Disease|3|||
170532403|NCT00903968|616295383|FG005|Overall Study|Progressive Disease|3|||
170532404|NCT00903968|616295384|FG006|Overall Study|Progressive Disease|0|||
170532405|NCT00903968|616295385|FG007|Overall Study|Progressive Disease|18|||
170532406|NCT00903968|616295378|FG000|Overall Study|Lack of Efficacy|0|||
170532407|NCT00903968|616295379|FG001|Overall Study|Lack of Efficacy|0|||
170532408|NCT00903968|616295380|FG002|Overall Study|Lack of Efficacy|0|||
170532409|NCT00903968|616295381|FG003|Overall Study|Lack of Efficacy|0|||
170532410|NCT00903968|616295382|FG004|Overall Study|Lack of Efficacy|0|||
170532411|NCT00903968|616295383|FG005|Overall Study|Lack of Efficacy|0|||
170532412|NCT00903968|616295384|FG006|Overall Study|Lack of Efficacy|0|||
170532413|NCT00903968|616295385|FG007|Overall Study|Lack of Efficacy|3|||
170532414|NCT04889040|616295388|FG000|Overall Study|Withdrawal by Subject|3|||
170532415|NCT04889040|616295389|FG001|Overall Study|Withdrawal by Subject|3|||
170532416|NCT04889040|616295388|FG000|Overall Study|Lost to Follow-up|0|||
170532417|NCT04889040|616295389|FG001|Overall Study|Lost to Follow-up|1|||
170532418|NCT04889040|616295388|FG000|Overall Study|Adverse Event|2|||
170532419|NCT04889040|616295389|FG001|Overall Study|Adverse Event|1|||
170532420|NCT03738696|616295390|FG000|Overall Study|Withdrawal by Subject|0|||
170532421|NCT03738696|616295391|FG001|Overall Study|Withdrawal by Subject|1|||
170532422|NCT03738696|616295390|FG000|Overall Study|Lost to Follow-up|8|||
170532423|NCT03738696|616295391|FG001|Overall Study|Lost to Follow-up|14|||
170532424|NCT02911116|616295396|FG000|Overall Study|Insufficient Therapeutic Response|1|||
170532425|NCT02911116|616295397|FG001|Overall Study|Insufficient Therapeutic Response|0|||
170532426|NCT02911116|616295396|FG000|Overall Study|Lost to Follow-up|0|||
170532427|NCT02911116|616295397|FG001|Overall Study|Lost to Follow-up|1|||
170532428|NCT01240694|616295398|FG000|Overall Study|Adverse Event|9|||
170532429|NCT01240694|616295398|FG000|Overall Study|Lack of Efficacy|6|||
170532430|NCT01240694|616295398|FG000|Overall Study|Withdrawal by Subject|6|||
170532431|NCT01240694|616295398|FG000|Overall Study|Protocol Violation|2|||
170532432|NCT01240694|616295398|FG000|Overall Study|Lost to Follow-up|2|||
170532433|NCT01240694|616295398|FG000|Overall Study|Other than specified|3|||
170532434|NCT01240694|616295398|FG000|Overall Study|Withdrawn due to early study termination|107|||
170532435|NCT04154956|616295402|FG000|Overall Study|Death|109|||
170532436|NCT04154956|616295403|FG001|Overall Study|Death|110|||
170532437|NCT04154956|616295402|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
170532438|NCT04154956|616295403|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
170532439|NCT04154956|616295402|FG000|Overall Study|Withdrawal by Subject|1|||
170532440|NCT04154956|616295403|FG001|Overall Study|Withdrawal by Subject|7|||
170532441|NCT04154956|616295402|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
170532442|NCT04154956|616295403|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
170532443|NCT02606253|616295404|FG000|Overall Study|Adverse Event|2|||
170532444|NCT02606253|616295405|FG001|Overall Study|Adverse Event|0|||
170421576|NCT00577460|615884112|FG002|Overall Study|Lost to Follow-up|4|||
170421577|NCT00577460|615884110|FG000|Overall Study|Withdrawal by Subject|5|||
170421578|NCT00577460|615884111|FG001|Overall Study|Withdrawal by Subject|5|||
170421579|NCT00577460|615884112|FG002|Overall Study|Withdrawal by Subject|6|||
170421580|NCT00577460|615884110|FG000|Overall Study|Other|0|||
170421581|NCT00577460|615884111|FG001|Overall Study|Other|3|||
170421582|NCT00577460|615884112|FG002|Overall Study|Other|2|||
170421583|NCT00162123|615884113|FG000|Overall Study|Disease progression|27|||
170421584|NCT00162123|615884114|FG001|Overall Study|Disease progression|19|||
170421585|NCT00162123|615884115|FG002|Overall Study|Disease progression|10|||
170421586|NCT00162123|615884116|FG003|Overall Study|Disease progression|4|||
170421587|NCT00162123|615884117|FG004|Overall Study|Disease progression|8|||
170421588|NCT00162123|615884118|FG005|Overall Study|Disease progression|3|||
170421589|NCT00162123|615884119|FG006|Overall Study|Disease progression|1|||
170421590|NCT00162123|615884120|FG007|Overall Study|Disease progression|0|||
170421591|NCT00162123|615884113|FG000|Overall Study|Study drug toxicity|6|||
170879035|NCT04129528|617569171|FG001|Overall Study|Adverse Event|0|||
170879036|NCT04129528|617569170|FG000|Overall Study|Physician Decision|1|||
170879037|NCT04129528|617569171|FG001|Overall Study|Physician Decision|1|||
170879038|NCT04129528|617569170|FG000|Overall Study|Withdrawal by Subject|1|||
170879039|NCT04129528|617569171|FG001|Overall Study|Withdrawal by Subject|1|||
170879040|NCT02356562|617569172|FG000|Overall Study|Withdrawal by Subject|0|||
170879041|NCT02356562|617569173|FG001|Overall Study|Withdrawal by Subject|1|||
170879042|NCT02356562|617569172|FG000|Overall Study|Re-entered treatment in a previous study|1|||
170879043|NCT02356562|617569173|FG001|Overall Study|Re-entered treatment in a previous study|0|||
170879044|NCT02356562|617569172|FG000|Overall Study|site closure|1|||
170879045|NCT02356562|617569173|FG001|Overall Study|site closure|0|||
170421592|NCT00162123|615884114|FG001|Overall Study|Study drug toxicity|1|||
170532445|NCT02606253|616295406|FG002|Overall Study|Adverse Event|0|||
170532446|NCT02606253|616295404|FG000|Overall Study|Protocol Violation|2|||
170532447|NCT02606253|616295405|FG001|Overall Study|Protocol Violation|1|||
170532448|NCT02606253|616295406|FG002|Overall Study|Protocol Violation|0|||
170532449|NCT02606253|616295404|FG000|Overall Study|Physician Decision|1|||
170532450|NCT02606253|616295405|FG001|Overall Study|Physician Decision|1|||
170532451|NCT02606253|616295406|FG002|Overall Study|Physician Decision|0|||
170532452|NCT03834350|616295407|FG000|Overall Study|Withdrawal by Subject|1|||
170879046|NCT00150592|617569174|FG000|Overall Study|Adverse Event|4|||
170421593|NCT00162123|615884115|FG002|Overall Study|Study drug toxicity|5|||
170421594|NCT00162123|615884116|FG003|Overall Study|Study drug toxicity|0|||
170532453|NCT02382939|616295412|FG000|Overall Study|Adverse Event|1|||
170532454|NCT02382939|616295413|FG001|Overall Study|Adverse Event|1|||
170532455|NCT02382939|616295412|FG000|Overall Study|Withdrawal by Subject|2|||
170532456|NCT02382939|616295413|FG001|Overall Study|Withdrawal by Subject|2|||
170532457|NCT00142415|616295416|FG000|Overall Study|Physician Decision|0|||
170532458|NCT00142415|616295417|FG001|Overall Study|Physician Decision|0|||
170532459|NCT00142415|616295418|FG002|Overall Study|Physician Decision|0|||
170532460|NCT00142415|616295419|FG003|Overall Study|Physician Decision|0|||
170532461|NCT00142415|616295420|FG004|Overall Study|Physician Decision|1|||
170532462|NCT00142415|616295421|FG005|Overall Study|Physician Decision|2|||
170532463|NCT01189266|616295422|FG000|Overall Study|Adverse Event|1|||
170532464|NCT01189266|616295423|FG001|Overall Study|Adverse Event|0|||
170532465|NCT01189266|616295424|FG002|Overall Study|Adverse Event|5|||
170532466|NCT01189266|616295422|FG000|Overall Study|Death|0|||
170532467|NCT01189266|616295423|FG001|Overall Study|Death|0|||
170532468|NCT01189266|616295424|FG002|Overall Study|Death|5|||
170532469|NCT01189266|616295422|FG000|Overall Study|Lack of Efficacy|4|||
170532470|NCT01189266|616295423|FG001|Overall Study|Lack of Efficacy|5|||
170532471|NCT01189266|616295424|FG002|Overall Study|Lack of Efficacy|44|||
170532472|NCT01189266|616295422|FG000|Overall Study|Physician Decision|0|||
170532473|NCT01189266|616295423|FG001|Overall Study|Physician Decision|0|||
170532474|NCT01189266|616295424|FG002|Overall Study|Physician Decision|1|||
170532475|NCT01189266|616295422|FG000|Overall Study|Protocol Violation|0|||
170532476|NCT01189266|616295423|FG001|Overall Study|Protocol Violation|1|||
170532477|NCT01189266|616295424|FG002|Overall Study|Protocol Violation|1|||
170532478|NCT01189266|616295422|FG000|Overall Study|Withdrawal by Subject|0|||
170532479|NCT01189266|616295423|FG001|Overall Study|Withdrawal by Subject|0|||
170532480|NCT01189266|616295424|FG002|Overall Study|Withdrawal by Subject|1|||
170532481|NCT01189266|616295422|FG000|Overall Study|Patient refuses further therapy|1|||
170532482|NCT01189266|616295423|FG001|Overall Study|Patient refuses further therapy|0|||
170532483|NCT01189266|616295424|FG002|Overall Study|Patient refuses further therapy|7|||
170532484|NCT01189266|616295422|FG000|Overall Study|No treatment|0|||
170532485|NCT01189266|616295423|FG001|Overall Study|No treatment|0|||
170532486|NCT01189266|616295424|FG002|Overall Study|No treatment|1|||
170532487|NCT00321763|616295425|FG000|Overall Study|Adverse Event|1|||
170532488|NCT00321763|616295426|FG001|Overall Study|Adverse Event|1|||
170532489|NCT00321763|616295427|FG002|Overall Study|Adverse Event|0|||
170532490|NCT00321763|616295428|FG003|Overall Study|Adverse Event|1|||
170532491|NCT00321763|616295425|FG000|Overall Study|Withdrawal by Subject|2|||
170532492|NCT00321763|616295426|FG001|Overall Study|Withdrawal by Subject|0|||
170532493|NCT00321763|616295427|FG002|Overall Study|Withdrawal by Subject|1|||
170532494|NCT00321763|616295428|FG003|Overall Study|Withdrawal by Subject|0|||
170532495|NCT00321763|616295425|FG000|Overall Study|Lost to Follow-up|3|||
170532496|NCT00321763|616295426|FG001|Overall Study|Lost to Follow-up|1|||
170532497|NCT00321763|616295427|FG002|Overall Study|Lost to Follow-up|5|||
170532498|NCT00321763|616295428|FG003|Overall Study|Lost to Follow-up|4|||
170532499|NCT01572792|616295432|FG000|Lead-in Study|Lost to Follow-up|5|||
170532500|NCT01572792|616295433|FG001|Lead-in Study|Lost to Follow-up|9|||
170532501|NCT01572792|616295434|FG002|Lead-in Study|Lost to Follow-up|4|||
170532502|NCT01572792|616295435|FG003|Lead-in Study|Lost to Follow-up|2|||
170532503|NCT01572792|616295436|FG004|Lead-in Study|Lost to Follow-up|4|||
170532504|NCT01572792|616295432|FG000|Lead-in Study|Withdrawal by Subject|22|||
170532505|NCT01572792|616295433|FG001|Lead-in Study|Withdrawal by Subject|11|||
170532506|NCT01572792|616295434|FG002|Lead-in Study|Withdrawal by Subject|12|||
170532507|NCT01572792|616295435|FG003|Lead-in Study|Withdrawal by Subject|24|||
170532508|NCT01572792|616295436|FG004|Lead-in Study|Withdrawal by Subject|11|||
170532509|NCT01572792|616295432|FG000|Lead-in Study|Protocol Violation|19|||
170532510|NCT01572792|616295433|FG001|Lead-in Study|Protocol Violation|10|||
170532511|NCT01572792|616295434|FG002|Lead-in Study|Protocol Violation|12|||
170532512|NCT01572792|616295435|FG003|Lead-in Study|Protocol Violation|13|||
170532513|NCT01572792|616295436|FG004|Lead-in Study|Protocol Violation|21|||
170532514|NCT01572792|616295432|FG000|Lead-in Study|Lack of Efficacy|20|||
170532515|NCT01572792|616295433|FG001|Lead-in Study|Lack of Efficacy|5|||
170532516|NCT01572792|616295434|FG002|Lead-in Study|Lack of Efficacy|4|||
170532517|NCT01572792|616295435|FG003|Lead-in Study|Lack of Efficacy|8|||
170532518|NCT01572792|616295436|FG004|Lead-in Study|Lack of Efficacy|10|||
170532519|NCT01572792|616295432|FG000|Lead-in Study|Adverse Event|21|||
170532520|NCT01572792|616295433|FG001|Lead-in Study|Adverse Event|21|||
170532521|NCT01572792|616295434|FG002|Lead-in Study|Adverse Event|22|||
170532522|NCT01572792|616295435|FG003|Lead-in Study|Adverse Event|16|||
170879047|NCT00150592|617569175|FG001|Overall Study|Adverse Event|1|||
170532523|NCT01572792|616295436|FG004|Lead-in Study|Adverse Event|14|||
170532524|NCT01572792|616295432|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
170532525|NCT01572792|616295433|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
170879048|NCT00150592|617569174|FG000|Overall Study|Protocol Violation|1|||
170532526|NCT01572792|616295434|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
170532527|NCT01572792|616295435|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
170532528|NCT01572792|616295436|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
170532529|NCT01572792|616295432|FG000|Extension Study|Lost to Follow-up|6|||
170532530|NCT01572792|616295433|FG001|Extension Study|Lost to Follow-up|2|||
170532531|NCT01572792|616295434|FG002|Extension Study|Lost to Follow-up|0|||
170532532|NCT01572792|616295435|FG003|Extension Study|Lost to Follow-up|3|||
170532533|NCT01572792|616295436|FG004|Extension Study|Lost to Follow-up|3|||
170532534|NCT01572792|616295432|FG000|Extension Study|Withdrawal by Subject|7|||
170532535|NCT01572792|616295433|FG001|Extension Study|Withdrawal by Subject|6|||
170532536|NCT01572792|616295434|FG002|Extension Study|Withdrawal by Subject|11|||
170532537|NCT01572792|616295435|FG003|Extension Study|Withdrawal by Subject|8|||
170532538|NCT01572792|616295436|FG004|Extension Study|Withdrawal by Subject|14|||
170532539|NCT01572792|616295432|FG000|Extension Study|Protocol Violation|0|||
170532540|NCT01572792|616295433|FG001|Extension Study|Protocol Violation|4|||
170532541|NCT01572792|616295434|FG002|Extension Study|Protocol Violation|3|||
170532542|NCT01572792|616295435|FG003|Extension Study|Protocol Violation|4|||
170532543|NCT01572792|616295436|FG004|Extension Study|Protocol Violation|3|||
170532544|NCT01572792|616295432|FG000|Extension Study|Lack of Efficacy|2|||
170532545|NCT01572792|616295433|FG001|Extension Study|Lack of Efficacy|3|||
170532546|NCT01572792|616295434|FG002|Extension Study|Lack of Efficacy|3|||
170532547|NCT01572792|616295435|FG003|Extension Study|Lack of Efficacy|2|||
170532548|NCT01572792|616295436|FG004|Extension Study|Lack of Efficacy|2|||
170532549|NCT01572792|616295432|FG000|Extension Study|Adverse Event|7|||
170532550|NCT01572792|616295433|FG001|Extension Study|Adverse Event|6|||
170532551|NCT01572792|616295434|FG002|Extension Study|Adverse Event|5|||
170532552|NCT01572792|616295435|FG003|Extension Study|Adverse Event|6|||
170532553|NCT01572792|616295436|FG004|Extension Study|Adverse Event|4|||
170532554|NCT01572792|616295432|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
170532555|NCT01572792|616295433|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
170532556|NCT01572792|616295434|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
170532557|NCT01572792|616295435|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
170532558|NCT01572792|616295436|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
170532559|NCT00701363|616295439|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
170532560|NCT00701363|616295440|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
170532561|NCT00701363|616295441|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
170532562|NCT00701363|616295442|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
170532563|NCT00701363|616295439|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
170532564|NCT00701363|616295440|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
170532565|NCT00701363|616295441|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
170532566|NCT00701363|616295442|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
170532567|NCT00701363|616295439|FG000|Treatment Phase 1|Adverse Event|7|||
170532568|NCT00701363|616295440|FG001|Treatment Phase 1|Adverse Event|0|||
170532569|NCT00701363|616295441|FG002|Treatment Phase 1|Adverse Event|0|||
170532570|NCT00701363|616295442|FG003|Treatment Phase 1|Adverse Event|0|||
170532571|NCT00701363|616295439|FG000|Treatment Phase 1|Protocol Violation|1|||
170532572|NCT00701363|616295440|FG001|Treatment Phase 1|Protocol Violation|0|||
170532573|NCT00701363|616295441|FG002|Treatment Phase 1|Protocol Violation|0|||
170532574|NCT00701363|616295442|FG003|Treatment Phase 1|Protocol Violation|0|||
170532575|NCT00701363|616295439|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
170532576|NCT00701363|616295440|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
170532577|NCT00701363|616295441|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
170532578|NCT00701363|616295442|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
170532579|NCT00701363|616295439|FG000|Treatment Phase 1|Lack of Efficacy|1|||
170532580|NCT00701363|616295440|FG001|Treatment Phase 1|Lack of Efficacy|0|||
170532581|NCT00701363|616295441|FG002|Treatment Phase 1|Lack of Efficacy|0|||
170532582|NCT00701363|616295442|FG003|Treatment Phase 1|Lack of Efficacy|0|||
170532583|NCT00701363|616295439|FG000|Treatment Phase 2|Adverse Event|0|||
170532584|NCT00701363|616295440|FG001|Treatment Phase 2|Adverse Event|0|||
170532585|NCT00701363|616295441|FG002|Treatment Phase 2|Adverse Event|1|||
170532586|NCT00701363|616295442|FG003|Treatment Phase 2|Adverse Event|0|||
170532587|NCT00701363|616295439|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
170532588|NCT00701363|616295440|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
170532589|NCT00701363|616295441|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
170532590|NCT00701363|616295442|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
170532591|NCT04759131|616295443|FG000|Overall Study|Investigator's discretion|1|||
170532592|NCT04759131|616295444|FG001|Overall Study|Investigator's discretion|0|||
170532593|NCT04759131|616295443|FG000|Overall Study|Subject withdrawal|1|||
170532594|NCT04759131|616295444|FG001|Overall Study|Subject withdrawal|0|||
170532595|NCT03692949|616295450|FG000|Overall Study|Lost to Follow-up|0|||
170532596|NCT03692949|616295451|FG001|Overall Study|Lost to Follow-up|0|||
170532597|NCT03692949|616295452|FG002|Overall Study|Lost to Follow-up|0|||
170532598|NCT03692949|616295453|FG003|Overall Study|Lost to Follow-up|0|||
170532599|NCT03692949|616295454|FG004|Overall Study|Lost to Follow-up|0|||
170532600|NCT03692949|616295455|FG005|Overall Study|Lost to Follow-up|0|||
170532601|NCT03692949|616295456|FG006|Overall Study|Lost to Follow-up|0|||
170532602|NCT03692949|616295457|FG007|Overall Study|Lost to Follow-up|1|||
170532603|NCT03426878|616295463|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
170532604|NCT03426878|616295463|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
170421595|NCT00162123|615884117|FG004|Overall Study|Study drug toxicity|4|||
170421596|NCT00162123|615884118|FG005|Overall Study|Study drug toxicity|1|||
170421597|NCT00162123|615884119|FG006|Overall Study|Study drug toxicity|1|||
170421598|NCT00162123|615884120|FG007|Overall Study|Study drug toxicity|0|||
170421599|NCT00162123|615884113|FG000|Overall Study|Death|3|||
170421600|NCT00162123|615884114|FG001|Overall Study|Death|3|||
170421601|NCT00162123|615884115|FG002|Overall Study|Death|1|||
170421602|NCT00162123|615884116|FG003|Overall Study|Death|1|||
170421603|NCT00162123|615884117|FG004|Overall Study|Death|1|||
170421604|NCT00162123|615884118|FG005|Overall Study|Death|1|||
170421605|NCT00162123|615884119|FG006|Overall Study|Death|0|||
170421606|NCT00162123|615884120|FG007|Overall Study|Death|0|||
170421607|NCT00162123|615884113|FG000|Overall Study|Withdrawal by Subject|2|||
170421608|NCT00162123|615884114|FG001|Overall Study|Withdrawal by Subject|0|||
170421609|NCT00162123|615884115|FG002|Overall Study|Withdrawal by Subject|2|||
170421610|NCT00162123|615884116|FG003|Overall Study|Withdrawal by Subject|1|||
170421611|NCT00162123|615884117|FG004|Overall Study|Withdrawal by Subject|1|||
170421612|NCT00162123|615884118|FG005|Overall Study|Withdrawal by Subject|2|||
170421613|NCT00162123|615884119|FG006|Overall Study|Withdrawal by Subject|1|||
170421614|NCT00162123|615884120|FG007|Overall Study|Withdrawal by Subject|0|||
170421615|NCT00162123|615884113|FG000|Overall Study|Deterioration without progression|2|||
170421616|NCT00162123|615884114|FG001|Overall Study|Deterioration without progression|2|||
170421617|NCT00162123|615884115|FG002|Overall Study|Deterioration without progression|3|||
170421618|NCT00162123|615884116|FG003|Overall Study|Deterioration without progression|0|||
170421619|NCT00162123|615884117|FG004|Overall Study|Deterioration without progression|1|||
170421620|NCT00162123|615884118|FG005|Overall Study|Deterioration without progression|0|||
170421621|NCT00162123|615884119|FG006|Overall Study|Deterioration without progression|0|||
170421622|NCT00162123|615884120|FG007|Overall Study|Deterioration without progression|0|||
170421623|NCT00162123|615884113|FG000|Overall Study|Adverse Event|1|||
170421624|NCT00162123|615884114|FG001|Overall Study|Adverse Event|2|||
170421625|NCT00162123|615884115|FG002|Overall Study|Adverse Event|0|||
170421626|NCT00162123|615884116|FG003|Overall Study|Adverse Event|2|||
170421627|NCT00162123|615884117|FG004|Overall Study|Adverse Event|1|||
170421628|NCT00162123|615884118|FG005|Overall Study|Adverse Event|0|||
170421629|NCT00162123|615884119|FG006|Overall Study|Adverse Event|0|||
170421630|NCT00162123|615884120|FG007|Overall Study|Adverse Event|0|||
170421631|NCT00162123|615884113|FG000|Overall Study|Not specified (before treatment)|2|||
170421632|NCT00162123|615884114|FG001|Overall Study|Not specified (before treatment)|0|||
170421633|NCT00162123|615884115|FG002|Overall Study|Not specified (before treatment)|0|||
170421634|NCT00162123|615884116|FG003|Overall Study|Not specified (before treatment)|0|||
170421635|NCT00162123|615884117|FG004|Overall Study|Not specified (before treatment)|12|||
170421636|NCT00162123|615884118|FG005|Overall Study|Not specified (before treatment)|1|||
170421637|NCT00162123|615884119|FG006|Overall Study|Not specified (before treatment)|0|||
170421638|NCT00162123|615884120|FG007|Overall Study|Not specified (before treatment)|0|||
170421639|NCT00162123|615884113|FG000|Overall Study|Not specified (after start of treatment)|0|||
170421640|NCT00162123|615884114|FG001|Overall Study|Not specified (after start of treatment)|0|||
170421641|NCT00162123|615884115|FG002|Overall Study|Not specified (after start of treatment)|0|||
170421642|NCT00162123|615884116|FG003|Overall Study|Not specified (after start of treatment)|0|||
170421643|NCT00162123|615884117|FG004|Overall Study|Not specified (after start of treatment)|3|||
170421644|NCT00162123|615884118|FG005|Overall Study|Not specified (after start of treatment)|0|||
170421645|NCT00162123|615884119|FG006|Overall Study|Not specified (after start of treatment)|0|||
170421646|NCT00162123|615884120|FG007|Overall Study|Not specified (after start of treatment)|0|||
170421647|NCT00162123|615884113|FG000|Overall Study|Physician Decision|1|||
170421648|NCT00162123|615884114|FG001|Overall Study|Physician Decision|2|||
170421649|NCT00162123|615884115|FG002|Overall Study|Physician Decision|0|||
170421650|NCT00162123|615884116|FG003|Overall Study|Physician Decision|0|||
170421651|NCT00162123|615884117|FG004|Overall Study|Physician Decision|0|||
170421652|NCT00162123|615884118|FG005|Overall Study|Physician Decision|1|||
170421653|NCT00162123|615884119|FG006|Overall Study|Physician Decision|1|||
170421654|NCT00162123|615884120|FG007|Overall Study|Physician Decision|0|||
170421655|NCT00162123|615884113|FG000|Overall Study|Tumor assessment only (not treated)|0|||
170421656|NCT00162123|615884114|FG001|Overall Study|Tumor assessment only (not treated)|0|||
170421657|NCT00162123|615884115|FG002|Overall Study|Tumor assessment only (not treated)|0|||
170421658|NCT00162123|615884116|FG003|Overall Study|Tumor assessment only (not treated)|0|||
170421659|NCT00162123|615884117|FG004|Overall Study|Tumor assessment only (not treated)|0|||
170532605|NCT03426878|616295463|FG000|Overall Study|Declined to receive results|3|||
170532606|NCT03426878|616295463|FG000|Overall Study|Received negative results by mailed letter|65|||
170532607|NCT03426878|616295463|FG000|Overall Study|Lost to Follow-up|177|||
170421660|NCT00162123|615884118|FG005|Overall Study|Tumor assessment only (not treated)|0|||
170879049|NCT00150592|617569175|FG001|Overall Study|Protocol Violation|0|||
170879050|NCT00150592|617569174|FG000|Overall Study|Withdrawal by Subject|1|||
170879051|NCT00150592|617569175|FG001|Overall Study|Withdrawal by Subject|2|||
170879052|NCT00150592|617569174|FG000|Overall Study|Non-compliance|1|||
170879053|NCT00150592|617569175|FG001|Overall Study|Non-compliance|0|||
170879054|NCT00412750|617569178|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170879055|NCT00412750|617569179|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170879056|NCT00412750|617569180|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170879057|NCT00412750|617569178|FG000|Overall Study|Administrative problems|21|||
170879058|NCT00412750|617569179|FG001|Overall Study|Administrative problems|17|||
170879059|NCT00412750|617569180|FG002|Overall Study|Administrative problems|14|||
170879060|NCT00412750|617569178|FG000|Overall Study|Adverse Event|8|||
170879061|NCT00412750|617569179|FG001|Overall Study|Adverse Event|3|||
170879062|NCT00412750|617569180|FG002|Overall Study|Adverse Event|3|||
170879063|NCT00412750|617569178|FG000|Overall Study|Lost to Follow-up|1|||
170879064|NCT00412750|617569179|FG001|Overall Study|Lost to Follow-up|0|||
170879065|NCT00412750|617569180|FG002|Overall Study|Lost to Follow-up|1|||
170879066|NCT00412750|617569178|FG000|Overall Study|Withdrawal by Subject|0|||
170879067|NCT00412750|617569179|FG001|Overall Study|Withdrawal by Subject|1|||
170879068|NCT00412750|617569180|FG002|Overall Study|Withdrawal by Subject|2|||
170879069|NCT00412750|617569178|FG000|Overall Study|Lack of Efficacy|0|||
170879070|NCT00412750|617569179|FG001|Overall Study|Lack of Efficacy|0|||
170879071|NCT00412750|617569180|FG002|Overall Study|Lack of Efficacy|3|||
170879072|NCT00874120|617569185|FG000|First Intervention|Adverse Event|0|||
170879073|NCT00874120|617569186|FG001|First Intervention|Adverse Event|1|||
170879074|NCT00874120|617569185|FG000|First Intervention|Withdrawal by Subject|2|||
170879075|NCT00874120|617569186|FG001|First Intervention|Withdrawal by Subject|0|||
170421661|NCT00162123|615884119|FG006|Overall Study|Tumor assessment only (not treated)|0|||
170421662|NCT00162123|615884120|FG007|Overall Study|Tumor assessment only (not treated)|1|||
170421663|NCT00162123|615884113|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
170421664|NCT00162123|615884114|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
170421665|NCT00162123|615884115|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
170421666|NCT00162123|615884116|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
170421667|NCT00162123|615884117|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
170421668|NCT00162123|615884118|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
170421669|NCT00162123|615884119|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
170421670|NCT00162123|615884120|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
170421671|NCT02016170|615884121|FG000|Overall Study|Adverse Event|1|||
170421672|NCT02016170|615884122|FG001|Overall Study|Adverse Event|1|||
170421673|NCT02016170|615884123|FG002|Overall Study|Adverse Event|0|||
170421674|NCT02016170|615884121|FG000|Overall Study|Protocol Violation|1|||
170421675|NCT02016170|615884122|FG001|Overall Study|Protocol Violation|0|||
170421676|NCT02016170|615884123|FG002|Overall Study|Protocol Violation|0|||
170421677|NCT02365207|615884124|FG000|Overall Study|Withdrawal by Subject|1|||
170421678|NCT02365207|615884124|FG000|Overall Study|Physician Decision|1|||
170421679|NCT02514174|615884128|FG000|Overall Study|Patient refused to continue medication|1|||
170421680|NCT02514174|615884128|FG000|Overall Study|Adverse Event|2|||
170421681|NCT02514174|615884128|FG000|Overall Study|Study closed by sponsor|9|||
170421682|NCT02514174|615884128|FG000|Overall Study|Progressive disease|11|||
170421683|NCT02514174|615884128|FG000|Overall Study|Treatment change|1|||
170421684|NCT02514174|615884128|FG000|Overall Study|Treated off study with Afatinib.|1|||
170421685|NCT02170688|615884129|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
170421686|NCT02170688|615884130|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
170421687|NCT02170688|615884131|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
170421688|NCT02170688|615884132|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
170421689|NCT02170688|615884133|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
170421690|NCT02170688|615884129|FG000|Overall Study|Full dose not received|0|||
170421691|NCT02170688|615884130|FG001|Overall Study|Full dose not received|1|||
170421692|NCT02170688|615884131|FG002|Overall Study|Full dose not received|0|||
170421693|NCT02170688|615884132|FG003|Overall Study|Full dose not received|0|||
170421694|NCT02170688|615884133|FG004|Overall Study|Full dose not received|0|||
170421695|NCT02170688|615884129|FG000|Overall Study|Physician Decision|0|||
170421696|NCT02170688|615884130|FG001|Overall Study|Physician Decision|0|||
170421697|NCT02170688|615884131|FG002|Overall Study|Physician Decision|1|||
170421698|NCT02170688|615884132|FG003|Overall Study|Physician Decision|0|||
170421699|NCT02170688|615884133|FG004|Overall Study|Physician Decision|0|||
170532608|NCT03704064|616295465|FG000|Overall Study|Lost to Follow-up|8|||
170532609|NCT03704064|616295466|FG001|Overall Study|Lost to Follow-up|4|||
170879076|NCT00874120|617569185|FG000|First Intervention|Lost to Follow-up|0|||
170421700|NCT02079532|615884136|FG000|Overall Study|Adverse Event|7|||
170421701|NCT02079532|615884136|FG000|Overall Study|Additional or changed therapy|2|||
170421702|NCT02079532|615884136|FG000|Overall Study|Lack of Efficacy|9|||
170421703|NCT02079532|615884136|FG000|Overall Study|Protocol Violation|3|||
170421704|NCT02079532|615884136|FG000|Overall Study|Withdrawal by Subject|1|||
170421705|NCT02079532|615884136|FG000|Overall Study|Administrative problems|1|||
170632661|NCT03815929|616666740|FG001|Overall Study|Physician Decision|2|||
170632662|NCT03815929|616666741|FG002|Overall Study|Physician Decision|0|||
170421706|NCT02079532|615884136|FG000|Overall Study|Inclusion into ReFIRST|3|||
170421707|NCT02079532|615884136|FG000|Overall Study|Other|3|||
170421708|NCT02920996|615884137|FG000|Overall Study|Adverse Event|8|||
170421709|NCT02920996|615884138|FG001|Overall Study|Adverse Event|0|||
170421710|NCT02920996|615884137|FG000|Overall Study|Physician Decision|1|||
170421711|NCT02920996|615884138|FG001|Overall Study|Physician Decision|0|||
170421712|NCT02920996|615884137|FG000|Overall Study|Death|1|||
170421713|NCT02920996|615884138|FG001|Overall Study|Death|0|||
170421714|NCT02920996|615884137|FG000|Overall Study|Missing|1|||
170421715|NCT02920996|615884138|FG001|Overall Study|Missing|0|||
170421716|NCT02920996|615884137|FG000|Overall Study|Subject Non-Compliance|1|||
170421717|NCT02920996|615884138|FG001|Overall Study|Subject Non-Compliance|0|||
170421718|NCT01402947|615884139|FG000|First Intervention|Adverse Event|0|||
170421719|NCT01402947|615884140|FG001|First Intervention|Adverse Event|1|||
170421720|NCT01471522|615884144|FG000|Overall Study|Withdrawal by Subject|28|||
170421721|NCT01471522|615884145|FG001|Overall Study|Withdrawal by Subject|22|||
170421722|NCT01471522|615884144|FG000|Overall Study|Lost to Follow-up|36|||
170421723|NCT01471522|615884145|FG001|Overall Study|Lost to Follow-up|26|||
170421724|NCT02937701|615886084|FG000|Day 1 to Week 22|Adverse Event|11|||
170421725|NCT02937701|615886085|FG001|Day 1 to Week 22|Adverse Event|14|||
170421726|NCT02937701|615886086|FG002|Day 1 to Week 22|Adverse Event|0|||
170421727|NCT02937701|615886087|FG003|Day 1 to Week 22|Adverse Event|0|||
170421728|NCT02937701|615886088|FG004|Day 1 to Week 22|Adverse Event|0|||
170421729|NCT02937701|615886084|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
170421730|NCT02937701|615886085|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
170421731|NCT02937701|615886086|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
170421732|NCT02937701|615886087|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
170421733|NCT02937701|615886088|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
170532610|NCT03704064|616295465|FG000|Overall Study|Withdrawal by Subject|1|||
170532611|NCT03704064|616295466|FG001|Overall Study|Withdrawal by Subject|1|||
170532612|NCT03704064|616295465|FG000|Overall Study|No longer available for study visits|0|||
170532613|NCT03704064|616295466|FG001|Overall Study|No longer available for study visits|1|||
170532614|NCT03704064|616295465|FG000|Overall Study|Censoring event|1|||
170532615|NCT03704064|616295466|FG001|Overall Study|Censoring event|0|||
170532616|NCT03197129|616295467|FG000|Overall Study|did not answer the VPT: shyness|4|||
170532617|NCT03197129|616295468|FG001|Overall Study|did not answer the VPT: shyness|5|||
170532618|NCT00746551|616295471|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
170532619|NCT00746551|616295472|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
170532620|NCT00746551|616295471|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
170532621|NCT00746551|616295472|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
170532622|NCT00746551|616295471|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
170532623|NCT00746551|616295472|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
170532624|NCT04848480|616295473|FG000|Main Phase (26 Weeks)|Death|1|||
170532625|NCT04848480|616295474|FG001|Main Phase (26 Weeks)|Death|0|||
170532626|NCT04848480|616295473|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
170532627|NCT04848480|616295474|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
170532628|NCT04848480|616295473|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
170532629|NCT04848480|616295474|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
170532630|NCT04848480|616295473|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
170532631|NCT04848480|616295474|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
170532632|NCT04848480|616295473|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
170532633|NCT04848480|616295474|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
170532634|NCT04848480|616295473|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
170532635|NCT04848480|616295474|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
170532636|NCT00833755|616295475|FG000|Overall Study|Physician Decision|4|||
170532637|NCT00833755|616295476|FG001|Overall Study|Physician Decision|4|||
170532638|NCT00833755|616295477|FG002|Overall Study|Physician Decision|2|||
170532639|NCT00833755|616295478|FG003|Overall Study|Physician Decision|6|||
170532640|NCT00833755|616295475|FG000|Overall Study|Subject had scheduling issues|0|||
170532641|NCT00833755|616295476|FG001|Overall Study|Subject had scheduling issues|1|||
170532642|NCT00833755|616295477|FG002|Overall Study|Subject had scheduling issues|0|||
170532643|NCT00833755|616295478|FG003|Overall Study|Subject had scheduling issues|0|||
170532644|NCT00560404|616295480|FG000|Overall Study|Adverse Event|2|||
170532645|NCT00560404|616295481|FG001|Overall Study|Adverse Event|3|||
170532646|NCT00560404|616295480|FG000|Overall Study|Death|3|||
170532647|NCT00560404|616295481|FG001|Overall Study|Death|3|||
170532648|NCT00560404|616295480|FG000|Overall Study|Protocol Violation|12|||
170532649|NCT00560404|616295481|FG001|Overall Study|Protocol Violation|7|||
170532650|NCT00560404|616295480|FG000|Overall Study|Administrative Reasons|1|||
170421734|NCT02937701|615886084|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
170421735|NCT02937701|615886085|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
170421736|NCT02937701|615886086|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
170421737|NCT02937701|615886087|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
170421738|NCT02937701|615886088|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
170421739|NCT02937701|615886084|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
170421740|NCT02937701|615886085|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
170421741|NCT02937701|615886086|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
170421742|NCT02937701|615886087|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
170421743|NCT02937701|615886088|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
170421744|NCT02937701|615886084|FG000|Day 1 to Week 22|Death|1|||
170421745|NCT02937701|615886085|FG001|Day 1 to Week 22|Death|1|||
170421746|NCT02937701|615886086|FG002|Day 1 to Week 22|Death|0|||
170421747|NCT02937701|615886087|FG003|Day 1 to Week 22|Death|0|||
170421748|NCT02937701|615886088|FG004|Day 1 to Week 22|Death|0|||
170421749|NCT02937701|615886084|FG000|Day 1 to Week 22|Protocol Violation|1|||
170421750|NCT02937701|615886085|FG001|Day 1 to Week 22|Protocol Violation|1|||
170532651|NCT00560404|616295481|FG001|Overall Study|Administrative Reasons|1|||
170532652|NCT00560404|616295480|FG000|Overall Study|Withdrew Consent|4|||
170532653|NCT00560404|616295481|FG001|Overall Study|Withdrew Consent|0|||
170532654|NCT00560404|616295480|FG000|Overall Study|Failure to return|1|||
170532655|NCT00560404|616295481|FG001|Overall Study|Failure to return|2|||
170532656|NCT00560404|616295480|FG000|Overall Study|Other withdrawal reason|13|||
170532657|NCT00560404|616295481|FG001|Overall Study|Other withdrawal reason|5|||
170532658|NCT05219162|616295482|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
170532659|NCT05219162|616295482|FG000|Overall Study|Withdrawal by Subject|23|||
170421751|NCT02937701|615886086|FG002|Day 1 to Week 22|Protocol Violation|0|||
170421752|NCT02937701|615886087|FG003|Day 1 to Week 22|Protocol Violation|0|||
170421753|NCT02937701|615886088|FG004|Day 1 to Week 22|Protocol Violation|0|||
170421754|NCT02937701|615886084|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
170532660|NCT05493111|616296590|FG000|Overall Study|Adverse Event|3|||
170421755|NCT02937701|615886085|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
170421756|NCT02937701|615886086|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
170421757|NCT02937701|615886087|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
170421758|NCT02937701|615886088|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
170421759|NCT02937701|615886084|FG000|Day 1 to Week 22|Physician Decision|2|||
170421760|NCT02937701|615886085|FG001|Day 1 to Week 22|Physician Decision|0|||
170421761|NCT02937701|615886086|FG002|Day 1 to Week 22|Physician Decision|0|||
170421762|NCT02937701|615886087|FG003|Day 1 to Week 22|Physician Decision|0|||
170421763|NCT02937701|615886088|FG004|Day 1 to Week 22|Physician Decision|0|||
170421764|NCT02937701|615886084|FG000|Day 1 to Week 22|Other|1|||
170421765|NCT02937701|615886085|FG001|Day 1 to Week 22|Other|0|||
170421766|NCT02937701|615886086|FG002|Day 1 to Week 22|Other|0|||
170421767|NCT02937701|615886087|FG003|Day 1 to Week 22|Other|0|||
170421768|NCT02937701|615886088|FG004|Day 1 to Week 22|Other|0|||
170421769|NCT02937701|615886084|FG000|Week 22 to Week 50|Adverse Event|0|||
170421770|NCT02937701|615886085|FG001|Week 22 to Week 50|Adverse Event|0|||
170421771|NCT02937701|615886086|FG002|Week 22 to Week 50|Adverse Event|10|||
170421772|NCT02937701|615886087|FG003|Week 22 to Week 50|Adverse Event|3|||
170421773|NCT02937701|615886088|FG004|Week 22 to Week 50|Adverse Event|3|||
170421774|NCT02937701|615886084|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
170421775|NCT02937701|615886085|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
170421776|NCT02937701|615886086|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
170421777|NCT02937701|615886087|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
170421778|NCT02937701|615886088|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
170421779|NCT02937701|615886084|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
170421780|NCT02937701|615886085|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
170421781|NCT02937701|615886086|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
170421782|NCT02937701|615886087|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
170421783|NCT02937701|615886088|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
170421784|NCT02937701|615886084|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
170421785|NCT02937701|615886085|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
170421786|NCT02937701|615886086|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
170421787|NCT02937701|615886087|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
170421788|NCT02937701|615886088|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
170421789|NCT02937701|615886084|FG000|Week 22 to Week 50|Physician Decision|0|||
170421790|NCT02937701|615886085|FG001|Week 22 to Week 50|Physician Decision|0|||
170421791|NCT02937701|615886086|FG002|Week 22 to Week 50|Physician Decision|2|||
170421792|NCT02937701|615886087|FG003|Week 22 to Week 50|Physician Decision|0|||
170421793|NCT02937701|615886088|FG004|Week 22 to Week 50|Physician Decision|1|||
170421794|NCT02937701|615886084|FG000|Week 22 to Week 50|Other|0|||
170421795|NCT02937701|615886085|FG001|Week 22 to Week 50|Other|0|||
170421796|NCT02937701|615886086|FG002|Week 22 to Week 50|Other|0|||
170421797|NCT02937701|615886087|FG003|Week 22 to Week 50|Other|0|||
170421798|NCT02937701|615886088|FG004|Week 22 to Week 50|Other|1|||
170421799|NCT04188106|615886090|FG000|Overall Study|Lost to Follow-up|5|||
170421800|NCT04188106|615886090|FG000|Overall Study|Non-Compliance|1|||
170421801|NCT00705536|615886091|FG000|Start Period 1|Withdrawal by Subject|0|||
170421802|NCT00705536|615886092|FG001|Start Period 1|Withdrawal by Subject|0|||
170421803|NCT00705536|615886093|FG002|Start Period 1|Withdrawal by Subject|0|||
170421804|NCT00705536|615886094|FG003|Start Period 1|Withdrawal by Subject|1|||
170421805|NCT02289963|615886095|FG000|Overall Study|Adverse Event|1|||
170421806|NCT02289963|615886096|FG001|Overall Study|Adverse Event|2|||
170421807|NCT02289963|615886095|FG000|Overall Study|Poor compliance to protocol|1|||
170421808|NCT02289963|615886096|FG001|Overall Study|Poor compliance to protocol|0|||
170421809|NCT02289963|615886095|FG000|Overall Study|Withdrawal by Subject|1|||
170421810|NCT02289963|615886096|FG001|Overall Study|Withdrawal by Subject|0|||
170421811|NCT02289963|615886095|FG000|Overall Study|Last injection missed|2|||
170421812|NCT02289963|615886096|FG001|Overall Study|Last injection missed|2|||
170421813|NCT02289963|615886095|FG000|Overall Study|End treatment visit outside visit window|0|||
170421814|NCT02289963|615886096|FG001|Overall Study|End treatment visit outside visit window|4|||
170421815|NCT02289963|615886095|FG000|Overall Study|Other than specified above|0|||
170421816|NCT02289963|615886096|FG001|Overall Study|Other than specified above|2|||
170421817|NCT01746017|615886101|FG000|Period 1|Withdrawal by Subject|0|||
170421818|NCT01746017|615886102|FG001|Period 1|Withdrawal by Subject|0|||
170421819|NCT01746017|615886103|FG002|Period 1|Withdrawal by Subject|0|||
170421820|NCT01746017|615886104|FG003|Period 1|Withdrawal by Subject|0|||
170421821|NCT01746017|615886105|FG004|Period 1|Withdrawal by Subject|0|||
170421822|NCT01746017|615886106|FG005|Period 1|Withdrawal by Subject|0|||
170421823|NCT01746017|615886107|FG006|Period 1|Withdrawal by Subject|1|||
170421824|NCT01746017|615886108|FG007|Period 1|Withdrawal by Subject|0|||
170421825|NCT01746017|615886109|FG008|Period 1|Withdrawal by Subject|0|||
170421826|NCT01746017|615886110|FG009|Period 1|Withdrawal by Subject|0|||
170421827|NCT01746017|615886111|FG010|Period 1|Withdrawal by Subject|0|||
170421828|NCT01746017|615886101|FG000|Period 3|Withdrawal by Subject|0|||
170421829|NCT01746017|615886102|FG001|Period 3|Withdrawal by Subject|0|||
170421830|NCT01746017|615886103|FG002|Period 3|Withdrawal by Subject|0|||
170421831|NCT01746017|615886104|FG003|Period 3|Withdrawal by Subject|0|||
170532661|NCT05493111|616296591|FG001|Overall Study|Adverse Event|4|||
170532662|NCT05493111|616296590|FG000|Overall Study|Withdrawal of Consent|19|||
170532663|NCT05493111|616296591|FG001|Overall Study|Withdrawal of Consent|10|||
170532664|NCT05493111|616296590|FG000|Overall Study|Non-compliance|1|||
170532665|NCT05493111|616296591|FG001|Overall Study|Non-compliance|1|||
170532666|NCT05493111|616296590|FG000|Overall Study|Lost to Follow-up|8|||
170532667|NCT05493111|616296591|FG001|Overall Study|Lost to Follow-up|1|||
170532668|NCT05493111|616296590|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
170532669|NCT05493111|616296591|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
170532670|NCT05493111|616296590|FG000|Overall Study|Withdrawal by Subject|1|||
170532671|NCT05493111|616296591|FG001|Overall Study|Withdrawal by Subject|1|||
170532672|NCT03846479|616296594|FG000|Overall Study|Death|8|||
170532673|NCT03846479|616296594|FG000|Overall Study|Lost to Follow-up|1|||
170532674|NCT02332707|616296595|FG000|Overall Study|Adverse Event|0|||
170532675|NCT02332707|616296596|FG001|Overall Study|Adverse Event|0|||
170532676|NCT02332707|616296597|FG002|Overall Study|Adverse Event|0|||
170532677|NCT02332707|616296598|FG003|Overall Study|Adverse Event|0|||
170532678|NCT02332707|616296599|FG004|Overall Study|Adverse Event|0|||
170532679|NCT02332707|616296600|FG005|Overall Study|Adverse Event|0|||
170532680|NCT02332707|616296601|FG006|Overall Study|Adverse Event|0|||
170532681|NCT02332707|616296602|FG007|Overall Study|Adverse Event|0|||
170532682|NCT02332707|616296603|FG008|Overall Study|Adverse Event|0|||
170532683|NCT02332707|616296604|FG009|Overall Study|Adverse Event|0|||
170532684|NCT02332707|616296605|FG010|Overall Study|Adverse Event|0|||
170532685|NCT02332707|616296606|FG011|Overall Study|Adverse Event|0|||
170532686|NCT02332707|616296607|FG012|Overall Study|Adverse Event|1|||
170532687|NCT02332707|616296608|FG013|Overall Study|Adverse Event|0|||
170532688|NCT02332707|616296609|FG014|Overall Study|Adverse Event|0|||
170532689|NCT02332707|616296610|FG015|Overall Study|Adverse Event|0|||
170532690|NCT02332707|616296611|FG016|Overall Study|Adverse Event|0|||
170532691|NCT02332707|616296612|FG017|Overall Study|Adverse Event|0|||
170532692|NCT02332707|616296595|FG000|Overall Study|Lost to Follow-up|0|||
170532693|NCT02332707|616296596|FG001|Overall Study|Lost to Follow-up|0|||
170632663|NCT03815929|616666739|FG000|Overall Study|Withdrawal by Subject|0|||
170632664|NCT03815929|616666740|FG001|Overall Study|Withdrawal by Subject|0|||
170632665|NCT03815929|616666741|FG002|Overall Study|Withdrawal by Subject|1|||
170632666|NCT02760498|616666742|FG000|Overall Study|Adverse Event|3|||
170632667|NCT02760498|616666743|FG001|Overall Study|Adverse Event|3|||
170532694|NCT02332707|616296597|FG002|Overall Study|Lost to Follow-up|0|||
170532695|NCT02332707|616296598|FG003|Overall Study|Lost to Follow-up|0|||
170532696|NCT02332707|616296599|FG004|Overall Study|Lost to Follow-up|0|||
170532697|NCT02332707|616296600|FG005|Overall Study|Lost to Follow-up|1|||
170532698|NCT02332707|616296601|FG006|Overall Study|Lost to Follow-up|0|||
170532699|NCT02332707|616296602|FG007|Overall Study|Lost to Follow-up|0|||
170532700|NCT02332707|616296603|FG008|Overall Study|Lost to Follow-up|0|||
170532701|NCT02332707|616296604|FG009|Overall Study|Lost to Follow-up|0|||
170532702|NCT02332707|616296605|FG010|Overall Study|Lost to Follow-up|2|||
170532703|NCT02332707|616296606|FG011|Overall Study|Lost to Follow-up|0|||
170532704|NCT02332707|616296607|FG012|Overall Study|Lost to Follow-up|3|||
170532705|NCT02332707|616296608|FG013|Overall Study|Lost to Follow-up|0|||
170532706|NCT02332707|616296609|FG014|Overall Study|Lost to Follow-up|0|||
170532707|NCT02332707|616296610|FG015|Overall Study|Lost to Follow-up|0|||
170532708|NCT02332707|616296611|FG016|Overall Study|Lost to Follow-up|0|||
170532709|NCT02332707|616296612|FG017|Overall Study|Lost to Follow-up|0|||
170532710|NCT02332707|616296595|FG000|Overall Study|Physician Decision|0|||
170532711|NCT02332707|616296596|FG001|Overall Study|Physician Decision|0|||
170532712|NCT02332707|616296597|FG002|Overall Study|Physician Decision|0|||
170532713|NCT02332707|616296598|FG003|Overall Study|Physician Decision|1|||
170532714|NCT02332707|616296599|FG004|Overall Study|Physician Decision|0|||
170532715|NCT02332707|616296600|FG005|Overall Study|Physician Decision|0|||
170632668|NCT02760498|616666744|FG002|Overall Study|Adverse Event|1|||
170879077|NCT00874120|617569186|FG001|First Intervention|Lost to Follow-up|1|||
170879078|NCT00874120|617569185|FG000|First Intervention|Protocol Violation|3|||
170532716|NCT02332707|616296601|FG006|Overall Study|Physician Decision|0|||
170532717|NCT02332707|616296602|FG007|Overall Study|Physician Decision|0|||
170532718|NCT02332707|616296603|FG008|Overall Study|Physician Decision|0|||
170532719|NCT02332707|616296604|FG009|Overall Study|Physician Decision|0|||
170532720|NCT02332707|616296605|FG010|Overall Study|Physician Decision|0|||
170532721|NCT02332707|616296606|FG011|Overall Study|Physician Decision|0|||
170532722|NCT02332707|616296607|FG012|Overall Study|Physician Decision|1|||
170532723|NCT02332707|616296608|FG013|Overall Study|Physician Decision|0|||
170632669|NCT02760498|616666745|FG003|Overall Study|Adverse Event|1|||
170632670|NCT02760498|616666746|FG004|Overall Study|Adverse Event|0|||
170532724|NCT02332707|616296609|FG014|Overall Study|Physician Decision|0|||
170532725|NCT02332707|616296610|FG015|Overall Study|Physician Decision|0|||
170532726|NCT02332707|616296611|FG016|Overall Study|Physician Decision|0|||
170532727|NCT02332707|616296612|FG017|Overall Study|Physician Decision|0|||
170532728|NCT02332707|616296595|FG000|Overall Study|Withdrawal by Subject|0|||
170532729|NCT02332707|616296596|FG001|Overall Study|Withdrawal by Subject|0|||
170879079|NCT00874120|617569186|FG001|First Intervention|Protocol Violation|0|||
170421832|NCT01746017|615886105|FG004|Period 3|Withdrawal by Subject|0|||
170421833|NCT01746017|615886106|FG005|Period 3|Withdrawal by Subject|1|||
170421834|NCT01746017|615886107|FG006|Period 3|Withdrawal by Subject|0|||
170421835|NCT01746017|615886108|FG007|Period 3|Withdrawal by Subject|0|||
170421836|NCT01746017|615886109|FG008|Period 3|Withdrawal by Subject|0|||
170421837|NCT01746017|615886110|FG009|Period 3|Withdrawal by Subject|0|||
170421838|NCT01746017|615886111|FG010|Period 3|Withdrawal by Subject|0|||
170421839|NCT00549718|615886112|FG000|Overall Study|Insufficient clinical response|20|||
170421840|NCT00549718|615886113|FG001|Overall Study|Insufficient clinical response|7|||
170421841|NCT00549718|615886114|FG002|Overall Study|Insufficient clinical response|18|||
170421842|NCT00549718|615886115|FG003|Overall Study|Insufficient clinical response|32|||
170421843|NCT00549718|615886112|FG000|Overall Study|Adverse Event|6|||
170421844|NCT00549718|615886113|FG001|Overall Study|Adverse Event|8|||
170421845|NCT00549718|615886114|FG002|Overall Study|Adverse Event|7|||
170421846|NCT00549718|615886115|FG003|Overall Study|Adverse Event|3|||
170421847|NCT00549718|615886112|FG000|Overall Study|Lost to Follow-up|4|||
170421848|NCT00549718|615886113|FG001|Overall Study|Lost to Follow-up|2|||
170421849|NCT00549718|615886114|FG002|Overall Study|Lost to Follow-up|0|||
170421850|NCT00549718|615886115|FG003|Overall Study|Lost to Follow-up|6|||
170421851|NCT00549718|615886112|FG000|Overall Study|Withdrawal by Subject|9|||
170421852|NCT00549718|615886113|FG001|Overall Study|Withdrawal by Subject|18|||
170421853|NCT00549718|615886114|FG002|Overall Study|Withdrawal by Subject|12|||
170421854|NCT00549718|615886115|FG003|Overall Study|Withdrawal by Subject|13|||
170421855|NCT00549718|615886112|FG000|Overall Study|Administrative|2|||
170421856|NCT00549718|615886113|FG001|Overall Study|Administrative|2|||
170421857|NCT00549718|615886114|FG002|Overall Study|Administrative|2|||
170421858|NCT00549718|615886115|FG003|Overall Study|Administrative|1|||
170421859|NCT00397488|615886116|FG000|Overall Study|Withdrawal by Subject|3|||
170421860|NCT00397488|615886116|FG000|Overall Study|Adverse Event|3|||
170421861|NCT00397488|615886116|FG000|Overall Study|Death|1|||
170421862|NCT02424097|615886119|FG000|Overall Study|Lost to Follow-up|1|||
170421863|NCT02424097|615886120|FG001|Overall Study|Lost to Follow-up|2|||
170421864|NCT01507051|615886121|FG000|Overall Study|Withdrawal by Subject|1|||
170421865|NCT01507051|615886122|FG001|Overall Study|Withdrawal by Subject|3|||
170421866|NCT01507051|615886123|FG002|Overall Study|Withdrawal by Subject|1|||
170421867|NCT01507051|615886124|FG003|Overall Study|Withdrawal by Subject|6|||
170421868|NCT01507051|615886121|FG000|Overall Study|Physician Decision|0|||
170421869|NCT01507051|615886122|FG001|Overall Study|Physician Decision|0|||
170421870|NCT01507051|615886123|FG002|Overall Study|Physician Decision|0|||
170421871|NCT01507051|615886124|FG003|Overall Study|Physician Decision|1|||
170421872|NCT01507051|615886121|FG000|Overall Study|Adverse Event|1|||
170421873|NCT01507051|615886122|FG001|Overall Study|Adverse Event|0|||
170421874|NCT01507051|615886123|FG002|Overall Study|Adverse Event|0|||
170421875|NCT01507051|615886124|FG003|Overall Study|Adverse Event|0|||
170421876|NCT01675622|615886125|FG000|Overall Study|Withdrawal by Subject|2|||
170421877|NCT01675622|615886126|FG001|Overall Study|Withdrawal by Subject|2|||
170421878|NCT01675622|615886125|FG000|Overall Study|Adverse Event|12|||
170421879|NCT01675622|615886126|FG001|Overall Study|Adverse Event|10|||
170421880|NCT01675622|615886125|FG000|Overall Study|Protocol Violation|4|||
170421881|NCT01675622|615886126|FG001|Overall Study|Protocol Violation|1|||
170421882|NCT01675622|615886125|FG000|Overall Study|Lack of Efficacy|2|||
170421883|NCT01675622|615886126|FG001|Overall Study|Lack of Efficacy|4|||
170421884|NCT01675622|615886125|FG000|Overall Study|Lost to Follow-up|1|||
170421885|NCT01675622|615886126|FG001|Overall Study|Lost to Follow-up|3|||
170421886|NCT01675622|615886125|FG000|Overall Study|Other|5|||
170421887|NCT01675622|615886126|FG001|Overall Study|Other|4|||
170421888|NCT04032977|615886127|FG000|Overall Study|Withdrawal by Subject|6|||
170421889|NCT04032977|615886128|FG001|Overall Study|Withdrawal by Subject|1|||
170421890|NCT04032977|615886127|FG000|Overall Study|Lost to Follow-up|2|||
170421891|NCT04032977|615886128|FG001|Overall Study|Lost to Follow-up|7|||
170421892|NCT04032977|615886127|FG000|Overall Study|Pregnancy|1|||
170421893|NCT04032977|615886128|FG001|Overall Study|Pregnancy|0|||
170421894|NCT01101022|615886129|FG000|Overall Study|Adverse Event|6|||
170421895|NCT01101022|615886130|FG001|Overall Study|Adverse Event|2|||
170421896|NCT01101022|615886129|FG000|Overall Study|Protocol Violation|4|||
170421897|NCT01101022|615886130|FG001|Overall Study|Protocol Violation|3|||
170421898|NCT01101022|615886129|FG000|Overall Study|Withdrawal by Subject|3|||
170421899|NCT01101022|615886130|FG001|Overall Study|Withdrawal by Subject|8|||
170421900|NCT01101022|615886129|FG000|Overall Study|Lost to Follow-up|1|||
170421901|NCT01101022|615886130|FG001|Overall Study|Lost to Follow-up|4|||
170421902|NCT01101022|615886129|FG000|Overall Study|Lack of Efficacy|0|||
170421903|NCT01101022|615886130|FG001|Overall Study|Lack of Efficacy|7|||
170421904|NCT01101022|615886129|FG000|Overall Study|Sponsor decision|1|||
170421905|NCT01101022|615886130|FG001|Overall Study|Sponsor decision|1|||
170421906|NCT01101022|615886129|FG000|Overall Study|Non-compliance|1|||
170421907|NCT01101022|615886130|FG001|Overall Study|Non-compliance|0|||
170421908|NCT01101022|615886129|FG000|Overall Study|Work schedule|1|||
170421909|NCT01101022|615886130|FG001|Overall Study|Work schedule|1|||
170421910|NCT01101022|615886129|FG000|Overall Study|Vacation|0|||
170421911|NCT01101022|615886130|FG001|Overall Study|Vacation|1|||
170879080|NCT00874120|617569185|FG000|First Intervention|positive drug test|1|||
170879081|NCT00874120|617569186|FG001|First Intervention|positive drug test|0|||
170879082|NCT00874120|617569185|FG000|Second Intervention|Withdrawal by Subject|1|||
170879083|NCT00874120|617569186|FG001|Second Intervention|Withdrawal by Subject|0|||
170879084|NCT00874120|617569185|FG000|Second Intervention|Protocol Violation|1|||
170879085|NCT00874120|617569186|FG001|Second Intervention|Protocol Violation|0|||
170421912|NCT02880761|615886132|FG000|Overall Study|Death|6|||
170421913|NCT02880761|615886133|FG001|Overall Study|Death|8|||
170421914|NCT02880761|615886132|FG000|Overall Study|Withdrawal by Subject|3|||
170421915|NCT02880761|615886133|FG001|Overall Study|Withdrawal by Subject|6|||
170421916|NCT02880761|615886132|FG000|Overall Study|Protocol Violation|4|||
170421917|NCT02880761|615886133|FG001|Overall Study|Protocol Violation|3|||
170421918|NCT02880761|615886132|FG000|Overall Study|Lost to Follow-up|3|||
170421919|NCT02880761|615886133|FG001|Overall Study|Lost to Follow-up|4|||
170421920|NCT01519661|615886134|FG000|Overall Study|Protocol deviation|6|||
170421921|NCT01519661|615886134|FG000|Overall Study|Lost to Follow-up|3|||
170421922|NCT01519661|615886134|FG000|Overall Study|Withdrawal by Subject|17|||
170421923|NCT01519661|615886134|FG000|Overall Study|Lack of Efficacy|6|||
170421924|NCT01519661|615886134|FG000|Overall Study|Adverse Event|29|||
170421925|NCT01139047|615886135|FG000|Overall Study|Withdrawal by Subject|1|||
170421926|NCT05628675|615886139|FG000|Overall Study|Lost to Follow-up|2|||
170421927|NCT05628675|615886139|FG000|Overall Study|Withdrawal by Subject|1|||
170421928|NCT00727571|615886145|FG000|Overall Study|Ineligibility determined|1|||
170421929|NCT00727571|615886146|FG001|Overall Study|Ineligibility determined|1|||
170421930|NCT00727571|615886147|FG002|Overall Study|Ineligibility determined|1|||
170421931|NCT00727571|615886148|FG003|Overall Study|Ineligibility determined|0|||
170421932|NCT00727571|615886145|FG000|Overall Study|Death|0|||
170421933|NCT00727571|615886146|FG001|Overall Study|Death|19|||
170421934|NCT00727571|615886147|FG002|Overall Study|Death|5|||
170421935|NCT00727571|615886148|FG003|Overall Study|Death|1|||
170421936|NCT00727571|615886145|FG000|Overall Study|Physician Decision|0|||
170421937|NCT00727571|615886146|FG001|Overall Study|Physician Decision|5|||
170421938|NCT00727571|615886147|FG002|Overall Study|Physician Decision|0|||
170421939|NCT00727571|615886148|FG003|Overall Study|Physician Decision|0|||
170421940|NCT00727571|615886145|FG000|Overall Study|Withdrawal by Subject|0|||
170421941|NCT00727571|615886146|FG001|Overall Study|Withdrawal by Subject|10|||
170421942|NCT00727571|615886147|FG002|Overall Study|Withdrawal by Subject|11|||
170421943|NCT00727571|615886148|FG003|Overall Study|Withdrawal by Subject|0|||
170421944|NCT00727571|615886145|FG000|Overall Study|Subject Non Compliance|0|||
170421945|NCT00727571|615886146|FG001|Overall Study|Subject Non Compliance|6|||
170421946|NCT00727571|615886147|FG002|Overall Study|Subject Non Compliance|0|||
170421947|NCT00727571|615886148|FG003|Overall Study|Subject Non Compliance|4|||
170421948|NCT00727571|615886145|FG000|Overall Study|Dismissed from nursing home|0|||
170421949|NCT00727571|615886146|FG001|Overall Study|Dismissed from nursing home|9|||
170421950|NCT00727571|615886147|FG002|Overall Study|Dismissed from nursing home|5|||
170421951|NCT00727571|615886148|FG003|Overall Study|Dismissed from nursing home|0|||
170421952|NCT00727571|615886145|FG000|Overall Study|Hospitalization|0|||
170421953|NCT00727571|615886146|FG001|Overall Study|Hospitalization|1|||
170421954|NCT00727571|615886147|FG002|Overall Study|Hospitalization|0|||
170421955|NCT00727571|615886148|FG003|Overall Study|Hospitalization|1|||
170421956|NCT00727571|615886145|FG000|Overall Study|AE not leading to hospitalization|0|||
170421957|NCT00727571|615886146|FG001|Overall Study|AE not leading to hospitalization|0|||
170421958|NCT00727571|615886147|FG002|Overall Study|AE not leading to hospitalization|2|||
170421959|NCT00727571|615886148|FG003|Overall Study|AE not leading to hospitalization|0|||
170421960|NCT00727571|615886145|FG000|Overall Study|Other|0|||
170421961|NCT00727571|615886146|FG001|Overall Study|Other|4|||
170421962|NCT00727571|615886147|FG002|Overall Study|Other|6|||
170421963|NCT00727571|615886148|FG003|Overall Study|Other|0|||
170421964|NCT03203447|615886150|FG000|Overall Study|Withdrawal by Subject|2|||
170421965|NCT03203447|615886151|FG001|Overall Study|Withdrawal by Subject|1|||
170421966|NCT03203447|615886150|FG000|Overall Study|Lost to Follow-up|1|||
170421967|NCT03203447|615886151|FG001|Overall Study|Lost to Follow-up|10|||
170421968|NCT03203447|615886150|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
170421969|NCT03203447|615886151|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
170421970|NCT00445003|615886152|FG000|Overall Study|Death|1|||
170421971|NCT00445003|615886153|FG001|Overall Study|Death|2|||
170421972|NCT00445003|615886154|FG002|Overall Study|Death|1|||
170421973|NCT00445003|615886152|FG000|Overall Study|Missed Visit|3|||
170421974|NCT00445003|615886153|FG001|Overall Study|Missed Visit|5|||
170421975|NCT00445003|615886154|FG002|Overall Study|Missed Visit|1|||
170421976|NCT00445003|615886152|FG000|Overall Study|Dropped|1|||
170421977|NCT00445003|615886153|FG001|Overall Study|Dropped|3|||
170421978|NCT00445003|615886154|FG002|Overall Study|Dropped|2|||
170421979|NCT00528606|615886157|FG000|Overall Study|Withdrew consent|4|||
170421980|NCT00528606|615886158|FG001|Overall Study|Withdrew consent|3|||
170879086|NCT01823679|617569187|FG000|Overall Study|Death|1|||
170879087|NCT00105443|617569193|FG000|Double-Blind Treatment|Adverse Event|1|||
170879088|NCT00105443|617569194|FG001|Double-Blind Treatment|Adverse Event|0|||
170532730|NCT02332707|616296597|FG002|Overall Study|Withdrawal by Subject|1|||
170532731|NCT02332707|616296598|FG003|Overall Study|Withdrawal by Subject|0|||
170532732|NCT02332707|616296599|FG004|Overall Study|Withdrawal by Subject|0|||
170532733|NCT02332707|616296600|FG005|Overall Study|Withdrawal by Subject|0|||
170532734|NCT02332707|616296601|FG006|Overall Study|Withdrawal by Subject|0|||
170532735|NCT02332707|616296602|FG007|Overall Study|Withdrawal by Subject|0|||
170532736|NCT02332707|616296603|FG008|Overall Study|Withdrawal by Subject|0|||
170532737|NCT02332707|616296604|FG009|Overall Study|Withdrawal by Subject|3|||
170532738|NCT02332707|616296605|FG010|Overall Study|Withdrawal by Subject|0|||
170532739|NCT02332707|616296606|FG011|Overall Study|Withdrawal by Subject|0|||
170532740|NCT02332707|616296607|FG012|Overall Study|Withdrawal by Subject|0|||
170532741|NCT02332707|616296608|FG013|Overall Study|Withdrawal by Subject|0|||
170532742|NCT02332707|616296609|FG014|Overall Study|Withdrawal by Subject|0|||
170532743|NCT02332707|616296610|FG015|Overall Study|Withdrawal by Subject|0|||
170532744|NCT02332707|616296611|FG016|Overall Study|Withdrawal by Subject|0|||
170532745|NCT02332707|616296612|FG017|Overall Study|Withdrawal by Subject|0|||
170532746|NCT02690727|616296618|FG000|Overall Study|Adverse Event|2|||
170532747|NCT02690727|616296619|FG001|Overall Study|Adverse Event|2|||
170532748|NCT04757636|616296620|FG000|Overall Study|Adverse Event|25|||
170532749|NCT04757636|616296621|FG001|Overall Study|Adverse Event|8|||
170532750|NCT04757636|616296622|FG002|Overall Study|Adverse Event|11|||
170532751|NCT04757636|616296620|FG000|Overall Study|Death|9|||
170532752|NCT04757636|616296621|FG001|Overall Study|Death|12|||
170532753|NCT04757636|616296622|FG002|Overall Study|Death|6|||
170532754|NCT04757636|616296620|FG000|Overall Study|Lack of Efficacy|2|||
170532755|NCT04757636|616296621|FG001|Overall Study|Lack of Efficacy|0|||
170532756|NCT04757636|616296622|FG002|Overall Study|Lack of Efficacy|0|||
170532757|NCT04757636|616296620|FG000|Overall Study|Lost to Follow-up|1|||
170532758|NCT04757636|616296621|FG001|Overall Study|Lost to Follow-up|6|||
170532759|NCT04757636|616296622|FG002|Overall Study|Lost to Follow-up|7|||
170532760|NCT04757636|616296620|FG000|Overall Study|Physician Decision|1|||
170532761|NCT04757636|616296621|FG001|Overall Study|Physician Decision|3|||
170532762|NCT04757636|616296622|FG002|Overall Study|Physician Decision|4|||
170532763|NCT04757636|616296620|FG000|Overall Study|Withdrawal by Subject|20|||
170532764|NCT04757636|616296621|FG001|Overall Study|Withdrawal by Subject|23|||
170532765|NCT04757636|616296622|FG002|Overall Study|Withdrawal by Subject|18|||
170532766|NCT04757636|616296620|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
170532767|NCT04757636|616296621|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
170532768|NCT04757636|616296622|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
170532769|NCT04757636|616296620|FG000|Overall Study|Study Terminated by Sponsor|103|||
170532770|NCT04757636|616296621|FG001|Overall Study|Study Terminated by Sponsor|104|||
170532771|NCT04757636|616296622|FG002|Overall Study|Study Terminated by Sponsor|114|||
170532772|NCT04757636|616296620|FG000|Overall Study|Sponsor Decision|0|||
170532773|NCT04757636|616296621|FG001|Overall Study|Sponsor Decision|0|||
170532774|NCT04757636|616296622|FG002|Overall Study|Sponsor Decision|1|||
170532775|NCT04757636|616296620|FG000|Overall Study|Randomized in Error|0|||
170532776|NCT04757636|616296621|FG001|Overall Study|Randomized in Error|0|||
170532777|NCT04757636|616296622|FG002|Overall Study|Randomized in Error|2|||
170532778|NCT00851591|616296623|FG000|Overall Study|Withdrawal by Subject|2|||
170532779|NCT00851591|616296624|FG001|Overall Study|Withdrawal by Subject|0|||
170532780|NCT02736617|616296629|FG000|Treatment|Adverse Event|1|||
170532781|NCT02736617|616296629|FG000|Treatment|Lack of Efficacy|1|||
170532782|NCT02736617|616296629|FG000|Treatment|Withdrawal by Subject|1|||
170532783|NCT02736617|616296629|FG000|Maintenance|Lack of Efficacy|4|||
170532784|NCT02736617|616296629|FG000|Maintenance|Physician Decision|1|||
170532785|NCT01513590|616296632|FG000|Overall Study|Adverse Event|2|||
170532786|NCT01513590|616296633|FG001|Overall Study|Adverse Event|3|||
170532787|NCT01513590|616296632|FG000|Overall Study|Withdrawal Criteria|3|||
170532788|NCT01513590|616296633|FG001|Overall Study|Withdrawal Criteria|0|||
170532789|NCT01513590|616296632|FG000|Overall Study|Unclassified|5|||
170532790|NCT01513590|616296633|FG001|Overall Study|Unclassified|10|||
170532791|NCT01056276|616296634|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
170532792|NCT01056276|616296635|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
170532793|NCT01056276|616296634|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
170532794|NCT01056276|616296635|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
170532795|NCT01056276|616296634|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
170532796|NCT01056276|616296635|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
170532797|NCT01056276|616296634|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
170532798|NCT01056276|616296635|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
170532799|NCT01056276|616296634|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
170532800|NCT01056276|616296635|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
170532801|NCT01056276|616296634|FG000|Treatment Period-Cycles 1-8|Death|3|||
170532802|NCT01056276|616296635|FG001|Treatment Period-Cycles 1-8|Death|1|||
170532803|NCT01056276|616296634|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
170532804|NCT01056276|616296635|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
170421981|NCT00528606|615886157|FG000|Overall Study|Lost to Follow-up|4|||
170421982|NCT00528606|615886158|FG001|Overall Study|Lost to Follow-up|1|||
170421983|NCT00528606|615886157|FG000|Overall Study|Adverse Event|3|||
170421984|NCT00528606|615886158|FG001|Overall Study|Adverse Event|0|||
170421985|NCT00528606|615886157|FG000|Overall Study|Other|2|||
170421986|NCT00528606|615886158|FG001|Overall Study|Other|0|||
170421987|NCT02475954|615886159|FG000|Overall Study|Withdrawal by Subject|2|||
170421988|NCT02475954|615886160|FG001|Overall Study|Withdrawal by Subject|2|||
170421989|NCT02475954|615886159|FG000|Overall Study|Lost to Follow-up|11|||
170421990|NCT02475954|615886160|FG001|Overall Study|Lost to Follow-up|9|||
170421991|NCT02475954|615886159|FG000|Overall Study|Death|1|||
170421992|NCT02475954|615886160|FG001|Overall Study|Death|1|||
170421993|NCT00880568|615886164|FG000|Overall Study|Disease progression|3|||
170421994|NCT00880568|615886165|FG001|Overall Study|Disease progression|3|||
170421995|NCT00880568|615886166|FG002|Overall Study|Disease progression|3|||
170421996|NCT00880568|615886167|FG003|Overall Study|Disease progression|1|||
170421997|NCT00880568|615886168|FG004|Overall Study|Disease progression|3|||
170421998|NCT00880568|615886169|FG005|Overall Study|Disease progression|3|||
170421999|NCT00880568|615886170|FG006|Overall Study|Disease progression|5|||
170422000|NCT00880568|615886171|FG007|Overall Study|Disease progression|0|||
170422001|NCT00880568|615886172|FG008|Overall Study|Disease progression|3|||
170422002|NCT00880568|615886164|FG000|Overall Study|Adverse Event|0|||
170422003|NCT00880568|615886165|FG001|Overall Study|Adverse Event|0|||
170422004|NCT00880568|615886166|FG002|Overall Study|Adverse Event|0|||
170422005|NCT00880568|615886167|FG003|Overall Study|Adverse Event|0|||
170422006|NCT00880568|615886168|FG004|Overall Study|Adverse Event|0|||
170422007|NCT00880568|615886169|FG005|Overall Study|Adverse Event|0|||
170422008|NCT00880568|615886170|FG006|Overall Study|Adverse Event|1|||
170422009|NCT00880568|615886171|FG007|Overall Study|Adverse Event|1|||
170422010|NCT00880568|615886172|FG008|Overall Study|Adverse Event|0|||
170422011|NCT00880568|615886164|FG000|Overall Study|Withdrawal by Subject|0|||
170422012|NCT00880568|615886165|FG001|Overall Study|Withdrawal by Subject|0|||
170422013|NCT00880568|615886166|FG002|Overall Study|Withdrawal by Subject|0|||
170422014|NCT00880568|615886167|FG003|Overall Study|Withdrawal by Subject|0|||
170422015|NCT00880568|615886168|FG004|Overall Study|Withdrawal by Subject|0|||
170422016|NCT00880568|615886169|FG005|Overall Study|Withdrawal by Subject|0|||
170422017|NCT00880568|615886170|FG006|Overall Study|Withdrawal by Subject|0|||
170422018|NCT00880568|615886171|FG007|Overall Study|Withdrawal by Subject|1|||
170422019|NCT00880568|615886172|FG008|Overall Study|Withdrawal by Subject|0|||
170422020|NCT01710657|615886175|FG000|Overall Study|Lost to Follow-up|2|||
170422021|NCT01710657|615886176|FG001|Overall Study|Lost to Follow-up|0|||
170422022|NCT01710657|615886177|FG002|Overall Study|Lost to Follow-up|1|||
170422023|NCT01710657|615886175|FG000|Overall Study|Protocol Violation|2|||
170422024|NCT01710657|615886176|FG001|Overall Study|Protocol Violation|2|||
170422025|NCT01710657|615886177|FG002|Overall Study|Protocol Violation|0|||
170422026|NCT01710657|615886175|FG000|Overall Study|Adverse Event|14|||
170422027|NCT01710657|615886176|FG001|Overall Study|Adverse Event|8|||
170422028|NCT01710657|615886177|FG002|Overall Study|Adverse Event|28|||
170422029|NCT01710657|615886175|FG000|Overall Study|Withdrawal by Subject|0|||
170422030|NCT01710657|615886176|FG001|Overall Study|Withdrawal by Subject|1|||
170422031|NCT01710657|615886177|FG002|Overall Study|Withdrawal by Subject|2|||
170422032|NCT01710657|615886175|FG000|Overall Study|Lack of Efficacy|0|||
170422033|NCT01710657|615886176|FG001|Overall Study|Lack of Efficacy|1|||
170422034|NCT01710657|615886177|FG002|Overall Study|Lack of Efficacy|1|||
170422035|NCT02334722|615886181|FG000|Overall Study|Lost to Follow-up|4|||
170422036|NCT02334722|615886182|FG001|Overall Study|Lost to Follow-up|0|||
170422037|NCT02334722|615886181|FG000|Overall Study|6 week questionnaire not completed|2|||
170422038|NCT02334722|615886182|FG001|Overall Study|6 week questionnaire not completed|0|||
170422039|NCT02334722|615886181|FG000|Overall Study|Unable to obtain medication|1|||
170422040|NCT02334722|615886182|FG001|Overall Study|Unable to obtain medication|1|||
170422041|NCT02334722|615886181|FG000|Overall Study|Withdrawal by Subject|0|||
170422042|NCT02334722|615886182|FG001|Overall Study|Withdrawal by Subject|3|||
170422043|NCT02334722|615886181|FG000|Overall Study|Adverse Event|0|||
170422044|NCT02334722|615886182|FG001|Overall Study|Adverse Event|2|||
170422045|NCT02334722|615886181|FG000|Overall Study|Physician Decision|0|||
170422046|NCT02334722|615886182|FG001|Overall Study|Physician Decision|1|||
170422047|NCT05612724|615886183|FG000|Overall Study|Lost to Follow-up|4|||
170422048|NCT00925769|615886185|FG000|Overall Study|Major toxicity|1|||
170422049|NCT00925769|615886186|FG001|Overall Study|Major toxicity|0|||
170422050|NCT00925769|615886187|FG002|Overall Study|Major toxicity|1|||
170422051|NCT00925769|615886188|FG003|Overall Study|Major toxicity|1|||
170422052|NCT00925769|615886189|FG004|Overall Study|Major toxicity|0|||
170422053|NCT00925769|615886190|FG005|Overall Study|Major toxicity|0|||
170422054|NCT00925769|615886185|FG000|Overall Study|Disease progression|4|||
170422055|NCT00925769|615886186|FG001|Overall Study|Disease progression|5|||
170422056|NCT00925769|615886187|FG002|Overall Study|Disease progression|3|||
170422057|NCT00925769|615886188|FG003|Overall Study|Disease progression|4|||
170422058|NCT00925769|615886189|FG004|Overall Study|Disease progression|2|||
170422059|NCT00925769|615886190|FG005|Overall Study|Disease progression|3|||
170422060|NCT00925769|615886185|FG000|Overall Study|Death|0|||
170532805|NCT01056276|616296634|FG000|Maintenance Therapy|Toxicity|0|||
170532806|NCT01056276|616296635|FG001|Maintenance Therapy|Toxicity|2|||
170532807|NCT01056276|616296634|FG000|Maintenance Therapy|Progressive Disease|0|||
170532808|NCT01056276|616296635|FG001|Maintenance Therapy|Progressive Disease|9|||
170532809|NCT01056276|616296634|FG000|Maintenance Therapy|Physician Decision|0|||
170532810|NCT01056276|616296635|FG001|Maintenance Therapy|Physician Decision|1|||
170532811|NCT01056276|616296634|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
170532812|NCT01056276|616296635|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
170532813|NCT01056276|616296634|FG000|Maintenance Therapy|Intercurrent Illness|0|||
170532814|NCT01056276|616296635|FG001|Maintenance Therapy|Intercurrent Illness|1|||
170532815|NCT01056276|616296634|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
170532816|NCT01056276|616296635|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
170532817|NCT01348269|616296637|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
170532818|NCT01348269|616296638|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
170532819|NCT01348269|616296637|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
170532820|NCT01348269|616296638|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
170532821|NCT01348269|616296637|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
170532822|NCT01348269|616296638|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
170532823|NCT04167462|616296639|FG000|Overall Study|Other reasons|3|||
170532824|NCT04167462|616296640|FG001|Overall Study|Other reasons|2|||
170532825|NCT04167462|616296639|FG000|Overall Study|Withdrawal by Subject|6|||
170532826|NCT04167462|616296640|FG001|Overall Study|Withdrawal by Subject|7|||
170532827|NCT04167462|616296639|FG000|Overall Study|Adverse Event|4|||
170532828|NCT04167462|616296640|FG001|Overall Study|Adverse Event|0|||
170532829|NCT04167462|616296639|FG000|Overall Study|Pregnancy|1|||
170532830|NCT04167462|616296640|FG001|Overall Study|Pregnancy|0|||
170532831|NCT04167462|616296639|FG000|Overall Study|Lack of Efficacy|0|||
170532832|NCT04167462|616296640|FG001|Overall Study|Lack of Efficacy|1|||
170532833|NCT00289276|616296645|FG000|Second Part of FAST Study (Expansion)|Death|0|||
170532834|NCT00289276|616296646|FG001|Second Part of FAST Study (Expansion)|Death|2|||
170532835|NCT00289276|616296645|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
170532836|NCT00289276|616296646|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
170532837|NCT00639509|616296647|FG000|Overall Study|Death|1|||
170532838|NCT02642042|616296654|FG000|Overall Study|Adverse Event|22|||
170532839|NCT02642042|616296654|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
170532840|NCT02642042|616296654|FG000|Overall Study|Progression/Relapse|28|||
170532841|NCT02642042|616296654|FG000|Overall Study|Death|1|||
170532842|NCT02642042|616296654|FG000|Overall Study|Not Protocol Specified|2|||
170532843|NCT04108468|616296655|FG000|Overall Study|Physician Decision|0|||
170532844|NCT04108468|616296656|FG001|Overall Study|Physician Decision|1|||
170532845|NCT04108468|616296655|FG000|Overall Study|Lost to Follow-up|0|||
170532846|NCT04108468|616296656|FG001|Overall Study|Lost to Follow-up|1|||
170532847|NCT04108468|616296655|FG000|Overall Study|Non-compliance|1|||
170532848|NCT04108468|616296656|FG001|Overall Study|Non-compliance|1|||
170532849|NCT04108468|616296655|FG000|Overall Study|Unable to attend final visit|2|||
170532850|NCT04108468|616296656|FG001|Overall Study|Unable to attend final visit|0|||
170532851|NCT04108468|616296655|FG000|Overall Study|Missed study medication|0|||
170532852|NCT04108468|616296656|FG001|Overall Study|Missed study medication|1|||
170532853|NCT05035407|616296659|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
170532854|NCT05035407|616296660|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
170532855|NCT05035407|616296661|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
170532856|NCT05035407|616296662|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
170422061|NCT00925769|615886186|FG001|Overall Study|Death|0|||
170422062|NCT00925769|615886187|FG002|Overall Study|Death|1|||
170422063|NCT00925769|615886188|FG003|Overall Study|Death|0|||
170422064|NCT00925769|615886189|FG004|Overall Study|Death|0|||
170422065|NCT00925769|615886190|FG005|Overall Study|Death|0|||
170422066|NCT00925769|615886185|FG000|Overall Study|Physician Decision|1|||
170422067|NCT00925769|615886186|FG001|Overall Study|Physician Decision|0|||
170422068|NCT00925769|615886187|FG002|Overall Study|Physician Decision|0|||
170422069|NCT00925769|615886188|FG003|Overall Study|Physician Decision|0|||
170422070|NCT00925769|615886189|FG004|Overall Study|Physician Decision|0|||
170422071|NCT00925769|615886190|FG005|Overall Study|Physician Decision|0|||
170422072|NCT00925769|615886185|FG000|Overall Study|Missing documentation|0|||
170422073|NCT00925769|615886186|FG001|Overall Study|Missing documentation|1|||
170422074|NCT00925769|615886187|FG002|Overall Study|Missing documentation|0|||
170422075|NCT00925769|615886188|FG003|Overall Study|Missing documentation|0|||
170422076|NCT00925769|615886189|FG004|Overall Study|Missing documentation|0|||
170422077|NCT00925769|615886190|FG005|Overall Study|Missing documentation|0|||
170565463|NCT05643495|616417170|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
170422078|NCT00925769|615886185|FG000|Overall Study|End of study visit not done|0|||
170422079|NCT00925769|615886186|FG001|Overall Study|End of study visit not done|0|||
170422080|NCT00925769|615886187|FG002|Overall Study|End of study visit not done|1|||
170532857|NCT05035407|616296663|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
170532858|NCT05035407|616296664|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
170532859|NCT04513366|616296665|FG000|Treatment Phase|Withdrawal by Subject|6|||
170532860|NCT04513366|616296666|FG001|Treatment Phase|Withdrawal by Subject|8|||
170532861|NCT04513366|616296667|FG002|Treatment Phase|Withdrawal by Subject|3|||
170532862|NCT04513366|616296665|FG000|Treatment Phase|Lost to Follow-up|1|||
170532863|NCT04513366|616296666|FG001|Treatment Phase|Lost to Follow-up|2|||
170532864|NCT04513366|616296667|FG002|Treatment Phase|Lost to Follow-up|5|||
170532865|NCT04513366|616296665|FG000|Treatment Phase|Other than Specified|1|||
170532866|NCT04513366|616296666|FG001|Treatment Phase|Other than Specified|0|||
170532867|NCT04513366|616296667|FG002|Treatment Phase|Other than Specified|2|||
170532868|NCT04513366|616296665|FG000|Treatment Phase|Physician Decision|2|||
170532869|NCT04513366|616296666|FG001|Treatment Phase|Physician Decision|0|||
170532870|NCT04513366|616296667|FG002|Treatment Phase|Physician Decision|0|||
170532871|NCT04513366|616296665|FG000|Treatment Phase|Adverse Event|0|||
170532872|NCT04513366|616296666|FG001|Treatment Phase|Adverse Event|1|||
170532873|NCT04513366|616296667|FG002|Treatment Phase|Adverse Event|1|||
170532874|NCT04513366|616296665|FG000|Extension Phase|Withdrawal by Subject|3|||
170532875|NCT04513366|616296666|FG001|Extension Phase|Withdrawal by Subject|1|||
170532876|NCT04513366|616296667|FG002|Extension Phase|Withdrawal by Subject|1|||
170532877|NCT04513366|616296665|FG000|Extension Phase|Other than Specified|4|||
170532878|NCT04513366|616296666|FG001|Extension Phase|Other than Specified|0|||
170532879|NCT04513366|616296667|FG002|Extension Phase|Other than Specified|1|||
170532880|NCT04513366|616296665|FG000|Extension Phase|Lost to Follow-up|1|||
170532881|NCT04513366|616296666|FG001|Extension Phase|Lost to Follow-up|1|||
170532882|NCT04513366|616296667|FG002|Extension Phase|Lost to Follow-up|1|||
170532883|NCT04513366|616296665|FG000|Extension Phase|Sponsor Decision|0|||
170532884|NCT04513366|616296666|FG001|Extension Phase|Sponsor Decision|1|||
170532885|NCT04513366|616296667|FG002|Extension Phase|Sponsor Decision|0|||
170532886|NCT04513366|616296665|FG000|Extension Phase|Death|0|||
170532887|NCT04513366|616296666|FG001|Extension Phase|Death|1|||
170532888|NCT04513366|616296667|FG002|Extension Phase|Death|0|||
170532889|NCT04513366|616296665|FG000|Extension Phase|Adverse Event|0|||
170532890|NCT04513366|616296666|FG001|Extension Phase|Adverse Event|0|||
170532891|NCT04513366|616296667|FG002|Extension Phase|Adverse Event|1|||
170532892|NCT06121609|616296669|FG000|Overall Study|Lack of Efficacy|0|||
170532893|NCT06121609|616296670|FG001|Overall Study|Lack of Efficacy|0|||
170532894|NCT06121609|616296671|FG002|Overall Study|Lack of Efficacy|45|||
170532895|NCT00269152|616296672|FG000|Overall Study|Adverse Event|9|||
170532896|NCT00269152|616296673|FG001|Overall Study|Adverse Event|3|||
170532897|NCT00269152|616296672|FG000|Overall Study|Withdrawal by Subject|7|||
170532898|NCT00269152|616296673|FG001|Overall Study|Withdrawal by Subject|3|||
170532899|NCT00269152|616296672|FG000|Overall Study|Physician Decision|2|||
170532900|NCT00269152|616296673|FG001|Overall Study|Physician Decision|3|||
170532901|NCT00269152|616296672|FG000|Overall Study|Protocol Violation|0|||
170532902|NCT00269152|616296673|FG001|Overall Study|Protocol Violation|1|||
170532903|NCT01832766|616296674|FG000|Washout|Lost to Follow-up|0|||
170532904|NCT01832766|616296675|FG001|Washout|Lost to Follow-up|1|||
170532905|NCT03074500|616296681|FG000|Overall Study|Lost to Follow-up|1|||
170532906|NCT03074500|616296682|FG001|Overall Study|Lost to Follow-up|0|||
170532907|NCT03074500|616296683|FG002|Overall Study|Lost to Follow-up|0|||
170532908|NCT03074500|616296681|FG000|Overall Study|Lack of Efficacy|0|||
170532909|NCT03074500|616296682|FG001|Overall Study|Lack of Efficacy|1|||
170532910|NCT03074500|616296683|FG002|Overall Study|Lack of Efficacy|0|||
170532911|NCT03074500|616296681|FG000|Overall Study|Adverse Event|0|||
170532912|NCT03074500|616296682|FG001|Overall Study|Adverse Event|0|||
170532913|NCT03074500|616296683|FG002|Overall Study|Adverse Event|1|||
170532914|NCT03321721|616296684|FG000|Overall Study|Lost to Follow-up|4|||
170532915|NCT03321721|616296685|FG001|Overall Study|Lost to Follow-up|8|||
170532916|NCT03321721|616296686|FG002|Overall Study|Lost to Follow-up|11|||
170532917|NCT03353220|616296688|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
170532918|NCT03353220|616296689|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
170532919|NCT03586479|616296690|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
170532920|NCT03586479|616296691|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
170532921|NCT03586479|616296692|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
170532922|NCT03586479|616296690|FG000|Overall Study|Protocol Violation|2|||
170532923|NCT03586479|616296691|FG001|Overall Study|Protocol Violation|0|||
170532924|NCT03586479|616296692|FG002|Overall Study|Protocol Violation|0|||
170532925|NCT03586479|616296690|FG000|Overall Study|Lost to Follow-up|1|||
170532926|NCT03586479|616296691|FG001|Overall Study|Lost to Follow-up|1|||
170532927|NCT03586479|616296692|FG002|Overall Study|Lost to Follow-up|2|||
170532928|NCT03586479|616296690|FG000|Overall Study|Behavioral Issues|1|||
170532929|NCT03586479|616296691|FG001|Overall Study|Behavioral Issues|0|||
170532930|NCT03586479|616296692|FG002|Overall Study|Behavioral Issues|0|||
170532931|NCT02634710|616296694|FG000|Overall Study|Death|4|||
170532932|NCT03454555|616298192|FG000|Overall Study|Death|6|||
170532933|NCT03454555|616298193|FG001|Overall Study|Death|6|||
170532934|NCT03454555|616298192|FG000|Overall Study|Lost to Follow-up|31|||
170532935|NCT03454555|616298193|FG001|Overall Study|Lost to Follow-up|12|||
170532936|NCT03454555|616298192|FG000|Overall Study|Physician Decision|2|||
170532937|NCT03454555|616298193|FG001|Overall Study|Physician Decision|6|||
170532938|NCT03454555|616298192|FG000|Overall Study|Withdrawal by Subject|34|||
170532939|NCT03454555|616298193|FG001|Overall Study|Withdrawal by Subject|5|||
170532940|NCT03454555|616298192|FG000|Overall Study|Ineligible|1|||
170532941|NCT03454555|616298193|FG001|Overall Study|Ineligible|5|||
170532942|NCT03834961|616298197|FG000|Overall Study|Lack of Efficacy|1|||
170532943|NCT03834961|616298198|FG001|Overall Study|Lack of Efficacy|1|||
170532944|NCT03834961|616298199|FG002|Overall Study|Lack of Efficacy|0|||
170532945|NCT03834961|616298197|FG000|Overall Study|Physician Decision|0|||
170532946|NCT03834961|616298198|FG001|Overall Study|Physician Decision|1|||
170532947|NCT03834961|616298199|FG002|Overall Study|Physician Decision|0|||
170532948|NCT03836053|616298200|FG000|Overall Study|Protocol-specified criteria|0|||
170532949|NCT03836053|616298201|FG001|Overall Study|Protocol-specified criteria|2|||
170532950|NCT03836053|616298202|FG002|Overall Study|Protocol-specified criteria|1|||
170532951|NCT03836053|616298200|FG000|Overall Study|Death|1|||
170532952|NCT03836053|616298201|FG001|Overall Study|Death|6|||
170532953|NCT03836053|616298202|FG002|Overall Study|Death|4|||
170532954|NCT03836053|616298200|FG000|Overall Study|Withdrawal of consent from study|0|||
170532955|NCT03836053|616298201|FG001|Overall Study|Withdrawal of consent from study|0|||
170532956|NCT03836053|616298202|FG002|Overall Study|Withdrawal of consent from study|1|||
170532957|NCT03836053|616298200|FG000|Overall Study|Decision by sponsor|0|||
170532958|NCT03836053|616298201|FG001|Overall Study|Decision by sponsor|2|||
170532959|NCT03836053|616298202|FG002|Overall Study|Decision by sponsor|4|||
170532960|NCT04761822|616298207|FG000|Overall Study|Adverse Event|3|||
170532961|NCT04761822|616298208|FG001|Overall Study|Adverse Event|1|||
170532962|NCT04761822|616298209|FG002|Overall Study|Adverse Event|1|||
170532963|NCT04761822|616298210|FG003|Overall Study|Adverse Event|3|||
170532964|NCT04761822|616298207|FG000|Overall Study|Lost to Follow-up|1|||
170879089|NCT00105443|617569195|FG002|Double-Blind Treatment|Adverse Event|0|||
170422081|NCT00925769|615886188|FG003|Overall Study|End of study visit not done|0|||
170422082|NCT00925769|615886189|FG004|Overall Study|End of study visit not done|0|||
170422083|NCT00925769|615886190|FG005|Overall Study|End of study visit not done|0|||
170422084|NCT00925769|615886185|FG000|Overall Study|Participant is unable to swallow drug|0|||
170422085|NCT00925769|615886186|FG001|Overall Study|Participant is unable to swallow drug|0|||
170422086|NCT00925769|615886187|FG002|Overall Study|Participant is unable to swallow drug|0|||
170422087|NCT00925769|615886188|FG003|Overall Study|Participant is unable to swallow drug|1|||
170422088|NCT00925769|615886189|FG004|Overall Study|Participant is unable to swallow drug|0|||
170422089|NCT00925769|615886190|FG005|Overall Study|Participant is unable to swallow drug|0|||
170422090|NCT00925769|615886185|FG000|Overall Study|Adverse Event|0|||
170422091|NCT00925769|615886186|FG001|Overall Study|Adverse Event|0|||
170422092|NCT00925769|615886187|FG002|Overall Study|Adverse Event|0|||
170422093|NCT00925769|615886188|FG003|Overall Study|Adverse Event|0|||
170422094|NCT00925769|615886189|FG004|Overall Study|Adverse Event|1|||
170422095|NCT00925769|615886190|FG005|Overall Study|Adverse Event|0|||
170422096|NCT00891293|615886194|FG000|Overall Study|Adverse Event|2|||
170422097|NCT00891293|615886194|FG000|Overall Study|Protocol Violation|2|||
170422098|NCT00891293|615886194|FG000|Overall Study|Laboratory abnormality|4|||
170422099|NCT00891293|615886194|FG000|Overall Study|Lost to Follow-up|7|||
170422100|NCT00891293|615886194|FG000|Overall Study|Subject withdrew consent|7|||
170422101|NCT00891293|615886194|FG000|Overall Study|Sponsor termination|62|||
170422102|NCT00440557|615886195|FG000|Overall Study|Withdrawal by Subject|10|||
170422103|NCT00440557|615886196|FG001|Overall Study|Withdrawal by Subject|5|||
170422104|NCT00440557|615886197|FG002|Overall Study|Withdrawal by Subject|11|||
170422105|NCT00440557|615886195|FG000|Overall Study|Lost to Follow-up|1|||
170422106|NCT00440557|615886196|FG001|Overall Study|Lost to Follow-up|2|||
170422107|NCT00440557|615886197|FG002|Overall Study|Lost to Follow-up|6|||
170422108|NCT00440557|615886195|FG000|Overall Study|Adverse Event|3|||
170422109|NCT00440557|615886196|FG001|Overall Study|Adverse Event|3|||
170422110|NCT00440557|615886197|FG002|Overall Study|Adverse Event|5|||
170422111|NCT00440557|615886195|FG000|Overall Study|Death|2|||
170422112|NCT00440557|615886196|FG001|Overall Study|Death|6|||
170422113|NCT00440557|615886197|FG002|Overall Study|Death|3|||
170532965|NCT04761822|616298208|FG001|Overall Study|Lost to Follow-up|0|||
170532966|NCT04761822|616298209|FG002|Overall Study|Lost to Follow-up|2|||
170532967|NCT04761822|616298210|FG003|Overall Study|Lost to Follow-up|3|||
170532968|NCT04761822|616298207|FG000|Overall Study|Physician Decision|0|||
170532969|NCT04761822|616298208|FG001|Overall Study|Physician Decision|1|||
170532970|NCT04761822|616298209|FG002|Overall Study|Physician Decision|0|||
170632671|NCT02760498|616666747|FG005|Overall Study|Adverse Event|6|||
170422114|NCT00440557|615886195|FG000|Overall Study|Began Dialysis|4|||
170422115|NCT00440557|615886196|FG001|Overall Study|Began Dialysis|1|||
170422116|NCT00440557|615886197|FG002|Overall Study|Began Dialysis|4|||
170879090|NCT00105443|617569196|FG003|Double-Blind Treatment|Adverse Event|0|||
170532971|NCT04761822|616298210|FG003|Overall Study|Physician Decision|0|||
170532972|NCT04761822|616298207|FG000|Overall Study|Withdrawal by Subject|3|||
170532973|NCT04761822|616298208|FG001|Overall Study|Withdrawal by Subject|8|||
170532974|NCT04761822|616298209|FG002|Overall Study|Withdrawal by Subject|1|||
170532975|NCT04761822|616298210|FG003|Overall Study|Withdrawal by Subject|11|||
170532976|NCT04761822|616298207|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
170532977|NCT04761822|616298208|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
170532978|NCT04761822|616298209|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
170532979|NCT04761822|616298210|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
170532980|NCT04761822|616298207|FG000|Overall Study|Participant requested unblinding|0|||
170532981|NCT04761822|616298208|FG001|Overall Study|Participant requested unblinding|0|||
170532982|NCT04761822|616298209|FG002|Overall Study|Participant requested unblinding|0|||
170532983|NCT04761822|616298210|FG003|Overall Study|Participant requested unblinding|1|||
170532984|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
170532985|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
170532986|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Death|1|||
170532987|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Death|3|||
170532988|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
170532989|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
170532990|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
170532991|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
170532992|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
170532993|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
170532994|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
170532995|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
170532996|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
170532997|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
170532998|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
170532999|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
170533000|NCT00362232|616298211|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
170533001|NCT00362232|616298212|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
170533002|NCT00362232|616298211|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
170533003|NCT00362232|616298212|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
170533004|NCT00362232|616298211|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
170533005|NCT00362232|616298212|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
170533006|NCT00362232|616298211|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
170533007|NCT00362232|616298212|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
170533008|NCT00362232|616298211|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
170533009|NCT00362232|616298212|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
170533010|NCT00375752|616298215|FG000|Overall Study|Lack of Efficacy|4|||
170533011|NCT00375752|616298216|FG001|Overall Study|Lack of Efficacy|4|||
170533012|NCT00375752|616298215|FG000|Overall Study|Adverse Event|1|||
170533013|NCT00375752|616298216|FG001|Overall Study|Adverse Event|6|||
170533014|NCT00375752|616298215|FG000|Overall Study|Withdrawal by Subject|6|||
170533015|NCT00375752|616298216|FG001|Overall Study|Withdrawal by Subject|1|||
170533016|NCT00375752|616298215|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
170533017|NCT00375752|616298216|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
170533018|NCT00375752|616298215|FG000|Overall Study|Protocol Violation|0|||
170533019|NCT00375752|616298216|FG001|Overall Study|Protocol Violation|2|||
170533020|NCT00375752|616298215|FG000|Overall Study|Administrative Problems|0|||
170533021|NCT00375752|616298216|FG001|Overall Study|Administrative Problems|1|||
170533022|NCT01799889|616298219|FG000|Overall Study|Adverse Event|4|||
170533023|NCT01799889|616298220|FG001|Overall Study|Adverse Event|4|||
170533024|NCT01799889|616298221|FG002|Overall Study|Adverse Event|5|||
170533025|NCT01799889|616298222|FG003|Overall Study|Adverse Event|1|||
170533026|NCT01799889|616298223|FG004|Overall Study|Adverse Event|11|||
170533027|NCT01799889|616298224|FG005|Overall Study|Adverse Event|1|||
170533028|NCT01799889|616298225|FG006|Overall Study|Adverse Event|5|||
170533029|NCT01799889|616298226|FG007|Overall Study|Adverse Event|2|||
170533030|NCT01799889|616298227|FG008|Overall Study|Adverse Event|3|||
170533031|NCT01799889|616298228|FG009|Overall Study|Adverse Event|1|||
170533032|NCT01799889|616298229|FG010|Overall Study|Adverse Event|1|||
170533033|NCT01799889|616298230|FG011|Overall Study|Adverse Event|0|||
170533034|NCT01799889|616298219|FG000|Overall Study|Death|1|||
170533035|NCT01799889|616298220|FG001|Overall Study|Death|0|||
170533036|NCT01799889|616298221|FG002|Overall Study|Death|5|||
170533037|NCT01799889|616298222|FG003|Overall Study|Death|3|||
170533038|NCT01799889|616298223|FG004|Overall Study|Death|1|||
170533039|NCT01799889|616298224|FG005|Overall Study|Death|0|||
170533040|NCT01799889|616298225|FG006|Overall Study|Death|0|||
170533041|NCT01799889|616298226|FG007|Overall Study|Death|0|||
170533042|NCT01799889|616298227|FG008|Overall Study|Death|1|||
170533043|NCT01799889|616298228|FG009|Overall Study|Death|0|||
170533044|NCT01799889|616298229|FG010|Overall Study|Death|1|||
170533045|NCT01799889|616298230|FG011|Overall Study|Death|0|||
170533046|NCT01799889|616298219|FG000|Overall Study|Lack of Efficacy|1|||
170533047|NCT01799889|616298220|FG001|Overall Study|Lack of Efficacy|1|||
170533048|NCT01799889|616298221|FG002|Overall Study|Lack of Efficacy|0|||
170533049|NCT01799889|616298222|FG003|Overall Study|Lack of Efficacy|1|||
170533050|NCT01799889|616298223|FG004|Overall Study|Lack of Efficacy|2|||
170533051|NCT01799889|616298224|FG005|Overall Study|Lack of Efficacy|2|||
170533052|NCT01799889|616298225|FG006|Overall Study|Lack of Efficacy|0|||
170533053|NCT01799889|616298226|FG007|Overall Study|Lack of Efficacy|0|||
170533054|NCT01799889|616298227|FG008|Overall Study|Lack of Efficacy|2|||
170533055|NCT01799889|616298228|FG009|Overall Study|Lack of Efficacy|0|||
170533056|NCT01799889|616298229|FG010|Overall Study|Lack of Efficacy|1|||
170533057|NCT01799889|616298230|FG011|Overall Study|Lack of Efficacy|0|||
170533058|NCT01799889|616298219|FG000|Overall Study|Lost to Follow-up|0|||
170533059|NCT01799889|616298220|FG001|Overall Study|Lost to Follow-up|1|||
170533060|NCT01799889|616298221|FG002|Overall Study|Lost to Follow-up|0|||
170533061|NCT01799889|616298222|FG003|Overall Study|Lost to Follow-up|0|||
170533062|NCT01799889|616298223|FG004|Overall Study|Lost to Follow-up|0|||
170533063|NCT01799889|616298224|FG005|Overall Study|Lost to Follow-up|0|||
170533064|NCT01799889|616298225|FG006|Overall Study|Lost to Follow-up|0|||
170533065|NCT01799889|616298226|FG007|Overall Study|Lost to Follow-up|0|||
170533066|NCT01799889|616298227|FG008|Overall Study|Lost to Follow-up|0|||
170533067|NCT01799889|616298228|FG009|Overall Study|Lost to Follow-up|0|||
170533068|NCT01799889|616298229|FG010|Overall Study|Lost to Follow-up|0|||
170533069|NCT01799889|616298230|FG011|Overall Study|Lost to Follow-up|0|||
170533070|NCT01799889|616298219|FG000|Overall Study|Physician Decision|3|||
170533071|NCT01799889|616298220|FG001|Overall Study|Physician Decision|2|||
170533072|NCT01799889|616298221|FG002|Overall Study|Physician Decision|4|||
170533073|NCT01799889|616298222|FG003|Overall Study|Physician Decision|4|||
170533074|NCT01799889|616298223|FG004|Overall Study|Physician Decision|5|||
170533075|NCT01799889|616298224|FG005|Overall Study|Physician Decision|5|||
170533076|NCT01799889|616298225|FG006|Overall Study|Physician Decision|5|||
170533077|NCT01799889|616298226|FG007|Overall Study|Physician Decision|2|||
170533078|NCT01799889|616298227|FG008|Overall Study|Physician Decision|6|||
170533079|NCT01799889|616298228|FG009|Overall Study|Physician Decision|0|||
170533080|NCT01799889|616298229|FG010|Overall Study|Physician Decision|0|||
170533081|NCT01799889|616298230|FG011|Overall Study|Physician Decision|1|||
170533082|NCT01799889|616298219|FG000|Overall Study|Progressive Disease|30|||
170533083|NCT01799889|616298220|FG001|Overall Study|Progressive Disease|26|||
170533084|NCT01799889|616298221|FG002|Overall Study|Progressive Disease|25|||
170533085|NCT01799889|616298222|FG003|Overall Study|Progressive Disease|30|||
170533086|NCT01799889|616298223|FG004|Overall Study|Progressive Disease|23|||
170533087|NCT01799889|616298224|FG005|Overall Study|Progressive Disease|9|||
170533088|NCT01799889|616298225|FG006|Overall Study|Progressive Disease|8|||
170533089|NCT01799889|616298226|FG007|Overall Study|Progressive Disease|13|||
170533090|NCT01799889|616298227|FG008|Overall Study|Progressive Disease|18|||
170533091|NCT01799889|616298228|FG009|Overall Study|Progressive Disease|5|||
170533092|NCT01799889|616298229|FG010|Overall Study|Progressive Disease|3|||
170533093|NCT01799889|616298230|FG011|Overall Study|Progressive Disease|1|||
170533094|NCT01799889|616298219|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
170533095|NCT01799889|616298220|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
170533096|NCT01799889|616298221|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
170533097|NCT01799889|616298222|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
170533098|NCT01799889|616298223|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
170533099|NCT01799889|616298224|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
170533100|NCT01799889|616298225|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
170533101|NCT01799889|616298226|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
170533102|NCT01799889|616298227|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
170533103|NCT01799889|616298228|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
170533104|NCT01799889|616298229|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
170533105|NCT01799889|616298230|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
170533106|NCT01799889|616298219|FG000|Overall Study|Study Terminated By Sponsor|1|||
170533107|NCT01799889|616298220|FG001|Overall Study|Study Terminated By Sponsor|0|||
170533108|NCT01799889|616298221|FG002|Overall Study|Study Terminated By Sponsor|0|||
170533109|NCT01799889|616298222|FG003|Overall Study|Study Terminated By Sponsor|0|||
170533110|NCT01799889|616298223|FG004|Overall Study|Study Terminated By Sponsor|2|||
170533111|NCT01799889|616298224|FG005|Overall Study|Study Terminated By Sponsor|1|||
170533112|NCT01799889|616298225|FG006|Overall Study|Study Terminated By Sponsor|0|||
170533113|NCT01799889|616298226|FG007|Overall Study|Study Terminated By Sponsor|2|||
170533114|NCT01799889|616298227|FG008|Overall Study|Study Terminated By Sponsor|1|||
170533115|NCT01799889|616298228|FG009|Overall Study|Study Terminated By Sponsor|1|||
170533116|NCT01799889|616298229|FG010|Overall Study|Study Terminated By Sponsor|0|||
170533117|NCT01799889|616298230|FG011|Overall Study|Study Terminated By Sponsor|0|||
170533118|NCT01799889|616298219|FG000|Overall Study|Withdrawal by Subject|1|||
170533119|NCT01799889|616298220|FG001|Overall Study|Withdrawal by Subject|6|||
170632672|NCT02760498|616666742|FG000|Overall Study|Death|7|||
170533120|NCT01799889|616298221|FG002|Overall Study|Withdrawal by Subject|4|||
170533121|NCT01799889|616298222|FG003|Overall Study|Withdrawal by Subject|0|||
170533122|NCT01799889|616298223|FG004|Overall Study|Withdrawal by Subject|5|||
170533123|NCT01799889|616298224|FG005|Overall Study|Withdrawal by Subject|1|||
170533124|NCT01799889|616298225|FG006|Overall Study|Withdrawal by Subject|3|||
170533125|NCT01799889|616298226|FG007|Overall Study|Withdrawal by Subject|1|||
170533126|NCT01799889|616298227|FG008|Overall Study|Withdrawal by Subject|2|||
170422117|NCT00440557|615886195|FG000|Overall Study|Principal Investigator decision|0|||
170422118|NCT00440557|615886196|FG001|Overall Study|Principal Investigator decision|3|||
170422119|NCT00440557|615886197|FG002|Overall Study|Principal Investigator decision|1|||
170422120|NCT00440557|615886195|FG000|Overall Study|Patient moved|1|||
170422121|NCT00440557|615886196|FG001|Overall Study|Patient moved|2|||
170422122|NCT00440557|615886197|FG002|Overall Study|Patient moved|1|||
170422123|NCT00440557|615886195|FG000|Overall Study|Principal Investigator's office closed|3|||
170422124|NCT00440557|615886196|FG001|Overall Study|Principal Investigator's office closed|6|||
170422125|NCT00440557|615886197|FG002|Overall Study|Principal Investigator's office closed|4|||
170422126|NCT00440557|615886195|FG000|Overall Study|Patient transferred to nursing home|0|||
170422127|NCT00440557|615886196|FG001|Overall Study|Patient transferred to nursing home|1|||
170422128|NCT00440557|615886197|FG002|Overall Study|Patient transferred to nursing home|0|||
170422129|NCT00440557|615886195|FG000|Overall Study|Patient had surgery|1|||
170422130|NCT00440557|615886196|FG001|Overall Study|Patient had surgery|0|||
170422131|NCT00440557|615886197|FG002|Overall Study|Patient had surgery|0|||
170422132|NCT01572948|615886198|FG000|Overall Study|Lost to Follow-up|1|||
170422133|NCT01572948|615886199|FG001|Overall Study|Lost to Follow-up|0|||
170422134|NCT01572948|615886198|FG000|Overall Study|unable to contact|0|||
170422135|NCT01572948|615886199|FG001|Overall Study|unable to contact|1|||
170422136|NCT00877032|615886208|FG000|Overall Study|Did not meet entrance criteria|0|||
170422137|NCT00877032|615886209|FG001|Overall Study|Did not meet entrance criteria|0|||
170422138|NCT00877032|615886210|FG002|Overall Study|Did not meet entrance criteria|0|||
170422139|NCT00877032|615886211|FG003|Overall Study|Did not meet entrance criteria|1|||
170422140|NCT00877032|615886212|FG004|Overall Study|Did not meet entrance criteria|0|||
170422141|NCT00877032|615886213|FG005|Overall Study|Did not meet entrance criteria|0|||
170422142|NCT00877032|615886214|FG006|Overall Study|Did not meet entrance criteria|2|||
170422143|NCT02107092|615886215|FG000|Overall Study|Miscellaneous|3|||
170422144|NCT02107092|615886215|FG000|Overall Study|Subject compliance|3|||
170422145|NCT02107092|615886215|FG000|Overall Study|Hypo-or hyperkalemia|2|||
170422146|NCT02107092|615886215|FG000|Overall Study|Met ECG withdrawal criteria|3|||
170422147|NCT02107092|615886215|FG000|Overall Study|Physician Decision|3|||
170422148|NCT02107092|615886215|FG000|Overall Study|Lost to Follow-up|2|||
170422149|NCT02107092|615886215|FG000|Overall Study|Withdrawal by Subject|9|||
170422150|NCT02107092|615886215|FG000|Overall Study|Adverse Event|7|||
170422151|NCT02107092|615886215|FG000|Overall Study|Expected progression of CKD|12|||
170422152|NCT04213326|615886217|FG000|Overall Study|Consent withdrawn|51|||
170422153|NCT04213326|615886218|FG001|Overall Study|Consent withdrawn|241|||
170422154|NCT04213326|615886217|FG000|Overall Study|Lost to Follow-up|50|||
170422155|NCT04213326|615886218|FG001|Overall Study|Lost to Follow-up|902|||
170422156|NCT04213326|615886217|FG000|Overall Study|Protocol Violation|3|||
170422157|NCT04213326|615886218|FG001|Overall Study|Protocol Violation|25|||
170422158|NCT04213326|615886217|FG000|Overall Study|Participant eligibility changed|106|||
170422159|NCT04213326|615886218|FG001|Overall Study|Participant eligibility changed|19|||
170422160|NCT04213326|615886217|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
170422161|NCT04213326|615886218|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
170422162|NCT04213326|615886217|FG000|Overall Study|Incomplete study visit|0|||
170422163|NCT04213326|615886218|FG001|Overall Study|Incomplete study visit|367|||
170422164|NCT01496183|615886219|FG000|Overall Study|Physician Decision|3|||
170422165|NCT01496183|615886220|FG001|Overall Study|Physician Decision|1|||
170422166|NCT01496183|615886219|FG000|Overall Study|Withdrawal by Subject|0|||
170422167|NCT01496183|615886220|FG001|Overall Study|Withdrawal by Subject|1|||
170422168|NCT00472290|615886227|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
170422169|NCT00472290|615886227|FG000|Overall Study|Protocol Specified Criteria|7|||
170422170|NCT00472290|615886227|FG000|Overall Study|Administrative Decision|37|||
170422171|NCT00472290|615886227|FG000|Overall Study|Death|3|||
170422172|NCT00472290|615886227|FG000|Overall Study|Lost to Follow-up|1|||
170422173|NCT00472290|615886227|FG000|Overall Study|Lack of Efficacy|1|||
170422174|NCT00472290|615886227|FG000|Overall Study|Disease Progression|4|||
170422175|NCT00472290|615886227|FG000|Overall Study|Withdrawal by Subject|5|||
170422176|NCT00472290|615886227|FG000|Overall Study|Adverse Event|6|||
170422177|NCT00472290|615886227|FG000|Overall Study|Requirement for alternative therapy|7|||
170422178|NCT02672553|615886230|FG000|Overall Study|Death|3|||
170422179|NCT02672553|615886231|FG001|Overall Study|Death|5|||
170422180|NCT02672553|615886230|FG000|Overall Study|Valve Explant|1|||
170422181|NCT02672553|615886231|FG001|Overall Study|Valve Explant|0|||
170422182|NCT02672553|615886230|FG000|Overall Study|Conversion to Commercial Valve|3|||
170422183|NCT02672553|615886231|FG001|Overall Study|Conversion to Commercial Valve|0|||
170422184|NCT02672553|615886230|FG000|Overall Study|Withdrawal by Subject|3|||
170422185|NCT02672553|615886231|FG001|Overall Study|Withdrawal by Subject|3|||
170422186|NCT02672553|615886230|FG000|Overall Study|Intraoperative screen failure|2|||
170422187|NCT02672553|615886231|FG001|Overall Study|Intraoperative screen failure|0|||
170422188|NCT00408902|615886232|FG000|Overall Study|Lack of Efficacy|7|||
170422189|NCT00408902|615886232|FG000|Overall Study|Adverse Event|3|||
170422190|NCT02480764|615886234|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
170422191|NCT02480764|615886235|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
170422192|NCT02480764|615886236|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
170422193|NCT02480764|615886234|FG000|Overall Study|Major Protocol Deviation|1|||
170422194|NCT02480764|615886235|FG001|Overall Study|Major Protocol Deviation|4|||
170422195|NCT02480764|615886236|FG002|Overall Study|Major Protocol Deviation|3|||
170422196|NCT02480764|615886234|FG000|Overall Study|Lost to Follow-up|0|||
170422197|NCT02480764|615886235|FG001|Overall Study|Lost to Follow-up|1|||
170422198|NCT02480764|615886236|FG002|Overall Study|Lost to Follow-up|2|||
170422199|NCT02480764|615886234|FG000|Overall Study|Voluntary Withdrawal|6|||
170422200|NCT02480764|615886235|FG001|Overall Study|Voluntary Withdrawal|5|||
170422201|NCT02480764|615886236|FG002|Overall Study|Voluntary Withdrawal|10|||
170422202|NCT02480764|615886234|FG000|Overall Study|Lack of Efficacy|0|||
170422203|NCT02480764|615886235|FG001|Overall Study|Lack of Efficacy|3|||
170422204|NCT02480764|615886236|FG002|Overall Study|Lack of Efficacy|3|||
170422205|NCT02480764|615886234|FG000|Overall Study|Reason not Specified|0|||
170422206|NCT02480764|615886235|FG001|Overall Study|Reason not Specified|1|||
170422207|NCT02480764|615886236|FG002|Overall Study|Reason not Specified|0|||
170422208|NCT03633721|615886241|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
170422209|NCT03633721|615886242|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
170422210|NCT03633721|615886243|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
170422211|NCT03633721|615886244|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
170422212|NCT02457832|615886245|FG000|Training|Lost to Follow-up|10|||
170422213|NCT02457832|615886246|FG001|Training|Lost to Follow-up|6|||
170422214|NCT02457832|615886247|FG002|Training|Lost to Follow-up|3|||
170422215|NCT02457832|615886245|FG000|One Month Washout|Lost to Follow-up|0|||
170422216|NCT02457832|615886246|FG001|One Month Washout|Lost to Follow-up|1|||
170422217|NCT02457832|615886247|FG002|One Month Washout|Lost to Follow-up|1|||
170422218|NCT01475474|615886248|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
170422219|NCT01475474|615886248|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
170422220|NCT01030965|615886249|FG000|Overall Study|Lack of Efficacy|3|||
170422221|NCT01030965|615886250|FG001|Overall Study|Lack of Efficacy|2|||
170422222|NCT01030965|615886251|FG002|Overall Study|Lack of Efficacy|0|||
170422223|NCT01030965|615886252|FG003|Overall Study|Lack of Efficacy|3|||
170422224|NCT01030965|615886249|FG000|Overall Study|Protocol Violation|1|||
170422225|NCT01030965|615886250|FG001|Overall Study|Protocol Violation|1|||
170422226|NCT01030965|615886251|FG002|Overall Study|Protocol Violation|1|||
170422227|NCT01030965|615886252|FG003|Overall Study|Protocol Violation|1|||
170422228|NCT01030965|615886249|FG000|Overall Study|Adverse Event|0|||
170422229|NCT01030965|615886250|FG001|Overall Study|Adverse Event|1|||
170422230|NCT01030965|615886251|FG002|Overall Study|Adverse Event|2|||
170422231|NCT01030965|615886252|FG003|Overall Study|Adverse Event|1|||
170422232|NCT01030965|615886249|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
170422233|NCT01030965|615886250|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
170422234|NCT01030965|615886251|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
170422235|NCT01030965|615886252|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
170422236|NCT01030965|615886249|FG000|Overall Study|Withdrawal by Subject|0|||
170422237|NCT01030965|615886250|FG001|Overall Study|Withdrawal by Subject|1|||
170422238|NCT01030965|615886251|FG002|Overall Study|Withdrawal by Subject|0|||
170422239|NCT01030965|615886252|FG003|Overall Study|Withdrawal by Subject|2|||
170422240|NCT02097290|615886253|FG000|Overall Study|Death|6|||
170422241|NCT02097290|615886253|FG000|Overall Study|Total Withdrawals|3|||
170422242|NCT02097290|615886253|FG000|Overall Study|Attempt|8|||
170422243|NCT01248247|615887907|FG000|Overall Study|Adverse Event|2|||
170422244|NCT01248247|615887908|FG001|Overall Study|Adverse Event|4|||
170422245|NCT01248247|615887909|FG002|Overall Study|Adverse Event|4|||
170422246|NCT01248247|615887910|FG003|Overall Study|Adverse Event|2|||
170422247|NCT01248247|615887907|FG000|Overall Study|Death|0|||
170422248|NCT01248247|615887908|FG001|Overall Study|Death|1|||
170422249|NCT01248247|615887909|FG002|Overall Study|Death|4|||
170422250|NCT01248247|615887910|FG003|Overall Study|Death|7|||
170422251|NCT01248247|615887907|FG000|Overall Study|Lost to Follow-up|0|||
170422252|NCT01248247|615887908|FG001|Overall Study|Lost to Follow-up|1|||
170422253|NCT01248247|615887909|FG002|Overall Study|Lost to Follow-up|1|||
170422254|NCT01248247|615887910|FG003|Overall Study|Lost to Follow-up|0|||
170422255|NCT01248247|615887907|FG000|Overall Study|Alternative treatment|0|||
170422256|NCT01248247|615887908|FG001|Overall Study|Alternative treatment|1|||
170422257|NCT01248247|615887909|FG002|Overall Study|Alternative treatment|0|||
170422258|NCT01248247|615887910|FG003|Overall Study|Alternative treatment|0|||
170422259|NCT01248247|615887907|FG000|Overall Study|Other|2|||
170422260|NCT01248247|615887908|FG001|Overall Study|Other|8|||
170422261|NCT01248247|615887909|FG002|Overall Study|Other|8|||
170422262|NCT01248247|615887910|FG003|Overall Study|Other|5|||
170422263|NCT01248247|615887907|FG000|Overall Study|Progression|18|||
170422264|NCT01248247|615887908|FG001|Overall Study|Progression|27|||
170422265|NCT01248247|615887909|FG002|Overall Study|Progression|56|||
170422266|NCT01248247|615887910|FG003|Overall Study|Progression|44|||
170422267|NCT01248247|615887907|FG000|Overall Study|Refuse further treatment|0|||
170422268|NCT01248247|615887908|FG001|Overall Study|Refuse further treatment|0|||
170422269|NCT01248247|615887909|FG002|Overall Study|Refuse further treatment|1|||
170422270|NCT01248247|615887910|FG003|Overall Study|Refuse further treatment|2|||
170533127|NCT01799889|616298228|FG009|Overall Study|Withdrawal by Subject|1|||
170533128|NCT01799889|616298229|FG010|Overall Study|Withdrawal by Subject|1|||
170533129|NCT01799889|616298230|FG011|Overall Study|Withdrawal by Subject|1|||
170533130|NCT01799889|616298219|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170533131|NCT01799889|616298220|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170533132|NCT01799889|616298221|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170533133|NCT01799889|616298222|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170533134|NCT01799889|616298223|FG004|Overall Study|Non-Compliance With Study Drug|0|||
170533135|NCT01799889|616298224|FG005|Overall Study|Non-Compliance With Study Drug|1|||
170533136|NCT01799889|616298225|FG006|Overall Study|Non-Compliance With Study Drug|0|||
170533137|NCT01799889|616298226|FG007|Overall Study|Non-Compliance With Study Drug|0|||
170533138|NCT01799889|616298227|FG008|Overall Study|Non-Compliance With Study Drug|0|||
170533139|NCT01799889|616298228|FG009|Overall Study|Non-Compliance With Study Drug|0|||
170533140|NCT01799889|616298229|FG010|Overall Study|Non-Compliance With Study Drug|0|||
170533141|NCT01799889|616298230|FG011|Overall Study|Non-Compliance With Study Drug|0|||
170533142|NCT06217380|616298235|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
170533143|NCT06217380|616298235|FG000|Overall Study|Physician Decision|1|||
170533144|NCT06217380|616298235|FG000|Overall Study|Withdrawal by Subject|2|||
170533145|NCT01649765|616298236|FG000|Overall Study|Adverse Event|5|||
170533146|NCT01649765|616298237|FG001|Overall Study|Adverse Event|3|||
170533147|NCT01649765|616298236|FG000|Overall Study|Lack of Efficacy|1|||
170533148|NCT01649765|616298237|FG001|Overall Study|Lack of Efficacy|1|||
170533149|NCT01649765|616298236|FG000|Overall Study|Physician Decision|0|||
170533150|NCT01649765|616298237|FG001|Overall Study|Physician Decision|3|||
170533151|NCT01649765|616298236|FG000|Overall Study|Protocol Violation|1|||
170533152|NCT01649765|616298237|FG001|Overall Study|Protocol Violation|0|||
170533153|NCT01649765|616298236|FG000|Overall Study|Withdrawal by Subject|2|||
170533154|NCT01649765|616298237|FG001|Overall Study|Withdrawal by Subject|1|||
170533155|NCT00481676|616298241|FG000|Overall Study|Adverse Event|0|||
170533156|NCT00481676|616298242|FG001|Overall Study|Adverse Event|1|||
170533157|NCT00481676|616298241|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170533158|NCT00481676|616298242|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
170533159|NCT00481676|616298241|FG000|Overall Study|Administrative problem|1|||
170533160|NCT00481676|616298242|FG001|Overall Study|Administrative problem|0|||
170533161|NCT02469857|616298243|FG000|Overall Study|Death|24|||
170533162|NCT02469857|616298244|FG001|Overall Study|Death|29|||
170533163|NCT02469857|616298243|FG000|Overall Study|Discontinuation|1|||
170533164|NCT02469857|616298244|FG001|Overall Study|Discontinuation|3|||
170533165|NCT02110693|616298245|FG000|Overall Study|Withdrawal by Subject|6|||
170533166|NCT02110693|616298246|FG001|Overall Study|Withdrawal by Subject|7|||
170533167|NCT02110693|616298245|FG000|Overall Study|skipped assessment|15|||
170533168|NCT02110693|616298246|FG001|Overall Study|skipped assessment|18|||
170533169|NCT02110693|616298245|FG000|Overall Study|technical difficulties|6|||
170533170|NCT02110693|616298246|FG001|Overall Study|technical difficulties|4|||
170533171|NCT02110693|616298245|FG000|Overall Study|Other|1|||
170533172|NCT02110693|616298246|FG001|Overall Study|Other|0|||
170533173|NCT01881425|616298247|FG000|Overall Study|Death|5|||
170879091|NCT00105443|617569193|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
170879092|NCT00105443|617569194|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
170879093|NCT00105443|617569195|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
170879094|NCT00105443|617569196|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
170879095|NCT00105443|617569193|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
170422271|NCT01248247|615887907|FG000|Overall Study|Complicating disease|0|||
170422272|NCT01248247|615887908|FG001|Overall Study|Complicating disease|0|||
170422273|NCT01248247|615887909|FG002|Overall Study|Complicating disease|1|||
170422274|NCT01248247|615887910|FG003|Overall Study|Complicating disease|1|||
170422275|NCT02817841|615887911|FG000|Overall Study|Lost to Follow-up|287|||
170422276|NCT02817841|615887911|FG000|Overall Study|Withdrawal by Subject|183|||
170422277|NCT02817841|615887911|FG000|Overall Study|Adverse event not related to bleeding|131|||
170422278|NCT02817841|615887911|FG000|Overall Study|Adverse event related to bleeding|51|||
170422279|NCT02817841|615887911|FG000|Overall Study|Pregnancy|32|||
170422280|NCT02817841|615887911|FG000|Overall Study|Pregnancy wish|17|||
170422281|NCT02817841|615887911|FG000|Overall Study|Other reasons|53|||
170422282|NCT02817841|615887911|FG000|Overall Study|Protocol Violation|94|||
170422283|NCT03597256|615887915|FG000|Overall Study|Lost to Follow-up|3|||
170422284|NCT03597256|615887916|FG001|Overall Study|Lost to Follow-up|1|||
170422285|NCT03597256|615887915|FG000|Overall Study|Withdrawal by Subject|0|||
170422286|NCT03597256|615887916|FG001|Overall Study|Withdrawal by Subject|1|||
170422287|NCT03597256|615887915|FG000|Overall Study|Could not return for treatment|0|||
170533174|NCT01881425|616298248|FG001|Overall Study|Death|1|||
170533175|NCT01881425|616298247|FG000|Overall Study|Withdrawal by Subject|8|||
170533176|NCT01881425|616298248|FG001|Overall Study|Withdrawal by Subject|3|||
170422288|NCT03597256|615887916|FG001|Overall Study|Could not return for treatment|1|||
170422289|NCT03597256|615887915|FG000|Overall Study|Moved from location|0|||
170422290|NCT03597256|615887916|FG001|Overall Study|Moved from location|1|||
170533177|NCT01881425|616298247|FG000|Overall Study|Physician Decision|2|||
170533178|NCT01881425|616298248|FG001|Overall Study|Physician Decision|1|||
170533179|NCT01881425|616298247|FG000|Overall Study|Adverse Event|3|||
170533180|NCT01881425|616298248|FG001|Overall Study|Adverse Event|0|||
170533181|NCT01881425|616298247|FG000|Overall Study|General Anesthesia panic attack|0|||
170533182|NCT01881425|616298248|FG001|Overall Study|General Anesthesia panic attack|1|||
170533183|NCT01881425|616298247|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
170533184|NCT01881425|616298248|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
170533185|NCT01881425|616298247|FG000|Overall Study|Lost to Follow-up|7|||
170533186|NCT01881425|616298248|FG001|Overall Study|Lost to Follow-up|2|||
170533187|NCT01531153|616298249|FG000|Overall Study|Withdrawal by Subject|10|||
170533188|NCT01531153|616298250|FG001|Overall Study|Withdrawal by Subject|9|||
170533189|NCT01531153|616298251|FG002|Overall Study|Withdrawal by Subject|15|||
170533190|NCT00147238|616298252|FG000|Overall Study|Inevaluable|8|||
170533191|NCT04727749|616298253|FG000|Overall Study|Lost to Follow-up|10|||
170533192|NCT04727749|616298254|FG001|Overall Study|Lost to Follow-up|3|||
170422291|NCT03597256|615887915|FG000|Overall Study|Not accepted the treatment|0|||
170533193|NCT02378181|616298255|FG000|Overall Study|Lost to Follow-up|2|||
170533194|NCT02378181|616298256|FG001|Overall Study|Lost to Follow-up|5|||
170533195|NCT02378181|616298255|FG000|Overall Study|Withdrawal by Subject|1|||
170533196|NCT02378181|616298256|FG001|Overall Study|Withdrawal by Subject|1|||
170533197|NCT02378181|616298255|FG000|Overall Study|Incarcerated|0|||
170533198|NCT02378181|616298256|FG001|Overall Study|Incarcerated|1|||
170533199|NCT00805532|616298257|FG000|Overall Study|invalid data|0|||
170533200|NCT00805532|616298258|FG001|Overall Study|invalid data|1|||
170533201|NCT01859741|616298259|FG000|Overall Study|Death|3|||
170533202|NCT01859741|616298260|FG001|Overall Study|Death|2|||
170533203|NCT01859741|616298261|FG002|Overall Study|Death|4|||
170533204|NCT01859741|616298262|FG003|Overall Study|Death|3|||
170533205|NCT01859741|616298263|FG004|Overall Study|Death|5|||
170533206|NCT01859741|616298264|FG005|Overall Study|Death|4|||
170533207|NCT01859741|616298265|FG006|Overall Study|Death|51|||
170533208|NCT01859741|616298266|FG007|Overall Study|Death|51|||
170533209|NCT01859741|616298259|FG000|Overall Study|Lost to Follow-up|0|||
170533210|NCT01859741|616298260|FG001|Overall Study|Lost to Follow-up|0|||
170533211|NCT01859741|616298261|FG002|Overall Study|Lost to Follow-up|0|||
170533212|NCT01859741|616298262|FG003|Overall Study|Lost to Follow-up|0|||
170533213|NCT01859741|616298263|FG004|Overall Study|Lost to Follow-up|0|||
170533214|NCT01859741|616298264|FG005|Overall Study|Lost to Follow-up|1|||
170533215|NCT01859741|616298265|FG006|Overall Study|Lost to Follow-up|0|||
170533216|NCT01859741|616298266|FG007|Overall Study|Lost to Follow-up|4|||
170533217|NCT01859741|616298259|FG000|Overall Study|Withdrawal by Subject|0|||
170533218|NCT01859741|616298260|FG001|Overall Study|Withdrawal by Subject|1|||
170533219|NCT01859741|616298261|FG002|Overall Study|Withdrawal by Subject|2|||
170533220|NCT01859741|616298262|FG003|Overall Study|Withdrawal by Subject|0|||
170533221|NCT01859741|616298263|FG004|Overall Study|Withdrawal by Subject|0|||
170533222|NCT01859741|616298264|FG005|Overall Study|Withdrawal by Subject|1|||
170533223|NCT01859741|616298265|FG006|Overall Study|Withdrawal by Subject|1|||
170533224|NCT01859741|616298266|FG007|Overall Study|Withdrawal by Subject|1|||
170533225|NCT01859741|616298259|FG000|Overall Study|Study Terminated by Sponsor|0|||
170533226|NCT01859741|616298260|FG001|Overall Study|Study Terminated by Sponsor|0|||
170533227|NCT01859741|616298261|FG002|Overall Study|Study Terminated by Sponsor|0|||
170533228|NCT01859741|616298262|FG003|Overall Study|Study Terminated by Sponsor|0|||
170533229|NCT01859741|616298263|FG004|Overall Study|Study Terminated by Sponsor|1|||
170533230|NCT01859741|616298264|FG005|Overall Study|Study Terminated by Sponsor|0|||
170533231|NCT01859741|616298265|FG006|Overall Study|Study Terminated by Sponsor|16|||
170533232|NCT01859741|616298266|FG007|Overall Study|Study Terminated by Sponsor|14|||
170533233|NCT01859741|616298259|FG000|Overall Study|Other|0|||
170422292|NCT03597256|615887916|FG001|Overall Study|Not accepted the treatment|1|||
170422293|NCT02943447|615887917|FG000|Blinded Study Phase|Withdrew Consent|1|||
170422294|NCT02943447|615887918|FG001|Blinded Study Phase|Withdrew Consent|2|||
170422295|NCT02943447|615887919|FG002|Blinded Study Phase|Withdrew Consent|1|||
170422296|NCT02943447|615887917|FG000|Blinded Study Phase|Adverse Event|3|||
170422297|NCT02943447|615887918|FG001|Blinded Study Phase|Adverse Event|0|||
170422298|NCT02943447|615887919|FG002|Blinded Study Phase|Adverse Event|0|||
170422299|NCT02943447|615887917|FG000|Blinded Study Phase|Investigator's discretion|1|||
170422300|NCT02943447|615887918|FG001|Blinded Study Phase|Investigator's discretion|0|||
170422301|NCT02943447|615887919|FG002|Blinded Study Phase|Investigator's discretion|0|||
170422302|NCT02943447|615887917|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
170422303|NCT02943447|615887918|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
170422304|NCT02943447|615887919|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
170422305|NCT02943447|615887917|FG000|Open-Label Extension Phase|Adverse Event|4|||
170422306|NCT02943447|615887918|FG001|Open-Label Extension Phase|Adverse Event|7|||
170422307|NCT02943447|615887919|FG002|Open-Label Extension Phase|Adverse Event|3|||
170422308|NCT02943447|615887917|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
170422309|NCT02943447|615887918|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
170422310|NCT02943447|615887919|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
170533234|NCT01859741|616298260|FG001|Overall Study|Other|0|||
170422311|NCT02943447|615887917|FG000|Open-Label Extension Phase|Withdrew consent|1|||
170422312|NCT02943447|615887918|FG001|Open-Label Extension Phase|Withdrew consent|1|||
170422313|NCT02943447|615887919|FG002|Open-Label Extension Phase|Withdrew consent|1|||
170422314|NCT02943447|615887917|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
170422315|NCT02943447|615887918|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
170422316|NCT02943447|615887919|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
170422317|NCT00840632|615887921|FG000|First Intervention|Withdrawal by Subject|0|||
170422318|NCT00840632|615887922|FG001|First Intervention|Withdrawal by Subject|1|||
170422319|NCT00840632|615887921|FG000|Washout|Withdrawal by Subject|1|||
170422320|NCT00840632|615887922|FG001|Washout|Withdrawal by Subject|1|||
170422321|NCT04657770|615887924|FG000|Overall Study|Withdrawal by Subject|3|||
170422322|NCT04657770|615887924|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
170422323|NCT04915755|615887927|FG000|Overall Study|Physician Decision|3|||
170422324|NCT04915755|615887928|FG001|Overall Study|Physician Decision|2|||
170422325|NCT04915755|615887927|FG000|Overall Study|Withdrawal by Subject|1|||
170422326|NCT04915755|615887928|FG001|Overall Study|Withdrawal by Subject|1|||
170422327|NCT04915755|615887927|FG000|Overall Study|Ongoing for PACT|3|||
170422328|NCT04915755|615887928|FG001|Overall Study|Ongoing for PACT|2|||
170422329|NCT04915755|615887927|FG000|Overall Study|Other|7|||
170422330|NCT04915755|615887928|FG001|Overall Study|Other|11|||
170422331|NCT01287013|615887931|FG000|Overall Study|Non-evaluable|3|||
170422332|NCT01287013|615887932|FG001|Overall Study|Non-evaluable|5|||
170422333|NCT01287013|615887933|FG002|Overall Study|Non-evaluable|21|||
170422334|NCT03247556|615887934|FG000|Overall Study|Adverse Event|1|||
170422335|NCT03247556|615887935|FG001|Overall Study|Adverse Event|4|||
170422336|NCT03247556|615887936|FG002|Overall Study|Adverse Event|5|||
170422337|NCT03247556|615887934|FG000|Overall Study|Lost to Follow-up|5|||
170422338|NCT03247556|615887935|FG001|Overall Study|Lost to Follow-up|5|||
170422339|NCT03247556|615887936|FG002|Overall Study|Lost to Follow-up|4|||
170422340|NCT03247556|615887934|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
170422341|NCT03247556|615887935|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
170422342|NCT03247556|615887936|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
170422343|NCT03247556|615887934|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
170422344|NCT03247556|615887935|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
170422345|NCT03247556|615887936|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
170422346|NCT03247556|615887934|FG000|Overall Study|Protocol Violation|2|||
170422347|NCT03247556|615887935|FG001|Overall Study|Protocol Violation|0|||
170422348|NCT03247556|615887936|FG002|Overall Study|Protocol Violation|1|||
170422349|NCT03247556|615887934|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
170422350|NCT03247556|615887935|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
170422351|NCT03247556|615887936|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
170422352|NCT02109042|615887938|FG000|Overall Study|Sponsor Decision|15|||
170422353|NCT02495857|615887947|FG000|Overall Study|Adverse Event|5|||
170422354|NCT02495857|615887948|FG001|Overall Study|Adverse Event|0|||
170422355|NCT02495857|615887949|FG002|Overall Study|Adverse Event|1|||
170422356|NCT02495857|615887947|FG000|Overall Study|Withdrawal by Subject|9|||
170422357|NCT02495857|615887948|FG001|Overall Study|Withdrawal by Subject|6|||
170422358|NCT02495857|615887949|FG002|Overall Study|Withdrawal by Subject|10|||
170422359|NCT02495857|615887947|FG000|Overall Study|Physician Decision|0|||
170422360|NCT02495857|615887948|FG001|Overall Study|Physician Decision|1|||
170422361|NCT02495857|615887949|FG002|Overall Study|Physician Decision|0|||
170422362|NCT02495857|615887947|FG000|Overall Study|Protocol Violation|1|||
170422363|NCT02495857|615887948|FG001|Overall Study|Protocol Violation|1|||
170422364|NCT02495857|615887949|FG002|Overall Study|Protocol Violation|2|||
170422365|NCT02495857|615887947|FG000|Overall Study|Lost to Follow-up|4|||
170422366|NCT02495857|615887948|FG001|Overall Study|Lost to Follow-up|5|||
170422367|NCT02495857|615887949|FG002|Overall Study|Lost to Follow-up|3|||
170422368|NCT02495857|615887947|FG000|Overall Study|Other|3|||
170422369|NCT02495857|615887948|FG001|Overall Study|Other|3|||
170422370|NCT02495857|615887949|FG002|Overall Study|Other|2|||
170422371|NCT00377260|615887955|FG000|Overall Study|Lost to Follow-up|0|||
170422372|NCT00377260|615887956|FG001|Overall Study|Lost to Follow-up|1|||
170422373|NCT00377260|615887955|FG000|Overall Study|Withdrawal by Subject|2|||
170422374|NCT00377260|615887956|FG001|Overall Study|Withdrawal by Subject|4|||
170422375|NCT00150462|615887958|FG000|Overall Study|Disease Progression or Relapse|3|||
170422376|NCT00150462|615887959|FG001|Overall Study|Disease Progression or Relapse|1|||
170422377|NCT00150462|615887960|FG002|Overall Study|Disease Progression or Relapse|2|||
170422378|NCT00150462|615887961|FG003|Overall Study|Disease Progression or Relapse|1|||
170422379|NCT00150462|615887962|FG004|Overall Study|Disease Progression or Relapse|2|||
170422380|NCT00150462|615887963|FG005|Overall Study|Disease Progression or Relapse|2|||
170422381|NCT00150462|615887964|FG006|Overall Study|Disease Progression or Relapse|3|||
170422382|NCT00150462|615887965|FG007|Overall Study|Disease Progression or Relapse|5|||
170422383|NCT00150462|615887966|FG008|Overall Study|Disease Progression or Relapse|5|||
170422384|NCT00150462|615887967|FG009|Overall Study|Disease Progression or Relapse|3|||
170422385|NCT00150462|615887968|FG010|Overall Study|Disease Progression or Relapse|2|||
170422386|NCT00150462|615887958|FG000|Overall Study|Withdrawal by Subject|0|||
170422387|NCT00150462|615887959|FG001|Overall Study|Withdrawal by Subject|1|||
170422388|NCT00150462|615887960|FG002|Overall Study|Withdrawal by Subject|1|||
170422389|NCT00150462|615887961|FG003|Overall Study|Withdrawal by Subject|0|||
170422390|NCT00150462|615887962|FG004|Overall Study|Withdrawal by Subject|1|||
170422391|NCT00150462|615887963|FG005|Overall Study|Withdrawal by Subject|2|||
170422392|NCT00150462|615887964|FG006|Overall Study|Withdrawal by Subject|0|||
170422393|NCT00150462|615887965|FG007|Overall Study|Withdrawal by Subject|1|||
170422394|NCT00150462|615887966|FG008|Overall Study|Withdrawal by Subject|0|||
170422395|NCT00150462|615887967|FG009|Overall Study|Withdrawal by Subject|1|||
170422396|NCT00150462|615887968|FG010|Overall Study|Withdrawal by Subject|0|||
170422397|NCT00150462|615887958|FG000|Overall Study|Death|0|||
170422398|NCT00150462|615887959|FG001|Overall Study|Death|1|||
170422399|NCT00150462|615887960|FG002|Overall Study|Death|0|||
170422400|NCT00150462|615887961|FG003|Overall Study|Death|0|||
170422401|NCT00150462|615887962|FG004|Overall Study|Death|0|||
170422402|NCT00150462|615887963|FG005|Overall Study|Death|0|||
170422403|NCT00150462|615887964|FG006|Overall Study|Death|0|||
170422404|NCT00150462|615887965|FG007|Overall Study|Death|0|||
170422405|NCT00150462|615887966|FG008|Overall Study|Death|1|||
170422406|NCT00150462|615887967|FG009|Overall Study|Death|0|||
170422407|NCT00150462|615887968|FG010|Overall Study|Death|0|||
170422408|NCT00150462|615887958|FG000|Overall Study|Adverse Event|0|||
170422409|NCT00150462|615887959|FG001|Overall Study|Adverse Event|0|||
170422410|NCT00150462|615887960|FG002|Overall Study|Adverse Event|0|||
170422411|NCT00150462|615887961|FG003|Overall Study|Adverse Event|1|||
170422412|NCT00150462|615887962|FG004|Overall Study|Adverse Event|0|||
170422413|NCT00150462|615887963|FG005|Overall Study|Adverse Event|0|||
170422414|NCT00150462|615887964|FG006|Overall Study|Adverse Event|0|||
170422415|NCT00150462|615887965|FG007|Overall Study|Adverse Event|2|||
170422416|NCT00150462|615887966|FG008|Overall Study|Adverse Event|0|||
170422417|NCT00150462|615887967|FG009|Overall Study|Adverse Event|1|||
170422418|NCT00150462|615887968|FG010|Overall Study|Adverse Event|0|||
170422419|NCT00150462|615887958|FG000|Overall Study|Physician Decision|0|||
170422420|NCT00150462|615887959|FG001|Overall Study|Physician Decision|0|||
170422421|NCT00150462|615887960|FG002|Overall Study|Physician Decision|1|||
170422422|NCT00150462|615887961|FG003|Overall Study|Physician Decision|1|||
170422423|NCT00150462|615887962|FG004|Overall Study|Physician Decision|0|||
170422424|NCT00150462|615887963|FG005|Overall Study|Physician Decision|0|||
170422425|NCT00150462|615887964|FG006|Overall Study|Physician Decision|0|||
170422426|NCT00150462|615887965|FG007|Overall Study|Physician Decision|0|||
170422427|NCT00150462|615887966|FG008|Overall Study|Physician Decision|0|||
170422428|NCT00150462|615887967|FG009|Overall Study|Physician Decision|0|||
170422429|NCT00150462|615887968|FG010|Overall Study|Physician Decision|0|||
170422430|NCT00150462|615887958|FG000|Overall Study|Other|0|||
170422431|NCT00150462|615887959|FG001|Overall Study|Other|0|||
170422432|NCT00150462|615887960|FG002|Overall Study|Other|0|||
170422433|NCT00150462|615887961|FG003|Overall Study|Other|0|||
170422434|NCT00150462|615887962|FG004|Overall Study|Other|0|||
170422435|NCT00150462|615887963|FG005|Overall Study|Other|0|||
170422436|NCT00150462|615887964|FG006|Overall Study|Other|0|||
170422437|NCT00150462|615887965|FG007|Overall Study|Other|0|||
170422438|NCT00150462|615887966|FG008|Overall Study|Other|0|||
170422439|NCT00150462|615887967|FG009|Overall Study|Other|1|||
170422440|NCT00150462|615887968|FG010|Overall Study|Other|1|||
170422441|NCT03107091|615887971|FG000|Overall Study|Physician Decision|1|||
170422442|NCT01666730|615887972|FG000|Overall Study|Adverse Event|16|||
170533235|NCT01859741|616298261|FG002|Overall Study|Other|0|||
170533236|NCT01859741|616298262|FG003|Overall Study|Other|0|||
170422443|NCT01666730|615887972|FG000|Overall Study|Death|2|||
170422444|NCT01666730|615887972|FG000|Overall Study|Physician Decision|5|||
170422445|NCT01666730|615887972|FG000|Overall Study|Withdrawal by Subject|9|||
170422446|NCT01666730|615887972|FG000|Overall Study|Disease progression/relapse|18|||
170422447|NCT04006171|615887973|FG000|Overall Study|Withdrawal by Subject|8|||
170422448|NCT04006171|615887974|FG001|Overall Study|Withdrawal by Subject|7|||
170422449|NCT04006171|615887973|FG000|Overall Study|missing serum samples|2|||
170422450|NCT04006171|615887974|FG001|Overall Study|missing serum samples|2|||
170422451|NCT04006171|615887973|FG000|Overall Study|insufficient sample volume|2|||
170422452|NCT04006171|615887974|FG001|Overall Study|insufficient sample volume|3|||
170422453|NCT02087904|615887975|FG000|Overall Study|Did Not Receive Study Drug|0|||
170422454|NCT02087904|615887976|FG001|Overall Study|Did Not Receive Study Drug|0|||
170422455|NCT02087904|615887977|FG002|Overall Study|Did Not Receive Study Drug|2|||
170422456|NCT02087904|615887978|FG003|Overall Study|Did Not Receive Study Drug|1|||
170422457|NCT02087904|615887975|FG000|Overall Study|Adverse Event|8|||
170422458|NCT02087904|615887976|FG001|Overall Study|Adverse Event|4|||
170422459|NCT02087904|615887977|FG002|Overall Study|Adverse Event|4|||
170422460|NCT02087904|615887978|FG003|Overall Study|Adverse Event|12|||
170422461|NCT02087904|615887975|FG000|Overall Study|Lack of Efficacy|3|||
170422462|NCT02087904|615887976|FG001|Overall Study|Lack of Efficacy|6|||
170422463|NCT02087904|615887977|FG002|Overall Study|Lack of Efficacy|3|||
170422464|NCT02087904|615887978|FG003|Overall Study|Lack of Efficacy|2|||
170422465|NCT02087904|615887975|FG000|Overall Study|Other|6|||
170533237|NCT01859741|616298263|FG004|Overall Study|Other|0|||
170422466|NCT02087904|615887976|FG001|Overall Study|Other|2|||
170422467|NCT02087904|615887977|FG002|Overall Study|Other|4|||
170422468|NCT02087904|615887978|FG003|Overall Study|Other|4|||
170422469|NCT02087904|615887975|FG000|Overall Study|Withdrawal by Subject|8|||
170422470|NCT02087904|615887976|FG001|Overall Study|Withdrawal by Subject|3|||
170422471|NCT02087904|615887977|FG002|Overall Study|Withdrawal by Subject|7|||
170422472|NCT02087904|615887978|FG003|Overall Study|Withdrawal by Subject|4|||
170422473|NCT02087904|615887975|FG000|Overall Study|Lost to Follow-up|0|||
170422474|NCT02087904|615887976|FG001|Overall Study|Lost to Follow-up|4|||
170422475|NCT02087904|615887977|FG002|Overall Study|Lost to Follow-up|2|||
170422476|NCT02087904|615887978|FG003|Overall Study|Lost to Follow-up|2|||
170422477|NCT03136380|615887980|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
170422478|NCT03136380|615887981|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
170422479|NCT03136380|615887982|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
170422480|NCT03136380|615887983|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
170422481|NCT03136380|615887984|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
170422482|NCT02202850|615887985|FG000|Overall Study|Other|2|||
170422483|NCT02202850|615887986|FG001|Overall Study|Other|2|||
170422484|NCT02202850|615887985|FG000|Overall Study|Enbrel treatment discontinued|15|||
170422485|NCT02202850|615887986|FG001|Overall Study|Enbrel treatment discontinued|3|||
170422486|NCT02202850|615887985|FG000|Overall Study|Lost to Follow-up|7|||
170422487|NCT02202850|615887986|FG001|Overall Study|Lost to Follow-up|1|||
170422488|NCT00282048|615887987|FG000|Overall Study|Lack of Efficacy|30|||
170422489|NCT00282048|615887987|FG000|Overall Study|Adverse Event|22|||
170422490|NCT00282048|615887987|FG000|Overall Study|Withdrawal by Subject|1|||
170422491|NCT00282048|615887987|FG000|Overall Study|Other|8|||
170422492|NCT00282048|615887987|FG000|Overall Study|Ongoing|1|||
170422493|NCT02674477|615887988|FG000|Overall Study|Protocol Violation|8|||
170422494|NCT02674477|615887989|FG001|Overall Study|Protocol Violation|2|||
170422495|NCT00854308|615887996|FG000|Overall Study|Disease progression|42|||
170422496|NCT00854308|615887997|FG001|Overall Study|Disease progression|50|||
170422497|NCT00854308|615887996|FG000|Overall Study|Adverse Event|8|||
170422498|NCT00854308|615887997|FG001|Overall Study|Adverse Event|3|||
170422499|NCT00854308|615887996|FG000|Overall Study|Death|2|||
170422500|NCT00854308|615887997|FG001|Overall Study|Death|5|||
170422501|NCT00854308|615887996|FG000|Overall Study|Physician Decision|6|||
170422502|NCT00854308|615887997|FG001|Overall Study|Physician Decision|6|||
170422503|NCT00854308|615887996|FG000|Overall Study|Withdrawal by Subject|4|||
170422504|NCT00854308|615887997|FG001|Overall Study|Withdrawal by Subject|2|||
170422505|NCT00854308|615887996|FG000|Overall Study|Sponsor's decision to terminate study|0|||
170422506|NCT00854308|615887997|FG001|Overall Study|Sponsor's decision to terminate study|1|||
170422507|NCT01941030|615888002|FG000|Overall Study|Death|3|||
170422508|NCT01941030|615888003|FG001|Overall Study|Death|2|||
170422509|NCT01941030|615888002|FG000|Overall Study|Lost to Follow-up|6|||
170422510|NCT01941030|615888003|FG001|Overall Study|Lost to Follow-up|5|||
170422511|NCT01941030|615888002|FG000|Overall Study|Withdrawal by Subject|4|||
170422512|NCT01941030|615888003|FG001|Overall Study|Withdrawal by Subject|6|||
170422513|NCT02373098|615888007|FG000|Overall Study|Lost to Follow-up|1|||
170422514|NCT02373098|615888008|FG001|Overall Study|Lost to Follow-up|0|||
170422515|NCT02373098|615888007|FG000|Overall Study|Protocol Violation|3|||
170422516|NCT02373098|615888008|FG001|Overall Study|Protocol Violation|0|||
170422517|NCT02373098|615888007|FG000|Overall Study|Withdrawal by Subject|5|||
170422518|NCT02373098|615888008|FG001|Overall Study|Withdrawal by Subject|0|||
170422519|NCT02373098|615888007|FG000|Overall Study|Adverse Event|3|||
170422520|NCT02373098|615888008|FG001|Overall Study|Adverse Event|0|||
170422521|NCT05067647|615888009|FG000|Overall Study|Lost to Follow-up|1|||
170422522|NCT01044732|615888011|FG000|Overall Study|Lost to Follow-up|2|||
170422523|NCT01044732|615888012|FG001|Overall Study|Lost to Follow-up|1|||
170422524|NCT01044732|615888011|FG000|Overall Study|Physician Decision|5|||
170422525|NCT01044732|615888012|FG001|Overall Study|Physician Decision|3|||
170422526|NCT01044732|615888011|FG000|Overall Study|Protocol Violation|11|||
170422527|NCT01044732|615888012|FG001|Overall Study|Protocol Violation|12|||
170422528|NCT01044732|615888011|FG000|Overall Study|Withdrawal by Subject|0|||
170422529|NCT01044732|615888012|FG001|Overall Study|Withdrawal by Subject|1|||
170422530|NCT01044732|615888011|FG000|Overall Study|Inadequate bowel preparation|11|||
170422531|NCT01044732|615888012|FG001|Overall Study|Inadequate bowel preparation|17|||
170422532|NCT01044732|615888011|FG000|Overall Study|Inability to reach cecum|5|||
170422533|NCT01044732|615888012|FG001|Overall Study|Inability to reach cecum|2|||
170422534|NCT01044732|615888011|FG000|Overall Study|Technical error or malfunction|15|||
170422535|NCT01044732|615888012|FG001|Overall Study|Technical error or malfunction|14|||
170422536|NCT05277389|615888018|FG000|Overall Study|Lost to Follow-up|1|||
170422537|NCT05277389|615888019|FG001|Overall Study|Lost to Follow-up|4|||
170422538|NCT01569152|615888035|FG000|Phase IIa, Period 1|Early Escape|5|||
170422539|NCT01569152|615888036|FG001|Phase IIa, Period 1|Early Escape|22|||
170422540|NCT01569152|615888037|FG002|Phase IIa, Period 1|Early Escape|0|||
170422541|NCT01569152|615888035|FG000|Phase IIa, Period 1|Adverse Event|4|||
170422542|NCT01569152|615888036|FG001|Phase IIa, Period 1|Adverse Event|0|||
170422543|NCT01569152|615888037|FG002|Phase IIa, Period 1|Adverse Event|0|||
170533238|NCT01859741|616298264|FG005|Overall Study|Other|0|||
170533239|NCT01859741|616298265|FG006|Overall Study|Other|2|||
170533240|NCT01859741|616298266|FG007|Overall Study|Other|0|||
170533241|NCT02412657|616298268|FG000|Overall Study|Lost to Follow-up|1|||
170533242|NCT02412657|616298269|FG001|Overall Study|Lost to Follow-up|0|||
170533243|NCT02412657|616298270|FG002|Overall Study|Lost to Follow-up|0|||
170533244|NCT02412657|616298268|FG000|Overall Study|Protocol Violation|0|||
170533245|NCT02412657|616298269|FG001|Overall Study|Protocol Violation|2|||
170533246|NCT02412657|616298270|FG002|Overall Study|Protocol Violation|3|||
170533247|NCT00920816|616298274|FG000|Overall Study|Death|116|||
170533248|NCT00920816|616298275|FG001|Overall Study|Death|63|||
170533249|NCT00920816|616298276|FG002|Overall Study|Death|8|||
170533250|NCT00920816|616298277|FG003|Overall Study|Death|3|||
170533251|NCT00920816|616298274|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
170533252|NCT00920816|616298275|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
170533253|NCT00920816|616298276|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
170533254|NCT00920816|616298277|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
170533255|NCT00920816|616298274|FG000|Overall Study|Global deterioration of health status|2|||
170533256|NCT00920816|616298275|FG001|Overall Study|Global deterioration of health status|0|||
170533257|NCT00920816|616298276|FG002|Overall Study|Global deterioration of health status|0|||
170533258|NCT00920816|616298277|FG003|Overall Study|Global deterioration of health status|0|||
170533259|NCT00920816|616298274|FG000|Overall Study|Objective progression or relapse|6|||
170533260|NCT00920816|616298275|FG001|Overall Study|Objective progression or relapse|2|||
170533261|NCT00920816|616298276|FG002|Overall Study|Objective progression or relapse|0|||
170533262|NCT00920816|616298277|FG003|Overall Study|Objective progression or relapse|0|||
170533263|NCT00920816|616298274|FG000|Overall Study|Other|26|||
170533264|NCT00920816|616298275|FG001|Overall Study|Other|15|||
170533265|NCT00920816|616298276|FG002|Overall Study|Other|1|||
170533266|NCT00920816|616298277|FG003|Overall Study|Other|2|||
170533267|NCT00920816|616298274|FG000|Overall Study|Lost to Follow-up|11|||
170533268|NCT00920816|616298275|FG001|Overall Study|Lost to Follow-up|2|||
170533269|NCT00920816|616298276|FG002|Overall Study|Lost to Follow-up|0|||
170533270|NCT00920816|616298277|FG003|Overall Study|Lost to Follow-up|0|||
170533271|NCT00920816|616298274|FG000|Overall Study|Adverse Event|1|||
170533272|NCT00920816|616298275|FG001|Overall Study|Adverse Event|1|||
170533273|NCT00920816|616298276|FG002|Overall Study|Adverse Event|1|||
170533274|NCT00920816|616298277|FG003|Overall Study|Adverse Event|0|||
170533275|NCT00920816|616298274|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
170533276|NCT00920816|616298275|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
170533277|NCT00920816|616298276|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
170533278|NCT00920816|616298277|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
170533279|NCT00920816|616298274|FG000|Overall Study|Randomized but not treated|3|||
170533280|NCT00920816|616298275|FG001|Overall Study|Randomized but not treated|0|||
170533281|NCT00920816|616298276|FG002|Overall Study|Randomized but not treated|0|||
170533282|NCT00920816|616298277|FG003|Overall Study|Randomized but not treated|0|||
170533283|NCT02320396|616298278|FG000|Overall Study|Adverse Event|2|||
170533284|NCT02320396|616298279|FG001|Overall Study|Adverse Event|2|||
170533285|NCT02320396|616298278|FG000|Overall Study|Pregnancy|0|||
170533286|NCT02320396|616298279|FG001|Overall Study|Pregnancy|1|||
170533287|NCT02320396|616298278|FG000|Overall Study|Protocol Violation|0|||
170533288|NCT02320396|616298279|FG001|Overall Study|Protocol Violation|1|||
170533289|NCT02320396|616298278|FG000|Overall Study|Withdrawal by Subject|2|||
170533290|NCT02320396|616298279|FG001|Overall Study|Withdrawal by Subject|0|||
170533291|NCT01129128|616298282|FG000|Overall Study|Lost to Follow-up|2|||
170533292|NCT01129128|616298283|FG001|Overall Study|Lost to Follow-up|2|||
170533293|NCT01129128|616298284|FG002|Overall Study|Lost to Follow-up|1|||
170533294|NCT01129128|616298282|FG000|Overall Study|Protocol Violation|0|||
170533295|NCT01129128|616298283|FG001|Overall Study|Protocol Violation|1|||
170533296|NCT01129128|616298284|FG002|Overall Study|Protocol Violation|0|||
170533297|NCT01129128|616298282|FG000|Overall Study|Withdrawal by Subject|0|||
170533298|NCT01129128|616298283|FG001|Overall Study|Withdrawal by Subject|1|||
170533299|NCT01129128|616298284|FG002|Overall Study|Withdrawal by Subject|3|||
170533300|NCT01129128|616298282|FG000|Overall Study|Physician Decision|1|||
170533301|NCT01129128|616298283|FG001|Overall Study|Physician Decision|0|||
170533302|NCT01129128|616298284|FG002|Overall Study|Physician Decision|0|||
170533303|NCT01311661|616298285|FG000|Overall Study|Adverse Event|2|||
170533304|NCT01311661|616298285|FG000|Overall Study|Protocol Violation|3|||
170533305|NCT01311661|616298285|FG000|Overall Study|Withdrawal by Subject|2|||
170533306|NCT01900314|616298286|FG000|Overall Study|Lost to Follow-up|1|||
170533307|NCT01900314|616298287|FG001|Overall Study|Lost to Follow-up|0|||
170533308|NCT01900314|616298286|FG000|Overall Study|Protocol Violation|0|||
170533309|NCT01900314|616298287|FG001|Overall Study|Protocol Violation|1|||
170533310|NCT01900314|616298286|FG000|Overall Study|Withdrawal by Subject|3|||
170533311|NCT01900314|616298287|FG001|Overall Study|Withdrawal by Subject|3|||
170533312|NCT05853120|616298289|FG000|Overall Study|Lost to Follow-up|4|||
170533313|NCT05853120|616298290|FG001|Overall Study|Lost to Follow-up|4|||
170533314|NCT05853120|616298289|FG000|Overall Study|Physician Decision|3|||
170533315|NCT05853120|616298290|FG001|Overall Study|Physician Decision|0|||
170533316|NCT05853120|616298289|FG000|Overall Study|Withdrawal by Subject|5|||
170533317|NCT05853120|616298290|FG001|Overall Study|Withdrawal by Subject|2|||
170533318|NCT02187783|616298291|FG000|Overall Study|Adverse Event|8|||
170533319|NCT02187783|616298291|FG000|Overall Study|Death|3|||
170533320|NCT02187783|616298291|FG000|Overall Study|Progressive disease|80|||
170533321|NCT02187783|616298291|FG000|Overall Study|Protocol Violation|3|||
170533322|NCT02187783|616298291|FG000|Overall Study|Physician Decision|2|||
170533323|NCT02187783|616298291|FG000|Overall Study|Withdrawal by Subject|9|||
170533324|NCT02187783|616298291|FG000|Overall Study|Study terminated by sponsor|1|||
170533325|NCT00171249|616298292|FG000|Overall Study|Withdrawal by Subject|2|||
170533326|NCT00171249|616298293|FG001|Overall Study|Withdrawal by Subject|0|||
170533327|NCT00171249|616298294|FG002|Overall Study|Withdrawal by Subject|0|||
170533328|NCT00171249|616298295|FG003|Overall Study|Withdrawal by Subject|6|||
170533329|NCT00171249|616298296|FG004|Overall Study|Withdrawal by Subject|0|||
170533330|NCT00171249|616298297|FG005|Overall Study|Withdrawal by Subject|0|||
170533331|NCT00171249|616298298|FG006|Overall Study|Withdrawal by Subject|0|||
170533332|NCT00171249|616298292|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
170533333|NCT00171249|616298293|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170533334|NCT00171249|616298294|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
170533335|NCT00171249|616298295|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
170533336|NCT00171249|616298296|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170533337|NCT00171249|616298297|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
170533338|NCT00171249|616298298|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
170533339|NCT00171249|616298292|FG000|Overall Study|Death|7|||
170533340|NCT00171249|616298293|FG001|Overall Study|Death|1|||
170533341|NCT00171249|616298294|FG002|Overall Study|Death|0|||
170533342|NCT00171249|616298295|FG003|Overall Study|Death|4|||
170533343|NCT00171249|616298296|FG004|Overall Study|Death|0|||
170533344|NCT00171249|616298297|FG005|Overall Study|Death|3|||
170533345|NCT00171249|616298298|FG006|Overall Study|Death|1|||
170533346|NCT00171249|616298292|FG000|Overall Study|Other|10|||
170533347|NCT00171249|616298293|FG001|Overall Study|Other|0|||
170533348|NCT00171249|616298294|FG002|Overall Study|Other|0|||
170533349|NCT00171249|616298295|FG003|Overall Study|Other|43|||
170533350|NCT00171249|616298296|FG004|Overall Study|Other|0|||
170533351|NCT00171249|616298297|FG005|Overall Study|Other|2|||
170533352|NCT00171249|616298298|FG006|Overall Study|Other|0|||
170533353|NCT00171249|616298292|FG000|Overall Study|No Longer Requires Study Drug|4|||
170533354|NCT00171249|616298293|FG001|Overall Study|No Longer Requires Study Drug|0|||
170533355|NCT00171249|616298294|FG002|Overall Study|No Longer Requires Study Drug|0|||
170533356|NCT00171249|616298295|FG003|Overall Study|No Longer Requires Study Drug|3|||
170533357|NCT00171249|616298296|FG004|Overall Study|No Longer Requires Study Drug|0|||
170533358|NCT00171249|616298297|FG005|Overall Study|No Longer Requires Study Drug|5|||
170533359|NCT00171249|616298298|FG006|Overall Study|No Longer Requires Study Drug|0|||
170533360|NCT00171249|616298292|FG000|Overall Study|Administrative Problems|1|||
170533361|NCT00171249|616298293|FG001|Overall Study|Administrative Problems|0|||
170533362|NCT00171249|616298294|FG002|Overall Study|Administrative Problems|0|||
170533363|NCT00171249|616298295|FG003|Overall Study|Administrative Problems|2|||
170533364|NCT00171249|616298296|FG004|Overall Study|Administrative Problems|0|||
170533365|NCT00171249|616298297|FG005|Overall Study|Administrative Problems|0|||
170533366|NCT00171249|616298298|FG006|Overall Study|Administrative Problems|0|||
170533367|NCT00171249|616298292|FG000|Overall Study|Adverse Event|3|||
170533368|NCT00171249|616298293|FG001|Overall Study|Adverse Event|1|||
170533369|NCT00171249|616298294|FG002|Overall Study|Adverse Event|0|||
170533370|NCT00171249|616298295|FG003|Overall Study|Adverse Event|15|||
170533371|NCT00171249|616298296|FG004|Overall Study|Adverse Event|0|||
170533372|NCT00171249|616298297|FG005|Overall Study|Adverse Event|2|||
170533373|NCT00171249|616298298|FG006|Overall Study|Adverse Event|0|||
170533374|NCT00171249|616298292|FG000|Overall Study|Lost to Follow-up|5|||
170533375|NCT00171249|616298293|FG001|Overall Study|Lost to Follow-up|0|||
170533376|NCT00171249|616298294|FG002|Overall Study|Lost to Follow-up|0|||
170533377|NCT00171249|616298295|FG003|Overall Study|Lost to Follow-up|9|||
170533378|NCT00171249|616298296|FG004|Overall Study|Lost to Follow-up|0|||
170533379|NCT00171249|616298297|FG005|Overall Study|Lost to Follow-up|0|||
170533380|NCT00171249|616298298|FG006|Overall Study|Lost to Follow-up|0|||
170533381|NCT00392223|616298299|FG000|Overall Study|Adverse Event|5|||
170533382|NCT00392223|616298300|FG001|Overall Study|Adverse Event|4|||
170533383|NCT00392223|616298299|FG000|Overall Study|Lost to Follow-up|1|||
170533384|NCT00392223|616298300|FG001|Overall Study|Lost to Follow-up|4|||
170533385|NCT00392223|616298299|FG000|Overall Study|Protocol Violation|0|||
170533386|NCT00392223|616298300|FG001|Overall Study|Protocol Violation|3|||
170533387|NCT00392223|616298299|FG000|Overall Study|Withdrawal by Subject|3|||
170879096|NCT00105443|617569194|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
170533388|NCT00392223|616298300|FG001|Overall Study|Withdrawal by Subject|2|||
170533389|NCT02908347|616298303|FG000|Overall Study|Adverse Event|0|||
170533390|NCT02908347|616298304|FG001|Overall Study|Adverse Event|1|||
170422544|NCT01569152|615888035|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
170422545|NCT01569152|615888036|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
170422546|NCT01569152|615888037|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
170422547|NCT01569152|615888035|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
170422548|NCT01569152|615888036|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
170422549|NCT01569152|615888037|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
170422550|NCT01569152|615888035|FG000|Phase IIa, Period 1|Protocol Violation|0|||
170422551|NCT01569152|615888036|FG001|Phase IIa, Period 1|Protocol Violation|1|||
170422552|NCT01569152|615888037|FG002|Phase IIa, Period 1|Protocol Violation|0|||
170422553|NCT01569152|615888035|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
170422554|NCT01569152|615888036|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
170422555|NCT01569152|615888037|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
170422556|NCT01569152|615888035|FG000|Safety Extension, Period 3|Adverse Event|0|||
170422557|NCT01569152|615888036|FG001|Safety Extension, Period 3|Adverse Event|0|||
170422558|NCT01569152|615888037|FG002|Safety Extension, Period 3|Adverse Event|4|||
170422559|NCT01569152|615888035|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
170422560|NCT01569152|615888036|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
170422561|NCT01569152|615888037|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
170422562|NCT01569152|615888035|FG000|Safety Extension, Period 3|Physician Decision|0|||
170422563|NCT01569152|615888036|FG001|Safety Extension, Period 3|Physician Decision|0|||
170422564|NCT01569152|615888037|FG002|Safety Extension, Period 3|Physician Decision|2|||
170422565|NCT01569152|615888035|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
170422566|NCT01569152|615888036|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
170422567|NCT01569152|615888037|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
170422568|NCT03144687|615888038|FG000|Overall Study|Death|0|||
170422569|NCT03144687|615888039|FG001|Overall Study|Death|2|||
170422570|NCT03144687|615888038|FG000|Overall Study|Lost to Follow-up|0|||
170422571|NCT03144687|615888039|FG001|Overall Study|Lost to Follow-up|1|||
170422572|NCT03144687|615888038|FG000|Overall Study|Physician Decision|0|||
170422573|NCT03144687|615888039|FG001|Overall Study|Physician Decision|1|||
170422574|NCT03144687|615888038|FG000|Overall Study|Withdrawal by Subject|1|||
170422575|NCT03144687|615888039|FG001|Overall Study|Withdrawal by Subject|3|||
170422576|NCT03144687|615888038|FG000|Overall Study|Not Reported|2|||
170422577|NCT03144687|615888039|FG001|Overall Study|Not Reported|0|||
170422578|NCT00824265|615888040|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
170422579|NCT00824265|615888041|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
170422580|NCT00824265|615888040|FG000|Treatment Phase|Protocol Violation|1|||
170422581|NCT00824265|615888041|FG001|Treatment Phase|Protocol Violation|0|||
170422582|NCT00824265|615888040|FG000|Treatment Phase|Lost to Follow-up|1|||
170422583|NCT00824265|615888041|FG001|Treatment Phase|Lost to Follow-up|1|||
170422584|NCT00824265|615888040|FG000|Treatment Phase|Physician Decision|6|||
170422585|NCT00824265|615888041|FG001|Treatment Phase|Physician Decision|12|||
170422586|NCT00824265|615888040|FG000|Treatment Phase|Withdrawal by Subject|6|||
170422587|NCT00824265|615888041|FG001|Treatment Phase|Withdrawal by Subject|15|||
170422588|NCT00824265|615888040|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
170422589|NCT00824265|615888041|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
170422590|NCT00824265|615888040|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
170422591|NCT00824265|615888041|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
170422592|NCT00591630|615888042|FG000|Overall Study|Death|0|||
170422593|NCT00591630|615888043|FG001|Overall Study|Death|0|||
170422594|NCT00591630|615888044|FG002|Overall Study|Death|1|||
170422595|NCT00591630|615888045|FG003|Overall Study|Death|0|||
170422596|NCT02507375|615888046|FG000|Overall Study|Progressive Disease|4|||
170422597|NCT02507375|615888047|FG001|Overall Study|Progressive Disease|5|||
170422598|NCT02507375|615888046|FG000|Overall Study|Death|0|||
170422599|NCT02507375|615888047|FG001|Overall Study|Death|1|||
170422600|NCT02507375|615888046|FG000|Overall Study|Refused treatment|0|||
170422601|NCT02507375|615888047|FG001|Overall Study|Refused treatment|1|||
170422602|NCT02507375|615888046|FG000|Overall Study|Adverse Event|0|||
170422603|NCT02507375|615888047|FG001|Overall Study|Adverse Event|1|||
170422604|NCT01691248|615888048|FG000|Overall Study|Protocol Violation|43|||
170422605|NCT01691248|615888049|FG001|Overall Study|Protocol Violation|27|||
170422606|NCT01691248|615888048|FG000|Overall Study|Adverse Event|24|||
170422607|NCT01691248|615888049|FG001|Overall Study|Adverse Event|22|||
170422608|NCT01691248|615888048|FG000|Overall Study|Withdrawal by Subject|20|||
170422609|NCT01691248|615888049|FG001|Overall Study|Withdrawal by Subject|18|||
170422610|NCT01691248|615888048|FG000|Overall Study|Confirmed CDAD|14|||
170422611|NCT01691248|615888049|FG001|Overall Study|Confirmed CDAD|31|||
170422612|NCT01691248|615888048|FG000|Overall Study|Lost to Follow-up|2|||
170422613|NCT01691248|615888049|FG001|Overall Study|Lost to Follow-up|5|||
170422614|NCT01691248|615888048|FG000|Overall Study|Reason not provided|4|||
170422615|NCT01691248|615888049|FG001|Overall Study|Reason not provided|4|||
170422616|NCT01691248|615888048|FG000|Overall Study|Not Treated|4|||
170422617|NCT01691248|615888049|FG001|Overall Study|Not Treated|7|||
170422618|NCT02653664|615889416|FG000|Post-Treatment|Withdrawal by Subject|6|||
170422619|NCT02653664|615889417|FG001|Post-Treatment|Withdrawal by Subject|5|||
170422620|NCT02653664|615889418|FG002|Post-Treatment|Withdrawal by Subject|7|||
170533391|NCT02908347|616298303|FG000|Overall Study|Lost to Follow-up|1|||
170533392|NCT02908347|616298304|FG001|Overall Study|Lost to Follow-up|0|||
170533393|NCT02783690|616298305|FG000|Overall Study|Withdrawal by Subject|3|||
170533394|NCT02783690|616298306|FG001|Overall Study|Withdrawal by Subject|3|||
170533395|NCT03344757|616298310|FG000|Overall Study|Withdrawal by Subject|18|||
170533396|NCT03344757|616298311|FG001|Overall Study|Withdrawal by Subject|16|||
170533397|NCT03344757|616298310|FG000|Overall Study|Lost to Follow-up|0|||
170533398|NCT03344757|616298311|FG001|Overall Study|Lost to Follow-up|2|||
170533399|NCT05516758|616298314|FG000|Overall Study|Adverse Event|5|||
170533400|NCT05516758|616298315|FG001|Overall Study|Adverse Event|1|||
170533401|NCT05516758|616298316|FG002|Overall Study|Adverse Event|3|||
170533402|NCT05516758|616298317|FG003|Overall Study|Adverse Event|0|||
170533403|NCT05516758|616298318|FG004|Overall Study|Adverse Event|1|||
170533404|NCT05516758|616298319|FG005|Overall Study|Adverse Event|3|||
170533405|NCT05516758|616298320|FG006|Overall Study|Adverse Event|5|||
170533406|NCT05516758|616298314|FG000|Overall Study|Assigned treatment by mistake|1|||
170533407|NCT05516758|616298315|FG001|Overall Study|Assigned treatment by mistake|0|||
170533408|NCT05516758|616298316|FG002|Overall Study|Assigned treatment by mistake|0|||
170533409|NCT05516758|616298317|FG003|Overall Study|Assigned treatment by mistake|0|||
170533410|NCT05516758|616298318|FG004|Overall Study|Assigned treatment by mistake|1|||
170533411|NCT05516758|616298319|FG005|Overall Study|Assigned treatment by mistake|0|||
170533412|NCT05516758|616298320|FG006|Overall Study|Assigned treatment by mistake|0|||
170533413|NCT05516758|616298314|FG000|Overall Study|Lack of Efficacy|6|||
170533414|NCT05516758|616298315|FG001|Overall Study|Lack of Efficacy|0|||
170533415|NCT05516758|616298316|FG002|Overall Study|Lack of Efficacy|2|||
170533416|NCT05516758|616298317|FG003|Overall Study|Lack of Efficacy|0|||
170533417|NCT05516758|616298318|FG004|Overall Study|Lack of Efficacy|3|||
170533418|NCT05516758|616298319|FG005|Overall Study|Lack of Efficacy|6|||
170533419|NCT05516758|616298320|FG006|Overall Study|Lack of Efficacy|3|||
170533420|NCT05516758|616298314|FG000|Overall Study|Lost to Follow-up|2|||
170533421|NCT05516758|616298315|FG001|Overall Study|Lost to Follow-up|0|||
170533422|NCT05516758|616298316|FG002|Overall Study|Lost to Follow-up|2|||
170533423|NCT05516758|616298317|FG003|Overall Study|Lost to Follow-up|0|||
170533424|NCT05516758|616298318|FG004|Overall Study|Lost to Follow-up|3|||
170533425|NCT05516758|616298319|FG005|Overall Study|Lost to Follow-up|2|||
170533426|NCT05516758|616298320|FG006|Overall Study|Lost to Follow-up|1|||
170533427|NCT05516758|616298314|FG000|Overall Study|Other- As reported by the site|2|||
170533428|NCT05516758|616298315|FG001|Overall Study|Other- As reported by the site|1|||
170533429|NCT05516758|616298316|FG002|Overall Study|Other- As reported by the site|8|||
170533430|NCT05516758|616298317|FG003|Overall Study|Other- As reported by the site|1|||
170533431|NCT05516758|616298318|FG004|Overall Study|Other- As reported by the site|2|||
170533432|NCT05516758|616298319|FG005|Overall Study|Other- As reported by the site|3|||
170533433|NCT05516758|616298320|FG006|Overall Study|Other- As reported by the site|8|||
170533434|NCT05516758|616298314|FG000|Overall Study|Physician Decision|1|||
170533435|NCT05516758|616298315|FG001|Overall Study|Physician Decision|0|||
170533436|NCT05516758|616298316|FG002|Overall Study|Physician Decision|7|||
170533437|NCT05516758|616298317|FG003|Overall Study|Physician Decision|0|||
170533438|NCT05516758|616298318|FG004|Overall Study|Physician Decision|1|||
170533439|NCT05516758|616298319|FG005|Overall Study|Physician Decision|1|||
170533440|NCT05516758|616298320|FG006|Overall Study|Physician Decision|2|||
170533441|NCT05516758|616298314|FG000|Overall Study|Protocol Deviation|1|||
170533442|NCT05516758|616298315|FG001|Overall Study|Protocol Deviation|0|||
170533443|NCT05516758|616298316|FG002|Overall Study|Protocol Deviation|0|||
170533444|NCT05516758|616298317|FG003|Overall Study|Protocol Deviation|0|||
170533445|NCT05516758|616298318|FG004|Overall Study|Protocol Deviation|0|||
170533446|NCT05516758|616298319|FG005|Overall Study|Protocol Deviation|1|||
170533447|NCT05516758|616298320|FG006|Overall Study|Protocol Deviation|5|||
170533448|NCT05516758|616298314|FG000|Overall Study|Withdrawal by Subject|11|||
170533449|NCT05516758|616298315|FG001|Overall Study|Withdrawal by Subject|1|||
170533450|NCT05516758|616298316|FG002|Overall Study|Withdrawal by Subject|15|||
170533451|NCT05516758|616298317|FG003|Overall Study|Withdrawal by Subject|2|||
170533452|NCT05516758|616298318|FG004|Overall Study|Withdrawal by Subject|7|||
170533453|NCT05516758|616298319|FG005|Overall Study|Withdrawal by Subject|7|||
170533454|NCT05516758|616298320|FG006|Overall Study|Withdrawal by Subject|6|||
170533455|NCT05516758|616298314|FG000|Overall Study|Death|1|||
170533456|NCT05516758|616298315|FG001|Overall Study|Death|0|||
170533457|NCT05516758|616298316|FG002|Overall Study|Death|0|||
170533458|NCT05516758|616298317|FG003|Overall Study|Death|0|||
170533459|NCT05516758|616298318|FG004|Overall Study|Death|0|||
170533460|NCT05516758|616298319|FG005|Overall Study|Death|0|||
170533461|NCT05516758|616298320|FG006|Overall Study|Death|0|||
170533462|NCT05516758|616298314|FG000|Overall Study|Non-compliance With Study Drug|0|||
170533463|NCT05516758|616298315|FG001|Overall Study|Non-compliance With Study Drug|0|||
170533464|NCT05516758|616298316|FG002|Overall Study|Non-compliance With Study Drug|1|||
170533465|NCT05516758|616298317|FG003|Overall Study|Non-compliance With Study Drug|0|||
170533466|NCT05516758|616298318|FG004|Overall Study|Non-compliance With Study Drug|0|||
170533467|NCT05516758|616298319|FG005|Overall Study|Non-compliance With Study Drug|0|||
170533468|NCT05516758|616298320|FG006|Overall Study|Non-compliance With Study Drug|0|||
170533469|NCT05516758|616298314|FG000|Overall Study|Site Terminated by Sponsor|2|||
170533470|NCT05516758|616298315|FG001|Overall Study|Site Terminated by Sponsor|0|||
170533471|NCT05516758|616298316|FG002|Overall Study|Site Terminated by Sponsor|0|||
170533472|NCT05516758|616298317|FG003|Overall Study|Site Terminated by Sponsor|0|||
170533473|NCT05516758|616298318|FG004|Overall Study|Site Terminated by Sponsor|0|||
170533474|NCT05516758|616298319|FG005|Overall Study|Site Terminated by Sponsor|0|||
170533475|NCT05516758|616298320|FG006|Overall Study|Site Terminated by Sponsor|0|||
170533476|NCT05516758|616298314|FG000|Overall Study|Study Terminated by Sponsor|4|||
170533477|NCT05516758|616298315|FG001|Overall Study|Study Terminated by Sponsor|0|||
170533478|NCT05516758|616298316|FG002|Overall Study|Study Terminated by Sponsor|3|||
170533479|NCT05516758|616298317|FG003|Overall Study|Study Terminated by Sponsor|0|||
170533480|NCT05516758|616298318|FG004|Overall Study|Study Terminated by Sponsor|2|||
170533481|NCT05516758|616298319|FG005|Overall Study|Study Terminated by Sponsor|3|||
170533482|NCT05516758|616298320|FG006|Overall Study|Study Terminated by Sponsor|0|||
170533483|NCT05516758|616298314|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
170533484|NCT05516758|616298315|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
170422621|NCT02653664|615889416|FG000|Post-Treatment|Lost to Follow-up|8|||
170422622|NCT02653664|615889417|FG001|Post-Treatment|Lost to Follow-up|1|||
170422623|NCT02653664|615889418|FG002|Post-Treatment|Lost to Follow-up|7|||
170422624|NCT02653664|615889416|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
170422625|NCT02653664|615889417|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
170422626|NCT02653664|615889418|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
170422627|NCT02653664|615889416|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
170422628|NCT02653664|615889417|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
170422629|NCT02653664|615889418|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
170422630|NCT02653664|615889416|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
170422631|NCT02653664|615889417|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
170422632|NCT02653664|615889418|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
170422633|NCT02653664|615889416|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
170422634|NCT02653664|615889417|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
170422635|NCT02653664|615889418|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
170422636|NCT02653664|615889416|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
170422637|NCT02653664|615889417|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
170422638|NCT02653664|615889418|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
170422639|NCT02653664|615889416|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
170422640|NCT02653664|615889417|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
170422641|NCT02653664|615889418|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
170422642|NCT02653664|615889416|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
170422643|NCT02653664|615889417|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
170422644|NCT02653664|615889418|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
170422645|NCT02653664|615889416|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
170422646|NCT02653664|615889417|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
170422647|NCT02653664|615889418|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
170422648|NCT00746798|615889419|FG000|Overall Study|Protocol Violation|0|||
170422649|NCT00746798|615889420|FG001|Overall Study|Protocol Violation|1|||
170422650|NCT00746798|615889421|FG002|Overall Study|Protocol Violation|0|||
170422651|NCT00746798|615889422|FG003|Overall Study|Protocol Violation|0|||
170422652|NCT00746798|615889419|FG000|Overall Study|Withdrawal by Subject|0|||
170422653|NCT00746798|615889420|FG001|Overall Study|Withdrawal by Subject|1|||
170422654|NCT00746798|615889421|FG002|Overall Study|Withdrawal by Subject|1|||
170422655|NCT00746798|615889422|FG003|Overall Study|Withdrawal by Subject|0|||
170422656|NCT00746798|615889419|FG000|Overall Study|Death|0|||
170422657|NCT00746798|615889420|FG001|Overall Study|Death|0|||
170422658|NCT00746798|615889421|FG002|Overall Study|Death|2|||
170422659|NCT00746798|615889422|FG003|Overall Study|Death|0|||
170422660|NCT00746798|615889419|FG000|Overall Study|Participant unable to return for visit|1|||
170422661|NCT00746798|615889420|FG001|Overall Study|Participant unable to return for visit|0|||
170422662|NCT00746798|615889421|FG002|Overall Study|Participant unable to return for visit|0|||
170422663|NCT00746798|615889422|FG003|Overall Study|Participant unable to return for visit|0|||
170422664|NCT01179048|615889423|FG000|Overall Study|Withdrawn - does not allow contact|4|||
170422665|NCT01179048|615889424|FG001|Overall Study|Withdrawn - does not allow contact|8|||
170422666|NCT01179048|615889423|FG000|Overall Study|Lost to Follow-up|8|||
170422667|NCT01179048|615889424|FG001|Overall Study|Lost to Follow-up|9|||
170422668|NCT01179048|615889423|FG000|Overall Study|Alive|127|||
170422669|NCT01179048|615889424|FG001|Overall Study|Alive|142|||
170422670|NCT01471093|615889425|FG000|Overall Study|Adverse Event|1|||
170422671|NCT01471093|615889426|FG001|Overall Study|Adverse Event|0|||
170422672|NCT01471093|615889427|FG002|Overall Study|Adverse Event|0|||
170422673|NCT01471093|615889428|FG003|Overall Study|Adverse Event|0|||
170422674|NCT00620022|615889429|FG000|Treatment Period 1|Adverse Event|4|||
170533485|NCT05516758|616298316|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
170533486|NCT05516758|616298317|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
170632673|NCT02760498|616666743|FG001|Overall Study|Death|5|||
170422675|NCT00620022|615889430|FG001|Treatment Period 1|Adverse Event|6|||
170422676|NCT00620022|615889429|FG000|Treatment Period 1|Subject withdrew consent|1|||
170422677|NCT00620022|615889430|FG001|Treatment Period 1|Subject withdrew consent|0|||
170422678|NCT00620022|615889429|FG000|Treatment Period 2|Adverse Event|2|||
170422679|NCT00620022|615889430|FG001|Treatment Period 2|Adverse Event|2|||
170422680|NCT01804270|615889432|FG000|Overall Study|Withdrawal by Subject|1|||
170422681|NCT01804270|615889433|FG001|Overall Study|Withdrawal by Subject|1|||
170422682|NCT01367457|615889435|FG000|Overall Study|Death|2|||
170422683|NCT01367457|615889436|FG001|Overall Study|Death|0|||
170422684|NCT01367457|615889437|FG002|Overall Study|Death|0|||
170422685|NCT01367457|615889435|FG000|Overall Study|Investigator's decision|2|||
170422686|NCT01367457|615889436|FG001|Overall Study|Investigator's decision|0|||
170422687|NCT01367457|615889437|FG002|Overall Study|Investigator's decision|0|||
170422688|NCT01367457|615889435|FG000|Overall Study|Clinical decline (CD)|2|||
170422689|NCT01367457|615889436|FG001|Overall Study|Clinical decline (CD)|0|||
170422690|NCT01367457|615889437|FG002|Overall Study|Clinical decline (CD)|0|||
170422691|NCT01367457|615889435|FG000|Overall Study|Progression and death|8|||
170422692|NCT01367457|615889436|FG001|Overall Study|Progression and death|0|||
170422693|NCT01367457|615889437|FG002|Overall Study|Progression and death|0|||
170422694|NCT01367457|615889435|FG000|Overall Study|Toxicity|16|||
170422695|NCT01367457|615889436|FG001|Overall Study|Toxicity|0|||
170422696|NCT01367457|615889437|FG002|Overall Study|Toxicity|0|||
170422697|NCT01367457|615889435|FG000|Overall Study|Progression|137|||
170422698|NCT01367457|615889436|FG001|Overall Study|Progression|0|||
170422699|NCT01367457|615889437|FG002|Overall Study|Progression|0|||
170422700|NCT01367457|615889435|FG000|Overall Study|Patient asks for rest + slow progression|1|||
170422701|NCT01367457|615889436|FG001|Overall Study|Patient asks for rest + slow progression|0|||
170422702|NCT01367457|615889437|FG002|Overall Study|Patient asks for rest + slow progression|0|||
170422703|NCT01367457|615889435|FG000|Overall Study|Investigator's opinion, stable disease|1|||
170422704|NCT01367457|615889436|FG001|Overall Study|Investigator's opinion, stable disease|0|||
170422705|NCT01367457|615889437|FG002|Overall Study|Investigator's opinion, stable disease|0|||
170422706|NCT01367457|615889435|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
170422707|NCT01367457|615889436|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
170422708|NCT01367457|615889437|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
170422709|NCT01367457|615889435|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
170422710|NCT01367457|615889436|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
170422711|NCT01367457|615889437|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
170422712|NCT01367457|615889435|FG000|Overall Study|low grade toxicities + stable disease|1|||
170422713|NCT01367457|615889436|FG001|Overall Study|low grade toxicities + stable disease|0|||
170422714|NCT01367457|615889437|FG002|Overall Study|low grade toxicities + stable disease|0|||
170422715|NCT01367457|615889435|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
170422716|NCT01367457|615889436|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
170422717|NCT01367457|615889437|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
170422718|NCT01367457|615889435|FG000|Overall Study|Withdrawal by Subject|1|||
170422719|NCT01367457|615889436|FG001|Overall Study|Withdrawal by Subject|0|||
170422720|NCT01367457|615889437|FG002|Overall Study|Withdrawal by Subject|0|||
170422721|NCT01367457|615889435|FG000|Overall Study|CD, associated leukaemia|1|||
170422722|NCT01367457|615889436|FG001|Overall Study|CD, associated leukaemia|0|||
170422723|NCT01367457|615889437|FG002|Overall Study|CD, associated leukaemia|0|||
170422724|NCT01367457|615889435|FG000|Overall Study|Uncontrolled pain|1|||
170422725|NCT01367457|615889436|FG001|Overall Study|Uncontrolled pain|0|||
170422726|NCT01367457|615889437|FG002|Overall Study|Uncontrolled pain|0|||
170422727|NCT01367457|615889435|FG000|Overall Study|Overall status worsens to grade 4|1|||
170422728|NCT01367457|615889436|FG001|Overall Study|Overall status worsens to grade 4|0|||
170422729|NCT01367457|615889437|FG002|Overall Study|Overall status worsens to grade 4|0|||
170422730|NCT01367457|615889435|FG000|Overall Study|Stabilisation + frequent infections|1|||
170422731|NCT01367457|615889436|FG001|Overall Study|Stabilisation + frequent infections|0|||
170422732|NCT01367457|615889437|FG002|Overall Study|Stabilisation + frequent infections|0|||
170422733|NCT01367457|615889435|FG000|Overall Study|No clinical benefit|1|||
170422734|NCT01367457|615889436|FG001|Overall Study|No clinical benefit|0|||
170422735|NCT01367457|615889437|FG002|Overall Study|No clinical benefit|0|||
170422736|NCT01367457|615889435|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
170422737|NCT01367457|615889436|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
170422738|NCT01367457|615889437|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
170422739|NCT01367457|615889435|FG000|Overall Study|Overall decline|1|||
170422740|NCT01367457|615889436|FG001|Overall Study|Overall decline|0|||
170422741|NCT01367457|615889437|FG002|Overall Study|Overall decline|0|||
170422742|NCT01367457|615889435|FG000|Overall Study|Rejection of treatment|1|||
170422743|NCT01367457|615889436|FG001|Overall Study|Rejection of treatment|0|||
170422744|NCT01367457|615889437|FG002|Overall Study|Rejection of treatment|0|||
170422745|NCT01367457|615889435|FG000|Overall Study|Lost to Follow-up|1|||
170422746|NCT01367457|615889436|FG001|Overall Study|Lost to Follow-up|0|||
170422747|NCT01367457|615889437|FG002|Overall Study|Lost to Follow-up|0|||
170422748|NCT01367457|615889435|FG000|Overall Study|Death from septic shock|1|||
170533487|NCT05516758|616298318|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
170533488|NCT05516758|616298319|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
170533489|NCT05516758|616298320|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
170533490|NCT05516758|616298314|FG000|Overall Study|Other|0|||
170533491|NCT05516758|616298315|FG001|Overall Study|Other|0|||
170533492|NCT05516758|616298316|FG002|Overall Study|Other|0|||
170533493|NCT05516758|616298317|FG003|Overall Study|Other|0|||
170533494|NCT05516758|616298318|FG004|Overall Study|Other|0|||
170533495|NCT05516758|616298319|FG005|Overall Study|Other|0|||
170533496|NCT05516758|616298320|FG006|Overall Study|Other|1|||
170533497|NCT01316575|616298321|FG000|Overall Study|Withdrawal by Subject|2|||
170632674|NCT02760498|616666744|FG002|Overall Study|Death|5|||
170422749|NCT01367457|615889436|FG001|Overall Study|Death from septic shock|0|||
170422750|NCT01367457|615889437|FG002|Overall Study|Death from septic shock|0|||
170422751|NCT01367457|615889435|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
170422752|NCT01367457|615889436|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
170422753|NCT01367457|615889437|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
170422754|NCT01367457|615889435|FG000|Overall Study|Patient's Wish|1|||
170422755|NCT01367457|615889436|FG001|Overall Study|Patient's Wish|0|||
170422756|NCT01367457|615889437|FG002|Overall Study|Patient's Wish|0|||
170422757|NCT01367457|615889435|FG000|Overall Study|Palliative. Overall decline|1|||
170422758|NCT01367457|615889436|FG001|Overall Study|Palliative. Overall decline|0|||
170422759|NCT01367457|615889437|FG002|Overall Study|Palliative. Overall decline|0|||
170422760|NCT01367457|615889435|FG000|Overall Study|Suspected DP/suspected active infection|1|||
170422761|NCT01367457|615889436|FG001|Overall Study|Suspected DP/suspected active infection|0|||
170422762|NCT01367457|615889437|FG002|Overall Study|Suspected DP/suspected active infection|0|||
170422763|NCT04407806|615889440|FG000|Overall Study|Withdrawal by Subject|1|||
170422764|NCT04407806|615889441|FG001|Overall Study|Withdrawal by Subject|2|||
170422765|NCT03447262|615889442|FG000|Overall Study|Adverse Event|7|||
170422766|NCT03447262|615889442|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
170422767|NCT03447262|615889442|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
170422768|NCT03447262|615889442|FG000|Overall Study|Death|2|||
170422769|NCT03447262|615889442|FG000|Overall Study|Study Termination by Sponsor|455|||
170422770|NCT03447262|615889442|FG000|Overall Study|Other|4|||
170422771|NCT02058498|615889446|FG000|Overall Study|Withdrawal by Subject|4|||
170422772|NCT04605094|615889447|FG000|Overall Study|Adverse Event|2|||
170422773|NCT04605094|615889448|FG001|Overall Study|Adverse Event|2|||
170422774|NCT04605094|615889447|FG000|Overall Study|Lost to Follow-up|1|||
170422775|NCT04605094|615889448|FG001|Overall Study|Lost to Follow-up|4|||
170422776|NCT04605094|615889447|FG000|Overall Study|Physician Decision|2|||
170422777|NCT04605094|615889448|FG001|Overall Study|Physician Decision|2|||
170422778|NCT04605094|615889447|FG000|Overall Study|Study terminated by Sponsor|31|||
170422779|NCT04605094|615889448|FG001|Overall Study|Study terminated by Sponsor|33|||
170422780|NCT04605094|615889447|FG000|Overall Study|Withdrawal by Subject|22|||
170422781|NCT04605094|615889448|FG001|Overall Study|Withdrawal by Subject|19|||
170422782|NCT04605094|615889447|FG000|Overall Study|Other|1|||
170422783|NCT04605094|615889448|FG001|Overall Study|Other|1|||
170422784|NCT02724462|615889449|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
170422785|NCT02724462|615889450|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
170422786|NCT02724462|615889449|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
170422787|NCT02724462|615889450|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
170422788|NCT02724462|615889449|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
170422789|NCT02724462|615889450|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
170422790|NCT02724462|615889449|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
170422791|NCT02724462|615889450|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
170422792|NCT02724462|615889449|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
170422793|NCT02724462|615889450|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
170422794|NCT02724462|615889449|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
170422795|NCT02724462|615889450|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
170422796|NCT01034358|615889451|FG000|Overall Study|Withdrawal by Subject|1|||
170422797|NCT01034358|615889451|FG000|Overall Study|Protocol Violation|1|||
170422798|NCT01015625|615889455|FG000|Overall Study|Lost to Follow-up|3|||
170422799|NCT01015625|615889456|FG001|Overall Study|Lost to Follow-up|1|||
170422800|NCT01015625|615889455|FG000|Overall Study|Withdrawal by Subject|2|||
170422801|NCT01015625|615889456|FG001|Overall Study|Withdrawal by Subject|3|||
170422802|NCT01015625|615889455|FG000|Overall Study|Physician Decision|2|||
170422803|NCT01015625|615889456|FG001|Overall Study|Physician Decision|0|||
170422804|NCT01015625|615889455|FG000|Overall Study|Death|30|||
170422805|NCT01015625|615889456|FG001|Overall Study|Death|22|||
170422806|NCT00569374|615889457|FG000|Overall Study|Withdrawal by Subject|4|||
170422807|NCT01434693|615889458|FG000|Overall Study|Adverse Event|1|||
170422808|NCT01434693|615889459|FG001|Overall Study|Adverse Event|0|||
170533498|NCT01316575|616298322|FG001|Overall Study|Withdrawal by Subject|0|||
170533499|NCT01316575|616298321|FG000|Overall Study|Required alternate treatment|0|||
170533500|NCT01316575|616298322|FG001|Overall Study|Required alternate treatment|1|||
170533501|NCT00402831|616298323|FG000|Overall Study|Lost to Follow-up|1|||
170533502|NCT00402831|616298324|FG001|Overall Study|Lost to Follow-up|2|||
170533503|NCT00402831|616298323|FG000|Overall Study|Non-compliance with protocol|0|||
170533504|NCT00402831|616298324|FG001|Overall Study|Non-compliance with protocol|1|||
170533505|NCT02792504|616298325|FG000|Overall Study|Lost to Follow-up|24|||
170533506|NCT02792504|616298325|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
170422809|NCT01434693|615889460|FG002|Overall Study|Adverse Event|0|||
170422810|NCT01434693|615889461|FG003|Overall Study|Adverse Event|0|||
170422811|NCT01434693|615889458|FG000|Overall Study|Withdrawal by Subject|1|||
170422812|NCT01434693|615889459|FG001|Overall Study|Withdrawal by Subject|0|||
170422813|NCT01434693|615889460|FG002|Overall Study|Withdrawal by Subject|1|||
170422814|NCT01434693|615889461|FG003|Overall Study|Withdrawal by Subject|1|||
170422815|NCT01434693|615889458|FG000|Overall Study|Lost to Follow-up|1|||
170422816|NCT01434693|615889459|FG001|Overall Study|Lost to Follow-up|0|||
170422817|NCT01434693|615889460|FG002|Overall Study|Lost to Follow-up|0|||
170422818|NCT01434693|615889461|FG003|Overall Study|Lost to Follow-up|0|||
170422819|NCT00912288|615889462|FG000|Overall Study|Death|0|||
170422820|NCT00912288|615889463|FG001|Overall Study|Death|1|||
170422821|NCT00912288|615889462|FG000|Overall Study|Adverse Event|1|||
170422822|NCT00912288|615889463|FG001|Overall Study|Adverse Event|1|||
170422823|NCT00912288|615889462|FG000|Overall Study|Lost to Follow-up|1|||
170422824|NCT00912288|615889463|FG001|Overall Study|Lost to Follow-up|0|||
170422825|NCT00912288|615889462|FG000|Overall Study|Protocol Violation|1|||
170422826|NCT00912288|615889463|FG001|Overall Study|Protocol Violation|0|||
170422827|NCT00912288|615889462|FG000|Overall Study|Withdrawal by Subject|3|||
170422828|NCT00912288|615889463|FG001|Overall Study|Withdrawal by Subject|3|||
170422829|NCT00912288|615889462|FG000|Overall Study|Study terminated by sponsor|34|||
170422830|NCT00912288|615889463|FG001|Overall Study|Study terminated by sponsor|35|||
170422831|NCT00912288|615889462|FG000|Overall Study|Other|1|||
170422832|NCT00912288|615889463|FG001|Overall Study|Other|0|||
170422833|NCT01449630|615889464|FG000|Period 1|Physician Decision|1|||
170422834|NCT01449630|615889465|FG001|Period 1|Physician Decision|0|||
170422835|NCT01449630|615889466|FG002|Period 1|Physician Decision|0|||
170422836|NCT01449630|615889467|FG003|Period 1|Physician Decision|1|||
170422837|NCT01449630|615889468|FG004|Period 1|Physician Decision|0|||
170422838|NCT01449630|615889469|FG005|Period 1|Physician Decision|0|||
170422839|NCT01449630|615889470|FG006|Period 1|Physician Decision|0|||
170422840|NCT01449630|615889471|FG007|Period 1|Physician Decision|0|||
170422841|NCT01449630|615889472|FG008|Period 1|Physician Decision|0|||
170422842|NCT01449630|615889464|FG000|Period 1|Sponsor Decision|0|||
170422843|NCT01449630|615889465|FG001|Period 1|Sponsor Decision|0|||
170422844|NCT01449630|615889466|FG002|Period 1|Sponsor Decision|0|||
170422845|NCT01449630|615889467|FG003|Period 1|Sponsor Decision|0|||
170422846|NCT01449630|615889468|FG004|Period 1|Sponsor Decision|0|||
170422847|NCT01449630|615889469|FG005|Period 1|Sponsor Decision|1|||
170422848|NCT01449630|615889470|FG006|Period 1|Sponsor Decision|0|||
170422849|NCT01449630|615889471|FG007|Period 1|Sponsor Decision|0|||
170422850|NCT01449630|615889472|FG008|Period 1|Sponsor Decision|0|||
170422851|NCT01449630|615889464|FG000|Period 2|Sponsor Decision|0|||
170422852|NCT01449630|615889465|FG001|Period 2|Sponsor Decision|0|||
170422853|NCT01449630|615889466|FG002|Period 2|Sponsor Decision|0|||
170422854|NCT01449630|615889467|FG003|Period 2|Sponsor Decision|0|||
170422855|NCT01449630|615889468|FG004|Period 2|Sponsor Decision|0|||
170422856|NCT01449630|615889469|FG005|Period 2|Sponsor Decision|0|||
170422857|NCT01449630|615889470|FG006|Period 2|Sponsor Decision|1|||
170422858|NCT01449630|615889471|FG007|Period 2|Sponsor Decision|0|||
170422859|NCT01449630|615889472|FG008|Period 2|Sponsor Decision|0|||
170422860|NCT01735630|615889473|FG000|Overall Study|Adverse Event|8|||
170422861|NCT01735630|615889474|FG001|Overall Study|Adverse Event|7|||
170422862|NCT01735630|615889473|FG000|Overall Study|Lost to Follow-up|1|||
170422863|NCT01735630|615889474|FG001|Overall Study|Lost to Follow-up|0|||
170422864|NCT01735630|615889473|FG000|Overall Study|Physician Decision|0|||
170422865|NCT01735630|615889474|FG001|Overall Study|Physician Decision|1|||
170422866|NCT01735630|615889473|FG000|Overall Study|Sponsor Decision|2|||
170422867|NCT01735630|615889474|FG001|Overall Study|Sponsor Decision|1|||
170422868|NCT01735630|615889473|FG000|Overall Study|Withdrawal by Subject|7|||
170422869|NCT01735630|615889474|FG001|Overall Study|Withdrawal by Subject|9|||
170422870|NCT03340727|615889475|FG000|Overall Study|Death|1|||
170422871|NCT03340727|615889476|FG001|Overall Study|Death|0|||
170422872|NCT03340727|615889475|FG000|Overall Study|Lost to Follow-up|31|||
170422873|NCT03340727|615889476|FG001|Overall Study|Lost to Follow-up|35|||
170422874|NCT03340727|615889475|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
170533507|NCT00848497|616298332|FG000|Overall Study|Screen failure|2|||
170422875|NCT03340727|615889476|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
170422876|NCT03340727|615889475|FG000|Overall Study|Transferred to another facility|10|||
170422877|NCT03340727|615889476|FG001|Overall Study|Transferred to another facility|7|||
170422878|NCT03340727|615889475|FG000|Overall Study|Withdrawal by Subject|28|||
170422879|NCT03340727|615889476|FG001|Overall Study|Withdrawal by Subject|17|||
170422880|NCT01544127|615889477|FG000|Overall Study|Lost to Follow-up|4|||
170879097|NCT00105443|617569195|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
170879098|NCT00105443|617569196|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
170879099|NCT00105443|617569193|FG000|Double-Blind Treatment|Physician Decision|1|||
170879100|NCT00105443|617569194|FG001|Double-Blind Treatment|Physician Decision|0|||
170879101|NCT00105443|617569195|FG002|Double-Blind Treatment|Physician Decision|2|||
170879102|NCT00105443|617569196|FG003|Double-Blind Treatment|Physician Decision|0|||
170879103|NCT00105443|617569193|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
170879104|NCT00105443|617569194|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
170879105|NCT00105443|617569195|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
170533508|NCT00848497|616298333|FG001|Overall Study|Screen failure|0|||
170533509|NCT00848497|616298332|FG000|Overall Study|Withdrawal by Subject|0|||
170879106|NCT00105443|617569196|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
170879107|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
170879108|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
170879109|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
170879110|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
170879111|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
170879112|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
170879113|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
170879114|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
170879115|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
170879116|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
170879117|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
170879118|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
170879119|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
170422881|NCT01544127|615889478|FG001|Overall Study|Lost to Follow-up|2|||
170533510|NCT00848497|616298333|FG001|Overall Study|Withdrawal by Subject|1|||
170533511|NCT01114724|616298334|FG000|Overall Study|Death|8|||
170533512|NCT01114724|616298334|FG000|Overall Study|Lost to Follow-up|1|||
170533513|NCT01114724|616298334|FG000|Overall Study|Withdrawal by Subject|1|||
170533514|NCT06178991|616298335|FG000|Overall Study|Withdrawal by Subject|2|||
170533515|NCT06178991|616298336|FG001|Overall Study|Withdrawal by Subject|6|||
170533516|NCT06178991|616298337|FG002|Overall Study|Withdrawal by Subject|44|||
170533517|NCT06178991|616298338|FG003|Overall Study|Withdrawal by Subject|23|||
170533518|NCT06178991|616298339|FG004|Overall Study|Withdrawal by Subject|7|||
170422882|NCT01544127|615889479|FG002|Overall Study|Lost to Follow-up|9|||
170422883|NCT01544127|615889477|FG000|Overall Study|Withdrawal by Subject|2|||
170533519|NCT06178991|616298340|FG005|Overall Study|Withdrawal by Subject|7|||
170533520|NCT06178991|616298341|FG006|Overall Study|Withdrawal by Subject|7|||
170422884|NCT01544127|615889478|FG001|Overall Study|Withdrawal by Subject|2|||
170422885|NCT01544127|615889479|FG002|Overall Study|Withdrawal by Subject|1|||
170422886|NCT01544127|615889477|FG000|Overall Study|Discharged out of catchment area|1|||
170422887|NCT01544127|615889478|FG001|Overall Study|Discharged out of catchment area|1|||
170422888|NCT01544127|615889479|FG002|Overall Study|Discharged out of catchment area|1|||
170422889|NCT01544127|615889477|FG000|Overall Study|Death|1|||
170422890|NCT01544127|615889478|FG001|Overall Study|Death|0|||
170422891|NCT01544127|615889479|FG002|Overall Study|Death|0|||
170422892|NCT01544127|615889477|FG000|Overall Study|Jail or Prison|1|||
170422893|NCT01544127|615889478|FG001|Overall Study|Jail or Prison|1|||
170422894|NCT01544127|615889479|FG002|Overall Study|Jail or Prison|2|||
170422895|NCT01544127|615889477|FG000|Overall Study|Became Psychotic|1|||
170422896|NCT01544127|615889478|FG001|Overall Study|Became Psychotic|0|||
170422897|NCT01544127|615889479|FG002|Overall Study|Became Psychotic|0|||
170422898|NCT01544127|615889477|FG000|Overall Study|Researcher withdrew|1|||
170422899|NCT01544127|615889478|FG001|Overall Study|Researcher withdrew|0|||
170422900|NCT01544127|615889479|FG002|Overall Study|Researcher withdrew|0|||
170422901|NCT01544127|615889477|FG000|Overall Study|Went active duty|0|||
170422902|NCT01544127|615889478|FG001|Overall Study|Went active duty|0|||
170422903|NCT01544127|615889479|FG002|Overall Study|Went active duty|1|||
170422904|NCT00533273|615889482|FG000|Double-blind|Withdrew consent|0|||
170422905|NCT00533273|615889483|FG001|Double-blind|Withdrew consent|2|||
170422906|NCT00533273|615889482|FG000|Open-label|Withdrawal by Subject|6|||
170533521|NCT06178991|616298342|FG007|Overall Study|Withdrawal by Subject|5|||
170632675|NCT02760498|616666745|FG003|Overall Study|Death|7|||
170422907|NCT00533273|615889483|FG001|Open-label|Withdrawal by Subject|0|||
170879120|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
170879121|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
170879122|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
170422908|NCT01873586|615889487|FG000|Overall Study|Lost to Follow-up|3|||
170422909|NCT00615069|615889488|FG000|Overall Study|Death|10|||
170422910|NCT00615069|615889488|FG000|Overall Study|Physician Decision|2|||
170422911|NCT00615069|615889488|FG000|Overall Study|Withdrawal by Subject|4|||
170533522|NCT06178991|616298335|FG000|Overall Study|Lost to Follow-up|2|||
170422912|NCT00669942|615889489|FG000|Parts 2 and 3|Adverse Event|0|||
170422913|NCT00669942|615889490|FG001|Parts 2 and 3|Adverse Event|0|||
170422914|NCT00669942|615889491|FG002|Parts 2 and 3|Adverse Event|0|||
170422915|NCT00669942|615889492|FG003|Parts 2 and 3|Adverse Event|0|||
170422916|NCT00669942|615889493|FG004|Parts 2 and 3|Adverse Event|0|||
170422917|NCT00669942|615889494|FG005|Parts 2 and 3|Adverse Event|0|||
170422918|NCT00669942|615889495|FG006|Parts 2 and 3|Adverse Event|0|||
170422919|NCT00669942|615889496|FG007|Parts 2 and 3|Adverse Event|2|||
170422920|NCT00669942|615889497|FG008|Parts 2 and 3|Adverse Event|1|||
170422921|NCT00669942|615889498|FG009|Parts 2 and 3|Adverse Event|0|||
170422922|NCT00669942|615889499|FG010|Parts 2 and 3|Adverse Event|0|||
170422923|NCT00669942|615889500|FG011|Parts 2 and 3|Adverse Event|0|||
170422924|NCT00669942|615889489|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
170422925|NCT00669942|615889490|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
170422926|NCT00669942|615889491|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
170422927|NCT00669942|615889492|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
170422928|NCT00669942|615889493|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
170422929|NCT00669942|615889494|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
170422930|NCT00669942|615889495|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
170422931|NCT00669942|615889496|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
170422932|NCT00669942|615889497|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
170422933|NCT00669942|615889498|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
170422934|NCT00669942|615889499|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
170422935|NCT00669942|615889500|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
170422936|NCT00669942|615889489|FG000|Parts 2 and 3|Protocol Violation|0|||
170422937|NCT00669942|615889490|FG001|Parts 2 and 3|Protocol Violation|0|||
170422938|NCT00669942|615889491|FG002|Parts 2 and 3|Protocol Violation|0|||
170422939|NCT00669942|615889492|FG003|Parts 2 and 3|Protocol Violation|0|||
170422940|NCT00669942|615889493|FG004|Parts 2 and 3|Protocol Violation|0|||
170422941|NCT00669942|615889494|FG005|Parts 2 and 3|Protocol Violation|1|||
170422942|NCT00669942|615889495|FG006|Parts 2 and 3|Protocol Violation|0|||
170422943|NCT00669942|615889496|FG007|Parts 2 and 3|Protocol Violation|0|||
170422944|NCT00669942|615889497|FG008|Parts 2 and 3|Protocol Violation|0|||
170422945|NCT00669942|615889498|FG009|Parts 2 and 3|Protocol Violation|0|||
170422946|NCT00669942|615889499|FG010|Parts 2 and 3|Protocol Violation|0|||
170422947|NCT00669942|615889500|FG011|Parts 2 and 3|Protocol Violation|0|||
170422948|NCT03752528|615889501|FG000|Part A|Lost to Follow-up|1|||
170422949|NCT03752528|615889501|FG000|Part A|Protocol Violation|1|||
170422950|NCT03752528|615889501|FG000|Part B|Protocol Violation|1|||
170422951|NCT03752528|615889501|FG000|Part B|Study terminated by sponsor|3|||
170422952|NCT03522675|615889503|FG000|Overall Study|Screen fail|1|||
170422953|NCT03522675|615889503|FG000|Overall Study|Non-reactive to histamine|1|||
170422954|NCT00707161|615889504|FG000|Overall Study|Physician Decision|6|||
170422955|NCT03002077|615889508|FG000|Overall Study|Non-compliance with Study Drug|4|||
170422956|NCT03002077|615889508|FG000|Overall Study|Non-compliance w/Background ADT|1|||
170422957|NCT03002077|615889508|FG000|Overall Study|Study Terminated by Sponsor|257|||
170422958|NCT03002077|615889508|FG000|Overall Study|Site Terminated by Sponsor|5|||
170422959|NCT03002077|615889508|FG000|Overall Study|Miscellaneous Reasons|10|||
170422960|NCT03002077|615889508|FG000|Overall Study|Adverse Event|23|||
170422961|NCT03002077|615889508|FG000|Overall Study|Lack of Efficacy|20|||
170422962|NCT03002077|615889508|FG000|Overall Study|Withdrawal by Subject|72|||
170422963|NCT03002077|615889508|FG000|Overall Study|Lost to Follow-up|21|||
170422964|NCT03002077|615889508|FG000|Overall Study|Pregnancy|4|||
170422965|NCT03002077|615889508|FG000|Overall Study|Protocol Violation|21|||
170422966|NCT01376167|615889511|FG000|Overall Study|Lost to Follow-up|2|||
170422967|NCT01376167|615889512|FG001|Overall Study|Lost to Follow-up|4|||
170422968|NCT01376167|615889513|FG002|Overall Study|Lost to Follow-up|2|||
170422969|NCT01376167|615889511|FG000|Overall Study|Physician Decision|1|||
170422970|NCT01376167|615889512|FG001|Overall Study|Physician Decision|1|||
170422971|NCT01376167|615889513|FG002|Overall Study|Physician Decision|0|||
170422972|NCT01376167|615889511|FG000|Overall Study|Withdrawal by Subject|1|||
170422973|NCT01376167|615889512|FG001|Overall Study|Withdrawal by Subject|5|||
170422974|NCT01376167|615889513|FG002|Overall Study|Withdrawal by Subject|4|||
170422975|NCT00834756|615889514|FG000|First Intervention|Adverse Event|1|||
170879123|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
170422976|NCT00834756|615889515|FG001|First Intervention|Adverse Event|0|||
170422977|NCT00834756|615889514|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
170422978|NCT00834756|615889515|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
170422979|NCT02514122|615889518|FG000|Overall Study|Withdrawal by Subject|2|||
170422980|NCT02514122|615889519|FG001|Overall Study|Withdrawal by Subject|0|||
170533523|NCT06178991|616298336|FG001|Overall Study|Lost to Follow-up|4|||
170422981|NCT01173692|615889522|FG000|Overall Study|Adverse Event|1|||
170422982|NCT01173692|615889523|FG001|Overall Study|Adverse Event|2|||
170422983|NCT01173692|615889522|FG000|Overall Study|Withdrawal by Subject|1|||
170422984|NCT01173692|615889523|FG001|Overall Study|Withdrawal by Subject|3|||
170422985|NCT00678639|615889527|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
170422986|NCT00678639|615889528|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
170422987|NCT00669864|615889531|FG000|Overall Study|Lost to Follow-up|2|||
170422988|NCT00669864|615889531|FG000|Overall Study|Protocol Violation|2|||
170422989|NCT00669864|615889531|FG000|Overall Study|Withdrawal by Subject|3|||
170422990|NCT00669864|615889531|FG000|Overall Study|Other|2|||
170422991|NCT04625114|615889532|FG000|Overall Study|Adverse Event|3|||
170422992|NCT04625114|615889533|FG001|Overall Study|Adverse Event|1|||
170422993|NCT04625114|615889532|FG000|Overall Study|Withdrawal by Subject|2|||
170422994|NCT04625114|615889533|FG001|Overall Study|Withdrawal by Subject|0|||
170422995|NCT01226797|615889534|FG000|Overall Study|Adverse Event|1|||
170422996|NCT01226797|615889535|FG001|Overall Study|Adverse Event|0|||
170422997|NCT01226797|615889534|FG000|Overall Study|No longer willing to participate|1|||
170422998|NCT01226797|615889535|FG001|Overall Study|No longer willing to participate|0|||
170422999|NCT01226797|615889534|FG000|Overall Study|Protocol Violation|0|||
170423000|NCT01226797|615889535|FG001|Overall Study|Protocol Violation|1|||
170423001|NCT03361228|615889539|FG000|Overall Study|Other|1|||
170423002|NCT03361228|615889540|FG001|Overall Study|Other|1|||
170423003|NCT03361228|615889539|FG000|Overall Study|Death|3|||
170533524|NCT06178991|616298337|FG002|Overall Study|Lost to Follow-up|133|||
170533525|NCT06178991|616298338|FG003|Overall Study|Lost to Follow-up|65|||
170533526|NCT06178991|616298339|FG004|Overall Study|Lost to Follow-up|68|||
170533527|NCT06178991|616298340|FG005|Overall Study|Lost to Follow-up|57|||
170533528|NCT06178991|616298341|FG006|Overall Study|Lost to Follow-up|25|||
170533529|NCT06178991|616298342|FG007|Overall Study|Lost to Follow-up|18|||
170533530|NCT06178991|616298335|FG000|Overall Study|Death|1|||
170533531|NCT06178991|616298336|FG001|Overall Study|Death|0|||
170533532|NCT06178991|616298337|FG002|Overall Study|Death|2|||
170533533|NCT06178991|616298338|FG003|Overall Study|Death|1|||
170533534|NCT06178991|616298339|FG004|Overall Study|Death|1|||
170533535|NCT06178991|616298340|FG005|Overall Study|Death|0|||
170533536|NCT06178991|616298341|FG006|Overall Study|Death|1|||
170533537|NCT06178991|616298342|FG007|Overall Study|Death|1|||
170533538|NCT06178991|616298335|FG000|Overall Study|Randomized but not Vaccinated|4|||
170533539|NCT06178991|616298336|FG001|Overall Study|Randomized but not Vaccinated|1|||
170533540|NCT06178991|616298337|FG002|Overall Study|Randomized but not Vaccinated|15|||
170533541|NCT06178991|616298338|FG003|Overall Study|Randomized but not Vaccinated|9|||
170533542|NCT06178991|616298339|FG004|Overall Study|Randomized but not Vaccinated|8|||
170533543|NCT06178991|616298340|FG005|Overall Study|Randomized but not Vaccinated|4|||
170533544|NCT06178991|616298341|FG006|Overall Study|Randomized but not Vaccinated|2|||
170533545|NCT06178991|616298342|FG007|Overall Study|Randomized but not Vaccinated|2|||
170533546|NCT06178991|616298335|FG000|Overall Study|Other: Unspecified|0|||
170533547|NCT06178991|616298336|FG001|Overall Study|Other: Unspecified|1|||
170533548|NCT06178991|616298337|FG002|Overall Study|Other: Unspecified|7|||
170533549|NCT06178991|616298338|FG003|Overall Study|Other: Unspecified|6|||
170533550|NCT06178991|616298339|FG004|Overall Study|Other: Unspecified|1|||
170533551|NCT06178991|616298340|FG005|Overall Study|Other: Unspecified|1|||
170533552|NCT06178991|616298341|FG006|Overall Study|Other: Unspecified|1|||
170533553|NCT06178991|616298342|FG007|Overall Study|Other: Unspecified|0|||
170533554|NCT06178991|616298335|FG000|Overall Study|Physician Decision|0|||
170533555|NCT06178991|616298336|FG001|Overall Study|Physician Decision|0|||
170533556|NCT06178991|616298337|FG002|Overall Study|Physician Decision|2|||
170533557|NCT06178991|616298338|FG003|Overall Study|Physician Decision|0|||
170533558|NCT06178991|616298339|FG004|Overall Study|Physician Decision|2|||
170423004|NCT03361228|615889540|FG001|Overall Study|Death|0|||
170423005|NCT01479439|615889541|FG000|Overall Study|Adverse Event|1|||
170423006|NCT01479439|615889542|FG001|Overall Study|Adverse Event|0|||
170423007|NCT01479439|615889543|FG002|Overall Study|Adverse Event|0|||
170423008|NCT01479439|615889541|FG000|Overall Study|Lost to Follow-up|0|||
170423009|NCT01479439|615889542|FG001|Overall Study|Lost to Follow-up|1|||
170423010|NCT01479439|615889543|FG002|Overall Study|Lost to Follow-up|0|||
170423011|NCT01479439|615889541|FG000|Overall Study|Protocol Violation|0|||
170423012|NCT01479439|615889542|FG001|Overall Study|Protocol Violation|0|||
170423013|NCT01479439|615889543|FG002|Overall Study|Protocol Violation|2|||
170423014|NCT02079766|615889544|FG000|Overall Study|Physician Decision|1|||
170423015|NCT02079766|615889545|FG001|Overall Study|Physician Decision|0|||
170423016|NCT02079766|615889544|FG000|Overall Study|Withdrawal by Subject|1|||
170423017|NCT02079766|615889545|FG001|Overall Study|Withdrawal by Subject|0|||
170423018|NCT02930005|615889546|FG000|Overall Study|Lost to Follow-up|1|||
170423019|NCT02930005|615889547|FG001|Overall Study|Lost to Follow-up|5|||
170423020|NCT00585689|615889548|FG000|Overall Study|Received different ABI-007 schedule|3|||
170423021|NCT00585689|615889548|FG000|Overall Study|Adverse Event|1|||
170423022|NCT00585689|615889548|FG000|Overall Study|Patient Declined Surgery|1|||
170423023|NCT00585689|615889548|FG000|Overall Study|Patient had unresectable disease|1|||
170533559|NCT06178991|616298340|FG005|Overall Study|Physician Decision|1|||
170423024|NCT00585689|615889548|FG000|Overall Study|Death|1|||
170423025|NCT00304083|615889553|FG000|Overall Study|Withdrawal by Subject|4|||
170423026|NCT00304083|615889554|FG001|Overall Study|Withdrawal by Subject|2|||
170423027|NCT00304083|615889553|FG000|Overall Study|Physician Decision|8|||
170533560|NCT06178991|616298341|FG006|Overall Study|Physician Decision|0|||
170533561|NCT06178991|616298342|FG007|Overall Study|Physician Decision|0|||
170533562|NCT06178991|616298335|FG000|Overall Study|Protocol Violation|0|||
170423028|NCT00304083|615889554|FG001|Overall Study|Physician Decision|3|||
170423029|NCT00304083|615889553|FG000|Overall Study|Disease Progression|5|||
170423030|NCT00304083|615889554|FG001|Overall Study|Disease Progression|1|||
170423031|NCT00304083|615889553|FG000|Overall Study|Other|5|||
170423032|NCT00304083|615889554|FG001|Overall Study|Other|2|||
170879124|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
170423033|NCT03966365|615889557|FG000|Overall Study|Protocol Violation|1|||
170423034|NCT03966365|615889558|FG001|Overall Study|Protocol Violation|0|||
170423035|NCT03991494|615889563|FG000|Overall Study|Progressive Disease|4|||
170423036|NCT00694551|615889564|FG000|Overall Study|Disease Progression|1|||
170423037|NCT00694551|615889565|FG001|Overall Study|Disease Progression|0|||
170423038|NCT00694551|615889566|FG002|Overall Study|Disease Progression|1|||
170423039|NCT00683293|615889568|FG000|Overall Study|Withdrawal by Subject|2|||
170423040|NCT00683293|615889569|FG001|Overall Study|Withdrawal by Subject|3|||
170423041|NCT01104662|615889570|FG000|Overall Study|Adverse Event|2|||
170423042|NCT01104662|615889571|FG001|Overall Study|Adverse Event|2|||
170423043|NCT01104662|615889572|FG002|Overall Study|Adverse Event|0|||
170423044|NCT01104662|615889573|FG003|Overall Study|Adverse Event|1|||
170423045|NCT01104662|615889574|FG004|Overall Study|Adverse Event|1|||
170423046|NCT01104662|615889575|FG005|Overall Study|Adverse Event|1|||
170423047|NCT01104662|615889576|FG006|Overall Study|Adverse Event|0|||
170423048|NCT01104662|615889577|FG007|Overall Study|Adverse Event|0|||
170423049|NCT01104662|615889570|FG000|Overall Study|Clinical Failure|1|||
170423050|NCT01104662|615889571|FG001|Overall Study|Clinical Failure|0|||
170423051|NCT01104662|615889572|FG002|Overall Study|Clinical Failure|0|||
170423052|NCT01104662|615889573|FG003|Overall Study|Clinical Failure|0|||
170423053|NCT01104662|615889574|FG004|Overall Study|Clinical Failure|0|||
170423054|NCT01104662|615889575|FG005|Overall Study|Clinical Failure|1|||
170423055|NCT01104662|615889576|FG006|Overall Study|Clinical Failure|0|||
170423056|NCT01104662|615889577|FG007|Overall Study|Clinical Failure|0|||
170423057|NCT01104662|615889570|FG000|Overall Study|Participant left investigator's care|1|||
170423058|NCT01104662|615889571|FG001|Overall Study|Participant left investigator's care|1|||
170423059|NCT01104662|615889572|FG002|Overall Study|Participant left investigator's care|0|||
170423060|NCT01104662|615889573|FG003|Overall Study|Participant left investigator's care|0|||
170423061|NCT01104662|615889574|FG004|Overall Study|Participant left investigator's care|0|||
170423062|NCT01104662|615889575|FG005|Overall Study|Participant left investigator's care|0|||
170423063|NCT01104662|615889576|FG006|Overall Study|Participant left investigator's care|0|||
170423064|NCT01104662|615889577|FG007|Overall Study|Participant left investigator's care|0|||
170423065|NCT01104662|615889570|FG000|Overall Study|Reason not specified|3|||
170423066|NCT01104662|615889571|FG001|Overall Study|Reason not specified|3|||
170423067|NCT01104662|615889572|FG002|Overall Study|Reason not specified|0|||
170423068|NCT01104662|615889573|FG003|Overall Study|Reason not specified|0|||
170423069|NCT01104662|615889574|FG004|Overall Study|Reason not specified|0|||
170423070|NCT01104662|615889575|FG005|Overall Study|Reason not specified|1|||
170423071|NCT01104662|615889576|FG006|Overall Study|Reason not specified|0|||
170423072|NCT01104662|615889577|FG007|Overall Study|Reason not specified|0|||
170423073|NCT01104662|615889570|FG000|Overall Study|Randomized but not treated|3|||
170423074|NCT01104662|615889571|FG001|Overall Study|Randomized but not treated|4|||
170423075|NCT01104662|615889572|FG002|Overall Study|Randomized but not treated|1|||
170423076|NCT01104662|615889573|FG003|Overall Study|Randomized but not treated|0|||
170423077|NCT01104662|615889574|FG004|Overall Study|Randomized but not treated|0|||
170423078|NCT01104662|615889575|FG005|Overall Study|Randomized but not treated|1|||
170423079|NCT01104662|615889576|FG006|Overall Study|Randomized but not treated|0|||
170423080|NCT01104662|615889577|FG007|Overall Study|Randomized but not treated|0|||
170423081|NCT01478620|615889578|FG000|Overall Study|Lost to Follow-up|6|||
170423082|NCT02863575|615889581|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
170423083|NCT02863575|615889582|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
170423084|NCT02863575|615889583|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
170423085|NCT02863575|615889581|FG000|Overall Study|Withdrawal by Subject|0|||
170879125|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
170879126|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
170879127|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
170879128|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
170879129|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
170423086|NCT02863575|615889582|FG001|Overall Study|Withdrawal by Subject|1|||
170423087|NCT02863575|615889583|FG002|Overall Study|Withdrawal by Subject|1|||
170423088|NCT02863575|615889581|FG000|Overall Study|Adverse Event|0|||
170423089|NCT02863575|615889582|FG001|Overall Study|Adverse Event|1|||
170423090|NCT02863575|615889583|FG002|Overall Study|Adverse Event|0|||
170423091|NCT01706926|615889584|FG000|Overall Study|Lost to Follow-up|0|||
170423092|NCT01706926|615889585|FG001|Overall Study|Lost to Follow-up|0|||
170423093|NCT01706926|615889586|FG002|Overall Study|Lost to Follow-up|1|||
170423094|NCT01706926|615889587|FG003|Overall Study|Lost to Follow-up|0|||
170879130|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
170423095|NCT01706926|615889584|FG000|Overall Study|Withdrawal by Subject|2|||
170423096|NCT01706926|615889585|FG001|Overall Study|Withdrawal by Subject|0|||
170423097|NCT01706926|615889586|FG002|Overall Study|Withdrawal by Subject|1|||
170533563|NCT06178991|616298336|FG001|Overall Study|Protocol Violation|0|||
170533564|NCT06178991|616298337|FG002|Overall Study|Protocol Violation|1|||
170533565|NCT06178991|616298338|FG003|Overall Study|Protocol Violation|0|||
170533566|NCT06178991|616298339|FG004|Overall Study|Protocol Violation|0|||
170533567|NCT06178991|616298340|FG005|Overall Study|Protocol Violation|0|||
170533568|NCT06178991|616298341|FG006|Overall Study|Protocol Violation|0|||
170533569|NCT06178991|616298342|FG007|Overall Study|Protocol Violation|0|||
170533570|NCT02485860|616298343|FG000|Overall Study|Lost to Follow-up|4|||
170533571|NCT02485860|616298344|FG001|Overall Study|Lost to Follow-up|1|||
170533572|NCT02485860|616298343|FG000|Overall Study|Physician Decision|1|||
170423098|NCT01706926|615889587|FG003|Overall Study|Withdrawal by Subject|2|||
170423099|NCT01706926|615889584|FG000|Overall Study|Other|4|||
170423100|NCT01706926|615889585|FG001|Overall Study|Other|4|||
170423101|NCT01706926|615889586|FG002|Overall Study|Other|4|||
170423102|NCT01706926|615889587|FG003|Overall Study|Other|3|||
170423103|NCT04934722|615891210|FG000|Overall Study|Death|4|||
170423104|NCT04934722|615891211|FG001|Overall Study|Death|3|||
170423105|NCT04934722|615891210|FG000|Overall Study|Participants Ongoing|88|||
170423106|NCT04934722|615891211|FG001|Overall Study|Participants Ongoing|91|||
170423107|NCT01215981|615891212|FG000|Overall Study|Physician Decision|0|||
170423108|NCT01215981|615891213|FG001|Overall Study|Physician Decision|1|||
170423109|NCT01215981|615891212|FG000|Overall Study|Protocol Violation|1|||
170423110|NCT01215981|615891213|FG001|Overall Study|Protocol Violation|0|||
170423111|NCT01215981|615891212|FG000|Overall Study|Withdrawal by Subject|1|||
170423112|NCT01215981|615891213|FG001|Overall Study|Withdrawal by Subject|0|||
170423113|NCT01294787|615891214|FG000|Period 1|Adverse Event|0|||
170423114|NCT01294787|615891215|FG001|Period 1|Adverse Event|0|||
170423115|NCT01294787|615891216|FG002|Period 1|Adverse Event|0|||
170423116|NCT01294787|615891217|FG003|Period 1|Adverse Event|0|||
170423117|NCT01294787|615891218|FG004|Period 1|Adverse Event|1|||
170423118|NCT01294787|615891219|FG005|Period 1|Adverse Event|0|||
170423119|NCT01294787|615891214|FG000|Period 1|Withdrawal by Subject|0|||
170423120|NCT01294787|615891215|FG001|Period 1|Withdrawal by Subject|0|||
170423121|NCT01294787|615891216|FG002|Period 1|Withdrawal by Subject|0|||
170423122|NCT01294787|615891217|FG003|Period 1|Withdrawal by Subject|1|||
170423123|NCT01294787|615891218|FG004|Period 1|Withdrawal by Subject|1|||
170423124|NCT01294787|615891219|FG005|Period 1|Withdrawal by Subject|1|||
170423125|NCT01294787|615891214|FG000|Period 1|Administrative problem|0|||
170423126|NCT01294787|615891215|FG001|Period 1|Administrative problem|0|||
170423127|NCT01294787|615891216|FG002|Period 1|Administrative problem|1|||
170423128|NCT01294787|615891217|FG003|Period 1|Administrative problem|0|||
170423129|NCT01294787|615891218|FG004|Period 1|Administrative problem|0|||
170423130|NCT01294787|615891219|FG005|Period 1|Administrative problem|1|||
170423131|NCT01294787|615891214|FG000|Period 2|Adverse Event|0|||
170423132|NCT01294787|615891215|FG001|Period 2|Adverse Event|3|||
170423133|NCT01294787|615891216|FG002|Period 2|Adverse Event|0|||
170423134|NCT01294787|615891217|FG003|Period 2|Adverse Event|1|||
170423135|NCT01294787|615891218|FG004|Period 2|Adverse Event|0|||
170423136|NCT01294787|615891219|FG005|Period 2|Adverse Event|0|||
170423137|NCT01294787|615891214|FG000|Period 2|No longer needs study drug|0|||
170423138|NCT01294787|615891215|FG001|Period 2|No longer needs study drug|0|||
170423139|NCT01294787|615891216|FG002|Period 2|No longer needs study drug|0|||
170423140|NCT01294787|615891217|FG003|Period 2|No longer needs study drug|1|||
170423141|NCT01294787|615891218|FG004|Period 2|No longer needs study drug|0|||
170423142|NCT01294787|615891219|FG005|Period 2|No longer needs study drug|0|||
170423143|NCT01294787|615891214|FG000|Period 3|Adverse Event|0|||
170423144|NCT01294787|615891215|FG001|Period 3|Adverse Event|0|||
170423145|NCT01294787|615891216|FG002|Period 3|Adverse Event|0|||
170423146|NCT01294787|615891217|FG003|Period 3|Adverse Event|0|||
170423147|NCT01294787|615891218|FG004|Period 3|Adverse Event|1|||
170423148|NCT01294787|615891219|FG005|Period 3|Adverse Event|0|||
170423149|NCT01340495|615891220|FG000|Overall Study|Withdrawal by Subject|1|||
170533573|NCT02485860|616298344|FG001|Overall Study|Physician Decision|2|||
170533574|NCT02485860|616298343|FG000|Overall Study|Health context (COVID-19)|1|||
170533575|NCT02485860|616298344|FG001|Overall Study|Health context (COVID-19)|0|||
170879131|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
170879132|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
170423150|NCT00723528|615891221|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
170423151|NCT00723528|615891222|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
170423152|NCT00723528|615891223|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
170423153|NCT00723528|615891224|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
170423154|NCT00723528|615891225|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
170423155|NCT00723528|615891226|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
170423156|NCT00723528|615891227|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
170423157|NCT00723528|615891221|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
170423158|NCT00723528|615891222|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
170423159|NCT00723528|615891223|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
170423160|NCT00723528|615891224|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
170533576|NCT01366092|616298347|FG000|Overall Study|Progressive cGVHD|2|||
170533577|NCT01366092|616298347|FG000|Overall Study|Physician Decision|1|||
170533578|NCT01366092|616298347|FG000|Overall Study|Withdrawal by Subject|1|||
170533579|NCT02273167|616298353|FG000|Overall Study|Adverse Event|1|||
170533580|NCT02273167|616298354|FG001|Overall Study|Adverse Event|0|||
170533581|NCT02273167|616298355|FG002|Overall Study|Adverse Event|0|||
170533582|NCT02273167|616298353|FG000|Overall Study|Protocol Violation|3|||
170533583|NCT02273167|616298354|FG001|Overall Study|Protocol Violation|1|||
170533584|NCT02273167|616298355|FG002|Overall Study|Protocol Violation|1|||
170533585|NCT02273167|616298353|FG000|Overall Study|Lost to Follow-up|0|||
170533586|NCT02273167|616298354|FG001|Overall Study|Lost to Follow-up|1|||
170533587|NCT02273167|616298355|FG002|Overall Study|Lost to Follow-up|1|||
170533588|NCT02273167|616298353|FG000|Overall Study|Withdrawal by Subject|10|||
170533589|NCT02273167|616298354|FG001|Overall Study|Withdrawal by Subject|12|||
170533590|NCT02273167|616298355|FG002|Overall Study|Withdrawal by Subject|11|||
170533591|NCT02273167|616298353|FG000|Overall Study|Various|10|||
170533592|NCT02273167|616298354|FG001|Overall Study|Various|9|||
170533593|NCT02273167|616298355|FG002|Overall Study|Various|8|||
170533594|NCT01431976|616300634|FG000|Overall Study|Adverse Event|6|||
170533595|NCT01431976|616300634|FG000|Overall Study|Lack of Efficacy|2|||
170533596|NCT01431976|616300634|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
170533597|NCT01431976|616300634|FG000|Overall Study|Physician Decision|1|||
170533598|NCT01431976|616300634|FG000|Overall Study|Withdrawal by Subject|1|||
170533599|NCT02394275|616300638|FG000|Overall Study|Adverse Event|22|||
170533600|NCT02394275|616300638|FG000|Overall Study|Lost to Follow-up|7|||
170533601|NCT00782067|616300639|FG000|Overall Study|Adverse Event|35|||
170533602|NCT00782067|616300639|FG000|Overall Study|Subject withdrew consent|11|||
170533603|NCT00782067|616300639|FG000|Overall Study|Lost to Follow-up|2|||
170533604|NCT00782067|616300639|FG000|Overall Study|Administrative problems|14|||
170533605|NCT00782067|616300639|FG000|Overall Study|Death|9|||
170533606|NCT00782067|616300639|FG000|Overall Study|Disease progression|43|||
170533607|NCT00782067|616300639|FG000|Overall Study|Protocol deviation|2|||
170533608|NCT02471183|616300640|FG000|Main Treatment Period|Adverse Event|1|||
170533609|NCT02471183|616300640|FG000|Main Treatment Period|Withdrawal by Subject|1|||
170533610|NCT02471183|616300640|FG000|Extended Treatment Period|Lack of Efficacy|1|||
170533611|NCT02328105|616300644|FG000|Overall Study|Death|6|||
170533612|NCT02328105|616300644|FG000|Overall Study|Withdrawal by Subject|1|||
170533613|NCT02328105|616300644|FG000|Overall Study|Still On Study in Follow-Up|4|||
170533614|NCT00614393|616300645|FG000|Overall Study|Adverse Event|20|||
170533615|NCT00614393|616300646|FG001|Overall Study|Adverse Event|2|||
170533616|NCT00614393|616300647|FG002|Overall Study|Adverse Event|3|||
170533617|NCT00614393|616300648|FG003|Overall Study|Adverse Event|13|||
170533618|NCT00614393|616300649|FG004|Overall Study|Adverse Event|21|||
170533619|NCT00614393|616300645|FG000|Overall Study|Lost to Follow-up|0|||
170533620|NCT00614393|616300646|FG001|Overall Study|Lost to Follow-up|0|||
170423161|NCT00723528|615891225|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
170423162|NCT00723528|615891226|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
170423163|NCT00723528|615891227|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
170423164|NCT00723528|615891221|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
170423165|NCT00723528|615891222|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
170423166|NCT00723528|615891223|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
170423167|NCT00723528|615891224|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
170423168|NCT00723528|615891225|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
170423169|NCT00723528|615891226|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
170423170|NCT00723528|615891227|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
170423171|NCT00723528|615891221|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
170423172|NCT00723528|615891222|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
170423173|NCT00723528|615891223|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
170423174|NCT00723528|615891224|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
170423175|NCT00723528|615891225|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
170423176|NCT00723528|615891226|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
170423177|NCT00723528|615891227|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
170423178|NCT00723528|615891221|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
170423179|NCT00723528|615891222|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
170423180|NCT00723528|615891223|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
170533621|NCT00614393|616300647|FG002|Overall Study|Lost to Follow-up|0|||
170533622|NCT00614393|616300648|FG003|Overall Study|Lost to Follow-up|1|||
170533623|NCT00614393|616300649|FG004|Overall Study|Lost to Follow-up|2|||
170533624|NCT00614393|616300645|FG000|Overall Study|Physician Decision|17|||
170533625|NCT00614393|616300646|FG001|Overall Study|Physician Decision|0|||
170533626|NCT00614393|616300647|FG002|Overall Study|Physician Decision|1|||
170533627|NCT00614393|616300648|FG003|Overall Study|Physician Decision|8|||
170533628|NCT00614393|616300649|FG004|Overall Study|Physician Decision|9|||
170533629|NCT00614393|616300645|FG000|Overall Study|Progressive Disease|118|||
170533630|NCT00614393|616300646|FG001|Overall Study|Progressive Disease|5|||
170423181|NCT00723528|615891224|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
170423182|NCT00723528|615891225|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
170423183|NCT00723528|615891226|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
170423184|NCT00723528|615891227|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
170423185|NCT00723528|615891221|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
170423186|NCT00723528|615891222|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
170423187|NCT00723528|615891223|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
170423188|NCT00723528|615891224|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
170423189|NCT00723528|615891225|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
170423190|NCT00723528|615891226|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
170423191|NCT00723528|615891227|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
170423192|NCT00723528|615891221|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
170423193|NCT00723528|615891222|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
170423194|NCT00723528|615891223|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
170423195|NCT00723528|615891224|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
170423196|NCT00723528|615891225|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
170423197|NCT00723528|615891226|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
170423198|NCT00723528|615891227|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
170423199|NCT00723528|615891221|FG000|Period 2: After Controlled Period|Other|0|||
170423200|NCT00723528|615891222|FG001|Period 2: After Controlled Period|Other|0|||
170423201|NCT00723528|615891223|FG002|Period 2: After Controlled Period|Other|0|||
170423202|NCT00723528|615891224|FG003|Period 2: After Controlled Period|Other|0|||
170423203|NCT00723528|615891225|FG004|Period 2: After Controlled Period|Other|1|||
170423204|NCT00723528|615891226|FG005|Period 2: After Controlled Period|Other|4|||
170423205|NCT00723528|615891227|FG006|Period 2: After Controlled Period|Other|0|||
170423206|NCT00723528|615891221|FG000|Period 2: After Controlled Period|Adverse Event|0|||
170423207|NCT00723528|615891222|FG001|Period 2: After Controlled Period|Adverse Event|0|||
170423208|NCT00723528|615891223|FG002|Period 2: After Controlled Period|Adverse Event|0|||
170423209|NCT00723528|615891224|FG003|Period 2: After Controlled Period|Adverse Event|0|||
170423210|NCT00723528|615891225|FG004|Period 2: After Controlled Period|Adverse Event|1|||
170423211|NCT00723528|615891226|FG005|Period 2: After Controlled Period|Adverse Event|0|||
170423212|NCT00723528|615891227|FG006|Period 2: After Controlled Period|Adverse Event|1|||
170423213|NCT00723528|615891221|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
170423214|NCT00723528|615891222|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
170423215|NCT00723528|615891223|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
170879133|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
170879134|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
170879135|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
170879136|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
170879137|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
170879138|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
170879139|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
170879140|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
170879141|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
170879142|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
170879143|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
170879144|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
170879145|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
170879146|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
170879147|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
170879148|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
170423216|NCT00723528|615891224|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
170423217|NCT00723528|615891225|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
170423218|NCT00723528|615891226|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
170423219|NCT00723528|615891227|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
170423220|NCT00723528|615891221|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
170423221|NCT00723528|615891222|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
170423222|NCT00723528|615891223|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
170423223|NCT00723528|615891224|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
170423224|NCT00723528|615891225|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
170533631|NCT00614393|616300647|FG002|Overall Study|Progressive Disease|5|||
170533632|NCT00614393|616300648|FG003|Overall Study|Progressive Disease|138|||
170423225|NCT00723528|615891226|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
170423226|NCT00723528|615891227|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
170423227|NCT00358449|615891228|FG000|Overall Study|Adverse Event|1|||
170423228|NCT00358449|615891229|FG001|Overall Study|Adverse Event|0|||
170423229|NCT00358449|615891230|FG002|Overall Study|Adverse Event|1|||
170423230|NCT00358449|615891228|FG000|Overall Study|Lost to Follow-up|1|||
170423231|NCT00358449|615891229|FG001|Overall Study|Lost to Follow-up|0|||
170423232|NCT00358449|615891230|FG002|Overall Study|Lost to Follow-up|0|||
170423233|NCT00358449|615891228|FG000|Overall Study|Withdrawal by Subject|2|||
170423234|NCT00358449|615891229|FG001|Overall Study|Withdrawal by Subject|0|||
170423235|NCT00358449|615891230|FG002|Overall Study|Withdrawal by Subject|0|||
170423236|NCT00358449|615891228|FG000|Overall Study|Lack of Efficacy|0|||
170423237|NCT00358449|615891229|FG001|Overall Study|Lack of Efficacy|1|||
170423238|NCT00358449|615891230|FG002|Overall Study|Lack of Efficacy|0|||
170423239|NCT00358449|615891228|FG000|Overall Study|Steriod Inhaler was Increased|0|||
170423240|NCT00358449|615891229|FG001|Overall Study|Steriod Inhaler was Increased|0|||
170423241|NCT00358449|615891230|FG002|Overall Study|Steriod Inhaler was Increased|1|||
170423242|NCT03478397|615891231|FG000|Overall Study|Refused to participate|31|||
170423243|NCT03478397|615891232|FG001|Overall Study|Refused to participate|7|||
170423244|NCT00469417|615891233|FG000|Overall Study|Treatment failure all lesions|18|||
170423245|NCT00469417|615891234|FG001|Overall Study|Treatment failure all lesions|11|||
170423246|NCT00469417|615891233|FG000|Overall Study|Consent withdrawn|1|||
170423247|NCT00469417|615891234|FG001|Overall Study|Consent withdrawn|1|||
170423248|NCT00469417|615891233|FG000|Overall Study|Adverse Event|8|||
170423249|NCT00469417|615891234|FG001|Overall Study|Adverse Event|2|||
170423250|NCT00469417|615891233|FG000|Overall Study|Lost to Follow-up|1|||
170423251|NCT00469417|615891234|FG001|Overall Study|Lost to Follow-up|2|||
170423252|NCT00469417|615891233|FG000|Overall Study|Intercurrent disease|0|||
170423253|NCT00469417|615891234|FG001|Overall Study|Intercurrent disease|1|||
170423254|NCT00469417|615891233|FG000|Overall Study|Randomized but not treated|2|||
170423255|NCT00469417|615891234|FG001|Overall Study|Randomized but not treated|0|||
170423256|NCT04000815|615891235|FG000|Overall Study|Lost to Follow-up|9|||
170423257|NCT04000815|615891236|FG001|Overall Study|Lost to Follow-up|2|||
170423258|NCT04000815|615891237|FG002|Overall Study|Lost to Follow-up|3|||
170423259|NCT04000815|615891235|FG000|Overall Study|Withdrawal by Subject|4|||
170423260|NCT04000815|615891236|FG001|Overall Study|Withdrawal by Subject|3|||
170423261|NCT04000815|615891237|FG002|Overall Study|Withdrawal by Subject|2|||
170423262|NCT04000815|615891235|FG000|Overall Study|Right ovarian cyst occured|1|||
170423263|NCT04000815|615891236|FG001|Overall Study|Right ovarian cyst occured|0|||
170423264|NCT04000815|615891237|FG002|Overall Study|Right ovarian cyst occured|0|||
170423265|NCT04000815|615891235|FG000|Overall Study|Hypertension occured on follow up|0|||
170423266|NCT04000815|615891236|FG001|Overall Study|Hypertension occured on follow up|0|||
170423267|NCT04000815|615891237|FG002|Overall Study|Hypertension occured on follow up|2|||
170423268|NCT03988803|615891238|FG000|Period 2|Prematurely discontinued from medication|2|||
170423269|NCT03988803|615891238|FG000|Period 2|Adverse Event|1|||
170423270|NCT02017964|615891241|FG000|Overall Study|Patient deemed ineligible|1|||
170423271|NCT02300103|615891244|FG000|Overall Study|Lack of Efficacy|3|||
170423272|NCT02300103|615891244|FG000|Overall Study|Protocol Violation|1|||
170423273|NCT02300103|615891244|FG000|Overall Study|Withdrew Consent|2|||
170423274|NCT04091971|615891245|FG000|Overall Study|Withdrawal by Subject|1|||
170423275|NCT04091971|615891245|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
170423276|NCT04091971|615891245|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
170423277|NCT01391793|615891246|FG000|Overall Study|Ineligible|3|||
170423278|NCT01391793|615891247|FG001|Overall Study|Ineligible|0|||
170423279|NCT01391793|615891246|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
170423280|NCT01391793|615891247|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
170423281|NCT01391793|615891246|FG000|Overall Study|No DMSA|73|||
170423282|NCT01391793|615891247|FG001|Overall Study|No DMSA|57|||
170423283|NCT04638153|615891250|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170423284|NCT04638153|615891251|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170423285|NCT04638153|615891252|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170423286|NCT04638153|615891250|FG000|Overall Study|Study terminated by sponsor|4|||
170423287|NCT04638153|615891251|FG001|Overall Study|Study terminated by sponsor|2|||
170879149|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
170879150|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
170423288|NCT04638153|615891252|FG002|Overall Study|Study terminated by sponsor|14|||
170423289|NCT04466111|615891253|FG000|Prior to Trial Phase|Physician Decision|1|||
170423290|NCT00105196|615891263|FG000|Overall Study|Lack of Efficacy|2|||
170423291|NCT00105196|615891264|FG001|Overall Study|Lack of Efficacy|3|||
170423292|NCT00105196|615891263|FG000|Overall Study|Adverse Event|11|||
170423293|NCT00105196|615891264|FG001|Overall Study|Adverse Event|3|||
170423294|NCT00105196|615891263|FG000|Overall Study|Withdrawal by Subject|6|||
170423295|NCT00105196|615891264|FG001|Overall Study|Withdrawal by Subject|6|||
170423296|NCT00105196|615891263|FG000|Overall Study|Lost to Follow-up|3|||
170879151|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
170879152|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
170879153|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
170879154|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
170879155|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
170879156|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
170879157|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
170879158|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
170879159|NCT00105443|617569193|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
170879160|NCT00105443|617569194|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
170879161|NCT00105443|617569195|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
170879162|NCT00105443|617569196|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
170879163|NCT01611974|617569199|FG000|Overall Study|Death|10|||
170879164|NCT01611974|617569200|FG001|Overall Study|Death|12|||
170879165|NCT01611974|617569201|FG002|Overall Study|Death|10|||
170879166|NCT01611974|617569199|FG000|Overall Study|Lost to Follow-up|0|||
170879167|NCT01611974|617569200|FG001|Overall Study|Lost to Follow-up|1|||
170879168|NCT01611974|617569201|FG002|Overall Study|Lost to Follow-up|0|||
170879169|NCT01611974|617569199|FG000|Overall Study|Physician Decision|5|||
170879170|NCT01611974|617569200|FG001|Overall Study|Physician Decision|1|||
170879171|NCT01611974|617569201|FG002|Overall Study|Physician Decision|2|||
170879172|NCT01611974|617569199|FG000|Overall Study|Withdrawal by Subject|0|||
170879173|NCT01611974|617569200|FG001|Overall Study|Withdrawal by Subject|1|||
170879174|NCT01611974|617569201|FG002|Overall Study|Withdrawal by Subject|4|||
170879175|NCT03551509|617569203|FG000|Overall Study|Lost to Follow-up|0|||
170879176|NCT03551509|617569204|FG001|Overall Study|Lost to Follow-up|1|||
170879177|NCT03551509|617569205|FG002|Overall Study|Lost to Follow-up|0|||
170879178|NCT01902966|617569206|FG000|Overall Study|Death|1|||
170879179|NCT01902966|617569206|FG000|Overall Study|Physician Decision|1|||
170879180|NCT01902966|617569206|FG000|Overall Study|Withdrawal by Subject|1|||
170879181|NCT02037295|617569207|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
170879182|NCT02037295|617569208|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
170879183|NCT02037295|617569209|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
170879184|NCT02037295|617569210|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
170879185|NCT03776175|617569211|FG000|Treatment Period (42 Days)|Adverse Event|0|||
170879186|NCT03776175|617569212|FG001|Treatment Period (42 Days)|Adverse Event|1|||
170879187|NCT03776175|617569213|FG002|Treatment Period (42 Days)|Adverse Event|1|||
170879188|NCT03776175|617569214|FG003|Treatment Period (42 Days)|Adverse Event|0|||
170879189|NCT03776175|617569211|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
170879190|NCT03776175|617569212|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
170879191|NCT03776175|617569213|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
170879192|NCT03776175|617569214|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
170879193|NCT03776175|617569211|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
170879194|NCT03776175|617569212|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
170879195|NCT03776175|617569213|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
170879196|NCT03776175|617569214|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
170879197|NCT03776175|617569211|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
170879198|NCT03776175|617569212|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
170879199|NCT03776175|617569213|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
170879200|NCT03776175|617569214|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
170879201|NCT03776175|617569211|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
170879202|NCT03776175|617569212|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
170879203|NCT03776175|617569213|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
170879204|NCT03776175|617569214|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
170879205|NCT03776175|617569211|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
170879206|NCT03776175|617569212|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
170879207|NCT03776175|617569213|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
170879208|NCT03776175|617569214|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
170423297|NCT00105196|615891264|FG001|Overall Study|Lost to Follow-up|2|||
170423298|NCT00105196|615891263|FG000|Overall Study|Poor/noncompliance|3|||
170423299|NCT00105196|615891264|FG001|Overall Study|Poor/noncompliance|4|||
170423300|NCT00105196|615891263|FG000|Overall Study|Protocol Violation|5|||
170879209|NCT02770547|617569217|FG000|Overall Study|Patient non-compliant|1|||
170879210|NCT02770547|617569218|FG001|Overall Study|Patient non-compliant|0|||
170879211|NCT02770547|617569217|FG000|Overall Study|Adverse Event|0|||
170879212|NCT02770547|617569218|FG001|Overall Study|Adverse Event|1|||
170879213|NCT01496885|617569219|FG000|Overall Study|Lost to Follow-up|13|||
170423301|NCT00105196|615891264|FG001|Overall Study|Protocol Violation|2|||
170423302|NCT00105196|615891263|FG000|Overall Study|pending surgery|0|||
170879214|NCT01496885|617569219|FG000|Overall Study|Withdrawal by Subject|7|||
170879215|NCT01496885|617569219|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
170879216|NCT01496885|617569219|FG000|Overall Study|Death|1|||
170879217|NCT03273166|617569220|FG000|Overall Study|Withdrawn prior to Completion|31|||
170879218|NCT01294670|617569221|FG000|Overall Study|Not treated|1|||
170879219|NCT01294670|617569222|FG001|Overall Study|Not treated|0|||
170879220|NCT01294670|617569223|FG002|Overall Study|Not treated|0|||
170423303|NCT00105196|615891264|FG001|Overall Study|pending surgery|1|||
170423304|NCT00105196|615891263|FG000|Overall Study|marijuana use|0|||
170423305|NCT00105196|615891264|FG001|Overall Study|marijuana use|1|||
170423306|NCT00105196|615891263|FG000|Overall Study|Subject became unblinded|0|||
170423307|NCT00105196|615891264|FG001|Overall Study|Subject became unblinded|1|||
170423308|NCT03553823|615891265|FG000|Overall Study|Physician Decision|0|||
170423309|NCT03553823|615891266|FG001|Overall Study|Physician Decision|1|||
170423310|NCT01389102|615891267|FG000|Overall Study|Adverse Event|1|||
170423311|NCT01389102|615891268|FG001|Overall Study|Adverse Event|3|||
170423312|NCT01389102|615891269|FG002|Overall Study|Adverse Event|2|||
170423313|NCT01389102|615891270|FG003|Overall Study|Adverse Event|2|||
170423314|NCT01389102|615891271|FG004|Overall Study|Adverse Event|2|||
170423315|NCT01389102|615891272|FG005|Overall Study|Adverse Event|2|||
170423316|NCT01389102|615891267|FG000|Overall Study|Hurricane Katrina|4|||
170423317|NCT01389102|615891268|FG001|Overall Study|Hurricane Katrina|2|||
170423318|NCT01389102|615891269|FG002|Overall Study|Hurricane Katrina|3|||
170423319|NCT01389102|615891270|FG003|Overall Study|Hurricane Katrina|0|||
170423320|NCT01389102|615891271|FG004|Overall Study|Hurricane Katrina|3|||
170423321|NCT01389102|615891272|FG005|Overall Study|Hurricane Katrina|1|||
170423322|NCT01389102|615891267|FG000|Overall Study|Lost to Follow-up|4|||
170423323|NCT01389102|615891268|FG001|Overall Study|Lost to Follow-up|1|||
170423324|NCT01389102|615891269|FG002|Overall Study|Lost to Follow-up|1|||
170423325|NCT01389102|615891270|FG003|Overall Study|Lost to Follow-up|2|||
170423326|NCT01389102|615891271|FG004|Overall Study|Lost to Follow-up|4|||
170423327|NCT01389102|615891272|FG005|Overall Study|Lost to Follow-up|1|||
170423328|NCT01389102|615891267|FG000|Overall Study|Protocol Violation|0|||
170423329|NCT01389102|615891268|FG001|Overall Study|Protocol Violation|0|||
170423330|NCT01389102|615891269|FG002|Overall Study|Protocol Violation|3|||
170423331|NCT01389102|615891270|FG003|Overall Study|Protocol Violation|0|||
170423332|NCT01389102|615891271|FG004|Overall Study|Protocol Violation|1|||
170423333|NCT01389102|615891272|FG005|Overall Study|Protocol Violation|1|||
170423334|NCT01389102|615891267|FG000|Overall Study|Withdrawal by Subject|7|||
170423335|NCT01389102|615891268|FG001|Overall Study|Withdrawal by Subject|4|||
170423336|NCT01389102|615891269|FG002|Overall Study|Withdrawal by Subject|9|||
170423337|NCT01389102|615891270|FG003|Overall Study|Withdrawal by Subject|2|||
170423338|NCT01389102|615891271|FG004|Overall Study|Withdrawal by Subject|3|||
170423339|NCT01389102|615891272|FG005|Overall Study|Withdrawal by Subject|3|||
170423340|NCT01389102|615891267|FG000|Overall Study|Subject Traveling Out of Country|0|||
170423341|NCT01389102|615891268|FG001|Overall Study|Subject Traveling Out of Country|0|||
170423342|NCT01389102|615891269|FG002|Overall Study|Subject Traveling Out of Country|0|||
170423343|NCT01389102|615891270|FG003|Overall Study|Subject Traveling Out of Country|1|||
170423344|NCT01389102|615891271|FG004|Overall Study|Subject Traveling Out of Country|0|||
170423345|NCT01389102|615891272|FG005|Overall Study|Subject Traveling Out of Country|0|||
170423346|NCT01389102|615891267|FG000|Overall Study|Subject Moved|2|||
170423347|NCT01389102|615891268|FG001|Overall Study|Subject Moved|0|||
170423348|NCT01389102|615891269|FG002|Overall Study|Subject Moved|1|||
170423349|NCT01389102|615891270|FG003|Overall Study|Subject Moved|0|||
170423350|NCT01389102|615891271|FG004|Overall Study|Subject Moved|0|||
170423351|NCT01389102|615891272|FG005|Overall Study|Subject Moved|0|||
170423352|NCT01389102|615891267|FG000|Overall Study|Unavailable due to husband's illness|0|||
170423353|NCT01389102|615891268|FG001|Overall Study|Unavailable due to husband's illness|1|||
170423354|NCT01389102|615891269|FG002|Overall Study|Unavailable due to husband's illness|0|||
170423355|NCT01389102|615891270|FG003|Overall Study|Unavailable due to husband's illness|0|||
170423356|NCT01389102|615891271|FG004|Overall Study|Unavailable due to husband's illness|0|||
170423357|NCT01389102|615891272|FG005|Overall Study|Unavailable due to husband's illness|0|||
170423358|NCT01389102|615891267|FG000|Overall Study|Investigator Judgement|0|||
170423359|NCT01389102|615891268|FG001|Overall Study|Investigator Judgement|1|||
170423360|NCT01389102|615891269|FG002|Overall Study|Investigator Judgement|0|||
170533633|NCT00614393|616300649|FG004|Overall Study|Progressive Disease|130|||
170879221|NCT01294670|617569224|FG003|Overall Study|Not treated|0|||
170423361|NCT01389102|615891270|FG003|Overall Study|Investigator Judgement|0|||
170423362|NCT01389102|615891271|FG004|Overall Study|Investigator Judgement|0|||
170423363|NCT01389102|615891272|FG005|Overall Study|Investigator Judgement|0|||
170423364|NCT00893464|615891273|FG000|Overall Study|Did not complete therapy/experience PD|0|||
170423365|NCT00893464|615891274|FG001|Overall Study|Did not complete therapy/experience PD|0|||
170423366|NCT00893464|615891275|FG002|Overall Study|Did not complete therapy/experience PD|0|||
170423367|NCT00893464|615891276|FG003|Overall Study|Did not complete therapy/experience PD|0|||
170423368|NCT00893464|615891277|FG004|Overall Study|Did not complete therapy/experience PD|0|||
170879222|NCT01294670|617569225|FG004|Overall Study|Not treated|0|||
170423369|NCT00893464|615891278|FG005|Overall Study|Did not complete therapy/experience PD|0|||
170423370|NCT00893464|615891279|FG006|Overall Study|Did not complete therapy/experience PD|2|||
170423371|NCT00893464|615891280|FG007|Overall Study|Did not complete therapy/experience PD|2|||
170423372|NCT02910037|615891283|FG000|Overall Study|Withdrawal by Subject|4|||
170423373|NCT02910037|615891283|FG000|Overall Study|Lost to Follow-up|6|||
170423374|NCT00625443|615891284|FG000|Overall Study|Adverse Event|1|||
170423375|NCT00625443|615891285|FG001|Overall Study|Adverse Event|4|||
170423376|NCT00625443|615891286|FG002|Overall Study|Adverse Event|0|||
170423377|NCT00625443|615891284|FG000|Overall Study|Non-compliance with protocol|0|||
170423378|NCT00625443|615891285|FG001|Overall Study|Non-compliance with protocol|1|||
170423379|NCT00625443|615891286|FG002|Overall Study|Non-compliance with protocol|0|||
170423380|NCT00625443|615891284|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
170423381|NCT00625443|615891285|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
170423382|NCT00625443|615891286|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
170423383|NCT00625443|615891284|FG000|Overall Study|Withdrawal by Subject|0|||
170423384|NCT00625443|615891285|FG001|Overall Study|Withdrawal by Subject|1|||
170423385|NCT00625443|615891286|FG002|Overall Study|Withdrawal by Subject|2|||
170423386|NCT00625443|615891284|FG000|Overall Study|Physician Decision|0|||
170423387|NCT00625443|615891285|FG001|Overall Study|Physician Decision|4|||
170423388|NCT00625443|615891286|FG002|Overall Study|Physician Decision|2|||
170423389|NCT00625443|615891284|FG000|Overall Study|Other|0|||
170423390|NCT00625443|615891285|FG001|Overall Study|Other|1|||
170423391|NCT00625443|615891286|FG002|Overall Study|Other|1|||
170423392|NCT01126736|615891287|FG000|Overall Study|Death|2|||
170423393|NCT01126736|615891288|FG001|Overall Study|Death|2|||
170423394|NCT01126736|615891289|FG002|Overall Study|Death|1|||
170423395|NCT01126736|615891290|FG003|Overall Study|Death|19|||
170423396|NCT01126736|615891291|FG004|Overall Study|Death|19|||
170423397|NCT01126736|615891287|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
170423398|NCT01126736|615891288|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
170423399|NCT01126736|615891289|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
170423400|NCT01126736|615891290|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
170423401|NCT01126736|615891291|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
170423402|NCT01126736|615891287|FG000|Overall Study|Lost to Follow-up|0|||
170423403|NCT01126736|615891288|FG001|Overall Study|Lost to Follow-up|0|||
170423404|NCT01126736|615891289|FG002|Overall Study|Lost to Follow-up|0|||
170423405|NCT01126736|615891290|FG003|Overall Study|Lost to Follow-up|1|||
170423406|NCT01126736|615891291|FG004|Overall Study|Lost to Follow-up|1|||
170423407|NCT01126736|615891287|FG000|Overall Study|Administrative reasons|0|||
170423408|NCT01126736|615891288|FG001|Overall Study|Administrative reasons|0|||
170423409|NCT01126736|615891289|FG002|Overall Study|Administrative reasons|0|||
170423410|NCT01126736|615891290|FG003|Overall Study|Administrative reasons|0|||
170423411|NCT01126736|615891291|FG004|Overall Study|Administrative reasons|1|||
170423412|NCT01126736|615891287|FG000|Overall Study|Progressive disease|0|||
170423413|NCT01126736|615891288|FG001|Overall Study|Progressive disease|0|||
170423414|NCT01126736|615891289|FG002|Overall Study|Progressive disease|0|||
170423415|NCT01126736|615891290|FG003|Overall Study|Progressive disease|2|||
170423416|NCT01126736|615891291|FG004|Overall Study|Progressive disease|1|||
170423417|NCT01126736|615891287|FG000|Overall Study|Withdrawal by Subject|0|||
170423418|NCT01126736|615891288|FG001|Overall Study|Withdrawal by Subject|0|||
170423419|NCT01126736|615891289|FG002|Overall Study|Withdrawal by Subject|0|||
170423420|NCT01126736|615891290|FG003|Overall Study|Withdrawal by Subject|1|||
170423421|NCT01126736|615891291|FG004|Overall Study|Withdrawal by Subject|1|||
170423422|NCT01126736|615891287|FG000|Overall Study|Other|2|||
170423423|NCT01126736|615891288|FG001|Overall Study|Other|4|||
170423424|NCT01126736|615891289|FG002|Overall Study|Other|4|||
170423425|NCT01126736|615891290|FG003|Overall Study|Other|16|||
170423426|NCT01126736|615891291|FG004|Overall Study|Other|15|||
170423427|NCT02015390|615891292|FG000|Overall Study|Lost to Follow-up|1|||
170423428|NCT02015390|615891293|FG001|Overall Study|Lost to Follow-up|0|||
170423429|NCT02015390|615891292|FG000|Overall Study|Adverse Event|0|||
170423430|NCT02015390|615891293|FG001|Overall Study|Adverse Event|3|||
170423431|NCT02015390|615891292|FG000|Overall Study|Physician Decision|0|||
170423432|NCT02015390|615891293|FG001|Overall Study|Physician Decision|1|||
170423433|NCT01661686|615891294|FG000|Overall Study|Lost to Follow-up|2|||
170423434|NCT01661686|615891295|FG001|Overall Study|Lost to Follow-up|1|||
170423435|NCT01661686|615891294|FG000|Overall Study|did not receive allocated intervention|0|||
170423436|NCT01661686|615891295|FG001|Overall Study|did not receive allocated intervention|1|||
170423437|NCT01720264|615891300|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
170423438|NCT01720264|615891300|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
170423439|NCT01720264|615891300|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
170423440|NCT02728102|615891301|FG000|Overall Study|Death|3|||
170423441|NCT02728102|615891302|FG001|Overall Study|Death|0|||
170423442|NCT02728102|615891303|FG002|Overall Study|Death|1|||
170423443|NCT02728102|615891301|FG000|Overall Study|Withdrawal by Subject|0|||
170423444|NCT02728102|615891302|FG001|Overall Study|Withdrawal by Subject|2|||
170423445|NCT02728102|615891303|FG002|Overall Study|Withdrawal by Subject|3|||
170423446|NCT02728102|615891301|FG000|Overall Study|Physician Decision|1|||
170423447|NCT02728102|615891302|FG001|Overall Study|Physician Decision|1|||
170423448|NCT02728102|615891303|FG002|Overall Study|Physician Decision|0|||
170879223|NCT00661531|617569226|FG000|Overall Study|Withdrawal by Subject|3|||
170879224|NCT03134599|617569228|FG000|Week 1|Lost to Follow-up|0|||
170879225|NCT03134599|617569229|FG001|Week 1|Lost to Follow-up|0|||
170879226|NCT03134599|617569230|FG002|Week 1|Lost to Follow-up|0|||
170879227|NCT03134599|617569231|FG003|Week 1|Lost to Follow-up|0|||
170879228|NCT03134599|617569232|FG004|Week 1|Lost to Follow-up|1|||
170879229|NCT03134599|617569233|FG005|Week 1|Lost to Follow-up|0|||
170879230|NCT03134599|617569228|FG000|Week 2|Lost to Follow-up|1|||
170879231|NCT03134599|617569229|FG001|Week 2|Lost to Follow-up|0|||
170879232|NCT03134599|617569230|FG002|Week 2|Lost to Follow-up|0|||
170879233|NCT03134599|617569231|FG003|Week 2|Lost to Follow-up|1|||
170879234|NCT03134599|617569232|FG004|Week 2|Lost to Follow-up|1|||
170879235|NCT03134599|617569233|FG005|Week 2|Lost to Follow-up|0|||
170879236|NCT03134599|617569228|FG000|Week 3|Lost to Follow-up|0|||
170879237|NCT03134599|617569229|FG001|Week 3|Lost to Follow-up|0|||
170879238|NCT03134599|617569230|FG002|Week 3|Lost to Follow-up|0|||
170879239|NCT03134599|617569231|FG003|Week 3|Lost to Follow-up|1|||
170879240|NCT03134599|617569232|FG004|Week 3|Lost to Follow-up|0|||
170879241|NCT03134599|617569233|FG005|Week 3|Lost to Follow-up|1|||
170879242|NCT03808077|617569234|FG000|Overall Study|Physician Decision|2|||
170879243|NCT03808077|617569235|FG001|Overall Study|Physician Decision|3|||
170879244|NCT03808077|617569234|FG000|Overall Study|Withdrawal by Subject|1|||
170879245|NCT03808077|617569235|FG001|Overall Study|Withdrawal by Subject|0|||
170879246|NCT03808077|617569234|FG000|Overall Study|Equipment Issues|2|||
170879247|NCT03808077|617569235|FG001|Overall Study|Equipment Issues|1|||
170879248|NCT02412787|617569236|FG000|Overall Study|Withdrawal by Subject|9|||
170879249|NCT02412787|617569236|FG000|Overall Study|Participation Terminated by Investigator|1|||
170879250|NCT02412787|617569236|FG000|Overall Study|Site Terminated by Sponsor|21|||
170879251|NCT02412787|617569236|FG000|Overall Study|Technical Problems|1|||
170879252|NCT02412787|617569236|FG000|Overall Study|Reason Not Specified|1|||
170879253|NCT00393887|617569237|FG000|Overall Study|Physician Decision|5|||
170423449|NCT02728102|615891301|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
170423450|NCT02728102|615891302|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
170423451|NCT02728102|615891303|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
170423452|NCT02728102|615891301|FG000|Overall Study|Covid|0|||
170423453|NCT02728102|615891302|FG001|Overall Study|Covid|0|||
170423454|NCT02728102|615891303|FG002|Overall Study|Covid|1|||
170423455|NCT04869787|615891304|FG000|Screening|Physician Decision|1|||
170423456|NCT04869787|615891304|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
170423457|NCT00813293|615891305|FG000|Overall Study|Intercurrent illness|1|||
170423458|NCT00813293|615891306|FG001|Overall Study|Intercurrent illness|0|||
170423459|NCT00813293|615891305|FG000|Overall Study|Adverse Event|0|||
170423460|NCT00813293|615891306|FG001|Overall Study|Adverse Event|1|||
170423461|NCT02794974|615891307|FG000|Overall Study|Physician Decision|0|||
170423462|NCT02794974|615891308|FG001|Overall Study|Physician Decision|1|||
170423463|NCT00454909|615891309|FG000|Overall Study|Withdrawal by Subject|1|||
170423464|NCT00454909|615891310|FG001|Overall Study|Withdrawal by Subject|0|||
170423465|NCT00454909|615891311|FG002|Overall Study|Withdrawal by Subject|0|||
170423466|NCT00454909|615891309|FG000|Overall Study|Migrated/moved from study area|0|||
170423467|NCT00454909|615891310|FG001|Overall Study|Migrated/moved from study area|0|||
170423468|NCT00454909|615891311|FG002|Overall Study|Migrated/moved from study area|1|||
170423469|NCT00454909|615891309|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
170423470|NCT00454909|615891310|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
170423471|NCT00454909|615891311|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
170423472|NCT00454909|615891309|FG000|Overall Study|Others|1|||
170423473|NCT00454909|615891310|FG001|Overall Study|Others|0|||
170423474|NCT00454909|615891311|FG002|Overall Study|Others|0|||
170879254|NCT00393887|617569238|FG001|Overall Study|Physician Decision|0|||
170879255|NCT00393887|617569237|FG000|Overall Study|Lost to Follow-up|11|||
170879256|NCT00393887|617569238|FG001|Overall Study|Lost to Follow-up|9|||
170423475|NCT02996682|615891313|FG000|Overall Study|Death|0|||
170423476|NCT02996682|615891314|FG001|Overall Study|Death|3|||
170533634|NCT00614393|616300645|FG000|Overall Study|Protocol Violation|1|||
170879257|NCT00705783|617569242|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
170879258|NCT00705783|617569243|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
170879259|NCT00705783|617569244|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
170879260|NCT00705783|617569242|FG000|Conversion Phase|Lost to Follow-up|13|||
170879261|NCT00705783|617569243|FG001|Conversion Phase|Lost to Follow-up|0|||
170879262|NCT00705783|617569244|FG002|Conversion Phase|Lost to Follow-up|0|||
170879263|NCT00705783|617569242|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
170423477|NCT01546545|615891318|FG000|Overall Study|Withdrawal by Subject|1|||
170423478|NCT00986245|615891319|FG000|First Intervention|Poor compliance|8|||
170423479|NCT00986245|615891320|FG001|First Intervention|Poor compliance|4|||
170423480|NCT00986245|615891319|FG000|First Intervention|Lack of Efficacy|1|||
170423481|NCT00986245|615891320|FG001|First Intervention|Lack of Efficacy|2|||
170423482|NCT00986245|615891319|FG000|First Intervention|Withdrawal by Subject|0|||
170423483|NCT00986245|615891320|FG001|First Intervention|Withdrawal by Subject|1|||
170423484|NCT00986245|615891319|FG000|First Intervention|Protocol Violation|0|||
170423485|NCT00986245|615891320|FG001|First Intervention|Protocol Violation|1|||
170423486|NCT00986245|615891319|FG000|First Intervention|Out of indication|1|||
170423487|NCT00986245|615891320|FG001|First Intervention|Out of indication|0|||
170423488|NCT00986245|615891319|FG000|Second Intervention|Poor compliance|1|||
170423489|NCT00986245|615891320|FG001|Second Intervention|Poor compliance|0|||
170423490|NCT00986245|615891319|FG000|Second Intervention|Lost to Follow-up|1|||
170423491|NCT00986245|615891320|FG001|Second Intervention|Lost to Follow-up|0|||
170423492|NCT00986245|615891319|FG000|Second Intervention|Protocol Violation|0|||
170423493|NCT00986245|615891320|FG001|Second Intervention|Protocol Violation|1|||
170423494|NCT01214850|615891321|FG000|Overall Study|Withdrawal by Subject|38|||
170423495|NCT01214850|615891322|FG001|Overall Study|Withdrawal by Subject|31|||
170423496|NCT01214850|615891323|FG002|Overall Study|Withdrawal by Subject|28|||
170423497|NCT01214850|615891321|FG000|Overall Study|Lost to Follow-up|124|||
170423498|NCT01214850|615891322|FG001|Overall Study|Lost to Follow-up|98|||
170423499|NCT01214850|615891323|FG002|Overall Study|Lost to Follow-up|123|||
170423500|NCT01214850|615891321|FG000|Overall Study|Protocol Violation|5|||
170423501|NCT01214850|615891322|FG001|Overall Study|Protocol Violation|5|||
170423502|NCT01214850|615891323|FG002|Overall Study|Protocol Violation|6|||
170423503|NCT01214850|615891321|FG000|Overall Study|Adverse event or death|11|||
170423504|NCT01214850|615891322|FG001|Overall Study|Adverse event or death|8|||
170423505|NCT01214850|615891323|FG002|Overall Study|Adverse event or death|3|||
170423506|NCT01214850|615891321|FG000|Overall Study|Inappropriate enrollment|2|||
170423507|NCT01214850|615891322|FG001|Overall Study|Inappropriate enrollment|1|||
170423508|NCT01214850|615891323|FG002|Overall Study|Inappropriate enrollment|0|||
170423509|NCT01214850|615891321|FG000|Overall Study|Administrative reason|1|||
170423510|NCT01214850|615891322|FG001|Overall Study|Administrative reason|0|||
170423511|NCT01214850|615891323|FG002|Overall Study|Administrative reason|0|||
170423512|NCT01214850|615891321|FG000|Overall Study|Unable to classify|2|||
170423513|NCT01214850|615891322|FG001|Overall Study|Unable to classify|1|||
170423514|NCT01214850|615891323|FG002|Overall Study|Unable to classify|1|||
170423515|NCT01863745|615891324|FG000|Overall Study|Disease Progression|9|||
170423516|NCT01863745|615891324|FG000|Overall Study|Adverse Event|2|||
170423517|NCT01863745|615891324|FG000|Overall Study|Death|1|||
170423518|NCT01863745|615891324|FG000|Overall Study|Withdrawal by Subject|1|||
170423519|NCT00610363|615891327|FG000|Overall Study|Non-compliance with protocol|0|||
170423520|NCT00610363|615891328|FG001|Overall Study|Non-compliance with protocol|1|||
170423521|NCT00610363|615891327|FG000|Overall Study|Adverse Event|3|||
170423522|NCT00610363|615891328|FG001|Overall Study|Adverse Event|1|||
170423523|NCT00610363|615891327|FG000|Overall Study|Lack of Efficacy|2|||
170423524|NCT00610363|615891328|FG001|Overall Study|Lack of Efficacy|0|||
170423525|NCT00610363|615891327|FG000|Overall Study|Lost to Follow-up|4|||
170423526|NCT00610363|615891328|FG001|Overall Study|Lost to Follow-up|0|||
170423527|NCT00610363|615891327|FG000|Overall Study|Withdrawal by Subject|1|||
170423528|NCT00610363|615891328|FG001|Overall Study|Withdrawal by Subject|0|||
170423529|NCT00610363|615891327|FG000|Overall Study|Other than specified above|1|||
170423530|NCT00610363|615891328|FG001|Overall Study|Other than specified above|1|||
170423531|NCT01171963|615891329|FG000|Overall Study|Adverse Event|10|||
170423532|NCT01171963|615891330|FG001|Overall Study|Adverse Event|15|||
170423533|NCT01171963|615891329|FG000|Overall Study|Lost to Follow-up|23|||
170423534|NCT01171963|615891330|FG001|Overall Study|Lost to Follow-up|24|||
170632676|NCT02760498|616666746|FG004|Overall Study|Death|0|||
170879264|NCT00705783|617569243|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
170879265|NCT00705783|617569244|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
170423535|NCT01171963|615891329|FG000|Overall Study|Other - diarrhoea|1|||
170423536|NCT01171963|615891330|FG001|Overall Study|Other - diarrhoea|0|||
170423537|NCT01171963|615891329|FG000|Overall Study|Withdrawal by Subject|114|||
170423538|NCT01171963|615891330|FG001|Overall Study|Withdrawal by Subject|129|||
170423539|NCT01722877|615891345|FG000|Overall Study|Death|1|||
170423540|NCT01722877|615891345|FG000|Overall Study|Lost to Follow-up|1|||
170423541|NCT03693430|615891346|FG000|Overall Study|Lost to Follow-up|3|||
170423542|NCT03693430|615891347|FG001|Overall Study|Lost to Follow-up|14|||
170423543|NCT03693430|615891346|FG000|Overall Study|Death|1|||
170423544|NCT03693430|615891347|FG001|Overall Study|Death|0|||
170423545|NCT03693430|615891346|FG000|Overall Study|Withdrawal by Subject|0|||
170423546|NCT03693430|615891347|FG001|Overall Study|Withdrawal by Subject|4|||
170423547|NCT03018249|615891352|FG000|Overall Study|Withdrawal by Subject|2|||
170423548|NCT03018249|615891353|FG001|Overall Study|Withdrawal by Subject|2|||
170423549|NCT03069937|615891354|FG000|Overall Study|Second primary malignancy noted|1|||
170879266|NCT00705783|617569242|FG000|Conversion Phase|Withdrawn by Investigator|4|||
170533635|NCT00614393|616300646|FG001|Overall Study|Protocol Violation|0|||
170533636|NCT00614393|616300647|FG002|Overall Study|Protocol Violation|0|||
170533637|NCT00614393|616300648|FG003|Overall Study|Protocol Violation|0|||
170533638|NCT00614393|616300649|FG004|Overall Study|Protocol Violation|0|||
170533639|NCT00614393|616300645|FG000|Overall Study|Terminated by Sponsor|0|||
170533640|NCT00614393|616300646|FG001|Overall Study|Terminated by Sponsor|0|||
170533641|NCT00614393|616300647|FG002|Overall Study|Terminated by Sponsor|0|||
170533642|NCT00614393|616300648|FG003|Overall Study|Terminated by Sponsor|0|||
170533643|NCT00614393|616300649|FG004|Overall Study|Terminated by Sponsor|1|||
170533644|NCT00614393|616300645|FG000|Overall Study|Withdrawal by Subject|20|||
170533645|NCT00614393|616300646|FG001|Overall Study|Withdrawal by Subject|1|||
170533646|NCT00614393|616300647|FG002|Overall Study|Withdrawal by Subject|1|||
170533647|NCT00614393|616300648|FG003|Overall Study|Withdrawal by Subject|16|||
170533648|NCT00614393|616300649|FG004|Overall Study|Withdrawal by Subject|13|||
170533649|NCT00614393|616300645|FG000|Overall Study|Other|4|||
170533650|NCT00614393|616300646|FG001|Overall Study|Other|0|||
170423550|NCT01706536|615891358|FG000|Overall Study|Withdrawal by Subject|1|||
170533651|NCT00614393|616300647|FG002|Overall Study|Other|0|||
170533652|NCT00614393|616300648|FG003|Overall Study|Other|4|||
170423551|NCT01706536|615891359|FG001|Overall Study|Withdrawal by Subject|0|||
170423552|NCT01706536|615891360|FG002|Overall Study|Withdrawal by Subject|1|||
170423553|NCT01706536|615891361|FG003|Overall Study|Withdrawal by Subject|0|||
170423554|NCT01706536|615891362|FG004|Overall Study|Withdrawal by Subject|0|||
170423555|NCT01706536|615891358|FG000|Overall Study|Adverse Event|2|||
170423556|NCT01706536|615891359|FG001|Overall Study|Adverse Event|3|||
170423557|NCT01706536|615891360|FG002|Overall Study|Adverse Event|4|||
170423558|NCT01706536|615891361|FG003|Overall Study|Adverse Event|3|||
170423559|NCT01706536|615891362|FG004|Overall Study|Adverse Event|2|||
170423560|NCT01706536|615891358|FG000|Overall Study|Lack of Efficacy|1|||
170423561|NCT01706536|615891359|FG001|Overall Study|Lack of Efficacy|0|||
170423562|NCT01706536|615891360|FG002|Overall Study|Lack of Efficacy|0|||
170423563|NCT01706536|615891361|FG003|Overall Study|Lack of Efficacy|1|||
170423564|NCT01706536|615891362|FG004|Overall Study|Lack of Efficacy|0|||
170423565|NCT01706536|615891358|FG000|Overall Study|non compliance|0|||
170423566|NCT01706536|615891359|FG001|Overall Study|non compliance|1|||
170423567|NCT01706536|615891360|FG002|Overall Study|non compliance|0|||
170423568|NCT01706536|615891361|FG003|Overall Study|non compliance|0|||
170423569|NCT01706536|615891362|FG004|Overall Study|non compliance|0|||
170423570|NCT01054599|615891371|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
170423571|NCT01054599|615891372|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
170423572|NCT01054599|615891371|FG000|Overall Study|Protocol Violation|1|||
170423573|NCT01054599|615891372|FG001|Overall Study|Protocol Violation|0|||
170423574|NCT01054599|615891371|FG000|Overall Study|Spells/seizure-like episodes|1|||
170423575|NCT01054599|615891372|FG001|Overall Study|Spells/seizure-like episodes|1|||
170423576|NCT01054599|615891371|FG000|Overall Study|Timing/scheduling difficulties|1|||
170423577|NCT01054599|615891372|FG001|Overall Study|Timing/scheduling difficulties|1|||
170423578|NCT01054599|615891371|FG000|Overall Study|Visual impairment, WTAR <80|0|||
170423579|NCT01054599|615891372|FG001|Overall Study|Visual impairment, WTAR <80|1|||
170423580|NCT01054599|615891371|FG000|Overall Study|Lost to Follow-up|0|||
170423581|NCT01054599|615891372|FG001|Overall Study|Lost to Follow-up|2|||
170423582|NCT01054599|615891371|FG000|Overall Study|Adverse Event|0|||
170423583|NCT01054599|615891372|FG001|Overall Study|Adverse Event|1|||
170423584|NCT01054599|615891371|FG000|Overall Study|Withdrawal by Subject|0|||
170423585|NCT01054599|615891372|FG001|Overall Study|Withdrawal by Subject|1|||
170423586|NCT00743197|615891375|FG000|Overall Study|Study terminated due to departure of PI.|1|||
170423587|NCT00743197|615891376|FG001|Overall Study|Study terminated due to departure of PI.|2|||
170423588|NCT01411332|615891381|FG000|Enrollment|Protocol Violation|0|||
170423589|NCT01411332|615891382|FG001|Enrollment|Protocol Violation|1|||
170423590|NCT01411332|615891381|FG000|Enrollment|Withdrawal by Subject|0|||
170423591|NCT01411332|615891382|FG001|Enrollment|Withdrawal by Subject|1|||
170423592|NCT01411332|615891381|FG000|Treatment|Lost to Follow-up|1|||
170423593|NCT01411332|615891382|FG001|Treatment|Lost to Follow-up|0|||
170533653|NCT00614393|616300649|FG004|Overall Study|Other|2|||
170533654|NCT00614393|616300645|FG000|Overall Study|Not Treated|0|||
170533655|NCT00614393|616300646|FG001|Overall Study|Not Treated|0|||
170533656|NCT00614393|616300647|FG002|Overall Study|Not Treated|0|||
170879267|NCT00705783|617569243|FG001|Conversion Phase|Withdrawn by Investigator|0|||
170879268|NCT00705783|617569244|FG002|Conversion Phase|Withdrawn by Investigator|0|||
170879269|NCT00705783|617569242|FG000|Conversion Phase|Withdrew Consent|24|||
170423594|NCT00385684|615891383|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
170423595|NCT00385684|615891384|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
170423596|NCT00385684|615891383|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
170423597|NCT00385684|615891384|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
170423598|NCT00385684|615891383|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
170423599|NCT00385684|615891384|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
170423600|NCT00522457|615891385|FG000|Overall Study|Due to disease progression|16|||
170533657|NCT00614393|616300648|FG003|Overall Study|Not Treated|0|||
170879270|NCT00705783|617569243|FG001|Conversion Phase|Withdrew Consent|0|||
170423601|NCT00522457|615891385|FG000|Overall Study|Adverse Event|2|||
170423602|NCT01432171|615891386|FG000|Overall Study|Death|1|||
170423603|NCT01432171|615891387|FG001|Overall Study|Death|2|||
170423604|NCT01432171|615891386|FG000|Overall Study|Lost to Follow-up|6|||
170423605|NCT01432171|615891387|FG001|Overall Study|Lost to Follow-up|5|||
170423606|NCT01432171|615891386|FG000|Overall Study|Withdrawal by Subject|3|||
170423607|NCT01432171|615891387|FG001|Overall Study|Withdrawal by Subject|1|||
170423608|NCT01432171|615891386|FG000|Overall Study|Noncompliance|2|||
170423609|NCT01432171|615891387|FG001|Overall Study|Noncompliance|3|||
170423610|NCT01432171|615891386|FG000|Overall Study|Insurance denial trial coverage|1|||
170423611|NCT01432171|615891387|FG001|Overall Study|Insurance denial trial coverage|0|||
170423612|NCT01432171|615891386|FG000|Overall Study|Patient moved to palliative care|1|||
170423613|NCT01432171|615891387|FG001|Overall Study|Patient moved to palliative care|0|||
170423614|NCT06358820|615893150|FG000|Overall Study|Adverse Event|11|||
170423615|NCT06358820|615893150|FG000|Overall Study|kidney transplantation|3|||
170423616|NCT06358820|615893150|FG000|Overall Study|patient voluntary withdrawal|6|||
170423617|NCT06358820|615893150|FG000|Overall Study|Physician Decision|1|||
170423618|NCT01066143|615893155|FG000|Overall Study|ineligible for the study|8|||
170423619|NCT05376319|615893156|FG000|Overall Study|Funding termination|2|||
170423620|NCT05376319|615893157|FG001|Overall Study|Funding termination|4|||
170423621|NCT01124175|615893158|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
170423622|NCT01124175|615893159|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
170423623|NCT00942968|615893160|FG000|Overall Study|Adverse Event|60|||
170423624|NCT00942968|615893160|FG000|Overall Study|Death|76|||
170423625|NCT00942968|615893160|FG000|Overall Study|Protocol Violation|9|||
170423626|NCT00942968|615893160|FG000|Overall Study|Lost to Follow-up|4|||
170423627|NCT00942968|615893160|FG000|Overall Study|Withdrawal by Subject|44|||
170423628|NCT00942968|615893160|FG000|Overall Study|Sponsor request|5|||
170423629|NCT00942968|615893160|FG000|Overall Study|Physician Decision|11|||
170423630|NCT00942968|615893160|FG000|Overall Study|Progression of disease|12|||
170423631|NCT00942968|615893160|FG000|Overall Study|Inferior vena cava filter placement|4|||
170423632|NCT00942968|615893160|FG000|Overall Study|Pulmonary embolism (PE)|1|||
170423633|NCT00942968|615893160|FG000|Overall Study|Participant required pancreatic biopsy|1|||
170423634|NCT00942968|615893160|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
170423635|NCT01948258|615893161|FG000|Overall Study|Pregnancy|41|||
170423636|NCT01948258|615893161|FG000|Overall Study|Did not complete by cut-off date|35|||
170423637|NCT01948258|615893161|FG000|Overall Study|Lost to Follow-up|27|||
170423638|NCT01948258|615893161|FG000|Overall Study|Withdrawal by SPD|8|||
170423639|NCT01948258|615893161|FG000|Overall Study|Withdrawal by Subject|6|||
170423640|NCT01948258|615893161|FG000|Overall Study|Health Care Professional|43|||
170423641|NCT01948258|615893161|FG000|Overall Study|Removed from statistical analysis|2|||
170423642|NCT03497897|615893166|FG000|Overall Study|Adverse Event|1|||
170423643|NCT03497897|615893167|FG001|Overall Study|Adverse Event|1|||
170423644|NCT03497897|615893168|FG002|Overall Study|Adverse Event|1|||
170423645|NCT03497897|615893166|FG000|Overall Study|Lost to Follow-up|2|||
170423646|NCT03497897|615893167|FG001|Overall Study|Lost to Follow-up|0|||
170423647|NCT03497897|615893168|FG002|Overall Study|Lost to Follow-up|2|||
170423648|NCT03497897|615893166|FG000|Overall Study|Physician Decision|1|||
170423649|NCT03497897|615893167|FG001|Overall Study|Physician Decision|0|||
170423650|NCT03497897|615893168|FG002|Overall Study|Physician Decision|0|||
170423651|NCT03497897|615893166|FG000|Overall Study|Subject/Guardian Decision|2|||
170533658|NCT00614393|616300649|FG004|Overall Study|Not Treated|2|||
170533659|NCT01013753|616300655|FG000|Overall Study|Adverse Event|8|||
170423652|NCT03497897|615893167|FG001|Overall Study|Subject/Guardian Decision|1|||
170423653|NCT03497897|615893168|FG002|Overall Study|Subject/Guardian Decision|3|||
170423654|NCT00667095|615893173|FG000|Overall Study|Withdrawal by Subject|0|||
170423655|NCT00667095|615893174|FG001|Overall Study|Withdrawal by Subject|1|||
170423656|NCT01520909|615893175|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
170423657|NCT01520909|615893176|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
170423658|NCT01520909|615893177|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
170423659|NCT01520909|615893175|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
170423660|NCT01520909|615893176|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
170423661|NCT01520909|615893177|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
170423662|NCT01520909|615893175|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
170423663|NCT01520909|615893176|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
170423664|NCT01520909|615893177|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
170423665|NCT01520909|615893175|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
170423666|NCT01520909|615893176|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
170423667|NCT01520909|615893177|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
170423668|NCT01149473|615893178|FG000|First Intervention|Adverse Event|1|||
170423669|NCT01149473|615893179|FG001|First Intervention|Adverse Event|1|||
170533660|NCT01013753|616300655|FG000|Overall Study|Protocol Violation|3|||
170423670|NCT01149473|615893178|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
170423671|NCT01149473|615893179|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
170423672|NCT02188303|615893180|FG000|Overall Study|Adverse Event|0|||
170423673|NCT02188303|615893181|FG001|Overall Study|Adverse Event|0|||
170423674|NCT02188303|615893182|FG002|Overall Study|Adverse Event|0|||
170423675|NCT02188303|615893183|FG003|Overall Study|Adverse Event|0|||
170423676|NCT02188303|615893184|FG004|Overall Study|Adverse Event|0|||
170423677|NCT02188303|615893185|FG005|Overall Study|Adverse Event|2|||
170423678|NCT02188303|615893186|FG006|Overall Study|Adverse Event|0|||
170423679|NCT02188303|615893187|FG007|Overall Study|Adverse Event|2|||
170423680|NCT02188303|615893180|FG000|Overall Study|Dose Termination Criteria Met|0|||
170423681|NCT02188303|615893181|FG001|Overall Study|Dose Termination Criteria Met|0|||
170423682|NCT02188303|615893182|FG002|Overall Study|Dose Termination Criteria Met|0|||
170423683|NCT02188303|615893183|FG003|Overall Study|Dose Termination Criteria Met|0|||
170423684|NCT02188303|615893184|FG004|Overall Study|Dose Termination Criteria Met|0|||
170423685|NCT02188303|615893185|FG005|Overall Study|Dose Termination Criteria Met|0|||
170423686|NCT02188303|615893186|FG006|Overall Study|Dose Termination Criteria Met|2|||
170423687|NCT02188303|615893187|FG007|Overall Study|Dose Termination Criteria Met|4|||
170423688|NCT04206332|615893188|FG000|Part A|Lost to Follow-up|0|||
170423689|NCT04206332|615893189|FG001|Part A|Lost to Follow-up|1|||
170423690|NCT04206332|615893190|FG002|Part A|Lost to Follow-up|0|||
170423691|NCT04206332|615893191|FG003|Part A|Lost to Follow-up|0|||
170423692|NCT04206332|615893192|FG004|Part A|Lost to Follow-up|0|||
170423693|NCT04206332|615893193|FG005|Part A|Lost to Follow-up|0|||
170423694|NCT04206332|615893194|FG006|Part A|Lost to Follow-up|0|||
170423695|NCT04206332|615893195|FG007|Part A|Lost to Follow-up|0|||
170423696|NCT04206332|615893196|FG008|Part A|Lost to Follow-up|0|||
170423697|NCT04206332|615893197|FG009|Part A|Lost to Follow-up|0|||
170423698|NCT04206332|615893198|FG010|Part A|Lost to Follow-up|0|||
170423699|NCT04206332|615893199|FG011|Part A|Lost to Follow-up|0|||
170423700|NCT04206332|615893200|FG012|Part A|Lost to Follow-up|0|||
170423701|NCT04206332|615893201|FG013|Part A|Lost to Follow-up|0|||
170423702|NCT04206332|615893202|FG014|Part A|Lost to Follow-up|0|||
170423703|NCT04206332|615893203|FG015|Part A|Lost to Follow-up|0|||
170423704|NCT04206332|615893204|FG016|Part A|Lost to Follow-up|0|||
170423705|NCT04206332|615893188|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423706|NCT04206332|615893189|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423707|NCT04206332|615893190|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423708|NCT04206332|615893191|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423709|NCT04206332|615893192|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423710|NCT04206332|615893193|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
170423711|NCT04206332|615893194|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423712|NCT04206332|615893195|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423713|NCT04206332|615893196|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423714|NCT04206332|615893197|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423715|NCT04206332|615893198|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423716|NCT04206332|615893199|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423717|NCT04206332|615893200|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423718|NCT04206332|615893201|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423719|NCT04206332|615893202|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423720|NCT04206332|615893203|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423721|NCT04206332|615893204|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
170423722|NCT04206332|615893188|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423723|NCT04206332|615893189|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423724|NCT04206332|615893190|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423725|NCT04206332|615893191|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423726|NCT04206332|615893192|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423727|NCT04206332|615893193|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170533661|NCT01013753|616300655|FG000|Overall Study|Lost to Follow-up|1|||
170533662|NCT01013753|616300655|FG000|Overall Study|Withdrawal by Subject|2|||
170533663|NCT01013753|616300655|FG000|Overall Study|Other|2|||
170533664|NCT03286504|616300659|FG000|Overall Study|Lost to Follow-up|19|||
170533665|NCT03286504|616300660|FG001|Overall Study|Lost to Follow-up|16|||
170533666|NCT02097277|616300661|FG000|Overall Study|Subject no longer meets study criteria|0|||
170533667|NCT02097277|616300662|FG001|Overall Study|Subject no longer meets study criteria|1|||
170533668|NCT02097277|616300663|FG002|Overall Study|Subject no longer meets study criteria|0|||
170533669|NCT02097277|616300664|FG003|Overall Study|Subject no longer meets study criteria|1|||
170632677|NCT02760498|616666747|FG005|Overall Study|Death|23|||
170423728|NCT04206332|615893194|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423729|NCT04206332|615893195|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
170423730|NCT04206332|615893196|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423731|NCT04206332|615893197|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423732|NCT04206332|615893198|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
170423733|NCT04206332|615893199|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423734|NCT04206332|615893200|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423735|NCT04206332|615893201|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423736|NCT04206332|615893202|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423737|NCT04206332|615893203|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423738|NCT04206332|615893204|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423739|NCT04206332|615893188|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423740|NCT04206332|615893189|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423741|NCT04206332|615893190|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423742|NCT04206332|615893191|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423743|NCT04206332|615893192|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423744|NCT04206332|615893193|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423745|NCT04206332|615893194|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423746|NCT04206332|615893195|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423747|NCT04206332|615893196|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423748|NCT04206332|615893197|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423749|NCT04206332|615893198|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423750|NCT04206332|615893199|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423751|NCT04206332|615893200|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423752|NCT04206332|615893201|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423753|NCT04206332|615893202|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423754|NCT04206332|615893203|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
170423755|NCT04206332|615893204|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
170423756|NCT04206332|615893188|FG000|Part C|Withdrawal by Subject|0|||
170423757|NCT04206332|615893189|FG001|Part C|Withdrawal by Subject|0|||
170423758|NCT04206332|615893190|FG002|Part C|Withdrawal by Subject|0|||
170423759|NCT04206332|615893191|FG003|Part C|Withdrawal by Subject|0|||
170423760|NCT04206332|615893192|FG004|Part C|Withdrawal by Subject|0|||
170423761|NCT04206332|615893193|FG005|Part C|Withdrawal by Subject|0|||
170423762|NCT04206332|615893194|FG006|Part C|Withdrawal by Subject|0|||
170423763|NCT04206332|615893195|FG007|Part C|Withdrawal by Subject|0|||
170423764|NCT04206332|615893196|FG008|Part C|Withdrawal by Subject|0|||
170423765|NCT04206332|615893197|FG009|Part C|Withdrawal by Subject|0|||
170423766|NCT04206332|615893198|FG010|Part C|Withdrawal by Subject|0|||
170423767|NCT04206332|615893199|FG011|Part C|Withdrawal by Subject|0|||
170423768|NCT04206332|615893200|FG012|Part C|Withdrawal by Subject|0|||
170423769|NCT04206332|615893201|FG013|Part C|Withdrawal by Subject|0|||
170423770|NCT04206332|615893202|FG014|Part C|Withdrawal by Subject|2|||
170423771|NCT04206332|615893203|FG015|Part C|Withdrawal by Subject|0|||
170423772|NCT04206332|615893204|FG016|Part C|Withdrawal by Subject|0|||
170423773|NCT00239577|615893209|FG000|Primary Phase|Adverse Event|0|||
170423774|NCT00239577|615893210|FG001|Primary Phase|Adverse Event|0|||
170632678|NCT02760498|616666742|FG000|Overall Study|Lost to Follow-up|0|||
170879271|NCT00705783|617569244|FG002|Conversion Phase|Withdrew Consent|0|||
170879272|NCT00705783|617569242|FG000|Conversion Phase|Protocol Deviation|2|||
170879273|NCT00705783|617569243|FG001|Conversion Phase|Protocol Deviation|0|||
170879274|NCT00705783|617569244|FG002|Conversion Phase|Protocol Deviation|0|||
170879275|NCT00705783|617569242|FG000|Conversion Phase|Adverse Event|11|||
170879276|NCT00705783|617569243|FG001|Conversion Phase|Adverse Event|0|||
170879277|NCT00705783|617569244|FG002|Conversion Phase|Adverse Event|0|||
170879278|NCT00705783|617569242|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
170879279|NCT00705783|617569243|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
170879280|NCT00705783|617569244|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
170879281|NCT00705783|617569242|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
170879282|NCT00705783|617569243|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
170879283|NCT00705783|617569244|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
170423775|NCT00239577|615893211|FG002|Primary Phase|Adverse Event|1|||
170423776|NCT00239577|615893212|FG003|Primary Phase|Adverse Event|0|||
170423777|NCT00239577|615893209|FG000|Primary Phase|Other|5|||
170423778|NCT00239577|615893210|FG001|Primary Phase|Other|3|||
170423779|NCT00239577|615893211|FG002|Primary Phase|Other|2|||
170423780|NCT00239577|615893212|FG003|Primary Phase|Other|0|||
170423781|NCT04123548|615893215|FG000|Overall Study|Withdrawal by Subject|1|||
170423782|NCT04123548|615893215|FG000|Overall Study|Lost to Follow-up|8|||
170423783|NCT04123548|615893215|FG000|Overall Study|Death|4|||
170423784|NCT04123548|615893215|FG000|Overall Study|Reason Not Specified|1|||
170423785|NCT00856388|615893216|FG000|Overall Study|Other|1|||
170423786|NCT05038293|615893217|FG000|Overall Study|device was not operating properly for one subject.|1|||
170423787|NCT05038293|615893218|FG001|Overall Study|device was not operating properly for one subject.|0|||
170423788|NCT05038293|615893217|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
170423789|NCT05038293|615893218|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
170423790|NCT04166630|615893220|FG000|Overall Study|Withdrawal by Subject|0|||
170423791|NCT04166630|615893221|FG001|Overall Study|Withdrawal by Subject|1|||
170423792|NCT00096447|615893222|FG000|Overall Study|Never treated|1|||
170423793|NCT01838941|615893223|FG000|Overall Study|Adverse Event|1|||
170423794|NCT01838941|615893223|FG000|Overall Study|Withdrawal by Subject|1|||
170423795|NCT01617668|615893226|FG000|Overall Study|Adverse Event|7|||
170423796|NCT01617668|615893227|FG001|Overall Study|Adverse Event|0|||
170423797|NCT01617668|615893228|FG002|Overall Study|Adverse Event|12|||
170423798|NCT01617668|615893229|FG003|Overall Study|Adverse Event|5|||
170423799|NCT01617668|615893226|FG000|Overall Study|Physician Decision|1|||
170423800|NCT01617668|615893227|FG001|Overall Study|Physician Decision|2|||
170423801|NCT01617668|615893228|FG002|Overall Study|Physician Decision|3|||
170423802|NCT01617668|615893229|FG003|Overall Study|Physician Decision|0|||
170423803|NCT01617668|615893226|FG000|Overall Study|Progressive Disease|4|||
170423804|NCT01617668|615893227|FG001|Overall Study|Progressive Disease|4|||
170423805|NCT01617668|615893228|FG002|Overall Study|Progressive Disease|6|||
170423806|NCT01617668|615893229|FG003|Overall Study|Progressive Disease|9|||
170423807|NCT01617668|615893226|FG000|Overall Study|Subject/guardian decision|1|||
170423808|NCT01617668|615893227|FG001|Overall Study|Subject/guardian decision|3|||
170423809|NCT01617668|615893228|FG002|Overall Study|Subject/guardian decision|2|||
170423810|NCT01617668|615893229|FG003|Overall Study|Subject/guardian decision|1|||
170423811|NCT01981720|615893234|FG000|Overall Study|Adverse Event|1|||
170423812|NCT01981720|615893234|FG000|Overall Study|Withdrawal by Subject|3|||
170423813|NCT01981720|615893234|FG000|Overall Study|Pregnancy|1|||
170423814|NCT01387022|615893235|FG000|Overall Study|Death|1|||
170423815|NCT01387022|615893236|FG001|Overall Study|Death|1|||
170423816|NCT01387022|615893235|FG000|Overall Study|Lost to Follow-up|0|||
170423817|NCT01387022|615893236|FG001|Overall Study|Lost to Follow-up|3|||
170423818|NCT02336165|615893241|FG000|Overall Study|Death|3|||
170423819|NCT02336165|615893242|FG001|Overall Study|Death|0|||
170423820|NCT02336165|615893243|FG002|Overall Study|Death|0|||
170423821|NCT02336165|615893244|FG003|Overall Study|Death|0|||
170423822|NCT02336165|615893245|FG004|Overall Study|Death|1|||
170423823|NCT02336165|615893241|FG000|Overall Study|Physician Decision|2|||
170423824|NCT02336165|615893242|FG001|Overall Study|Physician Decision|2|||
170423825|NCT02336165|615893243|FG002|Overall Study|Physician Decision|1|||
170423826|NCT02336165|615893244|FG003|Overall Study|Physician Decision|1|||
170423827|NCT02336165|615893245|FG004|Overall Study|Physician Decision|0|||
170423828|NCT02336165|615893241|FG000|Overall Study|Withdrawal by Subject|0|||
170423829|NCT02336165|615893242|FG001|Overall Study|Withdrawal by Subject|0|||
170423830|NCT02336165|615893243|FG002|Overall Study|Withdrawal by Subject|1|||
170423831|NCT02336165|615893244|FG003|Overall Study|Withdrawal by Subject|0|||
170423832|NCT02336165|615893245|FG004|Overall Study|Withdrawal by Subject|1|||
170423833|NCT02336165|615893241|FG000|Overall Study|Adverse Event|4|||
170423834|NCT02336165|615893242|FG001|Overall Study|Adverse Event|1|||
170423835|NCT02336165|615893243|FG002|Overall Study|Adverse Event|2|||
170423836|NCT02336165|615893244|FG003|Overall Study|Adverse Event|4|||
170423837|NCT02336165|615893245|FG004|Overall Study|Adverse Event|1|||
170423838|NCT02336165|615893241|FG000|Overall Study|Progressive disease|23|||
170423839|NCT02336165|615893242|FG001|Overall Study|Progressive disease|22|||
170423840|NCT02336165|615893243|FG002|Overall Study|Progressive disease|27|||
170423841|NCT02336165|615893244|FG003|Overall Study|Progressive disease|24|||
170423842|NCT02336165|615893245|FG004|Overall Study|Progressive disease|19|||
170423843|NCT02336165|615893241|FG000|Overall Study|Non-compliance|1|||
170879284|NCT00705783|617569242|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
170879285|NCT00705783|617569243|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
170423844|NCT02336165|615893242|FG001|Overall Study|Non-compliance|0|||
170423845|NCT02336165|615893243|FG002|Overall Study|Non-compliance|0|||
170423846|NCT02336165|615893244|FG003|Overall Study|Non-compliance|1|||
170423847|NCT02336165|615893245|FG004|Overall Study|Non-compliance|0|||
170423848|NCT02336165|615893241|FG000|Overall Study|Other|1|||
170423849|NCT02336165|615893242|FG001|Overall Study|Other|0|||
170423850|NCT02336165|615893243|FG002|Overall Study|Other|0|||
170423851|NCT02336165|615893244|FG003|Overall Study|Other|1|||
170423852|NCT02336165|615893245|FG004|Overall Study|Other|0|||
170423853|NCT02549092|615893248|FG000|Treatment Period|Adverse Event|2|||
170423854|NCT02549092|615893249|FG001|Treatment Period|Adverse Event|2|||
170423855|NCT02549092|615893248|FG000|Treatment Period|Withdrawal by Subject|1|||
170423856|NCT02549092|615893249|FG001|Treatment Period|Withdrawal by Subject|3|||
170423857|NCT02549092|615893248|FG000|Treatment Period|Lack of Efficacy|0|||
170423858|NCT02549092|615893249|FG001|Treatment Period|Lack of Efficacy|2|||
170423859|NCT02549092|615893248|FG000|Extension/Transition Period|Adverse Event|1|||
170423860|NCT02549092|615893249|FG001|Extension/Transition Period|Adverse Event|1|||
170423861|NCT02549092|615893248|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
170423862|NCT02549092|615893249|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
170423863|NCT02549092|615893248|FG000|Extension/Transition Period|Other, Not Specified|4|||
170423864|NCT02549092|615893249|FG001|Extension/Transition Period|Other, Not Specified|2|||
170423865|NCT00910663|615893250|FG000|Period 1|Withdrawal by Subject|0|||
170423866|NCT00910663|615893251|FG001|Period 1|Withdrawal by Subject|1|||
170423867|NCT03687736|615893252|FG000|Overall Study|Lost to Follow-up|7|||
170423868|NCT03687736|615893252|FG000|Overall Study|Withdrawal by Subject|3|||
170423869|NCT01772537|615893253|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
170423870|NCT01772537|615893254|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
170423871|NCT01772537|615893255|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
170423872|NCT02511782|615893256|FG000|Overall Study|Withdrawal by Subject|1|||
170423873|NCT02511782|615893257|FG001|Overall Study|Withdrawal by Subject|0|||
170423874|NCT02511782|615893258|FG002|Overall Study|Withdrawal by Subject|0|||
170423875|NCT00450190|615893259|FG000|Overall Study|Withdrawal by Subject|2|||
170423876|NCT01536574|615893262|FG000|Overall Study|Adverse Event|4|||
170423877|NCT01536574|615893263|FG001|Overall Study|Adverse Event|5|||
170423878|NCT01536574|615893262|FG000|Overall Study|Withdrawal by Subject|1|||
170423879|NCT01536574|615893263|FG001|Overall Study|Withdrawal by Subject|2|||
170423880|NCT01536574|615893262|FG000|Overall Study|Lack of Efficacy|1|||
170423881|NCT01536574|615893263|FG001|Overall Study|Lack of Efficacy|0|||
170423882|NCT02193165|615893264|FG000|4 Week Product Use|Lost to Follow-up|1|||
170423883|NCT02193165|615893265|FG001|4 Week Product Use|Lost to Follow-up|1|||
170423884|NCT02193165|615893266|FG002|4 Week Product Use|Lost to Follow-up|1|||
170423885|NCT02193165|615893264|FG000|6 Week Product Use|Lost to Follow-up|0|||
170423886|NCT02193165|615893265|FG001|6 Week Product Use|Lost to Follow-up|1|||
170423887|NCT02193165|615893266|FG002|6 Week Product Use|Lost to Follow-up|0|||
170423888|NCT01472341|615893270|FG000|Overall Study|Started insulin therapy|55|||
170423889|NCT01472341|615893270|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
170423890|NCT01472341|615893270|FG000|Overall Study|Withdrawal by Subject|39|||
170423891|NCT01472341|615893270|FG000|Overall Study|Lost to Follow-up|52|||
170423892|NCT01472341|615893270|FG000|Overall Study|Laboratory parameters unavailable|25|||
170423893|NCT01472341|615893270|FG000|Overall Study|Death|9|||
170423894|NCT05615935|615893274|FG000|Overall Study|Lost to Follow-up|1|||
170423895|NCT05615935|615893275|FG001|Overall Study|Lost to Follow-up|1|||
170423896|NCT00735904|615893276|FG000|Overall Study|Adverse Event|3|||
170423897|NCT00735904|615893276|FG000|Overall Study|Death|20|||
170423898|NCT00735904|615893276|FG000|Overall Study|Protocol Violation|1|||
170423899|NCT00735904|615893276|FG000|Overall Study|Withdrawal by Subject|1|||
170423900|NCT00735904|615893276|FG000|Overall Study|Study Terminated by Sponsor|5|||
170423901|NCT00735904|615893276|FG000|Overall Study|Other|8|||
170423902|NCT01390844|615893283|FG000|Treatment Phase|Adverse Event|12|||
170423903|NCT01390844|615893284|FG001|Treatment Phase|Adverse Event|2|||
170423904|NCT01390844|615893285|FG002|Treatment Phase|Adverse Event|3|||
170423905|NCT01390844|615893286|FG003|Treatment Phase|Adverse Event|2|||
170423906|NCT01390844|615893283|FG000|Treatment Phase|Treatment Failure|23|||
170423907|NCT01390844|615893284|FG001|Treatment Phase|Treatment Failure|25|||
170423908|NCT01390844|615893285|FG002|Treatment Phase|Treatment Failure|10|||
170423909|NCT01390844|615893286|FG003|Treatment Phase|Treatment Failure|13|||
170423910|NCT01390844|615893283|FG000|Treatment Phase|Non-Medical Reasons|5|||
170423911|NCT01390844|615893284|FG001|Treatment Phase|Non-Medical Reasons|1|||
170423912|NCT01390844|615893285|FG002|Treatment Phase|Non-Medical Reasons|8|||
170423913|NCT01390844|615893286|FG003|Treatment Phase|Non-Medical Reasons|1|||
170423914|NCT01390844|615893283|FG000|Treatment Phase|Non-GCP Compliant|0|||
170632679|NCT02760498|616666743|FG001|Overall Study|Lost to Follow-up|0|||
170879286|NCT00705783|617569244|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
170879287|NCT00705783|617569242|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
170423915|NCT01390844|615893284|FG001|Treatment Phase|Non-GCP Compliant|0|||
170423916|NCT01390844|615893285|FG002|Treatment Phase|Non-GCP Compliant|10|||
170423917|NCT01390844|615893286|FG003|Treatment Phase|Non-GCP Compliant|3|||
170423918|NCT01390844|615893283|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
170423919|NCT01390844|615893284|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
170423920|NCT01390844|615893285|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
170423921|NCT01390844|615893286|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
170423922|NCT03048500|615893289|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
170423923|NCT03048500|615893289|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
170423924|NCT03048500|615893289|FG000|Reached 1st Response/Continued Treatment|Death|1|||
170632680|NCT02760498|616666744|FG002|Overall Study|Lost to Follow-up|0|||
170423925|NCT03048500|615893289|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
170423926|NCT03048500|615893289|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
170632681|NCT02760498|616666745|FG003|Overall Study|Lost to Follow-up|0|||
170423927|NCT03048500|615893289|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
170423928|NCT03048500|615893289|FG000|Follow up for 3 Years|Death|12|||
170423929|NCT05093205|615893290|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
170423930|NCT05093205|615893291|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
170423931|NCT05093205|615893292|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
170423932|NCT05093205|615893293|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
170423933|NCT05093205|615893294|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
170423934|NCT05093205|615893295|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
170423935|NCT05093205|615893296|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
170423936|NCT05093205|615893297|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
170423937|NCT05093205|615893298|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
170423938|NCT05093205|615893299|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
170423939|NCT05093205|615893300|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
170423940|NCT05093205|615893301|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
170423941|NCT05093205|615893302|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
170423942|NCT05093205|615893290|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423943|NCT05093205|615893291|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423944|NCT05093205|615893292|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
170423945|NCT05093205|615893293|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423946|NCT05093205|615893294|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423947|NCT05093205|615893295|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423948|NCT05093205|615893296|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423949|NCT05093205|615893297|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423950|NCT05093205|615893298|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423951|NCT05093205|615893299|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423952|NCT05093205|615893300|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423953|NCT05093205|615893301|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423954|NCT05093205|615893302|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
170423955|NCT05093205|615893290|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
170423956|NCT05093205|615893291|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
170423957|NCT05093205|615893292|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
170423958|NCT05093205|615893293|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
170423959|NCT05093205|615893294|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
170423960|NCT05093205|615893295|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
170423961|NCT05093205|615893296|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
170423962|NCT05093205|615893297|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
170423963|NCT05093205|615893298|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
170423964|NCT05093205|615893299|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
170423965|NCT05093205|615893300|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
170423966|NCT05093205|615893301|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
170423967|NCT05093205|615893302|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
170423968|NCT05093205|615893290|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
170423969|NCT05093205|615893291|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
170423970|NCT05093205|615893292|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
170423971|NCT05093205|615893293|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
170423972|NCT05093205|615893294|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
170423973|NCT05093205|615893295|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
170423974|NCT05093205|615893296|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
170423975|NCT05093205|615893297|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
170423976|NCT05093205|615893298|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
170423977|NCT05093205|615893299|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
170423978|NCT05093205|615893300|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
170423979|NCT05093205|615893301|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
170423980|NCT05093205|615893302|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
170423981|NCT05093205|615893290|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
170423982|NCT05093205|615893291|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
170423983|NCT05093205|615893292|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
170423984|NCT05093205|615893293|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
170423985|NCT05093205|615893294|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
170423986|NCT05093205|615893295|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
170423987|NCT05093205|615893296|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
170423988|NCT05093205|615893297|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
170423989|NCT05093205|615893298|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
170423990|NCT05093205|615893299|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
170423991|NCT05093205|615893300|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
170423992|NCT05093205|615893301|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
170423993|NCT05093205|615893302|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
170423994|NCT05093205|615893290|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
170423995|NCT05093205|615893291|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
170423996|NCT05093205|615893292|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
170879288|NCT00705783|617569243|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
170879289|NCT00705783|617569244|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
170632682|NCT02760498|616666746|FG004|Overall Study|Lost to Follow-up|0|||
170632683|NCT02760498|616666747|FG005|Overall Study|Lost to Follow-up|3|||
170632684|NCT02760498|616666742|FG000|Overall Study|Non-compliance with study drug|0|||
170632685|NCT02760498|616666743|FG001|Overall Study|Non-compliance with study drug|2|||
170632686|NCT02760498|616666744|FG002|Overall Study|Non-compliance with study drug|0|||
170632687|NCT02760498|616666745|FG003|Overall Study|Non-compliance with study drug|0|||
170632688|NCT02760498|616666746|FG004|Overall Study|Non-compliance with study drug|0|||
170632689|NCT02760498|616666747|FG005|Overall Study|Non-compliance with study drug|0|||
170632690|NCT02760498|616666742|FG000|Overall Study|Participant decision|1|||
170632691|NCT02760498|616666743|FG001|Overall Study|Participant decision|4|||
170632692|NCT02760498|616666744|FG002|Overall Study|Participant decision|2|||
170632693|NCT02760498|616666745|FG003|Overall Study|Participant decision|2|||
170632694|NCT02760498|616666746|FG004|Overall Study|Participant decision|1|||
170632695|NCT02760498|616666747|FG005|Overall Study|Participant decision|6|||
170632696|NCT02760498|616666742|FG000|Overall Study|Sponsor decision|0|||
170632697|NCT02760498|616666743|FG001|Overall Study|Sponsor decision|0|||
170632698|NCT02760498|616666744|FG002|Overall Study|Sponsor decision|0|||
170632699|NCT02760498|616666745|FG003|Overall Study|Sponsor decision|3|||
170423997|NCT05093205|615893293|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
170423998|NCT05093205|615893294|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
170423999|NCT05093205|615893295|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
170424000|NCT05093205|615893296|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
170424001|NCT05093205|615893297|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
170424002|NCT05093205|615893298|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
170424003|NCT05093205|615893299|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
170424004|NCT05093205|615893300|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
170424005|NCT05093205|615893301|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
170424006|NCT05093205|615893302|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
170424007|NCT05093205|615893290|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
170424008|NCT05093205|615893291|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
170424009|NCT05093205|615893292|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
170424010|NCT05093205|615893293|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
170424011|NCT05093205|615893294|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
170424012|NCT05093205|615893295|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
170424013|NCT05093205|615893296|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
170424014|NCT05093205|615893297|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
170424015|NCT05093205|615893298|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
170424016|NCT05093205|615893299|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
170424017|NCT05093205|615893300|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
170424018|NCT05093205|615893301|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
170424019|NCT05093205|615893302|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
170424020|NCT05093205|615893290|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
170424021|NCT05093205|615893291|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
170424022|NCT05093205|615893292|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
170424023|NCT05093205|615893293|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
170424024|NCT05093205|615893294|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
170424025|NCT05093205|615893295|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
170424026|NCT05093205|615893296|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
170424027|NCT05093205|615893297|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
170424028|NCT05093205|615893298|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
170424029|NCT05093205|615893299|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
170424030|NCT05093205|615893300|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
170424031|NCT05093205|615893301|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
170424032|NCT05093205|615893302|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
170424033|NCT05093205|615893290|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424034|NCT05093205|615893291|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424035|NCT05093205|615893292|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424036|NCT05093205|615893293|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424037|NCT05093205|615893294|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424038|NCT05093205|615893295|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424039|NCT05093205|615893296|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424040|NCT05093205|615893297|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424041|NCT05093205|615893298|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424042|NCT05093205|615893299|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
170424043|NCT05093205|615893300|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424044|NCT05093205|615893301|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424045|NCT05093205|615893302|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
170424046|NCT05093205|615893290|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
170424047|NCT05093205|615893291|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
170424048|NCT05093205|615893292|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
170424049|NCT05093205|615893293|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
170424050|NCT05093205|615893294|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
170424051|NCT05093205|615893295|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
170424052|NCT05093205|615893296|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
170424053|NCT05093205|615893297|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
170424054|NCT05093205|615893298|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
170424055|NCT05093205|615893299|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
170424056|NCT05093205|615893300|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
170424057|NCT05093205|615893301|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
170424058|NCT05093205|615893302|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
170424059|NCT05093205|615893290|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424060|NCT05093205|615893291|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424061|NCT05093205|615893292|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424062|NCT05093205|615893293|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424063|NCT05093205|615893294|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424064|NCT05093205|615893295|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424065|NCT05093205|615893296|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424066|NCT05093205|615893297|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424067|NCT05093205|615893298|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424068|NCT05093205|615893299|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170632700|NCT02760498|616666746|FG004|Overall Study|Sponsor decision|0|||
170424069|NCT05093205|615893300|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
170424070|NCT05093205|615893301|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424071|NCT05093205|615893302|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
170424072|NCT05093205|615893290|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424073|NCT05093205|615893291|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424074|NCT05093205|615893292|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424075|NCT05093205|615893293|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424076|NCT05093205|615893294|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170533670|NCT02097277|616300665|FG004|Overall Study|Subject no longer meets study criteria|0|||
170533671|NCT02097277|616300661|FG000|Overall Study|Subject request to discontinue treatment|0|||
170632701|NCT02760498|616666747|FG005|Overall Study|Sponsor decision|0|||
170424077|NCT05093205|615893295|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424078|NCT05093205|615893296|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424079|NCT05093205|615893297|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424080|NCT05093205|615893298|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170533672|NCT02097277|616300662|FG001|Overall Study|Subject request to discontinue treatment|0|||
170533673|NCT02097277|616300663|FG002|Overall Study|Subject request to discontinue treatment|0|||
170533674|NCT02097277|616300664|FG003|Overall Study|Subject request to discontinue treatment|0|||
170533675|NCT02097277|616300665|FG004|Overall Study|Subject request to discontinue treatment|1|||
170533676|NCT02097277|616300661|FG000|Overall Study|Lost to Follow-up|0|||
170533677|NCT02097277|616300662|FG001|Overall Study|Lost to Follow-up|1|||
170533678|NCT02097277|616300663|FG002|Overall Study|Lost to Follow-up|1|||
170533679|NCT02097277|616300664|FG003|Overall Study|Lost to Follow-up|0|||
170533680|NCT02097277|616300665|FG004|Overall Study|Lost to Follow-up|0|||
170533681|NCT02097277|616300661|FG000|Overall Study|Withdrawal by Subject|2|||
170533682|NCT02097277|616300662|FG001|Overall Study|Withdrawal by Subject|1|||
170533683|NCT02097277|616300663|FG002|Overall Study|Withdrawal by Subject|0|||
170533684|NCT02097277|616300664|FG003|Overall Study|Withdrawal by Subject|1|||
170533685|NCT02097277|616300665|FG004|Overall Study|Withdrawal by Subject|0|||
170533686|NCT02097277|616300661|FG000|Overall Study|Adverse Event|0|||
170533687|NCT02097277|616300662|FG001|Overall Study|Adverse Event|0|||
170533688|NCT02097277|616300663|FG002|Overall Study|Adverse Event|1|||
170533689|NCT02097277|616300664|FG003|Overall Study|Adverse Event|2|||
170533690|NCT02097277|616300665|FG004|Overall Study|Adverse Event|0|||
170533691|NCT00141921|616300671|FG000|Overall Study|Remain on Study|28|||
170533692|NCT00141921|616300671|FG000|Overall Study|Withdrawal by Subject|42|||
170533693|NCT00141921|616300671|FG000|Overall Study|Lost to Follow-up|19|||
170533694|NCT00141921|616300671|FG000|Overall Study|Noncompliance|17|||
170533695|NCT00141921|616300671|FG000|Overall Study|Disease Progression|7|||
170533696|NCT00141921|616300671|FG000|Overall Study|Protocol Deviation|7|||
170533697|NCT00141921|616300671|FG000|Overall Study|Adverse Event|5|||
170533698|NCT00141921|616300671|FG000|Overall Study|Administrative Decision|2|||
170533699|NCT00141921|616300671|FG000|Overall Study|Pregnancy|4|||
170533700|NCT00141921|616300671|FG000|Overall Study|Ineligibility Determined|2|||
170533701|NCT00141921|616300671|FG000|Overall Study|Other|8|||
170533702|NCT03320369|616300672|FG000|Overall Study|Adverse Event|1|||
170533703|NCT03320369|616300672|FG000|Overall Study|Withdrawal by Subject|2|||
170533704|NCT03813654|616300673|FG000|Overall Study|Protocol Violation|0|||
170533705|NCT03813654|616300674|FG001|Overall Study|Protocol Violation|1|||
170533706|NCT03813654|616300675|FG002|Overall Study|Protocol Violation|2|||
170533707|NCT03813654|616300673|FG000|Overall Study|Withdrawal by Subject|1|||
170533708|NCT03813654|616300674|FG001|Overall Study|Withdrawal by Subject|0|||
170533709|NCT03813654|616300675|FG002|Overall Study|Withdrawal by Subject|0|||
170533710|NCT01461551|616300688|FG000|Overall Study|Physician Decision|2|||
170533711|NCT01461551|616300689|FG001|Overall Study|Physician Decision|1|||
170533712|NCT01461551|616300690|FG002|Overall Study|Physician Decision|2|||
170533713|NCT02326883|616300691|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
170533714|NCT02326883|616300692|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
170533715|NCT02326883|616300693|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
170533716|NCT03329989|616300694|FG000|Overall Study|Withdrawal by Subject|9|||
170533717|NCT03329989|616300694|FG000|Overall Study|Lost to Follow-up|8|||
170533718|NCT03329989|616300694|FG000|Overall Study|Adverse Event|5|||
170533719|NCT03329989|616300694|FG000|Overall Study|Protocol Violation|1|||
170533720|NCT01137786|616300695|FG000|Overall Study|Lost to Follow-up|0|||
170533721|NCT01137786|616300696|FG001|Overall Study|Lost to Follow-up|2|||
170533722|NCT01137786|616300695|FG000|Overall Study|Withdrawal by Subject|1|||
170533723|NCT01137786|616300696|FG001|Overall Study|Withdrawal by Subject|1|||
170533724|NCT03483103|616300697|FG000|Pre-Treatment Phase|Other reasons|1|||
170533725|NCT03483103|616300697|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
170424081|NCT05093205|615893299|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424082|NCT05093205|615893300|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424083|NCT05093205|615893301|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
170424084|NCT05093205|615893302|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
170424085|NCT05093205|615893290|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
170424086|NCT05093205|615893291|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
170424087|NCT05093205|615893292|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
170424088|NCT05093205|615893293|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
170533726|NCT03483103|616300697|FG000|Pre-Treatment Phase|Disease-related complications|1|||
170533727|NCT03483103|616300697|FG000|Pre-Treatment Phase|Death|5|||
170533728|NCT03483103|616300697|FG000|Treatment Phase|Withdrawal by Subject|7|||
170533729|NCT03483103|616300697|FG000|Treatment Phase|Other reasons|1|||
170533730|NCT03483103|616300697|FG000|Treatment Phase|Death|23|||
170533731|NCT03483103|616300697|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
170533732|NCT03483103|616300697|FG000|Treatment Phase|Received nonconforming product|1|||
170424089|NCT05093205|615893294|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
170424090|NCT05093205|615893295|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
170533733|NCT02709369|616300698|FG000|Overall Study|Lost to Follow-up|15|||
170424091|NCT05093205|615893296|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
170424092|NCT05093205|615893297|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
170533734|NCT02709369|616300698|FG000|Overall Study|Withdrawal by Subject|10|||
170533735|NCT02709369|616300698|FG000|Overall Study|Did not received intervention|2|||
170533736|NCT03282097|616300700|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
170879290|NCT00705783|617569242|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
170879291|NCT00705783|617569243|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
170879292|NCT00705783|617569244|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
170879293|NCT00705783|617569242|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
170879294|NCT00705783|617569243|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
170879295|NCT00705783|617569244|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
170879296|NCT00705783|617569242|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
170879297|NCT00705783|617569243|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
170879298|NCT00705783|617569244|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
170879299|NCT00705783|617569242|FG000|Oral Stabilization Phase|Adverse Event|14|||
170879300|NCT00705783|617569243|FG001|Oral Stabilization Phase|Adverse Event|0|||
170879301|NCT00705783|617569244|FG002|Oral Stabilization Phase|Adverse Event|0|||
170879302|NCT00705783|617569242|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
170879303|NCT00705783|617569243|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
170879304|NCT00705783|617569244|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
170879305|NCT00705783|617569242|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
170879306|NCT00705783|617569243|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
170879307|NCT00705783|617569244|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
170879308|NCT00705783|617569242|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
170879309|NCT00705783|617569243|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
170879310|NCT00705783|617569244|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
170879311|NCT00705783|617569242|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
170879312|NCT00705783|617569243|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
170879313|NCT00705783|617569244|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
170879314|NCT00705783|617569242|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
170879315|NCT00705783|617569243|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
170879316|NCT00705783|617569244|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
170879317|NCT00705783|617569242|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
170879318|NCT00705783|617569243|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
170879319|NCT00705783|617569244|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
170879320|NCT00705783|617569242|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
170879321|NCT00705783|617569243|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
170879322|NCT00705783|617569244|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
170879323|NCT00705783|617569242|FG000|Depot Stabilization Phase|Adverse Event|17|||
170879324|NCT00705783|617569243|FG001|Depot Stabilization Phase|Adverse Event|0|||
170879325|NCT00705783|617569244|FG002|Depot Stabilization Phase|Adverse Event|0|||
170879326|NCT00705783|617569242|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
170879327|NCT00705783|617569243|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
170879328|NCT00705783|617569244|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
170424093|NCT05093205|615893298|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
170424094|NCT05093205|615893299|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
170424095|NCT05093205|615893300|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
170424096|NCT05093205|615893301|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
170424097|NCT05093205|615893302|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
170424098|NCT05093205|615893290|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424099|NCT05093205|615893291|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424100|NCT05093205|615893292|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424101|NCT05093205|615893293|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424102|NCT05093205|615893294|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424103|NCT05093205|615893295|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424104|NCT05093205|615893296|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424105|NCT05093205|615893297|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424106|NCT05093205|615893298|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424107|NCT05093205|615893299|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424108|NCT05093205|615893300|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424109|NCT05093205|615893301|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
170424110|NCT05093205|615893302|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
170424111|NCT00268905|615893304|FG000|Overall Study|Adverse Event|3|||
170424112|NCT00268905|615893305|FG001|Overall Study|Adverse Event|0|||
170424113|NCT00268905|615893306|FG002|Overall Study|Adverse Event|4|||
170424114|NCT00268905|615893304|FG000|Overall Study|Lost to Follow-up|0|||
170533737|NCT03282097|616300701|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
170533738|NCT03282097|616300700|FG000|Intervention Visit Complete|Patient Death|13|||
170879329|NCT00705783|617569242|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
170879330|NCT00705783|617569243|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
170879331|NCT00705783|617569244|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
170424115|NCT00268905|615893305|FG001|Overall Study|Lost to Follow-up|1|||
170424116|NCT00268905|615893306|FG002|Overall Study|Lost to Follow-up|0|||
170424117|NCT00268905|615893304|FG000|Overall Study|Withdrawal by Subject|0|||
170424118|NCT00268905|615893305|FG001|Overall Study|Withdrawal by Subject|0|||
170424119|NCT00268905|615893306|FG002|Overall Study|Withdrawal by Subject|3|||
170424120|NCT00268905|615893304|FG000|Overall Study|Progressive Disease|28|||
170424121|NCT00268905|615893305|FG001|Overall Study|Progressive Disease|4|||
170424122|NCT00268905|615893306|FG002|Overall Study|Progressive Disease|3|||
170424123|NCT00268905|615893304|FG000|Overall Study|Physician Decision|3|||
170424124|NCT00268905|615893305|FG001|Overall Study|Physician Decision|0|||
170424125|NCT00268905|615893306|FG002|Overall Study|Physician Decision|1|||
170533739|NCT03282097|616300701|FG001|Intervention Visit Complete|Patient Death|15|||
170424126|NCT00268905|615893304|FG000|Overall Study|Clinical Progression|9|||
170424127|NCT00268905|615893305|FG001|Overall Study|Clinical Progression|4|||
170424128|NCT00268905|615893306|FG002|Overall Study|Clinical Progression|1|||
170424129|NCT02781727|615893307|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
170424130|NCT02781727|615893308|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
170424131|NCT02781727|615893307|FG000|Treatment Period|Withdrawal by Subject|1|||
170424132|NCT02781727|615893308|FG001|Treatment Period|Withdrawal by Subject|0|||
170424133|NCT02781727|615893307|FG000|Treatment Period|Lost to Follow-up|0|||
170424134|NCT02781727|615893308|FG001|Treatment Period|Lost to Follow-up|1|||
170424135|NCT00857623|615893309|FG000|Overall Study|Adverse Event|5|||
170424136|NCT00857623|615893310|FG001|Overall Study|Adverse Event|2|||
170424137|NCT00857623|615893309|FG000|Overall Study|Study-specific discontinuation criteria|5|||
170424138|NCT00857623|615893310|FG001|Overall Study|Study-specific discontinuation criteria|3|||
170424139|NCT00857623|615893309|FG000|Overall Study|Withdrawal by Subject|2|||
170424140|NCT00857623|615893310|FG001|Overall Study|Withdrawal by Subject|1|||
170424141|NCT00857623|615893309|FG000|Overall Study|Lack of Efficacy|1|||
170424142|NCT00857623|615893310|FG001|Overall Study|Lack of Efficacy|1|||
170424143|NCT00857623|615893309|FG000|Overall Study|Severe non-compliance to protocol|1|||
170424144|NCT00857623|615893310|FG001|Overall Study|Severe non-compliance to protocol|1|||
170424145|NCT00857623|615893309|FG000|Overall Study|Intake of prohibited medication|0|||
170424146|NCT00857623|615893310|FG001|Overall Study|Intake of prohibited medication|1|||
170424147|NCT00857623|615893309|FG000|Overall Study|Positive for HEP C|0|||
170424148|NCT00857623|615893310|FG001|Overall Study|Positive for HEP C|1|||
170424149|NCT00048581|615893311|FG000|Double-Blind Period|Adverse Event|9|||
170424150|NCT00048581|615893312|FG001|Double-Blind Period|Adverse Event|5|||
170424151|NCT00048581|615893313|FG002|Double-Blind Period|Adverse Event|0|||
170424152|NCT00048581|615893311|FG000|Double-Blind Period|Lack of Efficacy|14|||
170424153|NCT00048581|615893312|FG001|Double-Blind Period|Lack of Efficacy|27|||
170424154|NCT00048581|615893313|FG002|Double-Blind Period|Lack of Efficacy|0|||
170424155|NCT00048581|615893311|FG000|Double-Blind Period|Lost to Follow-up|5|||
170424156|NCT00048581|615893312|FG001|Double-Blind Period|Lost to Follow-up|0|||
170424157|NCT00048581|615893313|FG002|Double-Blind Period|Lost to Follow-up|0|||
170424158|NCT00048581|615893311|FG000|Double-Blind Period|Withdrawal by Subject|5|||
170424159|NCT00048581|615893312|FG001|Double-Blind Period|Withdrawal by Subject|2|||
170424160|NCT00048581|615893313|FG002|Double-Blind Period|Withdrawal by Subject|0|||
170424161|NCT00048581|615893311|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
170424162|NCT00048581|615893312|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
170424163|NCT00048581|615893313|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
170424164|NCT00048581|615893311|FG000|Double-Blind Period|Investigator Decision|1|||
170424165|NCT00048581|615893312|FG001|Double-Blind Period|Investigator Decision|0|||
170424166|NCT00048581|615893313|FG002|Double-Blind Period|Investigator Decision|0|||
170533740|NCT03282097|616300700|FG000|Intervention Visit Complete|Caregiver Death|0|||
170533741|NCT03282097|616300701|FG001|Intervention Visit Complete|Caregiver Death|3|||
170533742|NCT03282097|616300700|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
170424167|NCT00048581|615893311|FG000|Open-Label Period|Death|0|||
170424168|NCT00048581|615893312|FG001|Open-Label Period|Death|0|||
170424169|NCT00048581|615893313|FG002|Open-Label Period|Death|4|||
170424170|NCT00048581|615893311|FG000|Open-Label Period|Adverse Event|0|||
170424171|NCT00048581|615893312|FG001|Open-Label Period|Adverse Event|0|||
170424172|NCT00048581|615893313|FG002|Open-Label Period|Adverse Event|37|||
170424173|NCT00048581|615893311|FG000|Open-Label Period|Lack of Efficacy|0|||
170424174|NCT00048581|615893312|FG001|Open-Label Period|Lack of Efficacy|0|||
170424175|NCT00048581|615893313|FG002|Open-Label Period|Lack of Efficacy|69|||
170424176|NCT00048581|615893311|FG000|Open-Label Period|Lost to Follow-up|0|||
170424177|NCT00048581|615893312|FG001|Open-Label Period|Lost to Follow-up|0|||
170424178|NCT00048581|615893313|FG002|Open-Label Period|Lost to Follow-up|14|||
170424179|NCT00048581|615893311|FG000|Open-Label Period|Withdrawal by Subject|0|||
170424180|NCT00048581|615893312|FG001|Open-Label Period|Withdrawal by Subject|0|||
170424181|NCT00048581|615893313|FG002|Open-Label Period|Withdrawal by Subject|20|||
170424182|NCT00048581|615893311|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
170424183|NCT00048581|615893312|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
170424184|NCT00048581|615893313|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
170424185|NCT00048581|615893311|FG000|Open-Label Period|Poor/Non-compliance|0|||
170424186|NCT00048581|615893312|FG001|Open-Label Period|Poor/Non-compliance|0|||
170424187|NCT00048581|615893313|FG002|Open-Label Period|Poor/Non-compliance|5|||
170424188|NCT00048581|615893311|FG000|Open-Label Period|Pregnancy|0|||
170424189|NCT00048581|615893312|FG001|Open-Label Period|Pregnancy|0|||
170424190|NCT00048581|615893313|FG002|Open-Label Period|Pregnancy|7|||
170424191|NCT00048581|615893311|FG000|Open-Label Period|Study Site Closure|0|||
170424192|NCT00048581|615893312|FG001|Open-Label Period|Study Site Closure|0|||
170424193|NCT00048581|615893313|FG002|Open-Label Period|Study Site Closure|2|||
170424194|NCT00048581|615893311|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
170424195|NCT00048581|615893312|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
170424196|NCT00048581|615893313|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
170424197|NCT00048581|615893311|FG000|Open-Label Period|Problem With Transportation To Site|0|||
170424198|NCT00048581|615893312|FG001|Open-Label Period|Problem With Transportation To Site|0|||
170424199|NCT00048581|615893313|FG002|Open-Label Period|Problem With Transportation To Site|1|||
170424200|NCT00048581|615893311|FG000|Open-Label Period|Primary Investigator Retired|0|||
170424201|NCT00048581|615893312|FG001|Open-Label Period|Primary Investigator Retired|0|||
170424202|NCT00048581|615893313|FG002|Open-Label Period|Primary Investigator Retired|2|||
170424203|NCT00048581|615893311|FG000|Open-Label Period|Study Ended By Sponsor|0|||
170424204|NCT00048581|615893312|FG001|Open-Label Period|Study Ended By Sponsor|0|||
170424205|NCT00048581|615893313|FG002|Open-Label Period|Study Ended By Sponsor|1|||
170424206|NCT00319735|615893323|FG000|Overall Study|Death|2|||
170424207|NCT03929393|615893324|FG000|Overall Study|Death|1|||
170424208|NCT03929393|615893325|FG001|Overall Study|Death|0|||
170424209|NCT03929393|615893324|FG000|Overall Study|Time Commitment|2|||
170424210|NCT03929393|615893325|FG001|Overall Study|Time Commitment|5|||
170424211|NCT03929393|615893324|FG000|Overall Study|Motor Vehicle Accident|0|||
170424212|NCT03929393|615893325|FG001|Overall Study|Motor Vehicle Accident|1|||
170424213|NCT03929393|615893324|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
170424214|NCT03929393|615893325|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
170533743|NCT03282097|616300701|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
170533744|NCT03282097|616300700|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
170533745|NCT03282097|616300701|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
170424215|NCT03929393|615893324|FG000|Overall Study|Other|1|||
170424216|NCT03929393|615893325|FG001|Overall Study|Other|3|||
170424217|NCT02158936|615893326|FG000|Overall Study|Study closed/ terminated|57|||
170424218|NCT02158936|615893327|FG001|Overall Study|Study closed/ terminated|77|||
170424219|NCT02158936|615893326|FG000|Overall Study|Azacitidine tx discontinued|53|||
170424220|NCT02158936|615893327|FG001|Overall Study|Azacitidine tx discontinued|46|||
170424221|NCT02158936|615893326|FG000|Overall Study|Adverse Event|39|||
170424222|NCT02158936|615893327|FG001|Overall Study|Adverse Event|24|||
170424223|NCT02158936|615893326|FG000|Overall Study|Withdrawal by Subject|15|||
170424224|NCT02158936|615893327|FG001|Overall Study|Withdrawal by Subject|16|||
170424225|NCT02158936|615893326|FG000|Overall Study|Physician Decision|15|||
170424226|NCT02158936|615893327|FG001|Overall Study|Physician Decision|13|||
170424227|NCT02158936|615893326|FG000|Overall Study|Lost to Follow-up|0|||
170424228|NCT02158936|615893327|FG001|Overall Study|Lost to Follow-up|1|||
170424229|NCT01045096|615894981|FG000|Overall Study|Withdrawal by Subject|2|||
170424230|NCT01045096|615894982|FG001|Overall Study|Withdrawal by Subject|0|||
170424231|NCT01045096|615894983|FG002|Overall Study|Withdrawal by Subject|0|||
170424232|NCT01045096|615894981|FG000|Overall Study|Other|1|||
170424233|NCT01045096|615894982|FG001|Overall Study|Other|0|||
170424234|NCT01045096|615894983|FG002|Overall Study|Other|0|||
170533746|NCT03282097|616300700|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
170424235|NCT01882257|615894992|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
170424236|NCT01882257|615894993|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
170424237|NCT01882257|615894994|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
170424238|NCT01882257|615894992|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
170424239|NCT01882257|615894993|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
170424240|NCT01882257|615894994|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
170424241|NCT01435265|615894996|FG000|Overall Study|Lost to Follow-up|0|||
170424242|NCT01435265|615894997|FG001|Overall Study|Lost to Follow-up|1|||
170424243|NCT01900691|615894998|FG000|Overall Study|Death|7|||
170424244|NCT01900691|615894998|FG000|Overall Study|Lost to Follow-up|4|||
170424245|NCT01900691|615894998|FG000|Overall Study|Study Device Not Placed|3|||
170424246|NCT01900691|615894998|FG000|Overall Study|Non study stent placed|2|||
170424247|NCT01900691|615894998|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
170424248|NCT01900691|615894998|FG000|Overall Study|Complete stent migration through digestive tract|1|||
170424249|NCT01954394|615894999|FG000|Overall Study|Enrolled but not treated|1|||
170424250|NCT01954394|615895000|FG001|Overall Study|Enrolled but not treated|0|||
170424251|NCT01954394|615894999|FG000|Overall Study|Adverse Event|10|||
170424252|NCT01954394|615895000|FG001|Overall Study|Adverse Event|23|||
170424253|NCT01954394|615894999|FG000|Overall Study|Poor compliance to protocol|7|||
170424254|NCT01954394|615895000|FG001|Overall Study|Poor compliance to protocol|7|||
170424255|NCT01954394|615894999|FG000|Overall Study|Participant Moved|0|||
170424256|NCT01954394|615895000|FG001|Overall Study|Participant Moved|4|||
170424257|NCT01954394|615894999|FG000|Overall Study|Related to Study Drug administration|2|||
170424258|NCT01954394|615895000|FG001|Overall Study|Related to Study Drug administration|2|||
170424259|NCT01954394|615894999|FG000|Overall Study|Other than specified above|10|||
170424260|NCT01954394|615895000|FG001|Overall Study|Other than specified above|21|||
170424261|NCT05327491|615895001|FG000|Periods 1 & 2|Miscellaneous|0|||
170424262|NCT05327491|615895002|FG001|Periods 1 & 2|Miscellaneous|1|||
170424263|NCT05327491|615895003|FG002|Periods 1 & 2|Miscellaneous|0|||
170424264|NCT05327491|615895004|FG003|Periods 1 & 2|Miscellaneous|0|||
170424265|NCT05327491|615895001|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
170424266|NCT05327491|615895002|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
170424267|NCT05327491|615895003|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
170424268|NCT05327491|615895004|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
170424269|NCT02128997|615895007|FG000|Overall Study|Lost to Follow-up|6|||
170424270|NCT02128997|615895008|FG001|Overall Study|Lost to Follow-up|11|||
170424271|NCT00328926|615895020|FG000|Overall Study|Pregnancy|2|||
170424272|NCT00328926|615895021|FG001|Overall Study|Pregnancy|1|||
170424273|NCT00328926|615895022|FG002|Overall Study|Pregnancy|0|||
170424274|NCT00328926|615895020|FG000|Overall Study|Lost to Follow-up|0|||
170424275|NCT00328926|615895021|FG001|Overall Study|Lost to Follow-up|1|||
170424276|NCT00328926|615895022|FG002|Overall Study|Lost to Follow-up|0|||
170424277|NCT00328926|615895020|FG000|Overall Study|Death|0|||
170424278|NCT00328926|615895021|FG001|Overall Study|Death|0|||
170424279|NCT00328926|615895022|FG002|Overall Study|Death|1|||
170424280|NCT00328926|615895020|FG000|Overall Study|In vitro fertilization treatment|0|||
170424281|NCT00328926|615895021|FG001|Overall Study|In vitro fertilization treatment|0|||
170424282|NCT00328926|615895022|FG002|Overall Study|In vitro fertilization treatment|1|||
170424283|NCT00328926|615895020|FG000|Overall Study|Lack of ovarian response|0|||
170424284|NCT00328926|615895021|FG001|Overall Study|Lack of ovarian response|1|||
170424285|NCT00328926|615895022|FG002|Overall Study|Lack of ovarian response|0|||
170424286|NCT01171989|615895025|FG000|Overall Study|Lost to Follow-up|0|||
170424287|NCT01171989|615895026|FG001|Overall Study|Lost to Follow-up|0|||
170424288|NCT01171989|615895027|FG002|Overall Study|Lost to Follow-up|1|||
170424289|NCT00418184|615895028|FG000|Double-blind Phase|Withdrawal by Subject|22|||
170424290|NCT00418184|615895029|FG001|Double-blind Phase|Withdrawal by Subject|9|||
170424291|NCT00418184|615895028|FG000|Double-blind Phase|Adverse Event|2|||
170424292|NCT00418184|615895029|FG001|Double-blind Phase|Adverse Event|1|||
170424293|NCT00418184|615895028|FG000|Double-blind Phase|Poor compliance|3|||
170424294|NCT00418184|615895029|FG001|Double-blind Phase|Poor compliance|1|||
170424295|NCT00620074|615895030|FG000|Overall Study|Adverse Event|1|||
170424296|NCT02822235|615895032|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
170424297|NCT02822235|615895033|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
170424298|NCT02822235|615895032|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
170424299|NCT02822235|615895033|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
170424300|NCT02822235|615895032|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
170424301|NCT02822235|615895033|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
170424302|NCT02822235|615895032|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
170424303|NCT02822235|615895033|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
170424304|NCT02822235|615895032|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
170424305|NCT02822235|615895033|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
170424306|NCT02822235|615895032|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
170424307|NCT02822235|615895033|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
170424308|NCT01196052|615895036|FG000|Overall Study|Adverse Event|9|||
170424309|NCT01196052|615895036|FG000|Overall Study|Lost to Follow-up|1|||
170424310|NCT01196052|615895036|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
170424311|NCT01196052|615895036|FG000|Overall Study|Reason not Specified|5|||
170424312|NCT01196052|615895036|FG000|Overall Study|Withdrawal by Subject|6|||
170424313|NCT03450070|615895037|FG000|Overall Study|Withdrawal by Subject|8|||
170424314|NCT00436553|615895038|FG000|Overall Study|Adverse Event|4|||
170424315|NCT00436553|615895039|FG001|Overall Study|Adverse Event|3|||
170424316|NCT00436553|615895040|FG002|Overall Study|Adverse Event|4|||
170424317|NCT00436553|615895038|FG000|Overall Study|Death|3|||
170424318|NCT00436553|615895039|FG001|Overall Study|Death|1|||
170424319|NCT00436553|615895040|FG002|Overall Study|Death|3|||
170424320|NCT00436553|615895038|FG000|Overall Study|Lost to Follow-up|0|||
170424321|NCT00436553|615895039|FG001|Overall Study|Lost to Follow-up|2|||
170424322|NCT00436553|615895040|FG002|Overall Study|Lost to Follow-up|0|||
170424323|NCT00436553|615895038|FG000|Overall Study|Protocol Violation|1|||
170424324|NCT00436553|615895039|FG001|Overall Study|Protocol Violation|0|||
170424325|NCT00436553|615895040|FG002|Overall Study|Protocol Violation|0|||
170424326|NCT00436553|615895038|FG000|Overall Study|Withdrawal by Subject|5|||
170424327|NCT00436553|615895039|FG001|Overall Study|Withdrawal by Subject|6|||
170424328|NCT00436553|615895040|FG002|Overall Study|Withdrawal by Subject|3|||
170424329|NCT02193880|615895047|FG000|Overall Study|patients did not collect enough HPC|3|||
170424330|NCT01536405|615895048|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
170424331|NCT01536405|615895049|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
170424332|NCT01536405|615895048|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
170424333|NCT01536405|615895049|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
170424334|NCT01536405|615895048|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
170424335|NCT01536405|615895049|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
170424336|NCT01536405|615895048|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
170424337|NCT01536405|615895049|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
170424338|NCT01536405|615895048|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
170424339|NCT01536405|615895049|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
170424340|NCT01536405|615895048|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
170424341|NCT01536405|615895049|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
170424342|NCT01536405|615895048|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
170424343|NCT01536405|615895049|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
170424344|NCT01536405|615895048|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
170424345|NCT01536405|615895049|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
170424346|NCT01536405|615895048|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
170424347|NCT01536405|615895049|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
170424348|NCT01536405|615895048|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
170424349|NCT01536405|615895049|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
170424350|NCT01536405|615895048|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
170424351|NCT01536405|615895049|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
170424352|NCT01536405|615895048|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
170424353|NCT01536405|615895049|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
170424354|NCT01536405|615895048|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
170424355|NCT01536405|615895049|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
170424356|NCT03627091|615895053|FG000|Overall Study|Adverse Event|0|||
170424357|NCT03627091|615895054|FG001|Overall Study|Adverse Event|0|||
170424358|NCT03627091|615895055|FG002|Overall Study|Adverse Event|2|||
170424359|NCT03627091|615895053|FG000|Overall Study|Withdrawal by Subject|2|||
170424360|NCT03627091|615895054|FG001|Overall Study|Withdrawal by Subject|0|||
170424361|NCT03627091|615895055|FG002|Overall Study|Withdrawal by Subject|2|||
170424362|NCT03627091|615895053|FG000|Overall Study|Physician Decision|2|||
170424363|NCT03627091|615895054|FG001|Overall Study|Physician Decision|0|||
170424364|NCT03627091|615895055|FG002|Overall Study|Physician Decision|0|||
170424365|NCT03627091|615895053|FG000|Overall Study|Site terminated by sponsor|0|||
170424366|NCT03627091|615895054|FG001|Overall Study|Site terminated by sponsor|1|||
170424367|NCT03627091|615895055|FG002|Overall Study|Site terminated by sponsor|0|||
170424368|NCT03627091|615895053|FG000|Overall Study|Disease relapse|7|||
170424369|NCT03627091|615895054|FG001|Overall Study|Disease relapse|5|||
170424370|NCT03627091|615895055|FG002|Overall Study|Disease relapse|1|||
170424371|NCT03627091|615895053|FG000|Overall Study|Other|1|||
170424372|NCT03627091|615895054|FG001|Overall Study|Other|0|||
170424373|NCT03627091|615895055|FG002|Overall Study|Other|0|||
170424374|NCT02543203|615895056|FG000|Overall Study|Unpalatable Fragrance|2|||
170424375|NCT02543203|615895057|FG001|Overall Study|Unpalatable Fragrance|2|||
170424376|NCT02543203|615895056|FG000|Overall Study|Lost to Follow-up|1|||
170424377|NCT02543203|615895057|FG001|Overall Study|Lost to Follow-up|0|||
170424378|NCT02543203|615895056|FG000|Overall Study|Increased Irritability|1|||
170424379|NCT02543203|615895057|FG001|Overall Study|Increased Irritability|0|||
170424380|NCT02543203|615895056|FG000|Overall Study|Family|1|||
170424381|NCT02543203|615895057|FG001|Overall Study|Family|2|||
170424382|NCT02543203|615895056|FG000|Overall Study|Negative Behavior|1|||
170424383|NCT02543203|615895057|FG001|Overall Study|Negative Behavior|0|||
170424384|NCT02543203|615895056|FG000|Overall Study|Withdrawal by Subject|0|||
170424385|NCT02543203|615895057|FG001|Overall Study|Withdrawal by Subject|1|||
170424386|NCT00420238|615895060|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
170424387|NCT00420238|615895061|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
170424388|NCT00420238|615895060|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
170424389|NCT00420238|615895061|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
170424390|NCT00420238|615895060|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
170533747|NCT03282097|616300701|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
170424391|NCT00420238|615895061|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
170424392|NCT00420238|615895060|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
170424393|NCT00420238|615895061|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
170424394|NCT00420238|615895060|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
170424395|NCT00420238|615895061|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
170424396|NCT00420238|615895060|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
170424397|NCT00420238|615895061|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
170424398|NCT00626548|615895062|FG000|Overall Study|Adverse Event|164|||
170424399|NCT00626548|615895063|FG001|Overall Study|Adverse Event|44|||
170424400|NCT00626548|615895062|FG000|Overall Study|Withdrawal by Subject|42|||
170424401|NCT00626548|615895063|FG001|Overall Study|Withdrawal by Subject|46|||
170424402|NCT00626548|615895062|FG000|Overall Study|Protocol Violation|4|||
170424403|NCT00626548|615895063|FG001|Overall Study|Protocol Violation|11|||
170424404|NCT00626548|615895062|FG000|Overall Study|Lost to Follow-up|2|||
170424405|NCT00626548|615895063|FG001|Overall Study|Lost to Follow-up|2|||
170424406|NCT00626548|615895062|FG000|Overall Study|Other termination reason|493|||
170424407|NCT00626548|615895063|FG001|Overall Study|Other termination reason|613|||
170424408|NCT00855738|615895066|FG000|Overall Study|Lost to Follow-up|2|||
170424409|NCT00855738|615895066|FG000|Overall Study|Adverse Event|1|||
170424410|NCT00855738|615895066|FG000|Overall Study|Subject Defaulted|1|||
170424411|NCT00855738|615895066|FG000|Overall Study|Death|1|||
170424412|NCT04320849|615895067|FG000|Overall Study|Withdrawal by Subject|4|||
170424413|NCT04320849|615895067|FG000|Overall Study|Imaging data unavailable|2|||
170424414|NCT04320849|615895067|FG000|Overall Study|Incomplete imaging|2|||
170424415|NCT01378975|615895068|FG000|Overall Study|Death|77|||
170424416|NCT01378975|615895069|FG001|Overall Study|Death|46|||
170424417|NCT01378975|615895068|FG000|Overall Study|Investigator Request|1|||
170424418|NCT01378975|615895069|FG001|Overall Study|Investigator Request|0|||
170424419|NCT01378975|615895068|FG000|Overall Study|Lost to Follow-up|4|||
170424420|NCT01378975|615895069|FG001|Overall Study|Lost to Follow-up|1|||
170424421|NCT01378975|615895068|FG000|Overall Study|Withdrew Consent|4|||
170424422|NCT01378975|615895069|FG001|Overall Study|Withdrew Consent|3|||
170424423|NCT01937390|615895079|FG000|Overall Study|Death|2|||
170424424|NCT01937390|615895079|FG000|Overall Study|Lost to Follow-up|7|||
170533748|NCT03282097|616300700|FG000|Primary Outcome Data Collection Complete|Missing|2|||
170533749|NCT03282097|616300701|FG001|Primary Outcome Data Collection Complete|Missing|3|||
170533750|NCT03282097|616300700|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
170533751|NCT03282097|616300701|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
170533752|NCT03282097|616300700|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
170533753|NCT03282097|616300701|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
170424425|NCT01937390|615895079|FG000|Overall Study|Withdrawal by Subject|5|||
170424426|NCT01937390|615895079|FG000|Overall Study|Fail to return|21|||
170424427|NCT02216071|615895089|FG000|Overall Study|Withdrawal by Subject|7|||
170424428|NCT02216071|615895090|FG001|Overall Study|Withdrawal by Subject|2|||
170424429|NCT02216071|615895089|FG000|Overall Study|Lost to Follow-up|3|||
170424430|NCT02216071|615895090|FG001|Overall Study|Lost to Follow-up|3|||
170424431|NCT02216071|615895089|FG000|Overall Study|Protocol Violation|3|||
170424432|NCT02216071|615895090|FG001|Overall Study|Protocol Violation|5|||
170424433|NCT02216071|615895089|FG000|Overall Study|Other|2|||
170424434|NCT02216071|615895090|FG001|Overall Study|Other|2|||
170424435|NCT04753437|615895091|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
170424436|NCT04753437|615895092|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
170424437|NCT04753437|615895091|FG000|Overall Study|Liver Function Test Abnormalities|2|||
170424438|NCT04753437|615895092|FG001|Overall Study|Liver Function Test Abnormalities|4|||
170424439|NCT00154102|615895093|FG000|Overall Study|investigational study phase ongoing|7|||
170424440|NCT00154102|615895094|FG001|Overall Study|investigational study phase ongoing|2|||
170424441|NCT00463606|615895095|FG000|Overall Study|Adverse Event|21|||
170424442|NCT00463606|615895096|FG001|Overall Study|Adverse Event|18|||
170424443|NCT00463606|615895097|FG002|Overall Study|Adverse Event|11|||
170424444|NCT00463606|615895095|FG000|Overall Study|Withdrawal by Subject|11|||
170424445|NCT00463606|615895096|FG001|Overall Study|Withdrawal by Subject|11|||
170424446|NCT00463606|615895097|FG002|Overall Study|Withdrawal by Subject|5|||
170424447|NCT00463606|615895095|FG000|Overall Study|Lost to Follow-up|2|||
170424448|NCT00463606|615895096|FG001|Overall Study|Lost to Follow-up|2|||
170424449|NCT00463606|615895097|FG002|Overall Study|Lost to Follow-up|3|||
170424450|NCT00463606|615895095|FG000|Overall Study|Subject noncompliance|1|||
170424451|NCT00463606|615895096|FG001|Overall Study|Subject noncompliance|1|||
170424452|NCT00463606|615895097|FG002|Overall Study|Subject noncompliance|0|||
170424453|NCT00463606|615895095|FG000|Overall Study|Subject moved out of town|1|||
170424454|NCT00463606|615895096|FG001|Overall Study|Subject moved out of town|0|||
170424455|NCT00463606|615895097|FG002|Overall Study|Subject moved out of town|0|||
170424456|NCT00463606|615895095|FG000|Overall Study|Physician Decision|0|||
170424457|NCT00463606|615895096|FG001|Overall Study|Physician Decision|1|||
170424458|NCT00463606|615895097|FG002|Overall Study|Physician Decision|0|||
170424459|NCT00463606|615895095|FG000|Overall Study|Sponsor request|0|||
170424460|NCT00463606|615895096|FG001|Overall Study|Sponsor request|1|||
170424461|NCT00463606|615895097|FG002|Overall Study|Sponsor request|0|||
170424462|NCT00463606|615895095|FG000|Overall Study|Exclusion criteria violation|2|||
170424463|NCT00463606|615895096|FG001|Overall Study|Exclusion criteria violation|0|||
170424464|NCT00463606|615895097|FG002|Overall Study|Exclusion criteria violation|0|||
170424465|NCT00463606|615895095|FG000|Overall Study|Coordinator error|1|||
170424466|NCT00463606|615895096|FG001|Overall Study|Coordinator error|0|||
170424467|NCT00463606|615895097|FG002|Overall Study|Coordinator error|0|||
170424468|NCT00463606|615895095|FG000|Overall Study|Patient randomized in error|1|||
170424469|NCT00463606|615895096|FG001|Overall Study|Patient randomized in error|0|||
170424470|NCT00463606|615895097|FG002|Overall Study|Patient randomized in error|0|||
170424471|NCT00463606|615895095|FG000|Overall Study|Participation in another ABT-335 trial|1|||
170424472|NCT00463606|615895096|FG001|Overall Study|Participation in another ABT-335 trial|0|||
170424473|NCT00463606|615895097|FG002|Overall Study|Participation in another ABT-335 trial|0|||
170424474|NCT00463606|615895095|FG000|Overall Study|Protocol Violation|0|||
170424475|NCT00463606|615895096|FG001|Overall Study|Protocol Violation|0|||
170424476|NCT00463606|615895097|FG002|Overall Study|Protocol Violation|1|||
170424477|NCT03041025|615895099|FG000|Overall Study|Adverse Event|0|||
170424478|NCT03041025|615895100|FG001|Overall Study|Adverse Event|0|||
170424479|NCT03041025|615895101|FG002|Overall Study|Adverse Event|1|||
170424480|NCT03041025|615895099|FG000|Overall Study|Lost to Follow-up|1|||
170424481|NCT03041025|615895100|FG001|Overall Study|Lost to Follow-up|0|||
170424482|NCT03041025|615895101|FG002|Overall Study|Lost to Follow-up|0|||
170424483|NCT03041025|615895099|FG000|Overall Study|Withdrawal by Subject|0|||
170424484|NCT03041025|615895100|FG001|Overall Study|Withdrawal by Subject|0|||
170424485|NCT03041025|615895101|FG002|Overall Study|Withdrawal by Subject|1|||
170424486|NCT02682602|615895102|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
170424487|NCT02682602|615895103|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
170424488|NCT02682602|615895102|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
170424489|NCT02682602|615895103|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
170424490|NCT02140060|615895104|FG000|Overall Study|Adverse Event|0|||
170424491|NCT02140060|615895105|FG001|Overall Study|Adverse Event|0|||
170424492|NCT02140060|615895106|FG002|Overall Study|Adverse Event|0|||
170424493|NCT02140060|615895107|FG003|Overall Study|Adverse Event|1|||
170424494|NCT02140060|615895108|FG004|Overall Study|Adverse Event|1|||
170424495|NCT02140060|615895109|FG005|Overall Study|Adverse Event|1|||
170424496|NCT02140060|615895104|FG000|Overall Study|Lack of Efficacy|0|||
170424497|NCT02140060|615895105|FG001|Overall Study|Lack of Efficacy|0|||
170424498|NCT02140060|615895106|FG002|Overall Study|Lack of Efficacy|0|||
170424499|NCT02140060|615895107|FG003|Overall Study|Lack of Efficacy|1|||
170424500|NCT02140060|615895108|FG004|Overall Study|Lack of Efficacy|0|||
170424501|NCT02140060|615895109|FG005|Overall Study|Lack of Efficacy|0|||
170424502|NCT00909610|615897162|FG000|Period: First Intervention|Adverse Event|0|||
170424503|NCT00909610|615897163|FG001|Period: First Intervention|Adverse Event|1|||
170424504|NCT00909610|615897162|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
170424505|NCT00909610|615897163|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
170424506|NCT00909610|615897162|FG000|Period: Second Intervention|Adverse Event|1|||
170424507|NCT00909610|615897163|FG001|Period: Second Intervention|Adverse Event|0|||
170424508|NCT01247701|615897166|FG000|Overall Study|Death|2|||
170424509|NCT01247701|615897166|FG000|Overall Study|Relapsed|8|||
170424510|NCT00829530|615897167|FG000|First Intervention|Adverse Event|0|||
170424511|NCT00829530|615897168|FG001|First Intervention|Adverse Event|1|||
170424512|NCT00829530|615897167|FG000|First Intervention|Intolerance to Venopuncture|0|||
170424513|NCT00829530|615897168|FG001|First Intervention|Intolerance to Venopuncture|1|||
170424514|NCT00829530|615897167|FG000|Second Intervention|Intolerance to Venopuncture|1|||
170424515|NCT00829530|615897168|FG001|Second Intervention|Intolerance to Venopuncture|0|||
170424516|NCT01440283|615897171|FG000|Overall Study|Death|3|||
170424517|NCT01440283|615897171|FG000|Overall Study|Withdrawal by Subject|4|||
170424518|NCT01440283|615897171|FG000|Overall Study|Physician Decision|3|||
170424519|NCT03025880|615897172|FG000|Overall Study|Adverse Event|1|||
170424520|NCT03025880|615897173|FG001|Overall Study|Adverse Event|0|||
170424521|NCT03025880|615897172|FG000|Overall Study|Death|1|||
170424522|NCT03025880|615897173|FG001|Overall Study|Death|1|||
170424523|NCT03025880|615897172|FG000|Overall Study|Withdrawal by Subject|0|||
170424524|NCT03025880|615897173|FG001|Overall Study|Withdrawal by Subject|1|||
170424525|NCT03025880|615897172|FG000|Overall Study|Physician Decision|0|||
170424526|NCT03025880|615897173|FG001|Overall Study|Physician Decision|1|||
170424527|NCT03025880|615897172|FG000|Overall Study|Progressive Disease|12|||
170424528|NCT03025880|615897173|FG001|Overall Study|Progressive Disease|19|||
170424529|NCT03603314|615897174|FG000|Overall Study|Lost to Follow-up|0|||
170424530|NCT03603314|615897175|FG001|Overall Study|Lost to Follow-up|3|||
170424531|NCT03603314|615897176|FG002|Overall Study|Lost to Follow-up|0|||
170424532|NCT03603314|615897174|FG000|Overall Study|Protocol Violation|0|||
170424533|NCT03603314|615897175|FG001|Overall Study|Protocol Violation|1|||
170424534|NCT03603314|615897176|FG002|Overall Study|Protocol Violation|0|||
170424535|NCT03603314|615897174|FG000|Overall Study|Adverse Event|2|||
170424536|NCT03603314|615897175|FG001|Overall Study|Adverse Event|0|||
170424537|NCT03603314|615897176|FG002|Overall Study|Adverse Event|0|||
170424538|NCT03603314|615897174|FG000|Overall Study|Physician Decision|1|||
170424539|NCT03603314|615897175|FG001|Overall Study|Physician Decision|1|||
170424540|NCT03603314|615897176|FG002|Overall Study|Physician Decision|0|||
170424541|NCT03603314|615897174|FG000|Overall Study|Withdrawal by Subject|4|||
170424542|NCT03603314|615897175|FG001|Overall Study|Withdrawal by Subject|5|||
170424543|NCT03603314|615897176|FG002|Overall Study|Withdrawal by Subject|3|||
170424544|NCT03603314|615897174|FG000|Overall Study|Other|0|||
170424545|NCT03603314|615897175|FG001|Overall Study|Other|1|||
170424546|NCT03603314|615897176|FG002|Overall Study|Other|0|||
170424547|NCT00050778|615897177|FG000|Overall Study|Adverse Event|13|||
170424548|NCT00050778|615897178|FG001|Overall Study|Adverse Event|3|||
170424549|NCT00050778|615897179|FG002|Overall Study|Adverse Event|2|||
170424550|NCT00050778|615897177|FG000|Overall Study|Death|0|||
170424551|NCT00050778|615897178|FG001|Overall Study|Death|1|||
170424552|NCT00050778|615897179|FG002|Overall Study|Death|1|||
170424553|NCT00050778|615897177|FG000|Overall Study|Lack of Efficacy|16|||
170424554|NCT00050778|615897178|FG001|Overall Study|Lack of Efficacy|2|||
170424555|NCT00050778|615897179|FG002|Overall Study|Lack of Efficacy|2|||
170424556|NCT00050778|615897177|FG000|Overall Study|Lost to Follow-up|0|||
170424557|NCT00050778|615897178|FG001|Overall Study|Lost to Follow-up|2|||
170424558|NCT00050778|615897179|FG002|Overall Study|Lost to Follow-up|4|||
170424559|NCT00050778|615897177|FG000|Overall Study|Physician Decision|3|||
170424560|NCT00050778|615897178|FG001|Overall Study|Physician Decision|0|||
170424561|NCT00050778|615897179|FG002|Overall Study|Physician Decision|2|||
170424562|NCT00050778|615897177|FG000|Overall Study|Protocol Violation|2|||
170424563|NCT00050778|615897178|FG001|Overall Study|Protocol Violation|0|||
170424564|NCT00050778|615897179|FG002|Overall Study|Protocol Violation|1|||
170424565|NCT00050778|615897177|FG000|Overall Study|Withdrawal by Subject|6|||
170424566|NCT00050778|615897178|FG001|Overall Study|Withdrawal by Subject|8|||
170424567|NCT00050778|615897179|FG002|Overall Study|Withdrawal by Subject|4|||
170424568|NCT00050778|615897177|FG000|Overall Study|Randomized but not treated|4|||
170424569|NCT00050778|615897178|FG001|Overall Study|Randomized but not treated|5|||
170424570|NCT00050778|615897179|FG002|Overall Study|Randomized but not treated|2|||
170424571|NCT00050778|615897177|FG000|Overall Study|Familial and personal reasons|1|||
170424572|NCT00050778|615897178|FG001|Overall Study|Familial and personal reasons|0|||
170424573|NCT00050778|615897179|FG002|Overall Study|Familial and personal reasons|0|||
170424574|NCT01035060|615897184|FG000|Overall Study|Lost to Follow-up|0|||
170424575|NCT01035060|615897185|FG001|Overall Study|Lost to Follow-up|7|||
170424576|NCT01035060|615897184|FG000|Overall Study|Did not quality after 2nd screening|14|||
170424577|NCT01035060|615897185|FG001|Overall Study|Did not quality after 2nd screening|1|||
170424578|NCT01035060|615897184|FG000|Overall Study|Withdrawal by Subject|8|||
170424579|NCT01035060|615897185|FG001|Overall Study|Withdrawal by Subject|6|||
170424580|NCT01035060|615897184|FG000|Overall Study|Physician Decision|2|||
170424581|NCT01035060|615897185|FG001|Overall Study|Physician Decision|0|||
170424582|NCT02419937|615897190|FG000|Overall Study|Lost to Follow-up|1|||
170424583|NCT02419937|615897191|FG001|Overall Study|Lost to Follow-up|0|||
170424584|NCT00553280|615897193|FG000|Overall Study|Adverse Event|19|||
170424585|NCT00553280|615897193|FG000|Overall Study|Lack of Efficacy|3|||
170424586|NCT00553280|615897193|FG000|Overall Study|Withdrawal by Subject|3|||
170424587|NCT00553280|615897193|FG000|Overall Study|Physician Decision|1|||
170424588|NCT01256684|615897194|FG000|Overall Study|Adverse Event|1|||
170424589|NCT01256684|615897195|FG001|Overall Study|Adverse Event|4|||
170424590|NCT01256684|615897196|FG002|Overall Study|Adverse Event|2|||
170424591|NCT01256684|615897194|FG000|Overall Study|Withdrawal by Subject|4|||
170424592|NCT01256684|615897195|FG001|Overall Study|Withdrawal by Subject|0|||
170424593|NCT01256684|615897196|FG002|Overall Study|Withdrawal by Subject|2|||
170424594|NCT01256684|615897194|FG000|Overall Study|Physician Decision|0|||
170424595|NCT01256684|615897195|FG001|Overall Study|Physician Decision|1|||
170424596|NCT01256684|615897196|FG002|Overall Study|Physician Decision|0|||
170424597|NCT01256684|615897194|FG000|Overall Study|Lack of Efficacy|0|||
170424598|NCT01256684|615897195|FG001|Overall Study|Lack of Efficacy|1|||
170424599|NCT01256684|615897196|FG002|Overall Study|Lack of Efficacy|1|||
170424600|NCT01256684|615897194|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
170424601|NCT01256684|615897195|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
170424602|NCT01256684|615897196|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
170424603|NCT02914600|615897198|FG000|Overall Study|Adverse Event|298|||
170424604|NCT02914600|615897199|FG001|Overall Study|Adverse Event|35|||
170424605|NCT02914600|615897200|FG002|Overall Study|Adverse Event|25|||
170424606|NCT02914600|615897198|FG000|Overall Study|Sponsors decision|287|||
170424607|NCT02914600|615897199|FG001|Overall Study|Sponsors decision|41|||
170424608|NCT02914600|615897200|FG002|Overall Study|Sponsors decision|12|||
170424609|NCT02914600|615897198|FG000|Overall Study|Withdrawal by Subject|158|||
170424610|NCT02914600|615897199|FG001|Overall Study|Withdrawal by Subject|20|||
170424611|NCT02914600|615897200|FG002|Overall Study|Withdrawal by Subject|18|||
170424612|NCT02914600|615897198|FG000|Overall Study|Investigators discretion|169|||
170424613|NCT02914600|615897199|FG001|Overall Study|Investigators discretion|14|||
170424614|NCT02914600|615897200|FG002|Overall Study|Investigators discretion|13|||
170424615|NCT02914600|615897198|FG000|Overall Study|Lost to Follow-up|10|||
170424616|NCT02914600|615897199|FG001|Overall Study|Lost to Follow-up|4|||
170424617|NCT02914600|615897200|FG002|Overall Study|Lost to Follow-up|0|||
170424618|NCT02914600|615897198|FG000|Overall Study|Pregnancy|8|||
170424619|NCT02914600|615897199|FG001|Overall Study|Pregnancy|0|||
170424620|NCT02914600|615897200|FG002|Overall Study|Pregnancy|0|||
170424621|NCT02914600|615897198|FG000|Overall Study|Protocol Violation|5|||
170424622|NCT02914600|615897199|FG001|Overall Study|Protocol Violation|3|||
170424623|NCT02914600|615897200|FG002|Overall Study|Protocol Violation|0|||
170424624|NCT02914600|615897198|FG000|Overall Study|Non-compliance with study drug|6|||
170632702|NCT02760498|616666742|FG000|Overall Study|Physician Decision|3|||
170424625|NCT02914600|615897199|FG001|Overall Study|Non-compliance with study drug|1|||
170424626|NCT02914600|615897200|FG002|Overall Study|Non-compliance with study drug|0|||
170424627|NCT02914600|615897198|FG000|Overall Study|Death|3|||
170424628|NCT02914600|615897199|FG001|Overall Study|Death|1|||
170424629|NCT02914600|615897200|FG002|Overall Study|Death|1|||
170424630|NCT02914600|615897198|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
170424631|NCT02914600|615897199|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
170424632|NCT02914600|615897200|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
170424633|NCT02914600|615897198|FG000|Overall Study|Enrolled but not treated|1|||
170424634|NCT02914600|615897199|FG001|Overall Study|Enrolled but not treated|0|||
170424635|NCT02914600|615897200|FG002|Overall Study|Enrolled but not treated|0|||
170424636|NCT01185548|615897202|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
170424637|NCT01422538|615897205|FG000|Overall Study|Lost to Follow-up|0|||
170424638|NCT01422538|615897206|FG001|Overall Study|Lost to Follow-up|1|||
170424639|NCT01422538|615897207|FG002|Overall Study|Lost to Follow-up|1|||
170424640|NCT01422538|615897205|FG000|Overall Study|Missed visit|0|||
170424641|NCT01422538|615897206|FG001|Overall Study|Missed visit|1|||
170424642|NCT01422538|615897207|FG002|Overall Study|Missed visit|1|||
170424643|NCT00184600|615897208|FG000|Overall Study|Adverse Event|9|||
170424644|NCT00184600|615897209|FG001|Overall Study|Adverse Event|0|||
170424645|NCT00184600|615897210|FG002|Overall Study|Adverse Event|5|||
170424646|NCT00184600|615897208|FG000|Overall Study|Death|3|||
170424647|NCT00184600|615897209|FG001|Overall Study|Death|9|||
170424648|NCT00184600|615897210|FG002|Overall Study|Death|7|||
170424649|NCT00184600|615897208|FG000|Overall Study|Lack of Efficacy|3|||
170424650|NCT00184600|615897209|FG001|Overall Study|Lack of Efficacy|1|||
170424651|NCT00184600|615897210|FG002|Overall Study|Lack of Efficacy|3|||
170424652|NCT00184600|615897208|FG000|Overall Study|Lost to Follow-up|4|||
170424653|NCT00184600|615897209|FG001|Overall Study|Lost to Follow-up|6|||
170424654|NCT00184600|615897210|FG002|Overall Study|Lost to Follow-up|1|||
170424655|NCT00184600|615897208|FG000|Overall Study|Protocol Violation|2|||
170424656|NCT00184600|615897209|FG001|Overall Study|Protocol Violation|2|||
170424657|NCT00184600|615897210|FG002|Overall Study|Protocol Violation|3|||
170424658|NCT00184600|615897208|FG000|Overall Study|Withdrawal by Subject|20|||
170424659|NCT00184600|615897209|FG001|Overall Study|Withdrawal by Subject|28|||
170424660|NCT00184600|615897210|FG002|Overall Study|Withdrawal by Subject|12|||
170424661|NCT00184600|615897208|FG000|Overall Study|Unclassified|4|||
170424662|NCT00184600|615897209|FG001|Overall Study|Unclassified|5|||
170424663|NCT00184600|615897210|FG002|Overall Study|Unclassified|3|||
170424664|NCT03195491|615897214|FG000|Overall Study|Study drug toxicity|25|||
170424665|NCT03195491|615897215|FG001|Overall Study|Study drug toxicity|3|||
170424666|NCT03195491|615897214|FG000|Overall Study|Maximum clinical benefit|5|||
170424667|NCT03195491|615897215|FG001|Overall Study|Maximum clinical benefit|0|||
170424668|NCT03195491|615897214|FG000|Overall Study|Lost to Follow-up|1|||
170424669|NCT03195491|615897215|FG001|Overall Study|Lost to Follow-up|0|||
170424670|NCT03195491|615897214|FG000|Overall Study|Death|3|||
170424671|NCT03195491|615897215|FG001|Overall Study|Death|0|||
170424672|NCT03195491|615897214|FG000|Overall Study|Adverse event unrelated to study drug|19|||
170424673|NCT03195491|615897215|FG001|Overall Study|Adverse event unrelated to study drug|2|||
170424674|NCT03195491|615897214|FG000|Overall Study|Disease progression|266|||
170424675|NCT03195491|615897215|FG001|Overall Study|Disease progression|8|||
170424676|NCT03195491|615897214|FG000|Overall Study|Other reasons|10|||
170424677|NCT03195491|615897215|FG001|Overall Study|Other reasons|0|||
170424678|NCT03195491|615897214|FG000|Overall Study|Participant withdrew consent|8|||
170424679|NCT03195491|615897215|FG001|Overall Study|Participant withdrew consent|1|||
170424680|NCT03195491|615897214|FG000|Overall Study|Participant no longer meets study criteria|0|||
170424681|NCT03195491|615897215|FG001|Overall Study|Participant no longer meets study criteria|1|||
170424682|NCT03195491|615897214|FG000|Overall Study|Participant request to discontinue study treatment|10|||
170424683|NCT03195491|615897215|FG001|Overall Study|Participant request to discontinue study treatment|0|||
170424684|NCT03496623|615897216|FG000|Run-In Period (2 Weeks)|Death|1|||
170424685|NCT03496623|615897217|FG001|Run-In Period (2 Weeks)|Death|0|||
170424686|NCT03496623|615897218|FG002|Run-In Period (2 Weeks)|Death|0|||
170424687|NCT03496623|615897219|FG003|Run-In Period (2 Weeks)|Death|0|||
170424688|NCT03496623|615897220|FG004|Run-In Period (2 Weeks)|Death|0|||
170424689|NCT03496623|615897216|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
170424690|NCT03496623|615897217|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
170424691|NCT03496623|615897218|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
170424692|NCT03496623|615897219|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
170424693|NCT03496623|615897220|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
170424694|NCT03496623|615897216|FG000|Period 1 (12 Weeks)|Death|0|||
170424695|NCT03496623|615897217|FG001|Period 1 (12 Weeks)|Death|3|||
170424696|NCT03496623|615897218|FG002|Period 1 (12 Weeks)|Death|0|||
170424697|NCT03496623|615897219|FG003|Period 1 (12 Weeks)|Death|0|||
170424698|NCT03496623|615897220|FG004|Period 1 (12 Weeks)|Death|0|||
170424699|NCT03496623|615897216|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
170424700|NCT03496623|615897217|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
170424701|NCT03496623|615897218|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
170424702|NCT03496623|615897219|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
170424703|NCT03496623|615897220|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
170424704|NCT03496623|615897216|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170424705|NCT03496623|615897217|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
170424706|NCT03496623|615897218|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
170424707|NCT03496623|615897219|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170424708|NCT03496623|615897220|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170424709|NCT03496623|615897216|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
170424710|NCT03496623|615897217|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
170424711|NCT03496623|615897218|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
170424712|NCT03496623|615897219|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
170424713|NCT03496623|615897220|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
170424714|NCT03496623|615897216|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
170424715|NCT03496623|615897217|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
170424716|NCT03496623|615897218|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
170424717|NCT03496623|615897219|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
170424718|NCT03496623|615897220|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
170424719|NCT03496623|615897216|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
170424720|NCT03496623|615897217|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
170424721|NCT03496623|615897218|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
170424722|NCT03496623|615897219|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
170424723|NCT03496623|615897220|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
170424724|NCT03496623|615897216|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170424725|NCT03496623|615897217|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
170424726|NCT03496623|615897218|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170424727|NCT03496623|615897219|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170424728|NCT03496623|615897220|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170424729|NCT01270503|615897221|FG000|Overall Study|Lost to Follow-up|1|||
170424730|NCT02459951|615897222|FG000|Overall Study|Unable to meet holding requirement|1|||
170424731|NCT02255097|615897223|FG000|Overall Study|Death|151|||
170424732|NCT02255097|615897223|FG000|Overall Study|Lost to Follow-up|5|||
170424733|NCT02255097|615897223|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
170424734|NCT02255097|615897223|FG000|Overall Study|Withdrawal by Subject|7|||
170424735|NCT02255097|615897223|FG000|Overall Study|Allocated but not treated|1|||
170424736|NCT04239872|615897224|FG000|Overall Study|Lost to Follow-up|0|||
170424737|NCT04239872|615897225|FG001|Overall Study|Lost to Follow-up|1|||
170424738|NCT01498120|615897226|FG000|Overall Study|Lost to Follow-up|1|||
170424739|NCT01498120|615897226|FG000|Overall Study|Withdrawal by Subject|5|||
170424740|NCT01498120|615897226|FG000|Overall Study|AE, non-serious non-fatal|3|||
170424741|NCT01498120|615897226|FG000|Overall Study|Other|4|||
170424742|NCT00579670|615897227|FG000|Overall Study|Death|1|||
170424743|NCT00579670|615897228|FG001|Overall Study|Death|0|||
170424744|NCT00579670|615897229|FG002|Overall Study|Death|0|||
170424745|NCT00579670|615897230|FG003|Overall Study|Death|0|||
170424746|NCT00579670|615897231|FG004|Overall Study|Death|0|||
170424747|NCT00579670|615897227|FG000|Overall Study|Adverse Event|1|||
170424748|NCT00579670|615897228|FG001|Overall Study|Adverse Event|0|||
170424749|NCT00579670|615897229|FG002|Overall Study|Adverse Event|1|||
170424750|NCT00579670|615897230|FG003|Overall Study|Adverse Event|2|||
170424751|NCT00579670|615897231|FG004|Overall Study|Adverse Event|0|||
170424752|NCT00579670|615897227|FG000|Overall Study|Lack of Efficacy|0|||
170424753|NCT00579670|615897228|FG001|Overall Study|Lack of Efficacy|0|||
170424754|NCT00579670|615897229|FG002|Overall Study|Lack of Efficacy|1|||
170424755|NCT00579670|615897230|FG003|Overall Study|Lack of Efficacy|14|||
170424756|NCT00579670|615897231|FG004|Overall Study|Lack of Efficacy|0|||
170424757|NCT00579670|615897227|FG000|Overall Study|Lost to Follow-up|0|||
170424758|NCT00579670|615897228|FG001|Overall Study|Lost to Follow-up|1|||
170424759|NCT00579670|615897229|FG002|Overall Study|Lost to Follow-up|0|||
170424760|NCT00579670|615897230|FG003|Overall Study|Lost to Follow-up|4|||
170424761|NCT00579670|615897231|FG004|Overall Study|Lost to Follow-up|0|||
170424762|NCT00579670|615897227|FG000|Overall Study|Other|0|||
170424763|NCT00579670|615897228|FG001|Overall Study|Other|0|||
170424764|NCT00579670|615897229|FG002|Overall Study|Other|1|||
170424765|NCT00579670|615897230|FG003|Overall Study|Other|2|||
170424766|NCT00579670|615897231|FG004|Overall Study|Other|0|||
170424767|NCT00579670|615897227|FG000|Overall Study|Withdrawal by Subject|0|||
170879332|NCT00705783|617569242|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
170879333|NCT00705783|617569243|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
170879334|NCT00705783|617569244|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
170879335|NCT00705783|617569242|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
170879336|NCT00705783|617569243|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
170879337|NCT00705783|617569244|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
170879338|NCT00705783|617569242|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
170879339|NCT00705783|617569243|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
170879340|NCT00705783|617569244|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
170879341|NCT00705783|617569242|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
170879342|NCT00705783|617569243|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
170879343|NCT00705783|617569244|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
170879344|NCT00705783|617569242|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
170879345|NCT00705783|617569243|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
170879346|NCT00705783|617569244|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
170879347|NCT00705783|617569242|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
170879348|NCT00705783|617569243|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
170879349|NCT00705783|617569244|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
170879350|NCT00705783|617569242|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
170879351|NCT00705783|617569243|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
170879352|NCT00705783|617569244|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
170879353|NCT00705783|617569242|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
170879354|NCT00705783|617569243|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
170879355|NCT00705783|617569244|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
170879356|NCT00705783|617569242|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
170879357|NCT00705783|617569243|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
170879358|NCT00705783|617569244|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
170879359|NCT02182687|617569245|FG000|Overall Study|Withdrawal by Subject|4|||
170879360|NCT02182687|617569246|FG001|Overall Study|Withdrawal by Subject|0|||
170879361|NCT02182687|617569245|FG000|Overall Study|Adverse Event|1|||
170879362|NCT02182687|617569246|FG001|Overall Study|Adverse Event|0|||
170879363|NCT02182687|617569245|FG000|Overall Study|Lost to Follow-up|0|||
170879364|NCT02182687|617569246|FG001|Overall Study|Lost to Follow-up|1|||
170879365|NCT04251910|617569249|FG000|Overall Study|Covid 19 lockdown|0|||
170879366|NCT04251910|617569250|FG001|Overall Study|Covid 19 lockdown|5|||
170879367|NCT04251910|617569251|FG002|Overall Study|Covid 19 lockdown|0|||
170879368|NCT04251910|617569252|FG003|Overall Study|Covid 19 lockdown|4|||
170879369|NCT04251910|617569253|FG004|Overall Study|Covid 19 lockdown|0|||
170879370|NCT04251910|617569254|FG005|Overall Study|Covid 19 lockdown|0|||
170879371|NCT04251910|617569249|FG000|Overall Study|Assisted living facility was closed|0|||
170879372|NCT04251910|617569250|FG001|Overall Study|Assisted living facility was closed|0|||
170879373|NCT04251910|617569251|FG002|Overall Study|Assisted living facility was closed|0|||
170879374|NCT04251910|617569252|FG003|Overall Study|Assisted living facility was closed|0|||
170424768|NCT00579670|615897228|FG001|Overall Study|Withdrawal by Subject|0|||
170424769|NCT00579670|615897229|FG002|Overall Study|Withdrawal by Subject|1|||
170879375|NCT04251910|617569253|FG004|Overall Study|Assisted living facility was closed|1|||
170879376|NCT04251910|617569254|FG005|Overall Study|Assisted living facility was closed|0|||
170879377|NCT03451084|617569259|FG000|Overall Study|Withdrawal by Subject|2|||
170879378|NCT03451084|617569260|FG001|Overall Study|Withdrawal by Subject|1|||
170879379|NCT03451084|617569261|FG002|Overall Study|Withdrawal by Subject|2|||
170879380|NCT03451084|617569262|FG003|Overall Study|Withdrawal by Subject|1|||
170424770|NCT00579670|615897230|FG003|Overall Study|Withdrawal by Subject|0|||
170424771|NCT00579670|615897231|FG004|Overall Study|Withdrawal by Subject|0|||
170424772|NCT00112463|615897232|FG000|Overall Study|Physician Decision|1|||
170879381|NCT03451084|617569259|FG000|Overall Study|Disease recurrence|0|||
170424773|NCT00112463|615897232|FG000|Overall Study|Progression|30|||
170424774|NCT00112463|615897232|FG000|Overall Study|Second Primary|1|||
170879382|NCT03451084|617569260|FG001|Overall Study|Disease recurrence|2|||
170879383|NCT03451084|617569261|FG002|Overall Study|Disease recurrence|0|||
170879384|NCT03451084|617569262|FG003|Overall Study|Disease recurrence|0|||
170879385|NCT03451084|617569259|FG000|Overall Study|Lack of Efficacy|0|||
170879386|NCT03451084|617569260|FG001|Overall Study|Lack of Efficacy|3|||
170424775|NCT00112463|615897232|FG000|Overall Study|Toxicity|3|||
170424776|NCT00112463|615897232|FG000|Overall Study|Withdrawal by Subject|2|||
170424777|NCT00112463|615897232|FG000|Overall Study|Never started treatment|2|||
170424778|NCT01118312|615897233|FG000|Overall Study|Lost to Follow-up|33|||
170424779|NCT01118312|615897234|FG001|Overall Study|Lost to Follow-up|32|||
170424780|NCT01118312|615897233|FG000|Overall Study|Withdrawal by Subject|1|||
170424781|NCT01118312|615897234|FG001|Overall Study|Withdrawal by Subject|3|||
170424782|NCT01675765|615897235|FG000|Overall Study|Progressive disease|4|||
170424783|NCT01675765|615897236|FG001|Overall Study|Progressive disease|4|||
170424784|NCT01675765|615897235|FG000|Overall Study|Adverse Event|1|||
170424785|NCT01675765|615897236|FG001|Overall Study|Adverse Event|2|||
170424786|NCT01675765|615897235|FG000|Overall Study|Withdrawal by Subject|2|||
170424787|NCT01675765|615897236|FG001|Overall Study|Withdrawal by Subject|0|||
170424788|NCT01675765|615897235|FG000|Overall Study|Death|1|||
170424789|NCT01675765|615897236|FG001|Overall Study|Death|0|||
170424790|NCT01675765|615897235|FG000|Overall Study|Clinical progression|3|||
170424791|NCT01675765|615897236|FG001|Overall Study|Clinical progression|2|||
170424792|NCT00296647|615897237|FG000|Overall Study|Death|4|||
170424793|NCT00296647|615897238|FG001|Overall Study|Death|1|||
170424794|NCT00296647|615897239|FG002|Overall Study|Death|2|||
170424795|NCT00296647|615897240|FG003|Overall Study|Death|1|||
170424796|NCT00296647|615897241|FG004|Overall Study|Death|1|||
170424797|NCT00296647|615897237|FG000|Overall Study|Withdrawal by Subject|28|||
170424798|NCT00296647|615897238|FG001|Overall Study|Withdrawal by Subject|27|||
170424799|NCT00296647|615897239|FG002|Overall Study|Withdrawal by Subject|32|||
170424800|NCT00296647|615897240|FG003|Overall Study|Withdrawal by Subject|16|||
170424801|NCT00296647|615897241|FG004|Overall Study|Withdrawal by Subject|19|||
170424802|NCT04060147|615897242|FG000|Overall Study|Withdrew consent|1|||
170424803|NCT02008565|615897246|FG000|Overall Study|Protocol Violation|1|||
170424804|NCT02008565|615897247|FG001|Overall Study|Protocol Violation|1|||
170424805|NCT02008565|615897248|FG002|Overall Study|Protocol Violation|2|||
170424806|NCT02008565|615897249|FG003|Overall Study|Protocol Violation|0|||
170424807|NCT04185909|615897253|FG000|Overall Study|Lost to Follow-up|1|||
170424808|NCT02193178|615897255|FG000|Overall Study|Lost to Follow-up|1|||
170424809|NCT02193178|615897255|FG000|Overall Study|Dry eyes|1|||
170424810|NCT04510285|615897256|FG000|Overall Study|Death|1|||
170424811|NCT01417078|615897257|FG000|Overall Study|Withdrawal by Subject|1|||
170424812|NCT00870870|615897258|FG000|Overall Study|Withdrawal by Subject|0|||
170424813|NCT00870870|615897259|FG001|Overall Study|Withdrawal by Subject|1|||
170424814|NCT00870870|615897260|FG002|Overall Study|Withdrawal by Subject|1|||
170424815|NCT00870870|615897261|FG003|Overall Study|Withdrawal by Subject|3|||
170424816|NCT00870870|615897258|FG000|Overall Study|Adverse Event|0|||
170424817|NCT00870870|615897259|FG001|Overall Study|Adverse Event|0|||
170424818|NCT00870870|615897260|FG002|Overall Study|Adverse Event|2|||
170424819|NCT00870870|615897261|FG003|Overall Study|Adverse Event|2|||
170424820|NCT01406795|615897262|FG000|Overall Study|Withdrawal by Subject|1|||
170424821|NCT01059903|615897266|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
170424822|NCT01059903|615897267|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
170424823|NCT03639311|615897268|FG000|Maintenance Phase|Lost to Follow-up|1|||
170424824|NCT03639311|615897269|FG001|Maintenance Phase|Lost to Follow-up|0|||
170424825|NCT03639311|615897270|FG002|Maintenance Phase|Lost to Follow-up|0|||
170424826|NCT03639311|615897268|FG000|Maintenance Phase|Adverse Event|1|||
170424827|NCT03639311|615897269|FG001|Maintenance Phase|Adverse Event|0|||
170424828|NCT03639311|615897270|FG002|Maintenance Phase|Adverse Event|0|||
170424829|NCT03639311|615897268|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
170424830|NCT03639311|615897269|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
170424831|NCT03639311|615897270|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
170424832|NCT03639311|615897268|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
170424833|NCT03639311|615897269|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
170424834|NCT03639311|615897270|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
170424835|NCT03639311|615897268|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
170424836|NCT03639311|615897269|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
170424837|NCT03639311|615897270|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
170424838|NCT03639311|615897268|FG000|Maintenance Phase|Lack of Efficacy|1|||
170424839|NCT03639311|615897269|FG001|Maintenance Phase|Lack of Efficacy|0|||
170424840|NCT03639311|615897270|FG002|Maintenance Phase|Lack of Efficacy|0|||
170424841|NCT00822926|615897273|FG000|Second Injection Visit|Lost to Follow-up|1|||
170424842|NCT00822926|615897274|FG001|Second Injection Visit|Lost to Follow-up|0|||
170424843|NCT00822926|615897273|FG000|Second Injection Visit|Withdrawal by Subject|0|||
170424844|NCT00822926|615897274|FG001|Second Injection Visit|Withdrawal by Subject|1|||
170424845|NCT03897088|615897275|FG000|Overall Study|Withdrawal by Subject|12|||
170424846|NCT03897088|615897276|FG001|Overall Study|Withdrawal by Subject|12|||
170424847|NCT03897088|615897275|FG000|Overall Study|Lost to Follow-up|7|||
170533754|NCT03282097|616300700|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
170533755|NCT03282097|616300701|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
170533756|NCT01056536|616300702|FG000|Overall Study|Lost to Follow-up|202|||
170424848|NCT03897088|615897276|FG001|Overall Study|Lost to Follow-up|15|||
170424849|NCT03897088|615897275|FG000|Overall Study|Sponsor Decision|1|||
170424850|NCT03897088|615897276|FG001|Overall Study|Sponsor Decision|2|||
170424851|NCT03897088|615897275|FG000|Overall Study|COVID-19|2|||
170424852|NCT03897088|615897276|FG001|Overall Study|COVID-19|0|||
170424853|NCT03897088|615897275|FG000|Overall Study|Other|3|||
170424854|NCT03897088|615897276|FG001|Overall Study|Other|0|||
170424855|NCT03897088|615897275|FG000|Overall Study|Non-compliance with Study Drug|1|||
170424856|NCT03897088|615897276|FG001|Overall Study|Non-compliance with Study Drug|1|||
170424857|NCT03897088|615897275|FG000|Overall Study|Pregnancy|0|||
170424858|NCT03897088|615897276|FG001|Overall Study|Pregnancy|1|||
170424859|NCT04384978|615897285|FG000|Overall Study|Withdrawal by Subject|4|||
170424860|NCT04384978|615897286|FG001|Overall Study|Withdrawal by Subject|0|||
170424861|NCT00385593|615897287|FG000|Overall Study|Adverse Event|3|||
170424862|NCT00385593|615897288|FG001|Overall Study|Adverse Event|2|||
170424863|NCT00385593|615897287|FG000|Overall Study|Withdrawal by Subject|17|||
170424864|NCT00385593|615897288|FG001|Overall Study|Withdrawal by Subject|7|||
170424865|NCT00385593|615897287|FG000|Overall Study|Lost to Follow-up|12|||
170424866|NCT00385593|615897288|FG001|Overall Study|Lost to Follow-up|8|||
170424867|NCT00385593|615897287|FG000|Overall Study|Protocol Violation|7|||
170424868|NCT00385593|615897288|FG001|Overall Study|Protocol Violation|4|||
170424869|NCT00385593|615897287|FG000|Overall Study|Several reasons|17|||
170424870|NCT00385593|615897288|FG001|Overall Study|Several reasons|15|||
170879387|NCT03451084|617569261|FG002|Overall Study|Lack of Efficacy|0|||
170879388|NCT03451084|617569262|FG003|Overall Study|Lack of Efficacy|1|||
170879389|NCT03451084|617569259|FG000|Overall Study|Death|1|||
170879390|NCT03451084|617569260|FG001|Overall Study|Death|0|||
170879391|NCT03451084|617569261|FG002|Overall Study|Death|2|||
170879392|NCT03451084|617569262|FG003|Overall Study|Death|0|||
170879393|NCT03451084|617569259|FG000|Overall Study|Physician Decision|0|||
170879394|NCT03451084|617569260|FG001|Overall Study|Physician Decision|0|||
170879395|NCT03451084|617569261|FG002|Overall Study|Physician Decision|2|||
170879396|NCT03451084|617569262|FG003|Overall Study|Physician Decision|2|||
170879397|NCT03451084|617569259|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
170879398|NCT03451084|617569260|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
170879399|NCT03451084|617569261|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
170879400|NCT03451084|617569262|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
170879401|NCT03223428|617569264|FG000|Overall Study|No longer taking Xermelo|27|||
170879402|NCT03223428|617569264|FG000|Overall Study|Declined Consent|1|||
170879403|NCT03223428|617569264|FG000|Overall Study|Non-responders|56|||
170879404|NCT03223428|617569264|FG000|Overall Study|Withdrawal by Subject|14|||
170879405|NCT00501007|617569265|FG000|Overall Study|Inclusion criteria not met.|29|||
170879406|NCT00501007|617569266|FG001|Overall Study|Inclusion criteria not met.|25|||
170424871|NCT00385593|615897287|FG000|Overall Study|Incorrect inclusion|2|||
170424872|NCT00385593|615897288|FG001|Overall Study|Incorrect inclusion|0|||
170424873|NCT00385593|615897287|FG000|Overall Study|Incorrect randomization|0|||
170424874|NCT00385593|615897288|FG001|Overall Study|Incorrect randomization|1|||
170424875|NCT03555305|615897289|FG000|Period 1|Physician Decision|0|||
170424876|NCT03555305|615897290|FG001|Period 1|Physician Decision|1|||
170424877|NCT03555305|615897289|FG000|Period 1|Adverse Event|0|||
170424878|NCT03555305|615897290|FG001|Period 1|Adverse Event|1|||
170424879|NCT03135834|615897293|FG000|Stage 1|Adverse Event|1|||
170424880|NCT03135834|615897294|FG001|Stage 1|Adverse Event|2|||
170424881|NCT03135834|615897295|FG002|Stage 1|Adverse Event|2|||
170424882|NCT03135834|615897296|FG003|Stage 1|Adverse Event|1|||
170424883|NCT03135834|615897293|FG000|Stage 1|Death|1|||
170424884|NCT03135834|615897294|FG001|Stage 1|Death|0|||
170424885|NCT03135834|615897295|FG002|Stage 1|Death|0|||
170424886|NCT03135834|615897296|FG003|Stage 1|Death|0|||
170424887|NCT03135834|615897293|FG000|Stage 1|Lost to Follow-up|17|||
170424888|NCT03135834|615897294|FG001|Stage 1|Lost to Follow-up|24|||
170424889|NCT03135834|615897295|FG002|Stage 1|Lost to Follow-up|21|||
170879407|NCT03775421|617569268|FG000|Overall Study|Lost to Follow-up|2|||
170879408|NCT03775421|617569268|FG000|Overall Study|Withdrawal by Subject|10|||
170424890|NCT03135834|615897296|FG003|Stage 1|Lost to Follow-up|38|||
170424891|NCT03135834|615897293|FG000|Stage 1|No longer met eligibility criteria|1|||
170424892|NCT03135834|615897294|FG001|Stage 1|No longer met eligibility criteria|6|||
170424893|NCT03135834|615897295|FG002|Stage 1|No longer met eligibility criteria|2|||
170424894|NCT03135834|615897296|FG003|Stage 1|No longer met eligibility criteria|5|||
170424895|NCT03135834|615897293|FG000|Stage 1|Other|0|||
170424896|NCT03135834|615897294|FG001|Stage 1|Other|2|||
170424897|NCT03135834|615897295|FG002|Stage 1|Other|1|||
170424898|NCT03135834|615897296|FG003|Stage 1|Other|0|||
170424899|NCT03135834|615897293|FG000|Stage 1|Physician Decision|0|||
170424900|NCT03135834|615897294|FG001|Stage 1|Physician Decision|1|||
170424901|NCT03135834|615897295|FG002|Stage 1|Physician Decision|0|||
170424902|NCT03135834|615897296|FG003|Stage 1|Physician Decision|0|||
170424903|NCT03135834|615897293|FG000|Stage 1|Pregnancy|0|||
170424904|NCT03135834|615897294|FG001|Stage 1|Pregnancy|4|||
170424905|NCT03135834|615897295|FG002|Stage 1|Pregnancy|2|||
170424906|NCT03135834|615897296|FG003|Stage 1|Pregnancy|4|||
170424907|NCT03135834|615897293|FG000|Stage 1|Protocol Violation|1|||
170424908|NCT03135834|615897294|FG001|Stage 1|Protocol Violation|1|||
170424909|NCT03135834|615897295|FG002|Stage 1|Protocol Violation|2|||
170424910|NCT03135834|615897296|FG003|Stage 1|Protocol Violation|1|||
170424911|NCT03135834|615897293|FG000|Stage 1|Withdrawal by parent/guardian|2|||
170424912|NCT03135834|615897294|FG001|Stage 1|Withdrawal by parent/guardian|10|||
170424913|NCT03135834|615897295|FG002|Stage 1|Withdrawal by parent/guardian|2|||
170424914|NCT03135834|615897296|FG003|Stage 1|Withdrawal by parent/guardian|1|||
170424915|NCT03135834|615897293|FG000|Stage 1|Withdrawal by Subject|16|||
170424916|NCT03135834|615897294|FG001|Stage 1|Withdrawal by Subject|22|||
170424917|NCT03135834|615897295|FG002|Stage 1|Withdrawal by Subject|7|||
170424918|NCT03135834|615897296|FG003|Stage 1|Withdrawal by Subject|10|||
170424919|NCT03135834|615897293|FG000|Stage 1|Randomized but not Vaccinated|0|||
170424920|NCT03135834|615897294|FG001|Stage 1|Randomized but not Vaccinated|3|||
170424921|NCT03135834|615897295|FG002|Stage 1|Randomized but not Vaccinated|1|||
170424922|NCT03135834|615897296|FG003|Stage 1|Randomized but not Vaccinated|6|||
170424923|NCT03135834|615897293|FG000|Stage 2|Lost to Follow-up|0|||
170424924|NCT03135834|615897294|FG001|Stage 2|Lost to Follow-up|1|||
170424925|NCT03135834|615897295|FG002|Stage 2|Lost to Follow-up|0|||
170424926|NCT03135834|615897296|FG003|Stage 2|Lost to Follow-up|0|||
170424927|NCT03135834|615897293|FG000|Stage 2|Withdrawal by Subject|0|||
170424928|NCT03135834|615897294|FG001|Stage 2|Withdrawal by Subject|1|||
170424929|NCT03135834|615897295|FG002|Stage 2|Withdrawal by Subject|0|||
170424930|NCT03135834|615897296|FG003|Stage 2|Withdrawal by Subject|0|||
170424931|NCT03135834|615897293|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
170424932|NCT03135834|615897294|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
170424933|NCT03135834|615897295|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
170424934|NCT03135834|615897296|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
170424935|NCT03135834|615897293|FG000|Stage 2|Did not receive Booster Vaccination|1|||
170424936|NCT03135834|615897294|FG001|Stage 2|Did not receive Booster Vaccination|1|||
170424937|NCT03135834|615897295|FG002|Stage 2|Did not receive Booster Vaccination|0|||
170424938|NCT03135834|615897296|FG003|Stage 2|Did not receive Booster Vaccination|0|||
170424939|NCT00214422|615897299|FG000|Overall Study|Physician Decision|2|||
170424940|NCT00214422|615897300|FG001|Overall Study|Physician Decision|0|||
170424941|NCT00214422|615897301|FG002|Overall Study|Physician Decision|0|||
170424942|NCT00214422|615897299|FG000|Overall Study|Developed esophageal ca|1|||
170424943|NCT00214422|615897300|FG001|Overall Study|Developed esophageal ca|0|||
170424944|NCT00214422|615897301|FG002|Overall Study|Developed esophageal ca|0|||
170424945|NCT00214422|615897299|FG000|Overall Study|Pt taken off study|1|||
170424946|NCT00214422|615897300|FG001|Overall Study|Pt taken off study|1|||
170424947|NCT00214422|615897301|FG002|Overall Study|Pt taken off study|0|||
170424948|NCT00214422|615897299|FG000|Overall Study|Disease progression on study|1|||
170424949|NCT00214422|615897300|FG001|Overall Study|Disease progression on study|0|||
170879409|NCT03775421|617569268|FG000|Overall Study|Physician Decision|3|||
170424950|NCT00214422|615897301|FG002|Overall Study|Disease progression on study|0|||
170424951|NCT00214422|615897299|FG000|Overall Study|Unable to make a radiation treatment|0|||
170424952|NCT00214422|615897300|FG001|Overall Study|Unable to make a radiation treatment|0|||
170424953|NCT00214422|615897301|FG002|Overall Study|Unable to make a radiation treatment|1|||
170424954|NCT03125200|615897306|FG000|Overall Study|Study Termination|0|||
170424955|NCT03125200|615897307|FG001|Overall Study|Study Termination|0|||
170424956|NCT03125200|615897308|FG002|Overall Study|Study Termination|0|||
170424957|NCT03125200|615897309|FG003|Overall Study|Study Termination|1|||
170424958|NCT03125200|615897310|FG004|Overall Study|Study Termination|1|||
170424959|NCT03125200|615897311|FG005|Overall Study|Study Termination|2|||
170424960|NCT03125200|615897312|FG006|Overall Study|Study Termination|1|||
170424961|NCT03125200|615897306|FG000|Overall Study|Clinical Progression|0|||
170424962|NCT03125200|615897307|FG001|Overall Study|Clinical Progression|0|||
170424963|NCT03125200|615897308|FG002|Overall Study|Clinical Progression|0|||
170424964|NCT03125200|615897309|FG003|Overall Study|Clinical Progression|1|||
170424965|NCT03125200|615897310|FG004|Overall Study|Clinical Progression|0|||
170424966|NCT03125200|615897311|FG005|Overall Study|Clinical Progression|1|||
170424967|NCT03125200|615897312|FG006|Overall Study|Clinical Progression|0|||
170424968|NCT03125200|615897306|FG000|Overall Study|Progressive Disease|2|||
170424969|NCT03125200|615897307|FG001|Overall Study|Progressive Disease|1|||
170424970|NCT03125200|615897308|FG002|Overall Study|Progressive Disease|2|||
170424971|NCT03125200|615897309|FG003|Overall Study|Progressive Disease|1|||
170424972|NCT03125200|615897310|FG004|Overall Study|Progressive Disease|2|||
170424973|NCT03125200|615897311|FG005|Overall Study|Progressive Disease|0|||
170424974|NCT03125200|615897312|FG006|Overall Study|Progressive Disease|1|||
170424975|NCT03125200|615897306|FG000|Overall Study|Lack of Efficacy|0|||
170424976|NCT03125200|615897307|FG001|Overall Study|Lack of Efficacy|0|||
170424977|NCT03125200|615897308|FG002|Overall Study|Lack of Efficacy|0|||
170424978|NCT03125200|615897309|FG003|Overall Study|Lack of Efficacy|1|||
170424979|NCT03125200|615897310|FG004|Overall Study|Lack of Efficacy|0|||
170424980|NCT03125200|615897311|FG005|Overall Study|Lack of Efficacy|0|||
170424981|NCT03125200|615897312|FG006|Overall Study|Lack of Efficacy|0|||
170424982|NCT03125200|615897306|FG000|Overall Study|Toxicity|0|||
170424983|NCT03125200|615897307|FG001|Overall Study|Toxicity|0|||
170424984|NCT03125200|615897308|FG002|Overall Study|Toxicity|0|||
170879410|NCT03775421|617569268|FG000|Overall Study|Death|1|||
170879411|NCT03775421|617569268|FG000|Overall Study|Study Terminated by Sponsor|94|||
170424985|NCT03125200|615897309|FG003|Overall Study|Toxicity|1|||
170424986|NCT03125200|615897310|FG004|Overall Study|Toxicity|0|||
170424987|NCT03125200|615897311|FG005|Overall Study|Toxicity|0|||
170424988|NCT03125200|615897312|FG006|Overall Study|Toxicity|0|||
170424989|NCT03125200|615897306|FG000|Overall Study|Consent Withdrawn by Subject|0|||
170424990|NCT03125200|615897307|FG001|Overall Study|Consent Withdrawn by Subject|1|||
170424991|NCT03125200|615897308|FG002|Overall Study|Consent Withdrawn by Subject|0|||
170424992|NCT03125200|615897309|FG003|Overall Study|Consent Withdrawn by Subject|0|||
170424993|NCT03125200|615897310|FG004|Overall Study|Consent Withdrawn by Subject|1|||
170424994|NCT03125200|615897311|FG005|Overall Study|Consent Withdrawn by Subject|0|||
170424995|NCT03125200|615897312|FG006|Overall Study|Consent Withdrawn by Subject|1|||
170424996|NCT00119379|615897313|FG000|Overall Study|Adverse Event|4|||
170424997|NCT00119379|615897314|FG001|Overall Study|Adverse Event|1|||
170424998|NCT03544138|615897318|FG000|Overall Study|Lost to Follow-up|29|||
170424999|NCT01469546|615897321|FG000|Received 5 mg Dose|Adverse Event|13|||
170425000|NCT01469546|615897321|FG000|Received 5 mg Dose|Death|2|||
170425001|NCT01469546|615897321|FG000|Received 5 mg Dose|Protocol Violation|2|||
170425002|NCT01469546|615897321|FG000|Received 5 mg Dose|Progressive Disease|3|||
170425003|NCT01469546|615897321|FG000|Received 5 mg Dose|Physician Decision|3|||
170425004|NCT02131129|615897322|FG000|Overall Study|Withdrawal by Subject|1|||
170533757|NCT01056536|616300703|FG001|Overall Study|Lost to Follow-up|116|||
170879412|NCT00135668|617569269|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
170879413|NCT00135668|617569270|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
170425005|NCT02131129|615897323|FG001|Overall Study|Withdrawal by Subject|0|||
170425006|NCT02865122|615897324|FG000|Overall Study|Adverse Event|1|||
170425007|NCT02865122|615897325|FG001|Overall Study|Adverse Event|0|||
170425008|NCT02865122|615897326|FG002|Overall Study|Adverse Event|0|||
170425009|NCT03235739|615899082|FG000|Overall Study|Withdrawal by Subject|2|||
170425010|NCT03235739|615899083|FG001|Overall Study|Withdrawal by Subject|2|||
170425011|NCT03235739|615899082|FG000|Overall Study|Physician Decision|0|||
170425012|NCT03235739|615899083|FG001|Overall Study|Physician Decision|1|||
170425013|NCT02847650|615899084|FG000|Overall Study|Adverse Event|2|||
170425014|NCT02847650|615899085|FG001|Overall Study|Adverse Event|4|||
170425015|NCT02847650|615899084|FG000|Overall Study|Lost to Follow-up|1|||
170425016|NCT02847650|615899085|FG001|Overall Study|Lost to Follow-up|0|||
170533758|NCT01056536|616300704|FG002|Overall Study|Lost to Follow-up|248|||
170425017|NCT02847650|615899084|FG000|Overall Study|Protocol Violation|0|||
170425018|NCT02847650|615899085|FG001|Overall Study|Protocol Violation|1|||
170879414|NCT00135668|617569271|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
170879415|NCT00135668|617569272|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
170425019|NCT02847650|615899084|FG000|Overall Study|Withdrawal by Subject|1|||
170425020|NCT02847650|615899085|FG001|Overall Study|Withdrawal by Subject|1|||
170425021|NCT00467896|615899086|FG000|Overall Study|Consent Withdrawal|18|||
170425022|NCT00467896|615899086|FG000|Overall Study|Adverse Event|7|||
170425023|NCT00467896|615899086|FG000|Overall Study|Serious Adverse Event|13|||
170425024|NCT00467896|615899086|FG000|Overall Study|Non-compliance|3|||
170425025|NCT00467896|615899086|FG000|Overall Study|Changed therapy|2|||
170425026|NCT00467896|615899086|FG000|Overall Study|Patient received transplant|2|||
170425027|NCT00467896|615899086|FG000|Overall Study|Patient had atrial septostomy|1|||
170425028|NCT00467896|615899086|FG000|Overall Study|Patient weaned off iloprost|1|||
170425029|NCT00467896|615899086|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
170425030|NCT00467896|615899086|FG000|Overall Study|Started intravenous prostacyclin|1|||
170425031|NCT00467896|615899086|FG000|Overall Study|Started inhaled Remodulin|1|||
170425032|NCT00467896|615899086|FG000|Overall Study|Patient had no improvement|1|||
170425033|NCT03818581|615899087|FG000|Overall Study|Adverse Event|1|||
170425034|NCT03818581|615899088|FG001|Overall Study|Adverse Event|0|||
170425035|NCT03818581|615899089|FG002|Overall Study|Adverse Event|0|||
170425036|NCT03818581|615899090|FG003|Overall Study|Adverse Event|0|||
170425037|NCT03818581|615899091|FG004|Overall Study|Adverse Event|0|||
170425038|NCT03818581|615899087|FG000|Overall Study|Covid-19|2|||
170425039|NCT03818581|615899088|FG001|Overall Study|Covid-19|0|||
170425040|NCT03818581|615899089|FG002|Overall Study|Covid-19|0|||
170425041|NCT03818581|615899090|FG003|Overall Study|Covid-19|0|||
170425042|NCT03818581|615899091|FG004|Overall Study|Covid-19|1|||
170425043|NCT03818581|615899087|FG000|Overall Study|Withdrawal by Subject|0|||
170425044|NCT03818581|615899088|FG001|Overall Study|Withdrawal by Subject|0|||
170425045|NCT03818581|615899089|FG002|Overall Study|Withdrawal by Subject|0|||
170425046|NCT03818581|615899090|FG003|Overall Study|Withdrawal by Subject|0|||
170425047|NCT03818581|615899091|FG004|Overall Study|Withdrawal by Subject|1|||
170425048|NCT03818581|615899087|FG000|Overall Study|No longer met study criteria|0|||
170425049|NCT03818581|615899088|FG001|Overall Study|No longer met study criteria|0|||
170425050|NCT03818581|615899089|FG002|Overall Study|No longer met study criteria|0|||
170425051|NCT03818581|615899090|FG003|Overall Study|No longer met study criteria|0|||
170425052|NCT03818581|615899091|FG004|Overall Study|No longer met study criteria|1|||
170425053|NCT01811953|615899094|FG000|Overall Study|Adverse Event|0|||
170425054|NCT01811953|615899095|FG001|Overall Study|Adverse Event|0|||
170425055|NCT01811953|615899096|FG002|Overall Study|Adverse Event|0|||
170425056|NCT01811953|615899097|FG003|Overall Study|Adverse Event|1|||
170425057|NCT01811953|615899098|FG004|Overall Study|Adverse Event|0|||
170425058|NCT01811953|615899099|FG005|Overall Study|Adverse Event|1|||
170425059|NCT01811953|615899094|FG000|Overall Study|Protocol Violation|0|||
170425060|NCT01811953|615899095|FG001|Overall Study|Protocol Violation|0|||
170425061|NCT01811953|615899096|FG002|Overall Study|Protocol Violation|0|||
170425062|NCT01811953|615899097|FG003|Overall Study|Protocol Violation|0|||
170425063|NCT01811953|615899098|FG004|Overall Study|Protocol Violation|1|||
170425064|NCT01811953|615899099|FG005|Overall Study|Protocol Violation|0|||
170425065|NCT00520130|615899102|FG000|Overall Study|Disease progression on study|4|||
170425066|NCT00520130|615899103|FG001|Overall Study|Disease progression on study|0|||
170425067|NCT00520130|615899102|FG000|Overall Study|Physician Decision|1|||
170425068|NCT00520130|615899103|FG001|Overall Study|Physician Decision|1|||
170425069|NCT00667862|615899104|FG000|Overall Study|Adverse Event|9|||
170425070|NCT00667862|615899104|FG000|Overall Study|Death|1|||
170425071|NCT00667862|615899104|FG000|Overall Study|Disease Progression|22|||
170425072|NCT00667862|615899104|FG000|Overall Study|Withdrawal by Subject|3|||
170425073|NCT00830206|615899106|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
170425074|NCT00830206|615899107|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
170425075|NCT04089735|615899114|FG000|Overall Study|Adverse Event|1|||
170425076|NCT04089735|615899115|FG001|Overall Study|Adverse Event|0|||
170425077|NCT04089735|615899116|FG002|Overall Study|Adverse Event|1|||
170425078|NCT04089735|615899117|FG003|Overall Study|Adverse Event|1|||
170425079|NCT04089735|615899118|FG004|Overall Study|Adverse Event|0|||
170425080|NCT04089735|615899119|FG005|Overall Study|Adverse Event|0|||
170425081|NCT04089735|615899114|FG000|Overall Study|Physician Decision|0|||
170425082|NCT04089735|615899115|FG001|Overall Study|Physician Decision|3|||
170425083|NCT04089735|615899116|FG002|Overall Study|Physician Decision|0|||
170425084|NCT04089735|615899117|FG003|Overall Study|Physician Decision|0|||
170425085|NCT04089735|615899118|FG004|Overall Study|Physician Decision|0|||
170425086|NCT04089735|615899119|FG005|Overall Study|Physician Decision|0|||
170425087|NCT04089735|615899114|FG000|Overall Study|Withdrawal by Subject|0|||
170425088|NCT04089735|615899115|FG001|Overall Study|Withdrawal by Subject|0|||
170425089|NCT04089735|615899116|FG002|Overall Study|Withdrawal by Subject|1|||
170425090|NCT04089735|615899117|FG003|Overall Study|Withdrawal by Subject|0|||
170425091|NCT04089735|615899118|FG004|Overall Study|Withdrawal by Subject|0|||
170425092|NCT04089735|615899119|FG005|Overall Study|Withdrawal by Subject|0|||
170425093|NCT04089735|615899114|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
170425094|NCT04089735|615899115|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
170425095|NCT04089735|615899116|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
170425096|NCT04089735|615899117|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
170425097|NCT04089735|615899118|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
170425098|NCT04089735|615899119|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
170425099|NCT02736721|615899126|FG000|Overall Study|Adverse Event|8|||
170533759|NCT00284856|616300705|FG000|Overall Study|Adverse Event|3|||
170533760|NCT00284856|616300706|FG001|Overall Study|Adverse Event|3|||
170533761|NCT00284856|616300707|FG002|Overall Study|Adverse Event|3|||
170425100|NCT02736721|615899126|FG000|Overall Study|Lost to Follow-up|3|||
170425101|NCT02736721|615899126|FG000|Overall Study|Other|5|||
170425102|NCT02956460|615899127|FG000|Lens 1|Lost to Follow-up|1|||
170425103|NCT02956460|615899128|FG001|Lens 1|Lost to Follow-up|0|||
170425104|NCT00834249|615899130|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
170425105|NCT00834249|615899131|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
170425106|NCT00834249|615899130|FG000|Second Intervention|Adverse Event|1|||
170425107|NCT00834249|615899131|FG001|Second Intervention|Adverse Event|0|||
170879416|NCT01227044|617569274|FG000|Overall Study|Lost to Follow-up|5|||
170879417|NCT01227044|617569275|FG001|Overall Study|Lost to Follow-up|7|||
170879418|NCT01227044|617569274|FG000|Overall Study|Discontinued Intervention|1|||
170879419|NCT01227044|617569275|FG001|Overall Study|Discontinued Intervention|2|||
170879420|NCT00583362|617569278|FG000|Overall Study|Adverse Event|44|||
170879421|NCT00583362|617569278|FG000|Overall Study|Lack of Efficacy|22|||
170879422|NCT00583362|617569278|FG000|Overall Study|Lost to Follow-up|4|||
170879423|NCT00583362|617569278|FG000|Overall Study|Non-compliance with study drug|28|||
170879424|NCT00583362|617569278|FG000|Overall Study|Pregnancy|7|||
170879425|NCT00583362|617569278|FG000|Overall Study|Miscommunication of visit window|5|||
170879426|NCT00583362|617569278|FG000|Overall Study|Current site closed|7|||
170879427|NCT00583362|617569278|FG000|Overall Study|Subject not dosed in LBSL99|1|||
170879428|NCT00583362|617569278|FG000|Overall Study|Subject moved out of the country/state|2|||
170879429|NCT00583362|617569278|FG000|Overall Study|Missed visits due to staff changes|1|||
170879430|NCT00583362|617569278|FG000|Overall Study|Misunderstanding of protocol|1|||
170879431|NCT00583362|617569278|FG000|Overall Study|Behavioral problems and non-compliance|1|||
170879432|NCT00583362|617569278|FG000|Overall Study|Sponsor request due to missed doses|1|||
170879433|NCT00583362|617569278|FG000|Overall Study|Physician Decision|19|||
170879434|NCT00583362|617569278|FG000|Overall Study|Protocol Violation|2|||
170879435|NCT00583362|617569278|FG000|Overall Study|Withdrawal by Subject|57|||
170879436|NCT02370615|617569281|FG000|Overall Study|Adverse Event|1|||
170879437|NCT02370615|617569282|FG001|Overall Study|Adverse Event|0|||
170879438|NCT03715153|617569286|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
170879439|NCT03715153|617569287|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
170879440|NCT03715153|617569286|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
170879441|NCT03715153|617569287|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
170879442|NCT03715153|617569286|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
170879443|NCT03715153|617569287|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
170879444|NCT03715153|617569286|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
170879445|NCT03715153|617569287|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
170879446|NCT03715153|617569286|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
170879447|NCT03715153|617569287|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
170879448|NCT03715153|617569286|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
170879449|NCT03715153|617569287|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
170879450|NCT02287623|617569288|FG000|Overall Study|Protocol Violation|0|||
170879451|NCT02287623|617569289|FG001|Overall Study|Protocol Violation|1|||
170879452|NCT00205855|617569290|FG000|Overall Study|Only received temporary implants|16|||
170879453|NCT00205855|617569290|FG000|Overall Study|Withdrawal by Subject|5|||
170879454|NCT03610724|617569293|FG000|Overall Study|Death|17|||
170879455|NCT03610724|617569293|FG000|Overall Study|Lost to Follow-up|1|||
170879456|NCT03610724|617569293|FG000|Overall Study|Physician Decision|1|||
170879457|NCT03610724|617569293|FG000|Overall Study|Died prior to infusion|1|||
170879458|NCT01473563|617569294|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
170879459|NCT02739620|617569295|FG000|Overall Study|Lost to Follow-up|3|||
170879460|NCT02739620|617569296|FG001|Overall Study|Lost to Follow-up|1|||
170879461|NCT02739620|617569295|FG000|Overall Study|Adverse Event|0|||
170879462|NCT02739620|617569296|FG001|Overall Study|Adverse Event|1|||
170879463|NCT00786565|617569297|FG000|Enrollment Prior to Surgery|Site Closed|3|||
170879464|NCT00786565|617569297|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
170879465|NCT00786565|617569297|FG000|Post Surgery|Abnormal macular pucker|1|||
170879466|NCT00786565|617569297|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
170879467|NCT02943564|617569299|FG000|Overall Study|Miscellaneous Reasons|0|||
170879468|NCT02943564|617569300|FG001|Overall Study|Miscellaneous Reasons|0|||
170879469|NCT02943564|617569301|FG002|Overall Study|Miscellaneous Reasons|3|||
170879470|NCT02943564|617569299|FG000|Overall Study|Site terminated by sponsor|0|||
170879471|NCT02943564|617569300|FG001|Overall Study|Site terminated by sponsor|1|||
170425108|NCT00851877|615899132|FG000|Phase I-1|Death|1|||
170425109|NCT00851877|615899133|FG001|Phase I-1|Death|0|||
170879472|NCT02943564|617569301|FG002|Overall Study|Site terminated by sponsor|0|||
170879473|NCT02943564|617569299|FG000|Overall Study|Non-compliance with study drug|0|||
170879474|NCT02943564|617569300|FG001|Overall Study|Non-compliance with study drug|1|||
170879475|NCT02943564|617569301|FG002|Overall Study|Non-compliance with study drug|0|||
170425110|NCT00851877|615899134|FG002|Phase I-1|Death|0|||
170533762|NCT00284856|616300705|FG000|Overall Study|Lack of Efficacy|2|||
170533763|NCT00284856|616300706|FG001|Overall Study|Lack of Efficacy|1|||
170425111|NCT00851877|615899132|FG000|Phase II|Withdrawal by Subject|0|||
170425112|NCT00851877|615899133|FG001|Phase II|Withdrawal by Subject|0|||
170425113|NCT00851877|615899134|FG002|Phase II|Withdrawal by Subject|3|||
170425114|NCT00573066|615899135|FG000|Overall Study|Exclusion criteria|18|||
170425115|NCT00573066|615899135|FG000|Overall Study|IV malfunction|1|||
170425116|NCT00573066|615899135|FG000|Overall Study|Postoperative bleeding|1|||
170425117|NCT04129346|615899136|FG000|Overall Study|Death|1|||
170425118|NCT04129346|615899137|FG001|Overall Study|Death|0|||
170425119|NCT05755282|615899138|FG000|Overall Study|Protocol Violation|0|||
170425120|NCT05755282|615899139|FG001|Overall Study|Protocol Violation|1|||
170425121|NCT00834743|615899140|FG000|Second Intervention|Withdrawal by Subject|1|||
170425122|NCT00834743|615899141|FG001|Second Intervention|Withdrawal by Subject|0|||
170425123|NCT01534663|615899142|FG000|Overall Study|Lost to Follow-up|0|||
170425124|NCT01534663|615899143|FG001|Overall Study|Lost to Follow-up|2|||
170425125|NCT01534663|615899142|FG000|Overall Study|Adverse Event|2|||
170425126|NCT01534663|615899143|FG001|Overall Study|Adverse Event|1|||
170425127|NCT01038856|615899144|FG000|Overall Study|Adverse Event|2|||
170425128|NCT04112823|615899145|FG000|Overall Study|Lost to Follow-up|2|||
170425129|NCT04112823|615899146|FG001|Overall Study|Lost to Follow-up|3|||
170425130|NCT01693523|615899147|FG000|Overall Study|Adverse Event|2|||
170425131|NCT01693523|615899148|FG001|Overall Study|Adverse Event|1|||
170425132|NCT01693523|615899149|FG002|Overall Study|Adverse Event|0|||
170425133|NCT01693523|615899147|FG000|Overall Study|Death|0|||
170425134|NCT01693523|615899148|FG001|Overall Study|Death|1|||
170425135|NCT01693523|615899149|FG002|Overall Study|Death|1|||
170425136|NCT01693523|615899147|FG000|Overall Study|Lost to Follow-up|0|||
170425137|NCT01693523|615899148|FG001|Overall Study|Lost to Follow-up|0|||
170425138|NCT01693523|615899149|FG002|Overall Study|Lost to Follow-up|4|||
170425139|NCT01693523|615899147|FG000|Overall Study|Physician Decision|0|||
170425140|NCT01693523|615899148|FG001|Overall Study|Physician Decision|0|||
170425141|NCT01693523|615899149|FG002|Overall Study|Physician Decision|1|||
170425142|NCT01693523|615899147|FG000|Overall Study|Withdrawal by Subject|1|||
170425143|NCT01693523|615899148|FG001|Overall Study|Withdrawal by Subject|2|||
170425144|NCT01693523|615899149|FG002|Overall Study|Withdrawal by Subject|2|||
170425145|NCT01693523|615899147|FG000|Overall Study|Lack of compliance study medication|1|||
170425146|NCT01693523|615899148|FG001|Overall Study|Lack of compliance study medication|2|||
170425147|NCT01693523|615899149|FG002|Overall Study|Lack of compliance study medication|0|||
170425148|NCT01693523|615899147|FG000|Overall Study|Chemotherapy was held|1|||
170425149|NCT01693523|615899148|FG001|Overall Study|Chemotherapy was held|2|||
170425150|NCT01693523|615899149|FG002|Overall Study|Chemotherapy was held|0|||
170425151|NCT00064753|615899150|FG000|Overall Study|Death|251|||
170425152|NCT00064753|615899151|FG001|Overall Study|Death|242|||
170425153|NCT00064753|615899150|FG000|Overall Study|Withdrawal by Subject|198|||
170425154|NCT00064753|615899151|FG001|Overall Study|Withdrawal by Subject|171|||
170425155|NCT00064753|615899150|FG000|Overall Study|Lost to Follow-up|225|||
170425156|NCT00064753|615899151|FG001|Overall Study|Lost to Follow-up|235|||
170425157|NCT02457520|615899155|FG000|Active Treatment Phase|Adverse Event|10|||
170425158|NCT02457520|615899155|FG000|Active Treatment Phase|Lost to Follow-up|8|||
170425159|NCT02457520|615899155|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
170425160|NCT02457520|615899155|FG000|Active Treatment Phase|other|4|||
170425161|NCT02457520|615899155|FG000|Active Treatment Phase|Physician Decision|1|||
170425162|NCT02457520|615899155|FG000|Active Treatment Phase|Protocol Violation|1|||
170425163|NCT02457520|615899155|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
170425164|NCT02457520|615899155|FG000|Post-treatment Period|Other: Retreatment Required|7|||
170425165|NCT02457520|615899155|FG000|Post-treatment Period|Lost to Follow-up|23|||
170425166|NCT02457520|615899155|FG000|Post-treatment Period|Other|3|||
170425167|NCT02457520|615899155|FG000|Post-treatment Period|Physician Decision|1|||
170425168|NCT02457520|615899155|FG000|Post-treatment Period|Withdrawal by Subject|14|||
170425169|NCT02587962|615899156|FG000|Overall Study|Adverse Event|0|||
170425170|NCT02587962|615899157|FG001|Overall Study|Adverse Event|0|||
170425171|NCT02587962|615899158|FG002|Overall Study|Adverse Event|1|||
170425172|NCT02587962|615899159|FG003|Overall Study|Adverse Event|0|||
170425173|NCT02587962|615899160|FG004|Overall Study|Adverse Event|0|||
170425174|NCT02587962|615899156|FG000|Overall Study|Withdrawal by Subject|0|||
170533764|NCT00284856|616300707|FG002|Overall Study|Lack of Efficacy|8|||
170533765|NCT00284856|616300705|FG000|Overall Study|Lost to Follow-up|25|||
170425175|NCT02587962|615899157|FG001|Overall Study|Withdrawal by Subject|0|||
170425176|NCT02587962|615899158|FG002|Overall Study|Withdrawal by Subject|1|||
170425177|NCT02587962|615899159|FG003|Overall Study|Withdrawal by Subject|1|||
170425178|NCT02587962|615899160|FG004|Overall Study|Withdrawal by Subject|4|||
170425179|NCT02587962|615899156|FG000|Overall Study|Radiological progression|2|||
170425180|NCT02587962|615899157|FG001|Overall Study|Radiological progression|2|||
170425181|NCT02587962|615899158|FG002|Overall Study|Radiological progression|2|||
170533766|NCT00284856|616300706|FG001|Overall Study|Lost to Follow-up|21|||
170425182|NCT02587962|615899159|FG003|Overall Study|Radiological progression|5|||
170425183|NCT02587962|615899160|FG004|Overall Study|Radiological progression|10|||
170425184|NCT02587962|615899156|FG000|Overall Study|Clinical progression|0|||
170533767|NCT00284856|616300707|FG002|Overall Study|Lost to Follow-up|22|||
170879476|NCT02943564|617569299|FG000|Overall Study|Pregnancy|0|||
170533768|NCT00284856|616300705|FG000|Overall Study|Protocol Violation|5|||
170533769|NCT00284856|616300706|FG001|Overall Study|Protocol Violation|4|||
170879477|NCT02943564|617569300|FG001|Overall Study|Pregnancy|1|||
170879478|NCT02943564|617569301|FG002|Overall Study|Pregnancy|1|||
170879479|NCT02943564|617569299|FG000|Overall Study|Protocol Violation|2|||
170879480|NCT02943564|617569300|FG001|Overall Study|Protocol Violation|2|||
170879481|NCT02943564|617569301|FG002|Overall Study|Protocol Violation|2|||
170879482|NCT02943564|617569299|FG000|Overall Study|Lost to Follow-up|1|||
170879483|NCT02943564|617569300|FG001|Overall Study|Lost to Follow-up|0|||
170879484|NCT02943564|617569301|FG002|Overall Study|Lost to Follow-up|0|||
170879485|NCT02943564|617569299|FG000|Overall Study|Withdrawal by Subject|6|||
170533770|NCT00284856|616300707|FG002|Overall Study|Protocol Violation|5|||
170533771|NCT00284856|616300705|FG000|Overall Study|Withdrawal by Subject|12|||
170533772|NCT00284856|616300706|FG001|Overall Study|Withdrawal by Subject|16|||
170533773|NCT00284856|616300707|FG002|Overall Study|Withdrawal by Subject|18|||
170533774|NCT00284856|616300705|FG000|Overall Study|Other|4|||
170533775|NCT00284856|616300706|FG001|Overall Study|Other|5|||
170533776|NCT00284856|616300707|FG002|Overall Study|Other|4|||
170533777|NCT03034967|616300708|FG000|Overall Study|Withdrawal by Subject|9|||
170533778|NCT03034967|616300709|FG001|Overall Study|Withdrawal by Subject|2|||
170533779|NCT03034967|616300710|FG002|Overall Study|Withdrawal by Subject|6|||
170533780|NCT03034967|616300711|FG003|Overall Study|Withdrawal by Subject|6|||
170533781|NCT03034967|616300712|FG004|Overall Study|Withdrawal by Subject|9|||
170533782|NCT03034967|616300713|FG005|Overall Study|Withdrawal by Subject|2|||
170533783|NCT03034967|616300708|FG000|Overall Study|Physician Decision|1|||
170533784|NCT03034967|616300709|FG001|Overall Study|Physician Decision|0|||
170533785|NCT03034967|616300710|FG002|Overall Study|Physician Decision|1|||
170533786|NCT03034967|616300711|FG003|Overall Study|Physician Decision|1|||
170533787|NCT03034967|616300712|FG004|Overall Study|Physician Decision|1|||
170533788|NCT03034967|616300713|FG005|Overall Study|Physician Decision|0|||
170533789|NCT03034967|616300708|FG000|Overall Study|Lost to Follow-up|0|||
170533790|NCT03034967|616300709|FG001|Overall Study|Lost to Follow-up|0|||
170533791|NCT03034967|616300710|FG002|Overall Study|Lost to Follow-up|0|||
170533792|NCT03034967|616300711|FG003|Overall Study|Lost to Follow-up|1|||
170533793|NCT03034967|616300712|FG004|Overall Study|Lost to Follow-up|0|||
170533794|NCT03034967|616300713|FG005|Overall Study|Lost to Follow-up|2|||
170533795|NCT03034967|616300708|FG000|Overall Study|Liver function test abnormality|0|||
170533796|NCT03034967|616300709|FG001|Overall Study|Liver function test abnormality|0|||
170533797|NCT03034967|616300710|FG002|Overall Study|Liver function test abnormality|1|||
170533798|NCT03034967|616300711|FG003|Overall Study|Liver function test abnormality|0|||
170533799|NCT03034967|616300712|FG004|Overall Study|Liver function test abnormality|0|||
170533800|NCT03034967|616300713|FG005|Overall Study|Liver function test abnormality|0|||
170533801|NCT03034967|616300708|FG000|Overall Study|Protocol Violation|1|||
170533802|NCT03034967|616300709|FG001|Overall Study|Protocol Violation|0|||
170533803|NCT03034967|616300710|FG002|Overall Study|Protocol Violation|0|||
170533804|NCT03034967|616300711|FG003|Overall Study|Protocol Violation|0|||
170533805|NCT03034967|616300712|FG004|Overall Study|Protocol Violation|0|||
170533806|NCT03034967|616300713|FG005|Overall Study|Protocol Violation|2|||
170533807|NCT03034967|616300708|FG000|Overall Study|Lack of Efficacy|0|||
170533808|NCT03034967|616300709|FG001|Overall Study|Lack of Efficacy|1|||
170533809|NCT03034967|616300710|FG002|Overall Study|Lack of Efficacy|2|||
170879486|NCT02943564|617569300|FG001|Overall Study|Withdrawal by Subject|5|||
170879487|NCT02943564|617569301|FG002|Overall Study|Withdrawal by Subject|2|||
170533810|NCT03034967|616300711|FG003|Overall Study|Lack of Efficacy|1|||
170533811|NCT03034967|616300712|FG004|Overall Study|Lack of Efficacy|1|||
170533812|NCT03034967|616300713|FG005|Overall Study|Lack of Efficacy|0|||
170533813|NCT03034967|616300708|FG000|Overall Study|Adverse Event, non-fatal|3|||
170533814|NCT03034967|616300709|FG001|Overall Study|Adverse Event, non-fatal|1|||
170533815|NCT03034967|616300710|FG002|Overall Study|Adverse Event, non-fatal|2|||
170533816|NCT03034967|616300711|FG003|Overall Study|Adverse Event, non-fatal|0|||
170879488|NCT02943564|617569299|FG000|Overall Study|Adverse Event|1|||
170533817|NCT03034967|616300712|FG004|Overall Study|Adverse Event, non-fatal|2|||
170879489|NCT02943564|617569300|FG001|Overall Study|Adverse Event|2|||
170533818|NCT03034967|616300713|FG005|Overall Study|Adverse Event, non-fatal|8|||
170533819|NCT03034967|616300708|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
170533820|NCT03034967|616300709|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
170533821|NCT03034967|616300710|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
170879490|NCT02943564|617569301|FG002|Overall Study|Adverse Event|1|||
170879491|NCT02943564|617569299|FG000|Overall Study|Lack of Efficacy|0|||
170879492|NCT02943564|617569300|FG001|Overall Study|Lack of Efficacy|1|||
170879493|NCT02943564|617569301|FG002|Overall Study|Lack of Efficacy|0|||
170879494|NCT04770389|617569302|FG000|Overall Study|Adverse Event|1|||
170879495|NCT04770389|617569303|FG001|Overall Study|Adverse Event|2|||
170879496|NCT04770389|617569304|FG002|Overall Study|Adverse Event|0|||
170879497|NCT04770389|617569305|FG003|Overall Study|Adverse Event|1|||
170879498|NCT04770389|617569302|FG000|Overall Study|Withdrawal by Subject|0|||
170879499|NCT04770389|617569303|FG001|Overall Study|Withdrawal by Subject|2|||
170879500|NCT04770389|617569304|FG002|Overall Study|Withdrawal by Subject|1|||
170879501|NCT04770389|617569305|FG003|Overall Study|Withdrawal by Subject|0|||
170879502|NCT04770389|617569302|FG000|Overall Study|Failed attempt to draw blood|1|||
170879503|NCT04770389|617569303|FG001|Overall Study|Failed attempt to draw blood|0|||
170879504|NCT04770389|617569304|FG002|Overall Study|Failed attempt to draw blood|0|||
170879505|NCT04770389|617569305|FG003|Overall Study|Failed attempt to draw blood|0|||
170879506|NCT04770389|617569302|FG000|Overall Study|Left the country|0|||
170879507|NCT04770389|617569303|FG001|Overall Study|Left the country|0|||
170879508|NCT04770389|617569304|FG002|Overall Study|Left the country|1|||
170879509|NCT04770389|617569305|FG003|Overall Study|Left the country|2|||
170879510|NCT04770389|617569302|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
170879511|NCT04770389|617569303|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
170879512|NCT04770389|617569304|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
170879513|NCT04770389|617569305|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
170879514|NCT04770389|617569302|FG000|Overall Study|Lost to Follow-up|0|||
170879515|NCT04770389|617569303|FG001|Overall Study|Lost to Follow-up|0|||
170425185|NCT02587962|615899157|FG001|Overall Study|Clinical progression|1|||
170425186|NCT02587962|615899158|FG002|Overall Study|Clinical progression|2|||
170425187|NCT02587962|615899159|FG003|Overall Study|Clinical progression|0|||
170425188|NCT02587962|615899160|FG004|Overall Study|Clinical progression|1|||
170425189|NCT00696020|615899162|FG000|Overall Study|Adverse Event|3|||
170425190|NCT00696020|615899163|FG001|Overall Study|Adverse Event|1|||
170425191|NCT00696020|615899164|FG002|Overall Study|Adverse Event|2|||
170425192|NCT00696020|615899165|FG003|Overall Study|Adverse Event|1|||
170425193|NCT00696020|615899162|FG000|Overall Study|Lack of Efficacy|1|||
170425194|NCT00696020|615899163|FG001|Overall Study|Lack of Efficacy|0|||
170425195|NCT00696020|615899164|FG002|Overall Study|Lack of Efficacy|0|||
170425196|NCT00696020|615899165|FG003|Overall Study|Lack of Efficacy|0|||
170425197|NCT00696020|615899162|FG000|Overall Study|Protocol Violation|0|||
170425198|NCT00696020|615899163|FG001|Overall Study|Protocol Violation|0|||
170425199|NCT00696020|615899164|FG002|Overall Study|Protocol Violation|0|||
170425200|NCT00696020|615899165|FG003|Overall Study|Protocol Violation|1|||
170425201|NCT00696020|615899162|FG000|Overall Study|Withdrawal by Subject|0|||
170425202|NCT00696020|615899163|FG001|Overall Study|Withdrawal by Subject|1|||
170425203|NCT00696020|615899164|FG002|Overall Study|Withdrawal by Subject|0|||
170425204|NCT00696020|615899165|FG003|Overall Study|Withdrawal by Subject|1|||
170425205|NCT00696020|615899162|FG000|Overall Study|Other not stated above|0|||
170425206|NCT00696020|615899163|FG001|Overall Study|Other not stated above|0|||
170425207|NCT00696020|615899164|FG002|Overall Study|Other not stated above|1|||
170425208|NCT00696020|615899165|FG003|Overall Study|Other not stated above|1|||
170425209|NCT02770820|615899166|FG000|Overall Study|Death|1|||
170425210|NCT02770820|615899166|FG000|Overall Study|Physician Decision|2|||
170425211|NCT02076022|615899168|FG000|Overall Study|Withdrawal by Subject|2|||
170425212|NCT02076022|615899169|FG001|Overall Study|Withdrawal by Subject|0|||
170425213|NCT00312663|615899172|FG000|Immunization Phase|Adverse Event|0|||
170425214|NCT00312663|615899173|FG001|Immunization Phase|Adverse Event|1|||
170425215|NCT00312663|615899174|FG002|Immunization Phase|Adverse Event|0|||
170425216|NCT00376623|615899175|FG000|Overall Study|Progressive disease|35|||
170425217|NCT00376623|615899176|FG001|Overall Study|Progressive disease|22|||
170425218|NCT00376623|615899177|FG002|Overall Study|Progressive disease|17|||
170879516|NCT04770389|617569304|FG002|Overall Study|Lost to Follow-up|0|||
170879517|NCT04770389|617569305|FG003|Overall Study|Lost to Follow-up|1|||
170879518|NCT04770389|617569302|FG000|Overall Study|Moved away from study site|0|||
170533822|NCT03034967|616300711|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
170879519|NCT04770389|617569303|FG001|Overall Study|Moved away from study site|1|||
170425219|NCT00376623|615899175|FG000|Overall Study|Lost to Follow-up|0|||
170425220|NCT00376623|615899176|FG001|Overall Study|Lost to Follow-up|1|||
170425221|NCT00376623|615899177|FG002|Overall Study|Lost to Follow-up|0|||
170425222|NCT00376623|615899175|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
170879520|NCT04770389|617569304|FG002|Overall Study|Moved away from study site|0|||
170425223|NCT00376623|615899176|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
170425224|NCT00376623|615899177|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
170425225|NCT00376623|615899175|FG000|Overall Study|Not treated with BI 2536|1|||
170425226|NCT00376623|615899176|FG001|Overall Study|Not treated with BI 2536|0|||
170425227|NCT00376623|615899177|FG002|Overall Study|Not treated with BI 2536|0|||
170425228|NCT00376623|615899175|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
170425229|NCT00376623|615899176|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
170425230|NCT00376623|615899177|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
170425231|NCT00376623|615899175|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
170425232|NCT00376623|615899176|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
170425233|NCT00376623|615899177|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
170425234|NCT00376623|615899175|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
170425235|NCT00376623|615899176|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
170425236|NCT00376623|615899177|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
170425237|NCT00376623|615899175|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
170425238|NCT00376623|615899176|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
170425239|NCT00376623|615899177|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
170425240|NCT00376623|615899175|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
170425241|NCT00376623|615899176|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
170425242|NCT00376623|615899177|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
170425243|NCT00376623|615899175|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
170425244|NCT00376623|615899176|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
170425245|NCT00376623|615899177|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
170425246|NCT00376623|615899175|FG000|Overall Study|Increase of tumour markers|0|||
170425247|NCT00376623|615899176|FG001|Overall Study|Increase of tumour markers|1|||
170425248|NCT00376623|615899177|FG002|Overall Study|Increase of tumour markers|0|||
170425249|NCT00376623|615899175|FG000|Overall Study|Bone metastasis|1|||
170425250|NCT00376623|615899176|FG001|Overall Study|Bone metastasis|0|||
170425251|NCT00376623|615899177|FG002|Overall Study|Bone metastasis|0|||
170425252|NCT02726581|615899184|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
170425253|NCT02726581|615899185|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
170425254|NCT02726581|615899186|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
170425255|NCT02726581|615899184|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
170425256|NCT02726581|615899185|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
170425257|NCT02726581|615899186|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
170425258|NCT02726581|615899184|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
170425259|NCT02726581|615899185|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170425260|NCT02726581|615899186|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170425261|NCT02726581|615899184|FG000|Treatment Period|Disease progression|47|||
170425262|NCT02726581|615899185|FG001|Treatment Period|Disease progression|50|||
170425263|NCT02726581|615899186|FG002|Treatment Period|Disease progression|16|||
170425264|NCT02726581|615899184|FG000|Treatment Period|Other reasons|9|||
170425265|NCT02726581|615899185|FG001|Treatment Period|Other reasons|8|||
170425266|NCT02726581|615899186|FG002|Treatment Period|Other reasons|2|||
170425267|NCT02726581|615899184|FG000|Treatment Period|Study drug toxicity|6|||
170425268|NCT02726581|615899185|FG001|Treatment Period|Study drug toxicity|3|||
170425269|NCT02726581|615899186|FG002|Treatment Period|Study drug toxicity|2|||
170425270|NCT02726581|615899184|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
170425271|NCT02726581|615899185|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
170425272|NCT02726581|615899186|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
170425273|NCT02726581|615899184|FG000|Treatment Period|Participant withdrew consent|3|||
170425274|NCT02726581|615899185|FG001|Treatment Period|Participant withdrew consent|1|||
170425275|NCT02726581|615899186|FG002|Treatment Period|Participant withdrew consent|1|||
170425276|NCT02726581|615899184|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
170425277|NCT02726581|615899185|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
170425278|NCT02726581|615899186|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
170425279|NCT02726581|615899184|FG000|Treatment Period|Maximum clinical benefit|0|||
170425280|NCT02726581|615899185|FG001|Treatment Period|Maximum clinical benefit|2|||
170425281|NCT02726581|615899186|FG002|Treatment Period|Maximum clinical benefit|0|||
170425282|NCT02726581|615899184|FG000|Treatment Period|Death|1|||
170425283|NCT02726581|615899185|FG001|Treatment Period|Death|0|||
170425284|NCT02726581|615899186|FG002|Treatment Period|Death|0|||
170425285|NCT02726581|615899184|FG000|Treatment Period|Poor/non-compliance|1|||
170425286|NCT02726581|615899185|FG001|Treatment Period|Poor/non-compliance|0|||
170425287|NCT02726581|615899186|FG002|Treatment Period|Poor/non-compliance|0|||
170632703|NCT02760498|616666743|FG001|Overall Study|Physician Decision|4|||
170879521|NCT04770389|617569305|FG003|Overall Study|Moved away from study site|0|||
170425288|NCT02726581|615899184|FG000|Treatment Period|Participant no longer meets study criteria|0|||
170425289|NCT02726581|615899185|FG001|Treatment Period|Participant no longer meets study criteria|1|||
170425290|NCT02726581|615899186|FG002|Treatment Period|Participant no longer meets study criteria|0|||
170425291|NCT01844375|615899187|FG000|Overall Study|Protocol Violation|1|||
170425292|NCT01844375|615899188|FG001|Overall Study|Protocol Violation|1|||
170425293|NCT03956862|615899189|FG000|Overall Study|Lost to Follow-up|1|||
170425294|NCT03956862|615899190|FG001|Overall Study|Lost to Follow-up|1|||
170425295|NCT03956862|615899189|FG000|Overall Study|Withdrawal by Subject|1|||
170425296|NCT03956862|615899190|FG001|Overall Study|Withdrawal by Subject|1|||
170425297|NCT02294604|615899191|FG000|Overall Study|Did not provide samples for culture|0|||
170425298|NCT02294604|615899192|FG001|Overall Study|Did not provide samples for culture|1|||
170425299|NCT02294604|615899193|FG002|Overall Study|Did not provide samples for culture|0|||
170425300|NCT02294604|615899191|FG000|Overall Study|Culture contamination|1|||
170425301|NCT02294604|615899192|FG001|Overall Study|Culture contamination|2|||
170425302|NCT02294604|615899193|FG002|Overall Study|Culture contamination|0|||
170425303|NCT00467363|615899199|FG000|Overall Study|Lost to Follow-up|80|||
170425304|NCT00467363|615899200|FG001|Overall Study|Lost to Follow-up|70|||
170425305|NCT00473330|615899203|FG000|Core Study|Adverse Event|4|||
170425306|NCT00473330|615899204|FG001|Core Study|Adverse Event|4|||
170425307|NCT00473330|615899205|FG002|Core Study|Adverse Event|1|||
170425308|NCT00473330|615899203|FG000|Core Study|Death|6|||
170425309|NCT00473330|615899204|FG001|Core Study|Death|4|||
170425310|NCT00473330|615899205|FG002|Core Study|Death|4|||
170425311|NCT00473330|615899203|FG000|Core Study|Lost to Follow-up|5|||
170425312|NCT00473330|615899204|FG001|Core Study|Lost to Follow-up|5|||
170425313|NCT00473330|615899205|FG002|Core Study|Lost to Follow-up|10|||
170425314|NCT00473330|615899203|FG000|Core Study|Physician Decision|2|||
170425315|NCT00473330|615899204|FG001|Core Study|Physician Decision|1|||
170425316|NCT00473330|615899205|FG002|Core Study|Physician Decision|3|||
170425317|NCT00473330|615899203|FG000|Core Study|Subject Non-compliance|1|||
170425318|NCT00473330|615899204|FG001|Core Study|Subject Non-compliance|2|||
170425319|NCT00473330|615899205|FG002|Core Study|Subject Non-compliance|1|||
170425320|NCT00473330|615899203|FG000|Core Study|Subject Required Other Therapy|0|||
170425321|NCT00473330|615899204|FG001|Core Study|Subject Required Other Therapy|1|||
170425322|NCT00473330|615899205|FG002|Core Study|Subject Required Other Therapy|3|||
170425323|NCT00473330|615899203|FG000|Core Study|Subject's Decision|9|||
170425324|NCT00473330|615899204|FG001|Core Study|Subject's Decision|8|||
170425325|NCT00473330|615899205|FG002|Core Study|Subject's Decision|19|||
170425326|NCT00473330|615899203|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
170425327|NCT00473330|615899204|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
170425328|NCT00473330|615899205|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
170425329|NCT00473330|615899203|FG000|Open-label Extension Through Month 48|Death|2|||
170425330|NCT00473330|615899204|FG001|Open-label Extension Through Month 48|Death|0|||
170425331|NCT00473330|615899205|FG002|Open-label Extension Through Month 48|Death|0|||
170425332|NCT00473330|615899203|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
170425333|NCT00473330|615899204|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
170425334|NCT00473330|615899205|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
170425335|NCT00473330|615899203|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
170425336|NCT00473330|615899204|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
170425337|NCT00473330|615899205|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
170425338|NCT00473330|615899203|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
170425339|NCT00473330|615899204|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
170425340|NCT00473330|615899205|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
170425341|NCT00473330|615899203|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
170425342|NCT00473330|615899204|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
170425343|NCT00473330|615899205|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
170425344|NCT00473330|615899203|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
170425345|NCT00473330|615899204|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
170425346|NCT00473330|615899205|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
170425347|NCT00473330|615899203|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
170425348|NCT00473330|615899204|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
170425349|NCT00473330|615899205|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
170425350|NCT00473330|615899203|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
170425351|NCT00473330|615899204|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
170425352|NCT00473330|615899205|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
170425353|NCT00473330|615899203|FG000|Open-label Extension Through Month 60|Death|2|||
170425354|NCT00473330|615899204|FG001|Open-label Extension Through Month 60|Death|2|||
170425355|NCT00473330|615899205|FG002|Open-label Extension Through Month 60|Death|1|||
170425356|NCT00473330|615899203|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
170425357|NCT00473330|615899204|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
170632704|NCT02760498|616666744|FG002|Overall Study|Physician Decision|1|||
170425358|NCT00473330|615899205|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
170425359|NCT00473330|615899203|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
170425360|NCT00473330|615899204|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
170425361|NCT00473330|615899205|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
170425362|NCT00473330|615899203|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
170425363|NCT00473330|615899204|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
170425364|NCT00473330|615899205|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
170425365|NCT00473330|615899203|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
170425366|NCT00473330|615899204|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
170425367|NCT00473330|615899205|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
170425368|NCT00473330|615899203|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
170425369|NCT00473330|615899204|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
170425370|NCT00473330|615899205|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
170425371|NCT00473330|615899203|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
170425372|NCT00473330|615899204|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
170425373|NCT00473330|615899205|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
170425374|NCT01975948|615899206|FG000|Overall Study|Withdrawal by Subject|17|||
170425375|NCT01975948|615899207|FG001|Overall Study|Withdrawal by Subject|21|||
170425376|NCT01975948|615899208|FG002|Overall Study|Withdrawal by Subject|7|||
170425377|NCT01975948|615899209|FG003|Overall Study|Withdrawal by Subject|6|||
170425378|NCT03965091|615899210|FG000|Overall Study|Adverse Event|0|||
170425379|NCT03965091|615899211|FG001|Overall Study|Adverse Event|2|||
170425380|NCT03965091|615899212|FG002|Overall Study|Adverse Event|3|||
170425381|NCT03965091|615899210|FG000|Overall Study|Withdrawal by Subject|11|||
170425382|NCT03965091|615899211|FG001|Overall Study|Withdrawal by Subject|3|||
170425383|NCT03965091|615899212|FG002|Overall Study|Withdrawal by Subject|5|||
170425384|NCT03965091|615899210|FG000|Overall Study|Non-compliance with study drug|0|||
170425385|NCT03965091|615899211|FG001|Overall Study|Non-compliance with study drug|0|||
170425386|NCT03965091|615899212|FG002|Overall Study|Non-compliance with study drug|1|||
170425387|NCT03965091|615899210|FG000|Overall Study|Lost to Follow-up|1|||
170425388|NCT03965091|615899211|FG001|Overall Study|Lost to Follow-up|1|||
170425389|NCT03965091|615899212|FG002|Overall Study|Lost to Follow-up|1|||
170425390|NCT03965091|615899210|FG000|Overall Study|Lack of Efficacy|2|||
170425391|NCT03965091|615899211|FG001|Overall Study|Lack of Efficacy|0|||
170425392|NCT03965091|615899212|FG002|Overall Study|Lack of Efficacy|0|||
170425393|NCT03965091|615899210|FG000|Overall Study|Other than specified|9|||
170425394|NCT03965091|615899211|FG001|Overall Study|Other than specified|11|||
170425395|NCT03965091|615899212|FG002|Overall Study|Other than specified|8|||
170425396|NCT00537979|615899216|FG000|Overall Study|Adverse Event|2|||
170425397|NCT00537979|615899217|FG001|Overall Study|Adverse Event|2|||
170425398|NCT00537979|615899216|FG000|Overall Study|Withdrawal by Subject|1|||
170425399|NCT00537979|615899217|FG001|Overall Study|Withdrawal by Subject|4|||
170425400|NCT00537979|615899216|FG000|Overall Study|Lost to Follow-up|1|||
170425401|NCT00537979|615899217|FG001|Overall Study|Lost to Follow-up|4|||
170425402|NCT00537979|615899216|FG000|Overall Study|Lack of Efficacy|0|||
170425403|NCT00537979|615899217|FG001|Overall Study|Lack of Efficacy|1|||
170425404|NCT00537979|615899216|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
170425405|NCT00537979|615899217|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
170425406|NCT00537979|615899216|FG000|Overall Study|Death|0|||
170425407|NCT00537979|615899217|FG001|Overall Study|Death|3|||
170425408|NCT00537979|615899216|FG000|Overall Study|Kidney transplant|0|||
170425409|NCT00537979|615899217|FG001|Overall Study|Kidney transplant|3|||
170425410|NCT00537979|615899216|FG000|Overall Study|Heart failure|0|||
170425411|NCT00537979|615899217|FG001|Overall Study|Heart failure|1|||
170533823|NCT03034967|616300712|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
170425412|NCT03435081|615899218|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
170425413|NCT03435081|615899219|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
170879522|NCT04194528|617569314|FG000|Overall Study|Adverse Event|1|||
170533824|NCT03034967|616300713|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
170533825|NCT00790036|616300716|FG000|Overall Study|Abnormal lab values|3|||
170533826|NCT00790036|616300717|FG001|Overall Study|Abnormal lab values|2|||
170533827|NCT00790036|616300716|FG000|Overall Study|Administrative problems|5|||
170425414|NCT03435081|615899220|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
170425415|NCT03435081|615899218|FG000|Week 0 to Week 16|Adverse Event|2|||
170425416|NCT03435081|615899219|FG001|Week 0 to Week 16|Adverse Event|2|||
170879523|NCT03921424|617569321|FG000|Overall Study|Lost to Follow-up|0|||
170879524|NCT03921424|617569322|FG001|Overall Study|Lost to Follow-up|1|||
170425417|NCT03435081|615899220|FG002|Week 0 to Week 16|Adverse Event|2|||
170425418|NCT03435081|615899218|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
170425419|NCT03435081|615899219|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
170425420|NCT03435081|615899220|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
170425421|NCT03435081|615899218|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
170533828|NCT00790036|616300717|FG001|Overall Study|Administrative problems|9|||
170425422|NCT03435081|615899219|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
170425423|NCT03435081|615899220|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
170425424|NCT03435081|615899218|FG000|Week 0 to Week 16|Pregnancy|1|||
170425425|NCT03435081|615899219|FG001|Week 0 to Week 16|Pregnancy|0|||
170425426|NCT03435081|615899220|FG002|Week 0 to Week 16|Pregnancy|0|||
170425427|NCT03435081|615899218|FG000|Week 0 to Week 16|Non-compliance|1|||
170425428|NCT03435081|615899219|FG001|Week 0 to Week 16|Non-compliance|0|||
170425429|NCT03435081|615899220|FG002|Week 0 to Week 16|Non-compliance|2|||
170425430|NCT03435081|615899218|FG000|Week 0 to Week 16|Inadequate Response|0|||
170425431|NCT03435081|615899219|FG001|Week 0 to Week 16|Inadequate Response|1|||
170425432|NCT03435081|615899220|FG002|Week 0 to Week 16|Inadequate Response|0|||
170425433|NCT03435081|615899218|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
170425434|NCT03435081|615899219|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
170425435|NCT03435081|615899220|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
170425436|NCT03435081|615899218|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
170425437|NCT03435081|615899219|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
170425438|NCT03435081|615899220|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
170425439|NCT03435081|615899218|FG000|Week 16 to Week 104|Adverse Event|1|||
170425440|NCT03435081|615899219|FG001|Week 16 to Week 104|Adverse Event|0|||
170425441|NCT03435081|615899220|FG002|Week 16 to Week 104|Adverse Event|2|||
170425442|NCT03435081|615899218|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
170425443|NCT03435081|615899219|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
170425444|NCT03435081|615899220|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
170425445|NCT03435081|615899218|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
170425446|NCT03435081|615899219|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
170425447|NCT03435081|615899220|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
170425448|NCT03435081|615899218|FG000|Week 16 to Week 104|Non--Compliance|0|||
170425449|NCT03435081|615899219|FG001|Week 16 to Week 104|Non--Compliance|0|||
170425450|NCT03435081|615899220|FG002|Week 16 to Week 104|Non--Compliance|1|||
170425451|NCT02601560|615899221|FG000|Overall Study|Other|0|||
170425452|NCT02601560|615899222|FG001|Overall Study|Other|0|||
170425453|NCT02601560|615899223|FG002|Overall Study|Other|0|||
170425454|NCT02601560|615899224|FG003|Overall Study|Other|0|||
170425455|NCT02601560|615899225|FG004|Overall Study|Other|0|||
170425456|NCT02601560|615899226|FG005|Overall Study|Other|0|||
170425457|NCT02601560|615899227|FG006|Overall Study|Other|1|||
170425458|NCT02601560|615899228|FG007|Overall Study|Other|0|||
170425459|NCT02100228|615899229|FG000|Overall Study|Other|19|||
170425460|NCT02100228|615899230|FG001|Overall Study|Other|19|||
170425461|NCT02100228|615899229|FG000|Overall Study|Administrative reason|0|||
170425462|NCT02100228|615899230|FG001|Overall Study|Administrative reason|1|||
170425463|NCT02100228|615899229|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
170425464|NCT02100228|615899230|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
170425465|NCT02100228|615899229|FG000|Overall Study|Non-compliance|0|||
170425466|NCT02100228|615899230|FG001|Overall Study|Non-compliance|3|||
170425467|NCT02100228|615899229|FG000|Overall Study|Lost to Follow-up|0|||
170425468|NCT02100228|615899230|FG001|Overall Study|Lost to Follow-up|1|||
170425469|NCT02100228|615899229|FG000|Overall Study|Withdrawal by Subject|27|||
170425470|NCT02100228|615899230|FG001|Overall Study|Withdrawal by Subject|37|||
170425471|NCT02100228|615899229|FG000|Overall Study|Adverse Event|16|||
170425472|NCT02100228|615899230|FG001|Overall Study|Adverse Event|12|||
170425473|NCT02100228|615899229|FG000|Overall Study|Death|1|||
170425474|NCT02100228|615899230|FG001|Overall Study|Death|1|||
170533829|NCT00790036|616300716|FG000|Overall Study|Adverse Event|113|||
170425475|NCT02421952|615899235|FG000|Overall Study|Diary Not Returned|93|||
170425476|NCT02421952|615899235|FG000|Overall Study|Failed seriation task|13|||
170425477|NCT02421952|615899235|FG000|Overall Study|Subject uncooperative for baseline test|2|||
170425478|NCT02421952|615899235|FG000|Overall Study|Surgery cancelled|1|||
170425479|NCT05472038|615900640|FG000|Overall Study|Adverse Event|0|||
170425480|NCT05472038|615900641|FG001|Overall Study|Adverse Event|0|||
170425481|NCT05472038|615900642|FG002|Overall Study|Adverse Event|1|||
170533830|NCT00790036|616300717|FG001|Overall Study|Adverse Event|44|||
170533831|NCT00790036|616300716|FG000|Overall Study|Death|1|||
170533832|NCT00790036|616300717|FG001|Overall Study|Death|0|||
170533833|NCT00790036|616300716|FG000|Overall Study|Disease progression|24|||
170533834|NCT00790036|616300717|FG001|Overall Study|Disease progression|48|||
170425482|NCT05472038|615900643|FG003|Overall Study|Adverse Event|0|||
170425483|NCT05472038|615900644|FG004|Overall Study|Adverse Event|0|||
170425484|NCT05472038|615900645|FG005|Overall Study|Adverse Event|0|||
170425485|NCT05472038|615900646|FG006|Overall Study|Adverse Event|0|||
170425486|NCT05472038|615900647|FG007|Overall Study|Adverse Event|0|||
170425487|NCT05472038|615900648|FG008|Overall Study|Adverse Event|0|||
170425488|NCT05472038|615900649|FG009|Overall Study|Adverse Event|0|||
170533835|NCT00790036|616300716|FG000|Overall Study|Lost to Follow-up|1|||
170425489|NCT05472038|615900650|FG010|Overall Study|Adverse Event|0|||
170425490|NCT05472038|615900651|FG011|Overall Study|Adverse Event|0|||
170425491|NCT05472038|615900640|FG000|Overall Study|Death|0|||
170425492|NCT05472038|615900641|FG001|Overall Study|Death|0|||
170425493|NCT05472038|615900642|FG002|Overall Study|Death|0|||
170425494|NCT05472038|615900643|FG003|Overall Study|Death|0|||
170425495|NCT05472038|615900644|FG004|Overall Study|Death|0|||
170425496|NCT05472038|615900645|FG005|Overall Study|Death|1|||
170425497|NCT05472038|615900646|FG006|Overall Study|Death|0|||
170425498|NCT05472038|615900647|FG007|Overall Study|Death|0|||
170425499|NCT05472038|615900648|FG008|Overall Study|Death|0|||
170425500|NCT05472038|615900649|FG009|Overall Study|Death|0|||
170425501|NCT05472038|615900650|FG010|Overall Study|Death|0|||
170425502|NCT05472038|615900651|FG011|Overall Study|Death|0|||
170425503|NCT05472038|615900640|FG000|Overall Study|Lost to Follow-up|1|||
170425504|NCT05472038|615900641|FG001|Overall Study|Lost to Follow-up|3|||
170425505|NCT05472038|615900642|FG002|Overall Study|Lost to Follow-up|3|||
170425506|NCT05472038|615900643|FG003|Overall Study|Lost to Follow-up|9|||
170425507|NCT05472038|615900644|FG004|Overall Study|Lost to Follow-up|2|||
170425508|NCT05472038|615900645|FG005|Overall Study|Lost to Follow-up|2|||
170425509|NCT05472038|615900646|FG006|Overall Study|Lost to Follow-up|1|||
170425510|NCT05472038|615900647|FG007|Overall Study|Lost to Follow-up|0|||
170425511|NCT05472038|615900648|FG008|Overall Study|Lost to Follow-up|1|||
170425512|NCT05472038|615900649|FG009|Overall Study|Lost to Follow-up|0|||
170425513|NCT05472038|615900650|FG010|Overall Study|Lost to Follow-up|2|||
170425514|NCT05472038|615900651|FG011|Overall Study|Lost to Follow-up|1|||
170425515|NCT05472038|615900640|FG000|Overall Study|Physician Decision|0|||
170425516|NCT05472038|615900641|FG001|Overall Study|Physician Decision|0|||
170425517|NCT05472038|615900642|FG002|Overall Study|Physician Decision|0|||
170425518|NCT05472038|615900643|FG003|Overall Study|Physician Decision|0|||
170425519|NCT05472038|615900644|FG004|Overall Study|Physician Decision|1|||
170425520|NCT05472038|615900645|FG005|Overall Study|Physician Decision|0|||
170425521|NCT05472038|615900646|FG006|Overall Study|Physician Decision|0|||
170425522|NCT05472038|615900647|FG007|Overall Study|Physician Decision|0|||
170425523|NCT05472038|615900648|FG008|Overall Study|Physician Decision|0|||
170425524|NCT05472038|615900649|FG009|Overall Study|Physician Decision|0|||
170425525|NCT05472038|615900650|FG010|Overall Study|Physician Decision|0|||
170425526|NCT05472038|615900651|FG011|Overall Study|Physician Decision|0|||
170425527|NCT05472038|615900640|FG000|Overall Study|Withdrawal by Subject|1|||
170425528|NCT05472038|615900641|FG001|Overall Study|Withdrawal by Subject|3|||
170425529|NCT05472038|615900642|FG002|Overall Study|Withdrawal by Subject|1|||
170425530|NCT05472038|615900643|FG003|Overall Study|Withdrawal by Subject|6|||
170425531|NCT05472038|615900644|FG004|Overall Study|Withdrawal by Subject|1|||
170425532|NCT05472038|615900645|FG005|Overall Study|Withdrawal by Subject|3|||
170425533|NCT05472038|615900646|FG006|Overall Study|Withdrawal by Subject|0|||
170533836|NCT00790036|616300717|FG001|Overall Study|Lost to Follow-up|2|||
170533837|NCT00790036|616300716|FG000|Overall Study|Protocol Violation|10|||
170533838|NCT00790036|616300717|FG001|Overall Study|Protocol Violation|2|||
170533839|NCT00790036|616300716|FG000|Overall Study|Withdrawal by Subject|18|||
170533840|NCT00790036|616300717|FG001|Overall Study|Withdrawal by Subject|7|||
170533841|NCT00790036|616300716|FG000|Overall Study|Subject/guardian decision|20|||
170533842|NCT00790036|616300717|FG001|Overall Study|Subject/guardian decision|7|||
170533843|NCT00869960|616300718|FG000|Overall Study|Lost to Follow-up|2|||
170533844|NCT02921256|616300719|FG000|Arm 1a v. Arm II|Adverse Event|6|||
170533845|NCT02921256|616300720|FG001|Arm 1a v. Arm II|Adverse Event|15|||
170533846|NCT02921256|616300721|FG002|Arm 1a v. Arm II|Adverse Event|0|||
170879525|NCT03921424|617569321|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
170425534|NCT05472038|615900647|FG007|Overall Study|Withdrawal by Subject|2|||
170425535|NCT05472038|615900648|FG008|Overall Study|Withdrawal by Subject|3|||
170425536|NCT05472038|615900649|FG009|Overall Study|Withdrawal by Subject|1|||
170533847|NCT02921256|616300719|FG000|Arm 1a v. Arm II|Death|0|||
170425537|NCT05472038|615900650|FG010|Overall Study|Withdrawal by Subject|2|||
170425538|NCT05472038|615900651|FG011|Overall Study|Withdrawal by Subject|2|||
170425539|NCT05472038|615900640|FG000|Overall Study|Protocol Violation|0|||
170425540|NCT05472038|615900641|FG001|Overall Study|Protocol Violation|0|||
170425541|NCT05472038|615900642|FG002|Overall Study|Protocol Violation|0|||
170425542|NCT05472038|615900643|FG003|Overall Study|Protocol Violation|0|||
170425543|NCT05472038|615900644|FG004|Overall Study|Protocol Violation|0|||
170425544|NCT05472038|615900645|FG005|Overall Study|Protocol Violation|0|||
170425545|NCT05472038|615900646|FG006|Overall Study|Protocol Violation|0|||
170425546|NCT05472038|615900647|FG007|Overall Study|Protocol Violation|1|||
170425547|NCT05472038|615900648|FG008|Overall Study|Protocol Violation|1|||
170425548|NCT05472038|615900649|FG009|Overall Study|Protocol Violation|1|||
170425549|NCT05472038|615900650|FG010|Overall Study|Protocol Violation|1|||
170533848|NCT02921256|616300720|FG001|Arm 1a v. Arm II|Death|2|||
170533849|NCT02921256|616300721|FG002|Arm 1a v. Arm II|Death|0|||
170879526|NCT03921424|617569322|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
170879527|NCT01246583|617569325|FG000|Overall Study|Lost to Follow-up|0|||
170879528|NCT01246583|617569326|FG001|Overall Study|Lost to Follow-up|0|||
170425550|NCT05472038|615900651|FG011|Overall Study|Protocol Violation|1|||
170425551|NCT05472038|615900640|FG000|Overall Study|Not vaccinated|0|||
170425552|NCT05472038|615900641|FG001|Overall Study|Not vaccinated|0|||
170425553|NCT05472038|615900642|FG002|Overall Study|Not vaccinated|0|||
170425554|NCT05472038|615900643|FG003|Overall Study|Not vaccinated|1|||
170425555|NCT05472038|615900644|FG004|Overall Study|Not vaccinated|0|||
170425556|NCT05472038|615900645|FG005|Overall Study|Not vaccinated|0|||
170425557|NCT05472038|615900646|FG006|Overall Study|Not vaccinated|0|||
170425558|NCT05472038|615900647|FG007|Overall Study|Not vaccinated|0|||
170425559|NCT05472038|615900648|FG008|Overall Study|Not vaccinated|0|||
170425560|NCT05472038|615900649|FG009|Overall Study|Not vaccinated|0|||
170425561|NCT05472038|615900650|FG010|Overall Study|Not vaccinated|0|||
170425562|NCT05472038|615900651|FG011|Overall Study|Not vaccinated|0|||
170425563|NCT01466166|615900654|FG000|Overall Study|Death|1|||
170425564|NCT01466166|615900654|FG000|Overall Study|Lost to Follow-up|7|||
170425565|NCT01466166|615900654|FG000|Overall Study|Infusion Reaction (IR)|27|||
170425566|NCT01466166|615900654|FG000|Overall Study|Adverse Event (Other than IR)|11|||
170425567|NCT01466166|615900654|FG000|Overall Study|Elevated Serum Uric Acid|78|||
170425568|NCT01466166|615900654|FG000|Overall Study|Withdrawal by Subject|13|||
170425569|NCT01466166|615900654|FG000|Overall Study|Sponsor Decision|4|||
170425570|NCT01466166|615900654|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
170425571|NCT01466166|615900654|FG000|Overall Study|Other|20|||
170425572|NCT00905346|615900658|FG000|Period 1|Withdrawal by Subject|1|||
170425573|NCT00905346|615900659|FG001|Period 1|Withdrawal by Subject|0|||
170425574|NCT03351335|615900660|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
170425575|NCT03351335|615900661|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
170425576|NCT03351335|615900662|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
170425577|NCT02269657|615900665|FG000|Overall Study|Protocol Violation|3|||
170425578|NCT03450057|615900666|FG000|Overall Study|Death|17|||
170425579|NCT03450057|615900666|FG000|Overall Study|ICF withdrawal|4|||
170425580|NCT03450057|615900666|FG000|Overall Study|Lost to Follow-up|2|||
170425581|NCT02563561|615900667|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
170425582|NCT02563561|615900668|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
170425583|NCT02563561|615900669|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
170425584|NCT02563561|615900667|FG000|Overall Study|Withdrew of Consent|1|||
170425585|NCT02563561|615900668|FG001|Overall Study|Withdrew of Consent|1|||
170425586|NCT02563561|615900669|FG002|Overall Study|Withdrew of Consent|2|||
170425587|NCT02563561|615900667|FG000|Overall Study|Lost to Follow-up|1|||
170425588|NCT02563561|615900668|FG001|Overall Study|Lost to Follow-up|1|||
170425589|NCT02563561|615900669|FG002|Overall Study|Lost to Follow-up|0|||
170425590|NCT02563561|615900667|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
170425591|NCT02563561|615900668|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
170425592|NCT02563561|615900669|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
170425593|NCT02563561|615900667|FG000|Overall Study|Investigator Decision|3|||
170425594|NCT02563561|615900668|FG001|Overall Study|Investigator Decision|4|||
170425595|NCT02563561|615900669|FG002|Overall Study|Investigator Decision|2|||
170425596|NCT02563561|615900667|FG000|Overall Study|Sponsor Decision|5|||
170425597|NCT02563561|615900668|FG001|Overall Study|Sponsor Decision|2|||
170425598|NCT02563561|615900669|FG002|Overall Study|Sponsor Decision|4|||
170425599|NCT02563561|615900667|FG000|Overall Study|Other|1|||
170425600|NCT02563561|615900668|FG001|Overall Study|Other|5|||
170425601|NCT02563561|615900669|FG002|Overall Study|Other|2|||
170425602|NCT04088760|615900670|FG000|Overall Study|Physician Decision|1|||
170425603|NCT01182415|615900671|FG000|Overall Study|Lost to Follow-up|1|||
170425604|NCT00624065|615900672|FG000|Overall Study|Adverse Event|5|||
170425605|NCT00624065|615900673|FG001|Overall Study|Adverse Event|6|||
170425606|NCT00624065|615900672|FG000|Overall Study|Lost to Follow-up|4|||
170425607|NCT00624065|615900673|FG001|Overall Study|Lost to Follow-up|1|||
170533850|NCT02921256|616300719|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
170533851|NCT02921256|616300720|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
170879529|NCT01246583|617569327|FG002|Overall Study|Lost to Follow-up|0|||
170425608|NCT00624065|615900672|FG000|Overall Study|Consent withdrawn|6|||
170425609|NCT00624065|615900673|FG001|Overall Study|Consent withdrawn|5|||
170425610|NCT00624065|615900672|FG000|Overall Study|Lack of Efficacy|0|||
170425611|NCT00624065|615900673|FG001|Overall Study|Lack of Efficacy|3|||
170425612|NCT00624065|615900672|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
170425613|NCT00624065|615900673|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
170533852|NCT02921256|616300721|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
170533853|NCT02921256|616300719|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
170533854|NCT02921256|616300720|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
170879530|NCT01246583|617569328|FG003|Overall Study|Lost to Follow-up|1|||
170879531|NCT01246583|617569325|FG000|Overall Study|Protocol Violation|0|||
170879532|NCT01246583|617569326|FG001|Overall Study|Protocol Violation|0|||
170879533|NCT01246583|617569327|FG002|Overall Study|Protocol Violation|1|||
170879534|NCT01246583|617569328|FG003|Overall Study|Protocol Violation|0|||
170425614|NCT00286754|615900674|FG000|Overall Study|Adverse Event|2|||
170425615|NCT00286754|615900675|FG001|Overall Study|Adverse Event|2|||
170425616|NCT00286754|615900676|FG002|Overall Study|Adverse Event|3|||
170425617|NCT00286754|615900674|FG000|Overall Study|Withdrawal by Subject|6|||
170425618|NCT00286754|615900675|FG001|Overall Study|Withdrawal by Subject|2|||
170425619|NCT00286754|615900676|FG002|Overall Study|Withdrawal by Subject|0|||
170425620|NCT00286754|615900674|FG000|Overall Study|Lost to Follow-up|12|||
170425621|NCT00286754|615900675|FG001|Overall Study|Lost to Follow-up|14|||
170425622|NCT00286754|615900676|FG002|Overall Study|Lost to Follow-up|6|||
170425623|NCT00286754|615900674|FG000|Overall Study|Moved out of state|0|||
170425624|NCT00286754|615900675|FG001|Overall Study|Moved out of state|0|||
170425625|NCT00286754|615900676|FG002|Overall Study|Moved out of state|1|||
170425626|NCT02661295|615900677|FG000|Overall Study|Death|1|||
170425627|NCT02661295|615900677|FG000|Overall Study|Transferred Out|1|||
170425628|NCT02661295|615900677|FG000|Overall Study|Kidney Transplant|1|||
170425629|NCT02661295|615900677|FG000|Overall Study|Withdrawn due to side effects|8|||
170425630|NCT02661295|615900677|FG000|Overall Study|Withdrawn due to access type|1|||
170425631|NCT02661295|615900677|FG000|Overall Study|Withdrawn due to allergies|1|||
170425632|NCT02661295|615900677|FG000|Overall Study|Withdrawn due to non-compliance|1|||
170425633|NCT02661295|615900677|FG000|Overall Study|Withdrawal by Subject|3|||
170425634|NCT02661295|615900677|FG000|Overall Study|Failed screening|2|||
170425635|NCT00301366|615900678|FG000|Overall Study|Adverse Event|1|||
170425636|NCT01263704|615900682|FG000|Overall Study|Progressive disease|18|||
170425637|NCT01263704|615900682|FG000|Overall Study|Adverse Event|3|||
170425638|NCT01263704|615900682|FG000|Overall Study|Death|2|||
170425639|NCT01263704|615900682|FG000|Overall Study|Patient withdrew consent|2|||
170425640|NCT01263704|615900682|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
170425641|NCT01263704|615900682|FG000|Overall Study|Lost to Follow-up|1|||
170425642|NCT01263704|615900682|FG000|Overall Study|Colon metastases|1|||
170425643|NCT01263704|615900682|FG000|Overall Study|Principal Investigator (PI) decision|1|||
170425644|NCT04627038|615900685|FG000|Overall Study|Adverse Event|36|||
170425645|NCT04627038|615900686|FG001|Overall Study|Adverse Event|8|||
170425646|NCT04627038|615900685|FG000|Overall Study|Lost to Follow-up|1|||
170425647|NCT04627038|615900686|FG001|Overall Study|Lost to Follow-up|0|||
170425648|NCT04627038|615900685|FG000|Overall Study|Physician Decision|0|||
170425649|NCT04627038|615900686|FG001|Overall Study|Physician Decision|1|||
170425650|NCT04627038|615900685|FG000|Overall Study|Protocol Violation|3|||
170425651|NCT04627038|615900686|FG001|Overall Study|Protocol Violation|1|||
170425652|NCT04627038|615900685|FG000|Overall Study|Withdrawal by Subject|13|||
170425653|NCT04627038|615900686|FG001|Overall Study|Withdrawal by Subject|3|||
170425654|NCT04627038|615900685|FG000|Overall Study|Non-compliance with study drug|0|||
170425655|NCT04627038|615900686|FG001|Overall Study|Non-compliance with study drug|1|||
170425656|NCT04627038|615900685|FG000|Overall Study|Prohibited Concomitant Medication|1|||
170425657|NCT04627038|615900686|FG001|Overall Study|Prohibited Concomitant Medication|0|||
170425658|NCT04786184|615900687|FG000|Overall Study|Adverse Event|4|||
170425659|NCT04786184|615900688|FG001|Overall Study|Adverse Event|0|||
170425660|NCT04786184|615900687|FG000|Overall Study|Withdrawal by Subject|3|||
170425661|NCT04786184|615900688|FG001|Overall Study|Withdrawal by Subject|1|||
170425662|NCT04786184|615900687|FG000|Overall Study|Lost to Follow-up|4|||
170425663|NCT04786184|615900688|FG001|Overall Study|Lost to Follow-up|2|||
170425664|NCT01010542|615900695|FG000|Overall Study|Adverse Event|0|||
170425665|NCT01010542|615900696|FG001|Overall Study|Adverse Event|1|||
170425666|NCT01010542|615900697|FG002|Overall Study|Adverse Event|0|||
170425667|NCT01010542|615900695|FG000|Overall Study|Lost to Follow-up|0|||
170425668|NCT01010542|615900696|FG001|Overall Study|Lost to Follow-up|1|||
170425669|NCT01010542|615900697|FG002|Overall Study|Lost to Follow-up|0|||
170425670|NCT01010542|615900695|FG000|Overall Study|Withdrawal by Subject|0|||
170425671|NCT01010542|615900696|FG001|Overall Study|Withdrawal by Subject|3|||
170425672|NCT01010542|615900697|FG002|Overall Study|Withdrawal by Subject|2|||
170425673|NCT04533594|615900700|FG000|Overall Study|Death|26|||
170425674|NCT03181594|615900701|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
170425675|NCT03181594|615900701|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
170425676|NCT03181594|615900701|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
170425677|NCT03181594|615900701|FG000|Initial Study Protocol (12-month FU)|Death|1|||
170425678|NCT03181594|615900701|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
170425679|NCT03181594|615900701|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
170425680|NCT02017223|615900702|FG000|Overall Study|Algorithm problems|2|||
170425681|NCT01534520|615900709|FG000|Overall Study|Adverse Event|0|||
170425682|NCT01534520|615900710|FG001|Overall Study|Adverse Event|1|||
170425683|NCT00565448|615900711|FG000|Overall Study|Adverse Event|1|||
170425684|NCT00565448|615900712|FG001|Overall Study|Adverse Event|2|||
170425685|NCT00565448|615900711|FG000|Overall Study|Disease progression|1|||
170425686|NCT00565448|615900712|FG001|Overall Study|Disease progression|0|||
170425687|NCT00565448|615900711|FG000|Overall Study|Withdrawal by Subject|1|||
170425688|NCT00565448|615900712|FG001|Overall Study|Withdrawal by Subject|0|||
170425689|NCT00193609|615900713|FG000|Overall Study|Lack of Efficacy|2|||
170425690|NCT00193609|615900713|FG000|Overall Study|Adverse Event|2|||
170425691|NCT03204539|615900714|FG000|Overall Study|Loss of funding|0|||
170425692|NCT03204539|615900715|FG001|Overall Study|Loss of funding|1|||
170425693|NCT02979353|615900722|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
170425694|NCT02979353|615900723|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
170425695|NCT02979353|615900722|FG000|Overall Study|Withdrawal by Subject|16|||
170425696|NCT02979353|615900723|FG001|Overall Study|Withdrawal by Subject|12|||
170425697|NCT02979353|615900722|FG000|Overall Study|Death|10|||
170425698|NCT02979353|615900723|FG001|Overall Study|Death|11|||
170425699|NCT02979353|615900722|FG000|Overall Study|Transfer to Hospice Care|19|||
170425700|NCT02979353|615900723|FG001|Overall Study|Transfer to Hospice Care|14|||
170425701|NCT02979353|615900722|FG000|Overall Study|Lost to Follow-up|1|||
170425702|NCT02979353|615900723|FG001|Overall Study|Lost to Follow-up|5|||
170425703|NCT01079988|615900724|FG000|Overall Study|Lost to Follow-up|0|||
170425704|NCT01079988|615900725|FG001|Overall Study|Lost to Follow-up|0|||
170425705|NCT01079988|615900726|FG002|Overall Study|Lost to Follow-up|0|||
170425706|NCT01079988|615900727|FG003|Overall Study|Lost to Follow-up|1|||
170425707|NCT01079988|615900728|FG004|Overall Study|Lost to Follow-up|0|||
170425708|NCT01079988|615900724|FG000|Overall Study|Lack of Efficacy|1|||
170425709|NCT01079988|615900725|FG001|Overall Study|Lack of Efficacy|0|||
170425710|NCT01079988|615900726|FG002|Overall Study|Lack of Efficacy|0|||
170425711|NCT01079988|615900727|FG003|Overall Study|Lack of Efficacy|0|||
170425712|NCT01079988|615900728|FG004|Overall Study|Lack of Efficacy|0|||
170425713|NCT01079988|615900724|FG000|Overall Study|Other|0|||
170425714|NCT01079988|615900725|FG001|Overall Study|Other|0|||
170425715|NCT01079988|615900726|FG002|Overall Study|Other|0|||
170425716|NCT01079988|615900727|FG003|Overall Study|Other|2|||
170425717|NCT01079988|615900728|FG004|Overall Study|Other|1|||
170425718|NCT00550537|615900731|FG000|Overall Study|Death|18|||
170425719|NCT00550537|615900731|FG000|Overall Study|Adverse Event|20|||
170425720|NCT00550537|615900731|FG000|Overall Study|Disease progression before|46|||
170425721|NCT00550537|615900731|FG000|Overall Study|Withdrawal by Subject|7|||
170425722|NCT00550537|615900731|FG000|Overall Study|Change in treatment plan|4|||
170425723|NCT00550537|615900731|FG000|Overall Study|Other complicating ilness|3|||
170425724|NCT00550537|615900731|FG000|Overall Study|Declining performance status|2|||
170425725|NCT00550537|615900731|FG000|Overall Study|Treated closer to home|4|||
170425726|NCT00617305|615900732|FG000|Overall Study|Adverse Event|4|||
170425727|NCT00617305|615900733|FG001|Overall Study|Adverse Event|0|||
170425728|NCT00617305|615900734|FG002|Overall Study|Adverse Event|0|||
170425729|NCT00617305|615900732|FG000|Overall Study|Death|1|||
170425730|NCT00617305|615900733|FG001|Overall Study|Death|0|||
170425731|NCT00617305|615900734|FG002|Overall Study|Death|0|||
170425732|NCT00617305|615900732|FG000|Overall Study|Physician Decision|1|||
170425733|NCT00617305|615900733|FG001|Overall Study|Physician Decision|0|||
170425734|NCT00617305|615900734|FG002|Overall Study|Physician Decision|0|||
170425735|NCT00617305|615900732|FG000|Overall Study|Protocol Violation|1|||
170425736|NCT00617305|615900733|FG001|Overall Study|Protocol Violation|0|||
170425737|NCT00617305|615900734|FG002|Overall Study|Protocol Violation|1|||
170425738|NCT00617305|615900732|FG000|Overall Study|Withdrawal by Subject|1|||
170425739|NCT00617305|615900733|FG001|Overall Study|Withdrawal by Subject|0|||
170425740|NCT00617305|615900734|FG002|Overall Study|Withdrawal by Subject|0|||
170425741|NCT02612337|615900747|FG000|Overall Study|Lack of Efficacy|1|||
170425742|NCT02612337|615900748|FG001|Overall Study|Lack of Efficacy|0|||
170425743|NCT02612337|615900747|FG000|Overall Study|Withdrawal by Subject|2|||
170425744|NCT02612337|615900748|FG001|Overall Study|Withdrawal by Subject|2|||
170425745|NCT02612337|615900747|FG000|Overall Study|Did not receive study drug|0|||
170425746|NCT02612337|615900748|FG001|Overall Study|Did not receive study drug|1|||
170425747|NCT00854100|615900753|FG000|Overall Study|Inability to complete the study visits|0|||
170425748|NCT00854100|615900754|FG001|Overall Study|Inability to complete the study visits|0|||
170425749|NCT00854100|615900755|FG002|Overall Study|Inability to complete the study visits|1|||
170425750|NCT00854100|615900753|FG000|Overall Study|Lost to Follow-up|2|||
170425751|NCT00854100|615900754|FG001|Overall Study|Lost to Follow-up|0|||
170425752|NCT00854100|615900755|FG002|Overall Study|Lost to Follow-up|3|||
170425753|NCT00854100|615900753|FG000|Overall Study|Withdrawal by Subject|3|||
170425754|NCT00854100|615900754|FG001|Overall Study|Withdrawal by Subject|1|||
170533855|NCT02921256|616300721|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
170425755|NCT00854100|615900755|FG002|Overall Study|Withdrawal by Subject|2|||
170425756|NCT00854100|615900753|FG000|Overall Study|Protocol Violation|2|||
170425757|NCT00854100|615900754|FG001|Overall Study|Protocol Violation|4|||
170425758|NCT00854100|615900755|FG002|Overall Study|Protocol Violation|3|||
170425759|NCT00854100|615900753|FG000|Overall Study|Adverse Event|2|||
170425760|NCT00854100|615900754|FG001|Overall Study|Adverse Event|1|||
170425761|NCT00854100|615900755|FG002|Overall Study|Adverse Event|2|||
170425762|NCT02242201|615900758|FG000|Overall Study|preoperative identified neuropathy|2|||
170425763|NCT02242201|615900759|FG001|Overall Study|preoperative identified neuropathy|0|||
170879535|NCT01246583|617569325|FG000|Overall Study|Withdrawal by Subject|1|||
170533856|NCT02921256|616300719|FG000|Arm 1a v. Arm II|Physician Decision|1|||
170425764|NCT02242201|615900760|FG002|Overall Study|preoperative identified neuropathy|0|||
170425765|NCT02242201|615900758|FG000|Overall Study|planned post-op anticoagulation|1|||
170425766|NCT02242201|615900759|FG001|Overall Study|planned post-op anticoagulation|0|||
170425767|NCT02242201|615900760|FG002|Overall Study|planned post-op anticoagulation|0|||
170425768|NCT02242201|615900758|FG000|Overall Study|changed surgical procedure|1|||
170425769|NCT02242201|615900759|FG001|Overall Study|changed surgical procedure|0|||
170425770|NCT02242201|615900760|FG002|Overall Study|changed surgical procedure|0|||
170425771|NCT02242201|615900758|FG000|Overall Study|postponed surgery|0|||
170425772|NCT02242201|615900759|FG001|Overall Study|postponed surgery|0|||
170425773|NCT02242201|615900760|FG002|Overall Study|postponed surgery|1|||
170425774|NCT02242201|615900758|FG000|Overall Study|preoperative opioid consumption|0|||
170425775|NCT02242201|615900759|FG001|Overall Study|preoperative opioid consumption|1|||
170425776|NCT02242201|615900760|FG002|Overall Study|preoperative opioid consumption|0|||
170425777|NCT03262012|615900761|FG000|Overall Study|Withdrawal by Subject|15|||
170425778|NCT03262012|615900762|FG001|Overall Study|Withdrawal by Subject|13|||
170425779|NCT03262012|615900763|FG002|Overall Study|Withdrawal by Subject|8|||
170425780|NCT03262012|615900764|FG003|Overall Study|Withdrawal by Subject|7|||
170425781|NCT03262012|615900761|FG000|Overall Study|Adverse Event|10|||
170425782|NCT03262012|615900762|FG001|Overall Study|Adverse Event|12|||
170425783|NCT03262012|615900763|FG002|Overall Study|Adverse Event|4|||
170425784|NCT03262012|615900764|FG003|Overall Study|Adverse Event|6|||
170425785|NCT03262012|615900761|FG000|Overall Study|Physician Decision|2|||
170425786|NCT03262012|615900762|FG001|Overall Study|Physician Decision|5|||
170533857|NCT02921256|616300720|FG001|Arm 1a v. Arm II|Physician Decision|1|||
170533858|NCT02921256|616300721|FG002|Arm 1a v. Arm II|Physician Decision|0|||
170533859|NCT02921256|616300719|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
170533860|NCT02921256|616300720|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
170533861|NCT02921256|616300721|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
170533862|NCT02921256|616300719|FG000|Arm Ib v Arm III|Adverse Event|9|||
170533863|NCT02921256|616300720|FG001|Arm Ib v Arm III|Adverse Event|0|||
170533864|NCT02921256|616300721|FG002|Arm Ib v Arm III|Adverse Event|4|||
170533865|NCT02921256|616300719|FG000|Arm Ib v Arm III|Death|1|||
170533866|NCT02921256|616300720|FG001|Arm Ib v Arm III|Death|0|||
170533867|NCT02921256|616300721|FG002|Arm Ib v Arm III|Death|1|||
170533868|NCT02921256|616300719|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
170533869|NCT02921256|616300720|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
170533870|NCT02921256|616300721|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
170533871|NCT02921256|616300719|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
170533872|NCT02921256|616300720|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
170533873|NCT02921256|616300721|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
170533874|NCT02921256|616300719|FG000|Arm Ib v Arm III|Physician Decision|4|||
170533875|NCT02921256|616300720|FG001|Arm Ib v Arm III|Physician Decision|0|||
170533876|NCT02921256|616300721|FG002|Arm Ib v Arm III|Physician Decision|1|||
170533877|NCT02921256|616300719|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
170533878|NCT02921256|616300720|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
170533879|NCT02921256|616300721|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
170533880|NCT03507790|616300722|FG000|Overall Study|Adverse Event|0|||
170533881|NCT03507790|616300723|FG001|Overall Study|Adverse Event|11|||
170533882|NCT03507790|616300724|FG002|Overall Study|Adverse Event|3|||
170533883|NCT03507790|616300722|FG000|Overall Study|Withdrawal by Subject|2|||
170533884|NCT03507790|616300723|FG001|Overall Study|Withdrawal by Subject|0|||
170533885|NCT03507790|616300724|FG002|Overall Study|Withdrawal by Subject|0|||
170533886|NCT03507790|616300722|FG000|Overall Study|Subject moved to another location|1|||
170533887|NCT03507790|616300723|FG001|Overall Study|Subject moved to another location|2|||
170533888|NCT03507790|616300724|FG002|Overall Study|Subject moved to another location|0|||
170533889|NCT03507790|616300722|FG000|Overall Study|Non-compliance with study drug|0|||
170533890|NCT03507790|616300723|FG001|Overall Study|Non-compliance with study drug|0|||
170533891|NCT03507790|616300724|FG002|Overall Study|Non-compliance with study drug|1|||
170425787|NCT03262012|615900763|FG002|Overall Study|Physician Decision|1|||
170425788|NCT03262012|615900764|FG003|Overall Study|Physician Decision|0|||
170425789|NCT03262012|615900761|FG000|Overall Study|Lack of Efficacy|0|||
170533892|NCT03507790|616300722|FG000|Overall Study|COVID 19 Pandemic|0|||
170533893|NCT03507790|616300723|FG001|Overall Study|COVID 19 Pandemic|1|||
170425790|NCT03262012|615900762|FG001|Overall Study|Lack of Efficacy|5|||
170425791|NCT03262012|615900763|FG002|Overall Study|Lack of Efficacy|1|||
170425792|NCT03262012|615900764|FG003|Overall Study|Lack of Efficacy|2|||
170425793|NCT03262012|615900761|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
170425794|NCT03262012|615900762|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
170425795|NCT03262012|615900763|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
170425796|NCT03262012|615900764|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
170425797|NCT02801877|615900765|FG000|Overall Study|Lost to Follow-up|1|||
170425798|NCT02801877|615900766|FG001|Overall Study|Lost to Follow-up|1|||
170533894|NCT03507790|616300724|FG002|Overall Study|COVID 19 Pandemic|0|||
170533895|NCT03507790|616300722|FG000|Overall Study|Lost to Follow-up|0|||
170533896|NCT03507790|616300723|FG001|Overall Study|Lost to Follow-up|1|||
170533897|NCT03507790|616300724|FG002|Overall Study|Lost to Follow-up|0|||
170425799|NCT02801877|615900767|FG002|Overall Study|Lost to Follow-up|2|||
170533898|NCT03507790|616300722|FG000|Overall Study|Discontinuation of the trial at the site|1|||
170533899|NCT03507790|616300723|FG001|Overall Study|Discontinuation of the trial at the site|1|||
170879536|NCT01246583|617569326|FG001|Overall Study|Withdrawal by Subject|0|||
170879537|NCT01246583|617569327|FG002|Overall Study|Withdrawal by Subject|0|||
170425800|NCT02801877|615900768|FG003|Overall Study|Lost to Follow-up|0|||
170533900|NCT03507790|616300724|FG002|Overall Study|Discontinuation of the trial at the site|0|||
170425801|NCT02801877|615900765|FG000|Overall Study|Never Started Treatment|2|||
170425802|NCT02801877|615900766|FG001|Overall Study|Never Started Treatment|0|||
170425803|NCT02801877|615900767|FG002|Overall Study|Never Started Treatment|4|||
170425804|NCT02801877|615900768|FG003|Overall Study|Never Started Treatment|0|||
170425805|NCT02963259|615900770|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
170425806|NCT02963259|615900770|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
170425807|NCT02963259|615900770|FG000|Overall Study|Death|1|||
170425808|NCT02963259|615900770|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
170425809|NCT03243630|615900772|FG000|Overall Study|Protocol Violation|1|||
170425810|NCT03243630|615900772|FG000|Overall Study|Physician Decision|1|||
170425811|NCT00939003|615900773|FG000|Double-blind Treatment Period|Adverse Event|1|||
170425812|NCT00939003|615900774|FG001|Double-blind Treatment Period|Adverse Event|1|||
170425813|NCT00939003|615900773|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
170425814|NCT00939003|615900774|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
170425815|NCT00939003|615900773|FG000|Double-blind Treatment Period|Pregnancy|0|||
170425816|NCT00939003|615900774|FG001|Double-blind Treatment Period|Pregnancy|1|||
170425817|NCT00939003|615900773|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
170425818|NCT00939003|615900774|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
170425819|NCT00939003|615900773|FG000|Open-label Treatment Period|Adverse Event|4|||
170425820|NCT00939003|615900774|FG001|Open-label Treatment Period|Adverse Event|8|||
170425821|NCT00939003|615900773|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
170425822|NCT00939003|615900774|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
170425823|NCT00939003|615900773|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
170425824|NCT00939003|615900774|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
170425825|NCT00939003|615900773|FG000|Open-label Treatment Period|Pregnancy|1|||
170425826|NCT00939003|615900774|FG001|Open-label Treatment Period|Pregnancy|1|||
170425827|NCT00939003|615900773|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
170425828|NCT00939003|615900774|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
170425829|NCT00939003|615900773|FG000|Open-label Treatment Period|Site Closure|3|||
170425830|NCT00939003|615900774|FG001|Open-label Treatment Period|Site Closure|4|||
170425831|NCT03880266|615900775|FG000|Overall Study|Withdrawal by Subject|0|||
170425832|NCT03880266|615900776|FG001|Overall Study|Withdrawal by Subject|1|||
170425833|NCT03880266|615900777|FG002|Overall Study|Withdrawal by Subject|1|||
170425834|NCT03880266|615900778|FG003|Overall Study|Withdrawal by Subject|0|||
170425835|NCT03880266|615900779|FG004|Overall Study|Withdrawal by Subject|0|||
170425836|NCT03880266|615900780|FG005|Overall Study|Withdrawal by Subject|0|||
170533901|NCT03507790|616300722|FG000|Overall Study|Randomized in error|0|||
170533902|NCT03507790|616300723|FG001|Overall Study|Randomized in error|0|||
170533903|NCT03507790|616300724|FG002|Overall Study|Randomized in error|1|||
170533904|NCT04428151|616300725|FG000|Overall Study|Death|100|||
170533905|NCT04428151|616300726|FG001|Overall Study|Death|86|||
170533906|NCT04428151|616300727|FG002|Overall Study|Death|57|||
170533907|NCT04428151|616300725|FG000|Overall Study|Lost to Follow-up|1|||
170533908|NCT04428151|616300726|FG001|Overall Study|Lost to Follow-up|1|||
170533909|NCT04428151|616300727|FG002|Overall Study|Lost to Follow-up|0|||
170533910|NCT04428151|616300725|FG000|Overall Study|Withdrawal by Subject|2|||
170533911|NCT04428151|616300726|FG001|Overall Study|Withdrawal by Subject|2|||
170533912|NCT04428151|616300727|FG002|Overall Study|Withdrawal by Subject|3|||
170533913|NCT04428151|616300725|FG000|Overall Study|Participant Ongoing in Study|41|||
170533914|NCT04428151|616300726|FG001|Overall Study|Participant Ongoing in Study|53|||
170533915|NCT04428151|616300727|FG002|Overall Study|Participant Ongoing in Study|28|||
170533916|NCT02401230|616300728|FG000|Overall Study|Adverse Event|3|||
170533917|NCT02401230|616300729|FG001|Overall Study|Adverse Event|2|||
170533918|NCT02401230|616300730|FG002|Overall Study|Adverse Event|0|||
170533919|NCT02401230|616300728|FG000|Overall Study|Withdrawal by Subject|2|||
170533920|NCT02401230|616300729|FG001|Overall Study|Withdrawal by Subject|1|||
170533921|NCT02401230|616300730|FG002|Overall Study|Withdrawal by Subject|1|||
170533922|NCT02401230|616300728|FG000|Overall Study|Lost to Follow-up|1|||
170533923|NCT02401230|616300729|FG001|Overall Study|Lost to Follow-up|3|||
170533924|NCT02401230|616300730|FG002|Overall Study|Lost to Follow-up|3|||
170533925|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
170425837|NCT03880266|615900781|FG006|Overall Study|Withdrawal by Subject|0|||
170425838|NCT03880266|615900782|FG007|Overall Study|Withdrawal by Subject|0|||
170425839|NCT01511939|615902227|FG000|Overall Study|Withdrawal by Subject|2|||
170533926|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
170533927|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
170425840|NCT01511939|615902228|FG001|Overall Study|Withdrawal by Subject|1|||
170425841|NCT01511939|615902229|FG002|Overall Study|Withdrawal by Subject|0|||
170425842|NCT02422264|615902235|FG000|Overall Study|Serious Adverse Event|1|||
170425843|NCT02422264|615902236|FG001|Overall Study|Serious Adverse Event|0|||
170425844|NCT02422264|615902235|FG000|Overall Study|Withdrawal by Subject|1|||
170425845|NCT02422264|615902236|FG001|Overall Study|Withdrawal by Subject|2|||
170533928|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
170533929|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Death|38|||
170632705|NCT02760498|616666745|FG003|Overall Study|Physician Decision|4|||
170425846|NCT02422264|615902235|FG000|Overall Study|Migrated/moved from study area|3|||
170425847|NCT02422264|615902236|FG001|Overall Study|Migrated/moved from study area|1|||
170425848|NCT02422264|615902235|FG000|Overall Study|Subject vaccinated outside of the study|0|||
170425849|NCT02422264|615902236|FG001|Overall Study|Subject vaccinated outside of the study|1|||
170425850|NCT03021018|615902237|FG000|Overall Study|Adverse Event|1|||
170425851|NCT03021018|615902238|FG001|Overall Study|Adverse Event|0|||
170425852|NCT03021018|615902239|FG002|Overall Study|Adverse Event|0|||
170425853|NCT03021018|615902237|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
170425854|NCT03021018|615902238|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
170425855|NCT03021018|615902239|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
170425856|NCT01439880|615902244|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
170425857|NCT01439880|615902245|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
170425858|NCT01439880|615902244|FG000|SOC-controlled Period (Year 1)|Death|2|||
170425859|NCT01439880|615902245|FG001|SOC-controlled Period (Year 1)|Death|1|||
170425860|NCT01439880|615902244|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
170425861|NCT01439880|615902245|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
170425862|NCT01439880|615902244|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
170425863|NCT01439880|615902245|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
170425864|NCT01439880|615902244|FG000|SOC-controlled Period (Year 1)|Other|8|||
170425865|NCT01439880|615902245|FG001|SOC-controlled Period (Year 1)|Other|13|||
170425866|NCT01439880|615902244|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
170425867|NCT01439880|615902245|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
170425868|NCT01439880|615902244|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
170425869|NCT01439880|615902245|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
170425870|NCT01439880|615902244|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
170425871|NCT01439880|615902245|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
170425872|NCT01439880|615902244|FG000|All-IP Period (Years 2 to 5)|Death|3|||
170425873|NCT01439880|615902245|FG001|All-IP Period (Years 2 to 5)|Death|13|||
170879538|NCT01246583|617569328|FG003|Overall Study|Withdrawal by Subject|0|||
170879539|NCT01423851|617569329|FG000|Whole Study|Disease progression|2|||
170879540|NCT01423851|617569330|FG001|Whole Study|Disease progression|1|||
170879541|NCT01423851|617569331|FG002|Whole Study|Disease progression|1|||
170879542|NCT01423851|617569332|FG003|Whole Study|Disease progression|4|||
170879543|NCT01423851|617569333|FG004|Whole Study|Disease progression|1|||
170879544|NCT01423851|617569334|FG005|Whole Study|Disease progression|3|||
170879545|NCT01423851|617569335|FG006|Whole Study|Disease progression|1|||
170425874|NCT01439880|615902244|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
170425875|NCT01439880|615902245|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
170425876|NCT01439880|615902244|FG000|All-IP Period (Years 2 to 5)|Other|14|||
170425877|NCT01439880|615902245|FG001|All-IP Period (Years 2 to 5)|Other|31|||
170425878|NCT01439880|615902244|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
170425879|NCT01439880|615902245|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
170425880|NCT00829673|615902249|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
170425881|NCT00829673|615902250|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
170425882|NCT02378935|615902251|FG000|Overall Study|Lack of Efficacy|10|||
170425883|NCT02378935|615902252|FG001|Overall Study|Lack of Efficacy|0|||
170425884|NCT02378935|615902253|FG002|Overall Study|Lack of Efficacy|2|||
170425885|NCT02378935|615902254|FG003|Overall Study|Lack of Efficacy|6|||
170425886|NCT02378935|615902255|FG004|Overall Study|Lack of Efficacy|0|||
170425887|NCT02378935|615902256|FG005|Overall Study|Lack of Efficacy|0|||
170425888|NCT02378935|615902257|FG006|Overall Study|Lack of Efficacy|0|||
170425889|NCT02378935|615902251|FG000|Overall Study|Death|0|||
170425890|NCT02378935|615902252|FG001|Overall Study|Death|0|||
170425891|NCT02378935|615902253|FG002|Overall Study|Death|1|||
170425892|NCT02378935|615902254|FG003|Overall Study|Death|0|||
170425893|NCT02378935|615902255|FG004|Overall Study|Death|0|||
170425894|NCT02378935|615902256|FG005|Overall Study|Death|0|||
170425895|NCT02378935|615902257|FG006|Overall Study|Death|0|||
170425896|NCT00272779|615902258|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
170425897|NCT00272779|615902259|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
170425898|NCT00272779|615902258|FG000|Baseline Through Week 48|Death before Week 48|4|||
170425899|NCT00272779|615902259|FG001|Baseline Through Week 48|Death before Week 48|4|||
170425900|NCT00272779|615902258|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
170425901|NCT00272779|615902259|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
170425902|NCT00272779|615902258|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
170425903|NCT00272779|615902259|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
170425904|NCT00272779|615902258|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
170425905|NCT00272779|615902259|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
170425906|NCT00272779|615902258|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
170425907|NCT00272779|615902259|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
170425908|NCT00272779|615902258|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
170425909|NCT00272779|615902259|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
170425910|NCT00272779|615902258|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
170879546|NCT01423851|617569336|FG007|Whole Study|Disease progression|4|||
170879547|NCT01423851|617569337|FG008|Whole Study|Disease progression|0|||
170879548|NCT01423851|617569338|FG009|Whole Study|Disease progression|2|||
170879549|NCT01423851|617569339|FG010|Whole Study|Disease progression|10|||
170879550|NCT01423851|617569329|FG000|Whole Study|Physician Decision|0|||
170879551|NCT01423851|617569330|FG001|Whole Study|Physician Decision|1|||
170425911|NCT00272779|615902259|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
170425912|NCT00272779|615902258|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
170425913|NCT00272779|615902259|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
170425914|NCT00272779|615902258|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
170425915|NCT00272779|615902259|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
170425916|NCT00272779|615902258|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
170425917|NCT00272779|615902259|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
170425918|NCT00272779|615902258|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
170425919|NCT00272779|615902259|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
170425920|NCT00272779|615902258|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
170425921|NCT00272779|615902259|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
170425922|NCT00272779|615902258|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
170425923|NCT00272779|615902259|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
170425924|NCT00272779|615902258|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
170425925|NCT00272779|615902259|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
170425926|NCT00272779|615902258|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
170425927|NCT00272779|615902259|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
170425928|NCT00272779|615902258|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
170425929|NCT00272779|615902259|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
170425930|NCT00272779|615902258|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
170425931|NCT00272779|615902259|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
170425932|NCT00272779|615902258|FG000|Baseline Through Week 48|Continuing treatment|385|||
170425933|NCT00272779|615902259|FG001|Baseline Through Week 48|Continuing treatment|368|||
170425934|NCT00272779|615902258|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
170425935|NCT00272779|615902259|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
170425936|NCT00272779|615902258|FG000|Baseline Through Week 48|Never treated|2|||
170425937|NCT00272779|615902259|FG001|Baseline Through Week 48|Never treated|3|||
170425938|NCT00272779|615902258|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
170425939|NCT00272779|615902259|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
170425940|NCT00272779|615902258|FG000|Baseline Through Week 96|Death before Week 96|6|||
170425941|NCT00272779|615902259|FG001|Baseline Through Week 96|Death before Week 96|5|||
170425942|NCT00272779|615902258|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
170425943|NCT00272779|615902259|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
170425944|NCT00272779|615902258|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
170425945|NCT00272779|615902259|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
170425946|NCT00272779|615902258|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
170425947|NCT00272779|615902259|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
170425948|NCT00272779|615902258|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
170425949|NCT00272779|615902259|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
170425950|NCT00272779|615902258|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
170425951|NCT00272779|615902259|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
170425952|NCT00272779|615902258|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
170425953|NCT00272779|615902259|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
170425954|NCT00272779|615902258|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
170425955|NCT00272779|615902259|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
170425956|NCT00272779|615902258|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
170425957|NCT00272779|615902259|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
170425958|NCT00272779|615902258|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
170425959|NCT00272779|615902259|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
170425960|NCT00272779|615902258|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
170425961|NCT00272779|615902259|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
170425962|NCT00272779|615902258|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
170425963|NCT00272779|615902259|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
170425964|NCT00272779|615902258|FG000|Baseline Through Week 96|Never treated|2|||
170425965|NCT00272779|615902259|FG001|Baseline Through Week 96|Never treated|3|||
170425966|NCT00272779|615902258|FG000|Baseline Through Week 96|Continuing on treatment|61|||
170425967|NCT00272779|615902259|FG001|Baseline Through Week 96|Continuing on treatment|38|||
170425968|NCT02440711|615902260|FG000|Second Intervention|Lost to Follow-up|1|||
170425969|NCT02440711|615902261|FG001|Second Intervention|Lost to Follow-up|0|||
170879552|NCT01423851|617569331|FG002|Whole Study|Physician Decision|2|||
170879553|NCT01423851|617569332|FG003|Whole Study|Physician Decision|0|||
170533930|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Death|10|||
170533931|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
170533932|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
170533933|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
170533934|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
170533935|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
170533936|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
170533937|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
170533938|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
170533939|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
170533940|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
170533941|NCT02421939|616300731|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
170533942|NCT02421939|616300732|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
170533943|NCT02421939|616300731|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
170533944|NCT02421939|616300732|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
170533945|NCT02421939|616300731|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
170533946|NCT02421939|616300732|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
170533947|NCT02421939|616300731|FG000|Long Term Follow up: up to 3 Years|Death|118|||
170533948|NCT02421939|616300732|FG001|Long Term Follow up: up to 3 Years|Death|65|||
170533949|NCT02421939|616300731|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
170533950|NCT02421939|616300732|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
170533951|NCT04478266|616300733|FG000|Overall Study|Adverse Event|20|||
170533952|NCT04478266|616300734|FG001|Overall Study|Adverse Event|21|||
170533953|NCT04478266|616300733|FG000|Overall Study|Progressive disease|146|||
170533954|NCT04478266|616300734|FG001|Overall Study|Progressive disease|168|||
170533955|NCT04478266|616300733|FG000|Overall Study|Poor compliance to protocol|1|||
170533956|NCT04478266|616300734|FG001|Overall Study|Poor compliance to protocol|0|||
170533957|NCT04478266|616300733|FG000|Overall Study|Withdrawal by Subject|19|||
170533958|NCT04478266|616300734|FG001|Overall Study|Withdrawal by Subject|16|||
170533959|NCT04478266|616300733|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
170533960|NCT04478266|616300734|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
170533961|NCT04478266|616300733|FG000|Overall Study|Study terminated by sponsor|33|||
170533962|NCT04478266|616300734|FG001|Overall Study|Study terminated by sponsor|35|||
170533963|NCT04478266|616300733|FG000|Overall Study|Other: unspecified|5|||
170533964|NCT04478266|616300734|FG001|Overall Study|Other: unspecified|7|||
170533965|NCT04478266|616300733|FG000|Overall Study|Randomized but not treated|1|||
170533966|NCT04478266|616300734|FG001|Overall Study|Randomized but not treated|1|||
170533967|NCT00671788|616300739|FG000|Overall Study|Adverse Event|8|||
170533968|NCT00671788|616300739|FG000|Overall Study|Refused further treatment|3|||
170533969|NCT00671788|616300739|FG000|Overall Study|Ineligible|1|||
170533970|NCT00671788|616300739|FG000|Overall Study|MD Decision|1|||
170533971|NCT00671788|616300739|FG000|Overall Study|Other|1|||
170533972|NCT01035138|616300740|FG000|Overall Study|Adverse Event|4|||
170533973|NCT01035138|616300741|FG001|Overall Study|Adverse Event|0|||
170533974|NCT01035138|616300742|FG002|Overall Study|Adverse Event|2|||
170533975|NCT01035138|616300740|FG000|Overall Study|Caregiver Decision|2|||
170533976|NCT01035138|616300741|FG001|Overall Study|Caregiver Decision|0|||
170533977|NCT01035138|616300742|FG002|Overall Study|Caregiver Decision|1|||
170533978|NCT01035138|616300740|FG000|Overall Study|Withdrawal by Subject|1|||
170533979|NCT01035138|616300741|FG001|Overall Study|Withdrawal by Subject|0|||
170533980|NCT01035138|616300742|FG002|Overall Study|Withdrawal by Subject|0|||
170533981|NCT01035138|616300740|FG000|Overall Study|Physician Decision|0|||
170533982|NCT01035138|616300741|FG001|Overall Study|Physician Decision|0|||
170533983|NCT01035138|616300742|FG002|Overall Study|Physician Decision|1|||
170533984|NCT01035138|616300740|FG000|Overall Study|Sponsor Decision|66|||
170533985|NCT01035138|616300741|FG001|Overall Study|Sponsor Decision|60|||
170533986|NCT01035138|616300742|FG002|Overall Study|Sponsor Decision|42|||
170533987|NCT01035138|616300740|FG000|Overall Study|Lost to Follow-up|0|||
170533988|NCT01035138|616300741|FG001|Overall Study|Lost to Follow-up|0|||
170533989|NCT01035138|616300742|FG002|Overall Study|Lost to Follow-up|1|||
170533990|NCT02966834|616300743|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
170533991|NCT02966834|616300744|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
170533992|NCT02966834|616300745|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
170533993|NCT02966834|616300746|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
170533994|NCT02966834|616300747|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
170533995|NCT02966834|616300748|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
170533996|NCT02966834|616300743|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
170533997|NCT02966834|616300744|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170533998|NCT02966834|616300745|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170533999|NCT02966834|616300746|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170534000|NCT02966834|616300747|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170534001|NCT02966834|616300748|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170565464|NCT05643495|616417171|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
170534002|NCT02966834|616300743|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
170534003|NCT02966834|616300744|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
170534004|NCT02966834|616300745|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
170534005|NCT02966834|616300746|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
170534006|NCT02966834|616300747|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
170534007|NCT02966834|616300748|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
170534008|NCT02966834|616300743|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
170534009|NCT02966834|616300744|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
170534010|NCT02966834|616300745|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
170534011|NCT02966834|616300746|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
170534012|NCT02966834|616300747|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
170534013|NCT02966834|616300748|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
170534014|NCT02966834|616300743|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
170534015|NCT02966834|616300744|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
170534016|NCT02966834|616300745|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
170534017|NCT02966834|616300746|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
170534018|NCT02966834|616300747|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
170534019|NCT02966834|616300748|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
170534020|NCT02966834|616300743|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
170534021|NCT02966834|616300744|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
170534022|NCT02966834|616300745|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
170534023|NCT02966834|616300746|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
170534024|NCT02966834|616300747|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
170534025|NCT02966834|616300748|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
170534026|NCT02814526|616300749|FG000|Overall Study|Adverse Event|4|||
170534027|NCT02814526|616300750|FG001|Overall Study|Adverse Event|3|||
170534028|NCT02814526|616300749|FG000|Overall Study|Death|1|||
170534029|NCT02814526|616300750|FG001|Overall Study|Death|1|||
170534030|NCT02814526|616300749|FG000|Overall Study|Lost to Follow-up|3|||
170534031|NCT02814526|616300750|FG001|Overall Study|Lost to Follow-up|4|||
170534032|NCT02814526|616300749|FG000|Overall Study|non site physician decision|1|||
170534033|NCT02814526|616300750|FG001|Overall Study|non site physician decision|0|||
170534034|NCT02814526|616300749|FG000|Overall Study|participant noncompliance|1|||
170534035|NCT02814526|616300750|FG001|Overall Study|participant noncompliance|1|||
170534036|NCT02814526|616300749|FG000|Overall Study|Withdrawal by Subject|20|||
170534037|NCT02814526|616300750|FG001|Overall Study|Withdrawal by Subject|14|||
170534038|NCT02814526|616300749|FG000|Overall Study|safety risk|2|||
170534039|NCT02814526|616300750|FG001|Overall Study|safety risk|1|||
170534040|NCT02814526|616300749|FG000|Overall Study|early termination-study terminated|1|||
170534041|NCT02814526|616300750|FG001|Overall Study|early termination-study terminated|2|||
170534042|NCT02814526|616300749|FG000|Overall Study|Other|0|||
170534043|NCT02814526|616300750|FG001|Overall Study|Other|4|||
170879554|NCT01423851|617569333|FG004|Whole Study|Physician Decision|2|||
170879555|NCT01423851|617569334|FG005|Whole Study|Physician Decision|0|||
170879556|NCT01423851|617569335|FG006|Whole Study|Physician Decision|2|||
170879557|NCT01423851|617569336|FG007|Whole Study|Physician Decision|1|||
170879558|NCT01423851|617569337|FG008|Whole Study|Physician Decision|3|||
170879559|NCT01423851|617569338|FG009|Whole Study|Physician Decision|4|||
170879560|NCT01423851|617569339|FG010|Whole Study|Physician Decision|12|||
170879561|NCT01423851|617569329|FG000|Whole Study|Withdrawal by Subject|1|||
170879562|NCT01423851|617569330|FG001|Whole Study|Withdrawal by Subject|1|||
170879563|NCT01423851|617569331|FG002|Whole Study|Withdrawal by Subject|0|||
170879564|NCT01423851|617569332|FG003|Whole Study|Withdrawal by Subject|0|||
170879565|NCT01423851|617569333|FG004|Whole Study|Withdrawal by Subject|0|||
170879566|NCT01423851|617569334|FG005|Whole Study|Withdrawal by Subject|0|||
170879567|NCT01423851|617569335|FG006|Whole Study|Withdrawal by Subject|0|||
170879568|NCT01423851|617569336|FG007|Whole Study|Withdrawal by Subject|0|||
170879569|NCT01423851|617569337|FG008|Whole Study|Withdrawal by Subject|2|||
170879570|NCT01423851|617569338|FG009|Whole Study|Withdrawal by Subject|0|||
170879571|NCT01423851|617569339|FG010|Whole Study|Withdrawal by Subject|4|||
170879572|NCT01423851|617569329|FG000|Whole Study|Adverse Event|0|||
170879573|NCT01423851|617569330|FG001|Whole Study|Adverse Event|0|||
170879574|NCT01423851|617569331|FG002|Whole Study|Adverse Event|0|||
170879575|NCT01423851|617569332|FG003|Whole Study|Adverse Event|2|||
170879576|NCT01423851|617569333|FG004|Whole Study|Adverse Event|0|||
170534044|NCT00141817|616300754|FG000|Overall Study|Protocol Violation|0|||
170879577|NCT01423851|617569334|FG005|Whole Study|Adverse Event|0|||
170879578|NCT01423851|617569335|FG006|Whole Study|Adverse Event|0|||
170534045|NCT00141817|616300755|FG001|Overall Study|Protocol Violation|0|||
170879579|NCT01423851|617569336|FG007|Whole Study|Adverse Event|3|||
170879580|NCT01423851|617569337|FG008|Whole Study|Adverse Event|3|||
170879581|NCT01423851|617569338|FG009|Whole Study|Adverse Event|2|||
170879582|NCT01423851|617569339|FG010|Whole Study|Adverse Event|3|||
170879583|NCT05885737|617569343|FG000|DB Period|Adverse Event|4|||
170879584|NCT05885737|617569344|FG001|DB Period|Adverse Event|4|||
170879585|NCT05885737|617569343|FG000|DB Period|Lost to Follow-up|0|||
170534046|NCT00141817|616300756|FG002|Overall Study|Protocol Violation|1|||
170534047|NCT00141817|616300757|FG003|Overall Study|Protocol Violation|0|||
170534048|NCT00141817|616300754|FG000|Overall Study|Parent request|1|||
170534049|NCT00141817|616300755|FG001|Overall Study|Parent request|0|||
170534050|NCT00141817|616300756|FG002|Overall Study|Parent request|0|||
170534051|NCT00141817|616300757|FG003|Overall Study|Parent request|0|||
170534052|NCT01925417|616300767|FG000|Overall Study|Withdrawal by Subject|2|||
170534053|NCT01925417|616300767|FG000|Overall Study|Death|1|||
170534054|NCT00655889|616300768|FG000|Overall Study|Inadequate cell growth|1|||
170534055|NCT00655889|616300768|FG000|Overall Study|Protocol Violation|1|||
170534056|NCT04585893|616300769|FG000|Overall Study|Death|1|||
170534057|NCT04585893|616300770|FG001|Overall Study|Death|0|||
170534058|NCT03225287|616300773|FG000|Overall Study|Adverse Event|0|||
170534059|NCT03225287|616300774|FG001|Overall Study|Adverse Event|0|||
170534060|NCT03225287|616300775|FG002|Overall Study|Adverse Event|1|||
170534061|NCT03225287|616300773|FG000|Overall Study|Protocol non-compliance|0|||
170534062|NCT03225287|616300774|FG001|Overall Study|Protocol non-compliance|0|||
170534063|NCT03225287|616300775|FG002|Overall Study|Protocol non-compliance|1|||
170534064|NCT03225287|616300773|FG000|Overall Study|Subject withdraws consent|3|||
170534065|NCT03225287|616300774|FG001|Overall Study|Subject withdraws consent|0|||
170534066|NCT03225287|616300775|FG002|Overall Study|Subject withdraws consent|0|||
170534067|NCT03225287|616300773|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
170534068|NCT03225287|616300774|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
170534069|NCT03225287|616300775|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
170534070|NCT03225287|616300773|FG000|Overall Study|Trial drug not effective|0|||
170534071|NCT03225287|616300774|FG001|Overall Study|Trial drug not effective|1|||
170534072|NCT03225287|616300775|FG002|Overall Study|Trial drug not effective|0|||
170534073|NCT03225287|616300773|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
170534074|NCT03225287|616300774|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
170534075|NCT03225287|616300775|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
170534076|NCT03225287|616300773|FG000|Overall Study|Stem cell transplantation|0|||
170534077|NCT03225287|616300774|FG001|Overall Study|Stem cell transplantation|1|||
170534078|NCT03225287|616300775|FG002|Overall Study|Stem cell transplantation|0|||
170534079|NCT03415178|616300776|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
170534080|NCT03415178|616300777|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
170534081|NCT03415178|616300776|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
170534082|NCT03415178|616300777|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
170534083|NCT03082729|616300779|FG000|Overall Study|Lost to Follow-up|7|||
170534084|NCT03082729|616300779|FG000|Overall Study|Physician Decision|2|||
170534085|NCT03082729|616300779|FG000|Overall Study|Withdrawal by Subject|1|||
170534086|NCT03082729|616300779|FG000|Overall Study|Lack of Efficacy|9|||
170534087|NCT03082729|616300779|FG000|Overall Study|Adverse Event|4|||
170534088|NCT03082729|616300779|FG000|Overall Study|Protocol Violation|6|||
170534089|NCT03082729|616300779|FG000|Overall Study|Fear of study procedure|1|||
170534090|NCT03082729|616300779|FG000|Overall Study|Scheduling conflict|1|||
170534091|NCT01416571|616300780|FG000|Overall Study|Lost to Follow-up|2|||
170534092|NCT03608163|616300781|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
170534093|NCT03608163|616300782|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
170534094|NCT05020015|616302199|FG000|Overall Study|Ongoing on study|1|||
170534095|NCT05020015|616302200|FG001|Overall Study|Ongoing on study|3|||
170534096|NCT05020015|616302201|FG002|Overall Study|Ongoing on study|4|||
170534097|NCT05020015|616302202|FG003|Overall Study|Ongoing on study|7|||
170534098|NCT05020015|616302199|FG000|Overall Study|Death|2|||
170534099|NCT05020015|616302200|FG001|Overall Study|Death|3|||
170534100|NCT05020015|616302201|FG002|Overall Study|Death|4|||
170534101|NCT05020015|616302202|FG003|Overall Study|Death|0|||
170534102|NCT05020015|616302199|FG000|Overall Study|Withdrawal by Subject|0|||
170534103|NCT05020015|616302200|FG001|Overall Study|Withdrawal by Subject|0|||
170534104|NCT05020015|616302201|FG002|Overall Study|Withdrawal by Subject|1|||
170534105|NCT05020015|616302202|FG003|Overall Study|Withdrawal by Subject|0|||
170534106|NCT05020015|616302199|FG000|Overall Study|Reason Not Specified|0|||
170534107|NCT05020015|616302200|FG001|Overall Study|Reason Not Specified|0|||
170534108|NCT05020015|616302201|FG002|Overall Study|Reason Not Specified|2|||
170534109|NCT05020015|616302202|FG003|Overall Study|Reason Not Specified|0|||
170534110|NCT02233413|616302203|FG000|Overall Study|Lost to Follow-up|7|||
170534111|NCT02233413|616302204|FG001|Overall Study|Lost to Follow-up|9|||
170534112|NCT02233413|616302203|FG000|Overall Study|Withdrawal by Subject|4|||
170534113|NCT02233413|616302204|FG001|Overall Study|Withdrawal by Subject|5|||
170534114|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
170534115|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
170534116|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
170534117|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
170534118|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
170534119|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
170534120|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
170565465|NCT03545672|616418527|FG000|Overall Study|Uncertain diagnosis|2|||
170565466|NCT03545672|616418528|FG001|Overall Study|Uncertain diagnosis|1|||
170879586|NCT05885737|617569344|FG001|DB Period|Lost to Follow-up|1|||
170879587|NCT05885737|617569343|FG000|DB Period|Physician Decision|2|||
170879588|NCT05885737|617569344|FG001|DB Period|Physician Decision|0|||
170879589|NCT05885737|617569343|FG000|DB Period|Withdrawal by Subject|12|||
170879590|NCT05885737|617569344|FG001|DB Period|Withdrawal by Subject|6|||
170879591|NCT05885737|617569343|FG000|DB Period|Other: Unspecified|2|||
170879592|NCT05885737|617569344|FG001|DB Period|Other: Unspecified|2|||
170879593|NCT05885737|617569343|FG000|OLE Period|Adverse Event|3|||
170879594|NCT05885737|617569344|FG001|OLE Period|Adverse Event|2|||
170879595|NCT05885737|617569343|FG000|OLE Period|Physician Decision|1|||
170879596|NCT05885737|617569344|FG001|OLE Period|Physician Decision|0|||
170879597|NCT05885737|617569343|FG000|OLE Period|Withdrawal by Subject|5|||
170879598|NCT05885737|617569344|FG001|OLE Period|Withdrawal by Subject|5|||
170879599|NCT05885737|617569343|FG000|OLE Period|Other: Unspecified|2|||
170879600|NCT05885737|617569344|FG001|OLE Period|Other: Unspecified|1|||
170879601|NCT00876187|617571037|FG000|Overall Study|Adverse Event|14|||
170879602|NCT00876187|617571038|FG001|Overall Study|Adverse Event|12|||
170879603|NCT00876187|617571039|FG002|Overall Study|Adverse Event|19|||
170879604|NCT00876187|617571040|FG003|Overall Study|Adverse Event|29|||
170879605|NCT00876187|617571041|FG004|Overall Study|Adverse Event|10|||
170879606|NCT00876187|617571037|FG000|Overall Study|Lack of Efficacy|59|||
170879607|NCT00876187|617571038|FG001|Overall Study|Lack of Efficacy|34|||
170879608|NCT00876187|617571039|FG002|Overall Study|Lack of Efficacy|45|||
170879609|NCT00876187|617571040|FG003|Overall Study|Lack of Efficacy|34|||
170879610|NCT00876187|617571041|FG004|Overall Study|Lack of Efficacy|59|||
170879611|NCT00876187|617571037|FG000|Overall Study|Lost to Follow-up|9|||
170879612|NCT00876187|617571038|FG001|Overall Study|Lost to Follow-up|10|||
170879613|NCT00876187|617571039|FG002|Overall Study|Lost to Follow-up|8|||
170879614|NCT00876187|617571040|FG003|Overall Study|Lost to Follow-up|8|||
170879615|NCT00876187|617571041|FG004|Overall Study|Lost to Follow-up|11|||
170879616|NCT00876187|617571037|FG000|Overall Study|Protocol Violation|6|||
170879617|NCT00876187|617571038|FG001|Overall Study|Protocol Violation|7|||
170879618|NCT00876187|617571039|FG002|Overall Study|Protocol Violation|7|||
170879619|NCT00876187|617571040|FG003|Overall Study|Protocol Violation|6|||
170879620|NCT00876187|617571041|FG004|Overall Study|Protocol Violation|3|||
170879621|NCT00876187|617571037|FG000|Overall Study|Withdrawal by Subject|16|||
170879622|NCT00876187|617571038|FG001|Overall Study|Withdrawal by Subject|26|||
170425970|NCT03214952|615902271|FG000|Overall Study|Protocol Deviation|45|||
170425971|NCT03214952|615902271|FG000|Overall Study|Case Report Forms Uncollected|13|||
170425972|NCT03935880|615902272|FG000|Overall Study|Lost to Follow-up|0|||
170425973|NCT03935880|615902273|FG001|Overall Study|Lost to Follow-up|1|||
170425974|NCT03769896|615902274|FG000|Open-label Phase|Lack of Efficacy|5|||
170425975|NCT03769896|615902275|FG001|Open-label Phase|Lack of Efficacy|0|||
170425976|NCT03769896|615902274|FG000|Open-label Phase|Adverse Event|3|||
170425977|NCT03769896|615902275|FG001|Open-label Phase|Adverse Event|0|||
170425978|NCT03769896|615902274|FG000|Open-label Phase|Withdrawal by Subject|1|||
170425979|NCT03769896|615902275|FG001|Open-label Phase|Withdrawal by Subject|0|||
170425980|NCT01015703|615902276|FG000|Overall Study|Withdrawal by Subject|0|||
170425981|NCT01015703|615902277|FG001|Overall Study|Withdrawal by Subject|1|||
170425982|NCT01015703|615902278|FG002|Overall Study|Withdrawal by Subject|0|||
170425983|NCT01015703|615902279|FG003|Overall Study|Withdrawal by Subject|0|||
170425984|NCT01015703|615902280|FG004|Overall Study|Withdrawal by Subject|0|||
170425985|NCT01015703|615902276|FG000|Overall Study|Adverse Event|1|||
170425986|NCT01015703|615902277|FG001|Overall Study|Adverse Event|0|||
170425987|NCT01015703|615902278|FG002|Overall Study|Adverse Event|0|||
170425988|NCT01015703|615902279|FG003|Overall Study|Adverse Event|0|||
170425989|NCT01015703|615902280|FG004|Overall Study|Adverse Event|0|||
170425990|NCT01015703|615902276|FG000|Overall Study|Protocol Violation|1|||
170425991|NCT01015703|615902277|FG001|Overall Study|Protocol Violation|0|||
170425992|NCT01015703|615902278|FG002|Overall Study|Protocol Violation|0|||
170425993|NCT01015703|615902279|FG003|Overall Study|Protocol Violation|0|||
170425994|NCT01015703|615902280|FG004|Overall Study|Protocol Violation|0|||
170425995|NCT03122535|615902281|FG000|Overall Study|Lost to Follow-up|68|||
170425996|NCT03122535|615902282|FG001|Overall Study|Lost to Follow-up|68|||
170425997|NCT03122535|615902281|FG000|Overall Study|Physician Decision|3|||
170425998|NCT03122535|615902282|FG001|Overall Study|Physician Decision|3|||
170425999|NCT03122535|615902281|FG000|Overall Study|Withdrawal by Subject|2|||
170426000|NCT03122535|615902282|FG001|Overall Study|Withdrawal by Subject|2|||
170426001|NCT00627016|615902283|FG000|Overall Study|Adverse Event|1|||
170426002|NCT00627016|615902284|FG001|Overall Study|Adverse Event|1|||
170426003|NCT00627016|615902283|FG000|Overall Study|Protocol Violation|0|||
170426004|NCT00627016|615902284|FG001|Overall Study|Protocol Violation|2|||
170426005|NCT00627016|615902283|FG000|Overall Study|Lost to Follow-up|0|||
170426006|NCT00627016|615902284|FG001|Overall Study|Lost to Follow-up|1|||
170426007|NCT00627016|615902283|FG000|Overall Study|Withdrawal by Subject|2|||
170426008|NCT00627016|615902284|FG001|Overall Study|Withdrawal by Subject|1|||
170426009|NCT00627016|615902283|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
170426010|NCT00627016|615902284|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
170426011|NCT00627016|615902283|FG000|Overall Study|Lack of Efficacy|1|||
170426012|NCT00627016|615902284|FG001|Overall Study|Lack of Efficacy|0|||
170426013|NCT00627016|615902283|FG000|Overall Study|Placed on Excluded Drugs|1|||
170426014|NCT00627016|615902284|FG001|Overall Study|Placed on Excluded Drugs|0|||
170426015|NCT00627016|615902283|FG000|Overall Study|Pregnancy|1|||
170426016|NCT00627016|615902284|FG001|Overall Study|Pregnancy|0|||
170426017|NCT02646124|615902285|FG000|Overall Study|Lost to Follow-up|0|||
170426018|NCT02646124|615902286|FG001|Overall Study|Lost to Follow-up|2|||
170426019|NCT02331394|615902289|FG000|Overall Study|Disease progression|1|||
170426020|NCT01313273|615902290|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
170426021|NCT01313273|615902291|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
170426022|NCT01313273|615902290|FG000|Overall Study|Withdrawal by Subject|1|||
170426023|NCT01313273|615902291|FG001|Overall Study|Withdrawal by Subject|0|||
170426024|NCT01313273|615902290|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
170426025|NCT01313273|615902291|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
170426026|NCT00552669|615902292|FG000|Overall Study|Death|3|||
170426027|NCT00552669|615902293|FG001|Overall Study|Death|7|||
170426028|NCT02098876|615902295|FG000|Overall Study|Withdrawal by Subject|5|||
170426029|NCT02098876|615902296|FG001|Overall Study|Withdrawal by Subject|5|||
170426030|NCT01061866|615902299|FG000|Overall Study|Adverse Event|2|||
170426031|NCT00252720|615902300|FG000|Overall Study|Withdrawal by Subject|95|||
170426032|NCT00252720|615902301|FG001|Overall Study|Withdrawal by Subject|97|||
170426033|NCT00252720|615902300|FG000|Overall Study|Death|7|||
170426034|NCT00252720|615902301|FG001|Overall Study|Death|8|||
170426035|NCT00252720|615902300|FG000|Overall Study|Moving|23|||
170426036|NCT00252720|615902301|FG001|Overall Study|Moving|42|||
170426037|NCT00252720|615902300|FG000|Overall Study|Mainly patients lost to follow-up|7|||
170426038|NCT00252720|615902301|FG001|Overall Study|Mainly patients lost to follow-up|18|||
170426039|NCT01702987|615902308|FG000|Overall Study|Withdrawal by Subject|1|||
170426040|NCT01702987|615902309|FG001|Overall Study|Withdrawal by Subject|0|||
170426041|NCT01401647|615902310|FG000|Overall Study|Withdrawal by Subject|1|||
170426042|NCT01401647|615902311|FG001|Overall Study|Withdrawal by Subject|5|||
170426043|NCT01401647|615902312|FG002|Overall Study|Withdrawal by Subject|2|||
170534121|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
170534122|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
170534123|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
170426044|NCT01401647|615902310|FG000|Overall Study|Lost to Follow-up|3|||
170426045|NCT01401647|615902311|FG001|Overall Study|Lost to Follow-up|3|||
170426046|NCT01401647|615902312|FG002|Overall Study|Lost to Follow-up|1|||
170426047|NCT00365846|615902313|FG000|Overall Study|Lost to Follow-up|1|||
170426048|NCT00838630|615902316|FG000|First Intervention|Adverse Event|1|||
170426049|NCT00838630|615902317|FG001|First Intervention|Adverse Event|0|||
170426050|NCT00838630|615902316|FG000|Washout: 7 Days|Protocol Violation|1|||
170426051|NCT00838630|615902317|FG001|Washout: 7 Days|Protocol Violation|0|||
170426052|NCT00302952|615902318|FG000|Overall Study|Physician Decision|1|||
170426053|NCT00302952|615902319|FG001|Overall Study|Physician Decision|1|||
170426054|NCT00302952|615902318|FG000|Overall Study|Withdrawal by Subject|2|||
170879623|NCT00876187|617571039|FG002|Overall Study|Withdrawal by Subject|32|||
170879624|NCT00876187|617571040|FG003|Overall Study|Withdrawal by Subject|38|||
170879625|NCT00876187|617571041|FG004|Overall Study|Withdrawal by Subject|37|||
170879626|NCT00876187|617571037|FG000|Overall Study|Entered extension study|101|||
170879627|NCT00876187|617571038|FG001|Overall Study|Entered extension study|120|||
170879628|NCT00876187|617571039|FG002|Overall Study|Entered extension study|156|||
170879629|NCT00876187|617571040|FG003|Overall Study|Entered extension study|151|||
170879630|NCT00876187|617571041|FG004|Overall Study|Entered extension study|144|||
170879631|NCT00876187|617571037|FG000|Overall Study|Randomized but not treated|3|||
170879632|NCT00876187|617571038|FG001|Overall Study|Randomized but not treated|1|||
170879633|NCT00876187|617571039|FG002|Overall Study|Randomized but not treated|3|||
170879634|NCT00876187|617571040|FG003|Overall Study|Randomized but not treated|2|||
170879635|NCT00876187|617571041|FG004|Overall Study|Randomized but not treated|3|||
170879636|NCT00876187|617571037|FG000|Overall Study|Other|2|||
170879637|NCT00876187|617571038|FG001|Overall Study|Other|5|||
170879638|NCT00876187|617571039|FG002|Overall Study|Other|9|||
170879639|NCT00876187|617571040|FG003|Overall Study|Other|7|||
170879640|NCT00876187|617571041|FG004|Overall Study|Other|4|||
170879641|NCT01379274|617571042|FG000|Overall Study|funding withdrawn|1|||
170879642|NCT01560780|617571043|FG000|Overall Study|Death|2|||
170879643|NCT01560780|617571044|FG001|Overall Study|Death|1|||
170879644|NCT01560780|617571043|FG000|Overall Study|Patient Preference|11|||
170879645|NCT01560780|617571044|FG001|Overall Study|Patient Preference|11|||
170879646|NCT03972969|617571047|FG000|3-month Follow-up|Death|1|||
170879647|NCT03972969|617571048|FG001|3-month Follow-up|Death|1|||
170879648|NCT03972969|617571049|FG002|3-month Follow-up|Death|0|||
170879649|NCT03972969|617571047|FG000|6-month Follow-up|Death|1|||
170879650|NCT03972969|617571048|FG001|6-month Follow-up|Death|1|||
170879651|NCT03972969|617571049|FG002|6-month Follow-up|Death|1|||
170879652|NCT03972969|617571047|FG000|6-month Follow-up|Lost to Follow-up|2|||
170879653|NCT03972969|617571048|FG001|6-month Follow-up|Lost to Follow-up|2|||
170879654|NCT03972969|617571049|FG002|6-month Follow-up|Lost to Follow-up|2|||
170879655|NCT01399788|617571050|FG000|First Intervention Period|Adverse Event|1|||
170879656|NCT01399788|617571051|FG001|First Intervention Period|Adverse Event|0|||
170879657|NCT01970995|617571052|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
170879658|NCT01970995|617571053|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
170879659|NCT01970995|617571054|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
170879660|NCT01970995|617571052|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
170879661|NCT01970995|617571053|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
170879662|NCT01970995|617571054|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
170879663|NCT00414453|617571055|FG000|Overall Study|Abnormal lab work|16|||
170879664|NCT01780662|617571058|FG000|Overall Study|Adverse Event|1|||
170879665|NCT01780662|617571059|FG001|Overall Study|Adverse Event|0|||
170879666|NCT01780662|617571060|FG002|Overall Study|Adverse Event|2|||
170879667|NCT01780662|617571058|FG000|Overall Study|Physician Decision|0|||
170879668|NCT01780662|617571059|FG001|Overall Study|Physician Decision|5|||
170879669|NCT01780662|617571060|FG002|Overall Study|Physician Decision|7|||
170879670|NCT01780662|617571058|FG000|Overall Study|Protocol Violation|0|||
170879671|NCT01780662|617571059|FG001|Overall Study|Protocol Violation|1|||
170879672|NCT01780662|617571060|FG002|Overall Study|Protocol Violation|0|||
170879673|NCT01780662|617571058|FG000|Overall Study|Ineligible|0|||
170879674|NCT01780662|617571059|FG001|Overall Study|Ineligible|0|||
170879675|NCT01780662|617571060|FG002|Overall Study|Ineligible|1|||
170879676|NCT00143312|617571065|FG000|Overall Study|Death|11|||
170879677|NCT00143312|617571065|FG000|Overall Study|Adverse Event|2|||
170879678|NCT00143312|617571065|FG000|Overall Study|Lost to Follow-up|1|||
170879679|NCT00143312|617571065|FG000|Overall Study|Other|1|||
170879680|NCT00143312|617571065|FG000|Overall Study|Withdrawal by Subject|1|||
170879681|NCT02863809|617571066|FG000|Overall Study|Adverse Event|8|||
170879682|NCT02863809|617571067|FG001|Overall Study|Adverse Event|8|||
170879683|NCT02863809|617571066|FG000|Overall Study|Withdrawal by Subject|0|||
170879684|NCT02863809|617571067|FG001|Overall Study|Withdrawal by Subject|1|||
170879685|NCT02863809|617571066|FG000|Overall Study|Lost to Follow-up|1|||
170879686|NCT02863809|617571067|FG001|Overall Study|Lost to Follow-up|1|||
170426055|NCT00302952|615902319|FG001|Overall Study|Withdrawal by Subject|3|||
170426056|NCT00302952|615902318|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
170426057|NCT00302952|615902319|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
170879687|NCT02863809|617571066|FG000|Overall Study|Death|1|||
170879688|NCT02863809|617571067|FG001|Overall Study|Death|0|||
170879689|NCT04544475|617571072|FG000|Overall Study|Withdrawal by Subject|1|||
170879690|NCT04544475|617571073|FG001|Overall Study|Withdrawal by Subject|3|||
170879691|NCT01765920|617571074|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
170879692|NCT01765920|617571075|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
170879693|NCT01765920|617571074|FG000|Overall Study|Patient code disclosure|0|||
170879694|NCT01765920|617571075|FG001|Overall Study|Patient code disclosure|1|||
170426058|NCT00336479|615902320|FG000|Overall Study|Adverse Event|8|||
170879695|NCT02411539|617571076|FG000|Overall Study|Lost to Follow-up|2|||
170879696|NCT02411539|617571077|FG001|Overall Study|Lost to Follow-up|0|||
170879697|NCT02411539|617571076|FG000|Overall Study|Confounding medical condition|0|||
170879698|NCT02411539|617571077|FG001|Overall Study|Confounding medical condition|1|||
170879699|NCT01265797|617571086|FG000|Run-in Month|Withdrawal by Subject|0|||
170879700|NCT01265797|617571087|FG001|Run-in Month|Withdrawal by Subject|4|||
170879701|NCT01265797|617571086|FG000|Run-in Month|1st seizure during run-in month|0|||
170879702|NCT01265797|617571087|FG001|Run-in Month|1st seizure during run-in month|1|||
170879703|NCT01265797|617571086|FG000|Blinded Month|Lack of Efficacy|5|||
170879704|NCT01265797|617571087|FG001|Blinded Month|Lack of Efficacy|0|||
170879705|NCT01265797|617571086|FG000|Blinded Month|Lost to Follow-up|1|||
170879706|NCT01265797|617571087|FG001|Blinded Month|Lost to Follow-up|0|||
170879707|NCT01265797|617571086|FG000|Blinded Month|Protocol Violation|2|||
170879708|NCT01265797|617571087|FG001|Blinded Month|Protocol Violation|1|||
170879709|NCT01265797|617571086|FG000|Blinded Month|Adverse Event|2|||
170879710|NCT01265797|617571087|FG001|Blinded Month|Adverse Event|0|||
170879711|NCT01265797|617571086|FG000|Blinded Month|Diary data incomplete|0|||
170879712|NCT01265797|617571087|FG001|Blinded Month|Diary data incomplete|1|||
170879713|NCT01265797|617571086|FG000|Open Label Month|Lost to Follow-up|0|||
170879714|NCT01265797|617571087|FG001|Open Label Month|Lost to Follow-up|1|||
170879715|NCT01422915|617571088|FG000|Overall Study|Adverse Event|1|||
170879716|NCT00606320|617571089|FG000|Overall Study|Adverse Event|3|||
170879717|NCT00606320|617571089|FG000|Overall Study|Lack of Efficacy|5|||
170879718|NCT00606320|617571089|FG000|Overall Study|Physician Decision|7|||
170879719|NCT00606320|617571089|FG000|Overall Study|Protocol Violation|8|||
170534124|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
170534125|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
170534126|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
170534127|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
170534128|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
170534129|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
170534130|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
170534131|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
170534132|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
170534133|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
170534134|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
170534135|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
170534136|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
170879720|NCT00606320|617571089|FG000|Overall Study|Withdrawal by Subject|10|||
170426059|NCT00336479|615902321|FG001|Overall Study|Adverse Event|11|||
170426060|NCT00336479|615902322|FG002|Overall Study|Adverse Event|18|||
170426061|NCT00336479|615902323|FG003|Overall Study|Adverse Event|4|||
170426062|NCT00336479|615902320|FG000|Overall Study|Noncompliant|1|||
170426063|NCT00336479|615902321|FG001|Overall Study|Noncompliant|7|||
170426064|NCT00336479|615902322|FG002|Overall Study|Noncompliant|3|||
170426065|NCT00336479|615902323|FG003|Overall Study|Noncompliant|0|||
170426066|NCT00336479|615902320|FG000|Overall Study|Physician Decision|2|||
170426067|NCT00336479|615902321|FG001|Overall Study|Physician Decision|3|||
170426068|NCT00336479|615902322|FG002|Overall Study|Physician Decision|1|||
170426069|NCT00336479|615902323|FG003|Overall Study|Physician Decision|0|||
170426070|NCT00336479|615902320|FG000|Overall Study|Lost to Follow-up|3|||
170426071|NCT00336479|615902321|FG001|Overall Study|Lost to Follow-up|2|||
170426072|NCT00336479|615902322|FG002|Overall Study|Lost to Follow-up|0|||
170426073|NCT00336479|615902323|FG003|Overall Study|Lost to Follow-up|0|||
170426074|NCT00336479|615902320|FG000|Overall Study|Withdrawal by Subject|3|||
170426075|NCT00336479|615902321|FG001|Overall Study|Withdrawal by Subject|2|||
170426076|NCT00336479|615902322|FG002|Overall Study|Withdrawal by Subject|3|||
170426077|NCT00336479|615902323|FG003|Overall Study|Withdrawal by Subject|0|||
170426078|NCT00336479|615902320|FG000|Overall Study|Other|0|||
170426079|NCT00336479|615902321|FG001|Overall Study|Other|0|||
170426080|NCT00336479|615902322|FG002|Overall Study|Other|1|||
170426081|NCT00336479|615902323|FG003|Overall Study|Other|0|||
170426082|NCT00336479|615902320|FG000|Overall Study|Virologic Stopping Rule|20|||
170426083|NCT00336479|615902321|FG001|Overall Study|Virologic Stopping Rule|0|||
170426084|NCT00336479|615902322|FG002|Overall Study|Virologic Stopping Rule|0|||
170426085|NCT00336479|615902323|FG003|Overall Study|Virologic Stopping Rule|0|||
170426086|NCT00846495|615902324|FG000|Overall Study|Lost to Follow-up|1|||
170426087|NCT00846495|615902325|FG001|Overall Study|Lost to Follow-up|0|||
170426088|NCT00846495|615902324|FG000|Overall Study|Adverse Event|5|||
170426089|NCT00846495|615902325|FG001|Overall Study|Adverse Event|1|||
170426090|NCT00846495|615902324|FG000|Overall Study|Lack of Efficacy|1|||
170426091|NCT00846495|615902325|FG001|Overall Study|Lack of Efficacy|2|||
170426092|NCT00846495|615902324|FG000|Overall Study|Physician Decision|1|||
170426093|NCT00846495|615902325|FG001|Overall Study|Physician Decision|0|||
170426094|NCT00468286|615902328|FG000|Overall Study|Adverse Event|1|||
170426095|NCT00468286|615902329|FG001|Overall Study|Adverse Event|6|||
170426096|NCT00468286|615902328|FG000|Overall Study|Protocol Violation|2|||
170426097|NCT00468286|615902329|FG001|Overall Study|Protocol Violation|2|||
170426098|NCT00468286|615902328|FG000|Overall Study|Withdrawal by Subject|4|||
170426099|NCT00468286|615902329|FG001|Overall Study|Withdrawal by Subject|3|||
170426100|NCT00468286|615902328|FG000|Overall Study|Physician Decision|0|||
170426101|NCT00468286|615902329|FG001|Overall Study|Physician Decision|1|||
170426102|NCT02392000|615902333|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
170426103|NCT02392000|615902333|FG000|Overall Study|Withdrawal by Subject|1|||
170426104|NCT02392000|615902333|FG000|Overall Study|Lost to Follow-up|8|||
170426105|NCT00833937|615902334|FG000|Washout|Withdrawal by Subject|1|||
170426106|NCT00833937|615902335|FG001|Washout|Withdrawal by Subject|0|||
170426107|NCT04419311|615902336|FG000|Overall Study|Lost to Follow-up|1|||
170426108|NCT04419311|615902337|FG001|Overall Study|Lost to Follow-up|0|||
170426109|NCT01921062|615902343|FG000|Overall Study|Withdrawal by Subject|0|||
170426110|NCT01921062|615902344|FG001|Overall Study|Withdrawal by Subject|7|||
170426111|NCT01921062|615902343|FG000|Overall Study|Adverse Event|5|||
170426112|NCT01921062|615902344|FG001|Overall Study|Adverse Event|6|||
170426113|NCT01921062|615902343|FG000|Overall Study|Protocol Violation|0|||
170426114|NCT01921062|615902344|FG001|Overall Study|Protocol Violation|1|||
170426115|NCT01921062|615902343|FG000|Overall Study|VMIQ score > 72|4|||
170426116|NCT01921062|615902344|FG001|Overall Study|VMIQ score > 72|1|||
170426117|NCT01921062|615902343|FG000|Overall Study|Logistic error|0|||
170426118|NCT01921062|615902344|FG001|Overall Study|Logistic error|1|||
170426119|NCT00965185|615902345|FG000|Overall Study|Lost to Follow-up|2|||
170879721|NCT00606320|617571089|FG000|Overall Study|Progression to depressive phase|4|||
170879722|NCT00446511|617571097|FG000|Overall Study|Adverse Event|7|||
170879723|NCT00446511|617571098|FG001|Overall Study|Adverse Event|2|||
170879724|NCT00446511|617571099|FG002|Overall Study|Adverse Event|3|||
170879725|NCT00446511|617571100|FG003|Overall Study|Adverse Event|1|||
170879726|NCT00446511|617571097|FG000|Overall Study|Protocol Violation|0|||
170879727|NCT00446511|617571098|FG001|Overall Study|Protocol Violation|0|||
170879728|NCT00446511|617571099|FG002|Overall Study|Protocol Violation|0|||
170879729|NCT00446511|617571100|FG003|Overall Study|Protocol Violation|1|||
170879730|NCT00446511|617571097|FG000|Overall Study|Withdrawal by Subject|0|||
170879731|NCT00446511|617571098|FG001|Overall Study|Withdrawal by Subject|0|||
170879732|NCT00446511|617571099|FG002|Overall Study|Withdrawal by Subject|0|||
170879733|NCT00446511|617571100|FG003|Overall Study|Withdrawal by Subject|3|||
170879734|NCT00446511|617571097|FG000|Overall Study|Administrative Problems|3|||
170879735|NCT00446511|617571098|FG001|Overall Study|Administrative Problems|0|||
170879736|NCT00446511|617571099|FG002|Overall Study|Administrative Problems|4|||
170879737|NCT00446511|617571100|FG003|Overall Study|Administrative Problems|1|||
170879738|NCT04247061|617571101|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
170879739|NCT04247061|617571101|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
170879740|NCT04247061|617571101|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
170879741|NCT00455013|617571103|FG000|Short Term Period|Adverse Event|2|||
170879742|NCT00455013|617571104|FG001|Short Term Period|Adverse Event|5|||
170879743|NCT00455013|617571105|FG002|Short Term Period|Adverse Event|0|||
170879744|NCT00455013|617571103|FG000|Short Term Period|Withdrawal by Subject|0|||
170879745|NCT00455013|617571104|FG001|Short Term Period|Withdrawal by Subject|0|||
170879746|NCT00455013|617571105|FG002|Short Term Period|Withdrawal by Subject|1|||
170879747|NCT00455013|617571103|FG000|Short Term Period|Lack of Efficacy|4|||
170879748|NCT00455013|617571104|FG001|Short Term Period|Lack of Efficacy|0|||
170879749|NCT00455013|617571105|FG002|Short Term Period|Lack of Efficacy|0|||
170879750|NCT00455013|617571103|FG000|Short Term Period|Other|0|||
170879751|NCT00455013|617571104|FG001|Short Term Period|Other|0|||
170879752|NCT00455013|617571105|FG002|Short Term Period|Other|1|||
170879753|NCT00455013|617571103|FG000|Long Term Extension (LTE)|Adverse Event|0|||
170879754|NCT00455013|617571104|FG001|Long Term Extension (LTE)|Adverse Event|1|||
170879755|NCT00455013|617571105|FG002|Long Term Extension (LTE)|Adverse Event|1|||
170879756|NCT00455013|617571103|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
170879757|NCT00455013|617571104|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
170879758|NCT00455013|617571105|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
170879759|NCT00455013|617571103|FG000|Long Term Extension (LTE)|Death|1|||
170879760|NCT00455013|617571104|FG001|Long Term Extension (LTE)|Death|1|||
170879761|NCT00455013|617571105|FG002|Long Term Extension (LTE)|Death|0|||
170879762|NCT00455013|617571103|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
170879763|NCT00455013|617571104|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
170879764|NCT00455013|617571105|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
170879765|NCT00455013|617571103|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
170879766|NCT00455013|617571104|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
170879767|NCT00455013|617571105|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
170879768|NCT00455013|617571103|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
170879769|NCT00455013|617571104|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
170879770|NCT00455013|617571105|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
170879771|NCT00455013|617571103|FG000|Long Term Extension (LTE)|non-specified|0|||
170879772|NCT00455013|617571104|FG001|Long Term Extension (LTE)|non-specified|0|||
170879773|NCT00455013|617571105|FG002|Long Term Extension (LTE)|non-specified|1|||
170879774|NCT01445951|617571106|FG000|Overall Study|Adverse Event|16|||
170879775|NCT01445951|617571107|FG001|Overall Study|Adverse Event|9|||
170879776|NCT01445951|617571108|FG002|Overall Study|Adverse Event|0|||
170879777|NCT01445951|617571106|FG000|Overall Study|Protocol Violation|2|||
170879778|NCT01445951|617571107|FG001|Overall Study|Protocol Violation|2|||
170879779|NCT01445951|617571108|FG002|Overall Study|Protocol Violation|2|||
170879780|NCT01445951|617571106|FG000|Overall Study|Withdrawal by Subject|21|||
170426120|NCT00965185|615902346|FG001|Overall Study|Lost to Follow-up|0|||
170879781|NCT01445951|617571107|FG001|Overall Study|Withdrawal by Subject|16|||
170426121|NCT00965185|615902345|FG000|Overall Study|Withdrawal by Subject|0|||
170879782|NCT01445951|617571108|FG002|Overall Study|Withdrawal by Subject|8|||
170879783|NCT01445951|617571106|FG000|Overall Study|Physician Decision|3|||
170879784|NCT01445951|617571107|FG001|Overall Study|Physician Decision|1|||
170879785|NCT01445951|617571108|FG002|Overall Study|Physician Decision|0|||
170879786|NCT01445951|617571106|FG000|Overall Study|Lost to Follow-up|1|||
170879787|NCT01445951|617571107|FG001|Overall Study|Lost to Follow-up|2|||
170879788|NCT01445951|617571108|FG002|Overall Study|Lost to Follow-up|4|||
170879789|NCT01445951|617571106|FG000|Overall Study|Pregnancy|0|||
170879790|NCT01445951|617571107|FG001|Overall Study|Pregnancy|1|||
170879791|NCT01445951|617571108|FG002|Overall Study|Pregnancy|4|||
170879792|NCT01445951|617571106|FG000|Overall Study|Death|0|||
170879793|NCT01445951|617571107|FG001|Overall Study|Death|0|||
170879794|NCT01445951|617571108|FG002|Overall Study|Death|1|||
170879795|NCT01445951|617571106|FG000|Overall Study|Non-compliance with study drug|1|||
170879796|NCT01445951|617571107|FG001|Overall Study|Non-compliance with study drug|2|||
170879797|NCT01445951|617571108|FG002|Overall Study|Non-compliance with study drug|0|||
170879798|NCT01445951|617571106|FG000|Overall Study|Non-compliance with protocol|0|||
170879799|NCT01445951|617571107|FG001|Overall Study|Non-compliance with protocol|1|||
170879800|NCT01445951|617571108|FG002|Overall Study|Non-compliance with protocol|0|||
170426122|NCT00965185|615902346|FG001|Overall Study|Withdrawal by Subject|1|||
170426123|NCT00858845|615902347|FG000|Overall Study|Patient underwent heart transplant.|0|||
170426124|NCT00858845|615902348|FG001|Overall Study|Patient underwent heart transplant.|1|||
170426125|NCT02409355|615902349|FG000|Overall Study|Withdrawal by Subject|1|||
170426126|NCT02409355|615902350|FG001|Overall Study|Withdrawal by Subject|0|||
170426127|NCT02409355|615902349|FG000|Overall Study|Death|1|||
170426128|NCT02409355|615902350|FG001|Overall Study|Death|1|||
170426129|NCT02409355|615902349|FG000|Overall Study|Study terminated by Sponsor|2|||
170426130|NCT02409355|615902350|FG001|Overall Study|Study terminated by Sponsor|3|||
170426131|NCT00389064|615902352|FG000|Overall Study|Adverse Event|11|||
170426132|NCT00389064|615902353|FG001|Overall Study|Adverse Event|3|||
170426133|NCT00389064|615902352|FG000|Overall Study|Lack of Efficacy|3|||
170426134|NCT00389064|615902353|FG001|Overall Study|Lack of Efficacy|14|||
170426135|NCT00389064|615902352|FG000|Overall Study|Withdrawal by Subject|17|||
170426136|NCT00389064|615902353|FG001|Overall Study|Withdrawal by Subject|27|||
170426137|NCT00389064|615902352|FG000|Overall Study|Physician Decision|2|||
170426138|NCT00389064|615902353|FG001|Overall Study|Physician Decision|2|||
170426139|NCT00389064|615902352|FG000|Overall Study|Lost to Follow-up|1|||
170426140|NCT00389064|615902353|FG001|Overall Study|Lost to Follow-up|2|||
170426141|NCT00389064|615902352|FG000|Overall Study|Protocol Violation|2|||
170426142|NCT00389064|615902353|FG001|Overall Study|Protocol Violation|0|||
170426143|NCT00389064|615902352|FG000|Overall Study|Multiple Reasons|9|||
170426144|NCT00389064|615902353|FG001|Overall Study|Multiple Reasons|11|||
170426145|NCT03707912|615902358|FG000|Overall Study|Violation of inclusion criteria|1|||
170426146|NCT03707912|615902359|FG001|Overall Study|Violation of inclusion criteria|0|||
170426147|NCT00727961|615902360|FG000|Overall Study|Lost to Follow-up|1|||
170426148|NCT00727961|615902360|FG000|Overall Study|Adverse Event|4|||
170426149|NCT00727961|615902360|FG000|Overall Study|Patient's refusal|2|||
170426150|NCT00727961|615902360|FG000|Overall Study|Progression|30|||
170426151|NCT03238781|615902361|FG000|Overall Study|Adverse Event|1|||
170426152|NCT03238781|615902362|FG001|Overall Study|Adverse Event|1|||
170426153|NCT03238781|615902363|FG002|Overall Study|Adverse Event|2|||
170426154|NCT03238781|615902361|FG000|Overall Study|Lost to Follow-up|2|||
170426155|NCT03238781|615902362|FG001|Overall Study|Lost to Follow-up|1|||
170426156|NCT03238781|615902363|FG002|Overall Study|Lost to Follow-up|2|||
170426157|NCT03238781|615902361|FG000|Overall Study|Withdrawal by Subject|23|||
170426158|NCT03238781|615902362|FG001|Overall Study|Withdrawal by Subject|14|||
170426159|NCT03238781|615902363|FG002|Overall Study|Withdrawal by Subject|16|||
170426160|NCT03238781|615902361|FG000|Overall Study|Decision by sponsor|0|||
170426161|NCT03238781|615902362|FG001|Overall Study|Decision by sponsor|1|||
170426162|NCT03238781|615902363|FG002|Overall Study|Decision by sponsor|0|||
170426163|NCT02186821|615902365|FG000|Overall Study|Adverse Event|9|||
170426164|NCT02186821|615902365|FG000|Overall Study|Death|2|||
170426165|NCT02186821|615902365|FG000|Overall Study|Disease progression|32|||
170426166|NCT02186821|615902365|FG000|Overall Study|Protocol Violation|1|||
170426167|NCT02186821|615902365|FG000|Overall Study|Physician Decision|1|||
170426168|NCT02186821|615902365|FG000|Overall Study|Study terminated by sponsor|2|||
170426169|NCT03772522|615903559|FG000|Pre-intervention|Withdrawal by Subject|3|||
170426170|NCT03772522|615903560|FG001|Pre-intervention|Withdrawal by Subject|4|||
170426171|NCT03772522|615903559|FG000|Intervention|Withdrawal by Subject|1|||
170426172|NCT03772522|615903560|FG001|Intervention|Withdrawal by Subject|0|||
170426173|NCT03772522|615903559|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
170426174|NCT03772522|615903560|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
170426175|NCT02096211|615903564|FG000|Overall Study|Death|2|||
170426176|NCT02096211|615903564|FG000|Overall Study|Withdrawal by Subject|8|||
170426177|NCT02096211|615903564|FG000|Overall Study|Revision of implant|7|||
170426178|NCT02096211|615903564|FG000|Overall Study|Lost to Follow-up|43|||
170426179|NCT01993030|615903568|FG000|Overall Study|Adverse Event|0|||
170426180|NCT01993030|615903569|FG001|Overall Study|Adverse Event|4|||
170426181|NCT03785548|615903570|FG000|Overall Study|age > 80|1|||
170426182|NCT03785548|615903571|FG001|Overall Study|age > 80|0|||
170426183|NCT03785548|615903570|FG000|Overall Study|no Postop queries|1|||
170426184|NCT03785548|615903571|FG001|Overall Study|no Postop queries|0|||
170426185|NCT01591785|615903572|FG000|Overall Study|worsening condition|1|||
170879801|NCT01445951|617571106|FG000|Overall Study|Sponsor decision - subject travel|0|||
170879802|NCT01445951|617571107|FG001|Overall Study|Sponsor decision - subject travel|1|||
170426186|NCT01591785|615903573|FG001|Overall Study|worsening condition|2|||
170426187|NCT01591785|615903572|FG000|Overall Study|Protocol Violation|2|||
170426188|NCT01591785|615903573|FG001|Overall Study|Protocol Violation|0|||
170426189|NCT01591785|615903572|FG000|Overall Study|Lost to Follow-up|1|||
170426190|NCT01591785|615903573|FG001|Overall Study|Lost to Follow-up|0|||
170426191|NCT01049334|615903574|FG000|Overall Study|Withdrawal by Subject|5|||
170426192|NCT01049334|615903575|FG001|Overall Study|Withdrawal by Subject|3|||
170426193|NCT01049334|615903574|FG000|Overall Study|Adverse Event|2|||
170426194|NCT01049334|615903575|FG001|Overall Study|Adverse Event|3|||
170426195|NCT01049334|615903574|FG000|Overall Study|Physician Decision|2|||
170426196|NCT01049334|615903575|FG001|Overall Study|Physician Decision|0|||
170426197|NCT01049334|615903574|FG000|Overall Study|Protocol Violation|0|||
170426198|NCT01049334|615903575|FG001|Overall Study|Protocol Violation|1|||
170426199|NCT00396279|615903576|FG000|Overall Study|Ongoing in study|26|||
170426200|NCT00396279|615903576|FG000|Overall Study|Disease progression|2|||
170426201|NCT00396279|615903576|FG000|Overall Study|Withdrawal by Subject|1|||
170426202|NCT00396279|615903576|FG000|Overall Study|Physician Decision|1|||
170426203|NCT02883452|615903577|FG000|Overall Study|Withdrawal by Subject|1|||
170426204|NCT02883452|615903578|FG001|Overall Study|Withdrawal by Subject|1|||
170426205|NCT02883452|615903579|FG002|Overall Study|Withdrawal by Subject|3|||
170426206|NCT02883452|615903580|FG003|Overall Study|Withdrawal by Subject|0|||
170426207|NCT02883452|615903581|FG004|Overall Study|Withdrawal by Subject|2|||
170426208|NCT02883452|615903582|FG005|Overall Study|Withdrawal by Subject|5|||
170426209|NCT02883452|615903577|FG000|Overall Study|Disease progression|1|||
170426210|NCT02883452|615903578|FG001|Overall Study|Disease progression|0|||
170426211|NCT02883452|615903579|FG002|Overall Study|Disease progression|0|||
170426212|NCT02883452|615903580|FG003|Overall Study|Disease progression|1|||
170426213|NCT02883452|615903581|FG004|Overall Study|Disease progression|4|||
170426214|NCT02883452|615903582|FG005|Overall Study|Disease progression|5|||
170426215|NCT02883452|615903577|FG000|Overall Study|Adverse Event|2|||
170426216|NCT02883452|615903578|FG001|Overall Study|Adverse Event|1|||
170426217|NCT02883452|615903579|FG002|Overall Study|Adverse Event|1|||
170426218|NCT02883452|615903580|FG003|Overall Study|Adverse Event|1|||
170426219|NCT02883452|615903581|FG004|Overall Study|Adverse Event|1|||
170426220|NCT02883452|615903582|FG005|Overall Study|Adverse Event|3|||
170426221|NCT02883452|615903577|FG000|Overall Study|Physician Decision|0|||
170426222|NCT02883452|615903578|FG001|Overall Study|Physician Decision|0|||
170426223|NCT02883452|615903579|FG002|Overall Study|Physician Decision|0|||
170426224|NCT02883452|615903580|FG003|Overall Study|Physician Decision|0|||
170426225|NCT02883452|615903581|FG004|Overall Study|Physician Decision|4|||
170426226|NCT02883452|615903582|FG005|Overall Study|Physician Decision|1|||
170426227|NCT02883452|615903577|FG000|Overall Study|Death|1|||
170426228|NCT02883452|615903578|FG001|Overall Study|Death|0|||
170426229|NCT02883452|615903579|FG002|Overall Study|Death|1|||
170426230|NCT02883452|615903580|FG003|Overall Study|Death|0|||
170426231|NCT02883452|615903581|FG004|Overall Study|Death|0|||
170426232|NCT02883452|615903582|FG005|Overall Study|Death|0|||
170426233|NCT02883452|615903577|FG000|Overall Study|Other|0|||
170426234|NCT02883452|615903578|FG001|Overall Study|Other|0|||
170426235|NCT02883452|615903579|FG002|Overall Study|Other|0|||
170426236|NCT02883452|615903580|FG003|Overall Study|Other|0|||
170426237|NCT02883452|615903581|FG004|Overall Study|Other|0|||
170426238|NCT02883452|615903582|FG005|Overall Study|Other|1|||
170426239|NCT00461786|615903587|FG000|Overall Study|Entry Criteria Not Met|2|||
170426240|NCT00461786|615903587|FG000|Overall Study|Inevaluable (Never Treated)|1|||
170426241|NCT00834067|615903589|FG000|Washout of 21 Days|Protocol Violation|0|||
170426242|NCT00834067|615903590|FG001|Washout of 21 Days|Protocol Violation|1|||
170426243|NCT00829790|615903591|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
170426244|NCT00829790|615903592|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
170426245|NCT03154047|615903593|FG000|Overall Study|Death|1|||
170426246|NCT03154047|615903593|FG000|Overall Study|Study terminated by sponsor|76|||
170426247|NCT03154047|615903593|FG000|Overall Study|Withdrawal by Subject|3|||
170426248|NCT00857454|615903594|FG000|Overall Study|Withdrawal by Subject|2|||
170426249|NCT00857454|615903594|FG000|Overall Study|Lost to Follow-up|1|||
170426250|NCT00857454|615903594|FG000|Overall Study|Adverse Event|2|||
170426251|NCT00857454|615903594|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
170426252|NCT00857454|615903594|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
170426253|NCT00857454|615903594|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
170426254|NCT00365365|615903595|FG000|Overall Study|Randomized but not treated|0|||
170879803|NCT01445951|617571108|FG002|Overall Study|Sponsor decision - subject travel|0|||
170426255|NCT00365365|615903596|FG001|Overall Study|Randomized but not treated|2|||
170426256|NCT00365365|615903597|FG002|Overall Study|Randomized but not treated|0|||
170426257|NCT00365365|615903595|FG000|Overall Study|Poor compliance to protocol|0|||
170426258|NCT00365365|615903596|FG001|Overall Study|Poor compliance to protocol|1|||
170426259|NCT00365365|615903597|FG002|Overall Study|Poor compliance to protocol|0|||
170426260|NCT00365365|615903595|FG000|Overall Study|Lost to Follow-up|3|||
170426261|NCT00365365|615903596|FG001|Overall Study|Lost to Follow-up|3|||
170426262|NCT00365365|615903597|FG002|Overall Study|Lost to Follow-up|3|||
170426263|NCT00365365|615903595|FG000|Overall Study|Death|1|||
170426264|NCT00365365|615903596|FG001|Overall Study|Death|3|||
170426265|NCT00365365|615903597|FG002|Overall Study|Death|0|||
170426266|NCT00365365|615903595|FG000|Overall Study|Subject's request|11|||
170426267|NCT00365365|615903596|FG001|Overall Study|Subject's request|13|||
170426268|NCT00365365|615903597|FG002|Overall Study|Subject's request|1|||
170426269|NCT00365365|615903595|FG000|Overall Study|Disease progression/relapse|9|||
170426270|NCT00365365|615903596|FG001|Overall Study|Disease progression/relapse|6|||
170426271|NCT00365365|615903597|FG002|Overall Study|Disease progression/relapse|7|||
170426272|NCT00365365|615903595|FG000|Overall Study|Adverse Event|6|||
170879804|NCT01445951|617571106|FG000|Overall Study|Cough|0|||
170879805|NCT01445951|617571107|FG001|Overall Study|Cough|1|||
170879806|NCT01445951|617571108|FG002|Overall Study|Cough|0|||
170879807|NCT00078325|617571111|FG000|Overall Study|Adverse Event|15|||
170879808|NCT00078325|617571112|FG001|Overall Study|Adverse Event|10|||
170879809|NCT00078325|617571113|FG002|Overall Study|Adverse Event|5|||
170879810|NCT00078325|617571111|FG000|Overall Study|Protocol Violation|2|||
170879811|NCT00078325|617571112|FG001|Overall Study|Protocol Violation|2|||
170879812|NCT00078325|617571113|FG002|Overall Study|Protocol Violation|0|||
170879813|NCT00078325|617571111|FG000|Overall Study|Withdrawal by Subject|1|||
170879814|NCT00078325|617571112|FG001|Overall Study|Withdrawal by Subject|5|||
170879815|NCT00078325|617571113|FG002|Overall Study|Withdrawal by Subject|3|||
170879816|NCT00078325|617571111|FG000|Overall Study|Lost to Follow-up|0|||
170879817|NCT00078325|617571112|FG001|Overall Study|Lost to Follow-up|1|||
170879818|NCT00078325|617571113|FG002|Overall Study|Lost to Follow-up|1|||
170879819|NCT00078325|617571111|FG000|Overall Study|Physician Decision|2|||
170879820|NCT00078325|617571112|FG001|Overall Study|Physician Decision|0|||
170879821|NCT00078325|617571113|FG002|Overall Study|Physician Decision|1|||
170879822|NCT00078325|617571111|FG000|Overall Study|Miscellaneous|1|||
170879823|NCT00078325|617571112|FG001|Overall Study|Miscellaneous|1|||
170879824|NCT00078325|617571113|FG002|Overall Study|Miscellaneous|1|||
170879825|NCT00932360|617571119|FG000|Washout (One Week)|Withdrawal by Subject|0|||
170879826|NCT00932360|617571120|FG001|Washout (One Week)|Withdrawal by Subject|0|||
170879827|NCT00932360|617571121|FG002|Washout (One Week)|Withdrawal by Subject|0|||
170879828|NCT00932360|617571122|FG003|Washout (One Week)|Withdrawal by Subject|0|||
170879829|NCT00932360|617571123|FG004|Washout (One Week)|Withdrawal by Subject|2|||
170879830|NCT00932360|617571124|FG005|Washout (One Week)|Withdrawal by Subject|0|||
170879831|NCT02536313|617571125|FG000|Overall Study|Lack of Efficacy|0|||
170879832|NCT02536313|617571126|FG001|Overall Study|Lack of Efficacy|1|||
170879833|NCT00917150|617571131|FG000|Overall Study|Adverse Event|12|||
170879834|NCT00917150|617571132|FG001|Overall Study|Adverse Event|7|||
170879835|NCT00917150|617571133|FG002|Overall Study|Adverse Event|12|||
170879836|NCT00917150|617571134|FG003|Overall Study|Adverse Event|11|||
170879837|NCT00917150|617571131|FG000|Overall Study|Death|1|||
170879838|NCT00917150|617571132|FG001|Overall Study|Death|4|||
170879839|NCT00917150|617571133|FG002|Overall Study|Death|3|||
170879840|NCT00917150|617571134|FG003|Overall Study|Death|2|||
170879841|NCT00917150|617571131|FG000|Overall Study|Lost to Follow-up|1|||
170879842|NCT00917150|617571132|FG001|Overall Study|Lost to Follow-up|0|||
170879843|NCT00917150|617571133|FG002|Overall Study|Lost to Follow-up|4|||
170879844|NCT00917150|617571134|FG003|Overall Study|Lost to Follow-up|2|||
170879845|NCT00917150|617571131|FG000|Overall Study|Physician Decision|0|||
170879846|NCT00917150|617571132|FG001|Overall Study|Physician Decision|2|||
170879847|NCT00917150|617571133|FG002|Overall Study|Physician Decision|0|||
170879848|NCT00917150|617571134|FG003|Overall Study|Physician Decision|1|||
170879849|NCT00917150|617571131|FG000|Overall Study|Protocol Violation|5|||
170879850|NCT00917150|617571132|FG001|Overall Study|Protocol Violation|5|||
170879851|NCT00917150|617571133|FG002|Overall Study|Protocol Violation|3|||
170879852|NCT00917150|617571134|FG003|Overall Study|Protocol Violation|5|||
170879853|NCT00917150|617571131|FG000|Overall Study|Withdrawal by Subject|15|||
170879854|NCT00917150|617571132|FG001|Overall Study|Withdrawal by Subject|16|||
170879855|NCT00917150|617571133|FG002|Overall Study|Withdrawal by Subject|18|||
170879856|NCT00917150|617571134|FG003|Overall Study|Withdrawal by Subject|11|||
170879857|NCT00917150|617571131|FG000|Overall Study|Other than specified|3|||
170879858|NCT00917150|617571132|FG001|Overall Study|Other than specified|3|||
170879859|NCT00917150|617571133|FG002|Overall Study|Other than specified|2|||
170879860|NCT00917150|617571134|FG003|Overall Study|Other than specified|2|||
170879861|NCT02039375|617571135|FG000|Overall Study|Lost to Follow-up|2|||
170879862|NCT03891264|617571137|FG000|Overall Study|Adverse Event|1|||
170879863|NCT03891264|617571137|FG000|Overall Study|Withdrawal by Subject|2|||
170879864|NCT03891264|617571137|FG000|Overall Study|Physician Decision|2|||
170879865|NCT01924182|617571138|FG000|Overall Study|Withdrawal by Subject|1|||
170879866|NCT01924182|617571139|FG001|Overall Study|Withdrawal by Subject|0|||
170879867|NCT04143009|617571141|FG000|Pilot Trial|Lost to Follow-up|0|||
170879868|NCT04143009|617571142|FG001|Pilot Trial|Lost to Follow-up|1|||
170426273|NCT00365365|615903596|FG001|Overall Study|Adverse Event|6|||
170426274|NCT00365365|615903597|FG002|Overall Study|Adverse Event|3|||
170426275|NCT00365365|615903595|FG000|Overall Study|Moved|2|||
170426276|NCT00365365|615903596|FG001|Overall Study|Moved|0|||
170426277|NCT00365365|615903597|FG002|Overall Study|Moved|0|||
170426278|NCT00365365|615903595|FG000|Overall Study|New cancer|1|||
170426279|NCT00365365|615903596|FG001|Overall Study|New cancer|0|||
170426280|NCT00365365|615903597|FG002|Overall Study|New cancer|0|||
170426281|NCT00365365|615903595|FG000|Overall Study|Withdrew consent|1|||
170426282|NCT00365365|615903596|FG001|Overall Study|Withdrew consent|1|||
170426283|NCT00365365|615903597|FG002|Overall Study|Withdrew consent|0|||
170426284|NCT00365365|615903595|FG000|Overall Study|Second malignancy|0|||
170426285|NCT00365365|615903596|FG001|Overall Study|Second malignancy|1|||
170426286|NCT00365365|615903597|FG002|Overall Study|Second malignancy|0|||
170426287|NCT00365365|615903595|FG000|Overall Study|Patient/physician decision|0|||
170426288|NCT00365365|615903596|FG001|Overall Study|Patient/physician decision|0|||
170426289|NCT00365365|615903597|FG002|Overall Study|Patient/physician decision|1|||
170426290|NCT00984022|615903598|FG000|Overall Study|Lost to Follow-up|10|||
170426291|NCT00984022|615903599|FG001|Overall Study|Lost to Follow-up|14|||
170426292|NCT04567186|615903603|FG000|Period 1|COVID-19 related|1|||
170426293|NCT04567186|615903604|FG001|Period 1|COVID-19 related|0|||
170426294|NCT04567186|615903603|FG000|Period 1|Protocol Violation|0|||
170426295|NCT04567186|615903604|FG001|Period 1|Protocol Violation|1|||
170426296|NCT04567186|615903603|FG000|Period 1|Adverse Event|0|||
170426297|NCT04567186|615903604|FG001|Period 1|Adverse Event|2|||
170426298|NCT04567186|615903603|FG000|Period 2|COVID-19 Related|0|||
170426299|NCT04567186|615903604|FG001|Period 2|COVID-19 Related|1|||
170426300|NCT04567186|615903603|FG000|Period 2|Protocol Violation|0|||
170426301|NCT04567186|615903604|FG001|Period 2|Protocol Violation|1|||
170426302|NCT04567186|615903603|FG000|Period 2|Lost to Follow-up|0|||
170426303|NCT04567186|615903604|FG001|Period 2|Lost to Follow-up|1|||
170426304|NCT04567186|615903603|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
170426305|NCT04567186|615903604|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
170426306|NCT00086996|615903606|FG000|Overall Study|Adverse Event|29|||
170426307|NCT00086996|615903606|FG000|Overall Study|Death|4|||
170426308|NCT00086996|615903606|FG000|Overall Study|progression/relapse|7|||
170426309|NCT00086996|615903606|FG000|Overall Study|Withdrawal by Subject|13|||
170426310|NCT00086996|615903606|FG000|Overall Study|Other|6|||
170426311|NCT00086996|615903606|FG000|Overall Study|not eligible|5|||
170426312|NCT02865850|615903607|FG000|Overall Study|Death|15|||
170426313|NCT02865850|615903608|FG001|Overall Study|Death|19|||
170426314|NCT02865850|615903607|FG000|Overall Study|Withdrawal by Subject|3|||
170426315|NCT02865850|615903608|FG001|Overall Study|Withdrawal by Subject|2|||
170426316|NCT02865850|615903607|FG000|Overall Study|Lost to Follow-up|3|||
170426317|NCT02865850|615903608|FG001|Overall Study|Lost to Follow-up|2|||
170426318|NCT02682784|615903612|FG000|Overall Study|Withdrawal by Subject|0|||
170426319|NCT02682784|615903613|FG001|Overall Study|Withdrawal by Subject|2|||
170426320|NCT02682784|615903614|FG002|Overall Study|Withdrawal by Subject|1|||
170426321|NCT02682784|615903615|FG003|Overall Study|Withdrawal by Subject|2|||
170426322|NCT02682784|615903612|FG000|Overall Study|Physician Decision|1|||
170426323|NCT02682784|615903613|FG001|Overall Study|Physician Decision|0|||
170426324|NCT02682784|615903614|FG002|Overall Study|Physician Decision|1|||
170426325|NCT02682784|615903615|FG003|Overall Study|Physician Decision|1|||
170426326|NCT00904215|615903616|FG000|Overall Study|Adverse Event|25|||
170426327|NCT00904215|615903616|FG000|Overall Study|Protocol Violation|10|||
170426328|NCT00904215|615903616|FG000|Overall Study|Lost to Follow-up|63|||
170426329|NCT00904215|615903616|FG000|Overall Study|Withdrawal by Subject|9|||
170426330|NCT00904215|615903616|FG000|Overall Study|Other|28|||
170426331|NCT02699866|615903617|FG000|Overall Study|Withdrawal by Subject|3|||
170426332|NCT02699866|615903617|FG000|Overall Study|Physician Decision|2|||
170426333|NCT02699866|615903617|FG000|Overall Study|Adverse Event|3|||
170426334|NCT02937870|615903618|FG000|Overall Study|Adverse Event|1|||
170426335|NCT02937870|615903618|FG000|Overall Study|Protocol Deviation|2|||
170426336|NCT01185821|615903622|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170426337|NCT01185821|615903623|FG001|Overall Study|Abnormal laboratory value(s)|2|||
170426338|NCT01185821|615903624|FG002|Overall Study|Abnormal laboratory value(s)|1|||
170426339|NCT01185821|615903625|FG003|Overall Study|Abnormal laboratory value(s)|0|||
170426340|NCT01185821|615903626|FG004|Overall Study|Abnormal laboratory value(s)|0|||
170426341|NCT01185821|615903622|FG000|Overall Study|Protocol Violation|0|||
170426342|NCT01185821|615903623|FG001|Overall Study|Protocol Violation|0|||
170426343|NCT01185821|615903624|FG002|Overall Study|Protocol Violation|0|||
170426344|NCT01185821|615903625|FG003|Overall Study|Protocol Violation|1|||
170426345|NCT01185821|615903626|FG004|Overall Study|Protocol Violation|1|||
170426346|NCT01185821|615903622|FG000|Overall Study|Abnormal test procedure result|0|||
170426347|NCT01185821|615903623|FG001|Overall Study|Abnormal test procedure result|0|||
170426348|NCT01185821|615903624|FG002|Overall Study|Abnormal test procedure result|0|||
170426349|NCT01185821|615903625|FG003|Overall Study|Abnormal test procedure result|0|||
170426350|NCT01185821|615903626|FG004|Overall Study|Abnormal test procedure result|1|||
170426351|NCT01185821|615903622|FG000|Overall Study|Death|0|||
170426352|NCT01185821|615903623|FG001|Overall Study|Death|1|||
170426353|NCT01185821|615903624|FG002|Overall Study|Death|0|||
170426354|NCT01185821|615903625|FG003|Overall Study|Death|0|||
170426355|NCT01185821|615903626|FG004|Overall Study|Death|0|||
170426356|NCT01185821|615903622|FG000|Overall Study|Condition no longer required study drug|0|||
170426357|NCT01185821|615903623|FG001|Overall Study|Condition no longer required study drug|0|||
170426358|NCT01185821|615903624|FG002|Overall Study|Condition no longer required study drug|0|||
170426359|NCT01185821|615903625|FG003|Overall Study|Condition no longer required study drug|0|||
170426360|NCT01185821|615903626|FG004|Overall Study|Condition no longer required study drug|1|||
170426361|NCT01185821|615903622|FG000|Overall Study|Adverse Event|2|||
170426362|NCT01185821|615903623|FG001|Overall Study|Adverse Event|3|||
170426363|NCT01185821|615903624|FG002|Overall Study|Adverse Event|1|||
170426364|NCT01185821|615903625|FG003|Overall Study|Adverse Event|2|||
170426365|NCT01185821|615903626|FG004|Overall Study|Adverse Event|5|||
170426366|NCT01185821|615903622|FG000|Overall Study|Lack of Efficacy|0|||
170426367|NCT01185821|615903623|FG001|Overall Study|Lack of Efficacy|0|||
170426368|NCT01185821|615903624|FG002|Overall Study|Lack of Efficacy|3|||
170426369|NCT01185821|615903625|FG003|Overall Study|Lack of Efficacy|0|||
170426370|NCT01185821|615903626|FG004|Overall Study|Lack of Efficacy|9|||
170426371|NCT01185821|615903622|FG000|Overall Study|Withdrawal by Subject|3|||
170426372|NCT01185821|615903623|FG001|Overall Study|Withdrawal by Subject|2|||
170426373|NCT01185821|615903624|FG002|Overall Study|Withdrawal by Subject|2|||
170426374|NCT01185821|615903625|FG003|Overall Study|Withdrawal by Subject|1|||
170426375|NCT01185821|615903626|FG004|Overall Study|Withdrawal by Subject|3|||
170426376|NCT01185821|615903622|FG000|Overall Study|Lost to Follow-up|1|||
170426377|NCT01185821|615903623|FG001|Overall Study|Lost to Follow-up|1|||
170426378|NCT01185821|615903624|FG002|Overall Study|Lost to Follow-up|2|||
170426379|NCT01185821|615903625|FG003|Overall Study|Lost to Follow-up|1|||
170426380|NCT01185821|615903626|FG004|Overall Study|Lost to Follow-up|2|||
170426381|NCT01185821|615903622|FG000|Overall Study|Administrative problems|0|||
170426382|NCT01185821|615903623|FG001|Overall Study|Administrative problems|0|||
170426383|NCT01185821|615903624|FG002|Overall Study|Administrative problems|1|||
170426384|NCT01185821|615903625|FG003|Overall Study|Administrative problems|1|||
170426385|NCT01185821|615903626|FG004|Overall Study|Administrative problems|2|||
170426386|NCT04263649|615903632|FG000|Overall Study|Adverse Event|53|||
170426387|NCT04263649|615903632|FG000|Overall Study|Lost to Follow-up|3|||
170426388|NCT04263649|615903632|FG000|Overall Study|Death|29|||
170426389|NCT04263649|615903632|FG000|Overall Study|Device deficiency|19|||
170426390|NCT04263649|615903632|FG000|Overall Study|other reasons|11|||
170426391|NCT02057458|615903633|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
170426392|NCT02057458|615903634|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
170426393|NCT02057458|615903635|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
170426394|NCT02057458|615903633|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
170426395|NCT02057458|615903634|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
170426396|NCT02057458|615903635|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
170426397|NCT02057458|615903633|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
170426398|NCT02057458|615903634|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
170426399|NCT02057458|615903635|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
170426400|NCT05169710|615903636|FG000|Overall Study|Adverse Event|1|||
170426401|NCT05169710|615903637|FG001|Overall Study|Adverse Event|2|||
170426402|NCT05169710|615903638|FG002|Overall Study|Adverse Event|2|||
170426403|NCT05169710|615903636|FG000|Overall Study|Lost to Follow-up|0|||
170426404|NCT05169710|615903637|FG001|Overall Study|Lost to Follow-up|0|||
170426405|NCT05169710|615903638|FG002|Overall Study|Lost to Follow-up|1|||
170426406|NCT05169710|615903636|FG000|Overall Study|Withdrawal by Subject|2|||
170426407|NCT05169710|615903637|FG001|Overall Study|Withdrawal by Subject|1|||
170426408|NCT05169710|615903638|FG002|Overall Study|Withdrawal by Subject|0|||
170426409|NCT05169710|615903636|FG000|Overall Study|Other Study Discontinuation Reason|0|||
170426410|NCT05169710|615903637|FG001|Overall Study|Other Study Discontinuation Reason|2|||
170426411|NCT05169710|615903638|FG002|Overall Study|Other Study Discontinuation Reason|0|||
170426412|NCT04405570|615903643|FG000|Overall Study|Adverse Event|0|||
170426413|NCT04405570|615903644|FG001|Overall Study|Adverse Event|1|||
170426414|NCT04405570|615903645|FG002|Overall Study|Adverse Event|1|||
170426415|NCT04405570|615903646|FG003|Overall Study|Adverse Event|1|||
170426416|NCT04405570|615903643|FG000|Overall Study|Lost to Follow-up|0|||
170426417|NCT04405570|615903644|FG001|Overall Study|Lost to Follow-up|1|||
170426418|NCT04405570|615903645|FG002|Overall Study|Lost to Follow-up|0|||
170426419|NCT04405570|615903646|FG003|Overall Study|Lost to Follow-up|0|||
170426420|NCT04405570|615903643|FG000|Overall Study|Physician Decision|0|||
170426421|NCT04405570|615903644|FG001|Overall Study|Physician Decision|0|||
170426422|NCT04405570|615903645|FG002|Overall Study|Physician Decision|1|||
170565467|NCT03545672|616418527|FG000|Overall Study|Protocol Violation|2|||
170426423|NCT04405570|615903646|FG003|Overall Study|Physician Decision|0|||
170426424|NCT04405570|615903643|FG000|Overall Study|Withdrawal by Subject|0|||
170426425|NCT04405570|615903644|FG001|Overall Study|Withdrawal by Subject|1|||
170426426|NCT04405570|615903645|FG002|Overall Study|Withdrawal by Subject|1|||
170426427|NCT04405570|615903646|FG003|Overall Study|Withdrawal by Subject|0|||
170534137|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
170534138|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
170534139|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
170534140|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
170534141|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
170534142|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
170534143|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
170534144|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
170534145|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
170534146|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
170534147|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
170534148|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
170534149|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
170534150|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
170534151|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
170534152|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
170534153|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
170534154|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
170534155|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
170534156|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
170534157|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
170534158|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
170534159|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
170534160|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
170534161|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
170534162|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
170534163|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
170534164|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
170534165|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
170534166|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
170534167|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
170534168|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
170534169|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
170534170|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
170534171|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
170534172|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
170534173|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
170534174|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
170534175|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
170534176|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
170534177|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
170534178|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
170534179|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
170534180|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
170534181|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
170534182|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
170534183|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
170879869|NCT04143009|617571143|FG002|Pilot Trial|Lost to Follow-up|1|||
170879870|NCT00993265|617571144|FG000|Overall Study|Adverse Event|1|||
170879871|NCT00993265|617571145|FG001|Overall Study|Adverse Event|0|||
170879872|NCT00993265|617571144|FG000|Overall Study|Changed dose of concomitant drug|2|||
170879873|NCT00993265|617571145|FG001|Overall Study|Changed dose of concomitant drug|0|||
170879874|NCT00993265|617571144|FG000|Overall Study|Non-compliant with study medication|1|||
170879875|NCT00993265|617571145|FG001|Overall Study|Non-compliant with study medication|0|||
170879876|NCT01357655|617571146|FG000|Overall Study|Administrative Reason by Sponsor|45|||
170879877|NCT01357655|617571147|FG001|Overall Study|Administrative Reason by Sponsor|0|||
170879878|NCT01357655|617571146|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
170879879|NCT01357655|617571147|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170879880|NCT01357655|617571146|FG000|Overall Study|Disease Progression|1|||
170879881|NCT01357655|617571147|FG001|Overall Study|Disease Progression|0|||
170879882|NCT01357655|617571146|FG000|Overall Study|Lost to Follow-up|2|||
170879883|NCT01357655|617571147|FG001|Overall Study|Lost to Follow-up|0|||
170879884|NCT01357655|617571146|FG000|Overall Study|Maximum Clinical Benefit|2|||
170879885|NCT01357655|617571147|FG001|Overall Study|Maximum Clinical Benefit|0|||
170426428|NCT04405570|615903643|FG000|Overall Study|Randomized not dosed|0|||
170879886|NCT01357655|617571146|FG000|Overall Study|Reason Unspecified|1|||
170879887|NCT01357655|617571147|FG001|Overall Study|Reason Unspecified|0|||
170879888|NCT01357655|617571146|FG000|Overall Study|Study Drug Toxicity|11|||
170879889|NCT01357655|617571147|FG001|Overall Study|Study Drug Toxicity|0|||
170879890|NCT01357655|617571146|FG000|Overall Study|Subject Withdrew Consent|1|||
170879891|NCT01357655|617571147|FG001|Overall Study|Subject Withdrew Consent|0|||
170879892|NCT00531752|617571148|FG000|First Double-blind Intervention Period|Adverse Event|2|||
170879893|NCT00531752|617571149|FG001|First Double-blind Intervention Period|Adverse Event|0|||
170879894|NCT00531752|617571150|FG002|First Double-blind Intervention Period|Adverse Event|1|||
170879895|NCT00531752|617571151|FG003|First Double-blind Intervention Period|Adverse Event|1|||
170879896|NCT00531752|617571148|FG000|First Double-blind Intervention Period|Other|1|||
170879897|NCT00531752|617571149|FG001|First Double-blind Intervention Period|Other|4|||
170879898|NCT00531752|617571150|FG002|First Double-blind Intervention Period|Other|4|||
170879899|NCT00531752|617571151|FG003|First Double-blind Intervention Period|Other|0|||
170879900|NCT00531752|617571148|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
170879901|NCT00531752|617571149|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
170879902|NCT00531752|617571150|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
170879903|NCT00531752|617571151|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
170879904|NCT00531752|617571148|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
170879905|NCT00531752|617571149|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
170879906|NCT00531752|617571150|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
170879907|NCT00531752|617571151|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
170879908|NCT00531752|617571148|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
170879909|NCT00531752|617571149|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
170879910|NCT00531752|617571150|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
170879911|NCT00531752|617571151|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
170879912|NCT00531752|617571148|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
170879913|NCT00531752|617571149|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
170879914|NCT00531752|617571150|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
170879915|NCT00531752|617571151|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
170879916|NCT00531752|617571148|FG000|Second Double-blind Intervention Period|Other|1|||
170879917|NCT00531752|617571149|FG001|Second Double-blind Intervention Period|Other|1|||
170879918|NCT00531752|617571150|FG002|Second Double-blind Intervention Period|Other|0|||
170879919|NCT00531752|617571151|FG003|Second Double-blind Intervention Period|Other|0|||
170879920|NCT00531752|617571148|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
170879921|NCT00531752|617571149|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
170879922|NCT00531752|617571150|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
170879923|NCT00531752|617571151|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
170879924|NCT00531752|617571148|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
170426429|NCT04405570|615903644|FG001|Overall Study|Randomized not dosed|2|||
170426430|NCT04405570|615903645|FG002|Overall Study|Randomized not dosed|0|||
170426431|NCT04405570|615903646|FG003|Overall Study|Randomized not dosed|0|||
170426432|NCT00723710|615903647|FG000|Overall Study|Disease progression|48|||
170426433|NCT00723710|615903647|FG000|Overall Study|Adverse Event|88|||
170426434|NCT00723710|615903647|FG000|Overall Study|Withdrawal by Subject|36|||
170426435|NCT00723710|615903647|FG000|Overall Study|Physician Decision|2|||
170426436|NCT04499963|615903648|FG000|Overall Study|Adverse Event|3|||
170426437|NCT04499963|615903649|FG001|Overall Study|Adverse Event|0|||
170426438|NCT04499963|615903648|FG000|Overall Study|Death|3|||
170426439|NCT04499963|615903649|FG001|Overall Study|Death|0|||
170426440|NCT04499963|615903648|FG000|Overall Study|Lack of Efficacy|7|||
170426441|NCT04499963|615903649|FG001|Overall Study|Lack of Efficacy|0|||
170426442|NCT04499963|615903648|FG000|Overall Study|Lost to Follow-up|2|||
170426443|NCT04499963|615903649|FG001|Overall Study|Lost to Follow-up|0|||
170426444|NCT01208337|615903655|FG000|Overall Study|Death|3|||
170426445|NCT00836056|615903659|FG000|First Intervention|Adverse Event|1|||
170426446|NCT00836056|615903660|FG001|First Intervention|Adverse Event|0|||
170426447|NCT01265056|615903664|FG000|Initial Study Period|Withdrawal by Subject|1|||
170426448|NCT01265056|615903665|FG001|Initial Study Period|Withdrawal by Subject|1|||
170426449|NCT01265056|615903664|FG000|Initial Study Period|Withdrawal by Subject|1|||
170426450|NCT01265056|615903665|FG001|Initial Study Period|Withdrawal by Subject|1|||
170426451|NCT01265056|615903664|FG000|Follow up|Lost to Follow-up|7|||
170426452|NCT01265056|615903665|FG001|Follow up|Lost to Follow-up|3|||
170426453|NCT02601625|615903666|FG000|Overall Study|Lost to Follow-up|0|||
170426454|NCT02601625|615903667|FG001|Overall Study|Lost to Follow-up|0|||
170426455|NCT02601625|615903668|FG002|Overall Study|Lost to Follow-up|1|||
170426456|NCT02601625|615903669|FG003|Overall Study|Lost to Follow-up|1|||
170426457|NCT03031847|615903672|FG000|Overall Study|Death|1|||
170534184|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
170565468|NCT03545672|616418528|FG001|Overall Study|Protocol Violation|2|||
170534185|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
170534186|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
170534187|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
170534188|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
170534189|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
170534190|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
170534191|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
170534192|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
170534193|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
170426458|NCT03031847|615903673|FG001|Overall Study|Death|1|||
170426459|NCT03031847|615903674|FG002|Overall Study|Death|2|||
170426460|NCT03031847|615903675|FG003|Overall Study|Death|3|||
170426461|NCT03031847|615903672|FG000|Overall Study|Lost to Follow-up|1|||
170426462|NCT03031847|615903673|FG001|Overall Study|Lost to Follow-up|1|||
170426463|NCT03031847|615903674|FG002|Overall Study|Lost to Follow-up|2|||
170426464|NCT03031847|615903675|FG003|Overall Study|Lost to Follow-up|3|||
170426465|NCT01353664|615903676|FG000|Overall Study|Other|3|||
170426466|NCT01353664|615903676|FG000|Overall Study|Disease Progression|16|||
170426467|NCT01908205|615903677|FG000|Overall Study|Lost to Follow-up|2|||
170426468|NCT01908205|615903678|FG001|Overall Study|Lost to Follow-up|0|||
170426469|NCT01908205|615903677|FG000|Overall Study|Withdrawal by Subject|3|||
170426470|NCT01908205|615903678|FG001|Overall Study|Withdrawal by Subject|1|||
170426471|NCT05323396|615903679|FG000|Overall Study|Lost to Follow-up|1|||
170426472|NCT05323396|615903680|FG001|Overall Study|Lost to Follow-up|35|||
170426473|NCT05323396|615903679|FG000|Overall Study|Pregnancy|1|||
170426474|NCT05323396|615903680|FG001|Overall Study|Pregnancy|0|||
170426475|NCT01697696|615903681|FG000|Overall Study|Study terminated by sponsor|0|||
170426476|NCT01697696|615903682|FG001|Overall Study|Study terminated by sponsor|3|||
170426477|NCT01697696|615903681|FG000|Overall Study|Protocol deviation|1|||
170426478|NCT01697696|615903682|FG001|Overall Study|Protocol deviation|0|||
170426479|NCT01697696|615903681|FG000|Overall Study|Physician Decision|1|||
170426480|NCT01697696|615903682|FG001|Overall Study|Physician Decision|0|||
170426481|NCT01697696|615903681|FG000|Overall Study|Death|4|||
170426482|NCT01697696|615903682|FG001|Overall Study|Death|2|||
170426483|NCT01697696|615903681|FG000|Overall Study|Lost to Follow-up|10|||
170426484|NCT01697696|615903682|FG001|Overall Study|Lost to Follow-up|7|||
170426485|NCT01697696|615903681|FG000|Overall Study|Subject/guardian decision|31|||
170426486|NCT01697696|615903682|FG001|Overall Study|Subject/guardian decision|35|||
170426487|NCT03616106|615903683|FG000|Overall Study|Removed by PI|6|||
170426488|NCT03616106|615903684|FG001|Overall Study|Removed by PI|0|||
170426489|NCT03616106|615903683|FG000|Overall Study|Withdrawal by Subject|1|||
170426490|NCT03616106|615903684|FG001|Overall Study|Withdrawal by Subject|1|||
170426491|NCT03616106|615903683|FG000|Overall Study|Lost to Follow-up|7|||
170426492|NCT03616106|615903684|FG001|Overall Study|Lost to Follow-up|0|||
170426493|NCT01880593|615903687|FG000|Overall Study|Adverse Event|1|||
170426494|NCT01880593|615903688|FG001|Overall Study|Adverse Event|0|||
170426495|NCT01880593|615903687|FG000|Overall Study|Lack of Efficacy|1|||
170426496|NCT01880593|615903688|FG001|Overall Study|Lack of Efficacy|5|||
170426497|NCT01880593|615903687|FG000|Overall Study|Withdrawal by Subject|6|||
170426498|NCT01880593|615903688|FG001|Overall Study|Withdrawal by Subject|1|||
170426499|NCT05275205|615903692|FG000|Overall Study|Adverse Event|1|||
170426500|NCT05275205|615903693|FG001|Overall Study|Adverse Event|2|||
170426501|NCT05275205|615903692|FG000|Overall Study|Physician Decision|1|||
170426502|NCT05275205|615903693|FG001|Overall Study|Physician Decision|1|||
170426503|NCT05275205|615903692|FG000|Overall Study|Withdrawal by Subject|2|||
170426504|NCT05275205|615903693|FG001|Overall Study|Withdrawal by Subject|3|||
170426505|NCT05275205|615903692|FG000|Overall Study|Death|1|||
170426506|NCT05275205|615903693|FG001|Overall Study|Death|0|||
170426507|NCT05275205|615903692|FG000|Overall Study|Patient unable to attend visits|1|||
170426508|NCT05275205|615903693|FG001|Overall Study|Patient unable to attend visits|0|||
170426509|NCT01223365|615903695|FG000|Open-label Titration Period|Enrolled but not treated|1|||
170426510|NCT01223365|615903695|FG000|Open-label Titration Period|Adverse Event|23|||
170426511|NCT01223365|615903695|FG000|Open-label Titration Period|Lack of Efficacy|3|||
170426512|NCT01223365|615903695|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
170426513|NCT01223365|615903695|FG000|Open-label Titration Period|Protocol Violation|1|||
170565469|NCT00892008|616418529|FG000|Overall Study|Death|5|||
170426514|NCT01223365|615903695|FG000|Open-label Titration Period|Lost to Follow-up|2|||
170426515|NCT01223365|615903695|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
170426516|NCT01223365|615903695|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
170426517|NCT01223365|615903695|FG000|Open-label Titration Period|Starting physical therapy|1|||
170426518|NCT01223365|615903695|FG000|Open-label Treatment Period|Adverse Event|39|||
170426519|NCT01223365|615903695|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
170426520|NCT01223365|615903695|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
170426521|NCT01223365|615903695|FG000|Open-label Treatment Period|Protocol Violation|15|||
170534194|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
170534195|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
170534196|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
170534197|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
170534198|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
170534199|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
170534200|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
170534201|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
170534202|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
170534203|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
170534204|NCT00090103|616302205|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
170534205|NCT00090103|616302206|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
170534206|NCT00090103|616302207|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
170534207|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
170534208|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
170534209|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
170534210|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
170534211|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
170534212|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
170534213|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
170534214|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
170534215|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
170534216|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
170534217|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
170534218|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
170534219|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
170534220|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
170534221|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
170534222|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
170534223|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
170534224|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
170534225|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
170534226|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
170534227|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
170534228|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
170534229|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
170534230|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
170534231|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
170534232|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
170534233|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
170534234|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
170534235|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
170534236|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
170534237|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
170534238|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
170534239|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
170534240|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
170534241|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
170534242|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
170534243|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
170534244|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
170534245|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
170534246|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
170534247|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
170534248|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
170534249|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
170534250|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
170534251|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
170534252|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
170534253|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
170534254|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
170534255|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Death|1|||
170534256|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Death|0|||
170534257|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Death|1|||
170426522|NCT01223365|615903695|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
170426523|NCT01223365|615903695|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
170426524|NCT01223365|615903695|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
170426525|NCT01223365|615903695|FG000|Open-label Treatment Period|Moved out of area|2|||
170426526|NCT01223365|615903695|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
170426527|NCT01223365|615903695|FG000|Open-label Treatment Period|"Out of window"|1|||
170426528|NCT01223365|615903695|FG000|Open-label Treatment Period|Starting physical therapy|1|||
170426529|NCT01223365|615903695|FG000|Open-label Treatment Period|Physician Decision|2|||
170426530|NCT03161405|615903699|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
170426531|NCT02039908|615903700|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
170426532|NCT02039908|615903701|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
170426533|NCT02039908|615903702|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
170426534|NCT02039908|615903703|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
170426535|NCT02039908|615903700|FG000|Phase 1-Summer|Protocol Violation|6|||
170426536|NCT02039908|615903701|FG001|Phase 1-Summer|Protocol Violation|0|||
170426537|NCT02039908|615903702|FG002|Phase 1-Summer|Protocol Violation|0|||
170426538|NCT02039908|615903703|FG003|Phase 1-Summer|Protocol Violation|0|||
170426539|NCT02039908|615903700|FG000|Phase 2-School Year|Lost to Follow-up|0|||
170426540|NCT02039908|615903701|FG001|Phase 2-School Year|Lost to Follow-up|0|||
170426541|NCT02039908|615903702|FG002|Phase 2-School Year|Lost to Follow-up|1|||
170426542|NCT02039908|615903703|FG003|Phase 2-School Year|Lost to Follow-up|3|||
170426543|NCT02039908|615903700|FG000|Phase 2-School Year|Protocol Violation|0|||
170426544|NCT02039908|615903701|FG001|Phase 2-School Year|Protocol Violation|0|||
170426545|NCT02039908|615903702|FG002|Phase 2-School Year|Protocol Violation|3|||
170426546|NCT02039908|615903703|FG003|Phase 2-School Year|Protocol Violation|0|||
170426547|NCT02039908|615903700|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
170426548|NCT02039908|615903701|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
170426549|NCT02039908|615903702|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
170426550|NCT02039908|615903703|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
170426551|NCT01313780|615903704|FG000|Overall Study|Lack of Efficacy|4|||
170426552|NCT01313780|615903705|FG001|Overall Study|Lack of Efficacy|2|||
170426553|NCT01313780|615903704|FG000|Overall Study|Adverse Event|6|||
170426554|NCT01313780|615903705|FG001|Overall Study|Adverse Event|11|||
170426555|NCT01313780|615903704|FG000|Overall Study|Withdrawal by Subject|2|||
170426556|NCT01313780|615903705|FG001|Overall Study|Withdrawal by Subject|8|||
170426557|NCT01313780|615903704|FG000|Overall Study|Protocol Violation|10|||
170426558|NCT01313780|615903705|FG001|Overall Study|Protocol Violation|4|||
170426559|NCT01313780|615903704|FG000|Overall Study|missing data|3|||
170426560|NCT01313780|615903705|FG001|Overall Study|missing data|3|||
170426561|NCT02642653|615905468|FG000|Overall Study|Adverse Event|2|||
170426562|NCT02642653|615905469|FG001|Overall Study|Adverse Event|0|||
170426563|NCT00070291|615905470|FG000|Step 1|Withdrawal by Subject|1|||
170426564|NCT00070291|615905470|FG000|Step 1|Adverse Event|1|||
170426565|NCT00070291|615905470|FG000|Step 2|Adverse Event|1|||
170426566|NCT02262377|615905473|FG000|Overall Study|Lost to Follow-up|5|||
170426567|NCT02262377|615905474|FG001|Overall Study|Lost to Follow-up|6|||
170426568|NCT02262377|615905473|FG000|Overall Study|Found ineligible after enrollment|3|||
170426569|NCT02262377|615905474|FG001|Overall Study|Found ineligible after enrollment|0|||
170426570|NCT02262377|615905473|FG000|Overall Study|Withdrawal by Subject|4|||
170426571|NCT02262377|615905474|FG001|Overall Study|Withdrawal by Subject|0|||
170426572|NCT00371839|615905475|FG000|Overall Study|Death|4|||
170426573|NCT00371839|615905476|FG001|Overall Study|Death|0|||
170426574|NCT00371839|615905477|FG002|Overall Study|Death|0|||
170426575|NCT00371839|615905475|FG000|Overall Study|Withdrawal by Subject|7|||
170426576|NCT00371839|615905476|FG001|Overall Study|Withdrawal by Subject|4|||
170426577|NCT00371839|615905477|FG002|Overall Study|Withdrawal by Subject|0|||
170426578|NCT00371839|615905475|FG000|Overall Study|Lost to Follow-up|6|||
170426579|NCT00371839|615905476|FG001|Overall Study|Lost to Follow-up|3|||
170426580|NCT00371839|615905477|FG002|Overall Study|Lost to Follow-up|2|||
170426581|NCT00573443|615905481|FG000|Double-Blind Phase|Lost to Follow-up|1|||
170426582|NCT00573443|615905482|FG001|Double-Blind Phase|Lost to Follow-up|3|||
170426583|NCT00573443|615905483|FG002|Double-Blind Phase|Lost to Follow-up|2|||
170426584|NCT00573443|615905481|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
170426585|NCT00573443|615905482|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
170426586|NCT00573443|615905483|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
170426587|NCT00573443|615905481|FG000|Double-Blind Phase|Adverse Event|1|||
170426588|NCT00573443|615905482|FG001|Double-Blind Phase|Adverse Event|5|||
170426589|NCT00573443|615905483|FG002|Double-Blind Phase|Adverse Event|0|||
170426590|NCT00573443|615905481|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
170426591|NCT00573443|615905482|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
170426592|NCT00573443|615905483|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
170426593|NCT00573443|615905481|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
170426594|NCT00573443|615905482|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
170565470|NCT00892008|616418529|FG000|Overall Study|Lack of Efficacy|3|||
170565471|NCT00892008|616418529|FG000|Overall Study|Lost to Follow-up|142|||
170426595|NCT00573443|615905483|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
170426596|NCT00573443|615905481|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
170426597|NCT00573443|615905482|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
170426598|NCT00573443|615905483|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
170426599|NCT00573443|615905481|FG000|Double-Blind Phase|Protocol Violation|0|||
170426600|NCT00573443|615905482|FG001|Double-Blind Phase|Protocol Violation|2|||
170426601|NCT00573443|615905483|FG002|Double-Blind Phase|Protocol Violation|1|||
170426602|NCT00573443|615905481|FG000|Double-Blind Phase|Other|0|||
170426603|NCT00573443|615905482|FG001|Double-Blind Phase|Other|2|||
170426604|NCT00573443|615905483|FG002|Double-Blind Phase|Other|3|||
170426605|NCT00573443|615905481|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
170426606|NCT00573443|615905482|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
170426607|NCT00573443|615905483|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
170426608|NCT00573443|615905481|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
170426609|NCT00573443|615905482|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
170426610|NCT00573443|615905483|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
170426611|NCT00573443|615905481|FG000|Open-Label Extension Phase|Adverse Event|3|||
170426612|NCT00573443|615905482|FG001|Open-Label Extension Phase|Adverse Event|0|||
170426613|NCT00573443|615905483|FG002|Open-Label Extension Phase|Adverse Event|0|||
170426614|NCT00573443|615905481|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
170426615|NCT00573443|615905482|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
170426616|NCT00573443|615905483|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
170426617|NCT00573443|615905481|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
170426618|NCT00573443|615905482|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
170426619|NCT00573443|615905483|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
170426620|NCT00573443|615905481|FG000|Open-Label Extension Phase|Protocol Violation|2|||
170426621|NCT00573443|615905482|FG001|Open-Label Extension Phase|Protocol Violation|0|||
170426622|NCT00573443|615905483|FG002|Open-Label Extension Phase|Protocol Violation|0|||
170426623|NCT00573443|615905481|FG000|Open-Label Extension Phase|Other|2|||
170426624|NCT00573443|615905482|FG001|Open-Label Extension Phase|Other|0|||
170426625|NCT00573443|615905483|FG002|Open-Label Extension Phase|Other|0|||
170426626|NCT01796171|615905484|FG000|Enrolled|Death|0|||
170426627|NCT01796171|615905485|FG001|Enrolled|Death|0|||
170426628|NCT01796171|615905486|FG002|Enrolled|Death|0|||
170426629|NCT01796171|615905487|FG003|Enrolled|Death|0|||
170426630|NCT01796171|615905488|FG004|Enrolled|Death|0|||
170426631|NCT01796171|615905489|FG005|Enrolled|Death|0|||
170426632|NCT01796171|615905490|FG006|Enrolled|Death|0|||
170426633|NCT01796171|615905491|FG007|Enrolled|Death|0|||
170426634|NCT01796171|615905492|FG008|Enrolled|Death|0|||
170426635|NCT01796171|615905493|FG009|Enrolled|Death|0|||
170426636|NCT01796171|615905494|FG010|Enrolled|Death|0|||
170426637|NCT01796171|615905495|FG011|Enrolled|Death|0|||
170426638|NCT01796171|615905496|FG012|Enrolled|Death|0|||
170426639|NCT01796171|615905497|FG013|Enrolled|Death|0|||
170426640|NCT01796171|615905498|FG014|Enrolled|Death|1|||
170426641|NCT01796171|615905484|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
170426642|NCT01796171|615905485|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
170426643|NCT01796171|615905486|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
170426644|NCT01796171|615905487|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
170426645|NCT01796171|615905488|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
170426646|NCT01796171|615905489|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
170426647|NCT01796171|615905490|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
170426648|NCT01796171|615905491|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
170426649|NCT01796171|615905492|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
170426650|NCT01796171|615905493|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
170426651|NCT01796171|615905494|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
170426652|NCT01796171|615905495|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
170426653|NCT01796171|615905496|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
170534258|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
170534259|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
170426654|NCT01796171|615905497|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
170426655|NCT01796171|615905498|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
170426656|NCT01796171|615905484|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426657|NCT01796171|615905485|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426658|NCT01796171|615905486|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426659|NCT01796171|615905487|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426660|NCT01796171|615905488|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426661|NCT01796171|615905489|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426662|NCT01796171|615905490|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426663|NCT01796171|615905491|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426664|NCT01796171|615905492|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426665|NCT01796171|615905493|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426666|NCT01796171|615905494|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426667|NCT01796171|615905495|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426668|NCT01796171|615905496|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170534260|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
170534261|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
170534262|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
170534263|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
170534264|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
170534265|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
170534266|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
170534267|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
170534268|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
170534269|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
170534270|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
170534271|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
170534272|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
170534273|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
170534274|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
170534275|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
170534276|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
170534277|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
170534278|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
170534279|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Depression|0|||
170534280|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Depression|1|||
170534281|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Depression|0|||
170534282|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
170534283|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
170534284|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
170534285|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Jailed|0|||
170534286|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Jailed|1|||
170534287|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Jailed|0|||
170879925|NCT00531752|617571149|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
170879926|NCT00531752|617571150|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
170879927|NCT00531752|617571151|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
170879928|NCT01624662|617571153|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
170879929|NCT01624662|617571154|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
170879930|NCT01624662|617571155|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
170534288|NCT00090103|616302205|FG000|16-Week Safety Follow-up Period|Other|0|||
170534289|NCT00090103|616302206|FG001|16-Week Safety Follow-up Period|Other|1|||
170879931|NCT01624662|617571156|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
170879932|NCT01624662|617571153|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
170879933|NCT01624662|617571154|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
170879934|NCT01624662|617571155|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
170879935|NCT01624662|617571156|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
170879936|NCT01624662|617571153|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
170879937|NCT01624662|617571154|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
170879938|NCT01624662|617571155|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
170879939|NCT01624662|617571156|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
170879940|NCT01624662|617571153|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
170879941|NCT01624662|617571154|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
170879942|NCT01624662|617571155|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
170879943|NCT01624662|617571156|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
170879944|NCT01624662|617571153|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
170879945|NCT01624662|617571154|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
170879946|NCT01624662|617571155|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
170879947|NCT01624662|617571156|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
170879948|NCT01624662|617571153|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
170879949|NCT01624662|617571154|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
170879950|NCT01624662|617571155|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
170879951|NCT01624662|617571156|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
170879952|NCT01624662|617571153|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
170879953|NCT01624662|617571154|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
170879954|NCT01624662|617571155|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
170879955|NCT01624662|617571156|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
170879956|NCT02821715|617571157|FG000|Overall Study|Protocol Violation|1|||
170879957|NCT02821715|617571158|FG001|Overall Study|Protocol Violation|0|||
170879958|NCT02821715|617571159|FG002|Overall Study|Protocol Violation|0|||
170879959|NCT02821715|617571160|FG003|Overall Study|Protocol Violation|0|||
170879960|NCT02821715|617571161|FG004|Overall Study|Protocol Violation|0|||
170534290|NCT00090103|616302207|FG002|16-Week Safety Follow-up Period|Other|0|||
170534291|NCT06633965|616302208|FG000|Overall Study|Withdrawal by Subject|0|||
170426669|NCT01796171|615905497|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
170426670|NCT01796171|615905498|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
170426671|NCT01796171|615905484|FG000|Treatment Period With Betalutin|Progressive disease|0|||
170426672|NCT01796171|615905485|FG001|Treatment Period With Betalutin|Progressive disease|1|||
170426673|NCT01796171|615905486|FG002|Treatment Period With Betalutin|Progressive disease|0|||
170426674|NCT01796171|615905487|FG003|Treatment Period With Betalutin|Progressive disease|0|||
170426675|NCT01796171|615905488|FG004|Treatment Period With Betalutin|Progressive disease|0|||
170426676|NCT01796171|615905489|FG005|Treatment Period With Betalutin|Progressive disease|0|||
170426677|NCT01796171|615905490|FG006|Treatment Period With Betalutin|Progressive disease|0|||
170426678|NCT01796171|615905491|FG007|Treatment Period With Betalutin|Progressive disease|0|||
170426679|NCT01796171|615905492|FG008|Treatment Period With Betalutin|Progressive disease|0|||
170426680|NCT01796171|615905493|FG009|Treatment Period With Betalutin|Progressive disease|0|||
170426681|NCT01796171|615905494|FG010|Treatment Period With Betalutin|Progressive disease|0|||
170426682|NCT01796171|615905495|FG011|Treatment Period With Betalutin|Progressive disease|0|||
170426683|NCT01796171|615905496|FG012|Treatment Period With Betalutin|Progressive disease|0|||
170426684|NCT01796171|615905497|FG013|Treatment Period With Betalutin|Progressive disease|0|||
170426685|NCT01796171|615905498|FG014|Treatment Period With Betalutin|Progressive disease|0|||
170426686|NCT01796171|615905484|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426687|NCT01796171|615905485|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426688|NCT01796171|615905486|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426689|NCT01796171|615905487|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426690|NCT01796171|615905488|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426691|NCT01796171|615905489|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426692|NCT01796171|615905490|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426693|NCT01796171|615905491|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426694|NCT01796171|615905492|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
170426695|NCT01796171|615905493|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426696|NCT01796171|615905494|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
170426697|NCT01796171|615905495|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
170426698|NCT01796171|615905496|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426699|NCT01796171|615905497|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426700|NCT01796171|615905498|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
170426701|NCT01796171|615905484|FG000|Treatment Period With Betalutin|Physician Decision|0|||
170426702|NCT01796171|615905485|FG001|Treatment Period With Betalutin|Physician Decision|0|||
170426703|NCT01796171|615905486|FG002|Treatment Period With Betalutin|Physician Decision|0|||
170426704|NCT01796171|615905487|FG003|Treatment Period With Betalutin|Physician Decision|0|||
170426705|NCT01796171|615905488|FG004|Treatment Period With Betalutin|Physician Decision|0|||
170426706|NCT01796171|615905489|FG005|Treatment Period With Betalutin|Physician Decision|0|||
170426707|NCT01796171|615905490|FG006|Treatment Period With Betalutin|Physician Decision|0|||
170426708|NCT01796171|615905491|FG007|Treatment Period With Betalutin|Physician Decision|0|||
170426709|NCT01796171|615905492|FG008|Treatment Period With Betalutin|Physician Decision|0|||
170426710|NCT01796171|615905493|FG009|Treatment Period With Betalutin|Physician Decision|0|||
170426711|NCT01796171|615905494|FG010|Treatment Period With Betalutin|Physician Decision|5|||
170426712|NCT01796171|615905495|FG011|Treatment Period With Betalutin|Physician Decision|1|||
170426713|NCT01796171|615905496|FG012|Treatment Period With Betalutin|Physician Decision|1|||
170426714|NCT01796171|615905497|FG013|Treatment Period With Betalutin|Physician Decision|0|||
170426715|NCT01796171|615905498|FG014|Treatment Period With Betalutin|Physician Decision|0|||
170426716|NCT01796171|615905484|FG000|Treatment Period With Betalutin|Death|0|||
170426717|NCT01796171|615905485|FG001|Treatment Period With Betalutin|Death|0|||
170426718|NCT01796171|615905486|FG002|Treatment Period With Betalutin|Death|0|||
170426719|NCT01796171|615905487|FG003|Treatment Period With Betalutin|Death|0|||
170426720|NCT01796171|615905488|FG004|Treatment Period With Betalutin|Death|0|||
170426721|NCT01796171|615905489|FG005|Treatment Period With Betalutin|Death|0|||
170426722|NCT01796171|615905490|FG006|Treatment Period With Betalutin|Death|0|||
170426723|NCT01796171|615905491|FG007|Treatment Period With Betalutin|Death|0|||
170426724|NCT01796171|615905492|FG008|Treatment Period With Betalutin|Death|0|||
170426725|NCT01796171|615905493|FG009|Treatment Period With Betalutin|Death|0|||
170426726|NCT01796171|615905494|FG010|Treatment Period With Betalutin|Death|2|||
170426727|NCT01796171|615905495|FG011|Treatment Period With Betalutin|Death|0|||
170426728|NCT01796171|615905496|FG012|Treatment Period With Betalutin|Death|0|||
170426729|NCT01796171|615905497|FG013|Treatment Period With Betalutin|Death|0|||
170426730|NCT01796171|615905498|FG014|Treatment Period With Betalutin|Death|0|||
170426731|NCT01796171|615905484|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
170426732|NCT01796171|615905485|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
170426733|NCT01796171|615905486|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
170534292|NCT06633965|616302209|FG001|Overall Study|Withdrawal by Subject|1|||
170426734|NCT01796171|615905487|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
170426735|NCT01796171|615905488|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
170426736|NCT01796171|615905489|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
170426737|NCT01796171|615905490|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
170426738|NCT01796171|615905491|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
170426739|NCT01796171|615905492|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
170426740|NCT01796171|615905493|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
170426741|NCT01796171|615905494|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
170426742|NCT01796171|615905495|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
170426743|NCT01796171|615905496|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
170426744|NCT01796171|615905497|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
170426745|NCT01796171|615905498|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
170426746|NCT01796171|615905484|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426747|NCT01796171|615905485|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426748|NCT01796171|615905486|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426749|NCT01796171|615905487|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426750|NCT01796171|615905488|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426751|NCT01796171|615905489|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426752|NCT01796171|615905490|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426753|NCT01796171|615905491|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426754|NCT01796171|615905492|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426755|NCT01796171|615905493|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426756|NCT01796171|615905494|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
170426757|NCT01796171|615905495|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
170426758|NCT01796171|615905496|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426759|NCT01796171|615905497|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426760|NCT01796171|615905498|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
170426761|NCT01796171|615905484|FG000|Follow-up Period|Start of further anticancer therapy|4|||
170426762|NCT01796171|615905485|FG001|Follow-up Period|Start of further anticancer therapy|25|||
170426763|NCT01796171|615905486|FG002|Follow-up Period|Start of further anticancer therapy|2|||
170426764|NCT01796171|615905487|FG003|Follow-up Period|Start of further anticancer therapy|1|||
170426765|NCT01796171|615905488|FG004|Follow-up Period|Start of further anticancer therapy|2|||
170426766|NCT01796171|615905489|FG005|Follow-up Period|Start of further anticancer therapy|2|||
170426767|NCT01796171|615905490|FG006|Follow-up Period|Start of further anticancer therapy|1|||
170426768|NCT01796171|615905491|FG007|Follow-up Period|Start of further anticancer therapy|15|||
170426769|NCT01796171|615905492|FG008|Follow-up Period|Start of further anticancer therapy|2|||
170426770|NCT01796171|615905493|FG009|Follow-up Period|Start of further anticancer therapy|0|||
170426771|NCT01796171|615905494|FG010|Follow-up Period|Start of further anticancer therapy|0|||
170426772|NCT01796171|615905495|FG011|Follow-up Period|Start of further anticancer therapy|0|||
170426773|NCT01796171|615905496|FG012|Follow-up Period|Start of further anticancer therapy|0|||
170426774|NCT01796171|615905497|FG013|Follow-up Period|Start of further anticancer therapy|0|||
170426775|NCT01796171|615905498|FG014|Follow-up Period|Start of further anticancer therapy|0|||
170426776|NCT01796171|615905484|FG000|Follow-up Period|Progressive disease|0|||
170426777|NCT01796171|615905485|FG001|Follow-up Period|Progressive disease|1|||
170426778|NCT01796171|615905486|FG002|Follow-up Period|Progressive disease|0|||
170426779|NCT01796171|615905487|FG003|Follow-up Period|Progressive disease|0|||
170426780|NCT01796171|615905488|FG004|Follow-up Period|Progressive disease|0|||
170426781|NCT01796171|615905489|FG005|Follow-up Period|Progressive disease|0|||
170426782|NCT01796171|615905490|FG006|Follow-up Period|Progressive disease|0|||
170426783|NCT01796171|615905491|FG007|Follow-up Period|Progressive disease|3|||
170426784|NCT01796171|615905492|FG008|Follow-up Period|Progressive disease|0|||
170426785|NCT01796171|615905493|FG009|Follow-up Period|Progressive disease|0|||
170426786|NCT01796171|615905494|FG010|Follow-up Period|Progressive disease|0|||
170426787|NCT01796171|615905495|FG011|Follow-up Period|Progressive disease|0|||
170426788|NCT01796171|615905496|FG012|Follow-up Period|Progressive disease|0|||
170426789|NCT01796171|615905497|FG013|Follow-up Period|Progressive disease|0|||
170426790|NCT01796171|615905498|FG014|Follow-up Period|Progressive disease|0|||
170426791|NCT01796171|615905484|FG000|Follow-up Period|Physician Decision|0|||
170426792|NCT01796171|615905485|FG001|Follow-up Period|Physician Decision|2|||
170426793|NCT01796171|615905486|FG002|Follow-up Period|Physician Decision|0|||
170426794|NCT01796171|615905487|FG003|Follow-up Period|Physician Decision|0|||
170426795|NCT01796171|615905488|FG004|Follow-up Period|Physician Decision|0|||
170426796|NCT01796171|615905489|FG005|Follow-up Period|Physician Decision|0|||
170426797|NCT01796171|615905490|FG006|Follow-up Period|Physician Decision|0|||
170426798|NCT01796171|615905491|FG007|Follow-up Period|Physician Decision|0|||
170426799|NCT01796171|615905492|FG008|Follow-up Period|Physician Decision|0|||
170426800|NCT01796171|615905493|FG009|Follow-up Period|Physician Decision|0|||
170426801|NCT01796171|615905494|FG010|Follow-up Period|Physician Decision|5|||
170426802|NCT01796171|615905495|FG011|Follow-up Period|Physician Decision|0|||
170426803|NCT01796171|615905496|FG012|Follow-up Period|Physician Decision|0|||
170426804|NCT01796171|615905497|FG013|Follow-up Period|Physician Decision|0|||
170426805|NCT01796171|615905498|FG014|Follow-up Period|Physician Decision|0|||
170426806|NCT01796171|615905484|FG000|Follow-up Period|Withdrawal by Subject|0|||
170426807|NCT01796171|615905485|FG001|Follow-up Period|Withdrawal by Subject|1|||
170426808|NCT01796171|615905486|FG002|Follow-up Period|Withdrawal by Subject|0|||
170426809|NCT01796171|615905487|FG003|Follow-up Period|Withdrawal by Subject|0|||
170426810|NCT01796171|615905488|FG004|Follow-up Period|Withdrawal by Subject|0|||
170426811|NCT01796171|615905489|FG005|Follow-up Period|Withdrawal by Subject|1|||
170426812|NCT01796171|615905490|FG006|Follow-up Period|Withdrawal by Subject|0|||
170426813|NCT01796171|615905491|FG007|Follow-up Period|Withdrawal by Subject|0|||
170426814|NCT01796171|615905492|FG008|Follow-up Period|Withdrawal by Subject|0|||
170426815|NCT01796171|615905493|FG009|Follow-up Period|Withdrawal by Subject|0|||
170426816|NCT01796171|615905494|FG010|Follow-up Period|Withdrawal by Subject|3|||
170426817|NCT01796171|615905495|FG011|Follow-up Period|Withdrawal by Subject|1|||
170426818|NCT01796171|615905496|FG012|Follow-up Period|Withdrawal by Subject|0|||
170426819|NCT01796171|615905497|FG013|Follow-up Period|Withdrawal by Subject|0|||
170426820|NCT01796171|615905498|FG014|Follow-up Period|Withdrawal by Subject|0|||
170426821|NCT01796171|615905484|FG000|Follow-up Period|Death|0|||
170426822|NCT01796171|615905485|FG001|Follow-up Period|Death|0|||
170426823|NCT01796171|615905486|FG002|Follow-up Period|Death|0|||
170426824|NCT01796171|615905487|FG003|Follow-up Period|Death|0|||
170426825|NCT01796171|615905488|FG004|Follow-up Period|Death|0|||
170426826|NCT01796171|615905489|FG005|Follow-up Period|Death|0|||
170426827|NCT01796171|615905490|FG006|Follow-up Period|Death|1|||
170426828|NCT01796171|615905491|FG007|Follow-up Period|Death|0|||
170426829|NCT01796171|615905492|FG008|Follow-up Period|Death|0|||
170426830|NCT01796171|615905493|FG009|Follow-up Period|Death|0|||
170426831|NCT01796171|615905494|FG010|Follow-up Period|Death|17|||
170426832|NCT01796171|615905495|FG011|Follow-up Period|Death|9|||
170426833|NCT01796171|615905496|FG012|Follow-up Period|Death|1|||
170426834|NCT01796171|615905497|FG013|Follow-up Period|Death|0|||
170426835|NCT01796171|615905498|FG014|Follow-up Period|Death|0|||
170426836|NCT01796171|615905484|FG000|Follow-up Period|Patient transferred to other hospital|0|||
170426837|NCT01796171|615905485|FG001|Follow-up Period|Patient transferred to other hospital|1|||
170426838|NCT01796171|615905486|FG002|Follow-up Period|Patient transferred to other hospital|0|||
170426839|NCT01796171|615905487|FG003|Follow-up Period|Patient transferred to other hospital|0|||
170426840|NCT01796171|615905488|FG004|Follow-up Period|Patient transferred to other hospital|0|||
170426841|NCT01796171|615905489|FG005|Follow-up Period|Patient transferred to other hospital|0|||
170426842|NCT01796171|615905490|FG006|Follow-up Period|Patient transferred to other hospital|0|||
170426843|NCT01796171|615905491|FG007|Follow-up Period|Patient transferred to other hospital|0|||
170426844|NCT01796171|615905492|FG008|Follow-up Period|Patient transferred to other hospital|0|||
170426845|NCT01796171|615905493|FG009|Follow-up Period|Patient transferred to other hospital|0|||
170426846|NCT01796171|615905494|FG010|Follow-up Period|Patient transferred to other hospital|0|||
170426847|NCT01796171|615905495|FG011|Follow-up Period|Patient transferred to other hospital|0|||
170426848|NCT01796171|615905496|FG012|Follow-up Period|Patient transferred to other hospital|0|||
170426849|NCT01796171|615905497|FG013|Follow-up Period|Patient transferred to other hospital|0|||
170426850|NCT01796171|615905498|FG014|Follow-up Period|Patient transferred to other hospital|0|||
170426851|NCT01796171|615905484|FG000|Follow-up Period|Sponsor Decision|0|||
170426852|NCT01796171|615905485|FG001|Follow-up Period|Sponsor Decision|0|||
170426853|NCT01796171|615905486|FG002|Follow-up Period|Sponsor Decision|0|||
170426854|NCT01796171|615905487|FG003|Follow-up Period|Sponsor Decision|0|||
170426855|NCT01796171|615905488|FG004|Follow-up Period|Sponsor Decision|0|||
170426856|NCT01796171|615905489|FG005|Follow-up Period|Sponsor Decision|0|||
170426857|NCT01796171|615905490|FG006|Follow-up Period|Sponsor Decision|0|||
170426858|NCT01796171|615905491|FG007|Follow-up Period|Sponsor Decision|0|||
170426859|NCT01796171|615905492|FG008|Follow-up Period|Sponsor Decision|0|||
170426860|NCT01796171|615905493|FG009|Follow-up Period|Sponsor Decision|0|||
170426861|NCT01796171|615905494|FG010|Follow-up Period|Sponsor Decision|40|||
170426862|NCT01796171|615905495|FG011|Follow-up Period|Sponsor Decision|15|||
170426863|NCT01796171|615905496|FG012|Follow-up Period|Sponsor Decision|7|||
170426864|NCT01796171|615905497|FG013|Follow-up Period|Sponsor Decision|0|||
170426865|NCT01796171|615905498|FG014|Follow-up Period|Sponsor Decision|0|||
170426866|NCT00418561|615905499|FG000|Overall Study|Participant's (guardian's) decision|0|||
170426867|NCT00418561|615905500|FG001|Overall Study|Participant's (guardian's) decision|1|||
170426868|NCT00418561|615905501|FG002|Overall Study|Participant's (guardian's) decision|0|||
170426869|NCT00829309|615905502|FG000|Washout: 7 Days|Protocol Violation|1|||
170426870|NCT00829309|615905503|FG001|Washout: 7 Days|Protocol Violation|0|||
170426871|NCT02924883|615905507|FG000|Overall Study|Death|39|||
170879961|NCT02821715|617571162|FG005|Overall Study|Protocol Violation|0|||
170879962|NCT01033825|617571163|FG000|Overall Study|Withdrawal by Subject|2|||
170426872|NCT02924883|615905508|FG001|Overall Study|Death|20|||
170426873|NCT02924883|615905507|FG000|Overall Study|Lost to Follow-up|1|||
170426874|NCT02924883|615905508|FG001|Overall Study|Lost to Follow-up|0|||
170879963|NCT01033825|617571164|FG001|Overall Study|Withdrawal by Subject|3|||
170426875|NCT02924883|615905507|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
170426876|NCT02924883|615905508|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
170426877|NCT02924883|615905507|FG000|Overall Study|Protocol Violation|1|||
170426878|NCT02924883|615905508|FG001|Overall Study|Protocol Violation|0|||
170426879|NCT02924883|615905507|FG000|Overall Study|Withdrawal by Subject|22|||
170426880|NCT02924883|615905508|FG001|Overall Study|Withdrawal by Subject|16|||
170426881|NCT02924883|615905507|FG000|Overall Study|Progressive Disease|1|||
170426882|NCT02924883|615905508|FG001|Overall Study|Progressive Disease|0|||
170426883|NCT02924883|615905507|FG000|Overall Study|Study Terminated by Sponsor|69|||
170426884|NCT02924883|615905508|FG001|Overall Study|Study Terminated by Sponsor|32|||
170426885|NCT03699020|615905509|FG000|Overall Study|Withdrawal by Subject|3|||
170426886|NCT03699020|615905510|FG001|Overall Study|Withdrawal by Subject|2|||
170426887|NCT00004562|615905511|FG000|Overall Study|Lost to Follow-up|102|||
170426888|NCT00004562|615905512|FG001|Overall Study|Lost to Follow-up|91|||
170426889|NCT04247282|615905513|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
170426890|NCT04247282|615905514|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
170426891|NCT04247282|615905515|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
170426892|NCT04247282|615905516|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
170426893|NCT04247282|615905513|FG000|Overall Study|Refused further treatment|0|||
170426894|NCT04247282|615905514|FG001|Overall Study|Refused further treatment|1|||
170426895|NCT04247282|615905515|FG002|Overall Study|Refused further treatment|0|||
170426896|NCT04247282|615905516|FG003|Overall Study|Refused further treatment|0|||
170426897|NCT00905840|615905517|FG000|Overall Study|Lost to Follow-up|11|||
170426898|NCT00905840|615905517|FG000|Overall Study|Death|3|||
170426899|NCT00905840|615905517|FG000|Overall Study|Withdrawal by Subject|1|||
170426900|NCT00905840|615905517|FG000|Overall Study|Adverse Event|1|||
170426901|NCT00448019|615905518|FG000|Overall Study|Withdrawal by Subject|3|||
170426902|NCT00448019|615905518|FG000|Overall Study|Disease progression|1|||
170426903|NCT00448019|615905518|FG000|Overall Study|Death|2|||
170426904|NCT00448019|615905518|FG000|Overall Study|Insurance Issues|1|||
170426905|NCT03020615|615905519|FG000|Overall Study|Physician Decision|3|||
170426906|NCT03020615|615905520|FG001|Overall Study|Physician Decision|1|||
170426907|NCT03020615|615905521|FG002|Overall Study|Physician Decision|2|||
170426908|NCT03020615|615905519|FG000|Overall Study|Parent/guardian/patient choice|3|||
170426909|NCT03020615|615905520|FG001|Overall Study|Parent/guardian/patient choice|0|||
170426910|NCT03020615|615905521|FG002|Overall Study|Parent/guardian/patient choice|4|||
170426911|NCT03020615|615905519|FG000|Overall Study|Screen failure|0|||
170426912|NCT03020615|615905520|FG001|Overall Study|Screen failure|0|||
170426913|NCT03020615|615905521|FG002|Overall Study|Screen failure|1|||
170426914|NCT03020615|615905519|FG000|Overall Study|Death|1|||
170426915|NCT03020615|615905520|FG001|Overall Study|Death|0|||
170426916|NCT03020615|615905521|FG002|Overall Study|Death|0|||
170426917|NCT03020615|615905519|FG000|Overall Study|Lost to Follow-up|0|||
170426918|NCT03020615|615905520|FG001|Overall Study|Lost to Follow-up|1|||
170426919|NCT03020615|615905521|FG002|Overall Study|Lost to Follow-up|0|||
170426920|NCT02077465|615905525|FG000|Overall Study|Withdrew Consent|0|||
170426921|NCT02077465|615905526|FG001|Overall Study|Withdrew Consent|1|||
170426922|NCT02077465|615905525|FG000|Overall Study|Lost to Follow-up|1|||
170426923|NCT02077465|615905526|FG001|Overall Study|Lost to Follow-up|0|||
170426924|NCT02481830|615905527|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
170426925|NCT02481830|615905528|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
170426926|NCT02481830|615905527|FG000|Pre-treatment|Withdrawal by Subject|0|||
170426927|NCT02481830|615905528|FG001|Pre-treatment|Withdrawal by Subject|10|||
170426928|NCT02481830|615905527|FG000|Pre-treatment|Disease Progression|1|||
170426929|NCT02481830|615905528|FG001|Pre-treatment|Disease Progression|1|||
170426930|NCT02481830|615905527|FG000|Pre-treatment|Other reasons|0|||
170426931|NCT02481830|615905528|FG001|Pre-treatment|Other reasons|1|||
170426932|NCT02481830|615905527|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
170426933|NCT02481830|615905528|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
170426934|NCT02481830|615905527|FG000|Treatment|Disease Progression|233|||
170426935|NCT02481830|615905528|FG001|Treatment|Disease Progression|171|||
170426936|NCT02481830|615905527|FG000|Treatment|Study drug toxicity|18|||
170426937|NCT02481830|615905528|FG001|Treatment|Study drug toxicity|38|||
170426938|NCT02481830|615905527|FG000|Treatment|Death|1|||
170426939|NCT02481830|615905528|FG001|Treatment|Death|1|||
170426940|NCT02481830|615905527|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
170426941|NCT02481830|615905528|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
170426942|NCT02481830|615905527|FG000|Treatment|Participants request to discontinue Study treatment|6|||
170426943|NCT02481830|615905528|FG001|Treatment|Participants request to discontinue Study treatment|34|||
170426944|NCT02481830|615905527|FG000|Treatment|Withdrawal by Subject|2|||
170426945|NCT02481830|615905528|FG001|Treatment|Withdrawal by Subject|3|||
170426946|NCT02481830|615905527|FG000|Treatment|Lost to Follow-up|1|||
170426947|NCT02481830|615905528|FG001|Treatment|Lost to Follow-up|0|||
170426948|NCT02481830|615905527|FG000|Treatment|Maximum Clinical Benefit|0|||
170565472|NCT00892008|616418529|FG000|Overall Study|Other|378|||
170565473|NCT00892008|616418529|FG000|Overall Study|Adverse Event|37|||
170426949|NCT02481830|615905528|FG001|Treatment|Maximum Clinical Benefit|5|||
170426950|NCT02481830|615905527|FG000|Treatment|Administrative reason by sponsor|1|||
170426951|NCT02481830|615905528|FG001|Treatment|Administrative reason by sponsor|1|||
170426952|NCT02481830|615905527|FG000|Treatment|Other reasons|6|||
170426953|NCT02481830|615905528|FG001|Treatment|Other reasons|1|||
170426954|NCT00102440|615905529|FG000|Overall Study|Lost to Follow-up|25|||
170426955|NCT00102440|615905530|FG001|Overall Study|Lost to Follow-up|18|||
170426956|NCT00102440|615905531|FG002|Overall Study|Lost to Follow-up|21|||
170426957|NCT00102440|615905529|FG000|Overall Study|Adverse Event|16|||
170426958|NCT00102440|615905530|FG001|Overall Study|Adverse Event|23|||
170426959|NCT00102440|615905531|FG002|Overall Study|Adverse Event|8|||
170426960|NCT00102440|615905529|FG000|Overall Study|Gout Flare|10|||
170426961|NCT00102440|615905530|FG001|Overall Study|Gout Flare|28|||
170426962|NCT00102440|615905531|FG002|Overall Study|Gout Flare|9|||
170426963|NCT00102440|615905529|FG000|Overall Study|Personal Reason(s)|19|||
170426964|NCT00102440|615905530|FG001|Overall Study|Personal Reason(s)|13|||
170426965|NCT00102440|615905531|FG002|Overall Study|Personal Reason(s)|13|||
170426966|NCT00102440|615905529|FG000|Overall Study|Other|11|||
170426967|NCT00102440|615905530|FG001|Overall Study|Other|14|||
170426968|NCT00102440|615905531|FG002|Overall Study|Other|14|||
170426969|NCT00102440|615905529|FG000|Overall Study|Protocol Violation|7|||
170426970|NCT00102440|615905530|FG001|Overall Study|Protocol Violation|2|||
170426971|NCT00102440|615905531|FG002|Overall Study|Protocol Violation|1|||
170426972|NCT01602419|615905533|FG000|Overall Study|Not treated with Wilate|9|||
170426973|NCT01602419|615905533|FG000|Overall Study|Adverse Drug Reaction|4|||
170426974|NCT01602419|615905533|FG000|Overall Study|Insurance issues|3|||
170426975|NCT01602419|615905533|FG000|Overall Study|Changed treatment centre|1|||
170426976|NCT01602419|615905533|FG000|Overall Study|Treatment centre closed|1|||
170426977|NCT01602419|615905533|FG000|Overall Study|Withdrawal by Subject|5|||
170426978|NCT01602419|615905533|FG000|Overall Study|Lost to Follow-up|6|||
170426979|NCT01792635|615905538|FG000|Part B|Adverse Event|0|||
170426980|NCT01792635|615905539|FG001|Part B|Adverse Event|0|||
170426981|NCT01792635|615905540|FG002|Part B|Adverse Event|1|||
170426982|NCT01792635|615905538|FG000|Part B|Study terminated|0|||
170426983|NCT01792635|615905539|FG001|Part B|Study terminated|4|||
170426984|NCT01792635|615905540|FG002|Part B|Study terminated|3|||
170426985|NCT03620747|615905542|FG000|Overall Study|Participant decision|7|||
170426986|NCT03620747|615905542|FG000|Overall Study|Adverse Event|6|||
170426987|NCT03620747|615905542|FG000|Overall Study|Lack of Efficacy|1|||
170426988|NCT03620747|615905542|FG000|Overall Study|Poor compliance to protocol|2|||
170426989|NCT03620747|615905542|FG000|Overall Study|Other-unspecified|3|||
170426990|NCT02714062|615905543|FG000|Overall Study|Adverse Event|0|||
170426991|NCT02714062|615905544|FG001|Overall Study|Adverse Event|0|||
170426992|NCT02714062|615905545|FG002|Overall Study|Adverse Event|2|||
170426993|NCT02714062|615905543|FG000|Overall Study|Withdrawal by Subject|1|||
170426994|NCT02714062|615905544|FG001|Overall Study|Withdrawal by Subject|0|||
170426995|NCT02714062|615905545|FG002|Overall Study|Withdrawal by Subject|1|||
170426996|NCT02714062|615905543|FG000|Overall Study|Protocol Violation|0|||
170426997|NCT02714062|615905544|FG001|Overall Study|Protocol Violation|1|||
170426998|NCT02714062|615905545|FG002|Overall Study|Protocol Violation|0|||
170426999|NCT02909907|615905552|FG000|Overall Study|Withdrawal by Subject|0|||
170427000|NCT02909907|615905553|FG001|Overall Study|Withdrawal by Subject|1|||
170427001|NCT00850174|615905554|FG000|Washout: One Week|Withdrawal by Subject|0|||
170427002|NCT00850174|615905555|FG001|Washout: One Week|Withdrawal by Subject|2|||
170427003|NCT00850174|615905554|FG000|Second Intervention|Withdrawal by Subject|1|||
170427004|NCT00850174|615905555|FG001|Second Intervention|Withdrawal by Subject|0|||
170427005|NCT01363765|615905558|FG000|Overall Study|non-diagnostic|2621|||
170427006|NCT01363765|615905559|FG001|Overall Study|non-diagnostic|1124|||
170427007|NCT01363765|615905558|FG000|Overall Study|duplicate records|736|||
170427008|NCT01363765|615905559|FG001|Overall Study|duplicate records|3177|||
170427009|NCT01363765|615905558|FG000|Overall Study|non-resident|156|||
170427010|NCT01363765|615905559|FG001|Overall Study|non-resident|76|||
170427011|NCT01363765|615905558|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
170427012|NCT01363765|615905559|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
170427013|NCT01363765|615905558|FG000|Overall Study|smear during intervention|2170|||
170632706|NCT02760498|616666746|FG004|Overall Study|Physician Decision|0|||
170427014|NCT01363765|615905559|FG001|Overall Study|smear during intervention|0|||
170427015|NCT01900626|615905560|FG000|Overall Study|study was closed due to low enrollment|1|||
170427016|NCT01900626|615905561|FG001|Overall Study|study was closed due to low enrollment|1|||
170427017|NCT00635492|615905562|FG000|Overall Study|Death|12|||
170427018|NCT00635492|615905563|FG001|Overall Study|Death|40|||
170427019|NCT00635492|615905562|FG000|Overall Study|Lost to Follow-up|151|||
170427020|NCT00635492|615905563|FG001|Overall Study|Lost to Follow-up|172|||
170427021|NCT00635492|615905562|FG000|Overall Study|Physician Decision|32|||
170427022|NCT00635492|615905563|FG001|Overall Study|Physician Decision|22|||
170427023|NCT00635492|615905562|FG000|Overall Study|Sponsor decision|2|||
170427024|NCT00635492|615905563|FG001|Overall Study|Sponsor decision|3|||
170427025|NCT00635492|615905562|FG000|Overall Study|Withdrawal by Subject|82|||
170427026|NCT00635492|615905563|FG001|Overall Study|Withdrawal by Subject|45|||
170632707|NCT02760498|616666747|FG005|Overall Study|Physician Decision|2|||
170632708|NCT02760498|616666742|FG000|Overall Study|Disease progression|21|||
170632709|NCT02760498|616666743|FG001|Overall Study|Disease progression|19|||
170427027|NCT03098394|615905569|FG000|Overall Study|Pregnancy|0|||
170427028|NCT03098394|615905570|FG001|Overall Study|Pregnancy|1|||
170427029|NCT04408794|615905571|FG000|Overall Study|Adverse Event|43|||
170427030|NCT04408794|615905571|FG000|Overall Study|Infrequent study drug usage|43|||
170427031|NCT04408794|615905571|FG000|Overall Study|Lack of Efficacy|61|||
170427032|NCT04408794|615905571|FG000|Overall Study|Lost to Follow-up|33|||
170427033|NCT04408794|615905571|FG000|Overall Study|Non-compliance|6|||
170427034|NCT04408794|615905571|FG000|Overall Study|Physician Decision|1|||
170427035|NCT04408794|615905571|FG000|Overall Study|Pregnancy|6|||
170427036|NCT04408794|615905571|FG000|Overall Study|Protocol Deviation|9|||
170427037|NCT04408794|615905571|FG000|Overall Study|Sheehan-STS Result|1|||
170427038|NCT04408794|615905571|FG000|Overall Study|Withdrawal by Subject|57|||
170427039|NCT04408794|615905571|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
170427040|NCT04408794|615905571|FG000|Overall Study|Never Treated Migraine|5|||
170427041|NCT00571064|615905574|FG000|Overall Study|Adverse Event|13|||
170427042|NCT00571064|615905574|FG000|Overall Study|Protocol Violation|4|||
170427043|NCT00571064|615905574|FG000|Overall Study|Withdrawal by Subject|2|||
170427044|NCT00571064|615905574|FG000|Overall Study|Other|2|||
170427045|NCT00244764|615905575|FG000|Overall Study|Adverse Event|37|||
170427046|NCT00244764|615905575|FG000|Overall Study|Lost to Follow-up|23|||
170427047|NCT00244764|615905575|FG000|Overall Study|Withdrawal by Subject|12|||
170427048|NCT00244764|615905575|FG000|Overall Study|Disease Progression|13|||
170427049|NCT00244764|615905575|FG000|Overall Study|Protocol Violation|2|||
170427050|NCT00244764|615905575|FG000|Overall Study|Death|1|||
170427051|NCT00244764|615905575|FG000|Overall Study|Off Study Medication for >21 Days|1|||
170427052|NCT00244764|615905575|FG000|Overall Study|Declining Performance Status|1|||
170427053|NCT00244764|615905575|FG000|Overall Study|Participant was Hospitalized until Death|1|||
170427054|NCT00244764|615905575|FG000|Overall Study|Primary Investigator Discretion|2|||
170427055|NCT00244764|615905575|FG000|Overall Study|Sponsor Terminated Study|2|||
170427056|NCT00244764|615905575|FG000|Overall Study|Developed Secondary Malignancy|1|||
170427057|NCT01518972|615905576|FG000|Overall Study|Lost to Follow-up|2|||
170427058|NCT01518972|615905577|FG001|Overall Study|Lost to Follow-up|1|||
170427059|NCT01518972|615905576|FG000|Overall Study|Withdrawal by Subject|1|||
170427060|NCT01518972|615905577|FG001|Overall Study|Withdrawal by Subject|0|||
170427061|NCT01518972|615905576|FG000|Overall Study|Moved from area|1|||
170427062|NCT01518972|615905577|FG001|Overall Study|Moved from area|0|||
170427063|NCT01518972|615905576|FG000|Overall Study|Transportation problems|1|||
170427064|NCT01518972|615905577|FG001|Overall Study|Transportation problems|0|||
170427065|NCT01518972|615905576|FG000|Overall Study|Exclusionary medical condition|1|||
170427066|NCT01518972|615905577|FG001|Overall Study|Exclusionary medical condition|0|||
170427067|NCT01518972|615905576|FG000|Overall Study|Missed safety visits|0|||
170427068|NCT01518972|615905577|FG001|Overall Study|Missed safety visits|1|||
170427069|NCT01518972|615905576|FG000|Overall Study|Exclusionary medication|0|||
170427070|NCT01518972|615905577|FG001|Overall Study|Exclusionary medication|1|||
170427071|NCT01518972|615905576|FG000|Overall Study|Declined medication starting on day 12|0|||
170427072|NCT01518972|615905577|FG001|Overall Study|Declined medication starting on day 12|1|||
170427073|NCT01294917|615905578|FG000|Overall Study|Relocation|5|||
170427074|NCT01294917|615905578|FG000|Overall Study|Inconvenience|1|||
170427075|NCT02159950|615905582|FG000|Overall Study|Adverse Event|0|||
170427076|NCT02159950|615905583|FG001|Overall Study|Adverse Event|1|||
170427077|NCT02159950|615905582|FG000|Overall Study|Progression|0|||
170427078|NCT02159950|615905583|FG001|Overall Study|Progression|1|||
170427079|NCT00003659|615905584|FG000|Overall Study|Withdrawal by Subject|3|||
170427080|NCT04022954|615905585|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
170427081|NCT04022954|615905585|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
170427082|NCT04022954|615905585|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
170427083|NCT03017885|615905586|FG000|Overall Study|Adverse Event|2|||
170427084|NCT03017885|615905587|FG001|Overall Study|Adverse Event|0|||
170427085|NCT03017885|615905588|FG002|Overall Study|Adverse Event|0|||
170427086|NCT03017885|615905589|FG003|Overall Study|Adverse Event|0|||
170427087|NCT03017885|615905590|FG004|Overall Study|Adverse Event|0|||
170427088|NCT03017885|615905591|FG005|Overall Study|Adverse Event|0|||
170427089|NCT03017885|615905586|FG000|Overall Study|Progression of disease|4|||
170427090|NCT03017885|615905587|FG001|Overall Study|Progression of disease|3|||
170427091|NCT03017885|615905588|FG002|Overall Study|Progression of disease|4|||
170427092|NCT03017885|615905589|FG003|Overall Study|Progression of disease|0|||
170427093|NCT03017885|615905590|FG004|Overall Study|Progression of disease|0|||
170534293|NCT01294514|616302214|FG000|Overall Study|Excluded due to Arrhythmia|1|||
170427094|NCT03017885|615905591|FG005|Overall Study|Progression of disease|0|||
170427095|NCT03017885|615905586|FG000|Overall Study|Other than listed|1|||
170427096|NCT03017885|615905587|FG001|Overall Study|Other than listed|2|||
170427097|NCT03017885|615905588|FG002|Overall Study|Other than listed|1|||
170427098|NCT03017885|615905589|FG003|Overall Study|Other than listed|0|||
170427099|NCT03017885|615905590|FG004|Overall Study|Other than listed|0|||
170427100|NCT03017885|615905591|FG005|Overall Study|Other than listed|0|||
170427101|NCT03017885|615905586|FG000|Overall Study|Lost to Follow-up|2|||
170427102|NCT03017885|615905587|FG001|Overall Study|Lost to Follow-up|0|||
170427103|NCT03017885|615905588|FG002|Overall Study|Lost to Follow-up|3|||
170427104|NCT03017885|615905589|FG003|Overall Study|Lost to Follow-up|0|||
170427105|NCT03017885|615905590|FG004|Overall Study|Lost to Follow-up|0|||
170427106|NCT03017885|615905591|FG005|Overall Study|Lost to Follow-up|0|||
170427107|NCT03017885|615905586|FG000|Overall Study|Change to other anti-cancer therapy|0|||
170427108|NCT03017885|615905587|FG001|Overall Study|Change to other anti-cancer therapy|0|||
170427109|NCT03017885|615905588|FG002|Overall Study|Change to other anti-cancer therapy|1|||
170427110|NCT03017885|615905589|FG003|Overall Study|Change to other anti-cancer therapy|0|||
170427111|NCT03017885|615905590|FG004|Overall Study|Change to other anti-cancer therapy|0|||
170427112|NCT03017885|615905591|FG005|Overall Study|Change to other anti-cancer therapy|0|||
170427113|NCT03285594|615905595|FG000|Overall Study|At the Participant's Own Request|10|||
170427114|NCT03285594|615905596|FG001|Overall Study|At the Participant's Own Request|5|||
170427115|NCT03285594|615905597|FG002|Overall Study|At the Participant's Own Request|21|||
170427116|NCT03285594|615905595|FG000|Overall Study|Adverse Event|2|||
170427117|NCT03285594|615905596|FG001|Overall Study|Adverse Event|2|||
170427118|NCT03285594|615905597|FG002|Overall Study|Adverse Event|6|||
170427119|NCT03285594|615905595|FG000|Overall Study|Poor Compliance to Protocol|0|||
170427120|NCT03285594|615905596|FG001|Overall Study|Poor Compliance to Protocol|0|||
170427121|NCT03285594|615905597|FG002|Overall Study|Poor Compliance to Protocol|1|||
170427122|NCT03285594|615905595|FG000|Overall Study|Lost to Follow-up|0|||
170427123|NCT03285594|615905596|FG001|Overall Study|Lost to Follow-up|0|||
170427124|NCT03285594|615905597|FG002|Overall Study|Lost to Follow-up|1|||
170427125|NCT03285594|615905595|FG000|Overall Study|Reason Not Specified|3|||
170427126|NCT03285594|615905596|FG001|Overall Study|Reason Not Specified|4|||
170427127|NCT03285594|615905597|FG002|Overall Study|Reason Not Specified|8|||
170427128|NCT00556322|615905600|FG000|Overall Study|Insufficient therapeutic response|158|||
170427129|NCT00556322|615905601|FG001|Overall Study|Insufficient therapeutic response|168|||
170427130|NCT00556322|615905600|FG000|Overall Study|Adverse Event|7|||
170427131|NCT00556322|615905601|FG001|Overall Study|Adverse Event|4|||
170427132|NCT00556322|615905600|FG000|Overall Study|Other|4|||
170427133|NCT00556322|615905601|FG001|Overall Study|Other|1|||
170427134|NCT00556322|615905600|FG000|Overall Study|Lost to Follow-up|5|||
170427135|NCT00556322|615905601|FG001|Overall Study|Lost to Follow-up|3|||
170427136|NCT00556322|615905600|FG000|Overall Study|Withdrawal by Subject|19|||
170427137|NCT00556322|615905601|FG001|Overall Study|Withdrawal by Subject|7|||
170427138|NCT00556322|615905600|FG000|Overall Study|Protocol Violation|5|||
170427139|NCT00556322|615905601|FG001|Overall Study|Protocol Violation|1|||
170427140|NCT00556322|615905600|FG000|Overall Study|Ongoing at data cutoff|3|||
170427141|NCT00556322|615905601|FG001|Overall Study|Ongoing at data cutoff|5|||
170427142|NCT00556322|615905600|FG000|Overall Study|Death|20|||
170427143|NCT00556322|615905601|FG001|Overall Study|Death|14|||
170427144|NCT03733444|615905602|FG000|Overall Study|Adverse Event|8|||
170427145|NCT03733444|615905603|FG001|Overall Study|Adverse Event|10|||
170427146|NCT03733444|615905604|FG002|Overall Study|Adverse Event|5|||
170427147|NCT03733444|615905602|FG000|Overall Study|Death|20|||
170427148|NCT03733444|615905603|FG001|Overall Study|Death|19|||
170427149|NCT03733444|615905604|FG002|Overall Study|Death|11|||
170427150|NCT03733444|615905602|FG000|Overall Study|Lost to Follow-up|3|||
170427151|NCT03733444|615905603|FG001|Overall Study|Lost to Follow-up|0|||
170427152|NCT03733444|615905604|FG002|Overall Study|Lost to Follow-up|1|||
170427153|NCT03733444|615905602|FG000|Overall Study|Lack of Efficacy|0|||
170427154|NCT03733444|615905603|FG001|Overall Study|Lack of Efficacy|1|||
170427155|NCT03733444|615905604|FG002|Overall Study|Lack of Efficacy|1|||
170427156|NCT03733444|615905602|FG000|Overall Study|Physician Decision|2|||
170427157|NCT03733444|615905603|FG001|Overall Study|Physician Decision|1|||
170427158|NCT03733444|615905604|FG002|Overall Study|Physician Decision|0|||
170427159|NCT03733444|615905602|FG000|Overall Study|Protocol Violation|2|||
170427160|NCT03733444|615905603|FG001|Overall Study|Protocol Violation|1|||
170427161|NCT03733444|615905604|FG002|Overall Study|Protocol Violation|0|||
170427162|NCT03733444|615905602|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
170427163|NCT03733444|615905603|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
170427164|NCT03733444|615905604|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
170427165|NCT03733444|615905602|FG000|Overall Study|Study Terminated by Sponsor|203|||
170427166|NCT03733444|615905603|FG001|Overall Study|Study Terminated by Sponsor|209|||
170427167|NCT03733444|615905604|FG002|Overall Study|Study Terminated by Sponsor|221|||
170427168|NCT03733444|615905602|FG000|Overall Study|Withdrawal by Subject|19|||
170427169|NCT03733444|615905603|FG001|Overall Study|Withdrawal by Subject|18|||
170427170|NCT03733444|615905604|FG002|Overall Study|Withdrawal by Subject|16|||
170427171|NCT03733444|615905602|FG000|Overall Study|Miscellaneous|1|||
170427172|NCT03733444|615905603|FG001|Overall Study|Miscellaneous|0|||
170427173|NCT03733444|615905604|FG002|Overall Study|Miscellaneous|1|||
170427174|NCT03733444|615905602|FG000|Overall Study|Not Treated|1|||
170427175|NCT03733444|615905603|FG001|Overall Study|Not Treated|2|||
170427176|NCT03733444|615905604|FG002|Overall Study|Not Treated|1|||
170427177|NCT01001208|615905605|FG000|Overall Study|Adverse Event|10|||
170427178|NCT01001208|615905606|FG001|Overall Study|Adverse Event|5|||
170427179|NCT01001208|615905605|FG000|Overall Study|Lost to Follow-up|5|||
170427180|NCT01001208|615905606|FG001|Overall Study|Lost to Follow-up|9|||
170534294|NCT01963611|616302215|FG000|Overall Study|Adverse Event|1|||
170534295|NCT01963611|616302216|FG001|Overall Study|Adverse Event|1|||
170534296|NCT01963611|616302217|FG002|Overall Study|Adverse Event|3|||
170534297|NCT01963611|616302218|FG003|Overall Study|Adverse Event|4|||
170534298|NCT01963611|616302219|FG004|Overall Study|Adverse Event|3|||
170534299|NCT01963611|616302215|FG000|Overall Study|Protocol Violation|0|||
170534300|NCT01963611|616302216|FG001|Overall Study|Protocol Violation|0|||
170534301|NCT01963611|616302217|FG002|Overall Study|Protocol Violation|0|||
170534302|NCT01963611|616302218|FG003|Overall Study|Protocol Violation|1|||
170534303|NCT01963611|616302219|FG004|Overall Study|Protocol Violation|0|||
170534304|NCT01963611|616302215|FG000|Overall Study|Lack of Efficacy|0|||
170534305|NCT01963611|616302216|FG001|Overall Study|Lack of Efficacy|0|||
170534306|NCT01963611|616302217|FG002|Overall Study|Lack of Efficacy|0|||
170534307|NCT01963611|616302218|FG003|Overall Study|Lack of Efficacy|1|||
170534308|NCT01963611|616302219|FG004|Overall Study|Lack of Efficacy|0|||
170534309|NCT01963611|616302215|FG000|Overall Study|Withdrawal by Subject|3|||
170534310|NCT01963611|616302216|FG001|Overall Study|Withdrawal by Subject|2|||
170534311|NCT01963611|616302217|FG002|Overall Study|Withdrawal by Subject|1|||
170534312|NCT01963611|616302218|FG003|Overall Study|Withdrawal by Subject|1|||
170534313|NCT01963611|616302219|FG004|Overall Study|Withdrawal by Subject|3|||
170534314|NCT01963611|616302215|FG000|Overall Study|Other|47|||
170534315|NCT01963611|616302216|FG001|Overall Study|Other|46|||
170534316|NCT01963611|616302217|FG002|Overall Study|Other|48|||
170534317|NCT01963611|616302218|FG003|Overall Study|Other|45|||
170534318|NCT01963611|616302219|FG004|Overall Study|Other|45|||
170534319|NCT01126424|616302224|FG000|Overall Study|Adverse Event|0|||
170534320|NCT01126424|616302225|FG001|Overall Study|Adverse Event|0|||
170534321|NCT01126424|616302226|FG002|Overall Study|Adverse Event|0|||
170534322|NCT01126424|616302227|FG003|Overall Study|Adverse Event|0|||
170534323|NCT01126424|616302228|FG004|Overall Study|Adverse Event|1|||
170534324|NCT01126424|616302229|FG005|Overall Study|Adverse Event|0|||
170534325|NCT01126424|616302224|FG000|Overall Study|Withdrawal by Subject|0|||
170534326|NCT01126424|616302225|FG001|Overall Study|Withdrawal by Subject|0|||
170534327|NCT01126424|616302226|FG002|Overall Study|Withdrawal by Subject|1|||
170534328|NCT01126424|616302227|FG003|Overall Study|Withdrawal by Subject|3|||
170534329|NCT01126424|616302228|FG004|Overall Study|Withdrawal by Subject|1|||
170534330|NCT01126424|616302229|FG005|Overall Study|Withdrawal by Subject|0|||
170534331|NCT02127671|616302230|FG000|Overall Study|Death|2|||
170534332|NCT02127671|616302231|FG001|Overall Study|Death|2|||
170534333|NCT02127671|616302230|FG000|Overall Study|Lost to Follow-up|4|||
170534334|NCT02127671|616302231|FG001|Overall Study|Lost to Follow-up|2|||
170534335|NCT02127671|616302230|FG000|Overall Study|Physician Decision|1|||
170534336|NCT02127671|616302231|FG001|Overall Study|Physician Decision|0|||
170534337|NCT02127671|616302230|FG000|Overall Study|incarceration|0|||
170534338|NCT02127671|616302231|FG001|Overall Study|incarceration|1|||
170534339|NCT02127671|616302230|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
170534340|NCT02127671|616302231|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
170534341|NCT05350423|616302233|FG000|Overall Study|Lost to Follow-up|3|||
170534342|NCT05350423|616302234|FG001|Overall Study|Lost to Follow-up|3|||
170534343|NCT05350423|616302233|FG000|Overall Study|screen failure|5|||
170534344|NCT05350423|616302234|FG001|Overall Study|screen failure|6|||
170534345|NCT02107898|616302239|FG000|Overall Study|Adverse Event|4|||
170534346|NCT02107898|616302240|FG001|Overall Study|Adverse Event|7|||
170534347|NCT02107898|616302239|FG000|Overall Study|Poor compliance to protocol|0|||
170534348|NCT02107898|616302240|FG001|Overall Study|Poor compliance to protocol|1|||
170534349|NCT02107898|616302239|FG000|Overall Study|Participant moved|0|||
170534350|NCT02107898|616302240|FG001|Overall Study|Participant moved|2|||
170534351|NCT02107898|616302239|FG000|Overall Study|Consent withdrawn by participant|2|||
170534352|NCT02107898|616302240|FG001|Overall Study|Consent withdrawn by participant|1|||
170534353|NCT02107898|616302239|FG000|Overall Study|Randomized but not treated|0|||
170534354|NCT02107898|616302240|FG001|Overall Study|Randomized but not treated|1|||
170534355|NCT01283386|616302241|FG000|Overall Study|Death|2|||
170534356|NCT01283386|616302242|FG001|Overall Study|Death|0|||
170534357|NCT01283386|616302241|FG000|Overall Study|Withdrawal by Subject|2|||
170534358|NCT01283386|616302242|FG001|Overall Study|Withdrawal by Subject|1|||
170534359|NCT01283386|616302241|FG000|Overall Study|Relapse of underlying disease|1|||
170534360|NCT01283386|616302242|FG001|Overall Study|Relapse of underlying disease|3|||
170534361|NCT01283386|616302241|FG000|Overall Study|Progression of underlying disease|2|||
170534362|NCT01283386|616302242|FG001|Overall Study|Progression of underlying disease|7|||
170534363|NCT01283386|616302241|FG000|Overall Study|Reason not specified|1|||
170534364|NCT01283386|616302242|FG001|Overall Study|Reason not specified|0|||
170534365|NCT01283386|616302241|FG000|Overall Study|Protocol Violation|0|||
170534366|NCT01283386|616302242|FG001|Overall Study|Protocol Violation|1|||
170534367|NCT00297167|616302243|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
170534368|NCT00297167|616302244|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
170534369|NCT00297167|616302245|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
170427181|NCT01001208|615905605|FG000|Overall Study|Physician Decision|1|||
170427182|NCT01001208|615905606|FG001|Overall Study|Physician Decision|0|||
170427183|NCT01001208|615905605|FG000|Overall Study|Withdrawal by Subject|4|||
170427184|NCT01001208|615905606|FG001|Overall Study|Withdrawal by Subject|5|||
170427185|NCT01001208|615905605|FG000|Overall Study|Ineligibility Determined|4|||
170427186|NCT01001208|615905606|FG001|Overall Study|Ineligibility Determined|2|||
170427187|NCT01001208|615905605|FG000|Overall Study|Noncompliance|4|||
170427188|NCT01001208|615905606|FG001|Overall Study|Noncompliance|7|||
170427189|NCT01001208|615905605|FG000|Overall Study|Disease Progression|0|||
170427190|NCT01001208|615905606|FG001|Overall Study|Disease Progression|3|||
170427191|NCT01001208|615905605|FG000|Overall Study|Other|0|||
170427192|NCT01001208|615905606|FG001|Overall Study|Other|2|||
170427193|NCT01864174|615905608|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
170427194|NCT01864174|615905609|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
170427195|NCT01864174|615905608|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
170427196|NCT01864174|615905609|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
170427197|NCT01864174|615905608|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
170427198|NCT01864174|615905609|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
170427199|NCT01864174|615905608|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
170427200|NCT01864174|615905609|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
170427201|NCT01864174|615905608|FG000|Double Blind - Compliant Randomized|Death|1|||
170427202|NCT01864174|615905609|FG001|Double Blind - Compliant Randomized|Death|0|||
170427203|NCT01864174|615905608|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
170427204|NCT01864174|615905609|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
170427205|NCT01864174|615905608|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
170427206|NCT01864174|615905609|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
170427207|NCT01864174|615905608|FG000|Double Blind - Compliant Randomized|Other|6|||
170427208|NCT01864174|615905609|FG001|Double Blind - Compliant Randomized|Other|10|||
170427209|NCT01864174|615905608|FG000|Off Treatment Follow-Up|Other|2|||
170427210|NCT01864174|615905609|FG001|Off Treatment Follow-Up|Other|0|||
170427211|NCT01864174|615905608|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
170427212|NCT01864174|615905609|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
170427213|NCT02648347|615905610|FG000|Overall Study|Death|174|||
170427214|NCT02648347|615905611|FG001|Overall Study|Death|167|||
170427215|NCT02648347|615905610|FG000|Overall Study|Withdrawal by Subject|16|||
170427216|NCT02648347|615905611|FG001|Overall Study|Withdrawal by Subject|9|||
170427217|NCT02648347|615905610|FG000|Overall Study|Lost to Follow-up|18|||
170427218|NCT02648347|615905611|FG001|Overall Study|Lost to Follow-up|21|||
170427219|NCT02648347|615905610|FG000|Overall Study|Missing|1|||
170427220|NCT02648347|615905611|FG001|Overall Study|Missing|0|||
170427221|NCT03546842|615905613|FG000|Overall Study|Protocol Violation|1|||
170427222|NCT03546842|615905613|FG000|Overall Study|Withdrawal by Subject|2|||
170427223|NCT02196675|615905614|FG000|Overall Study|Withdrawal by Subject|1|||
170427224|NCT02196675|615905615|FG001|Overall Study|Withdrawal by Subject|0|||
170427225|NCT02196675|615905616|FG002|Overall Study|Withdrawal by Subject|0|||
170427226|NCT02196675|615905614|FG000|Overall Study|Intra-operative surgical exclusion|1|||
170427227|NCT02196675|615905615|FG001|Overall Study|Intra-operative surgical exclusion|1|||
170427228|NCT02196675|615905616|FG002|Overall Study|Intra-operative surgical exclusion|0|||
170427229|NCT02196675|615905614|FG000|Overall Study|Protocol Violation|0|||
170427230|NCT02196675|615905615|FG001|Overall Study|Protocol Violation|1|||
170427231|NCT02196675|615905616|FG002|Overall Study|Protocol Violation|0|||
170427232|NCT02196675|615905614|FG000|Overall Study|Death|0|||
170427233|NCT02196675|615905615|FG001|Overall Study|Death|0|||
170427234|NCT02196675|615905616|FG002|Overall Study|Death|1|||
170427235|NCT02158663|615905618|FG000|Overall Study|Withdrawal by Subject|5|||
170427236|NCT02158663|615905619|FG001|Overall Study|Withdrawal by Subject|4|||
170427237|NCT02711852|615905620|FG000|Overall Study|Death|5|||
170427238|NCT02711852|615905620|FG000|Overall Study|Lost to Follow-up|1|||
170427239|NCT02711852|615905620|FG000|Overall Study|Completed follow-up|3|||
170427240|NCT02711852|615905620|FG000|Overall Study|Withdrawal by Subject|1|||
170534370|NCT00297167|616302243|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
170534371|NCT00297167|616302244|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
170534372|NCT00297167|616302245|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
170534373|NCT00505921|616302246|FG000|Overall Study|Ineligible|1|||
170534374|NCT00505921|616302246|FG000|Overall Study|Failed to Mobilize|8|||
170534375|NCT00717886|616302247|FG000|Overall Study|Withdrawal by Subject|3|||
170534376|NCT00717886|616302247|FG000|Overall Study|Treatment Failure|1|||
170534377|NCT01369433|616302248|FG000|Overall Study|Adverse Event|31|||
170427241|NCT03459807|615905621|FG000|Overall Study|Withdrawal due to transplant|0|||
170427242|NCT03459807|615905622|FG001|Overall Study|Withdrawal due to transplant|1|||
170427243|NCT00838279|615905625|FG000|Washout|Protocol Violation|1|||
170427244|NCT00838279|615905626|FG001|Washout|Protocol Violation|0|||
170427245|NCT00838279|615905625|FG000|Washout|Withdrawal by Subject|0|||
170427246|NCT00838279|615905626|FG001|Washout|Withdrawal by Subject|1|||
170427247|NCT00576056|615905629|FG000|Overall Study|Adverse Event|1|||
170427248|NCT00576056|615905629|FG000|Overall Study|Death|1|||
170427249|NCT00576056|615905629|FG000|Overall Study|Lack of Efficacy|1|||
170427250|NCT00576056|615905629|FG000|Overall Study|Withdrawal by Subject|2|||
170427251|NCT00576056|615905629|FG000|Overall Study|did not meet eligibility criteria|8|||
170427252|NCT00576056|615905629|FG000|Overall Study|Physician Decision|1|||
170427253|NCT03273153|615905630|FG000|Overall Study|Adverse Event|1|||
170427254|NCT03273153|615905631|FG001|Overall Study|Adverse Event|2|||
170427255|NCT03273153|615905630|FG000|Overall Study|Missing|0|||
170427256|NCT03273153|615905631|FG001|Overall Study|Missing|2|||
170427257|NCT03273153|615905630|FG000|Overall Study|Other|3|||
170427258|NCT03273153|615905631|FG001|Overall Study|Other|2|||
170427259|NCT03273153|615905630|FG000|Overall Study|Symptomatic Deterioration|0|||
170427260|NCT03273153|615905631|FG001|Overall Study|Symptomatic Deterioration|1|||
170534378|NCT01369433|616302249|FG001|Overall Study|Adverse Event|1|||
170534379|NCT01369433|616302248|FG000|Overall Study|Required significant surgical procedure|1|||
170534380|NCT01369433|616302249|FG001|Overall Study|Required significant surgical procedure|0|||
170534381|NCT01369433|616302248|FG000|Overall Study|Non-compliance|1|||
170534382|NCT01369433|616302249|FG001|Overall Study|Non-compliance|0|||
170534383|NCT01369433|616302248|FG000|Overall Study|Withdrawal by Subject|5|||
170534384|NCT01369433|616302249|FG001|Overall Study|Withdrawal by Subject|2|||
170534385|NCT01369433|616302248|FG000|Overall Study|Study terminated by Sponsor|67|||
170534386|NCT01369433|616302249|FG001|Overall Study|Study terminated by Sponsor|0|||
170534387|NCT01369433|616302248|FG000|Overall Study|Lost to Follow-up|1|||
170534388|NCT01369433|616302249|FG001|Overall Study|Lost to Follow-up|0|||
170534389|NCT01369433|616302248|FG000|Overall Study|Death|5|||
170534390|NCT01369433|616302249|FG001|Overall Study|Death|0|||
170534391|NCT01369433|616302248|FG000|Overall Study|Investigator discretion|6|||
170534392|NCT01369433|616302249|FG001|Overall Study|Investigator discretion|1|||
170534393|NCT01369433|616302248|FG000|Overall Study|Progressive Disease|92|||
170534394|NCT01369433|616302249|FG001|Overall Study|Progressive Disease|12|||
170534395|NCT02313155|616302250|FG000|Overall Study|Lost to Follow-up|0|||
170534396|NCT02313155|616302251|FG001|Overall Study|Lost to Follow-up|1|||
170534397|NCT01285518|616302261|FG000|Overall Study|Lost to Follow-up|0|||
170534398|NCT01285518|616302262|FG001|Overall Study|Lost to Follow-up|0|||
170534399|NCT01285518|616302263|FG002|Overall Study|Lost to Follow-up|0|||
170534400|NCT01285518|616302264|FG003|Overall Study|Lost to Follow-up|0|||
170534401|NCT01285518|616302265|FG004|Overall Study|Lost to Follow-up|0|||
170534402|NCT01285518|616302266|FG005|Overall Study|Lost to Follow-up|1|||
170534403|NCT01285518|616302267|FG006|Overall Study|Lost to Follow-up|0|||
170534404|NCT01285518|616302268|FG007|Overall Study|Lost to Follow-up|0|||
170534405|NCT00879658|616302271|FG000|Overall Study|Abnormal laboratory value(s)|3|||
170534406|NCT00879658|616302272|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170534407|NCT00879658|616302273|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170534408|NCT00879658|616302274|FG003|Overall Study|Abnormal laboratory value(s)|1|||
170534409|NCT00879658|616302275|FG004|Overall Study|Abnormal laboratory value(s)|0|||
170534410|NCT00879658|616302276|FG005|Overall Study|Abnormal laboratory value(s)|0|||
170534411|NCT00879658|616302277|FG006|Overall Study|Abnormal laboratory value(s)|0|||
170534412|NCT00879658|616302271|FG000|Overall Study|Administrative problems|2|||
170534413|NCT00879658|616302272|FG001|Overall Study|Administrative problems|1|||
170534414|NCT00879658|616302273|FG002|Overall Study|Administrative problems|0|||
170534415|NCT00879658|616302274|FG003|Overall Study|Administrative problems|1|||
170534416|NCT00879658|616302275|FG004|Overall Study|Administrative problems|0|||
170534417|NCT00879658|616302276|FG005|Overall Study|Administrative problems|0|||
170534418|NCT00879658|616302277|FG006|Overall Study|Administrative problems|0|||
170534419|NCT00879658|616302271|FG000|Overall Study|Adverse Event|6|||
170534420|NCT00879658|616302272|FG001|Overall Study|Adverse Event|4|||
170534421|NCT00879658|616302273|FG002|Overall Study|Adverse Event|3|||
170534422|NCT00879658|616302274|FG003|Overall Study|Adverse Event|1|||
170534423|NCT00879658|616302275|FG004|Overall Study|Adverse Event|2|||
170534424|NCT00879658|616302276|FG005|Overall Study|Adverse Event|0|||
170427261|NCT03273153|615905630|FG000|Overall Study|Progressive Disease|6|||
170534425|NCT00879658|616302277|FG006|Overall Study|Adverse Event|0|||
170534426|NCT00879658|616302271|FG000|Overall Study|Protocol Violation|1|||
170534427|NCT00879658|616302272|FG001|Overall Study|Protocol Violation|0|||
170534428|NCT00879658|616302273|FG002|Overall Study|Protocol Violation|0|||
170534429|NCT00879658|616302274|FG003|Overall Study|Protocol Violation|0|||
170534430|NCT00879658|616302275|FG004|Overall Study|Protocol Violation|0|||
170534431|NCT00879658|616302276|FG005|Overall Study|Protocol Violation|0|||
170534432|NCT00879658|616302277|FG006|Overall Study|Protocol Violation|0|||
170534433|NCT00879658|616302271|FG000|Overall Study|Withdrawal by Subject|3|||
170534434|NCT00879658|616302272|FG001|Overall Study|Withdrawal by Subject|0|||
170534435|NCT00879658|616302273|FG002|Overall Study|Withdrawal by Subject|2|||
170534436|NCT00879658|616302274|FG003|Overall Study|Withdrawal by Subject|0|||
170534437|NCT00879658|616302275|FG004|Overall Study|Withdrawal by Subject|0|||
170534438|NCT00879658|616302276|FG005|Overall Study|Withdrawal by Subject|1|||
170534439|NCT00879658|616302277|FG006|Overall Study|Withdrawal by Subject|0|||
170534440|NCT00879658|616302271|FG000|Overall Study|Lack of Efficacy|0|||
170534441|NCT00879658|616302272|FG001|Overall Study|Lack of Efficacy|0|||
170632710|NCT02760498|616666744|FG002|Overall Study|Disease progression|20|||
170427262|NCT03273153|615905631|FG001|Overall Study|Progressive Disease|5|||
170427263|NCT03273153|615905630|FG000|Overall Study|Physician Decision|1|||
170427264|NCT03273153|615905631|FG001|Overall Study|Physician Decision|3|||
170427265|NCT03273153|615905630|FG000|Overall Study|Study Terminated by Sponsor|112|||
170427266|NCT03273153|615905631|FG001|Overall Study|Study Terminated by Sponsor|102|||
170427267|NCT03273153|615905630|FG000|Overall Study|Withdrawal by Subject|26|||
170427268|NCT03273153|615905631|FG001|Overall Study|Withdrawal by Subject|25|||
170427269|NCT03273153|615905630|FG000|Overall Study|Protocol Deviation|3|||
170427270|NCT03273153|615905631|FG001|Overall Study|Protocol Deviation|0|||
170427271|NCT03273153|615905630|FG000|Overall Study|Lost to Follow-up|6|||
170427272|NCT03273153|615905631|FG001|Overall Study|Lost to Follow-up|11|||
170427273|NCT03273153|615905630|FG000|Overall Study|Death|66|||
170427274|NCT03273153|615905631|FG001|Overall Study|Death|69|||
170427275|NCT00838539|615905632|FG000|Overall Study|Disease Progression|2|||
170427276|NCT00838539|615905633|FG001|Overall Study|Disease Progression|4|||
170427277|NCT00838539|615905634|FG002|Overall Study|Disease Progression|3|||
170427278|NCT00838539|615905635|FG003|Overall Study|Disease Progression|2|||
170427279|NCT00838539|615905636|FG004|Overall Study|Disease Progression|4|||
170427280|NCT00838539|615905637|FG005|Overall Study|Disease Progression|2|||
170427281|NCT00838539|615905638|FG006|Overall Study|Disease Progression|3|||
170427282|NCT00838539|615905639|FG007|Overall Study|Disease Progression|4|||
170427283|NCT00838539|615905640|FG008|Overall Study|Disease Progression|4|||
170427284|NCT00838539|615905641|FG009|Overall Study|Disease Progression|5|||
170427285|NCT00838539|615905642|FG010|Overall Study|Disease Progression|1|||
170427286|NCT00838539|615905643|FG011|Overall Study|Disease Progression|4|||
170427287|NCT00838539|615905632|FG000|Overall Study|Adverse Event|1|||
170427288|NCT00838539|615905633|FG001|Overall Study|Adverse Event|1|||
170427289|NCT00838539|615905634|FG002|Overall Study|Adverse Event|1|||
170427290|NCT00838539|615905635|FG003|Overall Study|Adverse Event|1|||
170427291|NCT00838539|615905636|FG004|Overall Study|Adverse Event|2|||
170427292|NCT00838539|615905637|FG005|Overall Study|Adverse Event|1|||
170427293|NCT00838539|615905638|FG006|Overall Study|Adverse Event|0|||
170427294|NCT00838539|615905639|FG007|Overall Study|Adverse Event|2|||
170427295|NCT00838539|615905640|FG008|Overall Study|Adverse Event|0|||
170427296|NCT00838539|615905641|FG009|Overall Study|Adverse Event|1|||
170427297|NCT00838539|615905642|FG010|Overall Study|Adverse Event|2|||
170427298|NCT00838539|615905643|FG011|Overall Study|Adverse Event|0|||
170427299|NCT00838539|615905632|FG000|Overall Study|Withdrawal by Subject|0|||
170427300|NCT00838539|615905633|FG001|Overall Study|Withdrawal by Subject|1|||
170427301|NCT00838539|615905634|FG002|Overall Study|Withdrawal by Subject|0|||
170427302|NCT00838539|615905635|FG003|Overall Study|Withdrawal by Subject|0|||
170427303|NCT00838539|615905636|FG004|Overall Study|Withdrawal by Subject|0|||
170427304|NCT00838539|615905637|FG005|Overall Study|Withdrawal by Subject|0|||
170427305|NCT00838539|615905638|FG006|Overall Study|Withdrawal by Subject|0|||
170427306|NCT00838539|615905639|FG007|Overall Study|Withdrawal by Subject|0|||
170427307|NCT00838539|615905640|FG008|Overall Study|Withdrawal by Subject|0|||
170427308|NCT00838539|615905641|FG009|Overall Study|Withdrawal by Subject|1|||
170427309|NCT00838539|615905642|FG010|Overall Study|Withdrawal by Subject|2|||
170427310|NCT00838539|615905643|FG011|Overall Study|Withdrawal by Subject|0|||
170427311|NCT00838539|615905632|FG000|Overall Study|Death|0|||
170427312|NCT00838539|615905633|FG001|Overall Study|Death|0|||
170427313|NCT00838539|615905634|FG002|Overall Study|Death|0|||
170427314|NCT00838539|615905635|FG003|Overall Study|Death|0|||
170427315|NCT00838539|615905636|FG004|Overall Study|Death|0|||
170427316|NCT00838539|615905637|FG005|Overall Study|Death|0|||
170427317|NCT00838539|615905638|FG006|Overall Study|Death|1|||
170427318|NCT00838539|615905639|FG007|Overall Study|Death|0|||
170427319|NCT00838539|615905640|FG008|Overall Study|Death|0|||
170427320|NCT00838539|615905641|FG009|Overall Study|Death|0|||
170427321|NCT00838539|615905642|FG010|Overall Study|Death|0|||
170427322|NCT00838539|615905643|FG011|Overall Study|Death|0|||
170427323|NCT00838539|615905632|FG000|Overall Study|Physician Decision|0|||
170427324|NCT00838539|615905633|FG001|Overall Study|Physician Decision|0|||
170427325|NCT00838539|615905634|FG002|Overall Study|Physician Decision|0|||
170427326|NCT00838539|615905635|FG003|Overall Study|Physician Decision|0|||
170427327|NCT00838539|615905636|FG004|Overall Study|Physician Decision|0|||
170427328|NCT00838539|615905637|FG005|Overall Study|Physician Decision|0|||
170427329|NCT00838539|615905638|FG006|Overall Study|Physician Decision|0|||
170427330|NCT00838539|615905639|FG007|Overall Study|Physician Decision|0|||
170427331|NCT00838539|615905640|FG008|Overall Study|Physician Decision|1|||
170427332|NCT00838539|615905641|FG009|Overall Study|Physician Decision|0|||
170427333|NCT00838539|615905642|FG010|Overall Study|Physician Decision|0|||
170427334|NCT00838539|615905643|FG011|Overall Study|Physician Decision|0|||
170427335|NCT00838539|615905632|FG000|Overall Study|Clinical Progression|0|||
170427336|NCT00838539|615905633|FG001|Overall Study|Clinical Progression|0|||
170427337|NCT00838539|615905634|FG002|Overall Study|Clinical Progression|0|||
170427338|NCT00838539|615905635|FG003|Overall Study|Clinical Progression|0|||
170427339|NCT00838539|615905636|FG004|Overall Study|Clinical Progression|0|||
170427340|NCT00838539|615905637|FG005|Overall Study|Clinical Progression|0|||
170427341|NCT00838539|615905638|FG006|Overall Study|Clinical Progression|1|||
170427342|NCT00838539|615905639|FG007|Overall Study|Clinical Progression|0|||
170427343|NCT00838539|615905640|FG008|Overall Study|Clinical Progression|0|||
170427344|NCT00838539|615905641|FG009|Overall Study|Clinical Progression|0|||
170534442|NCT00879658|616302273|FG002|Overall Study|Lack of Efficacy|2|||
170534443|NCT00879658|616302274|FG003|Overall Study|Lack of Efficacy|0|||
170534444|NCT00879658|616302275|FG004|Overall Study|Lack of Efficacy|0|||
170534445|NCT00879658|616302276|FG005|Overall Study|Lack of Efficacy|0|||
170534446|NCT00879658|616302277|FG006|Overall Study|Lack of Efficacy|0|||
170534447|NCT00879658|616302271|FG000|Overall Study|misrandomized (never received study med)|0|||
170632711|NCT02760498|616666745|FG003|Overall Study|Disease progression|18|||
170427345|NCT00838539|615905642|FG010|Overall Study|Clinical Progression|0|||
170427346|NCT00838539|615905643|FG011|Overall Study|Clinical Progression|0|||
170427347|NCT00838539|615905632|FG000|Overall Study|Symptomatic Deterioration|0|||
170427348|NCT00838539|615905633|FG001|Overall Study|Symptomatic Deterioration|0|||
170427349|NCT00838539|615905634|FG002|Overall Study|Symptomatic Deterioration|1|||
170427350|NCT00838539|615905635|FG003|Overall Study|Symptomatic Deterioration|1|||
170427351|NCT00838539|615905636|FG004|Overall Study|Symptomatic Deterioration|0|||
170427352|NCT00838539|615905637|FG005|Overall Study|Symptomatic Deterioration|1|||
170427353|NCT00838539|615905638|FG006|Overall Study|Symptomatic Deterioration|0|||
170427354|NCT00838539|615905639|FG007|Overall Study|Symptomatic Deterioration|0|||
170427355|NCT00838539|615905640|FG008|Overall Study|Symptomatic Deterioration|0|||
170427356|NCT00838539|615905641|FG009|Overall Study|Symptomatic Deterioration|1|||
170427357|NCT00838539|615905642|FG010|Overall Study|Symptomatic Deterioration|0|||
170427358|NCT00838539|615905643|FG011|Overall Study|Symptomatic Deterioration|0|||
170427359|NCT04646213|615905651|FG000|Overall Study|Physician Decision|3|||
170427360|NCT04646213|615905651|FG000|Overall Study|Withdrawal by Subject|2|||
170427361|NCT03206177|615905656|FG000|Overall Study|Withdrawal by Subject|1|||
170427362|NCT01421277|615905657|FG000|Overall Study|Lack of qualifying event|0|||
170427363|NCT01421277|615905658|FG001|Overall Study|Lack of qualifying event|61|||
170427364|NCT01421277|615905657|FG000|Overall Study|Incomplete baseline data|0|||
170427365|NCT01421277|615905658|FG001|Overall Study|Incomplete baseline data|31|||
170427366|NCT04115293|615907024|FG000|Overall Study|Adverse Event|0|||
170427367|NCT04115293|615907025|FG001|Overall Study|Adverse Event|2|||
170427368|NCT04115293|615907024|FG000|Overall Study|Withdrawal by Subject|2|||
170427369|NCT04115293|615907025|FG001|Overall Study|Withdrawal by Subject|1|||
170427370|NCT04115293|615907024|FG000|Overall Study|Physician Decision|1|||
170427371|NCT04115293|615907025|FG001|Overall Study|Physician Decision|0|||
170427372|NCT04115293|615907024|FG000|Overall Study|Death|1|||
170427373|NCT04115293|615907025|FG001|Overall Study|Death|1|||
170427374|NCT02674152|615907026|FG000|Overall Study|Personal Reasons|1|||
170427375|NCT02674152|615907027|FG001|Overall Study|Personal Reasons|0|||
170427376|NCT02674152|615907028|FG002|Overall Study|Personal Reasons|0|||
170427377|NCT02674152|615907029|FG003|Overall Study|Personal Reasons|1|||
170427378|NCT02674152|615907030|FG004|Overall Study|Personal Reasons|1|||
170427379|NCT02674152|615907026|FG000|Overall Study|Other adverse event or clinical progression|0|||
170427380|NCT02674152|615907027|FG001|Overall Study|Other adverse event or clinical progression|1|||
170427381|NCT02674152|615907028|FG002|Overall Study|Other adverse event or clinical progression|0|||
170427382|NCT02674152|615907029|FG003|Overall Study|Other adverse event or clinical progression|3|||
170427383|NCT02674152|615907030|FG004|Overall Study|Other adverse event or clinical progression|0|||
170427384|NCT02674152|615907026|FG000|Overall Study|Dose-limiting toxicity|0|||
170427385|NCT02674152|615907027|FG001|Overall Study|Dose-limiting toxicity|0|||
170427386|NCT02674152|615907028|FG002|Overall Study|Dose-limiting toxicity|0|||
170427387|NCT02674152|615907029|FG003|Overall Study|Dose-limiting toxicity|0|||
170427388|NCT02674152|615907030|FG004|Overall Study|Dose-limiting toxicity|1|||
170427389|NCT02674152|615907026|FG000|Overall Study|Progressive Disease|2|||
170427390|NCT02674152|615907027|FG001|Overall Study|Progressive Disease|1|||
170427391|NCT02674152|615907028|FG002|Overall Study|Progressive Disease|1|||
170534448|NCT00879658|616302272|FG001|Overall Study|misrandomized (never received study med)|0|||
170534449|NCT00879658|616302273|FG002|Overall Study|misrandomized (never received study med)|0|||
170427392|NCT02674152|615907029|FG003|Overall Study|Progressive Disease|13|||
170427393|NCT02674152|615907030|FG004|Overall Study|Progressive Disease|2|||
170427394|NCT02674152|615907026|FG000|Overall Study|Adverse Event|0|||
170534450|NCT00879658|616302274|FG003|Overall Study|misrandomized (never received study med)|1|||
170534451|NCT00879658|616302275|FG004|Overall Study|misrandomized (never received study med)|0|||
170534452|NCT00879658|616302276|FG005|Overall Study|misrandomized (never received study med)|0|||
170534453|NCT00879658|616302277|FG006|Overall Study|misrandomized (never received study med)|0|||
170534454|NCT00157755|616302284|FG000|Overall Study|Death|2|||
170534455|NCT00157755|616302285|FG001|Overall Study|Death|3|||
170534456|NCT00157755|616302286|FG002|Overall Study|Death|3|||
170534457|NCT00157755|616302287|FG003|Overall Study|Death|2|||
170534458|NCT00157755|616302288|FG004|Overall Study|Death|0|||
170534459|NCT00157755|616302289|FG005|Overall Study|Death|0|||
170534460|NCT00157755|616302284|FG000|Overall Study|Lost to Follow-up|0|||
170534461|NCT00157755|616302285|FG001|Overall Study|Lost to Follow-up|0|||
170534462|NCT00157755|616302286|FG002|Overall Study|Lost to Follow-up|1|||
170534463|NCT00157755|616302287|FG003|Overall Study|Lost to Follow-up|0|||
170534464|NCT00157755|616302288|FG004|Overall Study|Lost to Follow-up|0|||
170534465|NCT00157755|616302289|FG005|Overall Study|Lost to Follow-up|0|||
170534466|NCT00157755|616302284|FG000|Overall Study|Withdrawal by Subject|0|||
170534467|NCT00157755|616302285|FG001|Overall Study|Withdrawal by Subject|0|||
170534468|NCT00157755|616302286|FG002|Overall Study|Withdrawal by Subject|1|||
170534469|NCT00157755|616302287|FG003|Overall Study|Withdrawal by Subject|1|||
170534470|NCT00157755|616302288|FG004|Overall Study|Withdrawal by Subject|1|||
170534471|NCT00157755|616302289|FG005|Overall Study|Withdrawal by Subject|2|||
170534472|NCT00157755|616302284|FG000|Overall Study|Explant due to infection|0|||
170534473|NCT00157755|616302285|FG001|Overall Study|Explant due to infection|0|||
170534474|NCT00157755|616302286|FG002|Overall Study|Explant due to infection|1|||
170534475|NCT00157755|616302287|FG003|Overall Study|Explant due to infection|0|||
170534476|NCT00157755|616302288|FG004|Overall Study|Explant due to infection|0|||
170534477|NCT00157755|616302289|FG005|Overall Study|Explant due to infection|0|||
170534478|NCT00157755|616302284|FG000|Overall Study|Medical reason|0|||
170534479|NCT00157755|616302285|FG001|Overall Study|Medical reason|0|||
170534480|NCT00157755|616302286|FG002|Overall Study|Medical reason|1|||
170534481|NCT00157755|616302287|FG003|Overall Study|Medical reason|1|||
170534482|NCT00157755|616302288|FG004|Overall Study|Medical reason|0|||
170534483|NCT00157755|616302289|FG005|Overall Study|Medical reason|0|||
170534484|NCT00157755|616302284|FG000|Overall Study|Study site closure|0|||
170534485|NCT00157755|616302285|FG001|Overall Study|Study site closure|1|||
170534486|NCT00157755|616302286|FG002|Overall Study|Study site closure|0|||
170534487|NCT00157755|616302287|FG003|Overall Study|Study site closure|0|||
170534488|NCT00157755|616302288|FG004|Overall Study|Study site closure|0|||
170534489|NCT00157755|616302289|FG005|Overall Study|Study site closure|0|||
170534490|NCT00157755|616302284|FG000|Overall Study|Subject non-compliance|0|||
170534491|NCT00157755|616302285|FG001|Overall Study|Subject non-compliance|0|||
170534492|NCT00157755|616302286|FG002|Overall Study|Subject non-compliance|0|||
170534493|NCT00157755|616302287|FG003|Overall Study|Subject non-compliance|0|||
170534494|NCT00157755|616302288|FG004|Overall Study|Subject non-compliance|0|||
170534495|NCT00157755|616302289|FG005|Overall Study|Subject non-compliance|1|||
170534496|NCT00157755|616302284|FG000|Overall Study|Study completion|0|||
170534497|NCT00157755|616302285|FG001|Overall Study|Study completion|0|||
170534498|NCT00157755|616302286|FG002|Overall Study|Study completion|0|||
170534499|NCT00157755|616302287|FG003|Overall Study|Study completion|0|||
170534500|NCT00157755|616302288|FG004|Overall Study|Study completion|1|||
170534501|NCT00157755|616302289|FG005|Overall Study|Study completion|2|||
170534502|NCT05352399|616302295|FG000|Overall Study|Discontinued intervention|6|||
170534503|NCT00964782|616302296|FG000|Overall Study|Lost to Follow-up|1|||
170534504|NCT00964782|616302297|FG001|Overall Study|Lost to Follow-up|0|||
170534505|NCT01101178|616302298|FG000|Period 1|Withdrawal by Subject|1|||
170534506|NCT01101178|616302299|FG001|Period 1|Withdrawal by Subject|2|||
170534507|NCT01101178|616302298|FG000|Period 1|Positive drug screen|1|||
170427395|NCT02674152|615907027|FG001|Overall Study|Adverse Event|0|||
170427396|NCT02674152|615907028|FG002|Overall Study|Adverse Event|1|||
170427397|NCT02674152|615907029|FG003|Overall Study|Adverse Event|0|||
170427398|NCT02674152|615907030|FG004|Overall Study|Adverse Event|1|||
170427399|NCT02571907|615907031|FG000|Overall Study|Death|4|||
170427400|NCT02571907|615907031|FG000|Overall Study|Lost to Follow-up|3|||
170427401|NCT02571907|615907031|FG000|Overall Study|Withdrawal by Subject|3|||
170427402|NCT03071575|615907032|FG000|Overall Study|Death|0|||
170427403|NCT03071575|615907033|FG001|Overall Study|Death|1|||
170427404|NCT03071575|615907032|FG000|Overall Study|Lost to Follow-up|5|||
170427405|NCT03071575|615907033|FG001|Overall Study|Lost to Follow-up|11|||
170427406|NCT03071575|615907032|FG000|Overall Study|Withdrawal by Subject|4|||
170427407|NCT03071575|615907033|FG001|Overall Study|Withdrawal by Subject|2|||
170427408|NCT00218257|615907038|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
170427409|NCT00218257|615907039|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
170427410|NCT00579345|615907040|FG000|Overall Study|Withdrawal by Subject|2|||
170427411|NCT00579345|615907041|FG001|Overall Study|Withdrawal by Subject|0|||
170427412|NCT00579345|615907042|FG002|Overall Study|Withdrawal by Subject|0|||
170427413|NCT00579345|615907043|FG003|Overall Study|Withdrawal by Subject|0|||
170427414|NCT00579345|615907044|FG004|Overall Study|Withdrawal by Subject|0|||
170427415|NCT00579345|615907045|FG005|Overall Study|Withdrawal by Subject|0|||
170427416|NCT00579345|615907046|FG006|Overall Study|Withdrawal by Subject|0|||
170427417|NCT00579345|615907047|FG007|Overall Study|Withdrawal by Subject|1|||
170427418|NCT00579345|615907040|FG000|Overall Study|Lost to Follow-up|1|||
170427419|NCT00579345|615907041|FG001|Overall Study|Lost to Follow-up|0|||
170427420|NCT00579345|615907042|FG002|Overall Study|Lost to Follow-up|0|||
170427421|NCT00579345|615907043|FG003|Overall Study|Lost to Follow-up|0|||
170427422|NCT00579345|615907044|FG004|Overall Study|Lost to Follow-up|0|||
170427423|NCT00579345|615907045|FG005|Overall Study|Lost to Follow-up|0|||
170427424|NCT00579345|615907046|FG006|Overall Study|Lost to Follow-up|0|||
170427425|NCT00579345|615907047|FG007|Overall Study|Lost to Follow-up|0|||
170427426|NCT00579345|615907040|FG000|Overall Study|Adverse Event|0|||
170427427|NCT00579345|615907041|FG001|Overall Study|Adverse Event|0|||
170427428|NCT00579345|615907042|FG002|Overall Study|Adverse Event|1|||
170427429|NCT00579345|615907043|FG003|Overall Study|Adverse Event|0|||
170427430|NCT00579345|615907044|FG004|Overall Study|Adverse Event|0|||
170427431|NCT00579345|615907045|FG005|Overall Study|Adverse Event|0|||
170427432|NCT00579345|615907046|FG006|Overall Study|Adverse Event|0|||
170427433|NCT00579345|615907047|FG007|Overall Study|Adverse Event|0|||
170427434|NCT00579345|615907040|FG000|Overall Study|Protocol Violation|1|||
170427435|NCT00579345|615907041|FG001|Overall Study|Protocol Violation|0|||
170427436|NCT00579345|615907042|FG002|Overall Study|Protocol Violation|0|||
170427437|NCT00579345|615907043|FG003|Overall Study|Protocol Violation|0|||
170427438|NCT00579345|615907044|FG004|Overall Study|Protocol Violation|0|||
170427439|NCT00579345|615907045|FG005|Overall Study|Protocol Violation|0|||
170427440|NCT00579345|615907046|FG006|Overall Study|Protocol Violation|0|||
170427441|NCT00579345|615907047|FG007|Overall Study|Protocol Violation|1|||
170427442|NCT00579345|615907040|FG000|Overall Study|Death|1|||
170427443|NCT00579345|615907041|FG001|Overall Study|Death|1|||
170427444|NCT00579345|615907042|FG002|Overall Study|Death|1|||
170427445|NCT00579345|615907043|FG003|Overall Study|Death|1|||
170427446|NCT00579345|615907044|FG004|Overall Study|Death|0|||
170427447|NCT00579345|615907045|FG005|Overall Study|Death|0|||
170427448|NCT00579345|615907046|FG006|Overall Study|Death|0|||
170427449|NCT00579345|615907047|FG007|Overall Study|Death|0|||
170427450|NCT03447353|615907048|FG000|Overall Study|Failure at Screening Visit|2|||
170427451|NCT03447353|615907048|FG000|Overall Study|Lost to Follow-up|4|||
170427452|NCT03447353|615907048|FG000|Overall Study|Scheduling Conflicts|3|||
170427453|NCT03447353|615907048|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
170427454|NCT02175095|615907051|FG000|Overall Study|Withdrawal by Subject|3|||
170427455|NCT02635750|615907052|FG000|Part 1, Period 2|Adverse Event|1|||
170427456|NCT02635750|615907053|FG001|Part 1, Period 2|Adverse Event|0|||
170427457|NCT02635750|615907054|FG002|Part 1, Period 2|Adverse Event|0|||
170427458|NCT00462345|615907055|FG000|Overall Study|Withdrawal by Subject|2|||
170427459|NCT00462345|615907055|FG000|Overall Study|Did not complete second course|1|||
170427460|NCT02267187|615907057|FG000|Overall Study|Physician Decision|2|||
170427461|NCT02267187|615907057|FG000|Overall Study|Screen fail|3|||
170427462|NCT01660243|615907060|FG000|Overall Study|Adverse Event|1|||
170427463|NCT01660243|615907061|FG001|Overall Study|Adverse Event|0|||
170427464|NCT01660243|615907062|FG002|Overall Study|Adverse Event|1|||
170427465|NCT01660243|615907063|FG003|Overall Study|Adverse Event|0|||
170427466|NCT01660243|615907060|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
170427467|NCT01660243|615907061|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
170427468|NCT01660243|615907062|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
170427469|NCT01660243|615907063|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
170427470|NCT01660243|615907060|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
170534508|NCT01101178|616302299|FG001|Period 1|Positive drug screen|1|||
170427471|NCT01660243|615907061|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
170427472|NCT01660243|615907062|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
170427473|NCT01660243|615907063|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
170427474|NCT01660243|615907060|FG000|Overall Study|Randomization error|0|||
170427475|NCT01660243|615907061|FG001|Overall Study|Randomization error|0|||
170427476|NCT01660243|615907062|FG002|Overall Study|Randomization error|0|||
170427477|NCT01660243|615907063|FG003|Overall Study|Randomization error|1|||
170427478|NCT00089661|615907064|FG000|Overall Study|Adverse Event|0|||
170427479|NCT00089661|615907065|FG001|Overall Study|Adverse Event|2|||
170427480|NCT00089661|615907064|FG000|Overall Study|Death|1|||
170427481|NCT00089661|615907065|FG001|Overall Study|Death|0|||
170427482|NCT00089661|615907064|FG000|Overall Study|Lost to Follow-up|0|||
170427483|NCT00089661|615907065|FG001|Overall Study|Lost to Follow-up|3|||
170427484|NCT00089661|615907064|FG000|Overall Study|Withdrawal by Subject|11|||
170427485|NCT00089661|615907065|FG001|Overall Study|Withdrawal by Subject|9|||
170427486|NCT00089661|615907064|FG000|Overall Study|Disease progression|1|||
170427487|NCT00089661|615907065|FG001|Overall Study|Disease progression|3|||
170427488|NCT00089661|615907064|FG000|Overall Study|Ineligibility determined|4|||
170427489|NCT00089661|615907065|FG001|Overall Study|Ineligibility determined|4|||
170427490|NCT00089661|615907064|FG000|Overall Study|Noncompliance|2|||
170427491|NCT00089661|615907065|FG001|Overall Study|Noncompliance|4|||
170427492|NCT00089661|615907064|FG000|Overall Study|Other|2|||
170427493|NCT00089661|615907065|FG001|Overall Study|Other|1|||
170427494|NCT02647944|615907066|FG000|Overall Study|Withdrawal by Subject|0|||
170427495|NCT02647944|615907067|FG001|Overall Study|Withdrawal by Subject|3|||
170427496|NCT02647944|615907066|FG000|Overall Study|Adverse Event|2|||
170427497|NCT02647944|615907067|FG001|Overall Study|Adverse Event|0|||
170427498|NCT02760368|615907069|FG000|Overall Study|Withdrawal by Subject|8|||
170427499|NCT02760368|615907070|FG001|Overall Study|Withdrawal by Subject|12|||
170427500|NCT02760368|615907071|FG002|Overall Study|Withdrawal by Subject|9|||
170427501|NCT02760368|615907069|FG000|Overall Study|Screen Failure|0|||
170534509|NCT01101178|616302298|FG000|Period 1|Adverse Event|2|||
170534510|NCT01101178|616302299|FG001|Period 1|Adverse Event|1|||
170534511|NCT01101178|616302298|FG000|Period 2|Withdrawal by Subject|0|||
170534512|NCT01101178|616302299|FG001|Period 2|Withdrawal by Subject|1|||
170534513|NCT01850641|616302300|FG000|Overall Study|Physician Decision|1|||
170534514|NCT01850641|616302300|FG000|Overall Study|Decrease in serum phosphorus|1|||
170534515|NCT01850641|616302300|FG000|Overall Study|Decrease in serum calcium|2|||
170534516|NCT01850641|616302300|FG000|Overall Study|Increase in serum ferritin|1|||
170534517|NCT04739800|616302307|FG000|Overall Study|Adverse Event|2|||
170534518|NCT04739800|616302308|FG001|Overall Study|Adverse Event|1|||
170534519|NCT04739800|616302309|FG002|Overall Study|Adverse Event|4|||
170534520|NCT04739800|616302310|FG003|Overall Study|Adverse Event|5|||
170534521|NCT04739800|616302307|FG000|Overall Study|Never Treated|2|||
170534522|NCT04739800|616302308|FG001|Overall Study|Never Treated|0|||
170534523|NCT04739800|616302309|FG002|Overall Study|Never Treated|1|||
170534524|NCT04739800|616302310|FG003|Overall Study|Never Treated|1|||
170534525|NCT04739800|616302307|FG000|Overall Study|On Treatment|5|||
170534526|NCT04739800|616302308|FG001|Overall Study|On Treatment|9|||
170534527|NCT04739800|616302309|FG002|Overall Study|On Treatment|9|||
170534528|NCT04739800|616302310|FG003|Overall Study|On Treatment|9|||
170534529|NCT04739800|616302307|FG000|Overall Study|Symptomatic Deterioration|1|||
170534530|NCT04739800|616302308|FG001|Overall Study|Symptomatic Deterioration|1|||
170534531|NCT04739800|616302309|FG002|Overall Study|Symptomatic Deterioration|3|||
170534532|NCT04739800|616302310|FG003|Overall Study|Symptomatic Deterioration|0|||
170534533|NCT04739800|616302307|FG000|Overall Study|Withdrawal by Subject|1|||
170534534|NCT04739800|616302308|FG001|Overall Study|Withdrawal by Subject|2|||
170427502|NCT02760368|615907070|FG001|Overall Study|Screen Failure|0|||
170427503|NCT02760368|615907071|FG002|Overall Study|Screen Failure|1|||
170427504|NCT02760368|615907069|FG000|Overall Study|Death|0|||
170427505|NCT02760368|615907070|FG001|Overall Study|Death|1|||
170427506|NCT02760368|615907071|FG002|Overall Study|Death|0|||
170427507|NCT02760368|615907069|FG000|Overall Study|Withdrawal by Sponsor|0|||
170427508|NCT02760368|615907070|FG001|Overall Study|Withdrawal by Sponsor|0|||
170427509|NCT02760368|615907071|FG002|Overall Study|Withdrawal by Sponsor|1|||
170427510|NCT00794963|615907072|FG000|Overall Study|Withdrawal by Subject|1|||
170427511|NCT00794963|615907073|FG001|Overall Study|Withdrawal by Subject|4|||
170427512|NCT03375463|615907074|FG000|Period 1|Lost to Follow-up|0|||
170427513|NCT03375463|615907075|FG001|Period 1|Lost to Follow-up|0|||
170427514|NCT03375463|615907076|FG002|Period 1|Lost to Follow-up|1|||
170427515|NCT03375463|615907077|FG003|Period 1|Lost to Follow-up|0|||
170427516|NCT03375463|615907078|FG004|Period 1|Lost to Follow-up|0|||
170427517|NCT03375463|615907079|FG005|Period 1|Lost to Follow-up|0|||
170427518|NCT03375463|615907074|FG000|Period 1|Adverse Event|0|||
170427519|NCT03375463|615907075|FG001|Period 1|Adverse Event|0|||
170427520|NCT03375463|615907076|FG002|Period 1|Adverse Event|0|||
170427521|NCT03375463|615907077|FG003|Period 1|Adverse Event|0|||
170427522|NCT03375463|615907078|FG004|Period 1|Adverse Event|1|||
170427523|NCT03375463|615907079|FG005|Period 1|Adverse Event|0|||
170427524|NCT03375463|615907074|FG000|Period 2|Lost to Follow-up|1|||
170427525|NCT03375463|615907075|FG001|Period 2|Lost to Follow-up|1|||
170427526|NCT03375463|615907076|FG002|Period 2|Lost to Follow-up|0|||
170427527|NCT03375463|615907077|FG003|Period 2|Lost to Follow-up|0|||
170427528|NCT03375463|615907078|FG004|Period 2|Lost to Follow-up|0|||
170427529|NCT03375463|615907079|FG005|Period 2|Lost to Follow-up|0|||
170427530|NCT01037114|615907080|FG000|Year 20|Others|1|||
170427531|NCT01745120|615907085|FG000|Overall Study|Investigator decision|1|||
170427532|NCT01745120|615907086|FG001|Overall Study|Investigator decision|0|||
170427533|NCT01513174|615907090|FG000|Overall Study|Inclusion Error|1|||
170427534|NCT01513174|615907091|FG001|Overall Study|Inclusion Error|7|||
170534535|NCT04739800|616302309|FG002|Overall Study|Withdrawal by Subject|1|||
170534536|NCT04739800|616302310|FG003|Overall Study|Withdrawal by Subject|3|||
170534537|NCT04739800|616302307|FG000|Overall Study|Other Reason|1|||
170427535|NCT01513174|615907090|FG000|Overall Study|Not receive study treatment|3|||
170427536|NCT01513174|615907091|FG001|Overall Study|Not receive study treatment|1|||
170427537|NCT03500341|615907100|FG000|Overall Study|Withdrawn prior to Completion|2|||
170427538|NCT00640562|615907103|FG000|Overall Study|Adverse Event|8|||
170427539|NCT00640562|615907104|FG001|Overall Study|Adverse Event|5|||
170427540|NCT00640562|615907103|FG000|Overall Study|Lack of Efficacy|1|||
170427541|NCT00640562|615907104|FG001|Overall Study|Lack of Efficacy|4|||
170534538|NCT04739800|616302308|FG001|Overall Study|Other Reason|3|||
170534539|NCT04739800|616302309|FG002|Overall Study|Other Reason|5|||
170534540|NCT04739800|616302310|FG003|Overall Study|Other Reason|4|||
170534541|NCT04880850|616302314|FG000|Overall Study|Death|2|||
170534542|NCT04880850|616302315|FG001|Overall Study|Death|1|||
170534543|NCT04880850|616302314|FG000|Overall Study|Lost to Follow-up|3|||
170427542|NCT00640562|615907103|FG000|Overall Study|Protocol Violation|2|||
170534544|NCT04880850|616302315|FG001|Overall Study|Lost to Follow-up|6|||
170534545|NCT04880850|616302314|FG000|Overall Study|Physician Decision|2|||
170534546|NCT04880850|616302315|FG001|Overall Study|Physician Decision|1|||
170534547|NCT04880850|616302314|FG000|Overall Study|Withdrawal by Subject|9|||
170534548|NCT04880850|616302315|FG001|Overall Study|Withdrawal by Subject|10|||
170534549|NCT01093846|616302317|FG000|Overall Study|Adverse Event|0|||
170534550|NCT01093846|616302318|FG001|Overall Study|Adverse Event|0|||
170534551|NCT01093846|616302319|FG002|Overall Study|Adverse Event|1|||
170534552|NCT01093846|616302317|FG000|Overall Study|Lack of Efficacy|0|||
170534553|NCT01093846|616302318|FG001|Overall Study|Lack of Efficacy|0|||
170534554|NCT01093846|616302319|FG002|Overall Study|Lack of Efficacy|4|||
170534555|NCT01093846|616302317|FG000|Overall Study|Condition no longer required study drug|1|||
170534556|NCT01093846|616302318|FG001|Overall Study|Condition no longer required study drug|1|||
170534557|NCT01093846|616302319|FG002|Overall Study|Condition no longer required study drug|1|||
170534558|NCT01093846|616302317|FG000|Overall Study|Administrative Problems|18|||
170632712|NCT02760498|616666746|FG004|Overall Study|Disease progression|4|||
170632713|NCT02760498|616666747|FG005|Overall Study|Disease progression|55|||
170427543|NCT00640562|615907104|FG001|Overall Study|Protocol Violation|4|||
170427544|NCT00640562|615907103|FG000|Overall Study|Withdrawal by Subject|6|||
170427545|NCT00640562|615907104|FG001|Overall Study|Withdrawal by Subject|10|||
170427546|NCT00640562|615907103|FG000|Overall Study|Known risperidone intolerance|0|||
170427547|NCT00640562|615907104|FG001|Overall Study|Known risperidone intolerance|1|||
170427548|NCT00640562|615907103|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
170427549|NCT00640562|615907104|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
170427550|NCT00640562|615907103|FG000|Overall Study|Low study drug dose|0|||
170427551|NCT00640562|615907104|FG001|Overall Study|Low study drug dose|1|||
170427552|NCT00640562|615907103|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
170427553|NCT00640562|615907104|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
170427554|NCT00448591|615907105|FG000|Overall Study|Withdrawal by Subject|178|||
170427555|NCT00448591|615907105|FG000|Overall Study|Progressive Disease|1382|||
170427556|NCT00448591|615907105|FG000|Overall Study|Adverse Event|382|||
170427557|NCT00448591|615907105|FG000|Overall Study|Protocol Violation|41|||
170427558|NCT00448591|615907105|FG000|Overall Study|Lost to Follow-up|19|||
170879964|NCT01033825|617571165|FG002|Overall Study|Withdrawal by Subject|2|||
170879965|NCT01033825|617571166|FG003|Overall Study|Withdrawal by Subject|1|||
170879966|NCT01033825|617571167|FG004|Overall Study|Withdrawal by Subject|1|||
170879967|NCT01033825|617571168|FG005|Overall Study|Withdrawal by Subject|0|||
170879968|NCT01033825|617571169|FG006|Overall Study|Withdrawal by Subject|0|||
170879969|NCT01033825|617571163|FG000|Overall Study|Adverse Event|0|||
170879970|NCT01033825|617571164|FG001|Overall Study|Adverse Event|0|||
170879971|NCT01033825|617571165|FG002|Overall Study|Adverse Event|0|||
170879972|NCT01033825|617571166|FG003|Overall Study|Adverse Event|1|||
170879973|NCT01033825|617571167|FG004|Overall Study|Adverse Event|0|||
170879974|NCT01033825|617571168|FG005|Overall Study|Adverse Event|0|||
170879975|NCT01033825|617571169|FG006|Overall Study|Adverse Event|0|||
170879976|NCT01033825|617571163|FG000|Overall Study|Protocol Violation|1|||
170879977|NCT01033825|617571164|FG001|Overall Study|Protocol Violation|0|||
170879978|NCT01033825|617571165|FG002|Overall Study|Protocol Violation|0|||
170879979|NCT01033825|617571166|FG003|Overall Study|Protocol Violation|0|||
170879980|NCT01033825|617571167|FG004|Overall Study|Protocol Violation|0|||
170879981|NCT01033825|617571168|FG005|Overall Study|Protocol Violation|0|||
170879982|NCT01033825|617571169|FG006|Overall Study|Protocol Violation|0|||
170879983|NCT01033825|617571163|FG000|Overall Study|Other|0|||
170879984|NCT01033825|617571164|FG001|Overall Study|Other|0|||
170879985|NCT01033825|617571165|FG002|Overall Study|Other|0|||
170879986|NCT01033825|617571166|FG003|Overall Study|Other|0|||
170879987|NCT01033825|617571167|FG004|Overall Study|Other|1|||
170879988|NCT01033825|617571168|FG005|Overall Study|Other|0|||
170879989|NCT01033825|617571169|FG006|Overall Study|Other|0|||
170879990|NCT03693625|617571171|FG000|Overall Study|Adverse Event|2|||
170879991|NCT03693625|617571172|FG001|Overall Study|Adverse Event|0|||
170879992|NCT03693625|617571171|FG000|Overall Study|Study Terminated By Sponsor|20|||
170879993|NCT03693625|617571172|FG001|Overall Study|Study Terminated By Sponsor|7|||
170879994|NCT03693625|617571171|FG000|Overall Study|Withdrawal by Subject|1|||
170879995|NCT03693625|617571172|FG001|Overall Study|Withdrawal by Subject|1|||
170879996|NCT01883635|617571173|FG000|Overall Study|Withdrawal by Subject|4|||
170879997|NCT01883635|617571174|FG001|Overall Study|Withdrawal by Subject|0|||
170427559|NCT00448591|615907105|FG000|Overall Study|Treatment Regimen Completed|70|||
170427560|NCT00448591|615907105|FG000|Overall Study|Other|154|||
170534559|NCT01093846|616302318|FG001|Overall Study|Administrative Problems|17|||
170534560|NCT01093846|616302319|FG002|Overall Study|Administrative Problems|15|||
170632714|NCT02760498|616666742|FG000|Overall Study|Withdrawal by Subject|4|||
170632715|NCT02760498|616666743|FG001|Overall Study|Withdrawal by Subject|7|||
170632716|NCT02760498|616666744|FG002|Overall Study|Withdrawal by Subject|5|||
170879998|NCT01464307|617571175|FG000|Main Period|Death|0|||
170879999|NCT01464307|617571176|FG001|Main Period|Death|1|||
170880000|NCT01464307|617571175|FG000|Main Period|Adverse Event|6|||
170880001|NCT01464307|617571176|FG001|Main Period|Adverse Event|1|||
170880002|NCT01464307|617571175|FG000|Main Period|Lack of Efficacy|2|||
170880003|NCT01464307|617571176|FG001|Main Period|Lack of Efficacy|0|||
170427561|NCT00448591|615907105|FG000|Overall Study|Termination of Study|70|||
170427562|NCT03637764|615907106|FG000|Overall Study|Adverse Event|2|||
170427563|NCT03637764|615907107|FG001|Overall Study|Adverse Event|0|||
170427564|NCT03637764|615907108|FG002|Overall Study|Adverse Event|0|||
170427565|NCT03637764|615907109|FG003|Overall Study|Adverse Event|1|||
170427566|NCT03637764|615907106|FG000|Overall Study|Progressive Disease|23|||
170427567|NCT03637764|615907107|FG001|Overall Study|Progressive Disease|23|||
170427568|NCT03637764|615907108|FG002|Overall Study|Progressive Disease|18|||
170427569|NCT03637764|615907109|FG003|Overall Study|Progressive Disease|31|||
170427570|NCT03637764|615907106|FG000|Overall Study|Withdrawal by Subject|1|||
170427571|NCT03637764|615907107|FG001|Overall Study|Withdrawal by Subject|3|||
170427572|NCT03637764|615907108|FG002|Overall Study|Withdrawal by Subject|0|||
170427573|NCT03637764|615907109|FG003|Overall Study|Withdrawal by Subject|1|||
170427574|NCT01686438|615907113|FG000|Overall Study|Lost to Follow-up|8|||
170427575|NCT01686438|615907114|FG001|Overall Study|Lost to Follow-up|9|||
170427576|NCT01686438|615907115|FG002|Overall Study|Lost to Follow-up|10|||
170427577|NCT01686438|615907113|FG000|Overall Study|Adverse Event|0|||
170427578|NCT01686438|615907114|FG001|Overall Study|Adverse Event|0|||
170427579|NCT01686438|615907115|FG002|Overall Study|Adverse Event|1|||
170427580|NCT01686438|615907113|FG000|Overall Study|Protocol Violation|0|||
170427581|NCT01686438|615907114|FG001|Overall Study|Protocol Violation|0|||
170427582|NCT01686438|615907115|FG002|Overall Study|Protocol Violation|1|||
170427583|NCT01686438|615907113|FG000|Overall Study|Withdrawal by Subject|0|||
170427584|NCT01686438|615907114|FG001|Overall Study|Withdrawal by Subject|0|||
170427585|NCT01686438|615907115|FG002|Overall Study|Withdrawal by Subject|1|||
170427586|NCT01723397|615907116|FG000|Study Period 1|Protocol Violation|0|||
170427587|NCT01723397|615907117|FG001|Study Period 1|Protocol Violation|1|||
170427588|NCT01723397|615907116|FG000|Study Period 2|Protocol Violation|0|||
170427589|NCT01723397|615907117|FG001|Study Period 2|Protocol Violation|1|||
170427590|NCT02739997|615907118|FG000|Overall Study|Death|1|||
170427591|NCT02739997|615907118|FG000|Overall Study|Withdrawal by Subject|1|||
170427592|NCT04608188|615907121|FG000|Overall Study|Withdrawal by Subject|4|||
170427593|NCT04608188|615907122|FG001|Overall Study|Withdrawal by Subject|8|||
170427594|NCT01474551|615907124|FG000|Overall Study|Death|1|||
170427595|NCT03586726|615907125|FG000|Overall Study|Withdrawal by Subject|1|||
170427596|NCT03686033|615907126|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
170427597|NCT03686033|615907127|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
170427598|NCT03686033|615907128|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
170427599|NCT03686033|615907129|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
170427600|NCT03686033|615907130|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
170427601|NCT03686033|615907131|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
170427602|NCT03197883|615907132|FG000|Overall Study|Adverse Event|1|||
170427603|NCT03197883|615907133|FG001|Overall Study|Adverse Event|1|||
170427604|NCT03197883|615907132|FG000|Overall Study|Lost to Follow-up|1|||
170427605|NCT03197883|615907133|FG001|Overall Study|Lost to Follow-up|0|||
170427606|NCT03197883|615907132|FG000|Overall Study|Protocol Violation|1|||
170427607|NCT03197883|615907133|FG001|Overall Study|Protocol Violation|0|||
170427608|NCT03197883|615907132|FG000|Overall Study|Other (Not Specified)|0|||
170427609|NCT03197883|615907133|FG001|Overall Study|Other (Not Specified)|5|||
170427610|NCT01045161|615907134|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
170427611|NCT01045161|615907135|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
170427612|NCT01045161|615907136|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
170427613|NCT01045161|615907134|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
170427614|NCT01045161|615907135|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
170427615|NCT01045161|615907136|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
170427616|NCT01045161|615907134|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
170427617|NCT01045161|615907135|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
170427618|NCT01045161|615907136|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
170427619|NCT01045161|615907134|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
170427620|NCT01045161|615907135|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
170427621|NCT01045161|615907136|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
170427622|NCT01045161|615907134|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
170880004|NCT01464307|617571175|FG000|Main Period|Withdrawal by Subject|5|||
170427623|NCT01045161|615907135|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
170427624|NCT01045161|615907136|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
170427625|NCT01045161|615907134|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
170427626|NCT01045161|615907135|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
170427627|NCT01045161|615907136|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
170427628|NCT01045161|615907134|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
170427629|NCT01045161|615907135|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
170427630|NCT01045161|615907136|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
170427631|NCT01045161|615907134|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
170427632|NCT01045161|615907135|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
170427633|NCT01045161|615907136|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
170427634|NCT01045161|615907134|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
170427635|NCT01045161|615907135|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
170427636|NCT01045161|615907136|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
170427637|NCT01045161|615907134|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
170427638|NCT01045161|615907135|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
170427639|NCT01045161|615907136|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
170427640|NCT01045161|615907134|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
170427641|NCT01045161|615907135|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
170427642|NCT01045161|615907136|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
170427643|NCT01045161|615907134|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
170427644|NCT01045161|615907135|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
170427645|NCT01045161|615907136|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
170427646|NCT01045161|615907134|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
170427647|NCT01045161|615907135|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
170427648|NCT01045161|615907136|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
170427649|NCT01045161|615907134|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
170427650|NCT01045161|615907135|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
170427651|NCT01045161|615907136|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
170427652|NCT01302548|615907138|FG000|Overall Study|Lost to Follow-up|2|||
170427653|NCT01302548|615907139|FG001|Overall Study|Lost to Follow-up|1|||
170427654|NCT01110005|615907149|FG000|Overall Study|ineligible|1|||
170427655|NCT01110005|615907150|FG001|Overall Study|ineligible|2|||
170427656|NCT01110005|615907149|FG000|Overall Study|missing consent|3|||
170427657|NCT01110005|615907150|FG001|Overall Study|missing consent|2|||
170427658|NCT01110005|615907149|FG000|Overall Study|Withdrawal by Subject|0|||
170427659|NCT01110005|615907150|FG001|Overall Study|Withdrawal by Subject|1|||
170427660|NCT02305758|615907152|FG000|Overall Study|Death|27|||
170427661|NCT02305758|615907153|FG001|Overall Study|Death|27|||
170427662|NCT02305758|615907152|FG000|Overall Study|Withdrew consent|9|||
170427663|NCT02305758|615907153|FG001|Overall Study|Withdrew consent|2|||
170427664|NCT02305758|615907152|FG000|Overall Study|Lost to Follow-up|6|||
170427665|NCT02305758|615907153|FG001|Overall Study|Lost to Follow-up|1|||
170427666|NCT02305758|615907152|FG000|Overall Study|Study Terminated by Sponsor|21|||
170427667|NCT02305758|615907153|FG001|Overall Study|Study Terminated by Sponsor|34|||
170427668|NCT02305758|615907152|FG000|Overall Study|Other, not specified|2|||
170427669|NCT02305758|615907153|FG001|Overall Study|Other, not specified|1|||
170427670|NCT02032888|615907155|FG000|Treatment Period|Poor compliance/noncompliance|1|||
170427671|NCT02032888|615907156|FG001|Treatment Period|Poor compliance/noncompliance|1|||
170427672|NCT02032888|615907157|FG002|Treatment Period|Poor compliance/noncompliance|0|||
170427673|NCT02032888|615907155|FG000|Treatment Period|Other|1|||
170427674|NCT02032888|615907156|FG001|Treatment Period|Other|1|||
170427675|NCT02032888|615907157|FG002|Treatment Period|Other|0|||
170427676|NCT02032888|615907155|FG000|Follow-up Period|Lost to Follow-up|1|||
170880005|NCT01464307|617571176|FG001|Main Period|Withdrawal by Subject|2|||
170880006|NCT01464307|617571175|FG000|Main Period|Predefined discontinuation criteria|2|||
170880007|NCT01464307|617571176|FG001|Main Period|Predefined discontinuation criteria|1|||
170427677|NCT02032888|615907156|FG001|Follow-up Period|Lost to Follow-up|1|||
170427678|NCT02032888|615907157|FG002|Follow-up Period|Lost to Follow-up|0|||
170427679|NCT02032888|615907155|FG000|Follow-up Period|Death|1|||
170427680|NCT02032888|615907156|FG001|Follow-up Period|Death|1|||
170427681|NCT02032888|615907157|FG002|Follow-up Period|Death|0|||
170427682|NCT02032888|615907155|FG000|Follow-up Period|Other|1|||
170427683|NCT02032888|615907156|FG001|Follow-up Period|Other|0|||
170427684|NCT02032888|615907157|FG002|Follow-up Period|Other|0|||
170427685|NCT01424644|615907158|FG000|Overall Study|Adverse Event|2|||
170427686|NCT01424644|615907159|FG001|Overall Study|Adverse Event|0|||
170427687|NCT01424644|615907158|FG000|Overall Study|Withdrawal by Subject|9|||
170427688|NCT01424644|615907159|FG001|Overall Study|Withdrawal by Subject|12|||
170427689|NCT01424644|615907158|FG000|Overall Study|Lost to Follow-up|16|||
170427690|NCT01424644|615907159|FG001|Overall Study|Lost to Follow-up|12|||
170427691|NCT01424644|615907158|FG000|Overall Study|Protocol Violation|4|||
170427692|NCT01424644|615907159|FG001|Overall Study|Protocol Violation|3|||
170427693|NCT01424644|615907158|FG000|Overall Study|Administrative Reason|1|||
170427694|NCT01424644|615907159|FG001|Overall Study|Administrative Reason|0|||
170427695|NCT01424644|615907158|FG000|Overall Study|Unable to Classify|1|||
170632717|NCT02760498|616666745|FG003|Overall Study|Withdrawal by Subject|1|||
170632718|NCT02760498|616666746|FG004|Overall Study|Withdrawal by Subject|0|||
170427696|NCT01424644|615907159|FG001|Overall Study|Unable to Classify|0|||
170427697|NCT00440297|615907160|FG000|Overall Study|Adverse Event|8|||
170427698|NCT00440297|615907161|FG001|Overall Study|Adverse Event|5|||
170427699|NCT00440297|615907160|FG000|Overall Study|Lost to Follow-up|1|||
170427700|NCT00440297|615907161|FG001|Overall Study|Lost to Follow-up|0|||
170427701|NCT00440297|615907160|FG000|Overall Study|Physician Decision|1|||
170427702|NCT00440297|615907161|FG001|Overall Study|Physician Decision|0|||
170632719|NCT02760498|616666747|FG005|Overall Study|Withdrawal by Subject|6|||
170632720|NCT02760498|616666742|FG000|Overall Study|Other than specified|1|||
170632721|NCT02760498|616666743|FG001|Overall Study|Other than specified|6|||
170632722|NCT02760498|616666744|FG002|Overall Study|Other than specified|0|||
170632723|NCT02760498|616666745|FG003|Overall Study|Other than specified|3|||
170632724|NCT02760498|616666746|FG004|Overall Study|Other than specified|1|||
170632725|NCT02760498|616666747|FG005|Overall Study|Other than specified|0|||
170632726|NCT02760498|616666742|FG000|Overall Study|Not treated|0|||
170632727|NCT02760498|616666743|FG001|Overall Study|Not treated|0|||
170632728|NCT02760498|616666744|FG002|Overall Study|Not treated|0|||
170632729|NCT02760498|616666745|FG003|Overall Study|Not treated|0|||
170632730|NCT02760498|616666746|FG004|Overall Study|Not treated|0|||
170632731|NCT02760498|616666747|FG005|Overall Study|Not treated|2|||
170534577|NCT02781324|616302324|FG000|Overall Study|Withdrawal by Subject|1|||
170534578|NCT02781324|616302325|FG001|Overall Study|Withdrawal by Subject|0|||
170534579|NCT02781324|616302324|FG000|Overall Study|Physician Decision|1|||
170534580|NCT02781324|616302325|FG001|Overall Study|Physician Decision|2|||
170534581|NCT00661388|616302328|FG000|Overall Study|Adverse Event|14|||
170534582|NCT00661388|616302328|FG000|Overall Study|Protocol Violation|7|||
170534583|NCT00661388|616302328|FG000|Overall Study|Renal transplantation|1|||
170534584|NCT00661388|616302328|FG000|Overall Study|Dialysis initiation|1|||
170534585|NCT00661388|616302328|FG000|Overall Study|Administrative reasons|1|||
170534586|NCT04338581|616304063|FG000|Overall Study|Lack of Efficacy|1|||
170534587|NCT04338581|616304064|FG001|Overall Study|Lack of Efficacy|0|||
170534588|NCT04338581|616304063|FG000|Overall Study|Withdrawal by Subject|4|||
170534589|NCT04338581|616304064|FG001|Overall Study|Withdrawal by Subject|4|||
170534590|NCT04338581|616304063|FG000|Overall Study|Prohibited Medication|1|||
170534591|NCT04338581|616304064|FG001|Overall Study|Prohibited Medication|0|||
170534592|NCT00549055|616304065|FG000|Overall Study|Adverse Event|4|||
170534593|NCT00549055|616304065|FG000|Overall Study|Lack of Efficacy|18|||
170534594|NCT00549055|616304065|FG000|Overall Study|Stabilization|5|||
170534595|NCT00549055|616304065|FG000|Overall Study|Progression to fibrosis|2|||
170534596|NCT00549055|616304065|FG000|Overall Study|Decrease of size|1|||
170534597|NCT00549055|616304065|FG000|Overall Study|Active choroidal neovascula increased|1|||
170534598|NCT00549055|616304065|FG000|Overall Study|Vitreous hemorrhage|1|||
170534599|NCT00549055|616304065|FG000|Overall Study|Growth choroidal neovascularisation|1|||
170534600|NCT00549055|616304065|FG000|Overall Study|Choroidal neovascularization|1|||
170534601|NCT00549055|616304065|FG000|Overall Study|Very low visual acuity (VA)|1|||
170534602|NCT00947544|616304068|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
170534603|NCT00947544|616304069|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
170534604|NCT00300053|616304074|FG000|Overall Study|Patient/Caregiver Preference|2|||
170534605|NCT00300053|616304075|FG001|Overall Study|Patient/Caregiver Preference|2|||
170534606|NCT00300053|616304076|FG002|Overall Study|Patient/Caregiver Preference|3|||
170534607|NCT00300053|616304074|FG000|Overall Study|Death|0|||
170534608|NCT00300053|616304075|FG001|Overall Study|Death|0|||
170534609|NCT00300053|616304076|FG002|Overall Study|Death|3|||
170534610|NCT00300053|616304074|FG000|Overall Study|Lost to Follow-up|0|||
170534611|NCT00300053|616304075|FG001|Overall Study|Lost to Follow-up|1|||
170534612|NCT00300053|616304076|FG002|Overall Study|Lost to Follow-up|0|||
170534613|NCT02566005|616304077|FG000|Overall Study|vaginal bleeding|0|||
170534614|NCT02566005|616304078|FG001|Overall Study|vaginal bleeding|1|||
170534615|NCT02566005|616304077|FG000|Overall Study|received foley|8|||
170534616|NCT02566005|616304078|FG001|Overall Study|received foley|0|||
170534617|NCT02566005|616304077|FG000|Overall Study|did not receive foley|0|||
170534618|NCT02566005|616304078|FG001|Overall Study|did not receive foley|1|||
170534619|NCT02566005|616304077|FG000|Overall Study|labor after randomization|0|||
170534620|NCT02566005|616304078|FG001|Overall Study|labor after randomization|4|||
170534621|NCT02472405|616304079|FG000|Overall Study|Lost to Follow-up|9|||
170534622|NCT02472405|616304079|FG000|Overall Study|Adverse Event|1|||
170534623|NCT01134042|616304080|FG000|Overall Study|Adverse Event|3|||
170534624|NCT01134042|616304081|FG001|Overall Study|Adverse Event|7|||
170534625|NCT01134042|616304082|FG002|Overall Study|Adverse Event|2|||
170534626|NCT01134042|616304080|FG000|Overall Study|Lack of Efficacy|21|||
170534627|NCT01134042|616304081|FG001|Overall Study|Lack of Efficacy|6|||
170534628|NCT01134042|616304082|FG002|Overall Study|Lack of Efficacy|18|||
170534629|NCT01134042|616304080|FG000|Overall Study|Protocol Violation|5|||
170534630|NCT01134042|616304081|FG001|Overall Study|Protocol Violation|3|||
170534631|NCT01134042|616304082|FG002|Overall Study|Protocol Violation|5|||
170534632|NCT01134042|616304080|FG000|Overall Study|Lost to Follow-up|2|||
170534633|NCT01134042|616304081|FG001|Overall Study|Lost to Follow-up|0|||
170534634|NCT01134042|616304082|FG002|Overall Study|Lost to Follow-up|1|||
170534635|NCT01134042|616304080|FG000|Overall Study|Physician Decision|4|||
170534636|NCT01134042|616304081|FG001|Overall Study|Physician Decision|8|||
170534637|NCT01134042|616304082|FG002|Overall Study|Physician Decision|1|||
170534638|NCT01134042|616304080|FG000|Overall Study|Withdrawal by Subject|13|||
170534639|NCT01134042|616304081|FG001|Overall Study|Withdrawal by Subject|4|||
170534640|NCT01134042|616304082|FG002|Overall Study|Withdrawal by Subject|7|||
170632732|NCT02205736|616666748|FG000|Overall Study|Lost to Follow-up|106|||
170427703|NCT00440297|615907160|FG000|Overall Study|Protocol Violation|11|||
170427704|NCT00440297|615907161|FG001|Overall Study|Protocol Violation|7|||
170427705|NCT00440297|615907160|FG000|Overall Study|Withdrawal by Subject|1|||
170427706|NCT00440297|615907161|FG001|Overall Study|Withdrawal by Subject|6|||
170427707|NCT00440297|615907160|FG000|Overall Study|Randomized by mistake|1|||
170427708|NCT00440297|615907161|FG001|Overall Study|Randomized by mistake|0|||
170427709|NCT02024932|615907162|FG000|Overall Study|Adverse Event|2|||
170427710|NCT02024932|615907163|FG001|Overall Study|Adverse Event|3|||
170427711|NCT02024932|615907164|FG002|Overall Study|Adverse Event|0|||
170427712|NCT02024932|615907165|FG003|Overall Study|Adverse Event|0|||
170427713|NCT02024932|615907166|FG004|Overall Study|Adverse Event|2|||
170427714|NCT02024932|615907167|FG005|Overall Study|Adverse Event|0|||
170427715|NCT02024932|615907162|FG000|Overall Study|Abnormal laboratory value|0|||
170427716|NCT02024932|615907163|FG001|Overall Study|Abnormal laboratory value|0|||
170427717|NCT02024932|615907164|FG002|Overall Study|Abnormal laboratory value|0|||
170427718|NCT02024932|615907165|FG003|Overall Study|Abnormal laboratory value|2|||
170427719|NCT02024932|615907166|FG004|Overall Study|Abnormal laboratory value|0|||
170427720|NCT02024932|615907167|FG005|Overall Study|Abnormal laboratory value|0|||
170427721|NCT02445339|615907168|FG000|Overall Study|Physician Decision|1|||
170427722|NCT02445339|615907169|FG001|Overall Study|Physician Decision|0|||
170427723|NCT02445339|615907168|FG000|Overall Study|Lost to Follow-up|11|||
170427724|NCT02445339|615907169|FG001|Overall Study|Lost to Follow-up|15|||
170427725|NCT03020641|615907170|FG000|Overall Study|Lost to Follow-up|0|||
170427726|NCT03020641|615907171|FG001|Overall Study|Lost to Follow-up|1|||
170427727|NCT03020641|615907170|FG000|Overall Study|Converted to open surgery|2|||
170427728|NCT03020641|615907171|FG001|Overall Study|Converted to open surgery|1|||
170427729|NCT03020641|615907170|FG000|Overall Study|for surgery not performed|0|||
170427730|NCT03020641|615907171|FG001|Overall Study|for surgery not performed|1|||
170427731|NCT00731783|615907173|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
170427732|NCT00731783|615907174|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
170427733|NCT00731783|615907173|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
170427734|NCT00731783|615907174|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
170427735|NCT00731783|615907173|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
170427736|NCT00731783|615907174|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
170427737|NCT00731783|615907173|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
170427738|NCT00731783|615907174|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
170427739|NCT02875392|615908836|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
170427740|NCT02875392|615908837|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
170427741|NCT00834717|615908841|FG000|First Intervention|Adverse Event|1|||
170427742|NCT00834717|615908842|FG001|First Intervention|Adverse Event|0|||
170427743|NCT00834717|615908841|FG000|First Intervention|Withdrawal by Subject|0|||
170427744|NCT00834717|615908842|FG001|First Intervention|Withdrawal by Subject|1|||
170427745|NCT03025087|615908843|FG000|Overall Study|Physician Decision|3|||
170427746|NCT03025087|615908844|FG001|Overall Study|Physician Decision|3|||
170427747|NCT03025087|615908845|FG002|Overall Study|Physician Decision|0|||
170427748|NCT03025087|615908846|FG003|Overall Study|Physician Decision|0|||
170427749|NCT03025087|615908847|FG004|Overall Study|Physician Decision|0|||
170427750|NCT03025087|615908843|FG000|Overall Study|Withdrawal by Subject|1|||
170427751|NCT03025087|615908844|FG001|Overall Study|Withdrawal by Subject|1|||
170427752|NCT03025087|615908845|FG002|Overall Study|Withdrawal by Subject|0|||
170427753|NCT03025087|615908846|FG003|Overall Study|Withdrawal by Subject|0|||
170534641|NCT00671060|616304086|FG000|Overall Study|Protocol Violation|1|||
170427754|NCT03025087|615908847|FG004|Overall Study|Withdrawal by Subject|0|||
170427755|NCT03025087|615908843|FG000|Overall Study|Unable to complete MRI|2|||
170427756|NCT03025087|615908844|FG001|Overall Study|Unable to complete MRI|2|||
170427757|NCT03025087|615908845|FG002|Overall Study|Unable to complete MRI|0|||
170427758|NCT03025087|615908846|FG003|Overall Study|Unable to complete MRI|0|||
170427759|NCT03025087|615908847|FG004|Overall Study|Unable to complete MRI|0|||
170427760|NCT00795821|615908848|FG000|Acute Treatment Phase|Adverse Event|23|||
170427761|NCT00795821|615908849|FG001|Acute Treatment Phase|Adverse Event|4|||
170427762|NCT00795821|615908848|FG000|Acute Treatment Phase|Death|1|||
170427763|NCT00795821|615908849|FG001|Acute Treatment Phase|Death|0|||
170427764|NCT00795821|615908848|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
170427765|NCT00795821|615908849|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
170427766|NCT00795821|615908848|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
170427767|NCT00795821|615908849|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
170427768|NCT00795821|615908848|FG000|Acute Treatment Phase|Physician Decision|1|||
170427769|NCT00795821|615908849|FG001|Acute Treatment Phase|Physician Decision|1|||
170427770|NCT00795821|615908848|FG000|Acute Treatment Phase|Protocol Violation|1|||
170427771|NCT00795821|615908849|FG001|Acute Treatment Phase|Protocol Violation|2|||
170427772|NCT00795821|615908848|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
170427773|NCT00795821|615908849|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
170534642|NCT00671060|616304087|FG001|Overall Study|Protocol Violation|0|||
170880008|NCT01464307|617571175|FG000|Open-Label Extension Period|Adverse Event|15|||
170534643|NCT00671060|616304086|FG000|Overall Study|Physician Decision|0|||
170427774|NCT00795821|615908848|FG000|Long-term Extension Phase|Adverse Event|25|||
170427775|NCT00795821|615908849|FG001|Long-term Extension Phase|Adverse Event|32|||
170427776|NCT00795821|615908848|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
170427777|NCT00795821|615908849|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
170427778|NCT00795821|615908848|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
170427779|NCT00795821|615908849|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
170427780|NCT00795821|615908848|FG000|Long-term Extension Phase|Physician Decision|1|||
170427781|NCT00795821|615908849|FG001|Long-term Extension Phase|Physician Decision|2|||
170427782|NCT00795821|615908848|FG000|Long-term Extension Phase|Protocol Violation|3|||
170427783|NCT00795821|615908849|FG001|Long-term Extension Phase|Protocol Violation|5|||
170427784|NCT00795821|615908848|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
170427785|NCT00795821|615908849|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
170427786|NCT00795821|615908848|FG000|Taper Phase|Adverse Event|2|||
170427787|NCT00795821|615908849|FG001|Taper Phase|Adverse Event|0|||
170427788|NCT00795821|615908848|FG000|Taper Phase|Lost to Follow-up|1|||
170427789|NCT00795821|615908849|FG001|Taper Phase|Lost to Follow-up|0|||
170427790|NCT00795821|615908848|FG000|Taper Phase|Physician Decision|2|||
170427791|NCT00795821|615908849|FG001|Taper Phase|Physician Decision|0|||
170427792|NCT00795821|615908848|FG000|Taper Phase|Withdrawal by Subject|4|||
170427793|NCT00795821|615908849|FG001|Taper Phase|Withdrawal by Subject|0|||
170427794|NCT00712959|615908854|FG000|Overall Study|Protocol Violation|3|||
170427795|NCT00712959|615908855|FG001|Overall Study|Protocol Violation|1|||
170427796|NCT00712959|615908854|FG000|Overall Study|Lost to Follow-up|13|||
170427797|NCT00712959|615908855|FG001|Overall Study|Lost to Follow-up|2|||
170427798|NCT00712959|615908854|FG000|Overall Study|Withdrawal by Subject|3|||
170427799|NCT00712959|615908855|FG001|Overall Study|Withdrawal by Subject|0|||
170427800|NCT03874715|615908862|FG000|Overall Study|Adverse Event|2|||
170427801|NCT03874715|615908863|FG001|Overall Study|Adverse Event|0|||
170427802|NCT03874715|615908862|FG000|Overall Study|Poor compliance to protocol|5|||
170427803|NCT03874715|615908863|FG001|Overall Study|Poor compliance to protocol|1|||
170427804|NCT03874715|615908862|FG000|Overall Study|Withdrawal by Subject|1|||
170427805|NCT03874715|615908863|FG001|Overall Study|Withdrawal by Subject|0|||
170427806|NCT03874715|615908862|FG000|Overall Study|Other-unspecified|1|||
170427807|NCT03874715|615908863|FG001|Overall Study|Other-unspecified|0|||
170427808|NCT00934050|615908864|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
170427809|NCT00934050|615908865|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
170427810|NCT00934050|615908866|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
170427811|NCT00934050|615908867|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
170427812|NCT00934050|615908868|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
170427813|NCT00934050|615908869|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
170427814|NCT00934050|615908864|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
170427815|NCT00934050|615908865|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
170427816|NCT00934050|615908866|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
170427817|NCT00934050|615908867|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
170427818|NCT00934050|615908868|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
170427819|NCT00934050|615908869|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
170427820|NCT00934050|615908864|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
170427821|NCT00934050|615908865|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
170427822|NCT00934050|615908866|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
170427823|NCT00934050|615908867|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
170427824|NCT00934050|615908868|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
170427825|NCT00934050|615908869|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
170427826|NCT00934050|615908864|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
170427827|NCT00934050|615908865|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
170427828|NCT00934050|615908866|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
170427829|NCT00934050|615908867|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
170427830|NCT00934050|615908868|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
170427831|NCT00934050|615908869|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
170427832|NCT00934050|615908864|FG000|Enrolled After 15 Dec 2009|Death|0|||
170427833|NCT00934050|615908865|FG001|Enrolled After 15 Dec 2009|Death|0|||
170427834|NCT00934050|615908866|FG002|Enrolled After 15 Dec 2009|Death|0|||
170427835|NCT00934050|615908867|FG003|Enrolled After 15 Dec 2009|Death|0|||
170427836|NCT00934050|615908868|FG004|Enrolled After 15 Dec 2009|Death|0|||
170427837|NCT00934050|615908869|FG005|Enrolled After 15 Dec 2009|Death|1|||
170427838|NCT00934050|615908864|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
170427839|NCT00934050|615908865|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
170427840|NCT00934050|615908866|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
170427841|NCT00934050|615908867|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
170427842|NCT00934050|615908868|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
170427843|NCT00934050|615908869|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
170427844|NCT00934050|615908864|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
170427845|NCT00934050|615908865|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
170427846|NCT00934050|615908866|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
170427847|NCT00934050|615908867|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
170880009|NCT01464307|617571176|FG001|Open-Label Extension Period|Adverse Event|0|||
170880010|NCT01464307|617571175|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
170880011|NCT01464307|617571176|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
170880012|NCT01464307|617571175|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
170880013|NCT01464307|617571176|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
170880014|NCT01464307|617571175|FG000|Open-Label Extension Period|Death|1|||
170880015|NCT01464307|617571176|FG001|Open-Label Extension Period|Death|0|||
170880016|NCT01464307|617571175|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
170880017|NCT01464307|617571176|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
170880018|NCT01464307|617571175|FG000|Open-Label Extension Period|Non-compliance|9|||
170880019|NCT01464307|617571176|FG001|Open-Label Extension Period|Non-compliance|0|||
170880020|NCT01464307|617571175|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
170880021|NCT01464307|617571176|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
170880022|NCT00470054|617571178|FG000|Overall Study|Ineligible|1|||
170880023|NCT01439555|617571179|FG000|Overall Study|Protocol Violation|1|||
170880024|NCT01964352|617572683|FG000|Overall Study|Adverse Event|13|||
170880025|NCT01964352|617572684|FG001|Overall Study|Adverse Event|3|||
170880026|NCT01964352|617572685|FG002|Overall Study|Adverse Event|4|||
170880027|NCT01964352|617572686|FG003|Overall Study|Adverse Event|3|||
170880028|NCT01964352|617572683|FG000|Overall Study|Lack of Efficacy|6|||
170880029|NCT01964352|617572684|FG001|Overall Study|Lack of Efficacy|0|||
170880030|NCT01964352|617572685|FG002|Overall Study|Lack of Efficacy|0|||
170880031|NCT01964352|617572686|FG003|Overall Study|Lack of Efficacy|0|||
170880032|NCT01964352|617572683|FG000|Overall Study|Protocol Violation|2|||
170880033|NCT01964352|617572684|FG001|Overall Study|Protocol Violation|4|||
170880034|NCT01964352|617572685|FG002|Overall Study|Protocol Violation|0|||
170880035|NCT01964352|617572686|FG003|Overall Study|Protocol Violation|2|||
170880036|NCT01964352|617572683|FG000|Overall Study|Lost to Follow-up|1|||
170880037|NCT01964352|617572684|FG001|Overall Study|Lost to Follow-up|0|||
170880038|NCT01964352|617572685|FG002|Overall Study|Lost to Follow-up|0|||
170880039|NCT01964352|617572686|FG003|Overall Study|Lost to Follow-up|1|||
170880040|NCT01964352|617572683|FG000|Overall Study|Withdrawal by Subject|4|||
170880041|NCT01964352|617572684|FG001|Overall Study|Withdrawal by Subject|2|||
170880042|NCT01964352|617572685|FG002|Overall Study|Withdrawal by Subject|1|||
170880043|NCT01964352|617572686|FG003|Overall Study|Withdrawal by Subject|0|||
170880044|NCT01964352|617572683|FG000|Overall Study|Other than stated above|0|||
170880045|NCT01964352|617572684|FG001|Overall Study|Other than stated above|2|||
170880046|NCT01964352|617572685|FG002|Overall Study|Other than stated above|1|||
170880047|NCT01964352|617572686|FG003|Overall Study|Other than stated above|2|||
170880048|NCT03468855|617572687|FG000|Overall Study|Adverse Event|2|||
170880049|NCT03468855|617572687|FG000|Overall Study|Lost to Follow-up|5|||
170880050|NCT03468855|617572687|FG000|Overall Study|Withdrawal by Subject|3|||
170880051|NCT03468855|617572687|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
170880052|NCT01908101|617572688|FG000|Overall Study|Physician Decision|1|||
170880053|NCT01908101|617572688|FG000|Overall Study|Withdrawal by Subject|1|||
170880054|NCT01908101|617572688|FG000|Overall Study|Incorrect Diagnosis|2|||
170880055|NCT01908101|617572688|FG000|Overall Study|Incorrect Starting Dose|1|||
170880056|NCT01908101|617572688|FG000|Overall Study|Did not complete the first cycle|4|||
170880057|NCT01394939|617572689|FG000|Overall Study|Adverse Event|1|||
170880058|NCT01394939|617572690|FG001|Overall Study|Adverse Event|3|||
170880059|NCT01394939|617572691|FG002|Overall Study|Adverse Event|0|||
170880060|NCT01394939|617572692|FG003|Overall Study|Adverse Event|2|||
170880061|NCT01394939|617572689|FG000|Overall Study|Death|0|||
170880062|NCT01394939|617572690|FG001|Overall Study|Death|2|||
170880063|NCT01394939|617572691|FG002|Overall Study|Death|0|||
170880064|NCT01394939|617572692|FG003|Overall Study|Death|0|||
170880065|NCT01394939|617572689|FG000|Overall Study|Physician Decision|0|||
170880066|NCT01394939|617572690|FG001|Overall Study|Physician Decision|1|||
170880067|NCT01394939|617572691|FG002|Overall Study|Physician Decision|0|||
170880068|NCT01394939|617572692|FG003|Overall Study|Physician Decision|0|||
170880069|NCT01394939|617572689|FG000|Overall Study|Withdrawal by Subject|0|||
170880070|NCT01394939|617572690|FG001|Overall Study|Withdrawal by Subject|2|||
170880071|NCT01394939|617572691|FG002|Overall Study|Withdrawal by Subject|0|||
170880072|NCT01394939|617572692|FG003|Overall Study|Withdrawal by Subject|2|||
170880073|NCT01394939|617572689|FG000|Overall Study|Others|0|||
170880074|NCT01394939|617572690|FG001|Overall Study|Others|2|||
170880075|NCT01394939|617572691|FG002|Overall Study|Others|0|||
170880076|NCT01394939|617572692|FG003|Overall Study|Others|3|||
170880077|NCT02068547|617572693|FG000|Overall Study|Lost to Follow-up|3|||
170880078|NCT02068547|617572694|FG001|Overall Study|Lost to Follow-up|3|||
170427848|NCT00934050|615908868|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
170880079|NCT02068547|617572693|FG000|Overall Study|Physician Decision|1|||
170427849|NCT00934050|615908869|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
170427850|NCT03616535|615908872|FG000|Overall Study|Death|2|||
170880080|NCT02068547|617572694|FG001|Overall Study|Physician Decision|0|||
170880081|NCT02831673|617572696|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
170880082|NCT02831673|617572697|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
170880083|NCT02831673|617572698|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
170427851|NCT03616535|615908873|FG001|Overall Study|Death|0|||
170427852|NCT03616535|615908874|FG002|Overall Study|Death|0|||
170427853|NCT03616535|615908875|FG003|Overall Study|Death|1|||
170427854|NCT03616535|615908872|FG000|Overall Study|Lost to Follow-up|2|||
170427855|NCT03616535|615908873|FG001|Overall Study|Lost to Follow-up|1|||
170427856|NCT03616535|615908874|FG002|Overall Study|Lost to Follow-up|0|||
170427857|NCT03616535|615908875|FG003|Overall Study|Lost to Follow-up|2|||
170427858|NCT03616535|615908872|FG000|Overall Study|Withdrawal by Subject|1|||
170427859|NCT03616535|615908873|FG001|Overall Study|Withdrawal by Subject|2|||
170427860|NCT03616535|615908874|FG002|Overall Study|Withdrawal by Subject|5|||
170427861|NCT03616535|615908875|FG003|Overall Study|Withdrawal by Subject|1|||
170427862|NCT03616535|615908872|FG000|Overall Study|Not specified or change in eligibility|2|||
170427863|NCT03616535|615908873|FG001|Overall Study|Not specified or change in eligibility|3|||
170427864|NCT03616535|615908874|FG002|Overall Study|Not specified or change in eligibility|3|||
170427865|NCT03616535|615908875|FG003|Overall Study|Not specified or change in eligibility|1|||
170427866|NCT01531894|615908876|FG000|Overall Study|Physician Decision|8|||
170427867|NCT01531894|615908876|FG000|Overall Study|Death|1|||
170427868|NCT02476994|615908877|FG000|Overall Study|Based on feedback from FDA|1|||
170427869|NCT02476994|615908878|FG001|Overall Study|Based on feedback from FDA|0|||
170427870|NCT02246166|615908879|FG000|Overall Study|Protocol Violation|1|||
170427871|NCT02246166|615908880|FG001|Overall Study|Protocol Violation|0|||
170427872|NCT00834418|615908885|FG000|Overall Study|Adverse Event|0|||
170427873|NCT00834418|615908886|FG001|Overall Study|Adverse Event|2|||
170427874|NCT00777023|615908887|FG000|Overall Study|Adverse Event|15|||
170427875|NCT00777023|615908888|FG001|Overall Study|Adverse Event|21|||
170427876|NCT00777023|615908889|FG002|Overall Study|Adverse Event|8|||
170427877|NCT00777023|615908887|FG000|Overall Study|Lack of Efficacy|1|||
170427878|NCT00777023|615908888|FG001|Overall Study|Lack of Efficacy|0|||
170427879|NCT00777023|615908889|FG002|Overall Study|Lack of Efficacy|14|||
170427880|NCT00777023|615908887|FG000|Overall Study|Protocol Violation|2|||
170427881|NCT00777023|615908888|FG001|Overall Study|Protocol Violation|1|||
170427882|NCT00777023|615908889|FG002|Overall Study|Protocol Violation|1|||
170427883|NCT00777023|615908887|FG000|Overall Study|Lost to Follow-up|2|||
170427884|NCT00777023|615908888|FG001|Overall Study|Lost to Follow-up|3|||
170427885|NCT00777023|615908889|FG002|Overall Study|Lost to Follow-up|3|||
170427886|NCT00777023|615908887|FG000|Overall Study|Death|0|||
170427887|NCT00777023|615908888|FG001|Overall Study|Death|1|||
170427888|NCT00777023|615908889|FG002|Overall Study|Death|0|||
170427889|NCT00777023|615908887|FG000|Overall Study|Withdrawal by Subject|7|||
170427890|NCT00777023|615908888|FG001|Overall Study|Withdrawal by Subject|7|||
170427891|NCT00777023|615908889|FG002|Overall Study|Withdrawal by Subject|8|||
170427892|NCT00777023|615908887|FG000|Overall Study|Missing data|1|||
170427893|NCT00777023|615908888|FG001|Overall Study|Missing data|1|||
170427894|NCT00777023|615908889|FG002|Overall Study|Missing data|0|||
170427895|NCT00777023|615908887|FG000|Overall Study|Reasons not specified|4|||
170427896|NCT00777023|615908888|FG001|Overall Study|Reasons not specified|4|||
170427897|NCT00777023|615908889|FG002|Overall Study|Reasons not specified|2|||
170427898|NCT00777023|615908887|FG000|Overall Study|Last dose date unknown|3|||
170427899|NCT00777023|615908888|FG001|Overall Study|Last dose date unknown|3|||
170427900|NCT00777023|615908889|FG002|Overall Study|Last dose date unknown|1|||
170427901|NCT02678286|615908892|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
170427902|NCT02678286|615908893|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
170427903|NCT02678286|615908892|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
170534644|NCT00671060|616304087|FG001|Overall Study|Physician Decision|1|||
170534645|NCT00303186|616304088|FG000|Overall Study|Other|52|||
170534646|NCT03473197|616304089|FG000|Overall Study|Adverse Event|4|||
170534647|NCT03473197|616304089|FG000|Overall Study|Lost to Follow-up|1|||
170534648|NCT03473197|616304089|FG000|Overall Study|Withdrawal by Subject|5|||
170534649|NCT03575364|616304093|FG000|Overall Study|Death|45|||
170427904|NCT02678286|615908893|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
170427905|NCT02678286|615908892|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
170427906|NCT02678286|615908893|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
170534650|NCT03575364|616304093|FG000|Overall Study|Lost to Follow-up|114|||
170534651|NCT03575364|616304093|FG000|Overall Study|Withdrawal by Subject|21|||
170534652|NCT03575364|616304093|FG000|Overall Study|Physician Decision|11|||
170534653|NCT03575364|616304093|FG000|Overall Study|Subject Refused Follow-up|13|||
170534654|NCT03575364|616304093|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
170427907|NCT02678286|615908892|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
170427908|NCT02678286|615908893|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
170427909|NCT02678286|615908892|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
170427910|NCT02678286|615908893|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
170427911|NCT04274686|615908897|FG000|Overall Study|Physician Decision|1|||
170427912|NCT04274686|615908898|FG001|Overall Study|Physician Decision|0|||
170427913|NCT01827163|615908899|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
170427914|NCT01827163|615908899|FG000|Overall Study|Adverse Event|9|||
170534655|NCT03575364|616304093|FG000|Overall Study|Patient moved out of the state|1|||
170534656|NCT03575364|616304093|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
170534657|NCT03575364|616304093|FG000|Overall Study|Patient is lost to follow up|1|||
170534658|NCT03575364|616304093|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
170534659|NCT02475213|616304094|FG000|Overall Study|Adverse Event|2|||
170534660|NCT02475213|616304095|FG001|Overall Study|Adverse Event|0|||
170534661|NCT02475213|616304096|FG002|Overall Study|Adverse Event|0|||
170534662|NCT02475213|616304097|FG003|Overall Study|Adverse Event|1|||
170534663|NCT02475213|616304098|FG004|Overall Study|Adverse Event|1|||
170534664|NCT02475213|616304099|FG005|Overall Study|Adverse Event|4|||
170534665|NCT02475213|616304100|FG006|Overall Study|Adverse Event|6|||
170534666|NCT02475213|616304101|FG007|Overall Study|Adverse Event|2|||
170534667|NCT02475213|616304094|FG000|Overall Study|Physician Decision|1|||
170534668|NCT02475213|616304095|FG001|Overall Study|Physician Decision|1|||
170534669|NCT02475213|616304096|FG002|Overall Study|Physician Decision|1|||
170534670|NCT02475213|616304097|FG003|Overall Study|Physician Decision|0|||
170534671|NCT02475213|616304098|FG004|Overall Study|Physician Decision|0|||
170534672|NCT02475213|616304099|FG005|Overall Study|Physician Decision|1|||
170534673|NCT02475213|616304100|FG006|Overall Study|Physician Decision|4|||
170534674|NCT02475213|616304101|FG007|Overall Study|Physician Decision|0|||
170534675|NCT02475213|616304094|FG000|Overall Study|Progressive Disease|3|||
170534676|NCT02475213|616304095|FG001|Overall Study|Progressive Disease|2|||
170534677|NCT02475213|616304096|FG002|Overall Study|Progressive Disease|2|||
170534678|NCT02475213|616304097|FG003|Overall Study|Progressive Disease|13|||
170534679|NCT02475213|616304098|FG004|Overall Study|Progressive Disease|15|||
170534680|NCT02475213|616304099|FG005|Overall Study|Progressive Disease|25|||
170534681|NCT02475213|616304100|FG006|Overall Study|Progressive Disease|30|||
170534682|NCT02475213|616304101|FG007|Overall Study|Progressive Disease|10|||
170534683|NCT02475213|616304094|FG000|Overall Study|Death|0|||
170534684|NCT02475213|616304095|FG001|Overall Study|Death|0|||
170534685|NCT02475213|616304096|FG002|Overall Study|Death|0|||
170534686|NCT02475213|616304097|FG003|Overall Study|Death|0|||
170534687|NCT02475213|616304098|FG004|Overall Study|Death|0|||
170534688|NCT02475213|616304099|FG005|Overall Study|Death|4|||
170534689|NCT02475213|616304100|FG006|Overall Study|Death|1|||
170534690|NCT02475213|616304101|FG007|Overall Study|Death|0|||
170534691|NCT02475213|616304094|FG000|Overall Study|Protocol Violation|0|||
170534692|NCT02475213|616304095|FG001|Overall Study|Protocol Violation|0|||
170534693|NCT02475213|616304096|FG002|Overall Study|Protocol Violation|0|||
170534694|NCT02475213|616304097|FG003|Overall Study|Protocol Violation|0|||
170534695|NCT02475213|616304098|FG004|Overall Study|Protocol Violation|1|||
170534696|NCT02475213|616304099|FG005|Overall Study|Protocol Violation|0|||
170534697|NCT02475213|616304100|FG006|Overall Study|Protocol Violation|0|||
170534698|NCT02475213|616304101|FG007|Overall Study|Protocol Violation|0|||
170534699|NCT02475213|616304094|FG000|Overall Study|Withdrawal by Subject|0|||
170534700|NCT02475213|616304095|FG001|Overall Study|Withdrawal by Subject|0|||
170534701|NCT02475213|616304096|FG002|Overall Study|Withdrawal by Subject|0|||
170534702|NCT02475213|616304097|FG003|Overall Study|Withdrawal by Subject|1|||
170534703|NCT02475213|616304098|FG004|Overall Study|Withdrawal by Subject|0|||
170534704|NCT02475213|616304099|FG005|Overall Study|Withdrawal by Subject|2|||
170534705|NCT02475213|616304100|FG006|Overall Study|Withdrawal by Subject|2|||
170534706|NCT02475213|616304101|FG007|Overall Study|Withdrawal by Subject|0|||
170534707|NCT02475213|616304094|FG000|Overall Study|Other|0|||
170534708|NCT02475213|616304095|FG001|Overall Study|Other|0|||
170534709|NCT02475213|616304096|FG002|Overall Study|Other|0|||
170534710|NCT02475213|616304097|FG003|Overall Study|Other|1|||
170534711|NCT02475213|616304098|FG004|Overall Study|Other|3|||
170534712|NCT02475213|616304099|FG005|Overall Study|Other|1|||
170534713|NCT02475213|616304100|FG006|Overall Study|Other|0|||
170534714|NCT02475213|616304101|FG007|Overall Study|Other|0|||
170534715|NCT02567188|616304102|FG000|Overall Study|Death|10|||
170534716|NCT02567188|616304102|FG000|Overall Study|Terminated Mircera Treatment|9|||
170534717|NCT02567188|616304102|FG000|Overall Study|Lost to Follow-up|5|||
170534718|NCT02567188|616304102|FG000|Overall Study|Adverse Event|1|||
170534719|NCT02567188|616304102|FG000|Overall Study|Withdrawal by Subject|1|||
170534720|NCT02567188|616304102|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
170534721|NCT02567188|616304102|FG000|Overall Study|Moved and Changed Clinic|1|||
170534722|NCT02567188|616304102|FG000|Overall Study|Started Hemodialysis|2|||
170534723|NCT02567188|616304102|FG000|Overall Study|Protocol Violation|5|||
170534724|NCT01033136|616304103|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
170534725|NCT01033136|616304104|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
170534726|NCT00630292|616304105|FG000|Overall Study|Withdrawal by Subject|1|||
170534727|NCT05383209|616304106|FG000|Overall Study|Adverse Event: Non-ocular|0|||
170534728|NCT05383209|616304107|FG001|Overall Study|Adverse Event: Non-ocular|1|||
170534729|NCT05383209|616304108|FG002|Overall Study|Adverse Event: Non-ocular|0|||
170534730|NCT05383209|616304106|FG000|Overall Study|Lost to Follow-up|2|||
170534731|NCT05383209|616304107|FG001|Overall Study|Lost to Follow-up|1|||
170534732|NCT05383209|616304108|FG002|Overall Study|Lost to Follow-up|4|||
170534733|NCT05383209|616304106|FG000|Overall Study|Withdrawal by Subject|2|||
170534734|NCT05383209|616304107|FG001|Overall Study|Withdrawal by Subject|0|||
170427915|NCT01200810|615908900|FG000|Overall Study|Physician Decision|1|||
170427916|NCT01200810|615908901|FG001|Overall Study|Physician Decision|0|||
170427917|NCT01200810|615908900|FG000|Overall Study|Withdrawal by Subject|1|||
170427918|NCT01200810|615908901|FG001|Overall Study|Withdrawal by Subject|2|||
170427919|NCT01200810|615908900|FG000|Overall Study|Sponsor stopped making study drug|3|||
170427920|NCT01200810|615908901|FG001|Overall Study|Sponsor stopped making study drug|3|||
170427921|NCT00609674|615908903|FG000|Overall Study|Adverse Event|1|||
170427922|NCT00609674|615908904|FG001|Overall Study|Adverse Event|1|||
170427923|NCT00609674|615908903|FG000|Overall Study|Protocol Violation|3|||
170427924|NCT00609674|615908904|FG001|Overall Study|Protocol Violation|5|||
170427925|NCT00609674|615908903|FG000|Overall Study|Lost to Follow-up|1|||
170427926|NCT00609674|615908904|FG001|Overall Study|Lost to Follow-up|0|||
170427927|NCT00609674|615908903|FG000|Overall Study|Withdrew consent|2|||
170427928|NCT00609674|615908904|FG001|Overall Study|Withdrew consent|1|||
170427929|NCT00834431|615908918|FG000|First Intervention|Adverse Event|0|||
170427930|NCT00834431|615908919|FG001|First Intervention|Adverse Event|1|||
170427931|NCT00834431|615908918|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
170427932|NCT00834431|615908919|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
170427933|NCT02648438|615908920|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170427934|NCT02648438|615908921|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
170427935|NCT02648438|615908922|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
170427936|NCT02648438|615908920|FG000|Overall Study|Protocol Violation|2|||
170427937|NCT02648438|615908921|FG001|Overall Study|Protocol Violation|0|||
170427938|NCT02648438|615908922|FG002|Overall Study|Protocol Violation|0|||
170427939|NCT02648438|615908920|FG000|Overall Study|Withdrawal by Subject|1|||
170427940|NCT02648438|615908921|FG001|Overall Study|Withdrawal by Subject|1|||
170427941|NCT02648438|615908922|FG002|Overall Study|Withdrawal by Subject|0|||
170427942|NCT03249454|615908923|FG000|Overall Study|Withdrawal by Subject|0|||
170427943|NCT03249454|615908924|FG001|Overall Study|Withdrawal by Subject|0|||
170427944|NCT03249454|615908925|FG002|Overall Study|Withdrawal by Subject|0|||
170427945|NCT03249454|615908926|FG003|Overall Study|Withdrawal by Subject|0|||
170427946|NCT03249454|615908927|FG004|Overall Study|Withdrawal by Subject|0|||
170427947|NCT03249454|615908928|FG005|Overall Study|Withdrawal by Subject|0|||
170427948|NCT03249454|615908929|FG006|Overall Study|Withdrawal by Subject|0|||
170427949|NCT03249454|615908930|FG007|Overall Study|Withdrawal by Subject|0|||
170427950|NCT03249454|615908931|FG008|Overall Study|Withdrawal by Subject|0|||
170427951|NCT03249454|615908932|FG009|Overall Study|Withdrawal by Subject|1|||
170427952|NCT03249454|615908933|FG010|Overall Study|Withdrawal by Subject|1|||
170427953|NCT03138967|615908936|FG000|Overall Study|Death|0|||
170427954|NCT03138967|615908937|FG001|Overall Study|Death|1|||
170427955|NCT03138967|615908936|FG000|Overall Study|Physician Decision|1|||
170427956|NCT03138967|615908937|FG001|Overall Study|Physician Decision|3|||
170427957|NCT01913405|615908938|FG000|Overall Study|Withdrawal by Subject|1|||
170427958|NCT01913405|615908938|FG000|Overall Study|Adverse Event|1|||
170427959|NCT03987191|615908939|FG000|Overall Study|COVID-19 related research disruption|0|||
170427960|NCT03987191|615908940|FG001|Overall Study|COVID-19 related research disruption|2|||
170427961|NCT04400890|615908941|FG000|Overall Study|Withdrawal by Subject|3|||
170427962|NCT04400890|615908942|FG001|Overall Study|Withdrawal by Subject|2|||
170427963|NCT04604275|615908947|FG000|Washout-1 Week|Withdrawal by Subject|1|||
170427964|NCT04604275|615908948|FG001|Washout-1 Week|Withdrawal by Subject|0|||
170427965|NCT04659603|615908951|FG000|Overall Study|Study terminated by sponsor|0|||
170427966|NCT04659603|615908952|FG001|Overall Study|Study terminated by sponsor|0|||
170427967|NCT04659603|615908953|FG002|Overall Study|Study terminated by sponsor|2|||
170427968|NCT04659603|615908951|FG000|Overall Study|Withdrawal by Subject|0|||
170427969|NCT04659603|615908952|FG001|Overall Study|Withdrawal by Subject|5|||
170427970|NCT04659603|615908953|FG002|Overall Study|Withdrawal by Subject|0|||
170427971|NCT04659603|615908951|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
170427972|NCT04659603|615908952|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
170427973|NCT04659603|615908953|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
170427974|NCT03420300|615908954|FG000|Overall Study|Death|2|||
170427975|NCT00095212|615908955|FG000|Overall Study|Withdrawal by Subject|1|||
170427976|NCT00095212|615908956|FG001|Overall Study|Withdrawal by Subject|3|||
170427977|NCT02374853|615908959|FG000|Overall Study|Surgery Cancelled|5|||
170427978|NCT02374853|615908960|FG001|Overall Study|Surgery Cancelled|11|||
170427979|NCT03681470|615908962|FG000|Overall Study|Lack of Efficacy|3|||
170427980|NCT03681470|615908962|FG000|Overall Study|Lost to Follow-up|1|||
170427981|NCT03681470|615908962|FG000|Overall Study|Protocol Violation|3|||
170427982|NCT03681470|615908962|FG000|Overall Study|Withdrawal by Subject|1|||
170427983|NCT02335658|615908963|FG000|Overall Study|Adverse Event|18|||
170427984|NCT02335658|615908964|FG001|Overall Study|Adverse Event|12|||
170427985|NCT02335658|615908963|FG000|Overall Study|Lack of Efficacy|4|||
170427986|NCT02335658|615908964|FG001|Overall Study|Lack of Efficacy|5|||
170427987|NCT02335658|615908963|FG000|Overall Study|Pregnancy|1|||
170427988|NCT02335658|615908964|FG001|Overall Study|Pregnancy|0|||
170427989|NCT02335658|615908963|FG000|Overall Study|Withdrawal by Subject|13|||
170427990|NCT02335658|615908964|FG001|Overall Study|Withdrawal by Subject|21|||
170427991|NCT02335658|615908963|FG000|Overall Study|non-compliance|2|||
170534735|NCT05383209|616304108|FG002|Overall Study|Withdrawal by Subject|1|||
170534736|NCT05383209|616304106|FG000|Overall Study|Death|1|||
170534737|NCT05383209|616304107|FG001|Overall Study|Death|0|||
170534738|NCT05383209|616304108|FG002|Overall Study|Death|0|||
170534739|NCT05383209|616304106|FG000|Overall Study|Other|0|||
170534740|NCT05383209|616304107|FG001|Overall Study|Other|1|||
170534741|NCT05383209|616304108|FG002|Overall Study|Other|0|||
170534742|NCT01553851|616304110|FG000|Overall Study|Adverse Event|2|||
170534743|NCT01553851|616304110|FG000|Overall Study|constipation|1|||
170534744|NCT00797563|616304111|FG000|Overall Study|Adverse Event|1|||
170534745|NCT03416179|616304112|FG000|Overall Study|Death|90|||
170534746|NCT03416179|616304113|FG001|Overall Study|Death|87|||
170534747|NCT03416179|616304114|FG002|Overall Study|Death|117|||
170534748|NCT03416179|616304115|FG003|Overall Study|Death|113|||
170534749|NCT03416179|616304112|FG000|Overall Study|Withdrawal by Subject|15|||
170534750|NCT03416179|616304113|FG001|Overall Study|Withdrawal by Subject|20|||
170534751|NCT03416179|616304114|FG002|Overall Study|Withdrawal by Subject|6|||
170534752|NCT03416179|616304115|FG003|Overall Study|Withdrawal by Subject|9|||
170534753|NCT03416179|616304112|FG000|Overall Study|Lost to Follow-up|1|||
170534754|NCT03416179|616304113|FG001|Overall Study|Lost to Follow-up|1|||
170534755|NCT03416179|616304114|FG002|Overall Study|Lost to Follow-up|0|||
170534756|NCT03416179|616304115|FG003|Overall Study|Lost to Follow-up|3|||
170534757|NCT03416179|616304112|FG000|Overall Study|Study participation terminated by Sponsor|93|||
170534758|NCT03416179|616304113|FG001|Overall Study|Study participation terminated by Sponsor|91|||
170534759|NCT03416179|616304114|FG002|Overall Study|Study participation terminated by Sponsor|26|||
170534760|NCT03416179|616304115|FG003|Overall Study|Study participation terminated by Sponsor|31|||
170534761|NCT03416179|616304112|FG000|Overall Study|Other|2|||
170534762|NCT03416179|616304113|FG001|Overall Study|Other|3|||
170534763|NCT03416179|616304114|FG002|Overall Study|Other|1|||
170534764|NCT03416179|616304115|FG003|Overall Study|Other|0|||
170534765|NCT03822416|616304122|FG000|Overall Study|Lost to Follow-up|1|||
170534766|NCT03822416|616304123|FG001|Overall Study|Lost to Follow-up|0|||
170534767|NCT03822416|616304122|FG000|Overall Study|Withdrawal by Subject|0|||
170534768|NCT03822416|616304123|FG001|Overall Study|Withdrawal by Subject|1|||
170534769|NCT04666298|616304124|FG000|Overall Study|Subject decision|1|||
170534770|NCT04666298|616304125|FG001|Overall Study|Subject decision|0|||
170534771|NCT04666298|616304126|FG002|Overall Study|Subject decision|0|||
170534772|NCT04666298|616304127|FG003|Overall Study|Subject decision|2|||
170534773|NCT04666298|616304124|FG000|Overall Study|Death|1|||
170534774|NCT04666298|616304125|FG001|Overall Study|Death|0|||
170534775|NCT04666298|616304126|FG002|Overall Study|Death|0|||
170534776|NCT04666298|616304127|FG003|Overall Study|Death|0|||
170427992|NCT02335658|615908964|FG001|Overall Study|non-compliance|3|||
170427993|NCT02335658|615908963|FG000|Overall Study|other reason|2|||
170427994|NCT02335658|615908964|FG001|Overall Study|other reason|3|||
170427995|NCT05341622|615908965|FG000|Overall Study|Death|0|||
170427996|NCT05341622|615908966|FG001|Overall Study|Death|0|||
170427997|NCT05341622|615908967|FG002|Overall Study|Death|0|||
170427998|NCT05341622|615908968|FG003|Overall Study|Death|0|||
170427999|NCT05341622|615908969|FG004|Overall Study|Death|1|||
170428000|NCT05341622|615908970|FG005|Overall Study|Death|0|||
170428001|NCT05341622|615908971|FG006|Overall Study|Death|0|||
170428002|NCT05341622|615908972|FG007|Overall Study|Death|1|||
170428003|NCT05341622|615908965|FG000|Overall Study|Invalid Address|0|||
170534777|NCT04666298|616304124|FG000|Overall Study|Lost to Follow-up|0|||
170534778|NCT04666298|616304125|FG001|Overall Study|Lost to Follow-up|0|||
170534779|NCT04666298|616304126|FG002|Overall Study|Lost to Follow-up|0|||
170534780|NCT04666298|616304127|FG003|Overall Study|Lost to Follow-up|1|||
170534781|NCT04666298|616304124|FG000|Overall Study|Physician Decision|0|||
170534782|NCT04666298|616304125|FG001|Overall Study|Physician Decision|0|||
170534783|NCT04666298|616304126|FG002|Overall Study|Physician Decision|0|||
170534784|NCT04666298|616304127|FG003|Overall Study|Physician Decision|1|||
170534785|NCT04666298|616304124|FG000|Overall Study|Protocol deviation|0|||
170428004|NCT05341622|615908966|FG001|Overall Study|Invalid Address|1|||
170428005|NCT05341622|615908967|FG002|Overall Study|Invalid Address|0|||
170428006|NCT05341622|615908968|FG003|Overall Study|Invalid Address|0|||
170428007|NCT05341622|615908969|FG004|Overall Study|Invalid Address|0|||
170428008|NCT05341622|615908970|FG005|Overall Study|Invalid Address|0|||
170534786|NCT04666298|616304125|FG001|Overall Study|Protocol deviation|0|||
170534787|NCT04666298|616304126|FG002|Overall Study|Protocol deviation|1|||
170534788|NCT04666298|616304127|FG003|Overall Study|Protocol deviation|0|||
170534789|NCT00844519|616304128|FG000|Overall Study|Withdrawal by Subject|1|||
170534790|NCT00844519|616304129|FG001|Overall Study|Withdrawal by Subject|1|||
170428009|NCT05341622|615908971|FG006|Overall Study|Invalid Address|0|||
170428010|NCT05341622|615908972|FG007|Overall Study|Invalid Address|0|||
170428011|NCT05341622|615908965|FG000|Overall Study|Ineligible|26|||
170534791|NCT00844519|616304128|FG000|Overall Study|Adverse Event|1|||
170534792|NCT00844519|616304129|FG001|Overall Study|Adverse Event|0|||
170534793|NCT01303419|616304130|FG000|Overall Study|Discontinuation of study|60|||
170534794|NCT01303419|616304130|FG000|Overall Study|Did not complete both imaging methods|5|||
170534795|NCT01303419|616304130|FG000|Overall Study|Did not meet all I/E after screening|31|||
170428012|NCT05341622|615908966|FG001|Overall Study|Ineligible|21|||
170428013|NCT05341622|615908967|FG002|Overall Study|Ineligible|28|||
170428014|NCT05341622|615908968|FG003|Overall Study|Ineligible|24|||
170428015|NCT05341622|615908969|FG004|Overall Study|Ineligible|29|||
170428016|NCT05341622|615908970|FG005|Overall Study|Ineligible|31|||
170428017|NCT05341622|615908971|FG006|Overall Study|Ineligible|28|||
170428018|NCT05341622|615908972|FG007|Overall Study|Ineligible|26|||
170428019|NCT02658084|615908977|FG000|Overall Study|Withdrawal by Subject|1|||
170428020|NCT02658084|615908978|FG001|Overall Study|Withdrawal by Subject|0|||
170428021|NCT02658084|615908977|FG000|Overall Study|Study Termination|1|||
170428022|NCT02658084|615908978|FG001|Overall Study|Study Termination|0|||
170428023|NCT03500692|615908979|FG000|Overall Study|Death|163|||
170428024|NCT03500692|615908979|FG000|Overall Study|Lost to Follow-up|75|||
170428025|NCT03500692|615908979|FG000|Overall Study|Termination Reasons|3|||
170428026|NCT04149964|615908980|FG000|Overall Study|Lost to Follow-up|19|||
170428027|NCT04149964|615908981|FG001|Overall Study|Lost to Follow-up|18|||
170428028|NCT02957942|615908982|FG000|Overall Study|Withdrawal by Subject|0|||
170428029|NCT02957942|615908983|FG001|Overall Study|Withdrawal by Subject|1|||
170428030|NCT02957942|615908982|FG000|Overall Study|Practicing experiment protocol|0|||
170428031|NCT02957942|615908983|FG001|Overall Study|Practicing experiment protocol|6|||
170428032|NCT02272777|615908998|FG000|Overall Study|Adverse Event|0|||
170428033|NCT02272777|615908999|FG001|Overall Study|Adverse Event|1|||
170428034|NCT02272777|615908998|FG000|Overall Study|Withdrawal by Subject|0|||
170428035|NCT02272777|615908999|FG001|Overall Study|Withdrawal by Subject|3|||
170428036|NCT02272777|615908998|FG000|Overall Study|Lost to Follow-up|2|||
170428037|NCT02272777|615908999|FG001|Overall Study|Lost to Follow-up|0|||
170428038|NCT02272777|615908998|FG000|Overall Study|Other|2|||
170428039|NCT02272777|615908999|FG001|Overall Study|Other|0|||
170428040|NCT02066922|615909004|FG000|Overall Study|Adverse Event|1|||
170428041|NCT04611789|615909005|FG000|Overall Study|Lost to Follow-up|1|||
170428042|NCT04611789|615909006|FG001|Overall Study|Lost to Follow-up|0|||
170428043|NCT04611789|615909007|FG002|Overall Study|Lost to Follow-up|0|||
170428044|NCT00837486|615909008|FG000|Blinded-treatment Phase|Physician Decision|1|||
170428045|NCT00837486|615909009|FG001|Blinded-treatment Phase|Physician Decision|0|||
170428046|NCT00837486|615909008|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
170428047|NCT00837486|615909009|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
170428048|NCT00837486|615909008|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
170428049|NCT00837486|615909009|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
170428050|NCT00837486|615909008|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
170428051|NCT00837486|615909009|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
170428052|NCT01577381|615909010|FG000|Overall Study|Discontinued|2|||
170428053|NCT01577381|615909011|FG001|Overall Study|Discontinued|1|||
170428054|NCT01577381|615909012|FG002|Overall Study|Discontinued|2|||
170428055|NCT01577381|615909013|FG003|Overall Study|Discontinued|2|||
170428056|NCT01577381|615909010|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
170428057|NCT01577381|615909011|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
170428058|NCT01577381|615909012|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
170428059|NCT01577381|615909013|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
170428060|NCT03801707|615909014|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
170428061|NCT01754597|615909015|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
170428062|NCT01754597|615909016|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
170428063|NCT00819741|615909017|FG000|Overall Study|Adverse Event|5|||
170428064|NCT00819741|615909018|FG001|Overall Study|Adverse Event|2|||
170428065|NCT00819741|615909017|FG000|Overall Study|Lack of Efficacy|0|||
170428066|NCT00819741|615909018|FG001|Overall Study|Lack of Efficacy|2|||
170428067|NCT00819741|615909017|FG000|Overall Study|Lost to Follow-up|3|||
170428068|NCT00819741|615909018|FG001|Overall Study|Lost to Follow-up|1|||
170428069|NCT00819741|615909017|FG000|Overall Study|Protocol Violation|3|||
170428070|NCT00819741|615909018|FG001|Overall Study|Protocol Violation|4|||
170428071|NCT00819741|615909017|FG000|Overall Study|Withdrawal by Subject|2|||
170428072|NCT00819741|615909018|FG001|Overall Study|Withdrawal by Subject|2|||
170428073|NCT00819741|615909017|FG000|Overall Study|Unclassified|6|||
170428074|NCT00819741|615909018|FG001|Overall Study|Unclassified|0|||
170428075|NCT00819741|615909017|FG000|Overall Study|Reasons unknown|3|||
170428076|NCT00819741|615909018|FG001|Overall Study|Reasons unknown|3|||
170428077|NCT01597245|615909019|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
170428078|NCT01597245|615909020|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
170428079|NCT01597245|615909021|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
170428080|NCT01597245|615909022|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
170428081|NCT01597245|615909023|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428082|NCT01597245|615909024|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428083|NCT01597245|615909025|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428084|NCT01597245|615909026|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428085|NCT01597245|615909027|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428086|NCT01597245|615909028|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428087|NCT01597245|615909029|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170880084|NCT02831673|617572699|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
170880085|NCT02831673|617572700|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
170428088|NCT01597245|615909030|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428089|NCT01597245|615909031|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428090|NCT01597245|615909032|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428091|NCT01597245|615909033|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428092|NCT01597245|615909034|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428093|NCT01597245|615909035|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428094|NCT01597245|615909036|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428095|NCT01597245|615909037|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170880086|NCT02831673|617572696|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
170880087|NCT02831673|617572697|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
170880088|NCT02831673|617572698|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
170880089|NCT02831673|617572699|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
170880090|NCT02831673|617572700|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
170428096|NCT01597245|615909038|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428097|NCT01597245|615909039|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
170428098|NCT01597245|615909019|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
170428099|NCT01597245|615909020|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
170428100|NCT01597245|615909021|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
170428101|NCT01597245|615909022|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
170428102|NCT01597245|615909023|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428103|NCT01597245|615909024|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428104|NCT01597245|615909025|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428105|NCT01597245|615909026|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428106|NCT01597245|615909027|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428107|NCT01597245|615909028|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428108|NCT01597245|615909029|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170534796|NCT06438601|616304131|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
170534797|NCT06438601|616304132|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
170534798|NCT06438601|616304131|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
170534799|NCT06438601|616304132|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
170534800|NCT01136915|616304137|FG000|Overall Study|Lost to Follow-up|2|||
170534801|NCT01136915|616304138|FG001|Overall Study|Lost to Follow-up|0|||
170534802|NCT01136915|616304137|FG000|Overall Study|Exclusion criterion met|0|||
170534803|NCT01136915|616304138|FG001|Overall Study|Exclusion criterion met|1|||
170534804|NCT03965923|616304139|FG000|Overall Study|Withdrawal by Subject|1|||
170534805|NCT03965923|616304140|FG001|Overall Study|Withdrawal by Subject|2|||
170534806|NCT03965923|616304141|FG002|Overall Study|Withdrawal by Subject|3|||
170534807|NCT03965923|616304142|FG003|Overall Study|Withdrawal by Subject|1|||
170534808|NCT03965923|616304143|FG004|Overall Study|Withdrawal by Subject|2|||
170534809|NCT03965923|616304144|FG005|Overall Study|Withdrawal by Subject|0|||
170534810|NCT03965923|616304145|FG006|Overall Study|Withdrawal by Subject|4|||
170534811|NCT03965923|616304146|FG007|Overall Study|Withdrawal by Subject|3|||
170534812|NCT03965923|616304147|FG008|Overall Study|Withdrawal by Subject|4|||
170534813|NCT03965923|616304148|FG009|Overall Study|Withdrawal by Subject|0|||
170534814|NCT03965923|616304149|FG010|Overall Study|Withdrawal by Subject|2|||
170534815|NCT03965923|616304150|FG011|Overall Study|Withdrawal by Subject|0|||
170534816|NCT03965923|616304139|FG000|Overall Study|Lost to Follow-up|2|||
170534817|NCT03965923|616304140|FG001|Overall Study|Lost to Follow-up|1|||
170534818|NCT03965923|616304141|FG002|Overall Study|Lost to Follow-up|1|||
170534819|NCT03965923|616304142|FG003|Overall Study|Lost to Follow-up|0|||
170534820|NCT03965923|616304143|FG004|Overall Study|Lost to Follow-up|2|||
170534821|NCT03965923|616304144|FG005|Overall Study|Lost to Follow-up|1|||
170534822|NCT03965923|616304145|FG006|Overall Study|Lost to Follow-up|2|||
170534823|NCT03965923|616304146|FG007|Overall Study|Lost to Follow-up|1|||
170534824|NCT03965923|616304147|FG008|Overall Study|Lost to Follow-up|0|||
170534825|NCT03965923|616304148|FG009|Overall Study|Lost to Follow-up|2|||
170534826|NCT03965923|616304149|FG010|Overall Study|Lost to Follow-up|0|||
170534827|NCT03965923|616304150|FG011|Overall Study|Lost to Follow-up|0|||
170428109|NCT01597245|615909030|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170534828|NCT03965923|616304139|FG000|Overall Study|Death|0|||
170534829|NCT03965923|616304140|FG001|Overall Study|Death|0|||
170534830|NCT03965923|616304141|FG002|Overall Study|Death|0|||
170534831|NCT03965923|616304142|FG003|Overall Study|Death|0|||
170534832|NCT03965923|616304143|FG004|Overall Study|Death|0|||
170534833|NCT03965923|616304144|FG005|Overall Study|Death|0|||
170534834|NCT03965923|616304145|FG006|Overall Study|Death|0|||
170534835|NCT03965923|616304146|FG007|Overall Study|Death|1|||
170880091|NCT02831673|617572696|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
170428110|NCT01597245|615909031|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170534836|NCT03965923|616304147|FG008|Overall Study|Death|4|||
170534837|NCT03965923|616304148|FG009|Overall Study|Death|0|||
170534838|NCT03965923|616304149|FG010|Overall Study|Death|4|||
170534839|NCT03965923|616304150|FG011|Overall Study|Death|0|||
170534840|NCT03965923|616304139|FG000|Overall Study|Other reason|0|||
170534841|NCT03965923|616304140|FG001|Overall Study|Other reason|0|||
170534842|NCT03965923|616304141|FG002|Overall Study|Other reason|0|||
170534843|NCT03965923|616304142|FG003|Overall Study|Other reason|1|||
170534844|NCT03965923|616304143|FG004|Overall Study|Other reason|0|||
170534845|NCT03965923|616304144|FG005|Overall Study|Other reason|0|||
170534846|NCT03965923|616304145|FG006|Overall Study|Other reason|0|||
170534847|NCT03965923|616304146|FG007|Overall Study|Other reason|0|||
170534848|NCT03965923|616304147|FG008|Overall Study|Other reason|0|||
170534849|NCT03965923|616304148|FG009|Overall Study|Other reason|0|||
170534850|NCT03965923|616304149|FG010|Overall Study|Other reason|2|||
170534851|NCT03965923|616304150|FG011|Overall Study|Other reason|0|||
170428111|NCT01597245|615909032|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428112|NCT01597245|615909033|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428113|NCT01597245|615909034|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428114|NCT01597245|615909035|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428115|NCT01597245|615909036|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428116|NCT01597245|615909037|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428117|NCT01597245|615909038|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428118|NCT01597245|615909039|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
170428119|NCT01597245|615909019|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
170428120|NCT01597245|615909020|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
170428121|NCT01597245|615909021|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
170428122|NCT01597245|615909022|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
170428123|NCT01597245|615909023|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428124|NCT01597245|615909024|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428125|NCT01597245|615909025|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428126|NCT01597245|615909026|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428127|NCT01597245|615909027|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428128|NCT01597245|615909028|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428129|NCT01597245|615909029|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428130|NCT01597245|615909030|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428131|NCT01597245|615909031|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428132|NCT01597245|615909032|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428133|NCT01597245|615909033|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428134|NCT01597245|615909034|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428135|NCT01597245|615909035|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428136|NCT01597245|615909036|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428137|NCT01597245|615909037|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428138|NCT01597245|615909038|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428139|NCT01597245|615909039|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
170428140|NCT01597245|615909019|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
170428141|NCT01597245|615909020|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
170428142|NCT01597245|615909021|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
170428143|NCT01597245|615909022|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428144|NCT01597245|615909023|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428145|NCT01597245|615909024|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428146|NCT01597245|615909025|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428147|NCT01597245|615909026|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428148|NCT01597245|615909027|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428149|NCT01597245|615909028|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428150|NCT01597245|615909029|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428151|NCT01597245|615909030|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428152|NCT01597245|615909031|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428153|NCT01597245|615909032|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428154|NCT01597245|615909033|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428155|NCT01597245|615909034|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428156|NCT01597245|615909035|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428157|NCT01597245|615909036|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428158|NCT01597245|615909037|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428159|NCT01597245|615909038|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428160|NCT01597245|615909039|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
170428161|NCT01597245|615909019|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
170428162|NCT01597245|615909020|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170534852|NCT06001866|616304152|FG000|Overall Study|Withdrawal by Subject|0|||
170534853|NCT06001866|616304153|FG001|Overall Study|Withdrawal by Subject|2|||
170534854|NCT06001866|616304152|FG000|Overall Study|Protocol Violation|0|||
170534855|NCT06001866|616304153|FG001|Overall Study|Protocol Violation|2|||
170428163|NCT01597245|615909021|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428164|NCT01597245|615909022|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
170428165|NCT01597245|615909023|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428166|NCT01597245|615909024|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428167|NCT01597245|615909025|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428168|NCT01597245|615909026|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428169|NCT01597245|615909027|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428170|NCT01597245|615909028|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428171|NCT01597245|615909029|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428172|NCT01597245|615909030|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428173|NCT01597245|615909031|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428174|NCT01597245|615909032|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428175|NCT01597245|615909033|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428176|NCT01597245|615909034|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428177|NCT01597245|615909035|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428178|NCT01597245|615909036|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428179|NCT01597245|615909037|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428180|NCT01597245|615909038|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428181|NCT01597245|615909039|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
170428182|NCT01597245|615909019|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
170428183|NCT01597245|615909020|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
170428184|NCT01597245|615909021|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
170428185|NCT01597245|615909022|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428186|NCT01597245|615909023|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428187|NCT01597245|615909024|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428188|NCT01597245|615909025|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428189|NCT01597245|615909026|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428190|NCT01597245|615909027|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428191|NCT01597245|615909028|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428192|NCT01597245|615909029|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428193|NCT01597245|615909030|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428194|NCT01597245|615909031|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428195|NCT01597245|615909032|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428196|NCT01597245|615909033|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428197|NCT01597245|615909034|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428198|NCT01597245|615909035|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428199|NCT01597245|615909036|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428200|NCT01597245|615909037|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428201|NCT01597245|615909038|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428202|NCT01597245|615909039|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
170428203|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428204|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428205|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428206|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428207|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428208|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
170428209|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
170428210|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428211|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428212|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428213|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428214|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428215|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428216|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428217|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428218|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428219|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428220|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428221|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428222|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428223|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
170428224|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428225|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170534856|NCT04703192|616304154|FG000|Overall Study|Withdrawal by Subject|2|||
170534857|NCT04703192|616304155|FG001|Overall Study|Withdrawal by Subject|0|||
170534858|NCT04703192|616304154|FG000|Overall Study|Death|3|||
170534859|NCT04703192|616304155|FG001|Overall Study|Death|1|||
170534860|NCT04703192|616304154|FG000|Overall Study|Adverse Event|13|||
170534861|NCT04703192|616304155|FG001|Overall Study|Adverse Event|2|||
170534862|NCT04703192|616304154|FG000|Overall Study|Progressive or Relapsed Disease|46|||
170534863|NCT04703192|616304155|FG001|Overall Study|Progressive or Relapsed Disease|7|||
170534864|NCT04703192|616304154|FG000|Overall Study|Clinical Progression|19|||
170534865|NCT04703192|616304155|FG001|Overall Study|Clinical Progression|8|||
170534866|NCT04703192|616304154|FG000|Overall Study|Lost to Follow-up|1|||
170534867|NCT04703192|616304155|FG001|Overall Study|Lost to Follow-up|0|||
170534868|NCT04703192|616304154|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
170534869|NCT04703192|616304155|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
170534870|NCT04703192|616304154|FG000|Overall Study|Other|5|||
170534871|NCT04703192|616304155|FG001|Overall Study|Other|1|||
170534872|NCT00207740|616304156|FG000|Overall Study|Adverse Event|4|||
170534873|NCT00207740|616304157|FG001|Overall Study|Adverse Event|14|||
170534874|NCT00207740|616304158|FG002|Overall Study|Adverse Event|14|||
170534875|NCT00207740|616304159|FG003|Overall Study|Adverse Event|11|||
170534876|NCT00207740|616304156|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170534877|NCT00207740|616304157|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170534878|NCT00207740|616304158|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
170534879|NCT00207740|616304159|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
170534880|NCT00207740|616304156|FG000|Overall Study|Lost to Follow-up|0|||
170534881|NCT00207740|616304157|FG001|Overall Study|Lost to Follow-up|2|||
170534882|NCT00207740|616304158|FG002|Overall Study|Lost to Follow-up|1|||
170534883|NCT00207740|616304159|FG003|Overall Study|Lost to Follow-up|1|||
170534884|NCT00207740|616304156|FG000|Overall Study|Death|0|||
170534885|NCT00207740|616304157|FG001|Overall Study|Death|0|||
170534886|NCT00207740|616304158|FG002|Overall Study|Death|0|||
170534887|NCT00207740|616304159|FG003|Overall Study|Death|1|||
170534888|NCT00207740|616304156|FG000|Overall Study|Sponsor Directive|22|||
170534889|NCT00207740|616304157|FG001|Overall Study|Sponsor Directive|15|||
170534890|NCT00207740|616304158|FG002|Overall Study|Sponsor Directive|16|||
170534891|NCT00207740|616304159|FG003|Overall Study|Sponsor Directive|21|||
170534892|NCT00207740|616304156|FG000|Overall Study|Other|2|||
170534893|NCT00207740|616304157|FG001|Overall Study|Other|10|||
170534894|NCT00207740|616304158|FG002|Overall Study|Other|7|||
170534895|NCT00207740|616304159|FG003|Overall Study|Other|5|||
170534896|NCT03916926|616304160|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
170534897|NCT03916926|616304161|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
170534898|NCT03916926|616304160|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
170534899|NCT03916926|616304161|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
170534900|NCT03916926|616304160|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
170534901|NCT03916926|616304161|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
170534902|NCT03916926|616304160|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
170534903|NCT03916926|616304161|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
170534904|NCT03806296|616304164|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
170534905|NCT03806296|616304165|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
170534906|NCT03806296|616304166|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
170534907|NCT03806296|616304164|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
170534908|NCT03806296|616304165|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
170534909|NCT03806296|616304166|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
170534910|NCT03806296|616304164|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
170534911|NCT03806296|616304165|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
170534912|NCT03806296|616304166|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
170534913|NCT01931098|616304169|FG000|Overall Study|Withdrawal by Subject|0|||
170534914|NCT01931098|616304170|FG001|Overall Study|Withdrawal by Subject|1|||
170534915|NCT01931098|616304169|FG000|Overall Study|Enrolled in different protocol|0|||
170534916|NCT01931098|616304170|FG001|Overall Study|Enrolled in different protocol|1|||
170534917|NCT01931098|616304169|FG000|Overall Study|Unable to begin trmt:active infection|0|||
170534918|NCT01931098|616304170|FG001|Overall Study|Unable to begin trmt:active infection|1|||
170534919|NCT01931098|616304169|FG000|Overall Study|Refused further treatment|0|||
170534920|NCT01931098|616304170|FG001|Overall Study|Refused further treatment|1|||
170534921|NCT02612155|616304171|FG000|Overall Study|Death|1|||
170534922|NCT02612155|616304172|FG001|Overall Study|Death|1|||
170534923|NCT02612155|616304171|FG000|Overall Study|Lost to Follow-up|2|||
170534924|NCT02612155|616304172|FG001|Overall Study|Lost to Follow-up|2|||
170534925|NCT05233761|616304173|FG000|Treatment Period A|Withdrawal by Subject|12|||
170534926|NCT05233761|616304174|FG001|Treatment Period A|Withdrawal by Subject|10|||
170534927|NCT05233761|616304173|FG000|Treatment Period A|Lost to Follow-up|6|||
170534928|NCT05233761|616304174|FG001|Treatment Period A|Lost to Follow-up|12|||
170534929|NCT05233761|616304173|FG000|Treatment Period A|Protocol Violation|8|||
170534930|NCT05233761|616304174|FG001|Treatment Period A|Protocol Violation|15|||
170534931|NCT04235374|616304175|FG000|Overall Study|Death|91|||
170428226|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428227|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428228|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
170428229|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
170428230|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
170428231|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
170428232|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428233|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
170428234|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428235|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428236|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428237|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428238|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428239|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428240|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428241|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428242|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428243|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428244|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
170428245|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428246|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428247|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428248|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428249|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428250|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
170428251|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428252|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428253|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
170428254|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428255|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
170428256|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
170428257|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
170428258|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428259|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428260|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428261|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428262|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428263|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428264|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428265|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
170428266|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428267|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428268|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428269|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428270|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
170428271|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
170428272|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
170428273|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
170428274|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
170428275|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
170428276|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
170428277|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
170428278|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
170428279|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428280|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428281|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428282|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428283|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428284|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428285|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170428286|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
170880092|NCT02831673|617572697|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
170880093|NCT02831673|617572698|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
170880094|NCT02831673|617572699|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
170880095|NCT02831673|617572700|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
170880096|NCT02831673|617572696|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
170534932|NCT04235374|616304176|FG001|Overall Study|Death|91|||
170428287|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428288|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428289|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428290|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428291|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
170428292|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
170428293|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
170428294|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428295|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
170428296|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
170428297|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
170428298|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
170428299|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
170428300|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428301|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428302|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428303|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428304|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428305|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428306|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428307|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
170428308|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428309|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428310|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428311|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428312|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
170428313|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428314|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428315|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428316|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
170428317|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
170428318|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
170428319|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428320|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
170428321|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428322|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428323|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428324|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428325|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428326|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428327|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428328|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
170428329|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428330|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428331|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428332|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428333|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
170428334|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
170428335|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
170428336|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428337|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
170428338|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
170428339|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
170428340|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
170428341|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
170428342|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428343|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428344|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428345|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428346|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428347|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428348|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428349|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
170428350|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428351|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428352|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428353|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428354|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428355|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
170428356|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428357|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428358|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
170428359|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
170428360|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
170428361|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
170428362|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428363|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428364|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428365|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428366|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428367|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428368|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428369|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428370|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
170428371|NCT01597245|615909019|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428372|NCT01597245|615909020|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428373|NCT01597245|615909021|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428374|NCT01597245|615909022|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428375|NCT01597245|615909023|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428376|NCT01597245|615909024|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428377|NCT01597245|615909025|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428378|NCT01597245|615909026|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428379|NCT01597245|615909027|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428380|NCT01597245|615909028|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428381|NCT01597245|615909029|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
170428382|NCT01597245|615909030|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428383|NCT01597245|615909031|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428384|NCT01597245|615909032|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428385|NCT01597245|615909033|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428386|NCT01597245|615909034|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428387|NCT01597245|615909035|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428388|NCT01597245|615909036|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428389|NCT01597245|615909037|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428390|NCT01597245|615909038|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428391|NCT01597245|615909039|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
170428392|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428393|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428394|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428395|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428396|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428397|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428398|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428399|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428400|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428401|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428402|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428403|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428404|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428405|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
170428406|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
170880097|NCT02831673|617572697|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
170880098|NCT02831673|617572698|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
170880099|NCT02831673|617572699|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
170428407|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
170428408|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170534933|NCT04235374|616304175|FG000|Overall Study|Refused|2|||
170880100|NCT02831673|617572700|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
170428409|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428410|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428411|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428412|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
170428413|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428414|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428415|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428416|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428417|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428418|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428419|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428420|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428421|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428422|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428423|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428424|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428425|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428426|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
170428427|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
170428428|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
170428429|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428430|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428431|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428432|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428433|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
170428434|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428435|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428436|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428437|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428438|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428439|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428440|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428441|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428442|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428443|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428444|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428445|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428446|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428447|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428448|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
170428449|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
170428450|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428451|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428452|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428453|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428454|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
170428455|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428456|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428457|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428458|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428459|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428460|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428461|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428462|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428463|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428464|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428465|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428466|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428467|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428468|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428469|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
170428470|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
170428471|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428472|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428473|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428474|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428475|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
170428476|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428477|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428478|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428479|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428480|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428481|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428482|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428483|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428484|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428485|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428486|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428487|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428488|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428489|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
170428490|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
170428491|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
170428492|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170880101|NCT02831673|617572696|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
170880102|NCT02831673|617572697|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
170880103|NCT02831673|617572698|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
170880104|NCT02831673|617572699|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
170880105|NCT02831673|617572700|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
170880106|NCT02831673|617572696|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
170880107|NCT02831673|617572697|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
170880108|NCT02831673|617572698|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
170880109|NCT02831673|617572699|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
170880110|NCT02831673|617572700|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
170880111|NCT02831673|617572696|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
170428493|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428494|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428495|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428496|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
170428497|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428498|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
170534934|NCT04235374|616304176|FG001|Overall Study|Refused|2|||
170534935|NCT04235374|616304175|FG000|Overall Study|Unavailable|12|||
170534936|NCT04235374|616304176|FG001|Overall Study|Unavailable|3|||
170880112|NCT02831673|617572697|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
170880113|NCT02831673|617572698|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
170880114|NCT02831673|617572699|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
170880115|NCT02831673|617572700|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
170880116|NCT02831673|617572696|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
170880117|NCT02831673|617572697|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
170880118|NCT02831673|617572698|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
170880119|NCT02831673|617572699|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
170880120|NCT02831673|617572700|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
170880121|NCT02831673|617572696|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
170880122|NCT02831673|617572697|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
170880123|NCT02831673|617572698|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
170880124|NCT02831673|617572699|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
170880125|NCT02831673|617572700|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
170880126|NCT02831673|617572696|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
170880127|NCT02831673|617572697|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
170880128|NCT02831673|617572698|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
170428499|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428500|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428501|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428502|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428503|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428504|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
170534937|NCT04235374|616304175|FG000|Overall Study|Withdrawal by Subject|0|||
170534938|NCT04235374|616304176|FG001|Overall Study|Withdrawal by Subject|1|||
170428505|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428506|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428507|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428508|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428509|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428510|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428511|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
170428512|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
170428513|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428514|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428515|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428516|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428517|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
170428518|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428519|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428520|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428521|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428522|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428523|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428524|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428525|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428526|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428527|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428528|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428529|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428530|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428531|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428532|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
170428533|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
170428534|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428535|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170534939|NCT04235374|616304175|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
170534940|NCT04235374|616304176|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
170534941|NCT04530344|616304177|FG000|Overall Study|Lost to Follow-up|3|||
170534942|NCT04530344|616304178|FG001|Overall Study|Lost to Follow-up|3|||
170534943|NCT04530344|616304179|FG002|Overall Study|Lost to Follow-up|3|||
170534944|NCT04530344|616304180|FG003|Overall Study|Lost to Follow-up|10|||
170534945|NCT04530344|616304177|FG000|Overall Study|Withdrawal by Subject|14|||
170534946|NCT04530344|616304178|FG001|Overall Study|Withdrawal by Subject|5|||
170534947|NCT04530344|616304179|FG002|Overall Study|Withdrawal by Subject|18|||
170534948|NCT04530344|616304180|FG003|Overall Study|Withdrawal by Subject|33|||
170534949|NCT04530344|616304177|FG000|Overall Study|Adverse Event|0|||
170534950|NCT04530344|616304178|FG001|Overall Study|Adverse Event|0|||
170534951|NCT04530344|616304179|FG002|Overall Study|Adverse Event|0|||
170534952|NCT04530344|616304180|FG003|Overall Study|Adverse Event|1|||
170534953|NCT04530344|616304177|FG000|Overall Study|Lack of Efficacy|0|||
170534954|NCT04530344|616304178|FG001|Overall Study|Lack of Efficacy|0|||
170534955|NCT04530344|616304179|FG002|Overall Study|Lack of Efficacy|0|||
170534956|NCT04530344|616304180|FG003|Overall Study|Lack of Efficacy|1|||
170534957|NCT04530344|616304177|FG000|Overall Study|Physician Decision|0|||
170534958|NCT04530344|616304178|FG001|Overall Study|Physician Decision|0|||
170534959|NCT04530344|616304179|FG002|Overall Study|Physician Decision|1|||
170534960|NCT04530344|616304180|FG003|Overall Study|Physician Decision|1|||
170534961|NCT04530344|616304177|FG000|Overall Study|Pregnancy|0|||
170534962|NCT04530344|616304178|FG001|Overall Study|Pregnancy|0|||
170534963|NCT04530344|616304179|FG002|Overall Study|Pregnancy|2|||
170534964|NCT04530344|616304180|FG003|Overall Study|Pregnancy|1|||
170534965|NCT04530344|616304177|FG000|Overall Study|Protocol Violation|0|||
170534966|NCT04530344|616304178|FG001|Overall Study|Protocol Violation|0|||
170534967|NCT04530344|616304179|FG002|Overall Study|Protocol Violation|0|||
170534968|NCT04530344|616304180|FG003|Overall Study|Protocol Violation|1|||
170534969|NCT04530344|616304177|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
170534970|NCT04530344|616304178|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
170534971|NCT04530344|616304179|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
170534972|NCT04530344|616304180|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
170534973|NCT04530344|616304177|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
170534974|NCT04530344|616304178|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
170534975|NCT04530344|616304179|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
170534976|NCT04530344|616304180|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
170534977|NCT04530344|616304177|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
170534978|NCT04530344|616304178|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
170428536|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428537|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428538|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
170428539|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428540|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428541|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428542|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428543|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428544|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428545|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428546|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428547|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428548|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428549|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428550|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428551|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428552|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428553|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
170428554|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
170428555|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428556|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428557|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428558|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428559|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
170428560|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428561|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428562|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428563|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428564|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428565|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428566|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428567|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428568|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428569|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428570|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428571|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428572|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428573|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428574|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
170428575|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
170428576|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428577|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428578|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428579|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428580|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
170428581|NCT01597245|615909019|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428582|NCT01597245|615909020|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428583|NCT01597245|615909021|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428584|NCT01597245|615909022|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428585|NCT01597245|615909023|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428586|NCT01597245|615909024|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428587|NCT01597245|615909025|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428588|NCT01597245|615909026|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428589|NCT01597245|615909027|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428590|NCT01597245|615909028|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428591|NCT01597245|615909029|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428592|NCT01597245|615909030|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170534979|NCT04530344|616304179|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
170534980|NCT04530344|616304180|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
170534981|NCT04530344|616304177|FG000|Overall Study|Personal Reasons|0|||
170534982|NCT04530344|616304178|FG001|Overall Study|Personal Reasons|0|||
170534983|NCT04530344|616304179|FG002|Overall Study|Personal Reasons|0|||
170534984|NCT04530344|616304180|FG003|Overall Study|Personal Reasons|1|||
170534985|NCT04530344|616304177|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
170534986|NCT04530344|616304178|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
170428593|NCT01597245|615909031|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428594|NCT01597245|615909032|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
170428595|NCT01597245|615909033|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428596|NCT01597245|615909034|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428597|NCT01597245|615909035|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428598|NCT01597245|615909036|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428599|NCT01597245|615909037|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428600|NCT01597245|615909038|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428601|NCT01597245|615909039|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
170428602|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428603|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428604|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428605|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428606|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428607|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170880129|NCT02831673|617572699|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
170880130|NCT02831673|617572700|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
170880131|NCT02831673|617572696|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
170880132|NCT02831673|617572697|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
170880133|NCT02831673|617572698|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
170880134|NCT02831673|617572699|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
170428608|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428609|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428610|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428611|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428612|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428613|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428614|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428615|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428616|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428617|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
170428618|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
170428619|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
170428620|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
170428621|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
170428622|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
170428623|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428624|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428625|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428626|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428627|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428628|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428629|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428630|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428631|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428632|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428633|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428634|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428635|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428636|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428637|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428638|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428639|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
170428640|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
170428641|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
170428642|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
170428643|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
170428644|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428645|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428646|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428647|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428648|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170880135|NCT02831673|617572700|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
170428649|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428650|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428651|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428652|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428653|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428654|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428655|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428656|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428657|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428658|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428659|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428660|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
170428661|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428662|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
170428663|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
170428664|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
170428665|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428666|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428667|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428668|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428669|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428670|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428671|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428672|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428673|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428674|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428675|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428676|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428677|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428678|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428679|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428680|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428681|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428682|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
170428683|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
170428684|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
170428685|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
170428686|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428687|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428688|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428689|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428690|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428691|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428692|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428693|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428694|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428695|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428696|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428697|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428698|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428699|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428700|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428701|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428702|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
170428703|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428704|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
170428705|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
170428706|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
170428707|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428708|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428709|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428710|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170565474|NCT01049373|616418531|FG000|Overall Study|Protocol Violation|9|||
170534987|NCT04530344|616304179|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
170534988|NCT04530344|616304180|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
170534989|NCT03314935|616304181|FG000|Phase 1|Death|4|||
170534990|NCT03314935|616304182|FG001|Phase 1|Death|2|||
170534991|NCT03314935|616304183|FG002|Phase 1|Death|5|||
170534992|NCT03314935|616304184|FG003|Phase 1|Death|4|||
170534993|NCT03314935|616304185|FG004|Phase 1|Death|3|||
170534994|NCT03314935|616304186|FG005|Phase 1|Death|4|||
170534995|NCT03314935|616304187|FG006|Phase 1|Death|5|||
170534996|NCT03314935|616304188|FG007|Phase 1|Death|4|||
170534997|NCT03314935|616304189|FG008|Phase 1|Death|3|||
170534998|NCT03314935|616304190|FG009|Phase 1|Death|0|||
170534999|NCT03314935|616304191|FG010|Phase 1|Death|0|||
170535000|NCT03314935|616304192|FG011|Phase 1|Death|0|||
170535001|NCT03314935|616304193|FG012|Phase 1|Death|0|||
170535002|NCT03314935|616304194|FG013|Phase 1|Death|0|||
170535003|NCT03314935|616304195|FG014|Phase 1|Death|0|||
170535004|NCT03314935|616304181|FG000|Phase 1|Withdrawal by Subject|2|||
170428711|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428712|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428713|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428714|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428715|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428716|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428717|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428718|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428719|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428720|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428721|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428722|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428723|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
170428724|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428725|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
170428726|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
170428727|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
170428728|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428729|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428730|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428731|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428732|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428733|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428734|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428735|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428736|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428737|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428738|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428739|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428740|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428741|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428742|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428743|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428744|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
170428745|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428746|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428747|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
170428748|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
170428749|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428750|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428751|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428752|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428753|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428754|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428755|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428756|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428757|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428758|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428759|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428760|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428761|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428762|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428763|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428764|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428765|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
170428766|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428767|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428768|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
170428769|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
170428770|NCT01597245|615909019|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428771|NCT01597245|615909020|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428772|NCT01597245|615909021|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428773|NCT01597245|615909022|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428774|NCT01597245|615909023|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428775|NCT01597245|615909024|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428776|NCT01597245|615909025|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428777|NCT01597245|615909026|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428778|NCT01597245|615909027|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428779|NCT01597245|615909028|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428780|NCT01597245|615909029|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428781|NCT01597245|615909030|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428782|NCT01597245|615909031|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428783|NCT01597245|615909032|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428784|NCT01597245|615909033|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428785|NCT01597245|615909034|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428786|NCT01597245|615909035|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428787|NCT01597245|615909036|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428788|NCT01597245|615909037|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428789|NCT01597245|615909038|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
170428790|NCT01597245|615909039|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
170428791|NCT01952691|615910558|FG000|Overall Study|Lost to Follow-up|2|||
170428792|NCT00001703|615910559|FG000|Overall Study|progressed disease|2|||
170428793|NCT00001703|615910559|FG000|Overall Study|No evidence of disease|1|||
170428794|NCT00001703|615910559|FG000|Overall Study|recurrent disease|2|||
170428795|NCT02286739|615910560|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
170428796|NCT02286739|615910561|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
170428797|NCT02286739|615910560|FG000|Overall Study|No Verasense type documented|0|||
170428798|NCT02286739|615910561|FG001|Overall Study|No Verasense type documented|23|||
170428799|NCT02286739|615910560|FG000|Overall Study|Adverse Event|1|||
170535005|NCT03314935|616304182|FG001|Phase 1|Withdrawal by Subject|1|||
170535006|NCT03314935|616304183|FG002|Phase 1|Withdrawal by Subject|1|||
170535007|NCT03314935|616304184|FG003|Phase 1|Withdrawal by Subject|2|||
170535008|NCT03314935|616304185|FG004|Phase 1|Withdrawal by Subject|1|||
170535009|NCT03314935|616304186|FG005|Phase 1|Withdrawal by Subject|0|||
170535010|NCT03314935|616304187|FG006|Phase 1|Withdrawal by Subject|1|||
170535011|NCT03314935|616304188|FG007|Phase 1|Withdrawal by Subject|0|||
170535012|NCT03314935|616304189|FG008|Phase 1|Withdrawal by Subject|1|||
170535013|NCT03314935|616304190|FG009|Phase 1|Withdrawal by Subject|0|||
170535014|NCT03314935|616304191|FG010|Phase 1|Withdrawal by Subject|0|||
170535015|NCT03314935|616304192|FG011|Phase 1|Withdrawal by Subject|0|||
170535016|NCT03314935|616304193|FG012|Phase 1|Withdrawal by Subject|0|||
170535017|NCT03314935|616304194|FG013|Phase 1|Withdrawal by Subject|0|||
170535018|NCT03314935|616304195|FG014|Phase 1|Withdrawal by Subject|0|||
170535019|NCT03314935|616304181|FG000|Phase 1|Progressive Disease|2|||
170535020|NCT03314935|616304182|FG001|Phase 1|Progressive Disease|0|||
170535021|NCT03314935|616304183|FG002|Phase 1|Progressive Disease|0|||
170535022|NCT03314935|616304184|FG003|Phase 1|Progressive Disease|1|||
170535023|NCT03314935|616304185|FG004|Phase 1|Progressive Disease|0|||
170535024|NCT03314935|616304186|FG005|Phase 1|Progressive Disease|0|||
170535025|NCT03314935|616304187|FG006|Phase 1|Progressive Disease|0|||
170535026|NCT03314935|616304188|FG007|Phase 1|Progressive Disease|0|||
170535027|NCT03314935|616304189|FG008|Phase 1|Progressive Disease|0|||
170535028|NCT03314935|616304190|FG009|Phase 1|Progressive Disease|0|||
170535029|NCT03314935|616304191|FG010|Phase 1|Progressive Disease|0|||
170535030|NCT03314935|616304192|FG011|Phase 1|Progressive Disease|0|||
170535031|NCT03314935|616304193|FG012|Phase 1|Progressive Disease|0|||
170535032|NCT03314935|616304194|FG013|Phase 1|Progressive Disease|0|||
170535033|NCT03314935|616304195|FG014|Phase 1|Progressive Disease|0|||
170535034|NCT03314935|616304181|FG000|Phase 1|Study Terminated by Sponsor|0|||
170535035|NCT03314935|616304182|FG001|Phase 1|Study Terminated by Sponsor|1|||
170535036|NCT03314935|616304183|FG002|Phase 1|Study Terminated by Sponsor|0|||
170535037|NCT03314935|616304184|FG003|Phase 1|Study Terminated by Sponsor|0|||
170535038|NCT03314935|616304185|FG004|Phase 1|Study Terminated by Sponsor|0|||
170535039|NCT03314935|616304186|FG005|Phase 1|Study Terminated by Sponsor|0|||
170428800|NCT02286739|615910561|FG001|Overall Study|Adverse Event|2|||
170428801|NCT02286739|615910560|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
170428802|NCT02286739|615910561|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
170428803|NCT03255733|615910566|FG000|Overall Study|Lost to Follow-up|4|||
170428804|NCT00594035|615910567|FG000|Overall Study|Lost to Follow-up|1|||
170535040|NCT03314935|616304187|FG006|Phase 1|Study Terminated by Sponsor|0|||
170428805|NCT00594035|615910568|FG001|Overall Study|Lost to Follow-up|1|||
170428806|NCT00594035|615910567|FG000|Overall Study|Withdrawal by Subject|1|||
170535041|NCT03314935|616304188|FG007|Phase 1|Study Terminated by Sponsor|0|||
170535042|NCT03314935|616304189|FG008|Phase 1|Study Terminated by Sponsor|1|||
170535043|NCT03314935|616304190|FG009|Phase 1|Study Terminated by Sponsor|0|||
170535044|NCT03314935|616304191|FG010|Phase 1|Study Terminated by Sponsor|0|||
170535045|NCT03314935|616304192|FG011|Phase 1|Study Terminated by Sponsor|0|||
170428807|NCT00594035|615910568|FG001|Overall Study|Withdrawal by Subject|0|||
170428808|NCT00594035|615910567|FG000|Overall Study|Subject transferred to nursing home|0|||
170428809|NCT00594035|615910568|FG001|Overall Study|Subject transferred to nursing home|1|||
170428810|NCT00594035|615910567|FG000|Overall Study|Subject couldn't return due to job|0|||
170428811|NCT00594035|615910568|FG001|Overall Study|Subject couldn't return due to job|1|||
170428812|NCT00508651|615910569|FG000|Overall Study|Lost to Follow-up|3|||
170428813|NCT00508651|615910570|FG001|Overall Study|Lost to Follow-up|1|||
170428814|NCT00508651|615910569|FG000|Overall Study|Withdrawal by Subject|1|||
170428815|NCT00508651|615910570|FG001|Overall Study|Withdrawal by Subject|1|||
170428816|NCT02533258|615910571|FG000|Overall Study|Adverse Event|1|||
170428817|NCT02533258|615910571|FG000|Overall Study|Death|2|||
170428818|NCT02533258|615910571|FG000|Overall Study|Other|1|||
170428819|NCT02533258|615910571|FG000|Overall Study|Economic factor|1|||
170428820|NCT02533258|615910571|FG000|Overall Study|Progression of pleural effusion|1|||
170428821|NCT02533258|615910571|FG000|Overall Study|Lack of Efficacy|2|||
170428822|NCT03032172|615910572|FG000|Treatment Period|Adverse Event|0|||
170428823|NCT03032172|615910573|FG001|Treatment Period|Adverse Event|1|||
170428824|NCT03032172|615910574|FG002|Treatment Period|Adverse Event|0|||
170428825|NCT03032172|615910575|FG003|Treatment Period|Adverse Event|0|||
170428826|NCT03032172|615910576|FG004|Treatment Period|Adverse Event|0|||
170428827|NCT03032172|615910577|FG005|Treatment Period|Adverse Event|0|||
170428828|NCT03032172|615910578|FG006|Treatment Period|Adverse Event|0|||
170428829|NCT03032172|615910579|FG007|Treatment Period|Adverse Event|0|||
170428830|NCT03032172|615910572|FG000|Treatment Period|Lack of Efficacy|0|||
170428831|NCT03032172|615910573|FG001|Treatment Period|Lack of Efficacy|1|||
170428832|NCT03032172|615910574|FG002|Treatment Period|Lack of Efficacy|0|||
170428833|NCT03032172|615910575|FG003|Treatment Period|Lack of Efficacy|0|||
170428834|NCT03032172|615910576|FG004|Treatment Period|Lack of Efficacy|0|||
170428835|NCT03032172|615910577|FG005|Treatment Period|Lack of Efficacy|0|||
170428836|NCT03032172|615910578|FG006|Treatment Period|Lack of Efficacy|0|||
170428837|NCT03032172|615910579|FG007|Treatment Period|Lack of Efficacy|0|||
170428838|NCT03032172|615910572|FG000|Treatment Period|Non-compliance With Study Drug|0|||
170428839|NCT03032172|615910573|FG001|Treatment Period|Non-compliance With Study Drug|1|||
170428840|NCT03032172|615910574|FG002|Treatment Period|Non-compliance With Study Drug|0|||
170428841|NCT03032172|615910575|FG003|Treatment Period|Non-compliance With Study Drug|0|||
170428842|NCT03032172|615910576|FG004|Treatment Period|Non-compliance With Study Drug|0|||
170428843|NCT03032172|615910577|FG005|Treatment Period|Non-compliance With Study Drug|0|||
170428844|NCT03032172|615910578|FG006|Treatment Period|Non-compliance With Study Drug|0|||
170428845|NCT03032172|615910579|FG007|Treatment Period|Non-compliance With Study Drug|0|||
170428846|NCT03032172|615910572|FG000|Treatment Period|Reason Not Specified|0|||
170428847|NCT03032172|615910573|FG001|Treatment Period|Reason Not Specified|4|||
170428848|NCT03032172|615910574|FG002|Treatment Period|Reason Not Specified|1|||
170428849|NCT03032172|615910575|FG003|Treatment Period|Reason Not Specified|0|||
170428850|NCT03032172|615910576|FG004|Treatment Period|Reason Not Specified|0|||
170428851|NCT03032172|615910577|FG005|Treatment Period|Reason Not Specified|0|||
170428852|NCT03032172|615910578|FG006|Treatment Period|Reason Not Specified|0|||
170428853|NCT03032172|615910579|FG007|Treatment Period|Reason Not Specified|0|||
170428854|NCT03032172|615910572|FG000|Treatment Period|Physician Decision|0|||
170428855|NCT03032172|615910573|FG001|Treatment Period|Physician Decision|2|||
170428856|NCT03032172|615910574|FG002|Treatment Period|Physician Decision|1|||
170428857|NCT03032172|615910575|FG003|Treatment Period|Physician Decision|0|||
170428858|NCT03032172|615910576|FG004|Treatment Period|Physician Decision|0|||
170428859|NCT03032172|615910577|FG005|Treatment Period|Physician Decision|0|||
170428860|NCT03032172|615910578|FG006|Treatment Period|Physician Decision|0|||
170428861|NCT03032172|615910579|FG007|Treatment Period|Physician Decision|0|||
170428862|NCT03032172|615910572|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
170428863|NCT03032172|615910573|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
170428864|NCT03032172|615910574|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
170428865|NCT03032172|615910575|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
170428866|NCT03032172|615910576|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
170428867|NCT03032172|615910577|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
170428868|NCT03032172|615910578|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
170535046|NCT03314935|616304193|FG012|Phase 1|Study Terminated by Sponsor|0|||
170428869|NCT03032172|615910579|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
170428870|NCT03032172|615910572|FG000|Treatment Period|Withdrawal by Subject|2|||
170428871|NCT03032172|615910573|FG001|Treatment Period|Withdrawal by Subject|0|||
170428872|NCT03032172|615910574|FG002|Treatment Period|Withdrawal by Subject|3|||
170535047|NCT03314935|616304194|FG013|Phase 1|Study Terminated by Sponsor|0|||
170428873|NCT03032172|615910575|FG003|Treatment Period|Withdrawal by Subject|0|||
170428874|NCT03032172|615910576|FG004|Treatment Period|Withdrawal by Subject|0|||
170428875|NCT03032172|615910577|FG005|Treatment Period|Withdrawal by Subject|0|||
170428876|NCT03032172|615910578|FG006|Treatment Period|Withdrawal by Subject|0|||
170428877|NCT03032172|615910579|FG007|Treatment Period|Withdrawal by Subject|0|||
170428878|NCT03032172|615910572|FG000|Open-label Extension Period|Death|0|||
170428879|NCT03032172|615910573|FG001|Open-label Extension Period|Death|0|||
170428880|NCT03032172|615910574|FG002|Open-label Extension Period|Death|0|||
170428881|NCT03032172|615910575|FG003|Open-label Extension Period|Death|0|||
170428882|NCT03032172|615910576|FG004|Open-label Extension Period|Death|0|||
170428883|NCT03032172|615910577|FG005|Open-label Extension Period|Death|0|||
170428884|NCT03032172|615910578|FG006|Open-label Extension Period|Death|0|||
170428885|NCT03032172|615910579|FG007|Open-label Extension Period|Death|2|||
170428886|NCT03032172|615910572|FG000|Open-label Extension Period|Reason Not Specified|0|||
170428887|NCT03032172|615910573|FG001|Open-label Extension Period|Reason Not Specified|0|||
170428888|NCT03032172|615910574|FG002|Open-label Extension Period|Reason Not Specified|0|||
170428889|NCT03032172|615910575|FG003|Open-label Extension Period|Reason Not Specified|0|||
170428890|NCT03032172|615910576|FG004|Open-label Extension Period|Reason Not Specified|0|||
170428891|NCT03032172|615910577|FG005|Open-label Extension Period|Reason Not Specified|5|||
170428892|NCT03032172|615910578|FG006|Open-label Extension Period|Reason Not Specified|3|||
170428893|NCT03032172|615910579|FG007|Open-label Extension Period|Reason Not Specified|0|||
170428894|NCT03032172|615910572|FG000|Open-label Extension Period|Pregnancy|0|||
170428895|NCT03032172|615910573|FG001|Open-label Extension Period|Pregnancy|0|||
170428896|NCT03032172|615910574|FG002|Open-label Extension Period|Pregnancy|0|||
170428897|NCT03032172|615910575|FG003|Open-label Extension Period|Pregnancy|0|||
170428898|NCT03032172|615910576|FG004|Open-label Extension Period|Pregnancy|0|||
170428899|NCT03032172|615910577|FG005|Open-label Extension Period|Pregnancy|0|||
170428900|NCT03032172|615910578|FG006|Open-label Extension Period|Pregnancy|1|||
170428901|NCT03032172|615910579|FG007|Open-label Extension Period|Pregnancy|0|||
170428902|NCT03032172|615910572|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
170428903|NCT03032172|615910573|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
170428904|NCT03032172|615910574|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
170428905|NCT03032172|615910575|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
170535048|NCT03314935|616304195|FG014|Phase 1|Study Terminated by Sponsor|0|||
170535049|NCT03314935|616304181|FG000|Phase 1|"Captured as Other in Database"|0|||
170535050|NCT03314935|616304182|FG001|Phase 1|"Captured as Other in Database"|2|||
170535051|NCT03314935|616304183|FG002|Phase 1|"Captured as Other in Database"|0|||
170428906|NCT03032172|615910576|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
170535052|NCT03314935|616304184|FG003|Phase 1|"Captured as Other in Database"|0|||
170535053|NCT03314935|616304185|FG004|Phase 1|"Captured as Other in Database"|0|||
170535054|NCT03314935|616304186|FG005|Phase 1|"Captured as Other in Database"|0|||
170535055|NCT03314935|616304187|FG006|Phase 1|"Captured as Other in Database"|1|||
170535056|NCT03314935|616304188|FG007|Phase 1|"Captured as Other in Database"|1|||
170535057|NCT03314935|616304189|FG008|Phase 1|"Captured as Other in Database"|1|||
170535058|NCT03314935|616304190|FG009|Phase 1|"Captured as Other in Database"|0|||
170535059|NCT03314935|616304191|FG010|Phase 1|"Captured as Other in Database"|0|||
170535060|NCT03314935|616304192|FG011|Phase 1|"Captured as Other in Database"|0|||
170535061|NCT03314935|616304193|FG012|Phase 1|"Captured as Other in Database"|0|||
170535062|NCT03314935|616304194|FG013|Phase 1|"Captured as Other in Database"|0|||
170535063|NCT03314935|616304195|FG014|Phase 1|"Captured as Other in Database"|0|||
170535064|NCT03314935|616304181|FG000|Phase 1|Lost to Follow-up|0|||
170535065|NCT03314935|616304182|FG001|Phase 1|Lost to Follow-up|0|||
170535066|NCT03314935|616304183|FG002|Phase 1|Lost to Follow-up|0|||
170535067|NCT03314935|616304184|FG003|Phase 1|Lost to Follow-up|0|||
170535068|NCT03314935|616304185|FG004|Phase 1|Lost to Follow-up|0|||
170535069|NCT03314935|616304186|FG005|Phase 1|Lost to Follow-up|0|||
170535070|NCT03314935|616304187|FG006|Phase 1|Lost to Follow-up|0|||
170535071|NCT03314935|616304188|FG007|Phase 1|Lost to Follow-up|0|||
170535072|NCT03314935|616304189|FG008|Phase 1|Lost to Follow-up|1|||
170535073|NCT03314935|616304190|FG009|Phase 1|Lost to Follow-up|0|||
170535074|NCT03314935|616304191|FG010|Phase 1|Lost to Follow-up|0|||
170535075|NCT03314935|616304192|FG011|Phase 1|Lost to Follow-up|0|||
170535076|NCT03314935|616304193|FG012|Phase 1|Lost to Follow-up|0|||
170428907|NCT03032172|615910577|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
170428908|NCT03032172|615910578|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
170535077|NCT03314935|616304194|FG013|Phase 1|Lost to Follow-up|0|||
170428909|NCT03032172|615910579|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
170428910|NCT06144424|615910580|FG000|Overall Study|Withdrawal by Subject|2|||
170535078|NCT03314935|616304195|FG014|Phase 1|Lost to Follow-up|0|||
170535079|NCT03314935|616304181|FG000|Phase 2|Death|0|||
170535080|NCT03314935|616304182|FG001|Phase 2|Death|0|||
170535081|NCT03314935|616304183|FG002|Phase 2|Death|0|||
170535082|NCT03314935|616304184|FG003|Phase 2|Death|0|||
170428911|NCT06144424|615910581|FG001|Overall Study|Withdrawal by Subject|0|||
170428912|NCT06144424|615910580|FG000|Overall Study|Incarceration|1|||
170428913|NCT06144424|615910581|FG001|Overall Study|Incarceration|0|||
170428914|NCT02301975|615910582|FG000|Overall Study|Adverse Event|8|||
170535083|NCT03314935|616304185|FG004|Phase 2|Death|0|||
170428915|NCT02301975|615910583|FG001|Overall Study|Adverse Event|3|||
170428916|NCT02301975|615910584|FG002|Overall Study|Adverse Event|2|||
170535084|NCT03314935|616304186|FG005|Phase 2|Death|0|||
170535085|NCT03314935|616304187|FG006|Phase 2|Death|0|||
170535086|NCT03314935|616304188|FG007|Phase 2|Death|0|||
170535087|NCT03314935|616304189|FG008|Phase 2|Death|0|||
170535088|NCT03314935|616304190|FG009|Phase 2|Death|5|||
170535089|NCT03314935|616304191|FG010|Phase 2|Death|20|||
170535090|NCT03314935|616304192|FG011|Phase 2|Death|6|||
170535091|NCT03314935|616304193|FG012|Phase 2|Death|7|||
170535092|NCT03314935|616304194|FG013|Phase 2|Death|6|||
170535093|NCT03314935|616304195|FG014|Phase 2|Death|17|||
170535094|NCT03314935|616304181|FG000|Phase 2|Withdrawal by Subject|0|||
170535095|NCT03314935|616304182|FG001|Phase 2|Withdrawal by Subject|0|||
170535096|NCT03314935|616304183|FG002|Phase 2|Withdrawal by Subject|0|||
170535097|NCT03314935|616304184|FG003|Phase 2|Withdrawal by Subject|0|||
170535098|NCT03314935|616304185|FG004|Phase 2|Withdrawal by Subject|0|||
170535099|NCT03314935|616304186|FG005|Phase 2|Withdrawal by Subject|0|||
170535100|NCT03314935|616304187|FG006|Phase 2|Withdrawal by Subject|0|||
170535101|NCT03314935|616304188|FG007|Phase 2|Withdrawal by Subject|0|||
170535102|NCT03314935|616304189|FG008|Phase 2|Withdrawal by Subject|0|||
170535103|NCT03314935|616304190|FG009|Phase 2|Withdrawal by Subject|1|||
170535104|NCT03314935|616304191|FG010|Phase 2|Withdrawal by Subject|4|||
170535105|NCT03314935|616304192|FG011|Phase 2|Withdrawal by Subject|0|||
170535106|NCT03314935|616304193|FG012|Phase 2|Withdrawal by Subject|1|||
170535107|NCT03314935|616304194|FG013|Phase 2|Withdrawal by Subject|0|||
170535108|NCT03314935|616304195|FG014|Phase 2|Withdrawal by Subject|1|||
170535109|NCT03314935|616304181|FG000|Phase 2|Progressive Disease|0|||
170535110|NCT03314935|616304182|FG001|Phase 2|Progressive Disease|0|||
170535111|NCT03314935|616304183|FG002|Phase 2|Progressive Disease|0|||
170535112|NCT03314935|616304184|FG003|Phase 2|Progressive Disease|0|||
170535113|NCT03314935|616304185|FG004|Phase 2|Progressive Disease|0|||
170535114|NCT03314935|616304186|FG005|Phase 2|Progressive Disease|0|||
170535115|NCT03314935|616304187|FG006|Phase 2|Progressive Disease|0|||
170535116|NCT03314935|616304188|FG007|Phase 2|Progressive Disease|0|||
170535117|NCT03314935|616304189|FG008|Phase 2|Progressive Disease|0|||
170535118|NCT03314935|616304190|FG009|Phase 2|Progressive Disease|1|||
170535119|NCT03314935|616304191|FG010|Phase 2|Progressive Disease|1|||
170535120|NCT03314935|616304192|FG011|Phase 2|Progressive Disease|1|||
170535121|NCT03314935|616304193|FG012|Phase 2|Progressive Disease|2|||
170535122|NCT03314935|616304194|FG013|Phase 2|Progressive Disease|0|||
170535123|NCT03314935|616304195|FG014|Phase 2|Progressive Disease|1|||
170535124|NCT03314935|616304181|FG000|Phase 2|Study Terminated by Sponsor|0|||
170535125|NCT03314935|616304182|FG001|Phase 2|Study Terminated by Sponsor|0|||
170535126|NCT03314935|616304183|FG002|Phase 2|Study Terminated by Sponsor|0|||
170535127|NCT03314935|616304184|FG003|Phase 2|Study Terminated by Sponsor|0|||
170535128|NCT03314935|616304185|FG004|Phase 2|Study Terminated by Sponsor|0|||
170535129|NCT03314935|616304186|FG005|Phase 2|Study Terminated by Sponsor|0|||
170535130|NCT03314935|616304187|FG006|Phase 2|Study Terminated by Sponsor|0|||
170535131|NCT03314935|616304188|FG007|Phase 2|Study Terminated by Sponsor|0|||
170535132|NCT03314935|616304189|FG008|Phase 2|Study Terminated by Sponsor|0|||
170535133|NCT03314935|616304190|FG009|Phase 2|Study Terminated by Sponsor|0|||
170535134|NCT03314935|616304191|FG010|Phase 2|Study Terminated by Sponsor|7|||
170535135|NCT03314935|616304192|FG011|Phase 2|Study Terminated by Sponsor|2|||
170535136|NCT03314935|616304193|FG012|Phase 2|Study Terminated by Sponsor|1|||
170535137|NCT03314935|616304194|FG013|Phase 2|Study Terminated by Sponsor|4|||
170535138|NCT03314935|616304195|FG014|Phase 2|Study Terminated by Sponsor|4|||
170535139|NCT03314935|616304181|FG000|Phase 2|Lost to Follow-up|0|||
170535140|NCT03314935|616304182|FG001|Phase 2|Lost to Follow-up|0|||
170535141|NCT03314935|616304183|FG002|Phase 2|Lost to Follow-up|0|||
170535142|NCT03314935|616304184|FG003|Phase 2|Lost to Follow-up|0|||
170535143|NCT03314935|616304185|FG004|Phase 2|Lost to Follow-up|0|||
170535144|NCT03314935|616304186|FG005|Phase 2|Lost to Follow-up|0|||
170535145|NCT03314935|616304187|FG006|Phase 2|Lost to Follow-up|0|||
170535146|NCT03314935|616304188|FG007|Phase 2|Lost to Follow-up|0|||
170535147|NCT03314935|616304189|FG008|Phase 2|Lost to Follow-up|0|||
170535148|NCT03314935|616304190|FG009|Phase 2|Lost to Follow-up|1|||
170535149|NCT03314935|616304191|FG010|Phase 2|Lost to Follow-up|0|||
170535150|NCT03314935|616304192|FG011|Phase 2|Lost to Follow-up|0|||
170535151|NCT03314935|616304193|FG012|Phase 2|Lost to Follow-up|0|||
170535152|NCT03314935|616304194|FG013|Phase 2|Lost to Follow-up|0|||
170535153|NCT03314935|616304195|FG014|Phase 2|Lost to Follow-up|1|||
170535154|NCT03314935|616304181|FG000|Phase 2|Physician Decision|0|||
170535155|NCT03314935|616304182|FG001|Phase 2|Physician Decision|0|||
170535156|NCT03314935|616304183|FG002|Phase 2|Physician Decision|0|||
170535157|NCT03314935|616304184|FG003|Phase 2|Physician Decision|0|||
170535158|NCT03314935|616304185|FG004|Phase 2|Physician Decision|0|||
170535159|NCT03314935|616304186|FG005|Phase 2|Physician Decision|0|||
170535160|NCT03314935|616304187|FG006|Phase 2|Physician Decision|0|||
170535161|NCT03314935|616304188|FG007|Phase 2|Physician Decision|0|||
170535162|NCT03314935|616304189|FG008|Phase 2|Physician Decision|0|||
170535163|NCT03314935|616304190|FG009|Phase 2|Physician Decision|0|||
170535164|NCT03314935|616304191|FG010|Phase 2|Physician Decision|1|||
170535165|NCT03314935|616304192|FG011|Phase 2|Physician Decision|0|||
170535166|NCT03314935|616304193|FG012|Phase 2|Physician Decision|0|||
170535167|NCT03314935|616304194|FG013|Phase 2|Physician Decision|0|||
170535168|NCT03314935|616304195|FG014|Phase 2|Physician Decision|0|||
170535169|NCT05252702|616304196|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
170535170|NCT05252702|616304196|FG000|Overall Study|Death|16|||
170535171|NCT05252702|616304196|FG000|Overall Study|System explant|5|||
170535172|NCT05252702|616304196|FG000|Overall Study|Lost to Follow-up|1|||
170535173|NCT05252702|616304196|FG000|Overall Study|Withdrawn by investigator|1|||
170535174|NCT05252702|616304196|FG000|Overall Study|Visit not due|306|||
170428917|NCT02301975|615910582|FG000|Overall Study|Lack of Efficacy|1|||
170428918|NCT02301975|615910583|FG001|Overall Study|Lack of Efficacy|1|||
170428919|NCT02301975|615910584|FG002|Overall Study|Lack of Efficacy|1|||
170428920|NCT02301975|615910582|FG000|Overall Study|Protocol Violation|3|||
170428921|NCT02301975|615910583|FG001|Overall Study|Protocol Violation|5|||
170428922|NCT02301975|615910584|FG002|Overall Study|Protocol Violation|3|||
170428923|NCT02301975|615910582|FG000|Overall Study|Lost to Follow-up|0|||
170428924|NCT02301975|615910583|FG001|Overall Study|Lost to Follow-up|2|||
170428925|NCT02301975|615910584|FG002|Overall Study|Lost to Follow-up|2|||
170428926|NCT02301975|615910582|FG000|Overall Study|Physician Decision|4|||
170428927|NCT02301975|615910583|FG001|Overall Study|Physician Decision|2|||
170428928|NCT02301975|615910584|FG002|Overall Study|Physician Decision|3|||
170428929|NCT02301975|615910582|FG000|Overall Study|Withdrawal by Subject|15|||
170428930|NCT02301975|615910583|FG001|Overall Study|Withdrawal by Subject|12|||
170428931|NCT02301975|615910584|FG002|Overall Study|Withdrawal by Subject|11|||
170428932|NCT02149420|615910585|FG000|Core Study|Administrative problems|0|||
170428933|NCT02149420|615910586|FG001|Core Study|Administrative problems|1|||
170428934|NCT02149420|615910587|FG002|Core Study|Administrative problems|2|||
170428935|NCT02149420|615910585|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
170428936|NCT02149420|615910586|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
170428937|NCT02149420|615910587|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
170428938|NCT04278560|615910588|FG000|Overall Study|Adverse Event|1|||
170428939|NCT04278560|615910589|FG001|Overall Study|Adverse Event|2|||
170428940|NCT04278560|615910588|FG000|Overall Study|Withdrawal by Subject|0|||
170428941|NCT04278560|615910589|FG001|Overall Study|Withdrawal by Subject|1|||
170428942|NCT03570749|615910590|FG000|Overall Study|Ongoing|26|||
170535175|NCT05252702|616304196|FG000|Overall Study|Visit within window but not completed|92|||
170428943|NCT03570749|615910591|FG001|Overall Study|Ongoing|25|||
170428944|NCT03570749|615910592|FG002|Overall Study|Ongoing|25|||
170428945|NCT03570749|615910593|FG003|Overall Study|Ongoing|26|||
170535176|NCT05252702|616304196|FG000|Overall Study|Unsuccessful implant|1|||
170880136|NCT02831673|617572696|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
170880137|NCT02831673|617572697|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
170880138|NCT02831673|617572698|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
170880139|NCT02831673|617572699|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
170880140|NCT02831673|617572700|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
170880141|NCT02831673|617572696|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
170428946|NCT03570749|615910594|FG004|Overall Study|Ongoing|140|||
170428947|NCT03570749|615910595|FG005|Overall Study|Ongoing|142|||
170428948|NCT03570749|615910596|FG006|Overall Study|Ongoing|220|||
170428949|NCT03570749|615910590|FG000|Overall Study|Adverse Event|0|||
170428950|NCT03570749|615910591|FG001|Overall Study|Adverse Event|0|||
170428951|NCT03570749|615910592|FG002|Overall Study|Adverse Event|0|||
170428952|NCT03570749|615910593|FG003|Overall Study|Adverse Event|0|||
170428953|NCT03570749|615910594|FG004|Overall Study|Adverse Event|2|||
170428954|NCT03570749|615910595|FG005|Overall Study|Adverse Event|3|||
170428955|NCT03570749|615910596|FG006|Overall Study|Adverse Event|6|||
170428956|NCT03570749|615910590|FG000|Overall Study|Lack of Efficacy|0|||
170428957|NCT03570749|615910591|FG001|Overall Study|Lack of Efficacy|0|||
170428958|NCT03570749|615910592|FG002|Overall Study|Lack of Efficacy|0|||
170428959|NCT03570749|615910593|FG003|Overall Study|Lack of Efficacy|0|||
170428960|NCT03570749|615910594|FG004|Overall Study|Lack of Efficacy|8|||
170428961|NCT03570749|615910595|FG005|Overall Study|Lack of Efficacy|2|||
170428962|NCT03570749|615910596|FG006|Overall Study|Lack of Efficacy|7|||
170428963|NCT03570749|615910590|FG000|Overall Study|Lost to Follow-up|0|||
170428964|NCT03570749|615910591|FG001|Overall Study|Lost to Follow-up|0|||
170428965|NCT03570749|615910592|FG002|Overall Study|Lost to Follow-up|0|||
170428966|NCT03570749|615910593|FG003|Overall Study|Lost to Follow-up|0|||
170428967|NCT03570749|615910594|FG004|Overall Study|Lost to Follow-up|5|||
170428968|NCT03570749|615910595|FG005|Overall Study|Lost to Follow-up|10|||
170428969|NCT03570749|615910596|FG006|Overall Study|Lost to Follow-up|10|||
170428970|NCT03570749|615910590|FG000|Overall Study|Pregnancy|0|||
170428971|NCT03570749|615910591|FG001|Overall Study|Pregnancy|0|||
170428972|NCT03570749|615910592|FG002|Overall Study|Pregnancy|0|||
170428973|NCT03570749|615910593|FG003|Overall Study|Pregnancy|0|||
170428974|NCT03570749|615910594|FG004|Overall Study|Pregnancy|0|||
170428975|NCT03570749|615910595|FG005|Overall Study|Pregnancy|1|||
170428976|NCT03570749|615910596|FG006|Overall Study|Pregnancy|1|||
170428977|NCT03570749|615910590|FG000|Overall Study|Screen Fail|0|||
170428978|NCT03570749|615910591|FG001|Overall Study|Screen Fail|0|||
170428979|NCT03570749|615910592|FG002|Overall Study|Screen Fail|0|||
170428980|NCT03570749|615910593|FG003|Overall Study|Screen Fail|0|||
170428981|NCT03570749|615910594|FG004|Overall Study|Screen Fail|0|||
170428982|NCT03570749|615910595|FG005|Overall Study|Screen Fail|0|||
170428983|NCT03570749|615910596|FG006|Overall Study|Screen Fail|1|||
170428984|NCT03570749|615910590|FG000|Overall Study|Withdrawal by Subject|2|||
170428985|NCT03570749|615910591|FG001|Overall Study|Withdrawal by Subject|3|||
170428986|NCT03570749|615910592|FG002|Overall Study|Withdrawal by Subject|2|||
170428987|NCT03570749|615910593|FG003|Overall Study|Withdrawal by Subject|1|||
170428988|NCT03570749|615910594|FG004|Overall Study|Withdrawal by Subject|17|||
170428989|NCT03570749|615910595|FG005|Overall Study|Withdrawal by Subject|12|||
170428990|NCT03570749|615910596|FG006|Overall Study|Withdrawal by Subject|15|||
170428991|NCT03570749|615910590|FG000|Overall Study|Other|0|||
170428992|NCT03570749|615910591|FG001|Overall Study|Other|0|||
170428993|NCT03570749|615910592|FG002|Overall Study|Other|0|||
170428994|NCT03570749|615910593|FG003|Overall Study|Other|0|||
170428995|NCT03570749|615910594|FG004|Overall Study|Other|17|||
170428996|NCT03570749|615910595|FG005|Overall Study|Other|14|||
170428997|NCT03570749|615910596|FG006|Overall Study|Other|21|||
170428998|NCT00561015|615910597|FG000|Overall Study|Adverse Event|0|||
170428999|NCT00561015|615910598|FG001|Overall Study|Adverse Event|0|||
170429000|NCT00561015|615910599|FG002|Overall Study|Adverse Event|0|||
170429001|NCT00561015|615910600|FG003|Overall Study|Adverse Event|0|||
170429002|NCT00561015|615910601|FG004|Overall Study|Adverse Event|1|||
170429003|NCT00561015|615910602|FG005|Overall Study|Adverse Event|0|||
170429004|NCT00561015|615910597|FG000|Overall Study|Lost to Follow-up|2|||
170429005|NCT00561015|615910598|FG001|Overall Study|Lost to Follow-up|0|||
170429006|NCT00561015|615910599|FG002|Overall Study|Lost to Follow-up|0|||
170429007|NCT00561015|615910600|FG003|Overall Study|Lost to Follow-up|1|||
170429008|NCT00561015|615910601|FG004|Overall Study|Lost to Follow-up|0|||
170429009|NCT00561015|615910602|FG005|Overall Study|Lost to Follow-up|3|||
170429010|NCT00561015|615910597|FG000|Overall Study|Participant non-compliance|2|||
170429011|NCT00561015|615910598|FG001|Overall Study|Participant non-compliance|0|||
170429012|NCT00561015|615910599|FG002|Overall Study|Participant non-compliance|0|||
170429013|NCT00561015|615910600|FG003|Overall Study|Participant non-compliance|0|||
170429014|NCT00561015|615910601|FG004|Overall Study|Participant non-compliance|0|||
170429015|NCT00561015|615910602|FG005|Overall Study|Participant non-compliance|0|||
170429016|NCT00163657|615910603|FG000|Overall Study|Death|12|||
170429017|NCT00163657|615910604|FG001|Overall Study|Death|14|||
170429018|NCT00163657|615910605|FG002|Overall Study|Death|19|||
170429019|NCT00163657|615910603|FG000|Overall Study|graft loss|4|||
170429020|NCT00163657|615910604|FG001|Overall Study|graft loss|1|||
170429021|NCT00163657|615910605|FG002|Overall Study|graft loss|2|||
170429022|NCT00163657|615910603|FG000|Overall Study|Withdrawal by Subject|2|||
170429023|NCT00163657|615910604|FG001|Overall Study|Withdrawal by Subject|3|||
170429024|NCT00163657|615910605|FG002|Overall Study|Withdrawal by Subject|2|||
170429025|NCT00163657|615910603|FG000|Overall Study|Physician Decision|0|||
170429026|NCT00163657|615910604|FG001|Overall Study|Physician Decision|1|||
170429027|NCT00163657|615910605|FG002|Overall Study|Physician Decision|1|||
170429028|NCT00163657|615910603|FG000|Overall Study|Non Compliance|1|||
170429029|NCT00163657|615910604|FG001|Overall Study|Non Compliance|0|||
170429030|NCT00163657|615910605|FG002|Overall Study|Non Compliance|0|||
170429031|NCT00163657|615910603|FG000|Overall Study|Lost to Follow-up|1|||
170429032|NCT00163657|615910604|FG001|Overall Study|Lost to Follow-up|3|||
170429033|NCT00163657|615910605|FG002|Overall Study|Lost to Follow-up|10|||
170429034|NCT00163657|615910603|FG000|Overall Study|Other reason|0|||
170429035|NCT00163657|615910604|FG001|Overall Study|Other reason|1|||
170429036|NCT00163657|615910605|FG002|Overall Study|Other reason|3|||
170429037|NCT01319383|615910606|FG000|Overall Study|No ex vivo or in vivo response|4|||
170429038|NCT01319383|615910607|FG001|Overall Study|No ex vivo or in vivo response|0|||
170429039|NCT01319383|615910606|FG000|Overall Study|Physician Decision|3|||
170429040|NCT01319383|615910607|FG001|Overall Study|Physician Decision|0|||
170429041|NCT01319383|615910606|FG000|Overall Study|Lack of Efficacy|5|||
170429042|NCT01319383|615910607|FG001|Overall Study|Lack of Efficacy|9|||
170429043|NCT01319383|615910606|FG000|Overall Study|No in vivo response to interval doses|0|||
170429044|NCT01319383|615910607|FG001|Overall Study|No in vivo response to interval doses|1|||
170429045|NCT02472366|615910610|FG000|Overall Study|Lost to Follow-up|1|||
170429046|NCT02472366|615910611|FG001|Overall Study|Lost to Follow-up|0|||
170429047|NCT00968812|615910612|FG000|Overall Study|Adverse Event|30|||
170429048|NCT00968812|615910613|FG001|Overall Study|Adverse Event|46|||
170429049|NCT00968812|615910614|FG002|Overall Study|Adverse Event|33|||
170429050|NCT00968812|615910612|FG000|Overall Study|Death|2|||
170429051|NCT00968812|615910613|FG001|Overall Study|Death|2|||
170429052|NCT00968812|615910614|FG002|Overall Study|Death|1|||
170429053|NCT00968812|615910612|FG000|Overall Study|Lack of Efficacy|9|||
170429054|NCT00968812|615910613|FG001|Overall Study|Lack of Efficacy|7|||
170429055|NCT00968812|615910614|FG002|Overall Study|Lack of Efficacy|16|||
170429056|NCT00968812|615910612|FG000|Overall Study|Lost to Follow-up|17|||
170429057|NCT00968812|615910613|FG001|Overall Study|Lost to Follow-up|12|||
170429058|NCT00968812|615910614|FG002|Overall Study|Lost to Follow-up|11|||
170429059|NCT00968812|615910612|FG000|Overall Study|Physician Decision|8|||
170429060|NCT00968812|615910613|FG001|Overall Study|Physician Decision|5|||
170429061|NCT00968812|615910614|FG002|Overall Study|Physician Decision|9|||
170429062|NCT00968812|615910612|FG000|Overall Study|Protocol Violation|7|||
170429063|NCT00968812|615910613|FG001|Overall Study|Protocol Violation|4|||
170429064|NCT00968812|615910614|FG002|Overall Study|Protocol Violation|3|||
170429065|NCT00968812|615910612|FG000|Overall Study|Withdrawal by Subject|17|||
170429066|NCT00968812|615910613|FG001|Overall Study|Withdrawal by Subject|23|||
170429067|NCT00968812|615910614|FG002|Overall Study|Withdrawal by Subject|25|||
170429068|NCT00968812|615910612|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
170429069|NCT00968812|615910613|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
170429070|NCT00968812|615910614|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
170429071|NCT00968812|615910612|FG000|Overall Study|Noncompliance with study drug|4|||
170429072|NCT00968812|615910613|FG001|Overall Study|Noncompliance with study drug|1|||
170429073|NCT00968812|615910614|FG002|Overall Study|Noncompliance with study drug|6|||
170429074|NCT00968812|615910612|FG000|Overall Study|Unable to take rescue therapy|12|||
170429075|NCT00968812|615910613|FG001|Overall Study|Unable to take rescue therapy|12|||
170429076|NCT00968812|615910614|FG002|Overall Study|Unable to take rescue therapy|17|||
170429077|NCT00968812|615910612|FG000|Overall Study|Other|25|||
170429078|NCT00968812|615910613|FG001|Overall Study|Other|37|||
170429079|NCT00968812|615910614|FG002|Overall Study|Other|40|||
170429080|NCT02576938|615910615|FG000|Overall Study|Adverse Event|5|||
170429081|NCT02576938|615910616|FG001|Overall Study|Adverse Event|3|||
170429082|NCT02576938|615910617|FG002|Overall Study|Adverse Event|6|||
170429083|NCT02576938|615910615|FG000|Overall Study|Protocol Violation|1|||
170429084|NCT02576938|615910616|FG001|Overall Study|Protocol Violation|1|||
170429085|NCT02576938|615910617|FG002|Overall Study|Protocol Violation|1|||
170429086|NCT02576938|615910615|FG000|Overall Study|Withdrawal by Subject|3|||
170429087|NCT02576938|615910616|FG001|Overall Study|Withdrawal by Subject|2|||
170429088|NCT02576938|615910617|FG002|Overall Study|Withdrawal by Subject|4|||
170429089|NCT02576938|615910615|FG000|Overall Study|Lack of Efficacy|9|||
170429090|NCT02576938|615910616|FG001|Overall Study|Lack of Efficacy|4|||
170429091|NCT02576938|615910617|FG002|Overall Study|Lack of Efficacy|0|||
170429092|NCT02576938|615910615|FG000|Overall Study|Lost to Follow-up|2|||
170535177|NCT02657551|616304201|FG000|Overall Study|Adverse Event|2|||
170429093|NCT02576938|615910616|FG001|Overall Study|Lost to Follow-up|0|||
170535178|NCT02657551|616304201|FG000|Overall Study|Withdrawal by Subject|1|||
170880142|NCT02831673|617572697|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
170429094|NCT02576938|615910617|FG002|Overall Study|Lost to Follow-up|1|||
170429095|NCT02576938|615910615|FG000|Overall Study|Physician Decision|0|||
170429096|NCT02576938|615910616|FG001|Overall Study|Physician Decision|1|||
170429097|NCT02576938|615910617|FG002|Overall Study|Physician Decision|0|||
170429098|NCT02576938|615910615|FG000|Overall Study|Met Exclusion Criteria|0|||
170429099|NCT02576938|615910616|FG001|Overall Study|Met Exclusion Criteria|1|||
170429100|NCT02576938|615910617|FG002|Overall Study|Met Exclusion Criteria|0|||
170429101|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
170429102|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
170429103|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
170429104|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
170880143|NCT02831673|617572698|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
170429105|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
170429106|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
170429107|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
170429108|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
170429109|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
170429110|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
170429111|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
170429112|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
170429113|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
170429114|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
170429115|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
170429116|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
170429117|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
170429118|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
170429119|NCT01667679|615910618|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
170429120|NCT01667679|615910619|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
170429121|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
170429122|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
170429123|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
170429124|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
170429125|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
170429126|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
170429127|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
170429128|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
170880144|NCT02831673|617572699|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
170880145|NCT02831673|617572700|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
170880146|NCT02831673|617572696|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
170880147|NCT02831673|617572697|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
170880148|NCT02831673|617572698|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
170880149|NCT02831673|617572699|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
170880150|NCT02831673|617572700|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
170880151|NCT02831673|617572696|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
170880152|NCT02831673|617572697|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
170429129|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
170429130|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
170429131|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
170429132|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
170429133|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
170429134|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
170429135|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
170429136|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
170429137|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
170429138|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
170429139|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
170429140|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
170429141|NCT01667679|615910618|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
170429142|NCT01667679|615910619|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
170429143|NCT03872128|615910620|FG000|Overall Study|Dropped out before treatment|1|||
170429144|NCT03872128|615910621|FG001|Overall Study|Dropped out before treatment|0|||
170429145|NCT03872128|615910622|FG002|Overall Study|Dropped out before treatment|4|||
170429146|NCT03872128|615910620|FG000|Overall Study|Lost to Follow-up|2|||
170429147|NCT03872128|615910621|FG001|Overall Study|Lost to Follow-up|5|||
170429148|NCT03872128|615910622|FG002|Overall Study|Lost to Follow-up|8|||
170429149|NCT01788423|615910623|FG000|Overall Study|See Comments in Completed (above)|0|||
170429150|NCT01788423|615910624|FG001|Overall Study|See Comments in Completed (above)|4|||
170429151|NCT01788423|615910625|FG002|Overall Study|See Comments in Completed (above)|5|||
170429152|NCT00835263|615910626|FG000|Second Intervention|Adverse Event|1|||
170429153|NCT00835263|615910627|FG001|Second Intervention|Adverse Event|0|||
170429154|NCT03925532|615910628|FG000|Overall Study|Lost to Follow-up|1|||
170429155|NCT02258074|615910629|FG000|Overall Study|Withdrawal by Subject|1|||
170535179|NCT02657551|616304201|FG000|Overall Study|Non-Compliance|1|||
170535180|NCT02657551|616304201|FG000|Overall Study|Progression / Relapse|4|||
170535181|NCT04058717|616304202|FG000|Randomization Period|Lost to Follow-up|2|||
170535182|NCT04058717|616304203|FG001|Randomization Period|Lost to Follow-up|3|||
170535183|NCT04058717|616304204|FG002|Randomization Period|Lost to Follow-up|4|||
170429156|NCT02258074|615910630|FG001|Overall Study|Withdrawal by Subject|0|||
170429157|NCT02258074|615910631|FG002|Overall Study|Withdrawal by Subject|0|||
170535184|NCT04058717|616304205|FG003|Randomization Period|Lost to Follow-up|4|||
170429158|NCT02258074|615910632|FG003|Overall Study|Withdrawal by Subject|0|||
170429159|NCT05446870|615910633|FG000|Overall Study|Death|6|||
170429160|NCT05446870|615910634|FG001|Overall Study|Death|5|||
170429161|NCT05446870|615910633|FG000|Overall Study|Lost to Follow-up|0|||
170429162|NCT05446870|615910634|FG001|Overall Study|Lost to Follow-up|1|||
170429163|NCT05446870|615910633|FG000|Overall Study|Physician Decision|52|||
170429164|NCT05446870|615910634|FG001|Overall Study|Physician Decision|53|||
170429165|NCT05446870|615910633|FG000|Overall Study|Withdrawal by Subject|3|||
170429166|NCT05446870|615910634|FG001|Overall Study|Withdrawal by Subject|3|||
170429167|NCT05630885|615910635|FG000|Study Completion|Took prohibited medications|2|||
170429168|NCT05630885|615910636|FG001|Study Completion|Took prohibited medications|0|||
170429169|NCT05630885|615910635|FG000|Study Completion|Non-compliance with study drug|1|||
170429170|NCT05630885|615910636|FG001|Study Completion|Non-compliance with study drug|0|||
170429171|NCT05630885|615910635|FG000|Study Completion|Adverse Event|1|||
170429172|NCT05630885|615910636|FG001|Study Completion|Adverse Event|0|||
170429173|NCT05630885|615910635|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
170429174|NCT05630885|615910636|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
170429175|NCT05630885|615910635|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
170429176|NCT05630885|615910636|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
170429177|NCT02689505|615910637|FG000|Overall Study|Progressive disease|2|||
170429178|NCT02689505|615910638|FG001|Overall Study|Progressive disease|2|||
170429179|NCT02689505|615910639|FG002|Overall Study|Progressive disease|3|||
170429180|NCT02689505|615910640|FG003|Overall Study|Progressive disease|9|||
170429181|NCT02689505|615910641|FG004|Overall Study|Progressive disease|1|||
170429182|NCT02689505|615910637|FG000|Overall Study|Dose Limiting Toxicity|0|||
170429183|NCT02689505|615910638|FG001|Overall Study|Dose Limiting Toxicity|1|||
170429184|NCT02689505|615910639|FG002|Overall Study|Dose Limiting Toxicity|0|||
170429185|NCT02689505|615910640|FG003|Overall Study|Dose Limiting Toxicity|0|||
170429186|NCT02689505|615910641|FG004|Overall Study|Dose Limiting Toxicity|2|||
170429187|NCT02689505|615910637|FG000|Overall Study|Other AE or clinical progression|0|||
170429188|NCT02689505|615910638|FG001|Overall Study|Other AE or clinical progression|2|||
170429189|NCT02689505|615910639|FG002|Overall Study|Other AE or clinical progression|0|||
170429190|NCT02689505|615910640|FG003|Overall Study|Other AE or clinical progression|2|||
170429191|NCT02689505|615910641|FG004|Overall Study|Other AE or clinical progression|0|||
170429192|NCT01615198|615910642|FG000|Overall Study|Withdrawal by Subject|5|||
170429193|NCT01615198|615910643|FG001|Overall Study|Withdrawal by Subject|5|||
170429194|NCT01615198|615910642|FG000|Overall Study|Protocol deviation|1|||
170429195|NCT01615198|615910643|FG001|Overall Study|Protocol deviation|1|||
170429196|NCT01615198|615910642|FG000|Overall Study|Physician Decision|5|||
170429197|NCT01615198|615910643|FG001|Overall Study|Physician Decision|1|||
170429198|NCT01615198|615910642|FG000|Overall Study|Lost to Follow-up|1|||
170429199|NCT01615198|615910643|FG001|Overall Study|Lost to Follow-up|1|||
170429200|NCT01615198|615910642|FG000|Overall Study|Lack of Efficacy|1|||
170429201|NCT01615198|615910643|FG001|Overall Study|Lack of Efficacy|6|||
170429202|NCT01615198|615910642|FG000|Overall Study|Adverse Event|11|||
170429203|NCT01615198|615910643|FG001|Overall Study|Adverse Event|5|||
170429204|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
170429205|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
170429206|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
170429207|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
170429208|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
170429209|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
170429210|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
170429211|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
170429212|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
170429213|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
170429214|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
170535185|NCT04058717|616304202|FG000|Randomization Period|Withdrawal by Subject|1|||
170535186|NCT04058717|616304203|FG001|Randomization Period|Withdrawal by Subject|3|||
170535187|NCT04058717|616304204|FG002|Randomization Period|Withdrawal by Subject|3|||
170429215|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
170429216|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
170429217|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
170535188|NCT04058717|616304205|FG003|Randomization Period|Withdrawal by Subject|3|||
170429218|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
170429219|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
170429220|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
170429221|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
170429222|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
170429223|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
170429224|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Death|0|||
170429225|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Death|1|||
170429226|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Death|0|||
170429227|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Death|0|||
170429228|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
170429229|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
170429230|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
170429231|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
170429232|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
170429233|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
170429234|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
170429235|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
170429236|NCT01940341|615910644|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
170429237|NCT01940341|615910645|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
170429238|NCT01940341|615910646|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
170429239|NCT01940341|615910647|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
170429240|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
170429241|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
170429242|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
170429243|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
170429244|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
170429245|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
170429246|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
170429247|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
170429248|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
170429249|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
170429250|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
170429251|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
170429252|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
170429253|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
170429254|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
170429255|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
170429256|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
170429257|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
170429258|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
170429259|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
170429260|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
170429261|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
170429262|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
170429263|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
170429264|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
170429265|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
170429266|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
170429267|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
170429268|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
170429269|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
170429270|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
170429271|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
170429272|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
170429273|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
170429274|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
170429275|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
170429276|NCT01940341|615910644|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
170429277|NCT01940341|615910645|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
170429278|NCT01940341|615910646|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
170429279|NCT01940341|615910647|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
170429280|NCT02009163|615910648|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
170429281|NCT02009163|615910649|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
170429282|NCT02009163|615910650|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
170429283|NCT02009163|615910648|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
170429284|NCT02009163|615910649|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
170429285|NCT02009163|615910650|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
170429286|NCT02009163|615910648|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
170429287|NCT02009163|615910649|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
170429288|NCT02009163|615910650|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
170429289|NCT02009163|615910648|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
170429290|NCT02009163|615910649|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
170429291|NCT02009163|615910650|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
170429292|NCT02009163|615910648|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
170429293|NCT02009163|615910649|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
170429294|NCT02009163|615910650|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
170429295|NCT02009163|615910648|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
170429296|NCT02009163|615910649|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
170429297|NCT02009163|615910650|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
170429298|NCT02009163|615910648|FG000|Open-label Period (Non-randomized)|Other|13|||
170429299|NCT02009163|615910649|FG001|Open-label Period (Non-randomized)|Other|0|||
170429300|NCT02009163|615910650|FG002|Open-label Period (Non-randomized)|Other|0|||
170429301|NCT02009163|615910648|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
170429302|NCT02009163|615910649|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
170429303|NCT02009163|615910650|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
170429304|NCT02009163|615910648|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
170429305|NCT02009163|615910649|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
170429306|NCT02009163|615910650|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
170429307|NCT02009163|615910648|FG000|Randomized-withdrawal Period|Adverse Event|0|||
170429308|NCT02009163|615910649|FG001|Randomized-withdrawal Period|Adverse Event|0|||
170429309|NCT02009163|615910650|FG002|Randomized-withdrawal Period|Adverse Event|6|||
170429310|NCT02009163|615910648|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
170429311|NCT02009163|615910649|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
170429312|NCT02009163|615910650|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
170429313|NCT02009163|615910648|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
170429314|NCT02009163|615910649|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
170429315|NCT02009163|615910650|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
170429316|NCT02009163|615910648|FG000|Randomized-withdrawal Period|Pregnancy|0|||
170429317|NCT02009163|615910649|FG001|Randomized-withdrawal Period|Pregnancy|0|||
170429318|NCT02009163|615910650|FG002|Randomized-withdrawal Period|Pregnancy|2|||
170429319|NCT02009163|615910648|FG000|Randomized-withdrawal Period|Other|0|||
170429320|NCT02009163|615910649|FG001|Randomized-withdrawal Period|Other|9|||
170429321|NCT02009163|615910650|FG002|Randomized-withdrawal Period|Other|5|||
170429322|NCT01289262|615910653|FG000|Overall Study|Lost to Follow-up|29|||
170429323|NCT01289262|615910654|FG001|Overall Study|Lost to Follow-up|16|||
170429324|NCT01289262|615910653|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
170429325|NCT01289262|615910654|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
170429326|NCT01415986|615910657|FG000|Overall Study|Lost to Follow-up|1|||
170429327|NCT01854047|615910660|FG000|Overall Study|Lack of Efficacy|1|||
170429328|NCT01854047|615910661|FG001|Overall Study|Lack of Efficacy|0|||
170535189|NCT04058717|616304202|FG000|Randomization Period|PI decision|0|||
170535190|NCT04058717|616304203|FG001|Randomization Period|PI decision|1|||
170535191|NCT04058717|616304204|FG002|Randomization Period|PI decision|0|||
170429329|NCT01854047|615910662|FG002|Overall Study|Lack of Efficacy|0|||
170429330|NCT01854047|615910663|FG003|Overall Study|Lack of Efficacy|0|||
170429331|NCT01854047|615910664|FG004|Overall Study|Lack of Efficacy|0|||
170535192|NCT04058717|616304205|FG003|Randomization Period|PI decision|0|||
170535193|NCT02799602|616304206|FG000|Overall Study|Protocol Violation|1|||
170535194|NCT02799602|616304207|FG001|Overall Study|Protocol Violation|0|||
170535195|NCT02799602|616304206|FG000|Overall Study|Physician Decision|5|||
170535196|NCT02799602|616304207|FG001|Overall Study|Physician Decision|6|||
170535197|NCT02799602|616304206|FG000|Overall Study|Lost to Follow-up|4|||
170535198|NCT02799602|616304207|FG001|Overall Study|Lost to Follow-up|2|||
170535199|NCT02799602|616304206|FG000|Overall Study|Additional primary malignancy|11|||
170535200|NCT02799602|616304207|FG001|Overall Study|Additional primary malignancy|6|||
170535201|NCT02799602|616304206|FG000|Overall Study|Non-compliance with study drug|14|||
170535202|NCT02799602|616304207|FG001|Overall Study|Non-compliance with study drug|12|||
170535203|NCT02799602|616304206|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
170535204|NCT02799602|616304207|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
170535205|NCT02799602|616304206|FG000|Overall Study|Withdrawal by Subject|26|||
170429332|NCT01854047|615910660|FG000|Overall Study|Poor compliance to protocol|3|||
170429333|NCT01854047|615910661|FG001|Overall Study|Poor compliance to protocol|0|||
170429334|NCT01854047|615910662|FG002|Overall Study|Poor compliance to protocol|2|||
170429335|NCT01854047|615910663|FG003|Overall Study|Poor compliance to protocol|0|||
170429336|NCT01854047|615910664|FG004|Overall Study|Poor compliance to protocol|0|||
170429337|NCT01854047|615910660|FG000|Overall Study|Adverse Event|5|||
170429338|NCT01854047|615910661|FG001|Overall Study|Adverse Event|4|||
170429339|NCT01854047|615910662|FG002|Overall Study|Adverse Event|6|||
170429340|NCT01854047|615910663|FG003|Overall Study|Adverse Event|10|||
170535206|NCT02799602|616304207|FG001|Overall Study|Withdrawal by Subject|40|||
170535207|NCT02799602|616304206|FG000|Overall Study|Progressive disease - clinical progression|131|||
170535208|NCT02799602|616304207|FG001|Overall Study|Progressive disease - clinical progression|276|||
170632733|NCT04672239|616666761|FG000|Week 2 Survey|Failed survey check items|1|||
170429341|NCT01854047|615910664|FG004|Overall Study|Adverse Event|7|||
170429342|NCT01854047|615910660|FG000|Overall Study|Randomized but not treated|0|||
170429343|NCT01854047|615910661|FG001|Overall Study|Randomized but not treated|1|||
170429344|NCT01854047|615910662|FG002|Overall Study|Randomized but not treated|2|||
170429345|NCT01854047|615910663|FG003|Overall Study|Randomized but not treated|0|||
170429346|NCT01854047|615910664|FG004|Overall Study|Randomized but not treated|4|||
170429347|NCT01854047|615910660|FG000|Overall Study|Other than specified above|3|||
170429348|NCT01854047|615910661|FG001|Overall Study|Other than specified above|3|||
170429349|NCT01854047|615910662|FG002|Overall Study|Other than specified above|3|||
170429350|NCT01854047|615910663|FG003|Overall Study|Other than specified above|5|||
170429351|NCT01854047|615910664|FG004|Overall Study|Other than specified above|8|||
170429352|NCT03769025|615910665|FG000|Overall Study|Withdrawal by Subject|1|||
170429353|NCT03769025|615910666|FG001|Overall Study|Withdrawal by Subject|1|||
170429354|NCT03769025|615910665|FG000|Overall Study|Lost to Follow-up|4|||
170429355|NCT03769025|615910666|FG001|Overall Study|Lost to Follow-up|3|||
170429356|NCT02911701|615910669|FG000|Overall Study|Withdrawal by Subject|2|||
170429357|NCT02911701|615910670|FG001|Overall Study|Withdrawal by Subject|4|||
170880153|NCT02831673|617572698|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
170880154|NCT02831673|617572699|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
170880155|NCT02831673|617572700|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
170880156|NCT02831673|617572696|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
170429358|NCT02911701|615910669|FG000|Overall Study|Adverse Event|1|||
170429359|NCT02911701|615910670|FG001|Overall Study|Adverse Event|0|||
170429360|NCT02089997|615910673|FG000|Overall Study|Case report forms uncollected|99|||
170880157|NCT02831673|617572697|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
170880158|NCT02831673|617572698|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
170880159|NCT02831673|617572699|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
170880160|NCT02831673|617572700|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
170880161|NCT02831673|617572696|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
170880162|NCT02831673|617572697|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
170880163|NCT02831673|617572698|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
170880164|NCT02831673|617572699|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
170880165|NCT02831673|617572700|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
170880166|NCT02831673|617572696|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
170880167|NCT02831673|617572697|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
170880168|NCT02831673|617572698|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
170880169|NCT02831673|617572699|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
170880170|NCT02831673|617572700|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
170880171|NCT02831673|617572696|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
170880172|NCT02831673|617572697|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
170880173|NCT02831673|617572698|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
170880174|NCT02831673|617572699|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
170880175|NCT02831673|617572700|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
170880176|NCT02831673|617572696|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
170880177|NCT02831673|617572697|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
170880178|NCT02831673|617572698|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
170880179|NCT02831673|617572699|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
170880180|NCT02831673|617572700|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
170880181|NCT03657043|617572701|FG000|Overall Study|Withdrawal by Subject|1|||
170880182|NCT03657043|617572702|FG001|Overall Study|Withdrawal by Subject|1|||
170880183|NCT03657043|617572703|FG002|Overall Study|Withdrawal by Subject|0|||
170880184|NCT03657043|617572704|FG003|Overall Study|Withdrawal by Subject|0|||
170880185|NCT03657043|617572705|FG004|Overall Study|Withdrawal by Subject|4|||
170880186|NCT03657043|617572701|FG000|Overall Study|Study closure by Sponsor|0|||
170880187|NCT03657043|617572702|FG001|Overall Study|Study closure by Sponsor|2|||
170880188|NCT03657043|617572703|FG002|Overall Study|Study closure by Sponsor|0|||
170880189|NCT03657043|617572704|FG003|Overall Study|Study closure by Sponsor|0|||
170880190|NCT03657043|617572705|FG004|Overall Study|Study closure by Sponsor|17|||
170429361|NCT02089997|615910673|FG000|Overall Study|Protocol Violation|147|||
170429362|NCT02441309|615910674|FG000|Overall Study|Disease progression|2|||
170429363|NCT02441309|615910675|FG001|Overall Study|Disease progression|1|||
170429364|NCT02441309|615910676|FG002|Overall Study|Disease progression|2|||
170429365|NCT02441309|615910674|FG000|Overall Study|Adverse Event|0|||
170429366|NCT02441309|615910675|FG001|Overall Study|Adverse Event|1|||
170429367|NCT02441309|615910676|FG002|Overall Study|Adverse Event|0|||
170429368|NCT02441309|615910674|FG000|Overall Study|Withdrawal by Subject|1|||
170429369|NCT02441309|615910675|FG001|Overall Study|Withdrawal by Subject|0|||
170429370|NCT02441309|615910676|FG002|Overall Study|Withdrawal by Subject|1|||
170429371|NCT02281084|615910682|FG000|Overall Study|Death|21|||
170429372|NCT02281084|615910683|FG001|Overall Study|Death|18|||
170429373|NCT02281084|615910684|FG002|Overall Study|Death|3|||
170429374|NCT02281084|615910685|FG003|Overall Study|Death|5|||
170429375|NCT02281084|615910682|FG000|Overall Study|Adverse Event|1|||
170429376|NCT02281084|615910683|FG001|Overall Study|Adverse Event|0|||
170429377|NCT02281084|615910684|FG002|Overall Study|Adverse Event|0|||
170429378|NCT02281084|615910685|FG003|Overall Study|Adverse Event|0|||
170429379|NCT02281084|615910682|FG000|Overall Study|Withdrawal by Subject|2|||
170429380|NCT02281084|615910683|FG001|Overall Study|Withdrawal by Subject|2|||
170429381|NCT02281084|615910684|FG002|Overall Study|Withdrawal by Subject|0|||
170429382|NCT02281084|615910685|FG003|Overall Study|Withdrawal by Subject|0|||
170429383|NCT02281084|615910682|FG000|Overall Study|Site Closure by Sponsor|5|||
170429384|NCT02281084|615910683|FG001|Overall Study|Site Closure by Sponsor|1|||
170429385|NCT02281084|615910684|FG002|Overall Study|Site Closure by Sponsor|2|||
170429386|NCT02281084|615910685|FG003|Overall Study|Site Closure by Sponsor|0|||
170429387|NCT03290781|615910690|FG000|Overall Study|Adverse Event|5|||
170429388|NCT03290781|615910691|FG001|Overall Study|Adverse Event|7|||
170429389|NCT03290781|615910692|FG002|Overall Study|Adverse Event|4|||
170429390|NCT03290781|615910693|FG003|Overall Study|Adverse Event|1|||
170429391|NCT03290781|615910694|FG004|Overall Study|Adverse Event|0|||
170429392|NCT03290781|615910695|FG005|Overall Study|Adverse Event|0|||
170880191|NCT03657043|617572701|FG000|Overall Study|Lost to Follow-up|0|||
170880192|NCT03657043|617572702|FG001|Overall Study|Lost to Follow-up|0|||
170880193|NCT03657043|617572703|FG002|Overall Study|Lost to Follow-up|0|||
170880194|NCT03657043|617572704|FG003|Overall Study|Lost to Follow-up|0|||
170880195|NCT03657043|617572705|FG004|Overall Study|Lost to Follow-up|4|||
170880196|NCT03657043|617572701|FG000|Overall Study|Death|6|||
170880197|NCT03657043|617572702|FG001|Overall Study|Death|5|||
170880198|NCT03657043|617572703|FG002|Overall Study|Death|0|||
170880199|NCT03657043|617572704|FG003|Overall Study|Death|0|||
170880200|NCT03657043|617572705|FG004|Overall Study|Death|53|||
170880201|NCT03657043|617572701|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
170880202|NCT03657043|617572702|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
170880203|NCT03657043|617572703|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
170880204|NCT03657043|617572704|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
170880205|NCT03657043|617572705|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
170880206|NCT03657043|617572701|FG000|Overall Study|Adverse Event|0|||
170880207|NCT03657043|617572702|FG001|Overall Study|Adverse Event|0|||
170880208|NCT03657043|617572703|FG002|Overall Study|Adverse Event|0|||
170880209|NCT03657043|617572704|FG003|Overall Study|Adverse Event|0|||
170880210|NCT03657043|617572705|FG004|Overall Study|Adverse Event|2|||
170880211|NCT03657043|617572701|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
170880212|NCT03657043|617572702|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
170880213|NCT03657043|617572703|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
170880214|NCT03657043|617572704|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
170880215|NCT03657043|617572705|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
170880216|NCT03657043|617572701|FG000|Overall Study|Withdrawal - declined follow-up|0|||
170880217|NCT03657043|617572702|FG001|Overall Study|Withdrawal - declined follow-up|0|||
170880218|NCT03657043|617572703|FG002|Overall Study|Withdrawal - declined follow-up|0|||
170880219|NCT03657043|617572704|FG003|Overall Study|Withdrawal - declined follow-up|0|||
170880220|NCT03657043|617572705|FG004|Overall Study|Withdrawal - declined follow-up|1|||
170880221|NCT00477165|617572709|FG000|Overall Study|Adverse Event|7|||
170880222|NCT00477165|617572710|FG001|Overall Study|Adverse Event|2|||
170880223|NCT02135692|617572714|FG000|Overall Study|Adverse Event|3|||
170880224|NCT02135692|617572714|FG000|Overall Study|Lack of Efficacy|2|||
170429393|NCT03290781|615910696|FG006|Overall Study|Adverse Event|0|||
170880225|NCT02135692|617572714|FG000|Overall Study|Protocol Violation|2|||
170880226|NCT02135692|617572714|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
170880227|NCT02135692|617572714|FG000|Overall Study|Product commercially available|159|||
170880228|NCT02135692|617572714|FG000|Overall Study|Study closed/terminated|153|||
170880229|NCT02135692|617572714|FG000|Overall Study|Lost to Follow-up|4|||
170880230|NCT02135692|617572714|FG000|Overall Study|Withdrawal by Subject|15|||
170880231|NCT01995071|617572715|FG000|Overall Study|Adverse Event|0|||
170880232|NCT01995071|617572716|FG001|Overall Study|Adverse Event|0|||
170880233|NCT01995071|617572717|FG002|Overall Study|Adverse Event|0|||
170880234|NCT01995071|617572718|FG003|Overall Study|Adverse Event|0|||
170429394|NCT03290781|615910690|FG000|Overall Study|Death|0|||
170429395|NCT03290781|615910691|FG001|Overall Study|Death|0|||
170880235|NCT01995071|617572719|FG004|Overall Study|Adverse Event|0|||
170880236|NCT01995071|617572720|FG005|Overall Study|Adverse Event|0|||
170880237|NCT01995071|617572721|FG006|Overall Study|Adverse Event|1|||
170880238|NCT01995071|617572722|FG007|Overall Study|Adverse Event|0|||
170429396|NCT03290781|615910692|FG002|Overall Study|Death|1|||
170429397|NCT03290781|615910693|FG003|Overall Study|Death|0|||
170429398|NCT03290781|615910694|FG004|Overall Study|Death|1|||
170429399|NCT03290781|615910695|FG005|Overall Study|Death|0|||
170429400|NCT03290781|615910696|FG006|Overall Study|Death|0|||
170880239|NCT01995071|617572723|FG008|Overall Study|Adverse Event|0|||
170880240|NCT01995071|617572724|FG009|Overall Study|Adverse Event|0|||
170429401|NCT03290781|615910690|FG000|Overall Study|Withdrawal by Subject|6|||
170429402|NCT03290781|615910691|FG001|Overall Study|Withdrawal by Subject|5|||
170429403|NCT03290781|615910692|FG002|Overall Study|Withdrawal by Subject|9|||
170429404|NCT03290781|615910693|FG003|Overall Study|Withdrawal by Subject|10|||
170429405|NCT03290781|615910694|FG004|Overall Study|Withdrawal by Subject|1|||
170429406|NCT03290781|615910695|FG005|Overall Study|Withdrawal by Subject|2|||
170429407|NCT03290781|615910696|FG006|Overall Study|Withdrawal by Subject|0|||
170429408|NCT03290781|615910690|FG000|Overall Study|Physician Decision|0|||
170429409|NCT03290781|615910691|FG001|Overall Study|Physician Decision|1|||
170429410|NCT03290781|615910692|FG002|Overall Study|Physician Decision|0|||
170429411|NCT03290781|615910693|FG003|Overall Study|Physician Decision|0|||
170429412|NCT03290781|615910694|FG004|Overall Study|Physician Decision|0|||
170429413|NCT03290781|615910695|FG005|Overall Study|Physician Decision|0|||
170429414|NCT03290781|615910696|FG006|Overall Study|Physician Decision|0|||
170429415|NCT03290781|615910690|FG000|Overall Study|Site Terminated by Sponsor|1|||
170429416|NCT03290781|615910691|FG001|Overall Study|Site Terminated by Sponsor|0|||
170429417|NCT03290781|615910692|FG002|Overall Study|Site Terminated by Sponsor|2|||
170429418|NCT03290781|615910693|FG003|Overall Study|Site Terminated by Sponsor|1|||
170429419|NCT03290781|615910694|FG004|Overall Study|Site Terminated by Sponsor|0|||
170429420|NCT03290781|615910695|FG005|Overall Study|Site Terminated by Sponsor|0|||
170429421|NCT03290781|615910696|FG006|Overall Study|Site Terminated by Sponsor|0|||
170429422|NCT03290781|615910690|FG000|Overall Study|Lost to Follow-up|0|||
170429423|NCT03290781|615910691|FG001|Overall Study|Lost to Follow-up|0|||
170429424|NCT03290781|615910692|FG002|Overall Study|Lost to Follow-up|0|||
170429425|NCT03290781|615910693|FG003|Overall Study|Lost to Follow-up|1|||
170429426|NCT03290781|615910694|FG004|Overall Study|Lost to Follow-up|0|||
170429427|NCT03290781|615910695|FG005|Overall Study|Lost to Follow-up|0|||
170429428|NCT03290781|615910696|FG006|Overall Study|Lost to Follow-up|0|||
170429429|NCT03290781|615910690|FG000|Overall Study|Protocol Deviation|2|||
170429430|NCT03290781|615910691|FG001|Overall Study|Protocol Deviation|0|||
170429431|NCT03290781|615910692|FG002|Overall Study|Protocol Deviation|0|||
170429432|NCT03290781|615910693|FG003|Overall Study|Protocol Deviation|1|||
170429433|NCT03290781|615910694|FG004|Overall Study|Protocol Deviation|0|||
170429434|NCT03290781|615910695|FG005|Overall Study|Protocol Deviation|0|||
170429435|NCT03290781|615910696|FG006|Overall Study|Protocol Deviation|0|||
170429436|NCT03290781|615910690|FG000|Overall Study|Disease Relapse|32|||
170429437|NCT03290781|615910691|FG001|Overall Study|Disease Relapse|5|||
170429438|NCT03290781|615910692|FG002|Overall Study|Disease Relapse|38|||
170429439|NCT03290781|615910693|FG003|Overall Study|Disease Relapse|7|||
170429440|NCT03290781|615910694|FG004|Overall Study|Disease Relapse|3|||
170429441|NCT03290781|615910695|FG005|Overall Study|Disease Relapse|1|||
170429442|NCT03290781|615910696|FG006|Overall Study|Disease Relapse|4|||
170429443|NCT03290781|615910690|FG000|Overall Study|Other|3|||
170429444|NCT03290781|615910691|FG001|Overall Study|Other|0|||
170429445|NCT03290781|615910692|FG002|Overall Study|Other|2|||
170429446|NCT03290781|615910693|FG003|Overall Study|Other|2|||
170429447|NCT03290781|615910694|FG004|Overall Study|Other|0|||
170429448|NCT03290781|615910695|FG005|Overall Study|Other|0|||
170429449|NCT03290781|615910696|FG006|Overall Study|Other|0|||
170429450|NCT05593965|615910697|FG000|1st Intervention (1 Day)|Technical error|1|||
170429451|NCT05593965|615910698|FG001|1st Intervention (1 Day)|Technical error|0|||
170429452|NCT02655679|615910699|FG000|Overall Study|Adverse Event|0|||
170429453|NCT02655679|615910700|FG001|Overall Study|Adverse Event|1|||
170429454|NCT02655679|615910701|FG002|Overall Study|Adverse Event|0|||
170535209|NCT02799602|616304206|FG000|Overall Study|Progressive disease - radiological progression|90|||
170429455|NCT02655679|615910702|FG003|Overall Study|Adverse Event|0|||
170429456|NCT02655679|615910703|FG004|Overall Study|Adverse Event|0|||
170429457|NCT02655679|615910699|FG000|Overall Study|Withdrawal by Subject|1|||
170429458|NCT02655679|615910700|FG001|Overall Study|Withdrawal by Subject|1|||
170429459|NCT02655679|615910701|FG002|Overall Study|Withdrawal by Subject|0|||
170429460|NCT02655679|615910702|FG003|Overall Study|Withdrawal by Subject|3|||
170429461|NCT02655679|615910703|FG004|Overall Study|Withdrawal by Subject|1|||
170429462|NCT02655679|615910699|FG000|Overall Study|Inability to Comply with the Protocol|1|||
170429463|NCT02655679|615910700|FG001|Overall Study|Inability to Comply with the Protocol|0|||
170429464|NCT02655679|615910701|FG002|Overall Study|Inability to Comply with the Protocol|0|||
170429465|NCT02655679|615910702|FG003|Overall Study|Inability to Comply with the Protocol|0|||
170429466|NCT02655679|615910703|FG004|Overall Study|Inability to Comply with the Protocol|0|||
170535210|NCT02799602|616304207|FG001|Overall Study|Progressive disease - radiological progression|133|||
170429467|NCT02655679|615910699|FG000|Overall Study|Lost to Follow-up|0|||
170429468|NCT02655679|615910700|FG001|Overall Study|Lost to Follow-up|1|||
170429469|NCT02655679|615910701|FG002|Overall Study|Lost to Follow-up|1|||
170429470|NCT02655679|615910702|FG003|Overall Study|Lost to Follow-up|1|||
170429471|NCT02655679|615910703|FG004|Overall Study|Lost to Follow-up|0|||
170429472|NCT02655679|615910699|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170429473|NCT02655679|615910700|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170429474|NCT02655679|615910701|FG002|Overall Study|Other Miscellaneous Reasons|0|||
170429475|NCT02655679|615910702|FG003|Overall Study|Other Miscellaneous Reasons|0|||
170565475|NCT01049373|616418532|FG001|Overall Study|Protocol Violation|9|||
170429476|NCT02655679|615910703|FG004|Overall Study|Other Miscellaneous Reasons|0|||
170429477|NCT02820350|615910706|FG000|Overall Study|Withdrawal by Subject|3|||
170429478|NCT02820350|615910706|FG000|Overall Study|Death|4|||
170535211|NCT02799602|616304206|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
170535212|NCT02799602|616304207|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
170535213|NCT02799602|616304206|FG000|Overall Study|Death|9|||
170535214|NCT02799602|616304207|FG001|Overall Study|Death|5|||
170535215|NCT02799602|616304206|FG000|Overall Study|Other|287|||
170535216|NCT02799602|616304207|FG001|Overall Study|Other|118|||
170535217|NCT02799602|616304206|FG000|Overall Study|Study drug never administered|0|||
170535218|NCT02799602|616304207|FG001|Overall Study|Study drug never administered|3|||
170535219|NCT03573297|616304208|FG000|Open Label Treatment Period|Adverse Event|67|||
170535220|NCT03573297|616304209|FG001|Open Label Treatment Period|Adverse Event|0|||
170535221|NCT03573297|616304210|FG002|Open Label Treatment Period|Adverse Event|0|||
170535222|NCT03573297|616304211|FG003|Open Label Treatment Period|Adverse Event|0|||
170880241|NCT01995071|617572725|FG010|Overall Study|Adverse Event|0|||
170880242|NCT01995071|617572726|FG011|Overall Study|Adverse Event|0|||
170880243|NCT01995071|617572715|FG000|Overall Study|Moved|0|||
170880244|NCT01995071|617572716|FG001|Overall Study|Moved|0|||
170880245|NCT01995071|617572717|FG002|Overall Study|Moved|1|||
170880246|NCT01995071|617572718|FG003|Overall Study|Moved|0|||
170880247|NCT01995071|617572719|FG004|Overall Study|Moved|1|||
170880248|NCT01995071|617572720|FG005|Overall Study|Moved|0|||
170880249|NCT01995071|617572721|FG006|Overall Study|Moved|0|||
170880250|NCT01995071|617572722|FG007|Overall Study|Moved|0|||
170880251|NCT01995071|617572723|FG008|Overall Study|Moved|0|||
170880252|NCT01995071|617572724|FG009|Overall Study|Moved|0|||
170880253|NCT01995071|617572725|FG010|Overall Study|Moved|1|||
170880254|NCT01995071|617572726|FG011|Overall Study|Moved|0|||
170880255|NCT01995071|617572715|FG000|Overall Study|Lost to Follow-up|1|||
170880256|NCT01995071|617572716|FG001|Overall Study|Lost to Follow-up|0|||
170880257|NCT01995071|617572717|FG002|Overall Study|Lost to Follow-up|0|||
170880258|NCT01995071|617572718|FG003|Overall Study|Lost to Follow-up|0|||
170880259|NCT01995071|617572719|FG004|Overall Study|Lost to Follow-up|0|||
170880260|NCT01995071|617572720|FG005|Overall Study|Lost to Follow-up|0|||
170880261|NCT01995071|617572721|FG006|Overall Study|Lost to Follow-up|0|||
170880262|NCT01995071|617572722|FG007|Overall Study|Lost to Follow-up|1|||
170880263|NCT01995071|617572723|FG008|Overall Study|Lost to Follow-up|1|||
170880264|NCT01995071|617572724|FG009|Overall Study|Lost to Follow-up|0|||
170880265|NCT01995071|617572725|FG010|Overall Study|Lost to Follow-up|0|||
170880266|NCT01995071|617572726|FG011|Overall Study|Lost to Follow-up|0|||
170880267|NCT01995071|617572715|FG000|Overall Study|Incarcerated|0|||
170880268|NCT01995071|617572716|FG001|Overall Study|Incarcerated|0|||
170880269|NCT01995071|617572717|FG002|Overall Study|Incarcerated|0|||
170880270|NCT01995071|617572718|FG003|Overall Study|Incarcerated|0|||
170880271|NCT01995071|617572719|FG004|Overall Study|Incarcerated|0|||
170880272|NCT01995071|617572720|FG005|Overall Study|Incarcerated|0|||
170880273|NCT01995071|617572721|FG006|Overall Study|Incarcerated|0|||
170880274|NCT01995071|617572722|FG007|Overall Study|Incarcerated|1|||
170880275|NCT01995071|617572723|FG008|Overall Study|Incarcerated|0|||
170880276|NCT01995071|617572724|FG009|Overall Study|Incarcerated|0|||
170880277|NCT01995071|617572725|FG010|Overall Study|Incarcerated|0|||
170880278|NCT01995071|617572726|FG011|Overall Study|Incarcerated|0|||
170880279|NCT01783678|617572727|FG000|Overall Study|Randomized but Not Treated|0|||
170880280|NCT01783678|617572728|FG001|Overall Study|Randomized but Not Treated|0|||
170535223|NCT03573297|616304208|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
170880281|NCT01783678|617572729|FG002|Overall Study|Randomized but Not Treated|0|||
170880282|NCT01783678|617572730|FG003|Overall Study|Randomized but Not Treated|1|||
170880283|NCT01783678|617572731|FG004|Overall Study|Randomized but Not Treated|0|||
170880284|NCT01783678|617572732|FG005|Overall Study|Randomized but Not Treated|0|||
170880285|NCT01783678|617572727|FG000|Overall Study|Lack of Efficacy|1|||
170880286|NCT01783678|617572728|FG001|Overall Study|Lack of Efficacy|13|||
170535224|NCT03573297|616304209|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
170535225|NCT03573297|616304210|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
170535226|NCT03573297|616304211|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
170535227|NCT03573297|616304208|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
170535228|NCT03573297|616304209|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
170535229|NCT03573297|616304210|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
170880287|NCT01783678|617572729|FG002|Overall Study|Lack of Efficacy|1|||
170880288|NCT01783678|617572730|FG003|Overall Study|Lack of Efficacy|3|||
170880289|NCT01783678|617572731|FG004|Overall Study|Lack of Efficacy|6|||
170880290|NCT01783678|617572732|FG005|Overall Study|Lack of Efficacy|5|||
170880291|NCT01783678|617572727|FG000|Overall Study|Lost to Follow-up|0|||
170880292|NCT01783678|617572728|FG001|Overall Study|Lost to Follow-up|4|||
170880293|NCT01783678|617572729|FG002|Overall Study|Lost to Follow-up|0|||
170880294|NCT01783678|617572730|FG003|Overall Study|Lost to Follow-up|2|||
170880295|NCT01783678|617572731|FG004|Overall Study|Lost to Follow-up|1|||
170429479|NCT00199901|615912106|FG000|Overall Study|Protocol Violation|2|||
170429480|NCT00199901|615912107|FG001|Overall Study|Protocol Violation|0|||
170429481|NCT00199901|615912106|FG000|Overall Study|Withdrawal by Subject|1|||
170429482|NCT00199901|615912107|FG001|Overall Study|Withdrawal by Subject|0|||
170429483|NCT00199901|615912106|FG000|Overall Study|Progressive Disease|24|||
170429484|NCT00199901|615912107|FG001|Overall Study|Progressive Disease|24|||
170429485|NCT05265624|615912112|FG000|Overall Study|Lost to Follow-up|3|||
170429486|NCT05265624|615912113|FG001|Overall Study|Lost to Follow-up|0|||
170429487|NCT05265624|615912112|FG000|Overall Study|Withdrawal by Subject|1|||
170429488|NCT05265624|615912113|FG001|Overall Study|Withdrawal by Subject|0|||
170429489|NCT06137781|615912114|FG000|Baseline measurements|Lost to Follow-up|2|||
170429490|NCT06137781|615912114|FG000|Baseline measurements|Withdrawal by Subject|1|||
170429491|NCT06137781|615912114|FG000|Baseline measurements|Expedited surgery|1|||
170429492|NCT06137781|615912114|FG000|Intervention period|Lost to Follow-up|2|||
170429493|NCT06137781|615912114|FG000|Intervention period|Withdrawal by Subject|3|||
170429494|NCT06137781|615912114|FG000|Intervention period|Expedited surgery|1|||
170429495|NCT06137781|615912114|FG000|Intervention period|Adverse Event|1|||
170429496|NCT03697109|615912115|FG000|Open-label (OL) Phase|Adverse Event|24|||
170429497|NCT03697109|615912116|FG001|Open-label (OL) Phase|Adverse Event|0|||
170429498|NCT03697109|615912117|FG002|Open-label (OL) Phase|Adverse Event|0|||
170429499|NCT03697109|615912115|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
170429500|NCT03697109|615912116|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
170429501|NCT03697109|615912117|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
170429502|NCT03697109|615912115|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
170429503|NCT03697109|615912116|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
170429504|NCT03697109|615912117|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
170429505|NCT03697109|615912115|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
170429506|NCT03697109|615912116|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
170429507|NCT03697109|615912117|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
170429508|NCT03697109|615912115|FG000|Open-label (OL) Phase|Physician Decision|2|||
170429509|NCT03697109|615912116|FG001|Open-label (OL) Phase|Physician Decision|0|||
170429510|NCT03697109|615912117|FG002|Open-label (OL) Phase|Physician Decision|0|||
170429511|NCT03697109|615912115|FG000|Open-label (OL) Phase|Death|2|||
170429512|NCT03697109|615912116|FG001|Open-label (OL) Phase|Death|0|||
170429513|NCT03697109|615912117|FG002|Open-label (OL) Phase|Death|0|||
170429514|NCT03697109|615912115|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
170429515|NCT03697109|615912116|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
170429516|NCT03697109|615912117|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
170429517|NCT03697109|615912115|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
170429518|NCT03697109|615912116|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
170429519|NCT03697109|615912117|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
170429520|NCT03697109|615912115|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
170429521|NCT03697109|615912116|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
170429522|NCT03697109|615912117|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
170429523|NCT03165994|615912119|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
170429524|NCT03165994|615912119|FG000|Overall Study|Death|2|||
170429525|NCT03165994|615912119|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
170429526|NCT03165994|615912119|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
170429527|NCT03165994|615912119|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
170429528|NCT03165994|615912119|FG000|Overall Study|Miscellaneous|1|||
170429529|NCT00440518|615912122|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
170429530|NCT00440518|615912123|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
170429531|NCT00440518|615912124|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
170429532|NCT00440518|615912122|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
170429533|NCT00440518|615912123|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
170429534|NCT00440518|615912124|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
170429535|NCT00440518|615912122|FG000|Randomized /Titration Period|Protocol Deviation|1|||
170429536|NCT00440518|615912123|FG001|Randomized /Titration Period|Protocol Deviation|0|||
170429537|NCT00440518|615912124|FG002|Randomized /Titration Period|Protocol Deviation|0|||
170429538|NCT00440518|615912122|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
170429539|NCT00440518|615912123|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
170429540|NCT00440518|615912124|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
170429541|NCT00440518|615912122|FG000|Randomized /Titration Period|Other|1|||
170429542|NCT00440518|615912123|FG001|Randomized /Titration Period|Other|0|||
170429543|NCT00440518|615912124|FG002|Randomized /Titration Period|Other|0|||
170429544|NCT00440518|615912122|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
170429545|NCT00440518|615912123|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
170429546|NCT00440518|615912124|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
170429547|NCT00440518|615912122|FG000|Randomized /Titration Period|Adverse Event|2|||
170429548|NCT00440518|615912123|FG001|Randomized /Titration Period|Adverse Event|3|||
170429549|NCT00440518|615912124|FG002|Randomized /Titration Period|Adverse Event|0|||
170535230|NCT03573297|616304211|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
170429550|NCT00440518|615912122|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
170429551|NCT00440518|615912123|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
170429552|NCT00440518|615912124|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
170429553|NCT00440518|615912122|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
170429554|NCT00440518|615912123|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
170429555|NCT00440518|615912124|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
170429556|NCT00440518|615912122|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
170429557|NCT00440518|615912123|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
170429558|NCT00440518|615912124|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
170429559|NCT00440518|615912122|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
170429560|NCT00440518|615912123|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
170429561|NCT00440518|615912124|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
170429562|NCT00440518|615912122|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
170429563|NCT00440518|615912123|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
170429564|NCT00440518|615912124|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
170429565|NCT00440518|615912122|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
170429566|NCT00440518|615912123|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
170429567|NCT00440518|615912124|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
170429568|NCT02545283|615912139|FG000|Overall Study|Lost to Follow-up|2|||
170429569|NCT02545283|615912140|FG001|Overall Study|Lost to Follow-up|4|||
170429570|NCT02545283|615912139|FG000|Overall Study|Withdrawal by Subject|5|||
170429571|NCT02545283|615912140|FG001|Overall Study|Withdrawal by Subject|9|||
170429572|NCT02545283|615912139|FG000|Overall Study|Death|109|||
170429573|NCT02545283|615912140|FG001|Overall Study|Death|211|||
170429574|NCT02545283|615912139|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
170429575|NCT02545283|615912140|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
170429576|NCT02545283|615912139|FG000|Overall Study|Study Terminated By Sponsor|33|||
170429577|NCT02545283|615912140|FG001|Overall Study|Study Terminated By Sponsor|71|||
170429578|NCT00583453|615912141|FG000|Overall Study|discontinued intervention|0|||
170429579|NCT00583453|615912142|FG001|Overall Study|discontinued intervention|2|||
170429580|NCT02436005|615912143|FG000|Second Intervention|Adverse Event|0|||
170429581|NCT02436005|615912144|FG001|Second Intervention|Adverse Event|1|||
170429582|NCT00905606|615912145|FG000|Period 1|Adverse Event|0|||
170429583|NCT00905606|615912146|FG001|Period 1|Adverse Event|1|||
170429584|NCT00905606|615912145|FG000|Washout|Withdrawal by Subject|1|||
170429585|NCT00905606|615912146|FG001|Washout|Withdrawal by Subject|0|||
170429586|NCT03635320|615912147|FG000|Overall Study|not implanted the device|1|||
170429587|NCT03635320|615912148|FG001|Overall Study|not implanted the device|2|||
170429588|NCT03635320|615912147|FG000|Overall Study|Withdrawal by Subject|11|||
170429589|NCT03635320|615912148|FG001|Overall Study|Withdrawal by Subject|6|||
170429590|NCT01558635|615912149|FG000|Overall Study|Death|1|||
170429591|NCT01558635|615912149|FG000|Overall Study|Withdrawal by Subject|2|||
170429592|NCT01558635|615912149|FG000|Overall Study|Physician Decision|1|||
170429593|NCT01558635|615912149|FG000|Overall Study|Subject received other treatment|1|||
170429594|NCT01558635|615912149|FG000|Overall Study|Reveal XT was explanted|1|||
170429595|NCT01083693|615912150|FG000|Overall Study|Adverse Event|1|||
170429596|NCT01083693|615912151|FG001|Overall Study|Adverse Event|1|||
170429597|NCT01083693|615912152|FG002|Overall Study|Adverse Event|0|||
170429598|NCT01083693|615912150|FG000|Overall Study|Lost to Follow-up|2|||
170429599|NCT01083693|615912151|FG001|Overall Study|Lost to Follow-up|0|||
170429600|NCT01083693|615912152|FG002|Overall Study|Lost to Follow-up|2|||
170429601|NCT01083693|615912150|FG000|Overall Study|Lack of effectiveness|13|||
170429602|NCT01083693|615912151|FG001|Overall Study|Lack of effectiveness|2|||
170429603|NCT01083693|615912152|FG002|Overall Study|Lack of effectiveness|2|||
170429604|NCT01083693|615912150|FG000|Overall Study|Patient Moved|0|||
170429605|NCT01083693|615912151|FG001|Overall Study|Patient Moved|1|||
170429606|NCT01083693|615912152|FG002|Overall Study|Patient Moved|0|||
170429607|NCT01083693|615912150|FG000|Overall Study|Complete remission|0|||
170429608|NCT01083693|615912151|FG001|Overall Study|Complete remission|1|||
170429609|NCT01083693|615912152|FG002|Overall Study|Complete remission|0|||
170429610|NCT01083693|615912150|FG000|Overall Study|Other medical condition/surgery|1|||
170429611|NCT01083693|615912151|FG001|Overall Study|Other medical condition/surgery|1|||
170429612|NCT01083693|615912152|FG002|Overall Study|Other medical condition/surgery|0|||
170429613|NCT01083693|615912150|FG000|Overall Study|Withdrawal by Subject|3|||
170429614|NCT01083693|615912151|FG001|Overall Study|Withdrawal by Subject|0|||
170429615|NCT01083693|615912152|FG002|Overall Study|Withdrawal by Subject|2|||
170429616|NCT01083693|615912150|FG000|Overall Study|Reason unknown|0|||
170429617|NCT01083693|615912151|FG001|Overall Study|Reason unknown|0|||
170429618|NCT01083693|615912152|FG002|Overall Study|Reason unknown|1|||
170429619|NCT00455312|615912153|FG000|Overall Study|Death|0|||
170429620|NCT00455312|615912154|FG001|Overall Study|Death|1|||
170429621|NCT01705574|615912155|FG000|Double-Blind Phase|Lost to Follow-up|12|||
170429622|NCT01705574|615912156|FG001|Double-Blind Phase|Lost to Follow-up|16|||
170880296|NCT01783678|617572732|FG005|Overall Study|Lost to Follow-up|0|||
170429623|NCT01705574|615912157|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170429624|NCT01705574|615912158|FG003|Double-Blind Phase|Lost to Follow-up|0|||
170429625|NCT01705574|615912155|FG000|Double-Blind Phase|Adverse Event|3|||
170429626|NCT01705574|615912156|FG001|Double-Blind Phase|Adverse Event|10|||
170429627|NCT01705574|615912157|FG002|Double-Blind Phase|Adverse Event|0|||
170429628|NCT01705574|615912158|FG003|Double-Blind Phase|Adverse Event|0|||
170429629|NCT01705574|615912155|FG000|Double-Blind Phase|Withdrew Consent|8|||
170429630|NCT01705574|615912156|FG001|Double-Blind Phase|Withdrew Consent|5|||
170429631|NCT01705574|615912157|FG002|Double-Blind Phase|Withdrew Consent|0|||
170429632|NCT01705574|615912158|FG003|Double-Blind Phase|Withdrew Consent|0|||
170429633|NCT01705574|615912155|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
170429634|NCT01705574|615912156|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
170429635|NCT01705574|615912157|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
170429636|NCT01705574|615912158|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
170429637|NCT01705574|615912155|FG000|Double-Blind Phase|Pregnancy|1|||
170429638|NCT01705574|615912156|FG001|Double-Blind Phase|Pregnancy|1|||
170429639|NCT01705574|615912157|FG002|Double-Blind Phase|Pregnancy|0|||
170429640|NCT01705574|615912158|FG003|Double-Blind Phase|Pregnancy|0|||
170429641|NCT01705574|615912155|FG000|Double-Blind Phase|Protocol Violation|1|||
170429642|NCT01705574|615912156|FG001|Double-Blind Phase|Protocol Violation|0|||
170429643|NCT01705574|615912157|FG002|Double-Blind Phase|Protocol Violation|0|||
170429644|NCT01705574|615912158|FG003|Double-Blind Phase|Protocol Violation|0|||
170429645|NCT01705574|615912155|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
170429646|NCT01705574|615912156|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
170429647|NCT01705574|615912157|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
170429648|NCT01705574|615912158|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
170429649|NCT01705574|615912155|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
170429650|NCT01705574|615912156|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
170429651|NCT01705574|615912157|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
170429652|NCT01705574|615912158|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
170429653|NCT01705574|615912155|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
170429654|NCT01705574|615912156|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
170429655|NCT01705574|615912157|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
170429656|NCT01705574|615912158|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
170429657|NCT01705574|615912155|FG000|Open-Label Extension Phase|Adverse Event|3|||
170429658|NCT01705574|615912156|FG001|Open-Label Extension Phase|Adverse Event|0|||
170429659|NCT01705574|615912157|FG002|Open-Label Extension Phase|Adverse Event|0|||
170429660|NCT01705574|615912158|FG003|Open-Label Extension Phase|Adverse Event|1|||
170429661|NCT01705574|615912155|FG000|Open-Label Extension Phase|Death|2|||
170429662|NCT01705574|615912156|FG001|Open-Label Extension Phase|Death|0|||
170429663|NCT01705574|615912157|FG002|Open-Label Extension Phase|Death|1|||
170429664|NCT01705574|615912158|FG003|Open-Label Extension Phase|Death|0|||
170429665|NCT01705574|615912155|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
170429666|NCT01705574|615912156|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
170429667|NCT01705574|615912157|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
170429668|NCT01705574|615912158|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
170429669|NCT01705574|615912155|FG000|Open-Label Extension Phase|Physician Decision|0|||
170429670|NCT01705574|615912156|FG001|Open-Label Extension Phase|Physician Decision|0|||
170429671|NCT01705574|615912157|FG002|Open-Label Extension Phase|Physician Decision|2|||
170429672|NCT01705574|615912158|FG003|Open-Label Extension Phase|Physician Decision|0|||
170429673|NCT01705574|615912155|FG000|Open-Label Extension Phase|Pregnancy|0|||
170429674|NCT01705574|615912156|FG001|Open-Label Extension Phase|Pregnancy|0|||
170429675|NCT01705574|615912157|FG002|Open-Label Extension Phase|Pregnancy|1|||
170429676|NCT01705574|615912158|FG003|Open-Label Extension Phase|Pregnancy|1|||
170429677|NCT02659150|615912159|FG000|Subject Enrollment|Physician Decision|3|||
170429678|NCT02659150|615912159|FG000|Subject Enrollment|Withdrawal by Subject|2|||
170429679|NCT02659150|615912159|FG000|Baseline Imaging|Withdrawal by Subject|1|||
170429680|NCT02659150|615912159|FG000|Baseline Imaging|Physician Decision|1|||
170429681|NCT02659150|615912159|FG000|Study Drug Dosing|Adverse Event|1|||
170429682|NCT01735994|615912162|FG000|Overall Study|Withdrawal by Subject|6|||
170429683|NCT01735994|615912163|FG001|Overall Study|Withdrawal by Subject|4|||
170429684|NCT01735994|615912162|FG000|Overall Study|Injury|2|||
170429685|NCT01735994|615912163|FG001|Overall Study|Injury|0|||
170429686|NCT01735994|615912162|FG000|Overall Study|Kicked off team|5|||
170429687|NCT01735994|615912163|FG001|Overall Study|Kicked off team|0|||
170429688|NCT01735994|615912162|FG000|Overall Study|Lost to Follow-up|50|||
170429689|NCT01735994|615912163|FG001|Overall Study|Lost to Follow-up|62|||
170429690|NCT01158118|615912164|FG000|Overall Study|Screen failure|1|||
170429691|NCT01158118|615912165|FG001|Overall Study|Screen failure|0|||
170429692|NCT01158118|615912164|FG000|Overall Study|Donor match was a screen failure|0|||
170429693|NCT01158118|615912165|FG001|Overall Study|Donor match was a screen failure|1|||
170429694|NCT01158118|615912164|FG000|Overall Study|Suffered stroke prior to transplant|0|||
170429695|NCT01158118|615912165|FG001|Overall Study|Suffered stroke prior to transplant|1|||
170429696|NCT01158118|615912164|FG000|Overall Study|Death|0|||
170429697|NCT01158118|615912165|FG001|Overall Study|Death|1|||
170429698|NCT04994535|615912166|FG000|Overall Study|Lost to Follow-up|7|||
170429699|NCT04994535|615912167|FG001|Overall Study|Lost to Follow-up|7|||
170429700|NCT04994535|615912166|FG000|Overall Study|Withdrawal by Subject|10|||
170429701|NCT04994535|615912167|FG001|Overall Study|Withdrawal by Subject|7|||
170429702|NCT04994535|615912166|FG000|Overall Study|Other|1|||
170429703|NCT04994535|615912167|FG001|Overall Study|Other|1|||
170429704|NCT00604162|615912168|FG000|Overall Study|Physician Decision|3|||
170429705|NCT00604162|615912168|FG000|Overall Study|Withdrawal by Subject|1|||
170429706|NCT02246920|615912173|FG000|Overall Study|Adverse Event|3|||
170429707|NCT02246920|615912174|FG001|Overall Study|Adverse Event|1|||
170429708|NCT02246920|615912175|FG002|Overall Study|Adverse Event|1|||
170429709|NCT02246920|615912173|FG000|Overall Study|Lost to Follow-up|2|||
170429710|NCT02246920|615912174|FG001|Overall Study|Lost to Follow-up|1|||
170429711|NCT02246920|615912175|FG002|Overall Study|Lost to Follow-up|0|||
170429712|NCT02246920|615912173|FG000|Overall Study|Protocol Violation|2|||
170429713|NCT02246920|615912174|FG001|Overall Study|Protocol Violation|5|||
170429714|NCT02246920|615912175|FG002|Overall Study|Protocol Violation|1|||
170429715|NCT02246920|615912173|FG000|Overall Study|Withdrawal by Subject|0|||
170429716|NCT02246920|615912174|FG001|Overall Study|Withdrawal by Subject|0|||
170429717|NCT02246920|615912175|FG002|Overall Study|Withdrawal by Subject|1|||
170429718|NCT01273805|615912178|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
170429719|NCT01273805|615912179|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
170429720|NCT00772941|615912180|FG000|Overall Study|CRFs not available|195|||
170429721|NCT00772941|615912180|FG000|Overall Study|Study not completed|16|||
170429722|NCT00772941|615912180|FG000|Overall Study|Missed Visits|374|||
170429723|NCT00772941|615912180|FG000|Overall Study|Poor Compliance|7|||
170429724|NCT00772941|615912180|FG000|Overall Study|GPSP Violation|90|||
170429725|NCT02902211|615912184|FG000|First Three Months|Withdrawal by Subject|7|||
170429726|NCT02902211|615912185|FG001|First Three Months|Withdrawal by Subject|3|||
170429727|NCT00960297|615912186|FG000|Overall Study|Physician Decision|1|||
170429728|NCT00960297|615912186|FG000|Overall Study|Venous port infection|1|||
170429729|NCT00960297|615912186|FG000|Overall Study|Disease progression|1|||
170429730|NCT03247972|615912187|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
170429731|NCT03247972|615912187|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
170429732|NCT00834340|615912190|FG000|Washout|Adverse Event|1|||
170429733|NCT00834340|615912191|FG001|Washout|Adverse Event|0|||
170429734|NCT00834340|615912190|FG000|Washout|Withdrawal by Subject|1|||
170429735|NCT00834340|615912191|FG001|Washout|Withdrawal by Subject|0|||
170429736|NCT01175018|615912194|FG000|Overall Study|Adverse Event|3|||
170429737|NCT01175018|615912195|FG001|Overall Study|Adverse Event|1|||
170429738|NCT02911792|615912196|FG000|Overall Study|Lost to Follow-up|3|||
170429739|NCT02911792|615912197|FG001|Overall Study|Lost to Follow-up|3|||
170429740|NCT02911792|615912198|FG002|Overall Study|Lost to Follow-up|3|||
170429741|NCT02911792|615912199|FG003|Overall Study|Lost to Follow-up|3|||
170429742|NCT00840073|615912206|FG000|Second Intervention|Missed 72 hour blood draw|1|||
170429743|NCT00840073|615912207|FG001|Second Intervention|Missed 72 hour blood draw|1|||
170429744|NCT00796328|615912208|FG000|Overall Study|experienced hypotension requiring tx|6|||
170429745|NCT01020474|615912209|FG000|Overall Study|Adverse Event|4|||
170429746|NCT01020474|615912210|FG001|Overall Study|Adverse Event|4|||
170429747|NCT01020474|615912209|FG000|Overall Study|Protocol Violation|0|||
170429748|NCT01020474|615912210|FG001|Overall Study|Protocol Violation|2|||
170429749|NCT01020474|615912209|FG000|Overall Study|Withdrawal by Subject|5|||
170429750|NCT01020474|615912210|FG001|Overall Study|Withdrawal by Subject|7|||
170429751|NCT01020474|615912209|FG000|Overall Study|Other Reasons|1|||
170429752|NCT01020474|615912210|FG001|Overall Study|Other Reasons|1|||
170429753|NCT01020474|615912209|FG000|Overall Study|Insufficient Clinical Response|0|||
170429754|NCT01020474|615912210|FG001|Overall Study|Insufficient Clinical Response|3|||
170429755|NCT03669861|615912211|FG000|Overall Study|Disease Flare|5|||
170429756|NCT03669861|615912211|FG000|Overall Study|Lack of Efficacy|2|||
170429757|NCT04108858|615912213|FG000|Overall Study|Adverse Event|1|||
170429758|NCT00984126|615912214|FG000|Overall Study|Protocol Violation|0|||
170429759|NCT00984126|615912215|FG001|Overall Study|Protocol Violation|0|||
170429760|NCT00984126|615912216|FG002|Overall Study|Protocol Violation|1|||
170429761|NCT00984126|615912217|FG003|Overall Study|Protocol Violation|2|||
170429762|NCT00984126|615912214|FG000|Overall Study|Adverse Event|0|||
170429763|NCT00984126|615912215|FG001|Overall Study|Adverse Event|0|||
170429764|NCT00984126|615912216|FG002|Overall Study|Adverse Event|0|||
170429765|NCT00984126|615912217|FG003|Overall Study|Adverse Event|2|||
170429766|NCT00984126|615912214|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
170429767|NCT00984126|615912215|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
170429768|NCT00984126|615912216|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
170429769|NCT00984126|615912217|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
170429770|NCT00984126|615912214|FG000|Overall Study|Withdrawal criteria|0|||
170429771|NCT00984126|615912215|FG001|Overall Study|Withdrawal criteria|1|||
170429772|NCT00984126|615912216|FG002|Overall Study|Withdrawal criteria|3|||
170429773|NCT00984126|615912217|FG003|Overall Study|Withdrawal criteria|9|||
170429774|NCT02453386|615912220|FG000|Overall Study|Adverse Event|22|||
170429775|NCT02453386|615912221|FG001|Overall Study|Adverse Event|30|||
170880297|NCT01783678|617572727|FG000|Overall Study|Withdrew Consent|1|||
170880298|NCT01783678|617572728|FG001|Overall Study|Withdrew Consent|1|||
170880299|NCT01783678|617572729|FG002|Overall Study|Withdrew Consent|0|||
170880300|NCT01783678|617572730|FG003|Overall Study|Withdrew Consent|2|||
170880301|NCT01783678|617572731|FG004|Overall Study|Withdrew Consent|0|||
170880302|NCT01783678|617572732|FG005|Overall Study|Withdrew Consent|0|||
170880303|NCT02404103|617572733|FG000|Overall Study|Adverse Event|1|||
170880304|NCT02404103|617572734|FG001|Overall Study|Adverse Event|0|||
170880305|NCT02404103|617572733|FG000|Overall Study|Lost to Follow-up|3|||
170880306|NCT02404103|617572734|FG001|Overall Study|Lost to Follow-up|3|||
170880307|NCT01408147|617572735|FG000|Overall Study|Withdrawal by Subject|0|||
170880308|NCT01408147|617572736|FG001|Overall Study|Withdrawal by Subject|1|||
170429776|NCT02453386|615912222|FG002|Overall Study|Adverse Event|15|||
170429777|NCT02453386|615912220|FG000|Overall Study|Protocol Violation|1|||
170429778|NCT02453386|615912221|FG001|Overall Study|Protocol Violation|0|||
170429779|NCT02453386|615912222|FG002|Overall Study|Protocol Violation|1|||
170429780|NCT02453386|615912220|FG000|Overall Study|Withdrawal by Subject|10|||
170429781|NCT02453386|615912221|FG001|Overall Study|Withdrawal by Subject|9|||
170429782|NCT02453386|615912222|FG002|Overall Study|Withdrawal by Subject|9|||
170429783|NCT02453386|615912220|FG000|Overall Study|Sponsor Terminated Study|14|||
170429784|NCT02453386|615912221|FG001|Overall Study|Sponsor Terminated Study|8|||
170429785|NCT02453386|615912222|FG002|Overall Study|Sponsor Terminated Study|11|||
170429786|NCT02453386|615912220|FG000|Overall Study|Subject Terminated by Sponsor|1|||
170429787|NCT02453386|615912221|FG001|Overall Study|Subject Terminated by Sponsor|1|||
170429788|NCT02453386|615912222|FG002|Overall Study|Subject Terminated by Sponsor|1|||
170429789|NCT02453386|615912220|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
170429790|NCT02453386|615912221|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
170429791|NCT02453386|615912222|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
170429792|NCT02453386|615912220|FG000|Overall Study|Lost to Follow-up|0|||
170429793|NCT02453386|615912221|FG001|Overall Study|Lost to Follow-up|0|||
170429794|NCT02453386|615912222|FG002|Overall Study|Lost to Follow-up|1|||
170429795|NCT02453386|615912220|FG000|Overall Study|Other|1|||
170429796|NCT02453386|615912221|FG001|Overall Study|Other|0|||
170429797|NCT02453386|615912222|FG002|Overall Study|Other|1|||
170429798|NCT00359281|615912223|FG000|Overall Study|Adverse Event|1|||
170429799|NCT00359281|615912224|FG001|Overall Study|Adverse Event|0|||
170429800|NCT00359281|615912225|FG002|Overall Study|Adverse Event|0|||
170429801|NCT00359281|615912226|FG003|Overall Study|Adverse Event|0|||
170429802|NCT00359281|615912227|FG004|Overall Study|Adverse Event|0|||
170429803|NCT00359281|615912228|FG005|Overall Study|Adverse Event|0|||
170429804|NCT00359281|615912229|FG006|Overall Study|Adverse Event|1|||
170429805|NCT00359281|615912230|FG007|Overall Study|Adverse Event|0|||
170429806|NCT00359281|615912231|FG008|Overall Study|Adverse Event|0|||
170429807|NCT00359281|615912223|FG000|Overall Study|Withdrawal by Subject|0|||
170429808|NCT00359281|615912224|FG001|Overall Study|Withdrawal by Subject|0|||
170429809|NCT00359281|615912225|FG002|Overall Study|Withdrawal by Subject|0|||
170429810|NCT00359281|615912226|FG003|Overall Study|Withdrawal by Subject|0|||
170429811|NCT00359281|615912227|FG004|Overall Study|Withdrawal by Subject|0|||
170429812|NCT00359281|615912228|FG005|Overall Study|Withdrawal by Subject|0|||
170429813|NCT00359281|615912229|FG006|Overall Study|Withdrawal by Subject|1|||
170429814|NCT00359281|615912230|FG007|Overall Study|Withdrawal by Subject|0|||
170429815|NCT00359281|615912231|FG008|Overall Study|Withdrawal by Subject|0|||
170429816|NCT03233724|615912242|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
170429817|NCT03233724|615912243|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
170429818|NCT03233724|615912244|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
170429819|NCT03233724|615912245|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
170880309|NCT00621504|617572738|FG000|Overall Study|Adverse Event|1|||
170880310|NCT00621504|617572739|FG001|Overall Study|Adverse Event|3|||
170880311|NCT00621504|617572738|FG000|Overall Study|At the request of sponsor/investigator|1|||
170880312|NCT00621504|617572739|FG001|Overall Study|At the request of sponsor/investigator|0|||
170880313|NCT00621504|617572738|FG000|Overall Study|Withdrew consent|9|||
170880314|NCT00621504|617572739|FG001|Overall Study|Withdrew consent|6|||
170880315|NCT00621504|617572738|FG000|Overall Study|Lost to Follow-up|8|||
170429820|NCT03233724|615912246|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
170535231|NCT03573297|616304208|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
170535232|NCT03573297|616304209|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
170880316|NCT00621504|617572739|FG001|Overall Study|Lost to Follow-up|10|||
170429821|NCT03233724|615912242|FG000|Phase I Dose Escalation|Best interest of participant|1|||
170429822|NCT03233724|615912243|FG001|Phase I Dose Escalation|Best interest of participant|1|||
170429823|NCT03233724|615912244|FG002|Phase I Dose Escalation|Best interest of participant|1|||
170535233|NCT03573297|616304210|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
170880317|NCT00621504|617572738|FG000|Overall Study|Other|1|||
170880318|NCT00621504|617572739|FG001|Overall Study|Other|0|||
170429824|NCT03233724|615912245|FG003|Phase I Dose Escalation|Best interest of participant|0|||
170429825|NCT03233724|615912246|FG004|Phase I Dose Escalation|Best interest of participant|0|||
170429826|NCT03233724|615912242|FG000|Phase I Dose Escalation|Physician Decision|0|||
170429827|NCT03233724|615912243|FG001|Phase I Dose Escalation|Physician Decision|0|||
170429828|NCT03233724|615912244|FG002|Phase I Dose Escalation|Physician Decision|1|||
170429829|NCT03233724|615912245|FG003|Phase I Dose Escalation|Physician Decision|0|||
170429830|NCT03233724|615912246|FG004|Phase I Dose Escalation|Physician Decision|0|||
170429831|NCT03233724|615912242|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
170429832|NCT03233724|615912243|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
170429833|NCT03233724|615912244|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
170429834|NCT03233724|615912245|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
170429835|NCT03233724|615912246|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
170429836|NCT03122457|615912248|FG000|Overall Study|Withdrawal by Subject|6|||
170429837|NCT03173547|615912252|FG000|Overall Study|Adverse Event|2|||
170429838|NCT03173547|615912253|FG001|Overall Study|Adverse Event|0|||
170429839|NCT03173547|615912252|FG000|Overall Study|Withdrawal by Subject|2|||
170535234|NCT03573297|616304211|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
170535235|NCT03573297|616304208|FG000|Open Label Treatment Period|Pregnancy|1|||
170535236|NCT03573297|616304209|FG001|Open Label Treatment Period|Pregnancy|0|||
170535237|NCT03573297|616304210|FG002|Open Label Treatment Period|Pregnancy|0|||
170535238|NCT03573297|616304211|FG003|Open Label Treatment Period|Pregnancy|0|||
170535239|NCT03573297|616304208|FG000|Open Label Treatment Period|Protocol Violation|17|||
170535240|NCT03573297|616304209|FG001|Open Label Treatment Period|Protocol Violation|0|||
170535241|NCT03573297|616304210|FG002|Open Label Treatment Period|Protocol Violation|0|||
170535242|NCT03573297|616304211|FG003|Open Label Treatment Period|Protocol Violation|0|||
170535243|NCT03573297|616304208|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
170535244|NCT03573297|616304209|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
170535245|NCT03573297|616304210|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
170535246|NCT03573297|616304211|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
170535247|NCT03573297|616304208|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
170535248|NCT03573297|616304209|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
170535249|NCT03573297|616304210|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
170535250|NCT03573297|616304211|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
170535251|NCT03573297|616304208|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
170535252|NCT03573297|616304209|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
170535253|NCT03573297|616304210|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
170535254|NCT03573297|616304211|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
170429840|NCT03173547|615912253|FG001|Overall Study|Withdrawal by Subject|2|||
170429841|NCT00446563|615912254|FG000|Overall Study|Adverse Event|4|||
170429842|NCT00446563|615912255|FG001|Overall Study|Adverse Event|3|||
170429843|NCT00446563|615912254|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170429844|NCT00446563|615912255|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170429845|NCT00446563|615912254|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170429846|NCT00446563|615912255|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170429847|NCT00446563|615912254|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170429848|NCT00446563|615912255|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170429849|NCT00446563|615912254|FG000|Overall Study|Withdrawal by Subject|2|||
170429850|NCT00446563|615912255|FG001|Overall Study|Withdrawal by Subject|1|||
170429851|NCT00446563|615912254|FG000|Overall Study|Administrative problems|0|||
170429852|NCT00446563|615912255|FG001|Overall Study|Administrative problems|1|||
170429853|NCT01169558|615912256|FG000|Overall Study|Disease progression|98|||
170429854|NCT01169558|615912256|FG000|Overall Study|Adverse Event|25|||
170429855|NCT01169558|615912256|FG000|Overall Study|Withdrawal of Consent|8|||
170429856|NCT01169558|615912256|FG000|Overall Study|Medical Decision|7|||
170429857|NCT01169558|615912256|FG000|Overall Study|Stable Disease|4|||
170429858|NCT01169558|615912256|FG000|Overall Study|Lost to Follow-up|4|||
170429859|NCT01169558|615912256|FG000|Overall Study|Need for Surgery|4|||
170429860|NCT01169558|615912256|FG000|Overall Study|Non-compliance|2|||
170429861|NCT01169558|615912256|FG000|Overall Study|Protocol Violation|2|||
170429862|NCT01169558|615912256|FG000|Overall Study|Partial response|2|||
170429863|NCT05776901|615913958|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
170429864|NCT01958294|615913965|FG000|Overall Study|Clinical Circumstances|2|||
170429865|NCT02222818|615913967|FG000|Period 1|Eligibility criteria not met|0|||
170429866|NCT02222818|615913968|FG001|Period 1|Eligibility criteria not met|3|||
170429867|NCT04299087|615913969|FG000|Overall Study|Lost to Follow-up|2|||
170429868|NCT04299087|615913970|FG001|Overall Study|Lost to Follow-up|1|||
170429869|NCT00665925|615913971|FG000|Overall Study|Lack of Efficacy|10|||
170429870|NCT00665925|615913972|FG001|Overall Study|Lack of Efficacy|8|||
170429871|NCT00665925|615913973|FG002|Overall Study|Lack of Efficacy|9|||
170429872|NCT00665925|615913974|FG003|Overall Study|Lack of Efficacy|8|||
170429873|NCT00665925|615913971|FG000|Overall Study|Lost to Follow-up|1|||
170429874|NCT00665925|615913972|FG001|Overall Study|Lost to Follow-up|2|||
170429875|NCT00665925|615913973|FG002|Overall Study|Lost to Follow-up|2|||
170429876|NCT00665925|615913974|FG003|Overall Study|Lost to Follow-up|2|||
170429877|NCT00665925|615913971|FG000|Overall Study|Withdrawal by Subject|2|||
170429878|NCT00665925|615913972|FG001|Overall Study|Withdrawal by Subject|2|||
170429879|NCT00665925|615913973|FG002|Overall Study|Withdrawal by Subject|3|||
170429880|NCT00665925|615913974|FG003|Overall Study|Withdrawal by Subject|2|||
170429881|NCT00665925|615913971|FG000|Overall Study|Physician Decision|0|||
170429882|NCT00665925|615913972|FG001|Overall Study|Physician Decision|0|||
170429883|NCT00665925|615913973|FG002|Overall Study|Physician Decision|1|||
170429884|NCT00665925|615913974|FG003|Overall Study|Physician Decision|2|||
170429885|NCT00665925|615913971|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
170429886|NCT00665925|615913972|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
170429887|NCT00665925|615913973|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
170429888|NCT00665925|615913974|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
170429889|NCT00665925|615913971|FG000|Overall Study|Adverse Event|1|||
170429890|NCT00665925|615913972|FG001|Overall Study|Adverse Event|5|||
170429891|NCT00665925|615913973|FG002|Overall Study|Adverse Event|10|||
170429892|NCT00665925|615913974|FG003|Overall Study|Adverse Event|5|||
170429893|NCT00665925|615913971|FG000|Overall Study|Enrolled by mistake|0|||
170429894|NCT00665925|615913972|FG001|Overall Study|Enrolled by mistake|0|||
170429895|NCT00665925|615913973|FG002|Overall Study|Enrolled by mistake|0|||
170429896|NCT00665925|615913974|FG003|Overall Study|Enrolled by mistake|1|||
170429897|NCT00665925|615913971|FG000|Overall Study|Due to exclusion criteria|1|||
170429898|NCT00665925|615913972|FG001|Overall Study|Due to exclusion criteria|0|||
170429899|NCT00665925|615913973|FG002|Overall Study|Due to exclusion criteria|0|||
170429900|NCT00665925|615913974|FG003|Overall Study|Due to exclusion criteria|0|||
170429901|NCT01376037|615913979|FG000|Overall Study|Lost to Follow-up|0|||
170429902|NCT01376037|615913980|FG001|Overall Study|Lost to Follow-up|2|||
170429903|NCT02328040|615913983|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
170429904|NCT02328040|615913984|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
170429905|NCT00834522|615913988|FG000|Washout|Adverse Event|1|||
170429906|NCT00834522|615913989|FG001|Washout|Adverse Event|0|||
170429907|NCT00834522|615913988|FG000|Washout|Withdrawal by Subject|2|||
170429908|NCT00834522|615913989|FG001|Washout|Withdrawal by Subject|1|||
170429909|NCT00519194|615913990|FG000|Overall Study|Withdrawal by Subject|9|||
170429910|NCT00519194|615913990|FG000|Overall Study|Death|9|||
170429911|NCT00519194|615913990|FG000|Overall Study|Lost to Follow-up|3|||
170429912|NCT00835991|615913991|FG000|First Intervention|Adverse Event|0|||
170429913|NCT00835991|615913992|FG001|First Intervention|Adverse Event|1|||
170429914|NCT00835991|615913991|FG000|Washout|Protocol Violation|0|||
170429915|NCT00835991|615913992|FG001|Washout|Protocol Violation|2|||
170429916|NCT00835991|615913991|FG000|Washout|Withdrawal by Subject|3|||
170535255|NCT03573297|616304208|FG000|Open Label Treatment Period|Other, Not Specified|7|||
170535256|NCT03573297|616304209|FG001|Open Label Treatment Period|Other, Not Specified|0|||
170535257|NCT03573297|616304210|FG002|Open Label Treatment Period|Other, Not Specified|0|||
170535258|NCT03573297|616304211|FG003|Open Label Treatment Period|Other, Not Specified|0|||
170535259|NCT03573297|616304208|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
170535260|NCT03573297|616304209|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
170535261|NCT03573297|616304210|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
170535262|NCT03573297|616304211|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
170535263|NCT03573297|616304208|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170535264|NCT03573297|616304209|FG001|Double-Blind Treatment Period|Adverse Event|1|||
170535265|NCT03573297|616304210|FG002|Double-Blind Treatment Period|Adverse Event|5|||
170535266|NCT03573297|616304211|FG003|Double-Blind Treatment Period|Adverse Event|1|||
170535267|NCT03573297|616304208|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
170535268|NCT03573297|616304209|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
170535269|NCT03573297|616304210|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
170429917|NCT00835991|615913992|FG001|Washout|Withdrawal by Subject|1|||
170429918|NCT01111461|615913993|FG000|Overall Study|Adverse Event|32|||
170429919|NCT01111461|615913993|FG000|Overall Study|Participant choice|11|||
170429920|NCT01111461|615913993|FG000|Overall Study|Lost to Follow-up|1|||
170429921|NCT01111461|615913993|FG000|Overall Study|Withdrawal by Subject|1|||
170429922|NCT01111461|615913993|FG000|Overall Study|Other|6|||
170429923|NCT03086460|615913994|FG000|Study Participants|Lost to Follow-up|2|||
170535270|NCT03573297|616304211|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
170535271|NCT03573297|616304208|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170429924|NCT03086460|615913994|FG000|Study Participants|Protocol Violation|1|||
170429925|NCT03086460|615913994|FG000|Study Participants|Withdrawal by Subject|6|||
170429926|NCT03086460|615913994|FG000|Treatment A|Lost to Follow-up|1|||
170429927|NCT03086460|615913994|FG000|Treatment A|Protocol Violation|1|||
170429928|NCT03086460|615913994|FG000|Treatment A|Withdrawal by Subject|2|||
170429929|NCT03086460|615913994|FG000|Treatment C|Withdrawal by Subject|2|||
170429930|NCT03086460|615913994|FG000|Treatment E|Lost to Follow-up|1|||
170429931|NCT03086460|615913994|FG000|Treatment E|Withdrawal by Subject|3|||
170429932|NCT01471353|615913997|FG000|Overall Study|remain on study|3|||
170429933|NCT03123094|615913998|FG000|Overall Study|Withdrawal by Subject|0|||
170429934|NCT03123094|615913999|FG001|Overall Study|Withdrawal by Subject|2|||
170429935|NCT03123094|615914000|FG002|Overall Study|Withdrawal by Subject|1|||
170429936|NCT03123094|615914001|FG003|Overall Study|Withdrawal by Subject|0|||
170429937|NCT03123094|615914002|FG004|Overall Study|Withdrawal by Subject|1|||
170429938|NCT05014828|615914003|FG000|Overall Study|Study Completed by Sponsor|16|||
170429939|NCT05014828|615914004|FG001|Overall Study|Study Completed by Sponsor|16|||
170429940|NCT05014828|615914005|FG002|Overall Study|Study Completed by Sponsor|3|||
170429941|NCT05014828|615914006|FG003|Overall Study|Study Completed by Sponsor|3|||
170429942|NCT05014828|615914003|FG000|Overall Study|Death|11|||
170429943|NCT05014828|615914004|FG001|Overall Study|Death|6|||
170429944|NCT05014828|615914005|FG002|Overall Study|Death|0|||
170429945|NCT05014828|615914006|FG003|Overall Study|Death|0|||
170429946|NCT05014828|615914003|FG000|Overall Study|Lost to Follow-up|0|||
170429947|NCT05014828|615914004|FG001|Overall Study|Lost to Follow-up|0|||
170429948|NCT05014828|615914005|FG002|Overall Study|Lost to Follow-up|2|||
170429949|NCT05014828|615914006|FG003|Overall Study|Lost to Follow-up|0|||
170429950|NCT05014828|615914003|FG000|Overall Study|Miscellaneous.|0|||
170429951|NCT05014828|615914004|FG001|Overall Study|Miscellaneous.|1|||
170429952|NCT05014828|615914005|FG002|Overall Study|Miscellaneous.|0|||
170429953|NCT05014828|615914006|FG003|Overall Study|Miscellaneous.|0|||
170429954|NCT00395694|615914009|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
170429955|NCT00395694|615914010|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
170429956|NCT00395694|615914009|FG000|Continuation Phase|Adverse Event|1|||
170429957|NCT00395694|615914010|FG001|Continuation Phase|Adverse Event|0|||
170429958|NCT00395694|615914009|FG000|Continuation Phase|Lack of Efficacy|12|||
170429959|NCT00395694|615914010|FG001|Continuation Phase|Lack of Efficacy|11|||
170429960|NCT00395694|615914009|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
170429961|NCT00395694|615914010|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
170429962|NCT00395694|615914009|FG000|Continuation Phase|Poor Compliance|1|||
170429963|NCT00395694|615914010|FG001|Continuation Phase|Poor Compliance|0|||
170429964|NCT00395694|615914009|FG000|Continuation Phase|Withdrawal by Subject|0|||
170429965|NCT00395694|615914010|FG001|Continuation Phase|Withdrawal by Subject|2|||
170429966|NCT01058668|615914012|FG000|Double-blind Treatment Phase|Adverse Event|8|||
170429967|NCT01058668|615914013|FG001|Double-blind Treatment Phase|Adverse Event|15|||
170429968|NCT01058668|615914014|FG002|Double-blind Treatment Phase|Adverse Event|25|||
170429969|NCT01058668|615914012|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
170429970|NCT01058668|615914013|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
170429971|NCT01058668|615914014|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
170429972|NCT01058668|615914012|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
170429973|NCT01058668|615914013|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
170429974|NCT01058668|615914014|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
170429975|NCT01058668|615914012|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
170429976|NCT01058668|615914013|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
170429977|NCT01058668|615914014|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
170429978|NCT01058668|615914012|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
170429979|NCT01058668|615914013|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
170429980|NCT01058668|615914014|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
170429981|NCT01058668|615914012|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
170429982|NCT01058668|615914013|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
170535272|NCT03573297|616304209|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
170429983|NCT01058668|615914014|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
170429984|NCT00107991|615914025|FG000|Eligibility Assessment|Disease not severe enough|7|||
170429985|NCT00107991|615914025|FG000|Eligibility Assessment|Unwilling to participate|7|||
170429986|NCT00107991|615914025|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
170429987|NCT00107991|615914025|FG000|Eligibility Assessment|Abnormal labs|2|||
170429988|NCT00107991|615914025|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
170429989|NCT00107991|615914025|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
170429990|NCT00107991|615914025|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
170429991|NCT00107991|615914025|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
170429992|NCT00107991|615914025|FG000|12 Week Treatment Period|Adverse Event|1|||
170429993|NCT00107991|615914025|FG000|12 Week Treatment Period|Protocol Violation|1|||
170429994|NCT00107991|615914025|FG000|12 Week Treatment Period|Incarcerated|1|||
170429995|NCT00107991|615914025|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
170429996|NCT00705666|615914026|FG000|Overall Study|No post-treatment questionnaire|279|||
170429997|NCT00705666|615914026|FG000|Overall Study|Withdrawal by Subject|21|||
170429998|NCT00705666|615914026|FG000|Overall Study|Physician Decision|7|||
170429999|NCT00705666|615914026|FG000|Overall Study|Lost to Follow-up|5|||
170430000|NCT00705666|615914026|FG000|Overall Study|Death|1|||
170430001|NCT00705666|615914026|FG000|Overall Study|Adverse Event|4|||
170430002|NCT00705666|615914026|FG000|Overall Study|Other|12|||
170430003|NCT00705666|615914026|FG000|Overall Study|Other|2|||
170430004|NCT00705666|615914026|FG000|Overall Study|Lack of data|3|||
170430005|NCT00705666|615914026|FG000|Overall Study|Untreated|5|||
170430006|NCT03256695|615914028|FG000|Overall Study|Adverse Event|8|||
170430007|NCT03256695|615914028|FG000|Overall Study|Death|2|||
170430008|NCT03256695|615914028|FG000|Overall Study|Withdrawal by Subject|14|||
170430009|NCT03256695|615914028|FG000|Overall Study|Non-compliance with study drug|1|||
170430010|NCT03256695|615914028|FG000|Overall Study|Lost to Follow-up|3|||
170430011|NCT03256695|615914028|FG000|Overall Study|Lack of Efficacy|3|||
170430012|NCT03256695|615914028|FG000|Overall Study|Protocol Violation|5|||
170430013|NCT03256695|615914028|FG000|Overall Study|Other than specified|3|||
170430014|NCT03663179|615914031|FG000|Overall Study|Withdrawal by Subject|2|||
170430015|NCT03663179|615914032|FG001|Overall Study|Withdrawal by Subject|0|||
170430016|NCT03663179|615914031|FG000|Overall Study|Lost to Follow-up|1|||
170430017|NCT03663179|615914032|FG001|Overall Study|Lost to Follow-up|1|||
170430018|NCT03663179|615914031|FG000|Overall Study|Revealed exclusionary condition|1|||
170430019|NCT03663179|615914032|FG001|Overall Study|Revealed exclusionary condition|0|||
170430020|NCT02089685|615914033|FG000|Overall Study|Adverse Event|1|||
170430021|NCT02089685|615914034|FG001|Overall Study|Adverse Event|0|||
170430022|NCT02089685|615914035|FG002|Overall Study|Adverse Event|0|||
170430023|NCT02089685|615914036|FG003|Overall Study|Adverse Event|0|||
170430024|NCT02089685|615914037|FG004|Overall Study|Adverse Event|1|||
170430025|NCT02089685|615914038|FG005|Overall Study|Adverse Event|0|||
170430026|NCT02089685|615914033|FG000|Overall Study|Clinical Progression|4|||
170430027|NCT02089685|615914034|FG001|Overall Study|Clinical Progression|0|||
170430028|NCT02089685|615914035|FG002|Overall Study|Clinical Progression|0|||
170430029|NCT02089685|615914036|FG003|Overall Study|Clinical Progression|5|||
170430030|NCT02089685|615914037|FG004|Overall Study|Clinical Progression|1|||
170430031|NCT02089685|615914038|FG005|Overall Study|Clinical Progression|2|||
170430032|NCT02089685|615914033|FG000|Overall Study|Excluded Medication|1|||
170430033|NCT02089685|615914034|FG001|Overall Study|Excluded Medication|0|||
170430034|NCT02089685|615914035|FG002|Overall Study|Excluded Medication|0|||
170430035|NCT02089685|615914036|FG003|Overall Study|Excluded Medication|11|||
170430036|NCT02089685|615914037|FG004|Overall Study|Excluded Medication|2|||
170430037|NCT02089685|615914038|FG005|Overall Study|Excluded Medication|1|||
170430038|NCT02089685|615914033|FG000|Overall Study|Progressive disease|13|||
170430039|NCT02089685|615914034|FG001|Overall Study|Progressive disease|10|||
170430040|NCT02089685|615914035|FG002|Overall Study|Progressive disease|3|||
170430041|NCT02089685|615914036|FG003|Overall Study|Progressive disease|51|||
170430042|NCT02089685|615914037|FG004|Overall Study|Progressive disease|17|||
170430043|NCT02089685|615914038|FG005|Overall Study|Progressive disease|12|||
170430044|NCT02089685|615914033|FG000|Overall Study|Follow up ended by sponsor|2|||
170430045|NCT02089685|615914034|FG001|Overall Study|Follow up ended by sponsor|2|||
170430046|NCT02089685|615914035|FG002|Overall Study|Follow up ended by sponsor|0|||
170430047|NCT02089685|615914036|FG003|Overall Study|Follow up ended by sponsor|70|||
170430048|NCT02089685|615914037|FG004|Overall Study|Follow up ended by sponsor|26|||
170430049|NCT02089685|615914038|FG005|Overall Study|Follow up ended by sponsor|26|||
170430050|NCT02089685|615914033|FG000|Overall Study|Withdrawal by Subject|0|||
170430051|NCT02089685|615914034|FG001|Overall Study|Withdrawal by Subject|2|||
170430052|NCT02089685|615914035|FG002|Overall Study|Withdrawal by Subject|0|||
170430053|NCT02089685|615914036|FG003|Overall Study|Withdrawal by Subject|8|||
170430054|NCT02089685|615914037|FG004|Overall Study|Withdrawal by Subject|1|||
170430055|NCT02089685|615914038|FG005|Overall Study|Withdrawal by Subject|1|||
170430056|NCT02089685|615914033|FG000|Overall Study|Status not recorded|1|||
170430057|NCT02089685|615914034|FG001|Overall Study|Status not recorded|0|||
170430058|NCT02089685|615914035|FG002|Overall Study|Status not recorded|0|||
170430059|NCT02089685|615914036|FG003|Overall Study|Status not recorded|0|||
170430060|NCT02089685|615914037|FG004|Overall Study|Status not recorded|1|||
170430061|NCT02089685|615914038|FG005|Overall Study|Status not recorded|0|||
170430062|NCT02089685|615914033|FG000|Overall Study|Death|0|||
170430063|NCT02089685|615914034|FG001|Overall Study|Death|0|||
170430064|NCT02089685|615914035|FG002|Overall Study|Death|0|||
170430065|NCT02089685|615914036|FG003|Overall Study|Death|7|||
170430066|NCT02089685|615914037|FG004|Overall Study|Death|2|||
170535273|NCT03573297|616304210|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
170430067|NCT02089685|615914038|FG005|Overall Study|Death|5|||
170430068|NCT02089685|615914033|FG000|Overall Study|Lost to Follow-up|0|||
170430069|NCT02089685|615914034|FG001|Overall Study|Lost to Follow-up|0|||
170430070|NCT02089685|615914035|FG002|Overall Study|Lost to Follow-up|0|||
170430071|NCT02089685|615914036|FG003|Overall Study|Lost to Follow-up|1|||
170430072|NCT02089685|615914037|FG004|Overall Study|Lost to Follow-up|0|||
170430073|NCT02089685|615914038|FG005|Overall Study|Lost to Follow-up|0|||
170430074|NCT02089685|615914033|FG000|Overall Study|Physician Decision|0|||
170430075|NCT02089685|615914034|FG001|Overall Study|Physician Decision|0|||
170430076|NCT02089685|615914035|FG002|Overall Study|Physician Decision|0|||
170430077|NCT02089685|615914036|FG003|Overall Study|Physician Decision|0|||
170430078|NCT02089685|615914037|FG004|Overall Study|Physician Decision|0|||
170880319|NCT00621504|617572738|FG000|Overall Study|Death|6|||
170880320|NCT00621504|617572739|FG001|Overall Study|Death|6|||
170880321|NCT03246958|617572742|FG000|Overall Study|Withdrawal by Subject|0|||
170430079|NCT02089685|615914038|FG005|Overall Study|Physician Decision|4|||
170430080|NCT02089685|615914033|FG000|Overall Study|Screen failure|1|||
170430081|NCT02089685|615914034|FG001|Overall Study|Screen failure|0|||
170430082|NCT02089685|615914035|FG002|Overall Study|Screen failure|0|||
170430083|NCT02089685|615914036|FG003|Overall Study|Screen failure|0|||
170430084|NCT02089685|615914037|FG004|Overall Study|Screen failure|0|||
170430085|NCT02089685|615914038|FG005|Overall Study|Screen failure|0|||
170430086|NCT03792477|615914045|FG000|Overall Study|Adverse Event|0|||
170430087|NCT03792477|615914046|FG001|Overall Study|Adverse Event|0|||
170430088|NCT03792477|615914047|FG002|Overall Study|Adverse Event|0|||
170430089|NCT03792477|615914048|FG003|Overall Study|Adverse Event|1|||
170430090|NCT03792477|615914049|FG004|Overall Study|Adverse Event|0|||
170430091|NCT03792477|615914045|FG000|Overall Study|Lost to Follow-up|0|||
170430092|NCT03792477|615914046|FG001|Overall Study|Lost to Follow-up|0|||
170430093|NCT03792477|615914047|FG002|Overall Study|Lost to Follow-up|2|||
170430094|NCT03792477|615914048|FG003|Overall Study|Lost to Follow-up|0|||
170880322|NCT03246958|617572743|FG001|Overall Study|Withdrawal by Subject|1|||
170880323|NCT03246958|617572744|FG002|Overall Study|Withdrawal by Subject|0|||
170880324|NCT03246958|617572745|FG003|Overall Study|Withdrawal by Subject|0|||
170430095|NCT03792477|615914049|FG004|Overall Study|Lost to Follow-up|0|||
170430096|NCT03792477|615914045|FG000|Overall Study|Other|0|||
170430097|NCT03792477|615914046|FG001|Overall Study|Other|0|||
170430098|NCT03792477|615914047|FG002|Overall Study|Other|0|||
170430099|NCT03792477|615914048|FG003|Overall Study|Other|0|||
170430100|NCT03792477|615914049|FG004|Overall Study|Other|1|||
170430101|NCT00840411|615914051|FG000|First Intervention|Adverse Event|1|||
170430102|NCT00840411|615914052|FG001|First Intervention|Adverse Event|0|||
170430103|NCT00840411|615914051|FG000|Washout|Withdrawal by Subject|1|||
170430104|NCT00840411|615914052|FG001|Washout|Withdrawal by Subject|0|||
170430105|NCT01576042|615914054|FG000|Overall Study|Physician Decision|2|||
170430106|NCT01576042|615914055|FG001|Overall Study|Physician Decision|0|||
170430107|NCT00773253|615914058|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
170430108|NCT00773253|615914059|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
170430109|NCT00657553|615914063|FG000|Overall Study|low accrual, no analysis run|5|||
170430110|NCT00657553|615914064|FG001|Overall Study|low accrual, no analysis run|5|||
170430111|NCT03134222|615914065|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
170430112|NCT03134222|615914066|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
170430113|NCT03134222|615914067|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
170430114|NCT03134222|615914068|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
170430115|NCT03134222|615914069|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
170430116|NCT03134222|615914065|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
170430117|NCT03134222|615914066|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
170430118|NCT03134222|615914067|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
170430119|NCT03134222|615914068|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
170430120|NCT03134222|615914069|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
170430121|NCT03134222|615914065|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
170430122|NCT03134222|615914066|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
170430123|NCT03134222|615914067|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
170430124|NCT03134222|615914068|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
170430125|NCT03134222|615914069|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
170430126|NCT03134222|615914065|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
170430127|NCT03134222|615914066|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
170430128|NCT03134222|615914067|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
170430129|NCT03134222|615914068|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
170430130|NCT03134222|615914069|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
170430131|NCT03134222|615914065|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
170430132|NCT03134222|615914066|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
170880325|NCT03246958|617572746|FG004|Overall Study|Withdrawal by Subject|0|||
170880326|NCT03246958|617572747|FG005|Overall Study|Withdrawal by Subject|1|||
170880327|NCT03246958|617572748|FG006|Overall Study|Withdrawal by Subject|0|||
170430133|NCT03134222|615914067|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
170430134|NCT03134222|615914068|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
170430135|NCT03134222|615914069|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
170430136|NCT03134222|615914065|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
170430137|NCT03134222|615914066|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
170430138|NCT03134222|615914067|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
170430139|NCT03134222|615914068|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
170430140|NCT03134222|615914069|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
170430141|NCT03134222|615914065|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
170430142|NCT03134222|615914066|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
170880328|NCT03246958|617572742|FG000|Overall Study|Progression|13|||
170880329|NCT03246958|617572743|FG001|Overall Study|Progression|9|||
170880330|NCT03246958|617572744|FG002|Overall Study|Progression|3|||
170880331|NCT03246958|617572745|FG003|Overall Study|Progression|2|||
170880332|NCT03246958|617572746|FG004|Overall Study|Progression|1|||
170880333|NCT03246958|617572747|FG005|Overall Study|Progression|2|||
170880334|NCT03246958|617572748|FG006|Overall Study|Progression|1|||
170535274|NCT03573297|616304211|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
170535275|NCT03573297|616304208|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170880335|NCT03246958|617572742|FG000|Overall Study|Adverse Event|2|||
170535276|NCT03573297|616304209|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
170880336|NCT03246958|617572743|FG001|Overall Study|Adverse Event|2|||
170880337|NCT03246958|617572744|FG002|Overall Study|Adverse Event|0|||
170880338|NCT03246958|617572745|FG003|Overall Study|Adverse Event|1|||
170880339|NCT03246958|617572746|FG004|Overall Study|Adverse Event|1|||
170880340|NCT03246958|617572747|FG005|Overall Study|Adverse Event|0|||
170880341|NCT03246958|617572748|FG006|Overall Study|Adverse Event|2|||
170880342|NCT03246958|617572742|FG000|Overall Study|Death|0|||
170880343|NCT03246958|617572743|FG001|Overall Study|Death|1|||
170880344|NCT03246958|617572744|FG002|Overall Study|Death|0|||
170880345|NCT03246958|617572745|FG003|Overall Study|Death|0|||
170880346|NCT03246958|617572746|FG004|Overall Study|Death|0|||
170880347|NCT03246958|617572747|FG005|Overall Study|Death|0|||
170880348|NCT03246958|617572748|FG006|Overall Study|Death|0|||
170880349|NCT03246958|617572742|FG000|Overall Study|Physician Decision|0|||
170880350|NCT03246958|617572743|FG001|Overall Study|Physician Decision|0|||
170880351|NCT03246958|617572744|FG002|Overall Study|Physician Decision|0|||
170880352|NCT03246958|617572745|FG003|Overall Study|Physician Decision|1|||
170880353|NCT03246958|617572746|FG004|Overall Study|Physician Decision|0|||
170880354|NCT03246958|617572747|FG005|Overall Study|Physician Decision|0|||
170880355|NCT03246958|617572748|FG006|Overall Study|Physician Decision|0|||
170880356|NCT03246958|617572742|FG000|Overall Study|Never start treatment|1|||
170880357|NCT03246958|617572743|FG001|Overall Study|Never start treatment|0|||
170880358|NCT03246958|617572744|FG002|Overall Study|Never start treatment|0|||
170880359|NCT03246958|617572745|FG003|Overall Study|Never start treatment|0|||
170880360|NCT03246958|617572746|FG004|Overall Study|Never start treatment|0|||
170880361|NCT03246958|617572747|FG005|Overall Study|Never start treatment|0|||
170880362|NCT03246958|617572748|FG006|Overall Study|Never start treatment|0|||
170880363|NCT03246958|617572742|FG000|Overall Study|Over enrollment|0|||
170880364|NCT03246958|617572743|FG001|Overall Study|Over enrollment|2|||
170880365|NCT03246958|617572744|FG002|Overall Study|Over enrollment|0|||
170880366|NCT03246958|617572745|FG003|Overall Study|Over enrollment|0|||
170880367|NCT03246958|617572746|FG004|Overall Study|Over enrollment|0|||
170880368|NCT03246958|617572747|FG005|Overall Study|Over enrollment|0|||
170880369|NCT03246958|617572748|FG006|Overall Study|Over enrollment|0|||
170880370|NCT02311153|617572751|FG000|Overall Study|Lost to Follow-up|5|||
170880371|NCT02311153|617572752|FG001|Overall Study|Lost to Follow-up|7|||
170880372|NCT00838331|617572753|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
170880373|NCT03571646|617572756|FG000|Overall Study|Adverse Event|1|||
170880374|NCT03571646|617572757|FG001|Overall Study|Adverse Event|0|||
170880375|NCT03571646|617572756|FG000|Overall Study|Withdrawal by Subject|1|||
170880376|NCT03571646|617572757|FG001|Overall Study|Withdrawal by Subject|1|||
170880377|NCT01500278|617572758|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
170880378|NCT01500278|617572759|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
170880379|NCT01500278|617572758|FG000|Week 0 - Week 12|Protocol Violation|10|||
170880380|NCT01500278|617572759|FG001|Week 0 - Week 12|Protocol Violation|16|||
170880381|NCT01500278|617572758|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
170880382|NCT01500278|617572759|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
170880383|NCT01500278|617572758|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
170880384|NCT01500278|617572759|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
170880385|NCT01500278|617572758|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
170880386|NCT01500278|617572759|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
170880387|NCT01500278|617572758|FG000|Week 0 - Week 12|Patient decision|1|||
170880388|NCT01500278|617572759|FG001|Week 0 - Week 12|Patient decision|0|||
170880389|NCT01500278|617572758|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
170880390|NCT01500278|617572759|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
170880391|NCT01500278|617572758|FG000|Week 0 - Week 12|Investigator decision|1|||
170880392|NCT01500278|617572759|FG001|Week 0 - Week 12|Investigator decision|0|||
170880393|NCT01500278|617572758|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
170880394|NCT01500278|617572759|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
170880395|NCT01500278|617572758|FG000|Week 0 - Week 12|Sponsor decision|1|||
170880396|NCT01500278|617572759|FG001|Week 0 - Week 12|Sponsor decision|0|||
170880397|NCT01500278|617572758|FG000|Week 0 - Week 12|Personal reason|0|||
170880398|NCT01500278|617572759|FG001|Week 0 - Week 12|Personal reason|1|||
170880399|NCT01500278|617572758|FG000|Week 0 - Week 12|Other serious disease|0|||
170880400|NCT01500278|617572759|FG001|Week 0 - Week 12|Other serious disease|1|||
170880401|NCT01500278|617572758|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
170880402|NCT01500278|617572759|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
170880403|NCT01500278|617572758|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
170430143|NCT03134222|615914067|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
170430144|NCT03134222|615914068|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
170430145|NCT03134222|615914069|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
170430146|NCT03134222|615914065|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
170430147|NCT03134222|615914066|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
170430148|NCT03134222|615914067|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
170430149|NCT03134222|615914068|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
170430150|NCT03134222|615914069|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
170430151|NCT02605928|615914070|FG000|Overall Study|Model tuning phase|28|||
170430152|NCT02605928|615914070|FG000|Overall Study|Lack of Efficacy|5|||
170430153|NCT03482882|615914071|FG000|Overall Study|Adverse Event|3|||
170430154|NCT03482882|615914071|FG000|Overall Study|Lost to Follow-up|1|||
170430155|NCT03482882|615914071|FG000|Overall Study|Protocol Violation|2|||
170430156|NCT03482882|615914071|FG000|Overall Study|Not further specified|1|||
170535277|NCT03573297|616304210|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
170535278|NCT03573297|616304211|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
170535279|NCT03573297|616304208|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
170535280|NCT03573297|616304209|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
170535281|NCT03573297|616304210|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
170535282|NCT03573297|616304211|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
170535283|NCT03573297|616304208|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
170535284|NCT03573297|616304209|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
170535285|NCT03573297|616304210|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
170535286|NCT03573297|616304211|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
170535287|NCT03573297|616304208|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
170535288|NCT03573297|616304209|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
170430157|NCT02530905|615914074|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
170430158|NCT02530905|615914075|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
170430159|NCT02530905|615914076|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
170430160|NCT01136174|615914079|FG000|Overall Study|Adverse Event|0|||
170430161|NCT01136174|615914080|FG001|Overall Study|Adverse Event|0|||
170430162|NCT01136174|615914081|FG002|Overall Study|Adverse Event|0|||
170430163|NCT01136174|615914082|FG003|Overall Study|Adverse Event|4|||
170430164|NCT00811655|615914087|FG000|Overall Study|Physician Decision|1|||
170430165|NCT00787254|615914091|FG000|Overall Study|Adverse Event|24|||
170430166|NCT00787254|615914092|FG001|Overall Study|Adverse Event|23|||
170430167|NCT00787254|615914091|FG000|Overall Study|Protocol Violation|26|||
170430168|NCT00787254|615914092|FG001|Overall Study|Protocol Violation|23|||
170430169|NCT00787254|615914091|FG000|Overall Study|Withdrawal by Subject|16|||
170430170|NCT00787254|615914092|FG001|Overall Study|Withdrawal by Subject|11|||
170430171|NCT00787254|615914091|FG000|Overall Study|Lack of Efficacy|4|||
170430172|NCT00787254|615914092|FG001|Overall Study|Lack of Efficacy|15|||
170430173|NCT00787254|615914091|FG000|Overall Study|NSAIDs discontinuation|1|||
170430174|NCT00787254|615914092|FG001|Overall Study|NSAIDs discontinuation|2|||
170430175|NCT00787254|615914091|FG000|Overall Study|Institution closed|1|||
170430176|NCT00787254|615914092|FG001|Overall Study|Institution closed|0|||
170430177|NCT00787254|615914091|FG000|Overall Study|Physician Decision|4|||
170430178|NCT00787254|615914092|FG001|Overall Study|Physician Decision|8|||
170430179|NCT00859430|615914093|FG000|First Intervention|Withdrawal by Subject|0|||
170430180|NCT00859430|615914094|FG001|First Intervention|Withdrawal by Subject|1|||
170430181|NCT00834795|615915518|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
170430182|NCT00834795|615915519|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
170430183|NCT00834795|615915518|FG000|Second Intervention|Adverse Event|1|||
170430184|NCT00834795|615915519|FG001|Second Intervention|Adverse Event|0|||
170430185|NCT02566850|615915523|FG000|Overall Study|Protocol Violation|1|||
170430186|NCT02255149|615915525|FG000|Overall Study|Lost to Follow-up|2|||
170430187|NCT02255149|615915525|FG000|Overall Study|Withdrawal by Subject|1|||
170430188|NCT02255149|615915525|FG000|Overall Study|Withdrawal by PI|1|||
170430189|NCT02255149|615915525|FG000|Overall Study|Implant Failure|1|||
170430190|NCT00373256|615915526|FG000|Overall Study|Adverse Event (AE)|1|||
170430191|NCT00373256|615915527|FG001|Overall Study|Adverse Event (AE)|5|||
170430192|NCT00373256|615915526|FG000|Overall Study|Lost to Follow-up|2|||
170430193|NCT00373256|615915527|FG001|Overall Study|Lost to Follow-up|1|||
170430194|NCT00373256|615915526|FG000|Overall Study|Death|9|||
170430195|NCT00373256|615915527|FG001|Overall Study|Death|8|||
170430196|NCT00373256|615915526|FG000|Overall Study|Objective Progression or Relapse|111|||
170430197|NCT00373256|615915527|FG001|Overall Study|Objective Progression or Relapse|104|||
170430198|NCT00373256|615915526|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
170430199|NCT00373256|615915527|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
170430200|NCT00373256|615915526|FG000|Overall Study|Other|73|||
170430201|NCT00373256|615915527|FG001|Overall Study|Other|107|||
170430202|NCT00373256|615915526|FG000|Overall Study|Protocol Violation|0|||
170430203|NCT00373256|615915527|FG001|Overall Study|Protocol Violation|2|||
170430204|NCT00373256|615915526|FG000|Overall Study|Study Terminated by Sponsor|41|||
170430205|NCT00373256|615915527|FG001|Overall Study|Study Terminated by Sponsor|13|||
170430206|NCT02146105|615915528|FG000|Overall Study|Adverse Event|1|||
170430207|NCT02146105|615915528|FG000|Overall Study|Withdrawal by Subject|5|||
170430208|NCT02718326|615915531|FG000|Overall Study|Adverse Event|4|||
170430209|NCT02718326|615915532|FG001|Overall Study|Adverse Event|9|||
170430210|NCT02718326|615915533|FG002|Overall Study|Adverse Event|0|||
170430211|NCT02718326|615915531|FG000|Overall Study|Death|8|||
170430212|NCT02718326|615915532|FG001|Overall Study|Death|1|||
170430213|NCT02718326|615915533|FG002|Overall Study|Death|2|||
170430214|NCT02718326|615915531|FG000|Overall Study|Withdrawal by Subject|4|||
170430215|NCT02718326|615915532|FG001|Overall Study|Withdrawal by Subject|9|||
170430216|NCT02718326|615915533|FG002|Overall Study|Withdrawal by Subject|6|||
170430217|NCT02718326|615915531|FG000|Overall Study|Lost to Follow-up|18|||
170430218|NCT02718326|615915532|FG001|Overall Study|Lost to Follow-up|5|||
170430219|NCT02718326|615915533|FG002|Overall Study|Lost to Follow-up|14|||
170430220|NCT02718326|615915531|FG000|Overall Study|Protocol Deviation|1|||
170535289|NCT03573297|616304210|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
170535290|NCT03573297|616304211|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
170430221|NCT02718326|615915532|FG001|Overall Study|Protocol Deviation|0|||
170430222|NCT02718326|615915533|FG002|Overall Study|Protocol Deviation|0|||
170430223|NCT02718326|615915531|FG000|Overall Study|Pregnancy|1|||
170430224|NCT02718326|615915532|FG001|Overall Study|Pregnancy|0|||
170430225|NCT02718326|615915533|FG002|Overall Study|Pregnancy|0|||
170430226|NCT03600805|615915534|FG000|Overall Study|Adverse Event|2|||
170430227|NCT03600805|615915535|FG001|Overall Study|Adverse Event|1|||
170430228|NCT03600805|615915536|FG002|Overall Study|Adverse Event|1|||
170430229|NCT03600805|615915537|FG003|Overall Study|Adverse Event|7|||
170430230|NCT03600805|615915534|FG000|Overall Study|Lack of Efficacy|2|||
170430231|NCT03600805|615915535|FG001|Overall Study|Lack of Efficacy|1|||
170430232|NCT03600805|615915536|FG002|Overall Study|Lack of Efficacy|0|||
170430233|NCT03600805|615915537|FG003|Overall Study|Lack of Efficacy|0|||
170430234|NCT03600805|615915534|FG000|Overall Study|Withdrawal by Subject|1|||
170430235|NCT03600805|615915535|FG001|Overall Study|Withdrawal by Subject|0|||
170430236|NCT03600805|615915536|FG002|Overall Study|Withdrawal by Subject|0|||
170430237|NCT03600805|615915537|FG003|Overall Study|Withdrawal by Subject|1|||
170430238|NCT03600805|615915534|FG000|Overall Study|Other unspecified|14|||
170430239|NCT03600805|615915535|FG001|Overall Study|Other unspecified|6|||
170430240|NCT03600805|615915536|FG002|Overall Study|Other unspecified|7|||
170430241|NCT03600805|615915537|FG003|Overall Study|Other unspecified|11|||
170430242|NCT06195579|615915538|FG000|Overall Study|Withdrawal by Subject|1|||
170430243|NCT03868891|615915541|FG000|Overall Study|Adverse Event|1|||
170430244|NCT03868891|615915542|FG001|Overall Study|Adverse Event|0|||
170430245|NCT03868891|615915541|FG000|Overall Study|Lost to Follow-up|2|||
170430246|NCT03868891|615915542|FG001|Overall Study|Lost to Follow-up|1|||
170430247|NCT03868891|615915541|FG000|Overall Study|COVID-19 Restrictions|1|||
170430248|NCT03868891|615915542|FG001|Overall Study|COVID-19 Restrictions|2|||
170430249|NCT03049748|615915543|FG000|Overall Study|Lost to Follow-up|1|||
170430250|NCT03049748|615915544|FG001|Overall Study|Lost to Follow-up|0|||
170430251|NCT03049748|615915543|FG000|Overall Study|Death|3|||
170430252|NCT03049748|615915544|FG001|Overall Study|Death|0|||
170430253|NCT03049748|615915543|FG000|Overall Study|Withdrawal by Subject|0|||
170430254|NCT03049748|615915544|FG001|Overall Study|Withdrawal by Subject|3|||
170430255|NCT03049748|615915543|FG000|Overall Study|Protocol Violation|0|||
170430256|NCT03049748|615915544|FG001|Overall Study|Protocol Violation|2|||
170430257|NCT03049748|615915543|FG000|Overall Study|Moved out of state (relocation)|0|||
170430258|NCT03049748|615915544|FG001|Overall Study|Moved out of state (relocation)|1|||
170430259|NCT03689400|615915550|FG000|Overall Study|Lost to Follow-up|4|||
170430260|NCT02075463|615915551|FG000|Overall Study|Adverse Event|3|||
170430261|NCT02075463|615915551|FG000|Overall Study|Par. reached stopping criteria|4|||
170430262|NCT02075463|615915551|FG000|Overall Study|Withdrawal by Subject|1|||
170430263|NCT00673660|615915555|FG000|Overall Study|Lost to Follow-up|107|||
170430264|NCT03673670|615915564|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
170430265|NCT03673670|615915565|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
170430266|NCT03673670|615915566|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
170430267|NCT03673670|615915567|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
170430268|NCT03673670|615915568|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
170430269|NCT03673670|615915569|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
170430270|NCT03673670|615915564|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
170430271|NCT03673670|615915565|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
170430272|NCT03673670|615915566|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
170430273|NCT03673670|615915567|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
170430274|NCT03673670|615915568|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
170430275|NCT03673670|615915569|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
170430276|NCT03673670|615915564|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
170430277|NCT03673670|615915565|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
170430278|NCT03673670|615915566|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
170430279|NCT03673670|615915567|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
170430280|NCT03673670|615915568|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
170430281|NCT03673670|615915569|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
170430282|NCT03673670|615915564|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
170430283|NCT03673670|615915565|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
170430284|NCT03673670|615915566|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
170430285|NCT03673670|615915567|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
170430286|NCT03673670|615915568|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
170430287|NCT03673670|615915569|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
170430288|NCT03673670|615915564|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
170535291|NCT02696798|616304213|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
170535292|NCT02696798|616304214|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
170535293|NCT02696798|616304215|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
170535294|NCT02696798|616304213|FG000|Blinded Treatment Dosing Period|Death|0|||
170430289|NCT03673670|615915565|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
170430290|NCT03673670|615915566|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
170535295|NCT02696798|616304214|FG001|Blinded Treatment Dosing Period|Death|0|||
170535296|NCT02696798|616304215|FG002|Blinded Treatment Dosing Period|Death|1|||
170430291|NCT03673670|615915567|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
170430292|NCT03673670|615915568|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
170430293|NCT03673670|615915569|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
170430294|NCT03673670|615915564|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
170430295|NCT03673670|615915565|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
170430296|NCT03673670|615915566|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
170430297|NCT03673670|615915567|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
170430298|NCT03673670|615915568|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
170430299|NCT03673670|615915569|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
170430300|NCT03673670|615915564|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
170430301|NCT03673670|615915565|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
170430302|NCT03673670|615915566|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
170430303|NCT03673670|615915567|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
170430304|NCT03673670|615915568|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
170430305|NCT03673670|615915569|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
170430306|NCT03437265|615915570|FG000|Overall Study|Protocol Violation|6|||
170430307|NCT01778010|615915571|FG000|Overall Study|Withdrawal by Subject|2|||
170430308|NCT01778010|615915571|FG000|Overall Study|abnormal ECG before meds|1|||
170430309|NCT01778010|615915571|FG000|Overall Study|Arrested|1|||
170430310|NCT01778010|615915571|FG000|Overall Study|rash while on placebo|1|||
170430311|NCT04238754|615915577|FG000|Washout - 1 Week|Lost to Follow-up|1|||
170430312|NCT04238754|615915578|FG001|Washout - 1 Week|Lost to Follow-up|0|||
170430313|NCT02159183|615915579|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
170430314|NCT02159183|615915580|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
170430315|NCT02159183|615915579|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
170430316|NCT02159183|615915580|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
170430317|NCT02159183|615915579|FG000|Analysis After the 36 Months Follow-up|Death|0|||
170430318|NCT02159183|615915580|FG001|Analysis After the 36 Months Follow-up|Death|1|||
170430319|NCT02159183|615915579|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
170430320|NCT02159183|615915580|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
170430321|NCT02159183|615915579|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
170430322|NCT02159183|615915580|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
170430323|NCT02558491|615915588|FG000|First Invention|Withdrawal by Subject|3|||
170430324|NCT02558491|615915589|FG001|First Invention|Withdrawal by Subject|1|||
170430325|NCT02558491|615915588|FG000|First Invention|Data collection issues|1|||
170430326|NCT02558491|615915589|FG001|First Invention|Data collection issues|0|||
170430327|NCT02558491|615915588|FG000|First Invention|Stopping criteria|0|||
170430328|NCT02558491|615915589|FG001|First Invention|Stopping criteria|1|||
170430329|NCT02558491|615915588|FG000|First Invention|Changed parameters during trial|1|||
170430330|NCT02558491|615915589|FG001|First Invention|Changed parameters during trial|0|||
170430331|NCT02558491|615915588|FG000|Second Intervention|Withdrawal by Subject|1|||
170430332|NCT02558491|615915589|FG001|Second Intervention|Withdrawal by Subject|0|||
170430333|NCT02558491|615915588|FG000|Second Intervention|Stopping Criteria|1|||
170430334|NCT02558491|615915589|FG001|Second Intervention|Stopping Criteria|0|||
170430335|NCT03406156|615915599|FG000|Overall Study|Death|9|||
170430336|NCT03406156|615915600|FG001|Overall Study|Death|3|||
170430337|NCT03406156|615915599|FG000|Overall Study|Withdrawal by Subject|1|||
170430338|NCT03406156|615915600|FG001|Overall Study|Withdrawal by Subject|2|||
170430339|NCT03406156|615915599|FG000|Overall Study|COVID-19 infection|1|||
170430340|NCT03406156|615915600|FG001|Overall Study|COVID-19 infection|0|||
170430341|NCT03406156|615915599|FG000|Overall Study|Non-compliance with study procedures|1|||
170430342|NCT03406156|615915600|FG001|Overall Study|Non-compliance with study procedures|1|||
170535297|NCT02696798|616304213|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
170880404|NCT01500278|617572759|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
170880405|NCT01500278|617572758|FG000|Week 13 - Week 104|Protocol Violation|6|||
170535298|NCT02696798|616304214|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
170535299|NCT02696798|616304215|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
170535300|NCT02696798|616304213|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
170535301|NCT02696798|616304214|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
170535302|NCT02696798|616304215|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
170535303|NCT02696798|616304213|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
170535304|NCT02696798|616304214|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
170535305|NCT02696798|616304215|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
170535306|NCT02696798|616304213|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
170430343|NCT03406156|615915599|FG000|Overall Study|Lost to Follow-up|0|||
170430344|NCT03406156|615915600|FG001|Overall Study|Lost to Follow-up|2|||
170430345|NCT03406156|615915599|FG000|Overall Study|Other, not specified|72|||
170430346|NCT03406156|615915600|FG001|Overall Study|Other, not specified|28|||
170430347|NCT02964039|615915603|FG000|Overall Study|Medical reason unrelated to study participation|1|||
170535307|NCT02696798|616304214|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
170535308|NCT02696798|616304215|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
170535309|NCT02696798|616304213|FG000|Extended Treatment Period|Adverse Event|1|||
170535310|NCT02696798|616304214|FG001|Extended Treatment Period|Adverse Event|4|||
170535311|NCT02696798|616304215|FG002|Extended Treatment Period|Adverse Event|5|||
170535312|NCT02696798|616304213|FG000|Extended Treatment Period|Lack of Efficacy|7|||
170535313|NCT02696798|616304214|FG001|Extended Treatment Period|Lack of Efficacy|2|||
170535314|NCT02696798|616304215|FG002|Extended Treatment Period|Lack of Efficacy|2|||
170535315|NCT02696798|616304213|FG000|Extended Treatment Period|Lost to Follow-up|1|||
170535316|NCT02696798|616304214|FG001|Extended Treatment Period|Lost to Follow-up|0|||
170535317|NCT02696798|616304215|FG002|Extended Treatment Period|Lost to Follow-up|0|||
170535318|NCT02696798|616304213|FG000|Extended Treatment Period|Physician Decision|0|||
170535319|NCT02696798|616304214|FG001|Extended Treatment Period|Physician Decision|1|||
170535320|NCT02696798|616304215|FG002|Extended Treatment Period|Physician Decision|0|||
170535321|NCT02696798|616304213|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
170535322|NCT02696798|616304214|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
170535323|NCT02696798|616304215|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
170535324|NCT02696798|616304213|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
170535325|NCT02696798|616304214|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
170535326|NCT02696798|616304215|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
170535327|NCT02696798|616304213|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
170535328|NCT02696798|616304214|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
170535329|NCT02696798|616304215|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
170535330|NCT02696798|616304213|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
170535331|NCT02696798|616304214|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
170535332|NCT02696798|616304215|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
170535333|NCT02696798|616304213|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
170535334|NCT02696798|616304214|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
170535335|NCT02696798|616304215|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
170535336|NCT02696798|616304213|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
170535337|NCT02696798|616304214|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
170535338|NCT02696798|616304215|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
170535339|NCT02696798|616304213|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
170535340|NCT02696798|616304214|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
170535341|NCT02696798|616304215|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
170535342|NCT04091451|616304216|FG000|Overall Study|Adverse Event|15|||
170535343|NCT04091451|616304217|FG001|Overall Study|Adverse Event|10|||
170535344|NCT04091451|616304216|FG000|Overall Study|Lost to Follow-up|8|||
170535345|NCT04091451|616304217|FG001|Overall Study|Lost to Follow-up|8|||
170535346|NCT04091451|616304216|FG000|Overall Study|Protocol Violation|5|||
170535347|NCT04091451|616304217|FG001|Overall Study|Protocol Violation|4|||
170535348|NCT04091451|616304216|FG000|Overall Study|Withdrawal by Subject|21|||
170535349|NCT04091451|616304217|FG001|Overall Study|Withdrawal by Subject|27|||
170535350|NCT04091451|616304216|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
170535351|NCT04091451|616304217|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
170535352|NCT04091451|616304216|FG000|Overall Study|Migrated/moved from the study area|3|||
170535353|NCT04091451|616304217|FG001|Overall Study|Migrated/moved from the study area|5|||
170535354|NCT04091451|616304216|FG000|Overall Study|Suspected HZ episode|1|||
170535355|NCT04091451|616304217|FG001|Overall Study|Suspected HZ episode|0|||
170535356|NCT03907488|616304218|FG000|Overall Study|Adverse Event|20|||
170535357|NCT03907488|616304219|FG001|Overall Study|Adverse Event|20|||
170535358|NCT03907488|616304218|FG000|Overall Study|Withdrawal by Subject|9|||
170880406|NCT01500278|617572759|FG001|Week 13 - Week 104|Protocol Violation|6|||
170880407|NCT01500278|617572758|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
170430348|NCT02964039|615915604|FG001|Overall Study|Medical reason unrelated to study participation|0|||
170430349|NCT02964039|615915605|FG002|Overall Study|Medical reason unrelated to study participation|3|||
170430350|NCT02964039|615915603|FG000|Overall Study|Research shutdown due to pandemic|2|||
170430351|NCT02964039|615915604|FG001|Overall Study|Research shutdown due to pandemic|0|||
170430352|NCT02964039|615915605|FG002|Overall Study|Research shutdown due to pandemic|1|||
170430353|NCT02964039|615915603|FG000|Overall Study|Withdrawal by Subject|0|||
170430354|NCT02964039|615915604|FG001|Overall Study|Withdrawal by Subject|1|||
170430355|NCT02964039|615915605|FG002|Overall Study|Withdrawal by Subject|0|||
170430356|NCT02964039|615915603|FG000|Overall Study|Lost to Follow-up|1|||
170430357|NCT02964039|615915604|FG001|Overall Study|Lost to Follow-up|0|||
170430358|NCT02964039|615915605|FG002|Overall Study|Lost to Follow-up|1|||
170430359|NCT05479058|615915606|FG000|Overall Study|Withdrawal by Subject|1|||
170430360|NCT05479058|615915607|FG001|Overall Study|Withdrawal by Subject|1|||
170430361|NCT05479058|615915606|FG000|Overall Study|Study terminated by sponsor|10|||
170535359|NCT03907488|616304219|FG001|Overall Study|Withdrawal by Subject|13|||
170535360|NCT03907488|616304218|FG000|Overall Study|Lack of Efficacy|0|||
170535361|NCT03907488|616304219|FG001|Overall Study|Lack of Efficacy|9|||
170535362|NCT03907488|616304218|FG000|Overall Study|Death|3|||
170535363|NCT03907488|616304219|FG001|Overall Study|Death|8|||
170535364|NCT03907488|616304218|FG000|Overall Study|not protocol specified|5|||
170430362|NCT05479058|615915607|FG001|Overall Study|Study terminated by sponsor|10|||
170430363|NCT01103713|615915608|FG000|Overall Study|Lost to Follow-up|2|||
170430364|NCT01103713|615915608|FG000|Overall Study|Withdrawal by Subject|8|||
170430365|NCT01103713|615915608|FG000|Overall Study|Study terminated by sponsor|2|||
170430366|NCT01103713|615915608|FG000|Overall Study|Other|1|||
170430367|NCT02645409|615915609|FG000|Overall Study|Withdrawal by Subject|3|||
170430368|NCT02645409|615915610|FG001|Overall Study|Withdrawal by Subject|0|||
170430369|NCT02645409|615915609|FG000|Overall Study|Physician Decision|1|||
170430370|NCT02645409|615915610|FG001|Overall Study|Physician Decision|0|||
170430371|NCT01029340|615915611|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
170430372|NCT01029340|615915612|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
170430373|NCT01029340|615915613|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
170430374|NCT01029340|615915614|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
170430375|NCT01029340|615915615|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
170430376|NCT01029340|615915616|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
170430377|NCT01029340|615915611|FG000|Part B Treatment Period|Protocol Violation|0|||
170430378|NCT01029340|615915612|FG001|Part B Treatment Period|Protocol Violation|0|||
170430379|NCT01029340|615915613|FG002|Part B Treatment Period|Protocol Violation|1|||
170430380|NCT01029340|615915614|FG003|Part B Treatment Period|Protocol Violation|0|||
170430381|NCT01029340|615915615|FG004|Part B Treatment Period|Protocol Violation|0|||
170430382|NCT01029340|615915616|FG005|Part B Treatment Period|Protocol Violation|0|||
170430383|NCT01029340|615915611|FG000|Extension Period|Adverse Event|0|||
170430384|NCT01029340|615915612|FG001|Extension Period|Adverse Event|0|||
170430385|NCT01029340|615915613|FG002|Extension Period|Adverse Event|0|||
170430386|NCT01029340|615915614|FG003|Extension Period|Adverse Event|0|||
170430387|NCT01029340|615915615|FG004|Extension Period|Adverse Event|0|||
170430388|NCT01029340|615915616|FG005|Extension Period|Adverse Event|1|||
170430389|NCT01029340|615915611|FG000|Extension Period|starting another study|0|||
170430390|NCT01029340|615915612|FG001|Extension Period|starting another study|0|||
170430391|NCT01029340|615915613|FG002|Extension Period|starting another study|0|||
170430392|NCT01029340|615915614|FG003|Extension Period|starting another study|0|||
170430393|NCT01029340|615915615|FG004|Extension Period|starting another study|0|||
170430394|NCT01029340|615915616|FG005|Extension Period|starting another study|8|||
170430395|NCT01029340|615915611|FG000|Extension Period|non-compliance|0|||
170430396|NCT01029340|615915612|FG001|Extension Period|non-compliance|0|||
170430397|NCT01029340|615915613|FG002|Extension Period|non-compliance|0|||
170430398|NCT01029340|615915614|FG003|Extension Period|non-compliance|0|||
170430399|NCT01029340|615915615|FG004|Extension Period|non-compliance|0|||
170430400|NCT01029340|615915616|FG005|Extension Period|non-compliance|1|||
170430401|NCT01029340|615915611|FG000|Extension Period|Withdrawal by Subject|0|||
170430402|NCT01029340|615915612|FG001|Extension Period|Withdrawal by Subject|0|||
170430403|NCT01029340|615915613|FG002|Extension Period|Withdrawal by Subject|0|||
170430404|NCT01029340|615915614|FG003|Extension Period|Withdrawal by Subject|0|||
170430405|NCT01029340|615915615|FG004|Extension Period|Withdrawal by Subject|0|||
170430406|NCT01029340|615915616|FG005|Extension Period|Withdrawal by Subject|1|||
170430407|NCT01029340|615915611|FG000|Extension Period|Physician Decision|0|||
170430408|NCT01029340|615915612|FG001|Extension Period|Physician Decision|0|||
170430409|NCT01029340|615915613|FG002|Extension Period|Physician Decision|0|||
170430410|NCT01029340|615915614|FG003|Extension Period|Physician Decision|0|||
170430411|NCT01029340|615915615|FG004|Extension Period|Physician Decision|0|||
170430412|NCT01029340|615915616|FG005|Extension Period|Physician Decision|1|||
170430413|NCT04887415|615915620|FG000|Overall Study|Lost to Follow-up|2|||
170430414|NCT00651820|615915621|FG000|Overall Study|Lost to Follow-up|2|||
170430415|NCT01911676|615915622|FG000|Period 1 of Study|Withdrawal by Subject|4|||
170430416|NCT01911676|615915623|FG001|Period 1 of Study|Withdrawal by Subject|2|||
170430417|NCT01911676|615915624|FG002|Period 1 of Study|Withdrawal by Subject|1|||
170430418|NCT01911676|615915625|FG003|Period 1 of Study|Withdrawal by Subject|2|||
170430419|NCT01911676|615915622|FG000|Period 1 of Study|Physician Decision|2|||
170430420|NCT01911676|615915623|FG001|Period 1 of Study|Physician Decision|0|||
170430421|NCT01911676|615915624|FG002|Period 1 of Study|Physician Decision|0|||
170430422|NCT01911676|615915625|FG003|Period 1 of Study|Physician Decision|1|||
170430423|NCT01911676|615915622|FG000|Period 2 of Study|Physician Decision|2|||
170430424|NCT01911676|615915623|FG001|Period 2 of Study|Physician Decision|0|||
170430425|NCT01911676|615915624|FG002|Period 2 of Study|Physician Decision|0|||
170430426|NCT01911676|615915625|FG003|Period 2 of Study|Physician Decision|1|||
170880408|NCT01500278|617572759|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
170880409|NCT01500278|617572758|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
170430427|NCT01911676|615915622|FG000|Period 2 of Study|Lost to Follow-up|0|||
170430428|NCT01911676|615915623|FG001|Period 2 of Study|Lost to Follow-up|0|||
170430429|NCT01911676|615915624|FG002|Period 2 of Study|Lost to Follow-up|0|||
170430430|NCT01911676|615915625|FG003|Period 2 of Study|Lost to Follow-up|1|||
170430431|NCT01566721|615915626|FG000|Treatment Period|Withdrawal by Subject|35|||
170430432|NCT01566721|615915627|FG001|Treatment Period|Withdrawal by Subject|9|||
170430433|NCT01566721|615915626|FG000|Treatment Period|Disease Progression/Recurrence|37|||
170430434|NCT01566721|615915627|FG001|Treatment Period|Disease Progression/Recurrence|13|||
170880410|NCT01500278|617572759|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
170430435|NCT01566721|615915626|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
170430436|NCT01566721|615915627|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
170430437|NCT01566721|615915626|FG000|Treatment Period|Other|13|||
170430438|NCT01566721|615915627|FG001|Treatment Period|Other|2|||
170430439|NCT01566721|615915626|FG000|Treatment Period|Lack of Compliance|5|||
170430440|NCT01566721|615915627|FG001|Treatment Period|Lack of Compliance|1|||
170430441|NCT01566721|615915626|FG000|Treatment Period|Adverse Event|100|||
170430442|NCT01566721|615915627|FG001|Treatment Period|Adverse Event|30|||
170430443|NCT01566721|615915626|FG000|Treatment Period|Pregnancy|1|||
170430444|NCT01566721|615915627|FG001|Treatment Period|Pregnancy|0|||
170430445|NCT01566721|615915626|FG000|Safety Follow-up|Physician Decision|6|||
170430446|NCT01566721|615915627|FG001|Safety Follow-up|Physician Decision|4|||
170430447|NCT01566721|615915626|FG000|Safety Follow-up|Lost to Follow-up|101|||
170430448|NCT01566721|615915627|FG001|Safety Follow-up|Lost to Follow-up|48|||
170430449|NCT01566721|615915626|FG000|Safety Follow-up|Withdrawal by Subject|155|||
170430450|NCT01566721|615915627|FG001|Safety Follow-up|Withdrawal by Subject|49|||
170430451|NCT01566721|615915626|FG000|Safety Follow-up|Death|28|||
170430452|NCT01566721|615915627|FG001|Safety Follow-up|Death|4|||
170430453|NCT01566721|615915626|FG000|Safety Follow-up|Non-compliance|7|||
170430454|NCT01566721|615915627|FG001|Safety Follow-up|Non-compliance|3|||
170430455|NCT01566721|615915626|FG000|Safety Follow-up|Protocol Violation|7|||
170430456|NCT01566721|615915627|FG001|Safety Follow-up|Protocol Violation|0|||
170430457|NCT01566721|615915626|FG000|Safety Follow-up|Site closure|2|||
170430458|NCT01566721|615915627|FG001|Safety Follow-up|Site closure|3|||
170430459|NCT01566721|615915626|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
170430460|NCT01566721|615915627|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
170430461|NCT01566721|615915626|FG000|Safety Follow-up|Missing|7|||
170430462|NCT01566721|615915627|FG001|Safety Follow-up|Missing|2|||
170430463|NCT01566721|615915626|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
170430464|NCT01566721|615915627|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
170430465|NCT01566721|615915626|FG000|Safety Follow-up|Sponsor decision|1|||
170430466|NCT01566721|615915627|FG001|Safety Follow-up|Sponsor decision|0|||
170430467|NCT01566721|615915626|FG000|Safety Follow-up|Adverse Event|8|||
170430468|NCT01566721|615915627|FG001|Safety Follow-up|Adverse Event|4|||
170430469|NCT00730691|615915628|FG000|Overall Study|Adverse Event|4|||
170430470|NCT00730691|615915629|FG001|Overall Study|Adverse Event|8|||
170430471|NCT00730691|615915630|FG002|Overall Study|Adverse Event|11|||
170430472|NCT00730691|615915631|FG003|Overall Study|Adverse Event|11|||
170430473|NCT00730691|615915632|FG004|Overall Study|Adverse Event|23|||
170430474|NCT00730691|615915628|FG000|Overall Study|Lack of Efficacy|4|||
170430475|NCT00730691|615915629|FG001|Overall Study|Lack of Efficacy|4|||
170430476|NCT00730691|615915630|FG002|Overall Study|Lack of Efficacy|2|||
170430477|NCT00730691|615915631|FG003|Overall Study|Lack of Efficacy|1|||
170430478|NCT00730691|615915632|FG004|Overall Study|Lack of Efficacy|1|||
170430479|NCT00730691|615915628|FG000|Overall Study|Non-compliance with Study Drug|6|||
170430480|NCT00730691|615915629|FG001|Overall Study|Non-compliance with Study Drug|1|||
170430481|NCT00730691|615915630|FG002|Overall Study|Non-compliance with Study Drug|6|||
170430482|NCT00730691|615915631|FG003|Overall Study|Non-compliance with Study Drug|3|||
170430483|NCT00730691|615915632|FG004|Overall Study|Non-compliance with Study Drug|3|||
170430484|NCT00730691|615915628|FG000|Overall Study|Protocol Deviations|3|||
170430485|NCT00730691|615915629|FG001|Overall Study|Protocol Deviations|5|||
170430486|NCT00730691|615915630|FG002|Overall Study|Protocol Deviations|3|||
170430487|NCT00730691|615915631|FG003|Overall Study|Protocol Deviations|7|||
170430488|NCT00730691|615915632|FG004|Overall Study|Protocol Deviations|5|||
170430489|NCT00730691|615915628|FG000|Overall Study|Withdrawal of Consent|7|||
170430490|NCT00730691|615915629|FG001|Overall Study|Withdrawal of Consent|9|||
170430491|NCT00730691|615915630|FG002|Overall Study|Withdrawal of Consent|3|||
170430492|NCT00730691|615915631|FG003|Overall Study|Withdrawal of Consent|6|||
170430493|NCT00730691|615915632|FG004|Overall Study|Withdrawal of Consent|3|||
170535365|NCT03907488|616304219|FG001|Overall Study|not protocol specified|8|||
170535366|NCT03907488|616304218|FG000|Overall Study|Ineligible|9|||
170430494|NCT00730691|615915628|FG000|Overall Study|Lost to Follow-up|11|||
170430495|NCT00730691|615915629|FG001|Overall Study|Lost to Follow-up|8|||
170430496|NCT00730691|615915630|FG002|Overall Study|Lost to Follow-up|13|||
170430497|NCT00730691|615915631|FG003|Overall Study|Lost to Follow-up|15|||
170430498|NCT00730691|615915632|FG004|Overall Study|Lost to Follow-up|13|||
170535367|NCT03907488|616304219|FG001|Overall Study|Ineligible|15|||
170535368|NCT04817410|616306149|FG000|Overall Study|Withdrawal by Subject|5|||
170430499|NCT00730691|615915628|FG000|Overall Study|Other|1|||
170430500|NCT00730691|615915629|FG001|Overall Study|Other|1|||
170430501|NCT00730691|615915630|FG002|Overall Study|Other|1|||
170430502|NCT00730691|615915631|FG003|Overall Study|Other|2|||
170430503|NCT00730691|615915632|FG004|Overall Study|Other|2|||
170430504|NCT01249651|615915633|FG000|Overall Study|Withdrawal by Subject|4|||
170430505|NCT01249651|615915633|FG000|Overall Study|Adverse Event|1|||
170430506|NCT01249651|615915633|FG000|Overall Study|Protocol Violation|1|||
170430507|NCT01249651|615915633|FG000|Overall Study|Sponsor Decision|1|||
170430508|NCT03873272|615915634|FG000|Overall Study|Withdrawal by Subject|2|||
170535369|NCT04817410|616306149|FG000|Overall Study|Physician Decision|3|||
170430509|NCT03873272|615915635|FG001|Overall Study|Withdrawal by Subject|0|||
170430510|NCT03873272|615915636|FG002|Overall Study|Withdrawal by Subject|1|||
170430511|NCT03873272|615915634|FG000|Overall Study|Death|0|||
170430512|NCT03873272|615915635|FG001|Overall Study|Death|2|||
170430513|NCT03873272|615915636|FG002|Overall Study|Death|1|||
170430514|NCT00119015|615915637|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
170430515|NCT00119015|615915638|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
170430516|NCT00119015|615915639|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
170430517|NCT01097577|615915649|FG000|Overall Study|Adverse Event|0|||
170430518|NCT01097577|615915650|FG001|Overall Study|Adverse Event|1|||
170430519|NCT03761173|615915651|FG000|Overall Study|Lost to Follow-up|93|||
170430520|NCT03761173|615915651|FG000|Overall Study|Withdrawal by Subject|74|||
170430521|NCT03761173|615915651|FG000|Overall Study|Death|45|||
170430522|NCT03761173|615915651|FG000|Overall Study|Withdrawal for Other Reasons|29|||
170430523|NCT03761173|615915651|FG000|Overall Study|Protocol Violation|1|||
170430524|NCT05152576|615915654|FG000|Overall Study|Lost to Follow-up|3|||
170430525|NCT05152576|615915655|FG001|Overall Study|Lost to Follow-up|0|||
170430526|NCT05152576|615915656|FG002|Overall Study|Lost to Follow-up|0|||
170430527|NCT05152576|615915657|FG003|Overall Study|Lost to Follow-up|1|||
170430528|NCT05152576|615915654|FG000|Overall Study|Withdrawal by Subject|0|||
170430529|NCT05152576|615915655|FG001|Overall Study|Withdrawal by Subject|1|||
170430530|NCT05152576|615915656|FG002|Overall Study|Withdrawal by Subject|0|||
170430531|NCT05152576|615915657|FG003|Overall Study|Withdrawal by Subject|1|||
170430532|NCT05152576|615915654|FG000|Overall Study|Other|2|||
170430533|NCT05152576|615915655|FG001|Overall Study|Other|0|||
170430534|NCT05152576|615915656|FG002|Overall Study|Other|0|||
170430535|NCT05152576|615915657|FG003|Overall Study|Other|0|||
170430536|NCT02057835|615917566|FG000|Overall Study|Withdrawal by Subject|0|||
170430537|NCT02057835|615917567|FG001|Overall Study|Withdrawal by Subject|2|||
170430538|NCT02057835|615917568|FG002|Overall Study|Withdrawal by Subject|0|||
170430539|NCT02057835|615917569|FG003|Overall Study|Withdrawal by Subject|0|||
170430540|NCT02057835|615917570|FG004|Overall Study|Withdrawal by Subject|0|||
170430541|NCT02057835|615917571|FG005|Overall Study|Withdrawal by Subject|0|||
170430542|NCT02057835|615917572|FG006|Overall Study|Withdrawal by Subject|0|||
170430543|NCT02057835|615917573|FG007|Overall Study|Withdrawal by Subject|0|||
170430544|NCT02057835|615917574|FG008|Overall Study|Withdrawal by Subject|0|||
170430545|NCT02057835|615917575|FG009|Overall Study|Withdrawal by Subject|0|||
170430546|NCT00682461|615917576|FG000|Overall Study|Adverse Event|5|||
170430547|NCT00682461|615917577|FG001|Overall Study|Adverse Event|7|||
170430548|NCT00682461|615917576|FG000|Overall Study|Lost to Follow-up|8|||
170430549|NCT00682461|615917577|FG001|Overall Study|Lost to Follow-up|5|||
170430550|NCT00682461|615917576|FG000|Overall Study|Withdrawal by Subject|12|||
170430551|NCT00682461|615917577|FG001|Overall Study|Withdrawal by Subject|19|||
170430552|NCT06298396|615917592|FG000|Default MAP|Protocol Violation|1|||
170430553|NCT05710718|615917593|FG000|Overall Study|Withdrawal by Subject|5|||
170430554|NCT05710718|615917594|FG001|Overall Study|Withdrawal by Subject|1|||
170430555|NCT05710718|615917593|FG000|Overall Study|Lost to Follow-up|0|||
170430556|NCT05710718|615917594|FG001|Overall Study|Lost to Follow-up|1|||
170430557|NCT05710718|615917593|FG000|Overall Study|Death|0|||
170430558|NCT05710718|615917594|FG001|Overall Study|Death|1|||
170430559|NCT06284525|615917604|FG000|Overall Study|Withdrawal by Subject|1|||
170430560|NCT00446966|615917605|FG000|Overall Study|Lost to Follow-up|10|||
170430561|NCT00446966|615917606|FG001|Overall Study|Lost to Follow-up|7|||
170430562|NCT01440803|615917607|FG000|Overall Study|Met study stopping rule|2|||
170430563|NCT01440803|615917608|FG001|Overall Study|Met study stopping rule|1|||
170430564|NCT01440803|615917607|FG000|Overall Study|Lost to Follow-up|0|||
170430565|NCT01440803|615917608|FG001|Overall Study|Lost to Follow-up|2|||
170430566|NCT01440803|615917607|FG000|Overall Study|Withdrawal by Subject|0|||
170430567|NCT01440803|615917608|FG001|Overall Study|Withdrawal by Subject|1|||
170430568|NCT01547286|615917619|FG000|Overall Study|Did not meet all eligibility criteria|1|||
170430569|NCT01547286|615917619|FG000|Overall Study|Physician Decision|1|||
170430570|NCT03415308|615917620|FG000|Overall Study|Lost to Follow-up|0|||
170430571|NCT03415308|615917621|FG001|Overall Study|Lost to Follow-up|0|||
170430572|NCT03415308|615917622|FG002|Overall Study|Lost to Follow-up|1|||
170430573|NCT03415308|615917620|FG000|Overall Study|Scheduling Conflicts|0|||
170430574|NCT03415308|615917621|FG001|Overall Study|Scheduling Conflicts|0|||
170430575|NCT03415308|615917622|FG002|Overall Study|Scheduling Conflicts|7|||
170430576|NCT00836472|615917625|FG000|Washout|Adverse Event|1|||
170430577|NCT00836472|615917626|FG001|Washout|Adverse Event|2|||
170430578|NCT00836472|615917625|FG000|Washout|Withdrawal by Subject|1|||
170430579|NCT00836472|615917626|FG001|Washout|Withdrawal by Subject|1|||
170430580|NCT01695239|615917627|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
170430581|NCT01695239|615917628|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
170430582|NCT01695239|615917629|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
170430583|NCT01695239|615917630|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
170430584|NCT01695239|615917631|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430585|NCT01695239|615917632|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430586|NCT01695239|615917633|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430587|NCT01695239|615917634|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430588|NCT01695239|615917635|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430589|NCT01695239|615917636|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430590|NCT01695239|615917637|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430591|NCT01695239|615917638|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430592|NCT01695239|615917639|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430593|NCT01695239|615917640|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
170430594|NCT01695239|615917627|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
170430595|NCT01695239|615917628|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
170430596|NCT01695239|615917629|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
170430597|NCT01695239|615917630|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
170430598|NCT01695239|615917631|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430599|NCT01695239|615917632|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430600|NCT01695239|615917633|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430601|NCT01695239|615917634|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430602|NCT01695239|615917635|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430603|NCT01695239|615917636|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430604|NCT01695239|615917637|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430605|NCT01695239|615917638|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430606|NCT01695239|615917639|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430607|NCT01695239|615917640|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
170430608|NCT01695239|615917627|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
170430609|NCT01695239|615917628|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430610|NCT01695239|615917629|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
170430611|NCT01695239|615917630|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430612|NCT01695239|615917631|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430613|NCT01695239|615917632|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430614|NCT01695239|615917633|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430615|NCT01695239|615917634|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430616|NCT01695239|615917635|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430617|NCT01695239|615917636|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430618|NCT01695239|615917637|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430619|NCT01695239|615917638|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430620|NCT01695239|615917639|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430621|NCT01695239|615917640|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
170430622|NCT01695239|615917627|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
170430623|NCT01695239|615917628|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
170430624|NCT01695239|615917629|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
170430625|NCT01695239|615917630|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430626|NCT01695239|615917631|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430627|NCT01695239|615917632|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430628|NCT01695239|615917633|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430629|NCT01695239|615917634|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430630|NCT01695239|615917635|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430631|NCT01695239|615917636|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430632|NCT01695239|615917637|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430633|NCT01695239|615917638|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430634|NCT01695239|615917639|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430635|NCT01695239|615917640|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170430636|NCT01695239|615917627|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
170430637|NCT01695239|615917628|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430638|NCT01695239|615917629|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
170430639|NCT01695239|615917630|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430640|NCT01695239|615917631|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430641|NCT01695239|615917632|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170535370|NCT03264404|616306150|FG000|Overall Study|Death|2|||
170535371|NCT03264404|616306150|FG000|Overall Study|Physician Decision|1|||
170535372|NCT03264404|616306150|FG000|Overall Study|Disease Progression|28|||
170535373|NCT03264404|616306150|FG000|Overall Study|Adverse Event|1|||
170535374|NCT03264404|616306150|FG000|Overall Study|Off study prior to treatment|2|||
170430642|NCT01695239|615917633|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170535375|NCT03595748|616306151|FG000|Overall Study|Death|11|||
170535376|NCT03595748|616306152|FG001|Overall Study|Death|12|||
170430643|NCT01695239|615917634|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430644|NCT01695239|615917635|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430645|NCT01695239|615917636|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430646|NCT01695239|615917637|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430647|NCT01695239|615917638|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430648|NCT01695239|615917639|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430649|NCT01695239|615917640|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
170430650|NCT01695239|615917627|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
170430651|NCT01695239|615917628|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430652|NCT01695239|615917629|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
170430653|NCT01695239|615917630|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430654|NCT01695239|615917631|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430655|NCT01695239|615917632|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430656|NCT01695239|615917633|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430657|NCT01695239|615917634|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430658|NCT01695239|615917635|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430659|NCT01695239|615917636|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430660|NCT01695239|615917637|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430661|NCT01695239|615917638|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430662|NCT01695239|615917639|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430663|NCT01695239|615917640|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170430664|NCT01695239|615917627|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
170430665|NCT01695239|615917628|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430666|NCT01695239|615917629|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430667|NCT01695239|615917630|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430668|NCT01695239|615917631|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430669|NCT01695239|615917632|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430670|NCT01695239|615917633|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430671|NCT01695239|615917634|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430672|NCT01695239|615917635|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430673|NCT01695239|615917636|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430674|NCT01695239|615917637|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430675|NCT01695239|615917638|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430676|NCT01695239|615917639|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430677|NCT01695239|615917640|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
170430678|NCT01695239|615917627|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430679|NCT01695239|615917628|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430680|NCT01695239|615917629|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430681|NCT01695239|615917630|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430682|NCT01695239|615917631|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430683|NCT01695239|615917632|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430684|NCT01695239|615917633|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430685|NCT01695239|615917634|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
170430686|NCT01695239|615917635|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430687|NCT01695239|615917636|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430688|NCT01695239|615917637|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430689|NCT01695239|615917638|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430690|NCT01695239|615917639|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430691|NCT01695239|615917640|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
170430692|NCT01695239|615917627|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430693|NCT01695239|615917628|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430694|NCT01695239|615917629|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430695|NCT01695239|615917630|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430696|NCT01695239|615917631|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430697|NCT01695239|615917632|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430698|NCT01695239|615917633|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430699|NCT01695239|615917634|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
170430700|NCT01695239|615917635|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430701|NCT01695239|615917636|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430702|NCT01695239|615917637|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430703|NCT01695239|615917638|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430704|NCT01695239|615917639|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430705|NCT01695239|615917640|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
170430706|NCT01695239|615917627|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430707|NCT01695239|615917628|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430708|NCT01695239|615917629|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430709|NCT01695239|615917630|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430710|NCT01695239|615917631|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430711|NCT01695239|615917632|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430712|NCT01695239|615917633|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430713|NCT01695239|615917634|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
170430714|NCT01695239|615917635|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430715|NCT01695239|615917636|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430716|NCT01695239|615917637|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430717|NCT01695239|615917638|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430718|NCT01695239|615917639|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430719|NCT01695239|615917640|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
170430720|NCT01695239|615917627|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430721|NCT01695239|615917628|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430722|NCT01695239|615917629|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430723|NCT01695239|615917630|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430724|NCT01695239|615917631|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430725|NCT01695239|615917632|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430726|NCT01695239|615917633|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430727|NCT01695239|615917634|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430728|NCT01695239|615917635|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
170430729|NCT01695239|615917636|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
170430730|NCT01695239|615917637|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430731|NCT01695239|615917638|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430732|NCT01695239|615917639|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430733|NCT01695239|615917640|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
170430734|NCT01695239|615917627|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
170430735|NCT01695239|615917628|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
170535377|NCT03595748|616306151|FG000|Overall Study|Withdrawal by Subject|28|||
170430736|NCT01695239|615917629|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
170430737|NCT01695239|615917630|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
170430738|NCT01695239|615917631|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
170430739|NCT01695239|615917632|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
170430740|NCT01695239|615917633|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
170430741|NCT01695239|615917634|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
170430742|NCT01695239|615917635|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
170430743|NCT01695239|615917636|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
170535378|NCT03595748|616306152|FG001|Overall Study|Withdrawal by Subject|29|||
170778435|NCT01695954|617195633|FG001|Overall Study|Withdrawal by Subject|0|||
170778436|NCT01695954|617195632|FG000|Overall Study|Adverse Event|0|||
170778437|NCT01695954|617195633|FG001|Overall Study|Adverse Event|2|||
170778438|NCT04149002|617195642|FG000|Overall Study|Lost to Follow-up|1|||
170778439|NCT04149002|617195643|FG001|Overall Study|Lost to Follow-up|0|||
170778440|NCT04149002|617195642|FG000|Overall Study|Withdrawal by Subject|1|||
170778441|NCT04149002|617195643|FG001|Overall Study|Withdrawal by Subject|0|||
170778442|NCT02088853|617195644|FG000|Overall Study|Pregnancy|1|||
170778443|NCT02088853|617195645|FG001|Overall Study|Pregnancy|0|||
170778444|NCT00510887|617195650|FG000|Overall Study|Lost to Follow-up|1|||
170778445|NCT05609032|617195651|FG000|Overall Study|Lost to Follow-up|3|||
170778446|NCT05609032|617195652|FG001|Overall Study|Lost to Follow-up|1|||
170778447|NCT05609032|617195651|FG000|Overall Study|Withdrawal by Subject|1|||
170778448|NCT05609032|617195652|FG001|Overall Study|Withdrawal by Subject|0|||
170778449|NCT02372253|617195665|FG000|Overall Study|Non Compliance|2|||
170778450|NCT02372253|617195666|FG001|Overall Study|Non Compliance|0|||
170778451|NCT01803555|617195667|FG000|Overall Study|Adverse Event|3|||
170778452|NCT01803555|617195668|FG001|Overall Study|Adverse Event|2|||
170778453|NCT01803555|617195667|FG000|Overall Study|Withdrawal by Subject|3|||
170778454|NCT01803555|617195668|FG001|Overall Study|Withdrawal by Subject|3|||
170778455|NCT01803555|617195667|FG000|Overall Study|Non-compliance|1|||
170778456|NCT01803555|617195668|FG001|Overall Study|Non-compliance|1|||
170778457|NCT01803555|617195667|FG000|Overall Study|Protocol Violation|3|||
170778458|NCT01803555|617195668|FG001|Overall Study|Protocol Violation|5|||
170880411|NCT01500278|617572758|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
170880412|NCT01500278|617572759|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
170880413|NCT01500278|617572758|FG000|Week 13 - Week 104|Non/bad compliance|7|||
170880414|NCT01500278|617572759|FG001|Week 13 - Week 104|Non/bad compliance|5|||
170880415|NCT01500278|617572758|FG000|Week 13 - Week 104|Recurrent infections|1|||
170880416|NCT01500278|617572759|FG001|Week 13 - Week 104|Recurrent infections|0|||
170880417|NCT01500278|617572758|FG000|Week 13 - Week 104|False positive test|1|||
170880418|NCT01500278|617572759|FG001|Week 13 - Week 104|False positive test|2|||
170880419|NCT01500278|617572758|FG000|Week 13 - Week 104|Sponsor request|4|||
170880420|NCT01500278|617572759|FG001|Week 13 - Week 104|Sponsor request|0|||
170880421|NCT01500278|617572758|FG000|Week 13 - Week 104|Withdrawn in error|1|||
170880422|NCT01500278|617572759|FG001|Week 13 - Week 104|Withdrawn in error|0|||
170880423|NCT01500278|617572758|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
170880424|NCT01500278|617572759|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
170880425|NCT01500278|617572758|FG000|Week 13 - Week 104|Protocol deviation|1|||
170880426|NCT01500278|617572759|FG001|Week 13 - Week 104|Protocol deviation|0|||
170535379|NCT03595748|616306151|FG000|Overall Study|Protocol Violation|0|||
170778459|NCT01803555|617195667|FG000|Overall Study|Lost to Follow-up|0|||
170778460|NCT01803555|617195668|FG001|Overall Study|Lost to Follow-up|2|||
170778461|NCT01803555|617195667|FG000|Overall Study|Other than specified|3|||
170778462|NCT01803555|617195668|FG001|Overall Study|Other than specified|5|||
170778463|NCT03201562|617195669|FG000|Overall Study|Physician Decision|0|||
170778464|NCT03201562|617195670|FG001|Overall Study|Physician Decision|0|||
170778465|NCT03201562|617195671|FG002|Overall Study|Physician Decision|1|||
170778466|NCT03201562|617195669|FG000|Overall Study|Adverse Event|0|||
170430744|NCT01695239|615917637|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
170430745|NCT01695239|615917638|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
170430746|NCT01695239|615917639|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
170430747|NCT01695239|615917640|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
170430748|NCT01695239|615917627|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430749|NCT01695239|615917628|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430750|NCT01695239|615917629|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430751|NCT01695239|615917630|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430752|NCT01695239|615917631|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430753|NCT01695239|615917632|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430754|NCT01695239|615917633|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430755|NCT01695239|615917634|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430756|NCT01695239|615917635|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
170430757|NCT01695239|615917636|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
170430758|NCT01695239|615917637|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430759|NCT01695239|615917638|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430760|NCT01695239|615917639|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430761|NCT01695239|615917640|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
170430762|NCT01695239|615917627|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
170430763|NCT01695239|615917628|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
170430764|NCT01695239|615917629|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
170430765|NCT01695239|615917630|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
170430766|NCT01695239|615917631|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
170430767|NCT01695239|615917632|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
170430768|NCT01695239|615917633|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
170430769|NCT01695239|615917634|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
170430770|NCT01695239|615917635|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
170430771|NCT01695239|615917636|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
170430772|NCT01695239|615917637|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
170430773|NCT01695239|615917638|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
170430774|NCT01695239|615917639|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
170430775|NCT01695239|615917640|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
170430776|NCT01695239|615917627|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170778467|NCT03201562|617195670|FG001|Overall Study|Adverse Event|0|||
170430777|NCT01695239|615917628|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430778|NCT01695239|615917629|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430779|NCT01695239|615917630|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430780|NCT01695239|615917631|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430781|NCT01695239|615917632|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430782|NCT01695239|615917633|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430783|NCT01695239|615917634|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430784|NCT01695239|615917635|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
170430785|NCT01695239|615917636|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
170430786|NCT01695239|615917637|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430787|NCT01695239|615917638|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430788|NCT01695239|615917639|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430789|NCT01695239|615917640|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
170430790|NCT01695239|615917627|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430791|NCT01695239|615917628|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430792|NCT01695239|615917629|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430793|NCT01695239|615917630|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430794|NCT01695239|615917631|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430795|NCT01695239|615917632|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430796|NCT01695239|615917633|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430797|NCT01695239|615917634|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430798|NCT01695239|615917635|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
170430799|NCT01695239|615917636|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
170430800|NCT01695239|615917637|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430801|NCT01695239|615917638|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430802|NCT01695239|615917639|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430803|NCT01695239|615917640|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
170430804|NCT01695239|615917627|FG000|Extension Long-Term Extension Periods|Death|0|||
170430805|NCT01695239|615917628|FG001|Extension Long-Term Extension Periods|Death|0|||
170778468|NCT03201562|617195671|FG002|Overall Study|Adverse Event|1|||
170430806|NCT01695239|615917629|FG002|Extension Long-Term Extension Periods|Death|0|||
170430807|NCT01695239|615917630|FG003|Extension Long-Term Extension Periods|Death|0|||
170430808|NCT01695239|615917631|FG004|Extension Long-Term Extension Periods|Death|0|||
170430809|NCT01695239|615917632|FG005|Extension Long-Term Extension Periods|Death|0|||
170430810|NCT01695239|615917633|FG006|Extension Long-Term Extension Periods|Death|0|||
170430811|NCT01695239|615917634|FG007|Extension Long-Term Extension Periods|Death|0|||
170430812|NCT01695239|615917635|FG008|Extension Long-Term Extension Periods|Death|1|||
170430813|NCT01695239|615917636|FG009|Extension Long-Term Extension Periods|Death|0|||
170430814|NCT01695239|615917637|FG010|Extension Long-Term Extension Periods|Death|0|||
170430815|NCT01695239|615917638|FG011|Extension Long-Term Extension Periods|Death|0|||
170430816|NCT01695239|615917639|FG012|Extension Long-Term Extension Periods|Death|0|||
170430817|NCT01695239|615917640|FG013|Extension Long-Term Extension Periods|Death|0|||
170430818|NCT01695239|615917627|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430819|NCT01695239|615917628|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430820|NCT01695239|615917629|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430821|NCT01695239|615917630|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430822|NCT01695239|615917631|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430823|NCT01695239|615917632|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430824|NCT01695239|615917633|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170535380|NCT03595748|616306152|FG001|Overall Study|Protocol Violation|1|||
170535381|NCT02328014|616306153|FG000|Overall Study|Adverse Event|1|||
170535382|NCT02328014|616306154|FG001|Overall Study|Adverse Event|0|||
170535383|NCT02328014|616306155|FG002|Overall Study|Adverse Event|0|||
170535384|NCT02328014|616306156|FG003|Overall Study|Adverse Event|1|||
170535385|NCT02328014|616306153|FG000|Overall Study|Death|0|||
170535386|NCT02328014|616306154|FG001|Overall Study|Death|0|||
170535387|NCT02328014|616306155|FG002|Overall Study|Death|0|||
170535388|NCT02328014|616306156|FG003|Overall Study|Death|4|||
170535389|NCT02328014|616306153|FG000|Overall Study|Physician Decision|0|||
170535390|NCT02328014|616306154|FG001|Overall Study|Physician Decision|0|||
170535391|NCT02328014|616306155|FG002|Overall Study|Physician Decision|0|||
170535392|NCT02328014|616306156|FG003|Overall Study|Physician Decision|1|||
170535393|NCT02328014|616306153|FG000|Overall Study|Disease Progression|1|||
170535394|NCT02328014|616306154|FG001|Overall Study|Disease Progression|0|||
170535395|NCT02328014|616306155|FG002|Overall Study|Disease Progression|1|||
170535396|NCT02328014|616306156|FG003|Overall Study|Disease Progression|3|||
170535397|NCT02328014|616306153|FG000|Overall Study|Study Terminated by Sponsor|4|||
170535398|NCT02328014|616306154|FG001|Overall Study|Study Terminated by Sponsor|1|||
170535399|NCT02328014|616306155|FG002|Overall Study|Study Terminated by Sponsor|1|||
170535400|NCT02328014|616306156|FG003|Overall Study|Study Terminated by Sponsor|0|||
170535401|NCT02328014|616306153|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
170535402|NCT02328014|616306154|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
170535403|NCT02328014|616306155|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
170778469|NCT03201562|617195669|FG000|Overall Study|Lost to Follow-up|0|||
170778470|NCT03201562|617195670|FG001|Overall Study|Lost to Follow-up|1|||
170778471|NCT03201562|617195671|FG002|Overall Study|Lost to Follow-up|2|||
170778472|NCT00001277|617195672|FG000|Overall Study|Adverse Event|0|||
170778473|NCT00001277|617195673|FG001|Overall Study|Adverse Event|0|||
170778474|NCT00001277|617195674|FG002|Overall Study|Adverse Event|1|||
170535404|NCT02328014|616306156|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
170535405|NCT02328014|616306153|FG000|Overall Study|Withdrawal by Subject|0|||
170535406|NCT02328014|616306154|FG001|Overall Study|Withdrawal by Subject|0|||
170535407|NCT02328014|616306155|FG002|Overall Study|Withdrawal by Subject|0|||
170535408|NCT02328014|616306156|FG003|Overall Study|Withdrawal by Subject|1|||
170778475|NCT00001277|617195672|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
170778476|NCT00001277|617195673|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
170430825|NCT01695239|615917634|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430826|NCT01695239|615917635|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430827|NCT01695239|615917636|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430828|NCT01695239|615917637|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170430829|NCT01695239|615917638|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
170430830|NCT01695239|615917639|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
170430831|NCT01695239|615917640|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
170430832|NCT01695239|615917627|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430833|NCT01695239|615917628|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430834|NCT01695239|615917629|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430835|NCT01695239|615917630|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430836|NCT01695239|615917631|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430837|NCT01695239|615917632|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430838|NCT01695239|615917633|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430839|NCT01695239|615917634|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430840|NCT01695239|615917635|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430841|NCT01695239|615917636|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430842|NCT01695239|615917637|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430843|NCT01695239|615917638|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170430844|NCT01695239|615917639|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
170430845|NCT01695239|615917640|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
170430846|NCT01695239|615917627|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430847|NCT01695239|615917628|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430848|NCT01695239|615917629|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430849|NCT01695239|615917630|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430850|NCT01695239|615917631|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430851|NCT01695239|615917632|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430852|NCT01695239|615917633|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430853|NCT01695239|615917634|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430854|NCT01695239|615917635|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430855|NCT01695239|615917636|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430856|NCT01695239|615917637|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430857|NCT01695239|615917638|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430858|NCT01695239|615917639|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
170430859|NCT01695239|615917640|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
170430860|NCT01695239|615917627|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430861|NCT01695239|615917628|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430862|NCT01695239|615917629|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170778477|NCT00001277|617195674|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
170778478|NCT03750968|617195675|FG000|Overall Study|Adverse Event|2|||
170778479|NCT03750968|617195676|FG001|Overall Study|Adverse Event|0|||
170778480|NCT03750968|617195675|FG000|Overall Study|Lost to Follow-up|1|||
170778481|NCT03750968|617195676|FG001|Overall Study|Lost to Follow-up|3|||
170778482|NCT00031694|617195683|FG000|Overall Study|Adverse Event|12|||
170778483|NCT00031694|617195683|FG000|Overall Study|Death|2|||
170778484|NCT00031694|617195683|FG000|Overall Study|Withdrawal by Subject|5|||
170778485|NCT01976312|617195684|FG000|Overall Study|Pregnancy|0|||
170778486|NCT01976312|617195685|FG001|Overall Study|Pregnancy|1|||
170778487|NCT01976312|617195684|FG000|Overall Study|Lost to Follow-up|2|||
170778488|NCT01976312|617195685|FG001|Overall Study|Lost to Follow-up|0|||
170778489|NCT01976312|617195684|FG000|Overall Study|Withdrawal by Subject|7|||
170778490|NCT01976312|617195685|FG001|Overall Study|Withdrawal by Subject|2|||
170778491|NCT01976312|617195684|FG000|Overall Study|Adverse Event|6|||
170778492|NCT01976312|617195685|FG001|Overall Study|Adverse Event|6|||
170778493|NCT01976312|617195684|FG000|Overall Study|Protocol Violation|2|||
170778494|NCT01976312|617195685|FG001|Overall Study|Protocol Violation|0|||
170778495|NCT01538719|617195690|FG000|Overall Study|Lost to Follow-up|2|||
170778496|NCT01538719|617195691|FG001|Overall Study|Lost to Follow-up|0|||
170778497|NCT02556138|617195692|FG000|Overall Study|Withdrawal by Subject|1|||
170778498|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
170778499|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
170778500|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
170778501|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
170778502|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
170778503|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
170778504|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
170778505|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
170778506|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
170778507|NCT03939312|617195695|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
170430863|NCT01695239|615917630|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430864|NCT01695239|615917631|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430865|NCT01695239|615917632|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430866|NCT01695239|615917633|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430867|NCT01695239|615917634|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430868|NCT01695239|615917635|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430869|NCT01695239|615917636|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430870|NCT01695239|615917637|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430871|NCT01695239|615917638|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430872|NCT01695239|615917639|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170430873|NCT01695239|615917640|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
170430874|NCT03502811|615917642|FG000|Overall Study|Death|157|||
170430875|NCT03502811|615917642|FG000|Overall Study|Withdrawal by Subject|105|||
170430876|NCT03502811|615917642|FG000|Overall Study|Lost to Follow-up|26|||
170430877|NCT03502811|615917642|FG000|Overall Study|No Visits (Missed)|31|||
170430878|NCT03246503|615917645|FG000|Overall Study|Lost to Follow-up|23|||
170430879|NCT03246503|615917645|FG000|Overall Study|Withdrawal by Subject|20|||
170430880|NCT03246503|615917645|FG000|Overall Study|Physician Decision|5|||
170430881|NCT03246503|615917645|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
170430882|NCT00736190|615917646|FG000|Overall Study|Pregnancy|1|||
170430883|NCT00736190|615917646|FG000|Overall Study|Withdrawal by Subject|1|||
170430884|NCT00736190|615917646|FG000|Overall Study|Adverse Event|1|||
170430885|NCT02197416|615917647|FG000|Overall Study|Other reasons|0|||
170430886|NCT02197416|615917648|FG001|Overall Study|Other reasons|2|||
170430887|NCT02197416|615917649|FG002|Overall Study|Other reasons|5|||
170430888|NCT02197416|615917647|FG000|Overall Study|Withdrawal by Subject|0|||
170430889|NCT02197416|615917648|FG001|Overall Study|Withdrawal by Subject|2|||
170430890|NCT02197416|615917649|FG002|Overall Study|Withdrawal by Subject|1|||
170430891|NCT02197416|615917647|FG000|Overall Study|Protocol Violation|1|||
170430892|NCT02197416|615917648|FG001|Overall Study|Protocol Violation|0|||
170778508|NCT03939312|617195695|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
170778509|NCT03939312|617195695|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
170778510|NCT03807778|617195699|FG000|Overall Study|Adverse Event|0|||
170778511|NCT03807778|617195700|FG001|Overall Study|Adverse Event|0|||
170778512|NCT03807778|617195701|FG002|Overall Study|Adverse Event|3|||
170778513|NCT03807778|617195702|FG003|Overall Study|Adverse Event|5|||
170778514|NCT03807778|617195699|FG000|Overall Study|Progressive Disease|4|||
170778515|NCT03807778|617195700|FG001|Overall Study|Progressive Disease|2|||
170778516|NCT03807778|617195701|FG002|Overall Study|Progressive Disease|8|||
170778517|NCT03807778|617195702|FG003|Overall Study|Progressive Disease|15|||
170778518|NCT03807778|617195699|FG000|Overall Study|Symptomatic Deterioration|0|||
170778519|NCT03807778|617195700|FG001|Overall Study|Symptomatic Deterioration|1|||
170778520|NCT03807778|617195701|FG002|Overall Study|Symptomatic Deterioration|0|||
170778521|NCT03807778|617195702|FG003|Overall Study|Symptomatic Deterioration|1|||
170778522|NCT03807778|617195699|FG000|Overall Study|Withdrawal by Subject|0|||
170778523|NCT03807778|617195700|FG001|Overall Study|Withdrawal by Subject|1|||
170778524|NCT03807778|617195701|FG002|Overall Study|Withdrawal by Subject|0|||
170778525|NCT03807778|617195702|FG003|Overall Study|Withdrawal by Subject|1|||
170778526|NCT03807778|617195699|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
170778527|NCT03807778|617195700|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
170778528|NCT03807778|617195701|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
170778529|NCT03807778|617195702|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
170778530|NCT01207492|617195703|FG000|Overall Study|Still on study|1|||
170778531|NCT01207492|617195703|FG000|Overall Study|Withdrawal by Subject|9|||
170778532|NCT01207492|617195703|FG000|Overall Study|Physician Decision|1|||
170778533|NCT01207492|617195703|FG000|Overall Study|Progressive disease|3|||
170778534|NCT01207492|617195703|FG000|Overall Study|Toxicity|1|||
170778535|NCT02807779|617195704|FG000|Overall Study|Lost to Follow-up|1|||
170778536|NCT02807779|617195705|FG001|Overall Study|Lost to Follow-up|0|||
170778537|NCT02807779|617195706|FG002|Overall Study|Lost to Follow-up|0|||
170778538|NCT02807779|617195704|FG000|Overall Study|Physician Decision|2|||
170778539|NCT02807779|617195705|FG001|Overall Study|Physician Decision|0|||
170778540|NCT02807779|617195706|FG002|Overall Study|Physician Decision|1|||
170778541|NCT02807779|617195704|FG000|Overall Study|Death|1|||
170778542|NCT02807779|617195705|FG001|Overall Study|Death|1|||
170778543|NCT02807779|617195706|FG002|Overall Study|Death|0|||
170778544|NCT01303445|617195707|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
170778545|NCT01303445|617195708|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
170778546|NCT01303445|617195707|FG000|Second Intervention (7 Days)|Adverse Event|0|||
170430893|NCT02197416|615917649|FG002|Overall Study|Protocol Violation|1|||
170430894|NCT02197416|615917647|FG000|Overall Study|Adverse Event|0|||
170430895|NCT02197416|615917648|FG001|Overall Study|Adverse Event|0|||
170430896|NCT02197416|615917649|FG002|Overall Study|Adverse Event|1|||
170778547|NCT01303445|617195708|FG001|Second Intervention (7 Days)|Adverse Event|2|||
170880427|NCT01500278|617572758|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
170880428|NCT01500278|617572759|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
170880429|NCT01500278|617572758|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
170880430|NCT01500278|617572759|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
170880431|NCT01500278|617572758|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
170880432|NCT01500278|617572759|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
170880433|NCT01500278|617572758|FG000|Week 13 - Week 104|Relocation|0|||
170880434|NCT01500278|617572759|FG001|Week 13 - Week 104|Relocation|1|||
170880435|NCT01500278|617572758|FG000|Week 13 - Week 104|Sponsor decision|0|||
170880436|NCT01500278|617572759|FG001|Week 13 - Week 104|Sponsor decision|2|||
170880437|NCT01500278|617572758|FG000|Week 13 - Week 104|Medical monitor decision|0|||
170880438|NCT01500278|617572759|FG001|Week 13 - Week 104|Medical monitor decision|2|||
170880439|NCT01500278|617572758|FG000|Week 13 - Week 104|Personal reason|0|||
170880440|NCT01500278|617572759|FG001|Week 13 - Week 104|Personal reason|1|||
170880441|NCT01500278|617572758|FG000|Week 13 - Week 104|Not completed|0|||
170880442|NCT01500278|617572759|FG001|Week 13 - Week 104|Not completed|1|||
170880443|NCT01500278|617572758|FG000|Week 13 - Week 104|Death|2|||
170880444|NCT01500278|617572759|FG001|Week 13 - Week 104|Death|4|||
170880445|NCT01500278|617572758|FG000|Week 13 - Week 104|Adverse Event|54|||
170880446|NCT01500278|617572759|FG001|Week 13 - Week 104|Adverse Event|54|||
170880447|NCT00794677|617572762|FG000|First Intervention|Withdrawal by Subject|2|||
170880448|NCT00794677|617572763|FG001|First Intervention|Withdrawal by Subject|0|||
170880449|NCT03882970|617572764|FG000|Overall Study|Adverse Event|5|||
170880450|NCT03882970|617572765|FG001|Overall Study|Adverse Event|7|||
170880451|NCT03882970|617572766|FG002|Overall Study|Adverse Event|3|||
170880452|NCT03882970|617572767|FG003|Overall Study|Adverse Event|1|||
170880453|NCT03882970|617572764|FG000|Overall Study|Death|1|||
170880454|NCT03882970|617572765|FG001|Overall Study|Death|2|||
170880455|NCT03882970|617572766|FG002|Overall Study|Death|1|||
170880456|NCT03882970|617572767|FG003|Overall Study|Death|1|||
170880457|NCT03882970|617572764|FG000|Overall Study|Lost to Follow-up|8|||
170880458|NCT03882970|617572765|FG001|Overall Study|Lost to Follow-up|9|||
170880459|NCT03882970|617572766|FG002|Overall Study|Lost to Follow-up|5|||
170880460|NCT03882970|617572767|FG003|Overall Study|Lost to Follow-up|5|||
170880461|NCT03882970|617572764|FG000|Overall Study|Physician Decision|0|||
170880462|NCT03882970|617572765|FG001|Overall Study|Physician Decision|2|||
170880463|NCT03882970|617572766|FG002|Overall Study|Physician Decision|2|||
170880464|NCT03882970|617572767|FG003|Overall Study|Physician Decision|2|||
170880465|NCT03882970|617572764|FG000|Overall Study|Protocol Violation|2|||
170880466|NCT03882970|617572765|FG001|Overall Study|Protocol Violation|0|||
170880467|NCT03882970|617572766|FG002|Overall Study|Protocol Violation|0|||
170880468|NCT03882970|617572767|FG003|Overall Study|Protocol Violation|0|||
170880469|NCT03882970|617572764|FG000|Overall Study|Withdrawal by Subject|8|||
170880470|NCT03882970|617572765|FG001|Overall Study|Withdrawal by Subject|17|||
170880471|NCT03882970|617572766|FG002|Overall Study|Withdrawal by Subject|7|||
170880472|NCT03882970|617572767|FG003|Overall Study|Withdrawal by Subject|22|||
170880473|NCT03882970|617572764|FG000|Overall Study|Personal Reason|2|||
170880474|NCT03882970|617572765|FG001|Overall Study|Personal Reason|3|||
170880475|NCT03882970|617572766|FG002|Overall Study|Personal Reason|1|||
170430897|NCT01492439|615917650|FG000|Overall Study|Withdrew from RTE|4|||
170430898|NCT01492439|615917651|FG001|Overall Study|Withdrew from RTE|9|||
170880476|NCT03882970|617572767|FG003|Overall Study|Personal Reason|3|||
170880477|NCT00607386|617572768|FG000|Overall Study|Physician Decision|1|||
170880478|NCT01046877|617572771|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
170880479|NCT01046877|617572771|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
170880480|NCT01081249|617572772|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
170880481|NCT01081249|617572773|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
170880482|NCT00282334|617572776|FG000|Overall Study|Withdrawal by Subject|8|||
170880483|NCT00282334|617572777|FG001|Overall Study|Withdrawal by Subject|5|||
170880484|NCT02813694|617572780|FG000|Overall Study|Physician Decision|0|||
170880485|NCT02813694|617572781|FG001|Overall Study|Physician Decision|1|||
170880486|NCT02813694|617572780|FG000|Overall Study|Withdrawal by Subject|10|||
170880487|NCT02813694|617572781|FG001|Overall Study|Withdrawal by Subject|9|||
170880488|NCT02813694|617572780|FG000|Overall Study|Lost to Follow-up|1|||
170880489|NCT02813694|617572781|FG001|Overall Study|Lost to Follow-up|1|||
170430899|NCT01204294|615917652|FG000|Overall Study|Adverse Event|2|||
170880490|NCT02813694|617572780|FG000|Overall Study|Death|3|||
170880491|NCT02813694|617572781|FG001|Overall Study|Death|3|||
170880492|NCT02813694|617572780|FG000|Overall Study|Randomized- did not receive study drug|2|||
170880493|NCT02813694|617572781|FG001|Overall Study|Randomized- did not receive study drug|0|||
170880494|NCT02813694|617572780|FG000|Overall Study|Patient hospitalized|1|||
170880495|NCT02813694|617572781|FG001|Overall Study|Patient hospitalized|0|||
170880496|NCT00939783|617572786|FG000|Overall Study|Death|6|||
170430900|NCT01204294|615917653|FG001|Overall Study|Adverse Event|6|||
170430901|NCT01204294|615917654|FG002|Overall Study|Adverse Event|0|||
170880497|NCT00939783|617572786|FG000|Overall Study|Adverse Event|39|||
170880498|NCT00939783|617572786|FG000|Overall Study|Study Terminated by Sponsor|498|||
170880499|NCT00939783|617572786|FG000|Overall Study|Withdrawal by Subject|78|||
170880500|NCT00939783|617572786|FG000|Overall Study|Other|16|||
170880501|NCT00939783|617572786|FG000|Overall Study|Lost to Follow-up|8|||
170430902|NCT01204294|615917655|FG003|Overall Study|Adverse Event|7|||
170430903|NCT01204294|615917656|FG004|Overall Study|Adverse Event|1|||
170430904|NCT01204294|615917657|FG005|Overall Study|Adverse Event|4|||
170430905|NCT01204294|615917658|FG006|Overall Study|Adverse Event|0|||
170430906|NCT01204294|615917652|FG000|Overall Study|Protocol Violation|1|||
170430907|NCT01204294|615917653|FG001|Overall Study|Protocol Violation|0|||
170430908|NCT01204294|615917654|FG002|Overall Study|Protocol Violation|2|||
170430909|NCT01204294|615917655|FG003|Overall Study|Protocol Violation|1|||
170430910|NCT01204294|615917656|FG004|Overall Study|Protocol Violation|0|||
170430911|NCT01204294|615917657|FG005|Overall Study|Protocol Violation|0|||
170430912|NCT01204294|615917658|FG006|Overall Study|Protocol Violation|0|||
170430913|NCT01204294|615917652|FG000|Overall Study|Withdrawal by Subject|0|||
170430914|NCT01204294|615917653|FG001|Overall Study|Withdrawal by Subject|2|||
170430915|NCT01204294|615917654|FG002|Overall Study|Withdrawal by Subject|2|||
170430916|NCT01204294|615917655|FG003|Overall Study|Withdrawal by Subject|1|||
170430917|NCT01204294|615917656|FG004|Overall Study|Withdrawal by Subject|1|||
170430918|NCT01204294|615917657|FG005|Overall Study|Withdrawal by Subject|1|||
170430919|NCT01204294|615917658|FG006|Overall Study|Withdrawal by Subject|2|||
170430920|NCT01204294|615917652|FG000|Overall Study|Lack of Efficacy|0|||
170430921|NCT01204294|615917653|FG001|Overall Study|Lack of Efficacy|0|||
170430922|NCT01204294|615917654|FG002|Overall Study|Lack of Efficacy|0|||
170430923|NCT01204294|615917655|FG003|Overall Study|Lack of Efficacy|2|||
170430924|NCT01204294|615917656|FG004|Overall Study|Lack of Efficacy|0|||
170430925|NCT01204294|615917657|FG005|Overall Study|Lack of Efficacy|0|||
170430926|NCT01204294|615917658|FG006|Overall Study|Lack of Efficacy|0|||
170430927|NCT01204294|615917652|FG000|Overall Study|Other (house moving)|0|||
170430928|NCT01204294|615917653|FG001|Overall Study|Other (house moving)|0|||
170430929|NCT01204294|615917654|FG002|Overall Study|Other (house moving)|1|||
170430930|NCT01204294|615917655|FG003|Overall Study|Other (house moving)|0|||
170430931|NCT01204294|615917656|FG004|Overall Study|Other (house moving)|0|||
170880502|NCT00939783|617572786|FG000|Overall Study|Protocol Violation|3|||
170430932|NCT01204294|615917657|FG005|Overall Study|Other (house moving)|0|||
170535409|NCT04809974|616306157|FG000|Lead-in Phase|Withdrawal by Subject|3|||
170535410|NCT04809974|616306158|FG001|Lead-in Phase|Withdrawal by Subject|0|||
170535411|NCT04809974|616306159|FG002|Lead-in Phase|Withdrawal by Subject|0|||
170535412|NCT04809974|616306157|FG000|Lead-in Phase|No longer eligible|11|||
170535413|NCT04809974|616306158|FG001|Lead-in Phase|No longer eligible|0|||
170535414|NCT04809974|616306159|FG002|Lead-in Phase|No longer eligible|0|||
170535415|NCT04809974|616306157|FG000|Randomized Phase|Lost to Follow-up|0|||
170535416|NCT04809974|616306158|FG001|Randomized Phase|Lost to Follow-up|1|||
170535417|NCT04809974|616306159|FG002|Randomized Phase|Lost to Follow-up|5|||
170535418|NCT04809974|616306157|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
170535419|NCT04809974|616306158|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
170535420|NCT04809974|616306159|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
170535421|NCT04809974|616306157|FG000|Randomized Phase|Adverse Event|0|||
170535422|NCT04809974|616306158|FG001|Randomized Phase|Adverse Event|1|||
170535423|NCT04809974|616306159|FG002|Randomized Phase|Adverse Event|4|||
170535424|NCT04809974|616306157|FG000|Randomized Phase|Withdrawal by Subject|0|||
170535425|NCT04809974|616306158|FG001|Randomized Phase|Withdrawal by Subject|0|||
170535426|NCT04809974|616306159|FG002|Randomized Phase|Withdrawal by Subject|5|||
170535427|NCT00770809|616306179|FG000|Overall Study|Adverse Event|9|||
170535428|NCT00770809|616306180|FG001|Overall Study|Adverse Event|1|||
170535429|NCT00770809|616306181|FG002|Overall Study|Adverse Event|12|||
170535430|NCT00770809|616306179|FG000|Overall Study|Death|1|||
170880503|NCT00939783|617572786|FG000|Overall Study|Enrolled but not treated|1|||
170880504|NCT04839380|617572787|FG000|Overall Study|Withdrawal by Subject|2|||
170880505|NCT04839380|617572787|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
170880506|NCT00879645|617572792|FG000|Overall Study|Adverse Event|1|||
170430933|NCT01204294|615917658|FG006|Overall Study|Other (house moving)|0|||
170430934|NCT01370317|615917661|FG000|Overall Study|Participant withdrew consent|1|||
170430935|NCT01370317|615917662|FG001|Overall Study|Participant withdrew consent|0|||
170430936|NCT01370317|615917661|FG000|Overall Study|Protocol deviation|0|||
170535431|NCT00770809|616306180|FG001|Overall Study|Death|0|||
170535432|NCT00770809|616306181|FG002|Overall Study|Death|0|||
170535433|NCT00770809|616306179|FG000|Overall Study|Withdrawal by Subject|3|||
170535434|NCT00770809|616306180|FG001|Overall Study|Withdrawal by Subject|3|||
170430937|NCT01370317|615917662|FG001|Overall Study|Protocol deviation|1|||
170430938|NCT03128723|615917663|FG000|Overall Study|Withdrawal by Subject|2|||
170430939|NCT00075478|615917665|FG000|Overall Study|not eligible|1|||
170430940|NCT00075478|615917666|FG001|Overall Study|not eligible|0|||
170430941|NCT00075478|615917665|FG000|Overall Study|Physician Decision|0|||
170430942|NCT00075478|615917666|FG001|Overall Study|Physician Decision|1|||
170430943|NCT00824291|615917670|FG000|Overall Study|Adverse Event|15|||
170880507|NCT00879645|617572793|FG001|Overall Study|Adverse Event|0|||
170880508|NCT00879645|617572794|FG002|Overall Study|Adverse Event|0|||
170880509|NCT00879645|617572795|FG003|Overall Study|Adverse Event|0|||
170880510|NCT01549002|617572796|FG000|Overall Study|Excessive pain|0|||
170880511|NCT01549002|617572797|FG001|Overall Study|Excessive pain|2|||
170880512|NCT01549002|617572796|FG000|Overall Study|Moderate sedation required|0|||
170880513|NCT01549002|617572797|FG001|Overall Study|Moderate sedation required|2|||
170880514|NCT00749996|617572798|FG000|Overall Study|Lost to Follow-up|7|||
170880515|NCT00749996|617572799|FG001|Overall Study|Lost to Follow-up|4|||
170880516|NCT00749996|617572798|FG000|Overall Study|Withdrawal by Subject|5|||
170880517|NCT00749996|617572799|FG001|Overall Study|Withdrawal by Subject|4|||
170880518|NCT00749996|617572798|FG000|Overall Study|Protocol Violation|2|||
170880519|NCT00749996|617572799|FG001|Overall Study|Protocol Violation|3|||
170880520|NCT00749996|617572798|FG000|Overall Study|Physician Decision|2|||
170880521|NCT00749996|617572799|FG001|Overall Study|Physician Decision|0|||
170880522|NCT00749996|617572798|FG000|Overall Study|Pregnancy|0|||
170880523|NCT00749996|617572799|FG001|Overall Study|Pregnancy|2|||
170880524|NCT00749996|617572798|FG000|Overall Study|Adverse Event|1|||
170880525|NCT00749996|617572799|FG001|Overall Study|Adverse Event|0|||
170880526|NCT00749996|617572798|FG000|Overall Study|Death|1|||
170880527|NCT00749996|617572799|FG001|Overall Study|Death|0|||
170880528|NCT00996944|617572800|FG000|Double-blind Treatment Period|Adverse Event|2|||
170880529|NCT00996944|617572801|FG001|Double-blind Treatment Period|Adverse Event|1|||
170880530|NCT00996944|617572800|FG000|Double-blind Treatment Period|Protocol Violation|1|||
170880531|NCT00996944|617572801|FG001|Double-blind Treatment Period|Protocol Violation|0|||
170880532|NCT00996944|617572800|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
170880533|NCT00996944|617572801|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
170880534|NCT00996944|617572800|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
170880535|NCT00996944|617572801|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
170880536|NCT00996944|617572800|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
170880537|NCT00996944|617572801|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
170880538|NCT02250274|617572802|FG000|Overall Study|Insufficient blood draw amount|7|||
170880539|NCT02250274|617572803|FG001|Overall Study|Insufficient blood draw amount|6|||
170880540|NCT01378104|617572806|FG000|Overall Study|Adverse Event|8|||
170880541|NCT01378104|617572807|FG001|Overall Study|Adverse Event|8|||
170880542|NCT01378104|617572806|FG000|Overall Study|Lack of Efficacy|7|||
170880543|NCT01378104|617572807|FG001|Overall Study|Lack of Efficacy|5|||
170880544|NCT01378104|617572806|FG000|Overall Study|Withdrawal by Subject|12|||
170880545|NCT01378104|617572807|FG001|Overall Study|Withdrawal by Subject|13|||
170880546|NCT02700997|617572816|FG000|Overall Study|Did not undergo CT imaging|1|||
170880547|NCT02700997|617572816|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
170880548|NCT01073267|617572819|FG000|Overall Study|Disease Progression|3|||
170880549|NCT03765138|617572822|FG000|Overall Study|Lost to Follow-up|1|||
170880550|NCT00781911|617572823|FG000|Overall Study|Adverse Event|4|||
170880551|NCT00781911|617572824|FG001|Overall Study|Adverse Event|4|||
170880552|NCT00781911|617572823|FG000|Overall Study|Withdrawal by Subject|1|||
170880553|NCT00781911|617572824|FG001|Overall Study|Withdrawal by Subject|2|||
170880554|NCT00781911|617572823|FG000|Overall Study|Physician Decision|0|||
170880555|NCT00781911|617572824|FG001|Overall Study|Physician Decision|2|||
170880556|NCT00781911|617572823|FG000|Overall Study|Sponsor Decision|1|||
170880557|NCT00781911|617572824|FG001|Overall Study|Sponsor Decision|0|||
170880558|NCT03873714|617572825|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
170880559|NCT00219284|617572826|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
170880560|NCT00219284|617572827|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
170880561|NCT00219284|617572826|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
170880562|NCT00219284|617572827|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
170880563|NCT00219284|617572826|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
170880564|NCT00219284|617572827|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
170880565|NCT00219284|617572826|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
170880566|NCT00219284|617572827|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
170880567|NCT00219284|617572826|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
170880568|NCT00219284|617572827|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
170880569|NCT00219284|617572826|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
170880570|NCT00219284|617572827|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
170880571|NCT00219284|617572826|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
170880572|NCT00219284|617572827|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
170880573|NCT00219284|617572826|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
170880574|NCT00219284|617572827|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
170880575|NCT00219284|617572826|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
170880576|NCT00219284|617572827|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
170880577|NCT05003622|617572828|FG000|Overall Study|Progressive disease|2|||
170880578|NCT05003622|617572828|FG000|Overall Study|Withdrawal by Subject|1|||
170430944|NCT00824291|615917671|FG001|Overall Study|Adverse Event|6|||
170430945|NCT00824291|615917670|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
170430946|NCT00824291|615917671|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
170430947|NCT00824291|615917670|FG000|Overall Study|Lost to Follow-up|11|||
170430948|NCT00824291|615917671|FG001|Overall Study|Lost to Follow-up|9|||
170430949|NCT00824291|615917670|FG000|Overall Study|Non-compliance|1|||
170430950|NCT00824291|615917671|FG001|Overall Study|Non-compliance|1|||
170430951|NCT00824291|615917670|FG000|Overall Study|Protocol Violation|4|||
170430952|NCT00824291|615917671|FG001|Overall Study|Protocol Violation|1|||
170430953|NCT00824291|615917670|FG000|Overall Study|Withdrawal by Subject|14|||
170430954|NCT00824291|615917671|FG001|Overall Study|Withdrawal by Subject|8|||
170430955|NCT00824291|615917670|FG000|Overall Study|Lack of Efficacy|7|||
170430956|NCT00824291|615917671|FG001|Overall Study|Lack of Efficacy|8|||
170430957|NCT00824291|615917670|FG000|Overall Study|Participant on prohibited medication|1|||
170430958|NCT00824291|615917671|FG001|Overall Study|Participant on prohibited medication|0|||
170430959|NCT00933686|615917673|FG000|Overall Study|Protocol Violation|0|||
170430960|NCT00933686|615917674|FG001|Overall Study|Protocol Violation|1|||
170430961|NCT00933686|615917673|FG000|Overall Study|Lost to Follow-up|2|||
170430962|NCT00933686|615917674|FG001|Overall Study|Lost to Follow-up|2|||
170430963|NCT00933686|615917673|FG000|Overall Study|Withdrawal by Subject|6|||
170430964|NCT00933686|615917674|FG001|Overall Study|Withdrawal by Subject|5|||
170430965|NCT00933686|615917673|FG000|Overall Study|Adverse Event|1|||
170430966|NCT00933686|615917674|FG001|Overall Study|Adverse Event|1|||
170430967|NCT00933686|615917673|FG000|Overall Study|Physician Decision|1|||
170430968|NCT00933686|615917674|FG001|Overall Study|Physician Decision|0|||
170430969|NCT00933686|615917673|FG000|Overall Study|Failure to show up at endpoint visits|0|||
170430970|NCT00933686|615917674|FG001|Overall Study|Failure to show up at endpoint visits|2|||
170430971|NCT00245063|615917675|FG000|Overall Study|Adverse Event|6|||
170430972|NCT00245063|615917676|FG001|Overall Study|Adverse Event|5|||
170430973|NCT00245063|615917675|FG000|Overall Study|Death|1|||
170430974|NCT00245063|615917676|FG001|Overall Study|Death|0|||
170430975|NCT05919823|615917680|FG000|Pre-Treatment Period|Screen failure|1|||
170430976|NCT05919823|615917681|FG001|Pre-Treatment Period|Screen failure|0|||
170430977|NCT05919823|615917682|FG002|Pre-Treatment Period|Screen failure|0|||
170430978|NCT05919823|615917683|FG003|Pre-Treatment Period|Screen failure|0|||
170430979|NCT05919823|615917680|FG000|Pre-Treatment Period|Protocol Violation|0|||
170430980|NCT05919823|615917681|FG001|Pre-Treatment Period|Protocol Violation|1|||
170430981|NCT05919823|615917682|FG002|Pre-Treatment Period|Protocol Violation|0|||
170430982|NCT05919823|615917683|FG003|Pre-Treatment Period|Protocol Violation|0|||
170430983|NCT05919823|615917680|FG000|Double-Blind Period|Adverse Event|8|||
170430984|NCT05919823|615917681|FG001|Double-Blind Period|Adverse Event|9|||
170430985|NCT05919823|615917682|FG002|Double-Blind Period|Adverse Event|0|||
170430986|NCT05919823|615917683|FG003|Double-Blind Period|Adverse Event|0|||
170430987|NCT05919823|615917680|FG000|Double-Blind Period|Protocol Violation|2|||
170430988|NCT05919823|615917681|FG001|Double-Blind Period|Protocol Violation|1|||
170430989|NCT05919823|615917682|FG002|Double-Blind Period|Protocol Violation|0|||
170430990|NCT05919823|615917683|FG003|Double-Blind Period|Protocol Violation|0|||
170430991|NCT05919823|615917680|FG000|Double-Blind Period|Participant withdrew consent|11|||
170430992|NCT05919823|615917681|FG001|Double-Blind Period|Participant withdrew consent|7|||
170430993|NCT05919823|615917682|FG002|Double-Blind Period|Participant withdrew consent|0|||
170430994|NCT05919823|615917683|FG003|Double-Blind Period|Participant withdrew consent|0|||
170430995|NCT05919823|615917680|FG000|Double-Blind Period|Other reasons|2|||
170430996|NCT05919823|615917681|FG001|Double-Blind Period|Other reasons|3|||
170430997|NCT05919823|615917682|FG002|Double-Blind Period|Other reasons|0|||
170430998|NCT05919823|615917683|FG003|Double-Blind Period|Other reasons|0|||
170430999|NCT05919823|615917680|FG000|Open Label Period|Adverse Event|0|||
170431000|NCT05919823|615917681|FG001|Open Label Period|Adverse Event|0|||
170535435|NCT00770809|616306181|FG002|Overall Study|Withdrawal by Subject|7|||
170535436|NCT00770809|616306179|FG000|Overall Study|Progression|2|||
170778548|NCT01303445|617195707|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
170431001|NCT05919823|615917682|FG002|Open Label Period|Adverse Event|2|||
170431002|NCT05919823|615917683|FG003|Open Label Period|Adverse Event|4|||
170431003|NCT05919823|615917680|FG000|Open Label Period|Lost to Follow-up|0|||
170431004|NCT05919823|615917681|FG001|Open Label Period|Lost to Follow-up|0|||
170431005|NCT05919823|615917682|FG002|Open Label Period|Lost to Follow-up|1|||
170431006|NCT05919823|615917683|FG003|Open Label Period|Lost to Follow-up|0|||
170778549|NCT01303445|617195708|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
170778550|NCT01303445|617195707|FG000|Washout (14 Days)|Protocol Violation|1|||
170778551|NCT01303445|617195708|FG001|Washout (14 Days)|Protocol Violation|0|||
170431007|NCT05919823|615917680|FG000|Open Label Period|Protocol Violation|0|||
170431008|NCT05919823|615917681|FG001|Open Label Period|Protocol Violation|0|||
170431009|NCT05919823|615917682|FG002|Open Label Period|Protocol Violation|0|||
170431010|NCT05919823|615917683|FG003|Open Label Period|Protocol Violation|1|||
170431011|NCT05919823|615917680|FG000|Open Label Period|Participant withdrew consent|0|||
170535437|NCT00770809|616306180|FG001|Overall Study|Progression|2|||
170778552|NCT01303445|617195707|FG000|Washout (14 Days)|Lost to Follow-up|0|||
170431012|NCT05919823|615917681|FG001|Open Label Period|Participant withdrew consent|0|||
170431013|NCT05919823|615917682|FG002|Open Label Period|Participant withdrew consent|8|||
170431014|NCT05919823|615917683|FG003|Open Label Period|Participant withdrew consent|6|||
170431015|NCT05919823|615917680|FG000|Open Label Period|Death|0|||
170431016|NCT05919823|615917681|FG001|Open Label Period|Death|0|||
170431017|NCT05919823|615917682|FG002|Open Label Period|Death|0|||
170431018|NCT05919823|615917683|FG003|Open Label Period|Death|1|||
170431019|NCT05919823|615917680|FG000|Open Label Period|Other reasons|0|||
170431020|NCT05919823|615917681|FG001|Open Label Period|Other reasons|0|||
170431021|NCT05919823|615917682|FG002|Open Label Period|Other reasons|9|||
170431022|NCT05919823|615917683|FG003|Open Label Period|Other reasons|5|||
170431023|NCT01648582|615917684|FG000|Overall Study|Adverse Event|6|||
170431024|NCT01648582|615917685|FG001|Overall Study|Adverse Event|11|||
170431025|NCT01648582|615917686|FG002|Overall Study|Adverse Event|2|||
170431026|NCT01648582|615917684|FG000|Overall Study|Lost to Follow-up|9|||
170431027|NCT01648582|615917685|FG001|Overall Study|Lost to Follow-up|6|||
170431028|NCT01648582|615917686|FG002|Overall Study|Lost to Follow-up|8|||
170431029|NCT01648582|615917684|FG000|Overall Study|Protocol Violation|1|||
170431030|NCT01648582|615917685|FG001|Overall Study|Protocol Violation|2|||
170431031|NCT01648582|615917686|FG002|Overall Study|Protocol Violation|1|||
170431032|NCT01648582|615917684|FG000|Overall Study|Withdrawal by Subject|15|||
170431033|NCT01648582|615917685|FG001|Overall Study|Withdrawal by Subject|17|||
170431034|NCT01648582|615917686|FG002|Overall Study|Withdrawal by Subject|17|||
170431035|NCT01648582|615917684|FG000|Overall Study|Physician Decision|0|||
170431036|NCT01648582|615917685|FG001|Overall Study|Physician Decision|1|||
170431037|NCT01648582|615917686|FG002|Overall Study|Physician Decision|3|||
170431038|NCT01648582|615917684|FG000|Overall Study|Death|1|||
170431039|NCT01648582|615917685|FG001|Overall Study|Death|0|||
170431040|NCT01648582|615917686|FG002|Overall Study|Death|0|||
170431041|NCT01648582|615917684|FG000|Overall Study|Sponsor Decision|0|||
170431042|NCT01648582|615917685|FG001|Overall Study|Sponsor Decision|1|||
170431043|NCT01648582|615917686|FG002|Overall Study|Sponsor Decision|1|||
170431044|NCT02849457|615917687|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
170431045|NCT02849457|615917688|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
170431046|NCT02849457|615917689|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
170431047|NCT02849457|615917690|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
170431048|NCT00392665|615917691|FG000|Overall Study|Death|16|||
170431049|NCT00392665|615917692|FG001|Overall Study|Death|14|||
170431050|NCT00392665|615917691|FG000|Overall Study|Lost to Follow-up|1|||
170431051|NCT00392665|615917692|FG001|Overall Study|Lost to Follow-up|1|||
170431052|NCT02294786|615917695|FG000|Overall Study|Withdrawal by Subject|0|||
170431053|NCT02294786|615917696|FG001|Overall Study|Withdrawal by Subject|1|||
170431054|NCT02294786|615917695|FG000|Overall Study|Physician Decision|6|||
170431055|NCT02294786|615917696|FG001|Overall Study|Physician Decision|7|||
170535438|NCT00770809|616306181|FG002|Overall Study|Progression|0|||
170535439|NCT00770809|616306179|FG000|Overall Study|Complicating illness|0|||
170535440|NCT00770809|616306180|FG001|Overall Study|Complicating illness|0|||
170535441|NCT00770809|616306181|FG002|Overall Study|Complicating illness|1|||
170535442|NCT00770809|616306179|FG000|Overall Study|Other Medical Reasons|2|||
170535443|NCT00770809|616306180|FG001|Overall Study|Other Medical Reasons|4|||
170535444|NCT00770809|616306181|FG002|Overall Study|Other Medical Reasons|3|||
170535445|NCT05028569|616306182|FG000|Double-Blind Phase|Death|0|||
170535446|NCT05028569|616306183|FG001|Double-Blind Phase|Death|0|||
170535447|NCT05028569|616306184|FG002|Double-Blind Phase|Death|0|||
170535448|NCT05028569|616306185|FG003|Double-Blind Phase|Death|1|||
170535449|NCT05028569|616306186|FG004|Double-Blind Phase|Death|0|||
170535450|NCT05028569|616306187|FG005|Double-Blind Phase|Death|0|||
170535451|NCT05028569|616306188|FG006|Double-Blind Phase|Death|0|||
170778553|NCT01303445|617195708|FG001|Washout (14 Days)|Lost to Follow-up|2|||
170778554|NCT01303445|617195707|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
170778555|NCT01303445|617195708|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
170431056|NCT02294786|615917695|FG000|Overall Study|Lost to Follow-up|1|||
170431057|NCT02294786|615917696|FG001|Overall Study|Lost to Follow-up|2|||
170431058|NCT02294786|615917695|FG000|Overall Study|Protocol Violation|1|||
170431059|NCT02294786|615917696|FG001|Overall Study|Protocol Violation|0|||
170431060|NCT02294786|615917695|FG000|Overall Study|Adverse Event|1|||
170431061|NCT02294786|615917696|FG001|Overall Study|Adverse Event|1|||
170431062|NCT02294786|615917695|FG000|Overall Study|Death|2|||
170431063|NCT02294786|615917696|FG001|Overall Study|Death|3|||
170431064|NCT01444378|615917701|FG000|Overall Study|Lost to Follow-up|1|||
170431065|NCT01444378|615917701|FG000|Overall Study|Withdrawal by Subject|1|||
170535452|NCT05028569|616306182|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170535453|NCT05028569|616306183|FG001|Double-Blind Phase|Lost to Follow-up|6|||
170535454|NCT05028569|616306184|FG002|Double-Blind Phase|Lost to Follow-up|3|||
170535455|NCT05028569|616306185|FG003|Double-Blind Phase|Lost to Follow-up|9|||
170535456|NCT05028569|616306186|FG004|Double-Blind Phase|Lost to Follow-up|0|||
170778556|NCT01303445|617195707|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
170778557|NCT01303445|617195708|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
170778558|NCT03582722|617195709|FG000|Overall Study|Lost to Follow-up|1|||
170778559|NCT03582722|617195710|FG001|Overall Study|Lost to Follow-up|4|||
170778560|NCT03582722|617195709|FG000|Overall Study|Withdrawal by Subject|3|||
170778561|NCT03582722|617195710|FG001|Overall Study|Withdrawal by Subject|3|||
170431066|NCT01444378|615917701|FG000|Overall Study|Death|3|||
170431067|NCT01444378|615917701|FG000|Overall Study|Administrative Closure Of The Study|2|||
170431068|NCT01444378|615917701|FG000|Overall Study|Missed Visits|10|||
170431069|NCT02760927|615917702|FG000|Overall Study|Tube Slippage from Device|1|||
170431070|NCT03419403|615917703|FG000|Overall Study|Withdrawal by Subject|5|||
170778562|NCT02576509|617197286|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
170778563|NCT02576509|617197287|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
170778564|NCT02576509|617197286|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
170778565|NCT02576509|617197287|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
170778566|NCT02576509|617197286|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
170778567|NCT02576509|617197287|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
170778568|NCT02576509|617197286|FG000|Treatment Period|Disease progression|263|||
170778569|NCT02576509|617197287|FG001|Treatment Period|Disease progression|244|||
170778570|NCT02576509|617197286|FG000|Treatment Period|Study drug toxicity|37|||
170778571|NCT02576509|617197287|FG001|Treatment Period|Study drug toxicity|41|||
170778572|NCT02576509|617197286|FG000|Treatment Period|Death|1|||
170778573|NCT02576509|617197287|FG001|Treatment Period|Death|1|||
170778574|NCT02576509|617197286|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
170778575|NCT02576509|617197287|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
170778576|NCT02576509|617197286|FG000|Treatment Period|Participant request to stop treatment|8|||
170778577|NCT02576509|617197287|FG001|Treatment Period|Participant request to stop treatment|18|||
170778578|NCT02576509|617197286|FG000|Treatment Period|Participant withdrew consent|3|||
170778579|NCT02576509|617197287|FG001|Treatment Period|Participant withdrew consent|7|||
170778580|NCT02576509|617197286|FG000|Treatment Period|Lost to Follow-up|0|||
170778581|NCT02576509|617197287|FG001|Treatment Period|Lost to Follow-up|1|||
170431071|NCT03419403|615917704|FG001|Overall Study|Withdrawal by Subject|2|||
170431072|NCT03419403|615917705|FG002|Overall Study|Withdrawal by Subject|5|||
170431073|NCT03419403|615917706|FG003|Overall Study|Withdrawal by Subject|1|||
170431074|NCT03419403|615917703|FG000|Overall Study|Progressive disease (per protocol)|0|||
170431075|NCT03419403|615917704|FG001|Overall Study|Progressive disease (per protocol)|2|||
170431076|NCT03419403|615917705|FG002|Overall Study|Progressive disease (per protocol)|2|||
170431077|NCT03419403|615917706|FG003|Overall Study|Progressive disease (per protocol)|0|||
170431078|NCT03419403|615917703|FG000|Overall Study|Other, not specified|6|||
170431079|NCT03419403|615917704|FG001|Overall Study|Other, not specified|4|||
170431080|NCT03419403|615917705|FG002|Overall Study|Other, not specified|5|||
170431081|NCT03419403|615917706|FG003|Overall Study|Other, not specified|1|||
170431082|NCT03419403|615917703|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
170431083|NCT03419403|615917704|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
170431084|NCT03419403|615917705|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
170431085|NCT03419403|615917706|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
170431086|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Adverse Event|11|||
170431087|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Adverse Event|23|||
170431088|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Adverse Event|29|||
170431089|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Adverse Event|2|||
170431090|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Adverse Event|8|||
170431091|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
170431092|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
170431093|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
170431094|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
170431095|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
170431096|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
170431097|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
170431098|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
170431099|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
170431100|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
170431101|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
170431102|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
170431103|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
170431104|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
170431105|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
170431106|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
170431107|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
170431108|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
170431109|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
170431110|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
170431111|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
170431112|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
170431113|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
170431114|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
170431115|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
170431116|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
170431117|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
170431118|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
170431119|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
170431120|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
170431121|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Move|0|||
170431122|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Move|1|||
170778582|NCT02576509|617197286|FG000|Treatment Period|Maximum clinical benefit|1|||
170778583|NCT02576509|617197287|FG001|Treatment Period|Maximum clinical benefit|0|||
170431123|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Move|0|||
170431124|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Move|0|||
170431125|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Move|0|||
170431126|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
170431127|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
170431128|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
170431129|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
170431130|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
170431131|NCT00318461|615917709|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
170431132|NCT00318461|615917710|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
170431133|NCT00318461|615917711|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
170431134|NCT00318461|615917712|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
170431135|NCT00318461|615917713|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
170431136|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Work commitment|0|||
170431137|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Work commitment|0|||
170431138|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Work commitment|0|||
170431139|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Work commitment|0|||
170778584|NCT02576509|617197286|FG000|Treatment Period|Poor/non-compliance|1|||
170778585|NCT02576509|617197287|FG001|Treatment Period|Poor/non-compliance|1|||
170778586|NCT02576509|617197286|FG000|Treatment Period|Participant no longer meets criteria|1|||
170778587|NCT02576509|617197287|FG001|Treatment Period|Participant no longer meets criteria|0|||
170778588|NCT02576509|617197286|FG000|Treatment Period|Other reason|12|||
170778589|NCT02576509|617197287|FG001|Treatment Period|Other reason|8|||
170778590|NCT02576509|617197286|FG000|Treatment Period|NOT REPORTED|1|||
170778591|NCT02576509|617197287|FG001|Treatment Period|NOT REPORTED|0|||
170778592|NCT02576509|617197286|FG000|Treatment Period|Administrative reason by sponsor|0|||
170778593|NCT02576509|617197287|FG001|Treatment Period|Administrative reason by sponsor|1|||
170778594|NCT03398148|617197288|FG000|Substudy 1 Period 1|Adverse Event|5|||
170778595|NCT03398148|617197289|FG001|Substudy 1 Period 1|Adverse Event|2|||
170778596|NCT03398148|617197290|FG002|Substudy 1 Period 1|Adverse Event|2|||
170778597|NCT03398148|617197291|FG003|Substudy 1 Period 1|Adverse Event|0|||
170431140|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Work commitment|1|||
170431141|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Investigator decision|0|||
170431142|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Investigator decision|0|||
170431143|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Investigator decision|0|||
170431144|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Investigator decision|0|||
170431145|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Investigator decision|1|||
170431146|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Lack of time|1|||
170431147|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Lack of time|0|||
170535457|NCT05028569|616306187|FG005|Double-Blind Phase|Lost to Follow-up|0|||
170535458|NCT05028569|616306188|FG006|Double-Blind Phase|Lost to Follow-up|0|||
170778598|NCT03398148|617197292|FG004|Substudy 1 Period 1|Adverse Event|8|||
170778599|NCT03398148|617197293|FG005|Substudy 1 Period 1|Adverse Event|0|||
170778600|NCT03398148|617197294|FG006|Substudy 1 Period 1|Adverse Event|0|||
170778601|NCT03398148|617197295|FG007|Substudy 1 Period 1|Adverse Event|0|||
170778602|NCT03398148|617197296|FG008|Substudy 1 Period 1|Adverse Event|0|||
170778603|NCT03398148|617197297|FG009|Substudy 1 Period 1|Adverse Event|0|||
170778604|NCT03398148|617197298|FG010|Substudy 1 Period 1|Adverse Event|0|||
170778605|NCT03398148|617197299|FG011|Substudy 1 Period 1|Adverse Event|0|||
170778606|NCT03398148|617197300|FG012|Substudy 1 Period 1|Adverse Event|0|||
170778607|NCT03398148|617197301|FG013|Substudy 1 Period 1|Adverse Event|0|||
170778608|NCT03398148|617197302|FG014|Substudy 1 Period 1|Adverse Event|0|||
170778609|NCT03398148|617197288|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
170778610|NCT03398148|617197289|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
170778611|NCT03398148|617197290|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778612|NCT03398148|617197291|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
170778613|NCT03398148|617197292|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
170778614|NCT03398148|617197293|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778615|NCT03398148|617197294|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778616|NCT03398148|617197295|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778617|NCT03398148|617197296|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778618|NCT03398148|617197297|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778619|NCT03398148|617197298|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778620|NCT03398148|617197299|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778621|NCT03398148|617197300|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778622|NCT03398148|617197301|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778623|NCT03398148|617197302|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
170778624|NCT03398148|617197288|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
170778625|NCT03398148|617197289|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
170778626|NCT03398148|617197290|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
170778627|NCT03398148|617197291|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
170778628|NCT03398148|617197292|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
170778629|NCT03398148|617197293|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
170778630|NCT03398148|617197294|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
170778631|NCT03398148|617197295|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
170778632|NCT03398148|617197296|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
170778633|NCT03398148|617197297|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
170778634|NCT03398148|617197298|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
170778635|NCT03398148|617197299|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
170778636|NCT03398148|617197300|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
170778637|NCT03398148|617197301|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
170778638|NCT03398148|617197302|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
170778639|NCT03398148|617197288|FG000|Substudy 1 Period 1|Other|0|||
170778640|NCT03398148|617197289|FG001|Substudy 1 Period 1|Other|1|||
170778641|NCT03398148|617197290|FG002|Substudy 1 Period 1|Other|0|||
170778642|NCT03398148|617197291|FG003|Substudy 1 Period 1|Other|0|||
170778643|NCT03398148|617197292|FG004|Substudy 1 Period 1|Other|3|||
170778644|NCT03398148|617197293|FG005|Substudy 1 Period 1|Other|0|||
170778645|NCT03398148|617197294|FG006|Substudy 1 Period 1|Other|0|||
170778646|NCT03398148|617197295|FG007|Substudy 1 Period 1|Other|0|||
170778647|NCT03398148|617197296|FG008|Substudy 1 Period 1|Other|0|||
170778648|NCT03398148|617197297|FG009|Substudy 1 Period 1|Other|0|||
170778649|NCT03398148|617197298|FG010|Substudy 1 Period 1|Other|0|||
170778650|NCT03398148|617197299|FG011|Substudy 1 Period 1|Other|0|||
170535459|NCT05028569|616306182|FG000|Double-Blind Phase|Protocol Deviation|0|||
170778651|NCT03398148|617197300|FG012|Substudy 1 Period 1|Other|0|||
170778652|NCT03398148|617197301|FG013|Substudy 1 Period 1|Other|0|||
170778653|NCT03398148|617197302|FG014|Substudy 1 Period 1|Other|0|||
170778654|NCT03398148|617197288|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778655|NCT03398148|617197289|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778656|NCT03398148|617197290|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
170431148|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Lack of time|0|||
170431149|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Lack of time|0|||
170535460|NCT05028569|616306183|FG001|Double-Blind Phase|Protocol Deviation|2|||
170535461|NCT05028569|616306184|FG002|Double-Blind Phase|Protocol Deviation|0|||
170535462|NCT05028569|616306185|FG003|Double-Blind Phase|Protocol Deviation|0|||
170431150|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Lack of time|0|||
170431151|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
170431152|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
170431153|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
170431154|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
170431155|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
170431156|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
170431157|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
170431158|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
170431159|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
170431160|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
170431161|NCT00318461|615917709|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
170431162|NCT00318461|615917710|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
170431163|NCT00318461|615917711|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
170431164|NCT00318461|615917712|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
170431165|NCT00318461|615917713|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
170431166|NCT00318461|615917709|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
170431167|NCT00318461|615917710|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
170431168|NCT00318461|615917711|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
170431169|NCT00318461|615917712|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
170431170|NCT00318461|615917713|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
170431171|NCT00318461|615917709|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
170431172|NCT00318461|615917710|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
170431173|NCT00318461|615917711|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
170431174|NCT00318461|615917712|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
170431175|NCT00318461|615917713|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
170431176|NCT00318461|615917709|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
170431177|NCT00318461|615917710|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
170431178|NCT00318461|615917711|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
170431179|NCT00318461|615917712|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
170431180|NCT00318461|615917713|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
170431181|NCT00318461|615917709|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
170431182|NCT00318461|615917710|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
170431183|NCT00318461|615917711|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
170431184|NCT00318461|615917712|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
170431185|NCT00318461|615917713|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
170431186|NCT00318461|615917709|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
170431187|NCT00318461|615917710|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
170431188|NCT00318461|615917711|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
170431189|NCT00318461|615917712|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
170431190|NCT00318461|615917713|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
170431191|NCT00505622|615917716|FG000|Overall Study|Adverse Event|5|||
170431192|NCT00505622|615917717|FG001|Overall Study|Adverse Event|6|||
170431193|NCT00505622|615917718|FG002|Overall Study|Adverse Event|4|||
170431194|NCT00505622|615917716|FG000|Overall Study|Protocol Violation|1|||
170431195|NCT00505622|615917717|FG001|Overall Study|Protocol Violation|1|||
170431196|NCT00505622|615917718|FG002|Overall Study|Protocol Violation|0|||
170431197|NCT00505622|615917716|FG000|Overall Study|Withdrawal by Subject|0|||
170778657|NCT03398148|617197291|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778658|NCT03398148|617197292|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
170778659|NCT03398148|617197293|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
170431198|NCT00505622|615917717|FG001|Overall Study|Withdrawal by Subject|3|||
170535463|NCT05028569|616306186|FG004|Double-Blind Phase|Protocol Deviation|0|||
170535464|NCT05028569|616306187|FG005|Double-Blind Phase|Protocol Deviation|0|||
170535465|NCT05028569|616306188|FG006|Double-Blind Phase|Protocol Deviation|0|||
170535466|NCT05028569|616306182|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
170535467|NCT05028569|616306183|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
170535468|NCT05028569|616306184|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
170535469|NCT05028569|616306185|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
170535470|NCT05028569|616306186|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
170535471|NCT05028569|616306187|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
170535472|NCT05028569|616306188|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
170535473|NCT05028569|616306182|FG000|Double-Blind Phase|Other, not specified|0|||
170535474|NCT05028569|616306183|FG001|Double-Blind Phase|Other, not specified|5|||
170535475|NCT05028569|616306184|FG002|Double-Blind Phase|Other, not specified|4|||
170535476|NCT05028569|616306185|FG003|Double-Blind Phase|Other, not specified|6|||
170535477|NCT05028569|616306186|FG004|Double-Blind Phase|Other, not specified|0|||
170535478|NCT05028569|616306187|FG005|Double-Blind Phase|Other, not specified|0|||
170535479|NCT05028569|616306188|FG006|Double-Blind Phase|Other, not specified|0|||
170535480|NCT05028569|616306182|FG000|Open-Label Phase|Death|0|||
170880579|NCT00794157|617572829|FG000|Overall Study|Adverse Event|4|||
170880580|NCT00794157|617572830|FG001|Overall Study|Adverse Event|1|||
170880581|NCT00794157|617572831|FG002|Overall Study|Adverse Event|8|||
170880582|NCT00794157|617572829|FG000|Overall Study|Subject withdrew consent|2|||
170880583|NCT00794157|617572830|FG001|Overall Study|Subject withdrew consent|0|||
170880584|NCT00794157|617572831|FG002|Overall Study|Subject withdrew consent|3|||
170880585|NCT00794157|617572829|FG000|Overall Study|Lost to Follow-up|2|||
170880586|NCT00794157|617572830|FG001|Overall Study|Lost to Follow-up|0|||
170880587|NCT00794157|617572831|FG002|Overall Study|Lost to Follow-up|1|||
170880588|NCT00794157|617572829|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170880589|NCT00794157|617572830|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170880590|NCT00794157|617572831|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
170880591|NCT00794157|617572829|FG000|Overall Study|Administrative problems|1|||
170880592|NCT00794157|617572830|FG001|Overall Study|Administrative problems|7|||
170880593|NCT00794157|617572831|FG002|Overall Study|Administrative problems|4|||
170880594|NCT00794157|617572829|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170880595|NCT00794157|617572830|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170880596|NCT00794157|617572831|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170880597|NCT00794157|617572829|FG000|Overall Study|Protocol deviation|0|||
170880598|NCT00794157|617572830|FG001|Overall Study|Protocol deviation|1|||
170880599|NCT00794157|617572831|FG002|Overall Study|Protocol deviation|1|||
170880600|NCT01692275|617572832|FG000|Overall Study|Lost to Follow-up|57|||
170880601|NCT01692275|617572833|FG001|Overall Study|Lost to Follow-up|48|||
170880602|NCT01692275|617572832|FG000|Overall Study|Withdrawal by Subject|9|||
170880603|NCT01692275|617572833|FG001|Overall Study|Withdrawal by Subject|11|||
170880604|NCT00708123|617572840|FG000|Period 1|Protocol Violation|0|||
170880605|NCT00708123|617572841|FG001|Period 1|Protocol Violation|1|||
170535481|NCT05028569|616306183|FG001|Open-Label Phase|Death|0|||
170535482|NCT05028569|616306184|FG002|Open-Label Phase|Death|0|||
170880606|NCT00708123|617572842|FG002|Period 1|Protocol Violation|0|||
170880607|NCT00708123|617572843|FG003|Period 1|Protocol Violation|1|||
170880608|NCT00708123|617572844|FG004|Period 1|Protocol Violation|0|||
170880609|NCT00708123|617572840|FG000|Period 1|Adverse Event|0|||
170880610|NCT00708123|617572841|FG001|Period 1|Adverse Event|0|||
170880611|NCT00708123|617572842|FG002|Period 1|Adverse Event|1|||
170880612|NCT00708123|617572843|FG003|Period 1|Adverse Event|0|||
170880613|NCT00708123|617572844|FG004|Period 1|Adverse Event|0|||
170880614|NCT00708123|617572840|FG000|Period 2|Protocol Violation|0|||
170880615|NCT00708123|617572841|FG001|Period 2|Protocol Violation|0|||
170880616|NCT00708123|617572842|FG002|Period 2|Protocol Violation|0|||
170880617|NCT00708123|617572843|FG003|Period 2|Protocol Violation|1|||
170880618|NCT00708123|617572844|FG004|Period 2|Protocol Violation|0|||
170880619|NCT00708123|617572840|FG000|Period 2|Other Reason|1|||
170880620|NCT00708123|617572841|FG001|Period 2|Other Reason|0|||
170880621|NCT00708123|617572842|FG002|Period 2|Other Reason|0|||
170880622|NCT00708123|617572843|FG003|Period 2|Other Reason|0|||
170880623|NCT00708123|617572844|FG004|Period 2|Other Reason|0|||
170880624|NCT00708123|617572840|FG000|Period 3|Lost to Follow-up|0|||
170880625|NCT00708123|617572841|FG001|Period 3|Lost to Follow-up|0|||
170880626|NCT00708123|617572842|FG002|Period 3|Lost to Follow-up|1|||
170880627|NCT00708123|617572843|FG003|Period 3|Lost to Follow-up|1|||
170880628|NCT00708123|617572844|FG004|Period 3|Lost to Follow-up|0|||
170880629|NCT00708123|617572840|FG000|Period 4|Protocol Violation|0|||
170880630|NCT00708123|617572841|FG001|Period 4|Protocol Violation|1|||
170880631|NCT00708123|617572842|FG002|Period 4|Protocol Violation|0|||
170535483|NCT05028569|616306185|FG003|Open-Label Phase|Death|0|||
170535484|NCT05028569|616306186|FG004|Open-Label Phase|Death|0|||
170535485|NCT05028569|616306187|FG005|Open-Label Phase|Death|0|||
170535486|NCT05028569|616306188|FG006|Open-Label Phase|Death|1|||
170535487|NCT05028569|616306182|FG000|Open-Label Phase|Lost to Follow-up|0|||
170535488|NCT05028569|616306183|FG001|Open-Label Phase|Lost to Follow-up|0|||
170880632|NCT00708123|617572843|FG003|Period 4|Protocol Violation|0|||
170880633|NCT00708123|617572844|FG004|Period 4|Protocol Violation|0|||
170880634|NCT02970292|617572845|FG000|Overall Study|Physician Decision|1|||
170880635|NCT02970292|617572846|FG001|Overall Study|Physician Decision|1|||
170535489|NCT05028569|616306184|FG002|Open-Label Phase|Lost to Follow-up|0|||
170535490|NCT05028569|616306185|FG003|Open-Label Phase|Lost to Follow-up|0|||
170880636|NCT02970292|617572845|FG000|Overall Study|Withdrawal by Subject|11|||
170880637|NCT02970292|617572846|FG001|Overall Study|Withdrawal by Subject|5|||
170535491|NCT05028569|616306186|FG004|Open-Label Phase|Lost to Follow-up|5|||
170880638|NCT02970292|617572845|FG000|Overall Study|Noncompliance with study drug|2|||
170880639|NCT02970292|617572846|FG001|Overall Study|Noncompliance with study drug|2|||
170880640|NCT02970292|617572845|FG000|Overall Study|Adverse Event|5|||
170535492|NCT05028569|616306187|FG005|Open-Label Phase|Lost to Follow-up|5|||
170880641|NCT02970292|617572846|FG001|Overall Study|Adverse Event|0|||
170880642|NCT02970292|617572845|FG000|Overall Study|Lack of Efficacy|1|||
170880643|NCT02970292|617572846|FG001|Overall Study|Lack of Efficacy|0|||
170880644|NCT02970292|617572845|FG000|Overall Study|Lost to Follow-up|1|||
170880645|NCT02970292|617572846|FG001|Overall Study|Lost to Follow-up|0|||
170880646|NCT02970292|617572845|FG000|Overall Study|Protocol Violation|2|||
170431199|NCT00505622|615917718|FG002|Overall Study|Withdrawal by Subject|2|||
170431200|NCT00505622|615917716|FG000|Overall Study|Study termination by sponsor|115|||
170431201|NCT00505622|615917717|FG001|Overall Study|Study termination by sponsor|98|||
170431202|NCT00505622|615917718|FG002|Overall Study|Study termination by sponsor|90|||
170431203|NCT03084471|615917719|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
170431204|NCT03084471|615917719|FG000|Overall Study|Condition under investigation worsened|84|||
170431205|NCT03084471|615917719|FG000|Overall Study|Lack of therapeutic response|2|||
170431206|NCT03084471|615917719|FG000|Overall Study|Protocol Violation|1|||
170431207|NCT03084471|615917719|FG000|Overall Study|Adverse Event|73|||
170431208|NCT03084471|615917719|FG000|Overall Study|Withdrawal by Subject|12|||
170431209|NCT03084471|615917719|FG000|Overall Study|Disease relapse|181|||
170431210|NCT03084471|615917719|FG000|Overall Study|Subjective disease progression|359|||
170431211|NCT03084471|615917719|FG000|Overall Study|Other (as recorded)|33|||
170431212|NCT03084471|615917719|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
170431213|NCT00796653|615917720|FG000|Overall Study|Adverse Event|19|||
170431214|NCT00796653|615917721|FG001|Overall Study|Adverse Event|16|||
170431215|NCT00796653|615917722|FG002|Overall Study|Adverse Event|16|||
170431216|NCT00796653|615917723|FG003|Overall Study|Adverse Event|16|||
170431217|NCT00796653|615917720|FG000|Overall Study|Lost to Follow-up|2|||
170431218|NCT00796653|615917721|FG001|Overall Study|Lost to Follow-up|1|||
170431219|NCT00796653|615917722|FG002|Overall Study|Lost to Follow-up|2|||
170431220|NCT00796653|615917723|FG003|Overall Study|Lost to Follow-up|3|||
170431221|NCT00796653|615917720|FG000|Overall Study|Withdrawal by Subject|16|||
170431222|NCT00796653|615917721|FG001|Overall Study|Withdrawal by Subject|8|||
170431223|NCT00796653|615917722|FG002|Overall Study|Withdrawal by Subject|8|||
170431224|NCT00796653|615917723|FG003|Overall Study|Withdrawal by Subject|13|||
170431225|NCT00796653|615917720|FG000|Overall Study|Lack of Efficacy|8|||
170431226|NCT00796653|615917721|FG001|Overall Study|Lack of Efficacy|1|||
170431227|NCT00796653|615917722|FG002|Overall Study|Lack of Efficacy|3|||
170431228|NCT00796653|615917723|FG003|Overall Study|Lack of Efficacy|2|||
170431229|NCT00796653|615917720|FG000|Overall Study|Non compliance with protocol|2|||
170431230|NCT00796653|615917721|FG001|Overall Study|Non compliance with protocol|2|||
170431231|NCT00796653|615917722|FG002|Overall Study|Non compliance with protocol|0|||
170431232|NCT00796653|615917723|FG003|Overall Study|Non compliance with protocol|2|||
170431233|NCT00796653|615917720|FG000|Overall Study|Other reason not described above|4|||
170431234|NCT00796653|615917721|FG001|Overall Study|Other reason not described above|9|||
170431235|NCT00796653|615917722|FG002|Overall Study|Other reason not described above|7|||
170431236|NCT00796653|615917723|FG003|Overall Study|Other reason not described above|4|||
170431237|NCT02152163|615917733|FG000|Overall Study|Physician Decision|12|||
170431238|NCT02152163|615917734|FG001|Overall Study|Physician Decision|13|||
170431239|NCT04035187|615919126|FG000|Overall Study|Withdrawal by Subject|2|||
170431240|NCT04035187|615919127|FG001|Overall Study|Withdrawal by Subject|1|||
170431241|NCT04035187|615919128|FG002|Overall Study|Withdrawal by Subject|0|||
170431242|NCT04035187|615919129|FG003|Overall Study|Withdrawal by Subject|0|||
170431243|NCT04035187|615919126|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
170431244|NCT04035187|615919127|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
170431245|NCT04035187|615919128|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
170431246|NCT04035187|615919129|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
170431247|NCT03696160|615919134|FG000|Overall Study|Withdrew before IMP dosing|2|||
170431248|NCT03696160|615919135|FG001|Overall Study|Withdrew before IMP dosing|3|||
170431249|NCT00804856|615919141|FG000|Overall Study|Progressive Disease|3|||
170431250|NCT00804856|615919142|FG001|Overall Study|Progressive Disease|2|||
170431251|NCT00804856|615919143|FG002|Overall Study|Progressive Disease|4|||
170431252|NCT00804856|615919144|FG003|Overall Study|Progressive Disease|6|||
170431253|NCT00804856|615919145|FG004|Overall Study|Progressive Disease|4|||
170431254|NCT00804856|615919146|FG005|Overall Study|Progressive Disease|1|||
170431255|NCT00804856|615919147|FG006|Overall Study|Progressive Disease|8|||
170431256|NCT00804856|615919148|FG007|Overall Study|Progressive Disease|2|||
170431257|NCT00804856|615919149|FG008|Overall Study|Progressive Disease|4|||
170431258|NCT00804856|615919150|FG009|Overall Study|Progressive Disease|5|||
170431259|NCT00804856|615919151|FG010|Overall Study|Progressive Disease|12|||
170431260|NCT00804856|615919152|FG011|Overall Study|Progressive Disease|2|||
170431261|NCT00804856|615919153|FG012|Overall Study|Progressive Disease|2|||
170431262|NCT00804856|615919154|FG013|Overall Study|Progressive Disease|26|||
170632734|NCT04672239|616666762|FG001|Week 2 Survey|Failed survey check items|2|||
170632735|NCT04672239|616666763|FG002|Week 2 Survey|Failed survey check items|3|||
170778660|NCT03398148|617197294|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
170431263|NCT00804856|615919155|FG014|Overall Study|Progressive Disease|20|||
170431264|NCT00804856|615919141|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431265|NCT00804856|615919142|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431266|NCT00804856|615919143|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431267|NCT00804856|615919144|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431268|NCT00804856|615919145|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
170431269|NCT00804856|615919146|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431270|NCT00804856|615919147|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431271|NCT00804856|615919148|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431272|NCT00804856|615919149|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431273|NCT00804856|615919150|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431274|NCT00804856|615919151|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431275|NCT00804856|615919152|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431276|NCT00804856|615919153|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431277|NCT00804856|615919154|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170431278|NCT00804856|615919155|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
170431279|NCT00804856|615919141|FG000|Overall Study|Other Adverse Event|1|||
170431280|NCT00804856|615919142|FG001|Overall Study|Other Adverse Event|1|||
170431281|NCT00804856|615919143|FG002|Overall Study|Other Adverse Event|1|||
170431282|NCT00804856|615919144|FG003|Overall Study|Other Adverse Event|2|||
170431283|NCT00804856|615919145|FG004|Overall Study|Other Adverse Event|2|||
170431284|NCT00804856|615919146|FG005|Overall Study|Other Adverse Event|1|||
170431285|NCT00804856|615919147|FG006|Overall Study|Other Adverse Event|3|||
170431286|NCT00804856|615919148|FG007|Overall Study|Other Adverse Event|0|||
170431287|NCT00804856|615919149|FG008|Overall Study|Other Adverse Event|0|||
170431288|NCT00804856|615919150|FG009|Overall Study|Other Adverse Event|1|||
170431289|NCT00804856|615919151|FG010|Overall Study|Other Adverse Event|5|||
170431290|NCT00804856|615919152|FG011|Overall Study|Other Adverse Event|2|||
170431291|NCT00804856|615919153|FG012|Overall Study|Other Adverse Event|0|||
170431292|NCT00804856|615919154|FG013|Overall Study|Other Adverse Event|6|||
170431293|NCT00804856|615919155|FG014|Overall Study|Other Adverse Event|13|||
170431294|NCT00804856|615919141|FG000|Overall Study|Non compliance with protocol|0|||
170431295|NCT00804856|615919142|FG001|Overall Study|Non compliance with protocol|0|||
170431296|NCT00804856|615919143|FG002|Overall Study|Non compliance with protocol|0|||
170431297|NCT00804856|615919144|FG003|Overall Study|Non compliance with protocol|0|||
170431298|NCT00804856|615919145|FG004|Overall Study|Non compliance with protocol|0|||
170431299|NCT00804856|615919146|FG005|Overall Study|Non compliance with protocol|0|||
170431300|NCT00804856|615919147|FG006|Overall Study|Non compliance with protocol|0|||
170431301|NCT00804856|615919148|FG007|Overall Study|Non compliance with protocol|0|||
170431302|NCT00804856|615919149|FG008|Overall Study|Non compliance with protocol|0|||
170431303|NCT00804856|615919150|FG009|Overall Study|Non compliance with protocol|0|||
170431304|NCT00804856|615919151|FG010|Overall Study|Non compliance with protocol|0|||
170431305|NCT00804856|615919152|FG011|Overall Study|Non compliance with protocol|0|||
170431306|NCT00804856|615919153|FG012|Overall Study|Non compliance with protocol|0|||
170431307|NCT00804856|615919154|FG013|Overall Study|Non compliance with protocol|2|||
170431308|NCT00804856|615919155|FG014|Overall Study|Non compliance with protocol|0|||
170431309|NCT00804856|615919141|FG000|Overall Study|Refused to continue medication|0|||
170431310|NCT00804856|615919142|FG001|Overall Study|Refused to continue medication|0|||
170431311|NCT00804856|615919143|FG002|Overall Study|Refused to continue medication|0|||
170431312|NCT00804856|615919144|FG003|Overall Study|Refused to continue medication|1|||
170431313|NCT00804856|615919145|FG004|Overall Study|Refused to continue medication|1|||
170431314|NCT00804856|615919146|FG005|Overall Study|Refused to continue medication|0|||
170431315|NCT00804856|615919147|FG006|Overall Study|Refused to continue medication|0|||
170431316|NCT00804856|615919148|FG007|Overall Study|Refused to continue medication|0|||
170431317|NCT00804856|615919149|FG008|Overall Study|Refused to continue medication|0|||
170431318|NCT00804856|615919150|FG009|Overall Study|Refused to continue medication|0|||
170431319|NCT00804856|615919151|FG010|Overall Study|Refused to continue medication|3|||
170431320|NCT00804856|615919152|FG011|Overall Study|Refused to continue medication|0|||
170431321|NCT00804856|615919153|FG012|Overall Study|Refused to continue medication|1|||
170431322|NCT00804856|615919154|FG013|Overall Study|Refused to continue medication|1|||
170431323|NCT00804856|615919155|FG014|Overall Study|Refused to continue medication|5|||
170431324|NCT00804856|615919141|FG000|Overall Study|Other reason than listed above|0|||
170431325|NCT00804856|615919142|FG001|Overall Study|Other reason than listed above|0|||
170431326|NCT00804856|615919143|FG002|Overall Study|Other reason than listed above|0|||
170431327|NCT00804856|615919144|FG003|Overall Study|Other reason than listed above|0|||
170431328|NCT00804856|615919145|FG004|Overall Study|Other reason than listed above|0|||
170431329|NCT00804856|615919146|FG005|Overall Study|Other reason than listed above|1|||
170431330|NCT00804856|615919147|FG006|Overall Study|Other reason than listed above|0|||
170431331|NCT00804856|615919148|FG007|Overall Study|Other reason than listed above|0|||
170431332|NCT00804856|615919149|FG008|Overall Study|Other reason than listed above|1|||
170431333|NCT00804856|615919150|FG009|Overall Study|Other reason than listed above|0|||
170431334|NCT00804856|615919151|FG010|Overall Study|Other reason than listed above|3|||
170431335|NCT00804856|615919152|FG011|Overall Study|Other reason than listed above|1|||
170431336|NCT00804856|615919153|FG012|Overall Study|Other reason than listed above|1|||
170431337|NCT00804856|615919154|FG013|Overall Study|Other reason than listed above|10|||
170431338|NCT00804856|615919155|FG014|Overall Study|Other reason than listed above|3|||
170431339|NCT03343535|615919156|FG000|Overall Study|Lost to Follow-up|1|||
170431340|NCT03343535|615919156|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
170431341|NCT03343535|615919156|FG000|Overall Study|Death|12|||
170431342|NCT05239195|615919159|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
170431343|NCT05239195|615919160|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
170431344|NCT00081653|615919161|FG000|Overall Study|Adverse Event|23|||
170431345|NCT00081653|615919162|FG001|Overall Study|Adverse Event|17|||
170880647|NCT02970292|617572846|FG001|Overall Study|Protocol Violation|0|||
170880648|NCT02970292|617572845|FG000|Overall Study|Other|1|||
170880649|NCT02970292|617572846|FG001|Overall Study|Other|0|||
170431346|NCT00081653|615919161|FG000|Overall Study|Lost to Follow-up|2|||
170431347|NCT00081653|615919162|FG001|Overall Study|Lost to Follow-up|4|||
170431348|NCT00081653|615919161|FG000|Overall Study|Refused Treatment|18|||
170431349|NCT00081653|615919162|FG001|Overall Study|Refused Treatment|14|||
170431350|NCT00081653|615919161|FG000|Overall Study|Low bone mineral density|1|||
170431351|NCT00081653|615919162|FG001|Overall Study|Low bone mineral density|0|||
170431352|NCT00081653|615919161|FG000|Overall Study|Bone loss|2|||
170431353|NCT00081653|615919162|FG001|Overall Study|Bone loss|0|||
170431354|NCT00081653|615919161|FG000|Overall Study|Participant leaving country|1|||
170431355|NCT00081653|615919162|FG001|Overall Study|Participant leaving country|0|||
170431356|NCT00081653|615919161|FG000|Overall Study|Loss of bone mass|0|||
170431357|NCT00081653|615919162|FG001|Overall Study|Loss of bone mass|2|||
170431358|NCT02682238|615919163|FG000|Overall Study|Lost to Follow-up|0|||
170431359|NCT02682238|615919164|FG001|Overall Study|Lost to Follow-up|2|||
170431360|NCT02682238|615919163|FG000|Overall Study|Withdrawal by Subject|1|||
170431361|NCT02682238|615919164|FG001|Overall Study|Withdrawal by Subject|0|||
170431362|NCT02682238|615919163|FG000|Overall Study|Adverse Event|1|||
170431363|NCT02682238|615919164|FG001|Overall Study|Adverse Event|0|||
170431364|NCT02682238|615919163|FG000|Overall Study|Non-compliance with Study Drug|1|||
170431365|NCT02682238|615919164|FG001|Overall Study|Non-compliance with Study Drug|0|||
170431366|NCT02682238|615919163|FG000|Overall Study|Non-compliance with Protocol|0|||
170431367|NCT02682238|615919164|FG001|Overall Study|Non-compliance with Protocol|2|||
170431368|NCT01383486|615919165|FG000|Overall Study|Lost to Follow-up|10|||
170431369|NCT01383486|615919165|FG000|Overall Study|Incomplete information for analysis|2|||
170431370|NCT01383486|615919165|FG000|Overall Study|Did not take any product|6|||
170431371|NCT02105272|615919180|FG000|Overall Study|Adverse Event|1|||
170431372|NCT02105272|615919181|FG001|Overall Study|Adverse Event|2|||
170431373|NCT02105272|615919180|FG000|Overall Study|Physician Decision|0|||
170431374|NCT02105272|615919181|FG001|Overall Study|Physician Decision|1|||
170431375|NCT02105272|615919180|FG000|Overall Study|Protocol Violation|2|||
170431376|NCT02105272|615919181|FG001|Overall Study|Protocol Violation|0|||
170431377|NCT02105272|615919180|FG000|Overall Study|Withdrawal by Subject|2|||
170431378|NCT02105272|615919181|FG001|Overall Study|Withdrawal by Subject|0|||
170431379|NCT03552393|615919188|FG000|Core Period|Kidney Transplant|1|||
170431380|NCT03552393|615919188|FG000|Core Period|Prohibited Medication|1|||
170431381|NCT03552393|615919188|FG000|Safety Extension Period|Kidney Transplant|4|||
170431382|NCT02414152|615919189|FG000|Overall Study|Withdrawal by Subject|1|||
170431383|NCT02414152|615919189|FG000|Overall Study|Lack of Efficacy|1|||
170431384|NCT01757392|615919193|FG000|Overall Study|Withdrawal by Subject|1|||
170431385|NCT01757392|615919193|FG000|Overall Study|Screen Fail|3|||
170431386|NCT00909038|615919198|FG000|Overall Study|Protocol Violation|187|||
170431387|NCT00909038|615919198|FG000|Overall Study|Non-evaluable Subjects|230|||
170431388|NCT00207090|615919199|FG000|Overall Study|Study drug toxicity|3|||
170431389|NCT00207090|615919199|FG000|Overall Study|Chest wall mass larger|1|||
170431390|NCT00207090|615919199|FG000|Overall Study|Disease progression/relapse|2|||
170431391|NCT00207090|615919199|FG000|Overall Study|Physician Decision|1|||
170431392|NCT00841698|615919202|FG000|First Intervention|Withdrawal by Subject|1|||
170431393|NCT00841698|615919203|FG001|First Intervention|Withdrawal by Subject|0|||
170431394|NCT00835692|615919204|FG000|First Intervention|Withdrawal by Subject|1|||
170431395|NCT00835692|615919205|FG001|First Intervention|Withdrawal by Subject|0|||
170431396|NCT04078022|615919210|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
170431397|NCT04078022|615919211|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
170431398|NCT01250912|615919212|FG000|Overall Study|Lost to Follow-up|1|||
170431399|NCT01895335|615919213|FG000|Overall Study|Adverse Event|106|||
170431400|NCT01895335|615919213|FG000|Overall Study|Lack of Efficacy|53|||
170431401|NCT01895335|615919213|FG000|Overall Study|Poor Compliance to Protocol|11|||
170431402|NCT01895335|615919213|FG000|Overall Study|Included But Not treated|1|||
170431403|NCT01895335|615919213|FG000|Overall Study|Other than Specified Above|44|||
170431404|NCT01647828|615919216|FG000|Overall Study|Death|3|||
170431405|NCT01647828|615919217|FG001|Overall Study|Death|4|||
170431406|NCT01647828|615919218|FG002|Overall Study|Death|4|||
170431407|NCT01647828|615919219|FG003|Overall Study|Death|5|||
170880650|NCT00814892|617572847|FG000|Overall Study|Disease Progression|1|||
170431408|NCT01647828|615919220|FG004|Overall Study|Death|6|||
170431409|NCT01647828|615919221|FG005|Overall Study|Death|3|||
170431410|NCT01647828|615919222|FG006|Overall Study|Death|10|||
170431411|NCT01647828|615919223|FG007|Overall Study|Death|60|||
170431412|NCT01647828|615919224|FG008|Overall Study|Death|71|||
170431413|NCT01647828|615919216|FG000|Overall Study|Withdrawal by Subject|2|||
170431414|NCT01647828|615919217|FG001|Overall Study|Withdrawal by Subject|0|||
170431415|NCT01647828|615919218|FG002|Overall Study|Withdrawal by Subject|0|||
170431416|NCT01647828|615919219|FG003|Overall Study|Withdrawal by Subject|1|||
170431417|NCT01647828|615919220|FG004|Overall Study|Withdrawal by Subject|0|||
170431418|NCT01647828|615919221|FG005|Overall Study|Withdrawal by Subject|0|||
170431419|NCT01647828|615919222|FG006|Overall Study|Withdrawal by Subject|1|||
170431420|NCT01647828|615919223|FG007|Overall Study|Withdrawal by Subject|0|||
170431421|NCT01647828|615919224|FG008|Overall Study|Withdrawal by Subject|2|||
170431422|NCT01647828|615919216|FG000|Overall Study|Study terminated by Sponsor|0|||
170431423|NCT01647828|615919217|FG001|Overall Study|Study terminated by Sponsor|0|||
170431424|NCT01647828|615919218|FG002|Overall Study|Study terminated by Sponsor|0|||
170431425|NCT01647828|615919219|FG003|Overall Study|Study terminated by Sponsor|0|||
170431426|NCT01647828|615919220|FG004|Overall Study|Study terminated by Sponsor|0|||
170431427|NCT01647828|615919221|FG005|Overall Study|Study terminated by Sponsor|0|||
170431428|NCT01647828|615919222|FG006|Overall Study|Study terminated by Sponsor|1|||
170431429|NCT01647828|615919223|FG007|Overall Study|Study terminated by Sponsor|26|||
170431430|NCT01647828|615919224|FG008|Overall Study|Study terminated by Sponsor|16|||
170431431|NCT01647828|615919216|FG000|Overall Study|Lost to Follow-up|0|||
170431432|NCT01647828|615919217|FG001|Overall Study|Lost to Follow-up|0|||
170431433|NCT01647828|615919218|FG002|Overall Study|Lost to Follow-up|0|||
170431434|NCT01647828|615919219|FG003|Overall Study|Lost to Follow-up|0|||
170431435|NCT01647828|615919220|FG004|Overall Study|Lost to Follow-up|0|||
170431436|NCT01647828|615919221|FG005|Overall Study|Lost to Follow-up|0|||
170431437|NCT01647828|615919222|FG006|Overall Study|Lost to Follow-up|0|||
170431438|NCT01647828|615919223|FG007|Overall Study|Lost to Follow-up|2|||
170431439|NCT01647828|615919224|FG008|Overall Study|Lost to Follow-up|0|||
170431440|NCT00191815|615919227|FG000|Overall Study|Adverse Event|2|||
170431441|NCT00191815|615919227|FG000|Overall Study|Disease progression or relapse|24|||
170431442|NCT00191815|615919227|FG000|Overall Study|Death|2|||
170431443|NCT00191815|615919227|FG000|Overall Study|Protocol Violation|3|||
170431444|NCT00191815|615919227|FG000|Overall Study|Physician Decision|2|||
170431445|NCT00191815|615919227|FG000|Overall Study|Withdrawal by Subject|7|||
170431446|NCT03644550|615919230|FG000|Overall Study|Withdrawal by Subject|3|||
170431447|NCT03644550|615919230|FG000|Overall Study|Progressive disease|15|||
170431448|NCT05646251|615919231|FG000|Overall Study|Physician Decision|1|||
170880651|NCT00814892|617572847|FG000|Overall Study|Study Termination|1|||
170431449|NCT05646251|615919232|FG001|Overall Study|Physician Decision|0|||
170431450|NCT05646251|615919233|FG002|Overall Study|Physician Decision|2|||
170431451|NCT01929863|615919234|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
170431452|NCT01929863|615919235|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
170431453|NCT01929863|615919234|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
170431454|NCT01929863|615919235|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
170431455|NCT01929863|615919234|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
170431456|NCT01929863|615919235|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
170431457|NCT01218867|615919236|FG000|Overall Study|Death during treatment|0|||
170431458|NCT01218867|615919237|FG001|Overall Study|Death during treatment|0|||
170431459|NCT01218867|615919238|FG002|Overall Study|Death during treatment|0|||
170431460|NCT01218867|615919239|FG003|Overall Study|Death during treatment|0|||
170431461|NCT01218867|615919240|FG004|Overall Study|Death during treatment|0|||
170431462|NCT01218867|615919241|FG005|Overall Study|Death during treatment|0|||
170431463|NCT01218867|615919242|FG006|Overall Study|Death during treatment|1|||
170431464|NCT01218867|615919243|FG007|Overall Study|Death during treatment|0|||
170431465|NCT01218867|615919244|FG008|Overall Study|Death during treatment|0|||
170431466|NCT01218867|615919245|FG009|Overall Study|Death during treatment|0|||
170431467|NCT01218867|615919246|FG010|Overall Study|Death during treatment|0|||
170431468|NCT00251979|615919247|FG000|Overall Study|Protocol Violation|3|||
170431469|NCT00251979|615919248|FG001|Overall Study|Protocol Violation|5|||
170431470|NCT00251979|615919247|FG000|Overall Study|Adverse Event|11|||
170431471|NCT00251979|615919248|FG001|Overall Study|Adverse Event|17|||
170431472|NCT00251979|615919247|FG000|Overall Study|Withdrawal by Subject|13|||
170431473|NCT00251979|615919248|FG001|Overall Study|Withdrawal by Subject|7|||
170431474|NCT00251979|615919247|FG000|Overall Study|Lost to Follow-up|8|||
170431475|NCT00251979|615919248|FG001|Overall Study|Lost to Follow-up|6|||
170431476|NCT00251979|615919247|FG000|Overall Study|Death|3|||
170431477|NCT00251979|615919248|FG001|Overall Study|Death|5|||
170431478|NCT00465270|615919253|FG000|Overall Study|Death|7|||
170431479|NCT00465270|615919254|FG001|Overall Study|Death|11|||
170431480|NCT00465270|615919253|FG000|Overall Study|Withdrawal by Subject|34|||
170431481|NCT00465270|615919254|FG001|Overall Study|Withdrawal by Subject|78|||
170431482|NCT00465270|615919253|FG000|Overall Study|Lost to Follow-up|60|||
170431483|NCT00465270|615919254|FG001|Overall Study|Lost to Follow-up|67|||
170431484|NCT00465270|615919253|FG000|Overall Study|Investigator request|3|||
170431485|NCT00465270|615919254|FG001|Overall Study|Investigator request|4|||
170431486|NCT01348789|615919255|FG000|Overall Study|Protocol Violation|2|||
170431487|NCT01348789|615919255|FG000|Overall Study|Withdrawal by Subject|2|||
170431488|NCT00323882|615919256|FG000|Overall Study|Adverse Event|2|||
170880652|NCT00845650|617572848|FG000|Overall Study|Withdrawal by Subject|0|||
170880653|NCT00845650|617572849|FG001|Overall Study|Withdrawal by Subject|0|||
170880654|NCT00845650|617572850|FG002|Overall Study|Withdrawal by Subject|0|||
170880655|NCT00845650|617572851|FG003|Overall Study|Withdrawal by Subject|0|||
170880656|NCT00845650|617572852|FG004|Overall Study|Withdrawal by Subject|2|||
170880657|NCT00845650|617572853|FG005|Overall Study|Withdrawal by Subject|0|||
170880658|NCT00845650|617572848|FG000|Overall Study|Lost to Follow-up|0|||
170880659|NCT00845650|617572849|FG001|Overall Study|Lost to Follow-up|0|||
170880660|NCT00845650|617572850|FG002|Overall Study|Lost to Follow-up|3|||
170880661|NCT00845650|617572851|FG003|Overall Study|Lost to Follow-up|1|||
170880662|NCT00845650|617572852|FG004|Overall Study|Lost to Follow-up|0|||
170880663|NCT00845650|617572853|FG005|Overall Study|Lost to Follow-up|1|||
170880664|NCT00845650|617572848|FG000|Overall Study|Sponsor hold on dosing|0|||
170880665|NCT00845650|617572849|FG001|Overall Study|Sponsor hold on dosing|0|||
170880666|NCT00845650|617572850|FG002|Overall Study|Sponsor hold on dosing|0|||
170880667|NCT00845650|617572851|FG003|Overall Study|Sponsor hold on dosing|0|||
170431489|NCT00323882|615919257|FG001|Overall Study|Adverse Event|1|||
170431490|NCT00323882|615919258|FG002|Overall Study|Adverse Event|1|||
170431491|NCT00323882|615919259|FG003|Overall Study|Adverse Event|1|||
170431492|NCT00323882|615919260|FG004|Overall Study|Adverse Event|3|||
170431493|NCT00323882|615919256|FG000|Overall Study|Disease Progression|6|||
170431494|NCT00323882|615919257|FG001|Overall Study|Disease Progression|4|||
170535493|NCT05028569|616306188|FG006|Open-Label Phase|Lost to Follow-up|4|||
170535494|NCT05028569|616306182|FG000|Open-Label Phase|Protocol Deviation|0|||
170535495|NCT05028569|616306183|FG001|Open-Label Phase|Protocol Deviation|0|||
170535496|NCT05028569|616306184|FG002|Open-Label Phase|Protocol Deviation|0|||
170431495|NCT00323882|615919258|FG002|Overall Study|Disease Progression|10|||
170431496|NCT00323882|615919259|FG003|Overall Study|Disease Progression|5|||
170431497|NCT00323882|615919260|FG004|Overall Study|Disease Progression|22|||
170431498|NCT00323882|615919256|FG000|Overall Study|Death|0|||
170431499|NCT00323882|615919257|FG001|Overall Study|Death|1|||
170431500|NCT00323882|615919258|FG002|Overall Study|Death|1|||
170431501|NCT00323882|615919259|FG003|Overall Study|Death|0|||
170431502|NCT00323882|615919260|FG004|Overall Study|Death|5|||
170431503|NCT00323882|615919256|FG000|Overall Study|Lost to Follow-up|0|||
170431504|NCT00323882|615919257|FG001|Overall Study|Lost to Follow-up|0|||
170431505|NCT00323882|615919258|FG002|Overall Study|Lost to Follow-up|1|||
170431506|NCT00323882|615919259|FG003|Overall Study|Lost to Follow-up|0|||
170431507|NCT00323882|615919260|FG004|Overall Study|Lost to Follow-up|1|||
170431508|NCT00323882|615919256|FG000|Overall Study|Other|0|||
170431509|NCT00323882|615919257|FG001|Overall Study|Other|0|||
170431510|NCT00323882|615919258|FG002|Overall Study|Other|0|||
170431511|NCT00323882|615919259|FG003|Overall Study|Other|1|||
170431512|NCT00323882|615919260|FG004|Overall Study|Other|1|||
170431513|NCT00429416|615919263|FG000|Overall Study|Death|1|||
170431514|NCT00415363|615919265|FG000|Overall Study|Withdrawal by Subject|4|||
170431515|NCT00415363|615919266|FG001|Overall Study|Withdrawal by Subject|4|||
170431516|NCT00415363|615919265|FG000|Overall Study|Adverse Event|4|||
170431517|NCT00415363|615919266|FG001|Overall Study|Adverse Event|4|||
170431518|NCT00415363|615919265|FG000|Overall Study|Lost to Follow-up|2|||
170431519|NCT00415363|615919266|FG001|Overall Study|Lost to Follow-up|1|||
170431520|NCT00415363|615919265|FG000|Overall Study|Physician Decision|3|||
170431521|NCT00415363|615919266|FG001|Overall Study|Physician Decision|1|||
170431522|NCT00415363|615919265|FG000|Overall Study|Death|16|||
170431523|NCT00415363|615919266|FG001|Overall Study|Death|12|||
170431524|NCT00415363|615919265|FG000|Overall Study|Progressive disease|26|||
170431525|NCT00415363|615919266|FG001|Overall Study|Progressive disease|32|||
170431526|NCT03123471|615919267|FG000|Placebo-controlled Phase|Adverse Event|3|||
170431527|NCT03123471|615919268|FG001|Placebo-controlled Phase|Adverse Event|8|||
170431528|NCT03123471|615919267|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
170431529|NCT03123471|615919268|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
170880668|NCT00845650|617572852|FG004|Overall Study|Sponsor hold on dosing|1|||
170880669|NCT00845650|617572853|FG005|Overall Study|Sponsor hold on dosing|1|||
170880670|NCT00845650|617572848|FG000|Overall Study|Unable to access IV line|1|||
170535497|NCT05028569|616306185|FG003|Open-Label Phase|Protocol Deviation|0|||
170431530|NCT03123471|615919267|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
170431531|NCT03123471|615919268|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
170431532|NCT03123471|615919267|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
170535498|NCT05028569|616306186|FG004|Open-Label Phase|Protocol Deviation|1|||
170880671|NCT00845650|617572849|FG001|Overall Study|Unable to access IV line|0|||
170431533|NCT03123471|615919268|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
170431534|NCT03123471|615919267|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
170431535|NCT03123471|615919268|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
170880672|NCT00845650|617572850|FG002|Overall Study|Unable to access IV line|0|||
170880673|NCT00845650|617572851|FG003|Overall Study|Unable to access IV line|0|||
170880674|NCT00845650|617572852|FG004|Overall Study|Unable to access IV line|0|||
170431536|NCT03123471|615919267|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
170431537|NCT03123471|615919268|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
170431538|NCT03123471|615919267|FG000|Placebo-controlled Phase|Miscellaneous|0|||
170431539|NCT03123471|615919268|FG001|Placebo-controlled Phase|Miscellaneous|1|||
170431540|NCT03123471|615919267|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
170431541|NCT03123471|615919268|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
170431542|NCT03123471|615919267|FG000|Apremilast Extension Phase|Adverse Event|1|||
170431543|NCT03123471|615919268|FG001|Apremilast Extension Phase|Adverse Event|5|||
170431544|NCT03123471|615919267|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
170431545|NCT03123471|615919268|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
170431546|NCT03123471|615919267|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
170431547|NCT03123471|615919268|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
170535499|NCT05028569|616306187|FG005|Open-Label Phase|Protocol Deviation|0|||
170880675|NCT00845650|617572853|FG005|Overall Study|Unable to access IV line|0|||
170880676|NCT05054114|617572854|FG000|Overall Study|Protocol Violation|13|||
170880677|NCT05054114|617572855|FG001|Overall Study|Protocol Violation|1|||
170880678|NCT05054114|617572854|FG000|Overall Study|Pregnancy|0|||
170880679|NCT05054114|617572855|FG001|Overall Study|Pregnancy|1|||
170880680|NCT02595450|617572858|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
170880681|NCT02595450|617572858|FG000|Overall Study|Enrolled, but not treated|8|||
170880682|NCT05264740|617572859|FG000|Baseline|Withdrawal by Subject|0|||
170880683|NCT05264740|617572860|FG001|Baseline|Withdrawal by Subject|1|||
170535500|NCT05028569|616306188|FG006|Open-Label Phase|Protocol Deviation|0|||
170535501|NCT05028569|616306182|FG000|Open-Label Phase|Pregnancy|0|||
170535502|NCT05028569|616306183|FG001|Open-Label Phase|Pregnancy|0|||
170535503|NCT05028569|616306184|FG002|Open-Label Phase|Pregnancy|0|||
170535504|NCT05028569|616306185|FG003|Open-Label Phase|Pregnancy|0|||
170535505|NCT05028569|616306186|FG004|Open-Label Phase|Pregnancy|0|||
170535506|NCT05028569|616306187|FG005|Open-Label Phase|Pregnancy|1|||
170535507|NCT05028569|616306188|FG006|Open-Label Phase|Pregnancy|0|||
170535508|NCT05028569|616306182|FG000|Open-Label Phase|Withdrawal by Subject|0|||
170535509|NCT05028569|616306183|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170535510|NCT05028569|616306184|FG002|Open-Label Phase|Withdrawal by Subject|0|||
170535511|NCT05028569|616306185|FG003|Open-Label Phase|Withdrawal by Subject|0|||
170535512|NCT05028569|616306186|FG004|Open-Label Phase|Withdrawal by Subject|15|||
170535513|NCT05028569|616306187|FG005|Open-Label Phase|Withdrawal by Subject|8|||
170535514|NCT05028569|616306188|FG006|Open-Label Phase|Withdrawal by Subject|13|||
170535515|NCT05028569|616306182|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
170535516|NCT05028569|616306183|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
170535517|NCT05028569|616306184|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
170535518|NCT05028569|616306185|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
170535519|NCT05028569|616306186|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
170535520|NCT05028569|616306187|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
170535521|NCT05028569|616306188|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
170535522|NCT05028569|616306182|FG000|Open-Label Phase|Other, not specified|0|||
170535523|NCT05028569|616306183|FG001|Open-Label Phase|Other, not specified|0|||
170535524|NCT05028569|616306184|FG002|Open-Label Phase|Other, not specified|0|||
170535525|NCT05028569|616306185|FG003|Open-Label Phase|Other, not specified|0|||
170535526|NCT05028569|616306186|FG004|Open-Label Phase|Other, not specified|6|||
170535527|NCT05028569|616306187|FG005|Open-Label Phase|Other, not specified|5|||
170535528|NCT05028569|616306188|FG006|Open-Label Phase|Other, not specified|7|||
170535529|NCT05028569|616306182|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
170880684|NCT05264740|617572859|FG000|Follow Up 1|Lost to Follow-up|1|||
170880685|NCT05264740|617572860|FG001|Follow Up 1|Lost to Follow-up|1|||
170880686|NCT05264740|617572859|FG000|Follow Up 1|Withdrawal by Subject|0|||
170880687|NCT05264740|617572860|FG001|Follow Up 1|Withdrawal by Subject|1|||
170880688|NCT05264740|617572859|FG000|Follow Up 2|Lost to Follow-up|1|||
170535530|NCT05028569|616306183|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
170535531|NCT05028569|616306184|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
170535532|NCT05028569|616306185|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
170535533|NCT05028569|616306186|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
170535534|NCT05028569|616306187|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
170535535|NCT05028569|616306188|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
170431548|NCT02358538|615919271|FG000|Through Week 26|Adverse Event|0|||
170431549|NCT02358538|615919272|FG001|Through Week 26|Adverse Event|1|||
170431550|NCT02358538|615919273|FG002|Through Week 26|Adverse Event|1|||
170535536|NCT05028569|616306182|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
170535537|NCT05028569|616306183|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
170535538|NCT05028569|616306184|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
170880689|NCT05264740|617572860|FG001|Follow Up 2|Lost to Follow-up|4|||
170880690|NCT05264740|617572859|FG000|Follow Up 3|Lost to Follow-up|7|||
170535539|NCT05028569|616306185|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
170535540|NCT05028569|616306186|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
170431551|NCT02358538|615919274|FG003|Through Week 26|Adverse Event|2|||
170431552|NCT02358538|615919271|FG000|Through Week 26|Lack of Efficacy|1|||
170431553|NCT02358538|615919272|FG001|Through Week 26|Lack of Efficacy|1|||
170431554|NCT02358538|615919273|FG002|Through Week 26|Lack of Efficacy|3|||
170431555|NCT02358538|615919274|FG003|Through Week 26|Lack of Efficacy|3|||
170431556|NCT02358538|615919271|FG000|Through Week 26|Withdrawal by Subject|1|||
170431557|NCT02358538|615919272|FG001|Through Week 26|Withdrawal by Subject|0|||
170431558|NCT02358538|615919273|FG002|Through Week 26|Withdrawal by Subject|0|||
170431559|NCT02358538|615919274|FG003|Through Week 26|Withdrawal by Subject|0|||
170431560|NCT02358538|615919271|FG000|Through Week 26|Non-Compliance|0|||
170431561|NCT02358538|615919272|FG001|Through Week 26|Non-Compliance|0|||
170431562|NCT02358538|615919273|FG002|Through Week 26|Non-Compliance|1|||
170431563|NCT02358538|615919274|FG003|Through Week 26|Non-Compliance|0|||
170431564|NCT02358538|615919271|FG000|Through Week 26|Family did not see benefit from IP|1|||
170431565|NCT02358538|615919272|FG001|Through Week 26|Family did not see benefit from IP|0|||
170431566|NCT02358538|615919273|FG002|Through Week 26|Family did not see benefit from IP|0|||
170431567|NCT02358538|615919274|FG003|Through Week 26|Family did not see benefit from IP|0|||
170431568|NCT02358538|615919271|FG000|52 Week Extension Period|Lack of Efficacy|0|||
170431569|NCT02358538|615919272|FG001|52 Week Extension Period|Lack of Efficacy|0|||
170431570|NCT02358538|615919273|FG002|52 Week Extension Period|Lack of Efficacy|2|||
170431571|NCT02358538|615919274|FG003|52 Week Extension Period|Lack of Efficacy|4|||
170431572|NCT01686477|615919275|FG000|Feeding Intervention|Death|1|||
170431573|NCT01686477|615919276|FG001|Feeding Intervention|Death|0|||
170431574|NCT01686477|615919277|FG002|Feeding Intervention|Death|1|||
170431575|NCT01686477|615919275|FG000|Feeding Intervention|Withdrawal by Subject|0|||
170431576|NCT01686477|615919276|FG001|Feeding Intervention|Withdrawal by Subject|6|||
170431577|NCT01686477|615919277|FG002|Feeding Intervention|Withdrawal by Subject|0|||
170431578|NCT01686477|615919275|FG000|Feeding Intervention|Physician Decision|1|||
170431579|NCT01686477|615919276|FG001|Feeding Intervention|Physician Decision|2|||
170431580|NCT01686477|615919277|FG002|Feeding Intervention|Physician Decision|0|||
170431581|NCT01686477|615919275|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
170431582|NCT01686477|615919276|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
170431583|NCT01686477|615919277|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
170431584|NCT01686477|615919275|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
170431585|NCT01686477|615919276|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
170431586|NCT01686477|615919277|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
170431587|NCT01686477|615919275|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
170431588|NCT01686477|615919276|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
170431589|NCT01686477|615919277|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
170431590|NCT01686477|615919275|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
170431591|NCT01686477|615919276|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
170431592|NCT01686477|615919277|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
170431593|NCT01686477|615919275|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
170431594|NCT01686477|615919276|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
170431595|NCT01686477|615919277|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
170431596|NCT01686477|615919275|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
170431597|NCT01686477|615919276|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
170431598|NCT01686477|615919277|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
170431599|NCT01686477|615919275|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
170431600|NCT01686477|615919276|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
170431601|NCT01686477|615919277|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
170431602|NCT06999265|615919279|FG000|Overall Study|Lost to Follow-up|1|||
170431603|NCT06999265|615919280|FG001|Overall Study|Lost to Follow-up|1|||
170431604|NCT02178787|615919282|FG000|Overall Study|Lost to Follow-up|1|||
170431605|NCT02178787|615919283|FG001|Overall Study|Lost to Follow-up|0|||
170431606|NCT02178787|615919282|FG000|Overall Study|Withdrawal by Subject|0|||
170431607|NCT02178787|615919283|FG001|Overall Study|Withdrawal by Subject|2|||
170431608|NCT02178787|615919282|FG000|Overall Study|No TCD window|3|||
170431609|NCT02178787|615919283|FG001|Overall Study|No TCD window|7|||
170431610|NCT02178787|615919282|FG000|Overall Study|Physician Decision|1|||
170431611|NCT02178787|615919283|FG001|Overall Study|Physician Decision|0|||
170431612|NCT00316186|615919289|FG000|Overall Study|Adverse Event|6|||
170431613|NCT00316186|615919289|FG000|Overall Study|Disease Progression|4|||
170431614|NCT00316186|615919289|FG000|Overall Study|Lost to Follow-up|1|||
170431615|NCT00316186|615919289|FG000|Overall Study|Other|1|||
170431616|NCT01802320|615919290|FG000|Overall Study|Death|1|||
170431617|NCT01802320|615919290|FG000|Overall Study|Withdrawal by Subject|1|||
170431618|NCT04372238|615920668|FG000|Overall Study|Duplicate|3|||
170431619|NCT04372238|615920669|FG001|Overall Study|Duplicate|3|||
170431620|NCT04372238|615920668|FG000|Overall Study|Did not consent for data linkage|6|||
170431621|NCT04372238|615920669|FG001|Overall Study|Did not consent for data linkage|10|||
170431622|NCT05005442|615920670|FG000|Overall Study|Death|14|||
170431623|NCT05005442|615920671|FG001|Overall Study|Death|10|||
170431624|NCT05005442|615920672|FG002|Overall Study|Death|8|||
170431625|NCT05005442|615920673|FG003|Overall Study|Death|22|||
170431626|NCT05005442|615920674|FG004|Overall Study|Death|13|||
170431627|NCT05005442|615920675|FG005|Overall Study|Death|15|||
170431628|NCT05005442|615920670|FG000|Overall Study|Lost to Follow-up|0|||
170431629|NCT05005442|615920671|FG001|Overall Study|Lost to Follow-up|2|||
170431630|NCT05005442|615920672|FG002|Overall Study|Lost to Follow-up|0|||
170431631|NCT05005442|615920673|FG003|Overall Study|Lost to Follow-up|0|||
170431632|NCT05005442|615920674|FG004|Overall Study|Lost to Follow-up|1|||
170431633|NCT05005442|615920675|FG005|Overall Study|Lost to Follow-up|0|||
170431634|NCT05005442|615920670|FG000|Overall Study|Physician Decision|0|||
170431635|NCT05005442|615920671|FG001|Overall Study|Physician Decision|0|||
170431636|NCT05005442|615920672|FG002|Overall Study|Physician Decision|1|||
170431637|NCT05005442|615920673|FG003|Overall Study|Physician Decision|0|||
170431638|NCT05005442|615920674|FG004|Overall Study|Physician Decision|2|||
170431639|NCT05005442|615920675|FG005|Overall Study|Physician Decision|0|||
170431640|NCT05005442|615920670|FG000|Overall Study|Sponsor decision|26|||
170431641|NCT05005442|615920671|FG001|Overall Study|Sponsor decision|26|||
170431642|NCT05005442|615920672|FG002|Overall Study|Sponsor decision|10|||
170431643|NCT05005442|615920673|FG003|Overall Study|Sponsor decision|5|||
170431644|NCT05005442|615920674|FG004|Overall Study|Sponsor decision|9|||
170431645|NCT05005442|615920675|FG005|Overall Study|Sponsor decision|12|||
170431646|NCT05005442|615920670|FG000|Overall Study|Withdrawal by Subject|2|||
170431647|NCT05005442|615920671|FG001|Overall Study|Withdrawal by Subject|2|||
170431648|NCT05005442|615920672|FG002|Overall Study|Withdrawal by Subject|1|||
170431649|NCT05005442|615920673|FG003|Overall Study|Withdrawal by Subject|3|||
170431650|NCT05005442|615920674|FG004|Overall Study|Withdrawal by Subject|0|||
170431651|NCT05005442|615920675|FG005|Overall Study|Withdrawal by Subject|5|||
170431652|NCT05005442|615920670|FG000|Overall Study|Site terminated by sponsor|0|||
170431653|NCT05005442|615920671|FG001|Overall Study|Site terminated by sponsor|2|||
170431654|NCT05005442|615920672|FG002|Overall Study|Site terminated by sponsor|0|||
170431655|NCT05005442|615920673|FG003|Overall Study|Site terminated by sponsor|0|||
170431656|NCT05005442|615920674|FG004|Overall Study|Site terminated by sponsor|0|||
170431657|NCT05005442|615920675|FG005|Overall Study|Site terminated by sponsor|1|||
170880691|NCT05264740|617572860|FG001|Follow Up 3|Lost to Follow-up|4|||
170431658|NCT00334815|615920678|FG000|Overall Study|Adverse Event|3|||
170431659|NCT00334815|615920679|FG001|Overall Study|Adverse Event|2|||
170431660|NCT00334815|615920678|FG000|Overall Study|Death|0|||
170431661|NCT00334815|615920679|FG001|Overall Study|Death|2|||
170431662|NCT00334815|615920678|FG000|Overall Study|Progression|1|||
170431663|NCT00334815|615920679|FG001|Overall Study|Progression|0|||
170431664|NCT00334815|615920678|FG000|Overall Study|ineligible|1|||
170431665|NCT00334815|615920679|FG001|Overall Study|ineligible|1|||
170431666|NCT00334815|615920678|FG000|Overall Study|patient refused treatment|0|||
170431667|NCT00334815|615920679|FG001|Overall Study|patient refused treatment|1|||
170431668|NCT00334815|615920678|FG000|Overall Study|Physician Decision|2|||
170431669|NCT00334815|615920679|FG001|Overall Study|Physician Decision|4|||
170431670|NCT03121586|615920680|FG000|Overall Study|Study terminated by sponsor|0|||
170431671|NCT03121586|615920681|FG001|Overall Study|Study terminated by sponsor|0|||
170431672|NCT03121586|615920682|FG002|Overall Study|Study terminated by sponsor|99|||
170431673|NCT03121586|615920680|FG000|Overall Study|Withdrawal by Subject|37|||
170431674|NCT03121586|615920681|FG001|Overall Study|Withdrawal by Subject|14|||
170431675|NCT03121586|615920682|FG002|Overall Study|Withdrawal by Subject|9|||
170431676|NCT03121586|615920680|FG000|Overall Study|Not further specified|6|||
170431677|NCT03121586|615920681|FG001|Overall Study|Not further specified|11|||
170431678|NCT03121586|615920682|FG002|Overall Study|Not further specified|10|||
170431679|NCT03121586|615920680|FG000|Overall Study|Adverse Event|16|||
170431680|NCT03121586|615920681|FG001|Overall Study|Adverse Event|5|||
170431681|NCT03121586|615920682|FG002|Overall Study|Adverse Event|6|||
170431682|NCT03121586|615920680|FG000|Overall Study|Protocol Violation|0|||
170431683|NCT03121586|615920681|FG001|Overall Study|Protocol Violation|5|||
170431684|NCT03121586|615920682|FG002|Overall Study|Protocol Violation|0|||
170431685|NCT03121586|615920680|FG000|Overall Study|Lack of Efficacy|3|||
170431686|NCT03121586|615920681|FG001|Overall Study|Lack of Efficacy|3|||
170880692|NCT04294901|617572861|FG000|Overall Study|Death|86|||
170431687|NCT03121586|615920682|FG002|Overall Study|Lack of Efficacy|1|||
170431688|NCT03121586|615920680|FG000|Overall Study|Physician Decision|2|||
170431689|NCT03121586|615920681|FG001|Overall Study|Physician Decision|2|||
170431690|NCT03121586|615920682|FG002|Overall Study|Physician Decision|0|||
170431691|NCT03121586|615920680|FG000|Overall Study|Noncompliance with study drug|5|||
170431692|NCT03121586|615920681|FG001|Overall Study|Noncompliance with study drug|3|||
170431693|NCT03121586|615920682|FG002|Overall Study|Noncompliance with study drug|5|||
170431694|NCT03121586|615920680|FG000|Overall Study|Lost to Follow-up|4|||
170431695|NCT03121586|615920681|FG001|Overall Study|Lost to Follow-up|2|||
170431696|NCT03121586|615920682|FG002|Overall Study|Lost to Follow-up|0|||
170431697|NCT03121586|615920680|FG000|Overall Study|Death|2|||
170431698|NCT03121586|615920681|FG001|Overall Study|Death|0|||
170431699|NCT03121586|615920682|FG002|Overall Study|Death|0|||
170431700|NCT02832063|615920684|FG000|Overall Study|Adverse Event|2|||
170880693|NCT04294901|617572862|FG001|Overall Study|Death|110|||
170431701|NCT02832063|615920685|FG001|Overall Study|Adverse Event|1|||
170431702|NCT02832063|615920684|FG000|Overall Study|Physician Decision|5|||
170431703|NCT02832063|615920685|FG001|Overall Study|Physician Decision|7|||
170431704|NCT02832063|615920684|FG000|Overall Study|Lost to Follow-up|15|||
170431705|NCT02832063|615920685|FG001|Overall Study|Lost to Follow-up|8|||
170431706|NCT02832063|615920684|FG000|Overall Study|Withdrawal by Subject|10|||
170431707|NCT02832063|615920685|FG001|Overall Study|Withdrawal by Subject|21|||
170431708|NCT02832063|615920684|FG000|Overall Study|Other|2|||
170431709|NCT02832063|615920685|FG001|Overall Study|Other|1|||
170431710|NCT03733730|615920686|FG000|Overall Study|Lost to Follow-up|1|||
170431711|NCT03733730|615920687|FG001|Overall Study|Lost to Follow-up|32|||
170431712|NCT03733730|615920686|FG000|Overall Study|Other|1|||
170431713|NCT03733730|615920687|FG001|Overall Study|Other|0|||
170431714|NCT03733730|615920686|FG000|Overall Study|Adverse Event|0|||
170431715|NCT03733730|615920687|FG001|Overall Study|Adverse Event|4|||
170431716|NCT03733730|615920686|FG000|Overall Study|Death|0|||
170431717|NCT03733730|615920687|FG001|Overall Study|Death|5|||
170431718|NCT03733730|615920686|FG000|Overall Study|Withdrawal by Subject|0|||
170431719|NCT03733730|615920687|FG001|Overall Study|Withdrawal by Subject|8|||
170431720|NCT01987765|615920688|FG000|Overall Study|Protocol Violation|65|||
170431721|NCT01987765|615920688|FG000|Overall Study|Lost to Follow-up|37|||
170431722|NCT01528696|615920689|FG000|Overall Study|See detailed description|18|||
170431723|NCT01528696|615920690|FG001|Overall Study|See detailed description|19|||
170431724|NCT01056484|615920691|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
170431725|NCT01056484|615920692|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
170431726|NCT01056484|615920691|FG000|Randomized Controlled Trial|Physician Decision|1|||
170431727|NCT01056484|615920692|FG001|Randomized Controlled Trial|Physician Decision|0|||
170431728|NCT01056484|615920691|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
170431729|NCT01056484|615920692|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
170431730|NCT03913377|615920695|FG000|Period 1|Test Article no longer available|0|||
170431731|NCT03913377|615920696|FG001|Period 1|Test Article no longer available|1|||
170431732|NCT03913377|615920697|FG002|Period 1|Test Article no longer available|0|||
170431733|NCT03913377|615920695|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
170431734|NCT03913377|615920696|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
170431735|NCT03913377|615920697|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
170431736|NCT01527006|615920698|FG000|Core Study|Adverse Event|0|||
170431737|NCT01527006|615920699|FG001|Core Study|Adverse Event|2|||
170431738|NCT01527006|615920698|FG000|Core Study|Lost to Follow-up|0|||
170431739|NCT01527006|615920699|FG001|Core Study|Lost to Follow-up|1|||
170431740|NCT01527006|615920698|FG000|Core Study|Subject Choice|1|||
170431741|NCT01527006|615920699|FG001|Core Study|Subject Choice|0|||
170431742|NCT01527006|615920698|FG000|Core Study|Inadequate Therapeutic Effect|1|||
170431743|NCT01527006|615920699|FG001|Core Study|Inadequate Therapeutic Effect|0|||
170431744|NCT01527006|615920698|FG000|Core Study|Withdrawal by Subject|0|||
170431745|NCT01527006|615920699|FG001|Core Study|Withdrawal by Subject|1|||
170431746|NCT01527006|615920698|FG000|Core Study|Other|0|||
170431747|NCT01527006|615920699|FG001|Core Study|Other|2|||
170431748|NCT01527006|615920698|FG000|Extension Phase|Adverse Event|4|||
170431749|NCT01527006|615920699|FG001|Extension Phase|Adverse Event|2|||
170431750|NCT01527006|615920698|FG000|Extension Phase|Lost to Follow-up|0|||
170431751|NCT01527006|615920699|FG001|Extension Phase|Lost to Follow-up|1|||
170431752|NCT01527006|615920698|FG000|Extension Phase|Subject Choice|1|||
170431753|NCT01527006|615920699|FG001|Extension Phase|Subject Choice|1|||
170431754|NCT01527006|615920698|FG000|Extension Phase|Inadequate therapeutic effect|1|||
170431755|NCT01527006|615920699|FG001|Extension Phase|Inadequate therapeutic effect|1|||
170431756|NCT01527006|615920698|FG000|Extension Phase|Other|0|||
170431757|NCT01527006|615920699|FG001|Extension Phase|Other|3|||
170431758|NCT00123734|615920701|FG000|Overall Study|Death|3|||
170431759|NCT00123734|615920701|FG000|Overall Study|Lost to Follow-up|3|||
170431760|NCT00123734|615920701|FG000|Overall Study|Dropout|1|||
170431761|NCT00123734|615920701|FG000|Overall Study|Withdrawal by Subject|1|||
170431762|NCT00113386|615920702|FG000|Overall Study|Withdrawal by Subject|1|||
170431763|NCT00113386|615920703|FG001|Overall Study|Withdrawal by Subject|0|||
170431764|NCT00113386|615920702|FG000|Overall Study|Physician Decision|0|||
170431765|NCT00113386|615920703|FG001|Overall Study|Physician Decision|1|||
170431766|NCT00113386|615920702|FG000|Overall Study|Toxicity|3|||
170431767|NCT00113386|615920703|FG001|Overall Study|Toxicity|0|||
170431768|NCT00113386|615920702|FG000|Overall Study|Ineligible|1|||
170431769|NCT00113386|615920703|FG001|Overall Study|Ineligible|2|||
170431770|NCT00113386|615920702|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
170431771|NCT00113386|615920703|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
170431772|NCT01839279|615920704|FG000|Overall Study|Adverse Event|4|||
170431773|NCT01839279|615920705|FG001|Overall Study|Adverse Event|1|||
170431774|NCT01839279|615920706|FG002|Overall Study|Adverse Event|1|||
170431775|NCT01839279|615920704|FG000|Overall Study|Withdrawal by Subject|4|||
170431776|NCT01839279|615920705|FG001|Overall Study|Withdrawal by Subject|1|||
170431777|NCT01839279|615920706|FG002|Overall Study|Withdrawal by Subject|1|||
170431778|NCT01839279|615920704|FG000|Overall Study|Classified as 'Other'|5|||
170431779|NCT01839279|615920705|FG001|Overall Study|Classified as 'Other'|0|||
170431780|NCT01839279|615920706|FG002|Overall Study|Classified as 'Other'|0|||
170431781|NCT02321098|615920708|FG000|12 Weeks Treament|Lost to Follow-up|1|||
170431782|NCT02321098|615920709|FG001|12 Weeks Treament|Lost to Follow-up|1|||
170431783|NCT02321098|615920710|FG002|12 Weeks Treament|Lost to Follow-up|0|||
170431784|NCT02321098|615920708|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
170431785|NCT02321098|615920709|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
170431786|NCT02321098|615920710|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
170431787|NCT02321098|615920708|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
170431788|NCT02321098|615920709|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
170431789|NCT02321098|615920710|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
170431790|NCT02321098|615920708|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
170431791|NCT02321098|615920709|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
170431792|NCT02321098|615920710|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
170431793|NCT01663233|615920711|FG000|Overall Study|Withdrawal by Subject|3|||
170431794|NCT01663233|615920712|FG001|Overall Study|Withdrawal by Subject|2|||
170431795|NCT01663233|615920711|FG000|Overall Study|Protocol Deviation|1|||
170431796|NCT01663233|615920712|FG001|Overall Study|Protocol Deviation|4|||
170431797|NCT01663233|615920711|FG000|Overall Study|Lost to Follow-up|0|||
170431798|NCT01663233|615920712|FG001|Overall Study|Lost to Follow-up|1|||
170431799|NCT00848536|615920715|FG000|Overall Study|Adverse Event|2|||
170431800|NCT00848536|615920716|FG001|Overall Study|Adverse Event|2|||
170431801|NCT00848536|615920715|FG000|Overall Study|Withdrawal by Subject|0|||
170431802|NCT00848536|615920716|FG001|Overall Study|Withdrawal by Subject|1|||
170431803|NCT00848536|615920715|FG000|Overall Study|Protocol Violation|0|||
170431804|NCT00848536|615920716|FG001|Overall Study|Protocol Violation|1|||
170431805|NCT00848536|615920715|FG000|Overall Study|Noncompliance|1|||
170431806|NCT00848536|615920716|FG001|Overall Study|Noncompliance|0|||
170431807|NCT00848536|615920715|FG000|Overall Study|Inadequate Control of IOP|1|||
170431808|NCT00848536|615920716|FG001|Overall Study|Inadequate Control of IOP|1|||
170431809|NCT00848536|615920715|FG000|Overall Study|Patient Moved|0|||
170431810|NCT00848536|615920716|FG001|Overall Study|Patient Moved|2|||
170431811|NCT01175135|615920717|FG000|Overall Study|Adverse Event|2|||
170431812|NCT01175135|615920718|FG001|Overall Study|Adverse Event|5|||
170431813|NCT01175135|615920719|FG002|Overall Study|Adverse Event|3|||
170431814|NCT01175135|615920720|FG003|Overall Study|Adverse Event|4|||
170431815|NCT01175135|615920717|FG000|Overall Study|Death|1|||
170431816|NCT01175135|615920718|FG001|Overall Study|Death|0|||
170431817|NCT01175135|615920719|FG002|Overall Study|Death|0|||
170431818|NCT01175135|615920720|FG003|Overall Study|Death|0|||
170431819|NCT01175135|615920717|FG000|Overall Study|Lack of Efficacy|4|||
170431820|NCT01175135|615920718|FG001|Overall Study|Lack of Efficacy|5|||
170431821|NCT01175135|615920719|FG002|Overall Study|Lack of Efficacy|0|||
170431822|NCT01175135|615920720|FG003|Overall Study|Lack of Efficacy|5|||
170431823|NCT01175135|615920717|FG000|Overall Study|Lost to Follow-up|1|||
170431824|NCT01175135|615920718|FG001|Overall Study|Lost to Follow-up|2|||
170431825|NCT01175135|615920719|FG002|Overall Study|Lost to Follow-up|0|||
170431826|NCT01175135|615920720|FG003|Overall Study|Lost to Follow-up|0|||
170431827|NCT01175135|615920717|FG000|Overall Study|Protocol Violation|1|||
170431828|NCT01175135|615920718|FG001|Overall Study|Protocol Violation|1|||
170431829|NCT01175135|615920719|FG002|Overall Study|Protocol Violation|0|||
170431830|NCT01175135|615920720|FG003|Overall Study|Protocol Violation|0|||
170431831|NCT01175135|615920717|FG000|Overall Study|Withdrawal by Subject|4|||
170431832|NCT01175135|615920718|FG001|Overall Study|Withdrawal by Subject|8|||
170431833|NCT01175135|615920719|FG002|Overall Study|Withdrawal by Subject|5|||
170431834|NCT01175135|615920720|FG003|Overall Study|Withdrawal by Subject|5|||
170431835|NCT01175135|615920717|FG000|Overall Study|Other|3|||
170431836|NCT01175135|615920718|FG001|Overall Study|Other|1|||
170431837|NCT01175135|615920719|FG002|Overall Study|Other|3|||
170431838|NCT01175135|615920720|FG003|Overall Study|Other|0|||
170431839|NCT01175135|615920717|FG000|Overall Study|Randomized But Not Treated|0|||
170431840|NCT01175135|615920718|FG001|Overall Study|Randomized But Not Treated|0|||
170535541|NCT05028569|616306187|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
170535542|NCT05028569|616306188|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
170431841|NCT01175135|615920719|FG002|Overall Study|Randomized But Not Treated|1|||
170431842|NCT01175135|615920720|FG003|Overall Study|Randomized But Not Treated|0|||
170431843|NCT03199963|615920721|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
170431844|NCT03199963|615920722|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
170431845|NCT03199963|615920721|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
170431846|NCT03199963|615920722|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
170431847|NCT03199963|615920721|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
170431848|NCT03199963|615920722|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
170431849|NCT03199963|615920721|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
170431850|NCT03199963|615920722|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
170431851|NCT03199963|615920721|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
170431852|NCT03199963|615920722|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
170431853|NCT03199963|615920721|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
170431854|NCT03199963|615920722|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
170431855|NCT05470699|615920723|FG000|Overall Study|Did not receive intervention|13|||
170431856|NCT05470699|615920723|FG000|Overall Study|Ineligible|1|||
170431857|NCT03480763|615920724|FG000|Overall Study|Withdrawal by Subject|18|||
170431858|NCT03480763|615920725|FG001|Overall Study|Withdrawal by Subject|10|||
170431859|NCT03480763|615920724|FG000|Overall Study|Lost to Follow-up|4|||
170431860|NCT03480763|615920725|FG001|Overall Study|Lost to Follow-up|7|||
170431861|NCT03480763|615920724|FG000|Overall Study|non-study pneumococcal vaccine|1|||
170431862|NCT03480763|615920725|FG001|Overall Study|non-study pneumococcal vaccine|0|||
170431863|NCT03480763|615920724|FG000|Overall Study|oncological treatment|0|||
170431864|NCT03480763|615920725|FG001|Overall Study|oncological treatment|2|||
170431865|NCT03480763|615920724|FG000|Overall Study|pain with vaccination|1|||
170431866|NCT03480763|615920725|FG001|Overall Study|pain with vaccination|0|||
170431867|NCT02388191|615920726|FG000|Overall Study|Patient did not receive IUD|1|||
170431868|NCT02388191|615920727|FG001|Overall Study|Patient did not receive IUD|0|||
170431869|NCT01878292|615920728|FG000|Randomized|Protocol Violation|1|||
170431870|NCT01878292|615920729|FG001|Randomized|Protocol Violation|0|||
170431871|NCT01878292|615920730|FG002|Randomized|Protocol Violation|0|||
170431872|NCT01878292|615920728|FG000|Randomized|Lost to Follow-up|1|||
170431873|NCT01878292|615920729|FG001|Randomized|Lost to Follow-up|0|||
170431874|NCT01878292|615920730|FG002|Randomized|Lost to Follow-up|0|||
170431875|NCT01878292|615920728|FG000|Randomized|Adverse Event|1|||
170431876|NCT01878292|615920729|FG001|Randomized|Adverse Event|0|||
170431877|NCT01878292|615920730|FG002|Randomized|Adverse Event|0|||
170431878|NCT01878292|615920728|FG000|Double-blind Treatment Period|Other Reasons|2|||
170431879|NCT01878292|615920729|FG001|Double-blind Treatment Period|Other Reasons|0|||
170431880|NCT01878292|615920730|FG002|Double-blind Treatment Period|Other Reasons|0|||
170431881|NCT01878292|615920728|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
170431882|NCT01878292|615920729|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
170431883|NCT01878292|615920730|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
170431884|NCT01878292|615920728|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
170431885|NCT01878292|615920729|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
170431886|NCT01878292|615920730|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
170431887|NCT01878292|615920728|FG000|Double-blind Treatment Period|Protocol Violation|3|||
170431888|NCT01878292|615920729|FG001|Double-blind Treatment Period|Protocol Violation|4|||
170431889|NCT01878292|615920730|FG002|Double-blind Treatment Period|Protocol Violation|2|||
170431890|NCT01878292|615920728|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
170431891|NCT01878292|615920729|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
170431892|NCT01878292|615920730|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
170431893|NCT01878292|615920728|FG000|Double-blind Treatment Period|Adverse Event|4|||
170431894|NCT01878292|615920729|FG001|Double-blind Treatment Period|Adverse Event|9|||
170431895|NCT01878292|615920730|FG002|Double-blind Treatment Period|Adverse Event|8|||
170431896|NCT01878292|615920728|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
170431897|NCT01878292|615920729|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
170431898|NCT01878292|615920730|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
170431899|NCT03600376|615920731|FG000|Overall Study|Adverse Event|1|||
170431900|NCT03600376|615920732|FG001|Overall Study|Adverse Event|1|||
170431901|NCT03600376|615920731|FG000|Overall Study|Transferred to other facility|1|||
170431902|NCT03600376|615920732|FG001|Overall Study|Transferred to other facility|0|||
170431903|NCT03600376|615920731|FG000|Overall Study|Investigator Decision|0|||
170431904|NCT03600376|615920732|FG001|Overall Study|Investigator Decision|4|||
170431905|NCT03600376|615920731|FG000|Overall Study|Determined to be ineligible for study|0|||
170431906|NCT03600376|615920732|FG001|Overall Study|Determined to be ineligible for study|1|||
170431907|NCT00813592|615920733|FG000|Overall Study|Disease assessment was not completed per|2|||
170431908|NCT02430480|615920736|FG000|Overall Study|Death|1|||
170431909|NCT02430480|615920736|FG000|Overall Study|Anesthesia concerns|1|||
170431910|NCT02430480|615920736|FG000|Overall Study|Progressed on treatment|1|||
170431911|NCT04493684|615920738|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
170431912|NCT04493684|615920739|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431913|NCT04493684|615920740|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
170431914|NCT04493684|615920741|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431915|NCT04493684|615920742|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431916|NCT04493684|615920743|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
170431917|NCT04493684|615920744|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431918|NCT04493684|615920745|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431919|NCT04493684|615920746|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431920|NCT04493684|615920747|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431921|NCT04493684|615920748|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170778661|NCT03398148|617197295|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778662|NCT03398148|617197296|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778663|NCT03398148|617197297|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778664|NCT03398148|617197298|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778665|NCT03398148|617197299|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778666|NCT03398148|617197300|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778667|NCT03398148|617197301|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778668|NCT03398148|617197302|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
170778669|NCT03398148|617197288|FG000|Substudy 1 Period 2|Adverse Event|0|||
170778670|NCT03398148|617197289|FG001|Substudy 1 Period 2|Adverse Event|0|||
170778671|NCT03398148|617197290|FG002|Substudy 1 Period 2|Adverse Event|0|||
170778672|NCT03398148|617197291|FG003|Substudy 1 Period 2|Adverse Event|0|||
170431922|NCT04493684|615920749|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170778673|NCT03398148|617197292|FG004|Substudy 1 Period 2|Adverse Event|0|||
170778674|NCT03398148|617197293|FG005|Substudy 1 Period 2|Adverse Event|2|||
170778675|NCT03398148|617197294|FG006|Substudy 1 Period 2|Adverse Event|4|||
170778676|NCT03398148|617197295|FG007|Substudy 1 Period 2|Adverse Event|0|||
170778677|NCT03398148|617197296|FG008|Substudy 1 Period 2|Adverse Event|0|||
170778678|NCT03398148|617197297|FG009|Substudy 1 Period 2|Adverse Event|0|||
170778679|NCT03398148|617197298|FG010|Substudy 1 Period 2|Adverse Event|0|||
170778680|NCT03398148|617197299|FG011|Substudy 1 Period 2|Adverse Event|0|||
170778681|NCT03398148|617197300|FG012|Substudy 1 Period 2|Adverse Event|0|||
170778682|NCT03398148|617197301|FG013|Substudy 1 Period 2|Adverse Event|0|||
170778683|NCT03398148|617197302|FG014|Substudy 1 Period 2|Adverse Event|0|||
170778684|NCT03398148|617197288|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778685|NCT03398148|617197289|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778686|NCT03398148|617197290|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778687|NCT03398148|617197291|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778688|NCT03398148|617197292|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778689|NCT03398148|617197293|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778690|NCT03398148|617197294|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
170778691|NCT03398148|617197295|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
170778692|NCT03398148|617197296|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778693|NCT03398148|617197297|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778694|NCT03398148|617197298|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778695|NCT03398148|617197299|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778696|NCT03398148|617197300|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778697|NCT03398148|617197301|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778698|NCT03398148|617197302|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
170778699|NCT03398148|617197288|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
170778700|NCT03398148|617197289|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
170778701|NCT03398148|617197290|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
170778702|NCT03398148|617197291|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
170778703|NCT03398148|617197292|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
170778704|NCT03398148|617197293|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
170778705|NCT03398148|617197294|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
170778706|NCT03398148|617197295|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
170778707|NCT03398148|617197296|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
170778708|NCT03398148|617197297|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
170778709|NCT03398148|617197298|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
170778710|NCT03398148|617197299|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
170778711|NCT03398148|617197300|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
170778712|NCT03398148|617197301|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
170778713|NCT03398148|617197302|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
170778714|NCT03398148|617197288|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778715|NCT03398148|617197289|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778716|NCT03398148|617197290|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778717|NCT03398148|617197291|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778718|NCT03398148|617197292|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778719|NCT03398148|617197293|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778720|NCT03398148|617197294|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
170778721|NCT03398148|617197295|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778722|NCT03398148|617197296|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778723|NCT03398148|617197297|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778724|NCT03398148|617197298|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778725|NCT03398148|617197299|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170431923|NCT04493684|615920750|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170778726|NCT03398148|617197300|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778727|NCT03398148|617197301|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778728|NCT03398148|617197302|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778729|NCT03398148|617197288|FG000|Substudy 1 Period 2|Other|0|||
170778730|NCT03398148|617197289|FG001|Substudy 1 Period 2|Other|0|||
170778731|NCT03398148|617197290|FG002|Substudy 1 Period 2|Other|0|||
170778732|NCT03398148|617197291|FG003|Substudy 1 Period 2|Other|0|||
170431924|NCT04493684|615920751|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431925|NCT04493684|615920752|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431926|NCT04493684|615920753|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431927|NCT04493684|615920754|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
170431928|NCT04493684|615920738|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
170431929|NCT04493684|615920739|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431930|NCT04493684|615920740|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431931|NCT04493684|615920741|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431932|NCT04493684|615920742|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431933|NCT04493684|615920743|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431934|NCT04493684|615920744|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431935|NCT04493684|615920745|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431936|NCT04493684|615920746|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431937|NCT04493684|615920747|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431938|NCT04493684|615920748|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431939|NCT04493684|615920749|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431940|NCT04493684|615920750|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431941|NCT04493684|615920751|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431942|NCT04493684|615920752|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431943|NCT04493684|615920753|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431944|NCT04493684|615920754|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
170431945|NCT04493684|615920738|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431946|NCT04493684|615920739|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431947|NCT04493684|615920740|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431948|NCT04493684|615920741|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431949|NCT04493684|615920742|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431950|NCT04493684|615920743|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431951|NCT04493684|615920744|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
170431952|NCT04493684|615920745|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431953|NCT04493684|615920746|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431954|NCT04493684|615920747|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431955|NCT04493684|615920748|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431956|NCT04493684|615920749|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431957|NCT04493684|615920750|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431958|NCT04493684|615920751|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431959|NCT04493684|615920752|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431960|NCT04493684|615920753|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431961|NCT04493684|615920754|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
170431962|NCT04493684|615920738|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
170431963|NCT04493684|615920739|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431964|NCT04493684|615920740|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431965|NCT04493684|615920741|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431966|NCT04493684|615920742|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431967|NCT04493684|615920743|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431968|NCT04493684|615920744|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431969|NCT04493684|615920745|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431970|NCT04493684|615920746|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431971|NCT04493684|615920747|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431972|NCT04493684|615920748|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431973|NCT04493684|615920749|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431974|NCT04493684|615920750|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431975|NCT04493684|615920751|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431976|NCT04493684|615920752|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431977|NCT04493684|615920753|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431978|NCT04493684|615920754|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
170431979|NCT04493684|615920738|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431980|NCT04493684|615920739|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431981|NCT04493684|615920740|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431982|NCT04493684|615920741|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431983|NCT04493684|615920742|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431984|NCT04493684|615920743|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
170431985|NCT04493684|615920744|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170535543|NCT04609553|616306191|FG000|Overall Study|Lost to Follow-up|27|||
170431986|NCT04493684|615920745|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431987|NCT04493684|615920746|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431988|NCT04493684|615920747|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431989|NCT04493684|615920748|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431990|NCT04493684|615920749|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431991|NCT04493684|615920750|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431992|NCT04493684|615920751|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431993|NCT04493684|615920752|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170535544|NCT04609553|616306192|FG001|Overall Study|Lost to Follow-up|31|||
170535545|NCT04609553|616306193|FG002|Overall Study|Lost to Follow-up|24|||
170535546|NCT04609553|616306191|FG000|Overall Study|Discontinued|12|||
170535547|NCT04609553|616306192|FG001|Overall Study|Discontinued|10|||
170535548|NCT04609553|616306193|FG002|Overall Study|Discontinued|9|||
170535549|NCT03095287|616306194|FG000|Overall Study|Treatment Failure|1|||
170535550|NCT03095287|616306194|FG000|Overall Study|Adverse Event|1|||
170535551|NCT03345004|616306197|FG000|Overall Study|Physician Decision|1|||
170535552|NCT03345004|616306198|FG001|Overall Study|Physician Decision|0|||
170535553|NCT03345004|616306197|FG000|Overall Study|Withdrawal by Subject|0|||
170535554|NCT03345004|616306198|FG001|Overall Study|Withdrawal by Subject|1|||
170535555|NCT01091259|616306199|FG000|Overall Study|Adverse Event|3|||
170535556|NCT01091259|616306199|FG000|Overall Study|Lack of Efficacy|2|||
170535557|NCT00984867|616306208|FG000|Overall Study|Adverse Event|3|||
170535558|NCT00984867|616306209|FG001|Overall Study|Adverse Event|7|||
170535559|NCT00984867|616306208|FG000|Overall Study|Death|1|||
170535560|NCT00984867|616306209|FG001|Overall Study|Death|0|||
170535561|NCT00984867|616306208|FG000|Overall Study|Withdrawal by Subject|13|||
170535562|NCT00984867|616306209|FG001|Overall Study|Withdrawal by Subject|4|||
170535563|NCT00984867|616306208|FG000|Overall Study|Lost to Follow-up|3|||
170535564|NCT00984867|616306209|FG001|Overall Study|Lost to Follow-up|4|||
170535565|NCT00984867|616306208|FG000|Overall Study|Poor/non-compliance|0|||
170535566|NCT00984867|616306209|FG001|Overall Study|Poor/non-compliance|1|||
170535567|NCT00984867|616306208|FG000|Overall Study|Subject no longer meets study criteria|1|||
170535568|NCT00984867|616306209|FG001|Overall Study|Subject no longer meets study criteria|1|||
170535569|NCT00984867|616306208|FG000|Overall Study|site closing|1|||
170535570|NCT00984867|616306209|FG001|Overall Study|site closing|0|||
170535571|NCT00984867|616306208|FG000|Overall Study|lack of efficacy and subject compliance|1|||
170535572|NCT00984867|616306209|FG001|Overall Study|lack of efficacy and subject compliance|0|||
170535573|NCT01541748|616306210|FG000|Overall Study|Lost to Follow-up|17|||
170535574|NCT01541748|616306210|FG000|Overall Study|Moved out of state|1|||
170535575|NCT01541748|616306210|FG000|Overall Study|Withdrawal by Subject|7|||
170535576|NCT01541748|616306210|FG000|Overall Study|Screen failure|5|||
170535577|NCT01541748|616306210|FG000|Overall Study|Did not receive study device|1|||
170535578|NCT00626639|616306218|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
170535579|NCT00626639|616306219|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
170535580|NCT01155141|616306220|FG000|Overall Study|Withdrawal by Subject|1|||
170535581|NCT01155141|616306220|FG000|Overall Study|Screen Failure|1|||
170535582|NCT00785629|616306221|FG000|Overall Study|Adverse Event|2|||
170535583|NCT00785629|616306222|FG001|Overall Study|Adverse Event|1|||
170535584|NCT00785629|616306223|FG002|Overall Study|Adverse Event|1|||
170535585|NCT00785629|616306224|FG003|Overall Study|Adverse Event|5|||
170535586|NCT00785629|616306221|FG000|Overall Study|Protocol Violation|1|||
170535587|NCT00785629|616306222|FG001|Overall Study|Protocol Violation|2|||
170535588|NCT00785629|616306223|FG002|Overall Study|Protocol Violation|4|||
170535589|NCT00785629|616306224|FG003|Overall Study|Protocol Violation|5|||
170535590|NCT00785629|616306221|FG000|Overall Study|administrative decision|5|||
170778733|NCT03398148|617197292|FG004|Substudy 1 Period 2|Other|0|||
170778734|NCT03398148|617197293|FG005|Substudy 1 Period 2|Other|0|||
170778735|NCT03398148|617197294|FG006|Substudy 1 Period 2|Other|1|||
170778736|NCT03398148|617197295|FG007|Substudy 1 Period 2|Other|0|||
170778737|NCT03398148|617197296|FG008|Substudy 1 Period 2|Other|0|||
170778738|NCT03398148|617197297|FG009|Substudy 1 Period 2|Other|0|||
170778739|NCT03398148|617197298|FG010|Substudy 1 Period 2|Other|0|||
170535591|NCT00785629|616306222|FG001|Overall Study|administrative decision|1|||
170535592|NCT00785629|616306223|FG002|Overall Study|administrative decision|3|||
170535593|NCT00785629|616306224|FG003|Overall Study|administrative decision|4|||
170535594|NCT00785629|616306221|FG000|Overall Study|Withdrawal by Subject|0|||
170535595|NCT00785629|616306222|FG001|Overall Study|Withdrawal by Subject|1|||
170431994|NCT04493684|615920753|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170535596|NCT00785629|616306223|FG002|Overall Study|Withdrawal by Subject|2|||
170535597|NCT00785629|616306224|FG003|Overall Study|Withdrawal by Subject|2|||
170535598|NCT02020941|616306225|FG000|Overall Study|Adverse Event|1|||
170535599|NCT02020941|616306225|FG000|Overall Study|Physician Decision|2|||
170535600|NCT02020941|616306225|FG000|Overall Study|Withdrawal by Subject|1|||
170535601|NCT02020941|616306225|FG000|Overall Study|Disease Progression|4|||
170778740|NCT03398148|617197299|FG011|Substudy 1 Period 2|Other|0|||
170778741|NCT03398148|617197300|FG012|Substudy 1 Period 2|Other|0|||
170535602|NCT00634504|616306226|FG000|Overall Study|Protocol Violation|1|||
170535603|NCT00634504|616306227|FG001|Overall Study|Protocol Violation|0|||
170535604|NCT00770367|616306230|FG000|First Intervention|Withdrawal by Subject|0|||
170535605|NCT00770367|616306231|FG001|First Intervention|Withdrawal by Subject|2|||
170535606|NCT00770367|616306230|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
170535607|NCT00770367|616306231|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
170535608|NCT00770367|616306230|FG000|Second Intervention|Lost to Follow-up|2|||
170535609|NCT00770367|616306231|FG001|Second Intervention|Lost to Follow-up|0|||
170535610|NCT00435942|616306232|FG000|Overall Study|Death|17|||
170535611|NCT00435942|616306233|FG001|Overall Study|Death|10|||
170535612|NCT00435942|616306232|FG000|Overall Study|Withdrawal by Subject|2|||
170535613|NCT00435942|616306233|FG001|Overall Study|Withdrawal by Subject|0|||
170535614|NCT00435942|616306232|FG000|Overall Study|Lost to Follow-up|0|||
170535615|NCT00435942|616306233|FG001|Overall Study|Lost to Follow-up|16|||
170535616|NCT00435942|616306232|FG000|Overall Study|Conversion to Open Repair|1|||
170535617|NCT00435942|616306233|FG001|Overall Study|Conversion to Open Repair|0|||
170535618|NCT00435942|616306232|FG000|Overall Study|Technical Failure|3|||
170535619|NCT00435942|616306233|FG001|Overall Study|Technical Failure|0|||
170535620|NCT00435942|616306232|FG000|Overall Study|Other|0|||
170535621|NCT00435942|616306233|FG001|Overall Study|Other|1|||
170535622|NCT01898130|616306234|FG000|Treatment|Withdrawal by Subject|2|||
170535623|NCT01898130|616306234|FG000|Treatment|Progressive Disease|4|||
170535624|NCT01898130|616306234|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
170535625|NCT04115059|616306235|FG000|Overall Study|Withdrawal by Subject|1|||
170535626|NCT04115059|616306235|FG000|Overall Study|Lack of Efficacy|2|||
170535627|NCT04491994|616306236|FG000|Overall Study|Withdrawal by Subject|10|||
170535628|NCT04491994|616306237|FG001|Overall Study|Withdrawal by Subject|5|||
170535629|NCT04491994|616306236|FG000|Overall Study|developed fever > 3 days|4|||
170535630|NCT04491994|616306237|FG001|Overall Study|developed fever > 3 days|1|||
170535631|NCT04491994|616306236|FG000|Overall Study|Protocol Violation|11|||
170535632|NCT04491994|616306237|FG001|Overall Study|Protocol Violation|2|||
170535633|NCT04491994|616306236|FG000|Overall Study|Lost to Follow-up|4|||
170535634|NCT04491994|616306237|FG001|Overall Study|Lost to Follow-up|3|||
170535635|NCT01104766|616306242|FG000|Overall Study|Did not meet inc/exc criteria|1|||
170535636|NCT01104766|616306243|FG001|Overall Study|Did not meet inc/exc criteria|0|||
170535637|NCT01104766|616306244|FG002|Overall Study|Did not meet inc/exc criteria|0|||
170535638|NCT01104766|616306245|FG003|Overall Study|Did not meet inc/exc criteria|0|||
170535639|NCT01104766|616306242|FG000|Overall Study|Adverse Event|17|||
170535640|NCT01104766|616306243|FG001|Overall Study|Adverse Event|15|||
170535641|NCT01104766|616306244|FG002|Overall Study|Adverse Event|20|||
170535642|NCT01104766|616306245|FG003|Overall Study|Adverse Event|14|||
170535643|NCT01104766|616306242|FG000|Overall Study|Lack of Efficacy|20|||
170535644|NCT01104766|616306243|FG001|Overall Study|Lack of Efficacy|15|||
170535645|NCT01104766|616306244|FG002|Overall Study|Lack of Efficacy|14|||
170535646|NCT01104766|616306245|FG003|Overall Study|Lack of Efficacy|8|||
170535647|NCT01104766|616306242|FG000|Overall Study|Protocol Violation|2|||
170535648|NCT01104766|616306243|FG001|Overall Study|Protocol Violation|0|||
170535649|NCT01104766|616306244|FG002|Overall Study|Protocol Violation|0|||
170535650|NCT01104766|616306245|FG003|Overall Study|Protocol Violation|0|||
170535651|NCT01104766|616306242|FG000|Overall Study|Withdrawal by Subject|17|||
170535652|NCT01104766|616306243|FG001|Overall Study|Withdrawal by Subject|19|||
170535653|NCT01104766|616306244|FG002|Overall Study|Withdrawal by Subject|25|||
170535654|NCT01104766|616306245|FG003|Overall Study|Withdrawal by Subject|15|||
170535655|NCT01104766|616306242|FG000|Overall Study|Lost to Follow-up|1|||
170535656|NCT01104766|616306243|FG001|Overall Study|Lost to Follow-up|2|||
170535657|NCT01104766|616306244|FG002|Overall Study|Lost to Follow-up|1|||
170535658|NCT01104766|616306245|FG003|Overall Study|Lost to Follow-up|1|||
170535659|NCT01341470|616306246|FG000|Overall Study|Sponsor decision|0|||
170535660|NCT01341470|616306247|FG001|Overall Study|Sponsor decision|0|||
170535661|NCT01341470|616306248|FG002|Overall Study|Sponsor decision|1|||
170535662|NCT01341470|616306249|FG003|Overall Study|Sponsor decision|1|||
170535663|NCT01341470|616306250|FG004|Overall Study|Sponsor decision|0|||
170535664|NCT01341470|616306251|FG005|Overall Study|Sponsor decision|1|||
170535665|NCT02755090|616306254|FG000|Overall Study|equipment malfunction|1|||
170778742|NCT03398148|617197301|FG013|Substudy 1 Period 2|Other|0|||
170535666|NCT02755090|616306255|FG001|Overall Study|equipment malfunction|0|||
170535667|NCT04797169|616306256|FG000|Overall Study|Lost to Follow-up|84|||
170535668|NCT04797169|616306257|FG001|Overall Study|Lost to Follow-up|67|||
170535669|NCT04797169|616306256|FG000|Overall Study|Pregnancy|1|||
170535670|NCT04797169|616306257|FG001|Overall Study|Pregnancy|3|||
170535671|NCT04797169|616306256|FG000|Overall Study|Withdrawal by Subject|27|||
170535672|NCT04797169|616306257|FG001|Overall Study|Withdrawal by Subject|35|||
170535673|NCT03188822|616306259|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
170535674|NCT03188822|616306259|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
170535675|NCT04537299|616306260|FG000|Overall Study|Withdrawal by Subject|2|||
170535676|NCT04537299|616306261|FG001|Overall Study|Withdrawal by Subject|0|||
170535677|NCT04537299|616306260|FG000|Overall Study|Protocol Violation|1|||
170535678|NCT04537299|616306261|FG001|Overall Study|Protocol Violation|1|||
170880694|NCT04294901|617572861|FG000|Overall Study|Provider did not have historical control patients|581|||
170535679|NCT00924898|616306273|FG000|Overall Study|Withdrawal by Subject|2|||
170535680|NCT04896385|616306274|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
170535681|NCT04896385|616306275|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
170880695|NCT04294901|617572862|FG001|Overall Study|Provider did not have historical control patients|0|||
170880696|NCT04294901|617572861|FG000|Overall Study|Provider did not have intervention patients|0|||
170880697|NCT04294901|617572862|FG001|Overall Study|Provider did not have intervention patients|98|||
170880698|NCT03770260|617574344|FG000|Overall Study|Disease progression|0|||
170880699|NCT03770260|617574345|FG001|Overall Study|Disease progression|1|||
170535682|NCT04896385|616306276|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
170535683|NCT04896385|616306277|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
170535684|NCT04896385|616306274|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
170535685|NCT04896385|616306275|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
170535686|NCT04896385|616306276|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
170535687|NCT04896385|616306277|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
170535688|NCT04896385|616306274|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
170535689|NCT04896385|616306275|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
170535690|NCT04896385|616306276|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
170535691|NCT04896385|616306277|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
170535692|NCT04896385|616306274|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
170535693|NCT04896385|616306275|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
170535694|NCT04896385|616306276|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
170535695|NCT04896385|616306277|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
170535696|NCT04896385|616306274|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
170535697|NCT04896385|616306275|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
170535698|NCT04896385|616306276|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
170535699|NCT04896385|616306277|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
170535700|NCT04896385|616306274|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
170535701|NCT04896385|616306275|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
170535702|NCT04896385|616306276|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
170535703|NCT04896385|616306277|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
170535704|NCT05291689|616306280|FG000|Overall Study|Adverse Event|3|||
170535705|NCT05291689|616306280|FG000|Overall Study|Lack of Efficacy|10|||
170535706|NCT05291689|616306280|FG000|Overall Study|Withdrawal by Subject|4|||
170535707|NCT01551173|616306281|FG000|Overall Study|Withdrawal by Subject|11|||
170535708|NCT01551173|616306282|FG001|Overall Study|Withdrawal by Subject|16|||
170535709|NCT01551173|616306281|FG000|Overall Study|Adverse Event|7|||
170535710|NCT01551173|616306282|FG001|Overall Study|Adverse Event|6|||
170535711|NCT01551173|616306281|FG000|Overall Study|Lost to Follow-up|5|||
170535712|NCT01551173|616306282|FG001|Overall Study|Lost to Follow-up|7|||
170535713|NCT01551173|616306281|FG000|Overall Study|Other|5|||
170535714|NCT01551173|616306282|FG001|Overall Study|Other|3|||
170535715|NCT01394276|616306285|FG000|Overall Study|Related Adverse event (AEs)|15|||
170535716|NCT01394276|616306285|FG000|Overall Study|Not related AEs|9|||
170535717|NCT01394276|616306285|FG000|Overall Study|Remission of disease|2|||
170535718|NCT01394276|616306285|FG000|Overall Study|Insufficient therapeutic effect|17|||
170535719|NCT01394276|616306285|FG000|Overall Study|Insufficient compliance|9|||
170535720|NCT01394276|616306285|FG000|Overall Study|Lost to Follow-up|5|||
170535721|NCT01394276|616306285|FG000|Overall Study|Participant moved to another site|1|||
170535722|NCT01394276|616306285|FG000|Overall Study|Pregnancy|1|||
170535723|NCT01394276|616306285|FG000|Overall Study|unavailability of drug at the Hospital|2|||
170535724|NCT01394276|616306285|FG000|Overall Study|Symptoms of concurrent diseases|1|||
170535725|NCT01402700|616306286|FG000|Overall Study|Death|3|||
170535726|NCT01402700|616306286|FG000|Overall Study|Withdrawal by Subject|3|||
170535727|NCT01402700|616306286|FG000|Overall Study|Missed Visit|1|||
170535728|NCT01933594|616306288|FG000|Overall Study|Lost to Follow-up|1|||
170535729|NCT01933594|616306289|FG001|Overall Study|Lost to Follow-up|0|||
170535730|NCT01933594|616306290|FG002|Overall Study|Lost to Follow-up|0|||
170535731|NCT01933594|616306291|FG003|Overall Study|Lost to Follow-up|0|||
170535732|NCT01933594|616306292|FG004|Overall Study|Lost to Follow-up|1|||
170535733|NCT01933594|616306293|FG005|Overall Study|Lost to Follow-up|0|||
170535734|NCT01933594|616306288|FG000|Overall Study|Ineligible for subsequent study step|0|||
170535735|NCT01933594|616306289|FG001|Overall Study|Ineligible for subsequent study step|0|||
170535736|NCT01933594|616306290|FG002|Overall Study|Ineligible for subsequent study step|0|||
170535737|NCT01933594|616306291|FG003|Overall Study|Ineligible for subsequent study step|0|||
170535738|NCT01933594|616306292|FG004|Overall Study|Ineligible for subsequent study step|1|||
170535739|NCT01933594|616306293|FG005|Overall Study|Ineligible for subsequent study step|0|||
170535740|NCT04153864|616306297|FG000|Overall Study|Withdrawal by Subject|21|||
170535741|NCT04153864|616306298|FG001|Overall Study|Withdrawal by Subject|7|||
170535742|NCT04153864|616306299|FG002|Overall Study|Withdrawal by Subject|23|||
170535743|NCT04153864|616306300|FG003|Overall Study|Withdrawal by Subject|2|||
170535744|NCT04153864|616306297|FG000|Overall Study|Lost to Follow-up|4|||
170431995|NCT04493684|615920754|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
170431996|NCT04493684|615920738|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170431997|NCT04493684|615920739|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170431998|NCT04493684|615920740|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170431999|NCT04493684|615920741|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432000|NCT04493684|615920742|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432001|NCT04493684|615920743|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432002|NCT04493684|615920744|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432003|NCT04493684|615920745|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432004|NCT04493684|615920746|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432005|NCT04493684|615920747|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432006|NCT04493684|615920748|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432007|NCT04493684|615920749|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
170432008|NCT04493684|615920750|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432009|NCT04493684|615920751|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432010|NCT04493684|615920752|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432011|NCT04493684|615920753|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432012|NCT04493684|615920754|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
170432013|NCT04493684|615920738|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432014|NCT04493684|615920739|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432015|NCT04493684|615920740|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432016|NCT04493684|615920741|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432017|NCT04493684|615920742|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432018|NCT04493684|615920743|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432019|NCT04493684|615920744|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432020|NCT04493684|615920745|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432021|NCT04493684|615920746|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432022|NCT04493684|615920747|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432023|NCT04493684|615920748|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432024|NCT04493684|615920749|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432025|NCT04493684|615920750|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432026|NCT04493684|615920751|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432027|NCT04493684|615920752|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432028|NCT04493684|615920753|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
170432029|NCT04493684|615920754|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
170432030|NCT04493684|615920738|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432031|NCT04493684|615920739|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432032|NCT04493684|615920740|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432033|NCT04493684|615920741|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432034|NCT04493684|615920742|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432035|NCT04493684|615920743|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432036|NCT04493684|615920744|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432037|NCT04493684|615920745|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432038|NCT04493684|615920746|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432039|NCT04493684|615920747|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432040|NCT04493684|615920748|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432041|NCT04493684|615920749|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432042|NCT04493684|615920750|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432043|NCT04493684|615920751|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432044|NCT04493684|615920752|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432045|NCT04493684|615920753|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
170432046|NCT04493684|615920754|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
170432047|NCT01750294|615922198|FG000|Overall Study|Withdrawal by Subject|1|||
170432048|NCT01750294|615922198|FG000|Overall Study|Safety Endpoint|1|||
170432049|NCT01624233|615922200|FG000|Period 2 - Induction|Adverse Event|1|||
170432050|NCT01624233|615922200|FG000|Period 3 - Maintenance|Adverse Event|2|||
170880700|NCT03770260|617574346|FG002|Overall Study|Disease progression|0|||
170432051|NCT01624233|615922200|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
170432052|NCT01624233|615922200|FG000|Period 3 - Maintenance|Physician Decision|2|||
170432053|NCT01624233|615922200|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
170432054|NCT01624233|615922200|FG000|Period 4 - Drug Free Period|Relapsed|61|||
170432055|NCT01624233|615922200|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
170432056|NCT01624233|615922200|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
170535745|NCT04153864|616306298|FG001|Overall Study|Lost to Follow-up|0|||
170432057|NCT01624233|615922200|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
170432058|NCT01624233|615922200|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
170432059|NCT01624233|615922200|FG000|Period 6: Follow-up|Adverse Event|3|||
170432060|NCT01624233|615922200|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
170432061|NCT01624233|615922200|FG000|Period 6: Follow-up|Physician Decision|1|||
170432062|NCT01624233|615922200|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
170432063|NCT02591420|615922201|FG000|Overall Study|Lost to Follow-up|0|||
170432064|NCT02591420|615922202|FG001|Overall Study|Lost to Follow-up|1|||
170432065|NCT02591420|615922203|FG002|Overall Study|Lost to Follow-up|2|||
170432066|NCT04241458|615922204|FG000|Overall Study|Withdrawal by Subject|0|||
170432067|NCT04241458|615922205|FG001|Overall Study|Withdrawal by Subject|0|||
170432068|NCT04241458|615922206|FG002|Overall Study|Withdrawal by Subject|0|||
170432069|NCT04241458|615922207|FG003|Overall Study|Withdrawal by Subject|0|||
170432070|NCT04241458|615922208|FG004|Overall Study|Withdrawal by Subject|1|||
170432071|NCT05604170|615922209|FG000|Overall Study|Lack of Efficacy|5|||
170432072|NCT05604170|615922209|FG000|Overall Study|Adverse Event|6|||
170432073|NCT05604170|615922209|FG000|Overall Study|Physician Decision|6|||
170432074|NCT05604170|615922209|FG000|Overall Study|Lost to Follow-up|6|||
170432075|NCT05604170|615922209|FG000|Overall Study|Withdrawal by Subject|11|||
170432076|NCT05604170|615922209|FG000|Overall Study|Early study termination by sponsor|77|||
170432077|NCT05604170|615922209|FG000|Overall Study|Other|6|||
170432078|NCT04970810|615922210|FG000|Overall Study|deemed ineligible after randomization|3|||
170432079|NCT04970810|615922211|FG001|Overall Study|deemed ineligible after randomization|0|||
170432080|NCT04970810|615922212|FG002|Overall Study|deemed ineligible after randomization|4|||
170432081|NCT03317899|615922216|FG000|Overall Study|Death|6|||
170432082|NCT03317899|615922217|FG001|Overall Study|Death|9|||
170432083|NCT06381102|615922219|FG000|Washout 5 Days|Withdrawal by Subject|0|||
170432084|NCT06381102|615922220|FG001|Washout 5 Days|Withdrawal by Subject|2|||
170432085|NCT00772603|615922221|FG000|Overall Study|Withdrawal by Subject|11|||
170432086|NCT00772603|615922222|FG001|Overall Study|Withdrawal by Subject|10|||
170432087|NCT00772603|615922223|FG002|Overall Study|Withdrawal by Subject|6|||
170432088|NCT00772603|615922221|FG000|Overall Study|Adverse Event|37|||
170432089|NCT00772603|615922222|FG001|Overall Study|Adverse Event|18|||
170432090|NCT00772603|615922223|FG002|Overall Study|Adverse Event|10|||
170432091|NCT00772603|615922221|FG000|Overall Study|Subject Non-compliance|1|||
170432092|NCT00772603|615922222|FG001|Overall Study|Subject Non-compliance|6|||
170432093|NCT00772603|615922223|FG002|Overall Study|Subject Non-compliance|4|||
170432094|NCT00772603|615922221|FG000|Overall Study|Protocol Violation|0|||
170432095|NCT00772603|615922222|FG001|Overall Study|Protocol Violation|1|||
170432096|NCT00772603|615922223|FG002|Overall Study|Protocol Violation|1|||
170432097|NCT00772603|615922221|FG000|Overall Study|Lost to Follow-up|1|||
170432098|NCT00772603|615922222|FG001|Overall Study|Lost to Follow-up|5|||
170432099|NCT00772603|615922223|FG002|Overall Study|Lost to Follow-up|2|||
170432100|NCT00772603|615922221|FG000|Overall Study|Physician Decision|0|||
170432101|NCT00772603|615922222|FG001|Overall Study|Physician Decision|0|||
170432102|NCT00772603|615922223|FG002|Overall Study|Physician Decision|1|||
170432103|NCT00772603|615922221|FG000|Overall Study|Other|2|||
170432104|NCT00772603|615922222|FG001|Overall Study|Other|0|||
170432105|NCT00772603|615922223|FG002|Overall Study|Other|2|||
170432106|NCT00443651|615922226|FG000|Overall Study|Death|1|||
170432107|NCT00443651|615922227|FG001|Overall Study|Death|5|||
170432108|NCT00443651|615922226|FG000|Overall Study|Adverse Event|5|||
170432109|NCT00443651|615922227|FG001|Overall Study|Adverse Event|6|||
170432110|NCT00443651|615922226|FG000|Overall Study|Lost to Follow-up|18|||
170432111|NCT00443651|615922227|FG001|Overall Study|Lost to Follow-up|12|||
170432112|NCT00443651|615922226|FG000|Overall Study|Patient's/Guardian's Decision|58|||
170432113|NCT00443651|615922227|FG001|Overall Study|Patient's/Guardian's Decision|30|||
170432114|NCT00443651|615922226|FG000|Overall Study|Physician Decision|13|||
170432115|NCT00443651|615922227|FG001|Overall Study|Physician Decision|4|||
170432116|NCT00443651|615922226|FG000|Overall Study|Pregnancy|0|||
170432117|NCT00443651|615922227|FG001|Overall Study|Pregnancy|1|||
170432118|NCT02751424|615922228|FG000|Part 2|Adverse Event|0|||
170778743|NCT03398148|617197302|FG014|Substudy 1 Period 2|Other|0|||
170432119|NCT02751424|615922229|FG001|Part 2|Adverse Event|0|||
170432120|NCT02751424|615922230|FG002|Part 2|Adverse Event|0|||
170432121|NCT02751424|615922231|FG003|Part 2|Adverse Event|0|||
170432122|NCT02751424|615922232|FG004|Part 2|Adverse Event|0|||
170432123|NCT02751424|615922233|FG005|Part 2|Adverse Event|0|||
170432124|NCT02751424|615922234|FG006|Part 2|Adverse Event|0|||
170432125|NCT02751424|615922235|FG007|Part 2|Adverse Event|5|||
170432126|NCT02751424|615922236|FG008|Part 2|Adverse Event|0|||
170432127|NCT00716625|615922237|FG000|Overall Study|Safety was not Assessable|1|||
170432128|NCT04349267|615922238|FG000|Overall Study|Adverse Event|0|||
170432129|NCT04349267|615922239|FG001|Overall Study|Adverse Event|0|||
170535746|NCT04153864|616306299|FG002|Overall Study|Lost to Follow-up|3|||
170535747|NCT04153864|616306300|FG003|Overall Study|Lost to Follow-up|0|||
170535748|NCT04153864|616306297|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
170535749|NCT04153864|616306298|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
170535750|NCT04153864|616306299|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
170535751|NCT04153864|616306300|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
170535752|NCT06354257|616306309|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170535753|NCT06354257|616306309|FG000|Treatment Period 2|Adverse Event|1|||
170535754|NCT01654276|616306310|FG000|Overall Study|Lack of Efficacy|1|||
170535755|NCT01654276|616306310|FG000|Overall Study|Lost to Follow-up|4|||
170535756|NCT01654276|616306310|FG000|Overall Study|Withdrawal by Subject|1|||
170535757|NCT00127803|616306321|FG000|Overall Study|Adverse Event|2|||
170535758|NCT00127803|616306322|FG001|Overall Study|Adverse Event|0|||
170535759|NCT00127803|616306323|FG002|Overall Study|Adverse Event|0|||
170535760|NCT00127803|616306324|FG003|Overall Study|Adverse Event|0|||
170535761|NCT00127803|616306321|FG000|Overall Study|Withdrawal by Subject|1|||
170535762|NCT00127803|616306322|FG001|Overall Study|Withdrawal by Subject|0|||
170535763|NCT00127803|616306323|FG002|Overall Study|Withdrawal by Subject|0|||
170535764|NCT00127803|616306324|FG003|Overall Study|Withdrawal by Subject|0|||
170535765|NCT00127803|616306321|FG000|Overall Study|Lost to Follow-up|0|||
170535766|NCT00127803|616306322|FG001|Overall Study|Lost to Follow-up|0|||
170535767|NCT00127803|616306323|FG002|Overall Study|Lost to Follow-up|0|||
170535768|NCT00127803|616306324|FG003|Overall Study|Lost to Follow-up|1|||
170535769|NCT00846365|616306325|FG000|Overall Study|Adverse Event|20|||
170535770|NCT00846365|616306326|FG001|Overall Study|Adverse Event|30|||
170535771|NCT00846365|616306327|FG002|Overall Study|Adverse Event|11|||
170535772|NCT00846365|616306325|FG000|Overall Study|Protocol Violation|5|||
170535773|NCT00846365|616306326|FG001|Overall Study|Protocol Violation|4|||
170535774|NCT00846365|616306327|FG002|Overall Study|Protocol Violation|0|||
170535775|NCT00846365|616306325|FG000|Overall Study|Lost to Follow-up|8|||
170535776|NCT00846365|616306326|FG001|Overall Study|Lost to Follow-up|2|||
170535777|NCT00846365|616306327|FG002|Overall Study|Lost to Follow-up|5|||
170535778|NCT00846365|616306325|FG000|Overall Study|Withdrawal by Subject|11|||
170535779|NCT00846365|616306326|FG001|Overall Study|Withdrawal by Subject|11|||
170535780|NCT00846365|616306327|FG002|Overall Study|Withdrawal by Subject|9|||
170535781|NCT00846365|616306325|FG000|Overall Study|Pregnancy|1|||
170535782|NCT00846365|616306326|FG001|Overall Study|Pregnancy|0|||
170535783|NCT00846365|616306327|FG002|Overall Study|Pregnancy|0|||
170535784|NCT00846365|616306325|FG000|Overall Study|Lack of Efficacy|1|||
170535785|NCT00846365|616306326|FG001|Overall Study|Lack of Efficacy|1|||
170535786|NCT00846365|616306327|FG002|Overall Study|Lack of Efficacy|2|||
170535787|NCT00846365|616306325|FG000|Overall Study|Other|9|||
170535788|NCT00846365|616306326|FG001|Overall Study|Other|1|||
170535789|NCT00846365|616306327|FG002|Overall Study|Other|6|||
170535790|NCT01349595|616306328|FG000|Overall Study|Lack of funding|2|||
170535791|NCT01349595|616306329|FG001|Overall Study|Lack of funding|2|||
170535792|NCT00764517|616307872|FG000|Overall Study|Adverse Event|9|||
170535793|NCT00764517|616307873|FG001|Overall Study|Adverse Event|3|||
170535794|NCT00764517|616307872|FG000|Overall Study|Death|3|||
170778744|NCT03398148|617197288|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778745|NCT03398148|617197289|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778746|NCT03398148|617197290|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778747|NCT03398148|617197291|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778748|NCT03398148|617197292|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778749|NCT03398148|617197293|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778750|NCT03398148|617197294|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
170778751|NCT03398148|617197295|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778752|NCT03398148|617197296|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778753|NCT03398148|617197297|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778754|NCT03398148|617197298|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778755|NCT03398148|617197299|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778756|NCT03398148|617197300|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778757|NCT03398148|617197301|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
170778758|NCT03398148|617197302|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
170880701|NCT03770260|617574347|FG003|Overall Study|Disease progression|0|||
170880702|NCT05121480|617574348|FG000|Overall Study|Lack of Efficacy|2|||
170880703|NCT05121480|617574349|FG001|Overall Study|Lack of Efficacy|2|||
170535795|NCT00764517|616307873|FG001|Overall Study|Death|11|||
170535796|NCT00764517|616307872|FG000|Overall Study|Physician Decision|3|||
170535797|NCT00764517|616307873|FG001|Overall Study|Physician Decision|0|||
170535798|NCT02362451|616307882|FG000|Overall Study|Withdrawal by Subject|0|||
170535799|NCT02362451|616307883|FG001|Overall Study|Withdrawal by Subject|1|||
170535800|NCT02362451|616307882|FG000|Overall Study|Lack of Efficacy|2|||
170535801|NCT02362451|616307883|FG001|Overall Study|Lack of Efficacy|0|||
170535802|NCT02362451|616307882|FG000|Overall Study|Progression|1|||
170880704|NCT05121480|617574350|FG002|Overall Study|Lack of Efficacy|1|||
170432130|NCT04349267|615922240|FG002|Overall Study|Adverse Event|0|||
170432131|NCT04349267|615922241|FG003|Overall Study|Adverse Event|0|||
170432132|NCT04349267|615922242|FG004|Overall Study|Adverse Event|0|||
170432133|NCT04349267|615922243|FG005|Overall Study|Adverse Event|1|||
170432134|NCT04349267|615922244|FG006|Overall Study|Adverse Event|0|||
170432135|NCT04349267|615922238|FG000|Overall Study|Other reason|0|||
170432136|NCT04349267|615922239|FG001|Overall Study|Other reason|1|||
170432137|NCT04349267|615922240|FG002|Overall Study|Other reason|0|||
170432138|NCT04349267|615922241|FG003|Overall Study|Other reason|0|||
170432139|NCT04349267|615922242|FG004|Overall Study|Other reason|1|||
170432140|NCT04349267|615922243|FG005|Overall Study|Other reason|1|||
170432141|NCT04349267|615922244|FG006|Overall Study|Other reason|1|||
170432142|NCT04349267|615922238|FG000|Overall Study|Disease Progression|2|||
170432143|NCT04349267|615922239|FG001|Overall Study|Disease Progression|0|||
170432144|NCT04349267|615922240|FG002|Overall Study|Disease Progression|2|||
170432145|NCT04349267|615922241|FG003|Overall Study|Disease Progression|3|||
170432146|NCT04349267|615922242|FG004|Overall Study|Disease Progression|3|||
170432147|NCT04349267|615922243|FG005|Overall Study|Disease Progression|7|||
170432148|NCT04349267|615922244|FG006|Overall Study|Disease Progression|10|||
170432149|NCT04349267|615922238|FG000|Overall Study|Participant withdrew consent|0|||
170432150|NCT04349267|615922239|FG001|Overall Study|Participant withdrew consent|1|||
170432151|NCT04349267|615922240|FG002|Overall Study|Participant withdrew consent|0|||
170432152|NCT04349267|615922241|FG003|Overall Study|Participant withdrew consent|0|||
170432153|NCT04349267|615922242|FG004|Overall Study|Participant withdrew consent|0|||
170432154|NCT04349267|615922243|FG005|Overall Study|Participant withdrew consent|0|||
170432155|NCT04349267|615922244|FG006|Overall Study|Participant withdrew consent|1|||
170432156|NCT04618211|615922245|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
170432157|NCT04618211|615922246|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
170432158|NCT04618211|615922247|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
170432159|NCT04618211|615922245|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
170432160|NCT04618211|615922246|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
170432161|NCT04618211|615922247|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
170432162|NCT04618211|615922245|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
170432163|NCT04618211|615922246|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
170432164|NCT04618211|615922247|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
170432165|NCT00316277|615922248|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
170432166|NCT00316277|615922249|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
170432167|NCT00316277|615922248|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
170432168|NCT00316277|615922249|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
170432169|NCT00316277|615922248|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
170432170|NCT00316277|615922249|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
170432171|NCT00316277|615922248|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
170432172|NCT00316277|615922249|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
170432173|NCT00316277|615922248|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
170432174|NCT00316277|615922249|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
170432175|NCT01244620|615922252|FG000|Overall Study|Study terminated|4|||
170432176|NCT01244620|615922253|FG001|Overall Study|Study terminated|4|||
170432177|NCT01244620|615922254|FG002|Overall Study|Study terminated|4|||
170432178|NCT01244620|615922255|FG003|Overall Study|Study terminated|4|||
170432179|NCT03261167|615922256|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
170432180|NCT03261167|615922257|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
170432181|NCT03261167|615922256|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
170432182|NCT03261167|615922257|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
170432183|NCT03261167|615922256|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
170432184|NCT03261167|615922257|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
170432185|NCT03261167|615922256|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
170432186|NCT03261167|615922257|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
170432187|NCT03261167|615922256|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
170432188|NCT03261167|615922257|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
170432189|NCT00466167|615922258|FG000|Overall Study|Adverse Event|8|||
170535803|NCT02362451|616307883|FG001|Overall Study|Progression|0|||
170535804|NCT02362451|616307882|FG000|Overall Study|Participant chose other therapy.|1|||
170535805|NCT02362451|616307883|FG001|Overall Study|Participant chose other therapy.|0|||
170535806|NCT00937950|616307884|FG000|Overall Study|Withdrawal by Subject|23|||
170535807|NCT00937950|616307884|FG000|Overall Study|Migrated/moved from study area|27|||
170535808|NCT00937950|616307884|FG000|Overall Study|Lost to Follow-up|144|||
170432190|NCT00466167|615922259|FG001|Overall Study|Adverse Event|8|||
170432191|NCT00466167|615922260|FG002|Overall Study|Adverse Event|7|||
170432192|NCT00466167|615922258|FG000|Overall Study|Lack of Efficacy|2|||
170432193|NCT00466167|615922259|FG001|Overall Study|Lack of Efficacy|0|||
170432194|NCT00466167|615922260|FG002|Overall Study|Lack of Efficacy|3|||
170535809|NCT00937950|616307884|FG000|Overall Study|Missing confirmed|4|||
170535810|NCT00937950|616307884|FG000|Overall Study|Other|18|||
170535811|NCT00460798|616307887|FG000|Overall Study|Death|59|||
170535812|NCT00460798|616307887|FG000|Overall Study|Adverse Event|27|||
170535813|NCT00460798|616307887|FG000|Overall Study|Lost to Follow-up|19|||
170535814|NCT00460798|616307887|FG000|Overall Study|Progressive Disease|99|||
170535815|NCT00460798|616307887|FG000|Overall Study|Other|27|||
170535816|NCT00460798|616307887|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
170535817|NCT00460798|616307887|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
170535818|NCT03718000|616307893|FG000|Overall Study|Relocation|2|||
170535819|NCT03718000|616307894|FG001|Overall Study|Relocation|4|||
170535820|NCT03718000|616307893|FG000|Overall Study|Pregnancy|0|||
170535821|NCT03718000|616307894|FG001|Overall Study|Pregnancy|1|||
170535822|NCT01186770|616307898|FG000|Overall Study|Ineligibility|0|||
170535823|NCT01186770|616307899|FG001|Overall Study|Ineligibility|0|||
170535824|NCT01186770|616307900|FG002|Overall Study|Ineligibility|2|||
170535825|NCT01186770|616307901|FG003|Overall Study|Ineligibility|0|||
170535826|NCT01186770|616307898|FG000|Overall Study|Protocol Violation|7|||
170535827|NCT01186770|616307899|FG001|Overall Study|Protocol Violation|9|||
170535828|NCT01186770|616307900|FG002|Overall Study|Protocol Violation|12|||
170535829|NCT01186770|616307901|FG003|Overall Study|Protocol Violation|14|||
170778759|NCT03398148|617197288|FG000|Substudy 2 Period 1|Adverse Event|0|||
170778760|NCT03398148|617197289|FG001|Substudy 2 Period 1|Adverse Event|0|||
170778761|NCT03398148|617197290|FG002|Substudy 2 Period 1|Adverse Event|0|||
170778762|NCT03398148|617197291|FG003|Substudy 2 Period 1|Adverse Event|0|||
170778763|NCT03398148|617197292|FG004|Substudy 2 Period 1|Adverse Event|0|||
170778764|NCT03398148|617197293|FG005|Substudy 2 Period 1|Adverse Event|0|||
170778765|NCT03398148|617197294|FG006|Substudy 2 Period 1|Adverse Event|0|||
170778766|NCT03398148|617197295|FG007|Substudy 2 Period 1|Adverse Event|0|||
170778767|NCT03398148|617197296|FG008|Substudy 2 Period 1|Adverse Event|0|||
170778768|NCT03398148|617197297|FG009|Substudy 2 Period 1|Adverse Event|12|||
170778769|NCT03398148|617197298|FG010|Substudy 2 Period 1|Adverse Event|2|||
170778770|NCT03398148|617197299|FG011|Substudy 2 Period 1|Adverse Event|0|||
170778771|NCT03398148|617197300|FG012|Substudy 2 Period 1|Adverse Event|0|||
170778772|NCT03398148|617197301|FG013|Substudy 2 Period 1|Adverse Event|0|||
170778773|NCT03398148|617197302|FG014|Substudy 2 Period 1|Adverse Event|0|||
170778774|NCT03398148|617197288|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778775|NCT03398148|617197289|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778776|NCT03398148|617197290|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778777|NCT03398148|617197291|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778778|NCT03398148|617197292|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778779|NCT03398148|617197293|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778780|NCT03398148|617197294|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778781|NCT03398148|617197295|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778782|NCT03398148|617197296|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778783|NCT03398148|617197297|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
170778784|NCT03398148|617197298|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
170778785|NCT03398148|617197299|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778786|NCT03398148|617197300|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778787|NCT03398148|617197301|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778788|NCT03398148|617197302|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
170778789|NCT03398148|617197288|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
170778790|NCT03398148|617197289|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
170778791|NCT03398148|617197290|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
170778792|NCT03398148|617197291|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
170778793|NCT03398148|617197292|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
170778794|NCT03398148|617197293|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
170778795|NCT03398148|617197294|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
170778796|NCT03398148|617197295|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
170778797|NCT03398148|617197296|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
170778798|NCT03398148|617197297|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
170778799|NCT03398148|617197298|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
170778800|NCT03398148|617197299|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
170778801|NCT03398148|617197300|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
170535830|NCT01186770|616307898|FG000|Overall Study|Adverse Event|2|||
170778802|NCT03398148|617197301|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
170535831|NCT01186770|616307899|FG001|Overall Study|Adverse Event|9|||
170778803|NCT03398148|617197302|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
170778804|NCT03398148|617197288|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778805|NCT03398148|617197289|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778806|NCT03398148|617197290|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778807|NCT03398148|617197291|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778808|NCT03398148|617197292|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778809|NCT03398148|617197293|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170535832|NCT01186770|616307900|FG002|Overall Study|Adverse Event|7|||
170535833|NCT01186770|616307901|FG003|Overall Study|Adverse Event|9|||
170535834|NCT01186770|616307898|FG000|Overall Study|Withdrawal by Subject|15|||
170535835|NCT01186770|616307899|FG001|Overall Study|Withdrawal by Subject|13|||
170432195|NCT00466167|615922258|FG000|Overall Study|Protocol Violation|1|||
170432196|NCT00466167|615922259|FG001|Overall Study|Protocol Violation|1|||
170432197|NCT00466167|615922260|FG002|Overall Study|Protocol Violation|2|||
170432198|NCT00466167|615922258|FG000|Overall Study|Lost to Follow-up|3|||
170432199|NCT00466167|615922259|FG001|Overall Study|Lost to Follow-up|2|||
170432200|NCT00466167|615922260|FG002|Overall Study|Lost to Follow-up|2|||
170432201|NCT00466167|615922258|FG000|Overall Study|Withdrawal by Subject|4|||
170432202|NCT00466167|615922259|FG001|Overall Study|Withdrawal by Subject|1|||
170432203|NCT00466167|615922260|FG002|Overall Study|Withdrawal by Subject|6|||
170432204|NCT00466167|615922258|FG000|Overall Study|patient did not meet inclusion criteria|1|||
170432205|NCT00466167|615922259|FG001|Overall Study|patient did not meet inclusion criteria|0|||
170432206|NCT00466167|615922260|FG002|Overall Study|patient did not meet inclusion criteria|1|||
170432207|NCT00466167|615922258|FG000|Overall Study|Not treated|1|||
170432208|NCT00466167|615922259|FG001|Overall Study|Not treated|0|||
170432209|NCT00466167|615922260|FG002|Overall Study|Not treated|0|||
170432210|NCT03364192|615922261|FG000|Overall Study|Ineligible|10|||
170432211|NCT03364192|615922261|FG000|Overall Study|Withdrawal by Subject|5|||
170432212|NCT03364192|615922261|FG000|Overall Study|Lost to Follow-up|1|||
170432213|NCT03930732|615922268|FG000|Overall Study|Adverse Event|9|||
170432214|NCT03930732|615922269|FG001|Overall Study|Adverse Event|7|||
170432215|NCT03930732|615922268|FG000|Overall Study|Poor compliance to protocol|0|||
170432216|NCT03930732|615922269|FG001|Overall Study|Poor compliance to protocol|1|||
170432217|NCT03930732|615922268|FG000|Overall Study|Withdrawal by Subject|23|||
170432218|NCT03930732|615922269|FG001|Overall Study|Withdrawal by Subject|11|||
170432219|NCT03930732|615922268|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
170432220|NCT03930732|615922269|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
170432221|NCT03930732|615922268|FG000|Overall Study|Other reason not related to COVID-19|5|||
170432222|NCT03930732|615922269|FG001|Overall Study|Other reason not related to COVID-19|8|||
170432223|NCT02699463|615922272|FG000|Overall Study|Lost to Follow-up|11|||
170432224|NCT02699463|615922273|FG001|Overall Study|Lost to Follow-up|8|||
170432225|NCT02699463|615922272|FG000|Overall Study|Withdrawal by Subject|4|||
170432226|NCT02699463|615922273|FG001|Overall Study|Withdrawal by Subject|1|||
170432227|NCT02488239|615922276|FG000|Overall Study|Death|3|||
170432228|NCT02488239|615922276|FG000|Overall Study|Withdrawal by Subject|3|||
170432229|NCT02488239|615922276|FG000|Overall Study|Physician Decision|2|||
170432230|NCT02488239|615922276|FG000|Overall Study|Consent ineligible|1|||
170432231|NCT02488239|615922276|FG000|Overall Study|Did not undergo implant procedure|1|||
170432232|NCT04414930|615922280|FG000|Overall Study|Withdrawal by Subject|1|||
170432233|NCT04414930|615922281|FG001|Overall Study|Withdrawal by Subject|3|||
170432234|NCT03325881|615922282|FG000|Overall Study|Protocol Violation|0|||
170432235|NCT03325881|615922283|FG001|Overall Study|Protocol Violation|1|||
170432236|NCT03325881|615922282|FG000|Overall Study|Withdrawal by Subject|0|||
170432237|NCT03325881|615922283|FG001|Overall Study|Withdrawal by Subject|2|||
170432238|NCT03325881|615922282|FG000|Overall Study|Lack of Efficacy|2|||
170432239|NCT03325881|615922283|FG001|Overall Study|Lack of Efficacy|0|||
170432240|NCT03325881|615922282|FG000|Overall Study|Not treated|1|||
170432241|NCT03325881|615922283|FG001|Overall Study|Not treated|0|||
170432242|NCT02294981|615922286|FG000|Overall Study|Lost to Follow-up|1|||
170432243|NCT06539676|615922287|FG000|Overall Study|Early study termination|1|||
170432244|NCT06539676|615922288|FG001|Overall Study|Early study termination|0|||
170535836|NCT01186770|616307900|FG002|Overall Study|Withdrawal by Subject|11|||
170432245|NCT06539676|615922289|FG002|Overall Study|Early study termination|6|||
170432246|NCT01848938|615922298|FG000|Overall Study|Lost to Follow-up|1|||
170432247|NCT01848938|615922299|FG001|Overall Study|Lost to Follow-up|1|||
170432248|NCT00115063|615922304|FG000|Overall Study|Lost to Follow-up|98|||
170432249|NCT00115063|615922305|FG001|Overall Study|Lost to Follow-up|104|||
170432250|NCT00115063|615922304|FG000|Overall Study|Death|1|||
170432251|NCT00115063|615922305|FG001|Overall Study|Death|0|||
170432252|NCT01588236|615922314|FG000|Overall Study|Adverse Event|5|||
170432253|NCT01588236|615922315|FG001|Overall Study|Adverse Event|4|||
170432254|NCT01588236|615922316|FG002|Overall Study|Adverse Event|1|||
170432255|NCT01588236|615922314|FG000|Overall Study|Lost to Follow-up|8|||
170535837|NCT01186770|616307901|FG003|Overall Study|Withdrawal by Subject|17|||
170432256|NCT01588236|615922315|FG001|Overall Study|Lost to Follow-up|13|||
170432257|NCT01588236|615922316|FG002|Overall Study|Lost to Follow-up|6|||
170432258|NCT01588236|615922314|FG000|Overall Study|Physician Decision|1|||
170432259|NCT01588236|615922315|FG001|Overall Study|Physician Decision|2|||
170432260|NCT01588236|615922316|FG002|Overall Study|Physician Decision|0|||
170432261|NCT01588236|615922314|FG000|Overall Study|Protocol Violation|0|||
170432262|NCT01588236|615922315|FG001|Overall Study|Protocol Violation|1|||
170432263|NCT01588236|615922316|FG002|Overall Study|Protocol Violation|1|||
170535838|NCT01186770|616307898|FG000|Overall Study|Lost to Follow-up|10|||
170432264|NCT01588236|615922314|FG000|Overall Study|Withdrawal by Subject|14|||
170432265|NCT01588236|615922315|FG001|Overall Study|Withdrawal by Subject|16|||
170535839|NCT01186770|616307899|FG001|Overall Study|Lost to Follow-up|6|||
170432266|NCT01588236|615922316|FG002|Overall Study|Withdrawal by Subject|18|||
170432267|NCT01588236|615922314|FG000|Overall Study|Exclusion Criteria met during study|2|||
170535840|NCT01186770|616307900|FG002|Overall Study|Lost to Follow-up|14|||
170432268|NCT01588236|615922315|FG001|Overall Study|Exclusion Criteria met during study|1|||
170432269|NCT01588236|615922316|FG002|Overall Study|Exclusion Criteria met during study|0|||
170432270|NCT01588236|615922314|FG000|Overall Study|sponsor decision|1|||
170432271|NCT01588236|615922315|FG001|Overall Study|sponsor decision|6|||
170432272|NCT01588236|615922316|FG002|Overall Study|sponsor decision|2|||
170432273|NCT01030133|615922317|FG000|Overall Study|failed to experience pain at level 7/10|2|||
170432274|NCT01030133|615922318|FG001|Overall Study|failed to experience pain at level 7/10|2|||
170432275|NCT04742491|615923764|FG000|Overall Study|Death|2|||
170432276|NCT04742491|615923765|FG001|Overall Study|Death|0|||
170432277|NCT04742491|615923764|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
170432278|NCT04742491|615923765|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
170432279|NCT04742491|615923764|FG000|Overall Study|Lost to Follow-up|6|||
170432280|NCT04742491|615923765|FG001|Overall Study|Lost to Follow-up|8|||
170432281|NCT04742491|615923764|FG000|Overall Study|Withdrawal by Subject|4|||
170432282|NCT04742491|615923765|FG001|Overall Study|Withdrawal by Subject|2|||
170432283|NCT04742491|615923764|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
170432284|NCT04742491|615923765|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
170432285|NCT04742491|615923764|FG000|Overall Study|Participant refused further participation|2|||
170432286|NCT04742491|615923765|FG001|Overall Study|Participant refused further participation|7|||
170432287|NCT04742491|615923764|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
170432288|NCT04742491|615923765|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
170432289|NCT04742491|615923764|FG000|Overall Study|Other reasons|3|||
170432290|NCT04742491|615923765|FG001|Overall Study|Other reasons|4|||
170432291|NCT01564394|615923766|FG000|Overall Study|Withdrawal by Subject|6|||
170432292|NCT01564394|615923767|FG001|Overall Study|Withdrawal by Subject|10|||
170432293|NCT03606174|615923772|FG000|Overall Study|Death|37|||
170432294|NCT03606174|615923773|FG001|Overall Study|Death|15|||
170432295|NCT03606174|615923774|FG002|Overall Study|Death|15|||
170432296|NCT03606174|615923775|FG003|Overall Study|Death|7|||
170432297|NCT03606174|615923776|FG004|Overall Study|Death|35|||
170432298|NCT03606174|615923777|FG005|Overall Study|Death|12|||
170432299|NCT03606174|615923778|FG006|Overall Study|Death|35|||
170432300|NCT03606174|615923779|FG007|Overall Study|Death|8|||
170432301|NCT03606174|615923780|FG008|Overall Study|Death|5|||
170432302|NCT03606174|615923781|FG009|Overall Study|Death|3|||
170432303|NCT03606174|615923782|FG010|Overall Study|Death|0|||
170432304|NCT03606174|615923772|FG000|Overall Study|Lost to Follow-up|0|||
170432305|NCT03606174|615923773|FG001|Overall Study|Lost to Follow-up|0|||
170432306|NCT03606174|615923774|FG002|Overall Study|Lost to Follow-up|0|||
170432307|NCT03606174|615923775|FG003|Overall Study|Lost to Follow-up|0|||
170432308|NCT03606174|615923776|FG004|Overall Study|Lost to Follow-up|1|||
170432309|NCT03606174|615923777|FG005|Overall Study|Lost to Follow-up|1|||
170432310|NCT03606174|615923778|FG006|Overall Study|Lost to Follow-up|0|||
170432311|NCT03606174|615923779|FG007|Overall Study|Lost to Follow-up|0|||
170432312|NCT03606174|615923780|FG008|Overall Study|Lost to Follow-up|0|||
170432313|NCT03606174|615923781|FG009|Overall Study|Lost to Follow-up|0|||
170432314|NCT03606174|615923782|FG010|Overall Study|Lost to Follow-up|0|||
170432315|NCT03606174|615923772|FG000|Overall Study|Withdrawal by Subject|6|||
170432316|NCT03606174|615923773|FG001|Overall Study|Withdrawal by Subject|0|||
170432317|NCT03606174|615923774|FG002|Overall Study|Withdrawal by Subject|0|||
170535841|NCT01186770|616307901|FG003|Overall Study|Lost to Follow-up|9|||
170535842|NCT01186770|616307898|FG000|Overall Study|Insufficient response to treatment|7|||
170535843|NCT01186770|616307899|FG001|Overall Study|Insufficient response to treatment|8|||
170535844|NCT01186770|616307900|FG002|Overall Study|Insufficient response to treatment|5|||
170535845|NCT01186770|616307901|FG003|Overall Study|Insufficient response to treatment|7|||
170535846|NCT01186770|616307898|FG000|Overall Study|Other than specified|0|||
170535847|NCT01186770|616307899|FG001|Overall Study|Other than specified|1|||
170535848|NCT01186770|616307900|FG002|Overall Study|Other than specified|1|||
170535849|NCT01186770|616307901|FG003|Overall Study|Other than specified|2|||
170535850|NCT02101294|616307904|FG000|Overall Study|Withdrawal by Subject|5|||
170535851|NCT02101294|616307904|FG000|Overall Study|Lost to Follow-up|6|||
170535852|NCT00688597|616307905|FG000|Overall Study|Adverse Event|2|||
170535853|NCT00688597|616307906|FG001|Overall Study|Adverse Event|0|||
170535854|NCT00688597|616307907|FG002|Overall Study|Adverse Event|0|||
170432318|NCT03606174|615923775|FG003|Overall Study|Withdrawal by Subject|1|||
170535855|NCT00688597|616307905|FG000|Overall Study|Physician Decision|1|||
170535856|NCT00688597|616307906|FG001|Overall Study|Physician Decision|0|||
170535857|NCT00688597|616307907|FG002|Overall Study|Physician Decision|0|||
170432319|NCT03606174|615923776|FG004|Overall Study|Withdrawal by Subject|2|||
170432320|NCT03606174|615923777|FG005|Overall Study|Withdrawal by Subject|1|||
170432321|NCT03606174|615923778|FG006|Overall Study|Withdrawal by Subject|4|||
170432322|NCT03606174|615923779|FG007|Overall Study|Withdrawal by Subject|0|||
170432323|NCT03606174|615923780|FG008|Overall Study|Withdrawal by Subject|0|||
170432324|NCT03606174|615923781|FG009|Overall Study|Withdrawal by Subject|0|||
170432325|NCT03606174|615923782|FG010|Overall Study|Withdrawal by Subject|1|||
170535858|NCT00689936|616307908|FG000|Active Treatment Phase|Adverse Event|68|||
170535859|NCT00689936|616307909|FG001|Active Treatment Phase|Adverse Event|71|||
170535860|NCT00689936|616307910|FG002|Active Treatment Phase|Adverse Event|76|||
170432326|NCT03606174|615923772|FG000|Overall Study|Study Terminated by Sponsor|5|||
170432327|NCT03606174|615923773|FG001|Overall Study|Study Terminated by Sponsor|7|||
170432328|NCT03606174|615923774|FG002|Overall Study|Study Terminated by Sponsor|3|||
170432329|NCT03606174|615923775|FG003|Overall Study|Study Terminated by Sponsor|0|||
170432330|NCT03606174|615923776|FG004|Overall Study|Study Terminated by Sponsor|11|||
170432331|NCT03606174|615923777|FG005|Overall Study|Study Terminated by Sponsor|6|||
170432332|NCT03606174|615923778|FG006|Overall Study|Study Terminated by Sponsor|12|||
170432333|NCT03606174|615923779|FG007|Overall Study|Study Terminated by Sponsor|1|||
170432334|NCT03606174|615923780|FG008|Overall Study|Study Terminated by Sponsor|3|||
170432335|NCT03606174|615923781|FG009|Overall Study|Study Terminated by Sponsor|1|||
170432336|NCT03606174|615923782|FG010|Overall Study|Study Terminated by Sponsor|2|||
170432337|NCT03606174|615923772|FG000|Overall Study|Miscellaneous|1|||
170432338|NCT03606174|615923773|FG001|Overall Study|Miscellaneous|1|||
170432339|NCT03606174|615923774|FG002|Overall Study|Miscellaneous|0|||
170432340|NCT03606174|615923775|FG003|Overall Study|Miscellaneous|1|||
170432341|NCT03606174|615923776|FG004|Overall Study|Miscellaneous|4|||
170432342|NCT03606174|615923777|FG005|Overall Study|Miscellaneous|7|||
170432343|NCT03606174|615923778|FG006|Overall Study|Miscellaneous|5|||
170432344|NCT03606174|615923779|FG007|Overall Study|Miscellaneous|0|||
170432345|NCT03606174|615923780|FG008|Overall Study|Miscellaneous|0|||
170432346|NCT03606174|615923781|FG009|Overall Study|Miscellaneous|0|||
170432347|NCT03606174|615923782|FG010|Overall Study|Miscellaneous|1|||
170432348|NCT00859521|615923783|FG000|Washout|Withdrawal by Subject|0|||
170432349|NCT00859521|615923784|FG001|Washout|Withdrawal by Subject|1|||
170432350|NCT02125461|615923785|FG000|Overall Study|Withdrawal by Subject|30|||
170432351|NCT02125461|615923786|FG001|Overall Study|Withdrawal by Subject|16|||
170432352|NCT02125461|615923785|FG000|Overall Study|Lost to Follow-up|8|||
170432353|NCT02125461|615923786|FG001|Overall Study|Lost to Follow-up|3|||
170432354|NCT02125461|615923785|FG000|Overall Study|Death|260|||
170432355|NCT02125461|615923786|FG001|Overall Study|Death|149|||
170432356|NCT02125461|615923785|FG000|Overall Study|Missing Termination Reason|0|||
170432357|NCT02125461|615923786|FG001|Overall Study|Missing Termination Reason|1|||
170432358|NCT03552484|615923794|FG000|Overall Study|Death|6|||
170432359|NCT03552484|615923795|FG001|Overall Study|Death|4|||
170432360|NCT03552484|615923794|FG000|Overall Study|Lost to Follow-up|0|||
170432361|NCT03552484|615923795|FG001|Overall Study|Lost to Follow-up|16|||
170432362|NCT02241551|615923796|FG000|Overall Study|Adverse Event|1|||
170432363|NCT02241551|615923797|FG001|Overall Study|Adverse Event|0|||
170432364|NCT03499353|615923798|FG000|Treatment|Adverse Event|3|||
170432365|NCT03499353|615923798|FG000|Treatment|Progressive Disease|10|||
170432366|NCT03499353|615923798|FG000|Treatment|Other|1|||
170432367|NCT03499353|615923798|FG000|Treatment|Withdrawal by Subject|2|||
170432368|NCT03499353|615923798|FG000|Long-Term Follow-up|Death|2|||
170432369|NCT03499353|615923798|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
170535861|NCT00689936|616307908|FG000|Active Treatment Phase|Disease Progression|273|||
170535862|NCT00689936|616307909|FG001|Active Treatment Phase|Disease Progression|362|||
170535863|NCT00689936|616307910|FG002|Active Treatment Phase|Disease Progression|339|||
170535864|NCT00689936|616307908|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
170432370|NCT03499353|615923798|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
170535865|NCT00689936|616307909|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
170535866|NCT00689936|616307910|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
170535867|NCT00689936|616307908|FG000|Active Treatment Phase|Death|60|||
170535868|NCT00689936|616307909|FG001|Active Treatment Phase|Death|28|||
170535869|NCT00689936|616307910|FG002|Active Treatment Phase|Death|37|||
170535870|NCT00689936|616307908|FG000|Active Treatment Phase|Lost to Follow-up|0|||
170535871|NCT00689936|616307909|FG001|Active Treatment Phase|Lost to Follow-up|2|||
170535872|NCT00689936|616307910|FG002|Active Treatment Phase|Lost to Follow-up|2|||
170432371|NCT00469898|615923810|FG000|Overall Study|Adverse Event|7|||
170432372|NCT00469898|615923810|FG000|Overall Study|Withdrawal by Subject|4|||
170432373|NCT00469898|615923810|FG000|Overall Study|Death|4|||
170535873|NCT00689936|616307908|FG000|Active Treatment Phase|Protocol Violation|2|||
170535874|NCT00689936|616307909|FG001|Active Treatment Phase|Protocol Violation|2|||
170535875|NCT00689936|616307910|FG002|Active Treatment Phase|Protocol Violation|4|||
170535876|NCT00689936|616307908|FG000|Active Treatment Phase|Study Close Out|64|||
170432374|NCT00469898|615923810|FG000|Overall Study|Disease progression|9|||
170632736|NCT04672239|616666761|FG000|Week 2 Survey|Partially completed survey|7|||
170432375|NCT00469898|615923810|FG000|Overall Study|Decreased performance status|1|||
170432376|NCT01205035|615923813|FG000|Overall Study|Withdrawal by Subject|1|||
170432377|NCT01205035|615923814|FG001|Overall Study|Withdrawal by Subject|0|||
170432378|NCT01205035|615923813|FG000|Overall Study|Physician Decision|1|||
170432379|NCT01205035|615923814|FG001|Overall Study|Physician Decision|0|||
170432380|NCT02663349|615923815|FG000|Overall Study|Withdrawal by Subject|6|||
170432381|NCT00928057|615923816|FG000|Overall Study|Adverse Event|1|||
170432382|NCT00928057|615923817|FG001|Overall Study|Adverse Event|2|||
170432383|NCT00928057|615923816|FG000|Overall Study|Withdrawal by Subject|1|||
170432384|NCT00928057|615923817|FG001|Overall Study|Withdrawal by Subject|0|||
170432385|NCT00928057|615923816|FG000|Overall Study|Lost to Follow-up|0|||
170432386|NCT00928057|615923817|FG001|Overall Study|Lost to Follow-up|1|||
170432387|NCT00928057|615923816|FG000|Overall Study|Protocol Violation|0|||
170432388|NCT00928057|615923817|FG001|Overall Study|Protocol Violation|1|||
170432389|NCT01572662|615923827|FG000|Overall Study|Withdrawal by Subject|1|||
170432390|NCT01572662|615923828|FG001|Overall Study|Withdrawal by Subject|0|||
170432391|NCT01572662|615923827|FG000|Overall Study|Physician Decision|0|||
170432392|NCT01572662|615923828|FG001|Overall Study|Physician Decision|1|||
170432393|NCT01535222|615923829|FG000|Overall Study|Inclusion/exclusion|0|||
170432394|NCT01535222|615923830|FG001|Overall Study|Inclusion/exclusion|0|||
170432395|NCT01535222|615923831|FG002|Overall Study|Inclusion/exclusion|1|||
170432396|NCT01535222|615923832|FG003|Overall Study|Inclusion/exclusion|0|||
170432397|NCT01535222|615923833|FG004|Overall Study|Inclusion/exclusion|0|||
170432398|NCT01535222|615923834|FG005|Overall Study|Inclusion/exclusion|0|||
170432399|NCT00935012|615923835|FG000|Overall Study|Death|19|||
170432400|NCT00935012|615923835|FG000|Overall Study|Withdrawal by Subject|3|||
170432401|NCT00935012|615923835|FG000|Overall Study|Other|5|||
170432402|NCT00935012|615923835|FG000|Overall Study|Adverse Event|2|||
170432403|NCT01442155|615923836|FG000|Overall Study|Complete remission|35|||
170432404|NCT01442155|615923836|FG000|Overall Study|Recurrence|26|||
170432405|NCT01442155|615923836|FG000|Overall Study|Adverse Event|2|||
170432406|NCT01442155|615923836|FG000|Overall Study|Lost to Follow-up|2|||
170432407|NCT01590563|615923839|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
170432408|NCT03534193|615923842|FG000|Overall Study|Lost to Follow-up|1|||
170432409|NCT03534193|615923843|FG001|Overall Study|Lost to Follow-up|3|||
170432410|NCT01370733|615923845|FG000|Overall Study|Withdrawal by Subject|8|||
170432411|NCT01370733|615923846|FG001|Overall Study|Withdrawal by Subject|8|||
170432412|NCT01370733|615923845|FG000|Overall Study|Lost to Follow-up|3|||
170432413|NCT01370733|615923846|FG001|Overall Study|Lost to Follow-up|0|||
170432414|NCT01370733|615923845|FG000|Overall Study|Adverse Event|2|||
170432415|NCT01370733|615923846|FG001|Overall Study|Adverse Event|4|||
170432416|NCT01370733|615923845|FG000|Overall Study|Lack of Efficacy|3|||
170432417|NCT01370733|615923846|FG001|Overall Study|Lack of Efficacy|5|||
170432418|NCT01370733|615923845|FG000|Overall Study|Physician Decision|0|||
170432419|NCT01370733|615923846|FG001|Overall Study|Physician Decision|2|||
170432420|NCT01370733|615923845|FG000|Overall Study|Protocol Violation|1|||
170432421|NCT01370733|615923846|FG001|Overall Study|Protocol Violation|3|||
170432422|NCT01484912|615923849|FG000|Overall Study|Withdrawal by Subject|1|||
170432423|NCT01484912|615923850|FG001|Overall Study|Withdrawal by Subject|0|||
170535877|NCT00689936|616307909|FG001|Active Treatment Phase|Study Close Out|26|||
170535878|NCT00689936|616307910|FG002|Active Treatment Phase|Study Close Out|21|||
170535879|NCT00689936|616307908|FG000|Active Treatment Phase|Miscellaneous|52|||
170535880|NCT00689936|616307909|FG001|Active Treatment Phase|Miscellaneous|34|||
170535881|NCT00689936|616307910|FG002|Active Treatment Phase|Miscellaneous|47|||
170535882|NCT00689936|616307908|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
170535883|NCT00689936|616307909|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
170535884|NCT00689936|616307910|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
170535885|NCT00933933|616307912|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
170535886|NCT00933933|616307913|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
170535887|NCT00933933|616307914|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
170535888|NCT00933933|616307912|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
170535889|NCT00933933|616307913|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
170535890|NCT00933933|616307914|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
170535891|NCT01995201|616307917|FG000|From Baseline Until Week 24|Adverse Event|4|||
170535892|NCT01995201|616307918|FG001|From Baseline Until Week 24|Adverse Event|15|||
170535893|NCT01995201|616307919|FG002|From Baseline Until Week 24|Adverse Event|0|||
170535894|NCT01995201|616307920|FG003|From Baseline Until Week 24|Adverse Event|0|||
170535895|NCT01995201|616307921|FG004|From Baseline Until Week 24|Adverse Event|0|||
170535896|NCT01995201|616307922|FG005|From Baseline Until Week 24|Adverse Event|0|||
170778810|NCT03398148|617197294|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170432424|NCT01484912|615923849|FG000|Overall Study|Physician Decision|0|||
170432425|NCT01484912|615923850|FG001|Overall Study|Physician Decision|1|||
170432426|NCT00829712|615923851|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
170432427|NCT00829712|615923852|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
170432428|NCT04128761|615923853|FG000|Overall Study|Lost to Follow-up|5|||
170432429|NCT04128761|615923854|FG001|Overall Study|Lost to Follow-up|6|||
170432430|NCT01188681|615923857|FG000|Overall Study|bladder cancer|0|||
170432431|NCT01188681|615923858|FG001|Overall Study|bladder cancer|0|||
170432432|NCT01188681|615923859|FG002|Overall Study|bladder cancer|1|||
170432433|NCT01188681|615923860|FG003|Overall Study|bladder cancer|0|||
170535897|NCT01995201|616307923|FG006|From Baseline Until Week 24|Adverse Event|0|||
170535898|NCT01995201|616307917|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
170565476|NCT01049373|616418531|FG000|Overall Study|Withdrawal by Subject|8|||
170880705|NCT05121480|617574351|FG003|Overall Study|Lack of Efficacy|4|||
170432434|NCT01188681|615923857|FG000|Overall Study|Withdrawal by Subject|0|||
170432435|NCT01188681|615923858|FG001|Overall Study|Withdrawal by Subject|0|||
170535899|NCT01995201|616307918|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
170535900|NCT01995201|616307919|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
170432436|NCT01188681|615923859|FG002|Overall Study|Withdrawal by Subject|0|||
170432437|NCT01188681|615923860|FG003|Overall Study|Withdrawal by Subject|1|||
170432438|NCT00700739|615923870|FG000|Overall Study|Lost to Follow-up|4|||
170432439|NCT00700739|615923871|FG001|Overall Study|Lost to Follow-up|4|||
170432440|NCT01316055|615923875|FG000|Overall Study|Lost to Follow-up|1|||
170432441|NCT01316055|615923876|FG001|Overall Study|Lost to Follow-up|0|||
170432442|NCT01316055|615923877|FG002|Overall Study|Lost to Follow-up|0|||
170432443|NCT00003470|615923878|FG000|Overall Study|Not evaluable|6|||
170432444|NCT00185458|615923879|FG000|Contraception Phase|Adverse Event|37|||
170432445|NCT00185458|615923879|FG000|Contraception Phase|Lost to Follow-up|10|||
170432446|NCT00185458|615923879|FG000|Contraception Phase|Protocol Violation|2|||
170432447|NCT00185458|615923879|FG000|Contraception Phase|Physician Decision|2|||
170432448|NCT00185458|615923879|FG000|Contraception Phase|Withdrawal by Subject|7|||
170432449|NCT00185458|615923879|FG000|HRT Phase|Adverse Event|18|||
170432450|NCT00185458|615923879|FG000|HRT Phase|Lost to Follow-up|4|||
170432451|NCT00185458|615923879|FG000|HRT Phase|Protocol Violation|2|||
170432452|NCT00185458|615923879|FG000|HRT Phase|Withdrawal by Subject|3|||
170432453|NCT00835536|615923884|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
170432454|NCT00835536|615923885|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
170432455|NCT01794845|615923886|FG000|Overall Study|Withdrawal by Subject|1|||
170432456|NCT00830024|615923889|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
170432457|NCT00830024|615923890|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
170432458|NCT00424047|615923891|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
170432459|NCT00424047|615923892|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
170432460|NCT00424047|615923891|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
170432461|NCT00424047|615923892|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
170432462|NCT00424047|615923891|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
170432463|NCT00424047|615923892|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
170432464|NCT00424047|615923891|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
170432465|NCT00424047|615923892|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
170432466|NCT00424047|615923891|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
170432467|NCT00424047|615923892|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
170432468|NCT00424047|615923891|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
170432469|NCT00424047|615923892|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
170432470|NCT00424047|615923891|FG000|On Study at Time of Unblinding|Adverse Event|22|||
170432471|NCT00424047|615923892|FG001|On Study at Time of Unblinding|Adverse Event|12|||
170432472|NCT00424047|615923891|FG000|On Study at Time of Unblinding|Progression of disease|92|||
170432473|NCT00424047|615923892|FG001|On Study at Time of Unblinding|Progression of disease|128|||
170432474|NCT00424047|615923891|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
170432475|NCT00424047|615923892|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
170432476|NCT00424047|615923891|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
170432477|NCT00424047|615923892|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
170432478|NCT00424047|615923891|FG000|On Study at Time of Unblinding|Death|11|||
170432479|NCT00424047|615923892|FG001|On Study at Time of Unblinding|Death|11|||
170432480|NCT00424047|615923891|FG000|On Study at Time of Unblinding|Other|5|||
170432481|NCT00424047|615923892|FG001|On Study at Time of Unblinding|Other|4|||
170432482|NCT00424047|615923891|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
170535901|NCT01995201|616307920|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
170535902|NCT01995201|616307921|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
170535903|NCT01995201|616307922|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
170535904|NCT01995201|616307923|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
170778811|NCT03398148|617197295|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778812|NCT03398148|617197296|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778813|NCT03398148|617197297|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778814|NCT03398148|617197298|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
170778815|NCT03398148|617197299|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778816|NCT03398148|617197300|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778817|NCT03398148|617197301|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778818|NCT03398148|617197302|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
170778819|NCT03398148|617197288|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170432483|NCT00424047|615923892|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
170535905|NCT01995201|616307917|FG000|From Baseline Until Week 24|Death|0|||
170535906|NCT01995201|616307918|FG001|From Baseline Until Week 24|Death|1|||
170778820|NCT03398148|617197289|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170880706|NCT05121480|617574352|FG004|Overall Study|Lack of Efficacy|0|||
170432484|NCT00424047|615923891|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
170432485|NCT00424047|615923892|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
170432486|NCT00424047|615923891|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
170432487|NCT00424047|615923892|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
170432488|NCT00424047|615923891|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
170432489|NCT00424047|615923892|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
170432490|NCT00424047|615923891|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
170432491|NCT00424047|615923892|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
170432492|NCT01229150|615923895|FG000|Overall Study|Toxicity|2|||
170432493|NCT01229150|615923896|FG001|Overall Study|Toxicity|2|||
170432494|NCT01229150|615923897|FG002|Overall Study|Toxicity|0|||
170432495|NCT01229150|615923898|FG003|Overall Study|Toxicity|0|||
170432496|NCT05248204|615923899|FG000|Overall Study|Lost to Follow-up|13|||
170432497|NCT05248204|615923900|FG001|Overall Study|Lost to Follow-up|13|||
170432498|NCT05248204|615923899|FG000|Overall Study|Protocol Violation|1|||
170432499|NCT05248204|615923900|FG001|Overall Study|Protocol Violation|0|||
170432500|NCT00312897|615923901|FG000|Overall Study|Adverse Event|1|||
170432501|NCT00312897|615923902|FG001|Overall Study|Adverse Event|0|||
170432502|NCT00312897|615923901|FG000|Overall Study|Lost to Follow-up|2|||
170432503|NCT00312897|615923902|FG001|Overall Study|Lost to Follow-up|0|||
170432504|NCT00312897|615923901|FG000|Overall Study|Physician Decision|1|||
170432505|NCT00312897|615923902|FG001|Overall Study|Physician Decision|0|||
170432506|NCT00312897|615923901|FG000|Overall Study|Withdrawal by Subject|1|||
170432507|NCT00312897|615923902|FG001|Overall Study|Withdrawal by Subject|3|||
170432508|NCT00312897|615923901|FG000|Overall Study|Pregnancy|1|||
170432509|NCT00312897|615923902|FG001|Overall Study|Pregnancy|0|||
170432510|NCT00312897|615923901|FG000|Overall Study|discontinued prior to getting treatment|0|||
170432511|NCT00312897|615923902|FG001|Overall Study|discontinued prior to getting treatment|3|||
170432512|NCT03100344|615923903|FG000|Overall Study|Adverse Event|0|||
170432513|NCT03100344|615923904|FG001|Overall Study|Adverse Event|3|||
170432514|NCT03100344|615923905|FG002|Overall Study|Adverse Event|2|||
170432515|NCT03100344|615923906|FG003|Overall Study|Adverse Event|3|||
170432516|NCT03100344|615923903|FG000|Overall Study|Lack of Efficacy|2|||
170432517|NCT03100344|615923904|FG001|Overall Study|Lack of Efficacy|0|||
170432518|NCT03100344|615923905|FG002|Overall Study|Lack of Efficacy|0|||
170432519|NCT03100344|615923906|FG003|Overall Study|Lack of Efficacy|0|||
170432520|NCT03100344|615923903|FG000|Overall Study|Protocol Violation|1|||
170432521|NCT03100344|615923904|FG001|Overall Study|Protocol Violation|0|||
170432522|NCT03100344|615923905|FG002|Overall Study|Protocol Violation|0|||
170432523|NCT03100344|615923906|FG003|Overall Study|Protocol Violation|0|||
170432524|NCT03100344|615923903|FG000|Overall Study|Withdrawal by Subject|10|||
170432525|NCT03100344|615923904|FG001|Overall Study|Withdrawal by Subject|7|||
170432526|NCT03100344|615923905|FG002|Overall Study|Withdrawal by Subject|4|||
170432527|NCT03100344|615923906|FG003|Overall Study|Withdrawal by Subject|8|||
170432528|NCT03100344|615923903|FG000|Overall Study|Lost to Follow-up|1|||
170432529|NCT03100344|615923904|FG001|Overall Study|Lost to Follow-up|1|||
170432530|NCT03100344|615923905|FG002|Overall Study|Lost to Follow-up|1|||
170778821|NCT03398148|617197290|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778822|NCT03398148|617197291|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778823|NCT03398148|617197292|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778824|NCT03398148|617197293|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778825|NCT03398148|617197294|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778826|NCT03398148|617197295|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778827|NCT03398148|617197296|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778828|NCT03398148|617197297|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778829|NCT03398148|617197298|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
170778830|NCT03398148|617197299|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778831|NCT03398148|617197300|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778832|NCT03398148|617197301|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778833|NCT03398148|617197302|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
170778834|NCT03398148|617197288|FG000|Substudy 2 Period 1|Other|0|||
170778835|NCT03398148|617197289|FG001|Substudy 2 Period 1|Other|0|||
170778836|NCT03398148|617197290|FG002|Substudy 2 Period 1|Other|0|||
170778837|NCT03398148|617197291|FG003|Substudy 2 Period 1|Other|0|||
170432531|NCT03100344|615923906|FG003|Overall Study|Lost to Follow-up|1|||
170432532|NCT01010503|615923907|FG000|Overall Study|Adverse Event|1|||
170432533|NCT01010503|615923907|FG000|Overall Study|Death|1|||
170432534|NCT01154231|615923912|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
170432535|NCT01154231|615923912|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
170778838|NCT03398148|617197292|FG004|Substudy 2 Period 1|Other|0|||
170778839|NCT03398148|617197293|FG005|Substudy 2 Period 1|Other|0|||
170778840|NCT03398148|617197294|FG006|Substudy 2 Period 1|Other|0|||
170432536|NCT01963728|615923913|FG000|Overall Study|Study terminated early|0|||
170432537|NCT01963728|615923914|FG001|Overall Study|Study terminated early|1|||
170432538|NCT03599193|615925682|FG000|Overall Study|Adverse Event|0|||
170432539|NCT03599193|615925683|FG001|Overall Study|Adverse Event|2|||
170432540|NCT03599193|615925682|FG000|Overall Study|Withdrawal by Subject|1|||
170432541|NCT03599193|615925683|FG001|Overall Study|Withdrawal by Subject|0|||
170432542|NCT03599193|615925682|FG000|Overall Study|Protocol Violation|1|||
170432543|NCT03599193|615925683|FG001|Overall Study|Protocol Violation|0|||
170432544|NCT03599193|615925682|FG000|Overall Study|Lost to Follow-up|0|||
170432545|NCT03599193|615925683|FG001|Overall Study|Lost to Follow-up|1|||
170432546|NCT00835705|615925684|FG000|First Intervention|Difficulty with vein|1|||
170778841|NCT03398148|617197295|FG007|Substudy 2 Period 1|Other|0|||
170778842|NCT03398148|617197296|FG008|Substudy 2 Period 1|Other|0|||
170778843|NCT03398148|617197297|FG009|Substudy 2 Period 1|Other|4|||
170778844|NCT03398148|617197298|FG010|Substudy 2 Period 1|Other|4|||
170778845|NCT03398148|617197299|FG011|Substudy 2 Period 1|Other|0|||
170778846|NCT03398148|617197300|FG012|Substudy 2 Period 1|Other|0|||
170778847|NCT03398148|617197301|FG013|Substudy 2 Period 1|Other|0|||
170778848|NCT03398148|617197302|FG014|Substudy 2 Period 1|Other|0|||
170778849|NCT03398148|617197288|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778850|NCT03398148|617197289|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778851|NCT03398148|617197290|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778852|NCT03398148|617197291|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778853|NCT03398148|617197292|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778854|NCT03398148|617197293|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778855|NCT03398148|617197294|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778856|NCT03398148|617197295|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778857|NCT03398148|617197296|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778858|NCT03398148|617197297|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778859|NCT03398148|617197298|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
170778860|NCT03398148|617197299|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778861|NCT03398148|617197300|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778862|NCT03398148|617197301|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
170880707|NCT05121480|617574353|FG005|Overall Study|Lack of Efficacy|1|||
170880708|NCT05121480|617574354|FG006|Overall Study|Lack of Efficacy|0|||
170880709|NCT05121480|617574355|FG007|Overall Study|Lack of Efficacy|2|||
170880710|NCT05121480|617574348|FG000|Overall Study|Treatment Failure|0|||
170880711|NCT05121480|617574349|FG001|Overall Study|Treatment Failure|2|||
170880712|NCT05121480|617574350|FG002|Overall Study|Treatment Failure|0|||
170880713|NCT05121480|617574351|FG003|Overall Study|Treatment Failure|1|||
170880714|NCT05121480|617574352|FG004|Overall Study|Treatment Failure|0|||
170880715|NCT05121480|617574353|FG005|Overall Study|Treatment Failure|0|||
170880716|NCT05121480|617574354|FG006|Overall Study|Treatment Failure|0|||
170880717|NCT05121480|617574355|FG007|Overall Study|Treatment Failure|0|||
170880718|NCT05121480|617574348|FG000|Overall Study|Adverse Event|0|||
170880719|NCT05121480|617574349|FG001|Overall Study|Adverse Event|1|||
170880720|NCT05121480|617574350|FG002|Overall Study|Adverse Event|0|||
170880721|NCT05121480|617574351|FG003|Overall Study|Adverse Event|5|||
170880722|NCT05121480|617574352|FG004|Overall Study|Adverse Event|3|||
170880723|NCT05121480|617574353|FG005|Overall Study|Adverse Event|2|||
170880724|NCT05121480|617574354|FG006|Overall Study|Adverse Event|0|||
170880725|NCT05121480|617574355|FG007|Overall Study|Adverse Event|4|||
170880726|NCT05121480|617574348|FG000|Overall Study|Withdrawal by Subject|4|||
170880727|NCT05121480|617574349|FG001|Overall Study|Withdrawal by Subject|9|||
170880728|NCT05121480|617574350|FG002|Overall Study|Withdrawal by Subject|1|||
170880729|NCT05121480|617574351|FG003|Overall Study|Withdrawal by Subject|8|||
170880730|NCT05121480|617574352|FG004|Overall Study|Withdrawal by Subject|0|||
170880731|NCT05121480|617574353|FG005|Overall Study|Withdrawal by Subject|9|||
170880732|NCT05121480|617574354|FG006|Overall Study|Withdrawal by Subject|0|||
170880733|NCT05121480|617574355|FG007|Overall Study|Withdrawal by Subject|4|||
170880734|NCT05121480|617574348|FG000|Overall Study|Non-compliance with the protocol|0|||
170880735|NCT05121480|617574349|FG001|Overall Study|Non-compliance with the protocol|0|||
170880736|NCT05121480|617574350|FG002|Overall Study|Non-compliance with the protocol|0|||
170880737|NCT05121480|617574351|FG003|Overall Study|Non-compliance with the protocol|0|||
170880738|NCT05121480|617574352|FG004|Overall Study|Non-compliance with the protocol|1|||
170880739|NCT05121480|617574353|FG005|Overall Study|Non-compliance with the protocol|6|||
170880740|NCT05121480|617574354|FG006|Overall Study|Non-compliance with the protocol|0|||
170880741|NCT05121480|617574355|FG007|Overall Study|Non-compliance with the protocol|1|||
170880742|NCT05121480|617574348|FG000|Overall Study|Lost to Follow-up|0|||
170880743|NCT05121480|617574349|FG001|Overall Study|Lost to Follow-up|4|||
170880744|NCT05121480|617574350|FG002|Overall Study|Lost to Follow-up|1|||
170880745|NCT05121480|617574351|FG003|Overall Study|Lost to Follow-up|3|||
170880746|NCT05121480|617574352|FG004|Overall Study|Lost to Follow-up|1|||
170880747|NCT05121480|617574353|FG005|Overall Study|Lost to Follow-up|1|||
170432547|NCT00835705|615925685|FG001|First Intervention|Difficulty with vein|0|||
170778863|NCT03398148|617197302|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
170778864|NCT03398148|617197288|FG000|Substudy 2 Period 2|Adverse Event|0|||
170778865|NCT03398148|617197289|FG001|Substudy 2 Period 2|Adverse Event|0|||
170880748|NCT05121480|617574354|FG006|Overall Study|Lost to Follow-up|1|||
170880749|NCT05121480|617574355|FG007|Overall Study|Lost to Follow-up|4|||
170880750|NCT05121480|617574348|FG000|Overall Study|Physician Decision|0|||
170880751|NCT05121480|617574349|FG001|Overall Study|Physician Decision|0|||
170880752|NCT05121480|617574350|FG002|Overall Study|Physician Decision|0|||
170432548|NCT00835705|615925684|FG000|Second Intervention|Difficulty with vein|1|||
170432549|NCT00835705|615925685|FG001|Second Intervention|Difficulty with vein|0|||
170432550|NCT01116739|615925686|FG000|Overall Study|Child had 2 years of HS|110|||
170432551|NCT01116739|615925687|FG001|Overall Study|Child had 2 years of HS|128|||
170432552|NCT01116739|615925686|FG000|Overall Study|Withdrawal by Subject|6|||
170432553|NCT01116739|615925687|FG001|Overall Study|Withdrawal by Subject|0|||
170432554|NCT01116739|615925686|FG000|Overall Study|child too young|2|||
170432555|NCT01116739|615925687|FG001|Overall Study|child too young|6|||
170432556|NCT01116739|615925686|FG000|Overall Study|child not enrolled in head start|10|||
170432557|NCT01116739|615925687|FG001|Overall Study|child not enrolled in head start|2|||
170432558|NCT01116739|615925686|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
170432559|NCT01116739|615925687|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
170432560|NCT03676634|615925688|FG000|Overall Study|Red blood cell loss|1|||
170432561|NCT03676634|615925688|FG000|Overall Study|Out-of-limit pulse|2|||
170432562|NCT00909753|615925689|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
170432563|NCT00909753|615925690|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
170432564|NCT00909753|615925689|FG000|Period: Second Intervention|Protocol Violation|1|||
170432565|NCT00909753|615925690|FG001|Period: Second Intervention|Protocol Violation|0|||
170432566|NCT00205777|615925691|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
170432567|NCT00205777|615925692|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
170432568|NCT00205777|615925693|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
170432569|NCT00205777|615925694|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
170432570|NCT00205777|615925695|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
170432571|NCT00205777|615925696|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
170432572|NCT00205777|615925691|FG000|Core Study (Up to 3 Years)|Death|9|||
170432573|NCT00205777|615925692|FG001|Core Study (Up to 3 Years)|Death|7|||
170432574|NCT00205777|615925693|FG002|Core Study (Up to 3 Years)|Death|14|||
170432575|NCT00205777|615925694|FG003|Core Study (Up to 3 Years)|Death|7|||
170432576|NCT00205777|615925695|FG004|Core Study (Up to 3 Years)|Death|0|||
170432577|NCT00205777|615925696|FG005|Core Study (Up to 3 Years)|Death|0|||
170432578|NCT00205777|615925691|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
170432579|NCT00205777|615925692|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
170432580|NCT00205777|615925693|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
170432581|NCT00205777|615925694|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
170432582|NCT00205777|615925695|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
170432583|NCT00205777|615925696|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
170432584|NCT00205777|615925691|FG000|Core Study (Up to 3 Years)|Other Event|49|||
170432585|NCT00205777|615925692|FG001|Core Study (Up to 3 Years)|Other Event|52|||
170432586|NCT00205777|615925693|FG002|Core Study (Up to 3 Years)|Other Event|41|||
170432587|NCT00205777|615925694|FG003|Core Study (Up to 3 Years)|Other Event|58|||
170432588|NCT00205777|615925695|FG004|Core Study (Up to 3 Years)|Other Event|0|||
170432589|NCT00205777|615925696|FG005|Core Study (Up to 3 Years)|Other Event|0|||
170432590|NCT00205777|615925691|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
170432591|NCT00205777|615925692|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
170432592|NCT00205777|615925693|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
170432593|NCT00205777|615925694|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
170432594|NCT00205777|615925695|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
170432595|NCT00205777|615925696|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
170432596|NCT00205777|615925691|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
170432597|NCT00205777|615925692|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
170432598|NCT00205777|615925693|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
170432599|NCT00205777|615925694|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
170432600|NCT00205777|615925695|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
170432601|NCT00205777|615925696|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
170432602|NCT00205777|615925691|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
170432603|NCT00205777|615925692|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
170632737|NCT04672239|616666762|FG001|Week 2 Survey|Partially completed survey|1|||
170778866|NCT03398148|617197290|FG002|Substudy 2 Period 2|Adverse Event|0|||
170778867|NCT03398148|617197291|FG003|Substudy 2 Period 2|Adverse Event|0|||
170778868|NCT03398148|617197292|FG004|Substudy 2 Period 2|Adverse Event|0|||
170778869|NCT03398148|617197293|FG005|Substudy 2 Period 2|Adverse Event|0|||
170778870|NCT03398148|617197294|FG006|Substudy 2 Period 2|Adverse Event|0|||
170778871|NCT03398148|617197295|FG007|Substudy 2 Period 2|Adverse Event|0|||
170432604|NCT00205777|615925693|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
170432605|NCT00205777|615925694|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
170432606|NCT00205777|615925695|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
170432607|NCT00205777|615925696|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
170432608|NCT00205777|615925691|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
170432609|NCT00205777|615925692|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
170432610|NCT00205777|615925693|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
170432611|NCT00205777|615925694|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
170432612|NCT00205777|615925695|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
170778872|NCT03398148|617197296|FG008|Substudy 2 Period 2|Adverse Event|0|||
170778873|NCT03398148|617197297|FG009|Substudy 2 Period 2|Adverse Event|0|||
170432613|NCT00205777|615925696|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
170432614|NCT00205777|615925691|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
170432615|NCT00205777|615925692|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
170432616|NCT00205777|615925693|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
170432617|NCT00205777|615925694|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
170432618|NCT00205777|615925695|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
170432619|NCT00205777|615925696|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
170432620|NCT00205777|615925691|FG000|Completed Core Study, Entered SE I|Other Event|52|||
170432621|NCT00205777|615925692|FG001|Completed Core Study, Entered SE I|Other Event|46|||
170432622|NCT00205777|615925693|FG002|Completed Core Study, Entered SE I|Other Event|47|||
170432623|NCT00205777|615925694|FG003|Completed Core Study, Entered SE I|Other Event|50|||
170432624|NCT00205777|615925695|FG004|Completed Core Study, Entered SE I|Other Event|0|||
170432625|NCT00205777|615925696|FG005|Completed Core Study, Entered SE I|Other Event|0|||
170432626|NCT00205777|615925691|FG000|Study Extension I|Adverse Event|57|||
170432627|NCT00205777|615925692|FG001|Study Extension I|Adverse Event|0|||
170432628|NCT00205777|615925693|FG002|Study Extension I|Adverse Event|0|||
170432629|NCT00205777|615925694|FG003|Study Extension I|Adverse Event|61|||
170432630|NCT00205777|615925695|FG004|Study Extension I|Adverse Event|58|||
170432631|NCT00205777|615925696|FG005|Study Extension I|Adverse Event|0|||
170432632|NCT00205777|615925691|FG000|Study Extension I|Death|5|||
170432633|NCT00205777|615925692|FG001|Study Extension I|Death|0|||
170432634|NCT00205777|615925693|FG002|Study Extension I|Death|0|||
170432635|NCT00205777|615925694|FG003|Study Extension I|Death|1|||
170432636|NCT00205777|615925695|FG004|Study Extension I|Death|2|||
170432637|NCT00205777|615925696|FG005|Study Extension I|Death|0|||
170432638|NCT00205777|615925691|FG000|Study Extension I|Withdrawal by Subject|99|||
170432639|NCT00205777|615925692|FG001|Study Extension I|Withdrawal by Subject|0|||
170432640|NCT00205777|615925693|FG002|Study Extension I|Withdrawal by Subject|0|||
170432641|NCT00205777|615925694|FG003|Study Extension I|Withdrawal by Subject|106|||
170432642|NCT00205777|615925695|FG004|Study Extension I|Withdrawal by Subject|89|||
170432643|NCT00205777|615925696|FG005|Study Extension I|Withdrawal by Subject|0|||
170432644|NCT00205777|615925691|FG000|Study Extension I|Protocol Violation|4|||
170432645|NCT00205777|615925692|FG001|Study Extension I|Protocol Violation|0|||
170432646|NCT00205777|615925693|FG002|Study Extension I|Protocol Violation|0|||
170432647|NCT00205777|615925694|FG003|Study Extension I|Protocol Violation|8|||
170432648|NCT00205777|615925695|FG004|Study Extension I|Protocol Violation|8|||
170432649|NCT00205777|615925696|FG005|Study Extension I|Protocol Violation|0|||
170432650|NCT00205777|615925691|FG000|Study Extension I|Lack of Efficacy|0|||
170432651|NCT00205777|615925692|FG001|Study Extension I|Lack of Efficacy|0|||
170432652|NCT00205777|615925693|FG002|Study Extension I|Lack of Efficacy|0|||
170432653|NCT00205777|615925694|FG003|Study Extension I|Lack of Efficacy|1|||
170432654|NCT00205777|615925695|FG004|Study Extension I|Lack of Efficacy|2|||
170432655|NCT00205777|615925696|FG005|Study Extension I|Lack of Efficacy|0|||
170432656|NCT00205777|615925691|FG000|Study Extension I|Failed to return|15|||
170432657|NCT00205777|615925692|FG001|Study Extension I|Failed to return|0|||
170432658|NCT00205777|615925693|FG002|Study Extension I|Failed to return|0|||
170432659|NCT00205777|615925694|FG003|Study Extension I|Failed to return|17|||
170632738|NCT04672239|616666763|FG002|Week 2 Survey|Partially completed survey|4|||
170880753|NCT05121480|617574351|FG003|Overall Study|Physician Decision|0|||
170880754|NCT05121480|617574352|FG004|Overall Study|Physician Decision|0|||
170880755|NCT05121480|617574353|FG005|Overall Study|Physician Decision|1|||
170432660|NCT00205777|615925695|FG004|Study Extension I|Failed to return|13|||
170432661|NCT00205777|615925696|FG005|Study Extension I|Failed to return|0|||
170432662|NCT00205777|615925691|FG000|Study Extension I|Other Event|34|||
170432663|NCT00205777|615925692|FG001|Study Extension I|Other Event|0|||
170432664|NCT00205777|615925693|FG002|Study Extension I|Other Event|0|||
170432665|NCT00205777|615925694|FG003|Study Extension I|Other Event|34|||
170432666|NCT00205777|615925695|FG004|Study Extension I|Other Event|29|||
170432667|NCT00205777|615925696|FG005|Study Extension I|Other Event|0|||
170432668|NCT00205777|615925691|FG000|Study Extension I|Withdrawn as per protocol|0|||
170432669|NCT00205777|615925692|FG001|Study Extension I|Withdrawn as per protocol|0|||
170432670|NCT00205777|615925693|FG002|Study Extension I|Withdrawn as per protocol|1070|||
170432671|NCT00205777|615925694|FG003|Study Extension I|Withdrawn as per protocol|0|||
170432672|NCT00205777|615925695|FG004|Study Extension I|Withdrawn as per protocol|0|||
170432673|NCT00205777|615925696|FG005|Study Extension I|Withdrawn as per protocol|0|||
170432674|NCT00205777|615925691|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
170432675|NCT00205777|615925692|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
170432676|NCT00205777|615925693|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
170432677|NCT00205777|615925694|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
170432678|NCT00205777|615925695|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
170432679|NCT00205777|615925696|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
170880756|NCT05121480|617574354|FG006|Overall Study|Physician Decision|0|||
170880757|NCT05121480|617574355|FG007|Overall Study|Physician Decision|1|||
170432680|NCT00205777|615925691|FG000|Study Extension II|Adverse Event|0|||
170432681|NCT00205777|615925692|FG001|Study Extension II|Adverse Event|0|||
170432682|NCT00205777|615925693|FG002|Study Extension II|Adverse Event|0|||
170432683|NCT00205777|615925694|FG003|Study Extension II|Adverse Event|14|||
170432684|NCT00205777|615925695|FG004|Study Extension II|Adverse Event|0|||
170432685|NCT00205777|615925696|FG005|Study Extension II|Adverse Event|30|||
170432686|NCT00205777|615925691|FG000|Study Extension II|Death|0|||
170432687|NCT00205777|615925692|FG001|Study Extension II|Death|0|||
170432688|NCT00205777|615925693|FG002|Study Extension II|Death|0|||
170432689|NCT00205777|615925694|FG003|Study Extension II|Death|2|||
170432690|NCT00205777|615925695|FG004|Study Extension II|Death|0|||
170432691|NCT00205777|615925696|FG005|Study Extension II|Death|5|||
170432692|NCT00205777|615925691|FG000|Study Extension II|Withdrawal by Subject|0|||
170432693|NCT00205777|615925692|FG001|Study Extension II|Withdrawal by Subject|0|||
170432694|NCT00205777|615925693|FG002|Study Extension II|Withdrawal by Subject|0|||
170432695|NCT00205777|615925694|FG003|Study Extension II|Withdrawal by Subject|35|||
170432696|NCT00205777|615925695|FG004|Study Extension II|Withdrawal by Subject|0|||
170778874|NCT03398148|617197298|FG010|Substudy 2 Period 2|Adverse Event|0|||
170778875|NCT03398148|617197299|FG011|Substudy 2 Period 2|Adverse Event|0|||
170778876|NCT03398148|617197300|FG012|Substudy 2 Period 2|Adverse Event|0|||
170432697|NCT00205777|615925696|FG005|Study Extension II|Withdrawal by Subject|59|||
170432698|NCT00205777|615925691|FG000|Study Extension II|Protocol Violation|0|||
170432699|NCT00205777|615925692|FG001|Study Extension II|Protocol Violation|0|||
170432700|NCT00205777|615925693|FG002|Study Extension II|Protocol Violation|0|||
170432701|NCT00205777|615925694|FG003|Study Extension II|Protocol Violation|1|||
170432702|NCT00205777|615925695|FG004|Study Extension II|Protocol Violation|0|||
170432703|NCT00205777|615925696|FG005|Study Extension II|Protocol Violation|10|||
170432704|NCT00205777|615925691|FG000|Study Extension II|Lack of Efficacy|0|||
170432705|NCT00205777|615925692|FG001|Study Extension II|Lack of Efficacy|0|||
170432706|NCT00205777|615925693|FG002|Study Extension II|Lack of Efficacy|0|||
170432707|NCT00205777|615925694|FG003|Study Extension II|Lack of Efficacy|0|||
170432708|NCT00205777|615925695|FG004|Study Extension II|Lack of Efficacy|0|||
170432709|NCT00205777|615925696|FG005|Study Extension II|Lack of Efficacy|1|||
170432710|NCT00205777|615925691|FG000|Study Extension II|Failed to return|0|||
170432711|NCT00205777|615925692|FG001|Study Extension II|Failed to return|0|||
170432712|NCT00205777|615925693|FG002|Study Extension II|Failed to return|0|||
170432713|NCT00205777|615925694|FG003|Study Extension II|Failed to return|14|||
170432714|NCT00205777|615925695|FG004|Study Extension II|Failed to return|0|||
170432715|NCT00205777|615925696|FG005|Study Extension II|Failed to return|26|||
170432716|NCT00205777|615925691|FG000|Study Extension II|Other Event|0|||
170432717|NCT00205777|615925692|FG001|Study Extension II|Other Event|0|||
170432718|NCT00205777|615925693|FG002|Study Extension II|Other Event|0|||
170432719|NCT00205777|615925694|FG003|Study Extension II|Other Event|12|||
170432720|NCT00205777|615925695|FG004|Study Extension II|Other Event|0|||
170432721|NCT00205777|615925696|FG005|Study Extension II|Other Event|20|||
170432722|NCT00205777|615925691|FG000|Study Extension II|Enrolled but not treated|0|||
170432723|NCT00205777|615925692|FG001|Study Extension II|Enrolled but not treated|0|||
170432724|NCT00205777|615925693|FG002|Study Extension II|Enrolled but not treated|0|||
170778877|NCT03398148|617197301|FG013|Substudy 2 Period 2|Adverse Event|1|||
170778878|NCT03398148|617197302|FG014|Substudy 2 Period 2|Adverse Event|3|||
170432725|NCT00205777|615925694|FG003|Study Extension II|Enrolled but not treated|71|||
170432726|NCT00205777|615925695|FG004|Study Extension II|Enrolled but not treated|0|||
170432727|NCT00205777|615925696|FG005|Study Extension II|Enrolled but not treated|131|||
170432728|NCT02462837|615925697|FG000|Overall Study|pt developed hives|1|||
170432729|NCT02462837|615925698|FG001|Overall Study|pt developed hives|0|||
170432730|NCT02462837|615925697|FG000|Overall Study|Withdrawal by Subject|1|||
170432731|NCT02462837|615925698|FG001|Overall Study|Withdrawal by Subject|0|||
170432732|NCT02679729|615925703|FG000|Overall Study|Lost to Follow-up|0|||
170432733|NCT02679729|615925704|FG001|Overall Study|Lost to Follow-up|1|||
170432734|NCT02679729|615925705|FG002|Overall Study|Lost to Follow-up|0|||
170432735|NCT02679729|615925706|FG003|Overall Study|Lost to Follow-up|0|||
170432736|NCT02679729|615925707|FG004|Overall Study|Lost to Follow-up|1|||
170432737|NCT02679729|615925708|FG005|Overall Study|Lost to Follow-up|0|||
170432738|NCT02679729|615925709|FG006|Overall Study|Lost to Follow-up|0|||
170432739|NCT02679729|615925710|FG007|Overall Study|Lost to Follow-up|0|||
170432740|NCT02679729|615925711|FG008|Overall Study|Lost to Follow-up|0|||
170432741|NCT02679729|615925703|FG000|Overall Study|Participant decision|0|||
170432742|NCT02679729|615925704|FG001|Overall Study|Participant decision|1|||
170432743|NCT02679729|615925705|FG002|Overall Study|Participant decision|0|||
170432744|NCT02679729|615925706|FG003|Overall Study|Participant decision|0|||
170432745|NCT02679729|615925707|FG004|Overall Study|Participant decision|0|||
170432746|NCT02679729|615925708|FG005|Overall Study|Participant decision|0|||
170432747|NCT02679729|615925709|FG006|Overall Study|Participant decision|1|||
170778879|NCT03398148|617197288|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
170778880|NCT03398148|617197289|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
170432748|NCT02679729|615925710|FG007|Overall Study|Participant decision|0|||
170432749|NCT02679729|615925711|FG008|Overall Study|Participant decision|0|||
170432750|NCT02139826|615925713|FG000|Overall Study|Adverse Event|1|||
170880758|NCT05121480|617574348|FG000|Overall Study|Other Reason|0|||
170880759|NCT05121480|617574349|FG001|Overall Study|Other Reason|0|||
170432751|NCT01559363|615925719|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
170432752|NCT01559363|615925720|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
170432753|NCT01559363|615925721|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
170432754|NCT01559363|615925722|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
170432755|NCT01559363|615925723|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
170432756|NCT01559363|615925724|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
170432757|NCT01559363|615925719|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
170432758|NCT01559363|615925720|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
170432759|NCT01559363|615925721|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
170432760|NCT01559363|615925722|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
170432761|NCT01559363|615925723|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
170432762|NCT01559363|615925724|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
170432763|NCT01559363|615925719|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
170432764|NCT01559363|615925720|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
170432765|NCT01559363|615925721|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
170432766|NCT01559363|615925722|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
170432767|NCT01559363|615925723|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
170432768|NCT01559363|615925724|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
170432769|NCT01559363|615925719|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
170432770|NCT01559363|615925720|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
170432771|NCT01559363|615925721|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
170432772|NCT01559363|615925722|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
170432773|NCT01559363|615925723|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
170432774|NCT01559363|615925724|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
170432775|NCT01559363|615925719|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
170432776|NCT01559363|615925720|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
170432777|NCT01559363|615925721|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
170432778|NCT01559363|615925722|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
170432779|NCT01559363|615925723|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
170432780|NCT01559363|615925724|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
170432781|NCT01559363|615925719|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
170432782|NCT01559363|615925720|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
170432783|NCT01559363|615925721|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
170432784|NCT01559363|615925722|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
170432785|NCT01559363|615925723|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
170432786|NCT01559363|615925724|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
170432787|NCT01559363|615925719|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
170432788|NCT01559363|615925720|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
170432789|NCT01559363|615925721|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
170432790|NCT01559363|615925722|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
170432791|NCT01559363|615925723|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
170432792|NCT01559363|615925724|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
170432793|NCT01004510|615925727|FG000|Overall Study|Adverse Event|1|||
170432794|NCT00112437|615925730|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
170432795|NCT00112437|615925731|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
170432796|NCT00112437|615925732|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
170432797|NCT00112437|615925733|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
170432798|NCT00112437|615925734|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
170432799|NCT00112437|615925735|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432800|NCT00112437|615925736|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432801|NCT00112437|615925737|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432802|NCT00112437|615925738|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432803|NCT00112437|615925739|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432804|NCT00112437|615925740|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432805|NCT00112437|615925741|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432806|NCT00112437|615925742|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432807|NCT00112437|615925743|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432808|NCT00112437|615925744|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432809|NCT00112437|615925745|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432810|NCT00112437|615925746|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432811|NCT00112437|615925747|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432812|NCT00112437|615925748|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432813|NCT00112437|615925749|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
170535907|NCT01995201|616307919|FG002|From Baseline Until Week 24|Death|0|||
170535908|NCT01995201|616307920|FG003|From Baseline Until Week 24|Death|0|||
170880760|NCT05121480|617574350|FG002|Overall Study|Other Reason|0|||
170535909|NCT01995201|616307921|FG004|From Baseline Until Week 24|Death|0|||
170432814|NCT00112437|615925750|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432815|NCT00112437|615925751|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432816|NCT00112437|615925752|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432817|NCT00112437|615925753|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432818|NCT00112437|615925754|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432819|NCT00112437|615925755|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
170432820|NCT00112437|615925730|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432821|NCT00112437|615925731|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
170432822|NCT00112437|615925732|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432823|NCT00112437|615925733|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432824|NCT00112437|615925734|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432825|NCT00112437|615925735|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432826|NCT00112437|615925736|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432827|NCT00112437|615925737|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432828|NCT00112437|615925738|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432829|NCT00112437|615925739|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432830|NCT00112437|615925740|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432831|NCT00112437|615925741|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432832|NCT00112437|615925742|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432833|NCT00112437|615925743|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432834|NCT00112437|615925744|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432835|NCT00112437|615925745|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432836|NCT00112437|615925746|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432837|NCT00112437|615925747|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432838|NCT00112437|615925748|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432839|NCT00112437|615925749|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432840|NCT00112437|615925750|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432841|NCT00112437|615925751|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432842|NCT00112437|615925752|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432843|NCT00112437|615925753|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432844|NCT00112437|615925754|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432845|NCT00112437|615925755|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
170432846|NCT00112437|615925730|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432847|NCT00112437|615925731|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
170432848|NCT00112437|615925732|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432849|NCT00112437|615925733|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432850|NCT00112437|615925734|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432851|NCT00112437|615925735|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432852|NCT00112437|615925736|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432853|NCT00112437|615925737|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432854|NCT00112437|615925738|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432855|NCT00112437|615925739|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432856|NCT00112437|615925740|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432857|NCT00112437|615925741|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432858|NCT00112437|615925742|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432859|NCT00112437|615925743|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432860|NCT00112437|615925744|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432861|NCT00112437|615925745|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432862|NCT00112437|615925746|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432863|NCT00112437|615925747|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432864|NCT00112437|615925748|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432865|NCT00112437|615925749|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432866|NCT00112437|615925750|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432867|NCT00112437|615925751|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432868|NCT00112437|615925752|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432869|NCT00112437|615925753|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432870|NCT00112437|615925754|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432871|NCT00112437|615925755|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
170432872|NCT00112437|615925730|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
170432873|NCT00112437|615925731|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432874|NCT00112437|615925732|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
170432875|NCT00112437|615925733|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
170432876|NCT00112437|615925734|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
170432877|NCT00112437|615925735|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432878|NCT00112437|615925736|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170535910|NCT01995201|616307922|FG005|From Baseline Until Week 24|Death|0|||
170432879|NCT00112437|615925737|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170535911|NCT01995201|616307923|FG006|From Baseline Until Week 24|Death|0|||
170432880|NCT00112437|615925738|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432881|NCT00112437|615925739|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432882|NCT00112437|615925740|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432883|NCT00112437|615925741|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432884|NCT00112437|615925742|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432885|NCT00112437|615925743|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432886|NCT00112437|615925744|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432887|NCT00112437|615925745|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432888|NCT00112437|615925746|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432889|NCT00112437|615925747|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432890|NCT00112437|615925748|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432891|NCT00112437|615925749|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432892|NCT00112437|615925750|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432893|NCT00112437|615925751|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432894|NCT00112437|615925752|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432895|NCT00112437|615925753|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432896|NCT00112437|615925754|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432897|NCT00112437|615925755|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
170432898|NCT00112437|615925730|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
170432899|NCT00112437|615925731|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
170432900|NCT00112437|615925732|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
170432901|NCT00112437|615925733|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
170432902|NCT00112437|615925734|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
170432903|NCT00112437|615925735|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432904|NCT00112437|615925736|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432905|NCT00112437|615925737|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432906|NCT00112437|615925738|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432907|NCT00112437|615925739|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432908|NCT00112437|615925740|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432909|NCT00112437|615925741|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432910|NCT00112437|615925742|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432911|NCT00112437|615925743|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432912|NCT00112437|615925744|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432913|NCT00112437|615925745|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432914|NCT00112437|615925746|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432915|NCT00112437|615925747|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432916|NCT00112437|615925748|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432917|NCT00112437|615925749|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432918|NCT00112437|615925750|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432919|NCT00112437|615925751|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432920|NCT00112437|615925752|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432921|NCT00112437|615925753|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432922|NCT00112437|615925754|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432923|NCT00112437|615925755|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
170432924|NCT00112437|615925730|FG000|Year 1 (12-Month Base Study)|moved|0|||
170432925|NCT00112437|615925731|FG001|Year 1 (12-Month Base Study)|moved|1|||
170432926|NCT00112437|615925732|FG002|Year 1 (12-Month Base Study)|moved|1|||
170432927|NCT00112437|615925733|FG003|Year 1 (12-Month Base Study)|moved|0|||
170432928|NCT00112437|615925734|FG004|Year 1 (12-Month Base Study)|moved|0|||
170432929|NCT00112437|615925735|FG005|Year 1 (12-Month Base Study)|moved|0|||
170432930|NCT00112437|615925736|FG006|Year 1 (12-Month Base Study)|moved|0|||
170432931|NCT00112437|615925737|FG007|Year 1 (12-Month Base Study)|moved|0|||
170432932|NCT00112437|615925738|FG008|Year 1 (12-Month Base Study)|moved|0|||
170432933|NCT00112437|615925739|FG009|Year 1 (12-Month Base Study)|moved|0|||
170432934|NCT00112437|615925740|FG010|Year 1 (12-Month Base Study)|moved|0|||
170432935|NCT00112437|615925741|FG011|Year 1 (12-Month Base Study)|moved|0|||
170432936|NCT00112437|615925742|FG012|Year 1 (12-Month Base Study)|moved|0|||
170432937|NCT00112437|615925743|FG013|Year 1 (12-Month Base Study)|moved|0|||
170432938|NCT00112437|615925744|FG014|Year 1 (12-Month Base Study)|moved|0|||
170432939|NCT00112437|615925745|FG015|Year 1 (12-Month Base Study)|moved|0|||
170432940|NCT00112437|615925746|FG016|Year 1 (12-Month Base Study)|moved|0|||
170432941|NCT00112437|615925747|FG017|Year 1 (12-Month Base Study)|moved|0|||
170432942|NCT00112437|615925748|FG018|Year 1 (12-Month Base Study)|moved|0|||
170432943|NCT00112437|615925749|FG019|Year 1 (12-Month Base Study)|moved|0|||
170432944|NCT00112437|615925750|FG020|Year 1 (12-Month Base Study)|moved|0|||
170432945|NCT00112437|615925751|FG021|Year 1 (12-Month Base Study)|moved|0|||
170432946|NCT00112437|615925752|FG022|Year 1 (12-Month Base Study)|moved|0|||
170432947|NCT00112437|615925753|FG023|Year 1 (12-Month Base Study)|moved|0|||
170432948|NCT00112437|615925754|FG024|Year 1 (12-Month Base Study)|moved|0|||
170432949|NCT00112437|615925755|FG025|Year 1 (12-Month Base Study)|moved|0|||
170432950|NCT00112437|615925730|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432951|NCT00112437|615925731|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432952|NCT00112437|615925732|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432953|NCT00112437|615925733|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
170432954|NCT00112437|615925734|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432955|NCT00112437|615925735|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432956|NCT00112437|615925736|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432957|NCT00112437|615925737|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432958|NCT00112437|615925738|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432959|NCT00112437|615925739|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432960|NCT00112437|615925740|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432961|NCT00112437|615925741|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432962|NCT00112437|615925742|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432963|NCT00112437|615925743|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432964|NCT00112437|615925744|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432965|NCT00112437|615925745|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432966|NCT00112437|615925746|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432967|NCT00112437|615925747|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432968|NCT00112437|615925748|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432969|NCT00112437|615925749|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170778881|NCT03398148|617197290|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
170778882|NCT03398148|617197291|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
170432970|NCT00112437|615925750|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432971|NCT00112437|615925751|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432972|NCT00112437|615925752|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432973|NCT00112437|615925753|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432974|NCT00112437|615925754|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432975|NCT00112437|615925755|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
170432976|NCT00112437|615925730|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432977|NCT00112437|615925731|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432978|NCT00112437|615925732|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432979|NCT00112437|615925733|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432980|NCT00112437|615925734|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
170432981|NCT00112437|615925735|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432982|NCT00112437|615925736|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432983|NCT00112437|615925737|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432984|NCT00112437|615925738|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432985|NCT00112437|615925739|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432986|NCT00112437|615925740|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432987|NCT00112437|615925741|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432988|NCT00112437|615925742|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432989|NCT00112437|615925743|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170535912|NCT01995201|616307917|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
170535913|NCT01995201|616307918|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
170535914|NCT01995201|616307919|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
170535915|NCT01995201|616307920|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
170535916|NCT01995201|616307921|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
170535917|NCT01995201|616307922|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
170535918|NCT01995201|616307923|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
170535919|NCT01995201|616307917|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
170535920|NCT01995201|616307918|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
170535921|NCT01995201|616307919|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
170535922|NCT01995201|616307920|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
170535923|NCT01995201|616307921|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
170535924|NCT01995201|616307922|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
170535925|NCT01995201|616307923|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
170632739|NCT04672239|616666761|FG000|Week 2 Survey|Withdrawal by Subject|0|||
170778883|NCT03398148|617197292|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
170778884|NCT03398148|617197293|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
170535926|NCT01995201|616307917|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
170535927|NCT01995201|616307918|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
170535928|NCT01995201|616307919|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
170535929|NCT01995201|616307920|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
170535930|NCT01995201|616307921|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
170535931|NCT01995201|616307922|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
170535932|NCT01995201|616307923|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
170535933|NCT01995201|616307917|FG000|From Baseline Until Week 24|Physician Decision|0|||
170535934|NCT01995201|616307918|FG001|From Baseline Until Week 24|Physician Decision|2|||
170535935|NCT01995201|616307919|FG002|From Baseline Until Week 24|Physician Decision|0|||
170535936|NCT01995201|616307920|FG003|From Baseline Until Week 24|Physician Decision|0|||
170535937|NCT01995201|616307921|FG004|From Baseline Until Week 24|Physician Decision|0|||
170535938|NCT01995201|616307922|FG005|From Baseline Until Week 24|Physician Decision|0|||
170535939|NCT01995201|616307923|FG006|From Baseline Until Week 24|Physician Decision|0|||
170535940|NCT01995201|616307917|FG000|From Baseline Until Week 24|Protocol Violation|0|||
170535941|NCT01995201|616307918|FG001|From Baseline Until Week 24|Protocol Violation|9|||
170535942|NCT01995201|616307919|FG002|From Baseline Until Week 24|Protocol Violation|0|||
170535943|NCT01995201|616307920|FG003|From Baseline Until Week 24|Protocol Violation|0|||
170535944|NCT01995201|616307921|FG004|From Baseline Until Week 24|Protocol Violation|0|||
170535945|NCT01995201|616307922|FG005|From Baseline Until Week 24|Protocol Violation|0|||
170535946|NCT01995201|616307923|FG006|From Baseline Until Week 24|Protocol Violation|0|||
170535947|NCT01995201|616307917|FG000|From Week 24 Until Week 48|Adverse Event|0|||
170432990|NCT00112437|615925744|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432991|NCT00112437|615925745|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432992|NCT00112437|615925746|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432993|NCT00112437|615925747|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432994|NCT00112437|615925748|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432995|NCT00112437|615925749|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432996|NCT00112437|615925750|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432997|NCT00112437|615925751|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170432998|NCT00112437|615925752|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170535948|NCT01995201|616307918|FG001|From Week 24 Until Week 48|Adverse Event|0|||
170535949|NCT01995201|616307919|FG002|From Week 24 Until Week 48|Adverse Event|2|||
170535950|NCT01995201|616307920|FG003|From Week 24 Until Week 48|Adverse Event|1|||
170535951|NCT01995201|616307921|FG004|From Week 24 Until Week 48|Adverse Event|1|||
170535952|NCT01995201|616307922|FG005|From Week 24 Until Week 48|Adverse Event|3|||
170535953|NCT01995201|616307923|FG006|From Week 24 Until Week 48|Adverse Event|1|||
170535954|NCT01995201|616307917|FG000|From Week 24 Until Week 48|Death|0|||
170535955|NCT01995201|616307918|FG001|From Week 24 Until Week 48|Death|0|||
170535956|NCT01995201|616307919|FG002|From Week 24 Until Week 48|Death|0|||
170535957|NCT01995201|616307920|FG003|From Week 24 Until Week 48|Death|0|||
170535958|NCT01995201|616307921|FG004|From Week 24 Until Week 48|Death|0|||
170535959|NCT01995201|616307922|FG005|From Week 24 Until Week 48|Death|2|||
170535960|NCT01995201|616307923|FG006|From Week 24 Until Week 48|Death|0|||
170535961|NCT01995201|616307917|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
170535962|NCT01995201|616307918|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
170535963|NCT01995201|616307919|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
170535964|NCT01995201|616307920|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
170535965|NCT01995201|616307921|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
170535966|NCT01995201|616307922|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
170535967|NCT01995201|616307923|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
170535968|NCT01995201|616307917|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
170535969|NCT01995201|616307918|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
170535970|NCT01995201|616307919|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
170880761|NCT05121480|617574351|FG003|Overall Study|Other Reason|0|||
170535971|NCT01995201|616307920|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
170535972|NCT01995201|616307921|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
170535973|NCT01995201|616307922|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
170535974|NCT01995201|616307923|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
170535975|NCT01995201|616307917|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
170535976|NCT01995201|616307918|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
170535977|NCT01995201|616307919|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
170535978|NCT01995201|616307920|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
170535979|NCT01995201|616307921|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
170535980|NCT01995201|616307922|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
170535981|NCT01995201|616307923|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
170535982|NCT01995201|616307917|FG000|From Week 24 Until Week 48|Physician Decision|0|||
170535983|NCT01995201|616307918|FG001|From Week 24 Until Week 48|Physician Decision|0|||
170535984|NCT01995201|616307919|FG002|From Week 24 Until Week 48|Physician Decision|0|||
170535985|NCT01995201|616307920|FG003|From Week 24 Until Week 48|Physician Decision|0|||
170880762|NCT05121480|617574352|FG004|Overall Study|Other Reason|0|||
170880763|NCT05121480|617574353|FG005|Overall Study|Other Reason|1|||
170880764|NCT05121480|617574354|FG006|Overall Study|Other Reason|1|||
170432999|NCT00112437|615925753|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170433000|NCT00112437|615925754|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170433001|NCT00112437|615925755|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
170433002|NCT00112437|615925730|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
170433003|NCT00112437|615925731|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
170433004|NCT00112437|615925732|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
170433005|NCT00112437|615925733|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
170433006|NCT00112437|615925734|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
170433007|NCT00112437|615925735|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
170535986|NCT01995201|616307921|FG004|From Week 24 Until Week 48|Physician Decision|1|||
170535987|NCT01995201|616307922|FG005|From Week 24 Until Week 48|Physician Decision|0|||
170535988|NCT01995201|616307923|FG006|From Week 24 Until Week 48|Physician Decision|0|||
170535989|NCT01995201|616307917|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
170535990|NCT01995201|616307918|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
170535991|NCT01995201|616307919|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
170535992|NCT01995201|616307920|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
170535993|NCT01995201|616307921|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
170535994|NCT01995201|616307922|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
170535995|NCT01995201|616307923|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
170535996|NCT03329001|616307924|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
170535997|NCT03329001|616307925|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
170535998|NCT03329001|616307926|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
170535999|NCT03329001|616307927|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
170536000|NCT03329001|616307928|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
170536001|NCT03329001|616307929|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
170536002|NCT03329001|616307930|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
170536003|NCT03329001|616307931|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
170536004|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
170536005|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
170536006|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
170536007|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
170536008|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
170536009|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
170536010|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
170536011|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
170536012|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
170536013|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
170536014|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
170536015|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
170536016|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
170536017|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
170536018|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
170536019|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
170536020|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
170536021|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
170536022|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
170536023|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
170536024|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
170565477|NCT01049373|616418532|FG001|Overall Study|Withdrawal by Subject|5|||
170880765|NCT05121480|617574355|FG007|Overall Study|Other Reason|1|||
170880766|NCT03311711|617574358|FG000|Overall Study|Death|1|||
170880767|NCT03311711|617574359|FG001|Overall Study|Death|0|||
170880768|NCT03311711|617574360|FG002|Overall Study|Death|0|||
170880769|NCT03311711|617574361|FG003|Overall Study|Death|0|||
170880770|NCT03311711|617574362|FG004|Overall Study|Death|0|||
170880771|NCT03311711|617574363|FG005|Overall Study|Death|0|||
170880772|NCT03311711|617574364|FG006|Overall Study|Death|1|||
170880773|NCT03311711|617574365|FG007|Overall Study|Death|0|||
170880774|NCT03311711|617574366|FG008|Overall Study|Death|1|||
170880775|NCT03311711|617574367|FG009|Overall Study|Death|0|||
170880776|NCT03311711|617574358|FG000|Overall Study|Death of dyad partner|0|||
170880777|NCT03311711|617574359|FG001|Overall Study|Death of dyad partner|1|||
170880778|NCT03311711|617574360|FG002|Overall Study|Death of dyad partner|0|||
170880779|NCT03311711|617574361|FG003|Overall Study|Death of dyad partner|0|||
170880780|NCT03311711|617574362|FG004|Overall Study|Death of dyad partner|0|||
170880781|NCT03311711|617574363|FG005|Overall Study|Death of dyad partner|0|||
170880782|NCT03311711|617574364|FG006|Overall Study|Death of dyad partner|0|||
170433008|NCT00112437|615925736|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
170433009|NCT00112437|615925737|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
170433010|NCT00112437|615925738|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
170433011|NCT00112437|615925739|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
170433012|NCT00112437|615925740|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
170536025|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
170536026|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
170536027|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
170536028|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
170536029|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
170536030|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
170565478|NCT01049373|616418531|FG000|Overall Study|Adverse Event|3|||
170880783|NCT03311711|617574365|FG007|Overall Study|Death of dyad partner|1|||
170880784|NCT03311711|617574366|FG008|Overall Study|Death of dyad partner|0|||
170880785|NCT03311711|617574367|FG009|Overall Study|Death of dyad partner|1|||
170433013|NCT00112437|615925741|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
170433014|NCT00112437|615925742|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
170433015|NCT00112437|615925743|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
170433016|NCT00112437|615925744|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
170433017|NCT00112437|615925745|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
170433018|NCT00112437|615925746|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
170433019|NCT00112437|615925747|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
170433020|NCT00112437|615925748|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
170433021|NCT00112437|615925749|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
170433022|NCT00112437|615925750|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
170433023|NCT00112437|615925751|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
170433024|NCT00112437|615925752|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
170433025|NCT00112437|615925753|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
170433026|NCT00112437|615925754|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
170433027|NCT00112437|615925755|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
170433028|NCT00112437|615925730|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433029|NCT00112437|615925731|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433030|NCT00112437|615925732|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433031|NCT00112437|615925733|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433032|NCT00112437|615925734|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433033|NCT00112437|615925735|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
170433034|NCT00112437|615925736|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
170433035|NCT00112437|615925737|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433036|NCT00112437|615925738|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433037|NCT00112437|615925739|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
170433038|NCT00112437|615925740|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433039|NCT00112437|615925741|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433040|NCT00112437|615925742|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433041|NCT00112437|615925743|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433042|NCT00112437|615925744|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433043|NCT00112437|615925745|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433044|NCT00112437|615925746|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433045|NCT00112437|615925747|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433046|NCT00112437|615925748|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433047|NCT00112437|615925749|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433048|NCT00112437|615925750|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433049|NCT00112437|615925751|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433050|NCT00112437|615925752|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433051|NCT00112437|615925753|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433052|NCT00112437|615925754|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433053|NCT00112437|615925755|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
170433054|NCT00112437|615925730|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433055|NCT00112437|615925731|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433056|NCT00112437|615925732|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433057|NCT00112437|615925733|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433058|NCT00112437|615925734|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433059|NCT00112437|615925735|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433060|NCT00112437|615925736|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433061|NCT00112437|615925737|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433062|NCT00112437|615925738|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
170880786|NCT03311711|617574358|FG000|Overall Study|Lost to Follow-up|2|||
170880787|NCT03311711|617574359|FG001|Overall Study|Lost to Follow-up|2|||
170880788|NCT03311711|617574360|FG002|Overall Study|Lost to Follow-up|0|||
170880789|NCT03311711|617574361|FG003|Overall Study|Lost to Follow-up|0|||
170880790|NCT03311711|617574362|FG004|Overall Study|Lost to Follow-up|0|||
170536031|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
170536032|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
170536033|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
170536034|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
170536035|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
170536036|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
170536037|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
170536038|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
170536039|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
170536040|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
170536041|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
170536042|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
170536043|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
170536044|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
170536045|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
170536046|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
170536047|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
170536048|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
170536049|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
170778885|NCT03398148|617197294|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
170778886|NCT03398148|617197295|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
170778887|NCT03398148|617197296|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
170778888|NCT03398148|617197297|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
170778889|NCT03398148|617197298|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
170778890|NCT03398148|617197299|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
170778891|NCT03398148|617197300|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
170778892|NCT03398148|617197301|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
170778893|NCT03398148|617197302|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
170778894|NCT03398148|617197288|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778895|NCT03398148|617197289|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778896|NCT03398148|617197290|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778897|NCT03398148|617197291|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778898|NCT03398148|617197292|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778899|NCT03398148|617197293|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778900|NCT03398148|617197294|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778901|NCT03398148|617197295|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778902|NCT03398148|617197296|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778903|NCT03398148|617197297|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778904|NCT03398148|617197298|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778905|NCT03398148|617197299|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
170778906|NCT03398148|617197300|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
170778907|NCT03398148|617197301|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
170778908|NCT03398148|617197302|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
170778909|NCT03398148|617197288|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
170778910|NCT03398148|617197289|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
170778911|NCT03398148|617197290|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
170778912|NCT03398148|617197291|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
170778913|NCT03398148|617197292|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
170778914|NCT03398148|617197293|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
170778915|NCT03398148|617197294|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
170778916|NCT03398148|617197295|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
170778917|NCT03398148|617197296|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
170778918|NCT03398148|617197297|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
170778919|NCT03398148|617197298|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
170778920|NCT03398148|617197299|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
170778921|NCT03398148|617197300|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
170778922|NCT03398148|617197301|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
170778923|NCT03398148|617197302|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
170880791|NCT03311711|617574363|FG005|Overall Study|Lost to Follow-up|0|||
170880792|NCT03311711|617574364|FG006|Overall Study|Lost to Follow-up|1|||
170880793|NCT03311711|617574365|FG007|Overall Study|Lost to Follow-up|1|||
170880794|NCT03311711|617574366|FG008|Overall Study|Lost to Follow-up|0|||
170778924|NCT03398148|617197288|FG000|Substudy 2 Period 2|Other|0|||
170778925|NCT03398148|617197289|FG001|Substudy 2 Period 2|Other|0|||
170778926|NCT03398148|617197290|FG002|Substudy 2 Period 2|Other|0|||
170433063|NCT00112437|615925739|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433064|NCT00112437|615925740|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433065|NCT00112437|615925741|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433066|NCT00112437|615925742|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433067|NCT00112437|615925743|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433068|NCT00112437|615925744|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170536050|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
170536051|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
170778927|NCT03398148|617197291|FG003|Substudy 2 Period 2|Other|0|||
170778928|NCT03398148|617197292|FG004|Substudy 2 Period 2|Other|0|||
170778929|NCT03398148|617197293|FG005|Substudy 2 Period 2|Other|0|||
170778930|NCT03398148|617197294|FG006|Substudy 2 Period 2|Other|0|||
170778931|NCT03398148|617197295|FG007|Substudy 2 Period 2|Other|0|||
170778932|NCT03398148|617197296|FG008|Substudy 2 Period 2|Other|0|||
170778933|NCT03398148|617197297|FG009|Substudy 2 Period 2|Other|0|||
170778934|NCT03398148|617197298|FG010|Substudy 2 Period 2|Other|0|||
170778935|NCT03398148|617197299|FG011|Substudy 2 Period 2|Other|0|||
170433069|NCT00112437|615925745|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433070|NCT00112437|615925746|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433071|NCT00112437|615925747|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433072|NCT00112437|615925748|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433073|NCT00112437|615925749|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433074|NCT00112437|615925750|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433075|NCT00112437|615925751|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433076|NCT00112437|615925752|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433077|NCT00112437|615925753|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433078|NCT00112437|615925754|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433079|NCT00112437|615925755|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
170433080|NCT00112437|615925730|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433081|NCT00112437|615925731|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433082|NCT00112437|615925732|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433083|NCT00112437|615925733|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433084|NCT00112437|615925734|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433085|NCT00112437|615925735|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433086|NCT00112437|615925736|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433087|NCT00112437|615925737|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433088|NCT00112437|615925738|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
170433089|NCT00112437|615925739|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433090|NCT00112437|615925740|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433091|NCT00112437|615925741|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433092|NCT00112437|615925742|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433093|NCT00112437|615925743|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433094|NCT00112437|615925744|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433095|NCT00112437|615925745|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433096|NCT00112437|615925746|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433097|NCT00112437|615925747|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433098|NCT00112437|615925748|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433099|NCT00112437|615925749|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433100|NCT00112437|615925750|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433101|NCT00112437|615925751|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433102|NCT00112437|615925752|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433103|NCT00112437|615925753|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433104|NCT00112437|615925754|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433105|NCT00112437|615925755|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
170433106|NCT00112437|615925730|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433107|NCT00112437|615925731|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433108|NCT00112437|615925732|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433109|NCT00112437|615925733|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433110|NCT00112437|615925734|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433111|NCT00112437|615925735|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
170433112|NCT00112437|615925736|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
170433113|NCT00112437|615925737|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
170433114|NCT00112437|615925738|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
170433115|NCT00112437|615925739|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
170433116|NCT00112437|615925740|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433117|NCT00112437|615925741|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433118|NCT00112437|615925742|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433119|NCT00112437|615925743|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170778936|NCT03398148|617197300|FG012|Substudy 2 Period 2|Other|0|||
170778937|NCT03398148|617197301|FG013|Substudy 2 Period 2|Other|1|||
170778938|NCT03398148|617197302|FG014|Substudy 2 Period 2|Other|1|||
170778939|NCT03398148|617197288|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
170880795|NCT03311711|617574367|FG009|Overall Study|Lost to Follow-up|0|||
170880796|NCT03311711|617574358|FG000|Overall Study|Withdrawal by Subject|1|||
170880797|NCT03311711|617574359|FG001|Overall Study|Withdrawal by Subject|1|||
170880798|NCT03311711|617574360|FG002|Overall Study|Withdrawal by Subject|0|||
170880799|NCT03311711|617574361|FG003|Overall Study|Withdrawal by Subject|0|||
170880800|NCT03311711|617574362|FG004|Overall Study|Withdrawal by Subject|0|||
170880801|NCT03311711|617574363|FG005|Overall Study|Withdrawal by Subject|0|||
170880802|NCT03311711|617574364|FG006|Overall Study|Withdrawal by Subject|3|||
170880803|NCT03311711|617574365|FG007|Overall Study|Withdrawal by Subject|3|||
170880804|NCT03311711|617574366|FG008|Overall Study|Withdrawal by Subject|0|||
170880805|NCT03311711|617574367|FG009|Overall Study|Withdrawal by Subject|0|||
170880806|NCT01097746|617574368|FG000|Overall Study|Adverse Event|4|||
170880807|NCT01097746|617574368|FG000|Overall Study|taken off study before any treatment given|1|||
170880808|NCT01514682|617574369|FG000|Overall Study|Withdrawal by Subject|2|||
170880809|NCT01514682|617574370|FG001|Overall Study|Withdrawal by Subject|3|||
170880810|NCT01514682|617574369|FG000|Overall Study|Physician Decision|4|||
170880811|NCT01514682|617574370|FG001|Overall Study|Physician Decision|3|||
170433120|NCT00112437|615925744|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433121|NCT00112437|615925745|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433122|NCT00112437|615925746|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433123|NCT00112437|615925747|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433124|NCT00112437|615925748|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433125|NCT00112437|615925749|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433126|NCT00112437|615925750|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433127|NCT00112437|615925751|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433128|NCT00112437|615925752|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433129|NCT00112437|615925753|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433130|NCT00112437|615925754|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433131|NCT00112437|615925755|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
170433132|NCT00112437|615925730|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433133|NCT00112437|615925731|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433134|NCT00112437|615925732|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433135|NCT00112437|615925733|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433136|NCT00112437|615925734|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433137|NCT00112437|615925735|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433138|NCT00112437|615925736|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433139|NCT00112437|615925737|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433140|NCT00112437|615925738|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433141|NCT00112437|615925739|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
170433142|NCT00112437|615925740|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433143|NCT00112437|615925741|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433144|NCT00112437|615925742|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433145|NCT00112437|615925743|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433146|NCT00112437|615925744|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433147|NCT00112437|615925745|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433148|NCT00112437|615925746|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433149|NCT00112437|615925747|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433150|NCT00112437|615925748|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433151|NCT00112437|615925749|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433152|NCT00112437|615925750|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433153|NCT00112437|615925751|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433154|NCT00112437|615925752|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433155|NCT00112437|615925753|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433156|NCT00112437|615925754|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433157|NCT00112437|615925755|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
170433158|NCT00112437|615925730|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433159|NCT00112437|615925731|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433160|NCT00112437|615925732|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433161|NCT00112437|615925733|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433162|NCT00112437|615925734|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433163|NCT00112437|615925735|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433164|NCT00112437|615925736|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433165|NCT00112437|615925737|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
170565479|NCT01049373|616418532|FG001|Overall Study|Adverse Event|3|||
170880812|NCT05594173|617574373|FG000|Overall Study|Adverse Event|1|||
170880813|NCT05594173|617574373|FG000|Overall Study|COVID-19 Pandemic|2|||
170880814|NCT05634577|617574374|FG000|Overall Study|Lost to Follow-up|1|||
170433166|NCT00112437|615925738|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433167|NCT00112437|615925739|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
170536052|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
170536053|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
170536054|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
170536055|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
170536056|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
170536057|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
170536058|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
170536059|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
170536060|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
170536061|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
170536062|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
170536063|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
170536064|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
170536065|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
170536066|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
170536067|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
170536068|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
170536069|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
170536070|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
170536071|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
170536072|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
170536073|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
170536074|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
170536075|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
170536076|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
170536077|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
170433168|NCT00112437|615925740|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433169|NCT00112437|615925741|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433170|NCT00112437|615925742|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433171|NCT00112437|615925743|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
170536078|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
170536079|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
170536080|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
170536081|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
170536082|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
170536083|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
170536084|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
170536085|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
170536086|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
170536087|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
170536088|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
170536089|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
170433172|NCT00112437|615925744|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433173|NCT00112437|615925745|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433174|NCT00112437|615925746|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433175|NCT00112437|615925747|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433176|NCT00112437|615925748|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433177|NCT00112437|615925749|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433178|NCT00112437|615925750|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433179|NCT00112437|615925751|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433180|NCT00112437|615925752|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433181|NCT00112437|615925753|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433182|NCT00112437|615925754|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433183|NCT00112437|615925755|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
170433184|NCT00112437|615925730|FG000|Year 2 (12-Month Extension)|Moved|0|||
170433185|NCT00112437|615925731|FG001|Year 2 (12-Month Extension)|Moved|0|||
170433186|NCT00112437|615925732|FG002|Year 2 (12-Month Extension)|Moved|0|||
170433187|NCT00112437|615925733|FG003|Year 2 (12-Month Extension)|Moved|0|||
170433188|NCT00112437|615925734|FG004|Year 2 (12-Month Extension)|Moved|0|||
170433189|NCT00112437|615925735|FG005|Year 2 (12-Month Extension)|Moved|0|||
170433190|NCT00112437|615925736|FG006|Year 2 (12-Month Extension)|Moved|0|||
170433191|NCT00112437|615925737|FG007|Year 2 (12-Month Extension)|Moved|0|||
170433192|NCT00112437|615925738|FG008|Year 2 (12-Month Extension)|Moved|0|||
170433193|NCT00112437|615925739|FG009|Year 2 (12-Month Extension)|Moved|1|||
170433194|NCT00112437|615925740|FG010|Year 2 (12-Month Extension)|Moved|0|||
170433195|NCT00112437|615925741|FG011|Year 2 (12-Month Extension)|Moved|0|||
170433196|NCT00112437|615925742|FG012|Year 2 (12-Month Extension)|Moved|0|||
170433197|NCT00112437|615925743|FG013|Year 2 (12-Month Extension)|Moved|0|||
170433198|NCT00112437|615925744|FG014|Year 2 (12-Month Extension)|Moved|0|||
170433199|NCT00112437|615925745|FG015|Year 2 (12-Month Extension)|Moved|0|||
170433200|NCT00112437|615925746|FG016|Year 2 (12-Month Extension)|Moved|0|||
170433201|NCT00112437|615925747|FG017|Year 2 (12-Month Extension)|Moved|0|||
170433202|NCT00112437|615925748|FG018|Year 2 (12-Month Extension)|Moved|0|||
170433203|NCT00112437|615925749|FG019|Year 2 (12-Month Extension)|Moved|0|||
170433204|NCT00112437|615925750|FG020|Year 2 (12-Month Extension)|Moved|0|||
170433205|NCT00112437|615925751|FG021|Year 2 (12-Month Extension)|Moved|0|||
170433206|NCT00112437|615925752|FG022|Year 2 (12-Month Extension)|Moved|0|||
170433207|NCT00112437|615925753|FG023|Year 2 (12-Month Extension)|Moved|0|||
170433208|NCT00112437|615925754|FG024|Year 2 (12-Month Extension)|Moved|0|||
170433209|NCT00112437|615925755|FG025|Year 2 (12-Month Extension)|Moved|0|||
170433210|NCT00112437|615925730|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
170433211|NCT00112437|615925731|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
170433212|NCT00112437|615925732|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
170536090|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
170536091|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
170536092|NCT03329001|616307924|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
170536093|NCT03329001|616307925|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
170536094|NCT03329001|616307926|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
170536095|NCT03329001|616307927|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
170536096|NCT03329001|616307928|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
170536097|NCT03329001|616307929|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
170536098|NCT03329001|616307930|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
170536099|NCT03329001|616307931|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
170536100|NCT03329001|616307924|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
170536101|NCT03329001|616307925|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
170536102|NCT03329001|616307926|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
170536103|NCT03329001|616307927|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
170536104|NCT03329001|616307928|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
170536105|NCT03329001|616307929|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
170536106|NCT03329001|616307930|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
170536107|NCT03329001|616307931|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
170536108|NCT03329001|616307924|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
170536109|NCT03329001|616307925|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
170536110|NCT03329001|616307926|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
170536111|NCT03329001|616307927|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
170536112|NCT03329001|616307928|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
170536113|NCT03329001|616307929|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
170536114|NCT03329001|616307930|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
170536115|NCT03329001|616307931|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
170536116|NCT03329001|616307924|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
170536117|NCT03329001|616307925|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
170536118|NCT03329001|616307926|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
170536119|NCT03329001|616307927|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
170536120|NCT03329001|616307928|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
170536121|NCT03329001|616307929|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
170565480|NCT01049373|616418531|FG000|Overall Study|Lost to Follow-up|9|||
170778940|NCT03398148|617197289|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778941|NCT03398148|617197290|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778942|NCT03398148|617197291|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778943|NCT03398148|617197292|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778944|NCT03398148|617197293|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778945|NCT03398148|617197294|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
170433213|NCT00112437|615925733|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
170433214|NCT00112437|615925734|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
170433215|NCT00112437|615925735|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
170778946|NCT03398148|617197295|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
170433216|NCT00112437|615925736|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
170433217|NCT00112437|615925737|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
170433218|NCT00112437|615925738|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
170880815|NCT05634577|617574374|FG000|Overall Study|Withdrawal by Subject|1|||
170880816|NCT00769002|617574375|FG000|Overall Study|Study was not completed, no data|9|||
170880817|NCT00769002|617574376|FG001|Overall Study|Study was not completed, no data|9|||
170880818|NCT01967628|617574377|FG000|Overall Study|Withdrawal by Subject|2|||
170880819|NCT01967628|617574378|FG001|Overall Study|Withdrawal by Subject|0|||
170433219|NCT00112437|615925739|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
170433220|NCT00112437|615925740|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
170433221|NCT00112437|615925741|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
170433222|NCT00112437|615925742|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
170433223|NCT00112437|615925743|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
170433224|NCT00112437|615925744|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
170433225|NCT00112437|615925745|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
170433226|NCT00112437|615925746|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
170433227|NCT00112437|615925747|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
170433228|NCT00112437|615925748|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
170433229|NCT00112437|615925749|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
170433230|NCT00112437|615925750|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
170433231|NCT00112437|615925751|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
170433232|NCT00112437|615925752|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
170433233|NCT00112437|615925753|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
170433234|NCT00112437|615925754|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
170433235|NCT00112437|615925755|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
170433236|NCT00112437|615925730|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433237|NCT00112437|615925731|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433238|NCT00112437|615925732|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433239|NCT00112437|615925733|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433240|NCT00112437|615925734|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433241|NCT00112437|615925735|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433242|NCT00112437|615925736|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433243|NCT00112437|615925737|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433244|NCT00112437|615925738|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433245|NCT00112437|615925739|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433246|NCT00112437|615925740|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433247|NCT00112437|615925741|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
170433248|NCT00112437|615925742|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433249|NCT00112437|615925743|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
170433250|NCT00112437|615925744|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433251|NCT00112437|615925745|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
170433252|NCT00112437|615925746|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433253|NCT00112437|615925747|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433254|NCT00112437|615925748|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
170433255|NCT00112437|615925749|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433256|NCT00112437|615925750|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433257|NCT00112437|615925751|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433258|NCT00112437|615925752|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433259|NCT00112437|615925753|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433260|NCT00112437|615925754|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433261|NCT00112437|615925755|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
170433262|NCT00112437|615925730|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433263|NCT00112437|615925731|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433264|NCT00112437|615925732|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433265|NCT00112437|615925733|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433266|NCT00112437|615925734|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433267|NCT00112437|615925735|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433268|NCT00112437|615925736|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433269|NCT00112437|615925737|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433270|NCT00112437|615925738|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433271|NCT00112437|615925739|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433272|NCT00112437|615925740|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433273|NCT00112437|615925741|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433274|NCT00112437|615925742|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433275|NCT00112437|615925743|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433276|NCT00112437|615925744|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433277|NCT00112437|615925745|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
170433278|NCT00112437|615925746|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170880820|NCT01967628|617574377|FG000|Overall Study|Unable to complete bronchoscopy|4|||
170880821|NCT01967628|617574378|FG001|Overall Study|Unable to complete bronchoscopy|6|||
170433279|NCT00112437|615925747|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433280|NCT00112437|615925748|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433281|NCT00112437|615925749|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433282|NCT00112437|615925750|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170536122|NCT03329001|616307930|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
170536123|NCT03329001|616307931|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
170536124|NCT03329001|616307924|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
170536125|NCT03329001|616307925|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
170536126|NCT03329001|616307926|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
170536127|NCT03329001|616307927|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
170536128|NCT03329001|616307928|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
170536129|NCT03329001|616307929|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
170536130|NCT03329001|616307930|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
170536131|NCT03329001|616307931|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
170536132|NCT03329001|616307924|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
170536133|NCT03329001|616307925|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
170536134|NCT03329001|616307926|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
170536135|NCT03329001|616307927|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
170536136|NCT03329001|616307928|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
170536137|NCT03329001|616307929|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
170536138|NCT03329001|616307930|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
170536139|NCT03329001|616307931|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
170536140|NCT03329001|616307924|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
170536141|NCT03329001|616307925|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
170536142|NCT03329001|616307926|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
170536143|NCT03329001|616307927|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
170536144|NCT03329001|616307928|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
170536145|NCT03329001|616307929|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
170536146|NCT03329001|616307930|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
170536147|NCT03329001|616307931|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
170536148|NCT03329001|616307924|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
170536149|NCT03329001|616307925|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
170536150|NCT03329001|616307926|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
170536151|NCT03329001|616307927|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
170536152|NCT03329001|616307928|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
170536153|NCT03329001|616307929|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
170536154|NCT03329001|616307930|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
170536155|NCT03329001|616307931|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
170536156|NCT03329001|616307924|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
170536157|NCT03329001|616307925|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
170536158|NCT03329001|616307926|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
170536159|NCT03329001|616307927|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
170536160|NCT03329001|616307928|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
170536161|NCT03329001|616307929|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
170536162|NCT03329001|616307930|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
170536163|NCT03329001|616307931|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
170536164|NCT03329001|616307924|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
170536165|NCT03329001|616307925|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
170536166|NCT03329001|616307926|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
170433283|NCT00112437|615925751|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433284|NCT00112437|615925752|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433285|NCT00112437|615925753|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433286|NCT00112437|615925754|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433287|NCT00112437|615925755|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
170433288|NCT00112437|615925730|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433289|NCT00112437|615925731|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
170536167|NCT03329001|616307927|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
170536168|NCT03329001|616307928|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
170778947|NCT03398148|617197296|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
170433290|NCT00112437|615925732|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433291|NCT00112437|615925733|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433292|NCT00112437|615925734|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433293|NCT00112437|615925735|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433294|NCT00112437|615925736|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433295|NCT00112437|615925737|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433296|NCT00112437|615925738|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433297|NCT00112437|615925739|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433298|NCT00112437|615925740|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433299|NCT00112437|615925741|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433300|NCT00112437|615925742|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433301|NCT00112437|615925743|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433302|NCT00112437|615925744|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433303|NCT00112437|615925745|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
170433304|NCT00112437|615925746|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433305|NCT00112437|615925747|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433306|NCT00112437|615925748|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433307|NCT00112437|615925749|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433308|NCT00112437|615925750|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433309|NCT00112437|615925751|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433310|NCT00112437|615925752|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433311|NCT00112437|615925753|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433312|NCT00112437|615925754|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433313|NCT00112437|615925755|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
170433314|NCT00112437|615925730|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433315|NCT00112437|615925731|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433316|NCT00112437|615925732|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433317|NCT00112437|615925733|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433318|NCT00112437|615925734|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433319|NCT00112437|615925735|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433320|NCT00112437|615925736|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433321|NCT00112437|615925737|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433322|NCT00112437|615925738|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433323|NCT00112437|615925739|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433324|NCT00112437|615925740|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433325|NCT00112437|615925741|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
170433326|NCT00112437|615925742|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433327|NCT00112437|615925743|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433328|NCT00112437|615925744|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
170433329|NCT00112437|615925745|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433330|NCT00112437|615925746|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433331|NCT00112437|615925747|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433332|NCT00112437|615925748|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433333|NCT00112437|615925749|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433334|NCT00112437|615925750|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433335|NCT00112437|615925751|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433336|NCT00112437|615925752|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433337|NCT00112437|615925753|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433338|NCT00112437|615925754|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433339|NCT00112437|615925755|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
170433340|NCT00112437|615925730|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433341|NCT00112437|615925731|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433342|NCT00112437|615925732|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433343|NCT00112437|615925733|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433344|NCT00112437|615925734|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433345|NCT00112437|615925735|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433346|NCT00112437|615925736|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433347|NCT00112437|615925737|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433348|NCT00112437|615925738|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433349|NCT00112437|615925739|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433350|NCT00112437|615925740|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
170433351|NCT00112437|615925741|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
170433352|NCT00112437|615925742|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433353|NCT00112437|615925743|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433354|NCT00112437|615925744|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433355|NCT00112437|615925745|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433356|NCT00112437|615925746|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433357|NCT00112437|615925747|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433358|NCT00112437|615925748|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433359|NCT00112437|615925749|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433360|NCT00112437|615925750|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433361|NCT00112437|615925751|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433362|NCT00112437|615925752|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170536169|NCT03329001|616307929|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
170536170|NCT03329001|616307930|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
170433363|NCT00112437|615925753|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433364|NCT00112437|615925754|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433365|NCT00112437|615925755|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
170433366|NCT00112437|615925730|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433367|NCT00112437|615925731|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433368|NCT00112437|615925732|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433369|NCT00112437|615925733|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433370|NCT00112437|615925734|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433371|NCT00112437|615925735|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433372|NCT00112437|615925736|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433373|NCT00112437|615925737|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433374|NCT00112437|615925738|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433375|NCT00112437|615925739|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433376|NCT00112437|615925740|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433377|NCT00112437|615925741|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433378|NCT00112437|615925742|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433379|NCT00112437|615925743|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433380|NCT00112437|615925744|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433381|NCT00112437|615925745|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433382|NCT00112437|615925746|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433383|NCT00112437|615925747|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433384|NCT00112437|615925748|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433385|NCT00112437|615925749|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433386|NCT00112437|615925750|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
170433387|NCT00112437|615925751|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
170433388|NCT00112437|615925752|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433389|NCT00112437|615925753|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433390|NCT00112437|615925754|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433391|NCT00112437|615925755|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
170433392|NCT00112437|615925730|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433393|NCT00112437|615925731|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433394|NCT00112437|615925732|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433395|NCT00112437|615925733|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433396|NCT00112437|615925734|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433397|NCT00112437|615925735|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433398|NCT00112437|615925736|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433399|NCT00112437|615925737|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433400|NCT00112437|615925738|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433401|NCT00112437|615925739|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433402|NCT00112437|615925740|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433403|NCT00112437|615925741|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433404|NCT00112437|615925742|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433405|NCT00112437|615925743|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433406|NCT00112437|615925744|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433407|NCT00112437|615925745|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433408|NCT00112437|615925746|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433409|NCT00112437|615925747|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433410|NCT00112437|615925748|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433411|NCT00112437|615925749|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433412|NCT00112437|615925750|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
170433413|NCT00112437|615925751|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433414|NCT00112437|615925752|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433415|NCT00112437|615925753|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433416|NCT00112437|615925754|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433417|NCT00112437|615925755|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
170433418|NCT00112437|615925730|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433419|NCT00112437|615925731|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433420|NCT00112437|615925732|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433421|NCT00112437|615925733|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433422|NCT00112437|615925734|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433423|NCT00112437|615925735|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433424|NCT00112437|615925736|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433425|NCT00112437|615925737|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170536171|NCT03329001|616307931|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
170778948|NCT03398148|617197297|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778949|NCT03398148|617197298|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778950|NCT03398148|617197299|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778951|NCT03398148|617197300|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
170778952|NCT03398148|617197301|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
170778953|NCT03398148|617197302|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
170778954|NCT04278586|617197303|FG000|Overall Study|Withdrawal by Subject|13|||
170778955|NCT04278586|617197304|FG001|Overall Study|Withdrawal by Subject|6|||
170778956|NCT04278586|617197303|FG000|Overall Study|Lost to Follow-up|37|||
170778957|NCT04278586|617197304|FG001|Overall Study|Lost to Follow-up|24|||
170778958|NCT05478525|617197305|FG000|Overall Study|Withdrawal by Subject|0|||
170778959|NCT05478525|617197306|FG001|Overall Study|Withdrawal by Subject|1|||
170778960|NCT05478525|617197307|FG002|Overall Study|Withdrawal by Subject|2|||
170778961|NCT05478525|617197308|FG003|Overall Study|Withdrawal by Subject|0|||
170778962|NCT05478525|617197305|FG000|Overall Study|COVID-19 Infection|2|||
170778963|NCT05478525|617197306|FG001|Overall Study|COVID-19 Infection|0|||
170778964|NCT05478525|617197307|FG002|Overall Study|COVID-19 Infection|1|||
170778965|NCT05478525|617197308|FG003|Overall Study|COVID-19 Infection|1|||
170433426|NCT00112437|615925738|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433427|NCT00112437|615925739|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433428|NCT00112437|615925740|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433429|NCT00112437|615925741|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433430|NCT00112437|615925742|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433431|NCT00112437|615925743|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433432|NCT00112437|615925744|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433433|NCT00112437|615925745|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170536172|NCT03329001|616307924|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
170536173|NCT03329001|616307925|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
170536174|NCT03329001|616307926|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
170536175|NCT03329001|616307927|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
170536176|NCT03329001|616307928|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
170536177|NCT03329001|616307929|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
170536178|NCT03329001|616307930|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
170536179|NCT03329001|616307931|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
170536180|NCT03329001|616307924|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
170536181|NCT03329001|616307925|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
170536182|NCT03329001|616307926|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
170536183|NCT03329001|616307927|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
170536184|NCT03329001|616307928|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
170536185|NCT03329001|616307929|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
170536186|NCT03329001|616307930|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
170536187|NCT03329001|616307931|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
170536188|NCT03329001|616307924|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
170536189|NCT03329001|616307925|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
170536190|NCT03329001|616307926|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
170536191|NCT03329001|616307927|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
170536192|NCT03329001|616307928|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
170536193|NCT03329001|616307929|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
170536194|NCT03329001|616307930|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
170536195|NCT03329001|616307931|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
170536196|NCT03329001|616307924|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
170536197|NCT03329001|616307925|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
170536198|NCT03329001|616307926|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
170536199|NCT03329001|616307927|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
170536200|NCT03329001|616307928|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
170536201|NCT03329001|616307929|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
170536202|NCT03329001|616307930|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
170536203|NCT03329001|616307931|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
170565481|NCT01049373|616418532|FG001|Overall Study|Lost to Follow-up|4|||
170565482|NCT01049373|616418531|FG000|Overall Study|no evaluable study values|9|||
170565483|NCT01049373|616418532|FG001|Overall Study|no evaluable study values|21|||
170778966|NCT05756075|617197311|FG000|Overall Study|Withdrawal by Subject|16|||
170778967|NCT05756075|617197312|FG001|Overall Study|Withdrawal by Subject|9|||
170778968|NCT02605837|617197313|FG000|Overall Study|Adverse Event|3|||
170778969|NCT02605837|617197314|FG001|Overall Study|Adverse Event|1|||
170433434|NCT00112437|615925746|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170880822|NCT01967628|617574377|FG000|Overall Study|Lost to Follow-up|1|||
170880823|NCT01967628|617574378|FG001|Overall Study|Lost to Follow-up|0|||
170880824|NCT01967628|617574377|FG000|Overall Study|Low protein concentration in sample|20|||
170880825|NCT01967628|617574378|FG001|Overall Study|Low protein concentration in sample|25|||
170880826|NCT01650636|617574383|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
170433435|NCT00112437|615925747|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433436|NCT00112437|615925748|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433437|NCT00112437|615925749|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433438|NCT00112437|615925750|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433439|NCT00112437|615925751|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
170433440|NCT00112437|615925752|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433441|NCT00112437|615925753|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433442|NCT00112437|615925754|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433443|NCT00112437|615925755|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
170433444|NCT00112437|615925730|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433445|NCT00112437|615925731|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433446|NCT00112437|615925732|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433447|NCT00112437|615925733|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433448|NCT00112437|615925734|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433449|NCT00112437|615925735|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433450|NCT00112437|615925736|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433451|NCT00112437|615925737|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433452|NCT00112437|615925738|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433453|NCT00112437|615925739|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433454|NCT00112437|615925740|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433455|NCT00112437|615925741|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433456|NCT00112437|615925742|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433457|NCT00112437|615925743|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433458|NCT00112437|615925744|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433459|NCT00112437|615925745|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433460|NCT00112437|615925746|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433461|NCT00112437|615925747|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433462|NCT00112437|615925748|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433463|NCT00112437|615925749|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433464|NCT00112437|615925750|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433465|NCT00112437|615925751|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
170433466|NCT00112437|615925752|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433467|NCT00112437|615925753|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433468|NCT00112437|615925754|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433469|NCT00112437|615925755|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
170433470|NCT00112437|615925730|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433471|NCT00112437|615925731|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433472|NCT00112437|615925732|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433473|NCT00112437|615925733|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433474|NCT00112437|615925734|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433475|NCT00112437|615925735|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433476|NCT00112437|615925736|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433477|NCT00112437|615925737|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433478|NCT00112437|615925738|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433479|NCT00112437|615925739|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433480|NCT00112437|615925740|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433481|NCT00112437|615925741|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433482|NCT00112437|615925742|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433483|NCT00112437|615925743|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433484|NCT00112437|615925744|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433485|NCT00112437|615925745|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433486|NCT00112437|615925746|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433487|NCT00112437|615925747|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433488|NCT00112437|615925748|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433489|NCT00112437|615925749|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433490|NCT00112437|615925750|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
170433491|NCT00112437|615925751|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
170536204|NCT03329001|616307924|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
170433492|NCT00112437|615925752|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433493|NCT00112437|615925753|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433494|NCT00112437|615925754|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170433495|NCT00112437|615925755|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
170536205|NCT03329001|616307925|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
170536206|NCT03329001|616307926|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
170536207|NCT03329001|616307927|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
170536208|NCT03329001|616307928|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
170536209|NCT03329001|616307929|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
170536210|NCT03329001|616307930|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
170536211|NCT03329001|616307931|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
170536212|NCT03329001|616307924|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
170536213|NCT03329001|616307925|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
170536214|NCT03329001|616307926|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
170536215|NCT03329001|616307927|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
170536216|NCT03329001|616307928|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
170536217|NCT03329001|616307929|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
170536218|NCT03329001|616307930|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
170536219|NCT03329001|616307931|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
170536220|NCT03329001|616307924|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
170536221|NCT03329001|616307925|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
170536222|NCT03329001|616307926|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
170536223|NCT03329001|616307927|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
170536224|NCT03329001|616307928|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
170536225|NCT03329001|616307929|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
170536226|NCT03329001|616307930|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
170536227|NCT03329001|616307931|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
170536228|NCT01138046|616307932|FG000|Overall Study|Withdrawal due to death|6|||
170536229|NCT02178956|616307933|FG000|Overall Study|Lost to Follow-up|4|||
170536230|NCT02178956|616307934|FG001|Overall Study|Lost to Follow-up|4|||
170536231|NCT02178956|616307933|FG000|Overall Study|Sponsor terminated study|49|||
170536232|NCT02178956|616307934|FG001|Overall Study|Sponsor terminated study|58|||
170536233|NCT02178956|616307933|FG000|Overall Study|Withdrawal by Subject|15|||
170536234|NCT02178956|616307934|FG001|Overall Study|Withdrawal by Subject|11|||
170536235|NCT02178956|616307933|FG000|Overall Study|Various Reasons|3|||
170536236|NCT02178956|616307934|FG001|Overall Study|Various Reasons|5|||
170536237|NCT04225832|616307936|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
170536238|NCT04225832|616307937|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
170536239|NCT04225832|616307936|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
170536240|NCT04225832|616307937|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
170536241|NCT00390013|616307941|FG000|Phase 1|tired|0|||
170536242|NCT00390013|616307942|FG001|Phase 1|tired|0|||
170536243|NCT00390013|616307943|FG002|Phase 1|tired|0|||
170536244|NCT00390013|616307944|FG003|Phase 1|tired|1|||
170536245|NCT00390013|616307941|FG000|Phase 2 First Treatment|tired|1|||
170536246|NCT00390013|616307942|FG001|Phase 2 First Treatment|tired|0|||
170536247|NCT00390013|616307943|FG002|Phase 2 First Treatment|tired|0|||
170536248|NCT00390013|616307944|FG003|Phase 2 First Treatment|tired|0|||
170536249|NCT00390013|616307941|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
170536250|NCT00390013|616307942|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
170536251|NCT00390013|616307943|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
170536252|NCT00390013|616307944|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
170536253|NCT00876343|616307954|FG000|Overall Study|Adverse Event|7|||
170536254|NCT00876343|616307955|FG001|Overall Study|Adverse Event|8|||
170536255|NCT00876343|616307956|FG002|Overall Study|Adverse Event|2|||
170536256|NCT00876343|616307954|FG000|Overall Study|Withdrawal by Subject|4|||
170536257|NCT00876343|616307955|FG001|Overall Study|Withdrawal by Subject|4|||
170536258|NCT00876343|616307956|FG002|Overall Study|Withdrawal by Subject|3|||
170536259|NCT00876343|616307954|FG000|Overall Study|Lack of Efficacy|0|||
170536260|NCT00876343|616307955|FG001|Overall Study|Lack of Efficacy|0|||
170536261|NCT00876343|616307956|FG002|Overall Study|Lack of Efficacy|1|||
170778970|NCT02605837|617197313|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170778971|NCT02605837|617197314|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170778972|NCT02605837|617197313|FG000|Overall Study|Withdrawal by Subject|8|||
170778973|NCT02605837|617197314|FG001|Overall Study|Withdrawal by Subject|8|||
170778974|NCT02605837|617197313|FG000|Overall Study|Physician Decision|0|||
170778975|NCT02605837|617197314|FG001|Overall Study|Physician Decision|1|||
170778976|NCT05656911|617197315|FG000|Treatment Phase|Physician Decision|2|||
170778977|NCT05656911|617197316|FG001|Treatment Phase|Physician Decision|0|||
170778978|NCT05656911|617197315|FG000|Treatment Phase|Lack of Efficacy|6|||
170778979|NCT05656911|617197316|FG001|Treatment Phase|Lack of Efficacy|3|||
170778980|NCT05656911|617197315|FG000|Treatment Phase|Subject Decision|4|||
170536262|NCT00876343|616307954|FG000|Overall Study|Protocol Violation|4|||
170536263|NCT00876343|616307955|FG001|Overall Study|Protocol Violation|1|||
170536264|NCT00876343|616307956|FG002|Overall Study|Protocol Violation|1|||
170536265|NCT00876343|616307954|FG000|Overall Study|Physician Decision|0|||
170536266|NCT00876343|616307955|FG001|Overall Study|Physician Decision|1|||
170433496|NCT00112437|615925730|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433497|NCT00112437|615925731|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433498|NCT00112437|615925732|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433499|NCT00112437|615925733|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433500|NCT00112437|615925734|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433501|NCT00112437|615925735|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433502|NCT00112437|615925736|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433503|NCT00112437|615925737|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433504|NCT00112437|615925738|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433505|NCT00112437|615925739|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433506|NCT00112437|615925740|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433507|NCT00112437|615925741|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433508|NCT00112437|615925742|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433509|NCT00112437|615925743|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433510|NCT00112437|615925744|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433511|NCT00112437|615925745|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433512|NCT00112437|615925746|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433513|NCT00112437|615925747|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433514|NCT00112437|615925748|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433515|NCT00112437|615925749|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433516|NCT00112437|615925750|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433517|NCT00112437|615925751|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433518|NCT00112437|615925752|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
170536267|NCT00876343|616307956|FG002|Overall Study|Physician Decision|1|||
170536268|NCT00876343|616307954|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
170536269|NCT00876343|616307955|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
170536270|NCT00876343|616307956|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
170536271|NCT00876343|616307954|FG000|Overall Study|Change of residence or other commitments|2|||
170536272|NCT00876343|616307955|FG001|Overall Study|Change of residence or other commitments|2|||
170536273|NCT00876343|616307956|FG002|Overall Study|Change of residence or other commitments|3|||
170536274|NCT01901562|616307960|FG000|Overall Study|Protocol Violation|5|||
170536275|NCT01901562|616307960|FG000|Overall Study|Excluded intraoperatively|4|||
170536276|NCT00294658|616307961|FG000|Overall Study|Death|0|||
170536277|NCT00294658|616307962|FG001|Overall Study|Death|1|||
170536278|NCT00294658|616307961|FG000|Overall Study|Lost to Follow-up|4|||
170536279|NCT00294658|616307962|FG001|Overall Study|Lost to Follow-up|0|||
170536280|NCT00294658|616307961|FG000|Overall Study|Physician Decision|1|||
170536281|NCT00294658|616307962|FG001|Overall Study|Physician Decision|2|||
170536282|NCT00294658|616307961|FG000|Overall Study|Pregnancy|0|||
170536283|NCT00294658|616307962|FG001|Overall Study|Pregnancy|1|||
170536284|NCT00294658|616307961|FG000|Overall Study|Withdrawal by Subject|0|||
170536285|NCT00294658|616307962|FG001|Overall Study|Withdrawal by Subject|4|||
170536286|NCT00294658|616307961|FG000|Overall Study|Found to have invasive thymoma|1|||
170536287|NCT00294658|616307962|FG001|Overall Study|Found to have invasive thymoma|0|||
170536288|NCT00294658|616307961|FG000|Overall Study|Patient and family were not satisfied|0|||
170536289|NCT00294658|616307962|FG001|Overall Study|Patient and family were not satisfied|1|||
170536290|NCT01192178|616307964|FG000|Overall Study|Withdrawal by Subject|6|||
170536291|NCT01192178|616307965|FG001|Overall Study|Withdrawal by Subject|10|||
170433519|NCT00112437|615925753|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
170433520|NCT00112437|615925754|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
170433521|NCT00112437|615925755|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
170433522|NCT00112437|615925730|FG000|Years 6-10 (60-Month Extension)|Death|0|||
170433523|NCT00112437|615925731|FG001|Years 6-10 (60-Month Extension)|Death|0|||
170536292|NCT01192178|616307964|FG000|Overall Study|Protocol Violation|10|||
170536293|NCT01192178|616307965|FG001|Overall Study|Protocol Violation|3|||
170536294|NCT01192178|616307964|FG000|Overall Study|Physician Decision|2|||
170536295|NCT01192178|616307965|FG001|Overall Study|Physician Decision|4|||
170536296|NCT01192178|616307964|FG000|Overall Study|Lost to Follow-up|3|||
170778981|NCT05656911|617197316|FG001|Treatment Phase|Subject Decision|2|||
170433524|NCT00112437|615925732|FG002|Years 6-10 (60-Month Extension)|Death|0|||
170536297|NCT01192178|616307965|FG001|Overall Study|Lost to Follow-up|3|||
170433525|NCT00112437|615925733|FG003|Years 6-10 (60-Month Extension)|Death|0|||
170433526|NCT00112437|615925734|FG004|Years 6-10 (60-Month Extension)|Death|0|||
170536298|NCT01192178|616307964|FG000|Overall Study|Adverse Event|2|||
170536299|NCT01192178|616307965|FG001|Overall Study|Adverse Event|1|||
170536300|NCT01192178|616307964|FG000|Overall Study|Lack of Efficacy|1|||
170536301|NCT01192178|616307965|FG001|Overall Study|Lack of Efficacy|2|||
170536302|NCT02460289|616307968|FG000|Overall Study|Adverse Event|1|||
170536303|NCT02460289|616307968|FG000|Overall Study|Withdrawal by Subject|8|||
170536304|NCT02460289|616307968|FG000|Overall Study|Lost to Follow-up|1|||
170536305|NCT00296517|616307969|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
170536306|NCT00296517|616307970|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
170536307|NCT00296517|616307969|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
170536308|NCT00296517|616307970|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
170536309|NCT00296517|616307969|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
170536310|NCT00296517|616307970|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
170536311|NCT00296517|616307969|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
170536312|NCT00296517|616307970|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
170536313|NCT00296517|616307969|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
170536314|NCT00296517|616307970|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
170536315|NCT00296517|616307969|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
170536316|NCT00296517|616307970|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
170536317|NCT00296517|616307969|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
170536318|NCT00296517|616307970|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
170536319|NCT00296517|616307969|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
170536320|NCT00296517|616307970|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
170536321|NCT00296517|616307969|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
170536322|NCT00296517|616307970|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
170536323|NCT02164916|616307971|FG000|Overall Study|Adverse Event|3|||
170536324|NCT02164916|616307972|FG001|Overall Study|Adverse Event|8|||
170536325|NCT02164916|616307971|FG000|Overall Study|Death|1|||
170536326|NCT02164916|616307972|FG001|Overall Study|Death|1|||
170536327|NCT02164916|616307971|FG000|Overall Study|Refusal unrelated to adverse event|3|||
170536328|NCT02164916|616307972|FG001|Overall Study|Refusal unrelated to adverse event|7|||
170536329|NCT02164916|616307971|FG000|Overall Study|Progression|37|||
170536330|NCT02164916|616307972|FG001|Overall Study|Progression|26|||
170536331|NCT02164916|616307971|FG000|Overall Study|Not protocol specified|5|||
170536332|NCT02164916|616307972|FG001|Overall Study|Not protocol specified|1|||
170536333|NCT02164916|616307971|FG000|Overall Study|Reason under review|1|||
170536334|NCT02164916|616307972|FG001|Overall Study|Reason under review|6|||
170536335|NCT02164916|616307971|FG000|Overall Study|Not eligible|2|||
170536336|NCT02164916|616307972|FG001|Overall Study|Not eligible|5|||
170536337|NCT01155570|616307973|FG000|Overall Study|Adverse Event|39|||
170536338|NCT01155570|616307973|FG000|Overall Study|Lack of Efficacy|46|||
170536339|NCT01155570|616307973|FG000|Overall Study|Participant's Economic Reasons|17|||
170536340|NCT01155570|616307973|FG000|Overall Study|No Hospital Visits|7|||
170536341|NCT01155570|616307973|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
170536342|NCT01155570|616307973|FG000|Overall Study|Adverse Event + Other Reasons|7|||
170433527|NCT00112437|615925735|FG005|Years 6-10 (60-Month Extension)|Death|0|||
170433528|NCT00112437|615925736|FG006|Years 6-10 (60-Month Extension)|Death|0|||
170433529|NCT00112437|615925737|FG007|Years 6-10 (60-Month Extension)|Death|0|||
170433530|NCT00112437|615925738|FG008|Years 6-10 (60-Month Extension)|Death|0|||
170433531|NCT00112437|615925739|FG009|Years 6-10 (60-Month Extension)|Death|0|||
170433532|NCT00112437|615925740|FG010|Years 6-10 (60-Month Extension)|Death|0|||
170433533|NCT00112437|615925741|FG011|Years 6-10 (60-Month Extension)|Death|0|||
170433534|NCT00112437|615925742|FG012|Years 6-10 (60-Month Extension)|Death|0|||
170433535|NCT00112437|615925743|FG013|Years 6-10 (60-Month Extension)|Death|0|||
170433536|NCT00112437|615925744|FG014|Years 6-10 (60-Month Extension)|Death|0|||
170433537|NCT00112437|615925745|FG015|Years 6-10 (60-Month Extension)|Death|0|||
170433538|NCT00112437|615925746|FG016|Years 6-10 (60-Month Extension)|Death|0|||
170433539|NCT00112437|615925747|FG017|Years 6-10 (60-Month Extension)|Death|0|||
170433540|NCT00112437|615925748|FG018|Years 6-10 (60-Month Extension)|Death|0|||
170433541|NCT00112437|615925749|FG019|Years 6-10 (60-Month Extension)|Death|0|||
170433542|NCT00112437|615925750|FG020|Years 6-10 (60-Month Extension)|Death|0|||
170433543|NCT00112437|615925751|FG021|Years 6-10 (60-Month Extension)|Death|0|||
170433544|NCT00112437|615925752|FG022|Years 6-10 (60-Month Extension)|Death|0|||
170433545|NCT00112437|615925753|FG023|Years 6-10 (60-Month Extension)|Death|2|||
170433546|NCT00112437|615925754|FG024|Years 6-10 (60-Month Extension)|Death|0|||
170433547|NCT00112437|615925755|FG025|Years 6-10 (60-Month Extension)|Death|0|||
170433548|NCT00112437|615925730|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433549|NCT00112437|615925731|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433550|NCT00112437|615925732|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433551|NCT00112437|615925733|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433552|NCT00112437|615925734|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170536343|NCT01155570|616307973|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
170536344|NCT01155570|616307973|FG000|Overall Study|Other Reasons|23|||
170536345|NCT01922934|616307974|FG000|Eligible Patients|Death|0|||
170536346|NCT01922934|616307975|FG001|Eligible Patients|Death|7|||
170536347|NCT01922934|616307974|FG000|Eligible Patients|Physician Decision|17|||
170536348|NCT01922934|616307975|FG001|Eligible Patients|Physician Decision|0|||
170536349|NCT01922934|616307974|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
170536350|NCT01922934|616307975|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
170536351|NCT01922934|616307974|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
170536352|NCT01922934|616307975|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
170536353|NCT01922934|616307974|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
170536354|NCT01922934|616307975|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
170536355|NCT01922934|616307974|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
170536356|NCT01922934|616307975|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
170536357|NCT00596635|616307983|FG000|Overall Study|Lost to Follow-up|0|||
170536358|NCT00596635|616307984|FG001|Overall Study|Lost to Follow-up|2|||
170536359|NCT00596635|616307985|FG002|Overall Study|Lost to Follow-up|0|||
170536360|NCT00596635|616307983|FG000|Overall Study|Treatment for symptomatic UTI|4|||
170536361|NCT00596635|616307984|FG001|Overall Study|Treatment for symptomatic UTI|6|||
170536362|NCT00596635|616307985|FG002|Overall Study|Treatment for symptomatic UTI|3|||
170536363|NCT00596635|616307983|FG000|Overall Study|Hip fracture|2|||
170536364|NCT00596635|616307984|FG001|Overall Study|Hip fracture|3|||
170536365|NCT00596635|616307985|FG002|Overall Study|Hip fracture|3|||
170536366|NCT00596635|616307983|FG000|Overall Study|Could not provide urine specimen|1|||
170433553|NCT00112437|615925735|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433554|NCT00112437|615925736|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433555|NCT00112437|615925737|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433556|NCT00112437|615925738|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433557|NCT00112437|615925739|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433558|NCT00112437|615925740|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433559|NCT00112437|615925741|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433560|NCT00112437|615925742|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433561|NCT00112437|615925743|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433562|NCT00112437|615925744|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433563|NCT00112437|615925745|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433564|NCT00112437|615925746|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433565|NCT00112437|615925747|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433566|NCT00112437|615925748|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433567|NCT00112437|615925749|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433568|NCT00112437|615925750|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433569|NCT00112437|615925751|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433570|NCT00112437|615925752|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433571|NCT00112437|615925753|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433572|NCT00112437|615925754|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
170433573|NCT00112437|615925755|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
170433574|NCT00112437|615925730|FG000|Years 6-10 (60-Month Extension)|Other|0|||
170433575|NCT00112437|615925731|FG001|Years 6-10 (60-Month Extension)|Other|0|||
170433576|NCT00112437|615925732|FG002|Years 6-10 (60-Month Extension)|Other|0|||
170433577|NCT00112437|615925733|FG003|Years 6-10 (60-Month Extension)|Other|0|||
170433578|NCT00112437|615925734|FG004|Years 6-10 (60-Month Extension)|Other|0|||
170433579|NCT00112437|615925735|FG005|Years 6-10 (60-Month Extension)|Other|0|||
170433580|NCT00112437|615925736|FG006|Years 6-10 (60-Month Extension)|Other|0|||
170433581|NCT00112437|615925737|FG007|Years 6-10 (60-Month Extension)|Other|0|||
170433582|NCT00112437|615925738|FG008|Years 6-10 (60-Month Extension)|Other|0|||
170433583|NCT00112437|615925739|FG009|Years 6-10 (60-Month Extension)|Other|0|||
170433584|NCT00112437|615925740|FG010|Years 6-10 (60-Month Extension)|Other|0|||
170433585|NCT00112437|615925741|FG011|Years 6-10 (60-Month Extension)|Other|0|||
170433586|NCT00112437|615925742|FG012|Years 6-10 (60-Month Extension)|Other|0|||
170433587|NCT00112437|615925743|FG013|Years 6-10 (60-Month Extension)|Other|0|||
170433588|NCT00112437|615925744|FG014|Years 6-10 (60-Month Extension)|Other|0|||
170433589|NCT00112437|615925745|FG015|Years 6-10 (60-Month Extension)|Other|0|||
170433590|NCT00112437|615925746|FG016|Years 6-10 (60-Month Extension)|Other|0|||
170433591|NCT00112437|615925747|FG017|Years 6-10 (60-Month Extension)|Other|0|||
170433592|NCT00112437|615925748|FG018|Years 6-10 (60-Month Extension)|Other|0|||
170433593|NCT00112437|615925749|FG019|Years 6-10 (60-Month Extension)|Other|0|||
170433594|NCT00112437|615925750|FG020|Years 6-10 (60-Month Extension)|Other|0|||
170433595|NCT00112437|615925751|FG021|Years 6-10 (60-Month Extension)|Other|0|||
170433596|NCT00112437|615925752|FG022|Years 6-10 (60-Month Extension)|Other|0|||
170433597|NCT00112437|615925753|FG023|Years 6-10 (60-Month Extension)|Other|0|||
170433598|NCT00112437|615925754|FG024|Years 6-10 (60-Month Extension)|Other|1|||
170433599|NCT00112437|615925755|FG025|Years 6-10 (60-Month Extension)|Other|0|||
170433600|NCT00112437|615925730|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433601|NCT00112437|615925731|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433602|NCT00112437|615925732|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433603|NCT00112437|615925733|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433604|NCT00112437|615925734|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433605|NCT00112437|615925735|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433606|NCT00112437|615925736|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433607|NCT00112437|615925737|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433608|NCT00112437|615925738|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433609|NCT00112437|615925739|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433610|NCT00112437|615925740|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433611|NCT00112437|615925741|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433612|NCT00112437|615925742|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433613|NCT00112437|615925743|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433614|NCT00112437|615925744|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433615|NCT00112437|615925745|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433616|NCT00112437|615925746|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433617|NCT00112437|615925747|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433618|NCT00112437|615925748|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433619|NCT00112437|615925749|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433620|NCT00112437|615925750|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433621|NCT00112437|615925751|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433622|NCT00112437|615925752|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433623|NCT00112437|615925753|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
170433624|NCT00112437|615925754|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433625|NCT00112437|615925755|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
170433626|NCT00112437|615925730|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433627|NCT00112437|615925731|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433628|NCT00112437|615925732|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433629|NCT00112437|615925733|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433630|NCT00112437|615925734|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433631|NCT00112437|615925735|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433632|NCT00112437|615925736|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433633|NCT00112437|615925737|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433634|NCT00112437|615925738|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433635|NCT00112437|615925739|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433636|NCT00112437|615925740|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433637|NCT00112437|615925741|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433638|NCT00112437|615925742|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433639|NCT00112437|615925743|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433640|NCT00112437|615925744|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433641|NCT00112437|615925745|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433642|NCT00112437|615925746|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433643|NCT00112437|615925747|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433644|NCT00112437|615925748|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433645|NCT00112437|615925749|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433646|NCT00112437|615925750|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433647|NCT00112437|615925751|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433648|NCT00112437|615925752|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
170433649|NCT00112437|615925753|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
170433650|NCT00112437|615925754|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
170433651|NCT00112437|615925755|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
170433652|NCT01983969|615925757|FG000|Overall Study|Disease Progression|0|||
170433653|NCT01983969|615925758|FG001|Overall Study|Disease Progression|1|||
170433654|NCT01983969|615925759|FG002|Overall Study|Disease Progression|0|||
170433655|NCT03218787|615925760|FG000|Overall Study|Lost to Follow-up|12|||
170433656|NCT03218787|615925760|FG000|Overall Study|Withdrawal by Subject|72|||
170433657|NCT03218787|615925760|FG000|Overall Study|Physician Decision|11|||
170433658|NCT03218787|615925760|FG000|Overall Study|Death|111|||
170433659|NCT00436163|615925761|FG000|Overall Study|Lost to Follow-up|2|||
170433660|NCT00436163|615925761|FG000|Overall Study|Adverse Event|1|||
170433661|NCT03719040|615925762|FG000|Overall Study|Withdrawal by Subject|177|||
170433662|NCT03719040|615925762|FG000|Overall Study|Lost to Follow-up|26|||
170433663|NCT02896296|615925763|FG000|Overall Study|Adverse Event|1|||
170433664|NCT02896296|615925763|FG000|Overall Study|Lost to Follow-up|19|||
170433665|NCT02896296|615925763|FG000|Overall Study|Pregnancy|1|||
170433666|NCT02896296|615925763|FG000|Overall Study|Physician Decision|2|||
170433667|NCT02896296|615925763|FG000|Overall Study|Withdrawal by Subject|10|||
170433668|NCT02896296|615925763|FG000|Overall Study|Site closing|7|||
170433669|NCT02896296|615925763|FG000|Overall Study|Incarceration|1|||
170433670|NCT02896296|615925763|FG000|Overall Study|Relocation|1|||
170433671|NCT00268203|615925764|FG000|Overall Study|Lost to Follow-up|92|||
170433672|NCT00268203|615925764|FG000|Overall Study|Withdrawal by Subject|9|||
170433673|NCT00268203|615925764|FG000|Overall Study|Received Other NHL Therapy|7|||
170433674|NCT00268203|615925764|FG000|Overall Study|Progressive Disease|359|||
170536367|NCT00596635|616307984|FG001|Overall Study|Could not provide urine specimen|2|||
170536368|NCT00596635|616307985|FG002|Overall Study|Could not provide urine specimen|2|||
170536369|NCT01143324|616307986|FG000|Overall Study|Lost to Follow-up|11|||
170880827|NCT01650636|617574384|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
170433675|NCT00268203|615925764|FG000|Overall Study|Death|84|||
170433676|NCT00268203|615925764|FG000|Overall Study|Reason Not Specified|34|||
170433677|NCT00268203|615925764|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
170880828|NCT01650636|617574383|FG000|Washout up to 5 Months|Physician Decision|2|||
170536370|NCT01143324|616307986|FG000|Overall Study|Withdrawal by Subject|4|||
170536371|NCT01143324|616307986|FG000|Overall Study|Explant of the device|4|||
170880829|NCT01650636|617574384|FG001|Washout up to 5 Months|Physician Decision|2|||
170632740|NCT04672239|616666762|FG001|Week 2 Survey|Withdrawal by Subject|1|||
170632741|NCT04672239|616666763|FG002|Week 2 Survey|Withdrawal by Subject|0|||
170632742|NCT04672239|616666761|FG000|Week 2 Survey|Lost to Follow-up|3|||
170880830|NCT01650636|617574383|FG000|Washout up to 5 Months|Death|1|||
170632743|NCT04672239|616666762|FG001|Week 2 Survey|Lost to Follow-up|2|||
170632744|NCT04672239|616666763|FG002|Week 2 Survey|Lost to Follow-up|5|||
170632745|NCT04672239|616666761|FG000|Week 6 Survey|Failed survey check items|2|||
170632746|NCT04672239|616666762|FG001|Week 6 Survey|Failed survey check items|2|||
170632747|NCT04672239|616666763|FG002|Week 6 Survey|Failed survey check items|2|||
170632748|NCT04672239|616666761|FG000|Week 6 Survey|Partially completed survey|3|||
170632749|NCT04672239|616666762|FG001|Week 6 Survey|Partially completed survey|3|||
170632750|NCT04672239|616666763|FG002|Week 6 Survey|Partially completed survey|2|||
170632751|NCT04672239|616666761|FG000|Week 6 Survey|Withdrawal by Subject|1|||
170632752|NCT04672239|616666762|FG001|Week 6 Survey|Withdrawal by Subject|1|||
170632753|NCT04672239|616666763|FG002|Week 6 Survey|Withdrawal by Subject|1|||
170632754|NCT04672239|616666761|FG000|Week 6 Survey|Withdrawn by PI|0|||
170632755|NCT04672239|616666762|FG001|Week 6 Survey|Withdrawn by PI|1|||
170632756|NCT04672239|616666763|FG002|Week 6 Survey|Withdrawn by PI|0|||
170632757|NCT04672239|616666761|FG000|Week 6 Survey|Lost to Follow-up|12|||
170632758|NCT04672239|616666762|FG001|Week 6 Survey|Lost to Follow-up|2|||
170632759|NCT04672239|616666763|FG002|Week 6 Survey|Lost to Follow-up|5|||
170632760|NCT04672239|616666761|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
170632761|NCT04672239|616666762|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
170632762|NCT04672239|616666763|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
170632763|NCT04672239|616666761|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
170632764|NCT04672239|616666762|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
170632765|NCT04672239|616666763|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
170632766|NCT04672239|616666761|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
170632767|NCT04672239|616666762|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
170632768|NCT04672239|616666763|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
170632769|NCT04672239|616666761|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
170632770|NCT04672239|616666762|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
170632771|NCT04672239|616666763|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
170632772|NCT04672239|616666761|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
170433714|NCT02923349|615925779|FG000|Overall Study|Other|1|||
170433715|NCT02923349|615925780|FG001|Overall Study|Other|2|||
170433716|NCT02923349|615925781|FG002|Overall Study|Other|4|||
170433717|NCT02923349|615925782|FG003|Overall Study|Other|1|||
170433718|NCT02923349|615925783|FG004|Overall Study|Other|3|||
170433719|NCT02923349|615925784|FG005|Overall Study|Other|0|||
170433720|NCT02923349|615925785|FG006|Overall Study|Other|1|||
170433721|NCT02923349|615925779|FG000|Overall Study|Withdrawal by Subject|2|||
170433722|NCT02923349|615925780|FG001|Overall Study|Withdrawal by Subject|2|||
170433723|NCT02923349|615925781|FG002|Overall Study|Withdrawal by Subject|8|||
170433724|NCT02923349|615925782|FG003|Overall Study|Withdrawal by Subject|10|||
170433725|NCT02923349|615925783|FG004|Overall Study|Withdrawal by Subject|12|||
170433726|NCT02923349|615925784|FG005|Overall Study|Withdrawal by Subject|3|||
170433727|NCT02923349|615925785|FG006|Overall Study|Withdrawal by Subject|0|||
170433728|NCT02923349|615925779|FG000|Overall Study|Physician Decision|0|||
170433729|NCT02923349|615925780|FG001|Overall Study|Physician Decision|0|||
170433730|NCT02923349|615925781|FG002|Overall Study|Physician Decision|0|||
170433731|NCT02923349|615925782|FG003|Overall Study|Physician Decision|1|||
170433732|NCT02923349|615925783|FG004|Overall Study|Physician Decision|1|||
170433733|NCT02923349|615925784|FG005|Overall Study|Physician Decision|0|||
170433734|NCT02923349|615925785|FG006|Overall Study|Physician Decision|2|||
170433735|NCT02923349|615925779|FG000|Overall Study|Lost to Follow-up|0|||
170433736|NCT02923349|615925780|FG001|Overall Study|Lost to Follow-up|0|||
170433737|NCT02923349|615925781|FG002|Overall Study|Lost to Follow-up|3|||
170433738|NCT02923349|615925782|FG003|Overall Study|Lost to Follow-up|0|||
170433739|NCT02923349|615925783|FG004|Overall Study|Lost to Follow-up|1|||
170433740|NCT02923349|615925784|FG005|Overall Study|Lost to Follow-up|1|||
170433741|NCT02923349|615925785|FG006|Overall Study|Lost to Follow-up|0|||
170433742|NCT02923349|615925779|FG000|Overall Study|Death|1|||
170433743|NCT02923349|615925780|FG001|Overall Study|Death|0|||
170433744|NCT02923349|615925781|FG002|Overall Study|Death|2|||
170433745|NCT02923349|615925782|FG003|Overall Study|Death|4|||
170433746|NCT02923349|615925783|FG004|Overall Study|Death|2|||
170433747|NCT02923349|615925784|FG005|Overall Study|Death|3|||
170433748|NCT02923349|615925785|FG006|Overall Study|Death|0|||
170433749|NCT03250117|615925788|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
170433750|NCT03250117|615925789|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
170433751|NCT03250117|615925790|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
170433752|NCT03250117|615925791|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
170433753|NCT02751827|615925792|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
170433754|NCT02751827|615925793|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
170433755|NCT02751827|615925794|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
170433756|NCT01248728|615925795|FG000|Overall Study|Adverse Event|1|||
170433757|NCT01248728|615925796|FG001|Overall Study|Adverse Event|1|||
170433758|NCT01248728|615925795|FG000|Overall Study|Withdrawal by Subject|2|||
170433759|NCT01248728|615925796|FG001|Overall Study|Withdrawal by Subject|1|||
170433760|NCT01248728|615925795|FG000|Overall Study|Lack of Efficacy|1|||
170433761|NCT01248728|615925796|FG001|Overall Study|Lack of Efficacy|0|||
170433762|NCT03804983|615925797|FG000|Overall Study|Adverse Event|0|||
170433763|NCT03804983|615925798|FG001|Overall Study|Adverse Event|1|||
170433764|NCT03804983|615925797|FG000|Overall Study|Family Obligation|1|||
170433765|NCT03804983|615925798|FG001|Overall Study|Family Obligation|0|||
170433766|NCT01838681|615925799|FG000|Period A|Adverse Event|39|||
170433767|NCT01838681|615925800|FG001|Period A|Adverse Event|0|||
170433768|NCT01838681|615925801|FG002|Period A|Adverse Event|0|||
170433769|NCT01838681|615925802|FG003|Period A|Adverse Event|0|||
170433770|NCT01838681|615925799|FG000|Period A|Lack of Efficacy|21|||
170433771|NCT01838681|615925800|FG001|Period A|Lack of Efficacy|0|||
170433772|NCT01838681|615925801|FG002|Period A|Lack of Efficacy|0|||
170433773|NCT01838681|615925802|FG003|Period A|Lack of Efficacy|0|||
170433774|NCT01838681|615925799|FG000|Period A|Early response|148|||
170433775|NCT01838681|615925800|FG001|Period A|Early response|0|||
170433776|NCT01838681|615925801|FG002|Period A|Early response|0|||
170433777|NCT01838681|615925802|FG003|Period A|Early response|0|||
170433778|NCT01838681|615925799|FG000|Period A|Withdrawal by Subject|70|||
170433779|NCT01838681|615925800|FG001|Period A|Withdrawal by Subject|0|||
170433780|NCT01838681|615925801|FG002|Period A|Withdrawal by Subject|0|||
170433781|NCT01838681|615925802|FG003|Period A|Withdrawal by Subject|0|||
170433782|NCT01838681|615925799|FG000|Period A|Protocol Violation|16|||
170433783|NCT01838681|615925800|FG001|Period A|Protocol Violation|0|||
170433784|NCT01838681|615925801|FG002|Period A|Protocol Violation|0|||
170433785|NCT01838681|615925802|FG003|Period A|Protocol Violation|0|||
170433786|NCT01838681|615925799|FG000|Period A|Non-compliance with IMP|6|||
170433787|NCT01838681|615925800|FG001|Period A|Non-compliance with IMP|0|||
170433788|NCT01838681|615925801|FG002|Period A|Non-compliance with IMP|0|||
170433789|NCT01838681|615925802|FG003|Period A|Non-compliance with IMP|0|||
170433790|NCT01838681|615925799|FG000|Period A|Lost to Follow-up|4|||
170433791|NCT01838681|615925800|FG001|Period A|Lost to Follow-up|0|||
170433792|NCT01838681|615925801|FG002|Period A|Lost to Follow-up|0|||
170433793|NCT01838681|615925802|FG003|Period A|Lost to Follow-up|0|||
170433794|NCT01838681|615925799|FG000|Period A|Withdrawal before treatment|4|||
170433795|NCT01838681|615925800|FG001|Period A|Withdrawal before treatment|0|||
170433796|NCT01838681|615925801|FG002|Period A|Withdrawal before treatment|0|||
170433797|NCT01838681|615925802|FG003|Period A|Withdrawal before treatment|0|||
170433798|NCT01838681|615925799|FG000|Period A|Administrative or other reasons|17|||
170433799|NCT01838681|615925800|FG001|Period A|Administrative or other reasons|0|||
170433800|NCT01838681|615925801|FG002|Period A|Administrative or other reasons|0|||
170433801|NCT01838681|615925802|FG003|Period A|Administrative or other reasons|0|||
170433802|NCT01838681|615925799|FG000|Period B/A+|Adverse Event|0|||
170433803|NCT01838681|615925800|FG001|Period B/A+|Adverse Event|13|||
170433804|NCT01838681|615925801|FG002|Period B/A+|Adverse Event|27|||
170433805|NCT01838681|615925802|FG003|Period B/A+|Adverse Event|16|||
170433806|NCT01838681|615925799|FG000|Period B/A+|Lack of Efficacy|0|||
170433807|NCT01838681|615925800|FG001|Period B/A+|Lack of Efficacy|9|||
170433808|NCT01838681|615925801|FG002|Period B/A+|Lack of Efficacy|11|||
170433809|NCT01838681|615925802|FG003|Period B/A+|Lack of Efficacy|6|||
170433810|NCT01838681|615925799|FG000|Period B/A+|Withdrawal by Subject|0|||
170433811|NCT01838681|615925800|FG001|Period B/A+|Withdrawal by Subject|28|||
170433812|NCT01838681|615925801|FG002|Period B/A+|Withdrawal by Subject|35|||
170433813|NCT01838681|615925802|FG003|Period B/A+|Withdrawal by Subject|47|||
170433814|NCT01838681|615925799|FG000|Period B/A+|Protocol Violation|0|||
170433815|NCT01838681|615925800|FG001|Period B/A+|Protocol Violation|1|||
170433816|NCT01838681|615925801|FG002|Period B/A+|Protocol Violation|4|||
170433817|NCT01838681|615925802|FG003|Period B/A+|Protocol Violation|6|||
170433818|NCT01838681|615925799|FG000|Period B/A+|Non-compliance with IMP|0|||
170433819|NCT01838681|615925800|FG001|Period B/A+|Non-compliance with IMP|2|||
170433820|NCT01838681|615925801|FG002|Period B/A+|Non-compliance with IMP|3|||
170433821|NCT01838681|615925802|FG003|Period B/A+|Non-compliance with IMP|3|||
170433822|NCT01838681|615925799|FG000|Period B/A+|Lost to Follow-up|0|||
170433823|NCT01838681|615925800|FG001|Period B/A+|Lost to Follow-up|2|||
170433824|NCT01838681|615925801|FG002|Period B/A+|Lost to Follow-up|5|||
170433825|NCT01838681|615925802|FG003|Period B/A+|Lost to Follow-up|11|||
170433826|NCT01838681|615925799|FG000|Period B/A+|Withdrawal before treatment|0|||
170433827|NCT01838681|615925800|FG001|Period B/A+|Withdrawal before treatment|1|||
170433828|NCT01838681|615925801|FG002|Period B/A+|Withdrawal before treatment|0|||
170433829|NCT01838681|615925802|FG003|Period B/A+|Withdrawal before treatment|0|||
170433830|NCT01838681|615925799|FG000|Period B/A+|Administrative or other reasons|0|||
170433831|NCT01838681|615925800|FG001|Period B/A+|Administrative or other reasons|6|||
170433832|NCT01838681|615925801|FG002|Period B/A+|Administrative or other reasons|10|||
170433833|NCT01838681|615925802|FG003|Period B/A+|Administrative or other reasons|28|||
170433834|NCT00796562|615925806|FG000|Overall Study|Death|49|||
170433835|NCT05655520|615925807|FG000|Overall Study|Adverse Event|2|||
170433836|NCT05655520|615925808|FG001|Overall Study|Adverse Event|3|||
170433837|NCT05655520|615925807|FG000|Overall Study|Physician Decision|2|||
170433838|NCT05655520|615925808|FG001|Overall Study|Physician Decision|0|||
170433839|NCT05655520|615925807|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170433840|NCT05655520|615925808|FG001|Overall Study|Non-Compliance with Study Drug|2|||
170433841|NCT05655520|615925807|FG000|Overall Study|Lost to Follow-up|1|||
170433842|NCT05655520|615925808|FG001|Overall Study|Lost to Follow-up|0|||
170433843|NCT05655520|615925807|FG000|Overall Study|Withdrawal by Subject|4|||
170433844|NCT05655520|615925808|FG001|Overall Study|Withdrawal by Subject|4|||
170433845|NCT05655520|615925807|FG000|Overall Study|Study Terminated by Sponsor|61|||
170433846|NCT05655520|615925808|FG001|Overall Study|Study Terminated by Sponsor|68|||
170433847|NCT04633564|615925811|FG000|Period 1|Adverse Event|28|||
170433848|NCT04633564|615925812|FG001|Period 1|Adverse Event|19|||
170433849|NCT04633564|615925811|FG000|Period 1|Death|8|||
170433850|NCT04633564|615925812|FG001|Period 1|Death|7|||
170433851|NCT04633564|615925811|FG000|Period 1|Lost to Follow-up|3|||
170433852|NCT04633564|615925812|FG001|Period 1|Lost to Follow-up|5|||
170433853|NCT04633564|615925811|FG000|Period 1|Physician Decision|4|||
170433854|NCT04633564|615925812|FG001|Period 1|Physician Decision|12|||
170433855|NCT04633564|615925811|FG000|Period 1|Protocol Violation|0|||
170433856|NCT04633564|615925812|FG001|Period 1|Protocol Violation|1|||
170433857|NCT04633564|615925811|FG000|Period 1|Withdrawal by Subject|10|||
170433858|NCT04633564|615925812|FG001|Period 1|Withdrawal by Subject|8|||
170433859|NCT04633564|615925811|FG000|Period 1|Progressive disease|47|||
170433860|NCT04633564|615925812|FG001|Period 1|Progressive disease|51|||
170433861|NCT04633564|615925811|FG000|Period 1|Terminated by Sponsor|8|||
170433862|NCT04633564|615925812|FG001|Period 1|Terminated by Sponsor|6|||
170433863|NCT04633564|615925811|FG000|Period 2|Adverse Event|3|||
170433864|NCT04633564|615925812|FG001|Period 2|Adverse Event|4|||
170433865|NCT04633564|615925811|FG000|Period 2|Death|0|||
170433866|NCT04633564|615925812|FG001|Period 2|Death|2|||
170433867|NCT04633564|615925811|FG000|Period 2|Lost to Follow-up|0|||
170433868|NCT04633564|615925812|FG001|Period 2|Lost to Follow-up|1|||
170433869|NCT04633564|615925811|FG000|Period 2|Physician Decision|2|||
170433870|NCT04633564|615925812|FG001|Period 2|Physician Decision|4|||
170433871|NCT04633564|615925811|FG000|Period 2|Withdrawal by Subject|5|||
170433872|NCT04633564|615925812|FG001|Period 2|Withdrawal by Subject|1|||
170433873|NCT04633564|615925811|FG000|Period 2|Progressive Disease|74|||
170433874|NCT04633564|615925812|FG001|Period 2|Progressive Disease|82|||
170433875|NCT04633564|615925811|FG000|Period 2|Terminated by Sponsor|9|||
170433876|NCT04633564|615925812|FG001|Period 2|Terminated by Sponsor|3|||
170433877|NCT00902538|615925813|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
170433878|NCT00902538|615925814|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
170433879|NCT00902538|615925815|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
170433880|NCT00902538|615925816|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
170433881|NCT00902538|615925817|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
170433882|NCT00902538|615925818|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
170433883|NCT00902538|615925813|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
170433884|NCT00902538|615925814|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
170433885|NCT00902538|615925815|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
170433886|NCT00902538|615925816|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
170433887|NCT00902538|615925817|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
170433888|NCT00902538|615925818|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
170433889|NCT00902538|615925813|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
170433890|NCT00902538|615925814|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
170433891|NCT00902538|615925815|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
170433892|NCT00902538|615925816|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
170433893|NCT00902538|615925817|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
170433894|NCT00902538|615925818|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
170433895|NCT00902538|615925813|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
170433896|NCT00902538|615925814|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
170536372|NCT02916927|616307989|FG000|Overall Study|Discharged prior to study drug receipt|0|||
170536373|NCT02916927|616307990|FG001|Overall Study|Discharged prior to study drug receipt|2|||
170433897|NCT00902538|615925815|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
170433898|NCT00902538|615925816|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
170433899|NCT00902538|615925817|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
170433900|NCT00902538|615925818|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
170536374|NCT02916927|616307989|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
170536375|NCT02916927|616307990|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
170536376|NCT02916927|616307989|FG000|Overall Study|Withdrawal before first time point|1|||
170536377|NCT02916927|616307990|FG001|Overall Study|Withdrawal before first time point|0|||
170536378|NCT00858988|616307995|FG000|Analysis|Lactulose unable to be detected in urine|2|||
170536379|NCT00858988|616307996|FG001|Analysis|Lactulose unable to be detected in urine|1|||
170536380|NCT01020123|616307997|FG000|Main Period|Withdrawal by Subject|6|||
170536381|NCT01020123|616307998|FG001|Main Period|Withdrawal by Subject|5|||
170536382|NCT01020123|616307999|FG002|Main Period|Withdrawal by Subject|3|||
170536383|NCT01020123|616308000|FG003|Main Period|Withdrawal by Subject|1|||
170536384|NCT01020123|616308001|FG004|Main Period|Withdrawal by Subject|6|||
170536385|NCT01020123|616308002|FG005|Main Period|Withdrawal by Subject|3|||
170536386|NCT01020123|616308003|FG006|Main Period|Withdrawal by Subject|2|||
170536387|NCT01020123|616307997|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
170536388|NCT01020123|616307998|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
170536389|NCT01020123|616307999|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
170536390|NCT01020123|616308000|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
170536391|NCT01020123|616308001|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
170536392|NCT01020123|616308002|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
170536393|NCT01020123|616308003|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
170536394|NCT01020123|616307997|FG000|Main Period|Adverse Event|5|||
170536395|NCT01020123|616307998|FG001|Main Period|Adverse Event|2|||
170536396|NCT01020123|616307999|FG002|Main Period|Adverse Event|2|||
170536397|NCT01020123|616308000|FG003|Main Period|Adverse Event|1|||
170536398|NCT01020123|616308001|FG004|Main Period|Adverse Event|1|||
170536399|NCT01020123|616308002|FG005|Main Period|Adverse Event|2|||
170536400|NCT01020123|616308003|FG006|Main Period|Adverse Event|1|||
170536401|NCT01020123|616307997|FG000|Main Period|Protocol Violation|4|||
170536402|NCT01020123|616307998|FG001|Main Period|Protocol Violation|4|||
170536403|NCT01020123|616307999|FG002|Main Period|Protocol Violation|2|||
170536404|NCT01020123|616308000|FG003|Main Period|Protocol Violation|5|||
170536405|NCT01020123|616308001|FG004|Main Period|Protocol Violation|2|||
170536406|NCT01020123|616308002|FG005|Main Period|Protocol Violation|3|||
170536407|NCT01020123|616308003|FG006|Main Period|Protocol Violation|2|||
170778982|NCT05656911|617197315|FG000|Treatment Phase|Other Reasons|1|||
170778983|NCT05656911|617197316|FG001|Treatment Phase|Other Reasons|0|||
170778984|NCT05656911|617197315|FG000|Treatment Phase|Adverse Event|3|||
170433901|NCT00902538|615925813|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
170433902|NCT00902538|615925814|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
170433903|NCT00902538|615925815|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
170433904|NCT00902538|615925816|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
170433905|NCT00902538|615925817|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
170433906|NCT00902538|615925818|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
170433907|NCT00902538|615925813|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
170433908|NCT00902538|615925814|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
170433909|NCT00902538|615925815|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
170433910|NCT00902538|615925816|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
170433911|NCT00902538|615925817|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
170536408|NCT01020123|616307997|FG000|Main Period|Lost to Follow-up|0|||
170536409|NCT01020123|616307998|FG001|Main Period|Lost to Follow-up|2|||
170536410|NCT01020123|616307999|FG002|Main Period|Lost to Follow-up|0|||
170536411|NCT01020123|616308000|FG003|Main Period|Lost to Follow-up|0|||
170778985|NCT05656911|617197316|FG001|Treatment Phase|Adverse Event|1|||
170778986|NCT05656911|617197315|FG000|Follow-up Phase|Subject Decision|0|||
170778987|NCT05656911|617197316|FG001|Follow-up Phase|Subject Decision|1|||
170778988|NCT05656911|617197315|FG000|Follow-up Phase|Missing|1|||
170778989|NCT05656911|617197316|FG001|Follow-up Phase|Missing|0|||
170778990|NCT03547908|617197317|FG000|Blinded Phase|Lost to Follow-up|3|||
170778991|NCT03547908|617197318|FG001|Blinded Phase|Lost to Follow-up|3|||
170778992|NCT03547908|617197319|FG002|Blinded Phase|Lost to Follow-up|0|||
170778993|NCT03547908|617197320|FG003|Blinded Phase|Lost to Follow-up|0|||
170778994|NCT03547908|617197317|FG000|Blinded Phase|Withdrew Consent|2|||
170778995|NCT03547908|617197318|FG001|Blinded Phase|Withdrew Consent|3|||
170536412|NCT01020123|616308001|FG004|Main Period|Lost to Follow-up|0|||
170536413|NCT01020123|616308002|FG005|Main Period|Lost to Follow-up|0|||
170536414|NCT01020123|616308003|FG006|Main Period|Lost to Follow-up|0|||
170536415|NCT01020123|616307997|FG000|Main Period|Unclasified|2|||
170536416|NCT01020123|616307998|FG001|Main Period|Unclasified|0|||
170778996|NCT03547908|617197319|FG002|Blinded Phase|Withdrew Consent|0|||
170778997|NCT03547908|617197320|FG003|Blinded Phase|Withdrew Consent|0|||
170778998|NCT03547908|617197317|FG000|Blinded Phase|Investigator's Discretion|2|||
170778999|NCT03547908|617197318|FG001|Blinded Phase|Investigator's Discretion|1|||
170536417|NCT01020123|616307999|FG002|Main Period|Unclasified|1|||
170536418|NCT01020123|616308000|FG003|Main Period|Unclasified|0|||
170536419|NCT01020123|616308001|FG004|Main Period|Unclasified|1|||
170536420|NCT01020123|616308002|FG005|Main Period|Unclasified|3|||
170536421|NCT01020123|616308003|FG006|Main Period|Unclasified|6|||
170536422|NCT01020123|616307997|FG000|Extention Period|Withdrawal by Subject|2|||
170536423|NCT01020123|616307998|FG001|Extention Period|Withdrawal by Subject|1|||
170536424|NCT01020123|616307999|FG002|Extention Period|Withdrawal by Subject|1|||
170536425|NCT01020123|616308000|FG003|Extention Period|Withdrawal by Subject|0|||
170536426|NCT01020123|616308001|FG004|Extention Period|Withdrawal by Subject|0|||
170536427|NCT01020123|616308002|FG005|Extention Period|Withdrawal by Subject|0|||
170536428|NCT01020123|616308003|FG006|Extention Period|Withdrawal by Subject|0|||
170536429|NCT01020123|616307997|FG000|Extention Period|Adverse Event|0|||
170536430|NCT01020123|616307998|FG001|Extention Period|Adverse Event|0|||
170536431|NCT01020123|616307999|FG002|Extention Period|Adverse Event|0|||
170536432|NCT01020123|616308000|FG003|Extention Period|Adverse Event|1|||
170536433|NCT01020123|616308001|FG004|Extention Period|Adverse Event|0|||
170536434|NCT01020123|616308002|FG005|Extention Period|Adverse Event|0|||
170536435|NCT01020123|616308003|FG006|Extention Period|Adverse Event|0|||
170536436|NCT01020123|616307997|FG000|Extention Period|Protocol Violation|1|||
170536437|NCT01020123|616307998|FG001|Extention Period|Protocol Violation|1|||
170536438|NCT01020123|616307999|FG002|Extention Period|Protocol Violation|1|||
170536439|NCT01020123|616308000|FG003|Extention Period|Protocol Violation|0|||
170536440|NCT01020123|616308001|FG004|Extention Period|Protocol Violation|0|||
170536441|NCT01020123|616308002|FG005|Extention Period|Protocol Violation|0|||
170536442|NCT01020123|616308003|FG006|Extention Period|Protocol Violation|1|||
170536443|NCT01020123|616307997|FG000|Extention Period|Lost to Follow-up|0|||
170536444|NCT01020123|616307998|FG001|Extention Period|Lost to Follow-up|0|||
170536445|NCT01020123|616307999|FG002|Extention Period|Lost to Follow-up|0|||
170536446|NCT01020123|616308000|FG003|Extention Period|Lost to Follow-up|0|||
170536447|NCT01020123|616308001|FG004|Extention Period|Lost to Follow-up|0|||
170536448|NCT01020123|616308002|FG005|Extention Period|Lost to Follow-up|2|||
170536449|NCT01020123|616308003|FG006|Extention Period|Lost to Follow-up|0|||
170536450|NCT00720759|616308006|FG000|Overall Study|Lost to Follow-up|0|||
170536451|NCT00720759|616308007|FG001|Overall Study|Lost to Follow-up|1|||
170536452|NCT00720759|616308008|FG002|Overall Study|Lost to Follow-up|1|||
170536453|NCT00720759|616308009|FG003|Overall Study|Lost to Follow-up|0|||
170536454|NCT02318940|616308010|FG000|Overall Study|lost the record|1|||
170536455|NCT02318940|616308011|FG001|Overall Study|lost the record|0|||
170536456|NCT01047319|616308012|FG000|Overall Study|Teva requested participant withdrawal|3|||
170536457|NCT01047319|616308013|FG001|Overall Study|Teva requested participant withdrawal|0|||
170536458|NCT01047319|616308014|FG002|Overall Study|Teva requested participant withdrawal|1|||
170536459|NCT01047319|616308012|FG000|Overall Study|Protocol Violation|3|||
170536460|NCT01047319|616308013|FG001|Overall Study|Protocol Violation|2|||
170536461|NCT01047319|616308014|FG002|Overall Study|Protocol Violation|4|||
170536462|NCT01047319|616308012|FG000|Overall Study|Lack of Efficacy|4|||
170536463|NCT01047319|616308013|FG001|Overall Study|Lack of Efficacy|3|||
170536464|NCT01047319|616308014|FG002|Overall Study|Lack of Efficacy|3|||
170536465|NCT01047319|616308012|FG000|Overall Study|Death|5|||
170536466|NCT01047319|616308013|FG001|Overall Study|Death|1|||
170536467|NCT01047319|616308014|FG002|Overall Study|Death|5|||
170536468|NCT01047319|616308012|FG000|Overall Study|Pregnancy|13|||
170536469|NCT01047319|616308013|FG001|Overall Study|Pregnancy|8|||
170536470|NCT01047319|616308014|FG002|Overall Study|Pregnancy|8|||
170536471|NCT01047319|616308012|FG000|Overall Study|Physician Decision|12|||
170536472|NCT01047319|616308013|FG001|Overall Study|Physician Decision|9|||
170536473|NCT01047319|616308014|FG002|Overall Study|Physician Decision|10|||
170536474|NCT01047319|616308012|FG000|Overall Study|Lost to Follow-up|14|||
170536475|NCT01047319|616308013|FG001|Overall Study|Lost to Follow-up|10|||
170536476|NCT01047319|616308014|FG002|Overall Study|Lost to Follow-up|10|||
170536477|NCT01047319|616308012|FG000|Overall Study|Adverse Event|16|||
170536478|NCT01047319|616308013|FG001|Overall Study|Adverse Event|27|||
170536479|NCT01047319|616308014|FG002|Overall Study|Adverse Event|21|||
170536480|NCT01047319|616308012|FG000|Overall Study|Withdrawal by Subject|77|||
170565484|NCT01049373|616418531|FG000|Overall Study|Other|1|||
170433912|NCT00902538|615925818|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
170433913|NCT00902538|615925813|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
170433914|NCT00902538|615925814|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
170433915|NCT00902538|615925815|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
170433916|NCT00902538|615925816|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
170433917|NCT00902538|615925817|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
170433918|NCT00902538|615925818|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
170433919|NCT00902538|615925813|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
170433920|NCT00902538|615925814|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
170433921|NCT00902538|615925815|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
170433922|NCT00902538|615925816|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
170433923|NCT00902538|615925817|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
170433924|NCT00902538|615925818|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
170433925|NCT00902538|615925813|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
170433926|NCT00902538|615925814|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
170433927|NCT00902538|615925815|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
170433928|NCT00902538|615925816|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
170433929|NCT00902538|615925817|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
170433930|NCT00902538|615925818|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
170433931|NCT00902538|615925813|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
170433932|NCT00902538|615925814|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
170433933|NCT00902538|615925815|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
170433934|NCT00902538|615925816|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
170433935|NCT00902538|615925817|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
170433936|NCT00902538|615925818|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
170433937|NCT00902538|615925813|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
170433938|NCT00902538|615925814|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
170433939|NCT00902538|615925815|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
170433940|NCT00902538|615925816|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
170433941|NCT00902538|615925817|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
170433942|NCT00902538|615925818|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
170433943|NCT00902538|615925813|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
170433944|NCT00902538|615925814|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
170433945|NCT00902538|615925815|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
170433946|NCT00902538|615925816|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
170433947|NCT00902538|615925817|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
170433948|NCT00902538|615925818|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
170433949|NCT00902538|615925813|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
170433950|NCT00902538|615925814|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
170433951|NCT00902538|615925815|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
170433952|NCT00902538|615925816|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
170433953|NCT00902538|615925817|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
170433954|NCT00902538|615925818|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
170433955|NCT00902538|615925813|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
170433956|NCT00902538|615925814|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
170433957|NCT00902538|615925815|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
170433958|NCT00902538|615925816|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
170433959|NCT00902538|615925817|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
170433960|NCT00902538|615925818|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
170433961|NCT00902538|615925813|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
170433962|NCT00902538|615925814|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
170433963|NCT00902538|615925815|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
170433964|NCT00902538|615925816|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
170433965|NCT00902538|615925817|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
170433966|NCT00902538|615925818|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
170779000|NCT03547908|617197319|FG002|Blinded Phase|Investigator's Discretion|0|||
170779001|NCT03547908|617197320|FG003|Blinded Phase|Investigator's Discretion|0|||
170779002|NCT03547908|617197317|FG000|Blinded Phase|Death|2|||
170779003|NCT03547908|617197318|FG001|Blinded Phase|Death|0|||
170779004|NCT03547908|617197319|FG002|Blinded Phase|Death|0|||
170779005|NCT03547908|617197320|FG003|Blinded Phase|Death|0|||
170779006|NCT03547908|617197317|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
170779007|NCT03547908|617197318|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
170779008|NCT03547908|617197319|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
170779009|NCT03547908|617197320|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
170433967|NCT00902538|615925813|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
170433968|NCT00902538|615925814|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
170433969|NCT00902538|615925815|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
170433970|NCT00902538|615925816|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
170433971|NCT00902538|615925817|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
170433972|NCT00902538|615925818|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
170433973|NCT00902538|615925813|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
170433974|NCT00902538|615925814|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
170433975|NCT00902538|615925815|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
170433976|NCT00902538|615925816|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
170433977|NCT00902538|615925817|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
170433978|NCT00902538|615925818|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
170433979|NCT06336356|615925819|FG000|Overall Study|Withdrawal by Subject|1|||
170433980|NCT06336356|615925820|FG001|Overall Study|Withdrawal by Subject|0|||
170433981|NCT06336356|615925819|FG000|Overall Study|Lost to Follow Up|1|||
170433982|NCT06336356|615925820|FG001|Overall Study|Lost to Follow Up|0|||
170433983|NCT00725322|615925821|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
170433984|NCT00725322|615925822|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
170433985|NCT00725322|615925821|FG000|Washout (28 Days)|Protocol Violation|0|||
170433986|NCT00725322|615925822|FG001|Washout (28 Days)|Protocol Violation|1|||
170433987|NCT02554890|615925825|FG000|Double-blind|Adverse Event|45|||
170632773|NCT04672239|616666762|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
170632774|NCT04672239|616666763|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
170779010|NCT03547908|617197317|FG000|Blinded Phase|Adverse Event|1|||
170779011|NCT03547908|617197318|FG001|Blinded Phase|Adverse Event|0|||
170779012|NCT03547908|617197319|FG002|Blinded Phase|Adverse Event|0|||
170779013|NCT03547908|617197320|FG003|Blinded Phase|Adverse Event|0|||
170779014|NCT03547908|617197317|FG000|Blinded Phase|Randomized But Never Treated|1|||
170779015|NCT03547908|617197318|FG001|Blinded Phase|Randomized But Never Treated|0|||
170880831|NCT01650636|617574384|FG001|Washout up to 5 Months|Death|0|||
170880832|NCT01650636|617574383|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
170880833|NCT01650636|617574384|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
170880834|NCT01650636|617574383|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
170880835|NCT01650636|617574384|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
170880836|NCT01650636|617574383|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
170880837|NCT01650636|617574384|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
170880838|NCT00930761|617574385|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
170880839|NCT00930761|617574386|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
170880840|NCT00930761|617574385|FG000|Overall Study|less than 3 music therapy sessions|0|||
170880841|NCT00930761|617574386|FG001|Overall Study|less than 3 music therapy sessions|3|||
170880842|NCT00264875|617574387|FG000|Overall Study|Adverse Event|6|||
170880843|NCT00264875|617574387|FG000|Overall Study|Lost to Follow-up|6|||
170880844|NCT00264875|617574387|FG000|Overall Study|Protocol Violation|11|||
170880845|NCT00264875|617574387|FG000|Overall Study|Withdrawal by Subject|7|||
170880846|NCT03699007|617574389|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
170880847|NCT03699007|617574390|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
170880848|NCT03699007|617574389|FG000|6-month Follow Up|Lost to Follow-up|2|||
170880849|NCT03699007|617574390|FG001|6-month Follow Up|Lost to Follow-up|3|||
170880850|NCT01709435|617574391|FG000|Overall Study|Adverse Event|1|||
170880851|NCT01709435|617574392|FG001|Overall Study|Adverse Event|1|||
170880852|NCT01709435|617574393|FG002|Overall Study|Adverse Event|1|||
170880853|NCT01709435|617574394|FG003|Overall Study|Adverse Event|0|||
170880854|NCT01709435|617574395|FG004|Overall Study|Adverse Event|0|||
170880855|NCT01709435|617574396|FG005|Overall Study|Adverse Event|1|||
170880856|NCT01709435|617574391|FG000|Overall Study|Lack of Efficacy|5|||
170880857|NCT01709435|617574392|FG001|Overall Study|Lack of Efficacy|7|||
170880858|NCT01709435|617574393|FG002|Overall Study|Lack of Efficacy|2|||
170880859|NCT01709435|617574394|FG003|Overall Study|Lack of Efficacy|2|||
170880860|NCT01709435|617574395|FG004|Overall Study|Lack of Efficacy|6|||
170880861|NCT01709435|617574396|FG005|Overall Study|Lack of Efficacy|3|||
170880862|NCT01709435|617574391|FG000|Overall Study|Physician Decision|0|||
170880863|NCT01709435|617574392|FG001|Overall Study|Physician Decision|1|||
170880864|NCT01709435|617574393|FG002|Overall Study|Physician Decision|0|||
170880865|NCT01709435|617574394|FG003|Overall Study|Physician Decision|1|||
170433988|NCT02554890|615925826|FG001|Double-blind|Adverse Event|51|||
170433989|NCT02554890|615925825|FG000|Double-blind|Death|6|||
170433990|NCT02554890|615925826|FG001|Double-blind|Death|4|||
170433991|NCT02554890|615925825|FG000|Double-blind|Protocol Violation|1|||
170433992|NCT02554890|615925826|FG001|Double-blind|Protocol Violation|1|||
170433993|NCT02554890|615925825|FG000|Double-blind|Physician Decision|4|||
170433994|NCT02554890|615925826|FG001|Double-blind|Physician Decision|3|||
170433995|NCT02554890|615925825|FG000|Double-blind|Subject/Guardian decision|21|||
170433996|NCT02554890|615925826|FG001|Double-blind|Subject/Guardian decision|16|||
170433997|NCT02554890|615925825|FG000|Double-blind|Lost to Follow-up|7|||
170433998|NCT02554890|615925826|FG001|Double-blind|Lost to Follow-up|5|||
170433999|NCT02554890|615925825|FG000|Double-blind|Technical problems|1|||
170434000|NCT02554890|615925826|FG001|Double-blind|Technical problems|0|||
170434001|NCT02554890|615925825|FG000|Double-blind|Withdrawal by Subject|5|||
170434002|NCT02554890|615925826|FG001|Double-blind|Withdrawal by Subject|6|||
170434003|NCT02554890|615925825|FG000|Double-blind|Noncompliance with study treatment|6|||
170434004|NCT02554890|615925826|FG001|Double-blind|Noncompliance with study treatment|5|||
170434005|NCT02554890|615925825|FG000|Open-label|Adverse Event|0|||
170434006|NCT02554890|615925826|FG001|Open-label|Adverse Event|30|||
170434007|NCT02554890|615925825|FG000|Open-label|Death|0|||
170434008|NCT02554890|615925826|FG001|Open-label|Death|1|||
170434009|NCT02554890|615925825|FG000|Open-label|Physician Decision|0|||
170434010|NCT02554890|615925826|FG001|Open-label|Physician Decision|1|||
170434011|NCT02554890|615925825|FG000|Open-label|Subject/Guardian decision|0|||
170434012|NCT02554890|615925826|FG001|Open-label|Subject/Guardian decision|11|||
170434013|NCT02554890|615925825|FG000|Open-label|Lost to Follow-up|0|||
170434014|NCT02554890|615925826|FG001|Open-label|Lost to Follow-up|7|||
170434015|NCT02554890|615925825|FG000|Open-label|Technical problems|0|||
170434016|NCT02554890|615925826|FG001|Open-label|Technical problems|1|||
170434017|NCT02554890|615925825|FG000|Open-label|Withdrawal by Subject|0|||
170434018|NCT02554890|615925826|FG001|Open-label|Withdrawal by Subject|1|||
170434019|NCT04827394|615925830|FG000|Overall Study|Physician Decision|0|||
170434020|NCT04827394|615925831|FG001|Overall Study|Physician Decision|2|||
170434021|NCT03649477|615925834|FG000|Overall Study|Adverse Event|2|||
170434022|NCT03649477|615925835|FG001|Overall Study|Adverse Event|0|||
170434023|NCT03649477|615925836|FG002|Overall Study|Adverse Event|0|||
170434024|NCT04544410|615925837|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
170434025|NCT04544410|615925838|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
170434026|NCT04544410|615925837|FG000|Double-blind Treatment Period|Adverse Event|1|||
170434027|NCT04544410|615925838|FG001|Double-blind Treatment Period|Adverse Event|0|||
170434028|NCT04544410|615925837|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
170434029|NCT04544410|615925838|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
170434030|NCT04544410|615925837|FG000|Double-blind Treatment Period|Protocol Violation|1|||
170434031|NCT04544410|615925838|FG001|Double-blind Treatment Period|Protocol Violation|0|||
170434032|NCT04544410|615925837|FG000|Open-Label Treatment Period|Study Terminated|15|||
170434033|NCT04544410|615925838|FG001|Open-Label Treatment Period|Study Terminated|19|||
170434034|NCT04544410|615925837|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
170434035|NCT04544410|615925838|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
170434036|NCT04544410|615925837|FG000|Open-Label Treatment Period|Adverse Event|0|||
170434037|NCT04544410|615925838|FG001|Open-Label Treatment Period|Adverse Event|1|||
170536481|NCT01047319|616308013|FG001|Overall Study|Withdrawal by Subject|75|||
170536482|NCT01047319|616308014|FG002|Overall Study|Withdrawal by Subject|87|||
170536483|NCT01047319|616308012|FG000|Overall Study|Study terminated by Sponsor|198|||
170536484|NCT01047319|616308013|FG001|Overall Study|Study terminated by Sponsor|215|||
170536485|NCT01047319|616308014|FG002|Overall Study|Study terminated by Sponsor|203|||
170536486|NCT05260008|616308018|FG000|Overall Study|Physician Decision|0|||
170536487|NCT05260008|616308019|FG001|Overall Study|Physician Decision|1|||
170536488|NCT05260008|616308020|FG002|Overall Study|Physician Decision|0|||
170536489|NCT05260008|616308021|FG003|Overall Study|Physician Decision|0|||
170536490|NCT04828161|616309504|FG000|Overall Study|Withdrawal by Subject|0|||
170536491|NCT04828161|616309505|FG001|Overall Study|Withdrawal by Subject|3|||
170536492|NCT04828161|616309506|FG002|Overall Study|Withdrawal by Subject|3|||
170536493|NCT04828161|616309507|FG003|Overall Study|Withdrawal by Subject|4|||
170536494|NCT04828161|616309504|FG000|Overall Study|Lost to Follow-up|1|||
170536495|NCT04828161|616309505|FG001|Overall Study|Lost to Follow-up|4|||
170536496|NCT04828161|616309506|FG002|Overall Study|Lost to Follow-up|2|||
170536497|NCT04828161|616309507|FG003|Overall Study|Lost to Follow-up|2|||
170536498|NCT04828161|616309504|FG000|Overall Study|Other|2|||
170536499|NCT04828161|616309505|FG001|Overall Study|Other|0|||
170536500|NCT04828161|616309506|FG002|Overall Study|Other|2|||
170536501|NCT04828161|616309507|FG003|Overall Study|Other|0|||
170536502|NCT04828161|616309504|FG000|Overall Study|Death|0|||
170536503|NCT04828161|616309505|FG001|Overall Study|Death|0|||
170536504|NCT04828161|616309506|FG002|Overall Study|Death|0|||
170536505|NCT04828161|616309507|FG003|Overall Study|Death|2|||
170536506|NCT05555290|616309508|FG000|Part 1|Development of study-specific withdrawal criteria|1|||
170536507|NCT05555290|616309509|FG001|Part 1|Development of study-specific withdrawal criteria|1|||
170536508|NCT05555290|616309508|FG000|Part 2|Withdrawal by Subject|3|||
170536509|NCT05555290|616309509|FG001|Part 2|Withdrawal by Subject|1|||
170536510|NCT05555290|616309508|FG000|Part 2|Early termination|0|||
170536511|NCT05555290|616309509|FG001|Part 2|Early termination|3|||
170536512|NCT04429971|616309510|FG000|Overall Study|Lost to Follow-up|7|||
170536513|NCT04429971|616309511|FG001|Overall Study|Lost to Follow-up|8|||
170536514|NCT03517137|616309519|FG000|Overall Study|Lack of Efficacy|1|||
170536515|NCT03517137|616309519|FG000|Overall Study|Adverse Event|2|||
170536516|NCT03517137|616309519|FG000|Overall Study|Withdrawal by Subject|2|||
170536517|NCT03517137|616309519|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
170536518|NCT02441283|616309520|FG000|Overall Study|Withdrew consent|15|||
170536519|NCT02441283|616309520|FG000|Overall Study|Lost to Follow-up|42|||
170536520|NCT02441283|616309520|FG000|Overall Study|Death|1|||
170536521|NCT02441283|616309520|FG000|Overall Study|Other, not specified|32|||
170536522|NCT01582451|616309521|FG000|Overall Study|Adverse Event|1|||
170536523|NCT01582451|616309522|FG001|Overall Study|Adverse Event|3|||
170536524|NCT01582451|616309521|FG000|Overall Study|Death|3|||
170536525|NCT01582451|616309522|FG001|Overall Study|Death|3|||
170536526|NCT01582451|616309521|FG000|Overall Study|Lost to Follow-up|0|||
170536527|NCT01582451|616309522|FG001|Overall Study|Lost to Follow-up|2|||
170536528|NCT01582451|616309521|FG000|Overall Study|Protocol Violation|11|||
170536529|NCT01582451|616309522|FG001|Overall Study|Protocol Violation|3|||
170536530|NCT01582451|616309521|FG000|Overall Study|Withdrawal by Subject|13|||
170536531|NCT01582451|616309522|FG001|Overall Study|Withdrawal by Subject|9|||
170536532|NCT01582451|616309521|FG000|Overall Study|Physician Decision|3|||
170536533|NCT01582451|616309522|FG001|Overall Study|Physician Decision|0|||
170536534|NCT01582451|616309521|FG000|Overall Study|Sponsor Decision|1|||
170536535|NCT01582451|616309522|FG001|Overall Study|Sponsor Decision|0|||
170536536|NCT00716417|616309523|FG000|Overall Study|Adverse Event|0|||
170536537|NCT00716417|616309524|FG001|Overall Study|Adverse Event|0|||
170536538|NCT00716417|616309525|FG002|Overall Study|Adverse Event|2|||
170536539|NCT00716417|616309526|FG003|Overall Study|Adverse Event|1|||
170536540|NCT00716417|616309527|FG004|Overall Study|Adverse Event|0|||
170536541|NCT00716417|616309528|FG005|Overall Study|Adverse Event|0|||
170536542|NCT00716417|616309529|FG006|Overall Study|Adverse Event|3|||
170536543|NCT00716417|616309530|FG007|Overall Study|Adverse Event|1|||
170536544|NCT00716417|616309531|FG008|Overall Study|Adverse Event|0|||
170536545|NCT00716417|616309532|FG009|Overall Study|Adverse Event|3|||
170536546|NCT00716417|616309523|FG000|Overall Study|Withdrawal by Subject|0|||
170536547|NCT00716417|616309524|FG001|Overall Study|Withdrawal by Subject|1|||
170536548|NCT00716417|616309525|FG002|Overall Study|Withdrawal by Subject|0|||
170536549|NCT00716417|616309526|FG003|Overall Study|Withdrawal by Subject|2|||
170536550|NCT00716417|616309527|FG004|Overall Study|Withdrawal by Subject|0|||
170536551|NCT00716417|616309528|FG005|Overall Study|Withdrawal by Subject|0|||
170536552|NCT00716417|616309529|FG006|Overall Study|Withdrawal by Subject|1|||
170536553|NCT00716417|616309530|FG007|Overall Study|Withdrawal by Subject|0|||
170536554|NCT00716417|616309531|FG008|Overall Study|Withdrawal by Subject|0|||
170536555|NCT00716417|616309532|FG009|Overall Study|Withdrawal by Subject|0|||
170880866|NCT01709435|617574395|FG004|Overall Study|Physician Decision|2|||
170536556|NCT00716417|616309523|FG000|Overall Study|Progressive disease|3|||
170536557|NCT00716417|616309524|FG001|Overall Study|Progressive disease|5|||
170536558|NCT00716417|616309525|FG002|Overall Study|Progressive disease|3|||
170536559|NCT00716417|616309526|FG003|Overall Study|Progressive disease|8|||
170536560|NCT00716417|616309527|FG004|Overall Study|Progressive disease|0|||
170536561|NCT00716417|616309528|FG005|Overall Study|Progressive disease|3|||
170536562|NCT00716417|616309529|FG006|Overall Study|Progressive disease|3|||
170880867|NCT01709435|617574396|FG005|Overall Study|Physician Decision|0|||
170880868|NCT01709435|617574391|FG000|Overall Study|Withdrawal by Subject|0|||
170880869|NCT01709435|617574392|FG001|Overall Study|Withdrawal by Subject|0|||
170880870|NCT01709435|617574393|FG002|Overall Study|Withdrawal by Subject|3|||
170880871|NCT01709435|617574394|FG003|Overall Study|Withdrawal by Subject|0|||
170880872|NCT01709435|617574395|FG004|Overall Study|Withdrawal by Subject|2|||
170880873|NCT01709435|617574396|FG005|Overall Study|Withdrawal by Subject|2|||
170880874|NCT01157364|617574397|FG000|Overall Study|Other Reasons|1|||
170880875|NCT01157364|617574398|FG001|Overall Study|Other Reasons|1|||
170880876|NCT01157364|617574399|FG002|Overall Study|Other Reasons|2|||
170880877|NCT01157364|617574400|FG003|Overall Study|Other Reasons|1|||
170880878|NCT01157364|617574401|FG004|Overall Study|Other Reasons|0|||
170880879|NCT01157364|617574402|FG005|Overall Study|Other Reasons|0|||
170880880|NCT01157364|617574397|FG000|Overall Study|Personal Reasons|0|||
170880881|NCT01157364|617574398|FG001|Overall Study|Personal Reasons|2|||
170536563|NCT00716417|616309530|FG007|Overall Study|Progressive disease|1|||
170536564|NCT00716417|616309531|FG008|Overall Study|Progressive disease|5|||
170536565|NCT00716417|616309532|FG009|Overall Study|Progressive disease|0|||
170536566|NCT00716417|616309523|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
170536567|NCT00716417|616309524|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
170536568|NCT00716417|616309525|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
170536569|NCT00716417|616309526|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
170536570|NCT00716417|616309527|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
170536571|NCT00716417|616309528|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
170536572|NCT00716417|616309529|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
170536573|NCT00716417|616309530|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
170536574|NCT00716417|616309531|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
170536575|NCT00716417|616309532|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
170536576|NCT00716417|616309523|FG000|Overall Study|On patient request due to toxicities|0|||
170536577|NCT00716417|616309524|FG001|Overall Study|On patient request due to toxicities|0|||
170536578|NCT00716417|616309525|FG002|Overall Study|On patient request due to toxicities|0|||
170536579|NCT00716417|616309526|FG003|Overall Study|On patient request due to toxicities|0|||
170536580|NCT00716417|616309527|FG004|Overall Study|On patient request due to toxicities|0|||
170536581|NCT00716417|616309528|FG005|Overall Study|On patient request due to toxicities|0|||
170536582|NCT00716417|616309529|FG006|Overall Study|On patient request due to toxicities|0|||
170536583|NCT00716417|616309530|FG007|Overall Study|On patient request due to toxicities|1|||
170536584|NCT00716417|616309531|FG008|Overall Study|On patient request due to toxicities|0|||
170536585|NCT00716417|616309532|FG009|Overall Study|On patient request due to toxicities|0|||
170536586|NCT02472353|616309533|FG000|Overall Study|Lost to Follow-up|1|||
170536587|NCT02472353|616309534|FG001|Overall Study|Lost to Follow-up|1|||
170536588|NCT02472353|616309533|FG000|Overall Study|Withdrawal by Subject|2|||
170536589|NCT02472353|616309534|FG001|Overall Study|Withdrawal by Subject|1|||
170536590|NCT02472353|616309533|FG000|Overall Study|Study Termination|1|||
170536591|NCT02472353|616309534|FG001|Overall Study|Study Termination|4|||
170536592|NCT01838876|616309535|FG000|Overall Study|Adverse Event|49|||
170536593|NCT01838876|616309535|FG000|Overall Study|Insufficient Therapeutic Response|10|||
170536594|NCT01838876|616309535|FG000|Overall Study|Protocol Violation|34|||
170536595|NCT01838876|616309535|FG000|Overall Study|Withdrawal of Consent|33|||
170536596|NCT01838876|616309535|FG000|Overall Study|Lost to Follow-up|21|||
170536597|NCT01838876|616309535|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
170536598|NCT01838876|616309535|FG000|Overall Study|Reason not Specified|7|||
170536599|NCT01838876|616309535|FG000|Overall Study|Did not meet eligibility criteria|78|||
170536600|NCT03338790|616309543|FG000|Overall Study|Disease Progression|65|||
170536601|NCT03338790|616309544|FG001|Overall Study|Disease Progression|46|||
170536602|NCT03338790|616309545|FG002|Overall Study|Disease Progression|54|||
170536603|NCT03338790|616309546|FG003|Overall Study|Disease Progression|42|||
170536604|NCT03338790|616309543|FG000|Overall Study|Study Drug Toxicity|12|||
170536605|NCT03338790|616309544|FG001|Overall Study|Study Drug Toxicity|8|||
170779016|NCT03547908|617197319|FG002|Blinded Phase|Randomized But Never Treated|0|||
170779017|NCT03547908|617197320|FG003|Blinded Phase|Randomized But Never Treated|0|||
170779018|NCT03547908|617197317|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
170779019|NCT03547908|617197318|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
170779020|NCT03547908|617197319|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
170779021|NCT03547908|617197320|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
170779022|NCT03547908|617197317|FG000|Open-label Extension Phase|Death|0|||
170779023|NCT03547908|617197318|FG001|Open-label Extension Phase|Death|0|||
170779024|NCT03547908|617197319|FG002|Open-label Extension Phase|Death|1|||
170779025|NCT03547908|617197320|FG003|Open-label Extension Phase|Death|0|||
170779026|NCT05419505|617197327|FG000|Overall Study|Adverse Event|0|||
170779027|NCT05419505|617197328|FG001|Overall Study|Adverse Event|0|||
170779028|NCT05419505|617197329|FG002|Overall Study|Adverse Event|0|||
170779029|NCT05419505|617197330|FG003|Overall Study|Adverse Event|1|||
170779030|NCT05419505|617197331|FG004|Overall Study|Adverse Event|0|||
170779031|NCT05419505|617197332|FG005|Overall Study|Adverse Event|0|||
170779032|NCT05419505|617197333|FG006|Overall Study|Adverse Event|0|||
170779033|NCT05419505|617197334|FG007|Overall Study|Adverse Event|0|||
170779034|NCT05419505|617197327|FG000|Overall Study|Withdrawal by Subject|1|||
170779035|NCT05419505|617197328|FG001|Overall Study|Withdrawal by Subject|2|||
170779036|NCT05419505|617197329|FG002|Overall Study|Withdrawal by Subject|0|||
170779037|NCT05419505|617197330|FG003|Overall Study|Withdrawal by Subject|0|||
170779038|NCT05419505|617197331|FG004|Overall Study|Withdrawal by Subject|0|||
170779039|NCT05419505|617197332|FG005|Overall Study|Withdrawal by Subject|0|||
170779040|NCT05419505|617197333|FG006|Overall Study|Withdrawal by Subject|1|||
170779041|NCT05419505|617197334|FG007|Overall Study|Withdrawal by Subject|0|||
170779042|NCT05419505|617197327|FG000|Overall Study|Lost to Follow-up|2|||
170779043|NCT05419505|617197328|FG001|Overall Study|Lost to Follow-up|1|||
170779044|NCT05419505|617197329|FG002|Overall Study|Lost to Follow-up|0|||
170536606|NCT03338790|616309545|FG002|Overall Study|Study Drug Toxicity|14|||
170779045|NCT05419505|617197330|FG003|Overall Study|Lost to Follow-up|0|||
170434038|NCT04544410|615925837|FG000|Open-Label Treatment Period|Physician Decision|1|||
170434039|NCT04544410|615925838|FG001|Open-Label Treatment Period|Physician Decision|0|||
170434040|NCT04544410|615925837|FG000|Open-Label Treatment Period|Other|0|||
170434041|NCT04544410|615925838|FG001|Open-Label Treatment Period|Other|1|||
170434042|NCT05871151|615925839|FG000|Overall Study|Lost to Follow-up|1|||
170434043|NCT05871151|615925840|FG001|Overall Study|Lost to Follow-up|0|||
170434044|NCT05871151|615925839|FG000|Overall Study|Unrelated illness|0|||
170434045|NCT05871151|615925840|FG001|Overall Study|Unrelated illness|1|||
170434046|NCT03506633|615927047|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
170434047|NCT03506633|615927048|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
170434048|NCT03578809|615927054|FG000|Overall Study|Death|0|||
170434049|NCT03578809|615927055|FG001|Overall Study|Death|2|||
170434050|NCT03578809|615927056|FG002|Overall Study|Death|0|||
170434051|NCT03578809|615927057|FG003|Overall Study|Death|1|||
170434052|NCT03578809|615927054|FG000|Overall Study|Lost to Follow-up|0|||
170434053|NCT03578809|615927055|FG001|Overall Study|Lost to Follow-up|1|||
170434054|NCT03578809|615927056|FG002|Overall Study|Lost to Follow-up|0|||
170536607|NCT03338790|616309546|FG003|Overall Study|Study Drug Toxicity|0|||
170434055|NCT03578809|615927057|FG003|Overall Study|Lost to Follow-up|0|||
170434056|NCT03578809|615927054|FG000|Overall Study|Withdrawal by Subject|3|||
170434057|NCT03578809|615927055|FG001|Overall Study|Withdrawal by Subject|5|||
170434058|NCT03578809|615927056|FG002|Overall Study|Withdrawal by Subject|2|||
170434059|NCT03578809|615927057|FG003|Overall Study|Withdrawal by Subject|0|||
170434060|NCT03578809|615927054|FG000|Overall Study|Other|3|||
170434061|NCT03578809|615927055|FG001|Overall Study|Other|6|||
170434062|NCT03578809|615927056|FG002|Overall Study|Other|2|||
170779046|NCT05419505|617197331|FG004|Overall Study|Lost to Follow-up|1|||
170779047|NCT05419505|617197332|FG005|Overall Study|Lost to Follow-up|2|||
170779048|NCT05419505|617197333|FG006|Overall Study|Lost to Follow-up|0|||
170779049|NCT05419505|617197334|FG007|Overall Study|Lost to Follow-up|1|||
170779050|NCT05107401|617197337|FG000|Overall Study|Lost to Follow-up|13|||
170779051|NCT05107401|617197338|FG001|Overall Study|Lost to Follow-up|12|||
170779052|NCT02349412|617197339|FG000|Overall Study|Withdrawal by Subject|7|||
170779053|NCT02349412|617197340|FG001|Overall Study|Withdrawal by Subject|7|||
170779054|NCT03857620|617197341|FG000|Overall Study|Death|4|||
170779055|NCT03857620|617197342|FG001|Overall Study|Death|5|||
170779056|NCT03857620|617197343|FG002|Overall Study|Death|7|||
170779057|NCT03857620|617197341|FG000|Overall Study|Lost to Follow-up|2|||
170779058|NCT03857620|617197342|FG001|Overall Study|Lost to Follow-up|5|||
170779059|NCT03857620|617197343|FG002|Overall Study|Lost to Follow-up|3|||
170779060|NCT03857620|617197341|FG000|Overall Study|Disease progression or relapse after study registration|1|||
170779061|NCT03857620|617197342|FG001|Overall Study|Disease progression or relapse after study registration|5|||
170779062|NCT03857620|617197343|FG002|Overall Study|Disease progression or relapse after study registration|1|||
170779063|NCT03857620|617197341|FG000|Overall Study|Ineligible|5|||
170779064|NCT03857620|617197342|FG001|Overall Study|Ineligible|0|||
170779065|NCT03857620|617197343|FG002|Overall Study|Ineligible|2|||
170779066|NCT03857620|617197341|FG000|Overall Study|No malignancy|1|||
170779067|NCT03857620|617197342|FG001|Overall Study|No malignancy|0|||
170779068|NCT03857620|617197343|FG002|Overall Study|No malignancy|1|||
170779069|NCT03857620|617197341|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
170779070|NCT03857620|617197342|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
170779071|NCT03857620|617197343|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
170779072|NCT03857620|617197341|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
170536608|NCT03338790|616309543|FG000|Overall Study|Death|2|||
170536609|NCT03338790|616309544|FG001|Overall Study|Death|1|||
170536610|NCT03338790|616309545|FG002|Overall Study|Death|1|||
170536611|NCT03338790|616309546|FG003|Overall Study|Death|0|||
170536612|NCT03338790|616309543|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
170536613|NCT03338790|616309544|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
170536614|NCT03338790|616309545|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
170536615|NCT03338790|616309546|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
170536616|NCT03338790|616309543|FG000|Overall Study|Participant request to discontinue study treatment|4|||
170536617|NCT03338790|616309544|FG001|Overall Study|Participant request to discontinue study treatment|3|||
170536618|NCT03338790|616309545|FG002|Overall Study|Participant request to discontinue study treatment|3|||
170536619|NCT03338790|616309546|FG003|Overall Study|Participant request to discontinue study treatment|1|||
170536620|NCT03338790|616309543|FG000|Overall Study|Poor/non-compliance|0|||
170536621|NCT03338790|616309544|FG001|Overall Study|Poor/non-compliance|1|||
170536622|NCT03338790|616309545|FG002|Overall Study|Poor/non-compliance|0|||
170536623|NCT03338790|616309546|FG003|Overall Study|Poor/non-compliance|0|||
170536624|NCT03338790|616309543|FG000|Overall Study|Participant withdrew consent|1|||
170536625|NCT03338790|616309544|FG001|Overall Study|Participant withdrew consent|0|||
170536626|NCT03338790|616309545|FG002|Overall Study|Participant withdrew consent|1|||
170536627|NCT03338790|616309546|FG003|Overall Study|Participant withdrew consent|1|||
170536628|NCT03338790|616309543|FG000|Overall Study|Other reasons|0|||
170536629|NCT03338790|616309544|FG001|Overall Study|Other reasons|5|||
170779073|NCT03857620|617197342|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
170779074|NCT03857620|617197343|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
170779075|NCT03857620|617197341|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
170779076|NCT03857620|617197342|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
170779077|NCT03857620|617197343|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
170779078|NCT03857620|617197341|FG000|Overall Study|Surgery not performed, patient decision|0|||
170779079|NCT03857620|617197342|FG001|Overall Study|Surgery not performed, patient decision|3|||
170779080|NCT03857620|617197343|FG002|Overall Study|Surgery not performed, patient decision|1|||
170779081|NCT03857620|617197341|FG000|Overall Study|Surgery not performed, other reason|3|||
170434063|NCT03578809|615927057|FG003|Overall Study|Other|8|||
170434064|NCT03247686|615927058|FG000|Overall Study|Withdrawal by Subject|1|||
170434065|NCT03247686|615927059|FG001|Overall Study|Withdrawal by Subject|2|||
170434066|NCT01993186|615927060|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
170880882|NCT01157364|617574399|FG002|Overall Study|Personal Reasons|0|||
170434067|NCT01993186|615927061|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
170536630|NCT03338790|616309545|FG002|Overall Study|Other reasons|1|||
170536631|NCT03338790|616309546|FG003|Overall Study|Other reasons|1|||
170536632|NCT03338790|616309543|FG000|Overall Study|Maximum clinical benefit|0|||
170536633|NCT03338790|616309544|FG001|Overall Study|Maximum clinical benefit|0|||
170779082|NCT03857620|617197342|FG001|Overall Study|Surgery not performed, other reason|1|||
170779083|NCT03857620|617197343|FG002|Overall Study|Surgery not performed, other reason|4|||
170779084|NCT03857620|617197341|FG000|Overall Study|Worsening performance status after surgery performed|0|||
170779085|NCT03857620|617197342|FG001|Overall Study|Worsening performance status after surgery performed|1|||
170779086|NCT03857620|617197343|FG002|Overall Study|Worsening performance status after surgery performed|1|||
170779087|NCT02473250|617197344|FG000|Overall Study|Lost to Follow-up|10|||
170779088|NCT02473250|617197344|FG000|Overall Study|Physician Decision|5|||
170779089|NCT02473250|617197344|FG000|Overall Study|Did not tolerate medication washout|3|||
170779090|NCT02473250|617197344|FG000|Overall Study|Antidepressant effect of divalproex|2|||
170779091|NCT00567398|617197345|FG000|Overall Study|Adverse Event|6|||
170779092|NCT00567398|617197346|FG001|Overall Study|Adverse Event|14|||
170779093|NCT00567398|617197345|FG000|Overall Study|Physician Decision|0|||
170779094|NCT00567398|617197346|FG001|Overall Study|Physician Decision|4|||
170779095|NCT00567398|617197345|FG000|Overall Study|Withdrawal by Subject|0|||
170779096|NCT00567398|617197346|FG001|Overall Study|Withdrawal by Subject|2|||
170779097|NCT00567398|617197345|FG000|Overall Study|Renal Transplantation|0|||
170779098|NCT00567398|617197346|FG001|Overall Study|Renal Transplantation|3|||
170779099|NCT00567398|617197345|FG000|Overall Study|Other|1|||
170779100|NCT00567398|617197346|FG001|Overall Study|Other|0|||
170779101|NCT04093362|617197347|FG000|Overall Study|Study Termination|1|||
170779102|NCT04093362|617197348|FG001|Overall Study|Study Termination|1|||
170779103|NCT04093362|617197347|FG000|Overall Study|Withdrawal of Consent|1|||
170779104|NCT04093362|617197348|FG001|Overall Study|Withdrawal of Consent|0|||
170779105|NCT04093362|617197347|FG000|Overall Study|Death|1|||
170779106|NCT04093362|617197348|FG001|Overall Study|Death|3|||
170779107|NCT04093362|617197347|FG000|Overall Study|Reason not Specified|1|||
170779108|NCT04093362|617197348|FG001|Overall Study|Reason not Specified|2|||
170779109|NCT02879448|617197349|FG000|Overall Study|Death|251|||
170779110|NCT02879448|617197350|FG001|Overall Study|Death|263|||
170779111|NCT02879448|617197349|FG000|Overall Study|Lost to Follow-up|23|||
170779112|NCT02879448|617197350|FG001|Overall Study|Lost to Follow-up|28|||
170779113|NCT02879448|617197349|FG000|Overall Study|Withdrawal by Subject|42|||
170779114|NCT02879448|617197350|FG001|Overall Study|Withdrawal by Subject|79|||
170779115|NCT02879448|617197349|FG000|Overall Study|Other Reasons|8|||
170779116|NCT02879448|617197350|FG001|Overall Study|Other Reasons|12|||
170779117|NCT03948763|617197351|FG000|Overall Study|Sponsor's decision|0|||
170779118|NCT03948763|617197352|FG001|Overall Study|Sponsor's decision|2|||
170779119|NCT03948763|617197353|FG002|Overall Study|Sponsor's decision|6|||
170779120|NCT03948763|617197354|FG003|Overall Study|Sponsor's decision|4|||
170779121|NCT03948763|617197355|FG004|Overall Study|Sponsor's decision|0|||
170779122|NCT03948763|617197351|FG000|Overall Study|Physician Decision|0|||
170779123|NCT03948763|617197352|FG001|Overall Study|Physician Decision|0|||
170779124|NCT03948763|617197353|FG002|Overall Study|Physician Decision|1|||
170779125|NCT03948763|617197354|FG003|Overall Study|Physician Decision|0|||
170779126|NCT03948763|617197355|FG004|Overall Study|Physician Decision|0|||
170779127|NCT03948763|617197351|FG000|Overall Study|Lost to Follow-up|0|||
170779128|NCT03948763|617197352|FG001|Overall Study|Lost to Follow-up|0|||
170779129|NCT03948763|617197353|FG002|Overall Study|Lost to Follow-up|0|||
170779130|NCT03948763|617197354|FG003|Overall Study|Lost to Follow-up|0|||
170779131|NCT03948763|617197355|FG004|Overall Study|Lost to Follow-up|1|||
170779132|NCT03948763|617197351|FG000|Overall Study|Death|2|||
170779133|NCT03948763|617197352|FG001|Overall Study|Death|12|||
170779134|NCT03948763|617197353|FG002|Overall Study|Death|13|||
170779135|NCT03948763|617197354|FG003|Overall Study|Death|10|||
170779136|NCT03948763|617197355|FG004|Overall Study|Death|11|||
170779137|NCT03948763|617197351|FG000|Overall Study|Withdrawal by Subject|1|||
170779138|NCT03948763|617197352|FG001|Overall Study|Withdrawal by Subject|1|||
170434068|NCT01993186|615927060|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
170434069|NCT01993186|615927061|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
170434070|NCT01993186|615927060|FG000|Open-Label Extension Period|Other, Not Specified|0|||
170434071|NCT01993186|615927061|FG001|Open-Label Extension Period|Other, Not Specified|1|||
170434072|NCT01993186|615927060|FG000|Open-Label Extension Period|Adverse Event|1|||
170434073|NCT01993186|615927061|FG001|Open-Label Extension Period|Adverse Event|0|||
170779139|NCT03948763|617197353|FG002|Overall Study|Withdrawal by Subject|0|||
170779140|NCT03948763|617197354|FG003|Overall Study|Withdrawal by Subject|2|||
170779141|NCT03948763|617197355|FG004|Overall Study|Withdrawal by Subject|4|||
170779142|NCT00894543|617197366|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
170779143|NCT00894543|617197367|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
170632775|NCT04672239|616666761|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
170779144|NCT00894543|617197366|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
170779145|NCT00894543|617197367|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
170779146|NCT02461628|617197368|FG000|Overall Study|Refused to complete survey|4|||
170779147|NCT02461628|617197369|FG001|Overall Study|Refused to complete survey|7|||
170779148|NCT01376700|617197370|FG000|Overall Study|Sponsor terminated study early|8|||
170779149|NCT01376700|617197370|FG000|Overall Study|Low or high titer inhibitor|8|||
170779150|NCT00727909|617197371|FG000|Overall Study|Withdrawal by Subject|5|||
170779151|NCT00727909|617197372|FG001|Overall Study|Withdrawal by Subject|11|||
170779152|NCT00727909|617197373|FG002|Overall Study|Withdrawal by Subject|8|||
170536634|NCT03338790|616309545|FG002|Overall Study|Maximum clinical benefit|1|||
170565485|NCT01049373|616418532|FG001|Overall Study|Other|1|||
170434074|NCT01993186|615927060|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
170434075|NCT01993186|615927061|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
170434076|NCT01993186|615927060|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
170434077|NCT01993186|615927061|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
170434078|NCT01993186|615927060|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
170434079|NCT01993186|615927061|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
170434080|NCT04406194|615927062|FG000|Period 1|Withdrawal by Subject|0|||
170434081|NCT04406194|615927063|FG001|Period 1|Withdrawal by Subject|1|||
170434082|NCT04102345|615927064|FG000|Overall Study|Withdrawal by Subject|1|||
170434083|NCT04102345|615927065|FG001|Overall Study|Withdrawal by Subject|0|||
170434084|NCT00835575|615927066|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
170434085|NCT00835575|615927067|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
170434086|NCT02752074|615927073|FG000|Overall Study|Lost to Follow-up|1|||
170434087|NCT02752074|615927074|FG001|Overall Study|Lost to Follow-up|4|||
170434088|NCT02752074|615927073|FG000|Overall Study|Death|146|||
170434089|NCT02752074|615927074|FG001|Overall Study|Death|129|||
170434090|NCT02752074|615927073|FG000|Overall Study|Withdrawal by Subject|9|||
170434091|NCT02752074|615927074|FG001|Overall Study|Withdrawal by Subject|10|||
170434092|NCT05041361|615927075|FG000|Overall Study|Lost to Follow-up|1|||
170434093|NCT05041361|615927076|FG001|Overall Study|Lost to Follow-up|3|||
170434094|NCT01642277|615927077|FG000|Overall Study|Adverse Event|10|||
170434095|NCT01642277|615927078|FG001|Overall Study|Adverse Event|0|||
170434096|NCT01642277|615927077|FG000|Overall Study|Physician Decision|2|||
170434097|NCT01642277|615927078|FG001|Overall Study|Physician Decision|0|||
170434098|NCT01642277|615927077|FG000|Overall Study|Protocol Violation|1|||
170434099|NCT01642277|615927078|FG001|Overall Study|Protocol Violation|0|||
170434100|NCT01642277|615927077|FG000|Overall Study|Withdrawal by Subject|11|||
170434101|NCT01642277|615927078|FG001|Overall Study|Withdrawal by Subject|0|||
170434102|NCT03679598|615927079|FG000|Overall Study|Adverse Event|2|||
170434103|NCT03679598|615927080|FG001|Overall Study|Adverse Event|0|||
170434104|NCT03605342|615927081|FG000|Overall Study|Withdrawal by Subject|9|||
170434105|NCT03605342|615927082|FG001|Overall Study|Withdrawal by Subject|7|||
170434106|NCT03605342|615927081|FG000|Overall Study|Lost to Follow-up|1|||
170434107|NCT03605342|615927082|FG001|Overall Study|Lost to Follow-up|1|||
170434108|NCT00927069|615927083|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
170434109|NCT00927069|615927084|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
170434110|NCT00927069|615927085|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
170434111|NCT00927069|615927086|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
170434112|NCT00927069|615927083|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
170434113|NCT00927069|615927084|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
170434114|NCT00927069|615927085|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
170434115|NCT00927069|615927086|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
170434116|NCT00927069|615927083|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
170434117|NCT00927069|615927084|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
170434118|NCT00927069|615927085|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
170434119|NCT00927069|615927086|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
170434120|NCT00927069|615927083|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
170434121|NCT00927069|615927084|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
170434122|NCT00927069|615927085|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
170434123|NCT00927069|615927086|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
170434124|NCT00927069|615927083|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
170434125|NCT00927069|615927084|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
170434126|NCT00927069|615927085|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
170434127|NCT00927069|615927086|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
170434128|NCT03214588|615927093|FG000|Overall Study|Adverse Event|1|||
170434129|NCT03214588|615927094|FG001|Overall Study|Adverse Event|0|||
170434130|NCT03214588|615927095|FG002|Overall Study|Adverse Event|2|||
170434131|NCT03214588|615927093|FG000|Overall Study|Reason Not Specified|0|||
170434132|NCT03214588|615927094|FG001|Overall Study|Reason Not Specified|1|||
170434133|NCT03214588|615927095|FG002|Overall Study|Reason Not Specified|0|||
170434134|NCT00418938|615927096|FG000|Overall Study|Reimbursement|1|||
170434135|NCT00418938|615927097|FG001|Overall Study|Reimbursement|0|||
170779153|NCT00727909|617197374|FG003|Overall Study|Withdrawal by Subject|5|||
170779154|NCT00727909|617197371|FG000|Overall Study|Death|0|||
170779155|NCT00727909|617197372|FG001|Overall Study|Death|0|||
170779156|NCT00727909|617197373|FG002|Overall Study|Death|1|||
170779157|NCT00727909|617197374|FG003|Overall Study|Death|0|||
170779158|NCT05623345|617197375|FG000|Overall Study|Withdrawal by Subject|14|||
170779159|NCT05623345|617197376|FG001|Overall Study|Withdrawal by Subject|0|||
170779160|NCT05623345|617197377|FG002|Overall Study|Withdrawal by Subject|9|||
170779161|NCT05623345|617197378|FG003|Overall Study|Withdrawal by Subject|20|||
170779162|NCT05623345|617197375|FG000|Overall Study|Lost to Follow-up|3|||
170779163|NCT05623345|617197376|FG001|Overall Study|Lost to Follow-up|0|||
170779164|NCT05623345|617197377|FG002|Overall Study|Lost to Follow-up|7|||
170779165|NCT05623345|617197378|FG003|Overall Study|Lost to Follow-up|2|||
170779166|NCT05623345|617197375|FG000|Overall Study|Termination of Study By Sponsor|37|||
170779167|NCT05623345|617197376|FG001|Overall Study|Termination of Study By Sponsor|4|||
170779168|NCT05623345|617197377|FG002|Overall Study|Termination of Study By Sponsor|40|||
170434136|NCT00418938|615927096|FG000|Overall Study|Administrative decision|3|||
170434137|NCT00418938|615927097|FG001|Overall Study|Administrative decision|3|||
170434138|NCT00418938|615927096|FG000|Overall Study|Withdrawal by Subject|16|||
170434139|NCT00418938|615927097|FG001|Overall Study|Withdrawal by Subject|15|||
170434140|NCT00418938|615927096|FG000|Overall Study|Lost to Follow-up|1|||
170434141|NCT00418938|615927097|FG001|Overall Study|Lost to Follow-up|3|||
170434142|NCT00418938|615927096|FG000|Overall Study|Adverse Event|1|||
170434143|NCT00418938|615927097|FG001|Overall Study|Adverse Event|1|||
170536635|NCT03338790|616309546|FG003|Overall Study|Maximum clinical benefit|0|||
170536636|NCT03338790|616309543|FG000|Overall Study|Administrative reason by sponsor|0|||
170536637|NCT03338790|616309544|FG001|Overall Study|Administrative reason by sponsor|0|||
170536638|NCT03338790|616309545|FG002|Overall Study|Administrative reason by sponsor|1|||
170536639|NCT03338790|616309546|FG003|Overall Study|Administrative reason by sponsor|0|||
170536640|NCT03338790|616309543|FG000|Overall Study|Participant no longer meets study criteria|0|||
170536641|NCT03338790|616309544|FG001|Overall Study|Participant no longer meets study criteria|0|||
170536642|NCT03338790|616309545|FG002|Overall Study|Participant no longer meets study criteria|1|||
170536643|NCT03338790|616309546|FG003|Overall Study|Participant no longer meets study criteria|0|||
170536644|NCT04303078|616309549|FG000|Overall Study|Withdrawal by Subject|1|||
170536645|NCT04303078|616309550|FG001|Overall Study|Withdrawal by Subject|0|||
170536646|NCT03895203|616309551|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
170536647|NCT03895203|616309552|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
170536648|NCT03895203|616309553|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
170536649|NCT03895203|616309554|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
170536650|NCT03895203|616309555|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
170536651|NCT03895203|616309556|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
170536652|NCT03895203|616309551|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
170536653|NCT03895203|616309552|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
170536654|NCT03895203|616309553|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
170536655|NCT03895203|616309554|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
170536656|NCT03895203|616309555|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
170536657|NCT03895203|616309556|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
170536658|NCT03895203|616309551|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
170565486|NCT01049373|616418531|FG000|Overall Study|Non-cooperation|0|||
170779169|NCT05623345|617197378|FG003|Overall Study|Termination of Study By Sponsor|38|||
170779170|NCT01121991|617197380|FG000|Overall Study|Lack of Ovarian Response|2|||
170779171|NCT01121991|617197380|FG000|Overall Study|No Oocytes Retrieved|3|||
170779172|NCT01121991|617197380|FG000|Overall Study|No Fertilization|1|||
170434144|NCT00418938|615927096|FG000|Overall Study|On-going|1|||
170434145|NCT00418938|615927097|FG001|Overall Study|On-going|1|||
170434146|NCT00418938|615927096|FG000|Overall Study|Ineligibility Determined|1|||
170434147|NCT00418938|615927097|FG001|Overall Study|Ineligibility Determined|0|||
170434148|NCT04404725|615927102|FG000|First Intervention|Withdrawal by Subject|0|||
170434149|NCT04404725|615927103|FG001|First Intervention|Withdrawal by Subject|2|||
170434150|NCT04404725|615927102|FG000|Second Intervention|Adverse Event|1|||
170434151|NCT04404725|615927103|FG001|Second Intervention|Adverse Event|1|||
170434152|NCT04404725|615927102|FG000|Second Intervention|Withdrawal by Subject|0|||
170434153|NCT04404725|615927103|FG001|Second Intervention|Withdrawal by Subject|1|||
170779173|NCT02006758|617197384|FG000|Overall Study|Protocol Violation|1|||
170434154|NCT01075516|615927104|FG000|Overall Study|Death|5|||
170434155|NCT01075516|615927105|FG001|Overall Study|Death|9|||
170434156|NCT01075516|615927104|FG000|Overall Study|Lost to Follow-up|10|||
170434157|NCT01075516|615927105|FG001|Overall Study|Lost to Follow-up|2|||
170434158|NCT01075516|615927104|FG000|Overall Study|Withdrawal by Subject|3|||
170434159|NCT01075516|615927105|FG001|Overall Study|Withdrawal by Subject|5|||
170434160|NCT02252016|615927106|FG000|Overall Study|Lost to Follow-up|2|||
170434161|NCT02252016|615927107|FG001|Overall Study|Lost to Follow-up|1|||
170434162|NCT02252016|615927106|FG000|Overall Study|Physician Decision|1|||
170434163|NCT02252016|615927107|FG001|Overall Study|Physician Decision|0|||
170434164|NCT02252016|615927106|FG000|Overall Study|Withdrawal by Subject|0|||
170779174|NCT02006758|617197384|FG000|Overall Study|Death|1|||
170779175|NCT02006758|617197384|FG000|Overall Study|Lost to Follow-up|4|||
170779176|NCT02006758|617197384|FG000|Overall Study|Withdrawal by Subject|4|||
170779177|NCT02006758|617197384|FG000|Overall Study|Procedurally excluded|1|||
170779178|NCT02006758|617197384|FG000|Overall Study|Other|2|||
170779179|NCT00520546|617197386|FG000|Overall Study|Withdrawal by Subject|1|||
170779180|NCT00520546|617197386|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
170779181|NCT04583423|617197387|FG000|Overall Study|Lost to Follow-up|0|||
170779182|NCT04583423|617197388|FG001|Overall Study|Lost to Follow-up|1|||
170779183|NCT04583423|617197389|FG002|Overall Study|Lost to Follow-up|0|||
170779184|NCT04583423|617197390|FG003|Overall Study|Lost to Follow-up|2|||
170779185|NCT04583423|617197387|FG000|Overall Study|Study Terminated by Sponsor|32|||
170880883|NCT01157364|617574400|FG003|Overall Study|Personal Reasons|0|||
170880884|NCT01157364|617574401|FG004|Overall Study|Personal Reasons|1|||
170434165|NCT02252016|615927107|FG001|Overall Study|Withdrawal by Subject|2|||
170434166|NCT00674128|615927108|FG000|Overall Study|Withdrawal by Subject|25|||
170434167|NCT00674128|615927109|FG001|Overall Study|Withdrawal by Subject|23|||
170434168|NCT04631562|615927112|FG000|Overall Study|Withdrawal by Subject|0|||
170434169|NCT04631562|615927113|FG001|Overall Study|Withdrawal by Subject|0|||
170434170|NCT04631562|615927114|FG002|Overall Study|Withdrawal by Subject|0|||
170434171|NCT04631562|615927115|FG003|Overall Study|Withdrawal by Subject|0|||
170434172|NCT04631562|615927116|FG004|Overall Study|Withdrawal by Subject|0|||
170434173|NCT04631562|615927117|FG005|Overall Study|Withdrawal by Subject|0|||
170434174|NCT04631562|615927118|FG006|Overall Study|Withdrawal by Subject|0|||
170434175|NCT04631562|615927119|FG007|Overall Study|Withdrawal by Subject|1|||
170434176|NCT04631562|615927120|FG008|Overall Study|Withdrawal by Subject|0|||
170434177|NCT04631562|615927112|FG000|Overall Study|Other|0|||
170434178|NCT04631562|615927113|FG001|Overall Study|Other|0|||
170434179|NCT04631562|615927114|FG002|Overall Study|Other|0|||
170434180|NCT04631562|615927115|FG003|Overall Study|Other|0|||
170434181|NCT04631562|615927116|FG004|Overall Study|Other|0|||
170434182|NCT04631562|615927117|FG005|Overall Study|Other|0|||
170434183|NCT04631562|615927118|FG006|Overall Study|Other|0|||
170434184|NCT04631562|615927119|FG007|Overall Study|Other|0|||
170434185|NCT04631562|615927120|FG008|Overall Study|Other|1|||
170434186|NCT04631562|615927112|FG000|Overall Study|Lost to Follow-up|0|||
170434187|NCT04631562|615927113|FG001|Overall Study|Lost to Follow-up|0|||
170434188|NCT04631562|615927114|FG002|Overall Study|Lost to Follow-up|0|||
170434189|NCT04631562|615927115|FG003|Overall Study|Lost to Follow-up|1|||
170434190|NCT04631562|615927116|FG004|Overall Study|Lost to Follow-up|0|||
170434191|NCT04631562|615927117|FG005|Overall Study|Lost to Follow-up|0|||
170434192|NCT04631562|615927118|FG006|Overall Study|Lost to Follow-up|0|||
170434193|NCT04631562|615927119|FG007|Overall Study|Lost to Follow-up|0|||
170434194|NCT04631562|615927120|FG008|Overall Study|Lost to Follow-up|0|||
170434195|NCT04631562|615927112|FG000|Overall Study|Adverse Event|0|||
170434196|NCT04631562|615927113|FG001|Overall Study|Adverse Event|0|||
170434197|NCT04631562|615927114|FG002|Overall Study|Adverse Event|0|||
170434198|NCT04631562|615927115|FG003|Overall Study|Adverse Event|0|||
170434199|NCT04631562|615927116|FG004|Overall Study|Adverse Event|0|||
170434200|NCT04631562|615927117|FG005|Overall Study|Adverse Event|0|||
170434201|NCT04631562|615927118|FG006|Overall Study|Adverse Event|1|||
170434202|NCT04631562|615927119|FG007|Overall Study|Adverse Event|0|||
170434203|NCT04631562|615927120|FG008|Overall Study|Adverse Event|0|||
170434204|NCT03503318|615927123|FG000|Overall Study|Death|1|||
170434205|NCT03503318|615927124|FG001|Overall Study|Death|0|||
170434206|NCT03503318|615927125|FG002|Overall Study|Death|4|||
170434207|NCT03503318|615927123|FG000|Overall Study|Adverse Event|3|||
170434208|NCT03503318|615927124|FG001|Overall Study|Adverse Event|4|||
170434209|NCT03503318|615927125|FG002|Overall Study|Adverse Event|2|||
170434210|NCT03503318|615927123|FG000|Overall Study|Withdrawal by Subject|12|||
170632776|NCT04672239|616666762|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
170779186|NCT04583423|617197388|FG001|Overall Study|Study Terminated by Sponsor|35|||
170880885|NCT01157364|617574402|FG005|Overall Study|Personal Reasons|1|||
170434211|NCT03503318|615927124|FG001|Overall Study|Withdrawal by Subject|17|||
170434212|NCT03503318|615927125|FG002|Overall Study|Withdrawal by Subject|16|||
170434213|NCT03503318|615927123|FG000|Overall Study|Protocol Violation|5|||
170434214|NCT03503318|615927124|FG001|Overall Study|Protocol Violation|0|||
170434215|NCT03503318|615927125|FG002|Overall Study|Protocol Violation|3|||
170880886|NCT01157364|617574397|FG000|Overall Study|Lost to Follow-up|1|||
170434216|NCT03503318|615927123|FG000|Overall Study|Lost to Follow-up|17|||
170434217|NCT03503318|615927124|FG001|Overall Study|Lost to Follow-up|15|||
170434218|NCT03503318|615927125|FG002|Overall Study|Lost to Follow-up|12|||
170434219|NCT03503318|615927123|FG000|Overall Study|Other than specified|1|||
170434220|NCT03503318|615927124|FG001|Overall Study|Other than specified|3|||
170434221|NCT03503318|615927125|FG002|Overall Study|Other than specified|3|||
170434222|NCT01825798|615927127|FG000|Overall Study|Adverse Event|1|||
170434223|NCT01825798|615927128|FG001|Overall Study|Adverse Event|5|||
170779187|NCT04583423|617197389|FG002|Overall Study|Study Terminated by Sponsor|36|||
170434224|NCT01825798|615927127|FG000|Overall Study|Lost to Follow-up|1|||
170779188|NCT04583423|617197390|FG003|Overall Study|Study Terminated by Sponsor|33|||
170434225|NCT01825798|615927128|FG001|Overall Study|Lost to Follow-up|0|||
170434226|NCT02471807|615927130|FG000|Overall Study|Death|14|||
170434227|NCT02471807|615927130|FG000|Overall Study|Withdrawal by Subject|2|||
170434228|NCT02471807|615927130|FG000|Overall Study|Explant|5|||
170434229|NCT02471807|615927130|FG000|Overall Study|Lost to Follow-up|1|||
170434230|NCT03498560|615927132|FG000|Overall Study|Found Ineligible|2|||
170434231|NCT03498560|615927132|FG000|Overall Study|Withdrawal by Subject|14|||
170779189|NCT04583423|617197387|FG000|Overall Study|Withdrawal by Subject|3|||
170779190|NCT04583423|617197388|FG001|Overall Study|Withdrawal by Subject|1|||
170779191|NCT04583423|617197389|FG002|Overall Study|Withdrawal by Subject|2|||
170779192|NCT04583423|617197390|FG003|Overall Study|Withdrawal by Subject|1|||
170779193|NCT00879333|617197391|FG000|Overall Study|Adverse Event|94|||
170779194|NCT00879333|617197392|FG001|Overall Study|Adverse Event|34|||
170779195|NCT00879333|617197391|FG000|Overall Study|Abnormal Laboratory Value|1|||
170779196|NCT00879333|617197392|FG001|Overall Study|Abnormal Laboratory Value|0|||
170779197|NCT00879333|617197391|FG000|Overall Study|Withdrawal by Subject|20|||
170779198|NCT00879333|617197392|FG001|Overall Study|Withdrawal by Subject|7|||
170779199|NCT00879333|617197391|FG000|Overall Study|Lost to Follow-up|2|||
170779200|NCT00879333|617197392|FG001|Overall Study|Lost to Follow-up|1|||
170779201|NCT00879333|617197391|FG000|Overall Study|Administrative Problems|2|||
170779202|NCT00879333|617197392|FG001|Overall Study|Administrative Problems|0|||
170779203|NCT00879333|617197391|FG000|Overall Study|Death|16|||
170779204|NCT00879333|617197392|FG001|Overall Study|Death|5|||
170779205|NCT00879333|617197391|FG000|Overall Study|Disease Progression|292|||
170779206|NCT00879333|617197392|FG001|Overall Study|Disease Progression|169|||
170779207|NCT00879333|617197391|FG000|Overall Study|Protocol Violation|1|||
170779208|NCT00879333|617197392|FG001|Overall Study|Protocol Violation|1|||
170779209|NCT04154384|617197393|FG000|Overall Study|Lost to Follow-up|24|||
170779210|NCT04154384|617197394|FG001|Overall Study|Lost to Follow-up|33|||
170779211|NCT04154384|617197395|FG002|Overall Study|Lost to Follow-up|0|||
170779212|NCT04154384|617197393|FG000|Overall Study|Withdrawal by Subject|7|||
170779213|NCT04154384|617197394|FG001|Overall Study|Withdrawal by Subject|18|||
170779214|NCT04154384|617197395|FG002|Overall Study|Withdrawal by Subject|0|||
170779215|NCT04154384|617197393|FG000|Overall Study|Missing outcome data|1|||
170779216|NCT04154384|617197394|FG001|Overall Study|Missing outcome data|0|||
170779217|NCT04154384|617197395|FG002|Overall Study|Missing outcome data|0|||
170779218|NCT04095104|617197396|FG000|Overall Study|Withdrawal by Subject|0|||
170779219|NCT04095104|617197397|FG001|Overall Study|Withdrawal by Subject|1|||
170779220|NCT01136876|617197398|FG000|Overall Study|Lost to Follow-up|0|||
170779221|NCT01136876|617197399|FG001|Overall Study|Lost to Follow-up|1|||
170779222|NCT01136876|617197398|FG000|Overall Study|Physician Decision|3|||
170779223|NCT01136876|617197399|FG001|Overall Study|Physician Decision|5|||
170779224|NCT01136876|617197398|FG000|Overall Study|Missing NGAL measurement|2|||
170779225|NCT01136876|617197399|FG001|Overall Study|Missing NGAL measurement|5|||
170779226|NCT02412748|617197402|FG000|Overall Study|Lost to Follow-up|38|||
170779227|NCT02412748|617197403|FG001|Overall Study|Lost to Follow-up|39|||
170779228|NCT04732338|617197406|FG000|Overall Study|Lost to Follow-up|3|||
170779229|NCT04732338|617197407|FG001|Overall Study|Lost to Follow-up|3|||
170779230|NCT00393484|617197408|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
170779231|NCT00393484|617197409|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
170779232|NCT00393484|617197408|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
170779233|NCT00393484|617197409|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
170779234|NCT00393484|617197408|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
170779235|NCT00393484|617197409|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
170779236|NCT00393484|617197408|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
170779237|NCT00393484|617197409|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
170779238|NCT00393484|617197408|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
170779239|NCT00393484|617197409|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
170779240|NCT00393484|617197408|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
170779241|NCT00393484|617197409|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
170779242|NCT00393484|617197408|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
170779243|NCT00393484|617197409|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
170779244|NCT00393484|617197408|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
170779245|NCT00393484|617197409|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
170779246|NCT00393484|617197408|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
170779247|NCT00393484|617197409|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
170434232|NCT03498560|615927132|FG000|Overall Study|Lost to Follow-up|4|||
170779248|NCT00393484|617197408|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
170434233|NCT03498560|615927132|FG000|Overall Study|Death|1|||
170779249|NCT00393484|617197409|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
170779250|NCT04484935|617197410|FG000|Overall Study|Other|0|||
170779251|NCT04484935|617197411|FG001|Overall Study|Other|1|||
170779252|NCT04484935|617197410|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170779253|NCT04484935|617197411|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170779254|NCT04484935|617197410|FG000|Overall Study|Lost to Follow-up|1|||
170779255|NCT04484935|617197411|FG001|Overall Study|Lost to Follow-up|0|||
170779256|NCT04484935|617197410|FG000|Overall Study|Death|2|||
170779257|NCT04484935|617197411|FG001|Overall Study|Death|1|||
170779258|NCT00088413|617197413|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
170779259|NCT00088413|617197414|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
170434234|NCT00867360|615927133|FG000|Overall Study|Withdrawal by Subject|1|||
170434235|NCT00867360|615927134|FG001|Overall Study|Withdrawal by Subject|0|||
170779260|NCT00088413|617197415|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
170779261|NCT00088413|617197416|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
170779262|NCT00088413|617197413|FG000|Overall Study|Adverse Events/Side Effects|0|||
170779263|NCT00088413|617197414|FG001|Overall Study|Adverse Events/Side Effects|1|||
170779264|NCT00088413|617197415|FG002|Overall Study|Adverse Events/Side Effects|1|||
170779265|NCT00088413|617197416|FG003|Overall Study|Adverse Events/Side Effects|0|||
170434236|NCT00867360|615927133|FG000|Overall Study|Physician Decision|0|||
170434237|NCT00867360|615927134|FG001|Overall Study|Physician Decision|1|||
170434238|NCT01824576|615927139|FG000|Overall Study|Device deficiency|2|||
170434239|NCT02597049|615927145|FG000|Overall Study|Lost to Follow-up|0|||
170434240|NCT02597049|615927146|FG001|Overall Study|Lost to Follow-up|3|||
170434241|NCT02597049|615927147|FG002|Overall Study|Lost to Follow-up|2|||
170434242|NCT02597049|615927145|FG000|Overall Study|Withdrawal by Subject|2|||
170434243|NCT02597049|615927146|FG001|Overall Study|Withdrawal by Subject|2|||
170434244|NCT02597049|615927147|FG002|Overall Study|Withdrawal by Subject|1|||
170779266|NCT00088413|617197413|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
170779267|NCT00088413|617197414|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
170779268|NCT00088413|617197415|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
170434245|NCT02597049|615927145|FG000|Overall Study|Adverse Event|2|||
170779269|NCT00088413|617197416|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
170434246|NCT02597049|615927146|FG001|Overall Study|Adverse Event|0|||
170434247|NCT02597049|615927147|FG002|Overall Study|Adverse Event|0|||
170779270|NCT00088413|617197413|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
170779271|NCT00088413|617197414|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
170779272|NCT00088413|617197415|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
170779273|NCT00088413|617197416|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
170779274|NCT00088413|617197413|FG000|Overall Study|Death|0|||
170779275|NCT00088413|617197414|FG001|Overall Study|Death|1|||
170779276|NCT00088413|617197415|FG002|Overall Study|Death|0|||
170779277|NCT00088413|617197416|FG003|Overall Study|Death|0|||
170779278|NCT00088413|617197413|FG000|Overall Study|Progressive disease|9|||
170779279|NCT00088413|617197414|FG001|Overall Study|Progressive disease|11|||
170779280|NCT00088413|617197415|FG002|Overall Study|Progressive disease|8|||
170880887|NCT01157364|617574398|FG001|Overall Study|Lost to Follow-up|0|||
170434248|NCT02597049|615927145|FG000|Overall Study|Death|2|||
170434249|NCT02597049|615927146|FG001|Overall Study|Death|0|||
170434250|NCT02597049|615927147|FG002|Overall Study|Death|0|||
170434251|NCT02597049|615927145|FG000|Overall Study|Noncompliant with Study Visits|1|||
170434252|NCT02597049|615927146|FG001|Overall Study|Noncompliant with Study Visits|0|||
170434253|NCT02597049|615927147|FG002|Overall Study|Noncompliant with Study Visits|0|||
170434254|NCT06647173|615927149|FG000|Overall Study|Lost to Follow-up|24|||
170434255|NCT04063878|615927150|FG000|Overall Study|Withdrawal by Subject|2|||
170434256|NCT04063878|615927150|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
170434257|NCT00950989|615927151|FG000|Overall Study|Death|0|||
170434258|NCT00950989|615927152|FG001|Overall Study|Death|0|||
170434259|NCT00950989|615927153|FG002|Overall Study|Death|1|||
170434260|NCT00950989|615927154|FG003|Overall Study|Death|0|||
170434261|NCT00950989|615927151|FG000|Overall Study|Administrative Decision|0|||
170434262|NCT00950989|615927152|FG001|Overall Study|Administrative Decision|1|||
170434263|NCT00950989|615927153|FG002|Overall Study|Administrative Decision|0|||
170434264|NCT00950989|615927154|FG003|Overall Study|Administrative Decision|0|||
170434265|NCT00950989|615927151|FG000|Overall Study|Disease Progression|0|||
170434266|NCT00950989|615927152|FG001|Overall Study|Disease Progression|0|||
170434267|NCT00950989|615927153|FG002|Overall Study|Disease Progression|1|||
170434268|NCT00950989|615927154|FG003|Overall Study|Disease Progression|0|||
170434269|NCT00950989|615927151|FG000|Overall Study|Withdrawal by Subject|2|||
170434270|NCT00950989|615927152|FG001|Overall Study|Withdrawal by Subject|1|||
170434271|NCT00950989|615927153|FG002|Overall Study|Withdrawal by Subject|0|||
170434272|NCT00950989|615927154|FG003|Overall Study|Withdrawal by Subject|0|||
170434273|NCT00950989|615927151|FG000|Overall Study|Adverse Event|2|||
170434274|NCT00950989|615927152|FG001|Overall Study|Adverse Event|1|||
170434275|NCT00950989|615927153|FG002|Overall Study|Adverse Event|1|||
170434276|NCT00950989|615927154|FG003|Overall Study|Adverse Event|0|||
170434277|NCT00147498|615927155|FG000|Overall Study|Adverse Event|1|||
170434278|NCT00147498|615927156|FG001|Overall Study|Adverse Event|6|||
170434279|NCT00147498|615927157|FG002|Overall Study|Adverse Event|7|||
170434280|NCT00147498|615927158|FG003|Overall Study|Adverse Event|3|||
170434281|NCT00147498|615927155|FG000|Overall Study|Lack of Efficacy|1|||
170434282|NCT00147498|615927156|FG001|Overall Study|Lack of Efficacy|1|||
170434283|NCT00147498|615927157|FG002|Overall Study|Lack of Efficacy|1|||
170434284|NCT00147498|615927158|FG003|Overall Study|Lack of Efficacy|8|||
170434285|NCT00147498|615927155|FG000|Overall Study|Laboratory abnormality|0|||
170434286|NCT00147498|615927156|FG001|Overall Study|Laboratory abnormality|0|||
170434287|NCT00147498|615927157|FG002|Overall Study|Laboratory abnormality|2|||
170434288|NCT00147498|615927158|FG003|Overall Study|Laboratory abnormality|0|||
170434289|NCT00147498|615927155|FG000|Overall Study|Participant defaulted|0|||
170434290|NCT00147498|615927156|FG001|Overall Study|Participant defaulted|1|||
170434291|NCT00147498|615927157|FG002|Overall Study|Participant defaulted|4|||
170434292|NCT00147498|615927158|FG003|Overall Study|Participant defaulted|3|||
170434293|NCT00147498|615927155|FG000|Overall Study|Other|1|||
170434294|NCT00147498|615927156|FG001|Overall Study|Other|1|||
170434295|NCT00147498|615927157|FG002|Overall Study|Other|3|||
170434296|NCT00147498|615927158|FG003|Overall Study|Other|3|||
170434297|NCT01841554|615927159|FG000|Overall Study|Death|7|||
170880888|NCT01157364|617574399|FG002|Overall Study|Lost to Follow-up|1|||
170880889|NCT01157364|617574400|FG003|Overall Study|Lost to Follow-up|0|||
170880890|NCT01157364|617574401|FG004|Overall Study|Lost to Follow-up|0|||
170880891|NCT01157364|617574402|FG005|Overall Study|Lost to Follow-up|0|||
170880892|NCT01157364|617574397|FG000|Overall Study|Lack of Efficacy|0|||
170880893|NCT01157364|617574398|FG001|Overall Study|Lack of Efficacy|0|||
170880894|NCT01157364|617574399|FG002|Overall Study|Lack of Efficacy|0|||
170880895|NCT01157364|617574400|FG003|Overall Study|Lack of Efficacy|1|||
170880896|NCT01157364|617574401|FG004|Overall Study|Lack of Efficacy|0|||
170434298|NCT01841554|615927159|FG000|Overall Study|No Implantation|1|||
170434299|NCT01841554|615927159|FG000|Overall Study|Discontinued Follow Up|5|||
170434300|NCT01841554|615927159|FG000|Overall Study|Study exit due to secondary intervention|6|||
170434301|NCT06041256|615927162|FG000|Overall Study|Withdrawal by Subject|1|||
170434302|NCT06041256|615927163|FG001|Overall Study|Withdrawal by Subject|0|||
170880897|NCT01157364|617574402|FG005|Overall Study|Lack of Efficacy|0|||
170434303|NCT06041256|615927164|FG002|Overall Study|Withdrawal by Subject|3|||
170434304|NCT06041256|615927165|FG003|Overall Study|Withdrawal by Subject|1|||
170434305|NCT06041256|615927166|FG004|Overall Study|Withdrawal by Subject|1|||
170779281|NCT00088413|617197416|FG003|Overall Study|Progressive disease|14|||
170779282|NCT00088413|617197413|FG000|Overall Study|Other|0|||
170779283|NCT00088413|617197414|FG001|Overall Study|Other|1|||
170779284|NCT00088413|617197415|FG002|Overall Study|Other|0|||
170779285|NCT00088413|617197416|FG003|Overall Study|Other|0|||
170779286|NCT00088413|617197413|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
170779287|NCT00088413|617197414|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
170779288|NCT00088413|617197415|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
170434306|NCT06041256|615927162|FG000|Overall Study|Rescue|17|||
170434307|NCT06041256|615927163|FG001|Overall Study|Rescue|6|||
170434308|NCT06041256|615927164|FG002|Overall Study|Rescue|9|||
170434309|NCT06041256|615927165|FG003|Overall Study|Rescue|6|||
170434310|NCT06041256|615927166|FG004|Overall Study|Rescue|2|||
170434311|NCT03215706|615927167|FG000|Randomization|Adverse Event unrelated to study drug|1|||
170434312|NCT03215706|615927168|FG001|Randomization|Adverse Event unrelated to study drug|0|||
170434313|NCT03215706|615927167|FG000|Randomization|participant withdrew consent|1|||
170434314|NCT03215706|615927168|FG001|Randomization|participant withdrew consent|3|||
170434315|NCT03215706|615927167|FG000|Randomization|no longer meets study criteria|1|||
170434316|NCT03215706|615927168|FG001|Randomization|no longer meets study criteria|4|||
170434317|NCT03215706|615927167|FG000|Randomization|other reasons|0|||
170434318|NCT03215706|615927168|FG001|Randomization|other reasons|2|||
170434319|NCT03215706|615927167|FG000|Treatment Period|Disease Progression|184|||
170434320|NCT03215706|615927168|FG001|Treatment Period|Disease Progression|174|||
170434321|NCT03215706|615927167|FG000|Treatment Period|Study Drug Toxicity|70|||
170434322|NCT03215706|615927168|FG001|Treatment Period|Study Drug Toxicity|24|||
170434323|NCT03215706|615927167|FG000|Treatment Period|Death|7|||
170434324|NCT03215706|615927168|FG001|Treatment Period|Death|1|||
170434325|NCT03215706|615927167|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
170434326|NCT03215706|615927168|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
170434327|NCT03215706|615927167|FG000|Treatment Period|Request to D/C treatment|2|||
170434328|NCT03215706|615927168|FG001|Treatment Period|Request to D/C treatment|10|||
170434329|NCT03215706|615927167|FG000|Treatment Period|Participant withdrew consent|4|||
170434330|NCT03215706|615927168|FG001|Treatment Period|Participant withdrew consent|5|||
170434331|NCT03215706|615927167|FG000|Treatment Period|Lost to Follow-up|0|||
170434332|NCT03215706|615927168|FG001|Treatment Period|Lost to Follow-up|1|||
170434333|NCT03215706|615927167|FG000|Treatment Period|Administrative reason by sponsor|0|||
170434334|NCT03215706|615927168|FG001|Treatment Period|Administrative reason by sponsor|2|||
170434335|NCT03215706|615927167|FG000|Treatment Period|other reasons|10|||
170434336|NCT03215706|615927168|FG001|Treatment Period|other reasons|5|||
170434337|NCT03215706|615927167|FG000|Treatment Period|Not reported|1|||
170434338|NCT03215706|615927168|FG001|Treatment Period|Not reported|0|||
170434339|NCT03114891|615927170|FG000|First Treatment Round|Lost to Follow-up|0|||
170779289|NCT00088413|617197416|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
170779290|NCT03101371|617197417|FG000|Overall Study|Physician Decision|0|||
170536659|NCT03895203|616309552|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
170536660|NCT03895203|616309553|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
170536661|NCT03895203|616309554|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
170536662|NCT03895203|616309555|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
170536663|NCT03895203|616309556|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
170536664|NCT03895203|616309551|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
170536665|NCT03895203|616309552|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
170536666|NCT03895203|616309553|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
170536667|NCT03895203|616309554|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
170536668|NCT03895203|616309555|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
170536669|NCT03895203|616309556|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
170536670|NCT03895203|616309551|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
170536671|NCT03895203|616309552|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
170536672|NCT03895203|616309553|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
170536673|NCT03895203|616309554|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
170536674|NCT03895203|616309555|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
170536675|NCT03895203|616309556|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
170536676|NCT03895203|616309551|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
170536677|NCT03895203|616309552|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
170536678|NCT03895203|616309553|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
170536679|NCT03895203|616309554|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
170536680|NCT03895203|616309555|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
170536681|NCT03895203|616309556|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
170536682|NCT03895203|616309551|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
170536683|NCT03895203|616309552|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
170536684|NCT03895203|616309553|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
170536685|NCT03895203|616309554|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
170536686|NCT03895203|616309555|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
170536687|NCT03895203|616309556|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
170536688|NCT03895203|616309551|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
170536689|NCT03895203|616309552|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
170536690|NCT03895203|616309553|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
170536691|NCT03895203|616309554|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
170536692|NCT03895203|616309555|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
170536693|NCT03895203|616309556|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
170536694|NCT03895203|616309551|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
170536695|NCT03895203|616309552|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
170536696|NCT03895203|616309553|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
170536697|NCT03895203|616309554|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
170536698|NCT03895203|616309555|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
170536699|NCT03895203|616309556|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
170880898|NCT01157364|617574397|FG000|Overall Study|Adverse Event|0|||
170880899|NCT01157364|617574398|FG001|Overall Study|Adverse Event|1|||
170880900|NCT01157364|617574399|FG002|Overall Study|Adverse Event|1|||
170880901|NCT01157364|617574400|FG003|Overall Study|Adverse Event|0|||
170880902|NCT01157364|617574401|FG004|Overall Study|Adverse Event|1|||
170880903|NCT01157364|617574402|FG005|Overall Study|Adverse Event|0|||
170880904|NCT00183274|617574403|FG000|Phase 1: Open-Label|Adverse Event|31|||
170880905|NCT00183274|617574404|FG001|Phase 1: Open-Label|Adverse Event|0|||
170880906|NCT00183274|617574405|FG002|Phase 1: Open-Label|Adverse Event|0|||
170880907|NCT00183274|617574406|FG003|Phase 1: Open-Label|Adverse Event|0|||
170880908|NCT00183274|617574407|FG004|Phase 1: Open-Label|Adverse Event|0|||
170880909|NCT00183274|617574408|FG005|Phase 1: Open-Label|Adverse Event|0|||
170880910|NCT00183274|617574403|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
170880911|NCT00183274|617574404|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
170880912|NCT00183274|617574405|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
170880913|NCT00183274|617574406|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
170880914|NCT00183274|617574407|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
170880915|NCT00183274|617574408|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
170880916|NCT00183274|617574403|FG000|Phase 1: Open-Label|Protocol Violation|11|||
170880917|NCT00183274|617574404|FG001|Phase 1: Open-Label|Protocol Violation|0|||
170880918|NCT00183274|617574405|FG002|Phase 1: Open-Label|Protocol Violation|0|||
170880919|NCT00183274|617574406|FG003|Phase 1: Open-Label|Protocol Violation|0|||
170880920|NCT00183274|617574407|FG004|Phase 1: Open-Label|Protocol Violation|0|||
170880921|NCT00183274|617574408|FG005|Phase 1: Open-Label|Protocol Violation|0|||
170880922|NCT00183274|617574403|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
170536700|NCT03895203|616309551|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
170536701|NCT03895203|616309552|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
170565487|NCT01049373|616418532|FG001|Overall Study|Non-cooperation|1|||
170779291|NCT03101371|617197418|FG001|Overall Study|Physician Decision|1|||
170536702|NCT03895203|616309553|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
170779292|NCT03101371|617197417|FG000|Overall Study|Lost to Follow-up|1|||
170779293|NCT03101371|617197418|FG001|Overall Study|Lost to Follow-up|4|||
170779294|NCT03101371|617197417|FG000|Overall Study|Did not meet eligibility criteria|2|||
170779295|NCT03101371|617197418|FG001|Overall Study|Did not meet eligibility criteria|1|||
170779296|NCT02318134|617197419|FG000|Overall Study|Withdrawal by Subject|2|||
170779297|NCT02318134|617197420|FG001|Overall Study|Withdrawal by Subject|1|||
170779298|NCT01753570|617197421|FG000|Overall Study|Adverse Event|1|||
170779299|NCT01753570|617197422|FG001|Overall Study|Adverse Event|0|||
170779300|NCT01753570|617197423|FG002|Overall Study|Adverse Event|1|||
170779301|NCT01753570|617197421|FG000|Overall Study|Physician Decision|0|||
170779302|NCT01753570|617197422|FG001|Overall Study|Physician Decision|1|||
170779303|NCT01753570|617197423|FG002|Overall Study|Physician Decision|0|||
170779304|NCT01753570|617197421|FG000|Overall Study|Withdrawal by Subject|1|||
170779305|NCT01753570|617197422|FG001|Overall Study|Withdrawal by Subject|4|||
170779306|NCT01753570|617197423|FG002|Overall Study|Withdrawal by Subject|0|||
170779307|NCT02119650|617197424|FG000|Overall Study|Adverse Event|3|||
170779308|NCT02119650|617197425|FG001|Overall Study|Adverse Event|4|||
170779309|NCT02119650|617197424|FG000|Overall Study|Subject decision|2|||
170779310|NCT02119650|617197425|FG001|Overall Study|Subject decision|3|||
170779311|NCT02119650|617197424|FG000|Overall Study|Disease progression|11|||
170779312|NCT02119650|617197425|FG001|Overall Study|Disease progression|14|||
170779313|NCT02119650|617197424|FG000|Overall Study|Death|5|||
170779314|NCT02119650|617197425|FG001|Overall Study|Death|1|||
170779315|NCT02119650|617197424|FG000|Overall Study|Noncompliance with study treatment|1|||
170779316|NCT02119650|617197425|FG001|Overall Study|Noncompliance with study treatment|1|||
170779317|NCT02119650|617197424|FG000|Overall Study|Study terminated by the sponsor|1|||
170779318|NCT02119650|617197425|FG001|Overall Study|Study terminated by the sponsor|0|||
170779319|NCT02119650|617197424|FG000|Overall Study|Physician Decision|0|||
170779320|NCT02119650|617197425|FG001|Overall Study|Physician Decision|2|||
170779321|NCT02119650|617197424|FG000|Overall Study|Multiple reasons for termination|2|||
170779322|NCT02119650|617197425|FG001|Overall Study|Multiple reasons for termination|1|||
170779323|NCT01255670|617197426|FG000|Overall Study|Adverse Event|10|||
170779324|NCT01255670|617197427|FG001|Overall Study|Adverse Event|10|||
170779325|NCT01255670|617197426|FG000|Overall Study|Lost to Follow-up|16|||
170779326|NCT01255670|617197427|FG001|Overall Study|Lost to Follow-up|10|||
170779327|NCT03481816|617197428|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
170779328|NCT03481816|617197429|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
170779329|NCT03481816|617197428|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
170779330|NCT03481816|617197429|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
170779331|NCT03481816|617197428|FG000|Dose Expansion|Withdrawal by Subject|0|||
170779332|NCT03481816|617197429|FG001|Dose Expansion|Withdrawal by Subject|2|||
170779333|NCT03481816|617197428|FG000|Dose Expansion|Physician Decision|0|||
170779334|NCT03481816|617197429|FG001|Dose Expansion|Physician Decision|5|||
170779335|NCT03664960|617197430|FG000|Overall Study|Adverse Event|0|||
170779336|NCT03664960|617197431|FG001|Overall Study|Adverse Event|3|||
170779337|NCT03664960|617197430|FG000|Overall Study|Lost to Follow-up|3|||
170779338|NCT03664960|617197431|FG001|Overall Study|Lost to Follow-up|2|||
170779339|NCT03664960|617197430|FG000|Overall Study|Physician Decision|1|||
170779340|NCT03664960|617197431|FG001|Overall Study|Physician Decision|0|||
170779341|NCT03664960|617197430|FG000|Overall Study|Withdrawal by Subject|3|||
170779342|NCT03664960|617197431|FG001|Overall Study|Withdrawal by Subject|14|||
170880923|NCT00183274|617574404|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
170880924|NCT00183274|617574405|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
170880925|NCT00183274|617574406|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
170880926|NCT00183274|617574407|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
170536703|NCT03895203|616309554|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
170536704|NCT03895203|616309555|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
170536705|NCT03895203|616309556|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
170536706|NCT03895203|616309551|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
170536707|NCT03895203|616309552|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
170536708|NCT03895203|616309553|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
170536709|NCT03895203|616309554|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
170779343|NCT03664960|617197430|FG000|Overall Study|Sponsor Decision|1|||
170779344|NCT03664960|617197431|FG001|Overall Study|Sponsor Decision|1|||
170880927|NCT00183274|617574408|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
170880928|NCT00183274|617574403|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
170880929|NCT00183274|617574404|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
170880930|NCT00183274|617574405|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
170779345|NCT03664960|617197430|FG000|Overall Study|Other|1|||
170779346|NCT03664960|617197431|FG001|Overall Study|Other|2|||
170880931|NCT00183274|617574406|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
170880932|NCT00183274|617574407|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
170779347|NCT01609218|617197432|FG000|Period 1|Adverse Event|3|||
170779348|NCT01609218|617197433|FG001|Period 1|Adverse Event|5|||
170434340|NCT03114891|615927171|FG001|First Treatment Round|Lost to Follow-up|1|||
170434341|NCT03114891|615927172|FG002|First Treatment Round|Lost to Follow-up|1|||
170434342|NCT03114891|615927173|FG003|First Treatment Round|Lost to Follow-up|0|||
170434343|NCT03114891|615927170|FG000|First Treatment Round|Withdrawal by Subject|0|||
170434344|NCT03114891|615927171|FG001|First Treatment Round|Withdrawal by Subject|2|||
170434345|NCT03114891|615927172|FG002|First Treatment Round|Withdrawal by Subject|0|||
170434346|NCT03114891|615927173|FG003|First Treatment Round|Withdrawal by Subject|1|||
170434347|NCT03114891|615927170|FG000|3 Week Break|Lost to Follow-up|1|||
170434348|NCT03114891|615927171|FG001|3 Week Break|Lost to Follow-up|0|||
170434349|NCT03114891|615927172|FG002|3 Week Break|Lost to Follow-up|0|||
170434350|NCT03114891|615927173|FG003|3 Week Break|Lost to Follow-up|1|||
170434351|NCT03114891|615927170|FG000|3 Week Break|Withdrawal by Subject|0|||
170434352|NCT03114891|615927171|FG001|3 Week Break|Withdrawal by Subject|1|||
170434353|NCT03114891|615927172|FG002|3 Week Break|Withdrawal by Subject|0|||
170434354|NCT03114891|615927173|FG003|3 Week Break|Withdrawal by Subject|0|||
170434355|NCT03114891|615927170|FG000|Second Treatment Round|Lost to Follow-up|1|||
170434356|NCT03114891|615927171|FG001|Second Treatment Round|Lost to Follow-up|0|||
170434357|NCT03114891|615927172|FG002|Second Treatment Round|Lost to Follow-up|0|||
170434358|NCT03114891|615927173|FG003|Second Treatment Round|Lost to Follow-up|0|||
170434359|NCT03114891|615927170|FG000|Second Treatment Round|Physician Decision|1|||
170434360|NCT03114891|615927171|FG001|Second Treatment Round|Physician Decision|0|||
170434361|NCT03114891|615927172|FG002|Second Treatment Round|Physician Decision|0|||
170434362|NCT03114891|615927173|FG003|Second Treatment Round|Physician Decision|0|||
170434363|NCT00640341|615928606|FG000|Overall Study|Adverse Event|0|||
170434364|NCT00640341|615928607|FG001|Overall Study|Adverse Event|0|||
170434365|NCT00640341|615928608|FG002|Overall Study|Adverse Event|1|||
170779349|NCT01609218|617197432|FG000|Period 1|Sponsor Decision|0|||
170779350|NCT01609218|617197433|FG001|Period 1|Sponsor Decision|1|||
170779351|NCT01609218|617197432|FG000|Period 2|Adverse Event|1|||
170779352|NCT01609218|617197433|FG001|Period 2|Adverse Event|0|||
170779353|NCT05094141|617197436|FG000|Overall Study|Death|0|||
170779354|NCT05094141|617197437|FG001|Overall Study|Death|0|||
170779355|NCT05094141|617197438|FG002|Overall Study|Death|1|||
170779356|NCT05094141|617197436|FG000|Overall Study|Withdrawal by Subject|0|||
170779357|NCT05094141|617197437|FG001|Overall Study|Withdrawal by Subject|0|||
170779358|NCT05094141|617197438|FG002|Overall Study|Withdrawal by Subject|1|||
170779359|NCT05094141|617197436|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
170779360|NCT05094141|617197437|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
170779361|NCT05094141|617197438|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
170779362|NCT05094141|617197436|FG000|Overall Study|Did not participate in randomization|0|||
170779363|NCT05094141|617197437|FG001|Overall Study|Did not participate in randomization|0|||
170779364|NCT05094141|617197438|FG002|Overall Study|Did not participate in randomization|33|||
170779365|NCT04459416|617199296|FG000|Overall Study|Lost to Follow-up|2|||
170779366|NCT04459416|617199297|FG001|Overall Study|Lost to Follow-up|0|||
170779367|NCT04459416|617199296|FG000|Overall Study|Withdrawal by Subject|8|||
170779368|NCT04459416|617199297|FG001|Overall Study|Withdrawal by Subject|10|||
170779369|NCT04459416|617199296|FG000|Overall Study|Disease progression|0|||
170779370|NCT04459416|617199297|FG001|Overall Study|Disease progression|3|||
170779371|NCT03744312|617199298|FG000|Overall Study|Withdrawal by Subject|0|||
170779372|NCT03744312|617199299|FG001|Overall Study|Withdrawal by Subject|1|||
170779373|NCT03744312|617199298|FG000|Overall Study|Screen fail|0|||
170779374|NCT03744312|617199299|FG001|Overall Study|Screen fail|1|||
170779375|NCT05134337|617199300|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
170779376|NCT05134337|617199301|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
170779377|NCT01216176|617199305|FG000|Overall Study|Adverse Event|0|||
170779378|NCT01216176|617199306|FG001|Overall Study|Adverse Event|8|||
170779379|NCT01216176|617199307|FG002|Overall Study|Adverse Event|0|||
170779380|NCT01216176|617199305|FG000|Overall Study|Physician Decision|0|||
170779381|NCT01216176|617199306|FG001|Overall Study|Physician Decision|0|||
170779382|NCT01216176|617199307|FG002|Overall Study|Physician Decision|1|||
170779383|NCT03725722|617199310|FG000|Overall Study|Lack of Efficacy|2|||
170779384|NCT03725722|617199311|FG001|Overall Study|Lack of Efficacy|1|||
170779385|NCT03725722|617199312|FG002|Overall Study|Lack of Efficacy|2|||
170779386|NCT03725722|617199313|FG003|Overall Study|Lack of Efficacy|0|||
170779387|NCT03725722|617199314|FG004|Overall Study|Lack of Efficacy|2|||
170779388|NCT03725722|617199310|FG000|Overall Study|Adverse Event|2|||
170779389|NCT03725722|617199311|FG001|Overall Study|Adverse Event|2|||
170779390|NCT03725722|617199312|FG002|Overall Study|Adverse Event|1|||
170779391|NCT03725722|617199313|FG003|Overall Study|Adverse Event|0|||
170779392|NCT03725722|617199314|FG004|Overall Study|Adverse Event|6|||
170779393|NCT03725722|617199310|FG000|Overall Study|Withdrawal by Subject|4|||
170779394|NCT03725722|617199311|FG001|Overall Study|Withdrawal by Subject|1|||
170779395|NCT03725722|617199312|FG002|Overall Study|Withdrawal by Subject|0|||
170779396|NCT03725722|617199313|FG003|Overall Study|Withdrawal by Subject|4|||
170779397|NCT03725722|617199314|FG004|Overall Study|Withdrawal by Subject|4|||
170779398|NCT03725722|617199310|FG000|Overall Study|Lost to Follow-up|3|||
170779399|NCT03725722|617199311|FG001|Overall Study|Lost to Follow-up|1|||
170779400|NCT03725722|617199312|FG002|Overall Study|Lost to Follow-up|2|||
170779401|NCT03725722|617199313|FG003|Overall Study|Lost to Follow-up|2|||
170779402|NCT03725722|617199314|FG004|Overall Study|Lost to Follow-up|1|||
170779403|NCT03725722|617199310|FG000|Overall Study|Personal reasons|0|||
170779404|NCT03725722|617199311|FG001|Overall Study|Personal reasons|0|||
170779405|NCT03725722|617199312|FG002|Overall Study|Personal reasons|1|||
170779406|NCT03725722|617199313|FG003|Overall Study|Personal reasons|0|||
170779407|NCT03725722|617199314|FG004|Overall Study|Personal reasons|1|||
170779408|NCT03725722|617199310|FG000|Overall Study|COVID-19 situation|0|||
170779409|NCT03725722|617199311|FG001|Overall Study|COVID-19 situation|1|||
170779410|NCT03725722|617199312|FG002|Overall Study|COVID-19 situation|0|||
170779411|NCT03725722|617199313|FG003|Overall Study|COVID-19 situation|0|||
170779412|NCT03725722|617199314|FG004|Overall Study|COVID-19 situation|0|||
170779413|NCT01600014|617199315|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
170779414|NCT01600014|617199316|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
170779415|NCT01600014|617199315|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
170779416|NCT01600014|617199316|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
170779417|NCT01600014|617199315|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
170779418|NCT01600014|617199316|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
170779419|NCT01600014|617199315|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
170779420|NCT01600014|617199316|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
170779421|NCT01600014|617199315|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
170779422|NCT01600014|617199316|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
170536710|NCT03895203|616309555|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
170536711|NCT03895203|616309556|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
170536712|NCT03895203|616309551|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
170536713|NCT03895203|616309552|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
170536714|NCT03895203|616309553|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
170536715|NCT03895203|616309554|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
170536716|NCT03895203|616309555|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
170536717|NCT03895203|616309556|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
170536718|NCT03895203|616309551|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
170536719|NCT03895203|616309552|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
170536720|NCT03895203|616309553|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
170536721|NCT03895203|616309554|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
170536722|NCT03895203|616309555|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
170536723|NCT03895203|616309556|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
170536724|NCT03895203|616309551|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
170536725|NCT03895203|616309552|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
170536726|NCT03895203|616309553|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
170536727|NCT03895203|616309554|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
170536728|NCT03895203|616309555|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
170536729|NCT03895203|616309556|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
170536730|NCT04725188|616309557|FG000|Overall Study|Death|72|||
170536731|NCT04725188|616309558|FG001|Overall Study|Death|69|||
170536732|NCT04725188|616309559|FG002|Overall Study|Death|76|||
170536733|NCT04725188|616309557|FG000|Overall Study|Lost to Follow-up|1|||
170536734|NCT04725188|616309558|FG001|Overall Study|Lost to Follow-up|0|||
170536735|NCT04725188|616309559|FG002|Overall Study|Lost to Follow-up|1|||
170536736|NCT04725188|616309557|FG000|Overall Study|Withdrawal by Subject|2|||
170536737|NCT04725188|616309558|FG001|Overall Study|Withdrawal by Subject|2|||
170536738|NCT04725188|616309559|FG002|Overall Study|Withdrawal by Subject|1|||
170536739|NCT04725188|616309557|FG000|Overall Study|Sponsor Decision|12|||
170536740|NCT04725188|616309558|FG001|Overall Study|Sponsor Decision|12|||
170536741|NCT04725188|616309559|FG002|Overall Study|Sponsor Decision|7|||
170536742|NCT03839641|616309560|FG000|Overall Study|Withdrawal by Subject|1|||
170536743|NCT03839641|616309561|FG001|Overall Study|Withdrawal by Subject|1|||
170536744|NCT01771107|616309576|FG000|Overall Study|Adverse Event|1|||
170536745|NCT01771107|616309577|FG001|Overall Study|Adverse Event|3|||
170536746|NCT01771107|616309576|FG000|Overall Study|Withdrawal by Subject|0|||
170536747|NCT01771107|616309577|FG001|Overall Study|Withdrawal by Subject|2|||
170536748|NCT01771107|616309576|FG000|Overall Study|Lost to Follow-up|0|||
170536749|NCT01771107|616309577|FG001|Overall Study|Lost to Follow-up|1|||
170536750|NCT01771107|616309576|FG000|Overall Study|participant moved|0|||
170536751|NCT01771107|616309577|FG001|Overall Study|participant moved|1|||
170536752|NCT01771107|616309576|FG000|Overall Study|Other|0|||
170536753|NCT01771107|616309577|FG001|Overall Study|Other|1|||
170536754|NCT03805841|616309578|FG000|Overall Study|Clinical Progression|2|||
170536755|NCT03805841|616309579|FG001|Overall Study|Clinical Progression|0|||
170779423|NCT01600014|617199315|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
170779424|NCT01600014|617199316|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
170779425|NCT01600014|617199315|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
170779426|NCT01600014|617199316|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
170779427|NCT01600014|617199315|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
170779428|NCT01600014|617199316|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
170779429|NCT01600014|617199315|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
170779430|NCT01600014|617199316|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
170779431|NCT01600014|617199315|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
170779432|NCT01600014|617199316|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
170779433|NCT01600014|617199315|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
170779434|NCT01600014|617199316|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
170779435|NCT01600014|617199315|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
170880933|NCT00183274|617574408|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
170536756|NCT03805841|616309580|FG002|Overall Study|Clinical Progression|0|||
170536757|NCT03805841|616309578|FG000|Overall Study|Death|0|||
170779436|NCT01600014|617199316|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
170880934|NCT00183274|617574403|FG000|Phase 1: Open-Label|Other|9|||
170880935|NCT00183274|617574404|FG001|Phase 1: Open-Label|Other|0|||
170880936|NCT00183274|617574405|FG002|Phase 1: Open-Label|Other|0|||
170880937|NCT00183274|617574406|FG003|Phase 1: Open-Label|Other|0|||
170880938|NCT00183274|617574407|FG004|Phase 1: Open-Label|Other|0|||
170880939|NCT00183274|617574408|FG005|Phase 1: Open-Label|Other|0|||
170779437|NCT01600014|617199315|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
170779438|NCT01600014|617199316|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
170779439|NCT01600014|617199315|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
170779440|NCT01600014|617199316|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
170779441|NCT01600014|617199315|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
170779442|NCT01600014|617199316|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
170779443|NCT01600014|617199315|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
170779444|NCT01600014|617199316|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
170779445|NCT01600014|617199315|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
170779446|NCT01600014|617199316|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
170779447|NCT03152786|617199317|FG000|Overall Study|Withdrawal by Subject|2|||
170779448|NCT03152786|617199318|FG001|Overall Study|Withdrawal by Subject|1|||
170779449|NCT04923347|617199319|FG000|Overall Study|Withdrawal by Subject|14|||
170779450|NCT01259401|617199320|FG000|4-month Follow-up|Death|0|||
170779451|NCT01259401|617199321|FG001|4-month Follow-up|Death|1|||
170779452|NCT01259401|617199320|FG000|4-month Follow-up|Lost to Follow-up|0|||
170779453|NCT01259401|617199321|FG001|4-month Follow-up|Lost to Follow-up|1|||
170779454|NCT00212355|617199322|FG000|Overall Study|Adverse Event|1|||
170779455|NCT00212355|617199322|FG000|Overall Study|Withdrawal by Subject|1|||
170779456|NCT00212355|617199322|FG000|Overall Study|A change of address|1|||
170779457|NCT00186992|617199329|FG000|Overall Study|Withdrawal by Subject|5|||
170779458|NCT00186992|617199329|FG000|Overall Study|Physician's discretion|13|||
170779459|NCT00186992|617199329|FG000|Overall Study|PI Discretion|4|||
170779460|NCT00186992|617199329|FG000|Overall Study|Ineligible|2|||
170779461|NCT00186992|617199329|FG000|Overall Study|Lost to Follow-up|2|||
170779462|NCT00186992|617199329|FG000|Overall Study|Still on Study|9|||
170779463|NCT03683069|617199330|FG000|Overall Study|see limitations|12|||
170779464|NCT03683069|617199331|FG001|Overall Study|see limitations|13|||
170779465|NCT01649271|617199334|FG000|Overall Study|Progressive disease|4|||
170779466|NCT01649271|617199335|FG001|Overall Study|Progressive disease|5|||
170779467|NCT01649271|617199334|FG000|Overall Study|Other Adverse Event|0|||
170779468|NCT01649271|617199335|FG001|Overall Study|Other Adverse Event|2|||
170779469|NCT01649271|617199334|FG000|Overall Study|Withdrawal by Subject|1|||
170779470|NCT01649271|617199335|FG001|Overall Study|Withdrawal by Subject|0|||
170779471|NCT01649271|617199334|FG000|Overall Study|Other than stated above|1|||
170779472|NCT01649271|617199335|FG001|Overall Study|Other than stated above|0|||
170779473|NCT05644002|617199338|FG000|Overall Study|Lost to Follow-up|1|||
170779474|NCT05644002|617199339|FG001|Overall Study|Lost to Follow-up|2|||
170779475|NCT05644002|617199338|FG000|Overall Study|Withdrawal by Subject|0|||
170779476|NCT05644002|617199339|FG001|Overall Study|Withdrawal by Subject|1|||
170779477|NCT03821844|617199344|FG000|Overall Study|Death|37|||
170779478|NCT03821844|617199345|FG001|Overall Study|Death|31|||
170779479|NCT03821844|617199344|FG000|Overall Study|Discharged|10|||
170779480|NCT03821844|617199345|FG001|Overall Study|Discharged|14|||
170779481|NCT03821844|617199344|FG000|Overall Study|Not present in facility at followup|2|||
170779482|NCT03821844|617199345|FG001|Overall Study|Not present in facility at followup|3|||
170779483|NCT05104697|617199346|FG000|Overall Study|Withdrawal by Subject|0|||
170779484|NCT05104697|617199347|FG001|Overall Study|Withdrawal by Subject|1|||
170779485|NCT03845465|617199348|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
170779486|NCT03845465|617199349|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
170779487|NCT03845465|617199348|FG000|6-month Data Collection|Withdrawal by Subject|0|||
170779488|NCT03845465|617199349|FG001|6-month Data Collection|Withdrawal by Subject|2|||
170779489|NCT03845465|617199348|FG000|12-month Data Collection|Withdrawal by Subject|0|||
170779490|NCT03845465|617199349|FG001|12-month Data Collection|Withdrawal by Subject|2|||
170779491|NCT03913195|617199350|FG000|Overall Study|Adverse Event|0|||
170779492|NCT03913195|617199351|FG001|Overall Study|Adverse Event|0|||
170779493|NCT03913195|617199352|FG002|Overall Study|Adverse Event|1|||
170779494|NCT03913195|617199353|FG003|Overall Study|Adverse Event|1|||
170779495|NCT03913195|617199354|FG004|Overall Study|Adverse Event|0|||
170779496|NCT03913195|617199350|FG000|Overall Study|Withdrawal by Subject|0|||
170779497|NCT03913195|617199351|FG001|Overall Study|Withdrawal by Subject|0|||
170779498|NCT03913195|617199352|FG002|Overall Study|Withdrawal by Subject|1|||
170779499|NCT03913195|617199353|FG003|Overall Study|Withdrawal by Subject|0|||
170779500|NCT03913195|617199354|FG004|Overall Study|Withdrawal by Subject|1|||
170779501|NCT03913195|617199350|FG000|Overall Study|non adherence to study|0|||
170779502|NCT03913195|617199351|FG001|Overall Study|non adherence to study|0|||
170779503|NCT03913195|617199352|FG002|Overall Study|non adherence to study|1|||
170779504|NCT03913195|617199353|FG003|Overall Study|non adherence to study|0|||
170779505|NCT03913195|617199354|FG004|Overall Study|non adherence to study|0|||
170779506|NCT02780388|617199361|FG000|Overall Study|Lost to Follow-up|0|||
170779507|NCT02780388|617199362|FG001|Overall Study|Lost to Follow-up|1|||
170779508|NCT02780388|617199363|FG002|Overall Study|Lost to Follow-up|0|||
170779509|NCT02780388|617199364|FG003|Overall Study|Lost to Follow-up|0|||
170779510|NCT02780388|617199365|FG004|Overall Study|Lost to Follow-up|0|||
170536758|NCT03805841|616309579|FG001|Overall Study|Death|3|||
170779511|NCT02780388|617199361|FG000|Overall Study|Withdrawal by Subject|1|||
170779512|NCT02780388|617199362|FG001|Overall Study|Withdrawal by Subject|1|||
170779513|NCT02780388|617199363|FG002|Overall Study|Withdrawal by Subject|0|||
170779514|NCT02780388|617199364|FG003|Overall Study|Withdrawal by Subject|0|||
170779515|NCT02780388|617199365|FG004|Overall Study|Withdrawal by Subject|0|||
170779516|NCT00979576|617199366|FG000|Combination Treatment Phase|Progressive disease|3|||
170779517|NCT00979576|617199367|FG001|Combination Treatment Phase|Progressive disease|1|||
170779518|NCT00979576|617199368|FG002|Combination Treatment Phase|Progressive disease|5|||
170779519|NCT00979576|617199366|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
170779520|NCT00979576|617199367|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
170779521|NCT00979576|617199368|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
170779522|NCT00979576|617199366|FG000|Combination Treatment Phase|Adverse Event|0|||
170779523|NCT00979576|617199367|FG001|Combination Treatment Phase|Adverse Event|2|||
170779524|NCT00979576|617199368|FG002|Combination Treatment Phase|Adverse Event|2|||
170779525|NCT00979576|617199366|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
170779526|NCT00979576|617199367|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
170779527|NCT00979576|617199368|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
170779528|NCT03517553|617199372|FG000|Overall Study|Withdrawal by Subject|2|||
170779529|NCT03271151|617199373|FG000|Overall Study|Lost to Follow-up|1|||
170779530|NCT03271151|617199374|FG001|Overall Study|Lost to Follow-up|3|||
170779531|NCT03271151|617199373|FG000|Overall Study|Withdrawal by Subject|1|||
170779532|NCT03271151|617199374|FG001|Overall Study|Withdrawal by Subject|0|||
170779533|NCT02201108|617199379|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
170779534|NCT02201108|617199380|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
170779535|NCT02201108|617199381|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
170779536|NCT02201108|617199379|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
170779537|NCT02201108|617199380|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
170779538|NCT02201108|617199381|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
170779539|NCT02201108|617199379|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
170779540|NCT02201108|617199380|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
170779541|NCT02201108|617199381|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
170779542|NCT02201108|617199379|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
170779543|NCT02201108|617199380|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
170779544|NCT02201108|617199381|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
170779545|NCT02201108|617199379|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
170779546|NCT02201108|617199380|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
170779547|NCT02201108|617199381|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
170779548|NCT02201108|617199379|FG000|Open Label Period (up to Week 192)|Other reason|4|||
170779549|NCT02201108|617199380|FG001|Open Label Period (up to Week 192)|Other reason|7|||
170779550|NCT02201108|617199381|FG002|Open Label Period (up to Week 192)|Other reason|0|||
170779551|NCT02201108|617199379|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
170779552|NCT02201108|617199380|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
170779553|NCT02201108|617199381|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
170779554|NCT02201108|617199379|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
170779555|NCT02201108|617199380|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
170779556|NCT02201108|617199381|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
170779557|NCT02201108|617199379|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
170779558|NCT02201108|617199380|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
170779559|NCT02201108|617199381|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
170779560|NCT03055377|617199391|FG000|Treatment Phase|Lost to Follow-up|28|||
170779561|NCT03055377|617199392|FG001|Treatment Phase|Lost to Follow-up|24|||
170779562|NCT03055377|617199391|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
170779563|NCT03055377|617199392|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
170779564|NCT05919082|617199398|FG000|Overall Study|Adverse Event|3|||
170779565|NCT05919082|617199399|FG001|Overall Study|Adverse Event|0|||
170779566|NCT05919082|617199398|FG000|Overall Study|Lost to Follow-up|0|||
170779567|NCT05919082|617199399|FG001|Overall Study|Lost to Follow-up|1|||
170779568|NCT05919082|617199398|FG000|Overall Study|Withdrawal by Subject|8|||
170779569|NCT05919082|617199399|FG001|Overall Study|Withdrawal by Subject|9|||
170779570|NCT05919082|617199398|FG000|Overall Study|Lack of Efficacy|0|||
170779571|NCT05919082|617199399|FG001|Overall Study|Lack of Efficacy|1|||
170779572|NCT05919082|617199398|FG000|Overall Study|Investigator Decision|1|||
170779573|NCT05919082|617199399|FG001|Overall Study|Investigator Decision|0|||
170779574|NCT04424927|617199403|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
170779575|NCT04424927|617199404|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
170779576|NCT04424927|617199405|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
170779577|NCT04424927|617199406|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
170779578|NCT04424927|617199407|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
170779579|NCT04424927|617199403|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
170779580|NCT04424927|617199404|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
170779581|NCT04424927|617199405|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
170536759|NCT03805841|616309580|FG002|Overall Study|Death|1|||
170536760|NCT03805841|616309578|FG000|Overall Study|Lost to Follow-up|0|||
170536761|NCT03805841|616309579|FG001|Overall Study|Lost to Follow-up|0|||
170536762|NCT03805841|616309580|FG002|Overall Study|Lost to Follow-up|1|||
170536763|NCT03805841|616309578|FG000|Overall Study|Withdrawal by Subject|2|||
170536764|NCT03805841|616309579|FG001|Overall Study|Withdrawal by Subject|3|||
170536765|NCT03805841|616309580|FG002|Overall Study|Withdrawal by Subject|0|||
170536766|NCT03805841|616309578|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
170536767|NCT03805841|616309579|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
170536768|NCT03805841|616309580|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
170880940|NCT00183274|617574403|FG000|Phase 2: Double-Blind|Relapsed|0|||
170880941|NCT00183274|617574404|FG001|Phase 2: Double-Blind|Relapsed|8|||
170880942|NCT00183274|617574405|FG002|Phase 2: Double-Blind|Relapsed|29|||
170880943|NCT00183274|617574406|FG003|Phase 2: Double-Blind|Relapsed|0|||
170880944|NCT00183274|617574407|FG004|Phase 2: Double-Blind|Relapsed|0|||
170880945|NCT00183274|617574408|FG005|Phase 2: Double-Blind|Relapsed|0|||
170880946|NCT00183274|617574403|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
170880947|NCT00183274|617574404|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
170880948|NCT00183274|617574405|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
170880949|NCT00183274|617574406|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
170880950|NCT00183274|617574407|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
170880951|NCT00183274|617574408|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
170880952|NCT00183274|617574403|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
170880953|NCT00183274|617574404|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
170880954|NCT00183274|617574405|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
170880955|NCT00183274|617574406|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
170880956|NCT00183274|617574407|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
170880957|NCT00183274|617574408|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
170880958|NCT00183274|617574403|FG000|Phase 3: Double-Blind|Relapsed|0|||
170880959|NCT00183274|617574404|FG001|Phase 3: Double-Blind|Relapsed|0|||
170880960|NCT00183274|617574405|FG002|Phase 3: Double-Blind|Relapsed|0|||
170880961|NCT00183274|617574406|FG003|Phase 3: Double-Blind|Relapsed|1|||
170880962|NCT00183274|617574407|FG004|Phase 3: Double-Blind|Relapsed|11|||
170880963|NCT00183274|617574408|FG005|Phase 3: Double-Blind|Relapsed|2|||
170880964|NCT04486950|617574413|FG000|Overall Study|Lost to Follow-up|0|||
170880965|NCT04486950|617574414|FG001|Overall Study|Lost to Follow-up|0|||
170880966|NCT04486950|617574415|FG002|Overall Study|Lost to Follow-up|0|||
170880967|NCT04486950|617574416|FG003|Overall Study|Lost to Follow-up|0|||
170880968|NCT04486950|617574417|FG004|Overall Study|Lost to Follow-up|0|||
170880969|NCT04486950|617574418|FG005|Overall Study|Lost to Follow-up|1|||
170880970|NCT04486950|617574419|FG006|Overall Study|Lost to Follow-up|0|||
170880971|NCT00401375|617574420|FG000|Overall Study|Protocol Violation|2|||
170880972|NCT00401375|617574421|FG001|Overall Study|Protocol Violation|2|||
170880973|NCT00401375|617574422|FG002|Overall Study|Protocol Violation|1|||
170880974|NCT00401375|617574420|FG000|Overall Study|Adverse Event|6|||
170880975|NCT00401375|617574421|FG001|Overall Study|Adverse Event|11|||
170880976|NCT00401375|617574422|FG002|Overall Study|Adverse Event|10|||
170880977|NCT00401375|617574420|FG000|Overall Study|Withdrawal by Subject|9|||
170880978|NCT00401375|617574421|FG001|Overall Study|Withdrawal by Subject|7|||
170880979|NCT00401375|617574422|FG002|Overall Study|Withdrawal by Subject|7|||
170880980|NCT00401375|617574420|FG000|Overall Study|Lost to Follow-up|0|||
170880981|NCT00401375|617574421|FG001|Overall Study|Lost to Follow-up|1|||
170880982|NCT00401375|617574422|FG002|Overall Study|Lost to Follow-up|1|||
170880983|NCT00401375|617574420|FG000|Overall Study|Other than specified|2|||
170880984|NCT00401375|617574421|FG001|Overall Study|Other than specified|1|||
170880985|NCT00401375|617574422|FG002|Overall Study|Other than specified|3|||
170880986|NCT00401375|617574420|FG000|Overall Study|Randomized but not treated|3|||
170880987|NCT00401375|617574421|FG001|Overall Study|Randomized but not treated|3|||
170880988|NCT00401375|617574422|FG002|Overall Study|Randomized but not treated|3|||
170880989|NCT00361270|617574423|FG000|Overall Study|Death|0|||
170880990|NCT00361270|617574424|FG001|Overall Study|Death|0|||
170880991|NCT00361270|617574425|FG002|Overall Study|Death|0|||
170880992|NCT00361270|617574426|FG003|Overall Study|Death|2|||
170880993|NCT00361270|617574423|FG000|Overall Study|Lost to Follow-up|4|||
170880994|NCT00361270|617574424|FG001|Overall Study|Lost to Follow-up|1|||
170880995|NCT00361270|617574425|FG002|Overall Study|Lost to Follow-up|0|||
170880996|NCT00361270|617574426|FG003|Overall Study|Lost to Follow-up|0|||
170880997|NCT00361270|617574423|FG000|Overall Study|Physician Decision|0|||
170880998|NCT00361270|617574424|FG001|Overall Study|Physician Decision|0|||
170880999|NCT00361270|617574425|FG002|Overall Study|Physician Decision|1|||
170881000|NCT00361270|617574426|FG003|Overall Study|Physician Decision|0|||
170881001|NCT00361270|617574423|FG000|Overall Study|Protocol Violation|9|||
170536769|NCT01723774|616309583|FG000|Neoadjuvant|Ki67 > 10%|4|||
170536770|NCT01723774|616309584|FG001|Neoadjuvant|Ki67 > 10%|0|||
170536771|NCT01723774|616309585|FG002|Neoadjuvant|Ki67 > 10%|10|||
170881002|NCT00361270|617574424|FG001|Overall Study|Protocol Violation|4|||
170881003|NCT00361270|617574425|FG002|Overall Study|Protocol Violation|5|||
170881004|NCT00361270|617574426|FG003|Overall Study|Protocol Violation|4|||
170881005|NCT00361270|617574423|FG000|Overall Study|Withdrawal by Subject|6|||
170881006|NCT00361270|617574424|FG001|Overall Study|Withdrawal by Subject|6|||
170881007|NCT00361270|617574425|FG002|Overall Study|Withdrawal by Subject|3|||
170881008|NCT00361270|617574426|FG003|Overall Study|Withdrawal by Subject|7|||
170881009|NCT00361270|617574423|FG000|Overall Study|Afraid of Hypnosis|1|||
170881010|NCT00361270|617574424|FG001|Overall Study|Afraid of Hypnosis|2|||
170881011|NCT00361270|617574425|FG002|Overall Study|Afraid of Hypnosis|0|||
170881012|NCT00361270|617574426|FG003|Overall Study|Afraid of Hypnosis|0|||
170881013|NCT00361270|617574423|FG000|Overall Study|Problems with Transportation|4|||
170881014|NCT00361270|617574424|FG001|Overall Study|Problems with Transportation|0|||
170881015|NCT00361270|617574425|FG002|Overall Study|Problems with Transportation|0|||
170536772|NCT01723774|616309586|FG003|Neoadjuvant|Ki67 > 10%|0|||
170536773|NCT01723774|616309583|FG000|Neoadjuvant|Withdrawal by Subject|3|||
170536774|NCT01723774|616309584|FG001|Neoadjuvant|Withdrawal by Subject|1|||
170536775|NCT01723774|616309585|FG002|Neoadjuvant|Withdrawal by Subject|0|||
170536776|NCT01723774|616309586|FG003|Neoadjuvant|Withdrawal by Subject|0|||
170536777|NCT01723774|616309583|FG000|Neoadjuvant|Disease progression|0|||
170536778|NCT01723774|616309584|FG001|Neoadjuvant|Disease progression|1|||
170536779|NCT01723774|616309585|FG002|Neoadjuvant|Disease progression|1|||
170536780|NCT01723774|616309586|FG003|Neoadjuvant|Disease progression|0|||
170536781|NCT01723774|616309583|FG000|Neoadjuvant|Adverse Event|0|||
170536782|NCT01723774|616309584|FG001|Neoadjuvant|Adverse Event|1|||
170536783|NCT01723774|616309585|FG002|Neoadjuvant|Adverse Event|2|||
170536784|NCT01723774|616309586|FG003|Neoadjuvant|Adverse Event|0|||
170536785|NCT01723774|616309583|FG000|Neoadjuvant|High estradiol|0|||
170536786|NCT01723774|616309584|FG001|Neoadjuvant|High estradiol|1|||
170536787|NCT01723774|616309585|FG002|Neoadjuvant|High estradiol|0|||
170536788|NCT01723774|616309586|FG003|Neoadjuvant|High estradiol|0|||
170536789|NCT02964182|616309587|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
170536790|NCT02964182|616309588|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
170536791|NCT02964182|616309589|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
170536792|NCT02964182|616309590|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
170536793|NCT02964182|616309591|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
170536794|NCT02964182|616309592|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
170536795|NCT02964182|616309593|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
170536796|NCT02964182|616309594|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
170536797|NCT02964182|616309587|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
170536798|NCT02964182|616309588|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
170536799|NCT02964182|616309589|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
170536800|NCT02964182|616309590|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
170536801|NCT02964182|616309591|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
170536802|NCT02964182|616309592|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
170536803|NCT02964182|616309593|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
170536804|NCT02964182|616309594|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
170536805|NCT02964182|616309587|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
170536806|NCT02964182|616309588|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
170536807|NCT02964182|616309589|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
170536808|NCT02964182|616309590|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
170536809|NCT02964182|616309591|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
170536810|NCT02964182|616309592|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
170536811|NCT02964182|616309593|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
170536812|NCT02964182|616309594|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
170536813|NCT02964182|616309587|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
170536814|NCT02964182|616309588|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
170536815|NCT02964182|616309589|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
170536816|NCT02964182|616309590|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
170536817|NCT02964182|616309591|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
170536818|NCT02964182|616309592|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
170536819|NCT02964182|616309593|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
170536820|NCT02964182|616309594|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
170536821|NCT02964182|616309587|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
170536822|NCT02964182|616309588|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
170536823|NCT02964182|616309589|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
170536824|NCT02964182|616309590|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
170536825|NCT02964182|616309591|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
170536826|NCT02964182|616309592|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
170536827|NCT02964182|616309593|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
170536828|NCT02964182|616309594|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
170536829|NCT02964182|616309587|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
170536830|NCT02964182|616309588|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
170536831|NCT02964182|616309589|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
170536832|NCT02964182|616309590|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
170536833|NCT02964182|616309591|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
170881016|NCT00361270|617574426|FG003|Overall Study|Problems with Transportation|0|||
170536834|NCT02964182|616309592|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
170536835|NCT02964182|616309593|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
170881017|NCT00361270|617574423|FG000|Overall Study|Adverse Event|0|||
170881018|NCT00361270|617574424|FG001|Overall Study|Adverse Event|1|||
170536836|NCT02964182|616309594|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
170536837|NCT02964182|616309587|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
170536838|NCT02964182|616309588|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
170536839|NCT02964182|616309589|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
170536840|NCT02964182|616309590|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
170881019|NCT00361270|617574425|FG002|Overall Study|Adverse Event|1|||
170881020|NCT00361270|617574426|FG003|Overall Study|Adverse Event|0|||
170881021|NCT00677014|617574430|FG000|Overall Study|Lost to Follow-up|20|||
170881022|NCT00677014|617574431|FG001|Overall Study|Lost to Follow-up|12|||
170881023|NCT00677014|617574432|FG002|Overall Study|Lost to Follow-up|24|||
170881024|NCT00677014|617574430|FG000|Overall Study|Death|6|||
170881025|NCT00677014|617574431|FG001|Overall Study|Death|15|||
170881026|NCT00677014|617574432|FG002|Overall Study|Death|7|||
170881027|NCT00677014|617574430|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
170881028|NCT00677014|617574431|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
170881029|NCT00677014|617574432|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
170881030|NCT00640328|617574433|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
170881031|NCT00640328|617574434|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
170881032|NCT00640328|617574435|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
170881033|NCT00640328|617574436|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
170881034|NCT00640328|617574437|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
170881035|NCT00640328|617574438|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
170881036|NCT00640328|617574433|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
170881037|NCT00640328|617574434|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
170881038|NCT00640328|617574435|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
170881039|NCT00640328|617574436|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
170881040|NCT00640328|617574437|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
170881041|NCT00640328|617574438|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
170881042|NCT00640328|617574433|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
170881043|NCT00640328|617574434|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
170881044|NCT00640328|617574435|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
170881045|NCT00640328|617574436|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
170881046|NCT00640328|617574437|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
170881047|NCT00640328|617574438|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
170881048|NCT00640328|617574433|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
170881049|NCT00640328|617574434|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
170881050|NCT00640328|617574435|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
170881051|NCT00640328|617574436|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
170881052|NCT00640328|617574437|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
170881053|NCT00640328|617574438|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
170881054|NCT02374099|617574439|FG000|Overall Study|Adverse Event|1|||
170881055|NCT02374099|617574440|FG001|Overall Study|Adverse Event|0|||
170881056|NCT02374099|617574439|FG000|Overall Study|Progressive Disease|35|||
170881057|NCT02374099|617574440|FG001|Overall Study|Progressive Disease|40|||
170881058|NCT02374099|617574439|FG000|Overall Study|Withdrawal by Subject|5|||
170881059|NCT02374099|617574440|FG001|Overall Study|Withdrawal by Subject|1|||
170881060|NCT02374099|617574439|FG000|Overall Study|Miscellaneous|2|||
170881061|NCT02374099|617574440|FG001|Overall Study|Miscellaneous|3|||
170881062|NCT02374099|617574439|FG000|Overall Study|Randomized, but not treated|2|||
170434366|NCT00640341|615928606|FG000|Overall Study|Positive Slit Lamp Findings|0|||
170434367|NCT00640341|615928607|FG001|Overall Study|Positive Slit Lamp Findings|0|||
170434368|NCT00640341|615928608|FG002|Overall Study|Positive Slit Lamp Findings|1|||
170434369|NCT00640341|615928606|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
170434370|NCT00640341|615928607|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
170434371|NCT00640341|615928608|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
170434372|NCT00640341|615928606|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
170434373|NCT00640341|615928607|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
170434374|NCT00640341|615928608|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
170434375|NCT00640341|615928606|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
170434376|NCT00640341|615928607|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
170434377|NCT00640341|615928608|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
170434378|NCT00640341|615928606|FG000|Overall Study|Lost to Follow-up|2|||
170434379|NCT00640341|615928607|FG001|Overall Study|Lost to Follow-up|0|||
170434380|NCT00640341|615928608|FG002|Overall Study|Lost to Follow-up|0|||
170881063|NCT02374099|617574440|FG001|Overall Study|Randomized, but not treated|1|||
170434381|NCT00640341|615928606|FG000|Overall Study|Withdrawal by Subject|4|||
170536841|NCT02964182|616309591|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
170536842|NCT02964182|616309592|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
170434382|NCT00640341|615928607|FG001|Overall Study|Withdrawal by Subject|0|||
170434383|NCT00640341|615928608|FG002|Overall Study|Withdrawal by Subject|1|||
170434384|NCT00640341|615928606|FG000|Overall Study|Unacceptable Lens Movement|1|||
170434385|NCT00640341|615928607|FG001|Overall Study|Unacceptable Lens Movement|0|||
170434386|NCT00640341|615928608|FG002|Overall Study|Unacceptable Lens Movement|0|||
170434387|NCT00640341|615928606|FG000|Overall Study|Poor fit/Uncomfortable|4|||
170434388|NCT00640341|615928607|FG001|Overall Study|Poor fit/Uncomfortable|0|||
170434389|NCT00640341|615928608|FG002|Overall Study|Poor fit/Uncomfortable|0|||
170434390|NCT00640341|615928606|FG000|Overall Study|Ineligable at Baseline|5|||
170434391|NCT00640341|615928607|FG001|Overall Study|Ineligable at Baseline|3|||
170434392|NCT00640341|615928608|FG002|Overall Study|Ineligable at Baseline|2|||
170434393|NCT00640341|615928606|FG000|Overall Study|Adverse event and positive slit lamp|1|||
170434394|NCT00640341|615928607|FG001|Overall Study|Adverse event and positive slit lamp|0|||
170434395|NCT00640341|615928608|FG002|Overall Study|Adverse event and positive slit lamp|0|||
170434396|NCT01541215|615928614|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
170434397|NCT01541215|615928615|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
170434398|NCT01541215|615928614|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
170434399|NCT01541215|615928615|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
170434400|NCT01541215|615928614|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
170434401|NCT01541215|615928615|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
170434402|NCT01541215|615928614|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
170434403|NCT01541215|615928615|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
170434404|NCT01541215|615928614|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
170434405|NCT01541215|615928615|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
170434406|NCT01541215|615928614|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
170434407|NCT01541215|615928615|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
170434408|NCT02302716|615928616|FG000|Overall Study|Adverse Event|1|||
170434409|NCT02302716|615928617|FG001|Overall Study|Adverse Event|1|||
170434410|NCT02302716|615928616|FG000|Overall Study|Death|0|||
170434411|NCT02302716|615928617|FG001|Overall Study|Death|1|||
170434412|NCT02302716|615928616|FG000|Overall Study|Lack of Efficacy|0|||
170434413|NCT02302716|615928617|FG001|Overall Study|Lack of Efficacy|1|||
170434414|NCT02302716|615928616|FG000|Overall Study|Lost to Follow-up|2|||
170434415|NCT02302716|615928617|FG001|Overall Study|Lost to Follow-up|4|||
170434416|NCT02302716|615928616|FG000|Overall Study|Physician Decision|3|||
170434417|NCT02302716|615928617|FG001|Overall Study|Physician Decision|4|||
170434418|NCT02302716|615928616|FG000|Overall Study|Withdrawal by Subject|13|||
170434419|NCT02302716|615928617|FG001|Overall Study|Withdrawal by Subject|7|||
170434420|NCT02302716|615928616|FG000|Overall Study|Protocol Violation|0|||
170434421|NCT02302716|615928617|FG001|Overall Study|Protocol Violation|1|||
170434422|NCT00557245|615928626|FG000|Overall Study|Lost to Follow-up|7|||
170434423|NCT00557245|615928627|FG001|Overall Study|Lost to Follow-up|8|||
170434424|NCT00557245|615928628|FG002|Overall Study|Lost to Follow-up|10|||
170434425|NCT00557245|615928626|FG000|Overall Study|Ineligible|5|||
170434426|NCT00557245|615928627|FG001|Overall Study|Ineligible|4|||
170434427|NCT00557245|615928628|FG002|Overall Study|Ineligible|2|||
170434428|NCT02658019|615928629|FG000|Overall Study|Adverse Event|1|||
170536843|NCT02964182|616309593|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
170881064|NCT02374099|617574439|FG000|Overall Study|Study Terminated by Sponsor|3|||
170881065|NCT02374099|617574440|FG001|Overall Study|Study Terminated by Sponsor|4|||
170881066|NCT01714687|617574443|FG000|Overall Study|Withdrawal by Subject|1|||
170881067|NCT01714687|617574444|FG001|Overall Study|Withdrawal by Subject|0|||
170881068|NCT01714687|617574443|FG000|Overall Study|Lost to Follow-up|2|||
170881069|NCT01714687|617574444|FG001|Overall Study|Lost to Follow-up|4|||
170881070|NCT00761514|617574451|FG000|Overall Study|Adverse Event|1|||
170881071|NCT00761514|617574451|FG000|Overall Study|Withdrawal by Subject|2|||
170881072|NCT00761514|617574451|FG000|Overall Study|Lost to Follow-up|1|||
170881073|NCT00761514|617574451|FG000|Overall Study|Health insurance didn't cover study drug|1|||
170881074|NCT00761514|617574451|FG000|Overall Study|Problem complying with study visit|1|||
170881075|NCT00761514|617574451|FG000|Overall Study|Unable to pay for medications|1|||
170881076|NCT02457637|617574452|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
170881077|NCT01035905|617574453|FG000|Overall Study|Lack of Efficacy|1|||
170881078|NCT01035905|617574454|FG001|Overall Study|Lack of Efficacy|1|||
170881079|NCT00159861|617574455|FG000|Core Study - 16 Weeks|Death|3|||
170881080|NCT00159861|617574456|FG001|Core Study - 16 Weeks|Death|0|||
170881081|NCT00159861|617574455|FG000|Core Study - 16 Weeks|Adverse Event|12|||
170881082|NCT00159861|617574456|FG001|Core Study - 16 Weeks|Adverse Event|6|||
170881083|NCT00159861|617574455|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
170881084|NCT00159861|617574456|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
170881085|NCT00159861|617574455|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
170881086|NCT00159861|617574456|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
170881087|NCT00159861|617574455|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
170881088|NCT00159861|617574456|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
170881089|NCT00159861|617574455|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
170881090|NCT00159861|617574456|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
170881091|NCT00159861|617574455|FG000|Extension Study - up to 3 Years|Death|24|||
170881092|NCT00159861|617574456|FG001|Extension Study - up to 3 Years|Death|28|||
170881093|NCT00159861|617574455|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
170881094|NCT00159861|617574456|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
170881095|NCT00159861|617574455|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
170881096|NCT00159861|617574456|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
170881097|NCT00159861|617574455|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
170881098|NCT00159861|617574456|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
170881099|NCT00159861|617574455|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
170881100|NCT00159861|617574456|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
170881101|NCT03099187|617574457|FG000|Double-blind Treatment|Adverse Event|19|||
170881102|NCT03099187|617574458|FG001|Double-blind Treatment|Adverse Event|1|||
170881103|NCT03099187|617574459|FG002|Double-blind Treatment|Adverse Event|0|||
170881104|NCT03099187|617574460|FG003|Double-blind Treatment|Adverse Event|0|||
170881105|NCT03099187|617574457|FG000|Double-blind Treatment|Death|1|||
170881106|NCT03099187|617574458|FG001|Double-blind Treatment|Death|3|||
170881107|NCT03099187|617574459|FG002|Double-blind Treatment|Death|0|||
170881108|NCT03099187|617574460|FG003|Double-blind Treatment|Death|0|||
170881109|NCT03099187|617574457|FG000|Double-blind Treatment|Lack of Efficacy|1|||
170881110|NCT03099187|617574458|FG001|Double-blind Treatment|Lack of Efficacy|0|||
170881111|NCT03099187|617574459|FG002|Double-blind Treatment|Lack of Efficacy|0|||
170881112|NCT03099187|617574460|FG003|Double-blind Treatment|Lack of Efficacy|0|||
170881113|NCT03099187|617574457|FG000|Double-blind Treatment|Physician Decision|2|||
170881114|NCT03099187|617574458|FG001|Double-blind Treatment|Physician Decision|1|||
170881115|NCT03099187|617574459|FG002|Double-blind Treatment|Physician Decision|0|||
170881116|NCT03099187|617574460|FG003|Double-blind Treatment|Physician Decision|0|||
170881117|NCT03099187|617574457|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
170881118|NCT03099187|617574458|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
170881119|NCT03099187|617574459|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
170881120|NCT03099187|617574460|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
170881121|NCT03099187|617574457|FG000|Double-blind Treatment|Lung transplantation|0|||
170434429|NCT03669250|615928633|FG000|Overall Study|Adverse Event|0|||
170434430|NCT03669250|615928634|FG001|Overall Study|Adverse Event|0|||
170881122|NCT03099187|617574458|FG001|Double-blind Treatment|Lung transplantation|1|||
170881123|NCT03099187|617574459|FG002|Double-blind Treatment|Lung transplantation|0|||
170881124|NCT03099187|617574460|FG003|Double-blind Treatment|Lung transplantation|0|||
170881125|NCT03099187|617574457|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
170881126|NCT03099187|617574458|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
170881127|NCT03099187|617574459|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
170881128|NCT03099187|617574460|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
170881129|NCT03099187|617574457|FG000|Double-blind Treatment|Disease progression|0|||
170881130|NCT03099187|617574458|FG001|Double-blind Treatment|Disease progression|1|||
170881131|NCT03099187|617574459|FG002|Double-blind Treatment|Disease progression|0|||
170881132|NCT03099187|617574460|FG003|Double-blind Treatment|Disease progression|0|||
170536844|NCT02964182|616309594|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
170536845|NCT03621592|616309595|FG000|Overall Study|Lost to Follow-up|1|||
170881133|NCT03099187|617574457|FG000|Double-blind Treatment|Randomization error|0|||
170881134|NCT03099187|617574458|FG001|Double-blind Treatment|Randomization error|2|||
170881135|NCT03099187|617574459|FG002|Double-blind Treatment|Randomization error|0|||
170881136|NCT03099187|617574460|FG003|Double-blind Treatment|Randomization error|0|||
170881137|NCT03099187|617574457|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
170881138|NCT03099187|617574458|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
170881139|NCT03099187|617574459|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
170881140|NCT03099187|617574460|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
170881141|NCT03099187|617574457|FG000|12-month Safety Follow-up|Adverse Event|0|||
170881142|NCT03099187|617574458|FG001|12-month Safety Follow-up|Adverse Event|0|||
170881143|NCT03099187|617574459|FG002|12-month Safety Follow-up|Adverse Event|5|||
170881144|NCT03099187|617574460|FG003|12-month Safety Follow-up|Adverse Event|12|||
170881145|NCT03099187|617574457|FG000|12-month Safety Follow-up|Death|0|||
170881146|NCT03099187|617574458|FG001|12-month Safety Follow-up|Death|0|||
170881147|NCT03099187|617574459|FG002|12-month Safety Follow-up|Death|7|||
170881148|NCT03099187|617574460|FG003|12-month Safety Follow-up|Death|9|||
170881149|NCT03099187|617574457|FG000|12-month Safety Follow-up|Lung transplantation|0|||
170881150|NCT03099187|617574458|FG001|12-month Safety Follow-up|Lung transplantation|0|||
170881151|NCT03099187|617574459|FG002|12-month Safety Follow-up|Lung transplantation|2|||
170881152|NCT03099187|617574460|FG003|12-month Safety Follow-up|Lung transplantation|1|||
170881153|NCT03099187|617574457|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
170881154|NCT03099187|617574458|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
170881155|NCT03099187|617574459|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
170881156|NCT03099187|617574460|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
170881157|NCT03099187|617574457|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
170881158|NCT03099187|617574458|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
170881159|NCT03099187|617574459|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
170881160|NCT03099187|617574460|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
170881161|NCT03099187|617574457|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
170881162|NCT03099187|617574458|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
170881163|NCT03099187|617574459|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
170881164|NCT03099187|617574460|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
170881165|NCT03099187|617574457|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
170881166|NCT03099187|617574458|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
170881167|NCT03099187|617574459|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
170881168|NCT03099187|617574460|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
170881169|NCT03885089|617574464|FG000|Overall Study|No informed consent for publication of study results|2|||
170434431|NCT03669250|615928635|FG002|Overall Study|Adverse Event|0|||
170434432|NCT03669250|615928636|FG003|Overall Study|Adverse Event|0|||
170434433|NCT03669250|615928637|FG004|Overall Study|Adverse Event|1|||
170434434|NCT03669250|615928638|FG005|Overall Study|Adverse Event|0|||
170434435|NCT03669250|615928633|FG000|Overall Study|Withdrawal by Subject|0|||
170434436|NCT03669250|615928634|FG001|Overall Study|Withdrawal by Subject|1|||
170434437|NCT03669250|615928635|FG002|Overall Study|Withdrawal by Subject|0|||
170434438|NCT03669250|615928636|FG003|Overall Study|Withdrawal by Subject|1|||
170434439|NCT03669250|615928637|FG004|Overall Study|Withdrawal by Subject|0|||
170434440|NCT03669250|615928638|FG005|Overall Study|Withdrawal by Subject|0|||
170434441|NCT05090839|615928639|FG000|Overall Study|Lost to Follow-up|2|||
170434442|NCT05090839|615928640|FG001|Overall Study|Lost to Follow-up|3|||
170881170|NCT03349099|617574467|FG000|Overall Study|Physician Decision|3|||
170881171|NCT03349099|617574468|FG001|Overall Study|Physician Decision|4|||
170881172|NCT03349099|617574467|FG000|Overall Study|Stone migrated from the kidney|1|||
170881173|NCT03349099|617574468|FG001|Overall Study|Stone migrated from the kidney|0|||
170881174|NCT01210690|617574470|FG000|Overall Study|Adverse Event|7|||
170881175|NCT01210690|617574470|FG000|Overall Study|Lack of Efficacy|12|||
170881176|NCT01210690|617574470|FG000|Overall Study|Lost to Follow-up|3|||
170881177|NCT01210690|617574470|FG000|Overall Study|Disease Remission|1|||
170881178|NCT01210690|617574470|FG000|Overall Study|Withdrawal by Subject|1|||
170881179|NCT01210690|617574470|FG000|Overall Study|Patient refused to swallow|1|||
170881180|NCT01210690|617574470|FG000|Overall Study|Patient could not take glucose|1|||
170881181|NCT00894556|617574471|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
170881182|NCT00894556|617574472|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
170881183|NCT00894556|617574473|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
170881184|NCT00894556|617574474|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
170881185|NCT00894556|617574471|FG000|Treatment Phase|Lost to Follow-up|2|||
170881186|NCT00894556|617574472|FG001|Treatment Phase|Lost to Follow-up|3|||
170881187|NCT00894556|617574473|FG002|Treatment Phase|Lost to Follow-up|1|||
170881188|NCT00894556|617574474|FG003|Treatment Phase|Lost to Follow-up|0|||
170881189|NCT00894556|617574471|FG000|Treatment Phase|Lack of Qualifying Event|2|||
170881190|NCT00894556|617574472|FG001|Treatment Phase|Lack of Qualifying Event|1|||
170881191|NCT00894556|617574473|FG002|Treatment Phase|Lack of Qualifying Event|0|||
170881192|NCT00894556|617574474|FG003|Treatment Phase|Lack of Qualifying Event|0|||
170881193|NCT04869345|617574475|FG000|Overall Study|Lost to Follow-up|8|||
170881194|NCT04869345|617574476|FG001|Overall Study|Lost to Follow-up|3|||
170881195|NCT01979536|617574484|FG000|Overall Study|Physician Decision|2|||
170881196|NCT01979536|617574485|FG001|Overall Study|Physician Decision|3|||
170881197|NCT01979536|617574484|FG000|Overall Study|Withdrawal by Subject|0|||
170881198|NCT01979536|617574485|FG001|Overall Study|Withdrawal by Subject|1|||
170881199|NCT01979536|617574484|FG000|Overall Study|Refusal|0|||
170881200|NCT01979536|617574485|FG001|Overall Study|Refusal|1|||
170881201|NCT01979536|617574484|FG000|Overall Study|Relapse|0|||
170881202|NCT01979536|617574485|FG001|Overall Study|Relapse|1|||
170881203|NCT01979536|617574484|FG000|Overall Study|Study terminated by Sponsor|0|||
170881204|NCT01979536|617574485|FG001|Overall Study|Study terminated by Sponsor|1|||
170881205|NCT01979536|617574484|FG000|Overall Study|Did not start treatment|0|||
170881206|NCT01979536|617574485|FG001|Overall Study|Did not start treatment|1|||
170881207|NCT00528021|617574487|FG000|Overall Study|Lack of Efficacy|17|||
170881208|NCT00528021|617574488|FG001|Overall Study|Lack of Efficacy|13|||
170881209|NCT00528021|617574489|FG002|Overall Study|Lack of Efficacy|7|||
170881210|NCT00528021|617574490|FG003|Overall Study|Lack of Efficacy|9|||
170881211|NCT01934556|617574497|FG000|Overall Study|Withdrawal by Subject|0|||
170881212|NCT01934556|617574498|FG001|Overall Study|Withdrawal by Subject|1|||
170881213|NCT01934556|617574499|FG002|Overall Study|Withdrawal by Subject|1|||
170881214|NCT01934556|617574497|FG000|Overall Study|Lost to Follow-up|4|||
170881215|NCT01934556|617574498|FG001|Overall Study|Lost to Follow-up|10|||
170881216|NCT01934556|617574499|FG002|Overall Study|Lost to Follow-up|7|||
170881217|NCT01934556|617574497|FG000|Overall Study|Death|1|||
170881218|NCT01934556|617574498|FG001|Overall Study|Death|5|||
170881219|NCT01934556|617574499|FG002|Overall Study|Death|2|||
170881220|NCT00102960|617574500|FG000|Overall Study|Death|23|||
170881221|NCT00102960|617574501|FG001|Overall Study|Death|11|||
170881222|NCT00102960|617574502|FG002|Overall Study|Death|11|||
170881223|NCT00102960|617574500|FG000|Overall Study|Lost to Follow-up|6|||
170881224|NCT00102960|617574501|FG001|Overall Study|Lost to Follow-up|12|||
170881225|NCT00102960|617574502|FG002|Overall Study|Lost to Follow-up|16|||
170881226|NCT00102960|617574500|FG000|Overall Study|Withdrawal by Subject|1|||
170881227|NCT00102960|617574501|FG001|Overall Study|Withdrawal by Subject|0|||
170881228|NCT00102960|617574502|FG002|Overall Study|Withdrawal by Subject|1|||
170881229|NCT05038020|617574503|FG000|Overall Study|Early Termination|3|||
170881230|NCT05038020|617574504|FG001|Overall Study|Early Termination|0|||
170881231|NCT01736579|617576023|FG000|Overall Study|Termination of Study by Sponsor|2|||
170881232|NCT01736579|617576024|FG001|Overall Study|Termination of Study by Sponsor|2|||
170881233|NCT02543528|617576027|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
170881234|NCT02543528|617576028|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
170881235|NCT02543528|617576029|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
170881236|NCT02543528|617576030|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
170881237|NCT02543528|617576031|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
170881238|NCT02543528|617576027|FG000|Adaptation Period|Lens Handling Difficultes|0|||
170881239|NCT02543528|617576028|FG001|Adaptation Period|Lens Handling Difficultes|0|||
170881240|NCT02543528|617576029|FG002|Adaptation Period|Lens Handling Difficultes|0|||
170881241|NCT02543528|617576030|FG003|Adaptation Period|Lens Handling Difficultes|0|||
170881242|NCT02543528|617576031|FG004|Adaptation Period|Lens Handling Difficultes|8|||
170779582|NCT04424927|617199406|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
170779583|NCT04424927|617199407|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
170779584|NCT04424927|617199403|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
170779585|NCT04424927|617199404|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
170779586|NCT04424927|617199405|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
170779587|NCT04424927|617199406|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
170779588|NCT04424927|617199407|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
170779589|NCT04424927|617199403|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
170779590|NCT04424927|617199404|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
170779591|NCT04424927|617199405|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
170779592|NCT04424927|617199406|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
170779593|NCT04424927|617199407|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
170779594|NCT04424927|617199403|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
170779595|NCT04424927|617199404|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
170779596|NCT04424927|617199405|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
170779597|NCT04424927|617199406|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
170779598|NCT04424927|617199407|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
170779599|NCT04424927|617199403|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
170779600|NCT04424927|617199404|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
170779601|NCT04424927|617199405|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
170779602|NCT04424927|617199406|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
170779603|NCT04424927|617199407|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
170779604|NCT04424927|617199403|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
170779605|NCT04424927|617199404|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
170779606|NCT04424927|617199405|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
170779607|NCT04424927|617199406|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
170779608|NCT04424927|617199407|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
170779609|NCT04424927|617199403|FG000|Double-blind Period (24 Weeks)|Other|0|||
170779610|NCT04424927|617199404|FG001|Double-blind Period (24 Weeks)|Other|1|||
170881243|NCT02543528|617576027|FG000|Adaptation Period|Lost to Follow-up|0|||
170881244|NCT02543528|617576028|FG001|Adaptation Period|Lost to Follow-up|0|||
170881245|NCT02543528|617576029|FG002|Adaptation Period|Lost to Follow-up|0|||
170881246|NCT02543528|617576030|FG003|Adaptation Period|Lost to Follow-up|0|||
170881247|NCT02543528|617576031|FG004|Adaptation Period|Lost to Follow-up|14|||
170881248|NCT02543528|617576027|FG000|Adaptation Period|Adverse Event|0|||
170881249|NCT02543528|617576028|FG001|Adaptation Period|Adverse Event|0|||
170881250|NCT02543528|617576029|FG002|Adaptation Period|Adverse Event|0|||
170881251|NCT02543528|617576030|FG003|Adaptation Period|Adverse Event|0|||
170881252|NCT02543528|617576031|FG004|Adaptation Period|Adverse Event|2|||
170881253|NCT02543528|617576027|FG000|Extended Wear Period|Adverse Event|17|||
170881254|NCT02543528|617576028|FG001|Extended Wear Period|Adverse Event|11|||
170881255|NCT02543528|617576029|FG002|Extended Wear Period|Adverse Event|16|||
170881256|NCT02543528|617576030|FG003|Extended Wear Period|Adverse Event|3|||
170881257|NCT02543528|617576031|FG004|Extended Wear Period|Adverse Event|0|||
170881258|NCT02543528|617576027|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
170881259|NCT02543528|617576028|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
170881260|NCT02543528|617576029|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
170881261|NCT02543528|617576030|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
170881262|NCT02543528|617576031|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
170881263|NCT02543528|617576027|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
170881264|NCT02543528|617576028|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
170881265|NCT02543528|617576029|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
170881266|NCT02543528|617576030|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
170881267|NCT02543528|617576031|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
170881268|NCT02543528|617576027|FG000|Extended Wear Period|Lost to Follow-up|0|||
170881269|NCT02543528|617576028|FG001|Extended Wear Period|Lost to Follow-up|1|||
170881270|NCT02543528|617576029|FG002|Extended Wear Period|Lost to Follow-up|2|||
170881271|NCT02543528|617576030|FG003|Extended Wear Period|Lost to Follow-up|1|||
170881272|NCT02543528|617576031|FG004|Extended Wear Period|Lost to Follow-up|0|||
170881273|NCT02543528|617576027|FG000|Extended Wear Period|Withdrawal by Subject|10|||
170779611|NCT04424927|617199405|FG002|Double-blind Period (24 Weeks)|Other|3|||
170779612|NCT04424927|617199406|FG003|Double-blind Period (24 Weeks)|Other|1|||
170779613|NCT04424927|617199407|FG004|Double-blind Period (24 Weeks)|Other|0|||
170779614|NCT01696773|617199413|FG000|Days 15-27, Washout|Adverse Event|1|||
170779615|NCT01696773|617199414|FG001|Days 15-27, Washout|Adverse Event|0|||
170779616|NCT02740231|617199424|FG000|Overall Study|Withdrawal by Subject|1|||
170779617|NCT02740231|617199425|FG001|Overall Study|Withdrawal by Subject|1|||
170779618|NCT02740231|617199426|FG002|Overall Study|Withdrawal by Subject|1|||
170779619|NCT02740231|617199427|FG003|Overall Study|Withdrawal by Subject|0|||
170434443|NCT05090839|615928641|FG002|Overall Study|Lost to Follow-up|1|||
170434444|NCT05090839|615928642|FG003|Overall Study|Lost to Follow-up|1|||
170881274|NCT02543528|617576028|FG001|Extended Wear Period|Withdrawal by Subject|9|||
170881275|NCT02543528|617576029|FG002|Extended Wear Period|Withdrawal by Subject|4|||
170881276|NCT02543528|617576030|FG003|Extended Wear Period|Withdrawal by Subject|5|||
170881277|NCT02543528|617576031|FG004|Extended Wear Period|Withdrawal by Subject|0|||
170881278|NCT02049944|617576032|FG000|Overall Study|Protocol Violation|2|||
170881279|NCT01979523|617576034|FG000|Overall Study|Withdrawal by Subject|1|||
170881280|NCT01979523|617576035|FG001|Overall Study|Withdrawal by Subject|0|||
170881281|NCT00772954|617576048|FG000|Overall Study|Adverse Event|0|||
170881282|NCT00772954|617576049|FG001|Overall Study|Adverse Event|0|||
170881283|NCT00772954|617576050|FG002|Overall Study|Adverse Event|1|||
170881284|NCT02239939|617576051|FG000|Overall Study|Adverse Event|1|||
170881285|NCT02239939|617576052|FG001|Overall Study|Adverse Event|0|||
170434445|NCT02986139|615928644|FG000|Overall Study|Sponsor Decision|1|||
170434446|NCT02986139|615928645|FG001|Overall Study|Sponsor Decision|2|||
170434447|NCT02986139|615928644|FG000|Overall Study|Withdrawal by Subject|0|||
170434448|NCT02986139|615928645|FG001|Overall Study|Withdrawal by Subject|1|||
170434449|NCT02986139|615928644|FG000|Overall Study|Lost to Follow-up|0|||
170434450|NCT02986139|615928645|FG001|Overall Study|Lost to Follow-up|1|||
170434451|NCT02107196|615928647|FG000|12-week Treatment Period|Adverse Event|6|||
170434452|NCT02107196|615928648|FG001|12-week Treatment Period|Adverse Event|3|||
170434453|NCT02107196|615928647|FG000|12-week Treatment Period|Lack of Efficacy|2|||
170434454|NCT02107196|615928648|FG001|12-week Treatment Period|Lack of Efficacy|1|||
170434455|NCT02107196|615928647|FG000|12-week Treatment Period|Lost to Follow-up|3|||
170434456|NCT02107196|615928648|FG001|12-week Treatment Period|Lost to Follow-up|6|||
170434457|NCT02107196|615928647|FG000|12-week Treatment Period|Physician Decision|0|||
170434458|NCT02107196|615928648|FG001|12-week Treatment Period|Physician Decision|1|||
170434459|NCT02107196|615928647|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
170434460|NCT02107196|615928648|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
170434461|NCT02107196|615928647|FG000|12-week Treatment Period|Protocol Violation|7|||
170434462|NCT02107196|615928648|FG001|12-week Treatment Period|Protocol Violation|8|||
170434463|NCT02107196|615928647|FG000|12-week Treatment Period|Reason Missing|11|||
170434464|NCT02107196|615928648|FG001|12-week Treatment Period|Reason Missing|8|||
170434465|NCT02107196|615928647|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
170434466|NCT02107196|615928648|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
170434467|NCT02107196|615928647|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
170434468|NCT02107196|615928648|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
170434469|NCT02107196|615928647|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
170434470|NCT02107196|615928648|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
170434471|NCT02107196|615928647|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
170434472|NCT02107196|615928648|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
170434473|NCT00691704|615928649|FG000|Induction Therapy|Disease Progression|1|||
170434474|NCT00691704|615928649|FG000|Induction Therapy|Active Hepatitis|1|||
170434475|NCT00691704|615928649|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
170434476|NCT00691704|615928649|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
170434477|NCT00691704|615928649|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
170434478|NCT04523480|615928650|FG000|Overall Study|Lost to Follow-up|30|||
170434479|NCT04523480|615928651|FG001|Overall Study|Lost to Follow-up|35|||
170434480|NCT04523480|615928652|FG002|Overall Study|Lost to Follow-up|0|||
170434481|NCT01609257|615928657|FG000|Overall Study|Lost to Follow-up|2|||
170434482|NCT01609257|615928658|FG001|Overall Study|Lost to Follow-up|1|||
170434483|NCT01609257|615928657|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
170434484|NCT01609257|615928658|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
170434485|NCT01609257|615928657|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
170434486|NCT01609257|615928658|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
170434487|NCT01592240|615928662|FG000|Overall Study|Adverse Event|1|||
170434488|NCT01592240|615928663|FG001|Overall Study|Adverse Event|0|||
170434489|NCT01592240|615928664|FG002|Overall Study|Adverse Event|0|||
170434490|NCT01592240|615928665|FG003|Overall Study|Adverse Event|1|||
170434491|NCT01592240|615928666|FG004|Overall Study|Adverse Event|1|||
170434492|NCT01592240|615928667|FG005|Overall Study|Adverse Event|0|||
170434493|NCT01592240|615928668|FG006|Overall Study|Adverse Event|0|||
170434494|NCT01592240|615928662|FG000|Overall Study|Death|0|||
170434495|NCT01592240|615928663|FG001|Overall Study|Death|1|||
170434496|NCT01592240|615928664|FG002|Overall Study|Death|0|||
170779620|NCT02740231|617199424|FG000|Overall Study|Lack of Efficacy|0|||
170779621|NCT02740231|617199425|FG001|Overall Study|Lack of Efficacy|1|||
170779622|NCT02740231|617199426|FG002|Overall Study|Lack of Efficacy|0|||
170779623|NCT02740231|617199427|FG003|Overall Study|Lack of Efficacy|4|||
170779624|NCT02740231|617199424|FG000|Overall Study|Lost to Follow-up|1|||
170779625|NCT02740231|617199425|FG001|Overall Study|Lost to Follow-up|3|||
170779626|NCT02740231|617199426|FG002|Overall Study|Lost to Follow-up|0|||
170779627|NCT02740231|617199427|FG003|Overall Study|Lost to Follow-up|3|||
170779628|NCT02740231|617199424|FG000|Overall Study|Adverse Event|0|||
170779629|NCT02740231|617199425|FG001|Overall Study|Adverse Event|1|||
170779630|NCT02740231|617199426|FG002|Overall Study|Adverse Event|0|||
170779631|NCT02740231|617199427|FG003|Overall Study|Adverse Event|1|||
170779632|NCT00243503|617199428|FG000|Overall Study|Adverse Event|11|||
170779633|NCT00243503|617199428|FG000|Overall Study|Withdrawal by Subject|1|||
170779634|NCT00243503|617199428|FG000|Overall Study|Lack of Efficacy|44|||
170779635|NCT00243503|617199428|FG000|Overall Study|Death|1|||
170779636|NCT00243503|617199428|FG000|Overall Study|Other|1|||
170779637|NCT00914589|617199429|FG000|Overall Study|Adverse Event|1|||
170779638|NCT00914589|617199430|FG001|Overall Study|Adverse Event|0|||
170779639|NCT00914589|617199431|FG002|Overall Study|Adverse Event|1|||
170779640|NCT00914589|617199429|FG000|Overall Study|Protocol Violation|8|||
170779641|NCT00914589|617199430|FG001|Overall Study|Protocol Violation|6|||
170779642|NCT00914589|617199431|FG002|Overall Study|Protocol Violation|3|||
170779643|NCT00914589|617199429|FG000|Overall Study|unclassified|16|||
170779644|NCT00914589|617199430|FG001|Overall Study|unclassified|9|||
170779645|NCT00914589|617199431|FG002|Overall Study|unclassified|7|||
170779646|NCT00914589|617199429|FG000|Overall Study|Death|0|||
170779647|NCT00914589|617199430|FG001|Overall Study|Death|1|||
170779648|NCT00914589|617199431|FG002|Overall Study|Death|1|||
170779649|NCT03988023|617199432|FG000|Overall Study|Non-compliance|3|||
170779650|NCT03988023|617199433|FG001|Overall Study|Non-compliance|0|||
170779651|NCT03988023|617199432|FG000|Overall Study|Withdrawal by Subject|39|||
170779652|NCT03988023|617199433|FG001|Overall Study|Withdrawal by Subject|37|||
170779653|NCT03988023|617199432|FG000|Overall Study|Adverse Event|0|||
170779654|NCT03988023|617199433|FG001|Overall Study|Adverse Event|2|||
170779655|NCT03988023|617199432|FG000|Overall Study|Physician Decision|0|||
170779656|NCT03988023|617199433|FG001|Overall Study|Physician Decision|1|||
170779657|NCT03988023|617199432|FG000|Overall Study|Lost to Follow-up|5|||
170779658|NCT03988023|617199433|FG001|Overall Study|Lost to Follow-up|8|||
170881286|NCT02239939|617576051|FG000|Overall Study|Withdrawal by Subject|1|||
170881287|NCT02239939|617576052|FG001|Overall Study|Withdrawal by Subject|1|||
170881288|NCT02239939|617576051|FG000|Overall Study|Lost to Follow-up|0|||
170881289|NCT02239939|617576052|FG001|Overall Study|Lost to Follow-up|1|||
170881290|NCT00763139|617576054|FG000|Overall Study|Adverse Event|4|||
170881291|NCT00763139|617576055|FG001|Overall Study|Adverse Event|2|||
170881292|NCT00763139|617576054|FG000|Overall Study|Withdrawal by Subject|0|||
170881293|NCT00763139|617576055|FG001|Overall Study|Withdrawal by Subject|1|||
170881294|NCT00763139|617576054|FG000|Overall Study|med change not allowed by protocol|1|||
170881295|NCT00763139|617576055|FG001|Overall Study|med change not allowed by protocol|0|||
170881296|NCT02095535|617576056|FG000|Recruitment|Protocol Violation|2|||
170881297|NCT02646982|617576057|FG000|Overall Study|Adverse Event|1|||
170881298|NCT02646982|617576058|FG001|Overall Study|Adverse Event|1|||
170881299|NCT02646982|617576057|FG000|Overall Study|Withdrawal by Subject|2|||
170881300|NCT02646982|617576058|FG001|Overall Study|Withdrawal by Subject|1|||
170881301|NCT00623480|617576059|FG000|Overall Study|Lost to Follow-up|0|||
170881302|NCT00623480|617576060|FG001|Overall Study|Lost to Follow-up|1|||
170881303|NCT00623480|617576059|FG000|Overall Study|Withdrawal by Subject|2|||
170881304|NCT00623480|617576060|FG001|Overall Study|Withdrawal by Subject|4|||
170881305|NCT00623480|617576059|FG000|Overall Study|Lack of Efficacy|1|||
170881306|NCT00623480|617576060|FG001|Overall Study|Lack of Efficacy|0|||
170881307|NCT00623480|617576059|FG000|Overall Study|Non-compliant with study medication|4|||
170881308|NCT00623480|617576060|FG001|Overall Study|Non-compliant with study medication|0|||
170881309|NCT00623480|617576059|FG000|Overall Study|Protocol Violation|0|||
170881310|NCT00623480|617576060|FG001|Overall Study|Protocol Violation|1|||
170881311|NCT00623480|617576059|FG000|Overall Study|Site closed by sponsor|0|||
170881312|NCT00623480|617576060|FG001|Overall Study|Site closed by sponsor|1|||
170881313|NCT01594853|617576061|FG000|Overall Study|Withdrawal by Subject|1|||
170881314|NCT01594853|617576062|FG001|Overall Study|Withdrawal by Subject|1|||
170881315|NCT01594853|617576061|FG000|Overall Study|Lost to Follow-up|1|||
170881316|NCT01594853|617576062|FG001|Overall Study|Lost to Follow-up|1|||
170881317|NCT01594853|617576061|FG000|Overall Study|noncompliance with exercise|0|||
170881318|NCT01594853|617576062|FG001|Overall Study|noncompliance with exercise|1|||
170881319|NCT02631200|617576065|FG000|First Period|Death|1|||
170881320|NCT02631200|617576066|FG001|First Period|Death|2|||
170779659|NCT03988023|617199432|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
170779660|NCT03988023|617199433|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
170779661|NCT03988023|617199432|FG000|Overall Study|Lack of Efficacy|3|||
170779662|NCT03988023|617199433|FG001|Overall Study|Lack of Efficacy|1|||
170779663|NCT03988023|617199432|FG000|Overall Study|COVID-19 pandemic|225|||
170434497|NCT01592240|615928665|FG003|Overall Study|Death|0|||
170434498|NCT01592240|615928666|FG004|Overall Study|Death|0|||
170434499|NCT01592240|615928667|FG005|Overall Study|Death|0|||
170779664|NCT03988023|617199433|FG001|Overall Study|COVID-19 pandemic|227|||
170779665|NCT01989455|617199435|FG000|Overall Study|Adverse Event|0|||
170779666|NCT01989455|617199436|FG001|Overall Study|Adverse Event|1|||
170779667|NCT01989455|617199437|FG002|Overall Study|Adverse Event|0|||
170779668|NCT01989455|617199438|FG003|Overall Study|Adverse Event|0|||
170779669|NCT01989455|617199439|FG004|Overall Study|Adverse Event|0|||
170779670|NCT01989455|617199435|FG000|Overall Study|Withdrawal by Subject|0|||
170779671|NCT01989455|617199436|FG001|Overall Study|Withdrawal by Subject|1|||
170779672|NCT01989455|617199437|FG002|Overall Study|Withdrawal by Subject|0|||
170779673|NCT01989455|617199438|FG003|Overall Study|Withdrawal by Subject|0|||
170779674|NCT01989455|617199439|FG004|Overall Study|Withdrawal by Subject|0|||
170779675|NCT01989455|617199435|FG000|Overall Study|Technical problems with infusion|0|||
170779676|NCT01989455|617199436|FG001|Overall Study|Technical problems with infusion|0|||
170779677|NCT01989455|617199437|FG002|Overall Study|Technical problems with infusion|1|||
170779678|NCT01989455|617199438|FG003|Overall Study|Technical problems with infusion|0|||
170779679|NCT01989455|617199439|FG004|Overall Study|Technical problems with infusion|1|||
170779680|NCT06061081|617199440|FG000|Overall Study|Withdrawal by Subject|1|||
170779681|NCT06061081|617199441|FG001|Overall Study|Withdrawal by Subject|0|||
170779682|NCT06061081|617199442|FG002|Overall Study|Withdrawal by Subject|0|||
170779683|NCT06061081|617199443|FG003|Overall Study|Withdrawal by Subject|0|||
170779684|NCT06061081|617199444|FG004|Overall Study|Withdrawal by Subject|0|||
170779685|NCT03330795|617199445|FG000|Overall Study|Death|3|||
170779686|NCT03330795|617199445|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
170779687|NCT00262301|617199448|FG000|Double-blind Phase|Lost to Follow-up|1|||
170779688|NCT00262301|617199449|FG001|Double-blind Phase|Lost to Follow-up|0|||
170779689|NCT00262301|617199450|FG002|Double-blind Phase|Lost to Follow-up|0|||
170779690|NCT00262301|617199448|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
170779691|NCT00262301|617199449|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
170779692|NCT00262301|617199450|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
170779693|NCT01017146|617199451|FG000|Overall Study|Adverse Event|11|||
170779694|NCT01017146|617199452|FG001|Overall Study|Adverse Event|1|||
170779695|NCT01017146|617199451|FG000|Overall Study|Lost to Follow-up|14|||
170779696|NCT01017146|617199452|FG001|Overall Study|Lost to Follow-up|14|||
170779697|NCT01017146|617199451|FG000|Overall Study|Noncompliance with Study Product|1|||
170779698|NCT01017146|617199452|FG001|Overall Study|Noncompliance with Study Product|1|||
170779699|NCT01017146|617199451|FG000|Overall Study|Withdrawal by Subject|32|||
170779700|NCT01017146|617199452|FG001|Overall Study|Withdrawal by Subject|16|||
170779701|NCT01017146|617199451|FG000|Overall Study|Relocation|0|||
170779702|NCT01017146|617199452|FG001|Overall Study|Relocation|4|||
170779703|NCT01017146|617199451|FG000|Overall Study|Pregnancy|2|||
170779704|NCT01017146|617199452|FG001|Overall Study|Pregnancy|1|||
170779705|NCT01017146|617199451|FG000|Overall Study|Protocol Violation|2|||
170779706|NCT01017146|617199452|FG001|Overall Study|Protocol Violation|0|||
170779707|NCT01017146|617199451|FG000|Overall Study|Took Excluded Medication|2|||
170779708|NCT01017146|617199452|FG001|Overall Study|Took Excluded Medication|0|||
170779709|NCT01017146|617199451|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
170779710|NCT01017146|617199452|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
170779711|NCT01017146|617199451|FG000|Overall Study|Change in Work Situation|1|||
170779712|NCT01017146|617199452|FG001|Overall Study|Change in Work Situation|0|||
170779713|NCT01771731|617199453|FG000|Overall Study|Physician Decision|1|||
170779714|NCT01771731|617199454|FG001|Overall Study|Physician Decision|0|||
170434500|NCT01592240|615928668|FG006|Overall Study|Death|0|||
170434501|NCT01592240|615928662|FG000|Overall Study|Lost to Follow-up|1|||
170779715|NCT01771731|617199453|FG000|Overall Study|Protocol Violation|0|||
170779716|NCT01771731|617199454|FG001|Overall Study|Protocol Violation|1|||
170434502|NCT01592240|615928663|FG001|Overall Study|Lost to Follow-up|3|||
170881321|NCT02631200|617576065|FG000|First Period|Patient ill-health|2|||
170881322|NCT02631200|617576066|FG001|First Period|Patient ill-health|4|||
170881323|NCT02631200|617576065|FG000|First Period|Withdrawal by Subject|4|||
170881324|NCT02631200|617576066|FG001|First Period|Withdrawal by Subject|1|||
170881325|NCT02631200|617576065|FG000|Deferred Period|Death|0|||
170881326|NCT02631200|617576066|FG001|Deferred Period|Death|1|||
170881327|NCT02631200|617576065|FG000|Deferred Period|Received kidney transplant|0|||
170881328|NCT02631200|617576066|FG001|Deferred Period|Received kidney transplant|1|||
170881329|NCT02631200|617576065|FG000|Deferred Period|Withdrawal by Subject|0|||
170434503|NCT01592240|615928664|FG002|Overall Study|Lost to Follow-up|1|||
170434504|NCT01592240|615928665|FG003|Overall Study|Lost to Follow-up|0|||
170434505|NCT01592240|615928666|FG004|Overall Study|Lost to Follow-up|3|||
170434506|NCT01592240|615928667|FG005|Overall Study|Lost to Follow-up|2|||
170434507|NCT01592240|615928668|FG006|Overall Study|Lost to Follow-up|0|||
170434508|NCT01592240|615928662|FG000|Overall Study|Protocol Violation|0|||
170434509|NCT01592240|615928663|FG001|Overall Study|Protocol Violation|0|||
170434510|NCT01592240|615928664|FG002|Overall Study|Protocol Violation|0|||
170881330|NCT02631200|617576066|FG001|Deferred Period|Withdrawal by Subject|2|||
170881331|NCT02631200|617576065|FG000|Deferred Period|Lost to Follow-up|0|||
170881332|NCT02631200|617576066|FG001|Deferred Period|Lost to Follow-up|1|||
170881333|NCT01877187|617576068|FG000|Overall Study|Death|2|||
170881334|NCT01877187|617576068|FG000|Overall Study|Withdrawal by Subject|4|||
170881335|NCT01877187|617576068|FG000|Overall Study|Lost to Follow-up|3|||
170881336|NCT01877187|617576068|FG000|Overall Study|Declining clinical status|11|||
170434511|NCT01592240|615928665|FG003|Overall Study|Protocol Violation|0|||
170434512|NCT01592240|615928666|FG004|Overall Study|Protocol Violation|0|||
170434513|NCT01592240|615928667|FG005|Overall Study|Protocol Violation|1|||
170632777|NCT04672239|616666763|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
170779717|NCT01771731|617199453|FG000|Overall Study|Adverse event: Pain Crisis|1|||
170779718|NCT01771731|617199454|FG001|Overall Study|Adverse event: Pain Crisis|1|||
170779719|NCT00087139|617199455|FG000|Overall Study|Adverse Event|18|||
170779720|NCT00087139|617199456|FG001|Overall Study|Adverse Event|17|||
170779721|NCT00087139|617199457|FG002|Overall Study|Adverse Event|13|||
170779722|NCT00087139|617199455|FG000|Overall Study|Death|2|||
170779723|NCT00087139|617199456|FG001|Overall Study|Death|1|||
170779724|NCT00087139|617199457|FG002|Overall Study|Death|0|||
170779725|NCT00087139|617199455|FG000|Overall Study|Withdrawal by Subject|3|||
170779726|NCT00087139|617199456|FG001|Overall Study|Withdrawal by Subject|2|||
170779727|NCT00087139|617199457|FG002|Overall Study|Withdrawal by Subject|2|||
170779728|NCT00087139|617199455|FG000|Overall Study|Physician Decision|1|||
170779729|NCT00087139|617199456|FG001|Overall Study|Physician Decision|1|||
170779730|NCT00087139|617199457|FG002|Overall Study|Physician Decision|1|||
170779731|NCT00087139|617199455|FG000|Overall Study|Disease progression|9|||
170779732|NCT00087139|617199456|FG001|Overall Study|Disease progression|19|||
170779733|NCT00087139|617199457|FG002|Overall Study|Disease progression|12|||
170779734|NCT00087139|617199455|FG000|Overall Study|Ineligible|4|||
170779735|NCT00087139|617199456|FG001|Overall Study|Ineligible|7|||
170779736|NCT00087139|617199457|FG002|Overall Study|Ineligible|4|||
170779737|NCT00087139|617199455|FG000|Overall Study|Symptomatic deterioration|1|||
170779738|NCT00087139|617199456|FG001|Overall Study|Symptomatic deterioration|1|||
170779739|NCT00087139|617199457|FG002|Overall Study|Symptomatic deterioration|3|||
170779740|NCT00087139|617199455|FG000|Overall Study|Use of coumadin|1|||
170779741|NCT00087139|617199456|FG001|Overall Study|Use of coumadin|0|||
170779742|NCT00087139|617199457|FG002|Overall Study|Use of coumadin|0|||
170779743|NCT00087139|617199455|FG000|Overall Study|Response achieved|0|||
170779744|NCT00087139|617199456|FG001|Overall Study|Response achieved|1|||
170779745|NCT00087139|617199457|FG002|Overall Study|Response achieved|0|||
170779746|NCT00087139|617199455|FG000|Overall Study|Extradural disease|0|||
170779747|NCT00087139|617199456|FG001|Overall Study|Extradural disease|0|||
170779748|NCT00087139|617199457|FG002|Overall Study|Extradural disease|1|||
170779749|NCT00976495|617199458|FG000|Overall Study|Withdrawal by Subject|0|||
170779750|NCT00976495|617199459|FG001|Overall Study|Withdrawal by Subject|1|||
170779751|NCT00976495|617199460|FG002|Overall Study|Withdrawal by Subject|0|||
170779752|NCT00611559|617199461|FG000|Overall Study|Lost to Follow-up|0|||
170779753|NCT00611559|617199462|FG001|Overall Study|Lost to Follow-up|1|||
170779754|NCT00611559|617199463|FG002|Overall Study|Lost to Follow-up|0|||
170779755|NCT00611559|617199461|FG000|Overall Study|Protocol Violation|1|||
170779756|NCT00611559|617199462|FG001|Overall Study|Protocol Violation|0|||
170881337|NCT01877187|617576068|FG000|Overall Study|Liver transplant|2|||
170434514|NCT01592240|615928668|FG006|Overall Study|Protocol Violation|0|||
170434515|NCT01592240|615928662|FG000|Overall Study|Withdrawal by Subject|0|||
170779757|NCT00611559|617199463|FG002|Overall Study|Protocol Violation|1|||
170779758|NCT00065260|617199470|FG000|Overall Study|Death|0|||
170779759|NCT00065260|617199471|FG001|Overall Study|Death|1|||
170779760|NCT00761189|617199472|FG000|Overall Study|Adverse Event|42|||
170881338|NCT00960661|617576070|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
170779761|NCT00761189|617199472|FG000|Overall Study|Lack of Efficacy|45|||
170779762|NCT00761189|617199472|FG000|Overall Study|Lost to Follow-up|36|||
170779763|NCT00761189|617199472|FG000|Overall Study|Withdrawal by Subject|49|||
170779764|NCT00761189|617199472|FG000|Overall Study|Other|13|||
170779765|NCT02891915|617199482|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
170779766|NCT02891915|617199483|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
170779767|NCT02891915|617199482|FG000|Overall Study|Withdrawal by Subject|3|||
170779768|NCT02891915|617199483|FG001|Overall Study|Withdrawal by Subject|3|||
170779769|NCT02891915|617199482|FG000|Overall Study|Became Ineligible After Enrollment|2|||
170779770|NCT02891915|617199483|FG001|Overall Study|Became Ineligible After Enrollment|1|||
170881339|NCT00960661|617576071|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
170881340|NCT00960661|617576072|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
170881341|NCT00960661|617576070|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
170881342|NCT00960661|617576071|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
170881343|NCT00960661|617576072|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
170881344|NCT00960661|617576070|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
170881345|NCT00960661|617576071|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
170881346|NCT00960661|617576072|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
170881347|NCT00960661|617576070|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
170881348|NCT00960661|617576071|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
170881349|NCT00960661|617576072|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
170881350|NCT00960661|617576070|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
170881351|NCT00960661|617576071|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
170881352|NCT00960661|617576072|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
170881353|NCT00960661|617576070|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
170881354|NCT00960661|617576071|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
170881355|NCT00960661|617576072|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
170881356|NCT00960661|617576070|FG000|Interventional Phase|Adverse Event|0|||
170881357|NCT00960661|617576071|FG001|Interventional Phase|Adverse Event|17|||
170881358|NCT00960661|617576072|FG002|Interventional Phase|Adverse Event|8|||
170881359|NCT00960661|617576070|FG000|Interventional Phase|Death|0|||
170881360|NCT00960661|617576071|FG001|Interventional Phase|Death|1|||
170881361|NCT00960661|617576072|FG002|Interventional Phase|Death|0|||
170881362|NCT00960661|617576070|FG000|Interventional Phase|Lost to Follow-up|0|||
170881363|NCT00960661|617576071|FG001|Interventional Phase|Lost to Follow-up|0|||
170881364|NCT00960661|617576072|FG002|Interventional Phase|Lost to Follow-up|2|||
170881365|NCT00960661|617576070|FG000|Interventional Phase|entry criteria not met|0|||
170881366|NCT00960661|617576071|FG001|Interventional Phase|entry criteria not met|3|||
170881367|NCT00960661|617576072|FG002|Interventional Phase|entry criteria not met|0|||
170881368|NCT00960661|617576070|FG000|Interventional Phase|Protocol Violation|0|||
170881369|NCT00960661|617576071|FG001|Interventional Phase|Protocol Violation|7|||
170881370|NCT00960661|617576072|FG002|Interventional Phase|Protocol Violation|2|||
170881371|NCT00960661|617576070|FG000|Interventional Phase|Withdrawal by Subject|0|||
170881372|NCT00960661|617576071|FG001|Interventional Phase|Withdrawal by Subject|18|||
170881373|NCT00960661|617576072|FG002|Interventional Phase|Withdrawal by Subject|29|||
170881374|NCT00960661|617576070|FG000|Interventional Phase|Physician Decision|0|||
170881375|NCT00960661|617576071|FG001|Interventional Phase|Physician Decision|3|||
170881376|NCT00960661|617576072|FG002|Interventional Phase|Physician Decision|5|||
170881377|NCT00960661|617576070|FG000|Interventional Phase|sponsor decision|0|||
170881378|NCT00960661|617576071|FG001|Interventional Phase|sponsor decision|1|||
170881379|NCT00960661|617576072|FG002|Interventional Phase|sponsor decision|0|||
170881380|NCT00960661|617576070|FG000|Interventional Phase|Lack of Efficacy|0|||
170881381|NCT00960661|617576071|FG001|Interventional Phase|Lack of Efficacy|2|||
170881382|NCT00960661|617576072|FG002|Interventional Phase|Lack of Efficacy|0|||
170881383|NCT02699892|617576073|FG000|Overall Study|Other|36|||
170881384|NCT00711100|617576074|FG000|Overall Study|Lack of Efficacy|5|||
170881385|NCT00711100|617576074|FG000|Overall Study|Withdrawal by Subject|8|||
170881386|NCT01263639|617576076|FG000|Overall Study|Lost to Follow-up|66|||
170881387|NCT01263639|617576077|FG001|Overall Study|Lost to Follow-up|70|||
170881388|NCT01263639|617576076|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
170881389|NCT01263639|617576077|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
170881390|NCT03975920|617576079|FG000|Overall Study|Lost to Follow-up|1|||
170881391|NCT03975920|617576080|FG001|Overall Study|Lost to Follow-up|2|||
170881392|NCT03975920|617576079|FG000|Overall Study|Protocol Violation|1|||
170881393|NCT03975920|617576080|FG001|Overall Study|Protocol Violation|1|||
170881394|NCT03975920|617576079|FG000|Overall Study|Did not complete survey|2|||
170881395|NCT03975920|617576080|FG001|Overall Study|Did not complete survey|1|||
170881396|NCT00586495|617576081|FG000|Treatment Period|Adverse Event|11|||
170881397|NCT00586495|617576081|FG000|Treatment Period|Death|1|||
170881398|NCT00586495|617576081|FG000|Treatment Period|Protocol Violation|1|||
170881399|NCT00586495|617576081|FG000|Treatment Period|Withdrawal by Subject|1|||
170881400|NCT00586495|617576081|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
170434516|NCT01592240|615928663|FG001|Overall Study|Withdrawal by Subject|4|||
170434517|NCT01592240|615928664|FG002|Overall Study|Withdrawal by Subject|4|||
170434518|NCT01592240|615928665|FG003|Overall Study|Withdrawal by Subject|1|||
170434519|NCT01592240|615928666|FG004|Overall Study|Withdrawal by Subject|3|||
170434520|NCT01592240|615928667|FG005|Overall Study|Withdrawal by Subject|0|||
170434521|NCT01592240|615928668|FG006|Overall Study|Withdrawal by Subject|2|||
170434522|NCT01592240|615928662|FG000|Overall Study|Other|0|||
170434523|NCT01592240|615928663|FG001|Overall Study|Other|3|||
170434524|NCT01592240|615928664|FG002|Overall Study|Other|1|||
170434525|NCT01592240|615928665|FG003|Overall Study|Other|1|||
170434526|NCT01592240|615928666|FG004|Overall Study|Other|0|||
170434527|NCT01592240|615928667|FG005|Overall Study|Other|0|||
170434528|NCT01592240|615928668|FG006|Overall Study|Other|1|||
170434529|NCT01592240|615928662|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
170434530|NCT01592240|615928663|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
170434531|NCT01592240|615928664|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
170434532|NCT01592240|615928665|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
170434533|NCT01592240|615928666|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
170434534|NCT01592240|615928667|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
170434535|NCT01592240|615928668|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
170434536|NCT02727192|615928670|FG000|Overall Study|Lost to Follow-up|1|||
170434537|NCT02727192|615928671|FG001|Overall Study|Lost to Follow-up|0|||
170434538|NCT02727192|615928672|FG002|Overall Study|Lost to Follow-up|0|||
170434539|NCT04590027|615928673|FG000|Overall Study|Lost to Follow-up|17|||
170434540|NCT04590027|615928674|FG001|Overall Study|Lost to Follow-up|14|||
170434541|NCT04590027|615928673|FG000|Overall Study|Protocol Violation|0|||
170434542|NCT04590027|615928674|FG001|Overall Study|Protocol Violation|3|||
170434543|NCT05523895|615928675|FG000|Overall Study|Adverse Event|2|||
170434544|NCT05523895|615928676|FG001|Overall Study|Adverse Event|1|||
170434545|NCT05523895|615928677|FG002|Overall Study|Adverse Event|1|||
170434546|NCT05523895|615928675|FG000|Overall Study|Lost to Follow-up|0|||
170434547|NCT05523895|615928676|FG001|Overall Study|Lost to Follow-up|1|||
170434548|NCT05523895|615928677|FG002|Overall Study|Lost to Follow-up|2|||
170434549|NCT05523895|615928675|FG000|Overall Study|Noncompliance with study drug|1|||
170434550|NCT05523895|615928676|FG001|Overall Study|Noncompliance with study drug|1|||
170434551|NCT05523895|615928677|FG002|Overall Study|Noncompliance with study drug|1|||
170434552|NCT05523895|615928675|FG000|Overall Study|Protocol Violation|0|||
170434553|NCT05523895|615928676|FG001|Overall Study|Protocol Violation|2|||
170434554|NCT05523895|615928677|FG002|Overall Study|Protocol Violation|0|||
170434555|NCT05523895|615928675|FG000|Overall Study|Withdrawal by Subject|1|||
170434556|NCT05523895|615928676|FG001|Overall Study|Withdrawal by Subject|3|||
170434557|NCT05523895|615928677|FG002|Overall Study|Withdrawal by Subject|1|||
170434558|NCT05523895|615928675|FG000|Overall Study|Not further specified|0|||
170434559|NCT05523895|615928676|FG001|Overall Study|Not further specified|3|||
170434560|NCT05523895|615928677|FG002|Overall Study|Not further specified|1|||
170434561|NCT05099380|615928678|FG000|Overall Study|Subject enrolled in error|1|||
170881401|NCT00586495|617576081|FG000|Treatment Period|Switch to commercial drug|10|||
170881402|NCT00586495|617576081|FG000|Follow-up|Death|40|||
170881403|NCT00586495|617576081|FG000|Follow-up|Lost to Follow-up|1|||
170881404|NCT00586495|617576081|FG000|Follow-up|Withdrawal by Subject|4|||
170881405|NCT00586495|617576081|FG000|Follow-up|Protocol driven decision point|37|||
170881406|NCT00586495|617576081|FG000|Follow-up|Switch to commercial drug|10|||
170881407|NCT01965262|617576108|FG000|Second Intervention (7 Days)|Discontinued|0|||
170881408|NCT01965262|617576109|FG001|Second Intervention (7 Days)|Discontinued|1|||
170881409|NCT01965262|617576108|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
170881410|NCT01965262|617576109|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
170881411|NCT01965262|617576108|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
170881412|NCT01965262|617576109|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
170881413|NCT01827670|617576110|FG000|Overall Study|Withdrawal of Consent|3|||
170881414|NCT01827670|617576111|FG001|Overall Study|Withdrawal of Consent|2|||
170881415|NCT01827670|617576110|FG000|Overall Study|Lost to Follow-up|0|||
170881416|NCT01827670|617576111|FG001|Overall Study|Lost to Follow-up|1|||
170881417|NCT03016325|617576112|FG000|Treatment Period|Participant withdrew consent|0|||
170881418|NCT03016325|617576113|FG001|Treatment Period|Participant withdrew consent|1|||
170881419|NCT03016325|617576114|FG002|Treatment Period|Participant withdrew consent|0|||
170881420|NCT03016325|617576115|FG003|Treatment Period|Participant withdrew consent|0|||
170881421|NCT03016325|617576116|FG004|Treatment Period|Participant withdrew consent|0|||
170881422|NCT03016325|617576117|FG005|Treatment Period|Participant withdrew consent|0|||
170881423|NCT03016325|617576118|FG006|Treatment Period|Participant withdrew consent|0|||
170881424|NCT03016325|617576119|FG007|Treatment Period|Participant withdrew consent|0|||
170881425|NCT03016325|617576112|FG000|Treatment Period|Death|0|||
170881426|NCT03016325|617576113|FG001|Treatment Period|Death|0|||
170881427|NCT03016325|617576114|FG002|Treatment Period|Death|0|||
170434562|NCT05099380|615928679|FG001|Overall Study|Subject enrolled in error|0|||
170434563|NCT05099380|615928678|FG000|Overall Study|Study Procedure|1|||
170434564|NCT05099380|615928679|FG001|Overall Study|Study Procedure|0|||
170434565|NCT05099380|615928678|FG000|Overall Study|Protocol Violation|1|||
170434566|NCT05099380|615928679|FG001|Overall Study|Protocol Violation|0|||
170434567|NCT05099380|615928678|FG000|Overall Study|Adverse Event|1|||
170434568|NCT05099380|615928679|FG001|Overall Study|Adverse Event|1|||
170434569|NCT05099380|615928678|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
170434570|NCT05099380|615928679|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
170434571|NCT01959672|615928685|FG000|Overall Study|Death|1|||
170434572|NCT02392195|615928686|FG000|Overall Study|Lost to Follow-up|4|||
170434573|NCT02392195|615928686|FG000|Overall Study|Withdrawal by Subject|4|||
170434574|NCT00840216|615928687|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
170881428|NCT03016325|617576115|FG003|Treatment Period|Death|0|||
170434575|NCT00840216|615928688|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
170434576|NCT03276754|615928691|FG000|Overall Study|Withdrawal of informed consent|4|||
170434577|NCT03276754|615928691|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
170434578|NCT03276754|615928691|FG000|Overall Study|Lost to Follow-up|27|||
170434579|NCT03276754|615928691|FG000|Overall Study|No data reported at Month 24|31|||
170434580|NCT03276754|615928691|FG000|Overall Study|Death|39|||
170434581|NCT04692155|615928693|FG000|Overall Study|Death|1|||
170434582|NCT04547192|615928696|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
170434583|NCT04547192|615928697|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
170434584|NCT04547192|615928698|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
170434585|NCT04547192|615928699|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
170434586|NCT04547192|615928696|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
170434587|NCT04547192|615928697|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
170434588|NCT04547192|615928698|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
170434589|NCT04547192|615928699|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
170434590|NCT04547192|615928696|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
170434591|NCT04547192|615928697|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
170434592|NCT04547192|615928698|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
170434593|NCT04547192|615928699|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
170434594|NCT04547192|615928696|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
170434595|NCT04547192|615928697|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
170434596|NCT04547192|615928698|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
170434597|NCT04547192|615928699|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
170434598|NCT04547192|615928696|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
170434599|NCT04547192|615928697|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
170434600|NCT04547192|615928698|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
170434601|NCT04547192|615928699|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
170434602|NCT04723693|615928700|FG000|Overall Study|Withdrawal by Subject|2|||
170434603|NCT03366792|615928701|FG000|Overall Study|Withdrawal by Subject|7|||
170434604|NCT03366792|615928701|FG000|Overall Study|Lost to Follow-up|2|||
170434605|NCT03366792|615928701|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
170434606|NCT03366792|615928701|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
170434607|NCT03497130|615928702|FG000|Overall Study|Lost to Follow-up|1|||
170434608|NCT03497130|615928703|FG001|Overall Study|Lost to Follow-up|1|||
170434609|NCT04002648|615928704|FG000|Overall Study|Lost to Follow-up|2|||
170434610|NCT04002648|615928705|FG001|Overall Study|Lost to Follow-up|0|||
170434611|NCT00606281|615928714|FG000|Overall Study|Adverse Event|11|||
170434612|NCT00606281|615928715|FG001|Overall Study|Adverse Event|12|||
170434613|NCT00606281|615928714|FG000|Overall Study|Death|1|||
170434614|NCT00606281|615928715|FG001|Overall Study|Death|0|||
170434615|NCT00606281|615928714|FG000|Overall Study|Lack of Efficacy|28|||
170434616|NCT00606281|615928715|FG001|Overall Study|Lack of Efficacy|35|||
170434617|NCT00606281|615928714|FG000|Overall Study|Physician Decision|0|||
170434618|NCT00606281|615928715|FG001|Overall Study|Physician Decision|1|||
170434619|NCT00606281|615928714|FG000|Overall Study|Protocol Violation|3|||
170434620|NCT00606281|615928715|FG001|Overall Study|Protocol Violation|3|||
170434621|NCT00606281|615928714|FG000|Overall Study|Withdrawal by Subject|11|||
170434622|NCT00606281|615928715|FG001|Overall Study|Withdrawal by Subject|13|||
170434623|NCT00606281|615928714|FG000|Overall Study|Progression to depressive phase|1|||
170434624|NCT00606281|615928715|FG001|Overall Study|Progression to depressive phase|1|||
170434625|NCT00606281|615928714|FG000|Overall Study|Change of residence or other commitments|1|||
170434626|NCT00606281|615928715|FG001|Overall Study|Change of residence or other commitments|1|||
170434627|NCT00216736|615928717|FG000|Overall Study|Lost to Follow-up|1|||
170779771|NCT02891915|617199482|FG000|Overall Study|Lost to Follow-up|1|||
170779772|NCT02891915|617199483|FG001|Overall Study|Lost to Follow-up|4|||
170779773|NCT02891915|617199482|FG000|Overall Study|Physician Decision|1|||
170779774|NCT02891915|617199483|FG001|Overall Study|Physician Decision|0|||
170779775|NCT01037985|617199484|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
170779776|NCT01037985|617199485|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
170779777|NCT01037985|617199484|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
170779778|NCT01037985|617199485|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
170779779|NCT01037985|617199484|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
170779780|NCT01037985|617199485|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
170434628|NCT00216736|615928718|FG001|Overall Study|Lost to Follow-up|1|||
170881429|NCT03016325|617576116|FG004|Treatment Period|Death|2|||
170434629|NCT02622386|615928721|FG000|First Assignment|Withdrawal by Subject|3|||
170434630|NCT02622386|615928722|FG001|First Assignment|Withdrawal by Subject|2|||
170434631|NCT02622386|615928721|FG000|Washout|Withdrawal by Subject|4|||
170434632|NCT02622386|615928722|FG001|Washout|Withdrawal by Subject|4|||
170434633|NCT02622386|615928721|FG000|Second Assignment|Withdrawal by Subject|0|||
170434634|NCT02622386|615928722|FG001|Second Assignment|Withdrawal by Subject|2|||
170434635|NCT00807495|615928723|FG000|Overall Study|Adverse Event|6|||
170434636|NCT00807495|615928724|FG001|Overall Study|Adverse Event|3|||
170434637|NCT00807495|615928725|FG002|Overall Study|Adverse Event|1|||
170881430|NCT03016325|617576117|FG005|Treatment Period|Death|0|||
170881431|NCT03016325|617576118|FG006|Treatment Period|Death|0|||
170434638|NCT00807495|615928726|FG003|Overall Study|Adverse Event|1|||
170434639|NCT00807495|615928727|FG004|Overall Study|Adverse Event|2|||
170434640|NCT00807495|615928723|FG000|Overall Study|Withdrawal by Patient|2|||
170434641|NCT00807495|615928724|FG001|Overall Study|Withdrawal by Patient|0|||
170434642|NCT00807495|615928725|FG002|Overall Study|Withdrawal by Patient|1|||
170434643|NCT00807495|615928726|FG003|Overall Study|Withdrawal by Patient|0|||
170434644|NCT00807495|615928727|FG004|Overall Study|Withdrawal by Patient|0|||
170434645|NCT00807495|615928723|FG000|Overall Study|Reason Not Specified|0|||
170434646|NCT00807495|615928724|FG001|Overall Study|Reason Not Specified|3|||
170434647|NCT00807495|615928725|FG002|Overall Study|Reason Not Specified|2|||
170434648|NCT00807495|615928726|FG003|Overall Study|Reason Not Specified|0|||
170434649|NCT00807495|615928727|FG004|Overall Study|Reason Not Specified|3|||
170434650|NCT02054715|615928731|FG000|Baseline/Follow-up 1|Refused|1|||
170434651|NCT02054715|615928732|FG001|Baseline/Follow-up 1|Refused|3|||
170434652|NCT02054715|615928731|FG000|Baseline/Follow-up 1|Medical|0|||
170434653|NCT02054715|615928732|FG001|Baseline/Follow-up 1|Medical|1|||
170434654|NCT02054715|615928731|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
170434655|NCT02054715|615928732|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
170434656|NCT02054715|615928731|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
170434657|NCT02054715|615928732|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
170434658|NCT02054715|615928731|FG000|Baseline/Follow-up 1|No Reason|0|||
170434659|NCT02054715|615928732|FG001|Baseline/Follow-up 1|No Reason|1|||
170434660|NCT02054715|615928731|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
170434661|NCT02054715|615928732|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
170434662|NCT02054715|615928731|FG000|Baseline/Follow-up 1|Ineligible|3|||
170434663|NCT02054715|615928732|FG001|Baseline/Follow-up 1|Ineligible|0|||
170434664|NCT02054715|615928731|FG000|Baseline/Follow-up 1|Hospitalization|1|||
170434665|NCT02054715|615928732|FG001|Baseline/Follow-up 1|Hospitalization|0|||
170434666|NCT02054715|615928731|FG000|Baseline/Follow-up 1|Changed Mind|1|||
170434667|NCT02054715|615928732|FG001|Baseline/Follow-up 1|Changed Mind|0|||
170434668|NCT02054715|615928731|FG000|Follow-up 2|Lost to Followup|3|||
170434669|NCT02054715|615928732|FG001|Follow-up 2|Lost to Followup|1|||
170434670|NCT02054715|615928731|FG000|Follow-up 2|Refused|3|||
170434671|NCT02054715|615928732|FG001|Follow-up 2|Refused|2|||
170434672|NCT02054715|615928731|FG000|Follow-up 2|Followup Not Completed|3|||
170434673|NCT02054715|615928732|FG001|Follow-up 2|Followup Not Completed|4|||
170434674|NCT02054715|615928731|FG000|Follow-up 2|Ineligible|4|||
170434675|NCT02054715|615928732|FG001|Follow-up 2|Ineligible|5|||
170434676|NCT02054715|615928731|FG000|Follow-up 2|Death|3|||
170779781|NCT01037985|617199484|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
170779782|NCT01037985|617199485|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
170779783|NCT02730871|617199486|FG000|Overall Study|Adverse Event|6|||
170779784|NCT02730871|617199487|FG001|Overall Study|Adverse Event|0|||
170779785|NCT02910713|617199488|FG000|Overall Study|Protocol Violation|2|||
170779786|NCT02910713|617199488|FG000|Overall Study|Subject Choice|4|||
170779787|NCT02910713|617199488|FG000|Overall Study|Received One Application|10|||
170779788|NCT02910713|617199488|FG000|Overall Study|Received Neither Application|18|||
170881432|NCT03016325|617576119|FG007|Treatment Period|Death|0|||
170779789|NCT02910713|617199488|FG000|Overall Study|Enrollment cap|7|||
170779790|NCT02910713|617199488|FG000|Overall Study|Investigator Discretion|1|||
170779791|NCT05368558|617199490|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
170779792|NCT05368558|617199491|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
170779793|NCT05368558|617199492|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
170779794|NCT05368558|617199493|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170779795|NCT05368558|617199494|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170779796|NCT05368558|617199495|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170881433|NCT03016325|617576112|FG000|Treatment Period|Participant refuses assessments|0|||
170881434|NCT03016325|617576113|FG001|Treatment Period|Participant refuses assessments|0|||
170881435|NCT03016325|617576114|FG002|Treatment Period|Participant refuses assessments|1|||
170881436|NCT03016325|617576115|FG003|Treatment Period|Participant refuses assessments|0|||
170881437|NCT03016325|617576116|FG004|Treatment Period|Participant refuses assessments|0|||
170881438|NCT03016325|617576117|FG005|Treatment Period|Participant refuses assessments|0|||
170881439|NCT03016325|617576118|FG006|Treatment Period|Participant refuses assessments|0|||
170881440|NCT03016325|617576119|FG007|Treatment Period|Participant refuses assessments|0|||
170881441|NCT03016325|617576112|FG000|32-Day Follow-Up Period|Death|2|||
170881442|NCT03016325|617576113|FG001|32-Day Follow-Up Period|Death|0|||
170881443|NCT03016325|617576114|FG002|32-Day Follow-Up Period|Death|5|||
170881444|NCT03016325|617576115|FG003|32-Day Follow-Up Period|Death|6|||
170881445|NCT03016325|617576116|FG004|32-Day Follow-Up Period|Death|3|||
170881446|NCT03016325|617576117|FG005|32-Day Follow-Up Period|Death|0|||
170881447|NCT03016325|617576118|FG006|32-Day Follow-Up Period|Death|0|||
170881448|NCT03016325|617576119|FG007|32-Day Follow-Up Period|Death|0|||
170434677|NCT02054715|615928732|FG001|Follow-up 2|Death|3|||
170779797|NCT05368558|617199496|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170881449|NCT03016325|617576112|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
170434678|NCT02054715|615928731|FG000|Follow-up 2|Hospitalization|0|||
170779798|NCT05368558|617199497|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170779799|NCT05368558|617199498|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170779800|NCT05368558|617199499|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170779801|NCT05368558|617199500|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170779802|NCT05368558|617199501|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
170779803|NCT05368558|617199490|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779804|NCT05368558|617199491|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779805|NCT05368558|617199492|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779806|NCT05368558|617199493|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
170779807|NCT05368558|617199494|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779808|NCT05368558|617199495|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
170779809|NCT05368558|617199496|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779810|NCT05368558|617199497|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779811|NCT05368558|617199498|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779812|NCT05368558|617199499|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779813|NCT05368558|617199500|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779814|NCT05368558|617199501|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
170779815|NCT05368558|617199490|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779816|NCT05368558|617199491|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779817|NCT05368558|617199492|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779818|NCT05368558|617199493|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
170779819|NCT05368558|617199494|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779820|NCT05368558|617199495|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779821|NCT05368558|617199496|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779822|NCT05368558|617199497|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779823|NCT05368558|617199498|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779824|NCT05368558|617199499|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779825|NCT05368558|617199500|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779826|NCT05368558|617199501|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
170779827|NCT05368558|617199490|FG000|Blinded Extension Period (BEP)|other|0|||
170779828|NCT05368558|617199491|FG001|Blinded Extension Period (BEP)|other|0|||
170779829|NCT05368558|617199492|FG002|Blinded Extension Period (BEP)|other|0|||
170779830|NCT05368558|617199493|FG003|Blinded Extension Period (BEP)|other|0|||
170779831|NCT05368558|617199494|FG004|Blinded Extension Period (BEP)|other|0|||
170779832|NCT05368558|617199495|FG005|Blinded Extension Period (BEP)|other|1|||
170779833|NCT05368558|617199496|FG006|Blinded Extension Period (BEP)|other|0|||
170779834|NCT05368558|617199497|FG007|Blinded Extension Period (BEP)|other|0|||
170779835|NCT05368558|617199498|FG008|Blinded Extension Period (BEP)|other|0|||
170779836|NCT05368558|617199499|FG009|Blinded Extension Period (BEP)|other|0|||
170779837|NCT05368558|617199500|FG010|Blinded Extension Period (BEP)|other|0|||
170779838|NCT05368558|617199501|FG011|Blinded Extension Period (BEP)|other|0|||
170779839|NCT04402294|617199502|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
170779840|NCT04402294|617199503|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
170779841|NCT04402294|617199502|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
170779842|NCT04402294|617199503|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
170779843|NCT04924062|617201194|FG000|Overall Study|Death|49|||
170779844|NCT04924062|617201195|FG001|Overall Study|Death|63|||
170779845|NCT04924062|617201194|FG000|Overall Study|Participant On-going|26|||
170779846|NCT04924062|617201195|FG001|Overall Study|Participant On-going|20|||
170779847|NCT01991977|617201196|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
170779848|NCT01991977|617201196|FG000|Overall Study|Withdrew after start of treatment|5|||
170779849|NCT04038957|617201198|FG000|Overall Study|Withdrawal by Subject|1|||
170779850|NCT04038957|617201198|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
170779851|NCT04586920|617201203|FG000|Overall Study|Lost to Follow-up|0|||
170779852|NCT04586920|617201204|FG001|Overall Study|Lost to Follow-up|0|||
170779853|NCT04586920|617201205|FG002|Overall Study|Lost to Follow-up|0|||
170779854|NCT04586920|617201206|FG003|Overall Study|Lost to Follow-up|0|||
170779855|NCT04586920|617201207|FG004|Overall Study|Lost to Follow-up|0|||
170779856|NCT04586920|617201208|FG005|Overall Study|Lost to Follow-up|0|||
170779857|NCT04586920|617201209|FG006|Overall Study|Lost to Follow-up|1|||
170779858|NCT04586920|617201210|FG007|Overall Study|Lost to Follow-up|1|||
170779859|NCT04586920|617201211|FG008|Overall Study|Lost to Follow-up|0|||
170779860|NCT04586920|617201212|FG009|Overall Study|Lost to Follow-up|1|||
170779861|NCT04586920|617201213|FG010|Overall Study|Lost to Follow-up|0|||
170779862|NCT04586920|617201214|FG011|Overall Study|Lost to Follow-up|0|||
170779863|NCT04586920|617201215|FG012|Overall Study|Lost to Follow-up|0|||
170779864|NCT04586920|617201216|FG013|Overall Study|Lost to Follow-up|1|||
170881450|NCT03016325|617576113|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
170881451|NCT03016325|617576114|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
170881452|NCT03016325|617576115|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
170881453|NCT03016325|617576116|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
170881454|NCT03016325|617576117|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
170881455|NCT03016325|617576118|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
170881456|NCT03016325|617576119|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
170881457|NCT03016325|617576112|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
170881458|NCT03016325|617576113|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
170881459|NCT03016325|617576114|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
170881460|NCT03016325|617576115|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
170881461|NCT03016325|617576116|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
170881462|NCT03016325|617576117|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
170881463|NCT03016325|617576118|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
170881464|NCT03016325|617576119|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
170881465|NCT03016325|617576112|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
170881466|NCT03016325|617576113|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
170881467|NCT03016325|617576114|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
170881468|NCT03016325|617576115|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
170881469|NCT03016325|617576116|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
170881470|NCT03016325|617576117|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
170881471|NCT03016325|617576118|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
170881472|NCT03016325|617576119|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
170881473|NCT03016325|617576112|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
170881474|NCT03016325|617576113|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
170881475|NCT03016325|617576114|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
170881476|NCT03016325|617576115|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
170881477|NCT03016325|617576116|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
170881478|NCT03016325|617576117|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
170881479|NCT03016325|617576118|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
170881480|NCT03016325|617576119|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
170881481|NCT03016325|617576112|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
170881482|NCT03016325|617576113|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
170881483|NCT03016325|617576114|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
170881484|NCT03016325|617576115|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
170881485|NCT03016325|617576116|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
170881486|NCT03016325|617576117|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
170881487|NCT03016325|617576118|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
170881488|NCT03016325|617576119|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
170881489|NCT03016325|617576112|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
170881490|NCT03016325|617576113|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
170881491|NCT03016325|617576114|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
170881492|NCT03016325|617576115|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
170881493|NCT03016325|617576116|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
170881494|NCT03016325|617576117|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
170881495|NCT03016325|617576118|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
170881496|NCT03016325|617576119|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
170881497|NCT03016325|617576112|FG000|182-Day Follow-Up Period|Death|3|||
170881498|NCT03016325|617576113|FG001|182-Day Follow-Up Period|Death|3|||
170881499|NCT03016325|617576114|FG002|182-Day Follow-Up Period|Death|11|||
170881500|NCT03016325|617576115|FG003|182-Day Follow-Up Period|Death|12|||
170881501|NCT03016325|617576116|FG004|182-Day Follow-Up Period|Death|9|||
170881502|NCT03016325|617576117|FG005|182-Day Follow-Up Period|Death|0|||
170881503|NCT03016325|617576118|FG006|182-Day Follow-Up Period|Death|0|||
170881504|NCT03016325|617576119|FG007|182-Day Follow-Up Period|Death|1|||
170881505|NCT03016325|617576112|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
170881506|NCT03016325|617576113|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
170881507|NCT03016325|617576114|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
170881508|NCT03016325|617576115|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
170881509|NCT03016325|617576116|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
170881510|NCT03016325|617576117|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
170881511|NCT03016325|617576118|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
170881512|NCT03016325|617576119|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
170881513|NCT03016325|617576112|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
170881514|NCT03016325|617576113|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
170881515|NCT03016325|617576114|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
170881516|NCT03016325|617576115|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
170881517|NCT03016325|617576116|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
170881518|NCT03016325|617576117|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
170881519|NCT03016325|617576118|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
170881520|NCT03016325|617576119|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
170881521|NCT03016325|617576112|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
170881522|NCT03016325|617576113|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
170881523|NCT03016325|617576114|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
170881524|NCT03016325|617576115|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
170881525|NCT03016325|617576116|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
170881526|NCT03016325|617576117|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
170881527|NCT03016325|617576118|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
170881528|NCT03016325|617576119|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
170881529|NCT03016325|617576112|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
170881530|NCT03016325|617576113|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
170881531|NCT03016325|617576114|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
170881532|NCT03016325|617576115|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
170881533|NCT03016325|617576116|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
170881534|NCT03016325|617576117|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
170881535|NCT03016325|617576118|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
170881536|NCT03016325|617576119|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
170881537|NCT03016325|617576112|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
170881538|NCT03016325|617576113|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
170881539|NCT03016325|617576114|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
170881540|NCT03016325|617576115|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
170881541|NCT03016325|617576116|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
170881542|NCT03016325|617576117|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
170881543|NCT03016325|617576118|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
170881544|NCT03016325|617576119|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
170881545|NCT03016325|617576112|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
170881546|NCT03016325|617576113|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
170881547|NCT03016325|617576114|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
170881548|NCT03016325|617576115|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
170881549|NCT03016325|617576116|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
170881550|NCT03016325|617576117|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
170881551|NCT03016325|617576118|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
170881552|NCT03016325|617576119|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
170881553|NCT03016325|617576112|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
170881554|NCT03016325|617576113|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
170881555|NCT03016325|617576114|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
170881556|NCT03016325|617576115|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
170881557|NCT03016325|617576116|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
170881558|NCT03016325|617576117|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
170881559|NCT03016325|617576118|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
170881560|NCT03016325|617576119|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
170881561|NCT02980224|617576121|FG000|Overall Study|Adverse Event|4|||
170881562|NCT02980224|617576122|FG001|Overall Study|Adverse Event|1|||
170881563|NCT02980224|617576121|FG000|Overall Study|Withdrawal by Subject|0|||
170881564|NCT02980224|617576122|FG001|Overall Study|Withdrawal by Subject|2|||
170881565|NCT01087905|617576123|FG000|Overall Study|Lost to Follow-up|24|||
170881566|NCT01087905|617576124|FG001|Overall Study|Lost to Follow-up|28|||
170881567|NCT01087905|617576125|FG002|Overall Study|Lost to Follow-up|18|||
170881568|NCT01087905|617576126|FG003|Overall Study|Lost to Follow-up|31|||
170881569|NCT01087905|617576127|FG004|Overall Study|Lost to Follow-up|27|||
170881570|NCT01087905|617576128|FG005|Overall Study|Lost to Follow-up|25|||
170881571|NCT01087905|617576129|FG006|Overall Study|Lost to Follow-up|20|||
170881572|NCT01087905|617576130|FG007|Overall Study|Lost to Follow-up|24|||
170881573|NCT01087905|617576123|FG000|Overall Study|Withdrawal by Subject|5|||
170881574|NCT01087905|617576124|FG001|Overall Study|Withdrawal by Subject|4|||
170881575|NCT01087905|617576125|FG002|Overall Study|Withdrawal by Subject|4|||
170881576|NCT01087905|617576126|FG003|Overall Study|Withdrawal by Subject|5|||
170881577|NCT01087905|617576127|FG004|Overall Study|Withdrawal by Subject|4|||
170881578|NCT01087905|617576128|FG005|Overall Study|Withdrawal by Subject|3|||
170881579|NCT01087905|617576129|FG006|Overall Study|Withdrawal by Subject|3|||
170881580|NCT01087905|617576130|FG007|Overall Study|Withdrawal by Subject|5|||
170881581|NCT00652366|617576141|FG000|Overall Study|Adverse Event|8|||
170881582|NCT00652366|617576142|FG001|Overall Study|Adverse Event|4|||
170881583|NCT00652366|617576143|FG002|Overall Study|Adverse Event|7|||
170881584|NCT00652366|617576144|FG003|Overall Study|Adverse Event|17|||
170881585|NCT00652366|617576145|FG004|Overall Study|Adverse Event|13|||
170779865|NCT04586920|617201217|FG014|Overall Study|Lost to Follow-up|0|||
170779866|NCT04586920|617201218|FG015|Overall Study|Lost to Follow-up|0|||
170779867|NCT04586920|617201219|FG016|Overall Study|Lost to Follow-up|0|||
170779868|NCT04586920|617201220|FG017|Overall Study|Lost to Follow-up|0|||
170779869|NCT04586920|617201203|FG000|Overall Study|Withdrawal by Subject|0|||
170779870|NCT04586920|617201204|FG001|Overall Study|Withdrawal by Subject|0|||
170779871|NCT04586920|617201205|FG002|Overall Study|Withdrawal by Subject|0|||
170779872|NCT04586920|617201206|FG003|Overall Study|Withdrawal by Subject|0|||
170779873|NCT04586920|617201207|FG004|Overall Study|Withdrawal by Subject|0|||
170779874|NCT04586920|617201208|FG005|Overall Study|Withdrawal by Subject|0|||
170881586|NCT00652366|617576141|FG000|Overall Study|Death|5|||
170881587|NCT00652366|617576142|FG001|Overall Study|Death|4|||
170881588|NCT00652366|617576143|FG002|Overall Study|Death|1|||
170881589|NCT00652366|617576144|FG003|Overall Study|Death|8|||
170881590|NCT00652366|617576145|FG004|Overall Study|Death|5|||
170881591|NCT00652366|617576141|FG000|Overall Study|Lack of Efficacy|84|||
170881592|NCT00652366|617576142|FG001|Overall Study|Lack of Efficacy|58|||
170881593|NCT00652366|617576143|FG002|Overall Study|Lack of Efficacy|53|||
170881594|NCT00652366|617576144|FG003|Overall Study|Lack of Efficacy|133|||
170881595|NCT00652366|617576145|FG004|Overall Study|Lack of Efficacy|13|||
170881596|NCT00652366|617576141|FG000|Overall Study|Violation of Selection Criteria|0|||
170881597|NCT00652366|617576142|FG001|Overall Study|Violation of Selection Criteria|0|||
170881598|NCT00652366|617576143|FG002|Overall Study|Violation of Selection Criteria|1|||
170881599|NCT00652366|617576144|FG003|Overall Study|Violation of Selection Criteria|0|||
170881600|NCT00652366|617576145|FG004|Overall Study|Violation of Selection Criteria|0|||
170881601|NCT00652366|617576141|FG000|Overall Study|Protocol Violation|1|||
170881602|NCT00652366|617576142|FG001|Overall Study|Protocol Violation|0|||
170881603|NCT00652366|617576143|FG002|Overall Study|Protocol Violation|0|||
170881604|NCT00652366|617576144|FG003|Overall Study|Protocol Violation|0|||
170881605|NCT00652366|617576145|FG004|Overall Study|Protocol Violation|0|||
170881606|NCT00652366|617576141|FG000|Overall Study|Refused treatment|3|||
170881607|NCT00652366|617576142|FG001|Overall Study|Refused treatment|7|||
170881608|NCT00652366|617576143|FG002|Overall Study|Refused treatment|6|||
170881609|NCT00652366|617576144|FG003|Overall Study|Refused treatment|17|||
170779875|NCT04586920|617201209|FG006|Overall Study|Withdrawal by Subject|0|||
170779876|NCT04586920|617201210|FG007|Overall Study|Withdrawal by Subject|1|||
170779877|NCT04586920|617201211|FG008|Overall Study|Withdrawal by Subject|0|||
170779878|NCT04586920|617201212|FG009|Overall Study|Withdrawal by Subject|1|||
170779879|NCT04586920|617201213|FG010|Overall Study|Withdrawal by Subject|0|||
170779880|NCT04586920|617201214|FG011|Overall Study|Withdrawal by Subject|1|||
170779881|NCT04586920|617201215|FG012|Overall Study|Withdrawal by Subject|0|||
170779882|NCT04586920|617201216|FG013|Overall Study|Withdrawal by Subject|0|||
170779883|NCT04586920|617201217|FG014|Overall Study|Withdrawal by Subject|0|||
170779884|NCT04586920|617201218|FG015|Overall Study|Withdrawal by Subject|0|||
170779885|NCT04586920|617201219|FG016|Overall Study|Withdrawal by Subject|0|||
170779886|NCT04586920|617201220|FG017|Overall Study|Withdrawal by Subject|0|||
170779887|NCT04905407|617201227|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
170779888|NCT04905407|617201228|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
170779889|NCT04905407|617201229|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
170779890|NCT04905407|617201230|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
170779891|NCT04905407|617201227|FG000|Part 1 and Part 2|Death|7|||
170779892|NCT04905407|617201228|FG001|Part 1 and Part 2|Death|7|||
170779893|NCT04905407|617201229|FG002|Part 1 and Part 2|Death|7|||
170779894|NCT04905407|617201230|FG003|Part 1 and Part 2|Death|0|||
170779895|NCT04905407|617201227|FG000|Part 1 and Part 2|Other than specified|0|||
170779896|NCT04905407|617201228|FG001|Part 1 and Part 2|Other than specified|0|||
170779897|NCT04905407|617201229|FG002|Part 1 and Part 2|Other than specified|1|||
170779898|NCT04905407|617201230|FG003|Part 1 and Part 2|Other than specified|0|||
170881610|NCT00652366|617576145|FG004|Overall Study|Refused treatment|5|||
170881611|NCT00652366|617576141|FG000|Overall Study|Other|5|||
170881612|NCT00652366|617576142|FG001|Overall Study|Other|2|||
170881613|NCT00652366|617576143|FG002|Overall Study|Other|3|||
170779899|NCT04905407|617201227|FG000|Part 3|Death|0|||
170881614|NCT00652366|617576144|FG003|Overall Study|Other|4|||
170881615|NCT00652366|617576145|FG004|Overall Study|Other|0|||
170881616|NCT01970501|617576146|FG000|Overall Study|Discontinuation of study by sponsor|16|||
170779900|NCT04905407|617201228|FG001|Part 3|Death|0|||
170779901|NCT04905407|617201229|FG002|Part 3|Death|0|||
170779902|NCT04905407|617201230|FG003|Part 3|Death|2|||
170779903|NCT05058391|617201231|FG000|Overall Study|Adverse Event|1|||
170779904|NCT03833245|617201232|FG000|Overall Study|Death|0|||
170779905|NCT03833245|617201233|FG001|Overall Study|Death|1|||
170779906|NCT03347383|617201234|FG000|Overall Study|Death|39|||
170881617|NCT01970501|617576147|FG001|Overall Study|Discontinuation of study by sponsor|14|||
170881618|NCT01970501|617576146|FG000|Overall Study|Withdrawal by Subject|6|||
170881619|NCT01970501|617576147|FG001|Overall Study|Withdrawal by Subject|7|||
170881620|NCT01970501|617576146|FG000|Overall Study|Adverse Event|2|||
170881621|NCT01970501|617576147|FG001|Overall Study|Adverse Event|4|||
170881622|NCT01970501|617576146|FG000|Overall Study|Death|1|||
170881623|NCT01970501|617576147|FG001|Overall Study|Death|3|||
170881624|NCT01970501|617576146|FG000|Overall Study|Physician Decision|2|||
170881625|NCT01970501|617576147|FG001|Overall Study|Physician Decision|0|||
170881626|NCT01181011|617576151|FG000|Overall Study|Adverse Event|2|||
170881627|NCT01181011|617576151|FG000|Overall Study|Lost to Follow-up|1|||
170881628|NCT00950664|617576152|FG000|First Intervention|Lost to Follow-up|1|||
170881629|NCT00950664|617576153|FG001|First Intervention|Lost to Follow-up|3|||
170536846|NCT03621592|616309596|FG001|Overall Study|Lost to Follow-up|0|||
170779907|NCT03347383|617201234|FG000|Overall Study|Withdrawal by Subject|3|||
170779908|NCT03347383|617201234|FG000|Overall Study|Lost to Follow-up|9|||
170779909|NCT05038566|617201236|FG000|Overall Study|Technical Difficulties with the Device|0|||
170779910|NCT05038566|617201237|FG001|Overall Study|Technical Difficulties with the Device|1|||
170779911|NCT00150813|617201241|FG000|Overall Study|Adverse Event|1|||
170779912|NCT00150813|617201241|FG000|Overall Study|Lack of Efficacy|1|||
170779913|NCT00150813|617201241|FG000|Overall Study|Lost to Follow-up|5|||
170779914|NCT00150813|617201241|FG000|Overall Study|Withdrawal by Subject|5|||
170779915|NCT00150813|617201241|FG000|Overall Study|Remission|3|||
170779916|NCT00150813|617201241|FG000|Overall Study|Planned pregancy|1|||
170779917|NCT00150813|617201241|FG000|Overall Study|Switch to commercially available LEV|2|||
170779918|NCT04737772|617201245|FG000|Phase 2 Study|Lost to Follow-up|15|||
170779919|NCT04737772|617201246|FG001|Phase 2 Study|Lost to Follow-up|15|||
170779920|NCT04737772|617201245|FG000|Phase 2 Study|Withdrawal by Subject|0|||
170779921|NCT04737772|617201246|FG001|Phase 2 Study|Withdrawal by Subject|1|||
170779922|NCT04737772|617201245|FG000|Phase 2 Study|Did not take any coaching calls|4|||
170779923|NCT04737772|617201246|FG001|Phase 2 Study|Did not take any coaching calls|0|||
170779924|NCT04737772|617201245|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
170779925|NCT04737772|617201246|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
170779926|NCT04737772|617201245|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
170779927|NCT04737772|617201246|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
170779928|NCT04048681|617201252|FG000|Overall Study|family emergency|0|||
170779929|NCT04048681|617201253|FG001|Overall Study|family emergency|0|||
170779930|NCT04048681|617201254|FG002|Overall Study|family emergency|0|||
170779931|NCT04048681|617201255|FG003|Overall Study|family emergency|1|||
170779932|NCT04048681|617201256|FG004|Overall Study|family emergency|0|||
170779933|NCT04579250|617201257|FG000|Overall Study|Withdrawal by Subject|1|||
170779934|NCT04579250|617201258|FG001|Overall Study|Withdrawal by Subject|1|||
170779935|NCT04579250|617201259|FG002|Overall Study|Withdrawal by Subject|0|||
170779936|NCT04579250|617201257|FG000|Overall Study|Lost to Follow-up|1|||
170779937|NCT04579250|617201258|FG001|Overall Study|Lost to Follow-up|1|||
170779938|NCT04579250|617201259|FG002|Overall Study|Lost to Follow-up|0|||
170779939|NCT04579250|617201257|FG000|Overall Study|Moved from area|0|||
170779940|NCT04579250|617201258|FG001|Overall Study|Moved from area|1|||
170779941|NCT04579250|617201259|FG002|Overall Study|Moved from area|2|||
170779942|NCT02919449|617201260|FG000|Overall Study|Withdrawal by Subject|1|||
170779943|NCT02919449|617201260|FG000|Overall Study|Investigator decision|1|||
170779944|NCT03446157|617201261|FG000|Overall Study|Death|11|||
170779945|NCT03446157|617201262|FG001|Overall Study|Death|9|||
170779946|NCT03446157|617201261|FG000|Overall Study|Lost to Follow-up|0|||
170779947|NCT03446157|617201262|FG001|Overall Study|Lost to Follow-up|1|||
170779948|NCT03446157|617201261|FG000|Overall Study|Withdrawal by Subject|2|||
170779949|NCT03446157|617201262|FG001|Overall Study|Withdrawal by Subject|1|||
170779950|NCT02386553|617201263|FG000|Overall Study|Reason Not Specified|1|||
170779951|NCT02386553|617201264|FG001|Overall Study|Reason Not Specified|1|||
170881630|NCT00950664|617576152|FG000|First Intervention|Withdrawal by Subject|2|||
170779952|NCT02386553|617201263|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
170779953|NCT02386553|617201264|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
170779954|NCT00411151|617201266|FG000|Overall Study|Death|38|||
170779955|NCT00411151|617201266|FG000|Overall Study|Withdrawal by Subject|2|||
170779956|NCT00411151|617201266|FG000|Overall Study|Lost to Follow-up|2|||
170779957|NCT00411151|617201266|FG000|Overall Study|Protocol Violation|1|||
170779958|NCT00411151|617201266|FG000|Overall Study|Trial prematurely closed|4|||
170779959|NCT01619410|617201270|FG000|Overall Study|Lost to Follow-up|7|||
170779960|NCT01619410|617201271|FG001|Overall Study|Lost to Follow-up|4|||
170779961|NCT00448669|617201286|FG000|Overall Study|Lost to Follow-up|52|||
170779962|NCT00448669|617201287|FG001|Overall Study|Lost to Follow-up|63|||
170779963|NCT00448669|617201286|FG000|Overall Study|Withdrawal by Subject|90|||
170779964|NCT00448669|617201287|FG001|Overall Study|Withdrawal by Subject|74|||
170779965|NCT00448669|617201286|FG000|Overall Study|Relocated|49|||
170779966|NCT00448669|617201287|FG001|Overall Study|Relocated|36|||
170779967|NCT00448669|617201286|FG000|Overall Study|Were withdrawn by investigator|10|||
170881631|NCT00950664|617576153|FG001|First Intervention|Withdrawal by Subject|2|||
170881632|NCT01326546|617576156|FG000|Overall Study|Lost to Follow-up|8|||
170779968|NCT00448669|617201287|FG001|Overall Study|Were withdrawn by investigator|6|||
170779969|NCT00448669|617201286|FG000|Overall Study|Death|2|||
170779970|NCT00448669|617201287|FG001|Overall Study|Death|4|||
170779971|NCT00448669|617201286|FG000|Overall Study|Had other reasons|5|||
170779972|NCT00448669|617201287|FG001|Overall Study|Had other reasons|6|||
170779973|NCT00448669|617201286|FG000|Overall Study|HIV-infected at enrollment|1|||
170779974|NCT00448669|617201287|FG001|Overall Study|HIV-infected at enrollment|2|||
170779975|NCT00448669|617201286|FG000|Overall Study|Never started drug|9|||
170779976|NCT00448669|617201287|FG001|Overall Study|Never started drug|7|||
170779977|NCT04287985|617201288|FG000|Overall Study|Adverse Event|1|||
170779978|NCT04287985|617201289|FG001|Overall Study|Adverse Event|0|||
170779979|NCT04287985|617201290|FG002|Overall Study|Adverse Event|0|||
170779980|NCT04287985|617201291|FG003|Overall Study|Adverse Event|0|||
170779981|NCT04287985|617201288|FG000|Overall Study|Protocol Violation|0|||
170779982|NCT04287985|617201289|FG001|Overall Study|Protocol Violation|1|||
170779983|NCT04287985|617201290|FG002|Overall Study|Protocol Violation|0|||
170779984|NCT04287985|617201291|FG003|Overall Study|Protocol Violation|0|||
170779985|NCT04287985|617201288|FG000|Overall Study|Physician Decision|0|||
170779986|NCT04287985|617201289|FG001|Overall Study|Physician Decision|0|||
170779987|NCT04287985|617201290|FG002|Overall Study|Physician Decision|0|||
170779988|NCT04287985|617201291|FG003|Overall Study|Physician Decision|1|||
170779989|NCT04287985|617201288|FG000|Overall Study|Withdrawal by Subject|2|||
170779990|NCT04287985|617201289|FG001|Overall Study|Withdrawal by Subject|1|||
170779991|NCT04287985|617201290|FG002|Overall Study|Withdrawal by Subject|1|||
170779992|NCT04287985|617201291|FG003|Overall Study|Withdrawal by Subject|2|||
170779993|NCT02638337|617201292|FG000|Overall Study|Adverse Event|6|||
170779994|NCT02638337|617201293|FG001|Overall Study|Adverse Event|10|||
170779995|NCT02638337|617201292|FG000|Overall Study|Protocol Violation|3|||
170779996|NCT02638337|617201293|FG001|Overall Study|Protocol Violation|0|||
170779997|NCT02638337|617201292|FG000|Overall Study|Withdrawal by Subject|13|||
170779998|NCT02638337|617201293|FG001|Overall Study|Withdrawal by Subject|16|||
170779999|NCT02638337|617201292|FG000|Overall Study|Lost to Follow-up|7|||
170780000|NCT02638337|617201293|FG001|Overall Study|Lost to Follow-up|7|||
170780001|NCT02638337|617201292|FG000|Overall Study|Other - Miscellaneous|4|||
170780002|NCT02638337|617201293|FG001|Overall Study|Other - Miscellaneous|3|||
170780003|NCT02789020|617201294|FG000|Overall Study|Withdrawal by Subject|6|||
170780004|NCT02789020|617201295|FG001|Overall Study|Withdrawal by Subject|5|||
170780005|NCT03771352|617201298|FG000|Overall Study|Screen failure|2|||
170780006|NCT03771352|617201298|FG000|Overall Study|Withdrawal by Subject|2|||
170780007|NCT03517969|617201304|FG000|Overall Study|Never started protocol treatment|3|||
170780008|NCT03517969|617201305|FG001|Overall Study|Never started protocol treatment|5|||
170780009|NCT03517969|617201304|FG000|Overall Study|Disease progression|11|||
170780010|NCT03517969|617201305|FG001|Overall Study|Disease progression|16|||
170780011|NCT03517969|617201304|FG000|Overall Study|PSA progression|8|||
170780012|NCT03517969|617201305|FG001|Overall Study|PSA progression|1|||
170780013|NCT03517969|617201304|FG000|Overall Study|Clinical progression|4|||
170780014|NCT03517969|617201305|FG001|Overall Study|Clinical progression|2|||
170780015|NCT03517969|617201304|FG000|Overall Study|Adverse Event|5|||
170780016|NCT03517969|617201305|FG001|Overall Study|Adverse Event|4|||
170780017|NCT03517969|617201304|FG000|Overall Study|Intercurrent illness|1|||
170780018|NCT03517969|617201305|FG001|Overall Study|Intercurrent illness|2|||
170780019|NCT03517969|617201304|FG000|Overall Study|Death|1|||
170780020|NCT03517969|617201305|FG001|Overall Study|Death|1|||
170780021|NCT03517969|617201304|FG000|Overall Study|Withdrawal by Subject|1|||
170780022|NCT03517969|617201305|FG001|Overall Study|Withdrawal by Subject|2|||
170780023|NCT03517969|617201304|FG000|Overall Study|Physician Decision|1|||
170780024|NCT03517969|617201305|FG001|Overall Study|Physician Decision|1|||
170780025|NCT03517969|617201304|FG000|Overall Study|No clinical benefit|1|||
170780026|NCT03517969|617201305|FG001|Overall Study|No clinical benefit|0|||
170780027|NCT03517969|617201304|FG000|Overall Study|Delayed treatment for dental treatment|1|||
170780028|NCT03517969|617201305|FG001|Overall Study|Delayed treatment for dental treatment|0|||
170881633|NCT01326546|617576157|FG001|Overall Study|Lost to Follow-up|7|||
170881634|NCT01326546|617576156|FG000|Overall Study|Protocol Violation|3|||
170536847|NCT03621592|616309595|FG000|Overall Study|Lack of Improvement|1|||
170780029|NCT03517969|617201304|FG000|Overall Study|Difficult to maintain appointment|0|||
170780030|NCT03517969|617201305|FG001|Overall Study|Difficult to maintain appointment|1|||
170780031|NCT03517969|617201304|FG000|Overall Study|Protocol Violation|0|||
170780032|NCT03517969|617201305|FG001|Overall Study|Protocol Violation|1|||
170780033|NCT05782231|617201306|FG000|Overall Study|Withdrawal by Subject|1|||
170780034|NCT03830866|617201307|FG000|Overall Study|Death|90|||
170780035|NCT03830866|617201308|FG001|Overall Study|Death|111|||
170780036|NCT03830866|617201307|FG000|Overall Study|Lost to Follow-up|7|||
170780037|NCT03830866|617201308|FG001|Overall Study|Lost to Follow-up|7|||
170780038|NCT03830866|617201307|FG000|Overall Study|Withdrawal by Subject|19|||
170780039|NCT03830866|617201308|FG001|Overall Study|Withdrawal by Subject|16|||
170881635|NCT01326546|617576157|FG001|Overall Study|Protocol Violation|4|||
170780040|NCT03830866|617201307|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
170881636|NCT01326546|617576156|FG000|Overall Study|Pregnancy|0|||
170434679|NCT02054715|615928732|FG001|Follow-up 2|Hospitalization|2|||
170434680|NCT02054715|615928731|FG000|Follow-up 2|Changed MD/Facility|0|||
170434681|NCT02054715|615928732|FG001|Follow-up 2|Changed MD/Facility|1|||
170780041|NCT03830866|617201308|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
170780042|NCT03830866|617201307|FG000|Overall Study|Other|1|||
170780043|NCT03830866|617201308|FG001|Overall Study|Other|1|||
170780044|NCT00136435|617201309|FG000|Overall Study|Ineligible|8|||
170780045|NCT00136435|617201309|FG000|Overall Study|Induction Death|1|||
170780046|NCT00136435|617201309|FG000|Overall Study|Induction Failure|10|||
170780047|NCT00136435|617201309|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
170780048|NCT00136435|617201309|FG000|Overall Study|Withdrawal by Subject|3|||
170780049|NCT00136435|617201309|FG000|Overall Study|Adverse Event|19|||
170780050|NCT00136435|617201309|FG000|Overall Study|Relapse|4|||
170780051|NCT00136435|617201309|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
170780052|NCT02814838|617201310|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
170780053|NCT02814838|617201311|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
170780054|NCT02814838|617201310|FG000|Overall Study|Consent withdrawal|1|||
170780055|NCT02814838|617201311|FG001|Overall Study|Consent withdrawal|1|||
170780056|NCT01747486|617201312|FG000|Stage 1|Physician Decision|3|||
170780057|NCT01747486|617201313|FG001|Stage 1|Physician Decision|0|||
170780058|NCT01747486|617201312|FG000|Stage 1|Withdrawal by Subject|4|||
170780059|NCT01747486|617201313|FG001|Stage 1|Withdrawal by Subject|3|||
170780060|NCT01747486|617201312|FG000|Stage 1|Disease progression|4|||
170780061|NCT01747486|617201313|FG001|Stage 1|Disease progression|9|||
170780062|NCT01747486|617201312|FG000|Stage 1|Death|1|||
170780063|NCT01747486|617201313|FG001|Stage 1|Death|1|||
170780064|NCT01747486|617201312|FG000|Stage 2|Physician Decision|2|||
170780065|NCT01747486|617201313|FG001|Stage 2|Physician Decision|0|||
170780066|NCT01747486|617201312|FG000|Stage 2|Withdrawal by Subject|1|||
170780067|NCT01747486|617201313|FG001|Stage 2|Withdrawal by Subject|0|||
170780068|NCT01747486|617201312|FG000|Stage 2|New Cancer Therapy|3|||
170780069|NCT01747486|617201313|FG001|Stage 2|New Cancer Therapy|0|||
170780070|NCT01747486|617201312|FG000|Stage 2|Disease Progression|3|||
170780071|NCT01747486|617201313|FG001|Stage 2|Disease Progression|0|||
170780072|NCT00073749|617201314|FG000|Overall Study|Disease Progression|2|||
170780073|NCT00073749|617201315|FG001|Overall Study|Disease Progression|0|||
170780074|NCT00073749|617201316|FG002|Overall Study|Disease Progression|3|||
170780075|NCT00073749|617201317|FG003|Overall Study|Disease Progression|2|||
170780076|NCT00073749|617201318|FG004|Overall Study|Disease Progression|3|||
170780077|NCT00073749|617201319|FG005|Overall Study|Disease Progression|1|||
170780078|NCT00073749|617201320|FG006|Overall Study|Disease Progression|3|||
170780079|NCT00073749|617201314|FG000|Overall Study|Death|0|||
170780080|NCT00073749|617201315|FG001|Overall Study|Death|1|||
170780081|NCT00073749|617201316|FG002|Overall Study|Death|1|||
170780082|NCT00073749|617201317|FG003|Overall Study|Death|0|||
170780083|NCT00073749|617201318|FG004|Overall Study|Death|0|||
170780084|NCT00073749|617201319|FG005|Overall Study|Death|0|||
170780085|NCT00073749|617201320|FG006|Overall Study|Death|29|||
170780086|NCT00073749|617201314|FG000|Overall Study|Adverse Event|0|||
170780087|NCT00073749|617201315|FG001|Overall Study|Adverse Event|3|||
170780088|NCT00073749|617201316|FG002|Overall Study|Adverse Event|6|||
170780089|NCT00073749|617201317|FG003|Overall Study|Adverse Event|4|||
170780090|NCT00073749|617201318|FG004|Overall Study|Adverse Event|2|||
170780091|NCT00073749|617201319|FG005|Overall Study|Adverse Event|1|||
170780092|NCT00073749|617201320|FG006|Overall Study|Adverse Event|0|||
170780093|NCT00073749|617201314|FG000|Overall Study|Physician Decision|0|||
170780094|NCT00073749|617201315|FG001|Overall Study|Physician Decision|0|||
170780095|NCT00073749|617201316|FG002|Overall Study|Physician Decision|1|||
170780096|NCT00073749|617201317|FG003|Overall Study|Physician Decision|0|||
170780097|NCT00073749|617201318|FG004|Overall Study|Physician Decision|0|||
170780098|NCT00073749|617201319|FG005|Overall Study|Physician Decision|2|||
170780099|NCT00073749|617201320|FG006|Overall Study|Physician Decision|0|||
170780100|NCT00073749|617201314|FG000|Overall Study|Withdrawal by Subject|0|||
170780101|NCT00073749|617201315|FG001|Overall Study|Withdrawal by Subject|1|||
170780102|NCT00073749|617201316|FG002|Overall Study|Withdrawal by Subject|0|||
170780103|NCT00073749|617201317|FG003|Overall Study|Withdrawal by Subject|0|||
170780104|NCT00073749|617201318|FG004|Overall Study|Withdrawal by Subject|1|||
170780105|NCT00073749|617201319|FG005|Overall Study|Withdrawal by Subject|0|||
170780106|NCT00073749|617201320|FG006|Overall Study|Withdrawal by Subject|2|||
170434682|NCT02054715|615928731|FG000|Follow-up 2|Changed Mind|0|||
170780107|NCT00073749|617201314|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
170780108|NCT00073749|617201315|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
170780109|NCT00073749|617201316|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
170780110|NCT00073749|617201317|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
170780111|NCT00073749|617201318|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
170780112|NCT00073749|617201319|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
170780113|NCT00073749|617201320|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
170780114|NCT00073749|617201314|FG000|Overall Study|Lost to Follow-up|0|||
170780115|NCT00073749|617201315|FG001|Overall Study|Lost to Follow-up|0|||
170881637|NCT01326546|617576157|FG001|Overall Study|Pregnancy|1|||
170881638|NCT01326546|617576156|FG000|Overall Study|Adverse Event|1|||
170881639|NCT01326546|617576157|FG001|Overall Study|Adverse Event|0|||
170881640|NCT01326546|617576156|FG000|Overall Study|Withdrawal by Subject|5|||
170881641|NCT01326546|617576157|FG001|Overall Study|Withdrawal by Subject|1|||
170881642|NCT03152019|617576158|FG000|Overall Study|Adverse Event|0|||
170881643|NCT03152019|617576159|FG001|Overall Study|Adverse Event|1|||
170434683|NCT02054715|615928732|FG001|Follow-up 2|Changed Mind|1|||
170434684|NCT02054715|615928731|FG000|Follow-up 2|No Reason|2|||
170434685|NCT02054715|615928732|FG001|Follow-up 2|No Reason|0|||
170434686|NCT02054715|615928731|FG000|Follow-up 2|Treatment Change or Delay|1|||
170536848|NCT03621592|616309596|FG001|Overall Study|Lack of Improvement|0|||
170881644|NCT04294719|617576160|FG000|Overall Study|Withdrawal by Subject|1|||
170881645|NCT04703075|617576161|FG000|Overall Study|Adverse Event|11|||
170881646|NCT04703075|617576162|FG001|Overall Study|Adverse Event|7|||
170881647|NCT04703075|617576161|FG000|Overall Study|Lost to Follow-up|6|||
170881648|NCT04703075|617576162|FG001|Overall Study|Lost to Follow-up|12|||
170881649|NCT04703075|617576161|FG000|Overall Study|Physician Decision|3|||
170881650|NCT04703075|617576162|FG001|Overall Study|Physician Decision|0|||
170881651|NCT04703075|617576161|FG000|Overall Study|Moved|0|||
170881652|NCT04703075|617576162|FG001|Overall Study|Moved|2|||
170881653|NCT04703075|617576161|FG000|Overall Study|Index INH Resistant|0|||
170881654|NCT04703075|617576162|FG001|Overall Study|Index INH Resistant|1|||
170881655|NCT04703075|617576161|FG000|Overall Study|Lack of Efficacy|6|||
170881656|NCT04703075|617576162|FG001|Overall Study|Lack of Efficacy|18|||
170881657|NCT00081159|617576165|FG000|Overall Study|Withdrawal by Subject|0|||
170881658|NCT00081159|617576166|FG001|Overall Study|Withdrawal by Subject|3|||
170881659|NCT00081159|617576165|FG000|Overall Study|Myelosuppression prior to treatment|0|||
170881660|NCT00081159|617576166|FG001|Overall Study|Myelosuppression prior to treatment|1|||
170881661|NCT00081159|617576165|FG000|Overall Study|Lost to Follow-up|2|||
170881662|NCT00081159|617576166|FG001|Overall Study|Lost to Follow-up|1|||
170881663|NCT00923130|617576167|FG000|Overall Study|Stopped treatment due to progression|17|||
170881664|NCT00923130|617576167|FG000|Overall Study|Death|1|||
170881665|NCT00923130|617576167|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
170881666|NCT00923130|617576167|FG000|Overall Study|Switched to alternative treatment|2|||
170881667|NCT00923130|617576167|FG000|Overall Study|Refused further treatment|2|||
170881668|NCT00788372|617576168|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
170881669|NCT00788372|617576168|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
170881670|NCT00788372|617576168|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
170881671|NCT00788372|617576168|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
170881672|NCT00788372|617576168|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
170881673|NCT00788372|617576168|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
170881674|NCT00788372|617576168|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
170881675|NCT01187953|617576169|FG000|Overall Study|Death|11|||
170881676|NCT01187953|617576170|FG001|Overall Study|Death|13|||
170881677|NCT01187953|617576169|FG000|Overall Study|Adverse Event|1|||
170881678|NCT01187953|617576170|FG001|Overall Study|Adverse Event|2|||
170881679|NCT01187953|617576169|FG000|Overall Study|Lost to Follow-up|0|||
170881680|NCT01187953|617576170|FG001|Overall Study|Lost to Follow-up|3|||
170881681|NCT01187953|617576169|FG000|Overall Study|Withdrawal by Subject|3|||
170881682|NCT01187953|617576170|FG001|Overall Study|Withdrawal by Subject|3|||
170881683|NCT01806779|617576177|FG000|Overall Study|Physician Decision|2|||
170881684|NCT01806779|617576178|FG001|Overall Study|Physician Decision|0|||
170881685|NCT01806779|617576179|FG002|Overall Study|Physician Decision|1|||
170881686|NCT01806779|617576177|FG000|Overall Study|Lack of Efficacy|1|||
170881687|NCT01806779|617576178|FG001|Overall Study|Lack of Efficacy|1|||
170881688|NCT01806779|617576179|FG002|Overall Study|Lack of Efficacy|0|||
170881689|NCT01806779|617576177|FG000|Overall Study|Lost to Follow-up|19|||
170881690|NCT01806779|617576178|FG001|Overall Study|Lost to Follow-up|20|||
170881691|NCT01806779|617576179|FG002|Overall Study|Lost to Follow-up|0|||
170536849|NCT03621592|616309595|FG000|Overall Study|Preference to receive wound care closer to home|1|||
170536850|NCT03621592|616309596|FG001|Overall Study|Preference to receive wound care closer to home|0|||
170536851|NCT03621592|616309595|FG000|Overall Study|Lack of healing|0|||
170536852|NCT03621592|616309596|FG001|Overall Study|Lack of healing|2|||
170536853|NCT03672929|616309597|FG000|Overall Study|Death|13|||
170536854|NCT03672929|616309597|FG000|Overall Study|Lost to Follow-up|32|||
170536855|NCT03672929|616309597|FG000|Overall Study|Withdrawal by Subject|18|||
170881692|NCT01806779|617576177|FG000|Overall Study|Withdrawal by Subject|20|||
170881693|NCT01806779|617576178|FG001|Overall Study|Withdrawal by Subject|23|||
170881694|NCT01806779|617576179|FG002|Overall Study|Withdrawal by Subject|22|||
170881695|NCT00805480|617576180|FG000|Overall Study|Withdrawal by Subject|13|||
170881696|NCT00805480|617576181|FG001|Overall Study|Withdrawal by Subject|5|||
170881697|NCT00805480|617576182|FG002|Overall Study|Withdrawal by Subject|11|||
170881698|NCT00805480|617576183|FG003|Overall Study|Withdrawal by Subject|5|||
170881699|NCT00805480|617576180|FG000|Overall Study|Lost to Follow-up|1|||
170881700|NCT00805480|617576181|FG001|Overall Study|Lost to Follow-up|2|||
170881701|NCT00805480|617576182|FG002|Overall Study|Lost to Follow-up|0|||
170881702|NCT00805480|617576183|FG003|Overall Study|Lost to Follow-up|0|||
170881703|NCT00805480|617576180|FG000|Overall Study|Adverse Event|0|||
170881704|NCT00805480|617576181|FG001|Overall Study|Adverse Event|0|||
170881705|NCT00805480|617576182|FG002|Overall Study|Adverse Event|1|||
170881706|NCT00805480|617576183|FG003|Overall Study|Adverse Event|0|||
170881707|NCT03077685|617576186|FG000|Overall Study|Lost to Follow-up|0|||
170881708|NCT03077685|617576187|FG001|Overall Study|Lost to Follow-up|0|||
170881709|NCT03077685|617576188|FG002|Overall Study|Lost to Follow-up|0|||
170881710|NCT03077685|617576189|FG003|Overall Study|Lost to Follow-up|0|||
170881711|NCT03077685|617576190|FG004|Overall Study|Lost to Follow-up|1|||
170881712|NCT03077685|617576186|FG000|Overall Study|Death|0|||
170881713|NCT03077685|617576187|FG001|Overall Study|Death|0|||
170881714|NCT03077685|617576188|FG002|Overall Study|Death|1|||
170881715|NCT03077685|617576189|FG003|Overall Study|Death|1|||
170881716|NCT03077685|617576190|FG004|Overall Study|Death|3|||
170881717|NCT03077685|617576186|FG000|Overall Study|Withdrawal by Subject|0|||
170881718|NCT03077685|617576187|FG001|Overall Study|Withdrawal by Subject|0|||
170881719|NCT03077685|617576188|FG002|Overall Study|Withdrawal by Subject|0|||
170881720|NCT03077685|617576189|FG003|Overall Study|Withdrawal by Subject|2|||
170881721|NCT03077685|617576190|FG004|Overall Study|Withdrawal by Subject|1|||
170881722|NCT03077685|617576186|FG000|Overall Study|Physician Decision|0|||
170881723|NCT03077685|617576187|FG001|Overall Study|Physician Decision|0|||
170881724|NCT03077685|617576188|FG002|Overall Study|Physician Decision|1|||
170881725|NCT03077685|617576189|FG003|Overall Study|Physician Decision|0|||
170881726|NCT03077685|617576190|FG004|Overall Study|Physician Decision|3|||
170881727|NCT03077685|617576186|FG000|Overall Study|Disease Progression|1|||
170881728|NCT03077685|617576187|FG001|Overall Study|Disease Progression|0|||
170881729|NCT03077685|617576188|FG002|Overall Study|Disease Progression|0|||
170881730|NCT03077685|617576189|FG003|Overall Study|Disease Progression|2|||
170881731|NCT03077685|617576190|FG004|Overall Study|Disease Progression|1|||
170881732|NCT03077685|617576186|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
170881733|NCT03077685|617576187|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
170881734|NCT03077685|617576188|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
170881735|NCT03077685|617576189|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
170881736|NCT03077685|617576190|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
170881737|NCT03077685|617576186|FG000|Overall Study|Subject entered hospice care|0|||
170881738|NCT03077685|617576187|FG001|Overall Study|Subject entered hospice care|0|||
170881739|NCT03077685|617576188|FG002|Overall Study|Subject entered hospice care|0|||
170881740|NCT03077685|617576189|FG003|Overall Study|Subject entered hospice care|0|||
170881741|NCT03077685|617576190|FG004|Overall Study|Subject entered hospice care|1|||
170881742|NCT02116777|617576191|FG000|Overall Study|Adverse Event|0|||
170780116|NCT00073749|617201316|FG002|Overall Study|Lost to Follow-up|0|||
170780117|NCT00073749|617201317|FG003|Overall Study|Lost to Follow-up|0|||
170780118|NCT00073749|617201318|FG004|Overall Study|Lost to Follow-up|0|||
170780119|NCT00073749|617201319|FG005|Overall Study|Lost to Follow-up|0|||
170780120|NCT00073749|617201320|FG006|Overall Study|Lost to Follow-up|2|||
170780121|NCT00073749|617201314|FG000|Overall Study|Other|0|||
170780122|NCT00073749|617201315|FG001|Overall Study|Other|0|||
170780123|NCT00073749|617201316|FG002|Overall Study|Other|0|||
170780124|NCT00073749|617201317|FG003|Overall Study|Other|0|||
170780125|NCT00073749|617201318|FG004|Overall Study|Other|0|||
170780126|NCT00073749|617201319|FG005|Overall Study|Other|2|||
170780127|NCT00073749|617201320|FG006|Overall Study|Other|0|||
170780128|NCT02272816|617201321|FG000|Overall Study|Adverse Event|1|||
170780129|NCT04377308|617201323|FG000|Overall Study|Withdrawal by Subject|0|||
170780130|NCT04377308|617201324|FG001|Overall Study|Withdrawal by Subject|1|||
170780131|NCT02759016|617201325|FG000|Overall Study|Not treated with BI 836826|1|||
170780132|NCT02759016|617201326|FG001|Overall Study|Not treated with BI 836826|0|||
170780133|NCT02759016|617201325|FG000|Overall Study|Progressive disease|1|||
170780134|NCT02759016|617201326|FG001|Overall Study|Progressive disease|0|||
170780135|NCT02759016|617201325|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
170780136|NCT02759016|617201326|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
170780137|NCT02759016|617201325|FG000|Overall Study|Other not defined above|2|||
170780138|NCT02759016|617201326|FG001|Overall Study|Other not defined above|1|||
170780139|NCT01494922|617201327|FG000|Overall Study|Adverse Event|1|||
170780140|NCT01094184|617201328|FG000|Overall Study|Death|35|||
170780141|NCT01094184|617201329|FG001|Overall Study|Death|11|||
170780142|NCT03988842|617201334|FG000|Overall Study|Death|1|||
170780143|NCT04766034|617201337|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
170780144|NCT04766034|617201338|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
170780145|NCT04766034|617201339|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
170780146|NCT04766034|617201340|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
170780147|NCT04766034|617201341|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
170780148|NCT04766034|617201337|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
170780149|NCT04766034|617201338|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
170780150|NCT04766034|617201339|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
170780151|NCT04766034|617201340|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
170780152|NCT04766034|617201341|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
170780153|NCT04766034|617201337|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
170780154|NCT04766034|617201338|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
170780155|NCT04766034|617201339|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
170780156|NCT04766034|617201340|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
170780157|NCT04766034|617201341|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
170780158|NCT04766034|617201337|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
170780159|NCT04766034|617201338|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
170780160|NCT04766034|617201339|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
170780161|NCT04766034|617201340|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
170780162|NCT04766034|617201341|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
170780163|NCT04048382|617201347|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
170780164|NCT04048382|617201348|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
170780165|NCT04048382|617201347|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
170780166|NCT04048382|617201348|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
170780167|NCT04048382|617201347|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
170780168|NCT04048382|617201348|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
170780169|NCT00709098|617201351|FG000|Double-blind Period|Withdrawal of consent|3|||
170780170|NCT00709098|617201352|FG001|Double-blind Period|Withdrawal of consent|3|||
170780171|NCT00709098|617201353|FG002|Double-blind Period|Withdrawal of consent|0|||
170780172|NCT00709098|617201351|FG000|Double-blind Period|Administrative reason|1|||
170780173|NCT00709098|617201352|FG001|Double-blind Period|Administrative reason|3|||
170780174|NCT00709098|617201353|FG002|Double-blind Period|Administrative reason|0|||
170780175|NCT00709098|617201351|FG000|Double-blind Period|Death|1|||
170780176|NCT00709098|617201352|FG001|Double-blind Period|Death|1|||
170780177|NCT00709098|617201353|FG002|Double-blind Period|Death|0|||
170780178|NCT00709098|617201351|FG000|Double-blind Period|Lost to Follow-up|1|||
170780179|NCT00709098|617201352|FG001|Double-blind Period|Lost to Follow-up|1|||
170780180|NCT00709098|617201353|FG002|Double-blind Period|Lost to Follow-up|0|||
170780181|NCT00709098|617201351|FG000|Open-label Period|Withdrawal of consent|0|||
170780182|NCT00709098|617201352|FG001|Open-label Period|Withdrawal of consent|0|||
170881743|NCT02116777|617576192|FG001|Overall Study|Adverse Event|0|||
170881744|NCT02116777|617576193|FG002|Overall Study|Adverse Event|0|||
170881745|NCT02116777|617576194|FG003|Overall Study|Adverse Event|0|||
170881746|NCT02116777|617576195|FG004|Overall Study|Adverse Event|2|||
170881747|NCT02116777|617576196|FG005|Overall Study|Adverse Event|2|||
170881748|NCT02116777|617576197|FG006|Overall Study|Adverse Event|0|||
170881749|NCT02116777|617576191|FG000|Overall Study|Death|0|||
170881750|NCT02116777|617576192|FG001|Overall Study|Death|0|||
170881751|NCT02116777|617576193|FG002|Overall Study|Death|0|||
170881752|NCT02116777|617576194|FG003|Overall Study|Death|1|||
170881753|NCT02116777|617576195|FG004|Overall Study|Death|0|||
170881754|NCT02116777|617576196|FG005|Overall Study|Death|0|||
170881755|NCT02116777|617576197|FG006|Overall Study|Death|0|||
170881756|NCT02116777|617576191|FG000|Overall Study|Lack of Efficacy|3|||
170881757|NCT02116777|617576192|FG001|Overall Study|Lack of Efficacy|3|||
170881758|NCT02116777|617576193|FG002|Overall Study|Lack of Efficacy|3|||
170881759|NCT02116777|617576194|FG003|Overall Study|Lack of Efficacy|8|||
170881760|NCT02116777|617576195|FG004|Overall Study|Lack of Efficacy|4|||
170881761|NCT02116777|617576196|FG005|Overall Study|Lack of Efficacy|1|||
170881762|NCT02116777|617576197|FG006|Overall Study|Lack of Efficacy|9|||
170881763|NCT02116777|617576191|FG000|Overall Study|Physician Decision|0|||
170881764|NCT02116777|617576192|FG001|Overall Study|Physician Decision|0|||
170881765|NCT02116777|617576193|FG002|Overall Study|Physician Decision|0|||
170881766|NCT02116777|617576194|FG003|Overall Study|Physician Decision|2|||
170881767|NCT02116777|617576195|FG004|Overall Study|Physician Decision|0|||
170881768|NCT02116777|617576196|FG005|Overall Study|Physician Decision|0|||
170881769|NCT02116777|617576197|FG006|Overall Study|Physician Decision|0|||
170881770|NCT02116777|617576191|FG000|Overall Study|Protocol Violation|0|||
170881771|NCT02116777|617576192|FG001|Overall Study|Protocol Violation|0|||
170881772|NCT02116777|617576193|FG002|Overall Study|Protocol Violation|0|||
170881773|NCT02116777|617576194|FG003|Overall Study|Protocol Violation|1|||
170881774|NCT02116777|617576195|FG004|Overall Study|Protocol Violation|0|||
170881775|NCT02116777|617576196|FG005|Overall Study|Protocol Violation|0|||
170881776|NCT02116777|617576197|FG006|Overall Study|Protocol Violation|0|||
170881777|NCT02116777|617576191|FG000|Overall Study|Withdrawal by Subject|0|||
170881778|NCT02116777|617576192|FG001|Overall Study|Withdrawal by Subject|0|||
170881779|NCT02116777|617576193|FG002|Overall Study|Withdrawal by Subject|0|||
170881780|NCT02116777|617576194|FG003|Overall Study|Withdrawal by Subject|1|||
170881781|NCT02116777|617576195|FG004|Overall Study|Withdrawal by Subject|0|||
170881782|NCT02116777|617576196|FG005|Overall Study|Withdrawal by Subject|0|||
170881783|NCT02116777|617576197|FG006|Overall Study|Withdrawal by Subject|0|||
170881784|NCT05032157|617577525|FG000|Overall Study|Adverse Event|12|||
170881785|NCT05032157|617577526|FG001|Overall Study|Adverse Event|7|||
170881786|NCT05032157|617577525|FG000|Overall Study|Pregnancy|0|||
170881787|NCT05032157|617577526|FG001|Overall Study|Pregnancy|2|||
170881788|NCT05032157|617577525|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170881789|NCT05032157|617577526|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
170881790|NCT05032157|617577525|FG000|Overall Study|Protocol Deviation|8|||
170881791|NCT05032157|617577526|FG001|Overall Study|Protocol Deviation|4|||
170881792|NCT05032157|617577525|FG000|Overall Study|Lost to Follow-up|1|||
170881793|NCT05032157|617577526|FG001|Overall Study|Lost to Follow-up|3|||
170881794|NCT05032157|617577525|FG000|Overall Study|Physician Decision|7|||
170881795|NCT05032157|617577526|FG001|Overall Study|Physician Decision|2|||
170881796|NCT05032157|617577525|FG000|Overall Study|Patient Decision|38|||
170881797|NCT05032157|617577526|FG001|Overall Study|Patient Decision|19|||
170881798|NCT00880893|617577530|FG000|Overall Study|Protocol Violation|13|||
170881799|NCT00880893|617577531|FG001|Overall Study|Protocol Violation|1|||
170881800|NCT00880893|617577530|FG000|Overall Study|Withdrawal by Subject|15|||
170881801|NCT00880893|617577531|FG001|Overall Study|Withdrawal by Subject|11|||
170881802|NCT00880893|617577530|FG000|Overall Study|Lost to Follow-up|76|||
170881803|NCT00880893|617577531|FG001|Overall Study|Lost to Follow-up|33|||
170881804|NCT00880893|617577530|FG000|Overall Study|Serious adverse event|3|||
170881805|NCT00880893|617577531|FG001|Overall Study|Serious adverse event|0|||
170881806|NCT01042600|617577532|FG000|Overall Study|Ineligible|1|||
170881807|NCT01042600|617577533|FG001|Overall Study|Ineligible|0|||
170881808|NCT02229552|617577536|FG000|Baseline|Withdrawal by Subject|6|||
170881809|NCT02229552|617577536|FG000|1-year Follow up|Withdrawal by Subject|7|||
170881810|NCT02229552|617577536|FG000|1-year Follow up|Lost to Follow-up|18|||
170881811|NCT02229552|617577536|FG000|2-Year Follow up|Withdrawal by Subject|9|||
170881812|NCT02229552|617577536|FG000|2-Year Follow up|Lost to Follow-up|17|||
170881813|NCT00706134|617577541|FG000|Overall Study|Adverse Event|8|||
170881814|NCT00706134|617577542|FG001|Overall Study|Adverse Event|7|||
170881815|NCT00706134|617577543|FG002|Overall Study|Adverse Event|2|||
170881816|NCT00706134|617577544|FG003|Overall Study|Adverse Event|3|||
170881817|NCT00706134|617577541|FG000|Overall Study|Lost to Follow-up|0|||
170881818|NCT00706134|617577542|FG001|Overall Study|Lost to Follow-up|1|||
170881819|NCT00706134|617577543|FG002|Overall Study|Lost to Follow-up|0|||
170881820|NCT00706134|617577544|FG003|Overall Study|Lost to Follow-up|0|||
170881821|NCT00706134|617577541|FG000|Overall Study|Protocol Violation|0|||
170881822|NCT00706134|617577542|FG001|Overall Study|Protocol Violation|6|||
170881823|NCT00706134|617577543|FG002|Overall Study|Protocol Violation|0|||
170536856|NCT03672929|616309597|FG000|Overall Study|Adverse Event|3|||
170536857|NCT03672929|616309597|FG000|Overall Study|Surgery with the device never took place|3|||
170536858|NCT03672929|616309597|FG000|Overall Study|Inactive site|30|||
170780183|NCT00709098|617201353|FG002|Open-label Period|Withdrawal of consent|7|||
170780184|NCT00709098|617201351|FG000|Open-label Period|Administrative reason|0|||
170780185|NCT00709098|617201352|FG001|Open-label Period|Administrative reason|0|||
170780186|NCT00709098|617201353|FG002|Open-label Period|Administrative reason|5|||
170780187|NCT00709098|617201351|FG000|Open-label Period|Death|0|||
170780188|NCT00709098|617201352|FG001|Open-label Period|Death|0|||
170780189|NCT00709098|617201353|FG002|Open-label Period|Death|1|||
170780190|NCT00709098|617201351|FG000|Open-label Period|Lost to Follow-up|0|||
170780191|NCT00709098|617201352|FG001|Open-label Period|Lost to Follow-up|0|||
170780192|NCT00709098|617201353|FG002|Open-label Period|Lost to Follow-up|1|||
170780193|NCT01227265|617201354|FG000|Overall Study|Did Not Receive Treatment|1|||
170780194|NCT01227265|617201355|FG001|Overall Study|Did Not Receive Treatment|2|||
170780195|NCT01227265|617201356|FG002|Overall Study|Did Not Receive Treatment|0|||
170780196|NCT01227265|617201354|FG000|Overall Study|Administrative|1|||
170780197|NCT01227265|617201355|FG001|Overall Study|Administrative|0|||
170780198|NCT01227265|617201356|FG002|Overall Study|Administrative|2|||
170780199|NCT01227265|617201354|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
170780200|NCT01227265|617201355|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
170780201|NCT01227265|617201356|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
170780202|NCT01227265|617201354|FG000|Overall Study|Protocol Violation|2|||
170780203|NCT01227265|617201355|FG001|Overall Study|Protocol Violation|1|||
170780204|NCT01227265|617201356|FG002|Overall Study|Protocol Violation|0|||
170780205|NCT01227265|617201354|FG000|Overall Study|Withdrawal by Subject|7|||
170780206|NCT01227265|617201355|FG001|Overall Study|Withdrawal by Subject|7|||
170780207|NCT01227265|617201356|FG002|Overall Study|Withdrawal by Subject|3|||
170780208|NCT01227265|617201354|FG000|Overall Study|Lost to Follow-up|2|||
170780209|NCT01227265|617201355|FG001|Overall Study|Lost to Follow-up|0|||
170780210|NCT01227265|617201356|FG002|Overall Study|Lost to Follow-up|3|||
170780211|NCT01227265|617201354|FG000|Overall Study|Adverse Event|6|||
170780212|NCT01227265|617201355|FG001|Overall Study|Adverse Event|10|||
170780213|NCT01227265|617201356|FG002|Overall Study|Adverse Event|5|||
170780214|NCT02269475|617201359|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
170780215|NCT02269475|617201360|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
170536859|NCT04717557|616309599|FG000|Overall Study|Withdrawal by Subject|2|||
170536860|NCT04717557|616309600|FG001|Overall Study|Withdrawal by Subject|0|||
170536861|NCT04717557|616309599|FG000|Overall Study|Death|1|||
170536862|NCT04717557|616309600|FG001|Overall Study|Death|0|||
170536863|NCT00831844|616309601|FG000|Overall Study|Adverse Event|2|||
170536864|NCT00831844|616309602|FG001|Overall Study|Adverse Event|0|||
170536865|NCT00831844|616309603|FG002|Overall Study|Adverse Event|0|||
170536866|NCT00831844|616309604|FG003|Overall Study|Adverse Event|0|||
170536867|NCT00831844|616309605|FG004|Overall Study|Adverse Event|1|||
170536868|NCT00831844|616309606|FG005|Overall Study|Adverse Event|1|||
170536869|NCT00831844|616309607|FG006|Overall Study|Adverse Event|2|||
170536870|NCT00831844|616309608|FG007|Overall Study|Adverse Event|0|||
170536871|NCT00831844|616309609|FG008|Overall Study|Adverse Event|0|||
170536872|NCT00831844|616309610|FG009|Overall Study|Adverse Event|0|||
170536873|NCT00831844|616309601|FG000|Overall Study|Death|0|||
170536874|NCT00831844|616309602|FG001|Overall Study|Death|0|||
170536875|NCT00831844|616309603|FG002|Overall Study|Death|0|||
170536876|NCT00831844|616309604|FG003|Overall Study|Death|1|||
170536877|NCT00831844|616309605|FG004|Overall Study|Death|0|||
170536878|NCT00831844|616309606|FG005|Overall Study|Death|0|||
170536879|NCT00831844|616309607|FG006|Overall Study|Death|0|||
170536880|NCT00831844|616309608|FG007|Overall Study|Death|0|||
170536881|NCT00831844|616309609|FG008|Overall Study|Death|0|||
170536882|NCT00831844|616309610|FG009|Overall Study|Death|0|||
170536883|NCT00831844|616309601|FG000|Overall Study|Lack of Efficacy|8|||
170536884|NCT00831844|616309602|FG001|Overall Study|Lack of Efficacy|10|||
170536885|NCT00831844|616309603|FG002|Overall Study|Lack of Efficacy|15|||
170536886|NCT00831844|616309604|FG003|Overall Study|Lack of Efficacy|8|||
170536887|NCT00831844|616309605|FG004|Overall Study|Lack of Efficacy|11|||
170536888|NCT00831844|616309606|FG005|Overall Study|Lack of Efficacy|17|||
170780216|NCT02269475|617201359|FG000|Overall Study|Withdrawal by Subject|0|||
170780217|NCT02269475|617201360|FG001|Overall Study|Withdrawal by Subject|1|||
170536889|NCT00831844|616309607|FG006|Overall Study|Lack of Efficacy|8|||
170780218|NCT04428112|617201363|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
170780219|NCT04428112|617201364|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
170806940|NCT01683409|617301668|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
170806941|NCT01683409|617301669|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
170536890|NCT00831844|616309608|FG007|Overall Study|Lack of Efficacy|9|||
170806942|NCT01683409|617301670|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
170806943|NCT01683409|617301666|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
170806944|NCT01683409|617301667|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
170536891|NCT00831844|616309609|FG008|Overall Study|Lack of Efficacy|7|||
170536892|NCT00831844|616309610|FG009|Overall Study|Lack of Efficacy|0|||
170536893|NCT00831844|616309601|FG000|Overall Study|Physician Decision|0|||
170536894|NCT00831844|616309602|FG001|Overall Study|Physician Decision|1|||
170881824|NCT00706134|617577544|FG003|Overall Study|Protocol Violation|3|||
170881825|NCT00706134|617577541|FG000|Overall Study|Withdrawal by Subject|1|||
170881826|NCT00706134|617577542|FG001|Overall Study|Withdrawal by Subject|2|||
170881827|NCT00706134|617577543|FG002|Overall Study|Withdrawal by Subject|1|||
170881828|NCT00706134|617577544|FG003|Overall Study|Withdrawal by Subject|0|||
170881829|NCT00706134|617577541|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
170881830|NCT00706134|617577542|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170881831|NCT00706134|617577543|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
170881832|NCT00706134|617577544|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
170881833|NCT00706134|617577541|FG000|Overall Study|Did not meet study criteria|2|||
170881834|NCT00706134|617577542|FG001|Overall Study|Did not meet study criteria|0|||
170881835|NCT00706134|617577543|FG002|Overall Study|Did not meet study criteria|0|||
170881836|NCT00706134|617577544|FG003|Overall Study|Did not meet study criteria|0|||
170881837|NCT00820898|617577546|FG000|Overall Study|Inelgible - wrong primary site|1|||
170536895|NCT00831844|616309603|FG002|Overall Study|Physician Decision|3|||
170536896|NCT00831844|616309604|FG003|Overall Study|Physician Decision|1|||
170536897|NCT00831844|616309605|FG004|Overall Study|Physician Decision|1|||
170536898|NCT00831844|616309606|FG005|Overall Study|Physician Decision|1|||
170536899|NCT00831844|616309607|FG006|Overall Study|Physician Decision|0|||
170536900|NCT00831844|616309608|FG007|Overall Study|Physician Decision|0|||
170536901|NCT00831844|616309609|FG008|Overall Study|Physician Decision|1|||
170536902|NCT00831844|616309610|FG009|Overall Study|Physician Decision|0|||
170536903|NCT00831844|616309601|FG000|Overall Study|Withdrawal by Subject|0|||
170536904|NCT00831844|616309602|FG001|Overall Study|Withdrawal by Subject|0|||
170536905|NCT00831844|616309603|FG002|Overall Study|Withdrawal by Subject|1|||
170536906|NCT00831844|616309604|FG003|Overall Study|Withdrawal by Subject|0|||
170536907|NCT00831844|616309605|FG004|Overall Study|Withdrawal by Subject|0|||
170536908|NCT00831844|616309606|FG005|Overall Study|Withdrawal by Subject|0|||
170536909|NCT00831844|616309607|FG006|Overall Study|Withdrawal by Subject|0|||
170536910|NCT00831844|616309608|FG007|Overall Study|Withdrawal by Subject|1|||
170536911|NCT00831844|616309609|FG008|Overall Study|Withdrawal by Subject|1|||
170536912|NCT00831844|616309610|FG009|Overall Study|Withdrawal by Subject|0|||
170536913|NCT00831844|616309601|FG000|Overall Study|Ineligible|0|||
170536914|NCT00831844|616309602|FG001|Overall Study|Ineligible|1|||
170536915|NCT00831844|616309603|FG002|Overall Study|Ineligible|1|||
170536916|NCT00831844|616309604|FG003|Overall Study|Ineligible|0|||
170536917|NCT00831844|616309605|FG004|Overall Study|Ineligible|1|||
170536918|NCT00831844|616309606|FG005|Overall Study|Ineligible|0|||
170536919|NCT00831844|616309607|FG006|Overall Study|Ineligible|0|||
170536920|NCT00831844|616309608|FG007|Overall Study|Ineligible|0|||
170536921|NCT00831844|616309609|FG008|Overall Study|Ineligible|0|||
170536922|NCT00831844|616309610|FG009|Overall Study|Ineligible|0|||
170536923|NCT04133909|616309613|FG000|Overall Study|Death|11|||
170536924|NCT04133909|616309614|FG001|Overall Study|Death|11|||
170536925|NCT04133909|616309613|FG000|Overall Study|Adverse Event|4|||
170881838|NCT02921971|617577547|FG000|Overall Study|Adverse Event|1|||
170780220|NCT04428112|617201363|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
170780221|NCT04428112|617201364|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
170780222|NCT04428112|617201363|FG000|Overall Study|Withdrawal by Subject|9|||
170780223|NCT04428112|617201364|FG001|Overall Study|Withdrawal by Subject|4|||
170780224|NCT04428112|617201363|FG000|Overall Study|Lost to Follow-up|27|||
170780225|NCT04428112|617201364|FG001|Overall Study|Lost to Follow-up|7|||
170780226|NCT04059354|617203391|FG000|Overall Study|COVID-19 pandemic|3|||
170780227|NCT02525692|617203395|FG000|Overall Study|Withdrawal by Subject|1|||
170780228|NCT02525692|617203396|FG001|Overall Study|Withdrawal by Subject|1|||
170780229|NCT02525692|617203397|FG002|Overall Study|Withdrawal by Subject|0|||
170780230|NCT02525692|617203398|FG003|Overall Study|Withdrawal by Subject|5|||
170780231|NCT02525692|617203399|FG004|Overall Study|Withdrawal by Subject|0|||
170780232|NCT02525692|617203400|FG005|Overall Study|Withdrawal by Subject|1|||
170780233|NCT02525692|617203395|FG000|Overall Study|Death|16|||
170780234|NCT02525692|617203396|FG001|Overall Study|Death|18|||
170780235|NCT02525692|617203397|FG002|Overall Study|Death|7|||
170881839|NCT02921971|617577548|FG001|Overall Study|Adverse Event|2|||
170881840|NCT02921971|617577547|FG000|Overall Study|Lack of Efficacy|3|||
170881841|NCT02921971|617577548|FG001|Overall Study|Lack of Efficacy|1|||
170536926|NCT04133909|616309614|FG001|Overall Study|Adverse Event|5|||
170536927|NCT04133909|616309613|FG000|Overall Study|Lost to Follow-up|3|||
170780236|NCT02525692|617203398|FG003|Overall Study|Death|20|||
170780237|NCT02525692|617203399|FG004|Overall Study|Death|3|||
170780238|NCT02525692|617203400|FG005|Overall Study|Death|6|||
170881842|NCT02921971|617577547|FG000|Overall Study|Other than specified above|2|||
170536928|NCT04133909|616309614|FG001|Overall Study|Lost to Follow-up|5|||
170536929|NCT04133909|616309613|FG000|Overall Study|Physician Decision|4|||
170881843|NCT02921971|617577548|FG001|Overall Study|Other than specified above|1|||
170434687|NCT02054715|615928732|FG001|Follow-up 2|Treatment Change or Delay|0|||
170434688|NCT01442376|615928733|FG000|Overall Study|Adverse Event|0|||
170434689|NCT01442376|615928734|FG001|Overall Study|Adverse Event|3|||
170434690|NCT01442376|615928735|FG002|Overall Study|Adverse Event|2|||
170434691|NCT01442376|615928733|FG000|Overall Study|Death|0|||
170434692|NCT01442376|615928734|FG001|Overall Study|Death|1|||
170434693|NCT01442376|615928735|FG002|Overall Study|Death|1|||
170434694|NCT01442376|615928733|FG000|Overall Study|Withdrawal of consent|0|||
170780239|NCT02525692|617203395|FG000|Overall Study|Lost to Follow-up|0|||
170780240|NCT02525692|617203396|FG001|Overall Study|Lost to Follow-up|0|||
170780241|NCT02525692|617203397|FG002|Overall Study|Lost to Follow-up|1|||
170780242|NCT02525692|617203398|FG003|Overall Study|Lost to Follow-up|5|||
170780243|NCT02525692|617203399|FG004|Overall Study|Lost to Follow-up|0|||
170780244|NCT02525692|617203400|FG005|Overall Study|Lost to Follow-up|0|||
170780245|NCT02396199|617203401|FG000|Overall Study|Lost to Follow-up|1|||
170780246|NCT02396199|617203401|FG000|Overall Study|Death|4|||
170780247|NCT05338086|617203404|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
170780248|NCT05338086|617203405|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
170780249|NCT05338086|617203406|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
170780250|NCT05338086|617203407|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
170780251|NCT05338086|617203408|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
170780252|NCT05338086|617203404|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
170780253|NCT05338086|617203405|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
170780254|NCT05338086|617203406|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
170780255|NCT05338086|617203407|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
170780256|NCT05338086|617203408|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
170780257|NCT05338086|617203404|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
170780258|NCT05338086|617203405|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
170780259|NCT05338086|617203406|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
170780260|NCT05338086|617203407|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
170780261|NCT05338086|617203408|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
170780262|NCT05338086|617203404|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
170780263|NCT05338086|617203405|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
170780264|NCT05338086|617203406|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
170780265|NCT05338086|617203407|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
170780266|NCT05338086|617203408|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
170806945|NCT01683409|617301668|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
170806946|NCT01683409|617301669|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
170806947|NCT01683409|617301670|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
170806948|NCT01683409|617301666|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
170806949|NCT01683409|617301667|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
170434695|NCT01442376|615928734|FG001|Overall Study|Withdrawal of consent|0|||
170434696|NCT01442376|615928735|FG002|Overall Study|Withdrawal of consent|1|||
170806950|NCT01683409|617301668|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
170806951|NCT01683409|617301669|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
170806952|NCT01683409|617301670|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
170806953|NCT01683409|617301666|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
170806954|NCT01683409|617301667|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
170806955|NCT01683409|617301668|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
170806956|NCT01683409|617301669|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
170806957|NCT01683409|617301670|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
170806958|NCT01683409|617301666|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
170806959|NCT01683409|617301667|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
170806960|NCT01683409|617301668|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
170806961|NCT01683409|617301669|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
170806962|NCT01683409|617301670|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
170806963|NCT04218864|617301671|FG000|Overall Study|Lost to Follow-up|8|||
170806964|NCT04218864|617301672|FG001|Overall Study|Lost to Follow-up|4|||
170806965|NCT04218864|617301671|FG000|Overall Study|Withdrawal by Subject|1|||
170806966|NCT04218864|617301672|FG001|Overall Study|Withdrawal by Subject|3|||
170806967|NCT02063659|617301673|FG000|Double-Blind Treatment Period|Adverse Event|1|||
170806968|NCT02063659|617301674|FG001|Double-Blind Treatment Period|Adverse Event|2|||
170806969|NCT02063659|617301675|FG002|Double-Blind Treatment Period|Adverse Event|0|||
170806970|NCT02063659|617301676|FG003|Double-Blind Treatment Period|Adverse Event|0|||
170806971|NCT02063659|617301673|FG000|Double-Blind Treatment Period|Physician Decision|1|||
170806972|NCT02063659|617301674|FG001|Double-Blind Treatment Period|Physician Decision|0|||
170806973|NCT02063659|617301675|FG002|Double-Blind Treatment Period|Physician Decision|0|||
170806974|NCT02063659|617301676|FG003|Double-Blind Treatment Period|Physician Decision|0|||
170806975|NCT02063659|617301673|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
170780267|NCT05338086|617203404|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
170780268|NCT05338086|617203405|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
170780269|NCT05338086|617203406|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
170780270|NCT05338086|617203407|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
170780271|NCT05338086|617203408|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
170780272|NCT05338086|617203404|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
170780273|NCT05338086|617203405|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
170780274|NCT05338086|617203406|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
170780275|NCT05338086|617203407|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
170780276|NCT05338086|617203408|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
170780277|NCT05338086|617203404|FG000|Transition Period (M12 to M18)|Death|0|||
170780278|NCT05338086|617203405|FG001|Transition Period (M12 to M18)|Death|0|||
170780279|NCT05338086|617203406|FG002|Transition Period (M12 to M18)|Death|1|||
170780280|NCT05338086|617203407|FG003|Transition Period (M12 to M18)|Death|0|||
170780281|NCT05338086|617203408|FG004|Transition Period (M12 to M18)|Death|0|||
170780282|NCT05338086|617203404|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
170780283|NCT05338086|617203405|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
170780284|NCT05338086|617203406|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
170780285|NCT05338086|617203407|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
170780286|NCT05338086|617203408|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
170780287|NCT05338086|617203404|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
170780288|NCT05338086|617203405|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
170780289|NCT05338086|617203406|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
170780290|NCT05338086|617203407|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
170780291|NCT05338086|617203408|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
170780292|NCT05338086|617203404|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
170780293|NCT05338086|617203405|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
170780294|NCT05338086|617203406|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
170780295|NCT05338086|617203407|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
170780296|NCT05338086|617203408|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
170780297|NCT03424811|617203411|FG000|Overall Study|Lost to Follow-up|9|||
170780298|NCT03424811|617203412|FG001|Overall Study|Lost to Follow-up|0|||
170780299|NCT04112316|617203417|FG000|First Period (8 Weeks)|Protocol Violation|1|||
170780300|NCT04112316|617203418|FG001|First Period (8 Weeks)|Protocol Violation|0|||
170780301|NCT04112316|617203417|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
170780302|NCT04112316|617203418|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
170780303|NCT04247542|617203421|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
170780304|NCT04247542|617203422|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
170780305|NCT04247542|617203423|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
170780306|NCT04247542|617203421|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
170780307|NCT04247542|617203422|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
170881844|NCT00452699|617577549|FG000|Overall Study|Adverse Event|10|||
170881845|NCT00452699|617577550|FG001|Overall Study|Adverse Event|3|||
170881846|NCT00452699|617577549|FG000|Overall Study|Lack of Efficacy|6|||
170881847|NCT00452699|617577550|FG001|Overall Study|Lack of Efficacy|4|||
170881848|NCT00452699|617577549|FG000|Overall Study|Lost to Follow-up|6|||
170881849|NCT00452699|617577550|FG001|Overall Study|Lost to Follow-up|9|||
170881850|NCT00452699|617577549|FG000|Overall Study|Protocol Violation|21|||
170881851|NCT00452699|617577550|FG001|Overall Study|Protocol Violation|25|||
170881852|NCT00452699|617577549|FG000|Overall Study|Withdrawal by Subject|26|||
170881853|NCT00452699|617577550|FG001|Overall Study|Withdrawal by Subject|25|||
170881854|NCT00452699|617577549|FG000|Overall Study|Other|12|||
170881855|NCT00452699|617577550|FG001|Overall Study|Other|7|||
170881856|NCT03847987|617577553|FG000|Overall Study|Lost to Follow-up|1|||
170881857|NCT03847987|617577554|FG001|Overall Study|Lost to Follow-up|0|||
170881858|NCT03847987|617577553|FG000|Overall Study|Adverse Event|2|||
170881859|NCT03847987|617577554|FG001|Overall Study|Adverse Event|0|||
170881860|NCT00493870|617577555|FG000|Overall Study|Lost to Follow-up|12|||
170881861|NCT00493870|617577556|FG001|Overall Study|Lost to Follow-up|15|||
170881862|NCT00272038|617577557|FG000|Overall Study|withdrew before they received 2 cycles|7|||
170881863|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
170881864|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
170881865|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
170881866|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
170881867|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
170780308|NCT04247542|617203423|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
170780309|NCT03438188|617203424|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
170780310|NCT03438188|617203425|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
170780311|NCT03438188|617203426|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
170780312|NCT03438188|617203424|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
170780313|NCT03438188|617203425|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
170780314|NCT03438188|617203426|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
170780315|NCT03438188|617203424|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
170780316|NCT03438188|617203425|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
170780317|NCT03438188|617203426|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
170780318|NCT03438188|617203424|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
170780319|NCT03438188|617203425|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
170780320|NCT03438188|617203426|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
170434697|NCT01442376|615928733|FG000|Overall Study|Patients not treated|2|||
170434698|NCT01442376|615928734|FG001|Overall Study|Patients not treated|3|||
170434699|NCT01442376|615928735|FG002|Overall Study|Patients not treated|1|||
170434700|NCT01442376|615928733|FG000|Overall Study|Not eligible for subsequent cycles|1|||
170434701|NCT01442376|615928734|FG001|Overall Study|Not eligible for subsequent cycles|2|||
170434702|NCT01442376|615928735|FG002|Overall Study|Not eligible for subsequent cycles|0|||
170434703|NCT02911025|615928736|FG000|Overall Study|Lost to Follow-up|3|||
170434704|NCT01120028|615928739|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
170434705|NCT01120028|615928740|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
170434706|NCT01120028|615928741|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
170434707|NCT01120028|615928742|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
170434708|NCT01120028|615928739|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
170434709|NCT01120028|615928740|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
170434710|NCT01120028|615928741|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
170434711|NCT01120028|615928742|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
170434712|NCT01279486|615928745|FG000|Overall Study|Lost to Follow-up|1|||
170434713|NCT04198363|615928746|FG000|Overall Study|Adverse Event|1|||
170434714|NCT04198363|615928747|FG001|Overall Study|Adverse Event|1|||
170434715|NCT04198363|615928746|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
170434716|NCT04198363|615928747|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
170434717|NCT04198363|615928746|FG000|Overall Study|Reason not Specified|1|||
170434718|NCT04198363|615928747|FG001|Overall Study|Reason not Specified|0|||
170434719|NCT03500094|615928748|FG000|Overall Study|Withdrawal by Subject|1|||
170434720|NCT03500094|615928748|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
170434721|NCT03500094|615928748|FG000|Overall Study|Lost to Follow-up|1|||
170434722|NCT00798603|615930481|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
170434723|NCT00798603|615930481|FG000|Overall Study|Withdrawal by Subject|10|||
170434724|NCT00798603|615930481|FG000|Overall Study|Adverse Event|22|||
170434725|NCT00798603|615930481|FG000|Overall Study|Physician Decision|1|||
170434726|NCT00798603|615930481|FG000|Overall Study|Lack of insurance coverage|1|||
170434727|NCT00521586|615930482|FG000|Initial Vaccination (Year 0)|Subject request|8|||
170434728|NCT00521586|615930483|FG001|Initial Vaccination (Year 0)|Subject request|11|||
170434729|NCT00521586|615930482|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
170434730|NCT00521586|615930483|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
170434731|NCT00521586|615930482|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
170434732|NCT00521586|615930483|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
170434733|NCT00521586|615930482|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
170434734|NCT00521586|615930483|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
170434735|NCT00521586|615930482|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
170434736|NCT00521586|615930483|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
170434737|NCT00521586|615930482|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
170434738|NCT00521586|615930483|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
170434739|NCT00521586|615930482|FG000|Initial Vaccination (Year 0)|Death|1|||
170434740|NCT00521586|615930483|FG001|Initial Vaccination (Year 0)|Death|0|||
170434741|NCT00521586|615930482|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
170434742|NCT00521586|615930483|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
170434743|NCT00521586|615930482|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
170434744|NCT00521586|615930483|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
170434745|NCT00521586|615930482|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
170434746|NCT00521586|615930483|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
170434747|NCT00521586|615930482|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
170434748|NCT00521586|615930483|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
170434749|NCT00521586|615930482|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
170434750|NCT00521586|615930483|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
170881868|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
170881869|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
170881870|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
170881871|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
170881872|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
170881873|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
170881874|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
170881875|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
170881876|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
170881877|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
170881878|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
170881879|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
170881880|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
170881881|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
170881882|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
170881883|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
170881884|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
170881885|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
170881886|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
170881887|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
170881888|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
170434751|NCT00521586|615930482|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
170434752|NCT00521586|615930483|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
170434753|NCT00521586|615930482|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
170434754|NCT00521586|615930483|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
170434755|NCT00521586|615930482|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
170434756|NCT00521586|615930483|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
170434757|NCT00521586|615930482|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
170434758|NCT00521586|615930483|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
170434759|NCT00521586|615930482|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
170434760|NCT00521586|615930483|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
170434761|NCT00521586|615930482|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
170434762|NCT00521586|615930483|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
170434763|NCT00521586|615930482|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
170434764|NCT00521586|615930483|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
170434765|NCT05511935|615930484|FG000|Overall Study|Lost to Follow-up|9|||
170434766|NCT05511935|615930485|FG001|Overall Study|Lost to Follow-up|27|||
170434767|NCT03234907|615930486|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
170434768|NCT03234907|615930487|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
170434769|NCT03234907|615930488|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
170434770|NCT03234907|615930489|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
170434771|NCT03234907|615930490|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
170434772|NCT03234907|615930491|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
170434773|NCT03234907|615930486|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
170434774|NCT03234907|615930487|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
170434775|NCT03234907|615930488|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
170434776|NCT03234907|615930489|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
170434777|NCT03234907|615930490|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
170434778|NCT03234907|615930491|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
170434779|NCT03234907|615930486|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
170434780|NCT03234907|615930487|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
170434781|NCT03234907|615930488|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
170434782|NCT03234907|615930489|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
170434783|NCT03234907|615930490|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
170434784|NCT03234907|615930491|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
170434785|NCT03234907|615930486|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
170434786|NCT03234907|615930487|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
170434787|NCT03234907|615930488|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
170434788|NCT03234907|615930489|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
170434789|NCT03234907|615930490|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
170434790|NCT03234907|615930491|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
170434791|NCT03234907|615930486|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
170434792|NCT03234907|615930487|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
170434793|NCT03234907|615930488|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
170434794|NCT03234907|615930489|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
170434795|NCT03234907|615930490|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
170434796|NCT03234907|615930491|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
170434797|NCT03234907|615930486|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
170434798|NCT03234907|615930487|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
170434799|NCT03234907|615930488|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
170434800|NCT03234907|615930489|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
170434801|NCT03234907|615930490|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
170434802|NCT03234907|615930491|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
170434803|NCT03234907|615930486|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
170434804|NCT03234907|615930487|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
170434805|NCT03234907|615930488|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
170434806|NCT03234907|615930489|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
170434807|NCT03234907|615930490|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
170434808|NCT03234907|615930491|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
170434809|NCT02583048|615930494|FG000|Overall Study|Withdrawal by Subject|0|||
170434810|NCT02583048|615930495|FG001|Overall Study|Withdrawal by Subject|1|||
170434811|NCT02583048|615930496|FG002|Overall Study|Withdrawal by Subject|0|||
170434812|NCT02583048|615930494|FG000|Overall Study|Failed to meet eligibility criterion|0|||
170780321|NCT03438188|617203424|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
170780322|NCT03438188|617203425|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
170780323|NCT03438188|617203426|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
170780324|NCT05952076|617203427|FG000|Overall Study|Death|1|||
170780325|NCT05952076|617203428|FG001|Overall Study|Death|1|||
170536930|NCT04133909|616309614|FG001|Overall Study|Physician Decision|7|||
170536931|NCT04133909|616309613|FG000|Overall Study|Withdrawal by Subject|40|||
170536932|NCT04133909|616309614|FG001|Overall Study|Withdrawal by Subject|35|||
170536933|NCT04133909|616309613|FG000|Overall Study|Lack of Efficacy|2|||
170536934|NCT04133909|616309614|FG001|Overall Study|Lack of Efficacy|7|||
170536935|NCT04133909|616309613|FG000|Overall Study|Randomized in error|1|||
170536936|NCT04133909|616309614|FG001|Overall Study|Randomized in error|1|||
170536937|NCT06142383|616309615|FG000|Overall Study|Mis-randomized|0|||
170536938|NCT06142383|616309616|FG001|Overall Study|Mis-randomized|0|||
170536939|NCT06142383|616309617|FG002|Overall Study|Mis-randomized|1|||
170536940|NCT06142383|616309618|FG003|Overall Study|Mis-randomized|0|||
170536941|NCT06142383|616309619|FG004|Overall Study|Mis-randomized|0|||
170536942|NCT06142383|616309615|FG000|Overall Study|Adverse Event|0|||
170536943|NCT06142383|616309616|FG001|Overall Study|Adverse Event|1|||
170536944|NCT06142383|616309617|FG002|Overall Study|Adverse Event|1|||
170536945|NCT06142383|616309618|FG003|Overall Study|Adverse Event|0|||
170536946|NCT06142383|616309619|FG004|Overall Study|Adverse Event|0|||
170536947|NCT06142383|616309615|FG000|Overall Study|Death|0|||
170536948|NCT06142383|616309616|FG001|Overall Study|Death|1|||
170536949|NCT06142383|616309617|FG002|Overall Study|Death|3|||
170536950|NCT06142383|616309618|FG003|Overall Study|Death|0|||
170536951|NCT06142383|616309619|FG004|Overall Study|Death|1|||
170536952|NCT06142383|616309615|FG000|Overall Study|Study Terminated by Sponsor|20|||
170780326|NCT05952076|617203427|FG000|Overall Study|Lost to Follow-up|0|||
170780327|NCT05952076|617203428|FG001|Overall Study|Lost to Follow-up|1|||
170780328|NCT04143061|617203429|FG000|Overall Study|Protocol Deviation|0|||
170780329|NCT04143061|617203430|FG001|Overall Study|Protocol Deviation|0|||
170780330|NCT04143061|617203431|FG002|Overall Study|Protocol Deviation|0|||
170780331|NCT04143061|617203432|FG003|Overall Study|Protocol Deviation|0|||
170780332|NCT04143061|617203433|FG004|Overall Study|Protocol Deviation|0|||
170780333|NCT04143061|617203434|FG005|Overall Study|Protocol Deviation|0|||
170780334|NCT04143061|617203435|FG006|Overall Study|Protocol Deviation|5|||
170780335|NCT04143061|617203436|FG007|Overall Study|Protocol Deviation|5|||
170780336|NCT04143061|617203429|FG000|Overall Study|Withdrawal by Subject|2|||
170780337|NCT04143061|617203430|FG001|Overall Study|Withdrawal by Subject|0|||
170780338|NCT04143061|617203431|FG002|Overall Study|Withdrawal by Subject|0|||
170780339|NCT04143061|617203432|FG003|Overall Study|Withdrawal by Subject|0|||
170780340|NCT04143061|617203433|FG004|Overall Study|Withdrawal by Subject|0|||
170780341|NCT04143061|617203434|FG005|Overall Study|Withdrawal by Subject|1|||
170780342|NCT04143061|617203435|FG006|Overall Study|Withdrawal by Subject|0|||
170780343|NCT04143061|617203436|FG007|Overall Study|Withdrawal by Subject|0|||
170780344|NCT04143061|617203429|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170780345|NCT04143061|617203430|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170780346|NCT04143061|617203431|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170780347|NCT04143061|617203432|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170780348|NCT04143061|617203433|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
170780349|NCT04143061|617203434|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
170780350|NCT04143061|617203435|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
170780351|NCT04143061|617203436|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
170780352|NCT02163447|617203437|FG000|Overall Study|Withdrawal by Subject|2|||
170780353|NCT02163447|617203438|FG001|Overall Study|Withdrawal by Subject|0|||
170780354|NCT02163447|617203439|FG002|Overall Study|Withdrawal by Subject|1|||
170780355|NCT02163447|617203437|FG000|Overall Study|Lost to Follow-up|1|||
170780356|NCT02163447|617203438|FG001|Overall Study|Lost to Follow-up|3|||
170780357|NCT02163447|617203439|FG002|Overall Study|Lost to Follow-up|0|||
170780358|NCT02163447|617203437|FG000|Overall Study|Moved out of study area|2|||
170780359|NCT02163447|617203438|FG001|Overall Study|Moved out of study area|3|||
170780360|NCT02163447|617203439|FG002|Overall Study|Moved out of study area|2|||
170780361|NCT02163447|617203437|FG000|Overall Study|Became HIV infected at time of delivery|1|||
170780362|NCT02163447|617203438|FG001|Overall Study|Became HIV infected at time of delivery|0|||
170780363|NCT02163447|617203439|FG002|Overall Study|Became HIV infected at time of delivery|0|||
170780364|NCT03897686|617203440|FG000|Overall Study|Protocol Violation|1|||
170780365|NCT03897686|617203441|FG001|Overall Study|Protocol Violation|1|||
170780366|NCT03897686|617203440|FG000|Overall Study|Withdrawal by Subject|1|||
170780367|NCT03897686|617203441|FG001|Overall Study|Withdrawal by Subject|1|||
170780368|NCT05386355|617203452|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
170780369|NCT05386355|617203453|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
170780370|NCT05386355|617203454|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
170806976|NCT02063659|617301674|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
170806977|NCT02063659|617301675|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
170536953|NCT06142383|616309616|FG001|Overall Study|Study Terminated by Sponsor|17|||
170536954|NCT06142383|616309617|FG002|Overall Study|Study Terminated by Sponsor|33|||
170536955|NCT06142383|616309618|FG003|Overall Study|Study Terminated by Sponsor|0|||
170434813|NCT02583048|615930495|FG001|Overall Study|Failed to meet eligibility criterion|0|||
170434814|NCT02583048|615930496|FG002|Overall Study|Failed to meet eligibility criterion|1|||
170434815|NCT00660660|615930499|FG000|Overall Study|Adverse Event|1|||
170434816|NCT00660660|615930500|FG001|Overall Study|Adverse Event|0|||
170434817|NCT00660660|615930499|FG000|Overall Study|Lost to Follow-up|0|||
170434818|NCT00660660|615930500|FG001|Overall Study|Lost to Follow-up|6|||
170434819|NCT00660660|615930499|FG000|Overall Study|Lack of Efficacy|0|||
170434820|NCT00660660|615930500|FG001|Overall Study|Lack of Efficacy|2|||
170434821|NCT00660660|615930499|FG000|Overall Study|Withdrawal by Subject|3|||
170434822|NCT00660660|615930500|FG001|Overall Study|Withdrawal by Subject|0|||
170434823|NCT00660660|615930499|FG000|Overall Study|Incorrect enrollment and other|0|||
170434824|NCT00660660|615930500|FG001|Overall Study|Incorrect enrollment and other|1|||
170434825|NCT00660660|615930499|FG000|Overall Study|New medication after randomization|1|||
170434826|NCT00660660|615930500|FG001|Overall Study|New medication after randomization|0|||
170434827|NCT02725515|615930502|FG000|Overall Study|Refused infusion (no study treatment)|1|||
170434828|NCT02725515|615930503|FG001|Overall Study|Refused infusion (no study treatment)|0|||
170434829|NCT02725515|615930502|FG000|Overall Study|Loss of Improvement per Protocol|14|||
170434830|NCT02725515|615930503|FG001|Overall Study|Loss of Improvement per Protocol|25|||
170434831|NCT02725515|615930502|FG000|Overall Study|Withdrawal by Subject|2|||
170434832|NCT02725515|615930503|FG001|Overall Study|Withdrawal by Subject|1|||
170434833|NCT02725515|615930502|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170434834|NCT02725515|615930503|FG001|Overall Study|Non-Compliance With Study Drug|3|||
170434835|NCT02725515|615930502|FG000|Overall Study|Lost to Follow-up|1|||
170434836|NCT02725515|615930503|FG001|Overall Study|Lost to Follow-up|1|||
170434837|NCT02725515|615930502|FG000|Overall Study|Adverse Event|7|||
170434838|NCT02725515|615930503|FG001|Overall Study|Adverse Event|2|||
170434839|NCT02725515|615930502|FG000|Overall Study|No Documented Disease Improvement|0|||
170434840|NCT02725515|615930503|FG001|Overall Study|No Documented Disease Improvement|1|||
170434841|NCT02725515|615930502|FG000|Overall Study|Completed Study Under Original Protocol|0|||
170434842|NCT02725515|615930503|FG001|Overall Study|Completed Study Under Original Protocol|1|||
170434843|NCT02725515|615930502|FG000|Overall Study|Lack of Response|0|||
170434844|NCT02725515|615930503|FG001|Overall Study|Lack of Response|1|||
170434845|NCT00640393|615930505|FG000|Part 1|Lost to Follow-up|2|||
170434846|NCT00640393|615930506|FG001|Part 1|Lost to Follow-up|0|||
170434847|NCT00640393|615930507|FG002|Part 1|Lost to Follow-up|0|||
170434848|NCT00640393|615930505|FG000|Part 1|Withdrawal by Subject|3|||
170881889|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
170881890|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
170881891|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
170881892|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
170881893|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
170881894|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
170780371|NCT05386355|617203455|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
170780372|NCT03157167|617203456|FG000|Overall Study|Withdrawal by Subject|1|||
170780373|NCT03157167|617203457|FG001|Overall Study|Withdrawal by Subject|0|||
170780374|NCT03157167|617203458|FG002|Overall Study|Withdrawal by Subject|0|||
170780375|NCT03263026|617203462|FG000|Overall Study|Withdrawal by Subject|1|||
170780376|NCT03263026|617203463|FG001|Overall Study|Withdrawal by Subject|0|||
170780377|NCT03263026|617203462|FG000|Overall Study|Death|1|||
170780378|NCT03263026|617203463|FG001|Overall Study|Death|0|||
170780379|NCT03263026|617203462|FG000|Overall Study|Other/ Various|41|||
170780380|NCT03263026|617203463|FG001|Overall Study|Other/ Various|29|||
170780381|NCT04850807|617203475|FG000|Overall Study|Death|50|||
170780382|NCT04850807|617203476|FG001|Overall Study|Death|55|||
170780383|NCT04850807|617203475|FG000|Overall Study|Discharged|17|||
170780384|NCT04850807|617203476|FG001|Overall Study|Discharged|13|||
170780385|NCT04850807|617203475|FG000|Overall Study|Incomplete baseline data|3|||
170780386|NCT04850807|617203476|FG001|Overall Study|Incomplete baseline data|2|||
170780387|NCT05141903|617203477|FG000|Overall Study|Withdrawal by Subject|0|||
170780388|NCT05141903|617203478|FG001|Overall Study|Withdrawal by Subject|1|||
170780389|NCT05141903|617203479|FG002|Overall Study|Withdrawal by Subject|1|||
170780390|NCT05141903|617203480|FG003|Overall Study|Withdrawal by Subject|0|||
170881895|NCT03605680|617577558|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
170434849|NCT00640393|615930506|FG001|Part 1|Withdrawal by Subject|0|||
170434850|NCT00640393|615930507|FG002|Part 1|Withdrawal by Subject|0|||
170434851|NCT00640393|615930505|FG000|Randomization|Withdrawn per protocol|17|||
170434852|NCT00640393|615930506|FG001|Randomization|Withdrawn per protocol|0|||
170434853|NCT00640393|615930507|FG002|Randomization|Withdrawn per protocol|0|||
170780391|NCT05141903|617203481|FG004|Overall Study|Withdrawal by Subject|0|||
170434854|NCT00640393|615930505|FG000|Randomization|Never randomized by site|2|||
170434855|NCT00640393|615930506|FG001|Randomization|Never randomized by site|0|||
170434856|NCT00640393|615930507|FG002|Randomization|Never randomized by site|0|||
170780392|NCT05141903|617203477|FG000|Overall Study|Other|1|||
170780393|NCT05141903|617203478|FG001|Overall Study|Other|1|||
170536956|NCT06142383|616309619|FG004|Overall Study|Study Terminated by Sponsor|21|||
170536957|NCT06142383|616309615|FG000|Overall Study|Subject Decision|0|||
170536958|NCT06142383|616309616|FG001|Overall Study|Subject Decision|1|||
170536959|NCT06142383|616309617|FG002|Overall Study|Subject Decision|2|||
170536960|NCT06142383|616309618|FG003|Overall Study|Subject Decision|0|||
170536961|NCT06142383|616309619|FG004|Overall Study|Subject Decision|0|||
170536962|NCT05020743|616309620|FG000|Overall Study|Enrollment in Interventional Study|2|||
170536963|NCT05020743|616309621|FG001|Overall Study|Enrollment in Interventional Study|9|||
170536964|NCT05020743|616309622|FG002|Overall Study|Enrollment in Interventional Study|0|||
170536965|NCT05020743|616309620|FG000|Overall Study|Withdrawal by Subject|0|||
170536966|NCT05020743|616309621|FG001|Overall Study|Withdrawal by Subject|3|||
170536967|NCT05020743|616309622|FG002|Overall Study|Withdrawal by Subject|1|||
170536968|NCT05020743|616309620|FG000|Overall Study|Lost to Follow-up|1|||
170536969|NCT05020743|616309621|FG001|Overall Study|Lost to Follow-up|0|||
170536970|NCT05020743|616309622|FG002|Overall Study|Lost to Follow-up|0|||
170536971|NCT05020743|616309620|FG000|Overall Study|Study Termination by Sponsor|10|||
170536972|NCT05020743|616309621|FG001|Overall Study|Study Termination by Sponsor|11|||
170536973|NCT05020743|616309622|FG002|Overall Study|Study Termination by Sponsor|10|||
170536974|NCT02003924|616309623|FG000|Double-blind Phase|Lost to Follow-up|2|||
170536975|NCT02003924|616309624|FG001|Double-blind Phase|Lost to Follow-up|1|||
170536976|NCT02003924|616309625|FG002|Double-blind Phase|Lost to Follow-up|0|||
170881896|NCT03605680|617577559|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
170881897|NCT03605680|617577560|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
170881898|NCT03605680|617577561|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
170881899|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
170881900|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
170881901|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
170881902|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
170881903|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
170881904|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
170881905|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
170881906|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
170881907|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
170881908|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
170881909|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
170881910|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
170881911|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
170881912|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
170881913|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
170881914|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
170881915|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
170881916|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
170881917|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
170881918|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
170881919|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
170881920|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
170881921|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
170881922|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
170881923|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
170881924|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
170881925|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
170881926|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
170881927|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
170881928|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
170881929|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
170881930|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
170881931|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
170881932|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
170881933|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
170881934|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
170881935|NCT03605680|617577558|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
170881936|NCT03605680|617577559|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
170881937|NCT03605680|617577560|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
170881938|NCT03605680|617577561|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
170536977|NCT02003924|616309623|FG000|Double-blind Phase|Protocol Violation|1|||
170434857|NCT00640393|615930505|FG000|Part 2|Lost to Follow-up|0|||
170434858|NCT00640393|615930506|FG001|Part 2|Lost to Follow-up|2|||
170434859|NCT00640393|615930507|FG002|Part 2|Lost to Follow-up|2|||
170434860|NCT00640393|615930505|FG000|Part 2|Withdrawal by Subject|0|||
170434861|NCT00640393|615930506|FG001|Part 2|Withdrawal by Subject|6|||
170434862|NCT00640393|615930507|FG002|Part 2|Withdrawal by Subject|1|||
170434863|NCT00640393|615930505|FG000|Part 2|Non-adherence|0|||
170434864|NCT00640393|615930506|FG001|Part 2|Non-adherence|1|||
170434865|NCT00640393|615930507|FG002|Part 2|Non-adherence|0|||
170434866|NCT00640393|615930505|FG000|Part 2|Adverse Event|0|||
170434867|NCT00640393|615930506|FG001|Part 2|Adverse Event|1|||
170434868|NCT00640393|615930507|FG002|Part 2|Adverse Event|0|||
170434869|NCT02888756|615930508|FG000|Analytical Treatment Interruption|Physician Decision|10|||
170434870|NCT02888756|615930509|FG001|Analytical Treatment Interruption|Physician Decision|6|||
170434871|NCT02888756|615930510|FG002|Analytical Treatment Interruption|Physician Decision|5|||
170434872|NCT01015287|615930511|FG000|Overall Study|Death|21|||
170434873|NCT01015287|615930512|FG001|Overall Study|Death|16|||
170434874|NCT01015287|615930511|FG000|Overall Study|Adverse Event|1|||
170434875|NCT01015287|615930512|FG001|Overall Study|Adverse Event|0|||
170434876|NCT01015287|615930511|FG000|Overall Study|Sponsor Decision|3|||
170434877|NCT01015287|615930512|FG001|Overall Study|Sponsor Decision|7|||
170434878|NCT01015287|615930511|FG000|Overall Study|Physician Decision|19|||
170434879|NCT01015287|615930512|FG001|Overall Study|Physician Decision|21|||
170434880|NCT01015287|615930511|FG000|Overall Study|Withdrawal by Subject|14|||
170434881|NCT01015287|615930512|FG001|Overall Study|Withdrawal by Subject|19|||
170434882|NCT01015287|615930511|FG000|Overall Study|Entry Criteria not Met|11|||
170434883|NCT01015287|615930512|FG001|Overall Study|Entry Criteria not Met|14|||
170434884|NCT01015287|615930511|FG000|Overall Study|Lost to Follow-up|2|||
170434885|NCT01015287|615930512|FG001|Overall Study|Lost to Follow-up|1|||
170434886|NCT01015287|615930511|FG000|Overall Study|Protocol Violation|1|||
170434887|NCT01015287|615930512|FG001|Overall Study|Protocol Violation|1|||
170434888|NCT05497557|615930514|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
170434889|NCT05497557|615930515|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
170434890|NCT05497557|615930516|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
170434891|NCT01896934|615930517|FG000|Overall Study|Adverse Event|1|||
170780394|NCT05141903|617203479|FG002|Overall Study|Other|0|||
170780395|NCT05141903|617203480|FG003|Overall Study|Other|0|||
170780396|NCT05141903|617203481|FG004|Overall Study|Other|0|||
170780397|NCT05387447|617203483|FG000|Overall Study|Participants changed their minds about study participation.|3|||
170434892|NCT01896934|615930517|FG000|Overall Study|Withdrawal by Subject|1|||
170434893|NCT03206749|615930518|FG000|Overall Study|Withdrawal of consent|5|||
170434894|NCT03206749|615930519|FG001|Overall Study|Withdrawal of consent|3|||
170434895|NCT03206749|615930520|FG002|Overall Study|Withdrawal of consent|6|||
170780398|NCT05387447|617203484|FG001|Overall Study|Participants changed their minds about study participation.|5|||
170780399|NCT01673984|617203485|FG000|Overall Study|Adverse Event|1|||
170780400|NCT01673984|617203486|FG001|Overall Study|Adverse Event|0|||
170780401|NCT01673984|617203485|FG000|Overall Study|Study termination|9|||
170780402|NCT01673984|617203486|FG001|Overall Study|Study termination|6|||
170780403|NCT04178733|617203487|FG000|Overall Study|Investigator Decision|0|||
170780404|NCT04178733|617203488|FG001|Overall Study|Investigator Decision|0|||
170434896|NCT03206749|615930518|FG000|Overall Study|Lost to Follow-up|0|||
170780405|NCT04178733|617203489|FG002|Overall Study|Investigator Decision|0|||
170780406|NCT04178733|617203490|FG003|Overall Study|Investigator Decision|1|||
170780407|NCT04178733|617203491|FG004|Overall Study|Investigator Decision|2|||
170434897|NCT03206749|615930519|FG001|Overall Study|Lost to Follow-up|0|||
170434898|NCT03206749|615930520|FG002|Overall Study|Lost to Follow-up|1|||
170780408|NCT03896516|617203495|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
170434899|NCT02451696|615930521|FG000|Overall Study|Surgery postponed|1|||
170434900|NCT02451696|615930522|FG001|Overall Study|Surgery postponed|0|||
170434901|NCT00198133|615930525|FG000|Overall Study|Disease progression|2|||
170434902|NCT00198133|615930526|FG001|Overall Study|Disease progression|5|||
170434903|NCT00198133|615930525|FG000|Overall Study|Adverse Event|1|||
170434904|NCT00198133|615930526|FG001|Overall Study|Adverse Event|3|||
170434905|NCT00198133|615930525|FG000|Overall Study|Withdrawal by Subject|1|||
170434906|NCT00198133|615930526|FG001|Overall Study|Withdrawal by Subject|0|||
170434907|NCT00198133|615930525|FG000|Overall Study|Physician Decision|1|||
170434908|NCT00198133|615930526|FG001|Overall Study|Physician Decision|0|||
170434909|NCT01557751|615930527|FG000|Overall Study|Physician Decision|3|||
170434910|NCT00488774|615930528|FG000|Overall Study|Withdrawal of consent|2|||
170434911|NCT00488774|615930529|FG001|Overall Study|Withdrawal of consent|2|||
170434912|NCT00488774|615930530|FG002|Overall Study|Withdrawal of consent|2|||
170434913|NCT00488774|615930531|FG003|Overall Study|Withdrawal of consent|0|||
170434914|NCT00488774|615930528|FG000|Overall Study|Other|6|||
170434915|NCT00488774|615930529|FG001|Overall Study|Other|3|||
170434916|NCT00488774|615930530|FG002|Overall Study|Other|2|||
170434917|NCT00488774|615930531|FG003|Overall Study|Other|2|||
170434918|NCT00488774|615930528|FG000|Overall Study|Lost to Follow-up|0|||
170434919|NCT00488774|615930529|FG001|Overall Study|Lost to Follow-up|0|||
170434920|NCT00488774|615930530|FG002|Overall Study|Lost to Follow-up|1|||
170434921|NCT00488774|615930531|FG003|Overall Study|Lost to Follow-up|1|||
170434922|NCT00545792|615930532|FG000|Overall Study|Withdrawal by Subject|1|||
170434923|NCT01380782|615930533|FG000|Overall Study|Adverse Event|0|||
170434924|NCT01380782|615930534|FG001|Overall Study|Adverse Event|1|||
170434925|NCT01380782|615930535|FG002|Overall Study|Adverse Event|0|||
170434926|NCT01380782|615930536|FG003|Overall Study|Adverse Event|0|||
170434927|NCT01380782|615930533|FG000|Overall Study|Death|1|||
170434928|NCT01380782|615930534|FG001|Overall Study|Death|0|||
170434929|NCT01380782|615930535|FG002|Overall Study|Death|0|||
170434930|NCT01380782|615930536|FG003|Overall Study|Death|0|||
170434931|NCT01380782|615930533|FG000|Overall Study|Lack of Efficacy|10|||
170434932|NCT01380782|615930534|FG001|Overall Study|Lack of Efficacy|9|||
170434933|NCT01380782|615930535|FG002|Overall Study|Lack of Efficacy|10|||
170434934|NCT01380782|615930536|FG003|Overall Study|Lack of Efficacy|3|||
170434935|NCT01380782|615930533|FG000|Overall Study|Physician Decision|1|||
170434936|NCT01380782|615930534|FG001|Overall Study|Physician Decision|0|||
170434937|NCT01380782|615930535|FG002|Overall Study|Physician Decision|0|||
170536978|NCT02003924|616309624|FG001|Double-blind Phase|Protocol Violation|2|||
170536979|NCT02003924|616309625|FG002|Double-blind Phase|Protocol Violation|0|||
170536980|NCT02003924|616309623|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
170536981|NCT02003924|616309624|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
170536982|NCT02003924|616309625|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
170536983|NCT02003924|616309623|FG000|Double-blind Phase|Disease Progression|229|||
170536984|NCT02003924|616309624|FG001|Double-blind Phase|Disease Progression|247|||
170536985|NCT02003924|616309625|FG002|Double-blind Phase|Disease Progression|0|||
170536986|NCT02003924|616309623|FG000|Double-blind Phase|Adverse Event|120|||
170536987|NCT02003924|616309624|FG001|Double-blind Phase|Adverse Event|31|||
170536988|NCT02003924|616309625|FG002|Double-blind Phase|Adverse Event|0|||
170536989|NCT02003924|616309623|FG000|Double-blind Phase|Randomized But not Treated|3|||
170536990|NCT02003924|616309624|FG001|Double-blind Phase|Randomized But not Treated|3|||
170536991|NCT02003924|616309625|FG002|Double-blind Phase|Randomized But not Treated|0|||
170536992|NCT02003924|616309623|FG000|Double-blind Phase|Other|29|||
170536993|NCT02003924|616309624|FG001|Double-blind Phase|Other|50|||
170536994|NCT02003924|616309625|FG002|Double-blind Phase|Other|0|||
170536995|NCT02003924|616309623|FG000|Open-label Phase|Lost to Follow-up|0|||
170536996|NCT02003924|616309624|FG001|Open-label Phase|Lost to Follow-up|0|||
170632778|NCT04672239|616666761|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
170881939|NCT03468309|617577565|FG000|Overall Study|Lost to Follow-up|4|||
170881940|NCT03468309|617577565|FG000|Overall Study|Withdrawal by Subject|2|||
170881941|NCT00847912|617577568|FG000|Overall Study|Protocol Violation|6|||
170881942|NCT00847912|617577569|FG001|Overall Study|Protocol Violation|7|||
170434938|NCT01380782|615930536|FG003|Overall Study|Physician Decision|0|||
170434939|NCT01380782|615930533|FG000|Overall Study|Withdrawal by Subject|0|||
170434940|NCT01380782|615930534|FG001|Overall Study|Withdrawal by Subject|0|||
170881943|NCT00847912|617577568|FG000|Overall Study|Withdrawal by Subject|3|||
170881944|NCT00847912|617577569|FG001|Overall Study|Withdrawal by Subject|6|||
170434941|NCT01380782|615930535|FG002|Overall Study|Withdrawal by Subject|1|||
170434942|NCT01380782|615930536|FG003|Overall Study|Withdrawal by Subject|1|||
170434943|NCT03428750|615930537|FG000|Overall Study|Withdrawal by Subject|11|||
170434944|NCT03428750|615930538|FG001|Overall Study|Withdrawal by Subject|10|||
170434945|NCT03428750|615930537|FG000|Overall Study|Lost to Follow-up|3|||
170434946|NCT03428750|615930538|FG001|Overall Study|Lost to Follow-up|9|||
170434947|NCT03428750|615930537|FG000|Overall Study|Adverse Event|9|||
170434948|NCT03428750|615930538|FG001|Overall Study|Adverse Event|1|||
170434949|NCT03428750|615930537|FG000|Overall Study|Protocol Violation|1|||
170536997|NCT02003924|616309625|FG002|Open-label Phase|Lost to Follow-up|1|||
170536998|NCT02003924|616309623|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
170881945|NCT04152161|617577571|FG000|Overall Study|Death|0|||
170434950|NCT03428750|615930538|FG001|Overall Study|Protocol Violation|0|||
170881946|NCT04152161|617577572|FG001|Overall Study|Death|1|||
170881947|NCT04152161|617577571|FG000|Overall Study|Physician Decision|0|||
170881948|NCT04152161|617577572|FG001|Overall Study|Physician Decision|1|||
170881949|NCT04152161|617577571|FG000|Overall Study|Lost to Follow-up|9|||
170881950|NCT04152161|617577572|FG001|Overall Study|Lost to Follow-up|3|||
170881951|NCT04152161|617577571|FG000|Overall Study|Protocol Violation|1|||
170881952|NCT04152161|617577572|FG001|Overall Study|Protocol Violation|0|||
170434951|NCT03428750|615930537|FG000|Overall Study|Administrative|0|||
170434952|NCT03428750|615930538|FG001|Overall Study|Administrative|1|||
170434953|NCT02157974|615930541|FG000|Overall Study|Withdrawal by Subject|0|||
170434954|NCT02157974|615930542|FG001|Overall Study|Withdrawal by Subject|1|||
170434955|NCT02157974|615930543|FG002|Overall Study|Withdrawal by Subject|0|||
170434956|NCT02157974|615930544|FG003|Overall Study|Withdrawal by Subject|0|||
170434957|NCT02157974|615930545|FG004|Overall Study|Withdrawal by Subject|0|||
170434958|NCT02157974|615930541|FG000|Overall Study|Screen Failure|0|||
170434959|NCT02157974|615930542|FG001|Overall Study|Screen Failure|1|||
170434960|NCT02157974|615930543|FG002|Overall Study|Screen Failure|0|||
170434961|NCT02157974|615930544|FG003|Overall Study|Screen Failure|0|||
170434962|NCT02157974|615930545|FG004|Overall Study|Screen Failure|0|||
170434963|NCT02157974|615930541|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
170434964|NCT02157974|615930542|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
170434965|NCT02157974|615930543|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
170434966|NCT02157974|615930544|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
170434967|NCT02157974|615930545|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
170434968|NCT01808651|615930546|FG000|Study Period 1|Lost to Follow-up|1|||
170434969|NCT01808651|615930547|FG001|Study Period 1|Lost to Follow-up|3|||
170434970|NCT01808651|615930548|FG002|Study Period 1|Lost to Follow-up|0|||
170434971|NCT01808651|615930546|FG000|Study Period 1|Protocol Violation|1|||
170434972|NCT01808651|615930547|FG001|Study Period 1|Protocol Violation|0|||
170434973|NCT01808651|615930548|FG002|Study Period 1|Protocol Violation|1|||
170434974|NCT01808651|615930546|FG000|Study Period 1|Physician Decision|3|||
170434975|NCT01808651|615930547|FG001|Study Period 1|Physician Decision|2|||
170434976|NCT01808651|615930548|FG002|Study Period 1|Physician Decision|0|||
170434977|NCT01808651|615930546|FG000|Study Period 1|Lack of Efficacy|2|||
170434978|NCT01808651|615930547|FG001|Study Period 1|Lack of Efficacy|1|||
170434979|NCT01808651|615930548|FG002|Study Period 1|Lack of Efficacy|0|||
170434980|NCT01808651|615930546|FG000|Study Period 1|Adverse Event|10|||
170434981|NCT01808651|615930547|FG001|Study Period 1|Adverse Event|4|||
170434982|NCT01808651|615930548|FG002|Study Period 1|Adverse Event|1|||
170434983|NCT01808651|615930546|FG000|Study Period 1|Participant Decision|9|||
170434984|NCT01808651|615930547|FG001|Study Period 1|Participant Decision|7|||
170434985|NCT01808651|615930548|FG002|Study Period 1|Participant Decision|3|||
170434986|NCT03131895|615930550|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
170434987|NCT03131895|615930551|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
170434988|NCT03131895|615930552|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
170434989|NCT03131895|615930553|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
170434990|NCT03131895|615930550|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
170434991|NCT03131895|615930551|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
170434992|NCT03131895|615930552|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
170434993|NCT03131895|615930553|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
170434994|NCT03131895|615930550|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170434995|NCT03131895|615930551|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
170434996|NCT03131895|615930552|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170434997|NCT03131895|615930553|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
170434998|NCT03131895|615930550|FG000|Washout Period (at Least 5 Days)|Other|0|||
170434999|NCT03131895|615930551|FG001|Washout Period (at Least 5 Days)|Other|0|||
170435000|NCT03131895|615930552|FG002|Washout Period (at Least 5 Days)|Other|2|||
170435001|NCT03131895|615930553|FG003|Washout Period (at Least 5 Days)|Other|0|||
170435002|NCT03131895|615930550|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
170435003|NCT03131895|615930551|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
170435004|NCT03131895|615930552|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
170435005|NCT03131895|615930553|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
170435006|NCT03131895|615930550|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
170435007|NCT03131895|615930551|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
170435008|NCT03131895|615930552|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
170435009|NCT03131895|615930553|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
170632779|NCT04672239|616666762|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
170435010|NCT00540423|615930554|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170435011|NCT00540423|615930555|FG001|Double-Blind Treatment Period|Adverse Event|1|||
170435012|NCT00540423|615930556|FG002|Double-Blind Treatment Period|Adverse Event|0|||
170435013|NCT00540423|615930554|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
170435014|NCT00540423|615930555|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
170881953|NCT04152161|617577571|FG000|Overall Study|Withdrawal by Subject|29|||
170435015|NCT00540423|615930556|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
170435016|NCT00731939|615930562|FG000|Overall Study|Adverse Event|6|||
170435017|NCT00731939|615930562|FG000|Overall Study|Lost to Follow-up|15|||
170435018|NCT00731939|615930562|FG000|Overall Study|Not implanted with study device|9|||
170435019|NCT00731939|615930562|FG000|Overall Study|Withdrawal by Subject|2|||
170435020|NCT00731939|615930562|FG000|Overall Study|Did not meet enrollment criteria|2|||
170435021|NCT02213263|615930563|FG000|Overall Study|Insufficient clinical response|4|||
170435022|NCT02213263|615930564|FG001|Overall Study|Insufficient clinical response|3|||
170435023|NCT02213263|615930563|FG000|Overall Study|Lost to Follow-up|0|||
170435024|NCT02213263|615930564|FG001|Overall Study|Lost to Follow-up|1|||
170435025|NCT02213263|615930563|FG000|Overall Study|No longer willing to participate|3|||
170435026|NCT02213263|615930564|FG001|Overall Study|No longer willing to participate|4|||
170435027|NCT02213263|615930563|FG000|Overall Study|Progressive disease|20|||
170435028|NCT02213263|615930564|FG001|Overall Study|Progressive disease|14|||
170881954|NCT04152161|617577572|FG001|Overall Study|Withdrawal by Subject|28|||
170536999|NCT02003924|616309624|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
170537000|NCT02003924|616309625|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
170537001|NCT02003924|616309623|FG000|Open-label Phase|Disease Progression|59|||
170537002|NCT02003924|616309624|FG001|Open-label Phase|Disease Progression|0|||
170537003|NCT02003924|616309625|FG002|Open-label Phase|Disease Progression|5|||
170537004|NCT02003924|616309623|FG000|Open-label Phase|Adverse Event|25|||
170537005|NCT02003924|616309624|FG001|Open-label Phase|Adverse Event|0|||
170537006|NCT02003924|616309625|FG002|Open-label Phase|Adverse Event|10|||
170537007|NCT02003924|616309623|FG000|Open-label Phase|Other|7|||
170537008|NCT02003924|616309624|FG001|Open-label Phase|Other|0|||
170537009|NCT02003924|616309625|FG002|Open-label Phase|Other|0|||
170537010|NCT02003924|616309623|FG000|Long-term Follow-up Phase|Death|288|||
170537011|NCT02003924|616309624|FG001|Long-term Follow-up Phase|Death|174|||
170537012|NCT02003924|616309625|FG002|Long-term Follow-up Phase|Death|4|||
170537013|NCT02003924|616309623|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
170537014|NCT02003924|616309624|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
170881955|NCT04152161|617577571|FG000|Overall Study|Sponsor termination of study|750|||
170881956|NCT04152161|617577572|FG001|Overall Study|Sponsor termination of study|755|||
170881957|NCT04152161|617577571|FG000|Overall Study|Other|20|||
170881958|NCT04152161|617577572|FG001|Overall Study|Other|18|||
170881959|NCT00001379|617577573|FG000|Initial Treatment|Disease progression|21|||
170881960|NCT00001379|617577574|FG001|Initial Treatment|Disease progression|3|||
170881961|NCT00001379|617577575|FG002|Initial Treatment|Disease progression|0|||
170881962|NCT00001379|617577576|FG003|Initial Treatment|Disease progression|0|||
170881963|NCT00001379|617577573|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
170881964|NCT00001379|617577574|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
170537015|NCT02003924|616309625|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
170632780|NCT04672239|616666763|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
170881965|NCT00001379|617577575|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
170881966|NCT00001379|617577576|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
170881967|NCT00001379|617577573|FG000|Initial Treatment|Received alternative treatment|2|||
170881968|NCT00001379|617577574|FG001|Initial Treatment|Received alternative treatment|1|||
170881969|NCT00001379|617577575|FG002|Initial Treatment|Received alternative treatment|0|||
170881970|NCT00001379|617577576|FG003|Initial Treatment|Received alternative treatment|0|||
170881971|NCT00001379|617577573|FG000|Initial Treatment|Refused further treatment|2|||
170881972|NCT00001379|617577574|FG001|Initial Treatment|Refused further treatment|0|||
170881973|NCT00001379|617577575|FG002|Initial Treatment|Refused further treatment|0|||
170881974|NCT00001379|617577576|FG003|Initial Treatment|Refused further treatment|0|||
170881975|NCT00001379|617577573|FG000|Initial Treatment|Did not receive protocol treatment|0|||
170881976|NCT00001379|617577574|FG001|Initial Treatment|Did not receive protocol treatment|0|||
170881977|NCT00001379|617577575|FG002|Initial Treatment|Did not receive protocol treatment|5|||
170881978|NCT00001379|617577576|FG003|Initial Treatment|Did not receive protocol treatment|0|||
170881979|NCT00001379|617577573|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
170881980|NCT00001379|617577574|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
170881981|NCT00001379|617577575|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
170881982|NCT00001379|617577576|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
170435029|NCT02213263|615930563|FG000|Overall Study|Protocol Violation|0|||
170435030|NCT02213263|615930564|FG001|Overall Study|Protocol Violation|1|||
170435031|NCT02213263|615930563|FG000|Overall Study|Adverse Event|1|||
170435032|NCT02213263|615930564|FG001|Overall Study|Adverse Event|3|||
170537016|NCT02003924|616309623|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
170537017|NCT02003924|616309624|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
170537018|NCT02003924|616309625|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
170537019|NCT02003924|616309623|FG000|Long-term Follow-up Phase|Other|5|||
170537020|NCT02003924|616309624|FG001|Long-term Follow-up Phase|Other|2|||
170435033|NCT05752721|615930565|FG000|Overall Study|Lost to Follow-up|22|||
170435034|NCT05752721|615930566|FG001|Overall Study|Lost to Follow-up|20|||
170435035|NCT05752721|615930565|FG000|Overall Study|Withdrawal by Subject|15|||
170435036|NCT05752721|615930566|FG001|Overall Study|Withdrawal by Subject|12|||
170435037|NCT00263588|615930567|FG000|Overall Study|Death|54|||
170435038|NCT00263588|615930568|FG001|Overall Study|Death|90|||
170435039|NCT00263588|615930567|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
170435040|NCT00263588|615930568|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
170435041|NCT00263588|615930567|FG000|Overall Study|Lost to Follow-up|7|||
170435042|NCT00263588|615930568|FG001|Overall Study|Lost to Follow-up|10|||
170435043|NCT00263588|615930567|FG000|Overall Study|Withdrawal by Subject|3|||
170435044|NCT00263588|615930568|FG001|Overall Study|Withdrawal by Subject|4|||
170435045|NCT00263588|615930567|FG000|Overall Study|Protocol Violation|0|||
170435046|NCT00263588|615930568|FG001|Overall Study|Protocol Violation|1|||
170435047|NCT00263588|615930567|FG000|Overall Study|Investigator decision|7|||
170435048|NCT00263588|615930568|FG001|Overall Study|Investigator decision|15|||
170435049|NCT00263588|615930567|FG000|Overall Study|Sponsor terminated study|0|||
170435050|NCT00263588|615930568|FG001|Overall Study|Sponsor terminated study|1|||
170435051|NCT05274763|615930575|FG000|Overall Study|Lost to Follow-up|1|||
170435052|NCT00918684|615930576|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
170435053|NCT00918684|615930576|FG000|Treatment Phase|Lack of Efficacy|6|||
170435054|NCT00918684|615930576|FG000|Treatment Phase|Lost to Follow-up|2|||
170435055|NCT00918684|615930576|FG000|Treatment Phase|Physician Decision|8|||
170435056|NCT00918684|615930576|FG000|Treatment Phase|Protocol Violation|1|||
170435057|NCT00918684|615930576|FG000|Treatment Phase|Withdrawal by Subject|8|||
170435058|NCT00402103|615930577|FG000|Overall Study|Adverse Event|60|||
170435059|NCT00402103|615930578|FG001|Overall Study|Adverse Event|7|||
170435060|NCT00402103|615930577|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170435061|NCT00402103|615930578|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170435062|NCT00402103|615930577|FG000|Overall Study|Condition no longer requires study drug|2|||
170435063|NCT00402103|615930578|FG001|Overall Study|Condition no longer requires study drug|0|||
170537021|NCT02003924|616309625|FG002|Long-term Follow-up Phase|Other|1|||
170537022|NCT01811238|616309626|FG000|Overall Study|Withdrawal by Subject|42|||
170435064|NCT00402103|615930577|FG000|Overall Study|Protocol Deviation|8|||
170435065|NCT00402103|615930578|FG001|Overall Study|Protocol Deviation|0|||
170435066|NCT00402103|615930577|FG000|Overall Study|Patient withdrew consent|12|||
170435067|NCT00402103|615930578|FG001|Overall Study|Patient withdrew consent|1|||
170435068|NCT00402103|615930577|FG000|Overall Study|Lost to Follow-up|6|||
170537023|NCT01811238|616309626|FG000|Overall Study|Adverse Event|25|||
170435069|NCT00402103|615930578|FG001|Overall Study|Lost to Follow-up|3|||
170435070|NCT00402103|615930577|FG000|Overall Study|Administrative problems|2|||
170537024|NCT01811238|616309626|FG000|Overall Study|Protocol Violation|4|||
170435071|NCT00402103|615930578|FG001|Overall Study|Administrative problems|0|||
170435072|NCT00841542|615930579|FG000|Period 1|Adverse Event|1|||
170435073|NCT00841542|615930580|FG001|Period 1|Adverse Event|0|||
170435074|NCT04345653|615930581|FG000|Overall Study|Withdrawal by Subject|2|||
170435075|NCT00425308|615930582|FG000|Overall Study|Adverse Event|2|||
170435076|NCT00425308|615930583|FG001|Overall Study|Adverse Event|1|||
170435077|NCT00425308|615930582|FG000|Overall Study|Withdrawal by Subject|1|||
170435078|NCT00425308|615930583|FG001|Overall Study|Withdrawal by Subject|0|||
170435079|NCT00425308|615930582|FG000|Overall Study|Death|1|||
170435080|NCT00425308|615930583|FG001|Overall Study|Death|0|||
170435081|NCT01906372|615930588|FG000|Overall Study|Withdrawal by Subject|2|||
170435082|NCT03629054|615930589|FG000|Period 2 (4 Days)|Not treated|0|||
170435083|NCT03629054|615930590|FG001|Period 2 (4 Days)|Not treated|1|||
170435084|NCT03808376|615930591|FG000|Overall Study|Withdrawal by Subject|10|||
170435085|NCT01075282|615930592|FG000|Overall Study|Withdrawal by Subject|11|||
170435086|NCT01075282|615930593|FG001|Overall Study|Withdrawal by Subject|7|||
170435087|NCT01075282|615930594|FG002|Overall Study|Withdrawal by Subject|11|||
170435088|NCT01075282|615930592|FG000|Overall Study|Adverse Event|9|||
170435089|NCT01075282|615930593|FG001|Overall Study|Adverse Event|8|||
170435090|NCT01075282|615930594|FG002|Overall Study|Adverse Event|5|||
170435091|NCT01075282|615930592|FG000|Overall Study|Entry Criteria Not Met|3|||
170435092|NCT01075282|615930593|FG001|Overall Study|Entry Criteria Not Met|2|||
170435093|NCT01075282|615930594|FG002|Overall Study|Entry Criteria Not Met|0|||
170881983|NCT00001379|617577573|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
170881984|NCT00001379|617577574|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
170881985|NCT00001379|617577575|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
170780409|NCT03896516|617203496|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
170780410|NCT03896516|617203495|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
170780411|NCT03896516|617203496|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
170780412|NCT03896516|617203495|FG000|Washout Period|Physician Decision|3|||
170780413|NCT03896516|617203496|FG001|Washout Period|Physician Decision|1|||
170780414|NCT03896516|617203495|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
170780415|NCT03896516|617203496|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
170780416|NCT05461131|617203497|FG000|Overall Study|Lost to Follow-up|0|||
170780417|NCT05461131|617203498|FG001|Overall Study|Lost to Follow-up|2|||
170780418|NCT04549168|617203504|FG000|Randomization Phase|Adverse Event|0|||
170780419|NCT04549168|617203505|FG001|Randomization Phase|Adverse Event|0|||
170780420|NCT04549168|617203506|FG002|Randomization Phase|Adverse Event|1|||
170780421|NCT04549168|617203504|FG000|Randomization Phase|Other|0|||
170780422|NCT04549168|617203505|FG001|Randomization Phase|Other|2|||
170780423|NCT04549168|617203506|FG002|Randomization Phase|Other|0|||
170780424|NCT04549168|617203504|FG000|Randomization Phase|Withdrawal by Subject|0|||
170780425|NCT04549168|617203505|FG001|Randomization Phase|Withdrawal by Subject|2|||
170780426|NCT04549168|617203506|FG002|Randomization Phase|Withdrawal by Subject|1|||
170780427|NCT04437433|617203507|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
170780428|NCT04437433|617203508|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
170780429|NCT04437433|617203507|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
170780430|NCT04437433|617203508|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
170780431|NCT04437433|617203507|FG000|Overall Study|Adverse Event|9|||
170780432|NCT04437433|617203508|FG001|Overall Study|Adverse Event|0|||
170780433|NCT04437433|617203507|FG000|Overall Study|Lack of Efficacy|4|||
170780434|NCT04437433|617203508|FG001|Overall Study|Lack of Efficacy|0|||
170780435|NCT04437433|617203507|FG000|Overall Study|Withdrawal by Subject|4|||
170780436|NCT04437433|617203508|FG001|Overall Study|Withdrawal by Subject|1|||
170780437|NCT04437433|617203507|FG000|Overall Study|Protocol Deviation|0|||
170780438|NCT04437433|617203508|FG001|Overall Study|Protocol Deviation|1|||
170780439|NCT04437433|617203507|FG000|Overall Study|Other, not specified|0|||
170780440|NCT04437433|617203508|FG001|Overall Study|Other, not specified|1|||
170881986|NCT00001379|617577576|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
170435094|NCT01075282|615930592|FG000|Overall Study|Lost to Follow-up|3|||
170435095|NCT01075282|615930593|FG001|Overall Study|Lost to Follow-up|3|||
170435096|NCT01075282|615930594|FG002|Overall Study|Lost to Follow-up|3|||
170435097|NCT01075282|615930592|FG000|Overall Study|Physician Decision|3|||
170435098|NCT01075282|615930593|FG001|Overall Study|Physician Decision|3|||
170435099|NCT01075282|615930594|FG002|Overall Study|Physician Decision|3|||
170537025|NCT01811238|616309626|FG000|Overall Study|Lack of Efficacy|4|||
170435100|NCT01075282|615930592|FG000|Overall Study|Lack of Efficacy|1|||
170435101|NCT01075282|615930593|FG001|Overall Study|Lack of Efficacy|1|||
170435102|NCT01075282|615930594|FG002|Overall Study|Lack of Efficacy|0|||
170780441|NCT05384730|617203517|FG000|Overall Study|Adverse Event|1|||
170780442|NCT05384730|617203518|FG001|Overall Study|Adverse Event|0|||
170780443|NCT05384730|617203517|FG000|Overall Study|Lack of social support|2|||
170780444|NCT05384730|617203518|FG001|Overall Study|Lack of social support|0|||
170780445|NCT05384730|617203517|FG000|Overall Study|Hospital readmission|2|||
170435103|NCT01075282|615930592|FG000|Overall Study|Treatment Non-compliance|1|||
170435104|NCT01075282|615930593|FG001|Overall Study|Treatment Non-compliance|2|||
170435105|NCT01075282|615930594|FG002|Overall Study|Treatment Non-compliance|2|||
170780446|NCT05384730|617203518|FG001|Overall Study|Hospital readmission|0|||
170780447|NCT05384730|617203517|FG000|Overall Study|Disease progression|5|||
170780448|NCT05384730|617203518|FG001|Overall Study|Disease progression|0|||
170780449|NCT05384730|617203517|FG000|Overall Study|Overwhelmed with College commitments|0|||
170780450|NCT05384730|617203518|FG001|Overall Study|Overwhelmed with College commitments|2|||
170780451|NCT00999167|617203522|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
170780452|NCT00999167|617203523|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
170780453|NCT00999167|617203524|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
170780454|NCT00999167|617203522|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
170780455|NCT00999167|617203523|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
170780456|NCT00999167|617203524|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
170780457|NCT00999167|617203522|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
170780458|NCT00999167|617203523|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
170780459|NCT00999167|617203524|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
170780460|NCT00999167|617203522|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
170780461|NCT00999167|617203523|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
170780462|NCT00999167|617203524|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
170780463|NCT00999167|617203522|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
170780464|NCT00999167|617203523|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
170780465|NCT00999167|617203524|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
170780466|NCT00999167|617203522|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
170780467|NCT00999167|617203523|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
170780468|NCT00999167|617203524|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
170780469|NCT00999167|617203522|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
170780470|NCT00999167|617203523|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
170435106|NCT01075282|615930592|FG000|Overall Study|Protocol Violation|0|||
170435107|NCT01075282|615930593|FG001|Overall Study|Protocol Violation|2|||
170435108|NCT01075282|615930594|FG002|Overall Study|Protocol Violation|1|||
170435109|NCT01075282|615930592|FG000|Overall Study|Death|0|||
170435110|NCT01075282|615930593|FG001|Overall Study|Death|1|||
170435111|NCT01075282|615930594|FG002|Overall Study|Death|2|||
170780471|NCT00999167|617203524|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
170780472|NCT00999167|617203522|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
170780473|NCT00999167|617203523|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
170780474|NCT00999167|617203524|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
170780475|NCT04452318|617203525|FG000|Overall Study|Physician Decision|1|||
170780476|NCT04452318|617203526|FG001|Overall Study|Physician Decision|2|||
170780477|NCT04452318|617203527|FG002|Overall Study|Physician Decision|0|||
170780478|NCT04452318|617203528|FG003|Overall Study|Physician Decision|2|||
170780479|NCT04452318|617203529|FG004|Overall Study|Physician Decision|0|||
170780480|NCT04452318|617203530|FG005|Overall Study|Physician Decision|2|||
170881987|NCT00001379|617577573|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
170881988|NCT00001379|617577574|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
170435112|NCT00989950|615930595|FG000|Randomized Phase|Protocol Violation|1|||
170435113|NCT00989950|615930596|FG001|Randomized Phase|Protocol Violation|0|||
170435114|NCT00989950|615930597|FG002|Randomized Phase|Protocol Violation|0|||
170435115|NCT00989950|615930598|FG003|Randomized Phase|Protocol Violation|0|||
170435116|NCT00989950|615930595|FG000|Randomized Phase|Adverse Event|0|||
170435117|NCT00989950|615930596|FG001|Randomized Phase|Adverse Event|1|||
170435118|NCT00989950|615930597|FG002|Randomized Phase|Adverse Event|0|||
170435119|NCT00989950|615930598|FG003|Randomized Phase|Adverse Event|0|||
170435120|NCT00624286|615930599|FG000|Overall Study|Protocol Deviation|7|||
170435121|NCT00624286|615930600|FG001|Overall Study|Protocol Deviation|9|||
170435122|NCT00624286|615930599|FG000|Overall Study|Adverse Event|6|||
170435123|NCT00624286|615930600|FG001|Overall Study|Adverse Event|3|||
170435124|NCT00624286|615930599|FG000|Overall Study|Withdrawal by Subject|5|||
170435125|NCT00624286|615930600|FG001|Overall Study|Withdrawal by Subject|4|||
170435126|NCT00624286|615930599|FG000|Overall Study|Lost to Follow-up|3|||
170435127|NCT00624286|615930600|FG001|Overall Study|Lost to Follow-up|2|||
170435128|NCT00624286|615930599|FG000|Overall Study|Administrative problems|3|||
170435129|NCT00624286|615930600|FG001|Overall Study|Administrative problems|0|||
170435130|NCT00624286|615930599|FG000|Overall Study|Lack of Efficacy|1|||
170435131|NCT00624286|615930600|FG001|Overall Study|Lack of Efficacy|6|||
170435132|NCT00624286|615930599|FG000|Overall Study|Not stated|0|||
170435133|NCT00624286|615930600|FG001|Overall Study|Not stated|1|||
170780481|NCT04452318|617203531|FG006|Overall Study|Physician Decision|5|||
170435134|NCT00624286|615930599|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170435135|NCT00624286|615930600|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170435136|NCT00624286|615930599|FG000|Overall Study|Death|0|||
170435137|NCT00624286|615930600|FG001|Overall Study|Death|1|||
170435138|NCT03488108|615930603|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
170435139|NCT03488108|615930604|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
170435140|NCT03488108|615930603|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
170435141|NCT03488108|615930604|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
170435142|NCT00714051|615930605|FG000|Overall Study|Withdrawal by Subject|1|||
170435143|NCT00714051|615930606|FG001|Overall Study|Withdrawal by Subject|0|||
170435144|NCT00714051|615930605|FG000|Overall Study|Death|0|||
170435145|NCT00714051|615930606|FG001|Overall Study|Death|1|||
170435146|NCT01390948|615930607|FG000|Overall Study|End of Study|1|||
170435147|NCT01390948|615930608|FG001|Overall Study|End of Study|0|||
170435148|NCT01390948|615930609|FG002|Overall Study|End of Study|0|||
170435149|NCT01390948|615930607|FG000|Overall Study|Withdrew consent|2|||
170435150|NCT01390948|615930608|FG001|Overall Study|Withdrew consent|2|||
170435151|NCT01390948|615930609|FG002|Overall Study|Withdrew consent|0|||
170435152|NCT01390948|615930607|FG000|Overall Study|Progressive Disease|2|||
170435153|NCT01390948|615930608|FG001|Overall Study|Progressive Disease|5|||
170435154|NCT01390948|615930609|FG002|Overall Study|Progressive Disease|0|||
170881989|NCT00001379|617577575|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
170881990|NCT00001379|617577576|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
170881991|NCT00001379|617577573|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
170881992|NCT00001379|617577574|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
170881993|NCT00001379|617577575|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
170881994|NCT00001379|617577576|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
170881995|NCT00001379|617577573|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
170881996|NCT00001379|617577574|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
170881997|NCT00001379|617577575|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
170881998|NCT00001379|617577576|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
170881999|NCT02797808|617577583|FG000|Overall Study|Withdrawal by Subject|1|||
170882000|NCT02797808|617577584|FG001|Overall Study|Withdrawal by Subject|1|||
170882001|NCT02797808|617577583|FG000|Overall Study|Physician Decision|6|||
170882002|NCT02797808|617577584|FG001|Overall Study|Physician Decision|2|||
170882003|NCT00535132|617577587|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
170882004|NCT00535132|617577588|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
170882005|NCT00535132|617577587|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
170882006|NCT00535132|617577588|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
170882007|NCT02590588|617577589|FG000|Overall Study|Adverse Event|1|||
170435155|NCT01390948|615930607|FG000|Overall Study|Death during follow-up|10|||
170435156|NCT01390948|615930608|FG001|Overall Study|Death during follow-up|11|||
170435157|NCT01390948|615930609|FG002|Overall Study|Death during follow-up|1|||
170435158|NCT03961204|615930610|FG000|Overall Study|Withdrawal by Subject|2|||
170435159|NCT03961204|615930610|FG000|Overall Study|Lost to Follow-up|3|||
170435160|NCT03961204|615930610|FG000|Overall Study|Other|1|||
170435161|NCT03961204|615930610|FG000|Overall Study|Missing|1|||
170435162|NCT02218216|615930611|FG000|Overall Study|Study terminated before completed|6|||
170435163|NCT02218216|615930612|FG001|Overall Study|Study terminated before completed|0|||
170435164|NCT02218216|615930613|FG002|Overall Study|Study terminated before completed|0|||
170435165|NCT05740098|615930619|FG000|Overall Study|Lost to Follow-up|26|||
170435166|NCT05740098|615930620|FG001|Overall Study|Lost to Follow-up|17|||
170435167|NCT05740098|615930621|FG002|Overall Study|Lost to Follow-up|21|||
170435168|NCT02011945|615930622|FG000|Overall Study|Participant requested to Discontinue|0|||
170435169|NCT02011945|615930623|FG001|Overall Study|Participant requested to Discontinue|1|||
170435170|NCT02011945|615930624|FG002|Overall Study|Participant requested to Discontinue|1|||
170435171|NCT02011945|615930622|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
170435172|NCT02011945|615930623|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
170435173|NCT02011945|615930624|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
170435174|NCT02011945|615930622|FG000|Overall Study|Study Drug Toxicity|0|||
170435175|NCT02011945|615930623|FG001|Overall Study|Study Drug Toxicity|0|||
170435176|NCT02011945|615930624|FG002|Overall Study|Study Drug Toxicity|1|||
170435177|NCT02011945|615930622|FG000|Overall Study|Treatment Failure|0|||
170435178|NCT02011945|615930623|FG001|Overall Study|Treatment Failure|7|||
170435179|NCT02011945|615930624|FG002|Overall Study|Treatment Failure|6|||
170435180|NCT02011945|615930622|FG000|Overall Study|No Longer Meets Study Criteria|1|||
170435181|NCT02011945|615930623|FG001|Overall Study|No Longer Meets Study Criteria|0|||
170780482|NCT04452318|617203525|FG000|Overall Study|Death|2|||
170780483|NCT04452318|617203526|FG001|Overall Study|Death|3|||
170435182|NCT02011945|615930624|FG002|Overall Study|No Longer Meets Study Criteria|0|||
170780484|NCT04452318|617203527|FG002|Overall Study|Death|0|||
170780485|NCT04452318|617203528|FG003|Overall Study|Death|0|||
170780486|NCT04452318|617203529|FG004|Overall Study|Death|0|||
170780487|NCT04452318|617203530|FG005|Overall Study|Death|0|||
170780488|NCT04452318|617203531|FG006|Overall Study|Death|0|||
170780489|NCT04452318|617203525|FG000|Overall Study|Lost to Follow-up|38|||
170435183|NCT02011945|615930622|FG000|Overall Study|Proceeded to stem cell transplant|0|||
170435184|NCT02011945|615930623|FG001|Overall Study|Proceeded to stem cell transplant|0|||
170435185|NCT02011945|615930624|FG002|Overall Study|Proceeded to stem cell transplant|1|||
170435186|NCT02011945|615930622|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
170780490|NCT04452318|617203526|FG001|Overall Study|Lost to Follow-up|28|||
170780491|NCT04452318|617203527|FG002|Overall Study|Lost to Follow-up|0|||
170780492|NCT04452318|617203528|FG003|Overall Study|Lost to Follow-up|3|||
170780493|NCT04452318|617203529|FG004|Overall Study|Lost to Follow-up|3|||
170882008|NCT00708500|617577602|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
170882009|NCT00708500|617577603|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
170882010|NCT00708500|617577604|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
170882011|NCT00708500|617577602|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
170882012|NCT00708500|617577603|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
170882013|NCT00708500|617577604|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
170882014|NCT00708500|617577602|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
170882015|NCT00708500|617577603|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
170882016|NCT00708500|617577604|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
170882017|NCT00708500|617577602|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
170882018|NCT00708500|617577603|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
170882019|NCT00708500|617577604|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
170882020|NCT00708500|617577602|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
170882021|NCT00708500|617577603|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
170882022|NCT00708500|617577604|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
170882023|NCT00708500|617577602|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
170882024|NCT00708500|617577603|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
170435187|NCT02011945|615930623|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
170435188|NCT02011945|615930624|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
170435189|NCT03531827|615930625|FG000|Overall Study|Adverse Event|2|||
170435190|NCT03531827|615930626|FG001|Overall Study|Adverse Event|0|||
170435191|NCT03531827|615930625|FG000|Overall Study|Progressive disease|1|||
170435192|NCT03531827|615930626|FG001|Overall Study|Progressive disease|0|||
170435193|NCT01494532|615930629|FG000|Overall Study|Adverse Event|4|||
170435194|NCT01494532|615930630|FG001|Overall Study|Adverse Event|1|||
170435195|NCT01494532|615930631|FG002|Overall Study|Adverse Event|8|||
170435196|NCT01494532|615930632|FG003|Overall Study|Adverse Event|6|||
170435197|NCT01494532|615930633|FG004|Overall Study|Adverse Event|5|||
170435198|NCT01494532|615930634|FG005|Overall Study|Adverse Event|0|||
170435199|NCT01494532|615930629|FG000|Overall Study|Lack of Efficacy|0|||
170435200|NCT01494532|615930630|FG001|Overall Study|Lack of Efficacy|0|||
170435201|NCT01494532|615930631|FG002|Overall Study|Lack of Efficacy|0|||
170435202|NCT01494532|615930632|FG003|Overall Study|Lack of Efficacy|0|||
170435203|NCT01494532|615930633|FG004|Overall Study|Lack of Efficacy|2|||
170435204|NCT01494532|615930634|FG005|Overall Study|Lack of Efficacy|0|||
170435205|NCT01494532|615930629|FG000|Overall Study|Protocol deviation|2|||
170435206|NCT01494532|615930630|FG001|Overall Study|Protocol deviation|1|||
170435207|NCT01494532|615930631|FG002|Overall Study|Protocol deviation|3|||
170435208|NCT01494532|615930632|FG003|Overall Study|Protocol deviation|2|||
170435209|NCT01494532|615930633|FG004|Overall Study|Protocol deviation|3|||
170435210|NCT01494532|615930634|FG005|Overall Study|Protocol deviation|0|||
170435211|NCT01494532|615930629|FG000|Overall Study|Protocol-defined stopping criteria|0|||
170435212|NCT01494532|615930630|FG001|Overall Study|Protocol-defined stopping criteria|0|||
170435213|NCT01494532|615930631|FG002|Overall Study|Protocol-defined stopping criteria|1|||
170435214|NCT01494532|615930632|FG003|Overall Study|Protocol-defined stopping criteria|0|||
170435215|NCT01494532|615930633|FG004|Overall Study|Protocol-defined stopping criteria|0|||
170435216|NCT01494532|615930634|FG005|Overall Study|Protocol-defined stopping criteria|0|||
170435217|NCT01494532|615930629|FG000|Overall Study|Lost to Follow-up|1|||
170435218|NCT01494532|615930630|FG001|Overall Study|Lost to Follow-up|0|||
170435219|NCT01494532|615930631|FG002|Overall Study|Lost to Follow-up|0|||
170435220|NCT01494532|615930632|FG003|Overall Study|Lost to Follow-up|2|||
170435221|NCT01494532|615930633|FG004|Overall Study|Lost to Follow-up|0|||
170435222|NCT01494532|615930634|FG005|Overall Study|Lost to Follow-up|0|||
170435223|NCT01494532|615930629|FG000|Overall Study|Physician Decision|0|||
170435224|NCT01494532|615930630|FG001|Overall Study|Physician Decision|1|||
170435225|NCT01494532|615930631|FG002|Overall Study|Physician Decision|1|||
170435226|NCT01494532|615930632|FG003|Overall Study|Physician Decision|2|||
170435227|NCT01494532|615930633|FG004|Overall Study|Physician Decision|0|||
170435228|NCT01494532|615930634|FG005|Overall Study|Physician Decision|0|||
170435229|NCT01494532|615930629|FG000|Overall Study|Withdrawal by Subject|3|||
170882025|NCT00708500|617577604|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
170435230|NCT01494532|615930630|FG001|Overall Study|Withdrawal by Subject|1|||
170435231|NCT01494532|615930631|FG002|Overall Study|Withdrawal by Subject|4|||
170435232|NCT01494532|615930632|FG003|Overall Study|Withdrawal by Subject|3|||
170435233|NCT01494532|615930633|FG004|Overall Study|Withdrawal by Subject|2|||
170632781|NCT01198977|616666767|FG000|Overall Study|Lost to Follow-up|1|||
170435234|NCT01494532|615930634|FG005|Overall Study|Withdrawal by Subject|0|||
170435235|NCT00258856|615932521|FG000|Overall Study|Lost to Follow-up|1|||
170435236|NCT00258856|615932522|FG001|Overall Study|Lost to Follow-up|0|||
170435237|NCT00258856|615932523|FG002|Overall Study|Lost to Follow-up|2|||
170435238|NCT00258856|615932524|FG003|Overall Study|Lost to Follow-up|0|||
170435239|NCT00258856|615932521|FG000|Overall Study|Non-compliance|2|||
170435240|NCT00258856|615932522|FG001|Overall Study|Non-compliance|0|||
170435241|NCT00258856|615932523|FG002|Overall Study|Non-compliance|0|||
170435242|NCT00258856|615932524|FG003|Overall Study|Non-compliance|1|||
170435243|NCT00754052|615932530|FG000|Overall Study|Study terminated by Sponsor|5|||
170435244|NCT00754052|615932531|FG001|Overall Study|Study terminated by Sponsor|3|||
170435245|NCT00830258|615932534|FG000|First Intervention|Adverse Event|1|||
170435246|NCT00830258|615932535|FG001|First Intervention|Adverse Event|0|||
170435247|NCT00830258|615932534|FG000|Washout: 7 Days|Protocol Violation|1|||
170435248|NCT00830258|615932535|FG001|Washout: 7 Days|Protocol Violation|0|||
170435249|NCT02316223|615932538|FG000|Overall Study|Lack of Efficacy|0|||
170435250|NCT02316223|615932539|FG001|Overall Study|Lack of Efficacy|1|||
170435251|NCT02316223|615932540|FG002|Overall Study|Lack of Efficacy|1|||
170435252|NCT02316223|615932538|FG000|Overall Study|Lost to Follow-up|27|||
170435253|NCT02316223|615932539|FG001|Overall Study|Lost to Follow-up|34|||
170435254|NCT02316223|615932540|FG002|Overall Study|Lost to Follow-up|36|||
170435255|NCT02316223|615932538|FG000|Overall Study|COPD Diagnosis|3|||
170435256|NCT02316223|615932539|FG001|Overall Study|COPD Diagnosis|2|||
170435257|NCT02316223|615932540|FG002|Overall Study|COPD Diagnosis|3|||
170435258|NCT02316223|615932538|FG000|Overall Study|Reside outside study area|1|||
170435259|NCT02316223|615932539|FG001|Overall Study|Reside outside study area|1|||
170435260|NCT02316223|615932540|FG002|Overall Study|Reside outside study area|1|||
170435261|NCT02316223|615932538|FG000|Overall Study|No asthma|2|||
170435262|NCT02316223|615932539|FG001|Overall Study|No asthma|0|||
170435263|NCT02316223|615932540|FG002|Overall Study|No asthma|0|||
170435264|NCT02316223|615932538|FG000|Overall Study|Discontinued by PI|11|||
170435265|NCT02316223|615932539|FG001|Overall Study|Discontinued by PI|19|||
170435266|NCT02316223|615932540|FG002|Overall Study|Discontinued by PI|3|||
170435267|NCT00529763|615932541|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
170435268|NCT00529763|615932542|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
170435269|NCT00529763|615932543|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
170435270|NCT00529763|615932541|FG000|Overall Study|Death|1|||
170435271|NCT00529763|615932542|FG001|Overall Study|Death|1|||
170435272|NCT00529763|615932543|FG002|Overall Study|Death|1|||
170435273|NCT00529763|615932541|FG000|Overall Study|Disease Progression|10|||
170435274|NCT00529763|615932542|FG001|Overall Study|Disease Progression|16|||
170435275|NCT00529763|615932543|FG002|Overall Study|Disease Progression|11|||
170435276|NCT00529763|615932541|FG000|Overall Study|Lost to Follow-up|1|||
170435277|NCT00529763|615932542|FG001|Overall Study|Lost to Follow-up|2|||
170435278|NCT00529763|615932543|FG002|Overall Study|Lost to Follow-up|3|||
170435279|NCT00529763|615932541|FG000|Overall Study|Stem Cell Transplant|0|||
170435280|NCT00529763|615932542|FG001|Overall Study|Stem Cell Transplant|3|||
170435281|NCT00529763|615932543|FG002|Overall Study|Stem Cell Transplant|1|||
170435282|NCT00529763|615932541|FG000|Overall Study|Study Drug Toxicity|3|||
170435283|NCT00529763|615932542|FG001|Overall Study|Study Drug Toxicity|6|||
170435284|NCT00529763|615932543|FG002|Overall Study|Study Drug Toxicity|4|||
170435285|NCT00529763|615932541|FG000|Overall Study|Participant Withdrew Consent|2|||
170780494|NCT04452318|617203530|FG005|Overall Study|Lost to Follow-up|2|||
170435286|NCT00529763|615932542|FG001|Overall Study|Participant Withdrew Consent|3|||
170435287|NCT00529763|615932543|FG002|Overall Study|Participant Withdrew Consent|4|||
170435288|NCT00529763|615932541|FG000|Overall Study|Other reasons|2|||
170435289|NCT00529763|615932542|FG001|Overall Study|Other reasons|0|||
170435290|NCT00529763|615932543|FG002|Overall Study|Other reasons|2|||
170435291|NCT00529763|615932541|FG000|Overall Study|Participant request to discontinue treatment|1|||
170435292|NCT00529763|615932542|FG001|Overall Study|Participant request to discontinue treatment|1|||
170435293|NCT00529763|615932543|FG002|Overall Study|Participant request to discontinue treatment|3|||
170435294|NCT00828321|615932544|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
170435295|NCT00828321|615932545|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
170435296|NCT00828321|615932544|FG000|Second Intervention|Protocol Violation|0|||
170435297|NCT00828321|615932545|FG001|Second Intervention|Protocol Violation|1|||
170435298|NCT02997176|615932546|FG000|Overall Study|Adverse Event|0|||
170435299|NCT02997176|615932547|FG001|Overall Study|Adverse Event|0|||
170435300|NCT02997176|615932548|FG002|Overall Study|Adverse Event|0|||
170435301|NCT02997176|615932549|FG003|Overall Study|Adverse Event|8|||
170435302|NCT02997176|615932546|FG000|Overall Study|Progressive Disease|1|||
170435303|NCT02997176|615932547|FG001|Overall Study|Progressive Disease|0|||
170435304|NCT02997176|615932548|FG002|Overall Study|Progressive Disease|1|||
170435305|NCT02997176|615932549|FG003|Overall Study|Progressive Disease|1|||
170435306|NCT02997176|615932546|FG000|Overall Study|Death|0|||
170435307|NCT02997176|615932547|FG001|Overall Study|Death|0|||
170435308|NCT02997176|615932548|FG002|Overall Study|Death|1|||
170435309|NCT02997176|615932549|FG003|Overall Study|Death|1|||
170435310|NCT02997176|615932546|FG000|Overall Study|Withdrawal by Subject|0|||
170780495|NCT04452318|617203531|FG006|Overall Study|Lost to Follow-up|1|||
170780496|NCT04452318|617203525|FG000|Overall Study|Withdrawal by Subject|46|||
170780497|NCT04452318|617203526|FG001|Overall Study|Withdrawal by Subject|40|||
170780498|NCT04452318|617203527|FG002|Overall Study|Withdrawal by Subject|0|||
170780499|NCT04452318|617203528|FG003|Overall Study|Withdrawal by Subject|18|||
170780500|NCT04452318|617203529|FG004|Overall Study|Withdrawal by Subject|6|||
170780501|NCT04452318|617203530|FG005|Overall Study|Withdrawal by Subject|8|||
170780502|NCT04452318|617203531|FG006|Overall Study|Withdrawal by Subject|6|||
170780503|NCT00604669|617203536|FG000|Overall Study|lack of information in chart|7|||
170780504|NCT01340066|617203538|FG000|Placebo Run in Period|Screen Failures|27|||
170780505|NCT01340066|617203539|FG001|Placebo Run in Period|Screen Failures|0|||
170780506|NCT01340066|617203540|FG002|Placebo Run in Period|Screen Failures|0|||
170780507|NCT01340066|617203538|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
170780508|NCT01340066|617203539|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
170780509|NCT01340066|617203540|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
170780510|NCT01340066|617203538|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
170780511|NCT01340066|617203539|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
170780512|NCT01340066|617203540|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
170780513|NCT01340066|617203538|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
170780514|NCT01340066|617203539|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
170780515|NCT01340066|617203540|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
170780516|NCT04315181|617203551|FG000|Overall Study|Non-responsive to drug conditions.|1|||
170780517|NCT03380390|617203552|FG000|Overall Study|Adverse Event|3|||
170780518|NCT03014453|617203553|FG000|Overall Study|Lost to Follow-up|12|||
170780519|NCT03014453|617203553|FG000|Overall Study|Discontinued GER|3|||
170780520|NCT03014453|617203553|FG000|Overall Study|Excluded|19|||
170780521|NCT03014453|617203553|FG000|Overall Study|Refused to take part in|37|||
170780522|NCT05494788|617203556|FG000|Initial Treatment Period|Adverse Event|2|||
170780523|NCT05494788|617203556|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
170780524|NCT05494788|617203556|FG000|Extension Period|Adverse Event|1|||
170780525|NCT05494788|617203556|FG000|Extension Period|Withdrawal by Subject|1|||
170780526|NCT00390299|617203561|FG000|Overall Study|Cancellation|1|||
170780527|NCT00390299|617203562|FG001|Overall Study|Cancellation|0|||
170780528|NCT00390299|617203563|FG002|Overall Study|Cancellation|0|||
170780529|NCT00390299|617203564|FG003|Overall Study|Cancellation|0|||
170780530|NCT00390299|617203565|FG004|Overall Study|Cancellation|0|||
170780531|NCT05321069|617203566|FG000|Overall Study|Adverse Event|52|||
170780532|NCT05321069|617203567|FG001|Overall Study|Adverse Event|52|||
170780533|NCT05321069|617203568|FG002|Overall Study|Adverse Event|64|||
170780534|NCT05321069|617203566|FG000|Overall Study|Protocol Violation|1|||
170780535|NCT05321069|617203567|FG001|Overall Study|Protocol Violation|1|||
170780536|NCT05321069|617203568|FG002|Overall Study|Protocol Violation|0|||
170780537|NCT05321069|617203566|FG000|Overall Study|Withdrawal by Subject|23|||
170780538|NCT05321069|617203567|FG001|Overall Study|Withdrawal by Subject|18|||
170780539|NCT05321069|617203568|FG002|Overall Study|Withdrawal by Subject|12|||
170780540|NCT05321069|617203566|FG000|Overall Study|Lost to Follow-up|1|||
170780541|NCT05321069|617203567|FG001|Overall Study|Lost to Follow-up|0|||
170780542|NCT05321069|617203568|FG002|Overall Study|Lost to Follow-up|1|||
170780543|NCT05321069|617203566|FG000|Overall Study|No reason stated by the participants|23|||
170780544|NCT05321069|617203567|FG001|Overall Study|No reason stated by the participants|22|||
170780545|NCT05321069|617203568|FG002|Overall Study|No reason stated by the participants|16|||
170780546|NCT05321069|617203566|FG000|Overall Study|Lack of Efficacy|1|||
170780547|NCT05321069|617203567|FG001|Overall Study|Lack of Efficacy|1|||
170780548|NCT05321069|617203568|FG002|Overall Study|Lack of Efficacy|0|||
170780549|NCT05048186|617203569|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
170780550|NCT05048186|617203570|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
170780551|NCT05048186|617203569|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
170780552|NCT05048186|617203570|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
170780553|NCT04218266|617203572|FG000|Overall Study|Death|1|||
170780554|NCT04218266|617203573|FG001|Overall Study|Death|2|||
170780555|NCT04218266|617203574|FG002|Overall Study|Death|3|||
170780556|NCT04218266|617203572|FG000|Overall Study|Adverse Event|13|||
170780557|NCT04218266|617203573|FG001|Overall Study|Adverse Event|14|||
170780558|NCT04218266|617203574|FG002|Overall Study|Adverse Event|11|||
170780559|NCT04218266|617203572|FG000|Overall Study|Other|7|||
170780560|NCT04218266|617203573|FG001|Overall Study|Other|5|||
170780561|NCT04218266|617203574|FG002|Overall Study|Other|14|||
170780562|NCT04218266|617203572|FG000|Overall Study|Physician Decision|1|||
170780563|NCT04218266|617203573|FG001|Overall Study|Physician Decision|3|||
170435311|NCT02997176|615932547|FG001|Overall Study|Withdrawal by Subject|2|||
170435312|NCT02997176|615932548|FG002|Overall Study|Withdrawal by Subject|0|||
170435313|NCT02997176|615932549|FG003|Overall Study|Withdrawal by Subject|1|||
170435314|NCT00414726|615932553|FG000|Overall Study|Withdrawal by Subject|0|||
170435315|NCT00414726|615932554|FG001|Overall Study|Withdrawal by Subject|1|||
170435316|NCT02651987|615932557|FG000|Overall Study|Adverse Event|2|||
170435317|NCT02651987|615932558|FG001|Overall Study|Adverse Event|2|||
170435318|NCT02651987|615932557|FG000|Overall Study|Consent Withdrawn|2|||
170435319|NCT02651987|615932558|FG001|Overall Study|Consent Withdrawn|0|||
170435320|NCT02651987|615932557|FG000|Overall Study|Local PD|0|||
170435321|NCT02651987|615932558|FG001|Overall Study|Local PD|2|||
170435322|NCT02651987|615932557|FG000|Overall Study|Investigator Decision|1|||
170435323|NCT02651987|615932558|FG001|Overall Study|Investigator Decision|1|||
170435324|NCT01630616|615932559|FG000|Overall Study|Adverse Event|0|||
170435325|NCT01630616|615932560|FG001|Overall Study|Adverse Event|0|||
170435326|NCT01630616|615932561|FG002|Overall Study|Adverse Event|0|||
170435327|NCT01630616|615932562|FG003|Overall Study|Adverse Event|1|||
170435328|NCT01630616|615932563|FG004|Overall Study|Adverse Event|0|||
170435329|NCT01630616|615932564|FG005|Overall Study|Adverse Event|0|||
170435330|NCT01630616|615932559|FG000|Overall Study|Withdrawal by Subject|0|||
170435331|NCT01630616|615932560|FG001|Overall Study|Withdrawal by Subject|0|||
170435332|NCT01630616|615932561|FG002|Overall Study|Withdrawal by Subject|0|||
170435333|NCT01630616|615932562|FG003|Overall Study|Withdrawal by Subject|2|||
170435334|NCT01630616|615932563|FG004|Overall Study|Withdrawal by Subject|0|||
170435335|NCT01630616|615932564|FG005|Overall Study|Withdrawal by Subject|0|||
170435336|NCT01117623|615932565|FG000|Overall Study|Adverse Event|0|||
170435337|NCT01117623|615932566|FG001|Overall Study|Adverse Event|2|||
170435338|NCT01117623|615932567|FG002|Overall Study|Adverse Event|4|||
170435339|NCT01117623|615932568|FG003|Overall Study|Adverse Event|0|||
170435340|NCT01117623|615932569|FG004|Overall Study|Adverse Event|2|||
170435341|NCT01117623|615932570|FG005|Overall Study|Adverse Event|0|||
170435342|NCT01117623|615932571|FG006|Overall Study|Adverse Event|0|||
170435343|NCT01117623|615932572|FG007|Overall Study|Adverse Event|2|||
170435344|NCT01117623|615932565|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
170435345|NCT01117623|615932566|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
170435346|NCT01117623|615932567|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
170882026|NCT00708500|617577602|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
170882027|NCT00708500|617577603|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
170435347|NCT01117623|615932568|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
170435348|NCT01117623|615932569|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
170435349|NCT01117623|615932570|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
170435350|NCT01117623|615932571|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
170435351|NCT01117623|615932572|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
170435352|NCT01117623|615932565|FG000|Overall Study|Withdrawal by Subject|0|||
170435353|NCT01117623|615932566|FG001|Overall Study|Withdrawal by Subject|0|||
170435354|NCT01117623|615932567|FG002|Overall Study|Withdrawal by Subject|2|||
170435355|NCT01117623|615932568|FG003|Overall Study|Withdrawal by Subject|0|||
170435356|NCT01117623|615932569|FG004|Overall Study|Withdrawal by Subject|0|||
170435357|NCT01117623|615932570|FG005|Overall Study|Withdrawal by Subject|1|||
170435358|NCT01117623|615932571|FG006|Overall Study|Withdrawal by Subject|1|||
170435359|NCT01117623|615932572|FG007|Overall Study|Withdrawal by Subject|1|||
170435360|NCT01117623|615932565|FG000|Overall Study|Non-compliance with study medication|0|||
170435361|NCT01117623|615932566|FG001|Overall Study|Non-compliance with study medication|0|||
170435362|NCT01117623|615932567|FG002|Overall Study|Non-compliance with study medication|0|||
170435363|NCT01117623|615932568|FG003|Overall Study|Non-compliance with study medication|0|||
170435364|NCT01117623|615932569|FG004|Overall Study|Non-compliance with study medication|0|||
170435365|NCT01117623|615932570|FG005|Overall Study|Non-compliance with study medication|0|||
170435366|NCT01117623|615932571|FG006|Overall Study|Non-compliance with study medication|0|||
170435367|NCT01117623|615932572|FG007|Overall Study|Non-compliance with study medication|1|||
170435368|NCT01117623|615932565|FG000|Overall Study|Invest. text: completed all planned txs|0|||
170435369|NCT01117623|615932566|FG001|Overall Study|Invest. text: completed all planned txs|0|||
170435370|NCT01117623|615932567|FG002|Overall Study|Invest. text: completed all planned txs|0|||
170435371|NCT01117623|615932568|FG003|Overall Study|Invest. text: completed all planned txs|0|||
170435372|NCT01117623|615932569|FG004|Overall Study|Invest. text: completed all planned txs|0|||
170435373|NCT01117623|615932570|FG005|Overall Study|Invest. text: completed all planned txs|1|||
170435374|NCT01117623|615932571|FG006|Overall Study|Invest. text: completed all planned txs|0|||
170435375|NCT01117623|615932572|FG007|Overall Study|Invest. text: completed all planned txs|0|||
170435376|NCT00687739|615932576|FG000|Overall Study|Lost to Follow-up|2|||
170435377|NCT00687739|615932577|FG001|Overall Study|Lost to Follow-up|2|||
170435378|NCT00687739|615932578|FG002|Overall Study|Lost to Follow-up|1|||
170435379|NCT00687739|615932579|FG003|Overall Study|Lost to Follow-up|2|||
170435380|NCT00687739|615932576|FG000|Overall Study|Adverse Event|0|||
170435381|NCT00687739|615932577|FG001|Overall Study|Adverse Event|1|||
170435382|NCT00687739|615932578|FG002|Overall Study|Adverse Event|1|||
170435383|NCT00687739|615932579|FG003|Overall Study|Adverse Event|0|||
170435384|NCT03674892|615932585|FG000|Overall Study|Lack of Efficacy|5|||
170435385|NCT03674892|615932585|FG000|Overall Study|Lost to Follow-up|3|||
170435386|NCT03674892|615932585|FG000|Overall Study|Migraine|2|||
170435387|NCT03674892|615932585|FG000|Overall Study|Excessive Tearing|1|||
170435388|NCT03674892|615932585|FG000|Overall Study|Increased Eye Pain|1|||
170435389|NCT03674892|615932585|FG000|Overall Study|Increased Facial Pain|1|||
170435390|NCT03674892|615932585|FG000|Overall Study|Sinus Irritation|1|||
170435391|NCT03674892|615932585|FG000|Overall Study|Sinus Infection|1|||
170435392|NCT02842853|615932586|FG000|Overall Study|Non-compliance with the protocol|3|||
170435393|NCT02842853|615932587|FG001|Overall Study|Non-compliance with the protocol|7|||
170435394|NCT02842853|615932588|FG002|Overall Study|Non-compliance with the protocol|2|||
170435395|NCT02842853|615932589|FG003|Overall Study|Non-compliance with the protocol|5|||
170435396|NCT02842853|615932586|FG000|Overall Study|Subject met exclusion criteria|0|||
170435397|NCT02842853|615932587|FG001|Overall Study|Subject met exclusion criteria|1|||
170435398|NCT02842853|615932588|FG002|Overall Study|Subject met exclusion criteria|0|||
170435399|NCT02842853|615932589|FG003|Overall Study|Subject met exclusion criteria|0|||
170435400|NCT02842853|615932586|FG000|Overall Study|Withdrawal by Subject|11|||
170435401|NCT02842853|615932587|FG001|Overall Study|Withdrawal by Subject|13|||
170435402|NCT02842853|615932588|FG002|Overall Study|Withdrawal by Subject|9|||
170435403|NCT02842853|615932589|FG003|Overall Study|Withdrawal by Subject|8|||
170435404|NCT02842853|615932586|FG000|Overall Study|Lost to Follow-up|9|||
170435405|NCT02842853|615932587|FG001|Overall Study|Lost to Follow-up|13|||
170435406|NCT02842853|615932588|FG002|Overall Study|Lost to Follow-up|10|||
170780564|NCT04218266|617203574|FG002|Overall Study|Physician Decision|2|||
170435407|NCT02842853|615932589|FG003|Overall Study|Lost to Follow-up|11|||
170435408|NCT04089553|615932592|FG000|Overall Study|Death|1|||
170435409|NCT04089553|615932593|FG001|Overall Study|Death|1|||
170435410|NCT04089553|615932592|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
170435411|NCT04089553|615932593|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
170435412|NCT04089553|615932592|FG000|Overall Study|Withdrawal by Subject|3|||
170435413|NCT04089553|615932593|FG001|Overall Study|Withdrawal by Subject|3|||
170435414|NCT04089553|615932592|FG000|Overall Study|Physician Decision|1|||
170435415|NCT04089553|615932593|FG001|Overall Study|Physician Decision|0|||
170435416|NCT04089553|615932592|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
170435417|NCT04089553|615932593|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
170435418|NCT04089553|615932592|FG000|Overall Study|Other|1|||
170435419|NCT04089553|615932593|FG001|Overall Study|Other|0|||
170435420|NCT04089553|615932592|FG000|Overall Study|Adverse Event|1|||
170435421|NCT04089553|615932593|FG001|Overall Study|Adverse Event|1|||
170435422|NCT01403194|615932597|FG000|Overall Study|Screen Failure|2|||
170435423|NCT01403194|615932597|FG000|Overall Study|Lost to Follow-up|8|||
170435424|NCT01701063|615932600|FG000|Overall Study|Lost to Follow-up|0|||
170435425|NCT01701063|615932601|FG001|Overall Study|Lost to Follow-up|1|||
170435426|NCT01701063|615932602|FG002|Overall Study|Lost to Follow-up|0|||
170435427|NCT01701063|615932600|FG000|Overall Study|Withdrawal by Subject|0|||
170435428|NCT01701063|615932601|FG001|Overall Study|Withdrawal by Subject|0|||
170435429|NCT01701063|615932602|FG002|Overall Study|Withdrawal by Subject|1|||
170435430|NCT01701063|615932600|FG000|Overall Study|Other|0|||
170435431|NCT01701063|615932601|FG001|Overall Study|Other|0|||
170435432|NCT01701063|615932602|FG002|Overall Study|Other|1|||
170435433|NCT01919112|615932605|FG000|Secondary Analysis-day 30|Death|1|||
170435434|NCT01919112|615932606|FG001|Secondary Analysis-day 30|Death|1|||
170435435|NCT01919112|615932607|FG002|Secondary Analysis-day 30|Death|1|||
170435436|NCT01919112|615932605|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
170435437|NCT01919112|615932606|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
170435438|NCT01919112|615932607|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
170435439|NCT02043132|615932608|FG000|Overall Study|Lost to Follow-up|1|||
170435440|NCT02043132|615932609|FG001|Overall Study|Lost to Follow-up|1|||
170435441|NCT02043132|615932608|FG000|Overall Study|screen failures|4|||
170435442|NCT02043132|615932609|FG001|Overall Study|screen failures|8|||
170435443|NCT00274651|615932610|FG000|Overall Study|Adverse Event|6|||
170435444|NCT00274651|615932611|FG001|Overall Study|Adverse Event|3|||
170435445|NCT00274651|615932610|FG000|Overall Study|Lack of Efficacy|13|||
170435446|NCT00274651|615932611|FG001|Overall Study|Lack of Efficacy|6|||
170435447|NCT00274651|615932610|FG000|Overall Study|Death|1|||
170435448|NCT00274651|615932611|FG001|Overall Study|Death|3|||
170435449|NCT00274651|615932610|FG000|Overall Study|Withdrawal by Subject|0|||
170435450|NCT00274651|615932611|FG001|Overall Study|Withdrawal by Subject|1|||
170435451|NCT00274651|615932610|FG000|Overall Study|Physician Decision|8|||
170435452|NCT00274651|615932611|FG001|Overall Study|Physician Decision|7|||
170435453|NCT04474405|615932612|FG000|Overall Study|Withdrawal by Subject|0|||
170435454|NCT04474405|615932613|FG001|Overall Study|Withdrawal by Subject|0|||
170435455|NCT04474405|615932614|FG002|Overall Study|Withdrawal by Subject|1|||
170435456|NCT04474405|615932615|FG003|Overall Study|Withdrawal by Subject|0|||
170435457|NCT04474405|615932616|FG004|Overall Study|Withdrawal by Subject|1|||
170435458|NCT04474405|615932617|FG005|Overall Study|Withdrawal by Subject|0|||
170435459|NCT04474405|615932612|FG000|Overall Study|Other|0|||
170435460|NCT04474405|615932613|FG001|Overall Study|Other|0|||
170435461|NCT04474405|615932614|FG002|Overall Study|Other|0|||
170435462|NCT04474405|615932615|FG003|Overall Study|Other|0|||
170435463|NCT04474405|615932616|FG004|Overall Study|Other|3|||
170435464|NCT04474405|615932617|FG005|Overall Study|Other|0|||
170435465|NCT00918645|615932618|FG000|Overall Study|Withdrawal by Subject|1|||
170435466|NCT00835666|615932619|FG000|Washout|Protocol Violation|1|||
170435467|NCT00835666|615932620|FG001|Washout|Protocol Violation|0|||
170435468|NCT00835666|615932619|FG000|Washout|Withdrawal by Subject|1|||
170435469|NCT00835666|615932620|FG001|Washout|Withdrawal by Subject|0|||
170435470|NCT03446768|615932621|FG000|Overall Study|Withdrawal by Subject|0|||
170435471|NCT03446768|615932622|FG001|Overall Study|Withdrawal by Subject|1|||
170882028|NCT00708500|617577604|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
170882029|NCT00708500|617577602|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
170882030|NCT00708500|617577603|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
170882031|NCT00708500|617577604|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
170882032|NCT00708500|617577602|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
170882033|NCT00708500|617577603|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
170882034|NCT00708500|617577604|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
170882035|NCT00708500|617577602|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
170882036|NCT00708500|617577603|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
170882037|NCT00708500|617577604|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
170882038|NCT00708500|617577602|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
170882039|NCT00708500|617577603|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
170882040|NCT00708500|617577604|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
170882041|NCT00708500|617577602|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
170882042|NCT00708500|617577603|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
170882043|NCT00708500|617577604|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
170882044|NCT00708500|617577602|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
170882045|NCT00708500|617577603|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
170882046|NCT00708500|617577604|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
170882047|NCT00708500|617577602|FG000|FOLLOWUP|Adverse Event|0|||
170882048|NCT00708500|617577603|FG001|FOLLOWUP|Adverse Event|1|||
170882049|NCT00708500|617577604|FG002|FOLLOWUP|Adverse Event|0|||
170882050|NCT00708500|617577602|FG000|FOLLOWUP|Lost to Follow-up|1|||
170882051|NCT00708500|617577603|FG001|FOLLOWUP|Lost to Follow-up|6|||
170882052|NCT00708500|617577604|FG002|FOLLOWUP|Lost to Follow-up|4|||
170882053|NCT00708500|617577602|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
170882054|NCT00708500|617577603|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
170882055|NCT00708500|617577604|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
170882056|NCT00708500|617577602|FG000|FOLLOWUP|Subject withdrew consent|31|||
170882057|NCT00708500|617577603|FG001|FOLLOWUP|Subject withdrew consent|4|||
170882058|NCT00708500|617577604|FG002|FOLLOWUP|Subject withdrew consent|5|||
170882059|NCT00708500|617577602|FG000|FOLLOWUP|Non-compliance with protocol|5|||
170882060|NCT00708500|617577603|FG001|FOLLOWUP|Non-compliance with protocol|0|||
170882061|NCT00708500|617577604|FG002|FOLLOWUP|Non-compliance with protocol|1|||
170882062|NCT01029366|617577612|FG000|Overall Study|Withdrawal by Subject|1|||
170882063|NCT01029366|617577613|FG001|Overall Study|Withdrawal by Subject|0|||
170882064|NCT01029366|617577612|FG000|Overall Study|Death|1|||
170882065|NCT01029366|617577613|FG001|Overall Study|Death|1|||
170882066|NCT01029366|617577612|FG000|Overall Study|disease progression|2|||
170882067|NCT01029366|617577613|FG001|Overall Study|disease progression|0|||
170882068|NCT01029366|617577612|FG000|Overall Study|manufacturing failure|0|||
170882069|NCT01029366|617577613|FG001|Overall Study|manufacturing failure|1|||
170882070|NCT00906087|617577619|FG000|Initial Washout|Withdrawal by Subject|1|||
170882071|NCT00906087|617577619|FG000|Initial Washout|Physician Decision|1|||
170882072|NCT00440947|617577620|FG000|36-Week Induction Phase|Adverse Event|16|||
170882073|NCT00440947|617577621|FG001|36-Week Induction Phase|Adverse Event|0|||
170882074|NCT00440947|617577622|FG002|36-Week Induction Phase|Adverse Event|0|||
170882075|NCT00440947|617577623|FG003|36-Week Induction Phase|Adverse Event|0|||
170435472|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
170435473|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
170435474|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
170632782|NCT01198977|616666768|FG001|Overall Study|Lost to Follow-up|0|||
170882076|NCT00440947|617577624|FG004|36-Week Induction Phase|Adverse Event|0|||
170882077|NCT00440947|617577620|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
170435475|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
170882078|NCT00440947|617577621|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
170882079|NCT00440947|617577622|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
170435476|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
170435477|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
170435478|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
170435479|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
170435480|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
170435481|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
170435482|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
170435483|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
170435484|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
170435485|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
170435486|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
170435487|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
170435488|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
170435489|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
170435490|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
170435491|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
170435492|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
170435493|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
170435494|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
170435495|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
170435496|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
170435497|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
170435498|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
170435499|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
170435500|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
170435501|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
170435502|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
170435503|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
170435504|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
170435505|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
170435506|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
170435507|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
170435508|NCT04194801|615932623|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
170435509|NCT04194801|615932624|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
170435510|NCT04194801|615932625|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
170435511|NCT04194801|615932623|FG000|Part Ib/II End of Study|Death|2|||
170435512|NCT04194801|615932624|FG001|Part Ib/II End of Study|Death|3|||
170435513|NCT04194801|615932625|FG002|Part Ib/II End of Study|Death|3|||
170435514|NCT04194801|615932623|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
170435515|NCT04194801|615932624|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
170435516|NCT04194801|615932625|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
170435517|NCT04194801|615932623|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
170435518|NCT04194801|615932624|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
170435519|NCT04194801|615932625|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
170632783|NCT03205423|616666771|FG000|Overall Study|Personal|1|||
170780565|NCT04218266|617203572|FG000|Overall Study|Non-compliance with study drug|0|||
170780566|NCT04218266|617203573|FG001|Overall Study|Non-compliance with study drug|0|||
170780567|NCT04218266|617203574|FG002|Overall Study|Non-compliance with study drug|1|||
170780568|NCT04218266|617203572|FG000|Overall Study|Withdrawal by Subject|1|||
170780569|NCT04218266|617203573|FG001|Overall Study|Withdrawal by Subject|3|||
170780570|NCT04218266|617203574|FG002|Overall Study|Withdrawal by Subject|1|||
170780571|NCT04218266|617203572|FG000|Overall Study|Study drug never administered|2|||
170780572|NCT04218266|617203573|FG001|Overall Study|Study drug never administered|0|||
170780573|NCT04218266|617203574|FG002|Overall Study|Study drug never administered|0|||
170632784|NCT03205423|616666772|FG001|Overall Study|Personal|1|||
170632785|NCT03205423|616666771|FG000|Overall Study|Physician Decision|0|||
170632786|NCT03205423|616666772|FG001|Overall Study|Physician Decision|2|||
170632787|NCT01899040|616666773|FG000|Overall Study|Randomized in error|0|||
170632788|NCT01899040|616666774|FG001|Overall Study|Randomized in error|1|||
170632789|NCT01899040|616666775|FG002|Overall Study|Randomized in error|1|||
170632790|NCT01899040|616666773|FG000|Overall Study|Adverse Event|3|||
170632791|NCT01899040|616666774|FG001|Overall Study|Adverse Event|1|||
170780574|NCT02597946|617205633|FG000|Overall Study|Withdrawal by Subject|1|||
170780575|NCT02597946|617205633|FG000|Overall Study|Progressive disease|16|||
170632792|NCT01899040|616666775|FG002|Overall Study|Adverse Event|2|||
170632793|NCT01899040|616666773|FG000|Overall Study|Unspecified reasons|4|||
170632794|NCT01899040|616666774|FG001|Overall Study|Unspecified reasons|4|||
170780576|NCT02597946|617205633|FG000|Overall Study|Other than above|1|||
170780577|NCT03775109|617205639|FG000|Overall Study|Adverse Event|1|||
170780578|NCT03775109|617205640|FG001|Overall Study|Adverse Event|0|||
170780579|NCT03775109|617205639|FG000|Overall Study|COVID-19 outbreak|2|||
170780580|NCT03775109|617205640|FG001|Overall Study|COVID-19 outbreak|0|||
170780581|NCT03775109|617205639|FG000|Overall Study|Lost to Follow-up|0|||
170780582|NCT03775109|617205640|FG001|Overall Study|Lost to Follow-up|2|||
170780583|NCT03775109|617205639|FG000|Overall Study|Withdrawal by Subject|1|||
170780584|NCT03775109|617205640|FG001|Overall Study|Withdrawal by Subject|1|||
170780585|NCT03775109|617205639|FG000|Overall Study|Death|0|||
170780586|NCT03775109|617205640|FG001|Overall Study|Death|1|||
170780587|NCT03775109|617205639|FG000|Overall Study|Lack of Efficacy|1|||
170780588|NCT03775109|617205640|FG001|Overall Study|Lack of Efficacy|0|||
170780589|NCT00739648|617205641|FG000|Overall Study|Adverse Event|3|||
170780590|NCT00739648|617205642|FG001|Overall Study|Adverse Event|15|||
170780591|NCT00739648|617205641|FG000|Overall Study|Withdrawal by Subject|13|||
170780592|NCT00739648|617205642|FG001|Overall Study|Withdrawal by Subject|25|||
170780593|NCT00739648|617205641|FG000|Overall Study|Lost to Follow-up|4|||
170780594|NCT00739648|617205642|FG001|Overall Study|Lost to Follow-up|7|||
170780595|NCT00739648|617205641|FG000|Overall Study|Death|2|||
170780596|NCT00739648|617205642|FG001|Overall Study|Death|0|||
170780597|NCT00739648|617205641|FG000|Overall Study|Do not know|4|||
170780598|NCT00739648|617205642|FG001|Overall Study|Do not know|6|||
170780599|NCT02840474|617205643|FG000|Overall Study|Lost to Follow-up|1|||
170780600|NCT02840474|617205644|FG001|Overall Study|Lost to Follow-up|0|||
170780601|NCT02287311|617205645|FG000|Cohort 1: Dose Level 1|Death|2|||
170780602|NCT02287311|617205646|FG001|Cohort 1: Dose Level 1|Death|0|||
170780603|NCT02287311|617205647|FG002|Cohort 1: Dose Level 1|Death|0|||
170780604|NCT02287311|617205648|FG003|Cohort 1: Dose Level 1|Death|3|||
170780605|NCT02287311|617205649|FG004|Cohort 1: Dose Level 1|Death|0|||
170780606|NCT02287311|617205650|FG005|Cohort 1: Dose Level 1|Death|0|||
170780607|NCT02287311|617205651|FG006|Cohort 1: Dose Level 1|Death|1|||
170780608|NCT02287311|617205652|FG007|Cohort 1: Dose Level 1|Death|0|||
170780609|NCT02287311|617205653|FG008|Cohort 1: Dose Level 1|Death|0|||
170780610|NCT02287311|617205645|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
170780611|NCT02287311|617205646|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
170780612|NCT02287311|617205647|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
170780613|NCT02287311|617205648|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
170780614|NCT02287311|617205649|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
170780615|NCT02287311|617205650|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
170780616|NCT02287311|617205651|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
170780617|NCT02287311|617205652|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
170780618|NCT02287311|617205653|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
170780619|NCT02287311|617205645|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
170780620|NCT02287311|617205646|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
170780621|NCT02287311|617205647|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
170882080|NCT00440947|617577623|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
170882081|NCT00440947|617577624|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
170882082|NCT00440947|617577620|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
170882083|NCT00440947|617577621|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
170780622|NCT02287311|617205648|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
170780623|NCT02287311|617205649|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
170780624|NCT02287311|617205650|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
170780625|NCT02287311|617205651|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
170780626|NCT02287311|617205652|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
170780627|NCT02287311|617205653|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
170632795|NCT01899040|616666775|FG002|Overall Study|Unspecified reasons|0|||
170780628|NCT02287311|617205645|FG000|Cohort 2: Dose Level 2|Death|0|||
170780629|NCT02287311|617205646|FG001|Cohort 2: Dose Level 2|Death|2|||
170780630|NCT02287311|617205647|FG002|Cohort 2: Dose Level 2|Death|0|||
170780631|NCT02287311|617205648|FG003|Cohort 2: Dose Level 2|Death|0|||
170780632|NCT02287311|617205649|FG004|Cohort 2: Dose Level 2|Death|2|||
170632796|NCT01899040|616666773|FG000|Overall Study|Compliance issues|1|||
170632797|NCT01899040|616666774|FG001|Overall Study|Compliance issues|2|||
170780633|NCT02287311|617205650|FG005|Cohort 2: Dose Level 2|Death|0|||
170435520|NCT04194801|615932623|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
170435521|NCT04194801|615932624|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
170435522|NCT04194801|615932625|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
170435523|NCT04194801|615932623|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
170435524|NCT04194801|615932624|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
170435525|NCT04194801|615932625|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
170435526|NCT03827395|615932626|FG000|Overall Study|Lost to Follow-up|1|||
170435527|NCT03827395|615932627|FG001|Overall Study|Lost to Follow-up|0|||
170435528|NCT03827395|615932626|FG000|Overall Study|Protocol Violation|1|||
170435529|NCT03827395|615932627|FG001|Overall Study|Protocol Violation|0|||
170435530|NCT03827395|615932626|FG000|Overall Study|Became ineligible after enrollment|1|||
170435531|NCT03827395|615932627|FG001|Overall Study|Became ineligible after enrollment|2|||
170435532|NCT02280863|615932631|FG000|Integrated Platform|Met stopping criteria|0|||
170435533|NCT02280863|615932632|FG001|Integrated Platform|Met stopping criteria|1|||
170435534|NCT00985439|615932633|FG000|Overall Study|Adverse Event|0|||
170435535|NCT00985439|615932634|FG001|Overall Study|Adverse Event|0|||
170435536|NCT00985439|615932635|FG002|Overall Study|Adverse Event|1|||
170435537|NCT00985439|615932636|FG003|Overall Study|Adverse Event|0|||
170435538|NCT01174186|615932637|FG000|Overall Study|Lost to Follow-up|0|||
170435539|NCT01174186|615932638|FG001|Overall Study|Lost to Follow-up|1|||
170435540|NCT01174186|615932637|FG000|Overall Study|Withdrawal by Subject|0|||
170435541|NCT01174186|615932638|FG001|Overall Study|Withdrawal by Subject|2|||
170435542|NCT00463684|615932640|FG000|Overall Study|Withdrawal by Subject|1|||
170435543|NCT00463684|615932640|FG000|Overall Study|Lost to Follow-up|3|||
170435544|NCT00924638|615932644|FG000|Overall Study|Death|3|||
170435545|NCT00924638|615932645|FG001|Overall Study|Death|2|||
170435546|NCT00924638|615932644|FG000|Overall Study|Lost to Follow-up|1|||
170435547|NCT00924638|615932645|FG001|Overall Study|Lost to Follow-up|1|||
170435548|NCT00924638|615932644|FG000|Overall Study|Withdrawal by Subject|5|||
170435549|NCT00924638|615932645|FG001|Overall Study|Withdrawal by Subject|7|||
170435550|NCT00924638|615932644|FG000|Overall Study|Physician Decision|3|||
170435551|NCT00924638|615932645|FG001|Overall Study|Physician Decision|3|||
170435552|NCT00367133|615932646|FG000|2 Years|Death|20|||
170435553|NCT00367133|615932647|FG001|2 Years|Death|12|||
170435554|NCT00367133|615932648|FG002|2 Years|Death|12|||
170435555|NCT00367133|615932646|FG000|2 Years|Dropped|34|||
170435556|NCT00367133|615932647|FG001|2 Years|Dropped|19|||
170435557|NCT00367133|615932648|FG002|2 Years|Dropped|33|||
170435558|NCT00367133|615932646|FG000|2 Years|Missed visit|4|||
170435559|NCT00367133|615932647|FG001|2 Years|Missed visit|5|||
170435560|NCT00367133|615932648|FG002|2 Years|Missed visit|4|||
170435561|NCT00847535|615932649|FG000|Overall Study|Withdrawal by Subject|2|||
170435562|NCT00847535|615932650|FG001|Overall Study|Withdrawal by Subject|1|||
170435563|NCT00847535|615932651|FG002|Overall Study|Withdrawal by Subject|1|||
170435564|NCT00847535|615932649|FG000|Overall Study|Lost to Follow-up|0|||
170435565|NCT00847535|615932650|FG001|Overall Study|Lost to Follow-up|1|||
170435566|NCT00847535|615932651|FG002|Overall Study|Lost to Follow-up|0|||
170435567|NCT00748566|615932654|FG000|Overall Study|Adverse Event|49|||
170435568|NCT00748566|615932654|FG000|Overall Study|Death|1|||
170435569|NCT00748566|615932654|FG000|Overall Study|Lack of Efficacy|12|||
170435570|NCT00748566|615932654|FG000|Overall Study|Lost to Follow-up|1|||
170435571|NCT00748566|615932654|FG000|Overall Study|Protocol Violation|13|||
170435572|NCT00748566|615932654|FG000|Overall Study|Withdrawal by Subject|22|||
170435573|NCT00748566|615932654|FG000|Overall Study|Study terminated by sponsor|5|||
170632798|NCT01899040|616666775|FG002|Overall Study|Compliance issues|0|||
170435574|NCT00748566|615932654|FG000|Overall Study|Other|9|||
170435575|NCT02845336|615932657|FG000|Overall Study|Lost to Follow-up|3|||
170435576|NCT02845336|615932658|FG001|Overall Study|Lost to Follow-up|1|||
170435577|NCT02845336|615932657|FG000|Overall Study|Inability to get medication|2|||
170435578|NCT02845336|615932658|FG001|Overall Study|Inability to get medication|0|||
170435579|NCT00868998|615932669|FG000|Overall Study|Screen Failure|1|||
170435580|NCT00868998|615932669|FG000|Overall Study|Withdrawal by Subject|1|||
170435581|NCT00868998|615932669|FG000|Overall Study|Progression of disease|2|||
170435582|NCT00868998|615932669|FG000|Overall Study|Death|1|||
170435583|NCT05412121|615932670|FG000|Overall Study|Withdrawal by Subject|4|||
170435584|NCT05412121|615932670|FG000|Overall Study|Physician Decision|1|||
170780634|NCT02287311|617205651|FG006|Cohort 2: Dose Level 2|Death|0|||
170780635|NCT02287311|617205652|FG007|Cohort 2: Dose Level 2|Death|2|||
170780636|NCT02287311|617205653|FG008|Cohort 2: Dose Level 2|Death|0|||
170780637|NCT02287311|617205645|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
170780638|NCT02287311|617205646|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
170780639|NCT02287311|617205647|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
170780640|NCT02287311|617205648|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
170780641|NCT02287311|617205649|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
170780642|NCT02287311|617205650|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
170780643|NCT02287311|617205651|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
170780644|NCT02287311|617205652|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
170780645|NCT02287311|617205653|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
170780646|NCT02287311|617205645|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
170780647|NCT02287311|617205646|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
170435585|NCT05412121|615932670|FG000|Overall Study|Lost to Follow-up|5|||
170435586|NCT01960296|615932671|FG000|Overall Study|Postponed surgery|1|||
170435587|NCT01960296|615932672|FG001|Overall Study|Postponed surgery|0|||
170435588|NCT01960296|615932671|FG000|Overall Study|Received different procedure|1|||
170435589|NCT01960296|615932672|FG001|Overall Study|Received different procedure|3|||
170435590|NCT02003391|615932673|FG000|Overall Study|Withdrawal by Subject|2|||
170435591|NCT02003391|615932674|FG001|Overall Study|Withdrawal by Subject|1|||
170435592|NCT02003391|615932673|FG000|Overall Study|Protocol Violation|0|||
170435593|NCT02003391|615932674|FG001|Overall Study|Protocol Violation|1|||
170435594|NCT02003391|615932673|FG000|Overall Study|Adverse Event|1|||
170435595|NCT02003391|615932674|FG001|Overall Study|Adverse Event|0|||
170435596|NCT02611323|615932677|FG000|Overall Study|Death|3|||
170435597|NCT02611323|615932678|FG001|Overall Study|Death|1|||
170435598|NCT02611323|615932679|FG002|Overall Study|Death|0|||
170435599|NCT02611323|615932680|FG003|Overall Study|Death|0|||
170435600|NCT02611323|615932681|FG004|Overall Study|Death|1|||
170435601|NCT02611323|615932682|FG005|Overall Study|Death|1|||
170435602|NCT02611323|615932683|FG006|Overall Study|Death|8|||
170435603|NCT02611323|615932684|FG007|Overall Study|Death|0|||
170435604|NCT02611323|615932685|FG008|Overall Study|Death|4|||
170435605|NCT02611323|615932686|FG009|Overall Study|Death|6|||
170435606|NCT02611323|615932687|FG010|Overall Study|Death|26|||
170435607|NCT02611323|615932677|FG000|Overall Study|Lost to Follow-up|1|||
170435608|NCT02611323|615932678|FG001|Overall Study|Lost to Follow-up|0|||
170435609|NCT02611323|615932679|FG002|Overall Study|Lost to Follow-up|0|||
170435610|NCT02611323|615932680|FG003|Overall Study|Lost to Follow-up|0|||
170435611|NCT02611323|615932681|FG004|Overall Study|Lost to Follow-up|0|||
170435612|NCT02611323|615932682|FG005|Overall Study|Lost to Follow-up|0|||
170435613|NCT02611323|615932683|FG006|Overall Study|Lost to Follow-up|3|||
170435614|NCT02611323|615932684|FG007|Overall Study|Lost to Follow-up|0|||
170435615|NCT02611323|615932685|FG008|Overall Study|Lost to Follow-up|0|||
170435616|NCT02611323|615932686|FG009|Overall Study|Lost to Follow-up|0|||
170435617|NCT02611323|615932687|FG010|Overall Study|Lost to Follow-up|2|||
170435618|NCT02611323|615932677|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435619|NCT02611323|615932678|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435620|NCT02611323|615932679|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435621|NCT02611323|615932680|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435622|NCT02611323|615932681|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435623|NCT02611323|615932682|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435624|NCT02611323|615932683|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435625|NCT02611323|615932684|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435626|NCT02611323|615932685|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435627|NCT02611323|615932686|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
170435628|NCT02611323|615932687|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
170435629|NCT02611323|615932677|FG000|Overall Study|Progressive Disease|0|||
170435630|NCT02611323|615932678|FG001|Overall Study|Progressive Disease|0|||
170435631|NCT02611323|615932679|FG002|Overall Study|Progressive Disease|0|||
170435632|NCT02611323|615932680|FG003|Overall Study|Progressive Disease|0|||
170435633|NCT02611323|615932681|FG004|Overall Study|Progressive Disease|0|||
170435634|NCT02611323|615932682|FG005|Overall Study|Progressive Disease|0|||
170435635|NCT02611323|615932683|FG006|Overall Study|Progressive Disease|0|||
170435636|NCT02611323|615932684|FG007|Overall Study|Progressive Disease|0|||
170435637|NCT02611323|615932685|FG008|Overall Study|Progressive Disease|0|||
170632799|NCT02638220|616666781|FG000|Overall Study|Lost to Follow-up|6|||
170632800|NCT02638220|616666781|FG000|Overall Study|Withdrawal by Subject|3|||
170632801|NCT02638220|616666781|FG000|Overall Study|Physician Decision|1|||
170632802|NCT02638220|616666781|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
170780648|NCT02287311|617205647|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
170780649|NCT02287311|617205648|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
170780650|NCT02287311|617205649|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
170435638|NCT02611323|615932686|FG009|Overall Study|Progressive Disease|0|||
170435639|NCT02611323|615932687|FG010|Overall Study|Progressive Disease|1|||
170435640|NCT02611323|615932677|FG000|Overall Study|Withdrawal by Subject|1|||
170435641|NCT02611323|615932678|FG001|Overall Study|Withdrawal by Subject|0|||
170435642|NCT02611323|615932679|FG002|Overall Study|Withdrawal by Subject|0|||
170435643|NCT02611323|615932680|FG003|Overall Study|Withdrawal by Subject|0|||
170435644|NCT02611323|615932681|FG004|Overall Study|Withdrawal by Subject|0|||
170435645|NCT02611323|615932682|FG005|Overall Study|Withdrawal by Subject|0|||
170435646|NCT02611323|615932683|FG006|Overall Study|Withdrawal by Subject|0|||
170435647|NCT02611323|615932684|FG007|Overall Study|Withdrawal by Subject|1|||
170435648|NCT02611323|615932685|FG008|Overall Study|Withdrawal by Subject|0|||
170435649|NCT02611323|615932686|FG009|Overall Study|Withdrawal by Subject|1|||
170435650|NCT02611323|615932687|FG010|Overall Study|Withdrawal by Subject|0|||
170435651|NCT02264977|615932688|FG000|Overall Study|Death|3|||
170435652|NCT02264977|615932688|FG000|Overall Study|Physician Decision|1|||
170435653|NCT02264977|615932688|FG000|Overall Study|Refuse to return|1|||
170632803|NCT04323124|616666783|FG000|Overall Study|Adverse Event|0|||
170435654|NCT00243347|615932689|FG000|Overall Study|Lack of Efficacy|4|||
170435655|NCT00243347|615932689|FG000|Overall Study|Adverse Event|2|||
170435656|NCT00243347|615932689|FG000|Overall Study|Death|1|||
170435657|NCT00243347|615932689|FG000|Overall Study|Withdrawal by Subject|5|||
170435658|NCT00243347|615932689|FG000|Overall Study|Condition worsened|7|||
170435659|NCT03573544|615932690|FG000|Overall Study|Adverse Event|0|||
170435660|NCT03573544|615932691|FG001|Overall Study|Adverse Event|0|||
170435661|NCT03573544|615932692|FG002|Overall Study|Adverse Event|0|||
170435662|NCT03573544|615932693|FG003|Overall Study|Adverse Event|3|||
170435663|NCT03573544|615932694|FG004|Overall Study|Adverse Event|1|||
170435664|NCT03573544|615932695|FG005|Overall Study|Adverse Event|0|||
170435665|NCT03573544|615932696|FG006|Overall Study|Adverse Event|2|||
170435666|NCT03573544|615932697|FG007|Overall Study|Adverse Event|0|||
170435667|NCT03573544|615932690|FG000|Overall Study|Physician Decision|0|||
170435668|NCT03573544|615932691|FG001|Overall Study|Physician Decision|0|||
170435669|NCT03573544|615932692|FG002|Overall Study|Physician Decision|0|||
170435670|NCT03573544|615932693|FG003|Overall Study|Physician Decision|0|||
170435671|NCT03573544|615932694|FG004|Overall Study|Physician Decision|0|||
170435672|NCT03573544|615932695|FG005|Overall Study|Physician Decision|0|||
170435673|NCT03573544|615932696|FG006|Overall Study|Physician Decision|1|||
170435674|NCT03573544|615932697|FG007|Overall Study|Physician Decision|0|||
170435675|NCT03573544|615932690|FG000|Overall Study|Withdrawal by Subject|2|||
170435676|NCT03573544|615932691|FG001|Overall Study|Withdrawal by Subject|0|||
170435677|NCT03573544|615932692|FG002|Overall Study|Withdrawal by Subject|0|||
170435678|NCT03573544|615932693|FG003|Overall Study|Withdrawal by Subject|1|||
170435679|NCT03573544|615932694|FG004|Overall Study|Withdrawal by Subject|1|||
170632804|NCT04323124|616666784|FG001|Overall Study|Adverse Event|0|||
170632805|NCT04323124|616666785|FG002|Overall Study|Adverse Event|0|||
170632806|NCT04323124|616666786|FG003|Overall Study|Adverse Event|0|||
170632807|NCT04323124|616666787|FG004|Overall Study|Adverse Event|0|||
170632808|NCT04323124|616666788|FG005|Overall Study|Adverse Event|1|||
170632809|NCT04323124|616666789|FG006|Overall Study|Adverse Event|0|||
170632810|NCT04323124|616666790|FG007|Overall Study|Adverse Event|1|||
170632811|NCT04323124|616666791|FG008|Overall Study|Adverse Event|1|||
170632812|NCT04323124|616666792|FG009|Overall Study|Adverse Event|0|||
170780651|NCT02287311|617205650|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
170632813|NCT04323124|616666793|FG010|Overall Study|Adverse Event|0|||
170435680|NCT03573544|615932695|FG005|Overall Study|Withdrawal by Subject|1|||
170435681|NCT03573544|615932696|FG006|Overall Study|Withdrawal by Subject|0|||
170435682|NCT03573544|615932697|FG007|Overall Study|Withdrawal by Subject|1|||
170435683|NCT03573544|615932690|FG000|Overall Study|Disease progression|3|||
170435684|NCT03573544|615932691|FG001|Overall Study|Disease progression|3|||
170435685|NCT03573544|615932692|FG002|Overall Study|Disease progression|6|||
170435686|NCT03573544|615932693|FG003|Overall Study|Disease progression|4|||
170435687|NCT03573544|615932694|FG004|Overall Study|Disease progression|5|||
170435688|NCT03573544|615932695|FG005|Overall Study|Disease progression|7|||
170780652|NCT02287311|617205651|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
170780653|NCT02287311|617205652|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
170780654|NCT02287311|617205653|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
170780655|NCT02287311|617205645|FG000|Cohort 3: Dose Level 3|Death|0|||
170780656|NCT02287311|617205646|FG001|Cohort 3: Dose Level 3|Death|0|||
170780657|NCT02287311|617205647|FG002|Cohort 3: Dose Level 3|Death|4|||
170780658|NCT02287311|617205648|FG003|Cohort 3: Dose Level 3|Death|0|||
170780659|NCT02287311|617205649|FG004|Cohort 3: Dose Level 3|Death|0|||
170780660|NCT02287311|617205650|FG005|Cohort 3: Dose Level 3|Death|4|||
170780661|NCT02287311|617205651|FG006|Cohort 3: Dose Level 3|Death|0|||
170780662|NCT02287311|617205652|FG007|Cohort 3: Dose Level 3|Death|0|||
170780663|NCT02287311|617205653|FG008|Cohort 3: Dose Level 3|Death|2|||
170780664|NCT02287311|617205645|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
170780665|NCT02287311|617205646|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
170780666|NCT02287311|617205647|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
170780667|NCT02287311|617205648|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
170780668|NCT02287311|617205649|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
170780669|NCT02287311|617205650|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
170780670|NCT02287311|617205651|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
170780671|NCT02287311|617205652|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
170780672|NCT02287311|617205653|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
170780673|NCT02287311|617205645|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
170780674|NCT02287311|617205646|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
170780675|NCT02287311|617205647|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
170435689|NCT03573544|615932696|FG006|Overall Study|Disease progression|6|||
170435690|NCT03573544|615932697|FG007|Overall Study|Disease progression|7|||
170435691|NCT01899053|615932700|FG000|Overall Study|Progressive Disease|4|||
170632814|NCT04323124|616666794|FG011|Overall Study|Adverse Event|0|||
170780676|NCT02287311|617205648|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
170780677|NCT02287311|617205649|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
170780678|NCT02287311|617205650|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
170780679|NCT02287311|617205651|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
170435692|NCT01899053|615932701|FG001|Overall Study|Progressive Disease|0|||
170435693|NCT01899053|615932702|FG002|Overall Study|Progressive Disease|3|||
170435694|NCT01899053|615932703|FG003|Overall Study|Progressive Disease|0|||
170435695|NCT01899053|615932704|FG004|Overall Study|Progressive Disease|3|||
170435696|NCT01899053|615932705|FG005|Overall Study|Progressive Disease|1|||
170435697|NCT01899053|615932706|FG006|Overall Study|Progressive Disease|1|||
170435698|NCT01899053|615932707|FG007|Overall Study|Progressive Disease|1|||
170435699|NCT01899053|615932708|FG008|Overall Study|Progressive Disease|4|||
170435700|NCT01899053|615932709|FG009|Overall Study|Progressive Disease|3|||
170435701|NCT01899053|615932710|FG010|Overall Study|Progressive Disease|12|||
170435702|NCT01899053|615932711|FG011|Overall Study|Progressive Disease|5|||
170435703|NCT01899053|615932712|FG012|Overall Study|Progressive Disease|8|||
170435704|NCT01899053|615932713|FG013|Overall Study|Progressive Disease|17|||
170435705|NCT01899053|615932700|FG000|Overall Study|Adverse Event|1|||
170435706|NCT01899053|615932701|FG001|Overall Study|Adverse Event|1|||
170435707|NCT01899053|615932702|FG002|Overall Study|Adverse Event|1|||
170435708|NCT01899053|615932703|FG003|Overall Study|Adverse Event|3|||
170435709|NCT01899053|615932704|FG004|Overall Study|Adverse Event|1|||
170435710|NCT01899053|615932705|FG005|Overall Study|Adverse Event|1|||
170435711|NCT01899053|615932706|FG006|Overall Study|Adverse Event|1|||
170435712|NCT01899053|615932707|FG007|Overall Study|Adverse Event|0|||
170435713|NCT01899053|615932708|FG008|Overall Study|Adverse Event|2|||
170435714|NCT01899053|615932709|FG009|Overall Study|Adverse Event|0|||
170435715|NCT01899053|615932710|FG010|Overall Study|Adverse Event|3|||
170435716|NCT01899053|615932711|FG011|Overall Study|Adverse Event|1|||
170435717|NCT01899053|615932712|FG012|Overall Study|Adverse Event|2|||
170435718|NCT01899053|615932713|FG013|Overall Study|Adverse Event|2|||
170435719|NCT01899053|615932700|FG000|Overall Study|Reason Not Specified|0|||
170435720|NCT01899053|615932701|FG001|Overall Study|Reason Not Specified|0|||
170435721|NCT01899053|615932702|FG002|Overall Study|Reason Not Specified|0|||
170435722|NCT01899053|615932703|FG003|Overall Study|Reason Not Specified|0|||
170435723|NCT01899053|615932704|FG004|Overall Study|Reason Not Specified|0|||
170435724|NCT01899053|615932705|FG005|Overall Study|Reason Not Specified|0|||
170435725|NCT01899053|615932706|FG006|Overall Study|Reason Not Specified|1|||
170435726|NCT01899053|615932707|FG007|Overall Study|Reason Not Specified|0|||
170435727|NCT01899053|615932708|FG008|Overall Study|Reason Not Specified|0|||
170435728|NCT01899053|615932709|FG009|Overall Study|Reason Not Specified|0|||
170435729|NCT01899053|615932710|FG010|Overall Study|Reason Not Specified|0|||
170435730|NCT01899053|615932711|FG011|Overall Study|Reason Not Specified|0|||
170435731|NCT01899053|615932712|FG012|Overall Study|Reason Not Specified|1|||
170435732|NCT01899053|615932713|FG013|Overall Study|Reason Not Specified|0|||
170435733|NCT01899053|615932700|FG000|Overall Study|Withdrawal by Subject|1|||
170435734|NCT01899053|615932701|FG001|Overall Study|Withdrawal by Subject|1|||
170435735|NCT01899053|615932702|FG002|Overall Study|Withdrawal by Subject|2|||
170435736|NCT01899053|615932703|FG003|Overall Study|Withdrawal by Subject|0|||
170435737|NCT01899053|615932704|FG004|Overall Study|Withdrawal by Subject|2|||
170435738|NCT01899053|615932705|FG005|Overall Study|Withdrawal by Subject|0|||
170435739|NCT01899053|615932706|FG006|Overall Study|Withdrawal by Subject|0|||
170435740|NCT01899053|615932707|FG007|Overall Study|Withdrawal by Subject|1|||
170435741|NCT01899053|615932708|FG008|Overall Study|Withdrawal by Subject|0|||
170435742|NCT01899053|615932709|FG009|Overall Study|Withdrawal by Subject|0|||
170435743|NCT01899053|615932710|FG010|Overall Study|Withdrawal by Subject|0|||
170435744|NCT01899053|615932711|FG011|Overall Study|Withdrawal by Subject|0|||
170435745|NCT01899053|615932712|FG012|Overall Study|Withdrawal by Subject|1|||
170435746|NCT01899053|615932713|FG013|Overall Study|Withdrawal by Subject|1|||
170435747|NCT01899053|615932700|FG000|Overall Study|Protocol Violation|0|||
170435748|NCT01899053|615932701|FG001|Overall Study|Protocol Violation|0|||
170435749|NCT01899053|615932702|FG002|Overall Study|Protocol Violation|1|||
170435750|NCT01899053|615932703|FG003|Overall Study|Protocol Violation|0|||
170435751|NCT01899053|615932704|FG004|Overall Study|Protocol Violation|0|||
170435752|NCT01899053|615932705|FG005|Overall Study|Protocol Violation|0|||
170435753|NCT01899053|615932706|FG006|Overall Study|Protocol Violation|0|||
170435754|NCT01899053|615932707|FG007|Overall Study|Protocol Violation|0|||
170435755|NCT01899053|615932708|FG008|Overall Study|Protocol Violation|0|||
170435756|NCT01899053|615932709|FG009|Overall Study|Protocol Violation|0|||
170537026|NCT01811238|616309626|FG000|Overall Study|subject refused study medication|6|||
170537027|NCT02340949|616309627|FG000|Overall Study|Adverse Event|4|||
170435757|NCT01899053|615932710|FG010|Overall Study|Protocol Violation|0|||
170537028|NCT02340949|616309628|FG001|Overall Study|Adverse Event|2|||
170537029|NCT02340949|616309627|FG000|Overall Study|Withdrawal by Subject|2|||
170435758|NCT01899053|615932711|FG011|Overall Study|Protocol Violation|0|||
170435759|NCT01899053|615932712|FG012|Overall Study|Protocol Violation|0|||
170882084|NCT00440947|617577622|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
170882085|NCT00440947|617577623|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
170882086|NCT00440947|617577624|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
170882087|NCT00440947|617577620|FG000|36-Week Induction Phase|Non-compliance|10|||
170882088|NCT00440947|617577621|FG001|36-Week Induction Phase|Non-compliance|0|||
170882089|NCT00440947|617577622|FG002|36-Week Induction Phase|Non-compliance|0|||
170882090|NCT00440947|617577623|FG003|36-Week Induction Phase|Non-compliance|0|||
170882091|NCT00440947|617577624|FG004|36-Week Induction Phase|Non-compliance|0|||
170882092|NCT00440947|617577620|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
170882093|NCT00440947|617577621|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
170882094|NCT00440947|617577622|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
170882095|NCT00440947|617577623|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
170882096|NCT00440947|617577624|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
170882097|NCT00440947|617577620|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
170882098|NCT00440947|617577621|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
170882099|NCT00440947|617577622|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
170882100|NCT00440947|617577623|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
170882101|NCT00440947|617577624|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
170882102|NCT00440947|617577620|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
170882103|NCT00440947|617577621|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
170882104|NCT00440947|617577622|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
170882105|NCT00440947|617577623|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
170882106|NCT00440947|617577624|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
170882107|NCT00440947|617577620|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
170882108|NCT00440947|617577621|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
170882109|NCT00440947|617577622|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
170882110|NCT00440947|617577623|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
170882111|NCT00440947|617577624|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
170882112|NCT00440947|617577620|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
170882113|NCT00440947|617577621|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
170882114|NCT00440947|617577622|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
170882115|NCT00440947|617577623|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
170882116|NCT00440947|617577624|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
170882117|NCT00440947|617577620|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
170882118|NCT00440947|617577621|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
170882119|NCT00440947|617577622|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
170882120|NCT00440947|617577623|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
170882121|NCT00440947|617577624|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
170882122|NCT00440947|617577620|FG000|36-Week Induction Phase|Incarceration|3|||
170882123|NCT00440947|617577621|FG001|36-Week Induction Phase|Incarceration|0|||
170882124|NCT00440947|617577622|FG002|36-Week Induction Phase|Incarceration|0|||
170882125|NCT00440947|617577623|FG003|36-Week Induction Phase|Incarceration|0|||
170882126|NCT00440947|617577624|FG004|36-Week Induction Phase|Incarceration|0|||
170882127|NCT00440947|617577620|FG000|36-Week Induction Phase|Pregnancy|1|||
170882128|NCT00440947|617577621|FG001|36-Week Induction Phase|Pregnancy|0|||
170882129|NCT00440947|617577622|FG002|36-Week Induction Phase|Pregnancy|0|||
170882130|NCT00440947|617577623|FG003|36-Week Induction Phase|Pregnancy|0|||
170882131|NCT00440947|617577624|FG004|36-Week Induction Phase|Pregnancy|0|||
170882132|NCT00440947|617577620|FG000|48-Week Randomization Phase|Adverse Event|0|||
170882133|NCT00440947|617577621|FG001|48-Week Randomization Phase|Adverse Event|2|||
170882134|NCT00440947|617577622|FG002|48-Week Randomization Phase|Adverse Event|5|||
170882135|NCT00440947|617577623|FG003|48-Week Randomization Phase|Adverse Event|0|||
170882136|NCT00440947|617577624|FG004|48-Week Randomization Phase|Adverse Event|0|||
170882137|NCT00440947|617577620|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
170882138|NCT00440947|617577621|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
170882139|NCT00440947|617577622|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
170882140|NCT00440947|617577623|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
170882141|NCT00440947|617577624|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
170882142|NCT00440947|617577620|FG000|48-Week Randomization Phase|Non-compliance|0|||
170882143|NCT00440947|617577621|FG001|48-Week Randomization Phase|Non-compliance|3|||
170882144|NCT00440947|617577622|FG002|48-Week Randomization Phase|Non-compliance|4|||
170435760|NCT01899053|615932713|FG013|Overall Study|Protocol Violation|0|||
170435761|NCT01899053|615932700|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
170435762|NCT01899053|615932701|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
170435763|NCT01899053|615932702|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435764|NCT01899053|615932703|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435765|NCT01899053|615932704|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435766|NCT01899053|615932705|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435767|NCT01899053|615932706|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435768|NCT01899053|615932707|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435769|NCT01899053|615932708|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435770|NCT01899053|615932709|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435771|NCT01899053|615932710|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
170435772|NCT01899053|615932711|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435773|NCT01899053|615932712|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435774|NCT01899053|615932713|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
170435775|NCT01899053|615932700|FG000|Overall Study|Symptomatic Deterioration|0|||
170435776|NCT01899053|615932701|FG001|Overall Study|Symptomatic Deterioration|0|||
170435777|NCT01899053|615932702|FG002|Overall Study|Symptomatic Deterioration|0|||
170435778|NCT01899053|615932703|FG003|Overall Study|Symptomatic Deterioration|0|||
170435779|NCT01899053|615932704|FG004|Overall Study|Symptomatic Deterioration|0|||
170435780|NCT01899053|615932705|FG005|Overall Study|Symptomatic Deterioration|1|||
170435781|NCT01899053|615932706|FG006|Overall Study|Symptomatic Deterioration|0|||
170435782|NCT01899053|615932707|FG007|Overall Study|Symptomatic Deterioration|1|||
170435783|NCT01899053|615932708|FG008|Overall Study|Symptomatic Deterioration|0|||
170435784|NCT01899053|615932709|FG009|Overall Study|Symptomatic Deterioration|0|||
170435785|NCT01899053|615932710|FG010|Overall Study|Symptomatic Deterioration|0|||
170435786|NCT01899053|615932711|FG011|Overall Study|Symptomatic Deterioration|1|||
170435787|NCT01899053|615932712|FG012|Overall Study|Symptomatic Deterioration|2|||
170435788|NCT01899053|615932713|FG013|Overall Study|Symptomatic Deterioration|0|||
170435789|NCT03105297|615932714|FG000|Baseline Phase (Day 1)|Other|21|||
170435790|NCT03105297|615932714|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
170435791|NCT03105297|615932714|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
170435792|NCT01691430|615934468|FG000|Overall Study|Death|17|||
170435793|NCT01691430|615934469|FG001|Overall Study|Death|16|||
170435794|NCT01691430|615934468|FG000|Overall Study|Withdrawal by Subject|5|||
170435795|NCT01691430|615934469|FG001|Overall Study|Withdrawal by Subject|1|||
170435796|NCT01691430|615934468|FG000|Overall Study|Lost to Follow-up|0|||
170435797|NCT01691430|615934469|FG001|Overall Study|Lost to Follow-up|3|||
170435798|NCT01894230|615934470|FG000|Overall Study|Lost to Follow-up|2|||
170435799|NCT01894230|615934471|FG001|Overall Study|Lost to Follow-up|2|||
170435800|NCT01894230|615934470|FG000|Overall Study|Withdrawal by Subject|4|||
170435801|NCT01894230|615934471|FG001|Overall Study|Withdrawal by Subject|4|||
170435802|NCT01894230|615934470|FG000|Overall Study|Non-adherent|0|||
170435803|NCT01894230|615934471|FG001|Overall Study|Non-adherent|1|||
170435804|NCT01894230|615934470|FG000|Overall Study|Death|1|||
170435805|NCT01894230|615934471|FG001|Overall Study|Death|0|||
170435806|NCT00856349|615934476|FG000|Overall Study|Death|418|||
170435807|NCT00856349|615934476|FG000|Overall Study|Withdrawal by Subject|116|||
170435808|NCT00856349|615934476|FG000|Overall Study|Lost to Follow-up|91|||
170435809|NCT00856349|615934476|FG000|Overall Study|Protocol Violation|38|||
170632815|NCT04323124|616666795|FG012|Overall Study|Adverse Event|0|||
170632816|NCT04323124|616666796|FG013|Overall Study|Adverse Event|0|||
170780680|NCT02287311|617205652|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
170780681|NCT02287311|617205653|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
170780682|NCT02549339|617205658|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
170780683|NCT02549339|617205659|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
170780684|NCT02549339|617205658|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
170780685|NCT02549339|617205659|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
170780686|NCT02549339|617205658|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
170780687|NCT02549339|617205659|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
170780688|NCT02549339|617205658|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
170780689|NCT02549339|617205659|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
170780690|NCT02549339|617205658|FG000|12-month Follow-up|Lack of Efficacy|0|||
170780691|NCT02549339|617205659|FG001|12-month Follow-up|Lack of Efficacy|2|||
170780692|NCT02549339|617205658|FG000|12-month Follow-up|Withdrawal by Subject|8|||
170780693|NCT02549339|617205659|FG001|12-month Follow-up|Withdrawal by Subject|3|||
170435810|NCT00856349|615934476|FG000|Overall Study|Physician Decision|13|||
170435811|NCT00856349|615934476|FG000|Overall Study|Subject relocation|104|||
170435812|NCT00856349|615934476|FG000|Overall Study|Device explant|33|||
170435813|NCT00856349|615934476|FG000|Overall Study|Site closure|78|||
170435814|NCT00856349|615934476|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
170435815|NCT00183196|615934477|FG000|Overall Study|Withdrawal by Subject|18|||
170435816|NCT00183196|615934478|FG001|Overall Study|Withdrawal by Subject|11|||
170780694|NCT02549339|617205658|FG000|12-month Follow-up|Lost to Follow-up|1|||
170435817|NCT00183196|615934479|FG002|Overall Study|Withdrawal by Subject|13|||
170435818|NCT00183196|615934477|FG000|Overall Study|Adverse Event|1|||
170435819|NCT00183196|615934478|FG001|Overall Study|Adverse Event|2|||
170435820|NCT00183196|615934479|FG002|Overall Study|Adverse Event|2|||
170435821|NCT00183196|615934477|FG000|Overall Study|Legal event|1|||
170435822|NCT00183196|615934478|FG001|Overall Study|Legal event|1|||
170435823|NCT00183196|615934479|FG002|Overall Study|Legal event|1|||
170435824|NCT00183196|615934477|FG000|Overall Study|Required more intensive care|0|||
170435825|NCT00183196|615934478|FG001|Overall Study|Required more intensive care|1|||
170435826|NCT00183196|615934479|FG002|Overall Study|Required more intensive care|2|||
170435827|NCT00385736|615934480|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
170435828|NCT00385736|615934481|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
170435829|NCT00385736|615934482|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
170435830|NCT00385736|615934480|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
170435831|NCT00385736|615934481|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
170435832|NCT00385736|615934482|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
170435833|NCT00385736|615934480|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
170435834|NCT00385736|615934481|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
170435835|NCT00385736|615934482|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
170435836|NCT00385736|615934480|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
170435837|NCT00385736|615934481|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
170435838|NCT00385736|615934482|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
170435839|NCT00385736|615934480|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
170435840|NCT00385736|615934481|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
170435841|NCT00385736|615934482|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
170435842|NCT00385736|615934480|FG000|Efficacy Analysis Set - Induction|Other|0|||
170435843|NCT00385736|615934481|FG001|Efficacy Analysis Set - Induction|Other|0|||
170435844|NCT00385736|615934482|FG002|Efficacy Analysis Set - Induction|Other|1|||
170435845|NCT00385736|615934480|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
170435846|NCT00385736|615934481|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
170435847|NCT00385736|615934482|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
170435848|NCT00385736|615934480|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
170435849|NCT00385736|615934481|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
170435850|NCT00385736|615934482|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
170435851|NCT00385736|615934480|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
170435852|NCT00385736|615934481|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
170435853|NCT00385736|615934482|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
170435854|NCT00385736|615934480|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
170435855|NCT00385736|615934481|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
170435856|NCT00385736|615934482|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
170435857|NCT00385736|615934480|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
170435858|NCT00385736|615934481|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
170435859|NCT00385736|615934482|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
170435860|NCT00385736|615934480|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
170435861|NCT00385736|615934481|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
170435862|NCT00385736|615934482|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
170435863|NCT00385736|615934480|FG000|Safety Analysis Set|Adverse Event|23|||
170435864|NCT00385736|615934481|FG001|Safety Analysis Set|Adverse Event|15|||
170435865|NCT00385736|615934482|FG002|Safety Analysis Set|Adverse Event|23|||
170435866|NCT00385736|615934480|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
170435867|NCT00385736|615934481|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
170435868|NCT00385736|615934482|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
170435869|NCT00385736|615934480|FG000|Safety Analysis Set|Lost to Follow-up|0|||
170435870|NCT00385736|615934481|FG001|Safety Analysis Set|Lost to Follow-up|2|||
170435871|NCT00385736|615934482|FG002|Safety Analysis Set|Lost to Follow-up|2|||
170435872|NCT00385736|615934480|FG000|Safety Analysis Set|Lack of Efficacy|38|||
170435873|NCT00385736|615934481|FG001|Safety Analysis Set|Lack of Efficacy|16|||
170435874|NCT00385736|615934482|FG002|Safety Analysis Set|Lack of Efficacy|31|||
170435875|NCT00385736|615934480|FG000|Safety Analysis Set|Protocol Violation|2|||
170435876|NCT00385736|615934481|FG001|Safety Analysis Set|Protocol Violation|1|||
170435877|NCT00385736|615934482|FG002|Safety Analysis Set|Protocol Violation|6|||
170435878|NCT00385736|615934480|FG000|Safety Analysis Set|Other|1|||
170882145|NCT00440947|617577623|FG003|48-Week Randomization Phase|Non-compliance|0|||
170882146|NCT00440947|617577624|FG004|48-Week Randomization Phase|Non-compliance|0|||
170435879|NCT00385736|615934481|FG001|Safety Analysis Set|Other|4|||
170435880|NCT00385736|615934482|FG002|Safety Analysis Set|Other|4|||
170435881|NCT02906917|615934484|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
170435882|NCT02906917|615934485|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
170435883|NCT02906917|615934484|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
170537030|NCT02340949|616309628|FG001|Overall Study|Withdrawal by Subject|0|||
170537031|NCT02340949|616309627|FG000|Overall Study|Progression disease|6|||
170537032|NCT02340949|616309628|FG001|Overall Study|Progression disease|2|||
170435884|NCT02906917|615934485|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
170435885|NCT02906917|615934484|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
170435886|NCT02906917|615934485|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
170435887|NCT02906917|615934484|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
170435888|NCT02906917|615934485|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
170632817|NCT04323124|616666797|FG014|Overall Study|Adverse Event|0|||
170435889|NCT02906917|615934484|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
170632818|NCT04323124|616666783|FG000|Overall Study|Other|0|||
170632819|NCT04323124|616666784|FG001|Overall Study|Other|0|||
170632820|NCT04323124|616666785|FG002|Overall Study|Other|0|||
170632821|NCT04323124|616666786|FG003|Overall Study|Other|0|||
170632822|NCT04323124|616666787|FG004|Overall Study|Other|1|||
170632823|NCT04323124|616666788|FG005|Overall Study|Other|0|||
170632824|NCT04323124|616666789|FG006|Overall Study|Other|0|||
170632825|NCT04323124|616666790|FG007|Overall Study|Other|0|||
170780695|NCT02549339|617205659|FG001|12-month Follow-up|Lost to Follow-up|3|||
170780696|NCT02549339|617205658|FG000|12-month Follow-up|Other|0|||
170780697|NCT02549339|617205659|FG001|12-month Follow-up|Other|3|||
170882147|NCT00440947|617577620|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
170882148|NCT00440947|617577621|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
170882149|NCT00440947|617577622|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
170882150|NCT00440947|617577623|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
170882151|NCT00440947|617577624|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
170882152|NCT00440947|617577620|FG000|48-Week Randomization Phase|Protocol Violation|0|||
170882153|NCT00440947|617577621|FG001|48-Week Randomization Phase|Protocol Violation|0|||
170882154|NCT00440947|617577622|FG002|48-Week Randomization Phase|Protocol Violation|1|||
170632826|NCT04323124|616666791|FG008|Overall Study|Other|1|||
170780698|NCT02724956|617205660|FG000|Overall Study|Physician Decision|1|||
170780699|NCT02724956|617205661|FG001|Overall Study|Physician Decision|0|||
170780700|NCT02724956|617205660|FG000|Overall Study|Lack of Efficacy|0|||
170780701|NCT02724956|617205661|FG001|Overall Study|Lack of Efficacy|1|||
170780702|NCT02724956|617205660|FG000|Overall Study|Withdrawal by Subject|0|||
170780703|NCT02724956|617205661|FG001|Overall Study|Withdrawal by Subject|1|||
170780704|NCT03436745|617205662|FG000|Overall Study|Ineligible|0|||
170780705|NCT03436745|617205663|FG001|Overall Study|Ineligible|0|||
170780706|NCT03436745|617205664|FG002|Overall Study|Ineligible|1|||
170780707|NCT03578536|617205672|FG000|Overall Study|Lost to Follow-up|1|||
170780708|NCT04600752|617205673|FG000|Overall Study|Physician Decision|0|||
170780709|NCT04600752|617205674|FG001|Overall Study|Physician Decision|0|||
170780710|NCT04600752|617205675|FG002|Overall Study|Physician Decision|1|||
170780711|NCT04600752|617205673|FG000|Overall Study|Adverse Event|0|||
170780712|NCT04600752|617205674|FG001|Overall Study|Adverse Event|1|||
170780713|NCT04600752|617205675|FG002|Overall Study|Adverse Event|0|||
170780714|NCT04600752|617205673|FG000|Overall Study|Withdrawal by Subject|2|||
170780715|NCT04600752|617205674|FG001|Overall Study|Withdrawal by Subject|1|||
170780716|NCT04600752|617205675|FG002|Overall Study|Withdrawal by Subject|0|||
170780717|NCT04600752|617205673|FG000|Overall Study|Lack of Efficacy|1|||
170780718|NCT04600752|617205674|FG001|Overall Study|Lack of Efficacy|0|||
170780719|NCT04600752|617205675|FG002|Overall Study|Lack of Efficacy|0|||
170780720|NCT04436107|617205676|FG000|Overall Study|Sponsor Ended Study|2|||
170780721|NCT04436107|617205677|FG001|Overall Study|Sponsor Ended Study|4|||
170780722|NCT04436107|617205678|FG002|Overall Study|Sponsor Ended Study|8|||
170780723|NCT04436107|617205679|FG003|Overall Study|Sponsor Ended Study|20|||
170780724|NCT04436107|617205676|FG000|Overall Study|Death|3|||
170780725|NCT04436107|617205677|FG001|Overall Study|Death|5|||
170780726|NCT04436107|617205678|FG002|Overall Study|Death|3|||
170780727|NCT04436107|617205679|FG003|Overall Study|Death|18|||
170780728|NCT04436107|617205676|FG000|Overall Study|Withdrawal by Subject|1|||
170780729|NCT04436107|617205677|FG001|Overall Study|Withdrawal by Subject|1|||
170780730|NCT04436107|617205678|FG002|Overall Study|Withdrawal by Subject|0|||
170780731|NCT04436107|617205679|FG003|Overall Study|Withdrawal by Subject|1|||
170780732|NCT01095796|617205680|FG000|Overall Study|Randomized but Not Treated|5|||
170780733|NCT01095796|617205681|FG001|Overall Study|Randomized but Not Treated|2|||
170780734|NCT01095796|617205680|FG000|Overall Study|Adverse Event|9|||
170780735|NCT01095796|617205681|FG001|Overall Study|Adverse Event|19|||
170780736|NCT01095796|617205680|FG000|Overall Study|Death|3|||
170632827|NCT04323124|616666792|FG009|Overall Study|Other|0|||
170780737|NCT01095796|617205681|FG001|Overall Study|Death|2|||
170435890|NCT02906917|615934485|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
170435891|NCT02906917|615934484|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
170632828|NCT04323124|616666793|FG010|Overall Study|Other|0|||
170632829|NCT04323124|616666794|FG011|Overall Study|Other|0|||
170780738|NCT01095796|617205680|FG000|Overall Study|Pregnancy|2|||
170780739|NCT01095796|617205681|FG001|Overall Study|Pregnancy|0|||
170780740|NCT01095796|617205680|FG000|Overall Study|Lack of Efficacy|5|||
170780741|NCT01095796|617205681|FG001|Overall Study|Lack of Efficacy|3|||
170780742|NCT01095796|617205680|FG000|Overall Study|Investigator's Discretion|7|||
170780743|NCT01095796|617205681|FG001|Overall Study|Investigator's Discretion|2|||
170780744|NCT01095796|617205680|FG000|Overall Study|Withdrew Consent|16|||
170435892|NCT02906917|615934485|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
170435893|NCT02906917|615934484|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
170435894|NCT02906917|615934485|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
170435895|NCT02906917|615934484|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
170435896|NCT02906917|615934485|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
170435897|NCT05133180|615934486|FG000|Overall Study|Withdrawal of consent|1|||
170435898|NCT05133180|615934487|FG001|Overall Study|Withdrawal of consent|1|||
170435899|NCT05133180|615934486|FG000|Overall Study|Lost to Follow-up|1|||
170435900|NCT05133180|615934487|FG001|Overall Study|Lost to Follow-up|1|||
170435901|NCT05133180|615934486|FG000|Overall Study|Documented disease progression|0|||
170435902|NCT05133180|615934487|FG001|Overall Study|Documented disease progression|1|||
170435903|NCT01923740|615934491|FG000|Overall Study|Lost to Follow-up|4|||
170435904|NCT01923740|615934492|FG001|Overall Study|Lost to Follow-up|9|||
170435905|NCT01923740|615934491|FG000|Overall Study|Withdrawal by Subject|2|||
170435906|NCT01923740|615934492|FG001|Overall Study|Withdrawal by Subject|0|||
170435907|NCT01537887|615934493|FG000|Period 1|Physician Decision|0|||
170435908|NCT01537887|615934494|FG001|Period 1|Physician Decision|0|||
170435909|NCT01537887|615934495|FG002|Period 1|Physician Decision|0|||
170435910|NCT01537887|615934496|FG003|Period 1|Physician Decision|0|||
170435911|NCT01537887|615934497|FG004|Period 1|Physician Decision|1|||
170435912|NCT01537887|615934498|FG005|Period 1|Physician Decision|1|||
170435913|NCT01537887|615934493|FG000|Period 1|Did not receive treatment|0|||
170435914|NCT01537887|615934494|FG001|Period 1|Did not receive treatment|0|||
170435915|NCT01537887|615934495|FG002|Period 1|Did not receive treatment|1|||
170435916|NCT01537887|615934496|FG003|Period 1|Did not receive treatment|0|||
170435917|NCT01537887|615934497|FG004|Period 1|Did not receive treatment|0|||
170435918|NCT01537887|615934498|FG005|Period 1|Did not receive treatment|0|||
170435919|NCT01537887|615934493|FG000|Period 2|Withdrawal by Subject|0|||
170435920|NCT01537887|615934494|FG001|Period 2|Withdrawal by Subject|1|||
170435921|NCT01537887|615934495|FG002|Period 2|Withdrawal by Subject|0|||
170435922|NCT01537887|615934496|FG003|Period 2|Withdrawal by Subject|0|||
170435923|NCT01537887|615934497|FG004|Period 2|Withdrawal by Subject|0|||
170435924|NCT01537887|615934498|FG005|Period 2|Withdrawal by Subject|0|||
170435925|NCT01537887|615934493|FG000|Period 3|Adverse Event|0|||
170435926|NCT01537887|615934494|FG001|Period 3|Adverse Event|0|||
170435927|NCT01537887|615934495|FG002|Period 3|Adverse Event|1|||
170435928|NCT01537887|615934496|FG003|Period 3|Adverse Event|0|||
170435929|NCT01537887|615934497|FG004|Period 3|Adverse Event|0|||
170435930|NCT01537887|615934498|FG005|Period 3|Adverse Event|0|||
170435931|NCT01537887|615934493|FG000|Period 3|Withdrawal by Subject|0|||
170435932|NCT01537887|615934494|FG001|Period 3|Withdrawal by Subject|1|||
170435933|NCT01537887|615934495|FG002|Period 3|Withdrawal by Subject|0|||
170435934|NCT01537887|615934496|FG003|Period 3|Withdrawal by Subject|0|||
170435935|NCT01537887|615934497|FG004|Period 3|Withdrawal by Subject|0|||
170435936|NCT01537887|615934498|FG005|Period 3|Withdrawal by Subject|0|||
170435937|NCT00294047|615934499|FG000|Month 48|Adverse Event|28|||
170435938|NCT00294047|615934500|FG001|Month 48|Adverse Event|13|||
170435939|NCT00294047|615934499|FG000|Month 48|Protocol Violation|4|||
170435940|NCT00294047|615934500|FG001|Month 48|Protocol Violation|4|||
170435941|NCT00294047|615934499|FG000|Month 48|Withdrawal by Subject|111|||
170632830|NCT04323124|616666795|FG012|Overall Study|Other|0|||
170632831|NCT04323124|616666796|FG013|Overall Study|Other|0|||
170632832|NCT04323124|616666797|FG014|Overall Study|Other|0|||
170632833|NCT04323124|616666783|FG000|Overall Study|Coming from a red zone (COVID)|0|||
170435942|NCT00294047|615934500|FG001|Month 48|Withdrawal by Subject|115|||
170435943|NCT00294047|615934499|FG000|Month 48|Lost to Follow-up|272|||
170435944|NCT00294047|615934500|FG001|Month 48|Lost to Follow-up|287|||
170435945|NCT00294047|615934499|FG000|Month 48|Other|10|||
170435946|NCT00294047|615934500|FG001|Month 48|Other|14|||
170435947|NCT00294047|615934499|FG000|Month 84|Adverse Event|4|||
170435948|NCT00294047|615934500|FG001|Month 84|Adverse Event|2|||
170435949|NCT00294047|615934499|FG000|Month 84|Protocol Violation|1|||
170632834|NCT04323124|616666784|FG001|Overall Study|Coming from a red zone (COVID)|0|||
170632835|NCT04323124|616666785|FG002|Overall Study|Coming from a red zone (COVID)|0|||
170435950|NCT00294047|615934500|FG001|Month 84|Protocol Violation|1|||
170632836|NCT04323124|616666786|FG003|Overall Study|Coming from a red zone (COVID)|0|||
170435951|NCT00294047|615934499|FG000|Month 84|Withdrawal by Subject|33|||
170435952|NCT00294047|615934500|FG001|Month 84|Withdrawal by Subject|31|||
170632837|NCT04323124|616666787|FG004|Overall Study|Coming from a red zone (COVID)|1|||
170435953|NCT00294047|615934499|FG000|Month 84|Lost to Follow-up|187|||
170435954|NCT00294047|615934500|FG001|Month 84|Lost to Follow-up|190|||
170435955|NCT00294047|615934499|FG000|Month 84|Absent Cervix|2|||
170435956|NCT00294047|615934500|FG001|Month 84|Absent Cervix|0|||
170435957|NCT00294047|615934499|FG000|Month 84|Work related reasons|4|||
170435958|NCT00294047|615934500|FG001|Month 84|Work related reasons|2|||
170435959|NCT00294047|615934499|FG000|Month 84|Center closed, subject did not transfer|1|||
170435960|NCT00294047|615934500|FG001|Month 84|Center closed, subject did not transfer|0|||
170435961|NCT00294047|615934499|FG000|Month 84|Family problems|2|||
170435962|NCT00294047|615934500|FG001|Month 84|Family problems|2|||
170435963|NCT00294047|615934499|FG000|Month 84|Lack of time|3|||
170435964|NCT00294047|615934500|FG001|Month 84|Lack of time|1|||
170435965|NCT00294047|615934499|FG000|Month 84|Personal reason|2|||
170435966|NCT00294047|615934500|FG001|Month 84|Personal reason|4|||
170435967|NCT00294047|615934499|FG000|Month 84|Subject does not want male physician|1|||
170435968|NCT00294047|615934500|FG001|Month 84|Subject does not want male physician|0|||
170780745|NCT01095796|617205681|FG001|Overall Study|Withdrew Consent|22|||
170435969|NCT00294047|615934499|FG000|Month 84|Transport reimbursement delayed|0|||
170435970|NCT00294047|615934500|FG001|Month 84|Transport reimbursement delayed|1|||
170435971|NCT00294047|615934499|FG000|Month 84|Unable to reach study site|1|||
170435972|NCT00294047|615934500|FG001|Month 84|Unable to reach study site|0|||
170435973|NCT00294047|615934499|FG000|Month 84|Under investigation locally|1|||
170435974|NCT00294047|615934500|FG001|Month 84|Under investigation locally|0|||
170435975|NCT00294047|615934499|FG000|Month 84|Visit missed|0|||
170435976|NCT00294047|615934500|FG001|Month 84|Visit missed|1|||
170435977|NCT00294047|615934499|FG000|Month 84|No consent for Month 84 Follow-up|731|||
170435978|NCT00294047|615934500|FG001|Month 84|No consent for Month 84 Follow-up|754|||
170435979|NCT01370083|615934501|FG000|Overall Study|Lost to Follow-up|2|||
170435980|NCT01370083|615934502|FG001|Overall Study|Lost to Follow-up|0|||
170435981|NCT01370083|615934501|FG000|Overall Study|Adverse Event|0|||
170435982|NCT01370083|615934502|FG001|Overall Study|Adverse Event|1|||
170435983|NCT00506831|615934505|FG000|Overall Study|Death|1|||
170435984|NCT00506831|615934505|FG000|Overall Study|Withdrawal by Subject|1|||
170435985|NCT01604941|615934506|FG000|Overall Study|Adverse Event|1|||
170435986|NCT01604941|615934507|FG001|Overall Study|Adverse Event|2|||
170435987|NCT01604941|615934508|FG002|Overall Study|Adverse Event|0|||
170435988|NCT01604941|615934509|FG003|Overall Study|Adverse Event|0|||
170435989|NCT01604941|615934510|FG004|Overall Study|Adverse Event|1|||
170435990|NCT01604941|615934511|FG005|Overall Study|Adverse Event|5|||
170435991|NCT01604941|615934506|FG000|Overall Study|Non-compliance|1|||
170435992|NCT01604941|615934507|FG001|Overall Study|Non-compliance|0|||
170435993|NCT01604941|615934508|FG002|Overall Study|Non-compliance|0|||
170435994|NCT01604941|615934509|FG003|Overall Study|Non-compliance|0|||
170435995|NCT01604941|615934510|FG004|Overall Study|Non-compliance|0|||
170435996|NCT01604941|615934511|FG005|Overall Study|Non-compliance|0|||
170435997|NCT01604941|615934506|FG000|Overall Study|Participant Decision|0|||
170435998|NCT01604941|615934507|FG001|Overall Study|Participant Decision|0|||
170435999|NCT01604941|615934508|FG002|Overall Study|Participant Decision|0|||
170436000|NCT01604941|615934509|FG003|Overall Study|Participant Decision|0|||
170436001|NCT01604941|615934510|FG004|Overall Study|Participant Decision|0|||
170436002|NCT01604941|615934511|FG005|Overall Study|Participant Decision|2|||
170436003|NCT01604941|615934506|FG000|Overall Study|Early Study Termination|9|||
170436004|NCT01604941|615934507|FG001|Overall Study|Early Study Termination|2|||
170436005|NCT01604941|615934508|FG002|Overall Study|Early Study Termination|3|||
170436006|NCT01604941|615934509|FG003|Overall Study|Early Study Termination|3|||
170436007|NCT01604941|615934510|FG004|Overall Study|Early Study Termination|0|||
170436008|NCT01604941|615934511|FG005|Overall Study|Early Study Termination|0|||
170436009|NCT03236311|615934512|FG000|Overall Study|Study terminated by sponsor|0|||
170436010|NCT03236311|615934513|FG001|Overall Study|Study terminated by sponsor|2|||
170780746|NCT01095796|617205680|FG000|Overall Study|Lost to Follow-up|27|||
170780747|NCT01095796|617205681|FG001|Overall Study|Lost to Follow-up|29|||
170780748|NCT01095796|617205680|FG000|Overall Study|Participant Noncompliance|5|||
170780749|NCT01095796|617205681|FG001|Overall Study|Participant Noncompliance|10|||
170780750|NCT01095796|617205680|FG000|Overall Study|Protocol Violation|1|||
170780751|NCT01095796|617205681|FG001|Overall Study|Protocol Violation|0|||
170780752|NCT01095796|617205680|FG000|Overall Study|Participant Transferred to Another Study|215|||
170780753|NCT01095796|617205681|FG001|Overall Study|Participant Transferred to Another Study|200|||
170780754|NCT02374307|617205686|FG000|3-months Follow-up|Lost to Follow-up|1|||
170780755|NCT02374307|617205687|FG001|3-months Follow-up|Lost to Follow-up|2|||
170780756|NCT02374307|617205686|FG000|3-months Follow-up|Withdrawal by Subject|1|||
170780757|NCT02374307|617205687|FG001|3-months Follow-up|Withdrawal by Subject|4|||
170780758|NCT02374307|617205686|FG000|3-months Follow-up|Death|1|||
170780759|NCT02374307|617205687|FG001|3-months Follow-up|Death|2|||
170780760|NCT02374307|617205686|FG000|3-months Follow-up|Missed first follow-up|5|||
170436011|NCT03236311|615934512|FG000|Overall Study|Adverse Event|0|||
170780761|NCT02374307|617205687|FG001|3-months Follow-up|Missed first follow-up|1|||
170780762|NCT02374307|617205686|FG000|6-months Follow-up|Lost to Follow-up|1|||
170436012|NCT03236311|615934513|FG001|Overall Study|Adverse Event|1|||
170436013|NCT02412852|615934514|FG000|Overall Study|Withdrawal by Subject|0|||
170436014|NCT02412852|615934515|FG001|Overall Study|Withdrawal by Subject|1|||
170436015|NCT02412852|615934516|FG002|Overall Study|Withdrawal by Subject|0|||
170780763|NCT02374307|617205687|FG001|6-months Follow-up|Lost to Follow-up|2|||
170436016|NCT02412852|615934517|FG003|Overall Study|Withdrawal by Subject|0|||
170436017|NCT02412852|615934514|FG000|Overall Study|Physician Decision|0|||
170436018|NCT02412852|615934515|FG001|Overall Study|Physician Decision|0|||
170436019|NCT02412852|615934516|FG002|Overall Study|Physician Decision|0|||
170436020|NCT02412852|615934517|FG003|Overall Study|Physician Decision|1|||
170436021|NCT01051349|615934518|FG000|Overall Study|Adverse Event|88|||
170436022|NCT01051349|615934518|FG000|Overall Study|Consent Withdrawn|54|||
170436023|NCT01051349|615934518|FG000|Overall Study|Investigator Decision|6|||
170436024|NCT01051349|615934518|FG000|Overall Study|Lost to Follow-up|6|||
170436025|NCT01051349|615934518|FG000|Overall Study|Subject non-compliance|7|||
170436026|NCT01051349|615934518|FG000|Overall Study|Reason not Specified|12|||
170436027|NCT00484679|615934519|FG000|Overall Study|Withdrawal by Subject|3|||
170436028|NCT00418145|615934522|FG000|Overall Study|study terminated|6|||
170436029|NCT00472212|615934523|FG000|Overall Study|Lost to Follow-up|6|||
170436030|NCT00472212|615934524|FG001|Overall Study|Lost to Follow-up|4|||
170436031|NCT00906399|615934528|FG000|Year 1|Randomized But Not Treated|0|||
170436032|NCT00906399|615934529|FG001|Year 1|Randomized But Not Treated|1|||
170436033|NCT00906399|615934530|FG002|Year 1|Randomized But Not Treated|3|||
170436034|NCT00906399|615934531|FG003|Year 1|Randomized But Not Treated|0|||
170436035|NCT00906399|615934532|FG004|Year 1|Randomized But Not Treated|0|||
170436036|NCT00906399|615934533|FG005|Year 1|Randomized But Not Treated|0|||
170436037|NCT00906399|615934534|FG006|Year 1|Randomized But Not Treated|0|||
170436038|NCT00906399|615934528|FG000|Year 1|Adverse Event|4|||
170436039|NCT00906399|615934529|FG001|Year 1|Adverse Event|22|||
170436040|NCT00906399|615934530|FG002|Year 1|Adverse Event|24|||
170436041|NCT00906399|615934531|FG003|Year 1|Adverse Event|0|||
170436042|NCT00906399|615934532|FG004|Year 1|Adverse Event|0|||
170436043|NCT00906399|615934533|FG005|Year 1|Adverse Event|0|||
170436044|NCT00906399|615934534|FG006|Year 1|Adverse Event|0|||
170436045|NCT00906399|615934528|FG000|Year 1|Lost to Follow-up|4|||
170436046|NCT00906399|615934529|FG001|Year 1|Lost to Follow-up|4|||
170436047|NCT00906399|615934530|FG002|Year 1|Lost to Follow-up|2|||
170436048|NCT00906399|615934531|FG003|Year 1|Lost to Follow-up|0|||
170436049|NCT00906399|615934532|FG004|Year 1|Lost to Follow-up|0|||
170436050|NCT00906399|615934533|FG005|Year 1|Lost to Follow-up|0|||
170436051|NCT00906399|615934534|FG006|Year 1|Lost to Follow-up|0|||
170436052|NCT00906399|615934528|FG000|Year 1|Withdrawal by Subject|30|||
170436053|NCT00906399|615934529|FG001|Year 1|Withdrawal by Subject|32|||
170436054|NCT00906399|615934530|FG002|Year 1|Withdrawal by Subject|36|||
170436055|NCT00906399|615934531|FG003|Year 1|Withdrawal by Subject|0|||
170436056|NCT00906399|615934532|FG004|Year 1|Withdrawal by Subject|0|||
170436057|NCT00906399|615934533|FG005|Year 1|Withdrawal by Subject|0|||
170436058|NCT00906399|615934534|FG006|Year 1|Withdrawal by Subject|0|||
170436059|NCT00906399|615934528|FG000|Year 1|Physician Decision|0|||
170436060|NCT00906399|615934529|FG001|Year 1|Physician Decision|1|||
170436061|NCT00906399|615934530|FG002|Year 1|Physician Decision|3|||
170436062|NCT00906399|615934531|FG003|Year 1|Physician Decision|0|||
170436063|NCT00906399|615934532|FG004|Year 1|Physician Decision|0|||
170436064|NCT00906399|615934533|FG005|Year 1|Physician Decision|0|||
170436065|NCT00906399|615934534|FG006|Year 1|Physician Decision|0|||
170436066|NCT00906399|615934528|FG000|Year 1|Death|2|||
170436067|NCT00906399|615934529|FG001|Year 1|Death|1|||
170436068|NCT00906399|615934530|FG002|Year 1|Death|1|||
170436069|NCT00906399|615934531|FG003|Year 1|Death|0|||
170436070|NCT00906399|615934532|FG004|Year 1|Death|0|||
170436071|NCT00906399|615934533|FG005|Year 1|Death|0|||
170436072|NCT00906399|615934534|FG006|Year 1|Death|0|||
170436073|NCT00906399|615934528|FG000|Year 1|Other|4|||
170436074|NCT00906399|615934529|FG001|Year 1|Other|2|||
170436075|NCT00906399|615934530|FG002|Year 1|Other|7|||
170780764|NCT02374307|617205686|FG000|6-months Follow-up|Death|2|||
170780765|NCT02374307|617205687|FG001|6-months Follow-up|Death|1|||
170780766|NCT02374307|617205686|FG000|6-months Follow-up|Withdrawal by Subject|0|||
170780767|NCT02374307|617205687|FG001|6-months Follow-up|Withdrawal by Subject|3|||
170780768|NCT00632203|617205688|FG000|Overall Study|Did not start study treatment|1|||
170780769|NCT00632203|617205689|FG001|Overall Study|Did not start study treatment|0|||
170780770|NCT04238247|617205690|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
170780771|NCT04238247|617205691|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
170780772|NCT04238247|617205692|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
170780773|NCT04238247|617205693|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
170436076|NCT00906399|615934531|FG003|Year 1|Other|0|||
170436077|NCT00906399|615934532|FG004|Year 1|Other|0|||
170436078|NCT00906399|615934533|FG005|Year 1|Other|0|||
170436079|NCT00906399|615934534|FG006|Year 1|Other|0|||
170436080|NCT00906399|615934528|FG000|Year 2|Adverse Event|0|||
170436081|NCT00906399|615934529|FG001|Year 2|Adverse Event|0|||
170436082|NCT00906399|615934530|FG002|Year 2|Adverse Event|0|||
170436083|NCT00906399|615934531|FG003|Year 2|Adverse Event|9|||
170436084|NCT00906399|615934532|FG004|Year 2|Adverse Event|8|||
170436085|NCT00906399|615934533|FG005|Year 2|Adverse Event|11|||
170436086|NCT00906399|615934534|FG006|Year 2|Adverse Event|6|||
170436087|NCT00906399|615934528|FG000|Year 2|Lost to Follow-up|0|||
170436088|NCT00906399|615934529|FG001|Year 2|Lost to Follow-up|0|||
170436089|NCT00906399|615934530|FG002|Year 2|Lost to Follow-up|0|||
170436090|NCT00906399|615934531|FG003|Year 2|Lost to Follow-up|1|||
170436091|NCT00906399|615934532|FG004|Year 2|Lost to Follow-up|4|||
170436092|NCT00906399|615934533|FG005|Year 2|Lost to Follow-up|2|||
170436093|NCT00906399|615934534|FG006|Year 2|Lost to Follow-up|4|||
170436094|NCT00906399|615934528|FG000|Year 2|Withdrawal by Subject|0|||
170436095|NCT00906399|615934529|FG001|Year 2|Withdrawal by Subject|0|||
170436096|NCT00906399|615934530|FG002|Year 2|Withdrawal by Subject|0|||
170436097|NCT00906399|615934531|FG003|Year 2|Withdrawal by Subject|17|||
170436098|NCT00906399|615934532|FG004|Year 2|Withdrawal by Subject|18|||
170436099|NCT00906399|615934533|FG005|Year 2|Withdrawal by Subject|27|||
170436100|NCT00906399|615934534|FG006|Year 2|Withdrawal by Subject|13|||
170436101|NCT00906399|615934528|FG000|Year 2|Physician Decision|0|||
170436102|NCT00906399|615934529|FG001|Year 2|Physician Decision|0|||
170436103|NCT00906399|615934530|FG002|Year 2|Physician Decision|0|||
170436104|NCT00906399|615934531|FG003|Year 2|Physician Decision|0|||
170436105|NCT00906399|615934532|FG004|Year 2|Physician Decision|2|||
170436106|NCT00906399|615934533|FG005|Year 2|Physician Decision|6|||
170436107|NCT00906399|615934534|FG006|Year 2|Physician Decision|3|||
170436108|NCT00906399|615934528|FG000|Year 2|Death|0|||
170436109|NCT00906399|615934529|FG001|Year 2|Death|0|||
170436110|NCT00906399|615934530|FG002|Year 2|Death|0|||
170436111|NCT00906399|615934531|FG003|Year 2|Death|1|||
170436112|NCT00906399|615934532|FG004|Year 2|Death|0|||
170436113|NCT00906399|615934533|FG005|Year 2|Death|0|||
170436114|NCT00906399|615934534|FG006|Year 2|Death|3|||
170436115|NCT00906399|615934528|FG000|Year 2|Other|0|||
170436116|NCT00906399|615934529|FG001|Year 2|Other|0|||
170436117|NCT00906399|615934530|FG002|Year 2|Other|0|||
170436118|NCT00906399|615934531|FG003|Year 2|Other|2|||
170436119|NCT00906399|615934532|FG004|Year 2|Other|3|||
170436120|NCT00906399|615934533|FG005|Year 2|Other|1|||
170436121|NCT00906399|615934534|FG006|Year 2|Other|0|||
170436122|NCT01266902|615934535|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
170436123|NCT01266902|615934536|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
170436124|NCT01266902|615934537|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
170436125|NCT01266902|615934535|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
170436126|NCT01266902|615934536|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
170436127|NCT01266902|615934537|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
170436128|NCT01266902|615934535|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
170436129|NCT01266902|615934536|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
170436130|NCT01266902|615934537|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
170436131|NCT01266902|615934535|FG000|Period 1 (Main Study)|Adverse Event|3|||
170436132|NCT01266902|615934536|FG001|Period 1 (Main Study)|Adverse Event|11|||
170436133|NCT01266902|615934537|FG002|Period 1 (Main Study)|Adverse Event|0|||
170436134|NCT01266902|615934535|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
170436135|NCT01266902|615934536|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
170436136|NCT01266902|615934537|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
170436137|NCT01266902|615934535|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
170436138|NCT01266902|615934536|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
170436139|NCT01266902|615934537|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
170436140|NCT01266902|615934535|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
170436141|NCT01266902|615934536|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
170436142|NCT01266902|615934537|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
170436143|NCT01266902|615934535|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
170436144|NCT01266902|615934536|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
170436145|NCT01266902|615934537|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
170436146|NCT01266902|615934535|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
170436147|NCT01266902|615934536|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
170436148|NCT01266902|615934537|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
170436149|NCT01266902|615934535|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
170436150|NCT01266902|615934536|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
170436151|NCT01266902|615934537|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
170436152|NCT02121184|615934538|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
170436153|NCT02121184|615934539|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
170436154|NCT02121184|615934538|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
170436155|NCT02121184|615934539|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
170436156|NCT02121184|615934538|FG000|Overall Study|Emergency cesarean section required|0|||
170436157|NCT02121184|615934539|FG001|Overall Study|Emergency cesarean section required|2|||
170436158|NCT02121184|615934538|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
170537033|NCT02340949|616309627|FG000|Overall Study|Death|3|||
170537034|NCT02340949|616309628|FG001|Overall Study|Death|0|||
170537035|NCT02340949|616309627|FG000|Overall Study|Physician Decision|1|||
170436159|NCT02121184|615934539|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
170436160|NCT04567329|615934542|FG000|Overall Study|Withdrawal by Subject|5|||
170436161|NCT04567329|615934543|FG001|Overall Study|Withdrawal by Subject|6|||
170436162|NCT04567329|615934542|FG000|Overall Study|Protocol Violation|2|||
170436163|NCT04567329|615934543|FG001|Overall Study|Protocol Violation|3|||
170436164|NCT04567329|615934542|FG000|Overall Study|Discontinued|2|||
170436165|NCT04567329|615934543|FG001|Overall Study|Discontinued|2|||
170436166|NCT04567329|615934542|FG000|Overall Study|Lost to Follow-up|0|||
170436167|NCT04567329|615934543|FG001|Overall Study|Lost to Follow-up|1|||
170436168|NCT04567329|615934542|FG000|Overall Study|Lack of Efficacy|0|||
170436169|NCT04567329|615934543|FG001|Overall Study|Lack of Efficacy|1|||
170436170|NCT01438060|615934548|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
170436171|NCT01438060|615934549|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
170436172|NCT01438060|615934548|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
170436173|NCT01438060|615934549|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
170436174|NCT01438060|615934548|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
170436175|NCT01438060|615934549|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
170436176|NCT01438060|615934548|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
170436177|NCT01438060|615934549|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
170436178|NCT01438060|615934548|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
170436179|NCT01438060|615934549|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
170436180|NCT01438060|615934548|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
170436181|NCT01438060|615934549|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
170436182|NCT01438060|615934548|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
170436183|NCT01438060|615934549|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
170436184|NCT01438060|615934548|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
170436185|NCT01438060|615934549|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
170436186|NCT01438060|615934548|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
170436187|NCT01438060|615934549|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
170436188|NCT01438060|615934548|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
170436189|NCT01438060|615934549|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
170436190|NCT01438060|615934548|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
170436191|NCT01438060|615934549|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
170436192|NCT01438060|615934548|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
170436193|NCT01438060|615934549|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
170436194|NCT01438060|615934548|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
170436195|NCT01438060|615934549|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
170436196|NCT01438060|615934548|FG000|On Study Beyond Week 140|Adverse Event|0|||
170436197|NCT01438060|615934549|FG001|On Study Beyond Week 140|Adverse Event|2|||
170780774|NCT04238247|617205690|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
170780775|NCT04238247|617205691|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
170780776|NCT04238247|617205692|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
170780777|NCT04238247|617205693|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
170780778|NCT04238247|617205690|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
170780779|NCT04238247|617205691|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
170780780|NCT04238247|617205692|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
170780781|NCT04238247|617205693|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
170780782|NCT04238247|617205690|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
170780783|NCT04238247|617205691|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
170780784|NCT04238247|617205692|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
170780785|NCT04238247|617205693|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
170780786|NCT05512962|617205694|FG000|Overall Study|Withdrawal by Subject|1|||
170780787|NCT05512962|617205695|FG001|Overall Study|Withdrawal by Subject|0|||
170780788|NCT04950127|617205696|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
170780789|NCT04950127|617205697|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
170780790|NCT04950127|617205698|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
170780791|NCT04950127|617205699|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
170780792|NCT04950127|617205700|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
170780793|NCT04950127|617205701|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
170780794|NCT04950127|617205696|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
170780795|NCT04950127|617205697|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
170882155|NCT00440947|617577623|FG003|48-Week Randomization Phase|Protocol Violation|0|||
170882156|NCT00440947|617577624|FG004|48-Week Randomization Phase|Protocol Violation|0|||
170882157|NCT00440947|617577620|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
170882158|NCT00440947|617577621|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
170436198|NCT01438060|615934548|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
170436199|NCT01438060|615934549|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
170436200|NCT01438060|615934548|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
170436201|NCT01438060|615934549|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
170436202|NCT01438060|615934548|FG000|On Study Beyond Week 140|Death|0|||
170882159|NCT00440947|617577622|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
170882160|NCT00440947|617577623|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
170882161|NCT00440947|617577624|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
170882162|NCT00440947|617577620|FG000|48-Week Randomization Phase|Pregnancy|0|||
170882163|NCT00440947|617577621|FG001|48-Week Randomization Phase|Pregnancy|0|||
170882164|NCT00440947|617577622|FG002|48-Week Randomization Phase|Pregnancy|1|||
170882165|NCT00440947|617577623|FG003|48-Week Randomization Phase|Pregnancy|0|||
170882166|NCT00440947|617577624|FG004|48-Week Randomization Phase|Pregnancy|0|||
170882167|NCT00440947|617577620|FG000|48-Week Randomization Phase|Incarceration|0|||
170436203|NCT01438060|615934549|FG001|On Study Beyond Week 140|Death|1|||
170436204|NCT01438060|615934548|FG000|On Study Beyond Week 140|Other Reason|0|||
170436205|NCT01438060|615934549|FG001|On Study Beyond Week 140|Other Reason|3|||
170436206|NCT00863330|615934550|FG000|Overall Study|study terminated early due to administra|6|||
170436207|NCT03602339|615934551|FG000|Overall Study|Withdrawal by Subject|9|||
170436208|NCT03602339|615934551|FG000|Overall Study|Physician Decision|2|||
170436209|NCT03602339|615934551|FG000|Overall Study|Other reason|4|||
170436210|NCT00829452|615934554|FG000|First Intervention|Withdrawal by Subject|0|||
170436211|NCT00829452|615934555|FG001|First Intervention|Withdrawal by Subject|1|||
170436212|NCT00829452|615934554|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
170436213|NCT00829452|615934555|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
170436214|NCT00829452|615934554|FG000|Second Intervention|Physician Decision|0|||
170436215|NCT00829452|615934555|FG001|Second Intervention|Physician Decision|1|||
170436216|NCT00834873|615934563|FG000|First Intervention|Adverse Event|0|||
170436217|NCT00834873|615934564|FG001|First Intervention|Adverse Event|1|||
170436218|NCT05098743|615934568|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
170436219|NCT05098743|615934569|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
170882168|NCT00440947|617577621|FG001|48-Week Randomization Phase|Incarceration|3|||
170882169|NCT00440947|617577622|FG002|48-Week Randomization Phase|Incarceration|0|||
170882170|NCT00440947|617577623|FG003|48-Week Randomization Phase|Incarceration|0|||
170882171|NCT00440947|617577624|FG004|48-Week Randomization Phase|Incarceration|0|||
170882172|NCT00440947|617577620|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
170882173|NCT00440947|617577621|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
170882174|NCT00440947|617577622|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
170882175|NCT00440947|617577623|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
170436220|NCT05098743|615934568|FG000|Overall Study|Lost to Follow-up|1|||
170436221|NCT05098743|615934569|FG001|Overall Study|Lost to Follow-up|2|||
170436222|NCT00487435|615934570|FG000|Overall Study|Adverse Event|146|||
170436223|NCT00487435|615934570|FG000|Overall Study|Death|2|||
170436224|NCT00487435|615934570|FG000|Overall Study|Lack of Efficacy|33|||
170436225|NCT00487435|615934570|FG000|Overall Study|Lost to Follow-up|54|||
170436226|NCT00487435|615934570|FG000|Overall Study|Pregnancy|2|||
170436227|NCT00487435|615934570|FG000|Overall Study|Withdrawal by Subject|132|||
170436228|NCT00487435|615934570|FG000|Overall Study|Resolution Of Pain|1|||
170436229|NCT00487435|615934570|FG000|Overall Study|Study Medication Non-Compliant|32|||
170436230|NCT00487435|615934570|FG000|Overall Study|Other|83|||
170436231|NCT01456221|615934571|FG000|Overall Study|Withdrawal by Subject|56|||
170436232|NCT01456221|615934572|FG001|Overall Study|Withdrawal by Subject|49|||
170436233|NCT01456221|615934571|FG000|Overall Study|Lost to Follow-up|1|||
170436234|NCT01456221|615934572|FG001|Overall Study|Lost to Follow-up|4|||
170537036|NCT02340949|616309628|FG001|Overall Study|Physician Decision|0|||
170882176|NCT00440947|617577624|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
170882177|NCT00440947|617577620|FG000|48-Week Randomization Phase|Physician Decision|0|||
170436235|NCT01456221|615934571|FG000|Overall Study|Received medication|3|||
170436236|NCT01456221|615934572|FG001|Overall Study|Received medication|2|||
170436237|NCT01456221|615934571|FG000|Overall Study|Incomplete data|4|||
170436238|NCT01456221|615934572|FG001|Overall Study|Incomplete data|2|||
170436239|NCT01151618|615934573|FG000|Overall Study|Adverse Event|2|||
170436240|NCT01151618|615934573|FG000|Overall Study|Withdrawal by Subject|7|||
170436241|NCT00985751|615934574|FG000|Overall Study|Adverse Event|0|||
170436242|NCT00985751|615934575|FG001|Overall Study|Adverse Event|0|||
170436243|NCT00985751|615934576|FG002|Overall Study|Adverse Event|0|||
170436244|NCT00985751|615934577|FG003|Overall Study|Adverse Event|0|||
170436245|NCT00985751|615934578|FG004|Overall Study|Adverse Event|1|||
170436246|NCT00474188|615934580|FG000|Overall Study|Withdrawal by Subject|1|||
170436247|NCT00474188|615934580|FG000|Overall Study|Study discontinued by sponsor|5|||
170436248|NCT03541252|615934581|FG000|Overall Study|Withdrawal by Subject|1|||
170436249|NCT00842309|615934582|FG000|Overall Study|Withdrawal by Subject|3|||
170436250|NCT00842309|615934583|FG001|Overall Study|Withdrawal by Subject|1|||
170436251|NCT00566722|615934584|FG000|Overall Study|Adverse Event|0|||
170436252|NCT00566722|615934585|FG001|Overall Study|Adverse Event|1|||
170436253|NCT00566722|615934586|FG002|Overall Study|Adverse Event|0|||
170436254|NCT00566722|615934584|FG000|Overall Study|Withdrawal by Subject|0|||
170436255|NCT00566722|615934585|FG001|Overall Study|Withdrawal by Subject|0|||
170436256|NCT00566722|615934586|FG002|Overall Study|Withdrawal by Subject|1|||
170436257|NCT00566722|615934584|FG000|Overall Study|Lost to Follow-up|1|||
170436258|NCT00566722|615934585|FG001|Overall Study|Lost to Follow-up|1|||
170436259|NCT00566722|615934586|FG002|Overall Study|Lost to Follow-up|1|||
170436260|NCT00566722|615934584|FG000|Overall Study|Lack of Efficacy|1|||
170436261|NCT00566722|615934585|FG001|Overall Study|Lack of Efficacy|2|||
170882178|NCT00440947|617577621|FG001|48-Week Randomization Phase|Physician Decision|2|||
170882179|NCT00440947|617577622|FG002|48-Week Randomization Phase|Physician Decision|0|||
170882180|NCT00440947|617577623|FG003|48-Week Randomization Phase|Physician Decision|0|||
170882181|NCT00440947|617577624|FG004|48-Week Randomization Phase|Physician Decision|0|||
170882182|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
170882183|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
170882184|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
170882185|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
170882186|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
170882187|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
170882188|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
170882189|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
170882190|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
170882191|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
170882192|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
170882193|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
170882194|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
170882195|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
170882196|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
170882197|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
170882198|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
170882199|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
170882200|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
170882201|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
170882202|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
170882203|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
170882204|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
170882205|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
170882206|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
170882207|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
170882208|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
170882209|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
170882210|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
170882211|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
170882212|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
170882213|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
170882214|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
170882215|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
170882216|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
170882217|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
170882218|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
170882219|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
170436262|NCT00566722|615934586|FG002|Overall Study|Lack of Efficacy|4|||
170537037|NCT03980223|616309629|FG000|Overall Study|Lost to Follow-up|3|||
170882220|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
170436263|NCT00566722|615934584|FG000|Overall Study|Did not meet exclusion criteria|0|||
170436264|NCT00566722|615934585|FG001|Overall Study|Did not meet exclusion criteria|0|||
170436265|NCT00566722|615934586|FG002|Overall Study|Did not meet exclusion criteria|2|||
170436266|NCT00566722|615934584|FG000|Overall Study|Serious adverse event|0|||
170632838|NCT04323124|616666788|FG005|Overall Study|Coming from a red zone (COVID)|1|||
170632839|NCT04323124|616666789|FG006|Overall Study|Coming from a red zone (COVID)|0|||
170632840|NCT04323124|616666790|FG007|Overall Study|Coming from a red zone (COVID)|0|||
170632841|NCT04323124|616666791|FG008|Overall Study|Coming from a red zone (COVID)|0|||
170632842|NCT04323124|616666792|FG009|Overall Study|Coming from a red zone (COVID)|0|||
170632843|NCT04323124|616666793|FG010|Overall Study|Coming from a red zone (COVID)|0|||
170632844|NCT04323124|616666794|FG011|Overall Study|Coming from a red zone (COVID)|0|||
170632845|NCT04323124|616666795|FG012|Overall Study|Coming from a red zone (COVID)|0|||
170632846|NCT04323124|616666796|FG013|Overall Study|Coming from a red zone (COVID)|0|||
170632847|NCT04323124|616666797|FG014|Overall Study|Coming from a red zone (COVID)|0|||
170632848|NCT04323124|616666783|FG000|Overall Study|No longer meets eligibility criteria|0|||
170632849|NCT04323124|616666784|FG001|Overall Study|No longer meets eligibility criteria|0|||
170632850|NCT04323124|616666785|FG002|Overall Study|No longer meets eligibility criteria|0|||
170632851|NCT04323124|616666786|FG003|Overall Study|No longer meets eligibility criteria|0|||
170632852|NCT04323124|616666787|FG004|Overall Study|No longer meets eligibility criteria|0|||
170632853|NCT04323124|616666788|FG005|Overall Study|No longer meets eligibility criteria|0|||
170632854|NCT04323124|616666789|FG006|Overall Study|No longer meets eligibility criteria|0|||
170632855|NCT04323124|616666790|FG007|Overall Study|No longer meets eligibility criteria|1|||
170632856|NCT04323124|616666791|FG008|Overall Study|No longer meets eligibility criteria|0|||
170632857|NCT04323124|616666792|FG009|Overall Study|No longer meets eligibility criteria|0|||
170632858|NCT04323124|616666793|FG010|Overall Study|No longer meets eligibility criteria|0|||
170632859|NCT04323124|616666794|FG011|Overall Study|No longer meets eligibility criteria|0|||
170632860|NCT04323124|616666795|FG012|Overall Study|No longer meets eligibility criteria|0|||
170882221|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
170882222|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
170882223|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
170882224|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
170882225|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
170882226|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
170882227|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
170882228|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
170632861|NCT04323124|616666796|FG013|Overall Study|No longer meets eligibility criteria|1|||
170632862|NCT04323124|616666797|FG014|Overall Study|No longer meets eligibility criteria|1|||
170632863|NCT04323124|616666783|FG000|Overall Study|Study terminated by sponsor|0|||
170632864|NCT04323124|616666784|FG001|Overall Study|Study terminated by sponsor|0|||
170632865|NCT04323124|616666785|FG002|Overall Study|Study terminated by sponsor|0|||
170632866|NCT04323124|616666786|FG003|Overall Study|Study terminated by sponsor|0|||
170632867|NCT04323124|616666787|FG004|Overall Study|Study terminated by sponsor|0|||
170632868|NCT04323124|616666788|FG005|Overall Study|Study terminated by sponsor|0|||
170632869|NCT04323124|616666789|FG006|Overall Study|Study terminated by sponsor|0|||
170632870|NCT04323124|616666790|FG007|Overall Study|Study terminated by sponsor|0|||
170632871|NCT04323124|616666791|FG008|Overall Study|Study terminated by sponsor|0|||
170632872|NCT04323124|616666792|FG009|Overall Study|Study terminated by sponsor|0|||
170632873|NCT04323124|616666793|FG010|Overall Study|Study terminated by sponsor|0|||
170632874|NCT04323124|616666794|FG011|Overall Study|Study terminated by sponsor|2|||
170632875|NCT04323124|616666795|FG012|Overall Study|Study terminated by sponsor|1|||
170632876|NCT04323124|616666796|FG013|Overall Study|Study terminated by sponsor|0|||
170632877|NCT04323124|616666797|FG014|Overall Study|Study terminated by sponsor|0|||
170632878|NCT00815659|616668422|FG000|Overall Study|Adverse Event|9|||
170632879|NCT00815659|616668422|FG000|Overall Study|Withdrawal by Subject|9|||
170632880|NCT00815659|616668422|FG000|Overall Study|Lost to Follow-up|4|||
170632881|NCT00815659|616668422|FG000|Overall Study|Protocol Violation|1|||
170632882|NCT01938716|616668425|FG000|Overall Study|Physician Decision|2|||
170632883|NCT01938716|616668425|FG000|Overall Study|Withdrawal by Subject|2|||
170632884|NCT00823615|616668426|FG000|Period 2|Lost to Follow-up|2|||
170632885|NCT00823615|616668427|FG001|Period 2|Lost to Follow-up|0|||
170632886|NCT00823615|616668426|FG000|Period 2|Time/Job Conflict|1|||
170632887|NCT00823615|616668427|FG001|Period 2|Time/Job Conflict|2|||
170632888|NCT00098813|616668428|FG000|Overall Study|Death|8|||
170632889|NCT00098813|616668428|FG000|Overall Study|Protocol Violation|1|||
170632890|NCT00098813|616668428|FG000|Overall Study|Withdrawal by Subject|7|||
170632891|NCT00098813|616668428|FG000|Overall Study|Progression of Disease|1|||
170882229|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
170882230|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
170882231|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
170882232|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
170882233|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
170632892|NCT00098813|616668428|FG000|Overall Study|Other complicating disease|1|||
170632893|NCT00098813|616668428|FG000|Overall Study|Reversal of RAI resistance|1|||
170632894|NCT01554241|616668429|FG000|Overall Study|Death|3|||
170632895|NCT01554241|616668430|FG001|Overall Study|Death|1|||
170632896|NCT01554241|616668431|FG002|Overall Study|Death|1|||
170780796|NCT04950127|617205698|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
170780797|NCT04950127|617205699|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
170780798|NCT04950127|617205700|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
170780799|NCT04950127|617205701|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
170780800|NCT04950127|617205696|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
170780801|NCT04950127|617205697|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
170780802|NCT04950127|617205698|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
170780803|NCT04950127|617205699|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
170780804|NCT04950127|617205700|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
170780805|NCT04950127|617205701|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
170780806|NCT04950127|617205696|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
170780807|NCT04950127|617205697|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
170780808|NCT04950127|617205698|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
170780809|NCT04950127|617205699|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
170780810|NCT04950127|617205700|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
170780811|NCT04950127|617205701|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
170780812|NCT04950127|617205696|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
170780813|NCT04950127|617205697|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
170780814|NCT04950127|617205698|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
170780815|NCT04950127|617205699|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
170780816|NCT04950127|617205700|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
170780817|NCT04950127|617205701|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
170780818|NCT01711632|617205702|FG000|Overall Study|Adverse Event|4|||
170780819|NCT01711632|617205702|FG000|Overall Study|Death|3|||
170780820|NCT01711632|617205702|FG000|Overall Study|Lost to Follow-up|3|||
170780821|NCT01711632|617205702|FG000|Overall Study|Withdrawal by Subject|4|||
170780822|NCT01711632|617205702|FG000|Overall Study|Progressive disease|2|||
170780823|NCT01711632|617205702|FG000|Overall Study|No follow up required in re-treatment|3|||
170780824|NCT01711632|617205702|FG000|Overall Study|No follow up required in re-treatment|3|||
170780825|NCT02860130|617205703|FG000|Overall Study|Adverse Event|2|||
170780826|NCT02860130|617205704|FG001|Overall Study|Adverse Event|3|||
170780827|NCT02860130|617205703|FG000|Overall Study|Protocol Violation|1|||
170780828|NCT02860130|617205704|FG001|Overall Study|Protocol Violation|1|||
170780829|NCT02860130|617205703|FG000|Overall Study|Withdrawal by Subject|0|||
170780830|NCT02860130|617205704|FG001|Overall Study|Withdrawal by Subject|2|||
170780831|NCT02860130|617205703|FG000|Overall Study|Physician Decision|2|||
170780832|NCT02860130|617205704|FG001|Overall Study|Physician Decision|2|||
170780833|NCT02860130|617205703|FG000|Overall Study|Other|2|||
170780834|NCT02860130|617205704|FG001|Overall Study|Other|1|||
170780835|NCT00522951|617205707|FG000|Period 1|body motion|0|||
170780836|NCT00522951|617205708|FG001|Period 1|body motion|1|||
170780837|NCT00522951|617205707|FG000|Washout Period|Adverse Event|0|||
170780838|NCT00522951|617205708|FG001|Washout Period|Adverse Event|1|||
170780839|NCT00522951|617205707|FG000|Washout Period|Death|0|||
170780840|NCT00522951|617205708|FG001|Washout Period|Death|1|||
170780841|NCT00522951|617205707|FG000|Period 2|Withdrawal by Subject|1|||
170780842|NCT00522951|617205708|FG001|Period 2|Withdrawal by Subject|0|||
170780843|NCT00522951|617205707|FG000|Period 2|residual contrast medium|1|||
170780844|NCT00522951|617205708|FG001|Period 2|residual contrast medium|1|||
170780845|NCT02140645|617205712|FG000|Overall Study|Not linked|5489|||
170780846|NCT02140645|617205713|FG001|Overall Study|Not linked|61654|||
170780847|NCT02140645|617205714|FG002|Overall Study|Not linked|4236|||
170780848|NCT02140645|617205715|FG003|Overall Study|Not linked|13833|||
170780849|NCT02140645|617205716|FG004|Overall Study|Not linked|3286|||
170780850|NCT02140645|617205717|FG005|Overall Study|Not linked|70896|||
170780851|NCT05450458|617205718|FG000|Overall Study|Lost to Follow-up|4|||
170780852|NCT01101451|617205720|FG000|Overall Study|Eligible and never treated|0|||
170780853|NCT01101451|617205721|FG001|Overall Study|Eligible and never treated|5|||
170780854|NCT01101451|617205720|FG000|Overall Study|Ineligible and treated|12|||
170780855|NCT01101451|617205721|FG001|Overall Study|Ineligible and treated|8|||
170780856|NCT01101451|617205720|FG000|Overall Study|Ineligible and never treated|2|||
170780857|NCT01101451|617205721|FG001|Overall Study|Ineligible and never treated|2|||
170780858|NCT00539734|617205724|FG000|Overall Study|Protocol Violation|1|||
170780859|NCT02794480|617205725|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
170780860|NCT02794480|617205726|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
170780861|NCT02794480|617205727|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
170780862|NCT02794480|617205728|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
170780863|NCT02794480|617205725|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
170780864|NCT02794480|617205726|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
170780865|NCT02794480|617205727|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
170537038|NCT03980223|616309630|FG001|Overall Study|Lost to Follow-up|7|||
170780866|NCT02794480|617205728|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
170780867|NCT02794480|617205725|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170537039|NCT03980223|616309631|FG002|Overall Study|Lost to Follow-up|10|||
170632897|NCT01554241|616668432|FG003|Overall Study|Death|0|||
170632898|NCT01554241|616668429|FG000|Overall Study|protocol specified renal stone|0|||
170632899|NCT01554241|616668430|FG001|Overall Study|protocol specified renal stone|0|||
170632900|NCT01554241|616668431|FG002|Overall Study|protocol specified renal stone|0|||
170632901|NCT01554241|616668432|FG003|Overall Study|protocol specified renal stone|1|||
170632902|NCT01554241|616668429|FG000|Overall Study|protocol specified change in eGFR|0|||
170632903|NCT01554241|616668430|FG001|Overall Study|protocol specified change in eGFR|0|||
170632904|NCT01554241|616668431|FG002|Overall Study|protocol specified change in eGFR|1|||
170632905|NCT01554241|616668432|FG003|Overall Study|protocol specified change in eGFR|0|||
170632906|NCT01554241|616668429|FG000|Overall Study|Withdrawal by Subject|0|||
170632907|NCT01554241|616668430|FG001|Overall Study|Withdrawal by Subject|0|||
170632908|NCT01554241|616668431|FG002|Overall Study|Withdrawal by Subject|2|||
170632909|NCT01554241|616668432|FG003|Overall Study|Withdrawal by Subject|0|||
170632910|NCT03910244|616668436|FG000|Overall Study|Adverse Event|14|||
170632911|NCT03910244|616668437|FG001|Overall Study|Adverse Event|0|||
170632912|NCT03910244|616668436|FG000|Overall Study|Death|1|||
170632913|NCT03910244|616668437|FG001|Overall Study|Death|0|||
170632914|NCT03910244|616668436|FG000|Overall Study|Lost to Follow-up|0|||
170632915|NCT03910244|616668437|FG001|Overall Study|Lost to Follow-up|2|||
170436267|NCT00566722|615934585|FG001|Overall Study|Serious adverse event|1|||
170436268|NCT00566722|615934586|FG002|Overall Study|Serious adverse event|0|||
170632916|NCT03910244|616668436|FG000|Overall Study|Joint withdrawal decision|1|||
170632917|NCT03910244|616668437|FG001|Overall Study|Joint withdrawal decision|0|||
170632918|NCT03910244|616668436|FG000|Overall Study|Study Terminated by Sponsor|7|||
170632919|NCT03910244|616668437|FG001|Overall Study|Study Terminated by Sponsor|4|||
170632920|NCT03910244|616668436|FG000|Overall Study|Physician Decision|1|||
170780868|NCT02794480|617205726|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170780869|NCT02794480|617205727|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170780870|NCT02794480|617205728|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
170780871|NCT02794480|617205725|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170780872|NCT02794480|617205726|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
170436269|NCT00566722|615934584|FG000|Overall Study|Noncompliant with drug administration|0|||
170436270|NCT00566722|615934585|FG001|Overall Study|Noncompliant with drug administration|0|||
170436271|NCT00566722|615934586|FG002|Overall Study|Noncompliant with drug administration|1|||
170436272|NCT02272803|615934587|FG000|Overall Study|Disease progression|16|||
170436273|NCT02272803|615934588|FG001|Overall Study|Disease progression|8|||
170436274|NCT02272803|615934587|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
170436275|NCT02272803|615934588|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
170436276|NCT02272803|615934587|FG000|Overall Study|Study drug toxicity|4|||
170436277|NCT02272803|615934588|FG001|Overall Study|Study drug toxicity|9|||
170436278|NCT02272803|615934587|FG000|Overall Study|Participant request to discontinue study treatment|3|||
170436279|NCT02272803|615934588|FG001|Overall Study|Participant request to discontinue study treatment|7|||
170436280|NCT02272803|615934587|FG000|Overall Study|Maximum clinical benefit|4|||
170436281|NCT02272803|615934588|FG001|Overall Study|Maximum clinical benefit|2|||
170436282|NCT02272803|615934587|FG000|Overall Study|Poor/non-compliance|2|||
170436283|NCT02272803|615934588|FG001|Overall Study|Poor/non-compliance|2|||
170436284|NCT02272803|615934587|FG000|Overall Study|Withdrawal by Subject|2|||
170436285|NCT02272803|615934588|FG001|Overall Study|Withdrawal by Subject|1|||
170436286|NCT02272803|615934587|FG000|Overall Study|Death|0|||
170436287|NCT02272803|615934588|FG001|Overall Study|Death|1|||
170436288|NCT02272803|615934587|FG000|Overall Study|Other reasons|1|||
170436289|NCT02272803|615934588|FG001|Overall Study|Other reasons|3|||
170436290|NCT02272803|615934587|FG000|Overall Study|Administrative reason by sponsor|5|||
170436291|NCT02272803|615934588|FG001|Overall Study|Administrative reason by sponsor|4|||
170436292|NCT02943096|615934591|FG000|Overall Study|Lack of Efficacy|0|||
170436293|NCT02943096|615934592|FG001|Overall Study|Lack of Efficacy|1|||
170436294|NCT00227370|615934593|FG000|Overall Study|Withdrawal by Subject|1|||
170436295|NCT00227370|615934594|FG001|Overall Study|Withdrawal by Subject|2|||
170436296|NCT00227370|615934593|FG000|Overall Study|Death|3|||
170436297|NCT00227370|615934594|FG001|Overall Study|Death|4|||
170436298|NCT00227370|615934593|FG000|Overall Study|Adverse Event|6|||
170632921|NCT03910244|616668437|FG001|Overall Study|Physician Decision|0|||
170632922|NCT03910244|616668436|FG000|Overall Study|Protocol Violation|1|||
170780873|NCT02794480|617205727|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170780874|NCT02794480|617205728|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
170780875|NCT02794480|617205725|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
170436299|NCT00227370|615934594|FG001|Overall Study|Adverse Event|11|||
170436300|NCT00227370|615934593|FG000|Overall Study|Physician Decision|9|||
170436301|NCT00227370|615934594|FG001|Overall Study|Physician Decision|6|||
170436302|NCT00227370|615934593|FG000|Overall Study|Other reasons|2|||
170436303|NCT00227370|615934594|FG001|Overall Study|Other reasons|1|||
170436304|NCT02452463|615934599|FG000|Overall Study|Death|1|||
170436305|NCT02452463|615934600|FG001|Overall Study|Death|0|||
170436306|NCT02452463|615934601|FG002|Overall Study|Death|0|||
170436307|NCT02452463|615934599|FG000|Overall Study|Study Suspended|1|||
170436308|NCT02452463|615934600|FG001|Overall Study|Study Suspended|0|||
170436309|NCT02452463|615934601|FG002|Overall Study|Study Suspended|0|||
170436310|NCT02452463|615934599|FG000|Overall Study|Recommended by DSMB|0|||
170436311|NCT02452463|615934600|FG001|Overall Study|Recommended by DSMB|1|||
170436312|NCT02452463|615934601|FG002|Overall Study|Recommended by DSMB|0|||
170436313|NCT02452463|615934599|FG000|Overall Study|Withdrawal by Subject|0|||
170436314|NCT02452463|615934600|FG001|Overall Study|Withdrawal by Subject|1|||
170436315|NCT02452463|615934601|FG002|Overall Study|Withdrawal by Subject|0|||
170436316|NCT01073631|615934602|FG000|Overall Study|Death|82|||
170436317|NCT01073631|615934602|FG000|Overall Study|Adverse Event|24|||
170436318|NCT01073631|615934602|FG000|Overall Study|Other|63|||
170436319|NCT01131260|615934607|FG000|Overall Study|Randomization error|5|||
170436320|NCT01131260|615934608|FG001|Overall Study|Randomization error|1|||
170436321|NCT01131260|615934607|FG000|Overall Study|Declined to continue participation|8|||
170436322|NCT01131260|615934608|FG001|Overall Study|Declined to continue participation|13|||
170436323|NCT01131260|615934607|FG000|Overall Study|Physician Decision|22|||
170436324|NCT01131260|615934608|FG001|Overall Study|Physician Decision|24|||
170436325|NCT01131260|615934607|FG000|Overall Study|Technical problems|7|||
170436326|NCT01131260|615934608|FG001|Overall Study|Technical problems|6|||
170436327|NCT01131260|615934607|FG000|Overall Study|Staff error|2|||
170436328|NCT01131260|615934608|FG001|Overall Study|Staff error|1|||
170436329|NCT01131260|615934607|FG000|Overall Study|Ineligible|0|||
170436330|NCT01131260|615934608|FG001|Overall Study|Ineligible|2|||
170436331|NCT01473953|615934609|FG000|Overall Study|Other|1|||
170436332|NCT01473953|615934610|FG001|Overall Study|Other|0|||
170436333|NCT01473953|615934611|FG002|Overall Study|Other|0|||
170436334|NCT01473953|615934612|FG003|Overall Study|Other|0|||
170436335|NCT01473953|615934613|FG004|Overall Study|Other|0|||
170436336|NCT00849797|615934616|FG000|First Intervention|bad veins|1|||
170436337|NCT00849797|615934617|FG001|First Intervention|bad veins|0|||
170436338|NCT00849797|615934616|FG000|First Intervention|Adverse Event|0|||
170436339|NCT00849797|615934617|FG001|First Intervention|Adverse Event|1|||
170436340|NCT00849797|615934616|FG000|Washout: One Week|Withdrawal by Subject|0|||
170436341|NCT00849797|615934617|FG001|Washout: One Week|Withdrawal by Subject|2|||
170436342|NCT00679081|615934618|FG000|Overall Study|Lost to Follow-up|1|||
170436343|NCT01675596|615934619|FG000|Overall Study|Death|6|||
170436344|NCT01675596|615934619|FG000|Overall Study|Exit with other reason|1|||
170436345|NCT01675596|615934619|FG000|Overall Study|Missed Visit|1|||
170436346|NCT01139762|615934620|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
170436347|NCT01139762|615934621|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
170436348|NCT01139762|615934622|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
170436349|NCT01139762|615934620|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
170436350|NCT01139762|615934621|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
170436351|NCT01139762|615934622|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
170436352|NCT01139762|615934620|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
170436353|NCT01139762|615934621|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
170436354|NCT01139762|615934622|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
170436355|NCT01139762|615934620|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
170436356|NCT01139762|615934621|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
170436357|NCT01139762|615934622|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
170436358|NCT01139762|615934620|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
170436359|NCT01139762|615934621|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
170436360|NCT01139762|615934622|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
170436361|NCT01139762|615934620|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
170436362|NCT01139762|615934621|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
170436363|NCT01139762|615934622|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
170436364|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
170436365|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
170780876|NCT02794480|617205726|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170780877|NCT02794480|617205727|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170780878|NCT02794480|617205728|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
170436366|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
170436367|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Death|0|||
170436368|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Death|1|||
170780879|NCT01070069|617205729|FG000|Overall Study|Death|1|||
170436369|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Death|1|||
170436370|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
170436371|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
170436372|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
170436373|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
170436374|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
170436375|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
170436376|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
170436377|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
170436378|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
170436379|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
170436380|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
170436381|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
170436382|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
170436383|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
170436384|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
170436385|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
170436386|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
170436387|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
170436388|NCT01139762|615934620|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
170436389|NCT01139762|615934621|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
170436390|NCT01139762|615934622|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
170436391|NCT03067987|615934629|FG000|Overall Study|Lost to Follow-up|7|||
170436392|NCT03067987|615934630|FG001|Overall Study|Lost to Follow-up|10|||
170436393|NCT03067987|615934629|FG000|Overall Study|Protocol Violation|1|||
170436394|NCT03067987|615934630|FG001|Overall Study|Protocol Violation|2|||
170436395|NCT03067987|615934629|FG000|Overall Study|Withdrawal by Subject|2|||
170436396|NCT03067987|615934630|FG001|Overall Study|Withdrawal by Subject|1|||
170436397|NCT01018862|615934631|FG000|Overall Study|Adverse Event|2|||
170436398|NCT01018862|615934632|FG001|Overall Study|Adverse Event|0|||
170436399|NCT01018862|615934633|FG002|Overall Study|Adverse Event|6|||
170436400|NCT01018862|615934631|FG000|Overall Study|Lack of Efficacy|1|||
170436401|NCT01018862|615934632|FG001|Overall Study|Lack of Efficacy|0|||
170436402|NCT01018862|615934633|FG002|Overall Study|Lack of Efficacy|2|||
170436403|NCT01018862|615934631|FG000|Overall Study|Lost to Follow-up|3|||
170436404|NCT01018862|615934632|FG001|Overall Study|Lost to Follow-up|1|||
170436405|NCT01018862|615934633|FG002|Overall Study|Lost to Follow-up|0|||
170436406|NCT01018862|615934631|FG000|Overall Study|Protocol Violation|1|||
170436407|NCT01018862|615934632|FG001|Overall Study|Protocol Violation|3|||
170436408|NCT01018862|615934633|FG002|Overall Study|Protocol Violation|3|||
170436409|NCT01018862|615934631|FG000|Overall Study|Withdrawal by Subject|1|||
170436410|NCT01018862|615934632|FG001|Overall Study|Withdrawal by Subject|2|||
170436411|NCT01018862|615934633|FG002|Overall Study|Withdrawal by Subject|1|||
170436412|NCT01018862|615934631|FG000|Overall Study|administrative problems|5|||
170436413|NCT01018862|615934632|FG001|Overall Study|administrative problems|4|||
170436414|NCT01018862|615934633|FG002|Overall Study|administrative problems|4|||
170436415|NCT01891357|615934634|FG000|Overall Study|Protocol Violation|3|||
170436416|NCT02219009|615936593|FG000|Overall Study|Withdrawal by Subject|5|||
170436417|NCT02219009|615936594|FG001|Overall Study|Withdrawal by Subject|1|||
170436418|NCT02219009|615936593|FG000|Overall Study|Adverse Event|2|||
170436419|NCT02219009|615936594|FG001|Overall Study|Adverse Event|4|||
170436420|NCT02219009|615936593|FG000|Overall Study|Lost to Follow-up|2|||
170436421|NCT02219009|615936594|FG001|Overall Study|Lost to Follow-up|2|||
170436422|NCT02219009|615936593|FG000|Overall Study|Protocol deviation|1|||
170436423|NCT02219009|615936594|FG001|Overall Study|Protocol deviation|0|||
170436424|NCT02219009|615936593|FG000|Overall Study|Physician Decision|0|||
170436425|NCT02219009|615936594|FG001|Overall Study|Physician Decision|1|||
170436426|NCT02488109|615936595|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
170436427|NCT02488109|615936596|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
170780880|NCT01070069|617205730|FG001|Overall Study|Death|0|||
170780881|NCT01070069|617205731|FG002|Overall Study|Death|2|||
170780882|NCT01070069|617205732|FG003|Overall Study|Death|0|||
170780883|NCT01070069|617205733|FG004|Overall Study|Death|1|||
170780884|NCT01070069|617205729|FG000|Overall Study|Withdrawal by Subject|1|||
170780885|NCT01070069|617205730|FG001|Overall Study|Withdrawal by Subject|1|||
170780886|NCT01070069|617205731|FG002|Overall Study|Withdrawal by Subject|4|||
170882234|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
170882235|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
170882236|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
170882237|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Other|0|||
170882238|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Other|0|||
170882239|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Other|0|||
170882240|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Other|1|||
170780887|NCT01070069|617205732|FG003|Overall Study|Withdrawal by Subject|0|||
170780888|NCT01070069|617205733|FG004|Overall Study|Withdrawal by Subject|0|||
170780889|NCT01070069|617205729|FG000|Overall Study|Lost to Follow-up|4|||
170882241|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Other|0|||
170436428|NCT02488109|615936595|FG000|12-month Follow-Up|Lost to Follow-up|4|||
170436429|NCT02488109|615936596|FG001|12-month Follow-Up|Lost to Follow-up|7|||
170436430|NCT03969641|615936597|FG000|Overall Study|Lost to Follow-up|5|||
170436431|NCT03969641|615936598|FG001|Overall Study|Lost to Follow-up|3|||
170780890|NCT01070069|617205730|FG001|Overall Study|Lost to Follow-up|1|||
170780891|NCT01070069|617205731|FG002|Overall Study|Lost to Follow-up|0|||
170780892|NCT01070069|617205732|FG003|Overall Study|Lost to Follow-up|0|||
170780893|NCT01070069|617205733|FG004|Overall Study|Lost to Follow-up|3|||
170780894|NCT03101930|617205734|FG000|Overall Study|Withdrawal by Subject|2|||
170780895|NCT03101930|617205735|FG001|Overall Study|Withdrawal by Subject|1|||
170780896|NCT03101930|617205736|FG002|Overall Study|Withdrawal by Subject|2|||
170780897|NCT00632749|617205737|FG000|Overall Study|Progressive disease|3|||
170780898|NCT00632749|617205738|FG001|Overall Study|Progressive disease|2|||
170780899|NCT00632749|617205739|FG002|Overall Study|Progressive disease|2|||
170780900|NCT00632749|617205740|FG003|Overall Study|Progressive disease|2|||
170780901|NCT00632749|617205741|FG004|Overall Study|Progressive disease|4|||
170780902|NCT00632749|617205742|FG005|Overall Study|Progressive disease|4|||
170780903|NCT00632749|617205743|FG006|Overall Study|Progressive disease|3|||
170780904|NCT00632749|617205744|FG007|Overall Study|Progressive disease|2|||
170780905|NCT00632749|617205745|FG008|Overall Study|Progressive disease|3|||
170780906|NCT00632749|617205746|FG009|Overall Study|Progressive disease|2|||
170780907|NCT00632749|617205747|FG010|Overall Study|Progressive disease|4|||
170780908|NCT00632749|617205748|FG011|Overall Study|Progressive disease|3|||
170780909|NCT00632749|617205749|FG012|Overall Study|Progressive disease|2|||
170780910|NCT00632749|617205750|FG013|Overall Study|Progressive disease|4|||
170780911|NCT00632749|617205737|FG000|Overall Study|Other Adverse event|1|||
170780912|NCT00632749|617205738|FG001|Overall Study|Other Adverse event|1|||
170780913|NCT00632749|617205739|FG002|Overall Study|Other Adverse event|1|||
170780914|NCT00632749|617205740|FG003|Overall Study|Other Adverse event|1|||
170780915|NCT00632749|617205741|FG004|Overall Study|Other Adverse event|2|||
170780916|NCT00632749|617205742|FG005|Overall Study|Other Adverse event|4|||
170780917|NCT00632749|617205743|FG006|Overall Study|Other Adverse event|1|||
170780918|NCT00632749|617205744|FG007|Overall Study|Other Adverse event|2|||
170780919|NCT00632749|617205745|FG008|Overall Study|Other Adverse event|2|||
170780920|NCT00632749|617205746|FG009|Overall Study|Other Adverse event|0|||
170780921|NCT00632749|617205747|FG010|Overall Study|Other Adverse event|1|||
170780922|NCT00632749|617205748|FG011|Overall Study|Other Adverse event|0|||
170780923|NCT00632749|617205749|FG012|Overall Study|Other Adverse event|1|||
170780924|NCT00632749|617205750|FG013|Overall Study|Other Adverse event|0|||
170780925|NCT00632749|617205737|FG000|Overall Study|Refuse to continue medication|0|||
170780926|NCT00632749|617205738|FG001|Overall Study|Refuse to continue medication|0|||
170780927|NCT00632749|617205739|FG002|Overall Study|Refuse to continue medication|0|||
170780928|NCT00632749|617205740|FG003|Overall Study|Refuse to continue medication|1|||
170780929|NCT00632749|617205741|FG004|Overall Study|Refuse to continue medication|0|||
170780930|NCT00632749|617205742|FG005|Overall Study|Refuse to continue medication|0|||
170780931|NCT00632749|617205743|FG006|Overall Study|Refuse to continue medication|0|||
170780932|NCT00632749|617205744|FG007|Overall Study|Refuse to continue medication|0|||
170780933|NCT00632749|617205745|FG008|Overall Study|Refuse to continue medication|0|||
170780934|NCT00632749|617205746|FG009|Overall Study|Refuse to continue medication|1|||
170780935|NCT00632749|617205747|FG010|Overall Study|Refuse to continue medication|0|||
170780936|NCT00632749|617205748|FG011|Overall Study|Refuse to continue medication|0|||
170780937|NCT00632749|617205749|FG012|Overall Study|Refuse to continue medication|0|||
170780938|NCT00632749|617205750|FG013|Overall Study|Refuse to continue medication|0|||
170780939|NCT00632749|617205737|FG000|Overall Study|Reason other than those specified above|0|||
170780940|NCT00632749|617205738|FG001|Overall Study|Reason other than those specified above|2|||
170780941|NCT00632749|617205739|FG002|Overall Study|Reason other than those specified above|0|||
170780942|NCT00632749|617205740|FG003|Overall Study|Reason other than those specified above|0|||
170780943|NCT00632749|617205741|FG004|Overall Study|Reason other than those specified above|1|||
170780944|NCT00632749|617205742|FG005|Overall Study|Reason other than those specified above|0|||
170780945|NCT00632749|617205743|FG006|Overall Study|Reason other than those specified above|1|||
170780946|NCT00632749|617205744|FG007|Overall Study|Reason other than those specified above|0|||
170780947|NCT00632749|617205745|FG008|Overall Study|Reason other than those specified above|0|||
170780948|NCT00632749|617205746|FG009|Overall Study|Reason other than those specified above|0|||
170780949|NCT00632749|617205747|FG010|Overall Study|Reason other than those specified above|2|||
170780950|NCT00632749|617205748|FG011|Overall Study|Reason other than those specified above|1|||
170780951|NCT00632749|617205749|FG012|Overall Study|Reason other than those specified above|0|||
170780952|NCT00632749|617205750|FG013|Overall Study|Reason other than those specified above|2|||
170882242|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
170780953|NCT04999592|617205751|FG000|Overall Study|Withdrawal by Subject|1|||
170780954|NCT04999592|617205752|FG001|Overall Study|Withdrawal by Subject|0|||
170780955|NCT04128319|617205755|FG000|Overall Study|Death|3|||
170780956|NCT00976937|617205756|FG000|Overall Study|Adverse Event|4|||
170780957|NCT00976937|617205757|FG001|Overall Study|Adverse Event|5|||
170780958|NCT00976937|617205756|FG000|Overall Study|Lost to Follow-up|2|||
170882243|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
170780959|NCT00976937|617205757|FG001|Overall Study|Lost to Follow-up|1|||
170780960|NCT00976937|617205756|FG000|Overall Study|Withdrawal by Subject|5|||
170780961|NCT00976937|617205757|FG001|Overall Study|Withdrawal by Subject|3|||
170436432|NCT03969641|615936597|FG000|Overall Study|Withdrawal by Subject|1|||
170436433|NCT03969641|615936598|FG001|Overall Study|Withdrawal by Subject|2|||
170436434|NCT03969641|615936597|FG000|Overall Study|Found to be ineligible|1|||
170436435|NCT03969641|615936598|FG001|Overall Study|Found to be ineligible|1|||
170436436|NCT03969641|615936597|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
170436437|NCT03969641|615936598|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
170436438|NCT03969641|615936597|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
170436439|NCT03969641|615936598|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
170436440|NCT03969641|615936597|FG000|Overall Study|Elective termination|0|||
170436441|NCT03969641|615936598|FG001|Overall Study|Elective termination|1|||
170436442|NCT01622660|615936599|FG000|Overall Study|Adverse Event|1|||
170436443|NCT02259348|615936600|FG000|Overall Study|Donors|6|||
170436444|NCT02259348|615936600|FG000|Overall Study|Death|4|||
170436445|NCT01098851|615936603|FG000|Overall Study|Equipment failure|1|||
170436446|NCT01098851|615936604|FG001|Overall Study|Equipment failure|0|||
170436447|NCT03087786|615936605|FG000|Overall Study|Withdrawal by Subject|2|||
170436448|NCT03087786|615936606|FG001|Overall Study|Withdrawal by Subject|0|||
170436449|NCT02034513|615936607|FG000|Overall Study|Adverse Event|11|||
170436450|NCT02034513|615936608|FG001|Overall Study|Adverse Event|10|||
170436451|NCT02034513|615936607|FG000|Overall Study|Lack of Efficacy|0|||
170436452|NCT02034513|615936608|FG001|Overall Study|Lack of Efficacy|1|||
170436453|NCT02034513|615936607|FG000|Overall Study|Lost to Follow-up|6|||
170436454|NCT02034513|615936608|FG001|Overall Study|Lost to Follow-up|7|||
170436455|NCT02034513|615936607|FG000|Overall Study|Pregnancy|0|||
170436456|NCT02034513|615936608|FG001|Overall Study|Pregnancy|3|||
170436457|NCT02034513|615936607|FG000|Overall Study|Protocol Violation|7|||
170436458|NCT02034513|615936608|FG001|Overall Study|Protocol Violation|10|||
170436459|NCT02034513|615936607|FG000|Overall Study|Withdrawal by Subject|25|||
170436460|NCT02034513|615936608|FG001|Overall Study|Withdrawal by Subject|25|||
170436461|NCT02034513|615936607|FG000|Overall Study|Unclassified|0|||
170436462|NCT02034513|615936608|FG001|Overall Study|Unclassified|1|||
170436463|NCT02218541|615936609|FG000|Overall Study|Lost to Follow-up|2|||
170436464|NCT02218541|615936610|FG001|Overall Study|Lost to Follow-up|1|||
170436465|NCT02218541|615936609|FG000|Overall Study|Implant Failure|4|||
170436466|NCT02218541|615936610|FG001|Overall Study|Implant Failure|1|||
170436467|NCT01944722|615936612|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
170436468|NCT01944722|615936612|FG000|Overall Study|Specimen Shipping Issues|34|||
170436469|NCT01944722|615936612|FG000|Overall Study|Improper Storage/Transport|5|||
170436470|NCT01944722|615936612|FG000|Overall Study|Insufficient Volume for Test|1|||
170436471|NCT01944722|615936612|FG000|Overall Study|Missing Specimens|3|||
170436472|NCT01944722|615936612|FG000|Overall Study|Specimens Mislabeled|2|||
170436473|NCT01944722|615936612|FG000|Overall Study|Withdrawal by Subject|8|||
170436474|NCT01944722|615936612|FG000|Overall Study|NILM Subjects <30 years old|8106|||
170436475|NCT01944722|615936612|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
170436476|NCT01944722|615936612|FG000|Overall Study|>ASCUS Cytology|1122|||
170436477|NCT02554877|615936615|FG000|Overall Study|Adverse Event|2|||
170436478|NCT02554877|615936616|FG001|Overall Study|Adverse Event|0|||
170436479|NCT02554877|615936617|FG002|Overall Study|Adverse Event|0|||
170436480|NCT02554877|615936618|FG003|Overall Study|Adverse Event|1|||
170436481|NCT02554877|615936615|FG000|Overall Study|Lost to Follow-up|1|||
170436482|NCT02554877|615936616|FG001|Overall Study|Lost to Follow-up|1|||
170436483|NCT02554877|615936617|FG002|Overall Study|Lost to Follow-up|1|||
170436484|NCT02554877|615936618|FG003|Overall Study|Lost to Follow-up|2|||
170436485|NCT02554877|615936615|FG000|Overall Study|Did not meet entrance criteria|0|||
170436486|NCT02554877|615936616|FG001|Overall Study|Did not meet entrance criteria|0|||
170436487|NCT02554877|615936617|FG002|Overall Study|Did not meet entrance criteria|1|||
170436488|NCT02554877|615936618|FG003|Overall Study|Did not meet entrance criteria|0|||
170436489|NCT02554877|615936615|FG000|Overall Study|No longer met eligibility criteria|1|||
170780962|NCT00976937|617205756|FG000|Overall Study|Poor compliance to protocol|3|||
170436490|NCT02554877|615936616|FG001|Overall Study|No longer met eligibility criteria|0|||
170436491|NCT02554877|615936617|FG002|Overall Study|No longer met eligibility criteria|1|||
170780963|NCT00976937|617205757|FG001|Overall Study|Poor compliance to protocol|0|||
170780964|NCT00976937|617205756|FG000|Overall Study|Personal and Familial Reason|2|||
170780965|NCT00976937|617205757|FG001|Overall Study|Personal and Familial Reason|2|||
170780966|NCT00951379|617205758|FG000|Overall Study|Adverse Event|4|||
170780967|NCT00951379|617205759|FG001|Overall Study|Adverse Event|1|||
170780968|NCT00951379|617205758|FG000|Overall Study|Withdrawal by Subject|1|||
170436492|NCT02554877|615936618|FG003|Overall Study|No longer met eligibility criteria|1|||
170436493|NCT02554877|615936615|FG000|Overall Study|Protocol Violation|3|||
170436494|NCT02554877|615936616|FG001|Overall Study|Protocol Violation|1|||
170436495|NCT02554877|615936617|FG002|Overall Study|Protocol Violation|1|||
170436496|NCT02554877|615936618|FG003|Overall Study|Protocol Violation|0|||
170436497|NCT02554877|615936615|FG000|Overall Study|Other|1|||
170436498|NCT02554877|615936616|FG001|Overall Study|Other|3|||
170436499|NCT02554877|615936617|FG002|Overall Study|Other|0|||
170436500|NCT02554877|615936618|FG003|Overall Study|Other|3|||
170436501|NCT02554877|615936615|FG000|Overall Study|Insufficient clinical response|4|||
170537040|NCT03980223|616309632|FG003|Overall Study|Lost to Follow-up|8|||
170436502|NCT02554877|615936616|FG001|Overall Study|Insufficient clinical response|0|||
170436503|NCT02554877|615936617|FG002|Overall Study|Insufficient clinical response|0|||
170436504|NCT02554877|615936618|FG003|Overall Study|Insufficient clinical response|0|||
170436505|NCT02554877|615936615|FG000|Overall Study|No longer willing to participate|0|||
170436506|NCT02554877|615936616|FG001|Overall Study|No longer willing to participate|2|||
170436507|NCT02554877|615936617|FG002|Overall Study|No longer willing to participate|2|||
170436508|NCT02554877|615936618|FG003|Overall Study|No longer willing to participate|0|||
170436509|NCT00635648|615936619|FG000|Overall Study|Adverse Event|12|||
170780969|NCT00951379|617205759|FG001|Overall Study|Withdrawal by Subject|0|||
170780970|NCT00951379|617205758|FG000|Overall Study|Noncompliance|1|||
170780971|NCT00951379|617205759|FG001|Overall Study|Noncompliance|0|||
170780972|NCT00951379|617205758|FG000|Overall Study|Disease Progression|0|||
170780973|NCT00951379|617205759|FG001|Overall Study|Disease Progression|1|||
170780974|NCT01044303|617205764|FG000|Overall Study|Lost to Follow-up|2|||
170780975|NCT02539225|617205768|FG000|Part A|Adverse Event|13|||
170780976|NCT02539225|617205769|FG001|Part A|Adverse Event|4|||
170780977|NCT02539225|617205768|FG000|Part A|Withdrawal by Subject|2|||
170780978|NCT02539225|617205769|FG001|Part A|Withdrawal by Subject|4|||
170780979|NCT02539225|617205768|FG000|Part A|Physician Decision|4|||
170780980|NCT02539225|617205769|FG001|Part A|Physician Decision|7|||
170780981|NCT02539225|617205768|FG000|Part A|Did Not Receive study Drug|1|||
170780982|NCT02539225|617205769|FG001|Part A|Did Not Receive study Drug|1|||
170780983|NCT02539225|617205768|FG000|Pre Treatment for Part B|Progressive disease|1|||
170780984|NCT02539225|617205769|FG001|Pre Treatment for Part B|Progressive disease|1|||
170780985|NCT02539225|617205768|FG000|Pre Treatment for Part B|Adverse Event|1|||
170780986|NCT02539225|617205769|FG001|Pre Treatment for Part B|Adverse Event|1|||
170780987|NCT02539225|617205768|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
170780988|NCT02539225|617205769|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
170780989|NCT02539225|617205768|FG000|Pre Treatment for Part B|Physician Decision|2|||
170780990|NCT02539225|617205769|FG001|Pre Treatment for Part B|Physician Decision|0|||
170780991|NCT02539225|617205768|FG000|Part B|Adverse Event|4|||
170780992|NCT02539225|617205769|FG001|Part B|Adverse Event|4|||
170780993|NCT02539225|617205768|FG000|Part B|Withdrawal by Subject|0|||
170780994|NCT02539225|617205769|FG001|Part B|Withdrawal by Subject|3|||
170780995|NCT02539225|617205768|FG000|Part B|Physician Decision|0|||
170780996|NCT02539225|617205769|FG001|Part B|Physician Decision|9|||
170780997|NCT04820686|617205770|FG000|Overall Study|Withdrawal by Subject|5|||
170780998|NCT04820686|617205771|FG001|Overall Study|Withdrawal by Subject|2|||
170780999|NCT04820686|617205772|FG002|Overall Study|Withdrawal by Subject|3|||
170781000|NCT04820686|617205770|FG000|Overall Study|Study Termination|25|||
170781001|NCT04820686|617205771|FG001|Overall Study|Study Termination|13|||
170882244|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
170882245|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
170882246|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
170882247|NCT00440947|617577620|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
170882248|NCT00440947|617577621|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
170882249|NCT00440947|617577622|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
170882250|NCT00440947|617577623|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
170882251|NCT00440947|617577624|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
170882252|NCT02898259|617577625|FG000|Overall Study|Adverse Event|0|||
170882253|NCT02898259|617577626|FG001|Overall Study|Adverse Event|0|||
170882254|NCT02898259|617577627|FG002|Overall Study|Adverse Event|1|||
170882255|NCT02898259|617577628|FG003|Overall Study|Adverse Event|0|||
170882256|NCT02898259|617577629|FG004|Overall Study|Adverse Event|0|||
170882257|NCT02898259|617577625|FG000|Overall Study|Lack of Efficacy|1|||
170882258|NCT02898259|617577626|FG001|Overall Study|Lack of Efficacy|1|||
170882259|NCT02898259|617577627|FG002|Overall Study|Lack of Efficacy|3|||
170882260|NCT02898259|617577628|FG003|Overall Study|Lack of Efficacy|0|||
170882261|NCT02898259|617577629|FG004|Overall Study|Lack of Efficacy|0|||
170882262|NCT02898259|617577625|FG000|Overall Study|Lost to Follow-up|0|||
170882263|NCT02898259|617577626|FG001|Overall Study|Lost to Follow-up|0|||
170882264|NCT02898259|617577627|FG002|Overall Study|Lost to Follow-up|1|||
170882265|NCT02898259|617577628|FG003|Overall Study|Lost to Follow-up|0|||
170882266|NCT02898259|617577629|FG004|Overall Study|Lost to Follow-up|0|||
170882267|NCT02898259|617577625|FG000|Overall Study|Transformation before study began|0|||
170882268|NCT02898259|617577626|FG001|Overall Study|Transformation before study began|0|||
170882269|NCT02898259|617577627|FG002|Overall Study|Transformation before study began|0|||
170882270|NCT02898259|617577628|FG003|Overall Study|Transformation before study began|1|||
170882271|NCT02898259|617577629|FG004|Overall Study|Transformation before study began|0|||
170781002|NCT04820686|617205772|FG002|Overall Study|Study Termination|14|||
170781003|NCT04820686|617205770|FG000|Overall Study|Adverse Event|0|||
170882272|NCT01834274|617577641|FG000|Overall Study|Study Termination|41|||
170882273|NCT01834274|617577642|FG001|Overall Study|Study Termination|38|||
170882274|NCT01834274|617577641|FG000|Overall Study|Withdrawal by Subject|1|||
170781004|NCT04820686|617205771|FG001|Overall Study|Adverse Event|1|||
170781005|NCT04820686|617205772|FG002|Overall Study|Adverse Event|0|||
170436510|NCT00635648|615936619|FG000|Overall Study|Withdrawal by Subject|9|||
170436511|NCT00635648|615936619|FG000|Overall Study|Physician Decision|4|||
170436512|NCT00635648|615936619|FG000|Overall Study|Rapid progression of baseline disease|4|||
170436513|NCT00635648|615936619|FG000|Overall Study|Use of other antifungal agent needed|1|||
170436514|NCT00635648|615936619|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
170436515|NCT00635648|615936619|FG000|Overall Study|Noncompliance with protocol|1|||
170436516|NCT00635648|615936619|FG000|Overall Study|Other reason|2|||
170436517|NCT02450539|615936623|FG000|Overall Study|Withdrawal by Subject|12|||
170436518|NCT02450539|615936624|FG001|Overall Study|Withdrawal by Subject|6|||
170436519|NCT02450539|615936623|FG000|Overall Study|Lost to Follow-up|4|||
170436520|NCT02450539|615936624|FG001|Overall Study|Lost to Follow-up|1|||
170436521|NCT00608322|615936626|FG000|Overall Study|Death|2|||
170436522|NCT00608322|615936627|FG001|Overall Study|Death|1|||
170436523|NCT02072096|615936638|FG000|Overall Study|Lack of Efficacy|18|||
170436524|NCT02072096|615936639|FG001|Overall Study|Lack of Efficacy|29|||
170436525|NCT02072096|615936638|FG000|Overall Study|Protocol Violation|7|||
170436526|NCT02072096|615936639|FG001|Overall Study|Protocol Violation|7|||
170436527|NCT02072096|615936638|FG000|Overall Study|Withdrawal by Subject|5|||
170436528|NCT02072096|615936639|FG001|Overall Study|Withdrawal by Subject|7|||
170436529|NCT02072096|615936638|FG000|Overall Study|Adverse Event|5|||
170436530|NCT02072096|615936639|FG001|Overall Study|Adverse Event|2|||
170436531|NCT02072096|615936638|FG000|Overall Study|No Reason Provided|4|||
170436532|NCT02072096|615936639|FG001|Overall Study|No Reason Provided|2|||
170436533|NCT02072096|615936638|FG000|Overall Study|Death|2|||
170436534|NCT02072096|615936639|FG001|Overall Study|Death|0|||
170436535|NCT02072096|615936638|FG000|Overall Study|Physician Decision|0|||
170436536|NCT02072096|615936639|FG001|Overall Study|Physician Decision|1|||
170436537|NCT02072096|615936638|FG000|Overall Study|Study Terminated by Sponsor|43|||
170436538|NCT02072096|615936639|FG001|Overall Study|Study Terminated by Sponsor|30|||
170436539|NCT02072096|615936638|FG000|Overall Study|Lost to Follow-up|1|||
170436540|NCT02072096|615936639|FG001|Overall Study|Lost to Follow-up|0|||
170436541|NCT02890992|615936640|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
170436542|NCT02890992|615936641|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
170436543|NCT02890992|615936642|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
170436544|NCT02890992|615936643|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
170436545|NCT02890992|615936644|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
170436546|NCT02890992|615936645|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
170436547|NCT02890992|615936646|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
170436548|NCT02890992|615936647|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
170436549|NCT02890992|615936640|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
170436550|NCT02890992|615936641|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
170436551|NCT02890992|615936642|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
170436552|NCT02890992|615936643|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
170436553|NCT02890992|615936644|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
170436554|NCT02890992|615936645|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
170436555|NCT02890992|615936646|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
170436556|NCT02890992|615936647|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
170436557|NCT02890992|615936640|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
170436558|NCT02890992|615936641|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
170436559|NCT02890992|615936642|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
170436560|NCT02890992|615936643|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
170436561|NCT02890992|615936644|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
170436562|NCT02890992|615936645|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
170436563|NCT02890992|615936646|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
170436564|NCT02890992|615936647|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
170436565|NCT03158727|615936648|FG000|Overall Study|Withdrawal by Subject|2|||
170436566|NCT03158727|615936649|FG001|Overall Study|Withdrawal by Subject|6|||
170436567|NCT03158727|615936648|FG000|Overall Study|Death|11|||
170436568|NCT03158727|615936649|FG001|Overall Study|Death|12|||
170436569|NCT03158727|615936648|FG000|Overall Study|Lost to Follow-up|1|||
170537041|NCT03980223|616309629|FG000|Overall Study|Withdrawal by Subject|0|||
170436570|NCT03158727|615936649|FG001|Overall Study|Lost to Follow-up|0|||
170436571|NCT03158727|615936648|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
170436572|NCT03158727|615936649|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
170436573|NCT03158727|615936648|FG000|Overall Study|Visit 11 not done by mistake|0|||
170436574|NCT03158727|615936649|FG001|Overall Study|Visit 11 not done by mistake|1|||
170436575|NCT03158727|615936648|FG000|Overall Study|Enrolled, not treated|1|||
170436576|NCT03158727|615936649|FG001|Overall Study|Enrolled, not treated|0|||
170781006|NCT01424670|617205773|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
170781007|NCT01424670|617205774|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
170436577|NCT01252953|615936650|FG000|Overall Study|Withdrawal by Subject|16|||
170436578|NCT01252953|615936651|FG001|Overall Study|Withdrawal by Subject|17|||
170436579|NCT01252953|615936650|FG000|Overall Study|Lost to Follow-up|22|||
170436580|NCT01252953|615936651|FG001|Overall Study|Lost to Follow-up|21|||
170436581|NCT02336074|615936652|FG000|Overall Study|Adverse Event|0|||
170436582|NCT02336074|615936653|FG001|Overall Study|Adverse Event|2|||
170436583|NCT05604014|615936677|FG000|Overall Study|Lost to Follow-up|13|||
170436584|NCT00840203|615936682|FG000|First Intervention|Protocol Violation|1|||
170436585|NCT00840203|615936683|FG001|First Intervention|Protocol Violation|1|||
170436586|NCT00840203|615936682|FG000|Washout|Protocol Violation|1|||
170436587|NCT00840203|615936683|FG001|Washout|Protocol Violation|0|||
170436588|NCT01945580|615936686|FG000|Overall Study|Withdrawal by Subject|13|||
170436589|NCT01945580|615936687|FG001|Overall Study|Withdrawal by Subject|35|||
170436590|NCT01945580|615936686|FG000|Overall Study|Physician Decision|3|||
170436591|NCT01945580|615936687|FG001|Overall Study|Physician Decision|2|||
170436592|NCT01945580|615936686|FG000|Overall Study|Lost to Follow-up|26|||
170436593|NCT01945580|615936687|FG001|Overall Study|Lost to Follow-up|39|||
170436594|NCT01945580|615936686|FG000|Overall Study|Death|7|||
170436595|NCT01945580|615936687|FG001|Overall Study|Death|2|||
170436596|NCT01945580|615936686|FG000|Overall Study|Patient moved out of state|0|||
170436597|NCT01945580|615936687|FG001|Overall Study|Patient moved out of state|1|||
170436598|NCT01945580|615936686|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
170436599|NCT01945580|615936687|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
170436600|NCT01945580|615936686|FG000|Overall Study|Family illness - unable to return|0|||
170436601|NCT01945580|615936687|FG001|Overall Study|Family illness - unable to return|1|||
170436602|NCT01945580|615936686|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
170436603|NCT01945580|615936687|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
170436604|NCT01945580|615936686|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
170436605|NCT01945580|615936687|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
170436606|NCT01945580|615936686|FG000|Overall Study|Noncompliance with 36 month visit|1|||
170436607|NCT01945580|615936687|FG001|Overall Study|Noncompliance with 36 month visit|0|||
170436608|NCT01945580|615936686|FG000|Overall Study|The patient moved.|1|||
170436609|NCT01945580|615936687|FG001|Overall Study|The patient moved.|0|||
170436610|NCT01945580|615936686|FG000|Overall Study|No data available|0|||
170436611|NCT01945580|615936687|FG001|Overall Study|No data available|2|||
170436612|NCT00101439|615936688|FG000|Period 2|Withdrawal by Subject|0|||
170436613|NCT00101439|615936689|FG001|Period 2|Withdrawal by Subject|2|||
170436614|NCT00858780|615936691|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
170436615|NCT00858780|615936692|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
170436616|NCT00858780|615936693|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
170436617|NCT00858780|615936694|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
170436618|NCT00858780|615936695|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
170436619|NCT00858780|615936691|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
170436620|NCT00858780|615936692|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
170436621|NCT00858780|615936693|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
170436622|NCT00858780|615936694|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
170436623|NCT00858780|615936695|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
170436624|NCT00858780|615936691|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
170632923|NCT03910244|616668437|FG001|Overall Study|Protocol Violation|0|||
170632924|NCT03910244|616668436|FG000|Overall Study|Withdrawal by Subject|7|||
170632925|NCT03910244|616668437|FG001|Overall Study|Withdrawal by Subject|2|||
170632926|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
170632927|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
170632928|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
170632929|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
170632930|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
170632931|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
170632932|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
170632933|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
170632934|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
170882275|NCT01834274|617577642|FG001|Overall Study|Withdrawal by Subject|1|||
170436625|NCT00858780|615936692|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
170882276|NCT01834274|617577641|FG000|Overall Study|Lost to Follow-up|3|||
170436626|NCT00858780|615936693|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
170436627|NCT00858780|615936694|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
170436628|NCT00858780|615936695|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
170632935|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
170632936|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
170436629|NCT00858780|615936691|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
170436630|NCT00858780|615936692|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
170436631|NCT00858780|615936693|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
170436632|NCT00858780|615936694|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
170436633|NCT00858780|615936695|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
170436634|NCT00858780|615936691|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
170436635|NCT00858780|615936692|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
170436636|NCT00858780|615936693|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
170436637|NCT00858780|615936694|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
170436638|NCT00858780|615936695|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
170436639|NCT00858780|615936691|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
170436640|NCT00858780|615936692|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
170436641|NCT00858780|615936693|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
170436642|NCT00858780|615936694|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
170436643|NCT00858780|615936695|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
170436644|NCT04608448|615936696|FG000|Overall Study|Withdrawal by Subject|1|||
170436645|NCT04608448|615936696|FG000|Overall Study|Adverse Event|1|||
170436646|NCT03499873|615936697|FG000|Overall Study|Withdrawal by Subject|4|||
170436647|NCT03499873|615936698|FG001|Overall Study|Withdrawal by Subject|6|||
170436648|NCT03499873|615936699|FG002|Overall Study|Withdrawal by Subject|1|||
170436649|NCT03499873|615936697|FG000|Overall Study|Subjects condition worsened|0|||
170436650|NCT03499873|615936698|FG001|Overall Study|Subjects condition worsened|3|||
170436651|NCT03499873|615936699|FG002|Overall Study|Subjects condition worsened|11|||
170436652|NCT03499873|615936697|FG000|Overall Study|Adverse Event|8|||
170436653|NCT03499873|615936698|FG001|Overall Study|Adverse Event|3|||
170436654|NCT03499873|615936699|FG002|Overall Study|Adverse Event|6|||
170436655|NCT03499873|615936697|FG000|Overall Study|Physician Decision|1|||
170436656|NCT03499873|615936698|FG001|Overall Study|Physician Decision|0|||
170436657|NCT03499873|615936699|FG002|Overall Study|Physician Decision|0|||
170436658|NCT03499873|615936697|FG000|Overall Study|Administrative reasons|0|||
170436659|NCT03499873|615936698|FG001|Overall Study|Administrative reasons|1|||
170436660|NCT03499873|615936699|FG002|Overall Study|Administrative reasons|0|||
170436661|NCT03499873|615936697|FG000|Overall Study|Concomitant therapy|5|||
170436662|NCT03499873|615936698|FG001|Overall Study|Concomitant therapy|4|||
170781008|NCT01424670|617205773|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
170781009|NCT01424670|617205774|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
170781010|NCT01424670|617205773|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
170781011|NCT01424670|617205774|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
170781012|NCT01424670|617205773|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
170781013|NCT01424670|617205774|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
170781014|NCT01424670|617205773|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
170781015|NCT01424670|617205774|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
170781016|NCT01424670|617205773|FG000|Continuation Period|Adverse Event|13|||
170781017|NCT01424670|617205774|FG001|Continuation Period|Adverse Event|5|||
170781018|NCT01424670|617205773|FG000|Continuation Period|Lost to Follow-up|2|||
170781019|NCT01424670|617205774|FG001|Continuation Period|Lost to Follow-up|0|||
170781020|NCT01424670|617205773|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
170781021|NCT01424670|617205774|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
170781022|NCT01424670|617205773|FG000|Continuation Period|Physician Decision|5|||
170781023|NCT01424670|617205774|FG001|Continuation Period|Physician Decision|4|||
170781024|NCT01424670|617205773|FG000|Continuation Period|Withdrawal by Subject|13|||
170781025|NCT01424670|617205774|FG001|Continuation Period|Withdrawal by Subject|4|||
170781026|NCT03580369|617205775|FG000|Overall Study|No treatment due to mis-randomization|1|||
170781027|NCT03580369|617205776|FG001|Overall Study|No treatment due to mis-randomization|0|||
170781028|NCT03580369|617205777|FG002|Overall Study|No treatment due to mis-randomization|0|||
170781029|NCT03580369|617205778|FG003|Overall Study|No treatment due to mis-randomization|0|||
170781030|NCT03580369|617205779|FG004|Overall Study|No treatment due to mis-randomization|3|||
170781031|NCT03580369|617205780|FG005|Overall Study|No treatment due to mis-randomization|0|||
170781032|NCT03580369|617205781|FG006|Overall Study|No treatment due to mis-randomization|0|||
170781033|NCT03580369|617205782|FG007|Overall Study|No treatment due to mis-randomization|0|||
170781034|NCT03580369|617205775|FG000|Overall Study|Reason unknown|0|||
170781035|NCT03580369|617205776|FG001|Overall Study|Reason unknown|0|||
170781036|NCT03580369|617205777|FG002|Overall Study|Reason unknown|1|||
170781037|NCT03580369|617205778|FG003|Overall Study|Reason unknown|0|||
170781038|NCT03580369|617205779|FG004|Overall Study|Reason unknown|0|||
170781039|NCT03580369|617205780|FG005|Overall Study|Reason unknown|0|||
170781040|NCT03580369|617205781|FG006|Overall Study|Reason unknown|0|||
170781041|NCT03580369|617205782|FG007|Overall Study|Reason unknown|0|||
170781042|NCT03580369|617205775|FG000|Overall Study|Technical problems|0|||
170436663|NCT03499873|615936699|FG002|Overall Study|Concomitant therapy|7|||
170436664|NCT03499873|615936697|FG000|Overall Study|Miscellaneous|1|||
170436665|NCT03499873|615936698|FG001|Overall Study|Miscellaneous|2|||
170436666|NCT03499873|615936699|FG002|Overall Study|Miscellaneous|2|||
170436667|NCT03499873|615936697|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
170436668|NCT03499873|615936698|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
170436669|NCT03499873|615936699|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
170436670|NCT01297504|615936700|FG000|Overall Study|Invalid Consent|1|||
170436671|NCT01297504|615936700|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
170436672|NCT01297504|615936700|FG000|Overall Study|No Study Visits|4|||
170436673|NCT01297504|615936700|FG000|Overall Study|Death|3|||
170436674|NCT01297504|615936700|FG000|Overall Study|Lost to Follow-up|43|||
170436675|NCT01297504|615936700|FG000|Overall Study|Withdrawal by Subject|9|||
170436676|NCT01297504|615936700|FG000|Overall Study|Site Closure|3|||
170436677|NCT01297504|615936700|FG000|Overall Study|Protocol Violation|3|||
170882277|NCT01834274|617577642|FG001|Overall Study|Lost to Follow-up|1|||
170882278|NCT01834274|617577641|FG000|Overall Study|Other|2|||
170882279|NCT01834274|617577642|FG001|Overall Study|Other|1|||
170882280|NCT03681119|617577652|FG000|Overall Study|No specific reason|4|||
170882281|NCT03681119|617577653|FG001|Overall Study|No specific reason|0|||
170882282|NCT03681119|617577652|FG000|Overall Study|Sickness|2|||
170882283|NCT03681119|617577653|FG001|Overall Study|Sickness|0|||
170882284|NCT00606086|617577658|FG000|Overall Study|Adverse Event|1|||
170882285|NCT00606086|617577659|FG001|Overall Study|Adverse Event|1|||
170882286|NCT00606086|617577658|FG000|Overall Study|Lost to Follow-up|4|||
170882287|NCT00606086|617577659|FG001|Overall Study|Lost to Follow-up|8|||
170882288|NCT00606086|617577658|FG000|Overall Study|Protocol Violation|1|||
170882289|NCT00606086|617577659|FG001|Overall Study|Protocol Violation|0|||
170882290|NCT00606086|617577658|FG000|Overall Study|Withdrawal by Subject|5|||
170882291|NCT00606086|617577659|FG001|Overall Study|Withdrawal by Subject|3|||
170882292|NCT00606086|617577658|FG000|Overall Study|Non-compliance|0|||
170882293|NCT00606086|617577659|FG001|Overall Study|Non-compliance|1|||
170882294|NCT00606086|617577658|FG000|Overall Study|Randomized, not treated|1|||
170882295|NCT00606086|617577659|FG001|Overall Study|Randomized, not treated|2|||
170882296|NCT01929408|617577660|FG000|Overall Study|received HCT as initial treatment|8|||
170882297|NCT01452152|617577662|FG000|Overall Study|Study termination by sponsor|5|||
170882298|NCT01452152|617577663|FG001|Overall Study|Study termination by sponsor|0|||
170882299|NCT01452152|617577664|FG002|Overall Study|Study termination by sponsor|4|||
170882300|NCT00733954|617577668|FG000|Overall Study|Lost to Follow-up|5|||
170882301|NCT00733954|617577669|FG001|Overall Study|Lost to Follow-up|2|||
170882302|NCT00733954|617577668|FG000|Overall Study|Protocol Violation|1|||
170882303|NCT00733954|617577669|FG001|Overall Study|Protocol Violation|0|||
170882304|NCT00733954|617577668|FG000|Overall Study|Withdrawal by Subject|2|||
170882305|NCT00733954|617577669|FG001|Overall Study|Withdrawal by Subject|0|||
170882306|NCT02663453|617577670|FG000|Overall Study|Death|4|||
170882307|NCT02663453|617577671|FG001|Overall Study|Death|4|||
170882308|NCT02663453|617577670|FG000|Overall Study|Withdrawal by Subject|1|||
170781043|NCT03580369|617205776|FG001|Overall Study|Technical problems|0|||
170781044|NCT03580369|617205777|FG002|Overall Study|Technical problems|0|||
170781045|NCT03580369|617205778|FG003|Overall Study|Technical problems|0|||
170781046|NCT03580369|617205779|FG004|Overall Study|Technical problems|1|||
170781047|NCT03580369|617205780|FG005|Overall Study|Technical problems|0|||
170781048|NCT03580369|617205781|FG006|Overall Study|Technical problems|2|||
170781049|NCT03580369|617205782|FG007|Overall Study|Technical problems|0|||
170781050|NCT03580369|617205775|FG000|Overall Study|Pregnancy|2|||
170781051|NCT03580369|617205776|FG001|Overall Study|Pregnancy|0|||
170781052|NCT03580369|617205777|FG002|Overall Study|Pregnancy|3|||
170781053|NCT03580369|617205778|FG003|Overall Study|Pregnancy|0|||
170781054|NCT03580369|617205779|FG004|Overall Study|Pregnancy|2|||
170781055|NCT03580369|617205780|FG005|Overall Study|Pregnancy|0|||
170781056|NCT03580369|617205781|FG006|Overall Study|Pregnancy|0|||
170781057|NCT03580369|617205782|FG007|Overall Study|Pregnancy|0|||
170781058|NCT03580369|617205775|FG000|Overall Study|Lost to Follow-up|2|||
170781059|NCT03580369|617205776|FG001|Overall Study|Lost to Follow-up|0|||
170781060|NCT03580369|617205777|FG002|Overall Study|Lost to Follow-up|2|||
170882309|NCT02663453|617577671|FG001|Overall Study|Withdrawal by Subject|0|||
170882310|NCT03416153|617577672|FG000|Overall Study|Physician Decision|1|||
170882311|NCT03416153|617577673|FG001|Overall Study|Physician Decision|1|||
170781061|NCT03580369|617205778|FG003|Overall Study|Lost to Follow-up|0|||
170781062|NCT03580369|617205779|FG004|Overall Study|Lost to Follow-up|3|||
170781063|NCT03580369|617205780|FG005|Overall Study|Lost to Follow-up|0|||
170781064|NCT03580369|617205781|FG006|Overall Study|Lost to Follow-up|1|||
170882312|NCT03416153|617577672|FG000|Overall Study|Withdrawal by Subject|1|||
170882313|NCT03416153|617577673|FG001|Overall Study|Withdrawal by Subject|0|||
170882314|NCT04099251|617579513|FG000|Pre-Treatment|Other reasons|1|||
170882315|NCT04099251|617579514|FG001|Pre-Treatment|Other reasons|0|||
170781065|NCT03580369|617205782|FG007|Overall Study|Lost to Follow-up|0|||
170882316|NCT04099251|617579513|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
170882317|NCT04099251|617579514|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
170882318|NCT04099251|617579513|FG000|Blinded Treatment Phase|Other reasons|16|||
170882319|NCT04099251|617579514|FG001|Blinded Treatment Phase|Other reasons|7|||
170882320|NCT04099251|617579513|FG000|Blinded Treatment Phase|Disease recurrence|26|||
170781066|NCT03580369|617205775|FG000|Overall Study|Physician Decision|4|||
170781067|NCT03580369|617205776|FG001|Overall Study|Physician Decision|0|||
170781068|NCT03580369|617205777|FG002|Overall Study|Physician Decision|4|||
170781069|NCT03580369|617205778|FG003|Overall Study|Physician Decision|1|||
170781070|NCT03580369|617205779|FG004|Overall Study|Physician Decision|1|||
170781071|NCT03580369|617205780|FG005|Overall Study|Physician Decision|0|||
170781072|NCT03580369|617205781|FG006|Overall Study|Physician Decision|0|||
170781073|NCT03580369|617205782|FG007|Overall Study|Physician Decision|0|||
170781074|NCT03580369|617205775|FG000|Overall Study|Lack of Efficacy|3|||
170781075|NCT03580369|617205776|FG001|Overall Study|Lack of Efficacy|0|||
170781076|NCT03580369|617205777|FG002|Overall Study|Lack of Efficacy|7|||
170781077|NCT03580369|617205778|FG003|Overall Study|Lack of Efficacy|0|||
170781078|NCT03580369|617205779|FG004|Overall Study|Lack of Efficacy|2|||
170781079|NCT03580369|617205780|FG005|Overall Study|Lack of Efficacy|0|||
170781080|NCT03580369|617205781|FG006|Overall Study|Lack of Efficacy|3|||
170781081|NCT03580369|617205782|FG007|Overall Study|Lack of Efficacy|0|||
170781082|NCT03580369|617205775|FG000|Overall Study|Protocol Violation|6|||
170781083|NCT03580369|617205776|FG001|Overall Study|Protocol Violation|0|||
170781084|NCT03580369|617205777|FG002|Overall Study|Protocol Violation|6|||
170781085|NCT03580369|617205778|FG003|Overall Study|Protocol Violation|1|||
170781086|NCT03580369|617205779|FG004|Overall Study|Protocol Violation|8|||
170781087|NCT03580369|617205780|FG005|Overall Study|Protocol Violation|2|||
170781088|NCT03580369|617205781|FG006|Overall Study|Protocol Violation|1|||
170781089|NCT03580369|617205782|FG007|Overall Study|Protocol Violation|0|||
170781090|NCT03580369|617205775|FG000|Overall Study|Adverse Event|7|||
170781091|NCT03580369|617205776|FG001|Overall Study|Adverse Event|0|||
170781092|NCT03580369|617205777|FG002|Overall Study|Adverse Event|14|||
170781093|NCT03580369|617205778|FG003|Overall Study|Adverse Event|1|||
170781094|NCT03580369|617205779|FG004|Overall Study|Adverse Event|6|||
170781095|NCT03580369|617205780|FG005|Overall Study|Adverse Event|0|||
170781096|NCT03580369|617205781|FG006|Overall Study|Adverse Event|1|||
170436678|NCT00654186|615936701|FG000|Overall Study|Withdrawal by Subject|5|||
170436679|NCT01024855|615936702|FG000|Overall Study|Inclusion/exclusion criteria|1|||
170436680|NCT02615249|615936709|FG000|Overall Study|Withdrawal by Subject|1|||
170436681|NCT00957021|615936713|FG000|Overall Study|Death|5|||
170436682|NCT00957021|615936713|FG000|Overall Study|Lost to Follow-up|8|||
170436683|NCT00957021|615936713|FG000|Overall Study|Withdrawal by Subject|34|||
170436684|NCT00957021|615936713|FG000|Overall Study|No 2 yr ROM data|35|||
170436685|NCT00957021|615936713|FG000|Overall Study|Revised study component by 2 yr visit|8|||
170436686|NCT00957021|615936713|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
170436687|NCT00957021|615936713|FG000|Overall Study|Surgery Cancelled|9|||
170436688|NCT00957021|615936713|FG000|Overall Study|Termination due to language issue|2|||
170436689|NCT02055547|615936719|FG000|Overall Study|Protocol Violation|0|||
170436690|NCT02055547|615936720|FG001|Overall Study|Protocol Violation|0|||
170436691|NCT02055547|615936721|FG002|Overall Study|Protocol Violation|1|||
170436692|NCT02055547|615936722|FG003|Overall Study|Protocol Violation|0|||
170436693|NCT02055547|615936723|FG004|Overall Study|Protocol Violation|0|||
170436694|NCT02055547|615936724|FG005|Overall Study|Protocol Violation|0|||
170436695|NCT02055547|615936725|FG006|Overall Study|Protocol Violation|1|||
170436696|NCT02055547|615936726|FG007|Overall Study|Protocol Violation|0|||
170436697|NCT02055547|615936727|FG008|Overall Study|Protocol Violation|0|||
170436698|NCT02055547|615936728|FG009|Overall Study|Protocol Violation|0|||
170436699|NCT02055547|615936729|FG010|Overall Study|Protocol Violation|0|||
170436700|NCT02055547|615936730|FG011|Overall Study|Protocol Violation|0|||
170436701|NCT02055547|615936731|FG012|Overall Study|Protocol Violation|0|||
170436702|NCT02055547|615936732|FG013|Overall Study|Protocol Violation|0|||
170436703|NCT02055547|615936733|FG014|Overall Study|Protocol Violation|0|||
170436704|NCT02055547|615936734|FG015|Overall Study|Protocol Violation|0|||
170436705|NCT02055547|615936735|FG016|Overall Study|Protocol Violation|0|||
170436706|NCT02055547|615936736|FG017|Overall Study|Protocol Violation|0|||
170436707|NCT02055547|615936737|FG018|Overall Study|Protocol Violation|0|||
170436708|NCT02055547|615936719|FG000|Overall Study|Physician Decision|0|||
170436709|NCT02055547|615936720|FG001|Overall Study|Physician Decision|1|||
170436710|NCT02055547|615936721|FG002|Overall Study|Physician Decision|1|||
170436711|NCT02055547|615936722|FG003|Overall Study|Physician Decision|0|||
170436712|NCT02055547|615936723|FG004|Overall Study|Physician Decision|1|||
170436713|NCT02055547|615936724|FG005|Overall Study|Physician Decision|0|||
170436714|NCT02055547|615936725|FG006|Overall Study|Physician Decision|0|||
170436715|NCT02055547|615936726|FG007|Overall Study|Physician Decision|0|||
170436716|NCT02055547|615936727|FG008|Overall Study|Physician Decision|0|||
170436717|NCT02055547|615936728|FG009|Overall Study|Physician Decision|1|||
170436718|NCT02055547|615936729|FG010|Overall Study|Physician Decision|1|||
170436719|NCT02055547|615936730|FG011|Overall Study|Physician Decision|0|||
170436720|NCT02055547|615936731|FG012|Overall Study|Physician Decision|0|||
170436721|NCT02055547|615936732|FG013|Overall Study|Physician Decision|0|||
170436722|NCT02055547|615936733|FG014|Overall Study|Physician Decision|0|||
170436723|NCT02055547|615936734|FG015|Overall Study|Physician Decision|0|||
170436724|NCT02055547|615936735|FG016|Overall Study|Physician Decision|0|||
170436725|NCT02055547|615936736|FG017|Overall Study|Physician Decision|0|||
170436726|NCT02055547|615936737|FG018|Overall Study|Physician Decision|0|||
170436727|NCT02055547|615936719|FG000|Overall Study|Adverse Event|0|||
170436728|NCT02055547|615936720|FG001|Overall Study|Adverse Event|0|||
170436729|NCT02055547|615936721|FG002|Overall Study|Adverse Event|0|||
170436730|NCT02055547|615936722|FG003|Overall Study|Adverse Event|0|||
170436731|NCT02055547|615936723|FG004|Overall Study|Adverse Event|0|||
170436732|NCT02055547|615936724|FG005|Overall Study|Adverse Event|0|||
170436733|NCT02055547|615936725|FG006|Overall Study|Adverse Event|1|||
170436734|NCT02055547|615936726|FG007|Overall Study|Adverse Event|0|||
170436735|NCT02055547|615936727|FG008|Overall Study|Adverse Event|1|||
170436736|NCT02055547|615936728|FG009|Overall Study|Adverse Event|0|||
170781097|NCT03580369|617205782|FG007|Overall Study|Adverse Event|0|||
170781098|NCT03580369|617205775|FG000|Overall Study|Withdrawal by Subject|19|||
170781099|NCT03580369|617205776|FG001|Overall Study|Withdrawal by Subject|0|||
170781100|NCT03580369|617205777|FG002|Overall Study|Withdrawal by Subject|17|||
170781101|NCT03580369|617205778|FG003|Overall Study|Withdrawal by Subject|0|||
170781102|NCT03580369|617205779|FG004|Overall Study|Withdrawal by Subject|16|||
170436737|NCT02055547|615936729|FG010|Overall Study|Adverse Event|0|||
170436738|NCT02055547|615936730|FG011|Overall Study|Adverse Event|0|||
170436739|NCT02055547|615936731|FG012|Overall Study|Adverse Event|0|||
170436740|NCT02055547|615936732|FG013|Overall Study|Adverse Event|0|||
170436741|NCT02055547|615936733|FG014|Overall Study|Adverse Event|0|||
170436742|NCT02055547|615936734|FG015|Overall Study|Adverse Event|0|||
170436743|NCT02055547|615936735|FG016|Overall Study|Adverse Event|0|||
170436744|NCT02055547|615936736|FG017|Overall Study|Adverse Event|0|||
170436745|NCT02055547|615936737|FG018|Overall Study|Adverse Event|0|||
170436746|NCT02055547|615936719|FG000|Overall Study|Withdrawal by Subject|0|||
170436747|NCT02055547|615936720|FG001|Overall Study|Withdrawal by Subject|0|||
170781103|NCT03580369|617205780|FG005|Overall Study|Withdrawal by Subject|1|||
170436748|NCT02055547|615936721|FG002|Overall Study|Withdrawal by Subject|0|||
170436749|NCT02055547|615936722|FG003|Overall Study|Withdrawal by Subject|0|||
170436750|NCT02055547|615936723|FG004|Overall Study|Withdrawal by Subject|0|||
170436751|NCT02055547|615936724|FG005|Overall Study|Withdrawal by Subject|1|||
170436752|NCT02055547|615936725|FG006|Overall Study|Withdrawal by Subject|0|||
170436753|NCT02055547|615936726|FG007|Overall Study|Withdrawal by Subject|0|||
170436754|NCT02055547|615936727|FG008|Overall Study|Withdrawal by Subject|1|||
170436755|NCT02055547|615936728|FG009|Overall Study|Withdrawal by Subject|0|||
170436756|NCT02055547|615936729|FG010|Overall Study|Withdrawal by Subject|0|||
170436757|NCT02055547|615936730|FG011|Overall Study|Withdrawal by Subject|0|||
170436758|NCT02055547|615936731|FG012|Overall Study|Withdrawal by Subject|0|||
170436759|NCT02055547|615936732|FG013|Overall Study|Withdrawal by Subject|1|||
170436760|NCT02055547|615936733|FG014|Overall Study|Withdrawal by Subject|0|||
170436761|NCT02055547|615936734|FG015|Overall Study|Withdrawal by Subject|1|||
170436762|NCT02055547|615936735|FG016|Overall Study|Withdrawal by Subject|0|||
170436763|NCT02055547|615936736|FG017|Overall Study|Withdrawal by Subject|0|||
170436764|NCT02055547|615936737|FG018|Overall Study|Withdrawal by Subject|0|||
170436765|NCT02055547|615936719|FG000|Overall Study|Lost to Follow-up|0|||
170436766|NCT02055547|615936720|FG001|Overall Study|Lost to Follow-up|0|||
170436767|NCT02055547|615936721|FG002|Overall Study|Lost to Follow-up|1|||
170436768|NCT02055547|615936722|FG003|Overall Study|Lost to Follow-up|0|||
170436769|NCT02055547|615936723|FG004|Overall Study|Lost to Follow-up|0|||
170436770|NCT02055547|615936724|FG005|Overall Study|Lost to Follow-up|0|||
170436771|NCT02055547|615936725|FG006|Overall Study|Lost to Follow-up|0|||
170436772|NCT02055547|615936726|FG007|Overall Study|Lost to Follow-up|0|||
170436773|NCT02055547|615936727|FG008|Overall Study|Lost to Follow-up|0|||
170436774|NCT02055547|615936728|FG009|Overall Study|Lost to Follow-up|0|||
170436775|NCT02055547|615936729|FG010|Overall Study|Lost to Follow-up|0|||
170436776|NCT02055547|615936730|FG011|Overall Study|Lost to Follow-up|0|||
170436777|NCT02055547|615936731|FG012|Overall Study|Lost to Follow-up|0|||
170436778|NCT02055547|615936732|FG013|Overall Study|Lost to Follow-up|0|||
170436779|NCT02055547|615936733|FG014|Overall Study|Lost to Follow-up|0|||
170436780|NCT02055547|615936734|FG015|Overall Study|Lost to Follow-up|0|||
170436781|NCT02055547|615936735|FG016|Overall Study|Lost to Follow-up|0|||
170436782|NCT02055547|615936736|FG017|Overall Study|Lost to Follow-up|0|||
170436783|NCT02055547|615936737|FG018|Overall Study|Lost to Follow-up|0|||
170436784|NCT04060251|615936745|FG000|Overall Study|Study terminated due to low enrollment.|7|||
170436785|NCT04060251|615936746|FG001|Overall Study|Study terminated due to low enrollment.|5|||
170436786|NCT04060251|615936747|FG002|Overall Study|Study terminated due to low enrollment.|7|||
170436787|NCT04060251|615936745|FG000|Overall Study|Adverse Event|1|||
170436788|NCT04060251|615936746|FG001|Overall Study|Adverse Event|1|||
170436789|NCT04060251|615936747|FG002|Overall Study|Adverse Event|0|||
170436790|NCT01087502|615936754|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
170436791|NCT01087502|615936755|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
170436792|NCT01087502|615936754|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
170436793|NCT01087502|615936755|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
170436794|NCT01087502|615936754|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
170436795|NCT01087502|615936755|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
170436796|NCT01087502|615936754|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
170436797|NCT01087502|615936755|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
170436798|NCT01087502|615936754|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
170436799|NCT01087502|615936755|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
170436800|NCT01087502|615936754|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
170436801|NCT01087502|615936755|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
170436802|NCT01087502|615936754|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
170436803|NCT01087502|615936755|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
170436804|NCT01087502|615936754|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
170436805|NCT01087502|615936755|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
170436806|NCT01087502|615936754|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
170436807|NCT01087502|615936755|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
170436808|NCT01087502|615936754|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
170436809|NCT01087502|615936755|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
170436810|NCT01087502|615936754|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
170436811|NCT01087502|615936755|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
170436812|NCT01087502|615936754|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
170436813|NCT01087502|615936755|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
170436814|NCT01653704|615936756|FG000|Overall Study|Technical failure during recording|1|||
170781104|NCT03580369|617205781|FG006|Overall Study|Withdrawal by Subject|7|||
170781105|NCT03580369|617205782|FG007|Overall Study|Withdrawal by Subject|0|||
170781106|NCT03912831|617205783|FG000|Overall Study|Death|1|||
170781107|NCT03912831|617205784|FG001|Overall Study|Death|1|||
170781108|NCT03912831|617205785|FG002|Overall Study|Death|1|||
170436815|NCT01653704|615936757|FG001|Overall Study|Technical failure during recording|1|||
170781109|NCT03912831|617205786|FG003|Overall Study|Death|1|||
170781110|NCT03912831|617205787|FG004|Overall Study|Death|1|||
170781111|NCT03912831|617205788|FG005|Overall Study|Death|1|||
170781112|NCT03912831|617205783|FG000|Overall Study|Reason not Specified|0|||
170781113|NCT03912831|617205784|FG001|Overall Study|Reason not Specified|0|||
170781114|NCT03912831|617205785|FG002|Overall Study|Reason not Specified|0|||
170781115|NCT03912831|617205786|FG003|Overall Study|Reason not Specified|0|||
170781116|NCT03912831|617205787|FG004|Overall Study|Reason not Specified|1|||
170781117|NCT03912831|617205788|FG005|Overall Study|Reason not Specified|0|||
170781118|NCT03912831|617205783|FG000|Overall Study|Withdrawal by Participant|0|||
170781119|NCT03912831|617205784|FG001|Overall Study|Withdrawal by Participant|0|||
170781120|NCT03912831|617205785|FG002|Overall Study|Withdrawal by Participant|0|||
170781121|NCT03912831|617205786|FG003|Overall Study|Withdrawal by Participant|0|||
170781122|NCT03912831|617205787|FG004|Overall Study|Withdrawal by Participant|1|||
170781123|NCT03912831|617205788|FG005|Overall Study|Withdrawal by Participant|0|||
170781124|NCT04442126|617205803|FG000|Overall Study|Withdrawal by Subject|0|||
170781125|NCT04442126|617205804|FG001|Overall Study|Withdrawal by Subject|0|||
170781126|NCT04442126|617205805|FG002|Overall Study|Withdrawal by Subject|0|||
170781127|NCT04442126|617205806|FG003|Overall Study|Withdrawal by Subject|2|||
170781128|NCT04442126|617205807|FG004|Overall Study|Withdrawal by Subject|1|||
170781129|NCT04442126|617205808|FG005|Overall Study|Withdrawal by Subject|0|||
170781130|NCT04442126|617205809|FG006|Overall Study|Withdrawal by Subject|1|||
170781131|NCT04442126|617205810|FG007|Overall Study|Withdrawal by Subject|1|||
170781132|NCT04442126|617205811|FG008|Overall Study|Withdrawal by Subject|3|||
170781133|NCT04442126|617205803|FG000|Overall Study|Death|1|||
170781134|NCT04442126|617205804|FG001|Overall Study|Death|0|||
170781135|NCT04442126|617205805|FG002|Overall Study|Death|0|||
170781136|NCT04442126|617205806|FG003|Overall Study|Death|1|||
170781137|NCT04442126|617205807|FG004|Overall Study|Death|2|||
170781138|NCT04442126|617205808|FG005|Overall Study|Death|2|||
170781139|NCT04442126|617205809|FG006|Overall Study|Death|4|||
170781140|NCT04442126|617205810|FG007|Overall Study|Death|1|||
170781141|NCT04442126|617205811|FG008|Overall Study|Death|5|||
170781142|NCT04442126|617205803|FG000|Overall Study|Study Terminated by Sponsor|0|||
170781143|NCT04442126|617205804|FG001|Overall Study|Study Terminated by Sponsor|0|||
170781144|NCT04442126|617205805|FG002|Overall Study|Study Terminated by Sponsor|0|||
170781145|NCT04442126|617205806|FG003|Overall Study|Study Terminated by Sponsor|0|||
170781146|NCT04442126|617205807|FG004|Overall Study|Study Terminated by Sponsor|0|||
170781147|NCT04442126|617205808|FG005|Overall Study|Study Terminated by Sponsor|1|||
170781148|NCT04442126|617205809|FG006|Overall Study|Study Terminated by Sponsor|4|||
170781149|NCT04442126|617205810|FG007|Overall Study|Study Terminated by Sponsor|2|||
170781150|NCT04442126|617205811|FG008|Overall Study|Study Terminated by Sponsor|10|||
170781151|NCT04442126|617205803|FG000|Overall Study|Lost to Follow-up|0|||
170781152|NCT04442126|617205804|FG001|Overall Study|Lost to Follow-up|0|||
170781153|NCT04442126|617205805|FG002|Overall Study|Lost to Follow-up|0|||
170781154|NCT04442126|617205806|FG003|Overall Study|Lost to Follow-up|0|||
170781155|NCT04442126|617205807|FG004|Overall Study|Lost to Follow-up|0|||
170781156|NCT04442126|617205808|FG005|Overall Study|Lost to Follow-up|0|||
170781157|NCT04442126|617205809|FG006|Overall Study|Lost to Follow-up|0|||
170781158|NCT04442126|617205810|FG007|Overall Study|Lost to Follow-up|1|||
170781159|NCT04442126|617205811|FG008|Overall Study|Lost to Follow-up|2|||
170781160|NCT04442126|617205803|FG000|Overall Study|Progressive Disease|0|||
170781161|NCT04442126|617205804|FG001|Overall Study|Progressive Disease|1|||
170781162|NCT04442126|617205805|FG002|Overall Study|Progressive Disease|3|||
170781163|NCT04442126|617205806|FG003|Overall Study|Progressive Disease|0|||
170781164|NCT04442126|617205807|FG004|Overall Study|Progressive Disease|3|||
170781165|NCT04442126|617205808|FG005|Overall Study|Progressive Disease|0|||
170781166|NCT04442126|617205809|FG006|Overall Study|Progressive Disease|0|||
170781167|NCT04442126|617205810|FG007|Overall Study|Progressive Disease|0|||
170781168|NCT04442126|617205811|FG008|Overall Study|Progressive Disease|0|||
170781169|NCT04442126|617205803|FG000|Overall Study|Other|0|||
170781170|NCT04442126|617205804|FG001|Overall Study|Other|0|||
170781171|NCT04442126|617205805|FG002|Overall Study|Other|0|||
170781172|NCT04442126|617205806|FG003|Overall Study|Other|0|||
170781173|NCT04442126|617205807|FG004|Overall Study|Other|0|||
170781174|NCT04442126|617205808|FG005|Overall Study|Other|0|||
170781175|NCT04442126|617205809|FG006|Overall Study|Other|0|||
170781176|NCT04442126|617205810|FG007|Overall Study|Other|0|||
170781177|NCT04442126|617205811|FG008|Overall Study|Other|1|||
170781178|NCT06450405|617205812|FG000|Overall Study|Study funding terminated.|0|||
170781179|NCT06450405|617205813|FG001|Overall Study|Study funding terminated.|2|||
170781180|NCT06066541|617207185|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
170781181|NCT06066541|617207186|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
170781182|NCT06066541|617207187|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
170781183|NCT06066541|617207188|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
170781184|NCT06066541|617207189|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
170781185|NCT06066541|617207190|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
170436816|NCT01653704|615936756|FG000|Overall Study|Performance not reflective of training|1|||
170436817|NCT01653704|615936757|FG001|Overall Study|Performance not reflective of training|0|||
170436818|NCT03966911|615936758|FG000|Overall Study|Adverse Event|1|||
170436819|NCT03966911|615936759|FG001|Overall Study|Adverse Event|1|||
170436820|NCT03966911|615936758|FG000|Overall Study|Withdrawal by Subject|8|||
170436821|NCT03966911|615936759|FG001|Overall Study|Withdrawal by Subject|2|||
170436822|NCT03966911|615936758|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
170436823|NCT03966911|615936759|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
170436824|NCT01986647|615936761|FG000|Overall Study|Lost to Follow-up|4|||
170436825|NCT01986647|615936762|FG001|Overall Study|Lost to Follow-up|1|||
170436826|NCT01986647|615936763|FG002|Overall Study|Lost to Follow-up|4|||
170436827|NCT01986647|615936764|FG003|Overall Study|Lost to Follow-up|4|||
170436828|NCT01986647|615936761|FG000|Overall Study|Withdrawal by Subject|1|||
170436829|NCT01986647|615936762|FG001|Overall Study|Withdrawal by Subject|3|||
170436830|NCT01986647|615936763|FG002|Overall Study|Withdrawal by Subject|2|||
170436831|NCT01986647|615936764|FG003|Overall Study|Withdrawal by Subject|3|||
170436832|NCT01986647|615936761|FG000|Overall Study|Health|5|||
170436833|NCT01986647|615936762|FG001|Overall Study|Health|3|||
170436834|NCT01986647|615936763|FG002|Overall Study|Health|6|||
170436835|NCT01986647|615936764|FG003|Overall Study|Health|4|||
170436836|NCT01483820|615936765|FG000|Overall Study|Lack of Efficacy|6|||
170436837|NCT01483820|615936765|FG000|Overall Study|Adverse Event|1|||
170436838|NCT01483820|615936765|FG000|Overall Study|Death|1|||
170436839|NCT01663896|615936766|FG000|Overall Study|Various reasons|43|||
170436840|NCT01968031|615936773|FG000|Overall Study|Adverse Event|13|||
170436841|NCT01968031|615936774|FG001|Overall Study|Adverse Event|10|||
170436842|NCT01968031|615936775|FG002|Overall Study|Adverse Event|22|||
170436843|NCT01968031|615936773|FG000|Overall Study|Withdrawal by Subject|3|||
170436844|NCT01968031|615936774|FG001|Overall Study|Withdrawal by Subject|7|||
170436845|NCT01968031|615936775|FG002|Overall Study|Withdrawal by Subject|3|||
170436846|NCT01968031|615936773|FG000|Overall Study|Did not meet entry criteria|1|||
170436847|NCT01968031|615936774|FG001|Overall Study|Did not meet entry criteria|1|||
170436848|NCT01968031|615936775|FG002|Overall Study|Did not meet entry criteria|1|||
170436849|NCT01968031|615936773|FG000|Overall Study|Noncompliance|0|||
170436850|NCT01968031|615936774|FG001|Overall Study|Noncompliance|0|||
170436851|NCT01968031|615936775|FG002|Overall Study|Noncompliance|2|||
170436852|NCT01968031|615936773|FG000|Overall Study|Failed inclusion criteria|0|||
170436853|NCT01968031|615936774|FG001|Overall Study|Failed inclusion criteria|2|||
170436854|NCT01968031|615936775|FG002|Overall Study|Failed inclusion criteria|0|||
170436855|NCT01968031|615936773|FG000|Overall Study|Death|0|||
170436856|NCT01968031|615936774|FG001|Overall Study|Death|0|||
170436857|NCT01968031|615936775|FG002|Overall Study|Death|1|||
170436858|NCT01968031|615936773|FG000|Overall Study|Prohibited concomitant medication|1|||
170436859|NCT01968031|615936774|FG001|Overall Study|Prohibited concomitant medication|0|||
170436860|NCT01968031|615936775|FG002|Overall Study|Prohibited concomitant medication|0|||
170436861|NCT00874276|615936776|FG000|Overall Study|Withdrawal by Subject|1|||
170436862|NCT00874276|615936777|FG001|Overall Study|Withdrawal by Subject|1|||
170436863|NCT03733145|615936778|FG000|Overall Study|screenfail|3|||
170436864|NCT03733145|615936779|FG001|Overall Study|screenfail|3|||
170436865|NCT03733145|615936780|FG002|Overall Study|screenfail|2|||
170436866|NCT04573309|615938192|FG000|Overall Study|Protocol Violation|1|||
170436867|NCT04573309|615938193|FG001|Overall Study|Protocol Violation|0|||
170436868|NCT01109849|615938196|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
170436869|NCT01109849|615938197|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
170436870|NCT01109849|615938198|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
170781186|NCT06066541|617207191|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
170781187|NCT06066541|617207185|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
170781188|NCT06066541|617207186|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
170436871|NCT01109849|615938199|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
170436872|NCT01109849|615938200|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
170436873|NCT01109849|615938196|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
170781189|NCT06066541|617207187|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
170436874|NCT01109849|615938197|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
170436875|NCT01109849|615938198|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
170436876|NCT01109849|615938199|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
170436877|NCT01109849|615938200|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
170436878|NCT01109849|615938196|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
170436879|NCT01109849|615938197|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
170436880|NCT01109849|615938198|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
170781190|NCT06066541|617207188|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
170436881|NCT01109849|615938199|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
170781191|NCT06066541|617207189|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
170436882|NCT01109849|615938200|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
170436883|NCT01109849|615938196|FG000|Initial Randomization: ADHD Treatment|move away|2|||
170436884|NCT01109849|615938197|FG001|Initial Randomization: ADHD Treatment|move away|7|||
170436885|NCT01109849|615938198|FG002|Initial Randomization: ADHD Treatment|move away|0|||
170436886|NCT01109849|615938199|FG003|Initial Randomization: ADHD Treatment|move away|0|||
170436887|NCT01109849|615938200|FG004|Initial Randomization: ADHD Treatment|move away|0|||
170436888|NCT01109849|615938196|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
170436889|NCT01109849|615938197|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
170436890|NCT01109849|615938198|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
170436891|NCT01109849|615938199|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
170436892|NCT01109849|615938200|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
170436893|NCT01109849|615938196|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
170436894|NCT01109849|615938197|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
170436895|NCT01109849|615938198|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
170436896|NCT01109849|615938199|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
170436897|NCT01109849|615938200|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
170436898|NCT02485158|615938204|FG000|Overall Study|Withdrawal by Subject|3|||
170436899|NCT02485158|615938204|FG000|Overall Study|expected drug side effect|1|||
170436900|NCT04402489|615938209|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
170436901|NCT04402489|615938210|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
170436902|NCT04402489|615938211|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
170436903|NCT04402489|615938212|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
170436904|NCT04402489|615938213|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
170436905|NCT04402489|615938209|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
170436906|NCT04402489|615938210|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
170436907|NCT04402489|615938211|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
170436908|NCT04402489|615938212|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
170436909|NCT04402489|615938213|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
170436910|NCT04402489|615938209|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
170436911|NCT04402489|615938210|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
170436912|NCT04402489|615938211|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
170436913|NCT04402489|615938212|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
170436914|NCT04402489|615938213|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
170436915|NCT04402489|615938209|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
170436916|NCT04402489|615938210|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
170436917|NCT04402489|615938211|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
170436918|NCT04402489|615938212|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
170436919|NCT04402489|615938213|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
170436920|NCT04402489|615938209|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
170436921|NCT04402489|615938210|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
170436922|NCT04402489|615938211|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
170436923|NCT04402489|615938212|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
170436924|NCT04402489|615938213|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
170436925|NCT04402489|615938209|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
170436926|NCT04402489|615938210|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
170436927|NCT04402489|615938211|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
170436928|NCT04402489|615938212|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
170781192|NCT06066541|617207190|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
170781193|NCT06066541|617207191|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
170781194|NCT04533022|617207192|FG000|Overall Study|Withdrawal by Subject|15|||
170781195|NCT04533022|617207192|FG000|Overall Study|Adverse Event|6|||
170781196|NCT04533022|617207192|FG000|Overall Study|Death|1|||
170781197|NCT04533022|617207192|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
170781198|NCT04533022|617207192|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
170781199|NCT05415436|617207193|FG000|Overall Study|Surgeon cancelled procedure|1|||
170781200|NCT05415436|617207194|FG001|Overall Study|Surgeon cancelled procedure|0|||
170436929|NCT04402489|615938213|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
170436930|NCT02664415|615938215|FG000|Overall Study|Adverse Event|1|||
170436931|NCT02664415|615938216|FG001|Overall Study|Adverse Event|0|||
170436932|NCT00516295|615938217|FG000|Overall Study|Lack of Efficacy|2|||
170537042|NCT03980223|616309630|FG001|Overall Study|Withdrawal by Subject|0|||
170537043|NCT03980223|616309631|FG002|Overall Study|Withdrawal by Subject|1|||
170537044|NCT03980223|616309632|FG003|Overall Study|Withdrawal by Subject|2|||
170537045|NCT03980223|616309629|FG000|Overall Study|Physician Decision|0|||
170781201|NCT05415436|617207193|FG000|Overall Study|Death|1|||
170781202|NCT05415436|617207194|FG001|Overall Study|Death|0|||
170781203|NCT03819686|617207195|FG000|Overall Study|Lost to Follow-up|2|||
170781204|NCT03819686|617207196|FG001|Overall Study|Lost to Follow-up|3|||
170436933|NCT00516295|615938218|FG001|Overall Study|Lack of Efficacy|0|||
170436934|NCT00516295|615938219|FG002|Overall Study|Lack of Efficacy|0|||
170436935|NCT00516295|615938217|FG000|Overall Study|Ineligible|1|||
170436936|NCT00516295|615938218|FG001|Overall Study|Ineligible|0|||
170436937|NCT00516295|615938219|FG002|Overall Study|Ineligible|0|||
170436938|NCT00757705|615938220|FG000|Overall Study|Adverse Event|19|||
170436939|NCT00757705|615938220|FG000|Overall Study|Lost to Follow-up|16|||
170436940|NCT00757705|615938220|FG000|Overall Study|Withdrawal by Subject|25|||
170436941|NCT00757705|615938220|FG000|Overall Study|Insufficient Response|26|||
170436942|NCT00757705|615938220|FG000|Overall Study|Ineligible to continue|8|||
170436943|NCT00757705|615938220|FG000|Overall Study|Non-compliant|9|||
170436944|NCT00757705|615938220|FG000|Overall Study|Other|18|||
170436945|NCT03609944|615938226|FG000|Overall Study|Lost to Follow-up|1|||
170436946|NCT03609944|615938227|FG001|Overall Study|Lost to Follow-up|5|||
170436947|NCT03609944|615938226|FG000|Overall Study|Withdrawal by Subject|1|||
170436948|NCT03609944|615938227|FG001|Overall Study|Withdrawal by Subject|1|||
170436949|NCT04408924|615938228|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
170436950|NCT04408924|615938228|FG000|Overall Study|Lost to Follow-up|3|||
170436951|NCT04408924|615938228|FG000|Overall Study|Withdrawal by Subject|5|||
170436952|NCT04408924|615938228|FG000|Overall Study|Sponsor Decision|2|||
170436953|NCT00486434|615938229|FG000|Overall Study|Withdrawal by Subject|34|||
170436954|NCT00486434|615938230|FG001|Overall Study|Withdrawal by Subject|39|||
170436955|NCT00486434|615938229|FG000|Overall Study|Adverse Event|118|||
170436956|NCT00486434|615938230|FG001|Overall Study|Adverse Event|44|||
170436957|NCT00486434|615938229|FG000|Overall Study|Protocol Violation|22|||
170436958|NCT00486434|615938230|FG001|Overall Study|Protocol Violation|21|||
170436959|NCT00486434|615938229|FG000|Overall Study|Lack of Efficacy|12|||
170436960|NCT00486434|615938230|FG001|Overall Study|Lack of Efficacy|19|||
170436961|NCT00486434|615938229|FG000|Overall Study|Lost to Follow-up|2|||
170436962|NCT00486434|615938230|FG001|Overall Study|Lost to Follow-up|3|||
170436963|NCT00486434|615938229|FG000|Overall Study|Death|1|||
170436964|NCT00486434|615938230|FG001|Overall Study|Death|2|||
170436965|NCT00486434|615938229|FG000|Overall Study|Personal reasons|5|||
170436966|NCT00486434|615938230|FG001|Overall Study|Personal reasons|6|||
170436967|NCT04661202|615938231|FG000|Overall Study|Withdrawal by Subject|1|||
170436968|NCT04661202|615938232|FG001|Overall Study|Withdrawal by Subject|1|||
170436969|NCT04661202|615938231|FG000|Overall Study|Lack of Efficacy|2|||
170436970|NCT04661202|615938232|FG001|Overall Study|Lack of Efficacy|0|||
170436971|NCT02578641|615938233|FG000|Overall Study|Adverse Event|5|||
170436972|NCT02578641|615938234|FG001|Overall Study|Adverse Event|15|||
170436973|NCT02578641|615938233|FG000|Overall Study|Death|16|||
170436974|NCT02578641|615938234|FG001|Overall Study|Death|8|||
170436975|NCT02578641|615938233|FG000|Overall Study|Lost to Follow-up|0|||
170436976|NCT02578641|615938234|FG001|Overall Study|Lost to Follow-up|1|||
170436977|NCT02578641|615938233|FG000|Overall Study|Withdrawal by Subject|14|||
170436978|NCT02578641|615938234|FG001|Overall Study|Withdrawal by Subject|7|||
170436979|NCT02578641|615938233|FG000|Overall Study|Progressive Disease|69|||
170436980|NCT02578641|615938234|FG001|Overall Study|Progressive Disease|21|||
170436981|NCT02578641|615938233|FG000|Overall Study|No Study Drug|2|||
170436982|NCT02578641|615938234|FG001|Overall Study|No Study Drug|0|||
170436983|NCT02578641|615938233|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
170436984|NCT02578641|615938234|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
170436985|NCT02578641|615938233|FG000|Overall Study|Non-compliance with Study Schedule|1|||
170436986|NCT02578641|615938234|FG001|Overall Study|Non-compliance with Study Schedule|0|||
170436987|NCT02578641|615938233|FG000|Overall Study|Other|1|||
170436988|NCT02578641|615938234|FG001|Overall Study|Other|10|||
170436989|NCT02578641|615938233|FG000|Overall Study|Not treated|1|||
170436990|NCT02578641|615938234|FG001|Overall Study|Not treated|4|||
170436991|NCT04158687|615938237|FG000|Overall Study|Adverse Event|2|||
170781205|NCT06143670|617207197|FG000|Overall Study|Lost to Follow-up|0|||
170781206|NCT06143670|617207198|FG001|Overall Study|Lost to Follow-up|1|||
170781207|NCT06143670|617207197|FG000|Overall Study|Withdrawal by Subject|3|||
170781208|NCT06143670|617207198|FG001|Overall Study|Withdrawal by Subject|0|||
170781209|NCT03747484|617207199|FG000|Overall Study|Lack of Efficacy|0|||
170436992|NCT04158687|615938238|FG001|Overall Study|Adverse Event|3|||
170781210|NCT03747484|617207200|FG001|Overall Study|Lack of Efficacy|1|||
170781211|NCT03747484|617207201|FG002|Overall Study|Lack of Efficacy|1|||
170781212|NCT03747484|617207202|FG003|Overall Study|Lack of Efficacy|2|||
170436993|NCT04158687|615938239|FG002|Overall Study|Adverse Event|0|||
170436994|NCT04158687|615938240|FG003|Overall Study|Adverse Event|3|||
170781213|NCT03747484|617207203|FG004|Overall Study|Lack of Efficacy|2|||
170436995|NCT04158687|615938237|FG000|Overall Study|Lost to Follow-up|5|||
170436996|NCT04158687|615938238|FG001|Overall Study|Lost to Follow-up|12|||
170436997|NCT04158687|615938239|FG002|Overall Study|Lost to Follow-up|4|||
170436998|NCT04158687|615938240|FG003|Overall Study|Lost to Follow-up|5|||
170781214|NCT03625882|617207205|FG000|Overall Study|Protocol Violation|3|||
170781215|NCT05691452|617207206|FG000|Overall Study|Withdrawal by Subject|1|||
170781216|NCT05691452|617207207|FG001|Overall Study|Withdrawal by Subject|1|||
170781217|NCT05691452|617207208|FG002|Overall Study|Withdrawal by Subject|0|||
170781218|NCT05691452|617207206|FG000|Overall Study|Physician Decision|1|||
170781219|NCT05691452|617207207|FG001|Overall Study|Physician Decision|0|||
170781220|NCT05691452|617207208|FG002|Overall Study|Physician Decision|0|||
170781221|NCT05691452|617207206|FG000|Overall Study|Lost to Follow-up|0|||
170537046|NCT03980223|616309630|FG001|Overall Study|Physician Decision|0|||
170781222|NCT05691452|617207207|FG001|Overall Study|Lost to Follow-up|0|||
170781223|NCT05691452|617207208|FG002|Overall Study|Lost to Follow-up|1|||
170882321|NCT04099251|617579514|FG001|Blinded Treatment Phase|Disease recurrence|41|||
170882322|NCT04099251|617579513|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
170882323|NCT04099251|617579514|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
170882324|NCT04099251|617579513|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
170882325|NCT04099251|617579514|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
170882326|NCT04099251|617579513|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
170882327|NCT04099251|617579514|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
170882328|NCT04099251|617579513|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
170882329|NCT04099251|617579514|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
170882330|NCT04099251|617579513|FG000|Blinded Treatment Phase|Death|6|||
170882331|NCT04099251|617579514|FG001|Blinded Treatment Phase|Death|2|||
170632937|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
170632938|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
170632939|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
170632940|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
170632941|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
170632942|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
170632943|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
170632944|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
170632945|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
170632946|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
170436999|NCT04158687|615938237|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
170437000|NCT04158687|615938238|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
170437001|NCT04158687|615938239|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
170437002|NCT04158687|615938240|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
170437003|NCT04158687|615938237|FG000|Overall Study|Non-Compliance with Study Medication|2|||
170437004|NCT04158687|615938238|FG001|Overall Study|Non-Compliance with Study Medication|2|||
170632947|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
170632948|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
170632949|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
170632950|NCT01106690|616668438|FG000|Core Period: Baseline to Week 26|Other|10|||
170632951|NCT01106690|616668439|FG001|Core Period: Baseline to Week 26|Other|2|||
170632952|NCT01106690|616668440|FG002|Core Period: Baseline to Week 26|Other|6|||
170632953|NCT01106690|616668438|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
170632954|NCT01106690|616668439|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
170632955|NCT01106690|616668440|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
170632956|NCT01106690|616668438|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
170632957|NCT01106690|616668439|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
170632958|NCT01106690|616668440|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
170632959|NCT01106690|616668438|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
170632960|NCT01106690|616668439|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
170882332|NCT04099251|617579513|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
170437005|NCT04158687|615938239|FG002|Overall Study|Non-Compliance with Study Medication|3|||
170437006|NCT04158687|615938240|FG003|Overall Study|Non-Compliance with Study Medication|0|||
170437007|NCT04158687|615938237|FG000|Overall Study|Investigator Decision|0|||
170882333|NCT04099251|617579514|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
170882334|NCT04099251|617579513|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
170882335|NCT04099251|617579514|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
170437008|NCT04158687|615938238|FG001|Overall Study|Investigator Decision|0|||
170437009|NCT04158687|615938239|FG002|Overall Study|Investigator Decision|2|||
170437010|NCT04158687|615938240|FG003|Overall Study|Investigator Decision|0|||
170437011|NCT04158687|615938237|FG000|Overall Study|Protocol Violation|0|||
170437012|NCT04158687|615938238|FG001|Overall Study|Protocol Violation|2|||
170437013|NCT04158687|615938239|FG002|Overall Study|Protocol Violation|1|||
170437014|NCT04158687|615938240|FG003|Overall Study|Protocol Violation|0|||
170437015|NCT04158687|615938237|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
170437016|NCT04158687|615938238|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
170437017|NCT04158687|615938239|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
170437018|NCT04158687|615938240|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
170437019|NCT04158687|615938237|FG000|Overall Study|Reason not Specified|3|||
170437020|NCT04158687|615938238|FG001|Overall Study|Reason not Specified|2|||
170437021|NCT04158687|615938239|FG002|Overall Study|Reason not Specified|4|||
170437022|NCT04158687|615938240|FG003|Overall Study|Reason not Specified|4|||
170437023|NCT05330975|615938243|FG000|Primary|Lost to Follow-up|12|||
170437024|NCT05330975|615938244|FG001|Primary|Lost to Follow-up|21|||
170437025|NCT05330975|615938245|FG002|Primary|Lost to Follow-up|38|||
170437026|NCT05330975|615938246|FG003|Primary|Lost to Follow-up|30|||
170437027|NCT05330975|615938247|FG004|Primary|Lost to Follow-up|25|||
170437028|NCT05330975|615938248|FG005|Primary|Lost to Follow-up|28|||
170437029|NCT05330975|615938249|FG006|Primary|Lost to Follow-up|0|||
170437030|NCT05330975|615938243|FG000|Primary|Withdrawal by Subject|4|||
170437031|NCT05330975|615938244|FG001|Primary|Withdrawal by Subject|11|||
170437032|NCT05330975|615938245|FG002|Primary|Withdrawal by Subject|8|||
170437033|NCT05330975|615938246|FG003|Primary|Withdrawal by Subject|23|||
170437034|NCT05330975|615938247|FG004|Primary|Withdrawal by Subject|20|||
170437035|NCT05330975|615938248|FG005|Primary|Withdrawal by Subject|19|||
170437036|NCT05330975|615938249|FG006|Primary|Withdrawal by Subject|0|||
170437037|NCT05330975|615938243|FG000|Primary|Protocol Violation|0|||
170437038|NCT05330975|615938244|FG001|Primary|Protocol Violation|2|||
170437039|NCT05330975|615938245|FG002|Primary|Protocol Violation|0|||
170437040|NCT05330975|615938246|FG003|Primary|Protocol Violation|4|||
170437041|NCT05330975|615938247|FG004|Primary|Protocol Violation|0|||
170437042|NCT05330975|615938248|FG005|Primary|Protocol Violation|3|||
170437043|NCT05330975|615938249|FG006|Primary|Protocol Violation|0|||
170437044|NCT05330975|615938243|FG000|Primary|Death|0|||
170437045|NCT05330975|615938244|FG001|Primary|Death|3|||
170437046|NCT05330975|615938245|FG002|Primary|Death|1|||
170437047|NCT05330975|615938246|FG003|Primary|Death|1|||
170437048|NCT05330975|615938247|FG004|Primary|Death|0|||
170437049|NCT05330975|615938248|FG005|Primary|Death|0|||
170437050|NCT05330975|615938249|FG006|Primary|Death|0|||
170437051|NCT05330975|615938243|FG000|Primary|Other Than Specified|0|||
170437052|NCT05330975|615938244|FG001|Primary|Other Than Specified|1|||
170437053|NCT05330975|615938245|FG002|Primary|Other Than Specified|2|||
170437054|NCT05330975|615938246|FG003|Primary|Other Than Specified|1|||
170437055|NCT05330975|615938247|FG004|Primary|Other Than Specified|2|||
170437056|NCT05330975|615938248|FG005|Primary|Other Than Specified|2|||
170437057|NCT05330975|615938249|FG006|Primary|Other Than Specified|0|||
170437058|NCT05330975|615938243|FG000|Primary|Adverse Event|0|||
170437059|NCT05330975|615938244|FG001|Primary|Adverse Event|0|||
170437060|NCT05330975|615938245|FG002|Primary|Adverse Event|0|||
170437061|NCT05330975|615938246|FG003|Primary|Adverse Event|1|||
170437062|NCT05330975|615938247|FG004|Primary|Adverse Event|0|||
170437063|NCT05330975|615938248|FG005|Primary|Adverse Event|0|||
170437064|NCT05330975|615938249|FG006|Primary|Adverse Event|0|||
170437065|NCT05330975|615938243|FG000|Primary|Physician Decision|0|||
170437066|NCT05330975|615938244|FG001|Primary|Physician Decision|0|||
170781224|NCT05691452|617207206|FG000|Overall Study|Adverse Event|0|||
170437067|NCT05330975|615938245|FG002|Primary|Physician Decision|0|||
170437068|NCT05330975|615938246|FG003|Primary|Physician Decision|0|||
170437069|NCT05330975|615938247|FG004|Primary|Physician Decision|1|||
170437070|NCT05330975|615938248|FG005|Primary|Physician Decision|0|||
170437071|NCT05330975|615938249|FG006|Primary|Physician Decision|0|||
170437072|NCT05330975|615938243|FG000|Revaccination|Adverse Event|0|||
170437073|NCT05330975|615938244|FG001|Revaccination|Adverse Event|0|||
170437074|NCT05330975|615938245|FG002|Revaccination|Adverse Event|0|||
170437075|NCT05330975|615938246|FG003|Revaccination|Adverse Event|0|||
170437076|NCT05330975|615938247|FG004|Revaccination|Adverse Event|0|||
170437077|NCT05330975|615938248|FG005|Revaccination|Adverse Event|0|||
170437078|NCT05330975|615938249|FG006|Revaccination|Adverse Event|3|||
170437079|NCT05330975|615938243|FG000|Revaccination|Lost to Follow-up|0|||
170437080|NCT05330975|615938244|FG001|Revaccination|Lost to Follow-up|0|||
170437081|NCT05330975|615938245|FG002|Revaccination|Lost to Follow-up|0|||
170437082|NCT05330975|615938246|FG003|Revaccination|Lost to Follow-up|0|||
170437083|NCT05330975|615938247|FG004|Revaccination|Lost to Follow-up|0|||
170781225|NCT05691452|617207207|FG001|Overall Study|Adverse Event|0|||
170781226|NCT05691452|617207208|FG002|Overall Study|Adverse Event|1|||
170781227|NCT04842643|617207215|FG000|Overall Study|Physician Decision|1|||
170781228|NCT04842643|617207215|FG000|Overall Study|Other|1|||
170781229|NCT01894061|617207218|FG000|Overall Study|Screen failure|1|||
170781230|NCT01894061|617207218|FG000|Overall Study|Withdrawal by Subject|1|||
170781231|NCT04173663|617207219|FG000|Overall Study|Withdrawal by Subject|1|||
170781232|NCT04173663|617207220|FG001|Overall Study|Withdrawal by Subject|6|||
170781233|NCT04173663|617207219|FG000|Overall Study|Lost to Follow-up|17|||
170781234|NCT04173663|617207220|FG001|Overall Study|Lost to Follow-up|24|||
170781235|NCT02651324|617207223|FG000|Overall Study|drug not administered, due dispensing issue|1|||
170781236|NCT02651324|617207224|FG001|Overall Study|drug not administered, due dispensing issue|0|||
170781237|NCT03101904|617207229|FG000|Wash Out (10 Days)|Adverse Event|1|||
170781238|NCT03101904|617207230|FG001|Wash Out (10 Days)|Adverse Event|0|||
170781239|NCT03101904|617207229|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
170781240|NCT03101904|617207230|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
170781241|NCT04538417|617207231|FG000|Overall Study|Withdrawal by Subject|2|||
170781242|NCT04638998|617207233|FG000|Overall Study|Withdrawal by Subject|1|||
170781243|NCT04638998|617207234|FG001|Overall Study|Withdrawal by Subject|3|||
170781244|NCT02097420|617207239|FG000|Overall Study|Death|6|||
170781245|NCT02097420|617207239|FG000|Overall Study|Valve explanted|13|||
170781246|NCT02097420|617207239|FG000|Overall Study|Other Reason|1|||
170781247|NCT02312960|617207240|FG000|Overall Study|Death|24|||
170781248|NCT02312960|617207241|FG001|Overall Study|Death|32|||
170781249|NCT02312960|617207242|FG002|Overall Study|Death|25|||
170781250|NCT02312960|617207243|FG003|Overall Study|Death|11|||
170781251|NCT02312960|617207244|FG004|Overall Study|Death|5|||
170781252|NCT02312960|617207245|FG005|Overall Study|Death|5|||
170781253|NCT02312960|617207246|FG006|Overall Study|Death|8|||
170781254|NCT02312960|617207247|FG007|Overall Study|Death|5|||
170781255|NCT02312960|617207248|FG008|Overall Study|Death|7|||
170781256|NCT02312960|617207249|FG009|Overall Study|Death|3|||
170781257|NCT02312960|617207250|FG010|Overall Study|Death|3|||
170781258|NCT02312960|617207251|FG011|Overall Study|Death|1|||
170781259|NCT02312960|617207252|FG012|Overall Study|Death|25|||
170781260|NCT02312960|617207253|FG013|Overall Study|Death|19|||
170781261|NCT02312960|617207240|FG000|Overall Study|Missing|0|||
170781262|NCT02312960|617207241|FG001|Overall Study|Missing|0|||
170781263|NCT02312960|617207242|FG002|Overall Study|Missing|2|||
170781264|NCT02312960|617207243|FG003|Overall Study|Missing|0|||
170781265|NCT02312960|617207244|FG004|Overall Study|Missing|0|||
170781266|NCT02312960|617207245|FG005|Overall Study|Missing|0|||
170781267|NCT02312960|617207246|FG006|Overall Study|Missing|0|||
170781268|NCT02312960|617207247|FG007|Overall Study|Missing|0|||
170781269|NCT02312960|617207248|FG008|Overall Study|Missing|0|||
170781270|NCT02312960|617207249|FG009|Overall Study|Missing|0|||
170781271|NCT02312960|617207250|FG010|Overall Study|Missing|0|||
170781272|NCT02312960|617207251|FG011|Overall Study|Missing|0|||
170781273|NCT02312960|617207252|FG012|Overall Study|Missing|0|||
170781274|NCT02312960|617207253|FG013|Overall Study|Missing|0|||
170781275|NCT02312960|617207240|FG000|Overall Study|Lost to Follow-up|0|||
170781276|NCT02312960|617207241|FG001|Overall Study|Lost to Follow-up|0|||
170781277|NCT02312960|617207242|FG002|Overall Study|Lost to Follow-up|1|||
170781278|NCT02312960|617207243|FG003|Overall Study|Lost to Follow-up|0|||
170781279|NCT02312960|617207244|FG004|Overall Study|Lost to Follow-up|0|||
170781280|NCT02312960|617207245|FG005|Overall Study|Lost to Follow-up|0|||
170781281|NCT02312960|617207246|FG006|Overall Study|Lost to Follow-up|1|||
170781282|NCT02312960|617207247|FG007|Overall Study|Lost to Follow-up|1|||
170781283|NCT02312960|617207248|FG008|Overall Study|Lost to Follow-up|0|||
170781284|NCT02312960|617207249|FG009|Overall Study|Lost to Follow-up|1|||
170781285|NCT02312960|617207250|FG010|Overall Study|Lost to Follow-up|0|||
170781286|NCT02312960|617207251|FG011|Overall Study|Lost to Follow-up|0|||
170781287|NCT02312960|617207252|FG012|Overall Study|Lost to Follow-up|1|||
170781288|NCT02312960|617207253|FG013|Overall Study|Lost to Follow-up|0|||
170781289|NCT02312960|617207240|FG000|Overall Study|Withdrawal by Subject|1|||
170437084|NCT05330975|615938248|FG005|Revaccination|Lost to Follow-up|0|||
170437085|NCT05330975|615938249|FG006|Revaccination|Lost to Follow-up|10|||
170781290|NCT02312960|617207241|FG001|Overall Study|Withdrawal by Subject|2|||
170781291|NCT02312960|617207242|FG002|Overall Study|Withdrawal by Subject|0|||
170437086|NCT05330975|615938243|FG000|Revaccination|Withdrawal by Subject|0|||
170781292|NCT02312960|617207243|FG003|Overall Study|Withdrawal by Subject|0|||
170781293|NCT02312960|617207244|FG004|Overall Study|Withdrawal by Subject|1|||
170781294|NCT02312960|617207245|FG005|Overall Study|Withdrawal by Subject|0|||
170781295|NCT02312960|617207246|FG006|Overall Study|Withdrawal by Subject|1|||
170781296|NCT02312960|617207247|FG007|Overall Study|Withdrawal by Subject|2|||
170781297|NCT02312960|617207248|FG008|Overall Study|Withdrawal by Subject|2|||
170781298|NCT02312960|617207249|FG009|Overall Study|Withdrawal by Subject|3|||
170781299|NCT02312960|617207250|FG010|Overall Study|Withdrawal by Subject|0|||
170632961|NCT01106690|616668440|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
170632962|NCT01106690|616668438|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
170632963|NCT01106690|616668439|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
170632964|NCT01106690|616668440|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
170632965|NCT01106690|616668438|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
170632966|NCT01106690|616668439|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
170632967|NCT01106690|616668440|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
170632968|NCT01106690|616668438|FG000|Extension Period: Week 26 to Week 52|Other|8|||
170632969|NCT01106690|616668439|FG001|Extension Period: Week 26 to Week 52|Other|3|||
170632970|NCT01106690|616668440|FG002|Extension Period: Week 26 to Week 52|Other|4|||
170632971|NCT01106690|616668438|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
170437087|NCT05330975|615938244|FG001|Revaccination|Withdrawal by Subject|0|||
170437088|NCT05330975|615938245|FG002|Revaccination|Withdrawal by Subject|0|||
170437089|NCT05330975|615938246|FG003|Revaccination|Withdrawal by Subject|0|||
170437090|NCT05330975|615938247|FG004|Revaccination|Withdrawal by Subject|0|||
170437091|NCT05330975|615938248|FG005|Revaccination|Withdrawal by Subject|0|||
170437092|NCT05330975|615938249|FG006|Revaccination|Withdrawal by Subject|2|||
170437093|NCT05330975|615938243|FG000|Revaccination|Death|0|||
170437094|NCT05330975|615938244|FG001|Revaccination|Death|0|||
170437095|NCT05330975|615938245|FG002|Revaccination|Death|0|||
170437096|NCT05330975|615938246|FG003|Revaccination|Death|0|||
170437097|NCT05330975|615938247|FG004|Revaccination|Death|0|||
170437098|NCT05330975|615938248|FG005|Revaccination|Death|0|||
170437099|NCT05330975|615938249|FG006|Revaccination|Death|3|||
170437100|NCT02655224|615938250|FG000|Overall Study|Adverse Event|1|||
170437101|NCT02655224|615938251|FG001|Overall Study|Adverse Event|1|||
170437102|NCT02998541|615938252|FG000|Overall Study|Adverse Event|4|||
170437103|NCT02998541|615938253|FG001|Overall Study|Adverse Event|5|||
170437104|NCT02998541|615938254|FG002|Overall Study|Adverse Event|1|||
170437105|NCT02998541|615938252|FG000|Overall Study|Protocol Violation|1|||
170437106|NCT02998541|615938253|FG001|Overall Study|Protocol Violation|0|||
170437107|NCT02998541|615938254|FG002|Overall Study|Protocol Violation|0|||
170437108|NCT02998541|615938252|FG000|Overall Study|Withdrawal by Subject|3|||
170437109|NCT02998541|615938253|FG001|Overall Study|Withdrawal by Subject|1|||
170437110|NCT02998541|615938254|FG002|Overall Study|Withdrawal by Subject|0|||
170437111|NCT02998541|615938252|FG000|Overall Study|Lost to Follow-up|0|||
170437112|NCT02998541|615938253|FG001|Overall Study|Lost to Follow-up|3|||
170437113|NCT02998541|615938254|FG002|Overall Study|Lost to Follow-up|1|||
170437114|NCT02998541|615938252|FG000|Overall Study|Physician Decision|0|||
170437115|NCT02998541|615938253|FG001|Overall Study|Physician Decision|0|||
170437116|NCT02998541|615938254|FG002|Overall Study|Physician Decision|3|||
170437117|NCT02998541|615938252|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170437118|NCT02998541|615938253|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170437119|NCT02998541|615938254|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
170437120|NCT03540160|615938257|FG000|Overall Study|Protocol Violation|1|||
170437121|NCT03540160|615938257|FG000|Overall Study|Physician Decision|8|||
170437122|NCT03540160|615938257|FG000|Overall Study|Lack of Efficacy|60|||
170437123|NCT03540160|615938257|FG000|Overall Study|Pregnancy|1|||
170437124|NCT03540160|615938257|FG000|Overall Study|Adverse Event|20|||
170437125|NCT03540160|615938257|FG000|Overall Study|Withdrawal by Subject|68|||
170437126|NCT03540160|615938257|FG000|Overall Study|COVID-19|2|||
170437127|NCT03540160|615938257|FG000|Overall Study|Study Closure|10|||
170437128|NCT03540160|615938257|FG000|Overall Study|Lost to Follow-up|18|||
170437129|NCT03540160|615938257|FG000|Overall Study|Sponsor decision|191|||
170437130|NCT01410227|615938258|FG000|Overall Study|Adverse Event|1|||
170437131|NCT01410227|615938259|FG001|Overall Study|Adverse Event|0|||
170437132|NCT01410227|615938260|FG002|Overall Study|Adverse Event|0|||
170437133|NCT01410227|615938261|FG003|Overall Study|Adverse Event|0|||
170437134|NCT01410227|615938258|FG000|Overall Study|Withdrawal by Subject|3|||
170437135|NCT01410227|615938259|FG001|Overall Study|Withdrawal by Subject|0|||
170437136|NCT01410227|615938260|FG002|Overall Study|Withdrawal by Subject|1|||
170437137|NCT01410227|615938261|FG003|Overall Study|Withdrawal by Subject|0|||
170632972|NCT01106690|616668439|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
170781300|NCT02312960|617207251|FG011|Overall Study|Withdrawal by Subject|0|||
170781301|NCT02312960|617207252|FG012|Overall Study|Withdrawal by Subject|2|||
170781302|NCT02312960|617207253|FG013|Overall Study|Withdrawal by Subject|0|||
170781303|NCT03131648|617207270|FG000|Initial Treatment Period|Not dosed|2|||
170781304|NCT03131648|617207271|FG001|Initial Treatment Period|Not dosed|2|||
170437138|NCT01410227|615938258|FG000|Overall Study|Pregnancy|0|||
170437139|NCT01410227|615938259|FG001|Overall Study|Pregnancy|0|||
170781305|NCT03131648|617207272|FG002|Initial Treatment Period|Not dosed|0|||
170781306|NCT03131648|617207273|FG003|Initial Treatment Period|Not dosed|0|||
170781307|NCT03131648|617207274|FG004|Initial Treatment Period|Not dosed|0|||
170781308|NCT03131648|617207275|FG005|Initial Treatment Period|Not dosed|0|||
170781309|NCT03131648|617207276|FG006|Initial Treatment Period|Not dosed|0|||
170781310|NCT03131648|617207277|FG007|Initial Treatment Period|Not dosed|0|||
170437140|NCT01410227|615938260|FG002|Overall Study|Pregnancy|0|||
170437141|NCT01410227|615938261|FG003|Overall Study|Pregnancy|1|||
170437142|NCT01410227|615938258|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
170437143|NCT01410227|615938259|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
170437144|NCT01410227|615938260|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
170437145|NCT01410227|615938261|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
170437146|NCT00585286|615938262|FG000|Overall Study|Lost to Follow-up|1|||
170437147|NCT03345420|615938263|FG000|Overall Study|Withdrawal by Subject|1|||
170437148|NCT00669162|615938264|FG000|Overall Study|Withdrawal by Subject|1|||
170437149|NCT00841659|615938265|FG000|Washout: 2 Weeks|Protocol Violation|1|||
170437150|NCT00841659|615938266|FG001|Washout: 2 Weeks|Protocol Violation|0|||
170437151|NCT01964950|615938273|FG000|Overall Study|Protocol Violation|25|||
170437152|NCT00577655|615938278|FG000|Overall Study|Patient Request|0|||
170437153|NCT00577655|615938279|FG001|Overall Study|Patient Request|2|||
170437154|NCT00577655|615938278|FG000|Overall Study|Protocol Violation|0|||
170437155|NCT00577655|615938279|FG001|Overall Study|Protocol Violation|1|||
170437156|NCT00577655|615938278|FG000|Overall Study|Lost to Follow-up|1|||
170437157|NCT00577655|615938279|FG001|Overall Study|Lost to Follow-up|1|||
170437158|NCT01190865|615938283|FG000|Overall Study|Withdrawal by Subject|1|||
170437159|NCT01190865|615938283|FG000|Overall Study|Non-compliance|2|||
170437160|NCT00875524|615938284|FG000|Overall Study|Serious adverse event|0|||
170437161|NCT00875524|615938285|FG001|Overall Study|Serious adverse event|1|||
170437162|NCT00875524|615938284|FG000|Overall Study|Protocol Violation|4|||
170437163|NCT00875524|615938285|FG001|Overall Study|Protocol Violation|0|||
170437164|NCT00875524|615938284|FG000|Overall Study|Lost to Follow-up|1|||
170437165|NCT00875524|615938285|FG001|Overall Study|Lost to Follow-up|0|||
170437166|NCT00875524|615938284|FG000|Overall Study|Withdrawal by Subject|3|||
170437167|NCT00875524|615938285|FG001|Overall Study|Withdrawal by Subject|5|||
170437168|NCT01155531|615938286|FG000|Overall Study|Adverse Event|0|||
170437169|NCT01155531|615938287|FG001|Overall Study|Adverse Event|0|||
170437170|NCT01155531|615938288|FG002|Overall Study|Adverse Event|1|||
170882336|NCT04099251|617579513|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
170882337|NCT04099251|617579514|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
170882338|NCT04099251|617579513|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
170882339|NCT04099251|617579514|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
170437171|NCT01155531|615938289|FG003|Overall Study|Adverse Event|0|||
170437172|NCT01155531|615938286|FG000|Overall Study|Lost to Follow-up|0|||
170882340|NCT04099251|617579513|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
170882341|NCT04099251|617579514|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
170882342|NCT04099251|617579513|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
170882343|NCT04099251|617579514|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
170882344|NCT04099251|617579513|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
170882345|NCT04099251|617579514|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
170437173|NCT01155531|615938287|FG001|Overall Study|Lost to Follow-up|0|||
170437174|NCT01155531|615938288|FG002|Overall Study|Lost to Follow-up|0|||
170437175|NCT01155531|615938289|FG003|Overall Study|Lost to Follow-up|1|||
170437176|NCT01155531|615938286|FG000|Overall Study|Withdrawal by Subject|1|||
170437177|NCT01155531|615938287|FG001|Overall Study|Withdrawal by Subject|0|||
170437178|NCT01155531|615938288|FG002|Overall Study|Withdrawal by Subject|1|||
170437179|NCT01155531|615938289|FG003|Overall Study|Withdrawal by Subject|0|||
170437180|NCT02227238|615938290|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
170437181|NCT02227238|615938291|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
170437182|NCT02227238|615938292|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
170437183|NCT02227238|615938290|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
170437184|NCT02227238|615938291|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
170437185|NCT02227238|615938292|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
170437186|NCT02227238|615938290|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
170437187|NCT02227238|615938291|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
170437188|NCT02227238|615938292|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
170437189|NCT02227238|615938290|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
170437190|NCT02227238|615938291|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
170437191|NCT02227238|615938292|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
170437192|NCT02227238|615938290|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
170437193|NCT02227238|615938291|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
170437194|NCT02227238|615938292|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
170437195|NCT02227238|615938290|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
170437196|NCT02227238|615938291|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
170437197|NCT02227238|615938292|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
170437198|NCT02227238|615938290|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
170437199|NCT02227238|615938291|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
170437200|NCT02227238|615938292|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
170537047|NCT03980223|616309631|FG002|Overall Study|Physician Decision|1|||
170537048|NCT03980223|616309632|FG003|Overall Study|Physician Decision|0|||
170537049|NCT03980223|616309629|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
170537050|NCT03980223|616309630|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
170537051|NCT03980223|616309631|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
170537052|NCT03980223|616309632|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
170537053|NCT01977846|616309636|FG000|Total Study - Prospective|Death|0|||
170537054|NCT01977846|616309637|FG001|Total Study - Prospective|Death|1|||
170537055|NCT01977846|616309636|FG000|Total Study - Prospective|Lost to Follow-up|0|||
170537056|NCT01977846|616309637|FG001|Total Study - Prospective|Lost to Follow-up|8|||
170537057|NCT01977846|616309636|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
170781311|NCT03131648|617207270|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
170781312|NCT03131648|617207271|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
170781313|NCT03131648|617207272|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170781314|NCT03131648|617207273|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170781315|NCT03131648|617207274|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170781316|NCT03131648|617207275|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170537058|NCT01977846|616309637|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
170781317|NCT03131648|617207276|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170781318|NCT03131648|617207277|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170781319|NCT03131648|617207270|FG000|Open-label Treatment|Discontinued IMP|0|||
170781320|NCT03131648|617207271|FG001|Open-label Treatment|Discontinued IMP|0|||
170781321|NCT03131648|617207272|FG002|Open-label Treatment|Discontinued IMP|0|||
170781322|NCT03131648|617207273|FG003|Open-label Treatment|Discontinued IMP|0|||
170781323|NCT03131648|617207274|FG004|Open-label Treatment|Discontinued IMP|0|||
170781324|NCT03131648|617207275|FG005|Open-label Treatment|Discontinued IMP|0|||
170781325|NCT03131648|617207276|FG006|Open-label Treatment|Discontinued IMP|112|||
170781326|NCT03131648|617207277|FG007|Open-label Treatment|Discontinued IMP|0|||
170781327|NCT03131648|617207270|FG000|Open-label Treatment|Completed Week 50|0|||
170781328|NCT03131648|617207271|FG001|Open-label Treatment|Completed Week 50|0|||
170781329|NCT03131648|617207272|FG002|Open-label Treatment|Completed Week 50|0|||
170781330|NCT03131648|617207273|FG003|Open-label Treatment|Completed Week 50|0|||
170781331|NCT03131648|617207274|FG004|Open-label Treatment|Completed Week 50|0|||
170781332|NCT03131648|617207275|FG005|Open-label Treatment|Completed Week 50|0|||
170781333|NCT03131648|617207276|FG006|Open-label Treatment|Completed Week 50|6|||
170781334|NCT03131648|617207277|FG007|Open-label Treatment|Completed Week 50|0|||
170781335|NCT03131648|617207270|FG000|Maintenance Treatment Period|Not dosed|0|||
170781336|NCT03131648|617207271|FG001|Maintenance Treatment Period|Not dosed|0|||
170781337|NCT03131648|617207272|FG002|Maintenance Treatment Period|Not dosed|3|||
170781338|NCT03131648|617207273|FG003|Maintenance Treatment Period|Not dosed|2|||
170781339|NCT03131648|617207274|FG004|Maintenance Treatment Period|Not dosed|1|||
170781340|NCT03131648|617207275|FG005|Maintenance Treatment Period|Not dosed|0|||
170781341|NCT03131648|617207276|FG006|Maintenance Treatment Period|Not dosed|0|||
170781342|NCT03131648|617207277|FG007|Maintenance Treatment Period|Not dosed|0|||
170781343|NCT03131648|617207270|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
170781344|NCT03131648|617207271|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
170781345|NCT03131648|617207272|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
170781346|NCT03131648|617207273|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
170781347|NCT03131648|617207274|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
170781348|NCT03131648|617207275|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
170781349|NCT03131648|617207276|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
170781350|NCT03131648|617207277|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
170781351|NCT03131648|617207270|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
170781352|NCT03131648|617207271|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
170781353|NCT03131648|617207272|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
170781354|NCT03131648|617207273|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
170781355|NCT03131648|617207274|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
170781356|NCT03131648|617207275|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
170781357|NCT03131648|617207276|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
170781358|NCT03131648|617207277|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
170781359|NCT03131648|617207270|FG000|Maintenance Treatment Period|Completed Week 50|0|||
170781360|NCT03131648|617207271|FG001|Maintenance Treatment Period|Completed Week 50|0|||
170781361|NCT03131648|617207272|FG002|Maintenance Treatment Period|Completed Week 50|0|||
170781362|NCT03131648|617207273|FG003|Maintenance Treatment Period|Completed Week 50|0|||
170781363|NCT03131648|617207274|FG004|Maintenance Treatment Period|Completed Week 50|1|||
170781364|NCT03131648|617207275|FG005|Maintenance Treatment Period|Completed Week 50|0|||
170781365|NCT03131648|617207276|FG006|Maintenance Treatment Period|Completed Week 50|0|||
170781366|NCT03131648|617207277|FG007|Maintenance Treatment Period|Completed Week 50|0|||
170781367|NCT03131648|617207270|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
170781368|NCT03131648|617207271|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
170781369|NCT03131648|617207272|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
170781370|NCT03131648|617207273|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
170781371|NCT03131648|617207274|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
170781372|NCT03131648|617207275|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
170781373|NCT03131648|617207276|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
170781374|NCT03131648|617207277|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
170537059|NCT01977846|616309636|FG000|Total Study - Prospective|Not available at time of visit|0|||
170537060|NCT01977846|616309637|FG001|Total Study - Prospective|Not available at time of visit|5|||
170537061|NCT01977846|616309636|FG000|Total Study - Prospective|No show|0|||
170781375|NCT04263311|617207278|FG000|Overall Study|Lost to Follow-up|1|||
170781376|NCT04263311|617207279|FG001|Overall Study|Lost to Follow-up|2|||
170781377|NCT04263311|617207280|FG002|Overall Study|Lost to Follow-up|0|||
170781378|NCT04263311|617207278|FG000|Overall Study|Health Issues|1|||
170781379|NCT04263311|617207279|FG001|Overall Study|Health Issues|0|||
170781380|NCT04263311|617207280|FG002|Overall Study|Health Issues|0|||
170781381|NCT04263311|617207278|FG000|Overall Study|Left the country|1|||
170781382|NCT04263311|617207279|FG001|Overall Study|Left the country|0|||
170781383|NCT04263311|617207280|FG002|Overall Study|Left the country|0|||
170781384|NCT04263311|617207278|FG000|Overall Study|Unable to maintain time commitment|1|||
170781385|NCT04263311|617207279|FG001|Overall Study|Unable to maintain time commitment|0|||
170781386|NCT04263311|617207280|FG002|Overall Study|Unable to maintain time commitment|0|||
170781387|NCT04263311|617207278|FG000|Overall Study|No longer interested|1|||
170781388|NCT04263311|617207279|FG001|Overall Study|No longer interested|0|||
170781389|NCT04263311|617207280|FG002|Overall Study|No longer interested|0|||
170781390|NCT04263311|617207278|FG000|Overall Study|Ineligible post consent|0|||
170781391|NCT04263311|617207279|FG001|Overall Study|Ineligible post consent|0|||
170781392|NCT04263311|617207280|FG002|Overall Study|Ineligible post consent|5|||
170781393|NCT05524233|617207283|FG000|Overall Study|Lost to Follow-up|2|||
170781394|NCT05524233|617207283|FG000|Overall Study|Adverse Event|2|||
170781395|NCT05524233|617207283|FG000|Overall Study|Withdrawal by Subject|1|||
170882346|NCT04099251|617579513|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
170882347|NCT04099251|617579514|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
170882348|NCT04099251|617579513|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
170882349|NCT04099251|617579514|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
170882350|NCT04311502|617579515|FG000|Overall Study|Death|1|||
170882351|NCT04311502|617579516|FG001|Overall Study|Death|1|||
170882352|NCT04311502|617579517|FG002|Overall Study|Death|1|||
170882353|NCT04311502|617579515|FG000|Overall Study|Lost to Follow-up|2|||
170882354|NCT04311502|617579516|FG001|Overall Study|Lost to Follow-up|3|||
170882355|NCT04311502|617579517|FG002|Overall Study|Lost to Follow-up|0|||
170882356|NCT04311502|617579515|FG000|Overall Study|Participant is in prison|1|||
170882357|NCT04311502|617579516|FG001|Overall Study|Participant is in prison|0|||
170882358|NCT04311502|617579517|FG002|Overall Study|Participant is in prison|0|||
170882359|NCT04311502|617579515|FG000|Overall Study|Participant moved out of country|1|||
170882360|NCT04311502|617579516|FG001|Overall Study|Participant moved out of country|0|||
170882361|NCT04311502|617579517|FG002|Overall Study|Participant moved out of country|0|||
170882362|NCT04311502|617579515|FG000|Overall Study|Withdrawal by Subject|2|||
170882363|NCT04311502|617579516|FG001|Overall Study|Withdrawal by Subject|0|||
170882364|NCT04311502|617579517|FG002|Overall Study|Withdrawal by Subject|0|||
170882365|NCT04311502|617579515|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
170882366|NCT04311502|617579516|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
170882367|NCT04311502|617579517|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
170882368|NCT03451773|617579524|FG000|Overall Study|Death on study|1|||
170882369|NCT03451773|617579525|FG001|Overall Study|Death on study|5|||
170882370|NCT03451773|617579524|FG000|Overall Study|Death during follow-up period|0|||
170882371|NCT03451773|617579525|FG001|Overall Study|Death during follow-up period|1|||
170882372|NCT02627495|617579526|FG000|Overall Study|Withdrawal by Subject|4|||
170882373|NCT00971945|617579533|FG000|Overall Study|Progressive Disease|3|||
170882374|NCT00971945|617579533|FG000|Overall Study|Change in treatment policy|1|||
170882375|NCT00971945|617579533|FG000|Overall Study|Other reasons|2|||
170882376|NCT03354663|617579534|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
170882377|NCT03354663|617579534|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
170882378|NCT03354663|617579534|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
170882379|NCT03354663|617579534|FG000|Completed 30-day Visit|Missed Visit|1|||
170882380|NCT03691974|617579535|FG000|Overall Study|Physician Decision|1|||
170882381|NCT03691974|617579536|FG001|Overall Study|Physician Decision|0|||
170882382|NCT03691974|617579535|FG000|Overall Study|Adverse Event|1|||
170882383|NCT03691974|617579536|FG001|Overall Study|Adverse Event|0|||
170882384|NCT03691974|617579535|FG000|Overall Study|Withdrawal by Subject|11|||
170882385|NCT03691974|617579536|FG001|Overall Study|Withdrawal by Subject|9|||
170882386|NCT03691974|617579535|FG000|Overall Study|Protocol Violation|1|||
170882387|NCT03691974|617579536|FG001|Overall Study|Protocol Violation|0|||
170882388|NCT03691974|617579535|FG000|Overall Study|Lost to Follow-up|8|||
170781396|NCT04791709|617207285|FG000|Overall Study|Withdrawal by Subject|3|||
170781397|NCT02538900|617207288|FG000|Overall Study|Death|2|||
170781398|NCT02538900|617207289|FG001|Overall Study|Death|2|||
170781399|NCT02538900|617207290|FG002|Overall Study|Death|2|||
170781400|NCT02538900|617207288|FG000|Overall Study|Withdrawal by Subject|18|||
170781401|NCT02538900|617207289|FG001|Overall Study|Withdrawal by Subject|16|||
170781402|NCT02538900|617207290|FG002|Overall Study|Withdrawal by Subject|15|||
170781403|NCT00274469|617207293|FG000|Overall Study|Death|63|||
170437201|NCT02227238|615938290|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
170437202|NCT02227238|615938291|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
170437203|NCT02227238|615938292|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
170437204|NCT02227238|615938290|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
170437205|NCT02227238|615938291|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
170437206|NCT02227238|615938292|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
170437207|NCT02227238|615938290|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
170437208|NCT02227238|615938291|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
170437209|NCT02227238|615938292|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
170437210|NCT02227238|615938290|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
170437211|NCT02227238|615938291|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
170437212|NCT02227238|615938292|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
170437213|NCT02227238|615938290|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
170437214|NCT02227238|615938291|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
170437215|NCT02227238|615938292|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
170437216|NCT02227238|615938290|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
170437217|NCT02227238|615938291|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
170437218|NCT02227238|615938292|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
170437219|NCT02227238|615938290|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
170437220|NCT02227238|615938291|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
170437221|NCT02227238|615938292|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
170437222|NCT04025021|615938293|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
170437223|NCT04025021|615938294|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
170437224|NCT00380588|615938295|FG000|Overall Study|Unequivocal Disease Progression|25|||
170437225|NCT00380588|615938296|FG001|Overall Study|Unequivocal Disease Progression|34|||
170437226|NCT00380588|615938295|FG000|Overall Study|Next Cycle Not Started|4|||
170437227|NCT00380588|615938296|FG001|Overall Study|Next Cycle Not Started|0|||
170437228|NCT00380588|615938295|FG000|Overall Study|Adverse Event|7|||
170437229|NCT00380588|615938296|FG001|Overall Study|Adverse Event|3|||
170437230|NCT00380588|615938295|FG000|Overall Study|Withdrawal by Subject|1|||
170437231|NCT00380588|615938296|FG001|Overall Study|Withdrawal by Subject|3|||
170437232|NCT00380588|615938295|FG000|Overall Study|Physician Decision|2|||
170437233|NCT00380588|615938296|FG001|Overall Study|Physician Decision|0|||
170437234|NCT00999687|615938298|FG000|First Intervention|Withdrawal by Subject|1|||
170437235|NCT00999687|615938298|FG000|Second Intervention|Withdrawal by Subject|2|||
170437236|NCT00999687|615938298|FG000|Second Intervention|Lack of Efficacy|1|||
170437237|NCT03614728|615938299|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
170437238|NCT03614728|615938300|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
170437239|NCT03614728|615938301|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
170437240|NCT03614728|615938302|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
170437241|NCT03614728|615938299|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
170437242|NCT03614728|615938300|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
170437243|NCT03614728|615938301|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
170437244|NCT03614728|615938302|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
170437245|NCT02670551|615938309|FG000|Overall Study|Adverse Event|4|||
170437246|NCT02670551|615938310|FG001|Overall Study|Adverse Event|7|||
170437247|NCT02670551|615938311|FG002|Overall Study|Adverse Event|9|||
170437248|NCT02670551|615938309|FG000|Overall Study|Lack of Efficacy|2|||
170437249|NCT02670551|615938310|FG001|Overall Study|Lack of Efficacy|0|||
170437250|NCT02670551|615938311|FG002|Overall Study|Lack of Efficacy|3|||
170437251|NCT02670551|615938309|FG000|Overall Study|Withdrawal of Consent|6|||
170437252|NCT02670551|615938310|FG001|Overall Study|Withdrawal of Consent|3|||
170437253|NCT02670551|615938311|FG002|Overall Study|Withdrawal of Consent|8|||
170437254|NCT02670551|615938309|FG000|Overall Study|Lost to Follow-up|5|||
170437255|NCT02670551|615938310|FG001|Overall Study|Lost to Follow-up|7|||
170437256|NCT02670551|615938311|FG002|Overall Study|Lost to Follow-up|6|||
170437257|NCT02670551|615938309|FG000|Overall Study|Protocol Violation|1|||
170437258|NCT02670551|615938310|FG001|Overall Study|Protocol Violation|0|||
170437259|NCT02670551|615938311|FG002|Overall Study|Protocol Violation|0|||
170437260|NCT02670551|615938309|FG000|Overall Study|Noncompliance with study drug|3|||
170537062|NCT01977846|616309637|FG001|Total Study - Prospective|No show|1|||
170882389|NCT03691974|617579536|FG001|Overall Study|Lost to Follow-up|7|||
170882390|NCT01661140|617579539|FG000|Open-Label Period|Adverse Event|44|||
170882391|NCT01661140|617579540|FG001|Open-Label Period|Adverse Event|0|||
170437261|NCT02670551|615938310|FG001|Overall Study|Noncompliance with study drug|3|||
170437262|NCT02670551|615938311|FG002|Overall Study|Noncompliance with study drug|2|||
170437263|NCT02670551|615938309|FG000|Overall Study|Other Miscellaneous Reasons|2|||
170437264|NCT02670551|615938310|FG001|Overall Study|Other Miscellaneous Reasons|3|||
170437265|NCT02670551|615938311|FG002|Overall Study|Other Miscellaneous Reasons|3|||
170537063|NCT01977846|616309636|FG000|Total Study - Prospective|Protocol Violation|0|||
170437266|NCT02670551|615938309|FG000|Overall Study|Did Not Receive Treatment|5|||
170437267|NCT02670551|615938310|FG001|Overall Study|Did Not Receive Treatment|3|||
170437268|NCT02670551|615938311|FG002|Overall Study|Did Not Receive Treatment|0|||
170437269|NCT01962298|615938312|FG000|Overall Study|Protocol Violation|1|||
170437270|NCT01962298|615938313|FG001|Overall Study|Protocol Violation|0|||
170437271|NCT01962298|615938314|FG002|Overall Study|Protocol Violation|1|||
170437272|NCT01962298|615938315|FG003|Overall Study|Protocol Violation|1|||
170437273|NCT01962298|615938316|FG004|Overall Study|Protocol Violation|0|||
170437274|NCT01962298|615938312|FG000|Overall Study|Data quality insufficient|2|||
170437275|NCT01962298|615938313|FG001|Overall Study|Data quality insufficient|0|||
170437276|NCT01962298|615938314|FG002|Overall Study|Data quality insufficient|3|||
170437277|NCT01962298|615938315|FG003|Overall Study|Data quality insufficient|1|||
170437278|NCT01962298|615938316|FG004|Overall Study|Data quality insufficient|4|||
170437279|NCT01962298|615938312|FG000|Overall Study|Insufficient data|0|||
170437280|NCT01962298|615938313|FG001|Overall Study|Insufficient data|2|||
170437281|NCT01962298|615938314|FG002|Overall Study|Insufficient data|1|||
170437282|NCT01962298|615938315|FG003|Overall Study|Insufficient data|0|||
170437283|NCT01962298|615938316|FG004|Overall Study|Insufficient data|1|||
170437284|NCT01962298|615938312|FG000|Overall Study|Incorrect data recorded|0|||
170437285|NCT01962298|615938313|FG001|Overall Study|Incorrect data recorded|1|||
170437286|NCT01962298|615938314|FG002|Overall Study|Incorrect data recorded|0|||
170437287|NCT01962298|615938315|FG003|Overall Study|Incorrect data recorded|0|||
170437288|NCT01962298|615938316|FG004|Overall Study|Incorrect data recorded|0|||
170437289|NCT01962298|615938312|FG000|Overall Study|Physician Decision|0|||
170437290|NCT01962298|615938313|FG001|Overall Study|Physician Decision|1|||
170437291|NCT01962298|615938314|FG002|Overall Study|Physician Decision|0|||
170437292|NCT01962298|615938315|FG003|Overall Study|Physician Decision|0|||
170437293|NCT01962298|615938316|FG004|Overall Study|Physician Decision|1|||
170437294|NCT01576705|615938317|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
170437295|NCT01576705|615938318|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
170437296|NCT01576705|615938319|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
170437297|NCT01576705|615938320|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
170437298|NCT01576705|615938317|FG000|Overall Study|invalid ICF|0|||
170437299|NCT01576705|615938318|FG001|Overall Study|invalid ICF|1|||
170437300|NCT01576705|615938319|FG002|Overall Study|invalid ICF|0|||
170437301|NCT01576705|615938320|FG003|Overall Study|invalid ICF|0|||
170437302|NCT00858403|615938321|FG000|Overall Study|Withdrawal by Subject|1|||
170437303|NCT00858403|615938321|FG000|Overall Study|Death|3|||
170437304|NCT00858403|615938321|FG000|Overall Study|Disease Progression|1|||
170437305|NCT03684928|615938322|FG000|First Intervention|Lost to Follow-up|0|||
170437306|NCT03684928|615938323|FG001|First Intervention|Lost to Follow-up|1|||
170437307|NCT03684928|615938322|FG000|First Intervention|Withdrawal by Subject|0|||
170437308|NCT03684928|615938323|FG001|First Intervention|Withdrawal by Subject|2|||
170437309|NCT03684928|615938322|FG000|Second Intervention|Soft Tissue Injury|1|||
170437310|NCT03684928|615938323|FG001|Second Intervention|Soft Tissue Injury|0|||
170437311|NCT03193021|615938324|FG000|Overall Study|Lost to Follow-up|1|||
170437312|NCT03193021|615938325|FG001|Overall Study|Lost to Follow-up|1|||
170437313|NCT02286466|615938326|FG000|Overall Study|Death|1|||
170437314|NCT02286466|615938327|FG001|Overall Study|Death|3|||
170437315|NCT02286466|615938326|FG000|Overall Study|Withdrawal by Subject|5|||
170437316|NCT02286466|615938327|FG001|Overall Study|Withdrawal by Subject|2|||
170437317|NCT02286466|615938326|FG000|Overall Study|Lost to Follow-up|1|||
170437318|NCT02286466|615938327|FG001|Overall Study|Lost to Follow-up|4|||
170437319|NCT02286466|615938326|FG000|Overall Study|Declined Clinician Assessment|0|||
170437320|NCT02286466|615938327|FG001|Overall Study|Declined Clinician Assessment|1|||
170437321|NCT05568615|615939904|FG000|Overall Study|Death|1|||
170437322|NCT05568615|615939904|FG000|Overall Study|Physician Decision|1|||
170437323|NCT02300987|615939910|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
170437324|NCT02300987|615939911|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
170437325|NCT02300987|615939910|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
170437326|NCT02300987|615939911|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
170437327|NCT02300987|615939910|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
170437328|NCT02300987|615939911|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
170437329|NCT02300987|615939910|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
170437330|NCT02300987|615939911|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
170437331|NCT02300987|615939910|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
170437332|NCT02300987|615939911|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
170437333|NCT00660387|615939912|FG000|Overall Study|Adverse Event|1|||
170437334|NCT00660387|615939913|FG001|Overall Study|Adverse Event|2|||
170437335|NCT00660387|615939912|FG000|Overall Study|Lack of Efficacy|0|||
170437336|NCT00660387|615939913|FG001|Overall Study|Lack of Efficacy|1|||
170437337|NCT00660387|615939912|FG000|Overall Study|Protocol Violation|1|||
170437338|NCT00660387|615939913|FG001|Overall Study|Protocol Violation|0|||
170437339|NCT01023061|615939916|FG000|Overall Study|Withdrawal prior to treatment|2|||
170437340|NCT02966340|615939917|FG000|Overall Study|Adverse Event|0|||
170437341|NCT02966340|615939918|FG001|Overall Study|Adverse Event|1|||
170437342|NCT02966340|615939917|FG000|Overall Study|Lost to Follow-up|0|||
170437343|NCT02966340|615939918|FG001|Overall Study|Lost to Follow-up|1|||
170437344|NCT02966340|615939917|FG000|Overall Study|Withdrawal by Subject|1|||
170437345|NCT02966340|615939918|FG001|Overall Study|Withdrawal by Subject|0|||
170437346|NCT02966340|615939917|FG000|Overall Study|data acquisition error|1|||
170437347|NCT02966340|615939918|FG001|Overall Study|data acquisition error|0|||
170437348|NCT02966340|615939917|FG000|Overall Study|startle non-responder|1|||
170437349|NCT02966340|615939918|FG001|Overall Study|startle non-responder|1|||
170437350|NCT00255346|615939923|FG000|Overall Study|Adverse Event|1|||
170437351|NCT00255346|615939924|FG001|Overall Study|Adverse Event|0|||
170437352|NCT00255346|615939925|FG002|Overall Study|Adverse Event|0|||
170437353|NCT00255346|615939926|FG003|Overall Study|Adverse Event|0|||
170437354|NCT00255346|615939927|FG004|Overall Study|Adverse Event|0|||
170437355|NCT03192891|615939928|FG000|Overall Study|Lost to Follow-up|55|||
170632973|NCT01106690|616668440|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
170632974|NCT04730271|616668443|FG000|Overall Study|Adverse Event|0|||
170632975|NCT04730271|616668444|FG001|Overall Study|Adverse Event|2|||
170632976|NCT04730271|616668443|FG000|Overall Study|Withdrawal by Subject|1|||
170632977|NCT04730271|616668444|FG001|Overall Study|Withdrawal by Subject|1|||
170632978|NCT04730271|616668443|FG000|Overall Study|Protocol Violation|7|||
170632979|NCT04730271|616668444|FG001|Overall Study|Protocol Violation|13|||
170632980|NCT04730271|616668443|FG000|Overall Study|Lost to Follow-up|3|||
170632981|NCT04730271|616668444|FG001|Overall Study|Lost to Follow-up|3|||
170632982|NCT04730271|616668443|FG000|Overall Study|Death|1|||
170632983|NCT04730271|616668444|FG001|Overall Study|Death|0|||
170632984|NCT00998296|616668445|FG000|Overall Study|Progressive disease|0|||
170781404|NCT00274469|617207294|FG001|Overall Study|Death|74|||
170781405|NCT00274469|617207293|FG000|Overall Study|Did not consent to OS follow-up|16|||
170632985|NCT00998296|616668446|FG001|Overall Study|Progressive disease|1|||
170632986|NCT00998296|616668447|FG002|Overall Study|Progressive disease|0|||
170632987|NCT00998296|616668448|FG003|Overall Study|Progressive disease|0|||
170781406|NCT00274469|617207294|FG001|Overall Study|Did not consent to OS follow-up|19|||
170632988|NCT00998296|616668449|FG004|Overall Study|Progressive disease|0|||
170632989|NCT00998296|616668450|FG005|Overall Study|Progressive disease|0|||
170781407|NCT03338816|617207295|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
170882392|NCT01661140|617579541|FG002|Open-Label Period|Adverse Event|0|||
170882393|NCT01661140|617579539|FG000|Open-Label Period|Protocol Violation|3|||
170882394|NCT01661140|617579540|FG001|Open-Label Period|Protocol Violation|0|||
170882395|NCT01661140|617579541|FG002|Open-Label Period|Protocol Violation|0|||
170882396|NCT01661140|617579539|FG000|Open-Label Period|Withdrawal by Subject|5|||
170882397|NCT01661140|617579540|FG001|Open-Label Period|Withdrawal by Subject|0|||
170882398|NCT01661140|617579541|FG002|Open-Label Period|Withdrawal by Subject|0|||
170882399|NCT01661140|617579539|FG000|Open-Label Period|Investigator Decision|3|||
170882400|NCT01661140|617579540|FG001|Open-Label Period|Investigator Decision|0|||
170882401|NCT01661140|617579541|FG002|Open-Label Period|Investigator Decision|0|||
170882402|NCT01661140|617579539|FG000|Open-Label Period|Death|1|||
170882403|NCT01661140|617579540|FG001|Open-Label Period|Death|0|||
170882404|NCT01661140|617579541|FG002|Open-Label Period|Death|0|||
170882405|NCT01661140|617579539|FG000|Open-Label Period|Administrative/Other|1|||
170882406|NCT01661140|617579540|FG001|Open-Label Period|Administrative/Other|0|||
170882407|NCT01661140|617579541|FG002|Open-Label Period|Administrative/Other|0|||
170882408|NCT01661140|617579539|FG000|Open-Label Period|Sponsor termination|16|||
170882409|NCT01661140|617579540|FG001|Open-Label Period|Sponsor termination|0|||
170882410|NCT01661140|617579541|FG002|Open-Label Period|Sponsor termination|0|||
170882411|NCT01661140|617579539|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
170882412|NCT01661140|617579540|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
170882413|NCT01661140|617579541|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
170882414|NCT01661140|617579539|FG000|Open-Label Period|Lost to Follow-up|2|||
170882415|NCT01661140|617579540|FG001|Open-Label Period|Lost to Follow-up|0|||
170882416|NCT01661140|617579541|FG002|Open-Label Period|Lost to Follow-up|0|||
170882417|NCT01661140|617579539|FG000|Double-Blind Period|Refused Treatment|0|||
170882418|NCT01661140|617579540|FG001|Double-Blind Period|Refused Treatment|0|||
170882419|NCT01661140|617579541|FG002|Double-Blind Period|Refused Treatment|1|||
170882420|NCT01661140|617579539|FG000|Double-Blind Period|Adverse Event|0|||
170882421|NCT01661140|617579540|FG001|Double-Blind Period|Adverse Event|16|||
170882422|NCT01661140|617579541|FG002|Double-Blind Period|Adverse Event|18|||
170882423|NCT01661140|617579539|FG000|Double-Blind Period|Protocol Violation|0|||
170882424|NCT01661140|617579540|FG001|Double-Blind Period|Protocol Violation|2|||
170882425|NCT01661140|617579541|FG002|Double-Blind Period|Protocol Violation|3|||
170882426|NCT01661140|617579539|FG000|Double-Blind Period|Withdrawal by Subject|0|||
170882427|NCT01661140|617579540|FG001|Double-Blind Period|Withdrawal by Subject|1|||
170882428|NCT01661140|617579541|FG002|Double-Blind Period|Withdrawal by Subject|3|||
170882429|NCT01661140|617579539|FG000|Double-Blind Period|Investigator's Decision|0|||
170882430|NCT01661140|617579540|FG001|Double-Blind Period|Investigator's Decision|1|||
170882431|NCT01661140|617579541|FG002|Double-Blind Period|Investigator's Decision|2|||
170882432|NCT01661140|617579539|FG000|Double-Blind Period|Sponsor Termination|0|||
170781408|NCT03338816|617207296|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
170781409|NCT03338816|617207297|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
170781410|NCT03338816|617207298|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
170781411|NCT03338816|617207295|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
170781412|NCT03338816|617207296|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
170781413|NCT03338816|617207297|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
170632990|NCT00998296|616668451|FG006|Overall Study|Progressive disease|1|||
170781414|NCT03338816|617207298|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
170632991|NCT00998296|616668452|FG007|Overall Study|Progressive disease|0|||
170781415|NCT03338816|617207295|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
170437374|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
170437375|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
170437376|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
170437377|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
170437378|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
170437379|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
170437380|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
170437381|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
170437382|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
170437383|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
170437384|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
170437385|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
170437386|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
170437387|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
170437388|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
170437389|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
170437390|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
170437391|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
170437392|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
170437393|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
170437394|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
170437395|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
170437396|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
170437397|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
170437398|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
170437399|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
170437400|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
170437401|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
170437402|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
170437403|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
170437404|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
170437405|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
170437406|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
170437407|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
170437408|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
170437409|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
170437410|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
170437411|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
170437412|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
170437413|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
170437414|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
170437415|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
170437416|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
170437417|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
170437418|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
170437419|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
170437420|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
170437421|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
170437422|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
170437423|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
170437424|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
170437425|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
170437426|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
170437427|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
170437428|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
170437429|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
170437430|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
170437431|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
170437432|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
170437433|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
170437434|NCT03395197|615939935|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
170437435|NCT03395197|615939936|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
170882433|NCT01661140|617579540|FG001|Double-Blind Period|Sponsor Termination|14|||
170882434|NCT01661140|617579541|FG002|Double-Blind Period|Sponsor Termination|17|||
170882435|NCT01661140|617579539|FG000|Double-Blind Period|Administrative/Other|0|||
170882436|NCT01661140|617579540|FG001|Double-Blind Period|Administrative/Other|7|||
170882437|NCT01661140|617579541|FG002|Double-Blind Period|Administrative/Other|6|||
170882438|NCT02495844|617579542|FG000|Overall Study|Lack of Efficacy|1|||
170537064|NCT01977846|616309637|FG001|Total Study - Prospective|Protocol Violation|1|||
170537065|NCT02774889|616309638|FG000|Overall Study|Lost to Follow-up|2|||
170537066|NCT02774889|616309639|FG001|Overall Study|Lost to Follow-up|1|||
170537067|NCT04603066|616309642|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
170537068|NCT04603066|616309643|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
170537069|NCT01277861|616309646|FG000|Overall Study|Physician Decision|2|||
170537070|NCT01277861|616309647|FG001|Overall Study|Physician Decision|2|||
170537071|NCT05032196|616309648|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
170537072|NCT05032196|616309649|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
170537073|NCT05032196|616309650|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
170537074|NCT05032196|616309651|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
170537075|NCT05032196|616309652|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
170537076|NCT05032196|616309653|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
170537077|NCT05032196|616309648|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
170537078|NCT05032196|616309649|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
170537079|NCT05032196|616309650|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
170537080|NCT05032196|616309651|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
170537081|NCT05032196|616309652|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
170537082|NCT05032196|616309653|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
170537083|NCT05032196|616309648|FG000|Period 2 (Multidose)|Physician Decision|0|||
170537084|NCT05032196|616309649|FG001|Period 2 (Multidose)|Physician Decision|0|||
170537085|NCT05032196|616309650|FG002|Period 2 (Multidose)|Physician Decision|0|||
170537086|NCT05032196|616309651|FG003|Period 2 (Multidose)|Physician Decision|0|||
170537087|NCT05032196|616309652|FG004|Period 2 (Multidose)|Physician Decision|1|||
170537088|NCT05032196|616309653|FG005|Period 2 (Multidose)|Physician Decision|0|||
170537089|NCT00857389|616309654|FG000|Overall Study|Did not proceed to transplant|2|||
170537090|NCT01157845|616309655|FG000|Overall Study|Lost to Follow-up|5|||
170537091|NCT01157845|616309655|FG000|Overall Study|Withdrawal by Subject|12|||
170537092|NCT01157845|616309655|FG000|Overall Study|Physician Decision|3|||
170537093|NCT01157845|616309655|FG000|Overall Study|Protocol Violation|13|||
170537094|NCT01157845|616309655|FG000|Overall Study|Study was ended|1|||
170537095|NCT01157845|616309655|FG000|Overall Study|Device malfunction|1|||
170537096|NCT04584788|616309656|FG000|Overall Study|Physician Decision|8|||
170537097|NCT04584788|616309656|FG000|Overall Study|Withdrawal by Subject|1|||
170537098|NCT04584788|616309656|FG000|Overall Study|Adverse Event|3|||
170537099|NCT03311555|616309657|FG000|Overall Study|Adverse Event|1|||
170537100|NCT06366087|616311531|FG000|Overall Study|Withdrawal by Subject|0|||
170537101|NCT06366087|616311532|FG001|Overall Study|Withdrawal by Subject|1|||
170537102|NCT04044690|616311534|FG000|Period 1|Lack of Efficacy|1|||
170537103|NCT04044690|616311535|FG001|Period 1|Lack of Efficacy|1|||
170882439|NCT02495844|617579543|FG001|Overall Study|Lack of Efficacy|2|||
170882440|NCT02495844|617579542|FG000|Overall Study|AE, non-fatal|0|||
170882441|NCT02495844|617579543|FG001|Overall Study|AE, non-fatal|1|||
170882442|NCT02495844|617579542|FG000|Overall Study|Hepatitis Positivity|0|||
170882443|NCT02495844|617579543|FG001|Overall Study|Hepatitis Positivity|1|||
170882444|NCT01659320|617579546|FG000|Overall Study|Withdrawal by Subject|2|||
170882445|NCT01659320|617579546|FG000|Overall Study|Physician Decision|1|||
170882446|NCT00590590|617579547|FG000|Overall Study|Lack of Efficacy|1|||
170882447|NCT00590590|617579548|FG001|Overall Study|Lack of Efficacy|2|||
170882448|NCT00590590|617579549|FG002|Overall Study|Lack of Efficacy|0|||
170882449|NCT00590590|617579547|FG000|Overall Study|Adverse Event|1|||
170882450|NCT00590590|617579548|FG001|Overall Study|Adverse Event|0|||
170882451|NCT00590590|617579549|FG002|Overall Study|Adverse Event|0|||
170882452|NCT00590590|617579547|FG000|Overall Study|Protocol Violation|0|||
170882453|NCT00590590|617579548|FG001|Overall Study|Protocol Violation|0|||
170882454|NCT00590590|617579549|FG002|Overall Study|Protocol Violation|2|||
170882455|NCT00590590|617579547|FG000|Overall Study|Lost to Follow-up|4|||
170882456|NCT00590590|617579548|FG001|Overall Study|Lost to Follow-up|1|||
170537104|NCT04044690|616311534|FG000|Period 1|Adverse Event|4|||
170537105|NCT04044690|616311535|FG001|Period 1|Adverse Event|2|||
170537106|NCT04044690|616311534|FG000|Period 1|Physician Decision|0|||
170537107|NCT04044690|616311535|FG001|Period 1|Physician Decision|1|||
170537108|NCT04044690|616311534|FG000|Period 1|Withdrawal by Subject|2|||
170882457|NCT00590590|617579549|FG002|Overall Study|Lost to Follow-up|2|||
170882458|NCT00590590|617579547|FG000|Overall Study|Withdrawal by Subject|0|||
170882459|NCT00590590|617579548|FG001|Overall Study|Withdrawal by Subject|1|||
170882460|NCT00590590|617579549|FG002|Overall Study|Withdrawal by Subject|1|||
170882461|NCT00590590|617579547|FG000|Overall Study|Did not complete due to study closure|1|||
170537109|NCT04044690|616311535|FG001|Period 1|Withdrawal by Subject|5|||
170537110|NCT04044690|616311534|FG000|Period 1|Protocol Deviation|2|||
170437436|NCT03395197|615939937|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
170437437|NCT03395197|615939938|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
170437438|NCT03395197|615939939|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
170437439|NCT03395197|615939940|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
170437440|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|Death|0|||
170437441|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|Death|0|||
170437442|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|Death|0|||
170437443|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|Death|0|||
170437444|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|Death|1|||
170437445|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|Death|4|||
170437446|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
170437447|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
170437448|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
170437449|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
170437450|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
170437451|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
170437452|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
170437453|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
170437454|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
170437455|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
170437456|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
170437457|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
170437458|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
170437459|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
170437460|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
170437461|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
170437462|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
170437463|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
170437464|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
170437465|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
170437466|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
170437467|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
170437468|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
170437469|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
170437470|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
170437471|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
170437472|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
170437473|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
170437474|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
170437475|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
170437476|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
170437477|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
170437478|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
170437479|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
170437480|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
170437481|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
170437482|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|Other|0|||
170437483|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|Other|0|||
170437484|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|Other|0|||
170437485|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|Other|0|||
170437486|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|Other|3|||
170437487|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|Other|3|||
170437488|NCT03395197|615939935|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
170437489|NCT03395197|615939936|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
170437490|NCT03395197|615939937|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
170437491|NCT03395197|615939938|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
170437492|NCT03395197|615939939|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
170437493|NCT03395197|615939940|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
170437494|NCT00642993|615939941|FG000|Overall Study|Adverse Event|85|||
170437495|NCT00642993|615939942|FG001|Overall Study|Adverse Event|4|||
170781416|NCT03338816|617207296|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
170781417|NCT03338816|617207297|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
170781418|NCT03338816|617207298|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
170437496|NCT00642993|615939941|FG000|Overall Study|Lost to Follow-up|8|||
170437497|NCT00642993|615939942|FG001|Overall Study|Lost to Follow-up|4|||
170437498|NCT00642993|615939941|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
170437499|NCT00642993|615939942|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
170437500|NCT00642993|615939941|FG000|Overall Study|Protocol Violation|1|||
170437501|NCT00642993|615939942|FG001|Overall Study|Protocol Violation|4|||
170437502|NCT00642993|615939941|FG000|Overall Study|Did not meet protocol eligibility|0|||
170437503|NCT00642993|615939942|FG001|Overall Study|Did not meet protocol eligibility|1|||
170437504|NCT00642993|615939941|FG000|Overall Study|Administrative|1|||
170437505|NCT00642993|615939942|FG001|Overall Study|Administrative|0|||
170437506|NCT00960154|615939943|FG000|Overall Study|Study termination|25|||
170437507|NCT00960154|615939944|FG001|Overall Study|Study termination|25|||
170437508|NCT02308241|615939945|FG000|Overall Study|Withdrawal by Subject|3|||
170437509|NCT00659815|615939946|FG000|Overall Study|Study related symptoms and complaints|2|||
170437510|NCT00659815|615939947|FG001|Overall Study|Study related symptoms and complaints|1|||
170437511|NCT00659815|615939946|FG000|Overall Study|Inability to maintain wearing schedule|1|||
170437512|NCT00659815|615939947|FG001|Overall Study|Inability to maintain wearing schedule|2|||
170437513|NCT00659815|615939946|FG000|Overall Study|Withdrawal by Subject|1|||
170437514|NCT00659815|615939947|FG001|Overall Study|Withdrawal by Subject|1|||
170437515|NCT02313558|615939948|FG000|Overall Study|Withdrawal by Subject|2|||
170437516|NCT02313558|615939949|FG001|Overall Study|Withdrawal by Subject|0|||
170437517|NCT02313558|615939948|FG000|Overall Study|Lost to Follow-up|4|||
170437518|NCT02313558|615939949|FG001|Overall Study|Lost to Follow-up|4|||
170437519|NCT04165824|615939956|FG000|Overall Study|Adverse Event|23|||
170437520|NCT04165824|615939956|FG000|Overall Study|Physician Decision|1|||
170632992|NCT00998296|616668453|FG008|Overall Study|Progressive disease|0|||
170632993|NCT00998296|616668454|FG009|Overall Study|Progressive disease|14|||
170437521|NCT04165824|615939956|FG000|Overall Study|Withdrawal by Subject|17|||
170437522|NCT04165824|615939956|FG000|Overall Study|Other|5|||
170437523|NCT03292458|615939962|FG000|Period 1|Adverse Event|2|||
170437524|NCT03292458|615939963|FG001|Period 1|Adverse Event|0|||
170437525|NCT01513239|615939964|FG000|Period 1: Main Phase|Adverse Event|1|||
170437526|NCT01513239|615939965|FG001|Period 1: Main Phase|Adverse Event|1|||
170437527|NCT01513239|615939966|FG002|Period 1: Main Phase|Adverse Event|2|||
170437528|NCT01513239|615939967|FG003|Period 1: Main Phase|Adverse Event|0|||
170437529|NCT01513239|615939968|FG004|Period 1: Main Phase|Adverse Event|0|||
170437530|NCT01513239|615939969|FG005|Period 1: Main Phase|Adverse Event|0|||
170437531|NCT01513239|615939964|FG000|Period 1: Main Phase|Death|29|||
170437532|NCT01513239|615939965|FG001|Period 1: Main Phase|Death|22|||
170437533|NCT01513239|615939966|FG002|Period 1: Main Phase|Death|32|||
170437534|NCT01513239|615939967|FG003|Period 1: Main Phase|Death|0|||
170437535|NCT01513239|615939968|FG004|Period 1: Main Phase|Death|0|||
170437536|NCT01513239|615939969|FG005|Period 1: Main Phase|Death|0|||
170437537|NCT01513239|615939964|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
170437538|NCT01513239|615939965|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
170437539|NCT01513239|615939966|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
170437540|NCT01513239|615939967|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
170437541|NCT01513239|615939968|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
170437542|NCT01513239|615939969|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
170437543|NCT01513239|615939964|FG000|Period 1: Main Phase|Physician Decision|4|||
170437544|NCT01513239|615939965|FG001|Period 1: Main Phase|Physician Decision|4|||
170632994|NCT00998296|616668455|FG010|Overall Study|Progressive disease|5|||
170632995|NCT00998296|616668445|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
170632996|NCT00998296|616668446|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
170632997|NCT00998296|616668447|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
170882462|NCT00590590|617579548|FG001|Overall Study|Did not complete due to study closure|1|||
170437545|NCT01513239|615939966|FG002|Period 1: Main Phase|Physician Decision|4|||
170437546|NCT01513239|615939967|FG003|Period 1: Main Phase|Physician Decision|0|||
170437547|NCT01513239|615939968|FG004|Period 1: Main Phase|Physician Decision|0|||
170437548|NCT01513239|615939969|FG005|Period 1: Main Phase|Physician Decision|0|||
170437549|NCT01513239|615939964|FG000|Period 1: Main Phase|Protocol Violation|2|||
170437550|NCT01513239|615939965|FG001|Period 1: Main Phase|Protocol Violation|2|||
170437551|NCT01513239|615939966|FG002|Period 1: Main Phase|Protocol Violation|2|||
170437552|NCT01513239|615939967|FG003|Period 1: Main Phase|Protocol Violation|0|||
170882463|NCT00590590|617579549|FG002|Overall Study|Did not complete due to study closure|1|||
170437553|NCT01513239|615939968|FG004|Period 1: Main Phase|Protocol Violation|0|||
170437554|NCT01513239|615939969|FG005|Period 1: Main Phase|Protocol Violation|0|||
170437555|NCT01513239|615939964|FG000|Period 1: Main Phase|Technical Problems|1|||
170437556|NCT01513239|615939965|FG001|Period 1: Main Phase|Technical Problems|2|||
170437557|NCT01513239|615939966|FG002|Period 1: Main Phase|Technical Problems|0|||
170437558|NCT01513239|615939967|FG003|Period 1: Main Phase|Technical Problems|0|||
170437559|NCT01513239|615939968|FG004|Period 1: Main Phase|Technical Problems|0|||
170437560|NCT01513239|615939969|FG005|Period 1: Main Phase|Technical Problems|0|||
170437561|NCT01513239|615939964|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
170632998|NCT00998296|616668448|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
170437562|NCT01513239|615939965|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
170437563|NCT01513239|615939966|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
170437564|NCT01513239|615939967|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
170437565|NCT01513239|615939968|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
170437566|NCT01513239|615939969|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
170437567|NCT01513239|615939964|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
170437568|NCT01513239|615939965|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
170437569|NCT01513239|615939966|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
170437570|NCT01513239|615939967|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
170437571|NCT01513239|615939968|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
170437572|NCT01513239|615939969|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
170437573|NCT01513239|615939964|FG000|Period 2: 9 Month Extension Phase|Death|0|||
170437574|NCT01513239|615939965|FG001|Period 2: 9 Month Extension Phase|Death|0|||
170437575|NCT01513239|615939966|FG002|Period 2: 9 Month Extension Phase|Death|0|||
170437576|NCT01513239|615939967|FG003|Period 2: 9 Month Extension Phase|Death|2|||
170437577|NCT01513239|615939968|FG004|Period 2: 9 Month Extension Phase|Death|5|||
170437578|NCT01513239|615939969|FG005|Period 2: 9 Month Extension Phase|Death|2|||
170437579|NCT01513239|615939964|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
170437580|NCT01513239|615939965|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
170437581|NCT01513239|615939966|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
170437582|NCT01513239|615939967|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
170437583|NCT01513239|615939968|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
170437584|NCT01513239|615939969|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
170437585|NCT01513239|615939964|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
170437586|NCT01513239|615939965|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
170437587|NCT01513239|615939966|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
170437588|NCT01513239|615939967|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
170437589|NCT01513239|615939968|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
170437590|NCT01513239|615939969|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
170437591|NCT01513239|615939964|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
170437592|NCT01513239|615939965|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
170437593|NCT01513239|615939966|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
170437594|NCT01513239|615939967|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
170437595|NCT01513239|615939968|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
170437596|NCT01513239|615939969|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
170437597|NCT01911429|615939970|FG000|Overall Study|Adverse Event|5|||
170437598|NCT01911429|615939971|FG001|Overall Study|Adverse Event|3|||
170437599|NCT01911429|615939972|FG002|Overall Study|Adverse Event|9|||
170437600|NCT01911429|615939970|FG000|Overall Study|Lack of Efficacy|1|||
170437601|NCT01911429|615939971|FG001|Overall Study|Lack of Efficacy|2|||
170437602|NCT01911429|615939972|FG002|Overall Study|Lack of Efficacy|4|||
170437603|NCT01911429|615939970|FG000|Overall Study|Lost to Follow-up|0|||
170437604|NCT01911429|615939971|FG001|Overall Study|Lost to Follow-up|0|||
170437605|NCT01911429|615939972|FG002|Overall Study|Lost to Follow-up|1|||
170437606|NCT01911429|615939970|FG000|Overall Study|Protocol Violation|0|||
170437607|NCT01911429|615939971|FG001|Overall Study|Protocol Violation|0|||
170437608|NCT01911429|615939972|FG002|Overall Study|Protocol Violation|1|||
170437609|NCT01911429|615939970|FG000|Overall Study|Withdrawal by Subject|5|||
170437610|NCT01911429|615939971|FG001|Overall Study|Withdrawal by Subject|5|||
170437611|NCT01911429|615939972|FG002|Overall Study|Withdrawal by Subject|4|||
170781419|NCT03338816|617207295|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
170781420|NCT03338816|617207296|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
170781421|NCT03338816|617207297|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
170781422|NCT03338816|617207298|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
170781423|NCT03338816|617207295|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
170781424|NCT03338816|617207296|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
170781425|NCT03338816|617207297|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
170781426|NCT03338816|617207298|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
170437612|NCT01911429|615939970|FG000|Overall Study|Accidental randomization|0|||
170437613|NCT01911429|615939971|FG001|Overall Study|Accidental randomization|0|||
170437614|NCT01911429|615939972|FG002|Overall Study|Accidental randomization|1|||
170437615|NCT01911429|615939970|FG000|Overall Study|subject left study|1|||
170437616|NCT01911429|615939971|FG001|Overall Study|subject left study|0|||
170437617|NCT01911429|615939972|FG002|Overall Study|subject left study|0|||
170781427|NCT03338816|617207295|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
170781428|NCT03338816|617207296|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
170437618|NCT03837626|615939973|FG000|Overall Study|Adverse Event|3|||
170437619|NCT03837626|615939974|FG001|Overall Study|Adverse Event|3|||
170437620|NCT03837626|615939973|FG000|Overall Study|Withdrawal by Subject|2|||
170437621|NCT03837626|615939974|FG001|Overall Study|Withdrawal by Subject|4|||
170437622|NCT03837626|615939973|FG000|Overall Study|Physician Decision|2|||
170437623|NCT03837626|615939974|FG001|Overall Study|Physician Decision|3|||
170437624|NCT03837626|615939973|FG000|Overall Study|Lost to Follow-up|3|||
170437625|NCT03837626|615939974|FG001|Overall Study|Lost to Follow-up|1|||
170437626|NCT02704091|615939976|FG000|Overall Study|Adverse Event|4|||
170437627|NCT02704091|615939977|FG001|Overall Study|Adverse Event|3|||
170437628|NCT02704091|615939976|FG000|Overall Study|Protocol Violation|5|||
170437629|NCT02704091|615939977|FG001|Overall Study|Protocol Violation|3|||
170437630|NCT02704091|615939976|FG000|Overall Study|Consent withdrawn|4|||
170437631|NCT02704091|615939977|FG001|Overall Study|Consent withdrawn|4|||
170437632|NCT02704091|615939976|FG000|Overall Study|Lost to Follow-up|13|||
170437633|NCT02704091|615939977|FG001|Overall Study|Lost to Follow-up|5|||
170437634|NCT02704091|615939976|FG000|Overall Study|Other|2|||
170437635|NCT02704091|615939977|FG001|Overall Study|Other|8|||
170437636|NCT02627963|615939985|FG000|Overall Study|Randomized but not treated|2|||
170437637|NCT02627963|615939986|FG001|Overall Study|Randomized but not treated|6|||
170437638|NCT00958724|615939987|FG000|Overall Study|Disease Progression|6|||
170437639|NCT01168856|615939988|FG000|Overall Study|Lost to Follow-up|4|||
170437640|NCT01168856|615939989|FG001|Overall Study|Lost to Follow-up|34|||
170437641|NCT01168856|615939988|FG000|Overall Study|Withdrawal by Subject|6|||
170437642|NCT01168856|615939989|FG001|Overall Study|Withdrawal by Subject|8|||
170437643|NCT01168856|615939988|FG000|Overall Study|Physician Decision|2|||
170437644|NCT01168856|615939989|FG001|Overall Study|Physician Decision|1|||
170437645|NCT01168856|615939988|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
170437646|NCT01168856|615939989|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
170437647|NCT01168856|615939988|FG000|Overall Study|Participant received anti-HCV treatment|1|||
170437648|NCT01168856|615939989|FG001|Overall Study|Participant received anti-HCV treatment|0|||
170437649|NCT01168856|615939988|FG000|Overall Study|Death|0|||
170437650|NCT01168856|615939989|FG001|Overall Study|Death|2|||
170437651|NCT01168856|615939988|FG000|Overall Study|Other|1|||
170437652|NCT01168856|615939989|FG001|Overall Study|Other|291|||
170437653|NCT01168856|615939988|FG000|Overall Study|Protocol Violation|4|||
170437654|NCT01168856|615939989|FG001|Overall Study|Protocol Violation|6|||
170437655|NCT04442503|615939990|FG000|Overall Study|Adverse Event|1|||
170437656|NCT04442503|615939991|FG001|Overall Study|Adverse Event|1|||
170437657|NCT04442503|615939990|FG000|Overall Study|Lost to Follow-up|8|||
170437658|NCT04442503|615939991|FG001|Overall Study|Lost to Follow-up|6|||
170437659|NCT04442503|615939990|FG000|Overall Study|Physician Decision|0|||
170437660|NCT04442503|615939991|FG001|Overall Study|Physician Decision|2|||
170437661|NCT04442503|615939990|FG000|Overall Study|Withdrawal by Subject|3|||
170437662|NCT04442503|615939991|FG001|Overall Study|Withdrawal by Subject|4|||
170437663|NCT04442503|615939990|FG000|Overall Study|Reason not Specified|0|||
170437664|NCT04442503|615939991|FG001|Overall Study|Reason not Specified|1|||
170437665|NCT04442503|615939990|FG000|Overall Study|Randomized but not Treated|3|||
170437666|NCT04442503|615939991|FG001|Overall Study|Randomized but not Treated|1|||
170437667|NCT05562011|615940002|FG000|Overall Study|Withdrawal by Subject|3|||
170437668|NCT05562011|615940002|FG000|Overall Study|Lost to Follow-up|1|||
170437669|NCT05562011|615940002|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
170437670|NCT05562011|615940002|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
170437671|NCT05562011|615940002|FG000|Overall Study|Device malfunction|13|||
170437672|NCT02933060|615940003|FG000|Overall Study|Withdrawal by Subject|0|||
170437673|NCT02933060|615940004|FG001|Overall Study|Withdrawal by Subject|1|||
170437674|NCT04411680|615940005|FG000|Treatment Period|Adverse Event|3|||
170437675|NCT04411680|615940006|FG001|Treatment Period|Adverse Event|0|||
170437676|NCT04411680|615940005|FG000|Treatment Period|Discharged from hospital|18|||
170437677|NCT04411680|615940006|FG001|Treatment Period|Discharged from hospital|7|||
170437678|NCT04411680|615940005|FG000|Treatment Period|Missed 1 or more doses|8|||
170437679|NCT04411680|615940006|FG001|Treatment Period|Missed 1 or more doses|0|||
170437680|NCT04411680|615940005|FG000|Treatment Period|Transferred to another hospital|0|||
170437681|NCT04411680|615940006|FG001|Treatment Period|Transferred to another hospital|1|||
170437682|NCT04411680|615940005|FG000|Follow up Period|Withdrawal by Subject|2|||
170437683|NCT04411680|615940006|FG001|Follow up Period|Withdrawal by Subject|0|||
170437684|NCT04411680|615940005|FG000|Follow up Period|Lost to Follow-up|5|||
170437685|NCT04411680|615940006|FG001|Follow up Period|Lost to Follow-up|6|||
170437686|NCT04411680|615940005|FG000|Follow up Period|Death|11|||
170437687|NCT04411680|615940006|FG001|Follow up Period|Death|8|||
170437688|NCT00881751|615940007|FG000|Overall Study|Physician Decision|0|||
170437689|NCT00881751|615940008|FG001|Overall Study|Physician Decision|1|||
170437690|NCT00881751|615940007|FG000|Overall Study|Adverse Event|0|||
170437691|NCT00881751|615940008|FG001|Overall Study|Adverse Event|2|||
170437692|NCT00881751|615940007|FG000|Overall Study|Withdrawal by Subject|0|||
170437693|NCT00881751|615940008|FG001|Overall Study|Withdrawal by Subject|2|||
170437694|NCT00301964|615940009|FG000|Overall Study|Second primary|2|||
170437695|NCT00301964|615940009|FG000|Overall Study|Wrong primary|1|||
170437696|NCT00301964|615940009|FG000|Overall Study|Inadequate pathology|1|||
170437697|NCT03504085|615940010|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
170437698|NCT03504085|615940011|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
170437699|NCT03504085|615940010|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
170437700|NCT03504085|615940011|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
170437701|NCT02761915|615940012|FG000|Overall Study|Death|3|||
170437702|NCT02761915|615940013|FG001|Overall Study|Death|1|||
170437703|NCT02761915|615940014|FG002|Overall Study|Death|1|||
170437704|NCT02761915|615940015|FG003|Overall Study|Death|1|||
170437705|NCT02761915|615940016|FG004|Overall Study|Death|0|||
170437706|NCT02761915|615940017|FG005|Overall Study|Death|1|||
170437707|NCT02761915|615940012|FG000|Overall Study|Withdrawal by Subject|1|||
170437708|NCT02761915|615940013|FG001|Overall Study|Withdrawal by Subject|0|||
170437709|NCT02761915|615940014|FG002|Overall Study|Withdrawal by Subject|0|||
170437710|NCT02761915|615940015|FG003|Overall Study|Withdrawal by Subject|0|||
170437711|NCT02761915|615940016|FG004|Overall Study|Withdrawal by Subject|1|||
170437712|NCT02761915|615940017|FG005|Overall Study|Withdrawal by Subject|2|||
170437713|NCT02761915|615940012|FG000|Overall Study|Disease Progression|0|||
170437714|NCT02761915|615940013|FG001|Overall Study|Disease Progression|0|||
170437715|NCT02761915|615940014|FG002|Overall Study|Disease Progression|0|||
170437716|NCT02761915|615940015|FG003|Overall Study|Disease Progression|2|||
170437717|NCT02761915|615940016|FG004|Overall Study|Disease Progression|2|||
170437718|NCT02761915|615940017|FG005|Overall Study|Disease Progression|2|||
170437719|NCT01926119|615940024|FG000|Overall Study|Withdrawal by Subject|1|||
170437720|NCT00819169|615940027|FG000|Overall Study|Withdrawal by Subject|2|||
170437721|NCT00819169|615940028|FG001|Overall Study|Withdrawal by Subject|0|||
170437722|NCT00819169|615940029|FG002|Overall Study|Withdrawal by Subject|0|||
170437723|NCT00819169|615940030|FG003|Overall Study|Withdrawal by Subject|1|||
170437724|NCT00819169|615940031|FG004|Overall Study|Withdrawal by Subject|1|||
170437725|NCT00819169|615940032|FG005|Overall Study|Withdrawal by Subject|1|||
170437726|NCT00819169|615940033|FG006|Overall Study|Withdrawal by Subject|5|||
170437727|NCT00819169|615940034|FG007|Overall Study|Withdrawal by Subject|1|||
170437728|NCT00819169|615940035|FG008|Overall Study|Withdrawal by Subject|4|||
170437729|NCT00819169|615940027|FG000|Overall Study|Lost to Follow-up|0|||
170437730|NCT00819169|615940028|FG001|Overall Study|Lost to Follow-up|2|||
170437731|NCT00819169|615940029|FG002|Overall Study|Lost to Follow-up|0|||
170437732|NCT00819169|615940030|FG003|Overall Study|Lost to Follow-up|1|||
170437733|NCT00819169|615940031|FG004|Overall Study|Lost to Follow-up|0|||
170437734|NCT00819169|615940032|FG005|Overall Study|Lost to Follow-up|6|||
170437735|NCT00819169|615940033|FG006|Overall Study|Lost to Follow-up|2|||
170437736|NCT00819169|615940034|FG007|Overall Study|Lost to Follow-up|2|||
170437737|NCT00819169|615940035|FG008|Overall Study|Lost to Follow-up|1|||
170437738|NCT00819169|615940027|FG000|Overall Study|Death|1|||
170437739|NCT00819169|615940028|FG001|Overall Study|Death|1|||
170437740|NCT00819169|615940029|FG002|Overall Study|Death|3|||
170437741|NCT00819169|615940030|FG003|Overall Study|Death|8|||
170437742|NCT00819169|615940031|FG004|Overall Study|Death|5|||
170437743|NCT00819169|615940032|FG005|Overall Study|Death|7|||
170437744|NCT00819169|615940033|FG006|Overall Study|Death|9|||
170437745|NCT00819169|615940034|FG007|Overall Study|Death|4|||
170437746|NCT00819169|615940035|FG008|Overall Study|Death|7|||
170437747|NCT00819169|615940027|FG000|Overall Study|Ineligibility determined|0|||
170437748|NCT00819169|615940028|FG001|Overall Study|Ineligibility determined|0|||
170437749|NCT00819169|615940029|FG002|Overall Study|Ineligibility determined|0|||
170437750|NCT00819169|615940030|FG003|Overall Study|Ineligibility determined|2|||
170437751|NCT00819169|615940031|FG004|Overall Study|Ineligibility determined|0|||
170437752|NCT00819169|615940032|FG005|Overall Study|Ineligibility determined|0|||
170437753|NCT00819169|615940033|FG006|Overall Study|Ineligibility determined|0|||
170437754|NCT00819169|615940034|FG007|Overall Study|Ineligibility determined|0|||
170437755|NCT00819169|615940035|FG008|Overall Study|Ineligibility determined|1|||
170437756|NCT00819169|615940027|FG000|Overall Study|Adverse Event|0|||
170437757|NCT00819169|615940028|FG001|Overall Study|Adverse Event|0|||
170437758|NCT00819169|615940029|FG002|Overall Study|Adverse Event|0|||
170437759|NCT00819169|615940030|FG003|Overall Study|Adverse Event|0|||
170437760|NCT00819169|615940031|FG004|Overall Study|Adverse Event|1|||
170437761|NCT00819169|615940032|FG005|Overall Study|Adverse Event|0|||
170437762|NCT00819169|615940033|FG006|Overall Study|Adverse Event|0|||
170437763|NCT00819169|615940034|FG007|Overall Study|Adverse Event|0|||
170437764|NCT00819169|615940035|FG008|Overall Study|Adverse Event|0|||
170437765|NCT00819169|615940027|FG000|Overall Study|Administrative Decision|0|||
170437766|NCT00819169|615940028|FG001|Overall Study|Administrative Decision|0|||
170437767|NCT00819169|615940029|FG002|Overall Study|Administrative Decision|0|||
170437768|NCT00819169|615940030|FG003|Overall Study|Administrative Decision|0|||
170437769|NCT00819169|615940031|FG004|Overall Study|Administrative Decision|1|||
170437770|NCT00819169|615940032|FG005|Overall Study|Administrative Decision|2|||
170437771|NCT00819169|615940033|FG006|Overall Study|Administrative Decision|0|||
170437772|NCT00819169|615940034|FG007|Overall Study|Administrative Decision|2|||
170437773|NCT00819169|615940035|FG008|Overall Study|Administrative Decision|0|||
170437774|NCT02637141|615940039|FG000|Overall Study|Adverse Event|1|||
170437775|NCT02637141|615940040|FG001|Overall Study|Adverse Event|1|||
170537111|NCT04044690|616311535|FG001|Period 1|Protocol Deviation|0|||
170537112|NCT04044690|616311534|FG000|Period 1|Site Terminated by Sponsor|0|||
170537113|NCT04044690|616311535|FG001|Period 1|Site Terminated by Sponsor|1|||
170437776|NCT02637141|615940041|FG002|Overall Study|Adverse Event|0|||
170437777|NCT02637141|615940039|FG000|Overall Study|Withdrawal by Subject|1|||
170632999|NCT00998296|616668449|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
170633000|NCT00998296|616668450|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
170633001|NCT00998296|616668451|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
170633002|NCT00998296|616668452|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
170633003|NCT00998296|616668453|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
170633004|NCT00998296|616668454|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
170633005|NCT00998296|616668455|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
170633006|NCT00998296|616668445|FG000|Overall Study|Other adverse event|0|||
170633007|NCT00998296|616668446|FG001|Overall Study|Other adverse event|0|||
170633008|NCT00998296|616668447|FG002|Overall Study|Other adverse event|0|||
170633009|NCT00998296|616668448|FG003|Overall Study|Other adverse event|0|||
170633010|NCT00998296|616668449|FG004|Overall Study|Other adverse event|1|||
170437778|NCT02637141|615940040|FG001|Overall Study|Withdrawal by Subject|1|||
170437779|NCT02637141|615940041|FG002|Overall Study|Withdrawal by Subject|1|||
170437780|NCT03885934|615940044|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
170437781|NCT03885934|615940045|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
170437782|NCT03885934|615940046|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
170437783|NCT03885934|615940047|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
170437784|NCT03885934|615940048|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
170437785|NCT03885934|615940049|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
170437786|NCT00406393|615940050|FG000|Overall Study|Did not undergo transplantation|2|||
170437787|NCT00406393|615940051|FG001|Overall Study|Did not undergo transplantation|1|||
170437788|NCT02705716|615940052|FG000|Overall Study|Adverse Event|0|||
170437789|NCT02705716|615940053|FG001|Overall Study|Adverse Event|1|||
170437790|NCT02705716|615940052|FG000|Overall Study|Protocol Violation|3|||
170437791|NCT02705716|615940053|FG001|Overall Study|Protocol Violation|0|||
170437792|NCT02705716|615940052|FG000|Overall Study|Withdrawal of Consent|1|||
170437793|NCT02705716|615940053|FG001|Overall Study|Withdrawal of Consent|1|||
170437794|NCT01868243|615940054|FG000|Overall Study|Death|0|||
170437795|NCT01868243|615940055|FG001|Overall Study|Death|1|||
170437796|NCT02096705|615940056|FG000|Treatment|Adverse Event|6|||
170437797|NCT02096705|615940057|FG001|Treatment|Adverse Event|3|||
170437798|NCT02096705|615940056|FG000|Treatment|Subject request to discontinue treatment|1|||
170437799|NCT02096705|615940057|FG001|Treatment|Subject request to discontinue treatment|1|||
170437800|NCT02096705|615940056|FG000|Treatment|Withdrawal by Subject|1|||
170437801|NCT02096705|615940057|FG001|Treatment|Withdrawal by Subject|0|||
170437802|NCT02096705|615940056|FG000|Treatment|Other|1|||
170437803|NCT02096705|615940057|FG001|Treatment|Other|1|||
170437804|NCT02096705|615940056|FG000|Follow-up|Withdrawal by Subject|1|||
170437805|NCT02096705|615940057|FG001|Follow-up|Withdrawal by Subject|0|||
170633011|NCT00998296|616668450|FG005|Overall Study|Other adverse event|0|||
170633012|NCT00998296|616668451|FG006|Overall Study|Other adverse event|0|||
170633013|NCT00998296|616668452|FG007|Overall Study|Other adverse event|0|||
170633014|NCT00998296|616668453|FG008|Overall Study|Other adverse event|0|||
170633015|NCT00998296|616668454|FG009|Overall Study|Other adverse event|1|||
170633016|NCT00998296|616668455|FG010|Overall Study|Other adverse event|2|||
170633017|NCT00998296|616668445|FG000|Overall Study|Refused to continue taking trial med.|0|||
170633018|NCT00998296|616668446|FG001|Overall Study|Refused to continue taking trial med.|0|||
170633019|NCT00998296|616668447|FG002|Overall Study|Refused to continue taking trial med.|0|||
170633020|NCT00998296|616668448|FG003|Overall Study|Refused to continue taking trial med.|0|||
170633021|NCT00998296|616668449|FG004|Overall Study|Refused to continue taking trial med.|0|||
170633022|NCT00998296|616668450|FG005|Overall Study|Refused to continue taking trial med.|0|||
170633023|NCT00998296|616668451|FG006|Overall Study|Refused to continue taking trial med.|0|||
170633024|NCT00998296|616668452|FG007|Overall Study|Refused to continue taking trial med.|0|||
170633025|NCT00998296|616668453|FG008|Overall Study|Refused to continue taking trial med.|0|||
170633026|NCT00998296|616668454|FG009|Overall Study|Refused to continue taking trial med.|2|||
170633027|NCT00998296|616668455|FG010|Overall Study|Refused to continue taking trial med.|0|||
170633028|NCT00998296|616668445|FG000|Overall Study|Reason other than those specified above|0|||
170633029|NCT00998296|616668446|FG001|Overall Study|Reason other than those specified above|0|||
170633030|NCT00998296|616668447|FG002|Overall Study|Reason other than those specified above|0|||
170633031|NCT00998296|616668448|FG003|Overall Study|Reason other than those specified above|0|||
170437806|NCT02096705|615940056|FG000|Follow-up|Adverse Event|2|||
170437807|NCT02096705|615940057|FG001|Follow-up|Adverse Event|2|||
170437808|NCT02096705|615940056|FG000|Follow-up|Subjects not reporting status|1|||
170437809|NCT02096705|615940057|FG001|Follow-up|Subjects not reporting status|2|||
170437810|NCT02905435|615940058|FG000|Overall Study|Death|2|||
170437811|NCT02905435|615940058|FG000|Overall Study|Physician Decision|1|||
170437812|NCT02905435|615940058|FG000|Overall Study|Lost to Follow-up|4|||
170437813|NCT02377349|615940062|FG000|Overall Study|Serious Adverse Event|1|||
170437814|NCT02377349|615940063|FG001|Overall Study|Serious Adverse Event|0|||
170437815|NCT02377349|615940062|FG000|Overall Study|Protocol Violation|3|||
170437816|NCT02377349|615940063|FG001|Overall Study|Protocol Violation|2|||
170781429|NCT03338816|617207297|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
170781430|NCT03338816|617207298|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
170781431|NCT03338816|617207295|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
170781432|NCT03338816|617207296|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
170781433|NCT03338816|617207297|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
170781434|NCT03338816|617207298|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
170781435|NCT01948661|617207299|FG000|Overall Study|Withdrawal by Subject|2|||
170781436|NCT01948661|617207300|FG001|Overall Study|Withdrawal by Subject|4|||
170781437|NCT01127373|617207301|FG000|Overall Study|Not Treated|3|||
170781438|NCT01127373|617207301|FG000|Overall Study|Lost to Follow-up|7|||
170781439|NCT01127373|617207301|FG000|Overall Study|Withdrawal by Subject|1|||
170781440|NCT01127373|617207301|FG000|Overall Study|Disease progression|1|||
170781441|NCT04757610|617207304|FG000|Overall Study|Adverse Event|13|||
170882464|NCT00590590|617579547|FG000|Overall Study|Did not complete study|0|||
170882465|NCT00590590|617579548|FG001|Overall Study|Did not complete study|1|||
170882466|NCT00590590|617579549|FG002|Overall Study|Did not complete study|0|||
170882467|NCT02684981|617579551|FG000|Overall Study|Permanently discontinued the treatment|157|||
170882468|NCT02684981|617579552|FG001|Overall Study|Permanently discontinued the treatment|161|||
170882469|NCT02684981|617579553|FG002|Overall Study|Permanently discontinued the treatment|110|||
170882470|NCT02684981|617579551|FG000|Overall Study|Other|83|||
170882471|NCT02684981|617579552|FG001|Overall Study|Other|49|||
170882472|NCT02684981|617579553|FG002|Overall Study|Other|17|||
170882473|NCT00356278|617579558|FG000|Overall Study|Withdrawal by Subject|25|||
170882474|NCT00356278|617579559|FG001|Overall Study|Withdrawal by Subject|15|||
170882475|NCT00356278|617579560|FG002|Overall Study|Withdrawal by Subject|19|||
170882476|NCT03189446|617579561|FG000|Overall Study|Adverse Event|2|||
170882477|NCT03189446|617579561|FG000|Overall Study|Withdrawal by Subject|2|||
170882478|NCT03189446|617579561|FG000|Overall Study|Physician Decision|1|||
170882479|NCT00647556|617579562|FG000|Overall Study|Adverse Event|0|||
170882480|NCT00647556|617579563|FG001|Overall Study|Adverse Event|1|||
170882481|NCT00647556|617579562|FG000|Overall Study|Lost to Follow-up|1|||
170882482|NCT00647556|617579563|FG001|Overall Study|Lost to Follow-up|0|||
170882483|NCT00647556|617579562|FG000|Overall Study|Protocol Violation|0|||
170882484|NCT00647556|617579563|FG001|Overall Study|Protocol Violation|1|||
170882485|NCT00647556|617579562|FG000|Overall Study|Withdrawal by Subject|1|||
170882486|NCT00647556|617579563|FG001|Overall Study|Withdrawal by Subject|0|||
170882487|NCT00647556|617579562|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
170882488|NCT00647556|617579563|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
170882489|NCT00883337|617579564|FG000|Core Treatment Period|Adverse Event|9|||
170882490|NCT00883337|617579565|FG001|Core Treatment Period|Adverse Event|12|||
170882491|NCT00883337|617579566|FG002|Core Treatment Period|Adverse Event|22|||
170882492|NCT00883337|617579564|FG000|Core Treatment Period|Lack of Efficacy|7|||
170882493|NCT00883337|617579565|FG001|Core Treatment Period|Lack of Efficacy|4|||
170882494|NCT00883337|617579566|FG002|Core Treatment Period|Lack of Efficacy|2|||
170882495|NCT00883337|617579564|FG000|Core Treatment Period|Lost to Follow-up|1|||
170882496|NCT00883337|617579565|FG001|Core Treatment Period|Lost to Follow-up|1|||
170882497|NCT00883337|617579566|FG002|Core Treatment Period|Lost to Follow-up|0|||
170882498|NCT00883337|617579564|FG000|Core Treatment Period|Withdrawal by Subject|2|||
170882499|NCT00883337|617579565|FG001|Core Treatment Period|Withdrawal by Subject|2|||
170781442|NCT04757610|617207305|FG001|Overall Study|Adverse Event|10|||
170781443|NCT04757610|617207306|FG002|Overall Study|Adverse Event|5|||
170781444|NCT04757610|617207304|FG000|Overall Study|Death|5|||
170781445|NCT04757610|617207305|FG001|Overall Study|Death|13|||
170781446|NCT04757610|617207306|FG002|Overall Study|Death|8|||
170781447|NCT04757610|617207304|FG000|Overall Study|Lack of Efficacy|1|||
170781448|NCT04757610|617207305|FG001|Overall Study|Lack of Efficacy|2|||
170781449|NCT04757610|617207306|FG002|Overall Study|Lack of Efficacy|3|||
170781450|NCT04757610|617207304|FG000|Overall Study|Lost to Follow-up|7|||
170781451|NCT04757610|617207305|FG001|Overall Study|Lost to Follow-up|2|||
170781452|NCT04757610|617207306|FG002|Overall Study|Lost to Follow-up|7|||
170781453|NCT04757610|617207304|FG000|Overall Study|Physician Decision|4|||
170781454|NCT04757610|617207305|FG001|Overall Study|Physician Decision|1|||
170781455|NCT04757610|617207306|FG002|Overall Study|Physician Decision|2|||
170781456|NCT04757610|617207304|FG000|Overall Study|Withdrawal by Subject|26|||
170781457|NCT04757610|617207305|FG001|Overall Study|Withdrawal by Subject|25|||
170781458|NCT04757610|617207306|FG002|Overall Study|Withdrawal by Subject|25|||
170781459|NCT04757610|617207304|FG000|Overall Study|Study Terminated by Sponsor|105|||
170781460|NCT04757610|617207305|FG001|Overall Study|Study Terminated by Sponsor|105|||
170781461|NCT04757610|617207306|FG002|Overall Study|Study Terminated by Sponsor|110|||
170781462|NCT04757610|617207304|FG000|Overall Study|Randomized in Error|1|||
170781463|NCT04757610|617207305|FG001|Overall Study|Randomized in Error|0|||
170781464|NCT04757610|617207306|FG002|Overall Study|Randomized in Error|0|||
170781465|NCT02965846|617207307|FG000|Overall Study|Lost to Follow-up|1|||
170781466|NCT02965846|617207308|FG001|Overall Study|Lost to Follow-up|0|||
170781467|NCT02965846|617207309|FG002|Overall Study|Lost to Follow-up|0|||
170781468|NCT02965846|617207307|FG000|Overall Study|Withdrawal by Subject|0|||
170781469|NCT02965846|617207308|FG001|Overall Study|Withdrawal by Subject|1|||
170781470|NCT02965846|617207309|FG002|Overall Study|Withdrawal by Subject|0|||
170882500|NCT00883337|617579566|FG002|Core Treatment Period|Withdrawal by Subject|6|||
170882501|NCT00883337|617579564|FG000|Core Treatment Period|Wish to be pregnant|1|||
170882502|NCT00883337|617579565|FG001|Core Treatment Period|Wish to be pregnant|2|||
170882503|NCT00883337|617579566|FG002|Core Treatment Period|Wish to be pregnant|1|||
170882504|NCT00883337|617579564|FG000|Core Treatment Period|Poor compliance to protocol|0|||
170781471|NCT02965846|617207307|FG000|Overall Study|Study Terminated By Sponsor|4|||
170781472|NCT02965846|617207308|FG001|Overall Study|Study Terminated By Sponsor|4|||
170781473|NCT02965846|617207309|FG002|Overall Study|Study Terminated By Sponsor|0|||
170882505|NCT00883337|617579565|FG001|Core Treatment Period|Poor compliance to protocol|0|||
170882506|NCT00883337|617579566|FG002|Core Treatment Period|Poor compliance to protocol|1|||
170882507|NCT00883337|617579564|FG000|Core Treatment Period|Other than above|0|||
170882508|NCT00883337|617579565|FG001|Core Treatment Period|Other than above|1|||
170437817|NCT02377349|615940062|FG000|Overall Study|Withdrawal by Subject|5|||
170437818|NCT02377349|615940063|FG001|Overall Study|Withdrawal by Subject|3|||
170437819|NCT02377349|615940062|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
170437820|NCT02377349|615940063|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
170437821|NCT02377349|615940062|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
170437822|NCT02377349|615940063|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
170437823|NCT02377349|615940062|FG000|Overall Study|Other|0|||
170437824|NCT02377349|615940063|FG001|Overall Study|Other|1|||
170437825|NCT01507662|615940068|FG000|Overall Study|Death|26|||
170437826|NCT01507662|615940069|FG001|Overall Study|Death|18|||
170437827|NCT01507662|615940068|FG000|Overall Study|Withdrawal by Subject|290|||
170437828|NCT01507662|615940069|FG001|Overall Study|Withdrawal by Subject|287|||
170437829|NCT01507662|615940068|FG000|Overall Study|Lost to Follow-up|498|||
170437830|NCT01507662|615940069|FG001|Overall Study|Lost to Follow-up|523|||
170437831|NCT01507662|615940068|FG000|Overall Study|Proxy interview done|2|||
170437832|NCT01507662|615940069|FG001|Overall Study|Proxy interview done|3|||
170437833|NCT00840879|615940072|FG000|Second Intervention|Withdrawal by Subject|1|||
170437834|NCT00840879|615940073|FG001|Second Intervention|Withdrawal by Subject|0|||
170437835|NCT04236596|615940074|FG000|Overall Study|Withdrawal by Subject|1|||
170437836|NCT04236596|615940074|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
170437837|NCT04236596|615940074|FG000|Overall Study|Participants did not receive implant at all|4|||
170437838|NCT01404988|615940077|FG000|Overall Study|Death|2|||
170537114|NCT04044690|616311534|FG000|Period 1|Study Terminated by Sponsor|0|||
170781474|NCT02965846|617207307|FG000|Overall Study|Participants not randomized|0|||
170781475|NCT02965846|617207308|FG001|Overall Study|Participants not randomized|0|||
170781476|NCT02965846|617207309|FG002|Overall Study|Participants not randomized|33|||
170781477|NCT03767517|617207310|FG000|Overall Study|Lost to Follow-up|16|||
170781478|NCT03767517|617207311|FG001|Overall Study|Lost to Follow-up|10|||
170781479|NCT03767517|617207310|FG000|Overall Study|Death|2|||
170781480|NCT03767517|617207311|FG001|Overall Study|Death|3|||
170781481|NCT01938547|617209180|FG000|Overall Study|Physician Decision|1|||
170781482|NCT05320432|617209181|FG000|Overall Study|Withdrawal by Subject|0|||
170781483|NCT05320432|617209182|FG001|Overall Study|Withdrawal by Subject|2|||
170781484|NCT04823611|617209183|FG000|Overall Study|Adverse Event|2|||
170437839|NCT01404988|615940078|FG001|Overall Study|Death|0|||
170437840|NCT01404988|615940079|FG002|Overall Study|Death|2|||
170437841|NCT01404988|615940077|FG000|Overall Study|Adverse Event|1|||
170437842|NCT01404988|615940078|FG001|Overall Study|Adverse Event|0|||
170437843|NCT01404988|615940079|FG002|Overall Study|Adverse Event|0|||
170437844|NCT01404988|615940077|FG000|Overall Study|Withdrawal by Subject|2|||
170437845|NCT01404988|615940078|FG001|Overall Study|Withdrawal by Subject|2|||
170437846|NCT01404988|615940079|FG002|Overall Study|Withdrawal by Subject|0|||
170437847|NCT01404988|615940077|FG000|Overall Study|Lost to Follow-up|1|||
170537115|NCT04044690|616311535|FG001|Period 1|Study Terminated by Sponsor|1|||
170781485|NCT04823611|617209184|FG001|Overall Study|Adverse Event|0|||
170781486|NCT04823611|617209185|FG002|Overall Study|Adverse Event|1|||
170781487|NCT04823611|617209186|FG003|Overall Study|Adverse Event|0|||
170781488|NCT04823611|617209187|FG004|Overall Study|Adverse Event|0|||
170781489|NCT04823611|617209188|FG005|Overall Study|Adverse Event|0|||
170781490|NCT04823611|617209189|FG006|Overall Study|Adverse Event|0|||
170781491|NCT03484702|617209192|FG000|Treatment Period|Death|3|||
170781492|NCT03484702|617209193|FG001|Treatment Period|Death|1|||
170781493|NCT03484702|617209194|FG002|Treatment Period|Death|0|||
170781494|NCT03484702|617209195|FG003|Treatment Period|Death|0|||
170781495|NCT03484702|617209196|FG004|Treatment Period|Death|0|||
170781496|NCT03484702|617209197|FG005|Treatment Period|Death|0|||
170781497|NCT03484702|617209192|FG000|Treatment Period|Adverse Event|1|||
170781498|NCT03484702|617209193|FG001|Treatment Period|Adverse Event|0|||
170781499|NCT03484702|617209194|FG002|Treatment Period|Adverse Event|0|||
170781500|NCT03484702|617209195|FG003|Treatment Period|Adverse Event|0|||
170781501|NCT03484702|617209196|FG004|Treatment Period|Adverse Event|0|||
170781502|NCT03484702|617209197|FG005|Treatment Period|Adverse Event|0|||
170781503|NCT03484702|617209192|FG000|Treatment Period|Participant Withdrew from Study|0|||
170781504|NCT03484702|617209193|FG001|Treatment Period|Participant Withdrew from Study|1|||
170781505|NCT03484702|617209194|FG002|Treatment Period|Participant Withdrew from Study|0|||
170781506|NCT03484702|617209195|FG003|Treatment Period|Participant Withdrew from Study|0|||
170781507|NCT03484702|617209196|FG004|Treatment Period|Participant Withdrew from Study|0|||
170781508|NCT03484702|617209197|FG005|Treatment Period|Participant Withdrew from Study|0|||
170781509|NCT03484702|617209192|FG000|Treatment Period|Physician Decision|0|||
170781510|NCT03484702|617209193|FG001|Treatment Period|Physician Decision|1|||
170781511|NCT03484702|617209194|FG002|Treatment Period|Physician Decision|0|||
170781512|NCT03484702|617209195|FG003|Treatment Period|Physician Decision|0|||
170781513|NCT03484702|617209196|FG004|Treatment Period|Physician Decision|0|||
170781514|NCT03484702|617209197|FG005|Treatment Period|Physician Decision|1|||
170781515|NCT03739996|617209202|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
170781516|NCT03739996|617209202|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
170781517|NCT03739996|617209202|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
170781518|NCT03739996|617209202|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
170781519|NCT03739996|617209202|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
170781520|NCT03739996|617209202|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
170781521|NCT03739996|617209202|FG000|Step 3 (SOC ART)|Death|1|||
170781522|NCT03739996|617209202|FG000|Step 3 (SOC ART)|Participant moved|1|||
170781523|NCT04716634|617209204|FG000|Overall Study|Death|24|||
170781524|NCT04716634|617209205|FG001|Overall Study|Death|24|||
170781525|NCT04716634|617209206|FG002|Overall Study|Death|8|||
170781526|NCT04716634|617209204|FG000|Overall Study|Closed by Sponsor|4|||
170781527|NCT04716634|617209205|FG001|Overall Study|Closed by Sponsor|4|||
170781528|NCT04716634|617209206|FG002|Overall Study|Closed by Sponsor|5|||
170781529|NCT04716634|617209204|FG000|Overall Study|Lost to Follow-up|1|||
170781530|NCT04716634|617209205|FG001|Overall Study|Lost to Follow-up|0|||
170781531|NCT04716634|617209206|FG002|Overall Study|Lost to Follow-up|1|||
170781532|NCT04716634|617209204|FG000|Overall Study|Withdrawal by Subject|0|||
170781533|NCT04716634|617209205|FG001|Overall Study|Withdrawal by Subject|0|||
170781534|NCT04716634|617209206|FG002|Overall Study|Withdrawal by Subject|1|||
170781535|NCT03655132|617209209|FG000|Overall Study|Lost to Follow-up|2|||
170781536|NCT03655132|617209210|FG001|Overall Study|Lost to Follow-up|1|||
170781537|NCT03655132|617209209|FG000|Overall Study|Withdrawal by Subject|0|||
170781538|NCT03655132|617209210|FG001|Overall Study|Withdrawal by Subject|1|||
170781539|NCT03655132|617209209|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
170781540|NCT03655132|617209210|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
170781541|NCT01180634|617209222|FG000|Overall Study|Adverse Event|4|||
170781542|NCT01180634|617209223|FG001|Overall Study|Adverse Event|1|||
170781543|NCT01180634|617209222|FG000|Overall Study|Miscellaneous|2|||
170781544|NCT01180634|617209223|FG001|Overall Study|Miscellaneous|0|||
170781545|NCT01180634|617209222|FG000|Overall Study|Withdrawal by Subject|4|||
170781546|NCT01180634|617209223|FG001|Overall Study|Withdrawal by Subject|0|||
170781547|NCT04419168|617209224|FG000|Overall Study|Protocol Violation|1|||
170781548|NCT04419168|617209225|FG001|Overall Study|Protocol Violation|1|||
170781549|NCT04419168|617209224|FG000|Overall Study|Lost to Follow-up|7|||
170781550|NCT04419168|617209225|FG001|Overall Study|Lost to Follow-up|7|||
170781551|NCT04419168|617209224|FG000|Overall Study|Missed 6-month Visit|48|||
170781552|NCT04419168|617209225|FG001|Overall Study|Missed 6-month Visit|45|||
170781553|NCT02662062|617209231|FG000|Overall Study|Withdrawal by Subject|1|||
170781554|NCT05374837|617209232|FG000|Overall Study|Lost to Follow-up|17|||
170781555|NCT05374837|617209233|FG001|Overall Study|Lost to Follow-up|18|||
170781556|NCT04725240|617209234|FG000|Overall Study|Adverse Event|2|||
170781557|NCT00676715|617209235|FG000|Treatment Period (TP)|Adverse Event|0|||
170781558|NCT00676715|617209236|FG001|Treatment Period (TP)|Adverse Event|3|||
170781559|NCT00676715|617209237|FG002|Treatment Period (TP)|Adverse Event|2|||
170781560|NCT00676715|617209238|FG003|Treatment Period (TP)|Adverse Event|2|||
170781561|NCT00676715|617209235|FG000|Treatment Period (TP)|Death|0|||
170781562|NCT00676715|617209236|FG001|Treatment Period (TP)|Death|0|||
170781563|NCT00676715|617209237|FG002|Treatment Period (TP)|Death|1|||
170781564|NCT00676715|617209238|FG003|Treatment Period (TP)|Death|0|||
170781565|NCT00676715|617209235|FG000|Treatment Period (TP)|Failure to return|1|||
170781566|NCT00676715|617209236|FG001|Treatment Period (TP)|Failure to return|0|||
170781567|NCT00676715|617209237|FG002|Treatment Period (TP)|Failure to return|0|||
170781568|NCT00676715|617209238|FG003|Treatment Period (TP)|Failure to return|0|||
170781569|NCT00676715|617209235|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
170781570|NCT00676715|617209236|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
170781571|NCT00676715|617209237|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
170781572|NCT00676715|617209238|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
170781573|NCT00676715|617209235|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
170781574|NCT00676715|617209236|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
170781575|NCT00676715|617209237|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
170781576|NCT00676715|617209238|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
170781577|NCT00676715|617209235|FG000|Treatment Period (TP)|Withdrew consent|3|||
170781578|NCT00676715|617209236|FG001|Treatment Period (TP)|Withdrew consent|3|||
170781579|NCT00676715|617209237|FG002|Treatment Period (TP)|Withdrew consent|3|||
170781580|NCT00676715|617209238|FG003|Treatment Period (TP)|Withdrew consent|3|||
170781581|NCT00676715|617209235|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
170781582|NCT00676715|617209236|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
170781583|NCT00676715|617209237|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
170781584|NCT00676715|617209238|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
170781585|NCT00676715|617209235|FG000|Treatment Period (TP)|Administrative|0|||
170882509|NCT00883337|617579566|FG002|Core Treatment Period|Other than above|1|||
170882510|NCT00883337|617579564|FG000|Extension Treatment Period|Adverse Event|8|||
170882511|NCT00883337|617579565|FG001|Extension Treatment Period|Adverse Event|5|||
170882512|NCT00883337|617579566|FG002|Extension Treatment Period|Adverse Event|5|||
170882513|NCT00883337|617579564|FG000|Extension Treatment Period|Lack of Efficacy|8|||
170882514|NCT00883337|617579565|FG001|Extension Treatment Period|Lack of Efficacy|8|||
170882515|NCT00883337|617579566|FG002|Extension Treatment Period|Lack of Efficacy|8|||
170437848|NCT01404988|615940078|FG001|Overall Study|Lost to Follow-up|2|||
170437849|NCT01404988|615940079|FG002|Overall Study|Lost to Follow-up|1|||
170437850|NCT00829764|615940080|FG000|First Intervention|Adverse Event|1|||
170437851|NCT00829764|615940081|FG001|First Intervention|Adverse Event|0|||
170437852|NCT00829764|615940080|FG000|First Intervention|Withdrawal by Subject|1|||
170437853|NCT00829764|615940081|FG001|First Intervention|Withdrawal by Subject|1|||
170437854|NCT04594252|615940082|FG000|Overall Study|Adverse Event|0|||
170437855|NCT04594252|615940083|FG001|Overall Study|Adverse Event|2|||
170633032|NCT00998296|616668449|FG004|Overall Study|Reason other than those specified above|0|||
170633033|NCT00998296|616668450|FG005|Overall Study|Reason other than those specified above|0|||
170633034|NCT00998296|616668451|FG006|Overall Study|Reason other than those specified above|0|||
170882516|NCT00883337|617579564|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
170882517|NCT00883337|617579565|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
170882518|NCT00883337|617579566|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
170882519|NCT00883337|617579564|FG000|Extension Treatment Period|Lost to Follow-up|1|||
170882520|NCT00883337|617579565|FG001|Extension Treatment Period|Lost to Follow-up|0|||
170882521|NCT00883337|617579566|FG002|Extension Treatment Period|Lost to Follow-up|0|||
170882522|NCT00883337|617579564|FG000|Extension Treatment Period|Other than above|10|||
170882523|NCT00883337|617579565|FG001|Extension Treatment Period|Other than above|9|||
170882524|NCT00883337|617579566|FG002|Extension Treatment Period|Other than above|5|||
170882525|NCT04677712|617579571|FG000|Overall Study|Lost to Follow-up|0|||
170882526|NCT04677712|617579572|FG001|Overall Study|Lost to Follow-up|1|||
170882527|NCT04677712|617579573|FG002|Overall Study|Lost to Follow-up|0|||
170882528|NCT04677712|617579574|FG003|Overall Study|Lost to Follow-up|0|||
170882529|NCT04677712|617579575|FG004|Overall Study|Lost to Follow-up|0|||
170882530|NCT04677712|617579576|FG005|Overall Study|Lost to Follow-up|0|||
170882531|NCT03446885|617579583|FG000|Overall Study|Lost to Follow-up|1|||
170882532|NCT03446885|617579584|FG001|Overall Study|Lost to Follow-up|0|||
170882533|NCT03446885|617579583|FG000|Overall Study|Did not complete entire visit|1|||
170882534|NCT03446885|617579584|FG001|Overall Study|Did not complete entire visit|0|||
170882535|NCT02083380|617579585|FG000|Overall Study|Lack of Efficacy|68|||
170882536|NCT02083380|617579586|FG001|Overall Study|Lack of Efficacy|79|||
170882537|NCT02083380|617579587|FG002|Overall Study|Lack of Efficacy|64|||
170882538|NCT02083380|617579585|FG000|Overall Study|Withdrawal by Subject|9|||
170882539|NCT02083380|617579586|FG001|Overall Study|Withdrawal by Subject|3|||
170882540|NCT02083380|617579587|FG002|Overall Study|Withdrawal by Subject|7|||
170882541|NCT02083380|617579585|FG000|Overall Study|Physician Decision|1|||
170882542|NCT02083380|617579586|FG001|Overall Study|Physician Decision|6|||
170882543|NCT02083380|617579587|FG002|Overall Study|Physician Decision|3|||
170882544|NCT02083380|617579585|FG000|Overall Study|Adverse Event|0|||
170882545|NCT02083380|617579586|FG001|Overall Study|Adverse Event|0|||
170882546|NCT02083380|617579587|FG002|Overall Study|Adverse Event|1|||
170882547|NCT02083380|617579585|FG000|Overall Study|Lost to Follow-up|5|||
170882548|NCT02083380|617579586|FG001|Overall Study|Lost to Follow-up|3|||
170882549|NCT02083380|617579587|FG002|Overall Study|Lost to Follow-up|3|||
170882550|NCT02083380|617579585|FG000|Overall Study|Other|8|||
170882551|NCT02083380|617579586|FG001|Overall Study|Other|4|||
170882552|NCT02083380|617579587|FG002|Overall Study|Other|6|||
170882553|NCT02669017|617579588|FG000|Overall Study|Death|1|||
170882554|NCT02669017|617579589|FG001|Overall Study|Death|2|||
170882555|NCT02669017|617579590|FG002|Overall Study|Death|2|||
170882556|NCT02669017|617579591|FG003|Overall Study|Death|3|||
170882557|NCT02669017|617579592|FG004|Overall Study|Death|8|||
170882558|NCT02669017|617579593|FG005|Overall Study|Death|18|||
170882559|NCT02669017|617579594|FG006|Overall Study|Death|10|||
170882560|NCT02669017|617579595|FG007|Overall Study|Death|47|||
170882561|NCT02669017|617579596|FG008|Overall Study|Death|20|||
170882562|NCT02669017|617579588|FG000|Overall Study|Withdrawal by Subject|0|||
170882563|NCT02669017|617579589|FG001|Overall Study|Withdrawal by Subject|0|||
170882564|NCT02669017|617579590|FG002|Overall Study|Withdrawal by Subject|0|||
170882565|NCT02669017|617579591|FG003|Overall Study|Withdrawal by Subject|1|||
170882566|NCT02669017|617579592|FG004|Overall Study|Withdrawal by Subject|2|||
170882567|NCT02669017|617579593|FG005|Overall Study|Withdrawal by Subject|0|||
170882568|NCT02669017|617579594|FG006|Overall Study|Withdrawal by Subject|0|||
170882569|NCT02669017|617579595|FG007|Overall Study|Withdrawal by Subject|2|||
170437856|NCT00477594|615940084|FG000|Year 1 and Year 2|Adverse Event|4|||
170437857|NCT00477594|615940085|FG001|Year 1 and Year 2|Adverse Event|2|||
170437858|NCT00477594|615940084|FG000|Year 1 and Year 2|Physician Decision|2|||
170437859|NCT00477594|615940085|FG001|Year 1 and Year 2|Physician Decision|1|||
170437860|NCT00477594|615940084|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
170882570|NCT02669017|617579596|FG008|Overall Study|Withdrawal by Subject|2|||
170882571|NCT02669017|617579588|FG000|Overall Study|Lost to Follow-up|0|||
170882572|NCT02669017|617579589|FG001|Overall Study|Lost to Follow-up|0|||
170882573|NCT02669017|617579590|FG002|Overall Study|Lost to Follow-up|0|||
170882574|NCT02669017|617579591|FG003|Overall Study|Lost to Follow-up|0|||
170882575|NCT02669017|617579592|FG004|Overall Study|Lost to Follow-up|0|||
170882576|NCT02669017|617579593|FG005|Overall Study|Lost to Follow-up|0|||
170882577|NCT02669017|617579594|FG006|Overall Study|Lost to Follow-up|0|||
170882578|NCT02669017|617579595|FG007|Overall Study|Lost to Follow-up|0|||
170882579|NCT02669017|617579596|FG008|Overall Study|Lost to Follow-up|1|||
170882580|NCT02669017|617579588|FG000|Overall Study|Miscellaneous|0|||
170882581|NCT02669017|617579589|FG001|Overall Study|Miscellaneous|0|||
170882582|NCT02669017|617579590|FG002|Overall Study|Miscellaneous|0|||
170882583|NCT02669017|617579591|FG003|Overall Study|Miscellaneous|0|||
170882584|NCT02669017|617579592|FG004|Overall Study|Miscellaneous|2|||
170882585|NCT02669017|617579593|FG005|Overall Study|Miscellaneous|1|||
170882586|NCT02669017|617579594|FG006|Overall Study|Miscellaneous|1|||
170882587|NCT02669017|617579595|FG007|Overall Study|Miscellaneous|13|||
170882588|NCT02669017|617579596|FG008|Overall Study|Miscellaneous|2|||
170882589|NCT01709149|617579600|FG000|Open-label Lead-in Phase|Adverse Event|109|||
170882590|NCT01709149|617579601|FG001|Open-label Lead-in Phase|Adverse Event|0|||
170882591|NCT01709149|617579602|FG002|Open-label Lead-in Phase|Adverse Event|0|||
170882592|NCT01709149|617579600|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
170882593|NCT01709149|617579601|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
170882594|NCT01709149|617579602|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
170437861|NCT00477594|615940085|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
170882595|NCT01709149|617579600|FG000|Open-label Lead-in Phase|Death|1|||
170882596|NCT01709149|617579601|FG001|Open-label Lead-in Phase|Death|0|||
170882597|NCT01709149|617579602|FG002|Open-label Lead-in Phase|Death|0|||
170882598|NCT01709149|617579600|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
170882599|NCT01709149|617579601|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
170781586|NCT00676715|617209236|FG001|Treatment Period (TP)|Administrative|0|||
170781587|NCT00676715|617209237|FG002|Treatment Period (TP)|Administrative|0|||
170781588|NCT00676715|617209238|FG003|Treatment Period (TP)|Administrative|1|||
170781589|NCT00676715|617209235|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
170781590|NCT00676715|617209236|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
170781591|NCT00676715|617209237|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
170781592|NCT00676715|617209238|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
170781593|NCT00676715|617209235|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
170781594|NCT00676715|617209236|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
170781595|NCT00676715|617209237|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
170781596|NCT00676715|617209238|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
170781597|NCT00676715|617209235|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
170781598|NCT00676715|617209236|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
170781599|NCT00676715|617209237|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
170781600|NCT00676715|617209238|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
170781601|NCT00676715|617209235|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
170781602|NCT00676715|617209236|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
170781603|NCT00676715|617209237|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
170781604|NCT00676715|617209238|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
170781605|NCT00676715|617209235|FG000|Treatment-free Period (TFP)|Death|1|||
170781606|NCT00676715|617209236|FG001|Treatment-free Period (TFP)|Death|1|||
170781607|NCT00676715|617209237|FG002|Treatment-free Period (TFP)|Death|1|||
170781608|NCT00676715|617209238|FG003|Treatment-free Period (TFP)|Death|0|||
170781609|NCT00676715|617209235|FG000|Open Label Extension (OLE)|Reason not provided|3|||
170781610|NCT00676715|617209236|FG001|Open Label Extension (OLE)|Reason not provided|4|||
170781611|NCT00676715|617209237|FG002|Open Label Extension (OLE)|Reason not provided|1|||
170781612|NCT00676715|617209238|FG003|Open Label Extension (OLE)|Reason not provided|4|||
170781613|NCT00676715|617209235|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
170882600|NCT01709149|617579602|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
170882601|NCT01709149|617579600|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
170882602|NCT01709149|617579601|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
170882603|NCT01709149|617579602|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
170882604|NCT01709149|617579600|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
170882605|NCT01709149|617579601|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
170437862|NCT00477594|615940084|FG000|Year 1 and Year 2|Other|1|||
170437863|NCT00477594|615940085|FG001|Year 1 and Year 2|Other|0|||
170437864|NCT00477594|615940084|FG000|Year 3|Adverse Event|1|||
170781614|NCT00676715|617209236|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
170781615|NCT00676715|617209237|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
170781616|NCT00676715|617209238|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
170781617|NCT00676715|617209235|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
170882606|NCT01709149|617579602|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
170882607|NCT01709149|617579600|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
170781618|NCT00676715|617209236|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
170781619|NCT00676715|617209237|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
170781620|NCT00676715|617209238|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
170781621|NCT00676715|617209235|FG000|Open Label Extension (OLE)|Adverse Event|0|||
170781622|NCT00676715|617209236|FG001|Open Label Extension (OLE)|Adverse Event|3|||
170781623|NCT00676715|617209237|FG002|Open Label Extension (OLE)|Adverse Event|1|||
170781624|NCT00676715|617209238|FG003|Open Label Extension (OLE)|Adverse Event|0|||
170781625|NCT00676715|617209235|FG000|Open Label Extension (OLE)|Death|2|||
170781626|NCT00676715|617209236|FG001|Open Label Extension (OLE)|Death|0|||
170781627|NCT00676715|617209237|FG002|Open Label Extension (OLE)|Death|2|||
170781628|NCT00676715|617209238|FG003|Open Label Extension (OLE)|Death|2|||
170781629|NCT04831281|617209239|FG000|Overall Study|Adverse Event|1|||
170781630|NCT04831281|617209240|FG001|Overall Study|Adverse Event|0|||
170781631|NCT04831281|617209241|FG002|Overall Study|Adverse Event|3|||
170781632|NCT04831281|617209239|FG000|Overall Study|Withdrawal by Subject|0|||
170781633|NCT04831281|617209240|FG001|Overall Study|Withdrawal by Subject|1|||
170781634|NCT04831281|617209241|FG002|Overall Study|Withdrawal by Subject|2|||
170781635|NCT04831281|617209239|FG000|Overall Study|Undetermined|1|||
170781636|NCT04831281|617209240|FG001|Overall Study|Undetermined|1|||
170781637|NCT04831281|617209241|FG002|Overall Study|Undetermined|0|||
170781638|NCT00616967|617209242|FG000|Overall Study|Withdrawal by Subject|0|||
170781639|NCT00616967|617209243|FG001|Overall Study|Withdrawal by Subject|0|||
170781640|NCT00616967|617209244|FG002|Overall Study|Withdrawal by Subject|1|||
170781641|NCT03161379|617209247|FG000|Overall Study|Withdrawal by Subject|4|||
170781642|NCT03161379|617209247|FG000|Overall Study|disease progression during chemotherapy|5|||
170781643|NCT03161379|617209247|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
170781644|NCT03161379|617209247|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
170781645|NCT02728076|617209249|FG000|Overall Study|Physician Decision|4|||
170781646|NCT05691309|617209250|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
170781647|NCT05691309|617209250|FG000|Overall Study|vancomycin levels not evaluable|2|||
170781648|NCT01707030|617209251|FG000|Overall Study|Death|1|||
170781649|NCT01707030|617209252|FG001|Overall Study|Death|1|||
170781650|NCT01707030|617209251|FG000|Overall Study|Withdrawal by Subject|2|||
170781651|NCT01707030|617209252|FG001|Overall Study|Withdrawal by Subject|3|||
170781652|NCT01707030|617209251|FG000|Overall Study|Lost to Follow-up|8|||
170781653|NCT01707030|617209252|FG001|Overall Study|Lost to Follow-up|13|||
170781654|NCT02724878|617209253|FG000|Overall Study|Still on Active Therapy|15|||
170781655|NCT02724878|617209253|FG000|Overall Study|Disease Progression|31|||
170781656|NCT02724878|617209253|FG000|Overall Study|Toxicity|5|||
170781657|NCT02724878|617209253|FG000|Overall Study|Death|1|||
170781658|NCT02724878|617209253|FG000|Overall Study|Withdrawal by Subject|4|||
170781659|NCT02724878|617209253|FG000|Overall Study|Lost to Follow-up|2|||
170781660|NCT02724878|617209253|FG000|Overall Study|Protocol Violation|1|||
170781661|NCT02724878|617209253|FG000|Overall Study|Ineligible for Study Drug|5|||
170781662|NCT02724878|617209253|FG000|Overall Study|not started|1|||
170781663|NCT05415410|617209255|FG000|Overall Study|Death|3|||
170781664|NCT05415410|617209256|FG001|Overall Study|Death|6|||
170781665|NCT05415410|617209257|FG002|Overall Study|Death|1|||
170781666|NCT05415410|617209255|FG000|Overall Study|Trial Terminated by Sponsor|1|||
170781667|NCT05415410|617209256|FG001|Overall Study|Trial Terminated by Sponsor|5|||
170781668|NCT05415410|617209257|FG002|Overall Study|Trial Terminated by Sponsor|0|||
170781669|NCT05415410|617209255|FG000|Overall Study|Adverse Event|2|||
170781670|NCT05415410|617209256|FG001|Overall Study|Adverse Event|1|||
170882608|NCT01709149|617579601|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
170882609|NCT01709149|617579602|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
170882610|NCT01709149|617579600|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
170882611|NCT01709149|617579601|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
170882612|NCT01709149|617579602|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
170882613|NCT01709149|617579600|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
170882614|NCT01709149|617579601|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
170882615|NCT01709149|617579602|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
170882616|NCT01709149|617579600|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170882617|NCT01709149|617579601|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
170882618|NCT01709149|617579602|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170882619|NCT03363321|617579603|FG000|Overall Study|Withdrawal by Subject|0|||
170882620|NCT03363321|617579604|FG001|Overall Study|Withdrawal by Subject|1|||
170882621|NCT03363321|617579605|FG002|Overall Study|Withdrawal by Subject|0|||
170882622|NCT03363321|617579606|FG003|Overall Study|Withdrawal by Subject|1|||
170882623|NCT03363321|617579607|FG004|Overall Study|Withdrawal by Subject|0|||
170882624|NCT01032915|617579608|FG000|Overall Study|Adverse Event|2|||
170882625|NCT01032915|617579609|FG001|Overall Study|Adverse Event|2|||
170882626|NCT01032915|617579610|FG002|Overall Study|Adverse Event|1|||
170882627|NCT01032915|617579611|FG003|Overall Study|Adverse Event|1|||
170882628|NCT01032915|617579608|FG000|Overall Study|Abnormal test procedure result|0|||
170882629|NCT01032915|617579609|FG001|Overall Study|Abnormal test procedure result|0|||
170882630|NCT01032915|617579610|FG002|Overall Study|Abnormal test procedure result|1|||
170882631|NCT01032915|617579611|FG003|Overall Study|Abnormal test procedure result|0|||
170882632|NCT01032915|617579608|FG000|Overall Study|Withdrawal by Subject|0|||
170882633|NCT01032915|617579609|FG001|Overall Study|Withdrawal by Subject|3|||
170882634|NCT01032915|617579610|FG002|Overall Study|Withdrawal by Subject|1|||
170882635|NCT01032915|617579611|FG003|Overall Study|Withdrawal by Subject|1|||
170882636|NCT01032915|617579608|FG000|Overall Study|Administrative reasons|5|||
170882637|NCT01032915|617579609|FG001|Overall Study|Administrative reasons|6|||
170882638|NCT01032915|617579610|FG002|Overall Study|Administrative reasons|4|||
170882639|NCT01032915|617579611|FG003|Overall Study|Administrative reasons|4|||
170882640|NCT01032915|617579608|FG000|Overall Study|Protocol Violation|1|||
170882641|NCT01032915|617579609|FG001|Overall Study|Protocol Violation|0|||
170882642|NCT01032915|617579610|FG002|Overall Study|Protocol Violation|0|||
170882643|NCT01032915|617579611|FG003|Overall Study|Protocol Violation|1|||
170882644|NCT01577186|617579612|FG000|Overall Study|Adverse Event|23|||
170882645|NCT01577186|617579612|FG000|Overall Study|Death|1|||
170882646|NCT01577186|617579612|FG000|Overall Study|Lost to Follow-up|28|||
170882647|NCT01577186|617579612|FG000|Overall Study|Withdrawal by Subject|35|||
170882648|NCT01577186|617579612|FG000|Overall Study|Insufficient Response|18|||
170882649|NCT01577186|617579612|FG000|Overall Study|Ineligible to Continue|15|||
170882650|NCT01577186|617579612|FG000|Overall Study|Non-Compliant|8|||
170882651|NCT01577186|617579612|FG000|Overall Study|Other|2|||
170882652|NCT02915523|617579613|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
170882653|NCT02915523|617579614|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
170882654|NCT02915523|617579615|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
170882655|NCT02915523|617579616|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
170882656|NCT02915523|617579613|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
170882657|NCT02915523|617579614|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
170882658|NCT02915523|617579615|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
170882659|NCT02915523|617579616|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
170882660|NCT02915523|617579613|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
170882661|NCT02915523|617579614|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
170882662|NCT02915523|617579615|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
170882663|NCT02915523|617579616|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
170882664|NCT02915523|617579613|FG000|Expansion Phase (Phase 2)|Death|0|||
170882665|NCT02915523|617579614|FG001|Expansion Phase (Phase 2)|Death|0|||
170882666|NCT02915523|617579615|FG002|Expansion Phase (Phase 2)|Death|26|||
170882667|NCT02915523|617579616|FG003|Expansion Phase (Phase 2)|Death|53|||
170882668|NCT02915523|617579613|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
170882669|NCT02915523|617579614|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
170882670|NCT02915523|617579615|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
170882671|NCT02915523|617579616|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
170882672|NCT02915523|617579613|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
170882673|NCT02915523|617579614|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
170882674|NCT02915523|617579615|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
170882675|NCT02915523|617579616|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
170882676|NCT02915523|617579613|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
170882677|NCT02915523|617579614|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
170882678|NCT02915523|617579615|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
170882679|NCT02915523|617579616|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
170882680|NCT00915681|617579617|FG000|Overall Study|Screening failures|46|||
170437865|NCT00477594|615940085|FG001|Year 3|Adverse Event|0|||
170437866|NCT00477594|615940084|FG000|Year 3|Withdrawal by Subject|1|||
170437867|NCT00477594|615940085|FG001|Year 3|Withdrawal by Subject|0|||
170437868|NCT00477594|615940084|FG000|Follow-up Period|Withdrawal by Subject|2|||
170437869|NCT00477594|615940085|FG001|Follow-up Period|Withdrawal by Subject|1|||
170437870|NCT00477594|615940084|FG000|Follow-up Period|Other|1|||
170437871|NCT00477594|615940085|FG001|Follow-up Period|Other|0|||
170437872|NCT03086135|615941574|FG000|Overall Study|Adverse Event|1|||
170437873|NCT03086135|615941574|FG000|Overall Study|Lost to Follow-up|2|||
170437874|NCT04211766|615941575|FG000|Overall Study|Withdrawal by Subject|5|||
170437875|NCT04211766|615941576|FG001|Overall Study|Withdrawal by Subject|1|||
170437876|NCT04590781|615941577|FG000|Overall Study|Death|0|||
170437877|NCT04590781|615941578|FG001|Overall Study|Death|2|||
170437878|NCT04590781|615941577|FG000|Overall Study|Withdrawal by Subject|2|||
170437879|NCT04590781|615941578|FG001|Overall Study|Withdrawal by Subject|0|||
170437880|NCT05267106|615941589|FG000|Overall Study|Death|50|||
170437881|NCT05267106|615941590|FG001|Overall Study|Death|2|||
170437882|NCT05267106|615941589|FG000|Overall Study|Study terminated by Sponsor|24|||
170437883|NCT05267106|615941590|FG001|Overall Study|Study terminated by Sponsor|6|||
170437884|NCT05267106|615941589|FG000|Overall Study|Withdrawal by Subject|0|||
170437885|NCT05267106|615941590|FG001|Overall Study|Withdrawal by Subject|1|||
170437886|NCT04227899|615941597|FG000|Overall Study|Withdrawal by Subject|6|||
170437887|NCT04227899|615941598|FG001|Overall Study|Withdrawal by Subject|3|||
170437888|NCT04227899|615941597|FG000|Overall Study|Death|12|||
170437889|NCT04227899|615941598|FG001|Overall Study|Death|6|||
170437890|NCT04227899|615941597|FG000|Overall Study|Lost to Follow-up|2|||
170437891|NCT04227899|615941598|FG001|Overall Study|Lost to Follow-up|1|||
170437892|NCT05151471|615941599|FG000|Overall Study|Adverse Event|21|||
170437893|NCT05151471|615941600|FG001|Overall Study|Adverse Event|16|||
170437894|NCT05151471|615941599|FG000|Overall Study|Death|1|||
170437895|NCT05151471|615941600|FG001|Overall Study|Death|0|||
170437896|NCT05151471|615941599|FG000|Overall Study|Lost to Follow-up|0|||
170437897|NCT05151471|615941600|FG001|Overall Study|Lost to Follow-up|1|||
170437898|NCT05151471|615941599|FG000|Overall Study|Withdrawal by Subject|7|||
170437899|NCT05151471|615941600|FG001|Overall Study|Withdrawal by Subject|9|||
170437900|NCT05151471|615941599|FG000|Overall Study|Study terminated by sponsor|49|||
170437901|NCT05151471|615941600|FG001|Overall Study|Study terminated by sponsor|47|||
170437902|NCT05151471|615941599|FG000|Overall Study|Other|2|||
170437903|NCT05151471|615941600|FG001|Overall Study|Other|1|||
170437904|NCT03988608|615941601|FG000|Overall Study|Adverse Event|1|||
170437905|NCT03988608|615941601|FG000|Overall Study|Lost to Follow-up|1|||
170437906|NCT03988608|615941601|FG000|Overall Study|Withdrawal by Subject|3|||
170437907|NCT03988608|615941601|FG000|Overall Study|Death|1|||
170437908|NCT00396162|615941605|FG000|Overall Study|Withdrawal by Subject|2|||
170437909|NCT00396162|615941606|FG001|Overall Study|Withdrawal by Subject|3|||
170437910|NCT02694536|615941607|FG000|Overall Study|Progressive Disease|40|||
170437911|NCT02694536|615941607|FG000|Overall Study|Lost to Follow-up|1|||
170437912|NCT02694536|615941607|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
170437913|NCT02694536|615941607|FG000|Overall Study|Withdrawal by Subject|8|||
170437914|NCT02694536|615941607|FG000|Overall Study|Death|8|||
170437915|NCT02694536|615941607|FG000|Overall Study|Other|22|||
170437916|NCT01741545|615941608|FG000|Treatment Period|Lack of Efficacy|0|||
170437917|NCT01741545|615941609|FG001|Treatment Period|Lack of Efficacy|1|||
170437918|NCT01741545|615941608|FG000|Treatment Period|Adverse event, non-fatal|1|||
170437919|NCT01741545|615941609|FG001|Treatment Period|Adverse event, non-fatal|3|||
170437920|NCT01741545|615941608|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
170437921|NCT01741545|615941609|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
170437922|NCT01741545|615941608|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
170437923|NCT01741545|615941609|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
170437924|NCT02483416|615941610|FG000|Overall Study|Other reason|0|||
170437925|NCT02483416|615941611|FG001|Overall Study|Other reason|1|||
170437926|NCT02483416|615941610|FG000|Overall Study|Treatment stop|3|||
170437927|NCT02483416|615941611|FG001|Overall Study|Treatment stop|0|||
170437928|NCT03387462|615941613|FG000|Overall Study|Lost to Follow-up|1|||
170437929|NCT01460628|615941614|FG000|Overall Study|Adverse Event|3|||
170437930|NCT01460628|615941614|FG000|Overall Study|Withdrawal by Subject|2|||
170437931|NCT01664039|615941618|FG000|Overall Study|Adverse Event|3|||
170437932|NCT01664039|615941619|FG001|Overall Study|Adverse Event|4|||
170437933|NCT01664039|615941618|FG000|Overall Study|Lost to Follow-up|1|||
170437934|NCT01664039|615941619|FG001|Overall Study|Lost to Follow-up|1|||
170437935|NCT01664039|615941618|FG000|Overall Study|Withdrawal by Subject|1|||
170437936|NCT01664039|615941619|FG001|Overall Study|Withdrawal by Subject|3|||
170437937|NCT01664039|615941618|FG000|Overall Study|Noncompliance|1|||
170437938|NCT01664039|615941619|FG001|Overall Study|Noncompliance|1|||
170437939|NCT01853176|615941620|FG000|Overall Study|Study terminated|4|||
170437940|NCT01853176|615941621|FG001|Overall Study|Study terminated|0|||
170437941|NCT02276885|615941623|FG000|Overall Study|Withdrawal by Subject|2|||
170437942|NCT02276885|615941624|FG001|Overall Study|Withdrawal by Subject|0|||
170437943|NCT02276885|615941623|FG000|Overall Study|Lost to Follow-up|5|||
170437944|NCT02276885|615941624|FG001|Overall Study|Lost to Follow-up|2|||
170437945|NCT04569032|615941625|FG000|Overall Study|Death|10|||
170437946|NCT04569032|615941626|FG001|Overall Study|Death|13|||
170437947|NCT04569032|615941625|FG000|Overall Study|Withdrawal by Subject|2|||
170437948|NCT04569032|615941626|FG001|Overall Study|Withdrawal by Subject|0|||
170437949|NCT04569032|615941625|FG000|Overall Study|Lost to Follow-up|0|||
170437950|NCT04569032|615941626|FG001|Overall Study|Lost to Follow-up|1|||
170437951|NCT04569032|615941625|FG000|Overall Study|In long term follow up|22|||
170437952|NCT04569032|615941626|FG001|Overall Study|In long term follow up|34|||
170437953|NCT05034874|615941645|FG000|Overall Study|Withdrawal by Subject|6|||
170437954|NCT05034874|615941646|FG001|Overall Study|Withdrawal by Subject|6|||
170437955|NCT05034874|615941645|FG000|Overall Study|Lost to Follow-up|18|||
170437956|NCT05034874|615941646|FG001|Overall Study|Lost to Follow-up|8|||
170437957|NCT05034874|615941645|FG000|Overall Study|Physician Decision|0|||
170437958|NCT05034874|615941646|FG001|Overall Study|Physician Decision|1|||
170437959|NCT05034874|615941645|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
170437960|NCT05034874|615941646|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
170437961|NCT02426918|615941647|FG000|Overall Study|Adverse Event|2|||
170437962|NCT02426918|615941648|FG001|Overall Study|Adverse Event|2|||
170437963|NCT02426918|615941649|FG002|Overall Study|Adverse Event|0|||
170437964|NCT02426918|615941647|FG000|Overall Study|Physician Decision|1|||
170437965|NCT02426918|615941648|FG001|Overall Study|Physician Decision|1|||
170437966|NCT02426918|615941649|FG002|Overall Study|Physician Decision|1|||
170437967|NCT02426918|615941647|FG000|Overall Study|Withdrawal by Subject|5|||
170437968|NCT02426918|615941648|FG001|Overall Study|Withdrawal by Subject|5|||
170437969|NCT02426918|615941649|FG002|Overall Study|Withdrawal by Subject|4|||
170437970|NCT02426918|615941647|FG000|Overall Study|Other|9|||
170437971|NCT02426918|615941648|FG001|Overall Study|Other|11|||
170437972|NCT02426918|615941649|FG002|Overall Study|Other|9|||
170437973|NCT01496118|615941650|FG000|Overall Study|Disease progression|3|||
170437974|NCT01496118|615941651|FG001|Overall Study|Disease progression|2|||
170437975|NCT01496118|615941652|FG002|Overall Study|Disease progression|3|||
170437976|NCT01496118|615941653|FG003|Overall Study|Disease progression|1|||
170437977|NCT01496118|615941654|FG004|Overall Study|Disease progression|2|||
170437978|NCT01496118|615941655|FG005|Overall Study|Disease progression|2|||
170437979|NCT01496118|615941656|FG006|Overall Study|Disease progression|14|||
170882681|NCT03221751|617579622|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
170882682|NCT03221751|617579623|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
170882683|NCT01780831|617579626|FG000|Overall Study|Withdrawal by Subject|0|||
170882684|NCT01780831|617579627|FG001|Overall Study|Withdrawal by Subject|0|||
170882685|NCT01780831|617579628|FG002|Overall Study|Withdrawal by Subject|4|||
170882686|NCT01780831|617579629|FG003|Overall Study|Withdrawal by Subject|0|||
170437980|NCT01496118|615941657|FG007|Overall Study|Disease progression|10|||
170437981|NCT01496118|615941650|FG000|Overall Study|Physician Decision|0|||
170437982|NCT01496118|615941651|FG001|Overall Study|Physician Decision|0|||
170882687|NCT01780831|617579626|FG000|Overall Study|Lost to Follow-up|0|||
170437983|NCT01496118|615941652|FG002|Overall Study|Physician Decision|0|||
170882688|NCT01780831|617579627|FG001|Overall Study|Lost to Follow-up|0|||
170882689|NCT01780831|617579628|FG002|Overall Study|Lost to Follow-up|0|||
170882690|NCT01780831|617579629|FG003|Overall Study|Lost to Follow-up|1|||
170437984|NCT01496118|615941653|FG003|Overall Study|Physician Decision|0|||
170437985|NCT01496118|615941654|FG004|Overall Study|Physician Decision|1|||
170437986|NCT01496118|615941655|FG005|Overall Study|Physician Decision|0|||
170437987|NCT01496118|615941656|FG006|Overall Study|Physician Decision|3|||
170437988|NCT01496118|615941657|FG007|Overall Study|Physician Decision|6|||
170437989|NCT01496118|615941650|FG000|Overall Study|Adverse Event|1|||
170437990|NCT01496118|615941651|FG001|Overall Study|Adverse Event|1|||
170437991|NCT01496118|615941652|FG002|Overall Study|Adverse Event|0|||
170633035|NCT00998296|616668452|FG007|Overall Study|Reason other than those specified above|0|||
170882691|NCT02429414|617579630|FG000|Overall Study|Physician Decision|0|||
170437992|NCT01496118|615941653|FG003|Overall Study|Adverse Event|0|||
170437993|NCT01496118|615941654|FG004|Overall Study|Adverse Event|0|||
170437994|NCT01496118|615941655|FG005|Overall Study|Adverse Event|0|||
170437995|NCT01496118|615941656|FG006|Overall Study|Adverse Event|6|||
170437996|NCT01496118|615941657|FG007|Overall Study|Adverse Event|10|||
170437997|NCT01496118|615941650|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
170437998|NCT01496118|615941651|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
170437999|NCT01496118|615941652|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
170438000|NCT01496118|615941653|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
170438001|NCT01496118|615941654|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
170438002|NCT01496118|615941655|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
170438003|NCT01496118|615941656|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
170438004|NCT01496118|615941657|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
170438005|NCT01496118|615941650|FG000|Overall Study|Death|0|||
170438006|NCT01496118|615941651|FG001|Overall Study|Death|0|||
170438007|NCT01496118|615941652|FG002|Overall Study|Death|0|||
170438008|NCT01496118|615941653|FG003|Overall Study|Death|0|||
170438009|NCT01496118|615941654|FG004|Overall Study|Death|0|||
170438010|NCT01496118|615941655|FG005|Overall Study|Death|0|||
170438011|NCT01496118|615941656|FG006|Overall Study|Death|1|||
170438012|NCT01496118|615941657|FG007|Overall Study|Death|1|||
170438013|NCT01496118|615941650|FG000|Overall Study|Withdrawal by Subject|0|||
170438014|NCT01496118|615941651|FG001|Overall Study|Withdrawal by Subject|0|||
170438015|NCT01496118|615941652|FG002|Overall Study|Withdrawal by Subject|0|||
170438016|NCT01496118|615941653|FG003|Overall Study|Withdrawal by Subject|2|||
170438017|NCT01496118|615941654|FG004|Overall Study|Withdrawal by Subject|0|||
170438018|NCT01496118|615941655|FG005|Overall Study|Withdrawal by Subject|1|||
170438019|NCT01496118|615941656|FG006|Overall Study|Withdrawal by Subject|6|||
170438020|NCT01496118|615941657|FG007|Overall Study|Withdrawal by Subject|3|||
170438021|NCT02420353|615941662|FG000|Overall Study|Withdrawal by Subject|0|||
170438022|NCT02420353|615941663|FG001|Overall Study|Withdrawal by Subject|1|||
170438023|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
170438024|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
170438025|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
170438026|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
170438027|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
170438028|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
170438029|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
170438030|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
170438031|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
170438032|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
170438033|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
170438034|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
170438035|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
170438036|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
170438037|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
170438038|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
170438039|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
170438040|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
170438041|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
170438042|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
170438043|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
170438044|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
170438045|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
170438046|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
170438047|NCT00073307|615941664|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
170537116|NCT04044690|616311534|FG000|Period 1|Death|1|||
170781671|NCT05415410|617209257|FG002|Overall Study|Adverse Event|0|||
170781672|NCT05415410|617209255|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
170781673|NCT05415410|617209256|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
170781674|NCT05415410|617209257|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
170781675|NCT05415410|617209255|FG000|Overall Study|Withdrawal by Subject|1|||
170781676|NCT05415410|617209256|FG001|Overall Study|Withdrawal by Subject|0|||
170781677|NCT05415410|617209257|FG002|Overall Study|Withdrawal by Subject|0|||
170781678|NCT05415410|617209255|FG000|Overall Study|Pregnancy|5|||
170781679|NCT05415410|617209256|FG001|Overall Study|Pregnancy|2|||
170781680|NCT05415410|617209257|FG002|Overall Study|Pregnancy|0|||
170781681|NCT04838262|617209258|FG000|Overall Study|Withdrawal by Subject|9|||
170781682|NCT04838262|617209259|FG001|Overall Study|Withdrawal by Subject|4|||
170781683|NCT03526861|617209260|FG000|Initial Treatment Period|Not dosed|1|||
170882692|NCT02429414|617579631|FG001|Overall Study|Physician Decision|1|||
170781684|NCT03526861|617209261|FG001|Initial Treatment Period|Not dosed|1|||
170781685|NCT03526861|617209262|FG002|Initial Treatment Period|Not dosed|1|||
170882693|NCT01098071|617579632|FG000|Overall Study|Surgery (adenoidectomy)|2|||
170438048|NCT00073307|615941665|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
170438049|NCT00073307|615941666|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
170438050|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
170438051|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
170438052|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
170438053|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
170438054|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
170438055|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
170438056|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
170438057|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
170438058|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
170438059|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
170438060|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
170438061|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
170438062|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
170438063|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
170438064|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
170438065|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
170438066|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
170438067|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
170438068|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
170438069|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
170438070|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
170438071|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
170438072|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
170438073|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
170438074|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
170438075|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
170438076|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
170438077|NCT00073307|615941664|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
170438078|NCT00073307|615941665|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
170438079|NCT00073307|615941666|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
170438080|NCT00503867|615941667|FG000|Overall Study|Lost to Follow-up|1|||
170438081|NCT00503867|615941667|FG000|Overall Study|Adverse Event|1|||
170438082|NCT05616728|615941668|FG000|Overall Study|Lost to Follow-up|0|||
170438083|NCT05616728|615941669|FG001|Overall Study|Lost to Follow-up|0|||
170438084|NCT05616728|615941670|FG002|Overall Study|Lost to Follow-up|1|||
170438085|NCT05616728|615941668|FG000|Overall Study|Withdrawal by Subject|1|||
170438086|NCT05616728|615941669|FG001|Overall Study|Withdrawal by Subject|1|||
170438087|NCT05616728|615941670|FG002|Overall Study|Withdrawal by Subject|0|||
170438088|NCT05616728|615941668|FG000|Overall Study|Physician Decision|1|||
170438089|NCT05616728|615941669|FG001|Overall Study|Physician Decision|1|||
170438090|NCT05616728|615941670|FG002|Overall Study|Physician Decision|1|||
170438091|NCT05616728|615941668|FG000|Overall Study|Other|0|||
170438092|NCT05616728|615941669|FG001|Overall Study|Other|2|||
170438093|NCT05616728|615941670|FG002|Overall Study|Other|0|||
170438094|NCT01370863|615941676|FG000|Overall Study|Adverse Event|1|||
170438095|NCT01370863|615941677|FG001|Overall Study|Adverse Event|1|||
170438096|NCT01370863|615941676|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
170438097|NCT01370863|615941677|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
170438098|NCT01370863|615941676|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
170438099|NCT01370863|615941677|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
170438100|NCT00574847|615941680|FG000|Overall Study|Adverse Event|2|||
170438101|NCT00574847|615941681|FG001|Overall Study|Adverse Event|0|||
170438102|NCT00574847|615941680|FG000|Overall Study|Death|1|||
170438103|NCT00574847|615941681|FG001|Overall Study|Death|0|||
170781686|NCT03526861|617209263|FG003|Initial Treatment Period|Not dosed|0|||
170781687|NCT03526861|617209264|FG004|Initial Treatment Period|Not dosed|0|||
170781688|NCT03526861|617209265|FG005|Initial Treatment Period|Not dosed|0|||
170781689|NCT03526861|617209266|FG006|Initial Treatment Period|Not dosed|0|||
170781690|NCT03526861|617209267|FG007|Initial Treatment Period|Not dosed|0|||
170781691|NCT03526861|617209268|FG008|Initial Treatment Period|Not dosed|0|||
170781692|NCT03526861|617209260|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
170882694|NCT01098071|617579632|FG000|Overall Study|Lost to Follow-up|13|||
170882695|NCT01784861|617579633|FG000|Overall Study|Adverse Event|0|||
170882696|NCT01784861|617579634|FG001|Overall Study|Adverse Event|0|||
170438104|NCT00574847|615941680|FG000|Overall Study|Withdrawal by Subject|2|||
170438105|NCT00574847|615941681|FG001|Overall Study|Withdrawal by Subject|2|||
170438106|NCT00574847|615941680|FG000|Overall Study|Physician Decision|1|||
170438107|NCT00574847|615941681|FG001|Overall Study|Physician Decision|0|||
170438108|NCT00574847|615941680|FG000|Overall Study|Did not receive medication (declined)|2|||
170438109|NCT00574847|615941681|FG001|Overall Study|Did not receive medication (declined)|5|||
170438110|NCT05004649|615941684|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
170438111|NCT05004649|615941684|FG000|Overall Study|Lost to Follow-up|1|||
170438112|NCT05004649|615941684|FG000|Overall Study|Withdrawal by Subject|2|||
170438113|NCT05004649|615941684|FG000|Overall Study|COVID-19|1|||
170438114|NCT02385708|615941685|FG000|Overall Study|Withdrawal by Subject|0|||
170438115|NCT02385708|615941686|FG001|Overall Study|Withdrawal by Subject|2|||
170438116|NCT02385708|615941685|FG000|Overall Study|Withdrawn - surgery canceled|2|||
170438117|NCT02385708|615941686|FG001|Overall Study|Withdrawn - surgery canceled|5|||
170438118|NCT02385708|615941685|FG000|Overall Study|Investigator decision|5|||
170438119|NCT02385708|615941686|FG001|Overall Study|Investigator decision|7|||
170438120|NCT02385708|615941685|FG000|Overall Study|Protocol Violation|1|||
170438121|NCT02385708|615941686|FG001|Overall Study|Protocol Violation|1|||
170438122|NCT02436200|615941689|FG000|Overall Study|Significant outlier|1|||
170438123|NCT00354835|615941692|FG000|Overall Study|Death|1|||
170438124|NCT00354835|615941693|FG001|Overall Study|Death|1|||
170438125|NCT00354835|615941692|FG000|Overall Study|Physician Decision|8|||
170438126|NCT00354835|615941693|FG001|Overall Study|Physician Decision|13|||
170438127|NCT00354835|615941692|FG000|Overall Study|Withdrawal by Subject|2|||
170438128|NCT00354835|615941693|FG001|Overall Study|Withdrawal by Subject|1|||
170438129|NCT00354835|615941692|FG000|Overall Study|Ineligible|17|||
170438130|NCT00354835|615941693|FG001|Overall Study|Ineligible|16|||
170438131|NCT00354835|615941692|FG000|Overall Study|Disease progression or relapse|15|||
170438132|NCT00354835|615941693|FG001|Overall Study|Disease progression or relapse|22|||
170438133|NCT00354835|615941692|FG000|Overall Study|Adverse Event|6|||
170438134|NCT00354835|615941693|FG001|Overall Study|Adverse Event|0|||
170438135|NCT00354835|615941692|FG000|Overall Study|Refusal of further therapy|3|||
170438136|NCT00354835|615941693|FG001|Overall Study|Refusal of further therapy|8|||
170438137|NCT01728116|615941694|FG000|Overall Study|Sponsor Terminated Study|106|||
170438138|NCT01728116|615941695|FG001|Overall Study|Sponsor Terminated Study|35|||
170438139|NCT01728116|615941694|FG000|Overall Study|Withdrawal by Subject|16|||
170438140|NCT01728116|615941695|FG001|Overall Study|Withdrawal by Subject|9|||
170438141|NCT01728116|615941694|FG000|Overall Study|Adverse Event|13|||
170438142|NCT01728116|615941695|FG001|Overall Study|Adverse Event|0|||
170438143|NCT01728116|615941694|FG000|Overall Study|Procedure/device failure|7|||
170438144|NCT01728116|615941695|FG001|Overall Study|Procedure/device failure|0|||
170438145|NCT01728116|615941694|FG000|Overall Study|Lost to Follow-up|9|||
170438146|NCT01728116|615941695|FG001|Overall Study|Lost to Follow-up|2|||
170438147|NCT01728116|615941694|FG000|Overall Study|Physician Decision|2|||
170438148|NCT01728116|615941695|FG001|Overall Study|Physician Decision|0|||
170438149|NCT01728116|615941694|FG000|Overall Study|Subject Non-Compliance|2|||
170438150|NCT01728116|615941695|FG001|Overall Study|Subject Non-Compliance|0|||
170438151|NCT01728116|615941694|FG000|Overall Study|Inter-current finding at procedure|1|||
170438152|NCT01728116|615941695|FG001|Overall Study|Inter-current finding at procedure|0|||
170438153|NCT01728116|615941694|FG000|Overall Study|Incorrectly enrolled in Study|0|||
170438154|NCT01728116|615941695|FG001|Overall Study|Incorrectly enrolled in Study|1|||
170438155|NCT01728116|615941694|FG000|Overall Study|various not noted previously|5|||
170438156|NCT01728116|615941695|FG001|Overall Study|various not noted previously|0|||
170438157|NCT00562718|615941696|FG000|Overall Study|Death|1|||
170438158|NCT00562718|615941696|FG000|Overall Study|Withdrawal by Subject|3|||
170438159|NCT00562718|615941696|FG000|Overall Study|Adverse Event|4|||
170438160|NCT00562718|615941696|FG000|Overall Study|Lack of Efficacy|2|||
170438161|NCT00562718|615941696|FG000|Overall Study|not stated|1|||
170438162|NCT03922750|615941697|FG000|Overall Study|Unclassified|0|||
170438163|NCT03922750|615941698|FG001|Overall Study|Unclassified|0|||
170438164|NCT03922750|615941699|FG002|Overall Study|Unclassified|1|||
170438165|NCT03922750|615941697|FG000|Overall Study|Adverse Event|0|||
170438166|NCT03922750|615941698|FG001|Overall Study|Adverse Event|1|||
170438167|NCT03922750|615941699|FG002|Overall Study|Adverse Event|0|||
170438168|NCT01395017|615941700|FG000|Overall Study|Lost to Follow-up|1|||
170438169|NCT01395017|615941701|FG001|Overall Study|Lost to Follow-up|0|||
170438170|NCT01395017|615941700|FG000|Overall Study|Adverse Event|26|||
170438171|NCT01395017|615941701|FG001|Overall Study|Adverse Event|12|||
170438172|NCT01395017|615941700|FG000|Overall Study|Physician Decision|11|||
170438173|NCT01395017|615941701|FG001|Overall Study|Physician Decision|15|||
170438174|NCT01395017|615941700|FG000|Overall Study|Withdrawal by Subject|14|||
170438175|NCT01395017|615941701|FG001|Overall Study|Withdrawal by Subject|8|||
170438176|NCT01395017|615941700|FG000|Overall Study|Protocol deviation|1|||
170438177|NCT01395017|615941701|FG001|Overall Study|Protocol deviation|2|||
170438178|NCT01395017|615941700|FG000|Overall Study|Death|4|||
170438179|NCT01395017|615941701|FG001|Overall Study|Death|3|||
170438180|NCT01395017|615941700|FG000|Overall Study|Disease progression|42|||
170438181|NCT01395017|615941701|FG001|Overall Study|Disease progression|58|||
170438182|NCT01395017|615941700|FG000|Overall Study|Sponsor discontinued study|1|||
170438183|NCT01395017|615941701|FG001|Overall Study|Sponsor discontinued study|4|||
170882697|NCT01784861|617579635|FG002|Overall Study|Adverse Event|1|||
170882698|NCT01784861|617579636|FG003|Overall Study|Adverse Event|2|||
170882699|NCT01784861|617579637|FG004|Overall Study|Adverse Event|1|||
170882700|NCT01784861|617579638|FG005|Overall Study|Adverse Event|0|||
170882701|NCT01784861|617579633|FG000|Overall Study|Withdrawal by Subject|0|||
170882702|NCT01784861|617579634|FG001|Overall Study|Withdrawal by Subject|0|||
170882703|NCT01784861|617579635|FG002|Overall Study|Withdrawal by Subject|0|||
170882704|NCT01784861|617579636|FG003|Overall Study|Withdrawal by Subject|1|||
170882705|NCT01784861|617579637|FG004|Overall Study|Withdrawal by Subject|0|||
170882706|NCT01784861|617579638|FG005|Overall Study|Withdrawal by Subject|0|||
170882707|NCT01784861|617579633|FG000|Overall Study|Physician Decision|0|||
170882708|NCT01784861|617579634|FG001|Overall Study|Physician Decision|0|||
170882709|NCT01784861|617579635|FG002|Overall Study|Physician Decision|0|||
170438184|NCT03366428|615941702|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
170882710|NCT01784861|617579636|FG003|Overall Study|Physician Decision|2|||
170882711|NCT01784861|617579637|FG004|Overall Study|Physician Decision|0|||
170882712|NCT01784861|617579638|FG005|Overall Study|Physician Decision|1|||
170882713|NCT02706873|617579643|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
170882714|NCT02706873|617579644|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
170882715|NCT02706873|617579645|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
170882716|NCT02706873|617579646|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
170882717|NCT02706873|617579643|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
170882718|NCT02706873|617579644|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
170882719|NCT02706873|617579645|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
170882720|NCT02706873|617579646|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
170882721|NCT02706873|617579643|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
170882722|NCT02706873|617579644|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
170882723|NCT02706873|617579645|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
170882724|NCT02706873|617579646|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
170882725|NCT02706873|617579643|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
170882726|NCT02706873|617579644|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
170882727|NCT02706873|617579645|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
170882728|NCT02706873|617579646|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
170882729|NCT02706873|617579643|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
170882730|NCT02706873|617579644|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
170882731|NCT02706873|617579645|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
170882732|NCT02706873|617579646|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
170438185|NCT03366428|615941702|FG000|Overall Study|Adverse Event|12|||
170438186|NCT03366428|615941702|FG000|Overall Study|Clinical progression|2|||
170438187|NCT03366428|615941702|FG000|Overall Study|Withdrawal by Subject|4|||
170438188|NCT01046084|615941703|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
170438189|NCT01046084|615941704|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
170438190|NCT02166606|615941705|FG000|Overall Study|Adverse Event|3|||
170438191|NCT02166606|615941705|FG000|Overall Study|Death|31|||
170438192|NCT02166606|615941705|FG000|Overall Study|Protocol Violation|7|||
170438193|NCT02166606|615941705|FG000|Overall Study|Lost to Follow-up|30|||
170438194|NCT02166606|615941705|FG000|Overall Study|Withdrawal by Subject|1|||
170438195|NCT02166606|615941705|FG000|Overall Study|Physician Decision|1|||
170438196|NCT02166606|615941705|FG000|Overall Study|Device upgrade|1|||
170438197|NCT02166606|615941705|FG000|Overall Study|Enrolled after End of Enrollment|4|||
170438198|NCT01958476|615941708|FG000|Overall Study|Parent requested exclusion from analysis|1|||
170438199|NCT01958476|615941709|FG001|Overall Study|Parent requested exclusion from analysis|0|||
170438200|NCT04476277|615941714|FG000|Overall Study|Withdrawal by Subject|0|||
170438201|NCT04476277|615941715|FG001|Overall Study|Withdrawal by Subject|0|||
170882733|NCT02706873|617579643|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
170882734|NCT02706873|617579644|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
170882735|NCT02706873|617579645|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
170882736|NCT02706873|617579646|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
170882737|NCT02706873|617579643|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
170882738|NCT02706873|617579644|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
170882739|NCT02706873|617579645|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
170882740|NCT02706873|617579646|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
170882741|NCT02706873|617579643|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
170882742|NCT02706873|617579644|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
170882743|NCT02706873|617579645|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
170438202|NCT04476277|615941716|FG002|Overall Study|Withdrawal by Subject|1|||
170438203|NCT04476277|615941717|FG003|Overall Study|Withdrawal by Subject|0|||
170438204|NCT01971645|615941718|FG000|Overall Study|Adverse Event|1|||
170882744|NCT02706873|617579646|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
170882745|NCT02706873|617579643|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
170882746|NCT02706873|617579644|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
170882747|NCT02706873|617579645|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
170882748|NCT02706873|617579646|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
170438205|NCT01971645|615941719|FG001|Overall Study|Adverse Event|0|||
170438206|NCT01971645|615941720|FG002|Overall Study|Adverse Event|0|||
170438207|NCT01971645|615941718|FG000|Overall Study|Lost to Follow-up|1|||
170438208|NCT01971645|615941719|FG001|Overall Study|Lost to Follow-up|0|||
170438209|NCT01971645|615941720|FG002|Overall Study|Lost to Follow-up|1|||
170438210|NCT01971645|615941718|FG000|Overall Study|Protocol Violation|0|||
170438211|NCT01971645|615941719|FG001|Overall Study|Protocol Violation|0|||
170438212|NCT01971645|615941720|FG002|Overall Study|Protocol Violation|1|||
170438213|NCT03727139|615941721|FG000|Overall Study|Protocol Violation|60|||
170438214|NCT01717040|615941725|FG000|Overall Study|Lost to Follow-up|2|||
170438215|NCT01717040|615941726|FG001|Overall Study|Lost to Follow-up|3|||
170438216|NCT01717040|615941725|FG000|Overall Study|Lack of Efficacy|1|||
170438217|NCT01717040|615941726|FG001|Overall Study|Lack of Efficacy|1|||
170438218|NCT01717040|615941725|FG000|Overall Study|Adverse Event|1|||
170438219|NCT01717040|615941726|FG001|Overall Study|Adverse Event|0|||
170438220|NCT01717040|615941725|FG000|Overall Study|Required Medication Change|0|||
170438221|NCT01717040|615941726|FG001|Overall Study|Required Medication Change|1|||
170438222|NCT01717040|615941725|FG000|Overall Study|New Substance Use Disorder|1|||
170438223|NCT01717040|615941726|FG001|Overall Study|New Substance Use Disorder|0|||
170438224|NCT04203823|615941727|FG000|Overall Study|Withdrawal by Subject|2|||
170438225|NCT04203823|615941728|FG001|Overall Study|Withdrawal by Subject|2|||
170438226|NCT04203823|615941727|FG000|Overall Study|Adverse Event|1|||
170438227|NCT04203823|615941728|FG001|Overall Study|Adverse Event|1|||
170438228|NCT04203823|615941727|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170438229|NCT04203823|615941728|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
170438230|NCT00835081|615941729|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
170438231|NCT00835081|615941730|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
170438232|NCT02710214|615943300|FG000|Overall Study|Lost to Follow-up|1|||
170438233|NCT02710214|615943301|FG001|Overall Study|Lost to Follow-up|0|||
170438234|NCT02710214|615943300|FG000|Overall Study|Lack of Efficacy|0|||
170438235|NCT02710214|615943301|FG001|Overall Study|Lack of Efficacy|1|||
170438236|NCT02710214|615943300|FG000|Overall Study|Death|0|||
170438237|NCT02710214|615943301|FG001|Overall Study|Death|1|||
170438238|NCT00202839|615943303|FG000|Overall Study|Adverse Event|1|||
170438239|NCT00202839|615943304|FG001|Overall Study|Adverse Event|5|||
170438240|NCT00202839|615943303|FG000|Overall Study|Physician Decision|12|||
170438241|NCT00202839|615943304|FG001|Overall Study|Physician Decision|0|||
170438242|NCT00202839|615943303|FG000|Overall Study|Withdrawal by Subject|6|||
170438243|NCT00202839|615943304|FG001|Overall Study|Withdrawal by Subject|2|||
170438244|NCT00202839|615943303|FG000|Overall Study|Protocol Violation|2|||
170438245|NCT00202839|615943304|FG001|Overall Study|Protocol Violation|1|||
170438246|NCT00202839|615943303|FG000|Overall Study|Lost to Follow-up|3|||
170438247|NCT00202839|615943304|FG001|Overall Study|Lost to Follow-up|2|||
170438248|NCT04768296|615943307|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
170438249|NCT04768296|615943308|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
170438250|NCT01490190|615943313|FG000|Overall Study|Withdrawal by Subject|9|||
170438251|NCT01490190|615943313|FG000|Overall Study|Adverse Event|17|||
170438252|NCT01490190|615943313|FG000|Overall Study|Protocol Violation|5|||
170438253|NCT01490190|615943313|FG000|Overall Study|Lost to Follow-up|13|||
170438254|NCT01490190|615943313|FG000|Overall Study|Relocation|1|||
170781693|NCT03526861|617209261|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
170438255|NCT01490190|615943313|FG000|Overall Study|Inconvenience|1|||
170438256|NCT01490190|615943313|FG000|Overall Study|Ring expulsion|2|||
170438257|NCT00084864|615943317|FG000|Overall Study|Adverse Event|1|||
170438258|NCT00084864|615943318|FG001|Overall Study|Adverse Event|0|||
170438259|NCT00084864|615943319|FG002|Overall Study|Adverse Event|0|||
170438260|NCT00084864|615943320|FG003|Overall Study|Adverse Event|0|||
170438261|NCT01456962|615943323|FG000|Overall Study|Lost to Follow-up|2|||
170438262|NCT01456962|615943324|FG001|Overall Study|Lost to Follow-up|1|||
170438263|NCT00210639|615943325|FG000|Overall Study|Lost to Follow-up|37|||
170438264|NCT00210639|615943326|FG001|Overall Study|Lost to Follow-up|29|||
170438265|NCT00210639|615943325|FG000|Overall Study|Withdrawal by Subject|8|||
170438266|NCT00210639|615943326|FG001|Overall Study|Withdrawal by Subject|1|||
170438267|NCT00210639|615943325|FG000|Overall Study|Other|18|||
170438268|NCT00210639|615943326|FG001|Overall Study|Other|12|||
170438269|NCT03599362|615943330|FG000|Overall Study|Screen Failure|3|||
170438270|NCT03707587|615943331|FG000|Overall Study|Death|0|||
170438271|NCT03707587|615943332|FG001|Overall Study|Death|1|||
170438272|NCT05029687|615943346|FG000|Overall Study|Withdrawal by Subject|4|||
170438273|NCT05029687|615943347|FG001|Overall Study|Withdrawal by Subject|0|||
170438274|NCT05029687|615943348|FG002|Overall Study|Withdrawal by Subject|2|||
170438275|NCT05029687|615943346|FG000|Overall Study|Lost to Follow-up|4|||
170438276|NCT05029687|615943347|FG001|Overall Study|Lost to Follow-up|0|||
170438277|NCT05029687|615943348|FG002|Overall Study|Lost to Follow-up|2|||
170438278|NCT05740371|615943351|FG000|Overall Study|Death|1|||
170438279|NCT00834444|615943352|FG000|First Intervention|Adverse Event|1|||
170438280|NCT00834444|615943353|FG001|First Intervention|Adverse Event|0|||
170438281|NCT00834444|615943352|FG000|First Intervention|Intolerance to Venopuncture|0|||
170438282|NCT00834444|615943353|FG001|First Intervention|Intolerance to Venopuncture|1|||
170438283|NCT00834444|615943352|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
170438284|NCT00834444|615943353|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
170438285|NCT00834444|615943352|FG000|Second Intervention|Adverse Event|1|||
170438286|NCT00834444|615943353|FG001|Second Intervention|Adverse Event|0|||
170438287|NCT03358147|615943355|FG000|Overall Study|Withdrawal by Subject|13|||
170438288|NCT03358147|615943356|FG001|Overall Study|Withdrawal by Subject|19|||
170438289|NCT03358147|615943357|FG002|Overall Study|Withdrawal by Subject|16|||
170438290|NCT03358147|615943358|FG003|Overall Study|Withdrawal by Subject|10|||
170438291|NCT03358147|615943359|FG004|Overall Study|Withdrawal by Subject|5|||
170438292|NCT03358147|615943355|FG000|Overall Study|Adverse Event|3|||
170438293|NCT03358147|615943356|FG001|Overall Study|Adverse Event|9|||
170438294|NCT03358147|615943357|FG002|Overall Study|Adverse Event|7|||
170438295|NCT03358147|615943358|FG003|Overall Study|Adverse Event|5|||
170438296|NCT03358147|615943359|FG004|Overall Study|Adverse Event|2|||
170438297|NCT03358147|615943355|FG000|Overall Study|Lost to Follow-up|4|||
170438298|NCT03358147|615943356|FG001|Overall Study|Lost to Follow-up|3|||
170438299|NCT03358147|615943357|FG002|Overall Study|Lost to Follow-up|7|||
170438300|NCT03358147|615943358|FG003|Overall Study|Lost to Follow-up|6|||
170438301|NCT03358147|615943359|FG004|Overall Study|Lost to Follow-up|4|||
170438302|NCT03358147|615943355|FG000|Overall Study|Major Protocol Deviation|11|||
170438303|NCT03358147|615943356|FG001|Overall Study|Major Protocol Deviation|3|||
170438304|NCT03358147|615943357|FG002|Overall Study|Major Protocol Deviation|2|||
170438305|NCT03358147|615943358|FG003|Overall Study|Major Protocol Deviation|3|||
170438306|NCT03358147|615943359|FG004|Overall Study|Major Protocol Deviation|1|||
170438307|NCT03358147|615943355|FG000|Overall Study|Protocol specified criteria|2|||
170438308|NCT03358147|615943356|FG001|Overall Study|Protocol specified criteria|3|||
170438309|NCT03358147|615943357|FG002|Overall Study|Protocol specified criteria|0|||
170438310|NCT03358147|615943358|FG003|Overall Study|Protocol specified criteria|3|||
170438311|NCT03358147|615943359|FG004|Overall Study|Protocol specified criteria|1|||
170438312|NCT03358147|615943355|FG000|Overall Study|Physician Decision|1|||
170438313|NCT03358147|615943356|FG001|Overall Study|Physician Decision|0|||
170438314|NCT03358147|615943357|FG002|Overall Study|Physician Decision|1|||
170438315|NCT03358147|615943358|FG003|Overall Study|Physician Decision|6|||
170438316|NCT03358147|615943359|FG004|Overall Study|Physician Decision|1|||
170438317|NCT03358147|615943355|FG000|Overall Study|Administrative reasons|0|||
170438318|NCT03358147|615943356|FG001|Overall Study|Administrative reasons|1|||
170438319|NCT03358147|615943357|FG002|Overall Study|Administrative reasons|0|||
170438320|NCT03358147|615943358|FG003|Overall Study|Administrative reasons|3|||
170438321|NCT03358147|615943359|FG004|Overall Study|Administrative reasons|0|||
170438322|NCT03358147|615943355|FG000|Overall Study|Lack of Efficacy|0|||
170438323|NCT03358147|615943356|FG001|Overall Study|Lack of Efficacy|1|||
170438324|NCT03358147|615943357|FG002|Overall Study|Lack of Efficacy|1|||
170438325|NCT03358147|615943358|FG003|Overall Study|Lack of Efficacy|0|||
170438326|NCT03358147|615943359|FG004|Overall Study|Lack of Efficacy|0|||
170438327|NCT00874822|615943363|FG000|Overall Study|excluded by criteria|8|||
170781694|NCT03526861|617209262|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
170438328|NCT02854800|615943364|FG000|Overall Study|Protocol Violation|16|||
170438329|NCT02854800|615943365|FG001|Overall Study|Protocol Violation|11|||
170781695|NCT03526861|617209263|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781696|NCT03526861|617209264|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170438330|NCT02854800|615943366|FG002|Overall Study|Protocol Violation|3|||
170438331|NCT02854800|615943364|FG000|Overall Study|Withdrawal by Subject|4|||
170438332|NCT02854800|615943365|FG001|Overall Study|Withdrawal by Subject|2|||
170438333|NCT02854800|615943366|FG002|Overall Study|Withdrawal by Subject|3|||
170438334|NCT01634139|615943367|FG000|Overall Study|Non compliant with protocol|1|||
170438335|NCT01634139|615943368|FG001|Overall Study|Non compliant with protocol|0|||
170438336|NCT01634139|615943369|FG002|Overall Study|Non compliant with protocol|0|||
170438337|NCT01634139|615943367|FG000|Overall Study|Consent withdrawn not due to AE|4|||
170438338|NCT01634139|615943368|FG001|Overall Study|Consent withdrawn not due to AE|3|||
170438339|NCT01634139|615943369|FG002|Overall Study|Consent withdrawn not due to AE|2|||
170438340|NCT01634139|615943367|FG000|Overall Study|Other|4|||
170438341|NCT01634139|615943368|FG001|Overall Study|Other|0|||
170438342|NCT01634139|615943369|FG002|Overall Study|Other|3|||
170438343|NCT01634139|615943367|FG000|Overall Study|Lost to Follow-up|0|||
170438344|NCT01634139|615943368|FG001|Overall Study|Lost to Follow-up|2|||
170438345|NCT01634139|615943369|FG002|Overall Study|Lost to Follow-up|0|||
170438346|NCT01634139|615943367|FG000|Overall Study|Not treated|1|||
170438347|NCT01634139|615943368|FG001|Overall Study|Not treated|1|||
170438348|NCT01634139|615943369|FG002|Overall Study|Not treated|0|||
170438349|NCT03073798|615943373|FG000|Overall Study|Adverse Event|1|||
170438350|NCT03073798|615943373|FG000|Overall Study|Withdrawal by Subject|1|||
170438351|NCT01186458|615943374|FG000|Overall Study|Adverse Event|1|||
170438352|NCT04281472|615943377|FG000|Stage A|Lack of Efficacy|8|||
170438353|NCT04281472|615943378|FG001|Stage A|Lack of Efficacy|0|||
170438354|NCT04281472|615943379|FG002|Stage A|Lack of Efficacy|0|||
170438355|NCT04281472|615943377|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
170438356|NCT04281472|615943378|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
170438357|NCT04281472|615943379|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
170438358|NCT04281472|615943377|FG000|Stage A|Adverse Event|20|||
170438359|NCT04281472|615943378|FG001|Stage A|Adverse Event|0|||
170438360|NCT04281472|615943379|FG002|Stage A|Adverse Event|0|||
170438361|NCT04281472|615943377|FG000|Stage A|Death|1|||
170438362|NCT04281472|615943378|FG001|Stage A|Death|0|||
170438363|NCT04281472|615943379|FG002|Stage A|Death|0|||
170438364|NCT04281472|615943377|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
170438365|NCT04281472|615943378|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
170438366|NCT04281472|615943379|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
170438367|NCT04281472|615943377|FG000|Stage A|Lost to Follow-up|2|||
170438368|NCT04281472|615943378|FG001|Stage A|Lost to Follow-up|0|||
170438369|NCT04281472|615943379|FG002|Stage A|Lost to Follow-up|0|||
170438370|NCT04281472|615943377|FG000|Stage A|Non-compliance with study drug|1|||
170438371|NCT04281472|615943378|FG001|Stage A|Non-compliance with study drug|0|||
170438372|NCT04281472|615943379|FG002|Stage A|Non-compliance with study drug|0|||
170438373|NCT04281472|615943377|FG000|Stage A|Physician Decision|1|||
170781697|NCT03526861|617209265|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781698|NCT03526861|617209266|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170882749|NCT02706873|617579643|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
170882750|NCT02706873|617579644|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
170882751|NCT02706873|617579645|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
170882752|NCT02706873|617579646|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
170882753|NCT02706873|617579643|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
170882754|NCT02706873|617579644|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
170882755|NCT02706873|617579645|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
170882756|NCT02706873|617579646|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
170882757|NCT02706873|617579643|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
170882758|NCT02706873|617579644|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
170882759|NCT02706873|617579645|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
170882760|NCT02706873|617579646|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
170882761|NCT02706873|617579643|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
170882762|NCT02706873|617579644|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
170882763|NCT02706873|617579645|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
170882764|NCT02706873|617579646|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
170882765|NCT00382993|617579648|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
170882766|NCT00382993|617579649|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
170882767|NCT00382993|617579648|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
170882768|NCT00382993|617579649|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
170882769|NCT00382993|617579648|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
170781699|NCT03526861|617209267|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781700|NCT03526861|617209268|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781701|NCT03526861|617209260|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
170781702|NCT03526861|617209261|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
170781703|NCT03526861|617209262|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
170781704|NCT03526861|617209263|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
170438374|NCT04281472|615943378|FG001|Stage A|Physician Decision|0|||
170438375|NCT04281472|615943379|FG002|Stage A|Physician Decision|0|||
170438376|NCT04281472|615943377|FG000|Stage A|Prohibited medications|2|||
170438377|NCT04281472|615943378|FG001|Stage A|Prohibited medications|0|||
170438378|NCT04281472|615943379|FG002|Stage A|Prohibited medications|0|||
170438379|NCT04281472|615943377|FG000|Stage A|Withdrawal by Subject|11|||
170438380|NCT04281472|615943378|FG001|Stage A|Withdrawal by Subject|0|||
170438381|NCT04281472|615943379|FG002|Stage A|Withdrawal by Subject|0|||
170438382|NCT04281472|615943377|FG000|Stage A|Other|5|||
170438383|NCT04281472|615943378|FG001|Stage A|Other|0|||
170438384|NCT04281472|615943379|FG002|Stage A|Other|0|||
170438385|NCT04281472|615943377|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
170438386|NCT04281472|615943378|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
170438387|NCT04281472|615943379|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
170438388|NCT04281472|615943377|FG000|Stage B|Adverse Event|0|||
170438389|NCT04281472|615943378|FG001|Stage B|Adverse Event|3|||
170438390|NCT04281472|615943379|FG002|Stage B|Adverse Event|0|||
170438391|NCT04281472|615943377|FG000|Stage B|Death|0|||
170438392|NCT04281472|615943378|FG001|Stage B|Death|0|||
170438393|NCT04281472|615943379|FG002|Stage B|Death|1|||
170438394|NCT04281472|615943377|FG000|Stage B|Lack of Efficacy|0|||
170438395|NCT04281472|615943378|FG001|Stage B|Lack of Efficacy|0|||
170438396|NCT04281472|615943379|FG002|Stage B|Lack of Efficacy|1|||
170438397|NCT04281472|615943377|FG000|Stage B|Lost to Follow-up|0|||
170438398|NCT04281472|615943378|FG001|Stage B|Lost to Follow-up|0|||
170438399|NCT04281472|615943379|FG002|Stage B|Lost to Follow-up|2|||
170438400|NCT04281472|615943377|FG000|Stage B|Prohibited medications|0|||
170438401|NCT04281472|615943378|FG001|Stage B|Prohibited medications|2|||
170438402|NCT04281472|615943379|FG002|Stage B|Prohibited medications|1|||
170438403|NCT04281472|615943377|FG000|Stage B|Protocol Violation|0|||
170438404|NCT04281472|615943378|FG001|Stage B|Protocol Violation|1|||
170438405|NCT04281472|615943379|FG002|Stage B|Protocol Violation|1|||
170438406|NCT04281472|615943377|FG000|Stage B|Sponsor decision|0|||
170438407|NCT04281472|615943378|FG001|Stage B|Sponsor decision|0|||
170438408|NCT04281472|615943379|FG002|Stage B|Sponsor decision|1|||
170438409|NCT04281472|615943377|FG000|Stage B|Withdrawal by Subject|0|||
170438410|NCT04281472|615943378|FG001|Stage B|Withdrawal by Subject|3|||
170438411|NCT04281472|615943379|FG002|Stage B|Withdrawal by Subject|3|||
170438412|NCT04281472|615943377|FG000|Stage B|Other|0|||
170438413|NCT04281472|615943378|FG001|Stage B|Other|3|||
170438414|NCT04281472|615943379|FG002|Stage B|Other|0|||
170438415|NCT05278858|615943380|FG000|Overall Study|Withdrawal by Subject|1|||
170438416|NCT00840658|615943381|FG000|Overall Study|Death|2|||
170438417|NCT00840658|615943382|FG001|Overall Study|Death|2|||
170438418|NCT00840658|615943383|FG002|Overall Study|Death|3|||
170438419|NCT00840658|615943384|FG003|Overall Study|Death|3|||
170438420|NCT00840658|615943381|FG000|Overall Study|Lost to Follow-up|3|||
170438421|NCT00840658|615943382|FG001|Overall Study|Lost to Follow-up|1|||
170438422|NCT00840658|615943383|FG002|Overall Study|Lost to Follow-up|2|||
170438423|NCT00840658|615943384|FG003|Overall Study|Lost to Follow-up|1|||
170438424|NCT01867658|615943385|FG000|Overall Study|Withdrawal by Subject|6|||
170438425|NCT01867658|615943385|FG000|Overall Study|Death|2|||
170438426|NCT01867658|615943385|FG000|Overall Study|Subject could not be contacted|1|||
170438427|NCT03101358|615943386|FG000|Overall Study|Non-compliance with study schedule|1|||
170438428|NCT03101358|615943387|FG001|Overall Study|Non-compliance with study schedule|0|||
170438429|NCT03101358|615943388|FG002|Overall Study|Non-compliance with study schedule|0|||
170438430|NCT03101358|615943389|FG003|Overall Study|Non-compliance with study schedule|1|||
170438431|NCT03101358|615943386|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
170438432|NCT03101358|615943387|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
170438433|NCT03101358|615943388|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
170438434|NCT03101358|615943389|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
170438435|NCT03101358|615943386|FG000|Overall Study|Physician Decision|1|||
170781705|NCT03526861|617209264|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
170781706|NCT03526861|617209265|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
170781707|NCT03526861|617209266|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
170781708|NCT03526861|617209267|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
170781709|NCT03526861|617209268|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
170781710|NCT03526861|617209260|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781711|NCT03526861|617209261|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781712|NCT03526861|617209262|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781713|NCT03526861|617209263|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
170438436|NCT03101358|615943387|FG001|Overall Study|Physician Decision|0|||
170438437|NCT03101358|615943388|FG002|Overall Study|Physician Decision|0|||
170438438|NCT03101358|615943389|FG003|Overall Study|Physician Decision|3|||
170438439|NCT03101358|615943386|FG000|Overall Study|Adverse Event|0|||
170438440|NCT03101358|615943387|FG001|Overall Study|Adverse Event|0|||
170438441|NCT03101358|615943388|FG002|Overall Study|Adverse Event|1|||
170438442|NCT03101358|615943389|FG003|Overall Study|Adverse Event|0|||
170438443|NCT03101358|615943386|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
170438444|NCT03101358|615943387|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
170438445|NCT03101358|615943388|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
170537117|NCT04044690|616311535|FG001|Period 1|Death|1|||
170438446|NCT03101358|615943389|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
170438447|NCT03101358|615943386|FG000|Overall Study|Lost to Follow-up|1|||
170438448|NCT03101358|615943387|FG001|Overall Study|Lost to Follow-up|0|||
170781714|NCT03526861|617209264|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
170781715|NCT03526861|617209265|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781716|NCT03526861|617209266|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
170781717|NCT03526861|617209267|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781718|NCT03526861|617209268|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781719|NCT03526861|617209260|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
170781720|NCT03526861|617209261|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
170781721|NCT03526861|617209262|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
170781722|NCT03526861|617209263|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
170781723|NCT03526861|617209264|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
170781724|NCT03526861|617209265|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
170781725|NCT03526861|617209266|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
170781726|NCT03526861|617209267|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
170781727|NCT03526861|617209268|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
170781728|NCT03526861|617209260|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781729|NCT03526861|617209261|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781730|NCT03526861|617209262|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781731|NCT03526861|617209263|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
170781732|NCT03526861|617209264|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781733|NCT03526861|617209265|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781734|NCT03526861|617209266|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781735|NCT03526861|617209267|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781736|NCT03526861|617209268|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781737|NCT03526861|617209260|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781738|NCT03526861|617209261|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781739|NCT03526861|617209262|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781740|NCT03526861|617209263|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781741|NCT03526861|617209264|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781742|NCT03526861|617209265|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781743|NCT03526861|617209266|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781744|NCT03526861|617209267|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
170781745|NCT03526861|617209268|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
170781746|NCT03526861|617209260|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
170781747|NCT03526861|617209261|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
170781748|NCT03526861|617209262|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
170781749|NCT03526861|617209263|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
170781750|NCT03526861|617209264|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
170781751|NCT03526861|617209265|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
170781752|NCT03526861|617209266|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
170781753|NCT03526861|617209267|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
170781754|NCT03526861|617209268|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
170438449|NCT03101358|615943388|FG002|Overall Study|Lost to Follow-up|0|||
170438450|NCT03101358|615943389|FG003|Overall Study|Lost to Follow-up|1|||
170438451|NCT00474058|615943390|FG000|Overall Study|Adverse Event|11|||
170438452|NCT00474058|615943391|FG001|Overall Study|Adverse Event|6|||
170438453|NCT00474058|615943390|FG000|Overall Study|Lack of Efficacy|0|||
170438454|NCT00474058|615943391|FG001|Overall Study|Lack of Efficacy|4|||
170537118|NCT04044690|616311534|FG000|Period 1|Other: Unspecified|1|||
170537119|NCT04044690|616311535|FG001|Period 1|Other: Unspecified|0|||
170537120|NCT04044690|616311534|FG000|Period 2|Lack of Efficacy|0|||
170781755|NCT03526861|617209260|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781756|NCT03526861|617209261|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781757|NCT03526861|617209262|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781758|NCT03526861|617209263|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781759|NCT03526861|617209264|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781760|NCT03526861|617209265|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781761|NCT03526861|617209266|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781762|NCT03526861|617209267|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
170781763|NCT03526861|617209268|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
170781764|NCT04089371|617209271|FG000|Overall Study|Withdrawal by Subject|0|||
170781765|NCT04089371|617209272|FG001|Overall Study|Withdrawal by Subject|1|||
170781766|NCT04089371|617209271|FG000|Overall Study|Study terminated early|0|||
170781767|NCT04089371|617209272|FG001|Overall Study|Study terminated early|9|||
170781768|NCT02365766|617209273|FG000|Overall Study|Withdrawal by Subject|0|||
170781769|NCT02365766|617209274|FG001|Overall Study|Withdrawal by Subject|0|||
170781770|NCT02365766|617209275|FG002|Overall Study|Withdrawal by Subject|1|||
170781771|NCT02365766|617209273|FG000|Overall Study|Eligibility Criteria Not Met|0|||
170781772|NCT02365766|617209274|FG001|Overall Study|Eligibility Criteria Not Met|0|||
170781773|NCT02365766|617209275|FG002|Overall Study|Eligibility Criteria Not Met|1|||
170781774|NCT00650104|617209279|FG000|Overall Study|Adverse Event|17|||
170781775|NCT00650104|617209279|FG000|Overall Study|Death|2|||
170781776|NCT00650104|617209279|FG000|Overall Study|Withdrawal by Subject|11|||
170781777|NCT00650104|617209279|FG000|Overall Study|Physician Decision|7|||
170781778|NCT00650104|617209279|FG000|Overall Study|Lost to Follow-up|1|||
170781779|NCT00650104|617209279|FG000|Overall Study|Non-compliance|2|||
170781780|NCT00650104|617209279|FG000|Overall Study|Sponsor Terminated Dosing|1|||
170781781|NCT04812535|617209280|FG000|Overall Study|Withdrawal by Subject|0|||
170781782|NCT04812535|617209281|FG001|Overall Study|Withdrawal by Subject|0|||
170781783|NCT04812535|617209282|FG002|Overall Study|Withdrawal by Subject|0|||
170781784|NCT04812535|617209283|FG003|Overall Study|Withdrawal by Subject|1|||
170781785|NCT04812535|617209280|FG000|Overall Study|Death|7|||
170781786|NCT04812535|617209281|FG001|Overall Study|Death|2|||
170781787|NCT04812535|617209282|FG002|Overall Study|Death|4|||
170781788|NCT04812535|617209283|FG003|Overall Study|Death|1|||
170781789|NCT04812535|617209280|FG000|Overall Study|Due to premature study termination by sponsor|2|||
170781790|NCT04812535|617209281|FG001|Overall Study|Due to premature study termination by sponsor|0|||
170781791|NCT04812535|617209282|FG002|Overall Study|Due to premature study termination by sponsor|1|||
170781792|NCT04812535|617209283|FG003|Overall Study|Due to premature study termination by sponsor|3|||
170781793|NCT01532388|617209284|FG000|3-month Follow-up|Lost to Follow-up|68|||
170781794|NCT01532388|617209285|FG001|3-month Follow-up|Lost to Follow-up|68|||
170781795|NCT01532388|617209284|FG000|6-month Follow-up|Lost to Follow-up|74|||
170781796|NCT01532388|617209285|FG001|6-month Follow-up|Lost to Follow-up|66|||
170781797|NCT01532388|617209284|FG000|12-month Follow-up|Lost to Follow-up|69|||
170781798|NCT01532388|617209285|FG001|12-month Follow-up|Lost to Follow-up|67|||
170781799|NCT02323321|617209289|FG000|Overall Study|Re-Transplant|1|||
170781800|NCT02323321|617209289|FG000|Overall Study|Death|12|||
170781801|NCT00446225|617209290|FG000|Overall Study|Protocol Violation|1|||
170781802|NCT00446225|617209291|FG001|Overall Study|Protocol Violation|0|||
170781803|NCT05633407|617209292|FG000|Overall Study|Physician Decision|2|||
170781804|NCT05633407|617209293|FG001|Overall Study|Physician Decision|0|||
170781805|NCT05633407|617209292|FG000|Overall Study|Adverse Event|1|||
170781806|NCT05633407|617209293|FG001|Overall Study|Adverse Event|0|||
170781807|NCT05633407|617209292|FG000|Overall Study|Withdrawal by Subject|1|||
170781808|NCT05633407|617209293|FG001|Overall Study|Withdrawal by Subject|0|||
170781809|NCT05633407|617209292|FG000|Overall Study|Other|1|||
170781810|NCT05633407|617209293|FG001|Overall Study|Other|1|||
170781811|NCT02500758|617209296|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
170781812|NCT02500758|617209297|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
170781813|NCT02500758|617209296|FG000|Washout (1 Week)|Lost to Follow-up|2|||
170781814|NCT02500758|617209297|FG001|Washout (1 Week)|Lost to Follow-up|2|||
170781815|NCT02500758|617209296|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
170781816|NCT02500758|617209297|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
170781817|NCT02500758|617209296|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
170781818|NCT02500758|617209297|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
170781819|NCT02500758|617209296|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
170781820|NCT02500758|617209297|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
170781821|NCT03271489|617209300|FG000|Double-Blind (DB) Period|Adverse Event|4|||
170781822|NCT03271489|617209301|FG001|Double-Blind (DB) Period|Adverse Event|1|||
170438455|NCT00474058|615943390|FG000|Overall Study|Withdrawal by Subject|11|||
170438456|NCT00474058|615943391|FG001|Overall Study|Withdrawal by Subject|7|||
170438457|NCT00474058|615943390|FG000|Overall Study|Other|2|||
170438458|NCT00474058|615943391|FG001|Overall Study|Other|0|||
170438459|NCT02640235|615943396|FG000|Overall Study|Withdrawal by Subject|7|||
170438460|NCT02640235|615943397|FG001|Overall Study|Withdrawal by Subject|6|||
170438461|NCT02640235|615943396|FG000|Overall Study|Lost to Follow-up|4|||
170438462|NCT02640235|615943397|FG001|Overall Study|Lost to Follow-up|3|||
170438463|NCT02640235|615943396|FG000|Overall Study|Death|2|||
170438464|NCT02640235|615943397|FG001|Overall Study|Death|3|||
170438465|NCT02640235|615943396|FG000|Overall Study|Other|1|||
170438466|NCT02640235|615943397|FG001|Overall Study|Other|2|||
170438467|NCT01149057|615943401|FG000|Overall Study|Lack of Efficacy|16|||
170781823|NCT03271489|617209300|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
170781824|NCT03271489|617209301|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
170781825|NCT03271489|617209300|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
170781826|NCT03271489|617209301|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
170781827|NCT03271489|617209300|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
170781828|NCT03271489|617209301|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
170781829|NCT03271489|617209300|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
170781830|NCT03271489|617209301|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
170781831|NCT03271489|617209300|FG000|Double-Blind (DB) Period|Other|6|||
170781832|NCT03271489|617209301|FG001|Double-Blind (DB) Period|Other|1|||
170781833|NCT03271489|617209300|FG000|Double-Blind (DB) Period|Missing|1|||
170781834|NCT03271489|617209301|FG001|Double-Blind (DB) Period|Missing|0|||
170781835|NCT03271489|617209300|FG000|Open-Label (OL) Period|Adverse Event|2|||
170781836|NCT03271489|617209301|FG001|Open-Label (OL) Period|Adverse Event|0|||
170781837|NCT03271489|617209300|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
170781838|NCT03271489|617209301|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
170781839|NCT03271489|617209300|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
170781840|NCT03271489|617209301|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
170781841|NCT03271489|617209300|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
170781842|NCT03271489|617209301|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
170781843|NCT03271489|617209300|FG000|Open-Label (OL) Period|No Specified|2|||
170781844|NCT03271489|617209301|FG001|Open-Label (OL) Period|No Specified|2|||
170781845|NCT03271489|617209300|FG000|Open-Label (OL) Period|Missing|2|||
170781846|NCT03271489|617209301|FG001|Open-Label (OL) Period|Missing|0|||
170781847|NCT03271489|617209300|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
170781848|NCT03271489|617209301|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
170781849|NCT03271489|617209300|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
170781850|NCT03271489|617209301|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
170781851|NCT03271489|617209300|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
170781852|NCT03271489|617209301|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
170781853|NCT03271489|617209300|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
170781854|NCT03271489|617209301|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
170781855|NCT03271489|617209300|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
170781856|NCT03271489|617209301|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
170781857|NCT03271489|617209300|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
170781858|NCT03271489|617209301|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
170781859|NCT03271489|617209300|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
170781860|NCT03271489|617209301|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
170781861|NCT03271489|617209300|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
170781862|NCT03271489|617209301|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
170781863|NCT02886286|617209302|FG000|Overall Study|pump motor stall|0|||
170781864|NCT02886286|617209303|FG001|Overall Study|pump motor stall|1|||
170781865|NCT04838613|617209304|FG000|Overall Study|Withdrawal by Subject|3|||
170781866|NCT04838613|617209305|FG001|Overall Study|Withdrawal by Subject|6|||
170781867|NCT04838613|617209304|FG000|Overall Study|Protocol Deviation|3|||
170781868|NCT04838613|617209305|FG001|Overall Study|Protocol Deviation|2|||
170781869|NCT04838613|617209304|FG000|Overall Study|Technical Problems|0|||
170781870|NCT04838613|617209305|FG001|Overall Study|Technical Problems|5|||
170781871|NCT04838613|617209304|FG000|Overall Study|Physician Decision|2|||
170781872|NCT04838613|617209305|FG001|Overall Study|Physician Decision|0|||
170781873|NCT02671435|617209308|FG000|Overall Study|Death|1|||
170781874|NCT02671435|617209309|FG001|Overall Study|Death|3|||
170781875|NCT02671435|617209310|FG002|Overall Study|Death|0|||
170781876|NCT02671435|617209311|FG003|Overall Study|Death|16|||
170781877|NCT02671435|617209312|FG004|Overall Study|Death|14|||
170438468|NCT01149057|615943401|FG000|Overall Study|Adverse Event|13|||
170781878|NCT02671435|617209313|FG005|Overall Study|Death|29|||
170438469|NCT01149057|615943401|FG000|Overall Study|Withdrawal by Subject|9|||
170438470|NCT01149057|615943401|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
170438471|NCT01149057|615943401|FG000|Overall Study|B Cell Depletion|4|||
170438472|NCT01149057|615943401|FG000|Overall Study|Participant Non-Compliance|2|||
170438473|NCT01149057|615943401|FG000|Overall Study|Lost to Follow-up|1|||
170438474|NCT01149057|615943401|FG000|Overall Study|High Parathyroid Hormone Value|1|||
170438475|NCT01149057|615943401|FG000|Overall Study|Other|6|||
170438476|NCT02372006|615943403|FG000|Overall Study|Progressive disease|8|||
170438477|NCT02372006|615943404|FG001|Overall Study|Progressive disease|7|||
170438478|NCT02372006|615943405|FG002|Overall Study|Progressive disease|34|||
170438479|NCT02372006|615943403|FG000|Overall Study|Dose limiting toxicity|0|||
170438480|NCT02372006|615943404|FG001|Overall Study|Dose limiting toxicity|1|||
170438481|NCT02372006|615943405|FG002|Overall Study|Dose limiting toxicity|0|||
170438482|NCT02372006|615943403|FG000|Overall Study|Adverse Event|0|||
170438483|NCT02372006|615943404|FG001|Overall Study|Adverse Event|0|||
170438484|NCT02372006|615943405|FG002|Overall Study|Adverse Event|3|||
170438485|NCT02372006|615943403|FG000|Overall Study|Withdrawal by Subject|0|||
170438486|NCT02372006|615943404|FG001|Overall Study|Withdrawal by Subject|1|||
170438487|NCT02372006|615943405|FG002|Overall Study|Withdrawal by Subject|1|||
170438488|NCT02372006|615943403|FG000|Overall Study|Other reason for not completing|0|||
170438489|NCT02372006|615943404|FG001|Overall Study|Other reason for not completing|0|||
170438490|NCT02372006|615943405|FG002|Overall Study|Other reason for not completing|1|||
170438491|NCT04133311|615943409|FG000|Period 1 Double Masked Treatment Period|Death|1|||
170438492|NCT04133311|615943410|FG001|Period 1 Double Masked Treatment Period|Death|0|||
170438493|NCT04133311|615943411|FG002|Period 1 Double Masked Treatment Period|Death|0|||
170438494|NCT04133311|615943412|FG003|Period 1 Double Masked Treatment Period|Death|0|||
170438495|NCT04133311|615943409|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
170438496|NCT04133311|615943410|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
170438497|NCT04133311|615943411|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
170438498|NCT04133311|615943412|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
170438499|NCT04133311|615943409|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
170438500|NCT04133311|615943410|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
170438501|NCT04133311|615943411|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
170438502|NCT04133311|615943412|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
170438503|NCT04133311|615943409|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
170438504|NCT04133311|615943410|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
170438505|NCT04133311|615943411|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
170438506|NCT04133311|615943412|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
170438507|NCT04133311|615943409|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
170438508|NCT04133311|615943410|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
170438509|NCT04133311|615943411|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
170537121|NCT04044690|616311535|FG001|Period 2|Lack of Efficacy|1|||
170537122|NCT04044690|616311534|FG000|Period 2|Adverse Event|0|||
170537123|NCT04044690|616311535|FG001|Period 2|Adverse Event|1|||
170537124|NCT04044690|616311534|FG000|Period 2|Physician Decision|0|||
170882770|NCT00382993|617579649|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
170882771|NCT00382993|617579648|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
170537125|NCT04044690|616311535|FG001|Period 2|Physician Decision|2|||
170537126|NCT04044690|616311534|FG000|Period 2|Withdrawal by Subject|5|||
170537127|NCT04044690|616311535|FG001|Period 2|Withdrawal by Subject|5|||
170537128|NCT04044690|616311534|FG000|Period 2|Lost to Follow-up|0|||
170537129|NCT04044690|616311535|FG001|Period 2|Lost to Follow-up|1|||
170537130|NCT04044690|616311534|FG000|Period 2|Site Terminated by Sponsor|1|||
170537131|NCT04044690|616311535|FG001|Period 2|Site Terminated by Sponsor|3|||
170633036|NCT00998296|616668453|FG008|Overall Study|Reason other than those specified above|0|||
170882772|NCT00382993|617579649|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
170882773|NCT00382993|617579648|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
170882774|NCT00382993|617579649|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
170882775|NCT00382993|617579648|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
170882776|NCT00382993|617579649|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
170882777|NCT00382993|617579648|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
170882778|NCT00382993|617579649|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
170882779|NCT00382993|617579648|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
170882780|NCT00382993|617579649|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
170438510|NCT04133311|615943412|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
170438511|NCT04133311|615943409|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
170438512|NCT04133311|615943410|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
170537132|NCT04044690|616311534|FG000|Period 2|Study Terminated by Sponsor|8|||
170537133|NCT04044690|616311535|FG001|Period 2|Study Terminated by Sponsor|3|||
170438513|NCT04133311|615943411|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
170438514|NCT04133311|615943412|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
170438515|NCT04133311|615943409|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
170438516|NCT04133311|615943410|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
170438517|NCT04133311|615943411|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
170438518|NCT04133311|615943412|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
170438519|NCT04133311|615943409|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
170438520|NCT04133311|615943410|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
170438521|NCT04133311|615943411|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
170438522|NCT04133311|615943412|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
170438523|NCT00295490|615943417|FG000|Overall Study|Protocol Violation|0|||
170438524|NCT00295490|615943418|FG001|Overall Study|Protocol Violation|0|||
170438525|NCT00295490|615943419|FG002|Overall Study|Protocol Violation|3|||
170438526|NCT00295490|615943420|FG003|Overall Study|Protocol Violation|3|||
170438527|NCT00295490|615943417|FG000|Overall Study|Withdrawal by Subject|0|||
170438528|NCT00295490|615943418|FG001|Overall Study|Withdrawal by Subject|2|||
170438529|NCT00295490|615943419|FG002|Overall Study|Withdrawal by Subject|0|||
170438530|NCT00295490|615943420|FG003|Overall Study|Withdrawal by Subject|1|||
170438531|NCT00295490|615943417|FG000|Overall Study|Lost to Follow-up|0|||
170438532|NCT00295490|615943418|FG001|Overall Study|Lost to Follow-up|0|||
170438533|NCT00295490|615943419|FG002|Overall Study|Lost to Follow-up|1|||
170438534|NCT00295490|615943420|FG003|Overall Study|Lost to Follow-up|0|||
170438535|NCT00295490|615943417|FG000|Overall Study|Adverse Event|1|||
170438536|NCT00295490|615943418|FG001|Overall Study|Adverse Event|0|||
170438537|NCT00295490|615943419|FG002|Overall Study|Adverse Event|0|||
170781879|NCT02671435|617209314|FG006|Overall Study|Death|34|||
170438538|NCT00295490|615943420|FG003|Overall Study|Adverse Event|0|||
170438539|NCT00295490|615943417|FG000|Overall Study|Other|0|||
170438540|NCT00295490|615943418|FG001|Overall Study|Other|2|||
170438541|NCT00295490|615943419|FG002|Overall Study|Other|0|||
170438542|NCT00295490|615943420|FG003|Overall Study|Other|1|||
170438543|NCT03255980|615943421|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
170438544|NCT03255980|615943422|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
170438545|NCT03255980|615943423|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
170438546|NCT03255980|615943424|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
170537134|NCT04044690|616311534|FG000|Period 2|Death|1|||
170781880|NCT02671435|617209315|FG007|Overall Study|Death|28|||
170438547|NCT03255980|615943421|FG000|Overall Study|Adverse Event|1|||
170438548|NCT03255980|615943422|FG001|Overall Study|Adverse Event|1|||
170438549|NCT03255980|615943423|FG002|Overall Study|Adverse Event|0|||
170438550|NCT03255980|615943424|FG003|Overall Study|Adverse Event|1|||
170438551|NCT03255980|615943421|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
170438552|NCT03255980|615943422|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
170438553|NCT03255980|615943423|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
170438554|NCT03255980|615943424|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
170438555|NCT03255980|615943421|FG000|Overall Study|Lost to Follow-up|1|||
170438556|NCT03255980|615943422|FG001|Overall Study|Lost to Follow-up|1|||
170438557|NCT03255980|615943423|FG002|Overall Study|Lost to Follow-up|0|||
170438558|NCT03255980|615943424|FG003|Overall Study|Lost to Follow-up|3|||
170438559|NCT03255980|615943421|FG000|Overall Study|Withdrawal by Subject|0|||
170438560|NCT03255980|615943422|FG001|Overall Study|Withdrawal by Subject|1|||
170438561|NCT03255980|615943423|FG002|Overall Study|Withdrawal by Subject|0|||
170438562|NCT03255980|615943424|FG003|Overall Study|Withdrawal by Subject|3|||
170438563|NCT01559116|615943432|FG000|Overall Study|Adverse Event|10|||
170438564|NCT01559116|615943432|FG000|Overall Study|Lack of Efficacy|1|||
170438565|NCT01559116|615943432|FG000|Overall Study|Lost to Follow-up|1|||
170438566|NCT01559116|615943432|FG000|Overall Study|Protocol Violation|1|||
170438567|NCT01559116|615943432|FG000|Overall Study|Withdrawal by Subject|4|||
170438568|NCT01559116|615943432|FG000|Overall Study|other than stated above|9|||
170438569|NCT06475729|615943433|FG000|Overall Study|Withdrawal by Subject|2|||
170438570|NCT06475729|615943434|FG001|Overall Study|Withdrawal by Subject|1|||
170438571|NCT06475729|615943433|FG000|Overall Study|Randomized but did not receive any dose|3|||
170438572|NCT06475729|615943434|FG001|Overall Study|Randomized but did not receive any dose|2|||
170438573|NCT06475729|615943433|FG000|Overall Study|Lost to Follow-up|1|||
170537135|NCT04044690|616311535|FG001|Period 2|Death|0|||
170438574|NCT06475729|615943434|FG001|Overall Study|Lost to Follow-up|2|||
170438575|NCT06475729|615943433|FG000|Overall Study|Physician Decision|5|||
170438576|NCT06475729|615943434|FG001|Overall Study|Physician Decision|2|||
170438577|NCT06475729|615943433|FG000|Overall Study|Adverse Event|1|||
170438578|NCT06475729|615943434|FG001|Overall Study|Adverse Event|1|||
170438579|NCT03867760|615943439|FG000|Overall Study|Lost to Follow-up|2|||
170438580|NCT03867760|615943440|FG001|Overall Study|Lost to Follow-up|3|||
170438581|NCT03867760|615943439|FG000|Overall Study|Withdrawal by Subject|1|||
170438582|NCT03867760|615943440|FG001|Overall Study|Withdrawal by Subject|2|||
170438583|NCT03867760|615943439|FG000|Overall Study|subject could not meet study logistics|3|||
170537136|NCT04044690|616311534|FG000|Period 2|Other: Unspecified|1|||
170781881|NCT02671435|617209316|FG008|Overall Study|Death|19|||
170438584|NCT03867760|615943440|FG001|Overall Study|subject could not meet study logistics|3|||
170438585|NCT01401062|615943441|FG000|Overall Study|Death|9|||
170438586|NCT01401062|615943442|FG001|Overall Study|Death|7|||
170438587|NCT01401062|615943441|FG000|Overall Study|Physician Decision|1|||
170438588|NCT01401062|615943442|FG001|Overall Study|Physician Decision|0|||
170438589|NCT01401062|615943441|FG000|Overall Study|Withdrawal by Subject|1|||
170438590|NCT01401062|615943442|FG001|Overall Study|Withdrawal by Subject|1|||
170438591|NCT00757172|615943443|FG000|Overall Study|Withdrawal by Subject|4|||
170438592|NCT00757172|615943443|FG000|Overall Study|Physician Decision|3|||
170438593|NCT00757172|615943443|FG000|Overall Study|Progression|4|||
170438594|NCT01942135|615943445|FG000|Overall Study|Adverse Event|21|||
170438595|NCT01942135|615943446|FG001|Overall Study|Adverse Event|7|||
170438596|NCT01942135|615943445|FG000|Overall Study|Global Deterioration of Health Status|9|||
170438597|NCT01942135|615943446|FG001|Overall Study|Global Deterioration of Health Status|6|||
170438598|NCT01942135|615943445|FG000|Overall Study|Randomized Not Treated|2|||
170438599|NCT01942135|615943446|FG001|Overall Study|Randomized Not Treated|2|||
170438600|NCT01942135|615943445|FG000|Overall Study|Death|2|||
170438601|NCT01942135|615943446|FG001|Overall Study|Death|1|||
170438602|NCT01942135|615943445|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
170438603|NCT01942135|615943446|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
170438604|NCT01942135|615943445|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
170438605|NCT01942135|615943446|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
170438606|NCT01942135|615943445|FG000|Overall Study|Withdrawal by Subject|4|||
170438607|NCT01942135|615943446|FG001|Overall Study|Withdrawal by Subject|3|||
170438608|NCT01942135|615943445|FG000|Overall Study|Protocol Violation|1|||
170438609|NCT01942135|615943446|FG001|Overall Study|Protocol Violation|0|||
170438610|NCT01942135|615943445|FG000|Overall Study|Other|19|||
170438611|NCT01942135|615943446|FG001|Overall Study|Other|4|||
170438612|NCT01499043|615943448|FG000|Overall Study|Progressive disease (radiographic)|2|||
170438613|NCT01499043|615943448|FG000|Overall Study|Progressive disease (clinical)|1|||
170438614|NCT01499043|615943448|FG000|Overall Study|Withdrawal by Subject|2|||
170438615|NCT01499043|615943448|FG000|Overall Study|Adverse Event|1|||
170438616|NCT00438633|615943451|FG000|Overall Study|Withdrawal by Subject|1|||
170438617|NCT00438633|615943452|FG001|Overall Study|Withdrawal by Subject|0|||
170438618|NCT00438633|615943451|FG000|Overall Study|Lost to Follow-up|15|||
170438619|NCT00438633|615943452|FG001|Overall Study|Lost to Follow-up|17|||
170438620|NCT04569084|615943453|FG000|Overall Study|Adverse Event|10|||
170438621|NCT04569084|615943454|FG001|Overall Study|Adverse Event|14|||
170438622|NCT04569084|615943453|FG000|Overall Study|Death|2|||
170438623|NCT04569084|615943454|FG001|Overall Study|Death|3|||
170438624|NCT04569084|615943453|FG000|Overall Study|Lost to Follow-up|1|||
170438625|NCT04569084|615943454|FG001|Overall Study|Lost to Follow-up|1|||
170438626|NCT04569084|615943453|FG000|Overall Study|Physician Decision|3|||
170438627|NCT04569084|615943454|FG001|Overall Study|Physician Decision|3|||
170438628|NCT04569084|615943453|FG000|Overall Study|Protocol Violation|2|||
170438629|NCT04569084|615943454|FG001|Overall Study|Protocol Violation|1|||
170438630|NCT04569084|615943453|FG000|Overall Study|Withdrawal by Subject|20|||
170438631|NCT04569084|615943454|FG001|Overall Study|Withdrawal by Subject|21|||
170438632|NCT04569084|615943453|FG000|Overall Study|Study terminated by sponsor|26|||
170438633|NCT04569084|615943454|FG001|Overall Study|Study terminated by sponsor|23|||
170438634|NCT04569084|615943453|FG000|Overall Study|Other|3|||
170438635|NCT04569084|615943454|FG001|Overall Study|Other|5|||
170438636|NCT01520987|615944949|FG000|Overall Study|Withdrawal by Subject|1|||
170438637|NCT01520987|615944950|FG001|Overall Study|Withdrawal by Subject|0|||
170438638|NCT01520987|615944951|FG002|Overall Study|Withdrawal by Subject|0|||
170438639|NCT01520987|615944952|FG003|Overall Study|Withdrawal by Subject|0|||
170438640|NCT01520987|615944953|FG004|Overall Study|Withdrawal by Subject|0|||
170438641|NCT01520987|615944954|FG005|Overall Study|Withdrawal by Subject|1|||
170438642|NCT01520987|615944955|FG006|Overall Study|Withdrawal by Subject|0|||
170438643|NCT01520987|615944956|FG007|Overall Study|Withdrawal by Subject|0|||
170438644|NCT02005562|615944957|FG000|Overall Study|Death|2|||
170633037|NCT00998296|616668454|FG009|Overall Study|Reason other than those specified above|1|||
170438645|NCT02005562|615944958|FG001|Overall Study|Death|2|||
170438646|NCT02005562|615944957|FG000|Overall Study|Graft loss|7|||
170438647|NCT02005562|615944958|FG001|Overall Study|Graft loss|6|||
170438648|NCT02005562|615944957|FG000|Overall Study|Withdrawal by Subject|2|||
170438649|NCT02005562|615944958|FG001|Overall Study|Withdrawal by Subject|2|||
170438650|NCT02005562|615944957|FG000|Overall Study|No transplant|1|||
170438651|NCT02005562|615944958|FG001|Overall Study|No transplant|4|||
170438652|NCT02005562|615944957|FG000|Overall Study|Physician Decision|0|||
170438653|NCT02005562|615944958|FG001|Overall Study|Physician Decision|1|||
170438654|NCT04729101|615944959|FG000|Overall Study|Adverse Event|1|||
170438655|NCT04729101|615944960|FG001|Overall Study|Adverse Event|0|||
170438656|NCT04729101|615944959|FG000|Overall Study|Physician Decision|1|||
170438657|NCT04729101|615944960|FG001|Overall Study|Physician Decision|0|||
170438658|NCT04729101|615944959|FG000|Overall Study|Withdrawal by Subject|1|||
170438659|NCT04729101|615944960|FG001|Overall Study|Withdrawal by Subject|0|||
170438660|NCT02832167|615944961|FG000|Treatment Period 1|Disease progression|90|||
170438661|NCT02832167|615944961|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
170438662|NCT02832167|615944961|FG000|Treatment Period 1|Death|2|||
170438663|NCT02832167|615944961|FG000|Treatment Period 1|Study Drug Toxicity|6|||
170438664|NCT02832167|615944961|FG000|Treatment Period 1|Participant request to discontinue|9|||
170438665|NCT02832167|615944961|FG000|Treatment Period 1|No longer meet study criteria|1|||
170438666|NCT02832167|615944961|FG000|Treatment Period 1|Participant withdrew consent|3|||
170438667|NCT02832167|615944961|FG000|Treatment Period 1|Other reasons|6|||
170438668|NCT02832167|615944961|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
170438669|NCT02832167|615944961|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
170438670|NCT02832167|615944961|FG000|Transition From Period 1 to Period 2|Death|2|||
170438671|NCT02832167|615944961|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
170438672|NCT02832167|615944961|FG000|Treatment Period 2|Disease progression|69|||
170438673|NCT02832167|615944961|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
170438674|NCT02832167|615944961|FG000|Treatment Period 2|Maximum clinical benefit|1|||
170438675|NCT02832167|615944961|FG000|Treatment Period 2|Study Drug Toxicity|5|||
170438676|NCT02832167|615944961|FG000|Treatment Period 2|Participant request to discontinue|2|||
170438677|NCT02832167|615944961|FG000|Treatment Period 2|Participant withdrew consent|3|||
170438678|NCT02832167|615944961|FG000|Treatment Period 2|Other reasons|3|||
170438679|NCT01754376|615944962|FG000|Overall Study|Adverse Event|1|||
170438680|NCT01754376|615944962|FG000|Overall Study|Lack of Efficacy|2|||
170438681|NCT04556734|615944963|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
170438682|NCT04556734|615944964|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
170438683|NCT04556734|615944965|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
170438684|NCT04556734|615944966|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170438685|NCT04556734|615944967|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170438686|NCT04556734|615944968|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170438687|NCT04556734|615944969|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170438688|NCT04556734|615944970|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170438689|NCT04556734|615944963|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
170438690|NCT04556734|615944964|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170438691|NCT04556734|615944965|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170438692|NCT04556734|615944966|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170438693|NCT04556734|615944967|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170438694|NCT04556734|615944968|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170438695|NCT04556734|615944969|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170438696|NCT04556734|615944970|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170438697|NCT04556734|615944963|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170438698|NCT04556734|615944964|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170438699|NCT04556734|615944965|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170438700|NCT04556734|615944966|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170438701|NCT04556734|615944967|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170438702|NCT04556734|615944968|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170438703|NCT04556734|615944969|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170438704|NCT04556734|615944970|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170438705|NCT04556734|615944963|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
170438706|NCT04556734|615944964|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170438707|NCT04556734|615944965|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170438708|NCT04556734|615944966|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170882781|NCT00382993|617579648|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
170882782|NCT00382993|617579649|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
170882783|NCT00382993|617579648|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
170882784|NCT00382993|617579649|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
170882785|NCT01857869|617579650|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
170882786|NCT01857869|617579651|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
170882787|NCT01857869|617579652|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
170882788|NCT01857869|617579653|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
170882789|NCT01857869|617579654|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
170882790|NCT01857869|617579655|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
170882791|NCT01857869|617579656|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
170438709|NCT04556734|615944967|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170438710|NCT04556734|615944968|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170882792|NCT01857869|617579657|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
170438711|NCT04556734|615944969|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170438712|NCT04556734|615944970|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170438713|NCT04556734|615944963|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
170438714|NCT04556734|615944964|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
170438715|NCT04556734|615944965|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
170438716|NCT04556734|615944966|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
170438717|NCT04556734|615944967|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
170438718|NCT04556734|615944968|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
170438719|NCT04556734|615944969|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
170438720|NCT04556734|615944970|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
170438721|NCT04556734|615944963|FG000|OLE Period (28 Weeks)|Not reported|0|||
170438722|NCT04556734|615944964|FG001|OLE Period (28 Weeks)|Not reported|0|||
170438723|NCT04556734|615944965|FG002|OLE Period (28 Weeks)|Not reported|0|||
170438724|NCT04556734|615944966|FG003|OLE Period (28 Weeks)|Not reported|0|||
170438725|NCT04556734|615944967|FG004|OLE Period (28 Weeks)|Not reported|0|||
170438726|NCT04556734|615944968|FG005|OLE Period (28 Weeks)|Not reported|1|||
170438727|NCT04556734|615944969|FG006|OLE Period (28 Weeks)|Not reported|0|||
170438728|NCT04556734|615944970|FG007|OLE Period (28 Weeks)|Not reported|0|||
170438729|NCT04556734|615944963|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170438730|NCT04556734|615944964|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170438731|NCT04556734|615944965|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170438732|NCT04556734|615944966|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170438733|NCT04556734|615944967|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170438734|NCT04556734|615944968|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170438735|NCT04556734|615944969|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
170438736|NCT04556734|615944970|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
170438737|NCT04556734|615944963|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
170438738|NCT04556734|615944964|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
170438739|NCT04556734|615944965|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
170438740|NCT04556734|615944966|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
170438741|NCT04556734|615944967|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
170438742|NCT04556734|615944968|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
170438743|NCT04556734|615944969|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
170438744|NCT04556734|615944970|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
170438745|NCT04556734|615944963|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
170438746|NCT04556734|615944964|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
170438747|NCT04556734|615944965|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
170438748|NCT04556734|615944966|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
170438749|NCT04556734|615944967|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
170438750|NCT04556734|615944968|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
170438751|NCT04556734|615944969|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
170438752|NCT04556734|615944970|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
170438753|NCT00820599|615944975|FG000|Overall Study|Death|129|||
170438754|NCT00820599|615944975|FG000|Overall Study|Withdrawal by Subject|2|||
170438755|NCT03686215|615944976|FG000|Overall Study|Adverse Event|0|||
170438756|NCT03686215|615944977|FG001|Overall Study|Adverse Event|0|||
170438757|NCT03686215|615944978|FG002|Overall Study|Adverse Event|7|||
170438758|NCT03686215|615944976|FG000|Overall Study|Physician Decision|0|||
170438759|NCT03686215|615944977|FG001|Overall Study|Physician Decision|0|||
170438760|NCT03686215|615944978|FG002|Overall Study|Physician Decision|1|||
170438761|NCT03686215|615944976|FG000|Overall Study|Protocol Violation|0|||
170438762|NCT03686215|615944977|FG001|Overall Study|Protocol Violation|0|||
170438763|NCT03686215|615944978|FG002|Overall Study|Protocol Violation|4|||
170438764|NCT03686215|615944976|FG000|Overall Study|Device issue|1|||
170438765|NCT03686215|615944977|FG001|Overall Study|Device issue|0|||
170438766|NCT03686215|615944978|FG002|Overall Study|Device issue|2|||
170438767|NCT01662024|615944979|FG000|Overall Study|Pregnancy|2|||
170438768|NCT01662024|615944979|FG000|Overall Study|Withdrawal by Subject|3|||
170438769|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
170438770|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
170438771|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
170438772|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
170438773|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
170438774|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
170438775|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
170438776|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
170438777|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
170633038|NCT00998296|616668455|FG010|Overall Study|Reason other than those specified above|0|||
170633039|NCT04396639|616668456|FG000|Overall Study|Withdrawal by Subject|1|||
170633040|NCT04396639|616668456|FG000|Overall Study|Other|1|||
170438778|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
170438779|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
170633041|NCT01544335|616668459|FG000|Overall Study|Lost to Follow-up|27|||
170633042|NCT01544335|616668459|FG000|Overall Study|Death|4|||
170438780|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
170438781|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
170438782|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
170438783|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
170438784|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
170438785|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
170438786|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
170438787|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
170438788|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
170438789|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
170438790|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
170438791|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
170438792|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
170438793|NCT01710358|615945002|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
170438794|NCT01710358|615945003|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
170438795|NCT01710358|615945004|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
170438796|NCT01710358|615945002|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
170438797|NCT01710358|615945003|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
170438798|NCT01710358|615945004|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
170438799|NCT01710358|615945002|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
170438800|NCT01710358|615945003|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
170438801|NCT01710358|615945004|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
170438802|NCT01710358|615945002|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
170438803|NCT01710358|615945003|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
170438804|NCT01710358|615945004|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
170438805|NCT01710358|615945002|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
170438806|NCT01710358|615945003|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
170438807|NCT01710358|615945004|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
170438808|NCT01710358|615945002|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
170438809|NCT01710358|615945003|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
170438810|NCT01710358|615945004|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
170438811|NCT01710358|615945002|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
170438812|NCT01710358|615945003|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
170438813|NCT01710358|615945004|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
170438814|NCT01710358|615945002|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
170438815|NCT01710358|615945003|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
170438816|NCT01710358|615945004|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
170438817|NCT01710358|615945002|FG000|Rescue Period|Adverse Event|0|||
170438818|NCT01710358|615945003|FG001|Rescue Period|Adverse Event|15|||
170438819|NCT01710358|615945004|FG002|Rescue Period|Adverse Event|0|||
170438820|NCT01710358|615945002|FG000|Rescue Period|Death|0|||
170438821|NCT01710358|615945003|FG001|Rescue Period|Death|1|||
170438822|NCT01710358|615945004|FG002|Rescue Period|Death|0|||
170438823|NCT01710358|615945002|FG000|Rescue Period|Lack of Efficacy|0|||
170438824|NCT01710358|615945003|FG001|Rescue Period|Lack of Efficacy|7|||
170438825|NCT01710358|615945004|FG002|Rescue Period|Lack of Efficacy|0|||
170438826|NCT01710358|615945002|FG000|Rescue Period|Withdrawal by Subject|0|||
170438827|NCT01710358|615945003|FG001|Rescue Period|Withdrawal by Subject|8|||
170438828|NCT01710358|615945004|FG002|Rescue Period|Withdrawal by Subject|0|||
170438829|NCT02460835|615945012|FG000|Overall Study|Disease progression prior to treatment|3|||
170438830|NCT02460835|615945012|FG000|Overall Study|Unable to complete planning scans|2|||
170438831|NCT02460835|615945012|FG000|Overall Study|Decrease in performance status|1|||
170438832|NCT02460835|615945012|FG000|Overall Study|Withdrawal by Subject|3|||
170438833|NCT02460835|615945012|FG000|Overall Study|Underwent fractionated RT|10|||
170438834|NCT02460835|615945012|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
170438835|NCT00063258|615945015|FG000|Overall Study|Physician Decision|2|||
170438836|NCT00063258|615945016|FG001|Overall Study|Physician Decision|0|||
170438837|NCT00063258|615945015|FG000|Overall Study|Lack of Efficacy|2|||
170438838|NCT00063258|615945016|FG001|Overall Study|Lack of Efficacy|0|||
170438839|NCT00387153|615945028|FG000|Overall Study|Adverse Event|1|||
170438840|NCT00387153|615945028|FG000|Overall Study|Disease Progression|3|||
170438841|NCT00387153|615945028|FG000|Overall Study|Lack of Response|4|||
170438842|NCT00728754|615945030|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
170438843|NCT00728754|615945031|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
170438844|NCT00728754|615945030|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
170438845|NCT00728754|615945031|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
170438846|NCT00728754|615945030|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
170438847|NCT00728754|615945031|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
170438848|NCT00672984|615945032|FG000|First Intervention|Adverse Event|5|||
170438849|NCT00672984|615945033|FG001|First Intervention|Adverse Event|0|||
170438850|NCT00672984|615945034|FG002|First Intervention|Adverse Event|0|||
170438851|NCT00672984|615945032|FG000|First Intervention|Withdrawal by Subject|1|||
170438852|NCT00672984|615945033|FG001|First Intervention|Withdrawal by Subject|2|||
170438853|NCT00672984|615945034|FG002|First Intervention|Withdrawal by Subject|2|||
170438854|NCT00672984|615945032|FG000|First Intervention|Sponsor decision|3|||
170438855|NCT00672984|615945033|FG001|First Intervention|Sponsor decision|0|||
170438856|NCT00672984|615945034|FG002|First Intervention|Sponsor decision|0|||
170438857|NCT00672984|615945032|FG000|Second Intervention|Non-compliance with facility policies|0|||
170438858|NCT00672984|615945033|FG001|Second Intervention|Non-compliance with facility policies|2|||
170438859|NCT00672984|615945034|FG002|Second Intervention|Non-compliance with facility policies|0|||
170438860|NCT00672984|615945032|FG000|Second Intervention|Withdrawal by Subject|0|||
170438861|NCT00672984|615945033|FG001|Second Intervention|Withdrawal by Subject|3|||
170438862|NCT00672984|615945034|FG002|Second Intervention|Withdrawal by Subject|0|||
170438863|NCT00672984|615945032|FG000|Second Intervention|Protocol Violation|0|||
170438864|NCT00672984|615945033|FG001|Second Intervention|Protocol Violation|1|||
170438865|NCT00672984|615945034|FG002|Second Intervention|Protocol Violation|1|||
170438866|NCT00672984|615945032|FG000|Third Intervention|Adverse Event|1|||
170438867|NCT00672984|615945033|FG001|Third Intervention|Adverse Event|0|||
170438868|NCT00672984|615945034|FG002|Third Intervention|Adverse Event|1|||
170438869|NCT01859598|615945035|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
170438870|NCT02654145|615945036|FG000|Overall Study|Lack of Efficacy|1|||
170438871|NCT02654145|615945036|FG000|Overall Study|Protocol Violation|1|||
170438872|NCT02654145|615945036|FG000|Overall Study|Withdrawal by Subject|5|||
170438873|NCT00009945|615945037|FG000|Overall Study|no follow up data|7|||
170438874|NCT00009945|615945038|FG001|Overall Study|no follow up data|5|||
170438875|NCT01968551|615945039|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
170438876|NCT01968551|615945040|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
170438877|NCT01968551|615945041|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
170438878|NCT01968551|615945039|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
170438879|NCT01968551|615945040|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
170438880|NCT01968551|615945041|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
170438881|NCT01968551|615945039|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
170438882|NCT01968551|615945040|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
170438883|NCT01968551|615945041|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
170438884|NCT01968551|615945039|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
170438885|NCT01968551|615945040|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
170438886|NCT01968551|615945041|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
170438887|NCT01968551|615945039|FG000|Extension Phase|Adverse Event|0|||
170438888|NCT01968551|615945040|FG001|Extension Phase|Adverse Event|0|||
170438889|NCT01968551|615945041|FG002|Extension Phase|Adverse Event|2|||
170438890|NCT01968551|615945039|FG000|Extension Phase|Death|0|||
170438891|NCT01968551|615945040|FG001|Extension Phase|Death|1|||
170438892|NCT01968551|615945041|FG002|Extension Phase|Death|0|||
170438893|NCT01968551|615945039|FG000|Extension Phase|Withdrew Consent|0|||
170438894|NCT01968551|615945040|FG001|Extension Phase|Withdrew Consent|0|||
170438895|NCT01968551|615945041|FG002|Extension Phase|Withdrew Consent|1|||
170438896|NCT01968551|615945039|FG000|Extension Phase|Lost to Follow-up|1|||
170438897|NCT01968551|615945040|FG001|Extension Phase|Lost to Follow-up|0|||
170438898|NCT01968551|615945041|FG002|Extension Phase|Lost to Follow-up|1|||
170438899|NCT00645853|615945042|FG000|Overall Study|Adverse Event|18|||
170438900|NCT00645853|615945043|FG001|Overall Study|Adverse Event|7|||
170438901|NCT00645853|615945042|FG000|Overall Study|AZ study closure in Hungary|60|||
170438902|NCT00645853|615945043|FG001|Overall Study|AZ study closure in Hungary|40|||
170438903|NCT00645853|615945042|FG000|Overall Study|Withdrawal by Subject|5|||
170438904|NCT00645853|615945043|FG001|Overall Study|Withdrawal by Subject|2|||
170438905|NCT00645853|615945042|FG000|Overall Study|Protocol Violation|0|||
170438906|NCT00645853|615945043|FG001|Overall Study|Protocol Violation|2|||
170438907|NCT00645853|615945042|FG000|Overall Study|Discontinuation criteria|2|||
170438908|NCT00645853|615945043|FG001|Overall Study|Discontinuation criteria|2|||
170781882|NCT02671435|617209317|FG009|Overall Study|Death|10|||
170781883|NCT02671435|617209318|FG010|Overall Study|Death|8|||
170781884|NCT02671435|617209319|FG011|Overall Study|Death|29|||
170781885|NCT02671435|617209320|FG012|Overall Study|Death|29|||
170781886|NCT02671435|617209321|FG013|Overall Study|Death|29|||
170781887|NCT02671435|617209322|FG014|Overall Study|Death|27|||
170781888|NCT02671435|617209308|FG000|Overall Study|Lost to Follow-up|0|||
170781889|NCT02671435|617209309|FG001|Overall Study|Lost to Follow-up|0|||
170781890|NCT02671435|617209310|FG002|Overall Study|Lost to Follow-up|1|||
170781891|NCT02671435|617209311|FG003|Overall Study|Lost to Follow-up|0|||
170781892|NCT02671435|617209312|FG004|Overall Study|Lost to Follow-up|1|||
170438909|NCT00645853|615945042|FG000|Overall Study|recall of ICF, planned operation, death|7|||
170438910|NCT00645853|615945043|FG001|Overall Study|recall of ICF, planned operation, death|4|||
170438911|NCT00573313|615945044|FG000|Overall Study|Protocol Violation|5|||
170438912|NCT00573313|615945045|FG001|Overall Study|Protocol Violation|0|||
170438913|NCT00573313|615945046|FG002|Overall Study|Protocol Violation|6|||
170781893|NCT02671435|617209313|FG005|Overall Study|Lost to Follow-up|1|||
170438914|NCT00573313|615945047|FG003|Overall Study|Protocol Violation|0|||
170438915|NCT01597791|615945050|FG000|Overall Study|Physician Decision|2|||
170438916|NCT01597791|615945051|FG001|Overall Study|Physician Decision|1|||
170438917|NCT01597791|615945050|FG000|Overall Study|Cesarean Section|6|||
170438918|NCT01597791|615945051|FG001|Overall Study|Cesarean Section|7|||
170438919|NCT01597791|615945050|FG000|Overall Study|Subject withdrawal|0|||
170438920|NCT01597791|615945051|FG001|Overall Study|Subject withdrawal|1|||
170438921|NCT01597791|615945050|FG000|Overall Study|Protocol Violation|0|||
170438922|NCT01597791|615945051|FG001|Overall Study|Protocol Violation|1|||
170438923|NCT02611362|615945052|FG000|Overall Study|Withdrawal by Subject|7|||
170438924|NCT02611362|615945053|FG001|Overall Study|Withdrawal by Subject|2|||
170438925|NCT02611362|615945052|FG000|Overall Study|Lost to Follow-up|2|||
170438926|NCT02611362|615945053|FG001|Overall Study|Lost to Follow-up|4|||
170438927|NCT00354159|615945054|FG000|Randomized Study Period|Withdrawal by Subject|5|||
170438928|NCT00354159|615945055|FG001|Randomized Study Period|Withdrawal by Subject|3|||
170438929|NCT00354159|615945054|FG000|Randomized Study Period|Physician Decision|6|||
170438930|NCT00354159|615945055|FG001|Randomized Study Period|Physician Decision|10|||
170438931|NCT00354159|615945054|FG000|Randomized Study Period|Lost to Follow-up|4|||
170438932|NCT00354159|615945055|FG001|Randomized Study Period|Lost to Follow-up|0|||
170438933|NCT00354159|615945054|FG000|Randomized Study Period|Death|7|||
170438934|NCT00354159|615945055|FG001|Randomized Study Period|Death|9|||
170438935|NCT00354159|615945054|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
170438936|NCT00354159|615945055|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
170438937|NCT00354159|615945054|FG000|Long-term Follow-up|Physician Decision|127|||
170438938|NCT00354159|615945055|FG001|Long-term Follow-up|Physician Decision|122|||
170438939|NCT00354159|615945054|FG000|Long-term Follow-up|Lost to Follow-up|1|||
170438940|NCT00354159|615945055|FG001|Long-term Follow-up|Lost to Follow-up|0|||
170438941|NCT00354159|615945054|FG000|Long-term Follow-up|Death|14|||
170438942|NCT00354159|615945055|FG001|Long-term Follow-up|Death|11|||
170438943|NCT00354159|615945054|FG000|Long-term Follow-up|Study Closed|29|||
170438944|NCT00354159|615945055|FG001|Long-term Follow-up|Study Closed|34|||
170438945|NCT02229084|615945057|FG000|Overall Study|Adverse Event|1|||
170438946|NCT02229084|615945058|FG001|Overall Study|Adverse Event|0|||
170438947|NCT02229084|615945059|FG002|Overall Study|Adverse Event|0|||
170438948|NCT02229084|615945060|FG003|Overall Study|Adverse Event|0|||
170438949|NCT02229084|615945061|FG004|Overall Study|Adverse Event|0|||
170438950|NCT02229084|615945062|FG005|Overall Study|Adverse Event|0|||
170438951|NCT02229084|615945063|FG006|Overall Study|Adverse Event|0|||
170438952|NCT02229084|615945057|FG000|Overall Study|Lost to Follow-up|0|||
170438953|NCT02229084|615945058|FG001|Overall Study|Lost to Follow-up|0|||
170438954|NCT02229084|615945059|FG002|Overall Study|Lost to Follow-up|1|||
170438955|NCT02229084|615945060|FG003|Overall Study|Lost to Follow-up|1|||
170438956|NCT02229084|615945061|FG004|Overall Study|Lost to Follow-up|0|||
170438957|NCT02229084|615945062|FG005|Overall Study|Lost to Follow-up|0|||
170438958|NCT02229084|615945063|FG006|Overall Study|Lost to Follow-up|1|||
170438959|NCT02229084|615945057|FG000|Overall Study|Physician Decision|0|||
170438960|NCT02229084|615945058|FG001|Overall Study|Physician Decision|0|||
170438961|NCT02229084|615945059|FG002|Overall Study|Physician Decision|0|||
170438962|NCT02229084|615945060|FG003|Overall Study|Physician Decision|1|||
170438963|NCT02229084|615945061|FG004|Overall Study|Physician Decision|3|||
170438964|NCT02229084|615945062|FG005|Overall Study|Physician Decision|0|||
170438965|NCT02229084|615945063|FG006|Overall Study|Physician Decision|1|||
170438966|NCT02229084|615945057|FG000|Overall Study|Withdrawal by Subject|0|||
170438967|NCT02229084|615945058|FG001|Overall Study|Withdrawal by Subject|0|||
170438968|NCT02229084|615945059|FG002|Overall Study|Withdrawal by Subject|1|||
170438969|NCT02229084|615945060|FG003|Overall Study|Withdrawal by Subject|0|||
170438970|NCT02229084|615945061|FG004|Overall Study|Withdrawal by Subject|1|||
170438971|NCT02229084|615945062|FG005|Overall Study|Withdrawal by Subject|1|||
170438972|NCT02229084|615945063|FG006|Overall Study|Withdrawal by Subject|1|||
170438973|NCT02229084|615945057|FG000|Overall Study|Death|0|||
170438974|NCT02229084|615945058|FG001|Overall Study|Death|0|||
170438975|NCT02229084|615945059|FG002|Overall Study|Death|0|||
170438976|NCT02229084|615945060|FG003|Overall Study|Death|0|||
170438977|NCT02229084|615945061|FG004|Overall Study|Death|0|||
170438978|NCT02229084|615945062|FG005|Overall Study|Death|0|||
170438979|NCT02229084|615945063|FG006|Overall Study|Death|1|||
170438980|NCT03141151|615945069|FG000|Overall Study|Lost to Follow-up|3|||
170438981|NCT03141151|615945070|FG001|Overall Study|Lost to Follow-up|2|||
170438982|NCT03141151|615945069|FG000|Overall Study|Withdrawal by Subject|3|||
170438983|NCT03141151|615945070|FG001|Overall Study|Withdrawal by Subject|2|||
170438984|NCT05665387|615945086|FG000|Overall Study|Withdrawal by Subject|1|||
170438985|NCT05665387|615945087|FG001|Overall Study|Withdrawal by Subject|0|||
170438986|NCT05665387|615945088|FG002|Overall Study|Withdrawal by Subject|1|||
170438987|NCT00006436|615945089|FG000|Overall Study|Refused further treatment|2|||
170438988|NCT00006436|615945089|FG000|Overall Study|Declined to participate (before treatment started)|1|||
170438989|NCT03868631|615945095|FG000|Baseline to Week 6|Adverse Event|0|||
170438990|NCT03868631|615945096|FG001|Baseline to Week 6|Adverse Event|3|||
170438991|NCT03868631|615945095|FG000|Baseline to Week 6|Protocol Violation|1|||
170438992|NCT03868631|615945096|FG001|Baseline to Week 6|Protocol Violation|1|||
170438993|NCT03868631|615945095|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
170438994|NCT03868631|615945096|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
170438995|NCT03868631|615945095|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
170438996|NCT03868631|615945096|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
170438997|NCT03868631|615945095|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
170438998|NCT03868631|615945096|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
170438999|NCT03868631|615945095|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
170439000|NCT03868631|615945096|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
170439001|NCT00556673|615945099|FG000|Overall Study|Protocol deviation|3|||
170439002|NCT00556673|615945100|FG001|Overall Study|Protocol deviation|2|||
170439003|NCT01528735|615945101|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
170439004|NCT01528735|615945102|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
170537137|NCT04044690|616311535|FG001|Period 2|Other: Unspecified|1|||
170537138|NCT04044690|616311534|FG000|Period 3|Site Terminated by Sponsor|1|||
170439005|NCT01528735|615945101|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
170439006|NCT01528735|615945102|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
170439007|NCT01971554|615945103|FG000|Overall Study|Lost to Follow-up|1|||
170439008|NCT01971554|615945104|FG001|Overall Study|Lost to Follow-up|0|||
170439009|NCT01971554|615945105|FG002|Overall Study|Lost to Follow-up|0|||
170439010|NCT01971554|615945106|FG003|Overall Study|Lost to Follow-up|0|||
170439011|NCT03196284|615945107|FG000|Main Part|Withdrawal by Subject|0|||
170439012|NCT03196284|615945108|FG001|Main Part|Withdrawal by Subject|1|||
170439013|NCT03196284|615945109|FG002|Main Part|Withdrawal by Subject|0|||
170439014|NCT03196284|615945107|FG000|Extension Part|Lack of Efficacy|0|||
170439015|NCT03196284|615945108|FG001|Extension Part|Lack of Efficacy|0|||
170439016|NCT03196284|615945109|FG002|Extension Part|Lack of Efficacy|1|||
170439017|NCT03196284|615945107|FG000|Extension Part|Withdrawal by Subject|0|||
170439018|NCT03196284|615945108|FG001|Extension Part|Withdrawal by Subject|0|||
170439019|NCT03196284|615945109|FG002|Extension Part|Withdrawal by Subject|1|||
170439020|NCT03196284|615945107|FG000|Extension Part|Physician Decision|0|||
170439021|NCT03196284|615945108|FG001|Extension Part|Physician Decision|0|||
170439022|NCT03196284|615945109|FG002|Extension Part|Physician Decision|1|||
170439023|NCT02535923|615945110|FG000|Overall Study|Lost to Follow-up|5|||
170439024|NCT02535923|615945111|FG001|Overall Study|Lost to Follow-up|5|||
170439025|NCT02535923|615945110|FG000|Overall Study|Withdrawal by Subject|4|||
170439026|NCT02535923|615945111|FG001|Overall Study|Withdrawal by Subject|3|||
170439027|NCT00685334|615945112|FG000|Overall Study|Withdrawal by Subject|5|||
170439028|NCT00685334|615945113|FG001|Overall Study|Withdrawal by Subject|6|||
170439029|NCT00685334|615945112|FG000|Overall Study|Lost to Follow-up|4|||
170439030|NCT00685334|615945113|FG001|Overall Study|Lost to Follow-up|0|||
170439031|NCT00685334|615945112|FG000|Overall Study|Chose to enter hospital|1|||
170439032|NCT00685334|615945113|FG001|Overall Study|Chose to enter hospital|1|||
170439033|NCT05468320|615945114|FG000|Overall Study|Other|1|||
170439034|NCT05468320|615945114|FG000|Overall Study|Adverse Event|1|||
170439035|NCT04440592|615945115|FG000|Overall Study|Adverse Event|8|||
170439036|NCT04440592|615945116|FG001|Overall Study|Adverse Event|0|||
170439037|NCT04440592|615945115|FG000|Overall Study|Lost to Follow-up|1|||
170439038|NCT04440592|615945116|FG001|Overall Study|Lost to Follow-up|0|||
170439039|NCT04440592|615945115|FG000|Overall Study|Withdrawal by Subject|1|||
170439040|NCT04440592|615945116|FG001|Overall Study|Withdrawal by Subject|1|||
170439041|NCT04440592|615945115|FG000|Overall Study|Other therapy needed|0|||
170439042|NCT04440592|615945116|FG001|Overall Study|Other therapy needed|1|||
170439043|NCT00565851|615946274|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
170439044|NCT00565851|615946275|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
170439045|NCT00565851|615946276|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
170439046|NCT00565851|615946277|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
170439047|NCT00565851|615946278|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
170439048|NCT00565851|615946279|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
170439049|NCT00565851|615946280|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
170439050|NCT00565851|615946281|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
170439051|NCT00565851|615946274|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
170439052|NCT00565851|615946275|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
170439053|NCT00565851|615946276|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
170439054|NCT00565851|615946277|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
170439055|NCT00565851|615946278|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
170439056|NCT00565851|615946279|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
170439057|NCT00565851|615946280|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
170439058|NCT00565851|615946281|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
170439059|NCT00274625|615946284|FG000|Overall Study|Lost to Follow-up|46|||
170439060|NCT00274625|615946285|FG001|Overall Study|Lost to Follow-up|54|||
170439061|NCT00274625|615946284|FG000|Overall Study|Excluded from analysis|14|||
170439062|NCT00274625|615946285|FG001|Overall Study|Excluded from analysis|8|||
170439063|NCT02940522|615946286|FG000|Overall Study|Lost to Follow-up|1|||
170439064|NCT02940522|615946287|FG001|Overall Study|Lost to Follow-up|2|||
170439065|NCT02940522|615946286|FG000|Overall Study|Withdrawal by Subject|1|||
170439066|NCT02940522|615946287|FG001|Overall Study|Withdrawal by Subject|0|||
170439067|NCT00762411|615946288|FG000|Initial Treatment|Death|7|||
170439068|NCT00762411|615946289|FG001|Initial Treatment|Death|6|||
170439069|NCT00762411|615946288|FG000|Initial Treatment|Adverse Event|132|||
170439070|NCT00762411|615946289|FG001|Initial Treatment|Adverse Event|40|||
170439071|NCT00762411|615946288|FG000|Initial Treatment|Protocol Violation|4|||
170439072|NCT00762411|615946289|FG001|Initial Treatment|Protocol Violation|1|||
170439073|NCT00762411|615946288|FG000|Initial Treatment|Withdrawal by Subject|65|||
170439074|NCT00762411|615946289|FG001|Initial Treatment|Withdrawal by Subject|52|||
170439075|NCT00762411|615946288|FG000|Initial Treatment|Physician Decision|1|||
170439076|NCT00762411|615946289|FG001|Initial Treatment|Physician Decision|0|||
170439077|NCT00762411|615946288|FG000|Initial Treatment|Sponsor Decision|293|||
170439078|NCT00762411|615946289|FG001|Initial Treatment|Sponsor Decision|401|||
170439079|NCT00762411|615946288|FG000|Initial Treatment|Lost to Follow-up|5|||
170439080|NCT00762411|615946289|FG001|Initial Treatment|Lost to Follow-up|0|||
170537139|NCT04044690|616311535|FG001|Period 3|Site Terminated by Sponsor|2|||
170537140|NCT04044690|616311534|FG000|Period 3|Study Terminated by Sponsor|24|||
170439081|NCT00762411|615946288|FG000|Initial Treatment|Caregiver Decision|21|||
170439082|NCT00762411|615946289|FG001|Initial Treatment|Caregiver Decision|16|||
170439083|NCT00762411|615946288|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
170439084|NCT00762411|615946289|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
170439085|NCT00762411|615946288|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
170439086|NCT00762411|615946289|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
170781894|NCT02671435|617209314|FG006|Overall Study|Lost to Follow-up|2|||
170781895|NCT02671435|617209315|FG007|Overall Study|Lost to Follow-up|2|||
170781896|NCT02671435|617209316|FG008|Overall Study|Lost to Follow-up|0|||
170781897|NCT02671435|617209317|FG009|Overall Study|Lost to Follow-up|2|||
170781898|NCT02671435|617209318|FG010|Overall Study|Lost to Follow-up|0|||
170781899|NCT02671435|617209319|FG011|Overall Study|Lost to Follow-up|3|||
170781900|NCT02671435|617209320|FG012|Overall Study|Lost to Follow-up|3|||
170781901|NCT02671435|617209321|FG013|Overall Study|Lost to Follow-up|2|||
170781902|NCT02671435|617209322|FG014|Overall Study|Lost to Follow-up|0|||
170781903|NCT02671435|617209308|FG000|Overall Study|Withdrawal by Subject|2|||
170781904|NCT02671435|617209309|FG001|Overall Study|Withdrawal by Subject|0|||
170781905|NCT02671435|617209310|FG002|Overall Study|Withdrawal by Subject|2|||
170781906|NCT02671435|617209311|FG003|Overall Study|Withdrawal by Subject|2|||
170781907|NCT02671435|617209312|FG004|Overall Study|Withdrawal by Subject|2|||
170781908|NCT02671435|617209313|FG005|Overall Study|Withdrawal by Subject|7|||
170781909|NCT02671435|617209314|FG006|Overall Study|Withdrawal by Subject|2|||
170439087|NCT00762411|615946288|FG000|Delayed Start|Adverse Event|0|||
170439088|NCT00762411|615946289|FG001|Delayed Start|Adverse Event|4|||
170781910|NCT02671435|617209315|FG007|Overall Study|Withdrawal by Subject|7|||
170781911|NCT02671435|617209316|FG008|Overall Study|Withdrawal by Subject|1|||
170781912|NCT02671435|617209317|FG009|Overall Study|Withdrawal by Subject|1|||
170882793|NCT01857869|617579658|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
170882794|NCT01857869|617579659|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
170882795|NCT01857869|617579650|FG000|Primary/Challenge Phase|Pregnancy|1|||
170882796|NCT01857869|617579651|FG001|Primary/Challenge Phase|Pregnancy|0|||
170882797|NCT01857869|617579652|FG002|Primary/Challenge Phase|Pregnancy|0|||
170882798|NCT01857869|617579653|FG003|Primary/Challenge Phase|Pregnancy|0|||
170882799|NCT01857869|617579654|FG004|Primary/Challenge Phase|Pregnancy|0|||
170439089|NCT00762411|615946288|FG000|Delayed Start|Protocol Violation|0|||
170439090|NCT00762411|615946289|FG001|Delayed Start|Protocol Violation|1|||
170439091|NCT00762411|615946288|FG000|Delayed Start|Sponsor Decision|16|||
170439092|NCT00762411|615946289|FG001|Delayed Start|Sponsor Decision|20|||
170439093|NCT00762411|615946288|FG000|Delayed Start|Caregiver Decision|1|||
170439094|NCT00762411|615946289|FG001|Delayed Start|Caregiver Decision|1|||
170882800|NCT01857869|617579655|FG005|Primary/Challenge Phase|Pregnancy|0|||
170882801|NCT01857869|617579656|FG006|Primary/Challenge Phase|Pregnancy|0|||
170439095|NCT00762411|615946288|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
170439096|NCT00762411|615946289|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
170439097|NCT00762411|615946288|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
170439098|NCT00762411|615946289|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
170439099|NCT00762411|615946288|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
170439100|NCT00762411|615946289|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
170882802|NCT01857869|617579657|FG007|Primary/Challenge Phase|Pregnancy|0|||
170439101|NCT00762411|615946288|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
170439102|NCT00762411|615946289|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
170882803|NCT01857869|617579658|FG008|Primary/Challenge Phase|Pregnancy|0|||
170882804|NCT01857869|617579659|FG009|Primary/Challenge Phase|Pregnancy|0|||
170882805|NCT01857869|617579650|FG000|Primary/Challenge Phase|Protocol Violation|1|||
170439103|NCT00762411|615946288|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
170439104|NCT00762411|615946289|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
170439105|NCT00762411|615946288|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
170439106|NCT00762411|615946289|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
170439107|NCT00442351|615946293|FG000|Overall Study|Administrative|6|||
170439108|NCT00442351|615946294|FG001|Overall Study|Administrative|5|||
170439109|NCT00442351|615946293|FG000|Overall Study|Did not meet protocol eligibility|1|||
170439110|NCT00442351|615946294|FG001|Overall Study|Did not meet protocol eligibility|0|||
170882806|NCT01857869|617579651|FG001|Primary/Challenge Phase|Protocol Violation|0|||
170781913|NCT02671435|617209318|FG010|Overall Study|Withdrawal by Subject|2|||
170439111|NCT00442351|615946293|FG000|Overall Study|Other|0|||
170439112|NCT00442351|615946294|FG001|Overall Study|Other|1|||
170439113|NCT00874549|615946303|FG000|Overall Study|Adverse Event|0|||
170439114|NCT00874549|615946304|FG001|Overall Study|Adverse Event|0|||
170439115|NCT00874549|615946305|FG002|Overall Study|Adverse Event|1|||
170439116|NCT00874549|615946306|FG003|Overall Study|Adverse Event|0|||
170439117|NCT00874549|615946303|FG000|Overall Study|Protocol Violation|1|||
170781914|NCT02671435|617209319|FG011|Overall Study|Withdrawal by Subject|4|||
170882807|NCT01857869|617579652|FG002|Primary/Challenge Phase|Protocol Violation|0|||
170882808|NCT01857869|617579653|FG003|Primary/Challenge Phase|Protocol Violation|0|||
170439118|NCT00874549|615946304|FG001|Overall Study|Protocol Violation|0|||
170781915|NCT02671435|617209320|FG012|Overall Study|Withdrawal by Subject|4|||
170439119|NCT00874549|615946305|FG002|Overall Study|Protocol Violation|2|||
170439120|NCT00874549|615946306|FG003|Overall Study|Protocol Violation|1|||
170439121|NCT00874549|615946303|FG000|Overall Study|Lost to Follow-up|0|||
170439122|NCT00874549|615946304|FG001|Overall Study|Lost to Follow-up|0|||
170439123|NCT00874549|615946305|FG002|Overall Study|Lost to Follow-up|1|||
170439124|NCT00874549|615946306|FG003|Overall Study|Lost to Follow-up|0|||
170439125|NCT00874549|615946303|FG000|Overall Study|Withdrawal by Subject|0|||
170439126|NCT00874549|615946304|FG001|Overall Study|Withdrawal by Subject|1|||
170439127|NCT00874549|615946305|FG002|Overall Study|Withdrawal by Subject|0|||
170439128|NCT00874549|615946306|FG003|Overall Study|Withdrawal by Subject|1|||
170439129|NCT01119625|615946308|FG000|Overall Study|Lost to Follow-up|1|||
170439130|NCT01119625|615946309|FG001|Overall Study|Lost to Follow-up|2|||
170439131|NCT01119625|615946308|FG000|Overall Study|Withdrawal by Subject|2|||
170439132|NCT01119625|615946309|FG001|Overall Study|Withdrawal by Subject|1|||
170439133|NCT01119625|615946308|FG000|Overall Study|Other|0|||
170439134|NCT01119625|615946309|FG001|Overall Study|Other|1|||
170439135|NCT04542694|615946314|FG000|Overall Study|The need for prohibited therapy|2|||
170439136|NCT04542694|615946315|FG001|Overall Study|The need for prohibited therapy|0|||
170439137|NCT04542694|615946314|FG000|Overall Study|Adverse Event|1|||
170439138|NCT04542694|615946315|FG001|Overall Study|Adverse Event|0|||
170439139|NCT04542694|615946314|FG000|Overall Study|Protocol Violation|1|||
170439140|NCT04542694|615946315|FG001|Overall Study|Protocol Violation|0|||
170439141|NCT00969124|615946318|FG000|Overall Study|Protocol Violation|2|||
170439142|NCT00969124|615946318|FG000|Overall Study|Inadequate bowel preparation|15|||
170439143|NCT00969124|615946318|FG000|Overall Study|Inability to reach cecum|9|||
170439144|NCT00969124|615946318|FG000|Overall Study|Previously unrecognized disease|3|||
170439145|NCT00969124|615946318|FG000|Overall Study|Technical error|1|||
170439146|NCT02786953|615946321|FG000|Overall Study|Withdrawal by Subject|3|||
170439147|NCT02786953|615946322|FG001|Overall Study|Withdrawal by Subject|0|||
170439148|NCT02786953|615946321|FG000|Overall Study|Physician Decision|0|||
170439149|NCT02786953|615946322|FG001|Overall Study|Physician Decision|1|||
170439150|NCT04697173|615946327|FG000|Overall Study|Withdrawal by Subject|34|||
170439151|NCT04697173|615946328|FG001|Overall Study|Withdrawal by Subject|38|||
170439152|NCT01717313|615946329|FG000|Phase A (Weeks 0 to 24)|Death|0|||
170439153|NCT01717313|615946330|FG001|Phase A (Weeks 0 to 24)|Death|1|||
170439154|NCT01717313|615946329|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
170439155|NCT01717313|615946330|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
170439156|NCT01717313|615946329|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
170439157|NCT01717313|615946330|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
170439158|NCT01717313|615946329|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
170439159|NCT01717313|615946330|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
170439160|NCT01717313|615946329|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
170439161|NCT01717313|615946330|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
170439162|NCT01717313|615946329|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
170439163|NCT01717313|615946330|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
170781916|NCT02671435|617209321|FG013|Overall Study|Withdrawal by Subject|4|||
170781917|NCT02671435|617209322|FG014|Overall Study|Withdrawal by Subject|2|||
170781918|NCT02671435|617209308|FG000|Overall Study|Un-specified|0|||
170781919|NCT02671435|617209309|FG001|Overall Study|Un-specified|0|||
170781920|NCT02671435|617209310|FG002|Overall Study|Un-specified|0|||
170781921|NCT02671435|617209311|FG003|Overall Study|Un-specified|0|||
170781922|NCT02671435|617209312|FG004|Overall Study|Un-specified|1|||
170781923|NCT02671435|617209313|FG005|Overall Study|Un-specified|3|||
170781924|NCT02671435|617209314|FG006|Overall Study|Un-specified|2|||
170781925|NCT02671435|617209315|FG007|Overall Study|Un-specified|3|||
170781926|NCT02671435|617209316|FG008|Overall Study|Un-specified|0|||
170781927|NCT02671435|617209317|FG009|Overall Study|Un-specified|5|||
170781928|NCT02671435|617209318|FG010|Overall Study|Un-specified|8|||
170781929|NCT02671435|617209319|FG011|Overall Study|Un-specified|4|||
170781930|NCT02671435|617209320|FG012|Overall Study|Un-specified|5|||
170781931|NCT02671435|617209321|FG013|Overall Study|Un-specified|9|||
170781932|NCT02671435|617209322|FG014|Overall Study|Un-specified|8|||
170781933|NCT03069313|617209323|FG000|Overall Study|Adverse Event|5|||
170439164|NCT01717313|615946329|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
170439165|NCT01717313|615946330|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
170439166|NCT01717313|615946329|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
170439167|NCT01717313|615946330|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
170439168|NCT01717313|615946329|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
170439169|NCT01717313|615946330|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
170537141|NCT04044690|616311535|FG001|Period 3|Study Terminated by Sponsor|18|||
170537142|NCT04044690|616311534|FG000|Period 3|Missing|0|||
170439170|NCT01943435|615946335|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
170537143|NCT04044690|616311535|FG001|Period 3|Missing|2|||
170537144|NCT02452190|616311538|FG000|Overall Study|Withdrawal by Sponsor|1|||
170882809|NCT01857869|617579654|FG004|Primary/Challenge Phase|Protocol Violation|0|||
170781934|NCT00774852|617209324|FG000|Overall Study|Adverse Event|9|||
170781935|NCT00774852|617209325|FG001|Overall Study|Adverse Event|6|||
170781936|NCT00774852|617209324|FG000|Overall Study|Death|2|||
170781937|NCT00774852|617209325|FG001|Overall Study|Death|1|||
170781938|NCT00774852|617209324|FG000|Overall Study|Lack of Efficacy|3|||
170781939|NCT00774852|617209325|FG001|Overall Study|Lack of Efficacy|7|||
170781940|NCT00774852|617209324|FG000|Overall Study|Lost to Follow-up|9|||
170781941|NCT00774852|617209325|FG001|Overall Study|Lost to Follow-up|5|||
170781942|NCT00774852|617209324|FG000|Overall Study|Physician Decision|2|||
170781943|NCT00774852|617209325|FG001|Overall Study|Physician Decision|6|||
170781944|NCT00774852|617209324|FG000|Overall Study|Pregnancy|1|||
170781945|NCT00774852|617209325|FG001|Overall Study|Pregnancy|2|||
170781946|NCT00774852|617209324|FG000|Overall Study|Withdrawal by Subject|2|||
170781947|NCT00774852|617209325|FG001|Overall Study|Withdrawal by Subject|2|||
170781948|NCT00774852|617209324|FG000|Overall Study|Non-responder|15|||
170781949|NCT00774852|617209325|FG001|Overall Study|Non-responder|11|||
170439171|NCT01943435|615946336|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
170439172|NCT01943435|615946337|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
170439173|NCT01943435|615946335|FG000|Intervention Period|Withdrawal by Subject|3|||
170439174|NCT01943435|615946336|FG001|Intervention Period|Withdrawal by Subject|3|||
170439175|NCT01943435|615946337|FG002|Intervention Period|Withdrawal by Subject|4|||
170439176|NCT01943435|615946335|FG000|2 Month Follow up|Lost to Follow-up|2|||
170439177|NCT01943435|615946336|FG001|2 Month Follow up|Lost to Follow-up|3|||
170439178|NCT01943435|615946337|FG002|2 Month Follow up|Lost to Follow-up|0|||
170439179|NCT01943435|615946335|FG000|6 Month Follow up|Lost to Follow-up|12|||
170439180|NCT01943435|615946336|FG001|6 Month Follow up|Lost to Follow-up|7|||
170439181|NCT01943435|615946337|FG002|6 Month Follow up|Lost to Follow-up|15|||
170439182|NCT01617096|615946342|FG000|Overall Study|Withdrawal by Subject|96|||
170439183|NCT01617096|615946343|FG001|Overall Study|Withdrawal by Subject|81|||
170439184|NCT01617096|615946342|FG000|Overall Study|Lost to Follow-up|37|||
170439185|NCT01617096|615946343|FG001|Overall Study|Lost to Follow-up|32|||
170439186|NCT01617096|615946342|FG000|Overall Study|Physician Decision|10|||
170439187|NCT01617096|615946343|FG001|Overall Study|Physician Decision|18|||
170439188|NCT01617096|615946342|FG000|Overall Study|Death|4|||
170439189|NCT01617096|615946343|FG001|Overall Study|Death|3|||
170439190|NCT01617096|615946342|FG000|Overall Study|Other|1|||
170439191|NCT01617096|615946343|FG001|Overall Study|Other|3|||
170439192|NCT00467597|615946345|FG000|Overall Study|Withdrawal by Subject|2|||
170439193|NCT00467597|615946346|FG001|Overall Study|Withdrawal by Subject|0|||
170439194|NCT04561115|615946357|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
170439195|NCT04561115|615946358|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
170439196|NCT04561115|615946357|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
170439197|NCT04561115|615946358|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
170439198|NCT04561115|615946357|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
170439199|NCT04561115|615946358|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
170439200|NCT01745094|615946359|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
170439201|NCT01745094|615946360|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
170439202|NCT01745094|615946361|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
170439203|NCT01745094|615946362|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
170439204|NCT01745094|615946359|FG000|Overall Study|Adverse Event|0|||
170439205|NCT01745094|615946360|FG001|Overall Study|Adverse Event|0|||
170439206|NCT01745094|615946361|FG002|Overall Study|Adverse Event|3|||
170439207|NCT01745094|615946362|FG003|Overall Study|Adverse Event|0|||
170439208|NCT01745094|615946359|FG000|Overall Study|Withdrawal by Subject|2|||
170439209|NCT01745094|615946360|FG001|Overall Study|Withdrawal by Subject|0|||
170781950|NCT00774852|617209324|FG000|Overall Study|Subject non-compliance|0|||
170439210|NCT01745094|615946361|FG002|Overall Study|Withdrawal by Subject|1|||
170439211|NCT01745094|615946362|FG003|Overall Study|Withdrawal by Subject|2|||
170439212|NCT01745094|615946359|FG000|Overall Study|Protocol Violation|1|||
170439213|NCT01745094|615946360|FG001|Overall Study|Protocol Violation|0|||
170439214|NCT01745094|615946361|FG002|Overall Study|Protocol Violation|3|||
170439215|NCT01745094|615946362|FG003|Overall Study|Protocol Violation|1|||
170439216|NCT01745094|615946359|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
170439217|NCT01745094|615946360|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
170439218|NCT01745094|615946361|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
170439219|NCT01745094|615946362|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
170439220|NCT01745094|615946359|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
170439221|NCT01745094|615946360|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
170439222|NCT01745094|615946361|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
170439223|NCT01745094|615946362|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
170439224|NCT01745094|615946359|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
170439225|NCT01745094|615946360|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
170439226|NCT01745094|615946361|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
170439227|NCT01745094|615946362|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
170439228|NCT02179190|615946363|FG000|Enrollment|Exit Prior to Device Attempt|11|||
170439229|NCT02179190|615946363|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
170439230|NCT02179190|615946363|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
170439231|NCT02179190|615946363|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
170439232|NCT02179190|615946363|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
170439233|NCT02179190|615946363|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
170439234|NCT01451541|615946364|FG000|Overall Study|Adverse Event|4|||
170439235|NCT01451541|615946365|FG001|Overall Study|Adverse Event|3|||
170439236|NCT01451541|615946366|FG002|Overall Study|Adverse Event|6|||
170439237|NCT01451541|615946364|FG000|Overall Study|Lack of Efficacy|2|||
170439238|NCT01451541|615946365|FG001|Overall Study|Lack of Efficacy|0|||
170439239|NCT01451541|615946366|FG002|Overall Study|Lack of Efficacy|0|||
170439240|NCT01451541|615946364|FG000|Overall Study|Lost to Follow-up|4|||
170439241|NCT01451541|615946365|FG001|Overall Study|Lost to Follow-up|4|||
170439242|NCT01451541|615946366|FG002|Overall Study|Lost to Follow-up|7|||
170439243|NCT01451541|615946364|FG000|Overall Study|Withdrawal by Subject|15|||
170439244|NCT01451541|615946365|FG001|Overall Study|Withdrawal by Subject|8|||
170439245|NCT01451541|615946366|FG002|Overall Study|Withdrawal by Subject|6|||
170439246|NCT01451541|615946364|FG000|Overall Study|randomization error, noncompliance|11|||
170439247|NCT01451541|615946365|FG001|Overall Study|randomization error, noncompliance|10|||
170439248|NCT01451541|615946366|FG002|Overall Study|randomization error, noncompliance|8|||
170439249|NCT04164758|615946371|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
170439250|NCT04164758|615946372|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
170439251|NCT04164758|615946373|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
170439252|NCT04164758|615946371|FG000|Overall Study|Adverse Event|0|||
170439253|NCT04164758|615946372|FG001|Overall Study|Adverse Event|1|||
170439254|NCT04164758|615946373|FG002|Overall Study|Adverse Event|0|||
170439255|NCT00939523|615946374|FG000|Overall Study|Lack of Efficacy|1|||
170439256|NCT00939523|615946374|FG000|Overall Study|Physician Decision|2|||
170439257|NCT02119936|615946375|FG000|Overall Study|Lost to Follow-up|10|||
170439258|NCT00570128|615946376|FG000|Overall Study|Adverse Event|1|||
170439259|NCT00570128|615946377|FG001|Overall Study|Adverse Event|0|||
170439260|NCT00570128|615946376|FG000|Overall Study|Lost to Follow-up|1|||
170439261|NCT00570128|615946377|FG001|Overall Study|Lost to Follow-up|0|||
170439262|NCT00570128|615946376|FG000|Overall Study|Withdrawal by Subject|2|||
170439263|NCT00570128|615946377|FG001|Overall Study|Withdrawal by Subject|0|||
170439264|NCT05315713|615946378|FG000|Overall Study|Death|5|||
170439265|NCT05315713|615946378|FG000|Overall Study|Progressive disease|1|||
170439266|NCT05315713|615946378|FG000|Overall Study|Withdrawal by Subject|1|||
170439267|NCT05315713|615946378|FG000|Overall Study|Study terminated by sponsor|1|||
170439268|NCT03555695|615946381|FG000|Overall Study|Withdrawal by Subject|1|||
170439269|NCT03555695|615946381|FG000|Overall Study|Lost to Follow-up|1|||
170439270|NCT03555695|615946381|FG000|Overall Study|appendicitis (unrelated)|1|||
170439271|NCT03555695|615946381|FG000|Overall Study|pre-existing sciatica|1|||
170439272|NCT01426854|615946382|FG000|Overall Study|Adverse Event|1|||
170439273|NCT01426854|615946383|FG001|Overall Study|Adverse Event|5|||
170439274|NCT01426854|615946382|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
170439275|NCT01426854|615946383|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
170439276|NCT01426854|615946382|FG000|Overall Study|Lost to Follow-up|3|||
170439277|NCT01426854|615946383|FG001|Overall Study|Lost to Follow-up|0|||
170781951|NCT00774852|617209325|FG001|Overall Study|Subject non-compliance|1|||
170781952|NCT00774852|617209324|FG000|Overall Study|Protocol Violation|1|||
170781953|NCT00774852|617209325|FG001|Overall Study|Protocol Violation|0|||
170781954|NCT00774852|617209324|FG000|Overall Study|Subject received prohibited medication|1|||
170439278|NCT01426854|615946382|FG000|Overall Study|Noncompliance|0|||
170439279|NCT01426854|615946383|FG001|Overall Study|Noncompliance|1|||
170439280|NCT01426854|615946382|FG000|Overall Study|Treatment Failure|0|||
170439281|NCT01426854|615946383|FG001|Overall Study|Treatment Failure|16|||
170781955|NCT00774852|617209325|FG001|Overall Study|Subject received prohibited medication|0|||
170439282|NCT01426854|615946382|FG000|Overall Study|Protocol Deviation|0|||
170439283|NCT01426854|615946383|FG001|Overall Study|Protocol Deviation|1|||
170439284|NCT01426854|615946382|FG000|Overall Study|Other|3|||
170781956|NCT06024174|617209326|FG000|Overall Study|Other Reasons|1|||
170439285|NCT01426854|615946383|FG001|Overall Study|Other|2|||
170439286|NCT00124618|615946386|FG000|Overall Study|Ineligible|1|||
170439287|NCT01596127|615946387|FG000|Overall Study|Patient Ineligible|1|||
170633043|NCT01544335|616668459|FG000|Overall Study|Disease progression|3|||
170439288|NCT01566435|615946388|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
170439289|NCT00919711|615946389|FG000|Overall Study|Withdrawal by Subject|15|||
170439290|NCT00919711|615946390|FG001|Overall Study|Withdrawal by Subject|7|||
170439291|NCT00919711|615946389|FG000|Overall Study|Adverse Event|13|||
170439292|NCT00919711|615946390|FG001|Overall Study|Adverse Event|3|||
170439293|NCT00919711|615946389|FG000|Overall Study|Other|1|||
170439294|NCT00919711|615946390|FG001|Overall Study|Other|2|||
170439295|NCT00919711|615946389|FG000|Overall Study|Administrative Decision|0|||
170439296|NCT00919711|615946390|FG001|Overall Study|Administrative Decision|1|||
170439297|NCT00919711|615946389|FG000|Overall Study|Lost to Follow-up|2|||
170439298|NCT00919711|615946390|FG001|Overall Study|Lost to Follow-up|0|||
170439299|NCT00919711|615946389|FG000|Overall Study|Death|1|||
170439300|NCT00919711|615946390|FG001|Overall Study|Death|0|||
170439301|NCT00919711|615946389|FG000|Overall Study|Noncompliance|1|||
170439302|NCT00919711|615946390|FG001|Overall Study|Noncompliance|0|||
170439303|NCT00903877|615946391|FG000|Overall Study|Did not meet study criteria|33|||
170439304|NCT00903877|615946391|FG000|Overall Study|Withdrawal by Subject|3|||
170439305|NCT00903877|615946391|FG000|Overall Study|Adverse Event|2|||
170439306|NCT00903877|615946391|FG000|Overall Study|Lost to Follow-up|1|||
170439307|NCT00903877|615946391|FG000|Overall Study|Participation put on hold|4|||
170439308|NCT02957331|615946394|FG000|Overall Study|Protocol Violation|1|||
170439309|NCT02957331|615946395|FG001|Overall Study|Protocol Violation|0|||
170439310|NCT02588339|615946396|FG000|Overall Study|Withdrawal by Subject|1|||
170439311|NCT02588339|615946396|FG000|Overall Study|GVHD Progression prior to treatment|2|||
170439312|NCT04264819|615947977|FG000|Overall Study|Physician Decision|19|||
170439313|NCT04264819|615947977|FG000|Overall Study|Adverse Event|12|||
170439314|NCT04264819|615947977|FG000|Overall Study|Withdrawal by Subject|11|||
170439315|NCT04264819|615947977|FG000|Overall Study|Lost to Follow-up|2|||
170439316|NCT04264819|615947977|FG000|Overall Study|Death|2|||
170439317|NCT00927251|615947979|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
170439318|NCT00500318|615947982|FG000|Overall Study|Adverse Event|3|||
170439319|NCT00500318|615947983|FG001|Overall Study|Adverse Event|8|||
170439320|NCT00500318|615947982|FG000|Overall Study|Protocol Violation|1|||
170439321|NCT00500318|615947983|FG001|Overall Study|Protocol Violation|3|||
170439322|NCT00500318|615947982|FG000|Overall Study|Withdrawal by Subject|1|||
170439323|NCT00500318|615947983|FG001|Overall Study|Withdrawal by Subject|2|||
170439324|NCT00500318|615947982|FG000|Overall Study|Lack of Efficacy|0|||
170439325|NCT00500318|615947983|FG001|Overall Study|Lack of Efficacy|3|||
170439326|NCT00500318|615947982|FG000|Overall Study|Other Reason|0|||
170439327|NCT00500318|615947983|FG001|Overall Study|Other Reason|1|||
170439328|NCT01350934|615947984|FG000|Base Study|Adverse Event|6|||
170439329|NCT01350934|615947985|FG001|Base Study|Adverse Event|0|||
170439330|NCT01350934|615947984|FG000|Base Study|Lost to Follow-up|1|||
170439331|NCT01350934|615947985|FG001|Base Study|Lost to Follow-up|0|||
170439332|NCT01350934|615947984|FG000|Base Study|Protocol Violation|1|||
170439333|NCT01350934|615947985|FG001|Base Study|Protocol Violation|1|||
170439334|NCT01350934|615947984|FG000|Base Study|Withdrawal by Subject|1|||
170439335|NCT01350934|615947985|FG001|Base Study|Withdrawal by Subject|2|||
170439336|NCT01350934|615947984|FG000|Base Study|Non-Compliance With Study Drug|2|||
170781957|NCT06024174|617209326|FG000|Overall Study|Study terminated by Sponsor|4|||
170781958|NCT05110495|617211144|FG000|Overall Study|Lost to Follow-up|1|||
170781959|NCT05110495|617211144|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
170781960|NCT04833777|617211149|FG000|Overall Study|Lost to Follow-up|1|||
170781961|NCT04833777|617211150|FG001|Overall Study|Lost to Follow-up|0|||
170781962|NCT03089398|617211151|FG000|Overall Study|Death|4|||
170781963|NCT03089398|617211152|FG001|Overall Study|Death|9|||
170781964|NCT03089398|617211151|FG000|Overall Study|Lost to Follow-up|21|||
170781965|NCT03089398|617211152|FG001|Overall Study|Lost to Follow-up|30|||
170781966|NCT03089398|617211151|FG000|Overall Study|Withdrawal by Subject|2|||
170781967|NCT03089398|617211152|FG001|Overall Study|Withdrawal by Subject|2|||
170781968|NCT05439603|617211153|FG000|Overall Study|met withdrawal criteria|2|||
170781969|NCT03713086|617211158|FG000|Overall Study|Withdrawal by Subject|0|||
170781970|NCT03713086|617211159|FG001|Overall Study|Withdrawal by Subject|2|||
170781971|NCT03713086|617211160|FG002|Overall Study|Withdrawal by Subject|1|||
170781972|NCT03713086|617211161|FG003|Overall Study|Withdrawal by Subject|0|||
170781973|NCT03713086|617211158|FG000|Overall Study|Lost to Follow-up|0|||
170781974|NCT03713086|617211159|FG001|Overall Study|Lost to Follow-up|1|||
170439337|NCT01350934|615947985|FG001|Base Study|Non-Compliance With Study Drug|0|||
170439338|NCT01350934|615947984|FG000|Extension Study|Adverse Event|2|||
170439339|NCT01350934|615947985|FG001|Extension Study|Adverse Event|1|||
170439340|NCT01350934|615947984|FG000|Extension Study|Lost to Follow-up|2|||
170439341|NCT01350934|615947985|FG001|Extension Study|Lost to Follow-up|0|||
170439342|NCT01350934|615947984|FG000|Extension Study|Protocol Violation|1|||
170439343|NCT01350934|615947985|FG001|Extension Study|Protocol Violation|1|||
170439344|NCT01350934|615947984|FG000|Extension Study|Lack of Efficacy|0|||
170439345|NCT01350934|615947985|FG001|Extension Study|Lack of Efficacy|1|||
170439346|NCT01350934|615947984|FG000|Extension Study|Withdrawal by Subject|0|||
170439347|NCT01350934|615947985|FG001|Extension Study|Withdrawal by Subject|1|||
170439348|NCT01011335|615947988|FG000|Overall Study|Lost to Follow-up|0|||
170439349|NCT01011335|615947989|FG001|Overall Study|Lost to Follow-up|0|||
170439350|NCT01011335|615947990|FG002|Overall Study|Lost to Follow-up|1|||
170439351|NCT01011335|615947991|FG003|Overall Study|Lost to Follow-up|1|||
170439352|NCT01011335|615947992|FG004|Overall Study|Lost to Follow-up|1|||
170439353|NCT01011335|615947993|FG005|Overall Study|Lost to Follow-up|1|||
170439354|NCT01011335|615947994|FG006|Overall Study|Lost to Follow-up|2|||
170439355|NCT01011335|615947995|FG007|Overall Study|Lost to Follow-up|2|||
170439356|NCT01011335|615947996|FG008|Overall Study|Lost to Follow-up|1|||
170439357|NCT01011335|615947997|FG009|Overall Study|Lost to Follow-up|0|||
170439358|NCT01011335|615947998|FG010|Overall Study|Lost to Follow-up|0|||
170439359|NCT01011335|615947999|FG011|Overall Study|Lost to Follow-up|1|||
170439360|NCT01011335|615948000|FG012|Overall Study|Lost to Follow-up|2|||
170439361|NCT01011335|615947988|FG000|Overall Study|Protocol Violation|0|||
170439362|NCT01011335|615947989|FG001|Overall Study|Protocol Violation|1|||
170439363|NCT01011335|615947990|FG002|Overall Study|Protocol Violation|0|||
170439364|NCT01011335|615947991|FG003|Overall Study|Protocol Violation|0|||
170439365|NCT01011335|615947992|FG004|Overall Study|Protocol Violation|0|||
170439366|NCT01011335|615947993|FG005|Overall Study|Protocol Violation|0|||
170439367|NCT01011335|615947994|FG006|Overall Study|Protocol Violation|0|||
170439368|NCT01011335|615947995|FG007|Overall Study|Protocol Violation|0|||
170439369|NCT01011335|615947996|FG008|Overall Study|Protocol Violation|0|||
170439370|NCT01011335|615947997|FG009|Overall Study|Protocol Violation|0|||
170439371|NCT01011335|615947998|FG010|Overall Study|Protocol Violation|0|||
170439372|NCT01011335|615947999|FG011|Overall Study|Protocol Violation|0|||
170439373|NCT01011335|615948000|FG012|Overall Study|Protocol Violation|0|||
170439374|NCT01011335|615947988|FG000|Overall Study|Moved/deployed or no booster|1|||
170439375|NCT01011335|615947989|FG001|Overall Study|Moved/deployed or no booster|0|||
170439376|NCT01011335|615947990|FG002|Overall Study|Moved/deployed or no booster|0|||
170439377|NCT01011335|615947991|FG003|Overall Study|Moved/deployed or no booster|1|||
170439378|NCT01011335|615947992|FG004|Overall Study|Moved/deployed or no booster|0|||
170439379|NCT01011335|615947993|FG005|Overall Study|Moved/deployed or no booster|0|||
170439380|NCT01011335|615947994|FG006|Overall Study|Moved/deployed or no booster|1|||
170439381|NCT01011335|615947995|FG007|Overall Study|Moved/deployed or no booster|0|||
170439382|NCT01011335|615947996|FG008|Overall Study|Moved/deployed or no booster|1|||
170439383|NCT01011335|615947997|FG009|Overall Study|Moved/deployed or no booster|0|||
170439384|NCT01011335|615947998|FG010|Overall Study|Moved/deployed or no booster|2|||
170439385|NCT01011335|615947999|FG011|Overall Study|Moved/deployed or no booster|0|||
170439386|NCT01011335|615948000|FG012|Overall Study|Moved/deployed or no booster|0|||
170439387|NCT01011335|615947988|FG000|Overall Study|Adverse Event|0|||
170439388|NCT01011335|615947989|FG001|Overall Study|Adverse Event|0|||
170439389|NCT01011335|615947990|FG002|Overall Study|Adverse Event|0|||
170439390|NCT01011335|615947991|FG003|Overall Study|Adverse Event|0|||
170439391|NCT01011335|615947992|FG004|Overall Study|Adverse Event|0|||
170439392|NCT01011335|615947993|FG005|Overall Study|Adverse Event|0|||
170439393|NCT01011335|615947994|FG006|Overall Study|Adverse Event|0|||
170439394|NCT01011335|615947995|FG007|Overall Study|Adverse Event|0|||
170439395|NCT01011335|615947996|FG008|Overall Study|Adverse Event|0|||
170439396|NCT01011335|615947997|FG009|Overall Study|Adverse Event|0|||
170439397|NCT01011335|615947998|FG010|Overall Study|Adverse Event|4|||
170439398|NCT01011335|615947999|FG011|Overall Study|Adverse Event|0|||
170439399|NCT01011335|615948000|FG012|Overall Study|Adverse Event|1|||
170439400|NCT01813435|615948001|FG000|Overall Study|did not finish experimental regimen|1902|||
170439401|NCT01813435|615948002|FG001|Overall Study|did not finish experimental regimen|770|||
170439402|NCT01813435|615948001|FG000|Overall Study|Lost to Follow-up|268|||
170439403|NCT01813435|615948002|FG001|Overall Study|Lost to Follow-up|237|||
170439404|NCT01765751|615948003|FG000|Overall Study|Lost to Follow-up|0|||
170439405|NCT01765751|615948004|FG001|Overall Study|Lost to Follow-up|2|||
170439406|NCT01765751|615948005|FG002|Overall Study|Lost to Follow-up|1|||
170439407|NCT00452348|615948006|FG000|Overall Study|Adverse Event|6|||
170439408|NCT00452348|615948007|FG001|Overall Study|Adverse Event|9|||
170439409|NCT00452348|615948006|FG000|Overall Study|Lack of Efficacy|10|||
170439410|NCT00452348|615948007|FG001|Overall Study|Lack of Efficacy|9|||
170439411|NCT00452348|615948006|FG000|Overall Study|Lost to Follow-up|14|||
170439412|NCT00452348|615948007|FG001|Overall Study|Lost to Follow-up|8|||
170439413|NCT00452348|615948006|FG000|Overall Study|Protocol Violation|22|||
170439414|NCT00452348|615948007|FG001|Overall Study|Protocol Violation|28|||
170439415|NCT00452348|615948006|FG000|Overall Study|Withdrawal by Subject|18|||
170439416|NCT00452348|615948007|FG001|Overall Study|Withdrawal by Subject|21|||
170439417|NCT00452348|615948006|FG000|Overall Study|Other|9|||
170439418|NCT00452348|615948007|FG001|Overall Study|Other|9|||
170439419|NCT02435433|615948010|FG000|Overall Study|Withdrawal by Subject|2|||
170439420|NCT02435433|615948011|FG001|Overall Study|Withdrawal by Subject|3|||
170439421|NCT02435433|615948012|FG002|Overall Study|Withdrawal by Subject|1|||
170439422|NCT02435433|615948013|FG003|Overall Study|Withdrawal by Subject|0|||
170439423|NCT02435433|615948014|FG004|Overall Study|Withdrawal by Subject|0|||
170439424|NCT02435433|615948010|FG000|Overall Study|Lost to Follow-up|2|||
170439425|NCT02435433|615948011|FG001|Overall Study|Lost to Follow-up|2|||
170439426|NCT02435433|615948012|FG002|Overall Study|Lost to Follow-up|4|||
170439427|NCT02435433|615948013|FG003|Overall Study|Lost to Follow-up|1|||
170439428|NCT02435433|615948014|FG004|Overall Study|Lost to Follow-up|0|||
170439429|NCT01243151|615948015|FG000|Overall Study|Adverse Event|0|||
170439430|NCT01243151|615948016|FG001|Overall Study|Adverse Event|1|||
170439431|NCT01243151|615948017|FG002|Overall Study|Adverse Event|0|||
170439432|NCT01243151|615948018|FG003|Overall Study|Adverse Event|0|||
170439433|NCT01243151|615948019|FG004|Overall Study|Adverse Event|0|||
170439434|NCT01243151|615948015|FG000|Overall Study|Protocol Violation|0|||
170439435|NCT01243151|615948016|FG001|Overall Study|Protocol Violation|0|||
170439436|NCT01243151|615948017|FG002|Overall Study|Protocol Violation|1|||
170439437|NCT01243151|615948018|FG003|Overall Study|Protocol Violation|0|||
170439438|NCT01243151|615948019|FG004|Overall Study|Protocol Violation|0|||
170439439|NCT01243151|615948015|FG000|Overall Study|Other|0|||
170439440|NCT01243151|615948016|FG001|Overall Study|Other|0|||
170439441|NCT01243151|615948017|FG002|Overall Study|Other|0|||
170439442|NCT01243151|615948018|FG003|Overall Study|Other|1|||
170439443|NCT01243151|615948019|FG004|Overall Study|Other|0|||
170439444|NCT01243151|615948015|FG000|Overall Study|Randomized but not treated|0|||
170439445|NCT01243151|615948016|FG001|Overall Study|Randomized but not treated|0|||
170439446|NCT01243151|615948017|FG002|Overall Study|Randomized but not treated|0|||
170439447|NCT01243151|615948018|FG003|Overall Study|Randomized but not treated|1|||
170439448|NCT01243151|615948019|FG004|Overall Study|Randomized but not treated|0|||
170439449|NCT03119662|615948020|FG000|Overall Study|Withdrawal by Subject|0|||
170439450|NCT03119662|615948021|FG001|Overall Study|Withdrawal by Subject|1|||
170439451|NCT02817828|615948022|FG000|Overall Study|Lost to Follow-up|41|||
170439452|NCT02817828|615948022|FG000|Overall Study|Adverse event not related to bleeding|104|||
170439453|NCT02817828|615948022|FG000|Overall Study|Adverse event related to bleeding|53|||
170439454|NCT02817828|615948022|FG000|Overall Study|Protocol Violation|11|||
170439455|NCT02817828|615948022|FG000|Overall Study|Pregnancy|7|||
170439456|NCT02817828|615948022|FG000|Overall Study|Pregnancy wish|15|||
170439457|NCT02817828|615948022|FG000|Overall Study|Withdrawal by Subject|78|||
170439458|NCT02817828|615948022|FG000|Overall Study|Other|26|||
170439459|NCT00544167|615948024|FG000|Overall Study|Adverse Event|21|||
170439460|NCT00544167|615948024|FG000|Overall Study|Physician Decision|8|||
170439461|NCT00799708|615948025|FG000|Overall Study|non-compliance|1|||
170439462|NCT00799708|615948026|FG001|Overall Study|non-compliance|0|||
170439463|NCT00799708|615948027|FG002|Overall Study|non-compliance|0|||
170439464|NCT00880334|615948028|FG000|Randomized Phase|Physician Decision|1|||
170439465|NCT00880334|615948029|FG001|Randomized Phase|Physician Decision|0|||
170439466|NCT00880334|615948028|FG000|Randomized Phase|Withdrawal by Subject|2|||
170439467|NCT00880334|615948029|FG001|Randomized Phase|Withdrawal by Subject|1|||
170439468|NCT00880334|615948028|FG000|Randomized Phase|Inadequate Labs|1|||
170439469|NCT00880334|615948029|FG001|Randomized Phase|Inadequate Labs|1|||
170439470|NCT00880334|615948028|FG000|Randomized Phase|Brain Metastasis|0|||
170439471|NCT00880334|615948029|FG001|Randomized Phase|Brain Metastasis|1|||
170439472|NCT00880334|615948028|FG000|Randomized Phase|Crossover Participants|0|||
170439473|NCT00880334|615948029|FG001|Randomized Phase|Crossover Participants|37|||
170439474|NCT02046122|615948037|FG000|Overall Study|Physician Decision|8|||
170439475|NCT02046122|615948037|FG000|Overall Study|Withdrawal by Subject|1|||
170439476|NCT04535986|615948038|FG000|Overall Study|Death|4|||
170439477|NCT04535986|615948039|FG001|Overall Study|Death|5|||
170439478|NCT04535986|615948038|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
170439479|NCT04535986|615948039|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
170439480|NCT04535986|615948038|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
170439481|NCT04535986|615948039|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
170439482|NCT04535986|615948038|FG000|Overall Study|Adverse Event|10|||
170439483|NCT04535986|615948039|FG001|Overall Study|Adverse Event|1|||
170439484|NCT04535986|615948038|FG000|Overall Study|Lack of Efficacy|3|||
170439485|NCT04535986|615948039|FG001|Overall Study|Lack of Efficacy|2|||
170439486|NCT04535986|615948038|FG000|Overall Study|Investigator discretion|3|||
170439487|NCT04535986|615948039|FG001|Overall Study|Investigator discretion|0|||
170439488|NCT04535986|615948038|FG000|Overall Study|Withdrawal by Subject|32|||
170439489|NCT04535986|615948039|FG001|Overall Study|Withdrawal by Subject|14|||
170439490|NCT04535986|615948038|FG000|Overall Study|Lost to Follow-up|5|||
170439491|NCT04535986|615948039|FG001|Overall Study|Lost to Follow-up|3|||
170439492|NCT04535986|615948038|FG000|Overall Study|Other|7|||
170439493|NCT04535986|615948039|FG001|Overall Study|Other|3|||
170439494|NCT04610580|615948040|FG000|Two-way Crossover Period|Adverse Event|1|||
170439495|NCT04610580|615948041|FG001|Two-way Crossover Period|Adverse Event|0|||
170439496|NCT04610580|615948042|FG002|Two-way Crossover Period|Adverse Event|0|||
170439497|NCT04610580|615948043|FG003|Two-way Crossover Period|Adverse Event|0|||
170439498|NCT04610580|615948044|FG004|Two-way Crossover Period|Adverse Event|0|||
170439499|NCT04610580|615948045|FG005|Two-way Crossover Period|Adverse Event|0|||
170439500|NCT04610580|615948040|FG000|Two-way Crossover Period|Physician Decision|1|||
170439501|NCT04610580|615948041|FG001|Two-way Crossover Period|Physician Decision|0|||
170439502|NCT04610580|615948042|FG002|Two-way Crossover Period|Physician Decision|0|||
170439503|NCT04610580|615948043|FG003|Two-way Crossover Period|Physician Decision|0|||
170439504|NCT04610580|615948044|FG004|Two-way Crossover Period|Physician Decision|0|||
170882810|NCT01857869|617579655|FG005|Primary/Challenge Phase|Protocol Violation|0|||
170882811|NCT01857869|617579656|FG006|Primary/Challenge Phase|Protocol Violation|0|||
170882812|NCT01857869|617579657|FG007|Primary/Challenge Phase|Protocol Violation|0|||
170882813|NCT01857869|617579658|FG008|Primary/Challenge Phase|Protocol Violation|0|||
170882814|NCT01857869|617579659|FG009|Primary/Challenge Phase|Protocol Violation|0|||
170882815|NCT01857869|617579650|FG000|Primary/Challenge Phase|Other|1|||
170882816|NCT01857869|617579651|FG001|Primary/Challenge Phase|Other|1|||
170882817|NCT01857869|617579652|FG002|Primary/Challenge Phase|Other|0|||
170781975|NCT03713086|617211160|FG002|Overall Study|Lost to Follow-up|0|||
170781976|NCT03713086|617211161|FG003|Overall Study|Lost to Follow-up|1|||
170781977|NCT05406921|617211165|FG000|Overall Study|Withdrawal by Subject|25|||
170781978|NCT05406921|617211166|FG001|Overall Study|Withdrawal by Subject|0|||
170781979|NCT05406921|617211167|FG002|Overall Study|Withdrawal by Subject|25|||
170781980|NCT05406921|617211165|FG000|Overall Study|Protocol Violation|0|||
170781981|NCT05406921|617211166|FG001|Overall Study|Protocol Violation|12|||
170781982|NCT05406921|617211167|FG002|Overall Study|Protocol Violation|0|||
170781983|NCT05249439|617211168|FG000|Overall Study|Withdrawal by Subject|2|||
170781984|NCT05249439|617211169|FG001|Overall Study|Withdrawal by Subject|5|||
170781985|NCT05249439|617211168|FG000|Overall Study|Physician Decision|3|||
170781986|NCT05249439|617211169|FG001|Overall Study|Physician Decision|1|||
170781987|NCT02910583|617211170|FG000|Overall Study|Death|7|||
170781988|NCT02910583|617211171|FG001|Overall Study|Death|3|||
170781989|NCT02910583|617211170|FG000|Overall Study|Lost to Follow-up|1|||
170781990|NCT02910583|617211171|FG001|Overall Study|Lost to Follow-up|0|||
170781991|NCT02910583|617211170|FG000|Overall Study|Withdrawal by Subject|12|||
170781992|NCT02910583|617211171|FG001|Overall Study|Withdrawal by Subject|8|||
170781993|NCT02910583|617211170|FG000|Overall Study|Other, Not Specified|6|||
170781994|NCT02910583|617211171|FG001|Overall Study|Other, Not Specified|3|||
170781995|NCT01331005|617211172|FG000|Overall Study|Lost to Follow-up|2|||
170781996|NCT01331005|617211173|FG001|Overall Study|Lost to Follow-up|1|||
170781997|NCT01331005|617211172|FG000|Overall Study|Withdrawal by Subject|2|||
170781998|NCT01331005|617211173|FG001|Overall Study|Withdrawal by Subject|3|||
170781999|NCT05059262|617211174|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
170782000|NCT05059262|617211175|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
170782001|NCT05059262|617211174|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
170782002|NCT05059262|617211175|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
170782003|NCT05059262|617211174|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
170782004|NCT05059262|617211175|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
170782005|NCT05059262|617211174|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
170782006|NCT05059262|617211175|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
170782007|NCT05059262|617211174|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
170782008|NCT05059262|617211175|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
170782009|NCT05059262|617211174|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
170782010|NCT05059262|617211175|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
170782011|NCT05059262|617211174|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
170782012|NCT05059262|617211175|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
170782013|NCT05059262|617211174|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
170782014|NCT05059262|617211175|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
170782015|NCT05059262|617211174|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
170782016|NCT05059262|617211175|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
170782017|NCT05054374|617211183|FG000|Overall Study|Withdrawal by Subject|1|||
170782018|NCT05054374|617211184|FG001|Overall Study|Withdrawal by Subject|0|||
170782019|NCT05054374|617211185|FG002|Overall Study|Withdrawal by Subject|0|||
170782020|NCT05054374|617211186|FG003|Overall Study|Withdrawal by Subject|0|||
170782021|NCT05054374|617211183|FG000|Overall Study|Progressive Disease|5|||
170782022|NCT05054374|617211184|FG001|Overall Study|Progressive Disease|0|||
170782023|NCT05054374|617211185|FG002|Overall Study|Progressive Disease|0|||
170782024|NCT05054374|617211186|FG003|Overall Study|Progressive Disease|0|||
170782025|NCT02927769|617211187|FG000|Induction Phase|Study drug toxicity|1|||
170782026|NCT02927769|617211188|FG001|Induction Phase|Study drug toxicity|1|||
170782027|NCT02927769|617211187|FG000|Induction Phase|Disease progression|0|||
170782028|NCT02927769|617211188|FG001|Induction Phase|Disease progression|1|||
170782029|NCT02927769|617211187|FG000|Intensification Phase|Study drug toxicity|1|||
170782030|NCT02927769|617211188|FG001|Intensification Phase|Study drug toxicity|0|||
170782031|NCT05337748|617211192|FG000|Overall Study|Withdrawal by Subject|1|||
170782032|NCT05337748|617211193|FG001|Overall Study|Withdrawal by Subject|0|||
170782033|NCT05337748|617211192|FG000|Overall Study|Death|1|||
170782034|NCT05337748|617211193|FG001|Overall Study|Death|0|||
170782035|NCT02506959|617211194|FG000|Overall Study|Physician Decision|2|||
170782036|NCT02506959|617211195|FG001|Overall Study|Physician Decision|1|||
170882818|NCT01857869|617579653|FG003|Primary/Challenge Phase|Other|0|||
170882819|NCT01857869|617579654|FG004|Primary/Challenge Phase|Other|0|||
170782037|NCT05470400|617211198|FG000|Overall Study|Lost to Follow-up|0|||
170782038|NCT05470400|617211199|FG001|Overall Study|Lost to Follow-up|0|||
170882820|NCT01857869|617579655|FG005|Primary/Challenge Phase|Other|0|||
170439505|NCT04610580|615948045|FG005|Two-way Crossover Period|Physician Decision|0|||
170439506|NCT04610580|615948040|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
170439507|NCT04610580|615948041|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
170439508|NCT04610580|615948042|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
170439509|NCT04610580|615948043|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
170439510|NCT04610580|615948044|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
170439511|NCT04610580|615948045|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
170439512|NCT04610580|615948040|FG000|Two-way Crossover Period|Other than specified|0|||
170439513|NCT04610580|615948041|FG001|Two-way Crossover Period|Other than specified|1|||
170439514|NCT04610580|615948042|FG002|Two-way Crossover Period|Other than specified|0|||
170439515|NCT04610580|615948043|FG003|Two-way Crossover Period|Other than specified|0|||
170439516|NCT04610580|615948044|FG004|Two-way Crossover Period|Other than specified|0|||
170439517|NCT04610580|615948045|FG005|Two-way Crossover Period|Other than specified|0|||
170439518|NCT04610580|615948040|FG000|Washout Before Extension Period|Other than specified|0|||
170439519|NCT04610580|615948041|FG001|Washout Before Extension Period|Other than specified|1|||
170439520|NCT04610580|615948042|FG002|Washout Before Extension Period|Other than specified|0|||
170439521|NCT04610580|615948043|FG003|Washout Before Extension Period|Other than specified|0|||
170439522|NCT04610580|615948044|FG004|Washout Before Extension Period|Other than specified|0|||
170439523|NCT04610580|615948045|FG005|Washout Before Extension Period|Other than specified|0|||
170439524|NCT04610580|615948040|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
170439525|NCT04610580|615948041|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
170439526|NCT04610580|615948042|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
170439527|NCT04610580|615948043|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
170439528|NCT04610580|615948044|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
170439529|NCT04610580|615948045|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
170439530|NCT04610580|615948040|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
170439531|NCT04610580|615948041|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
170439532|NCT04610580|615948042|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
170439533|NCT04610580|615948043|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
170439534|NCT04610580|615948044|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
170439535|NCT04610580|615948045|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
170439536|NCT01097694|615948046|FG000|Overall Study|Adverse Event|5|||
170439537|NCT01097694|615948047|FG001|Overall Study|Adverse Event|0|||
170439538|NCT01097694|615948046|FG000|Overall Study|Lost to Follow-up|0|||
170439539|NCT01097694|615948047|FG001|Overall Study|Lost to Follow-up|3|||
170439540|NCT01097694|615948046|FG000|Overall Study|Withdrawal by Subject|3|||
170439541|NCT01097694|615948047|FG001|Overall Study|Withdrawal by Subject|1|||
170439542|NCT00881569|615948049|FG000|Overall Study|Disease progression|1|||
170439543|NCT00881569|615948050|FG001|Overall Study|Disease progression|1|||
170439544|NCT03277248|615948051|FG000|Overall Study|Adverse Event|3|||
170439545|NCT03277248|615948052|FG001|Overall Study|Adverse Event|1|||
170439546|NCT03277248|615948051|FG000|Overall Study|Subject Withdrawal of Consent|6|||
170439547|NCT03277248|615948052|FG001|Overall Study|Subject Withdrawal of Consent|23|||
170439548|NCT03277248|615948051|FG000|Overall Study|Investigator/Sponsor Decision|2|||
170439549|NCT03277248|615948052|FG001|Overall Study|Investigator/Sponsor Decision|2|||
170439550|NCT03277248|615948051|FG000|Overall Study|Pregnancy|4|||
170439551|NCT03277248|615948052|FG001|Overall Study|Pregnancy|1|||
170782039|NCT05470400|617211200|FG002|Overall Study|Lost to Follow-up|0|||
170782040|NCT05470400|617211201|FG003|Overall Study|Lost to Follow-up|0|||
170782041|NCT05470400|617211202|FG004|Overall Study|Lost to Follow-up|0|||
170782042|NCT05470400|617211203|FG005|Overall Study|Lost to Follow-up|0|||
170782043|NCT05470400|617211204|FG006|Overall Study|Lost to Follow-up|0|||
170782044|NCT05470400|617211205|FG007|Overall Study|Lost to Follow-up|1|||
170782045|NCT05470400|617211198|FG000|Overall Study|Withdrawal by Subject|1|||
170782046|NCT05470400|617211199|FG001|Overall Study|Withdrawal by Subject|0|||
170782047|NCT05470400|617211200|FG002|Overall Study|Withdrawal by Subject|0|||
170782048|NCT05470400|617211201|FG003|Overall Study|Withdrawal by Subject|0|||
170782049|NCT05470400|617211202|FG004|Overall Study|Withdrawal by Subject|0|||
170782050|NCT05470400|617211203|FG005|Overall Study|Withdrawal by Subject|1|||
170782051|NCT05470400|617211204|FG006|Overall Study|Withdrawal by Subject|0|||
170882821|NCT01857869|617579656|FG006|Primary/Challenge Phase|Other|0|||
170882822|NCT01857869|617579657|FG007|Primary/Challenge Phase|Other|0|||
170439552|NCT03277248|615948051|FG000|Overall Study|Lost to Follow-up|0|||
170439553|NCT03277248|615948052|FG001|Overall Study|Lost to Follow-up|2|||
170439554|NCT03277248|615948051|FG000|Overall Study|Lack of Efficacy|0|||
170439555|NCT03277248|615948052|FG001|Overall Study|Lack of Efficacy|2|||
170439556|NCT03277248|615948051|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
170537145|NCT02452190|616311539|FG001|Overall Study|Withdrawal by Sponsor|3|||
170537146|NCT02452190|616311538|FG000|Overall Study|Pregnancy|1|||
170782052|NCT05470400|617211205|FG007|Overall Study|Withdrawal by Subject|2|||
170782053|NCT05956002|617211207|FG000|Treatment Period 3|Adverse Event|0|||
170782054|NCT05956002|617211208|FG001|Treatment Period 3|Adverse Event|0|||
170882823|NCT01857869|617579658|FG008|Primary/Challenge Phase|Other|0|||
170439557|NCT03277248|615948052|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
170439558|NCT01993940|615948053|FG000|Overall Study|Adverse Event|16|||
170439559|NCT01993940|615948054|FG001|Overall Study|Adverse Event|11|||
170439560|NCT01993940|615948053|FG000|Overall Study|Withdrawal by Subject|15|||
170439561|NCT01993940|615948054|FG001|Overall Study|Withdrawal by Subject|19|||
170439562|NCT01993940|615948053|FG000|Overall Study|Lost to Follow-up|2|||
170439563|NCT01993940|615948054|FG001|Overall Study|Lost to Follow-up|5|||
170439564|NCT01993940|615948053|FG000|Overall Study|Protocol Violation|5|||
170439565|NCT01993940|615948054|FG001|Overall Study|Protocol Violation|8|||
170439566|NCT01993940|615948053|FG000|Overall Study|Death|1|||
170439567|NCT01993940|615948054|FG001|Overall Study|Death|0|||
170439568|NCT01993940|615948053|FG000|Overall Study|Other - Miscellaneous|1|||
170439569|NCT01993940|615948054|FG001|Overall Study|Other - Miscellaneous|1|||
170439570|NCT01670097|615948055|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
170439571|NCT01670097|615948056|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
170439572|NCT01670097|615948055|FG000|Overall Study|Study burden|1|||
170439573|NCT01670097|615948056|FG001|Overall Study|Study burden|0|||
170439574|NCT01670097|615948055|FG000|Overall Study|COPD exacerbation|0|||
170439575|NCT01670097|615948056|FG001|Overall Study|COPD exacerbation|1|||
170439576|NCT01670097|615948055|FG000|Overall Study|Neutropenia|0|||
170439577|NCT01670097|615948056|FG001|Overall Study|Neutropenia|1|||
170439578|NCT01670097|615948055|FG000|Overall Study|Clinical deterioration|0|||
170439579|NCT01670097|615948056|FG001|Overall Study|Clinical deterioration|1|||
170439580|NCT01670097|615948055|FG000|Overall Study|Disease progression|0|||
170439581|NCT01670097|615948056|FG001|Overall Study|Disease progression|1|||
170439582|NCT03259165|615948057|FG000|Overall Study|COVID 19 pandemic|1|||
170439583|NCT03259165|615948058|FG001|Overall Study|COVID 19 pandemic|1|||
170439584|NCT00379353|615948059|FG000|Overall Study|Hospitalization|3|||
170439585|NCT00379353|615948060|FG001|Overall Study|Hospitalization|3|||
170439586|NCT00379353|615948059|FG000|Overall Study|Withdrawal by Subject|5|||
170439587|NCT00379353|615948060|FG001|Overall Study|Withdrawal by Subject|2|||
170439588|NCT00379353|615948059|FG000|Overall Study|Death|1|||
170439589|NCT00379353|615948060|FG001|Overall Study|Death|0|||
170439590|NCT00379353|615948059|FG000|Overall Study|Cardiac Tamponade|1|||
170439591|NCT00379353|615948060|FG001|Overall Study|Cardiac Tamponade|0|||
170439592|NCT00379353|615948059|FG000|Overall Study|Non-compliance|1|||
170439593|NCT00379353|615948060|FG001|Overall Study|Non-compliance|0|||
170439594|NCT00379353|615948059|FG000|Overall Study|Conflicting drug treatment|0|||
170439595|NCT00379353|615948060|FG001|Overall Study|Conflicting drug treatment|1|||
170439596|NCT02004691|615948061|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
170439597|NCT02004691|615948062|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
170439598|NCT02004691|615948061|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
170439599|NCT02004691|615948062|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
170439600|NCT02004691|615948061|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
170439601|NCT02004691|615948062|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
170439602|NCT02004691|615948061|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
170439603|NCT02004691|615948062|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
170439604|NCT02004691|615948061|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
170439605|NCT02004691|615948062|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
170439606|NCT02004691|615948061|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
170439607|NCT02004691|615948062|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
170439608|NCT02311894|615948063|FG000|Overall Study|Discontinued in error|1|||
170439609|NCT02311894|615948063|FG000|Overall Study|Lost to Follow-up|1|||
170537147|NCT02452190|616311539|FG001|Overall Study|Pregnancy|0|||
170882824|NCT01857869|617579659|FG009|Primary/Challenge Phase|Other|0|||
170882825|NCT01857869|617579650|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170882826|NCT01857869|617579651|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170882827|NCT01857869|617579652|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170882828|NCT01857869|617579653|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
170882829|NCT01857869|617579654|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170882830|NCT01857869|617579655|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170882831|NCT01857869|617579656|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170882832|NCT01857869|617579657|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170882833|NCT01857869|617579658|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170439610|NCT02311894|615948063|FG000|Overall Study|Adverse Event|1|||
170439611|NCT02311894|615948063|FG000|Overall Study|Withdrawal by Subject|1|||
170439612|NCT01277510|615948069|FG000|Double-blind Phase|Non-compliance|0|||
170439613|NCT01277510|615948070|FG001|Double-blind Phase|Non-compliance|1|||
170439614|NCT01277510|615948069|FG000|Double-blind Phase|Adverse Event|1|||
170439615|NCT01277510|615948070|FG001|Double-blind Phase|Adverse Event|0|||
170439616|NCT01277510|615948069|FG000|Double-blind Phase|Withdrawal by Subject|2|||
170439617|NCT01277510|615948070|FG001|Double-blind Phase|Withdrawal by Subject|0|||
170439618|NCT01277510|615948069|FG000|Double-blind Phase|Administrative decision|7|||
170882834|NCT01857869|617579659|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
170537148|NCT02452190|616311538|FG000|Overall Study|Investigator's Decision|2|||
170782055|NCT05956002|617211209|FG002|Treatment Period 3|Adverse Event|1|||
170782056|NCT05956002|617211210|FG003|Treatment Period 3|Adverse Event|0|||
170782057|NCT04784559|617211211|FG000|Overall Study|Withdrawal by Subject|3|||
170782058|NCT04784559|617211212|FG001|Overall Study|Withdrawal by Subject|2|||
170782059|NCT04784559|617211213|FG002|Overall Study|Withdrawal by Subject|1|||
170782060|NCT04784559|617211211|FG000|Overall Study|Death|2|||
170782061|NCT04784559|617211212|FG001|Overall Study|Death|1|||
170782062|NCT04784559|617211213|FG002|Overall Study|Death|2|||
170782063|NCT04784559|617211211|FG000|Overall Study|Lost to Follow-up|0|||
170782064|NCT04784559|617211212|FG001|Overall Study|Lost to Follow-up|0|||
170782065|NCT04784559|617211213|FG002|Overall Study|Lost to Follow-up|2|||
170782066|NCT04784559|617211211|FG000|Overall Study|Participant worsened, PI decision|1|||
170782067|NCT04784559|617211212|FG001|Overall Study|Participant worsened, PI decision|0|||
170782068|NCT04784559|617211213|FG002|Overall Study|Participant worsened, PI decision|0|||
170782069|NCT04784559|617211211|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
170782070|NCT04784559|617211212|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
170782071|NCT04784559|617211213|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
170782072|NCT04784559|617211211|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
170782073|NCT04784559|617211212|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
170782074|NCT04784559|617211213|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
170782075|NCT04784559|617211211|FG000|Overall Study|Did not meet all inclusion criteria|0|||
170782076|NCT04784559|617211212|FG001|Overall Study|Did not meet all inclusion criteria|1|||
170782077|NCT04784559|617211213|FG002|Overall Study|Did not meet all inclusion criteria|0|||
170782078|NCT04784559|617211211|FG000|Overall Study|The participant was transferred to IRCU|0|||
170782079|NCT04784559|617211212|FG001|Overall Study|The participant was transferred to IRCU|1|||
170782080|NCT04784559|617211213|FG002|Overall Study|The participant was transferred to IRCU|0|||
170782081|NCT04784559|617211211|FG000|Overall Study|SAE|0|||
170782082|NCT04784559|617211212|FG001|Overall Study|SAE|1|||
170782083|NCT04784559|617211213|FG002|Overall Study|SAE|0|||
170782084|NCT04784559|617211211|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
170782085|NCT04784559|617211212|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
170782086|NCT04784559|617211213|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
170782087|NCT02307565|617211217|FG000|Overall Study|Adverse Event|3|||
170782088|NCT02307565|617211218|FG001|Overall Study|Adverse Event|2|||
170782089|NCT02307565|617211217|FG000|Overall Study|Withdrawal by Subject|2|||
170782090|NCT02307565|617211218|FG001|Overall Study|Withdrawal by Subject|2|||
170782091|NCT03336333|617211222|FG000|Overall Study|Remained on study at time of data cut-off|202|||
170782092|NCT03336333|617211223|FG001|Overall Study|Remained on study at time of data cut-off|219|||
170782093|NCT03336333|617211224|FG002|Overall Study|Remained on study at time of data cut-off|102|||
170782094|NCT03336333|617211222|FG000|Overall Study|Death|14|||
170537149|NCT02452190|616311539|FG001|Overall Study|Investigator's Decision|0|||
170537150|NCT02452190|616311538|FG000|Overall Study|Lack of Efficacy|3|||
170537151|NCT02452190|616311539|FG001|Overall Study|Lack of Efficacy|1|||
170537152|NCT02452190|616311538|FG000|Overall Study|Lost to Follow-up|4|||
170537153|NCT02452190|616311539|FG001|Overall Study|Lost to Follow-up|3|||
170537154|NCT02452190|616311538|FG000|Overall Study|Adverse Event|2|||
170537155|NCT02452190|616311539|FG001|Overall Study|Adverse Event|5|||
170537156|NCT02452190|616311538|FG000|Overall Study|Withdrawal by Subject|20|||
170537157|NCT02452190|616311539|FG001|Overall Study|Withdrawal by Subject|11|||
170537158|NCT02452190|616311538|FG000|Overall Study|Noncompliance with study drug|1|||
170782095|NCT03336333|617211223|FG001|Overall Study|Death|16|||
170782096|NCT03336333|617211224|FG002|Overall Study|Death|8|||
170782097|NCT03336333|617211222|FG000|Overall Study|Withdrawal by Subject|16|||
170782098|NCT03336333|617211223|FG001|Overall Study|Withdrawal by Subject|5|||
170782099|NCT03336333|617211224|FG002|Overall Study|Withdrawal by Subject|1|||
170439619|NCT01277510|615948070|FG001|Double-blind Phase|Administrative decision|9|||
170439620|NCT01277510|615948069|FG000|Double-blind Phase|Death|0|||
170439621|NCT01277510|615948070|FG001|Double-blind Phase|Death|1|||
170439622|NCT01277510|615948069|FG000|Double-blind Phase|Protocol-specified criteria|2|||
170439623|NCT01277510|615948070|FG001|Double-blind Phase|Protocol-specified criteria|6|||
170439624|NCT01277510|615948069|FG000|Double-blind Phase|Other|1|||
170439625|NCT01277510|615948070|FG001|Double-blind Phase|Other|1|||
170439626|NCT01277510|615948069|FG000|Open-label Phase|Administrative decision|4|||
170439627|NCT01277510|615948070|FG001|Open-label Phase|Administrative decision|3|||
170439628|NCT01277510|615948069|FG000|Open-label Phase|Protocol-specified criteria|1|||
170439629|NCT01277510|615948070|FG001|Open-label Phase|Protocol-specified criteria|0|||
170439630|NCT01277510|615948069|FG000|Open-label Phase|Never received investigational product|2|||
170439631|NCT01277510|615948070|FG001|Open-label Phase|Never received investigational product|0|||
170439632|NCT04049097|615948071|FG000|Overall Study|Adverse Event|18|||
170439633|NCT04049097|615948071|FG000|Overall Study|Death|2|||
170439634|NCT04049097|615948071|FG000|Overall Study|Lost to Follow-up|1|||
170439635|NCT04049097|615948071|FG000|Overall Study|Physician Decision|2|||
170439636|NCT04049097|615948071|FG000|Overall Study|Withdrawal by Subject|9|||
170439637|NCT04049097|615948071|FG000|Overall Study|Protocol Violation|2|||
170439638|NCT04049097|615948071|FG000|Overall Study|Other|1|||
170439639|NCT04049097|615948071|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
170439640|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
170439641|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
170439642|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
170439643|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
170439644|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
170439645|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
170439646|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
170439647|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
170439648|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
170439649|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
170439650|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
170439651|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
170439652|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
170439653|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
170439654|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
170439655|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
170439656|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
170439657|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
170439658|NCT00950300|615948077|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
170537159|NCT02452190|616311539|FG001|Overall Study|Noncompliance with study drug|0|||
170537160|NCT02452190|616311538|FG000|Overall Study|Participant traveled abroad|1|||
170537161|NCT02452190|616311539|FG001|Overall Study|Participant traveled abroad|0|||
170439659|NCT00950300|615948078|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
170439660|NCT00950300|615948077|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
170439661|NCT00950300|615948078|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
170439662|NCT00950300|615948077|FG000|TFFU Period|Death|4|||
170439663|NCT00950300|615948078|FG001|TFFU Period|Death|1|||
170439664|NCT00950300|615948077|FG000|TFFU Period|Refused Treatment|10|||
170439665|NCT00950300|615948078|FG001|TFFU Period|Refused Treatment|11|||
170439666|NCT00950300|615948077|FG000|TFFU Period|Failure to Return|16|||
170439667|NCT00950300|615948078|FG001|TFFU Period|Failure to Return|16|||
170439668|NCT00950300|615948077|FG000|TFFU Period|Recurrence of Disease|63|||
170439669|NCT00950300|615948078|FG001|TFFU Period|Recurrence of Disease|72|||
170439670|NCT00950300|615948077|FG000|TFFU Period|Other|4|||
170439671|NCT00950300|615948078|FG001|TFFU Period|Other|3|||
170439672|NCT00950300|615948077|FG000|SFU Period|Death|44|||
170439673|NCT00950300|615948078|FG001|SFU Period|Death|42|||
170439674|NCT00950300|615948077|FG000|SFU Period|Lost to Follow-up|30|||
170439675|NCT00950300|615948078|FG001|SFU Period|Lost to Follow-up|28|||
170439676|NCT00950300|615948077|FG000|SFU Period|Withdrawal by Subject|4|||
170439677|NCT00950300|615948078|FG001|SFU Period|Withdrawal by Subject|8|||
170439678|NCT04194151|615948079|FG000|Overall Study|Physician Decision|1|||
170439679|NCT04194151|615948080|FG001|Overall Study|Physician Decision|1|||
170439680|NCT04194151|615948081|FG002|Overall Study|Physician Decision|1|||
170439681|NCT04194151|615948082|FG003|Overall Study|Physician Decision|1|||
170439682|NCT04194151|615948083|FG004|Overall Study|Physician Decision|0|||
170439683|NCT04194151|615948084|FG005|Overall Study|Physician Decision|1|||
170439684|NCT04194151|615948079|FG000|Overall Study|Monitorization problem|0|||
170439685|NCT04194151|615948080|FG001|Overall Study|Monitorization problem|1|||
170439686|NCT04194151|615948081|FG002|Overall Study|Monitorization problem|0|||
170439687|NCT04194151|615948082|FG003|Overall Study|Monitorization problem|0|||
170439688|NCT04194151|615948083|FG004|Overall Study|Monitorization problem|0|||
170439689|NCT04194151|615948084|FG005|Overall Study|Monitorization problem|0|||
170439690|NCT00421304|615948085|FG000|Overall Study|Lost to Follow-up|5|||
170439691|NCT00421304|615948086|FG001|Overall Study|Lost to Follow-up|2|||
170439692|NCT00421304|615948087|FG002|Overall Study|Lost to Follow-up|5|||
170439693|NCT00421304|615948085|FG000|Overall Study|Withdrawal by Subject|2|||
170439694|NCT00421304|615948086|FG001|Overall Study|Withdrawal by Subject|2|||
170439695|NCT00421304|615948087|FG002|Overall Study|Withdrawal by Subject|2|||
170439696|NCT00421304|615948085|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
170439697|NCT00421304|615948086|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
170439698|NCT00421304|615948087|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
170439699|NCT00421304|615948085|FG000|Overall Study|Did not attend Day 360 visit|0|||
170439700|NCT00421304|615948086|FG001|Overall Study|Did not attend Day 360 visit|0|||
170439701|NCT00421304|615948087|FG002|Overall Study|Did not attend Day 360 visit|1|||
170439702|NCT00087529|615948088|FG000|Overall Study|Death|1|||
170439703|NCT00087529|615948089|FG001|Overall Study|Death|0|||
170439704|NCT00087529|615948088|FG000|Overall Study|Adverse Event|0|||
170439705|NCT00087529|615948089|FG001|Overall Study|Adverse Event|8|||
170439706|NCT00087529|615948088|FG000|Overall Study|Pregnancy|0|||
170439707|NCT00087529|615948089|FG001|Overall Study|Pregnancy|1|||
170439708|NCT00087529|615948088|FG000|Overall Study|Lost to Follow-up|2|||
170439709|NCT00087529|615948089|FG001|Overall Study|Lost to Follow-up|3|||
170439710|NCT00087529|615948088|FG000|Overall Study|Participant Decision|14|||
170439711|NCT00087529|615948089|FG001|Overall Study|Participant Decision|37|||
170439712|NCT00087529|615948088|FG000|Overall Study|Physician Decision|4|||
170439713|NCT00087529|615948089|FG001|Overall Study|Physician Decision|8|||
170439714|NCT00087529|615948088|FG000|Overall Study|Initiation of Excluded Therapy|0|||
170439715|NCT00087529|615948089|FG001|Overall Study|Initiation of Excluded Therapy|1|||
170439716|NCT00087529|615948088|FG000|Overall Study|Participant Noncompliance|0|||
170439717|NCT00087529|615948089|FG001|Overall Study|Participant Noncompliance|1|||
170782100|NCT03336333|617211222|FG000|Overall Study|Physician Decision|5|||
170537162|NCT02452190|616311538|FG000|Overall Study|Death|0|||
170537163|NCT02452190|616311539|FG001|Overall Study|Death|1|||
170537164|NCT04851964|616311544|FG000|Overall Study|Death|0|||
170537165|NCT04851964|616311545|FG001|Overall Study|Death|1|||
170782101|NCT03336333|617211223|FG001|Overall Study|Physician Decision|1|||
170439718|NCT00087529|615948088|FG000|Overall Study|Disease Progression|5|||
170439719|NCT00087529|615948089|FG001|Overall Study|Disease Progression|4|||
170537166|NCT04851964|616311544|FG000|Overall Study|Lost to Follow-up|2|||
170537167|NCT04851964|616311545|FG001|Overall Study|Lost to Follow-up|2|||
170537168|NCT04851964|616311544|FG000|Overall Study|Withdrawal by Subject|8|||
170537169|NCT04851964|616311545|FG001|Overall Study|Withdrawal by Subject|23|||
170537170|NCT04851964|616311544|FG000|Overall Study|Severe incompliance|0|||
170439720|NCT00087529|615948088|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
170439721|NCT00087529|615948089|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
170439722|NCT04577404|615948097|FG000|Overall Study|Adverse Event|31|||
170439723|NCT04577404|615948097|FG000|Overall Study|Death|1|||
170439724|NCT04577404|615948097|FG000|Overall Study|Lack of Efficacy|3|||
170439725|NCT04577404|615948097|FG000|Overall Study|Physician Decision|7|||
170439726|NCT04577404|615948097|FG000|Overall Study|Withdrawal by Subject|21|||
170439727|NCT04577404|615948097|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
170782102|NCT03336333|617211224|FG002|Overall Study|Physician Decision|0|||
170782103|NCT03336333|617211222|FG000|Overall Study|Lost to Follow-up|1|||
170782104|NCT03336333|617211223|FG001|Overall Study|Lost to Follow-up|0|||
170782105|NCT03336333|617211224|FG002|Overall Study|Lost to Follow-up|0|||
170439728|NCT03694197|615948101|FG000|Overall Study|Adverse Event|9|||
170439729|NCT03694197|615948101|FG000|Overall Study|Protocol became inconvenient to participate|1|||
170439730|NCT03694197|615948101|FG000|Overall Study|Physician Decision|4|||
170439731|NCT03694197|615948101|FG000|Overall Study|Study terminated by sponsor|1350|||
170439732|NCT03694197|615948101|FG000|Overall Study|Participant moved|5|||
170439733|NCT03694197|615948101|FG000|Overall Study|Participant withdrew consent|10|||
170439734|NCT03694197|615948101|FG000|Overall Study|Related to IMP administration|1|||
170439735|NCT03694197|615948101|FG000|Overall Study|Not disclosed|5|||
170439736|NCT03921554|615948102|FG000|Overall Study|Adverse Event|2|||
170439737|NCT03921554|615948102|FG000|Overall Study|Withdrawal by Subject|1|||
170439738|NCT03921554|615948102|FG000|Overall Study|Death|3|||
170439739|NCT04584983|615948103|FG000|Overall Study|Parental request for withdraw|2|||
170439740|NCT04584983|615948104|FG001|Overall Study|Parental request for withdraw|0|||
170439741|NCT00697619|615948105|FG000|Overall Study|Lack of Efficacy|2|||
170439742|NCT00697619|615948106|FG001|Overall Study|Lack of Efficacy|2|||
170439743|NCT00697619|615948105|FG000|Overall Study|Adverse Event|4|||
170439744|NCT00697619|615948106|FG001|Overall Study|Adverse Event|6|||
170439745|NCT03820947|615948107|FG000|Overall Study|Physician Decision|0|||
170439746|NCT03820947|615948108|FG001|Overall Study|Physician Decision|1|||
170439747|NCT03820947|615948109|FG002|Overall Study|Physician Decision|1|||
170439748|NCT03820947|615948110|FG003|Overall Study|Physician Decision|0|||
170439749|NCT03820947|615948111|FG004|Overall Study|Physician Decision|3|||
170439750|NCT03820947|615948107|FG000|Overall Study|Withdrawal by Subject|6|||
170439751|NCT03820947|615948108|FG001|Overall Study|Withdrawal by Subject|10|||
170439752|NCT03820947|615948109|FG002|Overall Study|Withdrawal by Subject|3|||
170439753|NCT03820947|615948110|FG003|Overall Study|Withdrawal by Subject|8|||
170439754|NCT03820947|615948111|FG004|Overall Study|Withdrawal by Subject|5|||
170439755|NCT03820947|615948107|FG000|Overall Study|Procedure Not Attempted|0|||
170439756|NCT03820947|615948108|FG001|Overall Study|Procedure Not Attempted|2|||
170439757|NCT03820947|615948109|FG002|Overall Study|Procedure Not Attempted|1|||
170439758|NCT03820947|615948110|FG003|Overall Study|Procedure Not Attempted|0|||
170439759|NCT03820947|615948111|FG004|Overall Study|Procedure Not Attempted|0|||
170439760|NCT03820947|615948107|FG000|Overall Study|Other Exit|1|||
170439761|NCT03820947|615948108|FG001|Overall Study|Other Exit|3|||
170439762|NCT03820947|615948109|FG002|Overall Study|Other Exit|3|||
170439763|NCT03820947|615948110|FG003|Overall Study|Other Exit|3|||
170439764|NCT03820947|615948111|FG004|Overall Study|Other Exit|0|||
170439765|NCT03820947|615948107|FG000|Overall Study|Follow-up Not Done|10|||
170439766|NCT03820947|615948108|FG001|Overall Study|Follow-up Not Done|13|||
170439767|NCT03820947|615948109|FG002|Overall Study|Follow-up Not Done|2|||
170439768|NCT03820947|615948110|FG003|Overall Study|Follow-up Not Done|3|||
170439769|NCT03820947|615948111|FG004|Overall Study|Follow-up Not Done|12|||
170439770|NCT03820947|615948107|FG000|Overall Study|Death|0|||
170439771|NCT03820947|615948108|FG001|Overall Study|Death|0|||
170439772|NCT03820947|615948109|FG002|Overall Study|Death|0|||
170439773|NCT03820947|615948110|FG003|Overall Study|Death|0|||
170439774|NCT03820947|615948111|FG004|Overall Study|Death|9|||
170782106|NCT00931710|617211227|FG000|Overall Study|Adverse Event|16|||
170782107|NCT00931710|617211228|FG001|Overall Study|Adverse Event|10|||
170782108|NCT00931710|617211227|FG000|Overall Study|Abnormal test procedure results|2|||
170782109|NCT00931710|617211228|FG001|Overall Study|Abnormal test procedure results|0|||
170782110|NCT00931710|617211227|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
170782111|NCT00931710|617211228|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
170782112|NCT00931710|617211227|FG000|Overall Study|Patient withdrew consent|4|||
170782113|NCT00931710|617211228|FG001|Overall Study|Patient withdrew consent|9|||
170782114|NCT00931710|617211227|FG000|Overall Study|Lost to Follow-up|6|||
170782115|NCT00931710|617211228|FG001|Overall Study|Lost to Follow-up|5|||
170782116|NCT00931710|617211227|FG000|Overall Study|Protocol deviation|1|||
170439775|NCT03820947|615948107|FG000|Overall Study|Lost to Follow-up|4|||
170439776|NCT03820947|615948108|FG001|Overall Study|Lost to Follow-up|6|||
170439777|NCT03820947|615948109|FG002|Overall Study|Lost to Follow-up|0|||
170782117|NCT00931710|617211228|FG001|Overall Study|Protocol deviation|2|||
170782118|NCT04401800|617211229|FG000|Overall Study|Death|17|||
170782119|NCT04401800|617211229|FG000|Overall Study|Lost to Follow-up|5|||
170782120|NCT04401800|617211229|FG000|Overall Study|Withdrawal by Subject|4|||
170439778|NCT03820947|615948110|FG003|Overall Study|Lost to Follow-up|0|||
170439779|NCT03820947|615948111|FG004|Overall Study|Lost to Follow-up|9|||
170439780|NCT05135273|615949466|FG000|Overall Study|Recruited into the army|0|||
170439781|NCT05135273|615949467|FG001|Overall Study|Recruited into the army|0|||
170439782|NCT05135273|615949468|FG002|Overall Study|Recruited into the army|0|||
170439783|NCT05135273|615949469|FG003|Overall Study|Recruited into the army|0|||
170439784|NCT05135273|615949470|FG004|Overall Study|Recruited into the army|1|||
170439785|NCT05135273|615949471|FG005|Overall Study|Recruited into the army|0|||
170439786|NCT05135273|615949472|FG006|Overall Study|Recruited into the army|0|||
170439787|NCT05135273|615949473|FG007|Overall Study|Recruited into the army|0|||
170439788|NCT05135273|615949466|FG000|Overall Study|Moved away from study site|0|||
170439789|NCT05135273|615949467|FG001|Overall Study|Moved away from study site|0|||
170439790|NCT05135273|615949468|FG002|Overall Study|Moved away from study site|0|||
170439791|NCT05135273|615949469|FG003|Overall Study|Moved away from study site|0|||
170439792|NCT05135273|615949470|FG004|Overall Study|Moved away from study site|0|||
170439793|NCT05135273|615949471|FG005|Overall Study|Moved away from study site|1|||
170439794|NCT05135273|615949472|FG006|Overall Study|Moved away from study site|1|||
170439795|NCT05135273|615949473|FG007|Overall Study|Moved away from study site|0|||
170439796|NCT05135273|615949466|FG000|Overall Study|Travel|0|||
170439797|NCT05135273|615949467|FG001|Overall Study|Travel|0|||
170439798|NCT05135273|615949468|FG002|Overall Study|Travel|0|||
170439799|NCT05135273|615949469|FG003|Overall Study|Travel|0|||
170439800|NCT05135273|615949470|FG004|Overall Study|Travel|0|||
170439801|NCT05135273|615949471|FG005|Overall Study|Travel|0|||
170439802|NCT05135273|615949472|FG006|Overall Study|Travel|0|||
170439803|NCT05135273|615949473|FG007|Overall Study|Travel|1|||
170439804|NCT01958060|615949476|FG000|Overall Study|Not treated|2|||
170439805|NCT01958060|615949477|FG001|Overall Study|Not treated|0|||
170439806|NCT01958060|615949478|FG002|Overall Study|Not treated|0|||
170439807|NCT01958060|615949479|FG003|Overall Study|Not treated|0|||
170439808|NCT01958060|615949480|FG004|Overall Study|Not treated|1|||
170439809|NCT01958060|615949481|FG005|Overall Study|Not treated|0|||
170439810|NCT01188226|615949485|FG000|Overall Study|Withdrawal by Subject|4|||
170439811|NCT02031237|615949486|FG000|Overall Study|Death|1|||
170439812|NCT02031237|615949487|FG001|Overall Study|Death|5|||
170439813|NCT02031237|615949488|FG002|Overall Study|Death|0|||
170439814|NCT02031237|615949486|FG000|Overall Study|Physician Decision|0|||
170439815|NCT02031237|615949487|FG001|Overall Study|Physician Decision|1|||
170439816|NCT02031237|615949488|FG002|Overall Study|Physician Decision|0|||
170439817|NCT02031237|615949486|FG000|Overall Study|Withdrawal by Subject|2|||
170439818|NCT02031237|615949487|FG001|Overall Study|Withdrawal by Subject|2|||
170439819|NCT02031237|615949488|FG002|Overall Study|Withdrawal by Subject|0|||
170439820|NCT02031237|615949486|FG000|Overall Study|Protocol Violation|2|||
170439821|NCT02031237|615949487|FG001|Overall Study|Protocol Violation|6|||
170439822|NCT02031237|615949488|FG002|Overall Study|Protocol Violation|0|||
170439823|NCT02031237|615949486|FG000|Overall Study|Alternate Treatment Given|0|||
170439824|NCT02031237|615949487|FG001|Overall Study|Alternate Treatment Given|0|||
170439825|NCT02031237|615949488|FG002|Overall Study|Alternate Treatment Given|3|||
170439826|NCT04980456|615949489|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
170439827|NCT04980456|615949490|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
170439828|NCT04980456|615949489|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
170439829|NCT04980456|615949490|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
170439830|NCT04980456|615949489|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
170439831|NCT04980456|615949490|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
170439832|NCT04980456|615949489|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
170439833|NCT04980456|615949490|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
170439834|NCT02846883|615949493|FG000|Overall Study|Death|0|||
170439835|NCT02846883|615949494|FG001|Overall Study|Death|1|||
170439836|NCT02846883|615949495|FG002|Overall Study|Death|1|||
170439837|NCT02846883|615949493|FG000|Overall Study|Lost to Follow-up|0|||
170439838|NCT02846883|615949494|FG001|Overall Study|Lost to Follow-up|0|||
170439839|NCT02846883|615949495|FG002|Overall Study|Lost to Follow-up|1|||
170439840|NCT02846883|615949493|FG000|Overall Study|Withdrawal by Subject|1|||
170439841|NCT02846883|615949494|FG001|Overall Study|Withdrawal by Subject|0|||
170882835|NCT01857869|617579650|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882836|NCT01857869|617579651|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882837|NCT01857869|617579652|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882838|NCT01857869|617579653|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
170882839|NCT01857869|617579654|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882840|NCT01857869|617579655|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882841|NCT01857869|617579656|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882842|NCT01857869|617579657|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882843|NCT01857869|617579658|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882844|NCT01857869|617579659|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
170882845|NCT01152021|617579669|FG000|Overall Study|Adverse Event|4|||
170882846|NCT01152021|617579670|FG001|Overall Study|Adverse Event|4|||
170882847|NCT01152021|617579669|FG000|Overall Study|Study drug had expired|1|||
170439842|NCT02846883|615949495|FG002|Overall Study|Withdrawal by Subject|0|||
170439843|NCT02846883|615949493|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
170439844|NCT02846883|615949494|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
170439845|NCT02846883|615949495|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
170439846|NCT02846883|615949493|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
170439847|NCT02846883|615949494|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
170439848|NCT02846883|615949495|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
170439849|NCT01074008|615949501|FG000|Overall Study|Adverse Event|0|||
170439850|NCT01074008|615949502|FG001|Overall Study|Adverse Event|1|||
170439851|NCT01074008|615949503|FG002|Overall Study|Adverse Event|0|||
170439852|NCT01074008|615949504|FG003|Overall Study|Adverse Event|0|||
170439853|NCT01074008|615949505|FG004|Overall Study|Adverse Event|0|||
170439854|NCT01074008|615949506|FG005|Overall Study|Adverse Event|0|||
170439855|NCT01074008|615949507|FG006|Overall Study|Adverse Event|0|||
170439856|NCT01074008|615949508|FG007|Overall Study|Adverse Event|0|||
170439857|NCT01074008|615949509|FG008|Overall Study|Adverse Event|0|||
170439858|NCT01074008|615949501|FG000|Overall Study|Withdrawal by Subject|1|||
170439859|NCT01074008|615949502|FG001|Overall Study|Withdrawal by Subject|1|||
170439860|NCT01074008|615949503|FG002|Overall Study|Withdrawal by Subject|1|||
170439861|NCT01074008|615949504|FG003|Overall Study|Withdrawal by Subject|0|||
170439862|NCT01074008|615949505|FG004|Overall Study|Withdrawal by Subject|1|||
170439863|NCT01074008|615949506|FG005|Overall Study|Withdrawal by Subject|0|||
170439864|NCT01074008|615949507|FG006|Overall Study|Withdrawal by Subject|0|||
170439865|NCT01074008|615949508|FG007|Overall Study|Withdrawal by Subject|0|||
170439866|NCT01074008|615949509|FG008|Overall Study|Withdrawal by Subject|0|||
170439867|NCT01074008|615949501|FG000|Overall Study|Lost to Follow-up|0|||
170439868|NCT01074008|615949502|FG001|Overall Study|Lost to Follow-up|1|||
170439869|NCT01074008|615949503|FG002|Overall Study|Lost to Follow-up|1|||
170439870|NCT01074008|615949504|FG003|Overall Study|Lost to Follow-up|1|||
170439871|NCT01074008|615949505|FG004|Overall Study|Lost to Follow-up|1|||
170439872|NCT01074008|615949506|FG005|Overall Study|Lost to Follow-up|0|||
170439873|NCT01074008|615949507|FG006|Overall Study|Lost to Follow-up|1|||
170439874|NCT01074008|615949508|FG007|Overall Study|Lost to Follow-up|0|||
170439875|NCT01074008|615949509|FG008|Overall Study|Lost to Follow-up|4|||
170439876|NCT00224484|615949512|FG000|Overall Study|Serious Adverse Event|1|||
170439877|NCT00224484|615949513|FG001|Overall Study|Serious Adverse Event|1|||
170439878|NCT00224484|615949514|FG002|Overall Study|Serious Adverse Event|0|||
170439879|NCT00224484|615949512|FG000|Overall Study|Non-Serious Adverse Event|5|||
170439880|NCT00224484|615949513|FG001|Overall Study|Non-Serious Adverse Event|7|||
170439881|NCT00224484|615949514|FG002|Overall Study|Non-Serious Adverse Event|3|||
170439882|NCT00224484|615949512|FG000|Overall Study|Protocol Violation|2|||
170439883|NCT00224484|615949513|FG001|Overall Study|Protocol Violation|2|||
170439884|NCT00224484|615949514|FG002|Overall Study|Protocol Violation|0|||
170439885|NCT00224484|615949512|FG000|Overall Study|Withdrawal by Subject|49|||
170439886|NCT00224484|615949513|FG001|Overall Study|Withdrawal by Subject|18|||
170439887|NCT00224484|615949514|FG002|Overall Study|Withdrawal by Subject|16|||
170439888|NCT00224484|615949512|FG000|Overall Study|Migrated/moved from study area|18|||
170782121|NCT04927065|617211230|FG000|First Booster|Adverse Event|1|||
170782122|NCT04927065|617211231|FG001|First Booster|Adverse Event|0|||
170782123|NCT04927065|617211232|FG002|First Booster|Adverse Event|0|||
170782124|NCT04927065|617211233|FG003|First Booster|Adverse Event|0|||
170782125|NCT04927065|617211234|FG004|First Booster|Adverse Event|0|||
170782126|NCT04927065|617211235|FG005|First Booster|Adverse Event|0|||
170782127|NCT04927065|617211236|FG006|First Booster|Adverse Event|0|||
170782128|NCT04927065|617211237|FG007|First Booster|Adverse Event|1|||
170782129|NCT04927065|617211238|FG008|First Booster|Adverse Event|0|||
170782130|NCT04927065|617211239|FG009|First Booster|Adverse Event|0|||
170782131|NCT04927065|617211240|FG010|First Booster|Adverse Event|0|||
170782132|NCT04927065|617211241|FG011|First Booster|Adverse Event|0|||
170439889|NCT00224484|615949513|FG001|Overall Study|Migrated/moved from study area|5|||
170782133|NCT04927065|617211242|FG012|First Booster|Adverse Event|0|||
170439890|NCT00224484|615949514|FG002|Overall Study|Migrated/moved from study area|5|||
170439891|NCT00224484|615949512|FG000|Overall Study|Lost to Follow-up|66|||
170439892|NCT00224484|615949513|FG001|Overall Study|Lost to Follow-up|28|||
170439893|NCT00224484|615949514|FG002|Overall Study|Lost to Follow-up|36|||
170439894|NCT00224484|615949512|FG000|Overall Study|Reason not specified|5|||
170439895|NCT00224484|615949513|FG001|Overall Study|Reason not specified|4|||
170439896|NCT00224484|615949514|FG002|Overall Study|Reason not specified|2|||
170439897|NCT02805309|615949515|FG000|Overall Study|Lost to Follow-up|2|||
170439898|NCT02805309|615949516|FG001|Overall Study|Lost to Follow-up|2|||
170439899|NCT02805309|615949517|FG002|Overall Study|Lost to Follow-up|2|||
170439900|NCT02805309|615949515|FG000|Overall Study|Post-Randomization Exclusion|0|||
170439901|NCT02805309|615949516|FG001|Overall Study|Post-Randomization Exclusion|2|||
170439902|NCT02805309|615949517|FG002|Overall Study|Post-Randomization Exclusion|1|||
170782134|NCT04927065|617211243|FG013|First Booster|Adverse Event|0|||
170782135|NCT04927065|617211244|FG014|First Booster|Adverse Event|0|||
170782136|NCT04927065|617211245|FG015|First Booster|Adverse Event|0|||
170439903|NCT01579006|615949521|FG000|Overall Study|Lack of Efficacy|10|||
170439904|NCT01579006|615949521|FG000|Overall Study|Adverse Event|13|||
170439905|NCT01579006|615949521|FG000|Overall Study|Withdrawal by Subject|5|||
170782137|NCT04927065|617211230|FG000|First Booster|Death|1|||
170882848|NCT01152021|617579670|FG001|Overall Study|Study drug had expired|0|||
170882849|NCT01152021|617579669|FG000|Overall Study|Physician Decision|1|||
170882850|NCT01152021|617579670|FG001|Overall Study|Physician Decision|1|||
170882851|NCT01152021|617579669|FG000|Overall Study|No access to study drug in Pharmacy|0|||
170882852|NCT01152021|617579670|FG001|Overall Study|No access to study drug in Pharmacy|1|||
170882853|NCT00563186|617579671|FG000|Overall Study|LOS<48 hours|97|||
170882854|NCT00563186|617579672|FG001|Overall Study|LOS<48 hours|74|||
170882855|NCT00563186|617579671|FG000|Overall Study|Incomplete data|1|||
170882856|NCT00563186|617579672|FG001|Overall Study|Incomplete data|1|||
170882857|NCT00513500|617579673|FG000|Overall Study|Lost to Follow-up|35|||
170882858|NCT00513500|617579674|FG001|Overall Study|Lost to Follow-up|39|||
170882859|NCT00513500|617579673|FG000|Overall Study|Death|2|||
170882860|NCT00513500|617579674|FG001|Overall Study|Death|1|||
170882861|NCT00513500|617579673|FG000|Overall Study|Hospitalized|4|||
170882862|NCT00513500|617579674|FG001|Overall Study|Hospitalized|14|||
170439906|NCT01579006|615949521|FG000|Overall Study|Non-compliance|3|||
170439907|NCT01579006|615949521|FG000|Overall Study|Due to participant's health fund|1|||
170439908|NCT01579006|615949521|FG000|Overall Study|Scheduled surgery|1|||
170439909|NCT05061992|615949522|FG000|Overall Study|Excess bowel movements|1|||
170439910|NCT05061992|615949523|FG001|Overall Study|Excess bowel movements|0|||
170439911|NCT05061992|615949522|FG000|Overall Study|Complications of Medical Care|1|||
170882863|NCT01902290|617579675|FG000|Overall Study|Withdrawal by Subject|19|||
170882864|NCT01902290|617579676|FG001|Overall Study|Withdrawal by Subject|27|||
170882865|NCT01902290|617579675|FG000|Overall Study|Lost to Follow-up|2|||
170882866|NCT01902290|617579676|FG001|Overall Study|Lost to Follow-up|2|||
170882867|NCT01902290|617579675|FG000|Overall Study|Death|1|||
170882868|NCT01902290|617579676|FG001|Overall Study|Death|0|||
170882869|NCT01902290|617579675|FG000|Overall Study|Sponsor Decision|26|||
170882870|NCT01902290|617579676|FG001|Overall Study|Sponsor Decision|24|||
170882871|NCT00790907|617579677|FG000|Overall Study|Adverse Event|9|||
170439912|NCT05061992|615949523|FG001|Overall Study|Complications of Medical Care|0|||
170439913|NCT05061992|615949522|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
170882872|NCT00790907|617579678|FG001|Overall Study|Adverse Event|7|||
170882873|NCT00790907|617579679|FG002|Overall Study|Adverse Event|6|||
170882874|NCT00790907|617579677|FG000|Overall Study|Physician Decision|304|||
170882875|NCT00790907|617579678|FG001|Overall Study|Physician Decision|271|||
170882876|NCT00790907|617579679|FG002|Overall Study|Physician Decision|255|||
170882877|NCT00790907|617579677|FG000|Overall Study|Withdrawal by Subject|1|||
170882878|NCT00790907|617579678|FG001|Overall Study|Withdrawal by Subject|7|||
170882879|NCT00790907|617579679|FG002|Overall Study|Withdrawal by Subject|5|||
170882880|NCT00790907|617579677|FG000|Overall Study|Bleeding Event|11|||
170882881|NCT00790907|617579678|FG001|Overall Study|Bleeding Event|16|||
170882882|NCT00790907|617579679|FG002|Overall Study|Bleeding Event|21|||
170882883|NCT00790907|617579677|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
170882884|NCT00790907|617579678|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
170882885|NCT00790907|617579679|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
170882886|NCT00790907|617579677|FG000|Overall Study|Qualifying Condition Not Present|29|||
170882887|NCT00790907|617579678|FG001|Overall Study|Qualifying Condition Not Present|14|||
170882888|NCT00790907|617579679|FG002|Overall Study|Qualifying Condition Not Present|16|||
170882889|NCT00790907|617579677|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
170882890|NCT00790907|617579678|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
170882891|NCT00790907|617579679|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
170882892|NCT00790907|617579677|FG000|Overall Study|Did Not Receive Study Drug|10|||
170882893|NCT00790907|617579678|FG001|Overall Study|Did Not Receive Study Drug|0|||
170882894|NCT00790907|617579679|FG002|Overall Study|Did Not Receive Study Drug|0|||
170439914|NCT05061992|615949523|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
170439915|NCT05061992|615949522|FG000|Overall Study|Withdrawal by Subject|0|||
170439916|NCT05061992|615949523|FG001|Overall Study|Withdrawal by Subject|1|||
170439917|NCT00735696|615949526|FG000|Overall Study|Withdrawal by Subject|1|||
170439918|NCT00735696|615949526|FG000|Overall Study|Enrolled but never Treated|1|||
170439919|NCT02048813|615949527|FG000|Overall Study|Still on treatment|279|||
170439920|NCT02048813|615949528|FG001|Overall Study|Still on treatment|0|||
170439921|NCT02048813|615949527|FG000|Overall Study|Adverse Event|40|||
170439922|NCT02048813|615949528|FG001|Overall Study|Adverse Event|38|||
170439923|NCT02048813|615949527|FG000|Overall Study|Disease progression|13|||
170439924|NCT02048813|615949528|FG001|Overall Study|Disease progression|3|||
170439925|NCT02048813|615949527|FG000|Overall Study|Withdrawal by Subject|7|||
170537171|NCT04851964|616311545|FG001|Overall Study|Severe incompliance|1|||
170882895|NCT00769184|617579680|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
170882896|NCT00769184|617579681|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
170882897|NCT00769184|617579680|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
170882898|NCT00769184|617579681|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
170882899|NCT00769184|617579680|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
170439926|NCT02048813|615949528|FG001|Overall Study|Withdrawal by Subject|8|||
170439927|NCT02048813|615949527|FG000|Overall Study|Death|2|||
170439928|NCT02048813|615949528|FG001|Overall Study|Death|1|||
170439929|NCT02048813|615949527|FG000|Overall Study|Complication|2|||
170439930|NCT02048813|615949528|FG001|Overall Study|Complication|2|||
170439931|NCT02048813|615949527|FG000|Overall Study|Non-protocol therapy|0|||
170439932|NCT02048813|615949528|FG001|Overall Study|Non-protocol therapy|1|||
170439933|NCT02048813|615949527|FG000|Overall Study|Second primary cancer|2|||
170439934|NCT02048813|615949528|FG001|Overall Study|Second primary cancer|0|||
170439935|NCT02048813|615949527|FG000|Overall Study|Insurance|2|||
170439936|NCT02048813|615949528|FG001|Overall Study|Insurance|0|||
170782138|NCT04927065|617211231|FG001|First Booster|Death|0|||
170782139|NCT04927065|617211232|FG002|First Booster|Death|0|||
170782140|NCT04927065|617211233|FG003|First Booster|Death|1|||
170782141|NCT04927065|617211234|FG004|First Booster|Death|0|||
170782142|NCT04927065|617211235|FG005|First Booster|Death|1|||
170782143|NCT04927065|617211236|FG006|First Booster|Death|0|||
170782144|NCT04927065|617211237|FG007|First Booster|Death|0|||
170782145|NCT04927065|617211238|FG008|First Booster|Death|0|||
170782146|NCT04927065|617211239|FG009|First Booster|Death|0|||
170782147|NCT04927065|617211240|FG010|First Booster|Death|0|||
170782148|NCT04927065|617211241|FG011|First Booster|Death|0|||
170782149|NCT04927065|617211242|FG012|First Booster|Death|0|||
170782150|NCT04927065|617211243|FG013|First Booster|Death|0|||
170782151|NCT04927065|617211244|FG014|First Booster|Death|0|||
170782152|NCT04927065|617211245|FG015|First Booster|Death|0|||
170782153|NCT04927065|617211230|FG000|First Booster|Lost to Follow-up|8|||
170782154|NCT04927065|617211231|FG001|First Booster|Lost to Follow-up|20|||
170782155|NCT04927065|617211232|FG002|First Booster|Lost to Follow-up|0|||
170782156|NCT04927065|617211233|FG003|First Booster|Lost to Follow-up|11|||
170782157|NCT04927065|617211234|FG004|First Booster|Lost to Follow-up|43|||
170782158|NCT04927065|617211235|FG005|First Booster|Lost to Follow-up|30|||
170782159|NCT04927065|617211236|FG006|First Booster|Lost to Follow-up|28|||
170782160|NCT04927065|617211237|FG007|First Booster|Lost to Follow-up|23|||
170782161|NCT04927065|617211238|FG008|First Booster|Lost to Follow-up|4|||
170782162|NCT04927065|617211239|FG009|First Booster|Lost to Follow-up|15|||
170782163|NCT04927065|617211240|FG010|First Booster|Lost to Follow-up|0|||
170782164|NCT04927065|617211241|FG011|First Booster|Lost to Follow-up|0|||
170782165|NCT04927065|617211242|FG012|First Booster|Lost to Follow-up|0|||
170782166|NCT04927065|617211243|FG013|First Booster|Lost to Follow-up|0|||
170782167|NCT04927065|617211244|FG014|First Booster|Lost to Follow-up|0|||
170782168|NCT04927065|617211245|FG015|First Booster|Lost to Follow-up|0|||
170782169|NCT04927065|617211230|FG000|First Booster|Physician Decision|1|||
170782170|NCT04927065|617211231|FG001|First Booster|Physician Decision|0|||
170782171|NCT04927065|617211232|FG002|First Booster|Physician Decision|0|||
170782172|NCT04927065|617211233|FG003|First Booster|Physician Decision|3|||
170782173|NCT04927065|617211234|FG004|First Booster|Physician Decision|1|||
170782174|NCT04927065|617211235|FG005|First Booster|Physician Decision|1|||
170782175|NCT04927065|617211236|FG006|First Booster|Physician Decision|0|||
170782176|NCT04927065|617211237|FG007|First Booster|Physician Decision|3|||
170782177|NCT04927065|617211238|FG008|First Booster|Physician Decision|0|||
170782178|NCT04927065|617211239|FG009|First Booster|Physician Decision|0|||
170782179|NCT04927065|617211240|FG010|First Booster|Physician Decision|0|||
170782180|NCT04927065|617211241|FG011|First Booster|Physician Decision|0|||
170782181|NCT04927065|617211242|FG012|First Booster|Physician Decision|0|||
170782182|NCT04927065|617211243|FG013|First Booster|Physician Decision|0|||
170782183|NCT04927065|617211244|FG014|First Booster|Physician Decision|0|||
170782184|NCT04927065|617211245|FG015|First Booster|Physician Decision|0|||
170782185|NCT04927065|617211230|FG000|First Booster|Protocol Violation|4|||
170782186|NCT04927065|617211231|FG001|First Booster|Protocol Violation|4|||
170782187|NCT04927065|617211232|FG002|First Booster|Protocol Violation|0|||
170782188|NCT04927065|617211233|FG003|First Booster|Protocol Violation|3|||
170782189|NCT04927065|617211234|FG004|First Booster|Protocol Violation|0|||
170782190|NCT04927065|617211235|FG005|First Booster|Protocol Violation|0|||
170782191|NCT04927065|617211236|FG006|First Booster|Protocol Violation|0|||
170782192|NCT04927065|617211237|FG007|First Booster|Protocol Violation|2|||
170782193|NCT04927065|617211238|FG008|First Booster|Protocol Violation|0|||
170882900|NCT00769184|617579681|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
170782194|NCT04927065|617211239|FG009|First Booster|Protocol Violation|0|||
170782195|NCT04927065|617211240|FG010|First Booster|Protocol Violation|0|||
170782196|NCT04927065|617211241|FG011|First Booster|Protocol Violation|0|||
170439937|NCT02048813|615949527|FG000|Overall Study|Wound infection/healing|2|||
170782197|NCT04927065|617211242|FG012|First Booster|Protocol Violation|0|||
170782198|NCT04927065|617211243|FG013|First Booster|Protocol Violation|0|||
170439938|NCT02048813|615949528|FG001|Overall Study|Wound infection/healing|0|||
170782199|NCT04927065|617211244|FG014|First Booster|Protocol Violation|0|||
170782200|NCT04927065|617211245|FG015|First Booster|Protocol Violation|0|||
170782201|NCT04927065|617211230|FG000|First Booster|Withdrawal by Subject|8|||
170782202|NCT04927065|617211231|FG001|First Booster|Withdrawal by Subject|23|||
170782203|NCT04927065|617211232|FG002|First Booster|Withdrawal by Subject|0|||
170782204|NCT04927065|617211233|FG003|First Booster|Withdrawal by Subject|19|||
170782205|NCT04927065|617211234|FG004|First Booster|Withdrawal by Subject|20|||
170782206|NCT04927065|617211235|FG005|First Booster|Withdrawal by Subject|15|||
170782207|NCT04927065|617211236|FG006|First Booster|Withdrawal by Subject|6|||
170439939|NCT02048813|615949527|FG000|Overall Study|Missed appointment|3|||
170439940|NCT02048813|615949528|FG001|Overall Study|Missed appointment|0|||
170439941|NCT02048813|615949527|FG000|Overall Study|Never started treatment|2|||
170439942|NCT02048813|615949528|FG001|Overall Study|Never started treatment|17|||
170439943|NCT01192776|615949529|FG000|Overall Study|Death|8|||
170439944|NCT01192776|615949530|FG001|Overall Study|Death|15|||
170439945|NCT01192776|615949531|FG002|Overall Study|Death|18|||
170439946|NCT01192776|615949532|FG003|Overall Study|Death|15|||
170439947|NCT01192776|615949529|FG000|Overall Study|Lost to Follow-up|3|||
170439948|NCT01192776|615949530|FG001|Overall Study|Lost to Follow-up|6|||
170439949|NCT01192776|615949531|FG002|Overall Study|Lost to Follow-up|3|||
170439950|NCT01192776|615949532|FG003|Overall Study|Lost to Follow-up|5|||
170439951|NCT02587143|615949533|FG000|Overall Study|Adverse Event|1|||
170439952|NCT02587143|615949534|FG001|Overall Study|Adverse Event|0|||
170439953|NCT04633642|615949535|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
170439954|NCT04633642|615949536|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
170439955|NCT00611884|615949537|FG000|Overall Study|Adverse Event|1|||
170439956|NCT00611884|615949538|FG001|Overall Study|Adverse Event|0|||
170439957|NCT00611884|615949539|FG002|Overall Study|Adverse Event|0|||
170439958|NCT00611884|615949540|FG003|Overall Study|Adverse Event|1|||
170439959|NCT00611884|615949537|FG000|Overall Study|Non-Compliance|1|||
170439960|NCT00611884|615949538|FG001|Overall Study|Non-Compliance|4|||
170439961|NCT00611884|615949539|FG002|Overall Study|Non-Compliance|2|||
170439962|NCT00611884|615949540|FG003|Overall Study|Non-Compliance|2|||
170439963|NCT00611884|615949537|FG000|Overall Study|Lack of Efficacy|0|||
170439964|NCT00611884|615949538|FG001|Overall Study|Lack of Efficacy|1|||
170439965|NCT00611884|615949539|FG002|Overall Study|Lack of Efficacy|0|||
170439966|NCT00611884|615949540|FG003|Overall Study|Lack of Efficacy|0|||
170439967|NCT00611884|615949537|FG000|Overall Study|Unclassified|7|||
170439968|NCT00611884|615949538|FG001|Overall Study|Unclassified|4|||
170439969|NCT00611884|615949539|FG002|Overall Study|Unclassified|2|||
170439970|NCT00611884|615949540|FG003|Overall Study|Unclassified|3|||
170439971|NCT00981799|615949541|FG000|Overall Study|Adverse Event|1|||
170439972|NCT00981799|615949542|FG001|Overall Study|Adverse Event|1|||
170439973|NCT00981799|615949543|FG002|Overall Study|Adverse Event|0|||
170439974|NCT00981799|615949544|FG003|Overall Study|Adverse Event|0|||
170537172|NCT04851964|616311544|FG000|Overall Study|Nasal polyp surgery|0|||
170882901|NCT00774345|617579682|FG000|Pre-treatment|Other reasons|2|||
170882902|NCT00774345|617579683|FG001|Pre-treatment|Other reasons|0|||
170882903|NCT00774345|617579682|FG000|Treatment|Adverse Event|61|||
170882904|NCT00774345|617579683|FG001|Treatment|Adverse Event|15|||
170882905|NCT00774345|617579682|FG000|Treatment|Progressive Disease without histologic transformation|51|||
170882906|NCT00774345|617579683|FG001|Treatment|Progressive Disease without histologic transformation|111|||
170882907|NCT00774345|617579682|FG000|Treatment|Progressive Disease with histologic transformation|4|||
170882908|NCT00774345|617579683|FG001|Treatment|Progressive Disease with histologic transformation|2|||
170882909|NCT00774345|617579682|FG000|Treatment|Withdrawal by Subject|5|||
170882910|NCT00774345|617579683|FG001|Treatment|Withdrawal by Subject|2|||
170882911|NCT00774345|617579682|FG000|Treatment|Lost to Follow-up|1|||
170882912|NCT00774345|617579683|FG001|Treatment|Lost to Follow-up|1|||
170882913|NCT00774345|617579682|FG000|Treatment|Death|4|||
170882914|NCT00774345|617579683|FG001|Treatment|Death|0|||
170882915|NCT00774345|617579682|FG000|Treatment|Other Reasons|32|||
170882916|NCT00774345|617579683|FG001|Treatment|Other Reasons|26|||
170882917|NCT00517829|617579684|FG000|Overall Study|Adverse Event|22|||
170882918|NCT00517829|617579685|FG001|Overall Study|Adverse Event|34|||
170882919|NCT00517829|617579684|FG000|Overall Study|Disease Progression|39|||
170882920|NCT00517829|617579685|FG001|Overall Study|Disease Progression|32|||
170439975|NCT05387408|615949545|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
170439976|NCT01055834|615949559|FG000|Treatment Period I|Adverse Event|1|||
170439977|NCT01055834|615949560|FG001|Treatment Period I|Adverse Event|0|||
170439978|NCT01532908|615949567|FG000|Overall Study|Not Transplanted|1|||
170439979|NCT01532908|615949568|FG001|Overall Study|Not Transplanted|0|||
170439980|NCT01196390|615949569|FG000|Overall Study|Protocol Violation|4|||
170439981|NCT01196390|615949570|FG001|Overall Study|Protocol Violation|5|||
170439982|NCT00252564|615949571|FG000|Overall Study|Adverse Event|17|||
170439983|NCT00252564|615949572|FG001|Overall Study|Adverse Event|13|||
170439984|NCT00252564|615949571|FG000|Overall Study|Unrelated Complication|2|||
170882921|NCT00517829|617579684|FG000|Overall Study|Patient Request|6|||
170882922|NCT00517829|617579685|FG001|Overall Study|Patient Request|5|||
170882923|NCT00517829|617579684|FG000|Overall Study|Investigator Request|5|||
170882924|NCT00517829|617579685|FG001|Overall Study|Investigator Request|3|||
170882925|NCT00517829|617579684|FG000|Overall Study|Other|3|||
170882926|NCT00517829|617579685|FG001|Overall Study|Other|1|||
170882927|NCT01136655|617579686|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
170882928|NCT01136655|617579686|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
170882929|NCT01136655|617579686|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
170882930|NCT01136655|617579686|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
170882931|NCT02069899|617579691|FG000|Overall Study|Adverse Event|6|||
170882932|NCT02069899|617579692|FG001|Overall Study|Adverse Event|0|||
170882933|NCT02069899|617579693|FG002|Overall Study|Adverse Event|1|||
170882934|NCT02069899|617579691|FG000|Overall Study|Withdrawal by Participant|2|||
170882935|NCT02069899|617579692|FG001|Overall Study|Withdrawal by Participant|0|||
170882936|NCT02069899|617579693|FG002|Overall Study|Withdrawal by Participant|0|||
170882937|NCT02069899|617579691|FG000|Overall Study|Lost to Follow-up|1|||
170882938|NCT02069899|617579692|FG001|Overall Study|Lost to Follow-up|0|||
170882939|NCT02069899|617579693|FG002|Overall Study|Lost to Follow-up|1|||
170882940|NCT02069899|617579691|FG000|Overall Study|Other|4|||
170882941|NCT02069899|617579692|FG001|Overall Study|Other|0|||
170882942|NCT02069899|617579693|FG002|Overall Study|Other|0|||
170882943|NCT02069899|617579691|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
170882944|NCT02069899|617579692|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
170882945|NCT02069899|617579693|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
170882946|NCT02069899|617579691|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
170882947|NCT02069899|617579692|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
170882948|NCT02069899|617579693|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
170882949|NCT00550680|617579696|FG000|Overall Study|Administrative Reasons|1|||
170882950|NCT00550680|617579696|FG000|Overall Study|Adverse Event|5|||
170882951|NCT00550680|617579696|FG000|Overall Study|Death|3|||
170882952|NCT00550680|617579696|FG000|Overall Study|Early Improvement|1|||
170882953|NCT00550680|617579696|FG000|Overall Study|Lost to Follow-up|3|||
170882954|NCT00550680|617579696|FG000|Overall Study|Lack of Efficacy|1|||
170439985|NCT00252564|615949572|FG001|Overall Study|Unrelated Complication|1|||
170439986|NCT00252564|615949571|FG000|Overall Study|Disease Progression|14|||
170439987|NCT00252564|615949572|FG001|Overall Study|Disease Progression|20|||
170439988|NCT00252564|615949571|FG000|Overall Study|Death|0|||
170537173|NCT04851964|616311545|FG001|Overall Study|Nasal polyp surgery|2|||
170537174|NCT04851964|616311544|FG000|Overall Study|Other biologic treatment|0|||
170882955|NCT00550680|617579696|FG000|Overall Study|Other|10|||
170882956|NCT00550680|617579696|FG000|Overall Study|Protocol Violation|7|||
170882957|NCT00550680|617579696|FG000|Overall Study|Refused Treatment|19|||
170439989|NCT00252564|615949572|FG001|Overall Study|Death|3|||
170439990|NCT00252564|615949571|FG000|Overall Study|Physician Decision|1|||
170439991|NCT00252564|615949572|FG001|Overall Study|Physician Decision|0|||
170439992|NCT00252564|615949571|FG000|Overall Study|Lost to Follow-up|1|||
170439993|NCT00252564|615949572|FG001|Overall Study|Lost to Follow-up|0|||
170439994|NCT00252564|615949571|FG000|Overall Study|Patient Request|4|||
170439995|NCT00252564|615949572|FG001|Overall Study|Patient Request|5|||
170439996|NCT00252564|615949571|FG000|Overall Study|Withdrawal by Subject|0|||
170439997|NCT00252564|615949572|FG001|Overall Study|Withdrawal by Subject|2|||
170439998|NCT01632306|615949573|FG000|Overall Study|Protocol Violation|1|||
170439999|NCT01632306|615949574|FG001|Overall Study|Protocol Violation|0|||
170440000|NCT01632306|615949575|FG002|Overall Study|Protocol Violation|0|||
170440001|NCT00743145|615949576|FG000|Overall Study|Withdrawal by Subject|1|||
170440002|NCT00743145|615949576|FG000|Overall Study|Adverse Event|2|||
170440003|NCT00743145|615949576|FG000|Overall Study|Pregnancy|1|||
170440004|NCT01949532|615949577|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
170440005|NCT01949532|615949578|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
170440006|NCT01824498|615949579|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
170440007|NCT01824498|615949580|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
170440008|NCT01824498|615949581|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
170537175|NCT04851964|616311545|FG001|Overall Study|Other biologic treatment|2|||
170537176|NCT04092777|616311546|FG000|Overall Study|Lost to Follow-up|28|||
170782208|NCT04927065|617211237|FG007|First Booster|Withdrawal by Subject|24|||
170782209|NCT04927065|617211238|FG008|First Booster|Withdrawal by Subject|0|||
170782210|NCT04927065|617211239|FG009|First Booster|Withdrawal by Subject|4|||
170782211|NCT04927065|617211240|FG010|First Booster|Withdrawal by Subject|0|||
170782212|NCT04927065|617211241|FG011|First Booster|Withdrawal by Subject|0|||
170782213|NCT04927065|617211242|FG012|First Booster|Withdrawal by Subject|0|||
170782214|NCT04927065|617211243|FG013|First Booster|Withdrawal by Subject|0|||
170782215|NCT04927065|617211244|FG014|First Booster|Withdrawal by Subject|0|||
170782216|NCT04927065|617211245|FG015|First Booster|Withdrawal by Subject|0|||
170782217|NCT04927065|617211230|FG000|First Booster|Other Than Specified|1|||
170782218|NCT04927065|617211231|FG001|First Booster|Other Than Specified|1|||
170782219|NCT04927065|617211232|FG002|First Booster|Other Than Specified|0|||
170782220|NCT04927065|617211233|FG003|First Booster|Other Than Specified|1|||
170782221|NCT04927065|617211234|FG004|First Booster|Other Than Specified|2|||
170782222|NCT04927065|617211235|FG005|First Booster|Other Than Specified|3|||
170782223|NCT04927065|617211236|FG006|First Booster|Other Than Specified|2|||
170782224|NCT04927065|617211237|FG007|First Booster|Other Than Specified|6|||
170782225|NCT04927065|617211238|FG008|First Booster|Other Than Specified|0|||
170782226|NCT04927065|617211239|FG009|First Booster|Other Than Specified|4|||
170782227|NCT04927065|617211240|FG010|First Booster|Other Than Specified|0|||
170782228|NCT04927065|617211241|FG011|First Booster|Other Than Specified|0|||
170782229|NCT04927065|617211242|FG012|First Booster|Other Than Specified|0|||
170782230|NCT04927065|617211243|FG013|First Booster|Other Than Specified|0|||
170782231|NCT04927065|617211244|FG014|First Booster|Other Than Specified|0|||
170782232|NCT04927065|617211245|FG015|First Booster|Other Than Specified|0|||
170782233|NCT04927065|617211230|FG000|Second Booster|Death|0|||
170782234|NCT04927065|617211231|FG001|Second Booster|Death|0|||
170782235|NCT04927065|617211232|FG002|Second Booster|Death|0|||
170782236|NCT04927065|617211233|FG003|Second Booster|Death|0|||
170782237|NCT04927065|617211234|FG004|Second Booster|Death|0|||
170782238|NCT04927065|617211235|FG005|Second Booster|Death|0|||
170782239|NCT04927065|617211236|FG006|Second Booster|Death|0|||
170782240|NCT04927065|617211237|FG007|Second Booster|Death|0|||
170782241|NCT04927065|617211238|FG008|Second Booster|Death|0|||
170782242|NCT04927065|617211239|FG009|Second Booster|Death|0|||
170782243|NCT04927065|617211240|FG010|Second Booster|Death|2|||
170782244|NCT04927065|617211241|FG011|Second Booster|Death|0|||
170782245|NCT04927065|617211242|FG012|Second Booster|Death|2|||
170782246|NCT04927065|617211243|FG013|Second Booster|Death|2|||
170782247|NCT04927065|617211244|FG014|Second Booster|Death|0|||
170782248|NCT04927065|617211245|FG015|Second Booster|Death|0|||
170782249|NCT04927065|617211230|FG000|Second Booster|Lost to Follow-up|0|||
170782250|NCT04927065|617211231|FG001|Second Booster|Lost to Follow-up|0|||
170782251|NCT04927065|617211232|FG002|Second Booster|Lost to Follow-up|3|||
170882958|NCT00550680|617579696|FG000|Overall Study|Screen Failure|6|||
170882959|NCT01119248|617579697|FG000|Overall Study|Physician Decision|5|||
170440009|NCT01824498|615949582|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
170440010|NCT01824498|615949583|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
170440011|NCT01824498|615949584|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
170537177|NCT04092777|616311547|FG001|Overall Study|Lost to Follow-up|46|||
170782252|NCT04927065|617211233|FG003|Second Booster|Lost to Follow-up|0|||
170782253|NCT04927065|617211234|FG004|Second Booster|Lost to Follow-up|0|||
170782254|NCT04927065|617211235|FG005|Second Booster|Lost to Follow-up|0|||
170440012|NCT00884390|615949586|FG000|Overall Study|Adverse Event|0|||
170782255|NCT04927065|617211236|FG006|Second Booster|Lost to Follow-up|0|||
170782256|NCT04927065|617211237|FG007|Second Booster|Lost to Follow-up|0|||
170782257|NCT04927065|617211238|FG008|Second Booster|Lost to Follow-up|0|||
170440013|NCT00884390|615949587|FG001|Overall Study|Adverse Event|1|||
170440014|NCT00884390|615949586|FG000|Overall Study|Lost to Follow-up|0|||
170440015|NCT00884390|615949587|FG001|Overall Study|Lost to Follow-up|1|||
170440016|NCT00884390|615949586|FG000|Overall Study|Physician Decision|2|||
170440017|NCT00884390|615949587|FG001|Overall Study|Physician Decision|1|||
170440018|NCT00884390|615949586|FG000|Overall Study|Protocol Violation|4|||
170440019|NCT00884390|615949587|FG001|Overall Study|Protocol Violation|1|||
170440020|NCT00884390|615949586|FG000|Overall Study|Withdrawal by Subject|4|||
170782258|NCT04927065|617211239|FG009|Second Booster|Lost to Follow-up|0|||
170782259|NCT04927065|617211240|FG010|Second Booster|Lost to Follow-up|14|||
170782260|NCT04927065|617211241|FG011|Second Booster|Lost to Follow-up|10|||
170782261|NCT04927065|617211242|FG012|Second Booster|Lost to Follow-up|13|||
170782262|NCT04927065|617211243|FG013|Second Booster|Lost to Follow-up|16|||
170782263|NCT04927065|617211244|FG014|Second Booster|Lost to Follow-up|0|||
170782264|NCT04927065|617211245|FG015|Second Booster|Lost to Follow-up|0|||
170782265|NCT04927065|617211230|FG000|Second Booster|Physician Decision|0|||
170782266|NCT04927065|617211231|FG001|Second Booster|Physician Decision|0|||
170782267|NCT04927065|617211232|FG002|Second Booster|Physician Decision|0|||
170782268|NCT04927065|617211233|FG003|Second Booster|Physician Decision|0|||
170782269|NCT04927065|617211234|FG004|Second Booster|Physician Decision|0|||
170782270|NCT04927065|617211235|FG005|Second Booster|Physician Decision|0|||
170882960|NCT01553136|617579698|FG000|Overall Study|Adverse Event|3|||
170882961|NCT01553136|617579699|FG001|Overall Study|Adverse Event|2|||
170882962|NCT01553136|617579698|FG000|Overall Study|Withdrawal by Subject|2|||
170882963|NCT01553136|617579699|FG001|Overall Study|Withdrawal by Subject|3|||
170882964|NCT01553136|617579698|FG000|Overall Study|Lost to Follow-up|4|||
170882965|NCT01553136|617579699|FG001|Overall Study|Lost to Follow-up|10|||
170882966|NCT01553136|617579698|FG000|Overall Study|Physician Decision|2|||
170882967|NCT01553136|617579699|FG001|Overall Study|Physician Decision|3|||
170882968|NCT01553136|617579698|FG000|Overall Study|Scheduling Difficulties|5|||
170882969|NCT01553136|617579699|FG001|Overall Study|Scheduling Difficulties|4|||
170882970|NCT00328627|617583045|FG000|Overall Study|Hyperglycemic Rescue|41|||
170882971|NCT00328627|617583046|FG001|Overall Study|Hyperglycemic Rescue|18|||
170882972|NCT00328627|617583047|FG002|Overall Study|Hyperglycemic Rescue|16|||
170882973|NCT00328627|617583048|FG003|Overall Study|Hyperglycemic Rescue|13|||
170882974|NCT00328627|617583049|FG004|Overall Study|Hyperglycemic Rescue|6|||
170882975|NCT00328627|617583050|FG005|Overall Study|Hyperglycemic Rescue|5|||
170882976|NCT00328627|617583051|FG006|Overall Study|Hyperglycemic Rescue|19|||
170882977|NCT00328627|617583052|FG007|Overall Study|Hyperglycemic Rescue|6|||
170882978|NCT00328627|617583053|FG008|Overall Study|Hyperglycemic Rescue|6|||
170882979|NCT00328627|617583054|FG009|Overall Study|Hyperglycemic Rescue|11|||
170882980|NCT00328627|617583055|FG010|Overall Study|Hyperglycemic Rescue|3|||
170882981|NCT00328627|617583056|FG011|Overall Study|Hyperglycemic Rescue|2|||
170882982|NCT00328627|617583045|FG000|Overall Study|Adverse Event|3|||
170882983|NCT00328627|617583046|FG001|Overall Study|Adverse Event|1|||
170882984|NCT00328627|617583047|FG002|Overall Study|Adverse Event|2|||
170882985|NCT00328627|617583048|FG003|Overall Study|Adverse Event|3|||
170882986|NCT00328627|617583049|FG004|Overall Study|Adverse Event|1|||
170882987|NCT00328627|617583050|FG005|Overall Study|Adverse Event|2|||
170882988|NCT00328627|617583051|FG006|Overall Study|Adverse Event|1|||
170882989|NCT00328627|617583052|FG007|Overall Study|Adverse Event|2|||
170882990|NCT00328627|617583053|FG008|Overall Study|Adverse Event|0|||
170882991|NCT00328627|617583054|FG009|Overall Study|Adverse Event|7|||
170882992|NCT00328627|617583055|FG010|Overall Study|Adverse Event|5|||
170882993|NCT00328627|617583056|FG011|Overall Study|Adverse Event|4|||
170882994|NCT00328627|617583045|FG000|Overall Study|Protocol Violation|2|||
170882995|NCT00328627|617583046|FG001|Overall Study|Protocol Violation|2|||
170882996|NCT00328627|617583047|FG002|Overall Study|Protocol Violation|2|||
170882997|NCT00328627|617583048|FG003|Overall Study|Protocol Violation|8|||
170882998|NCT00328627|617583049|FG004|Overall Study|Protocol Violation|5|||
170882999|NCT00328627|617583050|FG005|Overall Study|Protocol Violation|5|||
170883000|NCT00328627|617583051|FG006|Overall Study|Protocol Violation|6|||
170883001|NCT00328627|617583052|FG007|Overall Study|Protocol Violation|2|||
170883002|NCT00328627|617583053|FG008|Overall Study|Protocol Violation|1|||
170883003|NCT00328627|617583054|FG009|Overall Study|Protocol Violation|4|||
170883004|NCT00328627|617583055|FG010|Overall Study|Protocol Violation|6|||
170883005|NCT00328627|617583056|FG011|Overall Study|Protocol Violation|2|||
170883006|NCT00328627|617583045|FG000|Overall Study|Lost to Follow-up|4|||
170883007|NCT00328627|617583046|FG001|Overall Study|Lost to Follow-up|2|||
170883008|NCT00328627|617583047|FG002|Overall Study|Lost to Follow-up|2|||
170782271|NCT04927065|617211236|FG006|Second Booster|Physician Decision|0|||
170883009|NCT00328627|617583048|FG003|Overall Study|Lost to Follow-up|4|||
170883010|NCT00328627|617583049|FG004|Overall Study|Lost to Follow-up|0|||
170883011|NCT00328627|617583050|FG005|Overall Study|Lost to Follow-up|2|||
170440021|NCT00884390|615949587|FG001|Overall Study|Withdrawal by Subject|1|||
170782272|NCT04927065|617211237|FG007|Second Booster|Physician Decision|0|||
170782273|NCT04927065|617211238|FG008|Second Booster|Physician Decision|0|||
170883012|NCT00328627|617583051|FG006|Overall Study|Lost to Follow-up|3|||
170883013|NCT00328627|617583052|FG007|Overall Study|Lost to Follow-up|0|||
170883014|NCT00328627|617583053|FG008|Overall Study|Lost to Follow-up|3|||
170883015|NCT00328627|617583054|FG009|Overall Study|Lost to Follow-up|2|||
170883016|NCT00328627|617583055|FG010|Overall Study|Lost to Follow-up|0|||
170883017|NCT00328627|617583056|FG011|Overall Study|Lost to Follow-up|1|||
170883018|NCT00328627|617583045|FG000|Overall Study|Withdrawal by Subject|5|||
170883019|NCT00328627|617583046|FG001|Overall Study|Withdrawal by Subject|4|||
170883020|NCT00328627|617583047|FG002|Overall Study|Withdrawal by Subject|5|||
170883021|NCT00328627|617583048|FG003|Overall Study|Withdrawal by Subject|6|||
170883022|NCT00328627|617583049|FG004|Overall Study|Withdrawal by Subject|2|||
170883023|NCT00328627|617583050|FG005|Overall Study|Withdrawal by Subject|5|||
170883024|NCT00328627|617583051|FG006|Overall Study|Withdrawal by Subject|4|||
170883025|NCT00328627|617583052|FG007|Overall Study|Withdrawal by Subject|4|||
170883026|NCT00328627|617583053|FG008|Overall Study|Withdrawal by Subject|4|||
170883027|NCT00328627|617583054|FG009|Overall Study|Withdrawal by Subject|5|||
170883028|NCT00328627|617583055|FG010|Overall Study|Withdrawal by Subject|2|||
170883029|NCT00328627|617583056|FG011|Overall Study|Withdrawal by Subject|7|||
170883030|NCT00328627|617583045|FG000|Overall Study|Pregnancy|0|||
170883031|NCT00328627|617583046|FG001|Overall Study|Pregnancy|1|||
170883032|NCT00328627|617583047|FG002|Overall Study|Pregnancy|0|||
170883033|NCT00328627|617583048|FG003|Overall Study|Pregnancy|0|||
170883034|NCT00328627|617583049|FG004|Overall Study|Pregnancy|0|||
170883035|NCT00328627|617583050|FG005|Overall Study|Pregnancy|0|||
170883036|NCT00328627|617583051|FG006|Overall Study|Pregnancy|0|||
170883037|NCT00328627|617583052|FG007|Overall Study|Pregnancy|0|||
170883038|NCT00328627|617583053|FG008|Overall Study|Pregnancy|0|||
170883039|NCT00328627|617583054|FG009|Overall Study|Pregnancy|0|||
170883040|NCT00328627|617583055|FG010|Overall Study|Pregnancy|0|||
170883041|NCT00328627|617583056|FG011|Overall Study|Pregnancy|0|||
170883042|NCT00328627|617583045|FG000|Overall Study|Physician Decision|4|||
170883043|NCT00328627|617583046|FG001|Overall Study|Physician Decision|3|||
170883044|NCT00328627|617583047|FG002|Overall Study|Physician Decision|1|||
170883045|NCT00328627|617583048|FG003|Overall Study|Physician Decision|2|||
170883046|NCT00328627|617583049|FG004|Overall Study|Physician Decision|1|||
170883047|NCT00328627|617583050|FG005|Overall Study|Physician Decision|1|||
170883048|NCT00328627|617583051|FG006|Overall Study|Physician Decision|1|||
170883049|NCT00328627|617583052|FG007|Overall Study|Physician Decision|0|||
170883050|NCT00328627|617583053|FG008|Overall Study|Physician Decision|3|||
170883051|NCT00328627|617583054|FG009|Overall Study|Physician Decision|2|||
170883052|NCT00328627|617583055|FG010|Overall Study|Physician Decision|1|||
170883053|NCT00328627|617583056|FG011|Overall Study|Physician Decision|0|||
170883054|NCT00328627|617583045|FG000|Overall Study|Other|0|||
170883055|NCT00328627|617583046|FG001|Overall Study|Other|0|||
170440022|NCT00884390|615949586|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
170440023|NCT00884390|615949587|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
170440024|NCT00884390|615949586|FG000|Overall Study|Other|11|||
170440025|NCT00884390|615949587|FG001|Overall Study|Other|1|||
170440026|NCT01691612|615949590|FG000|Overall Study|deemed ineligible after 1st visit|6|||
170440027|NCT01691612|615949590|FG000|Overall Study|Adverse Event|1|||
170440028|NCT02623218|615949591|FG000|Overall Study|Lost to Follow-up|0|||
170440029|NCT02623218|615949592|FG001|Overall Study|Lost to Follow-up|1|||
170440030|NCT02623218|615949593|FG002|Overall Study|Lost to Follow-up|0|||
170440031|NCT02623218|615949594|FG003|Overall Study|Lost to Follow-up|0|||
170440032|NCT02623218|615949595|FG004|Overall Study|Lost to Follow-up|0|||
170440033|NCT01211262|615949597|FG000|Overall Study|Progressive Disease|18|||
170440034|NCT01211262|615949598|FG001|Overall Study|Progressive Disease|9|||
170440035|NCT01211262|615949597|FG000|Overall Study|Adverse Event|4|||
170440036|NCT01211262|615949598|FG001|Overall Study|Adverse Event|0|||
170440037|NCT01211262|615949597|FG000|Overall Study|Withdrawal of Consent|1|||
170440038|NCT01211262|615949598|FG001|Overall Study|Withdrawal of Consent|0|||
170440039|NCT01211262|615949597|FG000|Overall Study|Other|0|||
170440040|NCT01211262|615949598|FG001|Overall Study|Other|1|||
170440041|NCT00537095|615949602|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
170440042|NCT00537095|615949603|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
170440043|NCT00537095|615949602|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
170440044|NCT00537095|615949603|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
170440045|NCT00537095|615949602|FG000|Randomized Treatment Period (433 Days)|Death|3|||
170440046|NCT00537095|615949603|FG001|Randomized Treatment Period (433 Days)|Death|1|||
170440047|NCT00537095|615949602|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
170883056|NCT00328627|617583047|FG002|Overall Study|Other|0|||
170883057|NCT00328627|617583048|FG003|Overall Study|Other|1|||
170883058|NCT00328627|617583049|FG004|Overall Study|Other|0|||
170883059|NCT00328627|617583050|FG005|Overall Study|Other|0|||
170883060|NCT00328627|617583051|FG006|Overall Study|Other|1|||
170883061|NCT00328627|617583052|FG007|Overall Study|Other|0|||
170883062|NCT00328627|617583053|FG008|Overall Study|Other|0|||
170440048|NCT00537095|615949603|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
170883063|NCT00328627|617583054|FG009|Overall Study|Other|1|||
170440049|NCT00537095|615949602|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
170883064|NCT00328627|617583055|FG010|Overall Study|Other|1|||
170883065|NCT00328627|617583056|FG011|Overall Study|Other|0|||
170883066|NCT00631371|617583058|FG000|Overall Study|Lost to Follow-up|24|||
170883067|NCT00631371|617583059|FG001|Overall Study|Lost to Follow-up|19|||
170883068|NCT00631371|617583058|FG000|Overall Study|Other reason|5|||
170883069|NCT00631371|617583059|FG001|Overall Study|Other reason|12|||
170883070|NCT00631371|617583058|FG000|Overall Study|subject request|38|||
170883071|NCT00631371|617583059|FG001|Overall Study|subject request|45|||
170883072|NCT00631371|617583058|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
170883073|NCT00631371|617583059|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
170883074|NCT00631371|617583058|FG000|Overall Study|Death|263|||
170883075|NCT00631371|617583059|FG001|Overall Study|Death|239|||
170883076|NCT01339559|617583060|FG000|Overall Study|Adverse Event|92|||
170883077|NCT01339559|617583060|FG000|Overall Study|Death|5|||
170883078|NCT01339559|617583060|FG000|Overall Study|Lack of Efficacy|164|||
170883079|NCT01339559|617583060|FG000|Overall Study|Lost to Follow-up|22|||
170883080|NCT01339559|617583060|FG000|Overall Study|Subject choice|89|||
170883081|NCT01339559|617583060|FG000|Overall Study|Protocol Violation|15|||
170883082|NCT01339559|617583060|FG000|Overall Study|Study closure at site|1|||
170883083|NCT01339559|617583060|FG000|Overall Study|Incarcerated|2|||
170883084|NCT01339559|617583060|FG000|Overall Study|Epilepsy surgery|1|||
170883085|NCT01339559|617583060|FG000|Overall Study|Pregnancy planned|2|||
170883086|NCT01339559|617583060|FG000|Overall Study|Left the country|1|||
170883087|NCT01339559|617583060|FG000|Overall Study|Investigator decision|2|||
170883088|NCT01339559|617583060|FG000|Overall Study|Patient didn't wish to continue|1|||
170883089|NCT01339559|617583060|FG000|Overall Study|PI decision|1|||
170883090|NCT00513409|617583061|FG000|Overall Study|Adverse Event|0|||
170883091|NCT00513409|617583062|FG001|Overall Study|Adverse Event|1|||
170883092|NCT00513409|617583061|FG000|Overall Study|Withdrawal by Subject|0|||
170883093|NCT00513409|617583062|FG001|Overall Study|Withdrawal by Subject|2|||
170883094|NCT00513409|617583061|FG000|Overall Study|Lost to Follow-up|0|||
170883095|NCT00513409|617583062|FG001|Overall Study|Lost to Follow-up|1|||
170883096|NCT00513409|617583061|FG000|Overall Study|Physician Decision|1|||
170883097|NCT00513409|617583062|FG001|Overall Study|Physician Decision|0|||
170883098|NCT00513409|617583061|FG000|Overall Study|Visit 3 not done|1|||
170883099|NCT00513409|617583062|FG001|Overall Study|Visit 3 not done|2|||
170883100|NCT01049035|617583063|FG000|Overall Study|Serious adverse event|0|||
170883101|NCT01049035|617583064|FG001|Overall Study|Serious adverse event|1|||
170883102|NCT01049035|617583065|FG002|Overall Study|Serious adverse event|1|||
170883103|NCT01049035|617583066|FG003|Overall Study|Serious adverse event|2|||
170883104|NCT01049035|617583067|FG004|Overall Study|Serious adverse event|0|||
170883105|NCT01049035|617583068|FG005|Overall Study|Serious adverse event|0|||
170883106|NCT01049035|617583069|FG006|Overall Study|Serious adverse event|0|||
170883107|NCT01049035|617583063|FG000|Overall Study|Other adverse event (AE)|0|||
170883108|NCT01049035|617583064|FG001|Overall Study|Other adverse event (AE)|0|||
170883109|NCT01049035|617583065|FG002|Overall Study|Other adverse event (AE)|0|||
170883110|NCT01049035|617583066|FG003|Overall Study|Other adverse event (AE)|1|||
170883111|NCT01049035|617583067|FG004|Overall Study|Other adverse event (AE)|0|||
170440050|NCT00537095|615949603|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
170440051|NCT00537095|615949602|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
170782274|NCT04927065|617211239|FG009|Second Booster|Physician Decision|0|||
170782275|NCT04927065|617211240|FG010|Second Booster|Physician Decision|0|||
170782276|NCT04927065|617211241|FG011|Second Booster|Physician Decision|3|||
170782277|NCT04927065|617211242|FG012|Second Booster|Physician Decision|0|||
170782278|NCT04927065|617211243|FG013|Second Booster|Physician Decision|1|||
170782279|NCT04927065|617211244|FG014|Second Booster|Physician Decision|0|||
170782280|NCT04927065|617211245|FG015|Second Booster|Physician Decision|0|||
170782281|NCT04927065|617211230|FG000|Second Booster|Withdrawal by Subject|0|||
170782282|NCT04927065|617211231|FG001|Second Booster|Withdrawal by Subject|0|||
170782283|NCT04927065|617211232|FG002|Second Booster|Withdrawal by Subject|4|||
170782284|NCT04927065|617211233|FG003|Second Booster|Withdrawal by Subject|0|||
170782285|NCT04927065|617211234|FG004|Second Booster|Withdrawal by Subject|0|||
170782286|NCT04927065|617211235|FG005|Second Booster|Withdrawal by Subject|0|||
170782287|NCT04927065|617211236|FG006|Second Booster|Withdrawal by Subject|0|||
170782288|NCT04927065|617211237|FG007|Second Booster|Withdrawal by Subject|0|||
170782289|NCT04927065|617211238|FG008|Second Booster|Withdrawal by Subject|0|||
170782290|NCT04927065|617211239|FG009|Second Booster|Withdrawal by Subject|0|||
170782291|NCT04927065|617211240|FG010|Second Booster|Withdrawal by Subject|3|||
170782292|NCT04927065|617211241|FG011|Second Booster|Withdrawal by Subject|16|||
170782293|NCT04927065|617211242|FG012|Second Booster|Withdrawal by Subject|13|||
170782294|NCT04927065|617211243|FG013|Second Booster|Withdrawal by Subject|9|||
170782295|NCT04927065|617211244|FG014|Second Booster|Withdrawal by Subject|0|||
170782296|NCT04927065|617211245|FG015|Second Booster|Withdrawal by Subject|0|||
170782297|NCT04927065|617211230|FG000|Second Booster|Other Than Specified|0|||
170782298|NCT04927065|617211231|FG001|Second Booster|Other Than Specified|0|||
170782299|NCT04927065|617211232|FG002|Second Booster|Other Than Specified|0|||
170782300|NCT04927065|617211233|FG003|Second Booster|Other Than Specified|0|||
170782301|NCT04927065|617211234|FG004|Second Booster|Other Than Specified|0|||
170782302|NCT04927065|617211235|FG005|Second Booster|Other Than Specified|0|||
170782303|NCT04927065|617211236|FG006|Second Booster|Other Than Specified|0|||
170782304|NCT04927065|617211237|FG007|Second Booster|Other Than Specified|0|||
170782305|NCT04927065|617211238|FG008|Second Booster|Other Than Specified|0|||
170782306|NCT04927065|617211239|FG009|Second Booster|Other Than Specified|0|||
170782307|NCT04927065|617211240|FG010|Second Booster|Other Than Specified|1|||
170782308|NCT04927065|617211241|FG011|Second Booster|Other Than Specified|1|||
170782309|NCT04927065|617211242|FG012|Second Booster|Other Than Specified|4|||
170782310|NCT04927065|617211243|FG013|Second Booster|Other Than Specified|0|||
170782311|NCT04927065|617211244|FG014|Second Booster|Other Than Specified|0|||
170782312|NCT04927065|617211245|FG015|Second Booster|Other Than Specified|0|||
170782313|NCT04927065|617211230|FG000|Third Booster|Lost to Follow-up|0|||
170782314|NCT04927065|617211231|FG001|Third Booster|Lost to Follow-up|0|||
170782315|NCT04927065|617211232|FG002|Third Booster|Lost to Follow-up|0|||
170782316|NCT04927065|617211233|FG003|Third Booster|Lost to Follow-up|0|||
170782317|NCT04927065|617211234|FG004|Third Booster|Lost to Follow-up|0|||
170782318|NCT04927065|617211235|FG005|Third Booster|Lost to Follow-up|0|||
170782319|NCT04927065|617211236|FG006|Third Booster|Lost to Follow-up|0|||
170782320|NCT04927065|617211237|FG007|Third Booster|Lost to Follow-up|0|||
170782321|NCT04927065|617211238|FG008|Third Booster|Lost to Follow-up|0|||
170782322|NCT04927065|617211239|FG009|Third Booster|Lost to Follow-up|0|||
170782323|NCT04927065|617211240|FG010|Third Booster|Lost to Follow-up|0|||
170782324|NCT04927065|617211241|FG011|Third Booster|Lost to Follow-up|0|||
170782325|NCT04927065|617211242|FG012|Third Booster|Lost to Follow-up|0|||
170782326|NCT04927065|617211243|FG013|Third Booster|Lost to Follow-up|0|||
170782327|NCT04927065|617211244|FG014|Third Booster|Lost to Follow-up|0|||
170782328|NCT04927065|617211245|FG015|Third Booster|Lost to Follow-up|1|||
170782329|NCT04927065|617211230|FG000|Third Booster|Withdrawal by Subject|0|||
170782330|NCT04927065|617211231|FG001|Third Booster|Withdrawal by Subject|0|||
170782331|NCT04927065|617211232|FG002|Third Booster|Withdrawal by Subject|0|||
170782332|NCT04927065|617211233|FG003|Third Booster|Withdrawal by Subject|0|||
170782333|NCT04927065|617211234|FG004|Third Booster|Withdrawal by Subject|0|||
170782334|NCT04927065|617211235|FG005|Third Booster|Withdrawal by Subject|0|||
170782335|NCT04927065|617211236|FG006|Third Booster|Withdrawal by Subject|0|||
170782336|NCT04927065|617211237|FG007|Third Booster|Withdrawal by Subject|0|||
170782337|NCT04927065|617211238|FG008|Third Booster|Withdrawal by Subject|0|||
170782338|NCT04927065|617211239|FG009|Third Booster|Withdrawal by Subject|0|||
170782339|NCT04927065|617211240|FG010|Third Booster|Withdrawal by Subject|0|||
170782340|NCT04927065|617211241|FG011|Third Booster|Withdrawal by Subject|0|||
170782341|NCT04927065|617211242|FG012|Third Booster|Withdrawal by Subject|0|||
170782342|NCT04927065|617211243|FG013|Third Booster|Withdrawal by Subject|0|||
170782343|NCT04927065|617211244|FG014|Third Booster|Withdrawal by Subject|0|||
170782344|NCT04927065|617211245|FG015|Third Booster|Withdrawal by Subject|1|||
170782345|NCT03385629|617211248|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
170782346|NCT03385629|617211249|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
170782347|NCT03385629|617211248|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
170440052|NCT00537095|615949603|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
170782348|NCT03385629|617211249|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
170782349|NCT03385629|617211248|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
170782350|NCT03385629|617211249|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
170782351|NCT00792636|617211250|FG000|Overall Study|Protocol Violation|17|||
170782352|NCT00792636|617211251|FG001|Overall Study|Protocol Violation|23|||
170782353|NCT00792636|617211252|FG002|Overall Study|Protocol Violation|20|||
170782354|NCT00792636|617211250|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
170782355|NCT00792636|617211251|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
170782356|NCT00792636|617211252|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
170782357|NCT00792636|617211250|FG000|Overall Study|Lost to Follow-up|13|||
170782358|NCT00792636|617211251|FG001|Overall Study|Lost to Follow-up|19|||
170782359|NCT00792636|617211252|FG002|Overall Study|Lost to Follow-up|14|||
170782360|NCT00792636|617211250|FG000|Overall Study|Withdrew Consent|10|||
170782361|NCT00792636|617211251|FG001|Overall Study|Withdrew Consent|13|||
170782362|NCT00792636|617211252|FG002|Overall Study|Withdrew Consent|9|||
170782363|NCT00792636|617211250|FG000|Overall Study|Lack of Efficacy|3|||
170782364|NCT00792636|617211251|FG001|Overall Study|Lack of Efficacy|4|||
170782365|NCT00792636|617211252|FG002|Overall Study|Lack of Efficacy|13|||
170782366|NCT00792636|617211250|FG000|Overall Study|Adverse Event|4|||
170782367|NCT00792636|617211251|FG001|Overall Study|Adverse Event|2|||
170782368|NCT00792636|617211252|FG002|Overall Study|Adverse Event|3|||
170782369|NCT00792636|617211250|FG000|Overall Study|Investigator Discretion|2|||
170782370|NCT00792636|617211251|FG001|Overall Study|Investigator Discretion|0|||
170782371|NCT00792636|617211252|FG002|Overall Study|Investigator Discretion|2|||
170782372|NCT02907099|617211260|FG000|Overall Study|Adverse Event|1|||
170782373|NCT02907099|617211260|FG000|Overall Study|Withdrawal by Subject|2|||
170782374|NCT02907099|617211260|FG000|Overall Study|Screen Fail|2|||
170782375|NCT02689284|617211262|FG000|Overall Study|Adverse Event|1|||
170782376|NCT02689284|617211263|FG001|Overall Study|Adverse Event|8|||
170782377|NCT02689284|617211262|FG000|Overall Study|Death|0|||
170782378|NCT02689284|617211263|FG001|Overall Study|Death|1|||
170782379|NCT02689284|617211262|FG000|Overall Study|Physician Decision|1|||
170782380|NCT02689284|617211263|FG001|Overall Study|Physician Decision|2|||
170782381|NCT02689284|617211262|FG000|Overall Study|Withdrawal by Subject|0|||
170782382|NCT02689284|617211263|FG001|Overall Study|Withdrawal by Subject|1|||
170782383|NCT02689284|617211262|FG000|Overall Study|progression of cancer|1|||
170782384|NCT02689284|617211263|FG001|Overall Study|progression of cancer|72|||
170782385|NCT02689284|617211262|FG000|Overall Study|decreased heart function|0|||
170782386|NCT02689284|617211263|FG001|Overall Study|decreased heart function|1|||
170782387|NCT02689284|617211262|FG000|Overall Study|concern for anemia|0|||
170782388|NCT02689284|617211263|FG001|Overall Study|concern for anemia|1|||
170782389|NCT02689284|617211262|FG000|Overall Study|no measurable cancer for evaluation|0|||
170782390|NCT02689284|617211263|FG001|Overall Study|no measurable cancer for evaluation|1|||
170782391|NCT05592418|617211264|FG000|Overall Study|Adverse Event|1|||
170782392|NCT05592418|617211265|FG001|Overall Study|Adverse Event|0|||
170782393|NCT05592418|617211264|FG000|Overall Study|Lost to Follow-up|1|||
170782394|NCT05592418|617211265|FG001|Overall Study|Lost to Follow-up|3|||
170782395|NCT05592418|617211264|FG000|Overall Study|Withdrawal by Subject|2|||
170782396|NCT05592418|617211265|FG001|Overall Study|Withdrawal by Subject|7|||
170782397|NCT05516147|617211266|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
170782398|NCT02697136|617211267|FG000|Overall Study|Adverse Event|3|||
170782399|NCT02697136|617211268|FG001|Overall Study|Adverse Event|0|||
170782400|NCT00220740|617211272|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
170782401|NCT00220740|617211273|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
170782402|NCT00220740|617211272|FG000|Efficacy Period|Adverse Event|1|||
170440053|NCT00537095|615949602|FG000|Open-label Period (590 Days)|Adverse Event|2|||
170440054|NCT00537095|615949603|FG001|Open-label Period (590 Days)|Adverse Event|11|||
170440055|NCT00537095|615949602|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
170440056|NCT00537095|615949603|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
170440057|NCT00537095|615949602|FG000|Open-label Period (590 Days)|Death|2|||
170782403|NCT00220740|617211273|FG001|Efficacy Period|Adverse Event|1|||
170782404|NCT00220740|617211272|FG000|Efficacy Period|Withdrawal by Subject|1|||
170782405|NCT00220740|617211273|FG001|Efficacy Period|Withdrawal by Subject|0|||
170782406|NCT00220740|617211272|FG000|Efficacy Period|Protocol Violation|1|||
170883112|NCT01049035|617583068|FG005|Overall Study|Other adverse event (AE)|0|||
170883113|NCT01049035|617583069|FG006|Overall Study|Other adverse event (AE)|0|||
170782407|NCT00220740|617211273|FG001|Efficacy Period|Protocol Violation|0|||
170782408|NCT00220740|617211272|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
170782409|NCT00220740|617211273|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
170782410|NCT01057433|617211274|FG000|Overall Study|Adverse Event|1|||
170782411|NCT03432858|617211278|FG000|Overall Study|Protocol Violation|2|||
170782412|NCT03432858|617211279|FG001|Overall Study|Protocol Violation|1|||
170782413|NCT03432858|617211280|FG002|Overall Study|Protocol Violation|9|||
170782414|NCT03432858|617211278|FG000|Overall Study|Withdrawal by Subject|0|||
170440058|NCT00537095|615949603|FG001|Open-label Period (590 Days)|Death|2|||
170782415|NCT03432858|617211279|FG001|Overall Study|Withdrawal by Subject|1|||
170782416|NCT03432858|617211280|FG002|Overall Study|Withdrawal by Subject|1|||
170782417|NCT03432858|617211278|FG000|Overall Study|Procedure canceled/rescheduled|0|||
170782418|NCT03432858|617211279|FG001|Overall Study|Procedure canceled/rescheduled|9|||
170782419|NCT03432858|617211280|FG002|Overall Study|Procedure canceled/rescheduled|6|||
170782420|NCT03432858|617211278|FG000|Overall Study|Required postop mobilization with splinting|0|||
170782421|NCT03432858|617211279|FG001|Overall Study|Required postop mobilization with splinting|0|||
170782422|NCT03432858|617211280|FG002|Overall Study|Required postop mobilization with splinting|1|||
170782423|NCT01011946|617211281|FG000|Overall Study|Transferred to another hospital|2|||
170782424|NCT01011946|617211281|FG000|Overall Study|No pathological lab value|1|||
170782425|NCT04623775|617211286|FG000|Randomization|No Longer Meets Study Criteria|2|||
170782426|NCT04623775|617211287|FG001|Randomization|No Longer Meets Study Criteria|1|||
170782427|NCT04623775|617211288|FG002|Randomization|No Longer Meets Study Criteria|0|||
170782428|NCT04623775|617211289|FG003|Randomization|No Longer Meets Study Criteria|0|||
170782429|NCT04623775|617211286|FG000|Randomization|Withdrew Consent|0|||
170782430|NCT04623775|617211287|FG001|Randomization|Withdrew Consent|0|||
170782431|NCT04623775|617211288|FG002|Randomization|Withdrew Consent|0|||
170782432|NCT04623775|617211289|FG003|Randomization|Withdrew Consent|1|||
170782433|NCT04623775|617211286|FG000|Randomization|Other Reasons|0|||
170782434|NCT04623775|617211287|FG001|Randomization|Other Reasons|0|||
170782435|NCT04623775|617211288|FG002|Randomization|Other Reasons|0|||
170782436|NCT04623775|617211289|FG003|Randomization|Other Reasons|1|||
170782437|NCT04623775|617211286|FG000|Treatment Period|participant withdrew consent|4|||
170782438|NCT04623775|617211287|FG001|Treatment Period|participant withdrew consent|0|||
170782439|NCT04623775|617211288|FG002|Treatment Period|participant withdrew consent|1|||
170782440|NCT04623775|617211289|FG003|Treatment Period|participant withdrew consent|2|||
170782441|NCT04623775|617211286|FG000|Treatment Period|Death|3|||
170782442|NCT04623775|617211287|FG001|Treatment Period|Death|1|||
170782443|NCT04623775|617211288|FG002|Treatment Period|Death|4|||
170782444|NCT04623775|617211289|FG003|Treatment Period|Death|2|||
170782445|NCT04623775|617211286|FG000|Treatment Period|Lost to Follow-up|0|||
170782446|NCT04623775|617211287|FG001|Treatment Period|Lost to Follow-up|2|||
170782447|NCT04623775|617211288|FG002|Treatment Period|Lost to Follow-up|0|||
170782448|NCT04623775|617211289|FG003|Treatment Period|Lost to Follow-up|0|||
170782449|NCT04623775|617211286|FG000|Treatment Period|poor/non compliance|0|||
170782450|NCT04623775|617211287|FG001|Treatment Period|poor/non compliance|0|||
170782451|NCT04623775|617211288|FG002|Treatment Period|poor/non compliance|1|||
170782452|NCT04623775|617211289|FG003|Treatment Period|poor/non compliance|0|||
170782453|NCT04623775|617211286|FG000|Treatment Period|participant no longer meets study criteria|0|||
170782454|NCT04623775|617211287|FG001|Treatment Period|participant no longer meets study criteria|1|||
170782455|NCT04623775|617211288|FG002|Treatment Period|participant no longer meets study criteria|0|||
170782456|NCT04623775|617211289|FG003|Treatment Period|participant no longer meets study criteria|0|||
170782457|NCT04623775|617211286|FG000|Treatment Period|administrative reasons by sponsor|3|||
170782458|NCT04623775|617211287|FG001|Treatment Period|administrative reasons by sponsor|2|||
170782459|NCT04623775|617211288|FG002|Treatment Period|administrative reasons by sponsor|0|||
170782460|NCT04623775|617211289|FG003|Treatment Period|administrative reasons by sponsor|0|||
170782461|NCT04623775|617211286|FG000|Treatment Period|other reasons|2|||
170782462|NCT04623775|617211287|FG001|Treatment Period|other reasons|0|||
170782463|NCT04623775|617211288|FG002|Treatment Period|other reasons|1|||
170782464|NCT04623775|617211289|FG003|Treatment Period|other reasons|1|||
170782465|NCT04623775|617211286|FG000|Treatment Period|disease progression|40|||
170782466|NCT04623775|617211287|FG001|Treatment Period|disease progression|35|||
170782467|NCT04623775|617211288|FG002|Treatment Period|disease progression|63|||
170782468|NCT04623775|617211289|FG003|Treatment Period|disease progression|63|||
170782469|NCT04623775|617211286|FG000|Treatment Period|study drug toxicity|12|||
170782470|NCT04623775|617211287|FG001|Treatment Period|study drug toxicity|15|||
170782471|NCT04623775|617211288|FG002|Treatment Period|study drug toxicity|13|||
170782472|NCT04623775|617211289|FG003|Treatment Period|study drug toxicity|12|||
170782473|NCT04623775|617211286|FG000|Treatment Period|AE unrelated to study drug|4|||
170782474|NCT04623775|617211287|FG001|Treatment Period|AE unrelated to study drug|9|||
170782475|NCT04623775|617211288|FG002|Treatment Period|AE unrelated to study drug|12|||
170782476|NCT04623775|617211289|FG003|Treatment Period|AE unrelated to study drug|9|||
170883114|NCT01049035|617583063|FG000|Overall Study|Non-compliance with the protocol|12|||
170883115|NCT01049035|617583064|FG001|Overall Study|Non-compliance with the protocol|6|||
170883116|NCT01049035|617583065|FG002|Overall Study|Non-compliance with the protocol|14|||
170782477|NCT04623775|617211286|FG000|Treatment Period|participant request to discontinue treatment|0|||
170782478|NCT04623775|617211287|FG001|Treatment Period|participant request to discontinue treatment|2|||
170782479|NCT04623775|617211288|FG002|Treatment Period|participant request to discontinue treatment|2|||
170782480|NCT04623775|617211289|FG003|Treatment Period|participant request to discontinue treatment|0|||
170782481|NCT03690206|617211290|FG000|Overall Study|Withdrawal by Subject|2|||
170782482|NCT03690206|617211291|FG001|Overall Study|Withdrawal by Subject|0|||
170883117|NCT01049035|617583066|FG003|Overall Study|Non-compliance with the protocol|5|||
170883118|NCT01049035|617583067|FG004|Overall Study|Non-compliance with the protocol|3|||
170883119|NCT01049035|617583068|FG005|Overall Study|Non-compliance with the protocol|4|||
170883120|NCT01049035|617583069|FG006|Overall Study|Non-compliance with the protocol|10|||
170883121|NCT01049035|617583063|FG000|Overall Study|Lost to Follow-up|5|||
170883122|NCT01049035|617583064|FG001|Overall Study|Lost to Follow-up|4|||
170883123|NCT01049035|617583065|FG002|Overall Study|Lost to Follow-up|4|||
170883124|NCT01049035|617583066|FG003|Overall Study|Lost to Follow-up|1|||
170883125|NCT01049035|617583067|FG004|Overall Study|Lost to Follow-up|0|||
170883126|NCT01049035|617583068|FG005|Overall Study|Lost to Follow-up|3|||
170883127|NCT01049035|617583069|FG006|Overall Study|Lost to Follow-up|3|||
170883128|NCT01049035|617583063|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
170883129|NCT01049035|617583064|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
170883130|NCT01049035|617583065|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
170883131|NCT01049035|617583066|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
170883132|NCT01049035|617583067|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
170883133|NCT01049035|617583068|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
170883134|NCT01049035|617583069|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
170883135|NCT00746252|617583070|FG000|Overall Study|weight gain >7.5 %|1|||
170883136|NCT00746252|617583071|FG001|Overall Study|weight gain >7.5 %|2|||
170883137|NCT01391000|617583073|FG000|Overall Study|Lost to Follow-up|2|||
170883138|NCT01391000|617583074|FG001|Overall Study|Lost to Follow-up|0|||
170883139|NCT00082888|617583075|FG000|Overall Study|Ineligible|1|||
170883140|NCT00082888|617583076|FG001|Overall Study|Ineligible|0|||
170883141|NCT00082888|617583077|FG002|Overall Study|Ineligible|0|||
170883142|NCT03860961|617583078|FG000|Overall Study|Withdrawal by Subject|6|||
170883143|NCT03860961|617583079|FG001|Overall Study|Withdrawal by Subject|11|||
170883144|NCT03860961|617583078|FG000|Overall Study|Death|10|||
170883145|NCT03860961|617583079|FG001|Overall Study|Death|6|||
170883146|NCT03860961|617583078|FG000|Overall Study|Incomplete two-year data|4|||
170883147|NCT03860961|617583079|FG001|Overall Study|Incomplete two-year data|0|||
170883148|NCT00817531|617583081|FG000|Overall Study|Adverse Event|1|||
170883149|NCT00817531|617583081|FG000|Overall Study|Lack of Efficacy|1|||
170883150|NCT03325673|617583084|FG000|Overall Study|Adverse Event|4|||
170883151|NCT03325673|617583085|FG001|Overall Study|Adverse Event|0|||
170883152|NCT00326898|617583086|FG000|Overall Study|Disease progression|52|||
170883153|NCT00326898|617583087|FG001|Overall Study|Disease progression|54|||
170883154|NCT00326898|617583088|FG002|Overall Study|Disease progression|102|||
170883155|NCT00326898|617583086|FG000|Overall Study|Adverse Event|124|||
170883156|NCT00326898|617583087|FG001|Overall Study|Adverse Event|128|||
170883157|NCT00326898|617583088|FG002|Overall Study|Adverse Event|33|||
170883158|NCT00326898|617583086|FG000|Overall Study|Death|2|||
170883159|NCT00326898|617583087|FG001|Overall Study|Death|0|||
170883160|NCT00326898|617583088|FG002|Overall Study|Death|0|||
170883161|NCT00326898|617583086|FG000|Overall Study|Withdrawal by Subject|134|||
170883162|NCT00326898|617583087|FG001|Overall Study|Withdrawal by Subject|128|||
170883163|NCT00326898|617583088|FG002|Overall Study|Withdrawal by Subject|32|||
170883164|NCT00326898|617583086|FG000|Overall Study|Alternative therapy|1|||
170883165|NCT00326898|617583087|FG001|Overall Study|Alternative therapy|0|||
170883166|NCT00326898|617583088|FG002|Overall Study|Alternative therapy|0|||
170883167|NCT00326898|617583086|FG000|Overall Study|Other complicating disease|5|||
170883168|NCT00326898|617583087|FG001|Overall Study|Other complicating disease|5|||
170883169|NCT00326898|617583088|FG002|Overall Study|Other complicating disease|4|||
170883170|NCT00326898|617583086|FG000|Overall Study|Other/Missing/Unknown|33|||
170883171|NCT00326898|617583087|FG001|Overall Study|Other/Missing/Unknown|28|||
170883172|NCT00326898|617583088|FG002|Overall Study|Other/Missing/Unknown|32|||
170883173|NCT02721355|617583089|FG000|Overall Study|Lost to Follow-up|6|||
170883174|NCT02721355|617583090|FG001|Overall Study|Lost to Follow-up|1|||
170883175|NCT02597855|617583091|FG000|Overall Study|Lost to Follow-up|2|||
170883176|NCT02597855|617583092|FG001|Overall Study|Lost to Follow-up|1|||
170883177|NCT00925015|617583093|FG000|Overall Study|Adverse Event|1|||
170883178|NCT00925015|617583094|FG001|Overall Study|Adverse Event|2|||
170883179|NCT00925015|617583095|FG002|Overall Study|Adverse Event|1|||
170883180|NCT00925015|617583093|FG000|Overall Study|Physician Decision|0|||
170883181|NCT00925015|617583094|FG001|Overall Study|Physician Decision|1|||
170883182|NCT00925015|617583095|FG002|Overall Study|Physician Decision|0|||
170883183|NCT00925015|617583093|FG000|Overall Study|Progressive Disease|7|||
170883184|NCT00925015|617583094|FG001|Overall Study|Progressive Disease|3|||
170883185|NCT00925015|617583095|FG002|Overall Study|Progressive Disease|4|||
170883186|NCT00925015|617583093|FG000|Overall Study|Withdrawal by Subject|0|||
170883187|NCT00925015|617583094|FG001|Overall Study|Withdrawal by Subject|0|||
170883188|NCT00925015|617583095|FG002|Overall Study|Withdrawal by Subject|1|||
170883189|NCT03865706|617583100|FG000|Overall Study|Death|0|||
170883190|NCT03865706|617583101|FG001|Overall Study|Death|3|||
170883191|NCT03865706|617583102|FG002|Overall Study|Death|1|||
170883192|NCT00781456|617583103|FG000|Overall Study|Adverse Event|3|||
170883193|NCT00781456|617583104|FG001|Overall Study|Adverse Event|3|||
170883194|NCT00781456|617583103|FG000|Overall Study|Withdrawal by Subject|3|||
170883195|NCT00781456|617583104|FG001|Overall Study|Withdrawal by Subject|5|||
170883196|NCT00781456|617583103|FG000|Overall Study|Protocol Violation|4|||
170883197|NCT00781456|617583104|FG001|Overall Study|Protocol Violation|1|||
170883198|NCT00781456|617583103|FG000|Overall Study|Noncompliance With Protocol|1|||
170883199|NCT00781456|617583104|FG001|Overall Study|Noncompliance With Protocol|1|||
170883200|NCT00781456|617583103|FG000|Overall Study|Lost to Follow-up|10|||
170883201|NCT00781456|617583104|FG001|Overall Study|Lost to Follow-up|5|||
170883202|NCT00781456|617583103|FG000|Overall Study|Other Reason, Unknown|0|||
170883203|NCT00781456|617583104|FG001|Overall Study|Other Reason, Unknown|1|||
170883204|NCT05131204|617583105|FG000|Overall Study|Sponsor request|2|||
170883205|NCT05131204|617583106|FG001|Overall Study|Sponsor request|1|||
170883206|NCT01777152|617583108|FG000|Overall Study|Withdrawal by Subject|22|||
170883207|NCT01777152|617583109|FG001|Overall Study|Withdrawal by Subject|16|||
170883208|NCT01777152|617583108|FG000|Overall Study|Lost to Follow-up|3|||
170883209|NCT01777152|617583109|FG001|Overall Study|Lost to Follow-up|5|||
170883210|NCT01777152|617583108|FG000|Overall Study|Death|68|||
170883211|NCT01777152|617583109|FG001|Overall Study|Death|89|||
170883212|NCT01777152|617583108|FG000|Overall Study|Not eligible, no study drug received|1|||
170883213|NCT01777152|617583109|FG001|Overall Study|Not eligible, no study drug received|0|||
170883214|NCT01777152|617583108|FG000|Overall Study|Change of diagnosis|1|||
170883215|NCT01777152|617583109|FG001|Overall Study|Change of diagnosis|0|||
170883216|NCT03548558|617583110|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
170883217|NCT03548558|617583111|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
170883218|NCT03548558|617583112|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
170883219|NCT03548558|617583113|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
170883220|NCT03548558|617583114|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
170883221|NCT03548558|617583115|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
170883222|NCT03548558|617583116|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
170883223|NCT03548558|617583110|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
170883224|NCT03548558|617583111|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
170883225|NCT03548558|617583112|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
170883226|NCT03548558|617583113|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
170883227|NCT03548558|617583114|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
170883228|NCT03548558|617583115|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
170883229|NCT03548558|617583116|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
170440059|NCT00537095|615949602|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
170883230|NCT03548558|617583110|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
170883231|NCT03548558|617583111|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
170883232|NCT03548558|617583112|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
170883233|NCT03548558|617583113|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
170883234|NCT03548558|617583114|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
170883235|NCT03548558|617583115|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
170883236|NCT03548558|617583116|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
170883237|NCT03548558|617583110|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
170883238|NCT03548558|617583111|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
170883239|NCT03548558|617583112|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
170883240|NCT03548558|617583113|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
170883241|NCT03548558|617583114|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
170883242|NCT03548558|617583115|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
170883243|NCT03548558|617583116|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
170883244|NCT03548558|617583110|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
170883245|NCT03548558|617583111|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
170883246|NCT03548558|617583112|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
170883247|NCT03548558|617583113|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
170883248|NCT03548558|617583114|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
170883249|NCT03548558|617583115|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
170883250|NCT03548558|617583116|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
170883251|NCT03548558|617583110|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
170883252|NCT03548558|617583111|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
170883253|NCT03548558|617583112|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
170883254|NCT03548558|617583113|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
170883255|NCT03548558|617583114|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
170883256|NCT03548558|617583115|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
170883257|NCT03548558|617583116|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
170883258|NCT02469090|617583117|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
170883259|NCT02469090|617583118|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
170883260|NCT02469090|617583119|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
170883261|NCT02469090|617583117|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
170883262|NCT02469090|617583118|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
170883263|NCT02469090|617583119|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
170883264|NCT02469090|617583117|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
170883265|NCT02469090|617583118|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
170883266|NCT02469090|617583119|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
170883267|NCT02469090|617583117|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
170883268|NCT02469090|617583118|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
170883269|NCT02469090|617583119|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
170883270|NCT02469090|617583117|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
170883271|NCT02469090|617583118|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
170883272|NCT02469090|617583119|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
170883273|NCT02469090|617583117|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
170883274|NCT02469090|617583118|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
170883275|NCT02469090|617583119|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
170883276|NCT02469090|617583117|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
170883277|NCT02469090|617583118|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
170883278|NCT02469090|617583119|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
170883279|NCT02469090|617583117|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
170883280|NCT02469090|617583118|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
170883281|NCT02469090|617583119|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
170883282|NCT04091087|617583122|FG000|Overall Study|Not treated|1|||
170883283|NCT04091087|617583123|FG001|Overall Study|Not treated|0|||
170883284|NCT04091087|617583122|FG000|Overall Study|Adverse Event|4|||
170883285|NCT04091087|617583123|FG001|Overall Study|Adverse Event|4|||
170883286|NCT04091087|617583122|FG000|Overall Study|Protocol Violation|0|||
170440060|NCT00537095|615949603|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
170440061|NCT00537095|615949602|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
170440062|NCT00537095|615949603|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
170440063|NCT00533507|615949604|FG000|Overall Study|Withdrawal by Subject|1|||
170440064|NCT00160524|615949605|FG000|Overall Study|Adverse Event|119|||
170440065|NCT00160524|615949605|FG000|Overall Study|Adverse Event and Other|94|||
170440066|NCT00160524|615949605|FG000|Overall Study|Protocol Violation|16|||
170883287|NCT04091087|617583123|FG001|Overall Study|Protocol Violation|1|||
170883288|NCT04091087|617583122|FG000|Overall Study|Withdrawal by Subject|5|||
170883289|NCT04091087|617583123|FG001|Overall Study|Withdrawal by Subject|2|||
170440067|NCT00160524|615949605|FG000|Overall Study|Protocol Violation and Other|2|||
170440068|NCT00160524|615949605|FG000|Overall Study|Withdrawal by Subject|141|||
170440069|NCT00160524|615949605|FG000|Overall Study|Withdrawal by Subject and Other|17|||
170440070|NCT00160524|615949605|FG000|Overall Study|Physician Decision|27|||
170440071|NCT00160524|615949605|FG000|Overall Study|Physician Decision and Other|6|||
170440072|NCT00160524|615949605|FG000|Overall Study|Lost to Follow-up|13|||
170440073|NCT00160524|615949605|FG000|Overall Study|Lost to Follow-up and Other|1|||
170440074|NCT00160524|615949605|FG000|Overall Study|Lack of Efficacy|21|||
170440075|NCT00160524|615949605|FG000|Overall Study|Lack of Efficacy and Other|1|||
170440076|NCT00160524|615949605|FG000|Overall Study|Other|20|||
170440077|NCT01874535|615949606|FG000|Overall Study|Lost to Follow-up|10|||
170440078|NCT01874535|615949607|FG001|Overall Study|Lost to Follow-up|9|||
170440079|NCT01874535|615949606|FG000|Overall Study|incomplete symptom resolution|45|||
170440080|NCT01874535|615949607|FG001|Overall Study|incomplete symptom resolution|35|||
170440081|NCT05065619|615949609|FG000|Up to Day 42|Lost to Follow-up|1|||
170440082|NCT05065619|615949610|FG001|Up to Day 42|Lost to Follow-up|0|||
170440083|NCT05065619|615949609|FG000|Up to Day 42|Withdrawal by Subject|1|||
170440084|NCT05065619|615949610|FG001|Up to Day 42|Withdrawal by Subject|0|||
170440085|NCT05065619|615949609|FG000|After Day 43|Lost to Follow-up|1|||
170440086|NCT05065619|615949610|FG001|After Day 43|Lost to Follow-up|0|||
170440087|NCT05065619|615949609|FG000|After Day 43|Physician Decision|3|||
170440088|NCT05065619|615949610|FG001|After Day 43|Physician Decision|0|||
170440089|NCT05065619|615949609|FG000|After Day 43|Withdrawal by Subject|1|||
170440090|NCT05065619|615949610|FG001|After Day 43|Withdrawal by Subject|2|||
170440091|NCT05065619|615949609|FG000|After Day 43|Public vaccination|6|||
170440092|NCT05065619|615949610|FG001|After Day 43|Public vaccination|8|||
170440093|NCT05065619|615949609|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
170782483|NCT03690206|617211292|FG002|Overall Study|Withdrawal by Subject|0|||
170782484|NCT03690206|617211290|FG000|Overall Study|ICF withdrawal|2|||
170782485|NCT03690206|617211291|FG001|Overall Study|ICF withdrawal|0|||
170782486|NCT03690206|617211292|FG002|Overall Study|ICF withdrawal|0|||
170782487|NCT03978637|617211295|FG000|Overall Study|Death|0|||
170782488|NCT03978637|617211296|FG001|Overall Study|Death|2|||
170440094|NCT05065619|615949610|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
170440095|NCT05065619|615949609|FG000|After Day 43|Study Terminated by Sponsor|88|||
170782489|NCT03978637|617211297|FG002|Overall Study|Death|2|||
170782490|NCT03978637|617211298|FG003|Overall Study|Death|0|||
170782491|NCT03978637|617211295|FG000|Overall Study|Withdrawal by Subject|0|||
170782492|NCT03978637|617211296|FG001|Overall Study|Withdrawal by Subject|0|||
170782493|NCT03978637|617211297|FG002|Overall Study|Withdrawal by Subject|1|||
170782494|NCT03978637|617211298|FG003|Overall Study|Withdrawal by Subject|0|||
170782495|NCT03978637|617211295|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
170782496|NCT03978637|617211296|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
170782497|NCT03978637|617211297|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
170782498|NCT03978637|617211298|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
170782499|NCT04994509|617211299|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
170782500|NCT04994509|617211300|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
170782501|NCT04994509|617211301|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
170782502|NCT04994509|617211299|FG000|Overall Study|Withdrew Consent|73|||
170782503|NCT04994509|617211300|FG001|Overall Study|Withdrew Consent|72|||
170782504|NCT04994509|617211301|FG002|Overall Study|Withdrew Consent|46|||
170782505|NCT04994509|617211299|FG000|Overall Study|Lost to Follow-up|39|||
170782506|NCT04994509|617211300|FG001|Overall Study|Lost to Follow-up|36|||
170782507|NCT04994509|617211301|FG002|Overall Study|Lost to Follow-up|26|||
170782508|NCT04994509|617211299|FG000|Overall Study|HIV-1 Infection|4|||
170782509|NCT04994509|617211300|FG001|Overall Study|HIV-1 Infection|20|||
170782510|NCT04994509|617211301|FG002|Overall Study|HIV-1 Infection|12|||
170782511|NCT04994509|617211299|FG000|Overall Study|Investigator's Discretion|9|||
170440096|NCT05065619|615949610|FG001|After Day 43|Study Terminated by Sponsor|16|||
170440097|NCT04388787|615949619|FG000|Blinded Period|Patient could not follow instructions|1|||
170440098|NCT04388787|615949619|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
170440099|NCT00663234|615949620|FG000|Overall Study|Not willing to adhere to requirements|1|||
170440100|NCT01680016|615951415|FG000|Overall Study|Adverse Event|0|||
170440101|NCT01680016|615951416|FG001|Overall Study|Adverse Event|0|||
170440102|NCT01680016|615951417|FG002|Overall Study|Adverse Event|1|||
170440103|NCT01680016|615951418|FG003|Overall Study|Adverse Event|4|||
170440104|NCT01680016|615951415|FG000|Overall Study|The Subject went out of The Trial|1|||
170440105|NCT01680016|615951416|FG001|Overall Study|The Subject went out of The Trial|0|||
170440106|NCT01680016|615951417|FG002|Overall Study|The Subject went out of The Trial|3|||
170440107|NCT01680016|615951418|FG003|Overall Study|The Subject went out of The Trial|0|||
170440108|NCT01680016|615951415|FG000|Overall Study|Protocol Violation|0|||
170440109|NCT01680016|615951416|FG001|Overall Study|Protocol Violation|1|||
170440110|NCT01680016|615951417|FG002|Overall Study|Protocol Violation|0|||
170782512|NCT04994509|617211300|FG001|Overall Study|Investigator's Discretion|8|||
170440111|NCT01680016|615951418|FG003|Overall Study|Protocol Violation|0|||
170782513|NCT04994509|617211301|FG002|Overall Study|Investigator's Discretion|11|||
170440112|NCT01680016|615951415|FG000|Overall Study|Withdrawal by Subject|5|||
170782514|NCT04994509|617211299|FG000|Overall Study|Randomized but Never Treated|10|||
170782515|NCT04994509|617211300|FG001|Overall Study|Randomized but Never Treated|10|||
170440113|NCT01680016|615951416|FG001|Overall Study|Withdrawal by Subject|7|||
170440114|NCT01680016|615951417|FG002|Overall Study|Withdrawal by Subject|1|||
170440115|NCT01680016|615951418|FG003|Overall Study|Withdrawal by Subject|1|||
170440116|NCT02722616|615951420|FG000|Overall Study|Sponsor closed study after one month|2|||
170440117|NCT02722616|615951421|FG001|Overall Study|Sponsor closed study after one month|0|||
170440118|NCT02722616|615951422|FG002|Overall Study|Sponsor closed study after one month|0|||
170440119|NCT02293460|615951424|FG000|Overall Study|Protocol Violation|1|||
170440120|NCT02293460|615951424|FG000|Overall Study|Lack of Efficacy|2|||
170440121|NCT02293460|615951424|FG000|Overall Study|Adverse Event|2|||
170440122|NCT02293460|615951424|FG000|Overall Study|Withdrawal by Subject|1|||
170440123|NCT00108628|615951431|FG000|Overall Study|Withdrawal by Subject|17|||
170440124|NCT00108628|615951432|FG001|Overall Study|Withdrawal by Subject|9|||
170440125|NCT00108628|615951431|FG000|Overall Study|Lack of Efficacy|2|||
170440126|NCT00108628|615951432|FG001|Overall Study|Lack of Efficacy|1|||
170537178|NCT04092777|616311546|FG000|Overall Study|Withdrawal by Subject|8|||
170782516|NCT04994509|617211301|FG002|Overall Study|Randomized but Never Treated|3|||
170782517|NCT04994509|617211299|FG000|Overall Study|Pregnancy|5|||
170782518|NCT04994509|617211300|FG001|Overall Study|Pregnancy|5|||
170782519|NCT04994509|617211301|FG002|Overall Study|Pregnancy|0|||
170782520|NCT04994509|617211299|FG000|Overall Study|Death|0|||
170782521|NCT04994509|617211300|FG001|Overall Study|Death|5|||
170782522|NCT04994509|617211301|FG002|Overall Study|Death|0|||
170782523|NCT04994509|617211299|FG000|Overall Study|Adverse Event|2|||
170782524|NCT04994509|617211300|FG001|Overall Study|Adverse Event|1|||
170782525|NCT04994509|617211301|FG002|Overall Study|Adverse Event|0|||
170782526|NCT04994509|617211299|FG000|Overall Study|Non-compliance With Study Drug|1|||
170782527|NCT04994509|617211300|FG001|Overall Study|Non-compliance With Study Drug|1|||
170782528|NCT04994509|617211301|FG002|Overall Study|Non-compliance With Study Drug|1|||
170782529|NCT04994509|617211299|FG000|Overall Study|Withdrew Assent|3|||
170782530|NCT04994509|617211300|FG001|Overall Study|Withdrew Assent|0|||
170782531|NCT04994509|617211301|FG002|Overall Study|Withdrew Assent|0|||
170782532|NCT04994509|617211299|FG000|Overall Study|Protocol Violation|1|||
170782533|NCT04994509|617211300|FG001|Overall Study|Protocol Violation|0|||
170782534|NCT04994509|617211301|FG002|Overall Study|Protocol Violation|0|||
170782535|NCT05792423|617211302|FG000|Overall Study|Withdrawal by Subject|2|||
170782536|NCT00753090|617212917|FG000|Overall Study|Withdrawal by Subject|10|||
170782537|NCT00753090|617212918|FG001|Overall Study|Withdrawal by Subject|10|||
170782538|NCT00753090|617212917|FG000|Overall Study|Death|17|||
170782539|NCT00753090|617212918|FG001|Overall Study|Death|6|||
170782540|NCT00753090|617212917|FG000|Overall Study|Study Prosthesis Removed|12|||
170782541|NCT00753090|617212918|FG001|Overall Study|Study Prosthesis Removed|3|||
170782542|NCT00753090|617212917|FG000|Overall Study|Lost to Follow-up|2|||
170782543|NCT00753090|617212918|FG001|Overall Study|Lost to Follow-up|2|||
170782544|NCT00753090|617212917|FG000|Overall Study|Other|127|||
170782545|NCT00753090|617212918|FG001|Overall Study|Other|75|||
170782546|NCT04052516|617212920|FG000|Overall Study|Withdrawal by Subject|4|||
170782547|NCT04052516|617212921|FG001|Overall Study|Withdrawal by Subject|5|||
170782548|NCT04052516|617212922|FG002|Overall Study|Withdrawal by Subject|6|||
170782549|NCT04052516|617212920|FG000|Overall Study|Adverse Event|3|||
170782550|NCT04052516|617212921|FG001|Overall Study|Adverse Event|2|||
170782551|NCT04052516|617212922|FG002|Overall Study|Adverse Event|8|||
170782552|NCT04052516|617212920|FG000|Overall Study|Lost to Follow-up|2|||
170782553|NCT04052516|617212921|FG001|Overall Study|Lost to Follow-up|5|||
170782554|NCT04052516|617212922|FG002|Overall Study|Lost to Follow-up|3|||
170782555|NCT04052516|617212920|FG000|Overall Study|Protocol Violation|1|||
170782556|NCT04052516|617212921|FG001|Overall Study|Protocol Violation|1|||
170782557|NCT04052516|617212922|FG002|Overall Study|Protocol Violation|0|||
170782558|NCT04052516|617212920|FG000|Overall Study|Death|1|||
170782559|NCT04052516|617212921|FG001|Overall Study|Death|0|||
170782560|NCT04052516|617212922|FG002|Overall Study|Death|0|||
170782561|NCT04052516|617212920|FG000|Overall Study|Physician Decision|0|||
170782562|NCT04052516|617212921|FG001|Overall Study|Physician Decision|1|||
170782563|NCT04052516|617212922|FG002|Overall Study|Physician Decision|0|||
170782564|NCT04052516|617212920|FG000|Overall Study|Pregnancy|1|||
170782565|NCT04052516|617212921|FG001|Overall Study|Pregnancy|0|||
170440127|NCT00108628|615951431|FG000|Overall Study|Death|1|||
170440128|NCT00108628|615951432|FG001|Overall Study|Death|0|||
170782566|NCT04052516|617212922|FG002|Overall Study|Pregnancy|0|||
170782567|NCT04052516|617212920|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
170782568|NCT04052516|617212921|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
170883290|NCT03509350|617583124|FG000|Overall Study|Withdrawal by Subject|0|||
170440129|NCT01453153|615951433|FG000|Overall Study|Physician Decision|0|||
170782569|NCT04052516|617212922|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
170782570|NCT04052516|617212920|FG000|Overall Study|Reason not recorded|0|||
170782571|NCT04052516|617212921|FG001|Overall Study|Reason not recorded|1|||
170782572|NCT04052516|617212922|FG002|Overall Study|Reason not recorded|0|||
170782573|NCT05418296|617212928|FG000|Overall Study|Withdrawal by Subject|4|||
170782574|NCT05418296|617212929|FG001|Overall Study|Withdrawal by Subject|1|||
170782575|NCT06311084|617212934|FG000|Overall Study|Lost to Follow-up|14|||
170883291|NCT03509350|617583125|FG001|Overall Study|Withdrawal by Subject|2|||
170883292|NCT01425203|617583126|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
170883293|NCT01425203|617583127|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
170883294|NCT01425203|617583128|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
170883295|NCT01425203|617583126|FG000|Treatment Phase|Failure at futility timepoint|8|||
170883296|NCT01425203|617583127|FG001|Treatment Phase|Failure at futility timepoint|27|||
170883297|NCT01425203|617583128|FG002|Treatment Phase|Failure at futility timepoint|0|||
170883298|NCT01425203|617583126|FG000|Treatment Phase|Other virologic failure criteria|5|||
170883299|NCT01425203|617583127|FG001|Treatment Phase|Other virologic failure criteria|3|||
170883300|NCT01425203|617583128|FG002|Treatment Phase|Other virologic failure criteria|0|||
170883301|NCT01425203|617583126|FG000|Treatment Phase|Unidentified reasons|11|||
170883302|NCT01425203|617583127|FG001|Treatment Phase|Unidentified reasons|5|||
170883303|NCT01425203|617583128|FG002|Treatment Phase|Unidentified reasons|0|||
170883304|NCT01425203|617583126|FG000|Treatment Phase|Did not receive treatment|0|||
170883305|NCT01425203|617583127|FG001|Treatment Phase|Did not receive treatment|1|||
170883306|NCT01425203|617583128|FG002|Treatment Phase|Did not receive treatment|0|||
170883307|NCT01425203|617583126|FG000|Crossover Phase|Failure at futility timepoint|0|||
170883308|NCT01425203|617583127|FG001|Crossover Phase|Failure at futility timepoint|0|||
170883309|NCT01425203|617583128|FG002|Crossover Phase|Failure at futility timepoint|3|||
170883310|NCT01425203|617583126|FG000|Crossover Phase|Other virologic failure criteria|0|||
170883311|NCT01425203|617583127|FG001|Crossover Phase|Other virologic failure criteria|0|||
170883312|NCT01425203|617583128|FG002|Crossover Phase|Other virologic failure criteria|3|||
170883313|NCT00763815|617583129|FG000|Overall Study|Adverse Event|14|||
170883314|NCT00763815|617583130|FG001|Overall Study|Adverse Event|29|||
170883315|NCT00763815|617583129|FG000|Overall Study|Lack of Efficacy|10|||
170883316|NCT00763815|617583130|FG001|Overall Study|Lack of Efficacy|11|||
170883317|NCT00763815|617583129|FG000|Overall Study|Poor Compliance to Protocol|6|||
170883318|NCT00763815|617583130|FG001|Overall Study|Poor Compliance to Protocol|6|||
170883319|NCT00763815|617583129|FG000|Overall Study|Lost to Follow-up|2|||
170883320|NCT00763815|617583130|FG001|Overall Study|Lost to Follow-up|4|||
170883321|NCT00763815|617583129|FG000|Overall Study|Early Termination|1|||
170883322|NCT00763815|617583130|FG001|Overall Study|Early Termination|0|||
170883323|NCT00763815|617583129|FG000|Overall Study|Familial and Personal Reasons|9|||
170883324|NCT00763815|617583130|FG001|Overall Study|Familial and Personal Reasons|16|||
170883325|NCT00763815|617583129|FG000|Overall Study|Physician Decision|1|||
170883326|NCT00763815|617583130|FG001|Overall Study|Physician Decision|0|||
170883327|NCT00763815|617583129|FG000|Overall Study|Withdrawal by Subject|7|||
170883328|NCT00763815|617583130|FG001|Overall Study|Withdrawal by Subject|12|||
170883329|NCT00763815|617583129|FG000|Overall Study|Protocol Violation|2|||
170883330|NCT00763815|617583130|FG001|Overall Study|Protocol Violation|5|||
170883331|NCT00763815|617583129|FG000|Overall Study|Sponsor's Decision|0|||
170883332|NCT00763815|617583130|FG001|Overall Study|Sponsor's Decision|1|||
170883333|NCT00290433|617583133|FG000|Overall Study|Disease Progression|13|||
170883334|NCT00290433|617583133|FG000|Overall Study|Adverse Event|14|||
170883335|NCT00290433|617583133|FG000|Overall Study|Withdrawal by Subject|1|||
170883336|NCT00290433|617583133|FG000|Overall Study|Non-Compliance|1|||
170883337|NCT00290433|617583133|FG000|Overall Study|Congestive Heart Failure|1|||
170883338|NCT00290433|617583133|FG000|Overall Study|Transplant in CR|5|||
170883339|NCT00290433|617583133|FG000|Overall Study|Unrelated Infection/Death|1|||
170883340|NCT02559687|617583134|FG000|Overall Study|Death|112|||
170883341|NCT02559687|617583134|FG000|Overall Study|Sponsor Decision|5|||
170883342|NCT02559687|617583134|FG000|Overall Study|Withdrawal by Subject|4|||
170883343|NCT03245450|617583138|FG000|Overall Study|Radiological disease progression|3|||
170883344|NCT03245450|617583139|FG001|Overall Study|Radiological disease progression|3|||
170883345|NCT03245450|617583140|FG002|Overall Study|Radiological disease progression|2|||
170883346|NCT03245450|617583141|FG003|Overall Study|Radiological disease progression|2|||
170883347|NCT03245450|617583142|FG004|Overall Study|Radiological disease progression|7|||
170883348|NCT03245450|617583143|FG005|Overall Study|Radiological disease progression|6|||
170883349|NCT03245450|617583144|FG006|Overall Study|Radiological disease progression|6|||
170883350|NCT03245450|617583138|FG000|Overall Study|Clinical disease progression|0|||
170883351|NCT03245450|617583139|FG001|Overall Study|Clinical disease progression|0|||
170883352|NCT03245450|617583140|FG002|Overall Study|Clinical disease progression|1|||
170883353|NCT03245450|617583141|FG003|Overall Study|Clinical disease progression|0|||
170883354|NCT03245450|617583142|FG004|Overall Study|Clinical disease progression|0|||
170883355|NCT03245450|617583143|FG005|Overall Study|Clinical disease progression|2|||
170883356|NCT03245450|617583144|FG006|Overall Study|Clinical disease progression|0|||
170883357|NCT03245450|617583138|FG000|Overall Study|Other|0|||
170883358|NCT03245450|617583139|FG001|Overall Study|Other|0|||
170883359|NCT03245450|617583140|FG002|Overall Study|Other|0|||
170883360|NCT03245450|617583141|FG003|Overall Study|Other|1|||
170883361|NCT03245450|617583142|FG004|Overall Study|Other|1|||
170883362|NCT03245450|617583143|FG005|Overall Study|Other|1|||
170883363|NCT03245450|617583144|FG006|Overall Study|Other|1|||
170883364|NCT03245450|617583138|FG000|Overall Study|Withdrawal by Subject|0|||
170883365|NCT03245450|617583139|FG001|Overall Study|Withdrawal by Subject|1|||
170883366|NCT03245450|617583140|FG002|Overall Study|Withdrawal by Subject|0|||
170883367|NCT03245450|617583141|FG003|Overall Study|Withdrawal by Subject|0|||
170883368|NCT03245450|617583142|FG004|Overall Study|Withdrawal by Subject|0|||
170883369|NCT03245450|617583143|FG005|Overall Study|Withdrawal by Subject|0|||
170782576|NCT02249949|617212936|FG000|Overall Study|Cancelled prior to treatment|2|||
170782577|NCT05021640|617212948|FG000|Overall Study|Lost to Follow-up|0|||
170782578|NCT05021640|617212949|FG001|Overall Study|Lost to Follow-up|0|||
170782579|NCT05021640|617212950|FG002|Overall Study|Lost to Follow-up|0|||
170782580|NCT05021640|617212951|FG003|Overall Study|Lost to Follow-up|0|||
170782581|NCT05021640|617212952|FG004|Overall Study|Lost to Follow-up|1|||
170782582|NCT04820855|617212953|FG000|Overall Study|Lost to Follow-up|6|||
170782583|NCT04820855|617212954|FG001|Overall Study|Lost to Follow-up|9|||
170782584|NCT04673929|617212955|FG000|Overall Study|Death|73|||
170782585|NCT04673929|617212955|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
170782586|NCT05633953|617212956|FG000|Overall Study|Adverse Event|7|||
170782587|NCT05633953|617212956|FG000|Overall Study|Death|30|||
170782588|NCT05633953|617212956|FG000|Overall Study|Lost to Follow-up|1|||
170782589|NCT05633953|617212956|FG000|Overall Study|Osilodrostat discontinued|4|||
170782590|NCT05633953|617212956|FG000|Overall Study|Physician Decision|1|||
170782591|NCT05633953|617212956|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
170782592|NCT05633953|617212956|FG000|Overall Study|Progressive disease|2|||
170782593|NCT04245501|617212971|FG000|Overall Study|Adverse Event|2|||
170782594|NCT04245501|617212972|FG001|Overall Study|Adverse Event|0|||
170782595|NCT04245501|617212971|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
170782596|NCT04245501|617212972|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
170782597|NCT03453619|617212976|FG000|Core Study (Part A)|Physician Decision|0|||
170782598|NCT03453619|617212977|FG001|Core Study (Part A)|Physician Decision|0|||
170782599|NCT03453619|617212978|FG002|Core Study (Part A)|Physician Decision|2|||
170782600|NCT03453619|617212979|FG003|Core Study (Part A)|Physician Decision|0|||
170782601|NCT03453619|617212976|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
170782602|NCT03453619|617212977|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
170782603|NCT03453619|617212978|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
170782604|NCT03453619|617212979|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
170782605|NCT03453619|617212976|FG000|Core Study (Part A)|Other|0|||
170782606|NCT03453619|617212977|FG001|Core Study (Part A)|Other|1|||
170782607|NCT03453619|617212978|FG002|Core Study (Part A)|Other|0|||
170782608|NCT03453619|617212979|FG003|Core Study (Part A)|Other|0|||
170883370|NCT03245450|617583144|FG006|Overall Study|Withdrawal by Subject|0|||
170883371|NCT03245450|617583138|FG000|Overall Study|Adverse Event|0|||
170883372|NCT03245450|617583139|FG001|Overall Study|Adverse Event|0|||
170883373|NCT03245450|617583140|FG002|Overall Study|Adverse Event|0|||
170883374|NCT03245450|617583141|FG003|Overall Study|Adverse Event|0|||
170883375|NCT03245450|617583142|FG004|Overall Study|Adverse Event|1|||
170883376|NCT03245450|617583143|FG005|Overall Study|Adverse Event|0|||
170883377|NCT03245450|617583144|FG006|Overall Study|Adverse Event|2|||
170883378|NCT05098041|617583145|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
170883379|NCT00705939|617583146|FG000|Overall Study|Protocol Violation|0|||
170883380|NCT00705939|617583147|FG001|Overall Study|Protocol Violation|0|||
170883381|NCT00705939|617583148|FG002|Overall Study|Protocol Violation|1|||
170883382|NCT00705939|617583146|FG000|Overall Study|Withdrawal by Subject|0|||
170883383|NCT00705939|617583147|FG001|Overall Study|Withdrawal by Subject|1|||
170883384|NCT00705939|617583148|FG002|Overall Study|Withdrawal by Subject|3|||
170883385|NCT00705939|617583146|FG000|Overall Study|Physician Decision|0|||
170883386|NCT00705939|617583147|FG001|Overall Study|Physician Decision|1|||
170883387|NCT00705939|617583148|FG002|Overall Study|Physician Decision|0|||
170883388|NCT02599961|617583149|FG000|Overall Study|Withdrawal by Subject|1|||
170883389|NCT02599961|617583149|FG000|Overall Study|Subject Non-Compliance|2|||
170883390|NCT02599961|617583149|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
170883391|NCT02599961|617583149|FG000|Overall Study|Other, Not Specified|3|||
170883392|NCT02941627|617583154|FG000|Overall Study|Death|1|||
170883393|NCT02941627|617583154|FG000|Overall Study|Surgical failure|1|||
170883394|NCT02941627|617583154|FG000|Overall Study|cholesteatoma prevented implantation|1|||
170883395|NCT02595723|617583155|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
170883396|NCT02595723|617583156|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
170883397|NCT02595723|617583157|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
170440130|NCT01453153|615951434|FG001|Overall Study|Physician Decision|0|||
170782609|NCT03453619|617212976|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
170782610|NCT03453619|617212977|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
170782611|NCT03453619|617212978|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
170782612|NCT03453619|617212979|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
170782613|NCT03453619|617212976|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
170782614|NCT03453619|617212977|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
170883398|NCT02595723|617583155|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
170883399|NCT02595723|617583156|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
170883400|NCT02595723|617583157|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
170883401|NCT01347554|617583158|FG000|Overall Study|Lack of Efficacy|7|||
170883402|NCT01347554|617583159|FG001|Overall Study|Lack of Efficacy|11|||
170883403|NCT00385255|617583164|FG000|Overall Study|Serious Adverse Event|1|||
170883404|NCT00385255|617583165|FG001|Overall Study|Serious Adverse Event|2|||
170883405|NCT00385255|617583164|FG000|Overall Study|Protocol Violation|0|||
170883406|NCT00385255|617583165|FG001|Overall Study|Protocol Violation|4|||
170883407|NCT00385255|617583164|FG000|Overall Study|Withdrawal by Subject|0|||
170883408|NCT00385255|617583165|FG001|Overall Study|Withdrawal by Subject|8|||
170883409|NCT00385255|617583164|FG000|Overall Study|Migrated/moved from study area|0|||
170883410|NCT00385255|617583165|FG001|Overall Study|Migrated/moved from study area|1|||
170883411|NCT00385255|617583164|FG000|Overall Study|Lost to Follow-up|20|||
170883412|NCT00385255|617583165|FG001|Overall Study|Lost to Follow-up|58|||
170883413|NCT01265550|617583166|FG000|Pre Randomization|Withdrawal by Subject|0|||
170883414|NCT01265550|617583167|FG001|Pre Randomization|Withdrawal by Subject|0|||
170883415|NCT01265550|617583168|FG002|Pre Randomization|Withdrawal by Subject|0|||
170883416|NCT01265550|617583169|FG003|Pre Randomization|Withdrawal by Subject|70|||
170883417|NCT01265550|617583166|FG000|Pre Randomization|Technical Exclusions|0|||
170883418|NCT01265550|617583167|FG001|Pre Randomization|Technical Exclusions|0|||
170883419|NCT01265550|617583168|FG002|Pre Randomization|Technical Exclusions|0|||
170883420|NCT01265550|617583169|FG003|Pre Randomization|Technical Exclusions|54|||
170883421|NCT01265550|617583166|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
170883422|NCT01265550|617583167|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
170883423|NCT01265550|617583168|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
170883424|NCT01265550|617583169|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
170883425|NCT01265550|617583166|FG000|Pre Randomization|Non-GERD organic disorders|0|||
170883426|NCT01265550|617583167|FG001|Pre Randomization|Non-GERD organic disorders|0|||
170883427|NCT01265550|617583168|FG002|Pre Randomization|Non-GERD organic disorders|0|||
170883428|NCT01265550|617583169|FG003|Pre Randomization|Non-GERD organic disorders|23|||
170883429|NCT01265550|617583166|FG000|Pre Randomization|Functional heartburn|0|||
170883430|NCT01265550|617583167|FG001|Pre Randomization|Functional heartburn|0|||
170883431|NCT01265550|617583168|FG002|Pre Randomization|Functional heartburn|0|||
170883432|NCT01265550|617583169|FG003|Pre Randomization|Functional heartburn|99|||
170883433|NCT00391222|617583173|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
170883434|NCT00391222|617583174|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
170883435|NCT00391222|617583175|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
170883436|NCT00391222|617583176|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
170883437|NCT00391222|617583173|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
170883438|NCT00391222|617583174|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
170883439|NCT00391222|617583175|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
170883440|NCT00391222|617583176|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
170883441|NCT00391222|617583173|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
170883442|NCT00391222|617583174|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
170883443|NCT00391222|617583175|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
170883444|NCT00391222|617583176|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
170883445|NCT00391222|617583173|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
170883446|NCT00391222|617583174|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
170883447|NCT00391222|617583175|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
170883448|NCT00391222|617583176|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
170883449|NCT00391222|617583173|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
170883450|NCT00391222|617583174|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
170883451|NCT00391222|617583175|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
170883452|NCT00391222|617583176|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
170883453|NCT00391222|617583173|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
170883454|NCT00391222|617583174|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
170883455|NCT00391222|617583175|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
170883456|NCT00391222|617583176|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
170883457|NCT00391222|617583173|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
170883458|NCT00391222|617583174|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
170883459|NCT00391222|617583175|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
170883460|NCT00391222|617583176|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
170883461|NCT00391222|617583173|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
170883462|NCT00391222|617583174|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
170883463|NCT00391222|617583175|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
170883464|NCT00391222|617583176|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
170883465|NCT00391222|617583173|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
170883466|NCT00391222|617583174|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
170883467|NCT00391222|617583175|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
170883468|NCT00391222|617583176|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
170883469|NCT00391222|617583173|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
170883470|NCT00391222|617583174|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
170440131|NCT01453153|615951435|FG002|Overall Study|Physician Decision|1|||
170440132|NCT01453153|615951433|FG000|Overall Study|Progressive Disease|3|||
170440133|NCT01453153|615951434|FG001|Overall Study|Progressive Disease|2|||
170440134|NCT01453153|615951435|FG002|Overall Study|Progressive Disease|16|||
170440135|NCT01453153|615951433|FG000|Overall Study|Withdrawal by Subject|0|||
170440136|NCT01453153|615951434|FG001|Overall Study|Withdrawal by Subject|1|||
170440137|NCT01453153|615951435|FG002|Overall Study|Withdrawal by Subject|2|||
170440138|NCT01453153|615951433|FG000|Overall Study|Adverse Event|1|||
170440139|NCT01453153|615951434|FG001|Overall Study|Adverse Event|1|||
170440140|NCT01453153|615951435|FG002|Overall Study|Adverse Event|1|||
170440141|NCT03547635|615951438|FG000|Overall Study|Adverse Event|5|||
170440142|NCT03547635|615951439|FG001|Overall Study|Adverse Event|2|||
170440143|NCT03547635|615951440|FG002|Overall Study|Adverse Event|3|||
170440144|NCT03547635|615951438|FG000|Overall Study|Lost to Follow-up|1|||
170440145|NCT03547635|615951439|FG001|Overall Study|Lost to Follow-up|3|||
170440146|NCT03547635|615951440|FG002|Overall Study|Lost to Follow-up|4|||
170440147|NCT03547635|615951438|FG000|Overall Study|Withdrawal by Subject|1|||
170440148|NCT03547635|615951439|FG001|Overall Study|Withdrawal by Subject|0|||
170440149|NCT03547635|615951440|FG002|Overall Study|Withdrawal by Subject|0|||
170440150|NCT03547635|615951438|FG000|Overall Study|Withdrawal By PI|0|||
170782615|NCT03453619|617212978|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
170782616|NCT03453619|617212979|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
170782617|NCT03453619|617212976|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
170782618|NCT03453619|617212977|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
170782619|NCT03453619|617212978|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
170782620|NCT03453619|617212979|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
170782621|NCT03453619|617212976|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
170782622|NCT03453619|617212977|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
170782623|NCT03453619|617212978|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
170782624|NCT03453619|617212979|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
170782625|NCT04541706|617212980|FG000|Overall Study|Withdrawal by Subject|3|||
170782626|NCT04541706|617212980|FG000|Overall Study|Progressive disease|33|||
170782627|NCT04541706|617212980|FG000|Overall Study|Physician Decision|1|||
170782628|NCT04541706|617212980|FG000|Overall Study|Lost to Follow-up|2|||
170782629|NCT04541706|617212980|FG000|Overall Study|Death|5|||
170782630|NCT04541706|617212980|FG000|Overall Study|Adverse Event|1|||
170782631|NCT05536440|617212981|FG000|Overall Study|Adverse Event|0|||
170782632|NCT05536440|617212982|FG001|Overall Study|Adverse Event|0|||
170782633|NCT05536440|617212983|FG002|Overall Study|Adverse Event|0|||
170782634|NCT05536440|617212984|FG003|Overall Study|Adverse Event|0|||
170782635|NCT05536440|617212985|FG004|Overall Study|Adverse Event|0|||
170782636|NCT05536440|617212986|FG005|Overall Study|Adverse Event|0|||
170782637|NCT05536440|617212987|FG006|Overall Study|Adverse Event|0|||
170782638|NCT05536440|617212988|FG007|Overall Study|Adverse Event|0|||
170782639|NCT05536440|617212989|FG008|Overall Study|Adverse Event|1|||
170782640|NCT01566695|617212990|FG000|Overall Study|Lack of Efficacy|1|||
170782641|NCT01566695|617212991|FG001|Overall Study|Lack of Efficacy|0|||
170782642|NCT01566695|617212990|FG000|Overall Study|Adverse Event|3|||
170782643|NCT01566695|617212991|FG001|Overall Study|Adverse Event|0|||
170782644|NCT01566695|617212990|FG000|Overall Study|Death|79|||
170782645|NCT01566695|617212991|FG001|Overall Study|Death|86|||
170782646|NCT01566695|617212990|FG000|Overall Study|Withdrawal by Subject|13|||
170782647|NCT01566695|617212991|FG001|Overall Study|Withdrawal by Subject|12|||
170782648|NCT01566695|617212990|FG000|Overall Study|Lost to Follow-up|0|||
170782649|NCT01566695|617212991|FG001|Overall Study|Lost to Follow-up|3|||
170782650|NCT01566695|617212990|FG000|Overall Study|Other reasons|11|||
170782651|NCT01566695|617212991|FG001|Overall Study|Other reasons|8|||
170782652|NCT01416831|617212993|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
170782653|NCT01416831|617212994|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
170782654|NCT05323084|617212995|FG000|Period 2 - Washout|Lost to Follow-up|0|||
170782655|NCT05323084|617212996|FG001|Period 2 - Washout|Lost to Follow-up|1|||
170782656|NCT01261312|617212999|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
170782657|NCT01261312|617213000|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
170782658|NCT01261312|617213001|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
170440151|NCT03547635|615951439|FG001|Overall Study|Withdrawal By PI|1|||
170440152|NCT03547635|615951440|FG002|Overall Study|Withdrawal By PI|0|||
170440153|NCT03547635|615951438|FG000|Overall Study|Withdrawal by Sponsor|0|||
170440154|NCT03547635|615951439|FG001|Overall Study|Withdrawal by Sponsor|0|||
170440155|NCT03547635|615951440|FG002|Overall Study|Withdrawal by Sponsor|1|||
170440156|NCT03547635|615951438|FG000|Overall Study|Errant Randomization before Treatment|0|||
170440157|NCT03547635|615951439|FG001|Overall Study|Errant Randomization before Treatment|1|||
170440158|NCT03547635|615951440|FG002|Overall Study|Errant Randomization before Treatment|0|||
170440159|NCT03547635|615951438|FG000|Overall Study|Withdrawal by Subject|1|||
170440160|NCT03547635|615951439|FG001|Overall Study|Withdrawal by Subject|0|||
170440161|NCT03547635|615951440|FG002|Overall Study|Withdrawal by Subject|0|||
170440162|NCT01636934|615951441|FG000|Overall Study|Withdrawal by Subject|3|||
170440163|NCT01636934|615951442|FG001|Overall Study|Withdrawal by Subject|2|||
170440164|NCT01636934|615951441|FG000|Overall Study|Chemo cancel|1|||
170440165|NCT01636934|615951442|FG001|Overall Study|Chemo cancel|0|||
170440166|NCT01636934|615951441|FG000|Overall Study|Too ill to continue|1|||
170440167|NCT01636934|615951442|FG001|Overall Study|Too ill to continue|0|||
170440168|NCT01636934|615951441|FG000|Overall Study|Never started study medication|1|||
170440169|NCT01636934|615951442|FG001|Overall Study|Never started study medication|1|||
170440170|NCT01120899|615951450|FG000|Overall Study|Withdrawal by Subject|3|||
170440171|NCT05480800|615951453|FG000|Overall Study|Withdrawal by Subject|0|||
170440172|NCT05480800|615951454|FG001|Overall Study|Withdrawal by Subject|0|||
170440173|NCT05480800|615951455|FG002|Overall Study|Withdrawal by Subject|2|||
170440174|NCT05480800|615951456|FG003|Overall Study|Withdrawal by Subject|1|||
170440175|NCT05480800|615951457|FG004|Overall Study|Withdrawal by Subject|0|||
170440176|NCT05480800|615951458|FG005|Overall Study|Withdrawal by Subject|0|||
170440177|NCT05480800|615951459|FG006|Overall Study|Withdrawal by Subject|1|||
170782659|NCT01261312|617213002|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782660|NCT01261312|617213003|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782661|NCT01261312|617213004|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782662|NCT01261312|617213005|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782663|NCT01261312|617213006|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782664|NCT01261312|617213007|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782665|NCT01261312|617213008|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782666|NCT01261312|617213009|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782667|NCT01261312|617213010|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782668|NCT01261312|617213011|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
170782669|NCT01261312|617212999|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
170782670|NCT01261312|617213000|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
170782671|NCT01261312|617213001|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782672|NCT01261312|617213002|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782673|NCT01261312|617213003|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782674|NCT01261312|617213004|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782675|NCT01261312|617213005|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782676|NCT01261312|617213006|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782677|NCT01261312|617213007|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782678|NCT01261312|617213008|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782679|NCT01261312|617213009|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782680|NCT01261312|617213010|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782681|NCT01261312|617213011|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
170782682|NCT01261312|617212999|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
170782683|NCT01261312|617213000|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
170782684|NCT01261312|617213001|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782685|NCT01261312|617213002|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782686|NCT01261312|617213003|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782687|NCT01261312|617213004|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782688|NCT01261312|617213005|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782689|NCT01261312|617213006|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782690|NCT01261312|617213007|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782691|NCT01261312|617213008|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782692|NCT01261312|617213009|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782693|NCT01261312|617213010|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782694|NCT01261312|617213011|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
170782695|NCT01261312|617212999|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
170782696|NCT01261312|617213000|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
170883471|NCT00391222|617583175|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
170883472|NCT00391222|617583176|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
170883473|NCT00391222|617583173|FG000|Period III (Double-Blind Treatment)|Other|6|||
170883474|NCT00391222|617583174|FG001|Period III (Double-Blind Treatment)|Other|1|||
170440178|NCT05480800|615951460|FG007|Overall Study|Withdrawal by Subject|0|||
170440179|NCT05480800|615951453|FG000|Overall Study|Other|0|||
170440180|NCT05480800|615951454|FG001|Overall Study|Other|0|||
170440181|NCT05480800|615951455|FG002|Overall Study|Other|0|||
170440182|NCT05480800|615951456|FG003|Overall Study|Other|0|||
170440183|NCT05480800|615951457|FG004|Overall Study|Other|0|||
170440184|NCT05480800|615951458|FG005|Overall Study|Other|0|||
170440185|NCT05480800|615951459|FG006|Overall Study|Other|1|||
170440186|NCT05480800|615951460|FG007|Overall Study|Other|0|||
170440187|NCT01151280|615951463|FG000|Overall Study|Adverse Event|1|||
170440188|NCT01151280|615951463|FG000|Overall Study|Lack of Efficacy|3|||
170440189|NCT00377156|615951464|FG000|Overall Study|Death|23|||
170440190|NCT00377156|615951465|FG001|Overall Study|Death|19|||
170782697|NCT01261312|617213001|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170440191|NCT00377156|615951464|FG000|Overall Study|Withdrawal by Subject|16|||
170440192|NCT00377156|615951465|FG001|Overall Study|Withdrawal by Subject|24|||
170440193|NCT00377156|615951464|FG000|Overall Study|Had follow-up <90 d|3|||
170782698|NCT01261312|617213002|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782699|NCT01261312|617213003|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782700|NCT01261312|617213004|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782701|NCT01261312|617213005|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782702|NCT01261312|617213006|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782703|NCT01261312|617213007|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782704|NCT01261312|617213008|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782705|NCT01261312|617213009|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782706|NCT01261312|617213010|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782707|NCT01261312|617213011|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
170782708|NCT01261312|617212999|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
170782709|NCT01261312|617213000|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
170782710|NCT01261312|617213001|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
170782711|NCT01261312|617213002|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782712|NCT01261312|617213003|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782713|NCT01261312|617213004|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782714|NCT01261312|617213005|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782715|NCT01261312|617213006|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782716|NCT01261312|617213007|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782717|NCT01261312|617213008|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782718|NCT01261312|617213009|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782719|NCT01261312|617213010|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782720|NCT01261312|617213011|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
170782721|NCT01261312|617212999|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
170782722|NCT01261312|617213000|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
170782723|NCT01261312|617213001|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
170782724|NCT01261312|617213002|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782725|NCT01261312|617213003|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170440194|NCT00377156|615951465|FG001|Overall Study|Had follow-up <90 d|6|||
170440195|NCT00377156|615951464|FG000|Overall Study|Cancellation|1|||
170440196|NCT00377156|615951465|FG001|Overall Study|Cancellation|0|||
170440197|NCT00377156|615951464|FG000|Overall Study|Refused testing|0|||
170883475|NCT00391222|617583175|FG002|Period III (Double-Blind Treatment)|Other|6|||
170883476|NCT00391222|617583176|FG003|Period III (Double-Blind Treatment)|Other|0|||
170883477|NCT01627860|617583177|FG000|Overall Study|Adverse Event|9|||
170883478|NCT01627860|617583178|FG001|Overall Study|Adverse Event|4|||
170883479|NCT01627860|617583177|FG000|Overall Study|Withdrawal by Subject|2|||
170883480|NCT01627860|617583178|FG001|Overall Study|Withdrawal by Subject|1|||
170883481|NCT01627860|617583177|FG000|Overall Study|Seizure frequency doubled|0|||
170883482|NCT01627860|617583178|FG001|Overall Study|Seizure frequency doubled|1|||
170883483|NCT01627860|617583177|FG000|Overall Study|Protocol Violation|1|||
170883484|NCT01627860|617583178|FG001|Overall Study|Protocol Violation|0|||
170883485|NCT01225731|617583179|FG000|Part 1|Did not meet eligibility criteria|1|||
170883486|NCT01225731|617583180|FG001|Part 1|Did not meet eligibility criteria|0|||
170883487|NCT01225731|617583181|FG002|Part 1|Did not meet eligibility criteria|0|||
170883488|NCT01225731|617583182|FG003|Part 1|Did not meet eligibility criteria|0|||
170883489|NCT01225731|617583183|FG004|Part 1|Did not meet eligibility criteria|1|||
170883490|NCT01225731|617583184|FG005|Part 1|Did not meet eligibility criteria|0|||
170883491|NCT01225731|617583185|FG006|Part 1|Did not meet eligibility criteria|0|||
170883492|NCT01225731|617583186|FG007|Part 1|Did not meet eligibility criteria|0|||
170883493|NCT01225731|617583187|FG008|Part 1|Did not meet eligibility criteria|0|||
170883494|NCT01225731|617583188|FG009|Part 1|Did not meet eligibility criteria|0|||
170883495|NCT01225731|617583189|FG010|Part 1|Did not meet eligibility criteria|0|||
170883496|NCT01225731|617583190|FG011|Part 1|Did not meet eligibility criteria|0|||
170883497|NCT01225731|617583191|FG012|Part 1|Did not meet eligibility criteria|0|||
170883498|NCT01225731|617583179|FG000|Part 1|Adverse Event|1|||
170883499|NCT01225731|617583180|FG001|Part 1|Adverse Event|2|||
170883500|NCT01225731|617583181|FG002|Part 1|Adverse Event|1|||
170883501|NCT01225731|617583182|FG003|Part 1|Adverse Event|1|||
170883502|NCT01225731|617583183|FG004|Part 1|Adverse Event|1|||
170883503|NCT01225731|617583184|FG005|Part 1|Adverse Event|0|||
170883504|NCT01225731|617583185|FG006|Part 1|Adverse Event|0|||
170883505|NCT01225731|617583186|FG007|Part 1|Adverse Event|0|||
170883506|NCT01225731|617583187|FG008|Part 1|Adverse Event|0|||
170883507|NCT01225731|617583188|FG009|Part 1|Adverse Event|0|||
170883508|NCT01225731|617583189|FG010|Part 1|Adverse Event|0|||
170883509|NCT01225731|617583190|FG011|Part 1|Adverse Event|0|||
170883510|NCT01225731|617583191|FG012|Part 1|Adverse Event|0|||
170883511|NCT01225731|617583179|FG000|Part 1|Withdrawal by Subject|0|||
170883512|NCT01225731|617583180|FG001|Part 1|Withdrawal by Subject|3|||
170883513|NCT01225731|617583181|FG002|Part 1|Withdrawal by Subject|0|||
170883514|NCT01225731|617583182|FG003|Part 1|Withdrawal by Subject|0|||
170883515|NCT01225731|617583183|FG004|Part 1|Withdrawal by Subject|4|||
170883516|NCT01225731|617583184|FG005|Part 1|Withdrawal by Subject|0|||
170883517|NCT01225731|617583185|FG006|Part 1|Withdrawal by Subject|0|||
170883518|NCT01225731|617583186|FG007|Part 1|Withdrawal by Subject|0|||
170883519|NCT01225731|617583187|FG008|Part 1|Withdrawal by Subject|0|||
170883520|NCT01225731|617583188|FG009|Part 1|Withdrawal by Subject|0|||
170883521|NCT01225731|617583189|FG010|Part 1|Withdrawal by Subject|0|||
170883522|NCT01225731|617583190|FG011|Part 1|Withdrawal by Subject|0|||
170883523|NCT01225731|617583191|FG012|Part 1|Withdrawal by Subject|0|||
170883524|NCT01225731|617583179|FG000|Part 1|Protocol Violation|0|||
170883525|NCT01225731|617583180|FG001|Part 1|Protocol Violation|0|||
170883526|NCT01225731|617583181|FG002|Part 1|Protocol Violation|0|||
170883527|NCT01225731|617583182|FG003|Part 1|Protocol Violation|1|||
170883528|NCT01225731|617583183|FG004|Part 1|Protocol Violation|0|||
170883529|NCT01225731|617583184|FG005|Part 1|Protocol Violation|0|||
170883530|NCT01225731|617583185|FG006|Part 1|Protocol Violation|0|||
170883531|NCT01225731|617583186|FG007|Part 1|Protocol Violation|0|||
170883532|NCT01225731|617583187|FG008|Part 1|Protocol Violation|0|||
170883533|NCT01225731|617583188|FG009|Part 1|Protocol Violation|0|||
170883534|NCT01225731|617583189|FG010|Part 1|Protocol Violation|0|||
170883535|NCT01225731|617583190|FG011|Part 1|Protocol Violation|0|||
170883536|NCT01225731|617583191|FG012|Part 1|Protocol Violation|0|||
170883537|NCT01225731|617583179|FG000|Part 2|Protocol Violation|0|||
170537179|NCT04092777|616311547|FG001|Overall Study|Withdrawal by Subject|5|||
170883538|NCT01225731|617583180|FG001|Part 2|Protocol Violation|0|||
170883539|NCT01225731|617583181|FG002|Part 2|Protocol Violation|0|||
170883540|NCT01225731|617583182|FG003|Part 2|Protocol Violation|0|||
170883541|NCT01225731|617583183|FG004|Part 2|Protocol Violation|0|||
170883542|NCT01225731|617583184|FG005|Part 2|Protocol Violation|1|||
170883543|NCT01225731|617583185|FG006|Part 2|Protocol Violation|0|||
170883544|NCT01225731|617583186|FG007|Part 2|Protocol Violation|0|||
170883545|NCT01225731|617583187|FG008|Part 2|Protocol Violation|1|||
170883546|NCT01225731|617583188|FG009|Part 2|Protocol Violation|0|||
170883547|NCT01225731|617583189|FG010|Part 2|Protocol Violation|0|||
170883548|NCT01225731|617583190|FG011|Part 2|Protocol Violation|0|||
170883549|NCT01225731|617583191|FG012|Part 2|Protocol Violation|0|||
170883550|NCT01225731|617583179|FG000|Part 2|Adverse Event|0|||
170883551|NCT01225731|617583180|FG001|Part 2|Adverse Event|0|||
170883552|NCT01225731|617583181|FG002|Part 2|Adverse Event|0|||
170883553|NCT01225731|617583182|FG003|Part 2|Adverse Event|0|||
170883554|NCT01225731|617583183|FG004|Part 2|Adverse Event|0|||
170883555|NCT01225731|617583184|FG005|Part 2|Adverse Event|0|||
170883556|NCT01225731|617583185|FG006|Part 2|Adverse Event|4|||
170883557|NCT01225731|617583186|FG007|Part 2|Adverse Event|4|||
170883558|NCT01225731|617583187|FG008|Part 2|Adverse Event|2|||
170883559|NCT01225731|617583188|FG009|Part 2|Adverse Event|0|||
170883560|NCT01225731|617583189|FG010|Part 2|Adverse Event|0|||
170883561|NCT01225731|617583190|FG011|Part 2|Adverse Event|0|||
170883562|NCT01225731|617583191|FG012|Part 2|Adverse Event|0|||
170883563|NCT01225731|617583179|FG000|Part 2|Lack of Efficacy|0|||
170883564|NCT01225731|617583180|FG001|Part 2|Lack of Efficacy|0|||
170883565|NCT01225731|617583181|FG002|Part 2|Lack of Efficacy|0|||
170883566|NCT01225731|617583182|FG003|Part 2|Lack of Efficacy|0|||
170883567|NCT01225731|617583183|FG004|Part 2|Lack of Efficacy|0|||
170883568|NCT01225731|617583184|FG005|Part 2|Lack of Efficacy|1|||
170883569|NCT01225731|617583185|FG006|Part 2|Lack of Efficacy|0|||
170883570|NCT01225731|617583186|FG007|Part 2|Lack of Efficacy|12|||
170883571|NCT01225731|617583187|FG008|Part 2|Lack of Efficacy|3|||
170883572|NCT01225731|617583188|FG009|Part 2|Lack of Efficacy|0|||
170883573|NCT01225731|617583189|FG010|Part 2|Lack of Efficacy|0|||
170883574|NCT01225731|617583190|FG011|Part 2|Lack of Efficacy|0|||
170883575|NCT01225731|617583191|FG012|Part 2|Lack of Efficacy|0|||
170883576|NCT01225731|617583179|FG000|Part 2|Pregnancy|0|||
170883577|NCT01225731|617583180|FG001|Part 2|Pregnancy|0|||
170883578|NCT01225731|617583181|FG002|Part 2|Pregnancy|0|||
170883579|NCT01225731|617583182|FG003|Part 2|Pregnancy|0|||
170883580|NCT01225731|617583183|FG004|Part 2|Pregnancy|0|||
170883581|NCT01225731|617583184|FG005|Part 2|Pregnancy|0|||
170883582|NCT01225731|617583185|FG006|Part 2|Pregnancy|1|||
170883583|NCT01225731|617583186|FG007|Part 2|Pregnancy|0|||
170883584|NCT01225731|617583187|FG008|Part 2|Pregnancy|1|||
170883585|NCT01225731|617583188|FG009|Part 2|Pregnancy|0|||
170883586|NCT01225731|617583189|FG010|Part 2|Pregnancy|0|||
170883587|NCT01225731|617583190|FG011|Part 2|Pregnancy|0|||
170883588|NCT01225731|617583191|FG012|Part 2|Pregnancy|0|||
170883589|NCT01225731|617583179|FG000|Part 2|Lost to Follow-up|0|||
170883590|NCT01225731|617583180|FG001|Part 2|Lost to Follow-up|0|||
170883591|NCT01225731|617583181|FG002|Part 2|Lost to Follow-up|0|||
170883592|NCT01225731|617583182|FG003|Part 2|Lost to Follow-up|0|||
170883593|NCT01225731|617583183|FG004|Part 2|Lost to Follow-up|0|||
170883594|NCT01225731|617583184|FG005|Part 2|Lost to Follow-up|0|||
170883595|NCT01225731|617583185|FG006|Part 2|Lost to Follow-up|0|||
170883596|NCT01225731|617583186|FG007|Part 2|Lost to Follow-up|3|||
170883597|NCT01225731|617583187|FG008|Part 2|Lost to Follow-up|1|||
170883598|NCT01225731|617583188|FG009|Part 2|Lost to Follow-up|0|||
170883599|NCT01225731|617583189|FG010|Part 2|Lost to Follow-up|0|||
170883600|NCT01225731|617583190|FG011|Part 2|Lost to Follow-up|0|||
170883601|NCT01225731|617583191|FG012|Part 2|Lost to Follow-up|0|||
170883602|NCT01225731|617583179|FG000|Part 2|Physician Decision|0|||
170883603|NCT01225731|617583180|FG001|Part 2|Physician Decision|0|||
170883604|NCT01225731|617583181|FG002|Part 2|Physician Decision|0|||
170883605|NCT01225731|617583182|FG003|Part 2|Physician Decision|0|||
170883606|NCT01225731|617583183|FG004|Part 2|Physician Decision|0|||
170883607|NCT01225731|617583184|FG005|Part 2|Physician Decision|0|||
170883608|NCT01225731|617583185|FG006|Part 2|Physician Decision|0|||
170883609|NCT01225731|617583186|FG007|Part 2|Physician Decision|2|||
170883610|NCT01225731|617583187|FG008|Part 2|Physician Decision|2|||
170883611|NCT01225731|617583188|FG009|Part 2|Physician Decision|0|||
170883612|NCT01225731|617583189|FG010|Part 2|Physician Decision|0|||
170883613|NCT01225731|617583190|FG011|Part 2|Physician Decision|0|||
170883614|NCT01225731|617583191|FG012|Part 2|Physician Decision|0|||
170883615|NCT01225731|617583179|FG000|Part 2|Withdrawal by Subject|0|||
170883616|NCT01225731|617583180|FG001|Part 2|Withdrawal by Subject|0|||
170883617|NCT01225731|617583181|FG002|Part 2|Withdrawal by Subject|0|||
170883618|NCT01225731|617583182|FG003|Part 2|Withdrawal by Subject|0|||
170883619|NCT01225731|617583183|FG004|Part 2|Withdrawal by Subject|0|||
170883620|NCT01225731|617583184|FG005|Part 2|Withdrawal by Subject|1|||
170883621|NCT01225731|617583185|FG006|Part 2|Withdrawal by Subject|3|||
170883622|NCT01225731|617583186|FG007|Part 2|Withdrawal by Subject|4|||
170883623|NCT01225731|617583187|FG008|Part 2|Withdrawal by Subject|1|||
170883624|NCT01225731|617583188|FG009|Part 2|Withdrawal by Subject|0|||
170883625|NCT01225731|617583189|FG010|Part 2|Withdrawal by Subject|0|||
170883626|NCT01225731|617583190|FG011|Part 2|Withdrawal by Subject|0|||
170883627|NCT01225731|617583191|FG012|Part 2|Withdrawal by Subject|0|||
170883628|NCT01225731|617583179|FG000|Part 3|Adverse Event|0|||
170883629|NCT01225731|617583180|FG001|Part 3|Adverse Event|0|||
170883630|NCT01225731|617583181|FG002|Part 3|Adverse Event|0|||
170883631|NCT01225731|617583182|FG003|Part 3|Adverse Event|0|||
170883632|NCT01225731|617583183|FG004|Part 3|Adverse Event|0|||
170883633|NCT01225731|617583184|FG005|Part 3|Adverse Event|0|||
170883634|NCT01225731|617583185|FG006|Part 3|Adverse Event|0|||
170883635|NCT01225731|617583186|FG007|Part 3|Adverse Event|0|||
170883636|NCT01225731|617583187|FG008|Part 3|Adverse Event|0|||
170883637|NCT01225731|617583188|FG009|Part 3|Adverse Event|0|||
170883638|NCT01225731|617583189|FG010|Part 3|Adverse Event|1|||
170883639|NCT01225731|617583190|FG011|Part 3|Adverse Event|1|||
170883640|NCT01225731|617583191|FG012|Part 3|Adverse Event|0|||
170883641|NCT01225731|617583179|FG000|Part 3|Lost to Follow-up|0|||
170883642|NCT01225731|617583180|FG001|Part 3|Lost to Follow-up|0|||
170883643|NCT01225731|617583181|FG002|Part 3|Lost to Follow-up|0|||
170883644|NCT01225731|617583182|FG003|Part 3|Lost to Follow-up|0|||
170883645|NCT01225731|617583183|FG004|Part 3|Lost to Follow-up|0|||
170883646|NCT01225731|617583184|FG005|Part 3|Lost to Follow-up|0|||
170883647|NCT01225731|617583185|FG006|Part 3|Lost to Follow-up|0|||
170883648|NCT01225731|617583186|FG007|Part 3|Lost to Follow-up|0|||
170883649|NCT01225731|617583187|FG008|Part 3|Lost to Follow-up|0|||
170883650|NCT01225731|617583188|FG009|Part 3|Lost to Follow-up|0|||
170883651|NCT01225731|617583189|FG010|Part 3|Lost to Follow-up|1|||
170883652|NCT01225731|617583190|FG011|Part 3|Lost to Follow-up|2|||
170883653|NCT01225731|617583191|FG012|Part 3|Lost to Follow-up|1|||
170883654|NCT01225731|617583179|FG000|Part 3|Physician Decision|0|||
170883655|NCT01225731|617583180|FG001|Part 3|Physician Decision|0|||
170883656|NCT01225731|617583181|FG002|Part 3|Physician Decision|0|||
170883657|NCT01225731|617583182|FG003|Part 3|Physician Decision|0|||
170883658|NCT01225731|617583183|FG004|Part 3|Physician Decision|0|||
170883659|NCT01225731|617583184|FG005|Part 3|Physician Decision|0|||
170883660|NCT01225731|617583185|FG006|Part 3|Physician Decision|0|||
170883661|NCT01225731|617583186|FG007|Part 3|Physician Decision|0|||
170883662|NCT01225731|617583187|FG008|Part 3|Physician Decision|0|||
170883663|NCT01225731|617583188|FG009|Part 3|Physician Decision|0|||
170883664|NCT01225731|617583189|FG010|Part 3|Physician Decision|0|||
170883665|NCT01225731|617583190|FG011|Part 3|Physician Decision|1|||
170883666|NCT01225731|617583191|FG012|Part 3|Physician Decision|2|||
170883667|NCT01225731|617583179|FG000|Part 3|Withdrawal by Subject|0|||
170883668|NCT01225731|617583180|FG001|Part 3|Withdrawal by Subject|0|||
170440198|NCT00377156|615951465|FG001|Overall Study|Refused testing|1|||
170440199|NCT00377156|615951464|FG000|Overall Study|Ineligible|0|||
170440200|NCT00377156|615951465|FG001|Overall Study|Ineligible|1|||
170440201|NCT00377156|615951464|FG000|Overall Study|Disability or language problem|0|||
170440202|NCT00377156|615951465|FG001|Overall Study|Disability or language problem|1|||
170440203|NCT00377156|615951464|FG000|Overall Study|Other|5|||
170440204|NCT00377156|615951465|FG001|Overall Study|Other|2|||
170440205|NCT00522041|615951466|FG000|Overall Study|Adverse Event|9|||
170440206|NCT00522041|615951467|FG001|Overall Study|Adverse Event|3|||
170782726|NCT01261312|617213004|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782727|NCT01261312|617213005|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782728|NCT01261312|617213006|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782729|NCT01261312|617213007|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782730|NCT01261312|617213008|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782731|NCT01261312|617213009|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782732|NCT01261312|617213010|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782733|NCT01261312|617213011|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
170782734|NCT01261312|617212999|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
170782735|NCT01261312|617213000|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782736|NCT01261312|617213001|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
170782737|NCT01261312|617213002|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782738|NCT01261312|617213003|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782739|NCT01261312|617213004|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782740|NCT01261312|617213005|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782741|NCT01261312|617213006|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782742|NCT01261312|617213007|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782743|NCT01261312|617213008|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782744|NCT01261312|617213009|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782745|NCT01261312|617213010|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782746|NCT01261312|617213011|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
170782747|NCT01261312|617212999|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170883669|NCT01225731|617583181|FG002|Part 3|Withdrawal by Subject|0|||
170883670|NCT01225731|617583182|FG003|Part 3|Withdrawal by Subject|0|||
170883671|NCT01225731|617583183|FG004|Part 3|Withdrawal by Subject|0|||
170883672|NCT01225731|617583184|FG005|Part 3|Withdrawal by Subject|0|||
170883673|NCT01225731|617583185|FG006|Part 3|Withdrawal by Subject|0|||
170883674|NCT01225731|617583186|FG007|Part 3|Withdrawal by Subject|0|||
170883675|NCT01225731|617583187|FG008|Part 3|Withdrawal by Subject|0|||
170883676|NCT01225731|617583188|FG009|Part 3|Withdrawal by Subject|0|||
170883677|NCT01225731|617583189|FG010|Part 3|Withdrawal by Subject|4|||
170883678|NCT01225731|617583190|FG011|Part 3|Withdrawal by Subject|6|||
170883679|NCT01225731|617583191|FG012|Part 3|Withdrawal by Subject|4|||
170883680|NCT00577642|617583192|FG000|Overall Study|Clinical Disease Progression|1|||
170883681|NCT02054897|617583197|FG000|Overall Study|Withdrawal by Subject|2|||
170883682|NCT02054897|617583198|FG001|Overall Study|Withdrawal by Subject|0|||
170883683|NCT02054897|617583199|FG002|Overall Study|Withdrawal by Subject|2|||
170440207|NCT00522041|615951466|FG000|Overall Study|Protocol Violation|2|||
170440208|NCT00522041|615951467|FG001|Overall Study|Protocol Violation|0|||
170440209|NCT00522041|615951466|FG000|Overall Study|Lost to Follow-up|1|||
170883684|NCT02054897|617583197|FG000|Overall Study|Missing follow-up information|3|||
170883685|NCT02054897|617583198|FG001|Overall Study|Missing follow-up information|5|||
170883686|NCT02054897|617583199|FG002|Overall Study|Missing follow-up information|3|||
170883687|NCT02054897|617583197|FG000|Overall Study|Lost to Follow-up|4|||
170883688|NCT02054897|617583198|FG001|Overall Study|Lost to Follow-up|2|||
170883689|NCT02054897|617583199|FG002|Overall Study|Lost to Follow-up|7|||
170883690|NCT02054897|617583197|FG000|Overall Study|Randomized but not exposed|1|||
170883691|NCT02054897|617583198|FG001|Overall Study|Randomized but not exposed|0|||
170883692|NCT02054897|617583199|FG002|Overall Study|Randomized but not exposed|0|||
170883693|NCT00889265|617583200|FG000|Overall Study|Adverse Event|1|||
170782748|NCT01261312|617213000|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170883694|NCT00889265|617583200|FG000|Overall Study|Lost to Follow-up|5|||
170883695|NCT00889265|617583200|FG000|Overall Study|Protocol Violation|1|||
170883696|NCT00254501|617583203|FG000|Overall Study|Lost to Follow-up|1|||
170883697|NCT00254501|617583204|FG001|Overall Study|Lost to Follow-up|1|||
170883698|NCT02788747|617583205|FG000|Overall Study|Adverse Event|1|||
170883699|NCT02788747|617583206|FG001|Overall Study|Adverse Event|0|||
170883700|NCT02788747|617583207|FG002|Overall Study|Adverse Event|0|||
170883701|NCT01967550|617583208|FG000|Overall Study|Withdrawal by Subject|1|||
170883702|NCT01967550|617583209|FG001|Overall Study|Withdrawal by Subject|0|||
170883703|NCT01967550|617583208|FG000|Overall Study|Adverse Event|2|||
170883704|NCT01967550|617583209|FG001|Overall Study|Adverse Event|0|||
170883705|NCT01967550|617583208|FG000|Overall Study|Protocol Violation|2|||
170883706|NCT01967550|617583209|FG001|Overall Study|Protocol Violation|1|||
170883707|NCT01967550|617583208|FG000|Overall Study|Non Compliance|0|||
170883708|NCT01967550|617583209|FG001|Overall Study|Non Compliance|1|||
170883709|NCT00317109|617583212|FG000|Overall Study|Withdrawal by Subject|2|||
170883710|NCT00317109|617583213|FG001|Overall Study|Withdrawal by Subject|0|||
170883711|NCT00317109|617583212|FG000|Overall Study|Migated/moved from study area|1|||
170883712|NCT00317109|617583213|FG001|Overall Study|Migated/moved from study area|0|||
170883713|NCT01508702|617583217|FG000|Overall Study|Adverse Event|7|||
170883714|NCT01508702|617583218|FG001|Overall Study|Adverse Event|3|||
170883715|NCT01508702|617583217|FG000|Overall Study|Gout flare|2|||
170883716|NCT01508702|617583218|FG001|Overall Study|Gout flare|0|||
170883717|NCT01508702|617583217|FG000|Overall Study|Protocol Violation|2|||
170782749|NCT01261312|617213001|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170782750|NCT01261312|617213002|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
170782751|NCT01261312|617213003|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
170782752|NCT01261312|617213004|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
170782753|NCT01261312|617213005|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170782754|NCT01261312|617213006|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170782755|NCT01261312|617213007|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170782756|NCT01261312|617213008|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170782757|NCT01261312|617213009|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170782758|NCT01261312|617213010|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170782759|NCT01261312|617213011|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
170782760|NCT01261312|617212999|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170883718|NCT01508702|617583218|FG001|Overall Study|Protocol Violation|1|||
170883719|NCT01508702|617583217|FG000|Overall Study|Lost to Follow-up|1|||
170883720|NCT01508702|617583218|FG001|Overall Study|Lost to Follow-up|2|||
170883721|NCT01508702|617583217|FG000|Overall Study|Withdrawal by Subject|11|||
170883722|NCT01508702|617583218|FG001|Overall Study|Withdrawal by Subject|7|||
170883723|NCT04472429|617583219|FG000|Randomized Period|Ongoing|90|||
170883724|NCT04472429|617583220|FG001|Randomized Period|Ongoing|40|||
170440210|NCT00522041|615951467|FG001|Overall Study|Lost to Follow-up|4|||
170883725|NCT04472429|617583221|FG002|Randomized Period|Ongoing|0|||
170883726|NCT04472429|617583219|FG000|Randomized Period|Death|52|||
170883727|NCT04472429|617583220|FG001|Randomized Period|Death|37|||
170883728|NCT04472429|617583221|FG002|Randomized Period|Death|0|||
170883729|NCT04472429|617583219|FG000|Randomized Period|Lost to Follow-up|4|||
170883730|NCT04472429|617583220|FG001|Randomized Period|Lost to Follow-up|0|||
170883731|NCT04472429|617583221|FG002|Randomized Period|Lost to Follow-up|0|||
170883732|NCT04472429|617583219|FG000|Randomized Period|Physician Decision|1|||
170883733|NCT04472429|617583220|FG001|Randomized Period|Physician Decision|2|||
170883734|NCT04472429|617583221|FG002|Randomized Period|Physician Decision|0|||
170883735|NCT04472429|617583219|FG000|Randomized Period|Withdrawal by Subject|6|||
170883736|NCT04472429|617583220|FG001|Randomized Period|Withdrawal by Subject|5|||
170883737|NCT04472429|617583221|FG002|Randomized Period|Withdrawal by Subject|0|||
170883738|NCT04472429|617583219|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
170883739|NCT04472429|617583220|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
170883740|NCT04472429|617583221|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
170883741|NCT04472429|617583219|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
170883742|NCT04472429|617583220|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
170883743|NCT04472429|617583221|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
170883744|NCT04472429|617583219|FG000|Open-label Monotherapy Period|Ongoing|0|||
170883745|NCT04472429|617583220|FG001|Open-label Monotherapy Period|Ongoing|0|||
170883746|NCT04472429|617583221|FG002|Open-label Monotherapy Period|Ongoing|32|||
170883747|NCT04472429|617583219|FG000|Open-label Monotherapy Period|Death|0|||
170883748|NCT04472429|617583220|FG001|Open-label Monotherapy Period|Death|0|||
170883749|NCT04472429|617583221|FG002|Open-label Monotherapy Period|Death|35|||
170883750|NCT04472429|617583219|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
170883751|NCT04472429|617583220|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
170883752|NCT04472429|617583221|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
170883753|NCT00250835|617583222|FG000|Overall Study|Withdrawal by Subject|1|||
170883754|NCT03461757|617583223|FG000|Overall Study|Adverse Event|1|||
170883755|NCT03461757|617583224|FG001|Overall Study|Adverse Event|0|||
170883756|NCT03461757|617583223|FG000|Overall Study|Lost to Follow-up|13|||
170883757|NCT03461757|617583224|FG001|Overall Study|Lost to Follow-up|7|||
170883758|NCT03461757|617583223|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
170883759|NCT03461757|617583224|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
170883760|NCT03461757|617583223|FG000|Overall Study|Non-compliance with study treatment|0|||
170883761|NCT03461757|617583224|FG001|Overall Study|Non-compliance with study treatment|1|||
170883762|NCT03461757|617583223|FG000|Overall Study|Pregnancy|2|||
170883763|NCT03461757|617583224|FG001|Overall Study|Pregnancy|0|||
170883764|NCT03461757|617583223|FG000|Overall Study|Protocol Violation|1|||
170883765|NCT03461757|617583224|FG001|Overall Study|Protocol Violation|1|||
170883766|NCT03461757|617583223|FG000|Overall Study|Withdrawal by Subject|7|||
170883767|NCT03461757|617583224|FG001|Overall Study|Withdrawal by Subject|7|||
170883768|NCT03461757|617583223|FG000|Overall Study|Other Reasons|1|||
170883769|NCT03461757|617583224|FG001|Overall Study|Other Reasons|4|||
170883770|NCT02425826|617583225|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
170883771|NCT02425826|617583226|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
170883772|NCT02425826|617583227|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
170883773|NCT02425826|617583225|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
170883774|NCT02425826|617583226|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
170883775|NCT02425826|617583227|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
170883776|NCT02425826|617583225|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
170883777|NCT02425826|617583226|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
170883778|NCT02425826|617583227|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
170883779|NCT02425826|617583225|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
170883780|NCT02425826|617583226|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
170883781|NCT02425826|617583227|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
170883782|NCT02425826|617583225|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
170883783|NCT02425826|617583226|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
170883784|NCT02425826|617583227|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
170883785|NCT02425826|617583225|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
170883786|NCT02425826|617583226|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
170883787|NCT02425826|617583227|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
170883788|NCT02425826|617583225|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
170883789|NCT02425826|617583226|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
170883790|NCT02425826|617583227|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
170883791|NCT02425826|617583225|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
170883792|NCT02425826|617583226|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
170883793|NCT02425826|617583227|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
170883794|NCT02425826|617583225|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
170883795|NCT02425826|617583226|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
170883796|NCT02425826|617583227|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
170883797|NCT02425826|617583225|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
170883798|NCT02425826|617583226|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
170883799|NCT02425826|617583227|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
170883800|NCT03861559|617583229|FG000|Overall Study|Adverse Event|0|||
170883801|NCT03861559|617583230|FG001|Overall Study|Adverse Event|2|||
170883802|NCT03861559|617583229|FG000|Overall Study|Treatment failure|0|||
170883803|NCT03861559|617583230|FG001|Overall Study|Treatment failure|2|||
170883804|NCT03861559|617583229|FG000|Overall Study|Noncompliance|1|||
170883805|NCT03861559|617583230|FG001|Overall Study|Noncompliance|1|||
170883806|NCT03861559|617583229|FG000|Overall Study|Did not meet eligibility requirements|1|||
170883807|NCT03861559|617583230|FG001|Overall Study|Did not meet eligibility requirements|0|||
170883808|NCT02500121|617583233|FG000|Overall Study|Lost to Follow-up|0|||
170883809|NCT02500121|617583234|FG001|Overall Study|Lost to Follow-up|1|||
170883810|NCT02500121|617583233|FG000|Overall Study|Withdrawal by Subject|1|||
170883811|NCT02500121|617583234|FG001|Overall Study|Withdrawal by Subject|1|||
170883812|NCT02500121|617583233|FG000|Overall Study|Death|26|||
170883813|NCT02500121|617583234|FG001|Overall Study|Death|24|||
170883814|NCT03315871|617583236|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
170883815|NCT03315871|617583237|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
170883816|NCT03315871|617583238|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
170883817|NCT03315871|617583236|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
170883818|NCT03315871|617583237|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
170883819|NCT03315871|617583238|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
170883820|NCT03315871|617583236|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
170883821|NCT03315871|617583237|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
170883822|NCT03315871|617583238|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
170883823|NCT03315871|617583236|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
170883824|NCT03315871|617583237|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
170883825|NCT03315871|617583238|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
170883826|NCT03315871|617583236|FG000|PROSTVAC + CV301|Progressive disease|0|||
170883827|NCT03315871|617583237|FG001|PROSTVAC + CV301|Progressive disease|0|||
170883828|NCT03315871|617583238|FG002|PROSTVAC + CV301|Progressive disease|1|||
170883829|NCT03315871|617583236|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
170883830|NCT03315871|617583237|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
170883831|NCT03315871|617583238|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
170440211|NCT00522041|615951466|FG000|Overall Study|Voluntary withdrawal|5|||
170883832|NCT03368170|617585026|FG000|Overall Study|Adverse Event|2|||
170883833|NCT03368170|617585027|FG001|Overall Study|Adverse Event|1|||
170883834|NCT00605085|617585028|FG000|Overall Study|Withdrawal by Subject|8|||
170883835|NCT00605085|617585029|FG001|Overall Study|Withdrawal by Subject|5|||
170883836|NCT00605085|617585028|FG000|Overall Study|Adverse Event|9|||
170883837|NCT00605085|617585029|FG001|Overall Study|Adverse Event|5|||
170883838|NCT00605085|617585028|FG000|Overall Study|Pregnancy|2|||
170883839|NCT00605085|617585029|FG001|Overall Study|Pregnancy|0|||
170883840|NCT00605085|617585028|FG000|Overall Study|Protocol Violation|3|||
170883841|NCT00605085|617585029|FG001|Overall Study|Protocol Violation|2|||
170883842|NCT00605085|617585028|FG000|Overall Study|Lost to Follow-up|10|||
170440212|NCT00522041|615951467|FG001|Overall Study|Voluntary withdrawal|4|||
170440213|NCT00522041|615951466|FG000|Overall Study|Did not receive treatment|0|||
170440214|NCT00522041|615951467|FG001|Overall Study|Did not receive treatment|1|||
170440215|NCT00288704|615951468|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
170440216|NCT00288704|615951469|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
170440217|NCT00288704|615951470|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
170440218|NCT00288704|615951468|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
170440219|NCT00288704|615951469|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
170440220|NCT00288704|615951470|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
170883843|NCT00605085|617585029|FG001|Overall Study|Lost to Follow-up|5|||
170883844|NCT00605085|617585028|FG000|Overall Study|administrative reasons|18|||
170883845|NCT00605085|617585029|FG001|Overall Study|administrative reasons|8|||
170883846|NCT01137773|617585030|FG000|Overall Study|Death|3|||
170883847|NCT01137773|617585031|FG001|Overall Study|Death|3|||
170883848|NCT01137773|617585030|FG000|Overall Study|Lost to Follow-up|6|||
170883849|NCT01137773|617585031|FG001|Overall Study|Lost to Follow-up|0|||
170883850|NCT00812214|617585032|FG000|Overall Study|Lost to Follow-up|3|||
170883851|NCT00812214|617585033|FG001|Overall Study|Lost to Follow-up|1|||
170440221|NCT00288704|615951468|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
170883852|NCT04623242|617585034|FG000|Overall Study|Withdrawal by Subject|7|||
170883853|NCT04623242|617585035|FG001|Overall Study|Withdrawal by Subject|12|||
170883854|NCT04623242|617585036|FG002|Overall Study|Withdrawal by Subject|5|||
170883855|NCT04623242|617585037|FG003|Overall Study|Withdrawal by Subject|7|||
170883856|NCT04623242|617585038|FG004|Overall Study|Withdrawal by Subject|0|||
170883857|NCT04623242|617585034|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
170883858|NCT04623242|617585035|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
170883859|NCT04623242|617585036|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
170883860|NCT04623242|617585037|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
170883861|NCT04623242|617585038|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
170883862|NCT04623242|617585034|FG000|Overall Study|Subject unblinded to mutation status|0|||
170883863|NCT04623242|617585035|FG001|Overall Study|Subject unblinded to mutation status|0|||
170883864|NCT04623242|617585036|FG002|Overall Study|Subject unblinded to mutation status|0|||
170883865|NCT04623242|617585037|FG003|Overall Study|Subject unblinded to mutation status|13|||
170883866|NCT04623242|617585038|FG004|Overall Study|Subject unblinded to mutation status|0|||
170883867|NCT01262365|617585039|FG000|Overall Study|Lack of Efficacy|35|||
170883868|NCT01262365|617585040|FG001|Overall Study|Lack of Efficacy|30|||
170883869|NCT01262365|617585041|FG002|Overall Study|Lack of Efficacy|47|||
170883870|NCT01262365|617585039|FG000|Overall Study|Protocol Violation|3|||
170883871|NCT01262365|617585040|FG001|Overall Study|Protocol Violation|1|||
170883872|NCT01262365|617585041|FG002|Overall Study|Protocol Violation|1|||
170883873|NCT01262365|617585039|FG000|Overall Study|Lost to Follow-up|3|||
170883874|NCT01262365|617585040|FG001|Overall Study|Lost to Follow-up|7|||
170883875|NCT01262365|617585041|FG002|Overall Study|Lost to Follow-up|6|||
170883876|NCT01262365|617585039|FG000|Overall Study|Withdrawal by Subject|17|||
170883877|NCT01262365|617585040|FG001|Overall Study|Withdrawal by Subject|22|||
170883878|NCT01262365|617585041|FG002|Overall Study|Withdrawal by Subject|22|||
170883879|NCT01262365|617585039|FG000|Overall Study|Death|1|||
170883880|NCT01262365|617585040|FG001|Overall Study|Death|2|||
170883881|NCT01262365|617585041|FG002|Overall Study|Death|1|||
170883882|NCT01262365|617585039|FG000|Overall Study|Adverse Event|26|||
170883883|NCT01262365|617585040|FG001|Overall Study|Adverse Event|16|||
170883884|NCT01262365|617585041|FG002|Overall Study|Adverse Event|11|||
170883885|NCT01262365|617585039|FG000|Overall Study|sponsor decision|1|||
170883886|NCT01262365|617585040|FG001|Overall Study|sponsor decision|1|||
170883887|NCT01262365|617585041|FG002|Overall Study|sponsor decision|0|||
170883888|NCT01262365|617585039|FG000|Overall Study|Randomization error|1|||
170883889|NCT01262365|617585040|FG001|Overall Study|Randomization error|0|||
170883890|NCT01262365|617585041|FG002|Overall Study|Randomization error|2|||
170883891|NCT01262365|617585039|FG000|Overall Study|Non-compliance|1|||
170883892|NCT01262365|617585040|FG001|Overall Study|Non-compliance|0|||
170883893|NCT01262365|617585041|FG002|Overall Study|Non-compliance|2|||
170883894|NCT01262365|617585039|FG000|Overall Study|Suspected pregnancy|1|||
170883895|NCT01262365|617585040|FG001|Overall Study|Suspected pregnancy|0|||
170883896|NCT01262365|617585041|FG002|Overall Study|Suspected pregnancy|0|||
170883897|NCT01262365|617585039|FG000|Overall Study|Patient pregnant|1|||
170883898|NCT01262365|617585040|FG001|Overall Study|Patient pregnant|0|||
170883899|NCT01262365|617585041|FG002|Overall Study|Patient pregnant|1|||
170883900|NCT01262365|617585039|FG000|Overall Study|Toxicity related to study drug|0|||
170883901|NCT01262365|617585040|FG001|Overall Study|Toxicity related to study drug|1|||
170883902|NCT01262365|617585041|FG002|Overall Study|Toxicity related to study drug|0|||
170883903|NCT01262365|617585039|FG000|Overall Study|Cannot tolerate the protocol|0|||
170883904|NCT01262365|617585040|FG001|Overall Study|Cannot tolerate the protocol|1|||
170883905|NCT01262365|617585041|FG002|Overall Study|Cannot tolerate the protocol|0|||
170883906|NCT01262365|617585039|FG000|Overall Study|Patient unavailable|0|||
170883907|NCT01262365|617585040|FG001|Overall Study|Patient unavailable|0|||
170883908|NCT01262365|617585041|FG002|Overall Study|Patient unavailable|1|||
170883909|NCT01869114|617585047|FG000|Overall Study|Death|19|||
170883910|NCT01869114|617585048|FG001|Overall Study|Death|18|||
170883911|NCT01869114|617585049|FG002|Overall Study|Death|8|||
170883912|NCT01869114|617585047|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
170883913|NCT01869114|617585048|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
170883914|NCT01869114|617585049|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
170883915|NCT01869114|617585047|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
170883916|NCT01869114|617585048|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
170883917|NCT01869114|617585049|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
170883918|NCT01869114|617585047|FG000|Overall Study|Withdrawal by Subject|0|||
170883919|NCT01869114|617585048|FG001|Overall Study|Withdrawal by Subject|3|||
170883920|NCT01869114|617585049|FG002|Overall Study|Withdrawal by Subject|0|||
170883921|NCT01869114|617585047|FG000|Overall Study|Disease Progression|0|||
170883922|NCT01869114|617585048|FG001|Overall Study|Disease Progression|1|||
170883923|NCT01869114|617585049|FG002|Overall Study|Disease Progression|0|||
170883924|NCT03704194|617585056|FG000|Overall Study|Withdrawal by Subject|0|||
170883925|NCT03704194|617585057|FG001|Overall Study|Withdrawal by Subject|1|||
170883926|NCT05882318|617585062|FG000|Overall Study|Withdrawal by Subject|1|||
170883927|NCT05882318|617585063|FG001|Overall Study|Withdrawal by Subject|0|||
170883928|NCT05882318|617585062|FG000|Overall Study|Protocol Violation|0|||
170883929|NCT05882318|617585063|FG001|Overall Study|Protocol Violation|1|||
170883930|NCT01485627|617585066|FG000|Overall Study|Patient withdrew|6|||
170883931|NCT01485627|617585067|FG001|Overall Study|Patient withdrew|5|||
170883932|NCT01485627|617585066|FG000|Overall Study|Patient died|3|||
170883933|NCT01485627|617585067|FG001|Overall Study|Patient died|1|||
170883934|NCT01485627|617585066|FG000|Overall Study|Patient lost to followup|0|||
170883935|NCT01485627|617585067|FG001|Overall Study|Patient lost to followup|1|||
170883936|NCT01485627|617585066|FG000|Overall Study|Caregiver withdrew|3|||
170440222|NCT00288704|615951469|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
170440223|NCT00288704|615951470|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
170440224|NCT00288704|615951468|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
170440225|NCT00288704|615951469|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
170440226|NCT00288704|615951470|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
170440227|NCT00288704|615951468|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
170440228|NCT00288704|615951469|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
170440229|NCT00288704|615951470|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
170440230|NCT00288704|615951468|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
170440231|NCT00288704|615951469|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
170440232|NCT00288704|615951470|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
170440233|NCT00288704|615951468|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
170440234|NCT00288704|615951469|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
170440235|NCT00288704|615951470|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
170440236|NCT03343639|615951474|FG000|Overall Study|Withdrawal by Subject|10|||
170440237|NCT03343639|615951475|FG001|Overall Study|Withdrawal by Subject|6|||
170440238|NCT03343639|615951474|FG000|Overall Study|Lost to Follow-up|4|||
170440239|NCT03343639|615951475|FG001|Overall Study|Lost to Follow-up|5|||
170440240|NCT03343639|615951474|FG000|Overall Study|Protocol Violation|0|||
170440241|NCT03343639|615951475|FG001|Overall Study|Protocol Violation|1|||
170440242|NCT02473393|615951476|FG000|Overall Study|Adverse Event|0|||
170440243|NCT02473393|615951477|FG001|Overall Study|Adverse Event|0|||
170440244|NCT02473393|615951478|FG002|Overall Study|Adverse Event|1|||
170440245|NCT02473393|615951479|FG003|Overall Study|Adverse Event|0|||
170883937|NCT01485627|617585067|FG001|Overall Study|Caregiver withdrew|3|||
170883938|NCT01485627|617585066|FG000|Overall Study|Caregiver lost to follow up|11|||
170883939|NCT01485627|617585067|FG001|Overall Study|Caregiver lost to follow up|12|||
170883940|NCT01485627|617585066|FG000|Overall Study|Caregiver died|1|||
170883941|NCT01485627|617585067|FG001|Overall Study|Caregiver died|0|||
170883942|NCT01485627|617585066|FG000|Overall Study|caregiver was not bereaved|42|||
170883943|NCT01485627|617585067|FG001|Overall Study|caregiver was not bereaved|35|||
170883944|NCT04951037|617585069|FG000|Overall Study|Lost to Follow-up|16|||
170883945|NCT04951037|617585069|FG000|Overall Study|Withdrawal by Subject|5|||
170883946|NCT04951037|617585069|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
170883947|NCT05630937|617585072|FG000|Overall Study|Study terminated by sponsor|1|||
170883948|NCT05630937|617585073|FG001|Overall Study|Study terminated by sponsor|1|||
170883949|NCT05630937|617585074|FG002|Overall Study|Study terminated by sponsor|8|||
170883950|NCT05630937|617585075|FG003|Overall Study|Study terminated by sponsor|0|||
170883951|NCT05630937|617585072|FG000|Overall Study|Lost to Follow-up|0|||
170883952|NCT05630937|617585073|FG001|Overall Study|Lost to Follow-up|0|||
170883953|NCT05630937|617585074|FG002|Overall Study|Lost to Follow-up|1|||
170883954|NCT05630937|617585075|FG003|Overall Study|Lost to Follow-up|0|||
170883955|NCT05630937|617585072|FG000|Overall Study|Enrolled but not treated|0|||
170883956|NCT05630937|617585073|FG001|Overall Study|Enrolled but not treated|0|||
170883957|NCT05630937|617585074|FG002|Overall Study|Enrolled but not treated|0|||
170883958|NCT05630937|617585075|FG003|Overall Study|Enrolled but not treated|1|||
170883959|NCT02264990|617585076|FG000|Overall Study|Death|255|||
170440246|NCT02473393|615951476|FG000|Overall Study|Withdrawal by Subject|0|||
170440247|NCT02473393|615951477|FG001|Overall Study|Withdrawal by Subject|0|||
170440248|NCT02473393|615951478|FG002|Overall Study|Withdrawal by Subject|1|||
170883960|NCT02264990|617585077|FG001|Overall Study|Death|250|||
170440249|NCT02473393|615951479|FG003|Overall Study|Withdrawal by Subject|1|||
170883961|NCT02264990|617585076|FG000|Overall Study|Withdrawal by Subject|4|||
170883962|NCT02264990|617585077|FG001|Overall Study|Withdrawal by Subject|5|||
170883963|NCT02264990|617585076|FG000|Overall Study|Lost to Follow-up|1|||
170883964|NCT02264990|617585077|FG001|Overall Study|Lost to Follow-up|3|||
170440250|NCT03303417|615951490|FG000|Overall Study|Withdrawal by Subject|1|||
170440251|NCT03303417|615951491|FG001|Overall Study|Withdrawal by Subject|1|||
170440252|NCT02274558|615951495|FG000|Overall Study|Adverse Event|2|||
170440253|NCT02274558|615951496|FG001|Overall Study|Adverse Event|4|||
170883965|NCT02264990|617585076|FG000|Overall Study|Other|0|||
170883966|NCT02264990|617585077|FG001|Overall Study|Other|1|||
170883967|NCT03031301|617585079|FG000|Overall Study|Protocol Violation|4|||
170883968|NCT03031301|617585080|FG001|Overall Study|Protocol Violation|8|||
170883969|NCT03031301|617585079|FG000|Overall Study|Withdrawal by Subject|7|||
170440254|NCT02274558|615951497|FG002|Overall Study|Adverse Event|2|||
170440255|NCT02274558|615951495|FG000|Overall Study|Non-compliance|2|||
170440256|NCT02274558|615951496|FG001|Overall Study|Non-compliance|1|||
170440257|NCT02274558|615951497|FG002|Overall Study|Non-compliance|0|||
170440258|NCT02274558|615951495|FG000|Overall Study|Withdrawal by Subject|1|||
170440259|NCT02274558|615951496|FG001|Overall Study|Withdrawal by Subject|5|||
170440260|NCT02274558|615951497|FG002|Overall Study|Withdrawal by Subject|4|||
170440261|NCT02274558|615951495|FG000|Overall Study|Death|0|||
170440262|NCT02274558|615951496|FG001|Overall Study|Death|0|||
170440263|NCT02274558|615951497|FG002|Overall Study|Death|1|||
170440264|NCT02274558|615951495|FG000|Overall Study|Lost to Follow-up|2|||
170440265|NCT02274558|615951496|FG001|Overall Study|Lost to Follow-up|1|||
170440266|NCT02274558|615951497|FG002|Overall Study|Lost to Follow-up|1|||
170440267|NCT02274558|615951495|FG000|Overall Study|Physician Decision|0|||
170440268|NCT02274558|615951496|FG001|Overall Study|Physician Decision|2|||
170440269|NCT02274558|615951497|FG002|Overall Study|Physician Decision|1|||
170440270|NCT01765270|615951501|FG000|Overall Study|Physician Decision|1|||
170440271|NCT01765270|615951502|FG001|Overall Study|Physician Decision|0|||
170440272|NCT01765270|615951501|FG000|Overall Study|Withdrawal by Subject|0|||
170440273|NCT01765270|615951502|FG001|Overall Study|Withdrawal by Subject|1|||
170440274|NCT00517192|615951503|FG000|Overall Study|Adverse Event|1|||
170440275|NCT00517192|615951504|FG001|Overall Study|Adverse Event|1|||
170440276|NCT00517192|615951503|FG000|Overall Study|Lost to Follow-up|1|||
170440277|NCT00517192|615951504|FG001|Overall Study|Lost to Follow-up|1|||
170440278|NCT00517192|615951503|FG000|Overall Study|Withdrawal by Subject|1|||
170440279|NCT00517192|615951504|FG001|Overall Study|Withdrawal by Subject|0|||
170440280|NCT00517192|615951503|FG000|Overall Study|Early termination of the trial|16|||
170440281|NCT00517192|615951504|FG001|Overall Study|Early termination of the trial|18|||
170440282|NCT02733627|615951510|FG000|Overall Study|Adverse Event|0|||
170440283|NCT02733627|615951511|FG001|Overall Study|Adverse Event|1|||
170440284|NCT02733627|615951512|FG002|Overall Study|Adverse Event|1|||
170440285|NCT02733627|615951513|FG003|Overall Study|Adverse Event|0|||
170440286|NCT02733627|615951510|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
170440287|NCT02733627|615951511|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
170440288|NCT02733627|615951512|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
170440289|NCT02733627|615951513|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
170440290|NCT02246764|615951514|FG000|Overall Study|Adverse Event|15|||
170440291|NCT02246764|615951515|FG001|Overall Study|Adverse Event|29|||
170440292|NCT02246764|615951516|FG002|Overall Study|Adverse Event|1|||
170440293|NCT02246764|615951514|FG000|Overall Study|Withdrawal by Subject|0|||
170440294|NCT02246764|615951515|FG001|Overall Study|Withdrawal by Subject|0|||
170883970|NCT03031301|617585080|FG001|Overall Study|Withdrawal by Subject|4|||
170883971|NCT03031301|617585079|FG000|Overall Study|Lost to Follow-up|4|||
170883972|NCT03031301|617585080|FG001|Overall Study|Lost to Follow-up|12|||
170883973|NCT03031301|617585079|FG000|Overall Study|Noncompliance|1|||
170883974|NCT03031301|617585080|FG001|Overall Study|Noncompliance|3|||
170883975|NCT03031301|617585079|FG000|Overall Study|Technical issue|1|||
170883976|NCT03031301|617585080|FG001|Overall Study|Technical issue|1|||
170883977|NCT03031301|617585079|FG000|Overall Study|Adverse Event|1|||
170883978|NCT03031301|617585080|FG001|Overall Study|Adverse Event|0|||
170883979|NCT00267748|617585081|FG000|Non-randomized Period|Progressive disease|10|||
170883980|NCT00267748|617585082|FG001|Non-randomized Period|Progressive disease|0|||
170883981|NCT00267748|617585083|FG002|Non-randomized Period|Progressive disease|0|||
170883982|NCT00267748|617585081|FG000|Non-randomized Period|Adverse Event|8|||
170883983|NCT00267748|617585082|FG001|Non-randomized Period|Adverse Event|0|||
170440295|NCT02246764|615951516|FG002|Overall Study|Withdrawal by Subject|1|||
170440296|NCT02246764|615951514|FG000|Overall Study|Disallowed Concomitant Medication|1|||
170440297|NCT02246764|615951515|FG001|Overall Study|Disallowed Concomitant Medication|0|||
170440298|NCT02246764|615951516|FG002|Overall Study|Disallowed Concomitant Medication|0|||
170440299|NCT02246764|615951514|FG000|Overall Study|Physician Decision|0|||
170440300|NCT02246764|615951515|FG001|Overall Study|Physician Decision|2|||
170883984|NCT00267748|617585083|FG002|Non-randomized Period|Adverse Event|0|||
170440301|NCT02246764|615951516|FG002|Overall Study|Physician Decision|1|||
170440302|NCT02246764|615951514|FG000|Overall Study|Protocol Violation|2|||
170440303|NCT02246764|615951515|FG001|Overall Study|Protocol Violation|1|||
170440304|NCT02246764|615951516|FG002|Overall Study|Protocol Violation|1|||
170883985|NCT00267748|617585081|FG000|Non-randomized Period|Death|1|||
170440305|NCT05393271|615951517|FG000|Overall Study|Physician Decision|0|||
170440306|NCT05393271|615951518|FG001|Overall Study|Physician Decision|0|||
170440307|NCT05393271|615951519|FG002|Overall Study|Physician Decision|0|||
170440308|NCT05393271|615951520|FG003|Overall Study|Physician Decision|0|||
170440309|NCT05393271|615951521|FG004|Overall Study|Physician Decision|0|||
170440310|NCT05393271|615951522|FG005|Overall Study|Physician Decision|0|||
170440311|NCT05393271|615951523|FG006|Overall Study|Physician Decision|1|||
170440312|NCT05393271|615951524|FG007|Overall Study|Physician Decision|0|||
170440313|NCT05393271|615951525|FG008|Overall Study|Physician Decision|0|||
170440314|NCT05393271|615951526|FG009|Overall Study|Physician Decision|0|||
170440315|NCT05393271|615951527|FG010|Overall Study|Physician Decision|0|||
170440316|NCT01708954|615951528|FG000|Step 1|Disease progression|26|||
170440317|NCT01708954|615951529|FG001|Step 1|Disease progression|17|||
170440318|NCT01708954|615951530|FG002|Step 1|Disease progression|14|||
170440319|NCT01708954|615951528|FG000|Step 1|Adverse Event|3|||
170440320|NCT01708954|615951529|FG001|Step 1|Adverse Event|11|||
170440321|NCT01708954|615951530|FG002|Step 1|Adverse Event|13|||
170440322|NCT01708954|615951528|FG000|Step 1|Death|3|||
170440323|NCT01708954|615951529|FG001|Step 1|Death|2|||
170440324|NCT01708954|615951530|FG002|Step 1|Death|3|||
170440325|NCT01708954|615951528|FG000|Step 1|Withdrawal by Subject|2|||
170440326|NCT01708954|615951529|FG001|Step 1|Withdrawal by Subject|5|||
170440327|NCT01708954|615951530|FG002|Step 1|Withdrawal by Subject|3|||
170440328|NCT01708954|615951528|FG000|Step 1|Other complicating disease|0|||
170782761|NCT01261312|617213000|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782762|NCT01261312|617213001|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782763|NCT01261312|617213002|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782764|NCT01261312|617213003|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
170782765|NCT01261312|617213004|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
170782766|NCT01261312|617213005|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782767|NCT01261312|617213006|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782768|NCT01261312|617213007|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782769|NCT01261312|617213008|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782770|NCT01261312|617213009|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782771|NCT01261312|617213010|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782772|NCT01261312|617213011|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
170782773|NCT01261312|617212999|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782774|NCT01261312|617213000|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782775|NCT01261312|617213001|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782776|NCT01261312|617213002|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782777|NCT01261312|617213003|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
170782778|NCT01261312|617213004|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
170782779|NCT01261312|617213005|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782780|NCT01261312|617213006|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782781|NCT01261312|617213007|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782782|NCT01261312|617213008|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782783|NCT01261312|617213009|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782784|NCT01261312|617213010|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782785|NCT01261312|617213011|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
170782786|NCT01261312|617212999|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782787|NCT01261312|617213000|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782788|NCT01261312|617213001|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782789|NCT01261312|617213002|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
170440329|NCT01708954|615951529|FG001|Step 1|Other complicating disease|2|||
170440330|NCT01708954|615951530|FG002|Step 1|Other complicating disease|0|||
170440331|NCT01708954|615951528|FG000|Step 1|Crossed over to Step 2|2|||
170440332|NCT01708954|615951529|FG001|Step 1|Crossed over to Step 2|0|||
170440333|NCT01708954|615951530|FG002|Step 1|Crossed over to Step 2|0|||
170440334|NCT01708954|615951528|FG000|Step 1|Symptomatic deterioration|1|||
170440335|NCT01708954|615951529|FG001|Step 1|Symptomatic deterioration|0|||
170440336|NCT01708954|615951530|FG002|Step 1|Symptomatic deterioration|1|||
170440337|NCT01708954|615951528|FG000|Step 1|Off-treatment reason not submitted|1|||
170440338|NCT01708954|615951529|FG001|Step 1|Off-treatment reason not submitted|1|||
170440339|NCT01708954|615951530|FG002|Step 1|Off-treatment reason not submitted|1|||
170440340|NCT01708954|615951528|FG000|Step 1|Ineligible or never received treatment|4|||
170440341|NCT01708954|615951529|FG001|Step 1|Ineligible or never received treatment|2|||
170440342|NCT01708954|615951530|FG002|Step 1|Ineligible or never received treatment|8|||
170440343|NCT01708954|615951528|FG000|Step 2|Disease progression|9|||
170440344|NCT01708954|615951529|FG001|Step 2|Disease progression|4|||
170440345|NCT01708954|615951530|FG002|Step 2|Disease progression|0|||
170440346|NCT01708954|615951528|FG000|Step 2|Adverse Event|3|||
170440347|NCT01708954|615951529|FG001|Step 2|Adverse Event|2|||
170440348|NCT01708954|615951530|FG002|Step 2|Adverse Event|0|||
170440349|NCT01708954|615951528|FG000|Step 2|Withdrawal by Subject|1|||
170440350|NCT01708954|615951529|FG001|Step 2|Withdrawal by Subject|1|||
170440351|NCT01708954|615951530|FG002|Step 2|Withdrawal by Subject|0|||
170440352|NCT00059332|615951537|FG000|Overall Study|Withdrawal by Subject|2|||
170440353|NCT00059332|615951538|FG001|Overall Study|Withdrawal by Subject|1|||
170440354|NCT00059332|615951537|FG000|Overall Study|Lost to Follow-up|1|||
170440355|NCT00059332|615951538|FG001|Overall Study|Lost to Follow-up|1|||
170440356|NCT03314857|615951539|FG000|Overall Study|Death|4|||
170440357|NCT03314857|615951539|FG000|Overall Study|Physician Decision|1|||
170440358|NCT01721772|615951540|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
170440359|NCT01721772|615951541|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
170440360|NCT01721772|615951540|FG000|Pre-Treatment|Poor/non-compliance|0|||
170440361|NCT01721772|615951541|FG001|Pre-Treatment|Poor/non-compliance|1|||
170440362|NCT01721772|615951540|FG000|Pre-Treatment|Participant withdrew consent|0|||
170440363|NCT01721772|615951541|FG001|Pre-Treatment|Participant withdrew consent|1|||
170440364|NCT01721772|615951540|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
170440365|NCT01721772|615951541|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
170440366|NCT01721772|615951540|FG000|Treatment|Disease progression|119|||
170440367|NCT01721772|615951541|FG001|Treatment|Disease progression|168|||
170440368|NCT01721772|615951540|FG000|Treatment|Study drug toxicity|19|||
170440369|NCT01721772|615951541|FG001|Treatment|Study drug toxicity|10|||
170440370|NCT01721772|615951540|FG000|Treatment|Adverse event unrelated to study drug|7|||
170440371|NCT01721772|615951541|FG001|Treatment|Adverse event unrelated to study drug|7|||
170440372|NCT01721772|615951540|FG000|Treatment|Maximum clinical benefit|16|||
170440373|NCT01721772|615951541|FG001|Treatment|Maximum clinical benefit|4|||
170440374|NCT01721772|615951540|FG000|Treatment|Other|19|||
170440375|NCT01721772|615951541|FG001|Treatment|Other|2|||
170440376|NCT01721772|615951540|FG000|Treatment|Participant withdrew consent|2|||
170440377|NCT01721772|615951541|FG001|Treatment|Participant withdrew consent|5|||
170440378|NCT01721772|615951540|FG000|Treatment|Participant request to discontinue study treatment|21|||
170440379|NCT01721772|615951541|FG001|Treatment|Participant request to discontinue study treatment|8|||
170440380|NCT01721772|615951540|FG000|Treatment|Death|1|||
170440381|NCT01721772|615951541|FG001|Treatment|Death|0|||
170440382|NCT01721772|615951540|FG000|Treatment|Not reported|1|||
170440383|NCT01721772|615951541|FG001|Treatment|Not reported|0|||
170440384|NCT01721772|615951540|FG000|Treatment|Poor/non-compliance|1|||
170440385|NCT01721772|615951541|FG001|Treatment|Poor/non-compliance|0|||
170440386|NCT01721772|615951540|FG000|Treatment|Lost to Follow-up|0|||
170440387|NCT01721772|615951541|FG001|Treatment|Lost to Follow-up|1|||
170440388|NCT00697827|615951545|FG000|Overall Study|enrolled but not treated|2|||
170440389|NCT00697827|615951546|FG001|Overall Study|enrolled but not treated|1|||
170440390|NCT00715676|615951547|FG000|Overall Study|Adverse Event|3|||
170440391|NCT00715676|615951548|FG001|Overall Study|Adverse Event|5|||
170440392|NCT00715676|615951549|FG002|Overall Study|Adverse Event|21|||
170440393|NCT00715676|615951547|FG000|Overall Study|Withdrawal by Subject|1|||
170440394|NCT00715676|615951548|FG001|Overall Study|Withdrawal by Subject|3|||
170440395|NCT00715676|615951549|FG002|Overall Study|Withdrawal by Subject|8|||
170440396|NCT00715676|615951547|FG000|Overall Study|Lost to Follow-up|1|||
170440397|NCT00715676|615951548|FG001|Overall Study|Lost to Follow-up|2|||
170440398|NCT00715676|615951549|FG002|Overall Study|Lost to Follow-up|1|||
170440399|NCT00715676|615951547|FG000|Overall Study|Terminated by Sponsor|1|||
170440400|NCT00715676|615951548|FG001|Overall Study|Terminated by Sponsor|0|||
170440401|NCT00715676|615951549|FG002|Overall Study|Terminated by Sponsor|0|||
170440402|NCT00715676|615951547|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
170440403|NCT00715676|615951548|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
170440404|NCT00715676|615951549|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
170782790|NCT01261312|617213003|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
170440405|NCT00715676|615951547|FG000|Overall Study|Use of Exclusionary Medication|0|||
170440406|NCT00715676|615951548|FG001|Overall Study|Use of Exclusionary Medication|0|||
170440407|NCT00715676|615951549|FG002|Overall Study|Use of Exclusionary Medication|1|||
170440408|NCT00715676|615951547|FG000|Overall Study|Elevated Blood Glucose|0|||
170440409|NCT00715676|615951548|FG001|Overall Study|Elevated Blood Glucose|1|||
170440410|NCT00715676|615951549|FG002|Overall Study|Elevated Blood Glucose|0|||
170440411|NCT03980522|615951550|FG000|Treatment Period|Adverse Event|1|||
170440412|NCT03980522|615951551|FG001|Treatment Period|Adverse Event|0|||
170440413|NCT03980522|615951552|FG002|Treatment Period|Adverse Event|0|||
170440414|NCT03980522|615951553|FG003|Treatment Period|Adverse Event|0|||
170440415|NCT03980522|615951554|FG004|Treatment Period|Adverse Event|0|||
170440416|NCT01320722|615951555|FG000|Overall Study|Did not Receive Intervention|3|||
170440417|NCT01320722|615951556|FG001|Overall Study|Did not Receive Intervention|2|||
170440418|NCT01320722|615951557|FG002|Overall Study|Did not Receive Intervention|1|||
170440419|NCT01320722|615951558|FG003|Overall Study|Did not Receive Intervention|1|||
170440420|NCT01320722|615951559|FG004|Overall Study|Did not Receive Intervention|2|||
170440421|NCT01320722|615951555|FG000|Overall Study|Lost to Follow-up|0|||
170440422|NCT01320722|615951556|FG001|Overall Study|Lost to Follow-up|1|||
170440423|NCT01320722|615951557|FG002|Overall Study|Lost to Follow-up|0|||
170440424|NCT01320722|615951558|FG003|Overall Study|Lost to Follow-up|1|||
170440425|NCT01320722|615951559|FG004|Overall Study|Lost to Follow-up|3|||
170440426|NCT01320722|615951555|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
170440427|NCT01320722|615951556|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
170440428|NCT01320722|615951557|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
170440429|NCT01320722|615951558|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
170440430|NCT01320722|615951559|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
170440431|NCT01320722|615951555|FG000|Overall Study|Participant Developed a Rash|0|||
170440432|NCT01320722|615951556|FG001|Overall Study|Participant Developed a Rash|0|||
170440433|NCT01320722|615951557|FG002|Overall Study|Participant Developed a Rash|2|||
170440434|NCT01320722|615951558|FG003|Overall Study|Participant Developed a Rash|1|||
170440435|NCT01320722|615951559|FG004|Overall Study|Participant Developed a Rash|1|||
170440436|NCT01320722|615951555|FG000|Overall Study|Non-compliant with Medication|0|||
170440437|NCT01320722|615951556|FG001|Overall Study|Non-compliant with Medication|0|||
170440438|NCT01320722|615951557|FG002|Overall Study|Non-compliant with Medication|1|||
170440439|NCT01320722|615951558|FG003|Overall Study|Non-compliant with Medication|0|||
170440440|NCT01320722|615951559|FG004|Overall Study|Non-compliant with Medication|0|||
170440441|NCT01320722|615951555|FG000|Overall Study|Adverse Event|0|||
170440442|NCT01320722|615951556|FG001|Overall Study|Adverse Event|0|||
170440443|NCT01320722|615951557|FG002|Overall Study|Adverse Event|3|||
170440444|NCT01320722|615951558|FG003|Overall Study|Adverse Event|6|||
170440445|NCT01320722|615951559|FG004|Overall Study|Adverse Event|0|||
170440446|NCT01320722|615951555|FG000|Overall Study|Not Compliant with Study Procedures|0|||
170440447|NCT01320722|615951556|FG001|Overall Study|Not Compliant with Study Procedures|0|||
170440448|NCT01320722|615951557|FG002|Overall Study|Not Compliant with Study Procedures|0|||
170440449|NCT01320722|615951558|FG003|Overall Study|Not Compliant with Study Procedures|4|||
170440450|NCT01320722|615951559|FG004|Overall Study|Not Compliant with Study Procedures|0|||
170440451|NCT01320722|615951555|FG000|Overall Study|Pregnancy|0|||
170440452|NCT01320722|615951556|FG001|Overall Study|Pregnancy|0|||
170440453|NCT01320722|615951557|FG002|Overall Study|Pregnancy|0|||
170440454|NCT01320722|615951558|FG003|Overall Study|Pregnancy|1|||
170440455|NCT01320722|615951559|FG004|Overall Study|Pregnancy|0|||
170440456|NCT01320722|615951555|FG000|Overall Study|Started an Exclusionary Medication|0|||
170440457|NCT01320722|615951556|FG001|Overall Study|Started an Exclusionary Medication|0|||
170440458|NCT01320722|615951557|FG002|Overall Study|Started an Exclusionary Medication|0|||
170440459|NCT01320722|615951558|FG003|Overall Study|Started an Exclusionary Medication|0|||
170440460|NCT01320722|615951559|FG004|Overall Study|Started an Exclusionary Medication|1|||
170440461|NCT01320722|615951555|FG000|Overall Study|Withdrew due to Health Condition|0|||
170440462|NCT01320722|615951556|FG001|Overall Study|Withdrew due to Health Condition|0|||
170440463|NCT01320722|615951557|FG002|Overall Study|Withdrew due to Health Condition|0|||
170440464|NCT01320722|615951558|FG003|Overall Study|Withdrew due to Health Condition|0|||
170440465|NCT01320722|615951559|FG004|Overall Study|Withdrew due to Health Condition|1|||
170440466|NCT00021541|615951560|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
170883986|NCT00267748|617585082|FG001|Non-randomized Period|Death|0|||
170883987|NCT00267748|617585083|FG002|Non-randomized Period|Death|0|||
170883988|NCT00267748|617585081|FG000|Non-randomized Period|Participant not willing to participate|1|||
170883989|NCT00267748|617585082|FG001|Non-randomized Period|Participant not willing to participate|0|||
170883990|NCT00267748|617585083|FG002|Non-randomized Period|Participant not willing to participate|0|||
170883991|NCT00267748|617585081|FG000|Non-randomized Period|Other|3|||
170883992|NCT00267748|617585082|FG001|Non-randomized Period|Other|0|||
170883993|NCT00267748|617585083|FG002|Non-randomized Period|Other|0|||
170883994|NCT00267748|617585081|FG000|Randomized Period|Death|0|||
170440467|NCT00021541|615951561|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
170883995|NCT00267748|617585082|FG001|Randomized Period|Death|2|||
170440468|NCT00021541|615951560|FG000|Period 1-First Treatment|Adverse Event|2|||
170440469|NCT00021541|615951561|FG001|Period 1-First Treatment|Adverse Event|1|||
170440470|NCT00021541|615951560|FG000|Period 1-First Treatment|non-adherence|3|||
170537180|NCT03330197|616311548|FG000|Overall Study|Adverse Event|0|||
170440471|NCT00021541|615951561|FG001|Period 1-First Treatment|non-adherence|0|||
170782791|NCT01261312|617213004|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
170883996|NCT00267748|617585083|FG002|Randomized Period|Death|3|||
170883997|NCT00267748|617585081|FG000|Randomized Period|Adverse Event|0|||
170883998|NCT00267748|617585082|FG001|Randomized Period|Adverse Event|23|||
170883999|NCT00267748|617585083|FG002|Randomized Period|Adverse Event|25|||
170884000|NCT00267748|617585081|FG000|Randomized Period|Global deterioration of health status|0|||
170884001|NCT00267748|617585082|FG001|Randomized Period|Global deterioration of health status|6|||
170884002|NCT00267748|617585083|FG002|Randomized Period|Global deterioration of health status|7|||
170884003|NCT00267748|617585081|FG000|Randomized Period|Lost to Follow-up|0|||
170782792|NCT01261312|617213005|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782793|NCT01261312|617213006|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782794|NCT01261312|617213007|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782795|NCT01261312|617213008|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782796|NCT01261312|617213009|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782797|NCT01261312|617213010|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782798|NCT01261312|617213011|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
170782799|NCT01261312|617212999|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782800|NCT01261312|617213000|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782801|NCT01261312|617213001|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782802|NCT01261312|617213002|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782803|NCT01261312|617213003|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782804|NCT01261312|617213004|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
170782805|NCT01261312|617213005|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782806|NCT01261312|617213006|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782807|NCT01261312|617213007|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782808|NCT01261312|617213008|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782809|NCT01261312|617213009|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782810|NCT01261312|617213010|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782811|NCT01261312|617213011|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
170782812|NCT01261312|617212999|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782813|NCT01261312|617213000|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782814|NCT01261312|617213001|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782815|NCT01261312|617213002|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
170782816|NCT01261312|617213003|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
170782817|NCT01261312|617213004|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
170782818|NCT01261312|617213005|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782819|NCT01261312|617213006|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782820|NCT01261312|617213007|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782821|NCT01261312|617213008|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782822|NCT01261312|617213009|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782823|NCT01261312|617213010|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782824|NCT01261312|617213011|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
170782825|NCT01261312|617212999|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782826|NCT01261312|617213000|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782827|NCT01261312|617213001|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782828|NCT01261312|617213002|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
170782829|NCT01261312|617213003|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
170782830|NCT01261312|617213004|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
170782831|NCT01261312|617213005|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782832|NCT01261312|617213006|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782833|NCT01261312|617213007|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782834|NCT01261312|617213008|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170884004|NCT00267748|617585082|FG001|Randomized Period|Lost to Follow-up|1|||
170440472|NCT00021541|615951560|FG000|Period 1-First Treatment|Death|1|||
170782835|NCT01261312|617213009|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782836|NCT01261312|617213010|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782837|NCT01261312|617213011|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
170782838|NCT01261312|617212999|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782839|NCT01261312|617213000|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782840|NCT01261312|617213001|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782841|NCT01261312|617213002|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782842|NCT01261312|617213003|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782843|NCT01261312|617213004|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782844|NCT01261312|617213005|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
170782845|NCT01261312|617213006|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
170782846|NCT01261312|617213007|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
170782847|NCT01261312|617213008|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782848|NCT01261312|617213009|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782849|NCT01261312|617213010|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782850|NCT01261312|617213011|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
170782851|NCT01261312|617212999|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782852|NCT01261312|617213000|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782853|NCT01261312|617213001|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782854|NCT01261312|617213002|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782855|NCT01261312|617213003|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782856|NCT01261312|617213004|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782857|NCT01261312|617213005|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782858|NCT01261312|617213006|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
170782859|NCT01261312|617213007|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
170782860|NCT01261312|617213008|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782861|NCT01261312|617213009|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782862|NCT01261312|617213010|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782863|NCT01261312|617213011|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
170782864|NCT01261312|617212999|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782865|NCT01261312|617213000|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782866|NCT01261312|617213001|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782867|NCT01261312|617213002|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782868|NCT01261312|617213003|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782869|NCT01261312|617213004|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782870|NCT01261312|617213005|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
170782871|NCT01261312|617213006|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
170782872|NCT01261312|617213007|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
170782873|NCT01261312|617213008|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782874|NCT01261312|617213009|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782875|NCT01261312|617213010|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782876|NCT01261312|617213011|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
170782877|NCT01261312|617212999|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
170782878|NCT01261312|617213000|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
170782879|NCT01261312|617213001|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
170782880|NCT01261312|617213002|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
170782881|NCT01261312|617213003|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
170782882|NCT01261312|617213004|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
170782883|NCT01261312|617213005|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
170782884|NCT01261312|617213006|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
170782885|NCT01261312|617213007|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
170782886|NCT01261312|617213008|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
170782887|NCT01261312|617213009|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
170782888|NCT01261312|617213010|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
170782889|NCT01261312|617213011|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
170782890|NCT01261312|617212999|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782891|NCT01261312|617213000|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782892|NCT01261312|617213001|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782893|NCT01261312|617213002|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782894|NCT01261312|617213003|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782895|NCT01261312|617213004|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782896|NCT01261312|617213005|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
170782897|NCT01261312|617213006|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
170782898|NCT01261312|617213007|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
170782899|NCT01261312|617213008|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782900|NCT01261312|617213009|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782901|NCT01261312|617213010|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782902|NCT01261312|617213011|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
170782903|NCT01261312|617212999|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170884005|NCT00267748|617585083|FG002|Randomized Period|Lost to Follow-up|0|||
170884006|NCT00267748|617585081|FG000|Randomized Period|Objective progression or relapse|0|||
170884007|NCT00267748|617585082|FG001|Randomized Period|Objective progression or relapse|77|||
170884008|NCT00267748|617585083|FG002|Randomized Period|Objective progression or relapse|86|||
170884009|NCT00267748|617585081|FG000|Randomized Period|Withdrawal by Subject|0|||
170884010|NCT00267748|617585082|FG001|Randomized Period|Withdrawal by Subject|9|||
170884011|NCT00267748|617585083|FG002|Randomized Period|Withdrawal by Subject|2|||
170884012|NCT00267748|617585081|FG000|Randomized Period|Other|0|||
170884013|NCT00267748|617585082|FG001|Randomized Period|Other|9|||
170884014|NCT00267748|617585083|FG002|Randomized Period|Other|6|||
170884015|NCT00267748|617585081|FG000|Randomized Period|randomized but not treated|0|||
170884016|NCT00267748|617585082|FG001|Randomized Period|randomized but not treated|0|||
170884017|NCT00267748|617585083|FG002|Randomized Period|randomized but not treated|3|||
170884018|NCT01294800|617585086|FG000|Overall Study|Adverse Event|7|||
170884019|NCT01294800|617585087|FG001|Overall Study|Adverse Event|6|||
170884020|NCT01294800|617585088|FG002|Overall Study|Adverse Event|12|||
170884021|NCT01294800|617585089|FG003|Overall Study|Adverse Event|5|||
170884022|NCT01294800|617585086|FG000|Overall Study|Subject Withdrew Consent|2|||
170884023|NCT01294800|617585087|FG001|Overall Study|Subject Withdrew Consent|2|||
170884024|NCT01294800|617585088|FG002|Overall Study|Subject Withdrew Consent|2|||
170884025|NCT01294800|617585089|FG003|Overall Study|Subject Withdrew Consent|11|||
170884026|NCT01294800|617585086|FG000|Overall Study|Lost to Follow-up|0|||
170884027|NCT01294800|617585087|FG001|Overall Study|Lost to Follow-up|0|||
170884028|NCT01294800|617585088|FG002|Overall Study|Lost to Follow-up|1|||
170884029|NCT01294800|617585089|FG003|Overall Study|Lost to Follow-up|0|||
170884030|NCT01294800|617585086|FG000|Overall Study|Non-compliance With Protocol|0|||
170537181|NCT03330197|616311549|FG001|Overall Study|Adverse Event|1|||
170884031|NCT01294800|617585087|FG001|Overall Study|Non-compliance With Protocol|1|||
170884032|NCT01294800|617585088|FG002|Overall Study|Non-compliance With Protocol|1|||
170884033|NCT01294800|617585089|FG003|Overall Study|Non-compliance With Protocol|0|||
170884034|NCT01294800|617585086|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
170884035|NCT01294800|617585087|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
170884036|NCT01294800|617585088|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
170884037|NCT01294800|617585089|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
170884038|NCT01604265|617585101|FG000|Overall Study|Adverse Event|1|||
170884039|NCT01604265|617585102|FG001|Overall Study|Adverse Event|0|||
170884040|NCT01604265|617585101|FG000|Overall Study|Withdrawal by Subject|1|||
170884041|NCT01604265|617585102|FG001|Overall Study|Withdrawal by Subject|0|||
170884042|NCT01903837|617585103|FG000|Part A|Withdrawal by Subject|4|||
170884043|NCT01903837|617585104|FG001|Part A|Withdrawal by Subject|9|||
170884044|NCT01903837|617585105|FG002|Part A|Withdrawal by Subject|8|||
170884045|NCT01903837|617585106|FG003|Part A|Withdrawal by Subject|5|||
170884046|NCT01903837|617585103|FG000|Part A|Adverse Event|3|||
170884047|NCT01903837|617585104|FG001|Part A|Adverse Event|6|||
170884048|NCT01903837|617585105|FG002|Part A|Adverse Event|9|||
170884049|NCT01903837|617585106|FG003|Part A|Adverse Event|6|||
170884050|NCT01903837|617585103|FG000|Part A|Lost to Follow-up|9|||
170884051|NCT01903837|617585104|FG001|Part A|Lost to Follow-up|7|||
170884052|NCT01903837|617585105|FG002|Part A|Lost to Follow-up|7|||
170884053|NCT01903837|617585106|FG003|Part A|Lost to Follow-up|2|||
170884054|NCT01903837|617585103|FG000|Part A|Non-compliance with study drug|1|||
170884055|NCT01903837|617585104|FG001|Part A|Non-compliance with study drug|4|||
170884056|NCT01903837|617585105|FG002|Part A|Non-compliance with study drug|4|||
170884057|NCT01903837|617585106|FG003|Part A|Non-compliance with study drug|0|||
170884058|NCT01903837|617585103|FG000|Part A|Physician Decision|1|||
170884059|NCT01903837|617585104|FG001|Part A|Physician Decision|1|||
170884060|NCT01903837|617585105|FG002|Part A|Physician Decision|0|||
170884061|NCT01903837|617585106|FG003|Part A|Physician Decision|0|||
170884062|NCT01903837|617585103|FG000|Part A|Protocol Violation|1|||
170884063|NCT01903837|617585104|FG001|Part A|Protocol Violation|1|||
170884064|NCT01903837|617585105|FG002|Part A|Protocol Violation|0|||
170884065|NCT01903837|617585106|FG003|Part A|Protocol Violation|0|||
170884066|NCT01903837|617585103|FG000|Part B|Lost to Follow-up|0|||
170884067|NCT01903837|617585104|FG001|Part B|Lost to Follow-up|3|||
170884068|NCT01903837|617585105|FG002|Part B|Lost to Follow-up|3|||
170884069|NCT01903837|617585106|FG003|Part B|Lost to Follow-up|4|||
170884070|NCT01903837|617585103|FG000|Part B|Withdrawal by Subject|1|||
170884071|NCT01903837|617585104|FG001|Part B|Withdrawal by Subject|2|||
170884072|NCT01903837|617585105|FG002|Part B|Withdrawal by Subject|0|||
170884073|NCT01903837|617585106|FG003|Part B|Withdrawal by Subject|3|||
170884074|NCT01903837|617585103|FG000|Part B|Adverse Event|3|||
170884075|NCT01903837|617585104|FG001|Part B|Adverse Event|0|||
170884076|NCT01903837|617585105|FG002|Part B|Adverse Event|2|||
170884077|NCT01903837|617585106|FG003|Part B|Adverse Event|0|||
170884078|NCT01903837|617585103|FG000|Part B|Non-compliance with study drug|2|||
170884079|NCT01903837|617585104|FG001|Part B|Non-compliance with study drug|0|||
170884080|NCT01903837|617585105|FG002|Part B|Non-compliance with study drug|0|||
170884081|NCT01903837|617585106|FG003|Part B|Non-compliance with study drug|1|||
170884082|NCT01903837|617585103|FG000|Part B|Incarceration|2|||
170884083|NCT01903837|617585104|FG001|Part B|Incarceration|0|||
170782904|NCT01261312|617213000|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782905|NCT01261312|617213001|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782906|NCT01261312|617213002|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782907|NCT01261312|617213003|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782908|NCT01261312|617213004|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782909|NCT01261312|617213005|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
170782910|NCT01261312|617213006|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
170782911|NCT01261312|617213007|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
170782912|NCT01261312|617213008|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782913|NCT01261312|617213009|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782914|NCT01261312|617213010|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782915|NCT01261312|617213011|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
170782916|NCT01261312|617212999|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782917|NCT01261312|617213000|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782918|NCT01261312|617213001|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782919|NCT01261312|617213002|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782920|NCT01261312|617213003|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782921|NCT01261312|617213004|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782922|NCT01261312|617213005|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
170782923|NCT01261312|617213006|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
170782924|NCT01261312|617213007|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
170782925|NCT01261312|617213008|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782926|NCT01261312|617213009|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782927|NCT01261312|617213010|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782928|NCT01261312|617213011|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
170782929|NCT01261312|617212999|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782930|NCT01261312|617213000|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782931|NCT01261312|617213001|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782932|NCT01261312|617213002|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782933|NCT01261312|617213003|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782934|NCT01261312|617213004|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782935|NCT01261312|617213005|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782936|NCT01261312|617213006|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782937|NCT01261312|617213007|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
170782938|NCT01261312|617213008|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
170884084|NCT01903837|617585105|FG002|Part B|Incarceration|0|||
170884085|NCT01903837|617585106|FG003|Part B|Incarceration|1|||
170884086|NCT01903837|617585103|FG000|Part B|Physician Decision|1|||
170884087|NCT01903837|617585104|FG001|Part B|Physician Decision|0|||
170884088|NCT01903837|617585105|FG002|Part B|Physician Decision|0|||
170884089|NCT01903837|617585106|FG003|Part B|Physician Decision|2|||
170884090|NCT01903837|617585103|FG000|Part B|Lack of Efficacy|0|||
170884091|NCT01903837|617585104|FG001|Part B|Lack of Efficacy|1|||
170440473|NCT00021541|615951561|FG001|Period 1-First Treatment|Death|0|||
170884092|NCT01903837|617585105|FG002|Part B|Lack of Efficacy|0|||
170884093|NCT01903837|617585106|FG003|Part B|Lack of Efficacy|0|||
170884094|NCT02728830|617585114|FG000|Overall Study|Exclusionary Surgery|9|||
170884095|NCT02728830|617585114|FG000|Overall Study|Exclusionary Pathology|6|||
170440474|NCT00021541|615951560|FG000|Period 1-First Treatment|Pts that did not progress|2|||
170884096|NCT02728830|617585114|FG000|Overall Study|Physician Decision|3|||
170884097|NCT02728830|617585114|FG000|Overall Study|Withdrawal by Subject|2|||
170884098|NCT02728830|617585114|FG000|Overall Study|Lost to Follow-up|1|||
170884099|NCT02728830|617585114|FG000|Overall Study|Exclusionary Lab Values|1|||
170884100|NCT02728830|617585114|FG000|Overall Study|Contraindicated Illness|1|||
170884101|NCT02728830|617585114|FG000|Overall Study|Language Barrier|1|||
170884102|NCT03603496|617585116|FG000|Overall Study|Death|19|||
170884103|NCT03603496|617585117|FG001|Overall Study|Death|24|||
170884104|NCT03603496|617585116|FG000|Overall Study|Lost to Follow-up|141|||
170884105|NCT03603496|617585117|FG001|Overall Study|Lost to Follow-up|141|||
170884106|NCT03603496|617585116|FG000|Overall Study|Withdrawal by Subject|26|||
170884107|NCT03603496|617585117|FG001|Overall Study|Withdrawal by Subject|20|||
170884108|NCT04288154|617585118|FG000|Overall Study|Withdrawal by Subject|9|||
170884109|NCT04288154|617585119|FG001|Overall Study|Withdrawal by Subject|9|||
170884110|NCT00004259|617585121|FG000|Overall Study|Protocol Violation|1|||
170884111|NCT00004259|617585122|FG001|Overall Study|Protocol Violation|2|||
170884112|NCT00004259|617585123|FG002|Overall Study|Protocol Violation|0|||
170884113|NCT00004259|617585124|FG003|Overall Study|Protocol Violation|0|||
170884114|NCT00004259|617585121|FG000|Overall Study|Withdrawal by Subject|0|||
170884115|NCT00004259|617585122|FG001|Overall Study|Withdrawal by Subject|2|||
170884116|NCT00004259|617585123|FG002|Overall Study|Withdrawal by Subject|0|||
170884117|NCT00004259|617585124|FG003|Overall Study|Withdrawal by Subject|0|||
170884118|NCT03594227|617585125|FG000|Overall Study|Adverse Event|2|||
170884119|NCT03594227|617585126|FG001|Overall Study|Adverse Event|1|||
170884120|NCT03594227|617585127|FG002|Overall Study|Adverse Event|0|||
170884121|NCT03594227|617585128|FG003|Overall Study|Adverse Event|2|||
170884122|NCT03594227|617585125|FG000|Overall Study|Lost to Follow-up|1|||
170884123|NCT03594227|617585126|FG001|Overall Study|Lost to Follow-up|1|||
170884124|NCT03594227|617585127|FG002|Overall Study|Lost to Follow-up|1|||
170884125|NCT03594227|617585128|FG003|Overall Study|Lost to Follow-up|0|||
170884126|NCT03594227|617585125|FG000|Overall Study|Withdrawal by Subject|1|||
170884127|NCT03594227|617585126|FG001|Overall Study|Withdrawal by Subject|1|||
170884128|NCT03594227|617585127|FG002|Overall Study|Withdrawal by Subject|1|||
170884129|NCT03594227|617585128|FG003|Overall Study|Withdrawal by Subject|1|||
170884130|NCT03594227|617585125|FG000|Overall Study|Pregnancy|0|||
170884131|NCT03594227|617585126|FG001|Overall Study|Pregnancy|1|||
170884132|NCT03594227|617585127|FG002|Overall Study|Pregnancy|0|||
170884133|NCT03594227|617585128|FG003|Overall Study|Pregnancy|0|||
170884134|NCT03594227|617585125|FG000|Overall Study|Sponsor Decision|0|||
170884135|NCT03594227|617585126|FG001|Overall Study|Sponsor Decision|0|||
170884136|NCT03594227|617585127|FG002|Overall Study|Sponsor Decision|0|||
170884137|NCT03594227|617585128|FG003|Overall Study|Sponsor Decision|1|||
170884138|NCT03594227|617585125|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
170884139|NCT03594227|617585126|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
170884140|NCT03594227|617585127|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
170884141|NCT03594227|617585128|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
170884142|NCT00109707|617585133|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
170884143|NCT00109707|617585134|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
170884144|NCT00109707|617585135|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
170884145|NCT00109707|617585133|FG000|Overall Study|Abnormal laboratory values|1|||
170884146|NCT00109707|617585134|FG001|Overall Study|Abnormal laboratory values|0|||
170884147|NCT00109707|617585135|FG002|Overall Study|Abnormal laboratory values|0|||
170884148|NCT00109707|617585133|FG000|Overall Study|Administrative problems|2|||
170884149|NCT00109707|617585134|FG001|Overall Study|Administrative problems|0|||
170884150|NCT00109707|617585135|FG002|Overall Study|Administrative problems|1|||
170884151|NCT00109707|617585133|FG000|Overall Study|Adverse Event|10|||
170884152|NCT00109707|617585134|FG001|Overall Study|Adverse Event|2|||
170884153|NCT00109707|617585135|FG002|Overall Study|Adverse Event|3|||
170884154|NCT00109707|617585133|FG000|Overall Study|Death|4|||
170884155|NCT00109707|617585134|FG001|Overall Study|Death|0|||
170884156|NCT00109707|617585135|FG002|Overall Study|Death|0|||
170884157|NCT00109707|617585133|FG000|Overall Study|Disease progression|12|||
170884158|NCT00109707|617585134|FG001|Overall Study|Disease progression|4|||
170884159|NCT00109707|617585135|FG002|Overall Study|Disease progression|3|||
170884160|NCT00109707|617585133|FG000|Overall Study|Lost to Follow-up|3|||
170884161|NCT00109707|617585134|FG001|Overall Study|Lost to Follow-up|0|||
170884162|NCT00109707|617585135|FG002|Overall Study|Lost to Follow-up|0|||
170884163|NCT00109707|617585133|FG000|Overall Study|Protocol Violation|1|||
170884164|NCT00109707|617585134|FG001|Overall Study|Protocol Violation|0|||
170884165|NCT00109707|617585135|FG002|Overall Study|Protocol Violation|0|||
170884166|NCT00109707|617585133|FG000|Overall Study|Patient withdrew consent|6|||
170884167|NCT00109707|617585134|FG001|Overall Study|Patient withdrew consent|1|||
170884168|NCT00109707|617585135|FG002|Overall Study|Patient withdrew consent|0|||
170884169|NCT00835237|617585136|FG000|Overall Study|Lost to Follow-up|4|||
170884170|NCT00835237|617585137|FG001|Overall Study|Lost to Follow-up|0|||
170884171|NCT00835237|617585136|FG000|Overall Study|Withdrawal by Subject|2|||
170884172|NCT00835237|617585137|FG001|Overall Study|Withdrawal by Subject|0|||
170884173|NCT03436862|617585139|FG000|Overall Study|Adverse Event|4|||
170884174|NCT03436862|617585139|FG000|Overall Study|Progressive Disease|2|||
170884175|NCT02873936|617585140|FG000|Overall Study|Withdrew Consent|4|||
170884176|NCT02873936|617585141|FG001|Overall Study|Withdrew Consent|11|||
170884177|NCT02873936|617585142|FG002|Overall Study|Withdrew Consent|20|||
170884178|NCT02873936|617585140|FG000|Overall Study|Investigator's Discretion|3|||
170884179|NCT02873936|617585141|FG001|Overall Study|Investigator's Discretion|5|||
170884180|NCT02873936|617585142|FG002|Overall Study|Investigator's Discretion|4|||
170884181|NCT02873936|617585140|FG000|Overall Study|Adverse Event|3|||
170884182|NCT02873936|617585141|FG001|Overall Study|Adverse Event|5|||
170884183|NCT02873936|617585142|FG002|Overall Study|Adverse Event|3|||
170884184|NCT02873936|617585140|FG000|Overall Study|Protocol Violation|0|||
170884185|NCT02873936|617585141|FG001|Overall Study|Protocol Violation|1|||
170884186|NCT02873936|617585142|FG002|Overall Study|Protocol Violation|3|||
170884187|NCT02873936|617585140|FG000|Overall Study|Lost to Follow-up|1|||
170884188|NCT02873936|617585141|FG001|Overall Study|Lost to Follow-up|1|||
170884189|NCT02873936|617585142|FG002|Overall Study|Lost to Follow-up|1|||
170884190|NCT02873936|617585140|FG000|Overall Study|Non-compliance With Study Drug|1|||
170884191|NCT02873936|617585141|FG001|Overall Study|Non-compliance With Study Drug|0|||
170884192|NCT02873936|617585142|FG002|Overall Study|Non-compliance With Study Drug|1|||
170884193|NCT02873936|617585140|FG000|Overall Study|Randomized but not Dosed|1|||
170884194|NCT02873936|617585141|FG001|Overall Study|Randomized but not Dosed|0|||
170884195|NCT02873936|617585142|FG002|Overall Study|Randomized but not Dosed|0|||
170884196|NCT01505634|617585144|FG000|Overall Study|Withdrawal by Subject|2|||
170884197|NCT01505634|617585145|FG001|Overall Study|Withdrawal by Subject|5|||
170884198|NCT01505634|617585146|FG002|Overall Study|Withdrawal by Subject|1|||
170884199|NCT01505634|617585144|FG000|Overall Study|Physician Decision|1|||
170884200|NCT01505634|617585145|FG001|Overall Study|Physician Decision|1|||
170884201|NCT01505634|617585146|FG002|Overall Study|Physician Decision|0|||
170884202|NCT01505634|617585144|FG000|Overall Study|Adverse Event|1|||
170884203|NCT01505634|617585145|FG001|Overall Study|Adverse Event|0|||
170884204|NCT01505634|617585146|FG002|Overall Study|Adverse Event|0|||
170884205|NCT01505634|617585144|FG000|Overall Study|Insufficient supply of drug at site|1|||
170884206|NCT01505634|617585145|FG001|Overall Study|Insufficient supply of drug at site|0|||
170884207|NCT01505634|617585146|FG002|Overall Study|Insufficient supply of drug at site|0|||
170884208|NCT01505634|617585144|FG000|Overall Study|Protocol Violation|2|||
170884209|NCT01505634|617585145|FG001|Overall Study|Protocol Violation|0|||
170884210|NCT01505634|617585146|FG002|Overall Study|Protocol Violation|0|||
170884211|NCT01505634|617585144|FG000|Overall Study|Lost to Follow-up|1|||
170884212|NCT01505634|617585145|FG001|Overall Study|Lost to Follow-up|4|||
170884213|NCT01505634|617585146|FG002|Overall Study|Lost to Follow-up|4|||
170884214|NCT01505634|617585144|FG000|Overall Study|Death|1|||
170884215|NCT01505634|617585145|FG001|Overall Study|Death|0|||
170884216|NCT01505634|617585146|FG002|Overall Study|Death|0|||
170884217|NCT01505634|617585144|FG000|Overall Study|In a conflict zone|0|||
170884218|NCT01505634|617585145|FG001|Overall Study|In a conflict zone|0|||
170884219|NCT01505634|617585146|FG002|Overall Study|In a conflict zone|1|||
170884220|NCT00960843|617585147|FG000|Overall Study|Lost to Follow-up|2|||
170884221|NCT00960843|617585148|FG001|Overall Study|Lost to Follow-up|0|||
170884222|NCT00960843|617585147|FG000|Overall Study|Protocol Violation|0|||
170884223|NCT00960843|617585148|FG001|Overall Study|Protocol Violation|4|||
170884224|NCT00960843|617585147|FG000|Overall Study|Repeated needle dislodgment|0|||
170884225|NCT00960843|617585148|FG001|Overall Study|Repeated needle dislodgment|1|||
170884226|NCT00542269|617585149|FG000|Overall Study|Adverse Event|10|||
170884227|NCT00542269|617585150|FG001|Overall Study|Adverse Event|4|||
170884228|NCT00542269|617585151|FG002|Overall Study|Adverse Event|5|||
170884229|NCT00542269|617585149|FG000|Overall Study|Protocol Violation|1|||
170884230|NCT00542269|617585150|FG001|Overall Study|Protocol Violation|1|||
170884231|NCT00542269|617585151|FG002|Overall Study|Protocol Violation|0|||
170884232|NCT00542269|617585149|FG000|Overall Study|Withdrawal by Subject|1|||
170884233|NCT00542269|617585150|FG001|Overall Study|Withdrawal by Subject|0|||
170884234|NCT00542269|617585151|FG002|Overall Study|Withdrawal by Subject|0|||
170884235|NCT00542269|617585149|FG000|Overall Study|Administrative problems|1|||
170884236|NCT00542269|617585150|FG001|Overall Study|Administrative problems|1|||
170884237|NCT00542269|617585151|FG002|Overall Study|Administrative problems|1|||
170884238|NCT03028870|617585155|FG000|Overall Study|Adverse Event|7|||
170884239|NCT03028870|617585156|FG001|Overall Study|Adverse Event|4|||
170884240|NCT03028870|617585157|FG002|Overall Study|Adverse Event|3|||
170884241|NCT03028870|617585158|FG003|Overall Study|Adverse Event|3|||
170884242|NCT03028870|617585155|FG000|Overall Study|Withdrawal by Subject|1|||
170884243|NCT03028870|617585156|FG001|Overall Study|Withdrawal by Subject|1|||
170884244|NCT03028870|617585157|FG002|Overall Study|Withdrawal by Subject|1|||
170884245|NCT03028870|617585158|FG003|Overall Study|Withdrawal by Subject|2|||
170884246|NCT03028870|617585155|FG000|Overall Study|Lost to Follow-up|1|||
170884247|NCT03028870|617585156|FG001|Overall Study|Lost to Follow-up|0|||
170884248|NCT03028870|617585157|FG002|Overall Study|Lost to Follow-up|0|||
170884249|NCT03028870|617585158|FG003|Overall Study|Lost to Follow-up|0|||
170884250|NCT03028870|617585155|FG000|Overall Study|Lack of Efficacy|3|||
170884251|NCT03028870|617585156|FG001|Overall Study|Lack of Efficacy|0|||
170884252|NCT03028870|617585157|FG002|Overall Study|Lack of Efficacy|0|||
170884253|NCT03028870|617585158|FG003|Overall Study|Lack of Efficacy|0|||
170884254|NCT03028870|617585155|FG000|Overall Study|Administrative|5|||
170884255|NCT03028870|617585156|FG001|Overall Study|Administrative|5|||
170884256|NCT03028870|617585157|FG002|Overall Study|Administrative|12|||
170884257|NCT03028870|617585158|FG003|Overall Study|Administrative|4|||
170884258|NCT01294579|617585159|FG000|Overall Study|Disease progression|12|||
170884259|NCT01294579|617585159|FG000|Overall Study|Adverse Event|11|||
170884260|NCT01294579|617585159|FG000|Overall Study|Study closed/terminated|3|||
170884261|NCT01294579|617585159|FG000|Overall Study|Lost to Follow-up|1|||
170884262|NCT01294579|617585159|FG000|Overall Study|Physician Decision|3|||
170884263|NCT01294579|617585159|FG000|Overall Study|Withdrawal by Subject|5|||
170884264|NCT00490451|617585160|FG000|Overall Study|Adverse Event|3|||
170884265|NCT00490451|617585161|FG001|Overall Study|Adverse Event|3|||
170884266|NCT00490451|617585160|FG000|Overall Study|Death|3|||
170884267|NCT00490451|617585161|FG001|Overall Study|Death|1|||
170884268|NCT00490451|617585160|FG000|Overall Study|Withdrawal by Subject|2|||
170884269|NCT00490451|617585161|FG001|Overall Study|Withdrawal by Subject|0|||
170884270|NCT00490451|617585160|FG000|Overall Study|Investigator Decision|1|||
170884271|NCT00490451|617585161|FG001|Overall Study|Investigator Decision|0|||
170884272|NCT00490451|617585160|FG000|Overall Study|Protocol Violation|1|||
170884273|NCT00490451|617585161|FG001|Overall Study|Protocol Violation|0|||
170884274|NCT00490451|617585160|FG000|Overall Study|Progressive Disease|53|||
170884275|NCT00490451|617585161|FG001|Overall Study|Progressive Disease|34|||
170884276|NCT01967537|617585164|FG000|Overall Study|Withdrawal by Subject|52|||
170884277|NCT01967537|617585164|FG000|Overall Study|Refuse treatment|2|||
170884278|NCT01967537|617585164|FG000|Overall Study|Lost to Follow-up|6|||
170884279|NCT00562354|617585165|FG000|Overall Study|Physician Decision|0|||
170884280|NCT00562354|617585166|FG001|Overall Study|Physician Decision|1|||
170884281|NCT00562354|617585165|FG000|Overall Study|Lost to Follow-up|0|||
170884282|NCT00562354|617585166|FG001|Overall Study|Lost to Follow-up|1|||
170884283|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
170884284|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
170884285|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
170884286|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
170884287|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
170884288|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
170884289|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
170884290|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
170884291|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
170884292|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
170884293|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
170884294|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
170884295|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
170884296|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
170884297|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
170884298|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
170884299|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
170884300|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
170884301|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
170884302|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
170884303|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
170884304|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
170884305|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
170884306|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
170884307|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
170884308|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
170884309|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
170884310|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
170884311|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
170884312|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
170884313|NCT00784654|617585167|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
170884314|NCT00784654|617585168|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
170884315|NCT00784654|617585169|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
170884316|NCT00784654|617585167|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
170884317|NCT00784654|617585168|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
170884318|NCT00784654|617585169|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
170884319|NCT00784654|617585167|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
170884320|NCT00784654|617585168|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
170884321|NCT00784654|617585169|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
170884322|NCT00784654|617585167|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170884323|NCT00784654|617585168|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
170884324|NCT00784654|617585169|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
170884325|NCT00784654|617585167|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
170884326|NCT00784654|617585168|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
170884327|NCT00784654|617585169|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
170884328|NCT00784654|617585167|FG000|Randomized Withdrawal Period|Adverse Event|0|||
170884329|NCT00784654|617585168|FG001|Randomized Withdrawal Period|Adverse Event|1|||
170884330|NCT00784654|617585169|FG002|Randomized Withdrawal Period|Adverse Event|1|||
170884331|NCT00784654|617585167|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
170884332|NCT00784654|617585168|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
170884333|NCT00784654|617585169|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
170884334|NCT00784654|617585167|FG000|Randomized Withdrawal Period|Family reasons|0|||
170884335|NCT00784654|617585168|FG001|Randomized Withdrawal Period|Family reasons|0|||
170884336|NCT00784654|617585169|FG002|Randomized Withdrawal Period|Family reasons|1|||
170884337|NCT01079182|617585170|FG000|Overall Study|Lost to Follow-up|1634|||
170884338|NCT01079182|617585170|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
170884339|NCT01079182|617585170|FG000|Overall Study|Lack of Efficacy|514|||
170884340|NCT01079182|617585170|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
170884341|NCT01079182|617585170|FG000|Overall Study|Reasons not Evaluated|271|||
170884342|NCT01026831|617585171|FG000|Overall Study|Adverse Event|4|||
170884343|NCT01026831|617585172|FG001|Overall Study|Adverse Event|3|||
170884344|NCT01026831|617585171|FG000|Overall Study|Lost to Follow-up|2|||
170884345|NCT01026831|617585172|FG001|Overall Study|Lost to Follow-up|0|||
170884346|NCT01026831|617585171|FG000|Overall Study|Physician Decision|1|||
170884347|NCT01026831|617585172|FG001|Overall Study|Physician Decision|1|||
170884348|NCT01026831|617585171|FG000|Overall Study|Protocol Violation|0|||
170884349|NCT01026831|617585172|FG001|Overall Study|Protocol Violation|2|||
170884350|NCT01026831|617585171|FG000|Overall Study|Withdrawal by Subject|7|||
170884351|NCT01026831|617585172|FG001|Overall Study|Withdrawal by Subject|5|||
170884352|NCT01180660|617585173|FG000|Overall Study|Changed to open surgery|1|||
170884353|NCT01180660|617585174|FG001|Overall Study|Changed to open surgery|0|||
170884354|NCT01273883|617585181|FG000|First Intervention|Adverse Event|2|||
170884355|NCT01273883|617585182|FG001|First Intervention|Adverse Event|1|||
170884356|NCT01273883|617585181|FG000|Second Intervention|Lost to Follow-up|1|||
170884357|NCT01273883|617585182|FG001|Second Intervention|Lost to Follow-up|1|||
170884358|NCT01273883|617585181|FG000|Second Intervention|Lack of Efficacy|1|||
170884359|NCT01273883|617585182|FG001|Second Intervention|Lack of Efficacy|0|||
170884360|NCT00333359|617585189|FG000|Overall Study|Adverse Event|29|||
170884361|NCT00333359|617585190|FG001|Overall Study|Adverse Event|35|||
170884362|NCT00333359|617585189|FG000|Overall Study|Withdrawal by Subject|19|||
170884363|NCT00333359|617585190|FG001|Overall Study|Withdrawal by Subject|37|||
170884364|NCT00333359|617585189|FG000|Overall Study|Physician Decision|2|||
170884365|NCT00333359|617585190|FG001|Overall Study|Physician Decision|2|||
170884366|NCT00333359|617585189|FG000|Overall Study|Protocol Non-compliance|2|||
170884367|NCT00333359|617585190|FG001|Overall Study|Protocol Non-compliance|8|||
170884368|NCT00333359|617585189|FG000|Overall Study|Lost to Follow-up|15|||
170884369|NCT00333359|617585190|FG001|Overall Study|Lost to Follow-up|25|||
170884370|NCT00333359|617585189|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
170884371|NCT00333359|617585190|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
170884372|NCT00333359|617585189|FG000|Overall Study|Treatment Failure|3|||
170884373|NCT00333359|617585190|FG001|Overall Study|Treatment Failure|8|||
170884374|NCT00333359|617585189|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
170884375|NCT00333359|617585190|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
170884376|NCT03257267|617586684|FG000|Overall Study|Adverse Event|17|||
170884377|NCT03257267|617586685|FG001|Overall Study|Adverse Event|7|||
170884378|NCT03257267|617586684|FG000|Overall Study|Death|96|||
170884379|NCT03257267|617586685|FG001|Overall Study|Death|98|||
170884380|NCT03257267|617586684|FG000|Overall Study|Lost to Follow-up|2|||
170884381|NCT03257267|617586685|FG001|Overall Study|Lost to Follow-up|2|||
170884382|NCT03257267|617586684|FG000|Overall Study|Non-compliance with Study Drug|0|||
170884383|NCT03257267|617586685|FG001|Overall Study|Non-compliance with Study Drug|2|||
170884384|NCT03257267|617586684|FG000|Overall Study|Participant Decision|35|||
170884385|NCT03257267|617586685|FG001|Overall Study|Participant Decision|43|||
170884386|NCT03257267|617586684|FG000|Overall Study|Sponsor Decision|1|||
170884387|NCT03257267|617586685|FG001|Overall Study|Sponsor Decision|0|||
170884388|NCT03257267|617586684|FG000|Overall Study|Physician Decision|1|||
170884389|NCT03257267|617586685|FG001|Overall Study|Physician Decision|3|||
170884390|NCT03257267|617586684|FG000|Overall Study|Disease Progression|109|||
170884391|NCT03257267|617586685|FG001|Overall Study|Disease Progression|121|||
170884392|NCT03257267|617586684|FG000|Overall Study|Withdrawal by Subject|8|||
170440475|NCT00021541|615951561|FG001|Period 1-First Treatment|Pts that did not progress|2|||
170633044|NCT01544335|616668459|FG000|Overall Study|Baseline Measurements not Available|19|||
170633045|NCT01746901|616668460|FG000|Naloxone Challenge Phase|Adverse Event|2|||
170633046|NCT01746901|616668461|FG001|Naloxone Challenge Phase|Adverse Event|0|||
170633047|NCT01746901|616668462|FG002|Naloxone Challenge Phase|Adverse Event|0|||
170633048|NCT01746901|616668463|FG003|Naloxone Challenge Phase|Adverse Event|0|||
170633049|NCT01746901|616668464|FG004|Naloxone Challenge Phase|Adverse Event|0|||
170782939|NCT01261312|617213009|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
170782940|NCT01261312|617213010|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
170782941|NCT01261312|617213011|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
170782942|NCT01261312|617212999|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782943|NCT01261312|617213000|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782944|NCT01261312|617213001|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782945|NCT01261312|617213002|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782946|NCT01261312|617213003|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782947|NCT01261312|617213004|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782948|NCT01261312|617213005|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782949|NCT01261312|617213006|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782950|NCT01261312|617213007|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782951|NCT01261312|617213008|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
170782952|NCT01261312|617213009|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
170782953|NCT01261312|617213010|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
170782954|NCT01261312|617213011|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
170782955|NCT01261312|617212999|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782956|NCT01261312|617213000|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782957|NCT01261312|617213001|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782958|NCT01261312|617213002|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782959|NCT01261312|617213003|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782960|NCT01261312|617213004|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782961|NCT01261312|617213005|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782962|NCT01261312|617213006|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782963|NCT01261312|617213007|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
170782964|NCT01261312|617213008|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
170782965|NCT01261312|617213009|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
170782966|NCT01261312|617213010|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
170782967|NCT01261312|617213011|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
170782968|NCT01261312|617212999|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782969|NCT01261312|617213000|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782970|NCT01261312|617213001|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782971|NCT01261312|617213002|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782972|NCT01261312|617213003|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782973|NCT01261312|617213004|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782974|NCT01261312|617213005|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782975|NCT01261312|617213006|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782976|NCT01261312|617213007|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
170782977|NCT01261312|617213008|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
170782978|NCT01261312|617213009|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
170782979|NCT01261312|617213010|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
170782980|NCT01261312|617213011|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
170782981|NCT01261312|617212999|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170782982|NCT01261312|617213000|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170782983|NCT01261312|617213001|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170782984|NCT01261312|617213002|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170782985|NCT01261312|617213003|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170782986|NCT01261312|617213004|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170782987|NCT01261312|617213005|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170782988|NCT01261312|617213006|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170782989|NCT01261312|617213007|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
170884393|NCT03257267|617586685|FG001|Overall Study|Withdrawal by Subject|26|||
170633050|NCT01746901|616668465|FG005|Naloxone Challenge Phase|Adverse Event|0|||
170633051|NCT01746901|616668466|FG006|Naloxone Challenge Phase|Adverse Event|0|||
170633052|NCT01746901|616668467|FG007|Naloxone Challenge Phase|Adverse Event|0|||
170633053|NCT01746901|616668468|FG008|Naloxone Challenge Phase|Adverse Event|0|||
170633054|NCT01746901|616668460|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
170633055|NCT01746901|616668461|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
170884394|NCT03257267|617586684|FG000|Overall Study|Other|0|||
170884395|NCT03257267|617586685|FG001|Overall Study|Other|2|||
170884396|NCT03445000|617586686|FG000|Overall Study|Disease progression|8|||
170884397|NCT03445000|617586686|FG000|Overall Study|Adverse Event|3|||
170884398|NCT03445000|617586686|FG000|Overall Study|Death|2|||
170884399|NCT03445000|617586686|FG000|Overall Study|Physician Decision|1|||
170884400|NCT03409744|617586687|FG000|Overall Study|Death|2|||
170884401|NCT03409744|617586687|FG000|Overall Study|Physician Decision|5|||
170884402|NCT03409744|617586687|FG000|Overall Study|Pregnancy|1|||
170884403|NCT03409744|617586687|FG000|Overall Study|Lost to Follow-up|1|||
170884404|NCT03409744|617586687|FG000|Overall Study|Protocol Violation|1|||
170884405|NCT05804877|617586689|FG000|Overall Study|Lost to Follow-up|1|||
170884406|NCT05804877|617586690|FG001|Overall Study|Lost to Follow-up|3|||
170884407|NCT05804877|617586689|FG000|Overall Study|Withdrawal by Subject|1|||
170884408|NCT05804877|617586690|FG001|Overall Study|Withdrawal by Subject|0|||
170884409|NCT05804877|617586689|FG000|Overall Study|Withdrawal by Subject|1|||
170884410|NCT05804877|617586690|FG001|Overall Study|Withdrawal by Subject|0|||
170884411|NCT03548051|617586699|FG000|Overall Study|Death|1|||
170884412|NCT03548051|617586700|FG001|Overall Study|Death|1|||
170884413|NCT03548051|617586699|FG000|Overall Study|Withdrawal by Subject|1|||
170884414|NCT03548051|617586700|FG001|Overall Study|Withdrawal by Subject|0|||
170884415|NCT00494091|617586701|FG000|Overall Study|Death|5|||
170884416|NCT00494091|617586702|FG001|Overall Study|Death|54|||
170884417|NCT00494091|617586701|FG000|Overall Study|Lost to Follow-up|0|||
170884418|NCT00494091|617586702|FG001|Overall Study|Lost to Follow-up|4|||
170884419|NCT00494091|617586701|FG000|Overall Study|Other|1|||
170884420|NCT00494091|617586702|FG001|Overall Study|Other|11|||
170884421|NCT00494091|617586701|FG000|Overall Study|Withdrawal by Subject|0|||
170884422|NCT00494091|617586702|FG001|Overall Study|Withdrawal by Subject|7|||
170884423|NCT02105454|617586707|FG000|Overall Study|Withdrawal by Subject|1|||
170884424|NCT01268293|617586711|FG000|Overall Study|Disease progression|7|||
170884425|NCT01268293|617586711|FG000|Overall Study|Adverse Event|1|||
170884426|NCT01268293|617586711|FG000|Overall Study|Subject choice|1|||
170884427|NCT03806127|617586720|FG000|Overall Study|Withdrawal by Subject|4|||
170884428|NCT03806127|617586721|FG001|Overall Study|Withdrawal by Subject|5|||
170884429|NCT03806127|617586720|FG000|Overall Study|Protocol Violation|3|||
170884430|NCT03806127|617586721|FG001|Overall Study|Protocol Violation|1|||
170884431|NCT03806127|617586720|FG000|Overall Study|Adverse Event|3|||
170884432|NCT03806127|617586721|FG001|Overall Study|Adverse Event|0|||
170884433|NCT03806127|617586720|FG000|Overall Study|Unable to Complete Procedures|0|||
170884434|NCT03806127|617586721|FG001|Overall Study|Unable to Complete Procedures|1|||
170884435|NCT03806127|617586720|FG000|Overall Study|Pregnancy|0|||
170884436|NCT03806127|617586721|FG001|Overall Study|Pregnancy|1|||
170884437|NCT03806127|617586720|FG000|Overall Study|Lost to Follow-up|5|||
170884438|NCT03806127|617586721|FG001|Overall Study|Lost to Follow-up|1|||
170884439|NCT03806127|617586720|FG000|Overall Study|Physician Decision|1|||
170884440|NCT03806127|617586721|FG001|Overall Study|Physician Decision|1|||
170884441|NCT03806127|617586720|FG000|Overall Study|Could Not Come Due to Covid|1|||
170633056|NCT01746901|616668462|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
170633057|NCT01746901|616668463|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
170633058|NCT01746901|616668464|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
170633059|NCT01746901|616668465|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
170633060|NCT01746901|616668466|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
170884442|NCT03806127|617586721|FG001|Overall Study|Could Not Come Due to Covid|0|||
170884443|NCT03806127|617586720|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
170884444|NCT03806127|617586721|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
170884445|NCT03806127|617586720|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
170884446|NCT03806127|617586721|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
170884447|NCT03806127|617586720|FG000|Overall Study|Covid 19 Restrictions|2|||
170884448|NCT03806127|617586721|FG001|Overall Study|Covid 19 Restrictions|0|||
170633061|NCT01746901|616668467|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
170633062|NCT01746901|616668468|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
170633063|NCT01746901|616668460|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170633064|NCT01746901|616668461|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
170633065|NCT01746901|616668462|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170633066|NCT01746901|616668463|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170633067|NCT01746901|616668464|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170633068|NCT01746901|616668465|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170633069|NCT01746901|616668466|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170633070|NCT01746901|616668467|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170633071|NCT01746901|616668468|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170633072|NCT01746901|616668460|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
170633073|NCT01746901|616668461|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
170633074|NCT01746901|616668462|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
170884449|NCT03806127|617586720|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
170884450|NCT03806127|617586721|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
170884451|NCT03806127|617586720|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
170884452|NCT03806127|617586721|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
170884453|NCT05048342|617586724|FG000|Overall Study|Adverse Event|1|||
170884454|NCT05048342|617586724|FG000|Overall Study|Subject decision|2|||
170884455|NCT01441063|617586725|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
170884456|NCT01441063|617586725|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
170884457|NCT00618410|617586726|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
170884458|NCT00618410|617586727|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
170884459|NCT00464334|617586728|FG000|Overall Study|Adverse Event|0|||
170884460|NCT00464334|617586729|FG001|Overall Study|Adverse Event|0|||
170884461|NCT00464334|617586730|FG002|Overall Study|Adverse Event|0|||
170884462|NCT00464334|617586731|FG003|Overall Study|Adverse Event|1|||
170884463|NCT00464334|617586732|FG004|Overall Study|Adverse Event|1|||
170884464|NCT00464334|617586733|FG005|Overall Study|Adverse Event|1|||
170884465|NCT00464334|617586734|FG006|Overall Study|Adverse Event|0|||
170884466|NCT00464334|617586735|FG007|Overall Study|Adverse Event|0|||
170884467|NCT00464334|617586736|FG008|Overall Study|Adverse Event|2|||
170884468|NCT00464334|617586737|FG009|Overall Study|Adverse Event|1|||
170884469|NCT00464334|617586738|FG010|Overall Study|Adverse Event|2|||
170884470|NCT00464334|617586728|FG000|Overall Study|Lack of Efficacy|0|||
170884471|NCT00464334|617586729|FG001|Overall Study|Lack of Efficacy|1|||
170884472|NCT00464334|617586730|FG002|Overall Study|Lack of Efficacy|0|||
170884473|NCT00464334|617586731|FG003|Overall Study|Lack of Efficacy|0|||
170884474|NCT00464334|617586732|FG004|Overall Study|Lack of Efficacy|0|||
170884475|NCT00464334|617586733|FG005|Overall Study|Lack of Efficacy|0|||
170884476|NCT00464334|617586734|FG006|Overall Study|Lack of Efficacy|0|||
170884477|NCT00464334|617586735|FG007|Overall Study|Lack of Efficacy|0|||
170884478|NCT00464334|617586736|FG008|Overall Study|Lack of Efficacy|0|||
170884479|NCT00464334|617586737|FG009|Overall Study|Lack of Efficacy|0|||
170884480|NCT00464334|617586738|FG010|Overall Study|Lack of Efficacy|0|||
170884481|NCT00464334|617586728|FG000|Overall Study|Lost to Follow-up|0|||
170884482|NCT00464334|617586729|FG001|Overall Study|Lost to Follow-up|0|||
170884483|NCT00464334|617586730|FG002|Overall Study|Lost to Follow-up|1|||
170884484|NCT00464334|617586731|FG003|Overall Study|Lost to Follow-up|0|||
170884485|NCT00464334|617586732|FG004|Overall Study|Lost to Follow-up|1|||
170884486|NCT00464334|617586733|FG005|Overall Study|Lost to Follow-up|0|||
170884487|NCT00464334|617586734|FG006|Overall Study|Lost to Follow-up|1|||
170884488|NCT00464334|617586735|FG007|Overall Study|Lost to Follow-up|0|||
170884489|NCT00464334|617586736|FG008|Overall Study|Lost to Follow-up|0|||
170884490|NCT00464334|617586737|FG009|Overall Study|Lost to Follow-up|0|||
170884491|NCT00464334|617586738|FG010|Overall Study|Lost to Follow-up|2|||
170884492|NCT00464334|617586728|FG000|Overall Study|Progressive Disease|0|||
170884493|NCT00464334|617586729|FG001|Overall Study|Progressive Disease|0|||
170884494|NCT00464334|617586730|FG002|Overall Study|Progressive Disease|0|||
170884495|NCT00464334|617586731|FG003|Overall Study|Progressive Disease|0|||
170884496|NCT00464334|617586732|FG004|Overall Study|Progressive Disease|0|||
170884497|NCT00464334|617586733|FG005|Overall Study|Progressive Disease|1|||
170884498|NCT00464334|617586734|FG006|Overall Study|Progressive Disease|0|||
170884499|NCT00464334|617586735|FG007|Overall Study|Progressive Disease|0|||
170884500|NCT00464334|617586736|FG008|Overall Study|Progressive Disease|1|||
170884501|NCT00464334|617586737|FG009|Overall Study|Progressive Disease|0|||
170884502|NCT00464334|617586738|FG010|Overall Study|Progressive Disease|0|||
170884503|NCT00464334|617586728|FG000|Overall Study|Study Terminated by Sponsor|0|||
170884504|NCT00464334|617586729|FG001|Overall Study|Study Terminated by Sponsor|0|||
170884505|NCT00464334|617586730|FG002|Overall Study|Study Terminated by Sponsor|0|||
170884506|NCT00464334|617586731|FG003|Overall Study|Study Terminated by Sponsor|1|||
170884507|NCT00464334|617586732|FG004|Overall Study|Study Terminated by Sponsor|0|||
170884508|NCT00464334|617586733|FG005|Overall Study|Study Terminated by Sponsor|0|||
170884509|NCT00464334|617586734|FG006|Overall Study|Study Terminated by Sponsor|0|||
170884510|NCT00464334|617586735|FG007|Overall Study|Study Terminated by Sponsor|0|||
170884511|NCT00464334|617586736|FG008|Overall Study|Study Terminated by Sponsor|0|||
170884512|NCT00464334|617586737|FG009|Overall Study|Study Terminated by Sponsor|0|||
170884513|NCT00464334|617586738|FG010|Overall Study|Study Terminated by Sponsor|0|||
170884514|NCT00464334|617586728|FG000|Overall Study|Withdrawal by Subject|1|||
170884515|NCT00464334|617586729|FG001|Overall Study|Withdrawal by Subject|7|||
170884516|NCT00464334|617586730|FG002|Overall Study|Withdrawal by Subject|4|||
170884517|NCT00464334|617586731|FG003|Overall Study|Withdrawal by Subject|2|||
170884518|NCT00464334|617586732|FG004|Overall Study|Withdrawal by Subject|2|||
170884519|NCT00464334|617586733|FG005|Overall Study|Withdrawal by Subject|2|||
170884520|NCT00464334|617586734|FG006|Overall Study|Withdrawal by Subject|2|||
170884521|NCT00464334|617586735|FG007|Overall Study|Withdrawal by Subject|1|||
170884522|NCT00464334|617586736|FG008|Overall Study|Withdrawal by Subject|3|||
170884523|NCT00464334|617586737|FG009|Overall Study|Withdrawal by Subject|0|||
170884524|NCT00464334|617586738|FG010|Overall Study|Withdrawal by Subject|0|||
170884525|NCT00797732|617586739|FG000|Overall Study|Withdrawal by Subject|3|||
170884526|NCT00797732|617586740|FG001|Overall Study|Withdrawal by Subject|3|||
170884527|NCT00797732|617586741|FG002|Overall Study|Withdrawal by Subject|0|||
170884528|NCT00797732|617586739|FG000|Overall Study|Lost to Follow-up|1|||
170884529|NCT00797732|617586740|FG001|Overall Study|Lost to Follow-up|0|||
170884530|NCT00797732|617586741|FG002|Overall Study|Lost to Follow-up|0|||
170884531|NCT00797732|617586739|FG000|Overall Study|Death|1|||
170884532|NCT00797732|617586740|FG001|Overall Study|Death|0|||
170884533|NCT00797732|617586741|FG002|Overall Study|Death|0|||
170884534|NCT00797732|617586739|FG000|Overall Study|Not meet inclusion criteria|0|||
170884535|NCT00797732|617586740|FG001|Overall Study|Not meet inclusion criteria|0|||
170884536|NCT00797732|617586741|FG002|Overall Study|Not meet inclusion criteria|7|||
170884537|NCT00797732|617586739|FG000|Overall Study|Excluded due to time constraints|0|||
170884538|NCT00797732|617586740|FG001|Overall Study|Excluded due to time constraints|0|||
170884539|NCT00797732|617586741|FG002|Overall Study|Excluded due to time constraints|24|||
170884540|NCT00797732|617586739|FG000|Overall Study|Refused to Participate|0|||
170884541|NCT00797732|617586740|FG001|Overall Study|Refused to Participate|0|||
170884542|NCT00797732|617586741|FG002|Overall Study|Refused to Participate|123|||
170884543|NCT03948178|617586742|FG000|Overall Study|Protocol Violation|1|||
170884544|NCT03948178|617586742|FG000|Overall Study|Lost to Follow-up|2|||
170884545|NCT03948178|617586742|FG000|Overall Study|Withdrawal by Subject|2|||
170884546|NCT03948178|617586742|FG000|Overall Study|Reason not known|2|||
170884547|NCT03948178|617586742|FG000|Overall Study|Personal reason|14|||
170884548|NCT03948178|617586742|FG000|Overall Study|Disease progression|30|||
170884549|NCT03948178|617586742|FG000|Overall Study|Adverse Event|12|||
170884550|NCT03948178|617586742|FG000|Overall Study|Sponsor terminated study|164|||
170884551|NCT01297270|617586743|FG000|Overall Study|Adverse Event|19|||
170884552|NCT01297270|617586744|FG001|Overall Study|Adverse Event|32|||
170884553|NCT01297270|617586745|FG002|Overall Study|Adverse Event|5|||
170884554|NCT01297270|617586743|FG000|Overall Study|Lack of Efficacy|15|||
170884555|NCT01297270|617586744|FG001|Overall Study|Lack of Efficacy|17|||
170884556|NCT01297270|617586745|FG002|Overall Study|Lack of Efficacy|15|||
170884557|NCT01297270|617586743|FG000|Overall Study|Lost to Follow-up|1|||
170884558|NCT01297270|617586744|FG001|Overall Study|Lost to Follow-up|2|||
170884559|NCT01297270|617586745|FG002|Overall Study|Lost to Follow-up|1|||
170884560|NCT01297270|617586743|FG000|Overall Study|Protocol Violation|0|||
170884561|NCT01297270|617586744|FG001|Overall Study|Protocol Violation|2|||
170884562|NCT01297270|617586745|FG002|Overall Study|Protocol Violation|0|||
170884563|NCT01297270|617586743|FG000|Overall Study|Withdrawal by Subject|7|||
170884564|NCT01297270|617586744|FG001|Overall Study|Withdrawal by Subject|15|||
170884565|NCT01297270|617586745|FG002|Overall Study|Withdrawal by Subject|7|||
170884566|NCT01297270|617586743|FG000|Overall Study|Other reason not defined above|3|||
170884567|NCT01297270|617586744|FG001|Overall Study|Other reason not defined above|3|||
170884568|NCT01297270|617586745|FG002|Overall Study|Other reason not defined above|1|||
170884569|NCT01297270|617586743|FG000|Overall Study|Not treated|0|||
170884570|NCT01297270|617586744|FG001|Overall Study|Not treated|1|||
170884571|NCT01297270|617586745|FG002|Overall Study|Not treated|0|||
170884572|NCT00401752|617586748|FG000|Overall Study|Adverse Event|2|||
170884573|NCT00401752|617586749|FG001|Overall Study|Adverse Event|5|||
170884574|NCT00401752|617586748|FG000|Overall Study|Withdrawal by Subject|2|||
170884575|NCT00401752|617586749|FG001|Overall Study|Withdrawal by Subject|6|||
170884576|NCT00401752|617586748|FG000|Overall Study|Lost to Follow-up|1|||
170884577|NCT00401752|617586749|FG001|Overall Study|Lost to Follow-up|4|||
170884578|NCT00401752|617586748|FG000|Overall Study|Development of any exclusion criteria|4|||
170884579|NCT00401752|617586749|FG001|Overall Study|Development of any exclusion criteria|2|||
170884580|NCT00401752|617586748|FG000|Overall Study|Physician Decision|1|||
170884581|NCT00401752|617586749|FG001|Overall Study|Physician Decision|1|||
170884582|NCT01895322|617586750|FG000|Overall Study|Adverse Event|1|||
170884583|NCT01895322|617586750|FG000|Overall Study|Withdrawal by Subject|2|||
170884584|NCT01895322|617586750|FG000|Overall Study|Protocol Violation|10|||
170884585|NCT02275338|617586751|FG000|Overall Study|Adverse Event|15|||
170884586|NCT02275338|617586751|FG000|Overall Study|Lack of Efficacy|3|||
170884587|NCT02275338|617586751|FG000|Overall Study|Withdrawal by Subject|4|||
170884588|NCT02275338|617586751|FG000|Overall Study|Disease progression (death)|1|||
170884589|NCT02275338|617586751|FG000|Overall Study|Ineligible to start Phase 2|4|||
170884590|NCT02275338|617586751|FG000|Overall Study|Reason not specified|5|||
170884591|NCT02275338|617586751|FG000|Overall Study|Does not meet entry criteria|1|||
170884592|NCT01665807|617586758|FG000|Overall Study|Withdrawal by Subject|2|||
170884593|NCT01665807|617586759|FG001|Overall Study|Withdrawal by Subject|0|||
170884594|NCT01665807|617586760|FG002|Overall Study|Withdrawal by Subject|1|||
170884595|NCT03099707|617586769|FG000|Overall Study|Withdrawal by Subject|0|||
170884596|NCT03099707|617586770|FG001|Overall Study|Withdrawal by Subject|3|||
170884597|NCT03099707|617586769|FG000|Overall Study|Lost to Follow-up|0|||
170884598|NCT03099707|617586770|FG001|Overall Study|Lost to Follow-up|1|||
170884599|NCT01015768|617586777|FG000|Overall Study|Some subject data unuseable|4|||
170884600|NCT01015768|617586778|FG001|Overall Study|Some subject data unuseable|4|||
170884601|NCT03167073|617586785|FG000|Overall Study|Stillbirth|1|||
170884602|NCT03167073|617586786|FG001|Overall Study|Stillbirth|0|||
170884603|NCT01400451|617586787|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
170884604|NCT01400451|617586788|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
170884605|NCT01400451|617586789|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
170884606|NCT01400451|617586787|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
170884607|NCT01400451|617586788|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
170884608|NCT01400451|617586789|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
170884609|NCT01400451|617586787|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
170884610|NCT01400451|617586788|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
170884611|NCT01400451|617586789|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
170884612|NCT01400451|617586787|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
170884613|NCT01400451|617586788|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
170884614|NCT01400451|617586789|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
170884615|NCT01400451|617586787|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
170884616|NCT01400451|617586788|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
170884617|NCT01400451|617586789|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
170884618|NCT00574275|617586791|FG000|Overall Study|Randomized but not treated|2|||
170884619|NCT00574275|617586792|FG001|Overall Study|Randomized but not treated|3|||
170884620|NCT00574275|617586791|FG000|Overall Study|Adverse Event|32|||
170884621|NCT00574275|617586792|FG001|Overall Study|Adverse Event|76|||
170884622|NCT00574275|617586791|FG000|Overall Study|Disease progression|160|||
170884623|NCT00574275|617586792|FG001|Overall Study|Disease progression|146|||
170884624|NCT00574275|617586791|FG000|Overall Study|Lost to Follow-up|2|||
170884625|NCT00574275|617586792|FG001|Overall Study|Lost to Follow-up|1|||
170884626|NCT00574275|617586791|FG000|Overall Study|Study stopped based on DMC decision|62|||
170884627|NCT00574275|617586792|FG001|Overall Study|Study stopped based on DMC decision|23|||
170884628|NCT00574275|617586791|FG000|Overall Study|Withdrawal by Subject|15|||
170884629|NCT00574275|617586792|FG001|Overall Study|Withdrawal by Subject|17|||
170884630|NCT00574275|617586791|FG000|Overall Study|Error calculating tumor measurement|1|||
170884631|NCT00574275|617586792|FG001|Overall Study|Error calculating tumor measurement|0|||
170884632|NCT00574275|617586791|FG000|Overall Study|Physician Decision|1|||
170884633|NCT00574275|617586792|FG001|Overall Study|Physician Decision|1|||
170884634|NCT00574275|617586791|FG000|Overall Study|Protocol Violation|0|||
170884635|NCT00574275|617586792|FG001|Overall Study|Protocol Violation|1|||
170884636|NCT00574275|617586791|FG000|Overall Study|Patient and Investigator decision|0|||
170884637|NCT00574275|617586792|FG001|Overall Study|Patient and Investigator decision|1|||
170884638|NCT00574275|617586791|FG000|Overall Study|Insurance change|0|||
170782990|NCT01261312|617213008|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
170782991|NCT01261312|617213009|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
170782992|NCT01261312|617213010|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
170782993|NCT01261312|617213011|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
170782994|NCT01261312|617212999|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170782995|NCT01261312|617213000|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170782996|NCT01261312|617213001|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170782997|NCT01261312|617213002|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170782998|NCT01261312|617213003|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170782999|NCT01261312|617213004|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170783000|NCT01261312|617213005|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170884639|NCT00574275|617586792|FG001|Overall Study|Insurance change|1|||
170884640|NCT00574275|617586791|FG000|Overall Study|Operation for curative intent|0|||
170884641|NCT00574275|617586792|FG001|Overall Study|Operation for curative intent|1|||
170884642|NCT00879697|617586797|FG000|Overall Study|Physician Decision|2|||
170884643|NCT00879697|617586798|FG001|Overall Study|Physician Decision|2|||
170783001|NCT01261312|617213006|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170783002|NCT01261312|617213007|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
170783003|NCT01261312|617213008|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
170884644|NCT01110200|617586799|FG000|Overall Study|Adverse Event|28|||
170884645|NCT01110200|617586800|FG001|Overall Study|Adverse Event|28|||
170884646|NCT01110200|617586799|FG000|Overall Study|Withdrawal by Subject|25|||
170884647|NCT01110200|617586800|FG001|Overall Study|Withdrawal by Subject|32|||
170884648|NCT01110200|617586799|FG000|Overall Study|Lack of Efficacy|16|||
170884649|NCT01110200|617586800|FG001|Overall Study|Lack of Efficacy|25|||
170884650|NCT01110200|617586799|FG000|Overall Study|Protocol Violation|14|||
170884651|NCT01110200|617586800|FG001|Overall Study|Protocol Violation|12|||
170884652|NCT01110200|617586799|FG000|Overall Study|Physician Decision|13|||
170884653|NCT01110200|617586800|FG001|Overall Study|Physician Decision|17|||
170884654|NCT01110200|617586799|FG000|Overall Study|Lost to Follow-up|10|||
170884655|NCT01110200|617586800|FG001|Overall Study|Lost to Follow-up|7|||
170884656|NCT00903175|617586801|FG000|Period 1 - First Line|Adverse Event|36|||
170884657|NCT00903175|617586802|FG001|Period 1 - First Line|Adverse Event|50|||
170884658|NCT00903175|617586801|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
170884659|NCT00903175|617586802|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
170884660|NCT00903175|617586801|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
170884661|NCT00903175|617586802|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
170884662|NCT00903175|617586801|FG000|Period 1 - First Line|Protocol Violation|3|||
170884663|NCT00903175|617586802|FG001|Period 1 - First Line|Protocol Violation|3|||
170884664|NCT00903175|617586801|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
170884665|NCT00903175|617586802|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
170884666|NCT00903175|617586801|FG000|Period 1 - First Line|Administrative problems|12|||
170884667|NCT00903175|617586802|FG001|Period 1 - First Line|Administrative problems|13|||
170884668|NCT00903175|617586801|FG000|Period 1 - First Line|Death|17|||
170884669|NCT00903175|617586802|FG001|Period 1 - First Line|Death|10|||
170884670|NCT00903175|617586801|FG000|Period 2 - Second Line|Missing|1|||
170884671|NCT00903175|617586802|FG001|Period 2 - Second Line|Missing|0|||
170884672|NCT00903175|617586801|FG000|Period 2 - Second Line|Adverse Event|16|||
170884673|NCT00903175|617586802|FG001|Period 2 - Second Line|Adverse Event|20|||
170884674|NCT00903175|617586801|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
170884675|NCT00903175|617586802|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
170884676|NCT00903175|617586801|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
170884677|NCT00903175|617586802|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
170884678|NCT00903175|617586801|FG000|Period 2 - Second Line|Administrative problems|19|||
170884679|NCT00903175|617586802|FG001|Period 2 - Second Line|Administrative problems|9|||
170884680|NCT00903175|617586801|FG000|Period 2 - Second Line|Death|5|||
170884681|NCT00903175|617586802|FG001|Period 2 - Second Line|Death|2|||
170884682|NCT04942925|617586810|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
170884683|NCT04942925|617586811|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
170884684|NCT04942925|617586810|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
170884685|NCT04942925|617586811|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
170884686|NCT02124564|617586813|FG000|Treatment Period|Adverse Event|2|||
170884687|NCT02124564|617586813|FG000|Treatment Period|Lack of Efficacy|3|||
170884688|NCT02124564|617586813|FG000|Treatment Period|Withdrawal by Subject|2|||
170884689|NCT04489888|617586816|FG000|Overall Study|Death|75|||
170884690|NCT04489888|617586816|FG000|Overall Study|Sponsor Decision|26|||
170884691|NCT03829657|617586820|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
170884692|NCT03829657|617586821|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
170884693|NCT03829657|617586822|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
170884694|NCT03829657|617586823|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
170884695|NCT03829657|617586824|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
170884696|NCT03829657|617586820|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
170884697|NCT03829657|617586821|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170884698|NCT03829657|617586822|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170884699|NCT03829657|617586823|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170884700|NCT03829657|617586824|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
170884701|NCT03829657|617586820|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
170884702|NCT03829657|617586821|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
170884703|NCT03829657|617586822|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
170884704|NCT03829657|617586823|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
170884705|NCT03829657|617586824|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
170884706|NCT03829657|617586820|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
170884707|NCT03829657|617586821|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
170884708|NCT03829657|617586822|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
170884709|NCT03829657|617586823|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
170884710|NCT03829657|617586824|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
170884711|NCT03829657|617586820|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
170884712|NCT03829657|617586821|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
170884713|NCT03829657|617586822|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
170884714|NCT03829657|617586823|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
170884715|NCT03829657|617586824|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
170884716|NCT03829657|617586820|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
170884717|NCT03829657|617586821|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
170884718|NCT03829657|617586822|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
170884719|NCT03829657|617586823|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
170440476|NCT00021541|615951560|FG000|Period 1-First Treatment|Ineligible|0|||
170440477|NCT00021541|615951561|FG001|Period 1-First Treatment|Ineligible|2|||
170884720|NCT03829657|617586824|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
170884721|NCT03829657|617586820|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
170884722|NCT03829657|617586821|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
170884723|NCT03829657|617586822|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
170884724|NCT03829657|617586823|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
170884725|NCT03829657|617586824|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
170884726|NCT03829657|617586820|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
170884727|NCT03829657|617586821|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
170884728|NCT03829657|617586822|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
170884729|NCT03829657|617586823|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
170884730|NCT03829657|617586824|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
170884731|NCT03829657|617586820|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
170884732|NCT03829657|617586821|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
170884733|NCT03829657|617586822|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
170884734|NCT03829657|617586823|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
170884735|NCT03829657|617586824|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
170884736|NCT03829657|617586820|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
170884737|NCT03829657|617586821|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
170884738|NCT03829657|617586822|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
170884739|NCT03829657|617586823|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
170884740|NCT03829657|617586824|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
170884741|NCT04418076|617586825|FG000|Overall Study|Death|1|||
170884742|NCT04418076|617586826|FG001|Overall Study|Death|0|||
170884743|NCT04418076|617586827|FG002|Overall Study|Death|0|||
170884744|NCT04418076|617586828|FG003|Overall Study|Death|0|||
170884745|NCT04418076|617586825|FG000|Overall Study|Lost to Follow-up|2|||
170884746|NCT04418076|617586826|FG001|Overall Study|Lost to Follow-up|5|||
170884747|NCT04418076|617586827|FG002|Overall Study|Lost to Follow-up|1|||
170884748|NCT04418076|617586828|FG003|Overall Study|Lost to Follow-up|2|||
170884749|NCT04418076|617586825|FG000|Overall Study|Withdrawal by Subject|1|||
170884750|NCT04418076|617586826|FG001|Overall Study|Withdrawal by Subject|0|||
170884751|NCT04418076|617586827|FG002|Overall Study|Withdrawal by Subject|1|||
170884752|NCT04418076|617586828|FG003|Overall Study|Withdrawal by Subject|1|||
170884753|NCT04418076|617586825|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
170884754|NCT04418076|617586826|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
170884755|NCT04418076|617586827|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
170884756|NCT04418076|617586828|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
170884757|NCT01425008|617586829|FG000|Dose Escalation Phase|Progressive Disease|2|||
170884758|NCT01425008|617586830|FG001|Dose Escalation Phase|Progressive Disease|3|||
170884759|NCT01425008|617586831|FG002|Dose Escalation Phase|Progressive Disease|2|||
170884760|NCT01425008|617586832|FG003|Dose Escalation Phase|Progressive Disease|3|||
170884761|NCT01425008|617586833|FG004|Dose Escalation Phase|Progressive Disease|5|||
170884762|NCT01425008|617586834|FG005|Dose Escalation Phase|Progressive Disease|4|||
170884763|NCT01425008|617586835|FG006|Dose Escalation Phase|Progressive Disease|0|||
170884764|NCT01425008|617586836|FG007|Dose Escalation Phase|Progressive Disease|2|||
170884765|NCT01425008|617586837|FG008|Dose Escalation Phase|Progressive Disease|6|||
170884766|NCT01425008|617586838|FG009|Dose Escalation Phase|Progressive Disease|2|||
170884767|NCT01425008|617586839|FG010|Dose Escalation Phase|Progressive Disease|0|||
170884768|NCT01425008|617586840|FG011|Dose Escalation Phase|Progressive Disease|0|||
170884769|NCT01425008|617586841|FG012|Dose Escalation Phase|Progressive Disease|0|||
170884770|NCT01425008|617586842|FG013|Dose Escalation Phase|Progressive Disease|0|||
170884771|NCT01425008|617586843|FG014|Dose Escalation Phase|Progressive Disease|0|||
170884772|NCT01425008|617586844|FG015|Dose Escalation Phase|Progressive Disease|0|||
170884773|NCT01425008|617586845|FG016|Dose Escalation Phase|Progressive Disease|0|||
170884774|NCT01425008|617586846|FG017|Dose Escalation Phase|Progressive Disease|0|||
170884775|NCT01425008|617586847|FG018|Dose Escalation Phase|Progressive Disease|0|||
170884776|NCT01425008|617586829|FG000|Dose Escalation Phase|Adverse Event|2|||
170884777|NCT01425008|617586830|FG001|Dose Escalation Phase|Adverse Event|0|||
170884778|NCT01425008|617586831|FG002|Dose Escalation Phase|Adverse Event|0|||
170884779|NCT01425008|617586832|FG003|Dose Escalation Phase|Adverse Event|0|||
170884780|NCT01425008|617586833|FG004|Dose Escalation Phase|Adverse Event|0|||
170884781|NCT01425008|617586834|FG005|Dose Escalation Phase|Adverse Event|2|||
170884782|NCT01425008|617586835|FG006|Dose Escalation Phase|Adverse Event|0|||
170884783|NCT01425008|617586836|FG007|Dose Escalation Phase|Adverse Event|0|||
170884784|NCT01425008|617586837|FG008|Dose Escalation Phase|Adverse Event|2|||
170884785|NCT01425008|617586838|FG009|Dose Escalation Phase|Adverse Event|0|||
170884786|NCT01425008|617586839|FG010|Dose Escalation Phase|Adverse Event|0|||
170884787|NCT01425008|617586840|FG011|Dose Escalation Phase|Adverse Event|0|||
170884788|NCT01425008|617586841|FG012|Dose Escalation Phase|Adverse Event|0|||
170884789|NCT01425008|617586842|FG013|Dose Escalation Phase|Adverse Event|0|||
170884790|NCT01425008|617586843|FG014|Dose Escalation Phase|Adverse Event|0|||
170884791|NCT01425008|617586844|FG015|Dose Escalation Phase|Adverse Event|0|||
170884792|NCT01425008|617586845|FG016|Dose Escalation Phase|Adverse Event|0|||
170884793|NCT01425008|617586846|FG017|Dose Escalation Phase|Adverse Event|0|||
170884794|NCT01425008|617586847|FG018|Dose Escalation Phase|Adverse Event|0|||
170884795|NCT01425008|617586829|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884796|NCT01425008|617586830|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884797|NCT01425008|617586831|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884798|NCT01425008|617586832|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884799|NCT01425008|617586833|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
170884800|NCT01425008|617586834|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884801|NCT01425008|617586835|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
170884802|NCT01425008|617586836|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
170884803|NCT01425008|617586837|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
170884804|NCT01425008|617586838|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884805|NCT01425008|617586839|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884806|NCT01425008|617586840|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884807|NCT01425008|617586841|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884808|NCT01425008|617586842|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884809|NCT01425008|617586843|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884810|NCT01425008|617586844|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884811|NCT01425008|617586845|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884812|NCT01425008|617586846|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884813|NCT01425008|617586847|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170884814|NCT01425008|617586829|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
170884815|NCT01425008|617586830|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
170884816|NCT01425008|617586831|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
170884817|NCT01425008|617586832|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
170884818|NCT01425008|617586833|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
170884819|NCT01425008|617586834|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
170884820|NCT01425008|617586835|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
170884821|NCT01425008|617586836|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
170884822|NCT01425008|617586837|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
170884823|NCT01425008|617586838|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
170884824|NCT01425008|617586839|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
170884825|NCT01425008|617586840|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
170884826|NCT01425008|617586841|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
170884827|NCT01425008|617586842|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
170884828|NCT01425008|617586843|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
170884829|NCT01425008|617586844|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
170884830|NCT01425008|617586845|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
170884831|NCT01425008|617586846|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
170884832|NCT01425008|617586847|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
170884833|NCT01425008|617586829|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884834|NCT01425008|617586830|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884835|NCT01425008|617586831|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
170884836|NCT01425008|617586832|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884837|NCT01425008|617586833|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884838|NCT01425008|617586834|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884839|NCT01425008|617586835|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884840|NCT01425008|617586836|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884841|NCT01425008|617586837|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
170884842|NCT01425008|617586838|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
170884843|NCT01425008|617586839|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884844|NCT01425008|617586840|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884845|NCT01425008|617586841|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884846|NCT01425008|617586842|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884847|NCT01425008|617586843|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884848|NCT01425008|617586844|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884849|NCT01425008|617586845|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884850|NCT01425008|617586846|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884851|NCT01425008|617586847|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
170884852|NCT01425008|617586829|FG000|Dose Escalation Phase|Other|0|||
170884853|NCT01425008|617586830|FG001|Dose Escalation Phase|Other|0|||
170884854|NCT01425008|617586831|FG002|Dose Escalation Phase|Other|0|||
170884855|NCT01425008|617586832|FG003|Dose Escalation Phase|Other|0|||
170884856|NCT01425008|617586833|FG004|Dose Escalation Phase|Other|0|||
170884857|NCT01425008|617586834|FG005|Dose Escalation Phase|Other|0|||
170884858|NCT01425008|617586835|FG006|Dose Escalation Phase|Other|0|||
170884859|NCT01425008|617586836|FG007|Dose Escalation Phase|Other|0|||
170884860|NCT01425008|617586837|FG008|Dose Escalation Phase|Other|1|||
170884861|NCT01425008|617586838|FG009|Dose Escalation Phase|Other|0|||
170783004|NCT01261312|617213009|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
170783005|NCT01261312|617213010|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
170783006|NCT01261312|617213011|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
170783007|NCT01261312|617212999|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170884862|NCT01425008|617586839|FG010|Dose Escalation Phase|Other|0|||
170884863|NCT01425008|617586840|FG011|Dose Escalation Phase|Other|0|||
170884864|NCT01425008|617586841|FG012|Dose Escalation Phase|Other|0|||
170884865|NCT01425008|617586842|FG013|Dose Escalation Phase|Other|0|||
170884866|NCT01425008|617586843|FG014|Dose Escalation Phase|Other|0|||
170884867|NCT01425008|617586844|FG015|Dose Escalation Phase|Other|0|||
170884868|NCT01425008|617586845|FG016|Dose Escalation Phase|Other|0|||
170884869|NCT01425008|617586846|FG017|Dose Escalation Phase|Other|0|||
170884870|NCT01425008|617586847|FG018|Dose Escalation Phase|Other|0|||
170884871|NCT01425008|617586829|FG000|Dose Expansion Phase|Progressive Disease|0|||
170884872|NCT01425008|617586830|FG001|Dose Expansion Phase|Progressive Disease|0|||
170884873|NCT01425008|617586831|FG002|Dose Expansion Phase|Progressive Disease|0|||
170884874|NCT01425008|617586832|FG003|Dose Expansion Phase|Progressive Disease|0|||
170884875|NCT01425008|617586833|FG004|Dose Expansion Phase|Progressive Disease|0|||
170884876|NCT01425008|617586834|FG005|Dose Expansion Phase|Progressive Disease|0|||
170884877|NCT01425008|617586835|FG006|Dose Expansion Phase|Progressive Disease|0|||
170884878|NCT01425008|617586836|FG007|Dose Expansion Phase|Progressive Disease|0|||
170884879|NCT01425008|617586837|FG008|Dose Expansion Phase|Progressive Disease|0|||
170884880|NCT01425008|617586838|FG009|Dose Expansion Phase|Progressive Disease|0|||
170884881|NCT01425008|617586839|FG010|Dose Expansion Phase|Progressive Disease|10|||
170884882|NCT01425008|617586840|FG011|Dose Expansion Phase|Progressive Disease|4|||
170884883|NCT01425008|617586841|FG012|Dose Expansion Phase|Progressive Disease|12|||
170884884|NCT01425008|617586842|FG013|Dose Expansion Phase|Progressive Disease|1|||
170884885|NCT01425008|617586843|FG014|Dose Expansion Phase|Progressive Disease|5|||
170884886|NCT01425008|617586844|FG015|Dose Expansion Phase|Progressive Disease|8|||
170884887|NCT01425008|617586845|FG016|Dose Expansion Phase|Progressive Disease|9|||
170884888|NCT01425008|617586846|FG017|Dose Expansion Phase|Progressive Disease|2|||
170884889|NCT01425008|617586847|FG018|Dose Expansion Phase|Progressive Disease|10|||
170884890|NCT01425008|617586829|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
170884891|NCT01425008|617586830|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
170884892|NCT01425008|617586831|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
170884893|NCT01425008|617586832|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
170884894|NCT01425008|617586833|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
170884895|NCT01425008|617586834|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
170783008|NCT01261312|617213000|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170783009|NCT01261312|617213001|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170783010|NCT01261312|617213002|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170783011|NCT01261312|617213003|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170783012|NCT01261312|617213004|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170783013|NCT01261312|617213005|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170783014|NCT01261312|617213006|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170783015|NCT01261312|617213007|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
170783016|NCT01261312|617213008|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
170783017|NCT01261312|617213009|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
170783018|NCT01261312|617213010|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
170783019|NCT01261312|617213011|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
170783020|NCT04021602|617213017|FG000|Overall Study|Lost to Follow-up|3|||
170783021|NCT04021602|617213018|FG001|Overall Study|Lost to Follow-up|3|||
170783022|NCT04021602|617213019|FG002|Overall Study|Lost to Follow-up|1|||
170783023|NCT04021602|617213017|FG000|Overall Study|Adverse Event|1|||
170783024|NCT04021602|617213018|FG001|Overall Study|Adverse Event|0|||
170783025|NCT04021602|617213019|FG002|Overall Study|Adverse Event|1|||
170783026|NCT03699709|617213022|FG000|Overall Study|Death|1|||
170783027|NCT03699709|617213023|FG001|Overall Study|Death|2|||
170783028|NCT03699709|617213022|FG000|Overall Study|Lost to Follow-up|10|||
170783029|NCT03699709|617213023|FG001|Overall Study|Lost to Follow-up|3|||
170783030|NCT03699709|617213022|FG000|Overall Study|Withdrawal by Subject|5|||
170783031|NCT03699709|617213023|FG001|Overall Study|Withdrawal by Subject|0|||
170884896|NCT01425008|617586835|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
170884897|NCT01425008|617586836|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
170884898|NCT01425008|617586837|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
170884899|NCT01425008|617586838|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
170884900|NCT01425008|617586839|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
170884901|NCT01425008|617586840|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
170884902|NCT01425008|617586841|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
170884903|NCT01425008|617586842|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
170884904|NCT01425008|617586843|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
170884905|NCT01425008|617586844|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
170783032|NCT03699709|617213022|FG000|Overall Study|incarcerated|1|||
170783033|NCT03699709|617213023|FG001|Overall Study|incarcerated|0|||
170783034|NCT03699709|617213022|FG000|Overall Study|scheduled, but no show|0|||
170783035|NCT03699709|617213023|FG001|Overall Study|scheduled, but no show|1|||
170783036|NCT05368103|617213024|FG000|Overall Study|Withdrawal by Subject|4|||
170783037|NCT05368103|617213024|FG000|Overall Study|Lost to Follow-up|1|||
170783038|NCT05368103|617213024|FG000|Overall Study|Lack of Efficacy|3|||
170783039|NCT01772472|617213025|FG000|Overall Study|Death|126|||
170783040|NCT01772472|617213026|FG001|Overall Study|Death|94|||
170783041|NCT01772472|617213025|FG000|Overall Study|Lost to Follow-up|51|||
170783042|NCT01772472|617213026|FG001|Overall Study|Lost to Follow-up|50|||
170783043|NCT01772472|617213025|FG000|Overall Study|Other|9|||
170783044|NCT01772472|617213026|FG001|Overall Study|Other|7|||
170783045|NCT01772472|617213025|FG000|Overall Study|Physician Decision|1|||
170783046|NCT01772472|617213026|FG001|Overall Study|Physician Decision|7|||
170783047|NCT01772472|617213025|FG000|Overall Study|Withdrawal by Subject|115|||
170783048|NCT01772472|617213026|FG001|Overall Study|Withdrawal by Subject|90|||
170783049|NCT01772472|617213025|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
170783050|NCT01772472|617213026|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
170783051|NCT05569252|617213027|FG000|Overall Study|Adverse event (central vision loss)|1|||
170783052|NCT05569252|617213028|FG001|Overall Study|Adverse event (central vision loss)|0|||
170783053|NCT05569252|617213029|FG002|Overall Study|Adverse event (central vision loss)|0|||
170783054|NCT05569252|617213030|FG003|Overall Study|Adverse event (central vision loss)|0|||
170783055|NCT03665597|617213031|FG000|Period 1|Adverse Event|1|||
170783056|NCT03665597|617213032|FG001|Period 1|Adverse Event|0|||
170783057|NCT03665597|617213033|FG002|Period 1|Adverse Event|0|||
170783058|NCT03665597|617213034|FG003|Period 1|Adverse Event|1|||
170783059|NCT03665597|617213035|FG004|Period 1|Adverse Event|0|||
170783060|NCT03665597|617213036|FG005|Period 1|Adverse Event|0|||
170783061|NCT03665597|617213037|FG006|Period 1|Adverse Event|0|||
170783062|NCT03665597|617213031|FG000|Period 1|Screen Failure|0|||
170783063|NCT03665597|617213032|FG001|Period 1|Screen Failure|0|||
170783064|NCT03665597|617213033|FG002|Period 1|Screen Failure|0|||
170783065|NCT03665597|617213034|FG003|Period 1|Screen Failure|1|||
170783066|NCT03665597|617213035|FG004|Period 1|Screen Failure|0|||
170783067|NCT03665597|617213036|FG005|Period 1|Screen Failure|0|||
170783068|NCT03665597|617213037|FG006|Period 1|Screen Failure|0|||
170783069|NCT03665597|617213031|FG000|Period 1|Death|0|||
170783070|NCT03665597|617213032|FG001|Period 1|Death|0|||
170783071|NCT03665597|617213033|FG002|Period 1|Death|0|||
170783072|NCT03665597|617213034|FG003|Period 1|Death|0|||
170783073|NCT03665597|617213035|FG004|Period 1|Death|0|||
170783074|NCT03665597|617213036|FG005|Period 1|Death|0|||
170783075|NCT03665597|617213037|FG006|Period 1|Death|45|||
170783076|NCT03665597|617213031|FG000|Period 1|Withdrawal by Subject|0|||
170783077|NCT03665597|617213032|FG001|Period 1|Withdrawal by Subject|0|||
170783078|NCT03665597|617213033|FG002|Period 1|Withdrawal by Subject|0|||
170783079|NCT03665597|617213034|FG003|Period 1|Withdrawal by Subject|0|||
170783080|NCT03665597|617213035|FG004|Period 1|Withdrawal by Subject|0|||
170783081|NCT03665597|617213036|FG005|Period 1|Withdrawal by Subject|0|||
170783082|NCT03665597|617213037|FG006|Period 1|Withdrawal by Subject|5|||
170783083|NCT03665597|617213031|FG000|Period 2|Adverse Event|0|||
170783084|NCT03665597|617213032|FG001|Period 2|Adverse Event|0|||
170783085|NCT03665597|617213033|FG002|Period 2|Adverse Event|0|||
170783086|NCT03665597|617213034|FG003|Period 2|Adverse Event|0|||
170783087|NCT03665597|617213035|FG004|Period 2|Adverse Event|0|||
170783088|NCT03665597|617213036|FG005|Period 2|Adverse Event|1|||
170783089|NCT03665597|617213037|FG006|Period 2|Adverse Event|0|||
170783090|NCT03665597|617213031|FG000|Period 3|Adverse Event|0|||
170783091|NCT03665597|617213032|FG001|Period 3|Adverse Event|1|||
170783092|NCT03665597|617213033|FG002|Period 3|Adverse Event|0|||
170783093|NCT03665597|617213034|FG003|Period 3|Adverse Event|0|||
170783094|NCT03665597|617213035|FG004|Period 3|Adverse Event|0|||
170783095|NCT03665597|617213036|FG005|Period 3|Adverse Event|0|||
170783096|NCT03665597|617213037|FG006|Period 3|Adverse Event|0|||
170783097|NCT03665597|617213031|FG000|Period 3|Death|0|||
170783098|NCT03665597|617213032|FG001|Period 3|Death|0|||
170783099|NCT03665597|617213033|FG002|Period 3|Death|0|||
170783100|NCT03665597|617213034|FG003|Period 3|Death|0|||
170783101|NCT03665597|617213035|FG004|Period 3|Death|1|||
170783102|NCT03665597|617213036|FG005|Period 3|Death|0|||
170783103|NCT03665597|617213037|FG006|Period 3|Death|0|||
170633075|NCT01746901|616668463|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
170783104|NCT03665597|617213031|FG000|Period 4|Adverse Event|2|||
170783105|NCT03665597|617213032|FG001|Period 4|Adverse Event|2|||
170783106|NCT03665597|617213033|FG002|Period 4|Adverse Event|2|||
170783107|NCT03665597|617213034|FG003|Period 4|Adverse Event|2|||
170783108|NCT03665597|617213035|FG004|Period 4|Adverse Event|1|||
170783109|NCT03665597|617213036|FG005|Period 4|Adverse Event|0|||
170783110|NCT03665597|617213037|FG006|Period 4|Adverse Event|0|||
170783111|NCT03665597|617213031|FG000|Period 4|Death|0|||
170783112|NCT03665597|617213032|FG001|Period 4|Death|0|||
170783113|NCT03665597|617213033|FG002|Period 4|Death|2|||
170783114|NCT03665597|617213034|FG003|Period 4|Death|0|||
170783115|NCT03665597|617213035|FG004|Period 4|Death|0|||
170783116|NCT03665597|617213036|FG005|Period 4|Death|0|||
170884906|NCT01425008|617586845|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
170884907|NCT01425008|617586846|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
170884908|NCT01425008|617586847|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
170884909|NCT01425008|617586829|FG000|Dose Expansion Phase|Other|0|||
170884910|NCT01425008|617586830|FG001|Dose Expansion Phase|Other|0|||
170884911|NCT01425008|617586831|FG002|Dose Expansion Phase|Other|0|||
170884912|NCT01425008|617586832|FG003|Dose Expansion Phase|Other|0|||
170884913|NCT01425008|617586833|FG004|Dose Expansion Phase|Other|0|||
170884914|NCT01425008|617586834|FG005|Dose Expansion Phase|Other|0|||
170884915|NCT01425008|617586835|FG006|Dose Expansion Phase|Other|0|||
170884916|NCT01425008|617586836|FG007|Dose Expansion Phase|Other|0|||
170884917|NCT01425008|617586837|FG008|Dose Expansion Phase|Other|0|||
170884918|NCT01425008|617586838|FG009|Dose Expansion Phase|Other|0|||
170884919|NCT01425008|617586839|FG010|Dose Expansion Phase|Other|0|||
170884920|NCT01425008|617586840|FG011|Dose Expansion Phase|Other|0|||
170884921|NCT01425008|617586841|FG012|Dose Expansion Phase|Other|1|||
170884922|NCT01425008|617586842|FG013|Dose Expansion Phase|Other|0|||
170884923|NCT01425008|617586843|FG014|Dose Expansion Phase|Other|0|||
170884924|NCT01425008|617586844|FG015|Dose Expansion Phase|Other|0|||
170884925|NCT01425008|617586845|FG016|Dose Expansion Phase|Other|2|||
170884926|NCT01425008|617586846|FG017|Dose Expansion Phase|Other|0|||
170884927|NCT01425008|617586847|FG018|Dose Expansion Phase|Other|4|||
170884928|NCT01425008|617586829|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884929|NCT01425008|617586830|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884930|NCT01425008|617586831|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884931|NCT01425008|617586832|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884932|NCT01425008|617586833|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884933|NCT01425008|617586834|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884934|NCT01425008|617586835|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884935|NCT01425008|617586836|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884936|NCT01425008|617586837|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884937|NCT01425008|617586838|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884938|NCT01425008|617586839|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
170884939|NCT01425008|617586840|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
170884940|NCT01425008|617586841|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884941|NCT01425008|617586842|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884942|NCT01425008|617586843|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884943|NCT01425008|617586844|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
170884944|NCT01425008|617586845|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
170884945|NCT01425008|617586846|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
170884946|NCT01425008|617586847|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
170884947|NCT01425008|617586829|FG000|Dose Expansion Phase|Adverse Event|0|||
170884948|NCT01425008|617586830|FG001|Dose Expansion Phase|Adverse Event|0|||
170884949|NCT01425008|617586831|FG002|Dose Expansion Phase|Adverse Event|0|||
170537182|NCT03330197|616311548|FG000|Overall Study|Withdrawal by Subject|0|||
170884950|NCT01425008|617586832|FG003|Dose Expansion Phase|Adverse Event|0|||
170884951|NCT01425008|617586833|FG004|Dose Expansion Phase|Adverse Event|0|||
170884952|NCT01425008|617586834|FG005|Dose Expansion Phase|Adverse Event|0|||
170884953|NCT01425008|617586835|FG006|Dose Expansion Phase|Adverse Event|0|||
170884954|NCT01425008|617586836|FG007|Dose Expansion Phase|Adverse Event|0|||
170884955|NCT01425008|617586837|FG008|Dose Expansion Phase|Adverse Event|0|||
170884956|NCT01425008|617586838|FG009|Dose Expansion Phase|Adverse Event|0|||
170884957|NCT01425008|617586839|FG010|Dose Expansion Phase|Adverse Event|2|||
170884958|NCT01425008|617586840|FG011|Dose Expansion Phase|Adverse Event|3|||
170884959|NCT01425008|617586841|FG012|Dose Expansion Phase|Adverse Event|3|||
170884960|NCT01425008|617586842|FG013|Dose Expansion Phase|Adverse Event|0|||
170884961|NCT01425008|617586843|FG014|Dose Expansion Phase|Adverse Event|1|||
170884962|NCT01425008|617586844|FG015|Dose Expansion Phase|Adverse Event|1|||
170884963|NCT01425008|617586845|FG016|Dose Expansion Phase|Adverse Event|5|||
170884964|NCT01425008|617586846|FG017|Dose Expansion Phase|Adverse Event|0|||
170884965|NCT01425008|617586847|FG018|Dose Expansion Phase|Adverse Event|3|||
170884966|NCT01425008|617586829|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
170884967|NCT01425008|617586830|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
170884968|NCT01425008|617586831|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
170884969|NCT01425008|617586832|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
170537183|NCT03330197|616311549|FG001|Overall Study|Withdrawal by Subject|1|||
170537184|NCT03765073|616311552|FG000|Stage 1|Lost to Follow-up|1|||
170884970|NCT01425008|617586833|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
170884971|NCT01425008|617586834|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
170884972|NCT01425008|617586835|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
170884973|NCT01425008|617586836|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
170884974|NCT01425008|617586837|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
170884975|NCT01425008|617586838|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
170884976|NCT01425008|617586839|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
170884977|NCT01425008|617586840|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
170783117|NCT03665597|617213037|FG006|Period 4|Death|0|||
170783118|NCT03665597|617213031|FG000|Period 4|Physician Decision|1|||
170783119|NCT03665597|617213032|FG001|Period 4|Physician Decision|2|||
170783120|NCT03665597|617213033|FG002|Period 4|Physician Decision|0|||
170783121|NCT03665597|617213034|FG003|Period 4|Physician Decision|0|||
170783122|NCT03665597|617213035|FG004|Period 4|Physician Decision|0|||
170783123|NCT03665597|617213036|FG005|Period 4|Physician Decision|0|||
170783124|NCT03665597|617213037|FG006|Period 4|Physician Decision|0|||
170783125|NCT04391894|617213038|FG000|Overall Study|Adverse Event|1|||
170783126|NCT04391894|617213039|FG001|Overall Study|Adverse Event|1|||
170783127|NCT04391894|617213040|FG002|Overall Study|Adverse Event|1|||
170783128|NCT04391894|617213041|FG003|Overall Study|Adverse Event|1|||
170783129|NCT04391894|617213042|FG004|Overall Study|Adverse Event|1|||
170783130|NCT04391894|617213038|FG000|Overall Study|Lost to Follow-up|1|||
170783131|NCT04391894|617213039|FG001|Overall Study|Lost to Follow-up|0|||
170783132|NCT04391894|617213040|FG002|Overall Study|Lost to Follow-up|0|||
170783133|NCT04391894|617213041|FG003|Overall Study|Lost to Follow-up|0|||
170783134|NCT04391894|617213042|FG004|Overall Study|Lost to Follow-up|0|||
170783135|NCT04391894|617213038|FG000|Overall Study|Protocol Violation|0|||
170783136|NCT04391894|617213039|FG001|Overall Study|Protocol Violation|0|||
170783137|NCT04391894|617213040|FG002|Overall Study|Protocol Violation|0|||
170783138|NCT04391894|617213041|FG003|Overall Study|Protocol Violation|1|||
170783139|NCT04391894|617213042|FG004|Overall Study|Protocol Violation|0|||
170783140|NCT04391894|617213038|FG000|Overall Study|Withdrawal by Subject|2|||
170783141|NCT04391894|617213039|FG001|Overall Study|Withdrawal by Subject|0|||
170783142|NCT04391894|617213040|FG002|Overall Study|Withdrawal by Subject|3|||
170783143|NCT04391894|617213041|FG003|Overall Study|Withdrawal by Subject|0|||
170783144|NCT04391894|617213042|FG004|Overall Study|Withdrawal by Subject|1|||
170783145|NCT04391894|617213038|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
170783146|NCT04391894|617213039|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
170783147|NCT04391894|617213040|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
170783148|NCT04391894|617213041|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
170783149|NCT04391894|617213042|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
170783150|NCT05268302|617213043|FG000|Overall Study|Death|0|||
170783151|NCT05268302|617213044|FG001|Overall Study|Death|1|||
170783152|NCT02923180|617213045|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
170783153|NCT02923180|617213045|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
170783154|NCT05198310|617213046|FG000|Overall Study|Lost to Follow-up|0|||
170783155|NCT05198310|617213047|FG001|Overall Study|Lost to Follow-up|1|||
170783156|NCT05198310|617213048|FG002|Overall Study|Lost to Follow-up|0|||
170783157|NCT05198310|617213049|FG003|Overall Study|Lost to Follow-up|0|||
170783158|NCT05198310|617213050|FG004|Overall Study|Lost to Follow-up|0|||
170783159|NCT05198310|617213051|FG005|Overall Study|Lost to Follow-up|0|||
170783160|NCT05198310|617213052|FG006|Overall Study|Lost to Follow-up|0|||
170783161|NCT05198310|617213053|FG007|Overall Study|Lost to Follow-up|0|||
170783162|NCT05198310|617213046|FG000|Overall Study|Withdrawal by Subject|0|||
170783163|NCT05198310|617213047|FG001|Overall Study|Withdrawal by Subject|0|||
170783164|NCT05198310|617213048|FG002|Overall Study|Withdrawal by Subject|0|||
170783165|NCT05198310|617213049|FG003|Overall Study|Withdrawal by Subject|2|||
170783166|NCT05198310|617213050|FG004|Overall Study|Withdrawal by Subject|0|||
170783167|NCT05198310|617213051|FG005|Overall Study|Withdrawal by Subject|2|||
170783168|NCT05198310|617213052|FG006|Overall Study|Withdrawal by Subject|1|||
170783169|NCT05198310|617213053|FG007|Overall Study|Withdrawal by Subject|3|||
170783170|NCT02811679|617213056|FG000|Overall Study|Adverse Event|1|||
170783171|NCT02811679|617213056|FG000|Overall Study|Lack of Efficacy|6|||
170783172|NCT02811679|617213056|FG000|Overall Study|Early study closure due to slow accrual|3|||
170783173|NCT04854096|617213059|FG000|Overall Study|Adverse Event|1|||
170783174|NCT04854096|617213060|FG001|Overall Study|Adverse Event|0|||
170783175|NCT04854096|617213059|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
170783176|NCT04854096|617213060|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
170783177|NCT04854096|617213059|FG000|Overall Study|Withdrawal by Subject|1|||
170783178|NCT04854096|617213060|FG001|Overall Study|Withdrawal by Subject|0|||
170783179|NCT04854096|617213059|FG000|Overall Study|Other reasons|1|||
170783180|NCT04854096|617213060|FG001|Overall Study|Other reasons|0|||
170783181|NCT00593489|617213062|FG000|Allocation|did not attend workshop; allocation not|2|||
170783182|NCT00593489|617213063|FG001|Allocation|did not attend workshop; allocation not|1|||
170783183|NCT03930342|617213066|FG000|Overall Study|Lost to Follow-up|70|||
170783184|NCT03930342|617213067|FG001|Overall Study|Lost to Follow-up|77|||
170783185|NCT01872078|617213068|FG000|Overall Study|Adverse Event|0|||
170783186|NCT01872078|617213069|FG001|Overall Study|Adverse Event|0|||
170783187|NCT01872078|617213070|FG002|Overall Study|Adverse Event|1|||
170783188|NCT01872078|617213071|FG003|Overall Study|Adverse Event|0|||
170783189|NCT01872078|617213068|FG000|Overall Study|Dose administration non-compliance|0|||
170783190|NCT01872078|617213069|FG001|Overall Study|Dose administration non-compliance|0|||
170783191|NCT01872078|617213070|FG002|Overall Study|Dose administration non-compliance|0|||
170783192|NCT01872078|617213071|FG003|Overall Study|Dose administration non-compliance|1|||
170783193|NCT01872078|617213068|FG000|Overall Study|Protocol Violation|0|||
170884978|NCT01425008|617586841|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
170884979|NCT01425008|617586842|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
170884980|NCT01425008|617586843|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
170884981|NCT01425008|617586844|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
170884982|NCT01425008|617586845|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
170884983|NCT01425008|617586846|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
170884984|NCT01425008|617586847|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
170884985|NCT01425008|617586829|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884986|NCT01425008|617586830|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884987|NCT01425008|617586831|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884988|NCT01425008|617586832|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884989|NCT01425008|617586833|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884990|NCT01425008|617586834|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884991|NCT01425008|617586835|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884992|NCT01425008|617586836|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884993|NCT01425008|617586837|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884994|NCT01425008|617586838|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884995|NCT01425008|617586839|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884996|NCT01425008|617586840|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884997|NCT01425008|617586841|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884998|NCT01425008|617586842|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170884999|NCT01425008|617586843|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170885000|NCT01425008|617586844|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170885001|NCT01425008|617586845|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170633076|NCT01746901|616668464|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
170633077|NCT01746901|616668465|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
170885002|NCT01425008|617586846|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170885003|NCT01425008|617586847|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
170885004|NCT00562588|617586849|FG000|Overall Study|Adverse Event|40|||
170885005|NCT00562588|617586850|FG001|Overall Study|Adverse Event|58|||
170885006|NCT00562588|617586849|FG000|Overall Study|Protocol Violation|30|||
170885007|NCT00562588|617586850|FG001|Overall Study|Protocol Violation|26|||
170885008|NCT00562588|617586849|FG000|Overall Study|Lost to Follow-up|12|||
170885009|NCT00562588|617586850|FG001|Overall Study|Lost to Follow-up|4|||
170885010|NCT00562588|617586849|FG000|Overall Study|Withdrawal by Subject|10|||
170885011|NCT00562588|617586850|FG001|Overall Study|Withdrawal by Subject|9|||
170885012|NCT00562588|617586849|FG000|Overall Study|Other|0|||
170885013|NCT00562588|617586850|FG001|Overall Study|Other|2|||
170885014|NCT02867995|617586852|FG000|Overall Study|Withdrawal by Subject|0|||
170885015|NCT02867995|617586853|FG001|Overall Study|Withdrawal by Subject|1|||
170885016|NCT02867995|617586852|FG000|Overall Study|Lost to Follow-up|0|||
170885017|NCT02867995|617586853|FG001|Overall Study|Lost to Follow-up|2|||
170885018|NCT01534533|617586854|FG000|Overall Study|Lost to Follow-up|3|||
170885019|NCT01534533|617586855|FG001|Overall Study|Lost to Follow-up|0|||
170885020|NCT01534533|617586856|FG002|Overall Study|Lost to Follow-up|4|||
170885021|NCT01534533|617586857|FG003|Overall Study|Lost to Follow-up|3|||
170885022|NCT01534533|617586854|FG000|Overall Study|Withdrawal by Subject|5|||
170885023|NCT01534533|617586855|FG001|Overall Study|Withdrawal by Subject|3|||
170885024|NCT01534533|617586856|FG002|Overall Study|Withdrawal by Subject|4|||
170885025|NCT01534533|617586857|FG003|Overall Study|Withdrawal by Subject|1|||
170885026|NCT01662440|617588694|FG000|Overall Study|Adverse Event|1|||
170885027|NCT01662440|617588695|FG001|Overall Study|Adverse Event|0|||
170885028|NCT01662440|617588696|FG002|Overall Study|Adverse Event|0|||
170885029|NCT01662440|617588697|FG003|Overall Study|Adverse Event|1|||
170885030|NCT01662440|617588694|FG000|Overall Study|Death|0|||
170885031|NCT01662440|617588695|FG001|Overall Study|Death|1|||
170885032|NCT01662440|617588696|FG002|Overall Study|Death|0|||
170885033|NCT01662440|617588697|FG003|Overall Study|Death|0|||
170885034|NCT01662440|617588694|FG000|Overall Study|Lost to Follow-up|2|||
170885035|NCT01662440|617588695|FG001|Overall Study|Lost to Follow-up|2|||
170885036|NCT01662440|617588696|FG002|Overall Study|Lost to Follow-up|4|||
170885037|NCT01662440|617588697|FG003|Overall Study|Lost to Follow-up|1|||
170885038|NCT01662440|617588694|FG000|Overall Study|Subject moved to another country.|0|||
170885039|NCT01662440|617588695|FG001|Overall Study|Subject moved to another country.|1|||
170885040|NCT01662440|617588696|FG002|Overall Study|Subject moved to another country.|0|||
170885041|NCT01662440|617588697|FG003|Overall Study|Subject moved to another country.|0|||
170885042|NCT01662440|617588694|FG000|Overall Study|Protocol Violation|1|||
170885043|NCT01662440|617588695|FG001|Overall Study|Protocol Violation|0|||
170885044|NCT01662440|617588696|FG002|Overall Study|Protocol Violation|0|||
170885045|NCT01662440|617588697|FG003|Overall Study|Protocol Violation|0|||
170885046|NCT01662440|617588694|FG000|Overall Study|Withdrawal by Subject|5|||
170885047|NCT01662440|617588695|FG001|Overall Study|Withdrawal by Subject|2|||
170885048|NCT01662440|617588696|FG002|Overall Study|Withdrawal by Subject|2|||
170885049|NCT01662440|617588697|FG003|Overall Study|Withdrawal by Subject|2|||
170885050|NCT00112905|617588698|FG000|Overall Study|Adverse Event|4|||
170885051|NCT00112905|617588698|FG000|Overall Study|Death|1|||
170885052|NCT00112905|617588698|FG000|Overall Study|Ineligibility|5|||
170885053|NCT00112905|617588698|FG000|Overall Study|Alternative treatment|1|||
170885054|NCT00112905|617588698|FG000|Overall Study|performance status was deteiorating|1|||
170885055|NCT01982292|617588701|FG000|Overall Study|Adverse Event|2|||
170885056|NCT01982292|617588702|FG001|Overall Study|Adverse Event|0|||
170885057|NCT01982292|617588701|FG000|Overall Study|Death|1|||
170885058|NCT01982292|617588702|FG001|Overall Study|Death|0|||
170885059|NCT01982292|617588701|FG000|Overall Study|Lost to Follow-up|2|||
170885060|NCT01982292|617588702|FG001|Overall Study|Lost to Follow-up|0|||
170885061|NCT01982292|617588701|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
170885062|NCT01982292|617588702|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
170885063|NCT01982292|617588701|FG000|Overall Study|Protocol Deviation|1|||
170885064|NCT01982292|617588702|FG001|Overall Study|Protocol Deviation|0|||
170885065|NCT01982292|617588701|FG000|Overall Study|Patient/Guardian Decision|3|||
170633078|NCT01746901|616668466|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
170633079|NCT01746901|616668467|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
170633080|NCT01746901|616668468|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
170633081|NCT01746901|616668460|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
170633082|NCT01746901|616668461|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
170633083|NCT01746901|616668462|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
170633084|NCT01746901|616668463|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
170633085|NCT01746901|616668464|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
170633086|NCT01746901|616668465|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
170633087|NCT01746901|616668466|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
170633088|NCT01746901|616668467|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
170885066|NCT01982292|617588702|FG001|Overall Study|Patient/Guardian Decision|1|||
170885067|NCT01982292|617588701|FG000|Overall Study|Technical Problems|2|||
170885068|NCT01982292|617588702|FG001|Overall Study|Technical Problems|0|||
170885069|NCT04872101|617588703|FG000|Overall Study|Withdrawal by Subject|10|||
170885070|NCT04872101|617588704|FG001|Overall Study|Withdrawal by Subject|16|||
170885071|NCT04872101|617588703|FG000|Overall Study|Lack of Efficacy|6|||
170885072|NCT04872101|617588704|FG001|Overall Study|Lack of Efficacy|14|||
170885073|NCT04872101|617588703|FG000|Overall Study|Adverse Event|1|||
170885074|NCT04872101|617588704|FG001|Overall Study|Adverse Event|6|||
170885075|NCT04872101|617588703|FG000|Overall Study|Lost to Follow-up|2|||
170885076|NCT04872101|617588704|FG001|Overall Study|Lost to Follow-up|1|||
170885077|NCT04872101|617588703|FG000|Overall Study|Pregnancy|2|||
170885078|NCT04872101|617588704|FG001|Overall Study|Pregnancy|0|||
170885079|NCT04872101|617588703|FG000|Overall Study|Prohibited Medication|1|||
170885080|NCT04872101|617588704|FG001|Overall Study|Prohibited Medication|0|||
170885081|NCT04872101|617588703|FG000|Overall Study|Not dosed|1|||
170885082|NCT04872101|617588704|FG001|Overall Study|Not dosed|0|||
170885083|NCT01652287|617588712|FG000|Overall Study|Withdrawal by Subject|2|||
170885084|NCT01652287|617588713|FG001|Overall Study|Withdrawal by Subject|0|||
170885085|NCT00527605|617588714|FG000|Overall Study|Adverse Event|3|||
170885086|NCT00527605|617588715|FG001|Overall Study|Adverse Event|0|||
170885087|NCT00527605|617588714|FG000|Overall Study|Withdrawal by Subject|3|||
170885088|NCT00527605|617588715|FG001|Overall Study|Withdrawal by Subject|7|||
170885089|NCT00527605|617588714|FG000|Overall Study|Lost to Follow-up|6|||
170885090|NCT00527605|617588715|FG001|Overall Study|Lost to Follow-up|2|||
170885091|NCT00527605|617588714|FG000|Overall Study|Protocol Violation|1|||
170885092|NCT00527605|617588715|FG001|Overall Study|Protocol Violation|2|||
170885093|NCT01592760|617588721|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
170885094|NCT01592760|617588722|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
170885095|NCT01592760|617588723|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
170885096|NCT04312009|617588724|FG000|Overall Study|Withdrawal by Subject|2|||
170885097|NCT04312009|617588725|FG001|Overall Study|Withdrawal by Subject|1|||
170885098|NCT01363986|617588726|FG000|Overall Study|Disease progression|1|||
170885099|NCT02605642|617588730|FG000|Overall Study|Other|11|||
170885100|NCT02605642|617588731|FG001|Overall Study|Other|1|||
170885101|NCT02605642|617588730|FG000|Overall Study|Participant non-compliance|2|||
170885102|NCT02605642|617588731|FG001|Overall Study|Participant non-compliance|4|||
170885103|NCT02605642|617588730|FG000|Overall Study|Physician Decision|10|||
170885104|NCT02605642|617588731|FG001|Overall Study|Physician Decision|0|||
170885105|NCT02605642|617588730|FG000|Overall Study|Lost to Follow-up|12|||
170885106|NCT02605642|617588731|FG001|Overall Study|Lost to Follow-up|1|||
170885107|NCT02605642|617588730|FG000|Overall Study|Adverse Event|14|||
170885108|NCT02605642|617588731|FG001|Overall Study|Adverse Event|2|||
170885109|NCT02605642|617588730|FG000|Overall Study|Withdrawal by Subject|23|||
170885110|NCT02605642|617588731|FG001|Overall Study|Withdrawal by Subject|2|||
170885111|NCT02605642|617588730|FG000|Overall Study|Lack of response|24|||
170885112|NCT02605642|617588731|FG001|Overall Study|Lack of response|11|||
170885113|NCT02111564|617588740|FG000|Overall Study|Death|109|||
170885114|NCT02111564|617588741|FG001|Overall Study|Death|120|||
170885115|NCT02111564|617588740|FG000|Overall Study|Lost to Follow-up|2|||
170885116|NCT02111564|617588741|FG001|Overall Study|Lost to Follow-up|3|||
170885117|NCT02111564|617588740|FG000|Overall Study|Withdrawal by Subject|20|||
170885118|NCT02111564|617588741|FG001|Overall Study|Withdrawal by Subject|20|||
170885119|NCT00687362|617588742|FG000|Overall Study|Protocol Violation|2|||
170885120|NCT00687362|617588742|FG000|Overall Study|Withdrawal by Subject|1|||
170885121|NCT02354703|617588743|FG000|Overall Study|Withdrawal by Subject|1|||
170885122|NCT02354703|617588744|FG001|Overall Study|Withdrawal by Subject|1|||
170885123|NCT02354703|617588745|FG002|Overall Study|Withdrawal by Subject|1|||
170885124|NCT02354703|617588746|FG003|Overall Study|Withdrawal by Subject|1|||
170885125|NCT02354703|617588743|FG000|Overall Study|Lost to Follow-up|2|||
170885126|NCT02354703|617588744|FG001|Overall Study|Lost to Follow-up|7|||
170885127|NCT02354703|617588745|FG002|Overall Study|Lost to Follow-up|9|||
170885128|NCT02354703|617588746|FG003|Overall Study|Lost to Follow-up|2|||
170885129|NCT02354703|617588743|FG000|Overall Study|Adverse Event|0|||
170885130|NCT02354703|617588744|FG001|Overall Study|Adverse Event|0|||
170885131|NCT02354703|617588745|FG002|Overall Study|Adverse Event|1|||
170885132|NCT02354703|617588746|FG003|Overall Study|Adverse Event|0|||
170885133|NCT00984204|617588747|FG000|Overall Study|Death|1|||
170885134|NCT00984204|617588747|FG000|Overall Study|Lost to Follow-up|4|||
170885135|NCT00984204|617588747|FG000|Overall Study|Lack of Efficacy|10|||
170885136|NCT00699348|617588749|FG000|Overall Study|Death|6|||
170885137|NCT00699348|617588749|FG000|Overall Study|Adverse Event|15|||
170885138|NCT00699348|617588749|FG000|Overall Study|Withdrawal by Subject|11|||
170885139|NCT00699348|617588749|FG000|Overall Study|Protocol Violation|10|||
170885140|NCT00699348|617588749|FG000|Overall Study|Lack of Efficacy|8|||
170885141|NCT00699348|617588749|FG000|Overall Study|Failure to return|1|||
170885142|NCT00699348|617588749|FG000|Overall Study|Blood transfusion|24|||
170885143|NCT00699348|617588749|FG000|Overall Study|Renal transplantation|10|||
170885144|NCT00699348|617588749|FG000|Overall Study|Other|5|||
170885145|NCT04478708|617588752|FG000|Overall Study|Lost to Follow-up|0|||
170885146|NCT04478708|617588753|FG001|Overall Study|Lost to Follow-up|0|||
170885147|NCT04478708|617588754|FG002|Overall Study|Lost to Follow-up|0|||
170885148|NCT04478708|617588755|FG003|Overall Study|Lost to Follow-up|0|||
170885149|NCT04478708|617588756|FG004|Overall Study|Lost to Follow-up|0|||
170885150|NCT04478708|617588757|FG005|Overall Study|Lost to Follow-up|0|||
170885151|NCT04478708|617588758|FG006|Overall Study|Lost to Follow-up|0|||
170885152|NCT04478708|617588759|FG007|Overall Study|Lost to Follow-up|0|||
170885153|NCT04478708|617588760|FG008|Overall Study|Lost to Follow-up|1|||
170885154|NCT04478708|617588761|FG009|Overall Study|Lost to Follow-up|1|||
170885155|NCT04478708|617588762|FG010|Overall Study|Lost to Follow-up|1|||
170885156|NCT04478708|617588763|FG011|Overall Study|Lost to Follow-up|2|||
170885157|NCT04478708|617588764|FG012|Overall Study|Lost to Follow-up|1|||
170885158|NCT04478708|617588765|FG013|Overall Study|Lost to Follow-up|0|||
170885159|NCT04478708|617588766|FG014|Overall Study|Lost to Follow-up|0|||
170885160|NCT04478708|617588767|FG015|Overall Study|Lost to Follow-up|0|||
170783194|NCT01872078|617213069|FG001|Overall Study|Protocol Violation|0|||
170783195|NCT01872078|617213070|FG002|Overall Study|Protocol Violation|1|||
170783196|NCT01872078|617213071|FG003|Overall Study|Protocol Violation|0|||
170783197|NCT01872078|617213068|FG000|Overall Study|Withdrawal by Subject|0|||
170783198|NCT01872078|617213069|FG001|Overall Study|Withdrawal by Subject|0|||
170783199|NCT01872078|617213070|FG002|Overall Study|Withdrawal by Subject|1|||
170783200|NCT01872078|617213071|FG003|Overall Study|Withdrawal by Subject|0|||
170783201|NCT01872078|617213068|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
170783202|NCT01872078|617213069|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
170783203|NCT01872078|617213070|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
170783204|NCT01872078|617213071|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
170885161|NCT04478708|617588768|FG016|Overall Study|Lost to Follow-up|0|||
170885162|NCT04478708|617588752|FG000|Overall Study|Withdrawal of consent from study|0|||
170885163|NCT04478708|617588753|FG001|Overall Study|Withdrawal of consent from study|1|||
170885164|NCT04478708|617588754|FG002|Overall Study|Withdrawal of consent from study|2|||
170885165|NCT04478708|617588755|FG003|Overall Study|Withdrawal of consent from study|0|||
170440478|NCT00021541|615951560|FG000|Period 2-crossover|refused phase B|2|||
170885166|NCT04478708|617588756|FG004|Overall Study|Withdrawal of consent from study|1|||
170783205|NCT03527160|617213072|FG000|Overall Study|No urine collected|13|||
170885167|NCT04478708|617588757|FG005|Overall Study|Withdrawal of consent from study|1|||
170885168|NCT04478708|617588758|FG006|Overall Study|Withdrawal of consent from study|1|||
170885169|NCT04478708|617588759|FG007|Overall Study|Withdrawal of consent from study|0|||
170885170|NCT04478708|617588760|FG008|Overall Study|Withdrawal of consent from study|0|||
170885171|NCT04478708|617588761|FG009|Overall Study|Withdrawal of consent from study|0|||
170885172|NCT04478708|617588762|FG010|Overall Study|Withdrawal of consent from study|4|||
170885173|NCT04478708|617588763|FG011|Overall Study|Withdrawal of consent from study|3|||
170885174|NCT04478708|617588764|FG012|Overall Study|Withdrawal of consent from study|0|||
170885175|NCT04478708|617588765|FG013|Overall Study|Withdrawal of consent from study|0|||
170885176|NCT04478708|617588766|FG014|Overall Study|Withdrawal of consent from study|1|||
170885177|NCT04478708|617588767|FG015|Overall Study|Withdrawal of consent from study|0|||
170885178|NCT04478708|617588768|FG016|Overall Study|Withdrawal of consent from study|4|||
170885179|NCT00713700|617588769|FG000|Overall Study|Lost to Follow-up|3|||
170885180|NCT00713700|617588769|FG000|Overall Study|Withdrawal by Subject|1|||
170885181|NCT00179309|617588772|FG000|Treatment|Toxicity|2|||
170885182|NCT00179309|617588773|FG001|Treatment|Toxicity|3|||
170885183|NCT00179309|617588772|FG000|Treatment|Withdrawal by Subject|1|||
170885184|NCT00179309|617588773|FG001|Treatment|Withdrawal by Subject|2|||
170885185|NCT00179309|617588772|FG000|Treatment|Allergy|1|||
170885186|NCT00179309|617588773|FG001|Treatment|Allergy|0|||
170885187|NCT00559507|617588774|FG000|Overall Study|Not treated, patient ineligible|3|||
170885188|NCT04681170|617588775|FG000|Stratified Enrolment & run-in|Death|1|||
170885189|NCT04681170|617588776|FG001|Stratified Enrolment & run-in|Death|0|||
170885190|NCT04681170|617588775|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
170885191|NCT04681170|617588776|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
170885192|NCT04681170|617588775|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
170885193|NCT04681170|617588776|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
170885194|NCT04681170|617588775|FG000|Open Label Efficacy Phase|Adverse Event|0|||
170885195|NCT04681170|617588776|FG001|Open Label Efficacy Phase|Adverse Event|2|||
170885196|NCT04681170|617588775|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
170885197|NCT04681170|617588776|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
170885198|NCT04681170|617588775|FG000|Open Label Safety Phase|AEs and none compliance|0|||
170885199|NCT04681170|617588776|FG001|Open Label Safety Phase|AEs and none compliance|1|||
170885200|NCT04986202|617588779|FG000|Overall Study|Death|10|||
170885201|NCT04986202|617588780|FG001|Overall Study|Death|3|||
170885202|NCT04986202|617588781|FG002|Overall Study|Death|10|||
170885203|NCT04986202|617588779|FG000|Overall Study|Physician Decision|3|||
170885204|NCT04986202|617588780|FG001|Overall Study|Physician Decision|1|||
170885205|NCT04986202|617588781|FG002|Overall Study|Physician Decision|2|||
170885206|NCT04986202|617588779|FG000|Overall Study|Withdrawal by Subject|4|||
170885207|NCT04986202|617588780|FG001|Overall Study|Withdrawal by Subject|2|||
170885208|NCT04986202|617588781|FG002|Overall Study|Withdrawal by Subject|4|||
170885209|NCT03823391|617588782|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
170885210|NCT03823391|617588783|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
170885211|NCT03823391|617588782|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
170885212|NCT03823391|617588783|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
170885213|NCT02872311|617588788|FG000|Overall Study|Death|2|||
170885214|NCT02872311|617588789|FG001|Overall Study|Death|0|||
170885215|NCT02872311|617588790|FG002|Overall Study|Death|0|||
170885216|NCT02872311|617588791|FG003|Overall Study|Death|0|||
170885217|NCT02872311|617588792|FG004|Overall Study|Death|0|||
170885218|NCT02872311|617588788|FG000|Overall Study|Lost to Follow-up|2|||
170885219|NCT02872311|617588789|FG001|Overall Study|Lost to Follow-up|0|||
170885220|NCT02872311|617588790|FG002|Overall Study|Lost to Follow-up|0|||
170885221|NCT02872311|617588791|FG003|Overall Study|Lost to Follow-up|0|||
170885222|NCT02872311|617588792|FG004|Overall Study|Lost to Follow-up|0|||
170885223|NCT02872311|617588788|FG000|Overall Study|Protocol Violation|0|||
170885224|NCT02872311|617588789|FG001|Overall Study|Protocol Violation|2|||
170885225|NCT02872311|617588790|FG002|Overall Study|Protocol Violation|1|||
170885226|NCT02872311|617588791|FG003|Overall Study|Protocol Violation|0|||
170885227|NCT02872311|617588792|FG004|Overall Study|Protocol Violation|0|||
170885228|NCT05030311|617588793|FG000|Overall Study|Technical problems|0|||
170885229|NCT05030311|617588794|FG001|Overall Study|Technical problems|1|||
170885230|NCT05030311|617588793|FG000|Overall Study|Withdrawal by Subject|31|||
170885231|NCT05030311|617588794|FG001|Overall Study|Withdrawal by Subject|17|||
170633089|NCT01746901|616668468|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
170885232|NCT05030311|617588793|FG000|Overall Study|Adverse Event|13|||
170885233|NCT05030311|617588794|FG001|Overall Study|Adverse Event|5|||
170885234|NCT05030311|617588793|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170885235|NCT05030311|617588794|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170885236|NCT05030311|617588793|FG000|Overall Study|Physician Decision|5|||
170885237|NCT05030311|617588794|FG001|Overall Study|Physician Decision|2|||
170885238|NCT05030311|617588793|FG000|Overall Study|Lost to Follow-up|5|||
170885239|NCT05030311|617588794|FG001|Overall Study|Lost to Follow-up|1|||
170885240|NCT05030311|617588793|FG000|Overall Study|Protocol Violation|4|||
170885241|NCT05030311|617588794|FG001|Overall Study|Protocol Violation|4|||
170885242|NCT03042468|617588795|FG000|Overall Study|Death|0|||
170885243|NCT03042468|617588796|FG001|Overall Study|Death|1|||
170885244|NCT03042468|617588797|FG002|Overall Study|Death|1|||
170885245|NCT03042468|617588798|FG003|Overall Study|Death|0|||
170885246|NCT03042468|617588799|FG004|Overall Study|Death|0|||
170885247|NCT03042468|617588800|FG005|Overall Study|Death|0|||
170440479|NCT00021541|615951561|FG001|Period 2-crossover|refused phase B|2|||
170440480|NCT00021541|615951560|FG000|Period 2-crossover|Withdrawal by Subject|3|||
170440481|NCT00021541|615951561|FG001|Period 2-crossover|Withdrawal by Subject|4|||
170783206|NCT03527160|617213072|FG000|Overall Study|No clinical serum creatinine collected|6|||
170783207|NCT03527160|617213072|FG000|Overall Study|Did not meet inclusion|2|||
170783208|NCT05239039|617213073|FG000|Overall Study|Withdrawal by Subject|0|||
170783209|NCT05239039|617213074|FG001|Overall Study|Withdrawal by Subject|1|||
170783210|NCT05063994|617214433|FG000|Cortef Run-In|Withdrawal of Consent|1|||
170783211|NCT05063994|617214434|FG001|Cortef Run-In|Withdrawal of Consent|0|||
170783212|NCT05063994|617214435|FG002|Cortef Run-In|Withdrawal of Consent|0|||
170783213|NCT05063994|617214433|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
170783214|NCT05063994|617214434|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
170783215|NCT05063994|617214435|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
170783216|NCT05063994|617214433|FG000|Treatment|Physician Decision|0|||
170783217|NCT05063994|617214434|FG001|Treatment|Physician Decision|0|||
170783218|NCT05063994|617214435|FG002|Treatment|Physician Decision|1|||
170783219|NCT05063994|617214433|FG000|Treatment|Withdrawal by Subject|0|||
170783220|NCT05063994|617214434|FG001|Treatment|Withdrawal by Subject|0|||
170783221|NCT05063994|617214435|FG002|Treatment|Withdrawal by Subject|1|||
170783222|NCT05063994|617214433|FG000|Treatment|Withdrawal of Consent|0|||
170783223|NCT05063994|617214434|FG001|Treatment|Withdrawal of Consent|0|||
170783224|NCT05063994|617214435|FG002|Treatment|Withdrawal of Consent|1|||
170783225|NCT02682316|617214436|FG000|Overall Study|Benign Final Pathology|27|||
170783226|NCT02682316|617214437|FG001|Overall Study|Benign Final Pathology|26|||
170783227|NCT02682316|617214436|FG000|Overall Study|Reoperation before 30 days|7|||
170783228|NCT02682316|617214437|FG001|Overall Study|Reoperation before 30 days|6|||
170783229|NCT02682316|617214436|FG000|Overall Study|Ineligible|1|||
170783230|NCT02682316|617214437|FG001|Overall Study|Ineligible|0|||
170783231|NCT02682316|617214436|FG000|Overall Study|Death|1|||
170783232|NCT02682316|617214437|FG001|Overall Study|Death|0|||
170783233|NCT02682316|617214436|FG000|Overall Study|Lost to Follow-up|7|||
170783234|NCT02682316|617214437|FG001|Overall Study|Lost to Follow-up|3|||
170783235|NCT04703322|617214438|FG000|Overall Study|Ongoing|8|||
170783236|NCT04703322|617214438|FG000|Overall Study|Withdrawal by Subject|1|||
170783237|NCT03692611|617214440|FG000|Overall Study|Found to be ineligible postrandomization|3|||
170783238|NCT03692611|617214441|FG001|Overall Study|Found to be ineligible postrandomization|0|||
170783239|NCT05009251|617214442|FG000|Overall Study|Protocol Violation|100|||
170783240|NCT05009251|617214443|FG001|Overall Study|Protocol Violation|105|||
170783241|NCT05009251|617214444|FG002|Overall Study|Protocol Violation|119|||
170783242|NCT05009251|617214445|FG003|Overall Study|Protocol Violation|120|||
170783243|NCT05009251|617214446|FG004|Overall Study|Protocol Violation|119|||
170783244|NCT05009251|617214442|FG000|Overall Study|Death|25|||
170783245|NCT05009251|617214443|FG001|Overall Study|Death|22|||
170783246|NCT05009251|617214444|FG002|Overall Study|Death|24|||
170783247|NCT05009251|617214445|FG003|Overall Study|Death|19|||
170783248|NCT05009251|617214446|FG004|Overall Study|Death|15|||
170783249|NCT04083235|617214450|FG000|Overall Study|Death|252|||
170783250|NCT04083235|617214451|FG001|Overall Study|Death|277|||
170783251|NCT04083235|617214450|FG000|Overall Study|Withdrawal by Subject|13|||
170783252|NCT04083235|617214451|FG001|Overall Study|Withdrawal by Subject|17|||
170783253|NCT04083235|617214450|FG000|Overall Study|Lost to Follow-up|1|||
170783254|NCT04083235|617214451|FG001|Overall Study|Lost to Follow-up|1|||
170783255|NCT04083235|617214450|FG000|Overall Study|Does not meet entry criteria|1|||
170783256|NCT04083235|617214451|FG001|Overall Study|Does not meet entry criteria|0|||
170783257|NCT04083235|617214450|FG000|Overall Study|Did not receive treatment|13|||
170783258|NCT04083235|617214451|FG001|Overall Study|Did not receive treatment|8|||
170783259|NCT04083235|617214450|FG000|Overall Study|Ongoing at the time of DCO|44|||
170783260|NCT04083235|617214451|FG001|Overall Study|Ongoing at the time of DCO|7|||
170783261|NCT04060355|617214455|FG000|Overall Study|Lost to Follow-up|41|||
170783262|NCT01140880|617214456|FG000|Overall Study|Death|0|||
170783263|NCT01140880|617214457|FG001|Overall Study|Death|1|||
170783264|NCT01140880|617214456|FG000|Overall Study|Withdrawal by Subject|6|||
170783265|NCT01140880|617214457|FG001|Overall Study|Withdrawal by Subject|3|||
170783266|NCT01140880|617214456|FG000|Overall Study|Lost to Follow-up|8|||
170783267|NCT01140880|617214457|FG001|Overall Study|Lost to Follow-up|10|||
170783268|NCT01140880|617214456|FG000|Overall Study|Protocol Violation|0|||
170783269|NCT01140880|617214457|FG001|Overall Study|Protocol Violation|30|||
170783270|NCT03958955|617214458|FG000|Overall Study|Adverse Event|1|||
170783271|NCT02807636|617214462|FG000|Overall Study|Lost to Follow-up|10|||
170783272|NCT02807636|617214463|FG001|Overall Study|Lost to Follow-up|13|||
170783273|NCT02807636|617214464|FG002|Overall Study|Lost to Follow-up|6|||
170783274|NCT02807636|617214462|FG000|Overall Study|Protocol Deviation|1|||
170783275|NCT02807636|617214463|FG001|Overall Study|Protocol Deviation|0|||
170783276|NCT02807636|617214464|FG002|Overall Study|Protocol Deviation|0|||
170783277|NCT02807636|617214462|FG000|Overall Study|Symptomatic Deterioration|0|||
170783278|NCT02807636|617214463|FG001|Overall Study|Symptomatic Deterioration|1|||
170783279|NCT02807636|617214464|FG002|Overall Study|Symptomatic Deterioration|0|||
170783280|NCT02807636|617214462|FG000|Overall Study|Withdrawal by Subject|39|||
170783281|NCT02807636|617214463|FG001|Overall Study|Withdrawal by Subject|28|||
170783282|NCT02807636|617214464|FG002|Overall Study|Withdrawal by Subject|24|||
170783283|NCT02807636|617214462|FG000|Overall Study|Death|303|||
170783284|NCT02807636|617214463|FG001|Overall Study|Death|332|||
170783285|NCT02807636|617214464|FG002|Overall Study|Death|272|||
170783286|NCT02807636|617214462|FG000|Overall Study|Study Terminated By Sponsor|47|||
170783287|NCT02807636|617214463|FG001|Overall Study|Study Terminated By Sponsor|76|||
170783288|NCT02807636|617214464|FG002|Overall Study|Study Terminated By Sponsor|60|||
170783289|NCT02807636|617214462|FG000|Overall Study|Physician Decision|0|||
170783290|NCT02807636|617214463|FG001|Overall Study|Physician Decision|1|||
170783291|NCT02807636|617214464|FG002|Overall Study|Physician Decision|0|||
170783292|NCT04088630|617214465|FG000|Overall Study|Lost to Follow-up|3|||
170783293|NCT04088630|617214466|FG001|Overall Study|Lost to Follow-up|2|||
170783294|NCT04088630|617214467|FG002|Overall Study|Lost to Follow-up|6|||
170783295|NCT04088630|617214465|FG000|Overall Study|Death|3|||
170783296|NCT04088630|617214466|FG001|Overall Study|Death|1|||
170783297|NCT04088630|617214467|FG002|Overall Study|Death|1|||
170783298|NCT04088630|617214465|FG000|Overall Study|Physician Decision|0|||
170783299|NCT04088630|617214466|FG001|Overall Study|Physician Decision|1|||
170783300|NCT04088630|617214467|FG002|Overall Study|Physician Decision|1|||
170783301|NCT03175029|617214468|FG000|Overall Study|Withdrawal by Subject|2|||
170783302|NCT03175029|617214469|FG001|Overall Study|Withdrawal by Subject|1|||
170783303|NCT03175029|617214468|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
170783304|NCT03175029|617214469|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
170783305|NCT03315754|617214470|FG000|Overall Study|COVID-19 complications leading to death|1|||
170783306|NCT03315754|617214470|FG000|Overall Study|insurance coverage issue|1|||
170783307|NCT05227209|617214471|FG000|Overall Study|Adverse Event|11|||
170783308|NCT05227209|617214471|FG000|Overall Study|Lost to Follow-up|1|||
170783309|NCT05227209|617214471|FG000|Overall Study|Withdrawal by Subject|7|||
170783310|NCT05227209|617214471|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
170783311|NCT05324124|617214472|FG000|Period 1|Withdrawal by Subject|1|||
170783312|NCT05324124|617214473|FG001|Period 1|Withdrawal by Subject|0|||
170783313|NCT05324124|617214472|FG000|Period 1|Physician Decision|0|||
170783314|NCT05324124|617214473|FG001|Period 1|Physician Decision|1|||
170783315|NCT05273749|617214474|FG000|Overall Study|Adverse Event|14|||
170783316|NCT05273749|617214475|FG001|Overall Study|Adverse Event|8|||
170783317|NCT05273749|617214474|FG000|Overall Study|Lack of Efficacy|2|||
170783318|NCT05273749|617214475|FG001|Overall Study|Lack of Efficacy|8|||
170783319|NCT05273749|617214474|FG000|Overall Study|Physician Decision|0|||
170783320|NCT05273749|617214475|FG001|Overall Study|Physician Decision|2|||
170783321|NCT05273749|617214474|FG000|Overall Study|Withdrawal by Subject|14|||
170783322|NCT05273749|617214475|FG001|Overall Study|Withdrawal by Subject|16|||
170783323|NCT05273749|617214474|FG000|Overall Study|Lost to Follow-up|10|||
170783324|NCT05273749|617214475|FG001|Overall Study|Lost to Follow-up|10|||
170783325|NCT05273749|617214474|FG000|Overall Study|Pregnancy|1|||
170783326|NCT05273749|617214475|FG001|Overall Study|Pregnancy|0|||
170783327|NCT05273749|617214474|FG000|Overall Study|Non-Compliance|3|||
170783328|NCT05273749|617214475|FG001|Overall Study|Non-Compliance|2|||
170783329|NCT05273749|617214474|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
170783330|NCT05273749|617214475|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
170783331|NCT05229120|617214477|FG000|Overall Study|Withdrawal by Subject|8|||
170783332|NCT04237298|617214480|FG000|Overall Study|Lost to Follow-up|4|||
170783333|NCT04237298|617214481|FG001|Overall Study|Lost to Follow-up|5|||
170783334|NCT04556656|617214485|FG000|Overall Study|Withdrawal by Subject|14|||
170783335|NCT04556656|617214486|FG001|Overall Study|Withdrawal by Subject|12|||
170783336|NCT04556656|617214485|FG000|Overall Study|Physician Decision|1|||
170783337|NCT04556656|617214486|FG001|Overall Study|Physician Decision|0|||
170783338|NCT04556656|617214485|FG000|Overall Study|Adverse Event|4|||
170783339|NCT04556656|617214486|FG001|Overall Study|Adverse Event|7|||
170783340|NCT04556656|617214485|FG000|Overall Study|Death|4|||
170783341|NCT04556656|617214486|FG001|Overall Study|Death|0|||
170783342|NCT04556656|617214485|FG000|Overall Study|Lost to Follow-up|3|||
170783343|NCT04556656|617214486|FG001|Overall Study|Lost to Follow-up|2|||
170783344|NCT04556656|617214485|FG000|Overall Study|Not further specified|2|||
170783345|NCT04556656|617214486|FG001|Overall Study|Not further specified|1|||
170783346|NCT05563246|617214487|FG000|Overall Study|Withdrawal by Subject|1|||
170783347|NCT05563246|617214488|FG001|Overall Study|Withdrawal by Subject|2|||
170783348|NCT05563246|617214489|FG002|Overall Study|Withdrawal by Subject|0|||
170783349|NCT05563246|617214490|FG003|Overall Study|Withdrawal by Subject|0|||
170783350|NCT05563246|617214487|FG000|Overall Study|Protocol Deviation|0|||
170783351|NCT05563246|617214488|FG001|Overall Study|Protocol Deviation|1|||
170783352|NCT05563246|617214489|FG002|Overall Study|Protocol Deviation|0|||
170783353|NCT05563246|617214490|FG003|Overall Study|Protocol Deviation|0|||
170783354|NCT05563246|617214487|FG000|Overall Study|Physician Decision|0|||
170783355|NCT05563246|617214488|FG001|Overall Study|Physician Decision|1|||
170885248|NCT03042468|617588795|FG000|Overall Study|Withdrawal by Subject|0|||
170885249|NCT03042468|617588796|FG001|Overall Study|Withdrawal by Subject|0|||
170885250|NCT03042468|617588797|FG002|Overall Study|Withdrawal by Subject|0|||
170783356|NCT05563246|617214489|FG002|Overall Study|Physician Decision|0|||
170783357|NCT05563246|617214490|FG003|Overall Study|Physician Decision|0|||
170783358|NCT05563246|617214487|FG000|Overall Study|Adverse Event|0|||
170783359|NCT05563246|617214488|FG001|Overall Study|Adverse Event|0|||
170783360|NCT05563246|617214489|FG002|Overall Study|Adverse Event|2|||
170783361|NCT05563246|617214490|FG003|Overall Study|Adverse Event|0|||
170783362|NCT05563246|617214487|FG000|Overall Study|Lost to Follow-up|0|||
170783363|NCT05563246|617214488|FG001|Overall Study|Lost to Follow-up|0|||
170783364|NCT05563246|617214489|FG002|Overall Study|Lost to Follow-up|1|||
170783365|NCT05563246|617214490|FG003|Overall Study|Lost to Follow-up|0|||
170783366|NCT01580488|617214495|FG000|Overall Study|Withdrawal by Subject|1|||
170783367|NCT03892616|617214497|FG000|Washout Period 2|Met discontinuation criterion|0|||
170783368|NCT03892616|617214498|FG001|Washout Period 2|Met discontinuation criterion|0|||
170783369|NCT03892616|617214499|FG002|Washout Period 2|Met discontinuation criterion|0|||
170783370|NCT03892616|617214500|FG003|Washout Period 2|Met discontinuation criterion|0|||
170783371|NCT03892616|617214501|FG004|Washout Period 2|Met discontinuation criterion|0|||
170783372|NCT03892616|617214502|FG005|Washout Period 2|Met discontinuation criterion|0|||
170783373|NCT03892616|617214503|FG006|Washout Period 2|Met discontinuation criterion|0|||
170783374|NCT03892616|617214504|FG007|Washout Period 2|Met discontinuation criterion|0|||
170783375|NCT03892616|617214505|FG008|Washout Period 2|Met discontinuation criterion|1|||
170783376|NCT03892616|617214506|FG009|Washout Period 2|Met discontinuation criterion|0|||
170783377|NCT03892616|617214507|FG010|Washout Period 2|Met discontinuation criterion|0|||
170783378|NCT03892616|617214508|FG011|Washout Period 2|Met discontinuation criterion|0|||
170783379|NCT04562649|617214511|FG000|Overall Study|Withdrawal by Subject|11|||
170783380|NCT04562649|617214512|FG001|Overall Study|Withdrawal by Subject|8|||
170783381|NCT04562649|617214511|FG000|Overall Study|Lost to Follow-up|26|||
170783382|NCT04562649|617214512|FG001|Overall Study|Lost to Follow-up|20|||
170783383|NCT04322643|617214514|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
170783384|NCT05486078|617214515|FG000|Overall Study|4 drop out and one withdrawn|5|||
170783385|NCT03302494|617214516|FG000|Overall Study|Other|7|||
170783386|NCT03302494|617214517|FG001|Overall Study|Other|4|||
170783387|NCT03302494|617214518|FG002|Overall Study|Other|6|||
170783388|NCT03302494|617214516|FG000|Overall Study|Withdrawal by Subject|10|||
170783389|NCT03302494|617214517|FG001|Overall Study|Withdrawal by Subject|2|||
170783390|NCT03302494|617214518|FG002|Overall Study|Withdrawal by Subject|9|||
170783391|NCT03302494|617214516|FG000|Overall Study|Study Terminated by Sponsor|32|||
170783392|NCT03302494|617214517|FG001|Overall Study|Study Terminated by Sponsor|29|||
170783393|NCT03302494|617214518|FG002|Overall Study|Study Terminated by Sponsor|30|||
170783394|NCT03302494|617214516|FG000|Overall Study|Physician Decision|1|||
170783395|NCT03302494|617214517|FG001|Overall Study|Physician Decision|0|||
170783396|NCT03302494|617214518|FG002|Overall Study|Physician Decision|1|||
170783397|NCT03302494|617214516|FG000|Overall Study|Lost to Follow-up|1|||
170783398|NCT03302494|617214517|FG001|Overall Study|Lost to Follow-up|3|||
170783399|NCT03302494|617214518|FG002|Overall Study|Lost to Follow-up|3|||
170783400|NCT03302494|617214516|FG000|Overall Study|Death|13|||
170783401|NCT03302494|617214517|FG001|Overall Study|Death|11|||
170783402|NCT03302494|617214518|FG002|Overall Study|Death|4|||
170783403|NCT03302494|617214516|FG000|Overall Study|Adverse Event|1|||
170783404|NCT03302494|617214517|FG001|Overall Study|Adverse Event|2|||
170783405|NCT03302494|617214518|FG002|Overall Study|Adverse Event|0|||
170783406|NCT03302494|617214516|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
170783407|NCT03302494|617214517|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
170783408|NCT03302494|617214518|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
170783409|NCT05134233|617214519|FG000|Overall Study|Pregnancy|1|||
170783410|NCT05134233|617214519|FG000|Overall Study|MEP value too low|2|||
170783411|NCT05134233|617214519|FG000|Overall Study|Lost to Follow-up|1|||
170783412|NCT05710107|617214520|FG000|Overall Study|Withdrawal by Subject|1|||
170783413|NCT05710107|617214521|FG001|Overall Study|Withdrawal by Subject|1|||
170783414|NCT05710107|617214520|FG000|Overall Study|Lost to Follow-up|8|||
170783415|NCT05710107|617214521|FG001|Overall Study|Lost to Follow-up|9|||
170783416|NCT05710107|617214520|FG000|Overall Study|Unable to place assigned block|2|||
170783417|NCT05710107|617214521|FG001|Overall Study|Unable to place assigned block|0|||
170783418|NCT05710107|617214520|FG000|Overall Study|Withdrawn by study team|0|||
170783419|NCT05710107|617214521|FG001|Overall Study|Withdrawn by study team|1|||
170783420|NCT04450342|617214522|FG000|Overall Study|Adverse Event|1|||
170783421|NCT04450342|617214523|FG001|Overall Study|Adverse Event|1|||
170783422|NCT04450342|617214524|FG002|Overall Study|Adverse Event|0|||
170783423|NCT04450342|617214522|FG000|Overall Study|Device not used|1|||
170783424|NCT04450342|617214523|FG001|Overall Study|Device not used|0|||
170783425|NCT04450342|617214524|FG002|Overall Study|Device not used|0|||
170783426|NCT04450342|617214522|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
170885251|NCT03042468|617588798|FG003|Overall Study|Withdrawal by Subject|0|||
170885252|NCT03042468|617588799|FG004|Overall Study|Withdrawal by Subject|0|||
170885253|NCT03042468|617588800|FG005|Overall Study|Withdrawal by Subject|1|||
170885254|NCT03042468|617588795|FG000|Overall Study|Lost to Follow-up|0|||
170885255|NCT03042468|617588796|FG001|Overall Study|Lost to Follow-up|0|||
170885256|NCT03042468|617588797|FG002|Overall Study|Lost to Follow-up|0|||
170885257|NCT03042468|617588798|FG003|Overall Study|Lost to Follow-up|0|||
170885258|NCT03042468|617588799|FG004|Overall Study|Lost to Follow-up|1|||
170885259|NCT03042468|617588800|FG005|Overall Study|Lost to Follow-up|1|||
170885260|NCT03735667|617588801|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
170885261|NCT03735667|617588802|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
170885262|NCT03735667|617588803|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
170885263|NCT03735667|617588801|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
170885264|NCT03735667|617588802|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
170885265|NCT03735667|617588803|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
170537185|NCT03765073|616311553|FG001|Stage 1|Lost to Follow-up|0|||
170885266|NCT03735667|617588801|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
170885267|NCT03735667|617588802|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
170885268|NCT03735667|617588803|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
170885269|NCT03735667|617588801|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
170885270|NCT03735667|617588802|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
170885271|NCT03735667|617588803|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
170885272|NCT03735667|617588801|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
170885273|NCT03735667|617588802|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
170885274|NCT03735667|617588803|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
170885275|NCT03735667|617588801|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
170885276|NCT03735667|617588802|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
170885277|NCT03735667|617588803|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
170885278|NCT03735667|617588801|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
170885279|NCT03735667|617588802|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
170885280|NCT03735667|617588803|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
170885281|NCT03735667|617588801|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
170885282|NCT03735667|617588802|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
170885283|NCT03735667|617588803|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
170885284|NCT03735667|617588801|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
170885285|NCT03735667|617588802|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
170885286|NCT03735667|617588803|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
170885287|NCT03735667|617588801|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
170885288|NCT03735667|617588802|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
170885289|NCT03735667|617588803|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
170885290|NCT03735667|617588801|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
170885291|NCT03735667|617588802|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
170885292|NCT03735667|617588803|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
170885293|NCT03735667|617588801|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
170885294|NCT03735667|617588802|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
170885295|NCT03735667|617588803|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
170885296|NCT03092726|617588804|FG000|Overall Study|Adverse Event|3|||
170885297|NCT03092726|617588805|FG001|Overall Study|Adverse Event|10|||
170885298|NCT03092726|617588804|FG000|Overall Study|Lack of Efficacy|0|||
170885299|NCT03092726|617588805|FG001|Overall Study|Lack of Efficacy|1|||
170885300|NCT03092726|617588804|FG000|Overall Study|Lost to Follow-up|1|||
170885301|NCT03092726|617588805|FG001|Overall Study|Lost to Follow-up|0|||
170885302|NCT03092726|617588804|FG000|Overall Study|Withdrawal by Subject|5|||
170885303|NCT03092726|617588805|FG001|Overall Study|Withdrawal by Subject|3|||
170885304|NCT05980299|617588807|FG000|Overall Study|Death|28|||
170885305|NCT05980299|617588808|FG001|Overall Study|Death|0|||
170885306|NCT05980299|617588807|FG000|Overall Study|Discharged from Nursing Home|9|||
170885307|NCT05980299|617588808|FG001|Overall Study|Discharged from Nursing Home|0|||
170885308|NCT05980299|617588807|FG000|Overall Study|Lost to Follow-up|0|||
170885309|NCT05980299|617588808|FG001|Overall Study|Lost to Follow-up|10|||
170885310|NCT01662895|617588819|FG000|Overall Study|Lost to Follow-up|0|||
170885311|NCT01662895|617588820|FG001|Overall Study|Lost to Follow-up|1|||
170885312|NCT00493038|617588821|FG000|Treatment|Adverse Event|8|||
170885313|NCT00493038|617588822|FG001|Treatment|Adverse Event|4|||
170885314|NCT00493038|617588821|FG000|Treatment|Lost to Follow-up|5|||
170885315|NCT00493038|617588822|FG001|Treatment|Lost to Follow-up|3|||
170885316|NCT00493038|617588821|FG000|Treatment|Withdrawal by Subject|11|||
170885317|NCT00493038|617588822|FG001|Treatment|Withdrawal by Subject|12|||
170885318|NCT00493038|617588821|FG000|Treatment|Other|0|||
170885319|NCT00493038|617588822|FG001|Treatment|Other|1|||
170885320|NCT00493038|617588821|FG000|Follow-up|Lost to Follow-up|1|||
170885321|NCT00493038|617588822|FG001|Follow-up|Lost to Follow-up|0|||
170885322|NCT04418765|617588825|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
170537186|NCT03765073|616311554|FG002|Stage 1|Lost to Follow-up|0|||
170885323|NCT04418765|617588826|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
170885324|NCT04418765|617588827|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
170885325|NCT04418765|617588825|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
170885326|NCT04418765|617588826|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
170885327|NCT04418765|617588827|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
170885328|NCT04418765|617588825|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
170885329|NCT04418765|617588826|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
170885330|NCT04418765|617588827|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
170885331|NCT04418765|617588825|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
170885332|NCT04418765|617588826|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
170885333|NCT04418765|617588827|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
170885334|NCT04418765|617588825|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
170537187|NCT03765073|616311555|FG003|Stage 1|Lost to Follow-up|0|||
170537188|NCT03765073|616311556|FG004|Stage 1|Lost to Follow-up|0|||
170885335|NCT04418765|617588826|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
170885336|NCT04418765|617588827|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
170885337|NCT04418765|617588825|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
170885338|NCT04418765|617588826|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
170885339|NCT04418765|617588827|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
170885340|NCT04418765|617588825|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
170885341|NCT04418765|617588826|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
170885342|NCT04418765|617588827|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
170885343|NCT04418765|617588825|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
170885344|NCT04418765|617588826|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
170885345|NCT04418765|617588827|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
170885346|NCT04418765|617588825|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
170885347|NCT04418765|617588826|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
170885348|NCT04418765|617588827|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
170885349|NCT04418765|617588825|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
170885350|NCT04418765|617588826|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
170885351|NCT04418765|617588827|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
170885352|NCT04418765|617588825|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
170885353|NCT04418765|617588826|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
170885354|NCT04418765|617588827|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
170885355|NCT04418765|617588825|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
170885356|NCT04418765|617588826|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
170885357|NCT04418765|617588827|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
170885358|NCT04418765|617588825|FG000|Extension Period (48 Weeks)|Other than specified|0|||
170885359|NCT04418765|617588826|FG001|Extension Period (48 Weeks)|Other than specified|5|||
170885360|NCT04418765|617588827|FG002|Extension Period (48 Weeks)|Other than specified|2|||
170885361|NCT02432235|617588829|FG000|Overall Study|Death|1|||
170885362|NCT02432235|617588830|FG001|Overall Study|Death|1|||
170885363|NCT02432235|617588831|FG002|Overall Study|Death|2|||
170885364|NCT02432235|617588832|FG003|Overall Study|Death|2|||
170885365|NCT02432235|617588833|FG004|Overall Study|Death|1|||
170885366|NCT02432235|617588834|FG005|Overall Study|Death|3|||
170885367|NCT02432235|617588835|FG006|Overall Study|Death|11|||
170885368|NCT02432235|617588836|FG007|Overall Study|Death|15|||
170885369|NCT02432235|617588837|FG008|Overall Study|Death|15|||
170885370|NCT02432235|617588838|FG009|Overall Study|Death|3|||
170885371|NCT02432235|617588839|FG010|Overall Study|Death|1|||
170885372|NCT02432235|617588840|FG011|Overall Study|Death|0|||
170885373|NCT02432235|617588829|FG000|Overall Study|Withdrawal by Subject|0|||
170885374|NCT02432235|617588830|FG001|Overall Study|Withdrawal by Subject|1|||
170885375|NCT02432235|617588831|FG002|Overall Study|Withdrawal by Subject|0|||
170885376|NCT02432235|617588832|FG003|Overall Study|Withdrawal by Subject|0|||
170885377|NCT02432235|617588833|FG004|Overall Study|Withdrawal by Subject|0|||
170537189|NCT03765073|616311557|FG005|Stage 1|Lost to Follow-up|0|||
170885378|NCT02432235|617588834|FG005|Overall Study|Withdrawal by Subject|2|||
170885379|NCT02432235|617588835|FG006|Overall Study|Withdrawal by Subject|5|||
170885380|NCT02432235|617588836|FG007|Overall Study|Withdrawal by Subject|3|||
170885381|NCT02432235|617588837|FG008|Overall Study|Withdrawal by Subject|1|||
170885382|NCT02432235|617588838|FG009|Overall Study|Withdrawal by Subject|0|||
170885383|NCT02432235|617588839|FG010|Overall Study|Withdrawal by Subject|0|||
170885384|NCT02432235|617588840|FG011|Overall Study|Withdrawal by Subject|0|||
170885385|NCT02432235|617588829|FG000|Overall Study|Lost to Follow-up|0|||
170885386|NCT02432235|617588830|FG001|Overall Study|Lost to Follow-up|0|||
170885387|NCT02432235|617588831|FG002|Overall Study|Lost to Follow-up|0|||
170885388|NCT02432235|617588832|FG003|Overall Study|Lost to Follow-up|0|||
170885389|NCT02432235|617588833|FG004|Overall Study|Lost to Follow-up|0|||
170885390|NCT02432235|617588834|FG005|Overall Study|Lost to Follow-up|1|||
170885391|NCT02432235|617588835|FG006|Overall Study|Lost to Follow-up|0|||
170885392|NCT02432235|617588836|FG007|Overall Study|Lost to Follow-up|0|||
170440482|NCT00021541|615951560|FG000|Period 2-crossover|Adverse Event|2|||
170783427|NCT04450342|617214523|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
170783428|NCT04450342|617214524|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
170783429|NCT04450342|617214522|FG000|Overall Study|Physician Decision|1|||
170783430|NCT04450342|617214523|FG001|Overall Study|Physician Decision|0|||
170783431|NCT04450342|617214524|FG002|Overall Study|Physician Decision|1|||
170783432|NCT04450342|617214522|FG000|Overall Study|Protocol Deviation|0|||
170783433|NCT04450342|617214523|FG001|Overall Study|Protocol Deviation|1|||
170783434|NCT04450342|617214524|FG002|Overall Study|Protocol Deviation|0|||
170783435|NCT04450342|617214522|FG000|Overall Study|Reoperation|1|||
170783436|NCT04450342|617214523|FG001|Overall Study|Reoperation|1|||
170783437|NCT04450342|617214524|FG002|Overall Study|Reoperation|0|||
170783438|NCT04450342|617214522|FG000|Overall Study|Screen Failures|0|||
170783439|NCT04450342|617214523|FG001|Overall Study|Screen Failures|0|||
170783440|NCT04450342|617214524|FG002|Overall Study|Screen Failures|2|||
170783441|NCT04450342|617214522|FG000|Overall Study|Site Terminated by Sponsor|1|||
170783442|NCT04450342|617214523|FG001|Overall Study|Site Terminated by Sponsor|1|||
170783443|NCT04450342|617214524|FG002|Overall Study|Site Terminated by Sponsor|1|||
170783444|NCT04450342|617214522|FG000|Overall Study|Study Terminated by Sponsor|31|||
170783445|NCT04450342|617214523|FG001|Overall Study|Study Terminated by Sponsor|29|||
170783446|NCT04450342|617214524|FG002|Overall Study|Study Terminated by Sponsor|6|||
170783447|NCT04450342|617214522|FG000|Overall Study|Withdrawal by Subject|0|||
170783448|NCT04450342|617214523|FG001|Overall Study|Withdrawal by Subject|1|||
170783449|NCT04450342|617214524|FG002|Overall Study|Withdrawal by Subject|2|||
170783450|NCT03033576|617214525|FG000|Overall Study|Ineligible|1|||
170783451|NCT03033576|617214526|FG001|Overall Study|Ineligible|1|||
170783452|NCT03033576|617214525|FG000|Overall Study|Adverse Event|4|||
170783453|NCT03033576|617214526|FG001|Overall Study|Adverse Event|20|||
170783454|NCT03033576|617214525|FG000|Overall Study|Progression/relapse|9|||
170783455|NCT03033576|617214526|FG001|Overall Study|Progression/relapse|36|||
170783456|NCT03033576|617214525|FG000|Overall Study|Death|1|||
170783457|NCT03033576|617214526|FG001|Overall Study|Death|1|||
170783458|NCT03033576|617214525|FG000|Overall Study|Patient refusal|1|||
170783459|NCT03033576|617214526|FG001|Overall Study|Patient refusal|6|||
170783460|NCT03033576|617214525|FG000|Overall Study|Other, unspecified reasons|0|||
170783461|NCT03033576|617214526|FG001|Overall Study|Other, unspecified reasons|4|||
170783462|NCT03033576|617214525|FG000|Overall Study|Currently on protocol therapy|0|||
170783463|NCT03033576|617214526|FG001|Overall Study|Currently on protocol therapy|2|||
170783464|NCT03719443|617214527|FG000|Overall Study|Lost to Follow-up|0|||
170783465|NCT03719443|617214528|FG001|Overall Study|Lost to Follow-up|0|||
170783466|NCT03719443|617214529|FG002|Overall Study|Lost to Follow-up|1|||
170783467|NCT03719443|617214530|FG003|Overall Study|Lost to Follow-up|0|||
170783468|NCT03719443|617214531|FG004|Overall Study|Lost to Follow-up|1|||
170783469|NCT03719443|617214532|FG005|Overall Study|Lost to Follow-up|0|||
170783470|NCT03719443|617214533|FG006|Overall Study|Lost to Follow-up|1|||
170783471|NCT03719443|617214527|FG000|Overall Study|Withdrawal by Subject|0|||
170783472|NCT03719443|617214528|FG001|Overall Study|Withdrawal by Subject|0|||
170783473|NCT03719443|617214529|FG002|Overall Study|Withdrawal by Subject|1|||
170783474|NCT03719443|617214530|FG003|Overall Study|Withdrawal by Subject|0|||
170783475|NCT03719443|617214531|FG004|Overall Study|Withdrawal by Subject|0|||
170783476|NCT03719443|617214532|FG005|Overall Study|Withdrawal by Subject|0|||
170783477|NCT03719443|617214533|FG006|Overall Study|Withdrawal by Subject|0|||
170783478|NCT02742519|617214543|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
170783479|NCT02742519|617214544|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
170783480|NCT02742519|617214545|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
170783481|NCT02742519|617214543|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
170783482|NCT02742519|617214544|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
170783483|NCT02742519|617214545|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
170783484|NCT02742519|617214543|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
170783485|NCT02742519|617214544|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
170783486|NCT02742519|617214545|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
170783487|NCT01721291|617214546|FG000|Overall Study|Withdrawal by Subject|1|||
170783488|NCT01721291|617214547|FG001|Overall Study|Withdrawal by Subject|0|||
170783489|NCT01721291|617214546|FG000|Overall Study|did not like the treatment|1|||
170783490|NCT01721291|617214547|FG001|Overall Study|did not like the treatment|0|||
170783491|NCT01091168|617214548|FG000|Overall Study|Progressive disease|250|||
170783492|NCT01091168|617214549|FG001|Overall Study|Progressive disease|234|||
170783493|NCT01091168|617214548|FG000|Overall Study|Adverse Event|21|||
170783494|NCT01091168|617214549|FG001|Overall Study|Adverse Event|24|||
170783495|NCT01091168|617214548|FG000|Overall Study|Lost to Follow-up|0|||
170783496|NCT01091168|617214549|FG001|Overall Study|Lost to Follow-up|1|||
170783497|NCT01091168|617214548|FG000|Overall Study|Physician, patient's decision, other|27|||
170783498|NCT01091168|617214549|FG001|Overall Study|Physician, patient's decision, other|37|||
170783499|NCT05062265|617216500|FG000|Overall Study|Withdrawal by Subject|1|||
170783500|NCT05062265|617216501|FG001|Overall Study|Withdrawal by Subject|0|||
170783501|NCT05382936|617216504|FG000|Overall Study|Progressive Disease|3|||
170440483|NCT00021541|615951561|FG001|Period 2-crossover|Adverse Event|2|||
170440484|NCT00021541|615951560|FG000|Period 2-crossover|non-adherence|1|||
170885393|NCT02432235|617588837|FG008|Overall Study|Lost to Follow-up|1|||
170885394|NCT02432235|617588838|FG009|Overall Study|Lost to Follow-up|0|||
170885395|NCT02432235|617588839|FG010|Overall Study|Lost to Follow-up|0|||
170885396|NCT02432235|617588840|FG011|Overall Study|Lost to Follow-up|0|||
170885397|NCT02432235|617588829|FG000|Overall Study|Miscellaneous|0|||
170885398|NCT02432235|617588830|FG001|Overall Study|Miscellaneous|0|||
170885399|NCT02432235|617588831|FG002|Overall Study|Miscellaneous|0|||
170885400|NCT02432235|617588832|FG003|Overall Study|Miscellaneous|0|||
170885401|NCT02432235|617588833|FG004|Overall Study|Miscellaneous|1|||
170885402|NCT02432235|617588834|FG005|Overall Study|Miscellaneous|6|||
170885403|NCT02432235|617588835|FG006|Overall Study|Miscellaneous|2|||
170885404|NCT02432235|617588836|FG007|Overall Study|Miscellaneous|2|||
170885405|NCT02432235|617588837|FG008|Overall Study|Miscellaneous|4|||
170885406|NCT02432235|617588838|FG009|Overall Study|Miscellaneous|0|||
170885407|NCT02432235|617588839|FG010|Overall Study|Miscellaneous|0|||
170885408|NCT02432235|617588840|FG011|Overall Study|Miscellaneous|1|||
170885409|NCT01100944|617588841|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
170885410|NCT01100944|617588842|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
170885411|NCT01100944|617588843|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
170885412|NCT01100944|617588841|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
170885413|NCT01100944|617588842|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
170885414|NCT01100944|617588843|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
170885415|NCT01100944|617588841|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
170885416|NCT01100944|617588842|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
170885417|NCT01100944|617588843|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
170885418|NCT01100944|617588841|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
170885419|NCT01100944|617588842|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
170885420|NCT01100944|617588843|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
170885421|NCT00999908|617588846|FG000|Treatment Period 1|Subject withdrew consent|2|||
170885422|NCT00999908|617588847|FG001|Treatment Period 1|Subject withdrew consent|0|||
170885423|NCT00999908|617588848|FG002|Treatment Period 1|Subject withdrew consent|0|||
170885424|NCT00999908|617588846|FG000|Treatment Period 2|Protocol Violation|1|||
170885425|NCT00999908|617588847|FG001|Treatment Period 2|Protocol Violation|0|||
170885426|NCT00999908|617588848|FG002|Treatment Period 2|Protocol Violation|0|||
170885427|NCT01568593|617588849|FG000|Overall Study|Lack of Efficacy|4|||
170885428|NCT01568593|617588850|FG001|Overall Study|Lack of Efficacy|1|||
170885429|NCT01568593|617588849|FG000|Overall Study|Adverse Event|3|||
170885430|NCT01568593|617588850|FG001|Overall Study|Adverse Event|2|||
170885431|NCT02228590|617588851|FG000|Overall Study|Withdrawal by Subject|1|||
170885432|NCT02780648|617588852|FG000|Overall Study|Disease Progression|1|||
170885433|NCT02780648|617588853|FG001|Overall Study|Disease Progression|0|||
170885434|NCT02109484|617588854|FG000|Overall Study|Lost to Follow-up|0|||
170885435|NCT02109484|617588855|FG001|Overall Study|Lost to Follow-up|0|||
170633090|NCT01746901|616668460|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170633091|NCT01746901|616668461|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
170633092|NCT01746901|616668462|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
170633093|NCT01746901|616668463|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170633094|NCT01746901|616668464|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170633095|NCT01746901|616668465|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170633096|NCT01746901|616668466|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170633097|NCT01746901|616668467|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170633098|NCT01746901|616668468|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170633099|NCT01746901|616668460|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
170633100|NCT01746901|616668461|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
170633101|NCT01746901|616668462|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
170633102|NCT01746901|616668463|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
170633103|NCT01746901|616668464|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
170633104|NCT01746901|616668465|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
170633105|NCT01746901|616668466|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
170633106|NCT01746901|616668467|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
170633107|NCT01746901|616668468|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
170885436|NCT02109484|617588856|FG002|Overall Study|Lost to Follow-up|0|||
170885437|NCT02109484|617588857|FG003|Overall Study|Lost to Follow-up|1|||
170440485|NCT00021541|615951561|FG001|Period 2-crossover|non-adherence|0|||
170885438|NCT02109484|617588858|FG004|Overall Study|Lost to Follow-up|1|||
170885439|NCT02109484|617588859|FG005|Overall Study|Lost to Follow-up|0|||
170885440|NCT02109484|617588860|FG006|Overall Study|Lost to Follow-up|1|||
170885441|NCT02109484|617588861|FG007|Overall Study|Lost to Follow-up|0|||
170885442|NCT02109484|617588854|FG000|Overall Study|Withdrawal by Subject|0|||
170885443|NCT02109484|617588855|FG001|Overall Study|Withdrawal by Subject|0|||
170440486|NCT00021541|615951560|FG000|Period 2-crossover|Pts that did not progress|2|||
170440487|NCT00021541|615951561|FG001|Period 2-crossover|Pts that did not progress|3|||
170440488|NCT03950674|615951567|FG000|Overall Study|Death|16|||
170440489|NCT03950674|615951568|FG001|Overall Study|Death|15|||
170440490|NCT03950674|615951567|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
170440491|NCT03950674|615951568|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
170440492|NCT00830167|615951569|FG000|Overall Study|Lack of Efficacy|26|||
170440493|NCT00830167|615951570|FG001|Overall Study|Lack of Efficacy|10|||
170440494|NCT00830167|615951569|FG000|Overall Study|Adverse Event|8|||
170440495|NCT00830167|615951570|FG001|Overall Study|Adverse Event|24|||
170783502|NCT05382936|617216505|FG001|Overall Study|Progressive Disease|5|||
170783503|NCT05382936|617216506|FG002|Overall Study|Progressive Disease|2|||
170783504|NCT05382936|617216507|FG003|Overall Study|Progressive Disease|5|||
170783505|NCT05382936|617216504|FG000|Overall Study|Adverse Event|0|||
170783506|NCT05382936|617216505|FG001|Overall Study|Adverse Event|1|||
170783507|NCT05382936|617216506|FG002|Overall Study|Adverse Event|1|||
170783508|NCT05382936|617216507|FG003|Overall Study|Adverse Event|0|||
170783509|NCT05382936|617216504|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
170783510|NCT05382936|617216505|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
170783511|NCT05382936|617216506|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
170783512|NCT05382936|617216507|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
170783513|NCT05382936|617216504|FG000|Overall Study|Withdrawal by Subject|0|||
170783514|NCT05382936|617216505|FG001|Overall Study|Withdrawal by Subject|0|||
170783515|NCT05382936|617216506|FG002|Overall Study|Withdrawal by Subject|1|||
170783516|NCT05382936|617216507|FG003|Overall Study|Withdrawal by Subject|1|||
170783517|NCT04630262|617216514|FG000|Overall Study|Intraoperative Screen Failure|5|||
170783518|NCT04630262|617216514|FG000|Overall Study|Study terminated prematurely|71|||
170783519|NCT04630262|617216514|FG000|Overall Study|Withdrawal by Subject|2|||
170783520|NCT04630262|617216514|FG000|Overall Study|Physician Decision|2|||
170783521|NCT04490915|617216516|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
170783522|NCT04490915|617216517|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
170783523|NCT04490915|617216516|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170783524|NCT04490915|617216517|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170783525|NCT04490915|617216516|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170783526|NCT04490915|617216517|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
170783527|NCT04490915|617216516|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
170783528|NCT04490915|617216517|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
170783529|NCT04490915|617216516|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
170783530|NCT04490915|617216517|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
170783531|NCT04490915|617216516|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
170783532|NCT04490915|617216517|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
170783533|NCT04490915|617216516|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
170783534|NCT04490915|617216517|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
170783535|NCT03988634|617216518|FG000|Double-Blind|Adverse Event|4|||
170783536|NCT03988634|617216519|FG001|Double-Blind|Adverse Event|0|||
170783537|NCT03988634|617216520|FG002|Double-Blind|Adverse Event|0|||
170783538|NCT03988634|617216518|FG000|Double-Blind|Death|18|||
170783539|NCT03988634|617216519|FG001|Double-Blind|Death|26|||
170783540|NCT03988634|617216520|FG002|Double-Blind|Death|0|||
170783541|NCT03988634|617216518|FG000|Double-Blind|Lost to Follow-up|6|||
170783542|NCT03988634|617216519|FG001|Double-Blind|Lost to Follow-up|7|||
170783543|NCT03988634|617216520|FG002|Double-Blind|Lost to Follow-up|0|||
170783544|NCT03988634|617216518|FG000|Double-Blind|Physician Decision|9|||
170783545|NCT03988634|617216519|FG001|Double-Blind|Physician Decision|5|||
170783546|NCT03988634|617216520|FG002|Double-Blind|Physician Decision|0|||
170783547|NCT03988634|617216518|FG000|Double-Blind|Subject decision|24|||
170783548|NCT03988634|617216519|FG001|Double-Blind|Subject decision|13|||
170783549|NCT03988634|617216520|FG002|Double-Blind|Subject decision|0|||
170783550|NCT03988634|617216518|FG000|Open-Label|Adverse Event|0|||
170783551|NCT03988634|617216519|FG001|Open-Label|Adverse Event|0|||
170783552|NCT03988634|617216520|FG002|Open-Label|Adverse Event|7|||
170783553|NCT03988634|617216518|FG000|Open-Label|Physician Decision|0|||
170783554|NCT03988634|617216519|FG001|Open-Label|Physician Decision|0|||
170783555|NCT03988634|617216520|FG002|Open-Label|Physician Decision|1|||
170783556|NCT03988634|617216518|FG000|Open-Label|Technical problems|0|||
170440496|NCT00830167|615951569|FG000|Overall Study|Not meeting entrance criteria|2|||
170440497|NCT00830167|615951570|FG001|Overall Study|Not meeting entrance criteria|5|||
170440498|NCT00830167|615951569|FG000|Overall Study|Withdrawal by Subject|2|||
170440499|NCT00830167|615951570|FG001|Overall Study|Withdrawal by Subject|0|||
170783557|NCT03988634|617216519|FG001|Open-Label|Technical problems|0|||
170783558|NCT03988634|617216520|FG002|Open-Label|Technical problems|1|||
170783559|NCT03016169|617216532|FG000|Overall Study|Lost to Follow-up|4|||
170783560|NCT03016169|617216532|FG000|Overall Study|Death|54|||
170783561|NCT03016169|617216532|FG000|Overall Study|Device Explant|11|||
170783562|NCT03016169|617216532|FG000|Overall Study|Withdrawal by Subject|19|||
170783563|NCT03016169|617216532|FG000|Overall Study|Other Reasons|1|||
170885444|NCT02109484|617588856|FG002|Overall Study|Withdrawal by Subject|0|||
170885445|NCT02109484|617588857|FG003|Overall Study|Withdrawal by Subject|0|||
170885446|NCT02109484|617588858|FG004|Overall Study|Withdrawal by Subject|1|||
170885447|NCT02109484|617588859|FG005|Overall Study|Withdrawal by Subject|1|||
170885448|NCT02109484|617588860|FG006|Overall Study|Withdrawal by Subject|1|||
170885449|NCT02109484|617588861|FG007|Overall Study|Withdrawal by Subject|0|||
170885450|NCT02109484|617588854|FG000|Overall Study|Physician Decision|0|||
170885451|NCT02109484|617588855|FG001|Overall Study|Physician Decision|0|||
170885452|NCT02109484|617588856|FG002|Overall Study|Physician Decision|0|||
170885453|NCT02109484|617588857|FG003|Overall Study|Physician Decision|0|||
170885454|NCT02109484|617588858|FG004|Overall Study|Physician Decision|2|||
170885455|NCT02109484|617588859|FG005|Overall Study|Physician Decision|0|||
170885456|NCT02109484|617588860|FG006|Overall Study|Physician Decision|0|||
170885457|NCT02109484|617588861|FG007|Overall Study|Physician Decision|0|||
170885458|NCT02109484|617588854|FG000|Overall Study|Death|0|||
170885459|NCT02109484|617588855|FG001|Overall Study|Death|0|||
170885460|NCT02109484|617588856|FG002|Overall Study|Death|0|||
170885461|NCT02109484|617588857|FG003|Overall Study|Death|0|||
170885462|NCT02109484|617588858|FG004|Overall Study|Death|0|||
170885463|NCT02109484|617588859|FG005|Overall Study|Death|0|||
170885464|NCT02109484|617588860|FG006|Overall Study|Death|0|||
170537190|NCT03765073|616311558|FG006|Stage 1|Lost to Follow-up|0|||
170537191|NCT03765073|616311559|FG007|Stage 1|Lost to Follow-up|0|||
170537192|NCT03765073|616311560|FG008|Stage 1|Lost to Follow-up|0|||
170537193|NCT03765073|616311561|FG009|Stage 1|Lost to Follow-up|0|||
170537194|NCT03765073|616311562|FG010|Stage 1|Lost to Follow-up|0|||
170537195|NCT03765073|616311563|FG011|Stage 1|Lost to Follow-up|0|||
170537196|NCT03765073|616311564|FG012|Stage 1|Lost to Follow-up|0|||
170537197|NCT03765073|616311565|FG013|Stage 1|Lost to Follow-up|0|||
170537198|NCT03765073|616311566|FG014|Stage 1|Lost to Follow-up|0|||
170440500|NCT00830167|615951569|FG000|Overall Study|Lost to Follow-up|0|||
170440501|NCT00830167|615951570|FG001|Overall Study|Lost to Follow-up|1|||
170440502|NCT00830167|615951569|FG000|Overall Study|Protocol Violation|0|||
170440503|NCT00830167|615951570|FG001|Overall Study|Protocol Violation|1|||
170440504|NCT00830167|615951569|FG000|Overall Study|Other|2|||
170440505|NCT00830167|615951570|FG001|Overall Study|Other|2|||
170440506|NCT02224053|615951571|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
170440507|NCT02224053|615951571|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
170440508|NCT02224053|615951571|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
170783564|NCT04150718|617216533|FG000|Overall Study|Withdrawal by Subject|2|||
170783565|NCT04150718|617216534|FG001|Overall Study|Withdrawal by Subject|7|||
170783566|NCT04150718|617216535|FG002|Overall Study|Withdrawal by Subject|1|||
170783567|NCT04150718|617216533|FG000|Overall Study|Lost to Follow-up|1|||
170783568|NCT04150718|617216534|FG001|Overall Study|Lost to Follow-up|2|||
170783569|NCT04150718|617216535|FG002|Overall Study|Lost to Follow-up|0|||
170783570|NCT04150718|617216533|FG000|Overall Study|Ineligible|1|||
170783571|NCT04150718|617216534|FG001|Overall Study|Ineligible|0|||
170783572|NCT04150718|617216535|FG002|Overall Study|Ineligible|10|||
170783573|NCT04258709|617216536|FG000|Overall Study|Lost to Follow-up|10|||
170783574|NCT04258709|617216537|FG001|Overall Study|Lost to Follow-up|4|||
170783575|NCT04258709|617216536|FG000|Overall Study|Withdrawal by Subject|1|||
170783576|NCT04258709|617216537|FG001|Overall Study|Withdrawal by Subject|0|||
170783577|NCT04258709|617216536|FG000|Overall Study|Fetal demise|0|||
170783578|NCT04258709|617216537|FG001|Overall Study|Fetal demise|1|||
170783579|NCT04258709|617216536|FG000|Overall Study|Protocol Violation|1|||
170783580|NCT04258709|617216537|FG001|Overall Study|Protocol Violation|1|||
170783581|NCT02592330|617216538|FG000|Overall Study|Withdrawal by Subject|1|||
170783582|NCT02592330|617216539|FG001|Overall Study|Withdrawal by Subject|0|||
170783583|NCT02592330|617216538|FG000|Overall Study|Failed Biopsy|1|||
170783584|NCT02592330|617216539|FG001|Overall Study|Failed Biopsy|0|||
170783585|NCT05082909|617216540|FG000|Overall Study|Protocol Violation|0|||
170783586|NCT05082909|617216541|FG001|Overall Study|Protocol Violation|0|||
170783587|NCT05082909|617216542|FG002|Overall Study|Protocol Violation|1|||
170783588|NCT05082909|617216543|FG003|Overall Study|Protocol Violation|0|||
170783589|NCT05082909|617216544|FG004|Overall Study|Protocol Violation|0|||
170783590|NCT05082909|617216545|FG005|Overall Study|Protocol Violation|0|||
170783591|NCT03047928|617216550|FG000|Overall Study|Adverse Event|0|||
170783592|NCT03047928|617216551|FG001|Overall Study|Adverse Event|2|||
170783593|NCT03047928|617216552|FG002|Overall Study|Adverse Event|0|||
170783594|NCT03047928|617216550|FG000|Overall Study|Protocol Violation|0|||
170783595|NCT03047928|617216551|FG001|Overall Study|Protocol Violation|1|||
170885465|NCT02109484|617588861|FG007|Overall Study|Death|2|||
170885466|NCT02109484|617588854|FG000|Overall Study|Moved away from study area|0|||
170885467|NCT02109484|617588855|FG001|Overall Study|Moved away from study area|0|||
170885468|NCT02109484|617588856|FG002|Overall Study|Moved away from study area|0|||
170885469|NCT02109484|617588857|FG003|Overall Study|Moved away from study area|0|||
170885470|NCT02109484|617588858|FG004|Overall Study|Moved away from study area|0|||
170885471|NCT02109484|617588859|FG005|Overall Study|Moved away from study area|0|||
170885472|NCT02109484|617588860|FG006|Overall Study|Moved away from study area|1|||
170885473|NCT02109484|617588861|FG007|Overall Study|Moved away from study area|1|||
170885474|NCT02111993|617588866|FG000|Overall Study|Physician Decision|5|||
170885475|NCT02111993|617588867|FG001|Overall Study|Physician Decision|4|||
170885476|NCT01097863|617588868|FG000|Overall Study|Discomfort|1|||
170885477|NCT01097863|617588869|FG001|Overall Study|Discomfort|0|||
170885478|NCT01097863|617588870|FG002|Overall Study|Discomfort|1|||
170885479|NCT01097863|617588868|FG000|Overall Study|Did not return for final visit|0|||
170885480|NCT01097863|617588869|FG001|Overall Study|Did not return for final visit|0|||
170885481|NCT01097863|617588870|FG002|Overall Study|Did not return for final visit|1|||
170885482|NCT00419380|617588871|FG000|Overall Study|Lack of Efficacy|1|||
170885483|NCT00419380|617588872|FG001|Overall Study|Lack of Efficacy|7|||
170885484|NCT00419380|617588871|FG000|Overall Study|Physician Decision|0|||
170885485|NCT00419380|617588872|FG001|Overall Study|Physician Decision|1|||
170885486|NCT00419380|617588871|FG000|Overall Study|Lost to Follow-up|0|||
170885487|NCT00419380|617588872|FG001|Overall Study|Lost to Follow-up|1|||
170885488|NCT00419380|617588871|FG000|Overall Study|Withdrawal by Subject|0|||
170885489|NCT00419380|617588872|FG001|Overall Study|Withdrawal by Subject|1|||
170885490|NCT00796315|617588873|FG000|Overall Study|Protocol Violation|0|||
170783596|NCT03047928|617216552|FG002|Overall Study|Protocol Violation|0|||
170783597|NCT03047928|617216550|FG000|Overall Study|included in another protocol|0|||
170783598|NCT03047928|617216551|FG001|Overall Study|included in another protocol|1|||
170783599|NCT03047928|617216552|FG002|Overall Study|included in another protocol|0|||
170783600|NCT02729311|617216553|FG000|Overall Study|Withdrawal by Subject|8|||
170783601|NCT02729311|617216554|FG001|Overall Study|Withdrawal by Subject|2|||
170783602|NCT05034952|617216555|FG000|Overall Study|Adverse Event|1|||
170885491|NCT00796315|617588874|FG001|Overall Study|Protocol Violation|1|||
170783603|NCT05034952|617216556|FG001|Overall Study|Adverse Event|0|||
170783604|NCT05034952|617216557|FG002|Overall Study|Adverse Event|0|||
170885492|NCT00796315|617588875|FG002|Overall Study|Protocol Violation|0|||
170537199|NCT03765073|616311567|FG015|Stage 1|Lost to Follow-up|0|||
170440509|NCT02224053|615951571|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
170440510|NCT02224053|615951571|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
170440511|NCT03428945|615951575|FG000|Overall Study|Lost to Follow-up|5|||
170440512|NCT03428945|615951576|FG001|Overall Study|Lost to Follow-up|3|||
170440513|NCT03428945|615951575|FG000|Overall Study|Withdrawal by Subject|10|||
170440514|NCT03428945|615951576|FG001|Overall Study|Withdrawal by Subject|10|||
170440515|NCT00360490|615951579|FG000|Overall Study|Adverse Event|4|||
170440516|NCT00360490|615951580|FG001|Overall Study|Adverse Event|2|||
170440517|NCT00360490|615951579|FG000|Overall Study|Lost to Follow-up|2|||
170440518|NCT00360490|615951580|FG001|Overall Study|Lost to Follow-up|1|||
170440519|NCT00360490|615951579|FG000|Overall Study|Physician Decision|2|||
170440520|NCT00360490|615951580|FG001|Overall Study|Physician Decision|1|||
170440521|NCT00360490|615951579|FG000|Overall Study|Protocol Violation|0|||
170440522|NCT00360490|615951580|FG001|Overall Study|Protocol Violation|4|||
170440523|NCT00360490|615951579|FG000|Overall Study|Withdrawal by Subject|1|||
170440524|NCT00360490|615951580|FG001|Overall Study|Withdrawal by Subject|3|||
170440525|NCT02289820|615951581|FG000|Overall Study|Withdrawal by Subject|2|||
170440526|NCT02289820|615951582|FG001|Overall Study|Withdrawal by Subject|1|||
170440527|NCT02289820|615951583|FG002|Overall Study|Withdrawal by Subject|2|||
170440528|NCT02289820|615951584|FG003|Overall Study|Withdrawal by Subject|1|||
170440529|NCT02289820|615951585|FG004|Overall Study|Withdrawal by Subject|0|||
170440530|NCT02289820|615951586|FG005|Overall Study|Withdrawal by Subject|0|||
170440531|NCT02289820|615951587|FG006|Overall Study|Withdrawal by Subject|1|||
170440532|NCT02289820|615951581|FG000|Overall Study|Death|0|||
170440533|NCT02289820|615951582|FG001|Overall Study|Death|0|||
170440534|NCT02289820|615951583|FG002|Overall Study|Death|1|||
170440535|NCT02289820|615951584|FG003|Overall Study|Death|0|||
170440536|NCT02289820|615951585|FG004|Overall Study|Death|0|||
170440537|NCT02289820|615951586|FG005|Overall Study|Death|0|||
170440538|NCT02289820|615951587|FG006|Overall Study|Death|0|||
170440539|NCT02289820|615951581|FG000|Overall Study|Lost to Follow-up|0|||
170440540|NCT02289820|615951582|FG001|Overall Study|Lost to Follow-up|0|||
170440541|NCT02289820|615951583|FG002|Overall Study|Lost to Follow-up|3|||
170440542|NCT02289820|615951584|FG003|Overall Study|Lost to Follow-up|1|||
170440543|NCT02289820|615951585|FG004|Overall Study|Lost to Follow-up|0|||
170440544|NCT02289820|615951586|FG005|Overall Study|Lost to Follow-up|1|||
170440545|NCT02289820|615951587|FG006|Overall Study|Lost to Follow-up|1|||
170440546|NCT02289820|615951581|FG000|Overall Study|withdrawal of consent|0|||
170440547|NCT02289820|615951582|FG001|Overall Study|withdrawal of consent|1|||
170440548|NCT02289820|615951583|FG002|Overall Study|withdrawal of consent|0|||
170440549|NCT02289820|615951584|FG003|Overall Study|withdrawal of consent|0|||
170440550|NCT02289820|615951585|FG004|Overall Study|withdrawal of consent|0|||
170440551|NCT02289820|615951586|FG005|Overall Study|withdrawal of consent|0|||
170440552|NCT02289820|615951587|FG006|Overall Study|withdrawal of consent|0|||
170440553|NCT03294317|615951588|FG000|Overall Study|Physician Decision|1|||
170440554|NCT03294317|615951588|FG000|Overall Study|Withdrawal by Subject|6|||
170440555|NCT03294317|615951588|FG000|Overall Study|Lost to Follow-up|1|||
170440556|NCT03294317|615951588|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
170440557|NCT03294317|615951588|FG000|Overall Study|Failed HB lead implant|8|||
170440558|NCT03294317|615951588|FG000|Overall Study|Received CRT instead|1|||
170783605|NCT05034952|617216558|FG003|Overall Study|Adverse Event|0|||
170783606|NCT05034952|617216555|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
170783607|NCT05034952|617216556|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
170783608|NCT05034952|617216557|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
170783609|NCT05034952|617216558|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
170783610|NCT05034952|617216555|FG000|Overall Study|Lost to Follow-up|1|||
170783611|NCT05034952|617216556|FG001|Overall Study|Lost to Follow-up|4|||
170783612|NCT05034952|617216557|FG002|Overall Study|Lost to Follow-up|3|||
170783613|NCT05034952|617216558|FG003|Overall Study|Lost to Follow-up|3|||
170783614|NCT05034952|617216555|FG000|Overall Study|Other|0|||
170783615|NCT05034952|617216556|FG001|Overall Study|Other|0|||
170783616|NCT05034952|617216557|FG002|Overall Study|Other|0|||
170783617|NCT05034952|617216558|FG003|Overall Study|Other|1|||
170783618|NCT04783935|617216559|FG000|Overall Study|Withdrawal by Subject|6|||
170783619|NCT04783935|617216559|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
170783620|NCT04783935|617216559|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
170440559|NCT03294317|615951588|FG000|Overall Study|Exited after lead revision|2|||
170440560|NCT01929681|615951589|FG000|Overall Study|Withdrawal by Subject|1|||
170440561|NCT01929681|615951590|FG001|Overall Study|Withdrawal by Subject|0|||
170440562|NCT01929681|615951589|FG000|Overall Study|Physician Decision|1|||
170440563|NCT01929681|615951590|FG001|Overall Study|Physician Decision|1|||
170440564|NCT02129062|615953094|FG000|Overall Study|Death|1|||
170440565|NCT02129062|615953094|FG000|Overall Study|Disease Progression|2|||
170440566|NCT00559637|615953095|FG000|Overall Study|Adverse Event|22|||
170440567|NCT00559637|615953095|FG000|Overall Study|Withdrawal by Subject|4|||
170440568|NCT00559637|615953095|FG000|Overall Study|Protocol Violation|6|||
170783621|NCT04783935|617216559|FG000|Overall Study|Lost to Follow-up|3|||
170783622|NCT04783935|617216559|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
170440569|NCT00559637|615953095|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
170440570|NCT00559637|615953095|FG000|Overall Study|Failure to return|6|||
170440571|NCT00559637|615953095|FG000|Overall Study|Insufficient response|3|||
170440572|NCT00559637|615953095|FG000|Overall Study|Started requiring dialysis after month 7|2|||
170440573|NCT00559637|615953095|FG000|Overall Study|Suspected lung cancer|1|||
170440574|NCT00559637|615953095|FG000|Overall Study|Participation in another study|1|||
170440575|NCT00559637|615953095|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
170440576|NCT00559637|615953095|FG000|Overall Study|Change of center|1|||
170440577|NCT00559637|615953095|FG000|Overall Study|Change of home|1|||
170440578|NCT00559637|615953095|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
170440579|NCT04662710|615953096|FG000|Overall Study|Death|14|||
170783623|NCT02437318|617216561|FG000|Overall Study|Progressive disease|207|||
170783624|NCT02437318|617216562|FG001|Overall Study|Progressive disease|240|||
170783625|NCT02437318|617216561|FG000|Overall Study|Subject/guardian decision|24|||
170783626|NCT02437318|617216562|FG001|Overall Study|Subject/guardian decision|11|||
170783627|NCT02437318|617216561|FG000|Overall Study|Physician Decision|29|||
170783628|NCT02437318|617216562|FG001|Overall Study|Physician Decision|22|||
170783629|NCT02437318|617216561|FG000|Overall Study|Adverse Event|14|||
170783630|NCT02437318|617216562|FG001|Overall Study|Adverse Event|4|||
170783631|NCT02437318|617216561|FG000|Overall Study|Death|4|||
170783632|NCT02437318|617216562|FG001|Overall Study|Death|4|||
170783633|NCT02437318|617216561|FG000|Overall Study|Protocol deviation|5|||
170783634|NCT02437318|617216562|FG001|Overall Study|Protocol deviation|7|||
170783635|NCT02437318|617216561|FG000|Overall Study|Sponsor decision|1|||
170783636|NCT02437318|617216562|FG001|Overall Study|Sponsor decision|0|||
170783637|NCT04382898|617216563|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
170783638|NCT04382898|617216564|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
170783639|NCT04382898|617216565|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
170783640|NCT04382898|617216566|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
170783641|NCT04382898|617216567|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
170783642|NCT04382898|617216563|FG000|Part 1: Dose Titration|Death|6|||
170783643|NCT04382898|617216564|FG001|Part 1: Dose Titration|Death|0|||
170783644|NCT04382898|617216565|FG002|Part 1: Dose Titration|Death|0|||
170783645|NCT04382898|617216566|FG003|Part 1: Dose Titration|Death|0|||
170783646|NCT04382898|617216567|FG004|Part 1: Dose Titration|Death|0|||
170783647|NCT04382898|617216563|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170783648|NCT04382898|617216564|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170783649|NCT04382898|617216565|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
170783650|NCT04382898|617216566|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170783651|NCT04382898|617216567|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170783652|NCT04382898|617216563|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
170783653|NCT04382898|617216564|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
170783654|NCT04382898|617216565|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
170783655|NCT04382898|617216566|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
170783656|NCT04382898|617216567|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
170783657|NCT04382898|617216563|FG000|Part 2: Dose Expansion|Death|0|||
170783658|NCT04382898|617216564|FG001|Part 2: Dose Expansion|Death|17|||
170783659|NCT04382898|617216565|FG002|Part 2: Dose Expansion|Death|13|||
170783660|NCT04382898|617216566|FG003|Part 2: Dose Expansion|Death|1|||
170783661|NCT04382898|617216567|FG004|Part 2: Dose Expansion|Death|0|||
170783662|NCT04382898|617216563|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
170783663|NCT04382898|617216564|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
170783664|NCT04382898|617216565|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
170783665|NCT04382898|617216566|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
170783666|NCT04382898|617216567|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
170783667|NCT04382898|617216563|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
170783668|NCT04382898|617216564|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
170783669|NCT04382898|617216565|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
170783670|NCT04382898|617216566|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
170783671|NCT04382898|617216567|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
170783672|NCT04382898|617216563|FG000|Part 2: Dose Expansion|Other|0|||
170783673|NCT04382898|617216564|FG001|Part 2: Dose Expansion|Other|0|||
170783674|NCT04382898|617216565|FG002|Part 2: Dose Expansion|Other|1|||
170783675|NCT04382898|617216566|FG003|Part 2: Dose Expansion|Other|0|||
170440580|NCT04662710|615953097|FG001|Overall Study|Death|331|||
170440581|NCT04662710|615953098|FG002|Overall Study|Death|367|||
170440582|NCT04662710|615953096|FG000|Overall Study|Ongoing|1|||
170783676|NCT04382898|617216567|FG004|Part 2: Dose Expansion|Other|0|||
170440583|NCT04662710|615953097|FG001|Overall Study|Ongoing|109|||
170440584|NCT04662710|615953098|FG002|Overall Study|Ongoing|56|||
170783677|NCT03932682|617216568|FG000|Overall Study|Death|1|||
170783678|NCT03932682|617216569|FG001|Overall Study|Death|2|||
170783679|NCT03932682|617216568|FG000|Overall Study|Withdrawal by Subject|37|||
170783680|NCT03932682|617216569|FG001|Overall Study|Withdrawal by Subject|45|||
170783681|NCT03932682|617216568|FG000|Overall Study|Lost to Follow-up|19|||
170783682|NCT03932682|617216569|FG001|Overall Study|Lost to Follow-up|25|||
170783683|NCT03932682|617216568|FG000|Overall Study|Protocol Violation|0|||
170885493|NCT01836783|617588880|FG000|Overall Study|Withdrawal by Subject|0|||
170885494|NCT01836783|617588881|FG001|Overall Study|Withdrawal by Subject|2|||
170885495|NCT00371865|617588884|FG000|Overall Study|Lack of Efficacy|0|||
170885496|NCT00371865|617588885|FG001|Overall Study|Lack of Efficacy|2|||
170885497|NCT00371865|617588884|FG000|Overall Study|Protocol Violation|3|||
170885498|NCT00371865|617588885|FG001|Overall Study|Protocol Violation|2|||
170885499|NCT00371865|617588884|FG000|Overall Study|Withdrawal by Subject|12|||
170885500|NCT00371865|617588885|FG001|Overall Study|Withdrawal by Subject|10|||
170885501|NCT01014689|617588890|FG000|Overall Study|Lack of Efficacy|0|||
170440585|NCT04662710|615953096|FG000|Overall Study|Withdrawal by Subject|0|||
170440586|NCT04662710|615953097|FG001|Overall Study|Withdrawal by Subject|3|||
170440587|NCT04662710|615953098|FG002|Overall Study|Withdrawal by Subject|14|||
170440588|NCT01705717|615953101|FG000|Overall Study|Adverse Event|2|||
170440589|NCT01705717|615953102|FG001|Overall Study|Adverse Event|2|||
170440590|NCT01705717|615953101|FG000|Overall Study|Lack of Efficacy|0|||
170440591|NCT01705717|615953102|FG001|Overall Study|Lack of Efficacy|1|||
170440592|NCT01705717|615953101|FG000|Overall Study|Other|0|||
170440593|NCT01705717|615953102|FG001|Overall Study|Other|2|||
170440594|NCT02415387|615953105|FG000|Overall Study|Withdrawal by Subject|6|||
170440595|NCT02415387|615953106|FG001|Overall Study|Withdrawal by Subject|1|||
170440596|NCT02415387|615953105|FG000|Overall Study|blood draw problem|0|||
170440597|NCT02415387|615953106|FG001|Overall Study|blood draw problem|1|||
170440598|NCT02415387|615953105|FG000|Overall Study|Protocol Violation|1|||
170440599|NCT02415387|615953106|FG001|Overall Study|Protocol Violation|0|||
170440600|NCT03035890|615953111|FG000|Overall Study|Death|1|||
170440601|NCT03243396|615953113|FG000|Overall Study|Lost to Follow-up|2|||
170440602|NCT03243396|615953114|FG001|Overall Study|Lost to Follow-up|3|||
170440603|NCT03243396|615953115|FG002|Overall Study|Lost to Follow-up|15|||
170440604|NCT03243396|615953116|FG003|Overall Study|Lost to Follow-up|8|||
170440605|NCT03243396|615953117|FG004|Overall Study|Lost to Follow-up|1|||
170440606|NCT03243396|615953118|FG005|Overall Study|Lost to Follow-up|4|||
170440607|NCT03243396|615953119|FG006|Overall Study|Lost to Follow-up|9|||
170440608|NCT03687242|615953120|FG000|Overall Study|Adverse Event|1|||
170440609|NCT00676650|615953125|FG000|Overall Study|Death|45|||
170440610|NCT00676650|615953126|FG001|Overall Study|Death|14|||
170440611|NCT00676650|615953125|FG000|Overall Study|Adverse Event|159|||
170440612|NCT00676650|615953126|FG001|Overall Study|Adverse Event|21|||
170440613|NCT00676650|615953125|FG000|Overall Study|Global deterioration of health status|66|||
170440614|NCT00676650|615953126|FG001|Overall Study|Global deterioration of health status|31|||
170440615|NCT00676650|615953125|FG000|Overall Study|Lost to Follow-up|0|||
170440616|NCT00676650|615953126|FG001|Overall Study|Lost to Follow-up|1|||
170440617|NCT00676650|615953125|FG000|Overall Study|Objective progression or relapse|189|||
170440618|NCT00676650|615953126|FG001|Overall Study|Objective progression or relapse|140|||
170440619|NCT00676650|615953125|FG000|Overall Study|Other|14|||
170440620|NCT00676650|615953126|FG001|Overall Study|Other|10|||
170440621|NCT00676650|615953125|FG000|Overall Study|Protocol Violation|3|||
170440622|NCT00676650|615953126|FG001|Overall Study|Protocol Violation|1|||
170440623|NCT00676650|615953125|FG000|Overall Study|Study terminated by sponsor|57|||
170440624|NCT00676650|615953126|FG001|Overall Study|Study terminated by sponsor|43|||
170440625|NCT00676650|615953125|FG000|Overall Study|Withdrawal by Subject|48|||
170440626|NCT00676650|615953126|FG001|Overall Study|Withdrawal by Subject|24|||
170537200|NCT03765073|616311568|FG016|Stage 1|Lost to Follow-up|0|||
170537201|NCT03765073|616311569|FG017|Stage 1|Lost to Follow-up|0|||
170440627|NCT00676650|615953125|FG000|Overall Study|Randomized but not treated|3|||
170440628|NCT00676650|615953126|FG001|Overall Study|Randomized but not treated|4|||
170440629|NCT01802216|615953127|FG000|4 Month Visit|Participant did not show to visit|3|||
170440630|NCT01802216|615953128|FG001|4 Month Visit|Participant did not show to visit|4|||
170440631|NCT01802216|615953127|FG000|8 Month Visit|Participant did not show to visit|3|||
170440632|NCT01802216|615953128|FG001|8 Month Visit|Participant did not show to visit|5|||
170440633|NCT01802216|615953127|FG000|12 Month Visit|Participant did not show to visit|3|||
170440634|NCT01802216|615953128|FG001|12 Month Visit|Participant did not show to visit|4|||
170440635|NCT00653159|615953129|FG000|Overall Study|Adverse Event|4|||
170440636|NCT00653159|615953130|FG001|Overall Study|Adverse Event|1|||
170440637|NCT00653159|615953129|FG000|Overall Study|Lost to Follow-up|1|||
170440638|NCT00653159|615953130|FG001|Overall Study|Lost to Follow-up|2|||
170783684|NCT03932682|617216569|FG001|Overall Study|Protocol Violation|2|||
170783685|NCT03932682|617216568|FG000|Overall Study|Other|9|||
170783686|NCT03932682|617216569|FG001|Overall Study|Other|23|||
170783687|NCT02900924|617216570|FG000|Overall Study|Death|52|||
170783688|NCT02900924|617216570|FG000|Overall Study|Lost to Follow-up|4|||
170783689|NCT02900924|617216570|FG000|Overall Study|Withdrawal by Subject|20|||
170783690|NCT02900924|617216570|FG000|Overall Study|Missed Visit|33|||
170783691|NCT03143153|617216571|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
170783692|NCT03143153|617216572|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
170783693|NCT03143153|617216573|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
170783694|NCT03143153|617216571|FG000|Pre-Treatment|Participant withdrew consent|0|||
170783695|NCT03143153|617216572|FG001|Pre-Treatment|Participant withdrew consent|1|||
170783696|NCT03143153|617216573|FG002|Pre-Treatment|Participant withdrew consent|12|||
170783697|NCT03143153|617216571|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
170783698|NCT03143153|617216572|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
170783699|NCT03143153|617216573|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
170783700|NCT03143153|617216571|FG000|Pre-Treatment|Other Reasons|1|||
170783701|NCT03143153|617216572|FG001|Pre-Treatment|Other Reasons|2|||
170783702|NCT03143153|617216573|FG002|Pre-Treatment|Other Reasons|1|||
170783703|NCT03143153|617216571|FG000|Pre-Treatment|Disease Progression|1|||
170783704|NCT03143153|617216572|FG001|Pre-Treatment|Disease Progression|1|||
170783705|NCT03143153|617216573|FG002|Pre-Treatment|Disease Progression|2|||
170783706|NCT03143153|617216571|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
170783707|NCT03143153|617216572|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
170783708|NCT03143153|617216573|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
170783709|NCT03143153|617216571|FG000|Treatment|Disease progression|174|||
170783710|NCT03143153|617216572|FG001|Treatment|Disease progression|184|||
170783711|NCT03143153|617216573|FG002|Treatment|Disease progression|193|||
170783712|NCT03143153|617216571|FG000|Treatment|Study drug toxicity|59|||
170783713|NCT03143153|617216572|FG001|Treatment|Study drug toxicity|33|||
170783714|NCT03143153|617216573|FG002|Treatment|Study drug toxicity|40|||
170783715|NCT03143153|617216571|FG000|Treatment|Death|5|||
170783716|NCT03143153|617216572|FG001|Treatment|Death|3|||
170783717|NCT03143153|617216573|FG002|Treatment|Death|4|||
170783718|NCT03143153|617216571|FG000|Treatment|Adverse event unrelated to study drug|19|||
170783719|NCT03143153|617216572|FG001|Treatment|Adverse event unrelated to study drug|28|||
170783720|NCT03143153|617216573|FG002|Treatment|Adverse event unrelated to study drug|12|||
170783721|NCT03143153|617216571|FG000|Treatment|Participant request to discontinue study treatment|13|||
170783722|NCT03143153|617216572|FG001|Treatment|Participant request to discontinue study treatment|15|||
170783723|NCT03143153|617216573|FG002|Treatment|Participant request to discontinue study treatment|20|||
170783724|NCT03143153|617216571|FG000|Treatment|Participant withdrew consent|3|||
170783725|NCT03143153|617216572|FG001|Treatment|Participant withdrew consent|4|||
170783726|NCT03143153|617216573|FG002|Treatment|Participant withdrew consent|12|||
170783727|NCT03143153|617216571|FG000|Treatment|Pregnancy|1|||
170783728|NCT03143153|617216572|FG001|Treatment|Pregnancy|0|||
170783729|NCT03143153|617216573|FG002|Treatment|Pregnancy|0|||
170783730|NCT03143153|617216571|FG000|Treatment|Maximum clinical benefit|1|||
170783731|NCT03143153|617216572|FG001|Treatment|Maximum clinical benefit|3|||
170783732|NCT03143153|617216573|FG002|Treatment|Maximum clinical benefit|4|||
170783733|NCT03143153|617216571|FG000|Treatment|Completed treatment as per Protocol|13|||
170783734|NCT03143153|617216572|FG001|Treatment|Completed treatment as per Protocol|8|||
170783735|NCT03143153|617216573|FG002|Treatment|Completed treatment as per Protocol|0|||
170783736|NCT03143153|617216571|FG000|Treatment|Other reasons|12|||
170783737|NCT03143153|617216572|FG001|Treatment|Other reasons|7|||
170783738|NCT03143153|617216573|FG002|Treatment|Other reasons|15|||
170783739|NCT03143153|617216571|FG000|Treatment|Not reported|1|||
170783740|NCT03143153|617216572|FG001|Treatment|Not reported|0|||
170783741|NCT03143153|617216573|FG002|Treatment|Not reported|0|||
170783742|NCT01415154|617216579|FG000|Overall Study|Lack of Efficacy|4|||
170783743|NCT01415154|617216580|FG001|Overall Study|Lack of Efficacy|5|||
170783744|NCT01415154|617216579|FG000|Overall Study|Withdrawal by Subject|7|||
170783745|NCT01415154|617216580|FG001|Overall Study|Withdrawal by Subject|8|||
170783746|NCT01415154|617216579|FG000|Overall Study|Lost to Follow-up|1|||
170783747|NCT01415154|617216580|FG001|Overall Study|Lost to Follow-up|4|||
170783748|NCT01415154|617216579|FG000|Overall Study|Protocol Violation|0|||
170440639|NCT01872715|615953131|FG000|Overall Study|Adverse Event|1|||
170440640|NCT01872715|615953131|FG000|Overall Study|Protocol Violation|1|||
170440641|NCT01872715|615953131|FG000|Overall Study|Withdrawal by Subject|2|||
170440642|NCT02697617|615953132|FG000|Overall Study|Withdrawal by Subject|0|||
170440643|NCT02697617|615953133|FG001|Overall Study|Withdrawal by Subject|2|||
170440644|NCT02697617|615953132|FG000|Overall Study|Pregnancy|1|||
170440645|NCT02697617|615953133|FG001|Overall Study|Pregnancy|0|||
170440646|NCT01257581|615953136|FG000|Overall Study|Early Termination|3|||
170440647|NCT01257581|615953137|FG001|Overall Study|Early Termination|1|||
170440648|NCT01257581|615953138|FG002|Overall Study|Early Termination|2|||
170440649|NCT01257581|615953136|FG000|Overall Study|Death|2|||
170440650|NCT01257581|615953137|FG001|Overall Study|Death|2|||
170440651|NCT01257581|615953138|FG002|Overall Study|Death|4|||
170440652|NCT02152982|615953144|FG000|Overall Study|Withdrawal by Subject|17|||
170440653|NCT02152982|615953145|FG001|Overall Study|Withdrawal by Subject|16|||
170440654|NCT02152982|615953144|FG000|Overall Study|Did not start treatment|11|||
170440655|NCT02152982|615953145|FG001|Overall Study|Did not start treatment|5|||
170440656|NCT02152982|615953144|FG000|Overall Study|Disease progression|41|||
170440657|NCT02152982|615953145|FG001|Overall Study|Disease progression|52|||
170440658|NCT02152982|615953144|FG000|Overall Study|Adverse Event|7|||
170440659|NCT02152982|615953145|FG001|Overall Study|Adverse Event|12|||
170440660|NCT02152982|615953144|FG000|Overall Study|Complicating disease|1|||
170440661|NCT02152982|615953145|FG001|Overall Study|Complicating disease|1|||
170440662|NCT02152982|615953144|FG000|Overall Study|Death|0|||
170783749|NCT01415154|617216580|FG001|Overall Study|Protocol Violation|1|||
170440663|NCT02152982|615953145|FG001|Overall Study|Death|3|||
170440664|NCT02152982|615953144|FG000|Overall Study|Physician Decision|3|||
170440665|NCT02152982|615953145|FG001|Overall Study|Physician Decision|0|||
170440666|NCT05996198|615953146|FG000|Overall Study|Withdrawal by Subject|1|||
170440667|NCT05996198|615953147|FG001|Overall Study|Withdrawal by Subject|0|||
170440668|NCT02754492|615953152|FG000|Overall Study|Protocol Violation|2|||
170440669|NCT02754492|615953153|FG001|Overall Study|Protocol Violation|2|||
170783750|NCT01415154|617216579|FG000|Overall Study|Satisfactory Response|0|||
170783751|NCT01415154|617216580|FG001|Overall Study|Satisfactory Response|1|||
170783752|NCT01415154|617216579|FG000|Overall Study|Adverse Event|1|||
170783753|NCT01415154|617216580|FG001|Overall Study|Adverse Event|1|||
170783754|NCT03763708|617216581|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
170783755|NCT03763708|617216582|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
170783756|NCT03763708|617216583|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
170783757|NCT03763708|617216584|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
170783758|NCT03763708|617216585|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
170783759|NCT03763708|617216586|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
170783760|NCT03763708|617216587|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
170783761|NCT03763708|617216588|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
170783762|NCT03763708|617216589|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
170783763|NCT03763708|617216581|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
170783764|NCT03763708|617216582|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
170783765|NCT03763708|617216583|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
170783766|NCT03763708|617216584|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
170783767|NCT03763708|617216585|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
170783768|NCT03763708|617216586|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
170783769|NCT03763708|617216587|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
170783770|NCT03763708|617216588|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
170783771|NCT03763708|617216589|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
170783772|NCT03763708|617216581|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
170783773|NCT03763708|617216582|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
170783774|NCT03763708|617216583|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
170783775|NCT03763708|617216584|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
170783776|NCT03763708|617216585|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
170783777|NCT03763708|617216586|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
170783778|NCT03763708|617216587|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
170783779|NCT03763708|617216588|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
170783780|NCT03763708|617216589|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
170783781|NCT03763708|617216581|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
170783782|NCT03763708|617216582|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
170783783|NCT03763708|617216583|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
170783784|NCT03763708|617216584|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
170783785|NCT03763708|617216585|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
170783786|NCT03763708|617216586|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
170783787|NCT03763708|617216587|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
170783788|NCT03763708|617216588|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
170783789|NCT03763708|617216589|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
170783790|NCT03763708|617216581|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
170440670|NCT02754492|615953154|FG002|Overall Study|Protocol Violation|0|||
170440671|NCT02754492|615953155|FG003|Overall Study|Protocol Violation|1|||
170440672|NCT02754492|615953152|FG000|Overall Study|Withdrawal by Subject|2|||
170440673|NCT02754492|615953153|FG001|Overall Study|Withdrawal by Subject|0|||
170440674|NCT02754492|615953154|FG002|Overall Study|Withdrawal by Subject|0|||
170440675|NCT02754492|615953155|FG003|Overall Study|Withdrawal by Subject|0|||
170440676|NCT02754492|615953152|FG000|Overall Study|Equipment malfuntion|0|||
170440677|NCT02754492|615953153|FG001|Overall Study|Equipment malfuntion|0|||
170440678|NCT02754492|615953154|FG002|Overall Study|Equipment malfuntion|2|||
170440679|NCT02754492|615953155|FG003|Overall Study|Equipment malfuntion|5|||
170440680|NCT02754492|615953152|FG000|Overall Study|Adverse Event|0|||
170440681|NCT02754492|615953153|FG001|Overall Study|Adverse Event|0|||
170440682|NCT02754492|615953154|FG002|Overall Study|Adverse Event|0|||
170440683|NCT02754492|615953155|FG003|Overall Study|Adverse Event|13|||
170440684|NCT02754492|615953152|FG000|Overall Study|Venous access issues not resulting in AE|0|||
170440685|NCT02754492|615953153|FG001|Overall Study|Venous access issues not resulting in AE|0|||
170440686|NCT02754492|615953154|FG002|Overall Study|Venous access issues not resulting in AE|0|||
170440687|NCT02754492|615953155|FG003|Overall Study|Venous access issues not resulting in AE|4|||
170440688|NCT01408888|615953156|FG000|First Intervention|Adverse Event|0|||
170440689|NCT01408888|615953157|FG001|First Intervention|Adverse Event|1|||
170440690|NCT01408888|615953156|FG000|First Intervention|Withdrawal by Subject|0|||
170440691|NCT01408888|615953157|FG001|First Intervention|Withdrawal by Subject|2|||
170440692|NCT01408888|615953156|FG000|Second Intervention|Withdrawal by Subject|1|||
170440693|NCT01408888|615953157|FG001|Second Intervention|Withdrawal by Subject|0|||
170440694|NCT01408888|615953156|FG000|Second Intervention|Adverse Event|1|||
170440695|NCT01408888|615953157|FG001|Second Intervention|Adverse Event|0|||
170537202|NCT03765073|616311570|FG018|Stage 1|Lost to Follow-up|0|||
170783791|NCT03763708|617216582|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
170783792|NCT03763708|617216583|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
170783793|NCT03763708|617216584|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
170783794|NCT03763708|617216585|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
170783795|NCT03763708|617216586|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
170783796|NCT03763708|617216587|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
170783797|NCT03763708|617216588|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
170783798|NCT03763708|617216589|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
170783799|NCT03763708|617216581|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
170783800|NCT03763708|617216582|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
170783801|NCT03763708|617216583|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
170783802|NCT03763708|617216584|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
170783803|NCT03763708|617216585|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
170783804|NCT03763708|617216586|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
170783805|NCT03763708|617216587|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
170783806|NCT03763708|617216588|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
170783807|NCT03763708|617216589|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
170783808|NCT03763708|617216581|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
170783809|NCT03763708|617216582|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
170783810|NCT03763708|617216583|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
170783811|NCT03763708|617216584|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
170783812|NCT03763708|617216585|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
170783813|NCT03763708|617216586|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
170783814|NCT03763708|617216587|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
170783815|NCT03763708|617216588|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
170783816|NCT03763708|617216589|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
170783817|NCT03763708|617216581|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
170783818|NCT03763708|617216582|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
170783819|NCT03763708|617216583|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
170783820|NCT03763708|617216584|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
170783821|NCT03763708|617216585|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
170783822|NCT03763708|617216586|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
170783823|NCT03763708|617216587|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
170783824|NCT03763708|617216588|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
170783825|NCT03763708|617216589|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
170440696|NCT00487695|615953160|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
170537203|NCT03765073|616311571|FG019|Stage 1|Lost to Follow-up|0|||
170537204|NCT03765073|616311572|FG020|Stage 1|Lost to Follow-up|0|||
170783826|NCT03763708|617216581|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
170783827|NCT03763708|617216582|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
170783828|NCT03763708|617216583|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
170783829|NCT03763708|617216584|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
170783830|NCT03763708|617216585|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
170440697|NCT00487695|615953161|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
170440698|NCT00487695|615953160|FG000|First Procedure|active wheezing (did not have procedure)|1|||
170440699|NCT00487695|615953161|FG001|First Procedure|active wheezing (did not have procedure)|0|||
170537205|NCT03765073|616311552|FG000|Stage 1|Withdrawal by participant|0|||
170440700|NCT00487695|615953160|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
170783831|NCT03763708|617216586|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
170783832|NCT03763708|617216587|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
170440701|NCT00487695|615953161|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
170440702|NCT00487695|615953160|FG000|Second Procedure|active wheezing|0|||
170440703|NCT00487695|615953161|FG001|Second Procedure|active wheezing|1|||
170440704|NCT00487695|615953160|FG000|Second Procedure|Withdrawal by Subject|1|||
170440705|NCT00487695|615953161|FG001|Second Procedure|Withdrawal by Subject|2|||
170440706|NCT00852917|615953164|FG000|Overall Study|Adverse Event|13|||
170440707|NCT00852917|615953165|FG001|Overall Study|Adverse Event|20|||
170440708|NCT00852917|615953166|FG002|Overall Study|Adverse Event|35|||
170440709|NCT00852917|615953167|FG003|Overall Study|Adverse Event|17|||
170440710|NCT00852917|615953164|FG000|Overall Study|Lack of Efficacy|21|||
170440711|NCT00852917|615953165|FG001|Overall Study|Lack of Efficacy|11|||
170440712|NCT00852917|615953166|FG002|Overall Study|Lack of Efficacy|11|||
170440713|NCT00852917|615953167|FG003|Overall Study|Lack of Efficacy|47|||
170440714|NCT00852917|615953164|FG000|Overall Study|Withdrawal by Subject|4|||
170783833|NCT03763708|617216588|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
170783834|NCT03763708|617216589|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
170783835|NCT05215314|617216590|FG000|Overall Study|Lost to Follow-up|2|||
170783836|NCT05215314|617216591|FG001|Overall Study|Lost to Follow-up|2|||
170783837|NCT05215314|617216590|FG000|Overall Study|Withdrawal by Subject|2|||
170783838|NCT05215314|617216591|FG001|Overall Study|Withdrawal by Subject|0|||
170440715|NCT00852917|615953165|FG001|Overall Study|Withdrawal by Subject|8|||
170783839|NCT05215314|617216590|FG000|Overall Study|Physician Decision|1|||
170783840|NCT05215314|617216591|FG001|Overall Study|Physician Decision|0|||
170783841|NCT04382404|617216593|FG000|Overall Study|Adverse Event|1|||
170783842|NCT04382404|617216593|FG000|Overall Study|Lost to Follow-up|2|||
170783843|NCT05687916|617216595|FG000|Overall Study|Adverse Event|1|||
170783844|NCT05687916|617216596|FG001|Overall Study|Adverse Event|2|||
170783845|NCT05687916|617216597|FG002|Overall Study|Adverse Event|0|||
170783846|NCT05687916|617216595|FG000|Overall Study|Withdrawal by Subject|1|||
170783847|NCT05687916|617216596|FG001|Overall Study|Withdrawal by Subject|0|||
170783848|NCT05687916|617216597|FG002|Overall Study|Withdrawal by Subject|1|||
170440716|NCT00852917|615953166|FG002|Overall Study|Withdrawal by Subject|10|||
170783849|NCT05687916|617216595|FG000|Overall Study|Protocol Violation|0|||
170783850|NCT05687916|617216596|FG001|Overall Study|Protocol Violation|2|||
170440717|NCT00852917|615953167|FG003|Overall Study|Withdrawal by Subject|9|||
170783851|NCT05687916|617216597|FG002|Overall Study|Protocol Violation|1|||
170440718|NCT00852917|615953164|FG000|Overall Study|Physician Decision|6|||
170440719|NCT00852917|615953165|FG001|Overall Study|Physician Decision|7|||
170440720|NCT00852917|615953166|FG002|Overall Study|Physician Decision|2|||
170783852|NCT05687916|617216595|FG000|Overall Study|Reason not Specified|1|||
170783853|NCT05687916|617216596|FG001|Overall Study|Reason not Specified|0|||
170783854|NCT05687916|617216597|FG002|Overall Study|Reason not Specified|0|||
170783855|NCT04294225|617216602|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
170783856|NCT04294225|617216602|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
170783857|NCT04294225|617216602|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
170783858|NCT04294225|617216602|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
170783859|NCT04294225|617216602|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
170783860|NCT04588298|617216616|FG000|Overall Study|Adverse Event|0|||
170783861|NCT04588298|617216617|FG001|Overall Study|Adverse Event|0|||
170783862|NCT04588298|617216618|FG002|Overall Study|Adverse Event|1|||
170783863|NCT04588298|617216619|FG003|Overall Study|Adverse Event|0|||
170783864|NCT04588298|617216620|FG004|Overall Study|Adverse Event|2|||
170783865|NCT04588298|617216616|FG000|Overall Study|Withdrawal by Subject|1|||
170783866|NCT04588298|617216617|FG001|Overall Study|Withdrawal by Subject|0|||
170783867|NCT04588298|617216618|FG002|Overall Study|Withdrawal by Subject|0|||
170537206|NCT03765073|616311553|FG001|Stage 1|Withdrawal by participant|1|||
170783868|NCT04588298|617216619|FG003|Overall Study|Withdrawal by Subject|1|||
170537207|NCT03765073|616311554|FG002|Stage 1|Withdrawal by participant|0|||
170537208|NCT03765073|616311555|FG003|Stage 1|Withdrawal by participant|0|||
170783869|NCT04588298|617216620|FG004|Overall Study|Withdrawal by Subject|0|||
170783870|NCT03924986|617216621|FG000|Overall Study|Death|57|||
170440721|NCT00852917|615953167|FG003|Overall Study|Physician Decision|19|||
170440722|NCT00852917|615953164|FG000|Overall Study|Death|0|||
170783871|NCT03924986|617216622|FG001|Overall Study|Death|66|||
170783872|NCT03924986|617216621|FG000|Overall Study|Study Concluded by Sponsor|51|||
170783873|NCT03924986|617216622|FG001|Overall Study|Study Concluded by Sponsor|41|||
170783874|NCT03924986|617216621|FG000|Overall Study|Withdrawal by Subject|15|||
170783875|NCT03924986|617216622|FG001|Overall Study|Withdrawal by Subject|20|||
170783876|NCT03924986|617216621|FG000|Overall Study|Lost to Follow-up|7|||
170783877|NCT03924986|617216622|FG001|Overall Study|Lost to Follow-up|5|||
170783878|NCT03924986|617216621|FG000|Overall Study|Miscellaneous|1|||
170783879|NCT03924986|617216622|FG001|Overall Study|Miscellaneous|0|||
170783880|NCT04410042|617216624|FG000|Overall Study|Not Eligible|1|||
170783881|NCT04410042|617216625|FG001|Overall Study|Not Eligible|1|||
170783882|NCT03978871|617216628|FG000|Overall Study|Lost to Follow-up|11|||
170783883|NCT03978871|617216629|FG001|Overall Study|Lost to Follow-up|12|||
170783884|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Other|0|||
170783885|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Other|0|||
170783886|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Other|0|||
170783887|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Other|0|||
170783888|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Other|0|||
170783889|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Other|0|||
170783890|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Other|0|||
170783891|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Other|0|||
170783892|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Other|0|||
170783893|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Other|0|||
170783894|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Other|1|||
170783895|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Other|1|||
170783896|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Other|1|||
170783897|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Other|0|||
170783898|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Other|3|||
170783899|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Other|1|||
170783900|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Other|1|||
170783901|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Other|0|||
170783902|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783903|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783904|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783905|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783906|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783907|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783908|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
170783909|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783910|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
170783911|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783912|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783913|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783914|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
170783915|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783916|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783917|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783918|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
170440723|NCT00852917|615953165|FG001|Overall Study|Death|0|||
170440724|NCT00852917|615953166|FG002|Overall Study|Death|0|||
170783919|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
170783920|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783921|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170440725|NCT00852917|615953167|FG003|Overall Study|Death|1|||
170440726|NCT01358877|615953168|FG000|Overall Study|Withdrawal by Subject|475|||
170440727|NCT01358877|615953169|FG001|Overall Study|Withdrawal by Subject|466|||
170440728|NCT01358877|615953168|FG000|Overall Study|Recurrence of disease|181|||
170440729|NCT01358877|615953169|FG001|Overall Study|Recurrence of disease|269|||
170440730|NCT01358877|615953168|FG000|Overall Study|Lost to Follow-up|181|||
170440731|NCT01358877|615953169|FG001|Overall Study|Lost to Follow-up|176|||
170440732|NCT01358877|615953168|FG000|Overall Study|Death|41|||
170440733|NCT01358877|615953169|FG001|Overall Study|Death|46|||
170440734|NCT01358877|615953168|FG000|Overall Study|Adverse Event|39|||
170440735|NCT01358877|615953169|FG001|Overall Study|Adverse Event|42|||
170440736|NCT01358877|615953168|FG000|Overall Study|Physician Decision|43|||
170440737|NCT01358877|615953169|FG001|Overall Study|Physician Decision|32|||
170440738|NCT01358877|615953168|FG000|Overall Study|Contralateral breast cancer|42|||
170440739|NCT01358877|615953169|FG001|Overall Study|Contralateral breast cancer|28|||
170440740|NCT01358877|615953168|FG000|Overall Study|Reason not specified|37|||
170440741|NCT01358877|615953169|FG001|Overall Study|Reason not specified|29|||
170440742|NCT00397254|615953173|FG000|Overall Study|Lost to Follow-up|2|||
170537209|NCT03765073|616311556|FG004|Stage 1|Withdrawal by participant|0|||
170783922|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783923|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783924|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783925|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783926|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783927|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
170783928|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783929|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783930|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783931|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783932|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783933|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783934|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783935|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783936|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783937|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
170783938|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
170885502|NCT01014689|617588891|FG001|Overall Study|Lack of Efficacy|1|||
170885503|NCT01014689|617588890|FG000|Overall Study|Adverse Event|3|||
170885504|NCT01014689|617588891|FG001|Overall Study|Adverse Event|0|||
170885505|NCT01014689|617588890|FG000|Overall Study|Withdrawal by Subject|5|||
170885506|NCT01014689|617588891|FG001|Overall Study|Withdrawal by Subject|4|||
170885507|NCT01014689|617588890|FG000|Overall Study|Protocol Violation|1|||
170885508|NCT01014689|617588891|FG001|Overall Study|Protocol Violation|1|||
170885509|NCT01014689|617588890|FG000|Overall Study|Lost to Follow-up|3|||
170885510|NCT01014689|617588891|FG001|Overall Study|Lost to Follow-up|7|||
170885511|NCT01014689|617588890|FG000|Overall Study|Pregnancy|1|||
170885512|NCT01014689|617588891|FG001|Overall Study|Pregnancy|0|||
170885513|NCT05568888|617588892|FG000|Overall Study|Physician Decision|1|||
170885514|NCT05568888|617588893|FG001|Overall Study|Physician Decision|0|||
170885515|NCT05568888|617588892|FG000|Overall Study|Protocol Deviation|2|||
170885516|NCT05568888|617588893|FG001|Overall Study|Protocol Deviation|1|||
170885517|NCT05568888|617588892|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
170885518|NCT05568888|617588893|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
170885519|NCT05568888|617588892|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
170885520|NCT05568888|617588893|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
170885521|NCT05568888|617588892|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
170885522|NCT05568888|617588893|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
170885523|NCT01761266|617590084|FG000|Overall Study|Death|415|||
170885524|NCT01761266|617590085|FG001|Overall Study|Death|402|||
170885525|NCT01761266|617590084|FG000|Overall Study|Lost to Follow-up|8|||
170885526|NCT01761266|617590085|FG001|Overall Study|Lost to Follow-up|12|||
170885527|NCT01761266|617590084|FG000|Overall Study|Withdrawal by Subject|14|||
170885528|NCT01761266|617590085|FG001|Overall Study|Withdrawal by Subject|10|||
170885529|NCT01761266|617590084|FG000|Overall Study|Sponsor Decision|41|||
170885530|NCT01761266|617590085|FG001|Overall Study|Sponsor Decision|52|||
170885531|NCT01765673|617590086|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
170885532|NCT02600507|617590087|FG000|Overall Study|Adverse Event|3|||
170885533|NCT02600507|617590088|FG001|Overall Study|Adverse Event|15|||
170885534|NCT02600507|617590089|FG002|Overall Study|Adverse Event|5|||
170885535|NCT02600507|617590087|FG000|Overall Study|Lack of Efficacy|3|||
170885536|NCT02600507|617590088|FG001|Overall Study|Lack of Efficacy|8|||
170885537|NCT02600507|617590089|FG002|Overall Study|Lack of Efficacy|5|||
170885538|NCT02600507|617590087|FG000|Overall Study|Lost to Follow-up|3|||
170440743|NCT00397254|615953174|FG001|Overall Study|Lost to Follow-up|2|||
170440744|NCT01583530|615953181|FG000|Overall Study|Adverse Event|0|||
170783939|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783940|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
170440745|NCT01583530|615953182|FG001|Overall Study|Adverse Event|0|||
170440746|NCT01583530|615953183|FG002|Overall Study|Adverse Event|0|||
170440747|NCT01583530|615953184|FG003|Overall Study|Adverse Event|0|||
170440748|NCT01583530|615953185|FG004|Overall Study|Adverse Event|0|||
170783941|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783942|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783943|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783944|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783945|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783946|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783947|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
170783948|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783949|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783950|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783951|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783952|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783953|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783954|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783955|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
170783956|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Death|0|||
170783957|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Death|0|||
170783958|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Death|0|||
170783959|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Death|0|||
170783960|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Death|0|||
170783961|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Death|0|||
170783962|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Death|0|||
170783963|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Death|0|||
170783964|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Death|0|||
170783965|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Death|1|||
170783966|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Death|0|||
170783967|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Death|1|||
170783968|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Death|0|||
170783969|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Death|1|||
170783970|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Death|0|||
170783971|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Death|0|||
170783972|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Death|2|||
170783973|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Death|0|||
170783974|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
170783975|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
170783976|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
170783977|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
170783978|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
170783979|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
170783980|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
170783981|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
170783982|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
170783983|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
170783984|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
170783985|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
170783986|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
170783987|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
170783988|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
170783989|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
170783990|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
170783991|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
170783992|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Adverse Event|0|||
170783993|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Adverse Event|0|||
170783994|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Adverse Event|0|||
170783995|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Adverse Event|0|||
170783996|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Adverse Event|0|||
170783997|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Adverse Event|0|||
170783998|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Adverse Event|2|||
170783999|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Adverse Event|0|||
170784000|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Adverse Event|0|||
170784001|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Adverse Event|0|||
170784002|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Adverse Event|1|||
170784003|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Adverse Event|2|||
170784004|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Adverse Event|0|||
170784005|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Adverse Event|1|||
170784006|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Adverse Event|0|||
170784007|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Adverse Event|0|||
170784008|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Adverse Event|1|||
170784009|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Adverse Event|0|||
170784010|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
170784011|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
170784012|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
170784013|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
170784014|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
170784015|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
170784016|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
170885539|NCT02600507|617590088|FG001|Overall Study|Lost to Follow-up|5|||
170885540|NCT02600507|617590089|FG002|Overall Study|Lost to Follow-up|2|||
170885541|NCT02600507|617590087|FG000|Overall Study|Protocol Violation|12|||
170885542|NCT02600507|617590088|FG001|Overall Study|Protocol Violation|4|||
170885543|NCT02600507|617590089|FG002|Overall Study|Protocol Violation|4|||
170885544|NCT02600507|617590087|FG000|Overall Study|Physician Decision|1|||
170885545|NCT02600507|617590088|FG001|Overall Study|Physician Decision|0|||
170885546|NCT02600507|617590089|FG002|Overall Study|Physician Decision|1|||
170885547|NCT02600507|617590087|FG000|Overall Study|Withdrawal by Subject|7|||
170885548|NCT02600507|617590088|FG001|Overall Study|Withdrawal by Subject|11|||
170885549|NCT02600507|617590089|FG002|Overall Study|Withdrawal by Subject|7|||
170885550|NCT02600507|617590087|FG000|Overall Study|Other|0|||
170885551|NCT02600507|617590088|FG001|Overall Study|Other|1|||
170885552|NCT02600507|617590089|FG002|Overall Study|Other|1|||
170885553|NCT05048719|617590090|FG000|Overall Study|Withdrawal by Subject|2|||
170885554|NCT05048719|617590091|FG001|Overall Study|Withdrawal by Subject|1|||
170885555|NCT05048719|617590092|FG002|Overall Study|Withdrawal by Subject|3|||
170885556|NCT05048719|617590093|FG003|Overall Study|Withdrawal by Subject|1|||
170885557|NCT05048719|617590094|FG004|Overall Study|Withdrawal by Subject|0|||
170885558|NCT05048719|617590095|FG005|Overall Study|Withdrawal by Subject|2|||
170885559|NCT05048719|617590096|FG006|Overall Study|Withdrawal by Subject|1|||
170885560|NCT05048719|617590097|FG007|Overall Study|Withdrawal by Subject|1|||
170885561|NCT05048719|617590098|FG008|Overall Study|Withdrawal by Subject|0|||
170885562|NCT05048719|617590090|FG000|Overall Study|Death|1|||
170885563|NCT05048719|617590091|FG001|Overall Study|Death|0|||
170885564|NCT05048719|617590092|FG002|Overall Study|Death|0|||
170885565|NCT05048719|617590093|FG003|Overall Study|Death|0|||
170885566|NCT05048719|617590094|FG004|Overall Study|Death|0|||
170885567|NCT05048719|617590095|FG005|Overall Study|Death|0|||
170885568|NCT05048719|617590096|FG006|Overall Study|Death|0|||
170885569|NCT05048719|617590097|FG007|Overall Study|Death|0|||
170885570|NCT05048719|617590098|FG008|Overall Study|Death|0|||
170885571|NCT05048719|617590090|FG000|Overall Study|Adverse Event|0|||
170885572|NCT05048719|617590091|FG001|Overall Study|Adverse Event|1|||
170885573|NCT05048719|617590092|FG002|Overall Study|Adverse Event|2|||
170885574|NCT05048719|617590093|FG003|Overall Study|Adverse Event|0|||
170885575|NCT05048719|617590094|FG004|Overall Study|Adverse Event|1|||
170885576|NCT05048719|617590095|FG005|Overall Study|Adverse Event|0|||
170885577|NCT05048719|617590096|FG006|Overall Study|Adverse Event|0|||
170885578|NCT05048719|617590097|FG007|Overall Study|Adverse Event|0|||
170885579|NCT05048719|617590098|FG008|Overall Study|Adverse Event|0|||
170885580|NCT05048719|617590090|FG000|Overall Study|Lost to Follow-up|0|||
170885581|NCT05048719|617590091|FG001|Overall Study|Lost to Follow-up|0|||
170885582|NCT05048719|617590092|FG002|Overall Study|Lost to Follow-up|1|||
170885583|NCT05048719|617590093|FG003|Overall Study|Lost to Follow-up|3|||
170885584|NCT05048719|617590094|FG004|Overall Study|Lost to Follow-up|1|||
170885585|NCT05048719|617590095|FG005|Overall Study|Lost to Follow-up|1|||
170885586|NCT05048719|617590096|FG006|Overall Study|Lost to Follow-up|1|||
170885587|NCT05048719|617590097|FG007|Overall Study|Lost to Follow-up|1|||
170885588|NCT05048719|617590098|FG008|Overall Study|Lost to Follow-up|0|||
170885589|NCT05048719|617590090|FG000|Overall Study|Physician Decision|0|||
170885590|NCT05048719|617590091|FG001|Overall Study|Physician Decision|0|||
170885591|NCT05048719|617590092|FG002|Overall Study|Physician Decision|0|||
170885592|NCT05048719|617590093|FG003|Overall Study|Physician Decision|0|||
170885593|NCT05048719|617590094|FG004|Overall Study|Physician Decision|0|||
170885594|NCT05048719|617590095|FG005|Overall Study|Physician Decision|0|||
170885595|NCT05048719|617590096|FG006|Overall Study|Physician Decision|0|||
170885596|NCT05048719|617590097|FG007|Overall Study|Physician Decision|1|||
170885597|NCT05048719|617590098|FG008|Overall Study|Physician Decision|1|||
170885598|NCT05048719|617590090|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
170885599|NCT05048719|617590091|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
170885600|NCT05048719|617590092|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
170885601|NCT05048719|617590093|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
170885602|NCT05048719|617590094|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
170885603|NCT05048719|617590095|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
170885604|NCT05048719|617590096|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
170885605|NCT05048719|617590097|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
170885606|NCT05048719|617590098|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
170885607|NCT05048719|617590090|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
170885608|NCT05048719|617590091|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
170885609|NCT05048719|617590092|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
170885610|NCT05048719|617590093|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
170885611|NCT05048719|617590094|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
170885612|NCT05048719|617590095|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
170906121|NCT01097044|617658626|FG001|Overall Study|Withdrawal by Subject|4|||
170784017|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
170784018|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
170784019|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
170784020|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
170784021|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
170784022|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
170784023|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
170784024|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
170784025|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
170784026|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
170784027|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
170784028|NCT03269136|617216635|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784029|NCT03269136|617216636|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784030|NCT03269136|617216637|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784031|NCT03269136|617216638|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784032|NCT03269136|617216639|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784033|NCT03269136|617216640|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784034|NCT03269136|617216641|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784035|NCT03269136|617216642|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784036|NCT03269136|617216643|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784037|NCT03269136|617216644|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784038|NCT03269136|617216645|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784039|NCT03269136|617216646|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170440749|NCT01583530|615953186|FG005|Overall Study|Adverse Event|1|||
170784040|NCT03269136|617216647|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
170440750|NCT01583530|615953181|FG000|Overall Study|Withdrawal by Subject|0|||
170440751|NCT01583530|615953182|FG001|Overall Study|Withdrawal by Subject|3|||
170440752|NCT01583530|615953183|FG002|Overall Study|Withdrawal by Subject|0|||
170440753|NCT01583530|615953184|FG003|Overall Study|Withdrawal by Subject|1|||
170440754|NCT01583530|615953185|FG004|Overall Study|Withdrawal by Subject|1|||
170440755|NCT01583530|615953186|FG005|Overall Study|Withdrawal by Subject|2|||
170440756|NCT01583530|615953181|FG000|Overall Study|Lost to Follow-up|0|||
170440757|NCT01583530|615953182|FG001|Overall Study|Lost to Follow-up|0|||
170440758|NCT01583530|615953183|FG002|Overall Study|Lost to Follow-up|0|||
170440759|NCT01583530|615953184|FG003|Overall Study|Lost to Follow-up|0|||
170440760|NCT01583530|615953185|FG004|Overall Study|Lost to Follow-up|3|||
170440761|NCT01583530|615953186|FG005|Overall Study|Lost to Follow-up|0|||
170440762|NCT01583530|615953181|FG000|Overall Study|Lack of compliance|0|||
170440763|NCT01583530|615953182|FG001|Overall Study|Lack of compliance|0|||
170440764|NCT01583530|615953183|FG002|Overall Study|Lack of compliance|0|||
170784041|NCT03269136|617216648|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
170784042|NCT03269136|617216649|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
170784043|NCT03269136|617216650|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784044|NCT03269136|617216651|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
170784045|NCT03269136|617216652|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170784046|NCT03269136|617216635|FG000|Part 2A: Dose Expansion|Other|0|||
170784047|NCT03269136|617216636|FG001|Part 2A: Dose Expansion|Other|0|||
170784048|NCT03269136|617216637|FG002|Part 2A: Dose Expansion|Other|0|||
170784049|NCT03269136|617216638|FG003|Part 2A: Dose Expansion|Other|0|||
170784050|NCT03269136|617216639|FG004|Part 2A: Dose Expansion|Other|0|||
170784051|NCT03269136|617216640|FG005|Part 2A: Dose Expansion|Other|0|||
170784052|NCT03269136|617216641|FG006|Part 2A: Dose Expansion|Other|0|||
170784053|NCT03269136|617216642|FG007|Part 2A: Dose Expansion|Other|0|||
170784054|NCT03269136|617216643|FG008|Part 2A: Dose Expansion|Other|0|||
170784055|NCT03269136|617216644|FG009|Part 2A: Dose Expansion|Other|0|||
170784056|NCT03269136|617216645|FG010|Part 2A: Dose Expansion|Other|0|||
170784057|NCT03269136|617216646|FG011|Part 2A: Dose Expansion|Other|0|||
170784058|NCT03269136|617216647|FG012|Part 2A: Dose Expansion|Other|0|||
170440765|NCT01583530|615953184|FG003|Overall Study|Lack of compliance|0|||
170784059|NCT03269136|617216648|FG013|Part 2A: Dose Expansion|Other|0|||
170784060|NCT03269136|617216649|FG014|Part 2A: Dose Expansion|Other|0|||
170784061|NCT03269136|617216650|FG015|Part 2A: Dose Expansion|Other|0|||
170784062|NCT03269136|617216651|FG016|Part 2A: Dose Expansion|Other|0|||
170784063|NCT03269136|617216652|FG017|Part 2A: Dose Expansion|Other|1|||
170537210|NCT03765073|616311557|FG005|Stage 1|Withdrawal by participant|0|||
170537211|NCT03765073|616311558|FG006|Stage 1|Withdrawal by participant|0|||
170537212|NCT03765073|616311559|FG007|Stage 1|Withdrawal by participant|0|||
170537213|NCT03765073|616311560|FG008|Stage 1|Withdrawal by participant|0|||
170537214|NCT03765073|616311561|FG009|Stage 1|Withdrawal by participant|0|||
170537215|NCT03765073|616311562|FG010|Stage 1|Withdrawal by participant|0|||
170537216|NCT03765073|616311563|FG011|Stage 1|Withdrawal by participant|0|||
170537217|NCT03765073|616311564|FG012|Stage 1|Withdrawal by participant|0|||
170784064|NCT03269136|617216635|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784065|NCT03269136|617216636|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784066|NCT03269136|617216637|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784067|NCT03269136|617216638|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784068|NCT03269136|617216639|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784069|NCT03269136|617216640|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784070|NCT03269136|617216641|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784071|NCT03269136|617216642|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784072|NCT03269136|617216643|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784073|NCT03269136|617216644|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784074|NCT03269136|617216645|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784075|NCT03269136|617216646|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784076|NCT03269136|617216647|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784077|NCT03269136|617216648|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784078|NCT03269136|617216649|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784079|NCT03269136|617216650|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784080|NCT03269136|617216651|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
170784081|NCT03269136|617216652|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
170784082|NCT03269136|617216635|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
170784083|NCT03269136|617216636|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
170784084|NCT03269136|617216637|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
170784085|NCT03269136|617216638|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
170784086|NCT03269136|617216639|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
170784087|NCT03269136|617216640|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
170784088|NCT03269136|617216641|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
170784089|NCT03269136|617216642|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
170784090|NCT03269136|617216643|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
170784091|NCT03269136|617216644|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
170784092|NCT03269136|617216645|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
170784093|NCT03269136|617216646|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
170784094|NCT03269136|617216647|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
170784095|NCT03269136|617216648|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
170784096|NCT03269136|617216649|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
170784097|NCT03269136|617216650|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
170784098|NCT03269136|617216651|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
170784099|NCT03269136|617216652|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
170784100|NCT03269136|617216635|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
170784101|NCT03269136|617216636|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
170784102|NCT03269136|617216637|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
170784103|NCT03269136|617216638|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
170784104|NCT03269136|617216639|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
170784105|NCT03269136|617216640|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
170784106|NCT03269136|617216641|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
170784107|NCT03269136|617216642|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
170784108|NCT03269136|617216643|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
170784109|NCT03269136|617216644|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
170784110|NCT03269136|617216645|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
170784111|NCT03269136|617216646|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
170784112|NCT03269136|617216647|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
170784113|NCT03269136|617216648|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
170784114|NCT03269136|617216649|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
170784115|NCT03269136|617216650|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
170784116|NCT03269136|617216651|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
170784117|NCT03269136|617216652|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
170784118|NCT03269136|617216635|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
170784119|NCT03269136|617216636|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
170784120|NCT03269136|617216637|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
170784121|NCT03269136|617216638|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
170784122|NCT03269136|617216639|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
170784123|NCT03269136|617216640|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
170537218|NCT03765073|616311565|FG013|Stage 1|Withdrawal by participant|0|||
170885613|NCT05048719|617590096|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
170537219|NCT03765073|616311566|FG014|Stage 1|Withdrawal by participant|0|||
170537220|NCT03765073|616311567|FG015|Stage 1|Withdrawal by participant|0|||
170537221|NCT03765073|616311568|FG016|Stage 1|Withdrawal by participant|0|||
170885614|NCT05048719|617590097|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
170885615|NCT05048719|617590098|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
170885616|NCT05048719|617590090|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
170885617|NCT05048719|617590091|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
170885618|NCT05048719|617590092|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
170885619|NCT05048719|617590093|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
170885620|NCT05048719|617590094|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
170885621|NCT05048719|617590095|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
170885622|NCT05048719|617590096|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
170885623|NCT05048719|617590097|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
170885624|NCT05048719|617590098|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
170885625|NCT05048719|617590090|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
170885626|NCT05048719|617590091|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
170885627|NCT05048719|617590092|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
170885628|NCT05048719|617590093|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
170885629|NCT05048719|617590094|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
170885630|NCT05048719|617590095|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
170885631|NCT05048719|617590096|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
170885632|NCT05048719|617590097|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
170885633|NCT05048719|617590098|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
170440766|NCT01583530|615953185|FG004|Overall Study|Lack of compliance|1|||
170440767|NCT01583530|615953186|FG005|Overall Study|Lack of compliance|0|||
170440768|NCT02416180|615953187|FG000|Overall Study|Withdrawal by Subject|1|||
170440769|NCT03414034|615953188|FG000|Overall Study|Adverse Event|6|||
170440770|NCT03414034|615953189|FG001|Overall Study|Adverse Event|1|||
170440771|NCT03414034|615953190|FG002|Overall Study|Adverse Event|1|||
170440772|NCT03414034|615953188|FG000|Overall Study|Death|0|||
170440773|NCT03414034|615953189|FG001|Overall Study|Death|0|||
170440774|NCT03414034|615953190|FG002|Overall Study|Death|1|||
170440775|NCT03414034|615953188|FG000|Overall Study|Non-compliance With Study Drug|0|||
170440776|NCT03414034|615953189|FG001|Overall Study|Non-compliance With Study Drug|0|||
170440777|NCT03414034|615953190|FG002|Overall Study|Non-compliance With Study Drug|1|||
170440778|NCT03414034|615953188|FG000|Overall Study|Physician Decision|1|||
170440779|NCT03414034|615953189|FG001|Overall Study|Physician Decision|3|||
170440780|NCT03414034|615953190|FG002|Overall Study|Physician Decision|2|||
170440781|NCT03414034|615953188|FG000|Overall Study|Withdrawal of Informed Consent|2|||
170440782|NCT03414034|615953189|FG001|Overall Study|Withdrawal of Informed Consent|1|||
170440783|NCT03414034|615953190|FG002|Overall Study|Withdrawal of Informed Consent|4|||
170440784|NCT03414034|615953188|FG000|Overall Study|Progressive Disease|15|||
170440785|NCT03414034|615953189|FG001|Overall Study|Progressive Disease|15|||
170440786|NCT03414034|615953190|FG002|Overall Study|Progressive Disease|17|||
170440787|NCT03414034|615953188|FG000|Overall Study|Miscellaneous|0|||
170440788|NCT03414034|615953189|FG001|Overall Study|Miscellaneous|0|||
170440789|NCT03414034|615953190|FG002|Overall Study|Miscellaneous|2|||
170440790|NCT03480022|615953191|FG000|Overall Study|Pregnancy|2|||
170440791|NCT03480022|615953192|FG001|Overall Study|Pregnancy|0|||
170440792|NCT03480022|615953191|FG000|Overall Study|Adverse Event|6|||
170440793|NCT03480022|615953192|FG001|Overall Study|Adverse Event|0|||
170440794|NCT03480022|615953191|FG000|Overall Study|Lack of Efficacy|0|||
170440795|NCT03480022|615953192|FG001|Overall Study|Lack of Efficacy|2|||
170440796|NCT03480022|615953191|FG000|Overall Study|Physician Decision|0|||
170440797|NCT03480022|615953192|FG001|Overall Study|Physician Decision|1|||
170440798|NCT03480022|615953191|FG000|Overall Study|Withdrawal by Subject|2|||
170440799|NCT03480022|615953192|FG001|Overall Study|Withdrawal by Subject|0|||
170440800|NCT03480022|615953191|FG000|Overall Study|Medication concerns|1|||
170440801|NCT03480022|615953192|FG001|Overall Study|Medication concerns|0|||
170440802|NCT03480022|615953191|FG000|Overall Study|Family member COVID exposure|0|||
170440803|NCT03480022|615953192|FG001|Overall Study|Family member COVID exposure|1|||
170440804|NCT01970592|615953193|FG000|Overall Study|Withdrawal by Subject|4|||
170440805|NCT01970592|615953193|FG000|Overall Study|Physician Decision|1|||
170440806|NCT01970592|615953193|FG000|Overall Study|Adverse Event|1|||
170440807|NCT05263505|615953196|FG000|Overall Study|Adverse Event|0|||
170440808|NCT05263505|615953197|FG001|Overall Study|Adverse Event|1|||
170440809|NCT02616380|615953198|FG000|Overall Study|Lost to Follow-up|1|||
170440810|NCT02616380|615953198|FG000|Overall Study|Other|2|||
170440811|NCT00766493|615953199|FG000|30 Days Post-Procedure|Discontinued|7|||
170440812|NCT00766493|615953199|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
170440813|NCT00766493|615953199|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
170440814|NCT00826241|615953200|FG000|Overall Study|Withdrawal from Follow-up|1|||
170537222|NCT03765073|616311569|FG017|Stage 1|Withdrawal by participant|0|||
170537223|NCT03765073|616311570|FG018|Stage 1|Withdrawal by participant|0|||
170537224|NCT03765073|616311571|FG019|Stage 1|Withdrawal by participant|0|||
170537225|NCT03765073|616311572|FG020|Stage 1|Withdrawal by participant|0|||
170537226|NCT03765073|616311552|FG000|Stage 2|Death|0|||
170537227|NCT03765073|616311553|FG001|Stage 2|Death|0|||
170537228|NCT03765073|616311554|FG002|Stage 2|Death|0|||
170537229|NCT03765073|616311555|FG003|Stage 2|Death|0|||
170537230|NCT03765073|616311556|FG004|Stage 2|Death|0|||
170537231|NCT03765073|616311557|FG005|Stage 2|Death|0|||
170537232|NCT03765073|616311558|FG006|Stage 2|Death|0|||
170537233|NCT03765073|616311559|FG007|Stage 2|Death|0|||
170537234|NCT03765073|616311560|FG008|Stage 2|Death|0|||
170537235|NCT03765073|616311561|FG009|Stage 2|Death|1|||
170537236|NCT03765073|616311562|FG010|Stage 2|Death|0|||
170537237|NCT03765073|616311563|FG011|Stage 2|Death|1|||
170537238|NCT03765073|616311564|FG012|Stage 2|Death|0|||
170537239|NCT03765073|616311565|FG013|Stage 2|Death|0|||
170537240|NCT03765073|616311566|FG014|Stage 2|Death|0|||
170537241|NCT03765073|616311567|FG015|Stage 2|Death|0|||
170537242|NCT03765073|616311568|FG016|Stage 2|Death|2|||
170537243|NCT03765073|616311569|FG017|Stage 2|Death|0|||
170537244|NCT03765073|616311570|FG018|Stage 2|Death|0|||
170537245|NCT03765073|616311571|FG019|Stage 2|Death|0|||
170537246|NCT03765073|616311572|FG020|Stage 2|Death|0|||
170537247|NCT03765073|616311552|FG000|Stage 2|Lost to Follow-up|0|||
170537248|NCT03765073|616311553|FG001|Stage 2|Lost to Follow-up|0|||
170537249|NCT03765073|616311554|FG002|Stage 2|Lost to Follow-up|0|||
170537250|NCT03765073|616311555|FG003|Stage 2|Lost to Follow-up|5|||
170537251|NCT03765073|616311556|FG004|Stage 2|Lost to Follow-up|1|||
170537252|NCT03765073|616311557|FG005|Stage 2|Lost to Follow-up|0|||
170537253|NCT03765073|616311558|FG006|Stage 2|Lost to Follow-up|3|||
170537254|NCT03765073|616311559|FG007|Stage 2|Lost to Follow-up|3|||
170537255|NCT03765073|616311560|FG008|Stage 2|Lost to Follow-up|1|||
170537256|NCT03765073|616311561|FG009|Stage 2|Lost to Follow-up|6|||
170537257|NCT03765073|616311562|FG010|Stage 2|Lost to Follow-up|5|||
170537258|NCT03765073|616311563|FG011|Stage 2|Lost to Follow-up|1|||
170537259|NCT03765073|616311564|FG012|Stage 2|Lost to Follow-up|1|||
170537260|NCT03765073|616311565|FG013|Stage 2|Lost to Follow-up|3|||
170537261|NCT03765073|616311566|FG014|Stage 2|Lost to Follow-up|3|||
170537262|NCT03765073|616311567|FG015|Stage 2|Lost to Follow-up|1|||
170537263|NCT03765073|616311568|FG016|Stage 2|Lost to Follow-up|6|||
170537264|NCT03765073|616311569|FG017|Stage 2|Lost to Follow-up|0|||
170537265|NCT03765073|616311570|FG018|Stage 2|Lost to Follow-up|0|||
170537266|NCT03765073|616311571|FG019|Stage 2|Lost to Follow-up|0|||
170537267|NCT03765073|616311572|FG020|Stage 2|Lost to Follow-up|0|||
170537268|NCT03765073|616311552|FG000|Stage 2|Other|0|||
170537269|NCT03765073|616311553|FG001|Stage 2|Other|0|||
170537270|NCT03765073|616311554|FG002|Stage 2|Other|0|||
170537271|NCT03765073|616311555|FG003|Stage 2|Other|0|||
170537272|NCT03765073|616311556|FG004|Stage 2|Other|0|||
170537273|NCT03765073|616311557|FG005|Stage 2|Other|0|||
170537274|NCT03765073|616311558|FG006|Stage 2|Other|0|||
170537275|NCT03765073|616311559|FG007|Stage 2|Other|1|||
170537276|NCT03765073|616311560|FG008|Stage 2|Other|1|||
170537277|NCT03765073|616311561|FG009|Stage 2|Other|3|||
170537278|NCT03765073|616311562|FG010|Stage 2|Other|0|||
170537279|NCT03765073|616311563|FG011|Stage 2|Other|0|||
170537280|NCT03765073|616311564|FG012|Stage 2|Other|0|||
170537281|NCT03765073|616311565|FG013|Stage 2|Other|0|||
170537282|NCT03765073|616311566|FG014|Stage 2|Other|0|||
170537283|NCT03765073|616311567|FG015|Stage 2|Other|1|||
170537284|NCT03765073|616311568|FG016|Stage 2|Other|2|||
170537285|NCT03765073|616311569|FG017|Stage 2|Other|0|||
170537286|NCT03765073|616311570|FG018|Stage 2|Other|0|||
170537287|NCT03765073|616311571|FG019|Stage 2|Other|0|||
170537288|NCT03765073|616311572|FG020|Stage 2|Other|0|||
170537289|NCT03765073|616311552|FG000|Stage 2|Withdrawal by parent/guardian|0|||
170537290|NCT03765073|616311553|FG001|Stage 2|Withdrawal by parent/guardian|0|||
170537291|NCT03765073|616311554|FG002|Stage 2|Withdrawal by parent/guardian|0|||
170537292|NCT03765073|616311555|FG003|Stage 2|Withdrawal by parent/guardian|0|||
170537293|NCT03765073|616311556|FG004|Stage 2|Withdrawal by parent/guardian|0|||
170537294|NCT03765073|616311557|FG005|Stage 2|Withdrawal by parent/guardian|0|||
170537295|NCT03765073|616311558|FG006|Stage 2|Withdrawal by parent/guardian|0|||
170537296|NCT03765073|616311559|FG007|Stage 2|Withdrawal by parent/guardian|0|||
170537297|NCT03765073|616311560|FG008|Stage 2|Withdrawal by parent/guardian|0|||
170537298|NCT03765073|616311561|FG009|Stage 2|Withdrawal by parent/guardian|0|||
170537299|NCT03765073|616311562|FG010|Stage 2|Withdrawal by parent/guardian|3|||
170537300|NCT03765073|616311563|FG011|Stage 2|Withdrawal by parent/guardian|3|||
170537301|NCT03765073|616311564|FG012|Stage 2|Withdrawal by parent/guardian|3|||
170537302|NCT03765073|616311565|FG013|Stage 2|Withdrawal by parent/guardian|1|||
170537303|NCT03765073|616311566|FG014|Stage 2|Withdrawal by parent/guardian|1|||
170537304|NCT03765073|616311567|FG015|Stage 2|Withdrawal by parent/guardian|0|||
170537305|NCT03765073|616311568|FG016|Stage 2|Withdrawal by parent/guardian|3|||
170537306|NCT03765073|616311569|FG017|Stage 2|Withdrawal by parent/guardian|0|||
170537307|NCT03765073|616311570|FG018|Stage 2|Withdrawal by parent/guardian|0|||
170537308|NCT03765073|616311571|FG019|Stage 2|Withdrawal by parent/guardian|0|||
170537309|NCT03765073|616311572|FG020|Stage 2|Withdrawal by parent/guardian|0|||
170537310|NCT03765073|616311552|FG000|Stage 2|Withdrawal by Subject|0|||
170537311|NCT03765073|616311553|FG001|Stage 2|Withdrawal by Subject|0|||
170537312|NCT03765073|616311554|FG002|Stage 2|Withdrawal by Subject|0|||
170537313|NCT03765073|616311555|FG003|Stage 2|Withdrawal by Subject|3|||
170537314|NCT03765073|616311556|FG004|Stage 2|Withdrawal by Subject|3|||
170537315|NCT03765073|616311557|FG005|Stage 2|Withdrawal by Subject|3|||
170537316|NCT03765073|616311558|FG006|Stage 2|Withdrawal by Subject|0|||
170537317|NCT03765073|616311559|FG007|Stage 2|Withdrawal by Subject|1|||
170537318|NCT03765073|616311560|FG008|Stage 2|Withdrawal by Subject|0|||
170537319|NCT03765073|616311561|FG009|Stage 2|Withdrawal by Subject|5|||
170537320|NCT03765073|616311562|FG010|Stage 2|Withdrawal by Subject|0|||
170537321|NCT03765073|616311563|FG011|Stage 2|Withdrawal by Subject|0|||
170537322|NCT03765073|616311564|FG012|Stage 2|Withdrawal by Subject|0|||
170537323|NCT03765073|616311565|FG013|Stage 2|Withdrawal by Subject|0|||
170537324|NCT03765073|616311566|FG014|Stage 2|Withdrawal by Subject|0|||
170537325|NCT03765073|616311567|FG015|Stage 2|Withdrawal by Subject|0|||
170537326|NCT03765073|616311568|FG016|Stage 2|Withdrawal by Subject|0|||
170537327|NCT03765073|616311569|FG017|Stage 2|Withdrawal by Subject|0|||
170537328|NCT03765073|616311570|FG018|Stage 2|Withdrawal by Subject|0|||
170537329|NCT03765073|616311571|FG019|Stage 2|Withdrawal by Subject|0|||
170537330|NCT03765073|616311572|FG020|Stage 2|Withdrawal by Subject|0|||
170537331|NCT03765073|616311552|FG000|Stage 3|Adverse Event|0|||
170537332|NCT03765073|616311553|FG001|Stage 3|Adverse Event|0|||
170537333|NCT03765073|616311554|FG002|Stage 3|Adverse Event|0|||
170537334|NCT03765073|616311555|FG003|Stage 3|Adverse Event|0|||
170537335|NCT03765073|616311556|FG004|Stage 3|Adverse Event|0|||
170537336|NCT03765073|616311557|FG005|Stage 3|Adverse Event|0|||
170537337|NCT03765073|616311558|FG006|Stage 3|Adverse Event|0|||
170537338|NCT03765073|616311559|FG007|Stage 3|Adverse Event|0|||
170537339|NCT03765073|616311560|FG008|Stage 3|Adverse Event|0|||
170537340|NCT03765073|616311561|FG009|Stage 3|Adverse Event|0|||
170537341|NCT03765073|616311562|FG010|Stage 3|Adverse Event|0|||
170537342|NCT03765073|616311563|FG011|Stage 3|Adverse Event|0|||
170537343|NCT03765073|616311564|FG012|Stage 3|Adverse Event|0|||
170537344|NCT03765073|616311565|FG013|Stage 3|Adverse Event|0|||
170537345|NCT03765073|616311566|FG014|Stage 3|Adverse Event|0|||
170537346|NCT03765073|616311567|FG015|Stage 3|Adverse Event|0|||
170537347|NCT03765073|616311568|FG016|Stage 3|Adverse Event|0|||
170537348|NCT03765073|616311569|FG017|Stage 3|Adverse Event|0|||
170537349|NCT03765073|616311570|FG018|Stage 3|Adverse Event|1|||
170537350|NCT03765073|616311571|FG019|Stage 3|Adverse Event|0|||
170537351|NCT03765073|616311572|FG020|Stage 3|Adverse Event|0|||
170537352|NCT03765073|616311552|FG000|Stage 3|Death|0|||
170537353|NCT03765073|616311553|FG001|Stage 3|Death|0|||
170537354|NCT03765073|616311554|FG002|Stage 3|Death|0|||
170537355|NCT03765073|616311555|FG003|Stage 3|Death|0|||
170537356|NCT03765073|616311556|FG004|Stage 3|Death|0|||
170537357|NCT03765073|616311557|FG005|Stage 3|Death|0|||
170537358|NCT03765073|616311558|FG006|Stage 3|Death|0|||
170537359|NCT03765073|616311559|FG007|Stage 3|Death|0|||
170537360|NCT03765073|616311560|FG008|Stage 3|Death|0|||
170537361|NCT03765073|616311561|FG009|Stage 3|Death|0|||
170537362|NCT03765073|616311562|FG010|Stage 3|Death|0|||
170537363|NCT03765073|616311563|FG011|Stage 3|Death|0|||
170537364|NCT03765073|616311564|FG012|Stage 3|Death|0|||
170537365|NCT03765073|616311565|FG013|Stage 3|Death|0|||
170537366|NCT03765073|616311566|FG014|Stage 3|Death|0|||
170537367|NCT03765073|616311567|FG015|Stage 3|Death|0|||
170537368|NCT03765073|616311568|FG016|Stage 3|Death|0|||
170784124|NCT03269136|617216641|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
170784125|NCT03269136|617216642|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
170784126|NCT03269136|617216643|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
170784127|NCT03269136|617216644|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
170537369|NCT03765073|616311569|FG017|Stage 3|Death|0|||
170537370|NCT03765073|616311570|FG018|Stage 3|Death|0|||
170537371|NCT03765073|616311571|FG019|Stage 3|Death|3|||
170537372|NCT03765073|616311572|FG020|Stage 3|Death|2|||
170537373|NCT03765073|616311552|FG000|Stage 3|Lost to Follow-up|0|||
170537374|NCT03765073|616311553|FG001|Stage 3|Lost to Follow-up|0|||
170537375|NCT03765073|616311554|FG002|Stage 3|Lost to Follow-up|0|||
170537376|NCT03765073|616311555|FG003|Stage 3|Lost to Follow-up|0|||
170537377|NCT03765073|616311556|FG004|Stage 3|Lost to Follow-up|0|||
170537378|NCT03765073|616311557|FG005|Stage 3|Lost to Follow-up|0|||
170537379|NCT03765073|616311558|FG006|Stage 3|Lost to Follow-up|0|||
170537380|NCT03765073|616311559|FG007|Stage 3|Lost to Follow-up|0|||
170537381|NCT03765073|616311560|FG008|Stage 3|Lost to Follow-up|0|||
170537382|NCT03765073|616311561|FG009|Stage 3|Lost to Follow-up|0|||
170537383|NCT03765073|616311562|FG010|Stage 3|Lost to Follow-up|0|||
170537384|NCT03765073|616311563|FG011|Stage 3|Lost to Follow-up|0|||
170537385|NCT03765073|616311564|FG012|Stage 3|Lost to Follow-up|0|||
170537386|NCT03765073|616311565|FG013|Stage 3|Lost to Follow-up|0|||
170537387|NCT03765073|616311566|FG014|Stage 3|Lost to Follow-up|0|||
170537388|NCT03765073|616311567|FG015|Stage 3|Lost to Follow-up|0|||
170537389|NCT03765073|616311568|FG016|Stage 3|Lost to Follow-up|0|||
170537390|NCT03765073|616311569|FG017|Stage 3|Lost to Follow-up|8|||
170537391|NCT03765073|616311570|FG018|Stage 3|Lost to Follow-up|5|||
170537392|NCT03765073|616311571|FG019|Stage 3|Lost to Follow-up|7|||
170537393|NCT03765073|616311572|FG020|Stage 3|Lost to Follow-up|4|||
170537394|NCT03765073|616311552|FG000|Stage 3|No longer meets eligibility criteria|0|||
170440815|NCT00826241|615953200|FG000|Overall Study|Withdrew consent|2|||
170537395|NCT03765073|616311553|FG001|Stage 3|No longer meets eligibility criteria|0|||
170537396|NCT03765073|616311554|FG002|Stage 3|No longer meets eligibility criteria|0|||
170537397|NCT03765073|616311555|FG003|Stage 3|No longer meets eligibility criteria|0|||
170440816|NCT00826241|615953200|FG000|Overall Study|Death|4|||
170440817|NCT00826241|615953200|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
170440818|NCT00826241|615953200|FG000|Overall Study|Non-compliance|1|||
170440819|NCT00826241|615953200|FG000|Overall Study|Progression of disease|1|||
170440820|NCT00826241|615953200|FG000|Overall Study|Patient refused follow-up|3|||
170440821|NCT00826241|615953200|FG000|Overall Study|Lost to Follow-up|9|||
170440822|NCT00826241|615953200|FG000|Overall Study|Could not obtain records|1|||
170440823|NCT00826241|615953200|FG000|Overall Study|Screen failure|2|||
170440824|NCT00826241|615953200|FG000|Overall Study|Pt unable to proceed to registration|1|||
170440825|NCT00826241|615953200|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
170440826|NCT03407729|615953201|FG000|Overall Study|Lost to Follow-up|2|||
170440827|NCT03407729|615953202|FG001|Overall Study|Lost to Follow-up|0|||
170440828|NCT03407729|615953201|FG000|Overall Study|Unable to schedule|0|||
170440829|NCT03407729|615953202|FG001|Overall Study|Unable to schedule|3|||
170440830|NCT01849458|615953203|FG000|Overall Study|Lost to Follow-up|4|||
170440831|NCT00024258|615953204|FG000|Overall Study|Withdrawal by Subject|1|||
170440832|NCT00024258|615953204|FG000|Overall Study|Disease Progression|8|||
170440833|NCT03833427|615953207|FG000|Overall Study|Death|4|||
170440834|NCT03833427|615953208|FG001|Overall Study|Death|2|||
170440835|NCT03833427|615953209|FG002|Overall Study|Death|9|||
170440836|NCT03833427|615953210|FG003|Overall Study|Death|11|||
170440837|NCT03833427|615953211|FG004|Overall Study|Death|0|||
170440838|NCT03833427|615953212|FG005|Overall Study|Death|0|||
170440839|NCT03833427|615953213|FG006|Overall Study|Death|0|||
170440840|NCT03833427|615953207|FG000|Overall Study|Withdrawal by Subject|0|||
170440841|NCT03833427|615953208|FG001|Overall Study|Withdrawal by Subject|1|||
170440842|NCT03833427|615953209|FG002|Overall Study|Withdrawal by Subject|1|||
170440843|NCT03833427|615953210|FG003|Overall Study|Withdrawal by Subject|0|||
170440844|NCT03833427|615953211|FG004|Overall Study|Withdrawal by Subject|0|||
170440845|NCT03833427|615953212|FG005|Overall Study|Withdrawal by Subject|0|||
170440846|NCT03833427|615953213|FG006|Overall Study|Withdrawal by Subject|0|||
170440847|NCT03833427|615953207|FG000|Overall Study|Sponsor Decision|0|||
170440848|NCT03833427|615953208|FG001|Overall Study|Sponsor Decision|0|||
170440849|NCT03833427|615953209|FG002|Overall Study|Sponsor Decision|1|||
170440850|NCT03833427|615953210|FG003|Overall Study|Sponsor Decision|3|||
170440851|NCT03833427|615953211|FG004|Overall Study|Sponsor Decision|0|||
170440852|NCT03833427|615953212|FG005|Overall Study|Sponsor Decision|0|||
170537398|NCT03765073|616311556|FG004|Stage 3|No longer meets eligibility criteria|0|||
170537399|NCT03765073|616311557|FG005|Stage 3|No longer meets eligibility criteria|0|||
170440853|NCT03833427|615953213|FG006|Overall Study|Sponsor Decision|0|||
170440854|NCT03448692|615953214|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
170440855|NCT03448692|615953215|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
170440856|NCT03448692|615953214|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
170440857|NCT03448692|615953215|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
170885634|NCT05048719|617590090|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
170885635|NCT05048719|617590091|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
170885636|NCT05048719|617590092|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
170885637|NCT05048719|617590093|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
170885638|NCT05048719|617590094|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
170885639|NCT05048719|617590095|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
170885640|NCT05048719|617590096|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
170885641|NCT05048719|617590097|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
170885642|NCT05048719|617590098|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
170885643|NCT04541004|617590099|FG000|Overall Study|Adverse Event|2|||
170885644|NCT00264004|617590100|FG000|Overall Study|Adverse Event|2|||
170885645|NCT00264004|617590101|FG001|Overall Study|Adverse Event|3|||
170885646|NCT00264004|617590102|FG002|Overall Study|Adverse Event|6|||
170885647|NCT00264004|617590103|FG003|Overall Study|Adverse Event|4|||
170885648|NCT00264004|617590100|FG000|Overall Study|Withdrawal by Subject|0|||
170885649|NCT00264004|617590101|FG001|Overall Study|Withdrawal by Subject|1|||
170885650|NCT00264004|617590102|FG002|Overall Study|Withdrawal by Subject|2|||
170885651|NCT00264004|617590103|FG003|Overall Study|Withdrawal by Subject|2|||
170885652|NCT00264004|617590100|FG000|Overall Study|Other|2|||
170885653|NCT00264004|617590101|FG001|Overall Study|Other|2|||
170885654|NCT00264004|617590102|FG002|Overall Study|Other|0|||
170885655|NCT00264004|617590103|FG003|Overall Study|Other|3|||
170885656|NCT00264004|617590100|FG000|Overall Study|Development study specific disc. crit.|1|||
170440858|NCT03448692|615953214|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
170440859|NCT03448692|615953215|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
170440860|NCT03448692|615953214|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
170440861|NCT03448692|615953215|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
170440862|NCT03448692|615953214|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
170440863|NCT03448692|615953215|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
170440864|NCT00982228|615953218|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
170440865|NCT00982228|615953219|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
170440866|NCT00982228|615953218|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
170440867|NCT00982228|615953219|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
170440868|NCT00982228|615953218|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
170440869|NCT00982228|615953219|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
170440870|NCT00982228|615953218|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
170440871|NCT00982228|615953219|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
170440872|NCT00982228|615953218|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
170440873|NCT00982228|615953219|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
170440874|NCT00982228|615953218|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
170440875|NCT00982228|615953219|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
170440876|NCT00982228|615953218|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
170440877|NCT00982228|615953219|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
170440878|NCT00982228|615953218|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
170440879|NCT00982228|615953219|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
170440880|NCT00982228|615953218|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
170440881|NCT00982228|615953219|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
170440882|NCT00982228|615953218|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
170440883|NCT00982228|615953219|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
170440884|NCT02005276|615953220|FG000|Overall Study|No longer interested|5|||
170440885|NCT02005276|615953221|FG001|Overall Study|No longer interested|2|||
170440886|NCT02005276|615953222|FG002|Overall Study|No longer interested|3|||
170440887|NCT02005276|615953223|FG003|Overall Study|No longer interested|3|||
170440888|NCT03919695|615953230|FG000|3-month Follow-up|Death|1|||
170440889|NCT03919695|615953231|FG001|3-month Follow-up|Death|1|||
170440890|NCT03919695|615953230|FG000|3-month Follow-up|unable to contact|0|||
170440891|NCT03919695|615953231|FG001|3-month Follow-up|unable to contact|3|||
170440892|NCT03919695|615953230|FG000|3-month Follow-up|in prison|0|||
170440893|NCT03919695|615953231|FG001|3-month Follow-up|in prison|1|||
170440894|NCT03919695|615953230|FG000|6-month Follow-up|Death|0|||
170885657|NCT00264004|617590101|FG001|Overall Study|Development study specific disc. crit.|0|||
170885658|NCT00264004|617590102|FG002|Overall Study|Development study specific disc. crit.|1|||
170440895|NCT03919695|615953231|FG001|6-month Follow-up|Death|1|||
170440896|NCT03919695|615953230|FG000|6-month Follow-up|Lost to Follow-up|1|||
170440897|NCT03919695|615953231|FG001|6-month Follow-up|Lost to Follow-up|2|||
170440898|NCT03919695|615953230|FG000|6-month Follow-up|in prison|0|||
170440899|NCT03919695|615953231|FG001|6-month Follow-up|in prison|2|||
170440900|NCT03919695|615953230|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
170537400|NCT03765073|616311558|FG006|Stage 3|No longer meets eligibility criteria|0|||
170537401|NCT03765073|616311559|FG007|Stage 3|No longer meets eligibility criteria|0|||
170537402|NCT03765073|616311560|FG008|Stage 3|No longer meets eligibility criteria|0|||
170537403|NCT03765073|616311561|FG009|Stage 3|No longer meets eligibility criteria|0|||
170537404|NCT03765073|616311562|FG010|Stage 3|No longer meets eligibility criteria|0|||
170537405|NCT03765073|616311563|FG011|Stage 3|No longer meets eligibility criteria|0|||
170537406|NCT03765073|616311564|FG012|Stage 3|No longer meets eligibility criteria|0|||
170537407|NCT03765073|616311565|FG013|Stage 3|No longer meets eligibility criteria|0|||
170537408|NCT03765073|616311566|FG014|Stage 3|No longer meets eligibility criteria|0|||
170537409|NCT03765073|616311567|FG015|Stage 3|No longer meets eligibility criteria|0|||
170537410|NCT03765073|616311568|FG016|Stage 3|No longer meets eligibility criteria|0|||
170537411|NCT03765073|616311569|FG017|Stage 3|No longer meets eligibility criteria|0|||
170537412|NCT03765073|616311570|FG018|Stage 3|No longer meets eligibility criteria|1|||
170537413|NCT03765073|616311571|FG019|Stage 3|No longer meets eligibility criteria|0|||
170537414|NCT03765073|616311572|FG020|Stage 3|No longer meets eligibility criteria|1|||
170537415|NCT03765073|616311552|FG000|Stage 3|Other|0|||
170537416|NCT03765073|616311553|FG001|Stage 3|Other|0|||
170537417|NCT03765073|616311554|FG002|Stage 3|Other|0|||
170537418|NCT03765073|616311555|FG003|Stage 3|Other|0|||
170537419|NCT03765073|616311556|FG004|Stage 3|Other|0|||
170537420|NCT03765073|616311557|FG005|Stage 3|Other|0|||
170537421|NCT03765073|616311558|FG006|Stage 3|Other|0|||
170537422|NCT03765073|616311559|FG007|Stage 3|Other|0|||
170537423|NCT03765073|616311560|FG008|Stage 3|Other|0|||
170537424|NCT03765073|616311561|FG009|Stage 3|Other|0|||
170537425|NCT03765073|616311562|FG010|Stage 3|Other|0|||
170537426|NCT03765073|616311563|FG011|Stage 3|Other|0|||
170537427|NCT03765073|616311564|FG012|Stage 3|Other|0|||
170537428|NCT03765073|616311565|FG013|Stage 3|Other|0|||
170537429|NCT03765073|616311566|FG014|Stage 3|Other|0|||
170537430|NCT03765073|616311567|FG015|Stage 3|Other|0|||
170537431|NCT03765073|616311568|FG016|Stage 3|Other|0|||
170537432|NCT03765073|616311569|FG017|Stage 3|Other|1|||
170537433|NCT03765073|616311570|FG018|Stage 3|Other|2|||
170537434|NCT03765073|616311571|FG019|Stage 3|Other|2|||
170537435|NCT03765073|616311572|FG020|Stage 3|Other|2|||
170537436|NCT03765073|616311552|FG000|Stage 3|Withdrawal by parent/guardian|0|||
170537437|NCT03765073|616311553|FG001|Stage 3|Withdrawal by parent/guardian|0|||
170537438|NCT03765073|616311554|FG002|Stage 3|Withdrawal by parent/guardian|0|||
170537439|NCT03765073|616311555|FG003|Stage 3|Withdrawal by parent/guardian|0|||
170537440|NCT03765073|616311556|FG004|Stage 3|Withdrawal by parent/guardian|0|||
170537441|NCT03765073|616311557|FG005|Stage 3|Withdrawal by parent/guardian|0|||
170537442|NCT03765073|616311558|FG006|Stage 3|Withdrawal by parent/guardian|0|||
170784128|NCT03269136|617216645|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
170784129|NCT03269136|617216646|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
170784130|NCT03269136|617216647|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
170784131|NCT03269136|617216648|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
170784132|NCT03269136|617216649|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
170784133|NCT03269136|617216650|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
170784134|NCT03269136|617216651|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
170784135|NCT03269136|617216652|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
170784136|NCT05481320|617216655|FG000|Overall Study|Withdrawal by Subject|1|||
170784137|NCT05481320|617216656|FG001|Overall Study|Withdrawal by Subject|1|||
170784138|NCT05481320|617216655|FG000|Overall Study|Care recipent passed away|0|||
170784139|NCT05481320|617216656|FG001|Overall Study|Care recipent passed away|1|||
170784140|NCT05481320|617216655|FG000|Overall Study|Out-of-window assessment|0|||
170784141|NCT05481320|617216656|FG001|Overall Study|Out-of-window assessment|1|||
170784142|NCT05481320|617216655|FG000|Overall Study|No longer a primary caregiver|3|||
170784143|NCT05481320|617216656|FG001|Overall Study|No longer a primary caregiver|0|||
170784144|NCT05481320|617216655|FG000|Overall Study|Unable to contact|1|||
170784145|NCT05481320|617216656|FG001|Overall Study|Unable to contact|0|||
170784146|NCT02874534|617216661|FG000|Overall Study|Withdrawal by Subject|5|||
170784147|NCT02874534|617216662|FG001|Overall Study|Withdrawal by Subject|8|||
170537443|NCT03765073|616311559|FG007|Stage 3|Withdrawal by parent/guardian|0|||
170537444|NCT03765073|616311560|FG008|Stage 3|Withdrawal by parent/guardian|0|||
170784148|NCT02874534|617216661|FG000|Overall Study|Lost to Follow-up|2|||
170784149|NCT02874534|617216662|FG001|Overall Study|Lost to Follow-up|2|||
170784150|NCT02874534|617216661|FG000|Overall Study|Ongoing in study|1|||
170784151|NCT02874534|617216662|FG001|Overall Study|Ongoing in study|1|||
170537445|NCT03765073|616311561|FG009|Stage 3|Withdrawal by parent/guardian|0|||
170537446|NCT03765073|616311562|FG010|Stage 3|Withdrawal by parent/guardian|0|||
170537447|NCT03765073|616311563|FG011|Stage 3|Withdrawal by parent/guardian|0|||
170537448|NCT03765073|616311564|FG012|Stage 3|Withdrawal by parent/guardian|0|||
170537449|NCT03765073|616311565|FG013|Stage 3|Withdrawal by parent/guardian|0|||
170537450|NCT03765073|616311566|FG014|Stage 3|Withdrawal by parent/guardian|0|||
170537451|NCT03765073|616311567|FG015|Stage 3|Withdrawal by parent/guardian|0|||
170537452|NCT03765073|616311568|FG016|Stage 3|Withdrawal by parent/guardian|0|||
170784152|NCT04116736|617216663|FG000|Overall Study|Withdrew consent during study|3|||
170537453|NCT03765073|616311569|FG017|Stage 3|Withdrawal by parent/guardian|0|||
170537454|NCT03765073|616311570|FG018|Stage 3|Withdrawal by parent/guardian|0|||
170440901|NCT03919695|615953231|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
170440902|NCT03919695|615953230|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
170440903|NCT03919695|615953231|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
170440904|NCT04291508|615953232|FG000|Overall Study|Withdrawal by Subject|1|||
170440905|NCT04291508|615953233|FG001|Overall Study|Withdrawal by Subject|0|||
170440906|NCT04291508|615953234|FG002|Overall Study|Withdrawal by Subject|1|||
170440907|NCT04291508|615953235|FG003|Overall Study|Withdrawal by Subject|0|||
170537455|NCT03765073|616311571|FG019|Stage 3|Withdrawal by parent/guardian|6|||
170537456|NCT03765073|616311572|FG020|Stage 3|Withdrawal by parent/guardian|9|||
170537457|NCT03765073|616311552|FG000|Stage 3|Withdrawal by Subject|0|||
170537458|NCT03765073|616311553|FG001|Stage 3|Withdrawal by Subject|0|||
170537459|NCT03765073|616311554|FG002|Stage 3|Withdrawal by Subject|0|||
170537460|NCT03765073|616311555|FG003|Stage 3|Withdrawal by Subject|0|||
170537461|NCT03765073|616311556|FG004|Stage 3|Withdrawal by Subject|0|||
170537462|NCT03765073|616311557|FG005|Stage 3|Withdrawal by Subject|0|||
170537463|NCT03765073|616311558|FG006|Stage 3|Withdrawal by Subject|0|||
170537464|NCT03765073|616311559|FG007|Stage 3|Withdrawal by Subject|0|||
170537465|NCT03765073|616311560|FG008|Stage 3|Withdrawal by Subject|0|||
170537466|NCT03765073|616311561|FG009|Stage 3|Withdrawal by Subject|0|||
170537467|NCT03765073|616311562|FG010|Stage 3|Withdrawal by Subject|0|||
170537468|NCT03765073|616311563|FG011|Stage 3|Withdrawal by Subject|0|||
170537469|NCT03765073|616311564|FG012|Stage 3|Withdrawal by Subject|0|||
170537470|NCT03765073|616311565|FG013|Stage 3|Withdrawal by Subject|0|||
170537471|NCT03765073|616311566|FG014|Stage 3|Withdrawal by Subject|0|||
170537472|NCT03765073|616311567|FG015|Stage 3|Withdrawal by Subject|0|||
170537473|NCT03765073|616311568|FG016|Stage 3|Withdrawal by Subject|0|||
170537474|NCT03765073|616311569|FG017|Stage 3|Withdrawal by Subject|8|||
170537475|NCT03765073|616311570|FG018|Stage 3|Withdrawal by Subject|11|||
170537476|NCT03765073|616311571|FG019|Stage 3|Withdrawal by Subject|0|||
170537477|NCT03765073|616311572|FG020|Stage 3|Withdrawal by Subject|0|||
170537478|NCT03629431|616311573|FG000|Overall Study|Withdrawal by Subject|5|||
170537479|NCT03629431|616311574|FG001|Overall Study|Withdrawal by Subject|8|||
170537480|NCT01925794|616311579|FG000|180 Days|Death|2|||
170537481|NCT01925794|616311579|FG000|180 Days|Withdrawal by Subject|2|||
170537482|NCT01925794|616311579|FG000|270 Days|Death|2|||
170537483|NCT01925794|616311579|FG000|270 Days|Protocol Violation|3|||
170537484|NCT05468853|616311580|FG000|Overall Study|Lost to Follow-up|2|||
170537485|NCT05468853|616311581|FG001|Overall Study|Lost to Follow-up|0|||
170537486|NCT05468853|616311580|FG000|Overall Study|Withdrawal by Subject|0|||
170537487|NCT05468853|616311581|FG001|Overall Study|Withdrawal by Subject|1|||
170537488|NCT05468853|616311580|FG000|Overall Study|incidental MRI finding|1|||
170537489|NCT05468853|616311581|FG001|Overall Study|incidental MRI finding|2|||
170537490|NCT05468853|616311580|FG000|Overall Study|could not tolerate rmPFC-iTBS|3|||
170537491|NCT05468853|616311581|FG001|Overall Study|could not tolerate rmPFC-iTBS|2|||
170537492|NCT05468853|616311580|FG000|Overall Study|illness|1|||
170537493|NCT05468853|616311581|FG001|Overall Study|illness|1|||
170537494|NCT03126110|616311585|FG000|Phase 1|Death|2|||
170537495|NCT03126110|616311586|FG001|Phase 1|Death|2|||
170537496|NCT03126110|616311587|FG002|Phase 1|Death|4|||
170537497|NCT03126110|616311588|FG003|Phase 1|Death|3|||
170537498|NCT03126110|616311589|FG004|Phase 1|Death|4|||
170537499|NCT03126110|616311590|FG005|Phase 1|Death|4|||
170537500|NCT03126110|616311591|FG006|Phase 1|Death|3|||
170537501|NCT03126110|616311592|FG007|Phase 1|Death|4|||
170537502|NCT03126110|616311593|FG008|Phase 1|Death|5|||
170537503|NCT03126110|616311594|FG009|Phase 1|Death|2|||
170537504|NCT03126110|616311595|FG010|Phase 1|Death|6|||
170784153|NCT04116736|617216664|FG001|Overall Study|Withdrew consent during study|1|||
170784154|NCT04116736|617216663|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
170784155|NCT04116736|617216664|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
170784156|NCT04116736|617216663|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
170784157|NCT04116736|617216664|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
170784158|NCT04116736|617216663|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
170440908|NCT04291508|615953232|FG000|Overall Study|lost to follow up|4|||
170537505|NCT03126110|616311596|FG011|Phase 1|Death|0|||
170537506|NCT03126110|616311597|FG012|Phase 1|Death|0|||
170537507|NCT03126110|616311598|FG013|Phase 1|Death|0|||
170537508|NCT03126110|616311599|FG014|Phase 1|Death|0|||
170537509|NCT03126110|616311600|FG015|Phase 1|Death|0|||
170537510|NCT03126110|616311601|FG016|Phase 1|Death|0|||
170537511|NCT03126110|616311585|FG000|Phase 1|Lost to Follow-up|0|||
170784159|NCT04116736|617216664|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
170906122|NCT01097044|617658625|FG000|Overall Study|Lost to Follow-up|1|||
170440909|NCT04291508|615953233|FG001|Overall Study|lost to follow up|0|||
170537512|NCT03126110|616311586|FG001|Phase 1|Lost to Follow-up|1|||
170537513|NCT03126110|616311587|FG002|Phase 1|Lost to Follow-up|0|||
170537514|NCT03126110|616311588|FG003|Phase 1|Lost to Follow-up|0|||
170537515|NCT03126110|616311589|FG004|Phase 1|Lost to Follow-up|0|||
170537516|NCT03126110|616311590|FG005|Phase 1|Lost to Follow-up|0|||
170537517|NCT03126110|616311591|FG006|Phase 1|Lost to Follow-up|0|||
170537518|NCT03126110|616311592|FG007|Phase 1|Lost to Follow-up|0|||
170537519|NCT03126110|616311593|FG008|Phase 1|Lost to Follow-up|1|||
170537520|NCT03126110|616311594|FG009|Phase 1|Lost to Follow-up|0|||
170537521|NCT03126110|616311595|FG010|Phase 1|Lost to Follow-up|0|||
170537522|NCT03126110|616311596|FG011|Phase 1|Lost to Follow-up|0|||
170537523|NCT03126110|616311597|FG012|Phase 1|Lost to Follow-up|0|||
170537524|NCT03126110|616311598|FG013|Phase 1|Lost to Follow-up|0|||
170537525|NCT03126110|616311599|FG014|Phase 1|Lost to Follow-up|0|||
170537526|NCT03126110|616311600|FG015|Phase 1|Lost to Follow-up|0|||
170537527|NCT03126110|616311601|FG016|Phase 1|Lost to Follow-up|0|||
170537528|NCT03126110|616311585|FG000|Phase 1|Withdrawal by Subject|1|||
170537529|NCT03126110|616311586|FG001|Phase 1|Withdrawal by Subject|0|||
170537530|NCT03126110|616311587|FG002|Phase 1|Withdrawal by Subject|0|||
170537531|NCT03126110|616311588|FG003|Phase 1|Withdrawal by Subject|1|||
170537532|NCT03126110|616311589|FG004|Phase 1|Withdrawal by Subject|1|||
170537533|NCT03126110|616311590|FG005|Phase 1|Withdrawal by Subject|0|||
170537534|NCT03126110|616311591|FG006|Phase 1|Withdrawal by Subject|0|||
170537535|NCT03126110|616311592|FG007|Phase 1|Withdrawal by Subject|0|||
170537536|NCT03126110|616311593|FG008|Phase 1|Withdrawal by Subject|2|||
170537537|NCT03126110|616311594|FG009|Phase 1|Withdrawal by Subject|1|||
170537538|NCT03126110|616311595|FG010|Phase 1|Withdrawal by Subject|0|||
170537539|NCT03126110|616311596|FG011|Phase 1|Withdrawal by Subject|0|||
170537540|NCT03126110|616311597|FG012|Phase 1|Withdrawal by Subject|0|||
170537541|NCT03126110|616311598|FG013|Phase 1|Withdrawal by Subject|0|||
170537542|NCT03126110|616311599|FG014|Phase 1|Withdrawal by Subject|0|||
170537543|NCT03126110|616311600|FG015|Phase 1|Withdrawal by Subject|0|||
170537544|NCT03126110|616311601|FG016|Phase 1|Withdrawal by Subject|0|||
170537545|NCT03126110|616311585|FG000|Phase 1|Safety follow-up no longer necessary|1|||
170537546|NCT03126110|616311586|FG001|Phase 1|Safety follow-up no longer necessary|0|||
170537547|NCT03126110|616311587|FG002|Phase 1|Safety follow-up no longer necessary|0|||
170537548|NCT03126110|616311588|FG003|Phase 1|Safety follow-up no longer necessary|0|||
170537549|NCT03126110|616311589|FG004|Phase 1|Safety follow-up no longer necessary|0|||
170537550|NCT03126110|616311590|FG005|Phase 1|Safety follow-up no longer necessary|0|||
170537551|NCT03126110|616311591|FG006|Phase 1|Safety follow-up no longer necessary|0|||
170537552|NCT03126110|616311592|FG007|Phase 1|Safety follow-up no longer necessary|0|||
170537553|NCT03126110|616311593|FG008|Phase 1|Safety follow-up no longer necessary|0|||
170537554|NCT03126110|616311594|FG009|Phase 1|Safety follow-up no longer necessary|0|||
170537555|NCT03126110|616311595|FG010|Phase 1|Safety follow-up no longer necessary|0|||
170537556|NCT03126110|616311596|FG011|Phase 1|Safety follow-up no longer necessary|0|||
170537557|NCT03126110|616311597|FG012|Phase 1|Safety follow-up no longer necessary|0|||
170537558|NCT03126110|616311598|FG013|Phase 1|Safety follow-up no longer necessary|0|||
170537559|NCT03126110|616311599|FG014|Phase 1|Safety follow-up no longer necessary|0|||
170537560|NCT03126110|616311600|FG015|Phase 1|Safety follow-up no longer necessary|0|||
170537561|NCT03126110|616311601|FG016|Phase 1|Safety follow-up no longer necessary|0|||
170537562|NCT03126110|616311585|FG000|Phase 1|Survival follow-up no longer necessary|0|||
170537563|NCT03126110|616311586|FG001|Phase 1|Survival follow-up no longer necessary|0|||
170537564|NCT03126110|616311587|FG002|Phase 1|Survival follow-up no longer necessary|1|||
170537565|NCT03126110|616311588|FG003|Phase 1|Survival follow-up no longer necessary|0|||
170537566|NCT03126110|616311589|FG004|Phase 1|Survival follow-up no longer necessary|0|||
170537567|NCT03126110|616311590|FG005|Phase 1|Survival follow-up no longer necessary|0|||
170537568|NCT03126110|616311591|FG006|Phase 1|Survival follow-up no longer necessary|0|||
170537569|NCT03126110|616311592|FG007|Phase 1|Survival follow-up no longer necessary|0|||
170537570|NCT03126110|616311593|FG008|Phase 1|Survival follow-up no longer necessary|0|||
170537571|NCT03126110|616311594|FG009|Phase 1|Survival follow-up no longer necessary|0|||
170537572|NCT03126110|616311595|FG010|Phase 1|Survival follow-up no longer necessary|0|||
170537573|NCT03126110|616311596|FG011|Phase 1|Survival follow-up no longer necessary|0|||
170537574|NCT03126110|616311597|FG012|Phase 1|Survival follow-up no longer necessary|0|||
170537575|NCT03126110|616311598|FG013|Phase 1|Survival follow-up no longer necessary|0|||
170537576|NCT03126110|616311599|FG014|Phase 1|Survival follow-up no longer necessary|0|||
170537577|NCT03126110|616311600|FG015|Phase 1|Survival follow-up no longer necessary|0|||
170537578|NCT03126110|616311601|FG016|Phase 1|Survival follow-up no longer necessary|0|||
170537579|NCT03126110|616311585|FG000|Phase 2|Study terminated by the sponsor|0|||
170537580|NCT03126110|616311586|FG001|Phase 2|Study terminated by the sponsor|0|||
170537581|NCT03126110|616311587|FG002|Phase 2|Study terminated by the sponsor|0|||
170537582|NCT03126110|616311588|FG003|Phase 2|Study terminated by the sponsor|0|||
170784160|NCT04116736|617216663|FG000|Overall Study|Subject was enrolled in error|2|||
170784161|NCT04116736|617216664|FG001|Overall Study|Subject was enrolled in error|0|||
170784162|NCT04116736|617216663|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
170784163|NCT04116736|617216664|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
170784164|NCT04116736|617216663|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
170784165|NCT04116736|617216664|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
170784166|NCT04116736|617216663|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
170784167|NCT04116736|617216664|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
170537583|NCT03126110|616311589|FG004|Phase 2|Study terminated by the sponsor|0|||
170537584|NCT03126110|616311590|FG005|Phase 2|Study terminated by the sponsor|0|||
170537585|NCT03126110|616311591|FG006|Phase 2|Study terminated by the sponsor|0|||
170537586|NCT03126110|616311592|FG007|Phase 2|Study terminated by the sponsor|0|||
170537587|NCT03126110|616311593|FG008|Phase 2|Study terminated by the sponsor|0|||
170537588|NCT03126110|616311594|FG009|Phase 2|Study terminated by the sponsor|0|||
170537589|NCT03126110|616311595|FG010|Phase 2|Study terminated by the sponsor|0|||
170537590|NCT03126110|616311596|FG011|Phase 2|Study terminated by the sponsor|0|||
170537591|NCT03126110|616311597|FG012|Phase 2|Study terminated by the sponsor|0|||
170537592|NCT03126110|616311598|FG013|Phase 2|Study terminated by the sponsor|4|||
170537593|NCT03126110|616311599|FG014|Phase 2|Study terminated by the sponsor|0|||
170537594|NCT03126110|616311600|FG015|Phase 2|Study terminated by the sponsor|0|||
170537595|NCT03126110|616311601|FG016|Phase 2|Study terminated by the sponsor|0|||
170537596|NCT03126110|616311585|FG000|Phase 2|Withdrawal by Subject|0|||
170537597|NCT03126110|616311586|FG001|Phase 2|Withdrawal by Subject|0|||
170537598|NCT03126110|616311587|FG002|Phase 2|Withdrawal by Subject|0|||
170537599|NCT03126110|616311588|FG003|Phase 2|Withdrawal by Subject|0|||
170537600|NCT03126110|616311589|FG004|Phase 2|Withdrawal by Subject|0|||
170537601|NCT03126110|616311590|FG005|Phase 2|Withdrawal by Subject|0|||
170537602|NCT03126110|616311591|FG006|Phase 2|Withdrawal by Subject|0|||
170537603|NCT03126110|616311592|FG007|Phase 2|Withdrawal by Subject|0|||
170537604|NCT03126110|616311593|FG008|Phase 2|Withdrawal by Subject|0|||
170537605|NCT03126110|616311594|FG009|Phase 2|Withdrawal by Subject|0|||
170537606|NCT03126110|616311595|FG010|Phase 2|Withdrawal by Subject|0|||
170537607|NCT03126110|616311596|FG011|Phase 2|Withdrawal by Subject|1|||
170537608|NCT03126110|616311597|FG012|Phase 2|Withdrawal by Subject|3|||
170537609|NCT03126110|616311598|FG013|Phase 2|Withdrawal by Subject|3|||
170537610|NCT03126110|616311599|FG014|Phase 2|Withdrawal by Subject|2|||
170537611|NCT03126110|616311600|FG015|Phase 2|Withdrawal by Subject|1|||
170537612|NCT03126110|616311601|FG016|Phase 2|Withdrawal by Subject|0|||
170537613|NCT03126110|616311585|FG000|Phase 2|Lost to Follow-up|0|||
170537614|NCT03126110|616311586|FG001|Phase 2|Lost to Follow-up|0|||
170537615|NCT03126110|616311587|FG002|Phase 2|Lost to Follow-up|0|||
170537616|NCT03126110|616311588|FG003|Phase 2|Lost to Follow-up|0|||
170537617|NCT03126110|616311589|FG004|Phase 2|Lost to Follow-up|0|||
170537618|NCT03126110|616311590|FG005|Phase 2|Lost to Follow-up|0|||
170537619|NCT03126110|616311591|FG006|Phase 2|Lost to Follow-up|0|||
170537620|NCT03126110|616311592|FG007|Phase 2|Lost to Follow-up|0|||
170537621|NCT03126110|616311593|FG008|Phase 2|Lost to Follow-up|0|||
170537622|NCT03126110|616311594|FG009|Phase 2|Lost to Follow-up|0|||
170537623|NCT03126110|616311595|FG010|Phase 2|Lost to Follow-up|0|||
170537624|NCT03126110|616311596|FG011|Phase 2|Lost to Follow-up|1|||
170537625|NCT03126110|616311597|FG012|Phase 2|Lost to Follow-up|1|||
170537626|NCT03126110|616311598|FG013|Phase 2|Lost to Follow-up|1|||
170537627|NCT03126110|616311599|FG014|Phase 2|Lost to Follow-up|2|||
170537628|NCT03126110|616311600|FG015|Phase 2|Lost to Follow-up|0|||
170537629|NCT03126110|616311601|FG016|Phase 2|Lost to Follow-up|0|||
170537630|NCT03126110|616311585|FG000|Phase 2|Death|0|||
170537631|NCT03126110|616311586|FG001|Phase 2|Death|0|||
170537632|NCT03126110|616311587|FG002|Phase 2|Death|0|||
170537633|NCT03126110|616311588|FG003|Phase 2|Death|0|||
170537634|NCT03126110|616311589|FG004|Phase 2|Death|0|||
170537635|NCT03126110|616311590|FG005|Phase 2|Death|0|||
170537636|NCT03126110|616311591|FG006|Phase 2|Death|0|||
170537637|NCT03126110|616311592|FG007|Phase 2|Death|0|||
170537638|NCT03126110|616311593|FG008|Phase 2|Death|0|||
170537639|NCT03126110|616311594|FG009|Phase 2|Death|0|||
170537640|NCT03126110|616311595|FG010|Phase 2|Death|0|||
170537641|NCT03126110|616311596|FG011|Phase 2|Death|6|||
170537642|NCT03126110|616311597|FG012|Phase 2|Death|12|||
170784168|NCT04093752|617216669|FG000|Overall Study|Adverse Event|7|||
170784169|NCT04093752|617216670|FG001|Overall Study|Adverse Event|19|||
170537643|NCT03126110|616311598|FG013|Phase 2|Death|25|||
170537644|NCT03126110|616311599|FG014|Phase 2|Death|11|||
170537645|NCT03126110|616311600|FG015|Phase 2|Death|3|||
170537646|NCT03126110|616311601|FG016|Phase 2|Death|2|||
170537647|NCT03126110|616311585|FG000|Phase 2|Progressive Disease|0|||
170537648|NCT03126110|616311586|FG001|Phase 2|Progressive Disease|0|||
170537649|NCT03126110|616311587|FG002|Phase 2|Progressive Disease|0|||
170537650|NCT03126110|616311588|FG003|Phase 2|Progressive Disease|0|||
170537651|NCT03126110|616311589|FG004|Phase 2|Progressive Disease|0|||
170537652|NCT03126110|616311590|FG005|Phase 2|Progressive Disease|0|||
170537653|NCT03126110|616311591|FG006|Phase 2|Progressive Disease|0|||
170537654|NCT03126110|616311592|FG007|Phase 2|Progressive Disease|0|||
170784170|NCT04093752|617216671|FG002|Overall Study|Adverse Event|18|||
170784171|NCT04093752|617216672|FG003|Overall Study|Adverse Event|4|||
170784172|NCT04093752|617216669|FG000|Overall Study|Withdrawal by Subject|6|||
170537655|NCT03126110|616311593|FG008|Phase 2|Progressive Disease|0|||
170537656|NCT03126110|616311594|FG009|Phase 2|Progressive Disease|0|||
170537657|NCT03126110|616311595|FG010|Phase 2|Progressive Disease|0|||
170537658|NCT03126110|616311596|FG011|Phase 2|Progressive Disease|0|||
170537659|NCT03126110|616311597|FG012|Phase 2|Progressive Disease|0|||
170537660|NCT03126110|616311598|FG013|Phase 2|Progressive Disease|1|||
170537661|NCT03126110|616311599|FG014|Phase 2|Progressive Disease|0|||
170784173|NCT04093752|617216670|FG001|Overall Study|Withdrawal by Subject|6|||
170537662|NCT03126110|616311600|FG015|Phase 2|Progressive Disease|0|||
170537663|NCT03126110|616311601|FG016|Phase 2|Progressive Disease|0|||
170537664|NCT03126110|616311585|FG000|Phase 2|Started new treatment|0|||
170537665|NCT03126110|616311586|FG001|Phase 2|Started new treatment|0|||
170537666|NCT03126110|616311587|FG002|Phase 2|Started new treatment|0|||
170537667|NCT03126110|616311588|FG003|Phase 2|Started new treatment|0|||
170537668|NCT03126110|616311589|FG004|Phase 2|Started new treatment|0|||
170537669|NCT03126110|616311590|FG005|Phase 2|Started new treatment|0|||
170537670|NCT03126110|616311591|FG006|Phase 2|Started new treatment|0|||
170537671|NCT03126110|616311592|FG007|Phase 2|Started new treatment|0|||
170537672|NCT03126110|616311593|FG008|Phase 2|Started new treatment|0|||
170537673|NCT03126110|616311594|FG009|Phase 2|Started new treatment|0|||
170537674|NCT03126110|616311595|FG010|Phase 2|Started new treatment|0|||
170537675|NCT03126110|616311596|FG011|Phase 2|Started new treatment|0|||
170537676|NCT03126110|616311597|FG012|Phase 2|Started new treatment|0|||
170537677|NCT03126110|616311598|FG013|Phase 2|Started new treatment|0|||
170537678|NCT03126110|616311599|FG014|Phase 2|Started new treatment|1|||
170537679|NCT03126110|616311600|FG015|Phase 2|Started new treatment|0|||
170537680|NCT03126110|616311601|FG016|Phase 2|Started new treatment|0|||
170537681|NCT04435626|616311602|FG000|Overall Study|Lost to Follow-up|1|||
170537682|NCT04435626|616311603|FG001|Overall Study|Lost to Follow-up|5|||
170537683|NCT04435626|616311602|FG000|Overall Study|Withdrawal by Subject|6|||
170537684|NCT04435626|616311603|FG001|Overall Study|Withdrawal by Subject|7|||
170537685|NCT04435626|616311602|FG000|Overall Study|major GCP violations|8|||
170537686|NCT04435626|616311603|FG001|Overall Study|major GCP violations|7|||
170537687|NCT05140499|616311605|FG000|Overall Study|Lost to Follow-up|1|||
170537688|NCT05140499|616311606|FG001|Overall Study|Lost to Follow-up|2|||
170537689|NCT02427451|616311607|FG000|Overall Study|Adverse Event|0|||
170537690|NCT02427451|616311608|FG001|Overall Study|Adverse Event|0|||
170537691|NCT02427451|616311609|FG002|Overall Study|Adverse Event|0|||
170537692|NCT02427451|616311610|FG003|Overall Study|Adverse Event|1|||
170537693|NCT02427451|616311611|FG004|Overall Study|Adverse Event|2|||
170537694|NCT02427451|616311612|FG005|Overall Study|Adverse Event|1|||
170537695|NCT02427451|616311607|FG000|Overall Study|Physician Decision|0|||
170537696|NCT02427451|616311608|FG001|Overall Study|Physician Decision|0|||
170537697|NCT02427451|616311609|FG002|Overall Study|Physician Decision|0|||
170537698|NCT02427451|616311610|FG003|Overall Study|Physician Decision|2|||
170537699|NCT02427451|616311611|FG004|Overall Study|Physician Decision|2|||
170537700|NCT02427451|616311612|FG005|Overall Study|Physician Decision|0|||
170537701|NCT03636477|616311613|FG000|Overall Study|Adverse Event|0|||
170537702|NCT03636477|616311614|FG001|Overall Study|Adverse Event|0|||
170537703|NCT03636477|616311615|FG002|Overall Study|Adverse Event|1|||
170537704|NCT05764265|616311616|FG000|Overall Study|Adverse Event|1|||
170537705|NCT05764265|616311617|FG001|Overall Study|Adverse Event|0|||
170537706|NCT05764265|616311616|FG000|Overall Study|Physician Decision|1|||
170537707|NCT05764265|616311617|FG001|Overall Study|Physician Decision|8|||
170537708|NCT05764265|616311616|FG000|Overall Study|Study Terminated By Sponsor|20|||
170537709|NCT05764265|616311617|FG001|Overall Study|Study Terminated By Sponsor|0|||
170537710|NCT05764265|616311616|FG000|Overall Study|Participant Decision|1|||
170537711|NCT05764265|616311617|FG001|Overall Study|Participant Decision|0|||
170537712|NCT04958707|616311618|FG000|Post Intervention|Withdrawal by Subject|1|||
170537713|NCT04958707|616311619|FG001|Post Intervention|Withdrawal by Subject|0|||
170537714|NCT04958707|616311620|FG002|Post Intervention|Withdrawal by Subject|0|||
170537715|NCT04958707|616311618|FG000|3 Months Follow- up|Lost to Follow-up|0|||
170537716|NCT04958707|616311619|FG001|3 Months Follow- up|Lost to Follow-up|3|||
170537717|NCT04958707|616311620|FG002|3 Months Follow- up|Lost to Follow-up|0|||
170537718|NCT04958707|616311618|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
170537719|NCT04958707|616311619|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
170537720|NCT04958707|616311620|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
170784174|NCT04093752|617216671|FG002|Overall Study|Withdrawal by Subject|8|||
170784175|NCT04093752|617216672|FG003|Overall Study|Withdrawal by Subject|20|||
170537721|NCT05625061|616311621|FG000|Overall Study|Withdrawal by Subject|4|||
170537722|NCT05625061|616311621|FG000|Overall Study|Intervention Suspended|1|||
170537723|NCT02629159|616311622|FG000|Overall Study|Adverse Event|17|||
170537724|NCT02629159|616311623|FG001|Overall Study|Adverse Event|20|||
170537725|NCT02629159|616311624|FG002|Overall Study|Adverse Event|22|||
170537726|NCT02629159|616311622|FG000|Overall Study|Withdrawal by Subject|22|||
170537727|NCT02629159|616311623|FG001|Overall Study|Withdrawal by Subject|11|||
170537728|NCT02629159|616311624|FG002|Overall Study|Withdrawal by Subject|15|||
170537729|NCT02629159|616311622|FG000|Overall Study|Lost to Follow-up|7|||
170537730|NCT02629159|616311623|FG001|Overall Study|Lost to Follow-up|4|||
170537731|NCT02629159|616311624|FG002|Overall Study|Lost to Follow-up|5|||
170537732|NCT02629159|616311622|FG000|Overall Study|Lack of Efficacy|4|||
170537733|NCT02629159|616311623|FG001|Overall Study|Lack of Efficacy|0|||
170537734|NCT02629159|616311624|FG002|Overall Study|Lack of Efficacy|1|||
170537735|NCT02629159|616311622|FG000|Overall Study|Other|6|||
170537736|NCT02629159|616311623|FG001|Overall Study|Other|4|||
170440910|NCT04291508|615953234|FG002|Overall Study|lost to follow up|1|||
170440911|NCT04291508|615953235|FG003|Overall Study|lost to follow up|0|||
170440912|NCT05467540|615953239|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
170440913|NCT05467540|615953239|FG000|3-Month Follow-up|Lost to Follow-up|4|||
170440914|NCT05467540|615953239|FG000|3-Month Follow-up|Death|5|||
170537737|NCT02629159|616311624|FG002|Overall Study|Other|8|||
170537738|NCT05120843|616311626|FG000|Screening and Enrollment Phase|Not eligible on chart review|21|||
170537739|NCT05120843|616311626|FG000|Screening and Enrollment Phase|Not eligible on in-person screening|6|||
170537740|NCT05120843|616311626|FG000|Screening and Enrollment Phase|Too much going on during hospital stay|3|||
170537741|NCT05120843|616311626|FG000|Screening and Enrollment Phase|Perceived services not needed|2|||
170537742|NCT05120843|616311626|FG000|Screening and Enrollment Phase|Recently moved to the area|1|||
170537743|NCT05120843|616311626|FG000|Screening and Enrollment Phase|No reason given|3|||
170537744|NCT05120843|616311626|FG000|Intervention Phase|Lost to Follow-up|3|||
170537745|NCT04437368|616311627|FG000|Overall Study|Death|3|||
170537746|NCT04437368|616311628|FG001|Overall Study|Death|0|||
170537747|NCT04437368|616311629|FG002|Overall Study|Death|2|||
170537748|NCT04437368|616311627|FG000|Overall Study|Study terminated by sponsor|16|||
170537749|NCT04437368|616311628|FG001|Overall Study|Study terminated by sponsor|1|||
170537750|NCT04437368|616311629|FG002|Overall Study|Study terminated by sponsor|25|||
170537751|NCT04437368|616311627|FG000|Overall Study|Withdrawal by Subject|4|||
170537752|NCT04437368|616311628|FG001|Overall Study|Withdrawal by Subject|0|||
170537753|NCT04437368|616311629|FG002|Overall Study|Withdrawal by Subject|3|||
170537754|NCT04437368|616311627|FG000|Overall Study|Sponsor instructions|23|||
170537755|NCT04437368|616311628|FG001|Overall Study|Sponsor instructions|0|||
170537756|NCT04437368|616311629|FG002|Overall Study|Sponsor instructions|0|||
170537757|NCT04675814|616311630|FG000|Overall Study|Withdrawal by Subject|3|||
170537758|NCT04675814|616311630|FG000|Overall Study|Performance status alteration not related to study procedure|1|||
170537759|NCT05567172|616311631|FG000|Overall Study|Death|3|||
170537760|NCT05722015|616311632|FG000|Overall Study|Death|57|||
170537761|NCT05722015|616311633|FG001|Overall Study|Death|37|||
170537762|NCT05722015|616311632|FG000|Overall Study|Lost to Follow-up|1|||
170537763|NCT05722015|616311633|FG001|Overall Study|Lost to Follow-up|0|||
170537764|NCT05722015|616311632|FG000|Overall Study|Withdrawal by Subject|5|||
170537765|NCT05722015|616311633|FG001|Overall Study|Withdrawal by Subject|1|||
170537766|NCT05722015|616311632|FG000|Overall Study|Participants Ongoing|188|||
170537767|NCT05722015|616311633|FG001|Overall Study|Participants Ongoing|88|||
170537768|NCT02685735|616311634|FG000|Overall Study|Surgery Cancelled|4|||
170537769|NCT02685735|616311635|FG001|Overall Study|Surgery Cancelled|9|||
170537770|NCT02685735|616311634|FG000|Overall Study|Adverse Event|10|||
170537771|NCT02685735|616311635|FG001|Overall Study|Adverse Event|3|||
170537772|NCT02685735|616311634|FG000|Overall Study|Preop testing found to be incomplete|2|||
170440915|NCT05467540|615953239|FG000|12-Month Follow-up|Lost to Follow-up|6|||
170440916|NCT05467540|615953239|FG000|12-Month Follow-up|Death|8|||
170440917|NCT05467540|615953239|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
170440918|NCT04750239|615953240|FG000|Overall Study|Withdrawal by Subject|2|||
170440919|NCT04750239|615953240|FG000|Overall Study|Trial terminated by sponsor|1|||
170440920|NCT01337596|615953242|FG000|Overall Study|Withdrawal by Subject|0|||
170440921|NCT01337596|615953243|FG001|Overall Study|Withdrawal by Subject|0|||
170440922|NCT01337596|615953244|FG002|Overall Study|Withdrawal by Subject|0|||
170440923|NCT01337596|615953245|FG003|Overall Study|Withdrawal by Subject|0|||
170440924|NCT01337596|615953246|FG004|Overall Study|Withdrawal by Subject|2|||
170440925|NCT01337596|615953247|FG005|Overall Study|Withdrawal by Subject|0|||
170440926|NCT01337596|615953248|FG006|Overall Study|Withdrawal by Subject|0|||
170440927|NCT01337596|615953249|FG007|Overall Study|Withdrawal by Subject|0|||
170440928|NCT01337596|615953250|FG008|Overall Study|Withdrawal by Subject|0|||
170440929|NCT02459418|615954596|FG000|Overall Study|Exclusion Criteria|4|||
170440930|NCT02459418|615954597|FG001|Overall Study|Exclusion Criteria|0|||
170440931|NCT02459418|615954596|FG000|Overall Study|Protocol Violation|0|||
170440932|NCT02459418|615954597|FG001|Overall Study|Protocol Violation|2|||
170537773|NCT02685735|616311635|FG001|Overall Study|Preop testing found to be incomplete|2|||
170537774|NCT02685735|616311634|FG000|Overall Study|Withdrawal by Subject|1|||
170537775|NCT02685735|616311635|FG001|Overall Study|Withdrawal by Subject|2|||
170537776|NCT02685735|616311634|FG000|Overall Study|Death|1|||
170885659|NCT00264004|617590103|FG003|Overall Study|Development study specific disc. crit.|0|||
170440933|NCT02459418|615954596|FG000|Overall Study|Physician Decision|0|||
170440934|NCT02459418|615954597|FG001|Overall Study|Physician Decision|2|||
170440935|NCT02459418|615954596|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
170537777|NCT02685735|616311635|FG001|Overall Study|Death|0|||
170537778|NCT05436613|616311636|FG000|Overall Study|Lost to Follow-up|9|||
170537779|NCT05436613|616311636|FG000|Overall Study|Withdrawal by Subject|3|||
170537780|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
170537781|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
170537782|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
170537783|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
170440936|NCT02459418|615954597|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
170784176|NCT04093752|617216669|FG000|Overall Study|Lost to Follow-up|2|||
170784177|NCT04093752|617216670|FG001|Overall Study|Lost to Follow-up|1|||
170440937|NCT02459418|615954596|FG000|Overall Study|Adverse Event|0|||
170440938|NCT02459418|615954597|FG001|Overall Study|Adverse Event|1|||
170440939|NCT02459418|615954596|FG000|Overall Study|Withdrawal by Subject|1|||
170440940|NCT02459418|615954597|FG001|Overall Study|Withdrawal by Subject|1|||
170440941|NCT02459418|615954596|FG000|Overall Study|Elevated Creatine Kinase|1|||
170440942|NCT02459418|615954597|FG001|Overall Study|Elevated Creatine Kinase|0|||
170440943|NCT02459418|615954596|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
170440944|NCT02459418|615954597|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
170440945|NCT00683592|615954598|FG000|Overall Study|Adverse Event|12|||
170440946|NCT00683592|615954599|FG001|Overall Study|Adverse Event|4|||
170440947|NCT00683592|615954598|FG000|Overall Study|Withdrawal by Subject|11|||
170440948|NCT00683592|615954599|FG001|Overall Study|Withdrawal by Subject|11|||
170440949|NCT00683592|615954598|FG000|Overall Study|Lost to Follow-up|17|||
170440950|NCT00683592|615954599|FG001|Overall Study|Lost to Follow-up|17|||
170440951|NCT00683592|615954598|FG000|Overall Study|Lack of Efficacy|3|||
170440952|NCT00683592|615954599|FG001|Overall Study|Lack of Efficacy|7|||
170440953|NCT00683592|615954598|FG000|Overall Study|Physician Decision|0|||
170440954|NCT00683592|615954599|FG001|Overall Study|Physician Decision|1|||
170440955|NCT00683592|615954598|FG000|Overall Study|Non-compliance|3|||
170440956|NCT00683592|615954599|FG001|Overall Study|Non-compliance|5|||
170440957|NCT00683592|615954598|FG000|Overall Study|Other|1|||
170440958|NCT00683592|615954599|FG001|Overall Study|Other|1|||
170440959|NCT01848210|615954600|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
170440960|NCT01848210|615954601|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
170440961|NCT01848210|615954600|FG000|Overall Study|Lost to Follow-up|24|||
170440962|NCT01848210|615954601|FG001|Overall Study|Lost to Follow-up|12|||
170440963|NCT01848210|615954600|FG000|Overall Study|Protocol Violation|3|||
170440964|NCT01848210|615954601|FG001|Overall Study|Protocol Violation|5|||
170440965|NCT01848210|615954600|FG000|Overall Study|Use of Forbidden Drugs|9|||
170440966|NCT01848210|615954601|FG001|Overall Study|Use of Forbidden Drugs|10|||
170440967|NCT01848210|615954600|FG000|Overall Study|Impedition Condition|5|||
170440968|NCT01848210|615954601|FG001|Overall Study|Impedition Condition|9|||
170440969|NCT01848210|615954600|FG000|Overall Study|Adverse Event|7|||
170440970|NCT01848210|615954601|FG001|Overall Study|Adverse Event|9|||
170440971|NCT01848210|615954600|FG000|Overall Study|Discontinuation Criterion|5|||
170440972|NCT01848210|615954601|FG001|Overall Study|Discontinuation Criterion|7|||
170440973|NCT01848210|615954600|FG000|Overall Study|Hypesensitivity|1|||
170440974|NCT01848210|615954601|FG001|Overall Study|Hypesensitivity|0|||
170440975|NCT01848210|615954600|FG000|Overall Study|Hepatic Function Alteration|4|||
170440976|NCT01848210|615954601|FG001|Overall Study|Hepatic Function Alteration|0|||
170440977|NCT01848210|615954600|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
170440978|NCT01848210|615954601|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
170440979|NCT01848210|615954600|FG000|Overall Study|Administrative|1|||
170440980|NCT01848210|615954601|FG001|Overall Study|Administrative|0|||
170440981|NCT04592419|615954604|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
170440982|NCT04592419|615954605|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
170440983|NCT04592419|615954604|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
170440984|NCT04592419|615954605|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
170440985|NCT04592419|615954604|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
170440986|NCT04592419|615954605|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
170440987|NCT04592419|615954604|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
170440988|NCT04592419|615954605|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
170440989|NCT04592419|615954604|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
170440990|NCT04592419|615954605|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
170440991|NCT04592419|615954604|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
170440992|NCT04592419|615954605|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
170440993|NCT04592419|615954604|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
170440994|NCT04592419|615954605|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
170440995|NCT04592419|615954604|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
170440996|NCT04592419|615954605|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
170440997|NCT04592419|615954604|FG000|Open-Label Extension Period|Adverse Event|1|||
170440998|NCT04592419|615954605|FG001|Open-Label Extension Period|Adverse Event|2|||
170440999|NCT04592419|615954604|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
170441000|NCT04592419|615954605|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
170441001|NCT04592419|615954604|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
170441002|NCT04592419|615954605|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
170441003|NCT04592419|615954604|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
170441004|NCT04592419|615954605|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
170441005|NCT04592419|615954604|FG000|Open-Label Extension Period|Sponsor Request|73|||
170441006|NCT04592419|615954605|FG001|Open-Label Extension Period|Sponsor Request|84|||
170784178|NCT04093752|617216671|FG002|Overall Study|Lost to Follow-up|1|||
170537784|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
170537785|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
170537786|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
170537787|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
170537788|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
170537789|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
170537790|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
170537791|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
170537792|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
170537793|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
170537794|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
170537795|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
170537796|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
170537797|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
170537798|NCT01069939|616311637|FG000|Randomised and Included in the Analyses|Removal|1|||
170537799|NCT01069939|616311638|FG001|Randomised and Included in the Analyses|Removal|0|||
170537800|NCT00658528|616311639|FG000|Overall Study|Adverse Event|5|||
170537801|NCT00658528|616311640|FG001|Overall Study|Adverse Event|7|||
170537802|NCT00658528|616311639|FG000|Overall Study|Lost to Follow-up|14|||
170537803|NCT00658528|616311640|FG001|Overall Study|Lost to Follow-up|22|||
170537804|NCT00658528|616311639|FG000|Overall Study|Withdrawal by Subject|8|||
170537805|NCT00658528|616311640|FG001|Overall Study|Withdrawal by Subject|6|||
170537806|NCT00658528|616311639|FG000|Overall Study|Withdrawal of consent|5|||
170537807|NCT00658528|616311640|FG001|Overall Study|Withdrawal of consent|6|||
170537808|NCT00658528|616311639|FG000|Overall Study|Other|8|||
170537809|NCT00658528|616311640|FG001|Overall Study|Other|4|||
170537810|NCT01706328|616311649|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
170537811|NCT01706328|616311650|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
170537812|NCT01706328|616311651|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
170537813|NCT01706328|616311649|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
170537814|NCT01706328|616311650|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
170537815|NCT01706328|616311651|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
170537816|NCT01706328|616311649|FG000|2-week Run-in Period|Physician Decision|4|||
170537817|NCT01706328|616311650|FG001|2-week Run-in Period|Physician Decision|0|||
170537818|NCT01706328|616311651|FG002|2-week Run-in Period|Physician Decision|0|||
170537819|NCT01706328|616311649|FG000|2-week Run-in Period|Adverse Event|4|||
170537820|NCT01706328|616311650|FG001|2-week Run-in Period|Adverse Event|0|||
170537821|NCT01706328|616311651|FG002|2-week Run-in Period|Adverse Event|0|||
170537822|NCT01706328|616311649|FG000|2-week Run-in Period|Lost to Follow-up|2|||
170537823|NCT01706328|616311650|FG001|2-week Run-in Period|Lost to Follow-up|0|||
170537824|NCT01706328|616311651|FG002|2-week Run-in Period|Lost to Follow-up|0|||
170537825|NCT01706328|616311649|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
170537826|NCT01706328|616311650|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
170537827|NCT01706328|616311651|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
170537828|NCT01706328|616311649|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
170537829|NCT01706328|616311650|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
170537830|NCT01706328|616311651|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
170537831|NCT01706328|616311649|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
170537832|NCT01706328|616311650|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
170537833|NCT01706328|616311651|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
170537834|NCT01706328|616311649|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
170537835|NCT01706328|616311650|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
170537836|NCT01706328|616311651|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
170537837|NCT01706328|616311649|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
170537838|NCT01706328|616311650|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
170537839|NCT01706328|616311651|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
170537840|NCT01706328|616311649|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
170537841|NCT01706328|616311650|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
170885660|NCT00264004|617590100|FG000|Overall Study|Cond. under inv. worsened|9|||
170885661|NCT00264004|617590101|FG001|Overall Study|Cond. under inv. worsened|5|||
170885662|NCT00264004|617590102|FG002|Overall Study|Cond. under inv. worsened|3|||
170537842|NCT01706328|616311651|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
170537843|NCT01706328|616311649|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
170537844|NCT01706328|616311650|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
170537845|NCT01706328|616311651|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
170537846|NCT05759338|616311655|FG000|Overall Study|Withdrawal by Subject|3|||
170885663|NCT00264004|617590103|FG003|Overall Study|Cond. under inv. worsened|4|||
170537847|NCT04409002|616311656|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
170537848|NCT05414175|616311657|FG000|Overall Study|Withdrawal by Subject|1|||
170537849|NCT05414175|616311657|FG000|Overall Study|Other Reasons|1|||
170537850|NCT06481579|616311658|FG000|Overall Study|Death|1|||
170537851|NCT06481579|616311659|FG001|Overall Study|Death|0|||
170537852|NCT06481579|616311658|FG000|Overall Study|Withdrawal by Subject|3|||
170537853|NCT06481579|616311659|FG001|Overall Study|Withdrawal by Subject|0|||
170537854|NCT06481579|616311658|FG000|Overall Study|Other|1|||
170537855|NCT06481579|616311659|FG001|Overall Study|Other|1|||
170537856|NCT04611126|616311661|FG000|Overall Study|TIL expansion unsuccessful|1|||
170537857|NCT04611126|616311662|FG001|Overall Study|TIL expansion unsuccessful|0|||
170537858|NCT02952248|616311663|FG000|Overall Study|Adverse Event|0|||
170537859|NCT02952248|616311664|FG001|Overall Study|Adverse Event|0|||
170537860|NCT02952248|616311665|FG002|Overall Study|Adverse Event|0|||
170537861|NCT02952248|616311666|FG003|Overall Study|Adverse Event|1|||
170537862|NCT02952248|616311667|FG004|Overall Study|Adverse Event|0|||
170537863|NCT02952248|616311668|FG005|Overall Study|Adverse Event|3|||
170537864|NCT02952248|616311669|FG006|Overall Study|Adverse Event|2|||
170537865|NCT02952248|616311663|FG000|Overall Study|Progressive disease|3|||
170537866|NCT02952248|616311664|FG001|Overall Study|Progressive disease|3|||
170784179|NCT04093752|617216672|FG003|Overall Study|Lost to Follow-up|1|||
170441007|NCT00381849|615954608|FG000|Wash Out|Withdrawal by Subject|0|||
170441008|NCT00381849|615954609|FG001|Wash Out|Withdrawal by Subject|1|||
170441009|NCT00329160|615954612|FG000|Overall Study|Adverse Event|27|||
170441010|NCT00329160|615954612|FG000|Overall Study|Withdrawal by Subject|13|||
170441011|NCT00329160|615954612|FG000|Overall Study|Protocol Violation|2|||
170441012|NCT00329160|615954612|FG000|Overall Study|Did not Receive Study Drug|1|||
170441013|NCT00329160|615954612|FG000|Overall Study|Incomplete IVUS|45|||
170441014|NCT04501094|615954613|FG000|Overall Study|Death (unrelated to research)|1|||
170441015|NCT04501094|615954614|FG001|Overall Study|Death (unrelated to research)|0|||
170441016|NCT05212948|615954618|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
170441017|NCT05212948|615954619|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
170441018|NCT05212948|615954618|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
170441019|NCT05212948|615954619|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
170441020|NCT05212948|615954618|FG000|Initial Vaccination Period|Pregnancy|20|||
170441021|NCT05212948|615954619|FG001|Initial Vaccination Period|Pregnancy|14|||
170441022|NCT05212948|615954618|FG000|Initial Vaccination Period|Physician Decision|686|||
170441023|NCT05212948|615954619|FG001|Initial Vaccination Period|Physician Decision|401|||
170441024|NCT05212948|615954618|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
170441025|NCT05212948|615954619|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
170441026|NCT05212948|615954618|FG000|Initial Vaccination Period|Death|23|||
170441027|NCT05212948|615954619|FG001|Initial Vaccination Period|Death|18|||
170441028|NCT05212948|615954618|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
170441029|NCT05212948|615954619|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
170441030|NCT05212948|615954618|FG000|Initial Vaccination Period|Adverse Event|36|||
170441031|NCT05212948|615954619|FG001|Initial Vaccination Period|Adverse Event|23|||
170441032|NCT05212948|615954618|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
170441033|NCT05212948|615954619|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
170441034|NCT05212948|615954618|FG000|Crossover Vaccination Period|Pregnancy|6|||
170441035|NCT05212948|615954619|FG001|Crossover Vaccination Period|Pregnancy|1|||
170441036|NCT05212948|615954618|FG000|Crossover Vaccination Period|Physician Decision|49|||
170441037|NCT05212948|615954619|FG001|Crossover Vaccination Period|Physician Decision|24|||
170441038|NCT05212948|615954618|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
170441039|NCT05212948|615954619|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
170441040|NCT05212948|615954618|FG000|Crossover Vaccination Period|Death|10|||
170441041|NCT05212948|615954619|FG001|Crossover Vaccination Period|Death|5|||
170441042|NCT05212948|615954618|FG000|Crossover Vaccination Period|Adverse Event|9|||
170441043|NCT05212948|615954619|FG001|Crossover Vaccination Period|Adverse Event|4|||
170441044|NCT05347693|615954620|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
170441045|NCT05347693|615954621|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
170537867|NCT02952248|616311665|FG002|Overall Study|Progressive disease|3|||
170537868|NCT02952248|616311666|FG003|Overall Study|Progressive disease|27|||
170537869|NCT02952248|616311667|FG004|Overall Study|Progressive disease|20|||
170537870|NCT02952248|616311668|FG005|Overall Study|Progressive disease|22|||
170537871|NCT02952248|616311669|FG006|Overall Study|Progressive disease|9|||
170537872|NCT02952248|616311663|FG000|Overall Study|Missed 2 cycles of treatment due to COVID-19|0|||
170537873|NCT02952248|616311664|FG001|Overall Study|Missed 2 cycles of treatment due to COVID-19|0|||
170537874|NCT02952248|616311665|FG002|Overall Study|Missed 2 cycles of treatment due to COVID-19|0|||
170537875|NCT02952248|616311666|FG003|Overall Study|Missed 2 cycles of treatment due to COVID-19|0|||
170441046|NCT05347693|615954622|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
170441047|NCT05347693|615954620|FG000|Inpatient Period|Withdrawal of consent|10|||
170441048|NCT05347693|615954621|FG001|Inpatient Period|Withdrawal of consent|0|||
170441049|NCT05347693|615954622|FG002|Inpatient Period|Withdrawal of consent|0|||
170784180|NCT04093752|617216669|FG000|Overall Study|Death|0|||
170784181|NCT04093752|617216670|FG001|Overall Study|Death|0|||
170784182|NCT04093752|617216671|FG002|Overall Study|Death|1|||
170784183|NCT04093752|617216672|FG003|Overall Study|Death|2|||
170784184|NCT04093752|617216669|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
170784185|NCT04093752|617216670|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
170784186|NCT04093752|617216671|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
170784187|NCT04093752|617216672|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
170441050|NCT05347693|615954620|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
170441051|NCT05347693|615954621|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
170441052|NCT05347693|615954622|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
170441053|NCT05347693|615954620|FG000|Inpatient Period|Screening Failure|8|||
170441054|NCT05347693|615954621|FG001|Inpatient Period|Screening Failure|0|||
170441055|NCT05347693|615954622|FG002|Inpatient Period|Screening Failure|0|||
170441056|NCT05347693|615954620|FG000|Inpatient Period|Death|2|||
170441057|NCT05347693|615954621|FG001|Inpatient Period|Death|0|||
170441058|NCT05347693|615954622|FG002|Inpatient Period|Death|0|||
170441059|NCT05347693|615954620|FG000|Inpatient Period|Physician Decision|5|||
170441060|NCT05347693|615954621|FG001|Inpatient Period|Physician Decision|0|||
170441061|NCT05347693|615954622|FG002|Inpatient Period|Physician Decision|0|||
170441062|NCT05347693|615954620|FG000|Inpatient Period|Adverse Event|3|||
170441063|NCT05347693|615954621|FG001|Inpatient Period|Adverse Event|0|||
170441064|NCT05347693|615954622|FG002|Inpatient Period|Adverse Event|0|||
170441065|NCT05347693|615954620|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
170441066|NCT05347693|615954621|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
170441067|NCT05347693|615954622|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
170441068|NCT05347693|615954620|FG000|Outpatient Period|Adverse Event|0|||
170441069|NCT05347693|615954621|FG001|Outpatient Period|Adverse Event|9|||
170441070|NCT05347693|615954622|FG002|Outpatient Period|Adverse Event|0|||
170441071|NCT05347693|615954620|FG000|Outpatient Period|Death|0|||
170441072|NCT05347693|615954621|FG001|Outpatient Period|Death|6|||
170441073|NCT05347693|615954622|FG002|Outpatient Period|Death|2|||
170441074|NCT05347693|615954620|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
170441075|NCT05347693|615954621|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
170441076|NCT05347693|615954622|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
170441077|NCT05347693|615954620|FG000|Outpatient Period|Lost to Follow-up|0|||
170441078|NCT05347693|615954621|FG001|Outpatient Period|Lost to Follow-up|0|||
170441079|NCT05347693|615954622|FG002|Outpatient Period|Lost to Follow-up|1|||
170441080|NCT05347693|615954620|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
170441081|NCT05347693|615954621|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
170441082|NCT05347693|615954622|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
170441083|NCT05347693|615954620|FG000|Outpatient Period|Scheduled hemodialysis|0|||
170441084|NCT05347693|615954621|FG001|Outpatient Period|Scheduled hemodialysis|1|||
170441085|NCT05347693|615954622|FG002|Outpatient Period|Scheduled hemodialysis|0|||
170441086|NCT05347693|615954620|FG000|Outpatient Period|Severe HK|0|||
170441087|NCT05347693|615954621|FG001|Outpatient Period|Severe HK|0|||
170441088|NCT05347693|615954622|FG002|Outpatient Period|Severe HK|1|||
170441089|NCT05347693|615954620|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
170441090|NCT05347693|615954621|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
170441091|NCT05347693|615954622|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
170441092|NCT05347693|615954620|FG000|Outpatient Period|Start of dialysis|0|||
170441093|NCT05347693|615954621|FG001|Outpatient Period|Start of dialysis|0|||
170441094|NCT05347693|615954622|FG002|Outpatient Period|Start of dialysis|1|||
170441095|NCT05347693|615954620|FG000|Outpatient Period|The participant entered hemodialysis|0|||
170441096|NCT05347693|615954621|FG001|Outpatient Period|The participant entered hemodialysis|0|||
170441097|NCT05347693|615954622|FG002|Outpatient Period|The participant entered hemodialysis|1|||
170441098|NCT05347693|615954620|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
170441099|NCT05347693|615954621|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
170441100|NCT05347693|615954622|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
170441101|NCT05347693|615954620|FG000|Outpatient Period|Withdrawal by Subject|0|||
170441102|NCT05347693|615954621|FG001|Outpatient Period|Withdrawal by Subject|8|||
170441103|NCT05347693|615954622|FG002|Outpatient Period|Withdrawal by Subject|5|||
170441104|NCT03167606|615954623|FG000|Overall Study|Lost to Follow-up|73|||
170441105|NCT03167606|615954624|FG001|Overall Study|Lost to Follow-up|64|||
170441106|NCT03167606|615954623|FG000|Overall Study|Withdrawal by Subject|6|||
170441107|NCT03167606|615954624|FG001|Overall Study|Withdrawal by Subject|5|||
170441108|NCT03167606|615954623|FG000|Overall Study|Withdrawal by Investigator|0|||
170784188|NCT04093752|617216669|FG000|Overall Study|Covid 19|0|||
170784189|NCT04093752|617216670|FG001|Overall Study|Covid 19|0|||
170537876|NCT02952248|616311667|FG004|Overall Study|Missed 2 cycles of treatment due to COVID-19|0|||
170537877|NCT02952248|616311668|FG005|Overall Study|Missed 2 cycles of treatment due to COVID-19|1|||
170784190|NCT04093752|617216671|FG002|Overall Study|Covid 19|0|||
170784191|NCT04093752|617216672|FG003|Overall Study|Covid 19|1|||
170784192|NCT04093752|617216669|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
170784193|NCT04093752|617216670|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
170784194|NCT04093752|617216671|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
170784195|NCT04093752|617216672|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
170784196|NCT04093752|617216669|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
170784197|NCT04093752|617216670|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
170784198|NCT04093752|617216671|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
170784199|NCT04093752|617216672|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
170784200|NCT04093752|617216669|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
170784201|NCT04093752|617216670|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
170784202|NCT04093752|617216671|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
170784203|NCT04093752|617216672|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
170784204|NCT05113966|617218946|FG000|Overall Study|Death|21|||
170784205|NCT05113966|617218946|FG000|Overall Study|Study Terminated by Sponsor|9|||
170784206|NCT03648840|617218949|FG000|First IV Infusion Session|Adverse Event|0|||
170784207|NCT03648840|617218950|FG001|First IV Infusion Session|Adverse Event|2|||
170784208|NCT03648840|617218949|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
170784209|NCT03648840|617218950|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
170784210|NCT03648840|617218949|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
170784211|NCT03648840|617218950|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
170784212|NCT03648840|617218949|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
170784213|NCT03648840|617218950|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
170784214|NCT01195831|617218953|FG000|Overall Study|Lost to Follow-up|2|||
170784215|NCT01195831|617218954|FG001|Overall Study|Lost to Follow-up|4|||
170784216|NCT01195831|617218953|FG000|Overall Study|Withdrawal by Subject|2|||
170784217|NCT01195831|617218954|FG001|Overall Study|Withdrawal by Subject|2|||
170784218|NCT01195831|617218953|FG000|Overall Study|Adverse Event|4|||
170784219|NCT01195831|617218954|FG001|Overall Study|Adverse Event|2|||
170784220|NCT01195831|617218953|FG000|Overall Study|Protocol Violation|0|||
170784221|NCT01195831|617218954|FG001|Overall Study|Protocol Violation|2|||
170784222|NCT03692676|617218955|FG000|Overall Study|exclude patients with prior use|4424|||
170784223|NCT03692676|617218956|FG001|Overall Study|exclude patients with prior use|24726|||
170784224|NCT03692676|617218957|FG002|Overall Study|exclude patients with prior use|0|||
170784225|NCT03692676|617218958|FG003|Overall Study|exclude patients with prior use|0|||
170784226|NCT03692676|617218955|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
170784227|NCT03692676|617218956|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
170784228|NCT03692676|617218957|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
170784229|NCT03692676|617218958|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
170784230|NCT03692676|617218955|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
170784231|NCT03692676|617218956|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
170784232|NCT03692676|617218957|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
170784233|NCT03692676|617218958|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
170784234|NCT03692676|617218955|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
170784235|NCT03692676|617218956|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
170784236|NCT03692676|617218957|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
170784237|NCT03692676|617218958|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
170784238|NCT03692676|617218955|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
170784239|NCT03692676|617218956|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
170784240|NCT03692676|617218957|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
170784241|NCT03692676|617218958|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
170784242|NCT03692676|617218955|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
170784243|NCT03692676|617218956|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
170784244|NCT03692676|617218957|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
170784245|NCT03692676|617218958|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
170784246|NCT03692676|617218955|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
170784247|NCT03692676|617218956|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
170885664|NCT00264004|617590100|FG000|Overall Study|Not treated|3|||
170885665|NCT00264004|617590101|FG001|Overall Study|Not treated|0|||
170885666|NCT00264004|617590102|FG002|Overall Study|Not treated|2|||
170784248|NCT03692676|617218957|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
170885667|NCT00264004|617590103|FG003|Overall Study|Not treated|2|||
170441109|NCT03167606|615954624|FG001|Overall Study|Withdrawal by Investigator|2|||
170441110|NCT04968925|615954625|FG000|Phase I- Period 1|COVID-19 related|0|||
170441111|NCT04968925|615954626|FG001|Phase I- Period 1|COVID-19 related|1|||
170441112|NCT04968925|615954627|FG002|Phase I- Period 1|COVID-19 related|0|||
170441113|NCT04968925|615954628|FG003|Phase I- Period 1|COVID-19 related|0|||
170441114|NCT04968925|615954625|FG000|Phase I- Period 1|Subject enrolled in error|1|||
170441115|NCT04968925|615954626|FG001|Phase I- Period 1|Subject enrolled in error|1|||
170441116|NCT04968925|615954627|FG002|Phase I- Period 1|Subject enrolled in error|0|||
170441117|NCT04968925|615954628|FG003|Phase I- Period 1|Subject enrolled in error|0|||
170441118|NCT04968925|615954625|FG000|Phase II- Period 1|COVID-19 Related|0|||
170441119|NCT04968925|615954626|FG001|Phase II- Period 1|COVID-19 Related|0|||
170784249|NCT03692676|617218958|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
170784250|NCT03692676|617218955|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
170784251|NCT03692676|617218956|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
170784252|NCT03692676|617218957|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
170784253|NCT03692676|617218958|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
170441120|NCT04968925|615954627|FG002|Phase II- Period 1|COVID-19 Related|6|||
170441121|NCT04968925|615954628|FG003|Phase II- Period 1|COVID-19 Related|6|||
170441122|NCT04968925|615954625|FG000|Phase II- Period 1|Subject enrolled in error|0|||
170784254|NCT03692676|617218955|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
170885668|NCT00691483|617590104|FG000|Overall Study|Adverse Event|14|||
170441123|NCT04968925|615954626|FG001|Phase II- Period 1|Subject enrolled in error|0|||
170441124|NCT04968925|615954627|FG002|Phase II- Period 1|Subject enrolled in error|1|||
170441125|NCT04968925|615954628|FG003|Phase II- Period 1|Subject enrolled in error|0|||
170441126|NCT04968925|615954625|FG000|Phase II -Period 2|COVID-19 related|0|||
170441127|NCT04968925|615954626|FG001|Phase II -Period 2|COVID-19 related|0|||
170441128|NCT04968925|615954627|FG002|Phase II -Period 2|COVID-19 related|4|||
170441129|NCT04968925|615954628|FG003|Phase II -Period 2|COVID-19 related|3|||
170441130|NCT04968925|615954625|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
170441131|NCT04968925|615954626|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
170441132|NCT04968925|615954627|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
170441133|NCT04968925|615954628|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
170441134|NCT00413049|615954629|FG000|Overall Study|Adverse Event|10|||
170441135|NCT00413049|615954630|FG001|Overall Study|Adverse Event|8|||
170441136|NCT00413049|615954629|FG000|Overall Study|Withdrawal by Subject|7|||
170441137|NCT00413049|615954630|FG001|Overall Study|Withdrawal by Subject|5|||
170441138|NCT00413049|615954629|FG000|Overall Study|Lost to Follow-up|2|||
170441139|NCT00413049|615954630|FG001|Overall Study|Lost to Follow-up|3|||
170441140|NCT00413049|615954629|FG000|Overall Study|Protocol Violation|3|||
170441141|NCT00413049|615954630|FG001|Overall Study|Protocol Violation|1|||
170441142|NCT00413049|615954629|FG000|Overall Study|Subject no longer requires study drug|0|||
170441143|NCT00413049|615954630|FG001|Overall Study|Subject no longer requires study drug|1|||
170441144|NCT00413049|615954629|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170441145|NCT00413049|615954630|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170441146|NCT00413049|615954629|FG000|Overall Study|Lack of Efficacy|1|||
170441147|NCT00413049|615954630|FG001|Overall Study|Lack of Efficacy|0|||
170441148|NCT00835796|615954631|FG000|First Intervention|Withdrawal by Subject|0|||
170441149|NCT00835796|615954632|FG001|First Intervention|Withdrawal by Subject|1|||
170441150|NCT00396630|615954635|FG000|Overall Study|Lost to Follow-up|1|||
170441151|NCT00396630|615954636|FG001|Overall Study|Lost to Follow-up|1|||
170441152|NCT00396630|615954635|FG000|Overall Study|Withdrawal by Subject|1|||
170441153|NCT00396630|615954636|FG001|Overall Study|Withdrawal by Subject|1|||
170441154|NCT00396630|615954635|FG000|Overall Study|Not vaccinated at Visit 3|3|||
170441155|NCT00396630|615954636|FG001|Overall Study|Not vaccinated at Visit 3|3|||
170441156|NCT02327325|615954637|FG000|Overall Study|Withdrawal by Subject|1|||
170441157|NCT02327325|615954638|FG001|Overall Study|Withdrawal by Subject|4|||
170441158|NCT02327325|615954639|FG002|Overall Study|Withdrawal by Subject|4|||
170441159|NCT02327325|615954637|FG000|Overall Study|Excluded by Study Team|0|||
170441160|NCT02327325|615954638|FG001|Overall Study|Excluded by Study Team|0|||
170441161|NCT02327325|615954639|FG002|Overall Study|Excluded by Study Team|1|||
170441162|NCT00695110|615954640|FG000|Treatment Period 1|Adverse Event|1|||
170441163|NCT00695110|615954640|FG000|Treatment Period 1|Withdrawal by Subject|2|||
170441164|NCT00695110|615954640|FG000|Treatment Period 3|Withdrawal by Subject|1|||
170441165|NCT00695110|615954640|FG000|Treatment Period 4|Adverse Event|1|||
170441166|NCT01755975|615954646|FG000|Overall Study|Adverse Event|0|||
170441167|NCT01755975|615954647|FG001|Overall Study|Adverse Event|0|||
170441168|NCT01755975|615954648|FG002|Overall Study|Adverse Event|1|||
170441169|NCT01755975|615954649|FG003|Overall Study|Adverse Event|0|||
170441170|NCT01755975|615954650|FG004|Overall Study|Adverse Event|2|||
170441171|NCT02104817|615954651|FG000|Overall Study|Death|363|||
170441172|NCT02104817|615954652|FG001|Overall Study|Death|330|||
170441173|NCT02104817|615954651|FG000|Overall Study|Lost to Follow-up|3|||
170441174|NCT02104817|615954652|FG001|Overall Study|Lost to Follow-up|2|||
170441175|NCT02104817|615954651|FG000|Overall Study|Protocol Violation|0|||
170885669|NCT00691483|617590105|FG001|Overall Study|Adverse Event|6|||
170885670|NCT00691483|617590104|FG000|Overall Study|Lost to Follow-up|17|||
170885671|NCT00691483|617590105|FG001|Overall Study|Lost to Follow-up|10|||
170885672|NCT00691483|617590104|FG000|Overall Study|Withdrawal by Subject|24|||
170885673|NCT00691483|617590105|FG001|Overall Study|Withdrawal by Subject|7|||
170885674|NCT00691483|617590104|FG000|Overall Study|Other known cause|6|||
170885675|NCT00691483|617590105|FG001|Overall Study|Other known cause|1|||
170885676|NCT00691483|617590104|FG000|Overall Study|Randomized by not treated|7|||
170885677|NCT00691483|617590105|FG001|Overall Study|Randomized by not treated|1|||
170885678|NCT02475681|617590106|FG000|Overall Study|Death|16|||
170885679|NCT02475681|617590107|FG001|Overall Study|Death|6|||
170885680|NCT02475681|617590108|FG002|Overall Study|Death|9|||
170885681|NCT02475681|617590106|FG000|Overall Study|Physician Decision|0|||
170885682|NCT02475681|617590107|FG001|Overall Study|Physician Decision|3|||
170885683|NCT02475681|617590108|FG002|Overall Study|Physician Decision|1|||
170885684|NCT02475681|617590106|FG000|Overall Study|Withdrawal by Subject|12|||
170885685|NCT02475681|617590107|FG001|Overall Study|Withdrawal by Subject|6|||
170885686|NCT02475681|617590108|FG002|Overall Study|Withdrawal by Subject|9|||
170885687|NCT02475681|617590106|FG000|Overall Study|Lost to Follow-up|2|||
170885688|NCT02475681|617590107|FG001|Overall Study|Lost to Follow-up|1|||
170885689|NCT02475681|617590108|FG002|Overall Study|Lost to Follow-up|3|||
170885690|NCT02475681|617590106|FG000|Overall Study|Ongoing in Study|0|||
170885691|NCT02475681|617590107|FG001|Overall Study|Ongoing in Study|163|||
170885692|NCT02475681|617590108|FG002|Overall Study|Ongoing in Study|157|||
170885693|NCT02475681|617590106|FG000|Overall Study|Reasons other than above listed|2|||
170885694|NCT02475681|617590107|FG001|Overall Study|Reasons other than above listed|0|||
170885695|NCT02475681|617590108|FG002|Overall Study|Reasons other than above listed|0|||
170885696|NCT01637142|617590111|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
170885697|NCT00122135|617590112|FG000|Overall Study|Withdrawal by Subject|3|||
170885698|NCT00122135|617590113|FG001|Overall Study|Withdrawal by Subject|0|||
170885699|NCT03269344|617590114|FG000|Overall Study|Protocol Violation|4|||
170885700|NCT03269344|617590115|FG001|Overall Study|Protocol Violation|3|||
170885701|NCT02363686|617590118|FG000|Overall Study|Withdrawal by Subject|22|||
170885702|NCT02363686|617590118|FG000|Overall Study|incomplete FEES examinations|13|||
170885703|NCT01289015|617590125|FG000|Overall Study|Protocol Violation|12|||
170885704|NCT01289015|617590126|FG001|Overall Study|Protocol Violation|9|||
170885705|NCT01289015|617590125|FG000|Overall Study|Adverse Event|3|||
170885706|NCT01289015|617590126|FG001|Overall Study|Adverse Event|0|||
170885707|NCT01289015|617590125|FG000|Overall Study|Lost to Follow-up|33|||
170885708|NCT01289015|617590126|FG001|Overall Study|Lost to Follow-up|17|||
170885709|NCT01289015|617590125|FG000|Overall Study|Withdrawal by Subject|17|||
170885710|NCT01289015|617590126|FG001|Overall Study|Withdrawal by Subject|8|||
170885711|NCT01289015|617590125|FG000|Overall Study|Disease progression|1|||
170885712|NCT01289015|617590126|FG001|Overall Study|Disease progression|0|||
170885713|NCT01289015|617590125|FG000|Overall Study|Negative baseline culture and others|33|||
170885714|NCT01289015|617590126|FG001|Overall Study|Negative baseline culture and others|20|||
170885715|NCT03345472|617590133|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
170885716|NCT03345472|617590133|FG000|Implant to 3 Months|Physician Decision|1|||
170885717|NCT03345472|617590133|FG000|Implant to 3 Months|Adverse Event|1|||
170885718|NCT03345472|617590133|FG000|3 Months to 12 Months|Physician Decision|3|||
170885719|NCT03345472|617590133|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
170885720|NCT03345472|617590133|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
170885721|NCT03345472|617590133|FG000|3 Months to 12 Months|Adverse Event|1|||
170885722|NCT03345472|617590133|FG000|3 Months to 12 Months|Death|1|||
170885723|NCT01639833|617590141|FG000|Overall Study|Death|4|||
170885724|NCT01639833|617590142|FG001|Overall Study|Death|2|||
170885725|NCT01639833|617590141|FG000|Overall Study|Withdrawal by Subject|2|||
170885726|NCT01639833|617590142|FG001|Overall Study|Withdrawal by Subject|2|||
170885727|NCT02443883|617590147|FG000|Overall Study|Adverse Event|0|||
170885728|NCT02443883|617590148|FG001|Overall Study|Adverse Event|1|||
170885729|NCT02443883|617590149|FG002|Overall Study|Adverse Event|0|||
170885730|NCT02443883|617590150|FG003|Overall Study|Adverse Event|0|||
170885731|NCT02443883|617590147|FG000|Overall Study|Lost to Follow-up|3|||
170885732|NCT02443883|617590148|FG001|Overall Study|Lost to Follow-up|2|||
170885733|NCT02443883|617590149|FG002|Overall Study|Lost to Follow-up|1|||
170885734|NCT02443883|617590150|FG003|Overall Study|Lost to Follow-up|0|||
170885735|NCT02443883|617590147|FG000|Overall Study|Physician Decision|1|||
170885736|NCT02443883|617590148|FG001|Overall Study|Physician Decision|1|||
170885737|NCT02443883|617590149|FG002|Overall Study|Physician Decision|0|||
170885738|NCT02443883|617590150|FG003|Overall Study|Physician Decision|3|||
170885739|NCT02443883|617590147|FG000|Overall Study|Withdrawal by Subject|1|||
170885740|NCT02443883|617590148|FG001|Overall Study|Withdrawal by Subject|0|||
170885741|NCT02443883|617590149|FG002|Overall Study|Withdrawal by Subject|0|||
170885742|NCT02443883|617590150|FG003|Overall Study|Withdrawal by Subject|2|||
170885743|NCT02443883|617590147|FG000|Overall Study|Randomized, but never treated|1|||
170885744|NCT02443883|617590148|FG001|Overall Study|Randomized, but never treated|0|||
170885745|NCT02443883|617590149|FG002|Overall Study|Randomized, but never treated|0|||
170885746|NCT02443883|617590150|FG003|Overall Study|Randomized, but never treated|0|||
170441176|NCT02104817|615954652|FG001|Overall Study|Protocol Violation|1|||
170441177|NCT02104817|615954651|FG000|Overall Study|Study terminated by sponsor|5854|||
170441178|NCT02104817|615954652|FG001|Overall Study|Study terminated by sponsor|5901|||
170441179|NCT02104817|615954651|FG000|Overall Study|Withdrawal by Subject|111|||
170441180|NCT02104817|615954652|FG001|Overall Study|Withdrawal by Subject|78|||
170441181|NCT02104817|615954651|FG000|Overall Study|Other reasons|128|||
170441182|NCT02104817|615954652|FG001|Overall Study|Other reasons|135|||
170441183|NCT00108082|615954653|FG000|Overall Study|Adverse Event|14|||
170441184|NCT00108082|615954654|FG001|Overall Study|Adverse Event|12|||
170441185|NCT00108082|615954655|FG002|Overall Study|Adverse Event|17|||
170441186|NCT00108082|615954653|FG000|Overall Study|Lost to Follow-up|6|||
170441187|NCT00108082|615954654|FG001|Overall Study|Lost to Follow-up|3|||
170441188|NCT00108082|615954655|FG002|Overall Study|Lost to Follow-up|7|||
170441189|NCT00108082|615954653|FG000|Overall Study|Consent Withdrawn|3|||
170441190|NCT00108082|615954654|FG001|Overall Study|Consent Withdrawn|3|||
170441191|NCT00108082|615954655|FG002|Overall Study|Consent Withdrawn|5|||
170441192|NCT00108082|615954653|FG000|Overall Study|Protocol Violation|1|||
170885747|NCT02199080|617590151|FG000|Overall Study|Protocol Violation|12|||
170885748|NCT01618214|617590152|FG000|Overall Study|Adverse Event|3|||
170441193|NCT00108082|615954654|FG001|Overall Study|Protocol Violation|2|||
170441194|NCT00108082|615954655|FG002|Overall Study|Protocol Violation|0|||
170441195|NCT00108082|615954653|FG000|Overall Study|Lack of Efficacy|3|||
170441196|NCT00108082|615954654|FG001|Overall Study|Lack of Efficacy|1|||
170441197|NCT00108082|615954655|FG002|Overall Study|Lack of Efficacy|2|||
170441198|NCT00108082|615954653|FG000|Overall Study|Amendment 4: > Month 12|5|||
170441199|NCT00108082|615954654|FG001|Overall Study|Amendment 4: > Month 12|7|||
170441200|NCT00108082|615954655|FG002|Overall Study|Amendment 4: > Month 12|5|||
170441201|NCT00108082|615954653|FG000|Overall Study|Woman of Child-bearing Potential|2|||
170441202|NCT00108082|615954654|FG001|Overall Study|Woman of Child-bearing Potential|0|||
170441203|NCT00108082|615954655|FG002|Overall Study|Woman of Child-bearing Potential|2|||
170441204|NCT00108082|615954653|FG000|Overall Study|Incorrectly Randomized|0|||
170441205|NCT00108082|615954654|FG001|Overall Study|Incorrectly Randomized|0|||
170441206|NCT00108082|615954655|FG002|Overall Study|Incorrectly Randomized|2|||
170441207|NCT00108082|615954653|FG000|Overall Study|Non-compliance|1|||
170441208|NCT00108082|615954654|FG001|Overall Study|Non-compliance|0|||
170441209|NCT00108082|615954655|FG002|Overall Study|Non-compliance|2|||
170441210|NCT00108082|615954653|FG000|Overall Study|Stopped Study Medication|0|||
170441211|NCT00108082|615954654|FG001|Overall Study|Stopped Study Medication|0|||
170441212|NCT00108082|615954655|FG002|Overall Study|Stopped Study Medication|1|||
170441213|NCT00108082|615954653|FG000|Overall Study|Site Closed Study|0|||
170441214|NCT00108082|615954654|FG001|Overall Study|Site Closed Study|2|||
170441215|NCT00108082|615954655|FG002|Overall Study|Site Closed Study|0|||
170441216|NCT00108082|615954653|FG000|Overall Study|Protocol Amendment|0|||
170441217|NCT00108082|615954654|FG001|Overall Study|Protocol Amendment|1|||
170441218|NCT00108082|615954655|FG002|Overall Study|Protocol Amendment|0|||
170441219|NCT00108082|615954653|FG000|Overall Study|Study Medication Not Tapered|0|||
170441220|NCT00108082|615954654|FG001|Overall Study|Study Medication Not Tapered|1|||
170441221|NCT00108082|615954655|FG002|Overall Study|Study Medication Not Tapered|0|||
170441222|NCT00108082|615954653|FG000|Overall Study|Subject Left Site Location|1|||
170441223|NCT00108082|615954654|FG001|Overall Study|Subject Left Site Location|0|||
170441224|NCT00108082|615954655|FG002|Overall Study|Subject Left Site Location|0|||
170441225|NCT00108082|615954653|FG000|Overall Study|Investigator Not at Site|1|||
170441226|NCT00108082|615954654|FG001|Overall Study|Investigator Not at Site|0|||
170441227|NCT00108082|615954655|FG002|Overall Study|Investigator Not at Site|0|||
170441228|NCT00108082|615954653|FG000|Overall Study|Blood Pressure Not Controlled|1|||
170441229|NCT00108082|615954654|FG001|Overall Study|Blood Pressure Not Controlled|0|||
170441230|NCT00108082|615954655|FG002|Overall Study|Blood Pressure Not Controlled|0|||
170441231|NCT01045707|615954656|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
170441232|NCT01045707|615954657|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
170441233|NCT01045707|615954656|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
170441234|NCT01045707|615954657|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
170441235|NCT01045707|615954656|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
170441236|NCT01045707|615954657|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
170441237|NCT01045707|615954656|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
170441238|NCT01045707|615954657|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
170537878|NCT02952248|616311669|FG006|Overall Study|Missed 2 cycles of treatment due to COVID-19|0|||
170441239|NCT01045707|615954656|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
170441240|NCT01045707|615954657|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
170441241|NCT01045707|615954656|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
170441242|NCT01045707|615954657|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
170441243|NCT01045707|615954656|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
170441244|NCT01045707|615954657|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
170441245|NCT01045707|615954656|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
170537879|NCT02952248|616311663|FG000|Overall Study|Patient decision|0|||
170537880|NCT02952248|616311664|FG001|Overall Study|Patient decision|0|||
170441246|NCT01045707|615954657|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
170441247|NCT01045707|615954656|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
170441248|NCT01045707|615954657|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
170441249|NCT03302078|615954658|FG000|Washout Period|Adverse Event|0|||
170441250|NCT03302078|615954659|FG001|Washout Period|Adverse Event|1|||
170885749|NCT01618214|617590153|FG001|Overall Study|Adverse Event|1|||
170885750|NCT01618214|617590152|FG000|Overall Study|Lack of Efficacy|1|||
170441251|NCT02340780|615954660|FG000|Overall Study|Ineligible|1|||
170441252|NCT03422068|615954661|FG000|Overall Study|Adverse Event|0|||
170885751|NCT01618214|617590153|FG001|Overall Study|Lack of Efficacy|1|||
170885752|NCT01618214|617590152|FG000|Overall Study|Protocol Violation|1|||
170885753|NCT01618214|617590153|FG001|Overall Study|Protocol Violation|4|||
170885754|NCT01618214|617590152|FG000|Overall Study|Withdrawal Criteria|1|||
170885755|NCT01618214|617590153|FG001|Overall Study|Withdrawal Criteria|2|||
170885756|NCT01618214|617590152|FG000|Overall Study|Unclassified|4|||
170885757|NCT01618214|617590153|FG001|Overall Study|Unclassified|5|||
170885758|NCT00623428|617590156|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
170885759|NCT00623428|617590157|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
170885760|NCT00623428|617590156|FG000|Treatment Period|Death|0|||
170885761|NCT00623428|617590157|FG001|Treatment Period|Death|1|||
170885762|NCT00623428|617590156|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
170885763|NCT00623428|617590157|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
170885764|NCT00623428|617590156|FG000|Treatment Period|Insufficient therapeutic response|0|||
170885765|NCT00623428|617590157|FG001|Treatment Period|Insufficient therapeutic response|2|||
170885766|NCT00623428|617590156|FG000|Treatment Period|Other|0|||
170885767|NCT00623428|617590157|FG001|Treatment Period|Other|1|||
170885768|NCT00623428|617590156|FG000|Treatment Period|Withdrawal by Subject|0|||
170885769|NCT00623428|617590157|FG001|Treatment Period|Withdrawal by Subject|1|||
170885770|NCT00623428|617590156|FG000|Follow-up Period|Relapse post-treatment|11|||
170885771|NCT00623428|617590157|FG001|Follow-up Period|Relapse post-treatment|3|||
170885772|NCT00623428|617590156|FG000|Follow-up Period|Failure to return|10|||
170885773|NCT00623428|617590157|FG001|Follow-up Period|Failure to return|2|||
170885774|NCT00623428|617590156|FG000|Follow-up Period|Patient withdrew consent|5|||
170885775|NCT00623428|617590157|FG001|Follow-up Period|Patient withdrew consent|4|||
170885776|NCT00623428|617590156|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
170885777|NCT00623428|617590157|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
170885778|NCT00623428|617590156|FG000|Follow-up Period|Did not cooperate|0|||
170885779|NCT00623428|617590157|FG001|Follow-up Period|Did not cooperate|3|||
170885780|NCT00623428|617590156|FG000|Follow-up Period|Reason not specified|1|||
170885781|NCT00623428|617590157|FG001|Follow-up Period|Reason not specified|1|||
170885782|NCT00623428|617590156|FG000|Follow-up Period|Death|0|||
170885783|NCT00623428|617590157|FG001|Follow-up Period|Death|1|||
170885784|NCT02937818|617590158|FG000|Overall Study|Participants decision|2|||
170885785|NCT02937818|617590159|FG001|Overall Study|Participants decision|1|||
170885786|NCT02937818|617590160|FG002|Overall Study|Participants decision|1|||
170885787|NCT02937818|617590161|FG003|Overall Study|Participants decision|1|||
170885788|NCT02937818|617590158|FG000|Overall Study|Adverse Event|2|||
170885789|NCT02937818|617590159|FG001|Overall Study|Adverse Event|4|||
170885790|NCT02937818|617590160|FG002|Overall Study|Adverse Event|1|||
170885791|NCT02937818|617590161|FG003|Overall Study|Adverse Event|1|||
170885792|NCT02937818|617590158|FG000|Overall Study|Disease progression|17|||
170885793|NCT02937818|617590159|FG001|Overall Study|Disease progression|15|||
170885794|NCT02937818|617590160|FG002|Overall Study|Disease progression|7|||
170885795|NCT02937818|617590161|FG003|Overall Study|Disease progression|19|||
170441253|NCT03422068|615954662|FG001|Overall Study|Adverse Event|1|||
170441254|NCT03422068|615954661|FG000|Overall Study|Inconvenience to frequent study visits|0|||
170441255|NCT03422068|615954662|FG001|Overall Study|Inconvenience to frequent study visits|1|||
170441256|NCT00152451|615954664|FG000|Overall Study|Adverse Event|4|||
170441257|NCT00323258|615954665|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
170441258|NCT00323258|615954666|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
170885796|NCT02937818|617590158|FG000|Overall Study|Condition under investigation worsened|0|||
170885797|NCT02937818|617590159|FG001|Overall Study|Condition under investigation worsened|0|||
170441259|NCT00323258|615954665|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
170885798|NCT02937818|617590160|FG002|Overall Study|Condition under investigation worsened|1|||
170885799|NCT02937818|617590161|FG003|Overall Study|Condition under investigation worsened|0|||
170885800|NCT01692301|617590162|FG000|Overall Study|Adverse Event|15|||
170885801|NCT01692301|617590163|FG001|Overall Study|Adverse Event|12|||
170441260|NCT00323258|615954666|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
170441261|NCT00323258|615954665|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
170537881|NCT02952248|616311665|FG002|Overall Study|Patient decision|0|||
170885802|NCT01692301|617590162|FG000|Overall Study|Death|1|||
170885803|NCT01692301|617590163|FG001|Overall Study|Death|2|||
170885804|NCT01692301|617590162|FG000|Overall Study|Lack of Efficacy|0|||
170885805|NCT01692301|617590163|FG001|Overall Study|Lack of Efficacy|5|||
170885806|NCT01692301|617590162|FG000|Overall Study|Non-compliance with study treatment|1|||
170441262|NCT00323258|615954666|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
170441263|NCT00323258|615954665|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
170441264|NCT00323258|615954666|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
170441265|NCT00323258|615954665|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
170441266|NCT00323258|615954666|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
170441267|NCT00323258|615954665|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
170441268|NCT00323258|615954666|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
170441269|NCT00323258|615954665|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
170441270|NCT00323258|615954666|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
170441271|NCT02451358|615954670|FG000|Overall Study|Withdrawal by Subject|1|||
170441272|NCT02451358|615954671|FG001|Overall Study|Withdrawal by Subject|1|||
170784255|NCT03692676|617218956|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
170784256|NCT03692676|617218957|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
170784257|NCT03692676|617218958|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
170784258|NCT03692676|617218955|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
170784259|NCT03692676|617218956|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
170784260|NCT03692676|617218957|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
170784261|NCT03692676|617218958|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
170784262|NCT03692676|617218955|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
170784263|NCT03692676|617218956|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
170784264|NCT03692676|617218957|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
170784265|NCT03692676|617218958|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
170784266|NCT03692676|617218955|FG000|Overall Study|Other|0|||
170784267|NCT03692676|617218956|FG001|Overall Study|Other|805|||
170784268|NCT03692676|617218957|FG002|Overall Study|Other|758|||
170784269|NCT03692676|617218958|FG003|Overall Study|Other|277|||
170784270|NCT03692676|617218955|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
170784271|NCT03692676|617218956|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
170784272|NCT03692676|617218957|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
170784273|NCT03692676|617218958|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
170784274|NCT02995434|617218963|FG000|Overall Study|Adverse Event|1|||
170784275|NCT02995434|617218964|FG001|Overall Study|Adverse Event|0|||
170784276|NCT02995434|617218963|FG000|Overall Study|Withdrawal by Subject|6|||
170784277|NCT02995434|617218964|FG001|Overall Study|Withdrawal by Subject|3|||
170784278|NCT03779204|617218970|FG000|Overall Study|Lost to Follow-up|2|||
170784279|NCT03779204|617218971|FG001|Overall Study|Lost to Follow-up|0|||
170784280|NCT04421378|617218972|FG000|Overall Study|Adverse Event|2|||
170784281|NCT04421378|617218973|FG001|Overall Study|Adverse Event|7|||
170784282|NCT04421378|617218974|FG002|Overall Study|Adverse Event|0|||
170784283|NCT04421378|617218975|FG003|Overall Study|Adverse Event|1|||
170784284|NCT04421378|617218976|FG004|Overall Study|Adverse Event|0|||
170784285|NCT04421378|617218972|FG000|Overall Study|Physician Decision|1|||
170784286|NCT04421378|617218973|FG001|Overall Study|Physician Decision|2|||
170784287|NCT04421378|617218974|FG002|Overall Study|Physician Decision|0|||
170784288|NCT04421378|617218975|FG003|Overall Study|Physician Decision|0|||
170784289|NCT04421378|617218976|FG004|Overall Study|Physician Decision|0|||
170784290|NCT04421378|617218972|FG000|Overall Study|Progressive Disease|16|||
170784291|NCT04421378|617218973|FG001|Overall Study|Progressive Disease|4|||
170784292|NCT04421378|617218974|FG002|Overall Study|Progressive Disease|18|||
170784293|NCT04421378|617218975|FG003|Overall Study|Progressive Disease|11|||
170784294|NCT04421378|617218976|FG004|Overall Study|Progressive Disease|3|||
170784295|NCT04421378|617218972|FG000|Overall Study|Study Terminated by Sponsor|0|||
170784296|NCT04421378|617218973|FG001|Overall Study|Study Terminated by Sponsor|1|||
170784297|NCT04421378|617218974|FG002|Overall Study|Study Terminated by Sponsor|1|||
170784298|NCT04421378|617218975|FG003|Overall Study|Study Terminated by Sponsor|0|||
170784299|NCT04421378|617218976|FG004|Overall Study|Study Terminated by Sponsor|0|||
170784300|NCT04421378|617218972|FG000|Overall Study|Withdrawal by Subject|3|||
170784301|NCT04421378|617218973|FG001|Overall Study|Withdrawal by Subject|1|||
170784302|NCT04421378|617218974|FG002|Overall Study|Withdrawal by Subject|0|||
170784303|NCT04421378|617218975|FG003|Overall Study|Withdrawal by Subject|2|||
170784304|NCT04421378|617218976|FG004|Overall Study|Withdrawal by Subject|0|||
170784305|NCT04421378|617218972|FG000|Overall Study|Other|1|||
170784306|NCT04421378|617218973|FG001|Overall Study|Other|0|||
170784307|NCT04421378|617218974|FG002|Overall Study|Other|0|||
170784308|NCT04421378|617218975|FG003|Overall Study|Other|0|||
170784309|NCT04421378|617218976|FG004|Overall Study|Other|0|||
170784310|NCT03090152|617218977|FG000|Overall Study|Withdrawal by Subject|0|||
170784311|NCT03090152|617218978|FG001|Overall Study|Withdrawal by Subject|2|||
170784312|NCT03090152|617218979|FG002|Overall Study|Withdrawal by Subject|1|||
170784313|NCT03090152|617218977|FG000|Overall Study|Surgery Canceled|1|||
170784314|NCT03090152|617218978|FG001|Overall Study|Surgery Canceled|0|||
170784315|NCT03090152|617218979|FG002|Overall Study|Surgery Canceled|0|||
170784316|NCT03090152|617218977|FG000|Overall Study|Epidural catheter could not be placed|0|||
170784317|NCT03090152|617218978|FG001|Overall Study|Epidural catheter could not be placed|2|||
170784318|NCT03090152|617218979|FG002|Overall Study|Epidural catheter could not be placed|0|||
170784319|NCT02954341|617218980|FG000|Overall Study|Attempted Implant unsuccessful|5|||
170784320|NCT02954341|617218980|FG000|Overall Study|Death|90|||
170784321|NCT02954341|617218980|FG000|Overall Study|Withdrawal by Subject|4|||
170784322|NCT02954341|617218980|FG000|Overall Study|Physician Decision|13|||
170784323|NCT02954341|617218980|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
170784324|NCT02954341|617218980|FG000|Overall Study|Not implanted due to physician's decision|1|||
170784325|NCT02954341|617218980|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
170784326|NCT02287610|617218985|FG000|Overall Study|Lost to Follow-up|3|||
170784327|NCT02287610|617218985|FG000|Overall Study|Withdrawal by Subject|8|||
170784328|NCT02287610|617218985|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
170784329|NCT04950660|617218986|FG000|Overall Study|Protocol Violation|4|||
170784330|NCT04950660|617218987|FG001|Overall Study|Protocol Violation|2|||
170784331|NCT04950660|617218986|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
170784332|NCT04950660|617218987|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
170784333|NCT04950660|617218986|FG000|Overall Study|Withdrawal by Subject|0|||
170784334|NCT04950660|617218987|FG001|Overall Study|Withdrawal by Subject|1|||
170784335|NCT04950660|617218986|FG000|Overall Study|Hypotension|1|||
170784336|NCT04950660|617218987|FG001|Overall Study|Hypotension|0|||
170784337|NCT06074523|617218991|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
170784338|NCT06074523|617218991|FG000|Overall Study|Withdrawal by Subject|1|||
170784339|NCT04321031|617218997|FG000|Overall Study|Adverse Event|0|||
170784340|NCT04321031|617218998|FG001|Overall Study|Adverse Event|2|||
170784341|NCT04321031|617218999|FG002|Overall Study|Adverse Event|2|||
170784342|NCT04321031|617219000|FG003|Overall Study|Adverse Event|2|||
170784343|NCT04321031|617219001|FG004|Overall Study|Adverse Event|2|||
170784344|NCT04321031|617219002|FG005|Overall Study|Adverse Event|2|||
170784345|NCT04321031|617219003|FG006|Overall Study|Adverse Event|0|||
170784346|NCT04321031|617218997|FG000|Overall Study|Lost to Follow-up|0|||
170784347|NCT04321031|617218998|FG001|Overall Study|Lost to Follow-up|0|||
170784348|NCT04321031|617218999|FG002|Overall Study|Lost to Follow-up|0|||
170784349|NCT04321031|617219000|FG003|Overall Study|Lost to Follow-up|1|||
170784350|NCT04321031|617219001|FG004|Overall Study|Lost to Follow-up|0|||
170784351|NCT04321031|617219002|FG005|Overall Study|Lost to Follow-up|2|||
170784352|NCT04321031|617219003|FG006|Overall Study|Lost to Follow-up|1|||
170784353|NCT04321031|617218997|FG000|Overall Study|Withdrawal by Subject|2|||
170784354|NCT04321031|617218998|FG001|Overall Study|Withdrawal by Subject|2|||
170537882|NCT02952248|616311666|FG003|Overall Study|Patient decision|1|||
170784355|NCT04321031|617218999|FG002|Overall Study|Withdrawal by Subject|1|||
170784356|NCT04321031|617219000|FG003|Overall Study|Withdrawal by Subject|3|||
170784357|NCT04321031|617219001|FG004|Overall Study|Withdrawal by Subject|1|||
170784358|NCT04321031|617219002|FG005|Overall Study|Withdrawal by Subject|0|||
170784359|NCT04321031|617219003|FG006|Overall Study|Withdrawal by Subject|1|||
170784360|NCT04321031|617218997|FG000|Overall Study|Non-compliance with study drug|0|||
170784361|NCT04321031|617218998|FG001|Overall Study|Non-compliance with study drug|0|||
170784362|NCT04321031|617218999|FG002|Overall Study|Non-compliance with study drug|0|||
170784363|NCT04321031|617219000|FG003|Overall Study|Non-compliance with study drug|0|||
170784364|NCT04321031|617219001|FG004|Overall Study|Non-compliance with study drug|0|||
170784365|NCT04321031|617219002|FG005|Overall Study|Non-compliance with study drug|1|||
170784366|NCT04321031|617219003|FG006|Overall Study|Non-compliance with study drug|0|||
170784367|NCT04321031|617218997|FG000|Overall Study|Other|0|||
170784368|NCT04321031|617218998|FG001|Overall Study|Other|0|||
170784369|NCT04321031|617218999|FG002|Overall Study|Other|0|||
170784370|NCT04321031|617219000|FG003|Overall Study|Other|1|||
170885807|NCT01692301|617590163|FG001|Overall Study|Non-compliance with study treatment|2|||
170885808|NCT01692301|617590162|FG000|Overall Study|Protocol deviation|9|||
170885809|NCT01692301|617590163|FG001|Overall Study|Protocol deviation|2|||
170885810|NCT01692301|617590162|FG000|Overall Study|Patient/guardian decision|16|||
170885811|NCT01692301|617590163|FG001|Overall Study|Patient/guardian decision|15|||
170885812|NCT01692301|617590162|FG000|Overall Study|Technical problems|0|||
170885813|NCT01692301|617590163|FG001|Overall Study|Technical problems|1|||
170885814|NCT01692301|617590162|FG000|Overall Study|Physician Decision|2|||
170885815|NCT01692301|617590163|FG001|Overall Study|Physician Decision|2|||
170885816|NCT01692301|617590162|FG000|Overall Study|Lost to Follow-up|1|||
170885817|NCT01692301|617590163|FG001|Overall Study|Lost to Follow-up|1|||
170885818|NCT01290692|617590164|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
170885819|NCT01142726|617590165|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
170885820|NCT01142726|617590166|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
170885821|NCT01142726|617590167|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
170885822|NCT01142726|617590165|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
170885823|NCT01142726|617590166|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
170885824|NCT01142726|617590167|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
170885825|NCT01142726|617590165|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
170885826|NCT01142726|617590166|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
170885827|NCT01142726|617590167|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
170885828|NCT01142726|617590165|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
170885829|NCT01142726|617590166|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
170885830|NCT01142726|617590167|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
170885831|NCT01142726|617590165|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
170885832|NCT01142726|617590166|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
170885833|NCT01142726|617590167|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
170885834|NCT01142726|617590165|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
170885835|NCT01142726|617590166|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
170885836|NCT01142726|617590167|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
170885837|NCT01142726|617590165|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
170885838|NCT01142726|617590166|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
170885839|NCT01142726|617590167|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
170885840|NCT01142726|617590165|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
170885841|NCT01142726|617590166|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
170885842|NCT01142726|617590167|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
170885843|NCT01142726|617590165|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
170885844|NCT01142726|617590166|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
170885845|NCT01142726|617590167|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
170885846|NCT01142726|617590165|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
170885847|NCT01142726|617590166|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
170885848|NCT01142726|617590167|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
170885849|NCT01142726|617590165|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
170885850|NCT01142726|617590166|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
170885851|NCT01142726|617590167|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
170441273|NCT02451358|615954672|FG002|Overall Study|Withdrawal by Subject|0|||
170441274|NCT02451358|615954673|FG003|Overall Study|Withdrawal by Subject|0|||
170441275|NCT02451358|615954670|FG000|Overall Study|Protocol Violation|0|||
170441276|NCT02451358|615954671|FG001|Overall Study|Protocol Violation|1|||
170441277|NCT02451358|615954672|FG002|Overall Study|Protocol Violation|1|||
170441278|NCT02451358|615954673|FG003|Overall Study|Protocol Violation|0|||
170441279|NCT06128525|615954674|FG000|Overall Study|Patient withdrew consent|1|||
170885852|NCT01142726|617590165|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
170885853|NCT01142726|617590166|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
170885854|NCT01142726|617590167|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
170885855|NCT01142726|617590165|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
170885856|NCT01142726|617590166|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
170885857|NCT01142726|617590167|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
170441280|NCT01698554|615954675|FG000|Overall Study|Adverse Event|2|||
170441281|NCT01698554|615954676|FG001|Overall Study|Adverse Event|5|||
170537883|NCT02952248|616311667|FG004|Overall Study|Patient decision|3|||
170885858|NCT01142726|617590165|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
170885859|NCT01142726|617590166|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
170441282|NCT01698554|615954677|FG002|Overall Study|Adverse Event|0|||
170537884|NCT02952248|616311668|FG005|Overall Study|Patient decision|1|||
170537885|NCT02952248|616311669|FG006|Overall Study|Patient decision|2|||
170784371|NCT04321031|617219001|FG004|Overall Study|Other|0|||
170784372|NCT04321031|617219002|FG005|Overall Study|Other|0|||
170784373|NCT04321031|617219003|FG006|Overall Study|Other|0|||
170784374|NCT02543281|617219006|FG000|Overall Study|Lost to Follow-up|0|||
170784375|NCT02543281|617219007|FG001|Overall Study|Lost to Follow-up|0|||
170784376|NCT02543281|617219008|FG002|Overall Study|Lost to Follow-up|1|||
170784377|NCT04179500|617219049|FG000|Treatment|Withdrawal by Subject|1|||
170784378|NCT04179500|617219049|FG000|Treatment|Adverse Event|2|||
170784379|NCT04179500|617219049|FG000|Treatment|pyrazinamide resistance|1|||
170784380|NCT03332017|617219051|FG000|Overall Study|Lost to Follow-up|1|||
170784381|NCT03332017|617219052|FG001|Overall Study|Lost to Follow-up|2|||
170784382|NCT03332017|617219051|FG000|Overall Study|Death|17|||
170784383|NCT03332017|617219052|FG001|Overall Study|Death|16|||
170784384|NCT03332017|617219051|FG000|Overall Study|Withdrawal by Subject|6|||
170784385|NCT03332017|617219052|FG001|Overall Study|Withdrawal by Subject|14|||
170784386|NCT03332017|617219051|FG000|Overall Study|Other|1|||
170784387|NCT03332017|617219052|FG001|Overall Study|Other|3|||
170784388|NCT03332017|617219051|FG000|Overall Study|Remained in Study (Ongoing)|47|||
170784389|NCT03332017|617219052|FG001|Overall Study|Remained in Study (Ongoing)|110|||
170784390|NCT03406871|617219057|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
170784391|NCT03406871|617219058|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
170784392|NCT03406871|617219059|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
170784393|NCT03406871|617219057|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
170784394|NCT03406871|617219058|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
170784395|NCT03406871|617219059|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
170784396|NCT03406871|617219057|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
170784397|NCT03406871|617219058|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
170784398|NCT03406871|617219059|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
170784399|NCT03406871|617219057|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
170784400|NCT03406871|617219058|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
170784401|NCT03406871|617219059|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
170784402|NCT03406871|617219057|FG000|Expansion Cohort(Final Analysis)|Death|0|||
170784403|NCT03406871|617219058|FG001|Expansion Cohort(Final Analysis)|Death|1|||
170784404|NCT03406871|617219059|FG002|Expansion Cohort(Final Analysis)|Death|0|||
170784405|NCT03406871|617219057|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
170784406|NCT03406871|617219058|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
170784407|NCT03406871|617219059|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
170784408|NCT02783300|617219068|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784409|NCT02783300|617219069|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784410|NCT02783300|617219070|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784411|NCT02783300|617219071|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784412|NCT02783300|617219072|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784413|NCT02783300|617219073|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170441283|NCT01698554|615954678|FG003|Overall Study|Adverse Event|1|||
170441284|NCT01698554|615954675|FG000|Overall Study|Lost to Follow-up|1|||
170441285|NCT01698554|615954676|FG001|Overall Study|Lost to Follow-up|0|||
170441286|NCT01698554|615954677|FG002|Overall Study|Lost to Follow-up|0|||
170441287|NCT01698554|615954678|FG003|Overall Study|Lost to Follow-up|0|||
170441288|NCT01698554|615954675|FG000|Overall Study|Personal Reasons|0|||
170441289|NCT01698554|615954676|FG001|Overall Study|Personal Reasons|5|||
170441290|NCT01698554|615954677|FG002|Overall Study|Personal Reasons|1|||
170441291|NCT01698554|615954678|FG003|Overall Study|Personal Reasons|1|||
170784414|NCT02783300|617219074|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
170784415|NCT02783300|617219075|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784416|NCT02783300|617219076|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784417|NCT02783300|617219077|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784418|NCT02783300|617219078|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784419|NCT02783300|617219079|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784420|NCT02783300|617219080|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784421|NCT02783300|617219081|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784422|NCT02783300|617219082|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784423|NCT02783300|617219083|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784424|NCT02783300|617219084|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784425|NCT02783300|617219085|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170441292|NCT01698554|615954675|FG000|Overall Study|Protocol Violation|2|||
170537886|NCT02952248|616311663|FG000|Overall Study|Physician Decision|0|||
170784426|NCT02783300|617219086|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784427|NCT02783300|617219087|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784428|NCT02783300|617219088|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784429|NCT02783300|617219089|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170906123|NCT01097044|617658626|FG001|Overall Study|Lost to Follow-up|0|||
170441293|NCT01698554|615954676|FG001|Overall Study|Protocol Violation|0|||
170784430|NCT02783300|617219090|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784431|NCT02783300|617219091|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784432|NCT02783300|617219092|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784433|NCT02783300|617219093|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784434|NCT02783300|617219094|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
170784435|NCT02783300|617219068|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784436|NCT02783300|617219069|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784437|NCT02783300|617219070|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784438|NCT02783300|617219071|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
170784439|NCT02783300|617219072|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784440|NCT02783300|617219073|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784441|NCT02783300|617219074|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784442|NCT02783300|617219075|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784443|NCT02783300|617219076|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784444|NCT02783300|617219077|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784445|NCT02783300|617219078|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784446|NCT02783300|617219079|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784447|NCT02783300|617219080|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784448|NCT02783300|617219081|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784449|NCT02783300|617219082|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784450|NCT02783300|617219083|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784451|NCT02783300|617219084|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784452|NCT02783300|617219085|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784453|NCT02783300|617219086|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784454|NCT02783300|617219087|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784455|NCT02783300|617219088|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784456|NCT02783300|617219089|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784457|NCT02783300|617219090|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784458|NCT02783300|617219091|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784459|NCT02783300|617219092|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784460|NCT02783300|617219093|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784461|NCT02783300|617219094|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
170784462|NCT02783300|617219068|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
170784463|NCT02783300|617219069|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
170784464|NCT02783300|617219070|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
170784465|NCT02783300|617219071|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
170784466|NCT02783300|617219072|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
170784467|NCT02783300|617219073|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
170784468|NCT02783300|617219074|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
170784469|NCT02783300|617219075|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
170784470|NCT02783300|617219076|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
170784471|NCT02783300|617219077|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
170784472|NCT02783300|617219078|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
170784473|NCT02783300|617219079|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
170784474|NCT02783300|617219080|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
170784475|NCT02783300|617219081|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
170784476|NCT02783300|617219082|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
170784477|NCT02783300|617219083|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
170784478|NCT02783300|617219084|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
170784479|NCT02783300|617219085|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
170784480|NCT02783300|617219086|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
170784481|NCT02783300|617219087|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
170784482|NCT02783300|617219088|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
170784483|NCT02783300|617219089|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
170885860|NCT01142726|617590167|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
170885861|NCT01142726|617590165|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
170885862|NCT01142726|617590166|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
170885863|NCT01142726|617590167|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
170885864|NCT01142726|617590165|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
170885865|NCT01142726|617590166|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
170885866|NCT01142726|617590167|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
170885867|NCT01276236|617590170|FG000|Overall Study|Lack of Efficacy|2|||
170885868|NCT01276236|617590170|FG000|Overall Study|Withdrawal by Subject|4|||
170885869|NCT03127384|617590175|FG000|Overall Study|Lost to Follow-up|4|||
170885870|NCT03127384|617590175|FG000|Overall Study|Subject request|2|||
170885871|NCT05073458|617590186|FG000|24-week Double-blind Period|Adverse Event|1|||
170885872|NCT05073458|617590187|FG001|24-week Double-blind Period|Adverse Event|0|||
170885873|NCT05073458|617590186|FG000|24-week Double-blind Period|Physician Decision|1|||
170885874|NCT05073458|617590187|FG001|24-week Double-blind Period|Physician Decision|0|||
170885875|NCT05073458|617590186|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
170885876|NCT05073458|617590187|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
170885877|NCT05073458|617590186|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
170885878|NCT05073458|617590187|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
170885879|NCT05073458|617590186|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
170885880|NCT05073458|617590187|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
170885881|NCT05073458|617590186|FG000|24-week Open-label Period|Adverse Event|1|||
170885882|NCT05073458|617590187|FG001|24-week Open-label Period|Adverse Event|2|||
170885883|NCT03208231|617590196|FG000|Overall Study|Death|1|||
170885884|NCT03208231|617590197|FG001|Overall Study|Death|2|||
170885885|NCT03208231|617590196|FG000|Overall Study|Moved and unable to get to clinic|1|||
170885886|NCT03208231|617590197|FG001|Overall Study|Moved and unable to get to clinic|0|||
170885887|NCT03208231|617590196|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
170885888|NCT03208231|617590197|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
170885889|NCT03977467|617590199|FG000|Overall Study|Disease Progression|1|||
170885890|NCT03977467|617590200|FG001|Overall Study|Disease Progression|1|||
170885891|NCT03977467|617590201|FG002|Overall Study|Disease Progression|30|||
170441294|NCT01698554|615954677|FG002|Overall Study|Protocol Violation|1|||
170441295|NCT01698554|615954678|FG003|Overall Study|Protocol Violation|0|||
170885892|NCT03977467|617590202|FG003|Overall Study|Disease Progression|0|||
170885893|NCT03977467|617590199|FG000|Overall Study|Adverse Event|0|||
170885894|NCT03977467|617590200|FG001|Overall Study|Adverse Event|1|||
170885895|NCT03977467|617590201|FG002|Overall Study|Adverse Event|0|||
170885896|NCT03977467|617590202|FG003|Overall Study|Adverse Event|0|||
170885897|NCT03977467|617590199|FG000|Overall Study|Death|0|||
170885898|NCT03977467|617590200|FG001|Overall Study|Death|0|||
170885899|NCT03977467|617590201|FG002|Overall Study|Death|3|||
170885900|NCT03977467|617590202|FG003|Overall Study|Death|0|||
170885901|NCT03977467|617590199|FG000|Overall Study|Lack of Efficacy|0|||
170885902|NCT03977467|617590200|FG001|Overall Study|Lack of Efficacy|0|||
170885903|NCT03977467|617590201|FG002|Overall Study|Lack of Efficacy|1|||
170885904|NCT03977467|617590202|FG003|Overall Study|Lack of Efficacy|0|||
170885905|NCT03977467|617590199|FG000|Overall Study|Withdrawal by Subject|2|||
170885906|NCT03977467|617590200|FG001|Overall Study|Withdrawal by Subject|1|||
170885907|NCT03977467|617590201|FG002|Overall Study|Withdrawal by Subject|4|||
170885908|NCT03977467|617590202|FG003|Overall Study|Withdrawal by Subject|0|||
170537887|NCT02952248|616311664|FG001|Overall Study|Physician Decision|0|||
170537888|NCT02952248|616311665|FG002|Overall Study|Physician Decision|0|||
170537889|NCT02952248|616311666|FG003|Overall Study|Physician Decision|0|||
170784484|NCT02783300|617219090|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
170784485|NCT02783300|617219091|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
170784486|NCT02783300|617219092|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
170784487|NCT02783300|617219093|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
170784488|NCT02783300|617219094|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
170784489|NCT02783300|617219068|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784490|NCT02783300|617219069|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784491|NCT02783300|617219070|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784492|NCT02783300|617219071|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784493|NCT02783300|617219072|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784494|NCT02783300|617219073|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784495|NCT02783300|617219074|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
170784496|NCT02783300|617219075|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784497|NCT02783300|617219076|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784498|NCT02783300|617219077|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784499|NCT02783300|617219078|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784500|NCT02783300|617219079|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784501|NCT02783300|617219080|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
170784502|NCT02783300|617219081|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784503|NCT02783300|617219082|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784504|NCT02783300|617219083|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784505|NCT02783300|617219084|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784506|NCT02783300|617219085|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784507|NCT02783300|617219086|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784508|NCT02783300|617219087|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784509|NCT02783300|617219088|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784510|NCT02783300|617219089|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784511|NCT02783300|617219090|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784512|NCT02783300|617219091|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784513|NCT02783300|617219092|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784514|NCT02783300|617219093|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784515|NCT02783300|617219094|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
170784516|NCT02783300|617219068|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784517|NCT02783300|617219069|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784518|NCT02783300|617219070|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784519|NCT02783300|617219071|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784520|NCT02783300|617219072|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
170537890|NCT02952248|616311667|FG004|Overall Study|Physician Decision|1|||
170784521|NCT02783300|617219073|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784522|NCT02783300|617219074|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
170537891|NCT02952248|616311668|FG005|Overall Study|Physician Decision|0|||
170537892|NCT02952248|616311669|FG006|Overall Study|Physician Decision|0|||
170537893|NCT02952248|616311663|FG000|Overall Study|Clinical progression|0|||
170537894|NCT02952248|616311664|FG001|Overall Study|Clinical progression|0|||
170784523|NCT02783300|617219075|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784524|NCT02783300|617219076|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784525|NCT02783300|617219077|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
170784526|NCT02783300|617219078|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784527|NCT02783300|617219079|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784528|NCT02783300|617219080|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
170784529|NCT02783300|617219081|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784530|NCT02783300|617219082|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784531|NCT02783300|617219083|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784532|NCT02783300|617219084|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784533|NCT02783300|617219085|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784534|NCT02783300|617219086|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784535|NCT02783300|617219087|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784536|NCT02783300|617219088|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784537|NCT02783300|617219089|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784538|NCT02783300|617219090|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784539|NCT02783300|617219091|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784540|NCT02783300|617219092|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784541|NCT02783300|617219093|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784542|NCT02783300|617219094|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
170784543|NCT02783300|617219068|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784544|NCT02783300|617219069|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784545|NCT02783300|617219070|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784546|NCT02783300|617219071|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784547|NCT02783300|617219072|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784548|NCT02783300|617219073|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784549|NCT02783300|617219074|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784550|NCT02783300|617219075|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784551|NCT02783300|617219076|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784552|NCT02783300|617219077|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784553|NCT02783300|617219078|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784554|NCT02783300|617219079|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784555|NCT02783300|617219080|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784556|NCT02783300|617219081|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784557|NCT02783300|617219082|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784558|NCT02783300|617219083|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
170784559|NCT02783300|617219084|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784560|NCT02783300|617219085|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
170784561|NCT02783300|617219086|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
170784562|NCT02783300|617219087|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
170784563|NCT02783300|617219088|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784564|NCT02783300|617219089|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784565|NCT02783300|617219090|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784566|NCT02783300|617219091|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784567|NCT02783300|617219092|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
170784568|NCT02783300|617219093|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784569|NCT02783300|617219094|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
170784570|NCT02783300|617219068|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784571|NCT02783300|617219069|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784572|NCT02783300|617219070|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784573|NCT02783300|617219071|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784574|NCT02783300|617219072|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784575|NCT02783300|617219073|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784576|NCT02783300|617219074|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784577|NCT02783300|617219075|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784578|NCT02783300|617219076|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784579|NCT02783300|617219077|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784580|NCT02783300|617219078|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784581|NCT02783300|617219079|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170885909|NCT03977467|617590199|FG000|Overall Study|Study Terminated|1|||
170537895|NCT02952248|616311665|FG002|Overall Study|Clinical progression|0|||
170885910|NCT03977467|617590200|FG001|Overall Study|Study Terminated|0|||
170885911|NCT03977467|617590201|FG002|Overall Study|Study Terminated|0|||
170885912|NCT03977467|617590202|FG003|Overall Study|Study Terminated|1|||
170885913|NCT01100437|617590205|FG000|Titration/Stabilization|Adverse Event|0|||
170885914|NCT01100437|617590206|FG001|Titration/Stabilization|Adverse Event|0|||
170885915|NCT01100437|617590207|FG002|Titration/Stabilization|Adverse Event|4|||
170885916|NCT01100437|617590205|FG000|Titration/Stabilization|Non-compliance|0|||
170885917|NCT01100437|617590206|FG001|Titration/Stabilization|Non-compliance|0|||
170885918|NCT01100437|617590207|FG002|Titration/Stabilization|Non-compliance|1|||
170885919|NCT01100437|617590205|FG000|Titration/Stabilization|Sponsor canceled study|0|||
170885920|NCT01100437|617590206|FG001|Titration/Stabilization|Sponsor canceled study|0|||
170885921|NCT01100437|617590207|FG002|Titration/Stabilization|Sponsor canceled study|1|||
170885922|NCT01100437|617590205|FG000|Maintenance|Withdrawal by Subject|0|||
170885923|NCT01100437|617590206|FG001|Maintenance|Withdrawal by Subject|0|||
170885924|NCT01100437|617590207|FG002|Maintenance|Withdrawal by Subject|1|||
170885925|NCT01100437|617590205|FG000|Maintenance|Sponsor termination of study|0|||
170885926|NCT01100437|617590206|FG001|Maintenance|Sponsor termination of study|0|||
170885927|NCT01100437|617590207|FG002|Maintenance|Sponsor termination of study|1|||
170885928|NCT01344876|617590215|FG000|Overall Study|Adverse Event|0|||
170885929|NCT01344876|617590216|FG001|Overall Study|Adverse Event|0|||
170885930|NCT01344876|617590217|FG002|Overall Study|Adverse Event|0|||
170885931|NCT01344876|617590218|FG003|Overall Study|Adverse Event|0|||
170885932|NCT01344876|617590219|FG004|Overall Study|Adverse Event|1|||
170441296|NCT01698554|615954675|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170441297|NCT01698554|615954676|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170441298|NCT01698554|615954677|FG002|Overall Study|Other Miscellaneous Reasons|0|||
170441299|NCT01698554|615954678|FG003|Overall Study|Other Miscellaneous Reasons|0|||
170441300|NCT04473326|615954683|FG000|Overall Study|Death|0|||
170441301|NCT04473326|615954684|FG001|Overall Study|Death|1|||
170441302|NCT04473326|615954683|FG000|Overall Study|Withdrawal by Subject|1|||
170441303|NCT04473326|615954684|FG001|Overall Study|Withdrawal by Subject|2|||
170441304|NCT00640926|615954685|FG000|Overall Study|Adverse Event|2|||
170441305|NCT00640926|615954686|FG001|Overall Study|Adverse Event|3|||
170441306|NCT00640926|615954687|FG002|Overall Study|Adverse Event|2|||
170441307|NCT00640926|615954685|FG000|Overall Study|Lack of Efficacy|0|||
170441308|NCT00640926|615954686|FG001|Overall Study|Lack of Efficacy|2|||
170441309|NCT00640926|615954687|FG002|Overall Study|Lack of Efficacy|1|||
170885933|NCT01344876|617590215|FG000|Overall Study|Withdrawal by Subject|0|||
170885934|NCT01344876|617590216|FG001|Overall Study|Withdrawal by Subject|0|||
170885935|NCT01344876|617590217|FG002|Overall Study|Withdrawal by Subject|1|||
170885936|NCT01344876|617590218|FG003|Overall Study|Withdrawal by Subject|0|||
170885937|NCT01344876|617590219|FG004|Overall Study|Withdrawal by Subject|0|||
170885938|NCT01344876|617590215|FG000|Overall Study|Definite progression of primary disease|1|||
170885939|NCT01344876|617590216|FG001|Overall Study|Definite progression of primary disease|0|||
170441310|NCT00640926|615954685|FG000|Overall Study|Protocol Violation|2|||
170441311|NCT00640926|615954686|FG001|Overall Study|Protocol Violation|0|||
170441312|NCT00640926|615954687|FG002|Overall Study|Protocol Violation|2|||
170441313|NCT00640926|615954685|FG000|Overall Study|Lost to Follow-up|3|||
170441314|NCT00640926|615954686|FG001|Overall Study|Lost to Follow-up|1|||
170441315|NCT00640926|615954687|FG002|Overall Study|Lost to Follow-up|2|||
170885940|NCT01344876|617590217|FG002|Overall Study|Definite progression of primary disease|0|||
170885941|NCT01344876|617590218|FG003|Overall Study|Definite progression of primary disease|3|||
170885942|NCT01344876|617590219|FG004|Overall Study|Definite progression of primary disease|0|||
170885943|NCT05107765|617590220|FG000|Overall Study|Lost to Follow-up|4|||
170885944|NCT05107765|617590221|FG001|Overall Study|Lost to Follow-up|1|||
170885945|NCT05107765|617590220|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
170441316|NCT00640926|615954685|FG000|Overall Study|Withdrawal by Subject|1|||
170441317|NCT00640926|615954686|FG001|Overall Study|Withdrawal by Subject|0|||
170441318|NCT00640926|615954687|FG002|Overall Study|Withdrawal by Subject|1|||
170885946|NCT05107765|617590221|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
170885947|NCT05107765|617590220|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
170885948|NCT05107765|617590221|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
170885949|NCT03047980|617592054|FG000|Overall Study|Adverse Event|1|||
170885950|NCT00879229|617592057|FG000|Overall Study|Study terminated by Sponsor|13|||
170885951|NCT00879229|617592058|FG001|Overall Study|Study terminated by Sponsor|12|||
170441319|NCT02985398|615954688|FG000|Overall Study|Adverse Event|1|||
170441320|NCT02985398|615954688|FG000|Overall Study|Lost to Follow-up|4|||
170537896|NCT02952248|616311666|FG003|Overall Study|Clinical progression|1|||
170885952|NCT00879229|617592057|FG000|Overall Study|Death|4|||
170885953|NCT00879229|617592058|FG001|Overall Study|Death|2|||
170885954|NCT00879229|617592057|FG000|Overall Study|Adverse Event|2|||
170885955|NCT00879229|617592058|FG001|Overall Study|Adverse Event|0|||
170885956|NCT00879229|617592057|FG000|Overall Study|Withdrawal by Subject|1|||
170441321|NCT02985398|615954688|FG000|Overall Study|Withdrawal by Subject|8|||
170441322|NCT02985398|615954688|FG000|Overall Study|Study Burden|9|||
170537897|NCT02952248|616311667|FG004|Overall Study|Clinical progression|0|||
170885957|NCT00879229|617592058|FG001|Overall Study|Withdrawal by Subject|0|||
170885958|NCT00879229|617592057|FG000|Overall Study|Clinical status did not improve|1|||
170885959|NCT00879229|617592058|FG001|Overall Study|Clinical status did not improve|0|||
170885960|NCT00879229|617592057|FG000|Overall Study|Other|1|||
170885961|NCT00879229|617592058|FG001|Overall Study|Other|0|||
170885962|NCT04316585|617592059|FG000|Overall Study|Adverse Event|2|||
170885963|NCT04316585|617592060|FG001|Overall Study|Adverse Event|1|||
170885964|NCT04316585|617592059|FG000|Overall Study|Lost to Follow-up|1|||
170885965|NCT04316585|617592060|FG001|Overall Study|Lost to Follow-up|0|||
170885966|NCT04316585|617592059|FG000|Overall Study|Withdrawal by Subject|2|||
170885967|NCT04316585|617592060|FG001|Overall Study|Withdrawal by Subject|3|||
170885968|NCT04316585|617592059|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
170885969|NCT04316585|617592060|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
170885970|NCT04316585|617592059|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
170885971|NCT04316585|617592060|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
170885972|NCT02770326|617592062|FG000|Overall Study|Death|3|||
170885973|NCT02770326|617592062|FG000|Overall Study|Lost to Follow-up|1|||
170885974|NCT04232696|617592065|FG000|Overall Study|Implant attempted but not completed|5|||
170885975|NCT04232696|617592066|FG001|Overall Study|Implant attempted but not completed|2|||
170885976|NCT04232696|617592065|FG000|Overall Study|Not satisfied with therapy outcome|0|||
170885977|NCT04232696|617592066|FG001|Overall Study|Not satisfied with therapy outcome|8|||
170885978|NCT04232696|617592065|FG000|Overall Study|Adverse Event|0|||
170885979|NCT04232696|617592066|FG001|Overall Study|Adverse Event|3|||
170885980|NCT04232696|617592065|FG000|Overall Study|Withdrawal by Subject|0|||
170885981|NCT04232696|617592066|FG001|Overall Study|Withdrawal by Subject|3|||
170885982|NCT04232696|617592065|FG000|Overall Study|Missed Visit|0|||
170885983|NCT04232696|617592066|FG001|Overall Study|Missed Visit|2|||
170885984|NCT04232696|617592065|FG000|Overall Study|Other reason|0|||
170885985|NCT04232696|617592066|FG001|Overall Study|Other reason|1|||
170885986|NCT00488982|617592067|FG000|Course 1|Physician Decision|0|||
170885987|NCT00488982|617592068|FG001|Course 1|Physician Decision|2|||
170885988|NCT00488982|617592069|FG002|Course 1|Physician Decision|4|||
170885989|NCT00488982|617592067|FG000|Course 1|Withdrawal by Subject|0|||
170885990|NCT00488982|617592068|FG001|Course 1|Withdrawal by Subject|8|||
170885991|NCT00488982|617592069|FG002|Course 1|Withdrawal by Subject|2|||
170885992|NCT00488982|617592067|FG000|Course 1|nonprotocol therapy|0|||
170885993|NCT00488982|617592068|FG001|Course 1|nonprotocol therapy|2|||
170885994|NCT00488982|617592069|FG002|Course 1|nonprotocol therapy|2|||
170885995|NCT00488982|617592067|FG000|Course 1|Adverse Event|0|||
170885996|NCT00488982|617592068|FG001|Course 1|Adverse Event|0|||
170885997|NCT00488982|617592069|FG002|Course 1|Adverse Event|6|||
170885998|NCT01678144|617592070|FG000|Stage 1: MAR Classic|Adverse Event|1|||
170885999|NCT03118297|617592071|FG000|Overall Study|Lost to Follow-up|0|||
170886000|NCT03118297|617592072|FG001|Overall Study|Lost to Follow-up|2|||
170886001|NCT02792842|617592076|FG000|Overall Study|Adverse Event|4|||
170886002|NCT02792842|617592077|FG001|Overall Study|Adverse Event|2|||
170886003|NCT02792842|617592078|FG002|Overall Study|Adverse Event|3|||
170886004|NCT02792842|617592076|FG000|Overall Study|Withdrawal by Subject|0|||
170886005|NCT02792842|617592077|FG001|Overall Study|Withdrawal by Subject|1|||
170886006|NCT02792842|617592078|FG002|Overall Study|Withdrawal by Subject|2|||
170886007|NCT02792842|617592076|FG000|Overall Study|Lost to Follow-up|0|||
170441323|NCT01841073|615954691|FG000|Overall Study|Adverse Event|1|||
170441324|NCT01841073|615954692|FG001|Overall Study|Adverse Event|1|||
170441325|NCT01841073|615954691|FG000|Overall Study|Physician Decision|1|||
170441326|NCT01841073|615954692|FG001|Overall Study|Physician Decision|0|||
170441327|NCT01841073|615954691|FG000|Overall Study|Lost to Follow-up|0|||
170441328|NCT01841073|615954692|FG001|Overall Study|Lost to Follow-up|2|||
170441329|NCT00668395|615954693|FG000|Overall Study|Withdrawal by Subject|4|||
170441330|NCT00668395|615954694|FG001|Overall Study|Withdrawal by Subject|4|||
170441331|NCT00668395|615954695|FG002|Overall Study|Withdrawal by Subject|1|||
170441332|NCT00668395|615954693|FG000|Overall Study|Adverse Event|1|||
170441333|NCT00668395|615954694|FG001|Overall Study|Adverse Event|1|||
170441334|NCT00668395|615954695|FG002|Overall Study|Adverse Event|0|||
170441335|NCT00668395|615954693|FG000|Overall Study|Physician Decision|1|||
170441336|NCT00668395|615954694|FG001|Overall Study|Physician Decision|1|||
170441337|NCT00668395|615954695|FG002|Overall Study|Physician Decision|0|||
170441338|NCT02858037|615954698|FG000|Overall Study|Death|1|||
170784582|NCT02783300|617219080|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784583|NCT02783300|617219081|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784584|NCT02783300|617219082|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784585|NCT02783300|617219083|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784586|NCT02783300|617219084|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
170784587|NCT02783300|617219085|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784588|NCT02783300|617219086|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
170784589|NCT02783300|617219087|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
170784590|NCT02783300|617219088|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784591|NCT02783300|617219089|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784592|NCT02783300|617219090|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784593|NCT02783300|617219091|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784594|NCT02783300|617219092|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784595|NCT02783300|617219093|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784596|NCT02783300|617219094|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
170784597|NCT02783300|617219068|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784598|NCT02783300|617219069|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784599|NCT02783300|617219070|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784600|NCT02783300|617219071|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784601|NCT02783300|617219072|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784602|NCT02783300|617219073|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784603|NCT02783300|617219074|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784604|NCT02783300|617219075|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784605|NCT02783300|617219076|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784606|NCT02783300|617219077|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784607|NCT02783300|617219078|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784608|NCT02783300|617219079|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784609|NCT02783300|617219080|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784610|NCT02783300|617219081|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784611|NCT02783300|617219082|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784612|NCT02783300|617219083|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784613|NCT02783300|617219084|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
170784614|NCT02783300|617219085|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784615|NCT02783300|617219086|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
170784616|NCT02783300|617219087|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
170784617|NCT02783300|617219088|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
170784618|NCT02783300|617219089|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784619|NCT02783300|617219090|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784620|NCT02783300|617219091|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784621|NCT02783300|617219092|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784622|NCT02783300|617219093|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784623|NCT02783300|617219094|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
170784624|NCT02783300|617219068|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784625|NCT02783300|617219069|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784626|NCT02783300|617219070|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784627|NCT02783300|617219071|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784628|NCT02783300|617219072|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170441339|NCT02858037|615954698|FG000|Overall Study|Withdrawal by Subject|18|||
170441340|NCT02858037|615954698|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
170441341|NCT02858037|615954698|FG000|Overall Study|Lost to Follow-up|3|||
170441342|NCT02858037|615954698|FG000|Overall Study|Other|4|||
170441343|NCT00283842|615954705|FG000|Overall Study|Adverse Event|8|||
170441344|NCT00283842|615954706|FG001|Overall Study|Adverse Event|7|||
170441345|NCT00283842|615954707|FG002|Overall Study|Adverse Event|21|||
170441346|NCT00283842|615954708|FG003|Overall Study|Adverse Event|21|||
170441347|NCT00283842|615954709|FG004|Overall Study|Adverse Event|5|||
170441348|NCT00283842|615954705|FG000|Overall Study|Protocol Violation|1|||
170441349|NCT00283842|615954706|FG001|Overall Study|Protocol Violation|5|||
170784629|NCT02783300|617219073|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784630|NCT02783300|617219074|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784631|NCT02783300|617219075|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784632|NCT02783300|617219076|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784633|NCT02783300|617219077|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784634|NCT02783300|617219078|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784635|NCT02783300|617219079|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784636|NCT02783300|617219080|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784637|NCT02783300|617219081|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784638|NCT02783300|617219082|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784639|NCT02783300|617219083|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
170784640|NCT02783300|617219084|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784641|NCT02783300|617219085|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784642|NCT02783300|617219086|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784643|NCT02783300|617219087|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784644|NCT02783300|617219088|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784645|NCT02783300|617219089|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784646|NCT02783300|617219090|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
170784647|NCT02783300|617219091|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784648|NCT02783300|617219092|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784649|NCT02783300|617219093|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784650|NCT02783300|617219094|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
170784651|NCT02783300|617219068|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784652|NCT02783300|617219069|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784653|NCT02783300|617219070|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784654|NCT02783300|617219071|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784655|NCT02783300|617219072|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784656|NCT02783300|617219073|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784657|NCT02783300|617219074|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784658|NCT02783300|617219075|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784659|NCT02783300|617219076|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784660|NCT02783300|617219077|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784661|NCT02783300|617219078|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784662|NCT02783300|617219079|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784663|NCT02783300|617219080|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784664|NCT02783300|617219081|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
170784665|NCT02783300|617219082|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
170784666|NCT02783300|617219083|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
170784667|NCT02783300|617219084|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
170784668|NCT02783300|617219085|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784669|NCT02783300|617219086|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
170784670|NCT02783300|617219087|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
170784671|NCT02783300|617219088|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784672|NCT02783300|617219089|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784673|NCT02783300|617219090|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784674|NCT02783300|617219091|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784675|NCT02783300|617219092|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784676|NCT02783300|617219093|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784677|NCT02783300|617219094|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
170784678|NCT02783300|617219068|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784679|NCT02783300|617219069|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784680|NCT02783300|617219070|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784681|NCT02783300|617219071|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784682|NCT02783300|617219072|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170441350|NCT00283842|615954707|FG002|Overall Study|Protocol Violation|4|||
170886008|NCT02792842|617592077|FG001|Overall Study|Lost to Follow-up|0|||
170886009|NCT02792842|617592078|FG002|Overall Study|Lost to Follow-up|1|||
170886010|NCT02792842|617592076|FG000|Overall Study|Schedule delay|0|||
170886011|NCT02792842|617592077|FG001|Overall Study|Schedule delay|1|||
170886012|NCT02792842|617592078|FG002|Overall Study|Schedule delay|1|||
170886013|NCT05289830|617592084|FG000|Overall Study|Lost to Follow-up|1|||
170886014|NCT05289830|617592085|FG001|Overall Study|Lost to Follow-up|1|||
170886015|NCT05289830|617592084|FG000|Overall Study|Physician Decision|0|||
170886016|NCT05289830|617592085|FG001|Overall Study|Physician Decision|1|||
170886017|NCT01046825|617592088|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
170886018|NCT01046825|617592089|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
170886019|NCT01046825|617592090|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
170886020|NCT01046825|617592091|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
170886021|NCT01046825|617592092|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
170886022|NCT01046825|617592088|FG000|Overall Study|Physician Decision|0|||
170886023|NCT01046825|617592089|FG001|Overall Study|Physician Decision|1|||
170886024|NCT01046825|617592090|FG002|Overall Study|Physician Decision|2|||
170886025|NCT01046825|617592091|FG003|Overall Study|Physician Decision|0|||
170886026|NCT01046825|617592092|FG004|Overall Study|Physician Decision|0|||
170886027|NCT01046825|617592088|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
170886028|NCT01046825|617592089|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
170886029|NCT01046825|617592090|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
170886030|NCT01046825|617592091|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
170886031|NCT01046825|617592092|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
170886032|NCT01046825|617592088|FG000|Overall Study|Found to be ineligible|0|||
170886033|NCT01046825|617592089|FG001|Overall Study|Found to be ineligible|1|||
170886034|NCT01046825|617592090|FG002|Overall Study|Found to be ineligible|0|||
170886035|NCT01046825|617592091|FG003|Overall Study|Found to be ineligible|0|||
170886036|NCT01046825|617592092|FG004|Overall Study|Found to be ineligible|0|||
170886037|NCT01046825|617592088|FG000|Overall Study|Death|0|||
170886038|NCT01046825|617592089|FG001|Overall Study|Death|0|||
170886039|NCT01046825|617592090|FG002|Overall Study|Death|0|||
170886040|NCT01046825|617592091|FG003|Overall Study|Death|1|||
170886041|NCT01046825|617592092|FG004|Overall Study|Death|0|||
170886042|NCT01046825|617592088|FG000|Overall Study|Did not submit biology samples|0|||
170886043|NCT01046825|617592089|FG001|Overall Study|Did not submit biology samples|0|||
170886044|NCT01046825|617592090|FG002|Overall Study|Did not submit biology samples|0|||
170886045|NCT01046825|617592091|FG003|Overall Study|Did not submit biology samples|0|||
170886046|NCT01046825|617592092|FG004|Overall Study|Did not submit biology samples|13|||
170886047|NCT05617911|617592095|FG000|Overall Study|Withdrawal by Subject|1|||
170886048|NCT05617911|617592096|FG001|Overall Study|Withdrawal by Subject|0|||
170886049|NCT03557359|617592097|FG000|Dose 1: 240 mg|Adverse Event|1|||
170886050|NCT03557359|617592098|FG001|Dose 1: 240 mg|Adverse Event|0|||
170886051|NCT03975647|617592099|FG000|Overall Study|Death|71|||
170886052|NCT03975647|617592100|FG001|Overall Study|Death|63|||
170886053|NCT03975647|617592099|FG000|Overall Study|Lost to Follow-up|2|||
170886054|NCT03975647|617592100|FG001|Overall Study|Lost to Follow-up|2|||
170886055|NCT03975647|617592099|FG000|Overall Study|Subject withdrawal of consent|7|||
170886056|NCT03975647|617592100|FG001|Overall Study|Subject withdrawal of consent|11|||
170886057|NCT04868903|617592101|FG000|Overall Study|Adverse Event|0|||
170886058|NCT04868903|617592102|FG001|Overall Study|Adverse Event|0|||
170886059|NCT04868903|617592103|FG002|Overall Study|Adverse Event|0|||
170886060|NCT04868903|617592104|FG003|Overall Study|Adverse Event|1|||
170886061|NCT04868903|617592101|FG000|Overall Study|Withdrawal by Subject|29|||
170886062|NCT04868903|617592102|FG001|Overall Study|Withdrawal by Subject|44|||
170886063|NCT04868903|617592103|FG002|Overall Study|Withdrawal by Subject|17|||
170886064|NCT04868903|617592104|FG003|Overall Study|Withdrawal by Subject|12|||
170886065|NCT04868903|617592101|FG000|Overall Study|Hyperparathyroidism|3|||
170886066|NCT04868903|617592102|FG001|Overall Study|Hyperparathyroidism|5|||
170886067|NCT04868903|617592103|FG002|Overall Study|Hyperparathyroidism|2|||
170886068|NCT04868903|617592104|FG003|Overall Study|Hyperparathyroidism|3|||
170886069|NCT01121393|617592109|FG000|Overall Study|Progressive disease|201|||
170886070|NCT01121393|617592110|FG001|Overall Study|Progressive disease|20|||
170886071|NCT01121393|617592109|FG000|Overall Study|Other Adverse events|24|||
170886072|NCT01121393|617592110|FG001|Overall Study|Other Adverse events|45|||
170886073|NCT01121393|617592109|FG000|Overall Study|Non-compliant with protocol|0|||
170886074|NCT01121393|617592110|FG001|Overall Study|Non-compliant with protocol|3|||
170886075|NCT01121393|617592109|FG000|Overall Study|Lost to Follow-up|1|||
170886076|NCT01121393|617592110|FG001|Overall Study|Lost to Follow-up|0|||
170886077|NCT01121393|617592109|FG000|Overall Study|Refused cont. medication|7|||
170886078|NCT01121393|617592110|FG001|Overall Study|Refused cont. medication|7|||
170886079|NCT01121393|617592109|FG000|Overall Study|Not treated|3|||
170886080|NCT01121393|617592110|FG001|Overall Study|Not treated|9|||
170886081|NCT01121393|617592109|FG000|Overall Study|Other than listed|6|||
170886082|NCT01121393|617592110|FG001|Overall Study|Other than listed|0|||
170886083|NCT01926782|617592111|FG000|Overall Study|Participant moved|2|||
170886084|NCT01926782|617592112|FG001|Overall Study|Participant moved|0|||
170886085|NCT01926782|617592113|FG002|Overall Study|Participant moved|1|||
170886086|NCT01926782|617592114|FG003|Overall Study|Participant moved|1|||
170886087|NCT01926782|617592115|FG004|Overall Study|Participant moved|0|||
170886088|NCT01926782|617592116|FG005|Overall Study|Participant moved|3|||
170886089|NCT01926782|617592111|FG000|Overall Study|Physician Decision|0|||
170886090|NCT01926782|617592112|FG001|Overall Study|Physician Decision|2|||
170886091|NCT01926782|617592113|FG002|Overall Study|Physician Decision|1|||
170886092|NCT01926782|617592114|FG003|Overall Study|Physician Decision|1|||
170886093|NCT01926782|617592115|FG004|Overall Study|Physician Decision|0|||
170886094|NCT01926782|617592116|FG005|Overall Study|Physician Decision|0|||
170886095|NCT01926782|617592111|FG000|Overall Study|Other than specified|2|||
170886096|NCT01926782|617592112|FG001|Overall Study|Other than specified|3|||
170886097|NCT01926782|617592113|FG002|Overall Study|Other than specified|5|||
170886098|NCT01926782|617592114|FG003|Overall Study|Other than specified|12|||
170886099|NCT01926782|617592115|FG004|Overall Study|Other than specified|4|||
170886100|NCT01926782|617592116|FG005|Overall Study|Other than specified|11|||
170886101|NCT01926782|617592111|FG000|Overall Study|Adverse Event|13|||
170886102|NCT01926782|617592112|FG001|Overall Study|Adverse Event|4|||
170886103|NCT01926782|617592113|FG002|Overall Study|Adverse Event|17|||
170886104|NCT01926782|617592114|FG003|Overall Study|Adverse Event|4|||
170886105|NCT01926782|617592115|FG004|Overall Study|Adverse Event|3|||
170886106|NCT01926782|617592116|FG005|Overall Study|Adverse Event|14|||
170886107|NCT01926782|617592111|FG000|Overall Study|Poor compliance to protocol|5|||
170886108|NCT01926782|617592112|FG001|Overall Study|Poor compliance to protocol|3|||
170886109|NCT01926782|617592113|FG002|Overall Study|Poor compliance to protocol|8|||
170886110|NCT01926782|617592114|FG003|Overall Study|Poor compliance to protocol|0|||
170886111|NCT01926782|617592115|FG004|Overall Study|Poor compliance to protocol|1|||
170886112|NCT01926782|617592116|FG005|Overall Study|Poor compliance to protocol|6|||
170886113|NCT01926782|617592111|FG000|Overall Study|Randomized and not treated|0|||
170886114|NCT01926782|617592112|FG001|Overall Study|Randomized and not treated|0|||
170886115|NCT01926782|617592113|FG002|Overall Study|Randomized and not treated|0|||
170886116|NCT01926782|617592114|FG003|Overall Study|Randomized and not treated|1|||
170886117|NCT01926782|617592115|FG004|Overall Study|Randomized and not treated|0|||
170886118|NCT01926782|617592116|FG005|Overall Study|Randomized and not treated|0|||
170886119|NCT01926782|617592111|FG000|Overall Study|Withdrawal by Subject|6|||
170886120|NCT01926782|617592112|FG001|Overall Study|Withdrawal by Subject|1|||
170886121|NCT01926782|617592113|FG002|Overall Study|Withdrawal by Subject|8|||
170886122|NCT01926782|617592114|FG003|Overall Study|Withdrawal by Subject|1|||
170886123|NCT01926782|617592115|FG004|Overall Study|Withdrawal by Subject|0|||
170886124|NCT01926782|617592116|FG005|Overall Study|Withdrawal by Subject|5|||
170886125|NCT01926782|617592111|FG000|Overall Study|Related to study drug administration|0|||
170886126|NCT01926782|617592112|FG001|Overall Study|Related to study drug administration|0|||
170886127|NCT01926782|617592113|FG002|Overall Study|Related to study drug administration|0|||
170886128|NCT01926782|617592114|FG003|Overall Study|Related to study drug administration|0|||
170886129|NCT01926782|617592115|FG004|Overall Study|Related to study drug administration|0|||
170886130|NCT01926782|617592116|FG005|Overall Study|Related to study drug administration|2|||
170886131|NCT04607733|617592117|FG000|Overall Study|Lost to Follow-up|1|||
170886132|NCT04607733|617592118|FG001|Overall Study|Lost to Follow-up|0|||
170886133|NCT04607733|617592119|FG002|Overall Study|Lost to Follow-up|0|||
170886134|NCT04607733|617592120|FG003|Overall Study|Lost to Follow-up|1|||
170886135|NCT04607733|617592121|FG004|Overall Study|Lost to Follow-up|1|||
170886136|NCT04607733|617592122|FG005|Overall Study|Lost to Follow-up|0|||
170886137|NCT04607733|617592117|FG000|Overall Study|Withdrawal by Subject|0|||
170886138|NCT04607733|617592118|FG001|Overall Study|Withdrawal by Subject|0|||
170886139|NCT04607733|617592119|FG002|Overall Study|Withdrawal by Subject|0|||
170886140|NCT04607733|617592120|FG003|Overall Study|Withdrawal by Subject|0|||
170886141|NCT04607733|617592121|FG004|Overall Study|Withdrawal by Subject|1|||
170886142|NCT04607733|617592122|FG005|Overall Study|Withdrawal by Subject|0|||
170886143|NCT00577993|617592146|FG000|Overall Study|Adverse Event|1|||
170886144|NCT00577993|617592147|FG001|Overall Study|Adverse Event|0|||
170886145|NCT00577993|617592148|FG002|Overall Study|Adverse Event|0|||
170886146|NCT00577993|617592146|FG000|Overall Study|Death|0|||
170886147|NCT00577993|617592147|FG001|Overall Study|Death|1|||
170886148|NCT00577993|617592148|FG002|Overall Study|Death|1|||
170886149|NCT00577993|617592146|FG000|Overall Study|Lack of Efficacy|0|||
170886150|NCT00577993|617592147|FG001|Overall Study|Lack of Efficacy|1|||
170886151|NCT00577993|617592148|FG002|Overall Study|Lack of Efficacy|0|||
170886152|NCT00577993|617592146|FG000|Overall Study|Protocol Violation|2|||
170886153|NCT00577993|617592147|FG001|Overall Study|Protocol Violation|3|||
170886154|NCT00577993|617592148|FG002|Overall Study|Protocol Violation|0|||
170886155|NCT00577993|617592146|FG000|Overall Study|Withdrawal by Subject|1|||
170886156|NCT00577993|617592147|FG001|Overall Study|Withdrawal by Subject|0|||
170886157|NCT00577993|617592148|FG002|Overall Study|Withdrawal by Subject|2|||
170886158|NCT00577993|617592146|FG000|Overall Study|Conversion|2|||
170886159|NCT00577993|617592147|FG001|Overall Study|Conversion|5|||
170886160|NCT00577993|617592148|FG002|Overall Study|Conversion|0|||
170886161|NCT00577993|617592146|FG000|Overall Study|Uninsured|1|||
170886162|NCT00577993|617592147|FG001|Overall Study|Uninsured|0|||
170886163|NCT00577993|617592148|FG002|Overall Study|Uninsured|0|||
170886164|NCT02217566|617592151|FG000|Overall Study|Lost to Follow-up|2|||
170886165|NCT02217566|617592151|FG000|Overall Study|Death|3|||
170886166|NCT02217566|617592151|FG000|Overall Study|Early study termination|6|||
170886167|NCT02296242|617592152|FG000|Overall Study|Death|1|||
170886168|NCT02296242|617592153|FG001|Overall Study|Death|1|||
170886169|NCT02296242|617592154|FG002|Overall Study|Death|1|||
170886170|NCT02296242|617592155|FG003|Overall Study|Death|1|||
170886171|NCT02296242|617592156|FG004|Overall Study|Death|1|||
170886172|NCT02296242|617592152|FG000|Overall Study|Withdrawal by Subject|0|||
170886173|NCT02296242|617592153|FG001|Overall Study|Withdrawal by Subject|0|||
170886174|NCT02296242|617592154|FG002|Overall Study|Withdrawal by Subject|1|||
170886175|NCT02296242|617592155|FG003|Overall Study|Withdrawal by Subject|1|||
170886176|NCT02296242|617592156|FG004|Overall Study|Withdrawal by Subject|3|||
170886177|NCT02296242|617592152|FG000|Overall Study|Disease Progression|1|||
170886178|NCT02296242|617592153|FG001|Overall Study|Disease Progression|3|||
170886179|NCT02296242|617592154|FG002|Overall Study|Disease Progression|2|||
170886180|NCT02296242|617592155|FG003|Overall Study|Disease Progression|8|||
170886181|NCT02296242|617592156|FG004|Overall Study|Disease Progression|11|||
170886182|NCT02296242|617592152|FG000|Overall Study|Unacceptable Toxicity|0|||
170886183|NCT02296242|617592153|FG001|Overall Study|Unacceptable Toxicity|0|||
170886184|NCT02296242|617592154|FG002|Overall Study|Unacceptable Toxicity|0|||
170886185|NCT02296242|617592155|FG003|Overall Study|Unacceptable Toxicity|0|||
170886186|NCT02296242|617592156|FG004|Overall Study|Unacceptable Toxicity|1|||
170886187|NCT02296242|617592152|FG000|Overall Study|Patient Condition Changed|0|||
170886188|NCT02296242|617592153|FG001|Overall Study|Patient Condition Changed|0|||
170886189|NCT02296242|617592154|FG002|Overall Study|Patient Condition Changed|2|||
170886190|NCT02296242|617592155|FG003|Overall Study|Patient Condition Changed|0|||
170886191|NCT02296242|617592156|FG004|Overall Study|Patient Condition Changed|1|||
170886192|NCT02296242|617592152|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
170886193|NCT02296242|617592153|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
170886194|NCT02296242|617592154|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
170886195|NCT02296242|617592155|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
170886196|NCT02296242|617592156|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
170886197|NCT02296242|617592152|FG000|Overall Study|Lost to Follow-up|1|||
170886198|NCT02296242|617592153|FG001|Overall Study|Lost to Follow-up|0|||
170886199|NCT02296242|617592154|FG002|Overall Study|Lost to Follow-up|0|||
170886200|NCT02296242|617592155|FG003|Overall Study|Lost to Follow-up|0|||
170886201|NCT02296242|617592156|FG004|Overall Study|Lost to Follow-up|0|||
170886202|NCT02296242|617592152|FG000|Overall Study|Need for Hydroxyurea|2|||
170886203|NCT02296242|617592153|FG001|Overall Study|Need for Hydroxyurea|0|||
170886204|NCT02296242|617592154|FG002|Overall Study|Need for Hydroxyurea|0|||
170886205|NCT02296242|617592155|FG003|Overall Study|Need for Hydroxyurea|0|||
170886206|NCT02296242|617592156|FG004|Overall Study|Need for Hydroxyurea|0|||
170886207|NCT02296242|617592152|FG000|Overall Study|Screened for Other Protocol|0|||
170886208|NCT02296242|617592153|FG001|Overall Study|Screened for Other Protocol|1|||
170886209|NCT02296242|617592154|FG002|Overall Study|Screened for Other Protocol|0|||
170886210|NCT02296242|617592155|FG003|Overall Study|Screened for Other Protocol|0|||
170886211|NCT02296242|617592156|FG004|Overall Study|Screened for Other Protocol|0|||
170886212|NCT02296242|617592152|FG000|Overall Study|Physician Decision|0|||
170886213|NCT02296242|617592153|FG001|Overall Study|Physician Decision|1|||
170886214|NCT02296242|617592154|FG002|Overall Study|Physician Decision|0|||
170886215|NCT02296242|617592155|FG003|Overall Study|Physician Decision|1|||
170886216|NCT02296242|617592156|FG004|Overall Study|Physician Decision|0|||
170886217|NCT02296242|617592152|FG000|Overall Study|Alternative Treatment|0|||
170886218|NCT02296242|617592153|FG001|Overall Study|Alternative Treatment|0|||
170886219|NCT02296242|617592154|FG002|Overall Study|Alternative Treatment|0|||
170886220|NCT02296242|617592155|FG003|Overall Study|Alternative Treatment|1|||
170886221|NCT02296242|617592156|FG004|Overall Study|Alternative Treatment|0|||
170886222|NCT02296242|617592152|FG000|Overall Study|Adverse Event|0|||
170886223|NCT02296242|617592153|FG001|Overall Study|Adverse Event|0|||
170886224|NCT02296242|617592154|FG002|Overall Study|Adverse Event|0|||
170886225|NCT02296242|617592155|FG003|Overall Study|Adverse Event|1|||
170886226|NCT02296242|617592156|FG004|Overall Study|Adverse Event|0|||
170886227|NCT02296242|617592152|FG000|Overall Study|Lack of Efficacy|0|||
170886228|NCT02296242|617592153|FG001|Overall Study|Lack of Efficacy|0|||
170886229|NCT02296242|617592154|FG002|Overall Study|Lack of Efficacy|0|||
170886230|NCT02296242|617592155|FG003|Overall Study|Lack of Efficacy|0|||
170886231|NCT02296242|617592156|FG004|Overall Study|Lack of Efficacy|3|||
170886232|NCT00070941|617592164|FG000|Overall Study|Adverse Event|10|||
170886233|NCT00070941|617592165|FG001|Overall Study|Adverse Event|8|||
170886234|NCT00070941|617592166|FG002|Overall Study|Adverse Event|4|||
170886235|NCT02064387|617592167|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886236|NCT02064387|617592168|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886237|NCT02064387|617592169|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886238|NCT02064387|617592170|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170784683|NCT02783300|617219073|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784684|NCT02783300|617219074|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784685|NCT02783300|617219075|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784686|NCT02783300|617219076|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784687|NCT02783300|617219077|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784688|NCT02783300|617219078|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784689|NCT02783300|617219079|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784690|NCT02783300|617219080|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784691|NCT02783300|617219081|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
170784692|NCT02783300|617219082|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
170784693|NCT02783300|617219083|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
170784694|NCT02783300|617219084|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
170784695|NCT02783300|617219085|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
170784696|NCT02783300|617219086|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
170784697|NCT02783300|617219087|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
170784698|NCT02783300|617219088|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
170784699|NCT02783300|617219089|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
170784700|NCT02783300|617219090|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
170784701|NCT02783300|617219091|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
170784702|NCT02783300|617219092|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
170784703|NCT02783300|617219093|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
170784704|NCT02783300|617219094|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
170784705|NCT02783300|617219068|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784706|NCT02783300|617219069|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784707|NCT02783300|617219070|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784708|NCT02783300|617219071|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784709|NCT02783300|617219072|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784710|NCT02783300|617219073|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784711|NCT02783300|617219074|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784712|NCT02783300|617219075|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784713|NCT02783300|617219076|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784714|NCT02783300|617219077|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784715|NCT02783300|617219078|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784716|NCT02783300|617219079|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784717|NCT02783300|617219080|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784718|NCT02783300|617219081|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784719|NCT02783300|617219082|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784720|NCT02783300|617219083|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784721|NCT02783300|617219084|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784722|NCT02783300|617219085|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784723|NCT02783300|617219086|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784724|NCT02783300|617219087|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784725|NCT02783300|617219088|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784726|NCT02783300|617219089|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784727|NCT02783300|617219090|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784728|NCT02783300|617219091|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784729|NCT02783300|617219092|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784730|NCT02783300|617219093|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
170784731|NCT02783300|617219094|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
170784732|NCT02783300|617219068|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784733|NCT02783300|617219069|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784734|NCT02783300|617219070|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784735|NCT02783300|617219071|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784736|NCT02783300|617219072|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784737|NCT02783300|617219073|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784738|NCT02783300|617219074|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784739|NCT02783300|617219075|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784740|NCT02783300|617219076|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784741|NCT02783300|617219077|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784742|NCT02783300|617219078|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784743|NCT02783300|617219079|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784744|NCT02783300|617219080|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784745|NCT02783300|617219081|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784746|NCT02783300|617219082|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
170886239|NCT02064387|617592171|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886240|NCT02064387|617592172|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886241|NCT02064387|617592173|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886242|NCT02064387|617592174|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
170886243|NCT02064387|617592175|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886244|NCT02064387|617592176|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
170886245|NCT02064387|617592177|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886246|NCT02064387|617592178|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
170886247|NCT02064387|617592167|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886248|NCT02064387|617592168|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886249|NCT02064387|617592169|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886250|NCT02064387|617592170|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886251|NCT02064387|617592171|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886252|NCT02064387|617592172|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886253|NCT02064387|617592173|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886254|NCT02064387|617592174|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
170886255|NCT02064387|617592175|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886256|NCT02064387|617592176|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886257|NCT02064387|617592177|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886258|NCT02064387|617592178|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
170886259|NCT02064387|617592167|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886260|NCT02064387|617592168|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886261|NCT02064387|617592169|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886262|NCT02064387|617592170|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886263|NCT02064387|617592171|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886264|NCT02064387|617592172|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886265|NCT02064387|617592173|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886266|NCT02064387|617592174|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886267|NCT02064387|617592175|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
170886268|NCT02064387|617592176|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886269|NCT02064387|617592177|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886270|NCT02064387|617592178|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
170886271|NCT02064387|617592167|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
170886272|NCT02064387|617592168|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
170886273|NCT02064387|617592169|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
170886274|NCT02064387|617592170|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
170886275|NCT02064387|617592171|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
170886276|NCT02064387|617592172|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
170886277|NCT02064387|617592173|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
170886278|NCT02064387|617592174|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
170886279|NCT02064387|617592175|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
170886280|NCT02064387|617592176|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
170886281|NCT02064387|617592177|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
170886282|NCT02064387|617592178|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
170886283|NCT02064387|617592167|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170441351|NCT00283842|615954708|FG003|Overall Study|Protocol Violation|0|||
170441352|NCT00283842|615954709|FG004|Overall Study|Protocol Violation|0|||
170441353|NCT00283842|615954705|FG000|Overall Study|Protocol deviation|0|||
170886284|NCT02064387|617592168|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886285|NCT02064387|617592169|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886286|NCT02064387|617592170|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886287|NCT02064387|617592171|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170441354|NCT00283842|615954706|FG001|Overall Study|Protocol deviation|0|||
170886288|NCT02064387|617592172|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886289|NCT02064387|617592173|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886290|NCT02064387|617592174|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886291|NCT02064387|617592175|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886292|NCT02064387|617592176|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886293|NCT02064387|617592177|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
170886294|NCT02064387|617592178|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
170886295|NCT01888640|617592180|FG000|Overall Study|Lost to Follow-up|1|||
170886296|NCT01888640|617592181|FG001|Overall Study|Lost to Follow-up|2|||
170886297|NCT01888640|617592182|FG002|Overall Study|Lost to Follow-up|0|||
170886298|NCT01888640|617592180|FG000|Overall Study|Withdrawal by Subject|15|||
170886299|NCT01888640|617592181|FG001|Overall Study|Withdrawal by Subject|11|||
170441355|NCT00283842|615954707|FG002|Overall Study|Protocol deviation|0|||
170886300|NCT01888640|617592182|FG002|Overall Study|Withdrawal by Subject|4|||
170886301|NCT01888640|617592180|FG000|Overall Study|Minimum dose not met|10|||
170886302|NCT01888640|617592181|FG001|Overall Study|Minimum dose not met|16|||
170886303|NCT01888640|617592182|FG002|Overall Study|Minimum dose not met|0|||
170886304|NCT01888640|617592180|FG000|Overall Study|Given wrong unit (placebo)|1|||
170886305|NCT01888640|617592181|FG001|Overall Study|Given wrong unit (placebo)|0|||
170886306|NCT01888640|617592182|FG002|Overall Study|Given wrong unit (placebo)|0|||
170886307|NCT01888640|617592180|FG000|Overall Study|Excluded for prior TENS|0|||
170886308|NCT01888640|617592181|FG001|Overall Study|Excluded for prior TENS|1|||
170886309|NCT01888640|617592182|FG002|Overall Study|Excluded for prior TENS|0|||
170886310|NCT01888640|617592180|FG000|Overall Study|Researcher Termination of Participant|0|||
170886311|NCT01888640|617592181|FG001|Overall Study|Researcher Termination of Participant|1|||
170886312|NCT01888640|617592182|FG002|Overall Study|Researcher Termination of Participant|1|||
170886313|NCT01277549|617592183|FG000|Overall Study|Failed to meet eligibility criteria|13|||
170886314|NCT01277549|617592184|FG001|Overall Study|Failed to meet eligibility criteria|9|||
170886315|NCT01277549|617592183|FG000|Overall Study|Withdrawal by Subject|1|||
170886316|NCT01277549|617592184|FG001|Overall Study|Withdrawal by Subject|3|||
170886317|NCT01277549|617592183|FG000|Overall Study|Protocol Violation|10|||
170886318|NCT01277549|617592184|FG001|Overall Study|Protocol Violation|1|||
170886319|NCT01277549|617592183|FG000|Overall Study|Physician Decision|2|||
170886320|NCT01277549|617592184|FG001|Overall Study|Physician Decision|1|||
170886321|NCT02436876|617592188|FG000|Overall Study|Lost to Follow-up|0|||
170886322|NCT02436876|617592189|FG001|Overall Study|Lost to Follow-up|1|||
170886323|NCT02436876|617592190|FG002|Overall Study|Lost to Follow-up|1|||
170886324|NCT02436876|617592191|FG003|Overall Study|Lost to Follow-up|1|||
170886325|NCT02436876|617592188|FG000|Overall Study|Withdrawal by Subject|1|||
170886326|NCT02436876|617592189|FG001|Overall Study|Withdrawal by Subject|0|||
170886327|NCT02436876|617592190|FG002|Overall Study|Withdrawal by Subject|0|||
170886328|NCT02436876|617592191|FG003|Overall Study|Withdrawal by Subject|1|||
170886329|NCT02436876|617592188|FG000|Overall Study|Physician Decision|0|||
170784747|NCT02783300|617219083|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784748|NCT02783300|617219084|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784749|NCT02783300|617219085|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784750|NCT02783300|617219086|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784751|NCT02783300|617219087|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784752|NCT02783300|617219088|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784753|NCT02783300|617219089|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784754|NCT02783300|617219090|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784755|NCT02783300|617219091|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784756|NCT02783300|617219092|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784757|NCT02783300|617219093|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
170784758|NCT02783300|617219094|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
170784759|NCT03535272|617219095|FG000|Overall Study|Lost to Follow-up|71|||
170784760|NCT03535272|617219096|FG001|Overall Study|Lost to Follow-up|73|||
170784761|NCT01744782|617219097|FG000|Overall Study|Death|1|||
170784762|NCT00378105|617219099|FG000|Overall Study|Adverse Event|3|||
170784763|NCT00378105|617219100|FG001|Overall Study|Adverse Event|1|||
170784764|NCT00378105|617219099|FG000|Overall Study|Withdrawal by Subject|3|||
170784765|NCT00378105|617219100|FG001|Overall Study|Withdrawal by Subject|3|||
170784766|NCT00378105|617219099|FG000|Overall Study|Death|1|||
170784767|NCT00378105|617219100|FG001|Overall Study|Death|0|||
170784768|NCT00378105|617219099|FG000|Overall Study|Going to transplant|7|||
170784769|NCT00378105|617219100|FG001|Overall Study|Going to transplant|8|||
170784770|NCT00378105|617219099|FG000|Overall Study|Progressive disease|3|||
170784771|NCT00378105|617219100|FG001|Overall Study|Progressive disease|3|||
170784772|NCT00378105|617219099|FG000|Overall Study|remain on study|3|||
170886330|NCT02436876|617592189|FG001|Overall Study|Physician Decision|2|||
170886331|NCT02436876|617592190|FG002|Overall Study|Physician Decision|1|||
170886332|NCT02436876|617592191|FG003|Overall Study|Physician Decision|0|||
170441356|NCT00283842|615954708|FG003|Overall Study|Protocol deviation|0|||
170441357|NCT00283842|615954709|FG004|Overall Study|Protocol deviation|2|||
170441358|NCT00283842|615954705|FG000|Overall Study|Withdrawal by Subject|2|||
170441359|NCT00283842|615954706|FG001|Overall Study|Withdrawal by Subject|1|||
170441360|NCT00283842|615954707|FG002|Overall Study|Withdrawal by Subject|1|||
170441361|NCT00283842|615954708|FG003|Overall Study|Withdrawal by Subject|5|||
170441362|NCT00283842|615954709|FG004|Overall Study|Withdrawal by Subject|4|||
170441363|NCT00283842|615954705|FG000|Overall Study|Lack of Efficacy|1|||
170441364|NCT00283842|615954706|FG001|Overall Study|Lack of Efficacy|3|||
170441365|NCT00283842|615954707|FG002|Overall Study|Lack of Efficacy|1|||
170441366|NCT00283842|615954708|FG003|Overall Study|Lack of Efficacy|0|||
170784773|NCT00378105|617219100|FG001|Overall Study|remain on study|11|||
170784774|NCT00378105|617219099|FG000|Overall Study|Physician Decision|0|||
170784775|NCT00378105|617219100|FG001|Overall Study|Physician Decision|2|||
170784776|NCT00378105|617219099|FG000|Overall Study|Going non-protocol therapy|0|||
170784777|NCT00378105|617219100|FG001|Overall Study|Going non-protocol therapy|1|||
170886333|NCT02436876|617592188|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
170886334|NCT02436876|617592189|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
170886335|NCT02436876|617592190|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
170886336|NCT02436876|617592191|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
170886337|NCT00706030|617592193|FG000|Overall Study|Disease Progression|4|||
170886338|NCT00706030|617592194|FG001|Overall Study|Disease Progression|6|||
170886339|NCT00706030|617592195|FG002|Overall Study|Disease Progression|46|||
170886340|NCT00706030|617592196|FG003|Overall Study|Disease Progression|12|||
170886341|NCT00706030|617592193|FG000|Overall Study|Adverse Event|1|||
170886342|NCT00706030|617592194|FG001|Overall Study|Adverse Event|0|||
170886343|NCT00706030|617592195|FG002|Overall Study|Adverse Event|4|||
170886344|NCT00706030|617592196|FG003|Overall Study|Adverse Event|2|||
170886345|NCT00706030|617592193|FG000|Overall Study|Withdrawal by Subject|1|||
170886346|NCT00706030|617592194|FG001|Overall Study|Withdrawal by Subject|0|||
170886347|NCT00706030|617592195|FG002|Overall Study|Withdrawal by Subject|2|||
170886348|NCT00706030|617592196|FG003|Overall Study|Withdrawal by Subject|0|||
170886349|NCT00706030|617592193|FG000|Overall Study|Physician Decision|0|||
170886350|NCT00706030|617592194|FG001|Overall Study|Physician Decision|0|||
170886351|NCT00706030|617592195|FG002|Overall Study|Physician Decision|2|||
170886352|NCT00706030|617592196|FG003|Overall Study|Physician Decision|0|||
170886353|NCT00706030|617592193|FG000|Overall Study|Not recorded|0|||
170886354|NCT00706030|617592194|FG001|Overall Study|Not recorded|0|||
170886355|NCT00706030|617592195|FG002|Overall Study|Not recorded|2|||
170886356|NCT00706030|617592196|FG003|Overall Study|Not recorded|0|||
170886357|NCT00706030|617592193|FG000|Overall Study|Protocol Violation|0|||
170886358|NCT00706030|617592194|FG001|Overall Study|Protocol Violation|0|||
170886359|NCT00706030|617592195|FG002|Overall Study|Protocol Violation|1|||
170886360|NCT00706030|617592196|FG003|Overall Study|Protocol Violation|1|||
170886361|NCT00706030|617592193|FG000|Overall Study|Failed to return|0|||
170886362|NCT00706030|617592194|FG001|Overall Study|Failed to return|0|||
170886363|NCT00706030|617592195|FG002|Overall Study|Failed to return|1|||
170886364|NCT00706030|617592196|FG003|Overall Study|Failed to return|0|||
170886365|NCT00706030|617592193|FG000|Overall Study|Symptomatic Deterioration|0|||
170886366|NCT00706030|617592194|FG001|Overall Study|Symptomatic Deterioration|0|||
170886367|NCT00706030|617592195|FG002|Overall Study|Symptomatic Deterioration|1|||
170886368|NCT00706030|617592196|FG003|Overall Study|Symptomatic Deterioration|0|||
170886369|NCT00706030|617592193|FG000|Overall Study|No treatment received|0|||
170886370|NCT00706030|617592194|FG001|Overall Study|No treatment received|0|||
170886371|NCT00706030|617592195|FG002|Overall Study|No treatment received|0|||
170886372|NCT00706030|617592196|FG003|Overall Study|No treatment received|1|||
170886373|NCT00706030|617592193|FG000|Overall Study|Death|0|||
170886374|NCT00706030|617592194|FG001|Overall Study|Death|0|||
170886375|NCT00706030|617592195|FG002|Overall Study|Death|1|||
170886376|NCT00706030|617592196|FG003|Overall Study|Death|0|||
170886377|NCT03870555|617592197|FG000|Period 3 (2 Days)|Adverse Event|1|||
170886378|NCT03870555|617592198|FG001|Period 3 (2 Days)|Adverse Event|0|||
170886379|NCT03870555|617592199|FG002|Period 3 (2 Days)|Adverse Event|0|||
170886380|NCT03215771|617592200|FG000|Overall Study|Withdrawal by Subject|2|||
170886381|NCT03215771|617592200|FG000|Overall Study|Physician Decision|1|||
170886382|NCT02703311|617592201|FG000|Overall Study|Death|5|||
170886383|NCT02703311|617592201|FG000|Overall Study|Withdrawal by Subject|3|||
170886384|NCT00137111|617592202|FG000|Total Therapy|Death|35|||
170886385|NCT00137111|617592203|FG001|Total Therapy|Death|0|||
170886386|NCT00137111|617592204|FG002|Total Therapy|Death|0|||
170886387|NCT00137111|617592205|FG003|Total Therapy|Death|0|||
170886388|NCT00137111|617592202|FG000|Total Therapy|Non Compliance|5|||
170886389|NCT00137111|617592203|FG001|Total Therapy|Non Compliance|0|||
170886390|NCT00137111|617592204|FG002|Total Therapy|Non Compliance|0|||
170886391|NCT00137111|617592205|FG003|Total Therapy|Non Compliance|0|||
170886392|NCT00262873|617592206|FG000|Overall Study|Adverse Event|3|||
170886393|NCT00262873|617592206|FG000|Overall Study|Withdrawal by Subject|5|||
170886394|NCT00844753|617592207|FG000|Overall Study|Lack of Efficacy|1|||
170886395|NCT00844753|617592208|FG001|Overall Study|Lack of Efficacy|0|||
170886396|NCT00844753|617592209|FG002|Overall Study|Lack of Efficacy|2|||
170886397|NCT00844753|617592210|FG003|Overall Study|Lack of Efficacy|2|||
170441367|NCT00283842|615954709|FG004|Overall Study|Lack of Efficacy|3|||
170441368|NCT00283842|615954705|FG000|Overall Study|Lost to Follow-up|0|||
170441369|NCT00283842|615954706|FG001|Overall Study|Lost to Follow-up|2|||
170886398|NCT00844753|617592207|FG000|Overall Study|Adverse Event|3|||
170886399|NCT00844753|617592208|FG001|Overall Study|Adverse Event|2|||
170886400|NCT00844753|617592209|FG002|Overall Study|Adverse Event|5|||
170886401|NCT00844753|617592210|FG003|Overall Study|Adverse Event|5|||
170886402|NCT00844753|617592207|FG000|Overall Study|Lost to Follow-up|1|||
170441370|NCT00283842|615954707|FG002|Overall Study|Lost to Follow-up|4|||
170886403|NCT00844753|617592208|FG001|Overall Study|Lost to Follow-up|1|||
170886404|NCT00844753|617592209|FG002|Overall Study|Lost to Follow-up|0|||
170886405|NCT00844753|617592210|FG003|Overall Study|Lost to Follow-up|1|||
170886406|NCT00844753|617592207|FG000|Overall Study|could not swallow medication|2|||
170441371|NCT00283842|615954708|FG003|Overall Study|Lost to Follow-up|1|||
170441372|NCT00283842|615954709|FG004|Overall Study|Lost to Follow-up|1|||
170441373|NCT03732833|615954712|FG000|Overall Study|Adverse Event|0|||
170441374|NCT03732833|615954713|FG001|Overall Study|Adverse Event|3|||
170441375|NCT03732833|615954714|FG002|Overall Study|Adverse Event|1|||
170441376|NCT03732833|615954712|FG000|Overall Study|Withdrawal by Subject|11|||
170784778|NCT00378105|617219099|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
170784779|NCT00378105|617219100|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
170784780|NCT03443323|617219104|FG000|Overall Study|Lost to Follow-up|2|||
170784781|NCT03443323|617219105|FG001|Overall Study|Lost to Follow-up|2|||
170784782|NCT03443323|617219104|FG000|Overall Study|PI withdrawal|1|||
170784783|NCT03443323|617219105|FG001|Overall Study|PI withdrawal|0|||
170784784|NCT04177823|617219109|FG000|Overall Study|Physician Decision|1|||
170784785|NCT04177823|617219109|FG000|Overall Study|Withdrawal by Subject|1|||
170784786|NCT05178316|617219110|FG000|Overall Study|Adverse Event|5|||
170784787|NCT05178316|617219111|FG001|Overall Study|Adverse Event|4|||
170784788|NCT05178316|617219112|FG002|Overall Study|Adverse Event|9|||
170784789|NCT05178316|617219110|FG000|Overall Study|Enrolled in Error|1|||
170784790|NCT05178316|617219111|FG001|Overall Study|Enrolled in Error|2|||
170784791|NCT05178316|617219112|FG002|Overall Study|Enrolled in Error|1|||
170784792|NCT05178316|617219110|FG000|Overall Study|Lost to Follow-up|3|||
170784793|NCT05178316|617219111|FG001|Overall Study|Lost to Follow-up|15|||
170784794|NCT05178316|617219112|FG002|Overall Study|Lost to Follow-up|11|||
170784795|NCT05178316|617219110|FG000|Overall Study|Noncompliance|1|||
170784796|NCT05178316|617219111|FG001|Overall Study|Noncompliance|3|||
170784797|NCT05178316|617219112|FG002|Overall Study|Noncompliance|1|||
170784798|NCT05178316|617219110|FG000|Overall Study|Other|0|||
170784799|NCT05178316|617219111|FG001|Overall Study|Other|1|||
170784800|NCT05178316|617219112|FG002|Overall Study|Other|0|||
170784801|NCT05178316|617219110|FG000|Overall Study|Physician Decision|0|||
170784802|NCT05178316|617219111|FG001|Overall Study|Physician Decision|3|||
170784803|NCT05178316|617219112|FG002|Overall Study|Physician Decision|2|||
170784804|NCT05178316|617219110|FG000|Overall Study|Protocol deviation|1|||
170784805|NCT05178316|617219111|FG001|Overall Study|Protocol deviation|0|||
170784806|NCT05178316|617219112|FG002|Overall Study|Protocol deviation|1|||
170784807|NCT05178316|617219110|FG000|Overall Study|Sponsor decision|1|||
170784808|NCT05178316|617219111|FG001|Overall Study|Sponsor decision|0|||
170784809|NCT05178316|617219112|FG002|Overall Study|Sponsor decision|1|||
170784810|NCT05178316|617219110|FG000|Overall Study|Withdrawal by Subject|5|||
170784811|NCT05178316|617219111|FG001|Overall Study|Withdrawal by Subject|11|||
170441377|NCT03732833|615954713|FG001|Overall Study|Withdrawal by Subject|13|||
170784812|NCT05178316|617219112|FG002|Overall Study|Withdrawal by Subject|5|||
170784813|NCT01413100|617219113|FG000|Overall Study|Withdrawal by Subject|1|||
170784814|NCT05784662|617219122|FG000|Overall Study|Lost to Follow-up|21|||
170784815|NCT05784662|617219123|FG001|Overall Study|Lost to Follow-up|17|||
170784816|NCT04739956|617219124|FG000|Overall Study|Withdrawal by Subject|1|||
170784817|NCT04739956|617219125|FG001|Overall Study|Withdrawal by Subject|1|||
170784818|NCT03920111|617219126|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
170784819|NCT03920111|617219127|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
170784820|NCT03920111|617219128|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
170784821|NCT03519581|617219129|FG000|Overall Study|Lost to Follow-up|3|||
170784822|NCT03519581|617219130|FG001|Overall Study|Lost to Follow-up|2|||
170886407|NCT00844753|617592208|FG001|Overall Study|could not swallow medication|0|||
170886408|NCT00844753|617592209|FG002|Overall Study|could not swallow medication|0|||
170886409|NCT00844753|617592210|FG003|Overall Study|could not swallow medication|0|||
170886410|NCT00844753|617592207|FG000|Overall Study|Withdrawal by Subject|1|||
170886411|NCT00844753|617592208|FG001|Overall Study|Withdrawal by Subject|0|||
170886412|NCT00844753|617592209|FG002|Overall Study|Withdrawal by Subject|0|||
170886413|NCT00844753|617592210|FG003|Overall Study|Withdrawal by Subject|3|||
170886414|NCT02508194|617592214|FG000|Overall Study|Death|5|||
170886415|NCT02508194|617592215|FG001|Overall Study|Death|3|||
170886416|NCT02508194|617592214|FG000|Overall Study|Lost to Follow-up|25|||
170886417|NCT02508194|617592215|FG001|Overall Study|Lost to Follow-up|18|||
170886418|NCT02508194|617592214|FG000|Overall Study|Withdrawal by Subject|20|||
170886419|NCT02508194|617592215|FG001|Overall Study|Withdrawal by Subject|18|||
170886420|NCT02508194|617592214|FG000|Overall Study|Error in Randomization|1|||
170886421|NCT02508194|617592215|FG001|Overall Study|Error in Randomization|3|||
170886422|NCT02508194|617592214|FG000|Overall Study|Principal Investigator Decision|1|||
170886423|NCT02508194|617592215|FG001|Overall Study|Principal Investigator Decision|2|||
170886424|NCT00217087|617592216|FG000|Overall Study|decided to have esophagectomy|1|||
170886425|NCT00217087|617592217|FG001|Overall Study|decided to have esophagectomy|2|||
170886426|NCT00217087|617592216|FG000|Overall Study|completed less than 12 months return|10|||
170886427|NCT00217087|617592217|FG001|Overall Study|completed less than 12 months return|18|||
170886428|NCT03205995|617592218|FG000|Overall Study|Adverse Event|1|||
170886429|NCT03205995|617592218|FG000|Overall Study|Death|1|||
170886430|NCT03205995|617592218|FG000|Overall Study|Physician Decision|2|||
170886431|NCT03205995|617592218|FG000|Overall Study|Protocol Violation|2|||
170886432|NCT04947800|617592219|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
170886433|NCT04947800|617592220|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
170886434|NCT04947800|617592221|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
170886435|NCT05913232|617592222|FG000|Overall Study|Adverse Event|0|||
170886436|NCT05913232|617592223|FG001|Overall Study|Adverse Event|2|||
170886437|NCT05913232|617592224|FG002|Overall Study|Adverse Event|1|||
170886438|NCT05913232|617592225|FG003|Overall Study|Adverse Event|1|||
170886439|NCT05103332|617592226|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886440|NCT05103332|617592227|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
170886441|NCT05103332|617592228|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
170886442|NCT05103332|617592229|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886443|NCT05103332|617592230|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886444|NCT05103332|617592231|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
170886445|NCT05103332|617592232|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886446|NCT05103332|617592233|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886447|NCT05103332|617592234|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886448|NCT05103332|617592235|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886449|NCT05103332|617592236|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886450|NCT05103332|617592237|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886451|NCT05103332|617592238|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886452|NCT05103332|617592239|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886453|NCT05103332|617592240|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886454|NCT05103332|617592241|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886455|NCT05103332|617592242|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170784823|NCT03519581|617219129|FG000|Overall Study|Adverse Event|5|||
170784824|NCT03519581|617219130|FG001|Overall Study|Adverse Event|2|||
170784825|NCT03519581|617219129|FG000|Overall Study|Withdrawal by Subject|2|||
170784826|NCT03519581|617219130|FG001|Overall Study|Withdrawal by Subject|0|||
170784827|NCT03519581|617219129|FG000|Overall Study|Change to insurance|2|||
170784828|NCT03519581|617219130|FG001|Overall Study|Change to insurance|1|||
170784829|NCT03519581|617219129|FG000|Overall Study|Other|2|||
170784830|NCT03519581|617219130|FG001|Overall Study|Other|4|||
170784831|NCT05177848|617219131|FG000|Overall Study|Lost to Follow-up|1|||
170784832|NCT05177848|617219132|FG001|Overall Study|Lost to Follow-up|4|||
170784833|NCT05177848|617219131|FG000|Overall Study|Discontinued|2|||
170784834|NCT05177848|617219132|FG001|Overall Study|Discontinued|1|||
170784835|NCT06414213|617219133|FG000|Overall Study|Lost to Follow-up|1|||
170784836|NCT06414213|617219134|FG001|Overall Study|Lost to Follow-up|1|||
170886456|NCT05103332|617592243|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886457|NCT05103332|617592226|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886458|NCT05103332|617592227|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
170886459|NCT05103332|617592228|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
170441378|NCT03732833|615954714|FG002|Overall Study|Withdrawal by Subject|8|||
170784837|NCT06414213|617219135|FG002|Overall Study|Lost to Follow-up|3|||
170784838|NCT05256706|617219137|FG000|Overall Study|Lost to Follow-up|9|||
170886460|NCT05103332|617592229|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
170886461|NCT05103332|617592230|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886462|NCT05103332|617592231|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886463|NCT05103332|617592232|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886464|NCT05103332|617592233|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886465|NCT05103332|617592234|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886466|NCT05103332|617592235|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886467|NCT05103332|617592236|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
170441379|NCT03732833|615954712|FG000|Overall Study|Lost to Follow-up|3|||
170441380|NCT03732833|615954713|FG001|Overall Study|Lost to Follow-up|5|||
170441381|NCT03732833|615954714|FG002|Overall Study|Lost to Follow-up|4|||
170441382|NCT03732833|615954712|FG000|Overall Study|Pregnancy|0|||
170441383|NCT03732833|615954713|FG001|Overall Study|Pregnancy|2|||
170441384|NCT03732833|615954714|FG002|Overall Study|Pregnancy|0|||
170886468|NCT05103332|617592237|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886469|NCT05103332|617592238|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886470|NCT05103332|617592239|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886471|NCT05103332|617592240|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886472|NCT05103332|617592241|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886473|NCT05103332|617592242|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886474|NCT05103332|617592243|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
170886475|NCT05103332|617592226|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
170886476|NCT05103332|617592227|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
170886477|NCT05103332|617592228|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
170886478|NCT05103332|617592229|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
170886479|NCT05103332|617592230|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
170886480|NCT05103332|617592231|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
170886481|NCT05103332|617592232|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886482|NCT05103332|617592233|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886483|NCT05103332|617592234|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886484|NCT05103332|617592235|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886485|NCT05103332|617592236|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886486|NCT05103332|617592237|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886487|NCT05103332|617592238|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886488|NCT05103332|617592239|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170441385|NCT03732833|615954712|FG000|Overall Study|Physician Decision|2|||
170886489|NCT05103332|617592240|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886490|NCT05103332|617592241|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886491|NCT05103332|617592242|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886492|NCT05103332|617592243|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886493|NCT05103332|617592226|FG000|DB Period (6 Months=168 Days)|Other|0|||
170886494|NCT05103332|617592227|FG001|DB Period (6 Months=168 Days)|Other|0|||
170886495|NCT05103332|617592228|FG002|DB Period (6 Months=168 Days)|Other|0|||
170886496|NCT05103332|617592229|FG003|DB Period (6 Months=168 Days)|Other|1|||
170441386|NCT03732833|615954713|FG001|Overall Study|Physician Decision|3|||
170441387|NCT03732833|615954714|FG002|Overall Study|Physician Decision|1|||
170441388|NCT03732833|615954712|FG000|Overall Study|Covid-19 related and other reasons|2|||
170441389|NCT03732833|615954713|FG001|Overall Study|Covid-19 related and other reasons|7|||
170441390|NCT03732833|615954714|FG002|Overall Study|Covid-19 related and other reasons|3|||
170441391|NCT00550147|615954715|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
170441392|NCT00550147|615954715|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
170441393|NCT00550147|615954715|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
170441394|NCT00550147|615954715|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
170537898|NCT02952248|616311668|FG005|Overall Study|Clinical progression|0|||
170784839|NCT05256706|617219138|FG001|Overall Study|Lost to Follow-up|3|||
170784840|NCT05256706|617219137|FG000|Overall Study|Withdrawal by Subject|7|||
170784841|NCT05256706|617219138|FG001|Overall Study|Withdrawal by Subject|11|||
170784842|NCT05256706|617219137|FG000|Overall Study|Screen Failures|3|||
170784843|NCT05256706|617219138|FG001|Overall Study|Screen Failures|0|||
170784844|NCT04952909|617219144|FG000|Overall Study|Death|3|||
170784845|NCT04359108|617219145|FG000|Overall Study|Withdrawal by Subject|1|||
170784846|NCT04359108|617219146|FG001|Overall Study|Withdrawal by Subject|0|||
170784847|NCT04359108|617219145|FG000|Overall Study|Unable or too feeble to walk independently|0|||
170537899|NCT02952248|616311669|FG006|Overall Study|Clinical progression|0|||
170537900|NCT01240746|616312631|FG000|Overall Study|Adverse Event|2|||
170784848|NCT04359108|617219146|FG001|Overall Study|Unable or too feeble to walk independently|2|||
170537901|NCT01240746|616312632|FG001|Overall Study|Adverse Event|0|||
170537902|NCT01240746|616312633|FG002|Overall Study|Adverse Event|10|||
170537903|NCT01240746|616312631|FG000|Overall Study|Lost to Follow-up|23|||
170537904|NCT01240746|616312632|FG001|Overall Study|Lost to Follow-up|20|||
170537905|NCT01240746|616312633|FG002|Overall Study|Lost to Follow-up|102|||
170537906|NCT01240746|616312631|FG000|Overall Study|Protocol Violation|24|||
170537907|NCT01240746|616312632|FG001|Overall Study|Protocol Violation|15|||
170537908|NCT01240746|616312633|FG002|Overall Study|Protocol Violation|72|||
170537909|NCT01240746|616312631|FG000|Overall Study|Withdrawal by Subject|10|||
170537910|NCT01240746|616312632|FG001|Overall Study|Withdrawal by Subject|13|||
170537911|NCT01240746|616312633|FG002|Overall Study|Withdrawal by Subject|59|||
170537912|NCT04919161|616312636|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
170537913|NCT04919161|616312637|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
170537914|NCT04919161|616312636|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
170633108|NCT01746901|616668460|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
170633109|NCT01746901|616668461|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
170633110|NCT01746901|616668462|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
170633111|NCT01746901|616668463|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
170633112|NCT01746901|616668464|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
170633113|NCT01746901|616668465|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
170633114|NCT01746901|616668466|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
170784849|NCT04359108|617219145|FG000|Overall Study|Argus II system stopped functioning|0|||
170441395|NCT00550147|615954715|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
170441396|NCT04320745|615954716|FG000|Overall Study|Adverse Event|26|||
170537915|NCT04919161|616312637|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
170537916|NCT04919161|616312636|FG000|Overall Study|Acute ankle sprain after session 1|0|||
170537917|NCT04919161|616312637|FG001|Overall Study|Acute ankle sprain after session 1|1|||
170537918|NCT04190225|616312640|FG000|Overall Study|Lost to Follow-up|2|||
170537919|NCT04190225|616312641|FG001|Overall Study|Lost to Follow-up|3|||
170537920|NCT04190225|616312640|FG000|Overall Study|Withdrawal by Subject|3|||
170537921|NCT04190225|616312641|FG001|Overall Study|Withdrawal by Subject|2|||
170537922|NCT04190225|616312640|FG000|Overall Study|Unrelated health condition|2|||
170537923|NCT04190225|616312641|FG001|Overall Study|Unrelated health condition|0|||
170537924|NCT01732783|616312642|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
170537925|NCT01732783|616312643|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
170537926|NCT01732783|616312644|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
170537927|NCT01732783|616312642|FG000|Overall Study|Death|13|||
170537928|NCT01732783|616312643|FG001|Overall Study|Death|4|||
170537929|NCT01732783|616312644|FG002|Overall Study|Death|1|||
170537930|NCT01732783|616312642|FG000|Overall Study|Lost to Follow-up|7|||
170537931|NCT01732783|616312643|FG001|Overall Study|Lost to Follow-up|1|||
170537932|NCT01732783|616312644|FG002|Overall Study|Lost to Follow-up|1|||
170537933|NCT01732783|616312642|FG000|Overall Study|Administrative Decision|8|||
170537934|NCT01732783|616312643|FG001|Overall Study|Administrative Decision|2|||
170537935|NCT01732783|616312644|FG002|Overall Study|Administrative Decision|1|||
170537936|NCT01732783|616312642|FG000|Overall Study|Withdrawal by Subject|1|||
170537937|NCT01732783|616312643|FG001|Overall Study|Withdrawal by Subject|0|||
170537938|NCT01732783|616312644|FG002|Overall Study|Withdrawal by Subject|0|||
170537939|NCT01970371|616312645|FG000|Overall Study|Death|8|||
170537940|NCT01970371|616312646|FG001|Overall Study|Death|13|||
170537941|NCT01970371|616312647|FG002|Overall Study|Death|12|||
170537942|NCT01970371|616312645|FG000|Overall Study|Lost to Follow-up|0|||
170537943|NCT01970371|616312646|FG001|Overall Study|Lost to Follow-up|0|||
170537944|NCT01970371|616312647|FG002|Overall Study|Lost to Follow-up|1|||
170441397|NCT04320745|615954716|FG000|Overall Study|Withdrawal by Subject|4|||
170441398|NCT04320745|615954716|FG000|Overall Study|Lost to Follow-up|12|||
170441399|NCT04320745|615954716|FG000|Overall Study|Protocol Deviation|2|||
170441400|NCT04320745|615954716|FG000|Overall Study|Non-compliance With Study Drug|2|||
170441401|NCT04320745|615954716|FG000|Overall Study|Reason Not Specified|1|||
170441402|NCT01567527|615954717|FG000|Conversion Phase.|Protocol deviation|3|||
170441403|NCT01567527|615954718|FG001|Conversion Phase.|Protocol deviation|0|||
170441404|NCT01567527|615954719|FG002|Conversion Phase.|Protocol deviation|0|||
170441405|NCT01567527|615954720|FG003|Conversion Phase.|Protocol deviation|0|||
170441406|NCT01567527|615954721|FG004|Conversion Phase.|Protocol deviation|0|||
170441407|NCT01567527|615954717|FG000|Conversion Phase.|Met withdrawal criteria|10|||
170537945|NCT03331562|616312649|FG000|Overall Study|Adverse Event|2|||
170537946|NCT03331562|616312650|FG001|Overall Study|Adverse Event|0|||
170537947|NCT03331562|616312649|FG000|Overall Study|Death|1|||
170537948|NCT03331562|616312650|FG001|Overall Study|Death|0|||
170537949|NCT00487188|616312660|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
170537950|NCT00487188|616312661|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
170537951|NCT00487188|616312662|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
170537952|NCT00487188|616312660|FG000|Induction Phase|Adverse Event|5|||
170537953|NCT00487188|616312661|FG001|Induction Phase|Adverse Event|0|||
170537954|NCT00487188|616312662|FG002|Induction Phase|Adverse Event|0|||
170537955|NCT00487188|616312660|FG000|Induction Phase|Lack of Efficacy|0|||
170537956|NCT00487188|616312661|FG001|Induction Phase|Lack of Efficacy|1|||
170537957|NCT00487188|616312662|FG002|Induction Phase|Lack of Efficacy|0|||
170537958|NCT00487188|616312660|FG000|Induction Phase|Protocol Violation|1|||
170537959|NCT00487188|616312661|FG001|Induction Phase|Protocol Violation|0|||
170537960|NCT00487188|616312662|FG002|Induction Phase|Protocol Violation|0|||
170537961|NCT00487188|616312660|FG000|Induction Phase|Refused Treatment|1|||
170537962|NCT00487188|616312661|FG001|Induction Phase|Refused Treatment|2|||
170537963|NCT00487188|616312662|FG002|Induction Phase|Refused Treatment|0|||
170537964|NCT00487188|616312660|FG000|Induction Phase|Lost to Follow-up|2|||
170537965|NCT00487188|616312661|FG001|Induction Phase|Lost to Follow-up|2|||
170537966|NCT00487188|616312662|FG002|Induction Phase|Lost to Follow-up|0|||
170537967|NCT00487188|616312660|FG000|Induction Phase|Administrative|0|||
170537968|NCT00487188|616312661|FG001|Induction Phase|Administrative|1|||
170537969|NCT00487188|616312662|FG002|Induction Phase|Administrative|0|||
170537970|NCT00487188|616312660|FG000|Maintenance Phase|Adverse Event|1|||
170537971|NCT00487188|616312661|FG001|Maintenance Phase|Adverse Event|0|||
170537972|NCT00487188|616312662|FG002|Maintenance Phase|Adverse Event|0|||
170537973|NCT00487188|616312660|FG000|Maintenance Phase|Death|1|||
170537974|NCT00487188|616312661|FG001|Maintenance Phase|Death|0|||
170537975|NCT00487188|616312662|FG002|Maintenance Phase|Death|0|||
170537976|NCT00487188|616312660|FG000|Maintenance Phase|Lost to Follow-up|1|||
170537977|NCT00487188|616312661|FG001|Maintenance Phase|Lost to Follow-up|0|||
170537978|NCT00487188|616312662|FG002|Maintenance Phase|Lost to Follow-up|0|||
170537979|NCT00487188|616312660|FG000|Maintenance Phase|Administrative|0|||
170537980|NCT00487188|616312661|FG001|Maintenance Phase|Administrative|0|||
170537981|NCT00487188|616312662|FG002|Maintenance Phase|Administrative|1|||
170537982|NCT01682031|616312663|FG000|Overall Study|Withdrawal by Subject|0|||
170537983|NCT01682031|616312664|FG001|Overall Study|Withdrawal by Subject|1|||
170537984|NCT01682031|616312663|FG000|Overall Study|Adverse Event|0|||
170537985|NCT01682031|616312664|FG001|Overall Study|Adverse Event|2|||
170537986|NCT01682031|616312663|FG000|Overall Study|MRI results indicate increased nodul|0|||
170537987|NCT01682031|616312664|FG001|Overall Study|MRI results indicate increased nodul|1|||
170537988|NCT01682031|616312663|FG000|Overall Study|Patient could not swallow tablets|1|||
170537989|NCT01682031|616312664|FG001|Overall Study|Patient could not swallow tablets|0|||
170537990|NCT01682031|616312663|FG000|Overall Study|Patient stopped selenium on his own|0|||
170537991|NCT01682031|616312664|FG001|Overall Study|Patient stopped selenium on his own|1|||
170537992|NCT05376358|616312668|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
170537993|NCT05376358|616312669|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
170537994|NCT05376358|616312668|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
170537995|NCT05376358|616312669|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
170537996|NCT05376358|616312668|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
170537997|NCT05376358|616312669|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
170537998|NCT05376358|616312668|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
170537999|NCT05376358|616312669|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
170538000|NCT05376358|616312668|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
170538001|NCT05376358|616312669|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
170538002|NCT05376358|616312668|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
170538003|NCT05376358|616312669|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
170538004|NCT00311168|616312670|FG000|First Intervention|Withdrawal by Subject|2|||
170538005|NCT00311168|616312671|FG001|First Intervention|Withdrawal by Subject|2|||
170538006|NCT00311168|616312670|FG000|First Intervention|Lost to Follow-up|1|||
170538007|NCT00311168|616312671|FG001|First Intervention|Lost to Follow-up|1|||
170538008|NCT00311168|616312670|FG000|First Intervention|Protocol Violation|1|||
170538009|NCT00311168|616312671|FG001|First Intervention|Protocol Violation|1|||
170538010|NCT00311168|616312670|FG000|First Intervention|Adverse Event|1|||
170538011|NCT00311168|616312671|FG001|First Intervention|Adverse Event|0|||
170538012|NCT00311168|616312670|FG000|First Intervention|Other|2|||
170538013|NCT00311168|616312671|FG001|First Intervention|Other|2|||
170538014|NCT00311168|616312670|FG000|Second Intervention|Lost to Follow-up|9|||
170538015|NCT00311168|616312671|FG001|Second Intervention|Lost to Follow-up|2|||
170538016|NCT00311168|616312670|FG000|Second Intervention|Withdrawal by Subject|0|||
170538017|NCT00311168|616312671|FG001|Second Intervention|Withdrawal by Subject|1|||
170441408|NCT01567527|615954718|FG001|Conversion Phase.|Met withdrawal criteria|0|||
170441409|NCT01567527|615954719|FG002|Conversion Phase.|Met withdrawal criteria|0|||
170441410|NCT01567527|615954720|FG003|Conversion Phase.|Met withdrawal criteria|0|||
170441411|NCT01567527|615954721|FG004|Conversion Phase.|Met withdrawal criteria|0|||
170441412|NCT01567527|615954717|FG000|Conversion Phase.|Withdrawal by Subject|32|||
170441413|NCT01567527|615954718|FG001|Conversion Phase.|Withdrawal by Subject|0|||
170441414|NCT01567527|615954719|FG002|Conversion Phase.|Withdrawal by Subject|0|||
170441415|NCT01567527|615954720|FG003|Conversion Phase.|Withdrawal by Subject|0|||
170441416|NCT01567527|615954721|FG004|Conversion Phase.|Withdrawal by Subject|0|||
170441417|NCT01567527|615954717|FG000|Conversion Phase.|Lost to Follow-up|16|||
170441418|NCT01567527|615954718|FG001|Conversion Phase.|Lost to Follow-up|0|||
170441419|NCT01567527|615954719|FG002|Conversion Phase.|Lost to Follow-up|0|||
170441420|NCT01567527|615954720|FG003|Conversion Phase.|Lost to Follow-up|0|||
170441421|NCT01567527|615954721|FG004|Conversion Phase.|Lost to Follow-up|0|||
170441422|NCT01567527|615954717|FG000|Conversion Phase.|Lack of Efficacy|2|||
170441423|NCT01567527|615954718|FG001|Conversion Phase.|Lack of Efficacy|0|||
170441424|NCT01567527|615954719|FG002|Conversion Phase.|Lack of Efficacy|0|||
170441425|NCT01567527|615954720|FG003|Conversion Phase.|Lack of Efficacy|0|||
170441426|NCT01567527|615954721|FG004|Conversion Phase.|Lack of Efficacy|0|||
170441427|NCT01567527|615954717|FG000|Conversion Phase.|Adverse Event|33|||
170441428|NCT01567527|615954718|FG001|Conversion Phase.|Adverse Event|0|||
170441429|NCT01567527|615954719|FG002|Conversion Phase.|Adverse Event|0|||
170441430|NCT01567527|615954720|FG003|Conversion Phase.|Adverse Event|0|||
170441431|NCT01567527|615954721|FG004|Conversion Phase.|Adverse Event|0|||
170441432|NCT01567527|615954717|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
170538018|NCT00311168|616312670|FG000|Second Intervention|Other|1|||
170784850|NCT04359108|617219146|FG001|Overall Study|Argus II system stopped functioning|1|||
170784851|NCT04359108|617219145|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
170784852|NCT04359108|617219146|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
170784853|NCT02515773|617219147|FG000|Overall Study|Withdrawal by Subject|12|||
170784854|NCT02515773|617219148|FG001|Overall Study|Withdrawal by Subject|2|||
170784855|NCT02515773|617219147|FG000|Overall Study|Lost to Follow-up|119|||
170784856|NCT02515773|617219148|FG001|Overall Study|Lost to Follow-up|126|||
170784857|NCT02515773|617219147|FG000|Overall Study|Discharged from Clinic Services|53|||
170784858|NCT02515773|617219148|FG001|Overall Study|Discharged from Clinic Services|84|||
170784859|NCT02515773|617219147|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
170784860|NCT02515773|617219148|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
170784861|NCT02515773|617219147|FG000|Overall Study|Follow-up at non-study site|8|||
170784862|NCT02515773|617219148|FG001|Overall Study|Follow-up at non-study site|16|||
170784863|NCT02515773|617219147|FG000|Overall Study|Moved from area|9|||
170784864|NCT02515773|617219148|FG001|Overall Study|Moved from area|14|||
170784865|NCT01902173|617219152|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
170784866|NCT01902173|617219153|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
170784867|NCT01902173|617219154|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
170784868|NCT01902173|617219155|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
170784869|NCT01902173|617219156|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
170784870|NCT01902173|617219157|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
170784871|NCT01902173|617219152|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
170784872|NCT01902173|617219153|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
170784873|NCT01902173|617219154|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
170784874|NCT01902173|617219155|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
170784875|NCT01902173|617219156|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
170784876|NCT01902173|617219157|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
170784877|NCT01902173|617219152|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
170886497|NCT05103332|617592230|FG004|DB Period (6 Months=168 Days)|Other|0|||
170886498|NCT05103332|617592231|FG005|DB Period (6 Months=168 Days)|Other|0|||
170886499|NCT05103332|617592232|FG006|DB Period (6 Months=168 Days)|Other|0|||
170886500|NCT05103332|617592233|FG007|DB Period (6 Months=168 Days)|Other|0|||
170886501|NCT05103332|617592234|FG008|DB Period (6 Months=168 Days)|Other|0|||
170886502|NCT05103332|617592235|FG009|DB Period (6 Months=168 Days)|Other|0|||
170886503|NCT05103332|617592236|FG010|DB Period (6 Months=168 Days)|Other|0|||
170886504|NCT05103332|617592237|FG011|DB Period (6 Months=168 Days)|Other|0|||
170886505|NCT05103332|617592238|FG012|DB Period (6 Months=168 Days)|Other|0|||
170886506|NCT05103332|617592239|FG013|DB Period (6 Months=168 Days)|Other|0|||
170886507|NCT05103332|617592240|FG014|DB Period (6 Months=168 Days)|Other|0|||
170886508|NCT05103332|617592241|FG015|DB Period (6 Months=168 Days)|Other|0|||
170886509|NCT05103332|617592242|FG016|DB Period (6 Months=168 Days)|Other|0|||
170886510|NCT05103332|617592243|FG017|DB Period (6 Months=168 Days)|Other|0|||
170886511|NCT05103332|617592226|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886512|NCT05103332|617592227|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886513|NCT05103332|617592228|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886514|NCT05103332|617592229|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170538019|NCT00311168|616312671|FG001|Second Intervention|Other|1|||
170538020|NCT05472142|616312672|FG000|Total Participants|Lost to Follow-up|312|||
170538021|NCT05472142|616312673|FG001|Total Participants|Lost to Follow-up|0|||
170538022|NCT05472142|616312672|FG000|Clinic Patients|Lost to Follow-up|312|||
170538023|NCT05472142|616312673|FG001|Clinic Patients|Lost to Follow-up|0|||
170538024|NCT02278354|616312678|FG000|Overall Study|Lost to Follow-up|2|||
170538025|NCT02278354|616312679|FG001|Overall Study|Lost to Follow-up|2|||
170538026|NCT02278354|616312678|FG000|Overall Study|Withdrawal by Subject|0|||
170538027|NCT02278354|616312679|FG001|Overall Study|Withdrawal by Subject|1|||
170538028|NCT02278354|616312678|FG000|Overall Study|<10 professional fights|2|||
170538029|NCT02278354|616312679|FG001|Overall Study|<10 professional fights|0|||
170538030|NCT02382380|616312681|FG000|Overall Study|Withdrawal by Subject|2|||
170538031|NCT02382380|616312682|FG001|Overall Study|Withdrawal by Subject|2|||
170538032|NCT02382380|616312681|FG000|Overall Study|Lost to Follow-up|0|||
170538033|NCT02382380|616312682|FG001|Overall Study|Lost to Follow-up|1|||
170538034|NCT01295944|616312683|FG000|Overall Study|Switched to alternative treatment|1|||
170538035|NCT01295944|616312683|FG000|Overall Study|Ineligible|9|||
170538036|NCT01295944|616312683|FG000|Overall Study|Withdrawal by Subject|1|||
170538037|NCT01295944|616312683|FG000|Overall Study|Participant chose to be treated in Peru|1|||
170538038|NCT01295944|616312683|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
170538039|NCT01295944|616312683|FG000|Overall Study|Physician Decision|1|||
170538040|NCT01295944|616312683|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
170538041|NCT01295944|616312683|FG000|Overall Study|Disease progression|4|||
170538042|NCT01295944|616312683|FG000|Overall Study|Transferred care before starting new treatment|1|||
170538043|NCT03240874|616312684|FG000|Overall Study|Lost to Follow-up|0|||
170538044|NCT03240874|616312685|FG001|Overall Study|Lost to Follow-up|2|||
170886515|NCT05103332|617592230|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886516|NCT05103332|617592231|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886517|NCT05103332|617592232|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886518|NCT05103332|617592233|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170538045|NCT03240874|616312686|FG002|Overall Study|Lost to Follow-up|4|||
170538046|NCT03240874|616312687|FG003|Overall Study|Lost to Follow-up|1|||
170538047|NCT05350202|616312688|FG000|Visit 1 - Baseline|Not-treated|18|||
170538048|NCT05350202|616312689|FG001|Visit 1 - Baseline|Not-treated|0|||
170538049|NCT05350202|616312688|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
170538050|NCT05350202|616312689|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
170538051|NCT05350202|616312688|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
170538052|NCT05350202|616312689|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
170538053|NCT05350202|616312688|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
170538054|NCT05350202|616312689|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
170538055|NCT05350202|616312688|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
170538056|NCT05350202|616312689|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
170538057|NCT05350202|616312688|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
170538058|NCT05350202|616312689|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
170538059|NCT05350202|616312688|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
170538060|NCT05350202|616312689|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
170886519|NCT05103332|617592234|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886520|NCT05103332|617592235|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170538061|NCT04364646|616312691|FG000|Overall Study|Lost to Follow-up|1|||
170538062|NCT04364646|616312692|FG001|Overall Study|Lost to Follow-up|0|||
170538063|NCT04364646|616312691|FG000|Overall Study|Withdrawal by Subject|7|||
170538064|NCT04364646|616312692|FG001|Overall Study|Withdrawal by Subject|14|||
170538065|NCT04364646|616312691|FG000|Overall Study|Protocol Violation|4|||
170538066|NCT04364646|616312692|FG001|Overall Study|Protocol Violation|5|||
170784878|NCT01902173|617219153|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
170784879|NCT01902173|617219154|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
170784880|NCT01902173|617219155|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
170784881|NCT01902173|617219156|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
170784882|NCT01902173|617219157|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
170784883|NCT01902173|617219152|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
170784884|NCT01902173|617219153|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
170784885|NCT01902173|617219154|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
170784886|NCT01902173|617219155|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
170784887|NCT01902173|617219156|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
170784888|NCT01902173|617219157|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
170784889|NCT01902173|617219152|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
170538067|NCT03488524|616312693|FG000|Overall Study|Withdrawal by Subject|51|||
170538068|NCT03488524|616312693|FG000|Overall Study|Death|19|||
170538069|NCT03488524|616312693|FG000|Overall Study|Study Sponsor|11|||
170784890|NCT01902173|617219153|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
170538070|NCT03488524|616312693|FG000|Overall Study|Physician Decision|4|||
170538071|NCT03488524|616312693|FG000|Overall Study|Lost to Follow-up|3|||
170538072|NCT00830765|616312694|FG000|Overall Study|Protocol Violation|3|||
170538073|NCT00830765|616312695|FG001|Overall Study|Protocol Violation|2|||
170538074|NCT02390284|616312696|FG000|Overall Study|Physician Decision|0|||
170538075|NCT02390284|616312697|FG001|Overall Study|Physician Decision|0|||
170538076|NCT02390284|616312698|FG002|Overall Study|Physician Decision|9|||
170538077|NCT00724945|616312699|FG000|Period 1|non-compliance|1|||
170538078|NCT00724945|616312700|FG001|Period 1|non-compliance|0|||
170538079|NCT00724945|616312699|FG000|Period 1|Adverse Event|1|||
170538080|NCT00724945|616312700|FG001|Period 1|Adverse Event|1|||
170538081|NCT00724945|616312699|FG000|Period 1|Lost to Follow-up|1|||
170538082|NCT00724945|616312700|FG001|Period 1|Lost to Follow-up|0|||
170538083|NCT00724945|616312699|FG000|Period 2|lens comfort issue|3|||
170538084|NCT00724945|616312700|FG001|Period 2|lens comfort issue|0|||
170538085|NCT00724945|616312699|FG000|Period 2|lens physiology issue|1|||
170538086|NCT00724945|616312700|FG001|Period 2|lens physiology issue|0|||
170538087|NCT03697304|616312717|FG000|Overall Study|Other than listed|1|||
170538088|NCT03697304|616312718|FG001|Overall Study|Other than listed|0|||
170538089|NCT03697304|616312719|FG002|Overall Study|Other than listed|0|||
170538090|NCT03697304|616312720|FG003|Overall Study|Other than listed|0|||
170538091|NCT03697304|616312721|FG004|Overall Study|Other than listed|1|||
170538092|NCT03697304|616312722|FG005|Overall Study|Other than listed|0|||
170538093|NCT03697304|616312723|FG006|Overall Study|Other than listed|0|||
170538094|NCT03697304|616312724|FG007|Overall Study|Other than listed|0|||
170538095|NCT03697304|616312717|FG000|Overall Study|Physician Decision|0|||
170538096|NCT03697304|616312718|FG001|Overall Study|Physician Decision|2|||
170538097|NCT03697304|616312719|FG002|Overall Study|Physician Decision|0|||
170538098|NCT03697304|616312720|FG003|Overall Study|Physician Decision|0|||
170538099|NCT03697304|616312721|FG004|Overall Study|Physician Decision|0|||
170538100|NCT03697304|616312722|FG005|Overall Study|Physician Decision|0|||
170538101|NCT03697304|616312723|FG006|Overall Study|Physician Decision|1|||
170538102|NCT03697304|616312724|FG007|Overall Study|Physician Decision|1|||
170538103|NCT03697304|616312717|FG000|Overall Study|Death|1|||
170538104|NCT03697304|616312718|FG001|Overall Study|Death|2|||
170538105|NCT03697304|616312719|FG002|Overall Study|Death|4|||
170538106|NCT03697304|616312720|FG003|Overall Study|Death|0|||
170538107|NCT03697304|616312721|FG004|Overall Study|Death|1|||
170538108|NCT03697304|616312722|FG005|Overall Study|Death|0|||
170538109|NCT03697304|616312723|FG006|Overall Study|Death|1|||
170538110|NCT03697304|616312724|FG007|Overall Study|Death|0|||
170538111|NCT03697304|616312717|FG000|Overall Study|Consent withdrawal|1|||
170538112|NCT03697304|616312718|FG001|Overall Study|Consent withdrawal|2|||
170538113|NCT03697304|616312719|FG002|Overall Study|Consent withdrawal|0|||
170538114|NCT03697304|616312720|FG003|Overall Study|Consent withdrawal|4|||
170538115|NCT03697304|616312721|FG004|Overall Study|Consent withdrawal|4|||
170538116|NCT03697304|616312722|FG005|Overall Study|Consent withdrawal|0|||
170538117|NCT03697304|616312723|FG006|Overall Study|Consent withdrawal|1|||
170538118|NCT03697304|616312724|FG007|Overall Study|Consent withdrawal|1|||
170538119|NCT03697304|616312717|FG000|Overall Study|Adverse Event|4|||
170538120|NCT03697304|616312718|FG001|Overall Study|Adverse Event|4|||
170538121|NCT03697304|616312719|FG002|Overall Study|Adverse Event|2|||
170538122|NCT03697304|616312720|FG003|Overall Study|Adverse Event|4|||
170538123|NCT03697304|616312721|FG004|Overall Study|Adverse Event|4|||
170538124|NCT03697304|616312722|FG005|Overall Study|Adverse Event|1|||
170538125|NCT03697304|616312723|FG006|Overall Study|Adverse Event|5|||
170538126|NCT03697304|616312724|FG007|Overall Study|Adverse Event|3|||
170538127|NCT03697304|616312717|FG000|Overall Study|Progressive disease|21|||
170538128|NCT03697304|616312718|FG001|Overall Study|Progressive disease|20|||
170538129|NCT03697304|616312719|FG002|Overall Study|Progressive disease|22|||
170538130|NCT03697304|616312720|FG003|Overall Study|Progressive disease|22|||
170538131|NCT03697304|616312721|FG004|Overall Study|Progressive disease|8|||
170538132|NCT03697304|616312722|FG005|Overall Study|Progressive disease|1|||
170538133|NCT03697304|616312723|FG006|Overall Study|Progressive disease|25|||
170538134|NCT03697304|616312724|FG007|Overall Study|Progressive disease|37|||
170538135|NCT00143507|616313930|FG000|Overall Study|Death|572|||
170538136|NCT00143507|616313931|FG001|Overall Study|Death|547|||
170538137|NCT00143507|616313930|FG000|Overall Study|Withdrawal by Subject|114|||
170538138|NCT00143507|616313931|FG001|Overall Study|Withdrawal by Subject|102|||
170538139|NCT00143507|616313930|FG000|Overall Study|Lost to Follow-up|1|||
170538140|NCT00143507|616313931|FG001|Overall Study|Lost to Follow-up|0|||
170538141|NCT00143507|616313930|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
170538142|NCT00143507|616313931|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
170538143|NCT01136954|616313932|FG000|Overall Study|Adverse Event|3|||
170538144|NCT01136954|616313933|FG001|Overall Study|Adverse Event|2|||
170538145|NCT01136954|616313932|FG000|Overall Study|Withdrawal by Subject|6|||
170538146|NCT01136954|616313933|FG001|Overall Study|Withdrawal by Subject|2|||
170538147|NCT01136954|616313932|FG000|Overall Study|Lack of Efficacy|14|||
170538148|NCT01136954|616313933|FG001|Overall Study|Lack of Efficacy|13|||
170538149|NCT01136954|616313932|FG000|Overall Study|Physician Decision|0|||
170538150|NCT01136954|616313933|FG001|Overall Study|Physician Decision|1|||
170538151|NCT01136954|616313932|FG000|Overall Study|Other|1|||
170441433|NCT01567527|615954718|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
170441434|NCT01567527|615954719|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
170441435|NCT01567527|615954720|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
170441436|NCT01567527|615954721|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
170441437|NCT01567527|615954717|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
170441438|NCT01567527|615954718|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
170441439|NCT01567527|615954719|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
170441440|NCT01567527|615954720|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
170441441|NCT01567527|615954721|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
170441442|NCT01567527|615954717|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
170441443|NCT01567527|615954718|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
170441444|NCT01567527|615954719|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
170441445|NCT01567527|615954720|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
170441446|NCT01567527|615954721|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
170441447|NCT01567527|615954717|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
170441448|NCT01567527|615954718|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
170441449|NCT01567527|615954719|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
170441450|NCT01567527|615954720|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
170441451|NCT01567527|615954721|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
170441452|NCT01567527|615954717|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
170441453|NCT01567527|615954718|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
170441454|NCT01567527|615954719|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
170441455|NCT01567527|615954720|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
170441456|NCT01567527|615954721|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
170441457|NCT01567527|615954717|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
170441458|NCT01567527|615954718|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
170441459|NCT01567527|615954719|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
170441460|NCT01567527|615954720|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
170441461|NCT01567527|615954721|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
170441462|NCT01567527|615954717|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
170441463|NCT01567527|615954718|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
170441464|NCT01567527|615954719|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
170441465|NCT01567527|615954720|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
170441466|NCT01567527|615954721|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
170441467|NCT01567527|615954717|FG000|IM Depot Stabilization.|Protocol deviation|0|||
170441468|NCT01567527|615954718|FG001|IM Depot Stabilization.|Protocol deviation|0|||
170441469|NCT01567527|615954719|FG002|IM Depot Stabilization.|Protocol deviation|5|||
170441470|NCT01567527|615954720|FG003|IM Depot Stabilization.|Protocol deviation|0|||
170441471|NCT01567527|615954721|FG004|IM Depot Stabilization.|Protocol deviation|0|||
170441472|NCT01567527|615954717|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
170441473|NCT01567527|615954718|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
170441474|NCT01567527|615954719|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
170441475|NCT01567527|615954720|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
170441476|NCT01567527|615954721|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
170441477|NCT01567527|615954717|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
170441478|NCT01567527|615954718|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
170441479|NCT01567527|615954719|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
170538152|NCT01136954|616313933|FG001|Overall Study|Other|3|||
170784891|NCT01902173|617219154|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
170784892|NCT01902173|617219155|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
170784893|NCT01902173|617219156|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
170784894|NCT01902173|617219157|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
170784895|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
170784896|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
170784897|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
170784898|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
170784899|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
170784900|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
170784901|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
170784902|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
170784903|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
170784904|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
170784905|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
170784906|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
170441480|NCT01567527|615954720|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
170441481|NCT01567527|615954721|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
170441482|NCT01567527|615954717|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
170441483|NCT01567527|615954718|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
170441484|NCT01567527|615954719|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
170441485|NCT01567527|615954720|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
170441486|NCT01567527|615954721|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
170538153|NCT03317496|616313934|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
170538154|NCT03317496|616313935|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
170538155|NCT03317496|616313936|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
170538156|NCT03317496|616313937|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
170886521|NCT05103332|617592236|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
170886522|NCT05103332|617592237|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170538157|NCT03317496|616313938|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
170538158|NCT03317496|616313934|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
170538159|NCT03317496|616313935|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
170538160|NCT03317496|616313936|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
170538161|NCT03317496|616313937|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
170538162|NCT03317496|616313938|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
170538163|NCT03317496|616313934|FG000|Phase 1b Lead-in: Treatment|Death|0|||
170538164|NCT03317496|616313935|FG001|Phase 1b Lead-in: Treatment|Death|0|||
170538165|NCT03317496|616313936|FG002|Phase 1b Lead-in: Treatment|Death|1|||
170538166|NCT03317496|616313937|FG003|Phase 1b Lead-in: Treatment|Death|0|||
170538167|NCT03317496|616313938|FG004|Phase 1b Lead-in: Treatment|Death|0|||
170538168|NCT03317496|616313934|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
170538169|NCT03317496|616313935|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
170538170|NCT03317496|616313936|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
170538171|NCT03317496|616313937|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
170538172|NCT03317496|616313938|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
170538173|NCT03317496|616313934|FG000|Phase 1b Lead-in: Treatment|Other|2|||
170538174|NCT03317496|616313935|FG001|Phase 1b Lead-in: Treatment|Other|1|||
170538175|NCT03317496|616313936|FG002|Phase 1b Lead-in: Treatment|Other|0|||
170538176|NCT03317496|616313937|FG003|Phase 1b Lead-in: Treatment|Other|0|||
170538177|NCT03317496|616313938|FG004|Phase 1b Lead-in: Treatment|Other|0|||
170538178|NCT03317496|616313934|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
170538179|NCT03317496|616313935|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
170538180|NCT03317496|616313936|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
170538181|NCT03317496|616313937|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
170538182|NCT03317496|616313938|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
170538183|NCT03317496|616313934|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
170538184|NCT03317496|616313935|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
170538185|NCT03317496|616313936|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
170538186|NCT03317496|616313937|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
170538187|NCT03317496|616313938|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
170538188|NCT03317496|616313934|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
170538189|NCT03317496|616313935|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
170538190|NCT03317496|616313936|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
170538191|NCT03317496|616313937|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
170538192|NCT03317496|616313938|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
170538193|NCT03317496|616313934|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
170538194|NCT03317496|616313935|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
170538195|NCT03317496|616313936|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
170538196|NCT03317496|616313937|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
170784907|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
170784908|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
170784909|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
170784910|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
170784911|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
170784912|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
170784913|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
170784914|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
170784915|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
170784916|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
170784917|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
170784918|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
170441487|NCT01567527|615954717|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
170538197|NCT03317496|616313938|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
170538198|NCT03317496|616313934|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
170538199|NCT03317496|616313935|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
170784919|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
170886523|NCT05103332|617592238|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886524|NCT05103332|617592239|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886525|NCT05103332|617592240|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886526|NCT05103332|617592241|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886527|NCT05103332|617592242|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170886528|NCT05103332|617592243|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
170538200|NCT03317496|616313936|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
170538201|NCT03317496|616313937|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
170538202|NCT03317496|616313938|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
170538203|NCT03317496|616313934|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
170538204|NCT03317496|616313935|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
170538205|NCT03317496|616313936|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
170538206|NCT03317496|616313937|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
170538207|NCT03317496|616313938|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
170538208|NCT03317496|616313934|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
170538209|NCT03317496|616313935|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
170538210|NCT03317496|616313936|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
170538211|NCT03317496|616313937|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
170538212|NCT03317496|616313938|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
170538213|NCT03317496|616313934|FG000|Phase 2: Treatment|Adverse Event|0|||
170538214|NCT03317496|616313935|FG001|Phase 2: Treatment|Adverse Event|0|||
170538215|NCT03317496|616313936|FG002|Phase 2: Treatment|Adverse Event|0|||
170538216|NCT03317496|616313937|FG003|Phase 2: Treatment|Adverse Event|0|||
170538217|NCT03317496|616313938|FG004|Phase 2: Treatment|Adverse Event|6|||
170538218|NCT03317496|616313934|FG000|Phase 2: Treatment|Progressive disease|0|||
170538219|NCT03317496|616313935|FG001|Phase 2: Treatment|Progressive disease|0|||
170538220|NCT03317496|616313936|FG002|Phase 2: Treatment|Progressive disease|0|||
170538221|NCT03317496|616313937|FG003|Phase 2: Treatment|Progressive disease|0|||
170538222|NCT03317496|616313938|FG004|Phase 2: Treatment|Progressive disease|22|||
170538223|NCT03317496|616313934|FG000|Phase 2: Treatment|Other|0|||
170538224|NCT03317496|616313935|FG001|Phase 2: Treatment|Other|0|||
170538225|NCT03317496|616313936|FG002|Phase 2: Treatment|Other|0|||
170538226|NCT03317496|616313937|FG003|Phase 2: Treatment|Other|0|||
170538227|NCT03317496|616313938|FG004|Phase 2: Treatment|Other|4|||
170538228|NCT03317496|616313934|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
170538229|NCT03317496|616313935|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
170538230|NCT03317496|616313936|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
170538231|NCT03317496|616313937|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
170538232|NCT03317496|616313938|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
170538233|NCT03317496|616313934|FG000|Phase 2: Treatment|Physician Decision|0|||
170538234|NCT03317496|616313935|FG001|Phase 2: Treatment|Physician Decision|0|||
170538235|NCT03317496|616313936|FG002|Phase 2: Treatment|Physician Decision|0|||
170538236|NCT03317496|616313937|FG003|Phase 2: Treatment|Physician Decision|0|||
170538237|NCT03317496|616313938|FG004|Phase 2: Treatment|Physician Decision|1|||
170538238|NCT03317496|616313934|FG000|Phase 2: Treatment|Death|0|||
170538239|NCT03317496|616313935|FG001|Phase 2: Treatment|Death|0|||
170538240|NCT03317496|616313936|FG002|Phase 2: Treatment|Death|0|||
170538241|NCT03317496|616313937|FG003|Phase 2: Treatment|Death|0|||
170538242|NCT03317496|616313938|FG004|Phase 2: Treatment|Death|1|||
170538243|NCT03317496|616313934|FG000|Phase 2: Follow-up|Death|0|||
170538244|NCT03317496|616313935|FG001|Phase 2: Follow-up|Death|0|||
170538245|NCT03317496|616313936|FG002|Phase 2: Follow-up|Death|0|||
170538246|NCT03317496|616313937|FG003|Phase 2: Follow-up|Death|0|||
170538247|NCT03317496|616313938|FG004|Phase 2: Follow-up|Death|24|||
170538248|NCT03317496|616313934|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
170538249|NCT03317496|616313935|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
170538250|NCT03317496|616313936|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
170538251|NCT03317496|616313937|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
170538252|NCT03317496|616313938|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
170538253|NCT03317496|616313934|FG000|Phase 2: Follow-up|Other|0|||
170538254|NCT03317496|616313935|FG001|Phase 2: Follow-up|Other|0|||
170538255|NCT03317496|616313936|FG002|Phase 2: Follow-up|Other|0|||
170538256|NCT03317496|616313937|FG003|Phase 2: Follow-up|Other|0|||
170538257|NCT03317496|616313938|FG004|Phase 2: Follow-up|Other|1|||
170538258|NCT03317496|616313934|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
170633115|NCT01746901|616668467|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
170886529|NCT05103332|617592226|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886530|NCT05103332|617592227|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886531|NCT05103332|617592228|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886532|NCT05103332|617592229|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170538259|NCT03317496|616313935|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
170538260|NCT03317496|616313936|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
170538261|NCT03317496|616313937|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
170538262|NCT03317496|616313938|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
170538263|NCT02693418|616313939|FG000|Overall Study|Lost to Follow-up|1|||
170538264|NCT02693418|616313940|FG001|Overall Study|Lost to Follow-up|2|||
170538265|NCT02693418|616313941|FG002|Overall Study|Lost to Follow-up|0|||
170538266|NCT02693418|616313942|FG003|Overall Study|Lost to Follow-up|0|||
170784920|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
170784921|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
170784922|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
170784923|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
170538267|NCT02693418|616313943|FG004|Overall Study|Lost to Follow-up|0|||
170538268|NCT02693418|616313939|FG000|Overall Study|Menses during study period|0|||
170538269|NCT02693418|616313940|FG001|Overall Study|Menses during study period|0|||
170538270|NCT02693418|616313941|FG002|Overall Study|Menses during study period|2|||
170538271|NCT02693418|616313942|FG003|Overall Study|Menses during study period|0|||
170538272|NCT02693418|616313943|FG004|Overall Study|Menses during study period|0|||
170538273|NCT01750346|616313944|FG000|Overall Study|Adverse Event|1|||
170538274|NCT01750346|616313945|FG001|Overall Study|Adverse Event|0|||
170538275|NCT01750346|616313946|FG002|Overall Study|Adverse Event|0|||
170538276|NCT00599313|616313954|FG000|Overall Study|Adverse Event|19|||
170538277|NCT00599313|616313954|FG000|Overall Study|Disease Progression|12|||
170538278|NCT00599313|616313954|FG000|Overall Study|Patient Request|4|||
170538279|NCT00599313|616313954|FG000|Overall Study|Ineligible|1|||
170538280|NCT02239328|616313957|FG000|Overall Study|Benign disease noted at time of surgery|6|||
170538281|NCT02239328|616313957|FG000|Overall Study|Equipment or website malfunction|2|||
170538282|NCT03881371|616313962|FG000|Overall Study|Adverse Event|8|||
170538283|NCT03881371|616313963|FG001|Overall Study|Adverse Event|9|||
170538284|NCT03881371|616313962|FG000|Overall Study|Death|1|||
170538285|NCT03881371|616313963|FG001|Overall Study|Death|0|||
170538286|NCT03881371|616313962|FG000|Overall Study|Lost to Follow-up|1|||
170538287|NCT03881371|616313963|FG001|Overall Study|Lost to Follow-up|0|||
170538288|NCT03881371|616313962|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170538289|NCT03881371|616313963|FG001|Overall Study|Non-Compliance with Study Drug|2|||
170538290|NCT03881371|616313962|FG000|Overall Study|Physician Decision|3|||
170538291|NCT03881371|616313963|FG001|Overall Study|Physician Decision|3|||
170538292|NCT03881371|616313962|FG000|Overall Study|Withdrawal by Subject|2|||
170538293|NCT03881371|616313963|FG001|Overall Study|Withdrawal by Subject|10|||
170538294|NCT03881371|616313962|FG000|Overall Study|Discontinuation from Study|1|||
170538295|NCT03881371|616313963|FG001|Overall Study|Discontinuation from Study|0|||
170538296|NCT01756235|616313966|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
170538297|NCT02327078|616313969|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
170784924|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
170886533|NCT05103332|617592230|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886534|NCT05103332|617592231|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886535|NCT05103332|617592232|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886536|NCT05103332|617592233|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170538298|NCT02327078|616313970|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
170538299|NCT02327078|616313971|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
170538300|NCT02327078|616313972|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
170538301|NCT02327078|616313973|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
170538302|NCT02327078|616313974|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
170538303|NCT02327078|616313975|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
170538304|NCT02327078|616313976|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
170538305|NCT02327078|616313977|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
170538306|NCT02327078|616313969|FG000|Overall Study|Death|2|||
170538307|NCT02327078|616313970|FG001|Overall Study|Death|4|||
170538308|NCT02327078|616313971|FG002|Overall Study|Death|10|||
170538309|NCT02327078|616313972|FG003|Overall Study|Death|6|||
170538310|NCT02327078|616313973|FG004|Overall Study|Death|4|||
170538311|NCT02327078|616313974|FG005|Overall Study|Death|3|||
170538312|NCT02327078|616313975|FG006|Overall Study|Death|2|||
170538313|NCT02327078|616313976|FG007|Overall Study|Death|51|||
170538314|NCT02327078|616313977|FG008|Overall Study|Death|97|||
170538315|NCT02327078|616313969|FG000|Overall Study|Lost to Follow-up|0|||
170538316|NCT02327078|616313970|FG001|Overall Study|Lost to Follow-up|1|||
170538317|NCT02327078|616313971|FG002|Overall Study|Lost to Follow-up|1|||
170538318|NCT02327078|616313972|FG003|Overall Study|Lost to Follow-up|0|||
170538319|NCT02327078|616313973|FG004|Overall Study|Lost to Follow-up|0|||
170538320|NCT02327078|616313974|FG005|Overall Study|Lost to Follow-up|0|||
170538321|NCT02327078|616313975|FG006|Overall Study|Lost to Follow-up|0|||
170538322|NCT02327078|616313976|FG007|Overall Study|Lost to Follow-up|2|||
170538323|NCT02327078|616313977|FG008|Overall Study|Lost to Follow-up|5|||
170538324|NCT02327078|616313969|FG000|Overall Study|Site Terminated by Sponsor|1|||
170538325|NCT02327078|616313970|FG001|Overall Study|Site Terminated by Sponsor|0|||
170538326|NCT02327078|616313971|FG002|Overall Study|Site Terminated by Sponsor|1|||
170538327|NCT02327078|616313972|FG003|Overall Study|Site Terminated by Sponsor|4|||
170538328|NCT02327078|616313973|FG004|Overall Study|Site Terminated by Sponsor|0|||
170538329|NCT02327078|616313974|FG005|Overall Study|Site Terminated by Sponsor|0|||
170538330|NCT02327078|616313975|FG006|Overall Study|Site Terminated by Sponsor|0|||
170538331|NCT02327078|616313976|FG007|Overall Study|Site Terminated by Sponsor|11|||
170538332|NCT02327078|616313977|FG008|Overall Study|Site Terminated by Sponsor|25|||
170538333|NCT02327078|616313969|FG000|Overall Study|Physician Decision|0|||
170538334|NCT02327078|616313970|FG001|Overall Study|Physician Decision|0|||
170538335|NCT02327078|616313971|FG002|Overall Study|Physician Decision|0|||
170538336|NCT02327078|616313972|FG003|Overall Study|Physician Decision|1|||
170538337|NCT02327078|616313973|FG004|Overall Study|Physician Decision|0|||
170538338|NCT02327078|616313974|FG005|Overall Study|Physician Decision|0|||
170538339|NCT02327078|616313975|FG006|Overall Study|Physician Decision|0|||
170538340|NCT02327078|616313976|FG007|Overall Study|Physician Decision|0|||
170538341|NCT02327078|616313977|FG008|Overall Study|Physician Decision|1|||
170538342|NCT02327078|616313969|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
170538343|NCT02327078|616313970|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
170538344|NCT02327078|616313971|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
170538345|NCT02327078|616313972|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
170538346|NCT02327078|616313973|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
170538347|NCT02327078|616313974|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
170538348|NCT02327078|616313975|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
170538349|NCT02327078|616313976|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
170538350|NCT02327078|616313977|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
170538351|NCT02327078|616313969|FG000|Overall Study|Reason not Specified|0|||
170538352|NCT02327078|616313970|FG001|Overall Study|Reason not Specified|0|||
170538353|NCT02327078|616313971|FG002|Overall Study|Reason not Specified|0|||
170538354|NCT02327078|616313972|FG003|Overall Study|Reason not Specified|0|||
170538355|NCT02327078|616313973|FG004|Overall Study|Reason not Specified|0|||
170538356|NCT02327078|616313974|FG005|Overall Study|Reason not Specified|0|||
170538357|NCT02327078|616313975|FG006|Overall Study|Reason not Specified|0|||
170538358|NCT02327078|616313976|FG007|Overall Study|Reason not Specified|5|||
170538359|NCT02327078|616313977|FG008|Overall Study|Reason not Specified|12|||
170538360|NCT06001021|616313978|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
170538361|NCT06001021|616313979|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
170538362|NCT06001021|616313980|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
170538363|NCT06001021|616313981|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
170886537|NCT05103332|617592234|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
170538364|NCT06001021|616313982|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
170886538|NCT05103332|617592235|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886539|NCT05103332|617592236|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886540|NCT05103332|617592237|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886541|NCT05103332|617592238|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886542|NCT05103332|617592239|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886543|NCT05103332|617592240|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886544|NCT05103332|617592241|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886545|NCT05103332|617592242|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886546|NCT05103332|617592243|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
170886547|NCT05103332|617592226|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886548|NCT05103332|617592227|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886549|NCT05103332|617592228|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886550|NCT05103332|617592229|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886551|NCT05103332|617592230|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886552|NCT05103332|617592231|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886553|NCT05103332|617592232|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886554|NCT05103332|617592233|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886555|NCT05103332|617592234|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886556|NCT05103332|617592235|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886557|NCT05103332|617592236|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886558|NCT05103332|617592237|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
170886559|NCT05103332|617592238|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886560|NCT05103332|617592239|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886561|NCT05103332|617592240|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886562|NCT05103332|617592241|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886563|NCT05103332|617592242|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886564|NCT05103332|617592243|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
170886565|NCT05103332|617592226|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886566|NCT05103332|617592227|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886567|NCT05103332|617592228|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886568|NCT05103332|617592229|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886569|NCT05103332|617592230|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886570|NCT05103332|617592231|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886571|NCT05103332|617592232|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
170886572|NCT05103332|617592233|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
170886573|NCT05103332|617592234|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886574|NCT05103332|617592235|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
170886575|NCT05103332|617592236|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
170886576|NCT05103332|617592237|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
170784925|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
170784926|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
170784927|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
170784928|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
170784929|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
170784930|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
170784931|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
170784932|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
170784933|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
170784934|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
170784935|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
170784936|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
170784937|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
170784938|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
170784939|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
170784940|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
170784941|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
170784942|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
170784943|NCT01902173|617219152|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
170784944|NCT01902173|617219153|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
170784945|NCT01902173|617219154|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
170784946|NCT01902173|617219155|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
170784947|NCT01902173|617219156|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
170784948|NCT01902173|617219157|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
170784949|NCT05319860|617219162|FG000|Overall Study|Death|1|||
170886577|NCT05103332|617592238|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886578|NCT05103332|617592239|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170538365|NCT06001021|616313983|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
170784950|NCT05319860|617219163|FG001|Overall Study|Death|1|||
170441488|NCT01567527|615954718|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
170784951|NCT05319860|617219162|FG000|Overall Study|Lost to Follow-up|3|||
170784952|NCT05319860|617219163|FG001|Overall Study|Lost to Follow-up|1|||
170784953|NCT05319860|617219162|FG000|Overall Study|Withdrawal by Subject|1|||
170784954|NCT05319860|617219163|FG001|Overall Study|Withdrawal by Subject|7|||
170784955|NCT04314895|617219165|FG000|Overall Study|Lost to Follow-up|1|||
170784956|NCT04314895|617219165|FG000|Overall Study|Death|10|||
170784957|NCT04314895|617219165|FG000|Overall Study|Physician Decision|2|||
170784958|NCT03361748|617219169|FG000|Overall Study|Death|77|||
170784959|NCT03361748|617219169|FG000|Overall Study|Lost to Follow-up|4|||
170784960|NCT03361748|617219169|FG000|Overall Study|Withdrawal by Subject|20|||
170784961|NCT00901901|617219170|FG000|Treatment Period|Adverse Event|120|||
170784962|NCT00901901|617219171|FG001|Treatment Period|Adverse Event|128|||
170784963|NCT00901901|617219170|FG000|Treatment Period|Withdrawal by Subject|26|||
170784964|NCT00901901|617219171|FG001|Treatment Period|Withdrawal by Subject|24|||
170784965|NCT00901901|617219170|FG000|Treatment Period|Physician Decision|2|||
170784966|NCT00901901|617219171|FG001|Treatment Period|Physician Decision|2|||
170784967|NCT00901901|617219170|FG000|Treatment Period|Lost to Follow-up|3|||
170784968|NCT00901901|617219171|FG001|Treatment Period|Lost to Follow-up|5|||
170784969|NCT00901901|617219170|FG000|Treatment Period|Noncompliance with study medication|4|||
170784970|NCT00901901|617219171|FG001|Treatment Period|Noncompliance with study medication|1|||
170784971|NCT00901901|617219170|FG000|Treatment Period|Missing|1|||
170784972|NCT00901901|617219171|FG001|Treatment Period|Missing|0|||
170784973|NCT00901901|617219170|FG000|Treatment Period|Never treated|0|||
170784974|NCT00901901|617219171|FG001|Treatment Period|Never treated|3|||
170784975|NCT00901901|617219170|FG000|Treatment Period|Protocol driven decision point|0|||
170784976|NCT00901901|617219171|FG001|Treatment Period|Protocol driven decision point|2|||
170784977|NCT00901901|617219170|FG000|Treatment Period|Study terminated by sponsor|2|||
170784978|NCT00901901|617219171|FG001|Treatment Period|Study terminated by sponsor|0|||
170784979|NCT00901901|617219170|FG000|Treatment Period|Protocol Violation|5|||
170784980|NCT00901901|617219171|FG001|Treatment Period|Protocol Violation|9|||
170784981|NCT00901901|617219170|FG000|Treatment Period|Switch to commercial drug|1|||
170784982|NCT00901901|617219171|FG001|Treatment Period|Switch to commercial drug|1|||
170784983|NCT00901901|617219170|FG000|Treatment Period|Transfer to treatment continuation study|5|||
170784984|NCT00901901|617219171|FG001|Treatment Period|Transfer to treatment continuation study|2|||
170784985|NCT00901901|617219170|FG000|Follow-up Period|Death|181|||
170784986|NCT00901901|617219171|FG001|Follow-up Period|Death|208|||
170784987|NCT00901901|617219170|FG000|Follow-up Period|Protocol driven decision point|47|||
170784988|NCT00901901|617219171|FG001|Follow-up Period|Protocol driven decision point|36|||
170784989|NCT00901901|617219170|FG000|Follow-up Period|Withdrawal by Subject|6|||
170784990|NCT00901901|617219171|FG001|Follow-up Period|Withdrawal by Subject|9|||
170784991|NCT00901901|617219170|FG000|Follow-up Period|Lost to Follow-up|12|||
170784992|NCT00901901|617219171|FG001|Follow-up Period|Lost to Follow-up|8|||
170784993|NCT00901901|617219170|FG000|Follow-up Period|Missing|94|||
170784994|NCT00901901|617219171|FG001|Follow-up Period|Missing|80|||
170784995|NCT02471638|617219177|FG000|Overall Study|Early Term Withdrawal|10|||
170784996|NCT04521478|617221329|FG000|Overall Study|Protocol Violation|2|||
170784997|NCT04521478|617221330|FG001|Overall Study|Protocol Violation|0|||
170784998|NCT04521478|617221331|FG002|Overall Study|Protocol Violation|1|||
170784999|NCT04521478|617221332|FG003|Overall Study|Protocol Violation|0|||
170785000|NCT04521478|617221333|FG004|Overall Study|Protocol Violation|0|||
170785001|NCT04521478|617221334|FG005|Overall Study|Protocol Violation|0|||
170785002|NCT04521478|617221329|FG000|Overall Study|Technical Problems|0|||
170785003|NCT04521478|617221330|FG001|Overall Study|Technical Problems|0|||
170785004|NCT04521478|617221331|FG002|Overall Study|Technical Problems|0|||
170785005|NCT04521478|617221332|FG003|Overall Study|Technical Problems|1|||
170785006|NCT04521478|617221333|FG004|Overall Study|Technical Problems|0|||
170785007|NCT04521478|617221334|FG005|Overall Study|Technical Problems|0|||
170785008|NCT04521478|617221329|FG000|Overall Study|Burden of Study Procedures|1|||
170785009|NCT04521478|617221330|FG001|Overall Study|Burden of Study Procedures|0|||
170785010|NCT04521478|617221331|FG002|Overall Study|Burden of Study Procedures|0|||
170785011|NCT04521478|617221332|FG003|Overall Study|Burden of Study Procedures|1|||
170785012|NCT04521478|617221333|FG004|Overall Study|Burden of Study Procedures|0|||
170785013|NCT04521478|617221334|FG005|Overall Study|Burden of Study Procedures|1|||
170538366|NCT06001021|616313984|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
170785014|NCT04521478|617221329|FG000|Overall Study|Lack of Efficacy|0|||
170785015|NCT04521478|617221330|FG001|Overall Study|Lack of Efficacy|0|||
170785016|NCT04521478|617221331|FG002|Overall Study|Lack of Efficacy|0|||
170785017|NCT04521478|617221332|FG003|Overall Study|Lack of Efficacy|0|||
170785018|NCT04521478|617221333|FG004|Overall Study|Lack of Efficacy|1|||
170785019|NCT04521478|617221334|FG005|Overall Study|Lack of Efficacy|1|||
170785020|NCT04521478|617221329|FG000|Overall Study|Adverse Event|7|||
170785021|NCT04521478|617221330|FG001|Overall Study|Adverse Event|0|||
170785022|NCT04521478|617221331|FG002|Overall Study|Adverse Event|2|||
170785023|NCT04521478|617221332|FG003|Overall Study|Adverse Event|1|||
170785024|NCT04521478|617221333|FG004|Overall Study|Adverse Event|2|||
170785025|NCT04521478|617221334|FG005|Overall Study|Adverse Event|7|||
170785026|NCT04521478|617221329|FG000|Overall Study|No Reason Available|0|||
170785027|NCT04521478|617221330|FG001|Overall Study|No Reason Available|2|||
170785028|NCT04521478|617221331|FG002|Overall Study|No Reason Available|0|||
170785029|NCT04521478|617221332|FG003|Overall Study|No Reason Available|0|||
170785030|NCT04521478|617221333|FG004|Overall Study|No Reason Available|1|||
170785031|NCT04521478|617221334|FG005|Overall Study|No Reason Available|0|||
170785032|NCT04521478|617221329|FG000|Overall Study|Other than listed|3|||
170785033|NCT04521478|617221330|FG001|Overall Study|Other than listed|3|||
170785034|NCT04521478|617221331|FG002|Overall Study|Other than listed|3|||
170785035|NCT04521478|617221332|FG003|Overall Study|Other than listed|2|||
170785036|NCT04521478|617221333|FG004|Overall Study|Other than listed|3|||
170785037|NCT04521478|617221334|FG005|Overall Study|Other than listed|3|||
170785038|NCT04521478|617221329|FG000|Overall Study|Not treated|0|||
170441489|NCT01567527|615954719|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
170441490|NCT01567527|615954720|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
170441491|NCT01567527|615954721|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
170441492|NCT01567527|615954717|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
170441493|NCT01567527|615954718|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
170441494|NCT01567527|615954719|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
170441495|NCT01567527|615954720|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
170441496|NCT01567527|615954721|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
170441497|NCT01567527|615954717|FG000|IM Depot Stabilization.|Adverse Event|0|||
170441498|NCT01567527|615954718|FG001|IM Depot Stabilization.|Adverse Event|0|||
170441499|NCT01567527|615954719|FG002|IM Depot Stabilization.|Adverse Event|37|||
170441500|NCT01567527|615954720|FG003|IM Depot Stabilization.|Adverse Event|0|||
170441501|NCT01567527|615954721|FG004|IM Depot Stabilization.|Adverse Event|0|||
170441502|NCT01567527|615954717|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
170441503|NCT01567527|615954718|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
170441504|NCT01567527|615954719|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
170441505|NCT01567527|615954720|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
170441506|NCT01567527|615954721|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
170441507|NCT01567527|615954717|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
170441508|NCT01567527|615954718|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
170441509|NCT01567527|615954719|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
170441510|NCT01567527|615954720|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
170441511|NCT01567527|615954721|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
170441512|NCT01567527|615954717|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
170538367|NCT06001021|616313978|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
170538368|NCT06001021|616313979|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
170538369|NCT06001021|616313980|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
170538370|NCT06001021|616313981|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
170538371|NCT06001021|616313982|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
170538372|NCT06001021|616313983|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
170538373|NCT06001021|616313984|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
170538374|NCT03112603|616313985|FG000|End of Randomization Period|Lost to Follow-up|3|||
170538375|NCT03112603|616313986|FG001|End of Randomization Period|Lost to Follow-up|0|||
170538376|NCT03112603|616313987|FG002|End of Randomization Period|Lost to Follow-up|0|||
170538377|NCT03112603|616313985|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
170785039|NCT04521478|617221330|FG001|Overall Study|Not treated|0|||
170785040|NCT04521478|617221331|FG002|Overall Study|Not treated|0|||
170785041|NCT04521478|617221332|FG003|Overall Study|Not treated|0|||
170785042|NCT04521478|617221333|FG004|Overall Study|Not treated|0|||
170785043|NCT04521478|617221334|FG005|Overall Study|Not treated|1|||
170785044|NCT02187003|617221335|FG000|Overall Study|Adverse Event|2|||
170785045|NCT02187003|617221336|FG001|Overall Study|Adverse Event|0|||
170785046|NCT02187003|617221335|FG000|Overall Study|Lost to Follow-up|14|||
170785047|NCT02187003|617221336|FG001|Overall Study|Lost to Follow-up|10|||
170785048|NCT02187003|617221335|FG000|Overall Study|Withdrawal by Subject|3|||
170785049|NCT02187003|617221336|FG001|Overall Study|Withdrawal by Subject|7|||
170441513|NCT01567527|615954718|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
170441514|NCT01567527|615954719|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
170538378|NCT03112603|616313986|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
170538379|NCT03112603|616313987|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
170538380|NCT03112603|616313985|FG000|End of Randomization Period|Physician Decision|43|||
170538381|NCT03112603|616313986|FG001|End of Randomization Period|Physician Decision|18|||
170538382|NCT03112603|616313987|FG002|End of Randomization Period|Physician Decision|0|||
170538383|NCT03112603|616313985|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
170538384|NCT03112603|616313986|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
170538385|NCT03112603|616313987|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
170538386|NCT03112603|616313985|FG000|End of Randomization Period|Death|10|||
170538387|NCT03112603|616313986|FG001|End of Randomization Period|Death|7|||
170538388|NCT03112603|616313987|FG002|End of Randomization Period|Death|0|||
170538389|NCT03112603|616313985|FG000|End of Randomization Period|Disease Relapse|12|||
170538390|NCT03112603|616313986|FG001|End of Randomization Period|Disease Relapse|7|||
170538391|NCT03112603|616313987|FG002|End of Randomization Period|Disease Relapse|0|||
170538392|NCT03112603|616313985|FG000|End of Randomization Period|Lack of Efficacy|25|||
170538393|NCT03112603|616313986|FG001|End of Randomization Period|Lack of Efficacy|77|||
170538394|NCT03112603|616313987|FG002|End of Randomization Period|Lack of Efficacy|0|||
170538395|NCT03112603|616313985|FG000|End of Randomization Period|Adverse Event|32|||
170538396|NCT03112603|616313986|FG001|End of Randomization Period|Adverse Event|12|||
170538397|NCT03112603|616313987|FG002|End of Randomization Period|Adverse Event|0|||
170538398|NCT03112603|616313985|FG000|End of Cross Over Period|Death|0|||
170538399|NCT03112603|616313986|FG001|End of Cross Over Period|Death|0|||
170886579|NCT05103332|617592240|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886580|NCT05103332|617592241|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886581|NCT05103332|617592242|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886582|NCT05103332|617592243|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
170886583|NCT05103332|617592226|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886584|NCT05103332|617592227|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886585|NCT05103332|617592228|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886586|NCT05103332|617592229|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886587|NCT05103332|617592230|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886588|NCT05103332|617592231|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886589|NCT05103332|617592232|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886590|NCT05103332|617592233|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886591|NCT05103332|617592234|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886592|NCT05103332|617592235|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170538400|NCT03112603|616313987|FG002|End of Cross Over Period|Death|2|||
170538401|NCT03112603|616313985|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
170538402|NCT03112603|616313986|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
170538403|NCT03112603|616313987|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
170538404|NCT03112603|616313985|FG000|End of Cross Over Period|Physician Decision|0|||
170538405|NCT03112603|616313986|FG001|End of Cross Over Period|Physician Decision|0|||
170538406|NCT03112603|616313987|FG002|End of Cross Over Period|Physician Decision|29|||
170538407|NCT03112603|616313985|FG000|End of Cross Over Period|Lack of Efficacy|0|||
170538408|NCT03112603|616313986|FG001|End of Cross Over Period|Lack of Efficacy|0|||
170538409|NCT03112603|616313987|FG002|End of Cross Over Period|Lack of Efficacy|8|||
170538410|NCT03112603|616313985|FG000|End of Cross Over Period|Adverse Event|0|||
170538411|NCT03112603|616313986|FG001|End of Cross Over Period|Adverse Event|0|||
170538412|NCT03112603|616313987|FG002|End of Cross Over Period|Adverse Event|6|||
170538413|NCT03112603|616313985|FG000|End of Cross Over Period|Disease Relapse|0|||
170538414|NCT03112603|616313986|FG001|End of Cross Over Period|Disease Relapse|0|||
170538415|NCT03112603|616313987|FG002|End of Cross Over Period|Disease Relapse|2|||
170538416|NCT00314145|616313993|FG000|Overall Study|Withdrawal by Subject|8|||
170538417|NCT00314145|616313994|FG001|Overall Study|Withdrawal by Subject|10|||
170538418|NCT00314145|616313993|FG000|Overall Study|Lost to Follow-up|5|||
170538419|NCT00314145|616313994|FG001|Overall Study|Lost to Follow-up|12|||
170886593|NCT05103332|617592236|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886594|NCT05103332|617592237|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
170886595|NCT05103332|617592238|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
170886596|NCT05103332|617592239|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
170886597|NCT05103332|617592240|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
170538420|NCT00314145|616313993|FG000|Overall Study|Physician Decision|3|||
170538421|NCT00314145|616313994|FG001|Overall Study|Physician Decision|4|||
170538422|NCT00314145|616313993|FG000|Overall Study|Adverse Event|0|||
170785050|NCT02187003|617221335|FG000|Overall Study|Protocol Violation|2|||
170785051|NCT02187003|617221336|FG001|Overall Study|Protocol Violation|4|||
170785052|NCT02187003|617221335|FG000|Overall Study|Other|5|||
170785053|NCT02187003|617221336|FG001|Overall Study|Other|5|||
170785054|NCT02187003|617221335|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170785055|NCT02187003|617221336|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
170785056|NCT05816551|617221337|FG000|Overall Study|Withdrawal by Subject|0|||
170785057|NCT05816551|617221338|FG001|Overall Study|Withdrawal by Subject|1|||
170785058|NCT05816551|617221337|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
170785059|NCT05816551|617221338|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
170785060|NCT02630823|617221345|FG000|Overall Study|Withdrawal by Subject|1|||
170785061|NCT02630823|617221345|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
170785062|NCT04593472|617221346|FG000|Overall Study|Death|31|||
170785063|NCT04593472|617221347|FG001|Overall Study|Death|27|||
170785064|NCT04593472|617221346|FG000|Overall Study|Withdrawal by Subject|12|||
170785065|NCT04593472|617221347|FG001|Overall Study|Withdrawal by Subject|12|||
170785066|NCT04593472|617221346|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
170785067|NCT04593472|617221347|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
170785068|NCT04593472|617221346|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
170785069|NCT04593472|617221347|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
170785070|NCT04593472|617221346|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
170785071|NCT04593472|617221347|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
170785072|NCT04593472|617221346|FG000|Overall Study|Lost to Follow-up|0|||
170785073|NCT04593472|617221347|FG001|Overall Study|Lost to Follow-up|2|||
170785074|NCT04593472|617221346|FG000|Overall Study|Still collecting 24-month assessment|17|||
170785075|NCT04593472|617221347|FG001|Overall Study|Still collecting 24-month assessment|10|||
170785076|NCT04353661|617221353|FG000|Overall Study|Protocol Violation|0|||
170785077|NCT04353661|617221354|FG001|Overall Study|Protocol Violation|0|||
170785078|NCT04353661|617221355|FG002|Overall Study|Protocol Violation|1|||
170785079|NCT04353661|617221353|FG000|Overall Study|Study termination by the Sponsor|1|||
170785080|NCT04353661|617221354|FG001|Overall Study|Study termination by the Sponsor|1|||
170785081|NCT04353661|617221355|FG002|Overall Study|Study termination by the Sponsor|1|||
170785082|NCT00667251|617221356|FG000|Overall Study|Disease progression|232|||
170785083|NCT00667251|617221357|FG001|Overall Study|Disease progression|203|||
170785084|NCT00667251|617221356|FG000|Overall Study|Toxicity|44|||
170785085|NCT00667251|617221357|FG001|Overall Study|Toxicity|23|||
170785086|NCT00667251|617221356|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
170785087|NCT00667251|617221357|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
170785088|NCT00667251|617221356|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
170785089|NCT00667251|617221357|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
170785090|NCT00667251|617221356|FG000|Overall Study|Symptomatic progression|8|||
170785091|NCT00667251|617221357|FG001|Overall Study|Symptomatic progression|4|||
170785092|NCT00667251|617221356|FG000|Overall Study|Death|6|||
170785093|NCT00667251|617221357|FG001|Overall Study|Death|11|||
170785094|NCT00667251|617221356|FG000|Overall Study|Intercurrent illness|5|||
170785095|NCT00667251|617221357|FG001|Overall Study|Intercurrent illness|6|||
170785096|NCT00667251|617221356|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
170785097|NCT00667251|617221357|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
170785098|NCT00667251|617221356|FG000|Overall Study|Randomized not Treated|4|||
170785099|NCT00667251|617221357|FG001|Overall Study|Randomized not Treated|1|||
170785100|NCT03376321|617221362|FG000|Overall Study|Other|5|||
170785101|NCT03376321|617221363|FG001|Overall Study|Other|1|||
170785102|NCT03376321|617221362|FG000|Overall Study|Withdrawal by Subject|8|||
170785103|NCT03376321|617221363|FG001|Overall Study|Withdrawal by Subject|14|||
170785104|NCT03376321|617221362|FG000|Overall Study|Lost to Follow-up|1|||
170785105|NCT03376321|617221363|FG001|Overall Study|Lost to Follow-up|7|||
170785106|NCT03376321|617221362|FG000|Overall Study|Death|4|||
170785107|NCT03376321|617221363|FG001|Overall Study|Death|0|||
170785108|NCT03376321|617221362|FG000|Overall Study|Randomized, not treated|5|||
170785109|NCT03376321|617221363|FG001|Overall Study|Randomized, not treated|3|||
170785110|NCT02671903|617221364|FG000|Period 0 (Run-In)|Death|0|||
170785111|NCT02671903|617221365|FG001|Period 0 (Run-In)|Death|0|||
170538423|NCT00314145|616313994|FG001|Overall Study|Adverse Event|3|||
170538424|NCT00314145|616313993|FG000|Overall Study|Protocol Violation|3|||
170785112|NCT02671903|617221366|FG002|Period 0 (Run-In)|Death|3|||
170538425|NCT00314145|616313994|FG001|Overall Study|Protocol Violation|0|||
170785113|NCT02671903|617221364|FG000|Period 0 (Run-In)|Physician Decision|0|||
170785114|NCT02671903|617221365|FG001|Period 0 (Run-In)|Physician Decision|0|||
170785115|NCT02671903|617221366|FG002|Period 0 (Run-In)|Physician Decision|4|||
170785116|NCT02671903|617221364|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
170785117|NCT02671903|617221365|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
170538426|NCT00314145|616313993|FG000|Overall Study|Sponsor Decision|2|||
170538427|NCT00314145|616313994|FG001|Overall Study|Sponsor Decision|0|||
170538428|NCT02572167|616313995|FG000|Overall Study|Withdrawal by Subject|0|||
170538429|NCT02572167|616313996|FG001|Overall Study|Withdrawal by Subject|3|||
170538430|NCT02572167|616313997|FG002|Overall Study|Withdrawal by Subject|0|||
170538431|NCT02572167|616313995|FG000|Overall Study|Lost to Follow-up|2|||
170538432|NCT02572167|616313996|FG001|Overall Study|Lost to Follow-up|5|||
170538433|NCT02572167|616313997|FG002|Overall Study|Lost to Follow-up|3|||
170538434|NCT02572167|616313995|FG000|Overall Study|Death|0|||
170538435|NCT02572167|616313996|FG001|Overall Study|Death|8|||
170538436|NCT02572167|616313997|FG002|Overall Study|Death|3|||
170538437|NCT02572167|616313995|FG000|Overall Study|Did not meet inclusion criteria|0|||
170538438|NCT02572167|616313996|FG001|Overall Study|Did not meet inclusion criteria|0|||
170538439|NCT02572167|616313997|FG002|Overall Study|Did not meet inclusion criteria|1|||
170538440|NCT02572167|616313995|FG000|Overall Study|Study closure by Sponsor|4|||
170538441|NCT02572167|616313996|FG001|Overall Study|Study closure by Sponsor|40|||
170538442|NCT02572167|616313997|FG002|Overall Study|Study closure by Sponsor|24|||
170538443|NCT00005047|616313998|FG000|Overall Study|Withdrawal by Subject|12|||
170538444|NCT00005047|616313999|FG001|Overall Study|Withdrawal by Subject|0|||
170538445|NCT00005047|616314000|FG002|Overall Study|Withdrawal by Subject|0|||
170538446|NCT00005047|616314001|FG003|Overall Study|Withdrawal by Subject|0|||
170538447|NCT00005047|616313998|FG000|Overall Study|Adverse Event|5|||
170785118|NCT02671903|617221366|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
170785119|NCT02671903|617221364|FG000|Period 0 (Run-In)|Protocol Violation|0|||
170538448|NCT00005047|616313999|FG001|Overall Study|Adverse Event|0|||
170538449|NCT00005047|616314000|FG002|Overall Study|Adverse Event|0|||
170538450|NCT00005047|616314001|FG003|Overall Study|Adverse Event|0|||
170538451|NCT00005047|616313998|FG000|Overall Study|Lost to Follow-up|1|||
170538452|NCT00005047|616313999|FG001|Overall Study|Lost to Follow-up|0|||
170538453|NCT00005047|616314000|FG002|Overall Study|Lost to Follow-up|0|||
170441515|NCT01567527|615954720|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
170441516|NCT01567527|615954721|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
170441517|NCT01567527|615954717|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
170441518|NCT01567527|615954718|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
170441519|NCT01567527|615954719|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
170441520|NCT01567527|615954720|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
170441521|NCT01567527|615954721|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
170441522|NCT01567527|615954717|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
170441523|NCT01567527|615954718|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
170441524|NCT01567527|615954719|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
170441525|NCT01567527|615954720|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
170441526|NCT01567527|615954721|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
170441527|NCT01567527|615954717|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
170441528|NCT01567527|615954718|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
170441529|NCT01567527|615954719|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
170441530|NCT01567527|615954720|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
170441531|NCT01567527|615954721|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
170441532|NCT01567527|615954717|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
170441533|NCT01567527|615954718|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
170441534|NCT01567527|615954719|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
170441535|NCT01567527|615954720|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
170538454|NCT00005047|616314001|FG003|Overall Study|Lost to Follow-up|0|||
170538455|NCT00005047|616313998|FG000|Overall Study|Lack of Efficacy|1|||
170538456|NCT00005047|616313999|FG001|Overall Study|Lack of Efficacy|0|||
170785120|NCT02671903|617221365|FG001|Period 0 (Run-In)|Protocol Violation|0|||
170785121|NCT02671903|617221366|FG002|Period 0 (Run-In)|Protocol Violation|1|||
170785122|NCT02671903|617221364|FG000|Period 0 (Run-In)|Adverse Event|0|||
170785123|NCT02671903|617221365|FG001|Period 0 (Run-In)|Adverse Event|0|||
170785124|NCT02671903|617221366|FG002|Period 0 (Run-In)|Adverse Event|1|||
170785125|NCT02671903|617221364|FG000|Period 0 (Run-In)|Implantation Failure|0|||
170886598|NCT05103332|617592241|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
170886599|NCT05103332|617592242|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
170538457|NCT00005047|616314000|FG002|Overall Study|Lack of Efficacy|0|||
170538458|NCT00005047|616314001|FG003|Overall Study|Lack of Efficacy|0|||
170538459|NCT00580840|616314002|FG000|Run-in|Adverse Event|17|||
170538460|NCT00580840|616314003|FG001|Run-in|Adverse Event|0|||
170538461|NCT00580840|616314004|FG002|Run-in|Adverse Event|0|||
170785126|NCT02671903|617221365|FG001|Period 0 (Run-In)|Implantation Failure|0|||
170785127|NCT02671903|617221366|FG002|Period 0 (Run-In)|Implantation Failure|2|||
170886600|NCT05103332|617592243|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
170441536|NCT01567527|615954721|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
170441537|NCT01567527|615954717|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
170441538|NCT01567527|615954718|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
170441539|NCT01567527|615954719|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
170441540|NCT01567527|615954720|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
170441541|NCT01567527|615954721|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
170441542|NCT01567527|615954717|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170441543|NCT01567527|615954718|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170441544|NCT01567527|615954719|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170441545|NCT01567527|615954720|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
170441546|NCT01567527|615954721|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
170785128|NCT02671903|617221364|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
170785129|NCT02671903|617221365|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
170785130|NCT02671903|617221366|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
170785131|NCT04034251|617221367|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
170785132|NCT04034251|617221368|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
170785133|NCT04034251|617221369|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
170785134|NCT00961571|617221372|FG000|Overall Study|Physician Decision|39|||
170441547|NCT02472639|615954722|FG000|Overall Study|Physician Decision|4|||
170441548|NCT02472639|615954723|FG001|Overall Study|Physician Decision|3|||
170441549|NCT02050321|615954724|FG000|Overall Study|Withdrawal by Subject|1|||
170441550|NCT02050321|615954724|FG000|Overall Study|Adverse Event|1|||
170441551|NCT01726803|615954725|FG000|Overall Study|Lost to Follow-up|6|||
170441552|NCT01726803|615954726|FG001|Overall Study|Lost to Follow-up|1|||
170441553|NCT01726803|615954725|FG000|Overall Study|Withdrawal by Subject|1|||
170441554|NCT01726803|615954726|FG001|Overall Study|Withdrawal by Subject|0|||
170441555|NCT04768114|615954729|FG000|Overall Study|Lost to Follow-up|5|||
170441556|NCT04768114|615954730|FG001|Overall Study|Lost to Follow-up|10|||
170441557|NCT04768114|615954729|FG000|Overall Study|Withdrawal by Subject|0|||
170441558|NCT04768114|615954730|FG001|Overall Study|Withdrawal by Subject|1|||
170441559|NCT01091363|615954742|FG000|Overall Study|Withdrawal by Subject|11|||
170441560|NCT01091363|615954743|FG001|Overall Study|Withdrawal by Subject|15|||
170538462|NCT00580840|616314005|FG003|Run-in|Adverse Event|0|||
170538463|NCT00580840|616314002|FG000|Run-in|Lack of Efficacy|93|||
170538464|NCT00580840|616314003|FG001|Run-in|Lack of Efficacy|0|||
170538465|NCT00580840|616314004|FG002|Run-in|Lack of Efficacy|0|||
170538466|NCT00580840|616314005|FG003|Run-in|Lack of Efficacy|0|||
170538467|NCT00580840|616314002|FG000|Run-in|Loss of Efficacy|1|||
170538468|NCT00580840|616314003|FG001|Run-in|Loss of Efficacy|0|||
170538469|NCT00580840|616314004|FG002|Run-in|Loss of Efficacy|0|||
170538470|NCT00580840|616314005|FG003|Run-in|Loss of Efficacy|0|||
170538471|NCT00580840|616314002|FG000|Run-in|Lost to Follow-up|4|||
170538472|NCT00580840|616314003|FG001|Run-in|Lost to Follow-up|0|||
170538473|NCT00580840|616314004|FG002|Run-in|Lost to Follow-up|0|||
170538474|NCT00580840|616314005|FG003|Run-in|Lost to Follow-up|0|||
170538475|NCT00580840|616314002|FG000|Run-in|Withdrawal by Subject|5|||
170538476|NCT00580840|616314003|FG001|Run-in|Withdrawal by Subject|0|||
170538477|NCT00580840|616314004|FG002|Run-in|Withdrawal by Subject|0|||
170538478|NCT00580840|616314005|FG003|Run-in|Withdrawal by Subject|0|||
170538479|NCT00580840|616314002|FG000|Run-in|Other: Per Sponsor Request|2|||
170538480|NCT00580840|616314003|FG001|Run-in|Other: Per Sponsor Request|0|||
170538481|NCT00580840|616314004|FG002|Run-in|Other: Per Sponsor Request|0|||
170538482|NCT00580840|616314005|FG003|Run-in|Other: Per Sponsor Request|0|||
170538483|NCT00580840|616314002|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
170538484|NCT00580840|616314003|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
170538485|NCT00580840|616314004|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
170538486|NCT00580840|616314005|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
170538487|NCT00580840|616314002|FG000|Run-in|Other: Exclusionary Lab Value|1|||
170538488|NCT00580840|616314003|FG001|Run-in|Other: Exclusionary Lab Value|0|||
170538489|NCT00580840|616314004|FG002|Run-in|Other: Exclusionary Lab Value|0|||
170538490|NCT00580840|616314005|FG003|Run-in|Other: Exclusionary Lab Value|0|||
170538491|NCT00580840|616314002|FG000|Double-Blind|Adverse Event|0|||
170538492|NCT00580840|616314003|FG001|Double-Blind|Adverse Event|3|||
170538493|NCT00580840|616314004|FG002|Double-Blind|Adverse Event|4|||
170538494|NCT00580840|616314005|FG003|Double-Blind|Adverse Event|1|||
170538495|NCT00580840|616314002|FG000|Double-Blind|Loss of Efficacy|0|||
170538496|NCT00580840|616314003|FG001|Double-Blind|Loss of Efficacy|1|||
170538497|NCT00580840|616314004|FG002|Double-Blind|Loss of Efficacy|2|||
170785135|NCT02736409|617221373|FG000|Overall Study|Withdrawal by Subject|4|||
170886601|NCT05103332|617592226|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170441561|NCT01091363|615954742|FG000|Overall Study|Lost to Follow-up|2|||
170441562|NCT01091363|615954743|FG001|Overall Study|Lost to Follow-up|2|||
170538498|NCT00580840|616314005|FG003|Double-Blind|Loss of Efficacy|10|||
170538499|NCT00580840|616314002|FG000|Double-Blind|Lost to Follow-up|0|||
170441563|NCT04892147|615954744|FG000|Overall Study|Withdrawal by Subject|2|||
170441564|NCT04892147|615954745|FG001|Overall Study|Withdrawal by Subject|0|||
170441565|NCT01215721|615954746|FG000|Overall Study|Adverse Event|2|||
170441566|NCT00045162|615954747|FG000|Overall Study|Ineligible|12|||
170441567|NCT00045162|615954748|FG001|Overall Study|Ineligible|8|||
170441568|NCT00045162|615954747|FG000|Overall Study|Not treated|7|||
170441569|NCT00045162|615954748|FG001|Overall Study|Not treated|2|||
170441570|NCT00045162|615954747|FG000|Overall Study|Adverse Event|55|||
170441571|NCT00045162|615954748|FG001|Overall Study|Adverse Event|50|||
170441572|NCT00045162|615954747|FG000|Overall Study|Lack of Efficacy|32|||
170441573|NCT00045162|615954748|FG001|Overall Study|Lack of Efficacy|29|||
170441574|NCT00045162|615954747|FG000|Overall Study|Death|10|||
170441575|NCT00045162|615954748|FG001|Overall Study|Death|10|||
170441576|NCT00045162|615954747|FG000|Overall Study|Withdrawal by Subject|5|||
170441577|NCT00045162|615954748|FG001|Overall Study|Withdrawal by Subject|3|||
170538500|NCT00580840|616314003|FG001|Double-Blind|Lost to Follow-up|1|||
170538501|NCT00580840|616314004|FG002|Double-Blind|Lost to Follow-up|0|||
170538502|NCT00580840|616314005|FG003|Double-Blind|Lost to Follow-up|2|||
170538503|NCT00580840|616314002|FG000|Double-Blind|Withdrawal by Subject|0|||
170538504|NCT00580840|616314003|FG001|Double-Blind|Withdrawal by Subject|1|||
170538505|NCT00580840|616314004|FG002|Double-Blind|Withdrawal by Subject|2|||
170538506|NCT00580840|616314005|FG003|Double-Blind|Withdrawal by Subject|2|||
170538507|NCT00580840|616314002|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
170785136|NCT02736409|617221374|FG001|Overall Study|Withdrawal by Subject|2|||
170785137|NCT02736409|617221375|FG002|Overall Study|Withdrawal by Subject|17|||
170785138|NCT02736409|617221376|FG003|Overall Study|Withdrawal by Subject|3|||
170785139|NCT02736409|617221373|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170785140|NCT02736409|617221374|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170785141|NCT02736409|617221375|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170785142|NCT02736409|617221376|FG003|Overall Study|Non-Compliance with Study Drug|1|||
170785143|NCT02736409|617221373|FG000|Overall Study|Adverse Event|0|||
170785144|NCT02736409|617221374|FG001|Overall Study|Adverse Event|1|||
170785145|NCT02736409|617221375|FG002|Overall Study|Adverse Event|5|||
170785146|NCT02736409|617221376|FG003|Overall Study|Adverse Event|4|||
170785147|NCT02736409|617221373|FG000|Overall Study|Other|0|||
170785148|NCT02736409|617221374|FG001|Overall Study|Other|0|||
170785149|NCT02736409|617221375|FG002|Overall Study|Other|1|||
170785150|NCT02736409|617221376|FG003|Overall Study|Other|1|||
170785151|NCT02736409|617221373|FG000|Overall Study|Pregnancy|0|||
170785152|NCT02736409|617221374|FG001|Overall Study|Pregnancy|0|||
170785153|NCT02736409|617221375|FG002|Overall Study|Pregnancy|1|||
170785154|NCT02736409|617221376|FG003|Overall Study|Pregnancy|0|||
170785155|NCT02736409|617221373|FG000|Overall Study|Lost to Follow-up|0|||
170785156|NCT02736409|617221374|FG001|Overall Study|Lost to Follow-up|0|||
170785157|NCT02736409|617221375|FG002|Overall Study|Lost to Follow-up|2|||
170785158|NCT02736409|617221376|FG003|Overall Study|Lost to Follow-up|1|||
170785159|NCT02736409|617221373|FG000|Overall Study|Physician Decision|0|||
170886602|NCT05103332|617592227|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886603|NCT05103332|617592228|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886604|NCT05103332|617592229|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170538508|NCT00580840|616314003|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
170538509|NCT00580840|616314004|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
170886605|NCT05103332|617592230|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886606|NCT05103332|617592231|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886607|NCT05103332|617592232|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886608|NCT05103332|617592233|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886609|NCT05103332|617592234|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886610|NCT05103332|617592235|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886611|NCT05103332|617592236|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886612|NCT05103332|617592237|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886613|NCT05103332|617592238|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886614|NCT05103332|617592239|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886615|NCT05103332|617592240|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886616|NCT05103332|617592241|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886617|NCT05103332|617592242|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
170886618|NCT05103332|617592243|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
170785160|NCT02736409|617221374|FG001|Overall Study|Physician Decision|0|||
170785161|NCT02736409|617221375|FG002|Overall Study|Physician Decision|0|||
170785162|NCT02736409|617221376|FG003|Overall Study|Physician Decision|2|||
170785163|NCT03126019|617221377|FG000|Overall Study|Death|5|||
170785164|NCT03126019|617221378|FG001|Overall Study|Death|27|||
170785165|NCT03126019|617221377|FG000|Overall Study|Lost to Follow-up|2|||
170441578|NCT00045162|615954747|FG000|Overall Study|Other|21|||
170441579|NCT00045162|615954748|FG001|Overall Study|Other|16|||
170441580|NCT01044433|615954749|FG000|Overall Study|Lost to Follow-up|3|||
170441581|NCT01044433|615954749|FG000|Overall Study|Withdrawal by Subject|3|||
170785166|NCT03126019|617221378|FG001|Overall Study|Lost to Follow-up|4|||
170441582|NCT01547728|615954750|FG000|Overall Study|Change in procedure and equipment|1|||
170785167|NCT03126019|617221377|FG000|Overall Study|Withdrawal by Subject|1|||
170785168|NCT03126019|617221378|FG001|Overall Study|Withdrawal by Subject|9|||
170785169|NCT03126019|617221377|FG000|Overall Study|Physician Decision|1|||
170785170|NCT03126019|617221378|FG001|Overall Study|Physician Decision|0|||
170785171|NCT03126019|617221377|FG000|Overall Study|Transitioned to Rollover Study|0|||
170785172|NCT03126019|617221378|FG001|Overall Study|Transitioned to Rollover Study|11|||
170785173|NCT03126019|617221377|FG000|Overall Study|Did Not Return to Site for Care|0|||
170785174|NCT03126019|617221378|FG001|Overall Study|Did Not Return to Site for Care|1|||
170785175|NCT03126019|617221377|FG000|Overall Study|Site Closed|0|||
170785176|NCT03126019|617221378|FG001|Overall Study|Site Closed|1|||
170785177|NCT00170573|617221379|FG000|Overall Study|Violation of inclusion criteria|13|||
170785178|NCT03138512|617221387|FG000|Randomization|Participants withdrew consent|0|||
170785179|NCT03138512|617221388|FG001|Randomization|Participants withdrew consent|1|||
170785180|NCT03138512|617221389|FG002|Randomization|Participants withdrew consent|1|||
170785181|NCT03138512|617221390|FG003|Randomization|Participants withdrew consent|0|||
170785182|NCT03138512|617221391|FG004|Randomization|Participants withdrew consent|0|||
170785183|NCT03138512|617221387|FG000|Randomization|Participant no longer meets study criteria|0|||
170785184|NCT03138512|617221388|FG001|Randomization|Participant no longer meets study criteria|3|||
170785185|NCT03138512|617221389|FG002|Randomization|Participant no longer meets study criteria|1|||
170785186|NCT03138512|617221390|FG003|Randomization|Participant no longer meets study criteria|1|||
170785187|NCT03138512|617221391|FG004|Randomization|Participant no longer meets study criteria|3|||
170785188|NCT03138512|617221387|FG000|Randomization|Other reasons|1|||
170785189|NCT03138512|617221388|FG001|Randomization|Other reasons|0|||
170785190|NCT03138512|617221389|FG002|Randomization|Other reasons|0|||
170785191|NCT03138512|617221390|FG003|Randomization|Other reasons|0|||
170785192|NCT03138512|617221391|FG004|Randomization|Other reasons|0|||
170785193|NCT03138512|617221387|FG000|Treatment Part A|Disease recurrence|10|||
170785194|NCT03138512|617221388|FG001|Treatment Part A|Disease recurrence|20|||
170785195|NCT03138512|617221389|FG002|Treatment Part A|Disease recurrence|0|||
170785196|NCT03138512|617221390|FG003|Treatment Part A|Disease recurrence|0|||
170785197|NCT03138512|617221391|FG004|Treatment Part A|Disease recurrence|0|||
170785198|NCT03138512|617221387|FG000|Treatment Part A|Study Drug Toxicity|132|||
170785199|NCT03138512|617221388|FG001|Treatment Part A|Study Drug Toxicity|5|||
170785200|NCT03138512|617221389|FG002|Treatment Part A|Study Drug Toxicity|0|||
170785201|NCT03138512|617221390|FG003|Treatment Part A|Study Drug Toxicity|0|||
170785202|NCT03138512|617221391|FG004|Treatment Part A|Study Drug Toxicity|0|||
170785203|NCT03138512|617221387|FG000|Treatment Part A|Death|1|||
170785204|NCT03138512|617221388|FG001|Treatment Part A|Death|0|||
170785205|NCT03138512|617221389|FG002|Treatment Part A|Death|0|||
170785206|NCT03138512|617221390|FG003|Treatment Part A|Death|0|||
170785207|NCT03138512|617221391|FG004|Treatment Part A|Death|0|||
170785208|NCT03138512|617221387|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
170785209|NCT03138512|617221388|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
170785210|NCT03138512|617221389|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
170785211|NCT03138512|617221390|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
170785212|NCT03138512|617221391|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
170785213|NCT03138512|617221387|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
170785214|NCT03138512|617221388|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
170785215|NCT03138512|617221389|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
170785216|NCT03138512|617221390|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
170785217|NCT03138512|617221391|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
170785218|NCT03138512|617221387|FG000|Treatment Part A|Participant withdrew consent|2|||
170785219|NCT03138512|617221388|FG001|Treatment Part A|Participant withdrew consent|4|||
170785220|NCT03138512|617221389|FG002|Treatment Part A|Participant withdrew consent|0|||
170785221|NCT03138512|617221390|FG003|Treatment Part A|Participant withdrew consent|0|||
170785222|NCT03138512|617221391|FG004|Treatment Part A|Participant withdrew consent|0|||
170785223|NCT03138512|617221387|FG000|Treatment Part A|Lost to Follow-up|0|||
170785224|NCT03138512|617221388|FG001|Treatment Part A|Lost to Follow-up|1|||
170785225|NCT03138512|617221389|FG002|Treatment Part A|Lost to Follow-up|0|||
170785226|NCT03138512|617221390|FG003|Treatment Part A|Lost to Follow-up|0|||
170785227|NCT03138512|617221391|FG004|Treatment Part A|Lost to Follow-up|0|||
170441583|NCT01547728|615954750|FG000|Overall Study|Drug not ready for subject|1|||
170441584|NCT01547728|615954750|FG000|Overall Study|Screen failure|39|||
170441585|NCT01898598|615954751|FG000|Overall Study|Adverse Event|1|||
170441586|NCT01898598|615954752|FG001|Overall Study|Adverse Event|0|||
170785228|NCT03138512|617221387|FG000|Treatment Part A|Poor/non-compliance|1|||
170785229|NCT03138512|617221388|FG001|Treatment Part A|Poor/non-compliance|0|||
170785230|NCT03138512|617221389|FG002|Treatment Part A|Poor/non-compliance|0|||
170785231|NCT03138512|617221390|FG003|Treatment Part A|Poor/non-compliance|0|||
170785232|NCT03138512|617221391|FG004|Treatment Part A|Poor/non-compliance|0|||
170785233|NCT03138512|617221387|FG000|Treatment Part A|Pregnancy|0|||
170441587|NCT01898598|615954751|FG000|Overall Study|Withdrawal by Subject|3|||
170886619|NCT05103332|617592226|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886620|NCT05103332|617592227|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886621|NCT05103332|617592228|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886622|NCT05103332|617592229|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886623|NCT05103332|617592230|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170441588|NCT01898598|615954752|FG001|Overall Study|Withdrawal by Subject|0|||
170441589|NCT01898598|615954751|FG000|Overall Study|Lost to Follow-up|0|||
170441590|NCT01898598|615954752|FG001|Overall Study|Lost to Follow-up|1|||
170441591|NCT01898598|615954751|FG000|Overall Study|Other|0|||
170441592|NCT01898598|615954752|FG001|Overall Study|Other|1|||
170441593|NCT02297841|615956268|FG000|Overall Study|Withdrawal by Subject|1|||
170441594|NCT02297841|615956268|FG000|Overall Study|Protocol Violation|7|||
170441595|NCT01157234|615956269|FG000|Overall Study|Withdrawal by Subject|1|||
170441596|NCT01157234|615956270|FG001|Overall Study|Withdrawal by Subject|0|||
170441597|NCT00493792|615956271|FG000|Overall Study|Death|55|||
170441598|NCT00493792|615956272|FG001|Overall Study|Death|50|||
170441599|NCT00493792|615956271|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
170441600|NCT00493792|615956272|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
170785234|NCT03138512|617221388|FG001|Treatment Part A|Pregnancy|1|||
170785235|NCT03138512|617221389|FG002|Treatment Part A|Pregnancy|0|||
170785236|NCT03138512|617221390|FG003|Treatment Part A|Pregnancy|0|||
170441601|NCT00894933|615956280|FG000|Overall Study|Lost to Follow-up|2|||
170441602|NCT00894933|615956280|FG000|Overall Study|Cancelled Procedure|1|||
170441603|NCT00894933|615956280|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
170441604|NCT04241133|615956283|FG000|Overall Study|COVID19 Precautions|14|||
170441605|NCT04241133|615956284|FG001|Overall Study|COVID19 Precautions|34|||
170441606|NCT03653026|615956288|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
170441607|NCT03653026|615956289|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
170441608|NCT03653026|615956290|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
170441609|NCT03653026|615956291|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
170441610|NCT03653026|615956288|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
170441611|NCT03653026|615956289|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
170441612|NCT03653026|615956290|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
170441613|NCT03653026|615956291|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
170441614|NCT03653026|615956288|FG000|Part 1: Placebo-controlled Period|Other|0|||
170441615|NCT03653026|615956289|FG001|Part 1: Placebo-controlled Period|Other|3|||
170441616|NCT03653026|615956290|FG002|Part 1: Placebo-controlled Period|Other|0|||
170441617|NCT03653026|615956291|FG003|Part 1: Placebo-controlled Period|Other|0|||
170441618|NCT03653026|615956288|FG000|Part 2: Open-label Extension|Adverse Event|0|||
170441619|NCT03653026|615956289|FG001|Part 2: Open-label Extension|Adverse Event|0|||
170441620|NCT03653026|615956290|FG002|Part 2: Open-label Extension|Adverse Event|1|||
170441621|NCT03653026|615956291|FG003|Part 2: Open-label Extension|Adverse Event|1|||
170441622|NCT03653026|615956288|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
170441623|NCT03653026|615956289|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
170441624|NCT03653026|615956290|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
170441625|NCT03653026|615956291|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
170441626|NCT03653026|615956288|FG000|Part 2: Open-label Extension|Other|0|||
170441627|NCT03653026|615956289|FG001|Part 2: Open-label Extension|Other|0|||
170441628|NCT03653026|615956290|FG002|Part 2: Open-label Extension|Other|1|||
170441629|NCT03653026|615956291|FG003|Part 2: Open-label Extension|Other|2|||
170441630|NCT02510261|615956292|FG000|Overall Study|Adverse Event|5|||
170441631|NCT02510261|615956293|FG001|Overall Study|Adverse Event|8|||
170441632|NCT02510261|615956294|FG002|Overall Study|Adverse Event|0|||
170441633|NCT02510261|615956292|FG000|Overall Study|Physician Decision|1|||
170538510|NCT00580840|616314005|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
170785237|NCT03138512|617221391|FG004|Treatment Part A|Pregnancy|0|||
170785238|NCT03138512|617221387|FG000|Treatment Part A|Other reasons|11|||
170785239|NCT03138512|617221388|FG001|Treatment Part A|Other reasons|8|||
170785240|NCT03138512|617221389|FG002|Treatment Part A|Other reasons|0|||
170785241|NCT03138512|617221390|FG003|Treatment Part A|Other reasons|0|||
170785242|NCT03138512|617221391|FG004|Treatment Part A|Other reasons|0|||
170785243|NCT03138512|617221387|FG000|Treatment Part B|Disease recurrence|0|||
170785244|NCT03138512|617221388|FG001|Treatment Part B|Disease recurrence|0|||
170785245|NCT03138512|617221389|FG002|Treatment Part B|Disease recurrence|6|||
170785246|NCT03138512|617221390|FG003|Treatment Part B|Disease recurrence|12|||
170785247|NCT03138512|617221391|FG004|Treatment Part B|Disease recurrence|10|||
170785248|NCT03138512|617221387|FG000|Treatment Part B|Study drug toxicity|0|||
170785249|NCT03138512|617221388|FG001|Treatment Part B|Study drug toxicity|0|||
170441634|NCT02510261|615956293|FG001|Overall Study|Physician Decision|5|||
170441635|NCT02510261|615956294|FG002|Overall Study|Physician Decision|0|||
170441636|NCT02510261|615956292|FG000|Overall Study|Death|19|||
170441637|NCT02510261|615956293|FG001|Overall Study|Death|19|||
170441638|NCT02510261|615956294|FG002|Overall Study|Death|0|||
170538511|NCT00580840|616314002|FG000|Double-Blind|Other: Forbidden Medication|0|||
170538512|NCT00580840|616314003|FG001|Double-Blind|Other: Forbidden Medication|0|||
170538513|NCT00580840|616314004|FG002|Double-Blind|Other: Forbidden Medication|1|||
170441639|NCT02510261|615956292|FG000|Overall Study|Withdrawal by Subject|3|||
170441640|NCT02510261|615956293|FG001|Overall Study|Withdrawal by Subject|10|||
170441641|NCT02510261|615956294|FG002|Overall Study|Withdrawal by Subject|3|||
170441642|NCT01091103|615956298|FG000|Overall Study|Adverse Event|1|||
170441643|NCT01091103|615956298|FG000|Overall Study|Progressive Disease|3|||
170441644|NCT01597479|615956299|FG000|Overall Study|Protocol Violation|1|||
170441645|NCT01597479|615956300|FG001|Overall Study|Protocol Violation|0|||
170441646|NCT01597479|615956299|FG000|Overall Study|Lost to Follow-up|1|||
170441647|NCT01597479|615956300|FG001|Overall Study|Lost to Follow-up|0|||
170441648|NCT00348816|615956301|FG000|Overall Study|Noncompliance with radiation treatment|1|||
170441649|NCT04941768|615956303|FG000|Overall Study|Lost to Follow-up|10|||
170441650|NCT04941768|615956303|FG000|Overall Study|Death|24|||
170441651|NCT04941768|615956303|FG000|Overall Study|Progressive Disease|4|||
170441652|NCT04941768|615956303|FG000|Overall Study|Withdrawal by Subject|4|||
170441653|NCT04941768|615956303|FG000|Overall Study|Other|3|||
170441654|NCT04941768|615956303|FG000|Overall Study|Treatment ongoing|21|||
170441655|NCT04941768|615956303|FG000|Overall Study|Off treatment and in follow-up|21|||
170441656|NCT02167594|615956304|FG000|Overall Study|Withdrawal by Subject|2|||
170441657|NCT02167594|615956305|FG001|Overall Study|Withdrawal by Subject|0|||
170441658|NCT02167594|615956306|FG002|Overall Study|Withdrawal by Subject|0|||
170441659|NCT02167594|615956304|FG000|Overall Study|Death|0|||
170441660|NCT02167594|615956305|FG001|Overall Study|Death|1|||
170441661|NCT02167594|615956306|FG002|Overall Study|Death|0|||
170538514|NCT00580840|616314005|FG003|Double-Blind|Other: Forbidden Medication|0|||
170538515|NCT00976027|616314006|FG000|Overall Study|Serious Adverse Event|36|||
170538516|NCT00976027|616314007|FG001|Overall Study|Serious Adverse Event|17|||
170538517|NCT00976027|616314006|FG000|Overall Study|Adverse Event|0|||
170538518|NCT00976027|616314007|FG001|Overall Study|Adverse Event|2|||
170538519|NCT00976027|616314006|FG000|Overall Study|Protocol Violation|60|||
170538520|NCT00976027|616314007|FG001|Overall Study|Protocol Violation|27|||
170538521|NCT00976027|616314006|FG000|Overall Study|Lost to Follow-up|208|||
170538522|NCT00976027|616314007|FG001|Overall Study|Lost to Follow-up|103|||
170538523|NCT00976027|616314006|FG000|Overall Study|Withdrawal by Subject|107|||
170538524|NCT00976027|616314007|FG001|Overall Study|Withdrawal by Subject|66|||
170538525|NCT01160614|616314014|FG000|Overall Study|Withdrawal by Subject|0|||
170538526|NCT01160614|616314015|FG001|Overall Study|Withdrawal by Subject|2|||
170538527|NCT00984399|616314016|FG000|Overall Study|Adverse Event|0|||
170538528|NCT00984399|616314017|FG001|Overall Study|Adverse Event|1|||
170538529|NCT00984399|616314016|FG000|Overall Study|Physician Decision|1|||
170538530|NCT00984399|616314017|FG001|Overall Study|Physician Decision|0|||
170538531|NCT00984399|616314016|FG000|Overall Study|Withdrawal by Subject|1|||
170538532|NCT00984399|616314017|FG001|Overall Study|Withdrawal by Subject|1|||
170538533|NCT00984399|616314016|FG000|Overall Study|Protocol Violation|0|||
170538534|NCT00984399|616314017|FG001|Overall Study|Protocol Violation|1|||
170538535|NCT00984399|616314016|FG000|Overall Study|Pts did not start treatment|2|||
170633116|NCT01746901|616668468|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
170633117|NCT01746901|616668460|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
170633118|NCT01746901|616668461|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
170633119|NCT01746901|616668462|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
170633120|NCT01746901|616668463|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
170633121|NCT01746901|616668464|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
170633122|NCT01746901|616668465|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
170633123|NCT01746901|616668466|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
170633124|NCT01746901|616668467|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
170633125|NCT01746901|616668468|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
170633126|NCT01746901|616668460|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
170633127|NCT01746901|616668461|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
170785250|NCT03138512|617221389|FG002|Treatment Part B|Study drug toxicity|63|||
170785251|NCT03138512|617221390|FG003|Treatment Part B|Study drug toxicity|3|||
170441662|NCT03433703|615956307|FG000|Overall Study|Study terminated by Sponsor|2|||
170441663|NCT01856192|615956310|FG000|Overall Study|Adverse Event|12|||
170538536|NCT00984399|616314017|FG001|Overall Study|Pts did not start treatment|2|||
170538537|NCT05049122|616314018|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
170538538|NCT05049122|616314018|FG000|Overall Study|Participant moved|1|||
170633128|NCT01746901|616668462|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
170633129|NCT01746901|616668463|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
170441664|NCT01856192|615956311|FG001|Overall Study|Adverse Event|4|||
170441665|NCT01856192|615956310|FG000|Overall Study|Alternative therapy|0|||
170441666|NCT01856192|615956311|FG001|Overall Study|Alternative therapy|3|||
170441667|NCT01856192|615956310|FG000|Overall Study|Death|3|||
170441668|NCT01856192|615956311|FG001|Overall Study|Death|5|||
170441669|NCT01856192|615956310|FG000|Overall Study|Lack of Efficacy|0|||
170785252|NCT03138512|617221391|FG004|Treatment Part B|Study drug toxicity|45|||
170785253|NCT03138512|617221387|FG000|Treatment Part B|Death|0|||
170785254|NCT03138512|617221388|FG001|Treatment Part B|Death|0|||
170785255|NCT03138512|617221389|FG002|Treatment Part B|Death|1|||
170785256|NCT03138512|617221390|FG003|Treatment Part B|Death|0|||
170785257|NCT03138512|617221391|FG004|Treatment Part B|Death|0|||
170785258|NCT03138512|617221387|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
170785259|NCT03138512|617221388|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
170785260|NCT03138512|617221389|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
170785261|NCT03138512|617221390|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
170785262|NCT03138512|617221391|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
170785263|NCT03138512|617221387|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
170785264|NCT03138512|617221388|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
170785265|NCT03138512|617221389|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
170785266|NCT03138512|617221390|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
170785267|NCT03138512|617221391|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
170785268|NCT03138512|617221387|FG000|Treatment Part B|Participant withdrew consent|0|||
170785269|NCT03138512|617221388|FG001|Treatment Part B|Participant withdrew consent|0|||
170785270|NCT03138512|617221389|FG002|Treatment Part B|Participant withdrew consent|1|||
170785271|NCT03138512|617221390|FG003|Treatment Part B|Participant withdrew consent|1|||
170785272|NCT03138512|617221391|FG004|Treatment Part B|Participant withdrew consent|2|||
170785273|NCT03138512|617221387|FG000|Treatment Part B|Lost to Follow-up|0|||
170785274|NCT03138512|617221388|FG001|Treatment Part B|Lost to Follow-up|0|||
170441670|NCT01856192|615956311|FG001|Overall Study|Lack of Efficacy|5|||
170441671|NCT01856192|615956310|FG000|Overall Study|Withdrawal by Subject|1|||
170785275|NCT03138512|617221389|FG002|Treatment Part B|Lost to Follow-up|0|||
170785276|NCT03138512|617221390|FG003|Treatment Part B|Lost to Follow-up|1|||
170785277|NCT03138512|617221391|FG004|Treatment Part B|Lost to Follow-up|0|||
170785278|NCT03138512|617221387|FG000|Treatment Part B|Poor/non-compliance|0|||
170785279|NCT03138512|617221388|FG001|Treatment Part B|Poor/non-compliance|0|||
170785280|NCT03138512|617221389|FG002|Treatment Part B|Poor/non-compliance|1|||
170785281|NCT03138512|617221390|FG003|Treatment Part B|Poor/non-compliance|1|||
170785282|NCT03138512|617221391|FG004|Treatment Part B|Poor/non-compliance|1|||
170785283|NCT03138512|617221387|FG000|Treatment Part B|Other reasons|0|||
170785284|NCT03138512|617221388|FG001|Treatment Part B|Other reasons|0|||
170785285|NCT03138512|617221389|FG002|Treatment Part B|Other reasons|3|||
170785286|NCT03138512|617221390|FG003|Treatment Part B|Other reasons|1|||
170785287|NCT03138512|617221391|FG004|Treatment Part B|Other reasons|5|||
170785288|NCT03846505|617221396|FG000|Treatment Phase|Withdrawal by Subject|9|||
170785289|NCT03846505|617221397|FG001|Treatment Phase|Withdrawal by Subject|11|||
170785290|NCT03846505|617221396|FG000|Treatment Phase|Lost to Follow-up|6|||
170785291|NCT03846505|617221397|FG001|Treatment Phase|Lost to Follow-up|2|||
170785292|NCT03846505|617221396|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
170785293|NCT03846505|617221397|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
170785294|NCT03846505|617221396|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
170785295|NCT03846505|617221397|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
170785296|NCT02281955|617221398|FG000|Overall Study|Death|1|||
170785297|NCT03792555|617221404|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
170785298|NCT03792555|617221405|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
170785299|NCT03792555|617221406|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
170785300|NCT03792555|617221404|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
170785301|NCT03792555|617221405|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
170785302|NCT03792555|617221406|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
170785303|NCT03792555|617221404|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
170785304|NCT03792555|617221405|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
170441672|NCT01856192|615956311|FG001|Overall Study|Withdrawal by Subject|1|||
170441673|NCT01856192|615956310|FG000|Overall Study|Other diseases|1|||
170441674|NCT01856192|615956311|FG001|Overall Study|Other diseases|0|||
170441675|NCT01856192|615956310|FG000|Overall Study|Never started treatment|7|||
170441676|NCT01856192|615956311|FG001|Overall Study|Never started treatment|5|||
170441677|NCT01856192|615956310|FG000|Overall Study|Path ineligible|20|||
170441678|NCT01856192|615956311|FG001|Overall Study|Path ineligible|34|||
170441679|NCT01856192|615956310|FG000|Overall Study|Non-path ineligible|2|||
170441680|NCT01856192|615956311|FG001|Overall Study|Non-path ineligible|2|||
170441681|NCT01856192|615956310|FG000|Overall Study|Physician Decision|1|||
170785305|NCT03792555|617221406|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
170785306|NCT04485039|617221410|FG000|TPOXX Only|Adverse Event|2|||
170785307|NCT04485039|617221410|FG000|TPOXX Only|Physician Decision|1|||
170785308|NCT04485039|617221410|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
170441682|NCT01856192|615956311|FG001|Overall Study|Physician Decision|1|||
170441683|NCT01856192|615956310|FG000|Overall Study|Suspicion of progressive disease|1|||
170441684|NCT01856192|615956311|FG001|Overall Study|Suspicion of progressive disease|0|||
170441685|NCT01856192|615956310|FG000|Overall Study|Non-compliance|1|||
170441686|NCT01856192|615956311|FG001|Overall Study|Non-compliance|0|||
170441687|NCT01332968|615956312|FG000|Induction Period|Adverse Event|23|||
170441688|NCT01332968|615956313|FG001|Induction Period|Adverse Event|26|||
170441689|NCT01332968|615956314|FG002|Induction Period|Adverse Event|0|||
170441690|NCT01332968|615956315|FG003|Induction Period|Adverse Event|0|||
170441691|NCT01332968|615956316|FG004|Induction Period|Adverse Event|0|||
170785309|NCT04485039|617221410|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
170785310|NCT04005716|617221414|FG000|Overall Study|Death|175|||
170785311|NCT04005716|617221415|FG001|Overall Study|Death|196|||
170785312|NCT04005716|617221414|FG000|Overall Study|Withdrawal by Subject|1|||
170785313|NCT04005716|617221415|FG001|Overall Study|Withdrawal by Subject|6|||
170785314|NCT04005716|617221414|FG000|Overall Study|Lost to Follow-up|2|||
170785315|NCT04005716|617221415|FG001|Overall Study|Lost to Follow-up|2|||
170785316|NCT04060654|617221420|FG000|Overall Study|Withdrawal by Subject|1|||
170785317|NCT04060654|617221420|FG000|Overall Study|Lost to Follow-up|5|||
170785318|NCT04610892|617221421|FG000|Overall Study|Adverse Event|1|||
170785319|NCT04610892|617221422|FG001|Overall Study|Adverse Event|0|||
170785320|NCT04610892|617221423|FG002|Overall Study|Adverse Event|0|||
170785321|NCT04610892|617221424|FG003|Overall Study|Adverse Event|1|||
170785322|NCT04610892|617221425|FG004|Overall Study|Adverse Event|3|||
170785323|NCT04610892|617221421|FG000|Overall Study|Death|0|||
170785324|NCT04610892|617221422|FG001|Overall Study|Death|1|||
170785325|NCT04610892|617221423|FG002|Overall Study|Death|0|||
170785326|NCT04610892|617221424|FG003|Overall Study|Death|1|||
170785327|NCT04610892|617221425|FG004|Overall Study|Death|0|||
170785328|NCT04610892|617221421|FG000|Overall Study|Withdrawal by Subject|3|||
170785329|NCT04610892|617221422|FG001|Overall Study|Withdrawal by Subject|2|||
170785330|NCT04610892|617221423|FG002|Overall Study|Withdrawal by Subject|0|||
170785331|NCT04610892|617221424|FG003|Overall Study|Withdrawal by Subject|6|||
170785332|NCT04610892|617221425|FG004|Overall Study|Withdrawal by Subject|6|||
170785333|NCT04610892|617221421|FG000|Overall Study|Subjects who did not receive treatment|1|||
170785334|NCT04610892|617221422|FG001|Overall Study|Subjects who did not receive treatment|0|||
170785335|NCT04610892|617221423|FG002|Overall Study|Subjects who did not receive treatment|0|||
170785336|NCT04610892|617221424|FG003|Overall Study|Subjects who did not receive treatment|0|||
170785337|NCT04610892|617221425|FG004|Overall Study|Subjects who did not receive treatment|2|||
170785338|NCT01999075|617221426|FG000|Overall Study|Lost to Follow-up|0|||
170785339|NCT01999075|617221427|FG001|Overall Study|Lost to Follow-up|2|||
170785340|NCT01999075|617221426|FG000|Overall Study|Withdrawal by Subject|2|||
170785341|NCT01999075|617221427|FG001|Overall Study|Withdrawal by Subject|7|||
170785342|NCT01999075|617221426|FG000|Overall Study|Enrolled in drug trial|3|||
170785343|NCT01999075|617221427|FG001|Overall Study|Enrolled in drug trial|1|||
170785344|NCT01999075|617221426|FG000|Overall Study|Became ineligible|0|||
170785345|NCT01999075|617221427|FG001|Overall Study|Became ineligible|2|||
170785346|NCT05369403|617221429|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
170785347|NCT05369403|617221430|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
170785348|NCT05369403|617221431|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
170785349|NCT05369403|617221429|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
170785350|NCT05369403|617221430|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
170785351|NCT05369403|617221431|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
170785352|NCT05369403|617221429|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
170785353|NCT05369403|617221430|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
170785354|NCT05369403|617221431|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
170785355|NCT05369403|617221429|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
170785356|NCT05369403|617221430|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
170785357|NCT05369403|617221431|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
170785358|NCT05369403|617221429|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
170785359|NCT05369403|617221430|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
170441692|NCT01332968|615956317|FG005|Induction Period|Adverse Event|0|||
170441693|NCT01332968|615956318|FG006|Induction Period|Adverse Event|0|||
170538539|NCT05049122|616314018|FG000|Overall Study|At the direction of the doctor|1|||
170633130|NCT01746901|616668464|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
170633131|NCT01746901|616668465|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
170633132|NCT01746901|616668466|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
170633133|NCT01746901|616668467|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
170633134|NCT01746901|616668468|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
170633135|NCT01746901|616668460|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
170633136|NCT01746901|616668461|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
170633137|NCT01746901|616668462|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
170441694|NCT01332968|615956319|FG007|Induction Period|Adverse Event|0|||
170441695|NCT01332968|615956312|FG000|Induction Period|Death|1|||
170441696|NCT01332968|615956313|FG001|Induction Period|Death|4|||
170441697|NCT01332968|615956314|FG002|Induction Period|Death|0|||
170441698|NCT01332968|615956315|FG003|Induction Period|Death|0|||
170441699|NCT01332968|615956316|FG004|Induction Period|Death|0|||
170441700|NCT01332968|615956317|FG005|Induction Period|Death|0|||
170441701|NCT01332968|615956318|FG006|Induction Period|Death|0|||
170441702|NCT01332968|615956319|FG007|Induction Period|Death|0|||
170538540|NCT05248386|616314019|FG000|Overall Study|Technical problems|0|||
170538541|NCT05248386|616314020|FG001|Overall Study|Technical problems|1|||
170538542|NCT05248386|616314019|FG000|Overall Study|Withdrawal by Subject|15|||
170538543|NCT05248386|616314020|FG001|Overall Study|Withdrawal by Subject|10|||
170538544|NCT05248386|616314019|FG000|Overall Study|Physician Decision|0|||
170441703|NCT01332968|615956312|FG000|Induction Period|Non-compliance|1|||
170538545|NCT05248386|616314020|FG001|Overall Study|Physician Decision|1|||
170538546|NCT05248386|616314019|FG000|Overall Study|Adverse Event|2|||
170538547|NCT05248386|616314020|FG001|Overall Study|Adverse Event|4|||
170538548|NCT05248386|616314019|FG000|Overall Study|Other|1|||
170538549|NCT05248386|616314020|FG001|Overall Study|Other|0|||
170538550|NCT05248386|616314019|FG000|Overall Study|Lack of Efficacy|14|||
170538551|NCT05248386|616314020|FG001|Overall Study|Lack of Efficacy|12|||
170538552|NCT01910441|616314021|FG000|Overall Study|Sponsor decision|0|||
170538553|NCT01910441|616314022|FG001|Overall Study|Sponsor decision|2|||
170538554|NCT01910441|616314021|FG000|Overall Study|Lost to Follow-up|6|||
170538555|NCT01910441|616314022|FG001|Overall Study|Lost to Follow-up|5|||
170538556|NCT01910441|616314021|FG000|Overall Study|Withdrawal by Subject|0|||
170538557|NCT01910441|616314022|FG001|Overall Study|Withdrawal by Subject|1|||
170538558|NCT01910441|616314021|FG000|Overall Study|Non-compliance|0|||
170538559|NCT01910441|616314022|FG001|Overall Study|Non-compliance|1|||
170538560|NCT01910441|616314021|FG000|Overall Study|Adverse Event|1|||
170538561|NCT01910441|616314022|FG001|Overall Study|Adverse Event|0|||
170538562|NCT01910441|616314021|FG000|Overall Study|Physician Decision|0|||
170538563|NCT01910441|616314022|FG001|Overall Study|Physician Decision|1|||
170441704|NCT01332968|615956313|FG001|Induction Period|Non-compliance|0|||
170441705|NCT01332968|615956314|FG002|Induction Period|Non-compliance|0|||
170441706|NCT01332968|615956315|FG003|Induction Period|Non-compliance|0|||
170441707|NCT01332968|615956316|FG004|Induction Period|Non-compliance|0|||
170441708|NCT01332968|615956317|FG005|Induction Period|Non-compliance|0|||
170441709|NCT01332968|615956318|FG006|Induction Period|Non-compliance|0|||
170441710|NCT01332968|615956319|FG007|Induction Period|Non-compliance|0|||
170441711|NCT01332968|615956312|FG000|Induction Period|Other|2|||
170441712|NCT01332968|615956313|FG001|Induction Period|Other|2|||
170441713|NCT01332968|615956314|FG002|Induction Period|Other|0|||
170441714|NCT01332968|615956315|FG003|Induction Period|Other|0|||
170441715|NCT01332968|615956316|FG004|Induction Period|Other|0|||
170441716|NCT01332968|615956317|FG005|Induction Period|Other|0|||
170441717|NCT01332968|615956318|FG006|Induction Period|Other|0|||
170441718|NCT01332968|615956319|FG007|Induction Period|Other|0|||
170441719|NCT01332968|615956312|FG000|Induction Period|Physician Decision|6|||
170441720|NCT01332968|615956313|FG001|Induction Period|Physician Decision|1|||
170441721|NCT01332968|615956314|FG002|Induction Period|Physician Decision|0|||
170538564|NCT03785366|616314023|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
170538565|NCT03785366|616314024|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
170538566|NCT03785366|616314023|FG000|Overall Study|Lost to Follow-up|1|||
170538567|NCT03785366|616314024|FG001|Overall Study|Lost to Follow-up|0|||
170538568|NCT03785366|616314023|FG000|Overall Study|Partial IUD Expulsion|0|||
170538569|NCT03785366|616314024|FG001|Overall Study|Partial IUD Expulsion|2|||
170538570|NCT03785366|616314023|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
170441722|NCT01332968|615956315|FG003|Induction Period|Physician Decision|0|||
170441723|NCT01332968|615956316|FG004|Induction Period|Physician Decision|0|||
170441724|NCT01332968|615956317|FG005|Induction Period|Physician Decision|0|||
170441725|NCT01332968|615956318|FG006|Induction Period|Physician Decision|0|||
170441726|NCT01332968|615956319|FG007|Induction Period|Physician Decision|0|||
170441727|NCT01332968|615956312|FG000|Induction Period|Progressive Disease|15|||
170441728|NCT01332968|615956313|FG001|Induction Period|Progressive Disease|7|||
170441729|NCT01332968|615956314|FG002|Induction Period|Progressive Disease|0|||
170441730|NCT01332968|615956315|FG003|Induction Period|Progressive Disease|0|||
170441731|NCT01332968|615956316|FG004|Induction Period|Progressive Disease|0|||
170538571|NCT03785366|616314024|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
170538572|NCT02783274|616314029|FG000|Overall Study|Withdrawal by Subject|16|||
170538573|NCT02783274|616314029|FG000|Overall Study|Physician Decision|6|||
170633138|NCT01746901|616668463|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
170633139|NCT01746901|616668464|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
170441732|NCT01332968|615956317|FG005|Induction Period|Progressive Disease|0|||
170441733|NCT01332968|615956318|FG006|Induction Period|Progressive Disease|0|||
170441734|NCT01332968|615956319|FG007|Induction Period|Progressive Disease|0|||
170441735|NCT01332968|615956312|FG000|Induction Period|Protocol Violation|3|||
170441736|NCT01332968|615956313|FG001|Induction Period|Protocol Violation|4|||
170538574|NCT02783274|616314029|FG000|Overall Study|Death|9|||
170538575|NCT02783274|616314029|FG000|Overall Study|Lost to Follow-up|22|||
170538576|NCT02783274|616314029|FG000|Overall Study|Other|22|||
170538577|NCT00315445|616314045|FG000|Overall Study|Adverse Event|7|||
170441737|NCT01332968|615956314|FG002|Induction Period|Protocol Violation|0|||
170441738|NCT01332968|615956315|FG003|Induction Period|Protocol Violation|0|||
170441739|NCT01332968|615956316|FG004|Induction Period|Protocol Violation|0|||
170441740|NCT01332968|615956317|FG005|Induction Period|Protocol Violation|0|||
170441741|NCT01332968|615956318|FG006|Induction Period|Protocol Violation|0|||
170441742|NCT01332968|615956319|FG007|Induction Period|Protocol Violation|0|||
170441743|NCT01332968|615956312|FG000|Induction Period|Withdrawal by Subject|3|||
170441744|NCT01332968|615956313|FG001|Induction Period|Withdrawal by Subject|5|||
170441745|NCT01332968|615956314|FG002|Induction Period|Withdrawal by Subject|0|||
170441746|NCT01332968|615956315|FG003|Induction Period|Withdrawal by Subject|0|||
170441747|NCT01332968|615956316|FG004|Induction Period|Withdrawal by Subject|0|||
170441748|NCT01332968|615956317|FG005|Induction Period|Withdrawal by Subject|0|||
170441749|NCT01332968|615956318|FG006|Induction Period|Withdrawal by Subject|0|||
170441750|NCT01332968|615956319|FG007|Induction Period|Withdrawal by Subject|0|||
170441751|NCT01332968|615956312|FG000|Induction Period|Randomised but not treated|4|||
170441752|NCT01332968|615956313|FG001|Induction Period|Randomised but not treated|7|||
170441753|NCT01332968|615956314|FG002|Induction Period|Randomised but not treated|0|||
170441754|NCT01332968|615956315|FG003|Induction Period|Randomised but not treated|0|||
170441755|NCT01332968|615956316|FG004|Induction Period|Randomised but not treated|0|||
170441756|NCT01332968|615956317|FG005|Induction Period|Randomised but not treated|0|||
170441757|NCT01332968|615956318|FG006|Induction Period|Randomised but not treated|0|||
170441758|NCT01332968|615956319|FG007|Induction Period|Randomised but not treated|0|||
170441759|NCT01332968|615956312|FG000|Maintenance/Observation Period|Adverse Event|0|||
170441760|NCT01332968|615956313|FG001|Maintenance/Observation Period|Adverse Event|0|||
170441761|NCT01332968|615956314|FG002|Maintenance/Observation Period|Adverse Event|53|||
170441762|NCT01332968|615956315|FG003|Maintenance/Observation Period|Adverse Event|66|||
170441763|NCT01332968|615956316|FG004|Maintenance/Observation Period|Adverse Event|0|||
170441764|NCT01332968|615956317|FG005|Maintenance/Observation Period|Adverse Event|0|||
170441765|NCT01332968|615956318|FG006|Maintenance/Observation Period|Adverse Event|0|||
170441766|NCT01332968|615956319|FG007|Maintenance/Observation Period|Adverse Event|0|||
170441767|NCT01332968|615956312|FG000|Maintenance/Observation Period|Death|0|||
170441768|NCT01332968|615956313|FG001|Maintenance/Observation Period|Death|0|||
170441769|NCT01332968|615956314|FG002|Maintenance/Observation Period|Death|5|||
170441770|NCT01332968|615956315|FG003|Maintenance/Observation Period|Death|6|||
170441771|NCT01332968|615956316|FG004|Maintenance/Observation Period|Death|0|||
170441772|NCT01332968|615956317|FG005|Maintenance/Observation Period|Death|0|||
170441773|NCT01332968|615956318|FG006|Maintenance/Observation Period|Death|0|||
170441774|NCT01332968|615956319|FG007|Maintenance/Observation Period|Death|0|||
170441775|NCT01332968|615956312|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
170441776|NCT01332968|615956313|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
170441777|NCT01332968|615956314|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
170441778|NCT01332968|615956315|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
170441779|NCT01332968|615956316|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
170441780|NCT01332968|615956317|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
170441781|NCT01332968|615956318|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
170441782|NCT01332968|615956319|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
170538578|NCT00315445|616314046|FG001|Overall Study|Adverse Event|12|||
170538579|NCT00315445|616314047|FG002|Overall Study|Adverse Event|15|||
170538580|NCT00315445|616314045|FG000|Overall Study|Lack of Efficacy|16|||
170538581|NCT00315445|616314046|FG001|Overall Study|Lack of Efficacy|1|||
170538582|NCT00315445|616314047|FG002|Overall Study|Lack of Efficacy|7|||
170538583|NCT00315445|616314045|FG000|Overall Study|Lost to Follow-up|1|||
170538584|NCT00315445|616314046|FG001|Overall Study|Lost to Follow-up|0|||
170441783|NCT01332968|615956312|FG000|Maintenance/Observation Period|Non-compliance|0|||
170441784|NCT01332968|615956313|FG001|Maintenance/Observation Period|Non-compliance|0|||
170441785|NCT01332968|615956314|FG002|Maintenance/Observation Period|Non-compliance|4|||
170441786|NCT01332968|615956315|FG003|Maintenance/Observation Period|Non-compliance|3|||
170441787|NCT01332968|615956316|FG004|Maintenance/Observation Period|Non-compliance|0|||
170441788|NCT01332968|615956317|FG005|Maintenance/Observation Period|Non-compliance|0|||
170441789|NCT01332968|615956318|FG006|Maintenance/Observation Period|Non-compliance|0|||
170441790|NCT01332968|615956319|FG007|Maintenance/Observation Period|Non-compliance|0|||
170441791|NCT01332968|615956312|FG000|Maintenance/Observation Period|Other|0|||
170441792|NCT01332968|615956313|FG001|Maintenance/Observation Period|Other|0|||
170538585|NCT00315445|616314047|FG002|Overall Study|Lost to Follow-up|1|||
170538586|NCT00315445|616314045|FG000|Overall Study|Protocol Violation|2|||
170538587|NCT00315445|616314046|FG001|Overall Study|Protocol Violation|0|||
170538588|NCT00315445|616314047|FG002|Overall Study|Protocol Violation|1|||
170538589|NCT00315445|616314045|FG000|Overall Study|Other|1|||
170538590|NCT00315445|616314046|FG001|Overall Study|Other|3|||
170538591|NCT00315445|616314047|FG002|Overall Study|Other|0|||
170785360|NCT05369403|617221431|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
170441793|NCT01332968|615956314|FG002|Maintenance/Observation Period|Other|4|||
170441794|NCT01332968|615956315|FG003|Maintenance/Observation Period|Other|7|||
170538592|NCT01299909|616314048|FG000|Overall Study|Lost to Follow-up|22|||
170441795|NCT01332968|615956316|FG004|Maintenance/Observation Period|Other|0|||
170441796|NCT01332968|615956317|FG005|Maintenance/Observation Period|Other|0|||
170441797|NCT01332968|615956318|FG006|Maintenance/Observation Period|Other|0|||
170441798|NCT01332968|615956319|FG007|Maintenance/Observation Period|Other|0|||
170441799|NCT01332968|615956312|FG000|Maintenance/Observation Period|Physician Decision|0|||
170441800|NCT01332968|615956313|FG001|Maintenance/Observation Period|Physician Decision|0|||
170441801|NCT01332968|615956314|FG002|Maintenance/Observation Period|Physician Decision|14|||
170441802|NCT01332968|615956315|FG003|Maintenance/Observation Period|Physician Decision|19|||
170441803|NCT01332968|615956316|FG004|Maintenance/Observation Period|Physician Decision|0|||
170441804|NCT01332968|615956317|FG005|Maintenance/Observation Period|Physician Decision|1|||
170441805|NCT01332968|615956318|FG006|Maintenance/Observation Period|Physician Decision|0|||
170441806|NCT01332968|615956319|FG007|Maintenance/Observation Period|Physician Decision|0|||
170441807|NCT01332968|615956312|FG000|Maintenance/Observation Period|Progressive Disease|0|||
170441808|NCT01332968|615956313|FG001|Maintenance/Observation Period|Progressive Disease|0|||
170441809|NCT01332968|615956314|FG002|Maintenance/Observation Period|Progressive Disease|72|||
170441810|NCT01332968|615956315|FG003|Maintenance/Observation Period|Progressive Disease|40|||
170441811|NCT01332968|615956316|FG004|Maintenance/Observation Period|Progressive Disease|0|||
170441812|NCT01332968|615956317|FG005|Maintenance/Observation Period|Progressive Disease|0|||
170441813|NCT01332968|615956318|FG006|Maintenance/Observation Period|Progressive Disease|0|||
170441814|NCT01332968|615956319|FG007|Maintenance/Observation Period|Progressive Disease|0|||
170441815|NCT01332968|615956312|FG000|Maintenance/Observation Period|Protocol Violation|0|||
170441816|NCT01332968|615956313|FG001|Maintenance/Observation Period|Protocol Violation|0|||
170441817|NCT01332968|615956314|FG002|Maintenance/Observation Period|Protocol Violation|1|||
170441818|NCT01332968|615956315|FG003|Maintenance/Observation Period|Protocol Violation|1|||
170441819|NCT01332968|615956316|FG004|Maintenance/Observation Period|Protocol Violation|0|||
170441820|NCT01332968|615956317|FG005|Maintenance/Observation Period|Protocol Violation|0|||
170441821|NCT01332968|615956318|FG006|Maintenance/Observation Period|Protocol Violation|0|||
170441822|NCT01332968|615956319|FG007|Maintenance/Observation Period|Protocol Violation|0|||
170441823|NCT01332968|615956312|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
170441824|NCT01332968|615956313|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
170441825|NCT01332968|615956314|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
170441826|NCT01332968|615956315|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
170441827|NCT01332968|615956316|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
170441828|NCT01332968|615956317|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
170441829|NCT01332968|615956318|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
170441830|NCT01332968|615956319|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
170441831|NCT01332968|615956312|FG000|Follow-Up Period|Adverse Event|0|||
170441832|NCT01332968|615956313|FG001|Follow-Up Period|Adverse Event|0|||
170441833|NCT01332968|615956314|FG002|Follow-Up Period|Adverse Event|0|||
170441834|NCT01332968|615956315|FG003|Follow-Up Period|Adverse Event|0|||
170441835|NCT01332968|615956316|FG004|Follow-Up Period|Adverse Event|0|||
170886624|NCT05103332|617592231|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886625|NCT05103332|617592232|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886626|NCT05103332|617592233|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886627|NCT05103332|617592234|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886628|NCT05103332|617592235|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886629|NCT05103332|617592236|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886630|NCT05103332|617592237|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
170886631|NCT05103332|617592238|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
170441836|NCT01332968|615956317|FG005|Follow-Up Period|Adverse Event|0|||
170441837|NCT01332968|615956318|FG006|Follow-Up Period|Adverse Event|0|||
170441838|NCT01332968|615956319|FG007|Follow-Up Period|Adverse Event|4|||
170441839|NCT01332968|615956312|FG000|Follow-Up Period|Death|0|||
170441840|NCT01332968|615956313|FG001|Follow-Up Period|Death|0|||
170441841|NCT01332968|615956314|FG002|Follow-Up Period|Death|0|||
170441842|NCT01332968|615956315|FG003|Follow-Up Period|Death|0|||
170441843|NCT01332968|615956316|FG004|Follow-Up Period|Death|0|||
170441844|NCT01332968|615956317|FG005|Follow-Up Period|Death|0|||
170441845|NCT01332968|615956318|FG006|Follow-Up Period|Death|27|||
170441846|NCT01332968|615956319|FG007|Follow-Up Period|Death|30|||
170441847|NCT01332968|615956312|FG000|Follow-Up Period|Lost to Follow-up|0|||
170441848|NCT01332968|615956313|FG001|Follow-Up Period|Lost to Follow-up|0|||
170441849|NCT01332968|615956314|FG002|Follow-Up Period|Lost to Follow-up|0|||
170441850|NCT01332968|615956315|FG003|Follow-Up Period|Lost to Follow-up|0|||
170441851|NCT01332968|615956316|FG004|Follow-Up Period|Lost to Follow-up|0|||
170441852|NCT01332968|615956317|FG005|Follow-Up Period|Lost to Follow-up|0|||
170441853|NCT01332968|615956318|FG006|Follow-Up Period|Lost to Follow-up|11|||
170441854|NCT01332968|615956319|FG007|Follow-Up Period|Lost to Follow-up|15|||
170441855|NCT01332968|615956312|FG000|Follow-Up Period|Non-compliance|0|||
170441856|NCT01332968|615956313|FG001|Follow-Up Period|Non-compliance|0|||
170441857|NCT01332968|615956314|FG002|Follow-Up Period|Non-compliance|0|||
170441858|NCT01332968|615956315|FG003|Follow-Up Period|Non-compliance|0|||
170441859|NCT01332968|615956316|FG004|Follow-Up Period|Non-compliance|0|||
170441860|NCT01332968|615956317|FG005|Follow-Up Period|Non-compliance|0|||
170441861|NCT01332968|615956318|FG006|Follow-Up Period|Non-compliance|4|||
170441862|NCT01332968|615956319|FG007|Follow-Up Period|Non-compliance|9|||
170441863|NCT01332968|615956312|FG000|Follow-Up Period|Other|0|||
170441864|NCT01332968|615956313|FG001|Follow-Up Period|Other|0|||
170441865|NCT01332968|615956314|FG002|Follow-Up Period|Other|0|||
170441866|NCT01332968|615956315|FG003|Follow-Up Period|Other|0|||
170441867|NCT01332968|615956316|FG004|Follow-Up Period|Other|0|||
170441868|NCT01332968|615956317|FG005|Follow-Up Period|Other|0|||
170441869|NCT01332968|615956318|FG006|Follow-Up Period|Other|18|||
170441870|NCT01332968|615956319|FG007|Follow-Up Period|Other|21|||
170441871|NCT01332968|615956312|FG000|Follow-Up Period|Physician Decision|0|||
170441872|NCT01332968|615956313|FG001|Follow-Up Period|Physician Decision|0|||
170441873|NCT01332968|615956314|FG002|Follow-Up Period|Physician Decision|0|||
170441874|NCT01332968|615956315|FG003|Follow-Up Period|Physician Decision|0|||
170441875|NCT01332968|615956316|FG004|Follow-Up Period|Physician Decision|0|||
170441876|NCT01332968|615956317|FG005|Follow-Up Period|Physician Decision|0|||
170441877|NCT01332968|615956318|FG006|Follow-Up Period|Physician Decision|12|||
170441878|NCT01332968|615956319|FG007|Follow-Up Period|Physician Decision|15|||
170441879|NCT01332968|615956312|FG000|Follow-Up Period|Progressive Disease|0|||
170441880|NCT01332968|615956313|FG001|Follow-Up Period|Progressive Disease|0|||
170441881|NCT01332968|615956314|FG002|Follow-Up Period|Progressive Disease|0|||
170441882|NCT01332968|615956315|FG003|Follow-Up Period|Progressive Disease|0|||
170441883|NCT01332968|615956316|FG004|Follow-Up Period|Progressive Disease|0|||
170441884|NCT01332968|615956317|FG005|Follow-Up Period|Progressive Disease|0|||
170441885|NCT01332968|615956318|FG006|Follow-Up Period|Progressive Disease|126|||
170441886|NCT01332968|615956319|FG007|Follow-Up Period|Progressive Disease|106|||
170441887|NCT01332968|615956312|FG000|Follow-Up Period|Protocol Violation|0|||
170441888|NCT01332968|615956313|FG001|Follow-Up Period|Protocol Violation|0|||
170441889|NCT01332968|615956314|FG002|Follow-Up Period|Protocol Violation|0|||
170538593|NCT01299909|616314049|FG001|Overall Study|Lost to Follow-up|18|||
170538594|NCT01299909|616314050|FG002|Overall Study|Lost to Follow-up|17|||
170538595|NCT05166876|616314051|FG000|Overall Study|Withdrawal by Subject|1|||
170538596|NCT05166876|616314052|FG001|Overall Study|Withdrawal by Subject|0|||
170538597|NCT05166876|616314053|FG002|Overall Study|Withdrawal by Subject|0|||
170441890|NCT01332968|615956315|FG003|Follow-Up Period|Protocol Violation|0|||
170538598|NCT03479905|616314054|FG000|Overall Study|Other airway method used|4|||
170538599|NCT03479905|616314055|FG001|Overall Study|Other airway method used|5|||
170538600|NCT03479905|616314056|FG002|Overall Study|Other airway method used|5|||
170538601|NCT06081829|616314057|FG000|Overall Study|Participants still on-study|8|||
170538602|NCT06081829|616314057|FG000|Overall Study|Death|4|||
170538603|NCT03915067|616315696|FG000|Overall Study|Adverse Event|0|||
170538604|NCT03915067|616315697|FG001|Overall Study|Adverse Event|0|||
170538605|NCT03915067|616315698|FG002|Overall Study|Adverse Event|1|||
170538606|NCT03915067|616315696|FG000|Overall Study|Withdrawal by Subject|4|||
170538607|NCT03915067|616315697|FG001|Overall Study|Withdrawal by Subject|3|||
170538608|NCT03915067|616315698|FG002|Overall Study|Withdrawal by Subject|0|||
170538609|NCT03915067|616315696|FG000|Overall Study|Lost to Follow-up|3|||
170538610|NCT03915067|616315697|FG001|Overall Study|Lost to Follow-up|2|||
170538611|NCT03915067|616315698|FG002|Overall Study|Lost to Follow-up|0|||
170785361|NCT05369403|617221429|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
170441891|NCT01332968|615956316|FG004|Follow-Up Period|Protocol Violation|0|||
170441892|NCT01332968|615956317|FG005|Follow-Up Period|Protocol Violation|0|||
170441893|NCT01332968|615956318|FG006|Follow-Up Period|Protocol Violation|1|||
170538612|NCT03915067|616315696|FG000|Overall Study|Protocol Deviation|0|||
170538613|NCT03915067|616315697|FG001|Overall Study|Protocol Deviation|0|||
170538614|NCT03915067|616315698|FG002|Overall Study|Protocol Deviation|1|||
170538615|NCT03915067|616315696|FG000|Overall Study|Covid-19 Related Issues|2|||
170785362|NCT05369403|617221430|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
170785363|NCT05369403|617221431|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
170806978|NCT02063659|617301676|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
170441894|NCT01332968|615956319|FG007|Follow-Up Period|Protocol Violation|0|||
170441895|NCT01332968|615956312|FG000|Follow-Up Period|Withdrawal by Subject|0|||
170441896|NCT01332968|615956313|FG001|Follow-Up Period|Withdrawal by Subject|0|||
170538616|NCT03915067|616315697|FG001|Overall Study|Covid-19 Related Issues|4|||
170538617|NCT03915067|616315698|FG002|Overall Study|Covid-19 Related Issues|4|||
170538618|NCT03915067|616315696|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
170633140|NCT01746901|616668465|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
170441897|NCT01332968|615956314|FG002|Follow-Up Period|Withdrawal by Subject|0|||
170441898|NCT01332968|615956315|FG003|Follow-Up Period|Withdrawal by Subject|0|||
170441899|NCT01332968|615956316|FG004|Follow-Up Period|Withdrawal by Subject|0|||
170441900|NCT01332968|615956317|FG005|Follow-Up Period|Withdrawal by Subject|0|||
170441901|NCT01332968|615956318|FG006|Follow-Up Period|Withdrawal by Subject|29|||
170441902|NCT01332968|615956319|FG007|Follow-Up Period|Withdrawal by Subject|32|||
170441903|NCT01332968|615956312|FG000|Follow-Up Period|No reason provided|0|||
170441904|NCT01332968|615956313|FG001|Follow-Up Period|No reason provided|0|||
170441905|NCT01332968|615956314|FG002|Follow-Up Period|No reason provided|0|||
170441906|NCT01332968|615956315|FG003|Follow-Up Period|No reason provided|0|||
170441907|NCT01332968|615956316|FG004|Follow-Up Period|No reason provided|0|||
170441908|NCT01332968|615956317|FG005|Follow-Up Period|No reason provided|0|||
170441909|NCT01332968|615956318|FG006|Follow-Up Period|No reason provided|2|||
170441910|NCT01332968|615956319|FG007|Follow-Up Period|No reason provided|3|||
170441911|NCT00046839|615956321|FG000|Overall Study|Ineligible / No protocol treatment|0|||
170441912|NCT00046839|615956322|FG001|Overall Study|Ineligible / No protocol treatment|2|||
170441913|NCT00046839|615956321|FG000|Overall Study|Withdrawal of consent|1|||
170441914|NCT00046839|615956322|FG001|Overall Study|Withdrawal of consent|0|||
170441915|NCT00751023|615956323|FG000|Overall Study|Lost to Follow-up|11|||
170441916|NCT00751023|615956324|FG001|Overall Study|Lost to Follow-up|7|||
170441917|NCT01963260|615956327|FG000|Overall Study|Withdrawal by Subject|2|||
170441918|NCT01963260|615956328|FG001|Overall Study|Withdrawal by Subject|0|||
170441919|NCT01963260|615956329|FG002|Overall Study|Withdrawal by Subject|0|||
170441920|NCT01963260|615956330|FG003|Overall Study|Withdrawal by Subject|1|||
170441921|NCT01963260|615956331|FG004|Overall Study|Withdrawal by Subject|2|||
170441922|NCT01963260|615956332|FG005|Overall Study|Withdrawal by Subject|0|||
170441923|NCT01963260|615956333|FG006|Overall Study|Withdrawal by Subject|0|||
170441924|NCT01963260|615956334|FG007|Overall Study|Withdrawal by Subject|0|||
170441925|NCT01963260|615956335|FG008|Overall Study|Withdrawal by Subject|0|||
170441926|NCT01963260|615956336|FG009|Overall Study|Withdrawal by Subject|0|||
170441927|NCT02340962|615956337|FG000|Overall Study|Lost to Follow-up|1|||
170441928|NCT02340962|615956338|FG001|Overall Study|Lost to Follow-up|0|||
170441929|NCT04994431|615956339|FG000|Overall Study|Adverse Event|1|||
170441930|NCT04994431|615956340|FG001|Overall Study|Adverse Event|0|||
170441931|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
170441932|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
170441933|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
170441934|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
170441935|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
170441936|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
170441937|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
170441938|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
170441939|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
170441940|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
170441941|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
170785364|NCT05369403|617221429|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
170785365|NCT05369403|617221430|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
170785366|NCT05369403|617221431|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
170785367|NCT05369403|617221429|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
170785368|NCT05369403|617221430|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
170785369|NCT05369403|617221431|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
170785370|NCT05369403|617221429|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
170785371|NCT05369403|617221430|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
170785372|NCT05369403|617221431|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
170785373|NCT05369403|617221429|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
170785374|NCT05369403|617221430|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
170785375|NCT05369403|617221431|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
170785376|NCT05369403|617221429|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
170785377|NCT05369403|617221430|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
170785378|NCT05369403|617221431|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
170785379|NCT04760678|617221434|FG000|Overall Study|Death|13|||
170785380|NCT04760678|617221434|FG000|Overall Study|Lost to Follow-up|48|||
170785381|NCT04760678|617221434|FG000|Overall Study|Withdrawal by Subject|1|||
170785382|NCT01748448|617221435|FG000|Treatment Period|Consent withdrawn by subject|1|||
170785383|NCT01748448|617221436|FG001|Treatment Period|Consent withdrawn by subject|0|||
170785384|NCT01748448|617221435|FG000|Treatment Period|Adverse Event|1|||
170785385|NCT01748448|617221436|FG001|Treatment Period|Adverse Event|0|||
170886632|NCT05103332|617592239|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
170633141|NCT01746901|616668466|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
170633142|NCT01746901|616668467|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
170441942|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
170441943|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
170441944|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
170441945|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
170441946|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
170441947|NCT01067521|615956341|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
170441948|NCT01067521|615956342|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
170441949|NCT01067521|615956341|FG000|Open-Label Period|Death|3|||
170441950|NCT01067521|615956342|FG001|Open-Label Period|Death|1|||
170441951|NCT01067521|615956341|FG000|Open-Label Period|Adverse Event|30|||
170441952|NCT01067521|615956342|FG001|Open-Label Period|Adverse Event|28|||
170441953|NCT01067521|615956341|FG000|Open-Label Period|Withdrawal by Subject|160|||
170441954|NCT01067521|615956342|FG001|Open-Label Period|Withdrawal by Subject|88|||
170441955|NCT01067521|615956341|FG000|Open-Label Period|Physician Decision|13|||
170441956|NCT01067521|615956342|FG001|Open-Label Period|Physician Decision|11|||
170441957|NCT01067521|615956341|FG000|Open-Label Period|Non-compliance with study drug|5|||
170633143|NCT01746901|616668468|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
170633144|NCT01746901|616668460|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
170633145|NCT01746901|616668461|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
170441958|NCT01067521|615956342|FG001|Open-Label Period|Non-compliance with study drug|0|||
170441959|NCT01067521|615956341|FG000|Open-Label Period|Protocol Violation|3|||
170441960|NCT01067521|615956342|FG001|Open-Label Period|Protocol Violation|0|||
170441961|NCT01067521|615956341|FG000|Open-Label Period|Pregnancy|14|||
170441962|NCT01067521|615956342|FG001|Open-Label Period|Pregnancy|8|||
170441963|NCT01067521|615956341|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
170441964|NCT01067521|615956342|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
170441965|NCT01067521|615956341|FG000|Open-Label Period|Lost to Follow-up|21|||
170441966|NCT01067521|615956342|FG001|Open-Label Period|Lost to Follow-up|20|||
170441967|NCT03828539|615956348|FG000|Overall Study|Adverse Event|3|||
170441968|NCT03828539|615956349|FG001|Overall Study|Adverse Event|12|||
170441969|NCT03828539|615956348|FG000|Overall Study|Patient's/guardian's decision|3|||
170441970|NCT03828539|615956349|FG001|Overall Study|Patient's/guardian's decision|5|||
170441971|NCT03828539|615956348|FG000|Overall Study|Lost to Follow-up|4|||
170441972|NCT03828539|615956349|FG001|Overall Study|Lost to Follow-up|2|||
170441973|NCT03828539|615956348|FG000|Overall Study|Protocol Violation|3|||
170441974|NCT03828539|615956349|FG001|Overall Study|Protocol Violation|2|||
170441975|NCT03828539|615956348|FG000|Overall Study|Withdrawal of informed consent|2|||
170441976|NCT03828539|615956349|FG001|Overall Study|Withdrawal of informed consent|1|||
170441977|NCT03828539|615956348|FG000|Overall Study|New therapy for study indication|1|||
170441978|NCT03828539|615956349|FG001|Overall Study|New therapy for study indication|0|||
170441979|NCT01050764|615956352|FG000|Overall Study|Death, before HSCT|1|||
170441980|NCT01050764|615956352|FG000|Overall Study|Donor mobilization failure, death|1|||
170441981|NCT01050764|615956352|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
170441982|NCT01863433|615956353|FG000|Overall Study|Protocol Violation|1|||
170441983|NCT01785615|615956357|FG000|Dietary Phase|Lost to Follow-up|0|||
170441984|NCT01785615|615956358|FG001|Dietary Phase|Lost to Follow-up|0|||
170441985|NCT01785615|615956359|FG002|Dietary Phase|Lost to Follow-up|0|||
170441986|NCT01785615|615956360|FG003|Dietary Phase|Lost to Follow-up|24|||
170441987|NCT01438476|615956361|FG000|Overall Study|Protocol Violation|1|||
170441988|NCT01438476|615956362|FG001|Overall Study|Protocol Violation|0|||
170441989|NCT01438476|615956361|FG000|Overall Study|Withdrawal by Subject|1|||
170441990|NCT01438476|615956362|FG001|Overall Study|Withdrawal by Subject|0|||
170441991|NCT01438476|615956361|FG000|Overall Study|No Surgery- Disease|8|||
170441992|NCT01438476|615956362|FG001|Overall Study|No Surgery- Disease|10|||
170441993|NCT01438476|615956361|FG000|Overall Study|Communication barrier|0|||
170441994|NCT01438476|615956362|FG001|Overall Study|Communication barrier|1|||
170441995|NCT02522780|615956363|FG000|Overall Study|Consent withdrawn by subject|5|||
170441996|NCT02522780|615956364|FG001|Overall Study|Consent withdrawn by subject|7|||
170441997|NCT02522780|615956363|FG000|Overall Study|Protocol deviation|1|||
170441998|NCT02522780|615956364|FG001|Overall Study|Protocol deviation|3|||
170441999|NCT02522780|615956363|FG000|Overall Study|Subject refused endoscopic procedure|0|||
170538619|NCT03915067|616315697|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
170538620|NCT03915067|616315698|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
170538621|NCT02034591|616315699|FG000|Overall Study|Withdrawal by Subject|0|||
170538622|NCT02034591|616315700|FG001|Overall Study|Withdrawal by Subject|0|||
170538623|NCT02034591|616315701|FG002|Overall Study|Withdrawal by Subject|0|||
170538624|NCT02034591|616315702|FG003|Overall Study|Withdrawal by Subject|0|||
170538625|NCT02034591|616315703|FG004|Overall Study|Withdrawal by Subject|1|||
170538626|NCT02034591|616315704|FG005|Overall Study|Withdrawal by Subject|0|||
170442000|NCT02522780|615956364|FG001|Overall Study|Subject refused endoscopic procedure|1|||
170442001|NCT02522780|615956363|FG000|Overall Study|Adverse event, non-fatal|11|||
170442002|NCT02522780|615956364|FG001|Overall Study|Adverse event, non-fatal|16|||
170442003|NCT02786927|615956369|FG000|Overall Study|Adverse Event|1|||
170442004|NCT02786927|615956369|FG000|Overall Study|Protocol Violation|4|||
170442005|NCT03847974|615956370|FG000|Overall Study|relocated out of region|3|||
170442006|NCT03847974|615956370|FG000|Overall Study|Withdrawal by Subject|2|||
170442007|NCT03847974|615956370|FG000|Overall Study|Adverse Event|1|||
170538627|NCT00356590|616315705|FG000|Overall Study|Adverse Event|54|||
170442008|NCT01801917|615956371|FG000|Period 1 - Randomized|Adverse Event|1|||
170442009|NCT01801917|615956372|FG001|Period 1 - Randomized|Adverse Event|0|||
170442010|NCT01801917|615956373|FG002|Period 1 - Randomized|Adverse Event|1|||
170442011|NCT01801917|615956374|FG003|Period 1 - Randomized|Adverse Event|0|||
170442012|NCT01924364|615956375|FG000|Overall Study|Physician Decision|3|||
170442013|NCT00265785|615956376|FG000|Overall Study|Adverse Event|4|||
170442014|NCT00265785|615956376|FG000|Overall Study|Withdrawal by Subject|3|||
170442015|NCT00265785|615956376|FG000|Overall Study|Progression/Relapse|15|||
170442016|NCT00265785|615956376|FG000|Overall Study|Not protocol specified|2|||
170442017|NCT00265785|615956376|FG000|Overall Study|Ineligible|1|||
170442018|NCT00265785|615956376|FG000|Overall Study|Did not receive protocol treatment|2|||
170442019|NCT01688882|615956377|FG000|Overall Study|Adverse Event|1|||
170442020|NCT01688882|615956378|FG001|Overall Study|Adverse Event|0|||
170442021|NCT01688882|615956377|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170442022|NCT01688882|615956378|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170442023|NCT01688882|615956377|FG000|Overall Study|Administrative problems|1|||
170442024|NCT01688882|615956378|FG001|Overall Study|Administrative problems|0|||
170442025|NCT03259789|615956379|FG000|Overall Study|Adverse Event|3|||
170442026|NCT03259789|615956380|FG001|Overall Study|Adverse Event|2|||
170442027|NCT03259789|615956381|FG002|Overall Study|Adverse Event|1|||
170442028|NCT03259789|615956379|FG000|Overall Study|Withdrawal by Subject|9|||
170442029|NCT03259789|615956380|FG001|Overall Study|Withdrawal by Subject|5|||
170442030|NCT03259789|615956381|FG002|Overall Study|Withdrawal by Subject|1|||
170442031|NCT03259789|615956379|FG000|Overall Study|Lost to Follow-up|5|||
170442032|NCT03259789|615956380|FG001|Overall Study|Lost to Follow-up|9|||
170442033|NCT03259789|615956381|FG002|Overall Study|Lost to Follow-up|4|||
170442034|NCT03259789|615956379|FG000|Overall Study|Physician Decision|0|||
170442035|NCT03259789|615956380|FG001|Overall Study|Physician Decision|1|||
170442036|NCT03259789|615956381|FG002|Overall Study|Physician Decision|0|||
170442037|NCT02063217|615956383|FG000|Overall Study|Withdrawal by Subject|1|||
170442038|NCT02063217|615956384|FG001|Overall Study|Withdrawal by Subject|0|||
170442039|NCT02063217|615956385|FG002|Overall Study|Withdrawal by Subject|0|||
170538628|NCT00356590|616315705|FG000|Overall Study|Death|10|||
170538629|NCT00356590|616315705|FG000|Overall Study|Lost to Follow-up|35|||
170442040|NCT00889252|615956386|FG000|Overall Study|Adverse Event|2|||
170442041|NCT00889252|615956387|FG001|Overall Study|Adverse Event|4|||
170538630|NCT00356590|616315705|FG000|Overall Study|Physician Decision|46|||
170442042|NCT00889252|615956386|FG000|Overall Study|Withdrawal by Subject|3|||
170442043|NCT00889252|615956387|FG001|Overall Study|Withdrawal by Subject|0|||
170442044|NCT00889252|615956386|FG000|Overall Study|Protocol Violation|2|||
170442045|NCT00889252|615956387|FG001|Overall Study|Protocol Violation|0|||
170442046|NCT03566238|615956388|FG000|Overall Study|Adverse Event|0|||
170442047|NCT03566238|615956389|FG001|Overall Study|Adverse Event|0|||
170538631|NCT00356590|616315705|FG000|Overall Study|Withdrawal by Subject|41|||
170538632|NCT00356590|616315705|FG000|Overall Study|Completed month 12 only|2|||
170785386|NCT01748448|617221435|FG000|Treatment Period|Personal|0|||
170785387|NCT01748448|617221436|FG001|Treatment Period|Personal|1|||
170785388|NCT03110315|617221441|FG000|Overall Study|Withdrawal by Subject|1|||
170785389|NCT03110315|617221442|FG001|Overall Study|Withdrawal by Subject|0|||
170785390|NCT05371652|617221443|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
170785391|NCT05371652|617221443|FG000|Overall Study|Withdrawal by Subject|12|||
170785392|NCT05371652|617221443|FG000|Overall Study|Adverse Event|1|||
170785393|NCT05371652|617221443|FG000|Overall Study|Other|11|||
170785394|NCT05071807|617221444|FG000|Overall Study|Withdrawal by Subject|4|||
170785395|NCT05071807|617221445|FG001|Overall Study|Withdrawal by Subject|0|||
170785396|NCT05071807|617221444|FG000|Overall Study|Unrelated medical issues|3|||
170886633|NCT05103332|617592240|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
170886634|NCT05103332|617592241|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
170886635|NCT05103332|617592242|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
170886636|NCT05103332|617592243|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
170886637|NCT05103332|617592226|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886638|NCT05103332|617592227|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886639|NCT05103332|617592228|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170442048|NCT03566238|615956390|FG002|Overall Study|Adverse Event|1|||
170442049|NCT03566238|615956388|FG000|Overall Study|Lack of Efficacy|5|||
170442050|NCT03566238|615956389|FG001|Overall Study|Lack of Efficacy|4|||
170442051|NCT03566238|615956390|FG002|Overall Study|Lack of Efficacy|2|||
170442052|NCT03566238|615956388|FG000|Overall Study|Other|0|||
170442053|NCT03566238|615956389|FG001|Overall Study|Other|1|||
170442054|NCT03566238|615956390|FG002|Overall Study|Other|0|||
170442055|NCT02416934|615956391|FG000|Overall Study|given steroids|1|||
170442056|NCT02416934|615956392|FG001|Overall Study|given steroids|2|||
170538633|NCT00356590|616315705|FG000|Overall Study|Protocol issues|6|||
170785397|NCT05071807|617221445|FG001|Overall Study|Unrelated medical issues|0|||
170785398|NCT05071807|617221444|FG000|Overall Study|Relocated|0|||
170785399|NCT05071807|617221445|FG001|Overall Study|Relocated|1|||
170442057|NCT02416934|615956391|FG000|Overall Study|Lost to Follow-up|0|||
170442058|NCT02416934|615956392|FG001|Overall Study|Lost to Follow-up|2|||
170442059|NCT02416934|615956391|FG000|Overall Study|Withdrawal by Subject|1|||
170442060|NCT02416934|615956392|FG001|Overall Study|Withdrawal by Subject|0|||
170442061|NCT02416934|615956391|FG000|Overall Study|recruited during continuing renewal proc|0|||
170442062|NCT02416934|615956392|FG001|Overall Study|recruited during continuing renewal proc|1|||
170442063|NCT02416934|615956391|FG000|Overall Study|Protocol Violation|0|||
170442064|NCT02416934|615956392|FG001|Overall Study|Protocol Violation|1|||
170442065|NCT02416934|615956391|FG000|Overall Study|surgery started late|0|||
170442066|NCT02416934|615956392|FG001|Overall Study|surgery started late|1|||
170785400|NCT05116787|617221447|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
170785401|NCT05116787|617221448|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
170442067|NCT02416934|615956391|FG000|Overall Study|re-operation|1|||
170442068|NCT02416934|615956392|FG001|Overall Study|re-operation|0|||
170442069|NCT00494013|615956395|FG000|Overall Study|Adverse Event|0|||
170442070|NCT00494013|615956396|FG001|Overall Study|Adverse Event|1|||
170442071|NCT00494013|615956395|FG000|Overall Study|Entry Criteria Not Met|1|||
170442072|NCT00494013|615956396|FG001|Overall Study|Entry Criteria Not Met|4|||
170442073|NCT00494013|615956395|FG000|Overall Study|Lost to Follow-up|5|||
170442074|NCT00494013|615956396|FG001|Overall Study|Lost to Follow-up|6|||
170442075|NCT00494013|615956395|FG000|Overall Study|Physician Decision|3|||
170442076|NCT00494013|615956396|FG001|Overall Study|Physician Decision|5|||
170442077|NCT00494013|615956395|FG000|Overall Study|Protocol Violation|8|||
170442078|NCT00494013|615956396|FG001|Overall Study|Protocol Violation|5|||
170442079|NCT00494013|615956395|FG000|Overall Study|Withdrawal by Subject|13|||
170442080|NCT00494013|615956396|FG001|Overall Study|Withdrawal by Subject|14|||
170442081|NCT00494013|615956395|FG000|Overall Study|Sponsor Decision|0|||
170442082|NCT00494013|615956396|FG001|Overall Study|Sponsor Decision|1|||
170442083|NCT00593827|615956397|FG000|Overall Study|On Active Treatment/Pending|0|||
170442084|NCT00593827|615956398|FG001|Overall Study|On Active Treatment/Pending|2|||
170442085|NCT01833169|615956399|FG000|Overall Study|Disease Progression|99|||
170442086|NCT01833169|615956399|FG000|Overall Study|Adverse Event|33|||
170442087|NCT01833169|615956399|FG000|Overall Study|Withdrawal by Subject|9|||
170442088|NCT01833169|615956399|FG000|Overall Study|Death|3|||
170442089|NCT01833169|615956399|FG000|Overall Study|Physician Decision|2|||
170442090|NCT01912807|615956401|FG000|Overall Study|Did not meet elegibility criteria|6|||
170442091|NCT01912807|615956402|FG001|Overall Study|Did not meet elegibility criteria|4|||
170442092|NCT01912807|615956401|FG000|Overall Study|Lost to Follow-up|36|||
170442093|NCT01912807|615956402|FG001|Overall Study|Lost to Follow-up|37|||
170442094|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Adverse Event|8|||
170442095|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Adverse Event|5|||
170442096|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Adverse Event|9|||
170442097|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Adverse Event|0|||
170442098|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Adverse Event|0|||
170442099|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Adverse Event|0|||
170442100|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
170442101|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
170442102|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
170442103|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
170442104|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
170442105|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
170442106|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
170442107|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
170442108|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
170442109|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
170442110|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
170442111|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
170442112|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Physician Decision|4|||
170785402|NCT05116787|617221447|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
170442113|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Physician Decision|0|||
170442114|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Physician Decision|2|||
170442115|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Physician Decision|0|||
170442116|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Physician Decision|0|||
170442117|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Physician Decision|0|||
170442118|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Pregnancy|1|||
170442119|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Pregnancy|2|||
170442120|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Pregnancy|0|||
170442121|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Pregnancy|0|||
170442122|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Pregnancy|0|||
170442123|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Pregnancy|0|||
170442124|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
170442125|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
170442126|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
170442127|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
170442128|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
170442129|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
170442130|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
170442131|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
170442132|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
170442133|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
170442134|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
170442135|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
170442136|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
170442137|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
170442138|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
170442139|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
170442140|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
170442141|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
170442142|NCT02614196|615956403|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
170442143|NCT02614196|615956404|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
170442144|NCT02614196|615956405|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
170442145|NCT02614196|615956406|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
170442146|NCT02614196|615956407|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
170442147|NCT02614196|615956408|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
170442148|NCT02614196|615956403|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
170442149|NCT02614196|615956404|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
170442150|NCT02614196|615956405|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
170442151|NCT02614196|615956406|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
170442152|NCT02614196|615956407|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
170442153|NCT02614196|615956408|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
170442154|NCT02614196|615956403|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
170442155|NCT02614196|615956404|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
170442156|NCT02614196|615956405|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
170442157|NCT02614196|615956406|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
170442158|NCT02614196|615956407|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
170442159|NCT02614196|615956408|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
170442160|NCT02614196|615956403|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
170442161|NCT02614196|615956404|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
170442162|NCT02614196|615956405|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
170442163|NCT02614196|615956406|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
170442164|NCT02614196|615956407|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
170442165|NCT02614196|615956408|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
170442166|NCT02614196|615956403|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
170442167|NCT02614196|615956404|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
170442168|NCT02614196|615956405|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
170442169|NCT02614196|615956406|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
170442170|NCT02614196|615956407|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
170442171|NCT02614196|615956408|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
170442172|NCT01539239|615956409|FG000|Overall Study|Death|5|||
170442173|NCT01539239|615956410|FG001|Overall Study|Death|5|||
170442174|NCT01539239|615956409|FG000|Overall Study|Lost to Follow-up|7|||
170442175|NCT01539239|615956410|FG001|Overall Study|Lost to Follow-up|12|||
170442176|NCT01562613|615956411|FG000|Overall Study|Lost to Follow-up|2|||
170442177|NCT01562613|615956411|FG000|Overall Study|Withdrawal by Subject|2|||
170442178|NCT00089973|615956421|FG000|Overall Study|Adverse Event|3|||
170442179|NCT00089973|615956421|FG000|Overall Study|Withdrawal by Subject|1|||
170442180|NCT00089973|615956421|FG000|Overall Study|Disease progression|45|||
170442181|NCT00089973|615956421|FG000|Overall Study|Death|1|||
170538634|NCT00356590|616315705|FG000|Overall Study|Response status|28|||
170538635|NCT00356590|616315705|FG000|Overall Study|Other|52|||
170442182|NCT03201003|615956425|FG000|Overall Study|Adverse Event|14|||
170442183|NCT03201003|615956426|FG001|Overall Study|Adverse Event|1|||
170442184|NCT03201003|615956425|FG000|Overall Study|Other reasons|5|||
170442185|NCT03201003|615956426|FG001|Overall Study|Other reasons|1|||
170442186|NCT03201003|615956425|FG000|Overall Study|Withdrawal by Subject|4|||
170538636|NCT01496456|616315710|FG000|Overall Study|Protocol Violation|1|||
170538637|NCT01496456|616315710|FG000|Overall Study|Lost to Follow-up|7|||
170442187|NCT03201003|615956426|FG001|Overall Study|Withdrawal by Subject|1|||
170442188|NCT03201003|615956425|FG000|Overall Study|Lost to Follow-up|2|||
170442189|NCT03201003|615956426|FG001|Overall Study|Lost to Follow-up|0|||
170442190|NCT03201003|615956425|FG000|Overall Study|Protocol Violation|1|||
170442191|NCT03201003|615956426|FG001|Overall Study|Protocol Violation|0|||
170442192|NCT01709903|615956427|FG000|Overall Study|administrative problems|2|||
170442193|NCT01709903|615956428|FG001|Overall Study|administrative problems|6|||
170442194|NCT01709903|615956427|FG000|Overall Study|Abnormal test procedure results|1|||
170442195|NCT01709903|615956428|FG001|Overall Study|Abnormal test procedure results|0|||
170442196|NCT01709903|615956427|FG000|Overall Study|In ability to use device|1|||
170442197|NCT01709903|615956428|FG001|Overall Study|In ability to use device|1|||
170442198|NCT01709903|615956427|FG000|Overall Study|no longer needed study drug|0|||
170442199|NCT01709903|615956428|FG001|Overall Study|no longer needed study drug|1|||
170442200|NCT01709903|615956427|FG000|Overall Study|Lost to Follow-up|0|||
170442201|NCT01709903|615956428|FG001|Overall Study|Lost to Follow-up|2|||
170442202|NCT01709903|615956427|FG000|Overall Study|Death|2|||
170442203|NCT01709903|615956428|FG001|Overall Study|Death|0|||
170442204|NCT01709903|615956427|FG000|Overall Study|Protocol Violation|3|||
170442205|NCT01709903|615956428|FG001|Overall Study|Protocol Violation|2|||
170442206|NCT01709903|615956427|FG000|Overall Study|Lack of Efficacy|3|||
170442207|NCT01709903|615956428|FG001|Overall Study|Lack of Efficacy|3|||
170442208|NCT01709903|615956427|FG000|Overall Study|Withdrawal by Subject|6|||
170442209|NCT01709903|615956428|FG001|Overall Study|Withdrawal by Subject|6|||
170442210|NCT01709903|615956427|FG000|Overall Study|Adverse Event|11|||
170442211|NCT01709903|615956428|FG001|Overall Study|Adverse Event|18|||
170442212|NCT05377489|615956430|FG000|Overall Study|Withdrawal by Subject|122|||
170442213|NCT05377489|615956430|FG000|Overall Study|Lost to Follow-up|21|||
170442214|NCT05377489|615956430|FG000|Overall Study|Lack of Efficacy|10|||
170442215|NCT05377489|615956430|FG000|Overall Study|Adverse Event|5|||
170442216|NCT05377489|615956430|FG000|Overall Study|Death|4|||
170442217|NCT05377489|615956430|FG000|Overall Study|Physician Decision|3|||
170442218|NCT05377489|615956430|FG000|Overall Study|Protocol Violation|1|||
170442219|NCT05377489|615956430|FG000|Overall Study|Other|9|||
170442220|NCT00685035|615958195|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
170442221|NCT00685035|615958196|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
170442222|NCT02426541|615958200|FG000|Overall Study|Protocol Violation|1|||
170442223|NCT02426541|615958201|FG001|Overall Study|Protocol Violation|0|||
170886640|NCT05103332|617592229|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170442224|NCT02674633|615958203|FG000|Overall Study|Lost to Follow-up|3|||
170442225|NCT02674633|615958204|FG001|Overall Study|Lost to Follow-up|2|||
170442226|NCT02674633|615958203|FG000|Overall Study|Physician Decision|1|||
170442227|NCT02674633|615958204|FG001|Overall Study|Physician Decision|0|||
170442228|NCT02674633|615958203|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170442229|NCT02674633|615958204|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
170442230|NCT00683787|615958205|FG000|Overall Study|Progression|3|||
170442231|NCT00683787|615958206|FG001|Overall Study|Progression|3|||
170442232|NCT00683787|615958207|FG002|Overall Study|Progression|0|||
170442233|NCT00683787|615958205|FG000|Overall Study|Adverse Event|0|||
170442234|NCT00683787|615958206|FG001|Overall Study|Adverse Event|0|||
170442235|NCT00683787|615958207|FG002|Overall Study|Adverse Event|2|||
170442236|NCT03619876|615958208|FG000|Overall Study|Withdrawal by Subject|1|||
170442237|NCT03619876|615958209|FG001|Overall Study|Withdrawal by Subject|2|||
170442238|NCT03619876|615958208|FG000|Overall Study|Withdrawal due to incidental finding|0|||
170442239|NCT03619876|615958209|FG001|Overall Study|Withdrawal due to incidental finding|2|||
170442240|NCT05693805|615958210|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
170442241|NCT05693805|615958211|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
170442242|NCT02943993|615958214|FG000|Overall Study|Withdrawal by Subject|52|||
170442243|NCT02943993|615958214|FG000|Overall Study|Transfer to another institution|6|||
170442244|NCT02943993|615958214|FG000|Overall Study|Lost to Follow-up|135|||
170442245|NCT02943993|615958214|FG000|Overall Study|Death|98|||
170442246|NCT02943993|615958214|FG000|Overall Study|Other reason for premature termination|32|||
170442247|NCT02943993|615958214|FG000|Overall Study|Missing reason for termination|7|||
170442248|NCT04982445|615958215|FG000|Overall Study|Protocol Violation|1|||
170442249|NCT04982445|615958215|FG000|Overall Study|Withdrawal by Subject|4|||
170442250|NCT04982445|615958215|FG000|Overall Study|Lost to Follow-up|1|||
170442251|NCT03230487|615958223|FG000|Overall Study|Adverse Event|0|||
170442252|NCT03230487|615958224|FG001|Overall Study|Adverse Event|0|||
170442253|NCT03230487|615958225|FG002|Overall Study|Adverse Event|0|||
170442254|NCT03230487|615958226|FG003|Overall Study|Adverse Event|1|||
170442255|NCT03230487|615958227|FG004|Overall Study|Adverse Event|0|||
170442256|NCT03230487|615958228|FG005|Overall Study|Adverse Event|0|||
170442257|NCT00876265|615958235|FG000|Overall Study|Miscellaneous reasons|4|||
170442258|NCT00876265|615958235|FG000|Overall Study|Lost to Follow-up|6|||
170442259|NCT00876265|615958235|FG000|Overall Study|Withdrawal by Subject|2|||
170442260|NCT00651183|615958240|FG000|Overall Study|Lack of Efficacy|1|||
170442261|NCT00651183|615958241|FG001|Overall Study|Lack of Efficacy|0|||
170442262|NCT00651183|615958240|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
170442263|NCT00651183|615958241|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
170442264|NCT00651183|615958240|FG000|Overall Study|Tolerability insufficient|5|||
170442265|NCT00651183|615958241|FG001|Overall Study|Tolerability insufficient|2|||
170442266|NCT00651183|615958240|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
170442267|NCT00651183|615958241|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
170442268|NCT00651183|615958240|FG000|Overall Study|Withdrawal by Subject|6|||
170442269|NCT00651183|615958241|FG001|Overall Study|Withdrawal by Subject|3|||
170442270|NCT00651183|615958240|FG000|Overall Study|Lost to Follow-up|3|||
170442271|NCT00651183|615958241|FG001|Overall Study|Lost to Follow-up|1|||
170442272|NCT00651183|615958240|FG000|Overall Study|Other reasons|4|||
170442273|NCT00651183|615958241|FG001|Overall Study|Other reasons|2|||
170442274|NCT00651183|615958240|FG000|Overall Study|missing|1|||
170442275|NCT00651183|615958241|FG001|Overall Study|missing|0|||
170442276|NCT00114231|615958243|FG000|Overall Study|No consent|2|||
170442277|NCT00114231|615958244|FG001|Overall Study|No consent|0|||
170442278|NCT00114231|615958243|FG000|Overall Study|QARC requirement not met|1|||
170442279|NCT00114231|615958244|FG001|Overall Study|QARC requirement not met|0|||
170442280|NCT00114231|615958243|FG000|Overall Study|Suspected metastatic disease|1|||
170442281|NCT00114231|615958244|FG001|Overall Study|Suspected metastatic disease|0|||
170442282|NCT00114231|615958243|FG000|Overall Study|No adenocarcinoma|1|||
170442283|NCT00114231|615958244|FG001|Overall Study|No adenocarcinoma|0|||
170442284|NCT00114231|615958243|FG000|Overall Study|Low creatinine clearance|0|||
170442285|NCT00114231|615958244|FG001|Overall Study|Low creatinine clearance|1|||
170442286|NCT00114231|615958243|FG000|Overall Study|Tumor size > 4cm|1|||
170442287|NCT00114231|615958244|FG001|Overall Study|Tumor size > 4cm|0|||
170442288|NCT00114231|615958243|FG000|Overall Study|Tumor fixed on digital exam|0|||
170442289|NCT00114231|615958244|FG001|Overall Study|Tumor fixed on digital exam|1|||
170442290|NCT00114231|615958243|FG000|Overall Study|No Absolute Neutrophil Count|2|||
170442291|NCT00114231|615958244|FG001|Overall Study|No Absolute Neutrophil Count|0|||
170442292|NCT00114231|615958243|FG000|Overall Study|Biopsy done after registration|1|||
170442293|NCT00114231|615958244|FG001|Overall Study|Biopsy done after registration|0|||
170442294|NCT01933919|615958248|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
170442295|NCT01933919|615958249|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
170442296|NCT01933919|615958248|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
170442297|NCT01933919|615958249|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
170442298|NCT01933919|615958248|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
170442299|NCT01933919|615958249|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
170442300|NCT01933919|615958248|FG000|Open-label Long-term Phase|Adverse Event|2|||
170442301|NCT01933919|615958249|FG001|Open-label Long-term Phase|Adverse Event|0|||
170442302|NCT01933919|615958248|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
170442303|NCT01933919|615958249|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
170442304|NCT01933919|615958248|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
170442305|NCT01933919|615958249|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
170442306|NCT01933919|615958248|FG000|Open-label Long-term Phase|Other|1|||
170442307|NCT01933919|615958249|FG001|Open-label Long-term Phase|Other|2|||
170442308|NCT01961882|615958253|FG000|Overall Study|Adverse Event|3|||
170442309|NCT01961882|615958254|FG001|Overall Study|Adverse Event|2|||
170442310|NCT01961882|615958253|FG000|Overall Study|Physician Decision|1|||
170442311|NCT01961882|615958254|FG001|Overall Study|Physician Decision|0|||
170442312|NCT01961882|615958253|FG000|Overall Study|Withdrawal by Subject|4|||
170442313|NCT01961882|615958254|FG001|Overall Study|Withdrawal by Subject|1|||
170442314|NCT01961882|615958253|FG000|Overall Study|Relapse of AML|39|||
170442315|NCT01961882|615958254|FG001|Overall Study|Relapse of AML|37|||
170442316|NCT01961882|615958253|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
170442317|NCT01961882|615958254|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
170442318|NCT01961882|615958253|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
170442319|NCT01961882|615958254|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
170442320|NCT01901848|615958255|FG000|Randomized and Treated|Lost to Follow-up|3|||
170442321|NCT01901848|615958256|FG001|Randomized and Treated|Lost to Follow-up|6|||
170442322|NCT01901848|615958255|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
170442323|NCT01901848|615958256|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
170442324|NCT01270620|615958259|FG000|Overall Study|Withdrawal by Subject|1|||
170442325|NCT01270620|615958260|FG001|Overall Study|Withdrawal by Subject|3|||
170785403|NCT05116787|617221448|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
170785404|NCT05116787|617221447|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
170442326|NCT00809965|615958263|FG000|Overall Study|Death|194|||
170442327|NCT00809965|615958264|FG001|Overall Study|Death|147|||
170442328|NCT00809965|615958265|FG002|Overall Study|Death|196|||
170785405|NCT05116787|617221448|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
170442329|NCT00809965|615958263|FG000|Overall Study|Lost to Follow-up|17|||
170442330|NCT00809965|615958264|FG001|Overall Study|Lost to Follow-up|10|||
170785406|NCT05116787|617221447|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
170442331|NCT00809965|615958265|FG002|Overall Study|Lost to Follow-up|18|||
170442332|NCT00809965|615958263|FG000|Overall Study|Withdrawal by Subject|405|||
170442333|NCT00809965|615958264|FG001|Overall Study|Withdrawal by Subject|448|||
170442334|NCT00809965|615958265|FG002|Overall Study|Withdrawal by Subject|441|||
170442335|NCT00809965|615958263|FG000|Overall Study|Other Reason|167|||
170442336|NCT00809965|615958264|FG001|Overall Study|Other Reason|170|||
170442337|NCT00809965|615958265|FG002|Overall Study|Other Reason|189|||
170442338|NCT02780167|615958266|FG000|Overall Study|Adverse Event|9|||
170442339|NCT02780167|615958267|FG001|Overall Study|Adverse Event|8|||
170442340|NCT02780167|615958268|FG002|Overall Study|Adverse Event|8|||
170442341|NCT02780167|615958269|FG003|Overall Study|Adverse Event|12|||
170442342|NCT02780167|615958270|FG004|Overall Study|Adverse Event|8|||
170442343|NCT02780167|615958266|FG000|Overall Study|Lack of Efficacy|6|||
170442344|NCT02780167|615958267|FG001|Overall Study|Lack of Efficacy|5|||
170442345|NCT02780167|615958268|FG002|Overall Study|Lack of Efficacy|6|||
170442346|NCT02780167|615958269|FG003|Overall Study|Lack of Efficacy|1|||
170442347|NCT02780167|615958270|FG004|Overall Study|Lack of Efficacy|0|||
170442348|NCT02780167|615958266|FG000|Overall Study|Lost to Follow-up|2|||
170442349|NCT02780167|615958267|FG001|Overall Study|Lost to Follow-up|0|||
170442350|NCT02780167|615958268|FG002|Overall Study|Lost to Follow-up|1|||
170442351|NCT02780167|615958269|FG003|Overall Study|Lost to Follow-up|0|||
170442352|NCT02780167|615958270|FG004|Overall Study|Lost to Follow-up|0|||
170442353|NCT02780167|615958266|FG000|Overall Study|Does not meet entrance criteria|0|||
170442354|NCT02780167|615958267|FG001|Overall Study|Does not meet entrance criteria|0|||
170442355|NCT02780167|615958268|FG002|Overall Study|Does not meet entrance criteria|1|||
170442356|NCT02780167|615958269|FG003|Overall Study|Does not meet entrance criteria|0|||
170442357|NCT02780167|615958270|FG004|Overall Study|Does not meet entrance criteria|0|||
170442358|NCT02780167|615958266|FG000|Overall Study|No longer meets eligibility criteria|0|||
170442359|NCT02780167|615958267|FG001|Overall Study|No longer meets eligibility criteria|0|||
170442360|NCT02780167|615958268|FG002|Overall Study|No longer meets eligibility criteria|0|||
170442361|NCT02780167|615958269|FG003|Overall Study|No longer meets eligibility criteria|1|||
170442362|NCT02780167|615958270|FG004|Overall Study|No longer meets eligibility criteria|1|||
170442363|NCT02780167|615958266|FG000|Overall Study|Protocol Violation|5|||
170442364|NCT02780167|615958267|FG001|Overall Study|Protocol Violation|5|||
170442365|NCT02780167|615958268|FG002|Overall Study|Protocol Violation|1|||
170538638|NCT00712920|616315711|FG000|Overall Study|Adverse Event|3|||
170538639|NCT00712920|616315712|FG001|Overall Study|Adverse Event|4|||
170538640|NCT00712920|616315713|FG002|Overall Study|Adverse Event|7|||
170538641|NCT00712920|616315711|FG000|Overall Study|Withdrawal by Subject|4|||
170538642|NCT00712920|616315712|FG001|Overall Study|Withdrawal by Subject|2|||
170538643|NCT00712920|616315713|FG002|Overall Study|Withdrawal by Subject|1|||
170538644|NCT00712920|616315711|FG000|Overall Study|Lost to Follow-up|1|||
170538645|NCT00712920|616315712|FG001|Overall Study|Lost to Follow-up|4|||
170538646|NCT00712920|616315713|FG002|Overall Study|Lost to Follow-up|0|||
170538647|NCT00712920|616315711|FG000|Overall Study|Lack of Efficacy|1|||
170538648|NCT00712920|616315712|FG001|Overall Study|Lack of Efficacy|0|||
170538649|NCT00712920|616315713|FG002|Overall Study|Lack of Efficacy|1|||
170538650|NCT00712920|616315711|FG000|Overall Study|Other|5|||
170538651|NCT00712920|616315712|FG001|Overall Study|Other|7|||
170538652|NCT00712920|616315713|FG002|Overall Study|Other|3|||
170538653|NCT00712920|616315711|FG000|Overall Study|Non-compliance|3|||
170785407|NCT05116787|617221448|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
170785408|NCT04072380|617221449|FG000|Overall Study|Adverse Event|4|||
170785409|NCT04072380|617221450|FG001|Overall Study|Adverse Event|6|||
170785410|NCT04072380|617221451|FG002|Overall Study|Adverse Event|0|||
170785411|NCT04072380|617221449|FG000|Overall Study|Withdrawal by Subject|3|||
170785412|NCT04072380|617221450|FG001|Overall Study|Withdrawal by Subject|1|||
170785413|NCT04072380|617221451|FG002|Overall Study|Withdrawal by Subject|1|||
170785414|NCT04072380|617221449|FG000|Overall Study|Physician Decision|2|||
170785415|NCT04072380|617221450|FG001|Overall Study|Physician Decision|0|||
170785416|NCT04072380|617221451|FG002|Overall Study|Physician Decision|0|||
170785417|NCT04072380|617221449|FG000|Overall Study|Protocol Violation|0|||
170442366|NCT02780167|615958269|FG003|Overall Study|Protocol Violation|1|||
170442367|NCT02780167|615958270|FG004|Overall Study|Protocol Violation|2|||
170442368|NCT02780167|615958266|FG000|Overall Study|Withdrawal by Subject|6|||
170785418|NCT04072380|617221450|FG001|Overall Study|Protocol Violation|2|||
170442369|NCT02780167|615958267|FG001|Overall Study|Withdrawal by Subject|4|||
170442370|NCT02780167|615958268|FG002|Overall Study|Withdrawal by Subject|4|||
170442371|NCT02780167|615958269|FG003|Overall Study|Withdrawal by Subject|3|||
170538654|NCT00712920|616315712|FG001|Overall Study|Non-compliance|0|||
170538655|NCT00712920|616315713|FG002|Overall Study|Non-compliance|0|||
170538656|NCT02636283|616315714|FG000|Overall Study|Adverse Event|2|||
170538657|NCT02636283|616315715|FG001|Overall Study|Adverse Event|0|||
170538658|NCT02636283|616315714|FG000|Overall Study|Trial Terminated Prematurely|0|||
170785419|NCT04072380|617221451|FG002|Overall Study|Protocol Violation|3|||
170785420|NCT04072380|617221449|FG000|Overall Study|Intercurrent Illness and Others|3|||
170442372|NCT02780167|615958270|FG004|Overall Study|Withdrawal by Subject|4|||
170442373|NCT02780167|615958266|FG000|Overall Study|Other|0|||
170442374|NCT02780167|615958267|FG001|Overall Study|Other|0|||
170442375|NCT02780167|615958268|FG002|Overall Study|Other|3|||
170442376|NCT02780167|615958269|FG003|Overall Study|Other|1|||
170442377|NCT02780167|615958270|FG004|Overall Study|Other|2|||
170442378|NCT05552261|615958271|FG000|Overall Study|Withdrawal by Subject|1|||
170442379|NCT05552261|615958271|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
170442380|NCT02315066|615958272|FG000|Overall Study|Lost to Follow-up|0|||
170442381|NCT02315066|615958273|FG001|Overall Study|Lost to Follow-up|1|||
170442382|NCT02315066|615958274|FG002|Overall Study|Lost to Follow-up|1|||
170442383|NCT02315066|615958275|FG003|Overall Study|Lost to Follow-up|0|||
170442384|NCT02315066|615958276|FG004|Overall Study|Lost to Follow-up|1|||
170442385|NCT02315066|615958277|FG005|Overall Study|Lost to Follow-up|0|||
170442386|NCT02315066|615958278|FG006|Overall Study|Lost to Follow-up|2|||
170442387|NCT02315066|615958279|FG007|Overall Study|Lost to Follow-up|1|||
170442388|NCT02315066|615958280|FG008|Overall Study|Lost to Follow-up|0|||
170442389|NCT02315066|615958281|FG009|Overall Study|Lost to Follow-up|0|||
170442390|NCT02315066|615958282|FG010|Overall Study|Lost to Follow-up|1|||
170442391|NCT02315066|615958283|FG011|Overall Study|Lost to Follow-up|2|||
170442392|NCT02315066|615958284|FG012|Overall Study|Lost to Follow-up|0|||
170785421|NCT04072380|617221450|FG001|Overall Study|Intercurrent Illness and Others|5|||
170785422|NCT04072380|617221451|FG002|Overall Study|Intercurrent Illness and Others|6|||
170442393|NCT02315066|615958285|FG013|Overall Study|Lost to Follow-up|4|||
170442394|NCT02315066|615958272|FG000|Overall Study|Death|2|||
170442395|NCT02315066|615958273|FG001|Overall Study|Death|7|||
170442396|NCT02315066|615958274|FG002|Overall Study|Death|6|||
170442397|NCT02315066|615958275|FG003|Overall Study|Death|11|||
170442398|NCT02315066|615958276|FG004|Overall Study|Death|10|||
170442399|NCT02315066|615958277|FG005|Overall Study|Death|3|||
170442400|NCT02315066|615958278|FG006|Overall Study|Death|9|||
170442401|NCT02315066|615958279|FG007|Overall Study|Death|9|||
170442402|NCT02315066|615958280|FG008|Overall Study|Death|10|||
170442403|NCT02315066|615958281|FG009|Overall Study|Death|8|||
170442404|NCT02315066|615958282|FG010|Overall Study|Death|10|||
170442405|NCT02315066|615958283|FG011|Overall Study|Death|7|||
170442406|NCT02315066|615958284|FG012|Overall Study|Death|8|||
170442407|NCT02315066|615958285|FG013|Overall Study|Death|21|||
170442408|NCT02315066|615958272|FG000|Overall Study|Other|0|||
170442409|NCT02315066|615958273|FG001|Overall Study|Other|0|||
170442410|NCT02315066|615958274|FG002|Overall Study|Other|0|||
170442411|NCT02315066|615958275|FG003|Overall Study|Other|0|||
170442412|NCT02315066|615958276|FG004|Overall Study|Other|0|||
170442413|NCT02315066|615958277|FG005|Overall Study|Other|0|||
170442414|NCT02315066|615958278|FG006|Overall Study|Other|0|||
170442415|NCT02315066|615958279|FG007|Overall Study|Other|1|||
170442416|NCT02315066|615958280|FG008|Overall Study|Other|1|||
170442417|NCT02315066|615958281|FG009|Overall Study|Other|2|||
170442418|NCT02315066|615958282|FG010|Overall Study|Other|0|||
170442419|NCT02315066|615958283|FG011|Overall Study|Other|0|||
170442420|NCT02315066|615958284|FG012|Overall Study|Other|0|||
170442421|NCT02315066|615958285|FG013|Overall Study|Other|0|||
170442422|NCT02315066|615958272|FG000|Overall Study|Subject refused further follow-up|0|||
170442423|NCT02315066|615958273|FG001|Overall Study|Subject refused further follow-up|2|||
170538659|NCT02636283|616315715|FG001|Overall Study|Trial Terminated Prematurely|3|||
170538660|NCT01625182|616315721|FG000|Overall Study|Administrative problems|1|||
170538661|NCT01625182|616315722|FG001|Overall Study|Administrative problems|0|||
170538662|NCT01625182|616315721|FG000|Overall Study|Protocol deviation|0|||
170538663|NCT01625182|616315722|FG001|Overall Study|Protocol deviation|2|||
170538664|NCT01625182|616315721|FG000|Overall Study|Adverse Event|2|||
170538665|NCT01625182|616315722|FG001|Overall Study|Adverse Event|0|||
170538666|NCT01625182|616315721|FG000|Overall Study|Withdrawal by Subject|5|||
170785423|NCT02105766|617221455|FG000|Overall Study|Physician Decision|1|||
170442424|NCT02315066|615958274|FG002|Overall Study|Subject refused further follow-up|2|||
170442425|NCT02315066|615958275|FG003|Overall Study|Subject refused further follow-up|0|||
170442426|NCT02315066|615958276|FG004|Overall Study|Subject refused further follow-up|0|||
170442427|NCT02315066|615958277|FG005|Overall Study|Subject refused further follow-up|0|||
170442428|NCT02315066|615958278|FG006|Overall Study|Subject refused further follow-up|2|||
170785424|NCT02105766|617221456|FG001|Overall Study|Physician Decision|1|||
170785425|NCT02105766|617221457|FG002|Overall Study|Physician Decision|0|||
170785426|NCT02105766|617221455|FG000|Overall Study|Lost to Follow-up|2|||
170442429|NCT02315066|615958279|FG007|Overall Study|Subject refused further follow-up|3|||
170442430|NCT02315066|615958280|FG008|Overall Study|Subject refused further follow-up|0|||
170442431|NCT02315066|615958281|FG009|Overall Study|Subject refused further follow-up|1|||
170442432|NCT02315066|615958282|FG010|Overall Study|Subject refused further follow-up|1|||
170442433|NCT02315066|615958283|FG011|Overall Study|Subject refused further follow-up|2|||
170442434|NCT02315066|615958284|FG012|Overall Study|Subject refused further follow-up|2|||
170785427|NCT02105766|617221456|FG001|Overall Study|Lost to Follow-up|0|||
170442435|NCT02315066|615958285|FG013|Overall Study|Subject refused further follow-up|4|||
170538667|NCT01625182|616315722|FG001|Overall Study|Withdrawal by Subject|1|||
170442436|NCT02315066|615958272|FG000|Overall Study|Study ongoing at date of cut-off|0|||
170442437|NCT02315066|615958273|FG001|Overall Study|Study ongoing at date of cut-off|0|||
170442438|NCT02315066|615958274|FG002|Overall Study|Study ongoing at date of cut-off|0|||
170442439|NCT02315066|615958275|FG003|Overall Study|Study ongoing at date of cut-off|0|||
170442440|NCT02315066|615958276|FG004|Overall Study|Study ongoing at date of cut-off|0|||
170442441|NCT02315066|615958277|FG005|Overall Study|Study ongoing at date of cut-off|0|||
170442442|NCT02315066|615958278|FG006|Overall Study|Study ongoing at date of cut-off|0|||
170442443|NCT02315066|615958279|FG007|Overall Study|Study ongoing at date of cut-off|0|||
170442444|NCT02315066|615958280|FG008|Overall Study|Study ongoing at date of cut-off|0|||
170442445|NCT02315066|615958281|FG009|Overall Study|Study ongoing at date of cut-off|0|||
170442446|NCT02315066|615958282|FG010|Overall Study|Study ongoing at date of cut-off|0|||
170442447|NCT02315066|615958283|FG011|Overall Study|Study ongoing at date of cut-off|0|||
170442448|NCT02315066|615958284|FG012|Overall Study|Study ongoing at date of cut-off|0|||
170442449|NCT02315066|615958285|FG013|Overall Study|Study ongoing at date of cut-off|1|||
170442450|NCT02003222|615958286|FG000|Induction|Never started treatment|0|||
170442451|NCT02003222|615958287|FG001|Induction|Never started treatment|0|||
170442452|NCT02003222|615958288|FG002|Induction|Never started treatment|0|||
170442453|NCT02003222|615958289|FG003|Induction|Never started treatment|0|||
170442454|NCT02003222|615958290|FG004|Induction|Never started treatment|8|||
170442455|NCT02003222|615958286|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
170442456|NCT02003222|615958287|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
170442457|NCT02003222|615958288|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
170442458|NCT02003222|615958289|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
170442459|NCT02003222|615958290|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
170442460|NCT02003222|615958286|FG000|Induction|Adverse Event|0|||
170442461|NCT02003222|615958287|FG001|Induction|Adverse Event|0|||
170442462|NCT02003222|615958288|FG002|Induction|Adverse Event|0|||
170442463|NCT02003222|615958289|FG003|Induction|Adverse Event|0|||
170442464|NCT02003222|615958290|FG004|Induction|Adverse Event|13|||
170442465|NCT02003222|615958286|FG000|Induction|Alternative therapy|0|||
170442466|NCT02003222|615958287|FG001|Induction|Alternative therapy|0|||
170442467|NCT02003222|615958288|FG002|Induction|Alternative therapy|0|||
170442468|NCT02003222|615958289|FG003|Induction|Alternative therapy|0|||
170442469|NCT02003222|615958290|FG004|Induction|Alternative therapy|12|||
170442470|NCT02003222|615958286|FG000|Induction|Disease progression|0|||
170442471|NCT02003222|615958287|FG001|Induction|Disease progression|0|||
170442472|NCT02003222|615958288|FG002|Induction|Disease progression|0|||
170442473|NCT02003222|615958289|FG003|Induction|Disease progression|0|||
170442474|NCT02003222|615958290|FG004|Induction|Disease progression|22|||
170442475|NCT02003222|615958286|FG000|Induction|Death|0|||
170442476|NCT02003222|615958287|FG001|Induction|Death|0|||
170442477|NCT02003222|615958288|FG002|Induction|Death|0|||
170442478|NCT02003222|615958289|FG003|Induction|Death|0|||
170442479|NCT02003222|615958290|FG004|Induction|Death|3|||
170442480|NCT02003222|615958286|FG000|Induction|Withdrawal by Subject|0|||
170442481|NCT02003222|615958287|FG001|Induction|Withdrawal by Subject|0|||
170442482|NCT02003222|615958288|FG002|Induction|Withdrawal by Subject|0|||
170442483|NCT02003222|615958289|FG003|Induction|Withdrawal by Subject|0|||
170442484|NCT02003222|615958290|FG004|Induction|Withdrawal by Subject|8|||
170442485|NCT02003222|615958286|FG000|Induction|Other reasons|0|||
170442486|NCT02003222|615958287|FG001|Induction|Other reasons|0|||
170442487|NCT02003222|615958288|FG002|Induction|Other reasons|0|||
170442488|NCT02003222|615958289|FG003|Induction|Other reasons|0|||
170442489|NCT02003222|615958290|FG004|Induction|Other reasons|22|||
170442490|NCT02003222|615958286|FG000|Intensification|Never started treatment|0|||
170442491|NCT02003222|615958287|FG001|Intensification|Never started treatment|0|||
170442492|NCT02003222|615958288|FG002|Intensification|Never started treatment|0|||
170442493|NCT02003222|615958289|FG003|Intensification|Never started treatment|0|||
170442494|NCT02003222|615958290|FG004|Intensification|Never started treatment|2|||
170442495|NCT02003222|615958286|FG000|Intensification|Adverse Event|0|||
170442496|NCT02003222|615958287|FG001|Intensification|Adverse Event|0|||
170442497|NCT02003222|615958288|FG002|Intensification|Adverse Event|0|||
170442498|NCT02003222|615958289|FG003|Intensification|Adverse Event|0|||
170442499|NCT02003222|615958290|FG004|Intensification|Adverse Event|6|||
170442500|NCT02003222|615958286|FG000|Intensification|Alternative therapy|0|||
170442501|NCT02003222|615958287|FG001|Intensification|Alternative therapy|0|||
170442502|NCT02003222|615958288|FG002|Intensification|Alternative therapy|0|||
170442503|NCT02003222|615958289|FG003|Intensification|Alternative therapy|0|||
170442504|NCT02003222|615958290|FG004|Intensification|Alternative therapy|8|||
170442505|NCT02003222|615958286|FG000|Intensification|Disease progression|0|||
170442506|NCT02003222|615958287|FG001|Intensification|Disease progression|0|||
170442507|NCT02003222|615958288|FG002|Intensification|Disease progression|0|||
170442508|NCT02003222|615958289|FG003|Intensification|Disease progression|0|||
170442509|NCT02003222|615958290|FG004|Intensification|Disease progression|18|||
170442510|NCT02003222|615958286|FG000|Intensification|Withdrawal by Subject|0|||
170442511|NCT02003222|615958287|FG001|Intensification|Withdrawal by Subject|0|||
170442512|NCT02003222|615958288|FG002|Intensification|Withdrawal by Subject|0|||
170442513|NCT02003222|615958289|FG003|Intensification|Withdrawal by Subject|0|||
170442514|NCT02003222|615958290|FG004|Intensification|Withdrawal by Subject|5|||
170442515|NCT02003222|615958286|FG000|Intensification|Other reasons|0|||
170442516|NCT02003222|615958287|FG001|Intensification|Other reasons|0|||
170442517|NCT02003222|615958288|FG002|Intensification|Other reasons|0|||
170442518|NCT02003222|615958289|FG003|Intensification|Other reasons|0|||
170442519|NCT02003222|615958290|FG004|Intensification|Other reasons|8|||
170442520|NCT01957150|615958295|FG000|Overall Study|Adverse Event|23|||
170442521|NCT01957150|615958296|FG001|Overall Study|Adverse Event|20|||
170442522|NCT01957150|615958295|FG000|Overall Study|Withdrawal by Subject|13|||
170442523|NCT01957150|615958296|FG001|Overall Study|Withdrawal by Subject|17|||
170442524|NCT01957150|615958295|FG000|Overall Study|Physician Decision|3|||
170442525|NCT01957150|615958296|FG001|Overall Study|Physician Decision|6|||
170442526|NCT01957150|615958295|FG000|Overall Study|Lost to Follow-up|4|||
170442527|NCT01957150|615958296|FG001|Overall Study|Lost to Follow-up|4|||
170442528|NCT01957150|615958295|FG000|Overall Study|Protocol Violation|1|||
170442529|NCT01957150|615958296|FG001|Overall Study|Protocol Violation|0|||
170442530|NCT01957150|615958295|FG000|Overall Study|Lack of Efficacy|11|||
170442531|NCT01957150|615958296|FG001|Overall Study|Lack of Efficacy|11|||
170442532|NCT02618382|615958297|FG000|Overall Study|Physician Decision|1|||
170442533|NCT02618382|615958297|FG000|Overall Study|Withdrawal by Subject|1|||
170442534|NCT02618382|615958297|FG000|Overall Study|Protocol Violation|1|||
170442535|NCT00098475|615958298|FG000|Step 1|Progressive disease|33|||
170442536|NCT00098475|615958299|FG001|Step 1|Progressive disease|35|||
170442537|NCT00098475|615958300|FG002|Step 1|Progressive disease|2|||
170442538|NCT00098475|615958301|FG003|Step 1|Progressive disease|1|||
170442539|NCT00098475|615958298|FG000|Step 1|Adverse Event|56|||
170442540|NCT00098475|615958299|FG001|Step 1|Adverse Event|37|||
170442541|NCT00098475|615958300|FG002|Step 1|Adverse Event|0|||
170442542|NCT00098475|615958301|FG003|Step 1|Adverse Event|1|||
170442543|NCT00098475|615958298|FG000|Step 1|Death|8|||
170442544|NCT00098475|615958299|FG001|Step 1|Death|5|||
170442545|NCT00098475|615958300|FG002|Step 1|Death|0|||
170442546|NCT00098475|615958301|FG003|Step 1|Death|1|||
170442547|NCT00098475|615958298|FG000|Step 1|Withdrawal by Subject|14|||
170442548|NCT00098475|615958299|FG001|Step 1|Withdrawal by Subject|11|||
170442549|NCT00098475|615958300|FG002|Step 1|Withdrawal by Subject|0|||
170442550|NCT00098475|615958301|FG003|Step 1|Withdrawal by Subject|0|||
170442551|NCT00098475|615958298|FG000|Step 1|Physician Decision|5|||
170442552|NCT00098475|615958299|FG001|Step 1|Physician Decision|2|||
170442553|NCT00098475|615958300|FG002|Step 1|Physician Decision|0|||
170442554|NCT00098475|615958301|FG003|Step 1|Physician Decision|0|||
170442555|NCT00098475|615958298|FG000|Step 1|Alternative therapy|31|||
170442556|NCT00098475|615958299|FG001|Step 1|Alternative therapy|43|||
170442557|NCT00098475|615958300|FG002|Step 1|Alternative therapy|1|||
170442558|NCT00098475|615958301|FG003|Step 1|Alternative therapy|0|||
170442559|NCT00098475|615958298|FG000|Step 1|Other disease|2|||
170442560|NCT00098475|615958299|FG001|Step 1|Other disease|1|||
170442561|NCT00098475|615958300|FG002|Step 1|Other disease|1|||
170442562|NCT00098475|615958301|FG003|Step 1|Other disease|0|||
170442563|NCT00098475|615958298|FG000|Step 1|Never started treatment|0|||
170442564|NCT00098475|615958299|FG001|Step 1|Never started treatment|2|||
170442565|NCT00098475|615958300|FG002|Step 1|Never started treatment|0|||
170442566|NCT00098475|615958301|FG003|Step 1|Never started treatment|0|||
170442567|NCT00098475|615958298|FG000|Step 1|Still on treatment as of this analysis|14|||
170442568|NCT00098475|615958299|FG001|Step 1|Still on treatment as of this analysis|27|||
170442569|NCT00098475|615958300|FG002|Step 1|Still on treatment as of this analysis|0|||
170442570|NCT00098475|615958301|FG003|Step 1|Still on treatment as of this analysis|0|||
170442571|NCT00098475|615958298|FG000|Step 1|Knee surgery|1|||
170442572|NCT00098475|615958299|FG001|Step 1|Knee surgery|0|||
170442573|NCT00098475|615958300|FG002|Step 1|Knee surgery|0|||
170442574|NCT00098475|615958301|FG003|Step 1|Knee surgery|0|||
170442575|NCT00098475|615958298|FG000|Step 1|Complications|1|||
170442576|NCT00098475|615958299|FG001|Step 1|Complications|0|||
170538668|NCT01625182|616315721|FG000|Overall Study|Lack of Efficacy|12|||
170538669|NCT01625182|616315722|FG001|Overall Study|Lack of Efficacy|8|||
170442577|NCT00098475|615958300|FG002|Step 1|Complications|0|||
170442578|NCT00098475|615958301|FG003|Step 1|Complications|0|||
170442579|NCT00098475|615958298|FG000|Step 1|Cannot comply due to other tx|0|||
170442580|NCT00098475|615958299|FG001|Step 1|Cannot comply due to other tx|1|||
170442581|NCT00098475|615958300|FG002|Step 1|Cannot comply due to other tx|0|||
170538670|NCT00741611|616315723|FG000|Overall Study|Death|0|||
170538671|NCT00741611|616315724|FG001|Overall Study|Death|0|||
170442582|NCT00098475|615958301|FG003|Step 1|Cannot comply due to other tx|0|||
170442583|NCT00098475|615958298|FG000|Step 1|Both patient and physician's decision|2|||
170442584|NCT00098475|615958299|FG001|Step 1|Both patient and physician's decision|1|||
170442585|NCT00098475|615958300|FG002|Step 1|Both patient and physician's decision|0|||
170442586|NCT00098475|615958301|FG003|Step 1|Both patient and physician's decision|0|||
170442587|NCT00098475|615958298|FG000|Step 1|Incorrect disease assessment|2|||
170442588|NCT00098475|615958299|FG001|Step 1|Incorrect disease assessment|0|||
170442589|NCT00098475|615958300|FG002|Step 1|Incorrect disease assessment|0|||
170442590|NCT00098475|615958301|FG003|Step 1|Incorrect disease assessment|0|||
170442591|NCT00098475|615958298|FG000|Step 1|Off treatment for > specified timeframe|1|||
170442592|NCT00098475|615958299|FG001|Step 1|Off treatment for > specified timeframe|1|||
170442593|NCT00098475|615958300|FG002|Step 1|Off treatment for > specified timeframe|0|||
170442594|NCT00098475|615958301|FG003|Step 1|Off treatment for > specified timeframe|0|||
170442595|NCT00098475|615958298|FG000|Step 1|Declining performance status|0|||
170442596|NCT00098475|615958299|FG001|Step 1|Declining performance status|1|||
170442597|NCT00098475|615958300|FG002|Step 1|Declining performance status|0|||
170442598|NCT00098475|615958301|FG003|Step 1|Declining performance status|0|||
170442599|NCT00098475|615958298|FG000|Step 1|Insurance issue|0|||
170442600|NCT00098475|615958299|FG001|Step 1|Insurance issue|1|||
170442601|NCT00098475|615958300|FG002|Step 1|Insurance issue|0|||
170442602|NCT00098475|615958301|FG003|Step 1|Insurance issue|0|||
170442603|NCT00098475|615958298|FG000|Step 1|Rising paraprotein|0|||
170442604|NCT00098475|615958299|FG001|Step 1|Rising paraprotein|1|||
170442605|NCT00098475|615958300|FG002|Step 1|Rising paraprotein|0|||
170442606|NCT00098475|615958301|FG003|Step 1|Rising paraprotein|0|||
170442607|NCT00098475|615958298|FG000|Step 1|Referred to other physicians|0|||
170442608|NCT00098475|615958299|FG001|Step 1|Referred to other physicians|1|||
170442609|NCT00098475|615958300|FG002|Step 1|Referred to other physicians|0|||
170442610|NCT00098475|615958301|FG003|Step 1|Referred to other physicians|0|||
170442611|NCT00098475|615958298|FG000|Step 1|Criteria to continue treatment not met|0|||
170442612|NCT00098475|615958299|FG001|Step 1|Criteria to continue treatment not met|1|||
170442613|NCT00098475|615958300|FG002|Step 1|Criteria to continue treatment not met|0|||
170442614|NCT00098475|615958301|FG003|Step 1|Criteria to continue treatment not met|0|||
170442615|NCT00098475|615958298|FG000|Step 1|Misinterpretation of lab data|0|||
170442616|NCT00098475|615958299|FG001|Step 1|Misinterpretation of lab data|1|||
170442617|NCT00098475|615958300|FG002|Step 1|Misinterpretation of lab data|0|||
170442618|NCT00098475|615958301|FG003|Step 1|Misinterpretation of lab data|0|||
170442619|NCT00098475|615958298|FG000|Step 1|Patient fell with fracture|1|||
170442620|NCT00098475|615958299|FG001|Step 1|Patient fell with fracture|0|||
170442621|NCT00098475|615958300|FG002|Step 1|Patient fell with fracture|0|||
170442622|NCT00098475|615958301|FG003|Step 1|Patient fell with fracture|0|||
170442623|NCT00098475|615958298|FG000|Step 1|Not documented|0|||
170442624|NCT00098475|615958299|FG001|Step 1|Not documented|1|||
170442625|NCT00098475|615958300|FG002|Step 1|Not documented|0|||
170442626|NCT00098475|615958301|FG003|Step 1|Not documented|0|||
170442627|NCT00098475|615958298|FG000|Step 2|Disease progression|1|||
170442628|NCT00098475|615958299|FG001|Step 2|Disease progression|4|||
170442629|NCT00098475|615958300|FG002|Step 2|Disease progression|0|||
170442630|NCT00098475|615958301|FG003|Step 2|Disease progression|0|||
170442631|NCT00098475|615958298|FG000|Step 2|Adverse Event|2|||
170442632|NCT00098475|615958299|FG001|Step 2|Adverse Event|0|||
170442633|NCT00098475|615958300|FG002|Step 2|Adverse Event|0|||
170442634|NCT00098475|615958301|FG003|Step 2|Adverse Event|0|||
170442635|NCT00098475|615958298|FG000|Step 2|Withdrawal by Subject|0|||
170442636|NCT00098475|615958299|FG001|Step 2|Withdrawal by Subject|2|||
170442637|NCT00098475|615958300|FG002|Step 2|Withdrawal by Subject|0|||
170538672|NCT00741611|616315725|FG002|Overall Study|Death|1|||
170538673|NCT00741611|616315723|FG000|Overall Study|Withdrawal by Subject|0|||
170538674|NCT00741611|616315724|FG001|Overall Study|Withdrawal by Subject|2|||
170538675|NCT00741611|616315725|FG002|Overall Study|Withdrawal by Subject|2|||
170538676|NCT01922011|616315726|FG000|Overall Study|Protocol Violation|0|||
170538677|NCT01922011|616315727|FG001|Overall Study|Protocol Violation|1|||
170538678|NCT01922011|616315726|FG000|Overall Study|Physician Decision|0|||
170538679|NCT01922011|616315727|FG001|Overall Study|Physician Decision|1|||
170538680|NCT01922011|616315726|FG000|Overall Study|Parent/Guardian Decision|3|||
170538681|NCT01922011|616315727|FG001|Overall Study|Parent/Guardian Decision|0|||
170538682|NCT01922011|616315726|FG000|Overall Study|Lost to Follow-up|0|||
170538683|NCT01922011|616315727|FG001|Overall Study|Lost to Follow-up|1|||
170538684|NCT01922011|616315726|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
170538685|NCT01922011|616315727|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
170538686|NCT01922011|616315726|FG000|Overall Study|Not Treated|1|||
170538687|NCT01922011|616315727|FG001|Overall Study|Not Treated|0|||
170633146|NCT01746901|616668462|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
170442638|NCT00098475|615958301|FG003|Step 2|Withdrawal by Subject|0|||
170785428|NCT02105766|617221457|FG002|Overall Study|Lost to Follow-up|0|||
170785429|NCT02105766|617221455|FG000|Overall Study|Death|1|||
170442639|NCT00098475|615958298|FG000|Step 2|Physician Decision|0|||
170442640|NCT00098475|615958299|FG001|Step 2|Physician Decision|1|||
170442641|NCT00098475|615958300|FG002|Step 2|Physician Decision|0|||
170785430|NCT02105766|617221456|FG001|Overall Study|Death|1|||
170442642|NCT00098475|615958301|FG003|Step 2|Physician Decision|0|||
170442643|NCT00098475|615958298|FG000|Step 2|Alternative therapy|1|||
170442644|NCT00098475|615958299|FG001|Step 2|Alternative therapy|2|||
170442645|NCT00098475|615958300|FG002|Step 2|Alternative therapy|0|||
170442646|NCT00098475|615958301|FG003|Step 2|Alternative therapy|0|||
170442647|NCT00098475|615958298|FG000|Step 2|Never started treatment|1|||
170442648|NCT00098475|615958299|FG001|Step 2|Never started treatment|1|||
170538688|NCT01922011|616315726|FG000|Overall Study|Lack of willing home health agency|1|||
170442649|NCT00098475|615958300|FG002|Step 2|Never started treatment|0|||
170442650|NCT00098475|615958301|FG003|Step 2|Never started treatment|0|||
170442651|NCT01344018|615958304|FG000|Overall Study|Death|22|||
170442652|NCT01344018|615958305|FG001|Overall Study|Death|25|||
170442653|NCT01344018|615958304|FG000|Overall Study|Lost to Follow-up|4|||
170442654|NCT01344018|615958305|FG001|Overall Study|Lost to Follow-up|7|||
170442655|NCT01341405|615958307|FG000|Overall Study|Adverse Event|0|||
170442656|NCT01341405|615958308|FG001|Overall Study|Adverse Event|1|||
170442657|NCT01341405|615958309|FG002|Overall Study|Adverse Event|1|||
170442658|NCT01341405|615958307|FG000|Overall Study|Withdrawal by Subject|3|||
170442659|NCT01341405|615958308|FG001|Overall Study|Withdrawal by Subject|2|||
170442660|NCT01341405|615958309|FG002|Overall Study|Withdrawal by Subject|1|||
170442661|NCT02151149|615958310|FG000|Treatment Period|Death|2|||
170442662|NCT02151149|615958311|FG001|Treatment Period|Death|3|||
170442663|NCT02151149|615958310|FG000|Treatment Period|Adverse Event|17|||
170442664|NCT02151149|615958311|FG001|Treatment Period|Adverse Event|14|||
170442665|NCT02151149|615958310|FG000|Treatment Period|Progressive Disease|25|||
170442666|NCT02151149|615958311|FG001|Treatment Period|Progressive Disease|24|||
170442667|NCT02151149|615958310|FG000|Treatment Period|Symptomatic Deterioration|2|||
170442668|NCT02151149|615958311|FG001|Treatment Period|Symptomatic Deterioration|10|||
170442669|NCT02151149|615958310|FG000|Treatment Period|Withdrawal by Subject|13|||
170442670|NCT02151149|615958311|FG001|Treatment Period|Withdrawal by Subject|11|||
170442671|NCT02151149|615958310|FG000|Treatment Period|Miscellaneous|8|||
170442672|NCT02151149|615958311|FG001|Treatment Period|Miscellaneous|7|||
170442673|NCT02151149|615958310|FG000|Treatment Period|Participants randomized but not treated|3|||
170442674|NCT02151149|615958311|FG001|Treatment Period|Participants randomized but not treated|2|||
170442675|NCT02151149|615958310|FG000|Follow-Up Period|Lost to Follow-up|2|||
170442676|NCT02151149|615958311|FG001|Follow-Up Period|Lost to Follow-up|3|||
170442677|NCT02151149|615958310|FG000|Follow-Up Period|Death|37|||
170442678|NCT02151149|615958311|FG001|Follow-Up Period|Death|34|||
170442679|NCT00057941|615958312|FG000|Overall Study|Death|1|||
170442680|NCT00057941|615958313|FG001|Overall Study|Death|2|||
170442681|NCT00057941|615958312|FG000|Overall Study|Adverse Event|7|||
170442682|NCT00057941|615958313|FG001|Overall Study|Adverse Event|9|||
170442683|NCT00057941|615958312|FG000|Overall Study|Lack of Efficacy|54|||
170442684|NCT00057941|615958313|FG001|Overall Study|Lack of Efficacy|53|||
170442685|NCT00057941|615958312|FG000|Overall Study|Withdrawal by Subject|6|||
170442686|NCT00057941|615958313|FG001|Overall Study|Withdrawal by Subject|1|||
170442687|NCT00057941|615958312|FG000|Overall Study|still on treatment|3|||
170442688|NCT00057941|615958313|FG001|Overall Study|still on treatment|1|||
170442689|NCT00057941|615958312|FG000|Overall Study|insurance, symptomatic deterioration|1|||
170442690|NCT00057941|615958313|FG001|Overall Study|insurance, symptomatic deterioration|3|||
170442691|NCT00057941|615958312|FG000|Overall Study|Ineligible|2|||
170442692|NCT00057941|615958313|FG001|Overall Study|Ineligible|5|||
170442693|NCT03419962|615958315|FG000|Overall Study|Change to other medication|1|||
170442694|NCT03419962|615958315|FG000|Overall Study|Refusal of continuing with trial drug|1|||
170442695|NCT03419962|615958315|FG000|Overall Study|Lost to Follow-up|3|||
170442696|NCT03419962|615958315|FG000|Overall Study|Difficulty in inhaling the doses|1|||
170442697|NCT03419962|615958315|FG000|Overall Study|Missing completion data|31|||
170442698|NCT04142658|615958318|FG000|Overall Study|Death|2|||
170442699|NCT04142658|615958319|FG001|Overall Study|Death|1|||
170442700|NCT04142658|615958318|FG000|Overall Study|Lost to Follow-up|4|||
170442701|NCT04142658|615958319|FG001|Overall Study|Lost to Follow-up|13|||
170442702|NCT04142658|615958318|FG000|Overall Study|Withdrawal by Subject|9|||
170442703|NCT04142658|615958319|FG001|Overall Study|Withdrawal by Subject|16|||
170442704|NCT00721955|615958322|FG000|Overall Study|Adverse Event|0|||
170442705|NCT00721955|615958323|FG001|Overall Study|Adverse Event|0|||
170442706|NCT00721955|615958324|FG002|Overall Study|Adverse Event|2|||
170442707|NCT01055886|615958325|FG000|Overall Study|Withdrawal by Subject|4|||
170442708|NCT01055886|615958326|FG001|Overall Study|Withdrawal by Subject|9|||
170442709|NCT01055886|615958325|FG000|Overall Study|Lost to Follow-up|1|||
170442710|NCT01055886|615958326|FG001|Overall Study|Lost to Follow-up|1|||
170442711|NCT01055886|615958325|FG000|Overall Study|Withdrawal by PI|0|||
170442712|NCT01055886|615958326|FG001|Overall Study|Withdrawal by PI|1|||
170442713|NCT01499160|615958330|FG000|Overall Study|Adverse Event|1|||
170442714|NCT01499160|615958330|FG000|Overall Study|Withdrawal by Subject|1|||
170442715|NCT04718129|615958341|FG000|Overall Study|Lost to Follow-up|6|||
170442716|NCT04718129|615958342|FG001|Overall Study|Lost to Follow-up|7|||
170442717|NCT02212457|615958343|FG000|Overall Study|Adverse Event|1|||
170442718|NCT02212457|615958344|FG001|Overall Study|Adverse Event|2|||
170442719|NCT02212457|615958345|FG002|Overall Study|Adverse Event|2|||
170442720|NCT02212457|615958346|FG003|Overall Study|Adverse Event|2|||
170442721|NCT02212457|615958347|FG004|Overall Study|Adverse Event|0|||
170442722|NCT02212457|615958348|FG005|Overall Study|Adverse Event|1|||
170442723|NCT02212457|615958343|FG000|Overall Study|Withdrawal by Subject|8|||
170442724|NCT02212457|615958344|FG001|Overall Study|Withdrawal by Subject|10|||
170442725|NCT02212457|615958345|FG002|Overall Study|Withdrawal by Subject|8|||
170442726|NCT02212457|615958346|FG003|Overall Study|Withdrawal by Subject|6|||
170442727|NCT02212457|615958347|FG004|Overall Study|Withdrawal by Subject|5|||
170442728|NCT02212457|615958348|FG005|Overall Study|Withdrawal by Subject|4|||
170442729|NCT02212457|615958343|FG000|Overall Study|Lost to Follow-up|6|||
170442730|NCT02212457|615958344|FG001|Overall Study|Lost to Follow-up|7|||
170442731|NCT02212457|615958345|FG002|Overall Study|Lost to Follow-up|4|||
170442732|NCT02212457|615958346|FG003|Overall Study|Lost to Follow-up|1|||
170442733|NCT02212457|615958347|FG004|Overall Study|Lost to Follow-up|8|||
170442734|NCT02212457|615958348|FG005|Overall Study|Lost to Follow-up|4|||
170442735|NCT02212457|615958343|FG000|Overall Study|Protocol Violation|2|||
170442736|NCT02212457|615958344|FG001|Overall Study|Protocol Violation|1|||
170442737|NCT02212457|615958345|FG002|Overall Study|Protocol Violation|0|||
170442738|NCT02212457|615958346|FG003|Overall Study|Protocol Violation|1|||
170442739|NCT02212457|615958347|FG004|Overall Study|Protocol Violation|2|||
170442740|NCT02212457|615958348|FG005|Overall Study|Protocol Violation|3|||
170442741|NCT02212457|615958343|FG000|Overall Study|Other|2|||
170442742|NCT02212457|615958344|FG001|Overall Study|Other|1|||
170442743|NCT02212457|615958345|FG002|Overall Study|Other|2|||
170442744|NCT02212457|615958346|FG003|Overall Study|Other|1|||
170442745|NCT02212457|615958347|FG004|Overall Study|Other|0|||
170442746|NCT02212457|615958348|FG005|Overall Study|Other|1|||
170442747|NCT00420095|615958349|FG000|Overall Study|Adverse Event|1|||
170442748|NCT00420095|615958350|FG001|Overall Study|Adverse Event|0|||
170442749|NCT00420095|615958349|FG000|Overall Study|Protocol Violation|1|||
170538689|NCT01922011|616315727|FG001|Overall Study|Lack of willing home health agency|0|||
170538690|NCT01922011|616315726|FG000|Overall Study|Randomized in error|1|||
170538691|NCT01922011|616315727|FG001|Overall Study|Randomized in error|0|||
170538692|NCT05522751|616315728|FG000|Overall Study|Adverse Event|1|||
170538693|NCT02879695|616315730|FG000|Overall Study|Did not start study treatment|2|||
170538694|NCT02879695|616315731|FG001|Overall Study|Did not start study treatment|0|||
170538695|NCT02879695|616315732|FG002|Overall Study|Did not start study treatment|3|||
170538696|NCT02879695|616315733|FG003|Overall Study|Did not start study treatment|0|||
170442750|NCT00420095|615958350|FG001|Overall Study|Protocol Violation|1|||
170442751|NCT00420095|615958349|FG000|Overall Study|Lost to Follow-up|1|||
170442752|NCT00420095|615958350|FG001|Overall Study|Lost to Follow-up|0|||
170442753|NCT05258630|615960363|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
170442754|NCT05258630|615960364|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
170442755|NCT05258630|615960363|FG000|Overall Study|Lost to Follow-up|0|||
170442756|NCT05258630|615960364|FG001|Overall Study|Lost to Follow-up|2|||
170442757|NCT00784979|615960365|FG000|Overall Study|incomplete data|6|||
170442758|NCT00631007|615960367|FG000|Overall Study|Adverse Event|0|||
170442759|NCT00631007|615960368|FG001|Overall Study|Adverse Event|2|||
170442760|NCT00631007|615960369|FG002|Overall Study|Adverse Event|0|||
170442761|NCT00631007|615960370|FG003|Overall Study|Adverse Event|2|||
170442762|NCT00631007|615960371|FG004|Overall Study|Adverse Event|3|||
170442763|NCT00631007|615960372|FG005|Overall Study|Adverse Event|2|||
170442764|NCT00631007|615960367|FG000|Overall Study|Lost to Follow-up|2|||
170442765|NCT00631007|615960368|FG001|Overall Study|Lost to Follow-up|1|||
170442766|NCT00631007|615960369|FG002|Overall Study|Lost to Follow-up|2|||
170442767|NCT00631007|615960370|FG003|Overall Study|Lost to Follow-up|4|||
170442768|NCT00631007|615960371|FG004|Overall Study|Lost to Follow-up|5|||
170442769|NCT00631007|615960372|FG005|Overall Study|Lost to Follow-up|3|||
170442770|NCT00631007|615960367|FG000|Overall Study|Physician Decision|1|||
170442771|NCT00631007|615960368|FG001|Overall Study|Physician Decision|0|||
170442772|NCT00631007|615960369|FG002|Overall Study|Physician Decision|1|||
170442773|NCT00631007|615960370|FG003|Overall Study|Physician Decision|0|||
170442774|NCT00631007|615960371|FG004|Overall Study|Physician Decision|0|||
170442775|NCT00631007|615960372|FG005|Overall Study|Physician Decision|2|||
170442776|NCT00631007|615960367|FG000|Overall Study|Persistent Hyperglycemia|2|||
170442777|NCT00631007|615960368|FG001|Overall Study|Persistent Hyperglycemia|2|||
170442778|NCT00631007|615960369|FG002|Overall Study|Persistent Hyperglycemia|5|||
170442779|NCT00631007|615960370|FG003|Overall Study|Persistent Hyperglycemia|1|||
170442780|NCT00631007|615960371|FG004|Overall Study|Persistent Hyperglycemia|2|||
170538697|NCT04063163|616315734|FG000|Overall Study|Death|281|||
170538698|NCT04063163|616315735|FG001|Overall Study|Death|166|||
170442781|NCT00631007|615960372|FG005|Overall Study|Persistent Hyperglycemia|5|||
170442782|NCT00631007|615960367|FG000|Overall Study|Withdrawal by Subject|4|||
170442783|NCT00631007|615960368|FG001|Overall Study|Withdrawal by Subject|5|||
170442784|NCT00631007|615960369|FG002|Overall Study|Withdrawal by Subject|2|||
170442785|NCT00631007|615960370|FG003|Overall Study|Withdrawal by Subject|2|||
170538699|NCT04063163|616315734|FG000|Overall Study|Lost to Follow-up|12|||
170442786|NCT00631007|615960371|FG004|Overall Study|Withdrawal by Subject|1|||
170442787|NCT00631007|615960372|FG005|Overall Study|Withdrawal by Subject|3|||
170442788|NCT00631007|615960367|FG000|Overall Study|Other|2|||
170442789|NCT00631007|615960368|FG001|Overall Study|Other|1|||
170442790|NCT00631007|615960369|FG002|Overall Study|Other|0|||
170442791|NCT00631007|615960370|FG003|Overall Study|Other|0|||
170442792|NCT00631007|615960371|FG004|Overall Study|Other|1|||
170442793|NCT00631007|615960372|FG005|Overall Study|Other|0|||
170442794|NCT00460109|615960373|FG000|Overall Study|Death|1|||
170442795|NCT00112294|615960378|FG000|Overall Study|Still on study|5|||
170538700|NCT04063163|616315735|FG001|Overall Study|Lost to Follow-up|8|||
170442796|NCT00112294|615960379|FG001|Overall Study|Still on study|0|||
170442797|NCT01190930|615960381|FG000|Induction|Adverse Event|17|||
170442798|NCT01190930|615960382|FG001|Induction|Adverse Event|0|||
170442799|NCT01190930|615960383|FG002|Induction|Adverse Event|0|||
170442800|NCT01190930|615960384|FG003|Induction|Adverse Event|0|||
170442801|NCT01190930|615960385|FG004|Induction|Adverse Event|0|||
170442802|NCT01190930|615960386|FG005|Induction|Adverse Event|0|||
170442803|NCT01190930|615960387|FG006|Induction|Adverse Event|0|||
170442804|NCT01190930|615960388|FG007|Induction|Adverse Event|0|||
170442805|NCT01190930|615960389|FG008|Induction|Adverse Event|0|||
170442806|NCT01190930|615960390|FG009|Induction|Adverse Event|0|||
170442807|NCT01190930|615960381|FG000|Induction|Death|34|||
170442808|NCT01190930|615960382|FG001|Induction|Death|0|||
170442809|NCT01190930|615960383|FG002|Induction|Death|0|||
170442810|NCT01190930|615960384|FG003|Induction|Death|0|||
170442811|NCT01190930|615960385|FG004|Induction|Death|0|||
170442812|NCT01190930|615960386|FG005|Induction|Death|0|||
170442813|NCT01190930|615960387|FG006|Induction|Death|0|||
170442814|NCT01190930|615960388|FG007|Induction|Death|0|||
170442815|NCT01190930|615960389|FG008|Induction|Death|0|||
170442816|NCT01190930|615960390|FG009|Induction|Death|0|||
170442817|NCT01190930|615960381|FG000|Induction|Lost to Follow-up|1|||
170442818|NCT01190930|615960382|FG001|Induction|Lost to Follow-up|0|||
170442819|NCT01190930|615960383|FG002|Induction|Lost to Follow-up|0|||
170442820|NCT01190930|615960384|FG003|Induction|Lost to Follow-up|0|||
170442821|NCT01190930|615960385|FG004|Induction|Lost to Follow-up|0|||
170442822|NCT01190930|615960386|FG005|Induction|Lost to Follow-up|0|||
170442823|NCT01190930|615960387|FG006|Induction|Lost to Follow-up|0|||
170442824|NCT01190930|615960388|FG007|Induction|Lost to Follow-up|0|||
170442825|NCT01190930|615960389|FG008|Induction|Lost to Follow-up|0|||
170442826|NCT01190930|615960390|FG009|Induction|Lost to Follow-up|0|||
170442827|NCT01190930|615960381|FG000|Induction|Physician Decision|125|||
170442828|NCT01190930|615960382|FG001|Induction|Physician Decision|3|||
170442829|NCT01190930|615960383|FG002|Induction|Physician Decision|0|||
170442830|NCT01190930|615960384|FG003|Induction|Physician Decision|0|||
170442831|NCT01190930|615960385|FG004|Induction|Physician Decision|0|||
170442832|NCT01190930|615960386|FG005|Induction|Physician Decision|0|||
170442833|NCT01190930|615960387|FG006|Induction|Physician Decision|0|||
170442834|NCT01190930|615960388|FG007|Induction|Physician Decision|0|||
170442835|NCT01190930|615960389|FG008|Induction|Physician Decision|0|||
170442836|NCT01190930|615960390|FG009|Induction|Physician Decision|0|||
170442837|NCT01190930|615960381|FG000|Induction|Withdrawal by Subject|9|||
170442838|NCT01190930|615960382|FG001|Induction|Withdrawal by Subject|0|||
170442839|NCT01190930|615960383|FG002|Induction|Withdrawal by Subject|0|||
170442840|NCT01190930|615960384|FG003|Induction|Withdrawal by Subject|0|||
170442841|NCT01190930|615960385|FG004|Induction|Withdrawal by Subject|0|||
170442842|NCT01190930|615960386|FG005|Induction|Withdrawal by Subject|0|||
170442843|NCT01190930|615960387|FG006|Induction|Withdrawal by Subject|0|||
170442844|NCT01190930|615960388|FG007|Induction|Withdrawal by Subject|0|||
170442845|NCT01190930|615960389|FG008|Induction|Withdrawal by Subject|0|||
170442846|NCT01190930|615960390|FG009|Induction|Withdrawal by Subject|0|||
170442847|NCT01190930|615960381|FG000|Induction|Refusal|235|||
170442848|NCT01190930|615960382|FG001|Induction|Refusal|0|||
170442849|NCT01190930|615960383|FG002|Induction|Refusal|0|||
170442850|NCT01190930|615960384|FG003|Induction|Refusal|0|||
170442851|NCT01190930|615960385|FG004|Induction|Refusal|0|||
170538701|NCT04063163|616315734|FG000|Overall Study|Withdrawal by Subject|19|||
170538702|NCT04063163|616315735|FG001|Overall Study|Withdrawal by Subject|10|||
170442852|NCT01190930|615960386|FG005|Induction|Refusal|0|||
170442853|NCT01190930|615960387|FG006|Induction|Refusal|0|||
170442854|NCT01190930|615960388|FG007|Induction|Refusal|0|||
170442855|NCT01190930|615960389|FG008|Induction|Refusal|0|||
170442856|NCT01190930|615960390|FG009|Induction|Refusal|0|||
170442857|NCT01190930|615960381|FG000|Induction|Inevaluable|23|||
170442858|NCT01190930|615960382|FG001|Induction|Inevaluable|1|||
170442859|NCT01190930|615960383|FG002|Induction|Inevaluable|0|||
170442860|NCT01190930|615960384|FG003|Induction|Inevaluable|0|||
170442861|NCT01190930|615960385|FG004|Induction|Inevaluable|0|||
170442862|NCT01190930|615960386|FG005|Induction|Inevaluable|0|||
170442863|NCT01190930|615960387|FG006|Induction|Inevaluable|0|||
170442864|NCT01190930|615960388|FG007|Induction|Inevaluable|0|||
170442865|NCT01190930|615960389|FG008|Induction|Inevaluable|0|||
170442866|NCT01190930|615960390|FG009|Induction|Inevaluable|0|||
170442867|NCT01190930|615960381|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
170442868|NCT01190930|615960382|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442869|NCT01190930|615960383|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442870|NCT01190930|615960384|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442871|NCT01190930|615960385|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442872|NCT01190930|615960386|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442873|NCT01190930|615960387|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442874|NCT01190930|615960388|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442875|NCT01190930|615960389|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442876|NCT01190930|615960390|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
170442877|NCT01190930|615960381|FG000|Induction|High Risk Downs|80|||
170442878|NCT01190930|615960382|FG001|Induction|High Risk Downs|0|||
170442879|NCT01190930|615960383|FG002|Induction|High Risk Downs|0|||
170442880|NCT01190930|615960384|FG003|Induction|High Risk Downs|0|||
170442881|NCT01190930|615960385|FG004|Induction|High Risk Downs|0|||
170442882|NCT01190930|615960386|FG005|Induction|High Risk Downs|0|||
170442883|NCT01190930|615960387|FG006|Induction|High Risk Downs|0|||
170442884|NCT01190930|615960388|FG007|Induction|High Risk Downs|0|||
170442885|NCT01190930|615960389|FG008|Induction|High Risk Downs|0|||
170442886|NCT01190930|615960390|FG009|Induction|High Risk Downs|0|||
170442887|NCT01190930|615960381|FG000|Induction|Enrollment onto another COG Protocol|1|||
170785431|NCT02105766|617221457|FG002|Overall Study|Death|0|||
170442888|NCT01190930|615960382|FG001|Induction|Enrollment onto another COG Protocol|0|||
170442889|NCT01190930|615960383|FG002|Induction|Enrollment onto another COG Protocol|0|||
170442890|NCT01190930|615960384|FG003|Induction|Enrollment onto another COG Protocol|0|||
170442891|NCT01190930|615960385|FG004|Induction|Enrollment onto another COG Protocol|0|||
170442892|NCT01190930|615960386|FG005|Induction|Enrollment onto another COG Protocol|0|||
170442893|NCT01190930|615960387|FG006|Induction|Enrollment onto another COG Protocol|0|||
170442894|NCT01190930|615960388|FG007|Induction|Enrollment onto another COG Protocol|0|||
170442895|NCT01190930|615960389|FG008|Induction|Enrollment onto another COG Protocol|0|||
170442896|NCT01190930|615960390|FG009|Induction|Enrollment onto another COG Protocol|0|||
170442897|NCT01190930|615960381|FG000|Induction|Average Risk|1847|||
170442898|NCT01190930|615960382|FG001|Induction|Average Risk|0|||
170442899|NCT01190930|615960383|FG002|Induction|Average Risk|0|||
170442900|NCT01190930|615960384|FG003|Induction|Average Risk|0|||
170442901|NCT01190930|615960385|FG004|Induction|Average Risk|0|||
170442902|NCT01190930|615960386|FG005|Induction|Average Risk|0|||
170442903|NCT01190930|615960387|FG006|Induction|Average Risk|0|||
170442904|NCT01190930|615960388|FG007|Induction|Average Risk|0|||
170442905|NCT01190930|615960389|FG008|Induction|Average Risk|0|||
170442906|NCT01190930|615960390|FG009|Induction|Average Risk|0|||
170442907|NCT01190930|615960381|FG000|Induction|High Risk|1227|||
170442908|NCT01190930|615960382|FG001|Induction|High Risk|0|||
170442909|NCT01190930|615960383|FG002|Induction|High Risk|0|||
170442910|NCT01190930|615960384|FG003|Induction|High Risk|0|||
170442911|NCT01190930|615960385|FG004|Induction|High Risk|0|||
170442912|NCT01190930|615960386|FG005|Induction|High Risk|0|||
170442913|NCT01190930|615960387|FG006|Induction|High Risk|0|||
170442914|NCT01190930|615960388|FG007|Induction|High Risk|0|||
170442915|NCT01190930|615960389|FG008|Induction|High Risk|0|||
170442916|NCT01190930|615960390|FG009|Induction|High Risk|0|||
170442917|NCT01190930|615960381|FG000|Induction|Low Risk|443|||
170442918|NCT01190930|615960382|FG001|Induction|Low Risk|0|||
170442919|NCT01190930|615960383|FG002|Induction|Low Risk|0|||
170442920|NCT01190930|615960384|FG003|Induction|Low Risk|0|||
170442921|NCT01190930|615960385|FG004|Induction|Low Risk|0|||
170442922|NCT01190930|615960386|FG005|Induction|Low Risk|0|||
170442923|NCT01190930|615960387|FG006|Induction|Low Risk|0|||
170442924|NCT01190930|615960388|FG007|Induction|Low Risk|0|||
170442925|NCT01190930|615960389|FG008|Induction|Low Risk|0|||
170442926|NCT01190930|615960390|FG009|Induction|Low Risk|0|||
170442927|NCT01190930|615960381|FG000|Induction|Very High Risk|1012|||
170442928|NCT01190930|615960382|FG001|Induction|Very High Risk|0|||
170442929|NCT01190930|615960383|FG002|Induction|Very High Risk|0|||
170442930|NCT01190930|615960384|FG003|Induction|Very High Risk|0|||
170442931|NCT01190930|615960385|FG004|Induction|Very High Risk|0|||
170442932|NCT01190930|615960386|FG005|Induction|Very High Risk|0|||
170442933|NCT01190930|615960387|FG006|Induction|Very High Risk|0|||
170442934|NCT01190930|615960388|FG007|Induction|Very High Risk|0|||
170442935|NCT01190930|615960389|FG008|Induction|Very High Risk|0|||
170442936|NCT01190930|615960390|FG009|Induction|Very High Risk|0|||
170442937|NCT01190930|615960381|FG000|Induction|Philadelphia chromosome-positive|99|||
170442938|NCT01190930|615960382|FG001|Induction|Philadelphia chromosome-positive|0|||
170442939|NCT01190930|615960383|FG002|Induction|Philadelphia chromosome-positive|0|||
170442940|NCT01190930|615960384|FG003|Induction|Philadelphia chromosome-positive|0|||
170442941|NCT01190930|615960385|FG004|Induction|Philadelphia chromosome-positive|0|||
170442942|NCT01190930|615960386|FG005|Induction|Philadelphia chromosome-positive|0|||
170442943|NCT01190930|615960387|FG006|Induction|Philadelphia chromosome-positive|0|||
170442944|NCT01190930|615960388|FG007|Induction|Philadelphia chromosome-positive|0|||
170442945|NCT01190930|615960389|FG008|Induction|Philadelphia chromosome-positive|0|||
170633147|NCT01746901|616668463|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
170633148|NCT01746901|616668464|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
170785432|NCT00554788|617221458|FG000|Overall Study|Adverse Event|0|||
170442946|NCT01190930|615960390|FG009|Induction|Philadelphia chromosome-positive|0|||
170442947|NCT01190930|615960381|FG000|Induction|Incomplete Induction data|63|||
170442948|NCT01190930|615960382|FG001|Induction|Incomplete Induction data|0|||
170442949|NCT01190930|615960383|FG002|Induction|Incomplete Induction data|0|||
170442950|NCT01190930|615960384|FG003|Induction|Incomplete Induction data|0|||
170442951|NCT01190930|615960385|FG004|Induction|Incomplete Induction data|0|||
170442952|NCT01190930|615960386|FG005|Induction|Incomplete Induction data|0|||
170442953|NCT01190930|615960387|FG006|Induction|Incomplete Induction data|0|||
170442954|NCT01190930|615960388|FG007|Induction|Incomplete Induction data|0|||
170442955|NCT01190930|615960389|FG008|Induction|Incomplete Induction data|0|||
170442956|NCT01190930|615960390|FG009|Induction|Incomplete Induction data|0|||
170442957|NCT01190930|615960381|FG000|Induction|Progressive disease|0|||
170442958|NCT01190930|615960382|FG001|Induction|Progressive disease|1|||
170442959|NCT01190930|615960383|FG002|Induction|Progressive disease|0|||
170442960|NCT01190930|615960384|FG003|Induction|Progressive disease|0|||
170442961|NCT01190930|615960385|FG004|Induction|Progressive disease|0|||
170442962|NCT01190930|615960386|FG005|Induction|Progressive disease|0|||
170442963|NCT01190930|615960387|FG006|Induction|Progressive disease|0|||
170442964|NCT01190930|615960388|FG007|Induction|Progressive disease|0|||
170442965|NCT01190930|615960389|FG008|Induction|Progressive disease|0|||
170442966|NCT01190930|615960390|FG009|Induction|Progressive disease|0|||
170442967|NCT01190930|615960381|FG000|Induction|No treatment|3|||
170442968|NCT01190930|615960382|FG001|Induction|No treatment|0|||
170442969|NCT01190930|615960383|FG002|Induction|No treatment|0|||
170442970|NCT01190930|615960384|FG003|Induction|No treatment|0|||
170442971|NCT01190930|615960385|FG004|Induction|No treatment|0|||
170442972|NCT01190930|615960386|FG005|Induction|No treatment|0|||
170442973|NCT01190930|615960387|FG006|Induction|No treatment|0|||
170442974|NCT01190930|615960388|FG007|Induction|No treatment|0|||
170442975|NCT01190930|615960389|FG008|Induction|No treatment|0|||
170442976|NCT01190930|615960390|FG009|Induction|No treatment|0|||
170442977|NCT01190930|615960381|FG000|Induction|Ineligible|69|||
170442978|NCT01190930|615960382|FG001|Induction|Ineligible|4|||
170442979|NCT01190930|615960383|FG002|Induction|Ineligible|0|||
170442980|NCT01190930|615960384|FG003|Induction|Ineligible|0|||
170442981|NCT01190930|615960385|FG004|Induction|Ineligible|0|||
170442982|NCT01190930|615960386|FG005|Induction|Ineligible|0|||
170442983|NCT01190930|615960387|FG006|Induction|Ineligible|0|||
170442984|NCT01190930|615960388|FG007|Induction|Ineligible|0|||
170442985|NCT01190930|615960389|FG008|Induction|Ineligible|0|||
170442986|NCT01190930|615960390|FG009|Induction|Ineligible|0|||
170442987|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
170442988|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
170442989|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
170442990|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
170442991|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
170442992|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
170442993|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
170442994|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
170442995|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
170442996|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
170442997|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|Death|0|||
170442998|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|Death|0|||
170442999|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|Death|8|||
170443000|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|Death|4|||
170443001|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|Death|0|||
170443002|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|Death|0|||
170443003|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|Death|0|||
170443004|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|Death|0|||
170443005|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|Death|0|||
170443006|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|Death|0|||
170443007|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
170443008|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
170443009|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
170443010|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
170443011|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
170443012|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
170443013|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
170443014|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
170443015|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
170443016|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
170443017|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
170443018|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
170443019|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
170443020|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
170443021|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
170443022|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
170443023|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
170538703|NCT05845619|616315739|FG000|Overall Study|duplicate enrollment|2|||
170785433|NCT00554788|617221459|FG001|Overall Study|Adverse Event|1|||
170443024|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
170443025|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
170443026|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
170443027|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|Refusal|0|||
170443028|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|Refusal|2|||
170443029|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|Refusal|694|||
170443030|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|Refusal|4|||
170443031|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|Refusal|0|||
170443032|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|Refusal|3|||
170443033|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|Refusal|0|||
170443034|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|Refusal|0|||
170443035|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|Refusal|0|||
170443036|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|Refusal|0|||
170443037|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
170443038|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
170443039|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
170443040|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
170443041|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
170443042|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
170443043|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
170443044|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
170443045|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
170443046|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
170443047|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443048|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
170443049|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443050|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443051|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443052|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443053|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443054|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443055|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443056|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
170443057|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
170443058|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
170443059|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
170443060|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
170443061|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
170443062|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
170443063|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
170443064|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
170443065|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
170443066|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
170443067|NCT01190930|615960381|FG000|Post Induction Pre-Maintenance|Relapse|0|||
170443068|NCT01190930|615960382|FG001|Post Induction Pre-Maintenance|Relapse|0|||
170443069|NCT01190930|615960383|FG002|Post Induction Pre-Maintenance|Relapse|1|||
170443070|NCT01190930|615960384|FG003|Post Induction Pre-Maintenance|Relapse|0|||
170443071|NCT01190930|615960385|FG004|Post Induction Pre-Maintenance|Relapse|0|||
170443072|NCT01190930|615960386|FG005|Post Induction Pre-Maintenance|Relapse|0|||
170443073|NCT01190930|615960387|FG006|Post Induction Pre-Maintenance|Relapse|0|||
170443074|NCT01190930|615960388|FG007|Post Induction Pre-Maintenance|Relapse|0|||
170443075|NCT01190930|615960389|FG008|Post Induction Pre-Maintenance|Relapse|0|||
170443076|NCT01190930|615960390|FG009|Post Induction Pre-Maintenance|Relapse|0|||
170443077|NCT01190930|615960381|FG000|Maintenance|Adverse Event|0|||
170443078|NCT01190930|615960382|FG001|Maintenance|Adverse Event|0|||
170443079|NCT01190930|615960383|FG002|Maintenance|Adverse Event|0|||
170443080|NCT01190930|615960384|FG003|Maintenance|Adverse Event|0|||
170443081|NCT01190930|615960385|FG004|Maintenance|Adverse Event|0|||
170443082|NCT01190930|615960386|FG005|Maintenance|Adverse Event|1|||
170443083|NCT01190930|615960387|FG006|Maintenance|Adverse Event|1|||
170538704|NCT05845619|616315740|FG001|Overall Study|duplicate enrollment|2|||
170538705|NCT05845619|616315741|FG002|Overall Study|duplicate enrollment|1|||
170538706|NCT05168800|616315752|FG000|Time 1 Survey|Did not start T1 survey|182|||
170443084|NCT01190930|615960388|FG007|Maintenance|Adverse Event|3|||
170443085|NCT01190930|615960389|FG008|Maintenance|Adverse Event|3|||
170443086|NCT01190930|615960390|FG009|Maintenance|Adverse Event|0|||
170443087|NCT01190930|615960381|FG000|Maintenance|Death|0|||
170443088|NCT01190930|615960382|FG001|Maintenance|Death|0|||
170443089|NCT01190930|615960383|FG002|Maintenance|Death|0|||
170443090|NCT01190930|615960384|FG003|Maintenance|Death|1|||
170443091|NCT01190930|615960385|FG004|Maintenance|Death|0|||
170443092|NCT01190930|615960386|FG005|Maintenance|Death|0|||
170443093|NCT01190930|615960387|FG006|Maintenance|Death|2|||
170443094|NCT01190930|615960388|FG007|Maintenance|Death|2|||
170443095|NCT01190930|615960389|FG008|Maintenance|Death|2|||
170443096|NCT01190930|615960390|FG009|Maintenance|Death|2|||
170443097|NCT01190930|615960381|FG000|Maintenance|Lost to Follow-up|0|||
170443098|NCT01190930|615960382|FG001|Maintenance|Lost to Follow-up|0|||
170443099|NCT01190930|615960383|FG002|Maintenance|Lost to Follow-up|0|||
170443100|NCT01190930|615960384|FG003|Maintenance|Lost to Follow-up|0|||
170443101|NCT01190930|615960385|FG004|Maintenance|Lost to Follow-up|0|||
170443102|NCT01190930|615960386|FG005|Maintenance|Lost to Follow-up|0|||
170443103|NCT01190930|615960387|FG006|Maintenance|Lost to Follow-up|1|||
170443104|NCT01190930|615960388|FG007|Maintenance|Lost to Follow-up|1|||
170443105|NCT01190930|615960389|FG008|Maintenance|Lost to Follow-up|1|||
170443106|NCT01190930|615960390|FG009|Maintenance|Lost to Follow-up|0|||
170443107|NCT01190930|615960381|FG000|Maintenance|Physician Decision|0|||
170443108|NCT01190930|615960382|FG001|Maintenance|Physician Decision|1|||
170443109|NCT01190930|615960383|FG002|Maintenance|Physician Decision|0|||
170443110|NCT01190930|615960384|FG003|Maintenance|Physician Decision|5|||
170443111|NCT01190930|615960385|FG004|Maintenance|Physician Decision|9|||
170443112|NCT01190930|615960386|FG005|Maintenance|Physician Decision|4|||
170443113|NCT01190930|615960387|FG006|Maintenance|Physician Decision|8|||
170443114|NCT01190930|615960388|FG007|Maintenance|Physician Decision|8|||
170443115|NCT01190930|615960389|FG008|Maintenance|Physician Decision|10|||
170443116|NCT01190930|615960390|FG009|Maintenance|Physician Decision|17|||
170443117|NCT01190930|615960381|FG000|Maintenance|Withdrawal by Subject|0|||
170443118|NCT01190930|615960382|FG001|Maintenance|Withdrawal by Subject|0|||
170443119|NCT01190930|615960383|FG002|Maintenance|Withdrawal by Subject|0|||
170443120|NCT01190930|615960384|FG003|Maintenance|Withdrawal by Subject|0|||
170443121|NCT01190930|615960385|FG004|Maintenance|Withdrawal by Subject|0|||
170443122|NCT01190930|615960386|FG005|Maintenance|Withdrawal by Subject|0|||
170443123|NCT01190930|615960387|FG006|Maintenance|Withdrawal by Subject|2|||
170443124|NCT01190930|615960388|FG007|Maintenance|Withdrawal by Subject|1|||
170443125|NCT01190930|615960389|FG008|Maintenance|Withdrawal by Subject|4|||
170443126|NCT01190930|615960390|FG009|Maintenance|Withdrawal by Subject|1|||
170443127|NCT01190930|615960381|FG000|Maintenance|Refusal|0|||
170443128|NCT01190930|615960382|FG001|Maintenance|Refusal|1|||
170443129|NCT01190930|615960383|FG002|Maintenance|Refusal|0|||
170443130|NCT01190930|615960384|FG003|Maintenance|Refusal|2|||
170443131|NCT01190930|615960385|FG004|Maintenance|Refusal|0|||
170443132|NCT01190930|615960386|FG005|Maintenance|Refusal|4|||
170443133|NCT01190930|615960387|FG006|Maintenance|Refusal|5|||
170443134|NCT01190930|615960388|FG007|Maintenance|Refusal|17|||
170443135|NCT01190930|615960389|FG008|Maintenance|Refusal|13|||
170443136|NCT01190930|615960390|FG009|Maintenance|Refusal|6|||
170443137|NCT01190930|615960381|FG000|Maintenance|second malignant neoplasm|0|||
170443138|NCT01190930|615960382|FG001|Maintenance|second malignant neoplasm|0|||
170443139|NCT01190930|615960383|FG002|Maintenance|second malignant neoplasm|0|||
170443140|NCT01190930|615960384|FG003|Maintenance|second malignant neoplasm|1|||
170443141|NCT01190930|615960385|FG004|Maintenance|second malignant neoplasm|0|||
170443142|NCT01190930|615960386|FG005|Maintenance|second malignant neoplasm|1|||
170443143|NCT01190930|615960387|FG006|Maintenance|second malignant neoplasm|0|||
170443144|NCT01190930|615960388|FG007|Maintenance|second malignant neoplasm|0|||
170443145|NCT01190930|615960389|FG008|Maintenance|second malignant neoplasm|1|||
170443146|NCT01190930|615960390|FG009|Maintenance|second malignant neoplasm|0|||
170443147|NCT01190930|615960381|FG000|Maintenance|Inevaluable|0|||
170443148|NCT01190930|615960382|FG001|Maintenance|Inevaluable|0|||
170443149|NCT01190930|615960383|FG002|Maintenance|Inevaluable|0|||
170443150|NCT01190930|615960384|FG003|Maintenance|Inevaluable|0|||
170443151|NCT01190930|615960385|FG004|Maintenance|Inevaluable|0|||
170443152|NCT01190930|615960386|FG005|Maintenance|Inevaluable|1|||
170443153|NCT01190930|615960387|FG006|Maintenance|Inevaluable|1|||
170443154|NCT01190930|615960388|FG007|Maintenance|Inevaluable|1|||
170443155|NCT01190930|615960389|FG008|Maintenance|Inevaluable|0|||
170443156|NCT01190930|615960390|FG009|Maintenance|Inevaluable|0|||
170443157|NCT01190930|615960381|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
170443158|NCT01190930|615960382|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
170443159|NCT01190930|615960383|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
170443160|NCT01190930|615960384|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
170443161|NCT01190930|615960385|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
170443162|NCT01190930|615960386|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
170443163|NCT01190930|615960387|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
170443164|NCT01190930|615960388|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
170443165|NCT01190930|615960389|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
170443166|NCT01190930|615960390|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
170538707|NCT05168800|616315753|FG001|Time 1 Survey|Did not start T1 survey|150|||
170443167|NCT01190930|615960381|FG000|Maintenance|Relapse|0|||
170443168|NCT01190930|615960382|FG001|Maintenance|Relapse|0|||
170443169|NCT01190930|615960383|FG002|Maintenance|Relapse|0|||
170443170|NCT01190930|615960384|FG003|Maintenance|Relapse|2|||
170443171|NCT01190930|615960385|FG004|Maintenance|Relapse|0|||
170443172|NCT01190930|615960386|FG005|Maintenance|Relapse|1|||
170443173|NCT01190930|615960387|FG006|Maintenance|Relapse|6|||
170443174|NCT01190930|615960388|FG007|Maintenance|Relapse|13|||
170443175|NCT01190930|615960389|FG008|Maintenance|Relapse|11|||
170443176|NCT01190930|615960390|FG009|Maintenance|Relapse|11|||
170443177|NCT01190930|615960381|FG000|Maintenance|Still on therapy|0|||
170443178|NCT01190930|615960382|FG001|Maintenance|Still on therapy|8|||
170443179|NCT01190930|615960383|FG002|Maintenance|Still on therapy|0|||
170443180|NCT01190930|615960384|FG003|Maintenance|Still on therapy|29|||
170443181|NCT01190930|615960385|FG004|Maintenance|Still on therapy|0|||
170443182|NCT01190930|615960386|FG005|Maintenance|Still on therapy|0|||
170443183|NCT01190930|615960387|FG006|Maintenance|Still on therapy|0|||
170443184|NCT01190930|615960388|FG007|Maintenance|Still on therapy|0|||
170443185|NCT01190930|615960389|FG008|Maintenance|Still on therapy|0|||
170443186|NCT01190930|615960390|FG009|Maintenance|Still on therapy|0|||
170443187|NCT01886872|615960391|FG000|Overall Study|Ineligible|7|||
170443188|NCT01886872|615960392|FG001|Overall Study|Ineligible|4|||
170443189|NCT01886872|615960393|FG002|Overall Study|Ineligible|12|||
170443190|NCT05148299|615960394|FG000|Treatment Period|Adverse Event|1|||
170443191|NCT05148299|615960394|FG000|Treatment Period|Physician Decision|1|||
170443192|NCT05148299|615960394|FG000|Treatment Period|Death|1|||
170443193|NCT05148299|615960394|FG000|Follow-up Period|Death|3|||
170443194|NCT02161549|615960398|FG000|Overall Study|Physician Decision|6|||
170443195|NCT02161549|615960399|FG001|Overall Study|Physician Decision|2|||
170443196|NCT00979212|615960400|FG000|Overall Study|Protocol Violation|1|||
170443197|NCT00979212|615960401|FG001|Overall Study|Protocol Violation|8|||
170443198|NCT00979212|615960400|FG000|Overall Study|No protocol therapy received|1|||
170443199|NCT00979212|615960401|FG001|Overall Study|No protocol therapy received|0|||
170443200|NCT00337428|615960402|FG000|Overall Study|Withdrawal by Subject|1|||
170443201|NCT00337428|615960403|FG001|Overall Study|Withdrawal by Subject|2|||
170443202|NCT00337428|615960402|FG000|Overall Study|Lack of Time|1|||
170443203|NCT00337428|615960403|FG001|Overall Study|Lack of Time|1|||
170443204|NCT00337428|615960402|FG000|Overall Study|Unwilling to Continue|1|||
170443205|NCT00337428|615960403|FG001|Overall Study|Unwilling to Continue|0|||
170443206|NCT00337428|615960402|FG000|Overall Study|Anorexia|1|||
170443207|NCT00337428|615960403|FG001|Overall Study|Anorexia|0|||
170443208|NCT02418455|615960404|FG000|48-Week Treatment Period|Other- Not Specified|1|||
170443209|NCT02418455|615960404|FG000|Continuation Period|Sponsor Decision|7|||
170443210|NCT04886063|615960405|FG000|Overall Study|Adverse Event|50|||
170443211|NCT04886063|615960405|FG000|Overall Study|Lack of Efficacy|31|||
170443212|NCT04886063|615960405|FG000|Overall Study|Withdrawal by Subject|45|||
170443213|NCT04886063|615960405|FG000|Overall Study|Physician Decision|3|||
170443214|NCT04886063|615960405|FG000|Overall Study|Protocol Violation|3|||
170443215|NCT04886063|615960405|FG000|Overall Study|Site closure|4|||
170443216|NCT04886063|615960405|FG000|Overall Study|Nursing home replacement|3|||
170443217|NCT04886063|615960405|FG000|Overall Study|Lost to Follow-up|5|||
170443218|NCT04886063|615960405|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
170443219|NCT04886063|615960405|FG000|Overall Study|>1 reason|20|||
170443220|NCT00965757|615960406|FG000|Double-blind Phase|Progression of concomitant disease|1|||
170443221|NCT00965757|615960407|FG001|Double-blind Phase|Progression of concomitant disease|2|||
170443222|NCT00965757|615960408|FG002|Double-blind Phase|Progression of concomitant disease|0|||
170443223|NCT00965757|615960409|FG003|Double-blind Phase|Progression of concomitant disease|0|||
170443224|NCT00965757|615960406|FG000|Double-blind Phase|Adverse drug reaction|2|||
170443225|NCT00965757|615960407|FG001|Double-blind Phase|Adverse drug reaction|1|||
170443226|NCT00965757|615960408|FG002|Double-blind Phase|Adverse drug reaction|0|||
170538708|NCT05168800|616315754|FG002|Time 1 Survey|Did not start T1 survey|140|||
170538709|NCT05168800|616315752|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
170538710|NCT05168800|616315753|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
170538711|NCT05168800|616315754|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
170538712|NCT05168800|616315752|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
170538713|NCT05168800|616315753|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
170538714|NCT05168800|616315754|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
170538715|NCT05168800|616315752|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
170538716|NCT05168800|616315753|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
170538717|NCT05168800|616315754|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
170538718|NCT05168800|616315752|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
170443227|NCT00965757|615960409|FG003|Double-blind Phase|Adverse drug reaction|0|||
170443228|NCT00965757|615960406|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
170443229|NCT00965757|615960407|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
170443230|NCT00965757|615960408|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
170443231|NCT00965757|615960409|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
170538719|NCT05168800|616315753|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
170443232|NCT00965757|615960406|FG000|Double-blind Phase|Lack of Efficacy|7|||
170443233|NCT00965757|615960407|FG001|Double-blind Phase|Lack of Efficacy|11|||
170443234|NCT00965757|615960408|FG002|Double-blind Phase|Lack of Efficacy|0|||
170443235|NCT00965757|615960409|FG003|Double-blind Phase|Lack of Efficacy|0|||
170443236|NCT00965757|615960406|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
170538720|NCT05168800|616315754|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
170538721|NCT05168800|616315752|FG000|Time 1 Survey|Withdrawal by Subject|6|||
170538722|NCT05168800|616315753|FG001|Time 1 Survey|Withdrawal by Subject|3|||
170538723|NCT05168800|616315754|FG002|Time 1 Survey|Withdrawal by Subject|2|||
170538724|NCT05168800|616315752|FG000|Time 2 Survey|Already excluded at Time 1|228|||
170538725|NCT05168800|616315753|FG001|Time 2 Survey|Already excluded at Time 1|202|||
170538726|NCT05168800|616315754|FG002|Time 2 Survey|Already excluded at Time 1|173|||
170538727|NCT05168800|616315752|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
170443237|NCT00965757|615960407|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
170443238|NCT00965757|615960408|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
170443239|NCT00965757|615960409|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
170443240|NCT00965757|615960406|FG000|Double-blind Phase|Lost to Follow-up|0|||
170443241|NCT00965757|615960407|FG001|Double-blind Phase|Lost to Follow-up|1|||
170443242|NCT00965757|615960408|FG002|Double-blind Phase|Lost to Follow-up|0|||
170443243|NCT00965757|615960409|FG003|Double-blind Phase|Lost to Follow-up|0|||
170443244|NCT00965757|615960406|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
170443245|NCT00965757|615960407|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
170443246|NCT00965757|615960408|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
170443247|NCT00965757|615960409|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
170443248|NCT00965757|615960406|FG000|Double-blind Phase|Other|1|||
170443249|NCT00965757|615960407|FG001|Double-blind Phase|Other|0|||
170443250|NCT00965757|615960408|FG002|Double-blind Phase|Other|0|||
170443251|NCT00965757|615960409|FG003|Double-blind Phase|Other|0|||
170443252|NCT00965757|615960406|FG000|Extension Phase|Progression of concomitant disease|0|||
170443253|NCT00965757|615960407|FG001|Extension Phase|Progression of concomitant disease|0|||
170443254|NCT00965757|615960408|FG002|Extension Phase|Progression of concomitant disease|4|||
170443255|NCT00965757|615960409|FG003|Extension Phase|Progression of concomitant disease|2|||
170443256|NCT00965757|615960406|FG000|Extension Phase|Adverse drug reaction|0|||
170443257|NCT00965757|615960407|FG001|Extension Phase|Adverse drug reaction|0|||
170443258|NCT00965757|615960408|FG002|Extension Phase|Adverse drug reaction|6|||
170443259|NCT00965757|615960409|FG003|Extension Phase|Adverse drug reaction|3|||
170443260|NCT00965757|615960406|FG000|Extension Phase|Abnormal Laboratory Value|0|||
170443261|NCT00965757|615960407|FG001|Extension Phase|Abnormal Laboratory Value|0|||
170443262|NCT00965757|615960408|FG002|Extension Phase|Abnormal Laboratory Value|6|||
170443263|NCT00965757|615960409|FG003|Extension Phase|Abnormal Laboratory Value|1|||
170443264|NCT00965757|615960406|FG000|Extension Phase|Lack of Efficacy|0|||
170443265|NCT00965757|615960407|FG001|Extension Phase|Lack of Efficacy|0|||
170443266|NCT00965757|615960408|FG002|Extension Phase|Lack of Efficacy|8|||
170443267|NCT00965757|615960409|FG003|Extension Phase|Lack of Efficacy|12|||
170443268|NCT00965757|615960406|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
170443269|NCT00965757|615960407|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
170443270|NCT00965757|615960408|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
170443271|NCT00965757|615960409|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
170443272|NCT00965757|615960406|FG000|Extension Phase|Lost to Follow-up|0|||
170443273|NCT00965757|615960407|FG001|Extension Phase|Lost to Follow-up|0|||
170443274|NCT00965757|615960408|FG002|Extension Phase|Lost to Follow-up|0|||
170443275|NCT00965757|615960409|FG003|Extension Phase|Lost to Follow-up|1|||
170443276|NCT00965757|615960406|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
170443277|NCT00965757|615960407|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
170443278|NCT00965757|615960408|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
170443279|NCT00965757|615960409|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
170443280|NCT00965757|615960406|FG000|Extension Phase|Protocol Violation|0|||
170443281|NCT00965757|615960407|FG001|Extension Phase|Protocol Violation|0|||
170443282|NCT00965757|615960408|FG002|Extension Phase|Protocol Violation|0|||
170443283|NCT00965757|615960409|FG003|Extension Phase|Protocol Violation|1|||
170443284|NCT00965757|615960406|FG000|Extension Phase|Other|0|||
170785434|NCT00554788|617221460|FG002|Overall Study|Adverse Event|2|||
170443285|NCT00965757|615960407|FG001|Extension Phase|Other|0|||
170443286|NCT00965757|615960408|FG002|Extension Phase|Other|2|||
170443287|NCT00965757|615960409|FG003|Extension Phase|Other|1|||
170443288|NCT03807440|615960410|FG000|Overall Study|No documentation of index date 2|320|||
170443289|NCT03807440|615960410|FG000|Overall Study|No informed consent for index date 2|117|||
170443290|NCT02308696|615960420|FG000|Overall Study|Lost to Follow-up|28|||
170443291|NCT02308696|615960421|FG001|Overall Study|Lost to Follow-up|21|||
170443292|NCT02308696|615960420|FG000|Overall Study|Death|8|||
170443293|NCT02308696|615960421|FG001|Overall Study|Death|4|||
170443294|NCT02308696|615960420|FG000|Overall Study|Moved to a Higher Level of Care|17|||
170443295|NCT02308696|615960421|FG001|Overall Study|Moved to a Higher Level of Care|6|||
170443296|NCT02760433|615960424|FG000|Overall Study|Lost to Follow-up|1|||
170443297|NCT02760433|615960425|FG001|Overall Study|Lost to Follow-up|0|||
170443298|NCT02760433|615960426|FG002|Overall Study|Lost to Follow-up|1|||
170443299|NCT02760433|615960427|FG003|Overall Study|Lost to Follow-up|0|||
170443300|NCT02760433|615960428|FG004|Overall Study|Lost to Follow-up|0|||
170443301|NCT02760433|615960424|FG000|Overall Study|Withdrawal by Subject|23|||
170443302|NCT02760433|615960425|FG001|Overall Study|Withdrawal by Subject|9|||
170443303|NCT02760433|615960426|FG002|Overall Study|Withdrawal by Subject|0|||
170443304|NCT02760433|615960427|FG003|Overall Study|Withdrawal by Subject|2|||
170443305|NCT02760433|615960428|FG004|Overall Study|Withdrawal by Subject|9|||
170443306|NCT02760433|615960424|FG000|Overall Study|Lack of Response At Week 14|0|||
170538728|NCT05168800|616315753|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
170538729|NCT05168800|616315754|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
170538730|NCT05168800|616315752|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
170443307|NCT02760433|615960425|FG001|Overall Study|Lack of Response At Week 14|0|||
170443308|NCT02760433|615960426|FG002|Overall Study|Lack of Response At Week 14|0|||
170443309|NCT02760433|615960427|FG003|Overall Study|Lack of Response At Week 14|0|||
170443310|NCT02760433|615960428|FG004|Overall Study|Lack of Response At Week 14|1|||
170443311|NCT02760433|615960424|FG000|Overall Study|Subject refused to continue the study|1|||
170443312|NCT02760433|615960425|FG001|Overall Study|Subject refused to continue the study|0|||
170443313|NCT02760433|615960426|FG002|Overall Study|Subject refused to continue the study|0|||
170443314|NCT02760433|615960427|FG003|Overall Study|Subject refused to continue the study|0|||
170443315|NCT02760433|615960428|FG004|Overall Study|Subject refused to continue the study|0|||
170443316|NCT02760433|615960424|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
170443317|NCT02760433|615960425|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
170443318|NCT02760433|615960426|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
170443319|NCT02760433|615960427|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
170443320|NCT02760433|615960428|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
170443321|NCT02760433|615960424|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
170443322|NCT02760433|615960425|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
170443323|NCT02760433|615960426|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
170443324|NCT02760433|615960427|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
170443325|NCT02760433|615960428|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
170443326|NCT01781234|615960432|FG000|Overall Study|Adverse Event|2|||
170443327|NCT01781234|615960433|FG001|Overall Study|Adverse Event|0|||
170443328|NCT01781234|615960432|FG000|Overall Study|Protocol Violation|3|||
170443329|NCT01781234|615960433|FG001|Overall Study|Protocol Violation|0|||
170443330|NCT01781234|615960432|FG000|Overall Study|Withdrawal by Subject|4|||
170443331|NCT01781234|615960433|FG001|Overall Study|Withdrawal by Subject|3|||
170443332|NCT04254809|615960434|FG000|Overall Study|Lost to Follow-up|5|||
170443333|NCT04254809|615960435|FG001|Overall Study|Lost to Follow-up|10|||
170443334|NCT02972515|615960436|FG000|Overall Study|Lost to Follow-up|78|||
170443335|NCT01928615|615960437|FG000|Overall Study|Study Terminated by Sponsor|2|||
170443336|NCT01896505|615960444|FG000|Overall Study|Adverse Event|1|||
170443337|NCT01896505|615960445|FG001|Overall Study|Adverse Event|0|||
170443338|NCT01896505|615960446|FG002|Overall Study|Adverse Event|2|||
170443339|NCT01896505|615960447|FG003|Overall Study|Adverse Event|1|||
170443340|NCT01896505|615960448|FG004|Overall Study|Adverse Event|1|||
170443341|NCT01896505|615960449|FG005|Overall Study|Adverse Event|0|||
170443342|NCT01896505|615960444|FG000|Overall Study|Physician Decision|1|||
170443343|NCT01896505|615960445|FG001|Overall Study|Physician Decision|3|||
170443344|NCT01896505|615960446|FG002|Overall Study|Physician Decision|2|||
170443345|NCT01896505|615960447|FG003|Overall Study|Physician Decision|0|||
170443346|NCT01896505|615960448|FG004|Overall Study|Physician Decision|0|||
170443347|NCT01896505|615960449|FG005|Overall Study|Physician Decision|1|||
170443348|NCT01896505|615960444|FG000|Overall Study|Withdrawal by Subject|1|||
170443349|NCT01896505|615960445|FG001|Overall Study|Withdrawal by Subject|0|||
170443350|NCT01896505|615960446|FG002|Overall Study|Withdrawal by Subject|3|||
170443351|NCT01896505|615960447|FG003|Overall Study|Withdrawal by Subject|1|||
170443352|NCT01896505|615960448|FG004|Overall Study|Withdrawal by Subject|0|||
170443353|NCT01896505|615960449|FG005|Overall Study|Withdrawal by Subject|0|||
170443354|NCT01896505|615960444|FG000|Overall Study|Disease Progression|7|||
170443355|NCT01896505|615960445|FG001|Overall Study|Disease Progression|5|||
170633149|NCT01746901|616668465|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
170785435|NCT00554788|617221458|FG000|Overall Study|Lost to Follow-up|4|||
170785436|NCT00554788|617221459|FG001|Overall Study|Lost to Follow-up|3|||
170785437|NCT00554788|617221460|FG002|Overall Study|Lost to Follow-up|3|||
170785438|NCT00554788|617221458|FG000|Overall Study|Physician Decision|1|||
170785439|NCT00554788|617221459|FG001|Overall Study|Physician Decision|1|||
170785440|NCT00554788|617221460|FG002|Overall Study|Physician Decision|3|||
170785441|NCT00554788|617221458|FG000|Overall Study|Withdrawal by Subject|0|||
170785442|NCT00554788|617221459|FG001|Overall Study|Withdrawal by Subject|0|||
170785443|NCT00554788|617221460|FG002|Overall Study|Withdrawal by Subject|1|||
170785444|NCT00554788|617221458|FG000|Overall Study|Refusal of further protocol therapy|0|||
170443356|NCT01896505|615960446|FG002|Overall Study|Disease Progression|8|||
170443357|NCT01896505|615960447|FG003|Overall Study|Disease Progression|4|||
170443358|NCT01896505|615960448|FG004|Overall Study|Disease Progression|4|||
170443359|NCT01896505|615960449|FG005|Overall Study|Disease Progression|4|||
170785445|NCT00554788|617221459|FG001|Overall Study|Refusal of further protocol therapy|1|||
170785446|NCT00554788|617221460|FG002|Overall Study|Refusal of further protocol therapy|1|||
170443360|NCT01896505|615960444|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
170443361|NCT01896505|615960445|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
170443362|NCT01896505|615960446|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
170443363|NCT01896505|615960447|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
170785447|NCT00554788|617221458|FG000|Overall Study|Progressive disease|0|||
170886641|NCT05103332|617592230|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886642|NCT05103332|617592231|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886643|NCT05103332|617592232|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170443364|NCT01896505|615960448|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
170443365|NCT01896505|615960449|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
170443366|NCT01896505|615960444|FG000|Overall Study|Intercurrent illness|0|||
170443367|NCT01896505|615960445|FG001|Overall Study|Intercurrent illness|1|||
170443368|NCT01896505|615960446|FG002|Overall Study|Intercurrent illness|0|||
170443369|NCT01896505|615960447|FG003|Overall Study|Intercurrent illness|0|||
170443370|NCT01896505|615960448|FG004|Overall Study|Intercurrent illness|0|||
170443371|NCT01896505|615960449|FG005|Overall Study|Intercurrent illness|0|||
170443372|NCT01896505|615960444|FG000|Overall Study|Death|0|||
170443373|NCT01896505|615960445|FG001|Overall Study|Death|0|||
170443374|NCT01896505|615960446|FG002|Overall Study|Death|1|||
170443375|NCT01896505|615960447|FG003|Overall Study|Death|1|||
170443376|NCT01896505|615960448|FG004|Overall Study|Death|0|||
170443377|NCT01896505|615960449|FG005|Overall Study|Death|1|||
170443378|NCT02466386|615960450|FG000|Overall Study|Adverse Event|5|||
170443379|NCT02466386|615960450|FG000|Overall Study|Protocol Violation|2|||
170443380|NCT02466386|615960450|FG000|Overall Study|Withdrawal by Subject|14|||
170443381|NCT02466386|615960450|FG000|Overall Study|Lost to Follow-up|5|||
170443382|NCT02466386|615960450|FG000|Overall Study|Lack of Efficacy|8|||
170443383|NCT02466386|615960450|FG000|Overall Study|Other|10|||
170443384|NCT05317195|615960451|FG000|Randomization|Withdrawal by Subject|1|||
170443385|NCT05317195|615960451|FG000|Randomization|Discontinued|6|||
170443386|NCT05317195|615960451|FG000|Admission|Withdrawal by Subject|2|||
170443387|NCT00761176|615960454|FG000|Overall Study|Death|1|||
170443388|NCT00761176|615960455|FG001|Overall Study|Death|0|||
170443389|NCT00761176|615960454|FG000|Overall Study|Withdrawal by Subject|1|||
170443390|NCT00761176|615960455|FG001|Overall Study|Withdrawal by Subject|1|||
170443391|NCT02762994|615960456|FG000|Overall Study|Withdrawal by Subject|0|||
170633150|NCT01746901|616668466|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
170633151|NCT01746901|616668467|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
170633152|NCT01746901|616668468|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
170633153|NCT03594110|616668476|FG000|Interventional Part|Participant concerned about study treatment|23|||
170633154|NCT03594110|616668477|FG001|Interventional Part|Participant concerned about study treatment|28|||
170633155|NCT03594110|616668476|FG000|Interventional Part|Doctor advice|38|||
170633156|NCT03594110|616668477|FG001|Interventional Part|Doctor advice|40|||
170633157|NCT03594110|616668476|FG000|Interventional Part|Participants' wish|89|||
170633158|NCT03594110|616668477|FG001|Interventional Part|Participants' wish|68|||
170633159|NCT03594110|616668476|FG000|Interventional Part|Adverse event-non-fatal events|119|||
170633160|NCT03594110|616668477|FG001|Interventional Part|Adverse event-non-fatal events|116|||
170633161|NCT03594110|616668476|FG000|Interventional Part|Study drug stopped, reason missing|336|||
170633162|NCT03594110|616668477|FG001|Interventional Part|Study drug stopped, reason missing|294|||
170443392|NCT02762994|615960457|FG001|Overall Study|Withdrawal by Subject|1|||
170443393|NCT02762994|615960458|FG002|Overall Study|Withdrawal by Subject|2|||
170443394|NCT02762994|615960459|FG003|Overall Study|Withdrawal by Subject|0|||
170443395|NCT02762994|615960456|FG000|Overall Study|Protocol Violation|1|||
170443396|NCT02762994|615960457|FG001|Overall Study|Protocol Violation|0|||
170443397|NCT02762994|615960458|FG002|Overall Study|Protocol Violation|0|||
170443398|NCT02762994|615960459|FG003|Overall Study|Protocol Violation|2|||
170443399|NCT05103657|615960460|FG000|Overall Study|Other reasons than listed|9|||
170443400|NCT05103657|615960461|FG001|Overall Study|Other reasons than listed|8|||
170443401|NCT05103657|615960460|FG000|Overall Study|Protocol deviation|2|||
170443402|NCT05103657|615960461|FG001|Overall Study|Protocol deviation|2|||
170443403|NCT05103657|615960460|FG000|Overall Study|No reason available|5|||
170443404|NCT05103657|615960461|FG001|Overall Study|No reason available|4|||
170443405|NCT05103657|615960460|FG000|Overall Study|Burden of study procedures|3|||
170443406|NCT05103657|615960461|FG001|Overall Study|Burden of study procedures|1|||
170443407|NCT05103657|615960460|FG000|Overall Study|Perceived lack of efficacy|1|||
170443408|NCT05103657|615960461|FG001|Overall Study|Perceived lack of efficacy|1|||
170443409|NCT05103657|615960460|FG000|Overall Study|Adverse Event|6|||
170633163|NCT03594110|616668476|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
170633164|NCT03594110|616668477|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
170785448|NCT00554788|617221459|FG001|Overall Study|Progressive disease|0|||
170785449|NCT00554788|617221460|FG002|Overall Study|Progressive disease|3|||
170443410|NCT05103657|615960461|FG001|Overall Study|Adverse Event|14|||
170443411|NCT05103657|615960460|FG000|Overall Study|Not Treated|1|||
170443412|NCT05103657|615960461|FG001|Overall Study|Not Treated|1|||
170443413|NCT02020967|615960462|FG000|Overall Study|Withdrawal by Subject|51|||
170443414|NCT00251316|615960463|FG000|Overall Study|Physician Decision|2|||
170443415|NCT00251316|615960464|FG001|Overall Study|Physician Decision|3|||
170443416|NCT00398073|615960465|FG000|Overall Study|Withdrawal by Subject|1|||
170443417|NCT00398073|615960466|FG001|Overall Study|Withdrawal by Subject|0|||
170443418|NCT01183884|615960470|FG000|Overall Study|Progressive Disease|26|||
170443419|NCT01183884|615960470|FG000|Overall Study|Adverse Event|3|||
170443420|NCT01183884|615960470|FG000|Overall Study|Withdrawal by Subject|1|||
170443421|NCT01183884|615960470|FG000|Overall Study|Other Complicating Disease|3|||
170443422|NCT01183884|615960470|FG000|Overall Study|Not Treated|1|||
170633165|NCT03594110|616668476|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
170785450|NCT00554788|617221458|FG000|Overall Study|Ineligible|2|||
170538731|NCT05168800|616315753|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
170785451|NCT00554788|617221459|FG001|Overall Study|Ineligible|0|||
170785452|NCT00554788|617221460|FG002|Overall Study|Ineligible|1|||
170785453|NCT03197662|617221464|FG000|Overall Study|Withdrawn by family|0|||
170785454|NCT03197662|617221465|FG001|Overall Study|Withdrawn by family|2|||
170785455|NCT01214616|617221466|FG000|Overall Study|Progressive disease|2|||
170785456|NCT01214616|617221467|FG001|Overall Study|Progressive disease|2|||
170785457|NCT01214616|617221468|FG002|Overall Study|Progressive disease|2|||
170785458|NCT01214616|617221469|FG003|Overall Study|Progressive disease|4|||
170785459|NCT01214616|617221466|FG000|Overall Study|Dose limiting toxicity|0|||
170785460|NCT01214616|617221467|FG001|Overall Study|Dose limiting toxicity|2|||
170785461|NCT01214616|617221468|FG002|Overall Study|Dose limiting toxicity|0|||
170785462|NCT01214616|617221469|FG003|Overall Study|Dose limiting toxicity|0|||
170785463|NCT01214616|617221466|FG000|Overall Study|Other adverse events|0|||
170785464|NCT01214616|617221467|FG001|Overall Study|Other adverse events|1|||
170785465|NCT01214616|617221468|FG002|Overall Study|Other adverse events|1|||
170785466|NCT01214616|617221469|FG003|Overall Study|Other adverse events|1|||
170785467|NCT01214616|617221466|FG000|Overall Study|Withdrawal by Subject|1|||
170785468|NCT01214616|617221467|FG001|Overall Study|Withdrawal by Subject|0|||
170785469|NCT01214616|617221468|FG002|Overall Study|Withdrawal by Subject|0|||
170785470|NCT01214616|617221469|FG003|Overall Study|Withdrawal by Subject|1|||
170785471|NCT02949362|617221470|FG000|Retrospective Period|Inform consent not signed by participant|4|||
170785472|NCT02949362|617221471|FG001|Retrospective Period|Inform consent not signed by participant|1|||
170785473|NCT02949362|617221472|FG002|Retrospective Period|Inform consent not signed by participant|0|||
170785474|NCT02949362|617221473|FG003|Retrospective Period|Inform consent not signed by participant|0|||
170785475|NCT02949362|617221470|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
170785476|NCT02949362|617221471|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
170785477|NCT02949362|617221472|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
170785478|NCT02949362|617221473|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
170785479|NCT02949362|617221470|FG000|Prospective Period|Other|0|||
170785480|NCT02949362|617221471|FG001|Prospective Period|Other|0|||
170785481|NCT02949362|617221472|FG002|Prospective Period|Other|0|||
170785482|NCT02949362|617221473|FG003|Prospective Period|Other|4|||
170785483|NCT03447470|617221475|FG000|Overall Study|Death|0|||
170785484|NCT03447470|617221476|FG001|Overall Study|Death|1|||
170785485|NCT03447470|617221477|FG002|Overall Study|Death|3|||
170785486|NCT03447470|617221478|FG003|Overall Study|Death|0|||
170785487|NCT03447470|617221479|FG004|Overall Study|Death|1|||
170785488|NCT03447470|617221480|FG005|Overall Study|Death|0|||
170785489|NCT03447470|617221481|FG006|Overall Study|Death|3|||
170785490|NCT03447470|617221482|FG007|Overall Study|Death|3|||
170785491|NCT03447470|617221483|FG008|Overall Study|Death|1|||
170785492|NCT03447470|617221475|FG000|Overall Study|Withdrawal by Subject|1|||
170785493|NCT03447470|617221476|FG001|Overall Study|Withdrawal by Subject|0|||
170785494|NCT03447470|617221477|FG002|Overall Study|Withdrawal by Subject|0|||
170785495|NCT03447470|617221478|FG003|Overall Study|Withdrawal by Subject|0|||
170785496|NCT03447470|617221479|FG004|Overall Study|Withdrawal by Subject|1|||
170785497|NCT03447470|617221480|FG005|Overall Study|Withdrawal by Subject|0|||
170785498|NCT03447470|617221481|FG006|Overall Study|Withdrawal by Subject|1|||
170785499|NCT03447470|617221482|FG007|Overall Study|Withdrawal by Subject|1|||
170785500|NCT03447470|617221483|FG008|Overall Study|Withdrawal by Subject|3|||
170785501|NCT03447470|617221475|FG000|Overall Study|Treatment discontinued|3|||
170785502|NCT03447470|617221476|FG001|Overall Study|Treatment discontinued|2|||
170785503|NCT03447470|617221477|FG002|Overall Study|Treatment discontinued|4|||
170785504|NCT03447470|617221478|FG003|Overall Study|Treatment discontinued|6|||
170785505|NCT03447470|617221479|FG004|Overall Study|Treatment discontinued|2|||
170785506|NCT03447470|617221480|FG005|Overall Study|Treatment discontinued|1|||
170785507|NCT03447470|617221481|FG006|Overall Study|Treatment discontinued|2|||
170785508|NCT03447470|617221482|FG007|Overall Study|Treatment discontinued|4|||
170785509|NCT03447470|617221483|FG008|Overall Study|Treatment discontinued|3|||
170538732|NCT05168800|616315754|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
170538733|NCT05168800|616315752|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
170538734|NCT05168800|616315753|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
170538735|NCT05168800|616315754|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
170538736|NCT05168800|616315752|FG000|Time 2 Survey|Withdrawal by Subject|1|||
170538737|NCT05168800|616315753|FG001|Time 2 Survey|Withdrawal by Subject|0|||
170538738|NCT05168800|616315754|FG002|Time 2 Survey|Withdrawal by Subject|1|||
170785510|NCT03941860|617221487|FG000|Overall Study|Withdrawal by Subject|0|||
170785511|NCT03941860|617221488|FG001|Overall Study|Withdrawal by Subject|1|||
170785512|NCT01084707|617221489|FG000|Overall Study|Withdrawal by Subject|6|||
170785513|NCT01361711|617221491|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
170785514|NCT01361711|617221491|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
170443423|NCT01183884|615960470|FG000|Overall Study|Other|4|||
170443424|NCT02169336|615960473|FG000|Overall Study|Lack of Efficacy|1|||
170443425|NCT02169336|615960474|FG001|Overall Study|Lack of Efficacy|1|||
170443426|NCT02169336|615960475|FG002|Overall Study|Lack of Efficacy|0|||
170785515|NCT01361711|617221491|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
170785516|NCT01361711|617221491|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
170785517|NCT01361711|617221491|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
170785518|NCT01361711|617221491|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
170785519|NCT01361711|617221491|FG000|Completed Week 18 of Treatment|Other|9|||
170785520|NCT01361711|617221491|FG000|10 Year Follow-up|Still in follow-up|22|||
170785521|NCT01361711|617221491|FG000|10 Year Follow-up|Death|7|||
170785522|NCT01361711|617221491|FG000|10 Year Follow-up|Developed new cancer|1|||
170443427|NCT02169336|615960473|FG000|Overall Study|Adverse Event|2|||
170443428|NCT02169336|615960474|FG001|Overall Study|Adverse Event|3|||
170443429|NCT02169336|615960475|FG002|Overall Study|Adverse Event|1|||
170443430|NCT02169336|615960473|FG000|Overall Study|Withdrawal by Subject|1|||
170443431|NCT02169336|615960474|FG001|Overall Study|Withdrawal by Subject|0|||
170443432|NCT02169336|615960475|FG002|Overall Study|Withdrawal by Subject|0|||
170443433|NCT02169336|615960473|FG000|Overall Study|Physician Decision|0|||
170443434|NCT02169336|615960474|FG001|Overall Study|Physician Decision|0|||
170443435|NCT02169336|615960475|FG002|Overall Study|Physician Decision|1|||
170443436|NCT02169336|615960473|FG000|Overall Study|Subject declined to continue dosing|0|||
170443437|NCT02169336|615960474|FG001|Overall Study|Subject declined to continue dosing|0|||
170443438|NCT02169336|615960475|FG002|Overall Study|Subject declined to continue dosing|1|||
170443439|NCT01120691|615960495|FG000|Overall Study|Adverse Event|59|||
170443440|NCT01120691|615960496|FG001|Overall Study|Adverse Event|67|||
170443441|NCT01120691|615960497|FG002|Overall Study|Adverse Event|47|||
170443442|NCT01120691|615960495|FG000|Overall Study|Subject withdrew consent|33|||
170443443|NCT01120691|615960496|FG001|Overall Study|Subject withdrew consent|50|||
170443444|NCT01120691|615960497|FG002|Overall Study|Subject withdrew consent|44|||
170443445|NCT01120691|615960495|FG000|Overall Study|Death|21|||
170443446|NCT01120691|615960496|FG001|Overall Study|Death|22|||
170443447|NCT01120691|615960497|FG002|Overall Study|Death|24|||
170443448|NCT01120691|615960495|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
170443449|NCT01120691|615960496|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
170443450|NCT01120691|615960497|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
170443451|NCT01120691|615960495|FG000|Overall Study|Administrative problems|15|||
170443452|NCT01120691|615960496|FG001|Overall Study|Administrative problems|8|||
170443453|NCT01120691|615960497|FG002|Overall Study|Administrative problems|9|||
170443454|NCT01120691|615960495|FG000|Overall Study|Protocol deviation|13|||
170443455|NCT01120691|615960496|FG001|Overall Study|Protocol deviation|12|||
170443456|NCT01120691|615960497|FG002|Overall Study|Protocol deviation|12|||
170443457|NCT01120691|615960495|FG000|Overall Study|Lost to Follow-up|5|||
170443458|NCT01120691|615960496|FG001|Overall Study|Lost to Follow-up|6|||
170443459|NCT01120691|615960497|FG002|Overall Study|Lost to Follow-up|4|||
170443460|NCT01120691|615960495|FG000|Overall Study|Abnormal test procedure result(s)|3|||
170443461|NCT01120691|615960496|FG001|Overall Study|Abnormal test procedure result(s)|2|||
170443462|NCT01120691|615960497|FG002|Overall Study|Abnormal test procedure result(s)|1|||
170443463|NCT01120691|615960495|FG000|Overall Study|Patient's inability to use the device|3|||
170443464|NCT01120691|615960496|FG001|Overall Study|Patient's inability to use the device|1|||
170443465|NCT01120691|615960497|FG002|Overall Study|Patient's inability to use the device|0|||
170443466|NCT01120691|615960495|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170443467|NCT01120691|615960496|FG001|Overall Study|Abnormal laboratory value(s)|3|||
170443468|NCT01120691|615960497|FG002|Overall Study|Abnormal laboratory value(s)|4|||
170443469|NCT04553406|615960500|FG000|Overall Study|Study Discontinuation|0|||
170443470|NCT04553406|615960501|FG001|Overall Study|Study Discontinuation|1|||
170443471|NCT00772148|615960502|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
170443472|NCT00772148|615960503|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
170443473|NCT00772148|615960502|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
170443474|NCT00772148|615960503|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
170443475|NCT00772148|615960502|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
170785523|NCT01361711|617221491|FG000|10 Year Follow-up|Lost to Follow-up|2|||
170785524|NCT01361711|617221491|FG000|10 Year Follow-up|New treatment started|6|||
170785525|NCT01361711|617221491|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
170785526|NCT01361711|617221491|FG000|10 Year Follow-up|Progressive Disease|1|||
170785527|NCT02596126|617221492|FG000|Overall Study|Lost to Follow-up|12|||
170443476|NCT00772148|615960503|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
170443477|NCT00772148|615960502|FG000|Maintenance Phase (Week 52)|Death|2|||
170443478|NCT00772148|615960503|FG001|Maintenance Phase (Week 52)|Death|2|||
170443479|NCT00772148|615960502|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
170443480|NCT00772148|615960503|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
170443481|NCT00772148|615960502|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
170443482|NCT00772148|615960503|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
170443483|NCT00772148|615960502|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
170538739|NCT05168800|616315752|FG000|Time 3 Survey|Already excluded at Time 1|228|||
170538740|NCT05168800|616315753|FG001|Time 3 Survey|Already excluded at Time 1|200|||
170538741|NCT05168800|616315754|FG002|Time 3 Survey|Already excluded at Time 1|173|||
170538742|NCT05168800|616315752|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
170538743|NCT05168800|616315753|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
170538744|NCT05168800|616315754|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
170538745|NCT05168800|616315752|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
170538746|NCT05168800|616315753|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
170538747|NCT05168800|616315754|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
170538748|NCT05168800|616315752|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
170538749|NCT05168800|616315753|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
170538750|NCT05168800|616315754|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
170538751|NCT04279522|616315757|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
170538752|NCT04279522|616315758|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
170538753|NCT04279522|616315757|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
170538754|NCT04279522|616315758|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
170538755|NCT04279522|616315757|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
170538756|NCT04279522|616315758|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
170538757|NCT04279522|616315757|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
170538758|NCT04279522|616315758|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
170785528|NCT02596126|617221493|FG001|Overall Study|Lost to Follow-up|21|||
170538759|NCT04279522|616315757|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
170538760|NCT04279522|616315758|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
170538761|NCT04279522|616315757|FG000|Period 2: Open Label Phase|Physician Decision|0|||
170538762|NCT04279522|616315758|FG001|Period 2: Open Label Phase|Physician Decision|3|||
170538763|NCT04279522|616315757|FG000|Period 2: Open Label Phase|Adverse Event|0|||
170538764|NCT04279522|616315758|FG001|Period 2: Open Label Phase|Adverse Event|1|||
170538765|NCT04279522|616315757|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
170538766|NCT04279522|616315758|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
170538767|NCT03036254|616315761|FG000|Overall Study|Adverse Event|6|||
170785529|NCT02596126|617221492|FG000|Overall Study|Protocol Violation|7|||
170785530|NCT02596126|617221493|FG001|Overall Study|Protocol Violation|9|||
170785531|NCT04774237|617221494|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
170785532|NCT04774237|617221495|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
170785533|NCT04774237|617221496|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
170785534|NCT04774237|617221497|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
170785535|NCT04774237|617221498|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
170785536|NCT04774237|617221499|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
170538768|NCT03036254|616315762|FG001|Overall Study|Adverse Event|4|||
170538769|NCT03036254|616315761|FG000|Overall Study|Death|3|||
170785537|NCT04024813|617223425|FG000|Overall Study|Study terminated by Sponsor|1|||
170785538|NCT00920621|617223426|FG000|Overall Study|Lost to Follow-up|16|||
170785539|NCT00920621|617223427|FG001|Overall Study|Lost to Follow-up|17|||
170785540|NCT00920621|617223428|FG002|Overall Study|Lost to Follow-up|19|||
170785541|NCT00920621|617223429|FG003|Overall Study|Lost to Follow-up|21|||
170785542|NCT00920621|617223426|FG000|Overall Study|Fetal/neonatal deaths|16|||
170785543|NCT00920621|617223427|FG001|Overall Study|Fetal/neonatal deaths|14|||
170785544|NCT00920621|617223428|FG002|Overall Study|Fetal/neonatal deaths|16|||
170785545|NCT00920621|617223429|FG003|Overall Study|Fetal/neonatal deaths|14|||
170785546|NCT00920621|617223426|FG000|Overall Study|Blood sample not collected|22|||
170785547|NCT00920621|617223427|FG001|Overall Study|Blood sample not collected|14|||
170785548|NCT00920621|617223428|FG002|Overall Study|Blood sample not collected|0|||
170785549|NCT00920621|617223429|FG003|Overall Study|Blood sample not collected|0|||
170785550|NCT01426425|617223430|FG000|Overall Study|Exited prior to EP study|22|||
170785551|NCT01426425|617223430|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
170785552|NCT01426425|617223430|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
170785553|NCT03281291|617223436|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
170785554|NCT03281291|617223437|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
170785555|NCT03281291|617223438|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
170785556|NCT03281291|617223439|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
170785557|NCT03281291|617223440|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
170886644|NCT05103332|617592233|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886645|NCT05103332|617592234|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170538770|NCT03036254|616315762|FG001|Overall Study|Death|1|||
170538771|NCT03036254|616315761|FG000|Overall Study|Lack of Efficacy|5|||
170538772|NCT03036254|616315762|FG001|Overall Study|Lack of Efficacy|1|||
170538773|NCT03036254|616315761|FG000|Overall Study|Withdrawal by Subject|3|||
170538774|NCT03036254|616315762|FG001|Overall Study|Withdrawal by Subject|5|||
170538775|NCT01802281|616315775|FG000|Overall Study|Death|1|||
170538776|NCT01802281|616315776|FG001|Overall Study|Death|2|||
170538777|NCT01802281|616315775|FG000|Overall Study|Withdrawal by Subject|2|||
170538778|NCT01802281|616315776|FG001|Overall Study|Withdrawal by Subject|1|||
170886646|NCT05103332|617592235|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886647|NCT05103332|617592236|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886648|NCT05103332|617592237|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886649|NCT05103332|617592238|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886650|NCT05103332|617592239|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886651|NCT05103332|617592240|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
170886652|NCT05103332|617592241|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
170886653|NCT05103332|617592242|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
170886654|NCT05103332|617592243|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
170886655|NCT05103332|617592226|FG000|SFU Period (6 Months=168 Days)|Death|0|||
170886656|NCT05103332|617592227|FG001|SFU Period (6 Months=168 Days)|Death|0|||
170886657|NCT05103332|617592228|FG002|SFU Period (6 Months=168 Days)|Death|0|||
170886658|NCT05103332|617592229|FG003|SFU Period (6 Months=168 Days)|Death|0|||
170886659|NCT05103332|617592230|FG004|SFU Period (6 Months=168 Days)|Death|0|||
170886660|NCT05103332|617592231|FG005|SFU Period (6 Months=168 Days)|Death|0|||
170886661|NCT05103332|617592232|FG006|SFU Period (6 Months=168 Days)|Death|0|||
170886662|NCT05103332|617592233|FG007|SFU Period (6 Months=168 Days)|Death|0|||
170886663|NCT05103332|617592234|FG008|SFU Period (6 Months=168 Days)|Death|0|||
170886664|NCT05103332|617592235|FG009|SFU Period (6 Months=168 Days)|Death|0|||
170886665|NCT05103332|617592236|FG010|SFU Period (6 Months=168 Days)|Death|0|||
170886666|NCT05103332|617592237|FG011|SFU Period (6 Months=168 Days)|Death|0|||
170886667|NCT05103332|617592238|FG012|SFU Period (6 Months=168 Days)|Death|0|||
170886668|NCT05103332|617592239|FG013|SFU Period (6 Months=168 Days)|Death|0|||
170886669|NCT05103332|617592240|FG014|SFU Period (6 Months=168 Days)|Death|1|||
170886670|NCT05103332|617592241|FG015|SFU Period (6 Months=168 Days)|Death|0|||
170886671|NCT05103332|617592242|FG016|SFU Period (6 Months=168 Days)|Death|0|||
170886672|NCT05103332|617592243|FG017|SFU Period (6 Months=168 Days)|Death|1|||
170886673|NCT04179175|617593511|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
170886674|NCT04179175|617593512|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
170886675|NCT04179175|617593513|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
170886676|NCT04179175|617593514|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
170886677|NCT04179175|617593515|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
170886678|NCT04179175|617593516|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
170886679|NCT04179175|617593511|FG000|Overall Study|Adverse Event|5|||
170886680|NCT04179175|617593512|FG001|Overall Study|Adverse Event|3|||
170886681|NCT04179175|617593513|FG002|Overall Study|Adverse Event|3|||
170886682|NCT04179175|617593514|FG003|Overall Study|Adverse Event|4|||
170886683|NCT04179175|617593515|FG004|Overall Study|Adverse Event|6|||
170886684|NCT04179175|617593516|FG005|Overall Study|Adverse Event|6|||
170886685|NCT04179175|617593511|FG000|Overall Study|Lack of Efficacy|5|||
170886686|NCT04179175|617593512|FG001|Overall Study|Lack of Efficacy|1|||
170886687|NCT04179175|617593513|FG002|Overall Study|Lack of Efficacy|3|||
170886688|NCT04179175|617593514|FG003|Overall Study|Lack of Efficacy|2|||
170886689|NCT04179175|617593515|FG004|Overall Study|Lack of Efficacy|18|||
170886690|NCT04179175|617593516|FG005|Overall Study|Lack of Efficacy|7|||
170886691|NCT04179175|617593511|FG000|Overall Study|Lost to Follow-up|5|||
170886692|NCT04179175|617593512|FG001|Overall Study|Lost to Follow-up|3|||
170886693|NCT04179175|617593513|FG002|Overall Study|Lost to Follow-up|2|||
170886694|NCT04179175|617593514|FG003|Overall Study|Lost to Follow-up|2|||
170886695|NCT04179175|617593515|FG004|Overall Study|Lost to Follow-up|4|||
170886696|NCT04179175|617593516|FG005|Overall Study|Lost to Follow-up|5|||
170886697|NCT04179175|617593511|FG000|Overall Study|Physician Decision|2|||
170886698|NCT04179175|617593512|FG001|Overall Study|Physician Decision|0|||
170443484|NCT00772148|615960503|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
170443485|NCT00633022|615960504|FG000|Overall Study|Adverse Event|1|||
170443486|NCT00633022|615960505|FG001|Overall Study|Adverse Event|0|||
170443487|NCT00633022|615960506|FG002|Overall Study|Adverse Event|5|||
170443488|NCT00633022|615960504|FG000|Overall Study|Physician Decision|0|||
170443489|NCT00633022|615960505|FG001|Overall Study|Physician Decision|1|||
170443490|NCT00633022|615960506|FG002|Overall Study|Physician Decision|0|||
170886699|NCT04179175|617593513|FG002|Overall Study|Physician Decision|2|||
170886700|NCT04179175|617593514|FG003|Overall Study|Physician Decision|3|||
170886701|NCT04179175|617593515|FG004|Overall Study|Physician Decision|1|||
170886702|NCT04179175|617593516|FG005|Overall Study|Physician Decision|1|||
170538779|NCT01802281|616315775|FG000|Overall Study|Ineligible|5|||
170886703|NCT04179175|617593511|FG000|Overall Study|Pregnancy|3|||
170886704|NCT04179175|617593512|FG001|Overall Study|Pregnancy|0|||
170443491|NCT00787605|615960507|FG000|Overall Study|Administrative Problems|3|||
170443492|NCT00787605|615960508|FG001|Overall Study|Administrative Problems|0|||
170538780|NCT01802281|616315776|FG001|Overall Study|Ineligible|3|||
170538781|NCT03168672|616315777|FG000|Overall Study|Withdrawal by Subject|13|||
170886705|NCT04179175|617593513|FG002|Overall Study|Pregnancy|3|||
170886706|NCT04179175|617593514|FG003|Overall Study|Pregnancy|0|||
170886707|NCT04179175|617593515|FG004|Overall Study|Pregnancy|1|||
170886708|NCT04179175|617593516|FG005|Overall Study|Pregnancy|2|||
170886709|NCT04179175|617593511|FG000|Overall Study|Withdrawal by Subject|22|||
170886710|NCT04179175|617593512|FG001|Overall Study|Withdrawal by Subject|10|||
170785558|NCT03281291|617223436|FG000|Overall Study|Protocol Deviation|2|||
170785559|NCT03281291|617223437|FG001|Overall Study|Protocol Deviation|0|||
170785560|NCT03281291|617223438|FG002|Overall Study|Protocol Deviation|1|||
170785561|NCT03281291|617223439|FG003|Overall Study|Protocol Deviation|2|||
170785562|NCT03281291|617223440|FG004|Overall Study|Protocol Deviation|1|||
170785563|NCT03281291|617223436|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
170785564|NCT03281291|617223437|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
170443493|NCT00787605|615960507|FG000|Overall Study|Adverse Event|14|||
170443494|NCT00787605|615960508|FG001|Overall Study|Adverse Event|25|||
170443495|NCT00787605|615960507|FG000|Overall Study|Lost to Follow-up|3|||
170443496|NCT00787605|615960508|FG001|Overall Study|Lost to Follow-up|6|||
170443497|NCT00787605|615960507|FG000|Overall Study|Protocol Violation|7|||
170443498|NCT00787605|615960508|FG001|Overall Study|Protocol Violation|3|||
170443499|NCT00787605|615960507|FG000|Overall Study|Withdrawal by Subject|6|||
170443500|NCT00787605|615960508|FG001|Overall Study|Withdrawal by Subject|13|||
170443501|NCT00787605|615960507|FG000|Overall Study|Lack of Efficacy|13|||
170443502|NCT00787605|615960508|FG001|Overall Study|Lack of Efficacy|9|||
170443503|NCT03382041|615960509|FG000|Overall Study|Consent Form Lost|2|||
170443504|NCT03382041|615960510|FG001|Overall Study|Consent Form Lost|1|||
170443505|NCT03382041|615960509|FG000|Overall Study|Withdrawal by Subject|1|||
170443506|NCT03382041|615960510|FG001|Overall Study|Withdrawal by Subject|4|||
170443507|NCT03382041|615960509|FG000|Overall Study|Lost to Follow-up|1|||
170443508|NCT03382041|615960510|FG001|Overall Study|Lost to Follow-up|4|||
170443509|NCT00688844|615960513|FG000|Overall Study|Lost to Follow-up|10|||
170443510|NCT01374451|615960514|FG000|Overall Study|Administrative problems|1|||
170443511|NCT01374451|615960515|FG001|Overall Study|Administrative problems|0|||
170443512|NCT04640194|615960519|FG000|Overall Study|Adverse Event|3|||
170443513|NCT04640194|615960520|FG001|Overall Study|Adverse Event|7|||
170443514|NCT04640194|615960521|FG002|Overall Study|Adverse Event|0|||
170443515|NCT04640194|615960522|FG003|Overall Study|Adverse Event|5|||
170443516|NCT04640194|615960523|FG004|Overall Study|Adverse Event|0|||
170443517|NCT04640194|615960524|FG005|Overall Study|Adverse Event|4|||
170443518|NCT04640194|615960525|FG006|Overall Study|Adverse Event|0|||
170443519|NCT04640194|615960519|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
170538782|NCT03168672|616315777|FG000|Overall Study|Death|3|||
170538783|NCT03168672|616315777|FG000|Overall Study|Investigator's Decision|137|||
170538784|NCT03168672|616315777|FG000|Overall Study|Adverse Event|1|||
170538785|NCT03168672|616315777|FG000|Overall Study|Other|2|||
170538786|NCT03168672|616315777|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
170443520|NCT04640194|615960520|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
170443521|NCT04640194|615960521|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
170443522|NCT04640194|615960522|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
170538787|NCT02246777|616315778|FG000|Overall Study|Adverse Event|2|||
170538788|NCT02246777|616315778|FG000|Overall Study|Change of residence|1|||
170538789|NCT00927472|616315779|FG000|Overall Study|Withdrawal by Subject|10|||
170538790|NCT00927472|616315780|FG001|Overall Study|Withdrawal by Subject|11|||
170538791|NCT00927472|616315779|FG000|Overall Study|Lost to Follow-up|1|||
170538792|NCT00927472|616315780|FG001|Overall Study|Lost to Follow-up|6|||
170538793|NCT00927472|616315779|FG000|Overall Study|Protocol Violation|0|||
170785565|NCT03281291|617223438|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
170785566|NCT03281291|617223439|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
170785567|NCT03281291|617223440|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
170785568|NCT03281291|617223436|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
170785569|NCT03281291|617223437|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
170785570|NCT03281291|617223438|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
170785571|NCT03281291|617223439|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
170785572|NCT03281291|617223440|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
170785573|NCT03281291|617223436|FG000|Overall Study|Lost to Follow-up|10|||
170785574|NCT03281291|617223437|FG001|Overall Study|Lost to Follow-up|10|||
170785575|NCT03281291|617223438|FG002|Overall Study|Lost to Follow-up|4|||
170785576|NCT03281291|617223439|FG003|Overall Study|Lost to Follow-up|6|||
170785577|NCT03281291|617223440|FG004|Overall Study|Lost to Follow-up|10|||
170443523|NCT04640194|615960523|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
170538794|NCT00927472|616315780|FG001|Overall Study|Protocol Violation|1|||
170538795|NCT00927472|616315779|FG000|Overall Study|Post treatment Assessment out of window|0|||
170785578|NCT03281291|617223436|FG000|Overall Study|Other|0|||
170785579|NCT03281291|617223437|FG001|Overall Study|Other|2|||
170785580|NCT03281291|617223438|FG002|Overall Study|Other|0|||
170443524|NCT04640194|615960524|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
170443525|NCT04640194|615960525|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
170443526|NCT04640194|615960519|FG000|Overall Study|fibrinogen level too low|0|||
170443527|NCT04640194|615960520|FG001|Overall Study|fibrinogen level too low|0|||
170443528|NCT04640194|615960521|FG002|Overall Study|fibrinogen level too low|0|||
170443529|NCT04640194|615960522|FG003|Overall Study|fibrinogen level too low|1|||
170443530|NCT04640194|615960523|FG004|Overall Study|fibrinogen level too low|0|||
170785581|NCT03281291|617223439|FG003|Overall Study|Other|2|||
170785582|NCT03281291|617223440|FG004|Overall Study|Other|1|||
170785583|NCT00512070|617223441|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
170785584|NCT00512070|617223442|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
170785585|NCT00512070|617223443|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
170785586|NCT00512070|617223441|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
170785587|NCT00512070|617223442|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
170785588|NCT00512070|617223443|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
170785589|NCT04956861|617223444|FG000|Overall Study|Withdrawal by Subject|4|||
170785590|NCT04956861|617223445|FG001|Overall Study|Withdrawal by Subject|4|||
170785591|NCT04956861|617223446|FG002|Overall Study|Withdrawal by Subject|2|||
170785592|NCT04956861|617223444|FG000|Overall Study|Physician Decision|4|||
170785593|NCT04956861|617223445|FG001|Overall Study|Physician Decision|5|||
170785594|NCT04956861|617223446|FG002|Overall Study|Physician Decision|1|||
170785595|NCT05862870|617223449|FG000|Overall Study|Lost to Follow-up|3|||
170785596|NCT02530671|617223452|FG000|Overall Study|Lost to Follow-up|2|||
170443531|NCT04640194|615960524|FG005|Overall Study|fibrinogen level too low|0|||
170443532|NCT04640194|615960525|FG006|Overall Study|fibrinogen level too low|0|||
170443533|NCT04640194|615960519|FG000|Overall Study|mild bleeding|0|||
170443534|NCT04640194|615960520|FG001|Overall Study|mild bleeding|0|||
170443535|NCT04640194|615960521|FG002|Overall Study|mild bleeding|0|||
170443536|NCT04640194|615960522|FG003|Overall Study|mild bleeding|1|||
170443537|NCT04640194|615960523|FG004|Overall Study|mild bleeding|0|||
170443538|NCT04640194|615960524|FG005|Overall Study|mild bleeding|0|||
170443539|NCT04640194|615960525|FG006|Overall Study|mild bleeding|0|||
170443540|NCT04640194|615960519|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
170443541|NCT04640194|615960520|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
170443542|NCT04640194|615960521|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
170443543|NCT04640194|615960522|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
170443544|NCT04640194|615960523|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
170538796|NCT00927472|616315780|FG001|Overall Study|Post treatment Assessment out of window|4|||
170538797|NCT05317546|616315781|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
170538798|NCT05317546|616315782|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
170538799|NCT04707469|616315783|FG000|Overall Study|Site closure|0|||
170538800|NCT04707469|616315784|FG001|Overall Study|Site closure|2|||
170538801|NCT04707469|616315785|FG002|Overall Study|Site closure|0|||
170538802|NCT04707469|616315783|FG000|Overall Study|Physician Decision|2|||
170538803|NCT04707469|616315784|FG001|Overall Study|Physician Decision|2|||
170538804|NCT04707469|616315785|FG002|Overall Study|Physician Decision|2|||
170538805|NCT04707469|616315783|FG000|Overall Study|Death|1|||
170538806|NCT04707469|616315784|FG001|Overall Study|Death|6|||
170538807|NCT04707469|616315785|FG002|Overall Study|Death|2|||
170538808|NCT04707469|616315783|FG000|Overall Study|Lost to Follow-up|9|||
170538809|NCT04707469|616315784|FG001|Overall Study|Lost to Follow-up|19|||
170538810|NCT04707469|616315785|FG002|Overall Study|Lost to Follow-up|14|||
170538811|NCT04707469|616315783|FG000|Overall Study|Withdrawal by Subject|17|||
170538812|NCT04707469|616315784|FG001|Overall Study|Withdrawal by Subject|16|||
170538813|NCT04707469|616315785|FG002|Overall Study|Withdrawal by Subject|12|||
170538814|NCT04635423|616315786|FG000|Overall Study|Ongoing|493|||
170538815|NCT04635423|616315787|FG001|Overall Study|Ongoing|501|||
170538816|NCT04635423|616315786|FG000|Overall Study|Withdrawal by Subject|36|||
170538817|NCT04635423|616315787|FG001|Overall Study|Withdrawal by Subject|29|||
170538818|NCT05556057|616315788|FG000|Overall Study|Lost to Follow-up|5|||
170538819|NCT05556057|616315789|FG001|Overall Study|Lost to Follow-up|4|||
170538820|NCT05556057|616315788|FG000|Overall Study|Withdrawal by Subject|0|||
170538821|NCT05556057|616315789|FG001|Overall Study|Withdrawal by Subject|2|||
170538822|NCT01147458|616315800|FG000|First Intervention|Study terminated by sponsor|8|||
170538823|NCT01147458|616315801|FG001|First Intervention|Study terminated by sponsor|8|||
170538824|NCT01147458|616315802|FG002|First Intervention|Study terminated by sponsor|7|||
170538825|NCT01147458|616315803|FG003|First Intervention|Study terminated by sponsor|8|||
170538826|NCT01147458|616315800|FG000|First Intervention|Protocol Violation|2|||
170538827|NCT01147458|616315801|FG001|First Intervention|Protocol Violation|3|||
170538828|NCT01147458|616315802|FG002|First Intervention|Protocol Violation|2|||
170538829|NCT01147458|616315803|FG003|First Intervention|Protocol Violation|3|||
170538830|NCT01147458|616315800|FG000|First Intervention|Withdrawal by Subject|3|||
170785597|NCT02530671|617223453|FG001|Overall Study|Lost to Follow-up|0|||
170785598|NCT02530671|617223452|FG000|Overall Study|Withdrawal by Subject|1|||
170785599|NCT02530671|617223453|FG001|Overall Study|Withdrawal by Subject|0|||
170785600|NCT05247489|617223454|FG000|Overall Study|Lost to Follow-up|5|||
170785601|NCT05247489|617223455|FG001|Overall Study|Lost to Follow-up|1|||
170785602|NCT05247489|617223454|FG000|Overall Study|Withdrawal by Subject|6|||
170785603|NCT05247489|617223455|FG001|Overall Study|Withdrawal by Subject|7|||
170538831|NCT01147458|616315801|FG001|First Intervention|Withdrawal by Subject|0|||
170538832|NCT01147458|616315802|FG002|First Intervention|Withdrawal by Subject|1|||
170443545|NCT04640194|615960524|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
170886711|NCT04179175|617593513|FG002|Overall Study|Withdrawal by Subject|12|||
170886712|NCT04179175|617593514|FG003|Overall Study|Withdrawal by Subject|8|||
170886713|NCT04179175|617593515|FG004|Overall Study|Withdrawal by Subject|23|||
170886714|NCT04179175|617593516|FG005|Overall Study|Withdrawal by Subject|31|||
170886715|NCT04179175|617593511|FG000|Overall Study|Technical problems|0|||
170886716|NCT04179175|617593512|FG001|Overall Study|Technical problems|0|||
170886717|NCT04179175|617593513|FG002|Overall Study|Technical problems|1|||
170886718|NCT04179175|617593514|FG003|Overall Study|Technical problems|1|||
170886719|NCT04179175|617593515|FG004|Overall Study|Technical problems|0|||
170886720|NCT04179175|617593516|FG005|Overall Study|Technical problems|0|||
170886721|NCT02164981|617593517|FG000|Started|Withdrawal by Subject|2|||
170886722|NCT02164981|617593518|FG001|Started|Withdrawal by Subject|1|||
170886723|NCT02164981|617593519|FG002|Started|Withdrawal by Subject|0|||
170886724|NCT02164981|617593517|FG000|Started|Protocol Violation|2|||
170886725|NCT02164981|617593518|FG001|Started|Protocol Violation|0|||
170886726|NCT02164981|617593519|FG002|Started|Protocol Violation|0|||
170886727|NCT02164981|617593517|FG000|Started|Adverse Event|1|||
170886728|NCT02164981|617593518|FG001|Started|Adverse Event|2|||
170886729|NCT02164981|617593519|FG002|Started|Adverse Event|0|||
170443546|NCT04640194|615960525|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
170443547|NCT03168906|615960528|FG000|Overall Study|Lack of Efficacy|6|||
170443548|NCT03168906|615960529|FG001|Overall Study|Lack of Efficacy|6|||
170443549|NCT01321697|615960530|FG000|Overall Study|Study Terminated|7|||
170443550|NCT01049581|615960531|FG000|Overall Study|Lost to Follow-up|2|||
170886730|NCT02164981|617593517|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
170886731|NCT02164981|617593518|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
170886732|NCT02164981|617593519|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
170886733|NCT02164981|617593517|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
170886734|NCT02164981|617593518|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
170886735|NCT02164981|617593519|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
170886736|NCT02164981|617593517|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
170886737|NCT02164981|617593518|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
170886738|NCT02164981|617593519|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
170886739|NCT03160560|617593520|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
170886740|NCT03160560|617593521|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
170886741|NCT03160560|617593522|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
170886742|NCT03160560|617593523|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
170886743|NCT03160560|617593520|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
170886744|NCT03160560|617593521|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
170886745|NCT03160560|617593522|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
170886746|NCT03160560|617593523|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
170886747|NCT00049673|617593524|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
170886748|NCT00049673|617593525|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
170886749|NCT00618748|617593526|FG000|Overall Study|Adverse Event|4|||
170886750|NCT00618748|617593527|FG001|Overall Study|Adverse Event|3|||
170886751|NCT00618748|617593528|FG002|Overall Study|Adverse Event|8|||
170886752|NCT00618748|617593526|FG000|Overall Study|Physician Decision|3|||
170886753|NCT00618748|617593527|FG001|Overall Study|Physician Decision|1|||
170886754|NCT00618748|617593528|FG002|Overall Study|Physician Decision|1|||
170886755|NCT00618748|617593526|FG000|Overall Study|Withdrawal by Subject|4|||
170886756|NCT00618748|617593527|FG001|Overall Study|Withdrawal by Subject|1|||
170886757|NCT00618748|617593528|FG002|Overall Study|Withdrawal by Subject|5|||
170886758|NCT01407926|617593529|FG000|Overall Study|Lost to Follow-up|55|||
170886759|NCT01368835|617593530|FG000|Overall Study|Inclusion criteria/photography quality|22|||
170886760|NCT01368835|617593530|FG000|Overall Study|Lost to Follow-up|11|||
170443551|NCT01049581|615960532|FG001|Overall Study|Lost to Follow-up|1|||
170443552|NCT00834613|615960536|FG000|First Intervention|Protocol Violation|1|||
170443553|NCT00834613|615960537|FG001|First Intervention|Protocol Violation|0|||
170443554|NCT02061280|615960543|FG000|Overall Study|Protocol Violation|12|||
170443555|NCT02061280|615960544|FG001|Overall Study|Protocol Violation|8|||
170443556|NCT02061280|615960543|FG000|Overall Study|moved out of state|0|||
170443557|NCT02061280|615960544|FG001|Overall Study|moved out of state|1|||
170443558|NCT02061280|615960543|FG000|Overall Study|Withdrawal by Subject|1|||
170886761|NCT04372927|617593533|FG000|Overall Study|Death|1|||
170886762|NCT01847885|617593534|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
170886763|NCT01847885|617593535|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
170886764|NCT01847885|617593536|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
170886765|NCT01847885|617593534|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
170886766|NCT01847885|617593535|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
170443559|NCT02061280|615960544|FG001|Overall Study|Withdrawal by Subject|2|||
170443560|NCT02061280|615960543|FG000|Overall Study|Lost to Follow-up|5|||
170886767|NCT01847885|617593536|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
170443561|NCT02061280|615960544|FG001|Overall Study|Lost to Follow-up|1|||
170443562|NCT01977456|615960545|FG000|Overall Study|Death|5|||
170443563|NCT01253564|615960548|FG000|Overall Study|Disease Progression|22|||
170443564|NCT01253564|615960548|FG000|Overall Study|Withdrawal by Subject|1|||
170443565|NCT01253564|615960548|FG000|Overall Study|Serious Adverse Event|1|||
170443566|NCT01751087|615960549|FG000|Overall Study|Withdrawal by Subject|1|||
170443567|NCT01751087|615960550|FG001|Overall Study|Withdrawal by Subject|0|||
170785604|NCT05247489|617223454|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
170785605|NCT05247489|617223455|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
170785606|NCT05247489|617223454|FG000|Overall Study|Left Country|1|||
170785607|NCT05247489|617223455|FG001|Overall Study|Left Country|0|||
170785608|NCT05247489|617223454|FG000|Overall Study|Noncompliance with Investigational Product|1|||
170785609|NCT05247489|617223455|FG001|Overall Study|Noncompliance with Investigational Product|0|||
170785610|NCT05247489|617223454|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
170785611|NCT05247489|617223455|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
170443568|NCT01751087|615960551|FG002|Overall Study|Withdrawal by Subject|0|||
170443569|NCT01751087|615960549|FG000|Overall Study|Physician Decision|0|||
170443570|NCT01751087|615960550|FG001|Overall Study|Physician Decision|0|||
170443571|NCT01751087|615960551|FG002|Overall Study|Physician Decision|1|||
170443572|NCT00724958|615960560|FG000|Overall Study|Adverse Event|28|||
170443573|NCT00724958|615960560|FG000|Overall Study|Loss of Response|40|||
170443574|NCT00724958|615960560|FG000|Overall Study|No Response|18|||
170443575|NCT00724958|615960560|FG000|Overall Study|Remission|7|||
170443576|NCT00724958|615960560|FG000|Overall Study|Other Reason|76|||
170443577|NCT00724958|615960560|FG000|Overall Study|No documentation for end of therapy|13|||
170443578|NCT01841060|615962729|FG000|Overall Study|Protocol Violation|10|||
170443579|NCT03431337|615962730|FG000|Overall Study|Lost to Follow-up|21|||
170443580|NCT03431337|615962731|FG001|Overall Study|Lost to Follow-up|19|||
170443581|NCT03431337|615962730|FG000|Overall Study|Withdrawal by Subject|8|||
170443582|NCT03431337|615962731|FG001|Overall Study|Withdrawal by Subject|3|||
170443583|NCT00401245|615962732|FG000|Double Blind Titration Phase|Adverse Event|3|||
170443584|NCT00401245|615962733|FG001|Double Blind Titration Phase|Adverse Event|2|||
170443585|NCT00401245|615962734|FG002|Double Blind Titration Phase|Adverse Event|5|||
170443586|NCT00401245|615962735|FG003|Double Blind Titration Phase|Adverse Event|12|||
170443587|NCT00401245|615962736|FG004|Double Blind Titration Phase|Adverse Event|0|||
170443588|NCT00401245|615962737|FG005|Double Blind Titration Phase|Adverse Event|0|||
170443589|NCT00401245|615962738|FG006|Double Blind Titration Phase|Adverse Event|0|||
170443590|NCT00401245|615962739|FG007|Double Blind Titration Phase|Adverse Event|0|||
170443591|NCT00401245|615962732|FG000|Double Blind Titration Phase|Other|0|||
170443592|NCT00401245|615962733|FG001|Double Blind Titration Phase|Other|0|||
170443593|NCT00401245|615962734|FG002|Double Blind Titration Phase|Other|1|||
170443594|NCT00401245|615962735|FG003|Double Blind Titration Phase|Other|0|||
170443595|NCT00401245|615962736|FG004|Double Blind Titration Phase|Other|0|||
170443596|NCT00401245|615962737|FG005|Double Blind Titration Phase|Other|0|||
170443597|NCT00401245|615962738|FG006|Double Blind Titration Phase|Other|0|||
170443598|NCT00401245|615962739|FG007|Double Blind Titration Phase|Other|0|||
170443599|NCT00401245|615962732|FG000|Double Blind Titration Phase|Protocol Violation|0|||
170443600|NCT00401245|615962733|FG001|Double Blind Titration Phase|Protocol Violation|0|||
170443601|NCT00401245|615962734|FG002|Double Blind Titration Phase|Protocol Violation|0|||
170443602|NCT00401245|615962735|FG003|Double Blind Titration Phase|Protocol Violation|1|||
170443603|NCT00401245|615962736|FG004|Double Blind Titration Phase|Protocol Violation|0|||
170443604|NCT00401245|615962737|FG005|Double Blind Titration Phase|Protocol Violation|0|||
170443605|NCT00401245|615962738|FG006|Double Blind Titration Phase|Protocol Violation|0|||
170538833|NCT01147458|616315803|FG003|First Intervention|Withdrawal by Subject|0|||
170443606|NCT00401245|615962739|FG007|Double Blind Titration Phase|Protocol Violation|0|||
170443607|NCT00401245|615962732|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
170443608|NCT00401245|615962733|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
170443609|NCT00401245|615962734|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
170443610|NCT00401245|615962735|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
170443611|NCT00401245|615962736|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
170538834|NCT01147458|616315800|FG000|First Intervention|Adverse Event|0|||
170538835|NCT01147458|616315801|FG001|First Intervention|Adverse Event|3|||
170538836|NCT01147458|616315802|FG002|First Intervention|Adverse Event|2|||
170538837|NCT01147458|616315803|FG003|First Intervention|Adverse Event|3|||
170538838|NCT01147458|616315800|FG000|First Intervention|Other|1|||
170538839|NCT01147458|616315801|FG001|First Intervention|Other|2|||
170538840|NCT01147458|616315802|FG002|First Intervention|Other|0|||
170538841|NCT01147458|616315803|FG003|First Intervention|Other|0|||
170538842|NCT01147458|616315800|FG000|Second Intervention|Study terminated by sponsor|7|||
170538843|NCT01147458|616315801|FG001|Second Intervention|Study terminated by sponsor|5|||
170538844|NCT01147458|616315802|FG002|Second Intervention|Study terminated by sponsor|5|||
170538845|NCT01147458|616315803|FG003|Second Intervention|Study terminated by sponsor|3|||
170538846|NCT01147458|616315800|FG000|Second Intervention|Protocol Violation|0|||
170538847|NCT01147458|616315801|FG001|Second Intervention|Protocol Violation|1|||
170538848|NCT01147458|616315802|FG002|Second Intervention|Protocol Violation|1|||
170538849|NCT01147458|616315803|FG003|Second Intervention|Protocol Violation|0|||
170538850|NCT01147458|616315800|FG000|Second Intervention|Withdrawal by Subject|0|||
170538851|NCT01147458|616315801|FG001|Second Intervention|Withdrawal by Subject|1|||
170538852|NCT01147458|616315802|FG002|Second Intervention|Withdrawal by Subject|0|||
170538853|NCT01147458|616315803|FG003|Second Intervention|Withdrawal by Subject|0|||
170538854|NCT01147458|616315800|FG000|Second Intervention|Adverse Event|2|||
170538855|NCT01147458|616315801|FG001|Second Intervention|Adverse Event|0|||
170538856|NCT01147458|616315802|FG002|Second Intervention|Adverse Event|1|||
170538857|NCT01147458|616315803|FG003|Second Intervention|Adverse Event|1|||
170538858|NCT01147458|616315800|FG000|Second Intervention|Other|0|||
170538859|NCT01147458|616315801|FG001|Second Intervention|Other|0|||
170538860|NCT01147458|616315802|FG002|Second Intervention|Other|1|||
170538861|NCT01147458|616315803|FG003|Second Intervention|Other|0|||
170538862|NCT02555878|616315811|FG000|Overall Study|Lost to Follow-up|2|||
170538863|NCT02555878|616315812|FG001|Overall Study|Lost to Follow-up|3|||
170538864|NCT02555878|616315811|FG000|Overall Study|Withdrawal by Subject|48|||
170538865|NCT02555878|616315812|FG001|Overall Study|Withdrawal by Subject|48|||
170538866|NCT02555878|616315811|FG000|Overall Study|Adverse Event|12|||
170538867|NCT02555878|616315812|FG001|Overall Study|Adverse Event|8|||
170538868|NCT02555878|616315811|FG000|Overall Study|Death|74|||
170538869|NCT02555878|616315812|FG001|Overall Study|Death|59|||
170538870|NCT02555878|616315811|FG000|Overall Study|Protocol Violation|1|||
170538871|NCT02555878|616315812|FG001|Overall Study|Protocol Violation|2|||
170538872|NCT02555878|616315811|FG000|Overall Study|Physician Decision|12|||
170538873|NCT02555878|616315812|FG001|Overall Study|Physician Decision|13|||
170886768|NCT01847885|617593534|FG000|Initial Enrollment (Consented)|Screen failure|39|||
170886769|NCT01847885|617593535|FG001|Initial Enrollment (Consented)|Screen failure|0|||
170886770|NCT01847885|617593536|FG002|Initial Enrollment (Consented)|Screen failure|0|||
170443612|NCT00401245|615962737|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
170443613|NCT00401245|615962738|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
170443614|NCT00401245|615962739|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
170443615|NCT00401245|615962732|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
170443616|NCT00401245|615962733|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
170443617|NCT00401245|615962734|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
170443618|NCT00401245|615962735|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
170443619|NCT00401245|615962736|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
170443620|NCT00401245|615962737|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
170443621|NCT00401245|615962738|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
170443622|NCT00401245|615962739|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
170443623|NCT00401245|615962732|FG000|Open Label Phase|Adverse Event|5|||
170443624|NCT00401245|615962733|FG001|Open Label Phase|Adverse Event|14|||
170443625|NCT00401245|615962734|FG002|Open Label Phase|Adverse Event|6|||
170443626|NCT00401245|615962735|FG003|Open Label Phase|Adverse Event|7|||
170443627|NCT00401245|615962736|FG004|Open Label Phase|Adverse Event|0|||
170443628|NCT00401245|615962737|FG005|Open Label Phase|Adverse Event|0|||
170443629|NCT00401245|615962738|FG006|Open Label Phase|Adverse Event|0|||
170443630|NCT00401245|615962739|FG007|Open Label Phase|Adverse Event|0|||
170538874|NCT02555878|616315811|FG000|Overall Study|Other|17|||
170886771|NCT01847885|617593534|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
170538875|NCT02555878|616315812|FG001|Overall Study|Other|17|||
170538876|NCT01164475|616315813|FG000|Overall Study|Lack of Efficacy|1|||
170538877|NCT01164475|616315814|FG001|Overall Study|Lack of Efficacy|0|||
170538878|NCT01164475|616315813|FG000|Overall Study|Other|0|||
170538879|NCT01164475|616315814|FG001|Overall Study|Other|1|||
170538880|NCT01164475|616315813|FG000|Overall Study|Progressive disease|0|||
170538881|NCT01164475|616315814|FG001|Overall Study|Progressive disease|1|||
170538882|NCT01164475|616315813|FG000|Overall Study|Protocol Violation|1|||
170443631|NCT00401245|615962732|FG000|Open Label Phase|Lost to Follow-up|5|||
170443632|NCT00401245|615962733|FG001|Open Label Phase|Lost to Follow-up|7|||
170538883|NCT01164475|616315814|FG001|Overall Study|Protocol Violation|0|||
170538884|NCT02335944|616315815|FG000|Treatment Phase|Progressive Disease|2|||
170443633|NCT00401245|615962734|FG002|Open Label Phase|Lost to Follow-up|5|||
170443634|NCT00401245|615962735|FG003|Open Label Phase|Lost to Follow-up|4|||
170443635|NCT00401245|615962736|FG004|Open Label Phase|Lost to Follow-up|0|||
170443636|NCT00401245|615962737|FG005|Open Label Phase|Lost to Follow-up|0|||
170443637|NCT00401245|615962738|FG006|Open Label Phase|Lost to Follow-up|0|||
170443638|NCT00401245|615962739|FG007|Open Label Phase|Lost to Follow-up|0|||
170443639|NCT00401245|615962732|FG000|Open Label Phase|Other|4|||
170443640|NCT00401245|615962733|FG001|Open Label Phase|Other|8|||
170443641|NCT00401245|615962734|FG002|Open Label Phase|Other|7|||
170443642|NCT00401245|615962735|FG003|Open Label Phase|Other|8|||
170443643|NCT00401245|615962736|FG004|Open Label Phase|Other|0|||
170443644|NCT00401245|615962737|FG005|Open Label Phase|Other|0|||
170443645|NCT00401245|615962738|FG006|Open Label Phase|Other|0|||
170443646|NCT00401245|615962739|FG007|Open Label Phase|Other|0|||
170443647|NCT00401245|615962732|FG000|Open Label Phase|Protocol Violation|0|||
170443648|NCT00401245|615962733|FG001|Open Label Phase|Protocol Violation|1|||
170443649|NCT00401245|615962734|FG002|Open Label Phase|Protocol Violation|0|||
170443650|NCT00401245|615962735|FG003|Open Label Phase|Protocol Violation|1|||
170443651|NCT00401245|615962736|FG004|Open Label Phase|Protocol Violation|0|||
170443652|NCT00401245|615962737|FG005|Open Label Phase|Protocol Violation|0|||
170443653|NCT00401245|615962738|FG006|Open Label Phase|Protocol Violation|0|||
170443654|NCT00401245|615962739|FG007|Open Label Phase|Protocol Violation|0|||
170443655|NCT00401245|615962732|FG000|Open Label Phase|Withdrawal by Subject|3|||
170443656|NCT00401245|615962733|FG001|Open Label Phase|Withdrawal by Subject|3|||
170443657|NCT00401245|615962734|FG002|Open Label Phase|Withdrawal by Subject|2|||
170443658|NCT00401245|615962735|FG003|Open Label Phase|Withdrawal by Subject|1|||
170633166|NCT03594110|616668477|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
170633167|NCT03594110|616668476|FG000|Interventional Part|Contraindicated drug started|32|||
170443659|NCT00401245|615962736|FG004|Open Label Phase|Withdrawal by Subject|0|||
170443660|NCT00401245|615962737|FG005|Open Label Phase|Withdrawal by Subject|0|||
170443661|NCT00401245|615962738|FG006|Open Label Phase|Withdrawal by Subject|0|||
170443662|NCT00401245|615962739|FG007|Open Label Phase|Withdrawal by Subject|0|||
170443663|NCT00401245|615962732|FG000|Open Label Phase|Lack of Efficacy|4|||
170443664|NCT00401245|615962733|FG001|Open Label Phase|Lack of Efficacy|2|||
170443665|NCT00401245|615962734|FG002|Open Label Phase|Lack of Efficacy|3|||
170443666|NCT00401245|615962735|FG003|Open Label Phase|Lack of Efficacy|0|||
170886772|NCT01847885|617593535|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
170886773|NCT01847885|617593536|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
170886774|NCT01847885|617593534|FG000|Randomization|Protocol Violation|0|||
170886775|NCT01847885|617593535|FG001|Randomization|Protocol Violation|1|||
170886776|NCT01847885|617593536|FG002|Randomization|Protocol Violation|0|||
170886777|NCT01847885|617593534|FG000|Randomization|Withdrawal by Subject|0|||
170886778|NCT01847885|617593535|FG001|Randomization|Withdrawal by Subject|0|||
170886779|NCT01847885|617593536|FG002|Randomization|Withdrawal by Subject|2|||
170886780|NCT01847885|617593534|FG000|Randomization|Screen Failure|0|||
170886781|NCT01847885|617593535|FG001|Randomization|Screen Failure|3|||
170886782|NCT01847885|617593536|FG002|Randomization|Screen Failure|0|||
170886783|NCT00608985|617593537|FG000|Overall Study|Adverse Event|2|||
170886784|NCT00608985|617593538|FG001|Overall Study|Adverse Event|7|||
170886785|NCT00608985|617593539|FG002|Overall Study|Adverse Event|4|||
170886786|NCT00608985|617593540|FG003|Overall Study|Adverse Event|6|||
170886787|NCT00608985|617593537|FG000|Overall Study|Administrative/Other|7|||
170886788|NCT00608985|617593538|FG001|Overall Study|Administrative/Other|4|||
170886789|NCT00608985|617593539|FG002|Overall Study|Administrative/Other|1|||
170886790|NCT00608985|617593540|FG003|Overall Study|Administrative/Other|2|||
170886791|NCT00608985|617593537|FG000|Overall Study|Withdrawal of Consent|5|||
170886792|NCT00608985|617593538|FG001|Overall Study|Withdrawal of Consent|1|||
170886793|NCT00608985|617593539|FG002|Overall Study|Withdrawal of Consent|1|||
170886794|NCT00608985|617593540|FG003|Overall Study|Withdrawal of Consent|1|||
170886795|NCT00608985|617593537|FG000|Overall Study|Lost to Follow-up|2|||
170886796|NCT00608985|617593538|FG001|Overall Study|Lost to Follow-up|1|||
170886797|NCT00608985|617593539|FG002|Overall Study|Lost to Follow-up|0|||
170886798|NCT00608985|617593540|FG003|Overall Study|Lost to Follow-up|0|||
170886799|NCT03033745|617593541|FG000|Overall Study|Protocol Violation|0|||
170886800|NCT03033745|617593542|FG001|Overall Study|Protocol Violation|0|||
170886801|NCT03033745|617593543|FG002|Overall Study|Protocol Violation|1|||
170886802|NCT03033745|617593541|FG000|Overall Study|Adverse Event|1|||
170886803|NCT03033745|617593542|FG001|Overall Study|Adverse Event|0|||
170886804|NCT03033745|617593543|FG002|Overall Study|Adverse Event|1|||
170886805|NCT03033745|617593541|FG000|Overall Study|Withdrawal by Subject|0|||
170886806|NCT03033745|617593542|FG001|Overall Study|Withdrawal by Subject|1|||
170886807|NCT03033745|617593543|FG002|Overall Study|Withdrawal by Subject|0|||
170886808|NCT00661271|617593544|FG000|Overall Study|Lost to Follow-up|28|||
170886809|NCT00661271|617593545|FG001|Overall Study|Lost to Follow-up|25|||
170886810|NCT03728309|617593546|FG000|Overall Study|Randomized but not Treated|0|||
170886811|NCT03728309|617593547|FG001|Overall Study|Randomized but not Treated|1|||
170886812|NCT03728309|617593546|FG000|Overall Study|Adverse Event|0|||
170886813|NCT03728309|617593547|FG001|Overall Study|Adverse Event|1|||
170443667|NCT00401245|615962736|FG004|Open Label Phase|Lack of Efficacy|0|||
170443668|NCT00401245|615962737|FG005|Open Label Phase|Lack of Efficacy|0|||
170443669|NCT00401245|615962738|FG006|Open Label Phase|Lack of Efficacy|0|||
170443670|NCT00401245|615962739|FG007|Open Label Phase|Lack of Efficacy|0|||
170443671|NCT00401245|615962732|FG000|Double Blind Tapering Phase|Adverse Event|0|||
170443672|NCT00401245|615962733|FG001|Double Blind Tapering Phase|Adverse Event|0|||
170443673|NCT00401245|615962734|FG002|Double Blind Tapering Phase|Adverse Event|0|||
170886814|NCT03728309|617593546|FG000|Overall Study|Withdrawal by Subject|2|||
170886815|NCT03728309|617593547|FG001|Overall Study|Withdrawal by Subject|8|||
170886816|NCT03728309|617593546|FG000|Overall Study|Lost to Follow-up|9|||
170886817|NCT03728309|617593547|FG001|Overall Study|Lost to Follow-up|10|||
170886818|NCT03728309|617593546|FG000|Overall Study|Protocol Deviation|0|||
170886819|NCT03728309|617593547|FG001|Overall Study|Protocol Deviation|1|||
170886820|NCT03728309|617593546|FG000|Overall Study|Due to COVID|1|||
170886821|NCT03728309|617593547|FG001|Overall Study|Due to COVID|3|||
170886822|NCT00953758|617593550|FG000|Overall Study|Death|2|||
170443674|NCT00401245|615962735|FG003|Double Blind Tapering Phase|Adverse Event|0|||
170443675|NCT00401245|615962736|FG004|Double Blind Tapering Phase|Adverse Event|1|||
170443676|NCT00401245|615962737|FG005|Double Blind Tapering Phase|Adverse Event|1|||
170443677|NCT00401245|615962738|FG006|Double Blind Tapering Phase|Adverse Event|2|||
170443678|NCT00401245|615962739|FG007|Double Blind Tapering Phase|Adverse Event|4|||
170443679|NCT00401245|615962732|FG000|Double Blind Tapering Phase|Investigator request|0|||
170443680|NCT00401245|615962733|FG001|Double Blind Tapering Phase|Investigator request|0|||
170443681|NCT00401245|615962734|FG002|Double Blind Tapering Phase|Investigator request|0|||
170443682|NCT00401245|615962735|FG003|Double Blind Tapering Phase|Investigator request|0|||
170443683|NCT00401245|615962736|FG004|Double Blind Tapering Phase|Investigator request|0|||
170443684|NCT00401245|615962737|FG005|Double Blind Tapering Phase|Investigator request|0|||
170443685|NCT00401245|615962738|FG006|Double Blind Tapering Phase|Investigator request|0|||
170443686|NCT00401245|615962739|FG007|Double Blind Tapering Phase|Investigator request|1|||
170443687|NCT00401245|615962732|FG000|Double Blind Tapering Phase|Other|0|||
170443688|NCT00401245|615962733|FG001|Double Blind Tapering Phase|Other|0|||
170443689|NCT00401245|615962734|FG002|Double Blind Tapering Phase|Other|0|||
170443690|NCT00401245|615962735|FG003|Double Blind Tapering Phase|Other|0|||
170443691|NCT00401245|615962736|FG004|Double Blind Tapering Phase|Other|1|||
170886823|NCT00953758|617593551|FG001|Overall Study|Death|0|||
170443692|NCT00401245|615962737|FG005|Double Blind Tapering Phase|Other|0|||
170443693|NCT00401245|615962738|FG006|Double Blind Tapering Phase|Other|2|||
170443694|NCT00401245|615962739|FG007|Double Blind Tapering Phase|Other|2|||
170443695|NCT00401245|615962732|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
170443696|NCT00401245|615962733|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
170443697|NCT00401245|615962734|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
170443698|NCT00401245|615962735|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
170443699|NCT00401245|615962736|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
170443700|NCT00401245|615962737|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
170443701|NCT00401245|615962738|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
170443702|NCT00401245|615962739|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
170443703|NCT00401245|615962732|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
170443704|NCT00401245|615962733|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
170443705|NCT00401245|615962734|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
170443706|NCT00401245|615962735|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
170443707|NCT00401245|615962736|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
170443708|NCT00401245|615962737|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
170443709|NCT00401245|615962738|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
170443710|NCT00401245|615962739|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
170443711|NCT04167618|615962740|FG000|Overall Study|Trial terminated by sponsor|1|||
170443712|NCT04167618|615962741|FG001|Overall Study|Trial terminated by sponsor|1|||
170443713|NCT01235715|615962742|FG000|Overall Study|Physician Decision|0|||
170443714|NCT01235715|615962743|FG001|Overall Study|Physician Decision|2|||
170443715|NCT02994394|615962744|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
170443716|NCT02994394|615962745|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
170443717|NCT02994394|615962746|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
170443718|NCT02994394|615962747|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
170443719|NCT02994394|615962748|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
170443720|NCT02994394|615962749|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
170443721|NCT02994394|615962744|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
170443722|NCT02994394|615962745|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
170443723|NCT02994394|615962746|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
170443724|NCT02994394|615962747|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
170443725|NCT02994394|615962748|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
170443726|NCT02994394|615962749|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
170443727|NCT02344745|615962750|FG000|Overall Study|Data collection sheets were lost|2|||
170443728|NCT02344745|615962751|FG001|Overall Study|Data collection sheets were lost|0|||
170443729|NCT02788513|615962752|FG000|Overall Study|Withdrawal by Subject|3|||
170443730|NCT02788513|615962753|FG001|Overall Study|Withdrawal by Subject|0|||
170443731|NCT02788513|615962754|FG002|Overall Study|Withdrawal by Subject|2|||
170443732|NCT02788513|615962755|FG003|Overall Study|Withdrawal by Subject|3|||
170443733|NCT02788513|615962756|FG004|Overall Study|Withdrawal by Subject|1|||
170443734|NCT02788513|615962752|FG000|Overall Study|Lost to Follow-up|1|||
170443735|NCT02788513|615962753|FG001|Overall Study|Lost to Follow-up|0|||
170443736|NCT02788513|615962754|FG002|Overall Study|Lost to Follow-up|0|||
170443737|NCT02788513|615962755|FG003|Overall Study|Lost to Follow-up|0|||
170443738|NCT02788513|615962756|FG004|Overall Study|Lost to Follow-up|1|||
170443739|NCT02788513|615962752|FG000|Overall Study|Adverse Event|5|||
170443740|NCT02788513|615962753|FG001|Overall Study|Adverse Event|8|||
170443741|NCT02788513|615962754|FG002|Overall Study|Adverse Event|4|||
170443742|NCT02788513|615962755|FG003|Overall Study|Adverse Event|2|||
170443743|NCT02788513|615962756|FG004|Overall Study|Adverse Event|2|||
170443744|NCT02788513|615962752|FG000|Overall Study|Protocol Violation|0|||
170443745|NCT02788513|615962753|FG001|Overall Study|Protocol Violation|0|||
170443746|NCT02788513|615962754|FG002|Overall Study|Protocol Violation|1|||
170443747|NCT02788513|615962755|FG003|Overall Study|Protocol Violation|1|||
170443748|NCT02788513|615962756|FG004|Overall Study|Protocol Violation|0|||
170443749|NCT02788513|615962752|FG000|Overall Study|Subject decided to stop taking treatment|0|||
170443750|NCT02788513|615962753|FG001|Overall Study|Subject decided to stop taking treatment|0|||
170443751|NCT02788513|615962754|FG002|Overall Study|Subject decided to stop taking treatment|1|||
170443752|NCT02788513|615962755|FG003|Overall Study|Subject decided to stop taking treatment|0|||
170443753|NCT02788513|615962756|FG004|Overall Study|Subject decided to stop taking treatment|0|||
170443754|NCT02788513|615962752|FG000|Overall Study|Decision by the study team|0|||
170443755|NCT02788513|615962753|FG001|Overall Study|Decision by the study team|0|||
170443756|NCT02788513|615962754|FG002|Overall Study|Decision by the study team|0|||
170443757|NCT02788513|615962755|FG003|Overall Study|Decision by the study team|0|||
170443758|NCT02788513|615962756|FG004|Overall Study|Decision by the study team|1|||
170443759|NCT03330236|615962760|FG000|Overall Study|Death|2|||
170443760|NCT03330236|615962761|FG001|Overall Study|Death|1|||
170443761|NCT03330236|615962760|FG000|Overall Study|Withdrawal by Subject|2|||
170443762|NCT03330236|615962761|FG001|Overall Study|Withdrawal by Subject|4|||
170443763|NCT03330236|615962760|FG000|Overall Study|Lost to Follow-up|0|||
170443764|NCT03330236|615962761|FG001|Overall Study|Lost to Follow-up|2|||
170443765|NCT03330236|615962760|FG000|Overall Study|Physician Decision|2|||
170443766|NCT03330236|615962761|FG001|Overall Study|Physician Decision|0|||
170443767|NCT03330236|615962760|FG000|Overall Study|Protocol Violation|4|||
170443768|NCT03330236|615962761|FG001|Overall Study|Protocol Violation|3|||
170443769|NCT03330236|615962760|FG000|Overall Study|SedLine malfunction/blinding|19|||
170443770|NCT03330236|615962761|FG001|Overall Study|SedLine malfunction/blinding|14|||
170443771|NCT03330236|615962760|FG000|Overall Study|Volatile anesthetics used|11|||
170443772|NCT03330236|615962761|FG001|Overall Study|Volatile anesthetics used|8|||
170443773|NCT03330236|615962760|FG000|Overall Study|Surgery aborted/converted to open|60|||
170443774|NCT03330236|615962761|FG001|Overall Study|Surgery aborted/converted to open|52|||
170443775|NCT00763555|615962764|FG000|Overall Study|Adverse Event|2|||
170443776|NCT00763555|615962765|FG001|Overall Study|Adverse Event|1|||
170443777|NCT00763555|615962764|FG000|Overall Study|Withdrawal by Subject|2|||
170443778|NCT00763555|615962765|FG001|Overall Study|Withdrawal by Subject|6|||
170443779|NCT00763555|615962764|FG000|Overall Study|Lost to Follow-up|0|||
170443780|NCT00763555|615962765|FG001|Overall Study|Lost to Follow-up|3|||
170443781|NCT01729026|615962766|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
170443782|NCT01729026|615962767|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
170443783|NCT01729026|615962766|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
170443784|NCT01729026|615962767|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
170443785|NCT00848042|615962772|FG000|Overall Study|Death|1|||
170443786|NCT00848042|615962773|FG001|Overall Study|Death|2|||
170443787|NCT00848042|615962774|FG002|Overall Study|Death|0|||
170443788|NCT00848042|615962772|FG000|Overall Study|Other Therapy|3|||
170443789|NCT00848042|615962773|FG001|Overall Study|Other Therapy|0|||
170443790|NCT00848042|615962774|FG002|Overall Study|Other Therapy|0|||
170443791|NCT00483548|615962775|FG000|Overall Study|Randomized; not treated with study drug|1|||
170443792|NCT00483548|615962776|FG001|Overall Study|Randomized; not treated with study drug|3|||
170443793|NCT00483548|615962775|FG000|Overall Study|Adverse Event|25|||
170443794|NCT00483548|615962776|FG001|Overall Study|Adverse Event|14|||
170443795|NCT00483548|615962775|FG000|Overall Study|Laboratory abnormality|1|||
170443796|NCT00483548|615962776|FG001|Overall Study|Laboratory abnormality|2|||
170443797|NCT00483548|615962775|FG000|Overall Study|Lack of Efficacy|4|||
170443798|NCT00483548|615962776|FG001|Overall Study|Lack of Efficacy|8|||
170443799|NCT00483548|615962775|FG000|Overall Study|Protocol Violation|11|||
170443800|NCT00483548|615962776|FG001|Overall Study|Protocol Violation|7|||
170443801|NCT00483548|615962775|FG000|Overall Study|Pregnancy|1|||
170443802|NCT00483548|615962776|FG001|Overall Study|Pregnancy|0|||
170443803|NCT00483548|615962775|FG000|Overall Study|Protocol required discontinuation|6|||
170443804|NCT00483548|615962776|FG001|Overall Study|Protocol required discontinuation|6|||
170443805|NCT00483548|615962775|FG000|Overall Study|Unable to comply with protocol schedule|1|||
170443806|NCT00483548|615962776|FG001|Overall Study|Unable to comply with protocol schedule|0|||
170443807|NCT00483548|615962775|FG000|Overall Study|Non-compliance with medication|2|||
170443808|NCT00483548|615962776|FG001|Overall Study|Non-compliance with medication|0|||
170443809|NCT00483548|615962775|FG000|Overall Study|Lost to Follow-up|3|||
170443810|NCT00483548|615962776|FG001|Overall Study|Lost to Follow-up|4|||
170443811|NCT00483548|615962775|FG000|Overall Study|Withdrawal by Subject|5|||
170443812|NCT00483548|615962776|FG001|Overall Study|Withdrawal by Subject|2|||
170443813|NCT02916693|615962777|FG000|Overall Study|Lost to Follow-up|7|||
170443814|NCT03223909|615962778|FG000|Overall Study|Protocol Violation|48|||
170886824|NCT00953758|617593552|FG002|Overall Study|Death|1|||
170443815|NCT03223909|615962779|FG001|Overall Study|Protocol Violation|45|||
170443816|NCT03223909|615962780|FG002|Overall Study|Protocol Violation|16|||
170443817|NCT00177164|615962786|FG000|Overall Study|Protocol Violation|0|||
170886825|NCT00953758|617593553|FG003|Overall Study|Death|1|||
170886826|NCT00953758|617593554|FG004|Overall Study|Death|1|||
170886827|NCT00953758|617593555|FG005|Overall Study|Death|1|||
170886828|NCT00953758|617593556|FG006|Overall Study|Death|1|||
170886829|NCT00953758|617593557|FG007|Overall Study|Death|3|||
170886830|NCT00953758|617593558|FG008|Overall Study|Death|1|||
170886831|NCT00953758|617593559|FG009|Overall Study|Death|0|||
170886832|NCT00953758|617593550|FG000|Overall Study|Participant refused further follow-up|0|||
170443818|NCT00177164|615962787|FG001|Overall Study|Protocol Violation|7|||
170443819|NCT00177164|615962786|FG000|Overall Study|Lost to Follow-up|4|||
170443820|NCT00177164|615962787|FG001|Overall Study|Lost to Follow-up|5|||
170443821|NCT00177164|615962786|FG000|Overall Study|increase in alcohol and drug use|1|||
170443822|NCT00177164|615962787|FG001|Overall Study|increase in alcohol and drug use|2|||
170443823|NCT00177164|615962786|FG000|Overall Study|Adverse Event|1|||
170886833|NCT00953758|617593551|FG001|Overall Study|Participant refused further follow-up|0|||
170886834|NCT00953758|617593552|FG002|Overall Study|Participant refused further follow-up|1|||
170886835|NCT00953758|617593553|FG003|Overall Study|Participant refused further follow-up|0|||
170886836|NCT00953758|617593554|FG004|Overall Study|Participant refused further follow-up|3|||
170886837|NCT00953758|617593555|FG005|Overall Study|Participant refused further follow-up|0|||
170443824|NCT00177164|615962787|FG001|Overall Study|Adverse Event|0|||
170443825|NCT00177164|615962786|FG000|Overall Study|discharge from hospital|1|||
170443826|NCT00177164|615962787|FG001|Overall Study|discharge from hospital|0|||
170443827|NCT00177164|615962786|FG000|Overall Study|Lack of Efficacy|2|||
170443828|NCT00177164|615962787|FG001|Overall Study|Lack of Efficacy|1|||
170443829|NCT00177164|615962786|FG000|Overall Study|Pregnancy|0|||
170443830|NCT00177164|615962787|FG001|Overall Study|Pregnancy|1|||
170443831|NCT05070754|615962791|FG000|Overall Study|Withdrawal by Subject|0|||
170443832|NCT05070754|615962792|FG001|Overall Study|Withdrawal by Subject|0|||
170443833|NCT05070754|615962793|FG002|Overall Study|Withdrawal by Subject|0|||
170443834|NCT05070754|615962794|FG003|Overall Study|Withdrawal by Subject|1|||
170443835|NCT05070754|615962791|FG000|Overall Study|Protocol Violation|0|||
170443836|NCT05070754|615962792|FG001|Overall Study|Protocol Violation|0|||
170443837|NCT05070754|615962793|FG002|Overall Study|Protocol Violation|0|||
170443838|NCT05070754|615962794|FG003|Overall Study|Protocol Violation|1|||
170538885|NCT02335944|616315816|FG001|Treatment Phase|Progressive Disease|5|||
170538886|NCT02335944|616315817|FG002|Treatment Phase|Progressive Disease|2|||
170538887|NCT02335944|616315818|FG003|Treatment Phase|Progressive Disease|11|||
170538888|NCT02335944|616315819|FG004|Treatment Phase|Progressive Disease|4|||
170538889|NCT02335944|616315820|FG005|Treatment Phase|Progressive Disease|25|||
170538890|NCT02335944|616315821|FG006|Treatment Phase|Progressive Disease|2|||
170538891|NCT02335944|616315822|FG007|Treatment Phase|Progressive Disease|30|||
170538892|NCT02335944|616315823|FG008|Treatment Phase|Progressive Disease|27|||
170538893|NCT02335944|616315824|FG009|Treatment Phase|Progressive Disease|0|||
170886838|NCT00953758|617593556|FG006|Overall Study|Participant refused further follow-up|0|||
170886839|NCT00953758|617593557|FG007|Overall Study|Participant refused further follow-up|0|||
170886840|NCT00953758|617593558|FG008|Overall Study|Participant refused further follow-up|1|||
170886841|NCT00953758|617593559|FG009|Overall Study|Participant refused further follow-up|0|||
170886842|NCT00953758|617593550|FG000|Overall Study|Lost to Follow-up|0|||
170886843|NCT00953758|617593551|FG001|Overall Study|Lost to Follow-up|0|||
170886844|NCT00953758|617593552|FG002|Overall Study|Lost to Follow-up|0|||
170886845|NCT00953758|617593553|FG003|Overall Study|Lost to Follow-up|1|||
170886846|NCT00953758|617593554|FG004|Overall Study|Lost to Follow-up|0|||
170886847|NCT00953758|617593555|FG005|Overall Study|Lost to Follow-up|0|||
170886848|NCT00953758|617593556|FG006|Overall Study|Lost to Follow-up|0|||
170886849|NCT00953758|617593557|FG007|Overall Study|Lost to Follow-up|1|||
170886850|NCT00953758|617593558|FG008|Overall Study|Lost to Follow-up|0|||
170886851|NCT00953758|617593559|FG009|Overall Study|Lost to Follow-up|1|||
170886852|NCT00953758|617593550|FG000|Overall Study|Physician Decision|0|||
170443839|NCT04010227|615962796|FG000|Overall Study|Death|1|||
170538894|NCT02335944|616315815|FG000|Treatment Phase|Adverse Event|2|||
170538895|NCT02335944|616315816|FG001|Treatment Phase|Adverse Event|0|||
170538896|NCT02335944|616315817|FG002|Treatment Phase|Adverse Event|0|||
170538897|NCT02335944|616315818|FG003|Treatment Phase|Adverse Event|2|||
170886853|NCT00953758|617593551|FG001|Overall Study|Physician Decision|0|||
170443840|NCT04010227|615962797|FG001|Overall Study|Death|2|||
170538898|NCT02335944|616315819|FG004|Treatment Phase|Adverse Event|1|||
170538899|NCT02335944|616315820|FG005|Treatment Phase|Adverse Event|15|||
170443841|NCT04010227|615962796|FG000|Overall Study|Medical Reasons|4|||
170443842|NCT04010227|615962797|FG001|Overall Study|Medical Reasons|3|||
170443843|NCT04010227|615962796|FG000|Overall Study|Withdrawal by Subject|2|||
170886854|NCT00953758|617593552|FG002|Overall Study|Physician Decision|0|||
170443844|NCT04010227|615962797|FG001|Overall Study|Withdrawal by Subject|0|||
170443845|NCT04010227|615962796|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
170443846|NCT04010227|615962797|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
170443847|NCT00529217|615962798|FG000|Overall Study|Lack of Efficacy|2|||
170443848|NCT00529217|615962798|FG000|Overall Study|Unable to adhere to study schedule|2|||
170443849|NCT02448563|615962799|FG000|Overall Study|Lost to Follow-up|16|||
170443850|NCT02448563|615962800|FG001|Overall Study|Lost to Follow-up|10|||
170443851|NCT02448563|615962799|FG000|Overall Study|Withdrawal by Subject|0|||
170443852|NCT02448563|615962800|FG001|Overall Study|Withdrawal by Subject|1|||
170785612|NCT03673111|617223460|FG000|Overall Study|Protocol Violation|0|||
170785613|NCT03673111|617223461|FG001|Overall Study|Protocol Violation|0|||
170785614|NCT03673111|617223462|FG002|Overall Study|Protocol Violation|0|||
170785615|NCT03673111|617223463|FG003|Overall Study|Protocol Violation|0|||
170785616|NCT03673111|617223464|FG004|Overall Study|Protocol Violation|0|||
170785617|NCT03673111|617223465|FG005|Overall Study|Protocol Violation|0|||
170785618|NCT03673111|617223466|FG006|Overall Study|Protocol Violation|0|||
170785619|NCT03673111|617223467|FG007|Overall Study|Protocol Violation|0|||
170785620|NCT03673111|617223468|FG008|Overall Study|Protocol Violation|0|||
170785621|NCT03673111|617223469|FG009|Overall Study|Protocol Violation|0|||
170785622|NCT03673111|617223470|FG010|Overall Study|Protocol Violation|1|||
170785623|NCT03673111|617223471|FG011|Overall Study|Protocol Violation|0|||
170785624|NCT03673111|617223472|FG012|Overall Study|Protocol Violation|0|||
170785625|NCT03673111|617223473|FG013|Overall Study|Protocol Violation|0|||
170785626|NCT03673111|617223460|FG000|Overall Study|Adverse Event|1|||
170785627|NCT03673111|617223461|FG001|Overall Study|Adverse Event|0|||
170785628|NCT03673111|617223462|FG002|Overall Study|Adverse Event|0|||
170785629|NCT03673111|617223463|FG003|Overall Study|Adverse Event|0|||
170785630|NCT03673111|617223464|FG004|Overall Study|Adverse Event|0|||
170785631|NCT03673111|617223465|FG005|Overall Study|Adverse Event|0|||
170785632|NCT03673111|617223466|FG006|Overall Study|Adverse Event|0|||
170785633|NCT03673111|617223467|FG007|Overall Study|Adverse Event|0|||
170785634|NCT03673111|617223468|FG008|Overall Study|Adverse Event|0|||
170785635|NCT03673111|617223469|FG009|Overall Study|Adverse Event|0|||
170443853|NCT00702507|615962801|FG000|Initial Treatment Phase|Adverse Event|2|||
170443854|NCT00702507|615962801|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
170785636|NCT03673111|617223470|FG010|Overall Study|Adverse Event|0|||
170785637|NCT03673111|617223471|FG011|Overall Study|Adverse Event|0|||
170785638|NCT03673111|617223472|FG012|Overall Study|Adverse Event|0|||
170785639|NCT03673111|617223473|FG013|Overall Study|Adverse Event|0|||
170785640|NCT02243709|617223475|FG000|Phase 1|Lost to Follow-up|0|||
170785641|NCT02243709|617223476|FG001|Phase 1|Lost to Follow-up|1|||
170785642|NCT02243709|617223475|FG000|Phase 1|Withdrawal by Subject|1|||
170785643|NCT02243709|617223476|FG001|Phase 1|Withdrawal by Subject|0|||
170785644|NCT02243709|617223475|FG000|Phase 1|Protocol Violation|0|||
170785645|NCT02243709|617223476|FG001|Phase 1|Protocol Violation|1|||
170785646|NCT02243709|617223475|FG000|Phase 1|Adverse Event|0|||
170443855|NCT00702507|615962801|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
170443856|NCT00702507|615962801|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
170443857|NCT00702507|615962801|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
170443858|NCT00702507|615962801|FG000|Follow-up Phase|Protocol Violation|2|||
170443859|NCT00702507|615962801|FG000|Follow-up Phase|Lost to Follow-up|23|||
170443860|NCT00702507|615962801|FG000|Follow-up Phase|Late Enrollment|1|||
170443861|NCT00113919|615962802|FG000|Overall Study|Physician Decision|8|||
170443862|NCT00113919|615962802|FG000|Overall Study|Death|6|||
170443863|NCT01685008|615962803|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
170443864|NCT01685008|615962804|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
170443865|NCT01685008|615962805|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
170443866|NCT01685008|615962806|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
170443867|NCT01685008|615962803|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
170443868|NCT01685008|615962804|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
170443869|NCT01685008|615962805|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
170443870|NCT01685008|615962806|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
170443871|NCT01685008|615962803|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
170443872|NCT01685008|615962804|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
170443873|NCT01685008|615962805|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
170443874|NCT01685008|615962806|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
170443875|NCT01685008|615962803|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
170443876|NCT01685008|615962804|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
170785647|NCT02243709|617223476|FG001|Phase 1|Adverse Event|1|||
170785648|NCT04241068|617223477|FG000|Core Treatment Period|Adverse Event|91|||
170785649|NCT04241068|617223477|FG000|Core Treatment Period|Change of Treatment|4|||
170785650|NCT04241068|617223477|FG000|Core Treatment Period|Consent Withdrawn|143|||
170785651|NCT04241068|617223477|FG000|Core Treatment Period|Death|26|||
170785652|NCT04241068|617223477|FG000|Core Treatment Period|Disease Progression|67|||
170785653|NCT04241068|617223477|FG000|Core Treatment Period|Investigator Decision|40|||
170785654|NCT04241068|617223477|FG000|Core Treatment Period|Loss of Capacity|9|||
170785655|NCT04241068|617223477|FG000|Core Treatment Period|Lost to Follow-up|11|||
170785656|NCT04241068|617223477|FG000|Core Treatment Period|Relocation|4|||
170785657|NCT04241068|617223477|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
170785658|NCT04241068|617223477|FG000|Core Treatment Period|Study Visit Burden|40|||
170785659|NCT04241068|617223477|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
170785660|NCT04241068|617223477|FG000|Core Treatment Period|Missing|2|||
170785661|NCT04241068|617223477|FG000|Core Treatment Period|Reason Not Specified|41|||
170785662|NCT04241068|617223477|FG000|LTE Period|Adverse Event|19|||
170785663|NCT04241068|617223477|FG000|LTE Period|Change of Treatment|1|||
170785664|NCT04241068|617223477|FG000|LTE Period|Consent Withdrawn|71|||
170785665|NCT04241068|617223477|FG000|LTE Period|Death|8|||
170443877|NCT01685008|615962805|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
170443878|NCT01685008|615962806|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
170785666|NCT04241068|617223477|FG000|LTE Period|Disease Progression|11|||
170785667|NCT04241068|617223477|FG000|LTE Period|Investigator Decision|12|||
170785668|NCT04241068|617223477|FG000|LTE Period|Loss of Capacity|2|||
170785669|NCT04241068|617223477|FG000|LTE Period|Lost to Follow-up|7|||
170785670|NCT04241068|617223477|FG000|LTE Period|Relocation|6|||
170785671|NCT04241068|617223477|FG000|LTE Period|Site Terminated by Sponsor|26|||
170785672|NCT04241068|617223477|FG000|LTE Period|Study Terminated by Sponsor|276|||
170785673|NCT04241068|617223477|FG000|LTE Period|Study Visit Burden|10|||
170785674|NCT04241068|617223477|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
170785675|NCT04241068|617223477|FG000|LTE Period|Reason Not Specified|65|||
170785676|NCT04492007|617223481|FG000|Overall Study|Lost to Follow-up|1|||
170785677|NCT04492007|617223482|FG001|Overall Study|Lost to Follow-up|1|||
170785678|NCT04492007|617223483|FG002|Overall Study|Lost to Follow-up|2|||
170785679|NCT04492007|617223484|FG003|Overall Study|Lost to Follow-up|2|||
170785680|NCT04492007|617223481|FG000|Overall Study|Protocol Violation|1|||
170785681|NCT04492007|617223482|FG001|Overall Study|Protocol Violation|1|||
170785682|NCT04492007|617223483|FG002|Overall Study|Protocol Violation|1|||
170785683|NCT04492007|617223484|FG003|Overall Study|Protocol Violation|1|||
170785684|NCT04492007|617223481|FG000|Overall Study|Withdrawal by Subject|0|||
170785685|NCT04492007|617223482|FG001|Overall Study|Withdrawal by Subject|0|||
170785686|NCT04492007|617223483|FG002|Overall Study|Withdrawal by Subject|1|||
170785687|NCT04492007|617223484|FG003|Overall Study|Withdrawal by Subject|1|||
170785688|NCT04229992|617223487|FG000|Overall Study|Withdrawal by Subject|0|||
170785689|NCT04229992|617223488|FG001|Overall Study|Withdrawal by Subject|2|||
170785690|NCT04229992|617223489|FG002|Overall Study|Withdrawal by Subject|1|||
170785691|NCT04229992|617223490|FG003|Overall Study|Withdrawal by Subject|1|||
170785692|NCT04229992|617223487|FG000|Overall Study|Adverse Event|1|||
170785693|NCT04229992|617223488|FG001|Overall Study|Adverse Event|1|||
170785694|NCT04229992|617223489|FG002|Overall Study|Adverse Event|3|||
170785695|NCT04229992|617223490|FG003|Overall Study|Adverse Event|1|||
170785696|NCT04229992|617223487|FG000|Overall Study|Lost to Follow-up|0|||
170785697|NCT04229992|617223488|FG001|Overall Study|Lost to Follow-up|0|||
170538900|NCT02335944|616315821|FG006|Treatment Phase|Adverse Event|0|||
170538901|NCT02335944|616315822|FG007|Treatment Phase|Adverse Event|5|||
170538902|NCT02335944|616315823|FG008|Treatment Phase|Adverse Event|7|||
170538903|NCT02335944|616315824|FG009|Treatment Phase|Adverse Event|0|||
170538904|NCT02335944|616315815|FG000|Treatment Phase|Physician Decision|0|||
170538905|NCT02335944|616315816|FG001|Treatment Phase|Physician Decision|0|||
170538906|NCT02335944|616315817|FG002|Treatment Phase|Physician Decision|0|||
170538907|NCT02335944|616315818|FG003|Treatment Phase|Physician Decision|1|||
170538908|NCT02335944|616315819|FG004|Treatment Phase|Physician Decision|0|||
170538909|NCT02335944|616315820|FG005|Treatment Phase|Physician Decision|6|||
170538910|NCT02335944|616315821|FG006|Treatment Phase|Physician Decision|1|||
170538911|NCT02335944|616315822|FG007|Treatment Phase|Physician Decision|2|||
170538912|NCT02335944|616315823|FG008|Treatment Phase|Physician Decision|1|||
170538913|NCT02335944|616315824|FG009|Treatment Phase|Physician Decision|0|||
170538914|NCT02335944|616315815|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
170538915|NCT02335944|616315816|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
170785698|NCT04229992|617223489|FG002|Overall Study|Lost to Follow-up|0|||
170785699|NCT04229992|617223490|FG003|Overall Study|Lost to Follow-up|1|||
170785700|NCT03770273|617223491|FG000|Overall Study|Adverse Event|2|||
170785701|NCT03770273|617223492|FG001|Overall Study|Adverse Event|0|||
170785702|NCT03770273|617223491|FG000|Overall Study|Lost to Follow-up|1|||
170785703|NCT03770273|617223492|FG001|Overall Study|Lost to Follow-up|1|||
170785704|NCT00418886|617223493|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
170785705|NCT00418886|617223494|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
170785706|NCT00418886|617223493|FG000|Randomized Period|Death|122|||
170785707|NCT00418886|617223494|FG001|Randomized Period|Death|147|||
170785708|NCT00418886|617223493|FG000|Randomized Period|Withdrawal by Subject|9|||
170785709|NCT00418886|617223494|FG001|Randomized Period|Withdrawal by Subject|10|||
170785710|NCT00418886|617223493|FG000|Randomized Period|Lost to Follow-up|4|||
170785711|NCT00418886|617223494|FG001|Randomized Period|Lost to Follow-up|6|||
170785712|NCT00418886|617223493|FG000|Randomized Period|withdrawn due to other reason|1|||
170785713|NCT00418886|617223494|FG001|Randomized Period|withdrawn due to other reason|0|||
170785714|NCT00418886|617223493|FG000|Randomized Period|randomised but no treatment received|0|||
170785715|NCT00418886|617223494|FG001|Randomized Period|randomised but no treatment received|1|||
170785716|NCT04169373|617223495|FG000|Week 1 to Week 14|Adverse Event|1|||
170785717|NCT04169373|617223496|FG001|Week 1 to Week 14|Adverse Event|0|||
170785718|NCT04169373|617223497|FG002|Week 1 to Week 14|Adverse Event|1|||
170785719|NCT04169373|617223498|FG003|Week 1 to Week 14|Adverse Event|2|||
170785720|NCT04169373|617223495|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
170785721|NCT04169373|617223496|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
170785722|NCT04169373|617223497|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
170785723|NCT04169373|617223498|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
170785724|NCT04169373|617223495|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
170785725|NCT04169373|617223496|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
170785726|NCT04169373|617223497|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
170785727|NCT04169373|617223498|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
170785728|NCT04169373|617223495|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
170785729|NCT04169373|617223496|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
170785730|NCT04169373|617223497|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
170785731|NCT04169373|617223498|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
170785732|NCT04169373|617223495|FG000|Week 1 to Week 14|Other|1|||
170785733|NCT04169373|617223496|FG001|Week 1 to Week 14|Other|3|||
170785734|NCT04169373|617223497|FG002|Week 1 to Week 14|Other|3|||
170785735|NCT04169373|617223498|FG003|Week 1 to Week 14|Other|5|||
170785736|NCT04169373|617223495|FG000|Week 14 to Week 52|Adverse Event|1|||
170785737|NCT04169373|617223496|FG001|Week 14 to Week 52|Adverse Event|0|||
170785738|NCT04169373|617223497|FG002|Week 14 to Week 52|Adverse Event|0|||
170785739|NCT04169373|617223498|FG003|Week 14 to Week 52|Adverse Event|1|||
170785740|NCT04169373|617223495|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
170785741|NCT04169373|617223496|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
170785742|NCT04169373|617223497|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
170785743|NCT04169373|617223498|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
170785744|NCT04169373|617223495|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
170785745|NCT04169373|617223496|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
170785746|NCT04169373|617223497|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
170785747|NCT04169373|617223498|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
170785748|NCT04169373|617223495|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
170785749|NCT04169373|617223496|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
170538916|NCT02335944|616315817|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
170538917|NCT02335944|616315818|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
170785750|NCT04169373|617223497|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
170785751|NCT04169373|617223498|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
170538918|NCT02335944|616315819|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
170785752|NCT04169373|617223495|FG000|Week 14 to Week 52|Other|4|||
170538919|NCT02335944|616315820|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
170538920|NCT02335944|616315821|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
170443879|NCT01685008|615962803|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
170443880|NCT01685008|615962804|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
170443881|NCT01685008|615962805|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
170443882|NCT01685008|615962806|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
170443883|NCT00372996|615962807|FG000|Overall Study|Death|11|||
170443884|NCT00372996|615962808|FG001|Overall Study|Death|4|||
170443885|NCT00372996|615962809|FG002|Overall Study|Death|8|||
170443886|NCT00372996|615962810|FG003|Overall Study|Death|7|||
170443887|NCT00372996|615962807|FG000|Overall Study|Lost to Follow-up|0|||
170443888|NCT00372996|615962808|FG001|Overall Study|Lost to Follow-up|2|||
170443889|NCT00372996|615962809|FG002|Overall Study|Lost to Follow-up|0|||
170443890|NCT00372996|615962810|FG003|Overall Study|Lost to Follow-up|1|||
170443891|NCT00372996|615962807|FG000|Overall Study|Withdrawal by Subject|12|||
170443892|NCT00372996|615962808|FG001|Overall Study|Withdrawal by Subject|6|||
170443893|NCT00372996|615962809|FG002|Overall Study|Withdrawal by Subject|9|||
170443894|NCT00372996|615962810|FG003|Overall Study|Withdrawal by Subject|5|||
170443895|NCT00372996|615962807|FG000|Overall Study|Study Terminated by Sponsor|4|||
170443896|NCT00372996|615962808|FG001|Overall Study|Study Terminated by Sponsor|0|||
170443897|NCT00372996|615962809|FG002|Overall Study|Study Terminated by Sponsor|4|||
170443898|NCT00372996|615962810|FG003|Overall Study|Study Terminated by Sponsor|0|||
170443899|NCT00372996|615962807|FG000|Overall Study|Other|10|||
170443900|NCT00372996|615962808|FG001|Overall Study|Other|2|||
170443901|NCT00372996|615962809|FG002|Overall Study|Other|7|||
170443902|NCT00372996|615962810|FG003|Overall Study|Other|7|||
170443903|NCT02914457|615962811|FG000|Overall Study|Withdrawal by Subject|1|||
170443904|NCT02914457|615962811|FG000|Overall Study|Physician Decision|1|||
170443905|NCT02914457|615962811|FG000|Overall Study|No veins available for lead placement|1|||
170443906|NCT02914457|615962811|FG000|Overall Study|Electrical instability of patient|1|||
170443907|NCT02914457|615962811|FG000|Overall Study|ECG acquisition error due to sweating|1|||
170443908|NCT02914457|615962811|FG000|Overall Study|Protocol Violation|1|||
170443909|NCT03439085|615962814|FG000|Overall Study|Death|2|||
170443910|NCT03439085|615962814|FG000|Overall Study|Screen Failure|20|||
170443911|NCT04194008|615962815|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
170443912|NCT04194008|615962815|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
170443913|NCT04194008|615962815|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
170443914|NCT04194008|615962815|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
170443915|NCT04194008|615962815|FG000|Treatment Phase With Nerivio|Missing data|4|||
170443916|NCT04194008|615962815|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
170443917|NCT01203917|615962816|FG000|Overall Study|Death|29|||
170443918|NCT01203917|615962816|FG000|Overall Study|Lost to Follow-up|2|||
170443919|NCT01203917|615962816|FG000|Overall Study|Withdrawal by Subject|3|||
170443920|NCT01203917|615962816|FG000|Overall Study|Due to objective disease progression|1|||
170443921|NCT01203917|615962816|FG000|Overall Study|Due to EGFR M+I patient|1|||
170443922|NCT03310619|615962817|FG000|Pre-Treatment Period|Death|1|||
170443923|NCT03310619|615962818|FG001|Pre-Treatment Period|Death|0|||
170443924|NCT03310619|615962819|FG002|Pre-Treatment Period|Death|0|||
170443925|NCT03310619|615962820|FG003|Pre-Treatment Period|Death|0|||
170443926|NCT03310619|615962821|FG004|Pre-Treatment Period|Death|1|||
170443927|NCT03310619|615962822|FG005|Pre-Treatment Period|Death|0|||
170443928|NCT03310619|615962823|FG006|Pre-Treatment Period|Death|0|||
170443929|NCT03310619|615962824|FG007|Pre-Treatment Period|Death|0|||
170538921|NCT02335944|616315822|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
170538922|NCT02335944|616315823|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
170538923|NCT02335944|616315824|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
170538924|NCT02335944|616315815|FG000|Treatment Phase|Subject/Guardian Decision|0|||
170538925|NCT02335944|616315816|FG001|Treatment Phase|Subject/Guardian Decision|0|||
170443930|NCT03310619|615962817|FG000|Pre-Treatment Period|Other reasons|2|||
170443931|NCT03310619|615962818|FG001|Pre-Treatment Period|Other reasons|1|||
170443932|NCT03310619|615962819|FG002|Pre-Treatment Period|Other reasons|2|||
170443933|NCT03310619|615962820|FG003|Pre-Treatment Period|Other reasons|0|||
170443934|NCT03310619|615962821|FG004|Pre-Treatment Period|Other reasons|0|||
170443935|NCT03310619|615962822|FG005|Pre-Treatment Period|Other reasons|0|||
170443936|NCT03310619|615962823|FG006|Pre-Treatment Period|Other reasons|2|||
170538926|NCT02335944|616315817|FG002|Treatment Phase|Subject/Guardian Decision|1|||
170785753|NCT04169373|617223496|FG001|Week 14 to Week 52|Other|5|||
170785754|NCT04169373|617223497|FG002|Week 14 to Week 52|Other|4|||
170785755|NCT04169373|617223498|FG003|Week 14 to Week 52|Other|5|||
170443937|NCT03310619|615962824|FG007|Pre-Treatment Period|Other reasons|0|||
170443938|NCT03310619|615962817|FG000|Treatment Period|Death|1|||
170443939|NCT03310619|615962818|FG001|Treatment Period|Death|2|||
170443940|NCT03310619|615962819|FG002|Treatment Period|Death|0|||
170443941|NCT03310619|615962820|FG003|Treatment Period|Death|0|||
170443942|NCT03310619|615962821|FG004|Treatment Period|Death|1|||
170443943|NCT03310619|615962822|FG005|Treatment Period|Death|0|||
170443944|NCT03310619|615962823|FG006|Treatment Period|Death|2|||
170443945|NCT03310619|615962824|FG007|Treatment Period|Death|0|||
170443946|NCT03310619|615962817|FG000|Treatment Period|Adverse Event|0|||
170443947|NCT03310619|615962818|FG001|Treatment Period|Adverse Event|1|||
170443948|NCT03310619|615962819|FG002|Treatment Period|Adverse Event|4|||
170443949|NCT03310619|615962820|FG003|Treatment Period|Adverse Event|1|||
170443950|NCT03310619|615962821|FG004|Treatment Period|Adverse Event|0|||
170443951|NCT03310619|615962822|FG005|Treatment Period|Adverse Event|0|||
170443952|NCT03310619|615962823|FG006|Treatment Period|Adverse Event|0|||
170443953|NCT03310619|615962824|FG007|Treatment Period|Adverse Event|0|||
170443954|NCT03310619|615962817|FG000|Treatment Period|Withdrawal by participant|0|||
170443955|NCT03310619|615962818|FG001|Treatment Period|Withdrawal by participant|0|||
170443956|NCT03310619|615962819|FG002|Treatment Period|Withdrawal by participant|1|||
170443957|NCT03310619|615962820|FG003|Treatment Period|Withdrawal by participant|0|||
170443958|NCT03310619|615962821|FG004|Treatment Period|Withdrawal by participant|0|||
170443959|NCT03310619|615962822|FG005|Treatment Period|Withdrawal by participant|0|||
170443960|NCT03310619|615962823|FG006|Treatment Period|Withdrawal by participant|0|||
170443961|NCT03310619|615962824|FG007|Treatment Period|Withdrawal by participant|0|||
170443962|NCT03310619|615962817|FG000|Treatment Period|Lost to Follow-up|0|||
170443963|NCT03310619|615962818|FG001|Treatment Period|Lost to Follow-up|0|||
170443964|NCT03310619|615962819|FG002|Treatment Period|Lost to Follow-up|0|||
170443965|NCT03310619|615962820|FG003|Treatment Period|Lost to Follow-up|0|||
170443966|NCT03310619|615962821|FG004|Treatment Period|Lost to Follow-up|0|||
170443967|NCT03310619|615962822|FG005|Treatment Period|Lost to Follow-up|0|||
170443968|NCT03310619|615962823|FG006|Treatment Period|Lost to Follow-up|0|||
170443969|NCT03310619|615962824|FG007|Treatment Period|Lost to Follow-up|1|||
170443970|NCT03310619|615962817|FG000|Treatment Period|Study terminated by sponsor|0|||
170443971|NCT03310619|615962818|FG001|Treatment Period|Study terminated by sponsor|0|||
170443972|NCT03310619|615962819|FG002|Treatment Period|Study terminated by sponsor|0|||
170443973|NCT03310619|615962820|FG003|Treatment Period|Study terminated by sponsor|0|||
170443974|NCT03310619|615962821|FG004|Treatment Period|Study terminated by sponsor|0|||
170443975|NCT03310619|615962822|FG005|Treatment Period|Study terminated by sponsor|0|||
170443976|NCT03310619|615962823|FG006|Treatment Period|Study terminated by sponsor|0|||
170443977|NCT03310619|615962824|FG007|Treatment Period|Study terminated by sponsor|1|||
170443978|NCT03310619|615962817|FG000|Treatment Period|Physician Decision|0|||
170443979|NCT03310619|615962818|FG001|Treatment Period|Physician Decision|0|||
170443980|NCT03310619|615962819|FG002|Treatment Period|Physician Decision|0|||
170443981|NCT03310619|615962820|FG003|Treatment Period|Physician Decision|0|||
170443982|NCT03310619|615962821|FG004|Treatment Period|Physician Decision|3|||
170443983|NCT03310619|615962822|FG005|Treatment Period|Physician Decision|0|||
170443984|NCT03310619|615962823|FG006|Treatment Period|Physician Decision|0|||
170443985|NCT03310619|615962824|FG007|Treatment Period|Physician Decision|0|||
170443986|NCT03310619|615962817|FG000|Treatment Period|Other reasons|1|||
170443987|NCT03310619|615962818|FG001|Treatment Period|Other reasons|0|||
170443988|NCT03310619|615962819|FG002|Treatment Period|Other reasons|2|||
170443989|NCT03310619|615962820|FG003|Treatment Period|Other reasons|0|||
170443990|NCT03310619|615962821|FG004|Treatment Period|Other reasons|0|||
170443991|NCT03310619|615962822|FG005|Treatment Period|Other reasons|0|||
170443992|NCT03310619|615962823|FG006|Treatment Period|Other reasons|0|||
170443993|NCT03310619|615962824|FG007|Treatment Period|Other reasons|0|||
170443994|NCT01266603|615962826|FG000|Overall Study|Adverse Event|1|||
170443995|NCT01266603|615962826|FG000|Overall Study|Lack of Efficacy|14|||
170443996|NCT01266603|615962826|FG000|Overall Study|Withdrawal by Subject|1|||
170443997|NCT01266603|615962826|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
170443998|NCT02725411|615962827|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
170443999|NCT02725411|615962828|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
170444000|NCT02725411|615962829|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
170444001|NCT02725411|615962827|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
170444002|NCT02725411|615962828|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
170444003|NCT02725411|615962829|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
170444004|NCT02725411|615962827|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
170444005|NCT02725411|615962828|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
170444006|NCT02725411|615962829|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
170444007|NCT02725411|615962827|FG000|Treatment Period (56 Weeks)|Other|1|||
170444008|NCT02725411|615962828|FG001|Treatment Period (56 Weeks)|Other|4|||
170444009|NCT02725411|615962829|FG002|Treatment Period (56 Weeks)|Other|5|||
170444010|NCT02725411|615962827|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
170444011|NCT02725411|615962828|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
170444012|NCT02725411|615962829|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
170444013|NCT02725411|615962827|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
170444014|NCT02725411|615962828|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
170444015|NCT02725411|615962829|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
170444016|NCT02725411|615962827|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
170444017|NCT02725411|615962828|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
170444018|NCT02725411|615962829|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
170538927|NCT02335944|616315818|FG003|Treatment Phase|Subject/Guardian Decision|0|||
170538928|NCT02335944|616315819|FG004|Treatment Phase|Subject/Guardian Decision|0|||
170538929|NCT02335944|616315820|FG005|Treatment Phase|Subject/Guardian Decision|1|||
170538930|NCT02335944|616315821|FG006|Treatment Phase|Subject/Guardian Decision|0|||
170538931|NCT02335944|616315822|FG007|Treatment Phase|Subject/Guardian Decision|4|||
170538932|NCT02335944|616315823|FG008|Treatment Phase|Subject/Guardian Decision|0|||
170538933|NCT02335944|616315824|FG009|Treatment Phase|Subject/Guardian Decision|0|||
170538934|NCT02335944|616315815|FG000|Post-treatment Follow-up|Progressive Disease|0|||
170538935|NCT02335944|616315816|FG001|Post-treatment Follow-up|Progressive Disease|0|||
170538936|NCT02335944|616315817|FG002|Post-treatment Follow-up|Progressive Disease|0|||
170538937|NCT02335944|616315818|FG003|Post-treatment Follow-up|Progressive Disease|1|||
170444019|NCT02725411|615962827|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
170444020|NCT02725411|615962828|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
170444021|NCT02725411|615962829|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
170444022|NCT02725411|615962827|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
170444023|NCT02725411|615962828|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
170444024|NCT02725411|615962829|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
170444025|NCT02725411|615962827|FG000|Follow-up Period (24 Weeks)|Other|1|||
170538938|NCT02335944|616315819|FG004|Post-treatment Follow-up|Progressive Disease|0|||
170538939|NCT02335944|616315820|FG005|Post-treatment Follow-up|Progressive Disease|9|||
170538940|NCT02335944|616315821|FG006|Post-treatment Follow-up|Progressive Disease|0|||
170538941|NCT02335944|616315822|FG007|Post-treatment Follow-up|Progressive Disease|2|||
170538942|NCT02335944|616315823|FG008|Post-treatment Follow-up|Progressive Disease|3|||
170538943|NCT02335944|616315824|FG009|Post-treatment Follow-up|Progressive Disease|0|||
170538944|NCT02335944|616315815|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170538945|NCT02335944|616315816|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170538946|NCT02335944|616315817|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170538947|NCT02335944|616315818|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170538948|NCT02335944|616315819|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170538949|NCT02335944|616315820|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
170538950|NCT02335944|616315821|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170633168|NCT03594110|616668477|FG001|Interventional Part|Contraindicated drug started|18|||
170633169|NCT03594110|616668476|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
170633170|NCT03594110|616668477|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
170633171|NCT03594110|616668476|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
170633172|NCT03594110|616668477|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
170633173|NCT03594110|616668476|FG000|Non-interventional Part|Withdrawal by Subject|3|||
170633174|NCT03594110|616668477|FG001|Non-interventional Part|Withdrawal by Subject|4|||
170633175|NCT03594110|616668476|FG000|Non-interventional Part|Lost to Follow-up|45|||
170633176|NCT03594110|616668477|FG001|Non-interventional Part|Lost to Follow-up|41|||
170633177|NCT03219528|616668478|FG000|Overall Study|Lost to Follow-up|5|||
170633178|NCT03219528|616668479|FG001|Overall Study|Lost to Follow-up|4|||
170633179|NCT03219528|616668478|FG000|Overall Study|Withdrawal by Subject|4|||
170633180|NCT03219528|616668479|FG001|Overall Study|Withdrawal by Subject|4|||
170633181|NCT03809104|616668480|FG000|Overall Study|Withdrawal by Subject|3|||
170633182|NCT05029362|616668481|FG000|Overall Study|Lost to Follow-up|9|||
170633183|NCT00419952|616668484|FG000|Overall Study|Adverse Event|8|||
170633184|NCT00419952|616668485|FG001|Overall Study|Adverse Event|10|||
170633185|NCT00419952|616668484|FG000|Overall Study|Withdrawal by Subject|44|||
170633186|NCT00419952|616668485|FG001|Overall Study|Withdrawal by Subject|43|||
170633187|NCT00419952|616668484|FG000|Overall Study|Lost to Follow-up|43|||
170633188|NCT00419952|616668485|FG001|Overall Study|Lost to Follow-up|34|||
170633189|NCT00419952|616668484|FG000|Overall Study|Protocol Violation|32|||
170633190|NCT00419952|616668485|FG001|Overall Study|Protocol Violation|24|||
170633191|NCT00419952|616668484|FG000|Overall Study|Pregnancy|4|||
170633192|NCT00419952|616668485|FG001|Overall Study|Pregnancy|2|||
170633193|NCT00419952|616668484|FG000|Overall Study|Physician Decision|1|||
170633194|NCT00419952|616668485|FG001|Overall Study|Physician Decision|3|||
170633195|NCT00419952|616668484|FG000|Overall Study|Incorrectly enrolled|10|||
170444026|NCT02725411|615962828|FG001|Follow-up Period (24 Weeks)|Other|4|||
170538951|NCT02335944|616315822|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170538952|NCT02335944|616315823|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170538953|NCT02335944|616315824|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
170633196|NCT00419952|616668485|FG001|Overall Study|Incorrectly enrolled|3|||
170633197|NCT00419952|616668484|FG000|Overall Study|Intake of prohibited medication|2|||
170886855|NCT00953758|617593553|FG003|Overall Study|Physician Decision|0|||
170633198|NCT00419952|616668485|FG001|Overall Study|Intake of prohibited medication|2|||
170633199|NCT00419952|616668484|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
170633200|NCT00419952|616668485|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
170444027|NCT02725411|615962829|FG002|Follow-up Period (24 Weeks)|Other|2|||
170444028|NCT02725411|615962827|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
170633201|NCT00419952|616668484|FG000|Overall Study|Diary or medication non-compliance|2|||
170444029|NCT02725411|615962828|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
170444030|NCT02725411|615962829|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
170444031|NCT04307849|615962832|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
170444032|NCT04307849|615962833|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
170444033|NCT04307849|615962834|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
170444034|NCT04307849|615962835|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
170444035|NCT04307849|615962836|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
170444036|NCT04307849|615962837|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
170444037|NCT04307849|615962832|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
170444038|NCT04307849|615962833|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
170444039|NCT04307849|615962834|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
170444040|NCT04307849|615962835|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
170538954|NCT02335944|616315815|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538955|NCT02335944|616315816|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538956|NCT02335944|616315817|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538957|NCT02335944|616315818|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538958|NCT02335944|616315819|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538959|NCT02335944|616315820|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538960|NCT02335944|616315821|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538961|NCT02335944|616315822|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
170538962|NCT02335944|616315823|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538963|NCT02335944|616315824|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
170538964|NCT02335944|616315815|FG000|Post-treatment Follow-up|Adverse Event|0|||
170538965|NCT02335944|616315816|FG001|Post-treatment Follow-up|Adverse Event|0|||
170538966|NCT02335944|616315817|FG002|Post-treatment Follow-up|Adverse Event|0|||
170538967|NCT02335944|616315818|FG003|Post-treatment Follow-up|Adverse Event|0|||
170538968|NCT02335944|616315819|FG004|Post-treatment Follow-up|Adverse Event|0|||
170538969|NCT02335944|616315820|FG005|Post-treatment Follow-up|Adverse Event|1|||
170538970|NCT02335944|616315821|FG006|Post-treatment Follow-up|Adverse Event|0|||
170538971|NCT02335944|616315822|FG007|Post-treatment Follow-up|Adverse Event|0|||
170538972|NCT02335944|616315823|FG008|Post-treatment Follow-up|Adverse Event|0|||
170538973|NCT02335944|616315824|FG009|Post-treatment Follow-up|Adverse Event|0|||
170538974|NCT02335944|616315815|FG000|Post-treatment Follow-up|Death|0|||
170538975|NCT02335944|616315816|FG001|Post-treatment Follow-up|Death|0|||
170538976|NCT02335944|616315817|FG002|Post-treatment Follow-up|Death|0|||
170538977|NCT02335944|616315818|FG003|Post-treatment Follow-up|Death|1|||
170538978|NCT02335944|616315819|FG004|Post-treatment Follow-up|Death|0|||
170538979|NCT02335944|616315820|FG005|Post-treatment Follow-up|Death|1|||
170538980|NCT02335944|616315821|FG006|Post-treatment Follow-up|Death|0|||
170538981|NCT02335944|616315822|FG007|Post-treatment Follow-up|Death|0|||
170538982|NCT02335944|616315823|FG008|Post-treatment Follow-up|Death|0|||
170538983|NCT02335944|616315824|FG009|Post-treatment Follow-up|Death|0|||
170538984|NCT02335944|616315815|FG000|Post-treatment Follow-up|Physician Decision|1|||
170538985|NCT02335944|616315816|FG001|Post-treatment Follow-up|Physician Decision|0|||
170538986|NCT02335944|616315817|FG002|Post-treatment Follow-up|Physician Decision|0|||
170538987|NCT02335944|616315818|FG003|Post-treatment Follow-up|Physician Decision|0|||
170538988|NCT02335944|616315819|FG004|Post-treatment Follow-up|Physician Decision|0|||
170538989|NCT02335944|616315820|FG005|Post-treatment Follow-up|Physician Decision|0|||
170538990|NCT02335944|616315821|FG006|Post-treatment Follow-up|Physician Decision|0|||
170538991|NCT02335944|616315822|FG007|Post-treatment Follow-up|Physician Decision|1|||
170538992|NCT02335944|616315823|FG008|Post-treatment Follow-up|Physician Decision|0|||
170538993|NCT02335944|616315824|FG009|Post-treatment Follow-up|Physician Decision|0|||
170538994|NCT00832975|616315825|FG000|Overall Study|Lost to Follow-up|7|||
170538995|NCT00832975|616315825|FG000|Overall Study|Protocol Violation|6|||
170538996|NCT00832975|616315825|FG000|Overall Study|Death|5|||
170538997|NCT00832975|616315825|FG000|Overall Study|Physician Decision|4|||
170538998|NCT00832975|616315825|FG000|Overall Study|Withdrawal by Subject|3|||
170538999|NCT00832975|616315825|FG000|Overall Study|Other reasons|14|||
170539000|NCT02360579|616315831|FG000|Initial|Death|16|||
170539001|NCT02360579|616315832|FG001|Initial|Death|49|||
170539002|NCT02360579|616315833|FG002|Initial|Death|0|||
170539003|NCT02360579|616315834|FG003|Initial|Death|71|||
170539004|NCT02360579|616315831|FG000|Initial|Lost to Follow-up|0|||
170539005|NCT02360579|616315832|FG001|Initial|Lost to Follow-up|4|||
170539006|NCT02360579|616315833|FG002|Initial|Lost to Follow-up|0|||
170539007|NCT02360579|616315834|FG003|Initial|Lost to Follow-up|1|||
170785756|NCT04169373|617223495|FG000|Week 14 to Week 52|Ongoing|0|||
170539008|NCT02360579|616315831|FG000|Initial|Withdrawal by Subject|0|||
170539009|NCT02360579|616315832|FG001|Initial|Withdrawal by Subject|0|||
170539010|NCT02360579|616315833|FG002|Initial|Withdrawal by Subject|0|||
170539011|NCT02360579|616315834|FG003|Initial|Withdrawal by Subject|3|||
170539012|NCT02360579|616315831|FG000|Initial|Other|7|||
170539013|NCT02360579|616315832|FG001|Initial|Other|0|||
170539014|NCT02360579|616315833|FG002|Initial|Other|0|||
170785757|NCT04169373|617223496|FG001|Week 14 to Week 52|Ongoing|1|||
170539015|NCT02360579|616315834|FG003|Initial|Other|0|||
170539016|NCT02360579|616315831|FG000|Initial|Did not receive TIL|8|||
170539017|NCT02360579|616315832|FG001|Initial|Did not receive TIL|11|||
170539018|NCT02360579|616315833|FG002|Initial|Did not receive TIL|0|||
170539019|NCT02360579|616315834|FG003|Initial|Did not receive TIL|22|||
170539020|NCT02360579|616315831|FG000|Retreatment|Death|0|||
170539021|NCT02360579|616315832|FG001|Retreatment|Death|0|||
170539022|NCT02360579|616315833|FG002|Retreatment|Death|11|||
170539023|NCT02360579|616315834|FG003|Retreatment|Death|0|||
170539024|NCT06717399|616315837|FG000|Overall Study|Death|1|||
170539025|NCT04284774|616315839|FG000|Overall Study|Progressive disease|5|||
170539026|NCT00177671|616317101|FG000|Overall Study|Withdrawal by Subject|5|||
170539027|NCT00177671|616317102|FG001|Overall Study|Withdrawal by Subject|6|||
170539028|NCT00177671|616317101|FG000|Overall Study|medical complications|2|||
170539029|NCT00177671|616317102|FG001|Overall Study|medical complications|0|||
170539030|NCT00177671|616317101|FG000|Overall Study|Adverse Event|6|||
170539031|NCT00177671|616317102|FG001|Overall Study|Adverse Event|0|||
170539032|NCT00177671|616317101|FG000|Overall Study|Physician Decision|12|||
170539033|NCT00177671|616317102|FG001|Overall Study|Physician Decision|8|||
170539034|NCT02293499|616317103|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
170539035|NCT02293499|616317104|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
170539036|NCT02293499|616317105|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
170539037|NCT02293499|616317103|FG000|Intervention - Camp|Withdrawal by Subject|3|||
170539038|NCT02293499|616317104|FG001|Intervention - Camp|Withdrawal by Subject|6|||
170539039|NCT02293499|616317105|FG002|Intervention - Camp|Withdrawal by Subject|2|||
170539040|NCT02293499|616317103|FG000|Intervention - Camp|these are those not showing up at camp|24|||
170539041|NCT02293499|616317104|FG001|Intervention - Camp|these are those not showing up at camp|28|||
170539042|NCT02293499|616317105|FG002|Intervention - Camp|these are those not showing up at camp|4|||
170539043|NCT02293499|616317103|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
170539044|NCT02293499|616317104|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
170539045|NCT02293499|616317105|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
170539046|NCT02293499|616317103|FG000|3 Month Follow Up|Lost to Follow-up|14|||
170539047|NCT02293499|616317104|FG001|3 Month Follow Up|Lost to Follow-up|15|||
170539048|NCT02293499|616317105|FG002|3 Month Follow Up|Lost to Follow-up|6|||
170539049|NCT02293499|616317103|FG000|6 Month Follow Up|Lost to Follow-up|17|||
170539050|NCT02293499|616317104|FG001|6 Month Follow Up|Lost to Follow-up|27|||
170539051|NCT02293499|616317105|FG002|6 Month Follow Up|Lost to Follow-up|6|||
170539052|NCT02293499|616317103|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
170539053|NCT02293499|616317104|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
170539054|NCT02293499|616317105|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
170539055|NCT02293499|616317103|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
170539056|NCT02293499|616317104|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
170539057|NCT02293499|616317105|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
170539058|NCT02293499|616317103|FG000|9 Month Follow Up|Lost to Follow-up|24|||
170539059|NCT02293499|616317104|FG001|9 Month Follow Up|Lost to Follow-up|28|||
170539060|NCT02293499|616317105|FG002|9 Month Follow Up|Lost to Follow-up|4|||
170539061|NCT02293499|616317103|FG000|12 Month Follow Up|Lost to Follow-up|26|||
170539062|NCT02293499|616317104|FG001|12 Month Follow Up|Lost to Follow-up|25|||
170539063|NCT02293499|616317105|FG002|12 Month Follow Up|Lost to Follow-up|6|||
170539064|NCT02293499|616317103|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
170539065|NCT02293499|616317104|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
170539066|NCT02293499|616317105|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
170539067|NCT02293499|616317103|FG000|15 Month Follow Up|Lost to Follow-up|22|||
170539068|NCT02293499|616317104|FG001|15 Month Follow Up|Lost to Follow-up|22|||
170539069|NCT02293499|616317105|FG002|15 Month Follow Up|Lost to Follow-up|7|||
170539070|NCT00690898|616317106|FG000|SCREENING|Screen failure|18|||
170539071|NCT00690898|616317106|FG000|TREATMENT|Adverse Event|3|||
170539072|NCT00690898|616317106|FG000|TREATMENT|Lack of Efficacy|18|||
170539073|NCT00690898|616317106|FG000|TREATMENT|Withdrawal by Subject|4|||
170539074|NCT00690898|616317106|FG000|TREATMENT|Other (not otherwise specified)|1|||
170539075|NCT00970944|616317107|FG000|Overall Study|Death|1|||
170539076|NCT00970944|616317108|FG001|Overall Study|Death|0|||
170539077|NCT00970944|616317107|FG000|Overall Study|Physician Decision|0|||
170539078|NCT00970944|616317108|FG001|Overall Study|Physician Decision|2|||
170539079|NCT00662259|616317109|FG000|Overall Study|Adverse Event|2|||
170539080|NCT00662259|616317110|FG001|Overall Study|Adverse Event|0|||
170539081|NCT02782468|616317114|FG000|Overall Study|Progressive Disease|2|||
170539082|NCT02782468|616317115|FG001|Overall Study|Progressive Disease|5|||
170539083|NCT02782468|616317116|FG002|Overall Study|Progressive Disease|0|||
170539084|NCT02782468|616317117|FG003|Overall Study|Progressive Disease|4|||
170539085|NCT02782468|616317114|FG000|Overall Study|Adverse Event|0|||
170539086|NCT02782468|616317115|FG001|Overall Study|Adverse Event|2|||
170539087|NCT02782468|616317116|FG002|Overall Study|Adverse Event|2|||
170539088|NCT02782468|616317117|FG003|Overall Study|Adverse Event|3|||
170785758|NCT04169373|617223497|FG002|Week 14 to Week 52|Ongoing|0|||
170444041|NCT04307849|615962836|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
170444042|NCT04307849|615962837|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
170444043|NCT04307849|615962832|FG000|Overall Study|Family member did not want them to continue|0|||
170444044|NCT04307849|615962833|FG001|Overall Study|Family member did not want them to continue|0|||
170444045|NCT04307849|615962834|FG002|Overall Study|Family member did not want them to continue|1|||
170444046|NCT04307849|615962835|FG003|Overall Study|Family member did not want them to continue|0|||
170444047|NCT04307849|615962836|FG004|Overall Study|Family member did not want them to continue|0|||
170444048|NCT04307849|615962837|FG005|Overall Study|Family member did not want them to continue|0|||
170444049|NCT04307849|615962832|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
170444050|NCT04307849|615962833|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
170444051|NCT04307849|615962834|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
170444052|NCT04307849|615962835|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
170444053|NCT04307849|615962836|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
170444054|NCT04307849|615962837|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
170444055|NCT02911935|615962840|FG000|Overall Study|Lost to Follow-up|5|||
170444056|NCT02911935|615962841|FG001|Overall Study|Lost to Follow-up|7|||
170444057|NCT00756717|615962842|FG000|Overall Study|Withdrawal by Subject|2|||
170444058|NCT00603512|615962843|FG000|Overall Study|Adverse Event|0|||
170633202|NCT00419952|616668485|FG001|Overall Study|Diary or medication non-compliance|4|||
170633203|NCT00419952|616668484|FG000|Overall Study|Abnormal ECG|1|||
170444059|NCT00603512|615962844|FG001|Overall Study|Adverse Event|2|||
170444060|NCT00603512|615962845|FG002|Overall Study|Adverse Event|4|||
170444061|NCT00603512|615962846|FG003|Overall Study|Adverse Event|4|||
170444062|NCT00603512|615962847|FG004|Overall Study|Adverse Event|2|||
170444063|NCT00603512|615962843|FG000|Overall Study|Lack of Efficacy|0|||
170444064|NCT00603512|615962844|FG001|Overall Study|Lack of Efficacy|1|||
170444065|NCT00603512|615962845|FG002|Overall Study|Lack of Efficacy|0|||
170444066|NCT00603512|615962846|FG003|Overall Study|Lack of Efficacy|0|||
170444067|NCT00603512|615962847|FG004|Overall Study|Lack of Efficacy|1|||
170444068|NCT00603512|615962843|FG000|Overall Study|Other|2|||
170444069|NCT00603512|615962844|FG001|Overall Study|Other|1|||
170444070|NCT00603512|615962845|FG002|Overall Study|Other|0|||
170444071|NCT00603512|615962846|FG003|Overall Study|Other|1|||
170444072|NCT00603512|615962847|FG004|Overall Study|Other|1|||
170444073|NCT00603512|615962843|FG000|Overall Study|Withdrawal by Subject|0|||
170444074|NCT00603512|615962844|FG001|Overall Study|Withdrawal by Subject|0|||
170444075|NCT00603512|615962845|FG002|Overall Study|Withdrawal by Subject|0|||
170444076|NCT00603512|615962846|FG003|Overall Study|Withdrawal by Subject|0|||
170444077|NCT00603512|615962847|FG004|Overall Study|Withdrawal by Subject|1|||
170444078|NCT00603512|615962843|FG000|Overall Study|Randomized but not treated|0|||
170444079|NCT00603512|615962844|FG001|Overall Study|Randomized but not treated|1|||
170444080|NCT00603512|615962845|FG002|Overall Study|Randomized but not treated|1|||
170444081|NCT00603512|615962846|FG003|Overall Study|Randomized but not treated|2|||
170444082|NCT00603512|615962847|FG004|Overall Study|Randomized but not treated|0|||
170444083|NCT04979858|615962848|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
170444084|NCT04979858|615962849|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
170444085|NCT04253236|615962850|FG000|Overall Study|Adverse Event|1|||
170444086|NCT04253236|615962851|FG001|Overall Study|Adverse Event|0|||
170444087|NCT04253236|615962850|FG000|Overall Study|Safety Concerns|1|||
170444088|NCT04253236|615962851|FG001|Overall Study|Safety Concerns|0|||
170444089|NCT04253236|615962850|FG000|Overall Study|Study Terminated by Sponsor|1|||
170444090|NCT04253236|615962851|FG001|Overall Study|Study Terminated by Sponsor|0|||
170444091|NCT02654015|615962852|FG000|Overall Study|Death|12|||
170444092|NCT02654015|615962852|FG000|Overall Study|Lost to Follow-up|3|||
170444093|NCT02418754|615962853|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
170444094|NCT02418754|615962854|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
170444095|NCT02418754|615962855|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
170444096|NCT02418754|615962856|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
170444097|NCT02418754|615962857|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
170444098|NCT02418754|615962853|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
170444099|NCT02418754|615962854|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
170444100|NCT02418754|615962855|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
170444101|NCT02418754|615962856|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
170444102|NCT02418754|615962857|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
170444103|NCT02418754|615962853|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
170444104|NCT02418754|615962854|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
170444105|NCT02418754|615962855|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
170444106|NCT02418754|615962856|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
170444107|NCT02418754|615962857|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
170444108|NCT02418754|615962853|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
170444109|NCT02418754|615962854|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
170444110|NCT02418754|615962855|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
170444111|NCT02418754|615962856|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
170444112|NCT02418754|615962857|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
170444113|NCT02418754|615962853|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
170444114|NCT02418754|615962854|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
170444115|NCT02418754|615962855|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
170444116|NCT02418754|615962856|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
170444117|NCT02418754|615962857|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
170444118|NCT02418754|615962853|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
170444119|NCT02418754|615962854|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
170444120|NCT02418754|615962855|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
170444121|NCT02418754|615962856|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
170444122|NCT02418754|615962857|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
170444123|NCT02418754|615962853|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
170539089|NCT02782468|616317114|FG000|Overall Study|Other|0|||
170539090|NCT02782468|616317115|FG001|Overall Study|Other|0|||
170539091|NCT02782468|616317116|FG002|Overall Study|Other|1|||
170539092|NCT02782468|616317117|FG003|Overall Study|Other|1|||
170539093|NCT02782468|616317114|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
170539094|NCT02782468|616317115|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
170539095|NCT02782468|616317116|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
170539096|NCT02782468|616317117|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
170539097|NCT02782468|616317114|FG000|Overall Study|Symptomatic Deterioration|0|||
170539098|NCT02782468|616317115|FG001|Overall Study|Symptomatic Deterioration|0|||
170539099|NCT02782468|616317116|FG002|Overall Study|Symptomatic Deterioration|0|||
170539100|NCT02782468|616317117|FG003|Overall Study|Symptomatic Deterioration|1|||
170633204|NCT00419952|616668485|FG001|Overall Study|Abnormal ECG|0|||
170539101|NCT02782468|616317114|FG000|Overall Study|Withdrawal by Subject|1|||
170539102|NCT02782468|616317115|FG001|Overall Study|Withdrawal by Subject|0|||
170539103|NCT02782468|616317116|FG002|Overall Study|Withdrawal by Subject|0|||
170539104|NCT02782468|616317117|FG003|Overall Study|Withdrawal by Subject|0|||
170539105|NCT02489773|616317118|FG000|Overall Study|Lost to Follow-up|4|||
170633205|NCT03126591|616668488|FG000|Overall Study|Death|6|||
170633206|NCT03126591|616668489|FG001|Overall Study|Death|3|||
170633207|NCT03126591|616668490|FG002|Overall Study|Death|17|||
170633208|NCT03126591|616668488|FG000|Overall Study|Progressive Disease|0|||
170633209|NCT03126591|616668489|FG001|Overall Study|Progressive Disease|1|||
170633210|NCT03126591|616668490|FG002|Overall Study|Progressive Disease|2|||
170633211|NCT03126591|616668488|FG000|Overall Study|Terminated by Sponsor|0|||
170633212|NCT03126591|616668489|FG001|Overall Study|Terminated by Sponsor|1|||
170633213|NCT03126591|616668490|FG002|Overall Study|Terminated by Sponsor|4|||
170633214|NCT03126591|616668488|FG000|Overall Study|Withdrawal by Subject|1|||
170633215|NCT03126591|616668489|FG001|Overall Study|Withdrawal by Subject|1|||
170633216|NCT03126591|616668490|FG002|Overall Study|Withdrawal by Subject|4|||
170633217|NCT00686712|616668499|FG000|Overall Study|Protocol Violation|8|||
170633218|NCT00686712|616668500|FG001|Overall Study|Protocol Violation|8|||
170633219|NCT00686712|616668501|FG002|Overall Study|Protocol Violation|10|||
170633220|NCT00686712|616668499|FG000|Overall Study|Lost to Follow-up|1|||
170633221|NCT00686712|616668500|FG001|Overall Study|Lost to Follow-up|2|||
170633222|NCT00686712|616668501|FG002|Overall Study|Lost to Follow-up|3|||
170633223|NCT00686712|616668499|FG000|Overall Study|Adverse Event|1|||
170633224|NCT00686712|616668500|FG001|Overall Study|Adverse Event|1|||
170633225|NCT00686712|616668501|FG002|Overall Study|Adverse Event|0|||
170633226|NCT01318915|616668502|FG000|Overall Study|Lost to Follow-up|1|||
170633227|NCT03987503|616668503|FG000|Overall Study|Lost to Follow-up|20|||
170633228|NCT03987503|616668503|FG000|Overall Study|Withdrawal by Subject|2|||
170633229|NCT02379091|616668509|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
170633230|NCT02379091|616668510|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
170633231|NCT02379091|616668511|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
170633232|NCT02379091|616668512|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
170633233|NCT02379091|616668509|FG000|Overall Study|Principal Investigator Discretion|0|||
170633234|NCT02379091|616668510|FG001|Overall Study|Principal Investigator Discretion|1|||
170633235|NCT02379091|616668511|FG002|Overall Study|Principal Investigator Discretion|0|||
170633236|NCT02379091|616668512|FG003|Overall Study|Principal Investigator Discretion|0|||
170633237|NCT02379091|616668509|FG000|Overall Study|Lost to Follow-up|0|||
170539106|NCT02489773|616317119|FG001|Overall Study|Lost to Follow-up|1|||
170539107|NCT02489773|616317118|FG000|Overall Study|Physician Decision|1|||
170633238|NCT02379091|616668510|FG001|Overall Study|Lost to Follow-up|0|||
170633239|NCT02379091|616668511|FG002|Overall Study|Lost to Follow-up|0|||
170539108|NCT02489773|616317119|FG001|Overall Study|Physician Decision|0|||
170539109|NCT02489773|616317118|FG000|Overall Study|Withdrawal by Subject|1|||
170633240|NCT02379091|616668512|FG003|Overall Study|Lost to Follow-up|1|||
170633241|NCT02379091|616668509|FG000|Overall Study|Voluntary Withdrawal|2|||
170539110|NCT02489773|616317119|FG001|Overall Study|Withdrawal by Subject|0|||
170633242|NCT02379091|616668510|FG001|Overall Study|Voluntary Withdrawal|5|||
170633243|NCT02379091|616668511|FG002|Overall Study|Voluntary Withdrawal|2|||
170633244|NCT02379091|616668512|FG003|Overall Study|Voluntary Withdrawal|4|||
170633245|NCT02379091|616668509|FG000|Overall Study|Study Termination|7|||
170444124|NCT02418754|615962854|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
170444125|NCT02418754|615962855|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
170444126|NCT02418754|615962856|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
170444127|NCT02418754|615962857|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
170444128|NCT02418754|615962853|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
170444129|NCT02418754|615962854|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
170444130|NCT02418754|615962855|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
170444131|NCT02418754|615962856|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
170444132|NCT02418754|615962857|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
170444133|NCT02418754|615962853|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
170444134|NCT02418754|615962854|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
170444135|NCT02418754|615962855|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
170444136|NCT02418754|615962856|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
170444137|NCT02418754|615962857|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
170444138|NCT02418754|615962853|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
170444139|NCT02418754|615962854|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
170444140|NCT02418754|615962855|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
170444141|NCT02418754|615962856|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
170444142|NCT02418754|615962857|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
170444143|NCT02418754|615962853|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
170444144|NCT02418754|615962854|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
170444145|NCT02418754|615962855|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
170444146|NCT02418754|615962856|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
170444147|NCT02418754|615962857|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
170444148|NCT00250705|615962860|FG000|Overall Study|Lack of Efficacy|2|||
170444149|NCT00587431|615962861|FG000|Overall Study|Adverse Event|1|||
170444150|NCT00587431|615962862|FG001|Overall Study|Adverse Event|0|||
170444151|NCT00587431|615962861|FG000|Overall Study|Withdrawal by Subject|0|||
170444152|NCT00587431|615962862|FG001|Overall Study|Withdrawal by Subject|1|||
170444153|NCT00860262|615962863|FG000|Overall Study|Adverse Event|9|||
170444154|NCT00860262|615962864|FG001|Overall Study|Adverse Event|6|||
170444155|NCT00860262|615962865|FG002|Overall Study|Adverse Event|7|||
170444156|NCT00860262|615962863|FG000|Overall Study|Protocol Violation|0|||
170444157|NCT00860262|615962864|FG001|Overall Study|Protocol Violation|1|||
170444158|NCT00860262|615962865|FG002|Overall Study|Protocol Violation|0|||
170444159|NCT00860262|615962863|FG000|Overall Study|Lost to Follow-up|2|||
170444160|NCT00860262|615962864|FG001|Overall Study|Lost to Follow-up|0|||
170444161|NCT00860262|615962865|FG002|Overall Study|Lost to Follow-up|1|||
170444162|NCT00860262|615962863|FG000|Overall Study|Withdrawal by Subject|4|||
170444163|NCT00860262|615962864|FG001|Overall Study|Withdrawal by Subject|8|||
170444164|NCT00860262|615962865|FG002|Overall Study|Withdrawal by Subject|6|||
170444165|NCT00860262|615962863|FG000|Overall Study|Lack of Efficacy|0|||
170444166|NCT00860262|615962864|FG001|Overall Study|Lack of Efficacy|4|||
170444167|NCT00860262|615962865|FG002|Overall Study|Lack of Efficacy|3|||
170444168|NCT00860262|615962863|FG000|Overall Study|Other|5|||
170444169|NCT00860262|615962864|FG001|Overall Study|Other|3|||
170444170|NCT00860262|615962865|FG002|Overall Study|Other|1|||
170444171|NCT02387762|615962866|FG000|Overall Study|Withdrawal by Subject|1|||
170444172|NCT02387762|615962867|FG001|Overall Study|Withdrawal by Subject|0|||
170633246|NCT02379091|616668510|FG001|Overall Study|Study Termination|2|||
170633247|NCT02379091|616668511|FG002|Overall Study|Study Termination|5|||
170633248|NCT02379091|616668512|FG003|Overall Study|Study Termination|8|||
170633249|NCT02379091|616668509|FG000|Overall Study|Lack of Efficacy|3|||
170633250|NCT02379091|616668510|FG001|Overall Study|Lack of Efficacy|0|||
170633251|NCT02379091|616668511|FG002|Overall Study|Lack of Efficacy|0|||
170633252|NCT02379091|616668512|FG003|Overall Study|Lack of Efficacy|0|||
170633253|NCT03326713|616668514|FG000|Overall Study|Death|2|||
170633254|NCT03326713|616668515|FG001|Overall Study|Death|1|||
170633255|NCT03326713|616668516|FG002|Overall Study|Death|0|||
170633256|NCT03326713|616668514|FG000|Overall Study|Lost to Follow-up|20|||
170633257|NCT03326713|616668515|FG001|Overall Study|Lost to Follow-up|21|||
170633258|NCT03326713|616668516|FG002|Overall Study|Lost to Follow-up|33|||
170633259|NCT03326713|616668514|FG000|Overall Study|Withdrawal by Subject|1|||
170633260|NCT03326713|616668515|FG001|Overall Study|Withdrawal by Subject|2|||
170633261|NCT03326713|616668516|FG002|Overall Study|Withdrawal by Subject|11|||
170633262|NCT03326713|616668514|FG000|Overall Study|Found Ineligible|11|||
170633263|NCT03326713|616668515|FG001|Overall Study|Found Ineligible|11|||
170633264|NCT03326713|616668516|FG002|Overall Study|Found Ineligible|8|||
170633265|NCT00771758|616668517|FG000|Overall Study|Adverse Event|2|||
170633266|NCT00771758|616668518|FG001|Overall Study|Adverse Event|8|||
170633267|NCT00771758|616668519|FG002|Overall Study|Adverse Event|1|||
170633268|NCT00771758|616668517|FG000|Overall Study|Lack of Efficacy|0|||
170633269|NCT00771758|616668518|FG001|Overall Study|Lack of Efficacy|2|||
170633270|NCT00771758|616668519|FG002|Overall Study|Lack of Efficacy|1|||
170444173|NCT04203667|615962868|FG000|Overall Study|Withdrawal by Subject|1|||
170444174|NCT04203667|615962868|FG000|Overall Study|Lost to Follow-up|1|||
170444175|NCT04203667|615962868|FG000|Overall Study|Death|1|||
170444176|NCT04203667|615962868|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
170444177|NCT01160640|615962869|FG000|Overall Study|Physician Decision|3|||
170444178|NCT01160640|615962870|FG001|Overall Study|Physician Decision|3|||
170444179|NCT01160640|615962869|FG000|Overall Study|Incarceration|1|||
170444180|NCT01160640|615962870|FG001|Overall Study|Incarceration|0|||
170444181|NCT01160640|615962869|FG000|Overall Study|Withdrawal by Subject|0|||
170444182|NCT01160640|615962870|FG001|Overall Study|Withdrawal by Subject|3|||
170444183|NCT00642811|615962875|FG000|Overall Study|Adverse Event|2|||
170444184|NCT00642811|615962876|FG001|Overall Study|Adverse Event|3|||
170444185|NCT00642811|615962877|FG002|Overall Study|Adverse Event|0|||
170444186|NCT00642811|615962878|FG003|Overall Study|Adverse Event|0|||
170444187|NCT00642811|615962879|FG004|Overall Study|Adverse Event|0|||
170444188|NCT00642811|615962880|FG005|Overall Study|Adverse Event|1|||
170444189|NCT00642811|615962875|FG000|Overall Study|Developement of discontinuation criteria|0|||
170444190|NCT00642811|615962876|FG001|Overall Study|Developement of discontinuation criteria|0|||
170444191|NCT00642811|615962877|FG002|Overall Study|Developement of discontinuation criteria|0|||
170444192|NCT00642811|615962878|FG003|Overall Study|Developement of discontinuation criteria|0|||
170444193|NCT00642811|615962879|FG004|Overall Study|Developement of discontinuation criteria|1|||
170444194|NCT00642811|615962880|FG005|Overall Study|Developement of discontinuation criteria|0|||
170444195|NCT00642811|615962875|FG000|Overall Study|Severe Non-compliance to protocol|1|||
170444196|NCT00642811|615962876|FG001|Overall Study|Severe Non-compliance to protocol|0|||
170444197|NCT00642811|615962877|FG002|Overall Study|Severe Non-compliance to protocol|0|||
170444198|NCT00642811|615962878|FG003|Overall Study|Severe Non-compliance to protocol|0|||
170444199|NCT00642811|615962879|FG004|Overall Study|Severe Non-compliance to protocol|0|||
170444200|NCT00642811|615962880|FG005|Overall Study|Severe Non-compliance to protocol|0|||
170444201|NCT00642811|615962875|FG000|Overall Study|Other|0|||
170444202|NCT00642811|615962876|FG001|Overall Study|Other|1|||
170444203|NCT00642811|615962877|FG002|Overall Study|Other|0|||
170444204|NCT00642811|615962878|FG003|Overall Study|Other|1|||
170444205|NCT00642811|615962879|FG004|Overall Study|Other|0|||
170444206|NCT00642811|615962880|FG005|Overall Study|Other|0|||
170444207|NCT03370510|615962882|FG000|Overall Study|COVID-19|2|||
170444208|NCT03370510|615962883|FG001|Overall Study|COVID-19|0|||
170444209|NCT01525628|615962884|FG000|Overall Study|Adverse Event|1|||
170444210|NCT01525628|615962885|FG001|Overall Study|Adverse Event|1|||
170444211|NCT01525628|615962886|FG002|Overall Study|Adverse Event|2|||
170444212|NCT01525628|615962887|FG003|Overall Study|Adverse Event|0|||
170444213|NCT01525628|615962888|FG004|Overall Study|Adverse Event|1|||
170444214|NCT01525628|615962884|FG000|Overall Study|Lack of Efficacy|0|||
170444215|NCT01525628|615962885|FG001|Overall Study|Lack of Efficacy|2|||
170444216|NCT01525628|615962886|FG002|Overall Study|Lack of Efficacy|2|||
170444217|NCT01525628|615962887|FG003|Overall Study|Lack of Efficacy|1|||
170444218|NCT01525628|615962888|FG004|Overall Study|Lack of Efficacy|2|||
170444219|NCT01525628|615962884|FG000|Overall Study|Protocol Violation|0|||
170444220|NCT01525628|615962885|FG001|Overall Study|Protocol Violation|0|||
170444221|NCT01525628|615962886|FG002|Overall Study|Protocol Violation|1|||
170444222|NCT01525628|615962887|FG003|Overall Study|Protocol Violation|0|||
170444223|NCT01525628|615962888|FG004|Overall Study|Protocol Violation|0|||
170444224|NCT01525628|615962884|FG000|Overall Study|Lost to Follow-up|1|||
170444225|NCT01525628|615962885|FG001|Overall Study|Lost to Follow-up|1|||
170444226|NCT01525628|615962886|FG002|Overall Study|Lost to Follow-up|0|||
170444227|NCT01525628|615962887|FG003|Overall Study|Lost to Follow-up|0|||
170444228|NCT01525628|615962888|FG004|Overall Study|Lost to Follow-up|0|||
170444229|NCT01525628|615962884|FG000|Overall Study|Withdrawal by Subject|0|||
170444230|NCT01525628|615962885|FG001|Overall Study|Withdrawal by Subject|1|||
170444231|NCT01525628|615962886|FG002|Overall Study|Withdrawal by Subject|0|||
170444232|NCT01525628|615962887|FG003|Overall Study|Withdrawal by Subject|0|||
170444233|NCT01525628|615962888|FG004|Overall Study|Withdrawal by Subject|0|||
170444234|NCT01525628|615962884|FG000|Overall Study|Other reason not defined above|0|||
170444235|NCT01525628|615962885|FG001|Overall Study|Other reason not defined above|0|||
170444236|NCT01525628|615962886|FG002|Overall Study|Other reason not defined above|0|||
170444237|NCT01525628|615962887|FG003|Overall Study|Other reason not defined above|3|||
170444238|NCT01525628|615962888|FG004|Overall Study|Other reason not defined above|0|||
170444239|NCT02614898|615962889|FG000|Overall Study|Participated until study termination|10|||
170444240|NCT02614898|615962890|FG001|Overall Study|Participated until study termination|26|||
170444241|NCT02614898|615962889|FG000|Overall Study|Lost to Follow-up|0|||
170444242|NCT02614898|615962890|FG001|Overall Study|Lost to Follow-up|2|||
170444243|NCT02614898|615962889|FG000|Overall Study|Physician Decision|1|||
170444244|NCT02614898|615962890|FG001|Overall Study|Physician Decision|8|||
170444245|NCT02614898|615962889|FG000|Overall Study|Study Terminated by Sponsor|3|||
170444246|NCT02614898|615962890|FG001|Overall Study|Study Terminated by Sponsor|0|||
170444247|NCT02614898|615962889|FG000|Overall Study|Withdrawal by Subject|0|||
170444248|NCT02614898|615962890|FG001|Overall Study|Withdrawal by Subject|2|||
170444249|NCT02614898|615962889|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170633271|NCT00771758|616668517|FG000|Overall Study|Lost to Follow-up|1|||
170633272|NCT00771758|616668518|FG001|Overall Study|Lost to Follow-up|0|||
170633273|NCT00771758|616668519|FG002|Overall Study|Lost to Follow-up|0|||
170633274|NCT00771758|616668517|FG000|Overall Study|Protocol Violation|1|||
170633275|NCT00771758|616668518|FG001|Overall Study|Protocol Violation|0|||
170633276|NCT00771758|616668519|FG002|Overall Study|Protocol Violation|0|||
170633277|NCT00771758|616668517|FG000|Overall Study|Withdrawal by Subject|1|||
170633278|NCT00771758|616668518|FG001|Overall Study|Withdrawal by Subject|0|||
170633279|NCT00771758|616668519|FG002|Overall Study|Withdrawal by Subject|0|||
170633280|NCT00771758|616668517|FG000|Overall Study|Other|3|||
170633281|NCT00771758|616668518|FG001|Overall Study|Other|2|||
170633282|NCT00771758|616668519|FG002|Overall Study|Other|0|||
170633283|NCT04467905|616668528|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
170633284|NCT04467905|616668529|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
170785759|NCT04169373|617223498|FG003|Week 14 to Week 52|Ongoing|0|||
170785760|NCT03683719|617223499|FG000|Overall Study|Lack of Efficacy|1|||
170444250|NCT02614898|615962890|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170444251|NCT02614898|615962889|FG000|Overall Study|Other-Additional Information Unavailable|0|||
170444252|NCT02614898|615962890|FG001|Overall Study|Other-Additional Information Unavailable|11|||
170444253|NCT02614898|615962889|FG000|Overall Study|Missing|0|||
170444254|NCT02614898|615962890|FG001|Overall Study|Missing|1|||
170444255|NCT01992094|615962893|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
170444256|NCT01992094|615962894|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
170444257|NCT01992094|615962895|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
170444258|NCT01992094|615962893|FG000|Overall Study|Adverse Event|1|||
170444259|NCT01992094|615962894|FG001|Overall Study|Adverse Event|0|||
170444260|NCT01992094|615962895|FG002|Overall Study|Adverse Event|0|||
170444261|NCT01992094|615962893|FG000|Overall Study|Death|5|||
170444262|NCT01992094|615962894|FG001|Overall Study|Death|5|||
170444263|NCT01992094|615962895|FG002|Overall Study|Death|2|||
170444264|NCT01992094|615962893|FG000|Overall Study|Lost to Follow-up|26|||
170444265|NCT01992094|615962894|FG001|Overall Study|Lost to Follow-up|9|||
170444266|NCT01992094|615962895|FG002|Overall Study|Lost to Follow-up|13|||
170444267|NCT01992094|615962893|FG000|Overall Study|OTHER|4|||
170444268|NCT01992094|615962894|FG001|Overall Study|OTHER|0|||
170444269|NCT01992094|615962895|FG002|Overall Study|OTHER|0|||
170444270|NCT01992094|615962893|FG000|Overall Study|Protocol Violation|1|||
170444271|NCT01992094|615962894|FG001|Overall Study|Protocol Violation|0|||
170444272|NCT01992094|615962895|FG002|Overall Study|Protocol Violation|1|||
170444273|NCT01992094|615962893|FG000|Overall Study|Withdrawal by Subject|7|||
170444274|NCT01992094|615962894|FG001|Overall Study|Withdrawal by Subject|3|||
170444275|NCT01992094|615962895|FG002|Overall Study|Withdrawal by Subject|4|||
170444276|NCT04428645|615962896|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
170444277|NCT00857818|615962899|FG000|Overall Study|Lack of Efficacy|1|||
170444278|NCT00857818|615962900|FG001|Overall Study|Lack of Efficacy|0|||
170444279|NCT00857818|615962899|FG000|Overall Study|Adverse Event|3|||
170444280|NCT00857818|615962900|FG001|Overall Study|Adverse Event|0|||
170444281|NCT00857818|615962899|FG000|Overall Study|Withdrawal by Subject|0|||
170444282|NCT00857818|615962900|FG001|Overall Study|Withdrawal by Subject|4|||
170444283|NCT00857818|615962899|FG000|Overall Study|Sponsor terminated study|6|||
170444284|NCT00857818|615962900|FG001|Overall Study|Sponsor terminated study|4|||
170444285|NCT00857818|615962899|FG000|Overall Study|Investigator decision|1|||
170444286|NCT00857818|615962900|FG001|Overall Study|Investigator decision|0|||
170444287|NCT03180528|615964843|FG000|Overall Study|Adverse Event|1|||
170444288|NCT03180528|615964843|FG000|Overall Study|Withdrawal by Subject|1|||
170444289|NCT03180528|615964843|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
170444290|NCT03429049|615964844|FG000|Overall Study|Adverse Event|2|||
170444291|NCT03429049|615964845|FG001|Overall Study|Adverse Event|3|||
170444292|NCT03429049|615964844|FG000|Overall Study|Death|0|||
170633285|NCT04467905|616668530|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
170633286|NCT04467905|616668528|FG000|Overall Study|Conversion to SR|0|||
170633287|NCT04467905|616668529|FG001|Overall Study|Conversion to SR|0|||
170633288|NCT04467905|616668530|FG002|Overall Study|Conversion to SR|3|||
170633289|NCT04467905|616668528|FG000|Overall Study|Technical issue with Holter ECG|0|||
170444293|NCT03429049|615964845|FG001|Overall Study|Death|1|||
170444294|NCT03429049|615964844|FG000|Overall Study|Lack of Efficacy|4|||
170633290|NCT04467905|616668529|FG001|Overall Study|Technical issue with Holter ECG|0|||
170633291|NCT04467905|616668530|FG002|Overall Study|Technical issue with Holter ECG|3|||
170444295|NCT03429049|615964845|FG001|Overall Study|Lack of Efficacy|2|||
170444296|NCT03429049|615964844|FG000|Overall Study|Lost to Follow-up|9|||
170444297|NCT03429049|615964845|FG001|Overall Study|Lost to Follow-up|8|||
170444298|NCT03429049|615964844|FG000|Overall Study|Physician Decision|1|||
170444299|NCT03429049|615964845|FG001|Overall Study|Physician Decision|0|||
170444300|NCT03429049|615964844|FG000|Overall Study|Protocol Violation|3|||
170444301|NCT03429049|615964845|FG001|Overall Study|Protocol Violation|0|||
170633292|NCT04467905|616668528|FG000|Overall Study|Hemodynamic instability|0|||
170633293|NCT04467905|616668529|FG001|Overall Study|Hemodynamic instability|0|||
170785761|NCT03683719|617223500|FG001|Overall Study|Lack of Efficacy|3|||
170444302|NCT03429049|615964844|FG000|Overall Study|Sponsor Decision|2|||
170444303|NCT03429049|615964845|FG001|Overall Study|Sponsor Decision|0|||
170444304|NCT03429049|615964844|FG000|Overall Study|Withdrawal by Subject|4|||
170444305|NCT03429049|615964845|FG001|Overall Study|Withdrawal by Subject|20|||
170444306|NCT03429049|615964844|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
170444307|NCT03429049|615964845|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
170444308|NCT04703855|615964846|FG000|Overall Study|Heart Transplant|1|||
170444309|NCT04129944|615964848|FG000|Overall Study|Death|0|||
170444310|NCT04129944|615964849|FG001|Overall Study|Death|0|||
170444311|NCT04129944|615964850|FG002|Overall Study|Death|0|||
170444312|NCT04129944|615964851|FG003|Overall Study|Death|1|||
170444313|NCT04129944|615964848|FG000|Overall Study|Lost to Follow-up|1|||
170444314|NCT04129944|615964849|FG001|Overall Study|Lost to Follow-up|0|||
170444315|NCT04129944|615964850|FG002|Overall Study|Lost to Follow-up|0|||
170444316|NCT04129944|615964851|FG003|Overall Study|Lost to Follow-up|0|||
170444317|NCT04129944|615964848|FG000|Overall Study|Withdrawal by Subject|1|||
170444318|NCT04129944|615964849|FG001|Overall Study|Withdrawal by Subject|0|||
170444319|NCT04129944|615964850|FG002|Overall Study|Withdrawal by Subject|1|||
170444320|NCT04129944|615964851|FG003|Overall Study|Withdrawal by Subject|2|||
170444321|NCT02419573|615964852|FG000|Overall Study|Lost to Follow-up|3|||
170444322|NCT02419573|615964853|FG001|Overall Study|Lost to Follow-up|0|||
170444323|NCT02419573|615964852|FG000|Overall Study|Withdrawal by Subject|1|||
170444324|NCT02419573|615964853|FG001|Overall Study|Withdrawal by Subject|0|||
170444325|NCT01560819|615964858|FG000|Overall Study|Physician Decision|1|||
170444326|NCT01560819|615964859|FG001|Overall Study|Physician Decision|0|||
170444327|NCT02012452|615964860|FG000|Overall Study|Lost to Follow-up|2|||
170444328|NCT02012452|615964861|FG001|Overall Study|Lost to Follow-up|1|||
170444329|NCT02012452|615964860|FG000|Overall Study|Withdrawal by Subject|4|||
170444330|NCT02012452|615964861|FG001|Overall Study|Withdrawal by Subject|0|||
170444331|NCT02014441|615964862|FG000|Overall Study|Withdrawal by Subject|12|||
170444332|NCT00996437|615964864|FG000|Overall Study|Death|1|||
170444333|NCT00996437|615964865|FG001|Overall Study|Death|0|||
170444334|NCT00996437|615964864|FG000|Overall Study|Dropped|2|||
170444335|NCT00996437|615964865|FG001|Overall Study|Dropped|2|||
170444336|NCT00996437|615964864|FG000|Overall Study|Missed|2|||
170444337|NCT00996437|615964865|FG001|Overall Study|Missed|5|||
170785762|NCT03683719|617223501|FG002|Overall Study|Lack of Efficacy|4|||
170785763|NCT03683719|617223502|FG003|Overall Study|Lack of Efficacy|0|||
170444338|NCT02576717|615964866|FG000|Overall Study|Other Reasons|16|||
170444339|NCT02576717|615964867|FG001|Overall Study|Other Reasons|18|||
170444340|NCT02576717|615964868|FG002|Overall Study|Other Reasons|15|||
170444341|NCT02576717|615964866|FG000|Overall Study|Covid-19 Pandemic|0|||
170444342|NCT02576717|615964867|FG001|Overall Study|Covid-19 Pandemic|1|||
170444343|NCT02576717|615964868|FG002|Overall Study|Covid-19 Pandemic|1|||
170444344|NCT02576717|615964866|FG000|Overall Study|Sponsor Decision|0|||
170444345|NCT02576717|615964867|FG001|Overall Study|Sponsor Decision|0|||
170444346|NCT02576717|615964868|FG002|Overall Study|Sponsor Decision|1|||
170444347|NCT02576717|615964866|FG000|Overall Study|Physician Decision|3|||
170444348|NCT02576717|615964867|FG001|Overall Study|Physician Decision|8|||
170444349|NCT02576717|615964868|FG002|Overall Study|Physician Decision|9|||
170444350|NCT02576717|615964866|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
170444351|NCT02576717|615964867|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
170444352|NCT02576717|615964868|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
170444353|NCT02576717|615964866|FG000|Overall Study|Death|3|||
170444354|NCT02576717|615964867|FG001|Overall Study|Death|5|||
170444355|NCT02576717|615964868|FG002|Overall Study|Death|3|||
170444356|NCT02576717|615964866|FG000|Overall Study|Lost to Follow-up|9|||
170444357|NCT02576717|615964867|FG001|Overall Study|Lost to Follow-up|10|||
170444358|NCT02576717|615964868|FG002|Overall Study|Lost to Follow-up|19|||
170444359|NCT02576717|615964866|FG000|Overall Study|Protocol Violation|4|||
170444360|NCT02576717|615964867|FG001|Overall Study|Protocol Violation|0|||
170444361|NCT02576717|615964868|FG002|Overall Study|Protocol Violation|5|||
170785764|NCT03683719|617223503|FG004|Overall Study|Lack of Efficacy|4|||
170444362|NCT02576717|615964866|FG000|Overall Study|Lack of Efficacy|24|||
170444363|NCT02576717|615964867|FG001|Overall Study|Lack of Efficacy|28|||
170444364|NCT02576717|615964868|FG002|Overall Study|Lack of Efficacy|20|||
170444365|NCT02576717|615964866|FG000|Overall Study|Adverse Event|26|||
170444366|NCT02576717|615964867|FG001|Overall Study|Adverse Event|32|||
170444367|NCT02576717|615964868|FG002|Overall Study|Adverse Event|26|||
170444368|NCT01363011|615964869|FG000|Main Study|Adverse Event|2|||
170444369|NCT01363011|615964870|FG001|Main Study|Adverse Event|3|||
170444370|NCT01363011|615964869|FG000|Main Study|Investigator's Discretion|1|||
170539111|NCT02489773|616317118|FG000|Overall Study|Leave the country or the state|1|||
170539112|NCT02489773|616317119|FG001|Overall Study|Leave the country or the state|1|||
170539113|NCT01879852|616317120|FG000|Overall Study|Withdrawal by Subject|2|||
170539114|NCT01879852|616317121|FG001|Overall Study|Withdrawal by Subject|0|||
170539115|NCT00620542|616317122|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
170444371|NCT01363011|615964870|FG001|Main Study|Investigator's Discretion|1|||
170785765|NCT03683719|617223499|FG000|Overall Study|Adverse Event|6|||
170633294|NCT04467905|616668530|FG002|Overall Study|Hemodynamic instability|1|||
170633295|NCT04467905|616668528|FG000|Overall Study|Site misinterpretation of protocol|0|||
170886856|NCT00953758|617593554|FG004|Overall Study|Physician Decision|1|||
170886857|NCT00953758|617593555|FG005|Overall Study|Physician Decision|0|||
170886858|NCT00953758|617593556|FG006|Overall Study|Physician Decision|0|||
170633296|NCT04467905|616668529|FG001|Overall Study|Site misinterpretation of protocol|0|||
170633297|NCT04467905|616668530|FG002|Overall Study|Site misinterpretation of protocol|1|||
170633298|NCT05523089|616668531|FG000|Overall Study|Withdrawal by Subject|1|||
170633299|NCT05523089|616668532|FG001|Overall Study|Withdrawal by Subject|0|||
170633300|NCT05523089|616668533|FG002|Overall Study|Withdrawal by Subject|0|||
170633301|NCT05523089|616668531|FG000|Overall Study|Lost to Follow-up|1|||
170633302|NCT05523089|616668532|FG001|Overall Study|Lost to Follow-up|0|||
170886859|NCT00953758|617593557|FG007|Overall Study|Physician Decision|0|||
170633303|NCT05523089|616668533|FG002|Overall Study|Lost to Follow-up|0|||
170633304|NCT05530252|616668534|FG000|Overall Study|Lost to Follow-up|1|||
170633305|NCT05530252|616668535|FG001|Overall Study|Lost to Follow-up|1|||
170633306|NCT05530252|616668536|FG002|Overall Study|Lost to Follow-up|1|||
170633307|NCT04586205|616668537|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
170633308|NCT04586205|616668538|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
170633309|NCT01350999|616668542|FG000|Overall Study|Adverse Event|4|||
170633310|NCT01350999|616668543|FG001|Overall Study|Adverse Event|9|||
170633311|NCT01350999|616668544|FG002|Overall Study|Adverse Event|10|||
170633312|NCT01350999|616668542|FG000|Overall Study|Voluntary withdrawal|3|||
170633313|NCT01350999|616668543|FG001|Overall Study|Voluntary withdrawal|4|||
170633314|NCT01350999|616668544|FG002|Overall Study|Voluntary withdrawal|6|||
170633315|NCT01350999|616668542|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
170633316|NCT01350999|616668543|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
170633317|NCT01350999|616668544|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
170633318|NCT02083354|616670043|FG000|Overall Study|Withdrawal by Subject|9|||
170633319|NCT02083354|616670043|FG000|Overall Study|Lost to Follow-up|1|||
170633320|NCT02083354|616670043|FG000|Overall Study|Adverse Event|3|||
170633321|NCT02083354|616670043|FG000|Overall Study|Disease progression|46|||
170633322|NCT02083354|616670043|FG000|Overall Study|Study closed/terminated|5|||
170633323|NCT02273596|616670046|FG000|24-Week Treatment Period|Adverse Event|3|||
170633324|NCT02273596|616670046|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
170633325|NCT02273596|616670046|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
170633326|NCT02273596|616670046|FG000|24-Week Treatment Period|Physician Decision|1|||
170633327|NCT02273596|616670046|FG000|24-Week Treatment Period|Protocol Deviation|1|||
170633328|NCT02273596|616670046|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
170886860|NCT00953758|617593558|FG008|Overall Study|Physician Decision|0|||
170886861|NCT00953758|617593559|FG009|Overall Study|Physician Decision|0|||
170886862|NCT00953758|617593550|FG000|Overall Study|Disease progression|0|||
170886863|NCT00953758|617593551|FG001|Overall Study|Disease progression|0|||
170886864|NCT00953758|617593552|FG002|Overall Study|Disease progression|0|||
170886865|NCT00953758|617593553|FG003|Overall Study|Disease progression|0|||
170633329|NCT02273596|616670046|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
170633330|NCT02273596|616670046|FG000|Extension Period|Lost to Follow-up|1|||
170633331|NCT02273596|616670046|FG000|Extension Period|Protocol Deviation|1|||
170633332|NCT02139592|616670048|FG000|Overall Study|Case Report Forms Uncollected|8|||
170633333|NCT01177397|616670052|FG000|Overall Study|Protocol Violation|0|||
170633334|NCT01177397|616670053|FG001|Overall Study|Protocol Violation|0|||
170633335|NCT01177397|616670054|FG002|Overall Study|Protocol Violation|0|||
170633336|NCT01177397|616670055|FG003|Overall Study|Protocol Violation|0|||
170886866|NCT00953758|617593554|FG004|Overall Study|Disease progression|1|||
170633337|NCT01177397|616670056|FG004|Overall Study|Protocol Violation|0|||
170633338|NCT01177397|616670057|FG005|Overall Study|Protocol Violation|1|||
170633339|NCT01177397|616670058|FG006|Overall Study|Protocol Violation|0|||
170633340|NCT01177397|616670059|FG007|Overall Study|Protocol Violation|0|||
170633341|NCT01177397|616670060|FG008|Overall Study|Protocol Violation|0|||
170886867|NCT00953758|617593555|FG005|Overall Study|Disease progression|0|||
170886868|NCT00953758|617593556|FG006|Overall Study|Disease progression|0|||
170444372|NCT01363011|615964869|FG000|Main Study|Withdrew Consent|1|||
170444373|NCT01363011|615964870|FG001|Main Study|Withdrew Consent|4|||
170444374|NCT01363011|615964869|FG000|Main Study|Protocol Violation|0|||
170444375|NCT01363011|615964870|FG001|Main Study|Protocol Violation|1|||
170633342|NCT01177397|616670061|FG009|Overall Study|Protocol Violation|0|||
170633343|NCT01177397|616670062|FG010|Overall Study|Protocol Violation|0|||
170633344|NCT01177397|616670063|FG011|Overall Study|Protocol Violation|0|||
170633345|NCT01177397|616670052|FG000|Overall Study|Lost to Follow-up|0|||
170633346|NCT01177397|616670053|FG001|Overall Study|Lost to Follow-up|0|||
170633347|NCT01177397|616670054|FG002|Overall Study|Lost to Follow-up|0|||
170633348|NCT01177397|616670055|FG003|Overall Study|Lost to Follow-up|0|||
170633349|NCT01177397|616670056|FG004|Overall Study|Lost to Follow-up|1|||
170633350|NCT01177397|616670057|FG005|Overall Study|Lost to Follow-up|0|||
170633351|NCT01177397|616670058|FG006|Overall Study|Lost to Follow-up|0|||
170633352|NCT01177397|616670059|FG007|Overall Study|Lost to Follow-up|2|||
170886869|NCT00953758|617593557|FG007|Overall Study|Disease progression|0|||
170633353|NCT01177397|616670060|FG008|Overall Study|Lost to Follow-up|0|||
170633354|NCT01177397|616670061|FG009|Overall Study|Lost to Follow-up|0|||
170633355|NCT01177397|616670062|FG010|Overall Study|Lost to Follow-up|0|||
170444376|NCT01363011|615964869|FG000|Extension Phase|Adverse Event|1|||
170444377|NCT01363011|615964870|FG001|Extension Phase|Adverse Event|1|||
170444378|NCT01363011|615964869|FG000|Extension Phase|Lack of Efficacy|0|||
170444379|NCT01363011|615964870|FG001|Extension Phase|Lack of Efficacy|1|||
170444380|NCT01363011|615964869|FG000|Extension Phase|Investigator's Discretion|2|||
170444381|NCT01363011|615964870|FG001|Extension Phase|Investigator's Discretion|2|||
170444382|NCT01363011|615964869|FG000|Extension Phase|Withdrew Consent|0|||
170444383|NCT01363011|615964870|FG001|Extension Phase|Withdrew Consent|1|||
170444384|NCT01363011|615964869|FG000|Extension Phase|Lost to Follow-up|0|||
170444385|NCT01363011|615964870|FG001|Extension Phase|Lost to Follow-up|2|||
170444386|NCT01363011|615964869|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
170444387|NCT01363011|615964870|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
170444388|NCT00831233|615964871|FG000|Overall Study|Adverse Event|0|||
170444389|NCT00831233|615964872|FG001|Overall Study|Adverse Event|1|||
170444390|NCT00831233|615964871|FG000|Overall Study|Protocol Violation|1|||
170444391|NCT00831233|615964872|FG001|Overall Study|Protocol Violation|0|||
170444392|NCT00831233|615964871|FG000|Overall Study|Selection Criteria Not Met|2|||
170444393|NCT00831233|615964872|FG001|Overall Study|Selection Criteria Not Met|0|||
170444394|NCT02457819|615964873|FG000|Overall Study|reason not given|8|||
170444395|NCT02457819|615964873|FG000|Overall Study|Withdrawal by Subject|24|||
170444396|NCT02457819|615964873|FG000|Overall Study|Protocol Violation|1|||
170444397|NCT02457819|615964873|FG000|Overall Study|non compliance with study drug|4|||
170444398|NCT02457819|615964873|FG000|Overall Study|Lost to Follow-up|10|||
170444399|NCT02457819|615964873|FG000|Overall Study|Lack of Efficacy|19|||
170444400|NCT02457819|615964873|FG000|Overall Study|Adverse Event|33|||
170633356|NCT01177397|616670063|FG011|Overall Study|Lost to Follow-up|0|||
170633357|NCT01177397|616670052|FG000|Overall Study|Death|0|||
170886870|NCT00953758|617593558|FG008|Overall Study|Disease progression|0|||
170886871|NCT00953758|617593559|FG009|Overall Study|Disease progression|0|||
170444401|NCT02575339|615964876|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
170444402|NCT02575339|615964877|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
170444403|NCT02575339|615964878|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
170444404|NCT02575339|615964876|FG000|Study Treatment|Disease Progression|5|||
170444405|NCT02575339|615964877|FG001|Study Treatment|Disease Progression|2|||
170444406|NCT02575339|615964878|FG002|Study Treatment|Disease Progression|0|||
170444407|NCT02575339|615964876|FG000|Study Treatment|Adverse Event|1|||
170444408|NCT02575339|615964877|FG001|Study Treatment|Adverse Event|2|||
170444409|NCT02575339|615964878|FG002|Study Treatment|Adverse Event|0|||
170444410|NCT02575339|615964876|FG000|Follow up|Death|6|||
170444411|NCT02575339|615964877|FG001|Follow up|Death|2|||
170444412|NCT02575339|615964878|FG002|Follow up|Death|0|||
170444413|NCT02575339|615964876|FG000|Follow up|Study Terminated|0|||
170444414|NCT02575339|615964877|FG001|Follow up|Study Terminated|2|||
170444415|NCT02575339|615964878|FG002|Follow up|Study Terminated|0|||
170444416|NCT02575339|615964876|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
170444417|NCT02575339|615964877|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
170444418|NCT02575339|615964878|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
170444419|NCT04675775|615964880|FG000|Overall Study|Withdrawal by Subject|7|||
170444420|NCT00407745|615964883|FG000|Overall Study|Lack of Efficacy|1|||
170444421|NCT00407745|615964884|FG001|Overall Study|Lack of Efficacy|2|||
170444422|NCT00407745|615964883|FG000|Overall Study|Withdrawal by Subject|3|||
170444423|NCT00407745|615964884|FG001|Overall Study|Withdrawal by Subject|3|||
170444424|NCT00407745|615964883|FG000|Overall Study|Protocol Violation|5|||
170444425|NCT00407745|615964884|FG001|Overall Study|Protocol Violation|3|||
170444426|NCT00407745|615964883|FG000|Overall Study|Adverse Event|8|||
170444427|NCT00407745|615964884|FG001|Overall Study|Adverse Event|8|||
170444428|NCT00407745|615964883|FG000|Overall Study|Other|2|||
170444429|NCT00407745|615964884|FG001|Overall Study|Other|0|||
170444430|NCT00407745|615964883|FG000|Overall Study|Randomized, unknown if treated|0|||
170444431|NCT00407745|615964884|FG001|Overall Study|Randomized, unknown if treated|1|||
170444432|NCT02940730|615964887|FG000|Intervention 2|Physician Decision|7|||
170444433|NCT02940730|615964888|FG001|Intervention 2|Physician Decision|0|||
170444434|NCT02960438|615964889|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
170444435|NCT02960438|615964890|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
170444436|NCT02960438|615964891|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
170444437|NCT02960438|615964892|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
170444438|NCT02960438|615964889|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
170444439|NCT02960438|615964890|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
170444440|NCT02960438|615964891|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
170444441|NCT02960438|615964892|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
170633358|NCT01177397|616670053|FG001|Overall Study|Death|0|||
170633359|NCT01177397|616670054|FG002|Overall Study|Death|1|||
170444442|NCT02960438|615964889|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
170444443|NCT02960438|615964890|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
170444444|NCT02960438|615964891|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
170444445|NCT02960438|615964892|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
170444446|NCT02960438|615964889|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
170444447|NCT02960438|615964890|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
170444448|NCT02960438|615964891|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
170444449|NCT02960438|615964892|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
170444450|NCT02960438|615964889|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
170444451|NCT02960438|615964890|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
170444452|NCT02960438|615964891|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
170444453|NCT02960438|615964892|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
170444454|NCT02960438|615964889|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
170444455|NCT02960438|615964890|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
170444456|NCT02960438|615964891|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
170444457|NCT02960438|615964892|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
170444458|NCT02960438|615964889|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
170444459|NCT02960438|615964890|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
170444460|NCT02960438|615964891|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
170444461|NCT02960438|615964892|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
170444462|NCT02960438|615964889|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
170444463|NCT02960438|615964890|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
170444464|NCT02960438|615964891|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
170444465|NCT02960438|615964892|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
170444466|NCT02960438|615964889|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
170444467|NCT02960438|615964890|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
170444468|NCT02960438|615964891|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
170444469|NCT02960438|615964892|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
170444470|NCT02960438|615964889|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
170444471|NCT02960438|615964890|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
170444472|NCT02960438|615964891|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
170444473|NCT02960438|615964892|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
170444474|NCT02960438|615964889|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
170444475|NCT02960438|615964890|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
170444476|NCT02960438|615964891|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
170444477|NCT02960438|615964892|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
170444478|NCT02960438|615964889|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
170444479|NCT02960438|615964890|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
170444480|NCT02960438|615964891|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
170444481|NCT02960438|615964892|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
170444482|NCT01522950|615964893|FG000|Overall Study|Withdrawal by Subject|3|||
170444483|NCT01522950|615964894|FG001|Overall Study|Withdrawal by Subject|2|||
170444484|NCT01522950|615964895|FG002|Overall Study|Withdrawal by Subject|1|||
170444485|NCT01522950|615964893|FG000|Overall Study|Adverse Event|3|||
170444486|NCT01522950|615964894|FG001|Overall Study|Adverse Event|1|||
170444487|NCT01522950|615964895|FG002|Overall Study|Adverse Event|1|||
170444488|NCT01522950|615964893|FG000|Overall Study|Protocol Violation|0|||
170444489|NCT01522950|615964894|FG001|Overall Study|Protocol Violation|0|||
170444490|NCT01522950|615964895|FG002|Overall Study|Protocol Violation|2|||
170444491|NCT01522950|615964893|FG000|Overall Study|Death|0|||
170444492|NCT01522950|615964894|FG001|Overall Study|Death|1|||
170444493|NCT01522950|615964895|FG002|Overall Study|Death|1|||
170444494|NCT01522950|615964893|FG000|Overall Study|Study Medication Sensitivity|0|||
170444495|NCT01522950|615964894|FG001|Overall Study|Study Medication Sensitivity|1|||
170444496|NCT01522950|615964895|FG002|Overall Study|Study Medication Sensitivity|0|||
170444497|NCT01064531|615964898|FG000|Overall Study|Lost to Follow-up|0|||
170444498|NCT01064531|615964899|FG001|Overall Study|Lost to Follow-up|2|||
170539116|NCT00620542|616317123|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
170539117|NCT00620542|616317124|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
170539118|NCT00620542|616317125|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
170539119|NCT00620542|616317122|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
170539120|NCT00620542|616317123|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
170539121|NCT00620542|616317124|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
170785766|NCT03683719|617223500|FG001|Overall Study|Adverse Event|6|||
170444499|NCT01064531|615964898|FG000|Overall Study|Physician Decision|0|||
170539122|NCT00620542|616317125|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
170539123|NCT00620542|616317122|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
170785767|NCT03683719|617223501|FG002|Overall Study|Adverse Event|0|||
170785768|NCT03683719|617223502|FG003|Overall Study|Adverse Event|1|||
170886872|NCT00953758|617593550|FG000|Overall Study|Participant went for transplant|0|||
170886873|NCT00953758|617593551|FG001|Overall Study|Participant went for transplant|0|||
170886874|NCT00953758|617593552|FG002|Overall Study|Participant went for transplant|0|||
170886875|NCT00953758|617593553|FG003|Overall Study|Participant went for transplant|0|||
170886876|NCT00953758|617593554|FG004|Overall Study|Participant went for transplant|0|||
170886877|NCT00953758|617593555|FG005|Overall Study|Participant went for transplant|0|||
170886878|NCT00953758|617593556|FG006|Overall Study|Participant went for transplant|0|||
170886879|NCT00953758|617593557|FG007|Overall Study|Participant went for transplant|0|||
170886880|NCT00953758|617593558|FG008|Overall Study|Participant went for transplant|1|||
170886881|NCT00953758|617593559|FG009|Overall Study|Participant went for transplant|0|||
170886882|NCT00075504|617593560|FG000|Overall Study|Withdrawal by Subject|9|||
170886883|NCT00075504|617593561|FG001|Overall Study|Withdrawal by Subject|7|||
170886884|NCT03403205|617593562|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
170886885|NCT03403205|617593563|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
170886886|NCT03403205|617593564|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
170886887|NCT03403205|617593565|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
170444500|NCT01064531|615964899|FG001|Overall Study|Physician Decision|1|||
170444501|NCT01064531|615964898|FG000|Overall Study|Withdrawal by Subject|2|||
170444502|NCT01064531|615964899|FG001|Overall Study|Withdrawal by Subject|2|||
170444503|NCT01064531|615964898|FG000|Overall Study|Revision due to femoral stem loosening|1|||
170444504|NCT01064531|615964899|FG001|Overall Study|Revision due to femoral stem loosening|0|||
170444505|NCT01064531|615964898|FG000|Overall Study|Revision due to dislocation|0|||
170444506|NCT01064531|615964899|FG001|Overall Study|Revision due to dislocation|1|||
170444507|NCT01064531|615964898|FG000|Overall Study|Death|0|||
170444508|NCT01064531|615964899|FG001|Overall Study|Death|1|||
170444509|NCT00298740|615964900|FG000|Overall Study|Lack of Efficacy|6|||
170444510|NCT00298740|615964900|FG000|Overall Study|Withdrawal by Subject|3|||
170444511|NCT03449199|615964901|FG000|Overall Study|Lost to Follow-up|1|||
170444512|NCT03449199|615964902|FG001|Overall Study|Lost to Follow-up|1|||
170444513|NCT03449199|615964903|FG002|Overall Study|Lost to Follow-up|0|||
170444514|NCT03449199|615964901|FG000|Overall Study|Protocol Deviation|0|||
170444515|NCT03449199|615964902|FG001|Overall Study|Protocol Deviation|0|||
170444516|NCT03449199|615964903|FG002|Overall Study|Protocol Deviation|1|||
170444517|NCT03449199|615964901|FG000|Overall Study|Withdrawal by Subject|0|||
170539124|NCT00620542|616317123|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
170444518|NCT03449199|615964902|FG001|Overall Study|Withdrawal by Subject|0|||
170444519|NCT03449199|615964903|FG002|Overall Study|Withdrawal by Subject|1|||
170444520|NCT00684567|615964904|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
170444521|NCT00684567|615964904|FG000|Monotherapy Period|Adverse Event|2|||
170444522|NCT00684567|615964904|FG000|Monotherapy Period|Death|1|||
170444523|NCT00684567|615964904|FG000|Monotherapy Period|Progression of primary disease|11|||
170444524|NCT03136406|615964905|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
170444525|NCT01201759|615964906|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
170444526|NCT01201759|615964907|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
170444527|NCT01201759|615964906|FG000|Visit 3 - Washout|Adverse Event|0|||
170444528|NCT01201759|615964907|FG001|Visit 3 - Washout|Adverse Event|3|||
170444529|NCT01201759|615964906|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
170444530|NCT01201759|615964907|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
170444531|NCT01201759|615964906|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
170444532|NCT01201759|615964907|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
170444533|NCT00906373|615964908|FG000|Overall Study|Withdrawal by Subject|0|||
170444534|NCT00906373|615964909|FG001|Overall Study|Withdrawal by Subject|5|||
170444535|NCT00906373|615964908|FG000|Overall Study|Other|0|||
170444536|NCT00906373|615964909|FG001|Overall Study|Other|1|||
170444537|NCT00906373|615964908|FG000|Overall Study|Still on treatment at cutoff date|0|||
170444538|NCT00906373|615964909|FG001|Overall Study|Still on treatment at cutoff date|2|||
170444539|NCT02744755|615964918|FG000|Study Period 1|Protocol Violation|2|||
170444540|NCT02744755|615964919|FG001|Study Period 1|Protocol Violation|1|||
170444541|NCT02744755|615964918|FG000|Study Period 1|not defined|0|||
170444542|NCT02744755|615964919|FG001|Study Period 1|not defined|1|||
170444543|NCT02744755|615964918|FG000|Study Period 1|Pregnancy|1|||
170444544|NCT02744755|615964919|FG001|Study Period 1|Pregnancy|0|||
170444545|NCT02744755|615964918|FG000|Study Period 1|Adverse Event|1|||
170444546|NCT02744755|615964919|FG001|Study Period 1|Adverse Event|1|||
170444547|NCT02744755|615964918|FG000|Study Period 1|Lost to Follow-up|1|||
170444548|NCT02744755|615964919|FG001|Study Period 1|Lost to Follow-up|1|||
170444549|NCT02744755|615964918|FG000|Study Period 1|Lack of Efficacy|1|||
170444550|NCT02744755|615964919|FG001|Study Period 1|Lack of Efficacy|0|||
170444551|NCT02744755|615964918|FG000|Study Period 1|Withdrawal by Subject|8|||
170444552|NCT02744755|615964919|FG001|Study Period 1|Withdrawal by Subject|4|||
170444553|NCT02744755|615964918|FG000|Study Period 2|Adverse Event|5|||
170444554|NCT02744755|615964919|FG001|Study Period 2|Adverse Event|0|||
170539125|NCT00620542|616317124|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
170444555|NCT02744755|615964918|FG000|Study Period 2|Protocol Violation|1|||
170539126|NCT00620542|616317125|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
170886888|NCT03403205|617593566|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
170886889|NCT03403205|617593567|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
170886890|NCT03403205|617593562|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
170886891|NCT03403205|617593563|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170886892|NCT03403205|617593564|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
170886893|NCT03403205|617593565|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170886894|NCT03403205|617593566|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170886895|NCT03403205|617593567|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170886896|NCT03403205|617593562|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
170886897|NCT03403205|617593563|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
170886898|NCT03403205|617593564|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
170886899|NCT03403205|617593565|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
170886900|NCT03403205|617593566|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
170886901|NCT03403205|617593567|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
170886902|NCT03403205|617593562|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
170886903|NCT03403205|617593563|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
170886904|NCT03403205|617593564|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
170886905|NCT03403205|617593565|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
170886906|NCT03403205|617593566|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
170886907|NCT03403205|617593567|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
170886908|NCT03403205|617593562|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
170886909|NCT03403205|617593563|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
170886910|NCT03403205|617593564|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
170886911|NCT03403205|617593565|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
170886912|NCT03403205|617593566|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
170886913|NCT03403205|617593567|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
170886914|NCT03403205|617593562|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
170886915|NCT03403205|617593563|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
170886916|NCT03403205|617593564|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
170886917|NCT03403205|617593565|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
170539127|NCT00620542|616317122|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
170539128|NCT00620542|616317123|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
170539129|NCT00620542|616317124|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
170539130|NCT00620542|616317125|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
170539131|NCT00620542|616317122|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
170539132|NCT00620542|616317123|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
170539133|NCT00620542|616317124|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
170539134|NCT00620542|616317125|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
170539135|NCT00620542|616317122|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
170539136|NCT00620542|616317123|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
170539137|NCT00620542|616317124|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
170539138|NCT00620542|616317125|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
170539139|NCT00620542|616317122|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
170539140|NCT00620542|616317123|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
170539141|NCT00620542|616317124|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
170539142|NCT00620542|616317125|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
170539143|NCT00620542|616317122|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
170539144|NCT00620542|616317123|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
170539145|NCT00620542|616317124|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
170539146|NCT00620542|616317125|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
170539147|NCT00620542|616317122|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
170539148|NCT00620542|616317123|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
170539149|NCT00620542|616317124|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
170539150|NCT00620542|616317125|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
170539151|NCT00620542|616317122|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
170539152|NCT00620542|616317123|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
170539153|NCT00620542|616317124|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
170539154|NCT00620542|616317125|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
170539155|NCT00620542|616317122|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
170539156|NCT00620542|616317123|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
170539157|NCT00620542|616317124|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
170539158|NCT00620542|616317125|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
170539159|NCT00620542|616317122|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
170539160|NCT00620542|616317123|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
170539161|NCT00620542|616317124|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
170539162|NCT00620542|616317125|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
170539163|NCT00620542|616317122|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
170539164|NCT00620542|616317123|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
170539165|NCT00620542|616317124|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
170444556|NCT02744755|615964919|FG001|Study Period 2|Protocol Violation|0|||
170444557|NCT02744755|615964918|FG000|Study Period 2|not defined|3|||
170444558|NCT02744755|615964919|FG001|Study Period 2|not defined|2|||
170444559|NCT02744755|615964918|FG000|Study Period 2|Lost to Follow-up|0|||
170444560|NCT02744755|615964919|FG001|Study Period 2|Lost to Follow-up|2|||
170444561|NCT02744755|615964918|FG000|Study Period 2|Withdrawal by Subject|2|||
170444562|NCT02744755|615964919|FG001|Study Period 2|Withdrawal by Subject|2|||
170444563|NCT02744755|615964918|FG000|Study Period 2|Lack of Efficacy|3|||
170444564|NCT02744755|615964919|FG001|Study Period 2|Lack of Efficacy|2|||
170444565|NCT03180801|615964920|FG000|Overall Study|Physician Decision|3|||
170444566|NCT03180801|615964921|FG001|Overall Study|Physician Decision|3|||
170444567|NCT03180801|615964922|FG002|Overall Study|Physician Decision|1|||
170444568|NCT03180801|615964920|FG000|Overall Study|Non-compliance|1|||
170444569|NCT03180801|615964921|FG001|Overall Study|Non-compliance|4|||
170785769|NCT03683719|617223503|FG004|Overall Study|Adverse Event|3|||
170785770|NCT03683719|617223499|FG000|Overall Study|Withdrawal by Subject|4|||
170785771|NCT03683719|617223500|FG001|Overall Study|Withdrawal by Subject|4|||
170785772|NCT03683719|617223501|FG002|Overall Study|Withdrawal by Subject|3|||
170785773|NCT03683719|617223502|FG003|Overall Study|Withdrawal by Subject|5|||
170785774|NCT03683719|617223503|FG004|Overall Study|Withdrawal by Subject|5|||
170785775|NCT03683719|617223499|FG000|Overall Study|Lost to Follow-up|1|||
170785776|NCT03683719|617223500|FG001|Overall Study|Lost to Follow-up|0|||
170785777|NCT03683719|617223501|FG002|Overall Study|Lost to Follow-up|0|||
170785778|NCT03683719|617223502|FG003|Overall Study|Lost to Follow-up|1|||
170785779|NCT03683719|617223503|FG004|Overall Study|Lost to Follow-up|1|||
170785780|NCT03683719|617223499|FG000|Overall Study|Other personal reasons|0|||
170785781|NCT03683719|617223500|FG001|Overall Study|Other personal reasons|0|||
170785782|NCT03683719|617223501|FG002|Overall Study|Other personal reasons|1|||
170785783|NCT03683719|617223502|FG003|Overall Study|Other personal reasons|0|||
170785784|NCT03683719|617223503|FG004|Overall Study|Other personal reasons|1|||
170785785|NCT03907397|617223506|FG000|Overall Study|Lost to Follow-up|0|||
170785786|NCT03907397|617223507|FG001|Overall Study|Lost to Follow-up|1|||
170785787|NCT03907397|617223506|FG000|Overall Study|Physician Decision|2|||
170785788|NCT03907397|617223507|FG001|Overall Study|Physician Decision|1|||
170785789|NCT03907397|617223506|FG000|Overall Study|Withdrawal by Subject|5|||
170785790|NCT03907397|617223507|FG001|Overall Study|Withdrawal by Subject|4|||
170785791|NCT03907397|617223506|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
170785792|NCT03907397|617223507|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
170785793|NCT03792256|617223508|FG000|Overall Study|Death|0|||
170444570|NCT03180801|615964922|FG002|Overall Study|Non-compliance|0|||
170444571|NCT03180801|615964920|FG000|Overall Study|Inoculation Target Reached|1|||
170444572|NCT03180801|615964921|FG001|Overall Study|Inoculation Target Reached|1|||
170444573|NCT03180801|615964922|FG002|Overall Study|Inoculation Target Reached|3|||
170444574|NCT03180801|615964920|FG000|Overall Study|Adverse Event|1|||
170444575|NCT03180801|615964921|FG001|Overall Study|Adverse Event|0|||
170444576|NCT03180801|615964922|FG002|Overall Study|Adverse Event|2|||
170444577|NCT03180801|615964920|FG000|Overall Study|Withdrawal by Subject|2|||
170444578|NCT03180801|615964921|FG001|Overall Study|Withdrawal by Subject|2|||
170444579|NCT03180801|615964922|FG002|Overall Study|Withdrawal by Subject|1|||
170444580|NCT03180801|615964920|FG000|Overall Study|Lost to Follow-up|0|||
170444581|NCT03180801|615964921|FG001|Overall Study|Lost to Follow-up|2|||
170444582|NCT03180801|615964922|FG002|Overall Study|Lost to Follow-up|3|||
170444583|NCT01049412|615964923|FG000|Period I|Withdrawal by Subject|4|||
170444584|NCT01049412|615964924|FG001|Period I|Withdrawal by Subject|6|||
170444585|NCT01049412|615964923|FG000|Period I|Lost to Follow-up|2|||
170444586|NCT01049412|615964924|FG001|Period I|Lost to Follow-up|2|||
170444587|NCT01049412|615964923|FG000|Period I|Physician Decision|0|||
170444588|NCT01049412|615964924|FG001|Period I|Physician Decision|3|||
170444589|NCT01049412|615964923|FG000|Period I|Protocol Violation|1|||
170444590|NCT01049412|615964924|FG001|Period I|Protocol Violation|2|||
170539166|NCT00620542|616317125|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
170539167|NCT00620542|616317122|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
170539168|NCT00620542|616317123|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
170785794|NCT03792256|617223509|FG001|Overall Study|Death|1|||
170633360|NCT01177397|616670055|FG003|Overall Study|Death|1|||
170785795|NCT03792256|617223508|FG000|Overall Study|Lack of Efficacy|0|||
170444591|NCT01049412|615964923|FG000|Period I|Adverse Event|1|||
170444592|NCT01049412|615964924|FG001|Period I|Adverse Event|0|||
170444593|NCT01049412|615964923|FG000|Period II|Withdrawal by Subject|2|||
170444594|NCT01049412|615964924|FG001|Period II|Withdrawal by Subject|3|||
170444595|NCT01049412|615964923|FG000|Period II|Adverse Event|1|||
170444596|NCT01049412|615964924|FG001|Period II|Adverse Event|0|||
170444597|NCT01049412|615964923|FG000|Period II|Lost to Follow-up|1|||
170444598|NCT01049412|615964924|FG001|Period II|Lost to Follow-up|0|||
170444599|NCT04364737|615964926|FG000|Overall Study|Withdrawal by Subject|4|||
170785796|NCT03792256|617223509|FG001|Overall Study|Lack of Efficacy|1|||
170785797|NCT03792256|617223508|FG000|Overall Study|Withdrawal by Subject|0|||
170785798|NCT03792256|617223509|FG001|Overall Study|Withdrawal by Subject|1|||
170444600|NCT04364737|615964927|FG001|Overall Study|Withdrawal by Subject|9|||
170444601|NCT04364737|615964926|FG000|Overall Study|Lost to Follow-up|1|||
170444602|NCT04364737|615964927|FG001|Overall Study|Lost to Follow-up|1|||
170444603|NCT00035555|615964932|FG000|Overall Study|Adverse Event|5|||
170444604|NCT00035555|615964933|FG001|Overall Study|Adverse Event|8|||
170444605|NCT00035555|615964934|FG002|Overall Study|Adverse Event|9|||
170444606|NCT00035555|615964932|FG000|Overall Study|Allograft loss|1|||
170444607|NCT00035555|615964933|FG001|Overall Study|Allograft loss|1|||
170444608|NCT00035555|615964934|FG002|Overall Study|Allograft loss|2|||
170444609|NCT00035555|615964932|FG000|Overall Study|Death|0|||
170444610|NCT00035555|615964933|FG001|Overall Study|Death|0|||
170444611|NCT00035555|615964934|FG002|Overall Study|Death|2|||
170444612|NCT00035555|615964932|FG000|Overall Study|Lost to Follow-up|0|||
170444613|NCT00035555|615964933|FG001|Overall Study|Lost to Follow-up|0|||
170444614|NCT00035555|615964934|FG002|Overall Study|Lost to Follow-up|1|||
170444615|NCT00035555|615964932|FG000|Overall Study|Noncompliance|0|||
170444616|NCT00035555|615964933|FG001|Overall Study|Noncompliance|1|||
170444617|NCT00035555|615964934|FG002|Overall Study|Noncompliance|1|||
170444618|NCT00035555|615964932|FG000|Overall Study|Prohibited medication|1|||
170444619|NCT00035555|615964933|FG001|Overall Study|Prohibited medication|1|||
170444620|NCT00035555|615964934|FG002|Overall Study|Prohibited medication|0|||
170444621|NCT00035555|615964932|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
170444622|NCT00035555|615964933|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
170444623|NCT00035555|615964934|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
170444624|NCT00035555|615964932|FG000|Overall Study|Withdrawal by Subject|2|||
170444625|NCT00035555|615964933|FG001|Overall Study|Withdrawal by Subject|0|||
170444626|NCT00035555|615964934|FG002|Overall Study|Withdrawal by Subject|2|||
170444627|NCT00035555|615964932|FG000|Overall Study|Investigator deemed not a good candidate|0|||
170444628|NCT00035555|615964933|FG001|Overall Study|Investigator deemed not a good candidate|0|||
170444629|NCT00035555|615964934|FG002|Overall Study|Investigator deemed not a good candidate|1|||
170444630|NCT00035555|615964932|FG000|Overall Study|Received cyclosporin in error|0|||
170444631|NCT00035555|615964933|FG001|Overall Study|Received cyclosporin in error|0|||
170444632|NCT00035555|615964934|FG002|Overall Study|Received cyclosporin in error|1|||
170444633|NCT00194792|615964939|FG000|Overall Study|Withdrawal by Subject|1|||
170444634|NCT05889039|615964941|FG000|Overall Study|error in completing survey|0|||
170444635|NCT05889039|615964942|FG001|Overall Study|error in completing survey|2|||
170444636|NCT05889039|615964943|FG002|Overall Study|error in completing survey|0|||
170444637|NCT05889039|615964944|FG003|Overall Study|error in completing survey|0|||
170444638|NCT05889039|615964941|FG000|Overall Study|Lost to Follow-up|4|||
170444639|NCT05889039|615964942|FG001|Overall Study|Lost to Follow-up|0|||
170444640|NCT05889039|615964943|FG002|Overall Study|Lost to Follow-up|0|||
170444641|NCT05889039|615964944|FG003|Overall Study|Lost to Follow-up|0|||
170444642|NCT00609154|615964947|FG000|Overall Study|Protocol Violation|1|||
170444643|NCT00609154|615964948|FG001|Overall Study|Protocol Violation|2|||
170444644|NCT00609154|615964947|FG000|Overall Study|Unable to establish IV access|0|||
170444645|NCT00609154|615964948|FG001|Overall Study|Unable to establish IV access|4|||
170444646|NCT00609154|615964947|FG000|Overall Study|Adverse Event|0|||
170444647|NCT00609154|615964948|FG001|Overall Study|Adverse Event|2|||
170444648|NCT04531527|615964949|FG000|Overall Study|Found to be Ineligible|3|||
170444649|NCT00434837|615964956|FG000|Overall Study|Lost to Follow-up|20|||
170444650|NCT00434837|615964957|FG001|Overall Study|Lost to Follow-up|23|||
170444651|NCT00434837|615964958|FG002|Overall Study|Lost to Follow-up|30|||
170444652|NCT01881737|615964962|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
170444653|NCT01881737|615964962|FG000|Overall Study|Withdrawal by Subject|1|||
170444654|NCT01881737|615964962|FG000|Overall Study|Worsening of baseline behavior|1|||
170444655|NCT03023137|615964963|FG000|Overall Study|Multiple pregnancy|2|||
170444656|NCT03023137|615964964|FG001|Overall Study|Multiple pregnancy|4|||
170444657|NCT03023137|615964963|FG000|Overall Study|Lost to Follow-up|1|||
170444658|NCT03023137|615964964|FG001|Overall Study|Lost to Follow-up|1|||
170444659|NCT03023137|615964963|FG000|Overall Study|Protocol Violation|0|||
170444660|NCT03023137|615964964|FG001|Overall Study|Protocol Violation|4|||
170444661|NCT03023137|615964963|FG000|Overall Study|Lost the baby in a car accident|1|||
170444662|NCT03023137|615964964|FG001|Overall Study|Lost the baby in a car accident|0|||
170444663|NCT03496298|615964973|FG000|Overall Study|Adverse Event|49|||
170444664|NCT03496298|615964974|FG001|Overall Study|Adverse Event|68|||
170444665|NCT03496298|615964975|FG002|Overall Study|Adverse Event|79|||
170444666|NCT03496298|615964973|FG000|Overall Study|Study terminated by Sponsor|1050|||
170444667|NCT03496298|615964974|FG001|Overall Study|Study terminated by Sponsor|1063|||
170444668|NCT03496298|615964975|FG002|Overall Study|Study terminated by Sponsor|1071|||
170444669|NCT03496298|615964973|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
170444670|NCT03496298|615964974|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
170444671|NCT03496298|615964975|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
170444672|NCT03496298|615964973|FG000|Overall Study|Withdrawal by Subject|176|||
170444673|NCT03496298|615964974|FG001|Overall Study|Withdrawal by Subject|154|||
170444674|NCT03496298|615964975|FG002|Overall Study|Withdrawal by Subject|151|||
170444675|NCT03496298|615964973|FG000|Overall Study|Other|29|||
170886918|NCT03403205|617593566|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
170886919|NCT03403205|617593567|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
170886920|NCT03403205|617593562|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
170886921|NCT03403205|617593563|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
170886922|NCT03403205|617593564|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
170886923|NCT03403205|617593565|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
170886924|NCT03403205|617593566|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
170444676|NCT03496298|615964974|FG001|Overall Study|Other|20|||
170444677|NCT03496298|615964975|FG002|Overall Study|Other|23|||
170444678|NCT03496298|615964973|FG000|Overall Study|Randomized and not treated|1|||
170444679|NCT03496298|615964974|FG001|Overall Study|Randomized and not treated|1|||
170444680|NCT03496298|615964975|FG002|Overall Study|Randomized and not treated|1|||
170444681|NCT00676494|615964980|FG000|Overall Study|Missed Visit|8|||
170444682|NCT00676494|615964980|FG000|Overall Study|Withdrawal by Subject|6|||
170444683|NCT02608476|615964981|FG000|Overall Study|Withdrawal by Subject|30|||
170444684|NCT02608476|615964982|FG001|Overall Study|Withdrawal by Subject|37|||
170444685|NCT02608476|615964981|FG000|Overall Study|Lost to Follow-up|24|||
170444686|NCT02608476|615964982|FG001|Overall Study|Lost to Follow-up|24|||
170444687|NCT02608476|615964981|FG000|Overall Study|Adverse Event|2|||
170444688|NCT02608476|615964982|FG001|Overall Study|Adverse Event|8|||
170444689|NCT02608476|615964981|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
170444690|NCT02608476|615964982|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
170444691|NCT02608476|615964981|FG000|Overall Study|Noncompliance with treatment|1|||
170444692|NCT02608476|615964982|FG001|Overall Study|Noncompliance with treatment|5|||
170444693|NCT02608476|615964981|FG000|Overall Study|Lack of Efficacy|3|||
170444694|NCT02608476|615964982|FG001|Overall Study|Lack of Efficacy|1|||
170444695|NCT02608476|615964981|FG000|Overall Study|Other|0|||
170444696|NCT02608476|615964982|FG001|Overall Study|Other|1|||
170444697|NCT02608476|615964981|FG000|Overall Study|Physician Decision|1|||
170444698|NCT02608476|615964982|FG001|Overall Study|Physician Decision|0|||
170444699|NCT02608476|615964981|FG000|Overall Study|Pregnancy|0|||
170444700|NCT02608476|615964982|FG001|Overall Study|Pregnancy|1|||
170444701|NCT02608476|615964981|FG000|Overall Study|Progressive disease|1|||
170444702|NCT02608476|615964982|FG001|Overall Study|Progressive disease|0|||
170444703|NCT02058160|615964983|FG000|Overall Study|Randomized but not treated|2|||
170444704|NCT02058160|615964984|FG001|Overall Study|Randomized but not treated|4|||
170444705|NCT02058160|615964983|FG000|Overall Study|Poor compliance to protocol|4|||
170444706|NCT02058160|615964984|FG001|Overall Study|Poor compliance to protocol|1|||
170444707|NCT02058160|615964983|FG000|Overall Study|Adverse Event|12|||
170444708|NCT02058160|615964984|FG001|Overall Study|Adverse Event|3|||
170444709|NCT02058160|615964983|FG000|Overall Study|Lost to Follow-up|1|||
170444710|NCT02058160|615964984|FG001|Overall Study|Lost to Follow-up|0|||
170444711|NCT02058160|615964983|FG000|Overall Study|Other than specified above|12|||
170444712|NCT02058160|615964984|FG001|Overall Study|Other than specified above|6|||
170444713|NCT04106817|615964985|FG000|Overall Study|Lost to Follow-up|1|||
170444714|NCT04106817|615964986|FG001|Overall Study|Lost to Follow-up|0|||
170444715|NCT04106817|615964987|FG002|Overall Study|Lost to Follow-up|0|||
170444716|NCT00152516|615964992|FG000|Overall Study|Adverse Event|18|||
170444717|NCT00152516|615964992|FG000|Overall Study|Lack and Loss of Efficacy|30|||
170444718|NCT00152516|615964992|FG000|Overall Study|Lost to Follow-up|5|||
170444719|NCT00152516|615964992|FG000|Overall Study|Withdrawal by Subject|8|||
170444720|NCT00152516|615964992|FG000|Overall Study|Protocol Violation|3|||
170444721|NCT00152516|615964992|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
170444722|NCT00152516|615964992|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
170444723|NCT00152516|615964992|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
170444724|NCT00152516|615964992|FG000|Overall Study|Other: Non-Compliance|2|||
170444725|NCT00152516|615964992|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
170444726|NCT00152516|615964992|FG000|Overall Study|Other: Moved Out Of State|1|||
170444727|NCT00152516|615964992|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
170444728|NCT00152516|615964992|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
170444729|NCT00090753|615964995|FG000|First Treatment Period|Adverse Event|20|||
170444730|NCT00090753|615964996|FG001|First Treatment Period|Adverse Event|8|||
170444731|NCT00090753|615964995|FG000|First Treatment Period|Death|88|||
170444732|NCT00090753|615964996|FG001|First Treatment Period|Death|62|||
170444733|NCT00090753|615964995|FG000|First Treatment Period|Lack of Efficacy|2|||
170539169|NCT00620542|616317124|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
170539170|NCT00620542|616317125|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
170444734|NCT00090753|615964996|FG001|First Treatment Period|Lack of Efficacy|1|||
170444735|NCT00090753|615964995|FG000|First Treatment Period|Refused Treatment|32|||
170444736|NCT00090753|615964996|FG001|First Treatment Period|Refused Treatment|25|||
170444737|NCT00090753|615964995|FG000|First Treatment Period|Lost to Follow-up|4|||
170444738|NCT00090753|615964996|FG001|First Treatment Period|Lost to Follow-up|4|||
170444739|NCT00090753|615964995|FG000|First Treatment Period|Renal Transplant|70|||
170444740|NCT00090753|615964996|FG001|First Treatment Period|Renal Transplant|50|||
170444741|NCT00090753|615964995|FG000|First Treatment Period|Mircera Commercialization|1|||
170444742|NCT00090753|615964996|FG001|First Treatment Period|Mircera Commercialization|0|||
170444743|NCT00090753|615964995|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
170444744|NCT00090753|615964996|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
170444745|NCT00090753|615964995|FG000|Extended Treatment Period|Adverse Event|11|||
170444746|NCT00090753|615964996|FG001|Extended Treatment Period|Adverse Event|0|||
170444747|NCT00090753|615964995|FG000|Extended Treatment Period|Death|58|||
170444748|NCT00090753|615964996|FG001|Extended Treatment Period|Death|30|||
170444749|NCT00090753|615964995|FG000|Extended Treatment Period|Lack of Efficacy|1|||
170444750|NCT00090753|615964996|FG001|Extended Treatment Period|Lack of Efficacy|0|||
170444751|NCT00090753|615964995|FG000|Extended Treatment Period|Refused Treatment|18|||
170444752|NCT00090753|615964996|FG001|Extended Treatment Period|Refused Treatment|12|||
170444753|NCT00090753|615964995|FG000|Extended Treatment Period|Lost to Follow-up|3|||
170444754|NCT00090753|615964996|FG001|Extended Treatment Period|Lost to Follow-up|1|||
170444755|NCT00090753|615964995|FG000|Extended Treatment Period|Renal Transplant|15|||
170444756|NCT00090753|615964996|FG001|Extended Treatment Period|Renal Transplant|12|||
170444757|NCT00090753|615964995|FG000|Extended Treatment Period|Mircera Commercialization|188|||
170444758|NCT00090753|615964996|FG001|Extended Treatment Period|Mircera Commercialization|93|||
170444759|NCT00090753|615964995|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
170444760|NCT00090753|615964996|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
170444761|NCT00926367|615965003|FG000|Overall Study|Withdrawal by Subject|0|||
170444762|NCT00926367|615965004|FG001|Overall Study|Withdrawal by Subject|1|||
170444763|NCT00926367|615965003|FG000|Overall Study|Lost to Follow-up|1|||
170444764|NCT00926367|615965004|FG001|Overall Study|Lost to Follow-up|0|||
170444765|NCT00926367|615965003|FG000|Overall Study|Skin Irritation|1|||
170444766|NCT00926367|615965004|FG001|Overall Study|Skin Irritation|2|||
170444767|NCT01517867|615965005|FG000|Overall Study|never started treatment|29|||
170444768|NCT01517867|615965006|FG001|Overall Study|never started treatment|32|||
170444769|NCT01517867|615965005|FG000|Overall Study|Withdrawal by Subject|34|||
170444770|NCT01517867|615965006|FG001|Overall Study|Withdrawal by Subject|30|||
170444771|NCT01517867|615965005|FG000|Overall Study|Still in treatment at study end|0|||
170444772|NCT01517867|615965006|FG001|Overall Study|Still in treatment at study end|3|||
170444773|NCT01294449|615965007|FG000|Overall Study|Death|11|||
170444774|NCT01294449|615965008|FG001|Overall Study|Death|12|||
170444775|NCT01294449|615965007|FG000|Overall Study|Withdrawal by Subject|1|||
170444776|NCT01294449|615965008|FG001|Overall Study|Withdrawal by Subject|3|||
170444777|NCT01685216|615965009|FG000|Overall Study|Did not receive study drug|1|||
170444778|NCT05467982|615965012|FG000|Overall Study|Death|0|||
170444779|NCT05467982|615965013|FG001|Overall Study|Death|1|||
170444780|NCT05467982|615965012|FG000|Overall Study|Lost to Follow-up|3|||
170444781|NCT05467982|615965013|FG001|Overall Study|Lost to Follow-up|1|||
170444782|NCT02839798|615966497|FG000|Overall Study|Withdrawal by Subject|2|||
170444783|NCT02447887|615966498|FG000|Overall Study|Study was terminated|3|||
170444784|NCT02356211|615966501|FG000|Overall Study|Withdrawal by Subject|2|||
170444785|NCT02356211|615966502|FG001|Overall Study|Withdrawal by Subject|2|||
170444786|NCT02356211|615966501|FG000|Overall Study|ineligible|1|||
170444787|NCT02356211|615966502|FG001|Overall Study|ineligible|8|||
170444788|NCT01976728|615966503|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
170444789|NCT01976728|615966504|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
170444790|NCT01976728|615966505|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
170444791|NCT01976728|615966506|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
170444792|NCT01563237|615966508|FG000|Overall Study|Lost to Follow-up|6|||
170444793|NCT01563237|615966509|FG001|Overall Study|Lost to Follow-up|0|||
170444794|NCT01563237|615966508|FG000|Overall Study|Withdrawal by Subject|1|||
170444795|NCT01563237|615966509|FG001|Overall Study|Withdrawal by Subject|0|||
170444796|NCT01563237|615966508|FG000|Overall Study|Adverse Event|1|||
170444797|NCT01563237|615966509|FG001|Overall Study|Adverse Event|0|||
170444798|NCT01563237|615966508|FG000|Overall Study|Medical Reasons|1|||
170444799|NCT01563237|615966509|FG001|Overall Study|Medical Reasons|0|||
170444800|NCT01563237|615966508|FG000|Overall Study|Death|1|||
170444801|NCT01563237|615966509|FG001|Overall Study|Death|0|||
170444802|NCT02211014|615966510|FG000|Overall Study|Adverse Event|0|||
170444803|NCT02211014|615966511|FG001|Overall Study|Adverse Event|2|||
170444804|NCT02211014|615966510|FG000|Overall Study|Physician Decision|1|||
170444805|NCT02211014|615966511|FG001|Overall Study|Physician Decision|2|||
170444806|NCT02211014|615966510|FG000|Overall Study|Started another cancer therapy|1|||
170444807|NCT02211014|615966511|FG001|Overall Study|Started another cancer therapy|0|||
170444808|NCT02211014|615966510|FG000|Overall Study|Withdrawal by Subject|0|||
170444809|NCT02211014|615966511|FG001|Overall Study|Withdrawal by Subject|1|||
170444810|NCT02211014|615966510|FG000|Overall Study|In agreement with patient, no benefit|0|||
170444811|NCT02211014|615966511|FG001|Overall Study|In agreement with patient, no benefit|1|||
170444812|NCT01685073|615966519|FG000|Overall Study|Lost to Follow-up|6|||
170444813|NCT01685073|615966520|FG001|Overall Study|Lost to Follow-up|8|||
170444814|NCT01685073|615966519|FG000|Overall Study|Withdrawal by Subject|24|||
170444815|NCT01685073|615966520|FG001|Overall Study|Withdrawal by Subject|24|||
170444816|NCT01652729|615966523|FG000|Overall Study|Withdrawal by Subject|14|||
170444817|NCT01652729|615966524|FG001|Overall Study|Withdrawal by Subject|7|||
170444818|NCT01652729|615966525|FG002|Overall Study|Withdrawal by Subject|7|||
170444819|NCT01652729|615966523|FG000|Overall Study|Adverse Event|4|||
170444820|NCT01652729|615966524|FG001|Overall Study|Adverse Event|0|||
170444821|NCT01652729|615966525|FG002|Overall Study|Adverse Event|3|||
170444822|NCT01652729|615966523|FG000|Overall Study|Physician Decision|1|||
170444823|NCT01652729|615966524|FG001|Overall Study|Physician Decision|0|||
170444824|NCT01652729|615966525|FG002|Overall Study|Physician Decision|1|||
170444825|NCT01652729|615966523|FG000|Overall Study|Protocol Violation|1|||
170444826|NCT01652729|615966524|FG001|Overall Study|Protocol Violation|0|||
170633361|NCT01177397|616670056|FG004|Overall Study|Death|0|||
170633362|NCT01177397|616670057|FG005|Overall Study|Death|0|||
170633363|NCT01177397|616670058|FG006|Overall Study|Death|0|||
170633364|NCT01177397|616670059|FG007|Overall Study|Death|5|||
170633365|NCT01177397|616670060|FG008|Overall Study|Death|2|||
170633366|NCT01177397|616670061|FG009|Overall Study|Death|1|||
170633367|NCT01177397|616670062|FG010|Overall Study|Death|0|||
170633368|NCT01177397|616670063|FG011|Overall Study|Death|0|||
170633369|NCT01177397|616670052|FG000|Overall Study|Withdrawal by Subject|0|||
170633370|NCT01177397|616670053|FG001|Overall Study|Withdrawal by Subject|0|||
170633371|NCT01177397|616670054|FG002|Overall Study|Withdrawal by Subject|1|||
170633372|NCT01177397|616670055|FG003|Overall Study|Withdrawal by Subject|1|||
170633373|NCT01177397|616670056|FG004|Overall Study|Withdrawal by Subject|1|||
170633374|NCT01177397|616670057|FG005|Overall Study|Withdrawal by Subject|2|||
170633375|NCT01177397|616670058|FG006|Overall Study|Withdrawal by Subject|0|||
170785799|NCT00601900|617223510|FG000|Overall Study|Withdrawal by Subject|0|||
170444827|NCT01652729|615966525|FG002|Overall Study|Protocol Violation|0|||
170444828|NCT01652729|615966523|FG000|Overall Study|Lost to Follow-up|6|||
170444829|NCT01652729|615966524|FG001|Overall Study|Lost to Follow-up|6|||
170444830|NCT01652729|615966525|FG002|Overall Study|Lost to Follow-up|3|||
170444831|NCT01652729|615966523|FG000|Overall Study|Administrative|1|||
170444832|NCT01652729|615966524|FG001|Overall Study|Administrative|0|||
170444833|NCT01652729|615966525|FG002|Overall Study|Administrative|0|||
170444834|NCT01220609|615966526|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
170444835|NCT01220609|615966526|FG000|Overall Study|Ineligible- Wrong cell type|1|||
170444836|NCT01220609|615966526|FG000|Overall Study|Ineligible-Never treated|1|||
170444837|NCT05966090|615966528|FG000|Overall Study|Lost to Follow-up|6|||
170444838|NCT05966090|615966529|FG001|Overall Study|Lost to Follow-up|6|||
170444839|NCT05966090|615966528|FG000|Overall Study|Adverse Event|1|||
170444840|NCT05966090|615966529|FG001|Overall Study|Adverse Event|1|||
170444841|NCT05966090|615966528|FG000|Overall Study|Withdrawal by Subject|1|||
170444842|NCT05966090|615966529|FG001|Overall Study|Withdrawal by Subject|1|||
170444843|NCT05966090|615966528|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170444844|NCT05966090|615966529|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
170444845|NCT05966090|615966528|FG000|Overall Study|Other|1|||
170444846|NCT05966090|615966529|FG001|Overall Study|Other|1|||
170444847|NCT00804141|615966530|FG000|Overall Study|Adverse Event|157|||
170444848|NCT00804141|615966530|FG000|Overall Study|Death|4|||
170444849|NCT00804141|615966530|FG000|Overall Study|Failed to return|96|||
170444850|NCT00804141|615966530|FG000|Overall Study|Investigator request|8|||
170444851|NCT00804141|615966530|FG000|Overall Study|Protocol Violation|85|||
170444852|NCT00804141|615966530|FG000|Overall Study|Withdrawal by Subject|131|||
170444853|NCT00804141|615966530|FG000|Overall Study|Lack of Efficacy|46|||
170444854|NCT00804141|615966530|FG000|Overall Study|Other than specified|30|||
170444855|NCT00804141|615966530|FG000|Overall Study|Enrolled but not treated|6|||
170444856|NCT03235479|615966534|FG000|Overall Study|Lost to Follow-up|8|||
170444857|NCT03235479|615966535|FG001|Overall Study|Lost to Follow-up|11|||
170444858|NCT03235479|615966534|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
170444859|NCT03235479|615966535|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
170444860|NCT03235479|615966534|FG000|Overall Study|Pregnancy|1|||
170444861|NCT03235479|615966535|FG001|Overall Study|Pregnancy|0|||
170444862|NCT03235479|615966534|FG000|Overall Study|Protocol Deviation|1|||
170444863|NCT03235479|615966535|FG001|Overall Study|Protocol Deviation|3|||
170444864|NCT03235479|615966534|FG000|Overall Study|Technical Problems|3|||
170444865|NCT03235479|615966535|FG001|Overall Study|Technical Problems|2|||
170444866|NCT03235479|615966534|FG000|Overall Study|Withdrawal by Subject|2|||
170444867|NCT03235479|615966535|FG001|Overall Study|Withdrawal by Subject|2|||
170444868|NCT03235479|615966534|FG000|Overall Study|Other Reasons|3|||
170444869|NCT03235479|615966535|FG001|Overall Study|Other Reasons|5|||
170633376|NCT01177397|616670059|FG007|Overall Study|Withdrawal by Subject|5|||
170785800|NCT00601900|617223511|FG001|Overall Study|Withdrawal by Subject|3|||
170444870|NCT01628549|615966538|FG000|Overall Study|Adverse Event|1|||
170444871|NCT01628549|615966539|FG001|Overall Study|Adverse Event|1|||
170444872|NCT01628549|615966540|FG002|Overall Study|Adverse Event|0|||
170444873|NCT01628549|615966541|FG003|Overall Study|Adverse Event|4|||
170444874|NCT01628549|615966538|FG000|Overall Study|Lost to Follow-up|3|||
170633377|NCT01177397|616670060|FG008|Overall Study|Withdrawal by Subject|9|||
170633378|NCT01177397|616670061|FG009|Overall Study|Withdrawal by Subject|1|||
170633379|NCT01177397|616670062|FG010|Overall Study|Withdrawal by Subject|1|||
170444875|NCT01628549|615966539|FG001|Overall Study|Lost to Follow-up|4|||
170444876|NCT01628549|615966540|FG002|Overall Study|Lost to Follow-up|3|||
170444877|NCT01628549|615966541|FG003|Overall Study|Lost to Follow-up|3|||
170444878|NCT01628549|615966538|FG000|Overall Study|Withdrawal by Subject|3|||
170444879|NCT01628549|615966539|FG001|Overall Study|Withdrawal by Subject|4|||
170444880|NCT01628549|615966540|FG002|Overall Study|Withdrawal by Subject|4|||
170444881|NCT01628549|615966541|FG003|Overall Study|Withdrawal by Subject|1|||
170444882|NCT01628549|615966538|FG000|Overall Study|Protocol Violation|2|||
170444883|NCT01628549|615966539|FG001|Overall Study|Protocol Violation|1|||
170444884|NCT01628549|615966540|FG002|Overall Study|Protocol Violation|1|||
170444885|NCT01628549|615966541|FG003|Overall Study|Protocol Violation|0|||
170444886|NCT01628549|615966538|FG000|Overall Study|withdrawn for noncompliance|0|||
170444887|NCT01628549|615966539|FG001|Overall Study|withdrawn for noncompliance|2|||
170444888|NCT01628549|615966540|FG002|Overall Study|withdrawn for noncompliance|1|||
170444889|NCT01628549|615966541|FG003|Overall Study|withdrawn for noncompliance|0|||
170444890|NCT01628549|615966538|FG000|Overall Study|abnormal laboratory test results|0|||
170444891|NCT01628549|615966539|FG001|Overall Study|abnormal laboratory test results|0|||
170444892|NCT01628549|615966540|FG002|Overall Study|abnormal laboratory test results|1|||
170444893|NCT01628549|615966541|FG003|Overall Study|abnormal laboratory test results|0|||
170444894|NCT01628549|615966538|FG000|Overall Study|positive pregnancy test|0|||
170444895|NCT01628549|615966539|FG001|Overall Study|positive pregnancy test|0|||
170444896|NCT01628549|615966540|FG002|Overall Study|positive pregnancy test|0|||
170444897|NCT01628549|615966541|FG003|Overall Study|positive pregnancy test|1|||
170444898|NCT01398787|615966546|FG000|Overall Study|Adverse Event|1|||
170444899|NCT02351167|615966547|FG000|Overall Study|Withdrawal by Subject|19|||
170444900|NCT02351167|615966548|FG001|Overall Study|Withdrawal by Subject|18|||
170444901|NCT02351167|615966549|FG002|Overall Study|Withdrawal by Subject|21|||
170444902|NCT01999894|615966552|FG000|Overall Study|Adverse Event|9|||
170444903|NCT01999894|615966552|FG000|Overall Study|Lack of Efficacy|5|||
170444904|NCT01999894|615966552|FG000|Overall Study|Protocol Violation|1|||
170444905|NCT01999894|615966552|FG000|Overall Study|Withdrawal by Subject|7|||
170444906|NCT01999894|615966552|FG000|Overall Study|Lost to Follow-up|10|||
170444907|NCT01999894|615966552|FG000|Overall Study|Other Reason|3|||
170444908|NCT01999894|615966552|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
170444909|NCT03843125|615966556|FG000|Overall Study|Adverse Event|17|||
170444910|NCT03843125|615966557|FG001|Overall Study|Adverse Event|13|||
170444911|NCT03843125|615966558|FG002|Overall Study|Adverse Event|5|||
170444912|NCT03843125|615966559|FG003|Overall Study|Adverse Event|9|||
170444913|NCT03843125|615966556|FG000|Overall Study|Death|0|||
170444914|NCT03843125|615966557|FG001|Overall Study|Death|6|||
170444915|NCT03843125|615966558|FG002|Overall Study|Death|2|||
170444916|NCT03843125|615966559|FG003|Overall Study|Death|0|||
170444917|NCT03843125|615966556|FG000|Overall Study|Lack of Efficacy|14|||
170444918|NCT03843125|615966557|FG001|Overall Study|Lack of Efficacy|11|||
170444919|NCT03843125|615966558|FG002|Overall Study|Lack of Efficacy|9|||
170444920|NCT03843125|615966559|FG003|Overall Study|Lack of Efficacy|4|||
170444921|NCT03843125|615966556|FG000|Overall Study|Lost to Follow-up|3|||
170444922|NCT03843125|615966557|FG001|Overall Study|Lost to Follow-up|4|||
170444923|NCT03843125|615966558|FG002|Overall Study|Lost to Follow-up|0|||
170444924|NCT03843125|615966559|FG003|Overall Study|Lost to Follow-up|2|||
170444925|NCT03843125|615966556|FG000|Overall Study|Other|12|||
170444926|NCT03843125|615966557|FG001|Overall Study|Other|14|||
170444927|NCT03843125|615966558|FG002|Overall Study|Other|3|||
170444928|NCT03843125|615966559|FG003|Overall Study|Other|4|||
170444929|NCT03843125|615966556|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
170444930|NCT03843125|615966557|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
170444931|NCT03843125|615966558|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
170444932|NCT03843125|615966559|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
170444933|NCT03843125|615966556|FG000|Overall Study|Study Terminated by Sponsor|318|||
170444934|NCT03843125|615966557|FG001|Overall Study|Study Terminated by Sponsor|318|||
170444935|NCT03843125|615966558|FG002|Overall Study|Study Terminated by Sponsor|163|||
170444936|NCT03843125|615966559|FG003|Overall Study|Study Terminated by Sponsor|163|||
170444937|NCT03843125|615966556|FG000|Overall Study|Withdrawal by Subject|23|||
170444938|NCT03843125|615966557|FG001|Overall Study|Withdrawal by Subject|12|||
170444939|NCT03843125|615966558|FG002|Overall Study|Withdrawal by Subject|6|||
170444940|NCT03843125|615966559|FG003|Overall Study|Withdrawal by Subject|9|||
170444941|NCT03843125|615966556|FG000|Overall Study|Missing data|0|||
170444942|NCT03843125|615966557|FG001|Overall Study|Missing data|1|||
170444943|NCT03843125|615966558|FG002|Overall Study|Missing data|1|||
170539171|NCT00620542|616317122|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
170539172|NCT00620542|616317123|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
170785801|NCT03675282|617223517|FG000|Overall Study|Lost to Follow-up|4|||
170444944|NCT03843125|615966559|FG003|Overall Study|Missing data|0|||
170444945|NCT03173560|615966560|FG000|Overall Study|Death|70|||
170444946|NCT03173560|615966561|FG001|Overall Study|Death|60|||
170444947|NCT03173560|615966560|FG000|Overall Study|Lost to Follow-up|1|||
170444948|NCT03173560|615966561|FG001|Overall Study|Lost to Follow-up|4|||
170444949|NCT03173560|615966560|FG000|Overall Study|Withdrawal by Subject|10|||
170444950|NCT03173560|615966561|FG001|Overall Study|Withdrawal by Subject|5|||
170444951|NCT03173560|615966560|FG000|Overall Study|Other|0|||
170444952|NCT03173560|615966561|FG001|Overall Study|Other|1|||
170444953|NCT00725764|615966563|FG000|Overall Study|Withdrawal by Subject|2|||
170444954|NCT00725764|615966563|FG000|Overall Study|Physician Decision|1|||
170444955|NCT00725764|615966563|FG000|Overall Study|Progressive Disease|7|||
170444956|NCT00725764|615966563|FG000|Overall Study|Lost to Follow-up|1|||
170444957|NCT00725764|615966563|FG000|Overall Study|Death|1|||
170444958|NCT00725764|615966563|FG000|Overall Study|Participant non compliant with protocol|1|||
170444959|NCT00725764|615966563|FG000|Overall Study|Decline in performance status|1|||
170444960|NCT03507686|615966572|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
170444961|NCT03507686|615966573|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
170444962|NCT03507686|615966572|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
170444963|NCT03507686|615966573|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
170539173|NCT00620542|616317124|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
170539174|NCT00620542|616317125|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
170539175|NCT02696616|616317127|FG000|Overall Study|Adverse Event|0|||
170633380|NCT01177397|616670063|FG011|Overall Study|Withdrawal by Subject|0|||
170633381|NCT01177397|616670052|FG000|Overall Study|Adverse Event|0|||
170633382|NCT01177397|616670053|FG001|Overall Study|Adverse Event|0|||
170633383|NCT01177397|616670054|FG002|Overall Study|Adverse Event|1|||
170539176|NCT02696616|616317128|FG001|Overall Study|Adverse Event|1|||
170539177|NCT02696616|616317129|FG002|Overall Study|Adverse Event|0|||
170539178|NCT02696616|616317130|FG003|Overall Study|Adverse Event|0|||
170539179|NCT02696616|616317131|FG004|Overall Study|Adverse Event|0|||
170539180|NCT02696616|616317132|FG005|Overall Study|Adverse Event|0|||
170539181|NCT02696616|616317133|FG006|Overall Study|Adverse Event|0|||
170539182|NCT01500083|616317134|FG000|Overall Study|Adverse Event|4|||
170539183|NCT01500083|616317135|FG001|Overall Study|Adverse Event|17|||
170539184|NCT01500083|616317134|FG000|Overall Study|Death|0|||
170539185|NCT01500083|616317135|FG001|Overall Study|Death|2|||
170539186|NCT01500083|616317134|FG000|Overall Study|Lost to Follow-up|1|||
170539187|NCT01500083|616317135|FG001|Overall Study|Lost to Follow-up|0|||
170539188|NCT01500083|616317134|FG000|Overall Study|Withdrawal of Consent|0|||
170539189|NCT01500083|616317135|FG001|Overall Study|Withdrawal of Consent|1|||
170539190|NCT01500083|616317134|FG000|Overall Study|Disease Progression|2|||
170539191|NCT01500083|616317135|FG001|Overall Study|Disease Progression|10|||
170539192|NCT01500083|616317134|FG000|Overall Study|Investigator Discretion|3|||
170539193|NCT01500083|616317135|FG001|Overall Study|Investigator Discretion|8|||
170539194|NCT01500083|616317134|FG000|Overall Study|Other Reasons|2|||
170539195|NCT01500083|616317135|FG001|Overall Study|Other Reasons|5|||
170539196|NCT01555931|616317136|FG000|Overall Study|Lost to Follow-up|2|||
170539197|NCT01555931|616317137|FG001|Overall Study|Lost to Follow-up|5|||
170539198|NCT01510756|616317138|FG000|Overall Study|Death|1|||
170539199|NCT01510756|616317138|FG000|Overall Study|Lack of Efficacy|2|||
170539200|NCT01510756|616317138|FG000|Overall Study|Physician Decision|1|||
170539201|NCT04398134|616317145|FG000|Overall Study|Adverse Event|0|||
170539202|NCT04398134|616317146|FG001|Overall Study|Adverse Event|0|||
170539203|NCT04398134|616317147|FG002|Overall Study|Adverse Event|1|||
170539204|NCT04398134|616317148|FG003|Overall Study|Adverse Event|0|||
170539205|NCT04398134|616317145|FG000|Overall Study|Withdrawal by Subject|2|||
170539206|NCT04398134|616317146|FG001|Overall Study|Withdrawal by Subject|0|||
170539207|NCT04398134|616317147|FG002|Overall Study|Withdrawal by Subject|0|||
170539208|NCT04398134|616317148|FG003|Overall Study|Withdrawal by Subject|1|||
170539209|NCT04398134|616317145|FG000|Overall Study|Study Terminated by Sponsor|30|||
170539210|NCT04398134|616317146|FG001|Overall Study|Study Terminated by Sponsor|11|||
170539211|NCT04398134|616317147|FG002|Overall Study|Study Terminated by Sponsor|32|||
170539212|NCT04398134|616317148|FG003|Overall Study|Study Terminated by Sponsor|11|||
170785802|NCT03675282|617223518|FG001|Overall Study|Lost to Follow-up|8|||
170785803|NCT03675282|617223519|FG002|Overall Study|Lost to Follow-up|1|||
170444964|NCT03507686|615966572|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
170444965|NCT03507686|615966573|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
170444966|NCT03507686|615966572|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
170444967|NCT03507686|615966573|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
170444968|NCT03507686|615966572|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
170444969|NCT03507686|615966573|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
170444970|NCT03507686|615966572|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
170444971|NCT03507686|615966573|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
170444972|NCT00585312|615966574|FG000|Overall Study|Adverse Event|3|||
170539213|NCT00963235|616317151|FG000|Overall Study|Withdrawal by Subject|22|||
170539214|NCT00963235|616317151|FG000|Overall Study|Lost to Follow-up|14|||
170539215|NCT00963235|616317151|FG000|Overall Study|Failed to return|9|||
170539216|NCT00963235|616317151|FG000|Overall Study|Protocol Violation|7|||
170539217|NCT00963235|616317151|FG000|Overall Study|Adverse Event|5|||
170539218|NCT00963235|616317151|FG000|Overall Study|Physician Decision|2|||
170633384|NCT01177397|616670055|FG003|Overall Study|Adverse Event|2|||
170444973|NCT00585312|615966575|FG001|Overall Study|Adverse Event|0|||
170444974|NCT00585312|615966574|FG000|Overall Study|Lack of Efficacy|6|||
170444975|NCT00585312|615966575|FG001|Overall Study|Lack of Efficacy|11|||
170444976|NCT00585312|615966574|FG000|Overall Study|Lost to Follow-up|1|||
170444977|NCT00585312|615966575|FG001|Overall Study|Lost to Follow-up|1|||
170444978|NCT00585312|615966574|FG000|Overall Study|Reason not specified|2|||
170444979|NCT00585312|615966575|FG001|Overall Study|Reason not specified|0|||
170444980|NCT00585312|615966574|FG000|Overall Study|Withdrawal by Subject|5|||
170444981|NCT00585312|615966575|FG001|Overall Study|Withdrawal by Subject|1|||
170444982|NCT00585312|615966574|FG000|Overall Study|Study terminated by the sponsor|34|||
170444983|NCT00585312|615966575|FG001|Overall Study|Study terminated by the sponsor|31|||
170444984|NCT00569777|615966580|FG000|Overall Study|Withdrawal by Subject|4|||
170444985|NCT00569777|615966581|FG001|Overall Study|Withdrawal by Subject|0|||
170444986|NCT00569777|615966580|FG000|Overall Study|Adverse Event|3|||
170444987|NCT00569777|615966581|FG001|Overall Study|Adverse Event|0|||
170444988|NCT00569777|615966580|FG000|Overall Study|Lost to Follow-up|1|||
170444989|NCT00569777|615966581|FG001|Overall Study|Lost to Follow-up|0|||
170444990|NCT00569777|615966580|FG000|Overall Study|scheduled eye surgery|0|||
170444991|NCT00569777|615966581|FG001|Overall Study|scheduled eye surgery|1|||
170444992|NCT00569777|615966580|FG000|Overall Study|did not meet exclusion criteria|1|||
170444993|NCT00569777|615966581|FG001|Overall Study|did not meet exclusion criteria|2|||
170444994|NCT00569777|615966580|FG000|Overall Study|pregnant|1|||
170444995|NCT00569777|615966581|FG001|Overall Study|pregnant|0|||
170444996|NCT01598896|615966582|FG000|Overall Study|Withdrawal by Subject|0|||
170444997|NCT01598896|615966583|FG001|Overall Study|Withdrawal by Subject|1|||
170444998|NCT01598896|615966582|FG000|Overall Study|Lack of Efficacy|0|||
170444999|NCT01598896|615966583|FG001|Overall Study|Lack of Efficacy|1|||
170445000|NCT00393705|615966584|FG000|Overall Study|Adverse Event|0|||
170445001|NCT00393705|615966585|FG001|Overall Study|Adverse Event|2|||
170445002|NCT00393705|615966584|FG000|Overall Study|Death|0|||
170445003|NCT00393705|615966585|FG001|Overall Study|Death|1|||
170445004|NCT00393705|615966584|FG000|Overall Study|Lost to Follow-up|2|||
170445005|NCT00393705|615966585|FG001|Overall Study|Lost to Follow-up|2|||
170445006|NCT00393705|615966584|FG000|Overall Study|Entry Criteria Not Met|10|||
170445007|NCT00393705|615966585|FG001|Overall Study|Entry Criteria Not Met|10|||
170445008|NCT00393705|615966584|FG000|Overall Study|Protocol Violation|4|||
170445009|NCT00393705|615966585|FG001|Overall Study|Protocol Violation|3|||
170445010|NCT00393705|615966584|FG000|Overall Study|Withdrawal by Subject|5|||
170445011|NCT00393705|615966585|FG001|Overall Study|Withdrawal by Subject|3|||
170445012|NCT00393705|615966584|FG000|Overall Study|Physician Decision|2|||
170445013|NCT00393705|615966585|FG001|Overall Study|Physician Decision|2|||
170539219|NCT00963235|616317151|FG000|Overall Study|Other|1|||
170539220|NCT01697579|616317152|FG000|Base Study-Cycle 1|Adverse Event|1|||
170539221|NCT01697579|616317153|FG001|Base Study-Cycle 1|Adverse Event|0|||
170539222|NCT01697579|616317154|FG002|Base Study-Cycle 1|Adverse Event|0|||
170539223|NCT01697579|616317155|FG003|Base Study-Cycle 1|Adverse Event|0|||
170539224|NCT01697579|616317156|FG004|Base Study-Cycle 1|Adverse Event|0|||
170539225|NCT01697579|616317157|FG005|Base Study-Cycle 1|Adverse Event|0|||
170539226|NCT01697579|616317158|FG006|Base Study-Cycle 1|Adverse Event|0|||
170539227|NCT01697579|616317152|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
170539228|NCT01697579|616317153|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
170539229|NCT01697579|616317154|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
170539230|NCT01697579|616317155|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
170539231|NCT01697579|616317156|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
170539232|NCT01697579|616317157|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
170539233|NCT01697579|616317158|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
170539234|NCT01697579|616317152|FG000|Base Study-Cycle 1|Protocol Violation|0|||
170539235|NCT01697579|616317153|FG001|Base Study-Cycle 1|Protocol Violation|0|||
170539236|NCT01697579|616317154|FG002|Base Study-Cycle 1|Protocol Violation|0|||
170539237|NCT01697579|616317155|FG003|Base Study-Cycle 1|Protocol Violation|0|||
170539238|NCT01697579|616317156|FG004|Base Study-Cycle 1|Protocol Violation|3|||
170539239|NCT01697579|616317157|FG005|Base Study-Cycle 1|Protocol Violation|0|||
170539240|NCT01697579|616317158|FG006|Base Study-Cycle 1|Protocol Violation|0|||
170539241|NCT01697579|616317152|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
170539242|NCT01697579|616317153|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
170539243|NCT01697579|616317154|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
170539244|NCT01697579|616317155|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
170539245|NCT01697579|616317156|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
170539246|NCT01697579|616317157|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
170445014|NCT03573336|615966586|FG000|Overall Study|Study terminated|2|||
170445015|NCT03573336|615966587|FG001|Overall Study|Study terminated|4|||
170445016|NCT03573336|615966588|FG002|Overall Study|Study terminated|2|||
170445017|NCT03108820|615966589|FG000|Overall Study|Lost to Follow-up|30|||
170445018|NCT03108820|615966590|FG001|Overall Study|Lost to Follow-up|28|||
170445019|NCT03108820|615966589|FG000|Overall Study|Withdrawal by Subject|32|||
170445020|NCT03108820|615966590|FG001|Overall Study|Withdrawal by Subject|24|||
170445021|NCT03108820|615966589|FG000|Overall Study|Death|6|||
170445022|NCT03108820|615966590|FG001|Overall Study|Death|11|||
170445023|NCT01223027|615966591|FG000|Overall Study|Adverse Event|20|||
170445024|NCT01223027|615966592|FG001|Overall Study|Adverse Event|10|||
170445025|NCT01223027|615966591|FG000|Overall Study|Death|42|||
170445026|NCT01223027|615966592|FG001|Overall Study|Death|42|||
170445027|NCT01223027|615966591|FG000|Overall Study|Lost to Follow-up|2|||
170445028|NCT01223027|615966592|FG001|Overall Study|Lost to Follow-up|1|||
170445029|NCT01223027|615966591|FG000|Overall Study|Physician Decision|4|||
170445030|NCT01223027|615966592|FG001|Overall Study|Physician Decision|8|||
170445031|NCT01223027|615966591|FG000|Overall Study|Progressive Disease|167|||
170445032|NCT01223027|615966592|FG001|Overall Study|Progressive Disease|183|||
170539247|NCT01697579|616317158|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
170633385|NCT01177397|616670056|FG004|Overall Study|Adverse Event|0|||
170633386|NCT01177397|616670057|FG005|Overall Study|Adverse Event|12|||
170633387|NCT01177397|616670058|FG006|Overall Study|Adverse Event|1|||
170539248|NCT01697579|616317152|FG000|Base Study-Cycle 1|Technical Problems|0|||
170539249|NCT01697579|616317153|FG001|Base Study-Cycle 1|Technical Problems|0|||
170539250|NCT01697579|616317154|FG002|Base Study-Cycle 1|Technical Problems|1|||
170539251|NCT01697579|616317155|FG003|Base Study-Cycle 1|Technical Problems|1|||
170539252|NCT01697579|616317156|FG004|Base Study-Cycle 1|Technical Problems|0|||
170539253|NCT01697579|616317157|FG005|Base Study-Cycle 1|Technical Problems|0|||
170539254|NCT01697579|616317158|FG006|Base Study-Cycle 1|Technical Problems|0|||
170539255|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Death|0|||
170539256|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Death|0|||
170539257|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Death|0|||
170539258|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Death|0|||
170539259|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Death|0|||
170539260|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Death|0|||
170539261|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Death|2|||
170539262|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
170539263|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
170539264|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
170539265|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
170539266|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
170539267|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
170539268|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
170539269|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
170539270|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
170539271|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
170539272|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
170539273|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
170539274|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
170539275|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
170539276|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
170539277|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
170539278|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
170539279|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
170539280|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
170539281|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
170539282|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
170539283|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
170539284|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
170539285|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
170539286|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
170539287|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
170633388|NCT01177397|616670059|FG007|Overall Study|Adverse Event|14|||
170445033|NCT01223027|615966591|FG000|Overall Study|Protocol Violation|2|||
170445034|NCT01223027|615966592|FG001|Overall Study|Protocol Violation|1|||
170445035|NCT01223027|615966591|FG000|Overall Study|Subject/guardian decicion|18|||
170445036|NCT01223027|615966592|FG001|Overall Study|Subject/guardian decicion|16|||
170445037|NCT01223027|615966591|FG000|Overall Study|New therapy for study indication|17|||
170539288|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
170785804|NCT03675282|617223520|FG003|Overall Study|Lost to Follow-up|0|||
170445038|NCT01223027|615966592|FG001|Overall Study|New therapy for study indication|8|||
170539289|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
170539290|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
170539291|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
170539292|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
170633389|NCT01177397|616670060|FG008|Overall Study|Adverse Event|8|||
170445039|NCT01223027|615966591|FG000|Overall Study|Study terminated by sponsor|2|||
170445040|NCT01223027|615966592|FG001|Overall Study|Study terminated by sponsor|8|||
170445041|NCT00654641|615966593|FG000|Overall Study|Lost to Follow-up|2|||
170785805|NCT03675282|617223521|FG004|Overall Study|Lost to Follow-up|2|||
170785806|NCT03675282|617223522|FG005|Overall Study|Lost to Follow-up|7|||
170785807|NCT03675282|617223517|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
170785808|NCT03675282|617223518|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
170785809|NCT03675282|617223519|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
170445042|NCT00654641|615966594|FG001|Overall Study|Lost to Follow-up|3|||
170445043|NCT03493919|615966595|FG000|Overall Study|Other|2|||
170445044|NCT03493919|615966596|FG001|Overall Study|Other|0|||
170445045|NCT03493919|615966597|FG002|Overall Study|Other|1|||
170445046|NCT03493919|615966598|FG003|Overall Study|Other|0|||
170445047|NCT03493919|615966595|FG000|Overall Study|Withdrawal by Subject|9|||
170445048|NCT03493919|615966596|FG001|Overall Study|Withdrawal by Subject|3|||
170445049|NCT03493919|615966597|FG002|Overall Study|Withdrawal by Subject|1|||
170445050|NCT03493919|615966598|FG003|Overall Study|Withdrawal by Subject|1|||
170445051|NCT03493919|615966595|FG000|Overall Study|Lost to Follow-up|5|||
170445052|NCT03493919|615966596|FG001|Overall Study|Lost to Follow-up|0|||
170445053|NCT03493919|615966597|FG002|Overall Study|Lost to Follow-up|0|||
170445054|NCT03493919|615966598|FG003|Overall Study|Lost to Follow-up|3|||
170445055|NCT03493919|615966595|FG000|Overall Study|Adverse Event|0|||
170445056|NCT03493919|615966596|FG001|Overall Study|Adverse Event|1|||
170445057|NCT03493919|615966597|FG002|Overall Study|Adverse Event|0|||
170445058|NCT03493919|615966598|FG003|Overall Study|Adverse Event|0|||
170445059|NCT03253094|615966601|FG000|Overall Study|Adverse Event|2|||
170445060|NCT03253094|615966602|FG001|Overall Study|Adverse Event|0|||
170445061|NCT03253094|615966603|FG002|Overall Study|Adverse Event|0|||
170445062|NCT03253094|615966604|FG003|Overall Study|Adverse Event|0|||
170445063|NCT03253094|615966605|FG004|Overall Study|Adverse Event|0|||
170445064|NCT03253094|615966606|FG005|Overall Study|Adverse Event|0|||
170445065|NCT03253094|615966601|FG000|Overall Study|Lack of Efficacy|0|||
170445066|NCT03253094|615966602|FG001|Overall Study|Lack of Efficacy|0|||
170445067|NCT03253094|615966603|FG002|Overall Study|Lack of Efficacy|2|||
170445068|NCT03253094|615966604|FG003|Overall Study|Lack of Efficacy|1|||
170445069|NCT03253094|615966605|FG004|Overall Study|Lack of Efficacy|2|||
170445070|NCT03253094|615966606|FG005|Overall Study|Lack of Efficacy|1|||
170445071|NCT03253094|615966601|FG000|Overall Study|Lost to Follow-up|0|||
170445072|NCT03253094|615966602|FG001|Overall Study|Lost to Follow-up|0|||
170445073|NCT03253094|615966603|FG002|Overall Study|Lost to Follow-up|1|||
170445074|NCT03253094|615966604|FG003|Overall Study|Lost to Follow-up|1|||
170445075|NCT03253094|615966605|FG004|Overall Study|Lost to Follow-up|0|||
170445076|NCT03253094|615966606|FG005|Overall Study|Lost to Follow-up|1|||
170445077|NCT03253094|615966601|FG000|Overall Study|Physician Decision|1|||
170445078|NCT03253094|615966602|FG001|Overall Study|Physician Decision|0|||
170445079|NCT03253094|615966603|FG002|Overall Study|Physician Decision|0|||
170445080|NCT03253094|615966604|FG003|Overall Study|Physician Decision|1|||
170445081|NCT03253094|615966605|FG004|Overall Study|Physician Decision|0|||
170445082|NCT03253094|615966606|FG005|Overall Study|Physician Decision|2|||
170445083|NCT03253094|615966601|FG000|Overall Study|Withdrawal by Subject|1|||
170445084|NCT03253094|615966602|FG001|Overall Study|Withdrawal by Subject|2|||
170445085|NCT03253094|615966603|FG002|Overall Study|Withdrawal by Subject|1|||
170785810|NCT03675282|617223520|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
170785811|NCT03675282|617223521|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
170445086|NCT03253094|615966604|FG003|Overall Study|Withdrawal by Subject|0|||
170445087|NCT03253094|615966605|FG004|Overall Study|Withdrawal by Subject|3|||
170445088|NCT03253094|615966606|FG005|Overall Study|Withdrawal by Subject|0|||
170445089|NCT03253094|615966601|FG000|Overall Study|Other|0|||
170445090|NCT03253094|615966602|FG001|Overall Study|Other|1|||
170445091|NCT03253094|615966603|FG002|Overall Study|Other|2|||
170445092|NCT03253094|615966604|FG003|Overall Study|Other|1|||
170445093|NCT03253094|615966605|FG004|Overall Study|Other|0|||
170445094|NCT03253094|615966606|FG005|Overall Study|Other|0|||
170445095|NCT00810602|615966607|FG000|Overall Study|Withdrawal by Subject|8|||
170445096|NCT00810602|615966608|FG001|Overall Study|Withdrawal by Subject|3|||
170445097|NCT00824369|615966609|FG000|Overall Study|Nolonger willing to participate in study|1|||
170445098|NCT00824369|615966610|FG001|Overall Study|Nolonger willing to participate in study|0|||
170445099|NCT00824369|615966611|FG002|Overall Study|Nolonger willing to participate in study|1|||
170785812|NCT03675282|617223522|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
170445100|NCT00824369|615966612|FG003|Overall Study|Nolonger willing to participate in study|2|||
170445101|NCT00824369|615966613|FG004|Overall Study|Nolonger willing to participate in study|0|||
170445102|NCT00824369|615966614|FG005|Overall Study|Nolonger willing to participate in study|1|||
170539293|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
170539294|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
170445103|NCT00824369|615966609|FG000|Overall Study|Lost to Follow-up|0|||
170445104|NCT00824369|615966610|FG001|Overall Study|Lost to Follow-up|0|||
170445105|NCT00824369|615966611|FG002|Overall Study|Lost to Follow-up|0|||
170445106|NCT00824369|615966612|FG003|Overall Study|Lost to Follow-up|0|||
170445107|NCT00824369|615966613|FG004|Overall Study|Lost to Follow-up|1|||
170445108|NCT00824369|615966614|FG005|Overall Study|Lost to Follow-up|0|||
170445109|NCT03840382|615966615|FG000|Overall Study|Lost to Follow-up|11|||
170445110|NCT02625974|615966616|FG000|Part 1|Lost to Follow-up|9|||
170445111|NCT02625974|615966617|FG001|Part 1|Lost to Follow-up|3|||
170445112|NCT02625974|615966616|FG000|Part 2|Lost to Follow-up|4|||
170445113|NCT02625974|615966617|FG001|Part 2|Lost to Follow-up|6|||
170445114|NCT02625974|615966616|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
170445115|NCT02625974|615966617|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
170445116|NCT01142661|615966618|FG000|Overall Study|Adverse Event|2|||
170785813|NCT03675282|617223517|FG000|Overall Study|Physician Decision|1|||
170785814|NCT03675282|617223518|FG001|Overall Study|Physician Decision|0|||
170785815|NCT03675282|617223519|FG002|Overall Study|Physician Decision|0|||
170785816|NCT03675282|617223520|FG003|Overall Study|Physician Decision|0|||
170445117|NCT01142661|615966618|FG000|Overall Study|Withdrawal by Subject|1|||
170785817|NCT03675282|617223521|FG004|Overall Study|Physician Decision|0|||
170445118|NCT01142661|615966618|FG000|Overall Study|Physician Decision|1|||
170445119|NCT00434590|615966623|FG000|Overall Study|Administrative problems|5|||
170445120|NCT00434590|615966624|FG001|Overall Study|Administrative problems|5|||
170445121|NCT04773600|615966627|FG000|Overall Study|Withdrawal by Subject|15|||
170445122|NCT04773600|615966628|FG001|Overall Study|Withdrawal by Subject|9|||
170445123|NCT04773600|615966627|FG000|Overall Study|Lost to Follow-up|10|||
170445124|NCT04773600|615966628|FG001|Overall Study|Lost to Follow-up|6|||
170785818|NCT03675282|617223522|FG005|Overall Study|Physician Decision|0|||
170785819|NCT03056040|617223526|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
170445125|NCT04773600|615966627|FG000|Overall Study|Adverse Event|8|||
170445126|NCT04773600|615966628|FG001|Overall Study|Adverse Event|2|||
170445127|NCT04773600|615966627|FG000|Overall Study|Lack of Efficacy|2|||
170445128|NCT04773600|615966628|FG001|Overall Study|Lack of Efficacy|3|||
170445129|NCT04773600|615966627|FG000|Overall Study|Noncompliance|2|||
170445130|NCT04773600|615966628|FG001|Overall Study|Noncompliance|0|||
170445131|NCT04773600|615966627|FG000|Overall Study|Protocol Violation|2|||
170445132|NCT04773600|615966628|FG001|Overall Study|Protocol Violation|0|||
170445133|NCT04773600|615966627|FG000|Overall Study|Physician Decision|0|||
170445134|NCT04773600|615966628|FG001|Overall Study|Physician Decision|1|||
170445135|NCT04773600|615966627|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
170445136|NCT04773600|615966628|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
170445137|NCT04773600|615966627|FG000|Overall Study|Emergency Travel Out of Country|1|||
170445138|NCT04773600|615966628|FG001|Overall Study|Emergency Travel Out of Country|0|||
170445139|NCT03581188|615968351|FG000|Overall Study|Inclusion criteria not met|3|||
170445140|NCT03581188|615968352|FG001|Overall Study|Inclusion criteria not met|2|||
170445141|NCT03581188|615968351|FG000|Overall Study|Lost to Follow-up|5|||
170445142|NCT03581188|615968352|FG001|Overall Study|Lost to Follow-up|5|||
170445143|NCT03581188|615968351|FG000|Overall Study|Discontinued intervention|11|||
170445144|NCT03581188|615968352|FG001|Overall Study|Discontinued intervention|8|||
170445145|NCT03710590|615968355|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
170445146|NCT03710590|615968356|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
170445147|NCT00480324|615968357|FG000|Overall Study|Adverse Event|1|||
170445148|NCT00480324|615968358|FG001|Overall Study|Adverse Event|1|||
170445149|NCT00480324|615968357|FG000|Overall Study|Protocol Violation|0|||
170445150|NCT00480324|615968358|FG001|Overall Study|Protocol Violation|1|||
170445151|NCT00480324|615968357|FG000|Overall Study|Withdrawal by Subject|14|||
170445152|NCT00480324|615968358|FG001|Overall Study|Withdrawal by Subject|5|||
170445153|NCT00480324|615968357|FG000|Overall Study|Lost to Follow-up|17|||
170445154|NCT00480324|615968358|FG001|Overall Study|Lost to Follow-up|8|||
170445155|NCT00480324|615968357|FG000|Overall Study|Subject's mother pregnant|0|||
170445156|NCT00480324|615968358|FG001|Overall Study|Subject's mother pregnant|1|||
170445157|NCT02488824|615968359|FG000|Overall Study|Adverse Event|1|||
170445158|NCT02488824|615968360|FG001|Overall Study|Adverse Event|1|||
170785820|NCT03056040|617223527|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
170445159|NCT02443324|615968362|FG000|Overall Study|Death|4|||
170445160|NCT02443324|615968363|FG001|Overall Study|Death|1|||
170445161|NCT02443324|615968364|FG002|Overall Study|Death|0|||
170445162|NCT02443324|615968365|FG003|Overall Study|Death|3|||
170785821|NCT03056040|617223526|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
170886925|NCT03403205|617593567|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
170445163|NCT02443324|615968366|FG004|Overall Study|Death|1|||
170445164|NCT02443324|615968367|FG005|Overall Study|Death|3|||
170445165|NCT02443324|615968368|FG006|Overall Study|Death|2|||
170445166|NCT02443324|615968362|FG000|Overall Study|Lost to Follow-up|0|||
170445167|NCT02443324|615968363|FG001|Overall Study|Lost to Follow-up|0|||
170445168|NCT02443324|615968364|FG002|Overall Study|Lost to Follow-up|0|||
170445169|NCT02443324|615968365|FG003|Overall Study|Lost to Follow-up|1|||
170445170|NCT02443324|615968366|FG004|Overall Study|Lost to Follow-up|0|||
170445171|NCT02443324|615968367|FG005|Overall Study|Lost to Follow-up|1|||
170445172|NCT02443324|615968368|FG006|Overall Study|Lost to Follow-up|0|||
170445173|NCT02443324|615968362|FG000|Overall Study|Physician Decision|0|||
170445174|NCT02443324|615968363|FG001|Overall Study|Physician Decision|3|||
170445175|NCT02443324|615968364|FG002|Overall Study|Physician Decision|5|||
170445176|NCT02443324|615968365|FG003|Overall Study|Physician Decision|1|||
170445177|NCT02443324|615968366|FG004|Overall Study|Physician Decision|1|||
170445178|NCT02443324|615968367|FG005|Overall Study|Physician Decision|0|||
170445179|NCT02443324|615968368|FG006|Overall Study|Physician Decision|2|||
170445180|NCT02443324|615968362|FG000|Overall Study|Progressive Disease|20|||
170445181|NCT02443324|615968363|FG001|Overall Study|Progressive Disease|20|||
170445182|NCT02443324|615968364|FG002|Overall Study|Progressive Disease|13|||
170445183|NCT02443324|615968365|FG003|Overall Study|Progressive Disease|10|||
170445184|NCT02443324|615968366|FG004|Overall Study|Progressive Disease|13|||
170445185|NCT02443324|615968367|FG005|Overall Study|Progressive Disease|17|||
170445186|NCT02443324|615968368|FG006|Overall Study|Progressive Disease|10|||
170445187|NCT02443324|615968362|FG000|Overall Study|Withdrawal by Subject|0|||
170445188|NCT02443324|615968363|FG001|Overall Study|Withdrawal by Subject|0|||
170445189|NCT02443324|615968364|FG002|Overall Study|Withdrawal by Subject|3|||
170445190|NCT02443324|615968365|FG003|Overall Study|Withdrawal by Subject|1|||
170445191|NCT02443324|615968366|FG004|Overall Study|Withdrawal by Subject|1|||
170445192|NCT02443324|615968367|FG005|Overall Study|Withdrawal by Subject|0|||
170445193|NCT02443324|615968368|FG006|Overall Study|Withdrawal by Subject|1|||
170445194|NCT02443324|615968362|FG000|Overall Study|Adverse Event|0|||
170445195|NCT02443324|615968363|FG001|Overall Study|Adverse Event|1|||
170445196|NCT02443324|615968364|FG002|Overall Study|Adverse Event|3|||
170445197|NCT02443324|615968365|FG003|Overall Study|Adverse Event|0|||
170445198|NCT02443324|615968366|FG004|Overall Study|Adverse Event|4|||
170445199|NCT02443324|615968367|FG005|Overall Study|Adverse Event|3|||
170445200|NCT02443324|615968368|FG006|Overall Study|Adverse Event|3|||
170445201|NCT02443324|615968362|FG000|Overall Study|Enrolled but Never Treated|0|||
170445202|NCT02443324|615968363|FG001|Overall Study|Enrolled but Never Treated|0|||
170445203|NCT02443324|615968364|FG002|Overall Study|Enrolled but Never Treated|1|||
170445204|NCT02443324|615968365|FG003|Overall Study|Enrolled but Never Treated|0|||
170445205|NCT02443324|615968366|FG004|Overall Study|Enrolled but Never Treated|1|||
170445206|NCT02443324|615968367|FG005|Overall Study|Enrolled but Never Treated|0|||
170445207|NCT02443324|615968368|FG006|Overall Study|Enrolled but Never Treated|1|||
170445208|NCT03036839|615968369|FG000|Overall Study|Adverse Event|0|||
170445209|NCT03036839|615968370|FG001|Overall Study|Adverse Event|0|||
170445210|NCT03036839|615968371|FG002|Overall Study|Adverse Event|1|||
170445211|NCT03036839|615968369|FG000|Overall Study|Death|3|||
170445212|NCT03036839|615968370|FG001|Overall Study|Death|0|||
170445213|NCT03036839|615968371|FG002|Overall Study|Death|3|||
170445214|NCT03036839|615968369|FG000|Overall Study|Withdrew Consent|0|||
170445215|NCT03036839|615968370|FG001|Overall Study|Withdrew Consent|0|||
170445216|NCT03036839|615968371|FG002|Overall Study|Withdrew Consent|1|||
170445217|NCT00693225|615968373|FG000|Overall Study|Lost to Follow-up|1|||
170445218|NCT00693225|615968374|FG001|Overall Study|Lost to Follow-up|2|||
170445219|NCT00693225|615968373|FG000|Overall Study|Adverse Event|1|||
170539295|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
170539296|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
170539297|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
170539298|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
170539299|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
170539300|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
170633390|NCT01177397|616670061|FG009|Overall Study|Adverse Event|6|||
170785822|NCT03056040|617223527|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
170785823|NCT03056040|617223526|FG000|Primary Evaluation Period|Pregnancy|0|||
170445220|NCT00693225|615968374|FG001|Overall Study|Adverse Event|3|||
170445221|NCT03585959|615968379|FG000|Overall Study|Physician Decision|1|||
170445222|NCT03585959|615968379|FG000|Overall Study|Unsuccessful Procedure|2|||
170445223|NCT01186016|615968381|FG000|Overall Study|Withdrawal by Subject|46|||
170445224|NCT01186016|615968382|FG001|Overall Study|Withdrawal by Subject|29|||
170445225|NCT03750695|615968384|FG000|Overall Study|Lost to Follow-up|0|||
170445226|NCT03750695|615968385|FG001|Overall Study|Lost to Follow-up|1|||
170445227|NCT04480307|615968386|FG000|Overall Study|Withdrawal by Subject|0|||
170445228|NCT04480307|615968387|FG001|Overall Study|Withdrawal by Subject|1|||
170445229|NCT04480307|615968388|FG002|Overall Study|Withdrawal by Subject|0|||
170445230|NCT04480307|615968389|FG003|Overall Study|Withdrawal by Subject|0|||
170445231|NCT04480307|615968386|FG000|Overall Study|Adverse Event|0|||
170445232|NCT04480307|615968387|FG001|Overall Study|Adverse Event|0|||
170445233|NCT04480307|615968388|FG002|Overall Study|Adverse Event|0|||
170445234|NCT04480307|615968389|FG003|Overall Study|Adverse Event|1|||
170445235|NCT01077258|615968391|FG000|Overall Study|Lost to Follow-up|1390|||
170445236|NCT01077258|615968391|FG000|Overall Study|Adverse drug reaction|218|||
170445237|NCT01077258|615968391|FG000|Overall Study|Lack of Efficacy|663|||
170445238|NCT01077258|615968391|FG000|Overall Study|Clinical remission|37|||
170445239|NCT01077258|615968391|FG000|Overall Study|Other reasons|260|||
170445240|NCT00726895|615968393|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
170445241|NCT00726895|615968394|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
170445242|NCT01450800|615968395|FG000|Overall Study|Protocol Violation|1|||
170445243|NCT01450800|615968396|FG001|Overall Study|Protocol Violation|3|||
170445244|NCT00732160|615968400|FG000|Overall Study|Adverse Event|1|||
170445245|NCT00732160|615968401|FG001|Overall Study|Adverse Event|0|||
170445246|NCT00732160|615968402|FG002|Overall Study|Adverse Event|1|||
170445247|NCT00732160|615968403|FG003|Overall Study|Adverse Event|1|||
170445248|NCT00732160|615968400|FG000|Overall Study|scheduling|4|||
170445249|NCT00732160|615968401|FG001|Overall Study|scheduling|4|||
170445250|NCT00732160|615968402|FG002|Overall Study|scheduling|2|||
170445251|NCT00732160|615968403|FG003|Overall Study|scheduling|1|||
170445252|NCT02260635|615968407|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
170445253|NCT02260635|615968408|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
170445254|NCT02260635|615968407|FG000|Open-Label Extension|Study Termination|25|||
170445255|NCT02260635|615968408|FG001|Open-Label Extension|Study Termination|25|||
170445256|NCT02260635|615968407|FG000|Open-Label Extension|Withdrawal by Subject|1|||
170445257|NCT02260635|615968408|FG001|Open-Label Extension|Withdrawal by Subject|0|||
170445258|NCT04660032|615968411|FG000|Overall Study|Protocol Violation|1|||
170445259|NCT04660032|615968412|FG001|Overall Study|Protocol Violation|1|||
170445260|NCT01557920|615968415|FG000|Overall Study|Withdrawal by Subject|2|||
170445261|NCT01557920|615968416|FG001|Overall Study|Withdrawal by Subject|3|||
170445262|NCT01557920|615968415|FG000|Overall Study|Lack of Efficacy|1|||
170445263|NCT01557920|615968416|FG001|Overall Study|Lack of Efficacy|0|||
170445264|NCT01609582|615968421|FG000|Overall Study|Adverse Event|20|||
170445265|NCT01609582|615968422|FG001|Overall Study|Adverse Event|18|||
170445266|NCT01609582|615968421|FG000|Overall Study|Lost to Follow-up|10|||
170445267|NCT01609582|615968422|FG001|Overall Study|Lost to Follow-up|10|||
170445268|NCT01609582|615968421|FG000|Overall Study|Withdrawal by Subject|21|||
170445269|NCT01609582|615968422|FG001|Overall Study|Withdrawal by Subject|15|||
170445270|NCT01609582|615968421|FG000|Overall Study|Study Terminated by Sponsor|1543|||
170445271|NCT01609582|615968422|FG001|Overall Study|Study Terminated by Sponsor|1548|||
170445272|NCT01609582|615968421|FG000|Overall Study|Other|9|||
170445273|NCT01609582|615968422|FG001|Overall Study|Other|10|||
170445274|NCT01609582|615968421|FG000|Overall Study|Randomized, but not treated|0|||
170445275|NCT01609582|615968422|FG001|Overall Study|Randomized, but not treated|3|||
170539301|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
170539302|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
170539303|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
170539304|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
170539305|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
170539306|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
170539307|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
170539308|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
170539309|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
170539310|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
170539311|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
170539312|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
170539313|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
170539314|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
170539315|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
170539316|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
170539317|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
170539318|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
170539319|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
170539320|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
170539321|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
170539322|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
170539323|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
170539324|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
170539325|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
170539326|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
170539327|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
170539328|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
170539329|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
170539330|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
170539331|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
170539332|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
170539333|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
170539334|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
170633391|NCT01177397|616670062|FG010|Overall Study|Adverse Event|3|||
170633392|NCT01177397|616670063|FG011|Overall Study|Adverse Event|7|||
170633393|NCT01177397|616670052|FG000|Overall Study|Disease progression|1|||
170633394|NCT01177397|616670053|FG001|Overall Study|Disease progression|2|||
170633395|NCT01177397|616670054|FG002|Overall Study|Disease progression|5|||
170633396|NCT01177397|616670055|FG003|Overall Study|Disease progression|5|||
170633397|NCT01177397|616670056|FG004|Overall Study|Disease progression|4|||
170633398|NCT01177397|616670057|FG005|Overall Study|Disease progression|10|||
170633399|NCT01177397|616670058|FG006|Overall Study|Disease progression|10|||
170633400|NCT01177397|616670059|FG007|Overall Study|Disease progression|21|||
170633401|NCT01177397|616670060|FG008|Overall Study|Disease progression|18|||
170633402|NCT01177397|616670061|FG009|Overall Study|Disease progression|12|||
170633403|NCT01177397|616670062|FG010|Overall Study|Disease progression|10|||
170633404|NCT01177397|616670063|FG011|Overall Study|Disease progression|8|||
170633405|NCT01177397|616670052|FG000|Overall Study|Other reasons|0|||
170633406|NCT01177397|616670053|FG001|Overall Study|Other reasons|0|||
170633407|NCT01177397|616670054|FG002|Overall Study|Other reasons|1|||
170633408|NCT01177397|616670055|FG003|Overall Study|Other reasons|0|||
170633409|NCT01177397|616670056|FG004|Overall Study|Other reasons|1|||
170633410|NCT01177397|616670057|FG005|Overall Study|Other reasons|1|||
170633411|NCT01177397|616670058|FG006|Overall Study|Other reasons|2|||
170633412|NCT01177397|616670059|FG007|Overall Study|Other reasons|6|||
170633413|NCT01177397|616670060|FG008|Overall Study|Other reasons|10|||
170633414|NCT01177397|616670061|FG009|Overall Study|Other reasons|8|||
170633415|NCT01177397|616670062|FG010|Overall Study|Other reasons|0|||
170633416|NCT01177397|616670063|FG011|Overall Study|Other reasons|2|||
170633417|NCT01759446|616670064|FG000|Overall Study|Protocol Violation|1|||
170633418|NCT01759446|616670065|FG001|Overall Study|Protocol Violation|0|||
170633419|NCT01759446|616670066|FG002|Overall Study|Protocol Violation|1|||
170633420|NCT01759446|616670067|FG003|Overall Study|Protocol Violation|0|||
170633421|NCT01759446|616670068|FG004|Overall Study|Protocol Violation|0|||
170633422|NCT01759446|616670064|FG000|Overall Study|Withdrawal by Subject|0|||
170633423|NCT01759446|616670065|FG001|Overall Study|Withdrawal by Subject|1|||
170633424|NCT01759446|616670066|FG002|Overall Study|Withdrawal by Subject|0|||
170785824|NCT03056040|617223527|FG001|Primary Evaluation Period|Pregnancy|1|||
170785825|NCT03056040|617223526|FG000|Primary Evaluation Period|Randomized, not treated|1|||
170785826|NCT03056040|617223527|FG001|Primary Evaluation Period|Randomized, not treated|1|||
170785827|NCT03056040|617223526|FG000|Extension Period|Physician Decision|3|||
170633425|NCT01759446|616670067|FG003|Overall Study|Withdrawal by Subject|1|||
170633426|NCT01759446|616670068|FG004|Overall Study|Withdrawal by Subject|0|||
170633427|NCT01760733|616670069|FG000|Waiting List|Death|18|||
170633428|NCT01760733|616670069|FG000|Waiting List|Removed from waiting list|41|||
170633429|NCT01760733|616670069|FG000|Waiting List|Not received a transplant yet|13|||
170633430|NCT01760733|616670069|FG000|Transplanted|Not reached 10 years post transplant|184|||
170633431|NCT01760733|616670069|FG000|Transplanted|Death|26|||
170785828|NCT03056040|617223527|FG001|Extension Period|Physician Decision|3|||
170445276|NCT04974580|615968423|FG000|Overall Study|Lost to Follow-up|33|||
170445277|NCT04974580|615968424|FG001|Overall Study|Lost to Follow-up|39|||
170445278|NCT04974580|615968425|FG002|Overall Study|Lost to Follow-up|30|||
170445279|NCT04974580|615968426|FG003|Overall Study|Lost to Follow-up|29|||
170445280|NCT00476593|615968441|FG000|Overall Study|Lost to Follow-up|10|||
170445281|NCT00476593|615968442|FG001|Overall Study|Lost to Follow-up|2|||
170445282|NCT00476593|615968443|FG002|Overall Study|Lost to Follow-up|8|||
170445283|NCT00476593|615968444|FG003|Overall Study|Lost to Follow-up|22|||
170445284|NCT03430011|615968445|FG000|Pre-Treatment|Death|1|||
170445285|NCT03430011|615968446|FG001|Pre-Treatment|Death|0|||
170445286|NCT03430011|615968447|FG002|Pre-Treatment|Death|0|||
170445287|NCT03430011|615968448|FG003|Pre-Treatment|Death|0|||
170445288|NCT03430011|615968449|FG004|Pre-Treatment|Death|1|||
170445289|NCT03430011|615968450|FG005|Pre-Treatment|Death|0|||
170445290|NCT03430011|615968451|FG006|Pre-Treatment|Death|1|||
170445291|NCT03430011|615968452|FG007|Pre-Treatment|Death|0|||
170445292|NCT03430011|615968445|FG000|Pre-Treatment|Screen Fail|0|||
170445293|NCT03430011|615968446|FG001|Pre-Treatment|Screen Fail|0|||
170445294|NCT03430011|615968447|FG002|Pre-Treatment|Screen Fail|0|||
170445295|NCT03430011|615968448|FG003|Pre-Treatment|Screen Fail|0|||
170445296|NCT03430011|615968449|FG004|Pre-Treatment|Screen Fail|1|||
170445297|NCT03430011|615968450|FG005|Pre-Treatment|Screen Fail|0|||
170445298|NCT03430011|615968451|FG006|Pre-Treatment|Screen Fail|0|||
170445299|NCT03430011|615968452|FG007|Pre-Treatment|Screen Fail|0|||
170445300|NCT03430011|615968445|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
170445301|NCT03430011|615968446|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
170445302|NCT03430011|615968447|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
170633432|NCT01760733|616670069|FG000|Transplanted|Graft loss|7|||
170633433|NCT00719472|616670072|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
170633434|NCT00719472|616670072|FG000|Enrolled in Study|Subject decision to withdraw|8|||
170633435|NCT00719472|616670072|FG000|Enrolled in Study|Various Reasons|17|||
170633436|NCT00719472|616670072|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
170633437|NCT00719472|616670072|FG000|Received Cycle 1 Treatment|Death|5|||
170633438|NCT00719472|616670072|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
170633439|NCT00719472|616670072|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
170633440|NCT00719472|616670072|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
170633441|NCT00719472|616670072|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
170633442|NCT00719472|616670072|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
170445303|NCT03430011|615968448|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
170445304|NCT03430011|615968449|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
170445305|NCT03430011|615968450|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
170445306|NCT03430011|615968451|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
170445307|NCT03430011|615968452|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
170445308|NCT03430011|615968445|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
170445309|NCT03430011|615968446|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
170445310|NCT03430011|615968447|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
170445311|NCT03430011|615968448|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
170445312|NCT03430011|615968449|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
170445313|NCT03430011|615968450|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
170445314|NCT03430011|615968451|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
170445315|NCT03430011|615968452|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
170445316|NCT03430011|615968445|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
170445317|NCT03430011|615968446|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
170445318|NCT03430011|615968447|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
170445319|NCT03430011|615968448|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
170445320|NCT03430011|615968449|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
170445321|NCT03430011|615968450|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
170445322|NCT03430011|615968451|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
170445323|NCT03430011|615968452|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
170445324|NCT03430011|615968445|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
170445325|NCT03430011|615968446|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
170445326|NCT03430011|615968447|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
170445327|NCT03430011|615968448|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
170445328|NCT03430011|615968449|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
170445329|NCT03430011|615968450|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
170445330|NCT03430011|615968451|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
170445331|NCT03430011|615968452|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
170445332|NCT03430011|615968445|FG000|JCARH125 Treatment|Death|4|||
170445333|NCT03430011|615968446|FG001|JCARH125 Treatment|Death|19|||
170886926|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
170886927|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
170886928|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
170886929|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
170886930|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
170886931|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
170886932|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
170886933|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
170886934|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
170886935|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
170445334|NCT03430011|615968447|FG002|JCARH125 Treatment|Death|10|||
170445335|NCT03430011|615968448|FG003|JCARH125 Treatment|Death|8|||
170445336|NCT03430011|615968449|FG004|JCARH125 Treatment|Death|5|||
170445337|NCT03430011|615968450|FG005|JCARH125 Treatment|Death|3|||
170445338|NCT03430011|615968451|FG006|JCARH125 Treatment|Death|4|||
170445339|NCT03430011|615968452|FG007|JCARH125 Treatment|Death|2|||
170445340|NCT03430011|615968445|FG000|JCARH125 Treatment|Other reasons|1|||
170445341|NCT03430011|615968446|FG001|JCARH125 Treatment|Other reasons|0|||
170445342|NCT03430011|615968447|FG002|JCARH125 Treatment|Other reasons|4|||
170445343|NCT03430011|615968448|FG003|JCARH125 Treatment|Other reasons|2|||
170445344|NCT03430011|615968449|FG004|JCARH125 Treatment|Other reasons|2|||
170886936|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
170886937|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
170886938|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Death|1|||
170886939|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Death|0|||
170886940|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Death|0|||
170886941|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Death|0|||
170886942|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Death|0|||
170886943|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Death|0|||
170886944|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
170886945|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
170886946|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
170886947|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
170886948|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
170445345|NCT03430011|615968450|FG005|JCARH125 Treatment|Other reasons|1|||
170445346|NCT03430011|615968451|FG006|JCARH125 Treatment|Other reasons|3|||
170445347|NCT03430011|615968452|FG007|JCARH125 Treatment|Other reasons|2|||
170445348|NCT04126343|615968453|FG000|Overall Study|Adverse Event|0|||
170445349|NCT04126343|615968454|FG001|Overall Study|Adverse Event|0|||
170445350|NCT04126343|615968455|FG002|Overall Study|Adverse Event|0|||
170445351|NCT04126343|615968456|FG003|Overall Study|Adverse Event|0|||
170445352|NCT04126343|615968457|FG004|Overall Study|Adverse Event|0|||
170633443|NCT00719472|616670072|FG000|Received Cycle 2 Treatment|Death|6|||
170633444|NCT00719472|616670072|FG000|Received Cycle 2 Treatment|Disease progression|3|||
170633445|NCT00719472|616670072|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
170633446|NCT00719472|616670072|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
170633447|NCT00719472|616670072|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
170633448|NCT00719472|616670072|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
170633449|NCT00499616|616670073|FG000|Overall Study|Death|1|||
170633450|NCT00499616|616670074|FG001|Overall Study|Death|5|||
170633451|NCT00499616|616670075|FG002|Overall Study|Death|3|||
170633452|NCT00499616|616670076|FG003|Overall Study|Death|1|||
170633453|NCT00499616|616670073|FG000|Overall Study|Lack of Efficacy|5|||
170633454|NCT00499616|616670074|FG001|Overall Study|Lack of Efficacy|0|||
170633455|NCT00499616|616670075|FG002|Overall Study|Lack of Efficacy|19|||
170633456|NCT00499616|616670076|FG003|Overall Study|Lack of Efficacy|0|||
170633457|NCT00499616|616670073|FG000|Overall Study|Lost to Follow-up|0|||
170633458|NCT00499616|616670074|FG001|Overall Study|Lost to Follow-up|0|||
170633459|NCT00499616|616670075|FG002|Overall Study|Lost to Follow-up|1|||
170633460|NCT00499616|616670076|FG003|Overall Study|Lost to Follow-up|0|||
170539335|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
170539336|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
170539337|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
170539338|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
170539339|NCT01697579|616317152|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
170539340|NCT01697579|616317153|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
170539341|NCT01697579|616317154|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
170539342|NCT01697579|616317155|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
170539343|NCT01697579|616317156|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
170539344|NCT01697579|616317157|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
170539345|NCT01697579|616317158|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
170539346|NCT02550795|616317165|FG000|Overall Study|Physician Decision|0|||
170539347|NCT02550795|616317166|FG001|Overall Study|Physician Decision|1|||
170539348|NCT02550795|616317167|FG002|Overall Study|Physician Decision|0|||
170539349|NCT02802228|616317168|FG000|Overall Study|Withdrawal by Subject|2|||
170539350|NCT02802228|616317169|FG001|Overall Study|Withdrawal by Subject|0|||
170539351|NCT02802228|616317168|FG000|Overall Study|Lost to Follow-up|1|||
170539352|NCT02802228|616317169|FG001|Overall Study|Lost to Follow-up|0|||
170539353|NCT02802228|616317168|FG000|Overall Study|Adverse Event|1|||
170539354|NCT02802228|616317169|FG001|Overall Study|Adverse Event|0|||
170539355|NCT02802228|616317168|FG000|Overall Study|Physician Decision|1|||
170539356|NCT02802228|616317169|FG001|Overall Study|Physician Decision|0|||
170539357|NCT00695019|616317172|FG000|Overall Study|Withdrawal by Subject|8|||
170539358|NCT00695019|616317173|FG001|Overall Study|Withdrawal by Subject|6|||
170539359|NCT00695019|616317174|FG002|Overall Study|Withdrawal by Subject|4|||
170539360|NCT00695019|616317172|FG000|Overall Study|Protocol Violation|1|||
170539361|NCT00695019|616317173|FG001|Overall Study|Protocol Violation|3|||
170539362|NCT00695019|616317174|FG002|Overall Study|Protocol Violation|1|||
170539363|NCT00695019|616317172|FG000|Overall Study|Lack of Efficacy|0|||
170539364|NCT00695019|616317173|FG001|Overall Study|Lack of Efficacy|0|||
170539365|NCT00695019|616317174|FG002|Overall Study|Lack of Efficacy|1|||
170539366|NCT00695019|616317172|FG000|Overall Study|Various|4|||
170539367|NCT00695019|616317173|FG001|Overall Study|Various|5|||
170539368|NCT00695019|616317174|FG002|Overall Study|Various|4|||
170539369|NCT02225587|616317175|FG000|Overall Study|Adverse Event|5|||
170539370|NCT02225587|616317176|FG001|Overall Study|Adverse Event|5|||
170539371|NCT02225587|616317175|FG000|Overall Study|Lost to Follow-up|5|||
170539372|NCT02225587|616317176|FG001|Overall Study|Lost to Follow-up|5|||
170539373|NCT02225587|616317175|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170539374|NCT02225587|616317176|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170539375|NCT02225587|616317175|FG000|Overall Study|Physician Decision|2|||
170633461|NCT00499616|616670073|FG000|Overall Study|Physician Decision|6|||
170539376|NCT02225587|616317176|FG001|Overall Study|Physician Decision|0|||
170539377|NCT02225587|616317175|FG000|Overall Study|Protocol Violation|1|||
170539378|NCT02225587|616317176|FG001|Overall Study|Protocol Violation|0|||
170633462|NCT00499616|616670074|FG001|Overall Study|Physician Decision|16|||
170539379|NCT02225587|616317175|FG000|Overall Study|Participant Moved|1|||
170539380|NCT02225587|616317176|FG001|Overall Study|Participant Moved|0|||
170785829|NCT03056040|617223526|FG000|Extension Period|Lost to Follow-up|0|||
170539381|NCT02225587|616317175|FG000|Overall Study|Withdrawal by Subject|13|||
170633463|NCT00499616|616670075|FG002|Overall Study|Physician Decision|9|||
170633464|NCT00499616|616670076|FG003|Overall Study|Physician Decision|0|||
170633465|NCT00499616|616670073|FG000|Overall Study|Withdrawal by Subject|1|||
170633466|NCT00499616|616670074|FG001|Overall Study|Withdrawal by Subject|0|||
170633467|NCT00499616|616670075|FG002|Overall Study|Withdrawal by Subject|1|||
170785830|NCT03056040|617223527|FG001|Extension Period|Lost to Follow-up|1|||
170539382|NCT02225587|616317176|FG001|Overall Study|Withdrawal by Subject|28|||
170539383|NCT01564407|616317186|FG000|Overall Study|Lost to Follow-up|0|||
170539384|NCT01564407|616317187|FG001|Overall Study|Lost to Follow-up|1|||
170445353|NCT04126343|615968458|FG005|Overall Study|Adverse Event|1|||
170445354|NCT04126343|615968453|FG000|Overall Study|Withdrawal by Subject|0|||
170445355|NCT04126343|615968454|FG001|Overall Study|Withdrawal by Subject|0|||
170445356|NCT04126343|615968455|FG002|Overall Study|Withdrawal by Subject|0|||
170445357|NCT04126343|615968456|FG003|Overall Study|Withdrawal by Subject|1|||
170445358|NCT04126343|615968457|FG004|Overall Study|Withdrawal by Subject|0|||
170445359|NCT04126343|615968458|FG005|Overall Study|Withdrawal by Subject|0|||
170445360|NCT04126343|615968453|FG000|Overall Study|Related to COVID-19 pandemic|3|||
170445361|NCT04126343|615968454|FG001|Overall Study|Related to COVID-19 pandemic|4|||
170445362|NCT04126343|615968455|FG002|Overall Study|Related to COVID-19 pandemic|3|||
170445363|NCT04126343|615968456|FG003|Overall Study|Related to COVID-19 pandemic|3|||
170445364|NCT04126343|615968457|FG004|Overall Study|Related to COVID-19 pandemic|3|||
170445365|NCT04126343|615968458|FG005|Overall Study|Related to COVID-19 pandemic|3|||
170445366|NCT00559364|615968459|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
170445367|NCT00559364|615968460|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
170633468|NCT00499616|616670076|FG003|Overall Study|Withdrawal by Subject|0|||
170445368|NCT01235442|615968461|FG000|Overall Study|Lost to Follow-up|12|||
170445369|NCT01235442|615968462|FG001|Overall Study|Lost to Follow-up|10|||
170445370|NCT01235442|615968461|FG000|Overall Study|Death|0|||
170445371|NCT01235442|615968462|FG001|Overall Study|Death|2|||
170445372|NCT01235442|615968461|FG000|Overall Study|Pregnancy|1|||
170445373|NCT01235442|615968462|FG001|Overall Study|Pregnancy|1|||
170445374|NCT01235442|615968461|FG000|Overall Study|Ineligibility determined|5|||
170445375|NCT01235442|615968462|FG001|Overall Study|Ineligibility determined|4|||
170445376|NCT01235442|615968461|FG000|Overall Study|Protocol Violation|3|||
170445377|NCT01235442|615968462|FG001|Overall Study|Protocol Violation|3|||
170445378|NCT01235442|615968461|FG000|Overall Study|Adverse Event|4|||
170445379|NCT01235442|615968462|FG001|Overall Study|Adverse Event|6|||
170445380|NCT01235442|615968461|FG000|Overall Study|Withdrawal by Subject|15|||
170445381|NCT01235442|615968462|FG001|Overall Study|Withdrawal by Subject|9|||
170445382|NCT01235442|615968461|FG000|Overall Study|Lack of Efficacy|1|||
170445383|NCT01235442|615968462|FG001|Overall Study|Lack of Efficacy|3|||
170445384|NCT01235442|615968461|FG000|Overall Study|Noncompliance|1|||
170445385|NCT01235442|615968462|FG001|Overall Study|Noncompliance|2|||
170445386|NCT01235442|615968461|FG000|Overall Study|Administrative decision|1|||
170445387|NCT01235442|615968462|FG001|Overall Study|Administrative decision|2|||
170445388|NCT01235442|615968461|FG000|Overall Study|Other unspecified|1|||
170445389|NCT01235442|615968462|FG001|Overall Study|Other unspecified|2|||
170445390|NCT01857973|615968469|FG000|Overall Study|Subject did not meet required BG range|3|||
170445391|NCT01857973|615968469|FG000|Overall Study|drop out after 3 failed attempts|1|||
170445392|NCT01857973|615968469|FG000|Overall Study|Physician Decision|1|||
170445393|NCT00129116|615968474|FG000|Primary Phase|Lost to Follow-up|1|||
170445394|NCT00129116|615968475|FG001|Primary Phase|Lost to Follow-up|1|||
170445395|NCT00129116|615968476|FG002|Primary Phase|Lost to Follow-up|0|||
170445396|NCT00129116|615968477|FG003|Primary Phase|Lost to Follow-up|1|||
170445397|NCT00129116|615968478|FG004|Primary Phase|Lost to Follow-up|1|||
170445398|NCT00129116|615968474|FG000|Primary Phase|Protocol Violation|0|||
170445399|NCT00129116|615968475|FG001|Primary Phase|Protocol Violation|1|||
170445400|NCT00129116|615968476|FG002|Primary Phase|Protocol Violation|0|||
170445401|NCT00129116|615968477|FG003|Primary Phase|Protocol Violation|0|||
170445402|NCT00129116|615968478|FG004|Primary Phase|Protocol Violation|0|||
170445403|NCT00129116|615968474|FG000|Primary Phase|Adverse Event|1|||
170445404|NCT00129116|615968475|FG001|Primary Phase|Adverse Event|1|||
170445405|NCT00129116|615968476|FG002|Primary Phase|Adverse Event|0|||
170445406|NCT00129116|615968477|FG003|Primary Phase|Adverse Event|0|||
170445407|NCT00129116|615968478|FG004|Primary Phase|Adverse Event|0|||
170445408|NCT00129116|615968474|FG000|Primary Phase|Withdrawal by Subject|0|||
170445409|NCT00129116|615968475|FG001|Primary Phase|Withdrawal by Subject|1|||
170445410|NCT00129116|615968476|FG002|Primary Phase|Withdrawal by Subject|0|||
170445411|NCT00129116|615968477|FG003|Primary Phase|Withdrawal by Subject|0|||
170445412|NCT00129116|615968478|FG004|Primary Phase|Withdrawal by Subject|0|||
170445413|NCT00129116|615968474|FG000|Primary Phase|Other|0|||
170445414|NCT00129116|615968475|FG001|Primary Phase|Other|0|||
170445415|NCT00129116|615968476|FG002|Primary Phase|Other|1|||
170445416|NCT00129116|615968477|FG003|Primary Phase|Other|0|||
170445417|NCT00129116|615968478|FG004|Primary Phase|Other|0|||
170445418|NCT00129116|615968474|FG000|Booster Phase|Lost to Follow-up|2|||
170445419|NCT00129116|615968475|FG001|Booster Phase|Lost to Follow-up|0|||
170445420|NCT00129116|615968476|FG002|Booster Phase|Lost to Follow-up|0|||
170445421|NCT00129116|615968477|FG003|Booster Phase|Lost to Follow-up|0|||
170633469|NCT00499616|616670073|FG000|Overall Study|Ineligible|1|||
170633470|NCT00499616|616670074|FG001|Overall Study|Ineligible|2|||
170445422|NCT00129116|615968478|FG004|Booster Phase|Lost to Follow-up|1|||
170445423|NCT00388037|615968481|FG000|Overall Study|Protocol Violation|1|||
170633471|NCT00499616|616670075|FG002|Overall Study|Ineligible|0|||
170445424|NCT00602537|615968482|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
170445425|NCT00602537|615968483|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
170445426|NCT00602537|615968482|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
170445427|NCT00602537|615968483|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
170445428|NCT00602537|615968482|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
170445429|NCT00602537|615968483|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
170445430|NCT00602537|615968482|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
170445431|NCT00602537|615968483|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
170445432|NCT00602537|615968482|FG000|Follow Up Study Comparison|Adverse Event|1|||
170445433|NCT00602537|615968483|FG001|Follow Up Study Comparison|Adverse Event|0|||
170445434|NCT00602537|615968482|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
170445435|NCT00602537|615968483|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
170445436|NCT00602537|615968482|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
170445437|NCT00602537|615968483|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
170445438|NCT04330157|615968484|FG000|Overall Study|Protocol Violation|4|||
170445439|NCT04330157|615968484|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
170445440|NCT02539368|615968486|FG000|Overall Study|Death|4|||
170445441|NCT02539368|615968487|FG001|Overall Study|Death|2|||
170445442|NCT02539368|615968488|FG002|Overall Study|Death|1|||
170445443|NCT02539368|615968489|FG003|Overall Study|Death|0|||
170445444|NCT02539368|615968490|FG004|Overall Study|Death|0|||
170445445|NCT02539368|615968486|FG000|Overall Study|Withdrawal by Subject|44|||
170445446|NCT02539368|615968487|FG001|Overall Study|Withdrawal by Subject|35|||
170445447|NCT02539368|615968488|FG002|Overall Study|Withdrawal by Subject|9|||
170445448|NCT02539368|615968489|FG003|Overall Study|Withdrawal by Subject|1|||
170445449|NCT02539368|615968490|FG004|Overall Study|Withdrawal by Subject|3|||
170445450|NCT02539368|615968486|FG000|Overall Study|Physician Decision|49|||
170445451|NCT02539368|615968487|FG001|Overall Study|Physician Decision|15|||
170445452|NCT02539368|615968488|FG002|Overall Study|Physician Decision|7|||
170445453|NCT02539368|615968489|FG003|Overall Study|Physician Decision|0|||
170445454|NCT02539368|615968490|FG004|Overall Study|Physician Decision|2|||
170445455|NCT02539368|615968486|FG000|Overall Study|Lost to Follow-up|96|||
170445456|NCT02539368|615968487|FG001|Overall Study|Lost to Follow-up|21|||
170445457|NCT02539368|615968488|FG002|Overall Study|Lost to Follow-up|16|||
170445458|NCT02539368|615968489|FG003|Overall Study|Lost to Follow-up|4|||
170445459|NCT02539368|615968490|FG004|Overall Study|Lost to Follow-up|3|||
170445460|NCT02539368|615968486|FG000|Overall Study|Adverse Event|44|||
170445461|NCT02539368|615968487|FG001|Overall Study|Adverse Event|5|||
170445462|NCT02539368|615968488|FG002|Overall Study|Adverse Event|9|||
170445463|NCT02539368|615968489|FG003|Overall Study|Adverse Event|0|||
170445464|NCT02539368|615968490|FG004|Overall Study|Adverse Event|3|||
170445465|NCT02539368|615968486|FG000|Overall Study|Participant Non-compliant|13|||
170445466|NCT02539368|615968487|FG001|Overall Study|Participant Non-compliant|2|||
170445467|NCT02539368|615968488|FG002|Overall Study|Participant Non-compliant|1|||
170445468|NCT02539368|615968489|FG003|Overall Study|Participant Non-compliant|1|||
170445469|NCT02539368|615968490|FG004|Overall Study|Participant Non-compliant|0|||
170445470|NCT02539368|615968486|FG000|Overall Study|Other|145|||
170445471|NCT02539368|615968487|FG001|Overall Study|Other|18|||
170445472|NCT02539368|615968488|FG002|Overall Study|Other|24|||
170445473|NCT02539368|615968489|FG003|Overall Study|Other|1|||
170445474|NCT02539368|615968490|FG004|Overall Study|Other|3|||
170445475|NCT02539368|615968486|FG000|Overall Study|Missing|10|||
170445476|NCT02539368|615968487|FG001|Overall Study|Missing|3|||
170445477|NCT02539368|615968488|FG002|Overall Study|Missing|0|||
170445478|NCT02539368|615968489|FG003|Overall Study|Missing|0|||
170445479|NCT02539368|615968490|FG004|Overall Study|Missing|0|||
170445480|NCT01899326|615968492|FG000|Overall Study|Withdrawal by Subject|1|||
170445481|NCT01899326|615968492|FG000|Overall Study|Adverse Event|2|||
170445482|NCT01899326|615968492|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
170445483|NCT03558139|615968493|FG000|Overall Study|Consent Withdrawn|1|||
170445484|NCT03558139|615968494|FG001|Overall Study|Consent Withdrawn|1|||
170539385|NCT01564407|616317188|FG002|Overall Study|Lost to Follow-up|0|||
170539386|NCT01564407|616317189|FG003|Overall Study|Lost to Follow-up|0|||
170539387|NCT01564407|616317190|FG004|Overall Study|Lost to Follow-up|0|||
170539388|NCT01564407|616317186|FG000|Overall Study|Withdrawal by Subject|0|||
170539389|NCT01564407|616317187|FG001|Overall Study|Withdrawal by Subject|1|||
170539390|NCT01564407|616317188|FG002|Overall Study|Withdrawal by Subject|0|||
170539391|NCT01564407|616317189|FG003|Overall Study|Withdrawal by Subject|0|||
170445485|NCT03558139|615968495|FG002|Overall Study|Consent Withdrawn|4|||
170445486|NCT03558139|615968493|FG000|Overall Study|Death|5|||
170445487|NCT03558139|615968494|FG001|Overall Study|Death|3|||
170539392|NCT01564407|616317190|FG004|Overall Study|Withdrawal by Subject|0|||
170539393|NCT01564407|616317186|FG000|Overall Study|funding lost, study ended|0|||
170445488|NCT03558139|615968495|FG002|Overall Study|Death|8|||
170445489|NCT03558139|615968493|FG000|Overall Study|Lost to Follow-up|0|||
170445490|NCT03558139|615968494|FG001|Overall Study|Lost to Follow-up|0|||
170445491|NCT03558139|615968495|FG002|Overall Study|Lost to Follow-up|3|||
170445492|NCT03558139|615968493|FG000|Overall Study|Study Ended Per Protocol|0|||
170445493|NCT03558139|615968494|FG001|Overall Study|Study Ended Per Protocol|3|||
170445494|NCT03558139|615968495|FG002|Overall Study|Study Ended Per Protocol|6|||
170445495|NCT02752802|615968496|FG000|Overall Study|Contrast Volume Not Collected|1|||
170445496|NCT02752802|615968497|FG001|Overall Study|Contrast Volume Not Collected|0|||
170445497|NCT03689894|615968498|FG000|Overall Study|Adverse Event|1|||
170445498|NCT02056652|615968505|FG000|Overall Study|Withdrawal by Subject|1|||
170633472|NCT00499616|616670076|FG003|Overall Study|Ineligible|15|||
170445499|NCT02056652|615968506|FG001|Overall Study|Withdrawal by Subject|0|||
170445500|NCT02056652|615968505|FG000|Overall Study|Lost to Follow-up|0|||
170445501|NCT02056652|615968506|FG001|Overall Study|Lost to Follow-up|3|||
170445502|NCT03185741|615968511|FG000|Baseline|Withdrawal by Subject|1|||
170445503|NCT03185741|615968512|FG001|Baseline|Withdrawal by Subject|3|||
170445504|NCT03185741|615968513|FG002|Baseline|Withdrawal by Subject|2|||
170445505|NCT03185741|615968511|FG000|Baseline|Lost to Follow-up|1|||
170445506|NCT03185741|615968512|FG001|Baseline|Lost to Follow-up|2|||
170445507|NCT03185741|615968513|FG002|Baseline|Lost to Follow-up|3|||
170445508|NCT03185741|615968511|FG000|3Month|Death|1|||
170445509|NCT03185741|615968512|FG001|3Month|Death|1|||
170445510|NCT03185741|615968513|FG002|3Month|Death|2|||
170445511|NCT03185741|615968511|FG000|3Month|Withdrawal by Subject|1|||
170445512|NCT03185741|615968512|FG001|3Month|Withdrawal by Subject|5|||
170445513|NCT03185741|615968513|FG002|3Month|Withdrawal by Subject|1|||
170445514|NCT03185741|615968511|FG000|3Month|Lost to Follow-up|7|||
170445515|NCT03185741|615968512|FG001|3Month|Lost to Follow-up|9|||
170445516|NCT03185741|615968513|FG002|3Month|Lost to Follow-up|8|||
170445517|NCT03185741|615968511|FG000|3Month|Unavailable for 3Month|11|||
170445518|NCT03185741|615968512|FG001|3Month|Unavailable for 3Month|10|||
170445519|NCT03185741|615968513|FG002|3Month|Unavailable for 3Month|11|||
170445520|NCT03185741|615968511|FG000|3Month|Protocol Violation|0|||
170445521|NCT03185741|615968512|FG001|3Month|Protocol Violation|0|||
170445522|NCT03185741|615968513|FG002|3Month|Protocol Violation|3|||
170445523|NCT03185741|615968511|FG000|6Month|Death|1|||
170445524|NCT03185741|615968512|FG001|6Month|Death|1|||
170445525|NCT03185741|615968513|FG002|6Month|Death|2|||
170445526|NCT03185741|615968511|FG000|6Month|Withdrawal by Subject|2|||
170445527|NCT03185741|615968512|FG001|6Month|Withdrawal by Subject|3|||
170445528|NCT03185741|615968513|FG002|6Month|Withdrawal by Subject|1|||
170445529|NCT03185741|615968511|FG000|6Month|Lost to Follow-up|16|||
170445530|NCT03185741|615968512|FG001|6Month|Lost to Follow-up|15|||
170445531|NCT03185741|615968513|FG002|6Month|Lost to Follow-up|16|||
170445532|NCT00239005|615968516|FG000|Overall Study|Adverse Event|6|||
170445533|NCT00239005|615968517|FG001|Overall Study|Adverse Event|6|||
170445534|NCT00239005|615968516|FG000|Overall Study|Withdrawal by Subject|3|||
170445535|NCT00239005|615968517|FG001|Overall Study|Withdrawal by Subject|4|||
170445536|NCT00239005|615968516|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
170445537|NCT00239005|615968517|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
170445538|NCT00239005|615968516|FG000|Overall Study|Protocol Violation|1|||
170445539|NCT00239005|615968517|FG001|Overall Study|Protocol Violation|0|||
170445540|NCT00239005|615968516|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
170445541|NCT00239005|615968517|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
170445542|NCT00239005|615968516|FG000|Overall Study|Lost to Follow-up|0|||
170445543|NCT00239005|615968517|FG001|Overall Study|Lost to Follow-up|1|||
170445544|NCT01488448|615968523|FG000|Overall Study|Withdrawal by Subject|3|||
170445545|NCT01488448|615968524|FG001|Overall Study|Withdrawal by Subject|1|||
170445546|NCT01488448|615968523|FG000|Overall Study|Adverse Event|9|||
170445547|NCT01488448|615968524|FG001|Overall Study|Adverse Event|4|||
170445548|NCT01488448|615968523|FG000|Overall Study|Physician Decision|4|||
170445549|NCT01488448|615968524|FG001|Overall Study|Physician Decision|9|||
170445550|NCT01488448|615968523|FG000|Overall Study|Protocol Violation|4|||
170445551|NCT01488448|615968524|FG001|Overall Study|Protocol Violation|3|||
170445552|NCT03257254|615968525|FG000|Overall Study|Withdrawal by Subject|7|||
170445553|NCT03257254|615968525|FG000|Overall Study|Lost to Follow-up|9|||
170445554|NCT03257254|615968525|FG000|Overall Study|Study discontinued by sponsor|5|||
170886949|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
170445555|NCT03365791|615968526|FG000|Overall Study|Adverse Event|5|||
170445556|NCT03365791|615968526|FG000|Overall Study|Death|1|||
170445557|NCT03365791|615968526|FG000|Overall Study|Lost to Follow-up|1|||
170445558|NCT03365791|615968526|FG000|Overall Study|Physician Decision|9|||
170445559|NCT03365791|615968526|FG000|Overall Study|Progressive disease|51|||
170445560|NCT03365791|615968526|FG000|Overall Study|Subject/guardian decision|5|||
170445561|NCT01475487|615968527|FG000|Overall Study|had to leave early for personal reasons|2|||
170445562|NCT01475487|615968528|FG001|Overall Study|had to leave early for personal reasons|1|||
170445563|NCT01214239|615968529|FG000|Overall Study|Adverse Event|3|||
170445564|NCT01214239|615968530|FG001|Overall Study|Adverse Event|4|||
170445565|NCT01214239|615968529|FG000|Overall Study|Protocol Violation|2|||
170445566|NCT01214239|615968530|FG001|Overall Study|Protocol Violation|1|||
170886950|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
170633473|NCT00499616|616670073|FG000|Overall Study|Not evaluable|0|||
170445567|NCT01214239|615968529|FG000|Overall Study|Lost to Follow-up|1|||
170445568|NCT01214239|615968530|FG001|Overall Study|Lost to Follow-up|1|||
170445569|NCT01214239|615968529|FG000|Overall Study|Withdrawal by Subject|4|||
170445570|NCT01214239|615968530|FG001|Overall Study|Withdrawal by Subject|9|||
170445571|NCT01214239|615968529|FG000|Overall Study|Lack of Efficacy|1|||
170886951|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
170445572|NCT01214239|615968530|FG001|Overall Study|Lack of Efficacy|2|||
170445573|NCT01214239|615968529|FG000|Overall Study|patient's private reason|1|||
170445574|NCT01214239|615968530|FG001|Overall Study|patient's private reason|1|||
170445575|NCT00987831|615968531|FG000|Overall Study|Never flared in 12 months|1|||
170445576|NCT00987831|615968532|FG001|Overall Study|Never flared in 12 months|0|||
170445577|NCT00987831|615968533|FG002|Overall Study|Never flared in 12 months|0|||
170445578|NCT00987831|615968531|FG000|Overall Study|Lost to Follow-up|0|||
170445579|NCT00987831|615968532|FG001|Overall Study|Lost to Follow-up|3|||
170445580|NCT00987831|615968533|FG002|Overall Study|Lost to Follow-up|0|||
170445581|NCT00965731|615968534|FG000|Overall Study|Death|0|||
170445582|NCT00965731|615968535|FG001|Overall Study|Death|4|||
170445583|NCT00965731|615968534|FG000|Overall Study|Withdrawal by Subject|0|||
170445584|NCT00965731|615968535|FG001|Overall Study|Withdrawal by Subject|1|||
170445585|NCT00965731|615968534|FG000|Overall Study|Other|7|||
170445586|NCT00965731|615968535|FG001|Overall Study|Other|15|||
170445587|NCT01923311|615969872|FG000|Overall Study|Pregnancy|1|||
170445588|NCT01923311|615969873|FG001|Overall Study|Pregnancy|0|||
170445589|NCT01923311|615969872|FG000|Overall Study|Investigator's Discretion|1|||
170445590|NCT01923311|615969873|FG001|Overall Study|Investigator's Discretion|0|||
170445591|NCT01923311|615969872|FG000|Overall Study|Non-Compliance with Study Drug|2|||
170445592|NCT01923311|615969873|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170445593|NCT01923311|615969872|FG000|Overall Study|Withdrew Consent|1|||
170445594|NCT01923311|615969873|FG001|Overall Study|Withdrew Consent|0|||
170445595|NCT01923311|615969872|FG000|Overall Study|Study Terminated by Sponsor|12|||
170445596|NCT01923311|615969873|FG001|Overall Study|Study Terminated by Sponsor|0|||
170445597|NCT01619579|615969874|FG000|Overall Study|Withdrawal by Subject|0|||
170445598|NCT01619579|615969875|FG001|Overall Study|Withdrawal by Subject|3|||
170445599|NCT04403399|615969876|FG000|Period 2|Physician Decision|0|||
170445600|NCT04403399|615969877|FG001|Period 2|Physician Decision|1|||
170445601|NCT00802178|615969878|FG000|Overall Study|Lack of Efficacy|36|||
170445602|NCT00802178|615969878|FG000|Overall Study|Insufficient tolerability (IT)|17|||
170445603|NCT00802178|615969878|FG000|Overall Study|Withdrawal by Subject|18|||
170445604|NCT00802178|615969878|FG000|Overall Study|Other|32|||
170445605|NCT00802178|615969878|FG000|Overall Study|Lack of efficacy and patient wish|1|||
170445606|NCT00802178|615969878|FG000|Overall Study|IT and patient wish|8|||
170445607|NCT00802178|615969878|FG000|Overall Study|Patients wish and other reason|1|||
170445608|NCT00399893|615969879|FG000|Overall Study|Withdrawal by Subject|1|||
170445609|NCT00399893|615969880|FG001|Overall Study|Withdrawal by Subject|0|||
170445610|NCT04412057|615969881|FG000|Overall Study|Death|3|||
170445611|NCT04412057|615969882|FG001|Overall Study|Death|7|||
170445612|NCT04412057|615969881|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
170445613|NCT04412057|615969882|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
170445614|NCT04100096|615969883|FG000|Overall Study|Adverse Event|19|||
170445615|NCT04100096|615969884|FG001|Overall Study|Adverse Event|7|||
170445616|NCT04100096|615969883|FG000|Overall Study|Lack of Efficacy|0|||
170445617|NCT04100096|615969884|FG001|Overall Study|Lack of Efficacy|1|||
170445618|NCT04100096|615969883|FG000|Overall Study|Lost to Follow-up|13|||
170445619|NCT04100096|615969884|FG001|Overall Study|Lost to Follow-up|11|||
170445620|NCT04100096|615969883|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170445621|NCT04100096|615969884|FG001|Overall Study|Non-Compliance With Study Drug|3|||
170445622|NCT04100096|615969883|FG000|Overall Study|Protocol Deviation|1|||
170445623|NCT04100096|615969884|FG001|Overall Study|Protocol Deviation|1|||
170445624|NCT04100096|615969883|FG000|Overall Study|Withdrawal by Participant|13|||
170445625|NCT04100096|615969884|FG001|Overall Study|Withdrawal by Participant|15|||
170445626|NCT01684215|615969888|FG000|Phase 1, Part 1|Adverse Event|1|||
170445627|NCT01684215|615969889|FG001|Phase 1, Part 1|Adverse Event|0|||
170445628|NCT01684215|615969890|FG002|Phase 1, Part 1|Adverse Event|0|||
170886952|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
170886953|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
170445629|NCT01684215|615969891|FG003|Phase 1, Part 1|Adverse Event|0|||
170445630|NCT01684215|615969888|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
170445631|NCT01684215|615969889|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
170445632|NCT01684215|615969890|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
170445633|NCT01684215|615969891|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
170445634|NCT01684215|615969888|FG000|Phase 1, Part 2|Adverse Event|0|||
170445635|NCT01684215|615969889|FG001|Phase 1, Part 2|Adverse Event|0|||
170539394|NCT01564407|616317187|FG001|Overall Study|funding lost, study ended|0|||
170539395|NCT01564407|616317188|FG002|Overall Study|funding lost, study ended|0|||
170539396|NCT01564407|616317189|FG003|Overall Study|funding lost, study ended|1|||
170539397|NCT01564407|616317190|FG004|Overall Study|funding lost, study ended|0|||
170445636|NCT01684215|615969890|FG002|Phase 1, Part 2|Adverse Event|1|||
170445637|NCT01684215|615969891|FG003|Phase 1, Part 2|Adverse Event|0|||
170445638|NCT01684215|615969888|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
170886954|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
170445639|NCT01684215|615969889|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
170633474|NCT00499616|616670074|FG001|Overall Study|Not evaluable|0|||
170633475|NCT00499616|616670075|FG002|Overall Study|Not evaluable|0|||
170633476|NCT00499616|616670076|FG003|Overall Study|Not evaluable|41|||
170633477|NCT00499616|616670073|FG000|Overall Study|Patient/Parent Refusal|1|||
170633478|NCT00499616|616670074|FG001|Overall Study|Patient/Parent Refusal|5|||
170633479|NCT00499616|616670075|FG002|Overall Study|Patient/Parent Refusal|3|||
170633480|NCT00499616|616670076|FG003|Overall Study|Patient/Parent Refusal|0|||
170633481|NCT00123422|616670077|FG000|Overall Study|Physician Decision|2|||
170633482|NCT00123422|616670078|FG001|Overall Study|Physician Decision|2|||
170633483|NCT00123422|616670079|FG002|Overall Study|Physician Decision|6|||
170633484|NCT00123422|616670077|FG000|Overall Study|Withdrawal by Subject|1|||
170785831|NCT03056040|617223526|FG000|Extension Period|Death|0|||
170785832|NCT03056040|617223527|FG001|Extension Period|Death|3|||
170785833|NCT03056040|617223526|FG000|Extension Period|Withdrawal by Subject|1|||
170445640|NCT01684215|615969890|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
170445641|NCT01684215|615969891|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
170445642|NCT01684215|615969888|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
170445643|NCT01684215|615969889|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
170445644|NCT01684215|615969890|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
170445645|NCT01684215|615969891|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
170445646|NCT01684215|615969888|FG000|Phase 2|Death|0|||
170445647|NCT01684215|615969889|FG001|Phase 2|Death|0|||
170445648|NCT01684215|615969890|FG002|Phase 2|Death|0|||
170445649|NCT01684215|615969891|FG003|Phase 2|Death|8|||
170445650|NCT01684215|615969888|FG000|Phase 2|Study terminated by sponsor|0|||
170445651|NCT01684215|615969889|FG001|Phase 2|Study terminated by sponsor|0|||
170445652|NCT01684215|615969890|FG002|Phase 2|Study terminated by sponsor|0|||
170445653|NCT01684215|615969891|FG003|Phase 2|Study terminated by sponsor|30|||
170445654|NCT01684215|615969888|FG000|Phase 2|Enrolled but not treated|0|||
170445655|NCT01684215|615969889|FG001|Phase 2|Enrolled but not treated|0|||
170445656|NCT01684215|615969890|FG002|Phase 2|Enrolled but not treated|0|||
170445657|NCT01684215|615969891|FG003|Phase 2|Enrolled but not treated|1|||
170445658|NCT01684215|615969888|FG000|Phase 2|Lost to Follow-up|0|||
170445659|NCT01684215|615969889|FG001|Phase 2|Lost to Follow-up|0|||
170445660|NCT01684215|615969890|FG002|Phase 2|Lost to Follow-up|0|||
170445661|NCT01684215|615969891|FG003|Phase 2|Lost to Follow-up|4|||
170445662|NCT00991510|615969892|FG000|Period I (Days 1-14)|Adverse Event|1|||
170445663|NCT00991510|615969893|FG001|Period I (Days 1-14)|Adverse Event|0|||
170445664|NCT00991510|615969892|FG000|Period III (Days 29-112)|Adverse Event|1|||
170445665|NCT00991510|615969893|FG001|Period III (Days 29-112)|Adverse Event|1|||
170445666|NCT00784134|615969894|FG000|Overall Study|Lost to Follow-up|3|||
170445667|NCT00784134|615969895|FG001|Overall Study|Lost to Follow-up|6|||
170445668|NCT03785145|615969896|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
170445669|NCT03785145|615969897|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
170445670|NCT03785145|615969896|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
170445671|NCT03785145|615969897|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
170445672|NCT03785145|615969896|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
170445673|NCT03785145|615969897|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
170445674|NCT03785145|615969896|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
170445675|NCT03785145|615969897|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
170445676|NCT03785145|615969896|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
170445677|NCT03785145|615969897|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
170785834|NCT03056040|617223527|FG001|Extension Period|Withdrawal by Subject|0|||
170785835|NCT03445988|617223528|FG000|Overall Study|Lost to Follow-up|14|||
170785836|NCT03445988|617223529|FG001|Overall Study|Lost to Follow-up|26|||
170785837|NCT03445988|617223530|FG002|Overall Study|Lost to Follow-up|27|||
170785838|NCT03445988|617223531|FG003|Overall Study|Lost to Follow-up|66|||
170785839|NCT03445988|617223528|FG000|Overall Study|Withdrawal by Subject|7|||
170785840|NCT03445988|617223529|FG001|Overall Study|Withdrawal by Subject|4|||
170785841|NCT03445988|617223530|FG002|Overall Study|Withdrawal by Subject|3|||
170445678|NCT03785145|615969896|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
170445679|NCT03785145|615969897|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
170445680|NCT03785145|615969896|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
170445681|NCT03785145|615969897|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
170445682|NCT03785145|615969896|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
170445683|NCT03785145|615969897|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
170539398|NCT03483584|616317193|FG000|Overall Study|Lost to Follow-up|40|||
170539399|NCT03483584|616317194|FG001|Overall Study|Lost to Follow-up|7|||
170539400|NCT03483584|616317193|FG000|Overall Study|Withdrawal by Subject|4|||
170539401|NCT03483584|616317194|FG001|Overall Study|Withdrawal by Subject|1|||
170539402|NCT04967222|616317197|FG000|Randomized|Lost to Follow-up|0|||
170539403|NCT04967222|616317198|FG001|Randomized|Lost to Follow-up|1|||
170539404|NCT04967222|616317199|FG002|Randomized|Lost to Follow-up|1|||
170539405|NCT04967222|616317197|FG000|Randomized|Physician Decision|0|||
170445684|NCT03785145|615969896|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
170445685|NCT03785145|615969897|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
170445686|NCT03785145|615969896|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
170445687|NCT03785145|615969897|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
170445688|NCT03785145|615969896|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
170445689|NCT03785145|615969897|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
170445690|NCT00966381|615969898|FG000|Overall Study|Withdrawal by Subject|2|||
170445691|NCT00966381|615969899|FG001|Overall Study|Withdrawal by Subject|2|||
170445692|NCT01915940|615969900|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
170445693|NCT01915940|615969901|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
170445694|NCT01915940|615969902|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
170445695|NCT01915940|615969900|FG000|Treatment Period|Decision of Participant|0|||
170445696|NCT01915940|615969901|FG001|Treatment Period|Decision of Participant|1|||
170445697|NCT01915940|615969902|FG002|Treatment Period|Decision of Participant|3|||
170445698|NCT01915940|615969900|FG000|Treatment Period|Adverse Event|0|||
170445699|NCT01915940|615969901|FG001|Treatment Period|Adverse Event|9|||
170445700|NCT01915940|615969902|FG002|Treatment Period|Adverse Event|1|||
170445701|NCT01915940|615969900|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
170445702|NCT01915940|615969901|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
170445703|NCT01915940|615969902|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
170445704|NCT01124695|615969904|FG000|Overall Study|Disease progression|77|||
170445705|NCT01124695|615969904|FG000|Overall Study|Adverse Event|11|||
170445706|NCT01124695|615969904|FG000|Overall Study|Death|1|||
170445707|NCT01124695|615969904|FG000|Overall Study|Withdrawal by Subject|7|||
170445708|NCT01124695|615969904|FG000|Overall Study|Physician Decision|3|||
170445709|NCT01124695|615969904|FG000|Overall Study|Alternative therapy|9|||
170445710|NCT01124695|615969904|FG000|Overall Study|No documentation that patient went off treatment|4|||
170445711|NCT01124695|615969904|FG000|Overall Study|Ineligible|9|||
170445712|NCT01124695|615969904|FG000|Overall Study|Ineligible and never start treatment|2|||
170445713|NCT00097786|615969905|FG000|Overall Study|lost to follow-up for all-cause death|296|||
170445714|NCT00097786|615969906|FG001|Overall Study|lost to follow-up for all-cause death|292|||
170445715|NCT00097786|615969907|FG002|Overall Study|lost to follow-up for all-cause death|313|||
170445716|NCT00097786|615969908|FG003|Overall Study|lost to follow-up for all-cause death|310|||
170445717|NCT03686150|615969910|FG000|Overall Study|Withdrawal by Subject|1|||
170445718|NCT03686150|615969911|FG001|Overall Study|Withdrawal by Subject|1|||
170445719|NCT03686150|615969912|FG002|Overall Study|Withdrawal by Subject|1|||
170445720|NCT03686150|615969913|FG003|Overall Study|Withdrawal by Subject|0|||
170445721|NCT03686150|615969914|FG004|Overall Study|Withdrawal by Subject|1|||
170445722|NCT03686150|615969915|FG005|Overall Study|Withdrawal by Subject|2|||
170445723|NCT03686150|615969910|FG000|Overall Study|Physician Decision|1|||
170445724|NCT03686150|615969911|FG001|Overall Study|Physician Decision|0|||
170445725|NCT03686150|615969912|FG002|Overall Study|Physician Decision|0|||
170445726|NCT03686150|615969913|FG003|Overall Study|Physician Decision|0|||
170445727|NCT03686150|615969914|FG004|Overall Study|Physician Decision|0|||
170445728|NCT03686150|615969915|FG005|Overall Study|Physician Decision|1|||
170445729|NCT03686150|615969910|FG000|Overall Study|Lost to Follow-up|0|||
170445730|NCT03686150|615969911|FG001|Overall Study|Lost to Follow-up|1|||
170445731|NCT03686150|615969912|FG002|Overall Study|Lost to Follow-up|0|||
170445732|NCT03686150|615969913|FG003|Overall Study|Lost to Follow-up|0|||
170633485|NCT00123422|616670078|FG001|Overall Study|Withdrawal by Subject|2|||
170633486|NCT00123422|616670079|FG002|Overall Study|Withdrawal by Subject|2|||
170633487|NCT00123422|616670077|FG000|Overall Study|Lost to Follow-up|1|||
170633488|NCT00123422|616670078|FG001|Overall Study|Lost to Follow-up|2|||
170633489|NCT00123422|616670079|FG002|Overall Study|Lost to Follow-up|2|||
170445733|NCT03686150|615969914|FG004|Overall Study|Lost to Follow-up|0|||
170445734|NCT03686150|615969915|FG005|Overall Study|Lost to Follow-up|0|||
170445735|NCT01647711|615969916|FG000|Overall Study|Progressive disease|6|||
170445736|NCT01647711|615969917|FG001|Overall Study|Progressive disease|2|||
170445737|NCT01647711|615969918|FG002|Overall Study|Progressive disease|6|||
170445738|NCT01647711|615969919|FG003|Overall Study|Progressive disease|8|||
170445739|NCT01647711|615969920|FG004|Overall Study|Progressive disease|2|||
170445740|NCT01647711|615969916|FG000|Overall Study|Other adverse event|0|||
170445741|NCT01647711|615969917|FG001|Overall Study|Other adverse event|0|||
170445742|NCT01647711|615969918|FG002|Overall Study|Other adverse event|2|||
170445743|NCT01647711|615969919|FG003|Overall Study|Other adverse event|0|||
170785842|NCT03445988|617223531|FG003|Overall Study|Withdrawal by Subject|5|||
170785843|NCT03445988|617223528|FG000|Overall Study|Death (unrelated to study)|5|||
170785844|NCT03445988|617223529|FG001|Overall Study|Death (unrelated to study)|1|||
170785845|NCT03445988|617223530|FG002|Overall Study|Death (unrelated to study)|2|||
170785846|NCT03445988|617223531|FG003|Overall Study|Death (unrelated to study)|4|||
170785847|NCT05875142|617223532|FG000|Overall Study|Lost to Follow-up|0|||
170785848|NCT05875142|617223533|FG001|Overall Study|Lost to Follow-up|1|||
170785849|NCT05875142|617223534|FG002|Overall Study|Lost to Follow-up|1|||
170445744|NCT01647711|615969920|FG004|Overall Study|Other adverse event|2|||
170445745|NCT01647711|615969916|FG000|Overall Study|Protocol Violation|0|||
170445746|NCT01647711|615969917|FG001|Overall Study|Protocol Violation|0|||
170445747|NCT01647711|615969918|FG002|Overall Study|Protocol Violation|0|||
170445748|NCT01647711|615969919|FG003|Overall Study|Protocol Violation|0|||
170445749|NCT01647711|615969920|FG004|Overall Study|Protocol Violation|1|||
170445750|NCT01647711|615969916|FG000|Overall Study|Refused to continue taking medication|0|||
170445751|NCT01647711|615969917|FG001|Overall Study|Refused to continue taking medication|0|||
170445752|NCT01647711|615969918|FG002|Overall Study|Refused to continue taking medication|0|||
170445753|NCT01647711|615969919|FG003|Overall Study|Refused to continue taking medication|2|||
170445754|NCT01647711|615969920|FG004|Overall Study|Refused to continue taking medication|1|||
170445755|NCT01647711|615969916|FG000|Overall Study|Other reason not defined|0|||
170445756|NCT01647711|615969917|FG001|Overall Study|Other reason not defined|1|||
170445757|NCT01647711|615969918|FG002|Overall Study|Other reason not defined|1|||
170445758|NCT01647711|615969919|FG003|Overall Study|Other reason not defined|1|||
170445759|NCT01647711|615969920|FG004|Overall Study|Other reason not defined|0|||
170445760|NCT00412737|615969921|FG000|Overall Study|Death|1|||
170445761|NCT00412737|615969922|FG001|Overall Study|Death|0|||
170445762|NCT00412737|615969921|FG000|Overall Study|Adverse Event|3|||
170445763|NCT00412737|615969922|FG001|Overall Study|Adverse Event|2|||
170445764|NCT00412737|615969921|FG000|Overall Study|Refused Treatment|6|||
170445765|NCT00412737|615969922|FG001|Overall Study|Refused Treatment|2|||
170445766|NCT00412737|615969921|FG000|Overall Study|Failure to Return|6|||
170445767|NCT00412737|615969922|FG001|Overall Study|Failure to Return|2|||
170445768|NCT01292837|615969925|FG000|Overall Study|Adverse Event|1|||
170445769|NCT01292837|615969925|FG000|Overall Study|Further treatment determined|1|||
170445770|NCT02174276|615969926|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
170445771|NCT02174276|615969927|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
170445772|NCT02174276|615969928|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
170445773|NCT02174276|615969929|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
170445774|NCT02174276|615969926|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
170445775|NCT02174276|615969927|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
170445776|NCT02174276|615969928|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
170445777|NCT02174276|615969929|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
170445778|NCT02174276|615969926|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
170445779|NCT02174276|615969927|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
170445780|NCT02174276|615969928|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
170445781|NCT02174276|615969929|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
170445782|NCT02174276|615969926|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
170445783|NCT02174276|615969927|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
170445784|NCT02174276|615969928|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
170445785|NCT02174276|615969929|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
170445786|NCT02174276|615969926|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
170445787|NCT02174276|615969927|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
170445788|NCT02174276|615969928|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
170445789|NCT02174276|615969929|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
170445790|NCT02174276|615969926|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
170445791|NCT02174276|615969927|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
170445792|NCT02174276|615969928|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
170445793|NCT02174276|615969929|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
170445794|NCT01206439|615969932|FG000|Overall Study|subject did not meet inclusion criteria|1|||
170445795|NCT02661022|615969934|FG000|Overall Study|Withdrawal by Subject|3|||
170445796|NCT02661022|615969935|FG001|Overall Study|Withdrawal by Subject|0|||
170445797|NCT02661022|615969934|FG000|Overall Study|Adverse Event|1|||
170445798|NCT02661022|615969935|FG001|Overall Study|Adverse Event|1|||
170445799|NCT02661022|615969934|FG000|Overall Study|Physician Decision|1|||
170445800|NCT02661022|615969935|FG001|Overall Study|Physician Decision|0|||
170445801|NCT02661022|615969934|FG000|Overall Study|Progressive Disease|2|||
170445802|NCT02661022|615969935|FG001|Overall Study|Progressive Disease|1|||
170445803|NCT02359864|615969936|FG000|Overall Study|Withdrawal by Subject|1|||
170445804|NCT02359864|615969937|FG001|Overall Study|Withdrawal by Subject|0|||
170445805|NCT00515216|615969941|FG000|Overall Study|Withdrawal by Subject|1|||
170445806|NCT02250651|615969944|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
170445807|NCT02250651|615969945|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
170445808|NCT02250651|615969946|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
170445809|NCT02250651|615969944|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
170445810|NCT02250651|615969945|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
170445811|NCT02250651|615969946|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
170445812|NCT02250651|615969944|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
170445813|NCT02250651|615969945|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
170445814|NCT02250651|615969946|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
170445815|NCT02250651|615969944|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
170445816|NCT02250651|615969945|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
170445817|NCT02250651|615969946|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
170445818|NCT02250651|615969944|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
170445819|NCT02250651|615969945|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
170445820|NCT02250651|615969946|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
170445821|NCT02250651|615969944|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
170445822|NCT02250651|615969945|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
170445823|NCT02250651|615969946|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
170445824|NCT02250651|615969944|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
170445825|NCT02250651|615969945|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
170445826|NCT02250651|615969946|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
170445827|NCT02250651|615969944|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
170445828|NCT02250651|615969945|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
170445829|NCT02250651|615969946|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
170539406|NCT04967222|616317198|FG001|Randomized|Physician Decision|0|||
170539407|NCT04967222|616317199|FG002|Randomized|Physician Decision|1|||
170539408|NCT04967222|616317197|FG000|Randomized|Withdrawal by Subject|0|||
170539409|NCT04967222|616317198|FG001|Randomized|Withdrawal by Subject|0|||
170539410|NCT04967222|616317199|FG002|Randomized|Withdrawal by Subject|2|||
170539411|NCT04967222|616317197|FG000|Randomized|abnormal finding in MRI|0|||
170539412|NCT04967222|616317198|FG001|Randomized|abnormal finding in MRI|2|||
170539413|NCT04967222|616317199|FG002|Randomized|abnormal finding in MRI|0|||
170539414|NCT01964404|616317200|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
170539415|NCT01964404|616317201|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
170539416|NCT01964404|616317202|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
170539417|NCT01964404|616317203|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
170539418|NCT01964404|616317204|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
170539419|NCT01964404|616317205|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
170539420|NCT01964404|616317206|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
170539421|NCT01964404|616317207|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
170539422|NCT01964404|616317208|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
170539423|NCT01964404|616317209|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
170539424|NCT01964404|616317200|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
170539425|NCT01964404|616317201|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
170539426|NCT01964404|616317202|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
170539427|NCT01964404|616317203|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
170539428|NCT01964404|616317204|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539429|NCT01964404|616317205|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539430|NCT01964404|616317206|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539431|NCT01964404|616317207|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539432|NCT01964404|616317208|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539433|NCT01964404|616317209|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539434|NCT01964404|616317200|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
170539435|NCT01964404|616317201|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
170539436|NCT01964404|616317202|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539437|NCT01964404|616317203|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
170539438|NCT01964404|616317204|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539439|NCT01964404|616317205|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539440|NCT01964404|616317206|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539441|NCT01964404|616317207|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539442|NCT01964404|616317208|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539443|NCT01964404|616317209|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
170539444|NCT00433537|616317216|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
170539445|NCT00433537|616317217|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
170539446|NCT00433537|616317218|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
170539447|NCT00433537|616317216|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
170539448|NCT00433537|616317217|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
170539449|NCT00433537|616317218|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
170539450|NCT00433537|616317216|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
170539451|NCT00433537|616317217|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
170539452|NCT00433537|616317218|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
170539453|NCT00433537|616317216|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
170539454|NCT00433537|616317217|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
170539455|NCT00433537|616317218|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
170539456|NCT00433537|616317216|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
170539457|NCT00433537|616317217|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
170539458|NCT00433537|616317218|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
170539459|NCT00433537|616317216|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
170633490|NCT03584789|616670082|FG000|Overall Study|refused EHR permission|19|||
170785850|NCT04274764|617223535|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
170785851|NCT04274764|617223536|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
170445830|NCT02250651|615969944|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
170445831|NCT02250651|615969945|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
170445832|NCT02250651|615969946|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
170445833|NCT02250651|615969944|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
170445834|NCT02250651|615969945|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
170445835|NCT02250651|615969946|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
170785852|NCT03232138|617223538|FG000|Overall Study|Physician Decision|1|||
170785853|NCT03232138|617223539|FG001|Overall Study|Physician Decision|0|||
170785854|NCT03232138|617223538|FG000|Overall Study|Adverse Event|2|||
170785855|NCT03232138|617223539|FG001|Overall Study|Adverse Event|0|||
170785856|NCT03232138|617223538|FG000|Overall Study|Withdrawal by Subject|1|||
170785857|NCT03232138|617223539|FG001|Overall Study|Withdrawal by Subject|2|||
170785858|NCT05268393|617223542|FG000|Overall Study|Withdrawal by Subject|2|||
170785859|NCT05268393|617223543|FG001|Overall Study|Withdrawal by Subject|1|||
170785860|NCT00450658|617223547|FG000|Overall Study|Adverse Event|24|||
170785861|NCT00450658|617223548|FG001|Overall Study|Adverse Event|15|||
170785862|NCT00450658|617223547|FG000|Overall Study|Withdrawal by Subject|43|||
170785863|NCT00450658|617223548|FG001|Overall Study|Withdrawal by Subject|26|||
170785864|NCT00450658|617223547|FG000|Overall Study|Lost to Follow-up|22|||
170785865|NCT00450658|617223548|FG001|Overall Study|Lost to Follow-up|5|||
170785866|NCT00450658|617223547|FG000|Overall Study|UGI ulcer|33|||
170785867|NCT00450658|617223548|FG001|Overall Study|UGI ulcer|34|||
170785868|NCT00450658|617223547|FG000|Overall Study|misc|21|||
170785869|NCT00450658|617223548|FG001|Overall Study|misc|10|||
170785870|NCT05028634|617223551|FG000|Overall Study|Withdrawal by Subject|0|||
170785871|NCT05028634|617223552|FG001|Overall Study|Withdrawal by Subject|1|||
170785872|NCT03720795|617223556|FG000|Phase 1|Lost to Follow-up|4|||
170445836|NCT02250651|615969944|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
170785873|NCT03720795|617223556|FG000|Phase 1|Withdrawal by Subject|6|||
170785874|NCT03720795|617223556|FG000|Phase 1|Protocol Violation|1|||
170785875|NCT03720795|617223556|FG000|Phase 1|Other|1|||
170785876|NCT03720795|617223556|FG000|Phase 2|Lost to Follow-up|5|||
170785877|NCT03720795|617223556|FG000|Phase 2|Withdrawal by Subject|10|||
170785878|NCT03720795|617223556|FG000|Phase 2|Protocol Violation|2|||
170785879|NCT03720795|617223556|FG000|3 Month Follow Up|Lost to Follow-up|2|||
170785880|NCT05311384|617223564|FG000|Overall Study|Uncontrolled health conditions|2|||
170785881|NCT05311384|617223564|FG000|Overall Study|Withdrawal by Subject|1|||
170785882|NCT01573442|617223565|FG000|Overall Study|Cancels|9|||
170785883|NCT01573442|617223566|FG001|Overall Study|Cancels|10|||
170785884|NCT04166773|617223570|FG000|Overall Study|Adverse Event|2|||
170785885|NCT04166773|617223571|FG001|Overall Study|Adverse Event|0|||
170785886|NCT04166773|617223572|FG002|Overall Study|Adverse Event|2|||
170785887|NCT04166773|617223573|FG003|Overall Study|Adverse Event|1|||
170445837|NCT02250651|615969945|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
170445838|NCT02250651|615969946|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
170445839|NCT02250651|615969944|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
170445840|NCT02250651|615969945|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
170445841|NCT02250651|615969946|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
170445842|NCT02250651|615969944|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
170445843|NCT02250651|615969945|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
170445844|NCT02250651|615969946|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
170445845|NCT02250651|615969944|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
170445846|NCT02250651|615969945|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
170445847|NCT02250651|615969946|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
170445848|NCT02250651|615969944|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
170445849|NCT02250651|615969945|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
170445850|NCT02250651|615969946|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
170445851|NCT02795676|615969947|FG000|Overall Study|Adverse Event|2|||
170445852|NCT02795676|615969948|FG001|Overall Study|Adverse Event|0|||
170445853|NCT02795676|615969947|FG000|Overall Study|Withdrawal by Subject|3|||
170445854|NCT02795676|615969948|FG001|Overall Study|Withdrawal by Subject|1|||
170445855|NCT02427399|615969951|FG000|Overall Study|Protocol Violation|14|||
170445856|NCT02427399|615969952|FG001|Overall Study|Protocol Violation|16|||
170785888|NCT04166773|617223570|FG000|Overall Study|Lost to Follow-up|4|||
170785889|NCT04166773|617223571|FG001|Overall Study|Lost to Follow-up|2|||
170785890|NCT04166773|617223572|FG002|Overall Study|Lost to Follow-up|1|||
170785891|NCT04166773|617223573|FG003|Overall Study|Lost to Follow-up|3|||
170785892|NCT04166773|617223570|FG000|Overall Study|Physician Decision|0|||
170445857|NCT02427399|615969953|FG002|Overall Study|Protocol Violation|12|||
170539460|NCT00433537|616317217|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
170785893|NCT04166773|617223571|FG001|Overall Study|Physician Decision|0|||
170785894|NCT04166773|617223572|FG002|Overall Study|Physician Decision|0|||
170785895|NCT04166773|617223573|FG003|Overall Study|Physician Decision|1|||
170785896|NCT04166773|617223570|FG000|Overall Study|Withdrawal by Subject|1|||
170785897|NCT04166773|617223571|FG001|Overall Study|Withdrawal by Subject|1|||
170633491|NCT03584789|616670083|FG001|Overall Study|refused EHR permission|28|||
170633492|NCT03584789|616670084|FG002|Overall Study|refused EHR permission|23|||
170633493|NCT03584789|616670082|FG000|Overall Study|patients tied to a provider who retired|0|||
170633494|NCT03584789|616670083|FG001|Overall Study|patients tied to a provider who retired|0|||
170633495|NCT03584789|616670084|FG002|Overall Study|patients tied to a provider who retired|3|||
170633496|NCT04646044|616670086|FG000|Overall Study|Lost to Follow-up|0|||
170633497|NCT04646044|616670087|FG001|Overall Study|Lost to Follow-up|0|||
170633498|NCT04646044|616670088|FG002|Overall Study|Lost to Follow-up|1|||
170633499|NCT04646044|616670089|FG003|Overall Study|Lost to Follow-up|0|||
170633500|NCT04646044|616670086|FG000|Overall Study|Withdrawal by Subject|0|||
170633501|NCT04646044|616670087|FG001|Overall Study|Withdrawal by Subject|1|||
170633502|NCT04646044|616670088|FG002|Overall Study|Withdrawal by Subject|0|||
170633503|NCT04646044|616670089|FG003|Overall Study|Withdrawal by Subject|0|||
170633504|NCT00602472|616670090|FG000|Overall Study|Adverse Event|5|||
170633505|NCT00602472|616670091|FG001|Overall Study|Adverse Event|23|||
170633506|NCT00602472|616670090|FG000|Overall Study|Protocol Violation|4|||
170633507|NCT00602472|616670091|FG001|Overall Study|Protocol Violation|19|||
170633508|NCT00602472|616670090|FG000|Overall Study|Withdrawal by Subject|8|||
170633509|NCT00602472|616670091|FG001|Overall Study|Withdrawal by Subject|14|||
170633510|NCT00602472|616670090|FG000|Overall Study|Other incl. lack of efficacy|4|||
170633511|NCT00602472|616670091|FG001|Overall Study|Other incl. lack of efficacy|2|||
170633512|NCT00742235|616670093|FG000|Overall Study|Lost to Follow-up|0|||
170633513|NCT00742235|616670094|FG001|Overall Study|Lost to Follow-up|31|||
170633514|NCT00433004|616670095|FG000|Overall Study|Lost to Follow-up|5|||
170633515|NCT00433004|616670096|FG001|Overall Study|Lost to Follow-up|7|||
170633516|NCT05661409|616670097|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
170633517|NCT05661409|616670098|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
170633518|NCT05661409|616670099|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
170633519|NCT05661409|616670100|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
170633520|NCT05661409|616670101|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
170633521|NCT05661409|616670102|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
170633522|NCT05661409|616670097|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
170633523|NCT05661409|616670098|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
170633524|NCT05661409|616670099|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
170633525|NCT05661409|616670100|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
170633526|NCT05661409|616670101|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
170785898|NCT04166773|617223572|FG002|Overall Study|Withdrawal by Subject|2|||
170785899|NCT04166773|617223573|FG003|Overall Study|Withdrawal by Subject|5|||
170785900|NCT04072822|617223574|FG000|Treatment|Adverse Event|9|||
170785901|NCT04072822|617223575|FG001|Treatment|Adverse Event|5|||
170785902|NCT04072822|617223574|FG000|Treatment|Met Stopping Criteria|13|||
170785903|NCT04072822|617223575|FG001|Treatment|Met Stopping Criteria|24|||
170785904|NCT04072822|617223574|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
170445858|NCT02427399|615969954|FG003|Overall Study|Protocol Violation|18|||
170445859|NCT02427399|615969955|FG004|Overall Study|Protocol Violation|15|||
170445860|NCT00605176|615969958|FG000|Overall Study|Adverse Event|2|||
170445861|NCT00605176|615969959|FG001|Overall Study|Adverse Event|1|||
170445862|NCT00605176|615969960|FG002|Overall Study|Adverse Event|3|||
170445863|NCT00605176|615969958|FG000|Overall Study|Withdrawal by Subject|4|||
170445864|NCT00605176|615969959|FG001|Overall Study|Withdrawal by Subject|2|||
170445865|NCT00605176|615969960|FG002|Overall Study|Withdrawal by Subject|4|||
170445866|NCT00605176|615969958|FG000|Overall Study|Lost to Follow-up|2|||
170445867|NCT00605176|615969959|FG001|Overall Study|Lost to Follow-up|2|||
170445868|NCT00605176|615969960|FG002|Overall Study|Lost to Follow-up|1|||
170445869|NCT00605176|615969958|FG000|Overall Study|Non-complicance with study procedures|1|||
170445870|NCT00605176|615969959|FG001|Overall Study|Non-complicance with study procedures|0|||
170445871|NCT00605176|615969960|FG002|Overall Study|Non-complicance with study procedures|0|||
170785905|NCT04072822|617223575|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
170785906|NCT04072822|617223574|FG000|Treatment|Withdrawal by Subject|0|||
170785907|NCT04072822|617223575|FG001|Treatment|Withdrawal by Subject|2|||
170785908|NCT04072822|617223574|FG000|Treatment|Death|0|||
170785909|NCT04072822|617223575|FG001|Treatment|Death|2|||
170785910|NCT04072822|617223574|FG000|Treatment|Lost to Follow-up|11|||
170445872|NCT00605176|615969958|FG000|Overall Study|Use of concomitant therapy|1|||
170445873|NCT00605176|615969959|FG001|Overall Study|Use of concomitant therapy|0|||
170785911|NCT04072822|617223575|FG001|Treatment|Lost to Follow-up|3|||
170785912|NCT04072822|617223574|FG000|Treatment|Physician Decision|1|||
170445874|NCT00605176|615969960|FG002|Overall Study|Use of concomitant therapy|1|||
170445875|NCT00605176|615969958|FG000|Overall Study|Other (not due to AE)|1|||
170445876|NCT00605176|615969959|FG001|Overall Study|Other (not due to AE)|1|||
170633527|NCT05661409|616670102|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
170633528|NCT05661409|616670097|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
170633529|NCT05661409|616670098|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
170785913|NCT04072822|617223575|FG001|Treatment|Physician Decision|0|||
170785914|NCT04072822|617223574|FG000|Treatment|Other|7|||
170633530|NCT05661409|616670099|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
170633531|NCT05661409|616670100|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
170633532|NCT05661409|616670101|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
170633533|NCT05661409|616670102|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
170633534|NCT05661409|616670097|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
170633535|NCT05661409|616670098|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
170633536|NCT05661409|616670099|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
170633537|NCT05661409|616670100|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
170633538|NCT05661409|616670101|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
170633539|NCT05661409|616670102|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
170633540|NCT05661409|616670097|FG000|Overall Study|Miscommu-nication about administration|0|||
170633541|NCT05661409|616670098|FG001|Overall Study|Miscommu-nication about administration|0|||
170633542|NCT05661409|616670099|FG002|Overall Study|Miscommu-nication about administration|0|||
170633543|NCT05661409|616670100|FG003|Overall Study|Miscommu-nication about administration|0|||
170633544|NCT05661409|616670101|FG004|Overall Study|Miscommu-nication about administration|0|||
170633545|NCT05661409|616670102|FG005|Overall Study|Miscommu-nication about administration|1|||
170633546|NCT02346721|616670103|FG000|Overall Study|Withdrew Consent|3|||
170633547|NCT02346721|616670103|FG000|Overall Study|Lack of Efficacy|1|||
170633548|NCT02106390|616670104|FG000|Overall Study|Withdrawal by Subject|15|||
170633549|NCT02106390|616670105|FG001|Overall Study|Withdrawal by Subject|16|||
170633550|NCT02106390|616670106|FG002|Overall Study|Withdrawal by Subject|15|||
170633551|NCT02106390|616670104|FG000|Overall Study|Lost to Follow-up|25|||
170633552|NCT02106390|616670105|FG001|Overall Study|Lost to Follow-up|20|||
170633553|NCT02106390|616670106|FG002|Overall Study|Lost to Follow-up|13|||
170633554|NCT02106390|616670104|FG000|Overall Study|Other: Administrative Reason|8|||
170633555|NCT02106390|616670105|FG001|Overall Study|Other: Administrative Reason|5|||
170633556|NCT02106390|616670106|FG002|Overall Study|Other: Administrative Reason|12|||
170633557|NCT02106390|616670104|FG000|Overall Study|Other: Unspecified|1|||
170445877|NCT00605176|615969960|FG002|Overall Study|Other (not due to AE)|0|||
170445878|NCT01086969|615969961|FG000|Overall Study|Withdrawal by Subject|1|||
170445879|NCT01086969|615969962|FG001|Overall Study|Withdrawal by Subject|2|||
170445880|NCT01086969|615969963|FG002|Overall Study|Withdrawal by Subject|0|||
170633558|NCT02106390|616670105|FG001|Overall Study|Other: Unspecified|4|||
170633559|NCT02106390|616670106|FG002|Overall Study|Other: Unspecified|2|||
170633560|NCT02106390|616670104|FG000|Overall Study|Adverse Event|0|||
170633561|NCT02106390|616670105|FG001|Overall Study|Adverse Event|2|||
170633562|NCT02106390|616670106|FG002|Overall Study|Adverse Event|1|||
170785915|NCT04072822|617223575|FG001|Treatment|Other|9|||
170785916|NCT04072822|617223574|FG000|Follow-up|Withdrawal by Subject|1|||
170785917|NCT04072822|617223575|FG001|Follow-up|Withdrawal by Subject|0|||
170445881|NCT00819767|615969968|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170445882|NCT00819767|615969969|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170445883|NCT00685750|615969970|FG000|Overall Study|Tumor sampling failure|0|||
170445884|NCT00685750|615969971|FG001|Overall Study|Tumor sampling failure|0|||
170445885|NCT00685750|615969972|FG002|Overall Study|Tumor sampling failure|1|||
170445886|NCT00685750|615969973|FG003|Overall Study|Tumor sampling failure|0|||
170445887|NCT00685750|615969974|FG004|Overall Study|Tumor sampling failure|0|||
170445888|NCT00685750|615969975|FG005|Overall Study|Tumor sampling failure|0|||
170445889|NCT00685750|615969976|FG006|Overall Study|Tumor sampling failure|0|||
170445890|NCT00685750|615969970|FG000|Overall Study|Patient didn't receive the treatment|0|||
170445891|NCT00685750|615969971|FG001|Overall Study|Patient didn't receive the treatment|0|||
170445892|NCT00685750|615969972|FG002|Overall Study|Patient didn't receive the treatment|0|||
170445893|NCT00685750|615969973|FG003|Overall Study|Patient didn't receive the treatment|0|||
170785918|NCT04072822|617223574|FG000|Follow-up|Lost to Follow-up|5|||
170785919|NCT04072822|617223575|FG001|Follow-up|Lost to Follow-up|4|||
170785920|NCT05076708|617223576|FG000|Overall Study|Withdrawal by Subject|4|||
170785921|NCT05076708|617223576|FG000|Overall Study|Lost to study during switch phase|8|||
170785922|NCT02908477|617223577|FG000|Overall Study|Withdrawal by Subject|8|||
170785923|NCT02908477|617223578|FG001|Overall Study|Withdrawal by Subject|28|||
170785924|NCT04971395|617223585|FG000|Overall Study|Withdrawal by Subject|0|||
170633563|NCT02106390|616670104|FG000|Overall Study|Protocol Violation|0|||
170785925|NCT04971395|617223586|FG001|Overall Study|Withdrawal by Subject|1|||
170445894|NCT00685750|615969974|FG004|Overall Study|Patient didn't receive the treatment|0|||
170445895|NCT00685750|615969975|FG005|Overall Study|Patient didn't receive the treatment|0|||
170445896|NCT00685750|615969976|FG006|Overall Study|Patient didn't receive the treatment|1|||
170633564|NCT02106390|616670105|FG001|Overall Study|Protocol Violation|1|||
170633565|NCT02106390|616670106|FG002|Overall Study|Protocol Violation|0|||
170633566|NCT00790842|616670107|FG000|Dose Level 1|Adverse Event|1|||
170633567|NCT00790842|616670108|FG001|Dose Level 1|Adverse Event|0|||
170633568|NCT00790842|616670109|FG002|Dose Level 1|Adverse Event|0|||
170633569|NCT00790842|616670110|FG003|Dose Level 1|Adverse Event|2|||
170785926|NCT04971395|617223587|FG002|Overall Study|Withdrawal by Subject|0|||
170886955|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
170445897|NCT00685750|615969970|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170445898|NCT00685750|615969971|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170445899|NCT00685750|615969972|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
170445900|NCT00685750|615969973|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
170445901|NCT00685750|615969974|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
170445902|NCT00685750|615969975|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
170445903|NCT00685750|615969976|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
170445904|NCT00220727|615969997|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
170445905|NCT00220727|615969998|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
170445906|NCT00109850|615969999|FG000|Overall Study|Adverse Event|1|||
170445907|NCT00109850|615969999|FG000|Overall Study|Death|2|||
170445908|NCT00109850|615969999|FG000|Overall Study|Ineligible|1|||
170445909|NCT02941523|615970001|FG000|Monotherapy|Withdrawal by Subject|0|||
170445910|NCT02941523|615970002|FG001|Monotherapy|Withdrawal by Subject|1|||
170445911|NCT02941523|615970001|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
170445912|NCT02941523|615970002|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
170445913|NCT02941523|615970001|FG000|Carboplatin Combination Therapy|Death|1|||
170445914|NCT02941523|615970002|FG001|Carboplatin Combination Therapy|Death|2|||
170445915|NCT02941523|615970001|FG000|Carboplatin Combination Therapy|Disease progression|2|||
170445916|NCT02941523|615970002|FG001|Carboplatin Combination Therapy|Disease progression|0|||
170445917|NCT02941523|615970001|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
170445918|NCT02941523|615970002|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
170445919|NCT00869440|615970003|FG000|Overall Study|Withdrawal by Subject|1|||
170445920|NCT00869440|615970004|FG001|Overall Study|Withdrawal by Subject|0|||
170445921|NCT00869440|615970005|FG002|Overall Study|Withdrawal by Subject|0|||
170445922|NCT00869440|615970006|FG003|Overall Study|Withdrawal by Subject|0|||
170445923|NCT00869440|615970003|FG000|Overall Study|Physician Decision|1|||
170445924|NCT00869440|615970004|FG001|Overall Study|Physician Decision|1|||
170445925|NCT00869440|615970005|FG002|Overall Study|Physician Decision|0|||
170445926|NCT00869440|615970006|FG003|Overall Study|Physician Decision|0|||
170445927|NCT00708682|615970007|FG000|Infant Series|Adverse Event|1|||
170445928|NCT00708682|615970007|FG000|Infant Series|Lost to Follow-up|4|||
170445929|NCT00708682|615970007|FG000|Infant Series|Protocol Violation|1|||
170445930|NCT00708682|615970007|FG000|Infant Series|Parent/legal guardian request|6|||
170445931|NCT00708682|615970007|FG000|Infant Series|Failed to return|2|||
170445932|NCT00708682|615970007|FG000|Infant Series|Other|19|||
170445933|NCT00708682|615970007|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
170445934|NCT00708682|615970007|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
170445935|NCT00708682|615970007|FG000|Toddler Dose|Lost to Follow-up|3|||
170445936|NCT00708682|615970007|FG000|Toddler Dose|Failed to Return|4|||
170445937|NCT02030535|615970010|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
170445938|NCT01588548|615970011|FG000|Overall Study|Withdrawal by Subject|0|||
170445939|NCT01588548|615970012|FG001|Overall Study|Withdrawal by Subject|1|||
170445940|NCT01588548|615970013|FG002|Overall Study|Withdrawal by Subject|1|||
170445941|NCT01588548|615970014|FG003|Overall Study|Withdrawal by Subject|1|||
170445942|NCT01588548|615970015|FG004|Overall Study|Withdrawal by Subject|2|||
170445943|NCT01588548|615970016|FG005|Overall Study|Withdrawal by Subject|3|||
170445944|NCT01588548|615970011|FG000|Overall Study|Adverse Event|0|||
170445945|NCT01588548|615970012|FG001|Overall Study|Adverse Event|0|||
170445946|NCT01588548|615970013|FG002|Overall Study|Adverse Event|1|||
170445947|NCT01588548|615970014|FG003|Overall Study|Adverse Event|2|||
170445948|NCT01588548|615970015|FG004|Overall Study|Adverse Event|1|||
170445949|NCT01588548|615970016|FG005|Overall Study|Adverse Event|0|||
170445950|NCT01588548|615970011|FG000|Overall Study|Condition Under Investigation Worsened|3|||
170445951|NCT01588548|615970012|FG001|Overall Study|Condition Under Investigation Worsened|6|||
170445952|NCT01588548|615970013|FG002|Overall Study|Condition Under Investigation Worsened|4|||
170445953|NCT01588548|615970014|FG003|Overall Study|Condition Under Investigation Worsened|4|||
170445954|NCT01588548|615970015|FG004|Overall Study|Condition Under Investigation Worsened|3|||
170445955|NCT01588548|615970016|FG005|Overall Study|Condition Under Investigation Worsened|3|||
170785927|NCT04717492|617223588|FG000|Overall Study|Withdrawal by Subject|2|||
170785928|NCT04717492|617223589|FG001|Overall Study|Withdrawal by Subject|13|||
170785929|NCT04717492|617223588|FG000|Overall Study|Lost to Follow-up|2|||
170785930|NCT04717492|617223589|FG001|Overall Study|Lost to Follow-up|9|||
170785931|NCT02100813|617223590|FG000|Overall Study|Adverse Event|0|||
170445956|NCT03941834|615972013|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
170445957|NCT03941834|615972014|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
170445958|NCT03941834|615972015|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
170445959|NCT03941834|615972013|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
170445960|NCT03941834|615972014|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
170445961|NCT03941834|615972015|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
170445962|NCT03941834|615972013|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
170445963|NCT03941834|615972014|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
170445964|NCT03941834|615972015|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
170445965|NCT03941834|615972013|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
170445966|NCT03941834|615972014|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
170445967|NCT03941834|615972015|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
170445968|NCT03941834|615972013|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
170445969|NCT03941834|615972014|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
170445970|NCT03941834|615972015|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
170445971|NCT03941834|615972013|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
170445972|NCT03941834|615972014|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
170445973|NCT03941834|615972015|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
170445974|NCT02190279|615972017|FG000|Overall Study|Withdrawal consent|1|||
170445975|NCT02190279|615972018|FG001|Overall Study|Withdrawal consent|0|||
170445976|NCT02190279|615972019|FG002|Overall Study|Withdrawal consent|1|||
170445977|NCT02190279|615972017|FG000|Overall Study|Lost to Follow-up|2|||
170445978|NCT02190279|615972018|FG001|Overall Study|Lost to Follow-up|0|||
170445979|NCT02190279|615972019|FG002|Overall Study|Lost to Follow-up|0|||
170445980|NCT02190279|615972017|FG000|Overall Study|Refused further treatment|0|||
170445981|NCT02190279|615972018|FG001|Overall Study|Refused further treatment|0|||
170445982|NCT02190279|615972019|FG002|Overall Study|Refused further treatment|1|||
170445983|NCT02190279|615972017|FG000|Overall Study|Screening failure|0|||
170445984|NCT02190279|615972018|FG001|Overall Study|Screening failure|0|||
170445985|NCT02190279|615972019|FG002|Overall Study|Screening failure|1|||
170445986|NCT02688387|615972020|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445987|NCT02688387|615972021|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445988|NCT02688387|615972022|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
170445989|NCT02688387|615972023|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445990|NCT02688387|615972024|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445991|NCT02688387|615972025|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445992|NCT02688387|615972026|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445993|NCT02688387|615972027|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445994|NCT02688387|615972028|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445995|NCT02688387|615972029|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445996|NCT02688387|615972030|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445997|NCT02688387|615972031|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445998|NCT02688387|615972032|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170445999|NCT02688387|615972033|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446000|NCT02688387|615972034|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446001|NCT02688387|615972035|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446002|NCT02688387|615972036|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446003|NCT02688387|615972037|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446004|NCT02688387|615972038|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446005|NCT02688387|615972039|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446006|NCT02688387|615972040|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446007|NCT02688387|615972041|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
170446008|NCT02688387|615972020|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446009|NCT02688387|615972021|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446010|NCT02688387|615972022|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446011|NCT02688387|615972023|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
170446012|NCT02688387|615972024|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446013|NCT02688387|615972025|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446014|NCT02688387|615972026|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446015|NCT02688387|615972027|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446016|NCT02688387|615972028|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446017|NCT02688387|615972029|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446018|NCT02688387|615972030|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446019|NCT02688387|615972031|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446020|NCT02688387|615972032|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446021|NCT02688387|615972033|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446022|NCT02688387|615972034|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446023|NCT02688387|615972035|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170886956|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
170446024|NCT02688387|615972036|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446025|NCT02688387|615972037|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446026|NCT02688387|615972038|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446027|NCT02688387|615972039|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446028|NCT02688387|615972040|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446029|NCT02688387|615972041|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446030|NCT02688387|615972020|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446031|NCT02688387|615972021|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
170633570|NCT00790842|616670111|FG004|Dose Level 1|Adverse Event|0|||
170886957|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
170633571|NCT00790842|616670112|FG005|Dose Level 1|Adverse Event|0|||
170633572|NCT00790842|616670113|FG006|Dose Level 1|Adverse Event|0|||
170633573|NCT00790842|616670114|FG007|Dose Level 1|Adverse Event|1|||
170633574|NCT00790842|616670115|FG008|Dose Level 1|Adverse Event|0|||
170446032|NCT02688387|615972022|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446033|NCT02688387|615972023|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446034|NCT02688387|615972024|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446035|NCT02688387|615972025|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446036|NCT02688387|615972026|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446037|NCT02688387|615972027|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446038|NCT02688387|615972028|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446039|NCT02688387|615972029|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446040|NCT02688387|615972030|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446041|NCT02688387|615972031|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446042|NCT02688387|615972032|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446043|NCT02688387|615972033|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446044|NCT02688387|615972034|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170633575|NCT00790842|616670116|FG009|Dose Level 1|Adverse Event|0|||
170633576|NCT00790842|616670117|FG010|Dose Level 1|Adverse Event|0|||
170633577|NCT00790842|616670107|FG000|Dose Level 1|Physician Decision|1|||
170633578|NCT00790842|616670108|FG001|Dose Level 1|Physician Decision|0|||
170633579|NCT00790842|616670109|FG002|Dose Level 1|Physician Decision|0|||
170633580|NCT00790842|616670110|FG003|Dose Level 1|Physician Decision|0|||
170633581|NCT00790842|616670111|FG004|Dose Level 1|Physician Decision|0|||
170633582|NCT00790842|616670112|FG005|Dose Level 1|Physician Decision|0|||
170633583|NCT00790842|616670113|FG006|Dose Level 1|Physician Decision|0|||
170633584|NCT00790842|616670114|FG007|Dose Level 1|Physician Decision|1|||
170633585|NCT00790842|616670115|FG008|Dose Level 1|Physician Decision|0|||
170633586|NCT00790842|616670116|FG009|Dose Level 1|Physician Decision|0|||
170446045|NCT02688387|615972035|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446046|NCT02688387|615972036|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446047|NCT02688387|615972037|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446048|NCT02688387|615972038|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446049|NCT02688387|615972039|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446050|NCT02688387|615972040|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170633587|NCT00790842|616670117|FG010|Dose Level 1|Physician Decision|0|||
170633588|NCT00790842|616670107|FG000|Dose Level 1|Withdrawal by Subject|1|||
170633589|NCT00790842|616670108|FG001|Dose Level 1|Withdrawal by Subject|0|||
170633590|NCT00790842|616670109|FG002|Dose Level 1|Withdrawal by Subject|0|||
170633591|NCT00790842|616670110|FG003|Dose Level 1|Withdrawal by Subject|0|||
170633592|NCT00790842|616670111|FG004|Dose Level 1|Withdrawal by Subject|0|||
170633593|NCT00790842|616670112|FG005|Dose Level 1|Withdrawal by Subject|0|||
170633594|NCT00790842|616670113|FG006|Dose Level 1|Withdrawal by Subject|0|||
170633595|NCT00790842|616670114|FG007|Dose Level 1|Withdrawal by Subject|0|||
170785932|NCT02100813|617223591|FG001|Overall Study|Adverse Event|0|||
170785933|NCT02100813|617223592|FG002|Overall Study|Adverse Event|0|||
170785934|NCT02100813|617223593|FG003|Overall Study|Adverse Event|0|||
170785935|NCT02100813|617223594|FG004|Overall Study|Adverse Event|0|||
170785936|NCT02100813|617223595|FG005|Overall Study|Adverse Event|0|||
170785937|NCT02100813|617223596|FG006|Overall Study|Adverse Event|0|||
170785938|NCT02100813|617223597|FG007|Overall Study|Adverse Event|1|||
170785939|NCT05308004|617223598|FG000|Overall Study|Not seen by Palliative Care NP|0|||
170785940|NCT05308004|617223599|FG001|Overall Study|Not seen by Palliative Care NP|1|||
170785941|NCT04856163|617223606|FG000|Overall Study|Lost to Follow-up|97|||
170785942|NCT04856163|617223607|FG001|Overall Study|Lost to Follow-up|100|||
170785943|NCT00881621|617223608|FG000|Overall Study|Physician Decision|34|||
170785944|NCT06393088|617223610|FG000|Overall Study|Withdrawal by Subject|0|||
170785945|NCT06393088|617223611|FG001|Overall Study|Withdrawal by Subject|2|||
170785946|NCT04176965|617223612|FG000|Overall Study|Death|1|||
170785947|NCT04176965|617223613|FG001|Overall Study|Death|2|||
170785948|NCT04176965|617223612|FG000|Overall Study|Lost to Follow-up|10|||
170785949|NCT04176965|617223613|FG001|Overall Study|Lost to Follow-up|2|||
170785950|NCT04176965|617223612|FG000|Overall Study|Withdrawal by Subject|6|||
170785951|NCT04176965|617223613|FG001|Overall Study|Withdrawal by Subject|1|||
170633596|NCT00790842|616670115|FG008|Dose Level 1|Withdrawal by Subject|0|||
170633597|NCT00790842|616670116|FG009|Dose Level 1|Withdrawal by Subject|0|||
170785952|NCT03903146|617223614|FG000|Overall Study|Lost to Follow-up|6|||
170785953|NCT03903146|617223615|FG001|Overall Study|Lost to Follow-up|4|||
170785954|NCT03903146|617223614|FG000|Overall Study|Withdrawal by Subject|0|||
170785955|NCT03903146|617223615|FG001|Overall Study|Withdrawal by Subject|1|||
170785956|NCT05434078|617223616|FG000|Overall Study|Lost to Follow-up|2|||
170886958|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
170446051|NCT02688387|615972041|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
170446052|NCT02688387|615972020|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446053|NCT02688387|615972021|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446054|NCT02688387|615972022|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
170446055|NCT02688387|615972023|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446056|NCT02688387|615972024|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
170446057|NCT02688387|615972025|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446058|NCT02688387|615972026|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446059|NCT02688387|615972027|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446060|NCT02688387|615972028|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446061|NCT02688387|615972029|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446062|NCT02688387|615972030|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446063|NCT02688387|615972031|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170539461|NCT00433537|616317218|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
170539462|NCT00433537|616317216|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
170539463|NCT00433537|616317217|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
170539464|NCT00433537|616317218|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
170539465|NCT00433537|616317216|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
170539466|NCT00433537|616317217|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
170539467|NCT00433537|616317218|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
170539468|NCT00433537|616317216|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
170539469|NCT00433537|616317217|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
170539470|NCT00433537|616317218|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
170539471|NCT04556097|616317219|FG000|Overall Study|Death|0|||
170539472|NCT04556097|616317220|FG001|Overall Study|Death|5|||
170539473|NCT04556097|616317221|FG002|Overall Study|Death|0|||
170539474|NCT04556097|616317222|FG003|Overall Study|Death|0|||
170539475|NCT04556097|616317219|FG000|Overall Study|No caregiver|43|||
170539476|NCT04556097|616317220|FG001|Overall Study|No caregiver|53|||
170539477|NCT04556097|616317221|FG002|Overall Study|No caregiver|0|||
170539478|NCT04556097|616317222|FG003|Overall Study|No caregiver|0|||
170539479|NCT04556097|616317219|FG000|Overall Study|Ineligible, SNF|2|||
170539480|NCT04556097|616317220|FG001|Overall Study|Ineligible, SNF|2|||
170539481|NCT04556097|616317221|FG002|Overall Study|Ineligible, SNF|0|||
170539482|NCT04556097|616317222|FG003|Overall Study|Ineligible, SNF|0|||
170539483|NCT04556097|616317219|FG000|Overall Study|Ineligible, health|3|||
170539484|NCT04556097|616317220|FG001|Overall Study|Ineligible, health|4|||
170539485|NCT04556097|616317221|FG002|Overall Study|Ineligible, health|0|||
170539486|NCT04556097|616317222|FG003|Overall Study|Ineligible, health|0|||
170539487|NCT04556097|616317219|FG000|Overall Study|Ineligible, language|0|||
170539488|NCT04556097|616317220|FG001|Overall Study|Ineligible, language|1|||
170539489|NCT04556097|616317221|FG002|Overall Study|Ineligible, language|0|||
170539490|NCT04556097|616317222|FG003|Overall Study|Ineligible, language|0|||
170539491|NCT04556097|616317219|FG000|Overall Study|Ineligible, no longer in care management|0|||
170539492|NCT04556097|616317220|FG001|Overall Study|Ineligible, no longer in care management|2|||
170539493|NCT04556097|616317221|FG002|Overall Study|Ineligible, no longer in care management|1|||
170539494|NCT04556097|616317222|FG003|Overall Study|Ineligible, no longer in care management|0|||
170539495|NCT04556097|616317219|FG000|Overall Study|No dementia|13|||
170539496|NCT04556097|616317220|FG001|Overall Study|No dementia|3|||
170539497|NCT04556097|616317221|FG002|Overall Study|No dementia|0|||
170539498|NCT04556097|616317222|FG003|Overall Study|No dementia|0|||
170539499|NCT04556097|616317219|FG000|Overall Study|Missing identifier|2|||
170539500|NCT04556097|616317220|FG001|Overall Study|Missing identifier|4|||
170539501|NCT04556097|616317221|FG002|Overall Study|Missing identifier|0|||
170539502|NCT04556097|616317222|FG003|Overall Study|Missing identifier|0|||
170539503|NCT04556097|616317219|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
170539504|NCT04556097|616317220|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
170539505|NCT04556097|616317221|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
170539506|NCT04556097|616317222|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
170539507|NCT02811159|616317232|FG000|Treatment Course 1|Lost to Follow-up|1|||
170539508|NCT04835441|616317233|FG000|Overall Study|Physician Decision|4|||
170539509|NCT04835441|616317234|FG001|Overall Study|Physician Decision|4|||
170539510|NCT04835441|616317233|FG000|Overall Study|Other|1|||
170539511|NCT04835441|616317234|FG001|Overall Study|Other|1|||
170539512|NCT04835441|616317233|FG000|Overall Study|Lost to Follow-up|0|||
170539513|NCT04835441|616317234|FG001|Overall Study|Lost to Follow-up|1|||
170539514|NCT00972738|616318359|FG000|Overall Study|Adverse Event|7|||
170539515|NCT00972738|616318360|FG001|Overall Study|Adverse Event|1|||
170539516|NCT00972738|616318361|FG002|Overall Study|Adverse Event|8|||
170539517|NCT00972738|616318359|FG000|Overall Study|Protocol Violation|2|||
170539518|NCT00972738|616318360|FG001|Overall Study|Protocol Violation|1|||
170785957|NCT05434078|617223617|FG001|Overall Study|Lost to Follow-up|1|||
170785958|NCT05434078|617223616|FG000|Overall Study|Withdrawal by Subject|1|||
170785959|NCT05434078|617223617|FG001|Overall Study|Withdrawal by Subject|0|||
170785960|NCT05551637|617223619|FG000|Overall Study|Lack of Efficacy|0|||
170785961|NCT05551637|617223620|FG001|Overall Study|Lack of Efficacy|6|||
170785962|NCT05551637|617223619|FG000|Overall Study|Lost to Follow-up|1|||
170446064|NCT02688387|615972032|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446065|NCT02688387|615972033|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446066|NCT02688387|615972034|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446067|NCT02688387|615972035|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446068|NCT02688387|615972036|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446069|NCT02688387|615972037|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446070|NCT02688387|615972038|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446071|NCT02688387|615972039|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446072|NCT02688387|615972040|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446073|NCT02688387|615972041|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
170446074|NCT02688387|615972020|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
170446075|NCT02688387|615972021|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446076|NCT02688387|615972022|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446077|NCT02688387|615972023|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446078|NCT02688387|615972024|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446079|NCT02688387|615972025|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446080|NCT02688387|615972026|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446081|NCT02688387|615972027|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446082|NCT02688387|615972028|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446083|NCT02688387|615972029|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446084|NCT02688387|615972030|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446085|NCT02688387|615972031|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446086|NCT02688387|615972032|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446087|NCT02688387|615972033|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446088|NCT02688387|615972034|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446089|NCT02688387|615972035|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446090|NCT02688387|615972036|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446091|NCT02688387|615972037|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446092|NCT02688387|615972038|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446093|NCT02688387|615972039|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446094|NCT02688387|615972040|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446095|NCT02688387|615972041|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
170446096|NCT02688387|615972020|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446097|NCT02688387|615972021|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446098|NCT02688387|615972022|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446099|NCT02688387|615972023|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446100|NCT02688387|615972024|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446101|NCT02688387|615972025|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446102|NCT02688387|615972026|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446103|NCT02688387|615972027|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446104|NCT02688387|615972028|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446105|NCT02688387|615972029|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170539519|NCT00972738|616318361|FG002|Overall Study|Protocol Violation|3|||
170539520|NCT00972738|616318359|FG000|Overall Study|Lost to Follow-up|1|||
170539521|NCT00972738|616318360|FG001|Overall Study|Lost to Follow-up|0|||
170539522|NCT00972738|616318361|FG002|Overall Study|Lost to Follow-up|1|||
170539523|NCT00972738|616318359|FG000|Overall Study|Lack of Efficacy|5|||
170539524|NCT00972738|616318360|FG001|Overall Study|Lack of Efficacy|1|||
170539525|NCT00972738|616318361|FG002|Overall Study|Lack of Efficacy|11|||
170539526|NCT00972738|616318359|FG000|Overall Study|Withdrawal by Subject|5|||
170539527|NCT00972738|616318360|FG001|Overall Study|Withdrawal by Subject|1|||
170539528|NCT00972738|616318361|FG002|Overall Study|Withdrawal by Subject|4|||
170539529|NCT00972738|616318359|FG000|Overall Study|Moved|0|||
170539530|NCT00972738|616318360|FG001|Overall Study|Moved|0|||
170785963|NCT05551637|617223620|FG001|Overall Study|Lost to Follow-up|1|||
170785964|NCT05409183|617223636|FG000|Complete Study|Adverse Event|1|||
170539531|NCT00972738|616318361|FG002|Overall Study|Moved|1|||
170539532|NCT00972738|616318359|FG000|Overall Study|Other|1|||
170539533|NCT00972738|616318360|FG001|Overall Study|Other|2|||
170539534|NCT00972738|616318361|FG002|Overall Study|Other|1|||
170539535|NCT01033942|616318362|FG000|Overall Study|Withdrawal by Subject|1|||
170539536|NCT01033942|616318363|FG001|Overall Study|Withdrawal by Subject|1|||
170539537|NCT01033942|616318364|FG002|Overall Study|Withdrawal by Subject|1|||
170539538|NCT01033942|616318362|FG000|Overall Study|Lost to Follow-up|1|||
170446106|NCT02688387|615972030|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
170446107|NCT02688387|615972031|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446108|NCT02688387|615972032|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446109|NCT02688387|615972033|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446110|NCT02688387|615972034|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446111|NCT02688387|615972035|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446112|NCT02688387|615972036|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446113|NCT02688387|615972037|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446114|NCT02688387|615972038|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446115|NCT02688387|615972039|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446116|NCT02688387|615972040|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446117|NCT02688387|615972041|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
170446118|NCT02688387|615972020|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446119|NCT02688387|615972021|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446120|NCT02688387|615972022|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446121|NCT02688387|615972023|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446122|NCT02688387|615972024|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446123|NCT02688387|615972025|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446124|NCT02688387|615972026|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446125|NCT02688387|615972027|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446126|NCT02688387|615972028|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446127|NCT02688387|615972029|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446128|NCT02688387|615972030|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446129|NCT02688387|615972031|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446130|NCT02688387|615972032|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446131|NCT02688387|615972033|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446132|NCT02688387|615972034|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
170446133|NCT02688387|615972035|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446134|NCT02688387|615972036|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446135|NCT02688387|615972037|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446136|NCT02688387|615972038|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446137|NCT02688387|615972039|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170886959|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
170886960|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
170446138|NCT02688387|615972040|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446139|NCT02688387|615972041|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
170446140|NCT02688387|615972020|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446141|NCT02688387|615972021|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446142|NCT02688387|615972022|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446143|NCT02688387|615972023|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446144|NCT02688387|615972024|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446145|NCT02688387|615972025|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446146|NCT02688387|615972026|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446147|NCT02688387|615972027|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446148|NCT02688387|615972028|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446149|NCT02688387|615972029|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446150|NCT02688387|615972030|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446151|NCT02688387|615972031|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446152|NCT02688387|615972032|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446153|NCT02688387|615972033|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446154|NCT02688387|615972034|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446155|NCT02688387|615972035|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446156|NCT02688387|615972036|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446157|NCT02688387|615972037|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446158|NCT02688387|615972038|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446159|NCT02688387|615972039|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446160|NCT02688387|615972040|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
170446161|NCT02688387|615972041|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
170446162|NCT02688387|615972020|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446163|NCT02688387|615972021|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446164|NCT02688387|615972022|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446165|NCT02688387|615972023|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446166|NCT02688387|615972024|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446167|NCT02688387|615972025|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446168|NCT02688387|615972026|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446169|NCT02688387|615972027|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170539539|NCT01033942|616318363|FG001|Overall Study|Lost to Follow-up|0|||
170633598|NCT00790842|616670117|FG010|Dose Level 1|Withdrawal by Subject|0|||
170633599|NCT00790842|616670107|FG000|Dose Level 2|Death|0|||
170633600|NCT00790842|616670108|FG001|Dose Level 2|Death|1|||
170633601|NCT00790842|616670109|FG002|Dose Level 2|Death|0|||
170633602|NCT00790842|616670110|FG003|Dose Level 2|Death|0|||
170633603|NCT00790842|616670111|FG004|Dose Level 2|Death|1|||
170633604|NCT00790842|616670112|FG005|Dose Level 2|Death|0|||
170633605|NCT00790842|616670113|FG006|Dose Level 2|Death|0|||
170633606|NCT00790842|616670114|FG007|Dose Level 2|Death|0|||
170633607|NCT00790842|616670115|FG008|Dose Level 2|Death|0|||
170633608|NCT00790842|616670116|FG009|Dose Level 2|Death|0|||
170633609|NCT00790842|616670117|FG010|Dose Level 2|Death|0|||
170633610|NCT00790842|616670107|FG000|Dose Level 2|Physician Decision|0|||
170633611|NCT00790842|616670108|FG001|Dose Level 2|Physician Decision|1|||
170633612|NCT00790842|616670109|FG002|Dose Level 2|Physician Decision|0|||
170633613|NCT00790842|616670110|FG003|Dose Level 2|Physician Decision|0|||
170633614|NCT00790842|616670111|FG004|Dose Level 2|Physician Decision|0|||
170633615|NCT00790842|616670112|FG005|Dose Level 2|Physician Decision|0|||
170633616|NCT00790842|616670113|FG006|Dose Level 2|Physician Decision|0|||
170633617|NCT00790842|616670114|FG007|Dose Level 2|Physician Decision|0|||
170633618|NCT00790842|616670115|FG008|Dose Level 2|Physician Decision|0|||
170633619|NCT00790842|616670116|FG009|Dose Level 2|Physician Decision|0|||
170633620|NCT00790842|616670117|FG010|Dose Level 2|Physician Decision|0|||
170633621|NCT00790842|616670107|FG000|Dose Level 2|Withdrawal by Subject|0|||
170633622|NCT00790842|616670108|FG001|Dose Level 2|Withdrawal by Subject|1|||
170633623|NCT00790842|616670109|FG002|Dose Level 2|Withdrawal by Subject|0|||
170633624|NCT00790842|616670110|FG003|Dose Level 2|Withdrawal by Subject|0|||
170633625|NCT00790842|616670111|FG004|Dose Level 2|Withdrawal by Subject|0|||
170633626|NCT00790842|616670112|FG005|Dose Level 2|Withdrawal by Subject|0|||
170633627|NCT00790842|616670113|FG006|Dose Level 2|Withdrawal by Subject|0|||
170633628|NCT00790842|616670114|FG007|Dose Level 2|Withdrawal by Subject|0|||
170633629|NCT00790842|616670115|FG008|Dose Level 2|Withdrawal by Subject|0|||
170633630|NCT00790842|616670116|FG009|Dose Level 2|Withdrawal by Subject|0|||
170633631|NCT00790842|616670117|FG010|Dose Level 2|Withdrawal by Subject|0|||
170633632|NCT00790842|616670107|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633633|NCT00790842|616670108|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633634|NCT00790842|616670109|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633635|NCT00790842|616670110|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633636|NCT00790842|616670111|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633637|NCT00790842|616670112|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633638|NCT00790842|616670113|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633639|NCT00790842|616670114|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633640|NCT00790842|616670115|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
170633641|NCT00790842|616670116|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633642|NCT00790842|616670117|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
170633643|NCT00790842|616670107|FG000|Dose Level 3|Adverse Event|0|||
170633644|NCT00790842|616670108|FG001|Dose Level 3|Adverse Event|0|||
170633645|NCT00790842|616670109|FG002|Dose Level 3|Adverse Event|1|||
170633646|NCT00790842|616670110|FG003|Dose Level 3|Adverse Event|0|||
170633647|NCT00790842|616670111|FG004|Dose Level 3|Adverse Event|0|||
170633648|NCT00790842|616670112|FG005|Dose Level 3|Adverse Event|0|||
170633649|NCT00790842|616670113|FG006|Dose Level 3|Adverse Event|0|||
170633650|NCT00790842|616670114|FG007|Dose Level 3|Adverse Event|0|||
170633651|NCT00790842|616670115|FG008|Dose Level 3|Adverse Event|0|||
170633652|NCT00790842|616670116|FG009|Dose Level 3|Adverse Event|0|||
170633653|NCT00790842|616670117|FG010|Dose Level 3|Adverse Event|0|||
170633654|NCT00790842|616670107|FG000|Dose Level 3|Withdrawal by Subject|0|||
170633655|NCT00790842|616670108|FG001|Dose Level 3|Withdrawal by Subject|0|||
170633656|NCT00790842|616670109|FG002|Dose Level 3|Withdrawal by Subject|3|||
170633657|NCT00790842|616670110|FG003|Dose Level 3|Withdrawal by Subject|0|||
170633658|NCT00790842|616670111|FG004|Dose Level 3|Withdrawal by Subject|0|||
170633659|NCT00790842|616670112|FG005|Dose Level 3|Withdrawal by Subject|0|||
170633660|NCT00790842|616670113|FG006|Dose Level 3|Withdrawal by Subject|0|||
170633661|NCT00790842|616670114|FG007|Dose Level 3|Withdrawal by Subject|0|||
170633662|NCT00790842|616670115|FG008|Dose Level 3|Withdrawal by Subject|0|||
170633663|NCT00790842|616670116|FG009|Dose Level 3|Withdrawal by Subject|2|||
170633664|NCT00790842|616670117|FG010|Dose Level 3|Withdrawal by Subject|0|||
170633665|NCT00790842|616670107|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633666|NCT00790842|616670108|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633667|NCT00790842|616670109|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633668|NCT00790842|616670110|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633669|NCT00790842|616670111|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633670|NCT00790842|616670112|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
170633671|NCT00790842|616670113|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633672|NCT00790842|616670114|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633673|NCT00790842|616670115|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633674|NCT00790842|616670116|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633675|NCT00790842|616670117|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
170633676|NCT00790842|616670107|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633677|NCT00790842|616670108|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633678|NCT00790842|616670109|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
170633679|NCT00790842|616670110|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633680|NCT00790842|616670111|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633681|NCT00790842|616670112|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633682|NCT00790842|616670113|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633683|NCT00790842|616670114|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633684|NCT00790842|616670115|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633685|NCT00790842|616670116|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633686|NCT00790842|616670117|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
170633687|NCT00790842|616670107|FG000|Dose Level 4|Adverse Event|0|||
170633688|NCT00790842|616670108|FG001|Dose Level 4|Adverse Event|0|||
170633689|NCT00790842|616670109|FG002|Dose Level 4|Adverse Event|0|||
170633690|NCT00790842|616670110|FG003|Dose Level 4|Adverse Event|0|||
170633691|NCT00790842|616670111|FG004|Dose Level 4|Adverse Event|0|||
170633692|NCT00790842|616670112|FG005|Dose Level 4|Adverse Event|0|||
170633693|NCT00790842|616670113|FG006|Dose Level 4|Adverse Event|1|||
170633694|NCT00790842|616670114|FG007|Dose Level 4|Adverse Event|0|||
170633695|NCT00790842|616670115|FG008|Dose Level 4|Adverse Event|0|||
170633696|NCT00790842|616670116|FG009|Dose Level 4|Adverse Event|0|||
170633697|NCT00790842|616670117|FG010|Dose Level 4|Adverse Event|0|||
170633698|NCT00790842|616670107|FG000|Dose Level 4|Physician Decision|0|||
170633699|NCT00790842|616670108|FG001|Dose Level 4|Physician Decision|0|||
170633700|NCT00790842|616670109|FG002|Dose Level 4|Physician Decision|0|||
170446170|NCT02688387|615972028|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446171|NCT02688387|615972029|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446172|NCT02688387|615972030|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446173|NCT02688387|615972031|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446174|NCT02688387|615972032|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446175|NCT02688387|615972033|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170633701|NCT00790842|616670110|FG003|Dose Level 4|Physician Decision|0|||
170633702|NCT00790842|616670111|FG004|Dose Level 4|Physician Decision|0|||
170633703|NCT00790842|616670112|FG005|Dose Level 4|Physician Decision|0|||
170446176|NCT02688387|615972034|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170633704|NCT00790842|616670113|FG006|Dose Level 4|Physician Decision|1|||
170633705|NCT00790842|616670114|FG007|Dose Level 4|Physician Decision|0|||
170785965|NCT05409183|617223637|FG001|Complete Study|Adverse Event|2|||
170446177|NCT02688387|615972035|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446178|NCT02688387|615972036|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446179|NCT02688387|615972037|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446180|NCT02688387|615972038|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
170446181|NCT02688387|615972039|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446182|NCT02688387|615972040|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
170446183|NCT02688387|615972041|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
170446184|NCT02688387|615972020|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446185|NCT02688387|615972021|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446186|NCT02688387|615972022|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446187|NCT02688387|615972023|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446188|NCT02688387|615972024|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446189|NCT02688387|615972025|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446190|NCT02688387|615972026|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446191|NCT02688387|615972027|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446192|NCT02688387|615972028|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446193|NCT02688387|615972029|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446194|NCT02688387|615972030|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446195|NCT02688387|615972031|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446196|NCT02688387|615972032|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446197|NCT02688387|615972033|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446198|NCT02688387|615972034|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446199|NCT02688387|615972035|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446200|NCT02688387|615972036|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446201|NCT02688387|615972037|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446202|NCT02688387|615972038|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170633706|NCT00790842|616670115|FG008|Dose Level 4|Physician Decision|0|||
170633707|NCT00790842|616670116|FG009|Dose Level 4|Physician Decision|0|||
170633708|NCT00790842|616670117|FG010|Dose Level 4|Physician Decision|1|||
170633709|NCT00790842|616670107|FG000|Dose Level 4|Withdrawal by Subject|0|||
170633710|NCT00790842|616670108|FG001|Dose Level 4|Withdrawal by Subject|0|||
170633711|NCT00790842|616670109|FG002|Dose Level 4|Withdrawal by Subject|0|||
170446203|NCT02688387|615972039|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
170446204|NCT02688387|615972040|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446205|NCT02688387|615972041|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
170446206|NCT02938442|615972042|FG000|Overall Study|Death|0|||
170446207|NCT02938442|615972043|FG001|Overall Study|Death|1|||
170446208|NCT02938442|615972042|FG000|Overall Study|Lost to Follow-up|0|||
170446209|NCT02938442|615972043|FG001|Overall Study|Lost to Follow-up|1|||
170446210|NCT02938442|615972042|FG000|Overall Study|Physician Decision|0|||
170446211|NCT02938442|615972043|FG001|Overall Study|Physician Decision|1|||
170446212|NCT02938442|615972042|FG000|Overall Study|Withdrawal by Subject|2|||
170446213|NCT02938442|615972043|FG001|Overall Study|Withdrawal by Subject|0|||
170446214|NCT01606228|615972044|FG000|Overall Study|Lost to Follow-up|20|||
170446215|NCT01606228|615972044|FG000|Overall Study|Withdrawal by Subject|3|||
170446216|NCT01606228|615972044|FG000|Overall Study|Non-compliant|3|||
170446217|NCT01606228|615972044|FG000|Overall Study|Lack of Efficacy|2|||
170446218|NCT01606228|615972044|FG000|Overall Study|Adverse Event|1|||
170446219|NCT01115855|615972045|FG000|Overall Study|Adverse Event|16|||
170446220|NCT01115855|615972046|FG001|Overall Study|Adverse Event|18|||
170539540|NCT01033942|616318364|FG002|Overall Study|Lost to Follow-up|0|||
170539541|NCT01033942|616318362|FG000|Overall Study|Enrolled in Extension Study|0|||
170539542|NCT01033942|616318363|FG001|Overall Study|Enrolled in Extension Study|3|||
170539543|NCT01033942|616318364|FG002|Overall Study|Enrolled in Extension Study|0|||
170539544|NCT01001104|616318366|FG000|Overall Study|Adverse Event|2|||
170539545|NCT01001104|616318367|FG001|Overall Study|Adverse Event|1|||
170539546|NCT01001104|616318368|FG002|Overall Study|Adverse Event|0|||
170539547|NCT01001104|616318369|FG003|Overall Study|Adverse Event|0|||
170539548|NCT01001104|616318366|FG000|Overall Study|Lost to Follow-up|0|||
170539549|NCT01001104|616318367|FG001|Overall Study|Lost to Follow-up|0|||
170539550|NCT01001104|616318368|FG002|Overall Study|Lost to Follow-up|1|||
170539551|NCT01001104|616318369|FG003|Overall Study|Lost to Follow-up|0|||
170539552|NCT01001104|616318366|FG000|Overall Study|Entry Criteria Not Met|0|||
170539553|NCT01001104|616318367|FG001|Overall Study|Entry Criteria Not Met|0|||
170539554|NCT01001104|616318368|FG002|Overall Study|Entry Criteria Not Met|0|||
170539555|NCT01001104|616318369|FG003|Overall Study|Entry Criteria Not Met|1|||
170539556|NCT01001104|616318366|FG000|Overall Study|Withdrawal by Subject|0|||
170539557|NCT01001104|616318367|FG001|Overall Study|Withdrawal by Subject|0|||
170446221|NCT01115855|615972045|FG000|Overall Study|Death|6|||
170446222|NCT01115855|615972046|FG001|Overall Study|Death|5|||
170446223|NCT01115855|615972045|FG000|Overall Study|Lab Abnormality|1|||
170446224|NCT01115855|615972046|FG001|Overall Study|Lab Abnormality|1|||
170446225|NCT01115855|615972045|FG000|Overall Study|Protocol Violation|0|||
170446226|NCT01115855|615972046|FG001|Overall Study|Protocol Violation|1|||
170446227|NCT01115855|615972045|FG000|Overall Study|Withdrawal by Subject|5|||
170446228|NCT01115855|615972046|FG001|Overall Study|Withdrawal by Subject|5|||
170539558|NCT01001104|616318368|FG002|Overall Study|Withdrawal by Subject|0|||
170539559|NCT01001104|616318369|FG003|Overall Study|Withdrawal by Subject|2|||
170539560|NCT01793935|616318370|FG000|Overall Study|Pregnancy|1|||
170539561|NCT01793935|616318371|FG001|Overall Study|Pregnancy|0|||
170539562|NCT01793935|616318370|FG000|Overall Study|Protocol Violation|2|||
170539563|NCT01793935|616318371|FG001|Overall Study|Protocol Violation|1|||
170539564|NCT01793935|616318370|FG000|Overall Study|Adverse Event|2|||
170539565|NCT01793935|616318371|FG001|Overall Study|Adverse Event|0|||
170539566|NCT01793935|616318370|FG000|Overall Study|Patient did not take study medication|1|||
170539567|NCT01793935|616318371|FG001|Overall Study|Patient did not take study medication|1|||
170539568|NCT01793935|616318370|FG000|Overall Study|Lost to Follow-up|0|||
170539569|NCT01793935|616318371|FG001|Overall Study|Lost to Follow-up|1|||
170539570|NCT01121926|616318372|FG000|First Intervention Period|Adverse Event|1|||
170539571|NCT01121926|616318373|FG001|First Intervention Period|Adverse Event|0|||
170539572|NCT01121926|616318372|FG000|Washout Period|Adverse Event|0|||
170539573|NCT01121926|616318373|FG001|Washout Period|Adverse Event|1|||
170539574|NCT01121926|616318372|FG000|Washout Period|Positive pregnancy test|0|||
170539575|NCT01121926|616318373|FG001|Washout Period|Positive pregnancy test|1|||
170539576|NCT02175758|616318374|FG000|Treatment Phase|Lost to Follow-up|0|||
170539577|NCT02175758|616318375|FG001|Treatment Phase|Lost to Follow-up|1|||
170539578|NCT02175758|616318376|FG002|Treatment Phase|Lost to Follow-up|0|||
170539579|NCT02175758|616318377|FG003|Treatment Phase|Lost to Follow-up|0|||
170539580|NCT02175758|616318378|FG004|Treatment Phase|Lost to Follow-up|0|||
170539581|NCT02175758|616318379|FG005|Treatment Phase|Lost to Follow-up|0|||
170539582|NCT02175758|616318374|FG000|Treatment Phase|Adverse Event|0|||
170539583|NCT02175758|616318375|FG001|Treatment Phase|Adverse Event|0|||
170539584|NCT02175758|616318376|FG002|Treatment Phase|Adverse Event|0|||
170539585|NCT02175758|616318377|FG003|Treatment Phase|Adverse Event|0|||
170539586|NCT02175758|616318378|FG004|Treatment Phase|Adverse Event|1|||
170539587|NCT02175758|616318379|FG005|Treatment Phase|Adverse Event|0|||
170539588|NCT02299167|616318382|FG000|Overall Study|patients were excluded from the study|11|||
170539589|NCT03600428|616318383|FG000|Overall Study|Not eligible|0|||
170539590|NCT03600428|616318384|FG001|Overall Study|Not eligible|1|||
170539591|NCT03600428|616318383|FG000|Overall Study|Lost to Follow-up|5|||
170539592|NCT03600428|616318384|FG001|Overall Study|Lost to Follow-up|4|||
170539593|NCT03880565|616318385|FG000|Overall Study|Withdrawal by Subject|1|||
170539594|NCT03880565|616318386|FG001|Overall Study|Withdrawal by Subject|0|||
170539595|NCT04327271|616318390|FG000|Overall Study|Death|1|||
170539596|NCT04327271|616318391|FG001|Overall Study|Death|0|||
170539597|NCT04327271|616318390|FG000|Overall Study|Withdrawal by Subject|1|||
170539598|NCT04327271|616318391|FG001|Overall Study|Withdrawal by Subject|0|||
170539599|NCT04327271|616318390|FG000|Overall Study|randomization error (data capture)|4|||
170539600|NCT04327271|616318391|FG001|Overall Study|randomization error (data capture)|3|||
170539601|NCT00765076|616318400|FG000|Overall Study|Adverse Event|1|||
170539602|NCT00765076|616318401|FG001|Overall Study|Adverse Event|0|||
170539603|NCT00765076|616318402|FG002|Overall Study|Adverse Event|0|||
170539604|NCT00765076|616318400|FG000|Overall Study|Withdrawal by Subject|0|||
170539605|NCT00765076|616318401|FG001|Overall Study|Withdrawal by Subject|0|||
170539606|NCT00765076|616318402|FG002|Overall Study|Withdrawal by Subject|1|||
170539607|NCT02830087|616318403|FG000|Overall Study|No study staff to follow-up patients|4|||
170539608|NCT02830087|616318404|FG001|Overall Study|No study staff to follow-up patients|4|||
170539609|NCT02830087|616318405|FG002|Overall Study|No study staff to follow-up patients|4|||
170539610|NCT02830087|616318406|FG003|Overall Study|No study staff to follow-up patients|3|||
170539611|NCT02830087|616318407|FG004|Overall Study|No study staff to follow-up patients|3|||
170539612|NCT02830087|616318408|FG005|Overall Study|No study staff to follow-up patients|3|||
170539613|NCT01525589|616318411|FG000|Overall Study|Non-treatment-related AE|1|||
170539614|NCT01525589|616318412|FG001|Overall Study|Non-treatment-related AE|0|||
170539615|NCT01525589|616318413|FG002|Overall Study|Non-treatment-related AE|0|||
170539616|NCT01525589|616318411|FG000|Overall Study|Progressive disease|48|||
170539617|NCT01525589|616318412|FG001|Overall Study|Progressive disease|15|||
170539618|NCT01525589|616318413|FG002|Overall Study|Progressive disease|29|||
170539619|NCT01525589|616318411|FG000|Overall Study|Never treated|2|||
170539620|NCT01525589|616318412|FG001|Overall Study|Never treated|0|||
170539621|NCT01525589|616318413|FG002|Overall Study|Never treated|0|||
170539622|NCT01525589|616318411|FG000|Overall Study|Physician Decision|4|||
170539623|NCT01525589|616318412|FG001|Overall Study|Physician Decision|2|||
170539624|NCT01525589|616318413|FG002|Overall Study|Physician Decision|2|||
170539625|NCT01525589|616318411|FG000|Overall Study|Death|0|||
170539626|NCT01525589|616318412|FG001|Overall Study|Death|0|||
170785966|NCT05409183|617223636|FG000|Complete Study|Withdrawal by Subject|3|||
170785967|NCT05409183|617223637|FG001|Complete Study|Withdrawal by Subject|0|||
170785968|NCT02274662|617223638|FG000|Overall Study|Death|1|||
170785969|NCT02274662|617223638|FG000|Overall Study|Lost to Follow-up|3|||
170785970|NCT04064164|617223641|FG000|Overall Study|Withdrawal by Subject|8|||
170785971|NCT04064164|617223642|FG001|Overall Study|Withdrawal by Subject|8|||
170785972|NCT03640312|617223648|FG000|Overall Study|Lost to Follow-up|3|||
170785973|NCT03640312|617223649|FG001|Overall Study|Lost to Follow-up|6|||
170539627|NCT01525589|616318413|FG002|Overall Study|Death|2|||
170539628|NCT01525589|616318411|FG000|Overall Study|Treatment-related AE|1|||
170539629|NCT01525589|616318412|FG001|Overall Study|Treatment-related AE|1|||
170539630|NCT01525589|616318413|FG002|Overall Study|Treatment-related AE|2|||
170539631|NCT01525589|616318411|FG000|Overall Study|Other reasons|0|||
170539632|NCT01525589|616318412|FG001|Overall Study|Other reasons|1|||
170539633|NCT01525589|616318413|FG002|Overall Study|Other reasons|0|||
170539634|NCT01525589|616318411|FG000|Overall Study|Withdrawal by Subject|0|||
170539635|NCT01525589|616318412|FG001|Overall Study|Withdrawal by Subject|1|||
170539636|NCT01525589|616318413|FG002|Overall Study|Withdrawal by Subject|0|||
170539637|NCT02924376|616318415|FG000|Overall Study|Progressive Disease|4|||
170633712|NCT00790842|616670110|FG003|Dose Level 4|Withdrawal by Subject|0|||
170539638|NCT02924376|616318416|FG001|Overall Study|Progressive Disease|0|||
170539639|NCT02924376|616318417|FG002|Overall Study|Progressive Disease|1|||
170539640|NCT02924376|616318418|FG003|Overall Study|Progressive Disease|0|||
170539641|NCT02924376|616318415|FG000|Overall Study|Death|73|||
170539642|NCT02924376|616318416|FG001|Overall Study|Death|18|||
170539643|NCT02924376|616318417|FG002|Overall Study|Death|15|||
170539644|NCT02924376|616318418|FG003|Overall Study|Death|2|||
170539645|NCT02924376|616318415|FG000|Overall Study|Lost to Follow-up|3|||
170539646|NCT02924376|616318416|FG001|Overall Study|Lost to Follow-up|0|||
170539647|NCT02924376|616318417|FG002|Overall Study|Lost to Follow-up|0|||
170539648|NCT02924376|616318418|FG003|Overall Study|Lost to Follow-up|0|||
170539649|NCT02924376|616318415|FG000|Overall Study|Study Terminated by Sponsor|19|||
170539650|NCT02924376|616318416|FG001|Overall Study|Study Terminated by Sponsor|0|||
170539651|NCT02924376|616318417|FG002|Overall Study|Study Terminated by Sponsor|0|||
170539652|NCT02924376|616318418|FG003|Overall Study|Study Terminated by Sponsor|0|||
170539653|NCT02924376|616318415|FG000|Overall Study|Physician Decision|1|||
170539654|NCT02924376|616318416|FG001|Overall Study|Physician Decision|0|||
170539655|NCT02924376|616318417|FG002|Overall Study|Physician Decision|0|||
170539656|NCT02924376|616318418|FG003|Overall Study|Physician Decision|0|||
170539657|NCT02924376|616318415|FG000|Overall Study|Withdrawal by Subject|7|||
170539658|NCT02924376|616318416|FG001|Overall Study|Withdrawal by Subject|2|||
170539659|NCT02924376|616318417|FG002|Overall Study|Withdrawal by Subject|1|||
170539660|NCT02924376|616318418|FG003|Overall Study|Withdrawal by Subject|0|||
170539661|NCT02924376|616318415|FG000|Overall Study|Rolled Over to Another Study|1|||
170539662|NCT02924376|616318416|FG001|Overall Study|Rolled Over to Another Study|0|||
170539663|NCT02924376|616318417|FG002|Overall Study|Rolled Over to Another Study|0|||
170539664|NCT02924376|616318418|FG003|Overall Study|Rolled Over to Another Study|0|||
170539665|NCT03608033|616318419|FG000|Treatment Period|Death|0|||
170539666|NCT03608033|616318420|FG001|Treatment Period|Death|1|||
170539667|NCT03608033|616318419|FG000|Treatment Period|Adverse Event|1|||
170539668|NCT03608033|616318420|FG001|Treatment Period|Adverse Event|5|||
170539669|NCT03608033|616318419|FG000|Treatment Period|Lack of Efficacy|4|||
170539670|NCT03608033|616318420|FG001|Treatment Period|Lack of Efficacy|3|||
170539671|NCT03608033|616318419|FG000|Treatment Period|Lost to Follow-up|2|||
170539672|NCT03608033|616318420|FG001|Treatment Period|Lost to Follow-up|6|||
170539673|NCT03608033|616318419|FG000|Treatment Period|Physician Decision|6|||
170539674|NCT03608033|616318420|FG001|Treatment Period|Physician Decision|10|||
170539675|NCT03608033|616318419|FG000|Treatment Period|Pregnancy|1|||
170539676|NCT03608033|616318420|FG001|Treatment Period|Pregnancy|0|||
170539677|NCT03608033|616318419|FG000|Treatment Period|Protocol Violation|1|||
170539678|NCT03608033|616318420|FG001|Treatment Period|Protocol Violation|2|||
170539679|NCT03608033|616318419|FG000|Treatment Period|Withdrawal by Subject|46|||
170539680|NCT03608033|616318420|FG001|Treatment Period|Withdrawal by Subject|45|||
170539681|NCT03608033|616318419|FG000|Treatment Period|Study terminated by sponsor|82|||
170539682|NCT03608033|616318420|FG001|Treatment Period|Study terminated by sponsor|68|||
170633713|NCT00790842|616670111|FG004|Dose Level 4|Withdrawal by Subject|0|||
170633714|NCT00790842|616670112|FG005|Dose Level 4|Withdrawal by Subject|0|||
170785974|NCT04810650|617223650|FG000|Overall Study|Disenrolled in error|0|||
170785975|NCT04810650|617223651|FG001|Overall Study|Disenrolled in error|0|||
170785976|NCT04810650|617223652|FG002|Overall Study|Disenrolled in error|0|||
170785977|NCT04810650|617223653|FG003|Overall Study|Disenrolled in error|0|||
170785978|NCT04810650|617223654|FG004|Overall Study|Disenrolled in error|0|||
170785979|NCT04810650|617223655|FG005|Overall Study|Disenrolled in error|0|||
170785980|NCT04810650|617223656|FG006|Overall Study|Disenrolled in error|0|||
170785981|NCT04810650|617223657|FG007|Overall Study|Disenrolled in error|0|||
170633715|NCT00790842|616670113|FG006|Dose Level 4|Withdrawal by Subject|0|||
170785982|NCT04810650|617223658|FG008|Overall Study|Disenrolled in error|1|||
170785983|NCT04810650|617223659|FG009|Overall Study|Disenrolled in error|0|||
170539683|NCT03608033|616318419|FG000|Treatment Period|Site Terminated by Sponsor|1|||
170539684|NCT03608033|616318420|FG001|Treatment Period|Site Terminated by Sponsor|0|||
170539685|NCT03608033|616318419|FG000|Open-Label Period: OMS721|Adverse Event|1|||
170539686|NCT03608033|616318420|FG001|Open-Label Period: OMS721|Adverse Event|0|||
170539687|NCT03608033|616318419|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
170539688|NCT03608033|616318420|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
170539689|NCT03608033|616318419|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
170539690|NCT03608033|616318420|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
170539691|NCT03608033|616318419|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
170539692|NCT03608033|616318420|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
170539693|NCT03608033|616318419|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
170785984|NCT04810650|617223660|FG010|Overall Study|Disenrolled in error|0|||
170539694|NCT03608033|616318420|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
170539695|NCT03483012|616318422|FG000|Overall Study|Lack of Efficacy|6|||
170539696|NCT05253807|616318423|FG000|Overall Study|Death|1|||
170539697|NCT05253807|616318424|FG001|Overall Study|Death|4|||
170539698|NCT05253807|616318423|FG000|Overall Study|Withdrawal by Subject|1|||
170446229|NCT01115855|615972045|FG000|Overall Study|Other|8|||
170446230|NCT01115855|615972046|FG001|Overall Study|Other|6|||
170446231|NCT02668822|615972050|FG000|Overall Study|Protocol Violation|2|||
170446232|NCT02668822|615972051|FG001|Overall Study|Protocol Violation|0|||
170446233|NCT02668822|615972050|FG000|Overall Study|Study Terminated by Sponsor|7|||
170446234|NCT02668822|615972051|FG001|Overall Study|Study Terminated by Sponsor|9|||
170446235|NCT01316419|615972052|FG000|Overall Study|Not treated|103|||
170446236|NCT01316419|615972052|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
170446237|NCT01316419|615972052|FG000|Overall Study|Lost to Follow-up|19|||
170446238|NCT00983918|615972053|FG000|Overall Study|conversion to open cholecystectomy|0|||
170446239|NCT00983918|615972054|FG001|Overall Study|conversion to open cholecystectomy|2|||
170446240|NCT00983918|615972055|FG002|Overall Study|conversion to open cholecystectomy|2|||
170446241|NCT00983918|615972056|FG003|Overall Study|conversion to open cholecystectomy|2|||
170446242|NCT01796964|615972059|FG000|Overall Study|Adverse Event|1|||
170446243|NCT01796964|615972060|FG001|Overall Study|Adverse Event|1|||
170446244|NCT01796964|615972059|FG000|Overall Study|Death|1|||
170446245|NCT01796964|615972060|FG001|Overall Study|Death|0|||
170633716|NCT00790842|616670114|FG007|Dose Level 4|Withdrawal by Subject|0|||
170633717|NCT00790842|616670115|FG008|Dose Level 4|Withdrawal by Subject|0|||
170785985|NCT04810650|617223661|FG011|Overall Study|Disenrolled in error|0|||
170785986|NCT04810650|617223662|FG012|Overall Study|Disenrolled in error|0|||
170785987|NCT04810650|617223663|FG013|Overall Study|Disenrolled in error|0|||
170785988|NCT04810650|617223650|FG000|Overall Study|Death|0|||
170785989|NCT04810650|617223651|FG001|Overall Study|Death|0|||
170785990|NCT04810650|617223652|FG002|Overall Study|Death|0|||
170785991|NCT04810650|617223653|FG003|Overall Study|Death|0|||
170785992|NCT04810650|617223654|FG004|Overall Study|Death|0|||
170785993|NCT04810650|617223655|FG005|Overall Study|Death|0|||
170785994|NCT04810650|617223656|FG006|Overall Study|Death|2|||
170785995|NCT04810650|617223657|FG007|Overall Study|Death|2|||
170785996|NCT04810650|617223658|FG008|Overall Study|Death|0|||
170785997|NCT04810650|617223659|FG009|Overall Study|Death|1|||
170785998|NCT04810650|617223660|FG010|Overall Study|Death|0|||
170785999|NCT04810650|617223661|FG011|Overall Study|Death|0|||
170786000|NCT04810650|617223662|FG012|Overall Study|Death|2|||
170786001|NCT04810650|617223663|FG013|Overall Study|Death|1|||
170786002|NCT04810650|617223650|FG000|Overall Study|Moved/transferred care|0|||
170786003|NCT04810650|617223651|FG001|Overall Study|Moved/transferred care|0|||
170786004|NCT04810650|617223652|FG002|Overall Study|Moved/transferred care|0|||
170786005|NCT04810650|617223653|FG003|Overall Study|Moved/transferred care|0|||
170786006|NCT04810650|617223654|FG004|Overall Study|Moved/transferred care|0|||
170786007|NCT04810650|617223655|FG005|Overall Study|Moved/transferred care|0|||
170786008|NCT04810650|617223656|FG006|Overall Study|Moved/transferred care|0|||
170786009|NCT04810650|617223657|FG007|Overall Study|Moved/transferred care|1|||
170786010|NCT04810650|617223658|FG008|Overall Study|Moved/transferred care|12|||
170786011|NCT04810650|617223659|FG009|Overall Study|Moved/transferred care|10|||
170786012|NCT04810650|617223660|FG010|Overall Study|Moved/transferred care|0|||
170786013|NCT04810650|617223661|FG011|Overall Study|Moved/transferred care|0|||
170786014|NCT04810650|617223662|FG012|Overall Study|Moved/transferred care|0|||
170786015|NCT04810650|617223663|FG013|Overall Study|Moved/transferred care|0|||
170786016|NCT04810650|617223650|FG000|Overall Study|Lost to Follow-up|15|||
170786017|NCT04810650|617223651|FG001|Overall Study|Lost to Follow-up|12|||
170786018|NCT04810650|617223652|FG002|Overall Study|Lost to Follow-up|7|||
170786019|NCT04810650|617223653|FG003|Overall Study|Lost to Follow-up|9|||
170786020|NCT04810650|617223654|FG004|Overall Study|Lost to Follow-up|10|||
170786021|NCT04810650|617223655|FG005|Overall Study|Lost to Follow-up|6|||
170786022|NCT04810650|617223656|FG006|Overall Study|Lost to Follow-up|0|||
170786023|NCT04810650|617223657|FG007|Overall Study|Lost to Follow-up|0|||
170786024|NCT04810650|617223658|FG008|Overall Study|Lost to Follow-up|0|||
170786025|NCT04810650|617223659|FG009|Overall Study|Lost to Follow-up|0|||
170786026|NCT04810650|617223660|FG010|Overall Study|Lost to Follow-up|1|||
170786027|NCT04810650|617223661|FG011|Overall Study|Lost to Follow-up|0|||
170446246|NCT01796964|615972059|FG000|Overall Study|Protocol Violation|0|||
170446247|NCT01796964|615972060|FG001|Overall Study|Protocol Violation|1|||
170786028|NCT04810650|617223662|FG012|Overall Study|Lost to Follow-up|3|||
170446248|NCT01796964|615972059|FG000|Overall Study|Withdrawal by Subject|1|||
170446249|NCT01796964|615972060|FG001|Overall Study|Withdrawal by Subject|1|||
170446250|NCT04025684|615972061|FG000|Overall Study|Withdrawal by Subject|1|||
170446251|NCT04025684|615972062|FG001|Overall Study|Withdrawal by Subject|1|||
170446252|NCT04025684|615972063|FG002|Overall Study|Withdrawal by Subject|0|||
170633718|NCT00790842|616670116|FG009|Dose Level 4|Withdrawal by Subject|0|||
170786029|NCT04810650|617223663|FG013|Overall Study|Lost to Follow-up|9|||
170786030|NCT04810650|617223650|FG000|Overall Study|Participant declined|0|||
170786031|NCT04810650|617223651|FG001|Overall Study|Participant declined|0|||
170786032|NCT04810650|617223652|FG002|Overall Study|Participant declined|0|||
170446253|NCT04025684|615972064|FG003|Overall Study|Withdrawal by Subject|0|||
170446254|NCT04025684|615972061|FG000|Overall Study|Multiple reasons|1|||
170786033|NCT04810650|617223653|FG003|Overall Study|Participant declined|0|||
170786034|NCT04810650|617223654|FG004|Overall Study|Participant declined|0|||
170446255|NCT04025684|615972062|FG001|Overall Study|Multiple reasons|3|||
170446256|NCT04025684|615972063|FG002|Overall Study|Multiple reasons|0|||
170446257|NCT04025684|615972064|FG003|Overall Study|Multiple reasons|1|||
170446258|NCT01844531|615972067|FG000|Overall Study|Withdrawal by Subject|0|||
170446259|NCT01844531|615972068|FG001|Overall Study|Withdrawal by Subject|1|||
170446260|NCT01844531|615972069|FG002|Overall Study|Withdrawal by Subject|0|||
170446261|NCT01844531|615972070|FG003|Overall Study|Withdrawal by Subject|0|||
170446262|NCT01613378|615972080|FG000|Overall Study|Lack of Efficacy|13|||
170446263|NCT01613378|615972080|FG000|Overall Study|Adverse Event|11|||
170446264|NCT01613378|615972080|FG000|Overall Study|Withdrawal by Subject|8|||
170446265|NCT01613378|615972080|FG000|Overall Study|Death|2|||
170446266|NCT01613378|615972080|FG000|Overall Study|Lost to Follow-up|1|||
170446267|NCT01613378|615972080|FG000|Overall Study|Other Reason|4|||
170446268|NCT02000531|615972086|FG000|Overall Study|Lost to Follow-up|1|||
170446269|NCT02000531|615972087|FG001|Overall Study|Lost to Follow-up|0|||
170446270|NCT02000531|615972086|FG000|Overall Study|Discontinued due to data cut-off|3|||
170446271|NCT02000531|615972087|FG001|Overall Study|Discontinued due to data cut-off|8|||
170446272|NCT00794417|615972088|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
170446273|NCT00794417|615972089|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
170446274|NCT00794417|615972090|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
170446275|NCT00794417|615972091|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
170446276|NCT00794417|615972088|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
170446277|NCT00794417|615972089|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
170446278|NCT00794417|615972090|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
170446279|NCT00794417|615972091|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
170446280|NCT00794417|615972088|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
170446281|NCT00794417|615972089|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
170446282|NCT00794417|615972090|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
170446283|NCT00794417|615972091|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
170446284|NCT00794417|615972088|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
170446285|NCT00794417|615972089|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
170446286|NCT00794417|615972090|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
170446287|NCT00794417|615972091|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
170446288|NCT00794417|615972088|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
170446289|NCT00794417|615972089|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
170446290|NCT00794417|615972090|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
170446291|NCT00794417|615972091|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
170446292|NCT00794417|615972088|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
170446293|NCT00794417|615972089|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
170446294|NCT00794417|615972090|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
170446295|NCT00794417|615972091|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
170446296|NCT01345318|615972101|FG000|Overall Study|Adverse Event|16|||
170446297|NCT01345318|615972101|FG000|Overall Study|Lack of Efficacy|17|||
170446298|NCT01345318|615972101|FG000|Overall Study|Lost to Follow-up|2|||
170446299|NCT01345318|615972101|FG000|Overall Study|Protocol Violation|1|||
170446300|NCT01345318|615972101|FG000|Overall Study|Withdrawal by Subject|41|||
170446301|NCT01345318|615972101|FG000|Overall Study|Other|3|||
170446302|NCT00317642|615972102|FG000|Overall Study|Not Received Either Study Drug|1|||
170446303|NCT00317642|615972103|FG001|Overall Study|Not Received Either Study Drug|3|||
170446304|NCT00317642|615972102|FG000|Overall Study|Physician Decision|15|||
170446305|NCT00317642|615972103|FG001|Overall Study|Physician Decision|7|||
170446306|NCT00317642|615972102|FG000|Overall Study|Participant declined treatment|14|||
170446307|NCT00317642|615972103|FG001|Overall Study|Participant declined treatment|3|||
170446308|NCT00317642|615972102|FG000|Overall Study|Adverse Event|17|||
170446309|NCT00317642|615972103|FG001|Overall Study|Adverse Event|5|||
170446310|NCT00317642|615972102|FG000|Overall Study|Treatment Failure|56|||
170446311|NCT00317642|615972103|FG001|Overall Study|Treatment Failure|102|||
170446312|NCT00317642|615972102|FG000|Overall Study|Disease Recurrence|1|||
170446313|NCT00317642|615972103|FG001|Overall Study|Disease Recurrence|2|||
170446314|NCT00317642|615972102|FG000|Overall Study|Death|14|||
170539699|NCT05253807|616318424|FG001|Overall Study|Withdrawal by Subject|0|||
170786035|NCT04810650|617223655|FG005|Overall Study|Participant declined|0|||
170446315|NCT00317642|615972103|FG001|Overall Study|Death|7|||
170446316|NCT00317642|615972102|FG000|Overall Study|Not Continue to Consolidation|2|||
170446317|NCT00317642|615972103|FG001|Overall Study|Not Continue to Consolidation|0|||
170539700|NCT05253807|616318423|FG000|Overall Study|Study Terminated by Sponsor|1|||
170786036|NCT04810650|617223656|FG006|Overall Study|Participant declined|0|||
170446318|NCT00317642|615972102|FG000|Overall Study|Withdrawal by Subject|0|||
170446319|NCT00317642|615972103|FG001|Overall Study|Withdrawal by Subject|1|||
170446320|NCT00317642|615972102|FG000|Overall Study|Referred For Transplantation|1|||
170446321|NCT00317642|615972103|FG001|Overall Study|Referred For Transplantation|0|||
170446322|NCT00317642|615972102|FG000|Overall Study|AML Not Centrally Confirmed|1|||
170786037|NCT04810650|617223657|FG007|Overall Study|Participant declined|0|||
170446323|NCT00317642|615972103|FG001|Overall Study|AML Not Centrally Confirmed|5|||
170446324|NCT02225665|615972109|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
170446325|NCT02225665|615972110|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
170446326|NCT02225665|615972109|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
170446327|NCT02225665|615972110|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
170446328|NCT00608517|615972111|FG000|Overall Study|Death|1|||
170446329|NCT00608517|615972112|FG001|Overall Study|Death|0|||
170446330|NCT00608517|615972113|FG002|Overall Study|Death|0|||
170446331|NCT00572039|615972114|FG000|Overall Study|Withdrawal by Subject|9|||
170446332|NCT00572039|615972115|FG001|Overall Study|Withdrawal by Subject|6|||
170446333|NCT00572039|615972114|FG000|Overall Study|Death|2|||
170446334|NCT00572039|615972115|FG001|Overall Study|Death|3|||
170446335|NCT00572039|615972114|FG000|Overall Study|Ill|5|||
170446336|NCT00572039|615972115|FG001|Overall Study|Ill|1|||
170446337|NCT01142908|615972116|FG000|Overall Study|Lost to Follow-up|19|||
170446338|NCT01142908|615972117|FG001|Overall Study|Lost to Follow-up|13|||
170446339|NCT01142908|615972116|FG000|Overall Study|Death|1|||
170446340|NCT01142908|615972117|FG001|Overall Study|Death|4|||
170446341|NCT01142908|615972116|FG000|Overall Study|Excluded - did not meet criteria|9|||
170446342|NCT01142908|615972117|FG001|Overall Study|Excluded - did not meet criteria|5|||
170446343|NCT01142908|615972116|FG000|Overall Study|Withdrawal by Subject|3|||
170446344|NCT01142908|615972117|FG001|Overall Study|Withdrawal by Subject|0|||
170446345|NCT02001051|615972122|FG000|Overall Study|Deemed not eligible following enrollment|0|||
170446346|NCT02001051|615972123|FG001|Overall Study|Deemed not eligible following enrollment|1|||
170446347|NCT01519947|615972134|FG000|Overall Study|Death|0|||
170446348|NCT01519947|615972135|FG001|Overall Study|Death|0|||
170446349|NCT01519947|615972136|FG002|Overall Study|Death|0|||
170446350|NCT01519947|615972137|FG003|Overall Study|Death|1|||
170446351|NCT01519947|615972134|FG000|Overall Study|Protocol Violation|0|||
170446352|NCT01519947|615972135|FG001|Overall Study|Protocol Violation|0|||
170446353|NCT01519947|615972136|FG002|Overall Study|Protocol Violation|2|||
170446354|NCT01519947|615972137|FG003|Overall Study|Protocol Violation|1|||
170446355|NCT01519947|615972134|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
170446356|NCT01519947|615972135|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
170446357|NCT01519947|615972136|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
170446358|NCT01519947|615972137|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
170446359|NCT01519947|615972134|FG000|Overall Study|Development of Anemia|0|||
170539701|NCT05253807|616318424|FG001|Overall Study|Study Terminated by Sponsor|1|||
170539702|NCT03682848|616318428|FG000|Overall Study|Withdrawal by Subject|3|||
170539703|NCT03682848|616318428|FG000|Overall Study|Site closed|5|||
170539704|NCT03682848|616318428|FG000|Overall Study|Protocol Deviation|1|||
170539705|NCT03682848|616318428|FG000|Overall Study|Adverse Event|2|||
170539706|NCT03682848|616318428|FG000|Overall Study|Lack of Efficacy|1|||
170539707|NCT02872714|616318429|FG000|Overall Study|Progressive Disease|1|||
170539708|NCT02872714|616318430|FG001|Overall Study|Progressive Disease|2|||
170539709|NCT02872714|616318431|FG002|Overall Study|Progressive Disease|0|||
170539710|NCT02872714|616318432|FG003|Overall Study|Progressive Disease|0|||
170539711|NCT02872714|616318433|FG004|Overall Study|Progressive Disease|0|||
170539712|NCT02872714|616318429|FG000|Overall Study|Death|87|||
170539713|NCT02872714|616318430|FG001|Overall Study|Death|36|||
170539714|NCT02872714|616318431|FG002|Overall Study|Death|8|||
170539715|NCT02872714|616318432|FG003|Overall Study|Death|81|||
170539716|NCT02872714|616318433|FG004|Overall Study|Death|2|||
170539717|NCT02872714|616318429|FG000|Overall Study|Lost to Follow-up|2|||
170539718|NCT02872714|616318430|FG001|Overall Study|Lost to Follow-up|1|||
170539719|NCT02872714|616318431|FG002|Overall Study|Lost to Follow-up|0|||
170539720|NCT02872714|616318432|FG003|Overall Study|Lost to Follow-up|3|||
170539721|NCT02872714|616318433|FG004|Overall Study|Lost to Follow-up|0|||
170539722|NCT02872714|616318429|FG000|Overall Study|Physician Decision|0|||
170539723|NCT02872714|616318430|FG001|Overall Study|Physician Decision|0|||
170886961|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
170886962|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
170886963|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
170886964|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
170886965|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
170446360|NCT01519947|615972135|FG001|Overall Study|Development of Anemia|1|||
170446361|NCT01519947|615972136|FG002|Overall Study|Development of Anemia|0|||
170446362|NCT01519947|615972137|FG003|Overall Study|Development of Anemia|1|||
170446363|NCT01519947|615972134|FG000|Overall Study|Blood Transfusion|0|||
170446364|NCT01519947|615972135|FG001|Overall Study|Blood Transfusion|1|||
170446365|NCT01519947|615972136|FG002|Overall Study|Blood Transfusion|1|||
170446366|NCT01519947|615972137|FG003|Overall Study|Blood Transfusion|0|||
170446367|NCT01519947|615972134|FG000|Overall Study|Withdrawal by Subject|0|||
170539724|NCT02872714|616318431|FG002|Overall Study|Physician Decision|0|||
170539725|NCT02872714|616318432|FG003|Overall Study|Physician Decision|1|||
170539726|NCT02872714|616318433|FG004|Overall Study|Physician Decision|0|||
170539727|NCT02872714|616318429|FG000|Overall Study|Withdrawal by Subject|1|||
170446368|NCT01519947|615972135|FG001|Overall Study|Withdrawal by Subject|1|||
170446369|NCT01519947|615972136|FG002|Overall Study|Withdrawal by Subject|0|||
170446370|NCT01519947|615972137|FG003|Overall Study|Withdrawal by Subject|1|||
170446371|NCT01519947|615972134|FG000|Overall Study|Lost to Follow-up|0|||
170446372|NCT01519947|615972135|FG001|Overall Study|Lost to Follow-up|0|||
170446373|NCT01519947|615972136|FG002|Overall Study|Lost to Follow-up|3|||
170446374|NCT01519947|615972137|FG003|Overall Study|Lost to Follow-up|2|||
170446375|NCT01519947|615972134|FG000|Overall Study|Poor Response|1|||
170446376|NCT01519947|615972135|FG001|Overall Study|Poor Response|0|||
170446377|NCT01519947|615972136|FG002|Overall Study|Poor Response|0|||
170446378|NCT01519947|615972137|FG003|Overall Study|Poor Response|1|||
170446379|NCT01519947|615972134|FG000|Overall Study|Adverse Event|1|||
170446380|NCT01519947|615972135|FG001|Overall Study|Adverse Event|0|||
170446381|NCT01519947|615972136|FG002|Overall Study|Adverse Event|1|||
170539728|NCT02872714|616318430|FG001|Overall Study|Withdrawal by Subject|3|||
170539729|NCT02872714|616318431|FG002|Overall Study|Withdrawal by Subject|0|||
170539730|NCT02872714|616318432|FG003|Overall Study|Withdrawal by Subject|2|||
170539731|NCT02872714|616318433|FG004|Overall Study|Withdrawal by Subject|0|||
170539732|NCT02872714|616318429|FG000|Overall Study|Captured as Other|2|||
170539733|NCT02872714|616318430|FG001|Overall Study|Captured as Other|0|||
170539734|NCT02872714|616318431|FG002|Overall Study|Captured as Other|0|||
170539735|NCT02872714|616318432|FG003|Overall Study|Captured as Other|1|||
170539736|NCT02872714|616318433|FG004|Overall Study|Captured as Other|0|||
170539737|NCT03043573|616318434|FG000|Overall Study|Lost to Follow-up|3|||
170539738|NCT03043573|616318435|FG001|Overall Study|Lost to Follow-up|3|||
170539739|NCT03043573|616318434|FG000|Overall Study|Physician Decision|0|||
170539740|NCT03043573|616318435|FG001|Overall Study|Physician Decision|5|||
170539741|NCT03043573|616318434|FG000|Overall Study|Withdrawal by Subject|0|||
170539742|NCT03043573|616318435|FG001|Overall Study|Withdrawal by Subject|4|||
170539743|NCT01127061|616319462|FG000|Overall Study|Lost to Follow-up|7|||
170539744|NCT01127061|616319463|FG001|Overall Study|Lost to Follow-up|10|||
170539745|NCT01127061|616319462|FG000|Overall Study|Physician Decision|3|||
170539746|NCT01127061|616319463|FG001|Overall Study|Physician Decision|3|||
170539747|NCT00003456|616319466|FG000|Overall Study|Not evaluable|8|||
170539748|NCT00479232|616319468|FG000|Overall Study|Adverse Event|0|||
170539749|NCT00479232|616319469|FG001|Overall Study|Adverse Event|0|||
170539750|NCT00479232|616319470|FG002|Overall Study|Adverse Event|5|||
170539751|NCT00479232|616319471|FG003|Overall Study|Adverse Event|0|||
170539752|NCT00479232|616319472|FG004|Overall Study|Adverse Event|0|||
170539753|NCT00479232|616319473|FG005|Overall Study|Adverse Event|10|||
170539754|NCT00479232|616319468|FG000|Overall Study|Deviation from Protocol|0|||
170539755|NCT00479232|616319469|FG001|Overall Study|Deviation from Protocol|0|||
170539756|NCT00479232|616319470|FG002|Overall Study|Deviation from Protocol|1|||
170539757|NCT00479232|616319471|FG003|Overall Study|Deviation from Protocol|0|||
170539758|NCT00479232|616319472|FG004|Overall Study|Deviation from Protocol|0|||
170539759|NCT00479232|616319473|FG005|Overall Study|Deviation from Protocol|0|||
170539760|NCT00479232|616319468|FG000|Overall Study|Lack of Efficacy|0|||
170539761|NCT00479232|616319469|FG001|Overall Study|Lack of Efficacy|0|||
170539762|NCT00479232|616319470|FG002|Overall Study|Lack of Efficacy|2|||
170539763|NCT00479232|616319471|FG003|Overall Study|Lack of Efficacy|0|||
170539764|NCT00479232|616319472|FG004|Overall Study|Lack of Efficacy|0|||
170539765|NCT00479232|616319473|FG005|Overall Study|Lack of Efficacy|4|||
170539766|NCT00479232|616319468|FG000|Overall Study|Physician Decision|0|||
170539767|NCT00479232|616319469|FG001|Overall Study|Physician Decision|0|||
170539768|NCT00479232|616319470|FG002|Overall Study|Physician Decision|2|||
170539769|NCT00479232|616319471|FG003|Overall Study|Physician Decision|0|||
170539770|NCT00479232|616319472|FG004|Overall Study|Physician Decision|0|||
170539771|NCT00479232|616319473|FG005|Overall Study|Physician Decision|1|||
170539772|NCT00479232|616319468|FG000|Overall Study|Progressive Disease|3|||
170539773|NCT00479232|616319469|FG001|Overall Study|Progressive Disease|1|||
170446382|NCT01519947|615972137|FG003|Overall Study|Adverse Event|1|||
170539774|NCT00479232|616319470|FG002|Overall Study|Progressive Disease|12|||
170539775|NCT00479232|616319471|FG003|Overall Study|Progressive Disease|3|||
170446383|NCT04364763|615972143|FG000|Overall Study|Death|1|||
170446384|NCT04364763|615972144|FG001|Overall Study|Death|2|||
170446385|NCT04364763|615972143|FG000|Overall Study|Lost to Follow-up|1|||
170446386|NCT04364763|615972144|FG001|Overall Study|Lost to Follow-up|0|||
170446387|NCT01386125|615972147|FG000|Overall Study|Lost to Follow-up|3|||
170446388|NCT01386125|615972148|FG001|Overall Study|Lost to Follow-up|9|||
170446389|NCT01386125|615972147|FG000|Overall Study|Physician Decision|0|||
170539776|NCT00479232|616319472|FG004|Overall Study|Progressive Disease|3|||
170539777|NCT00479232|616319473|FG005|Overall Study|Progressive Disease|12|||
170539778|NCT00479232|616319468|FG000|Overall Study|Withdrew Consent|0|||
170539779|NCT00479232|616319469|FG001|Overall Study|Withdrew Consent|2|||
170539780|NCT00479232|616319470|FG002|Overall Study|Withdrew Consent|6|||
170539781|NCT00479232|616319471|FG003|Overall Study|Withdrew Consent|0|||
170539782|NCT00479232|616319472|FG004|Overall Study|Withdrew Consent|1|||
170539783|NCT00479232|616319473|FG005|Overall Study|Withdrew Consent|3|||
170539784|NCT00639379|616319480|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
170446390|NCT01386125|615972148|FG001|Overall Study|Physician Decision|1|||
170446391|NCT01386125|615972147|FG000|Overall Study|Protocol Violation|5|||
170446392|NCT01386125|615972148|FG001|Overall Study|Protocol Violation|7|||
170446393|NCT01386125|615972147|FG000|Overall Study|Disease Progress|1|||
170446394|NCT01386125|615972148|FG001|Overall Study|Disease Progress|2|||
170446395|NCT01386125|615972147|FG000|Overall Study|Withdrawal by Subject|13|||
170446396|NCT01386125|615972148|FG001|Overall Study|Withdrawal by Subject|12|||
170446397|NCT01386125|615972147|FG000|Overall Study|Adverse Event|2|||
170786038|NCT04810650|617223658|FG008|Overall Study|Participant declined|0|||
170786039|NCT04810650|617223659|FG009|Overall Study|Participant declined|0|||
170786040|NCT04810650|617223660|FG010|Overall Study|Participant declined|2|||
170786041|NCT04810650|617223661|FG011|Overall Study|Participant declined|0|||
170786042|NCT04810650|617223662|FG012|Overall Study|Participant declined|0|||
170446398|NCT01386125|615972148|FG001|Overall Study|Adverse Event|5|||
170446399|NCT01386125|615972147|FG000|Overall Study|Lack of Efficacy|0|||
170786043|NCT04810650|617223663|FG013|Overall Study|Participant declined|0|||
170786044|NCT05008835|617223664|FG000|Overall Study|Adverse Event|5|||
170786045|NCT05008835|617223665|FG001|Overall Study|Adverse Event|2|||
170786046|NCT05008835|617223666|FG002|Overall Study|Adverse Event|1|||
170786047|NCT05008835|617223664|FG000|Overall Study|Lack of Efficacy|0|||
170786048|NCT05008835|617223665|FG001|Overall Study|Lack of Efficacy|0|||
170786049|NCT05008835|617223666|FG002|Overall Study|Lack of Efficacy|1|||
170786050|NCT05008835|617223664|FG000|Overall Study|Study terminated by sponsor|0|||
170786051|NCT05008835|617223665|FG001|Overall Study|Study terminated by sponsor|0|||
170786052|NCT05008835|617223666|FG002|Overall Study|Study terminated by sponsor|1|||
170786053|NCT05008835|617223664|FG000|Overall Study|Not further specified|3|||
170786054|NCT05008835|617223665|FG001|Overall Study|Not further specified|2|||
170786055|NCT05008835|617223666|FG002|Overall Study|Not further specified|1|||
170786056|NCT04876118|617223667|FG000|Overall Study|Pregnancy|1|||
170786057|NCT04876118|617223667|FG000|Overall Study|Withdrawal by Subject|14|||
170786058|NCT02120456|617225351|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
170786059|NCT02120456|617225352|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
170786060|NCT02120456|617225353|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
170786061|NCT02120456|617225354|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
170786062|NCT02120456|617225355|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
170786063|NCT02120456|617225356|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
170786064|NCT02120456|617225357|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
170786065|NCT02120456|617225358|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
170786066|NCT02120456|617225359|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
170786067|NCT02120456|617225351|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
170786068|NCT02120456|617225352|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
170786069|NCT02120456|617225353|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
170786070|NCT02120456|617225354|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
170786071|NCT02120456|617225355|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
170786072|NCT02120456|617225356|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
170786073|NCT02120456|617225357|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
170786074|NCT02120456|617225358|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
170786075|NCT02120456|617225359|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
170786076|NCT02120456|617225351|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
170786077|NCT02120456|617225352|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
170786078|NCT02120456|617225353|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
170786079|NCT02120456|617225354|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
170786080|NCT02120456|617225355|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
170786081|NCT02120456|617225356|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
170786082|NCT02120456|617225357|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
170786083|NCT02120456|617225358|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
170786084|NCT02120456|617225359|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
170786085|NCT04347161|617225362|FG000|Overall Study|Death|0|||
170786086|NCT04347161|617225363|FG001|Overall Study|Death|2|||
170786087|NCT04347161|617225362|FG000|Overall Study|Withdrawal by Subject|1|||
170786088|NCT04347161|617225363|FG001|Overall Study|Withdrawal by Subject|0|||
170786089|NCT04347161|617225362|FG000|Overall Study|Lost to Follow-up|0|||
170786090|NCT04347161|617225363|FG001|Overall Study|Lost to Follow-up|1|||
170786091|NCT04347161|617225362|FG000|Overall Study|No longer on study medication|1|||
170786092|NCT04347161|617225363|FG001|Overall Study|No longer on study medication|1|||
170786093|NCT04896476|617225373|FG000|Overall Study|Withdrawal by Subject|1|||
170786094|NCT04896476|617225373|FG000|Overall Study|Lost to Follow-up|2|||
170786095|NCT02921230|617225376|FG000|Overall Study|Withdrawal by Subject|20|||
170786096|NCT02921230|617225377|FG001|Overall Study|Withdrawal by Subject|8|||
170786097|NCT02921230|617225376|FG000|Overall Study|Death|12|||
170786098|NCT02921230|617225377|FG001|Overall Study|Death|3|||
170786099|NCT02921230|617225376|FG000|Overall Study|Protocol Violation|17|||
170786100|NCT02921230|617225377|FG001|Overall Study|Protocol Violation|6|||
170446400|NCT01386125|615972148|FG001|Overall Study|Lack of Efficacy|1|||
170446401|NCT01386125|615972147|FG000|Overall Study|Participant Leaving Country|1|||
170539785|NCT00639379|616319481|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
170539786|NCT00639379|616319480|FG000|Period 1 - 2 Weeks|lens issue|3|||
170539787|NCT00639379|616319481|FG001|Period 1 - 2 Weeks|lens issue|0|||
170539788|NCT01797185|616319486|FG000|Overall Study|Adverse Event|5|||
170539789|NCT01797185|616319487|FG001|Overall Study|Adverse Event|15|||
170539790|NCT01797185|616319488|FG002|Overall Study|Adverse Event|6|||
170539791|NCT01797185|616319486|FG000|Overall Study|Withdrawal by Subject|6|||
170539792|NCT01797185|616319487|FG001|Overall Study|Withdrawal by Subject|9|||
170539793|NCT01797185|616319488|FG002|Overall Study|Withdrawal by Subject|5|||
170539794|NCT01797185|616319486|FG000|Overall Study|Site terminated|8|||
170539795|NCT01797185|616319487|FG001|Overall Study|Site terminated|4|||
170539796|NCT01797185|616319488|FG002|Overall Study|Site terminated|0|||
170539797|NCT01797185|616319486|FG000|Overall Study|Lost to Follow-up|2|||
170539798|NCT01797185|616319487|FG001|Overall Study|Lost to Follow-up|6|||
170539799|NCT01797185|616319488|FG002|Overall Study|Lost to Follow-up|1|||
170539800|NCT01797185|616319486|FG000|Overall Study|Withdrawn per sponsor|5|||
170539801|NCT01797185|616319487|FG001|Overall Study|Withdrawn per sponsor|0|||
170539802|NCT01797185|616319488|FG002|Overall Study|Withdrawn per sponsor|0|||
170539803|NCT01797185|616319486|FG000|Overall Study|Physician Decision|1|||
170539804|NCT01797185|616319487|FG001|Overall Study|Physician Decision|3|||
170539805|NCT01797185|616319488|FG002|Overall Study|Physician Decision|0|||
170539806|NCT01797185|616319486|FG000|Overall Study|Protocol Violation|1|||
170539807|NCT01797185|616319487|FG001|Overall Study|Protocol Violation|1|||
170539808|NCT01797185|616319488|FG002|Overall Study|Protocol Violation|0|||
170539809|NCT01991314|616319506|FG000|Overall Study|Adverse Event|5|||
170539810|NCT01991314|616319507|FG001|Overall Study|Adverse Event|1|||
170539811|NCT01991314|616319506|FG000|Overall Study|Lost to Follow-up|6|||
170539812|NCT01991314|616319507|FG001|Overall Study|Lost to Follow-up|10|||
170539813|NCT02008370|616319509|FG000|Overall Study|Lost to Follow-up|7|||
170539814|NCT02260986|616319510|FG000|Overall Study|Adverse Event|24|||
170539815|NCT02260986|616319511|FG001|Overall Study|Adverse Event|0|||
170539816|NCT02260986|616319512|FG002|Overall Study|Adverse Event|11|||
170539817|NCT02260986|616319510|FG000|Overall Study|Lack of Efficacy|27|||
170539818|NCT02260986|616319511|FG001|Overall Study|Lack of Efficacy|3|||
170539819|NCT02260986|616319512|FG002|Overall Study|Lack of Efficacy|0|||
170539820|NCT02260986|616319510|FG000|Overall Study|Protocol Violation|14|||
170539821|NCT02260986|616319511|FG001|Overall Study|Protocol Violation|5|||
170539822|NCT02260986|616319512|FG002|Overall Study|Protocol Violation|16|||
170539823|NCT02260986|616319510|FG000|Overall Study|Car accident|0|||
170539824|NCT02260986|616319511|FG001|Overall Study|Car accident|0|||
170539825|NCT02260986|616319512|FG002|Overall Study|Car accident|1|||
170539826|NCT02260986|616319510|FG000|Overall Study|Withdrawal by Subject|17|||
170539827|NCT02260986|616319511|FG001|Overall Study|Withdrawal by Subject|4|||
170539828|NCT02260986|616319512|FG002|Overall Study|Withdrawal by Subject|9|||
170539829|NCT02260986|616319510|FG000|Overall Study|Incorrect randomization|0|||
170539830|NCT02260986|616319511|FG001|Overall Study|Incorrect randomization|1|||
170539831|NCT02260986|616319512|FG002|Overall Study|Incorrect randomization|0|||
170539832|NCT02260986|616319510|FG000|Overall Study|Lack of investigation product supply|2|||
170539833|NCT02260986|616319511|FG001|Overall Study|Lack of investigation product supply|0|||
170539834|NCT02260986|616319512|FG002|Overall Study|Lack of investigation product supply|1|||
170539835|NCT02260986|616319510|FG000|Overall Study|Lost to Follow-up|4|||
170786101|NCT02921230|617225376|FG000|Overall Study|Early completion|5|||
170786102|NCT02921230|617225377|FG001|Overall Study|Early completion|1|||
170786103|NCT02921230|617225376|FG000|Overall Study|Pending data entry|1|||
170786104|NCT02921230|617225377|FG001|Overall Study|Pending data entry|0|||
170786105|NCT04977947|617225378|FG000|Overall Study|Lost to Follow-up|1|||
170786106|NCT04977947|617225379|FG001|Overall Study|Lost to Follow-up|1|||
170786107|NCT04142788|617225394|FG000|Overall Study|Trial terminated prematurely|2|||
170786108|NCT04142788|617225395|FG001|Overall Study|Trial terminated prematurely|2|||
170786109|NCT02913872|617225398|FG000|Overall Study|Withdrawal by Subject|1|||
170539836|NCT02260986|616319511|FG001|Overall Study|Lost to Follow-up|0|||
170539837|NCT02260986|616319512|FG002|Overall Study|Lost to Follow-up|3|||
170539838|NCT02260986|616319510|FG000|Overall Study|Pregnancy|2|||
170539839|NCT02260986|616319511|FG001|Overall Study|Pregnancy|0|||
170539840|NCT02260986|616319512|FG002|Overall Study|Pregnancy|0|||
170786110|NCT03853746|617225405|FG000|Overall Study|Withdrawal by Subject|1|||
170786111|NCT01396278|617225406|FG000|Overall Study|Adverse Event|0|||
170539841|NCT01481779|616319514|FG000|Overall Study|Adverse Event|23|||
170539842|NCT01481779|616319515|FG001|Overall Study|Adverse Event|5|||
170786112|NCT01396278|617225407|FG001|Overall Study|Adverse Event|0|||
170786113|NCT01396278|617225408|FG002|Overall Study|Adverse Event|0|||
170539843|NCT01481779|616319514|FG000|Overall Study|Lost to Follow-up|3|||
170539844|NCT01481779|616319515|FG001|Overall Study|Lost to Follow-up|2|||
170539845|NCT01481779|616319514|FG000|Overall Study|Protocol Violation|2|||
170539846|NCT01481779|616319515|FG001|Overall Study|Protocol Violation|3|||
170539847|NCT01481779|616319514|FG000|Overall Study|Withdrawal by Subject|26|||
170539848|NCT01481779|616319515|FG001|Overall Study|Withdrawal by Subject|13|||
170539849|NCT01481779|616319514|FG000|Overall Study|Physician Decision|13|||
170539850|NCT01481779|616319515|FG001|Overall Study|Physician Decision|4|||
170446402|NCT01386125|615972148|FG001|Overall Study|Participant Leaving Country|0|||
170446403|NCT01098539|615972149|FG000|Overall Study|Adverse Event|26|||
170446404|NCT01098539|615972150|FG001|Overall Study|Adverse Event|26|||
170446405|NCT01098539|615972149|FG000|Overall Study|Protocol Violation|1|||
170446406|NCT01098539|615972150|FG001|Overall Study|Protocol Violation|4|||
170446407|NCT01098539|615972149|FG000|Overall Study|Noncompliance|3|||
170446408|NCT01098539|615972150|FG001|Overall Study|Noncompliance|5|||
170446409|NCT01098539|615972149|FG000|Overall Study|Lost to Follow-up|4|||
170446410|NCT01098539|615972150|FG001|Overall Study|Lost to Follow-up|4|||
170446411|NCT01098539|615972149|FG000|Overall Study|Withdrawal by Subject|12|||
170446412|NCT01098539|615972150|FG001|Overall Study|Withdrawal by Subject|26|||
170446413|NCT01098539|615972149|FG000|Overall Study|Physician Decision|5|||
170446414|NCT01098539|615972150|FG001|Overall Study|Physician Decision|3|||
170446415|NCT02508116|615972153|FG000|Overall Study|Lost to Follow-up|2|||
170446416|NCT02508116|615972154|FG001|Overall Study|Lost to Follow-up|3|||
170446417|NCT02508116|615972153|FG000|Overall Study|Withdrawal by Subject|3|||
170446418|NCT02508116|615972154|FG001|Overall Study|Withdrawal by Subject|2|||
170446419|NCT02508116|615972153|FG000|Overall Study|Protocol Violation|1|||
170446420|NCT02508116|615972154|FG001|Overall Study|Protocol Violation|2|||
170446421|NCT02508116|615972153|FG000|Overall Study|Physician Decision|2|||
170446422|NCT02508116|615972154|FG001|Overall Study|Physician Decision|0|||
170446423|NCT03712124|615972157|FG000|Overall Study|Protocol Violation|1|||
170446424|NCT03712124|615972158|FG001|Overall Study|Protocol Violation|0|||
170446425|NCT04314843|615972159|FG000|Overall Study|Death|2|||
170446426|NCT04314843|615972160|FG001|Overall Study|Death|2|||
170446427|NCT04314843|615972159|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
170446428|NCT04314843|615972160|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
170446429|NCT00346164|615972161|FG000|Overall Study|Adverse Event|0|||
170446430|NCT00346164|615972162|FG001|Overall Study|Adverse Event|0|||
170446431|NCT00346164|615972163|FG002|Overall Study|Adverse Event|0|||
170446432|NCT00346164|615972164|FG003|Overall Study|Adverse Event|1|||
170446433|NCT00346164|615972161|FG000|Overall Study|Lack of Efficacy|0|||
170446434|NCT00346164|615972162|FG001|Overall Study|Lack of Efficacy|1|||
170446435|NCT00346164|615972163|FG002|Overall Study|Lack of Efficacy|7|||
170446436|NCT00346164|615972164|FG003|Overall Study|Lack of Efficacy|25|||
170446437|NCT00346164|615972161|FG000|Overall Study|Physician Decision|0|||
170446438|NCT00346164|615972162|FG001|Overall Study|Physician Decision|1|||
170446439|NCT00346164|615972163|FG002|Overall Study|Physician Decision|2|||
170446440|NCT00346164|615972164|FG003|Overall Study|Physician Decision|27|||
170446441|NCT00346164|615972161|FG000|Overall Study|Protocol Violation|6|||
170446442|NCT00346164|615972162|FG001|Overall Study|Protocol Violation|2|||
170446443|NCT00346164|615972163|FG002|Overall Study|Protocol Violation|10|||
170446444|NCT00346164|615972164|FG003|Overall Study|Protocol Violation|4|||
170446445|NCT00346164|615972161|FG000|Overall Study|Withdrawal by Subject|0|||
170446446|NCT00346164|615972162|FG001|Overall Study|Withdrawal by Subject|0|||
170446447|NCT00346164|615972163|FG002|Overall Study|Withdrawal by Subject|2|||
170446448|NCT00346164|615972164|FG003|Overall Study|Withdrawal by Subject|0|||
170446449|NCT00346164|615972161|FG000|Overall Study|Ineligible|11|||
170446450|NCT00346164|615972162|FG001|Overall Study|Ineligible|2|||
170446451|NCT00346164|615972163|FG002|Overall Study|Ineligible|2|||
170446452|NCT00346164|615972164|FG003|Overall Study|Ineligible|23|||
170446453|NCT00346164|615972161|FG000|Overall Study|Refusal of further protocol therapy|0|||
170446454|NCT00346164|615972162|FG001|Overall Study|Refusal of further protocol therapy|1|||
170446455|NCT00346164|615972163|FG002|Overall Study|Refusal of further protocol therapy|3|||
170446456|NCT00346164|615972164|FG003|Overall Study|Refusal of further protocol therapy|15|||
170446457|NCT00346164|615972161|FG000|Overall Study|Inability to start week 16 tx on time|0|||
170446458|NCT00346164|615972162|FG001|Overall Study|Inability to start week 16 tx on time|0|||
170446459|NCT00346164|615972163|FG002|Overall Study|Inability to start week 16 tx on time|0|||
170446460|NCT00346164|615972164|FG003|Overall Study|Inability to start week 16 tx on time|11|||
170446461|NCT01263561|615972165|FG000|Overall Study|Death|1|||
170446462|NCT01263561|615972166|FG001|Overall Study|Death|2|||
170446463|NCT00879684|615972167|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
170446464|NCT00879684|615972168|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
170446465|NCT00879684|615972169|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
170446466|NCT00879684|615972170|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
170446467|NCT00879684|615972171|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
170446468|NCT00879684|615972172|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
170446469|NCT00879684|615972173|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
170446470|NCT00879684|615972167|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
170446471|NCT00879684|615972168|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
170446472|NCT00879684|615972169|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
170446473|NCT00879684|615972170|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
170446474|NCT00879684|615972171|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
170446475|NCT00879684|615972172|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
170446476|NCT00879684|615972173|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
170446477|NCT00879684|615972167|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
170539851|NCT01481779|616319514|FG000|Overall Study|Sponsor Decision|3|||
170446478|NCT00879684|615972168|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
170446479|NCT00879684|615972169|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
170446480|NCT00879684|615972170|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
170446481|NCT00879684|615972171|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
170446482|NCT00879684|615972172|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
170446483|NCT00879684|615972173|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
170446484|NCT00879684|615972167|FG000|Stage 1: Dose Escalation|Death|0|||
170446485|NCT00879684|615972168|FG001|Stage 1: Dose Escalation|Death|0|||
170446486|NCT00879684|615972169|FG002|Stage 1: Dose Escalation|Death|1|||
170446487|NCT00879684|615972170|FG003|Stage 1: Dose Escalation|Death|0|||
170446488|NCT00879684|615972171|FG004|Stage 1: Dose Escalation|Death|0|||
170446489|NCT00879684|615972172|FG005|Stage 1: Dose Escalation|Death|0|||
170446490|NCT00879684|615972173|FG006|Stage 1: Dose Escalation|Death|0|||
170446491|NCT00879684|615972167|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
170446492|NCT00879684|615972168|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
170446493|NCT00879684|615972169|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
170446494|NCT00879684|615972170|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
170446495|NCT00879684|615972171|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
170446496|NCT00879684|615972172|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
170446497|NCT00879684|615972173|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
170446498|NCT00879684|615972167|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
170446499|NCT00879684|615972168|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
170446500|NCT00879684|615972169|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
170446501|NCT00879684|615972170|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
170446502|NCT00879684|615972171|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
170446503|NCT00879684|615972172|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
170446504|NCT00879684|615972173|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
170446505|NCT00879684|615972167|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
170446506|NCT00879684|615972168|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
170446507|NCT00879684|615972169|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
170446508|NCT00879684|615972170|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
170446509|NCT00879684|615972171|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
170446510|NCT00879684|615972172|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
170446511|NCT00879684|615972173|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
170446512|NCT00104247|615972176|FG000|Overall Study|Withdrawal by Subject|1|||
170446513|NCT00104247|615972177|FG001|Overall Study|Withdrawal by Subject|0|||
170446514|NCT00104247|615972176|FG000|Overall Study|Noncompliant with dosing|0|||
170446515|NCT00104247|615972177|FG001|Overall Study|Noncompliant with dosing|1|||
170446516|NCT03314662|615972178|FG000|Overall Study|Withdrawal by Subject|1|||
170446517|NCT03314662|615972179|FG001|Overall Study|Withdrawal by Subject|1|||
170446518|NCT03314662|615972180|FG002|Overall Study|Withdrawal by Subject|1|||
170446519|NCT03314662|615972178|FG000|Overall Study|Lost to Follow-up|5|||
170446520|NCT03314662|615972179|FG001|Overall Study|Lost to Follow-up|4|||
170446521|NCT03314662|615972180|FG002|Overall Study|Lost to Follow-up|4|||
170446522|NCT03314662|615972178|FG000|Overall Study|Death|2|||
170446523|NCT03314662|615972179|FG001|Overall Study|Death|0|||
170446524|NCT03314662|615972180|FG002|Overall Study|Death|0|||
170446525|NCT00925301|615972181|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
170446526|NCT00925301|615972182|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
170446527|NCT00925301|615972183|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
170446528|NCT00925301|615972184|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
170446529|NCT00925301|615972181|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
170446530|NCT00925301|615972182|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
170446531|NCT00925301|615972183|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
170446532|NCT00925301|615972184|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
170446533|NCT00925301|615972181|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
170446534|NCT00925301|615972182|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
170446535|NCT00925301|615972183|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
170446536|NCT00925301|615972184|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
170446537|NCT00925301|615972181|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
170446538|NCT00925301|615972182|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
170446539|NCT00925301|615972183|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
170446540|NCT00925301|615972184|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
170446541|NCT00925301|615972181|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
170446542|NCT00925301|615972182|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
170446543|NCT00925301|615972183|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
170446544|NCT00925301|615972184|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
170446545|NCT00925301|615972181|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
170446546|NCT00925301|615972182|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
170446547|NCT00925301|615972183|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
170539852|NCT01481779|616319515|FG001|Overall Study|Sponsor Decision|1|||
170539853|NCT02447029|616319516|FG000|Overall Study|Withdrawal by Subject|3|||
170539854|NCT02447029|616319517|FG001|Overall Study|Withdrawal by Subject|2|||
170539855|NCT00549328|616319519|FG000|Overall Study|Adverse Event|2|||
170539856|NCT00549328|616319519|FG000|Overall Study|Disease Progression|10|||
170539857|NCT00549328|616319519|FG000|Overall Study|Death|1|||
170539858|NCT00549328|616319519|FG000|Overall Study|Use of Prohibited Medication|1|||
170539859|NCT04868682|616319525|FG000|Post-treatment|Lost to Follow-up|1|||
170539860|NCT04868682|616319526|FG001|Post-treatment|Lost to Follow-up|1|||
170539861|NCT04868682|616319525|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
170539862|NCT04868682|616319526|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
170539863|NCT04868682|616319525|FG000|Six-month Assessment|Lost to Follow-up|1|||
170539864|NCT04868682|616319526|FG001|Six-month Assessment|Lost to Follow-up|0|||
170539865|NCT04868682|616319525|FG000|Six-month Assessment|Death|1|||
170539866|NCT04868682|616319526|FG001|Six-month Assessment|Death|0|||
170539867|NCT04868682|616319525|FG000|Six-month Assessment|Refused|0|||
170539868|NCT04868682|616319526|FG001|Six-month Assessment|Refused|1|||
170539869|NCT04868682|616319525|FG000|12-month Assessment|Lost to Follow-up|2|||
170539870|NCT04868682|616319526|FG001|12-month Assessment|Lost to Follow-up|1|||
170539871|NCT04868682|616319525|FG000|12-month Assessment|Death|0|||
170539872|NCT04868682|616319526|FG001|12-month Assessment|Death|1|||
170539873|NCT02202616|616319530|FG000|Overall Study|Screen failed|24|||
170539874|NCT02202616|616319530|FG000|Overall Study|Adverse Event|32|||
170539875|NCT02202616|616319530|FG000|Overall Study|Protocol deviation|18|||
170539876|NCT02202616|616319530|FG000|Overall Study|Patient withdrew consent|12|||
170539877|NCT02202616|616319530|FG000|Overall Study|Lost to Follow-up|6|||
170539878|NCT02202616|616319530|FG000|Overall Study|Administrative problems|6|||
170539879|NCT02202616|616319530|FG000|Overall Study|Abnormal test procedure result|1|||
170539880|NCT02202616|616319530|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170539881|NCT01044498|616319532|FG000|Overall Study|Withdrew consent|1|||
170539882|NCT01044498|616319533|FG001|Overall Study|Withdrew consent|1|||
170539883|NCT01044498|616319532|FG000|Overall Study|Adverse Event|1|||
170539884|NCT01044498|616319533|FG001|Overall Study|Adverse Event|1|||
170539885|NCT01044498|616319532|FG000|Overall Study|Other|1|||
170539886|NCT01044498|616319533|FG001|Overall Study|Other|0|||
170539887|NCT04225039|616319535|FG000|Overall Study|Withdrawal by Subject|1|||
170539888|NCT04225039|616319536|FG001|Overall Study|Withdrawal by Subject|0|||
170539889|NCT04225039|616319537|FG002|Overall Study|Withdrawal by Subject|0|||
170539890|NCT04225039|616319538|FG003|Overall Study|Withdrawal by Subject|1|||
170539891|NCT04225039|616319535|FG000|Overall Study|Currently active on study treatment|0|||
170539892|NCT04225039|616319536|FG001|Overall Study|Currently active on study treatment|1|||
170539893|NCT04225039|616319537|FG002|Overall Study|Currently active on study treatment|0|||
170539894|NCT04225039|616319538|FG003|Overall Study|Currently active on study treatment|0|||
170446548|NCT00925301|615972184|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
170446549|NCT00925301|615972181|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
170446550|NCT00925301|615972182|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
170446551|NCT00925301|615972183|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
170446552|NCT00925301|615972184|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
170446553|NCT01117766|615972185|FG000|First Intervention|Adverse Event|0|||
170446554|NCT01117766|615972186|FG001|First Intervention|Adverse Event|1|||
170446555|NCT01117766|615972185|FG000|First Intervention|Protocol Violation|1|||
170446556|NCT01117766|615972186|FG001|First Intervention|Protocol Violation|0|||
170446557|NCT01117766|615972185|FG000|Washout Period|Protocol Violation|0|||
170446558|NCT01117766|615972186|FG001|Washout Period|Protocol Violation|2|||
170446559|NCT01117766|615972185|FG000|Second Intervention|Lost to Follow-up|1|||
170446560|NCT01117766|615972186|FG001|Second Intervention|Lost to Follow-up|0|||
170446561|NCT01117766|615972185|FG000|Second Intervention|Other|1|||
170446562|NCT01117766|615972186|FG001|Second Intervention|Other|2|||
170446563|NCT01117766|615972185|FG000|Second Intervention|Adverse Event|0|||
170446564|NCT01117766|615972186|FG001|Second Intervention|Adverse Event|2|||
170446565|NCT01117766|615972185|FG000|Second Intervention|Withdrawal by Subject|0|||
170446566|NCT01117766|615972186|FG001|Second Intervention|Withdrawal by Subject|1|||
170446567|NCT04405739|615972187|FG000|Overall Study|Adverse Event|0|||
170446568|NCT04405739|615972188|FG001|Overall Study|Adverse Event|1|||
170446569|NCT04405739|615972189|FG002|Overall Study|Adverse Event|0|||
170446570|NCT04405739|615972190|FG003|Overall Study|Adverse Event|0|||
170446571|NCT04405739|615972187|FG000|Overall Study|Lost to Follow-up|0|||
170446572|NCT04405739|615972188|FG001|Overall Study|Lost to Follow-up|2|||
170446573|NCT04405739|615972189|FG002|Overall Study|Lost to Follow-up|1|||
170446574|NCT04405739|615972190|FG003|Overall Study|Lost to Follow-up|3|||
170446575|NCT04405739|615972187|FG000|Overall Study|Withdrawal by Subject|0|||
170446576|NCT04405739|615972188|FG001|Overall Study|Withdrawal by Subject|2|||
170539895|NCT04225039|616319535|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
170539896|NCT04225039|616319536|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
170539897|NCT04225039|616319537|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
170539898|NCT04225039|616319538|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
170539899|NCT04225039|616319535|FG000|Overall Study|Ineligible for treatment|0|||
170539900|NCT04225039|616319536|FG001|Overall Study|Ineligible for treatment|0|||
170539901|NCT04225039|616319537|FG002|Overall Study|Ineligible for treatment|0|||
170539902|NCT04225039|616319538|FG003|Overall Study|Ineligible for treatment|4|||
170539903|NCT05523297|616319539|FG000|Overall Study|Death|7|||
170539904|NCT05523297|616319540|FG001|Overall Study|Death|8|||
170539905|NCT05523297|616319539|FG000|Overall Study|Lost to Follow-up|2|||
170539906|NCT05523297|616319540|FG001|Overall Study|Lost to Follow-up|1|||
170539907|NCT00325416|616319543|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
170539908|NCT00325416|616319544|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
170539909|NCT00325416|616319543|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
170539910|NCT00325416|616319544|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
170539911|NCT00325416|616319543|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
170539912|NCT00325416|616319544|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
170539913|NCT00325416|616319543|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
170786114|NCT01396278|617225409|FG003|Overall Study|Adverse Event|2|||
170539914|NCT00325416|616319544|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
170539915|NCT00325416|616319543|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
170539916|NCT00325416|616319544|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
170539917|NCT00325416|616319543|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
170539918|NCT00325416|616319544|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
170539919|NCT06239610|616319545|FG000|Overall Study|no usable migration data for minimum of one day|11|||
170539920|NCT02406612|616319546|FG000|Overall Study|Screening Failure|3|||
170539921|NCT02406612|616319547|FG001|Overall Study|Screening Failure|0|||
170539922|NCT02406612|616319546|FG000|Overall Study|Intra-procedural Exclusion|1|||
170539923|NCT02406612|616319547|FG001|Overall Study|Intra-procedural Exclusion|3|||
170539924|NCT02406612|616319546|FG000|Overall Study|Guidewire Failure|0|||
170539925|NCT02406612|616319547|FG001|Overall Study|Guidewire Failure|1|||
170539926|NCT02916771|616319548|FG000|Overall Study|Withdrawal by Subject|9|||
170539927|NCT02916771|616319548|FG000|Overall Study|Physician Decision|1|||
170539928|NCT02916771|616319548|FG000|Overall Study|Began treatment for another active malignancy|1|||
170539929|NCT03069989|616319549|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
170539930|NCT03069989|616319550|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
170539931|NCT02337686|616319551|FG000|Overall Study|Adverse Event|1|||
170633719|NCT00790842|616670117|FG010|Dose Level 4|Withdrawal by Subject|1|||
170633720|NCT00790842|616670107|FG000|Expansion Cohort|Adverse Event|0|||
170633721|NCT00790842|616670108|FG001|Expansion Cohort|Adverse Event|0|||
170633722|NCT00790842|616670109|FG002|Expansion Cohort|Adverse Event|0|||
170633723|NCT00790842|616670110|FG003|Expansion Cohort|Adverse Event|0|||
170633724|NCT00790842|616670111|FG004|Expansion Cohort|Adverse Event|0|||
170633725|NCT00790842|616670112|FG005|Expansion Cohort|Adverse Event|0|||
170786115|NCT01396278|617225410|FG004|Overall Study|Adverse Event|0|||
170539940|NCT03921541|616320691|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
170539941|NCT03921541|616320692|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
170539942|NCT00182637|616320693|FG000|Overall Study|Adverse Event|2|||
170539943|NCT00182637|616320693|FG000|Overall Study|Disease Progression|1|||
170539944|NCT00420407|616320694|FG000|Overall Study|Lost to Follow-up|0|||
170539945|NCT00420407|616320695|FG001|Overall Study|Lost to Follow-up|3|||
170539946|NCT00420407|616320694|FG000|Overall Study|Physician Decision|2|||
170539947|NCT00420407|616320695|FG001|Overall Study|Physician Decision|1|||
170539948|NCT00420407|616320694|FG000|Overall Study|subject identified as detainee|1|||
170539949|NCT00420407|616320695|FG001|Overall Study|subject identified as detainee|0|||
170539950|NCT00420407|616320694|FG000|Overall Study|subject identified as Jehovah's witness|1|||
170539951|NCT00420407|616320695|FG001|Overall Study|subject identified as Jehovah's witness|0|||
170786116|NCT01396278|617225406|FG000|Overall Study|Withdraw due to trial termination|2|||
170786117|NCT01396278|617225407|FG001|Overall Study|Withdraw due to trial termination|1|||
170786118|NCT01396278|617225408|FG002|Overall Study|Withdraw due to trial termination|1|||
170786119|NCT01396278|617225409|FG003|Overall Study|Withdraw due to trial termination|0|||
170786120|NCT01396278|617225410|FG004|Overall Study|Withdraw due to trial termination|2|||
170786121|NCT04727554|617225412|FG000|Overall Study|Lost to Follow-up|0|||
170786122|NCT04727554|617225413|FG001|Overall Study|Lost to Follow-up|1|||
170786123|NCT04727554|617225412|FG000|Overall Study|Death|2|||
170786124|NCT04727554|617225413|FG001|Overall Study|Death|6|||
170786125|NCT04727554|617225412|FG000|Overall Study|Withdrawal by Subject|1|||
170786126|NCT04727554|617225413|FG001|Overall Study|Withdrawal by Subject|0|||
170786127|NCT05763823|617225414|FG000|Overall Study|Death|6|||
170786128|NCT05763823|617225414|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170786129|NCT05763823|617225414|FG000|Overall Study|Withdrawal by Subject|6|||
170539952|NCT00420407|616320694|FG000|Overall Study|Withdrawal by Subject|0|||
170539953|NCT00420407|616320695|FG001|Overall Study|Withdrawal by Subject|2|||
170446577|NCT04405739|615972189|FG002|Overall Study|Withdrawal by Subject|1|||
170446578|NCT04405739|615972190|FG003|Overall Study|Withdrawal by Subject|1|||
170446579|NCT04405739|615972187|FG000|Overall Study|Death|0|||
170446580|NCT04405739|615972188|FG001|Overall Study|Death|0|||
170446581|NCT04405739|615972189|FG002|Overall Study|Death|1|||
170446582|NCT04405739|615972190|FG003|Overall Study|Death|0|||
170446583|NCT04405739|615972187|FG000|Overall Study|Transferred to rehab|0|||
170446584|NCT04405739|615972188|FG001|Overall Study|Transferred to rehab|0|||
170446585|NCT04405739|615972189|FG002|Overall Study|Transferred to rehab|0|||
170446586|NCT04405739|615972190|FG003|Overall Study|Transferred to rehab|1|||
170446587|NCT04405739|615972187|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
170446588|NCT04405739|615972188|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
170446589|NCT04405739|615972189|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
170446590|NCT04405739|615972190|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
170446591|NCT05766787|615972191|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
170446592|NCT05766787|615972192|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
170446593|NCT05766787|615972191|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
170446594|NCT05766787|615972192|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
170446595|NCT05766787|615972191|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
170446596|NCT05766787|615972192|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
170446597|NCT01867606|615972193|FG000|Overall Study|Withdrawal by Subject|10|||
170446598|NCT01867606|615972194|FG001|Overall Study|Withdrawal by Subject|14|||
170446599|NCT01867606|615972193|FG000|Overall Study|Protocol Violation|0|||
170446600|NCT01867606|615972194|FG001|Overall Study|Protocol Violation|1|||
170446601|NCT01378962|615972195|FG000|Overall Study|Death|14|||
170446602|NCT01378962|615972195|FG000|Overall Study|Lost to Follow-up|1|||
170446603|NCT01378962|615972195|FG000|Overall Study|Other|2|||
170446604|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
170446605|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
170446606|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
170446607|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
170446608|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
170446609|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
170446610|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
170446611|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
170446612|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
170446613|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
170446614|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
170446615|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
170446616|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
170446617|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
170446618|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
170446619|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
170446620|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
170446621|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
170446622|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
170446623|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
170446624|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
170446625|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
170446626|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
170446627|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
170446628|NCT01435928|615972197|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
170446629|NCT01435928|615972198|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
170446630|NCT01435928|615972199|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
170446631|NCT01435928|615972197|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
170446632|NCT01435928|615972198|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
170446633|NCT01435928|615972199|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
170446634|NCT01435928|615972197|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
170446635|NCT01435928|615972198|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
170446636|NCT01435928|615972199|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
170446637|NCT01435928|615972197|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
170446638|NCT01435928|615972198|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
170446639|NCT01435928|615972199|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
170446640|NCT01435928|615972197|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
170446641|NCT01435928|615972198|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
170446642|NCT01435928|615972199|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
170446643|NCT01435928|615972197|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
170446644|NCT01435928|615972198|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
170446645|NCT01435928|615972199|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
170786130|NCT00999804|617225415|FG000|Overall Study|Lack of Efficacy|9|||
170633726|NCT00790842|616670113|FG006|Expansion Cohort|Adverse Event|1|||
170446646|NCT01435928|615972197|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
170446647|NCT01435928|615972198|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
170633727|NCT00790842|616670114|FG007|Expansion Cohort|Adverse Event|0|||
170633728|NCT00790842|616670115|FG008|Expansion Cohort|Adverse Event|0|||
170633729|NCT00790842|616670116|FG009|Expansion Cohort|Adverse Event|0|||
170633730|NCT00790842|616670117|FG010|Expansion Cohort|Adverse Event|0|||
170633731|NCT00790842|616670107|FG000|Expansion Cohort|Death|0|||
170633732|NCT00790842|616670108|FG001|Expansion Cohort|Death|0|||
170633733|NCT00790842|616670109|FG002|Expansion Cohort|Death|2|||
170633734|NCT00790842|616670110|FG003|Expansion Cohort|Death|0|||
170633735|NCT00790842|616670111|FG004|Expansion Cohort|Death|0|||
170633736|NCT00790842|616670112|FG005|Expansion Cohort|Death|0|||
170633737|NCT00790842|616670113|FG006|Expansion Cohort|Death|0|||
170633738|NCT00790842|616670114|FG007|Expansion Cohort|Death|0|||
170633739|NCT00790842|616670115|FG008|Expansion Cohort|Death|0|||
170633740|NCT00790842|616670116|FG009|Expansion Cohort|Death|0|||
170633741|NCT00790842|616670117|FG010|Expansion Cohort|Death|0|||
170446648|NCT01435928|615972199|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
170446649|NCT01435928|615972197|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
170446650|NCT01435928|615972198|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
170446651|NCT01435928|615972199|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
170446652|NCT01634854|615972200|FG000|Overall Study|Cesarean delivery|2|||
170446653|NCT01634854|615972201|FG001|Overall Study|Cesarean delivery|7|||
170446654|NCT00739973|615972202|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
170446655|NCT00739973|615972203|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
170446656|NCT00739973|615972204|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
170446657|NCT00739973|615972205|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
170446658|NCT00739973|615972206|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
170446659|NCT00739973|615972207|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
170446660|NCT00739973|615972208|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
170446661|NCT00739973|615972209|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
170446662|NCT00739973|615972210|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
170446663|NCT00739973|615972202|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
170446664|NCT00739973|615972203|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
170446665|NCT00739973|615972204|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
170446666|NCT00739973|615972205|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
170446667|NCT00739973|615972206|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
170446668|NCT00739973|615972207|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
170446669|NCT00739973|615972208|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
170446670|NCT00739973|615972209|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
170539954|NCT04633447|616320698|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
170539955|NCT04633447|616320699|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
170539956|NCT04633447|616320698|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
170539957|NCT04633447|616320699|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
170539958|NCT04633447|616320698|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
170539959|NCT04633447|616320699|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
170539960|NCT04633447|616320698|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
170539961|NCT04633447|616320699|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
170539962|NCT04633447|616320698|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
170539963|NCT04633447|616320699|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
170633742|NCT00790842|616670107|FG000|Expansion Cohort|Physician Decision|0|||
170633743|NCT00790842|616670108|FG001|Expansion Cohort|Physician Decision|0|||
170633744|NCT00790842|616670109|FG002|Expansion Cohort|Physician Decision|1|||
170633745|NCT00790842|616670110|FG003|Expansion Cohort|Physician Decision|0|||
170633746|NCT00790842|616670111|FG004|Expansion Cohort|Physician Decision|0|||
170633747|NCT00790842|616670112|FG005|Expansion Cohort|Physician Decision|0|||
170633748|NCT00790842|616670113|FG006|Expansion Cohort|Physician Decision|0|||
170633749|NCT00790842|616670114|FG007|Expansion Cohort|Physician Decision|0|||
170633750|NCT00790842|616670115|FG008|Expansion Cohort|Physician Decision|0|||
170633751|NCT00790842|616670116|FG009|Expansion Cohort|Physician Decision|0|||
170633752|NCT00790842|616670117|FG010|Expansion Cohort|Physician Decision|0|||
170446671|NCT00739973|615972210|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
170446672|NCT00739973|615972202|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
170446673|NCT00739973|615972203|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
170446674|NCT00739973|615972204|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
170446675|NCT00739973|615972205|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
170446676|NCT00739973|615972206|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
170446677|NCT00739973|615972207|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
170446678|NCT00739973|615972208|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
170446679|NCT00739973|615972209|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
170446680|NCT00739973|615972210|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
170446681|NCT00739973|615972202|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
170446682|NCT00739973|615972203|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
170446683|NCT00739973|615972204|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
170446684|NCT00739973|615972205|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
170446685|NCT00739973|615972206|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
170446686|NCT00739973|615972207|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
170446687|NCT00739973|615972208|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
170446688|NCT00739973|615972209|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
170446689|NCT00739973|615972210|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
170446690|NCT00739973|615972202|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
170446691|NCT00739973|615972203|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
170446692|NCT00739973|615972204|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
170446693|NCT00739973|615972205|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
170446694|NCT00739973|615972206|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
170446695|NCT00739973|615972207|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
170446696|NCT00739973|615972208|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
170446697|NCT00739973|615972209|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
170446698|NCT00739973|615972210|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
170446699|NCT00739973|615972202|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
170446700|NCT00739973|615972203|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
170446701|NCT00739973|615972204|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
170446702|NCT00739973|615972205|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
170446703|NCT00739973|615972206|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
170446704|NCT00739973|615972207|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
170446705|NCT00739973|615972208|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
170446706|NCT00739973|615972209|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
170446707|NCT00739973|615972210|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
170446708|NCT00739973|615972202|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
170446709|NCT00739973|615972203|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
170446710|NCT00739973|615972204|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
170446711|NCT00739973|615972205|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
170446712|NCT00739973|615972206|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
170446713|NCT00739973|615972207|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
170446714|NCT00739973|615972208|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
170446715|NCT00739973|615972209|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
170539964|NCT04633447|616320698|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
170539965|NCT04633447|616320699|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
170539966|NCT04333498|616320700|FG000|Overall Study|Lost to Follow-up|1|||
170539967|NCT04333498|616320701|FG001|Overall Study|Lost to Follow-up|0|||
170539968|NCT04333498|616320700|FG000|Overall Study|Lost to Follow-up|0|||
170539969|NCT04333498|616320701|FG001|Overall Study|Lost to Follow-up|1|||
170539970|NCT01565694|616320702|FG000|Dose-Titration Period|Adverse Event|4|||
170539971|NCT01565694|616320702|FG000|Dose-Titration Period|Protocol Violation|10|||
170539972|NCT01565694|616320702|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
170539973|NCT05399771|616320704|FG000|Overall Study|Physician Decision|3|||
170539974|NCT05399771|616320704|FG000|Overall Study|Adverse Event|1|||
170539975|NCT00484159|616320710|FG000|Overall Study|Lost to Follow-up|1|||
170539976|NCT00484159|616320711|FG001|Overall Study|Lost to Follow-up|1|||
170539977|NCT00484159|616320712|FG002|Overall Study|Lost to Follow-up|0|||
170539978|NCT04766333|616320713|FG000|Overall Study|Lost to Follow-up|40|||
170539979|NCT04766333|616320714|FG001|Overall Study|Lost to Follow-up|826|||
170539980|NCT03234881|616320715|FG000|Overall Study|Lost to Follow-up|9|||
170539981|NCT03234881|616320716|FG001|Overall Study|Lost to Follow-up|3|||
170539982|NCT00541229|616320717|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
170539983|NCT00541229|616320718|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
170539984|NCT00541229|616320719|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
170446716|NCT00739973|615972210|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
170446717|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
170446718|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
170446719|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
170446720|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
170446721|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
170446722|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
170446723|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
170446724|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
170446725|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
170446726|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
170446727|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
170446728|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
170446729|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
170446730|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
170446731|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
170446732|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
170446733|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
170446734|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
170446735|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
170446736|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
170446737|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
170446738|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
170446739|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
170446740|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
170446741|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
170446742|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
170446743|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
170446744|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
170446745|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
170446746|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
170446747|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
170446748|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
170446749|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
170446750|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
170446751|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
170446752|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
170446753|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
170446754|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
170446755|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
170446756|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
170446757|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
170446758|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
170446759|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
170446760|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
170446761|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
170446762|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
170446763|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
170446764|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
170446765|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
170539985|NCT00541229|616320720|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
170539986|NCT00541229|616320721|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
170539987|NCT00541229|616320722|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
170539988|NCT00541229|616320717|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
170539989|NCT00541229|616320718|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
170539990|NCT00541229|616320719|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
170539991|NCT00541229|616320720|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
170539992|NCT00541229|616320721|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
170539993|NCT00541229|616320722|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
170539994|NCT00541229|616320717|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
170446766|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
170446767|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
170446768|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
170446769|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
170446770|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
170446771|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
170446772|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
170446773|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
170446774|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
170446775|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
170446776|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
170446777|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
170446778|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
170446779|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
170446780|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
170446781|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
170446782|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
170446783|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
170446784|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
170446785|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
170446786|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
170446787|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
170446788|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
170446789|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
170446790|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
170446791|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
170446792|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
170446793|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
170446794|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
170446795|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
170446796|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
170446797|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
170446798|NCT00739973|615972202|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
170446799|NCT00739973|615972203|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
170446800|NCT00739973|615972204|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
170446801|NCT00739973|615972205|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
170446802|NCT00739973|615972206|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
170446803|NCT00739973|615972207|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
170446804|NCT00739973|615972208|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
170446805|NCT00739973|615972209|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
170446806|NCT00739973|615972210|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
170446807|NCT02413294|615972211|FG000|Overall Study|Withdrawal by Subject|1|||
170446808|NCT04149535|615972215|FG000|Overall Study|Death|11|||
170446809|NCT04149535|615972216|FG001|Overall Study|Death|7|||
170446810|NCT04149535|615972215|FG000|Overall Study|Physician Decision|10|||
170446811|NCT04149535|615972216|FG001|Overall Study|Physician Decision|4|||
170446812|NCT04149535|615972215|FG000|Overall Study|Withdrawal by Subject|6|||
170446813|NCT04149535|615972216|FG001|Overall Study|Withdrawal by Subject|7|||
170446814|NCT04149535|615972215|FG000|Overall Study|Not described|2|||
170446815|NCT04149535|615972216|FG001|Overall Study|Not described|0|||
170446816|NCT02875028|615972217|FG000|Washout Period|Withdrawal by Subject|0|||
170446817|NCT02875028|615972218|FG001|Washout Period|Withdrawal by Subject|1|||
170446818|NCT00109837|615974435|FG000|Overall Study|Adverse Event|2|||
170446819|NCT00109837|615974435|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
170446820|NCT00109837|615974435|FG000|Overall Study|Death|1|||
170446821|NCT00109837|615974435|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
170446822|NCT00109837|615974435|FG000|Overall Study|Not treated|1|||
170446823|NCT00109837|615974435|FG000|Overall Study|Ineligible|1|||
170446824|NCT01989676|615974436|FG000|Overall Study|Death|52|||
170446825|NCT01989676|615974437|FG001|Overall Study|Death|60|||
170539995|NCT00541229|616320718|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
170539996|NCT00541229|616320719|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
170633753|NCT00790842|616670107|FG000|Expansion Cohort|Withdrawal by Subject|0|||
170633754|NCT00790842|616670108|FG001|Expansion Cohort|Withdrawal by Subject|0|||
170633755|NCT00790842|616670109|FG002|Expansion Cohort|Withdrawal by Subject|3|||
170633756|NCT00790842|616670110|FG003|Expansion Cohort|Withdrawal by Subject|0|||
170446826|NCT01989676|615974436|FG000|Overall Study|Protocol Violation|2|||
170446827|NCT01989676|615974437|FG001|Overall Study|Protocol Violation|1|||
170446828|NCT01989676|615974436|FG000|Overall Study|Lost to Follow-up|8|||
170446829|NCT01989676|615974437|FG001|Overall Study|Lost to Follow-up|18|||
170446830|NCT01989676|615974436|FG000|Overall Study|No longer willing to participate in study|26|||
170446831|NCT01989676|615974437|FG001|Overall Study|No longer willing to participate in study|26|||
170446832|NCT01989676|615974436|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
170446833|NCT01989676|615974437|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
170446834|NCT01989676|615974436|FG000|Overall Study|Other|4|||
170446835|NCT01989676|615974437|FG001|Overall Study|Other|3|||
170446836|NCT00546910|615974442|FG000|Overall Study|Adverse Event|2|||
170446837|NCT00546910|615974443|FG001|Overall Study|Adverse Event|3|||
170446838|NCT00546910|615974442|FG000|Overall Study|Lack of Efficacy|5|||
170446839|NCT00546910|615974443|FG001|Overall Study|Lack of Efficacy|7|||
170446840|NCT00546910|615974442|FG000|Overall Study|Physician Decision|0|||
170446841|NCT00546910|615974443|FG001|Overall Study|Physician Decision|1|||
170446842|NCT00546910|615974442|FG000|Overall Study|Withdrawal by Subject|2|||
170446843|NCT00546910|615974443|FG001|Overall Study|Withdrawal by Subject|0|||
170446844|NCT03346070|615974450|FG000|Overall Study|Death|0|||
170446845|NCT03346070|615974451|FG001|Overall Study|Death|0|||
170446846|NCT03346070|615974452|FG002|Overall Study|Death|0|||
170446847|NCT03346070|615974453|FG003|Overall Study|Death|0|||
170446848|NCT03346070|615974454|FG004|Overall Study|Death|1|||
170446849|NCT03346070|615974450|FG000|Overall Study|Lost to Follow-up|0|||
170446850|NCT03346070|615974451|FG001|Overall Study|Lost to Follow-up|1|||
170446851|NCT03346070|615974452|FG002|Overall Study|Lost to Follow-up|2|||
170446852|NCT03346070|615974453|FG003|Overall Study|Lost to Follow-up|0|||
170446853|NCT03346070|615974454|FG004|Overall Study|Lost to Follow-up|0|||
170446854|NCT03346070|615974450|FG000|Overall Study|Physician Decision|0|||
170446855|NCT03346070|615974451|FG001|Overall Study|Physician Decision|0|||
170446856|NCT03346070|615974452|FG002|Overall Study|Physician Decision|0|||
170446857|NCT03346070|615974453|FG003|Overall Study|Physician Decision|1|||
170446858|NCT03346070|615974454|FG004|Overall Study|Physician Decision|1|||
170446859|NCT03346070|615974450|FG000|Overall Study|Withdrawal by Subject|1|||
170446860|NCT03346070|615974451|FG001|Overall Study|Withdrawal by Subject|0|||
170446861|NCT03346070|615974452|FG002|Overall Study|Withdrawal by Subject|0|||
170446862|NCT03346070|615974453|FG003|Overall Study|Withdrawal by Subject|1|||
170446863|NCT03346070|615974454|FG004|Overall Study|Withdrawal by Subject|0|||
170446864|NCT03346070|615974450|FG000|Overall Study|Study medication not received as planned|2|||
170446865|NCT03346070|615974451|FG001|Overall Study|Study medication not received as planned|3|||
170446866|NCT03346070|615974452|FG002|Overall Study|Study medication not received as planned|2|||
170446867|NCT03346070|615974453|FG003|Overall Study|Study medication not received as planned|3|||
170446868|NCT03346070|615974454|FG004|Overall Study|Study medication not received as planned|2|||
170446869|NCT03346070|615974450|FG000|Overall Study|Screen Failure|0|||
170446870|NCT03346070|615974451|FG001|Overall Study|Screen Failure|0|||
170446871|NCT03346070|615974452|FG002|Overall Study|Screen Failure|0|||
170446872|NCT03346070|615974453|FG003|Overall Study|Screen Failure|1|||
170446873|NCT03346070|615974454|FG004|Overall Study|Screen Failure|1|||
170446874|NCT00988208|615974456|FG000|Overall Study|Adverse Event|71|||
170446875|NCT00988208|615974457|FG001|Overall Study|Adverse Event|122|||
170446876|NCT00988208|615974456|FG000|Overall Study|Disease Progression|103|||
170446877|NCT00988208|615974457|FG001|Overall Study|Disease Progression|89|||
170446878|NCT00988208|615974456|FG000|Overall Study|Withdrawal by Subject|50|||
170446879|NCT00988208|615974457|FG001|Overall Study|Withdrawal by Subject|57|||
170446880|NCT00988208|615974456|FG000|Overall Study|Death|9|||
170446881|NCT00988208|615974457|FG001|Overall Study|Death|15|||
170446882|NCT00988208|615974456|FG000|Overall Study|Lost to Follow-up|2|||
170446883|NCT00988208|615974457|FG001|Overall Study|Lost to Follow-up|3|||
170446884|NCT00988208|615974456|FG000|Overall Study|Protocol Violation|9|||
170446885|NCT00988208|615974457|FG001|Overall Study|Protocol Violation|2|||
170446886|NCT00988208|615974456|FG000|Overall Study|Sponsor Decision|102|||
170446887|NCT00988208|615974457|FG001|Overall Study|Sponsor Decision|78|||
170446888|NCT00988208|615974456|FG000|Overall Study|Clinical Progression|17|||
170446889|NCT00988208|615974457|FG001|Overall Study|Clinical Progression|16|||
170446890|NCT00988208|615974456|FG000|Overall Study|Biochemical Progression|21|||
170446891|NCT00988208|615974457|FG001|Overall Study|Biochemical Progression|7|||
170446892|NCT00988208|615974456|FG000|Overall Study|Clinical Deterioration|7|||
170446893|NCT00988208|615974457|FG001|Overall Study|Clinical Deterioration|14|||
170446894|NCT00988208|615974456|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
170446895|NCT00988208|615974457|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
170446896|NCT00988208|615974456|FG000|Overall Study|Other|8|||
170446897|NCT00988208|615974457|FG001|Overall Study|Other|3|||
170446898|NCT00880087|615974467|FG000|Overall Study|Lost to Follow-up|0|||
170446899|NCT00880087|615974468|FG001|Overall Study|Lost to Follow-up|2|||
170446900|NCT00743509|615974469|FG000|Overall Study|Withdrawal by Subject|2|||
170786131|NCT00999804|617225416|FG001|Overall Study|Lack of Efficacy|2|||
170446901|NCT00418522|615974472|FG000|Overall Study|Adverse Event|7|||
170446902|NCT00418522|615974473|FG001|Overall Study|Adverse Event|1|||
170446903|NCT00418522|615974472|FG000|Overall Study|Lack of Efficacy|1|||
170446904|NCT00418522|615974473|FG001|Overall Study|Lack of Efficacy|3|||
170446905|NCT00418522|615974472|FG000|Overall Study|Lost to Follow-up|10|||
170446906|NCT00418522|615974473|FG001|Overall Study|Lost to Follow-up|4|||
170446907|NCT00418522|615974472|FG000|Overall Study|Withdrawal by Subject|31|||
170446908|NCT00418522|615974473|FG001|Overall Study|Withdrawal by Subject|7|||
170446909|NCT00418522|615974472|FG000|Overall Study|Other|27|||
170446910|NCT00418522|615974473|FG001|Overall Study|Other|23|||
170446911|NCT00418522|615974472|FG000|Overall Study|Randomized but did not receive treatment|7|||
170446912|NCT00418522|615974473|FG001|Overall Study|Randomized but did not receive treatment|4|||
170446913|NCT02695719|615974474|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
170446914|NCT02695719|615974475|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
170446915|NCT02695719|615974474|FG000|Overall Study|Significant Protocol Deviation|0|||
170446916|NCT02695719|615974475|FG001|Overall Study|Significant Protocol Deviation|1|||
170446917|NCT02695719|615974474|FG000|Overall Study|Voluntary Withdrawal|1|||
170446918|NCT02695719|615974475|FG001|Overall Study|Voluntary Withdrawal|0|||
170446919|NCT01005329|615974476|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
170446920|NCT00892281|615974477|FG000|Overall Study|Adverse Event|65|||
170446921|NCT00892281|615974478|FG001|Overall Study|Adverse Event|8|||
170446922|NCT00892281|615974477|FG000|Overall Study|Lost to Follow-up|81|||
170446923|NCT00892281|615974478|FG001|Overall Study|Lost to Follow-up|8|||
170446924|NCT00892281|615974477|FG000|Overall Study|Pregnancy|1|||
170446925|NCT00892281|615974478|FG001|Overall Study|Pregnancy|0|||
170446926|NCT00892281|615974477|FG000|Overall Study|Protocol Violation|7|||
170446927|NCT00892281|615974478|FG001|Overall Study|Protocol Violation|2|||
170446928|NCT00892281|615974477|FG000|Overall Study|Withdrawal by Subject|86|||
170446929|NCT00892281|615974478|FG001|Overall Study|Withdrawal by Subject|14|||
170446930|NCT00892281|615974477|FG000|Overall Study|Subject failed to return for final visit|2|||
170446931|NCT00892281|615974478|FG001|Overall Study|Subject failed to return for final visit|0|||
170446932|NCT00892281|615974477|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
170446933|NCT00892281|615974478|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
170446934|NCT00892281|615974477|FG000|Overall Study|Final visit completed 4 weeks late|0|||
170446935|NCT00892281|615974478|FG001|Overall Study|Final visit completed 4 weeks late|1|||
170446936|NCT00892281|615974477|FG000|Overall Study|Subject completed day after study closed|1|||
170446937|NCT00892281|615974478|FG001|Overall Study|Subject completed day after study closed|0|||
170446938|NCT00892281|615974477|FG000|Overall Study|Family emergency|1|||
170446939|NCT00892281|615974478|FG001|Overall Study|Family emergency|0|||
170446940|NCT00892281|615974477|FG000|Overall Study|Last visit not done - death in family|1|||
170446941|NCT00892281|615974478|FG001|Overall Study|Last visit not done - death in family|0|||
170786132|NCT00999804|617225415|FG000|Overall Study|Adverse Event|4|||
170786133|NCT00999804|617225416|FG001|Overall Study|Adverse Event|3|||
170786134|NCT00999804|617225415|FG000|Overall Study|Withdrawal by Subject|4|||
170786135|NCT00999804|617225416|FG001|Overall Study|Withdrawal by Subject|0|||
170786136|NCT00999804|617225415|FG000|Overall Study|Death|1|||
170786137|NCT00999804|617225416|FG001|Overall Study|Death|0|||
170446942|NCT00892281|615974477|FG000|Overall Study|Did not meet incl/excl criteria|1|||
170446943|NCT00892281|615974478|FG001|Overall Study|Did not meet incl/excl criteria|0|||
170446944|NCT00892281|615974477|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
170539997|NCT00541229|616320720|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
170539998|NCT00541229|616320721|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
170539999|NCT00541229|616320722|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
170540000|NCT00541229|616320717|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
170540001|NCT00541229|616320718|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
170540002|NCT00541229|616320719|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
170540003|NCT00541229|616320720|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
170540004|NCT00541229|616320721|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
170540005|NCT00541229|616320722|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
170540006|NCT00541229|616320717|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
170540007|NCT00541229|616320718|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
170540008|NCT00541229|616320719|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
170540009|NCT00541229|616320720|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
170540010|NCT00541229|616320721|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
170540011|NCT00541229|616320722|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
170540012|NCT00541229|616320717|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
170540013|NCT00541229|616320718|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
170540014|NCT00541229|616320719|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
170540015|NCT00541229|616320720|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
170540016|NCT00541229|616320721|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
170540017|NCT00541229|616320722|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
170540018|NCT00541229|616320717|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
170540019|NCT00541229|616320718|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
170540020|NCT00541229|616320719|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
170540021|NCT00541229|616320720|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
170540022|NCT00541229|616320721|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
170540023|NCT00541229|616320722|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
170540024|NCT00541229|616320717|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
170540025|NCT00541229|616320718|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
170540026|NCT00541229|616320719|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
170540027|NCT00541229|616320720|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
170540028|NCT00541229|616320721|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
170540029|NCT00541229|616320722|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
170540030|NCT00541229|616320717|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
170540031|NCT00541229|616320718|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
170540032|NCT00541229|616320719|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
170540033|NCT00541229|616320720|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
170540034|NCT00541229|616320721|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
170540035|NCT00541229|616320722|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
170540036|NCT00541229|616320717|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
170540037|NCT00541229|616320718|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
170540038|NCT00541229|616320719|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
170540039|NCT00541229|616320720|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
170540040|NCT00541229|616320721|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
170540041|NCT00541229|616320722|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
170540042|NCT00541229|616320717|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
170540043|NCT00541229|616320718|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
170786138|NCT00999804|617225415|FG000|Overall Study|Ineligible|3|||
170786139|NCT00999804|617225416|FG001|Overall Study|Ineligible|0|||
170786140|NCT01997840|617225420|FG000|Overall Study|Lost to Follow-up|0|||
170786141|NCT01997840|617225421|FG001|Overall Study|Lost to Follow-up|0|||
170786142|NCT01997840|617225422|FG002|Overall Study|Lost to Follow-up|1|||
170786143|NCT01997840|617225423|FG003|Overall Study|Lost to Follow-up|0|||
170786144|NCT01997840|617225420|FG000|Overall Study|Withdrawal by participant|0|||
170786145|NCT01997840|617225421|FG001|Overall Study|Withdrawal by participant|0|||
170786146|NCT01997840|617225422|FG002|Overall Study|Withdrawal by participant|8|||
170786147|NCT01997840|617225423|FG003|Overall Study|Withdrawal by participant|1|||
170786148|NCT01997840|617225420|FG000|Overall Study|Physician Decision|0|||
170786149|NCT01997840|617225421|FG001|Overall Study|Physician Decision|0|||
170446945|NCT00892281|615974478|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
170446946|NCT00892281|615974477|FG000|Overall Study|Unable to redeem the drug voucher|1|||
170446947|NCT00892281|615974478|FG001|Overall Study|Unable to redeem the drug voucher|0|||
170446948|NCT00892281|615974477|FG000|Overall Study|Subject not good candidate for study|1|||
170446949|NCT00892281|615974478|FG001|Overall Study|Subject not good candidate for study|0|||
170446950|NCT00892281|615974477|FG000|Overall Study|Subject did not return for any visits|1|||
170446951|NCT00892281|615974478|FG001|Overall Study|Subject did not return for any visits|0|||
170446952|NCT00892281|615974477|FG000|Overall Study|Subject missed several visits/lost meds|1|||
170446953|NCT00892281|615974478|FG001|Overall Study|Subject missed several visits/lost meds|0|||
170446954|NCT00892281|615974477|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
170446955|NCT00892281|615974478|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
170633757|NCT00790842|616670111|FG004|Expansion Cohort|Withdrawal by Subject|0|||
170633758|NCT00790842|616670112|FG005|Expansion Cohort|Withdrawal by Subject|0|||
170633759|NCT00790842|616670113|FG006|Expansion Cohort|Withdrawal by Subject|0|||
170633760|NCT00790842|616670114|FG007|Expansion Cohort|Withdrawal by Subject|0|||
170633761|NCT00790842|616670115|FG008|Expansion Cohort|Withdrawal by Subject|0|||
170633762|NCT00790842|616670116|FG009|Expansion Cohort|Withdrawal by Subject|0|||
170633763|NCT00790842|616670117|FG010|Expansion Cohort|Withdrawal by Subject|0|||
170633764|NCT00790842|616670107|FG000|Expansion Cohort|Study Closure|0|||
170633765|NCT00790842|616670108|FG001|Expansion Cohort|Study Closure|0|||
170633766|NCT00790842|616670109|FG002|Expansion Cohort|Study Closure|1|||
170633767|NCT00790842|616670110|FG003|Expansion Cohort|Study Closure|0|||
170633768|NCT00790842|616670111|FG004|Expansion Cohort|Study Closure|0|||
170633769|NCT00790842|616670112|FG005|Expansion Cohort|Study Closure|0|||
170633770|NCT00790842|616670113|FG006|Expansion Cohort|Study Closure|0|||
170633771|NCT00790842|616670114|FG007|Expansion Cohort|Study Closure|0|||
170446956|NCT00892281|615974477|FG000|Overall Study|Scheduled for knee replacement|0|||
170446957|NCT00892281|615974478|FG001|Overall Study|Scheduled for knee replacement|1|||
170446958|NCT00892281|615974477|FG000|Overall Study|PI complained of inadequate compensation|3|||
170446959|NCT00892281|615974478|FG001|Overall Study|PI complained of inadequate compensation|0|||
170446960|NCT00892281|615974477|FG000|Overall Study|Subject lost interest in program|0|||
170446961|NCT00892281|615974478|FG001|Overall Study|Subject lost interest in program|1|||
170446962|NCT00892281|615974477|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
170446963|NCT00892281|615974478|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
170446964|NCT00892281|615974477|FG000|Overall Study|Death in family|1|||
170446965|NCT00892281|615974478|FG001|Overall Study|Death in family|0|||
170446966|NCT00892281|615974477|FG000|Overall Study|Lack of efficacy of study product|2|||
170446967|NCT00892281|615974478|FG001|Overall Study|Lack of efficacy of study product|0|||
170446968|NCT00892281|615974477|FG000|Overall Study|Subject not seen by PI at final visit|1|||
170446969|NCT00892281|615974478|FG001|Overall Study|Subject not seen by PI at final visit|0|||
170446970|NCT00892281|615974477|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
170446971|NCT00892281|615974478|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
170446972|NCT00892281|615974477|FG000|Overall Study|Missed multiple visits|1|||
170446973|NCT00892281|615974478|FG001|Overall Study|Missed multiple visits|0|||
170446974|NCT00892281|615974477|FG000|Overall Study|Missed visits rescheduled out of window|1|||
170446975|NCT00892281|615974478|FG001|Overall Study|Missed visits rescheduled out of window|0|||
170446976|NCT00892281|615974477|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
170446977|NCT00892281|615974478|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
170446978|NCT00892281|615974477|FG000|Overall Study|Subject had history of drug abuse|1|||
170446979|NCT00892281|615974478|FG001|Overall Study|Subject had history of drug abuse|0|||
170446980|NCT00892281|615974477|FG000|Overall Study|Rash on hand|1|||
170446981|NCT00892281|615974478|FG001|Overall Study|Rash on hand|0|||
170446982|NCT00892281|615974477|FG000|Overall Study|Visit 4 date out of window|1|||
170446983|NCT00892281|615974478|FG001|Overall Study|Visit 4 date out of window|0|||
170446984|NCT00868296|615974479|FG000|Overall Study|Adverse Event|0|||
170446985|NCT00868296|615974480|FG001|Overall Study|Adverse Event|2|||
170446986|NCT00868296|615974479|FG000|Overall Study|Withdrawal by Subject|0|||
170446987|NCT00868296|615974480|FG001|Overall Study|Withdrawal by Subject|1|||
170446988|NCT01280617|615974481|FG000|Overall Study|Adverse Event|0|||
170446989|NCT01280617|615974482|FG001|Overall Study|Adverse Event|1|||
170446990|NCT00573170|615974483|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
170446991|NCT00573170|615974484|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
170446992|NCT00573170|615974485|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
170446993|NCT00573170|615974486|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
170446994|NCT00573170|615974487|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
170446995|NCT00573170|615974488|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
170446996|NCT00573170|615974483|FG000|First Washout Period|Adverse Event|1|||
170446997|NCT00573170|615974484|FG001|First Washout Period|Adverse Event|1|||
170446998|NCT00573170|615974485|FG002|First Washout Period|Adverse Event|0|||
170446999|NCT00573170|615974486|FG003|First Washout Period|Adverse Event|0|||
170447000|NCT00573170|615974487|FG004|First Washout Period|Adverse Event|0|||
170447001|NCT00573170|615974488|FG005|First Washout Period|Adverse Event|1|||
170447002|NCT00573170|615974483|FG000|First Washout Period|Lack of Efficacy|0|||
170447003|NCT00573170|615974484|FG001|First Washout Period|Lack of Efficacy|0|||
170447004|NCT00573170|615974485|FG002|First Washout Period|Lack of Efficacy|0|||
170447005|NCT00573170|615974486|FG003|First Washout Period|Lack of Efficacy|0|||
170633772|NCT00790842|616670115|FG008|Expansion Cohort|Study Closure|0|||
170633773|NCT00790842|616670116|FG009|Expansion Cohort|Study Closure|0|||
170447006|NCT00573170|615974487|FG004|First Washout Period|Lack of Efficacy|0|||
170447007|NCT00573170|615974488|FG005|First Washout Period|Lack of Efficacy|1|||
170447008|NCT00573170|615974483|FG000|First Washout Period|Lost to Follow-up|1|||
170447009|NCT00573170|615974484|FG001|First Washout Period|Lost to Follow-up|1|||
170633774|NCT00790842|616670117|FG010|Expansion Cohort|Study Closure|0|||
170633775|NCT02085460|616670122|FG000|Overall Study|Adverse Event|2|||
170633776|NCT02085460|616670123|FG001|Overall Study|Adverse Event|2|||
170633777|NCT02085460|616670124|FG002|Overall Study|Adverse Event|1|||
170633778|NCT02085460|616670122|FG000|Overall Study|Physician Decision|1|||
170447010|NCT00573170|615974485|FG002|First Washout Period|Lost to Follow-up|0|||
170447011|NCT00573170|615974486|FG003|First Washout Period|Lost to Follow-up|2|||
170447012|NCT00573170|615974487|FG004|First Washout Period|Lost to Follow-up|0|||
170447013|NCT00573170|615974488|FG005|First Washout Period|Lost to Follow-up|2|||
170447014|NCT00573170|615974483|FG000|First Washout Period|Withdrawal by Subject|2|||
170447015|NCT00573170|615974484|FG001|First Washout Period|Withdrawal by Subject|0|||
170447016|NCT00573170|615974485|FG002|First Washout Period|Withdrawal by Subject|0|||
170447017|NCT00573170|615974486|FG003|First Washout Period|Withdrawal by Subject|2|||
170447018|NCT00573170|615974487|FG004|First Washout Period|Withdrawal by Subject|3|||
170447019|NCT00573170|615974488|FG005|First Washout Period|Withdrawal by Subject|3|||
170447020|NCT00573170|615974483|FG000|First Washout Period|Other|4|||
170447021|NCT00573170|615974484|FG001|First Washout Period|Other|0|||
170447022|NCT00573170|615974485|FG002|First Washout Period|Other|1|||
170447023|NCT00573170|615974486|FG003|First Washout Period|Other|1|||
170447024|NCT00573170|615974487|FG004|First Washout Period|Other|0|||
170447025|NCT00573170|615974488|FG005|First Washout Period|Other|0|||
170447026|NCT00573170|615974483|FG000|Second Washout Period|Adverse Event|1|||
170447027|NCT00573170|615974484|FG001|Second Washout Period|Adverse Event|0|||
170447028|NCT00573170|615974485|FG002|Second Washout Period|Adverse Event|0|||
170447029|NCT00573170|615974486|FG003|Second Washout Period|Adverse Event|0|||
170447030|NCT00573170|615974487|FG004|Second Washout Period|Adverse Event|1|||
170447031|NCT00573170|615974488|FG005|Second Washout Period|Adverse Event|0|||
170447032|NCT00573170|615974483|FG000|Second Washout Period|Protocol Violation|2|||
170447033|NCT00573170|615974484|FG001|Second Washout Period|Protocol Violation|1|||
170447034|NCT00573170|615974485|FG002|Second Washout Period|Protocol Violation|1|||
170447035|NCT00573170|615974486|FG003|Second Washout Period|Protocol Violation|0|||
170447036|NCT00573170|615974487|FG004|Second Washout Period|Protocol Violation|0|||
170447037|NCT00573170|615974488|FG005|Second Washout Period|Protocol Violation|0|||
170447038|NCT00573170|615974483|FG000|Second Washout Period|Withdrawal by Subject|1|||
170447039|NCT00573170|615974484|FG001|Second Washout Period|Withdrawal by Subject|1|||
170447040|NCT00573170|615974485|FG002|Second Washout Period|Withdrawal by Subject|2|||
170447041|NCT00573170|615974486|FG003|Second Washout Period|Withdrawal by Subject|0|||
170447042|NCT00573170|615974487|FG004|Second Washout Period|Withdrawal by Subject|1|||
170447043|NCT00573170|615974488|FG005|Second Washout Period|Withdrawal by Subject|0|||
170447044|NCT00573170|615974483|FG000|Second Washout Period|Lost to Follow-up|0|||
170447045|NCT00573170|615974484|FG001|Second Washout Period|Lost to Follow-up|0|||
170447046|NCT00573170|615974485|FG002|Second Washout Period|Lost to Follow-up|0|||
170447047|NCT00573170|615974486|FG003|Second Washout Period|Lost to Follow-up|1|||
170447048|NCT00573170|615974487|FG004|Second Washout Period|Lost to Follow-up|0|||
170447049|NCT00573170|615974488|FG005|Second Washout Period|Lost to Follow-up|0|||
170447050|NCT00573170|615974483|FG000|Second Washout Period|Other|1|||
170447051|NCT00573170|615974484|FG001|Second Washout Period|Other|2|||
170447052|NCT00573170|615974485|FG002|Second Washout Period|Other|1|||
170447053|NCT00573170|615974486|FG003|Second Washout Period|Other|4|||
170447054|NCT00573170|615974487|FG004|Second Washout Period|Other|6|||
170447055|NCT00573170|615974488|FG005|Second Washout Period|Other|2|||
170447056|NCT00573170|615974483|FG000|Third Treatment Period|Withdrawal by Subject|1|||
170447057|NCT00573170|615974484|FG001|Third Treatment Period|Withdrawal by Subject|0|||
170447058|NCT00573170|615974485|FG002|Third Treatment Period|Withdrawal by Subject|0|||
170447059|NCT00573170|615974486|FG003|Third Treatment Period|Withdrawal by Subject|0|||
170447060|NCT00573170|615974487|FG004|Third Treatment Period|Withdrawal by Subject|0|||
170447061|NCT00573170|615974488|FG005|Third Treatment Period|Withdrawal by Subject|0|||
170447062|NCT00573170|615974483|FG000|Third Treatment Period|Lost to Follow-up|0|||
170447063|NCT00573170|615974484|FG001|Third Treatment Period|Lost to Follow-up|0|||
170447064|NCT00573170|615974485|FG002|Third Treatment Period|Lost to Follow-up|0|||
170447065|NCT00573170|615974486|FG003|Third Treatment Period|Lost to Follow-up|0|||
170447066|NCT00573170|615974487|FG004|Third Treatment Period|Lost to Follow-up|0|||
170447067|NCT00573170|615974488|FG005|Third Treatment Period|Lost to Follow-up|2|||
170447068|NCT00986570|615974489|FG000|Overall Study|Lost to Follow-up|6|||
170447069|NCT00986570|615974489|FG000|Overall Study|Potential bias for objective assessment|1|||
170447070|NCT01311557|615974490|FG000|Overall Study|Serious adverse event|0|||
170447071|NCT01311557|615974491|FG001|Overall Study|Serious adverse event|1|||
170447072|NCT01311557|615974490|FG000|Overall Study|Protocol Violation|4|||
170447073|NCT01311557|615974491|FG001|Overall Study|Protocol Violation|2|||
170447074|NCT01311557|615974490|FG000|Overall Study|Lost to Follow-up|0|||
170447075|NCT01311557|615974491|FG001|Overall Study|Lost to Follow-up|1|||
170447076|NCT01311557|615974490|FG000|Overall Study|Withdrawal by Subject|1|||
170447077|NCT01311557|615974491|FG001|Overall Study|Withdrawal by Subject|2|||
170447078|NCT04205162|615974492|FG000|Overall Study|Lost to Follow-up|1|||
170447079|NCT04205162|615974493|FG001|Overall Study|Lost to Follow-up|0|||
170447080|NCT04205162|615974492|FG000|Overall Study|Withdrawal by Subject|2|||
170447081|NCT04205162|615974493|FG001|Overall Study|Withdrawal by Subject|0|||
170633779|NCT02085460|616670123|FG001|Overall Study|Physician Decision|1|||
170447082|NCT04205162|615974492|FG000|Overall Study|University closure due to COVID-19|1|||
170447083|NCT04205162|615974493|FG001|Overall Study|University closure due to COVID-19|0|||
170447084|NCT03110380|615974496|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
170447085|NCT03110380|615974497|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
170447086|NCT03110380|615974498|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
170447087|NCT03110380|615974499|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
170447088|NCT03110380|615974496|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
170447089|NCT03110380|615974497|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
170447090|NCT03110380|615974498|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170447091|NCT03110380|615974499|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170447092|NCT03110380|615974496|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
170447093|NCT03110380|615974497|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
170447094|NCT03110380|615974498|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
170447095|NCT03110380|615974499|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
170447096|NCT03110380|615974496|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
170447097|NCT03110380|615974497|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
170447098|NCT03110380|615974498|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
170447099|NCT03110380|615974499|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
170447100|NCT03110380|615974496|FG000|Double-Blind Treatment Phase|Death|2|||
170447101|NCT03110380|615974497|FG001|Double-Blind Treatment Phase|Death|1|||
170447102|NCT03110380|615974498|FG002|Double-Blind Treatment Phase|Death|0|||
170447103|NCT03110380|615974499|FG003|Double-Blind Treatment Phase|Death|0|||
170447104|NCT03110380|615974496|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
170447105|NCT03110380|615974497|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
170447106|NCT03110380|615974498|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
170447107|NCT03110380|615974499|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
170447108|NCT03110380|615974496|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
170447109|NCT03110380|615974497|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
170447110|NCT03110380|615974498|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
170447111|NCT03110380|615974499|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
170447112|NCT03110380|615974496|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
170447113|NCT03110380|615974497|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
170447114|NCT03110380|615974498|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
170447115|NCT03110380|615974499|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
170447116|NCT03110380|615974496|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
170447117|NCT03110380|615974497|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
170447118|NCT03110380|615974498|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
170447119|NCT03110380|615974499|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
170447120|NCT03110380|615974496|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
170447121|NCT03110380|615974497|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
170447122|NCT03110380|615974498|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
170447123|NCT03110380|615974499|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
170447124|NCT03110380|615974496|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
170447125|NCT03110380|615974497|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
170447126|NCT03110380|615974498|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
170447127|NCT03110380|615974499|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
170447128|NCT01098110|615974501|FG000|Overall Study|Withdrawal by Subject|14|||
170447129|NCT01098110|615974502|FG001|Overall Study|Withdrawal by Subject|24|||
170633780|NCT02085460|616670124|FG002|Overall Study|Physician Decision|2|||
170633781|NCT02085460|616670122|FG000|Overall Study|Withdrawal by Subject|11|||
170633782|NCT02085460|616670123|FG001|Overall Study|Withdrawal by Subject|5|||
170633783|NCT02085460|616670124|FG002|Overall Study|Withdrawal by Subject|7|||
170633784|NCT01285323|616670125|FG000|Overall Study|Adverse Event|9|||
170633785|NCT01285323|616670126|FG001|Overall Study|Adverse Event|8|||
170633786|NCT01285323|616670125|FG000|Overall Study|Lack of Efficacy|4|||
170633787|NCT01285323|616670126|FG001|Overall Study|Lack of Efficacy|2|||
170633788|NCT01285323|616670125|FG000|Overall Study|Withdrawal by Subject|15|||
170633789|NCT01285323|616670126|FG001|Overall Study|Withdrawal by Subject|11|||
170447130|NCT01098110|615974503|FG002|Overall Study|Withdrawal by Subject|19|||
170447131|NCT01098110|615974501|FG000|Overall Study|Adverse Event|30|||
170447132|NCT01098110|615974502|FG001|Overall Study|Adverse Event|32|||
170447133|NCT01098110|615974503|FG002|Overall Study|Adverse Event|43|||
170447134|NCT01098110|615974501|FG000|Overall Study|Lack of Efficacy|13|||
170447135|NCT01098110|615974502|FG001|Overall Study|Lack of Efficacy|9|||
170447136|NCT01098110|615974503|FG002|Overall Study|Lack of Efficacy|27|||
170447137|NCT01098110|615974501|FG000|Overall Study|Other|4|||
170447138|NCT01098110|615974502|FG001|Overall Study|Other|7|||
170447139|NCT01098110|615974503|FG002|Overall Study|Other|5|||
170447140|NCT01098110|615974501|FG000|Overall Study|Untreated|1|||
170447141|NCT01098110|615974502|FG001|Overall Study|Untreated|1|||
170886966|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
170447142|NCT01098110|615974503|FG002|Overall Study|Untreated|0|||
170447143|NCT01546519|615974504|FG000|Overall Study|Adverse Event|0|||
170447144|NCT01546519|615974505|FG001|Overall Study|Adverse Event|0|||
170447145|NCT01546519|615974506|FG002|Overall Study|Adverse Event|1|||
170447146|NCT01546519|615974507|FG003|Overall Study|Adverse Event|1|||
170447147|NCT01546519|615974504|FG000|Overall Study|Death|0|||
170447148|NCT01546519|615974505|FG001|Overall Study|Death|1|||
170447149|NCT01546519|615974506|FG002|Overall Study|Death|3|||
170447150|NCT01546519|615974507|FG003|Overall Study|Death|1|||
170447151|NCT01546519|615974504|FG000|Overall Study|related to disease progression|2|||
170447152|NCT01546519|615974505|FG001|Overall Study|related to disease progression|2|||
170447153|NCT01546519|615974506|FG002|Overall Study|related to disease progression|2|||
170447154|NCT01546519|615974507|FG003|Overall Study|related to disease progression|1|||
170447155|NCT01546519|615974504|FG000|Overall Study|Physician Decision|6|||
170447156|NCT01546519|615974505|FG001|Overall Study|Physician Decision|5|||
170447157|NCT01546519|615974506|FG002|Overall Study|Physician Decision|2|||
170447158|NCT01546519|615974507|FG003|Overall Study|Physician Decision|3|||
170447159|NCT01546519|615974504|FG000|Overall Study|Withdrawal by Subject|1|||
170447160|NCT01546519|615974505|FG001|Overall Study|Withdrawal by Subject|0|||
170447161|NCT01546519|615974506|FG002|Overall Study|Withdrawal by Subject|0|||
170447162|NCT01546519|615974507|FG003|Overall Study|Withdrawal by Subject|0|||
170447163|NCT01355302|615974508|FG000|Phase 1b|Death|4|||
170447164|NCT01355302|615974509|FG001|Phase 1b|Death|0|||
170447165|NCT01355302|615974510|FG002|Phase 1b|Death|0|||
170447166|NCT01355302|615974508|FG000|Phase 1b|Study terminated by sponsor|2|||
170447167|NCT01355302|615974509|FG001|Phase 1b|Study terminated by sponsor|0|||
170447168|NCT01355302|615974510|FG002|Phase 1b|Study terminated by sponsor|0|||
170447169|NCT00779402|615974511|FG000|Treatment Phase 1|Disease Progression|1|||
170447170|NCT00779402|615974512|FG001|Treatment Phase 1|Disease Progression|0|||
170447171|NCT00779402|615974511|FG000|Treatment Phase 1|Adverse Event|2|||
170447172|NCT00779402|615974512|FG001|Treatment Phase 1|Adverse Event|0|||
170447173|NCT00779402|615974511|FG000|Treatment Phase 1|Protocol Violation|1|||
170633790|NCT01285323|616670125|FG000|Overall Study|Protocol Violation|1|||
170447174|NCT00779402|615974512|FG001|Treatment Phase 1|Protocol Violation|0|||
170447175|NCT00779402|615974511|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
170447176|NCT00779402|615974512|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
170447177|NCT00779402|615974511|FG000|Treatment Phase 1|Lost to Follow-up|0|||
170447178|NCT00779402|615974512|FG001|Treatment Phase 1|Lost to Follow-up|1|||
170447179|NCT00779402|615974511|FG000|Treatment Phase 1|Death|0|||
170447180|NCT00779402|615974512|FG001|Treatment Phase 1|Death|1|||
170447181|NCT00779402|615974511|FG000|Treatment Phase 1|Intercurrent Illness|1|||
170633791|NCT01285323|616670126|FG001|Overall Study|Protocol Violation|2|||
170447182|NCT00779402|615974512|FG001|Treatment Phase 1|Intercurrent Illness|1|||
170447183|NCT00779402|615974511|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
170447184|NCT00779402|615974512|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
170447185|NCT00779402|615974511|FG000|Treatment Phase 1|Other|4|||
170447186|NCT00779402|615974512|FG001|Treatment Phase 1|Other|2|||
170447187|NCT00779402|615974511|FG000|Treatment Phase 1|Closure of Study|3|||
170447188|NCT00779402|615974512|FG001|Treatment Phase 1|Closure of Study|2|||
170447189|NCT00779402|615974511|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
170447190|NCT00779402|615974512|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
170447191|NCT00779402|615974511|FG000|Surveillance Phase|Protocol Violation|0|||
170540044|NCT00541229|616320719|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
170540045|NCT00541229|616320720|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
170540046|NCT00541229|616320721|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
170540047|NCT00541229|616320722|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
170540048|NCT00541229|616320717|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
170540049|NCT00541229|616320718|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
170540050|NCT00541229|616320719|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
170540051|NCT00541229|616320720|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
170540052|NCT00541229|616320721|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
170540053|NCT00541229|616320722|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
170540054|NCT00541229|616320717|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
170633792|NCT01285323|616670125|FG000|Overall Study|Non-compliance with study procedures|2|||
170786150|NCT01997840|617225422|FG002|Overall Study|Physician Decision|3|||
170447192|NCT00779402|615974512|FG001|Surveillance Phase|Protocol Violation|1|||
170447193|NCT00779402|615974511|FG000|Surveillance Phase|Patient refused to continue|22|||
170447194|NCT00779402|615974512|FG001|Surveillance Phase|Patient refused to continue|14|||
170447195|NCT00779402|615974511|FG000|Surveillance Phase|Lost to Follow-up|2|||
170447196|NCT00779402|615974512|FG001|Surveillance Phase|Lost to Follow-up|1|||
170447197|NCT00779402|615974511|FG000|Surveillance Phase|Death|0|||
170447198|NCT00779402|615974512|FG001|Surveillance Phase|Death|1|||
170447199|NCT00779402|615974511|FG000|Surveillance Phase|Intercurrent Illness|2|||
170447200|NCT00779402|615974512|FG001|Surveillance Phase|Intercurrent Illness|0|||
170447201|NCT00779402|615974511|FG000|Surveillance Phase|Other|5|||
170447202|NCT00779402|615974512|FG001|Surveillance Phase|Other|5|||
170447203|NCT00779402|615974511|FG000|Surveillance Phase|Withdrawal by Subject|4|||
170447204|NCT00779402|615974512|FG001|Surveillance Phase|Withdrawal by Subject|1|||
170447205|NCT00779402|615974511|FG000|Surveillance Phase|Closure of study|5|||
170447206|NCT00779402|615974512|FG001|Surveillance Phase|Closure of study|6|||
170447207|NCT00779402|615974511|FG000|Surveillance Phase|Completed Protocol Visits|3|||
170447208|NCT00779402|615974512|FG001|Surveillance Phase|Completed Protocol Visits|2|||
170447209|NCT00779402|615974511|FG000|Long-term Follow-up|Patient refused to continue|2|||
170447210|NCT00779402|615974512|FG001|Long-term Follow-up|Patient refused to continue|0|||
170447211|NCT00779402|615974511|FG000|Long-term Follow-up|Other|5|||
170447212|NCT00779402|615974512|FG001|Long-term Follow-up|Other|0|||
170447213|NCT00779402|615974511|FG000|Long-term Follow-up|Closure of Study|8|||
170447214|NCT00779402|615974512|FG001|Long-term Follow-up|Closure of Study|4|||
170447215|NCT00779402|615974511|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
170447216|NCT00779402|615974512|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
170447217|NCT01315028|615974517|FG000|Overall Study|Lost to Follow-up|1|||
170447218|NCT01315028|615974518|FG001|Overall Study|Lost to Follow-up|0|||
170447219|NCT01315028|615974517|FG000|Overall Study|Death|0|||
170447220|NCT01315028|615974518|FG001|Overall Study|Death|1|||
170447221|NCT01714739|615974519|FG000|Overall Study|Disease progression|3|||
170447222|NCT01714739|615974520|FG001|Overall Study|Disease progression|5|||
170447223|NCT01714739|615974521|FG002|Overall Study|Disease progression|5|||
170447224|NCT01714739|615974522|FG003|Overall Study|Disease progression|204|||
170447225|NCT01714739|615974523|FG004|Overall Study|Disease progression|1|||
170447226|NCT01714739|615974524|FG005|Overall Study|Disease progression|3|||
170447227|NCT01714739|615974525|FG006|Overall Study|Disease progression|5|||
170447228|NCT01714739|615974519|FG000|Overall Study|Study drug toxicity|1|||
170447229|NCT01714739|615974520|FG001|Overall Study|Study drug toxicity|1|||
170447230|NCT01714739|615974521|FG002|Overall Study|Study drug toxicity|1|||
170447231|NCT01714739|615974522|FG003|Overall Study|Study drug toxicity|15|||
170447232|NCT01714739|615974523|FG004|Overall Study|Study drug toxicity|0|||
170447233|NCT01714739|615974524|FG005|Overall Study|Study drug toxicity|0|||
170447234|NCT01714739|615974525|FG006|Overall Study|Study drug toxicity|5|||
170447235|NCT01714739|615974519|FG000|Overall Study|Death|0|||
170447236|NCT01714739|615974520|FG001|Overall Study|Death|0|||
170447237|NCT01714739|615974521|FG002|Overall Study|Death|0|||
170447238|NCT01714739|615974522|FG003|Overall Study|Death|1|||
170447239|NCT01714739|615974523|FG004|Overall Study|Death|0|||
170447240|NCT01714739|615974524|FG005|Overall Study|Death|0|||
170447241|NCT01714739|615974525|FG006|Overall Study|Death|0|||
170447242|NCT01714739|615974519|FG000|Overall Study|Adverse Event unrelated to drug|0|||
170447243|NCT01714739|615974520|FG001|Overall Study|Adverse Event unrelated to drug|0|||
170447244|NCT01714739|615974521|FG002|Overall Study|Adverse Event unrelated to drug|3|||
170447245|NCT01714739|615974522|FG003|Overall Study|Adverse Event unrelated to drug|21|||
170447246|NCT01714739|615974523|FG004|Overall Study|Adverse Event unrelated to drug|0|||
170447247|NCT01714739|615974524|FG005|Overall Study|Adverse Event unrelated to drug|0|||
170447248|NCT01714739|615974525|FG006|Overall Study|Adverse Event unrelated to drug|0|||
170447249|NCT01714739|615974519|FG000|Overall Study|Participant request to stop therapy|0|||
170447250|NCT01714739|615974520|FG001|Overall Study|Participant request to stop therapy|1|||
170447251|NCT01714739|615974521|FG002|Overall Study|Participant request to stop therapy|0|||
170447252|NCT01714739|615974522|FG003|Overall Study|Participant request to stop therapy|6|||
170447253|NCT01714739|615974523|FG004|Overall Study|Participant request to stop therapy|0|||
170447254|NCT01714739|615974524|FG005|Overall Study|Participant request to stop therapy|0|||
170447255|NCT01714739|615974525|FG006|Overall Study|Participant request to stop therapy|0|||
170447256|NCT01714739|615974519|FG000|Overall Study|Participant withdrew consent|0|||
170447257|NCT01714739|615974520|FG001|Overall Study|Participant withdrew consent|1|||
170447258|NCT01714739|615974521|FG002|Overall Study|Participant withdrew consent|0|||
170447259|NCT01714739|615974522|FG003|Overall Study|Participant withdrew consent|8|||
170447260|NCT01714739|615974523|FG004|Overall Study|Participant withdrew consent|0|||
170447261|NCT01714739|615974524|FG005|Overall Study|Participant withdrew consent|0|||
170447262|NCT01714739|615974525|FG006|Overall Study|Participant withdrew consent|0|||
170447263|NCT01714739|615974519|FG000|Overall Study|Lost to Follow-up|0|||
170447264|NCT01714739|615974520|FG001|Overall Study|Lost to Follow-up|0|||
170447265|NCT01714739|615974521|FG002|Overall Study|Lost to Follow-up|0|||
170447266|NCT01714739|615974522|FG003|Overall Study|Lost to Follow-up|1|||
170447267|NCT01714739|615974523|FG004|Overall Study|Lost to Follow-up|0|||
170447268|NCT01714739|615974524|FG005|Overall Study|Lost to Follow-up|0|||
170447269|NCT01714739|615974525|FG006|Overall Study|Lost to Follow-up|0|||
170447270|NCT01714739|615974519|FG000|Overall Study|Maximum clinical benefit|0|||
170447271|NCT01714739|615974520|FG001|Overall Study|Maximum clinical benefit|1|||
170447272|NCT01714739|615974521|FG002|Overall Study|Maximum clinical benefit|1|||
170447273|NCT01714739|615974522|FG003|Overall Study|Maximum clinical benefit|3|||
170447274|NCT01714739|615974523|FG004|Overall Study|Maximum clinical benefit|0|||
170447275|NCT01714739|615974524|FG005|Overall Study|Maximum clinical benefit|0|||
170447276|NCT01714739|615974525|FG006|Overall Study|Maximum clinical benefit|0|||
170447277|NCT01714739|615974519|FG000|Overall Study|Poor/non-comliance|0|||
170447278|NCT01714739|615974520|FG001|Overall Study|Poor/non-comliance|1|||
170447279|NCT01714739|615974521|FG002|Overall Study|Poor/non-comliance|0|||
170447280|NCT01714739|615974522|FG003|Overall Study|Poor/non-comliance|1|||
170447281|NCT01714739|615974523|FG004|Overall Study|Poor/non-comliance|0|||
170447282|NCT01714739|615974524|FG005|Overall Study|Poor/non-comliance|0|||
170447283|NCT01714739|615974525|FG006|Overall Study|Poor/non-comliance|0|||
170447284|NCT01714739|615974519|FG000|Overall Study|No longer meets study criteria|0|||
170447285|NCT01714739|615974520|FG001|Overall Study|No longer meets study criteria|0|||
170447286|NCT01714739|615974521|FG002|Overall Study|No longer meets study criteria|0|||
170447287|NCT01714739|615974522|FG003|Overall Study|No longer meets study criteria|1|||
170447288|NCT01714739|615974523|FG004|Overall Study|No longer meets study criteria|0|||
170447289|NCT01714739|615974524|FG005|Overall Study|No longer meets study criteria|0|||
170447290|NCT01714739|615974525|FG006|Overall Study|No longer meets study criteria|0|||
170447291|NCT01714739|615974519|FG000|Overall Study|Other reason|0|||
170447292|NCT01714739|615974520|FG001|Overall Study|Other reason|0|||
170447293|NCT01714739|615974521|FG002|Overall Study|Other reason|0|||
170447294|NCT01714739|615974522|FG003|Overall Study|Other reason|3|||
170447295|NCT01714739|615974523|FG004|Overall Study|Other reason|1|||
170447296|NCT01714739|615974524|FG005|Overall Study|Other reason|0|||
170447297|NCT01714739|615974525|FG006|Overall Study|Other reason|0|||
170447298|NCT01264835|615974528|FG000|Overall Study|Lost to Follow-up|1|||
170447299|NCT01115933|615974529|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
170447300|NCT00089076|615974532|FG000|Overall Study|Alternate Therapy|1|||
170447301|NCT00089076|615974532|FG000|Overall Study|Withdrawal by Subject|2|||
170447302|NCT00089076|615974532|FG000|Overall Study|Progression|7|||
170447303|NCT00808509|615974533|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
170447304|NCT00808509|615974534|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
170447305|NCT00808509|615974533|FG000|Randomized Phase|Reduced methotrexate dose|1|||
170447306|NCT00808509|615974534|FG001|Randomized Phase|Reduced methotrexate dose|2|||
170447307|NCT00808509|615974533|FG000|Randomized Phase|Patient refused rescue therapy|0|||
170447308|NCT00808509|615974534|FG001|Randomized Phase|Patient refused rescue therapy|3|||
170447309|NCT03170869|615974537|FG000|Overall Study|Protocol Violation|5|||
170447310|NCT03170869|615974537|FG000|Overall Study|Early study termination|3|||
170447311|NCT01175473|615974542|FG000|Overall Study|Adverse Event|2|||
170447312|NCT01175473|615974543|FG001|Overall Study|Adverse Event|2|||
170447313|NCT01701973|615974548|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
170447314|NCT01701973|615974549|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
170447315|NCT01701973|615974550|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
170447316|NCT01701973|615974551|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
170447317|NCT01701973|615974552|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
170447318|NCT01701973|615974553|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
170447319|NCT01701973|615974554|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
170447320|NCT01701973|615974555|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
170447321|NCT00373425|615974556|FG000|Overall Study|Relapse of NSCLC|116|||
170447322|NCT00373425|615974557|FG001|Overall Study|Relapse of NSCLC|104|||
170447323|NCT00373425|615974558|FG002|Overall Study|Relapse of NSCLC|19|||
170447324|NCT00373425|615974559|FG003|Overall Study|Relapse of NSCLC|2|||
170447325|NCT00373425|615974560|FG004|Overall Study|Relapse of NSCLC|26|||
170447326|NCT00373425|615974556|FG000|Overall Study|Adverse Event|191|||
170447327|NCT00373425|615974557|FG001|Overall Study|Adverse Event|22|||
170447328|NCT00373425|615974558|FG002|Overall Study|Adverse Event|59|||
170447329|NCT00373425|615974559|FG003|Overall Study|Adverse Event|0|||
170447330|NCT00373425|615974560|FG004|Overall Study|Adverse Event|34|||
170447331|NCT00373425|615974556|FG000|Overall Study|Patient request|35|||
170447332|NCT00373425|615974557|FG001|Overall Study|Patient request|18|||
170447333|NCT00373425|615974558|FG002|Overall Study|Patient request|43|||
170447334|NCT00373425|615974559|FG003|Overall Study|Patient request|6|||
170447335|NCT00373425|615974560|FG004|Overall Study|Patient request|7|||
170447336|NCT00373425|615974556|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
170447337|NCT00373425|615974557|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
170447338|NCT00373425|615974558|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
170447339|NCT00373425|615974559|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
170447340|NCT00373425|615974560|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
170447341|NCT00373425|615974556|FG000|Overall Study|Death|7|||
170447342|NCT00373425|615974557|FG001|Overall Study|Death|0|||
170447343|NCT00373425|615974558|FG002|Overall Study|Death|3|||
170447344|NCT00373425|615974559|FG003|Overall Study|Death|1|||
170447345|NCT00373425|615974560|FG004|Overall Study|Death|0|||
170447346|NCT00003531|615974563|FG000|Overall Study|Not evaluable|10|||
170447347|NCT03297294|615974564|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
170447348|NCT03297294|615974565|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
170447349|NCT03297294|615974566|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
170447350|NCT03297294|615974567|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
170447351|NCT03297294|615974568|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
170447352|NCT03297294|615974564|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
170786151|NCT01997840|617225423|FG003|Overall Study|Physician Decision|0|||
170447353|NCT03297294|615974565|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
170447354|NCT03297294|615974566|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170447355|NCT03297294|615974567|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170447356|NCT03297294|615974568|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170447357|NCT03297294|615974564|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
170447358|NCT03297294|615974565|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
170447359|NCT03297294|615974566|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
170447360|NCT03297294|615974567|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
170447361|NCT03297294|615974568|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
170447362|NCT03297294|615974564|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
170447363|NCT03297294|615974565|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
170447364|NCT03297294|615974566|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170447365|NCT03297294|615974567|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170447366|NCT03297294|615974568|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170447367|NCT03297294|615974564|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
170447368|NCT03297294|615974565|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
170447369|NCT03297294|615974566|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
170447370|NCT03297294|615974567|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
170447371|NCT03297294|615974568|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
170447372|NCT02692482|615974569|FG000|Overall Study|Death|2|||
170447373|NCT02692482|615974570|FG001|Overall Study|Death|2|||
170447374|NCT02692482|615974569|FG000|Overall Study|Withdrawal by Subject|1|||
170447375|NCT02692482|615974570|FG001|Overall Study|Withdrawal by Subject|2|||
170447376|NCT01435031|615974571|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
170447377|NCT01435031|615974571|FG000|ITT at 1 Month|Death|1|||
170447378|NCT01435031|615974571|FG000|ITT at 1 Month|Lost to Follow-up|4|||
170447379|NCT01435031|615974571|FG000|ITT at 6 Months|Death|2|||
170447380|NCT01435031|615974571|FG000|ITT at 6 Months|Lost to Follow-up|3|||
170447381|NCT01435031|615974571|FG000|ITT at 1 Year|Death|1|||
170447382|NCT01435031|615974571|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
170447383|NCT01435031|615974571|FG000|ITT at 1 Year|Lost to Follow-up|6|||
170447384|NCT01435031|615974571|FG000|ITT at 2 Years|Death|7|||
170447385|NCT01435031|615974571|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
170447386|NCT01435031|615974571|FG000|ITT at 2 Years|Lost to Follow-up|4|||
170447387|NCT01435031|615974571|FG000|ITT at 3 Years|Death|5|||
170447388|NCT01435031|615974571|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
170447389|NCT01435031|615974571|FG000|ITT at 3 Years|Lost to Follow-up|4|||
170447390|NCT01435031|615974571|FG000|ITT at 4 Years|Death|4|||
170447391|NCT01435031|615974571|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
170447392|NCT01435031|615974571|FG000|ITT at 4 Years|Lost to Follow-up|1|||
170447393|NCT02260258|615974572|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
170447394|NCT02260258|615974573|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
170447395|NCT00438659|615974580|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
170447396|NCT00438659|615974581|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
170447397|NCT00438659|615974580|FG000|Overall Study|Cancel|5|||
170447398|NCT00438659|615974581|FG001|Overall Study|Cancel|2|||
170447399|NCT03718117|615974582|FG000|Overall Study|Death|12|||
170447400|NCT03718117|615974583|FG001|Overall Study|Death|11|||
170447401|NCT03718117|615974584|FG002|Overall Study|Death|0|||
170447402|NCT03718117|615974582|FG000|Overall Study|Other|0|||
170447403|NCT03718117|615974583|FG001|Overall Study|Other|1|||
170447404|NCT03718117|615974584|FG002|Overall Study|Other|0|||
170447405|NCT03718117|615974582|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
170447406|NCT03718117|615974583|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
170447407|NCT03718117|615974584|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
170447408|NCT03718117|615974582|FG000|Overall Study|Participant not met eligibility criteria|0|||
170447409|NCT03718117|615974583|FG001|Overall Study|Participant not met eligibility criteria|0|||
170447410|NCT03718117|615974584|FG002|Overall Study|Participant not met eligibility criteria|2|||
170447411|NCT00206102|615974585|FG000|Overall Study|Adverse Event|119|||
170447412|NCT00206102|615974586|FG001|Overall Study|Adverse Event|82|||
170447413|NCT00206102|615974585|FG000|Overall Study|Protocol Violation|0|||
170447414|NCT00206102|615974586|FG001|Overall Study|Protocol Violation|2|||
170447415|NCT00206102|615974585|FG000|Overall Study|Lack of therapeutic response|16|||
170540055|NCT00541229|616320718|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
170886967|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
170447416|NCT00206102|615974586|FG001|Overall Study|Lack of therapeutic response|11|||
170447417|NCT00206102|615974585|FG000|Overall Study|Lost to Follow-up|95|||
170447418|NCT00206102|615974586|FG001|Overall Study|Lost to Follow-up|66|||
170447419|NCT00206102|615974585|FG000|Overall Study|Withdrawal by Subject|118|||
170447420|NCT00206102|615974586|FG001|Overall Study|Withdrawal by Subject|101|||
170447421|NCT00206102|615974585|FG000|Overall Study|Study-specific discontinuation criteria|18|||
170447422|NCT00206102|615974586|FG001|Overall Study|Study-specific discontinuation criteria|17|||
170447423|NCT00206102|615974585|FG000|Overall Study|None of those categories|42|||
170447424|NCT00206102|615974586|FG001|Overall Study|None of those categories|36|||
170447425|NCT01169038|615974589|FG000|Overall Study|Death|1|||
170447426|NCT01169038|615974589|FG000|Overall Study|Adverse Event|5|||
170447427|NCT01169038|615974589|FG000|Overall Study|Required antibiotic administration|1|||
170447428|NCT02490800|615974590|FG000|Overall Study|Adverse Event|0|||
170447429|NCT02490800|615974591|FG001|Overall Study|Adverse Event|0|||
170447430|NCT02490800|615974592|FG002|Overall Study|Adverse Event|0|||
170447431|NCT02490800|615974593|FG003|Overall Study|Adverse Event|2|||
170447432|NCT02490800|615974594|FG004|Overall Study|Adverse Event|3|||
170447433|NCT02490800|615974595|FG005|Overall Study|Adverse Event|2|||
170447434|NCT02490800|615974596|FG006|Overall Study|Adverse Event|0|||
170447435|NCT02490800|615974597|FG007|Overall Study|Adverse Event|0|||
170447436|NCT02490800|615974598|FG008|Overall Study|Adverse Event|0|||
170447437|NCT02490800|615974599|FG009|Overall Study|Adverse Event|0|||
170447438|NCT02490800|615974600|FG010|Overall Study|Adverse Event|0|||
170447439|NCT02490800|615974601|FG011|Overall Study|Adverse Event|2|||
170447440|NCT02490800|615974602|FG012|Overall Study|Adverse Event|2|||
170447441|NCT02490800|615974590|FG000|Overall Study|Withdrawal by Subject|0|||
170447442|NCT02490800|615974591|FG001|Overall Study|Withdrawal by Subject|0|||
170447443|NCT02490800|615974592|FG002|Overall Study|Withdrawal by Subject|0|||
170447444|NCT02490800|615974593|FG003|Overall Study|Withdrawal by Subject|1|||
170447445|NCT02490800|615974594|FG004|Overall Study|Withdrawal by Subject|0|||
170447446|NCT02490800|615974595|FG005|Overall Study|Withdrawal by Subject|0|||
170447447|NCT02490800|615974596|FG006|Overall Study|Withdrawal by Subject|0|||
170447448|NCT02490800|615974597|FG007|Overall Study|Withdrawal by Subject|0|||
170447449|NCT02490800|615974598|FG008|Overall Study|Withdrawal by Subject|1|||
170447450|NCT02490800|615974599|FG009|Overall Study|Withdrawal by Subject|0|||
170447451|NCT02490800|615974600|FG010|Overall Study|Withdrawal by Subject|0|||
170447452|NCT02490800|615974601|FG011|Overall Study|Withdrawal by Subject|0|||
170447453|NCT02490800|615974602|FG012|Overall Study|Withdrawal by Subject|0|||
170447454|NCT02490800|615974590|FG000|Overall Study|Progressive disease|3|||
170447455|NCT02490800|615974591|FG001|Overall Study|Progressive disease|3|||
170447456|NCT02490800|615974592|FG002|Overall Study|Progressive disease|3|||
170447457|NCT02490800|615974593|FG003|Overall Study|Progressive disease|4|||
170447458|NCT02490800|615974594|FG004|Overall Study|Progressive disease|4|||
170447459|NCT02490800|615974595|FG005|Overall Study|Progressive disease|1|||
170447460|NCT02490800|615974596|FG006|Overall Study|Progressive disease|4|||
170447461|NCT02490800|615974597|FG007|Overall Study|Progressive disease|3|||
170447462|NCT02490800|615974598|FG008|Overall Study|Progressive disease|6|||
170447463|NCT02490800|615974599|FG009|Overall Study|Progressive disease|2|||
170447464|NCT02490800|615974600|FG010|Overall Study|Progressive disease|7|||
170447465|NCT02490800|615974601|FG011|Overall Study|Progressive disease|1|||
170447466|NCT02490800|615974602|FG012|Overall Study|Progressive disease|10|||
170447467|NCT02490800|615974590|FG000|Overall Study|Patient enrolled in post-trial access|0|||
170447468|NCT02490800|615974591|FG001|Overall Study|Patient enrolled in post-trial access|0|||
170447469|NCT02490800|615974592|FG002|Overall Study|Patient enrolled in post-trial access|0|||
170447470|NCT02490800|615974593|FG003|Overall Study|Patient enrolled in post-trial access|0|||
170447471|NCT02490800|615974594|FG004|Overall Study|Patient enrolled in post-trial access|0|||
170447472|NCT02490800|615974595|FG005|Overall Study|Patient enrolled in post-trial access|0|||
170447473|NCT02490800|615974596|FG006|Overall Study|Patient enrolled in post-trial access|0|||
170447474|NCT02490800|615974597|FG007|Overall Study|Patient enrolled in post-trial access|0|||
170447475|NCT02490800|615974598|FG008|Overall Study|Patient enrolled in post-trial access|0|||
170447476|NCT02490800|615974599|FG009|Overall Study|Patient enrolled in post-trial access|1|||
170447477|NCT02490800|615974600|FG010|Overall Study|Patient enrolled in post-trial access|1|||
170447478|NCT02490800|615974601|FG011|Overall Study|Patient enrolled in post-trial access|0|||
170447479|NCT02490800|615974602|FG012|Overall Study|Patient enrolled in post-trial access|6|||
170447480|NCT04232540|615974603|FG000|Overall Study|Lost to Follow-up|1|||
170447481|NCT04232540|615974604|FG001|Overall Study|Lost to Follow-up|0|||
170447482|NCT01662362|615974605|FG000|Overall Study|Lost to Follow-up|38|||
170447483|NCT00576303|615974606|FG000|Dose Titration Period|Early withdrawal|17|||
170447484|NCT00576303|615974606|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
170447485|NCT00576303|615974606|FG000|Long Term Safety Period|Early withdrawal|16|||
170447486|NCT03183141|615974607|FG000|Overall Study|Withdrawal by Subject|2|||
170447487|NCT03183141|615974608|FG001|Overall Study|Withdrawal by Subject|4|||
170447488|NCT03183141|615974607|FG000|Overall Study|Death|0|||
170447489|NCT03183141|615974608|FG001|Overall Study|Death|8|||
170447490|NCT02175368|615974610|FG000|Overall Study|Lost to Follow-up|1|||
170447491|NCT05068284|615974611|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
170540056|NCT00541229|616320719|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
170540057|NCT00541229|616320720|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
170540058|NCT00541229|616320721|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
170447492|NCT05068284|615974612|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
170447493|NCT05068284|615974613|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
170447494|NCT05068284|615974614|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
170447495|NCT05068284|615974615|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
170447496|NCT05068284|615974616|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
170447497|NCT05068284|615974617|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
170447498|NCT05068284|615974618|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
170447499|NCT05068284|615974611|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
170447500|NCT05068284|615974612|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
170447501|NCT05068284|615974613|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
170447502|NCT05068284|615974614|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
170447503|NCT05068284|615974615|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
170447504|NCT05068284|615974616|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
170447505|NCT05068284|615974617|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
170447506|NCT05068284|615974618|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
170447507|NCT05068284|615974611|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
170447508|NCT05068284|615974612|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
170447509|NCT05068284|615974613|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
170447510|NCT05068284|615974614|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
170447511|NCT05068284|615974615|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
170447512|NCT05068284|615974616|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
170447513|NCT05068284|615974617|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
170447514|NCT05068284|615974618|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
170447515|NCT05068284|615974611|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
170447516|NCT05068284|615974612|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
170447517|NCT05068284|615974613|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
170447518|NCT05068284|615974614|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
170447519|NCT05068284|615974615|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
170447520|NCT05068284|615974616|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
170447521|NCT05068284|615974617|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
170447522|NCT05068284|615974618|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
170447523|NCT05068284|615974611|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
170886968|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
170447524|NCT05068284|615974612|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
170447525|NCT05068284|615974613|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
170447526|NCT05068284|615974614|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
170447527|NCT05068284|615974615|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
170447528|NCT05068284|615974616|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
170447529|NCT05068284|615974617|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
170447530|NCT05068284|615974618|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
170540059|NCT00541229|616320722|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
170540060|NCT00541229|616320717|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
170540061|NCT00541229|616320718|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
170540062|NCT00541229|616320719|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
170540063|NCT00541229|616320720|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
170540064|NCT00541229|616320721|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
170540065|NCT00541229|616320722|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
170633793|NCT01285323|616670126|FG001|Overall Study|Non-compliance with study procedures|3|||
170886969|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
170886970|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
170447531|NCT05068284|615974611|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
170447532|NCT05068284|615974612|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
170447533|NCT05068284|615974613|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
170886971|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
170886972|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
170886973|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
170447534|NCT05068284|615974614|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
170447535|NCT05068284|615974615|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
170447536|NCT05068284|615974616|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
170886974|NCT03403205|617593562|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
170886975|NCT03403205|617593563|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
170886976|NCT03403205|617593564|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
170886977|NCT03403205|617593565|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
170886978|NCT03403205|617593566|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
170447537|NCT05068284|615974617|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
170447538|NCT05068284|615974618|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
170447539|NCT05068284|615974611|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
170447540|NCT05068284|615974612|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
170540066|NCT00541229|616320717|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
170633794|NCT01285323|616670125|FG000|Overall Study|Lost to Follow-up|1|||
170633795|NCT01285323|616670126|FG001|Overall Study|Lost to Follow-up|1|||
170540067|NCT00541229|616320718|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
170540068|NCT00541229|616320719|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
170540069|NCT00541229|616320720|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
170540070|NCT00541229|616320721|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
170540071|NCT00541229|616320722|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
170540072|NCT00541229|616320717|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
170540073|NCT00541229|616320718|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
170540074|NCT00541229|616320719|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
170540075|NCT00541229|616320720|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
170540076|NCT00541229|616320721|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
170540077|NCT00541229|616320722|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
170540078|NCT05977868|616320723|FG000|Overall Study|Withdrawal by Subject|1|||
170540079|NCT05977868|616320724|FG001|Overall Study|Withdrawal by Subject|2|||
170540080|NCT05977868|616320723|FG000|Overall Study|Transitioned to comfort care|1|||
170540081|NCT05977868|616320724|FG001|Overall Study|Transitioned to comfort care|0|||
170540082|NCT00876395|616320725|FG000|Overall Study|Untreated|8|||
170540083|NCT00876395|616320726|FG001|Overall Study|Untreated|1|||
170540084|NCT00876395|616320725|FG000|Overall Study|Adverse Event|63|||
170540085|NCT00876395|616320726|FG001|Overall Study|Adverse Event|11|||
170540086|NCT00876395|616320725|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170540087|NCT00876395|616320726|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170540088|NCT00876395|616320725|FG000|Overall Study|Disease progression|259|||
170540089|NCT00876395|616320726|FG001|Overall Study|Disease progression|162|||
170540090|NCT00876395|616320725|FG000|Overall Study|New cancer therapy|25|||
170540091|NCT00876395|616320726|FG001|Overall Study|New cancer therapy|7|||
170540092|NCT00876395|616320725|FG000|Overall Study|Protocol Violation|5|||
170540093|NCT00876395|616320726|FG001|Overall Study|Protocol Violation|2|||
170540094|NCT00876395|616320725|FG000|Overall Study|Withdrawal by Subject|66|||
170540095|NCT00876395|616320726|FG001|Overall Study|Withdrawal by Subject|33|||
170540096|NCT00876395|616320725|FG000|Overall Study|Lost to Follow-up|2|||
170540097|NCT00876395|616320726|FG001|Overall Study|Lost to Follow-up|0|||
170540098|NCT00876395|616320725|FG000|Overall Study|Administrative problems|39|||
170540099|NCT00876395|616320726|FG001|Overall Study|Administrative problems|23|||
170540100|NCT00876395|616320725|FG000|Overall Study|Death|12|||
170540101|NCT00876395|616320726|FG001|Overall Study|Death|0|||
170540102|NCT01312129|616320727|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
170540103|NCT01312129|616320728|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
170540104|NCT01239680|616320731|FG000|Overall Study|Withdrawal by Subject|2|||
170540105|NCT01239680|616320732|FG001|Overall Study|Withdrawal by Subject|0|||
170540106|NCT01787838|616320733|FG000|Overall Study|refused|1413|||
170540107|NCT05177094|616320737|FG000|Overall Study|Adverse Event|5|||
170540108|NCT05177094|616320738|FG001|Overall Study|Adverse Event|5|||
170540109|NCT05177094|616320737|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
170540110|NCT05177094|616320738|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
170540111|NCT05177094|616320737|FG000|Overall Study|Protocol Deviation|3|||
170540112|NCT05177094|616320738|FG001|Overall Study|Protocol Deviation|0|||
170540113|NCT05177094|616320737|FG000|Overall Study|Withdrawal by Subject|6|||
170540114|NCT05177094|616320738|FG001|Overall Study|Withdrawal by Subject|3|||
170540115|NCT05177094|616320737|FG000|Overall Study|Participant could not tolerate long study visits|1|||
170540116|NCT05177094|616320738|FG001|Overall Study|Participant could not tolerate long study visits|0|||
170540117|NCT02737618|616320739|FG000|Overall Study|Withdrawal by Subject|9|||
170540118|NCT02397837|616320747|FG000|Overall Study|Withdrawal by Subject|6|||
170540119|NCT02397837|616320748|FG001|Overall Study|Withdrawal by Subject|5|||
170540120|NCT02397837|616320747|FG000|Overall Study|Physician Decision|1|||
170540121|NCT02397837|616320748|FG001|Overall Study|Physician Decision|1|||
170540122|NCT02536794|616320752|FG000|Reached 1st Response Assessment|Adverse Event|2|||
170540123|NCT02536794|616320752|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
170540124|NCT02536794|616320752|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
170540125|NCT02536794|616320752|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
170540126|NCT02536794|616320752|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
170540127|NCT02536794|616320752|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
170540128|NCT00313170|616320753|FG000|Overall Study|Death|2|||
170540129|NCT00313170|616320754|FG001|Overall Study|Death|4|||
170540130|NCT00313170|616320755|FG002|Overall Study|Death|2|||
170786152|NCT01997840|617225420|FG000|Overall Study|Progressive disease|3|||
170540131|NCT00313170|616320753|FG000|Overall Study|Adverse Event|1|||
170540132|NCT00313170|616320754|FG001|Overall Study|Adverse Event|2|||
170540133|NCT00313170|616320755|FG002|Overall Study|Adverse Event|0|||
170540134|NCT00313170|616320753|FG000|Overall Study|Disease progression|31|||
170540135|NCT00313170|616320754|FG001|Overall Study|Disease progression|26|||
170540136|NCT00313170|616320755|FG002|Overall Study|Disease progression|27|||
170633796|NCT01285323|616670125|FG000|Overall Study|Other|1|||
170447541|NCT05068284|615974613|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
170786153|NCT01997840|617225421|FG001|Overall Study|Progressive disease|4|||
170786154|NCT01997840|617225422|FG002|Overall Study|Progressive disease|57|||
170786155|NCT01997840|617225423|FG003|Overall Study|Progressive disease|8|||
170786156|NCT01997840|617225420|FG000|Overall Study|Other reasons|0|||
170447542|NCT05068284|615974614|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
170447543|NCT05068284|615974615|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
170447544|NCT05068284|615974616|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
170447545|NCT05068284|615974617|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
170447546|NCT05068284|615974618|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
170447547|NCT05068284|615974611|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
170447548|NCT05068284|615974612|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
170447549|NCT05068284|615974613|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
170447550|NCT05068284|615974614|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
170447551|NCT05068284|615974615|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
170447552|NCT05068284|615974616|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
170447553|NCT05068284|615974617|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
170447554|NCT05068284|615974618|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
170447555|NCT05068284|615974611|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
170447556|NCT05068284|615974612|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
170447557|NCT05068284|615974613|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
170447558|NCT05068284|615974614|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
170447559|NCT05068284|615974615|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
170447560|NCT05068284|615974616|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
170447561|NCT05068284|615974617|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
170447562|NCT05068284|615974618|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
170447563|NCT05068284|615974611|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
170447564|NCT05068284|615974612|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
170447565|NCT05068284|615974613|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
170447566|NCT05068284|615974614|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
170447567|NCT05068284|615974615|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
170447568|NCT05068284|615974616|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
170447569|NCT05068284|615974617|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
170447570|NCT05068284|615974618|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
170447571|NCT05068284|615974611|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
170447572|NCT05068284|615974612|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
170447573|NCT05068284|615974613|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
170447574|NCT05068284|615974614|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
170447575|NCT05068284|615974615|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
170447576|NCT05068284|615974616|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
170447577|NCT05068284|615974617|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
170447578|NCT05068284|615974618|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
170447579|NCT05068284|615974611|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
170447580|NCT05068284|615974612|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
170447581|NCT05068284|615974613|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
170447582|NCT05068284|615974614|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
170447583|NCT05068284|615974615|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
170447584|NCT05068284|615974616|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
170447585|NCT05068284|615974617|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
170447586|NCT05068284|615974618|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
170447587|NCT05068284|615974611|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
170447588|NCT05068284|615974612|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
170447589|NCT05068284|615974613|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
170447590|NCT05068284|615974614|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
170447591|NCT05068284|615974615|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
170786157|NCT01997840|617225421|FG001|Overall Study|Other reasons|0|||
170786158|NCT01997840|617225422|FG002|Overall Study|Other reasons|1|||
170447592|NCT05068284|615974616|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
170447593|NCT05068284|615974617|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
170447594|NCT05068284|615974618|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
170447595|NCT05068284|615974611|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
170447596|NCT05068284|615974612|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
170447597|NCT05068284|615974613|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
170447598|NCT05068284|615974614|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
170447599|NCT05068284|615974615|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
170447600|NCT05068284|615974616|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
170447601|NCT05068284|615974617|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
170447602|NCT05068284|615974618|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
170447603|NCT03250299|615976638|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
170447604|NCT03250299|615976639|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
170447605|NCT03250299|615976640|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
170447606|NCT03250299|615976641|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
170447607|NCT03250299|615976642|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
170447608|NCT03250299|615976638|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
170447609|NCT03250299|615976639|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
170447610|NCT03250299|615976640|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
170447611|NCT03250299|615976641|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
170447612|NCT03250299|615976642|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
170447613|NCT03250299|615976638|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
170447614|NCT03250299|615976639|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
170447615|NCT03250299|615976640|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
170447616|NCT03250299|615976641|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
170447617|NCT03250299|615976642|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
170447618|NCT03250299|615976638|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
170447619|NCT03250299|615976639|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
170447620|NCT03250299|615976640|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
170447621|NCT03250299|615976641|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
170447622|NCT03250299|615976642|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
170786159|NCT01997840|617225423|FG003|Overall Study|Other reasons|0|||
170786160|NCT01997840|617225420|FG000|Overall Study|Adverse Event|0|||
170786161|NCT01997840|617225421|FG001|Overall Study|Adverse Event|0|||
170786162|NCT01997840|617225422|FG002|Overall Study|Adverse Event|15|||
170786163|NCT01997840|617225423|FG003|Overall Study|Adverse Event|2|||
170786164|NCT03850678|617225426|FG000|Overall Study|Withdrawal by Subject|3|||
170786165|NCT03850678|617225427|FG001|Overall Study|Withdrawal by Subject|0|||
170786166|NCT03850678|617225426|FG000|Overall Study|Experimenter Error|1|||
170786167|NCT03850678|617225427|FG001|Overall Study|Experimenter Error|1|||
170786168|NCT03850678|617225426|FG000|Overall Study|Did Not Condition To Experiment|7|||
170786169|NCT03850678|617225427|FG001|Overall Study|Did Not Condition To Experiment|2|||
170786170|NCT03891667|617225434|FG000|Overall Study|Physician Decision|1|||
170786171|NCT03891667|617225435|FG001|Overall Study|Physician Decision|1|||
170786172|NCT03891667|617225434|FG000|Overall Study|COVID related pause|1|||
170786173|NCT03891667|617225435|FG001|Overall Study|COVID related pause|0|||
170786174|NCT03891667|617225434|FG000|Overall Study|Withdrawal by Subject|0|||
170786175|NCT03891667|617225435|FG001|Overall Study|Withdrawal by Subject|1|||
170786176|NCT03891667|617225434|FG000|Overall Study|Adverse Event|0|||
170786177|NCT03891667|617225435|FG001|Overall Study|Adverse Event|1|||
170786178|NCT04763265|617225436|FG000|Overall Study|Adverse Event|1|||
170786179|NCT04763265|617225437|FG001|Overall Study|Adverse Event|0|||
170786180|NCT04763265|617225436|FG000|Overall Study|Lost to Follow-up|2|||
170786181|NCT04763265|617225437|FG001|Overall Study|Lost to Follow-up|4|||
170786182|NCT04763265|617225436|FG000|Overall Study|Withdrawal by Subject|0|||
170786183|NCT04763265|617225437|FG001|Overall Study|Withdrawal by Subject|1|||
170786184|NCT05590403|617225439|FG000|Overall Study|Lost to Follow-up|13|||
170786185|NCT05590403|617225440|FG001|Overall Study|Lost to Follow-up|1|||
170786186|NCT05590403|617225441|FG002|Overall Study|Lost to Follow-up|7|||
170786187|NCT05590403|617225442|FG003|Overall Study|Lost to Follow-up|3|||
170786188|NCT05590403|617225443|FG004|Overall Study|Lost to Follow-up|4|||
170786189|NCT05590403|617225439|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
170786190|NCT05590403|617225440|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
170786191|NCT05590403|617225441|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
170447623|NCT04373551|615976645|FG000|Overall Study|Lost to Follow-up|15|||
170447624|NCT04373551|615976645|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
170447625|NCT01546922|615976646|FG000|First Period of 10 Weeks|Protocol Violation|3|||
170786192|NCT05590403|617225442|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
170447626|NCT01546922|615976647|FG001|First Period of 10 Weeks|Protocol Violation|1|||
170786193|NCT05590403|617225443|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
170786194|NCT05590403|617225439|FG000|Overall Study|Other|2|||
170786195|NCT05590403|617225440|FG001|Overall Study|Other|0|||
170786196|NCT05590403|617225441|FG002|Overall Study|Other|2|||
170786197|NCT05590403|617225442|FG003|Overall Study|Other|2|||
170540137|NCT00313170|616320753|FG000|Overall Study|Withdrawal by Subject|1|||
170540138|NCT00313170|616320754|FG001|Overall Study|Withdrawal by Subject|0|||
170540139|NCT00313170|616320755|FG002|Overall Study|Withdrawal by Subject|1|||
170540140|NCT00313170|616320753|FG000|Overall Study|Incorrect enrollment|0|||
170540141|NCT00313170|616320754|FG001|Overall Study|Incorrect enrollment|2|||
170540142|NCT00313170|616320755|FG002|Overall Study|Incorrect enrollment|1|||
170540143|NCT00313170|616320753|FG000|Overall Study|Lost to Follow-up|0|||
170786198|NCT05590403|617225443|FG004|Overall Study|Other|0|||
170540144|NCT00313170|616320754|FG001|Overall Study|Lost to Follow-up|0|||
170540145|NCT00313170|616320755|FG002|Overall Study|Lost to Follow-up|1|||
170540146|NCT00313170|616320753|FG000|Overall Study|Progression (investigators opinion)|1|||
170540147|NCT00313170|616320754|FG001|Overall Study|Progression (investigators opinion)|0|||
170786199|NCT05590403|617225439|FG000|Overall Study|Migrated / moved from the study area|1|||
170786200|NCT05590403|617225440|FG001|Overall Study|Migrated / moved from the study area|1|||
170786201|NCT05590403|617225441|FG002|Overall Study|Migrated / moved from the study area|0|||
170786202|NCT05590403|617225442|FG003|Overall Study|Migrated / moved from the study area|3|||
170786203|NCT05590403|617225443|FG004|Overall Study|Migrated / moved from the study area|1|||
170786204|NCT05590403|617225439|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
170786205|NCT05590403|617225440|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
170786206|NCT05590403|617225441|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
170786207|NCT05590403|617225442|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
170786208|NCT05590403|617225443|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
170786209|NCT05659537|617225444|FG000|Overall Study|Adverse Event|5|||
170786210|NCT05659537|617225444|FG000|Overall Study|Lost to Follow-up|4|||
170786211|NCT05659537|617225444|FG000|Overall Study|Withdrawal by Subject|13|||
170786212|NCT05659537|617225444|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
170786213|NCT05659537|617225444|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
170786214|NCT05659537|617225444|FG000|Overall Study|Participant was suffering from anaemia|1|||
170786215|NCT02737436|617225452|FG000|Washout Period|Lost to Follow-up|5|||
170786216|NCT02737436|617225453|FG001|Washout Period|Lost to Follow-up|11|||
170786217|NCT02737436|617225452|FG000|Data Analysis|Scanning data problems|5|||
170786218|NCT02737436|617225453|FG001|Data Analysis|Scanning data problems|8|||
170786219|NCT03936322|617225454|FG000|Overall Study|Lost to Follow-up|1|||
170786220|NCT03936322|617225454|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
170786221|NCT03721952|617225456|FG000|Overall Study|Lost to Follow-up|0|||
170786222|NCT03721952|617225457|FG001|Overall Study|Lost to Follow-up|0|||
170786223|NCT03721952|617225458|FG002|Overall Study|Lost to Follow-up|2|||
170786224|NCT03721952|617225459|FG003|Overall Study|Lost to Follow-up|0|||
170786225|NCT03721952|617225460|FG004|Overall Study|Lost to Follow-up|0|||
170786226|NCT03721952|617225456|FG000|Overall Study|Protocol Violation|0|||
170786227|NCT03721952|617225457|FG001|Overall Study|Protocol Violation|1|||
170786228|NCT03721952|617225458|FG002|Overall Study|Protocol Violation|0|||
170786229|NCT03721952|617225459|FG003|Overall Study|Protocol Violation|0|||
170886979|NCT03403205|617593567|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
170886980|NCT05779072|617593568|FG000|Overall Study|Lost to Follow-up|0|||
170886981|NCT05779072|617593569|FG001|Overall Study|Lost to Follow-up|1|||
170886982|NCT05779072|617593568|FG000|Overall Study|Withdrawal by Subject|1|||
170886983|NCT05779072|617593569|FG001|Overall Study|Withdrawal by Subject|5|||
170886984|NCT01445769|617593571|FG000|Overall Study|Consent Withdrawn|2|||
170886985|NCT01445769|617593571|FG000|Overall Study|Disease Progression|1|||
170886986|NCT01445769|617593571|FG000|Overall Study|Lost to Follow-up|5|||
170886987|NCT00044512|617593572|FG000|Follow Up|Lost to Follow-up|2|||
170886988|NCT00689871|617593579|FG000|Overall Study|Lost to Follow-up|123|||
170886989|NCT00689871|617593580|FG001|Overall Study|Lost to Follow-up|13|||
170886990|NCT00689871|617593581|FG002|Overall Study|Lost to Follow-up|37|||
170886991|NCT00689871|617593582|FG003|Overall Study|Lost to Follow-up|1|||
170886992|NCT00689871|617593579|FG000|Overall Study|Explanted of All Study Devices|36|||
170886993|NCT00689871|617593580|FG001|Overall Study|Explanted of All Study Devices|25|||
170886994|NCT00689871|617593581|FG002|Overall Study|Explanted of All Study Devices|29|||
170886995|NCT00689871|617593582|FG003|Overall Study|Explanted of All Study Devices|3|||
170886996|NCT00689871|617593579|FG000|Overall Study|Withdrawal by Subject|13|||
170886997|NCT00689871|617593580|FG001|Overall Study|Withdrawal by Subject|3|||
170886998|NCT00689871|617593581|FG002|Overall Study|Withdrawal by Subject|4|||
170886999|NCT00689871|617593582|FG003|Overall Study|Withdrawal by Subject|1|||
170887000|NCT00689871|617593579|FG000|Overall Study|Death|1|||
170887001|NCT00689871|617593580|FG001|Overall Study|Death|10|||
170887002|NCT00689871|617593581|FG002|Overall Study|Death|2|||
170887003|NCT00689871|617593582|FG003|Overall Study|Death|2|||
170887004|NCT00689871|617593579|FG000|Overall Study|Physician Decision|2|||
170540148|NCT00313170|616320755|FG002|Overall Study|Progression (investigators opinion)|0|||
170540149|NCT00817063|616320761|FG000|Overall Study|Adverse Event|32|||
170887005|NCT00689871|617593580|FG001|Overall Study|Physician Decision|1|||
170887006|NCT00689871|617593581|FG002|Overall Study|Physician Decision|1|||
170887007|NCT00689871|617593582|FG003|Overall Study|Physician Decision|0|||
170887008|NCT00343889|617593592|FG000|Overall Study|Lost to Follow-up|2|||
170887009|NCT00343889|617593593|FG001|Overall Study|Lost to Follow-up|0|||
170887010|NCT00343889|617593592|FG000|Overall Study|Withdrawal by Subject|0|||
170887011|NCT00343889|617593593|FG001|Overall Study|Withdrawal by Subject|1|||
170887012|NCT00343889|617593592|FG000|Overall Study|Protocol Violation|1|||
170887013|NCT00343889|617593593|FG001|Overall Study|Protocol Violation|0|||
170887014|NCT04417894|617593596|FG000|Overall Study|Lost to Follow-up|3|||
170887015|NCT04417894|617593597|FG001|Overall Study|Lost to Follow-up|0|||
170887016|NCT04417894|617593596|FG000|Overall Study|Withdrawal by Subject|7|||
170887017|NCT04417894|617593597|FG001|Overall Study|Withdrawal by Subject|6|||
170887018|NCT04417894|617593596|FG000|Overall Study|Lack of Efficacy|3|||
170887019|NCT04417894|617593597|FG001|Overall Study|Lack of Efficacy|1|||
170887020|NCT03652662|617593598|FG000|Overall Study|Withdrawal by Subject|2|||
170887021|NCT03652662|617593599|FG001|Overall Study|Withdrawal by Subject|1|||
170887022|NCT03652662|617593598|FG000|Overall Study|Lost to Follow-up|1|||
170887023|NCT03652662|617593599|FG001|Overall Study|Lost to Follow-up|0|||
170887024|NCT01627899|617593600|FG000|Overall Study|Study terminated early by sponsor.|5|||
170887025|NCT04428476|617593601|FG000|Overall Study|Withdrawal by Subject|1|||
170887026|NCT04428476|617593601|FG000|Overall Study|Still on treatment|12|||
170887027|NCT02043548|617593604|FG000|Overall Study|Lack of Efficacy|1|||
170887028|NCT02043548|617593605|FG001|Overall Study|Lack of Efficacy|0|||
170887029|NCT02043548|617593604|FG000|Overall Study|Adverse Event|0|||
170887030|NCT02043548|617593605|FG001|Overall Study|Adverse Event|1|||
170887031|NCT01430455|617593607|FG000|Overall Study|Withdrawal by Subject|1|||
170887032|NCT01430455|617593607|FG000|Overall Study|Switched to follow-up phase|1|||
170887033|NCT00936208|617593611|FG000|Overall Study|Protocol Violation|37|||
170887034|NCT00936208|617593612|FG001|Overall Study|Protocol Violation|22|||
170887035|NCT04818593|617593613|FG000|Overall Study|Low Oocyte Yield|8|||
170887036|NCT04818593|617593614|FG001|Overall Study|Low Oocyte Yield|8|||
170887037|NCT04818593|617593613|FG000|Overall Study|Not ICSI Insemination|7|||
170887038|NCT04818593|617593614|FG001|Overall Study|Not ICSI Insemination|7|||
170887039|NCT04818593|617593613|FG000|Overall Study|Poor Sperm Quality|2|||
170887040|NCT04818593|617593614|FG001|Overall Study|Poor Sperm Quality|2|||
170887041|NCT04818593|617593613|FG000|Overall Study|Withdrawal by Subject|2|||
170887042|NCT04818593|617593614|FG001|Overall Study|Withdrawal by Subject|2|||
170887043|NCT04818593|617593613|FG000|Overall Study|Conversion to IUI due to low response|1|||
170887044|NCT04818593|617593614|FG001|Overall Study|Conversion to IUI due to low response|1|||
170887045|NCT02926950|617593617|FG000|Overall Study|Adverse Event|4|||
170887046|NCT02926950|617593618|FG001|Overall Study|Adverse Event|6|||
170887047|NCT02926950|617593617|FG000|Overall Study|At the participant's own request|21|||
170887048|NCT02926950|617593618|FG001|Overall Study|At the participant's own request|25|||
170887049|NCT02926950|617593617|FG000|Overall Study|Reason not Specified|17|||
170887050|NCT02926950|617593618|FG001|Overall Study|Reason not Specified|9|||
170887051|NCT02926950|617593617|FG000|Overall Study|Lost to Follow-up|7|||
170887052|NCT02926950|617593618|FG001|Overall Study|Lost to Follow-up|8|||
170887053|NCT03124563|617593619|FG000|Overall Study|Lost to Follow-up|1|||
170887054|NCT03124563|617593620|FG001|Overall Study|Lost to Follow-up|1|||
170887055|NCT03124563|617593619|FG000|Overall Study|Withdrawal by Subject|1|||
170887056|NCT03124563|617593620|FG001|Overall Study|Withdrawal by Subject|1|||
170887057|NCT04745689|617593623|FG000|Overall Study|Death|9|||
170540150|NCT00817063|616320762|FG001|Overall Study|Adverse Event|13|||
170540151|NCT00817063|616320761|FG000|Overall Study|Death|1|||
170540152|NCT00817063|616320762|FG001|Overall Study|Death|1|||
170540153|NCT00817063|616320761|FG000|Overall Study|Lack of Efficacy|33|||
170540154|NCT00817063|616320762|FG001|Overall Study|Lack of Efficacy|86|||
170540155|NCT00817063|616320761|FG000|Overall Study|Failure to Return|13|||
170540156|NCT00817063|616320762|FG001|Overall Study|Failure to Return|12|||
170540157|NCT00817063|616320761|FG000|Overall Study|Violation of Selection at Entry|7|||
170540158|NCT00817063|616320762|FG001|Overall Study|Violation of Selection at Entry|4|||
170540159|NCT00817063|616320761|FG000|Overall Study|Protocol Violation|3|||
170540160|NCT00817063|616320762|FG001|Overall Study|Protocol Violation|8|||
170540161|NCT00817063|616320761|FG000|Overall Study|Withdrawal by Subject|17|||
170540162|NCT00817063|616320762|FG001|Overall Study|Withdrawal by Subject|37|||
170540163|NCT00817063|616320761|FG000|Overall Study|Early Improvement|19|||
170887058|NCT04745689|617593624|FG001|Overall Study|Death|6|||
170887059|NCT04745689|617593623|FG000|Overall Study|Lost to Follow-up|1|||
170887060|NCT04745689|617593624|FG001|Overall Study|Lost to Follow-up|0|||
170887061|NCT04745689|617593623|FG000|Overall Study|Withdrawal by Subject|2|||
170887062|NCT04745689|617593624|FG001|Overall Study|Withdrawal by Subject|0|||
170887063|NCT04745689|617593623|FG000|Overall Study|Study terminated by sponsor|10|||
170887064|NCT04745689|617593624|FG001|Overall Study|Study terminated by sponsor|3|||
170540164|NCT00817063|616320762|FG001|Overall Study|Early Improvement|4|||
170887065|NCT05061719|617593627|FG000|Overall Study|Adverse Event|60|||
170887066|NCT05061719|617593627|FG000|Overall Study|Death|1|||
170887067|NCT05061719|617593627|FG000|Overall Study|Lack of Efficacy|7|||
170887068|NCT05061719|617593627|FG000|Overall Study|Lost to Follow-up|5|||
170540165|NCT00817063|616320761|FG000|Overall Study|Administrative|10|||
170540166|NCT00817063|616320762|FG001|Overall Study|Administrative|4|||
170540167|NCT00817063|616320761|FG000|Overall Study|Abnormality of Laboratory Test|2|||
170887069|NCT05061719|617593627|FG000|Overall Study|Pregnancy|1|||
170887070|NCT05061719|617593627|FG000|Overall Study|Protocol Violation|8|||
170887071|NCT05061719|617593627|FG000|Overall Study|Withdrawal by Subject|41|||
170887072|NCT05061719|617593627|FG000|Overall Study|Site Closure|2|||
170540168|NCT00817063|616320762|FG001|Overall Study|Abnormality of Laboratory Test|1|||
170540169|NCT00529035|616320763|FG000|Overall Study|Withdrawal by Subject|1|||
170540170|NCT03439514|616320764|FG000|Double-Blind Treatment Period|Other|4|||
170540171|NCT03439514|616320765|FG001|Double-Blind Treatment Period|Other|1|||
170540172|NCT03439514|616320764|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
170540173|NCT03439514|616320765|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
170540174|NCT03439514|616320764|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
170540175|NCT03439514|616320765|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
170540176|NCT03439514|616320764|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
170540177|NCT03439514|616320765|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
170540178|NCT03439514|616320764|FG000|Double-Blind Treatment Period|Death|1|||
170540179|NCT03439514|616320765|FG001|Double-Blind Treatment Period|Death|2|||
170540180|NCT01521364|616320766|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
170540181|NCT01521364|616320766|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
170540182|NCT03418675|616320767|FG000|Overall Study|Lost to Follow-up|13|||
170540183|NCT03418675|616320768|FG001|Overall Study|Lost to Follow-up|10|||
170540184|NCT03418675|616320767|FG000|Overall Study|Adverse Event|2|||
170540185|NCT03418675|616320768|FG001|Overall Study|Adverse Event|0|||
170540186|NCT02115386|616320769|FG000|Overall Study|Protocol Violation|1|||
170540187|NCT02115386|616320769|FG000|Overall Study|Administrative - trial was terminated|6|||
170887073|NCT05593016|617595867|FG000|Overall Study|Death|1|||
170887074|NCT05593016|617595868|FG001|Overall Study|Death|1|||
170887075|NCT05593016|617595869|FG002|Overall Study|Death|1|||
170887076|NCT05593016|617595870|FG003|Overall Study|Death|0|||
170887077|NCT05593016|617595871|FG004|Overall Study|Death|0|||
170887078|NCT05593016|617595867|FG000|Overall Study|Lost to Follow-up|1|||
170887079|NCT05593016|617595868|FG001|Overall Study|Lost to Follow-up|1|||
170887080|NCT05593016|617595869|FG002|Overall Study|Lost to Follow-up|1|||
170887081|NCT05593016|617595870|FG003|Overall Study|Lost to Follow-up|2|||
170887082|NCT05593016|617595871|FG004|Overall Study|Lost to Follow-up|0|||
170887083|NCT00768898|617595872|FG000|Overall Study|Unrelated injury|1|||
170887084|NCT00768898|617595872|FG000|Overall Study|Headache|1|||
170887085|NCT00542997|617595875|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
170887086|NCT00542997|617595875|FG000|Wash in / Wash Out Period|Adverse Event|3|||
170887087|NCT00542997|617595875|FG000|Efficacy Period|Adverse Event|3|||
170887088|NCT00598975|617595876|FG000|Overall Study|Adverse Event|1|||
170887089|NCT00598975|617595877|FG001|Overall Study|Adverse Event|1|||
170887090|NCT00598975|617595876|FG000|Overall Study|Brain metastases|1|||
170887091|NCT00598975|617595877|FG001|Overall Study|Brain metastases|0|||
170887092|NCT00598975|617595876|FG000|Overall Study|Withdrawal by Subject|1|||
170887093|NCT00598975|617595877|FG001|Overall Study|Withdrawal by Subject|1|||
170887094|NCT00598975|617595876|FG000|Overall Study|Withdrawal of consent|0|||
170887095|NCT00598975|617595877|FG001|Overall Study|Withdrawal of consent|1|||
170887096|NCT00598975|617595876|FG000|Overall Study|Disease progression|8|||
170887097|NCT00598975|617595877|FG001|Overall Study|Disease progression|3|||
170887098|NCT00598975|617595876|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
170887099|NCT00598975|617595877|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
170887100|NCT00403260|617595878|FG000|Overall Study|Adverse Event|5|||
170887101|NCT00403260|617595879|FG001|Overall Study|Adverse Event|4|||
170887102|NCT00403260|617595878|FG000|Overall Study|Withdrawal by Subject|5|||
170887103|NCT00403260|617595879|FG001|Overall Study|Withdrawal by Subject|6|||
170887104|NCT00403260|617595878|FG000|Overall Study|Lost to Follow-up|49|||
170887105|NCT00403260|617595879|FG001|Overall Study|Lost to Follow-up|25|||
170887106|NCT00403260|617595878|FG000|Overall Study|Re-appearance of P. falciparum|34|||
170887107|NCT00403260|617595879|FG001|Overall Study|Re-appearance of P. falciparum|25|||
170540188|NCT03086343|616320773|FG000|Period 1|Adverse Event|7|||
170540189|NCT03086343|616320774|FG001|Period 1|Adverse Event|7|||
170540190|NCT03086343|616320775|FG002|Period 1|Adverse Event|0|||
170540191|NCT03086343|616320776|FG003|Period 1|Adverse Event|1|||
170540192|NCT03086343|616320773|FG000|Period 1|Withdrawal by Subject|6|||
170540193|NCT03086343|616320774|FG001|Period 1|Withdrawal by Subject|10|||
170540194|NCT03086343|616320775|FG002|Period 1|Withdrawal by Subject|0|||
170540195|NCT03086343|616320776|FG003|Period 1|Withdrawal by Subject|0|||
170540196|NCT03086343|616320773|FG000|Period 1|Lost to Follow-up|1|||
170540197|NCT03086343|616320774|FG001|Period 1|Lost to Follow-up|3|||
170540198|NCT03086343|616320775|FG002|Period 1|Lost to Follow-up|1|||
170540199|NCT03086343|616320776|FG003|Period 1|Lost to Follow-up|0|||
170887108|NCT00403260|617595878|FG000|Overall Study|P. vivax infection|26|||
170887109|NCT00403260|617595879|FG001|Overall Study|P. vivax infection|4|||
170887110|NCT00403260|617595878|FG000|Overall Study|Mixed infection with P. vivax|2|||
170887111|NCT00403260|617595879|FG001|Overall Study|Mixed infection with P. vivax|0|||
170887112|NCT00403260|617595878|FG000|Overall Study|Mixed infection with P. falciparum|1|||
170887113|NCT00403260|617595879|FG001|Overall Study|Mixed infection with P. falciparum|0|||
170447627|NCT01546922|615976646|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
170447628|NCT01546922|615976647|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
170447629|NCT01546922|615976646|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
170447630|NCT01546922|615976647|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
170447631|NCT01546922|615976646|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
170540200|NCT03086343|616320773|FG000|Period 1|Other, Not Specified|10|||
170540201|NCT03086343|616320774|FG001|Period 1|Other, Not Specified|12|||
170540202|NCT03086343|616320775|FG002|Period 1|Other, Not Specified|2|||
170540203|NCT03086343|616320776|FG003|Period 1|Other, Not Specified|1|||
170540204|NCT03086343|616320773|FG000|Period 1|Missing|1|||
170540205|NCT03086343|616320774|FG001|Period 1|Missing|0|||
170540206|NCT03086343|616320775|FG002|Period 1|Missing|0|||
170540207|NCT03086343|616320776|FG003|Period 1|Missing|0|||
170540208|NCT03086343|616320773|FG000|Period 2|Adverse Event|20|||
170540209|NCT03086343|616320774|FG001|Period 2|Adverse Event|11|||
170540210|NCT03086343|616320775|FG002|Period 2|Adverse Event|1|||
170540211|NCT03086343|616320776|FG003|Period 2|Adverse Event|2|||
170540212|NCT03086343|616320773|FG000|Period 2|Withdrawal by Subject|15|||
170540213|NCT03086343|616320774|FG001|Period 2|Withdrawal by Subject|25|||
170540214|NCT03086343|616320775|FG002|Period 2|Withdrawal by Subject|2|||
170540215|NCT03086343|616320776|FG003|Period 2|Withdrawal by Subject|2|||
170540216|NCT03086343|616320773|FG000|Period 2|Lost to Follow-up|6|||
170540217|NCT03086343|616320774|FG001|Period 2|Lost to Follow-up|11|||
170540218|NCT03086343|616320775|FG002|Period 2|Lost to Follow-up|1|||
170540219|NCT03086343|616320776|FG003|Period 2|Lost to Follow-up|0|||
170540220|NCT03086343|616320773|FG000|Period 2|COVID-19 Infection|5|||
170540221|NCT03086343|616320774|FG001|Period 2|COVID-19 Infection|0|||
170540222|NCT03086343|616320775|FG002|Period 2|COVID-19 Infection|0|||
170540223|NCT03086343|616320776|FG003|Period 2|COVID-19 Infection|0|||
170540224|NCT03086343|616320773|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
170540225|NCT03086343|616320774|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
170540226|NCT03086343|616320775|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
170540227|NCT03086343|616320776|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
170540228|NCT03086343|616320773|FG000|Period 2|Other, Not Specified|23|||
170540229|NCT03086343|616320774|FG001|Period 2|Other, Not Specified|22|||
170540230|NCT03086343|616320775|FG002|Period 2|Other, Not Specified|2|||
170540231|NCT03086343|616320776|FG003|Period 2|Other, Not Specified|4|||
170540232|NCT04900272|616320777|FG000|Overall Study|Lost to Follow-up|2|||
170540233|NCT04900272|616320777|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
170540234|NCT04900272|616320777|FG000|Overall Study|Withdrawal by Subject|1|||
170540235|NCT00195429|616320779|FG000|Overall Study|Adverse Event|2|||
170540236|NCT00195429|616320780|FG001|Overall Study|Adverse Event|4|||
170540237|NCT00195429|616320779|FG000|Overall Study|Lack of Efficacy|2|||
170540238|NCT00195429|616320780|FG001|Overall Study|Lack of Efficacy|1|||
170540239|NCT00195429|616320779|FG000|Overall Study|Lost to Follow-up|1|||
170540240|NCT00195429|616320780|FG001|Overall Study|Lost to Follow-up|0|||
170786230|NCT03721952|617225460|FG004|Overall Study|Protocol Violation|0|||
170447632|NCT01546922|615976647|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
170447633|NCT01546922|615976646|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
170447634|NCT01546922|615976647|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
170447635|NCT00255151|615976649|FG000|Overall Study|Adverse Event|10|||
170447636|NCT00255151|615976650|FG001|Overall Study|Adverse Event|6|||
170447637|NCT00255151|615976651|FG002|Overall Study|Adverse Event|9|||
170447638|NCT00255151|615976649|FG000|Overall Study|Lost to Follow-up|4|||
170447639|NCT00255151|615976650|FG001|Overall Study|Lost to Follow-up|3|||
170447640|NCT00255151|615976651|FG002|Overall Study|Lost to Follow-up|4|||
170447641|NCT00255151|615976649|FG000|Overall Study|Withdrawal by Subject|18|||
170447642|NCT00255151|615976650|FG001|Overall Study|Withdrawal by Subject|17|||
170447643|NCT00255151|615976651|FG002|Overall Study|Withdrawal by Subject|8|||
170540241|NCT02903914|616320785|FG000|Overall Study|Adverse Event|0|||
170786231|NCT03721952|617225456|FG000|Overall Study|Withdrawal by Subject|1|||
170786232|NCT03721952|617225457|FG001|Overall Study|Withdrawal by Subject|0|||
170786233|NCT03721952|617225458|FG002|Overall Study|Withdrawal by Subject|40|||
170786234|NCT03721952|617225459|FG003|Overall Study|Withdrawal by Subject|28|||
170447644|NCT00255151|615976649|FG000|Overall Study|Noncompliance|0|||
170447645|NCT00255151|615976650|FG001|Overall Study|Noncompliance|1|||
170447646|NCT00255151|615976651|FG002|Overall Study|Noncompliance|2|||
170540242|NCT02903914|616320786|FG001|Overall Study|Adverse Event|0|||
170540243|NCT02903914|616320787|FG002|Overall Study|Adverse Event|1|||
170540244|NCT02903914|616320788|FG003|Overall Study|Adverse Event|0|||
170447647|NCT00255151|615976649|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
170540245|NCT02903914|616320789|FG004|Overall Study|Adverse Event|0|||
170540246|NCT02903914|616320790|FG005|Overall Study|Adverse Event|0|||
170540247|NCT02903914|616320791|FG006|Overall Study|Adverse Event|2|||
170540248|NCT02903914|616320792|FG007|Overall Study|Adverse Event|0|||
170540249|NCT02903914|616320785|FG000|Overall Study|Withdrawal by Subject|3|||
170540250|NCT02903914|616320786|FG001|Overall Study|Withdrawal by Subject|1|||
170540251|NCT02903914|616320787|FG002|Overall Study|Withdrawal by Subject|28|||
170786235|NCT03721952|617225460|FG004|Overall Study|Withdrawal by Subject|0|||
170633797|NCT01285323|616670126|FG001|Overall Study|Other|3|||
170633798|NCT02606643|616670127|FG000|Overall Study|did not meet inclusion criteria|1|||
170633799|NCT02606643|616670128|FG001|Overall Study|did not meet inclusion criteria|3|||
170633800|NCT02158546|616670135|FG000|Overall Study|Physician Decision|0|||
170633801|NCT02158546|616670136|FG001|Overall Study|Physician Decision|1|||
170633802|NCT02158546|616670137|FG002|Overall Study|Physician Decision|0|||
170633803|NCT02158546|616670138|FG003|Overall Study|Physician Decision|0|||
170633804|NCT02158546|616670135|FG000|Overall Study|Non-compliance|0|||
170633805|NCT02158546|616670136|FG001|Overall Study|Non-compliance|1|||
170633806|NCT02158546|616670137|FG002|Overall Study|Non-compliance|0|||
170633807|NCT02158546|616670138|FG003|Overall Study|Non-compliance|1|||
170633808|NCT02158546|616670135|FG000|Overall Study|Failure to meet eligibility criteria|0|||
170633809|NCT02158546|616670136|FG001|Overall Study|Failure to meet eligibility criteria|1|||
170633810|NCT02158546|616670137|FG002|Overall Study|Failure to meet eligibility criteria|0|||
170633811|NCT02158546|616670138|FG003|Overall Study|Failure to meet eligibility criteria|0|||
170633812|NCT02158546|616670135|FG000|Overall Study|Lack of Efficacy|1|||
170633813|NCT02158546|616670136|FG001|Overall Study|Lack of Efficacy|1|||
170633814|NCT02158546|616670137|FG002|Overall Study|Lack of Efficacy|0|||
170633815|NCT02158546|616670138|FG003|Overall Study|Lack of Efficacy|0|||
170633816|NCT02158546|616670135|FG000|Overall Study|Adverse Event|2|||
170633817|NCT02158546|616670136|FG001|Overall Study|Adverse Event|2|||
170633818|NCT02158546|616670137|FG002|Overall Study|Adverse Event|0|||
170633819|NCT02158546|616670138|FG003|Overall Study|Adverse Event|0|||
170633820|NCT02158546|616670135|FG000|Overall Study|Withdrawal by Subject|6|||
170633821|NCT02158546|616670136|FG001|Overall Study|Withdrawal by Subject|2|||
170633822|NCT02158546|616670137|FG002|Overall Study|Withdrawal by Subject|1|||
170633823|NCT02158546|616670138|FG003|Overall Study|Withdrawal by Subject|0|||
170633824|NCT02158546|616670135|FG000|Overall Study|Lost to Follow-up|5|||
170633825|NCT02158546|616670136|FG001|Overall Study|Lost to Follow-up|4|||
170633826|NCT02158546|616670137|FG002|Overall Study|Lost to Follow-up|0|||
170633827|NCT02158546|616670138|FG003|Overall Study|Lost to Follow-up|1|||
170633828|NCT02158546|616670135|FG000|Overall Study|Site Excluded|5|||
170633829|NCT02158546|616670136|FG001|Overall Study|Site Excluded|5|||
170633830|NCT02158546|616670137|FG002|Overall Study|Site Excluded|3|||
170633831|NCT02158546|616670138|FG003|Overall Study|Site Excluded|4|||
170633832|NCT02351817|616670140|FG000|Period 1|Adverse Event|1|||
170633833|NCT02351817|616670141|FG001|Period 1|Adverse Event|2|||
170633834|NCT02351817|616670140|FG000|Period 1|Lack of Efficacy|0|||
170633835|NCT02351817|616670141|FG001|Period 1|Lack of Efficacy|1|||
170786236|NCT04495894|617225461|FG000|Overall Study|Withdrawal by Subject|2|||
170786237|NCT04495894|617225462|FG001|Overall Study|Withdrawal by Subject|0|||
170786238|NCT04495894|617225463|FG002|Overall Study|Withdrawal by Subject|2|||
170786239|NCT04495894|617225464|FG003|Overall Study|Withdrawal by Subject|3|||
170786240|NCT04495894|617225461|FG000|Overall Study|Early termination|0|||
170786241|NCT04495894|617225462|FG001|Overall Study|Early termination|0|||
170786242|NCT04495894|617225463|FG002|Overall Study|Early termination|3|||
170786243|NCT04495894|617225464|FG003|Overall Study|Early termination|0|||
170786244|NCT03364647|617225465|FG000|Overall Study|Withdrawal by Subject|3|||
170786245|NCT03364647|617225466|FG001|Overall Study|Withdrawal by Subject|1|||
170786246|NCT01000961|617225467|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
170786247|NCT01000961|617225468|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
170786248|NCT01000961|617225467|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
170786249|NCT01000961|617225468|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
170786250|NCT03307343|617225472|FG000|Overall Study|Withdrawal by Subject|1|||
170786251|NCT03307343|617225473|FG001|Overall Study|Withdrawal by Subject|2|||
170786252|NCT03307343|617225472|FG000|Overall Study|Pregnancy|0|||
170786253|NCT03307343|617225473|FG001|Overall Study|Pregnancy|2|||
170786254|NCT03307343|617225472|FG000|Overall Study|Physician Decision|1|||
170786255|NCT03307343|617225473|FG001|Overall Study|Physician Decision|0|||
170786256|NCT03307343|617225472|FG000|Overall Study|Lost to Follow-up|0|||
170786257|NCT03307343|617225473|FG001|Overall Study|Lost to Follow-up|2|||
170633836|NCT02351817|616670140|FG000|Period 2|Adverse Event|0|||
170633837|NCT02351817|616670141|FG001|Period 2|Adverse Event|2|||
170633838|NCT02351817|616670140|FG000|Period 2|Protocol Violation|1|||
170633839|NCT02351817|616670141|FG001|Period 2|Protocol Violation|0|||
170633840|NCT01532986|616670144|FG000|Overall Study|Death|9|||
170447648|NCT00255151|615976650|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
170633841|NCT01532986|616670145|FG001|Overall Study|Death|9|||
170633842|NCT01532986|616670144|FG000|Overall Study|Withdrawal by Subject|7|||
170633843|NCT01532986|616670145|FG001|Overall Study|Withdrawal by Subject|10|||
170633844|NCT01532986|616670144|FG000|Overall Study|Physician Decision|7|||
170633845|NCT01532986|616670145|FG001|Overall Study|Physician Decision|5|||
170633846|NCT00885170|616670150|FG000|Overall Study|Adverse Event|12|||
170633847|NCT00885170|616670151|FG001|Overall Study|Adverse Event|4|||
170633848|NCT00885170|616670150|FG000|Overall Study|Excessive bone loss|6|||
170786258|NCT04624633|617225475|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
170447649|NCT00255151|615976651|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
170447650|NCT00255151|615976649|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
170447651|NCT00255151|615976650|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
170447652|NCT00255151|615976651|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
170447653|NCT00255151|615976649|FG000|Overall Study|Possible Barrett's Esophagus|1|||
170447654|NCT00255151|615976650|FG001|Overall Study|Possible Barrett's Esophagus|3|||
170447655|NCT00255151|615976651|FG002|Overall Study|Possible Barrett's Esophagus|8|||
170447656|NCT00255151|615976649|FG000|Overall Study|Esophageal Stricture|0|||
170447657|NCT00255151|615976650|FG001|Overall Study|Esophageal Stricture|0|||
170447658|NCT00255151|615976651|FG002|Overall Study|Esophageal Stricture|1|||
170447659|NCT00255151|615976649|FG000|Overall Study|Therapeutic Failure|11|||
170447660|NCT00255151|615976650|FG001|Overall Study|Therapeutic Failure|2|||
170447661|NCT00255151|615976651|FG002|Overall Study|Therapeutic Failure|3|||
170447662|NCT00792623|615976652|FG000|Overall Study|Adverse Event|2|||
170447663|NCT00792623|615976652|FG000|Overall Study|Withdrawal by Subject|5|||
170447664|NCT01239472|615976655|FG000|Overall Study|Withdrawal by Subject|5|||
170447665|NCT01239472|615976656|FG001|Overall Study|Withdrawal by Subject|1|||
170447666|NCT01239472|615976655|FG000|Overall Study|Adverse Event|0|||
170447667|NCT01239472|615976656|FG001|Overall Study|Adverse Event|1|||
170447668|NCT01239472|615976655|FG000|Overall Study|Lack of Efficacy|0|||
170447669|NCT01239472|615976656|FG001|Overall Study|Lack of Efficacy|1|||
170447670|NCT01534078|615976657|FG000|Overall Study|Death|1|||
170447671|NCT01534078|615976657|FG000|Overall Study|Withdrawal by Subject|1|||
170447672|NCT02147587|615976663|FG000|Overall Study|Adverse Event|9|||
170447673|NCT02147587|615976664|FG001|Overall Study|Adverse Event|4|||
170447674|NCT02147587|615976663|FG000|Overall Study|Lack of Efficacy|2|||
170447675|NCT02147587|615976664|FG001|Overall Study|Lack of Efficacy|1|||
170447676|NCT02531594|615976665|FG000|Overall Study|Withdrawal by Subject|7|||
170447677|NCT02531594|615976666|FG001|Overall Study|Withdrawal by Subject|8|||
170447678|NCT03649412|615976670|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
170447679|NCT03649412|615976671|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
170447680|NCT03649412|615976670|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
170447681|NCT03649412|615976671|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
170447682|NCT03649412|615976670|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
170447683|NCT03649412|615976671|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170447684|NCT03649412|615976670|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
170447685|NCT03649412|615976671|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
170447686|NCT03649412|615976670|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
170447687|NCT03649412|615976671|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
170447688|NCT03649412|615976670|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
170447689|NCT03649412|615976671|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
170447690|NCT00865514|615976672|FG000|Overall Study|Infusion cost exceeded funding|2|||
170447691|NCT02865395|615976673|FG000|Overall Study|Physician Decision|6|||
170447692|NCT02865395|615976674|FG001|Overall Study|Physician Decision|10|||
170447693|NCT02865395|615976675|FG002|Overall Study|Physician Decision|7|||
170447694|NCT01256060|615976676|FG000|Overall Study|Lost to Follow-up|0|||
170447695|NCT01256060|615976677|FG001|Overall Study|Lost to Follow-up|1|||
170447696|NCT01256060|615976678|FG002|Overall Study|Lost to Follow-up|0|||
170447697|NCT01256060|615976679|FG003|Overall Study|Lost to Follow-up|0|||
170447698|NCT01466036|615976686|FG000|Overall Study|Death|1|||
170447699|NCT01466036|615976687|FG001|Overall Study|Death|1|||
170447700|NCT01466036|615976686|FG000|Overall Study|Physician Decision|0|||
170447701|NCT01466036|615976687|FG001|Overall Study|Physician Decision|4|||
170447702|NCT01466036|615976686|FG000|Overall Study|Adverse Event|2|||
170447703|NCT01466036|615976687|FG001|Overall Study|Adverse Event|6|||
170447704|NCT01466036|615976686|FG000|Overall Study|Withdrawal by Subject|2|||
170447705|NCT01466036|615976687|FG001|Overall Study|Withdrawal by Subject|8|||
170447706|NCT01466036|615976686|FG000|Overall Study|progression/relapse|14|||
170447707|NCT01466036|615976687|FG001|Overall Study|progression/relapse|21|||
170447708|NCT01466036|615976686|FG000|Overall Study|prolonged treatment delay|1|||
170447709|NCT01466036|615976687|FG001|Overall Study|prolonged treatment delay|1|||
170447710|NCT00985231|615976694|FG000|Overall Study|ineligible|1|||
170447711|NCT00985231|615976695|FG001|Overall Study|ineligible|0|||
170447712|NCT00985231|615976694|FG000|Overall Study|Protocol Violation|1|||
170447713|NCT00985231|615976695|FG001|Overall Study|Protocol Violation|0|||
170447714|NCT00985231|615976694|FG000|Overall Study|Withdrawal by Subject|1|||
170447715|NCT00985231|615976695|FG001|Overall Study|Withdrawal by Subject|0|||
170447716|NCT00985231|615976694|FG000|Overall Study|Lost to Follow-up|0|||
170447717|NCT00985231|615976695|FG001|Overall Study|Lost to Follow-up|1|||
170447718|NCT00985231|615976694|FG000|Overall Study|Study related symptoms & complaints|0|||
170447719|NCT00985231|615976695|FG001|Overall Study|Study related symptoms & complaints|2|||
170447720|NCT01808248|615976696|FG000|Overall Study|Lack of Efficacy|3|||
170447721|NCT01808248|615976696|FG000|Overall Study|Withdrawal by Subject|1|||
170447722|NCT01808248|615976696|FG000|Overall Study|Lost to Follow-up|1|||
170447723|NCT00931463|615976699|FG000|Overall Study|Death|8|||
170447724|NCT00931463|615976700|FG001|Overall Study|Death|4|||
170447725|NCT00931463|615976699|FG000|Overall Study|Withdrawal by Subject|5|||
170633849|NCT00885170|616670151|FG001|Overall Study|Excessive bone loss|3|||
170633850|NCT00885170|616670150|FG000|Overall Study|Lost to Follow-up|2|||
170633851|NCT00885170|616670151|FG001|Overall Study|Lost to Follow-up|1|||
170633852|NCT00885170|616670150|FG000|Overall Study|Physician Decision|2|||
170633853|NCT00885170|616670151|FG001|Overall Study|Physician Decision|1|||
170633854|NCT00885170|616670150|FG000|Overall Study|Protocol Violation|3|||
170633855|NCT00885170|616670151|FG001|Overall Study|Protocol Violation|1|||
170633856|NCT00885170|616670150|FG000|Overall Study|Withdrawal by Subject|13|||
170633857|NCT00885170|616670151|FG001|Overall Study|Withdrawal by Subject|13|||
170633858|NCT03771664|616670152|FG000|Overall Study|Adverse Event|1|||
170633859|NCT03771664|616670153|FG001|Overall Study|Adverse Event|0|||
170633860|NCT03771664|616670152|FG000|Overall Study|Lost to Follow-up|1|||
170633861|NCT03771664|616670153|FG001|Overall Study|Lost to Follow-up|0|||
170633862|NCT03771664|616670152|FG000|Overall Study|Withdrawal by Participant|1|||
170633863|NCT03771664|616670153|FG001|Overall Study|Withdrawal by Participant|4|||
170633864|NCT03771664|616670152|FG000|Overall Study|Randomized but not Treated|0|||
170633865|NCT03771664|616670153|FG001|Overall Study|Randomized but not Treated|1|||
170633866|NCT02120898|616670154|FG000|Overall Study|Withdrawal by Subject|4|||
170633867|NCT02120898|616670155|FG001|Overall Study|Withdrawal by Subject|2|||
170633868|NCT02120898|616670156|FG002|Overall Study|Withdrawal by Subject|2|||
170633869|NCT02120898|616670154|FG000|Overall Study|Non-compliance with study drug|3|||
170633870|NCT02120898|616670155|FG001|Overall Study|Non-compliance with study drug|0|||
170633871|NCT02120898|616670156|FG002|Overall Study|Non-compliance with study drug|0|||
170633872|NCT02120898|616670154|FG000|Overall Study|Adverse Event|1|||
170633873|NCT02120898|616670155|FG001|Overall Study|Adverse Event|2|||
170633874|NCT02120898|616670156|FG002|Overall Study|Adverse Event|1|||
170633875|NCT02120898|616670154|FG000|Overall Study|Protocol Violation|1|||
170633876|NCT02120898|616670155|FG001|Overall Study|Protocol Violation|2|||
170633877|NCT02120898|616670156|FG002|Overall Study|Protocol Violation|0|||
170633878|NCT02120898|616670154|FG000|Overall Study|Lost to Follow-up|0|||
170633879|NCT02120898|616670155|FG001|Overall Study|Lost to Follow-up|0|||
170633880|NCT02120898|616670156|FG002|Overall Study|Lost to Follow-up|1|||
170633881|NCT00561925|616670157|FG000|14 Day Lead-In Period|Adverse Event|38|||
170633882|NCT00561925|616670158|FG001|14 Day Lead-In Period|Adverse Event|0|||
170633883|NCT00561925|616670159|FG002|14 Day Lead-In Period|Adverse Event|0|||
170633884|NCT00561925|616670160|FG003|14 Day Lead-In Period|Adverse Event|0|||
170633885|NCT00561925|616670161|FG004|14 Day Lead-In Period|Adverse Event|0|||
170633886|NCT00561925|616670157|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
170633887|NCT00561925|616670158|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
170540252|NCT02903914|616320788|FG003|Overall Study|Withdrawal by Subject|0|||
170540253|NCT02903914|616320789|FG004|Overall Study|Withdrawal by Subject|1|||
170540254|NCT02903914|616320790|FG005|Overall Study|Withdrawal by Subject|2|||
170540255|NCT02903914|616320791|FG006|Overall Study|Withdrawal by Subject|12|||
170540256|NCT02903914|616320792|FG007|Overall Study|Withdrawal by Subject|0|||
170540257|NCT02903914|616320785|FG000|Overall Study|Progressive Disease|1|||
170540258|NCT02903914|616320786|FG001|Overall Study|Progressive Disease|0|||
170540259|NCT02903914|616320787|FG002|Overall Study|Progressive Disease|4|||
170540260|NCT02903914|616320788|FG003|Overall Study|Progressive Disease|0|||
170540261|NCT02903914|616320789|FG004|Overall Study|Progressive Disease|0|||
170540262|NCT02903914|616320790|FG005|Overall Study|Progressive Disease|0|||
170540263|NCT02903914|616320791|FG006|Overall Study|Progressive Disease|2|||
170540264|NCT02903914|616320792|FG007|Overall Study|Progressive Disease|0|||
170540265|NCT02903914|616320785|FG000|Overall Study|Death|0|||
170540266|NCT02903914|616320786|FG001|Overall Study|Death|0|||
170540267|NCT02903914|616320787|FG002|Overall Study|Death|9|||
170540268|NCT02903914|616320788|FG003|Overall Study|Death|0|||
170540269|NCT02903914|616320789|FG004|Overall Study|Death|1|||
170540270|NCT02903914|616320790|FG005|Overall Study|Death|3|||
170540271|NCT02903914|616320791|FG006|Overall Study|Death|24|||
170540272|NCT02903914|616320792|FG007|Overall Study|Death|2|||
170540273|NCT02903914|616320785|FG000|Overall Study|Lost to Follow-up|0|||
170540274|NCT02903914|616320786|FG001|Overall Study|Lost to Follow-up|1|||
170540275|NCT02903914|616320787|FG002|Overall Study|Lost to Follow-up|0|||
170540276|NCT02903914|616320788|FG003|Overall Study|Lost to Follow-up|0|||
170540277|NCT02903914|616320789|FG004|Overall Study|Lost to Follow-up|2|||
170540278|NCT02903914|616320790|FG005|Overall Study|Lost to Follow-up|0|||
170540279|NCT02903914|616320791|FG006|Overall Study|Lost to Follow-up|1|||
170633888|NCT00561925|616670159|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
170633889|NCT00561925|616670160|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
170633890|NCT00561925|616670161|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
170633891|NCT00561925|616670157|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
170540280|NCT02903914|616320792|FG007|Overall Study|Lost to Follow-up|0|||
170540281|NCT02903914|616320785|FG000|Overall Study|Physician Decision|0|||
170540282|NCT02903914|616320786|FG001|Overall Study|Physician Decision|0|||
170540283|NCT02903914|616320787|FG002|Overall Study|Physician Decision|1|||
170633892|NCT00561925|616670158|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
170633893|NCT00561925|616670159|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
170633894|NCT00561925|616670160|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
170633895|NCT00561925|616670161|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
170786259|NCT04624633|617225476|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
170786260|NCT04624633|617225475|FG000|Overall Study|Death|1|||
170786261|NCT04624633|617225476|FG001|Overall Study|Death|0|||
170786262|NCT03536754|617225477|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
170786263|NCT03536754|617225478|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
170786264|NCT03536754|617225479|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
170786265|NCT03536754|617225480|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
170786266|NCT03536754|617225481|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
170786267|NCT03536754|617225477|FG000|Open Label Extension|Other|0|||
170786268|NCT03536754|617225478|FG001|Open Label Extension|Other|0|||
170786269|NCT03536754|617225479|FG002|Open Label Extension|Other|0|||
170786270|NCT03536754|617225480|FG003|Open Label Extension|Other|0|||
170786271|NCT03536754|617225481|FG004|Open Label Extension|Other|1|||
170786272|NCT03382652|617225482|FG000|Overall Study|Lost to Follow-up|6|||
170786273|NCT03382652|617225482|FG000|Overall Study|Death|4|||
170786274|NCT03382652|617225482|FG000|Overall Study|Revision|5|||
170540284|NCT02903914|616320788|FG003|Overall Study|Physician Decision|0|||
170540285|NCT02903914|616320789|FG004|Overall Study|Physician Decision|0|||
170540286|NCT02903914|616320790|FG005|Overall Study|Physician Decision|0|||
170540287|NCT02903914|616320791|FG006|Overall Study|Physician Decision|1|||
170540288|NCT02903914|616320792|FG007|Overall Study|Physician Decision|0|||
170540289|NCT02903914|616320785|FG000|Overall Study|Symptomatic Deterioration|0|||
170540290|NCT02903914|616320786|FG001|Overall Study|Symptomatic Deterioration|0|||
170540291|NCT02903914|616320787|FG002|Overall Study|Symptomatic Deterioration|1|||
170540292|NCT02903914|616320788|FG003|Overall Study|Symptomatic Deterioration|0|||
170540293|NCT02903914|616320789|FG004|Overall Study|Symptomatic Deterioration|0|||
170540294|NCT02903914|616320790|FG005|Overall Study|Symptomatic Deterioration|0|||
170540295|NCT02903914|616320791|FG006|Overall Study|Symptomatic Deterioration|0|||
170540296|NCT02903914|616320792|FG007|Overall Study|Symptomatic Deterioration|0|||
170540297|NCT02903914|616320785|FG000|Overall Study|New Cancer Therapy|2|||
170540298|NCT02903914|616320786|FG001|Overall Study|New Cancer Therapy|2|||
170540299|NCT02903914|616320787|FG002|Overall Study|New Cancer Therapy|21|||
170540300|NCT02903914|616320788|FG003|Overall Study|New Cancer Therapy|4|||
170540301|NCT02903914|616320789|FG004|Overall Study|New Cancer Therapy|3|||
170540302|NCT02903914|616320790|FG005|Overall Study|New Cancer Therapy|6|||
170540303|NCT02903914|616320791|FG006|Overall Study|New Cancer Therapy|56|||
170540304|NCT02903914|616320792|FG007|Overall Study|New Cancer Therapy|3|||
170540305|NCT02903914|616320785|FG000|Overall Study|Didn't Return to Site|1|||
170540306|NCT02903914|616320786|FG001|Overall Study|Didn't Return to Site|0|||
170540307|NCT02903914|616320787|FG002|Overall Study|Didn't Return to Site|1|||
170540308|NCT02903914|616320788|FG003|Overall Study|Didn't Return to Site|1|||
170540309|NCT02903914|616320789|FG004|Overall Study|Didn't Return to Site|0|||
170540310|NCT02903914|616320790|FG005|Overall Study|Didn't Return to Site|0|||
170540311|NCT02903914|616320791|FG006|Overall Study|Didn't Return to Site|2|||
170540312|NCT02903914|616320792|FG007|Overall Study|Didn't Return to Site|0|||
170540313|NCT02903914|616320785|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
170540314|NCT02903914|616320786|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
170540315|NCT02903914|616320787|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
170540316|NCT02903914|616320788|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
170540317|NCT02903914|616320789|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
170540318|NCT02903914|616320790|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
170540319|NCT02903914|616320791|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
170540320|NCT02903914|616320792|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
170540321|NCT02903914|616320785|FG000|Overall Study|Follow-up Did Not Occur|0|||
170540322|NCT02903914|616320786|FG001|Overall Study|Follow-up Did Not Occur|1|||
170540323|NCT02903914|616320787|FG002|Overall Study|Follow-up Did Not Occur|1|||
170540324|NCT02903914|616320788|FG003|Overall Study|Follow-up Did Not Occur|0|||
170540325|NCT02903914|616320789|FG004|Overall Study|Follow-up Did Not Occur|2|||
170540326|NCT02903914|616320790|FG005|Overall Study|Follow-up Did Not Occur|0|||
170540327|NCT02903914|616320791|FG006|Overall Study|Follow-up Did Not Occur|8|||
170540328|NCT02903914|616320792|FG007|Overall Study|Follow-up Did Not Occur|0|||
170540329|NCT02903914|616320785|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
170540330|NCT02903914|616320786|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
170540331|NCT02903914|616320787|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
170540332|NCT02903914|616320788|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
170540333|NCT02903914|616320789|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
170540334|NCT02903914|616320790|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
170540335|NCT02903914|616320791|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
170540336|NCT02903914|616320792|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
170540337|NCT02903914|616320785|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
170786275|NCT03382652|617225482|FG000|Overall Study|Patient withdrew|3|||
170786276|NCT03382652|617225482|FG000|Overall Study|Other reasons|21|||
170786277|NCT06037369|617225483|FG000|Overall Study|Lost to Follow-up|0|||
170786278|NCT06037369|617225484|FG001|Overall Study|Lost to Follow-up|1|||
170786279|NCT05603143|617225485|FG000|Overall Study|Withdrew consent|6|||
170786280|NCT05603143|617225486|FG001|Overall Study|Withdrew consent|2|||
170786281|NCT05603143|617225485|FG000|Overall Study|Randomized but never treated|0|||
170786282|NCT05603143|617225486|FG001|Overall Study|Randomized but never treated|3|||
170786283|NCT05603143|617225485|FG000|Overall Study|Adverse Event|2|||
170786284|NCT05603143|617225486|FG001|Overall Study|Adverse Event|0|||
170786285|NCT05603143|617225485|FG000|Overall Study|Death|0|||
170786286|NCT05603143|617225486|FG001|Overall Study|Death|1|||
170786287|NCT05603143|617225485|FG000|Overall Study|Investigator's discretion|1|||
170786288|NCT05603143|617225486|FG001|Overall Study|Investigator's discretion|0|||
170786289|NCT05603143|617225485|FG000|Overall Study|Lost to Follow-up|0|||
170786290|NCT05603143|617225486|FG001|Overall Study|Lost to Follow-up|1|||
170786291|NCT05603143|617225485|FG000|Overall Study|Protocol Violation|0|||
170887114|NCT00403260|617595878|FG000|Overall Study|P. vivax infection at screening|1|||
170447726|NCT00931463|615976700|FG001|Overall Study|Withdrawal by Subject|0|||
170447727|NCT00931463|615976699|FG000|Overall Study|Lost to Follow-up|4|||
170447728|NCT00931463|615976700|FG001|Overall Study|Lost to Follow-up|1|||
170447729|NCT01439724|615976701|FG000|Overall Study|missing consultation|9|||
170447730|NCT01439724|615976702|FG001|Overall Study|missing consultation|8|||
170447731|NCT04234464|615976704|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
170447732|NCT04234464|615976705|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
170447733|NCT00983528|615976710|FG000|Overall Study|Death|4|||
170447734|NCT00983528|615976710|FG000|Overall Study|Lost to Follow-up|1|||
170447735|NCT00983528|615976710|FG000|Overall Study|Study Terminated|1|||
170447736|NCT03635983|615976711|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
170447737|NCT03635983|615976712|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
170447738|NCT03635983|615976711|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
170447739|NCT03635983|615976712|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170447740|NCT03635983|615976711|FG000|Pre-Treatment Period|Other reasons|0|||
170447741|NCT03635983|615976712|FG001|Pre-Treatment Period|Other reasons|1|||
170447742|NCT03635983|615976711|FG000|Pre-Treatment Period|Disease Progression|0|||
170447743|NCT03635983|615976712|FG001|Pre-Treatment Period|Disease Progression|1|||
170447744|NCT03635983|615976711|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
170447745|NCT03635983|615976712|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
170447746|NCT03635983|615976711|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
170447747|NCT03635983|615976712|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
170447748|NCT03635983|615976711|FG000|Treatment Period|Withdrawal by Subject|3|||
170447749|NCT03635983|615976712|FG001|Treatment Period|Withdrawal by Subject|5|||
170447750|NCT03635983|615976711|FG000|Treatment Period|Death|3|||
170447751|NCT03635983|615976712|FG001|Treatment Period|Death|5|||
170447752|NCT03635983|615976711|FG000|Treatment Period|Poor/Non-compliance|2|||
170447753|NCT03635983|615976712|FG001|Treatment Period|Poor/Non-compliance|1|||
170447754|NCT03635983|615976711|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
170447755|NCT03635983|615976712|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
170447756|NCT03635983|615976711|FG000|Treatment Period|Other reasons|7|||
170447757|NCT03635983|615976712|FG001|Treatment Period|Other reasons|4|||
170447758|NCT03635983|615976711|FG000|Treatment Period|Disease progression|230|||
170447759|NCT03635983|615976712|FG001|Treatment Period|Disease progression|201|||
170447760|NCT03635983|615976711|FG000|Treatment Period|Study drug toxicity|35|||
170447761|NCT03635983|615976712|FG001|Treatment Period|Study drug toxicity|36|||
170447762|NCT03635983|615976711|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
170447763|NCT03635983|615976712|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
170447764|NCT03635983|615976711|FG000|Treatment Period|Maximum clinical benefit|3|||
170447765|NCT03635983|615976712|FG001|Treatment Period|Maximum clinical benefit|5|||
170447766|NCT03635983|615976711|FG000|Treatment Period|Administrative reason by the sponsor|1|||
170447767|NCT03635983|615976712|FG001|Treatment Period|Administrative reason by the sponsor|2|||
170447768|NCT03635983|615976711|FG000|Treatment Period|Lost to Follow-up|0|||
170447769|NCT03635983|615976712|FG001|Treatment Period|Lost to Follow-up|1|||
170447770|NCT00575380|615976714|FG000|Overall Study|Withdrawal by Subject|1|||
170447771|NCT00575380|615976715|FG001|Overall Study|Withdrawal by Subject|0|||
170447772|NCT00575380|615976714|FG000|Overall Study|Adverse Event|0|||
170447773|NCT00575380|615976715|FG001|Overall Study|Adverse Event|1|||
170447774|NCT00575380|615976714|FG000|Overall Study|Various|0|||
170447775|NCT00575380|615976715|FG001|Overall Study|Various|2|||
170447776|NCT00330460|615976718|FG000|Overall Study|Physician Decision|1|||
170447777|NCT00330460|615976719|FG001|Overall Study|Physician Decision|0|||
170447778|NCT00330460|615976718|FG000|Overall Study|Adverse Event|10|||
170887115|NCT00403260|617595879|FG001|Overall Study|P. vivax infection at screening|0|||
170447779|NCT00330460|615976719|FG001|Overall Study|Adverse Event|8|||
170447780|NCT00330460|615976718|FG000|Overall Study|Withdrawal by Subject|18|||
170786292|NCT05603143|617225486|FG001|Overall Study|Protocol Violation|1|||
170786293|NCT04505904|617225487|FG000|Overall Study|Withdrawal by Subject|1|||
170786294|NCT04505904|617225488|FG001|Overall Study|Withdrawal by Subject|2|||
170786295|NCT04505904|617225489|FG002|Overall Study|Withdrawal by Subject|0|||
170540338|NCT02903914|616320786|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
170540339|NCT02903914|616320787|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
170540340|NCT02903914|616320788|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
170540341|NCT02903914|616320789|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
170540342|NCT02903914|616320790|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
170540343|NCT02903914|616320791|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
170540344|NCT02903914|616320792|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
170540345|NCT02903914|616320785|FG000|Overall Study|Clinical Disease Progression|0|||
170540346|NCT02903914|616320786|FG001|Overall Study|Clinical Disease Progression|0|||
170540347|NCT02903914|616320787|FG002|Overall Study|Clinical Disease Progression|2|||
170540348|NCT02903914|616320788|FG003|Overall Study|Clinical Disease Progression|0|||
170540349|NCT02903914|616320789|FG004|Overall Study|Clinical Disease Progression|0|||
170540350|NCT02903914|616320790|FG005|Overall Study|Clinical Disease Progression|0|||
170540351|NCT02903914|616320791|FG006|Overall Study|Clinical Disease Progression|0|||
170540352|NCT02903914|616320792|FG007|Overall Study|Clinical Disease Progression|0|||
170540353|NCT02903914|616320785|FG000|Overall Study|Completed Follow-up Period|0|||
170540354|NCT02903914|616320786|FG001|Overall Study|Completed Follow-up Period|0|||
170540355|NCT02903914|616320787|FG002|Overall Study|Completed Follow-up Period|6|||
170540356|NCT02903914|616320788|FG003|Overall Study|Completed Follow-up Period|2|||
170540357|NCT02903914|616320789|FG004|Overall Study|Completed Follow-up Period|1|||
170540358|NCT02903914|616320790|FG005|Overall Study|Completed Follow-up Period|0|||
170540359|NCT02903914|616320791|FG006|Overall Study|Completed Follow-up Period|9|||
170540360|NCT02903914|616320792|FG007|Overall Study|Completed Follow-up Period|1|||
170540361|NCT02903914|616320785|FG000|Overall Study|Taken off Treatment per Protocol|0|||
170540362|NCT02903914|616320786|FG001|Overall Study|Taken off Treatment per Protocol|0|||
170540363|NCT02903914|616320787|FG002|Overall Study|Taken off Treatment per Protocol|0|||
170540364|NCT02903914|616320788|FG003|Overall Study|Taken off Treatment per Protocol|0|||
170540365|NCT02903914|616320789|FG004|Overall Study|Taken off Treatment per Protocol|0|||
170540366|NCT02903914|616320790|FG005|Overall Study|Taken off Treatment per Protocol|1|||
170540367|NCT02903914|616320791|FG006|Overall Study|Taken off Treatment per Protocol|0|||
170540368|NCT02903914|616320792|FG007|Overall Study|Taken off Treatment per Protocol|0|||
170540369|NCT02903914|616320785|FG000|Overall Study|Refused Further Treatment/Contact|0|||
170540370|NCT02903914|616320786|FG001|Overall Study|Refused Further Treatment/Contact|0|||
170540371|NCT02903914|616320787|FG002|Overall Study|Refused Further Treatment/Contact|0|||
170540372|NCT02903914|616320788|FG003|Overall Study|Refused Further Treatment/Contact|0|||
170540373|NCT02903914|616320789|FG004|Overall Study|Refused Further Treatment/Contact|0|||
170540374|NCT02903914|616320790|FG005|Overall Study|Refused Further Treatment/Contact|0|||
170540375|NCT02903914|616320791|FG006|Overall Study|Refused Further Treatment/Contact|1|||
170540376|NCT02903914|616320792|FG007|Overall Study|Refused Further Treatment/Contact|0|||
170540377|NCT02903914|616320785|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
170540378|NCT02903914|616320786|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
170540379|NCT02903914|616320787|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
170540380|NCT02903914|616320788|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
170540381|NCT02903914|616320789|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
170540382|NCT02903914|616320790|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
170540383|NCT02903914|616320791|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
170540384|NCT02903914|616320792|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
170540385|NCT05221866|616320793|FG000|Overall Study|Withdrawal by Subject|5|||
170540386|NCT05221866|616320794|FG001|Overall Study|Withdrawal by Subject|7|||
170540387|NCT05221866|616320795|FG002|Overall Study|Withdrawal by Subject|6|||
170540388|NCT05221866|616320796|FG003|Overall Study|Withdrawal by Subject|4|||
170540389|NCT05221866|616320793|FG000|Overall Study|Physician Decision|3|||
170540390|NCT05221866|616320794|FG001|Overall Study|Physician Decision|2|||
170540391|NCT05221866|616320795|FG002|Overall Study|Physician Decision|1|||
170540392|NCT05221866|616320796|FG003|Overall Study|Physician Decision|4|||
170540393|NCT05221866|616320793|FG000|Overall Study|Lost to Follow-up|12|||
170540394|NCT05221866|616320794|FG001|Overall Study|Lost to Follow-up|17|||
170540395|NCT05221866|616320795|FG002|Overall Study|Lost to Follow-up|14|||
170540396|NCT05221866|616320796|FG003|Overall Study|Lost to Follow-up|14|||
170540397|NCT05221866|616320793|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
170540398|NCT05221866|616320794|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
170633896|NCT00561925|616670157|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
170633897|NCT00561925|616670158|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
170633898|NCT00561925|616670159|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
170540399|NCT05221866|616320795|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
170540400|NCT05221866|616320796|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
170540401|NCT06455111|616320801|FG000|Overall Study|Withdrawal by Subject|11|||
170633899|NCT00561925|616670160|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
170786296|NCT04505904|617225490|FG003|Overall Study|Withdrawal by Subject|0|||
170786297|NCT04505904|617225487|FG000|Overall Study|Physician Decision|1|||
170786298|NCT04505904|617225488|FG001|Overall Study|Physician Decision|0|||
170786299|NCT04505904|617225489|FG002|Overall Study|Physician Decision|0|||
170786300|NCT04505904|617225490|FG003|Overall Study|Physician Decision|0|||
170786301|NCT04505904|617225487|FG000|Overall Study|Adverse Event|0|||
170786302|NCT04505904|617225488|FG001|Overall Study|Adverse Event|1|||
170786303|NCT04505904|617225489|FG002|Overall Study|Adverse Event|0|||
170786304|NCT04505904|617225490|FG003|Overall Study|Adverse Event|0|||
170786305|NCT05609760|617225491|FG000|Overall Study|Lost to Follow-up|0|||
170786306|NCT05609760|617225492|FG001|Overall Study|Lost to Follow-up|1|||
170786307|NCT05609760|617225491|FG000|Overall Study|Withdrawal by Subject|1|||
170786308|NCT05609760|617225492|FG001|Overall Study|Withdrawal by Subject|0|||
170786309|NCT05089734|617225493|FG000|Overall Study|Still on study|122|||
170786310|NCT05089734|617225494|FG001|Overall Study|Still on study|101|||
170786311|NCT05089734|617225493|FG000|Overall Study|Death|161|||
170786312|NCT05089734|617225494|FG001|Overall Study|Death|179|||
170786313|NCT05089734|617225493|FG000|Overall Study|Withdrew consent|11|||
170786314|NCT05089734|617225494|FG001|Overall Study|Withdrew consent|24|||
170887116|NCT00403260|617595878|FG000|Overall Study|P. ovale infection|1|||
170887117|NCT00403260|617595879|FG001|Overall Study|P. ovale infection|0|||
170540402|NCT06455111|616320802|FG001|Overall Study|Withdrawal by Subject|4|||
170540403|NCT02145390|616320812|FG000|Overall Study|Withdrawal by Subject|1|||
170540404|NCT03807843|616321993|FG000|Overall Study|Lost to Follow-up|1|||
170540405|NCT03807843|616321994|FG001|Overall Study|Lost to Follow-up|0|||
170540406|NCT00723944|616321995|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
170540407|NCT00723944|616321996|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
170540408|NCT00723944|616321995|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
170540409|NCT00723944|616321996|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
170540410|NCT00723944|616321995|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
170540411|NCT00723944|616321996|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
170540412|NCT02493855|616321998|FG000|Overall Study|Non-compliance|1|||
170540413|NCT02493855|616321999|FG001|Overall Study|Non-compliance|0|||
170540414|NCT02493855|616322000|FG002|Overall Study|Non-compliance|0|||
170540415|NCT02493855|616321998|FG000|Overall Study|Adverse Event|0|||
170540416|NCT02493855|616321999|FG001|Overall Study|Adverse Event|1|||
170540417|NCT02493855|616322000|FG002|Overall Study|Adverse Event|0|||
170540418|NCT02493855|616321998|FG000|Overall Study|Withdrawal by Subject|1|||
170540419|NCT02493855|616321999|FG001|Overall Study|Withdrawal by Subject|0|||
170540420|NCT02493855|616322000|FG002|Overall Study|Withdrawal by Subject|0|||
170540421|NCT05427916|616322001|FG000|Overall Study|Adverse Event|3|||
170540422|NCT05427916|616322002|FG001|Overall Study|Adverse Event|0|||
170540423|NCT05427916|616322001|FG000|Overall Study|Lack of Efficacy|6|||
170540424|NCT05427916|616322002|FG001|Overall Study|Lack of Efficacy|0|||
170540425|NCT05427916|616322001|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
170540426|NCT05427916|616322002|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
170540427|NCT00770484|616322008|FG000|Overall Study|Withdrawal by Subject|1|||
170540428|NCT00770484|616322009|FG001|Overall Study|Withdrawal by Subject|0|||
170540429|NCT06420232|616322010|FG000|Overall Study|Withdrawal by Subject|3|||
170540430|NCT03384966|616322011|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
170540431|NCT03384966|616322012|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
170540432|NCT03384966|616322013|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
170540433|NCT03384966|616322011|FG000|Follow-up Period|Adverse Event|1|||
170540434|NCT03384966|616322012|FG001|Follow-up Period|Adverse Event|0|||
170540435|NCT03384966|616322013|FG002|Follow-up Period|Adverse Event|0|||
170540436|NCT04790201|616322014|FG000|Overall Study|Lost to Follow-up|0|||
170540437|NCT04790201|616322015|FG001|Overall Study|Lost to Follow-up|0|||
170540438|NCT04790201|616322016|FG002|Overall Study|Lost to Follow-up|2|||
170540439|NCT04790201|616322014|FG000|Overall Study|Death|0|||
170540440|NCT04790201|616322015|FG001|Overall Study|Death|1|||
170540441|NCT04790201|616322016|FG002|Overall Study|Death|0|||
170540442|NCT04790201|616322014|FG000|Overall Study|Protocol Violation|1|||
170540443|NCT04790201|616322015|FG001|Overall Study|Protocol Violation|0|||
170540444|NCT04790201|616322016|FG002|Overall Study|Protocol Violation|1|||
170540445|NCT01334515|616322017|FG000|Overall Study|Adverse Event|1|||
170540446|NCT01334515|616322018|FG001|Overall Study|Adverse Event|6|||
170540447|NCT01334515|616322017|FG000|Overall Study|Death|1|||
170540448|NCT01334515|616322018|FG001|Overall Study|Death|0|||
170540449|NCT01334515|616322017|FG000|Overall Study|Lack of Efficacy|8|||
170540450|NCT01334515|616322018|FG001|Overall Study|Lack of Efficacy|21|||
170540451|NCT01334515|616322017|FG000|Overall Study|Physician Decision|1|||
170540452|NCT01334515|616322018|FG001|Overall Study|Physician Decision|1|||
170540453|NCT01334515|616322017|FG000|Overall Study|Withdrawal by Subject|1|||
170540454|NCT01334515|616322018|FG001|Overall Study|Withdrawal by Subject|1|||
170540455|NCT03637374|616322019|FG000|Overall Study|Death|2|||
170540456|NCT03637374|616322020|FG001|Overall Study|Death|0|||
170540457|NCT00776997|616322022|FG000|Overall Study|Adverse Event|2|||
170786315|NCT05089734|617225493|FG000|Overall Study|Lost to Follow-up|5|||
170447781|NCT00330460|615976719|FG001|Overall Study|Withdrawal by Subject|17|||
170447782|NCT00330460|615976718|FG000|Overall Study|Death|1|||
170447783|NCT00330460|615976719|FG001|Overall Study|Death|1|||
170447784|NCT00330460|615976718|FG000|Overall Study|Ineligibility determined|1|||
170447785|NCT00330460|615976719|FG001|Overall Study|Ineligibility determined|3|||
170447786|NCT00330460|615976718|FG000|Overall Study|Lost to Follow-up|8|||
170447787|NCT00330460|615976719|FG001|Overall Study|Lost to Follow-up|3|||
170447788|NCT00330460|615976718|FG000|Overall Study|Noncompliance|2|||
170447789|NCT00330460|615976719|FG001|Overall Study|Noncompliance|1|||
170447790|NCT00330460|615976718|FG000|Overall Study|Other|1|||
170447791|NCT00330460|615976719|FG001|Overall Study|Other|0|||
170447792|NCT02663882|615976720|FG000|Overall Study|Lost to Follow-up|4|||
170447793|NCT02663882|615976721|FG001|Overall Study|Lost to Follow-up|2|||
170447794|NCT02094261|615976722|FG000|Overall Study|Death|24|||
170447795|NCT02094261|615976722|FG000|Overall Study|Lost to Follow-up|1|||
170447796|NCT02094261|615976722|FG000|Overall Study|Withdrawal by Subject|4|||
170447797|NCT02094261|615976722|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
170447798|NCT00551616|615976725|FG000|Overall Study|Lost to Follow-up|48|||
170447799|NCT00551616|615976726|FG001|Overall Study|Lost to Follow-up|40|||
170447800|NCT02808819|615976727|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
170447801|NCT02808819|615976728|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
170447802|NCT02808819|615976727|FG000|Overall Study|Withdrawal by Subject|10|||
170447803|NCT02808819|615976728|FG001|Overall Study|Withdrawal by Subject|13|||
170447804|NCT02808819|615976727|FG000|Overall Study|Site terminated by sponsor|2|||
170447805|NCT02808819|615976728|FG001|Overall Study|Site terminated by sponsor|0|||
170447806|NCT02808819|615976727|FG000|Overall Study|Pregnancy|1|||
170540458|NCT05696847|616322023|FG000|Overall Study|Withdrawal by Subject|1|||
170540459|NCT05696847|616322024|FG001|Overall Study|Withdrawal by Subject|0|||
170540460|NCT05696847|616322025|FG002|Overall Study|Withdrawal by Subject|0|||
170540461|NCT05696847|616322026|FG003|Overall Study|Withdrawal by Subject|0|||
170540462|NCT05696847|616322027|FG004|Overall Study|Withdrawal by Subject|0|||
170540463|NCT05696847|616322028|FG005|Overall Study|Withdrawal by Subject|0|||
170540464|NCT05696847|616322023|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170540465|NCT05696847|616322024|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170540466|NCT05696847|616322025|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170540467|NCT05696847|616322026|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170540468|NCT05696847|616322027|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
170540469|NCT05696847|616322028|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
170540470|NCT05696847|616322023|FG000|Overall Study|Adverse Event|0|||
170540471|NCT05696847|616322024|FG001|Overall Study|Adverse Event|0|||
170540472|NCT05696847|616322025|FG002|Overall Study|Adverse Event|0|||
170540473|NCT05696847|616322026|FG003|Overall Study|Adverse Event|0|||
170540474|NCT05696847|616322027|FG004|Overall Study|Adverse Event|0|||
170540475|NCT05696847|616322028|FG005|Overall Study|Adverse Event|1|||
170540476|NCT05696847|616322023|FG000|Overall Study|Sponsor Decision|0|||
170540477|NCT05696847|616322024|FG001|Overall Study|Sponsor Decision|0|||
170540478|NCT05696847|616322025|FG002|Overall Study|Sponsor Decision|0|||
170540479|NCT05696847|616322026|FG003|Overall Study|Sponsor Decision|1|||
170540480|NCT05696847|616322027|FG004|Overall Study|Sponsor Decision|0|||
170540481|NCT05696847|616322028|FG005|Overall Study|Sponsor Decision|0|||
170540482|NCT02948400|616322029|FG000|Overall Study|Withdrawal by Subject|17|||
170540483|NCT02948400|616322030|FG001|Overall Study|Withdrawal by Subject|10|||
170540484|NCT02948400|616322029|FG000|Overall Study|failed to attend appointments|47|||
170540485|NCT02948400|616322030|FG001|Overall Study|failed to attend appointments|34|||
170540486|NCT02948400|616322029|FG000|Overall Study|COVID-related closure|6|||
170540487|NCT02948400|616322030|FG001|Overall Study|COVID-related closure|2|||
170540488|NCT02948400|616322029|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
170540489|NCT02948400|616322030|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
170540490|NCT02948400|616322029|FG000|Overall Study|motion sickness in virtual reality|2|||
170540491|NCT02948400|616322030|FG001|Overall Study|motion sickness in virtual reality|0|||
170786316|NCT05089734|617225494|FG001|Overall Study|Lost to Follow-up|0|||
170786317|NCT05179395|617225495|FG000|Overall Study|Lack of Efficacy|1|||
170786318|NCT05351554|617225496|FG000|Overall Study|Study terminated by sponsor|1|||
170786319|NCT05093829|617225497|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
170786320|NCT05093829|617225498|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
170786321|NCT05093829|617225499|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
170786322|NCT05093829|617225500|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
170786323|NCT05093829|617225501|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
170786324|NCT06283173|617227245|FG000|Overall Study|Did not show for first visit|10|||
170786325|NCT06283173|617227245|FG000|Overall Study|Lost to Follow-up|12|||
170447807|NCT02808819|615976728|FG001|Overall Study|Pregnancy|0|||
170447808|NCT02808819|615976727|FG000|Overall Study|Lost to Follow-up|1|||
170447809|NCT02808819|615976728|FG001|Overall Study|Lost to Follow-up|6|||
170447810|NCT02808819|615976727|FG000|Overall Study|Protocol Violation|0|||
170447811|NCT02808819|615976728|FG001|Overall Study|Protocol Violation|1|||
170786326|NCT06283173|617227245|FG000|Overall Study|Physician Decision|7|||
170786327|NCT03623321|617227246|FG000|Overall Study|Adverse Event|32|||
170786328|NCT03623321|617227246|FG000|Overall Study|Death|9|||
170786329|NCT03623321|617227246|FG000|Overall Study|Lack of Efficacy|9|||
170786330|NCT03623321|617227246|FG000|Overall Study|Lost to Follow-up|6|||
170786331|NCT03623321|617227246|FG000|Overall Study|Noncompliance with study drug|6|||
170786332|NCT03623321|617227246|FG000|Overall Study|Use of prohibited medication|3|||
170786333|NCT03623321|617227246|FG000|Overall Study|Physician Decision|5|||
170786334|NCT03623321|617227246|FG000|Overall Study|Protocol Violation|1|||
170786335|NCT03623321|617227246|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
170786336|NCT03623321|617227246|FG000|Overall Study|Not further specified|43|||
170786337|NCT03457142|617227249|FG000|Overall Study|Death|1|||
170786338|NCT03707951|617227250|FG000|Overall Study|Lost to Follow-up|8|||
170786339|NCT03707951|617227251|FG001|Overall Study|Lost to Follow-up|17|||
170786340|NCT03707951|617227250|FG000|Overall Study|Withdrawal by Subject|6|||
170786341|NCT03707951|617227251|FG001|Overall Study|Withdrawal by Subject|6|||
170786342|NCT04533347|617227252|FG000|Overall Study|Adverse Event|1|||
170786343|NCT04533347|617227253|FG001|Overall Study|Adverse Event|2|||
170786344|NCT04533347|617227252|FG000|Overall Study|Lost to Follow-up|2|||
170786345|NCT04533347|617227253|FG001|Overall Study|Lost to Follow-up|0|||
170786346|NCT04533347|617227252|FG000|Overall Study|Withdrawal by Subject|1|||
170786347|NCT04533347|617227253|FG001|Overall Study|Withdrawal by Subject|0|||
170786348|NCT05520190|617227254|FG000|Overall Study|Lost to Follow-up|7|||
170786349|NCT05520190|617227254|FG000|Overall Study|Withdrawal by Subject|2|||
170786350|NCT03476187|617227263|FG000|Overall Study|Protocol Violation|7|||
170786351|NCT03476187|617227263|FG000|Overall Study|Physician Decision|5|||
170786352|NCT05948670|617227264|FG000|Overall Study|Protocol Violation|6|||
170786353|NCT05948670|617227265|FG001|Overall Study|Protocol Violation|8|||
170786354|NCT05948670|617227264|FG000|Overall Study|Withdrawal by Subject|0|||
170786355|NCT05948670|617227265|FG001|Overall Study|Withdrawal by Subject|1|||
170786356|NCT04029688|617227266|FG000|Overall Study|Death|8|||
170786357|NCT04029688|617227267|FG001|Overall Study|Death|3|||
170786358|NCT04029688|617227268|FG002|Overall Study|Death|6|||
170786359|NCT04029688|617227269|FG003|Overall Study|Death|2|||
170786360|NCT04029688|617227270|FG004|Overall Study|Death|5|||
170786361|NCT04029688|617227271|FG005|Overall Study|Death|0|||
170786362|NCT04029688|617227272|FG006|Overall Study|Death|2|||
170786363|NCT04029688|617227273|FG007|Overall Study|Death|3|||
170786364|NCT04029688|617227266|FG000|Overall Study|Study Terminated by Sponsor|0|||
170786365|NCT04029688|617227267|FG001|Overall Study|Study Terminated by Sponsor|0|||
170786366|NCT04029688|617227268|FG002|Overall Study|Study Terminated by Sponsor|0|||
170786367|NCT04029688|617227269|FG003|Overall Study|Study Terminated by Sponsor|0|||
170786368|NCT04029688|617227270|FG004|Overall Study|Study Terminated by Sponsor|1|||
170786369|NCT04029688|617227271|FG005|Overall Study|Study Terminated by Sponsor|3|||
170786370|NCT04029688|617227272|FG006|Overall Study|Study Terminated by Sponsor|1|||
170786371|NCT04029688|617227273|FG007|Overall Study|Study Terminated by Sponsor|3|||
170786372|NCT04029688|617227266|FG000|Overall Study|Withdrawal by Subject|0|||
170786373|NCT04029688|617227267|FG001|Overall Study|Withdrawal by Subject|0|||
170786374|NCT04029688|617227268|FG002|Overall Study|Withdrawal by Subject|0|||
170786375|NCT04029688|617227269|FG003|Overall Study|Withdrawal by Subject|1|||
170786376|NCT04029688|617227270|FG004|Overall Study|Withdrawal by Subject|0|||
170786377|NCT04029688|617227271|FG005|Overall Study|Withdrawal by Subject|0|||
170786378|NCT04029688|617227272|FG006|Overall Study|Withdrawal by Subject|0|||
170786379|NCT04029688|617227273|FG007|Overall Study|Withdrawal by Subject|0|||
170786380|NCT04130438|617227289|FG000|Overall Study|Lost to Follow-up|0|||
170786381|NCT04130438|617227290|FG001|Overall Study|Lost to Follow-up|0|||
170887118|NCT00403260|617595878|FG000|Overall Study|Gametocyte re-appearance|1|||
170540492|NCT05513950|616322031|FG000|Overall Study|Not treated due to technical reasons|0|||
170540493|NCT05513950|616322032|FG001|Overall Study|Not treated due to technical reasons|0|||
170540494|NCT05513950|616322033|FG002|Overall Study|Not treated due to technical reasons|1|||
170540495|NCT05513950|616322034|FG003|Overall Study|Not treated due to technical reasons|0|||
170540496|NCT05561140|616322035|FG000|Randomized Treatment Period|Adverse Event|1|||
170540497|NCT05561140|616322036|FG001|Randomized Treatment Period|Adverse Event|0|||
170540498|NCT05561140|616322035|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
170540499|NCT05561140|616322036|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
170540500|NCT05561140|616322035|FG000|Open Label Treatment Period|Adverse Event|6|||
170540501|NCT05561140|616322036|FG001|Open Label Treatment Period|Adverse Event|4|||
170540502|NCT05561140|616322035|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
170540503|NCT05561140|616322036|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
170540504|NCT05561140|616322035|FG000|Open Label Treatment Period|Physician Decision|0|||
170540505|NCT05561140|616322036|FG001|Open Label Treatment Period|Physician Decision|1|||
170540506|NCT05561140|616322035|FG000|Open Label Treatment Period|Pregnancy|1|||
170786382|NCT04130438|617227291|FG002|Overall Study|Lost to Follow-up|1|||
170786383|NCT03396926|617227299|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
170786384|NCT03396926|617227300|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
170786385|NCT02035787|617227301|FG000|Overall Study- 12 Months|Adverse Event|3|||
170786386|NCT02035787|617227302|FG001|Overall Study- 12 Months|Adverse Event|0|||
170786387|NCT02035787|617227301|FG000|Overall Study- 12 Months|Complete response|4|||
170786388|NCT02035787|617227302|FG001|Overall Study- 12 Months|Complete response|1|||
170786389|NCT02035787|617227301|FG000|Overall Study- 12 Months|Protocol Violation|1|||
170786390|NCT02035787|617227302|FG001|Overall Study- 12 Months|Protocol Violation|1|||
170786391|NCT02924272|617227305|FG000|Overall Study|Site Terminated by Sponsor|4|||
170786392|NCT02924272|617227306|FG001|Overall Study|Site Terminated by Sponsor|1|||
170786393|NCT02924272|617227305|FG000|Overall Study|Withdrawal by Subject|2|||
170786394|NCT02924272|617227306|FG001|Overall Study|Withdrawal by Subject|0|||
170786395|NCT02924272|617227305|FG000|Overall Study|Adverse Event|3|||
170786396|NCT02924272|617227306|FG001|Overall Study|Adverse Event|0|||
170786397|NCT02924272|617227305|FG000|Overall Study|Progressive Disease|11|||
170786398|NCT02924272|617227306|FG001|Overall Study|Progressive Disease|8|||
170786399|NCT02924272|617227305|FG000|Overall Study|Clinical Deterioration|1|||
170786400|NCT02924272|617227306|FG001|Overall Study|Clinical Deterioration|0|||
170786401|NCT02924272|617227305|FG000|Overall Study|Death|1|||
170786402|NCT02924272|617227306|FG001|Overall Study|Death|0|||
170786403|NCT02924272|617227305|FG000|Overall Study|Reason Not Specified|1|||
170786404|NCT02924272|617227306|FG001|Overall Study|Reason Not Specified|0|||
170786405|NCT03575897|617227310|FG000|Overall Study|Lost to Follow-up|12|||
170786406|NCT03575897|617227311|FG001|Overall Study|Lost to Follow-up|13|||
170786407|NCT00506519|617227318|FG000|Overall Study|Death|4|||
170786408|NCT00506519|617227319|FG001|Overall Study|Death|6|||
170786409|NCT00506519|617227320|FG002|Overall Study|Death|0|||
170786410|NCT00506519|617227318|FG000|Overall Study|Adverse Event|1|||
170786411|NCT00506519|617227319|FG001|Overall Study|Adverse Event|0|||
170786412|NCT00506519|617227320|FG002|Overall Study|Adverse Event|0|||
170786413|NCT03150810|617227321|FG000|Overall Study|Death|4|||
170540507|NCT05561140|616322036|FG001|Open Label Treatment Period|Pregnancy|0|||
170540508|NCT05561140|616322035|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
170540509|NCT05561140|616322036|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
170540510|NCT05561140|616322035|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
170540511|NCT05561140|616322036|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
170540512|NCT05561140|616322035|FG000|Open Label Treatment Period|Other|1|||
170540513|NCT05561140|616322036|FG001|Open Label Treatment Period|Other|0|||
170540514|NCT03487445|616322040|FG000|Randomization|Not treated for administrative reasons|1|||
170540515|NCT03487445|616322041|FG001|Randomization|Not treated for administrative reasons|0|||
170540516|NCT00975923|616322046|FG000|Overall Study|Withdrawal by Subject|0|||
170540517|NCT00975923|616322047|FG001|Overall Study|Withdrawal by Subject|1|||
170540518|NCT00221104|616322049|FG000|Overall Study|Adverse Event|1|||
170540519|NCT00221104|616322050|FG001|Overall Study|Adverse Event|0|||
170633900|NCT00561925|616670161|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
170633901|NCT00561925|616670157|FG000|14 Day Lead-In Period|Other|5|||
170633902|NCT00561925|616670158|FG001|14 Day Lead-In Period|Other|0|||
170633903|NCT00561925|616670159|FG002|14 Day Lead-In Period|Other|0|||
170633904|NCT00561925|616670160|FG003|14 Day Lead-In Period|Other|0|||
170633905|NCT00561925|616670161|FG004|14 Day Lead-In Period|Other|0|||
170633906|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
170633907|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
170633908|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
170633909|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
170633910|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
170633911|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
170633912|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
170633913|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
170786414|NCT03150810|617227322|FG001|Overall Study|Death|8|||
170887119|NCT00403260|617595879|FG001|Overall Study|Gametocyte re-appearance|1|||
170887120|NCT00403260|617595878|FG000|Overall Study|Withdrawn from study accidentally|0|||
170887121|NCT00403260|617595879|FG001|Overall Study|Withdrawn from study accidentally|1|||
170540520|NCT00221104|616322049|FG000|Overall Study|Physician Decision|1|||
170540521|NCT00221104|616322050|FG001|Overall Study|Physician Decision|0|||
170540522|NCT00221104|616322049|FG000|Overall Study|Protocol Violation|2|||
170633914|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
170633915|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
170633916|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
170633917|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
170633918|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
170786415|NCT03150810|617227323|FG002|Overall Study|Death|7|||
170540523|NCT00221104|616322050|FG001|Overall Study|Protocol Violation|0|||
170786416|NCT03150810|617227324|FG003|Overall Study|Death|2|||
170786417|NCT03150810|617227325|FG004|Overall Study|Death|2|||
170786418|NCT03150810|617227326|FG005|Overall Study|Death|10|||
170786419|NCT03150810|617227327|FG006|Overall Study|Death|8|||
170786420|NCT03150810|617227328|FG007|Overall Study|Death|6|||
170786421|NCT03150810|617227329|FG008|Overall Study|Death|18|||
170633919|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
170447812|NCT02808819|615976727|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
170447813|NCT02808819|615976728|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
170447814|NCT02808819|615976727|FG000|Overall Study|Death|1|||
170447815|NCT02808819|615976728|FG001|Overall Study|Death|0|||
170447816|NCT02808819|615976727|FG000|Overall Study|Adverse Event|3|||
170447817|NCT02808819|615976728|FG001|Overall Study|Adverse Event|4|||
170447818|NCT03877926|615976729|FG000|Overall Study|Adverse Event|1|||
170447819|NCT03877926|615976730|FG001|Overall Study|Adverse Event|0|||
170447820|NCT03877926|615976731|FG002|Overall Study|Adverse Event|0|||
170447821|NCT03877926|615976732|FG003|Overall Study|Adverse Event|0|||
170447822|NCT03877926|615976729|FG000|Overall Study|Death|2|||
170447823|NCT03877926|615976730|FG001|Overall Study|Death|2|||
170447824|NCT03877926|615976731|FG002|Overall Study|Death|2|||
170447825|NCT03877926|615976732|FG003|Overall Study|Death|0|||
170447826|NCT03877926|615976729|FG000|Overall Study|Lost to Follow-up|41|||
170447827|NCT03877926|615976730|FG001|Overall Study|Lost to Follow-up|52|||
170447828|NCT03877926|615976731|FG002|Overall Study|Lost to Follow-up|45|||
170447829|NCT03877926|615976732|FG003|Overall Study|Lost to Follow-up|17|||
170447830|NCT03877926|615976729|FG000|Overall Study|Physician Decision|2|||
170447831|NCT03877926|615976730|FG001|Overall Study|Physician Decision|0|||
170447832|NCT03877926|615976731|FG002|Overall Study|Physician Decision|2|||
170447833|NCT03877926|615976732|FG003|Overall Study|Physician Decision|0|||
170447834|NCT03877926|615976729|FG000|Overall Study|Withdrawal by Subject|18|||
170447835|NCT03877926|615976730|FG001|Overall Study|Withdrawal by Subject|21|||
170447836|NCT03877926|615976731|FG002|Overall Study|Withdrawal by Subject|12|||
170447837|NCT03877926|615976732|FG003|Overall Study|Withdrawal by Subject|4|||
170633920|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
170633921|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
170633922|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
170447838|NCT03877926|615976729|FG000|Overall Study|Other - Various|4|||
170447839|NCT03877926|615976730|FG001|Overall Study|Other - Various|1|||
170447840|NCT03877926|615976731|FG002|Overall Study|Other - Various|1|||
170447841|NCT03877926|615976732|FG003|Overall Study|Other - Various|0|||
170447842|NCT03877926|615976729|FG000|Overall Study|Not Treated|3|||
170447843|NCT03877926|615976730|FG001|Overall Study|Not Treated|1|||
170447844|NCT03877926|615976731|FG002|Overall Study|Not Treated|1|||
170447845|NCT03877926|615976732|FG003|Overall Study|Not Treated|0|||
170447846|NCT03546647|615976736|FG000|Overall Study|Adverse Event|1|||
170447847|NCT03546647|615976737|FG001|Overall Study|Adverse Event|0|||
170447848|NCT03554317|615976738|FG000|Overall Study|Withdrawal by Subject|1|||
170447849|NCT03554317|615976738|FG000|Overall Study|PSA Progression|3|||
170447850|NCT03554317|615976738|FG000|Overall Study|Radiographic Progression|4|||
170447851|NCT00124462|615976739|FG000|Overall Study|Lost to Follow-up|3|||
170447852|NCT00124462|615976740|FG001|Overall Study|Lost to Follow-up|3|||
170447853|NCT00124462|615976739|FG000|Overall Study|Physician Decision|3|||
170447854|NCT00124462|615976740|FG001|Overall Study|Physician Decision|4|||
170447855|NCT00124462|615976739|FG000|Overall Study|Withdrawal by Subject|4|||
170447856|NCT00124462|615976740|FG001|Overall Study|Withdrawal by Subject|5|||
170447857|NCT00124462|615976739|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
170447858|NCT00124462|615976740|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
170447859|NCT02400476|615976741|FG000|Overall Study|Adverse Event|57|||
170447860|NCT02400476|615976742|FG001|Overall Study|Adverse Event|10|||
170447861|NCT02400476|615976743|FG002|Overall Study|Adverse Event|22|||
170447862|NCT02400476|615976744|FG003|Overall Study|Adverse Event|19|||
170447863|NCT02400476|615976745|FG004|Overall Study|Adverse Event|5|||
170447864|NCT02400476|615976746|FG005|Overall Study|Adverse Event|8|||
170447865|NCT02400476|615976741|FG000|Overall Study|Withdrawal by Subject|4|||
170447866|NCT02400476|615976742|FG001|Overall Study|Withdrawal by Subject|1|||
170447867|NCT02400476|615976743|FG002|Overall Study|Withdrawal by Subject|12|||
170786422|NCT03150810|617227330|FG009|Overall Study|Death|3|||
170447868|NCT02400476|615976744|FG003|Overall Study|Withdrawal by Subject|7|||
170447869|NCT02400476|615976745|FG004|Overall Study|Withdrawal by Subject|5|||
170447870|NCT02400476|615976746|FG005|Overall Study|Withdrawal by Subject|5|||
170447871|NCT02400476|615976741|FG000|Overall Study|Lost to Follow-up|0|||
170447872|NCT02400476|615976742|FG001|Overall Study|Lost to Follow-up|0|||
170447873|NCT02400476|615976743|FG002|Overall Study|Lost to Follow-up|0|||
170447874|NCT02400476|615976744|FG003|Overall Study|Lost to Follow-up|1|||
170447875|NCT02400476|615976745|FG004|Overall Study|Lost to Follow-up|3|||
170447876|NCT02400476|615976746|FG005|Overall Study|Lost to Follow-up|1|||
170447877|NCT02400476|615976741|FG000|Overall Study|Physician Decision|0|||
170447878|NCT02400476|615976742|FG001|Overall Study|Physician Decision|0|||
170447879|NCT02400476|615976743|FG002|Overall Study|Physician Decision|1|||
170447880|NCT02400476|615976744|FG003|Overall Study|Physician Decision|1|||
170447881|NCT02400476|615976745|FG004|Overall Study|Physician Decision|0|||
170447882|NCT02400476|615976746|FG005|Overall Study|Physician Decision|1|||
170447883|NCT02400476|615976741|FG000|Overall Study|Other, Disease Progression|0|||
170786423|NCT03150810|617227331|FG010|Overall Study|Death|19|||
170786424|NCT03150810|617227332|FG011|Overall Study|Death|1|||
170447884|NCT02400476|615976742|FG001|Overall Study|Other, Disease Progression|1|||
170447885|NCT02400476|615976743|FG002|Overall Study|Other, Disease Progression|2|||
170447886|NCT02400476|615976744|FG003|Overall Study|Other, Disease Progression|1|||
170447887|NCT02400476|615976745|FG004|Overall Study|Other, Disease Progression|2|||
170447888|NCT02400476|615976746|FG005|Overall Study|Other, Disease Progression|1|||
170447889|NCT02400476|615976741|FG000|Overall Study|Other, Decreased Quality of Life|0|||
170447890|NCT02400476|615976742|FG001|Overall Study|Other, Decreased Quality of Life|0|||
170633923|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
170447891|NCT02400476|615976743|FG002|Overall Study|Other, Decreased Quality of Life|2|||
170447892|NCT02400476|615976744|FG003|Overall Study|Other, Decreased Quality of Life|0|||
170447893|NCT02400476|615976745|FG004|Overall Study|Other, Decreased Quality of Life|0|||
170447894|NCT02400476|615976746|FG005|Overall Study|Other, Decreased Quality of Life|0|||
170447895|NCT02400476|615976741|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
170447896|NCT02400476|615976742|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
170447897|NCT02400476|615976743|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
170447898|NCT02400476|615976744|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
170540524|NCT00221104|616322049|FG000|Overall Study|Withdrawal by Subject|42|||
170540525|NCT00221104|616322050|FG001|Overall Study|Withdrawal by Subject|29|||
170540526|NCT00221104|616322049|FG000|Overall Study|Others|37|||
170540527|NCT00221104|616322050|FG001|Overall Study|Others|47|||
170540528|NCT02989389|616322051|FG000|Period 1|Lost to Follow-up|0|||
170540529|NCT02989389|616322052|FG001|Period 1|Lost to Follow-up|1|||
170540530|NCT02989389|616322053|FG002|Period 1|Lost to Follow-up|0|||
170540531|NCT02989389|616322054|FG003|Period 1|Lost to Follow-up|0|||
170540532|NCT02989389|616322055|FG004|Period 1|Lost to Follow-up|0|||
170540533|NCT02989389|616322056|FG005|Period 1|Lost to Follow-up|0|||
170540534|NCT02989389|616322057|FG006|Period 1|Lost to Follow-up|0|||
170540535|NCT02989389|616322058|FG007|Period 1|Lost to Follow-up|0|||
170540536|NCT02989389|616322059|FG008|Period 1|Lost to Follow-up|0|||
170540537|NCT02989389|616322060|FG009|Period 1|Lost to Follow-up|0|||
170540538|NCT02989389|616322051|FG000|Period 1|Physician Decision|0|||
170540539|NCT02989389|616322052|FG001|Period 1|Physician Decision|0|||
170540540|NCT02989389|616322053|FG002|Period 1|Physician Decision|0|||
170540541|NCT02989389|616322054|FG003|Period 1|Physician Decision|0|||
170540542|NCT02989389|616322055|FG004|Period 1|Physician Decision|0|||
170540543|NCT02989389|616322056|FG005|Period 1|Physician Decision|0|||
170540544|NCT02989389|616322057|FG006|Period 1|Physician Decision|0|||
170540545|NCT02989389|616322058|FG007|Period 1|Physician Decision|0|||
170540546|NCT02989389|616322059|FG008|Period 1|Physician Decision|1|||
170540547|NCT02989389|616322060|FG009|Period 1|Physician Decision|0|||
170540548|NCT01666652|616322061|FG000|Overall Study|Serious Adverse Event|0|||
170540549|NCT01666652|616322062|FG001|Overall Study|Serious Adverse Event|0|||
170540550|NCT01666652|616322063|FG002|Overall Study|Serious Adverse Event|0|||
170540551|NCT01666652|616322064|FG003|Overall Study|Serious Adverse Event|1|||
170540552|NCT01666652|616322065|FG004|Overall Study|Serious Adverse Event|0|||
170540553|NCT01666652|616322061|FG000|Overall Study|Withdrawal by Subject|0|||
170540554|NCT01666652|616322062|FG001|Overall Study|Withdrawal by Subject|0|||
170540555|NCT01666652|616322063|FG002|Overall Study|Withdrawal by Subject|0|||
170540556|NCT01666652|616322064|FG003|Overall Study|Withdrawal by Subject|0|||
170540557|NCT01666652|616322065|FG004|Overall Study|Withdrawal by Subject|1|||
170540558|NCT01666652|616322061|FG000|Overall Study|Moved from study area|1|||
170447899|NCT02400476|615976745|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
170540559|NCT01666652|616322062|FG001|Overall Study|Moved from study area|0|||
170540560|NCT01666652|616322063|FG002|Overall Study|Moved from study area|0|||
170540561|NCT01666652|616322064|FG003|Overall Study|Moved from study area|2|||
170540562|NCT01666652|616322065|FG004|Overall Study|Moved from study area|0|||
170633924|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
170633925|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
170633926|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
170447900|NCT02400476|615976746|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
170633927|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
170786425|NCT03150810|617227333|FG012|Overall Study|Death|19|||
170447901|NCT02487082|615976747|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
170447902|NCT02487082|615976748|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
170447903|NCT02487082|615976747|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
170447904|NCT02487082|615976748|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
170447905|NCT00588731|615976749|FG000|Overall Study|Withdrawal by Subject|3|||
170447906|NCT00588731|615976750|FG001|Overall Study|Withdrawal by Subject|2|||
170540563|NCT01666652|616322061|FG000|Overall Study|Lost to Follow-up|1|||
170540564|NCT01666652|616322062|FG001|Overall Study|Lost to Follow-up|1|||
170540565|NCT01666652|616322063|FG002|Overall Study|Lost to Follow-up|1|||
170540566|NCT01666652|616322064|FG003|Overall Study|Lost to Follow-up|1|||
170540567|NCT01666652|616322065|FG004|Overall Study|Lost to Follow-up|0|||
170540568|NCT01695746|616322066|FG000|Overall Study|Adverse Event|1|||
170540569|NCT01695746|616322066|FG000|Overall Study|Non-compliance by the participant|3|||
170447907|NCT01998243|615976751|FG000|Overall Study|Pregnancy|0|||
170447908|NCT01998243|615976752|FG001|Overall Study|Pregnancy|1|||
170447909|NCT01998243|615976751|FG000|Overall Study|Protocol Violation|5|||
170447910|NCT01998243|615976752|FG001|Overall Study|Protocol Violation|2|||
170447911|NCT01998243|615976751|FG000|Overall Study|Withdrawal by Subject|3|||
170447912|NCT01998243|615976752|FG001|Overall Study|Withdrawal by Subject|4|||
170447913|NCT01684878|615976757|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
170447914|NCT01684878|615976758|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
170447915|NCT01684878|615976759|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
170447916|NCT01684878|615976760|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
170447917|NCT01684878|615976757|FG000|Part 1: Safety Run in Phase|Death|15|||
170447918|NCT01684878|615976758|FG001|Part 1: Safety Run in Phase|Death|20|||
170447919|NCT01684878|615976759|FG002|Part 1: Safety Run in Phase|Death|0|||
170447920|NCT01684878|615976760|FG003|Part 1: Safety Run in Phase|Death|0|||
170447921|NCT01684878|615976757|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
170447922|NCT01684878|615976758|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
170447923|NCT01684878|615976759|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
170447924|NCT01684878|615976760|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
170447925|NCT01684878|615976757|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
170447926|NCT01684878|615976758|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
170447927|NCT01684878|615976759|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
170447928|NCT01684878|615976760|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
170447929|NCT01684878|615976757|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
170447930|NCT01684878|615976758|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
170447931|NCT01684878|615976759|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
170447932|NCT01684878|615976760|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
170447933|NCT01684878|615976757|FG000|Part 2: Randomized Phase|Death|0|||
170447934|NCT01684878|615976758|FG001|Part 2: Randomized Phase|Death|0|||
170447935|NCT01684878|615976759|FG002|Part 2: Randomized Phase|Death|62|||
170447936|NCT01684878|615976760|FG003|Part 2: Randomized Phase|Death|68|||
170786426|NCT03150810|617227321|FG000|Overall Study|Withdrawal by Subject|0|||
170447937|NCT01684878|615976757|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
170447938|NCT01684878|615976758|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
170447939|NCT01684878|615976759|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
170447940|NCT01684878|615976760|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
170447941|NCT01684878|615976757|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
170447942|NCT01684878|615976758|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
170447943|NCT01684878|615976759|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
170447944|NCT01684878|615976760|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
170447945|NCT04647383|615976761|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
170447946|NCT04647383|615976762|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
170447947|NCT04647383|615976763|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
170447948|NCT04647383|615976764|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
170447949|NCT02927834|615976765|FG000|Overall Study|Lost to Follow-up|1|||
170447950|NCT02927834|615976766|FG001|Overall Study|Lost to Follow-up|2|||
170447951|NCT02927834|615976767|FG002|Overall Study|Lost to Follow-up|2|||
170447952|NCT03812991|615976768|FG000|Overall Study|Lost to Follow-up|3|||
170447953|NCT03812991|615976769|FG001|Overall Study|Lost to Follow-up|1|||
170447954|NCT00479388|615976772|FG000|Overall Study|Adverse Event|90|||
170447955|NCT00479388|615976773|FG001|Overall Study|Adverse Event|45|||
170447956|NCT00479388|615976772|FG000|Overall Study|Lost to Follow-up|0|||
170540570|NCT01695746|616322066|FG000|Overall Study|Protocol Violation|5|||
170540571|NCT01695746|616322066|FG000|Overall Study|Participant not willing to participate|3|||
170540572|NCT01132755|616322067|FG000|Overall Study|Procedure not done due to medical reason|23|||
170540573|NCT01132755|616322067|FG000|Overall Study|Protocol Violation|15|||
170540574|NCT01132755|616322067|FG000|Overall Study|Withdrawal by Subject|4|||
170786427|NCT03150810|617227322|FG001|Overall Study|Withdrawal by Subject|1|||
170786428|NCT03150810|617227323|FG002|Overall Study|Withdrawal by Subject|1|||
170786429|NCT03150810|617227324|FG003|Overall Study|Withdrawal by Subject|1|||
170786430|NCT03150810|617227325|FG004|Overall Study|Withdrawal by Subject|0|||
170447957|NCT00479388|615976773|FG001|Overall Study|Lost to Follow-up|2|||
170447958|NCT00479388|615976772|FG000|Overall Study|Protocol Violation|10|||
170447959|NCT00479388|615976773|FG001|Overall Study|Protocol Violation|9|||
170447960|NCT00479388|615976772|FG000|Overall Study|Withdrawal by Subject|32|||
170447961|NCT00479388|615976773|FG001|Overall Study|Withdrawal by Subject|17|||
170447962|NCT00105157|615976774|FG000|Double-Blind (DB)|Never Treated|1|||
170447963|NCT00105157|615976775|FG001|Double-Blind (DB)|Never Treated|0|||
170447964|NCT00105157|615976776|FG002|Double-Blind (DB)|Never Treated|0|||
170447965|NCT00105157|615976777|FG003|Double-Blind (DB)|Never Treated|0|||
170540575|NCT04132050|616322075|FG000|Period I (Double-blind Period)|Adverse Event|3|||
170786431|NCT03150810|617227326|FG005|Overall Study|Withdrawal by Subject|0|||
170786432|NCT03150810|617227327|FG006|Overall Study|Withdrawal by Subject|2|||
170633928|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
170633929|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
170633930|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
170633931|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
170633932|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
170633933|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
170633934|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
170633935|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
170633936|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Death|0|||
170633937|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Death|6|||
170633938|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Death|3|||
170633939|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Death|0|||
170633940|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Death|0|||
170633941|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
170633942|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
170633943|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
170633944|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
170633945|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
170633946|NCT00561925|616670157|FG000|144-week Double-blind, Double-dummy|Other|0|||
170633947|NCT00561925|616670158|FG001|144-week Double-blind, Double-dummy|Other|8|||
170633948|NCT00561925|616670159|FG002|144-week Double-blind, Double-dummy|Other|11|||
170633949|NCT00561925|616670160|FG003|144-week Double-blind, Double-dummy|Other|0|||
170633950|NCT00561925|616670161|FG004|144-week Double-blind, Double-dummy|Other|0|||
170633951|NCT00561925|616670157|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
170633952|NCT00561925|616670158|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
170633953|NCT00561925|616670159|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
170633954|NCT00561925|616670160|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
170633955|NCT00561925|616670161|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
170633956|NCT04313244|616670162|FG000|Overall Study|Withdrawal of Consent|3|||
170633957|NCT04313244|616670163|FG001|Overall Study|Withdrawal of Consent|3|||
170633958|NCT04313244|616670162|FG000|Overall Study|Met Exclusion Criteria|1|||
170633959|NCT04313244|616670163|FG001|Overall Study|Met Exclusion Criteria|0|||
170633960|NCT04313244|616670162|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
170786433|NCT03150810|617227328|FG007|Overall Study|Withdrawal by Subject|0|||
170786434|NCT03150810|617227329|FG008|Overall Study|Withdrawal by Subject|2|||
170447966|NCT00105157|615976774|FG000|Double-Blind (DB)|Adverse Event|2|||
170447967|NCT00105157|615976775|FG001|Double-Blind (DB)|Adverse Event|0|||
170447968|NCT00105157|615976776|FG002|Double-Blind (DB)|Adverse Event|1|||
170447969|NCT00105157|615976777|FG003|Double-Blind (DB)|Adverse Event|1|||
170447970|NCT00105157|615976774|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
170447971|NCT00105157|615976775|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
170447972|NCT00105157|615976776|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
170447973|NCT00105157|615976777|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
170447974|NCT00105157|615976774|FG000|Open-Label Continuation of DB|Adverse Event|3|||
170447975|NCT00105157|615976775|FG001|Open-Label Continuation of DB|Adverse Event|1|||
170447976|NCT00105157|615976776|FG002|Open-Label Continuation of DB|Adverse Event|0|||
170447977|NCT00105157|615976777|FG003|Open-Label Continuation of DB|Adverse Event|0|||
170447978|NCT00105157|615976774|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
170447979|NCT00105157|615976775|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
170447980|NCT00105157|615976776|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
170447981|NCT00105157|615976777|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
170447982|NCT00105157|615976774|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
170447983|NCT00105157|615976775|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
170447984|NCT00105157|615976776|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
170447985|NCT00105157|615976777|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
170447986|NCT00105157|615976774|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
170447987|NCT00105157|615976775|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
170447988|NCT00105157|615976776|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
170447989|NCT00105157|615976777|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
170447990|NCT00105157|615976774|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
170447991|NCT00105157|615976775|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
170447992|NCT00105157|615976776|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
170447993|NCT00105157|615976777|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
170447994|NCT00105157|615976774|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
170447995|NCT00105157|615976775|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
170447996|NCT00105157|615976776|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
170447997|NCT00105157|615976777|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
170447998|NCT00105157|615976774|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
170447999|NCT00105157|615976775|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
170448000|NCT00105157|615976776|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
170448001|NCT00105157|615976777|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
170448002|NCT00105157|615976774|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
170448003|NCT00105157|615976775|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
170448004|NCT00105157|615976776|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
170448005|NCT00105157|615976777|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
170448006|NCT00105157|615976774|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
170448007|NCT00105157|615976775|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
170448008|NCT00105157|615976776|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
170448009|NCT00105157|615976777|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
170448010|NCT00105157|615976774|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
170448011|NCT00105157|615976775|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
170448012|NCT00105157|615976776|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
170448013|NCT00105157|615976777|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
170448014|NCT00105157|615976774|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
170448015|NCT00105157|615976775|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
170448016|NCT00105157|615976776|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
170448017|NCT00105157|615976777|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
170448018|NCT01396421|615976781|FG000|Overall Study|Lost to Follow-up|0|||
170448019|NCT01396421|615976782|FG001|Overall Study|Lost to Follow-up|0|||
170448020|NCT01396421|615976783|FG002|Overall Study|Lost to Follow-up|0|||
170448021|NCT01396421|615976784|FG003|Overall Study|Lost to Follow-up|1|||
170448022|NCT01396421|615976781|FG000|Overall Study|Adverse Event|17|||
170448023|NCT01396421|615976782|FG001|Overall Study|Adverse Event|15|||
170448024|NCT01396421|615976783|FG002|Overall Study|Adverse Event|12|||
170448025|NCT01396421|615976784|FG003|Overall Study|Adverse Event|32|||
170448026|NCT01396421|615976781|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
170448027|NCT01396421|615976782|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
170448028|NCT01396421|615976783|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
170448029|NCT01396421|615976784|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
170448030|NCT01396421|615976781|FG000|Overall Study|Physician Decision|1|||
170448031|NCT01396421|615976782|FG001|Overall Study|Physician Decision|1|||
170448032|NCT01396421|615976783|FG002|Overall Study|Physician Decision|0|||
170448033|NCT01396421|615976784|FG003|Overall Study|Physician Decision|3|||
170448034|NCT01396421|615976781|FG000|Overall Study|Withdrawal by Subject|31|||
170448035|NCT01396421|615976782|FG001|Overall Study|Withdrawal by Subject|24|||
170448036|NCT01396421|615976783|FG002|Overall Study|Withdrawal by Subject|13|||
170448037|NCT01396421|615976784|FG003|Overall Study|Withdrawal by Subject|21|||
170448038|NCT01396421|615976781|FG000|Overall Study|Protocol Deviation|2|||
170448039|NCT01396421|615976782|FG001|Overall Study|Protocol Deviation|1|||
170448040|NCT01396421|615976783|FG002|Overall Study|Protocol Deviation|1|||
170448041|NCT01396421|615976784|FG003|Overall Study|Protocol Deviation|0|||
170448042|NCT01396421|615976781|FG000|Overall Study|Lack of Efficacy|7|||
170448043|NCT01396421|615976782|FG001|Overall Study|Lack of Efficacy|17|||
170448044|NCT01396421|615976783|FG002|Overall Study|Lack of Efficacy|7|||
170448045|NCT01396421|615976784|FG003|Overall Study|Lack of Efficacy|18|||
170448046|NCT01148225|615976787|FG000|Overall Study|Other|185|||
170448047|NCT02820740|615976795|FG000|Overall Study|Did not have procedure|2|||
170448048|NCT00890552|615976796|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
170448049|NCT00890552|615976796|FG000|On-treatment|Early prog disease/ death|10|||
170448050|NCT04039919|615978154|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170448051|NCT04039919|615978155|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170448052|NCT04039919|615978156|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170448053|NCT04039919|615978157|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170448054|NCT04039919|615978158|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170448055|NCT04039919|615978154|FG000|Treatment Period 1|Sponsor's decision|0|||
170448056|NCT04039919|615978155|FG001|Treatment Period 1|Sponsor's decision|0|||
170448057|NCT04039919|615978156|FG002|Treatment Period 1|Sponsor's decision|0|||
170448058|NCT04039919|615978157|FG003|Treatment Period 1|Sponsor's decision|0|||
170448059|NCT04039919|615978158|FG004|Treatment Period 1|Sponsor's decision|16|||
170887122|NCT04137887|617595880|FG000|Overall Study|Death|102|||
170448060|NCT04039919|615978154|FG000|Treatment Period 5|Withdrawal by Subject|1|||
170448061|NCT04039919|615978155|FG001|Treatment Period 5|Withdrawal by Subject|0|||
170448062|NCT04039919|615978156|FG002|Treatment Period 5|Withdrawal by Subject|0|||
170448063|NCT04039919|615978157|FG003|Treatment Period 5|Withdrawal by Subject|0|||
170448064|NCT04039919|615978158|FG004|Treatment Period 5|Withdrawal by Subject|0|||
170887123|NCT04137887|617595881|FG001|Overall Study|Death|92|||
170887124|NCT04137887|617595880|FG000|Overall Study|Withdrawal by Subject|2|||
170887125|NCT04137887|617595881|FG001|Overall Study|Withdrawal by Subject|3|||
170887126|NCT04137887|617595880|FG000|Overall Study|Randomized but not treated|0|||
170786435|NCT03150810|617227330|FG009|Overall Study|Withdrawal by Subject|0|||
170786436|NCT03150810|617227331|FG010|Overall Study|Withdrawal by Subject|1|||
170786437|NCT03150810|617227332|FG011|Overall Study|Withdrawal by Subject|0|||
170786438|NCT03150810|617227333|FG012|Overall Study|Withdrawal by Subject|1|||
170786439|NCT03150810|617227321|FG000|Overall Study|Sponsor Decision|0|||
170786440|NCT03150810|617227322|FG001|Overall Study|Sponsor Decision|2|||
170786441|NCT03150810|617227323|FG002|Overall Study|Sponsor Decision|0|||
170786442|NCT03150810|617227324|FG003|Overall Study|Sponsor Decision|0|||
170786443|NCT03150810|617227325|FG004|Overall Study|Sponsor Decision|1|||
170786444|NCT03150810|617227326|FG005|Overall Study|Sponsor Decision|1|||
170786445|NCT03150810|617227327|FG006|Overall Study|Sponsor Decision|0|||
170786446|NCT03150810|617227328|FG007|Overall Study|Sponsor Decision|0|||
170786447|NCT03150810|617227329|FG008|Overall Study|Sponsor Decision|1|||
170786448|NCT03150810|617227330|FG009|Overall Study|Sponsor Decision|0|||
170786449|NCT03150810|617227331|FG010|Overall Study|Sponsor Decision|0|||
170786450|NCT03150810|617227332|FG011|Overall Study|Sponsor Decision|0|||
170786451|NCT03150810|617227333|FG012|Overall Study|Sponsor Decision|5|||
170786452|NCT03150810|617227321|FG000|Overall Study|Lost to Follow-up|0|||
170786453|NCT03150810|617227322|FG001|Overall Study|Lost to Follow-up|1|||
170786454|NCT03150810|617227323|FG002|Overall Study|Lost to Follow-up|1|||
170786455|NCT03150810|617227324|FG003|Overall Study|Lost to Follow-up|0|||
170786456|NCT03150810|617227325|FG004|Overall Study|Lost to Follow-up|0|||
170786457|NCT03150810|617227326|FG005|Overall Study|Lost to Follow-up|0|||
170786458|NCT03150810|617227327|FG006|Overall Study|Lost to Follow-up|1|||
170786459|NCT03150810|617227328|FG007|Overall Study|Lost to Follow-up|0|||
170786460|NCT03150810|617227329|FG008|Overall Study|Lost to Follow-up|0|||
170786461|NCT03150810|617227330|FG009|Overall Study|Lost to Follow-up|0|||
170786462|NCT03150810|617227331|FG010|Overall Study|Lost to Follow-up|1|||
170786463|NCT03150810|617227332|FG011|Overall Study|Lost to Follow-up|0|||
170786464|NCT03150810|617227333|FG012|Overall Study|Lost to Follow-up|0|||
170786465|NCT03150810|617227321|FG000|Overall Study|Physician Decision|0|||
170786466|NCT03150810|617227322|FG001|Overall Study|Physician Decision|0|||
170786467|NCT03150810|617227323|FG002|Overall Study|Physician Decision|0|||
170786468|NCT03150810|617227324|FG003|Overall Study|Physician Decision|0|||
170786469|NCT03150810|617227325|FG004|Overall Study|Physician Decision|0|||
170786470|NCT03150810|617227326|FG005|Overall Study|Physician Decision|1|||
170786471|NCT03150810|617227327|FG006|Overall Study|Physician Decision|1|||
170786472|NCT03150810|617227328|FG007|Overall Study|Physician Decision|0|||
170786473|NCT03150810|617227329|FG008|Overall Study|Physician Decision|0|||
170786474|NCT03150810|617227330|FG009|Overall Study|Physician Decision|0|||
170786475|NCT03150810|617227331|FG010|Overall Study|Physician Decision|0|||
170786476|NCT03150810|617227332|FG011|Overall Study|Physician Decision|0|||
170786477|NCT03150810|617227333|FG012|Overall Study|Physician Decision|0|||
170786478|NCT03150810|617227321|FG000|Overall Study|Site withdrawal from study|0|||
170786479|NCT03150810|617227322|FG001|Overall Study|Site withdrawal from study|1|||
170786480|NCT03150810|617227323|FG002|Overall Study|Site withdrawal from study|0|||
170786481|NCT03150810|617227324|FG003|Overall Study|Site withdrawal from study|0|||
170786482|NCT03150810|617227325|FG004|Overall Study|Site withdrawal from study|0|||
170786483|NCT03150810|617227326|FG005|Overall Study|Site withdrawal from study|0|||
170786484|NCT03150810|617227327|FG006|Overall Study|Site withdrawal from study|0|||
170786485|NCT03150810|617227328|FG007|Overall Study|Site withdrawal from study|0|||
170786486|NCT03150810|617227329|FG008|Overall Study|Site withdrawal from study|0|||
170786487|NCT03150810|617227330|FG009|Overall Study|Site withdrawal from study|1|||
170786488|NCT03150810|617227331|FG010|Overall Study|Site withdrawal from study|1|||
170786489|NCT03150810|617227332|FG011|Overall Study|Site withdrawal from study|0|||
170786490|NCT03150810|617227333|FG012|Overall Study|Site withdrawal from study|0|||
170786491|NCT03150810|617227321|FG000|Overall Study|Hospice|0|||
170786492|NCT03150810|617227322|FG001|Overall Study|Hospice|0|||
170786493|NCT03150810|617227323|FG002|Overall Study|Hospice|0|||
170786494|NCT03150810|617227324|FG003|Overall Study|Hospice|0|||
170786495|NCT03150810|617227325|FG004|Overall Study|Hospice|0|||
170786496|NCT03150810|617227326|FG005|Overall Study|Hospice|1|||
170786497|NCT03150810|617227327|FG006|Overall Study|Hospice|0|||
170786498|NCT03150810|617227328|FG007|Overall Study|Hospice|0|||
170786499|NCT03150810|617227329|FG008|Overall Study|Hospice|0|||
170786500|NCT03150810|617227330|FG009|Overall Study|Hospice|0|||
170786501|NCT03150810|617227331|FG010|Overall Study|Hospice|0|||
170786502|NCT03150810|617227332|FG011|Overall Study|Hospice|0|||
170786503|NCT03150810|617227333|FG012|Overall Study|Hospice|0|||
170786504|NCT03150810|617227321|FG000|Overall Study|Participant relocated abroad.|0|||
170786505|NCT03150810|617227322|FG001|Overall Study|Participant relocated abroad.|0|||
170786506|NCT03150810|617227323|FG002|Overall Study|Participant relocated abroad.|0|||
170786507|NCT03150810|617227324|FG003|Overall Study|Participant relocated abroad.|0|||
170786508|NCT03150810|617227325|FG004|Overall Study|Participant relocated abroad.|0|||
170786509|NCT03150810|617227326|FG005|Overall Study|Participant relocated abroad.|1|||
170786510|NCT03150810|617227327|FG006|Overall Study|Participant relocated abroad.|0|||
170786511|NCT03150810|617227328|FG007|Overall Study|Participant relocated abroad.|0|||
170786512|NCT03150810|617227329|FG008|Overall Study|Participant relocated abroad.|0|||
170786513|NCT03150810|617227330|FG009|Overall Study|Participant relocated abroad.|0|||
170540576|NCT04132050|616322076|FG001|Period I (Double-blind Period)|Adverse Event|0|||
170540577|NCT04132050|616322075|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
170540578|NCT04132050|616322076|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
170540579|NCT04132050|616322075|FG000|R788 Treatment Period|Adverse Event|5|||
170540580|NCT04132050|616322076|FG001|R788 Treatment Period|Adverse Event|0|||
170540581|NCT04132050|616322075|FG000|R788 Treatment Period|Lack of Efficacy|5|||
170540582|NCT04132050|616322076|FG001|R788 Treatment Period|Lack of Efficacy|0|||
170540583|NCT04132050|616322075|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
170540584|NCT04132050|616322076|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
170540585|NCT03462680|616322077|FG000|Overall Study|Withdrawal by Subject|3|||
170540586|NCT03462680|616322078|FG001|Overall Study|Withdrawal by Subject|5|||
170540587|NCT04598828|616322084|FG000|Overall Study|Physician Decision|1|||
170540588|NCT04598828|616322085|FG001|Overall Study|Physician Decision|0|||
170540589|NCT04598828|616322084|FG000|Overall Study|Withdrawal by Subject|0|||
170540590|NCT04598828|616322085|FG001|Overall Study|Withdrawal by Subject|1|||
170540591|NCT04598828|616322084|FG000|Overall Study|Withdrawal by Subject|0|||
170540592|NCT04598828|616322085|FG001|Overall Study|Withdrawal by Subject|1|||
170540593|NCT01913353|616322090|FG000|Overall Study|Adverse Event|2|||
170540594|NCT01913353|616322091|FG001|Overall Study|Adverse Event|0|||
170540595|NCT01913353|616322090|FG000|Overall Study|Physician Decision|0|||
170540596|NCT01913353|616322091|FG001|Overall Study|Physician Decision|2|||
170540597|NCT01913353|616322090|FG000|Overall Study|Withdrawal by Subject|20|||
170540598|NCT01913353|616322091|FG001|Overall Study|Withdrawal by Subject|6|||
170540599|NCT01913353|616322090|FG000|Overall Study|multiple reasons|10|||
170540600|NCT01913353|616322091|FG001|Overall Study|multiple reasons|7|||
170540601|NCT01260948|616322092|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
170540602|NCT01260948|616322093|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
170540603|NCT01260948|616322092|FG000|Second Intervention|Emesis|0|||
170540604|NCT01260948|616322093|FG001|Second Intervention|Emesis|1|||
170540605|NCT00462462|616322094|FG000|Overall Study|Physician Decision|0|||
170540606|NCT00462462|616322095|FG001|Overall Study|Physician Decision|1|||
170540607|NCT03018938|616322097|FG000|Overall Study|Death|0|||
170540608|NCT03018938|616322098|FG001|Overall Study|Death|1|||
170540609|NCT03018938|616322097|FG000|Overall Study|Lost to Follow-up|21|||
170540610|NCT03018938|616322098|FG001|Overall Study|Lost to Follow-up|32|||
170540611|NCT03018938|616322097|FG000|Overall Study|Withdrawal by Subject|38|||
170540612|NCT03018938|616322098|FG001|Overall Study|Withdrawal by Subject|45|||
170540613|NCT03018938|616322097|FG000|Overall Study|Physician Decision|3|||
170540614|NCT03018938|616322098|FG001|Overall Study|Physician Decision|2|||
170540615|NCT03018938|616322097|FG000|Overall Study|Sponsor Decision|0|||
170540616|NCT03018938|616322098|FG001|Overall Study|Sponsor Decision|1|||
170540617|NCT03018938|616322097|FG000|Overall Study|Screen failure-After randomization|4|||
170540618|NCT03018938|616322098|FG001|Overall Study|Screen failure-After randomization|2|||
170540619|NCT03018938|616322097|FG000|Overall Study|Not recorded|0|||
170540620|NCT03018938|616322098|FG001|Overall Study|Not recorded|2|||
170540621|NCT00191100|616322099|FG000|Overall Study|Adverse Event|18|||
170540622|NCT00191100|616322100|FG001|Overall Study|Adverse Event|1|||
170540623|NCT00191100|616322099|FG000|Overall Study|Lost to Follow-up|2|||
170540624|NCT00191100|616322100|FG001|Overall Study|Lost to Follow-up|0|||
170540625|NCT00191100|616322099|FG000|Overall Study|Patient Moved|0|||
170540626|NCT00191100|616322100|FG001|Overall Study|Patient Moved|1|||
170540627|NCT00191100|616322099|FG000|Overall Study|Withdrawal by Subject|9|||
170540628|NCT00191100|616322100|FG001|Overall Study|Withdrawal by Subject|3|||
170540629|NCT00191100|616322099|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
170540630|NCT00191100|616322100|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
170540631|NCT00191100|616322099|FG000|Overall Study|Clinical Relapse|2|||
170540632|NCT00191100|616322100|FG001|Overall Study|Clinical Relapse|1|||
170540633|NCT00191100|616322099|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
170540634|NCT00191100|616322100|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
170540635|NCT00191100|616322099|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
170540636|NCT00191100|616322100|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
170540637|NCT00191100|616322099|FG000|Overall Study|Physician Decision|3|||
170540638|NCT00191100|616322100|FG001|Overall Study|Physician Decision|1|||
170540639|NCT00191100|616322099|FG000|Overall Study|Death from Study Drug Toxicity|2|||
170540640|NCT00191100|616322100|FG001|Overall Study|Death from Study Drug Toxicity|0|||
170540641|NCT00191100|616322099|FG000|Overall Study|Protocol Violation|1|||
170540642|NCT00191100|616322100|FG001|Overall Study|Protocol Violation|1|||
170540643|NCT00191100|616322099|FG000|Overall Study|Death from Other Cause|1|||
170540644|NCT00191100|616322100|FG001|Overall Study|Death from Other Cause|0|||
170540645|NCT00191100|616322099|FG000|Overall Study|Reason Not Specified|0|||
170540646|NCT00191100|616322100|FG001|Overall Study|Reason Not Specified|1|||
170540647|NCT05578872|616322110|FG000|Overall Study|Withdrawal by Subject|2|||
170540648|NCT05578872|616322111|FG001|Overall Study|Withdrawal by Subject|1|||
170540649|NCT05578872|616322110|FG000|Overall Study|Adverse Event|1|||
170540650|NCT05578872|616322111|FG001|Overall Study|Adverse Event|1|||
170540651|NCT05578872|616322110|FG000|Overall Study|Physician Decision|1|||
170540652|NCT05578872|616322111|FG001|Overall Study|Physician Decision|2|||
170448065|NCT00977548|615978166|FG000|Overall Study|Ineligible|4|||
170448066|NCT00977548|615978166|FG000|Overall Study|Adverse Event|8|||
170448067|NCT00977548|615978166|FG000|Overall Study|Withdrawal by Subject|1|||
170448068|NCT01470417|615978176|FG000|Overall Study|Disease progression|0|||
170448069|NCT01470417|615978177|FG001|Overall Study|Disease progression|2|||
170448070|NCT01048502|615978182|FG000|Overall Study|Lost to Follow-up|2|||
170448071|NCT01048502|615978183|FG001|Overall Study|Lost to Follow-up|0|||
170448072|NCT01048502|615978184|FG002|Overall Study|Lost to Follow-up|0|||
170448073|NCT01048502|615978185|FG003|Overall Study|Lost to Follow-up|0|||
170448074|NCT01048502|615978182|FG000|Overall Study|Adverse Event|1|||
170448075|NCT01048502|615978183|FG001|Overall Study|Adverse Event|0|||
170448076|NCT01048502|615978184|FG002|Overall Study|Adverse Event|0|||
170448077|NCT01048502|615978185|FG003|Overall Study|Adverse Event|0|||
170448078|NCT01048502|615978182|FG000|Overall Study|Withdrawal by Subject|1|||
170448079|NCT01048502|615978183|FG001|Overall Study|Withdrawal by Subject|4|||
170448080|NCT01048502|615978184|FG002|Overall Study|Withdrawal by Subject|5|||
170448081|NCT01048502|615978185|FG003|Overall Study|Withdrawal by Subject|3|||
170448082|NCT01048502|615978182|FG000|Overall Study|Physician Decision|0|||
170448083|NCT01048502|615978183|FG001|Overall Study|Physician Decision|3|||
170448084|NCT01048502|615978184|FG002|Overall Study|Physician Decision|0|||
170448085|NCT01048502|615978185|FG003|Overall Study|Physician Decision|1|||
170448086|NCT02973321|615978186|FG000|Overall Study|Other than specified|0|||
170448087|NCT02973321|615978187|FG001|Overall Study|Other than specified|5|||
170448088|NCT02973321|615978188|FG002|Overall Study|Other than specified|3|||
170448089|NCT02973321|615978189|FG003|Overall Study|Other than specified|3|||
170448090|NCT02973321|615978190|FG004|Overall Study|Other than specified|1|||
170448091|NCT02973321|615978186|FG000|Overall Study|Lack of Efficacy|0|||
170448092|NCT02973321|615978187|FG001|Overall Study|Lack of Efficacy|0|||
170448093|NCT02973321|615978188|FG002|Overall Study|Lack of Efficacy|0|||
170448094|NCT02973321|615978189|FG003|Overall Study|Lack of Efficacy|0|||
170448095|NCT02973321|615978190|FG004|Overall Study|Lack of Efficacy|1|||
170448096|NCT02973321|615978186|FG000|Overall Study|Adverse Event|1|||
170448097|NCT02973321|615978187|FG001|Overall Study|Adverse Event|10|||
170448098|NCT02973321|615978188|FG002|Overall Study|Adverse Event|11|||
170448099|NCT02973321|615978189|FG003|Overall Study|Adverse Event|13|||
170448100|NCT02973321|615978190|FG004|Overall Study|Adverse Event|3|||
170448101|NCT01333072|615978192|FG000|Overall Study|Lost to Follow-up|3|||
170786514|NCT03150810|617227331|FG010|Overall Study|Participant relocated abroad.|0|||
170786515|NCT03150810|617227332|FG011|Overall Study|Participant relocated abroad.|0|||
170786516|NCT03150810|617227333|FG012|Overall Study|Participant relocated abroad.|0|||
170786517|NCT03150810|617227321|FG000|Overall Study|Transferred care to oncologist|0|||
170786518|NCT03150810|617227322|FG001|Overall Study|Transferred care to oncologist|0|||
170786519|NCT03150810|617227323|FG002|Overall Study|Transferred care to oncologist|0|||
170786520|NCT03150810|617227324|FG003|Overall Study|Transferred care to oncologist|0|||
170786521|NCT03150810|617227325|FG004|Overall Study|Transferred care to oncologist|0|||
170786522|NCT03150810|617227326|FG005|Overall Study|Transferred care to oncologist|0|||
170786523|NCT03150810|617227327|FG006|Overall Study|Transferred care to oncologist|2|||
170786524|NCT03150810|617227328|FG007|Overall Study|Transferred care to oncologist|0|||
170786525|NCT03150810|617227329|FG008|Overall Study|Transferred care to oncologist|0|||
170786526|NCT03150810|617227330|FG009|Overall Study|Transferred care to oncologist|0|||
170786527|NCT03150810|617227331|FG010|Overall Study|Transferred care to oncologist|0|||
170786528|NCT03150810|617227332|FG011|Overall Study|Transferred care to oncologist|0|||
170786529|NCT03150810|617227333|FG012|Overall Study|Transferred care to oncologist|0|||
170786530|NCT04526704|617227334|FG000|Overall Study|Adverse Event|1|||
170786531|NCT04526704|617227335|FG001|Overall Study|Adverse Event|0|||
170786532|NCT04526704|617227334|FG000|Overall Study|Physician Decision|1|||
170448102|NCT01333072|615978193|FG001|Overall Study|Lost to Follow-up|0|||
170448103|NCT01333072|615978192|FG000|Overall Study|Adverse Event|2|||
170448104|NCT01333072|615978193|FG001|Overall Study|Adverse Event|4|||
170448105|NCT01333072|615978192|FG000|Overall Study|Physician Decision|1|||
170448106|NCT01333072|615978193|FG001|Overall Study|Physician Decision|0|||
170448107|NCT00384293|615978194|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
170448108|NCT00384293|615978195|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
170448109|NCT00384293|615978196|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
170448110|NCT00384293|615978194|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
170448111|NCT00384293|615978195|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
170448112|NCT00384293|615978196|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
170448113|NCT00384293|615978194|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
170448114|NCT00384293|615978195|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
170448115|NCT00384293|615978196|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
170448116|NCT00384293|615978194|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
170448117|NCT00384293|615978195|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
170448118|NCT00384293|615978196|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
170448119|NCT00384293|615978194|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
170448120|NCT00384293|615978195|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
170448121|NCT00384293|615978196|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
170448122|NCT00384293|615978194|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
170448123|NCT00384293|615978195|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
170448124|NCT00384293|615978196|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
170448125|NCT00384293|615978194|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
170448126|NCT00384293|615978195|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
170448127|NCT00384293|615978196|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
170448128|NCT00384293|615978194|FG000|Post-randomization Period|Adverse Event|0|||
170448129|NCT00384293|615978195|FG001|Post-randomization Period|Adverse Event|23|||
170448130|NCT00384293|615978196|FG002|Post-randomization Period|Adverse Event|7|||
170448131|NCT00384293|615978194|FG000|Post-randomization Period|Lost to Follow-up|0|||
170448132|NCT00384293|615978195|FG001|Post-randomization Period|Lost to Follow-up|2|||
170448133|NCT00384293|615978196|FG002|Post-randomization Period|Lost to Follow-up|1|||
170448134|NCT00384293|615978194|FG000|Post-randomization Period|Protocol Violation|0|||
170448135|NCT00384293|615978195|FG001|Post-randomization Period|Protocol Violation|1|||
170448136|NCT00384293|615978196|FG002|Post-randomization Period|Protocol Violation|0|||
170448137|NCT00384293|615978194|FG000|Post-randomization Period|Withdrawal by Subject|0|||
170448138|NCT00384293|615978195|FG001|Post-randomization Period|Withdrawal by Subject|8|||
170448139|NCT00384293|615978196|FG002|Post-randomization Period|Withdrawal by Subject|6|||
170448140|NCT00384293|615978194|FG000|Post-randomization Period|Trial Termination|0|||
170448141|NCT00384293|615978195|FG001|Post-randomization Period|Trial Termination|180|||
170448142|NCT00384293|615978196|FG002|Post-randomization Period|Trial Termination|204|||
170448143|NCT00384293|615978194|FG000|Post-randomization Period|Patient Randomized in Error|0|||
170448144|NCT00384293|615978195|FG001|Post-randomization Period|Patient Randomized in Error|0|||
170448145|NCT00384293|615978196|FG002|Post-randomization Period|Patient Randomized in Error|1|||
170448146|NCT00263887|615978200|FG000|Overall Study|Withdrawal by Subject|1|||
170448147|NCT00263887|615978201|FG001|Overall Study|Withdrawal by Subject|1|||
170448148|NCT00263887|615978200|FG000|Overall Study|Lung transplantation|1|||
170448149|NCT00263887|615978201|FG001|Overall Study|Lung transplantation|2|||
170448150|NCT00263887|615978200|FG000|Overall Study|Too ill to attend visit|1|||
170448151|NCT00263887|615978201|FG001|Overall Study|Too ill to attend visit|0|||
170448152|NCT00263887|615978200|FG000|Overall Study|Adverse Event|0|||
170448153|NCT00263887|615978201|FG001|Overall Study|Adverse Event|2|||
170448154|NCT00263887|615978200|FG000|Overall Study|Disease progression|0|||
170448155|NCT00263887|615978201|FG001|Overall Study|Disease progression|1|||
170448156|NCT00263887|615978200|FG000|Overall Study|Lack of Efficacy|0|||
170448157|NCT00263887|615978201|FG001|Overall Study|Lack of Efficacy|1|||
170448158|NCT00493454|615978202|FG000|Overall Study|Withdrawal by Subject|1|||
170448159|NCT02274948|615978205|FG000|Overall Study|Lost to Follow-up|28|||
170448160|NCT02274948|615978206|FG001|Overall Study|Lost to Follow-up|25|||
170448161|NCT02274948|615978205|FG000|Overall Study|Withdrawal by Subject|64|||
170448162|NCT02274948|615978206|FG001|Overall Study|Withdrawal by Subject|58|||
170448163|NCT02274948|615978205|FG000|Overall Study|Stopped on family Practitioner advice|2|||
170448164|NCT02274948|615978206|FG001|Overall Study|Stopped on family Practitioner advice|5|||
170448165|NCT02274948|615978205|FG000|Overall Study|Left the area|4|||
170448166|NCT02274948|615978206|FG001|Overall Study|Left the area|3|||
170448167|NCT00707434|615978207|FG000|Overall Study|Adverse Event|1|||
170448168|NCT01011556|615978208|FG000|Overall Study|Adverse Event|1|||
170448169|NCT01011556|615978209|FG001|Overall Study|Adverse Event|3|||
170448170|NCT01011556|615978210|FG002|Overall Study|Adverse Event|2|||
170448171|NCT01011556|615978211|FG003|Overall Study|Adverse Event|1|||
170448172|NCT01011556|615978208|FG000|Overall Study|Lost to Follow-up|1|||
170448173|NCT01011556|615978209|FG001|Overall Study|Lost to Follow-up|0|||
170448174|NCT01011556|615978210|FG002|Overall Study|Lost to Follow-up|0|||
170448175|NCT01011556|615978211|FG003|Overall Study|Lost to Follow-up|0|||
170448176|NCT01011556|615978208|FG000|Overall Study|Physician Decision|1|||
170448177|NCT01011556|615978209|FG001|Overall Study|Physician Decision|0|||
170633961|NCT04313244|616670163|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
170448178|NCT01011556|615978210|FG002|Overall Study|Physician Decision|0|||
170448179|NCT01011556|615978211|FG003|Overall Study|Physician Decision|1|||
170448180|NCT01011556|615978208|FG000|Overall Study|Protocol Violation|0|||
170448181|NCT01011556|615978209|FG001|Overall Study|Protocol Violation|1|||
170448182|NCT01011556|615978210|FG002|Overall Study|Protocol Violation|0|||
170448183|NCT01011556|615978211|FG003|Overall Study|Protocol Violation|0|||
170448184|NCT01011556|615978208|FG000|Overall Study|Withdrawal by Subject|1|||
170448185|NCT01011556|615978209|FG001|Overall Study|Withdrawal by Subject|2|||
170448186|NCT01011556|615978210|FG002|Overall Study|Withdrawal by Subject|4|||
170448187|NCT01011556|615978211|FG003|Overall Study|Withdrawal by Subject|4|||
170448188|NCT01011556|615978208|FG000|Overall Study|Sponsor decision|0|||
170448189|NCT01011556|615978209|FG001|Overall Study|Sponsor decision|1|||
170448190|NCT01011556|615978210|FG002|Overall Study|Sponsor decision|1|||
170448191|NCT01011556|615978211|FG003|Overall Study|Sponsor decision|2|||
170448192|NCT01011556|615978208|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
170540653|NCT05578872|616322110|FG000|Overall Study|Progressive disease|10|||
170540654|NCT05578872|616322111|FG001|Overall Study|Progressive disease|9|||
170540655|NCT05578872|616322110|FG000|Overall Study|Sponsor decision|0|||
170540656|NCT05578872|616322111|FG001|Overall Study|Sponsor decision|1|||
170540657|NCT05578872|616322110|FG000|Overall Study|Toxicity and Patient's decision|0|||
170540658|NCT05578872|616322111|FG001|Overall Study|Toxicity and Patient's decision|1|||
170540659|NCT02068794|616323726|FG000|Overall Study|Withdrawal by Subject|0|||
170540660|NCT02068794|616323727|FG001|Overall Study|Withdrawal by Subject|1|||
170540661|NCT02068794|616323728|FG002|Overall Study|Withdrawal by Subject|2|||
170540662|NCT02068794|616323726|FG000|Overall Study|Early Progression|1|||
170540663|NCT02068794|616323727|FG001|Overall Study|Early Progression|0|||
170540664|NCT02068794|616323728|FG002|Overall Study|Early Progression|1|||
170540665|NCT02068794|616323726|FG000|Overall Study|Ineligible|0|||
170540666|NCT02068794|616323727|FG001|Overall Study|Ineligible|0|||
170540667|NCT02068794|616323728|FG002|Overall Study|Ineligible|1|||
170540668|NCT00924651|616323730|FG000|Overall Study|Chemo started too soon|2|||
170540669|NCT00924651|616323731|FG001|Overall Study|Chemo started too soon|3|||
170540670|NCT00924651|616323730|FG000|Overall Study|No Reason|3|||
170540671|NCT00924651|616323731|FG001|Overall Study|No Reason|7|||
170540672|NCT00924651|616323730|FG000|Overall Study|Overwhelmed|6|||
170540673|NCT00924651|616323731|FG001|Overall Study|Overwhelmed|6|||
170448193|NCT01011556|615978209|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
170448194|NCT01011556|615978210|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
170448195|NCT01011556|615978211|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
170448196|NCT05212883|615978212|FG000|Overall Study|Invalid test result|125|||
170448197|NCT00614822|615978213|FG000|Overall Study|Adverse Event|3|||
170448198|NCT03095118|615978214|FG000|Overall Study|Adverse Event|1|||
170448199|NCT03095118|615978214|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
170448200|NCT03920280|615978216|FG000|Overall Study|Adverse Event|2|||
170448201|NCT03920280|615978217|FG001|Overall Study|Adverse Event|3|||
170448202|NCT03920280|615978216|FG000|Overall Study|Lost to Follow-up|0|||
170448203|NCT03920280|615978217|FG001|Overall Study|Lost to Follow-up|1|||
170448204|NCT03920280|615978216|FG000|Overall Study|Withdrawal by Subject|1|||
170448205|NCT03920280|615978217|FG001|Overall Study|Withdrawal by Subject|1|||
170448206|NCT03920280|615978216|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
170448207|NCT03920280|615978217|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
170448208|NCT01463982|615978218|FG000|Overall Study|Withdrawal by Subject|0|||
170448209|NCT01463982|615978219|FG001|Overall Study|Withdrawal by Subject|1|||
170448210|NCT01463982|615978220|FG002|Overall Study|Withdrawal by Subject|1|||
170448211|NCT01463982|615978221|FG003|Overall Study|Withdrawal by Subject|0|||
170448212|NCT01463982|615978218|FG000|Overall Study|Treatment delay over 5 week|0|||
170448213|NCT01463982|615978219|FG001|Overall Study|Treatment delay over 5 week|0|||
170448214|NCT01463982|615978220|FG002|Overall Study|Treatment delay over 5 week|1|||
170448215|NCT01463982|615978221|FG003|Overall Study|Treatment delay over 5 week|0|||
170448216|NCT04220775|615978228|FG000|Overall Study|Adverse Event|1|||
170448217|NCT04220775|615978229|FG001|Overall Study|Adverse Event|0|||
170448218|NCT04220775|615978228|FG000|Overall Study|Disease Progression|1|||
170448219|NCT04220775|615978229|FG001|Overall Study|Disease Progression|0|||
170448220|NCT00436917|615978230|FG000|Overall Study|Withdrawal by Subject|13|||
170448221|NCT00436917|615978230|FG000|Overall Study|Adverse Event|2|||
170448222|NCT00436917|615978230|FG000|Overall Study|Physician Decision|1|||
170448223|NCT00436917|615978230|FG000|Overall Study|Death|1|||
170448224|NCT00436917|615978230|FG000|Overall Study|Lost to Follow-up|1|||
170448225|NCT00436917|615978230|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
170448226|NCT00436917|615978230|FG000|Overall Study|Increased creatinine|1|||
170448227|NCT00436917|615978230|FG000|Overall Study|Personal conflicts of patient|1|||
170448228|NCT02169791|615978231|FG000|Overall Study|Death|6|||
170448229|NCT02169791|615978231|FG000|Overall Study|patient withdrew consent|1|||
170448230|NCT02087176|615978232|FG000|Overall Study|Withdrawal by Subject|1|||
170540674|NCT00924651|616323730|FG000|Overall Study|Noncompliant|1|||
170540675|NCT00924651|616323731|FG001|Overall Study|Noncompliant|4|||
170540676|NCT00924651|616323730|FG000|Overall Study|Medical|1|||
170540677|NCT00924651|616323731|FG001|Overall Study|Medical|3|||
170540678|NCT00924651|616323730|FG000|Overall Study|Changed Mind|10|||
170540679|NCT00924651|616323731|FG001|Overall Study|Changed Mind|1|||
170540680|NCT00924651|616323730|FG000|Overall Study|Incomplete Form|2|||
170540681|NCT00924651|616323731|FG001|Overall Study|Incomplete Form|1|||
170540682|NCT01482221|616323737|FG000|Overall Study|Lack of Efficacy|1|||
170540683|NCT01482221|616323738|FG001|Overall Study|Lack of Efficacy|0|||
170448231|NCT02087176|615978232|FG000|Overall Study|Death|10|||
170448232|NCT02087176|615978232|FG000|Overall Study|Censored|19|||
170448233|NCT02087176|615978232|FG000|Overall Study|Study Terminated by Sponsor|2|||
170540684|NCT01482221|616323739|FG002|Overall Study|Lack of Efficacy|1|||
170540685|NCT01482221|616323737|FG000|Overall Study|Lost to Follow-up|3|||
170540686|NCT01482221|616323738|FG001|Overall Study|Lost to Follow-up|2|||
170540687|NCT01482221|616323739|FG002|Overall Study|Lost to Follow-up|1|||
170448234|NCT03942211|615978236|FG000|Overall Study|Death|1|||
170448235|NCT03942211|615978237|FG001|Overall Study|Death|0|||
170448236|NCT03942211|615978236|FG000|Overall Study|Study terminated by sponsor|5|||
170448237|NCT03942211|615978237|FG001|Overall Study|Study terminated by sponsor|3|||
170448238|NCT03942211|615978236|FG000|Overall Study|Adverse Event|0|||
170448239|NCT03942211|615978237|FG001|Overall Study|Adverse Event|1|||
170448240|NCT00127166|615978238|FG000|Period I|Protocol Violation|0|||
170448241|NCT00127166|615978239|FG001|Period I|Protocol Violation|2|||
170448242|NCT00127166|615978238|FG000|Period I|Withdrawal by Subject|2|||
170448243|NCT00127166|615978239|FG001|Period I|Withdrawal by Subject|0|||
170448244|NCT00127166|615978238|FG000|Period I|Patient did not meet inclusion criteria|1|||
170448245|NCT00127166|615978239|FG001|Period I|Patient did not meet inclusion criteria|0|||
170448246|NCT00127166|615978238|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
170448247|NCT00127166|615978239|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
170448248|NCT00127166|615978238|FG000|Period II|Withdrawal by Subject|2|||
170448249|NCT00127166|615978239|FG001|Period II|Withdrawal by Subject|0|||
170448250|NCT00127166|615978238|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
170448251|NCT00127166|615978239|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
170448252|NCT01876368|615978242|FG000|Overall Study|Adverse Event|2|||
170448253|NCT01876368|615978243|FG001|Overall Study|Adverse Event|5|||
170448254|NCT01876368|615978242|FG000|Overall Study|Lack of Efficacy|1|||
170448255|NCT01876368|615978243|FG001|Overall Study|Lack of Efficacy|0|||
170448256|NCT01876368|615978242|FG000|Overall Study|Lost to Follow-up|0|||
170448257|NCT01876368|615978243|FG001|Overall Study|Lost to Follow-up|1|||
170448258|NCT01876368|615978242|FG000|Overall Study|Non-compliance with study treatment|0|||
170448259|NCT01876368|615978243|FG001|Overall Study|Non-compliance with study treatment|1|||
170448260|NCT01876368|615978242|FG000|Overall Study|Physician Decision|0|||
170448261|NCT01876368|615978243|FG001|Overall Study|Physician Decision|2|||
170448262|NCT01876368|615978242|FG000|Overall Study|Protocol deviation|3|||
170448263|NCT01876368|615978243|FG001|Overall Study|Protocol deviation|3|||
170448264|NCT01876368|615978242|FG000|Overall Study|Subject/guardian decision|3|||
170448265|NCT01876368|615978243|FG001|Overall Study|Subject/guardian decision|1|||
170448266|NCT01955044|615978244|FG000|Overall Study|Death|1|||
170448267|NCT01955044|615978245|FG001|Overall Study|Death|1|||
170448268|NCT01955044|615978246|FG002|Overall Study|Death|0|||
170448269|NCT01644149|615978247|FG000|Overall Study|Withdrawal by Subject|1|||
170448270|NCT01644149|615978248|FG001|Overall Study|Withdrawal by Subject|0|||
170448271|NCT01644149|615978247|FG000|Overall Study|Lost to Follow-up|3|||
170448272|NCT01644149|615978248|FG001|Overall Study|Lost to Follow-up|1|||
170448273|NCT04798482|615978249|FG000|Overall Study|Physician Decision|1|||
170448274|NCT04798482|615978249|FG000|Overall Study|Lost eligibility|1|||
170448275|NCT00605917|615978253|FG000|Overall Study|Protocol Violation|79|||
170448276|NCT01506908|615978254|FG000|Overall Study|Adverse Event|1|||
170448277|NCT01506908|615978255|FG001|Overall Study|Adverse Event|0|||
170448278|NCT01610063|615978256|FG000|Overall Study|Lost to Follow-up|42|||
170448279|NCT01610063|615978257|FG001|Overall Study|Lost to Follow-up|20|||
170448280|NCT03043560|615978264|FG000|Overall Study|Discontinued Intervention|1|||
170448281|NCT03043560|615978265|FG001|Overall Study|Discontinued Intervention|2|||
170448282|NCT03043560|615978264|FG000|Overall Study|Lost to Follow-up|0|||
170448283|NCT03043560|615978265|FG001|Overall Study|Lost to Follow-up|1|||
170448284|NCT01436643|615978266|FG000|2-week Pre-treatment|Abnormal test result|0|||
170448285|NCT01436643|615978267|FG001|2-week Pre-treatment|Abnormal test result|0|||
170448286|NCT01436643|615978268|FG002|2-week Pre-treatment|Abnormal test result|0|||
170448287|NCT01436643|615978269|FG003|2-week Pre-treatment|Abnormal test result|1|||
170448288|NCT01436643|615978266|FG000|2-week Pre-treatment|Adverse Event|0|||
170448289|NCT01436643|615978267|FG001|2-week Pre-treatment|Adverse Event|0|||
170448290|NCT01436643|615978268|FG002|2-week Pre-treatment|Adverse Event|0|||
170448291|NCT01436643|615978269|FG003|2-week Pre-treatment|Adverse Event|5|||
170448292|NCT01436643|615978266|FG000|2-week Pre-treatment|Protocol Violation|0|||
170448293|NCT01436643|615978267|FG001|2-week Pre-treatment|Protocol Violation|0|||
170448294|NCT01436643|615978268|FG002|2-week Pre-treatment|Protocol Violation|0|||
170448295|NCT01436643|615978269|FG003|2-week Pre-treatment|Protocol Violation|4|||
170448296|NCT01436643|615978266|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
170448297|NCT01436643|615978267|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
170448298|NCT01436643|615978268|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
170448299|NCT01436643|615978269|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
170448300|NCT01436643|615978266|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
170448301|NCT01436643|615978267|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
170448302|NCT01436643|615978268|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
170448303|NCT01436643|615978269|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
170448304|NCT01436643|615978266|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
170448305|NCT01436643|615978267|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
170448306|NCT01436643|615978268|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
170448307|NCT01436643|615978269|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
170448308|NCT01917968|615978273|FG000|Overall Study|Death|3|||
170448309|NCT01917968|615978274|FG001|Overall Study|Death|2|||
170448310|NCT01917968|615978273|FG000|Overall Study|Lost to Follow-up|21|||
170448311|NCT01917968|615978274|FG001|Overall Study|Lost to Follow-up|39|||
170448312|NCT01917968|615978273|FG000|Overall Study|Physician Decision|1|||
170448313|NCT01917968|615978274|FG001|Overall Study|Physician Decision|2|||
170448314|NCT01917968|615978273|FG000|Overall Study|Withdrawal by Subject|20|||
170448315|NCT01917968|615978274|FG001|Overall Study|Withdrawal by Subject|35|||
170448316|NCT01917968|615978273|FG000|Overall Study|Subject Relocation|5|||
170448317|NCT01917968|615978274|FG001|Overall Study|Subject Relocation|1|||
170448318|NCT01917968|615978273|FG000|Overall Study|36M Missed Visit|3|||
170448319|NCT01917968|615978274|FG001|Overall Study|36M Missed Visit|2|||
170448320|NCT01917968|615978273|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
170448321|NCT01917968|615978274|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
170448322|NCT01917968|615978273|FG000|Overall Study|Change in Family Circumstances|0|||
170448323|NCT01917968|615978274|FG001|Overall Study|Change in Family Circumstances|1|||
170448324|NCT01917968|615978273|FG000|Overall Study|No Data Available|0|||
170448325|NCT01917968|615978274|FG001|Overall Study|No Data Available|2|||
170448326|NCT00562120|615978278|FG000|First Intervention Period|Adverse Event|1|||
170448327|NCT00562120|615978279|FG001|First Intervention Period|Adverse Event|0|||
170448328|NCT00562120|615978280|FG002|First Intervention Period|Adverse Event|0|||
170448329|NCT00562120|615978281|FG003|First Intervention Period|Adverse Event|0|||
170448330|NCT00562120|615978278|FG000|First Intervention Period|Randomized but not Treated|1|||
170448331|NCT00562120|615978279|FG001|First Intervention Period|Randomized but not Treated|0|||
170448332|NCT00562120|615978280|FG002|First Intervention Period|Randomized but not Treated|0|||
170448333|NCT00562120|615978281|FG003|First Intervention Period|Randomized but not Treated|0|||
170448334|NCT00537017|615978282|FG000|Treatment Phase|Adverse Event|19|||
170448335|NCT00537017|615978282|FG000|Treatment Phase|Withdrawal by Subject|13|||
170448336|NCT00537017|615978282|FG000|Treatment Phase|Protocol Violation|2|||
170448337|NCT00537017|615978282|FG000|Follow-up Phase|Withdrawal by Subject|9|||
170448338|NCT02093923|615978284|FG000|Overall Study|Lost to Follow-up|0|||
170448339|NCT02093923|615978285|FG001|Overall Study|Lost to Follow-up|0|||
170448340|NCT02093923|615978286|FG002|Overall Study|Lost to Follow-up|0|||
170448341|NCT02093923|615978287|FG003|Overall Study|Lost to Follow-up|1|||
170448342|NCT02093923|615978288|FG004|Overall Study|Lost to Follow-up|0|||
170448343|NCT02093923|615978284|FG000|Overall Study|Screen failure after randomization|0|||
170448344|NCT02093923|615978285|FG001|Overall Study|Screen failure after randomization|0|||
170448345|NCT02093923|615978286|FG002|Overall Study|Screen failure after randomization|0|||
170448346|NCT02093923|615978287|FG003|Overall Study|Screen failure after randomization|1|||
170448347|NCT02093923|615978288|FG004|Overall Study|Screen failure after randomization|0|||
170448348|NCT02219308|615978289|FG000|Overall Study|Withdrawal by Subject|1|||
170448349|NCT02219308|615978290|FG001|Overall Study|Withdrawal by Subject|2|||
170448350|NCT01507090|615978292|FG000|Overall Study|incomplete dataset|18|||
170448351|NCT02953678|615978295|FG000|Overall Study|Adverse Event|20|||
170448352|NCT02953678|615978295|FG000|Overall Study|Death|7|||
170448353|NCT02953678|615978295|FG000|Overall Study|Physician Decision|23|||
170448354|NCT02953678|615978295|FG000|Overall Study|Progressive Disease of GVHD|7|||
170448355|NCT02953678|615978295|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
170448356|NCT02953678|615978295|FG000|Overall Study|Withdrawal by participant|3|||
170448357|NCT02953678|615978295|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
170448358|NCT02953678|615978295|FG000|Overall Study|Participants were transferred to commercial product.|3|||
170448359|NCT04034355|615978298|FG000|Overall Study|Study terminated by Sponsor|10|||
170448360|NCT04034355|615978299|FG001|Overall Study|Study terminated by Sponsor|17|||
170448361|NCT04034355|615978298|FG000|Overall Study|Withdrawal by Subject|12|||
170448362|NCT04034355|615978299|FG001|Overall Study|Withdrawal by Subject|11|||
170448363|NCT04034355|615978298|FG000|Overall Study|Site terminated by Sponsor|4|||
170448364|NCT04034355|615978299|FG001|Overall Study|Site terminated by Sponsor|5|||
170448365|NCT04034355|615978298|FG000|Overall Study|Adverse Event|2|||
170448366|NCT04034355|615978299|FG001|Overall Study|Adverse Event|0|||
170448367|NCT04034355|615978298|FG000|Overall Study|Death|1|||
170448368|NCT04034355|615978299|FG001|Overall Study|Death|1|||
170448369|NCT04034355|615978298|FG000|Overall Study|Not reported|2|||
170448370|NCT04034355|615978299|FG001|Overall Study|Not reported|0|||
170448371|NCT04034355|615978298|FG000|Overall Study|Lost to Follow-up|1|||
170448372|NCT04034355|615978299|FG001|Overall Study|Lost to Follow-up|0|||
170448373|NCT04034355|615978298|FG000|Overall Study|Physician Decision|1|||
170448374|NCT04034355|615978299|FG001|Overall Study|Physician Decision|0|||
170448375|NCT04034355|615978298|FG000|Overall Study|Protocol Violation|0|||
170448376|NCT04034355|615978299|FG001|Overall Study|Protocol Violation|1|||
170448377|NCT04034355|615978298|FG000|Overall Study|Progressive disease|1|||
170448378|NCT04034355|615978299|FG001|Overall Study|Progressive disease|0|||
170448379|NCT04678817|615980112|FG000|Overall Study|Lost to Follow-up|28|||
170448380|NCT04678817|615980113|FG001|Overall Study|Lost to Follow-up|0|||
170448381|NCT04678817|615980114|FG002|Overall Study|Lost to Follow-up|0|||
170448382|NCT03064438|615980117|FG000|Overall Study|Lost to Follow-up|1|||
170448383|NCT03064438|615980118|FG001|Overall Study|Lost to Follow-up|0|||
170448384|NCT03064438|615980117|FG000|Overall Study|Withdrawal by Subject|0|||
170448385|NCT03064438|615980118|FG001|Overall Study|Withdrawal by Subject|1|||
170448386|NCT02457611|615980120|FG000|Overall Study|Lost to Follow-up|3|||
170448387|NCT02502734|615980121|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
170448388|NCT02502734|615980122|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
170448389|NCT02502734|615980121|FG000|Washout Period|Adverse Event|1|||
170448390|NCT02502734|615980122|FG001|Washout Period|Adverse Event|0|||
170448391|NCT01009515|615980123|FG000|Overall Study|Withdrawal by Subject|3|||
170448392|NCT01501110|615980125|FG000|Overall Study|Death|0|||
170448393|NCT01501110|615980126|FG001|Overall Study|Death|1|||
170448394|NCT02075606|615980127|FG000|Overall Study|Adverse Event|5|||
170448395|NCT02075606|615980127|FG000|Overall Study|Withdrawal by Subject|1|||
170448396|NCT02075606|615980127|FG000|Overall Study|Death|1|||
170448397|NCT02075606|615980127|FG000|Overall Study|Investigator's decision|1|||
170448398|NCT02075606|615980127|FG000|Overall Study|Symptom management|1|||
170448399|NCT02075606|615980127|FG000|Overall Study|Increasing Symptoms|1|||
170448400|NCT01857206|615980132|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
170448401|NCT01857206|615980133|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
170448402|NCT01857206|615980132|FG000|Overall Study|Lost to Follow-up|9|||
170448403|NCT01857206|615980133|FG001|Overall Study|Lost to Follow-up|6|||
170448404|NCT01857206|615980132|FG000|Overall Study|Unclassified|3|||
170448405|NCT01857206|615980133|FG001|Overall Study|Unclassified|3|||
170448406|NCT01857206|615980132|FG000|Overall Study|Withdrawal by Subject|1|||
170448407|NCT01857206|615980133|FG001|Overall Study|Withdrawal by Subject|0|||
170448408|NCT01483625|615980134|FG000|Overall Study|Adverse Event|1|||
170540688|NCT01482221|616323737|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
170540689|NCT01482221|616323738|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
170540690|NCT01482221|616323739|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
170540691|NCT01482221|616323737|FG000|Overall Study|Condition under Investigation Worsened|3|||
170540692|NCT01482221|616323738|FG001|Overall Study|Condition under Investigation Worsened|2|||
170540693|NCT01482221|616323739|FG002|Overall Study|Condition under Investigation Worsened|4|||
170540694|NCT01482221|616323737|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
170540695|NCT01482221|616323738|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
170540696|NCT01482221|616323739|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
170540697|NCT01482221|616323737|FG000|Overall Study|Adverse Event|1|||
170540698|NCT01482221|616323738|FG001|Overall Study|Adverse Event|7|||
170540699|NCT01482221|616323739|FG002|Overall Study|Adverse Event|3|||
170540700|NCT01482221|616323737|FG000|Overall Study|Withdrawal by Subject|10|||
170540701|NCT01482221|616323738|FG001|Overall Study|Withdrawal by Subject|7|||
170540702|NCT01482221|616323739|FG002|Overall Study|Withdrawal by Subject|12|||
170540703|NCT01482221|616323737|FG000|Overall Study|Incorrect randomization|0|||
170540704|NCT01482221|616323738|FG001|Overall Study|Incorrect randomization|1|||
170540705|NCT01482221|616323739|FG002|Overall Study|Incorrect randomization|0|||
170540706|NCT01482221|616323737|FG000|Overall Study|Physician Decision|0|||
170540707|NCT01482221|616323738|FG001|Overall Study|Physician Decision|1|||
170540708|NCT01482221|616323739|FG002|Overall Study|Physician Decision|0|||
170540709|NCT05059080|616323740|FG000|Overall Study|Withdrawal by Subject|3|||
170540710|NCT05059080|616323740|FG000|Overall Study|Study Terminated by Sponsor|64|||
170540711|NCT00263562|616323741|FG000|Overall Study|Protocol Violation|3|||
170540712|NCT00263562|616323742|FG001|Overall Study|Protocol Violation|0|||
170540713|NCT01047501|616323743|FG000|Overall Study|Adverse Event|7|||
170540714|NCT01047501|616323744|FG001|Overall Study|Adverse Event|8|||
170633962|NCT00684021|616670166|FG000|Overall Study|MRI Contraindicated|1|||
170633963|NCT00684021|616670167|FG001|Overall Study|MRI Contraindicated|1|||
170633964|NCT00684021|616670168|FG002|Overall Study|MRI Contraindicated|1|||
170633965|NCT00684021|616670169|FG003|Overall Study|MRI Contraindicated|0|||
170786533|NCT04526704|617227335|FG001|Overall Study|Physician Decision|0|||
170448409|NCT01483625|615980135|FG001|Overall Study|Adverse Event|1|||
170448410|NCT01483625|615980134|FG000|Overall Study|Refused to continue medication|2|||
170448411|NCT01483625|615980135|FG001|Overall Study|Refused to continue medication|1|||
170448412|NCT01483625|615980134|FG000|Overall Study|Due to other reason|1|||
170448413|NCT01483625|615980135|FG001|Overall Study|Due to other reason|0|||
170448414|NCT00084799|615980136|FG000|Overall Study|Disease Progression|1|||
170448415|NCT00084799|615980137|FG001|Overall Study|Disease Progression|0|||
170448416|NCT04019054|615980138|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
170540715|NCT01047501|616323745|FG002|Overall Study|Adverse Event|5|||
170540716|NCT01047501|616323743|FG000|Overall Study|Withdrew Consent|6|||
170540717|NCT01047501|616323744|FG001|Overall Study|Withdrew Consent|2|||
170540718|NCT01047501|616323745|FG002|Overall Study|Withdrew Consent|4|||
170540719|NCT01047501|616323743|FG000|Overall Study|Lost to Follow-up|0|||
170633966|NCT00684021|616670166|FG000|Overall Study|MRI not performed|0|||
170633967|NCT00684021|616670167|FG001|Overall Study|MRI not performed|1|||
170448417|NCT04019054|615980139|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
170448418|NCT04019054|615980138|FG000|Overall Study|Withdrawal by Subject|3|||
170448419|NCT04019054|615980139|FG001|Overall Study|Withdrawal by Subject|1|||
170448420|NCT01261624|615980144|FG000|Week 0 to Week 12|Disease Progression|1|||
170448421|NCT01261624|615980145|FG001|Week 0 to Week 12|Disease Progression|1|||
170540720|NCT01047501|616323744|FG001|Overall Study|Lost to Follow-up|1|||
170633968|NCT00684021|616670168|FG002|Overall Study|MRI not performed|1|||
170448422|NCT01261624|615980144|FG000|Week 0 to Week 12|Insufficient Response|0|||
170448423|NCT01261624|615980145|FG001|Week 0 to Week 12|Insufficient Response|2|||
170448424|NCT01261624|615980144|FG000|Week 13 to Week 24|Insufficient Response|0|||
170448425|NCT01261624|615980145|FG001|Week 13 to Week 24|Insufficient Response|1|||
170448426|NCT01040793|615980146|FG000|Overall Study|Adverse Event|5|||
170448427|NCT01040793|615980147|FG001|Overall Study|Adverse Event|3|||
170448428|NCT01040793|615980148|FG002|Overall Study|Adverse Event|0|||
170448429|NCT01040793|615980149|FG003|Overall Study|Adverse Event|2|||
170448430|NCT01040793|615980150|FG004|Overall Study|Adverse Event|2|||
170448431|NCT01040793|615980151|FG005|Overall Study|Adverse Event|1|||
170448432|NCT01040793|615980146|FG000|Overall Study|Protocol Violation|1|||
170448433|NCT01040793|615980147|FG001|Overall Study|Protocol Violation|1|||
170448434|NCT01040793|615980148|FG002|Overall Study|Protocol Violation|1|||
170448435|NCT01040793|615980149|FG003|Overall Study|Protocol Violation|0|||
170448436|NCT01040793|615980150|FG004|Overall Study|Protocol Violation|1|||
170448437|NCT01040793|615980151|FG005|Overall Study|Protocol Violation|0|||
170448438|NCT01040793|615980146|FG000|Overall Study|Lost to Follow-up|0|||
170448439|NCT01040793|615980147|FG001|Overall Study|Lost to Follow-up|1|||
170448440|NCT01040793|615980148|FG002|Overall Study|Lost to Follow-up|1|||
170448441|NCT01040793|615980149|FG003|Overall Study|Lost to Follow-up|0|||
170448442|NCT01040793|615980150|FG004|Overall Study|Lost to Follow-up|0|||
170448443|NCT01040793|615980151|FG005|Overall Study|Lost to Follow-up|0|||
170448444|NCT01040793|615980146|FG000|Overall Study|Withdrawal by Subject|0|||
170448445|NCT01040793|615980147|FG001|Overall Study|Withdrawal by Subject|0|||
170448446|NCT01040793|615980148|FG002|Overall Study|Withdrawal by Subject|0|||
170448447|NCT01040793|615980149|FG003|Overall Study|Withdrawal by Subject|2|||
170448448|NCT01040793|615980150|FG004|Overall Study|Withdrawal by Subject|0|||
170448449|NCT01040793|615980151|FG005|Overall Study|Withdrawal by Subject|0|||
170448450|NCT01040793|615980146|FG000|Overall Study|Other reasons not listed above|0|||
170448451|NCT01040793|615980147|FG001|Overall Study|Other reasons not listed above|0|||
170448452|NCT01040793|615980148|FG002|Overall Study|Other reasons not listed above|1|||
170448453|NCT01040793|615980149|FG003|Overall Study|Other reasons not listed above|0|||
170448454|NCT01040793|615980150|FG004|Overall Study|Other reasons not listed above|1|||
170448455|NCT01040793|615980151|FG005|Overall Study|Other reasons not listed above|0|||
170448456|NCT04668274|615980157|FG000|Part 1 Study Period 1|Adverse Event|3|||
170448457|NCT04668274|615980158|FG001|Part 1 Study Period 1|Adverse Event|0|||
170448458|NCT04668274|615980159|FG002|Part 1 Study Period 1|Adverse Event|0|||
170448459|NCT04668274|615980160|FG003|Part 1 Study Period 1|Adverse Event|0|||
170448460|NCT04668274|615980157|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
170448461|NCT04668274|615980158|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
170448462|NCT04668274|615980159|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
170448463|NCT04668274|615980160|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
170448464|NCT04668274|615980157|FG000|Part 1 Study Period 2|Other|0|||
170448465|NCT04668274|615980158|FG001|Part 1 Study Period 2|Other|1|||
170448466|NCT04668274|615980159|FG002|Part 1 Study Period 2|Other|0|||
170448467|NCT04668274|615980160|FG003|Part 1 Study Period 2|Other|0|||
170448468|NCT04668274|615980157|FG000|Part 1 Study Period 3|Adverse Event|0|||
170448469|NCT04668274|615980158|FG001|Part 1 Study Period 3|Adverse Event|0|||
170448470|NCT04668274|615980159|FG002|Part 1 Study Period 3|Adverse Event|1|||
170540721|NCT01047501|616323745|FG002|Overall Study|Lost to Follow-up|1|||
170540722|NCT01047501|616323743|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
170786534|NCT04526704|617227334|FG000|Overall Study|Withdrawal by Subject|2|||
170448471|NCT04668274|615980160|FG003|Part 1 Study Period 3|Adverse Event|0|||
170540723|NCT01047501|616323744|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
170786535|NCT04526704|617227335|FG001|Overall Study|Withdrawal by Subject|0|||
170786536|NCT02975882|617227336|FG000|Overall Study|Adverse Event|1|||
170786537|NCT02975882|617227337|FG001|Overall Study|Adverse Event|2|||
170786538|NCT02975882|617227338|FG002|Overall Study|Adverse Event|1|||
170786539|NCT02975882|617227339|FG003|Overall Study|Adverse Event|1|||
170448472|NCT04668274|615980157|FG000|Part 1 Study Period 3|Other|0|||
170540724|NCT01047501|616323745|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
170540725|NCT01047501|616323743|FG000|Overall Study|Death|1|||
170540726|NCT01047501|616323744|FG001|Overall Study|Death|0|||
170540727|NCT01047501|616323745|FG002|Overall Study|Death|0|||
170540728|NCT01047501|616323743|FG000|Overall Study|Other discontinuation|1|||
170786540|NCT02975882|617227336|FG000|Overall Study|Death|0|||
170786541|NCT02975882|617227337|FG001|Overall Study|Death|1|||
170786542|NCT02975882|617227338|FG002|Overall Study|Death|0|||
170786543|NCT02975882|617227339|FG003|Overall Study|Death|0|||
170448473|NCT04668274|615980158|FG001|Part 1 Study Period 3|Other|0|||
170448474|NCT04668274|615980159|FG002|Part 1 Study Period 3|Other|2|||
170448475|NCT04668274|615980160|FG003|Part 1 Study Period 3|Other|0|||
170448476|NCT04668274|615980157|FG000|Part 2 Study Period 4|Other|0|||
170448477|NCT04668274|615980158|FG001|Part 2 Study Period 4|Other|0|||
170448478|NCT04668274|615980159|FG002|Part 2 Study Period 4|Other|0|||
170448479|NCT04668274|615980160|FG003|Part 2 Study Period 4|Other|1|||
170448480|NCT01020526|615980162|FG000|Overall Study|Withdrawal by Subject|5|||
170448481|NCT01020526|615980162|FG000|Overall Study|Other reasons|3|||
170786544|NCT02975882|617227336|FG000|Overall Study|Lack of Efficacy|3|||
170786545|NCT02975882|617227337|FG001|Overall Study|Lack of Efficacy|7|||
170786546|NCT02975882|617227338|FG002|Overall Study|Lack of Efficacy|4|||
170786547|NCT02975882|617227339|FG003|Overall Study|Lack of Efficacy|3|||
170786548|NCT02975882|617227336|FG000|Overall Study|Physician Decision|0|||
170448482|NCT01020526|615980162|FG000|Overall Study|Insufficient clinical response|3|||
170448483|NCT01020526|615980162|FG000|Overall Study|Lost to Follow-up|1|||
170448484|NCT01020526|615980162|FG000|Overall Study|Adverse Event|2|||
170448485|NCT03573817|615980167|FG000|Overall Study|Adverse Event|0|||
170448486|NCT03573817|615980168|FG001|Overall Study|Adverse Event|2|||
170448487|NCT03573817|615980167|FG000|Overall Study|Protocol Violation|0|||
170448488|NCT03573817|615980168|FG001|Overall Study|Protocol Violation|1|||
170448489|NCT03573817|615980167|FG000|Overall Study|Withdrawal by Subject|1|||
170448490|NCT03573817|615980168|FG001|Overall Study|Withdrawal by Subject|1|||
170448491|NCT01083680|615980177|FG000|Overall Study|Lost to Follow-up|2758|||
170448492|NCT01083680|615980177|FG000|Overall Study|Withdrawal by Subject|1086|||
170448493|NCT00508027|615980178|FG000|Dose Level 1|Lost to Follow-up|4|||
170448494|NCT00508027|615980178|FG000|Dose Level 1|Withdrawal by Subject|2|||
170448495|NCT00508027|615980178|FG000|Dose Level 1|Physician Decision|2|||
170448496|NCT00508027|615980178|FG000|Dose Level 2|Lost to Follow-up|2|||
170448497|NCT00508027|615980178|FG000|Dose Level 2|Withdrawal by Subject|2|||
170448498|NCT01719562|615980179|FG000|Overall Study|Lost to Follow-up|1|||
170448499|NCT01719562|615980180|FG001|Overall Study|Lost to Follow-up|0|||
170448500|NCT01719562|615980179|FG000|Overall Study|Death|1|||
170448501|NCT01719562|615980180|FG001|Overall Study|Death|0|||
170448502|NCT01719562|615980179|FG000|Overall Study|New cancer diagnosis|1|||
170448503|NCT01719562|615980180|FG001|Overall Study|New cancer diagnosis|0|||
170448504|NCT02013531|615980183|FG000|Overall Study|Lost to Follow-up|3|||
170448505|NCT02013531|615980183|FG000|Overall Study|Met Withdrawal Criteria|1|||
170448506|NCT02013531|615980183|FG000|Overall Study|Withdrawal by Subject|1|||
170448507|NCT00537199|615980190|FG000|Overall Study|Study Terminated|1|||
170448508|NCT00941720|615980192|FG000|Overall Study|Withdrawal by Subject|1|||
170786549|NCT02975882|617227337|FG001|Overall Study|Physician Decision|2|||
170448509|NCT00941720|615980192|FG000|Overall Study|Insurance denied participation|11|||
170448510|NCT00941720|615980192|FG000|Overall Study|ineligible|2|||
170448511|NCT00268892|615980193|FG000|Overall Study|Adverse Event|14|||
170448512|NCT00268892|615980194|FG001|Overall Study|Adverse Event|17|||
170448513|NCT00268892|615980195|FG002|Overall Study|Adverse Event|20|||
170448514|NCT00268892|615980193|FG000|Overall Study|Lack of Efficacy|1|||
170448515|NCT00268892|615980194|FG001|Overall Study|Lack of Efficacy|3|||
170448516|NCT00268892|615980195|FG002|Overall Study|Lack of Efficacy|0|||
170448517|NCT00268892|615980193|FG000|Overall Study|Withdrawal by Subject|14|||
170448518|NCT00268892|615980194|FG001|Overall Study|Withdrawal by Subject|15|||
170448519|NCT00268892|615980195|FG002|Overall Study|Withdrawal by Subject|13|||
170448520|NCT00268892|615980193|FG000|Overall Study|Physician Decision|0|||
170448521|NCT00268892|615980194|FG001|Overall Study|Physician Decision|1|||
170448522|NCT00268892|615980195|FG002|Overall Study|Physician Decision|0|||
170448523|NCT00268892|615980193|FG000|Overall Study|Lost to Follow-up|5|||
170448524|NCT00268892|615980194|FG001|Overall Study|Lost to Follow-up|2|||
170448525|NCT00268892|615980195|FG002|Overall Study|Lost to Follow-up|4|||
170448526|NCT00268892|615980193|FG000|Overall Study|Protocol Violation|0|||
170448527|NCT00268892|615980194|FG001|Overall Study|Protocol Violation|1|||
170448528|NCT00268892|615980195|FG002|Overall Study|Protocol Violation|0|||
170448529|NCT00268892|615980193|FG000|Overall Study|Disease Progression|1|||
170448530|NCT00268892|615980194|FG001|Overall Study|Disease Progression|1|||
170448531|NCT00268892|615980195|FG002|Overall Study|Disease Progression|0|||
170448532|NCT00268892|615980193|FG000|Overall Study|Trial Site Closed|4|||
170448533|NCT00268892|615980194|FG001|Overall Study|Trial Site Closed|2|||
170448534|NCT00268892|615980195|FG002|Overall Study|Trial Site Closed|2|||
170448535|NCT04569786|615980198|FG000|Overall Study|Lost to Follow-up|1|||
170448536|NCT04569786|615980199|FG001|Overall Study|Lost to Follow-up|0|||
170786550|NCT02975882|617227338|FG002|Overall Study|Physician Decision|4|||
170448537|NCT04569786|615980200|FG002|Overall Study|Lost to Follow-up|4|||
170786551|NCT02975882|617227339|FG003|Overall Study|Physician Decision|2|||
170786552|NCT02975882|617227336|FG000|Overall Study|Ineligible|0|||
170786553|NCT02975882|617227337|FG001|Overall Study|Ineligible|1|||
170448538|NCT04569786|615980201|FG003|Overall Study|Lost to Follow-up|1|||
170448539|NCT04569786|615980202|FG004|Overall Study|Lost to Follow-up|0|||
170448540|NCT04569786|615980198|FG000|Overall Study|Withdrawal by Subject|0|||
170448541|NCT04569786|615980199|FG001|Overall Study|Withdrawal by Subject|0|||
170540729|NCT01047501|616323744|FG001|Overall Study|Other discontinuation|0|||
170540730|NCT01047501|616323745|FG002|Overall Study|Other discontinuation|1|||
170448542|NCT04569786|615980200|FG002|Overall Study|Withdrawal by Subject|0|||
170448543|NCT04569786|615980201|FG003|Overall Study|Withdrawal by Subject|5|||
170448544|NCT04569786|615980202|FG004|Overall Study|Withdrawal by Subject|1|||
170448545|NCT04569786|615980198|FG000|Overall Study|Physician Decision|0|||
170448546|NCT04569786|615980199|FG001|Overall Study|Physician Decision|0|||
170448547|NCT04569786|615980200|FG002|Overall Study|Physician Decision|0|||
170448548|NCT04569786|615980201|FG003|Overall Study|Physician Decision|1|||
170786554|NCT02975882|617227338|FG002|Overall Study|Ineligible|0|||
170540731|NCT01047501|616323743|FG000|Overall Study|Investigator judgement|0|||
170540732|NCT01047501|616323744|FG001|Overall Study|Investigator judgement|0|||
170540733|NCT01047501|616323745|FG002|Overall Study|Investigator judgement|1|||
170540734|NCT04602000|616323746|FG000|Overall Study|Withdrawal by Subject|3|||
170540735|NCT04602000|616323747|FG001|Overall Study|Withdrawal by Subject|6|||
170540736|NCT04602000|616323748|FG002|Overall Study|Withdrawal by Subject|3|||
170540737|NCT04602000|616323749|FG003|Overall Study|Withdrawal by Subject|27|||
170540738|NCT04602000|616323750|FG004|Overall Study|Withdrawal by Subject|39|||
170633969|NCT00684021|616670169|FG003|Overall Study|MRI not performed|2|||
170633970|NCT00684021|616670166|FG000|Overall Study|Death|1|||
170633971|NCT00684021|616670167|FG001|Overall Study|Death|0|||
170633972|NCT00684021|616670168|FG002|Overall Study|Death|0|||
170633973|NCT00684021|616670169|FG003|Overall Study|Death|0|||
170633974|NCT00891904|616670170|FG000|Overall Study|Death|1|||
170633975|NCT00891904|616670170|FG000|Overall Study|Adverse Event|1|||
170633976|NCT01046396|616670171|FG000|Overall Study|Withdrawal by Subject|5|||
170633977|NCT01208207|616670172|FG000|Part I|Adverse Event|19|||
170633978|NCT01208207|616670173|FG001|Part I|Adverse Event|2|||
170633979|NCT01208207|616670174|FG002|Part I|Adverse Event|6|||
170633980|NCT01208207|616670175|FG003|Part I|Adverse Event|0|||
170633981|NCT01208207|616670176|FG004|Part I|Adverse Event|0|||
170633982|NCT01208207|616670177|FG005|Part I|Adverse Event|0|||
170633983|NCT01208207|616670178|FG006|Part I|Adverse Event|0|||
170633984|NCT01208207|616670172|FG000|Part I|Lack of Efficacy|21|||
170633985|NCT01208207|616670173|FG001|Part I|Lack of Efficacy|3|||
170633986|NCT01208207|616670174|FG002|Part I|Lack of Efficacy|2|||
170633987|NCT01208207|616670175|FG003|Part I|Lack of Efficacy|0|||
170633988|NCT01208207|616670176|FG004|Part I|Lack of Efficacy|0|||
170633989|NCT01208207|616670177|FG005|Part I|Lack of Efficacy|0|||
170633990|NCT01208207|616670178|FG006|Part I|Lack of Efficacy|0|||
170633991|NCT01208207|616670172|FG000|Part I|Lost to Follow-up|6|||
170633992|NCT01208207|616670173|FG001|Part I|Lost to Follow-up|1|||
170633993|NCT01208207|616670174|FG002|Part I|Lost to Follow-up|0|||
170633994|NCT01208207|616670175|FG003|Part I|Lost to Follow-up|0|||
170633995|NCT01208207|616670176|FG004|Part I|Lost to Follow-up|0|||
170633996|NCT01208207|616670177|FG005|Part I|Lost to Follow-up|0|||
170633997|NCT01208207|616670178|FG006|Part I|Lost to Follow-up|0|||
170633998|NCT01208207|616670172|FG000|Part I|Non-Compliance With Study Drug|1|||
170633999|NCT01208207|616670173|FG001|Part I|Non-Compliance With Study Drug|0|||
170540739|NCT04602000|616323746|FG000|Overall Study|Physician Decision|1|||
170634000|NCT01208207|616670174|FG002|Part I|Non-Compliance With Study Drug|1|||
170634001|NCT01208207|616670175|FG003|Part I|Non-Compliance With Study Drug|0|||
170634002|NCT01208207|616670176|FG004|Part I|Non-Compliance With Study Drug|0|||
170634003|NCT01208207|616670177|FG005|Part I|Non-Compliance With Study Drug|0|||
170634004|NCT01208207|616670178|FG006|Part I|Non-Compliance With Study Drug|0|||
170634005|NCT01208207|616670172|FG000|Part I|Physician Decision|0|||
170634006|NCT01208207|616670173|FG001|Part I|Physician Decision|1|||
170634007|NCT01208207|616670174|FG002|Part I|Physician Decision|0|||
170634008|NCT01208207|616670175|FG003|Part I|Physician Decision|0|||
170634009|NCT01208207|616670176|FG004|Part I|Physician Decision|0|||
170634010|NCT01208207|616670177|FG005|Part I|Physician Decision|0|||
170634011|NCT01208207|616670178|FG006|Part I|Physician Decision|0|||
170634012|NCT01208207|616670172|FG000|Part I|Progressive Disease|1|||
170634013|NCT01208207|616670173|FG001|Part I|Progressive Disease|0|||
170634014|NCT01208207|616670174|FG002|Part I|Progressive Disease|0|||
170540740|NCT04602000|616323747|FG001|Overall Study|Physician Decision|0|||
170540741|NCT04602000|616323748|FG002|Overall Study|Physician Decision|0|||
170634015|NCT01208207|616670175|FG003|Part I|Progressive Disease|0|||
170634016|NCT01208207|616670176|FG004|Part I|Progressive Disease|0|||
170786555|NCT02975882|617227339|FG003|Overall Study|Ineligible|0|||
170786556|NCT03652688|617227343|FG000|Baseline|Withdrawal by Subject|0|||
170786557|NCT03652688|617227344|FG001|Baseline|Withdrawal by Subject|3|||
170786558|NCT03652688|617227343|FG000|Follow-up|Lost to Follow-up|56|||
170786559|NCT03652688|617227344|FG001|Follow-up|Lost to Follow-up|54|||
170786560|NCT02734290|617227345|FG000|Overall Study|Adverse Event|1|||
170786561|NCT02734290|617227346|FG001|Overall Study|Adverse Event|0|||
170786562|NCT02734290|617227345|FG000|Overall Study|Death|1|||
170786563|NCT02734290|617227346|FG001|Overall Study|Death|0|||
170786564|NCT03829410|617227347|FG000|Overall Study|Adverse Event|1|||
170786565|NCT03829410|617227348|FG001|Overall Study|Adverse Event|0|||
170887127|NCT04137887|617595881|FG001|Overall Study|Randomized but not treated|1|||
170540742|NCT04602000|616323749|FG003|Overall Study|Physician Decision|2|||
170634017|NCT01208207|616670177|FG005|Part I|Progressive Disease|0|||
170634018|NCT01208207|616670178|FG006|Part I|Progressive Disease|0|||
170634019|NCT01208207|616670172|FG000|Part I|Protocol Violation|8|||
170634020|NCT01208207|616670173|FG001|Part I|Protocol Violation|0|||
170634021|NCT01208207|616670174|FG002|Part I|Protocol Violation|2|||
170634022|NCT01208207|616670175|FG003|Part I|Protocol Violation|0|||
170634023|NCT01208207|616670176|FG004|Part I|Protocol Violation|0|||
170634024|NCT01208207|616670177|FG005|Part I|Protocol Violation|0|||
170634025|NCT01208207|616670178|FG006|Part I|Protocol Violation|0|||
170634026|NCT01208207|616670172|FG000|Part I|Withdrawal by Subject|14|||
170634027|NCT01208207|616670173|FG001|Part I|Withdrawal by Subject|4|||
170448549|NCT04569786|615980202|FG004|Overall Study|Physician Decision|0|||
170448550|NCT00680186|615980203|FG000|Overall Study|Adverse Event|47|||
170448551|NCT00680186|615980204|FG001|Overall Study|Adverse Event|44|||
170448552|NCT00680186|615980203|FG000|Overall Study|Protocol Violation|31|||
170786566|NCT03829410|617227349|FG002|Overall Study|Adverse Event|1|||
170786567|NCT03829410|617227350|FG003|Overall Study|Adverse Event|4|||
170786568|NCT03829410|617227347|FG000|Overall Study|Physician Decision|0|||
170786569|NCT03829410|617227348|FG001|Overall Study|Physician Decision|0|||
170448553|NCT00680186|615980204|FG001|Overall Study|Protocol Violation|26|||
170448554|NCT00680186|615980203|FG000|Overall Study|Lost to Follow-up|11|||
170448555|NCT00680186|615980204|FG001|Overall Study|Lost to Follow-up|6|||
170448556|NCT00680186|615980203|FG000|Overall Study|Withdrawal by Subject|32|||
170448557|NCT00680186|615980204|FG001|Overall Study|Withdrawal by Subject|39|||
170448558|NCT00680186|615980203|FG000|Overall Study|Other|4|||
170448559|NCT00680186|615980204|FG001|Overall Study|Other|1|||
170448560|NCT01351350|615980207|FG000|Overall Study|Disease Progression|5|||
170448561|NCT01351350|615980208|FG001|Overall Study|Disease Progression|13|||
170448562|NCT01351350|615980209|FG002|Overall Study|Disease Progression|6|||
170448563|NCT01351350|615980210|FG003|Overall Study|Disease Progression|8|||
170448564|NCT01351350|615980211|FG004|Overall Study|Disease Progression|5|||
170448565|NCT01351350|615980207|FG000|Overall Study|Adverse Event|1|||
170448566|NCT01351350|615980208|FG001|Overall Study|Adverse Event|10|||
170448567|NCT01351350|615980209|FG002|Overall Study|Adverse Event|1|||
170448568|NCT01351350|615980210|FG003|Overall Study|Adverse Event|2|||
170448569|NCT01351350|615980211|FG004|Overall Study|Adverse Event|0|||
170448570|NCT01351350|615980207|FG000|Overall Study|Participant Decision|2|||
170448571|NCT01351350|615980208|FG001|Overall Study|Participant Decision|6|||
170448572|NCT01351350|615980209|FG002|Overall Study|Participant Decision|3|||
170448573|NCT01351350|615980210|FG003|Overall Study|Participant Decision|3|||
170448574|NCT01351350|615980211|FG004|Overall Study|Participant Decision|2|||
170448575|NCT01351350|615980207|FG000|Overall Study|Enrolled but not Treated|0|||
170448576|NCT01351350|615980208|FG001|Overall Study|Enrolled but not Treated|0|||
170786570|NCT03829410|617227349|FG002|Overall Study|Physician Decision|0|||
170448577|NCT01351350|615980209|FG002|Overall Study|Enrolled but not Treated|1|||
170448578|NCT01351350|615980210|FG003|Overall Study|Enrolled but not Treated|0|||
170448579|NCT01351350|615980211|FG004|Overall Study|Enrolled but not Treated|0|||
170448580|NCT00690482|615980217|FG000|Overall Study|Adverse Event|2|||
170448581|NCT00690482|615980218|FG001|Overall Study|Adverse Event|1|||
170448582|NCT00690482|615980217|FG000|Overall Study|Incorrect enrolment|0|||
170448583|NCT00690482|615980218|FG001|Overall Study|Incorrect enrolment|1|||
170448584|NCT00690482|615980217|FG000|Overall Study|Study-specific discontinuation criteria|1|||
170448585|NCT00690482|615980218|FG001|Overall Study|Study-specific discontinuation criteria|0|||
170448586|NCT00690482|615980217|FG000|Overall Study|Intake of prohibited medicine|1|||
170448587|NCT00690482|615980218|FG001|Overall Study|Intake of prohibited medicine|0|||
170448588|NCT00690482|615980217|FG000|Overall Study|withdrew consent at rand.day|0|||
170448589|NCT00690482|615980218|FG001|Overall Study|withdrew consent at rand.day|1|||
170448590|NCT04965389|615980219|FG000|Overall Study|Other reasons|1|||
170448591|NCT04965389|615980220|FG001|Overall Study|Other reasons|0|||
170448592|NCT04965389|615980221|FG002|Overall Study|Other reasons|0|||
170448593|NCT04965389|615980222|FG003|Overall Study|Other reasons|0|||
170448594|NCT04965389|615980219|FG000|Overall Study|Participant withdrew consent|0|||
170448595|NCT04965389|615980220|FG001|Overall Study|Participant withdrew consent|1|||
170448596|NCT04965389|615980221|FG002|Overall Study|Participant withdrew consent|0|||
170448597|NCT04965389|615980222|FG003|Overall Study|Participant withdrew consent|0|||
170448598|NCT04965389|615980219|FG000|Overall Study|Poor/Non-compliance|0|||
170448599|NCT04965389|615980220|FG001|Overall Study|Poor/Non-compliance|1|||
170448600|NCT04965389|615980221|FG002|Overall Study|Poor/Non-compliance|0|||
170448601|NCT04965389|615980222|FG003|Overall Study|Poor/Non-compliance|0|||
170448602|NCT00702208|615980223|FG000|Overall Study|Lost to Follow-up|28|||
170448603|NCT00702208|615980223|FG000|Overall Study|Did not self-lavage|1|||
170448604|NCT00702208|615980223|FG000|Overall Study|Unsatisfactory colposcopy|2|||
170448605|NCT00292227|615980224|FG000|Patch Period|Adverse Event|1|||
170448606|NCT00292227|615980225|FG001|Patch Period|Adverse Event|0|||
170448607|NCT00292227|615980226|FG002|Patch Period|Adverse Event|2|||
170448608|NCT00292227|615980224|FG000|Patch Period|Withdrawal by Subject|0|||
170448609|NCT00292227|615980225|FG001|Patch Period|Withdrawal by Subject|0|||
170448610|NCT00292227|615980226|FG002|Patch Period|Withdrawal by Subject|1|||
170448611|NCT01835548|615980227|FG000|Dose Optimization Period|Adverse Event|0|||
170448612|NCT01835548|615980228|FG001|Dose Optimization Period|Adverse Event|0|||
170448613|NCT01835548|615980229|FG002|Dose Optimization Period|Adverse Event|1|||
170448614|NCT01835548|615980227|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
170448615|NCT01835548|615980228|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
170448616|NCT01835548|615980229|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
170448617|NCT01835548|615980227|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170448618|NCT01835548|615980228|FG001|Double-Blind Treatment Period|Adverse Event|1|||
170448619|NCT01835548|615980229|FG002|Double-Blind Treatment Period|Adverse Event|0|||
170448620|NCT01835548|615980227|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170448621|NCT01835548|615980228|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170448622|NCT01835548|615980229|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170448623|NCT02105701|615980233|FG000|Overall Study|Lost to Follow-up|1|||
170448624|NCT02105701|615980234|FG001|Overall Study|Lost to Follow-up|0|||
170448625|NCT02105701|615980235|FG002|Overall Study|Lost to Follow-up|2|||
170448626|NCT02105701|615980236|FG003|Overall Study|Lost to Follow-up|1|||
170448627|NCT02105701|615980233|FG000|Overall Study|Protocol Violation|0|||
170448628|NCT02105701|615980234|FG001|Overall Study|Protocol Violation|0|||
170448629|NCT02105701|615980235|FG002|Overall Study|Protocol Violation|1|||
170448630|NCT02105701|615980236|FG003|Overall Study|Protocol Violation|0|||
170448631|NCT02105701|615980233|FG000|Overall Study|Withdrawal by Subject|2|||
170448632|NCT02105701|615980234|FG001|Overall Study|Withdrawal by Subject|1|||
170448633|NCT02105701|615980235|FG002|Overall Study|Withdrawal by Subject|0|||
170448634|NCT02105701|615980236|FG003|Overall Study|Withdrawal by Subject|1|||
170448635|NCT02105701|615980233|FG000|Overall Study|Death|1|||
170448636|NCT02105701|615980234|FG001|Overall Study|Death|0|||
170448637|NCT02105701|615980235|FG002|Overall Study|Death|0|||
170448638|NCT02105701|615980236|FG003|Overall Study|Death|0|||
170448639|NCT03234608|615980237|FG000|Overall Study|Lost to Follow-up|23|||
170448640|NCT03234608|615980238|FG001|Overall Study|Lost to Follow-up|21|||
170448641|NCT02329431|615980239|FG000|Overall Study|Lost to Follow-up|20|||
170448642|NCT02329431|615980240|FG001|Overall Study|Lost to Follow-up|13|||
170448643|NCT01362296|615980241|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
170448644|NCT01362296|615980242|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
170448645|NCT01362296|615980243|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
170448646|NCT01362296|615980244|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
170448647|NCT01362296|615980241|FG000|Randomized Phase (RP)|Physician Decision|1|||
170448648|NCT01362296|615980242|FG001|Randomized Phase (RP)|Physician Decision|9|||
170448649|NCT01362296|615980243|FG002|Randomized Phase (RP)|Physician Decision|0|||
170448650|NCT01362296|615980244|FG003|Randomized Phase (RP)|Physician Decision|0|||
170448651|NCT01362296|615980241|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
170448652|NCT01362296|615980242|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
170448653|NCT01362296|615980243|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
170448654|NCT01362296|615980244|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
170448655|NCT01362296|615980241|FG000|Randomized Phase (RP)|Adverse Event|20|||
170448656|NCT01362296|615980242|FG001|Randomized Phase (RP)|Adverse Event|4|||
170448657|NCT01362296|615980243|FG002|Randomized Phase (RP)|Adverse Event|0|||
170448658|NCT01362296|615980244|FG003|Randomized Phase (RP)|Adverse Event|0|||
170448659|NCT01362296|615980241|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
170448660|NCT01362296|615980242|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
170448661|NCT01362296|615980243|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
170786571|NCT03829410|617227350|FG003|Overall Study|Physician Decision|2|||
170786572|NCT03829410|617227347|FG000|Overall Study|Disease Progressing|3|||
170786573|NCT03829410|617227348|FG001|Overall Study|Disease Progressing|4|||
170786574|NCT03829410|617227349|FG002|Overall Study|Disease Progressing|2|||
170786575|NCT03829410|617227350|FG003|Overall Study|Disease Progressing|31|||
170786576|NCT03829410|617227347|FG000|Overall Study|Miscellaneous|2|||
170448662|NCT01362296|615980244|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
170448663|NCT01362296|615980241|FG000|Crossover Phase|PD including Death due to PD|0|||
170448664|NCT01362296|615980242|FG001|Crossover Phase|PD including Death due to PD|0|||
170448665|NCT01362296|615980243|FG002|Crossover Phase|PD including Death due to PD|16|||
170448666|NCT01362296|615980244|FG003|Crossover Phase|PD including Death due to PD|1|||
170448667|NCT01362296|615980241|FG000|Crossover Phase|Withdrawal by Subject|0|||
170448668|NCT01362296|615980242|FG001|Crossover Phase|Withdrawal by Subject|0|||
170448669|NCT01362296|615980243|FG002|Crossover Phase|Withdrawal by Subject|2|||
170448670|NCT01362296|615980244|FG003|Crossover Phase|Withdrawal by Subject|1|||
170448671|NCT01362296|615980241|FG000|Crossover Phase|Adverse Event|0|||
170448672|NCT01362296|615980242|FG001|Crossover Phase|Adverse Event|0|||
170448673|NCT01362296|615980243|FG002|Crossover Phase|Adverse Event|4|||
170448674|NCT01362296|615980244|FG003|Crossover Phase|Adverse Event|0|||
170448675|NCT01362296|615980241|FG000|Crossover Phase|Study Closed/Terminated|0|||
170448676|NCT01362296|615980242|FG001|Crossover Phase|Study Closed/Terminated|0|||
170448677|NCT01362296|615980243|FG002|Crossover Phase|Study Closed/Terminated|1|||
170540743|NCT04602000|616323750|FG004|Overall Study|Physician Decision|2|||
170540744|NCT04602000|616323746|FG000|Overall Study|Death|0|||
170448678|NCT01362296|615980244|FG003|Crossover Phase|Study Closed/Terminated|0|||
170448679|NCT03693950|615980245|FG000|Overall Study|Withdrawal by Subject|1|||
170448680|NCT03693950|615980246|FG001|Overall Study|Withdrawal by Subject|0|||
170448681|NCT03366194|615980247|FG000|Overall Study|Lost to Follow-up|2|||
170448682|NCT04230876|615980249|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
170448683|NCT04230876|615980250|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
170448684|NCT03438006|615980251|FG000|Overall Study|Adverse Event|1|||
170448685|NCT03438006|615980251|FG000|Overall Study|Lost to Follow-up|67|||
170448686|NCT03438006|615980251|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
170540745|NCT04602000|616323747|FG001|Overall Study|Death|1|||
170448687|NCT03438006|615980251|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
170448688|NCT01181531|615980252|FG000|Overall Study|Other|17|||
170448689|NCT01181531|615980253|FG001|Overall Study|Other|12|||
170448690|NCT01181531|615980252|FG000|Overall Study|Partial consent by subject withdrawn|0|||
170448691|NCT01181531|615980253|FG001|Overall Study|Partial consent by subject withdrawn|1|||
170448692|NCT01181531|615980252|FG000|Overall Study|Physician Decision|3|||
170448693|NCT01181531|615980253|FG001|Overall Study|Physician Decision|1|||
170448694|NCT01181531|615980252|FG000|Overall Study|Noncompliance|2|||
170448695|NCT01181531|615980253|FG001|Overall Study|Noncompliance|2|||
170448696|NCT01181531|615980252|FG000|Overall Study|Ineligibility determined|1|||
170448697|NCT01181531|615980253|FG001|Overall Study|Ineligibility determined|2|||
170448698|NCT01181531|615980252|FG000|Overall Study|Protocol Specified Criteria|15|||
170448699|NCT01181531|615980253|FG001|Overall Study|Protocol Specified Criteria|8|||
170448700|NCT01181531|615980252|FG000|Overall Study|Pregnancy|0|||
170448701|NCT01181531|615980253|FG001|Overall Study|Pregnancy|1|||
170448702|NCT01181531|615980252|FG000|Overall Study|Withdrawal by Subject|8|||
170448703|NCT01181531|615980253|FG001|Overall Study|Withdrawal by Subject|7|||
170448704|NCT01181531|615980252|FG000|Overall Study|Protocol Violation|6|||
170448705|NCT01181531|615980253|FG001|Overall Study|Protocol Violation|6|||
170448706|NCT01181531|615980252|FG000|Overall Study|Death|9|||
170448707|NCT01181531|615980253|FG001|Overall Study|Death|12|||
170448708|NCT01181531|615980252|FG000|Overall Study|Adverse Event|0|||
170448709|NCT01181531|615980253|FG001|Overall Study|Adverse Event|1|||
170448710|NCT00545688|615980255|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
170448711|NCT00545688|615980256|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
170448712|NCT00545688|615980257|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
170448713|NCT00545688|615980258|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
170448714|NCT00545688|615980255|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
170448715|NCT00545688|615980256|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
170448716|NCT00545688|615980257|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
170448717|NCT00545688|615980258|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
170448718|NCT00545688|615980255|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
170448719|NCT00545688|615980256|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
170448720|NCT00545688|615980257|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
170448721|NCT00545688|615980258|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
170448722|NCT00545688|615980255|FG000|Neo-Adjuvant Treatment Period|Death|0|||
170448723|NCT00545688|615980256|FG001|Neo-Adjuvant Treatment Period|Death|1|||
170448724|NCT00545688|615980257|FG002|Neo-Adjuvant Treatment Period|Death|0|||
170448725|NCT00545688|615980258|FG003|Neo-Adjuvant Treatment Period|Death|0|||
170448726|NCT00545688|615980255|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
170448727|NCT00545688|615980256|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
170448728|NCT00545688|615980257|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
170448729|NCT00545688|615980258|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
170448730|NCT00545688|615980255|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
170448731|NCT00545688|615980256|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
170448732|NCT00545688|615980257|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
170448733|NCT00545688|615980258|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
170448734|NCT00545688|615980255|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
170448735|NCT00545688|615980256|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
170448736|NCT00545688|615980257|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
170448737|NCT00545688|615980258|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
170448738|NCT00545688|615980255|FG000|Adjuvant Treatment Period|Disease Progression|3|||
170448739|NCT00545688|615980256|FG001|Adjuvant Treatment Period|Disease Progression|3|||
170448740|NCT00545688|615980257|FG002|Adjuvant Treatment Period|Disease Progression|0|||
170448741|NCT00545688|615980258|FG003|Adjuvant Treatment Period|Disease Progression|7|||
170448742|NCT00545688|615980255|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
170448743|NCT00545688|615980256|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
170448744|NCT00545688|615980257|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
170448745|NCT00545688|615980258|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
170448746|NCT00545688|615980255|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
170448747|NCT00545688|615980256|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
170448748|NCT00545688|615980257|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
170448749|NCT00545688|615980258|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
170448750|NCT00545688|615980255|FG000|Adjuvant Treatment Period|Adverse Event|0|||
170448751|NCT00545688|615980256|FG001|Adjuvant Treatment Period|Adverse Event|3|||
170448752|NCT00545688|615980257|FG002|Adjuvant Treatment Period|Adverse Event|2|||
170448753|NCT00545688|615980258|FG003|Adjuvant Treatment Period|Adverse Event|2|||
170448754|NCT00545688|615980255|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
170448755|NCT00545688|615980256|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
170448756|NCT00545688|615980257|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
170448757|NCT00545688|615980258|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
170448758|NCT00545688|615980255|FG000|Follow-Up Period|Death|4|||
170448759|NCT00545688|615980256|FG001|Follow-Up Period|Death|2|||
170448760|NCT00545688|615980257|FG002|Follow-Up Period|Death|2|||
170786577|NCT03829410|617227348|FG001|Overall Study|Miscellaneous|4|||
170786578|NCT03829410|617227349|FG002|Overall Study|Miscellaneous|3|||
170887128|NCT01790503|617595884|FG000|Overall Study|Adverse Event|1|||
170887129|NCT01790503|617595885|FG001|Overall Study|Adverse Event|0|||
170887130|NCT01790503|617595886|FG002|Overall Study|Adverse Event|0|||
170887131|NCT01790503|617595887|FG003|Overall Study|Adverse Event|0|||
170887132|NCT01790503|617595888|FG004|Overall Study|Adverse Event|0|||
170887133|NCT01790503|617595889|FG005|Overall Study|Adverse Event|2|||
170887134|NCT01790503|617595890|FG006|Overall Study|Adverse Event|0|||
170887135|NCT01790503|617595891|FG007|Overall Study|Adverse Event|0|||
170887136|NCT01790503|617595892|FG008|Overall Study|Adverse Event|2|||
170887137|NCT01790503|617595893|FG009|Overall Study|Adverse Event|4|||
170786579|NCT03829410|617227350|FG003|Overall Study|Miscellaneous|10|||
170887138|NCT01790503|617595894|FG010|Overall Study|Adverse Event|7|||
170786580|NCT05179837|617227351|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
170786581|NCT05179837|617227351|FG000|Overall Study|Device malfunctioned|1|||
170786582|NCT05179837|617227351|FG000|Overall Study|Image quality too low|2|||
170786583|NCT03158129|617227352|FG000|Overall Study|Adverse Event|0|||
170786584|NCT03158129|617227353|FG001|Overall Study|Adverse Event|1|||
170786585|NCT03158129|617227354|FG002|Overall Study|Adverse Event|0|||
170786586|NCT03158129|617227355|FG003|Overall Study|Adverse Event|0|||
170786587|NCT03158129|617227352|FG000|Overall Study|Death|0|||
170786588|NCT03158129|617227353|FG001|Overall Study|Death|0|||
170786589|NCT03158129|617227354|FG002|Overall Study|Death|0|||
170786590|NCT03158129|617227355|FG003|Overall Study|Death|1|||
170786591|NCT03158129|617227352|FG000|Overall Study|High surgical risk|1|||
170786592|NCT03158129|617227353|FG001|Overall Study|High surgical risk|1|||
170786593|NCT03158129|617227354|FG002|Overall Study|High surgical risk|0|||
170786594|NCT03158129|617227355|FG003|Overall Study|High surgical risk|0|||
170786595|NCT03158129|617227352|FG000|Overall Study|Progression|1|||
170786596|NCT03158129|617227353|FG001|Overall Study|Progression|1|||
170786597|NCT03158129|617227354|FG002|Overall Study|Progression|0|||
170786598|NCT03158129|617227355|FG003|Overall Study|Progression|0|||
170786599|NCT03158129|617227352|FG000|Overall Study|Lack of resectability|0|||
170786600|NCT03158129|617227353|FG001|Overall Study|Lack of resectability|1|||
170786601|NCT03158129|617227354|FG002|Overall Study|Lack of resectability|0|||
170786602|NCT03158129|617227355|FG003|Overall Study|Lack of resectability|0|||
170786603|NCT03158129|617227352|FG000|Overall Study|Declined surgery|0|||
170786604|NCT03158129|617227353|FG001|Overall Study|Declined surgery|1|||
170786605|NCT03158129|617227354|FG002|Overall Study|Declined surgery|0|||
170786606|NCT03158129|617227355|FG003|Overall Study|Declined surgery|0|||
170786607|NCT03158129|617227352|FG000|Overall Study|No longer surgical candidate|0|||
170786608|NCT03158129|617227353|FG001|Overall Study|No longer surgical candidate|0|||
170786609|NCT03158129|617227354|FG002|Overall Study|No longer surgical candidate|0|||
170786610|NCT03158129|617227355|FG003|Overall Study|No longer surgical candidate|1|||
170786611|NCT04924660|617227356|FG000|United States|Death|29|||
170786612|NCT04924660|617227357|FG001|United States|Death|32|||
170786613|NCT04924660|617227358|FG002|United States|Death|34|||
170786614|NCT04924660|617227359|FG003|United States|Death|25|||
170786615|NCT04924660|617227360|FG004|United States|Death|26|||
170786616|NCT04924660|617227361|FG005|United States|Death|23|||
170786617|NCT04924660|617227356|FG000|United States|Lost to Follow-up|15|||
170887139|NCT01790503|617595884|FG000|Overall Study|Withdrawal by Subject|0|||
170448761|NCT00545688|615980258|FG003|Follow-Up Period|Death|6|||
170448762|NCT00545688|615980255|FG000|Follow-Up Period|Disease Progression|6|||
170448763|NCT00545688|615980256|FG001|Follow-Up Period|Disease Progression|5|||
170448764|NCT00545688|615980257|FG002|Follow-Up Period|Disease Progression|9|||
170448765|NCT00545688|615980258|FG003|Follow-Up Period|Disease Progression|9|||
170448766|NCT00545688|615980255|FG000|Follow-Up Period|Refused Treatment|6|||
170448767|NCT00545688|615980256|FG001|Follow-Up Period|Refused Treatment|2|||
170448768|NCT00545688|615980257|FG002|Follow-Up Period|Refused Treatment|0|||
170448769|NCT00545688|615980258|FG003|Follow-Up Period|Refused Treatment|2|||
170448770|NCT00545688|615980255|FG000|Follow-Up Period|Lost to Follow-up|3|||
170448771|NCT00545688|615980256|FG001|Follow-Up Period|Lost to Follow-up|3|||
170448772|NCT00545688|615980257|FG002|Follow-Up Period|Lost to Follow-up|3|||
170448773|NCT00545688|615980258|FG003|Follow-Up Period|Lost to Follow-up|1|||
170448774|NCT00545688|615980255|FG000|Follow-Up Period|Unspecified Reason|2|||
170448775|NCT00545688|615980256|FG001|Follow-Up Period|Unspecified Reason|5|||
170448776|NCT00545688|615980257|FG002|Follow-Up Period|Unspecified Reason|6|||
170448777|NCT00545688|615980258|FG003|Follow-Up Period|Unspecified Reason|8|||
170448778|NCT00545688|615980255|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
170786618|NCT04924660|617227357|FG001|United States|Lost to Follow-up|10|||
170786619|NCT04924660|617227358|FG002|United States|Lost to Follow-up|13|||
170786620|NCT04924660|617227359|FG003|United States|Lost to Follow-up|5|||
170786621|NCT04924660|617227360|FG004|United States|Lost to Follow-up|19|||
170786622|NCT04924660|617227361|FG005|United States|Lost to Follow-up|20|||
170786623|NCT04924660|617227356|FG000|United States|Withdrawal by Subject|8|||
170786624|NCT04924660|617227357|FG001|United States|Withdrawal by Subject|3|||
170887140|NCT01790503|617595885|FG001|Overall Study|Withdrawal by Subject|0|||
170448779|NCT00545688|615980256|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
170448780|NCT00545688|615980257|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
170448781|NCT00545688|615980258|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
170448782|NCT02339090|615980259|FG000|Overall Study|Adverse Event|1|||
170448783|NCT02339090|615980260|FG001|Overall Study|Adverse Event|0|||
170448784|NCT02339090|615980259|FG000|Overall Study|Lost to Follow-up|0|||
170786625|NCT04924660|617227358|FG002|United States|Withdrawal by Subject|3|||
170448785|NCT02339090|615980260|FG001|Overall Study|Lost to Follow-up|1|||
170448786|NCT02339090|615980259|FG000|Overall Study|Non-compliance With Study Drug|0|||
170448787|NCT02339090|615980260|FG001|Overall Study|Non-compliance With Study Drug|1|||
170448788|NCT02339090|615980259|FG000|Overall Study|Withdrawal by Subject|2|||
170448789|NCT02339090|615980260|FG001|Overall Study|Withdrawal by Subject|1|||
170448790|NCT02339090|615980259|FG000|Overall Study|Poor Growth|3|||
170448791|NCT02339090|615980260|FG001|Overall Study|Poor Growth|0|||
170448792|NCT02339090|615980259|FG000|Overall Study|Randomized but not treated|0|||
170448793|NCT02339090|615980260|FG001|Overall Study|Randomized but not treated|2|||
170448794|NCT02737592|615980263|FG000|Overall Study|Withdrawal by Subject|1|||
170448795|NCT00442546|615980265|FG000|Overall Study|Adverse Event|11|||
170448796|NCT00442546|615980266|FG001|Overall Study|Adverse Event|17|||
170448797|NCT00442546|615980267|FG002|Overall Study|Adverse Event|13|||
170448798|NCT00442546|615980265|FG000|Overall Study|Lost to Follow-up|1|||
170448799|NCT00442546|615980266|FG001|Overall Study|Lost to Follow-up|2|||
170448800|NCT00442546|615980267|FG002|Overall Study|Lost to Follow-up|1|||
170448801|NCT00442546|615980265|FG000|Overall Study|Other|4|||
170448802|NCT00442546|615980266|FG001|Overall Study|Other|9|||
170448803|NCT00442546|615980267|FG002|Overall Study|Other|6|||
170448804|NCT00442546|615980265|FG000|Overall Study|Withdrawal by Subject|5|||
170448805|NCT00442546|615980266|FG001|Overall Study|Withdrawal by Subject|5|||
170448806|NCT00442546|615980267|FG002|Overall Study|Withdrawal by Subject|7|||
170448807|NCT00442546|615980265|FG000|Overall Study|Randomized But Not Treated|5|||
170448808|NCT00442546|615980266|FG001|Overall Study|Randomized But Not Treated|4|||
170448809|NCT00442546|615980267|FG002|Overall Study|Randomized But Not Treated|6|||
170448810|NCT00248170|615980268|FG000|Overall Study|Withdrawal by Subject|71|||
170448811|NCT00248170|615980269|FG001|Overall Study|Withdrawal by Subject|79|||
170448812|NCT00248170|615980268|FG000|Overall Study|Protocol Violation|35|||
170448813|NCT00248170|615980269|FG001|Overall Study|Protocol Violation|30|||
170448814|NCT00248170|615980268|FG000|Overall Study|Lost to Follow-up|28|||
170448815|NCT00248170|615980269|FG001|Overall Study|Lost to Follow-up|35|||
170448816|NCT00248170|615980268|FG000|Overall Study|Disease progression|196|||
170448817|NCT00248170|615980269|FG001|Overall Study|Disease progression|216|||
170448818|NCT00248170|615980268|FG000|Overall Study|Death|28|||
170448819|NCT00248170|615980269|FG001|Overall Study|Death|47|||
170448820|NCT00248170|615980268|FG000|Overall Study|Adverse Event|311|||
170448821|NCT00248170|615980269|FG001|Overall Study|Adverse Event|296|||
170448822|NCT00248170|615980268|FG000|Overall Study|Administrative problems|22|||
170448823|NCT00248170|615980269|FG001|Overall Study|Administrative problems|25|||
170448824|NCT00248170|615980268|FG000|Overall Study|Abnormal test procedure(s) result|49|||
170448825|NCT00248170|615980269|FG001|Overall Study|Abnormal test procedure(s) result|61|||
170448826|NCT00248170|615980268|FG000|Overall Study|Abnormal laboratory values|4|||
170448827|NCT00248170|615980269|FG001|Overall Study|Abnormal laboratory values|0|||
170448828|NCT00248170|615980268|FG000|Overall Study|Protocol deviation|17|||
170448829|NCT00248170|615980269|FG001|Overall Study|Protocol deviation|19|||
170448830|NCT02843659|615980274|FG000|Overall Study|Subject Withdrew Consent|0|||
170448831|NCT02843659|615980275|FG001|Overall Study|Subject Withdrew Consent|0|||
170448832|NCT02843659|615980276|FG002|Overall Study|Subject Withdrew Consent|1|||
170448833|NCT02843659|615980274|FG000|Overall Study|Administrative Reason by Sponsor|4|||
170448834|NCT02843659|615980275|FG001|Overall Study|Administrative Reason by Sponsor|5|||
170448835|NCT02843659|615980276|FG002|Overall Study|Administrative Reason by Sponsor|4|||
170448836|NCT02843659|615980274|FG000|Overall Study|Adverse Event|0|||
170448837|NCT02843659|615980275|FG001|Overall Study|Adverse Event|1|||
170448838|NCT02843659|615980276|FG002|Overall Study|Adverse Event|0|||
170448839|NCT03203642|615980277|FG000|Overall Study|Adverse Event|3|||
170448840|NCT03203642|615980278|FG001|Overall Study|Adverse Event|1|||
170448841|NCT03203642|615980277|FG000|Overall Study|Withdrawal by Subject|6|||
170448842|NCT03203642|615980278|FG001|Overall Study|Withdrawal by Subject|6|||
170448843|NCT03203642|615980277|FG000|Overall Study|Lost to Follow-up|2|||
170448844|NCT03203642|615980278|FG001|Overall Study|Lost to Follow-up|1|||
170448845|NCT03203642|615980277|FG000|Overall Study|Termination of the study by sponsor|1|||
170448846|NCT03203642|615980278|FG001|Overall Study|Termination of the study by sponsor|1|||
170448847|NCT03203642|615980277|FG000|Overall Study|Participant moved|0|||
170448848|NCT03203642|615980278|FG001|Overall Study|Participant moved|1|||
170448849|NCT03203642|615980277|FG000|Overall Study|Investigator's decision|3|||
170448850|NCT03203642|615980278|FG001|Overall Study|Investigator's decision|0|||
170448851|NCT03203642|615980277|FG000|Overall Study|Other than above specified|0|||
170448852|NCT03203642|615980278|FG001|Overall Study|Other than above specified|1|||
170448853|NCT01253317|615980279|FG000|Overall Study|Adverse Event|2|||
170887141|NCT01790503|617595886|FG002|Overall Study|Withdrawal by Subject|1|||
170448854|NCT01301482|615982297|FG000|Overall Study|Withdrawal by Subject|1|||
170448855|NCT01432574|615982301|FG000|Overall Study|Moved|2|||
170448856|NCT01432574|615982301|FG000|Overall Study|Not interested|1|||
170448857|NCT02813421|615982308|FG000|Overall Study|Withdrawal by Subject|1|||
170448858|NCT02813421|615982309|FG001|Overall Study|Withdrawal by Subject|2|||
170448859|NCT02813421|615982308|FG000|Overall Study|Lost to Follow-up|1|||
170448860|NCT02813421|615982309|FG001|Overall Study|Lost to Follow-up|1|||
170448861|NCT03135899|615982310|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
170448862|NCT03135899|615982311|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
170448863|NCT03135899|615982312|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
170448864|NCT03135899|615982313|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
170448865|NCT03135899|615982314|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
170448866|NCT03135899|615982315|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
170448867|NCT03135899|615982316|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
170448868|NCT03135899|615982317|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
170448869|NCT03135899|615982310|FG000|Overall Study|Withdrawal by Subject|0|||
170448870|NCT03135899|615982311|FG001|Overall Study|Withdrawal by Subject|0|||
170448871|NCT03135899|615982312|FG002|Overall Study|Withdrawal by Subject|0|||
170448872|NCT03135899|615982313|FG003|Overall Study|Withdrawal by Subject|0|||
170448873|NCT03135899|615982314|FG004|Overall Study|Withdrawal by Subject|0|||
170448874|NCT03135899|615982315|FG005|Overall Study|Withdrawal by Subject|2|||
170448875|NCT03135899|615982316|FG006|Overall Study|Withdrawal by Subject|0|||
170448876|NCT03135899|615982317|FG007|Overall Study|Withdrawal by Subject|0|||
170448877|NCT02070757|615982318|FG000|Overall Study|Adverse Event|107|||
170448878|NCT02070757|615982319|FG001|Overall Study|Adverse Event|99|||
170448879|NCT02070757|615982318|FG000|Overall Study|Lost to Follow-up|7|||
170448880|NCT02070757|615982319|FG001|Overall Study|Lost to Follow-up|4|||
170448881|NCT02070757|615982318|FG000|Overall Study|Protocol Violation|0|||
170448882|NCT02070757|615982319|FG001|Overall Study|Protocol Violation|4|||
170448883|NCT02070757|615982318|FG000|Overall Study|Withdrawal by Subject|1|||
170448884|NCT02070757|615982319|FG001|Overall Study|Withdrawal by Subject|3|||
170448885|NCT02070757|615982318|FG000|Overall Study|Investigator Decision|0|||
170448886|NCT02070757|615982319|FG001|Overall Study|Investigator Decision|2|||
170448887|NCT02070757|615982318|FG000|Overall Study|Discharged from Study Hospital|2|||
170448888|NCT02070757|615982319|FG001|Overall Study|Discharged from Study Hospital|2|||
170448889|NCT04086641|615982320|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
170448890|NCT04086641|615982321|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
170448891|NCT00126126|615982322|FG000|Overall Study|Lost to Follow-up|0|||
170448892|NCT00126126|615982323|FG001|Overall Study|Lost to Follow-up|2|||
170448893|NCT00655850|615982324|FG000|Overall Study|Death|2|||
170448894|NCT00655850|615982324|FG000|Overall Study|Withdrawal by Subject|1|||
170448895|NCT00918463|615982325|FG000|Overall Study|Death|1|||
170448896|NCT00918463|615982325|FG000|Overall Study|Lack of Efficacy|1|||
170448897|NCT01659736|615982326|FG000|Treatment Period|Adverse Event|1|||
170448898|NCT01659736|615982327|FG001|Treatment Period|Adverse Event|1|||
170448899|NCT01659736|615982326|FG000|Treatment Period|Protocol Violation|3|||
170448900|NCT01659736|615982327|FG001|Treatment Period|Protocol Violation|1|||
170448901|NCT01659736|615982326|FG000|Treatment Period|Withdrawal by Subject|1|||
170448902|NCT01659736|615982327|FG001|Treatment Period|Withdrawal by Subject|0|||
170448903|NCT01659736|615982326|FG000|3-month Follow-up|Lost to Follow-up|0|||
170448904|NCT01659736|615982327|FG001|3-month Follow-up|Lost to Follow-up|1|||
170448905|NCT01570283|615982331|FG000|Cohort 1: Dose Level 1|Death|0|||
170448906|NCT01570283|615982332|FG001|Cohort 1: Dose Level 1|Death|1|||
170448907|NCT01570283|615982333|FG002|Cohort 1: Dose Level 1|Death|0|||
170448908|NCT01570283|615982334|FG003|Cohort 1: Dose Level 1|Death|0|||
170448909|NCT01570283|615982335|FG004|Cohort 1: Dose Level 1|Death|0|||
170448910|NCT01570283|615982336|FG005|Cohort 1: Dose Level 1|Death|0|||
170448911|NCT01570283|615982331|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
170448912|NCT01570283|615982332|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
170448913|NCT01570283|615982333|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
170448914|NCT01570283|615982334|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
170540746|NCT04602000|616323748|FG002|Overall Study|Death|0|||
170540747|NCT04602000|616323749|FG003|Overall Study|Death|1|||
170540748|NCT04602000|616323750|FG004|Overall Study|Death|2|||
170540749|NCT04602000|616323746|FG000|Overall Study|Lost to Follow-up|0|||
170540750|NCT04602000|616323747|FG001|Overall Study|Lost to Follow-up|0|||
170540751|NCT04602000|616323748|FG002|Overall Study|Lost to Follow-up|0|||
170540752|NCT04602000|616323749|FG003|Overall Study|Lost to Follow-up|3|||
170540753|NCT04602000|616323750|FG004|Overall Study|Lost to Follow-up|4|||
170540754|NCT04602000|616323746|FG000|Overall Study|Other|4|||
170540755|NCT04602000|616323747|FG001|Overall Study|Other|1|||
170540756|NCT04602000|616323748|FG002|Overall Study|Other|2|||
170540757|NCT04602000|616323749|FG003|Overall Study|Other|5|||
170540758|NCT04602000|616323750|FG004|Overall Study|Other|4|||
170540759|NCT04602000|616323746|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
170448915|NCT01570283|615982335|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
170448916|NCT01570283|615982336|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
170448917|NCT01570283|615982331|FG000|Cohort 2: Dose Level 2|Death|0|||
170448918|NCT01570283|615982332|FG001|Cohort 2: Dose Level 2|Death|0|||
170448919|NCT01570283|615982333|FG002|Cohort 2: Dose Level 2|Death|1|||
170448920|NCT01570283|615982334|FG003|Cohort 2: Dose Level 2|Death|0|||
170448921|NCT01570283|615982335|FG004|Cohort 2: Dose Level 2|Death|0|||
170448922|NCT01570283|615982336|FG005|Cohort 2: Dose Level 2|Death|0|||
170448923|NCT01570283|615982331|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
170448924|NCT01570283|615982332|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
170448925|NCT01570283|615982333|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
170448926|NCT01570283|615982334|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
170448927|NCT01570283|615982335|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
170448928|NCT01570283|615982336|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
170448929|NCT01570283|615982331|FG000|Cohort 3: Dose Level 3|Death|0|||
170448930|NCT01570283|615982332|FG001|Cohort 3: Dose Level 3|Death|0|||
170448931|NCT01570283|615982333|FG002|Cohort 3: Dose Level 3|Death|0|||
170448932|NCT01570283|615982334|FG003|Cohort 3: Dose Level 3|Death|0|||
170448933|NCT01570283|615982335|FG004|Cohort 3: Dose Level 3|Death|0|||
170448934|NCT01570283|615982336|FG005|Cohort 3: Dose Level 3|Death|1|||
170448935|NCT01570283|615982331|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
170448936|NCT01570283|615982332|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
170448937|NCT01570283|615982333|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
170448938|NCT01570283|615982334|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
170448939|NCT01570283|615982335|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
170448940|NCT01570283|615982336|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
170448941|NCT01833533|615982337|FG000|Overall Study|Adverse Event|0|||
170448942|NCT01833533|615982338|FG001|Overall Study|Adverse Event|1|||
170448943|NCT01833533|615982337|FG000|Overall Study|Lost to Follow-up|4|||
170448944|NCT01833533|615982338|FG001|Overall Study|Lost to Follow-up|9|||
170448945|NCT01833533|615982337|FG000|Overall Study|To Enter an Extension Study|0|||
170448946|NCT01833533|615982338|FG001|Overall Study|To Enter an Extension Study|4|||
170448947|NCT01833533|615982337|FG000|Overall Study|Other|2|||
170448948|NCT01833533|615982338|FG001|Overall Study|Other|7|||
170448949|NCT02017860|615982339|FG000|Overall Study|Adverse Event|1|||
170448950|NCT02017860|615982339|FG000|Overall Study|Withdrawal by Subject|1|||
170448951|NCT02772562|615982340|FG000|Overall Study|Withdrawal by Subject|1|||
170448952|NCT02772562|615982340|FG000|Overall Study|Protocol Violation|1|||
170448953|NCT00103038|615982343|FG000|Overall Study|Withdrawal by Subject|8|||
170448954|NCT00103038|615982343|FG000|Overall Study|Screen failure|3|||
170448955|NCT00103038|615982343|FG000|Overall Study|Death|1|||
170448956|NCT00103038|615982343|FG000|Overall Study|Physician Decision|1|||
170448957|NCT00530348|615982350|FG000|Overall Study|Adverse Event|5|||
170448958|NCT00530348|615982351|FG001|Overall Study|Adverse Event|1|||
170448959|NCT00530348|615982350|FG000|Overall Study|Death|0|||
170448960|NCT00530348|615982351|FG001|Overall Study|Death|1|||
170448961|NCT00530348|615982350|FG000|Overall Study|Lack of Efficacy|2|||
170448962|NCT00530348|615982351|FG001|Overall Study|Lack of Efficacy|0|||
170448963|NCT00530348|615982350|FG000|Overall Study|Lost to Follow-up|0|||
170448964|NCT00530348|615982351|FG001|Overall Study|Lost to Follow-up|2|||
170448965|NCT00530348|615982350|FG000|Overall Study|Physician Decision|1|||
170448966|NCT00530348|615982351|FG001|Overall Study|Physician Decision|2|||
170448967|NCT00530348|615982350|FG000|Overall Study|Pregnancy|1|||
170448968|NCT00530348|615982351|FG001|Overall Study|Pregnancy|0|||
170540760|NCT04602000|616323747|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
170887142|NCT01790503|617595887|FG003|Overall Study|Withdrawal by Subject|1|||
170887143|NCT01790503|617595888|FG004|Overall Study|Withdrawal by Subject|1|||
170887144|NCT01790503|617595889|FG005|Overall Study|Withdrawal by Subject|2|||
170887145|NCT01790503|617595890|FG006|Overall Study|Withdrawal by Subject|1|||
170887146|NCT01790503|617595891|FG007|Overall Study|Withdrawal by Subject|0|||
170887147|NCT01790503|617595892|FG008|Overall Study|Withdrawal by Subject|0|||
170887148|NCT01790503|617595893|FG009|Overall Study|Withdrawal by Subject|0|||
170887149|NCT01790503|617595894|FG010|Overall Study|Withdrawal by Subject|1|||
170448969|NCT00530348|615982350|FG000|Overall Study|Withdrawal by Subject|12|||
170448970|NCT00530348|615982351|FG001|Overall Study|Withdrawal by Subject|12|||
170448971|NCT00530348|615982350|FG000|Overall Study|Randomised in error|1|||
170448972|NCT00530348|615982351|FG001|Overall Study|Randomised in error|0|||
170448973|NCT00530348|615982350|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
170887150|NCT01790503|617595884|FG000|Overall Study|Disease progression|2|||
170887151|NCT01790503|617595885|FG001|Overall Study|Disease progression|1|||
170448974|NCT00530348|615982351|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
170448975|NCT05307679|615982352|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
170448976|NCT05307679|615982353|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
170448977|NCT01740791|615982354|FG000|Overall Study|Randomized but never treated|5|||
170448978|NCT01740791|615982355|FG001|Overall Study|Randomized but never treated|3|||
170448979|NCT01740791|615982356|FG002|Overall Study|Randomized but never treated|2|||
170448980|NCT01740791|615982357|FG003|Overall Study|Randomized but never treated|2|||
170448981|NCT01740791|615982358|FG004|Overall Study|Randomized but never treated|1|||
170448982|NCT01740791|615982359|FG005|Overall Study|Randomized but never treated|3|||
170448983|NCT01740791|615982354|FG000|Overall Study|Lost to Follow-up|2|||
170448984|NCT01740791|615982355|FG001|Overall Study|Lost to Follow-up|0|||
170448985|NCT01740791|615982356|FG002|Overall Study|Lost to Follow-up|2|||
170448986|NCT01740791|615982357|FG003|Overall Study|Lost to Follow-up|3|||
170448987|NCT01740791|615982358|FG004|Overall Study|Lost to Follow-up|2|||
170448988|NCT01740791|615982359|FG005|Overall Study|Lost to Follow-up|3|||
170448989|NCT01740791|615982354|FG000|Overall Study|Withdrew Consent|4|||
170448990|NCT01740791|615982355|FG001|Overall Study|Withdrew Consent|0|||
170448991|NCT01740791|615982356|FG002|Overall Study|Withdrew Consent|1|||
170448992|NCT01740791|615982357|FG003|Overall Study|Withdrew Consent|2|||
170448993|NCT01740791|615982358|FG004|Overall Study|Withdrew Consent|0|||
170448994|NCT01740791|615982359|FG005|Overall Study|Withdrew Consent|3|||
170448995|NCT01740791|615982354|FG000|Overall Study|Investigator's discretion|1|||
170448996|NCT01740791|615982355|FG001|Overall Study|Investigator's discretion|0|||
170448997|NCT01740791|615982356|FG002|Overall Study|Investigator's discretion|1|||
170448998|NCT01740791|615982357|FG003|Overall Study|Investigator's discretion|0|||
170448999|NCT01740791|615982358|FG004|Overall Study|Investigator's discretion|0|||
170449000|NCT01740791|615982359|FG005|Overall Study|Investigator's discretion|1|||
170449001|NCT01740791|615982354|FG000|Overall Study|Adverse Event|0|||
170449002|NCT01740791|615982355|FG001|Overall Study|Adverse Event|0|||
170449003|NCT01740791|615982356|FG002|Overall Study|Adverse Event|0|||
170449004|NCT01740791|615982357|FG003|Overall Study|Adverse Event|0|||
170449005|NCT01740791|615982358|FG004|Overall Study|Adverse Event|0|||
170449006|NCT01740791|615982359|FG005|Overall Study|Adverse Event|1|||
170449007|NCT00983476|615982360|FG000|Overall Study|Did not receive intervention|17|||
170449008|NCT00983476|615982361|FG001|Overall Study|Did not receive intervention|22|||
170449009|NCT00983476|615982362|FG002|Overall Study|Did not receive intervention|0|||
170449010|NCT02674386|615982363|FG000|Overall Study|Lost to Follow-up|0|||
170449011|NCT02674386|615982364|FG001|Overall Study|Lost to Follow-up|1|||
170449012|NCT02674386|615982365|FG002|Overall Study|Lost to Follow-up|1|||
170449013|NCT02674386|615982363|FG000|Overall Study|Withdrawal by Subject|0|||
170449014|NCT02674386|615982364|FG001|Overall Study|Withdrawal by Subject|4|||
170449015|NCT02674386|615982365|FG002|Overall Study|Withdrawal by Subject|0|||
170449016|NCT02674386|615982363|FG000|Overall Study|Other|0|||
170449017|NCT02674386|615982364|FG001|Overall Study|Other|1|||
170449018|NCT02674386|615982365|FG002|Overall Study|Other|0|||
170449019|NCT02674386|615982363|FG000|Overall Study|Enrolled but not evaluated|0|||
170449020|NCT02674386|615982364|FG001|Overall Study|Enrolled but not evaluated|4|||
170449021|NCT02674386|615982365|FG002|Overall Study|Enrolled but not evaluated|0|||
170449022|NCT02462486|615982366|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
170449023|NCT02462486|615982367|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
170449024|NCT02462486|615982368|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
170449025|NCT02462486|615982366|FG000|Overall Study|Adverse Event|53|||
170449026|NCT02462486|615982367|FG001|Overall Study|Adverse Event|48|||
170449027|NCT02462486|615982368|FG002|Overall Study|Adverse Event|21|||
170449028|NCT02462486|615982366|FG000|Overall Study|Lack of Efficacy|6|||
170449029|NCT02462486|615982367|FG001|Overall Study|Lack of Efficacy|12|||
170449030|NCT02462486|615982368|FG002|Overall Study|Lack of Efficacy|3|||
170449031|NCT02462486|615982366|FG000|Overall Study|Lost to Follow-up|3|||
170449032|NCT02462486|615982367|FG001|Overall Study|Lost to Follow-up|4|||
170449033|NCT02462486|615982368|FG002|Overall Study|Lost to Follow-up|2|||
170449034|NCT02462486|615982366|FG000|Overall Study|Withdrawal by Subject|25|||
170449035|NCT02462486|615982367|FG001|Overall Study|Withdrawal by Subject|22|||
170449036|NCT02462486|615982368|FG002|Overall Study|Withdrawal by Subject|19|||
170449037|NCT02462486|615982366|FG000|Overall Study|Protocol Violation|3|||
170449038|NCT02462486|615982367|FG001|Overall Study|Protocol Violation|1|||
170449039|NCT02462486|615982368|FG002|Overall Study|Protocol Violation|1|||
170449040|NCT02462486|615982366|FG000|Overall Study|Reason not Specified|3|||
170449041|NCT02462486|615982367|FG001|Overall Study|Reason not Specified|4|||
170449042|NCT02462486|615982368|FG002|Overall Study|Reason not Specified|3|||
170449043|NCT01731886|615982370|FG000|Overall Study|Death|1|||
170449044|NCT01731886|615982371|FG001|Overall Study|Death|0|||
170449045|NCT01731886|615982370|FG000|Overall Study|Never started treatment|0|||
170449046|NCT01731886|615982371|FG001|Overall Study|Never started treatment|1|||
170449047|NCT01731886|615982370|FG000|Overall Study|Non-compliant|1|||
170449048|NCT01731886|615982371|FG001|Overall Study|Non-compliant|0|||
170449049|NCT00271024|615982372|FG000|Overall Study|Lost Interest|3|||
170449050|NCT00271024|615982373|FG001|Overall Study|Lost Interest|4|||
170449051|NCT00271024|615982374|FG002|Overall Study|Lost Interest|2|||
170449052|NCT00271024|615982375|FG003|Overall Study|Lost Interest|3|||
170449053|NCT00271024|615982372|FG000|Overall Study|Unknown/Unspecified|11|||
170449054|NCT00271024|615982373|FG001|Overall Study|Unknown/Unspecified|11|||
170449055|NCT00271024|615982374|FG002|Overall Study|Unknown/Unspecified|8|||
170449056|NCT00271024|615982375|FG003|Overall Study|Unknown/Unspecified|4|||
170449057|NCT00271024|615982372|FG000|Overall Study|Protocol Violation|1|||
170449058|NCT00271024|615982373|FG001|Overall Study|Protocol Violation|6|||
170449059|NCT00271024|615982374|FG002|Overall Study|Protocol Violation|5|||
170449060|NCT00271024|615982375|FG003|Overall Study|Protocol Violation|11|||
170449061|NCT00271024|615982372|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
170449062|NCT00271024|615982373|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
170449063|NCT00271024|615982374|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
170449064|NCT00271024|615982375|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
170449065|NCT00271024|615982372|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
170449066|NCT00271024|615982373|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
170449067|NCT00271024|615982374|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
170449068|NCT00271024|615982375|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
170449069|NCT02280187|615982376|FG000|Overall Study|Lost to Follow-up|218|||
170449070|NCT02412722|615982381|FG000|Overall Study|Adverse Event|0|||
170449071|NCT02412722|615982382|FG001|Overall Study|Adverse Event|2|||
170449072|NCT02412722|615982383|FG002|Overall Study|Adverse Event|0|||
170449073|NCT02412722|615982384|FG003|Overall Study|Adverse Event|3|||
170449074|NCT02412722|615982385|FG004|Overall Study|Adverse Event|0|||
170449075|NCT02412722|615982386|FG005|Overall Study|Adverse Event|3|||
170449076|NCT02412722|615982381|FG000|Overall Study|Progressive Disease|6|||
170449077|NCT02412722|615982382|FG001|Overall Study|Progressive Disease|4|||
170449078|NCT02412722|615982383|FG002|Overall Study|Progressive Disease|4|||
170449079|NCT02412722|615982384|FG003|Overall Study|Progressive Disease|9|||
170449080|NCT02412722|615982385|FG004|Overall Study|Progressive Disease|3|||
170449081|NCT02412722|615982386|FG005|Overall Study|Progressive Disease|3|||
170449082|NCT02412722|615982381|FG000|Overall Study|Withdrawal by Subject|2|||
170449083|NCT02412722|615982382|FG001|Overall Study|Withdrawal by Subject|0|||
170449084|NCT02412722|615982383|FG002|Overall Study|Withdrawal by Subject|1|||
170449085|NCT02412722|615982384|FG003|Overall Study|Withdrawal by Subject|2|||
170449086|NCT02412722|615982385|FG004|Overall Study|Withdrawal by Subject|1|||
170449087|NCT02412722|615982386|FG005|Overall Study|Withdrawal by Subject|1|||
170449088|NCT02412722|615982381|FG000|Overall Study|Lost to Follow-up|0|||
170449089|NCT02412722|615982382|FG001|Overall Study|Lost to Follow-up|0|||
170449090|NCT02412722|615982383|FG002|Overall Study|Lost to Follow-up|0|||
170449091|NCT02412722|615982384|FG003|Overall Study|Lost to Follow-up|0|||
170449092|NCT02412722|615982385|FG004|Overall Study|Lost to Follow-up|1|||
170449093|NCT02412722|615982386|FG005|Overall Study|Lost to Follow-up|0|||
170449094|NCT02412722|615982381|FG000|Overall Study|Received drug in run-in and discontinued|0|||
170449095|NCT02412722|615982382|FG001|Overall Study|Received drug in run-in and discontinued|2|||
170449096|NCT02412722|615982383|FG002|Overall Study|Received drug in run-in and discontinued|0|||
170449097|NCT02412722|615982384|FG003|Overall Study|Received drug in run-in and discontinued|0|||
170449098|NCT02412722|615982385|FG004|Overall Study|Received drug in run-in and discontinued|0|||
170449099|NCT02412722|615982386|FG005|Overall Study|Received drug in run-in and discontinued|0|||
170449100|NCT02412722|615982381|FG000|Overall Study|Reason not Specified|3|||
170449101|NCT02412722|615982382|FG001|Overall Study|Reason not Specified|0|||
170540761|NCT04602000|616323748|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
170540762|NCT04602000|616323749|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
170540763|NCT04602000|616323750|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
170540764|NCT05607043|616323751|FG000|Overall Study|Lost to Follow-up|2|||
170540765|NCT01257542|616323758|FG000|Overall Study|Protocol Violation|3|||
170540766|NCT01257542|616323759|FG001|Overall Study|Protocol Violation|5|||
170540767|NCT01257542|616323758|FG000|Overall Study|Withdrawal by Subject|0|||
170786626|NCT04924660|617227359|FG003|United States|Withdrawal by Subject|3|||
170786627|NCT04924660|617227360|FG004|United States|Withdrawal by Subject|8|||
170786628|NCT04924660|617227361|FG005|United States|Withdrawal by Subject|4|||
170786629|NCT04924660|617227356|FG000|Spain|Death|0|||
170786630|NCT04924660|617227357|FG001|Spain|Death|0|||
170786631|NCT04924660|617227358|FG002|Spain|Death|0|||
170786632|NCT04924660|617227359|FG003|Spain|Death|0|||
170786633|NCT04924660|617227360|FG004|Spain|Death|0|||
170786634|NCT04924660|617227361|FG005|Spain|Death|2|||
170786635|NCT04924660|617227356|FG000|Spain|Lost to Follow-up|0|||
170786636|NCT04924660|617227357|FG001|Spain|Lost to Follow-up|0|||
170786637|NCT04924660|617227358|FG002|Spain|Lost to Follow-up|0|||
170786638|NCT04924660|617227359|FG003|Spain|Lost to Follow-up|0|||
170449102|NCT02412722|615982383|FG002|Overall Study|Reason not Specified|2|||
170449103|NCT02412722|615982384|FG003|Overall Study|Reason not Specified|1|||
170449104|NCT02412722|615982385|FG004|Overall Study|Reason not Specified|2|||
170449105|NCT02412722|615982386|FG005|Overall Study|Reason not Specified|6|||
170449106|NCT04449341|615982387|FG000|Overall Study|Protocol Violation|1|||
170449107|NCT04449341|615982388|FG001|Overall Study|Protocol Violation|0|||
170540768|NCT01257542|616323759|FG001|Overall Study|Withdrawal by Subject|2|||
170540769|NCT00081458|616323761|FG000|Overall Study|Adverse Event|1|||
170540770|NCT00081458|616323762|FG001|Overall Study|Adverse Event|5|||
170540771|NCT00081458|616323763|FG002|Overall Study|Adverse Event|2|||
170786639|NCT04924660|617227360|FG004|Spain|Lost to Follow-up|1|||
170786640|NCT04924660|617227361|FG005|Spain|Lost to Follow-up|0|||
170449108|NCT04499482|615982389|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
170449109|NCT02363439|615982390|FG000|Overall Study|Lack of Efficacy|4|||
170449110|NCT02010255|615982391|FG000|Overall Study|Death|0|||
170449111|NCT02010255|615982392|FG001|Overall Study|Death|1|||
170449112|NCT02010255|615982393|FG002|Overall Study|Death|4|||
170449113|NCT02010255|615982394|FG003|Overall Study|Death|4|||
170449114|NCT02010255|615982395|FG004|Overall Study|Death|2|||
170449115|NCT02010255|615982396|FG005|Overall Study|Death|0|||
170449116|NCT02010255|615982397|FG006|Overall Study|Death|1|||
170449117|NCT02010255|615982398|FG007|Overall Study|Death|1|||
170449118|NCT02010255|615982399|FG008|Overall Study|Death|1|||
170449119|NCT02010255|615982400|FG009|Overall Study|Death|0|||
170449120|NCT02010255|615982401|FG010|Overall Study|Death|1|||
170449121|NCT02010255|615982402|FG011|Overall Study|Death|1|||
170449122|NCT02010255|615982403|FG012|Overall Study|Death|0|||
170449123|NCT02010255|615982404|FG013|Overall Study|Death|0|||
170449124|NCT02010255|615982391|FG000|Overall Study|Lack of Efficacy|4|||
170449125|NCT02010255|615982392|FG001|Overall Study|Lack of Efficacy|1|||
170449126|NCT02010255|615982393|FG002|Overall Study|Lack of Efficacy|2|||
170449127|NCT02010255|615982394|FG003|Overall Study|Lack of Efficacy|1|||
170449128|NCT02010255|615982395|FG004|Overall Study|Lack of Efficacy|1|||
170449129|NCT02010255|615982396|FG005|Overall Study|Lack of Efficacy|0|||
170449130|NCT02010255|615982397|FG006|Overall Study|Lack of Efficacy|0|||
170449131|NCT02010255|615982398|FG007|Overall Study|Lack of Efficacy|0|||
170449132|NCT02010255|615982399|FG008|Overall Study|Lack of Efficacy|0|||
170449133|NCT02010255|615982400|FG009|Overall Study|Lack of Efficacy|0|||
170449134|NCT02010255|615982401|FG010|Overall Study|Lack of Efficacy|1|||
170449135|NCT02010255|615982402|FG011|Overall Study|Lack of Efficacy|0|||
170449136|NCT02010255|615982403|FG012|Overall Study|Lack of Efficacy|0|||
170449137|NCT02010255|615982404|FG013|Overall Study|Lack of Efficacy|0|||
170449138|NCT02010255|615982391|FG000|Overall Study|Withdrew Consent|1|||
170449139|NCT02010255|615982392|FG001|Overall Study|Withdrew Consent|0|||
170449140|NCT02010255|615982393|FG002|Overall Study|Withdrew Consent|0|||
170449141|NCT02010255|615982394|FG003|Overall Study|Withdrew Consent|1|||
170540772|NCT00081458|616323761|FG000|Overall Study|Withdrawal by Subject|0|||
170540773|NCT00081458|616323762|FG001|Overall Study|Withdrawal by Subject|3|||
170540774|NCT00081458|616323763|FG002|Overall Study|Withdrawal by Subject|1|||
170540775|NCT00081458|616323761|FG000|Overall Study|Randomized but not dosed|0|||
170540776|NCT00081458|616323762|FG001|Overall Study|Randomized but not dosed|0|||
170540777|NCT00081458|616323763|FG002|Overall Study|Randomized but not dosed|1|||
170540778|NCT03097315|616323765|FG000|Overall Study|Withdrawal by Subject|1|||
170540779|NCT00367458|616323766|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
170540780|NCT00367458|616323767|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
170540781|NCT01716156|616323770|FG000|Overall Study|Protocol Violation|1|||
170540782|NCT01716156|616323771|FG001|Overall Study|Protocol Violation|0|||
170540783|NCT01716156|616323772|FG002|Overall Study|Protocol Violation|0|||
170540784|NCT01716156|616323770|FG000|Overall Study|Withdrawal by Subject|0|||
170540785|NCT01716156|616323771|FG001|Overall Study|Withdrawal by Subject|1|||
170540786|NCT01716156|616323772|FG002|Overall Study|Withdrawal by Subject|2|||
170540787|NCT01716156|616323770|FG000|Overall Study|Lost to Follow-up|1|||
170540788|NCT01716156|616323771|FG001|Overall Study|Lost to Follow-up|0|||
170540789|NCT01716156|616323772|FG002|Overall Study|Lost to Follow-up|0|||
170540790|NCT03925220|616323775|FG000|Overall Study|Withdrawal by Subject|4|||
170540791|NCT03925220|616323776|FG001|Overall Study|Withdrawal by Subject|4|||
170540792|NCT03925220|616323777|FG002|Overall Study|Withdrawal by Subject|4|||
170540793|NCT03925220|616323778|FG003|Overall Study|Withdrawal by Subject|4|||
170540794|NCT03925220|616323775|FG000|Overall Study|Lost to Follow-up|40|||
170887152|NCT01790503|617595886|FG002|Overall Study|Disease progression|0|||
170887153|NCT01790503|617595887|FG003|Overall Study|Disease progression|1|||
170540795|NCT03925220|616323776|FG001|Overall Study|Lost to Follow-up|46|||
170540796|NCT03925220|616323777|FG002|Overall Study|Lost to Follow-up|37|||
170540797|NCT03925220|616323778|FG003|Overall Study|Lost to Follow-up|38|||
170540798|NCT05774977|616323779|FG000|Overall Study|Withdrawal by Subject|2|||
170540799|NCT00374868|616323780|FG000|Overall Study|Adverse Event|12|||
170540800|NCT00374868|616323780|FG000|Overall Study|Progressive Disease|7|||
170540801|NCT00374868|616323780|FG000|Overall Study|Physician Decision|13|||
170540802|NCT00374868|616323780|FG000|Overall Study|Lost to Follow-up|1|||
170540803|NCT00374868|616323780|FG000|Overall Study|Death|2|||
170540804|NCT00374868|616323780|FG000|Overall Study|Other - Not Specified|1|||
170449142|NCT02010255|615982395|FG004|Overall Study|Withdrew Consent|0|||
170449143|NCT02010255|615982396|FG005|Overall Study|Withdrew Consent|0|||
170449144|NCT02010255|615982397|FG006|Overall Study|Withdrew Consent|0|||
170449145|NCT02010255|615982398|FG007|Overall Study|Withdrew Consent|0|||
170540805|NCT04470427|616323781|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
170634028|NCT01208207|616670174|FG002|Part I|Withdrawal by Subject|4|||
170449146|NCT02010255|615982399|FG008|Overall Study|Withdrew Consent|0|||
170449147|NCT02010255|615982400|FG009|Overall Study|Withdrew Consent|0|||
170540806|NCT04470427|616323782|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
170634029|NCT01208207|616670175|FG003|Part I|Withdrawal by Subject|0|||
170634030|NCT01208207|616670176|FG004|Part I|Withdrawal by Subject|0|||
170634031|NCT01208207|616670177|FG005|Part I|Withdrawal by Subject|0|||
170634032|NCT01208207|616670178|FG006|Part I|Withdrawal by Subject|0|||
170634033|NCT01208207|616670172|FG000|Part II|Withdrawal by Subject|0|||
170634034|NCT01208207|616670173|FG001|Part II|Withdrawal by Subject|0|||
170634035|NCT01208207|616670174|FG002|Part II|Withdrawal by Subject|0|||
170634036|NCT01208207|616670175|FG003|Part II|Withdrawal by Subject|10|||
170634037|NCT01208207|616670176|FG004|Part II|Withdrawal by Subject|9|||
170634038|NCT01208207|616670177|FG005|Part II|Withdrawal by Subject|3|||
170634039|NCT01208207|616670178|FG006|Part II|Withdrawal by Subject|5|||
170634040|NCT01208207|616670172|FG000|Part II|Adverse Event|0|||
170634041|NCT01208207|616670173|FG001|Part II|Adverse Event|0|||
170634042|NCT01208207|616670174|FG002|Part II|Adverse Event|0|||
170634043|NCT01208207|616670175|FG003|Part II|Adverse Event|5|||
170634044|NCT01208207|616670176|FG004|Part II|Adverse Event|9|||
170634045|NCT01208207|616670177|FG005|Part II|Adverse Event|4|||
170634046|NCT01208207|616670178|FG006|Part II|Adverse Event|2|||
170634047|NCT01208207|616670172|FG000|Part II|Lack of Efficacy|0|||
170634048|NCT01208207|616670173|FG001|Part II|Lack of Efficacy|0|||
170634049|NCT01208207|616670174|FG002|Part II|Lack of Efficacy|0|||
170634050|NCT01208207|616670175|FG003|Part II|Lack of Efficacy|6|||
170634051|NCT01208207|616670176|FG004|Part II|Lack of Efficacy|4|||
170634052|NCT01208207|616670177|FG005|Part II|Lack of Efficacy|3|||
170634053|NCT01208207|616670178|FG006|Part II|Lack of Efficacy|3|||
170634054|NCT01208207|616670172|FG000|Part II|Lost to Follow-up|0|||
170634055|NCT01208207|616670173|FG001|Part II|Lost to Follow-up|0|||
170634056|NCT01208207|616670174|FG002|Part II|Lost to Follow-up|0|||
170634057|NCT01208207|616670175|FG003|Part II|Lost to Follow-up|4|||
170634058|NCT01208207|616670176|FG004|Part II|Lost to Follow-up|0|||
170634059|NCT01208207|616670177|FG005|Part II|Lost to Follow-up|2|||
170634060|NCT01208207|616670178|FG006|Part II|Lost to Follow-up|1|||
170634061|NCT01208207|616670172|FG000|Part II|Non-Compliance With Study Drug|0|||
170634062|NCT01208207|616670173|FG001|Part II|Non-Compliance With Study Drug|0|||
170634063|NCT01208207|616670174|FG002|Part II|Non-Compliance With Study Drug|0|||
170634064|NCT01208207|616670175|FG003|Part II|Non-Compliance With Study Drug|4|||
170634065|NCT01208207|616670176|FG004|Part II|Non-Compliance With Study Drug|1|||
170634066|NCT01208207|616670177|FG005|Part II|Non-Compliance With Study Drug|1|||
170634067|NCT01208207|616670178|FG006|Part II|Non-Compliance With Study Drug|0|||
170634068|NCT01208207|616670172|FG000|Part II|Physician Decision|0|||
170634069|NCT01208207|616670173|FG001|Part II|Physician Decision|0|||
170634070|NCT01208207|616670174|FG002|Part II|Physician Decision|0|||
170634071|NCT01208207|616670175|FG003|Part II|Physician Decision|1|||
170634072|NCT01208207|616670176|FG004|Part II|Physician Decision|0|||
170634073|NCT01208207|616670177|FG005|Part II|Physician Decision|2|||
170634074|NCT01208207|616670178|FG006|Part II|Physician Decision|0|||
170634075|NCT01208207|616670172|FG000|Part II|Protocol Violation|0|||
170634076|NCT01208207|616670173|FG001|Part II|Protocol Violation|0|||
170634077|NCT01208207|616670174|FG002|Part II|Protocol Violation|0|||
170634078|NCT01208207|616670175|FG003|Part II|Protocol Violation|1|||
170634079|NCT01208207|616670176|FG004|Part II|Protocol Violation|0|||
170634080|NCT01208207|616670177|FG005|Part II|Protocol Violation|0|||
170634081|NCT01208207|616670178|FG006|Part II|Protocol Violation|0|||
170634082|NCT01208207|616670172|FG000|Part II|Technical Problems|0|||
170634083|NCT01208207|616670173|FG001|Part II|Technical Problems|0|||
170634084|NCT01208207|616670174|FG002|Part II|Technical Problems|0|||
170634085|NCT01208207|616670175|FG003|Part II|Technical Problems|1|||
170634086|NCT01208207|616670176|FG004|Part II|Technical Problems|0|||
170634087|NCT01208207|616670177|FG005|Part II|Technical Problems|1|||
170634088|NCT01208207|616670178|FG006|Part II|Technical Problems|0|||
170634089|NCT03096288|616670181|FG000|Overall Study|Withdrawal by Subject|0|||
170634090|NCT03096288|616670182|FG001|Overall Study|Withdrawal by Subject|1|||
170634091|NCT03096288|616670183|FG002|Overall Study|Withdrawal by Subject|0|||
170634092|NCT03096288|616670184|FG003|Overall Study|Withdrawal by Subject|1|||
170634093|NCT02161016|616670190|FG000|Overall Study|withdrawn by IRB|1|||
170634094|NCT00658359|616670194|FG000|Overall Study|Death|3|||
170634095|NCT00658359|616670195|FG001|Overall Study|Death|1|||
170634096|NCT00658359|616670196|FG002|Overall Study|Death|2|||
170634097|NCT00658359|616670194|FG000|Overall Study|Adverse Event|13|||
170634098|NCT00658359|616670195|FG001|Overall Study|Adverse Event|6|||
170634099|NCT00658359|616670196|FG002|Overall Study|Adverse Event|9|||
170634100|NCT00658359|616670194|FG000|Overall Study|Protocol Violation|1|||
170634101|NCT00658359|616670195|FG001|Overall Study|Protocol Violation|0|||
170634102|NCT00658359|616670196|FG002|Overall Study|Protocol Violation|0|||
170634103|NCT00658359|616670194|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
170634104|NCT00658359|616670195|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
170634105|NCT00658359|616670196|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
170634106|NCT00658359|616670194|FG000|Overall Study|Withdrawal by Subject|7|||
170634107|NCT00658359|616670195|FG001|Overall Study|Withdrawal by Subject|4|||
170634108|NCT00658359|616670196|FG002|Overall Study|Withdrawal by Subject|2|||
170634109|NCT00658359|616670194|FG000|Overall Study|Lost to Follow-up|2|||
170634110|NCT00658359|616670195|FG001|Overall Study|Lost to Follow-up|2|||
170449148|NCT02010255|615982401|FG010|Overall Study|Withdrew Consent|0|||
170449149|NCT02010255|615982402|FG011|Overall Study|Withdrew Consent|0|||
170449150|NCT02010255|615982403|FG012|Overall Study|Withdrew Consent|0|||
170449151|NCT02010255|615982404|FG013|Overall Study|Withdrew Consent|0|||
170449152|NCT02010255|615982391|FG000|Overall Study|Adverse Event|1|||
170449153|NCT02010255|615982392|FG001|Overall Study|Adverse Event|0|||
170449154|NCT02010255|615982393|FG002|Overall Study|Adverse Event|0|||
170449155|NCT02010255|615982394|FG003|Overall Study|Adverse Event|0|||
170449156|NCT02010255|615982395|FG004|Overall Study|Adverse Event|0|||
170449157|NCT02010255|615982396|FG005|Overall Study|Adverse Event|0|||
170540807|NCT04470427|616323783|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
170540808|NCT04470427|616323784|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
170540809|NCT04470427|616323785|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
170540810|NCT04470427|616323786|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
170540811|NCT04470427|616323781|FG000|Part B :Open-label|Other than specified|0|||
170540812|NCT04470427|616323782|FG001|Part B :Open-label|Other than specified|0|||
170540813|NCT04470427|616323783|FG002|Part B :Open-label|Other than specified|788|||
170540814|NCT04470427|616323784|FG003|Part B :Open-label|Other than specified|0|||
170540815|NCT04470427|616323785|FG004|Part B :Open-label|Other than specified|523|||
170540816|NCT04470427|616323786|FG005|Part B :Open-label|Other than specified|0|||
170540817|NCT04470427|616323781|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
170540818|NCT04470427|616323782|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
170540819|NCT04470427|616323783|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
170540820|NCT04470427|616323784|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
170540821|NCT04470427|616323785|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
170540822|NCT04470427|616323786|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
170540823|NCT04470427|616323781|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
170540824|NCT04470427|616323782|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
170540825|NCT04470427|616323783|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
170540826|NCT04470427|616323784|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
170540827|NCT04470427|616323785|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
170540828|NCT04470427|616323786|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
170540829|NCT01018979|616323787|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
170540830|NCT01018979|616323788|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
170540831|NCT01018979|616323787|FG000|Overall Study|Not received at least one dose|0|||
170540832|NCT01018979|616323788|FG001|Overall Study|Not received at least one dose|1|||
170540833|NCT02965456|616323789|FG000|Overall Study|Lost to Follow-up|40|||
170540834|NCT02965456|616323790|FG001|Overall Study|Lost to Follow-up|18|||
170540835|NCT02965456|616323789|FG000|Overall Study|Subject Request|22|||
170540836|NCT02965456|616323790|FG001|Overall Study|Subject Request|13|||
170540837|NCT02965456|616323789|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
170540838|NCT02965456|616323790|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
170540839|NCT02965456|616323789|FG000|Overall Study|Adverse Event|3|||
170540840|NCT02965456|616323790|FG001|Overall Study|Adverse Event|0|||
170540841|NCT02965456|616323789|FG000|Overall Study|Noncompliance with Study Drug|1|||
170540842|NCT02965456|616323790|FG001|Overall Study|Noncompliance with Study Drug|1|||
170540843|NCT02965456|616323789|FG000|Overall Study|Worsening Condition|0|||
170634111|NCT00658359|616670196|FG002|Overall Study|Lost to Follow-up|4|||
170634112|NCT00658359|616670194|FG000|Overall Study|Lack of Efficacy|0|||
170634113|NCT00658359|616670195|FG001|Overall Study|Lack of Efficacy|1|||
170786641|NCT04924660|617227356|FG000|Brazil|Death|0|||
170786642|NCT04924660|617227357|FG001|Brazil|Death|0|||
170786643|NCT04924660|617227358|FG002|Brazil|Death|0|||
170786644|NCT04924660|617227359|FG003|Brazil|Death|0|||
170786645|NCT04924660|617227360|FG004|Brazil|Death|1|||
170786646|NCT04924660|617227361|FG005|Brazil|Death|0|||
170786647|NCT04924660|617227356|FG000|Italy|Lost to Follow-up|0|||
170786648|NCT04924660|617227357|FG001|Italy|Lost to Follow-up|0|||
170786649|NCT04924660|617227358|FG002|Italy|Lost to Follow-up|0|||
170786650|NCT04924660|617227359|FG003|Italy|Lost to Follow-up|0|||
170786651|NCT04924660|617227360|FG004|Italy|Lost to Follow-up|0|||
170786652|NCT04924660|617227361|FG005|Italy|Lost to Follow-up|1|||
170786653|NCT04924660|617227356|FG000|South Africa|Death|0|||
170786654|NCT04924660|617227357|FG001|South Africa|Death|0|||
170786655|NCT04924660|617227358|FG002|South Africa|Death|0|||
170786656|NCT04924660|617227359|FG003|South Africa|Death|0|||
170786657|NCT04924660|617227360|FG004|South Africa|Death|0|||
170786658|NCT04924660|617227361|FG005|South Africa|Death|1|||
170786659|NCT04924660|617227356|FG000|South Africa|Lost to Follow-up|0|||
170786660|NCT04924660|617227357|FG001|South Africa|Lost to Follow-up|0|||
170786661|NCT04924660|617227358|FG002|South Africa|Lost to Follow-up|0|||
170786662|NCT04924660|617227359|FG003|South Africa|Lost to Follow-up|0|||
170449158|NCT02010255|615982397|FG006|Overall Study|Adverse Event|0|||
170449159|NCT02010255|615982398|FG007|Overall Study|Adverse Event|0|||
170449160|NCT02010255|615982399|FG008|Overall Study|Adverse Event|0|||
170786663|NCT04924660|617227360|FG004|South Africa|Lost to Follow-up|0|||
170786664|NCT04924660|617227361|FG005|South Africa|Lost to Follow-up|1|||
170449161|NCT02010255|615982400|FG009|Overall Study|Adverse Event|0|||
170449162|NCT02010255|615982401|FG010|Overall Study|Adverse Event|0|||
170449163|NCT02010255|615982402|FG011|Overall Study|Adverse Event|0|||
170449164|NCT02010255|615982403|FG012|Overall Study|Adverse Event|0|||
170449165|NCT02010255|615982404|FG013|Overall Study|Adverse Event|0|||
170449166|NCT02010255|615982391|FG000|Overall Study|Lost to Follow-up|0|||
170449167|NCT02010255|615982392|FG001|Overall Study|Lost to Follow-up|0|||
170449168|NCT02010255|615982393|FG002|Overall Study|Lost to Follow-up|1|||
170449169|NCT02010255|615982394|FG003|Overall Study|Lost to Follow-up|0|||
170449170|NCT02010255|615982395|FG004|Overall Study|Lost to Follow-up|1|||
170449171|NCT02010255|615982396|FG005|Overall Study|Lost to Follow-up|0|||
170449172|NCT02010255|615982397|FG006|Overall Study|Lost to Follow-up|0|||
170449173|NCT02010255|615982398|FG007|Overall Study|Lost to Follow-up|0|||
170449174|NCT02010255|615982399|FG008|Overall Study|Lost to Follow-up|0|||
170449175|NCT02010255|615982400|FG009|Overall Study|Lost to Follow-up|0|||
170449176|NCT02010255|615982401|FG010|Overall Study|Lost to Follow-up|0|||
170449177|NCT02010255|615982402|FG011|Overall Study|Lost to Follow-up|0|||
170449178|NCT02010255|615982403|FG012|Overall Study|Lost to Follow-up|0|||
170449179|NCT02010255|615982404|FG013|Overall Study|Lost to Follow-up|0|||
170449180|NCT02010255|615982391|FG000|Overall Study|Randomized but Not Treated|0|||
170449181|NCT02010255|615982392|FG001|Overall Study|Randomized but Not Treated|0|||
170449182|NCT02010255|615982393|FG002|Overall Study|Randomized but Not Treated|0|||
170449183|NCT02010255|615982394|FG003|Overall Study|Randomized but Not Treated|0|||
170449184|NCT02010255|615982395|FG004|Overall Study|Randomized but Not Treated|0|||
170449185|NCT02010255|615982396|FG005|Overall Study|Randomized but Not Treated|0|||
170449186|NCT02010255|615982397|FG006|Overall Study|Randomized but Not Treated|0|||
170449187|NCT02010255|615982398|FG007|Overall Study|Randomized but Not Treated|0|||
170449188|NCT02010255|615982399|FG008|Overall Study|Randomized but Not Treated|0|||
170449189|NCT02010255|615982400|FG009|Overall Study|Randomized but Not Treated|0|||
170449190|NCT02010255|615982401|FG010|Overall Study|Randomized but Not Treated|0|||
170449191|NCT02010255|615982402|FG011|Overall Study|Randomized but Not Treated|0|||
170449192|NCT02010255|615982403|FG012|Overall Study|Randomized but Not Treated|0|||
170449193|NCT02010255|615982404|FG013|Overall Study|Randomized but Not Treated|1|||
170449194|NCT02039063|615982405|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
170449195|NCT02039063|615982406|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
170449196|NCT02039063|615982407|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
170449197|NCT02039063|615982408|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
170449198|NCT02039063|615982405|FG000|Treatment Phase|Progression of disease|0|||
170449199|NCT02039063|615982406|FG001|Treatment Phase|Progression of disease|0|||
170449200|NCT02039063|615982407|FG002|Treatment Phase|Progression of disease|1|||
170449201|NCT02039063|615982408|FG003|Treatment Phase|Progression of disease|1|||
170449202|NCT02039063|615982405|FG000|Extension Phase|Inadequate therapeutic effect|0|||
170449203|NCT02039063|615982406|FG001|Extension Phase|Inadequate therapeutic effect|1|||
170449204|NCT02039063|615982407|FG002|Extension Phase|Inadequate therapeutic effect|2|||
170887154|NCT01790503|617595888|FG004|Overall Study|Disease progression|2|||
170887155|NCT01790503|617595889|FG005|Overall Study|Disease progression|1|||
170887156|NCT01790503|617595890|FG006|Overall Study|Disease progression|0|||
170887157|NCT01790503|617595891|FG007|Overall Study|Disease progression|1|||
170887158|NCT01790503|617595892|FG008|Overall Study|Disease progression|0|||
170887159|NCT01790503|617595893|FG009|Overall Study|Disease progression|17|||
170887160|NCT01790503|617595894|FG010|Overall Study|Disease progression|7|||
170887161|NCT01790503|617595884|FG000|Overall Study|Protocol Violation|0|||
170887162|NCT01790503|617595885|FG001|Overall Study|Protocol Violation|0|||
170887163|NCT01790503|617595886|FG002|Overall Study|Protocol Violation|0|||
170887164|NCT01790503|617595887|FG003|Overall Study|Protocol Violation|0|||
170887165|NCT01790503|617595888|FG004|Overall Study|Protocol Violation|0|||
170887166|NCT01790503|617595889|FG005|Overall Study|Protocol Violation|0|||
170887167|NCT01790503|617595890|FG006|Overall Study|Protocol Violation|0|||
170887168|NCT01790503|617595891|FG007|Overall Study|Protocol Violation|0|||
170887169|NCT01790503|617595892|FG008|Overall Study|Protocol Violation|0|||
170887170|NCT01790503|617595893|FG009|Overall Study|Protocol Violation|1|||
170887171|NCT01790503|617595894|FG010|Overall Study|Protocol Violation|0|||
170449205|NCT02039063|615982408|FG003|Extension Phase|Inadequate therapeutic effect|0|||
170449206|NCT02039063|615982405|FG000|Extension Phase|Progression of disease|0|||
170449207|NCT02039063|615982406|FG001|Extension Phase|Progression of disease|0|||
170449208|NCT02039063|615982407|FG002|Extension Phase|Progression of disease|0|||
170449209|NCT02039063|615982408|FG003|Extension Phase|Progression of disease|1|||
170449210|NCT02039063|615982405|FG000|Extension Phase|Adverse Event|0|||
170449211|NCT02039063|615982406|FG001|Extension Phase|Adverse Event|0|||
170449212|NCT02039063|615982407|FG002|Extension Phase|Adverse Event|1|||
170449213|NCT02039063|615982408|FG003|Extension Phase|Adverse Event|0|||
170449214|NCT00467831|615982412|FG000|Overall Study|Death|2|||
170540844|NCT02965456|616323790|FG001|Overall Study|Worsening Condition|2|||
170540845|NCT02965456|616323789|FG000|Overall Study|Lack of Efficacy|1|||
170887172|NCT01790503|617595884|FG000|Overall Study|Physician Decision|0|||
170887173|NCT01790503|617595885|FG001|Overall Study|Physician Decision|0|||
170887174|NCT01790503|617595886|FG002|Overall Study|Physician Decision|0|||
170887175|NCT01790503|617595887|FG003|Overall Study|Physician Decision|0|||
170887176|NCT01790503|617595888|FG004|Overall Study|Physician Decision|0|||
170449215|NCT00467831|615982412|FG000|Overall Study|Withdrawal by Subject|1|||
170449216|NCT01198873|615982413|FG000|Overall Study|Adverse Event|4|||
170449217|NCT01198873|615982414|FG001|Overall Study|Adverse Event|7|||
170449218|NCT01198873|615982413|FG000|Overall Study|Study closure|29|||
170449219|NCT01198873|615982414|FG001|Overall Study|Study closure|23|||
170449220|NCT01198873|615982413|FG000|Overall Study|Other than above|4|||
170449221|NCT01198873|615982414|FG001|Overall Study|Other than above|2|||
170449222|NCT03139240|615982415|FG000|Overall Study|Lost to Follow-up|0|||
170449223|NCT03139240|615982416|FG001|Overall Study|Lost to Follow-up|1|||
170449224|NCT03139240|615982417|FG002|Overall Study|Lost to Follow-up|1|||
170449225|NCT03139240|615982418|FG003|Overall Study|Lost to Follow-up|0|||
170449226|NCT00823199|615982419|FG000|Overall Study|Withdrawal by Subject|2|||
170449227|NCT02776553|615982420|FG000|Overall Study|Lost to Follow-up|1|||
170449228|NCT02776553|615982421|FG001|Overall Study|Lost to Follow-up|0|||
170449229|NCT02776553|615982420|FG000|Overall Study|got liver transplant|1|||
170449230|NCT02776553|615982421|FG001|Overall Study|got liver transplant|2|||
170449231|NCT02776553|615982420|FG000|Overall Study|had other surgery|1|||
170449232|NCT02776553|615982421|FG001|Overall Study|had other surgery|0|||
170449233|NCT02776553|615982420|FG000|Overall Study|Protocol Violation|0|||
170449234|NCT02776553|615982421|FG001|Overall Study|Protocol Violation|1|||
170449235|NCT00171340|615982422|FG000|Overall Study|Adverse Event|46|||
170449236|NCT00171340|615982423|FG001|Overall Study|Adverse Event|42|||
170449237|NCT00171340|615982422|FG000|Overall Study|Lack of Efficacy|29|||
170449238|NCT00171340|615982423|FG001|Overall Study|Lack of Efficacy|41|||
170449239|NCT00171340|615982422|FG000|Overall Study|Protocol Violation|7|||
170449240|NCT00171340|615982423|FG001|Overall Study|Protocol Violation|8|||
170449241|NCT00171340|615982422|FG000|Overall Study|Withdrawal by Subject|22|||
170449242|NCT00171340|615982423|FG001|Overall Study|Withdrawal by Subject|19|||
170449243|NCT00171340|615982422|FG000|Overall Study|Lost to Follow-up|0|||
170449244|NCT00171340|615982423|FG001|Overall Study|Lost to Follow-up|5|||
170449245|NCT00171340|615982422|FG000|Overall Study|Abnormal Laboratory Results|2|||
170449246|NCT00171340|615982423|FG001|Overall Study|Abnormal Laboratory Results|0|||
170449247|NCT00171340|615982422|FG000|Overall Study|Abnormal Test Procedure Results|6|||
170449248|NCT00171340|615982423|FG001|Overall Study|Abnormal Test Procedure Results|11|||
170449249|NCT00171340|615982422|FG000|Overall Study|No Longer Required Study Drug|1|||
170449250|NCT00171340|615982423|FG001|Overall Study|No Longer Required Study Drug|1|||
170449251|NCT00171340|615982422|FG000|Overall Study|Administrative Problems|5|||
170449252|NCT00171340|615982423|FG001|Overall Study|Administrative Problems|2|||
170449253|NCT00171340|615982422|FG000|Overall Study|Death|6|||
170449254|NCT00171340|615982423|FG001|Overall Study|Death|6|||
170449255|NCT03827018|615982426|FG000|Overall Study|Adverse Event|1|||
170449256|NCT03827018|615982427|FG001|Overall Study|Adverse Event|0|||
170449257|NCT03827018|615982426|FG000|Overall Study|Withdrawal by Subject|2|||
170449258|NCT03827018|615982427|FG001|Overall Study|Withdrawal by Subject|2|||
170449259|NCT03827018|615982426|FG000|Overall Study|Lack of Efficacy|0|||
170449260|NCT03827018|615982427|FG001|Overall Study|Lack of Efficacy|1|||
170449261|NCT01640184|615982438|FG000|Overall Study|Death|1|||
170449262|NCT01640184|615982439|FG001|Overall Study|Death|0|||
170449263|NCT01640184|615982440|FG002|Overall Study|Death|0|||
170449264|NCT01640184|615982438|FG000|Overall Study|Lost to Follow-up|4|||
170449265|NCT01640184|615982439|FG001|Overall Study|Lost to Follow-up|1|||
170449266|NCT01640184|615982440|FG002|Overall Study|Lost to Follow-up|0|||
170449267|NCT01640184|615982438|FG000|Overall Study|Physician Decision|3|||
170449268|NCT01640184|615982439|FG001|Overall Study|Physician Decision|0|||
170786665|NCT03867500|617227362|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
170449269|NCT01640184|615982440|FG002|Overall Study|Physician Decision|0|||
170449270|NCT01640184|615982438|FG000|Overall Study|Withdrawal by Subject|0|||
170449271|NCT01640184|615982439|FG001|Overall Study|Withdrawal by Subject|1|||
170449272|NCT01640184|615982440|FG002|Overall Study|Withdrawal by Subject|1|||
170449273|NCT01640184|615982438|FG000|Overall Study|Protocol Violation|0|||
170449274|NCT01640184|615982439|FG001|Overall Study|Protocol Violation|0|||
170449275|NCT01640184|615982440|FG002|Overall Study|Protocol Violation|1|||
170449276|NCT00775528|615982443|FG000|Overall Study|Protocol Violation|1|||
170449277|NCT02492841|615982444|FG000|Overall Study|Lost to Follow-up|34|||
170449278|NCT02492841|615982445|FG001|Overall Study|Lost to Follow-up|31|||
170449279|NCT02492841|615982446|FG002|Overall Study|Lost to Follow-up|35|||
170449280|NCT02148445|615982447|FG000|Overall Study|Death|1|||
170449281|NCT02148445|615982448|FG001|Overall Study|Death|3|||
170449282|NCT03450629|615982449|FG000|Overall Study|Adverse Event|15|||
170449283|NCT03450629|615982450|FG001|Overall Study|Adverse Event|14|||
170449284|NCT03450629|615982449|FG000|Overall Study|Physician Decision|2|||
170449285|NCT03450629|615982450|FG001|Overall Study|Physician Decision|2|||
170449286|NCT03450629|615982449|FG000|Overall Study|Lack of Efficacy|2|||
170449287|NCT03450629|615982450|FG001|Overall Study|Lack of Efficacy|0|||
170449288|NCT03450629|615982449|FG000|Overall Study|Lost to Follow-up|4|||
170786666|NCT03557697|617227363|FG000|Overall Study|Withdrawal by Subject|2|||
170449289|NCT03450629|615982450|FG001|Overall Study|Lost to Follow-up|2|||
170449290|NCT03450629|615982449|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
170540846|NCT02965456|616323790|FG001|Overall Study|Lack of Efficacy|0|||
170540847|NCT02965456|616323789|FG000|Overall Study|Physician Decision|0|||
170540848|NCT02965456|616323790|FG001|Overall Study|Physician Decision|1|||
170540849|NCT02965456|616323789|FG000|Overall Study|Pregnancy|1|||
170540850|NCT02965456|616323790|FG001|Overall Study|Pregnancy|0|||
170540851|NCT02965456|616323789|FG000|Overall Study|Protocol Violation|0|||
170540852|NCT02965456|616323790|FG001|Overall Study|Protocol Violation|1|||
170540853|NCT02965456|616323789|FG000|Overall Study|Participant ran out of study drug|0|||
170540854|NCT02965456|616323790|FG001|Overall Study|Participant ran out of study drug|1|||
170540855|NCT05073315|616323791|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
170540856|NCT05073315|616323792|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
170540857|NCT05073315|616323793|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
170540858|NCT05073315|616323791|FG000|Period 1 (Lead-in Period)|Death|1|||
170540859|NCT05073315|616323792|FG001|Period 1 (Lead-in Period)|Death|0|||
170786667|NCT03557697|617227364|FG001|Overall Study|Withdrawal by Subject|4|||
170786668|NCT04676022|617227365|FG000|Overall Study|Screen Failure/|1|||
170786669|NCT04676022|617227366|FG001|Overall Study|Screen Failure/|1|||
170786670|NCT04676022|617227367|FG002|Overall Study|Screen Failure/|85|||
170786671|NCT04676022|617227365|FG000|Overall Study|Lost to Follow-up|1|||
170786672|NCT04676022|617227366|FG001|Overall Study|Lost to Follow-up|1|||
170786673|NCT04676022|617227367|FG002|Overall Study|Lost to Follow-up|0|||
170786674|NCT04676022|617227365|FG000|Overall Study|Adverse Event|2|||
170786675|NCT04676022|617227366|FG001|Overall Study|Adverse Event|0|||
170786676|NCT04676022|617227367|FG002|Overall Study|Adverse Event|1|||
170786677|NCT04676022|617227365|FG000|Overall Study|Physician Decision|2|||
170786678|NCT04676022|617227366|FG001|Overall Study|Physician Decision|0|||
170786679|NCT04676022|617227367|FG002|Overall Study|Physician Decision|1|||
170786680|NCT04676022|617227365|FG000|Overall Study|Withdrawal by Subject|3|||
170786681|NCT04676022|617227366|FG001|Overall Study|Withdrawal by Subject|1|||
170786682|NCT04676022|617227367|FG002|Overall Study|Withdrawal by Subject|6|||
170786683|NCT04676022|617227365|FG000|Overall Study|Will not move forward with permanent implant|6|||
170786684|NCT04676022|617227366|FG001|Overall Study|Will not move forward with permanent implant|0|||
170786685|NCT04676022|617227367|FG002|Overall Study|Will not move forward with permanent implant|0|||
170786686|NCT04676022|617227365|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
170786687|NCT04676022|617227366|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
170786688|NCT04676022|617227367|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
170786689|NCT04806451|617227373|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
170786690|NCT04806451|617227374|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
170786691|NCT04806451|617227373|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
170786692|NCT04806451|617227374|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
170786693|NCT04806451|617227373|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
170786694|NCT04806451|617227374|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
170786695|NCT02936752|617227375|FG000|Overall Study|Death|2|||
170786696|NCT02936752|617227376|FG001|Overall Study|Death|1|||
170786697|NCT02936752|617227375|FG000|Overall Study|Physician Decision|4|||
170786698|NCT02936752|617227376|FG001|Overall Study|Physician Decision|0|||
170786699|NCT02936752|617227375|FG000|Overall Study|Withdrawal by Subject|0|||
170786700|NCT02936752|617227376|FG001|Overall Study|Withdrawal by Subject|2|||
170786701|NCT03134196|617227386|FG000|Overall Study|Death|2|||
170786702|NCT03134196|617227387|FG001|Overall Study|Death|1|||
170786703|NCT03134196|617227386|FG000|Overall Study|Lost to Follow-up|13|||
170786704|NCT03134196|617227387|FG001|Overall Study|Lost to Follow-up|15|||
170786705|NCT03134196|617227386|FG000|Overall Study|Physician Decision|0|||
170786706|NCT03134196|617227387|FG001|Overall Study|Physician Decision|1|||
170786707|NCT03134196|617227386|FG000|Overall Study|Withdrawal by Subject|19|||
170786708|NCT03134196|617227387|FG001|Overall Study|Withdrawal by Subject|12|||
170786709|NCT03134196|617227386|FG000|Overall Study|Site Unable to Contact Participant|2|||
170786710|NCT03134196|617227387|FG001|Overall Study|Site Unable to Contact Participant|0|||
170786711|NCT03134196|617227386|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
170786712|NCT03134196|617227387|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
170786713|NCT03134196|617227386|FG000|Overall Study|Scheduling Conflict|1|||
170786714|NCT03134196|617227387|FG001|Overall Study|Scheduling Conflict|0|||
170786715|NCT05746455|617227396|FG000|Overall Study|Discharged from Clinical Service|1|||
170786716|NCT05746455|617227396|FG000|Overall Study|Lost to Follow-up|1|||
170786717|NCT02023866|617227397|FG000|Overall Study|Non-compliance|2|||
170786718|NCT02023866|617227397|FG000|Overall Study|Adverse Event|3|||
170786719|NCT02023866|617227397|FG000|Overall Study|Withdrawal by Subject|1|||
170786720|NCT04683744|617227400|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
170786721|NCT04683744|617227401|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
170786722|NCT04683744|617227402|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
170786723|NCT04592549|617227407|FG000|Overall Study|Withdrawal by Subject|0|||
170786724|NCT04592549|617227408|FG001|Overall Study|Withdrawal by Subject|1|||
170786725|NCT04592549|617227409|FG002|Overall Study|Withdrawal by Subject|0|||
170786726|NCT04592549|617227410|FG003|Overall Study|Withdrawal by Subject|1|||
170786727|NCT04592549|617227411|FG004|Overall Study|Withdrawal by Subject|1|||
170540860|NCT05073315|616323793|FG002|Period 1 (Lead-in Period)|Death|0|||
170540861|NCT05073315|616323791|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
170540862|NCT05073315|616323792|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
170540863|NCT05073315|616323793|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
170540864|NCT05073315|616323791|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
170540865|NCT05073315|616323792|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
170540866|NCT05073315|616323793|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
170540867|NCT05073315|616323791|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
170540868|NCT05073315|616323792|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
170540869|NCT05073315|616323793|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
170540870|NCT05073315|616323791|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
170540871|NCT05073315|616323792|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
170540872|NCT05073315|616323793|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
170540873|NCT05073315|616323791|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
170540874|NCT05073315|616323792|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
170540875|NCT05073315|616323793|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
170540876|NCT05073315|616323791|FG000|Period 2|Adverse Event|0|||
170540877|NCT05073315|616323792|FG001|Period 2|Adverse Event|3|||
170540878|NCT05073315|616323793|FG002|Period 2|Adverse Event|6|||
170540879|NCT05073315|616323791|FG000|Period 2|Lost to Follow-up|0|||
170540880|NCT05073315|616323792|FG001|Period 2|Lost to Follow-up|5|||
170540881|NCT05073315|616323793|FG002|Period 2|Lost to Follow-up|5|||
170540882|NCT05073315|616323791|FG000|Period 2|Withdrawal by Subject|0|||
170540883|NCT05073315|616323792|FG001|Period 2|Withdrawal by Subject|4|||
170540884|NCT05073315|616323793|FG002|Period 2|Withdrawal by Subject|9|||
170887177|NCT01790503|617595889|FG005|Overall Study|Physician Decision|0|||
170540885|NCT05073315|616323791|FG000|Period 2|Protocol Violation|0|||
170887178|NCT01790503|617595890|FG006|Overall Study|Physician Decision|0|||
170887179|NCT01790503|617595891|FG007|Overall Study|Physician Decision|0|||
170887180|NCT01790503|617595892|FG008|Overall Study|Physician Decision|0|||
170887181|NCT01790503|617595893|FG009|Overall Study|Physician Decision|1|||
170887182|NCT01790503|617595894|FG010|Overall Study|Physician Decision|1|||
170887183|NCT01790503|617595884|FG000|Overall Study|Death|0|||
170887184|NCT01790503|617595885|FG001|Overall Study|Death|0|||
170887185|NCT01790503|617595886|FG002|Overall Study|Death|0|||
170887186|NCT01790503|617595887|FG003|Overall Study|Death|0|||
170887187|NCT01790503|617595888|FG004|Overall Study|Death|0|||
170887188|NCT01790503|617595889|FG005|Overall Study|Death|0|||
170887189|NCT01790503|617595890|FG006|Overall Study|Death|0|||
170887190|NCT01790503|617595891|FG007|Overall Study|Death|0|||
170887191|NCT01790503|617595892|FG008|Overall Study|Death|0|||
170887192|NCT01790503|617595893|FG009|Overall Study|Death|1|||
170887193|NCT01790503|617595894|FG010|Overall Study|Death|0|||
170887194|NCT01790503|617595884|FG000|Overall Study|Non Compliance|0|||
170887195|NCT01790503|617595885|FG001|Overall Study|Non Compliance|0|||
170887196|NCT01790503|617595886|FG002|Overall Study|Non Compliance|0|||
170887197|NCT01790503|617595887|FG003|Overall Study|Non Compliance|0|||
170887198|NCT01790503|617595888|FG004|Overall Study|Non Compliance|1|||
170887199|NCT01790503|617595889|FG005|Overall Study|Non Compliance|0|||
170887200|NCT01790503|617595890|FG006|Overall Study|Non Compliance|0|||
170887201|NCT01790503|617595891|FG007|Overall Study|Non Compliance|0|||
170887202|NCT01790503|617595892|FG008|Overall Study|Non Compliance|0|||
170887203|NCT01790503|617595893|FG009|Overall Study|Non Compliance|0|||
170887204|NCT01790503|617595894|FG010|Overall Study|Non Compliance|0|||
170887205|NCT01790503|617595884|FG000|Overall Study|Other|0|||
170887206|NCT01790503|617595885|FG001|Overall Study|Other|0|||
170887207|NCT01790503|617595886|FG002|Overall Study|Other|0|||
170887208|NCT01790503|617595887|FG003|Overall Study|Other|0|||
170887209|NCT01790503|617595888|FG004|Overall Study|Other|1|||
170887210|NCT01790503|617595889|FG005|Overall Study|Other|0|||
170887211|NCT01790503|617595890|FG006|Overall Study|Other|0|||
170887212|NCT01790503|617595891|FG007|Overall Study|Other|0|||
170887213|NCT01790503|617595892|FG008|Overall Study|Other|1|||
170887214|NCT01790503|617595893|FG009|Overall Study|Other|2|||
170887215|NCT01790503|617595894|FG010|Overall Study|Other|0|||
170887216|NCT04183335|617595895|FG000|Overall Study|Adverse Event|1|||
170887217|NCT04183335|617595896|FG001|Overall Study|Adverse Event|0|||
170540886|NCT05073315|616323792|FG001|Period 2|Protocol Violation|0|||
170540887|NCT05073315|616323793|FG002|Period 2|Protocol Violation|1|||
170540888|NCT01529268|616323794|FG000|Overall Study|Lost to Follow-up|9|||
170540889|NCT01529268|616323795|FG001|Overall Study|Lost to Follow-up|3|||
170887218|NCT04183335|617595895|FG000|Overall Study|Withdrawal by Subject|12|||
170887219|NCT04183335|617595896|FG001|Overall Study|Withdrawal by Subject|3|||
170887220|NCT01535729|617595899|FG000|Overall Study|Withdrawal by Subject|2|||
170887221|NCT01535729|617595899|FG000|Overall Study|Disease progression|230|||
170887222|NCT01535729|617595899|FG000|Overall Study|Discontinued treatment|25|||
170887223|NCT01535729|617595899|FG000|Overall Study|Lost to Follow-up|8|||
170887224|NCT01535729|617595899|FG000|Overall Study|Death|52|||
170887225|NCT01535729|617595899|FG000|Overall Study|Other|19|||
170887226|NCT01535729|617595899|FG000|Overall Study|Did not sign informed consent|1|||
170449291|NCT03450629|615982450|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
170449292|NCT03450629|615982449|FG000|Overall Study|Non-Compliance With Study Drug|2|||
170449293|NCT03450629|615982450|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170449294|NCT03450629|615982449|FG000|Overall Study|Protocol Violation|11|||
170449295|NCT03450629|615982450|FG001|Overall Study|Protocol Violation|8|||
170449296|NCT03450629|615982449|FG000|Overall Study|Withdrawal by Subject|12|||
170449297|NCT03450629|615982450|FG001|Overall Study|Withdrawal by Subject|6|||
170449298|NCT02792218|615982451|FG000|Overall Study|Patient/guardian decision|15|||
170449299|NCT02792218|615982452|FG001|Overall Study|Patient/guardian decision|42|||
170449300|NCT02792218|615982451|FG000|Overall Study|Adverse Event|15|||
170449301|NCT02792218|615982452|FG001|Overall Study|Adverse Event|14|||
170449302|NCT02792218|615982451|FG000|Overall Study|Lost to Follow-up|10|||
170449303|NCT02792218|615982452|FG001|Overall Study|Lost to Follow-up|5|||
170449304|NCT02792218|615982451|FG000|Overall Study|Lack of Efficacy|1|||
170449305|NCT02792218|615982452|FG001|Overall Study|Lack of Efficacy|12|||
170449306|NCT02792218|615982451|FG000|Overall Study|Physician Decision|4|||
170449307|NCT02792218|615982452|FG001|Overall Study|Physician Decision|4|||
170449308|NCT02792218|615982451|FG000|Overall Study|Protocol deviation|3|||
170449309|NCT02792218|615982452|FG001|Overall Study|Protocol deviation|2|||
170449310|NCT02792218|615982451|FG000|Overall Study|New therapy for study indication|0|||
170449311|NCT02792218|615982452|FG001|Overall Study|New therapy for study indication|1|||
170449312|NCT02792218|615982451|FG000|Overall Study|Non-compliance with study treatment|0|||
170449313|NCT02792218|615982452|FG001|Overall Study|Non-compliance with study treatment|1|||
170449314|NCT02792218|615982451|FG000|Overall Study|Pregnancy|1|||
170449315|NCT02792218|615982452|FG001|Overall Study|Pregnancy|0|||
170449316|NCT03123783|615982453|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
170449317|NCT03123783|615982454|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
170449318|NCT03123783|615982455|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
170449319|NCT03123783|615982456|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
170449320|NCT03123783|615982457|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
170449321|NCT03123783|615982458|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
170449322|NCT03123783|615982459|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
170449323|NCT03123783|615982453|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
170449324|NCT03123783|615982454|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
170449325|NCT03123783|615982455|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
170449326|NCT03123783|615982456|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
170449327|NCT03123783|615982457|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
170449328|NCT03123783|615982458|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
170449329|NCT03123783|615982459|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
170449330|NCT03123783|615982453|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
170449331|NCT03123783|615982454|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
170449332|NCT03123783|615982455|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
170449333|NCT03123783|615982456|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
170449334|NCT03123783|615982457|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
170449335|NCT03123783|615982458|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
170786728|NCT04592549|617227412|FG005|Overall Study|Withdrawal by Subject|0|||
170786729|NCT04592549|617227407|FG000|Overall Study|Lost to Follow-up|2|||
170786730|NCT04592549|617227408|FG001|Overall Study|Lost to Follow-up|0|||
170786731|NCT04592549|617227409|FG002|Overall Study|Lost to Follow-up|0|||
170786732|NCT04592549|617227410|FG003|Overall Study|Lost to Follow-up|1|||
170786733|NCT04592549|617227411|FG004|Overall Study|Lost to Follow-up|1|||
170786734|NCT04592549|617227412|FG005|Overall Study|Lost to Follow-up|1|||
170786735|NCT03524118|617227413|FG000|Overall Study|Lost to Follow-up|0|||
170786736|NCT03524118|617227414|FG001|Overall Study|Lost to Follow-up|0|||
170786737|NCT03524118|617227415|FG002|Overall Study|Lost to Follow-up|0|||
170786738|NCT03524118|617227416|FG003|Overall Study|Lost to Follow-up|0|||
170786739|NCT03524118|617227417|FG004|Overall Study|Lost to Follow-up|1|||
170786740|NCT03524118|617227418|FG005|Overall Study|Lost to Follow-up|0|||
170786741|NCT03524118|617227413|FG000|Overall Study|Other|0|||
170786742|NCT03524118|617227414|FG001|Overall Study|Other|1|||
170786743|NCT03524118|617227415|FG002|Overall Study|Other|0|||
170786744|NCT03524118|617227416|FG003|Overall Study|Other|0|||
170786745|NCT03524118|617227417|FG004|Overall Study|Other|1|||
170786746|NCT03524118|617227418|FG005|Overall Study|Other|1|||
170786747|NCT03524118|617227413|FG000|Overall Study|Physician Decision|0|||
170786748|NCT03524118|617227414|FG001|Overall Study|Physician Decision|0|||
170786749|NCT03524118|617227415|FG002|Overall Study|Physician Decision|0|||
170786750|NCT03524118|617227416|FG003|Overall Study|Physician Decision|0|||
170786751|NCT03524118|617227417|FG004|Overall Study|Physician Decision|1|||
170786752|NCT03524118|617227418|FG005|Overall Study|Physician Decision|0|||
170449336|NCT03123783|615982459|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
170786753|NCT03524118|617227413|FG000|Overall Study|Protocol Violation|0|||
170786754|NCT03524118|617227414|FG001|Overall Study|Protocol Violation|0|||
170786755|NCT03524118|617227415|FG002|Overall Study|Protocol Violation|1|||
170786756|NCT03524118|617227416|FG003|Overall Study|Protocol Violation|0|||
170887227|NCT01535729|617595899|FG000|Overall Study|No previous chemotherapy|33|||
170887228|NCT01535729|617595899|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
170887229|NCT01535729|617595899|FG000|Overall Study|Protocol Violation|11|||
170887230|NCT01535729|617595899|FG000|Overall Study|Screening failure|1|||
170887231|NCT01535729|617595899|FG000|Overall Study|Not treated|9|||
170887232|NCT01535729|617595899|FG000|Overall Study|No participant record available|5|||
170887233|NCT01745146|617595904|FG000|Overall Study|Withdrawal by Subject|1|||
170887234|NCT01745146|617595905|FG001|Overall Study|Withdrawal by Subject|3|||
170887235|NCT01745146|617595904|FG000|Overall Study|Lost to Follow-up|2|||
170540890|NCT01529268|616323794|FG000|Overall Study|Moved|3|||
170540891|NCT01529268|616323795|FG001|Overall Study|Moved|0|||
170540892|NCT00303953|616323796|FG000|Overall Study|Ineligible|1|||
170540893|NCT00303953|616323796|FG000|Overall Study|Death|1|||
170540894|NCT00303953|616323796|FG000|Overall Study|Adverse Event|4|||
170540895|NCT00303953|616323796|FG000|Overall Study|Lack of Efficacy|12|||
170540896|NCT00303953|616323796|FG000|Overall Study|Physician Decision|1|||
170540897|NCT00088153|616323797|FG000|Overall Study|Physician Decision|3|||
170540898|NCT00088153|616323798|FG001|Overall Study|Physician Decision|3|||
170540899|NCT00088153|616323797|FG000|Overall Study|Withdrawal by Subject|10|||
170540900|NCT00088153|616323798|FG001|Overall Study|Withdrawal by Subject|10|||
170540901|NCT00088153|616323797|FG000|Overall Study|Lost to Follow-up|11|||
170540902|NCT00088153|616323798|FG001|Overall Study|Lost to Follow-up|12|||
170540903|NCT05182125|616323799|FG000|Overall Study|Withdrawal by Subject|0|||
170540904|NCT05182125|616323800|FG001|Overall Study|Withdrawal by Subject|0|||
170540905|NCT05182125|616323801|FG002|Overall Study|Withdrawal by Subject|0|||
170540906|NCT05182125|616323802|FG003|Overall Study|Withdrawal by Subject|0|||
170540907|NCT05182125|616323803|FG004|Overall Study|Withdrawal by Subject|2|||
170540908|NCT05182125|616323804|FG005|Overall Study|Withdrawal by Subject|0|||
170540909|NCT05182125|616323799|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
170540910|NCT05182125|616323800|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
170540911|NCT05182125|616323801|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
170540912|NCT05182125|616323802|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
170540913|NCT05182125|616323803|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
170540914|NCT05182125|616323804|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
170540915|NCT05182125|616323799|FG000|Overall Study|Death|0|||
170540916|NCT05182125|616323800|FG001|Overall Study|Death|0|||
170540917|NCT05182125|616323801|FG002|Overall Study|Death|0|||
170540918|NCT05182125|616323802|FG003|Overall Study|Death|0|||
170540919|NCT05182125|616323803|FG004|Overall Study|Death|1|||
170540920|NCT05182125|616323804|FG005|Overall Study|Death|0|||
170540921|NCT01757847|616323805|FG000|Overall Study|Withdrawal by Subject|3|||
170540922|NCT01757847|616323806|FG001|Overall Study|Withdrawal by Subject|4|||
170540923|NCT04057365|616323807|FG000|Overall Study|Withdrawal by Subject|2|||
170540924|NCT04057365|616323808|FG001|Overall Study|Withdrawal by Subject|0|||
170540925|NCT04738487|616323809|FG000|Overall Study|Participant Ongoing in Study|298|||
170540926|NCT04738487|616323810|FG001|Overall Study|Participant Ongoing in Study|297|||
170540927|NCT04738487|616323809|FG000|Overall Study|Withdrawal by Subject|7|||
170540928|NCT04738487|616323810|FG001|Overall Study|Withdrawal by Subject|9|||
170540929|NCT04738487|616323809|FG000|Overall Study|Lost to Follow-up|2|||
170540930|NCT04738487|616323810|FG001|Overall Study|Lost to Follow-up|0|||
170540931|NCT04738487|616323809|FG000|Overall Study|Death|287|||
170540932|NCT04738487|616323810|FG001|Overall Study|Death|306|||
170540933|NCT01063114|616323811|FG000|Overall Study|Lost to Follow-up|1|||
170540934|NCT02324153|616323814|FG000|Overall Study|Withdrawal by Subject|4|||
170540935|NCT02324153|616323815|FG001|Overall Study|Withdrawal by Subject|1|||
170540936|NCT02324153|616323814|FG000|Overall Study|Surgery postponed after randomization|3|||
170540937|NCT02324153|616323815|FG001|Overall Study|Surgery postponed after randomization|0|||
170540938|NCT02324153|616323814|FG000|Overall Study|Developed delirium preoperatively|1|||
170540939|NCT02324153|616323815|FG001|Overall Study|Developed delirium preoperatively|0|||
170540940|NCT00385840|616323818|FG000|Overall Study|Adverse Event|1|||
170540941|NCT00385840|616323819|FG001|Overall Study|Adverse Event|1|||
170540942|NCT00385840|616323818|FG000|Overall Study|Lost to Follow-up|3|||
170540943|NCT00385840|616323819|FG001|Overall Study|Lost to Follow-up|13|||
170540944|NCT00700635|616323820|FG000|Overall Study|Adverse Event|1|||
170540945|NCT00700635|616323821|FG001|Overall Study|Adverse Event|0|||
170887236|NCT01745146|617595905|FG001|Overall Study|Lost to Follow-up|0|||
170540946|NCT00700635|616323822|FG002|Overall Study|Adverse Event|0|||
170540947|NCT00700635|616323820|FG000|Overall Study|Lost to Follow-up|1|||
170540948|NCT00700635|616323821|FG001|Overall Study|Lost to Follow-up|3|||
170540949|NCT00700635|616323822|FG002|Overall Study|Lost to Follow-up|0|||
170540950|NCT00700635|616323820|FG000|Overall Study|Protocol Violation|2|||
170540951|NCT00700635|616323821|FG001|Overall Study|Protocol Violation|2|||
170540952|NCT00700635|616323822|FG002|Overall Study|Protocol Violation|0|||
170540953|NCT00700635|616323820|FG000|Overall Study|Withdrawal by Subject|7|||
170540954|NCT00700635|616323821|FG001|Overall Study|Withdrawal by Subject|3|||
170887237|NCT00130832|617595906|FG000|Overall Study|Adverse Event|1|||
170540955|NCT00700635|616323822|FG002|Overall Study|Withdrawal by Subject|1|||
170887238|NCT00130832|617595907|FG001|Overall Study|Adverse Event|1|||
170449337|NCT03123783|615982453|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
170449338|NCT03123783|615982454|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
170540956|NCT01163617|616323825|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
170786757|NCT03524118|617227417|FG004|Overall Study|Protocol Violation|1|||
170786758|NCT03524118|617227418|FG005|Overall Study|Protocol Violation|0|||
170786759|NCT03524118|617227413|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170786760|NCT03524118|617227414|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170786761|NCT03524118|617227415|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170786762|NCT03524118|617227416|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
170786763|NCT03524118|617227417|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
170786764|NCT03524118|617227418|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
170786765|NCT03452579|617227420|FG000|Overall Study|Death|0|||
170786766|NCT03452579|617227421|FG001|Overall Study|Death|1|||
170786767|NCT03452579|617227420|FG000|Overall Study|Withdrawal by Subject|2|||
170786768|NCT03452579|617227421|FG001|Overall Study|Withdrawal by Subject|0|||
170786769|NCT03452579|617227420|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
170786770|NCT03452579|617227421|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
170786771|NCT03452579|617227420|FG000|Overall Study|Physician Decision|1|||
170786772|NCT03452579|617227421|FG001|Overall Study|Physician Decision|1|||
170786773|NCT03452579|617227420|FG000|Overall Study|Adverse Event|1|||
170449339|NCT03123783|615982455|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
170449340|NCT03123783|615982456|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
170449341|NCT03123783|615982457|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
170449342|NCT03123783|615982458|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
170449343|NCT03123783|615982459|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
170449344|NCT01557582|615982460|FG000|Overall Study|Protocol Violation|4|||
170449345|NCT01557582|615982460|FG000|Overall Study|Operator error|2|||
170449346|NCT02723773|615984145|FG000|Overall Study|Adverse Event|934|||
170449347|NCT02723773|615984146|FG001|Overall Study|Adverse Event|3|||
170449348|NCT02723773|615984147|FG002|Overall Study|Adverse Event|1|||
170449349|NCT02723773|615984148|FG003|Overall Study|Adverse Event|9|||
170449350|NCT02723773|615984145|FG000|Overall Study|Protocol Violation|1|||
170449351|NCT02723773|615984146|FG001|Overall Study|Protocol Violation|0|||
170449352|NCT02723773|615984147|FG002|Overall Study|Protocol Violation|0|||
170449353|NCT02723773|615984148|FG003|Overall Study|Protocol Violation|0|||
170449354|NCT02723773|615984145|FG000|Overall Study|Withdrawal by Subject|360|||
170449355|NCT02723773|615984146|FG001|Overall Study|Withdrawal by Subject|5|||
170449356|NCT02723773|615984147|FG002|Overall Study|Withdrawal by Subject|6|||
170449357|NCT02723773|615984148|FG003|Overall Study|Withdrawal by Subject|10|||
170449358|NCT02723773|615984145|FG000|Overall Study|Migrated/moved from study area|37|||
170449359|NCT02723773|615984146|FG001|Overall Study|Migrated/moved from study area|0|||
170449360|NCT02723773|615984147|FG002|Overall Study|Migrated/moved from study area|0|||
170449361|NCT02723773|615984148|FG003|Overall Study|Migrated/moved from study area|1|||
170449362|NCT02723773|615984145|FG000|Overall Study|Lost to Follow-up|198|||
170449363|NCT02723773|615984146|FG001|Overall Study|Lost to Follow-up|0|||
170449364|NCT02723773|615984147|FG002|Overall Study|Lost to Follow-up|0|||
170449365|NCT02723773|615984148|FG003|Overall Study|Lost to Follow-up|0|||
170449366|NCT02723773|615984145|FG000|Overall Study|Other|189|||
170449367|NCT02723773|615984146|FG001|Overall Study|Other|1|||
170449368|NCT02723773|615984147|FG002|Overall Study|Other|2|||
170449369|NCT02723773|615984148|FG003|Overall Study|Other|2|||
170449370|NCT05168774|615984149|FG000|Overall Study|Lack of Efficacy|1|||
170449371|NCT05168774|615984150|FG001|Overall Study|Lack of Efficacy|2|||
170449372|NCT05168774|615984149|FG000|Overall Study|Withdrawal by Subject|1|||
170449373|NCT05168774|615984150|FG001|Overall Study|Withdrawal by Subject|2|||
170449374|NCT05168774|615984149|FG000|Overall Study|Adverse Event|2|||
170449375|NCT05168774|615984150|FG001|Overall Study|Adverse Event|0|||
170449376|NCT03940703|615984152|FG000|Overall Study|Still under treatment|31|||
170449377|NCT03940703|615984153|FG001|Overall Study|Still under treatment|0|||
170449378|NCT02124902|615984156|FG000|Overall Study|Adverse Event|7|||
170449379|NCT02124902|615984157|FG001|Overall Study|Adverse Event|2|||
170449380|NCT02124902|615984156|FG000|Overall Study|Went to alternative treatment|4|||
170449381|NCT02124902|615984157|FG001|Overall Study|Went to alternative treatment|0|||
170449382|NCT02124902|615984156|FG000|Overall Study|Withdrawal by Subject|2|||
170449383|NCT02124902|615984157|FG001|Overall Study|Withdrawal by Subject|1|||
170449384|NCT02124902|615984156|FG000|Overall Study|Physician Decision|2|||
170449385|NCT02124902|615984157|FG001|Overall Study|Physician Decision|0|||
170449386|NCT02124902|615984156|FG000|Overall Study|Not eligible|1|||
170449387|NCT02124902|615984157|FG001|Overall Study|Not eligible|0|||
170449388|NCT02124902|615984156|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
170449389|NCT02124902|615984157|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
170540957|NCT01163617|616323826|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
170634114|NCT00658359|616670196|FG002|Overall Study|Lack of Efficacy|0|||
170634115|NCT02560558|616670197|FG000|Overall Study|Adverse Event|1|||
170634116|NCT02560558|616670198|FG001|Overall Study|Adverse Event|0|||
170634117|NCT02560558|616670197|FG000|Overall Study|Death|0|||
170634118|NCT02560558|616670198|FG001|Overall Study|Death|2|||
170634119|NCT02560558|616670197|FG000|Overall Study|Lost to Follow-up|0|||
170634120|NCT02560558|616670198|FG001|Overall Study|Lost to Follow-up|4|||
170634121|NCT02560558|616670197|FG000|Overall Study|Protocol Violation|3|||
170634122|NCT02560558|616670198|FG001|Overall Study|Protocol Violation|0|||
170634123|NCT02560558|616670197|FG000|Overall Study|Withdrawal by Subject|3|||
170634124|NCT02560558|616670198|FG001|Overall Study|Withdrawal by Subject|0|||
170634125|NCT03818321|616670199|FG000|Overall Study|Withdrawal by Subject|1|||
170634126|NCT03818321|616670200|FG001|Overall Study|Withdrawal by Subject|2|||
170634127|NCT00275509|616670201|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
170634128|NCT00275509|616670202|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
170634129|NCT01254422|616670205|FG000|Overall Study|Protocol Violation|1|||
170634130|NCT01254422|616670206|FG001|Overall Study|Protocol Violation|0|||
170634131|NCT01254422|616670205|FG000|Overall Study|Adverse Event|1|||
170634132|NCT01254422|616670206|FG001|Overall Study|Adverse Event|0|||
170634133|NCT01254422|616670205|FG000|Overall Study|Serious adverse event|0|||
170634134|NCT01254422|616670206|FG001|Overall Study|Serious adverse event|1|||
170634135|NCT01254422|616670205|FG000|Overall Study|Lost to Follow-up|1|||
170634136|NCT01254422|616670206|FG001|Overall Study|Lost to Follow-up|0|||
170634137|NCT03486834|616670209|FG000|Overall Study|Withdrawal by Subject|46|||
170634138|NCT03486834|616670210|FG001|Overall Study|Withdrawal by Subject|46|||
170634139|NCT03486834|616670211|FG002|Overall Study|Withdrawal by Subject|52|||
170634140|NCT03486834|616670209|FG000|Overall Study|Adverse Event|8|||
170634141|NCT03486834|616670210|FG001|Overall Study|Adverse Event|7|||
170634142|NCT03486834|616670211|FG002|Overall Study|Adverse Event|0|||
170634143|NCT03486834|616670209|FG000|Overall Study|Lost to Follow-up|41|||
170634144|NCT03486834|616670210|FG001|Overall Study|Lost to Follow-up|24|||
170634145|NCT03486834|616670211|FG002|Overall Study|Lost to Follow-up|39|||
170634146|NCT03486834|616670209|FG000|Overall Study|Non-compliance with Study Drug|2|||
170634147|NCT03486834|616670210|FG001|Overall Study|Non-compliance with Study Drug|2|||
170634148|NCT03486834|616670211|FG002|Overall Study|Non-compliance with Study Drug|0|||
170634149|NCT03486834|616670209|FG000|Overall Study|Physician Decision|5|||
170634150|NCT03486834|616670210|FG001|Overall Study|Physician Decision|2|||
170634151|NCT03486834|616670211|FG002|Overall Study|Physician Decision|3|||
170634152|NCT03486834|616670209|FG000|Overall Study|Pregnancy|10|||
170634153|NCT03486834|616670210|FG001|Overall Study|Pregnancy|12|||
170634154|NCT03486834|616670211|FG002|Overall Study|Pregnancy|12|||
170634155|NCT03486834|616670209|FG000|Overall Study|Protocol Deviation|2|||
170634156|NCT03486834|616670210|FG001|Overall Study|Protocol Deviation|3|||
170634157|NCT03486834|616670211|FG002|Overall Study|Protocol Deviation|3|||
170634158|NCT03486834|616670209|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170634159|NCT03486834|616670210|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
170634160|NCT03486834|616670211|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
170634161|NCT03486834|616670209|FG000|Overall Study|Randomized but not treated|4|||
170634162|NCT03486834|616670210|FG001|Overall Study|Randomized but not treated|4|||
170634163|NCT03486834|616670211|FG002|Overall Study|Randomized but not treated|1|||
170634164|NCT00888940|616670212|FG000|Overall Study|Adverse Event|12|||
170634165|NCT00888940|616670213|FG001|Overall Study|Adverse Event|3|||
170634166|NCT00888940|616670212|FG000|Overall Study|Lost to Follow-up|5|||
170634167|NCT00888940|616670213|FG001|Overall Study|Lost to Follow-up|5|||
170634168|NCT00888940|616670212|FG000|Overall Study|Randomized Not Treated|11|||
170634169|NCT00888940|616670213|FG001|Overall Study|Randomized Not Treated|13|||
170887239|NCT00130832|617595906|FG000|Overall Study|Lost to Follow-up|1|||
170887240|NCT00130832|617595907|FG001|Overall Study|Lost to Follow-up|2|||
170887241|NCT00130832|617595906|FG000|Overall Study|Protocol Violation|6|||
170887242|NCT00130832|617595907|FG001|Overall Study|Protocol Violation|8|||
170887243|NCT00130832|617595906|FG000|Overall Study|Withdrawal by Subject|6|||
170634170|NCT00432172|616670214|FG000|Overall Study|Physician Decision|0|||
170634171|NCT00432172|616670215|FG001|Overall Study|Physician Decision|0|||
170634172|NCT00432172|616670216|FG002|Overall Study|Physician Decision|2|||
170634173|NCT00432172|616670217|FG003|Overall Study|Physician Decision|0|||
170634174|NCT00432172|616670214|FG000|Overall Study|Adverse Event|4|||
170634175|NCT00432172|616670215|FG001|Overall Study|Adverse Event|2|||
170634176|NCT00432172|616670216|FG002|Overall Study|Adverse Event|4|||
170634177|NCT00432172|616670217|FG003|Overall Study|Adverse Event|3|||
170634178|NCT00432172|616670214|FG000|Overall Study|Disease progression|0|||
170634179|NCT00432172|616670215|FG001|Overall Study|Disease progression|2|||
170449390|NCT01937351|615984158|FG000|Overall Study|Withdrawal by Subject|4|||
170634180|NCT00432172|616670216|FG002|Overall Study|Disease progression|5|||
170634181|NCT00432172|616670217|FG003|Overall Study|Disease progression|1|||
170634182|NCT00432172|616670214|FG000|Overall Study|Withdrawal by Subject|0|||
170634183|NCT00432172|616670215|FG001|Overall Study|Withdrawal by Subject|1|||
170634184|NCT00432172|616670216|FG002|Overall Study|Withdrawal by Subject|0|||
170634185|NCT00432172|616670217|FG003|Overall Study|Withdrawal by Subject|2|||
170449391|NCT01937351|615984159|FG001|Overall Study|Withdrawal by Subject|2|||
170449392|NCT01937351|615984158|FG000|Overall Study|Death|1|||
170449393|NCT01937351|615984159|FG001|Overall Study|Death|0|||
170449394|NCT01937351|615984158|FG000|Overall Study|Not treated w device, per protocol fail|4|||
170449395|NCT01937351|615984159|FG001|Overall Study|Not treated w device, per protocol fail|0|||
170449396|NCT01961687|615984160|FG000|Overall Study|Lost to Follow-up|19|||
170449397|NCT01961687|615984160|FG000|Overall Study|Re-operation|17|||
170449398|NCT01961687|615984160|FG000|Overall Study|Death|7|||
170449399|NCT01961687|615984160|FG000|Overall Study|Withdrawal by Subject|6|||
170449400|NCT01961687|615984160|FG000|Overall Study|Adverse Event|6|||
170449401|NCT01961687|615984160|FG000|Overall Study|Moved to area without study site|2|||
170449402|NCT01961687|615984160|FG000|Overall Study|Sponsor decision|2|||
170449403|NCT01961687|615984160|FG000|Overall Study|Physician Decision|1|||
170449404|NCT01961687|615984160|FG000|Overall Study|Unable to meet follow-up requirements|1|||
170449405|NCT01314118|615984161|FG000|Overall Study|Adverse Event|10|||
170449406|NCT01314118|615984161|FG000|Overall Study|Progressive disease|3|||
170449407|NCT01314118|615984161|FG000|Overall Study|Death|8|||
170449408|NCT01314118|615984161|FG000|Overall Study|Physician Decision|13|||
170449409|NCT01314118|615984161|FG000|Overall Study|Sponsor Decision|1|||
170449410|NCT01314118|615984161|FG000|Overall Study|Protocol Violation|2|||
170449411|NCT01314118|615984161|FG000|Overall Study|Withdrawal by Subject|26|||
170449412|NCT01314118|615984161|FG000|Overall Study|Other|21|||
170449413|NCT04079712|615984162|FG000|Overall Study|Disease progression before starting treatment|1|||
170449414|NCT01730040|615984173|FG000|Overall Study|Randomized but not treated|0|||
170449415|NCT01730040|615984174|FG001|Overall Study|Randomized but not treated|0|||
170449416|NCT01730040|615984175|FG002|Overall Study|Randomized but not treated|0|||
170449417|NCT01730040|615984176|FG003|Overall Study|Randomized but not treated|0|||
170449418|NCT01730040|615984177|FG004|Overall Study|Randomized but not treated|0|||
170449419|NCT01730040|615984178|FG005|Overall Study|Randomized but not treated|1|||
170449420|NCT01730040|615984179|FG006|Overall Study|Randomized but not treated|0|||
170449421|NCT01730040|615984173|FG000|Overall Study|Subject moved|0|||
170449422|NCT01730040|615984174|FG001|Overall Study|Subject moved|0|||
170449423|NCT01730040|615984175|FG002|Overall Study|Subject moved|1|||
170449424|NCT01730040|615984176|FG003|Overall Study|Subject moved|0|||
170449425|NCT01730040|615984177|FG004|Overall Study|Subject moved|0|||
170449426|NCT01730040|615984178|FG005|Overall Study|Subject moved|0|||
170449427|NCT01730040|615984179|FG006|Overall Study|Subject moved|1|||
170449428|NCT01730040|615984173|FG000|Overall Study|Physician Decision|0|||
170449429|NCT01730040|615984174|FG001|Overall Study|Physician Decision|0|||
170449430|NCT01730040|615984175|FG002|Overall Study|Physician Decision|0|||
170449431|NCT01730040|615984176|FG003|Overall Study|Physician Decision|0|||
170449432|NCT01730040|615984177|FG004|Overall Study|Physician Decision|0|||
170449433|NCT01730040|615984178|FG005|Overall Study|Physician Decision|1|||
170449434|NCT01730040|615984179|FG006|Overall Study|Physician Decision|1|||
170449435|NCT01730040|615984173|FG000|Overall Study|Other than specified|7|||
170449436|NCT01730040|615984174|FG001|Overall Study|Other than specified|8|||
170449437|NCT01730040|615984175|FG002|Overall Study|Other than specified|5|||
170449438|NCT01730040|615984176|FG003|Overall Study|Other than specified|5|||
170449439|NCT01730040|615984177|FG004|Overall Study|Other than specified|5|||
170449440|NCT01730040|615984178|FG005|Overall Study|Other than specified|4|||
170449441|NCT01730040|615984179|FG006|Overall Study|Other than specified|4|||
170449442|NCT01730040|615984173|FG000|Overall Study|Adverse Event|4|||
170449443|NCT01730040|615984174|FG001|Overall Study|Adverse Event|3|||
170449444|NCT01730040|615984175|FG002|Overall Study|Adverse Event|5|||
170449445|NCT01730040|615984176|FG003|Overall Study|Adverse Event|3|||
170449446|NCT01730040|615984177|FG004|Overall Study|Adverse Event|1|||
170449447|NCT01730040|615984178|FG005|Overall Study|Adverse Event|1|||
170449448|NCT01730040|615984179|FG006|Overall Study|Adverse Event|2|||
170449449|NCT01730040|615984173|FG000|Overall Study|Poor compliance to protocol|2|||
170449450|NCT01730040|615984174|FG001|Overall Study|Poor compliance to protocol|4|||
170449451|NCT01730040|615984175|FG002|Overall Study|Poor compliance to protocol|0|||
170449452|NCT01730040|615984176|FG003|Overall Study|Poor compliance to protocol|0|||
170449453|NCT01730040|615984177|FG004|Overall Study|Poor compliance to protocol|0|||
170449454|NCT01730040|615984178|FG005|Overall Study|Poor compliance to protocol|0|||
170449455|NCT01730040|615984179|FG006|Overall Study|Poor compliance to protocol|1|||
170449456|NCT01552369|615984183|FG000|Overall Study|Did not consent to extended follow up|8|||
170449457|NCT01552369|615984184|FG001|Overall Study|Did not consent to extended follow up|9|||
170449458|NCT00614926|615984185|FG000|Overall Study|Burden of travel|1|||
170449459|NCT00614926|615984186|FG001|Overall Study|Burden of travel|0|||
170449460|NCT00614926|615984185|FG000|Overall Study|Adverse Event|3|||
170449461|NCT00614926|615984186|FG001|Overall Study|Adverse Event|0|||
170449462|NCT02999984|615984193|FG000|Overall Study|Treatment Failure|1|||
170449463|NCT01042535|615984199|FG000|Overall Study|disease progression prior to treatment|3|||
170449464|NCT01042535|615984199|FG000|Overall Study|disease progression during treatment|3|||
170449465|NCT01042535|615984199|FG000|Overall Study|complications from other disease|2|||
170449466|NCT01546142|615984200|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
170449467|NCT01546142|615984201|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
170449468|NCT01546142|615984200|FG000|Overall Study|Subject Noncompliance|1|||
170449469|NCT01546142|615984201|FG001|Overall Study|Subject Noncompliance|1|||
170449470|NCT01546142|615984200|FG000|Overall Study|Adverse Event|6|||
170449471|NCT01546142|615984201|FG001|Overall Study|Adverse Event|3|||
170540958|NCT01163617|616323827|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
170540959|NCT01163617|616323828|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
170540960|NCT01163617|616323829|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
170540961|NCT01163617|616323830|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
170540962|NCT01163617|616323831|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
170540963|NCT01163617|616323832|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
170540964|NCT01163617|616323825|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
170540965|NCT01163617|616323826|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
170540966|NCT01163617|616323827|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
170540967|NCT01163617|616323828|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
170540968|NCT01163617|616323829|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
170540969|NCT01163617|616323830|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
170540970|NCT01163617|616323831|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
170540971|NCT01163617|616323832|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
170540972|NCT01163617|616323825|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
170540973|NCT01163617|616323826|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
170540974|NCT01163617|616323827|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
170540975|NCT01163617|616323828|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
170540976|NCT01163617|616323829|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
170634186|NCT00432172|616670214|FG000|Overall Study|No treatment received|2|||
170449472|NCT01546142|615984200|FG000|Overall Study|Lost to Follow-up|20|||
170449473|NCT01546142|615984201|FG001|Overall Study|Lost to Follow-up|15|||
170449474|NCT01546142|615984200|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
170449475|NCT01546142|615984201|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
170449476|NCT01546142|615984200|FG000|Overall Study|Subject Randomized but Not Treated|1|||
170449477|NCT01546142|615984201|FG001|Overall Study|Subject Randomized but Not Treated|0|||
170449478|NCT01213836|615984202|FG000|Period 1, First Intervention|Adverse Event|2|||
170449479|NCT01213836|615984203|FG001|Period 1, First Intervention|Adverse Event|1|||
170449480|NCT01213836|615984202|FG000|Period 1, First Intervention|Protocol Violation|0|||
170449481|NCT01213836|615984203|FG001|Period 1, First Intervention|Protocol Violation|1|||
170449482|NCT01213836|615984202|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
170449483|NCT01213836|615984203|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
170449484|NCT00706095|615984205|FG000|Overall Study|Progressive Disease|4|||
170449485|NCT00706095|615984206|FG001|Overall Study|Progressive Disease|5|||
170449486|NCT00706095|615984207|FG002|Overall Study|Progressive Disease|3|||
170449487|NCT00706095|615984205|FG000|Overall Study|Clinical Progression|1|||
170449488|NCT00706095|615984206|FG001|Overall Study|Clinical Progression|2|||
170449489|NCT00706095|615984207|FG002|Overall Study|Clinical Progression|2|||
170449490|NCT00706095|615984205|FG000|Overall Study|Withdrawal by Subject|1|||
170449491|NCT00706095|615984206|FG001|Overall Study|Withdrawal by Subject|0|||
170449492|NCT00706095|615984207|FG002|Overall Study|Withdrawal by Subject|0|||
170449493|NCT01221090|615984208|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
170449494|NCT01221090|615984209|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
170449495|NCT01221090|615984210|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
170449496|NCT01221090|615984211|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
170449497|NCT01221090|615984208|FG000|Overall Study|Withdrawal by Subject|0|||
170449498|NCT01221090|615984209|FG001|Overall Study|Withdrawal by Subject|22|||
170449499|NCT01221090|615984210|FG002|Overall Study|Withdrawal by Subject|27|||
170449500|NCT01221090|615984211|FG003|Overall Study|Withdrawal by Subject|2|||
170449501|NCT03438539|615984212|FG000|Overall Study|Lost to Follow-up|8|||
170449502|NCT03438539|615984213|FG001|Overall Study|Lost to Follow-up|4|||
170449503|NCT03438539|615984214|FG002|Overall Study|Lost to Follow-up|10|||
170449504|NCT03438539|615984215|FG003|Overall Study|Lost to Follow-up|9|||
170449505|NCT03438539|615984216|FG004|Overall Study|Lost to Follow-up|3|||
170449506|NCT03438539|615984217|FG005|Overall Study|Lost to Follow-up|8|||
170449507|NCT00440466|615984218|FG000|Overall Study|Death|3|||
170449508|NCT00440466|615984219|FG001|Overall Study|Death|2|||
170449509|NCT00440466|615984220|FG002|Overall Study|Death|9|||
170449510|NCT00440466|615984218|FG000|Overall Study|Adverse Event|3|||
170449511|NCT00440466|615984219|FG001|Overall Study|Adverse Event|4|||
170449512|NCT00440466|615984220|FG002|Overall Study|Adverse Event|11|||
170449513|NCT00440466|615984218|FG000|Overall Study|Lost to Follow-up|1|||
170449514|NCT00440466|615984219|FG001|Overall Study|Lost to Follow-up|0|||
170449515|NCT00440466|615984220|FG002|Overall Study|Lost to Follow-up|2|||
170449516|NCT00440466|615984218|FG000|Overall Study|Physician Decision|2|||
170449517|NCT00440466|615984219|FG001|Overall Study|Physician Decision|0|||
170449518|NCT00440466|615984220|FG002|Overall Study|Physician Decision|1|||
170449519|NCT00440466|615984218|FG000|Overall Study|Protocol Violation|2|||
170449520|NCT00440466|615984219|FG001|Overall Study|Protocol Violation|0|||
170449521|NCT00440466|615984220|FG002|Overall Study|Protocol Violation|4|||
170449522|NCT00440466|615984218|FG000|Overall Study|Withdrawal by Subject|2|||
170449523|NCT00440466|615984219|FG001|Overall Study|Withdrawal by Subject|5|||
170449524|NCT00440466|615984220|FG002|Overall Study|Withdrawal by Subject|9|||
170449525|NCT00440466|615984218|FG000|Overall Study|Began Dialysis|0|||
170449526|NCT00440466|615984219|FG001|Overall Study|Began Dialysis|0|||
170449527|NCT00440466|615984220|FG002|Overall Study|Began Dialysis|1|||
170449528|NCT00440466|615984218|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
170449529|NCT00440466|615984219|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
170449530|NCT00440466|615984220|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
170449531|NCT02065713|615984225|FG000|Overall Study|Adverse Event|0|||
170449532|NCT02065713|615984226|FG001|Overall Study|Adverse Event|1|||
170449533|NCT02065713|615984225|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170449534|NCT02065713|615984226|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170449535|NCT01223235|615984231|FG000|Overall Study|Withdrawal by Subject|1|||
170449536|NCT00865098|615984236|FG000|Overall Study|Progressive disease|1|||
170449537|NCT02129647|615984239|FG000|Overall Study|Adverse Event|2|||
170449538|NCT02129647|615984239|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
170449539|NCT01715896|615984240|FG000|Overall Study|Lost to Follow-up|0|||
170449540|NCT01715896|615984241|FG001|Overall Study|Lost to Follow-up|2|||
170449541|NCT01715896|615984240|FG000|Overall Study|Withdrawal by Subject|1|||
170449542|NCT01715896|615984241|FG001|Overall Study|Withdrawal by Subject|4|||
170449543|NCT01715896|615984240|FG000|Overall Study|Other|2|||
170449544|NCT01715896|615984241|FG001|Overall Study|Other|5|||
170449545|NCT01045993|615984243|FG000|Overall Study|Treated-later found eligibility not met|0|||
170449546|NCT01045993|615984244|FG001|Overall Study|Treated-later found eligibility not met|1|||
170449547|NCT01045993|615984245|FG002|Overall Study|Treated-later found eligibility not met|0|||
170449548|NCT01045993|615984246|FG003|Overall Study|Treated-later found eligibility not met|0|||
170449549|NCT01832402|615984254|FG000|Overall Study|Lost to Follow-up|2|||
170449550|NCT01832402|615984255|FG001|Overall Study|Lost to Follow-up|0|||
170449551|NCT01832402|615984254|FG000|Overall Study|Withdrawal by Subject|3|||
170449552|NCT01832402|615984255|FG001|Overall Study|Withdrawal by Subject|3|||
170449553|NCT01832402|615984254|FG000|Overall Study|Declining Performance status|2|||
170449554|NCT01832402|615984255|FG001|Overall Study|Declining Performance status|1|||
170449555|NCT00612677|615984256|FG000|Overall Study|study closed before treatment started|1|||
170449556|NCT03417830|615984257|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
170449557|NCT03417830|615984258|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
170449558|NCT00860743|615984259|FG000|Overall Study|Withdrawal by Subject|3|||
170449559|NCT00860743|615984260|FG001|Overall Study|Withdrawal by Subject|0|||
170449560|NCT00384176|615984269|FG000|Overall Study|Death|239|||
170449561|NCT00384176|615984270|FG001|Overall Study|Death|247|||
170449562|NCT00384176|615984271|FG002|Overall Study|Death|105|||
170449563|NCT00384176|615984269|FG000|Overall Study|Withdrawal by Subject|52|||
170449564|NCT00384176|615984270|FG001|Overall Study|Withdrawal by Subject|48|||
170449565|NCT00384176|615984271|FG002|Overall Study|Withdrawal by Subject|22|||
170449566|NCT00384176|615984269|FG000|Overall Study|Lost to Follow-up|16|||
170449567|NCT00384176|615984270|FG001|Overall Study|Lost to Follow-up|18|||
170449568|NCT00384176|615984271|FG002|Overall Study|Lost to Follow-up|4|||
170449569|NCT00384176|615984269|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
170449570|NCT00384176|615984270|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
170449571|NCT00384176|615984271|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
170449572|NCT00384176|615984269|FG000|Overall Study|Longer QTC as Visit 1|1|||
170449573|NCT00384176|615984270|FG001|Overall Study|Longer QTC as Visit 1|0|||
170449574|NCT00384176|615984271|FG002|Overall Study|Longer QTC as Visit 1|0|||
170449575|NCT00384176|615984269|FG000|Overall Study|Toxicity of treatment|1|||
170449576|NCT00384176|615984270|FG001|Overall Study|Toxicity of treatment|0|||
170786774|NCT03452579|617227421|FG001|Overall Study|Adverse Event|4|||
170449577|NCT00384176|615984271|FG002|Overall Study|Toxicity of treatment|0|||
170449578|NCT00384176|615984269|FG000|Overall Study|Did not receive study treatment|0|||
170449579|NCT00384176|615984270|FG001|Overall Study|Did not receive study treatment|1|||
170449580|NCT00384176|615984271|FG002|Overall Study|Did not receive study treatment|1|||
170449581|NCT00384176|615984269|FG000|Overall Study|Physician Decision|0|||
170786775|NCT04376502|617227422|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
170786776|NCT05647304|617227423|FG000|Overall Study|Withdrawal by Subject|1|||
170786777|NCT05647304|617227424|FG001|Overall Study|Withdrawal by Subject|0|||
170786778|NCT05030233|617227425|FG000|Overall Study|withdrawn for transfer|1|||
170786779|NCT05030233|617227426|FG001|Overall Study|withdrawn for transfer|0|||
170786780|NCT02727699|617229481|FG000|Overall Study|Adverse Event|2|||
170786781|NCT02727699|617229482|FG001|Overall Study|Adverse Event|0|||
170786782|NCT02727699|617229481|FG000|Overall Study|Withdrawal by Subject|5|||
170786783|NCT02727699|617229482|FG001|Overall Study|Withdrawal by Subject|3|||
170786784|NCT02727699|617229481|FG000|Overall Study|Protocol Violation|0|||
170634187|NCT00432172|616670215|FG001|Overall Study|No treatment received|2|||
170634188|NCT00432172|616670216|FG002|Overall Study|No treatment received|0|||
170634189|NCT00432172|616670217|FG003|Overall Study|No treatment received|1|||
170634190|NCT00515619|616670218|FG000|Overall Study|Adverse Event|34|||
170887244|NCT00130832|617595907|FG001|Overall Study|Withdrawal by Subject|1|||
170887245|NCT00130832|617595906|FG000|Overall Study|Moved|2|||
170540977|NCT01163617|616323830|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
170540978|NCT01163617|616323831|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
170540979|NCT01163617|616323832|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
170540980|NCT02875080|616323833|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
170540981|NCT02875080|616323834|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
170540982|NCT02875080|616323835|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
170540983|NCT02394756|616323836|FG000|Period 1|Lens Discomfort|0|||
170540984|NCT02394756|616323837|FG001|Period 1|Lens Discomfort|0|||
170540985|NCT02394756|616323838|FG002|Period 1|Lens Discomfort|0|||
170540986|NCT02394756|616323839|FG003|Period 1|Lens Discomfort|0|||
170540987|NCT02394756|616323840|FG004|Period 1|Lens Discomfort|0|||
170540988|NCT02394756|616323841|FG005|Period 1|Lens Discomfort|1|||
170540989|NCT02394756|616323836|FG000|Period 1|Withdrawal by Subject|0|||
170540990|NCT02394756|616323837|FG001|Period 1|Withdrawal by Subject|1|||
170540991|NCT02394756|616323838|FG002|Period 1|Withdrawal by Subject|1|||
170540992|NCT02394756|616323839|FG003|Period 1|Withdrawal by Subject|1|||
170540993|NCT02394756|616323840|FG004|Period 1|Withdrawal by Subject|0|||
170540994|NCT02394756|616323841|FG005|Period 1|Withdrawal by Subject|0|||
170540995|NCT02394756|616323836|FG000|Period 2|Unsatisfactory Visual Response|0|||
170540996|NCT02394756|616323837|FG001|Period 2|Unsatisfactory Visual Response|0|||
170540997|NCT02394756|616323838|FG002|Period 2|Unsatisfactory Visual Response|0|||
170540998|NCT02394756|616323839|FG003|Period 2|Unsatisfactory Visual Response|0|||
170540999|NCT02394756|616323840|FG004|Period 2|Unsatisfactory Visual Response|1|||
170541000|NCT02394756|616323841|FG005|Period 2|Unsatisfactory Visual Response|0|||
170541001|NCT03611946|616323848|FG000|Overall Study|Withdrawal by Subject|0|||
170541002|NCT03611946|616323849|FG001|Overall Study|Withdrawal by Subject|0|||
170541003|NCT03611946|616323850|FG002|Overall Study|Withdrawal by Subject|1|||
170541004|NCT03611946|616323851|FG003|Overall Study|Withdrawal by Subject|0|||
170541005|NCT01022580|616325123|FG000|Overall Study|Death|18|||
170541006|NCT01022580|616325124|FG001|Overall Study|Death|22|||
170541007|NCT03439839|616325125|FG000|Overall Study|Death|3|||
170541008|NCT03439839|616325126|FG001|Overall Study|Death|0|||
170541009|NCT03720847|616325127|FG000|Washout|Physician Decision|1|||
170541010|NCT03720847|616325128|FG001|Washout|Physician Decision|2|||
170887246|NCT00130832|617595907|FG001|Overall Study|Moved|2|||
170449582|NCT00384176|615984270|FG001|Overall Study|Physician Decision|2|||
170449583|NCT00384176|615984271|FG002|Overall Study|Physician Decision|0|||
170449584|NCT00384176|615984269|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
170449585|NCT00384176|615984270|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
170449586|NCT00384176|615984271|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
170449587|NCT02697773|615984272|FG000|Overall Study|Adverse Event|2|||
170449588|NCT02697773|615984273|FG001|Overall Study|Adverse Event|1|||
170449589|NCT02697773|615984274|FG002|Overall Study|Adverse Event|2|||
170449590|NCT02697773|615984272|FG000|Overall Study|Death|0|||
170449591|NCT02697773|615984273|FG001|Overall Study|Death|0|||
170449592|NCT02697773|615984274|FG002|Overall Study|Death|2|||
170449593|NCT02697773|615984272|FG000|Overall Study|Lack of Efficacy|4|||
170449594|NCT02697773|615984273|FG001|Overall Study|Lack of Efficacy|6|||
170449595|NCT02697773|615984274|FG002|Overall Study|Lack of Efficacy|6|||
170449596|NCT02697773|615984272|FG000|Overall Study|Lost to Follow-up|5|||
170449597|NCT02697773|615984273|FG001|Overall Study|Lost to Follow-up|5|||
170449598|NCT02697773|615984274|FG002|Overall Study|Lost to Follow-up|7|||
170449599|NCT02697773|615984272|FG000|Overall Study|Other|15|||
170449600|NCT02697773|615984273|FG001|Overall Study|Other|11|||
170449601|NCT02697773|615984274|FG002|Overall Study|Other|10|||
170449602|NCT02697773|615984272|FG000|Overall Study|Protocol Violation|1|||
170449603|NCT02697773|615984273|FG001|Overall Study|Protocol Violation|1|||
170449604|NCT02697773|615984274|FG002|Overall Study|Protocol Violation|0|||
170449605|NCT02697773|615984272|FG000|Overall Study|Withdrawal by Subject|10|||
170449606|NCT02697773|615984273|FG001|Overall Study|Withdrawal by Subject|13|||
170449607|NCT02697773|615984274|FG002|Overall Study|Withdrawal by Subject|13|||
170449608|NCT02697773|615984272|FG000|Overall Study|Randomized but not treated|1|||
170449609|NCT02697773|615984273|FG001|Overall Study|Randomized but not treated|1|||
170449610|NCT02697773|615984274|FG002|Overall Study|Randomized but not treated|0|||
170449611|NCT02243293|615984275|FG000|Overall Study|Adverse Event|1|||
170449612|NCT02243293|615984276|FG001|Overall Study|Adverse Event|0|||
170541011|NCT01500096|616325129|FG000|Overall Study|Lost to Follow-up|1|||
170541012|NCT01500096|616325130|FG001|Overall Study|Lost to Follow-up|0|||
170541013|NCT01500096|616325131|FG002|Overall Study|Lost to Follow-up|0|||
170541014|NCT01500096|616325132|FG003|Overall Study|Lost to Follow-up|2|||
170541015|NCT03033901|616325136|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
170449613|NCT02243293|615984277|FG002|Overall Study|Adverse Event|0|||
170449614|NCT02243293|615984278|FG003|Overall Study|Adverse Event|0|||
170449615|NCT02243293|615984279|FG004|Overall Study|Adverse Event|0|||
170449616|NCT02243293|615984280|FG005|Overall Study|Adverse Event|0|||
170449617|NCT02243293|615984281|FG006|Overall Study|Adverse Event|0|||
170449618|NCT02243293|615984282|FG007|Overall Study|Adverse Event|0|||
170449619|NCT02243293|615984283|FG008|Overall Study|Adverse Event|0|||
170449620|NCT02243293|615984284|FG009|Overall Study|Adverse Event|0|||
170449621|NCT02243293|615984285|FG010|Overall Study|Adverse Event|0|||
170449622|NCT02243293|615984286|FG011|Overall Study|Adverse Event|0|||
170449623|NCT02243293|615984287|FG012|Overall Study|Adverse Event|0|||
170449624|NCT02243293|615984288|FG013|Overall Study|Adverse Event|0|||
170449625|NCT02243293|615984289|FG014|Overall Study|Adverse Event|0|||
170449626|NCT02243293|615984290|FG015|Overall Study|Adverse Event|1|||
170449627|NCT02243293|615984291|FG016|Overall Study|Adverse Event|0|||
170449628|NCT02243293|615984292|FG017|Overall Study|Adverse Event|0|||
170449629|NCT02243293|615984293|FG018|Overall Study|Adverse Event|0|||
170449630|NCT02243293|615984294|FG019|Overall Study|Adverse Event|0|||
170449631|NCT02243293|615984295|FG020|Overall Study|Adverse Event|1|||
170449632|NCT02243293|615984296|FG021|Overall Study|Adverse Event|0|||
170449633|NCT02243293|615984275|FG000|Overall Study|Withdrawal by Subject|1|||
170449634|NCT02243293|615984276|FG001|Overall Study|Withdrawal by Subject|0|||
170449635|NCT02243293|615984277|FG002|Overall Study|Withdrawal by Subject|0|||
170449636|NCT02243293|615984278|FG003|Overall Study|Withdrawal by Subject|0|||
170449637|NCT02243293|615984279|FG004|Overall Study|Withdrawal by Subject|0|||
170449638|NCT02243293|615984280|FG005|Overall Study|Withdrawal by Subject|0|||
170449639|NCT02243293|615984281|FG006|Overall Study|Withdrawal by Subject|0|||
170449640|NCT02243293|615984282|FG007|Overall Study|Withdrawal by Subject|0|||
170449641|NCT02243293|615984283|FG008|Overall Study|Withdrawal by Subject|0|||
170449642|NCT02243293|615984284|FG009|Overall Study|Withdrawal by Subject|1|||
170449643|NCT02243293|615984285|FG010|Overall Study|Withdrawal by Subject|0|||
170449644|NCT02243293|615984286|FG011|Overall Study|Withdrawal by Subject|1|||
170449645|NCT02243293|615984287|FG012|Overall Study|Withdrawal by Subject|0|||
170449646|NCT02243293|615984288|FG013|Overall Study|Withdrawal by Subject|0|||
170449647|NCT02243293|615984289|FG014|Overall Study|Withdrawal by Subject|0|||
170449648|NCT02243293|615984290|FG015|Overall Study|Withdrawal by Subject|0|||
170449649|NCT02243293|615984291|FG016|Overall Study|Withdrawal by Subject|0|||
170449650|NCT02243293|615984292|FG017|Overall Study|Withdrawal by Subject|0|||
170449651|NCT02243293|615984293|FG018|Overall Study|Withdrawal by Subject|0|||
170449652|NCT02243293|615984294|FG019|Overall Study|Withdrawal by Subject|0|||
170449653|NCT02243293|615984295|FG020|Overall Study|Withdrawal by Subject|0|||
170449654|NCT02243293|615984296|FG021|Overall Study|Withdrawal by Subject|1|||
170449655|NCT02243293|615984275|FG000|Overall Study|Lost to Follow-up|0|||
170449656|NCT02243293|615984276|FG001|Overall Study|Lost to Follow-up|1|||
170449657|NCT02243293|615984277|FG002|Overall Study|Lost to Follow-up|1|||
170449658|NCT02243293|615984278|FG003|Overall Study|Lost to Follow-up|1|||
170449659|NCT02243293|615984279|FG004|Overall Study|Lost to Follow-up|0|||
170449660|NCT02243293|615984280|FG005|Overall Study|Lost to Follow-up|0|||
170449661|NCT02243293|615984281|FG006|Overall Study|Lost to Follow-up|3|||
170449662|NCT02243293|615984282|FG007|Overall Study|Lost to Follow-up|0|||
170449663|NCT02243293|615984283|FG008|Overall Study|Lost to Follow-up|0|||
170449664|NCT02243293|615984284|FG009|Overall Study|Lost to Follow-up|0|||
170449665|NCT02243293|615984285|FG010|Overall Study|Lost to Follow-up|0|||
170449666|NCT02243293|615984286|FG011|Overall Study|Lost to Follow-up|2|||
170449667|NCT02243293|615984287|FG012|Overall Study|Lost to Follow-up|0|||
170449668|NCT02243293|615984288|FG013|Overall Study|Lost to Follow-up|0|||
170449669|NCT02243293|615984289|FG014|Overall Study|Lost to Follow-up|0|||
170449670|NCT02243293|615984290|FG015|Overall Study|Lost to Follow-up|0|||
170449671|NCT02243293|615984291|FG016|Overall Study|Lost to Follow-up|3|||
170449672|NCT02243293|615984292|FG017|Overall Study|Lost to Follow-up|1|||
170449673|NCT02243293|615984293|FG018|Overall Study|Lost to Follow-up|0|||
170449674|NCT02243293|615984294|FG019|Overall Study|Lost to Follow-up|0|||
170449675|NCT02243293|615984295|FG020|Overall Study|Lost to Follow-up|1|||
170449676|NCT02243293|615984296|FG021|Overall Study|Lost to Follow-up|2|||
170449677|NCT02243293|615984275|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
170541016|NCT03033901|616325136|FG000|Overall Study|Refused PSG|23|||
170449678|NCT02243293|615984276|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
170449679|NCT02243293|615984277|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
170449680|NCT02243293|615984278|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
170449681|NCT02243293|615984279|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
170449682|NCT02243293|615984280|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
170449683|NCT02243293|615984281|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
170449684|NCT02243293|615984282|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
170449685|NCT02243293|615984283|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
170449686|NCT02243293|615984284|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
170449687|NCT02243293|615984285|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
170449688|NCT02243293|615984286|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
170541017|NCT03033901|616325136|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
170449689|NCT02243293|615984287|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
170449690|NCT02243293|615984288|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
170449691|NCT02243293|615984289|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
170449692|NCT02243293|615984290|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
170449693|NCT02243293|615984291|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
170449694|NCT02243293|615984292|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
170449695|NCT02243293|615984293|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
170449696|NCT02243293|615984294|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
170449697|NCT02243293|615984295|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
170449698|NCT02243293|615984296|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
170449699|NCT02243293|615984275|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
170449700|NCT02243293|615984276|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
170449701|NCT02243293|615984277|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
170449702|NCT02243293|615984278|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
170449703|NCT02243293|615984279|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
170449704|NCT02243293|615984280|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
170449705|NCT02243293|615984281|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
170449706|NCT02243293|615984282|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
170449707|NCT02243293|615984283|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
170449708|NCT02243293|615984284|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
170449709|NCT02243293|615984285|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
170449710|NCT02243293|615984286|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
170449711|NCT02243293|615984287|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
170449712|NCT02243293|615984288|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
170449713|NCT02243293|615984289|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
170449714|NCT02243293|615984290|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
170449715|NCT02243293|615984291|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
170449716|NCT02243293|615984292|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
170449717|NCT02243293|615984293|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
170449718|NCT02243293|615984294|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
170449719|NCT02243293|615984295|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
170449720|NCT02243293|615984296|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
170449721|NCT01382251|615984297|FG000|Overall Study|Surgeries cancelled or delayed|16|||
170449722|NCT01382251|615984298|FG001|Overall Study|Surgeries cancelled or delayed|16|||
170449723|NCT01382251|615984297|FG000|Overall Study|Lost to Follow-up|4|||
170449724|NCT01382251|615984298|FG001|Overall Study|Lost to Follow-up|4|||
170449725|NCT01382251|615984297|FG000|Overall Study|Contacted after study closed|1|||
170449726|NCT01382251|615984298|FG001|Overall Study|Contacted after study closed|1|||
170449727|NCT02377063|615984301|FG000|Overall Study|Non-compliance|5|||
170449728|NCT01524913|615984302|FG000|Overall Study|Lost to Follow-up|4|||
170449729|NCT01524913|615984303|FG001|Overall Study|Lost to Follow-up|0|||
170449730|NCT01524913|615984304|FG002|Overall Study|Lost to Follow-up|0|||
170449731|NCT01688466|615985564|FG000|Overall Study|Withdrawal by Subject|2|||
170449732|NCT01688466|615985565|FG001|Overall Study|Withdrawal by Subject|1|||
170449733|NCT01688466|615985564|FG000|Overall Study|Death|0|||
170449734|NCT01688466|615985565|FG001|Overall Study|Death|1|||
170449735|NCT01688466|615985564|FG000|Overall Study|Adverse Event|0|||
170449736|NCT01688466|615985565|FG001|Overall Study|Adverse Event|4|||
170449737|NCT01688466|615985564|FG000|Overall Study|Not evaluable|0|||
170449738|NCT01688466|615985565|FG001|Overall Study|Not evaluable|1|||
170449739|NCT02658487|615985568|FG000|Overall Study|Death|2|||
170449740|NCT02658487|615985568|FG000|Overall Study|Disease progression|10|||
170449741|NCT02658487|615985568|FG000|Overall Study|Alternative therapy|1|||
170449742|NCT02658487|615985568|FG000|Overall Study|Adverse Event|1|||
170449743|NCT02658487|615985568|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
170449744|NCT02658487|615985568|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
170449745|NCT01467479|615985569|FG000|Overall Study|No Study Medication|1|||
170449746|NCT01467479|615985570|FG001|Overall Study|No Study Medication|0|||
170449747|NCT01467479|615985571|FG002|Overall Study|No Study Medication|2|||
170449748|NCT01467479|615985569|FG000|Overall Study|Adverse Event|1|||
170449749|NCT01467479|615985570|FG001|Overall Study|Adverse Event|2|||
170449750|NCT01467479|615985571|FG002|Overall Study|Adverse Event|0|||
170887247|NCT00130832|617595906|FG000|Overall Study|Other|0|||
170449751|NCT01467479|615985569|FG000|Overall Study|Death|0|||
170449752|NCT01467479|615985570|FG001|Overall Study|Death|0|||
170449753|NCT01467479|615985571|FG002|Overall Study|Death|1|||
170449754|NCT01467479|615985569|FG000|Overall Study|Lost to Follow-up|2|||
170449755|NCT01467479|615985570|FG001|Overall Study|Lost to Follow-up|5|||
170449756|NCT01467479|615985571|FG002|Overall Study|Lost to Follow-up|3|||
170449757|NCT01467479|615985569|FG000|Overall Study|Withdrawal of Consent|3|||
170449758|NCT01467479|615985570|FG001|Overall Study|Withdrawal of Consent|7|||
170449759|NCT01467479|615985571|FG002|Overall Study|Withdrawal of Consent|7|||
170449760|NCT01467479|615985569|FG000|Overall Study|Study Terminated by Sponsor|1|||
170449761|NCT01467479|615985570|FG001|Overall Study|Study Terminated by Sponsor|3|||
170449762|NCT01467479|615985571|FG002|Overall Study|Study Terminated by Sponsor|3|||
170449763|NCT01467479|615985569|FG000|Overall Study|Other|1|||
170449764|NCT01467479|615985570|FG001|Overall Study|Other|0|||
170449765|NCT01467479|615985571|FG002|Overall Study|Other|0|||
170449766|NCT02284347|615985572|FG000|Overall Study|Lost to Follow-up|2|||
170449767|NCT02284347|615985572|FG000|Overall Study|Withdrawn prior to treatment|1|||
170449768|NCT00544817|615985575|FG000|Combined Modality|Lack of Efficacy|2|||
170449769|NCT00544817|615985575|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
170449770|NCT00544817|615985575|FG000|Combined Modality|Adverse Event|2|||
170449771|NCT00544817|615985575|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
170449772|NCT00544817|615985575|FG000|No Treatment Interval|Lack of Efficacy|8|||
170449773|NCT00544817|615985575|FG000|No Treatment Interval|Physician Decision|3|||
170449774|NCT00544817|615985575|FG000|No Treatment Interval|Adverse Event|1|||
170449775|NCT00544817|615985575|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
170449776|NCT00544817|615985575|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
170449777|NCT00544817|615985575|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
170449778|NCT00754013|615985585|FG000|Overall Study|Lost to Follow-up|1|||
170449779|NCT00754013|615985586|FG001|Overall Study|Lost to Follow-up|1|||
170449780|NCT00754013|615985585|FG000|Overall Study|didn't return after study termed|3|||
170449781|NCT00754013|615985586|FG001|Overall Study|didn't return after study termed|4|||
170449782|NCT01197417|615985587|FG000|Overall Study|Physician Decision|3|||
170449783|NCT01197417|615985588|FG001|Overall Study|Physician Decision|2|||
170449784|NCT01197417|615985587|FG000|Overall Study|Withdrawal by Subject|2|||
170449785|NCT01197417|615985588|FG001|Overall Study|Withdrawal by Subject|4|||
170449786|NCT01197417|615985587|FG000|Overall Study|Site miscommunication|0|||
170449787|NCT01197417|615985588|FG001|Overall Study|Site miscommunication|1|||
170449788|NCT01197417|615985587|FG000|Overall Study|Subject transferred to intensive care|0|||
170449789|NCT01197417|615985588|FG001|Overall Study|Subject transferred to intensive care|1|||
170449790|NCT01197417|615985587|FG000|Overall Study|Not consented in time to receive drug|0|||
170449791|NCT01197417|615985588|FG001|Overall Study|Not consented in time to receive drug|1|||
170449792|NCT01197417|615985587|FG000|Overall Study|Hypotension|1|||
170449793|NCT01197417|615985588|FG001|Overall Study|Hypotension|2|||
170449794|NCT01197417|615985587|FG000|Overall Study|Found to be ineligible|2|||
170449795|NCT01197417|615985588|FG001|Overall Study|Found to be ineligible|5|||
170449796|NCT01197417|615985587|FG000|Overall Study|No 25-hour magnesium level|0|||
170449797|NCT01197417|615985588|FG001|Overall Study|No 25-hour magnesium level|2|||
170449798|NCT01475253|615985589|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
170449799|NCT01475253|615985590|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
170449800|NCT01475253|615985591|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
170449801|NCT01475253|615985592|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
170449802|NCT01475253|615985589|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
170449803|NCT01475253|615985590|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
170449804|NCT01475253|615985591|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
170449805|NCT01475253|615985592|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
170449806|NCT02914236|615985593|FG000|Overall Study|Lost to Follow-up|1|||
170449807|NCT02676284|615985596|FG000|Overall Study|Withdrawal by Subject|1|||
170449808|NCT00708708|615985597|FG000|Overall Study|Another therapy instead of Enbrel|141|||
170449809|NCT00708708|615985597|FG000|Overall Study|Lost to Follow-up|52|||
170449810|NCT00708708|615985597|FG000|Overall Study|Withdrawal by Subject|51|||
170449811|NCT00708708|615985597|FG000|Overall Study|Intolerance|42|||
170449812|NCT00708708|615985597|FG000|Overall Study|Another therapy along with Enbrel|15|||
170449813|NCT00708708|615985597|FG000|Overall Study|Other unspecified|11|||
170541018|NCT03033901|616325136|FG000|Overall Study|Missing Oximetry Data|3|||
170541019|NCT00835978|616325139|FG000|Overall Study|Death|33|||
170541020|NCT00835978|616325140|FG001|Overall Study|Death|40|||
170541021|NCT00835978|616325141|FG002|Overall Study|Death|49|||
170541022|NCT00835978|616325142|FG003|Overall Study|Death|4|||
170541023|NCT00835978|616325139|FG000|Overall Study|Lost to Follow-up|3|||
170541024|NCT00835978|616325140|FG001|Overall Study|Lost to Follow-up|4|||
170541025|NCT00835978|616325141|FG002|Overall Study|Lost to Follow-up|2|||
170541026|NCT00835978|616325142|FG003|Overall Study|Lost to Follow-up|1|||
170449814|NCT00708708|615985597|FG000|Overall Study|Good effectiveness|9|||
170449815|NCT00708708|615985597|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
170449816|NCT00708708|615985597|FG000|Overall Study|Administrative reasons|7|||
170449817|NCT00708708|615985597|FG000|Overall Study|Lack of effectiveness|4|||
170449818|NCT00708708|615985597|FG000|Overall Study|Lack of compliance|3|||
170449819|NCT00708708|615985597|FG000|Overall Study|Pregnancy|3|||
170449820|NCT00708708|615985597|FG000|Overall Study|Adverse Event|3|||
170449821|NCT00708708|615985597|FG000|Overall Study|Missing values|392|||
170449822|NCT04213209|615985598|FG000|Overall Study|Protocol Violation|1|||
170449823|NCT04213209|615985599|FG001|Overall Study|Protocol Violation|0|||
170449824|NCT04213209|615985600|FG002|Overall Study|Protocol Violation|0|||
170449825|NCT04213209|615985601|FG003|Overall Study|Protocol Violation|0|||
170541027|NCT00835978|616325139|FG000|Overall Study|Other|5|||
170541028|NCT00835978|616325140|FG001|Overall Study|Other|1|||
170449826|NCT04213209|615985602|FG004|Overall Study|Protocol Violation|0|||
170449827|NCT04213209|615985603|FG005|Overall Study|Protocol Violation|0|||
170449828|NCT00140413|615985608|FG000|Overall Study|Lost to Follow-up|1|||
170449829|NCT00140413|615985609|FG001|Overall Study|Lost to Follow-up|0|||
170449830|NCT00140413|615985608|FG000|Overall Study|Withdrawal by Subject|2|||
170449831|NCT00140413|615985609|FG001|Overall Study|Withdrawal by Subject|0|||
170449832|NCT02459665|615985610|FG000|Overall Study|Withdrawal by Subject|0|||
170449833|NCT02459665|615985611|FG001|Overall Study|Withdrawal by Subject|1|||
170449834|NCT02459665|615985612|FG002|Overall Study|Withdrawal by Subject|1|||
170449835|NCT02459665|615985613|FG003|Overall Study|Withdrawal by Subject|2|||
170449836|NCT01567826|615985614|FG000|Overall Study|Lost to Follow-up|3|||
170449837|NCT01567826|615985615|FG001|Overall Study|Lost to Follow-up|2|||
170449838|NCT01014624|615985619|FG000|Overall Study|Adverse Event|0|||
170449839|NCT01014624|615985620|FG001|Overall Study|Adverse Event|1|||
170786785|NCT02727699|617229482|FG001|Overall Study|Protocol Violation|1|||
170449840|NCT01014624|615985619|FG000|Overall Study|Protocol Violation|1|||
170786786|NCT02727699|617229481|FG000|Overall Study|Physician Decision|0|||
170786787|NCT02727699|617229482|FG001|Overall Study|Physician Decision|1|||
170786788|NCT02727699|617229481|FG000|Overall Study|Lost to Follow-up|1|||
170786789|NCT02727699|617229482|FG001|Overall Study|Lost to Follow-up|0|||
170786790|NCT02727699|617229481|FG000|Overall Study|Sponsor Decision|1|||
170786791|NCT02727699|617229482|FG001|Overall Study|Sponsor Decision|0|||
170786792|NCT04806594|617229497|FG000|Overall Study|Withdrawal by Subject|2|||
170786793|NCT04806594|617229497|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
170786794|NCT04318548|617229498|FG000|Overall Study|Adverse Event|0|||
170786795|NCT04318548|617229499|FG001|Overall Study|Adverse Event|0|||
170786796|NCT04318548|617229500|FG002|Overall Study|Adverse Event|1|||
170786797|NCT04318548|617229498|FG000|Overall Study|Lost to Follow-up|6|||
170786798|NCT04318548|617229499|FG001|Overall Study|Lost to Follow-up|13|||
170786799|NCT04318548|617229500|FG002|Overall Study|Lost to Follow-up|9|||
170786800|NCT04318548|617229498|FG000|Overall Study|Protocol Violation|1|||
170786801|NCT04318548|617229499|FG001|Overall Study|Protocol Violation|0|||
170786802|NCT04318548|617229500|FG002|Overall Study|Protocol Violation|2|||
170786803|NCT04318548|617229498|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
170786804|NCT04318548|617229499|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
170786805|NCT04318548|617229500|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
170786806|NCT04318548|617229498|FG000|Overall Study|Migrated / moved from the study area|0|||
170786807|NCT04318548|617229499|FG001|Overall Study|Migrated / moved from the study area|0|||
170786808|NCT04318548|617229500|FG002|Overall Study|Migrated / moved from the study area|1|||
170786809|NCT04318548|617229498|FG000|Overall Study|Other|1|||
170786810|NCT04318548|617229499|FG001|Overall Study|Other|2|||
170786811|NCT04318548|617229500|FG002|Overall Study|Other|3|||
170786812|NCT04390048|617229501|FG000|Overall Study|Withdrawal by Subject|1|||
170786813|NCT04390048|617229502|FG001|Overall Study|Withdrawal by Subject|3|||
170786814|NCT03366649|617229505|FG000|Overall Study|Failed preoperative screening|4|||
170786815|NCT03366649|617229506|FG001|Overall Study|Failed preoperative screening|0|||
170786816|NCT03366649|617229507|FG002|Overall Study|Failed preoperative screening|0|||
170786817|NCT03366649|617229505|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
170786818|NCT03366649|617229506|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
170786819|NCT03366649|617229507|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
170786820|NCT05192200|617229508|FG000|Treatment Period|Other|1|||
170786821|NCT05192200|617229508|FG000|Treatment Period|Lack of Efficacy|1|||
170786822|NCT05192200|617229508|FG000|Treatment Period|Withdrawal by Subject|1|||
170786823|NCT05192200|617229508|FG000|Follow-up|Withdrawal by Subject|1|||
170786824|NCT01785719|617229509|FG000|4-week Baseline Evaluation|Physician Decision|1|||
170786825|NCT01785719|617229510|FG001|4-week Baseline Evaluation|Physician Decision|0|||
170786826|NCT01785719|617229509|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
170786827|NCT01785719|617229510|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
170786828|NCT01785719|617229509|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
170786829|NCT01785719|617229510|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
170786830|NCT01785719|617229509|FG000|4-week Baseline Evaluation|Pregnancy|0|||
170786831|NCT01785719|617229510|FG001|4-week Baseline Evaluation|Pregnancy|2|||
170786832|NCT01785719|617229509|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
170786833|NCT01785719|617229510|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
170786834|NCT01785719|617229509|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
170786835|NCT01785719|617229510|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
170786836|NCT01785719|617229509|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
170449841|NCT01014624|615985620|FG001|Overall Study|Protocol Violation|0|||
170634191|NCT00515619|616670218|FG000|Overall Study|Lack of Efficacy|92|||
170449842|NCT01014624|615985619|FG000|Overall Study|Withdrawal by Subject|1|||
170449843|NCT01014624|615985620|FG001|Overall Study|Withdrawal by Subject|0|||
170449844|NCT00685802|615985623|FG000|Washout Period of 7 Days|Protocol Violation|2|||
170449845|NCT00685802|615985624|FG001|Washout Period of 7 Days|Protocol Violation|0|||
170449846|NCT00685802|615985623|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
170449847|NCT00685802|615985624|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
170449848|NCT00296491|615985625|FG000|Overall Study|Low Pollen Counts|18|||
170449849|NCT00296491|615985626|FG001|Overall Study|Low Pollen Counts|26|||
170449850|NCT00296491|615985627|FG002|Overall Study|Low Pollen Counts|25|||
170449851|NCT00296491|615985628|FG003|Overall Study|Low Pollen Counts|16|||
170449852|NCT00296491|615985625|FG000|Overall Study|Protocol Violation|4|||
170449853|NCT00296491|615985626|FG001|Overall Study|Protocol Violation|6|||
170449854|NCT00296491|615985627|FG002|Overall Study|Protocol Violation|2|||
170634192|NCT00515619|616670218|FG000|Overall Study|Withdrawal by Subject|66|||
170634193|NCT00515619|616670218|FG000|Overall Study|Protocol Violation|3|||
170634194|NCT00515619|616670218|FG000|Overall Study|Lost to Follow-up|4|||
170634195|NCT00515619|616670218|FG000|Overall Study|Unsatisfactory compliance|6|||
170634196|NCT00515619|616670218|FG000|Overall Study|Other: Site discontinuing trials|2|||
170634197|NCT00515619|616670218|FG000|Overall Study|Other: Subject cannot attend visits|2|||
170634198|NCT00515619|616670218|FG000|Overall Study|Other: Subject required surgery|1|||
170634199|NCT00515619|616670218|FG000|Overall Study|Other: Subject moved to another country|1|||
170634200|NCT00515619|616670218|FG000|Overall Study|Other: Investigator decision|1|||
170634201|NCT00515619|616670218|FG000|Overall Study|Other: Subject became pregnant|1|||
170634202|NCT00515619|616670218|FG000|Overall Study|Other: Request from sponsor|1|||
170634203|NCT00515619|616670218|FG000|Overall Study|Other: Drug available on license|1|||
170634204|NCT00515619|616670218|FG000|Overall Study|Other: Subject interested in other AED|1|||
170634205|NCT03067077|616670219|FG000|Overall Study|Did not receive surgery|4|||
170634206|NCT03067077|616670220|FG001|Overall Study|Did not receive surgery|5|||
170634207|NCT03067077|616670219|FG000|Overall Study|Lost to Follow-up|3|||
170634208|NCT03067077|616670220|FG001|Overall Study|Lost to Follow-up|2|||
170634209|NCT03773796|616671878|FG000|Overall Study|Adverse Event|1|||
170634210|NCT03773796|616671878|FG000|Overall Study|Withdrawal by Subject|1|||
170634211|NCT03773796|616671878|FG000|Overall Study|Lack of Efficacy|1|||
170634212|NCT00145158|616671879|FG000|Overall Study|premature withdrawal|2|||
170634213|NCT00145158|616671880|FG001|Overall Study|premature withdrawal|3|||
170634214|NCT04050202|616671887|FG000|Overall Study|Lost to Follow-up|2|||
170634215|NCT03198507|616671888|FG000|Overall Study|Withdrawal by Subject|1|||
170634216|NCT03198507|616671889|FG001|Overall Study|Withdrawal by Subject|0|||
170634217|NCT03722238|616671890|FG000|Overall Study|Protocol Violation|1|||
170634218|NCT03722238|616671891|FG001|Overall Study|Protocol Violation|0|||
170634219|NCT03722238|616671890|FG000|Overall Study|Physician Decision|1|||
170634220|NCT03722238|616671891|FG001|Overall Study|Physician Decision|0|||
170634221|NCT03722238|616671890|FG000|Overall Study|Death|1|||
170634222|NCT03722238|616671891|FG001|Overall Study|Death|0|||
170634223|NCT03722238|616671890|FG000|Overall Study|Lost to Follow-up|6|||
170634224|NCT03722238|616671891|FG001|Overall Study|Lost to Follow-up|0|||
170634225|NCT03722238|616671890|FG000|Overall Study|Partial missing data|44|||
170634226|NCT03722238|616671891|FG001|Overall Study|Partial missing data|1|||
170634227|NCT03722238|616671890|FG000|Overall Study|Withdrawal by Subject|2|||
170634228|NCT03722238|616671891|FG001|Overall Study|Withdrawal by Subject|0|||
170634229|NCT03722238|616671890|FG000|Overall Study|Other|4|||
170634230|NCT03722238|616671891|FG001|Overall Study|Other|0|||
170634231|NCT03722238|616671890|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
170634232|NCT03722238|616671891|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
170634233|NCT03722238|616671890|FG000|Overall Study|Did not meet risk classification group criteria|90|||
170634234|NCT03722238|616671891|FG001|Overall Study|Did not meet risk classification group criteria|0|||
170634235|NCT03722238|616671890|FG000|Overall Study|Did not sign consent|17|||
170634236|NCT03722238|616671891|FG001|Overall Study|Did not sign consent|0|||
170634237|NCT03722238|616671890|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
170634238|NCT03722238|616671891|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
170634239|NCT03722238|616671890|FG000|Overall Study|Not willing to purchase study medication|142|||
170634240|NCT03722238|616671891|FG001|Overall Study|Not willing to purchase study medication|0|||
170634241|NCT03722238|616671890|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
170786837|NCT01785719|617229510|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
170786838|NCT01785719|617229509|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
170449855|NCT00296491|615985628|FG003|Overall Study|Protocol Violation|3|||
170449856|NCT00296491|615985625|FG000|Overall Study|Adverse Event|1|||
170449857|NCT00296491|615985626|FG001|Overall Study|Adverse Event|3|||
170449858|NCT00296491|615985627|FG002|Overall Study|Adverse Event|1|||
170449859|NCT00296491|615985628|FG003|Overall Study|Adverse Event|4|||
170449860|NCT00296491|615985625|FG000|Overall Study|Withdrawn due to Asthma|0|||
170449861|NCT00296491|615985626|FG001|Overall Study|Withdrawn due to Asthma|0|||
170449862|NCT00296491|615985627|FG002|Overall Study|Withdrawn due to Asthma|0|||
170449863|NCT00296491|615985628|FG003|Overall Study|Withdrawn due to Asthma|4|||
170449864|NCT00296491|615985625|FG000|Overall Study|Withdrawal by Subject|7|||
170449865|NCT00296491|615985626|FG001|Overall Study|Withdrawal by Subject|3|||
170449866|NCT00296491|615985627|FG002|Overall Study|Withdrawal by Subject|3|||
170449867|NCT00296491|615985628|FG003|Overall Study|Withdrawal by Subject|2|||
170786839|NCT01785719|617229510|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
170786840|NCT01785719|617229509|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
170449868|NCT00296491|615985625|FG000|Overall Study|Non-Compliance|12|||
170449869|NCT00296491|615985626|FG001|Overall Study|Non-Compliance|13|||
170449870|NCT00296491|615985627|FG002|Overall Study|Non-Compliance|10|||
170449871|NCT00296491|615985628|FG003|Overall Study|Non-Compliance|14|||
170449872|NCT00296491|615985625|FG000|Overall Study|Lost to Follow-up|0|||
170449873|NCT00296491|615985626|FG001|Overall Study|Lost to Follow-up|2|||
170449874|NCT00296491|615985627|FG002|Overall Study|Lost to Follow-up|2|||
170449875|NCT00296491|615985628|FG003|Overall Study|Lost to Follow-up|0|||
170449876|NCT00619359|615985631|FG000|Overall Study|Adverse Event|32|||
170449877|NCT00619359|615985632|FG001|Overall Study|Adverse Event|36|||
170449878|NCT00619359|615985631|FG000|Overall Study|Lost to Follow-up|12|||
170449879|NCT00619359|615985632|FG001|Overall Study|Lost to Follow-up|16|||
170449880|NCT00619359|615985631|FG000|Overall Study|Physician Decision|0|||
170449881|NCT00619359|615985632|FG001|Overall Study|Physician Decision|7|||
170449882|NCT00619359|615985631|FG000|Overall Study|Protocol Violation|1|||
170449883|NCT00619359|615985632|FG001|Overall Study|Protocol Violation|1|||
170449884|NCT00619359|615985631|FG000|Overall Study|Withdrawal by Subject|19|||
170449885|NCT00619359|615985632|FG001|Overall Study|Withdrawal by Subject|20|||
170449886|NCT00619359|615985631|FG000|Overall Study|Progressive Disease|3|||
170449887|NCT00619359|615985632|FG001|Overall Study|Progressive Disease|1|||
170449888|NCT01829113|615985634|FG000|Overall Study|Disease Progression|37|||
170449889|NCT01829113|615985635|FG001|Overall Study|Disease Progression|48|||
170449890|NCT01829113|615985634|FG000|Overall Study|Adverse Event|14|||
170449891|NCT01829113|615985635|FG001|Overall Study|Adverse Event|10|||
170449892|NCT01829113|615985634|FG000|Overall Study|Withdrawal by Subject|17|||
170449893|NCT01829113|615985635|FG001|Overall Study|Withdrawal by Subject|10|||
170449894|NCT01829113|615985634|FG000|Overall Study|Death|4|||
170449895|NCT01829113|615985635|FG001|Overall Study|Death|6|||
170449896|NCT01829113|615985634|FG000|Overall Study|Sponsor Decision|1|||
170449897|NCT01829113|615985635|FG001|Overall Study|Sponsor Decision|1|||
170449898|NCT01829113|615985634|FG000|Overall Study|No Study Treatment Received|3|||
170449899|NCT01829113|615985635|FG001|Overall Study|No Study Treatment Received|2|||
170449900|NCT01829113|615985634|FG000|Overall Study|Physician Decision|1|||
170449901|NCT01829113|615985635|FG001|Overall Study|Physician Decision|1|||
170449902|NCT04706507|615985642|FG000|Overall Study|Death|45|||
170449903|NCT04706507|615985643|FG001|Overall Study|Death|22|||
170449904|NCT04706507|615985642|FG000|Overall Study|Unable to adhere|0|||
170449905|NCT04706507|615985643|FG001|Overall Study|Unable to adhere|2|||
170449906|NCT04706507|615985642|FG000|Overall Study|Lost to Follow-up|13|||
170449907|NCT04706507|615985643|FG001|Overall Study|Lost to Follow-up|12|||
170449908|NCT04706507|615985642|FG000|Overall Study|Withdrawal of consent|1|||
170449909|NCT04706507|615985643|FG001|Overall Study|Withdrawal of consent|1|||
170449910|NCT04706507|615985642|FG000|Overall Study|Patient or LAR refuses further participation|0|||
170449911|NCT04706507|615985643|FG001|Overall Study|Patient or LAR refuses further participation|3|||
170449912|NCT02654587|615985644|FG000|Overall Study|patient alive at end of study|22|||
170449913|NCT02654587|615985645|FG001|Overall Study|patient alive at end of study|8|||
170449914|NCT02654587|615985644|FG000|Overall Study|Withdrawal by Subject|1|||
170449915|NCT02654587|615985645|FG001|Overall Study|Withdrawal by Subject|7|||
170449916|NCT00396331|615985648|FG000|Overall Study|Failed to mobilize - no transplant|8|||
170449917|NCT00396331|615985648|FG000|Overall Study|Did not go on to transplant|5|||
170449918|NCT00396331|615985648|FG000|Overall Study|Lost to Follow-up|3|||
170449919|NCT00396331|615985648|FG000|Overall Study|Death|16|||
170449920|NCT00873119|615985655|FG000|Overall Study|Patient request|4|||
170449921|NCT00873119|615985656|FG001|Overall Study|Patient request|2|||
170449922|NCT00873119|615985655|FG000|Overall Study|Adverse Event|8|||
170449923|NCT00873119|615985656|FG001|Overall Study|Adverse Event|0|||
170541029|NCT00835978|616325141|FG002|Overall Study|Other|8|||
170541030|NCT00835978|616325142|FG003|Overall Study|Other|0|||
170541031|NCT00835978|616325139|FG000|Overall Study|Objective progression or relapse|2|||
170541032|NCT00835978|616325140|FG001|Overall Study|Objective progression or relapse|0|||
170541033|NCT00835978|616325141|FG002|Overall Study|Objective progression or relapse|1|||
170541034|NCT00835978|616325142|FG003|Overall Study|Objective progression or relapse|0|||
170541035|NCT00835978|616325139|FG000|Overall Study|Adverse Event|1|||
170541036|NCT00835978|616325140|FG001|Overall Study|Adverse Event|0|||
170541037|NCT00835978|616325141|FG002|Overall Study|Adverse Event|1|||
170541038|NCT00835978|616325142|FG003|Overall Study|Adverse Event|0|||
170541039|NCT00835978|616325139|FG000|Overall Study|Withdrawal by Subject|0|||
170541040|NCT00835978|616325140|FG001|Overall Study|Withdrawal by Subject|3|||
170449924|NCT00873119|615985655|FG000|Overall Study|Progressive disease|26|||
170449925|NCT00873119|615985656|FG001|Overall Study|Progressive disease|18|||
170449926|NCT00873119|615985655|FG000|Overall Study|Death|2|||
170449927|NCT00873119|615985656|FG001|Overall Study|Death|1|||
170449928|NCT00873119|615985655|FG000|Overall Study|Other|2|||
170449929|NCT00873119|615985656|FG001|Overall Study|Other|5|||
170449930|NCT00873119|615985655|FG000|Overall Study|Not treated|2|||
170449931|NCT00873119|615985656|FG001|Overall Study|Not treated|0|||
170541041|NCT00835978|616325141|FG002|Overall Study|Withdrawal by Subject|0|||
170449932|NCT03648879|615985657|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
170449933|NCT00285584|615985658|FG000|Month 3|Lost to Follow-up|3|||
170449934|NCT00285584|615985659|FG001|Month 3|Lost to Follow-up|3|||
170449935|NCT00285584|615985658|FG000|Month 3|Withdrawal by Subject|1|||
170449936|NCT00285584|615985659|FG001|Month 3|Withdrawal by Subject|0|||
170449937|NCT00285584|615985658|FG000|Month 6|Lost to Follow-up|0|||
170449938|NCT00285584|615985659|FG001|Month 6|Lost to Follow-up|1|||
170449939|NCT00613730|615985662|FG000|Overall Study|Disease progression|2|||
170449940|NCT00613730|615985662|FG000|Overall Study|Administrative decision|1|||
170449941|NCT00895037|615985663|FG000|Overall Study|Death|0|||
170449942|NCT00895037|615985664|FG001|Overall Study|Death|2|||
170449943|NCT00895037|615985665|FG002|Overall Study|Death|1|||
170449944|NCT01930175|615985678|FG000|Core Study|Lost to Follow-up|0|||
170449945|NCT01930175|615985679|FG001|Core Study|Lost to Follow-up|1|||
170449946|NCT01930175|615985680|FG002|Core Study|Lost to Follow-up|0|||
170449947|NCT01930175|615985678|FG000|Core Study|Adverse Event|0|||
170449948|NCT01930175|615985679|FG001|Core Study|Adverse Event|0|||
170449949|NCT01930175|615985680|FG002|Core Study|Adverse Event|1|||
170449950|NCT03903159|615985682|FG000|Overall Study|Discharged with Staff Approval|2|||
170449951|NCT03903159|615985682|FG000|Overall Study|Discharged at Staff Request|2|||
170449952|NCT03903159|615985682|FG000|Overall Study|Discharged Against Staff Advice|1|||
170449953|NCT01425528|615985685|FG000|Overall Study|Withdrawal by Subject|1|||
170449954|NCT01425528|615985686|FG001|Overall Study|Withdrawal by Subject|1|||
170449955|NCT00842530|615985687|FG000|Overall Study|Serious adverse event|0|||
170449956|NCT00842530|615985688|FG001|Overall Study|Serious adverse event|6|||
170449957|NCT00842530|615985687|FG000|Overall Study|Other adverse event|6|||
170449958|NCT00842530|615985688|FG001|Overall Study|Other adverse event|1|||
170449959|NCT00842530|615985687|FG000|Overall Study|Protocol Violation|32|||
170449960|NCT00842530|615985688|FG001|Overall Study|Protocol Violation|14|||
170449961|NCT00842530|615985687|FG000|Overall Study|Lost to Follow-up|6|||
170449962|NCT00842530|615985688|FG001|Overall Study|Lost to Follow-up|8|||
170449963|NCT00842530|615985687|FG000|Overall Study|Withdrawal by Subject|73|||
170449964|NCT00842530|615985688|FG001|Overall Study|Withdrawal by Subject|28|||
170449965|NCT01117987|615985689|FG000|Overall Study|Protocol deviation|0|||
170449966|NCT01117987|615985690|FG001|Overall Study|Protocol deviation|1|||
170449967|NCT01117987|615985689|FG000|Overall Study|Subject no longer requires study drug|1|||
170449968|NCT01117987|615985690|FG001|Overall Study|Subject no longer requires study drug|0|||
170449969|NCT01117987|615985689|FG000|Overall Study|Lost to Follow-up|1|||
170449970|NCT01117987|615985690|FG001|Overall Study|Lost to Follow-up|1|||
170449971|NCT01117987|615985689|FG000|Overall Study|Abnormal test procedure result|2|||
170449972|NCT01117987|615985690|FG001|Overall Study|Abnormal test procedure result|0|||
170449973|NCT01117987|615985689|FG000|Overall Study|Lack of Efficacy|3|||
170449974|NCT01117987|615985690|FG001|Overall Study|Lack of Efficacy|4|||
170449975|NCT01117987|615985689|FG000|Overall Study|Death|5|||
170449976|NCT01117987|615985690|FG001|Overall Study|Death|10|||
170449977|NCT01117987|615985689|FG000|Overall Study|Withdrawal by Subject|5|||
170449978|NCT01117987|615985690|FG001|Overall Study|Withdrawal by Subject|10|||
170449979|NCT01117987|615985689|FG000|Overall Study|Adverse Event|19|||
170449980|NCT01117987|615985690|FG001|Overall Study|Adverse Event|26|||
170449981|NCT01117987|615985689|FG000|Overall Study|Administrative problems|25|||
170449982|NCT01117987|615985690|FG001|Overall Study|Administrative problems|22|||
170449983|NCT00402025|615985692|FG000|Overall Study|Adverse Event|0|||
170449984|NCT00402025|615985693|FG001|Overall Study|Adverse Event|0|||
170449985|NCT00402025|615985694|FG002|Overall Study|Adverse Event|2|||
170449986|NCT00402025|615985692|FG000|Overall Study|Death|0|||
170449987|NCT00402025|615985693|FG001|Overall Study|Death|1|||
170449988|NCT00402025|615985694|FG002|Overall Study|Death|5|||
170449989|NCT00402025|615985692|FG000|Overall Study|Disease Progression|1|||
170449990|NCT00402025|615985693|FG001|Overall Study|Disease Progression|1|||
170449991|NCT00402025|615985694|FG002|Overall Study|Disease Progression|2|||
170449992|NCT00402025|615985692|FG000|Overall Study|Physician Decision|1|||
170449993|NCT00402025|615985693|FG001|Overall Study|Physician Decision|1|||
170449994|NCT00402025|615985694|FG002|Overall Study|Physician Decision|0|||
170449995|NCT00402025|615985692|FG000|Overall Study|Participant Decision|0|||
170449996|NCT00402025|615985693|FG001|Overall Study|Participant Decision|0|||
170449997|NCT00402025|615985694|FG002|Overall Study|Participant Decision|1|||
170449998|NCT00955721|615985707|FG000|Overall Study|Physician Decision|1|||
170449999|NCT00955721|615985708|FG001|Overall Study|Physician Decision|0|||
170450000|NCT00955721|615985707|FG000|Overall Study|Death|1|||
170450001|NCT00955721|615985708|FG001|Overall Study|Death|0|||
170450002|NCT00955721|615985707|FG000|Overall Study|Withdrawal by Subject|1|||
170450003|NCT00955721|615985708|FG001|Overall Study|Withdrawal by Subject|0|||
170450004|NCT02310789|615987248|FG000|Overall Study|Adverse Event|1|||
170450005|NCT02516410|615987249|FG000|Overall Study|Adverse Event|0|||
170450006|NCT02516410|615987250|FG001|Overall Study|Adverse Event|1|||
170450007|NCT02516410|615987249|FG000|Overall Study|Withdrawal by Subject|0|||
170450008|NCT02516410|615987250|FG001|Overall Study|Withdrawal by Subject|1|||
170450009|NCT04146363|615987253|FG000|Induction Period|Adverse Event|1|||
170450010|NCT04146363|615987254|FG001|Induction Period|Adverse Event|2|||
170450011|NCT04146363|615987255|FG002|Induction Period|Adverse Event|0|||
170450012|NCT04146363|615987256|FG003|Induction Period|Adverse Event|0|||
170450013|NCT04146363|615987257|FG004|Induction Period|Adverse Event|0|||
170450014|NCT04146363|615987258|FG005|Induction Period|Adverse Event|0|||
170450015|NCT04146363|615987259|FG006|Induction Period|Adverse Event|0|||
170450016|NCT04146363|615987260|FG007|Induction Period|Adverse Event|0|||
170450017|NCT04146363|615987261|FG008|Induction Period|Adverse Event|0|||
170450018|NCT04146363|615987262|FG009|Induction Period|Adverse Event|0|||
170450019|NCT04146363|615987263|FG010|Induction Period|Adverse Event|0|||
170450020|NCT04146363|615987253|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
170450021|NCT04146363|615987254|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
170450022|NCT04146363|615987255|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
170450023|NCT04146363|615987256|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
170450024|NCT04146363|615987257|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
170450025|NCT04146363|615987258|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
170450026|NCT04146363|615987259|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
170450027|NCT04146363|615987260|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
170450028|NCT04146363|615987261|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
170450029|NCT04146363|615987262|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
170450030|NCT04146363|615987263|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
170450031|NCT04146363|615987253|FG000|Induction Period|Lack of Efficacy|7|||
170450032|NCT04146363|615987254|FG001|Induction Period|Lack of Efficacy|2|||
170450033|NCT04146363|615987255|FG002|Induction Period|Lack of Efficacy|0|||
170450034|NCT04146363|615987256|FG003|Induction Period|Lack of Efficacy|0|||
170450035|NCT04146363|615987257|FG004|Induction Period|Lack of Efficacy|0|||
170450036|NCT04146363|615987258|FG005|Induction Period|Lack of Efficacy|0|||
170450037|NCT04146363|615987259|FG006|Induction Period|Lack of Efficacy|0|||
170450038|NCT04146363|615987260|FG007|Induction Period|Lack of Efficacy|0|||
170450039|NCT04146363|615987261|FG008|Induction Period|Lack of Efficacy|0|||
170450040|NCT04146363|615987262|FG009|Induction Period|Lack of Efficacy|0|||
170450041|NCT04146363|615987263|FG010|Induction Period|Lack of Efficacy|0|||
170450042|NCT04146363|615987253|FG000|Induction Period|Lost to Follow-up|1|||
170450043|NCT04146363|615987254|FG001|Induction Period|Lost to Follow-up|4|||
170450044|NCT04146363|615987255|FG002|Induction Period|Lost to Follow-up|0|||
170450045|NCT04146363|615987256|FG003|Induction Period|Lost to Follow-up|0|||
170450046|NCT04146363|615987257|FG004|Induction Period|Lost to Follow-up|0|||
170450047|NCT04146363|615987258|FG005|Induction Period|Lost to Follow-up|0|||
170450048|NCT04146363|615987259|FG006|Induction Period|Lost to Follow-up|0|||
170450049|NCT04146363|615987260|FG007|Induction Period|Lost to Follow-up|0|||
170450050|NCT04146363|615987261|FG008|Induction Period|Lost to Follow-up|0|||
170450051|NCT04146363|615987262|FG009|Induction Period|Lost to Follow-up|0|||
170450052|NCT04146363|615987263|FG010|Induction Period|Lost to Follow-up|0|||
170450053|NCT04146363|615987253|FG000|Induction Period|Positive quantiferon test|0|||
170450054|NCT04146363|615987254|FG001|Induction Period|Positive quantiferon test|1|||
170450055|NCT04146363|615987255|FG002|Induction Period|Positive quantiferon test|0|||
170450056|NCT04146363|615987256|FG003|Induction Period|Positive quantiferon test|0|||
170450057|NCT04146363|615987257|FG004|Induction Period|Positive quantiferon test|0|||
170450058|NCT04146363|615987258|FG005|Induction Period|Positive quantiferon test|0|||
170450059|NCT04146363|615987259|FG006|Induction Period|Positive quantiferon test|0|||
170450060|NCT04146363|615987260|FG007|Induction Period|Positive quantiferon test|0|||
170450061|NCT04146363|615987261|FG008|Induction Period|Positive quantiferon test|0|||
170541042|NCT00835978|616325142|FG003|Overall Study|Withdrawal by Subject|5|||
170541043|NCT00835978|616325139|FG000|Overall Study|Study terminated by sponsor|12|||
170541044|NCT00835978|616325140|FG001|Overall Study|Study terminated by sponsor|8|||
170541045|NCT00835978|616325141|FG002|Overall Study|Study terminated by sponsor|30|||
170541046|NCT00835978|616325142|FG003|Overall Study|Study terminated by sponsor|0|||
170541047|NCT02927145|616325143|FG000|Initial Recruitment|Withdrawal by Subject|0|||
170541048|NCT02927145|616325144|FG001|Initial Recruitment|Withdrawal by Subject|1|||
170541049|NCT02927145|616325145|FG002|Initial Recruitment|Withdrawal by Subject|1|||
170541050|NCT02927145|616325146|FG003|Initial Recruitment|Withdrawal by Subject|4|||
170450062|NCT04146363|615987262|FG009|Induction Period|Positive quantiferon test|0|||
170450063|NCT04146363|615987263|FG010|Induction Period|Positive quantiferon test|0|||
170450064|NCT04146363|615987253|FG000|Induction Period|Protocol Deviation|5|||
170450065|NCT04146363|615987254|FG001|Induction Period|Protocol Deviation|6|||
170450066|NCT04146363|615987255|FG002|Induction Period|Protocol Deviation|0|||
170450067|NCT04146363|615987256|FG003|Induction Period|Protocol Deviation|0|||
170450068|NCT04146363|615987257|FG004|Induction Period|Protocol Deviation|0|||
170450069|NCT04146363|615987258|FG005|Induction Period|Protocol Deviation|0|||
170450070|NCT04146363|615987259|FG006|Induction Period|Protocol Deviation|0|||
170450071|NCT04146363|615987260|FG007|Induction Period|Protocol Deviation|0|||
170541051|NCT02927145|616325147|FG004|Initial Recruitment|Withdrawal by Subject|1|||
170541052|NCT02927145|616325148|FG005|Initial Recruitment|Withdrawal by Subject|1|||
170887248|NCT00130832|617595907|FG001|Overall Study|Other|3|||
170450072|NCT04146363|615987261|FG008|Induction Period|Protocol Deviation|0|||
170450073|NCT04146363|615987262|FG009|Induction Period|Protocol Deviation|0|||
170450074|NCT04146363|615987263|FG010|Induction Period|Protocol Deviation|0|||
170450075|NCT04146363|615987253|FG000|Induction Period|Withdrawal by Subject|6|||
170450076|NCT04146363|615987254|FG001|Induction Period|Withdrawal by Subject|3|||
170450077|NCT04146363|615987255|FG002|Induction Period|Withdrawal by Subject|0|||
170450078|NCT04146363|615987256|FG003|Induction Period|Withdrawal by Subject|0|||
170450079|NCT04146363|615987257|FG004|Induction Period|Withdrawal by Subject|0|||
170450080|NCT04146363|615987258|FG005|Induction Period|Withdrawal by Subject|0|||
170450081|NCT04146363|615987259|FG006|Induction Period|Withdrawal by Subject|0|||
170450082|NCT04146363|615987260|FG007|Induction Period|Withdrawal by Subject|0|||
170450083|NCT04146363|615987261|FG008|Induction Period|Withdrawal by Subject|0|||
170450084|NCT04146363|615987262|FG009|Induction Period|Withdrawal by Subject|0|||
170450085|NCT04146363|615987263|FG010|Induction Period|Withdrawal by Subject|0|||
170450086|NCT04146363|615987253|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450087|NCT04146363|615987254|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450088|NCT04146363|615987255|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450089|NCT04146363|615987256|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450090|NCT04146363|615987257|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450091|NCT04146363|615987258|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450092|NCT04146363|615987259|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
170450093|NCT04146363|615987260|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
170450094|NCT04146363|615987261|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450095|NCT04146363|615987262|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450096|NCT04146363|615987263|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
170450097|NCT04146363|615987253|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450098|NCT04146363|615987254|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450099|NCT04146363|615987255|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450100|NCT04146363|615987256|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450101|NCT04146363|615987257|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450102|NCT04146363|615987258|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450103|NCT04146363|615987259|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450104|NCT04146363|615987260|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
170450105|NCT04146363|615987261|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450106|NCT04146363|615987262|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450107|NCT04146363|615987263|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
170450108|NCT04146363|615987253|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450109|NCT04146363|615987254|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450110|NCT04146363|615987255|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450111|NCT04146363|615987256|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450112|NCT04146363|615987257|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450113|NCT04146363|615987258|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450114|NCT04146363|615987259|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
170450115|NCT04146363|615987260|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
170450116|NCT04146363|615987261|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450117|NCT04146363|615987262|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450118|NCT04146363|615987263|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
170450119|NCT04146363|615987253|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450120|NCT04146363|615987254|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450121|NCT04146363|615987255|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
170450122|NCT04146363|615987256|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450123|NCT04146363|615987257|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450124|NCT04146363|615987258|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
170450125|NCT04146363|615987259|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450126|NCT04146363|615987260|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450127|NCT04146363|615987261|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450128|NCT04146363|615987262|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450129|NCT04146363|615987263|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
170450130|NCT04146363|615987253|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170450131|NCT04146363|615987254|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170450132|NCT04146363|615987255|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170450133|NCT04146363|615987256|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170450134|NCT04146363|615987257|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
170541053|NCT02927145|616325149|FG006|Initial Recruitment|Withdrawal by Subject|0|||
170541054|NCT02927145|616325150|FG007|Initial Recruitment|Withdrawal by Subject|0|||
170450135|NCT04146363|615987258|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
170450136|NCT04146363|615987259|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
170541055|NCT02927145|616325151|FG008|Initial Recruitment|Withdrawal by Subject|2|||
170450137|NCT04146363|615987260|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
170450138|NCT04146363|615987261|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170786841|NCT01785719|617229510|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
170634242|NCT03722238|616671891|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
170634243|NCT02488915|616671892|FG000|Overall Study|Death|21|||
170634244|NCT02488915|616671892|FG000|Overall Study|Lost to Follow-up|4|||
170634245|NCT02488915|616671892|FG000|Overall Study|Withdrawal by Subject|1|||
170634246|NCT03196349|616671894|FG000|Overall Study|Did not receive study drug|0|||
170634247|NCT03196349|616671895|FG001|Overall Study|Did not receive study drug|1|||
170634248|NCT03196349|616671896|FG002|Overall Study|Did not receive study drug|2|||
170634249|NCT03196349|616671894|FG000|Overall Study|No data entered|2|||
170634250|NCT03196349|616671895|FG001|Overall Study|No data entered|4|||
170634251|NCT03196349|616671896|FG002|Overall Study|No data entered|0|||
170634252|NCT03196349|616671894|FG000|Overall Study|Study Terminated early|15|||
170634253|NCT03196349|616671895|FG001|Overall Study|Study Terminated early|9|||
170634254|NCT03196349|616671896|FG002|Overall Study|Study Terminated early|11|||
170634255|NCT02819804|616671897|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
170634256|NCT03388164|616671905|FG000|Overall Study|Withdrawal by Subject|3|||
170634257|NCT03388164|616671906|FG001|Overall Study|Withdrawal by Subject|1|||
170634258|NCT03967444|616671907|FG000|Overall Study|Lost to Follow-up|1|||
170634259|NCT03967444|616671908|FG001|Overall Study|Lost to Follow-up|2|||
170634260|NCT02858362|616671909|FG000|Overall Study|Protocol Violation|0|||
170634261|NCT02858362|616671910|FG001|Overall Study|Protocol Violation|1|||
170634262|NCT02858362|616671911|FG002|Overall Study|Protocol Violation|0|||
170634263|NCT02858362|616671909|FG000|Overall Study|Withdrawal by Subject|1|||
170634264|NCT02858362|616671910|FG001|Overall Study|Withdrawal by Subject|0|||
170634265|NCT02858362|616671911|FG002|Overall Study|Withdrawal by Subject|0|||
170634266|NCT02858362|616671909|FG000|Overall Study|Early Study Termination|0|||
170634267|NCT02858362|616671910|FG001|Overall Study|Early Study Termination|0|||
170634268|NCT02858362|616671911|FG002|Overall Study|Early Study Termination|3|||
170634269|NCT02858362|616671909|FG000|Overall Study|Lost to Follow-up|1|||
170634270|NCT02858362|616671910|FG001|Overall Study|Lost to Follow-up|0|||
170634271|NCT02858362|616671911|FG002|Overall Study|Lost to Follow-up|0|||
170634272|NCT00380367|616671919|FG000|Overall Study|Lost to Follow-up|1|||
170634273|NCT00380367|616671919|FG000|Overall Study|Withdrawal by Subject|1|||
170634274|NCT01821118|616671920|FG000|Overall Study|Death|0|||
170634275|NCT01821118|616671921|FG001|Overall Study|Death|1|||
170634276|NCT01605799|616671923|FG000|Overall Study|Withdrawal by Subject|2|||
170634277|NCT01605799|616671924|FG001|Overall Study|Withdrawal by Subject|1|||
170634278|NCT00345358|616671927|FG000|Primary Vaccination Phase|Other|0|||
170634279|NCT00345358|616671928|FG001|Primary Vaccination Phase|Other|1|||
170634280|NCT00345358|616671929|FG002|Primary Vaccination Phase|Other|1|||
170634281|NCT00345358|616671930|FG003|Primary Vaccination Phase|Other|0|||
170634282|NCT00345358|616671927|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
170634283|NCT00345358|616671928|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
170634284|NCT00345358|616671929|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
170634285|NCT00345358|616671930|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
170634286|NCT00345358|616671927|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
170634287|NCT00345358|616671928|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
170634288|NCT00345358|616671929|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
170634289|NCT00345358|616671930|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
170634290|NCT00345358|616671927|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
170634291|NCT00345358|616671928|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
170634292|NCT00345358|616671929|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
170634293|NCT00345358|616671930|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
170634294|NCT00345358|616671927|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
170541056|NCT02927145|616325143|FG000|Initial Recruitment|Adverse Event|0|||
170541057|NCT02927145|616325144|FG001|Initial Recruitment|Adverse Event|0|||
170541058|NCT02927145|616325145|FG002|Initial Recruitment|Adverse Event|0|||
170541059|NCT02927145|616325146|FG003|Initial Recruitment|Adverse Event|0|||
170541060|NCT02927145|616325147|FG004|Initial Recruitment|Adverse Event|2|||
170541061|NCT02927145|616325148|FG005|Initial Recruitment|Adverse Event|0|||
170541062|NCT02927145|616325149|FG006|Initial Recruitment|Adverse Event|0|||
170541063|NCT02927145|616325150|FG007|Initial Recruitment|Adverse Event|0|||
170541064|NCT02927145|616325151|FG008|Initial Recruitment|Adverse Event|0|||
170541065|NCT02927145|616325143|FG000|Invitation for Additional Challenge|Pregnancy|0|||
170634295|NCT00345358|616671928|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
170634296|NCT00345358|616671929|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
170634297|NCT00345358|616671930|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
170634298|NCT00345358|616671927|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
170634299|NCT00345358|616671928|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
170541066|NCT02927145|616325144|FG001|Invitation for Additional Challenge|Pregnancy|0|||
170634300|NCT00345358|616671929|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
170634301|NCT00345358|616671930|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
170634302|NCT00346697|616671932|FG000|Overall Study|Lost to Follow-up|0|||
170634303|NCT00346697|616671933|FG001|Overall Study|Lost to Follow-up|1|||
170634304|NCT00499083|616671934|FG000|Overall Study|Not evaluable|3|||
170887249|NCT01934140|617595909|FG000|Persistence Phase (Year 6-10)|Other|24|||
170887250|NCT01934140|617595910|FG001|Persistence Phase (Year 6-10)|Other|6|||
170887251|NCT01934140|617595909|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
170887252|NCT01934140|617595910|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
170634305|NCT00686686|616671935|FG000|Overall Study|Non-compliance|1|||
170887253|NCT01934140|617595909|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
170887254|NCT01934140|617595910|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
170887255|NCT01934140|617595909|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
170887256|NCT01934140|617595910|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
170887257|NCT01934140|617595909|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
170887258|NCT01934140|617595910|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
170887259|NCT01934140|617595909|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
170887260|NCT01934140|617595910|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
170887261|NCT01934140|617595909|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
170887262|NCT01934140|617595910|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
170887263|NCT01934140|617595909|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
170887264|NCT01934140|617595910|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
170887265|NCT00200850|617595916|FG000|Overall Study|relocation|1|||
170887266|NCT00200850|617595917|FG001|Overall Study|relocation|0|||
170887267|NCT00200850|617595918|FG002|Overall Study|relocation|1|||
170887268|NCT00200850|617595916|FG000|Overall Study|too busy|1|||
170887269|NCT00200850|617595917|FG001|Overall Study|too busy|0|||
170887270|NCT00200850|617595918|FG002|Overall Study|too busy|0|||
170887271|NCT00200850|617595916|FG000|Overall Study|Pregnancy|0|||
170887272|NCT00200850|617595917|FG001|Overall Study|Pregnancy|0|||
170887273|NCT00200850|617595918|FG002|Overall Study|Pregnancy|1|||
170887274|NCT00200850|617595916|FG000|Overall Study|Poor adherence|0|||
170887275|NCT00200850|617595917|FG001|Overall Study|Poor adherence|0|||
170887276|NCT00200850|617595918|FG002|Overall Study|Poor adherence|1|||
170887277|NCT00200850|617595916|FG000|Overall Study|optic neuritis|0|||
170887278|NCT00200850|617595917|FG001|Overall Study|optic neuritis|0|||
170887279|NCT00200850|617595918|FG002|Overall Study|optic neuritis|1|||
170887280|NCT00200850|617595916|FG000|Overall Study|Adverse Event|1|||
170887281|NCT00200850|617595917|FG001|Overall Study|Adverse Event|1|||
170887282|NCT00200850|617595918|FG002|Overall Study|Adverse Event|2|||
170887283|NCT04294459|617595924|FG000|Overall Study|Adverse Event|0|||
170887284|NCT04294459|617595925|FG001|Overall Study|Adverse Event|1|||
170887285|NCT02468648|617595926|FG000|Overall Study|Death|1|||
170887286|NCT02118792|617595927|FG000|Overall Study|Withdrawal by Subject|6|||
170887287|NCT02118792|617595928|FG001|Overall Study|Withdrawal by Subject|3|||
170887288|NCT02118792|617595927|FG000|Overall Study|Lost to Follow-up|4|||
170887289|NCT02118792|617595928|FG001|Overall Study|Lost to Follow-up|4|||
170887290|NCT02118792|617595927|FG000|Overall Study|Adverse Event|5|||
170887291|NCT02118792|617595928|FG001|Overall Study|Adverse Event|4|||
170887292|NCT02118792|617595927|FG000|Overall Study|Withdrawal by parent/guardian|14|||
170887293|NCT02118792|617595928|FG001|Overall Study|Withdrawal by parent/guardian|20|||
170887294|NCT02118792|617595927|FG000|Overall Study|Other|1|||
170887295|NCT02118792|617595928|FG001|Overall Study|Other|6|||
170887296|NCT02118792|617595927|FG000|Overall Study|Randomised but not treated|1|||
170887297|NCT02118792|617595928|FG001|Overall Study|Randomised but not treated|0|||
170887298|NCT01414257|617595930|FG000|Overall Study|No Visit After First Day of Treatment|12|||
170887299|NCT01414257|617595930|FG000|Overall Study|Protocol Violation|10|||
170887300|NCT01978093|617595931|FG000|Overall Study|Death|1|||
170887301|NCT01978093|617595932|FG001|Overall Study|Death|0|||
170887302|NCT01978093|617595931|FG000|Overall Study|Adverse Event|0|||
170887303|NCT01978093|617595932|FG001|Overall Study|Adverse Event|5|||
170887304|NCT01978093|617595931|FG000|Overall Study|Protocol Violation|8|||
170887305|NCT01978093|617595932|FG001|Overall Study|Protocol Violation|2|||
170887306|NCT01978093|617595931|FG000|Overall Study|Withdrawal by Subject|29|||
170887307|NCT01978093|617595932|FG001|Overall Study|Withdrawal by Subject|25|||
170887308|NCT01978093|617595931|FG000|Overall Study|Lost to Follow-up|11|||
170887309|NCT01978093|617595932|FG001|Overall Study|Lost to Follow-up|15|||
170887310|NCT01978093|617595931|FG000|Overall Study|Migrated/moved from study area|11|||
170887311|NCT01978093|617595932|FG001|Overall Study|Migrated/moved from study area|13|||
170634306|NCT00686686|616671935|FG000|Overall Study|Adverse Event|2|||
170634307|NCT00686686|616671935|FG000|Overall Study|Lost to Follow-up|3|||
170887312|NCT01978093|617595931|FG000|Overall Study|Loss of kaiser coverage|4|||
170887313|NCT01978093|617595932|FG001|Overall Study|Loss of kaiser coverage|10|||
170887314|NCT01978093|617595931|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
170887315|NCT01978093|617595932|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
170887316|NCT01978093|617595931|FG000|Overall Study|Mother lost custody of child|0|||
170887317|NCT01978093|617595932|FG001|Overall Study|Mother lost custody of child|1|||
170887318|NCT01978093|617595931|FG000|Overall Study|Child was in care of grandmother|0|||
170887319|NCT01978093|617595932|FG001|Overall Study|Child was in care of grandmother|1|||
170887320|NCT01978093|617595931|FG000|Overall Study|N/A for vaccine administration|0|||
170887321|NCT01978093|617595932|FG001|Overall Study|N/A for vaccine administration|1|||
170450139|NCT04146363|615987262|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170450140|NCT04146363|615987263|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
170450141|NCT04146363|615987253|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170450142|NCT04146363|615987254|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170450143|NCT04146363|615987255|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
170450144|NCT04146363|615987256|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170450145|NCT04146363|615987257|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170450146|NCT04146363|615987258|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
170450147|NCT04146363|615987259|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
170450148|NCT04146363|615987260|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
170450149|NCT04146363|615987261|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170450150|NCT04146363|615987262|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170450151|NCT04146363|615987263|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
170450152|NCT04146363|615987253|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450153|NCT04146363|615987254|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450154|NCT04146363|615987255|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450155|NCT04146363|615987256|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450156|NCT04146363|615987257|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450157|NCT04146363|615987258|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450158|NCT04146363|615987259|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450159|NCT04146363|615987260|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450160|NCT04146363|615987261|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
170450161|NCT04146363|615987262|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
170450162|NCT04146363|615987263|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
170450163|NCT04146363|615987253|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170450164|NCT04146363|615987254|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170450165|NCT04146363|615987255|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170450166|NCT04146363|615987256|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170450167|NCT04146363|615987257|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170450168|NCT04146363|615987258|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170450169|NCT04146363|615987259|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170450170|NCT04146363|615987260|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170450171|NCT04146363|615987261|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
170541067|NCT02927145|616325145|FG002|Invitation for Additional Challenge|Pregnancy|0|||
170541068|NCT02927145|616325146|FG003|Invitation for Additional Challenge|Pregnancy|0|||
170541069|NCT02927145|616325147|FG004|Invitation for Additional Challenge|Pregnancy|0|||
170541070|NCT02927145|616325148|FG005|Invitation for Additional Challenge|Pregnancy|0|||
170541071|NCT02927145|616325149|FG006|Invitation for Additional Challenge|Pregnancy|1|||
170541072|NCT02927145|616325150|FG007|Invitation for Additional Challenge|Pregnancy|0|||
170541073|NCT02927145|616325151|FG008|Invitation for Additional Challenge|Pregnancy|0|||
170541074|NCT03298061|616325152|FG000|Overall Study|Adverse Event|3|||
170541075|NCT03298061|616325152|FG000|Overall Study|Lack of Efficacy|6|||
170541076|NCT03298061|616325152|FG000|Overall Study|Protocol Violation|1|||
170541077|NCT03298061|616325152|FG000|Overall Study|Physician Decision|7|||
170541078|NCT03298061|616325152|FG000|Overall Study|Withdrawal by Subject|10|||
170541079|NCT02506036|616325154|FG000|First Intervention (4-6 Weeks)|Death|1|||
170541080|NCT02506036|616325155|FG001|First Intervention (4-6 Weeks)|Death|0|||
170541081|NCT02506036|616325154|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
170541082|NCT02506036|616325155|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
170541083|NCT02506036|616325154|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
170541084|NCT02506036|616325155|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
170541085|NCT05276804|616325156|FG000|Overall Study|screen failure|23|||
170541086|NCT05276804|616325157|FG001|Overall Study|screen failure|0|||
170541087|NCT01410604|616325159|FG000|Overall Study|Adverse Event|2|||
170634308|NCT00477386|616671937|FG000|Overall Study|Adverse Event|4|||
170634309|NCT00477386|616671938|FG001|Overall Study|Adverse Event|8|||
170887322|NCT02754726|617595933|FG000|Overall Study|Progressive Disease by RECIST|13|||
170450172|NCT04146363|615987262|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
170450173|NCT04146363|615987263|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
170450174|NCT04146363|615987253|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170450175|NCT04146363|615987254|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170450176|NCT04146363|615987255|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170450177|NCT04146363|615987256|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170541088|NCT01410604|616325160|FG001|Overall Study|Adverse Event|1|||
170541089|NCT01410604|616325159|FG000|Overall Study|Lost to Follow-up|1|||
170541090|NCT01410604|616325160|FG001|Overall Study|Lost to Follow-up|0|||
170450178|NCT04146363|615987257|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170541091|NCT01410604|616325159|FG000|Overall Study|Physician Decision|0|||
170634310|NCT00477386|616671937|FG000|Overall Study|Disease progression, relapse|3|||
170541092|NCT01410604|616325160|FG001|Overall Study|Physician Decision|1|||
170541093|NCT02827708|616325161|FG000|Overall Study|Lost to Follow-up|3|||
170541094|NCT02827708|616325162|FG001|Overall Study|Lost to Follow-up|1|||
170541095|NCT02827708|616325161|FG000|Overall Study|Withdrawal by Subject|1|||
170541096|NCT02827708|616325162|FG001|Overall Study|Withdrawal by Subject|2|||
170541097|NCT02827708|616325161|FG000|Overall Study|Death|1|||
170541098|NCT02827708|616325162|FG001|Overall Study|Death|2|||
170541099|NCT00898807|616325168|FG000|Overall Study|Withdrawal by Subject|5|||
170541100|NCT00898807|616325169|FG001|Overall Study|Withdrawal by Subject|3|||
170541101|NCT00898807|616325168|FG000|Overall Study|Family pressure to discontinue|2|||
170541102|NCT00898807|616325169|FG001|Overall Study|Family pressure to discontinue|2|||
170541103|NCT00898807|616325168|FG000|Overall Study|Lost to Follow-up|1|||
170541104|NCT00898807|616325169|FG001|Overall Study|Lost to Follow-up|3|||
170541105|NCT00898807|616325168|FG000|Overall Study|Death|0|||
170541106|NCT00898807|616325169|FG001|Overall Study|Death|1|||
170541107|NCT00407511|616325172|FG000|Overall Study|Adverse Event|9|||
170541108|NCT00407511|616325172|FG000|Overall Study|Lost to Follow-up|4|||
170541109|NCT00407511|616325172|FG000|Overall Study|Other|5|||
170541110|NCT00407511|616325172|FG000|Overall Study|Withdrawal by Subject|4|||
170541111|NCT00800540|616325178|FG000|Period One: 6 Weeks|Noncompliance|1|||
170541112|NCT00800540|616325179|FG001|Period One: 6 Weeks|Noncompliance|0|||
170541113|NCT00800540|616325178|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
170541114|NCT00800540|616325179|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
170541115|NCT00800540|616325178|FG000|Period 2: 6 Weeks|Adverse Event|0|||
170541116|NCT00800540|616325179|FG001|Period 2: 6 Weeks|Adverse Event|1|||
170541117|NCT00429299|616325180|FG000|Overall Study|Disease Progression|1|||
170541118|NCT00429299|616325181|FG001|Overall Study|Disease Progression|1|||
170541119|NCT00429299|616325182|FG002|Overall Study|Disease Progression|0|||
170541120|NCT00429299|616325180|FG000|Overall Study|Adverse Event|2|||
170541121|NCT00429299|616325181|FG001|Overall Study|Adverse Event|5|||
170541122|NCT00429299|616325182|FG002|Overall Study|Adverse Event|1|||
170786842|NCT01785719|617229509|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
170786843|NCT01785719|617229510|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
170786844|NCT01785719|617229509|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
170786845|NCT01785719|617229510|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
170786846|NCT01785719|617229509|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
170786847|NCT01785719|617229510|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
170786848|NCT01785719|617229509|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
170786849|NCT01785719|617229510|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
170887323|NCT02754726|617595933|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
170887324|NCT02754726|617595933|FG000|Overall Study|Clinical Disease Progression|5|||
170887325|NCT02754726|617595933|FG000|Overall Study|Adverse Event|3|||
170887326|NCT02754726|617595933|FG000|Overall Study|Withdrawal by Subject|1|||
170887327|NCT02754726|617595933|FG000|Overall Study|Tolerability|1|||
170887328|NCT01885000|617595934|FG000|Overall Study|Adverse Event|1|||
170887329|NCT01885000|617595935|FG001|Overall Study|Adverse Event|0|||
170887330|NCT01885000|617595934|FG000|Overall Study|Withdrawal by Subject|1|||
170887331|NCT01885000|617595935|FG001|Overall Study|Withdrawal by Subject|1|||
170887332|NCT01885000|617595934|FG000|Overall Study|Protocol Violation|0|||
170887333|NCT01885000|617595935|FG001|Overall Study|Protocol Violation|1|||
170887334|NCT02009878|617595938|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
170887335|NCT02009878|617595939|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
170887336|NCT02009878|617595940|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
170887337|NCT02450487|617595941|FG000|Overall Study|Lost to Follow-up|3|||
170887338|NCT04781816|617595942|FG000|Overall Study|Adverse Event|0|||
170887339|NCT04781816|617595943|FG001|Overall Study|Adverse Event|1|||
170887340|NCT04781816|617595942|FG000|Overall Study|Withdrawal by Subject|1|||
170887341|NCT04781816|617595943|FG001|Overall Study|Withdrawal by Subject|1|||
170887342|NCT04781816|617595942|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
170887343|NCT04781816|617595943|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
170887344|NCT02751502|617595944|FG000|Overall Study|Lack of funding|4|||
170887345|NCT00088374|617595945|FG000|Overall Study|patient did not receive any 17AAG|1|||
170541123|NCT00429299|616325180|FG000|Overall Study|Protocol Violation|1|||
170541124|NCT00429299|616325181|FG001|Overall Study|Protocol Violation|0|||
170541125|NCT00429299|616325182|FG002|Overall Study|Protocol Violation|0|||
170541126|NCT00429299|616325180|FG000|Overall Study|Withdrawal by Subject|0|||
170887346|NCT00088374|617595945|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
170887347|NCT00720109|617595946|FG000|Induction Period|Did not meet eligibility criteria|3|||
170541127|NCT00429299|616325181|FG001|Overall Study|Withdrawal by Subject|1|||
170541128|NCT00429299|616325182|FG002|Overall Study|Withdrawal by Subject|3|||
170541129|NCT02143778|616325183|FG000|Overall Study|Withdrawal by Subject|2|||
170887348|NCT00720109|617595947|FG001|Induction Period|Did not meet eligibility criteria|0|||
170541130|NCT02143778|616325183|FG000|Overall Study|Device malfunction|1|||
170541131|NCT05630755|616325184|FG000|Overall Study|Lost to Follow-up|7|||
170541132|NCT05630755|616325185|FG001|Overall Study|Lost to Follow-up|0|||
170541133|NCT05630755|616325184|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
170541134|NCT05630755|616325185|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
170541135|NCT05630755|616325184|FG000|Overall Study|Withdrawal by Subject|9|||
170541136|NCT05630755|616325185|FG001|Overall Study|Withdrawal by Subject|3|||
170541137|NCT05630755|616325184|FG000|Overall Study|Participant moved away from trial site|0|||
170541138|NCT05630755|616325185|FG001|Overall Study|Participant moved away from trial site|1|||
170887349|NCT00720109|617595948|FG002|Induction Period|Did not meet eligibility criteria|0|||
170887350|NCT00720109|617595946|FG000|Induction Period|Bone Marrow Transplant|2|||
170887351|NCT00720109|617595947|FG001|Induction Period|Bone Marrow Transplant|0|||
170887352|NCT00720109|617595948|FG002|Induction Period|Bone Marrow Transplant|0|||
170887353|NCT00720109|617595946|FG000|Induction Period|Physician Decision|1|||
170887354|NCT00720109|617595947|FG001|Induction Period|Physician Decision|0|||
170887355|NCT00720109|617595948|FG002|Induction Period|Physician Decision|0|||
170887356|NCT00720109|617595946|FG000|Risk Stratification Period|Adverse Event|0|||
170887357|NCT00720109|617595947|FG001|Risk Stratification Period|Adverse Event|1|||
170887358|NCT00720109|617595948|FG002|Risk Stratification Period|Adverse Event|0|||
170887359|NCT00720109|617595946|FG000|Risk Stratification Period|Physician Decision|0|||
170887360|NCT00720109|617595947|FG001|Risk Stratification Period|Physician Decision|2|||
170887361|NCT00720109|617595948|FG002|Risk Stratification Period|Physician Decision|1|||
170887362|NCT00720109|617595946|FG000|Risk Stratification Period|Bone marrow transplant|0|||
170887363|NCT00720109|617595947|FG001|Risk Stratification Period|Bone marrow transplant|9|||
170887364|NCT00720109|617595948|FG002|Risk Stratification Period|Bone marrow transplant|7|||
170887365|NCT00720109|617595946|FG000|Risk Stratification Period|Disease progression or relapse|0|||
170887366|NCT00720109|617595947|FG001|Risk Stratification Period|Disease progression or relapse|2|||
170887367|NCT00720109|617595948|FG002|Risk Stratification Period|Disease progression or relapse|0|||
170887368|NCT00720109|617595946|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
170887369|NCT00720109|617595947|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
170887370|NCT00720109|617595948|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
170887371|NCT01437397|617595949|FG000|Overall Study|Lost to Follow-up|9|||
170887372|NCT01437397|617595950|FG001|Overall Study|Lost to Follow-up|4|||
170887373|NCT01437397|617595951|FG002|Overall Study|Lost to Follow-up|2|||
170887374|NCT01437397|617595952|FG003|Overall Study|Lost to Follow-up|4|||
170887375|NCT01437397|617595953|FG004|Overall Study|Lost to Follow-up|5|||
170887376|NCT01437397|617595949|FG000|Overall Study|Withdrawal by Subject|11|||
170887377|NCT01437397|617595950|FG001|Overall Study|Withdrawal by Subject|12|||
170887378|NCT01437397|617595951|FG002|Overall Study|Withdrawal by Subject|24|||
170887379|NCT01437397|617595952|FG003|Overall Study|Withdrawal by Subject|11|||
170887380|NCT01437397|617595953|FG004|Overall Study|Withdrawal by Subject|22|||
170887381|NCT01437397|617595949|FG000|Overall Study|Protocol Violation|10|||
170887382|NCT01437397|617595950|FG001|Overall Study|Protocol Violation|12|||
170887383|NCT01437397|617595951|FG002|Overall Study|Protocol Violation|13|||
170887384|NCT01437397|617595952|FG003|Overall Study|Protocol Violation|21|||
170887385|NCT01437397|617595953|FG004|Overall Study|Protocol Violation|19|||
170887386|NCT01437397|617595949|FG000|Overall Study|Lack of Efficacy|5|||
170887387|NCT01437397|617595950|FG001|Overall Study|Lack of Efficacy|4|||
170887388|NCT01437397|617595951|FG002|Overall Study|Lack of Efficacy|8|||
170887389|NCT01437397|617595952|FG003|Overall Study|Lack of Efficacy|10|||
170887390|NCT01437397|617595953|FG004|Overall Study|Lack of Efficacy|20|||
170887391|NCT01437397|617595949|FG000|Overall Study|Adverse Event|21|||
170887392|NCT01437397|617595950|FG001|Overall Study|Adverse Event|22|||
170887393|NCT01437397|617595951|FG002|Overall Study|Adverse Event|16|||
170887394|NCT01437397|617595952|FG003|Overall Study|Adverse Event|14|||
170887395|NCT01437397|617595953|FG004|Overall Study|Adverse Event|21|||
170887396|NCT01437397|617595949|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
170887397|NCT01437397|617595950|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
170887398|NCT01437397|617595951|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
170887399|NCT01437397|617595952|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
170634311|NCT00477386|616671938|FG001|Overall Study|Disease progression, relapse|4|||
170450179|NCT04146363|615987258|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170450180|NCT04146363|615987259|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170450181|NCT04146363|615987260|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170450182|NCT04146363|615987261|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
170450183|NCT04146363|615987262|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
170450184|NCT04146363|615987263|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170450185|NCT04146363|615987253|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
170450186|NCT04146363|615987254|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
170450187|NCT04146363|615987255|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
170450188|NCT04146363|615987256|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
170450189|NCT04146363|615987257|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
170450190|NCT04146363|615987258|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
170450191|NCT04146363|615987259|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
170887400|NCT01437397|617595953|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
170450192|NCT04146363|615987260|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
170450193|NCT04146363|615987261|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
170450194|NCT04146363|615987262|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
170450195|NCT04146363|615987263|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
170450196|NCT04146363|615987253|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170450197|NCT04146363|615987254|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170450198|NCT04146363|615987255|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170450199|NCT04146363|615987256|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170450200|NCT04146363|615987257|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170450201|NCT04146363|615987258|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170450202|NCT04146363|615987259|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170450203|NCT04146363|615987260|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170450204|NCT04146363|615987261|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
170450205|NCT04146363|615987262|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
170450206|NCT04146363|615987263|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
170450207|NCT04146363|615987253|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450208|NCT04146363|615987254|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450209|NCT04146363|615987255|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450210|NCT04146363|615987256|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450211|NCT04146363|615987257|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450212|NCT04146363|615987258|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450213|NCT04146363|615987259|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450214|NCT04146363|615987260|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450215|NCT04146363|615987261|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450216|NCT04146363|615987262|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
170450217|NCT04146363|615987263|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
170450218|NCT04146363|615987253|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450219|NCT04146363|615987254|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450220|NCT04146363|615987255|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450221|NCT04146363|615987256|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450222|NCT04146363|615987257|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450223|NCT04146363|615987258|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450224|NCT04146363|615987259|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450225|NCT04146363|615987260|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450226|NCT04146363|615987261|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450227|NCT04146363|615987262|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
170450228|NCT04146363|615987263|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
170450229|NCT00380692|615987274|FG000|Study Period II - Double Blind|Adverse Event|1|||
170450230|NCT00380692|615987275|FG001|Study Period II - Double Blind|Adverse Event|0|||
170450231|NCT00380692|615987274|FG000|Study Period II - Double Blind|Protocol Violation|2|||
170450232|NCT00380692|615987275|FG001|Study Period II - Double Blind|Protocol Violation|2|||
170887401|NCT00866307|617595955|FG000|Induction|Adverse Event|5|||
170887402|NCT00866307|617595956|FG001|Induction|Adverse Event|0|||
170887403|NCT00866307|617595957|FG002|Induction|Adverse Event|0|||
170450233|NCT00380692|615987274|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
170450234|NCT00380692|615987275|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
170450235|NCT00380692|615987274|FG000|Study Period II - Double Blind|Physician Decision|0|||
170450236|NCT00380692|615987275|FG001|Study Period II - Double Blind|Physician Decision|1|||
170450237|NCT00380692|615987274|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
170450238|NCT00380692|615987275|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
170450239|NCT00380692|615987274|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
170450240|NCT00380692|615987275|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
170634312|NCT00477386|616671937|FG000|Overall Study|Disease progression, refractory|1|||
170887404|NCT00866307|617595955|FG000|Induction|Death|2|||
170450241|NCT00380692|615987274|FG000|Study Period III - Open Label|Adverse Event|5|||
170450242|NCT00380692|615987275|FG001|Study Period III - Open Label|Adverse Event|3|||
170450243|NCT00380692|615987274|FG000|Study Period III - Open Label|Protocol Violation|0|||
170450244|NCT00380692|615987275|FG001|Study Period III - Open Label|Protocol Violation|0|||
170450245|NCT00380692|615987274|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
170450246|NCT00380692|615987275|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
170450247|NCT00380692|615987274|FG000|Study Period III - Open Label|Physician Decision|0|||
170450248|NCT00380692|615987275|FG001|Study Period III - Open Label|Physician Decision|3|||
170450249|NCT00380692|615987274|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
170450250|NCT00380692|615987275|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
170450251|NCT00380692|615987274|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
170450252|NCT00380692|615987275|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
170450253|NCT04507126|615987280|FG000|Overall Study|Withdrawal by Subject|3|||
170450254|NCT04507126|615987280|FG000|Overall Study|Protocol Violation|4|||
170450255|NCT05444556|615987287|FG000|Overall Study|Withdrawal by Subject|0|||
170450256|NCT05444556|615987288|FG001|Overall Study|Withdrawal by Subject|0|||
170450257|NCT05444556|615987289|FG002|Overall Study|Withdrawal by Subject|2|||
170450258|NCT05444556|615987290|FG003|Overall Study|Withdrawal by Subject|1|||
170450259|NCT01173471|615987293|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170450260|NCT01173471|615987294|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170450261|NCT01173471|615987295|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
170450262|NCT01173471|615987296|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
170450263|NCT01173471|615987293|FG000|Overall Study|Condition under investigation worsened|2|||
170450264|NCT01173471|615987294|FG001|Overall Study|Condition under investigation worsened|0|||
170450265|NCT01173471|615987295|FG002|Overall Study|Condition under investigation worsened|0|||
170450266|NCT01173471|615987296|FG003|Overall Study|Condition under investigation worsened|0|||
170450267|NCT01173471|615987293|FG000|Overall Study|Lost to Follow-up|0|||
170450268|NCT01173471|615987294|FG001|Overall Study|Lost to Follow-up|0|||
170450269|NCT01173471|615987295|FG002|Overall Study|Lost to Follow-up|1|||
170450270|NCT01173471|615987296|FG003|Overall Study|Lost to Follow-up|0|||
170450271|NCT01173471|615987293|FG000|Overall Study|Reason given as Other|0|||
170450272|NCT01173471|615987294|FG001|Overall Study|Reason given as Other|0|||
170450273|NCT01173471|615987295|FG002|Overall Study|Reason given as Other|1|||
170450274|NCT01173471|615987296|FG003|Overall Study|Reason given as Other|0|||
170450275|NCT00584844|615987298|FG000|Overall Study|Withdrawal by Subject|59|||
170450276|NCT00584844|615987298|FG000|Overall Study|Screen Failure|20|||
170450277|NCT04319159|615987300|FG000|Overall Study|Screening failure|13|||
170450278|NCT04319159|615987300|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
170450279|NCT04319159|615987300|FG000|Overall Study|Withdrawal by Subject|1|||
170450280|NCT03756883|615987309|FG000|Overall Study|Adverse Event|2|||
170450281|NCT03756883|615987310|FG001|Overall Study|Adverse Event|2|||
170450282|NCT03756883|615987311|FG002|Overall Study|Adverse Event|2|||
170450283|NCT03756883|615987309|FG000|Overall Study|Lack of Efficacy|0|||
170450284|NCT03756883|615987310|FG001|Overall Study|Lack of Efficacy|1|||
170450285|NCT03756883|615987311|FG002|Overall Study|Lack of Efficacy|2|||
170450286|NCT03756883|615987309|FG000|Overall Study|Lost to Follow-up|3|||
170450287|NCT03756883|615987310|FG001|Overall Study|Lost to Follow-up|3|||
170450288|NCT03756883|615987311|FG002|Overall Study|Lost to Follow-up|0|||
170450289|NCT03756883|615987309|FG000|Overall Study|Protocol Violation|2|||
170450290|NCT03756883|615987310|FG001|Overall Study|Protocol Violation|0|||
170450291|NCT03756883|615987311|FG002|Overall Study|Protocol Violation|1|||
170450292|NCT03756883|615987309|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
170450293|NCT03756883|615987310|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
170450294|NCT03756883|615987311|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
170450295|NCT03756883|615987309|FG000|Overall Study|Withdrawal by Subject|4|||
170450296|NCT03756883|615987310|FG001|Overall Study|Withdrawal by Subject|1|||
170786850|NCT01785719|617229509|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
170450297|NCT03756883|615987311|FG002|Overall Study|Withdrawal by Subject|0|||
170450298|NCT03756883|615987309|FG000|Overall Study|Other Reasons|2|||
170786851|NCT01785719|617229510|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
170786852|NCT01785719|617229509|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
170450299|NCT03756883|615987310|FG001|Overall Study|Other Reasons|4|||
170450300|NCT03756883|615987311|FG002|Overall Study|Other Reasons|0|||
170450301|NCT03336242|615987312|FG000|Overall Study|Adverse Event|0|||
170450302|NCT03336242|615987313|FG001|Overall Study|Adverse Event|1|||
170450303|NCT00949988|615987320|FG000|Overall Study|Withdrawal by Subject|3|||
170450304|NCT01929395|615987322|FG000|Overall Study|Did not complete - non-related toxicity|1|||
170450305|NCT01929395|615987323|FG001|Overall Study|Did not complete - non-related toxicity|0|||
170450306|NCT01929395|615987324|FG002|Overall Study|Did not complete - non-related toxicity|0|||
170450307|NCT01929395|615987322|FG000|Overall Study|Withdrawal by Subject|0|||
170450308|NCT01929395|615987323|FG001|Overall Study|Withdrawal by Subject|1|||
170450309|NCT01929395|615987324|FG002|Overall Study|Withdrawal by Subject|0|||
170541139|NCT05630755|616325184|FG000|Overall Study|Status not Recorded|316|||
170450310|NCT01929395|615987322|FG000|Overall Study|Screen Fail|0|||
170450311|NCT01929395|615987323|FG001|Overall Study|Screen Fail|0|||
170450312|NCT01929395|615987324|FG002|Overall Study|Screen Fail|1|||
170450313|NCT02310763|615987330|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
170450314|NCT02310763|615987331|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
170450315|NCT02310763|615987332|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
170450316|NCT02310763|615987330|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
170450317|NCT02310763|615987331|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
170450318|NCT02310763|615987332|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
170450319|NCT02310763|615987330|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
170450320|NCT02310763|615987331|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
170450321|NCT02310763|615987332|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
170450322|NCT02310763|615987330|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
170450323|NCT02310763|615987331|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
170450324|NCT02310763|615987332|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
170450325|NCT02310763|615987330|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
170450326|NCT02310763|615987331|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
170450327|NCT02310763|615987332|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
170450328|NCT00939627|615987333|FG000|Overall Study|Disease Progression|16|||
170450329|NCT00939627|615987334|FG001|Overall Study|Disease Progression|12|||
170450330|NCT00939627|615987335|FG002|Overall Study|Disease Progression|0|||
170450331|NCT00939627|615987333|FG000|Overall Study|Adverse Event|6|||
170450332|NCT00939627|615987334|FG001|Overall Study|Adverse Event|7|||
170450333|NCT00939627|615987335|FG002|Overall Study|Adverse Event|0|||
170450334|NCT00939627|615987333|FG000|Overall Study|Death|0|||
170450335|NCT00939627|615987334|FG001|Overall Study|Death|2|||
170450336|NCT00939627|615987335|FG002|Overall Study|Death|0|||
170450337|NCT00939627|615987333|FG000|Overall Study|Withdrawal by Subject|2|||
170450338|NCT00939627|615987334|FG001|Overall Study|Withdrawal by Subject|4|||
170450339|NCT00939627|615987335|FG002|Overall Study|Withdrawal by Subject|0|||
170450340|NCT00939627|615987333|FG000|Overall Study|Other complicating disease|1|||
170450341|NCT00939627|615987334|FG001|Overall Study|Other complicating disease|1|||
170450342|NCT00939627|615987335|FG002|Overall Study|Other complicating disease|0|||
170450343|NCT00939627|615987333|FG000|Overall Study|Not compliant|2|||
170450344|NCT00939627|615987334|FG001|Overall Study|Not compliant|0|||
170450345|NCT00939627|615987335|FG002|Overall Study|Not compliant|0|||
170450346|NCT00939627|615987333|FG000|Overall Study|No off-tx reason given|0|||
170450347|NCT00939627|615987334|FG001|Overall Study|No off-tx reason given|2|||
170450348|NCT00939627|615987335|FG002|Overall Study|No off-tx reason given|0|||
170450349|NCT00904748|615987337|FG000|Overall Study|Withdrawal by Subject|1|||
170450350|NCT00904748|615987338|FG001|Overall Study|Withdrawal by Subject|1|||
170450351|NCT00904748|615987339|FG002|Overall Study|Withdrawal by Subject|1|||
170450352|NCT00904748|615987340|FG003|Overall Study|Withdrawal by Subject|2|||
170450353|NCT00904748|615987341|FG004|Overall Study|Withdrawal by Subject|0|||
170450354|NCT00904748|615987342|FG005|Overall Study|Withdrawal by Subject|0|||
170450355|NCT00904748|615987337|FG000|Overall Study|Adverse Event|0|||
170450356|NCT00904748|615987338|FG001|Overall Study|Adverse Event|0|||
170450357|NCT00904748|615987339|FG002|Overall Study|Adverse Event|0|||
170450358|NCT00904748|615987340|FG003|Overall Study|Adverse Event|0|||
170450359|NCT00904748|615987341|FG004|Overall Study|Adverse Event|1|||
170450360|NCT00904748|615987342|FG005|Overall Study|Adverse Event|0|||
170450361|NCT00303667|615987346|FG000|Overall Study|Death|0|||
170450362|NCT00303667|615987347|FG001|Overall Study|Death|4|||
170450363|NCT01192399|615987348|FG000|Overall Study|Lack of Efficacy|2|||
170450364|NCT01029392|615987349|FG000|Overall Study|Withdrawal by Subject|18|||
170450365|NCT01029392|615987350|FG001|Overall Study|Withdrawal by Subject|11|||
170450366|NCT01029392|615987349|FG000|Overall Study|Physician Decision|2|||
170634313|NCT00477386|616671938|FG001|Overall Study|Disease progression, refractory|3|||
170634314|NCT00477386|616671937|FG000|Overall Study|Other|1|||
170450367|NCT01029392|615987350|FG001|Overall Study|Physician Decision|0|||
170450368|NCT01103479|615987351|FG000|Overall Study|Up to date with CRC screening|1|||
170450369|NCT01103479|615987352|FG001|Overall Study|Up to date with CRC screening|9|||
170450370|NCT01103479|615987353|FG002|Overall Study|Up to date with CRC screening|12|||
170450371|NCT01103479|615987351|FG000|Overall Study|Family history of CRC|1|||
170450372|NCT01103479|615987352|FG001|Overall Study|Family history of CRC|0|||
170450373|NCT01103479|615987353|FG002|Overall Study|Family history of CRC|2|||
170450374|NCT01103479|615987351|FG000|Overall Study|Active cancer|1|||
170450375|NCT01103479|615987352|FG001|Overall Study|Active cancer|0|||
170450376|NCT01103479|615987353|FG002|Overall Study|Active cancer|0|||
170450377|NCT01103479|615987351|FG000|Overall Study|Saw non-study physician|2|||
170450378|NCT01103479|615987352|FG001|Overall Study|Saw non-study physician|0|||
170450379|NCT01103479|615987353|FG002|Overall Study|Saw non-study physician|0|||
170450380|NCT00834899|615987354|FG000|Overall Study|Withdrawal by Subject|1|||
170450381|NCT00834899|615987355|FG001|Overall Study|Withdrawal by Subject|1|||
170450382|NCT01523587|615987356|FG000|Overall Study|Other than listed|5|||
170450383|NCT01523587|615987357|FG001|Overall Study|Other than listed|5|||
170450384|NCT01523587|615987356|FG000|Overall Study|Worsening of underlying cancer disease|19|||
170450385|NCT01523587|615987357|FG001|Overall Study|Worsening of underlying cancer disease|34|||
170450386|NCT01523587|615987356|FG000|Overall Study|Adverse Event|68|||
170450387|NCT01523587|615987357|FG001|Overall Study|Adverse Event|52|||
170450388|NCT01523587|615987356|FG000|Overall Study|Protocol Violation|5|||
170450389|NCT01523587|615987357|FG001|Overall Study|Protocol Violation|3|||
170450390|NCT01523587|615987356|FG000|Overall Study|Lost to Follow-up|2|||
170450391|NCT01523587|615987357|FG001|Overall Study|Lost to Follow-up|2|||
170450392|NCT01523587|615987356|FG000|Overall Study|Withdrawal by Subject|28|||
170450393|NCT01523587|615987357|FG001|Overall Study|Withdrawal by Subject|20|||
170450394|NCT01523587|615987356|FG000|Overall Study|Withdrew due to Progressive disease|265|||
170450395|NCT01523587|615987357|FG001|Overall Study|Withdrew due to Progressive disease|279|||
170450396|NCT01523587|615987356|FG000|Overall Study|Randomised but bot treated|6|||
170450397|NCT01523587|615987357|FG001|Overall Study|Randomised but bot treated|2|||
170450398|NCT00724373|615987362|FG000|Overall Study|Adverse Event|41|||
170450399|NCT00724373|615987362|FG000|Overall Study|Lack of Efficacy|82|||
170450400|NCT00724373|615987362|FG000|Overall Study|Lost to Follow-up|7|||
170541140|NCT05630755|616325185|FG001|Overall Study|Status not Recorded|161|||
170541141|NCT02969018|616325186|FG000|Overall Study|Adverse Event|2|||
170541142|NCT02969018|616325187|FG001|Overall Study|Adverse Event|4|||
170541143|NCT02969018|616325188|FG002|Overall Study|Adverse Event|1|||
170541144|NCT02969018|616325189|FG003|Overall Study|Adverse Event|2|||
170541145|NCT02969018|616325190|FG004|Overall Study|Adverse Event|0|||
170541146|NCT02969018|616325191|FG005|Overall Study|Adverse Event|1|||
170541147|NCT02969018|616325192|FG006|Overall Study|Adverse Event|2|||
170541148|NCT02969018|616325193|FG007|Overall Study|Adverse Event|0|||
170541149|NCT02969018|616325186|FG000|Overall Study|Lack of Efficacy|0|||
170541150|NCT02969018|616325187|FG001|Overall Study|Lack of Efficacy|1|||
170541151|NCT02969018|616325188|FG002|Overall Study|Lack of Efficacy|0|||
170541152|NCT02969018|616325189|FG003|Overall Study|Lack of Efficacy|0|||
170541153|NCT02969018|616325190|FG004|Overall Study|Lack of Efficacy|1|||
170541154|NCT02969018|616325191|FG005|Overall Study|Lack of Efficacy|1|||
170541155|NCT02969018|616325192|FG006|Overall Study|Lack of Efficacy|1|||
170541156|NCT02969018|616325193|FG007|Overall Study|Lack of Efficacy|1|||
170541157|NCT02969018|616325186|FG000|Overall Study|Lost to Follow-up|1|||
170541158|NCT02969018|616325187|FG001|Overall Study|Lost to Follow-up|2|||
170541159|NCT02969018|616325188|FG002|Overall Study|Lost to Follow-up|2|||
170541160|NCT02969018|616325189|FG003|Overall Study|Lost to Follow-up|0|||
170541161|NCT02969018|616325190|FG004|Overall Study|Lost to Follow-up|1|||
170541162|NCT02969018|616325191|FG005|Overall Study|Lost to Follow-up|1|||
170541163|NCT02969018|616325192|FG006|Overall Study|Lost to Follow-up|0|||
170541164|NCT02969018|616325193|FG007|Overall Study|Lost to Follow-up|1|||
170541165|NCT02969018|616325186|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
170541166|NCT02969018|616325187|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170541167|NCT02969018|616325188|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
170541168|NCT02969018|616325189|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
170541169|NCT02969018|616325190|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
170541170|NCT02969018|616325191|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
170541171|NCT02969018|616325192|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
170541172|NCT02969018|616325193|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
170541173|NCT02969018|616325186|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170541174|NCT02969018|616325187|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170541175|NCT02969018|616325188|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170541176|NCT02969018|616325189|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170541177|NCT02969018|616325190|FG004|Overall Study|Non-Compliance With Study Drug|0|||
170541178|NCT02969018|616325191|FG005|Overall Study|Non-Compliance With Study Drug|0|||
170786853|NCT01785719|617229510|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
170786854|NCT04887129|617229511|FG000|Overall Study|Lost to Follow-up|0|||
170786855|NCT04887129|617229512|FG001|Overall Study|Lost to Follow-up|24|||
170450401|NCT00724373|615987362|FG000|Overall Study|Non-compliance|2|||
170450402|NCT00724373|615987362|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
170450403|NCT00724373|615987362|FG000|Overall Study|Participant moved away|1|||
170450404|NCT00724373|615987362|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
170450405|NCT00724373|615987362|FG000|Overall Study|Only to have 24 week regimen|1|||
170450406|NCT00724373|615987362|FG000|Overall Study|Viral Relapse|1|||
170450407|NCT00724373|615987362|FG000|Overall Study|Acute HCV infection|1|||
170541179|NCT02969018|616325192|FG006|Overall Study|Non-Compliance With Study Drug|0|||
170541180|NCT02969018|616325193|FG007|Overall Study|Non-Compliance With Study Drug|0|||
170541181|NCT02969018|616325186|FG000|Overall Study|Other|0|||
170541182|NCT02969018|616325187|FG001|Overall Study|Other|0|||
170541183|NCT02969018|616325188|FG002|Overall Study|Other|0|||
170541184|NCT02969018|616325189|FG003|Overall Study|Other|1|||
170541185|NCT02969018|616325190|FG004|Overall Study|Other|0|||
170450408|NCT00724373|615987362|FG000|Overall Study|Drug Relapse|1|||
170450409|NCT00724373|615987362|FG000|Overall Study|Tolerability|23|||
170450410|NCT01560507|615987363|FG000|Overall Study|Lost to Follow-up|3|||
170450411|NCT01560507|615987364|FG001|Overall Study|Lost to Follow-up|1|||
170450412|NCT01560507|615987365|FG002|Overall Study|Lost to Follow-up|2|||
170450413|NCT01560507|615987363|FG000|Overall Study|Withdrawal by Subject|1|||
170450414|NCT01560507|615987364|FG001|Overall Study|Withdrawal by Subject|1|||
170450415|NCT01560507|615987365|FG002|Overall Study|Withdrawal by Subject|0|||
170450416|NCT02080832|615987366|FG000|Overall Study|Excluded from analysis by MRI|9|||
170450417|NCT02080832|615987367|FG001|Overall Study|Excluded from analysis by MRI|10|||
170450418|NCT02080832|615987368|FG002|Overall Study|Excluded from analysis by MRI|14|||
170450419|NCT02080832|615987366|FG000|Overall Study|Lost to Follow-up|0|||
170450420|NCT02080832|615987367|FG001|Overall Study|Lost to Follow-up|2|||
170450421|NCT02080832|615987368|FG002|Overall Study|Lost to Follow-up|2|||
170450422|NCT00560937|615987369|FG000|Overall Study|Withdrawal by Subject|0|||
170450423|NCT00560937|615987370|FG001|Overall Study|Withdrawal by Subject|1|||
170450424|NCT00560937|615987369|FG000|Overall Study|Physician Decision|1|||
170450425|NCT00560937|615987370|FG001|Overall Study|Physician Decision|1|||
170450426|NCT02244424|615987371|FG000|Overall Study|Lost to Follow-up|20|||
170450427|NCT02244424|615987372|FG001|Overall Study|Lost to Follow-up|10|||
170450428|NCT01660022|615987373|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
170450429|NCT01660022|615987374|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
170450430|NCT01660022|615987375|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
170450431|NCT01660022|615987376|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
170450432|NCT01660022|615987377|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
170450433|NCT01660022|615987378|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
170450434|NCT01660022|615987373|FG000|First Sequence (7 Days)|Adverse Event|0|||
170450435|NCT01660022|615987374|FG001|First Sequence (7 Days)|Adverse Event|0|||
170450436|NCT01660022|615987375|FG002|First Sequence (7 Days)|Adverse Event|0|||
170450437|NCT01660022|615987376|FG003|First Sequence (7 Days)|Adverse Event|0|||
170450438|NCT01660022|615987377|FG004|First Sequence (7 Days)|Adverse Event|1|||
170450439|NCT01660022|615987378|FG005|First Sequence (7 Days)|Adverse Event|3|||
170450440|NCT01660022|615987373|FG000|First Sequence (7 Days)|Protocol Violation|0|||
170450441|NCT01660022|615987374|FG001|First Sequence (7 Days)|Protocol Violation|0|||
170450442|NCT01660022|615987375|FG002|First Sequence (7 Days)|Protocol Violation|0|||
170450443|NCT01660022|615987376|FG003|First Sequence (7 Days)|Protocol Violation|0|||
170450444|NCT01660022|615987377|FG004|First Sequence (7 Days)|Protocol Violation|0|||
170450445|NCT01660022|615987378|FG005|First Sequence (7 Days)|Protocol Violation|1|||
170450446|NCT04117945|615987379|FG000|Overall Study|Death|1|||
170450447|NCT04117945|615987380|FG001|Overall Study|Death|0|||
170450448|NCT04117945|615987379|FG000|Overall Study|Withdrawal by Subject|3|||
170450449|NCT04117945|615987380|FG001|Overall Study|Withdrawal by Subject|1|||
170450450|NCT04117945|615987379|FG000|Overall Study|Disease Progression|0|||
170450451|NCT04117945|615987380|FG001|Overall Study|Disease Progression|2|||
170450452|NCT04117945|615987379|FG000|Overall Study|Ineligible|8|||
170450453|NCT04117945|615987380|FG001|Overall Study|Ineligible|7|||
170450454|NCT00749411|615987408|FG000|Overall Study|Adverse Event|0|||
170450455|NCT00749411|615987409|FG001|Overall Study|Adverse Event|2|||
170634315|NCT00477386|616671938|FG001|Overall Study|Other|2|||
170634316|NCT00477386|616671937|FG000|Overall Study|Physician Decision|1|||
170634317|NCT00477386|616671938|FG001|Overall Study|Physician Decision|0|||
170634318|NCT00477386|616671937|FG000|Overall Study|Withdrawal by Subject|1|||
170634319|NCT00477386|616671938|FG001|Overall Study|Withdrawal by Subject|0|||
170634320|NCT00643162|616671939|FG000|Overall Study|Withdrawal by Subject|1|||
170634321|NCT00643162|616671940|FG001|Overall Study|Withdrawal by Subject|1|||
170634322|NCT00734539|616671941|FG000|Main Study|Death|33|||
170634323|NCT00734539|616671942|FG001|Main Study|Death|32|||
170634324|NCT00734539|616671941|FG000|Main Study|Physician Decision|2|||
170634325|NCT00734539|616671942|FG001|Main Study|Physician Decision|0|||
170634326|NCT00734539|616671941|FG000|Main Study|Withdrawal by Subject|1|||
170634327|NCT00734539|616671942|FG001|Main Study|Withdrawal by Subject|3|||
170634328|NCT00734539|616671941|FG000|Main Study|Enrolled in error; ineligible|1|||
170634329|NCT00734539|616671942|FG001|Main Study|Enrolled in error; ineligible|0|||
170786856|NCT04887129|617229511|FG000|Overall Study|Withdrawal by Subject|9|||
170786857|NCT04887129|617229512|FG001|Overall Study|Withdrawal by Subject|57|||
170634330|NCT01812252|616671945|FG000|Overall Study|Persistent Disease|1|||
170786858|NCT04887129|617229511|FG000|Overall Study|Other|2|||
170634331|NCT01812252|616671946|FG001|Overall Study|Persistent Disease|0|||
170634332|NCT01812252|616671945|FG000|Overall Study|Not transplanted|11|||
170786859|NCT04887129|617229512|FG001|Overall Study|Other|9|||
170450456|NCT00749411|615987408|FG000|Overall Study|Lack of Efficacy|0|||
170450457|NCT00749411|615987409|FG001|Overall Study|Lack of Efficacy|1|||
170450458|NCT00749411|615987408|FG000|Overall Study|Protocol Violation|1|||
170450459|NCT00749411|615987409|FG001|Overall Study|Protocol Violation|1|||
170450460|NCT00749411|615987408|FG000|Overall Study|Protocol-defined stopping criteria|0|||
170450461|NCT00749411|615987409|FG001|Overall Study|Protocol-defined stopping criteria|1|||
170450462|NCT02006628|615988893|FG000|Overall Study|Adverse Event|1|||
170450463|NCT02006628|615988894|FG001|Overall Study|Adverse Event|1|||
170450464|NCT02006628|615988893|FG000|Overall Study|Withdrawal by Subject|2|||
170634333|NCT01812252|616671946|FG001|Overall Study|Not transplanted|11|||
170786860|NCT03338933|617229514|FG000|Screening Visit|Lost to Follow-up|1|||
170541186|NCT02969018|616325191|FG005|Overall Study|Other|0|||
170541187|NCT02969018|616325192|FG006|Overall Study|Other|0|||
170541188|NCT02969018|616325193|FG007|Overall Study|Other|2|||
170541189|NCT02969018|616325186|FG000|Overall Study|Pregnancy|0|||
170450465|NCT02006628|615988894|FG001|Overall Study|Withdrawal by Subject|1|||
170450466|NCT02100319|615988904|FG000|Overall Study|Case Report Forms Uncollected|11|||
170450467|NCT02100319|615988904|FG000|Overall Study|Protocol Deviation|5|||
170450468|NCT02370914|615988905|FG000|Overall Study|Protocol Violation|2|||
170450469|NCT02566993|615988906|FG000|Overall Study|Randomized but not treated|5|||
170450470|NCT02566993|615988907|FG001|Overall Study|Randomized but not treated|16|||
170450471|NCT02566993|615988906|FG000|Overall Study|Progressive disease|213|||
170450472|NCT02566993|615988907|FG001|Overall Study|Progressive disease|152|||
170450473|NCT02566993|615988906|FG000|Overall Study|Withdrawal by Subject|12|||
170450474|NCT02566993|615988907|FG001|Overall Study|Withdrawal by Subject|28|||
170450475|NCT02566993|615988906|FG000|Overall Study|Death|17|||
170450476|NCT02566993|615988907|FG001|Overall Study|Death|23|||
170450477|NCT02566993|615988906|FG000|Overall Study|Physician Decision|10|||
170450478|NCT02566993|615988907|FG001|Overall Study|Physician Decision|17|||
170450479|NCT02566993|615988906|FG000|Overall Study|Study drug-related adverse event|20|||
170450480|NCT02566993|615988907|FG001|Overall Study|Study drug-related adverse event|41|||
170450481|NCT02566993|615988906|FG000|Overall Study|Non study drug-related adverse event|9|||
170450482|NCT02566993|615988907|FG001|Overall Study|Non study drug-related adverse event|9|||
170450483|NCT02566993|615988906|FG000|Overall Study|Symptomatic deterioration|9|||
170450484|NCT02566993|615988907|FG001|Overall Study|Symptomatic deterioration|16|||
170450485|NCT02566993|615988906|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
170450486|NCT02566993|615988907|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
170450487|NCT02566993|615988906|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
170450488|NCT02566993|615988907|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
170450489|NCT02566993|615988906|FG000|Overall Study|Screening failure|2|||
170450490|NCT02566993|615988907|FG001|Overall Study|Screening failure|0|||
170450491|NCT02566993|615988906|FG000|Overall Study|Lost to Follow-up|0|||
170450492|NCT02566993|615988907|FG001|Overall Study|Lost to Follow-up|1|||
170450493|NCT02566993|615988906|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
170450494|NCT02566993|615988907|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
170450495|NCT05206448|615988908|FG000|Overall Study|Lost to Follow-up|2|||
170450496|NCT05206448|615988909|FG001|Overall Study|Lost to Follow-up|2|||
170450497|NCT05206448|615988908|FG000|Overall Study|Withdrawal by Subject|2|||
170450498|NCT05206448|615988909|FG001|Overall Study|Withdrawal by Subject|0|||
170450499|NCT05206448|615988908|FG000|Overall Study|found ineligible after randomization|1|||
170450500|NCT05206448|615988909|FG001|Overall Study|found ineligible after randomization|1|||
170450501|NCT05206448|615988908|FG000|Overall Study|unable to complete study due to personal constraints|1|||
170450502|NCT05206448|615988909|FG001|Overall Study|unable to complete study due to personal constraints|0|||
170450503|NCT05206448|615988908|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
170450504|NCT05206448|615988909|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
170450505|NCT04976621|615988910|FG000|Overall Study|Lost to Follow-up|2|||
170450506|NCT04976621|615988911|FG001|Overall Study|Lost to Follow-up|2|||
170450507|NCT04976621|615988910|FG000|Overall Study|Withdrawal by Subject|1|||
170450508|NCT04976621|615988911|FG001|Overall Study|Withdrawal by Subject|1|||
170450509|NCT02589522|615988912|FG000|Overall Study|Physician Decision|1|||
170450510|NCT02589522|615988913|FG001|Overall Study|Physician Decision|2|||
170450511|NCT02589522|615988914|FG002|Overall Study|Physician Decision|0|||
170450512|NCT02589522|615988912|FG000|Overall Study|Did not start treatment|1|||
170450513|NCT02589522|615988913|FG001|Overall Study|Did not start treatment|0|||
170450514|NCT02589522|615988914|FG002|Overall Study|Did not start treatment|0|||
170450515|NCT01478828|615988915|FG000|Overall Study|Adverse Event|1|||
170786861|NCT03338933|617229515|FG001|Screening Visit|Lost to Follow-up|3|||
170450516|NCT00754442|615988916|FG000|Overall Study|Withdrawal by Subject|5|||
170450517|NCT00754442|615988917|FG001|Overall Study|Withdrawal by Subject|3|||
170450518|NCT01557842|615988918|FG000|Overall Study|Lost to Follow-up|0|||
170450519|NCT01557842|615988919|FG001|Overall Study|Lost to Follow-up|1|||
170450520|NCT01557842|615988918|FG000|Overall Study|Death|1|||
170786862|NCT03338933|617229516|FG002|Screening Visit|Lost to Follow-up|1|||
170786863|NCT03338933|617229517|FG003|Screening Visit|Lost to Follow-up|4|||
170786864|NCT03338933|617229514|FG000|Screening Visit|Screen fail after consent|2|||
170786865|NCT03338933|617229515|FG001|Screening Visit|Screen fail after consent|7|||
170786866|NCT03338933|617229516|FG002|Screening Visit|Screen fail after consent|1|||
170450521|NCT01557842|615988919|FG001|Overall Study|Death|0|||
170450522|NCT01557842|615988918|FG000|Overall Study|Lack of Efficacy|0|||
170450523|NCT01557842|615988919|FG001|Overall Study|Lack of Efficacy|1|||
170450524|NCT01557842|615988918|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
170450525|NCT01557842|615988919|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
170450526|NCT01557842|615988918|FG000|Overall Study|Study Terminated by Sponsor|3|||
170450527|NCT01557842|615988919|FG001|Overall Study|Study Terminated by Sponsor|4|||
170450528|NCT01557842|615988918|FG000|Overall Study|Not Ablated|2|||
170450529|NCT01557842|615988919|FG001|Overall Study|Not Ablated|0|||
170786867|NCT03338933|617229517|FG003|Screening Visit|Screen fail after consent|4|||
170887405|NCT00866307|617595956|FG001|Induction|Death|0|||
170450530|NCT05611996|615988920|FG000|Overall Study|Ineligible|1|||
170450531|NCT05611996|615988920|FG000|Overall Study|Withdrawal by Subject|9|||
170450532|NCT04479475|615988928|FG000|Overall Study|Withdrawal by Subject|7|||
170450533|NCT03005067|615988931|FG000|Overall Study|Withdrawal by Subject|3|||
170450534|NCT03005067|615988932|FG001|Overall Study|Withdrawal by Subject|2|||
170450535|NCT03005067|615988931|FG000|Overall Study|Adverse Event|4|||
170450536|NCT03005067|615988932|FG001|Overall Study|Adverse Event|3|||
170450537|NCT03005067|615988931|FG000|Overall Study|Other (reason not specified)|3|||
170450538|NCT03005067|615988932|FG001|Overall Study|Other (reason not specified)|1|||
170450539|NCT03005067|615988931|FG000|Overall Study|Protocol Violation|0|||
170450540|NCT03005067|615988932|FG001|Overall Study|Protocol Violation|1|||
170450541|NCT06972251|615988935|FG000|Overall Study|Withdrawal by Subject|1|||
170450542|NCT06972251|615988936|FG001|Overall Study|Withdrawal by Subject|0|||
170450543|NCT06972251|615988935|FG000|Overall Study|Lost to Follow-up|10|||
170450544|NCT06972251|615988936|FG001|Overall Study|Lost to Follow-up|2|||
170450545|NCT05575063|615988937|FG000|Overall Study|Withdrawal by Subject|1|||
170450546|NCT02278718|615988938|FG000|Overall Study|Adverse Event|1|||
170450547|NCT02278718|615988939|FG001|Overall Study|Adverse Event|0|||
170450548|NCT02278718|615988938|FG000|Overall Study|Lost to Follow-up|2|||
170450549|NCT02278718|615988939|FG001|Overall Study|Lost to Follow-up|4|||
170450550|NCT02278718|615988938|FG000|Overall Study|Withdrawal by Subject|1|||
170450551|NCT02278718|615988939|FG001|Overall Study|Withdrawal by Subject|4|||
170450552|NCT02278718|615988938|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
170450553|NCT02278718|615988939|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
170450554|NCT02278718|615988938|FG000|Overall Study|Missing|0|||
170450555|NCT02278718|615988939|FG001|Overall Study|Missing|1|||
170450556|NCT04440449|615988940|FG000|Overall Study|Lost to Follow-up|2|||
170450557|NCT04440449|615988941|FG001|Overall Study|Lost to Follow-up|0|||
170450558|NCT03212794|615988942|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
170450559|NCT03212794|615988943|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
170450560|NCT03212794|615988942|FG000|Overall Study|Lost to Follow-up|5|||
170450561|NCT03212794|615988943|FG001|Overall Study|Lost to Follow-up|6|||
170450562|NCT03212794|615988942|FG000|Overall Study|Incarcerated; unable to participate|2|||
170450563|NCT03212794|615988943|FG001|Overall Study|Incarcerated; unable to participate|0|||
170450564|NCT03212794|615988942|FG000|Overall Study|Withdrawal by Subject|1|||
170450565|NCT03212794|615988943|FG001|Overall Study|Withdrawal by Subject|0|||
170450566|NCT03212794|615988942|FG000|Overall Study|Death|0|||
170450567|NCT03212794|615988943|FG001|Overall Study|Death|1|||
170450568|NCT03212794|615988942|FG000|Overall Study|Found to be ineligible after allocation|0|||
170450569|NCT03212794|615988943|FG001|Overall Study|Found to be ineligible after allocation|1|||
170450570|NCT03212794|615988942|FG000|Overall Study|Relocated out of area|2|||
170450571|NCT03212794|615988943|FG001|Overall Study|Relocated out of area|0|||
170450572|NCT02547766|615988944|FG000|Overall Study|Withdrawal by Subject|1|||
170450573|NCT03604341|615988947|FG000|Overall Study|Withdrawal by Subject|1|||
170450574|NCT03604341|615988948|FG001|Overall Study|Withdrawal by Subject|1|||
170450575|NCT03604341|615988947|FG000|Overall Study|Adverse Event|1|||
170450576|NCT03604341|615988948|FG001|Overall Study|Adverse Event|0|||
170450577|NCT03604341|615988947|FG000|Overall Study|Protocol Violation|0|||
170450578|NCT03604341|615988948|FG001|Overall Study|Protocol Violation|1|||
170450579|NCT00484419|615988949|FG000|Overall Study|Adverse Event|3|||
170634334|NCT01812252|616671945|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
170634335|NCT01812252|616671946|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
170634336|NCT01812252|616671945|FG000|Overall Study|Withdrawal by Subject|1|||
170634337|NCT01812252|616671946|FG001|Overall Study|Withdrawal by Subject|1|||
170634338|NCT01812252|616671945|FG000|Overall Study|Screen Failure|1|||
170634339|NCT01812252|616671946|FG001|Overall Study|Screen Failure|0|||
170634340|NCT03739203|616671947|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
170634341|NCT03739203|616671948|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
170634342|NCT03739203|616671949|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
170450580|NCT00484419|615988950|FG001|Overall Study|Adverse Event|0|||
170786868|NCT03338933|617229514|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
170786869|NCT03338933|617229515|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
170450581|NCT00484419|615988951|FG002|Overall Study|Adverse Event|0|||
170450582|NCT00484419|615988949|FG000|Overall Study|Lost to Follow-up|1|||
170450583|NCT00484419|615988950|FG001|Overall Study|Lost to Follow-up|0|||
170450584|NCT00484419|615988951|FG002|Overall Study|Lost to Follow-up|2|||
170634343|NCT03739203|616671947|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
170786870|NCT03338933|617229516|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
170450585|NCT00484419|615988949|FG000|Overall Study|Withdrawal by Subject|3|||
170450586|NCT00484419|615988950|FG001|Overall Study|Withdrawal by Subject|1|||
170450587|NCT00484419|615988951|FG002|Overall Study|Withdrawal by Subject|1|||
170450588|NCT00484419|615988949|FG000|Overall Study|subject met discontinuation criteria|2|||
170450589|NCT00484419|615988950|FG001|Overall Study|subject met discontinuation criteria|2|||
170450590|NCT00484419|615988951|FG002|Overall Study|subject met discontinuation criteria|4|||
170450591|NCT00484419|615988949|FG000|Overall Study|required restricted medication|1|||
170450592|NCT00484419|615988950|FG001|Overall Study|required restricted medication|0|||
170450593|NCT00484419|615988951|FG002|Overall Study|required restricted medication|1|||
170450594|NCT00484419|615988949|FG000|Overall Study|Physician Decision|1|||
170450595|NCT00484419|615988950|FG001|Overall Study|Physician Decision|1|||
170450596|NCT00484419|615988951|FG002|Overall Study|Physician Decision|1|||
170450597|NCT00484419|615988949|FG000|Overall Study|subject unable to receive medication|1|||
170450598|NCT00484419|615988950|FG001|Overall Study|subject unable to receive medication|0|||
170450599|NCT00484419|615988951|FG002|Overall Study|subject unable to receive medication|0|||
170450600|NCT00484419|615988949|FG000|Overall Study|subject relocated|0|||
170450601|NCT00484419|615988950|FG001|Overall Study|subject relocated|1|||
170450602|NCT00484419|615988951|FG002|Overall Study|subject relocated|0|||
170450603|NCT00484419|615988949|FG000|Overall Study|sponsor decision, randomized in error|0|||
170450604|NCT00484419|615988950|FG001|Overall Study|sponsor decision, randomized in error|0|||
170450605|NCT00484419|615988951|FG002|Overall Study|sponsor decision, randomized in error|2|||
170450606|NCT00355472|615988953|FG000|Overall Study|Physician Decision|1|||
170634344|NCT03739203|616671948|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
170634345|NCT03739203|616671949|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
170634346|NCT03739203|616671947|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
170634347|NCT03739203|616671948|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
170634348|NCT03739203|616671949|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
170634349|NCT03739203|616671947|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
170634350|NCT03739203|616671948|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
170634351|NCT03739203|616671949|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
170634352|NCT03739203|616671947|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
170634353|NCT03739203|616671948|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
170786871|NCT03338933|617229517|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
170786872|NCT03338933|617229514|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
170450619|NCT05224544|615988956|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
170450620|NCT05224544|615988957|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
170450621|NCT00351351|615988958|FG000|Overall Study|surgical access pbs; device issues|9|||
170450622|NCT00351351|615988959|FG001|Overall Study|surgical access pbs; device issues|4|||
170450623|NCT03176784|615988964|FG000|Overall Study|Lost to Follow-up|77|||
170450624|NCT03176784|615988965|FG001|Overall Study|Lost to Follow-up|79|||
170450625|NCT03176784|615988966|FG002|Overall Study|Lost to Follow-up|79|||
170450626|NCT03176784|615988967|FG003|Overall Study|Lost to Follow-up|49|||
170450627|NCT03176784|615988964|FG000|Overall Study|Withdrawal by Subject|28|||
170450628|NCT03176784|615988965|FG001|Overall Study|Withdrawal by Subject|34|||
170450629|NCT03176784|615988966|FG002|Overall Study|Withdrawal by Subject|34|||
170450630|NCT03176784|615988967|FG003|Overall Study|Withdrawal by Subject|21|||
170450631|NCT01682148|615988968|FG000|Overall Study|Withdrawal by Subject|2|||
170450632|NCT01682148|615988969|FG001|Overall Study|Withdrawal by Subject|0|||
170450633|NCT01682148|615988968|FG000|Overall Study|Lost to Follow-up|1|||
170450634|NCT01682148|615988969|FG001|Overall Study|Lost to Follow-up|2|||
170450635|NCT01682148|615988968|FG000|Overall Study|Protocol Violation|1|||
170450636|NCT01682148|615988969|FG001|Overall Study|Protocol Violation|1|||
170450637|NCT01202877|615988970|FG000|Overall Study|Disease Progression|0|||
170450638|NCT01202877|615988971|FG001|Overall Study|Disease Progression|1|||
170786873|NCT03338933|617229515|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
170786874|NCT03338933|617229516|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
170786875|NCT03338933|617229517|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
170786876|NCT03338933|617229514|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
170786877|NCT03338933|617229515|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
170786878|NCT03338933|617229516|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
170786879|NCT03338933|617229517|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
170450639|NCT01202877|615988972|FG002|Overall Study|Disease Progression|2|||
170450640|NCT01202877|615988970|FG000|Overall Study|Adverse Event|0|||
170450641|NCT01202877|615988971|FG001|Overall Study|Adverse Event|0|||
170450642|NCT01202877|615988972|FG002|Overall Study|Adverse Event|2|||
170450643|NCT01202877|615988970|FG000|Overall Study|Withdrawal by Subject|0|||
170450644|NCT01202877|615988971|FG001|Overall Study|Withdrawal by Subject|0|||
170450645|NCT01202877|615988972|FG002|Overall Study|Withdrawal by Subject|1|||
170450646|NCT01202877|615988970|FG000|Overall Study|Death|0|||
170450647|NCT01202877|615988971|FG001|Overall Study|Death|0|||
170450648|NCT01202877|615988972|FG002|Overall Study|Death|1|||
170450649|NCT01884688|615988973|FG000|Overall Study|Screen Failure|2|||
170450650|NCT02563769|615988974|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
170450651|NCT02563769|615988975|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
170450652|NCT02563769|615988976|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
170450653|NCT02709486|615988985|FG000|Overall Study|Adverse Event|2|||
170450654|NCT02709486|615988986|FG001|Overall Study|Adverse Event|5|||
170450655|NCT02709486|615988987|FG002|Overall Study|Adverse Event|3|||
170450656|NCT02709486|615988985|FG000|Overall Study|Death|0|||
170450657|NCT02709486|615988986|FG001|Overall Study|Death|0|||
170450658|NCT02709486|615988987|FG002|Overall Study|Death|2|||
170450659|NCT02709486|615988985|FG000|Overall Study|Insufficient clinical response|7|||
170450660|NCT02709486|615988986|FG001|Overall Study|Insufficient clinical response|3|||
170450661|NCT02709486|615988987|FG002|Overall Study|Insufficient clinical response|3|||
170450662|NCT02709486|615988985|FG000|Overall Study|Lost to Follow-up|3|||
170450663|NCT02709486|615988986|FG001|Overall Study|Lost to Follow-up|2|||
170450664|NCT02709486|615988987|FG002|Overall Study|Lost to Follow-up|2|||
170450665|NCT02709486|615988985|FG000|Overall Study|Other|0|||
170450666|NCT02709486|615988986|FG001|Overall Study|Other|2|||
170450667|NCT02709486|615988987|FG002|Overall Study|Other|3|||
170450668|NCT02709486|615988985|FG000|Overall Study|Withdrawal by Subject|32|||
170450669|NCT02709486|615988986|FG001|Overall Study|Withdrawal by Subject|22|||
170450670|NCT02709486|615988987|FG002|Overall Study|Withdrawal by Subject|32|||
170450671|NCT02377921|615988990|FG000|Overall Study|Subject non-compliance|1|||
170450672|NCT02377921|615988991|FG001|Overall Study|Subject non-compliance|1|||
170450673|NCT02443545|615988992|FG000|Overall Study|Adverse Event|1|||
170450674|NCT02443545|615988993|FG001|Overall Study|Adverse Event|1|||
170450675|NCT02443545|615988992|FG000|Overall Study|Lost to Follow-up|0|||
170450676|NCT02443545|615988993|FG001|Overall Study|Lost to Follow-up|2|||
170450677|NCT02443545|615988992|FG000|Overall Study|Physician Decision|3|||
170450678|NCT02443545|615988993|FG001|Overall Study|Physician Decision|0|||
170450679|NCT02443545|615988992|FG000|Overall Study|Protocol Violation|8|||
170450680|NCT02443545|615988993|FG001|Overall Study|Protocol Violation|1|||
170450681|NCT02443545|615988992|FG000|Overall Study|Pregnancy|1|||
170450682|NCT02443545|615988993|FG001|Overall Study|Pregnancy|1|||
170450683|NCT02443545|615988992|FG000|Overall Study|Withdrawal by Subject|6|||
170450684|NCT02443545|615988993|FG001|Overall Study|Withdrawal by Subject|3|||
170450685|NCT02443545|615988992|FG000|Overall Study|Termination of study|20|||
170450686|NCT02443545|615988993|FG001|Overall Study|Termination of study|11|||
170450687|NCT00536484|615988996|FG000|Overall Study|Adverse Event|21|||
170450688|NCT00536484|615988997|FG001|Overall Study|Adverse Event|34|||
170450689|NCT00536484|615988996|FG000|Overall Study|Withdrawal by Subject|11|||
170450690|NCT00536484|615988997|FG001|Overall Study|Withdrawal by Subject|11|||
170786880|NCT04515576|617229518|FG000|Overall Study|Withdrawal by Subject|0|||
170450691|NCT00536484|615988996|FG000|Overall Study|Lost to Follow-up|8|||
170450692|NCT00536484|615988997|FG001|Overall Study|Lost to Follow-up|6|||
170450693|NCT00536484|615988996|FG000|Overall Study|Lack of Efficacy|16|||
170450694|NCT00536484|615988997|FG001|Overall Study|Lack of Efficacy|5|||
170450695|NCT00536484|615988996|FG000|Overall Study|Other|4|||
170450696|NCT00536484|615988997|FG001|Overall Study|Other|0|||
170450697|NCT04179019|615988998|FG000|Overall Study|Lost to Follow-up|2|||
170450698|NCT04179019|615988998|FG000|Overall Study|Physician Decision|2|||
170786881|NCT04515576|617229519|FG001|Overall Study|Withdrawal by Subject|0|||
170786882|NCT04515576|617229520|FG002|Overall Study|Withdrawal by Subject|0|||
170786883|NCT04515576|617229521|FG003|Overall Study|Withdrawal by Subject|0|||
170786884|NCT04515576|617229522|FG004|Overall Study|Withdrawal by Subject|0|||
170786885|NCT04515576|617229523|FG005|Overall Study|Withdrawal by Subject|1|||
170786886|NCT03812679|617229524|FG000|Overall Study|Adverse Event|2|||
170786887|NCT03812679|617229524|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
170786888|NCT03812679|617229524|FG000|Overall Study|Renal transplant|1|||
170786889|NCT03812679|617229524|FG000|Overall Study|Withdrawal by Subject|1|||
170786890|NCT03812679|617229524|FG000|Overall Study|Termination of study|2|||
170786891|NCT03812679|617229524|FG000|Overall Study|Water device replacement|1|||
170786892|NCT05653427|617229525|FG000|Overall Study|Study Terminated by Sponsor|13|||
170450699|NCT04179019|615988998|FG000|Overall Study|Withdrawal by Subject|5|||
170450700|NCT04179019|615988998|FG000|Overall Study|Adverse Event|4|||
170786893|NCT02724631|617229536|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
170786894|NCT02140554|617229537|FG000|Overall Study|Withdrawal of consent|1|||
170450701|NCT02549573|615989001|FG000|Overall Study|Withdrawal by Subject|0|||
170450702|NCT02549573|615989002|FG001|Overall Study|Withdrawal by Subject|2|||
170450703|NCT02549573|615989001|FG000|Overall Study|Protocol Violation|0|||
170450704|NCT02549573|615989002|FG001|Overall Study|Protocol Violation|1|||
170450705|NCT02083926|615989003|FG000|Overall Study|Withdrawal by Subject|1|||
170450706|NCT02083926|615989004|FG001|Overall Study|Withdrawal by Subject|0|||
170450707|NCT02139124|615989009|FG000|Overall Study|Adverse Event|2|||
170450708|NCT02139124|615989010|FG001|Overall Study|Adverse Event|0|||
170450709|NCT02139124|615989011|FG002|Overall Study|Adverse Event|1|||
170450710|NCT02139124|615989012|FG003|Overall Study|Adverse Event|2|||
170450711|NCT02139124|615989013|FG004|Overall Study|Adverse Event|5|||
170450712|NCT02139124|615989009|FG000|Overall Study|Withdrawal by Subject|2|||
170786895|NCT02140554|617229538|FG001|Overall Study|Withdrawal of consent|0|||
170786896|NCT02140554|617229539|FG002|Overall Study|Withdrawal of consent|4|||
170450713|NCT02139124|615989010|FG001|Overall Study|Withdrawal by Subject|2|||
170450714|NCT02139124|615989011|FG002|Overall Study|Withdrawal by Subject|2|||
170450715|NCT02139124|615989012|FG003|Overall Study|Withdrawal by Subject|2|||
170450716|NCT02139124|615989013|FG004|Overall Study|Withdrawal by Subject|3|||
170450717|NCT02139124|615989009|FG000|Overall Study|Protocol Violation|0|||
170450718|NCT02139124|615989010|FG001|Overall Study|Protocol Violation|0|||
170450719|NCT02139124|615989011|FG002|Overall Study|Protocol Violation|0|||
170450720|NCT02139124|615989012|FG003|Overall Study|Protocol Violation|1|||
170450721|NCT02139124|615989013|FG004|Overall Study|Protocol Violation|1|||
170450722|NCT02139124|615989009|FG000|Overall Study|non-compliant|1|||
170450723|NCT02139124|615989010|FG001|Overall Study|non-compliant|0|||
170450724|NCT02139124|615989011|FG002|Overall Study|non-compliant|0|||
170450725|NCT02139124|615989012|FG003|Overall Study|non-compliant|2|||
170450726|NCT02139124|615989013|FG004|Overall Study|non-compliant|0|||
170450727|NCT02139124|615989009|FG000|Overall Study|incarceration|0|||
170450728|NCT02139124|615989010|FG001|Overall Study|incarceration|0|||
170450729|NCT02139124|615989011|FG002|Overall Study|incarceration|1|||
170450730|NCT02139124|615989012|FG003|Overall Study|incarceration|0|||
170450731|NCT02139124|615989013|FG004|Overall Study|incarceration|0|||
170450732|NCT02139124|615989009|FG000|Overall Study|subject moved|1|||
170450733|NCT02139124|615989010|FG001|Overall Study|subject moved|0|||
170450734|NCT02139124|615989011|FG002|Overall Study|subject moved|0|||
170450735|NCT02139124|615989012|FG003|Overall Study|subject moved|0|||
170450736|NCT02139124|615989013|FG004|Overall Study|subject moved|0|||
170450737|NCT02139124|615989009|FG000|Overall Study|Lost to Follow-up|3|||
170450738|NCT02139124|615989010|FG001|Overall Study|Lost to Follow-up|2|||
170450739|NCT02139124|615989011|FG002|Overall Study|Lost to Follow-up|0|||
170450740|NCT02139124|615989012|FG003|Overall Study|Lost to Follow-up|5|||
170450741|NCT02139124|615989013|FG004|Overall Study|Lost to Follow-up|4|||
170450742|NCT02691741|615989014|FG000|Overall Study|Adverse Event|0|||
170450743|NCT02691741|615989015|FG001|Overall Study|Adverse Event|2|||
170450744|NCT02691741|615989014|FG000|Overall Study|Lost to Follow-up|1|||
170450745|NCT02691741|615989015|FG001|Overall Study|Lost to Follow-up|0|||
170450746|NCT02691741|615989014|FG000|Overall Study|Physician Decision|0|||
170450747|NCT02691741|615989015|FG001|Overall Study|Physician Decision|1|||
170450748|NCT02691741|615989014|FG000|Overall Study|Withdrawal by Subject|0|||
170450749|NCT02691741|615989015|FG001|Overall Study|Withdrawal by Subject|4|||
170450750|NCT03465436|615989016|FG000|Period 1|Protocol Violation|0|||
170450751|NCT03465436|615989017|FG001|Period 1|Protocol Violation|0|||
170450752|NCT03465436|615989018|FG002|Period 1|Protocol Violation|1|||
170450753|NCT03465436|615989019|FG003|Period 1|Protocol Violation|0|||
170634354|NCT03739203|616671949|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
170634355|NCT03739203|616671947|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
170634356|NCT03739203|616671948|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
170634357|NCT03739203|616671949|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
170634358|NCT03739203|616671947|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
170634359|NCT03739203|616671948|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
170450754|NCT03465436|615989016|FG000|Period 2|Protocol Violation|0|||
170450755|NCT03465436|615989017|FG001|Period 2|Protocol Violation|1|||
170450756|NCT03465436|615989018|FG002|Period 2|Protocol Violation|0|||
170450757|NCT03465436|615989019|FG003|Period 2|Protocol Violation|0|||
170450758|NCT03465436|615989016|FG000|Period 3|Protocol Violation|1|||
170450759|NCT03465436|615989017|FG001|Period 3|Protocol Violation|1|||
170450760|NCT03465436|615989018|FG002|Period 3|Protocol Violation|0|||
170450761|NCT03465436|615989019|FG003|Period 3|Protocol Violation|0|||
170450762|NCT03465436|615989016|FG000|Period 4|Protocol Violation|0|||
170450763|NCT03465436|615989017|FG001|Period 4|Protocol Violation|0|||
170634360|NCT03739203|616671949|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
170786897|NCT02140554|617229537|FG000|Overall Study|Physician Decision|1|||
170786898|NCT02140554|617229538|FG001|Overall Study|Physician Decision|0|||
170786899|NCT02140554|617229539|FG002|Overall Study|Physician Decision|2|||
170786900|NCT02140554|617229537|FG000|Overall Study|Death|0|||
170786901|NCT02140554|617229538|FG001|Overall Study|Death|0|||
170786902|NCT02140554|617229539|FG002|Overall Study|Death|1|||
170786903|NCT02140554|617229537|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
170786904|NCT02140554|617229538|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
170887406|NCT00866307|617595957|FG002|Induction|Death|0|||
170786905|NCT02140554|617229539|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
170786906|NCT03771417|617229541|FG000|Overall Study|Withdrawal by Subject|1|||
170887407|NCT00866307|617595955|FG000|Induction|Physician Decision|5|||
170450764|NCT03465436|615989018|FG002|Period 4|Protocol Violation|1|||
170450765|NCT03465436|615989019|FG003|Period 4|Protocol Violation|0|||
170450766|NCT00613834|615989020|FG000|Overall Study|Withdrawal by Subject|0|||
170450767|NCT00613834|615989021|FG001|Overall Study|Withdrawal by Subject|3|||
170450768|NCT02939950|615989022|FG000|Overall Study|Lost to Follow-up|13|||
170450769|NCT02939950|615989023|FG001|Overall Study|Lost to Follow-up|16|||
170450770|NCT02939950|615989022|FG000|Overall Study|Positive slit lamp findings|0|||
170887408|NCT00866307|617595956|FG001|Induction|Physician Decision|0|||
170887409|NCT00866307|617595957|FG002|Induction|Physician Decision|0|||
170887410|NCT00866307|617595955|FG000|Induction|Progressive Disease|1|||
170887411|NCT00866307|617595956|FG001|Induction|Progressive Disease|0|||
170887412|NCT00866307|617595957|FG002|Induction|Progressive Disease|0|||
170887413|NCT00866307|617595955|FG000|Induction|Identification of Patients with Day 29 M|3|||
170887414|NCT00866307|617595956|FG001|Induction|Identification of Patients with Day 29 M|0|||
170887415|NCT00866307|617595957|FG002|Induction|Identification of Patients with Day 29 M|0|||
170887416|NCT00866307|617595955|FG000|Induction|Inadequate cytognetic samples th|1|||
170887417|NCT00866307|617595956|FG001|Induction|Inadequate cytognetic samples th|0|||
170887418|NCT00866307|617595957|FG002|Induction|Inadequate cytognetic samples th|0|||
170887419|NCT00866307|617595955|FG000|Induction|Improper post-induction consent|2|||
170887420|NCT00866307|617595956|FG001|Induction|Improper post-induction consent|0|||
170887421|NCT00866307|617595957|FG002|Induction|Improper post-induction consent|0|||
170887422|NCT00866307|617595955|FG000|Induction|Study was closed at the time|1|||
170887423|NCT00866307|617595956|FG001|Induction|Study was closed at the time|0|||
170887424|NCT00866307|617595957|FG002|Induction|Study was closed at the time|0|||
170887425|NCT00866307|617595955|FG000|Consolidation/Maintenance|Adverse Event|0|||
170887426|NCT00866307|617595956|FG001|Consolidation/Maintenance|Adverse Event|0|||
170887427|NCT00866307|617595957|FG002|Consolidation/Maintenance|Adverse Event|8|||
170887428|NCT00866307|617595955|FG000|Consolidation/Maintenance|Death|0|||
170887429|NCT00866307|617595956|FG001|Consolidation/Maintenance|Death|0|||
170887430|NCT00866307|617595957|FG002|Consolidation/Maintenance|Death|1|||
170887431|NCT00866307|617595955|FG000|Consolidation/Maintenance|Physician Decision|0|||
170887432|NCT00866307|617595956|FG001|Consolidation/Maintenance|Physician Decision|3|||
170887433|NCT00866307|617595957|FG002|Consolidation/Maintenance|Physician Decision|2|||
170887434|NCT00866307|617595955|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
170887435|NCT00866307|617595956|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
170887436|NCT00866307|617595957|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
170887437|NCT00866307|617595955|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
170887438|NCT00866307|617595956|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
170887439|NCT00866307|617595957|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
170887440|NCT00866307|617595955|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
170887441|NCT00866307|617595956|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
170887442|NCT00866307|617595957|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
170887443|NCT00866307|617595955|FG000|Consolidation/Maintenance|Therapy error|0|||
170887444|NCT00866307|617595956|FG001|Consolidation/Maintenance|Therapy error|1|||
170887445|NCT00866307|617595957|FG002|Consolidation/Maintenance|Therapy error|0|||
170887446|NCT00866307|617595955|FG000|Consolidation/Maintenance|Non-compliance|0|||
170887447|NCT00866307|617595956|FG001|Consolidation/Maintenance|Non-compliance|0|||
170887448|NCT00866307|617595957|FG002|Consolidation/Maintenance|Non-compliance|1|||
170887449|NCT00866307|617595955|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
170887450|NCT00866307|617595956|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
170887451|NCT00866307|617595957|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
170887452|NCT03074474|617595962|FG000|Overall Study|Lost to Follow-up|10|||
170887453|NCT03074474|617595962|FG000|Overall Study|Withdrawal by Subject|10|||
170887454|NCT03074474|617595962|FG000|Overall Study|Death|4|||
170887455|NCT03074474|617595962|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
170887456|NCT02573155|617595963|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
170887457|NCT02573155|617595964|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
170887458|NCT02573155|617595963|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
170887459|NCT02573155|617595964|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
170887460|NCT02573155|617595963|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
170887461|NCT02573155|617595964|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
170887462|NCT02573155|617595963|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
170887463|NCT02573155|617595964|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
170887464|NCT02573155|617595963|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
170887465|NCT02573155|617595964|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
170887466|NCT02573155|617595963|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
170887467|NCT02573155|617595964|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
170887468|NCT02573155|617595963|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
170887469|NCT02573155|617595964|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
170887470|NCT02573155|617595963|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
170887471|NCT02573155|617595964|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
170887472|NCT01681433|617595967|FG000|Overall Study|Lack of Efficacy|23|||
170887473|NCT01681433|617595968|FG001|Overall Study|Lack of Efficacy|23|||
170887474|NCT01681433|617595967|FG000|Overall Study|Withdrawal by Subject|5|||
170887475|NCT01681433|617595968|FG001|Overall Study|Withdrawal by Subject|5|||
170887476|NCT01681433|617595967|FG000|Overall Study|Protocol Violation|2|||
170887477|NCT01681433|617595968|FG001|Overall Study|Protocol Violation|0|||
170887478|NCT01681433|617595967|FG000|Overall Study|Adverse Event|2|||
170450771|NCT02939950|615989023|FG001|Overall Study|Positive slit lamp findings|1|||
170450772|NCT02939950|615989022|FG000|Overall Study|Chalazion upper lid|0|||
170450773|NCT02939950|615989023|FG001|Overall Study|Chalazion upper lid|1|||
170450774|NCT02939950|615989022|FG000|Overall Study|Lack of motivation|0|||
170450775|NCT02939950|615989023|FG001|Overall Study|Lack of motivation|2|||
170450776|NCT02939950|615989022|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
170450777|NCT02939950|615989023|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
170450778|NCT02939950|615989022|FG000|Overall Study|Military orders|1|||
170450779|NCT02939950|615989023|FG001|Overall Study|Military orders|0|||
170450780|NCT02939950|615989022|FG000|Overall Study|Participant Relocated|5|||
170450781|NCT02939950|615989023|FG001|Overall Study|Participant Relocated|3|||
170450782|NCT02939950|615989022|FG000|Overall Study|Study related symptoms|8|||
170450783|NCT02939950|615989023|FG001|Overall Study|Study related symptoms|8|||
170450784|NCT02939950|615989022|FG000|Overall Study|Unacceptable lens movement|2|||
170450785|NCT02939950|615989023|FG001|Overall Study|Unacceptable lens movement|0|||
170450786|NCT02939950|615989022|FG000|Overall Study|Protocol Violation|6|||
170450787|NCT02939950|615989023|FG001|Overall Study|Protocol Violation|3|||
170450788|NCT02939950|615989022|FG000|Overall Study|Physician Decision|2|||
170634361|NCT03739203|616671947|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
170450789|NCT02939950|615989023|FG001|Overall Study|Physician Decision|0|||
170450790|NCT02939950|615989022|FG000|Overall Study|Pregnancy|6|||
170450791|NCT02939950|615989023|FG001|Overall Study|Pregnancy|7|||
170450792|NCT02939950|615989022|FG000|Overall Study|Withdrawal by Subject|12|||
170634362|NCT03739203|616671948|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
170634363|NCT03739203|616671949|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
170634364|NCT03739203|616671947|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
170634365|NCT03739203|616671948|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
170634366|NCT03739203|616671949|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
170634367|NCT03739203|616671947|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
170634368|NCT03739203|616671948|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
170634369|NCT03739203|616671949|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
170887479|NCT01681433|617595968|FG001|Overall Study|Adverse Event|4|||
170450793|NCT02939950|615989023|FG001|Overall Study|Withdrawal by Subject|28|||
170450794|NCT02939950|615989022|FG000|Overall Study|Adverse Event|7|||
170450795|NCT02939950|615989023|FG001|Overall Study|Adverse Event|3|||
170450796|NCT02939950|615989022|FG000|Overall Study|Randomized, not dispensed|1|||
170450797|NCT02939950|615989023|FG001|Overall Study|Randomized, not dispensed|0|||
170450798|NCT02939950|615989022|FG000|Overall Study|Ineligible at Baseline|2|||
170450799|NCT02939950|615989023|FG001|Overall Study|Ineligible at Baseline|8|||
170450800|NCT01172821|615989035|FG000|Overall Study|Adverse Event|5|||
170450801|NCT01172821|615989036|FG001|Overall Study|Adverse Event|2|||
170450802|NCT01172821|615989037|FG002|Overall Study|Adverse Event|2|||
170450803|NCT01172821|615989038|FG003|Overall Study|Adverse Event|7|||
170450804|NCT01172821|615989035|FG000|Overall Study|Protocol Violation|0|||
170450805|NCT01172821|615989036|FG001|Overall Study|Protocol Violation|2|||
170450806|NCT01172821|615989037|FG002|Overall Study|Protocol Violation|1|||
170450807|NCT01172821|615989038|FG003|Overall Study|Protocol Violation|2|||
170450808|NCT01172821|615989035|FG000|Overall Study|Lost to Follow-up|4|||
170450809|NCT01172821|615989036|FG001|Overall Study|Lost to Follow-up|1|||
170450810|NCT01172821|615989037|FG002|Overall Study|Lost to Follow-up|2|||
170450811|NCT01172821|615989038|FG003|Overall Study|Lost to Follow-up|2|||
170450812|NCT01172821|615989035|FG000|Overall Study|Withdrawal by Subject|2|||
170450813|NCT01172821|615989036|FG001|Overall Study|Withdrawal by Subject|3|||
170450814|NCT01172821|615989037|FG002|Overall Study|Withdrawal by Subject|3|||
170450815|NCT01172821|615989038|FG003|Overall Study|Withdrawal by Subject|3|||
170634370|NCT03739203|616671947|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
170634371|NCT03739203|616671948|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
170634372|NCT03739203|616671949|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
170887480|NCT01681433|617595967|FG000|Overall Study|Lost to Follow-up|0|||
170887481|NCT01681433|617595968|FG001|Overall Study|Lost to Follow-up|1|||
170887482|NCT00903929|617595969|FG000|Overall Study|Withdrawal by Subject|0|||
170887483|NCT00903929|617595970|FG001|Overall Study|Withdrawal by Subject|0|||
170887484|NCT00903929|617595971|FG002|Overall Study|Withdrawal by Subject|1|||
170887485|NCT00903929|617595972|FG003|Overall Study|Withdrawal by Subject|2|||
170450816|NCT01172821|615989035|FG000|Overall Study|Other|3|||
170450817|NCT01172821|615989036|FG001|Overall Study|Other|4|||
170450818|NCT01172821|615989037|FG002|Overall Study|Other|5|||
170634373|NCT00830440|616671950|FG000|Overall Study|Protocol Violation|1|||
170634374|NCT00830440|616671951|FG001|Overall Study|Protocol Violation|0|||
170634375|NCT00830440|616671950|FG000|Overall Study|Withdrawal by Subject|1|||
170887486|NCT00903929|617595969|FG000|Overall Study|Adverse Event|0|||
170450819|NCT01172821|615989038|FG003|Overall Study|Other|3|||
170450820|NCT03821272|615991148|FG000|Overall Study|Death|1|||
170450821|NCT03821272|615991149|FG001|Overall Study|Death|0|||
170450822|NCT03821272|615991148|FG000|Overall Study|Physician Decision|1|||
170450823|NCT03821272|615991149|FG001|Overall Study|Physician Decision|0|||
170887487|NCT00903929|617595970|FG001|Overall Study|Adverse Event|0|||
170450824|NCT03821272|615991148|FG000|Overall Study|Withdrawal by Subject|1|||
170450825|NCT03821272|615991149|FG001|Overall Study|Withdrawal by Subject|0|||
170450826|NCT05904769|615991150|FG000|Overall Study|Physician Decision|0|||
170450827|NCT05904769|615991151|FG001|Overall Study|Physician Decision|6|||
170450828|NCT05626803|615991157|FG000|Overall Study|Lost to Follow-up|0|||
170450829|NCT05626803|615991158|FG001|Overall Study|Lost to Follow-up|1|||
170450830|NCT05626803|615991159|FG002|Overall Study|Lost to Follow-up|0|||
170450831|NCT05626803|615991160|FG003|Overall Study|Lost to Follow-up|0|||
170450832|NCT04974619|615991161|FG000|Overall Study|Lost to Follow-up|0|||
170450833|NCT04974619|615991162|FG001|Overall Study|Lost to Follow-up|0|||
170450834|NCT04974619|615991163|FG002|Overall Study|Lost to Follow-up|1|||
170450835|NCT04974619|615991161|FG000|Overall Study|Withdrawal by Subject|0|||
170450836|NCT04974619|615991162|FG001|Overall Study|Withdrawal by Subject|0|||
170450837|NCT04974619|615991163|FG002|Overall Study|Withdrawal by Subject|1|||
170450838|NCT04974619|615991161|FG000|Overall Study|Protocol Violation|0|||
170450839|NCT04974619|615991162|FG001|Overall Study|Protocol Violation|1|||
170450840|NCT04974619|615991163|FG002|Overall Study|Protocol Violation|0|||
170450841|NCT03310957|615991164|FG000|Overall Study|Withdrawal by Subject|1|||
170450842|NCT03310957|615991165|FG001|Overall Study|Withdrawal by Subject|1|||
170450843|NCT03310957|615991166|FG002|Overall Study|Withdrawal by Subject|1|||
170450844|NCT03310957|615991167|FG003|Overall Study|Withdrawal by Subject|5|||
170450845|NCT03310957|615991168|FG004|Overall Study|Withdrawal by Subject|0|||
170450846|NCT03310957|615991169|FG005|Overall Study|Withdrawal by Subject|4|||
170450847|NCT03310957|615991170|FG006|Overall Study|Withdrawal by Subject|3|||
170450848|NCT03310957|615991164|FG000|Overall Study|Site Terminated|0|||
170450849|NCT03310957|615991165|FG001|Overall Study|Site Terminated|1|||
170450850|NCT03310957|615991166|FG002|Overall Study|Site Terminated|1|||
170450851|NCT03310957|615991167|FG003|Overall Study|Site Terminated|1|||
170450852|NCT03310957|615991168|FG004|Overall Study|Site Terminated|0|||
170450853|NCT03310957|615991169|FG005|Overall Study|Site Terminated|2|||
170450854|NCT03310957|615991170|FG006|Overall Study|Site Terminated|8|||
170450855|NCT03310957|615991164|FG000|Overall Study|Lost to Follow-up|1|||
170450856|NCT03310957|615991165|FG001|Overall Study|Lost to Follow-up|1|||
170450857|NCT03310957|615991166|FG002|Overall Study|Lost to Follow-up|1|||
170450858|NCT03310957|615991167|FG003|Overall Study|Lost to Follow-up|4|||
170450859|NCT03310957|615991168|FG004|Overall Study|Lost to Follow-up|0|||
170450860|NCT03310957|615991169|FG005|Overall Study|Lost to Follow-up|4|||
170450861|NCT03310957|615991170|FG006|Overall Study|Lost to Follow-up|2|||
170450862|NCT03310957|615991164|FG000|Overall Study|Death|5|||
170450863|NCT03310957|615991165|FG001|Overall Study|Death|8|||
170450864|NCT03310957|615991166|FG002|Overall Study|Death|18|||
170450865|NCT03310957|615991167|FG003|Overall Study|Death|31|||
170450866|NCT03310957|615991168|FG004|Overall Study|Death|1|||
170450867|NCT03310957|615991169|FG005|Overall Study|Death|29|||
170450868|NCT03310957|615991170|FG006|Overall Study|Death|7|||
170450869|NCT03310957|615991164|FG000|Overall Study|Discontinuation per sponsor|0|||
170450870|NCT03310957|615991165|FG001|Overall Study|Discontinuation per sponsor|1|||
170450871|NCT03310957|615991166|FG002|Overall Study|Discontinuation per sponsor|2|||
170450872|NCT03310957|615991167|FG003|Overall Study|Discontinuation per sponsor|4|||
170450873|NCT03310957|615991168|FG004|Overall Study|Discontinuation per sponsor|1|||
170450874|NCT03310957|615991169|FG005|Overall Study|Discontinuation per sponsor|9|||
170450875|NCT03310957|615991170|FG006|Overall Study|Discontinuation per sponsor|12|||
170450876|NCT03310957|615991164|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
170450877|NCT03310957|615991165|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
170450878|NCT03310957|615991166|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
170450879|NCT03310957|615991167|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
170450880|NCT03310957|615991168|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
170450881|NCT03310957|615991169|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
170450882|NCT03310957|615991170|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
170450883|NCT03310957|615991164|FG000|Overall Study|Treatment landscape|0|||
170786907|NCT03771417|617229542|FG001|Overall Study|Withdrawal by Subject|0|||
170450884|NCT03310957|615991165|FG001|Overall Study|Treatment landscape|0|||
170450885|NCT03310957|615991166|FG002|Overall Study|Treatment landscape|1|||
170450886|NCT03310957|615991167|FG003|Overall Study|Treatment landscape|1|||
170450887|NCT03310957|615991168|FG004|Overall Study|Treatment landscape|0|||
170450888|NCT03310957|615991169|FG005|Overall Study|Treatment landscape|1|||
170450889|NCT03310957|615991170|FG006|Overall Study|Treatment landscape|0|||
170450890|NCT03310957|615991164|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
170450891|NCT03310957|615991165|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
170450892|NCT03310957|615991166|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
170541190|NCT02969018|616325187|FG001|Overall Study|Pregnancy|0|||
170541191|NCT02969018|616325188|FG002|Overall Study|Pregnancy|0|||
170450893|NCT03310957|615991167|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
170450894|NCT03310957|615991168|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
170450895|NCT03310957|615991169|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
170450896|NCT03310957|615991170|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
170541192|NCT02969018|616325189|FG003|Overall Study|Pregnancy|0|||
170450897|NCT03310957|615991164|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
170450898|NCT03310957|615991165|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
170450899|NCT03310957|615991166|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
170450900|NCT03310957|615991167|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
170450901|NCT03310957|615991168|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
170450902|NCT03310957|615991169|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
170450903|NCT03310957|615991170|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
170450904|NCT03310957|615991164|FG000|Overall Study|Hospice|0|||
170450905|NCT03310957|615991165|FG001|Overall Study|Hospice|0|||
170450906|NCT03310957|615991166|FG002|Overall Study|Hospice|0|||
170450907|NCT03310957|615991167|FG003|Overall Study|Hospice|0|||
170450908|NCT03310957|615991168|FG004|Overall Study|Hospice|0|||
170450909|NCT03310957|615991169|FG005|Overall Study|Hospice|1|||
170450910|NCT03310957|615991170|FG006|Overall Study|Hospice|0|||
170450911|NCT03310957|615991164|FG000|Overall Study|Progressive|0|||
170450912|NCT03310957|615991165|FG001|Overall Study|Progressive|0|||
170450913|NCT03310957|615991166|FG002|Overall Study|Progressive|1|||
170450914|NCT03310957|615991167|FG003|Overall Study|Progressive|0|||
170450915|NCT03310957|615991168|FG004|Overall Study|Progressive|0|||
170450916|NCT03310957|615991169|FG005|Overall Study|Progressive|0|||
170450917|NCT03310957|615991170|FG006|Overall Study|Progressive|0|||
170450918|NCT01010126|615991171|FG000|Overall Study|Withdrawal by Subject|1|||
170450919|NCT01010126|615991172|FG001|Overall Study|Withdrawal by Subject|0|||
170450920|NCT01010126|615991173|FG002|Overall Study|Withdrawal by Subject|1|||
170450921|NCT01010126|615991174|FG003|Overall Study|Withdrawal by Subject|0|||
170450922|NCT01010126|615991175|FG004|Overall Study|Withdrawal by Subject|3|||
170450923|NCT01010126|615991176|FG005|Overall Study|Withdrawal by Subject|0|||
170450924|NCT04495283|615991179|FG000|Overall Study|Physician Decision|0|||
170450925|NCT04495283|615991180|FG001|Overall Study|Physician Decision|0|||
170450926|NCT04495283|615991181|FG002|Overall Study|Physician Decision|1|||
170450927|NCT04495283|615991179|FG000|Overall Study|Withdrawal by Subject|0|||
170450928|NCT04495283|615991180|FG001|Overall Study|Withdrawal by Subject|1|||
170450929|NCT04495283|615991181|FG002|Overall Study|Withdrawal by Subject|1|||
170450930|NCT04495283|615991179|FG000|Overall Study|Other|1|||
170450931|NCT04495283|615991180|FG001|Overall Study|Other|0|||
170450932|NCT04495283|615991181|FG002|Overall Study|Other|1|||
170450933|NCT01885182|615991197|FG000|Overall Study|Adverse Event|11|||
170450934|NCT01885182|615991198|FG001|Overall Study|Adverse Event|13|||
170450935|NCT01885182|615991197|FG000|Overall Study|Withdrawal by Subject|13|||
170450936|NCT01885182|615991198|FG001|Overall Study|Withdrawal by Subject|6|||
170450937|NCT01885182|615991197|FG000|Overall Study|Lost to Follow-up|2|||
170450938|NCT01885182|615991198|FG001|Overall Study|Lost to Follow-up|2|||
170450939|NCT01885182|615991197|FG000|Overall Study|Lack of Efficacy|8|||
170450940|NCT01885182|615991198|FG001|Overall Study|Lack of Efficacy|1|||
170450941|NCT04718194|615991203|FG000|Overall Study|Withdrawal by Subject|3|||
170450942|NCT04718194|615991204|FG001|Overall Study|Withdrawal by Subject|0|||
170450943|NCT04718194|615991203|FG000|Overall Study|Lost to Follow-up|3|||
170450944|NCT04718194|615991204|FG001|Overall Study|Lost to Follow-up|0|||
170450945|NCT00107042|615991205|FG000|Overall Study|Lost to Follow-up|9|||
170450946|NCT00107042|615991206|FG001|Overall Study|Lost to Follow-up|7|||
170450947|NCT00107042|615991205|FG000|Overall Study|Withdrawal by Subject|6|||
170450948|NCT00107042|615991206|FG001|Overall Study|Withdrawal by Subject|1|||
170450949|NCT00107042|615991205|FG000|Overall Study|Moved out of area|5|||
170450950|NCT00107042|615991206|FG001|Overall Study|Moved out of area|3|||
170634376|NCT00830440|616671951|FG001|Overall Study|Withdrawal by Subject|0|||
170634377|NCT00830440|616671950|FG000|Overall Study|unsuccessful procedure|4|||
170634378|NCT00830440|616671951|FG001|Overall Study|unsuccessful procedure|0|||
170634379|NCT00830440|616671950|FG000|Overall Study|Adverse Event|2|||
170634380|NCT00830440|616671951|FG001|Overall Study|Adverse Event|0|||
170634381|NCT03023397|616671952|FG000|Run-In|Failed screening allergen challenge|1|||
170450951|NCT00107042|615991205|FG000|Overall Study|Pregnancy|1|||
170450952|NCT00107042|615991206|FG001|Overall Study|Pregnancy|1|||
170450953|NCT00107042|615991205|FG000|Overall Study|Inadvertent enrollment|0|||
170450954|NCT00107042|615991206|FG001|Overall Study|Inadvertent enrollment|1|||
170450955|NCT00107042|615991205|FG000|Overall Study|vaccinated outside window|1|||
170450956|NCT00107042|615991206|FG001|Overall Study|vaccinated outside window|1|||
170450957|NCT00107042|615991205|FG000|Overall Study|Disallowed medications|0|||
170450958|NCT00107042|615991206|FG001|Overall Study|Disallowed medications|2|||
170450959|NCT03919448|615991207|FG000|Overall Study|Withdrawal by Subject|1|||
170450960|NCT03919448|615991208|FG001|Overall Study|Withdrawal by Subject|0|||
170450961|NCT03919448|615991209|FG002|Overall Study|Withdrawal by Subject|0|||
170450962|NCT04776746|615991210|FG000|Overall Study|Study terminated by sponsor|61|||
170450963|NCT04776746|615991210|FG000|Overall Study|Adverse Event|5|||
170450964|NCT04776746|615991210|FG000|Overall Study|Death|4|||
170450965|NCT04776746|615991210|FG000|Overall Study|Lack of Efficacy|3|||
170450966|NCT04776746|615991210|FG000|Overall Study|Noncompliance with study drug|2|||
170450967|NCT04776746|615991210|FG000|Overall Study|Not related to COVID-19|2|||
170450968|NCT00773734|615991213|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
170450969|NCT00773734|615991214|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
170450970|NCT00773734|615991215|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
170450971|NCT00773734|615991216|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
170450972|NCT00773734|615991217|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
170450973|NCT00773734|615991218|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
170450974|NCT00773734|615991213|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
170450975|NCT00773734|615991214|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
170450976|NCT00773734|615991215|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
170450977|NCT00773734|615991216|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
170450978|NCT00773734|615991217|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
170450979|NCT00773734|615991218|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
170450980|NCT00773734|615991213|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
170450981|NCT00773734|615991214|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
170450982|NCT00773734|615991215|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
170450983|NCT00773734|615991216|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
170450984|NCT00773734|615991217|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
170450985|NCT00773734|615991218|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
170450986|NCT00773734|615991213|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
170450987|NCT00773734|615991214|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
170450988|NCT00773734|615991215|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
170450989|NCT00773734|615991216|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
170450990|NCT00773734|615991217|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
170450991|NCT00773734|615991218|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
170450992|NCT00773734|615991213|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
170450993|NCT00773734|615991214|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
170450994|NCT00773734|615991215|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
170450995|NCT00773734|615991216|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
170450996|NCT00773734|615991217|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
170450997|NCT00773734|615991218|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
170450998|NCT00773734|615991213|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
170450999|NCT00773734|615991214|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
170887488|NCT00903929|617595971|FG002|Overall Study|Adverse Event|0|||
170887489|NCT00903929|617595972|FG003|Overall Study|Adverse Event|1|||
170887490|NCT00511355|617595974|FG000|Overall Study|Adverse Event|4|||
170887491|NCT00511355|617595975|FG001|Overall Study|Adverse Event|4|||
170887492|NCT00511355|617595974|FG000|Overall Study|Pregnancy Wish|1|||
170887493|NCT00511355|617595975|FG001|Overall Study|Pregnancy Wish|0|||
170887494|NCT00511355|617595974|FG000|Overall Study|Lost to Follow-up|2|||
170887495|NCT00511355|617595975|FG001|Overall Study|Lost to Follow-up|1|||
170887496|NCT00511355|617595974|FG000|Overall Study|Other Reason|0|||
170451000|NCT00773734|615991215|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
170451001|NCT00773734|615991216|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
170451002|NCT00773734|615991217|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
170451003|NCT00773734|615991218|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
170451004|NCT00773734|615991213|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
170451005|NCT00773734|615991214|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
170451006|NCT00773734|615991215|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
170451007|NCT00773734|615991216|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
170451008|NCT00773734|615991217|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
170451009|NCT00773734|615991218|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
170451010|NCT00773734|615991213|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
170451011|NCT00773734|615991214|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
170451012|NCT00773734|615991215|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
170451013|NCT00773734|615991216|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
170451014|NCT00773734|615991217|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
170451015|NCT00773734|615991218|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
170451016|NCT00773734|615991213|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
170451017|NCT00773734|615991214|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
170451018|NCT00773734|615991215|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
170541193|NCT02969018|616325190|FG004|Overall Study|Pregnancy|0|||
170887497|NCT00511355|617595975|FG001|Overall Study|Other Reason|1|||
170887498|NCT00511355|617595974|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
170541194|NCT02969018|616325191|FG005|Overall Study|Pregnancy|1|||
170541195|NCT02969018|616325192|FG006|Overall Study|Pregnancy|0|||
170541196|NCT02969018|616325193|FG007|Overall Study|Pregnancy|0|||
170541197|NCT02969018|616325186|FG000|Overall Study|Protocol Violation|0|||
170541198|NCT02969018|616325187|FG001|Overall Study|Protocol Violation|0|||
170541199|NCT02969018|616325188|FG002|Overall Study|Protocol Violation|1|||
170786908|NCT03771417|617229543|FG002|Overall Study|Withdrawal by Subject|0|||
170786909|NCT03771417|617229541|FG000|Overall Study|Covid-19 Shutdown|0|||
170786910|NCT03771417|617229542|FG001|Overall Study|Covid-19 Shutdown|1|||
170786911|NCT03771417|617229543|FG002|Overall Study|Covid-19 Shutdown|0|||
170786912|NCT01160211|617229545|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
170786913|NCT01160211|617229546|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
170786914|NCT01160211|617229547|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
170786915|NCT01160211|617229545|FG000|Overall Study|Lost to Follow-up|4|||
170786916|NCT01160211|617229546|FG001|Overall Study|Lost to Follow-up|8|||
170786917|NCT01160211|617229547|FG002|Overall Study|Lost to Follow-up|4|||
170786918|NCT01160211|617229545|FG000|Overall Study|Physician Decision|1|||
170786919|NCT01160211|617229546|FG001|Overall Study|Physician Decision|0|||
170786920|NCT01160211|617229547|FG002|Overall Study|Physician Decision|0|||
170786921|NCT01160211|617229545|FG000|Overall Study|Withdrawal by Subject|4|||
170786922|NCT01160211|617229546|FG001|Overall Study|Withdrawal by Subject|2|||
170786923|NCT01160211|617229547|FG002|Overall Study|Withdrawal by Subject|2|||
170786924|NCT01160211|617229545|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
170786925|NCT01160211|617229546|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
170786926|NCT01160211|617229547|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
170786927|NCT05051124|617229548|FG000|Overall Study|Lost to Follow-up|2|||
170786928|NCT05051124|617229548|FG000|Overall Study|Withdrawal by Subject|1|||
170786929|NCT05051124|617229548|FG000|Overall Study|Residential relocation|2|||
170786930|NCT05051124|617229548|FG000|Overall Study|Death|1|||
170786931|NCT04782973|617229549|FG000|Overall Study|Withdrawal by Subject|5|||
170786932|NCT04782973|617229549|FG000|Overall Study|Protocol Violation|6|||
170786933|NCT04782973|617229549|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
170786934|NCT06205407|617229554|FG000|Period 2|Withdrawal by Subject|0|||
170786935|NCT06205407|617229555|FG001|Period 2|Withdrawal by Subject|1|||
170786936|NCT06205407|617229554|FG000|Period 2|Adverse Event|2|||
170786937|NCT06205407|617229555|FG001|Period 2|Adverse Event|1|||
170451019|NCT00773734|615991216|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
170451020|NCT00773734|615991217|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
170451021|NCT00773734|615991218|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
170451022|NCT00773734|615991213|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
170786938|NCT02577835|617229557|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
170786939|NCT03611491|617229558|FG000|Overall Study|Lost to Follow-up|1|||
170786940|NCT04342494|617229561|FG000|Overall Study|Questionnaire partially completed|1|||
170786941|NCT04342494|617229562|FG001|Overall Study|Questionnaire partially completed|0|||
170786942|NCT04342494|617229563|FG002|Overall Study|Questionnaire partially completed|2|||
170541200|NCT02969018|616325189|FG003|Overall Study|Protocol Violation|1|||
170786943|NCT04342494|617229564|FG003|Overall Study|Questionnaire partially completed|0|||
170786944|NCT04342494|617229565|FG004|Overall Study|Questionnaire partially completed|1|||
170786945|NCT04342494|617229561|FG000|Overall Study|Lost to Follow-up|49|||
170786946|NCT04342494|617229562|FG001|Overall Study|Lost to Follow-up|38|||
170786947|NCT04342494|617229563|FG002|Overall Study|Lost to Follow-up|34|||
170786948|NCT04342494|617229564|FG003|Overall Study|Lost to Follow-up|34|||
170786949|NCT04342494|617229565|FG004|Overall Study|Lost to Follow-up|35|||
170786950|NCT05119023|617229567|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
170786951|NCT05119023|617229567|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
170786952|NCT05119023|617229567|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
170786953|NCT03476460|617229574|FG000|Overall Study|Withdrawal by Subject|3|||
170786954|NCT03476460|617229575|FG001|Overall Study|Withdrawal by Subject|2|||
170786955|NCT03476460|617229574|FG000|Overall Study|Non-compliance with treatment|3|||
170786956|NCT03476460|617229575|FG001|Overall Study|Non-compliance with treatment|0|||
170786957|NCT03476460|617229574|FG000|Overall Study|Missing laboratory tests|5|||
170786958|NCT03476460|617229575|FG001|Overall Study|Missing laboratory tests|5|||
170786959|NCT03476460|617229574|FG000|Overall Study|Adverse Event|0|||
170786960|NCT03476460|617229575|FG001|Overall Study|Adverse Event|1|||
170786961|NCT04292223|617229576|FG000|Overall Study|Adverse Event|1|||
170786962|NCT04292223|617229576|FG000|Overall Study|Lost to Follow-up|1|||
170786963|NCT04292223|617229576|FG000|Overall Study|Noncompliance with study drug|2|||
170786964|NCT04292223|617229576|FG000|Overall Study|Patient moved out of the state|1|||
170634382|NCT03023397|616671953|FG001|Run-In|Failed screening allergen challenge|0|||
170541201|NCT02969018|616325190|FG004|Overall Study|Protocol Violation|0|||
170541202|NCT02969018|616325191|FG005|Overall Study|Protocol Violation|0|||
170541203|NCT02969018|616325192|FG006|Overall Study|Protocol Violation|0|||
170541204|NCT02969018|616325193|FG007|Overall Study|Protocol Violation|0|||
170541205|NCT02969018|616325186|FG000|Overall Study|Withdrawal by Subject|0|||
170541206|NCT02969018|616325187|FG001|Overall Study|Withdrawal by Subject|1|||
170541207|NCT02969018|616325188|FG002|Overall Study|Withdrawal by Subject|2|||
170541208|NCT02969018|616325189|FG003|Overall Study|Withdrawal by Subject|1|||
170541209|NCT02969018|616325190|FG004|Overall Study|Withdrawal by Subject|0|||
170541210|NCT02969018|616325191|FG005|Overall Study|Withdrawal by Subject|4|||
170541211|NCT02969018|616325192|FG006|Overall Study|Withdrawal by Subject|4|||
170541212|NCT02969018|616325193|FG007|Overall Study|Withdrawal by Subject|3|||
170541213|NCT03506477|616325195|FG000|Overall Study|Withdrawal by Subject|1|||
170541214|NCT03506477|616325196|FG001|Overall Study|Withdrawal by Subject|0|||
170541215|NCT02965833|616325199|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
170541216|NCT02965833|616325200|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
170541217|NCT02965833|616325199|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
170541218|NCT02965833|616325200|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
170541219|NCT02965833|616325199|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
170541220|NCT02965833|616325200|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
170541221|NCT02965833|616325199|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
170541222|NCT02965833|616325200|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
170541223|NCT02965833|616325199|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
170541224|NCT02965833|616325200|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
170541225|NCT00118287|616325202|FG000|Overall Study|Intracranial haemorrhage|1|||
170541226|NCT00118287|616325202|FG000|Overall Study|Muscle pain|1|||
170541227|NCT03976375|616325203|FG000|Overall Study|Death|158|||
170541228|NCT03976375|616325204|FG001|Overall Study|Death|160|||
170541229|NCT03976375|616325205|FG002|Overall Study|Death|42|||
170541230|NCT03976375|616325203|FG000|Overall Study|Lost to Follow-up|2|||
170541231|NCT03976375|616325204|FG001|Overall Study|Lost to Follow-up|1|||
170541232|NCT03976375|616325205|FG002|Overall Study|Lost to Follow-up|1|||
170541233|NCT03976375|616325203|FG000|Overall Study|Withdrawal by Subject|5|||
170541234|NCT03976375|616325204|FG001|Overall Study|Withdrawal by Subject|9|||
170541235|NCT03976375|616325205|FG002|Overall Study|Withdrawal by Subject|4|||
170541236|NCT03976375|616325203|FG000|Overall Study|Sponsor decision|20|||
170541237|NCT03976375|616325204|FG001|Overall Study|Sponsor decision|19|||
170541238|NCT03976375|616325205|FG002|Overall Study|Sponsor decision|1|||
170541239|NCT04818112|616325208|FG000|Overall Study|Withdrawal by Subject|54|||
170541240|NCT04818112|616325209|FG001|Overall Study|Withdrawal by Subject|12|||
170541241|NCT04818112|616325208|FG000|Overall Study|Lost to Follow-up|38|||
170541242|NCT04818112|616325209|FG001|Overall Study|Lost to Follow-up|10|||
170541243|NCT02676973|616325210|FG000|Overall Study|Withdrawal by Subject|9|||
170541244|NCT02676973|616325211|FG001|Overall Study|Withdrawal by Subject|8|||
170634383|NCT03023397|616671954|FG002|Run-In|Failed screening allergen challenge|0|||
170786965|NCT01606215|617229582|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
170786966|NCT01606215|617229583|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
170786967|NCT05184192|617229584|FG000|Overall Study|Lost to Follow-up|4|||
170786968|NCT05184192|617229585|FG001|Overall Study|Lost to Follow-up|7|||
170786969|NCT05184192|617229584|FG000|Overall Study|Adverse Event|1|||
170786970|NCT05184192|617229585|FG001|Overall Study|Adverse Event|4|||
170786971|NCT05184192|617229584|FG000|Overall Study|PI withdrawal|1|||
170786972|NCT05184192|617229585|FG001|Overall Study|PI withdrawal|2|||
170786973|NCT05184192|617229584|FG000|Overall Study|Withdrew due to adverse effect|1|||
170786974|NCT05184192|617229585|FG001|Overall Study|Withdrew due to adverse effect|0|||
170786975|NCT05184192|617229584|FG000|Overall Study|Medication schedule|1|||
170786976|NCT05184192|617229585|FG001|Overall Study|Medication schedule|0|||
170786977|NCT05184192|617229584|FG000|Overall Study|Concern for adverse effects|0|||
170786978|NCT05184192|617229585|FG001|Overall Study|Concern for adverse effects|4|||
170541245|NCT02676973|616325212|FG002|Overall Study|Withdrawal by Subject|11|||
170541246|NCT02676973|616325210|FG000|Overall Study|Lost to Follow-up|8|||
170541247|NCT02676973|616325211|FG001|Overall Study|Lost to Follow-up|12|||
170541248|NCT02676973|616325212|FG002|Overall Study|Lost to Follow-up|8|||
170541249|NCT02676973|616325210|FG000|Overall Study|Death|2|||
170541250|NCT02676973|616325211|FG001|Overall Study|Death|1|||
170541251|NCT02676973|616325212|FG002|Overall Study|Death|5|||
170541252|NCT01078662|616325213|FG000|Overall Study|Death|41|||
170786979|NCT04295798|617229588|FG000|Overall Study|Lost to Follow-up|1|||
170786980|NCT04625283|617229598|FG000|Overall Study|post randomization exclusion|28|||
170786981|NCT04625283|617229599|FG001|Overall Study|post randomization exclusion|20|||
170786982|NCT01824394|617229600|FG000|Overall Study|Early Termination|1|||
170541253|NCT01078662|616325214|FG001|Overall Study|Death|103|||
170786983|NCT01824394|617229601|FG001|Overall Study|Early Termination|1|||
170541254|NCT01078662|616325215|FG002|Overall Study|Death|18|||
170541255|NCT01078662|616325216|FG003|Overall Study|Death|5|||
170541256|NCT01078662|616325217|FG004|Overall Study|Death|8|||
170541257|NCT01078662|616325213|FG000|Overall Study|Patients reached data cut-off|12|||
170541258|NCT01078662|616325214|FG001|Overall Study|Patients reached data cut-off|53|||
170541259|NCT01078662|616325215|FG002|Overall Study|Patients reached data cut-off|2|||
170541260|NCT01078662|616325216|FG003|Overall Study|Patients reached data cut-off|2|||
170541261|NCT01078662|616325217|FG004|Overall Study|Patients reached data cut-off|3|||
170541262|NCT01078662|616325213|FG000|Overall Study|Withdrawal by Subject|4|||
170541263|NCT01078662|616325214|FG001|Overall Study|Withdrawal by Subject|11|||
170541264|NCT01078662|616325215|FG002|Overall Study|Withdrawal by Subject|1|||
170541265|NCT01078662|616325216|FG003|Overall Study|Withdrawal by Subject|0|||
170541266|NCT01078662|616325217|FG004|Overall Study|Withdrawal by Subject|0|||
170541267|NCT01078662|616325213|FG000|Overall Study|Protocol Violation|0|||
170541268|NCT01078662|616325214|FG001|Overall Study|Protocol Violation|1|||
170541269|NCT01078662|616325215|FG002|Overall Study|Protocol Violation|0|||
170451023|NCT00773734|615991214|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
170451024|NCT00773734|615991215|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
170451025|NCT00773734|615991216|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
170451026|NCT00773734|615991217|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
170451027|NCT00773734|615991218|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
170451028|NCT00773734|615991213|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
170451029|NCT00773734|615991214|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
170451030|NCT00773734|615991215|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
170451031|NCT00773734|615991216|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
170451032|NCT00773734|615991217|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
170451033|NCT00773734|615991218|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
170451034|NCT00773734|615991213|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
170451035|NCT00773734|615991214|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
170451036|NCT00773734|615991215|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
170451037|NCT00773734|615991216|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
170451038|NCT00773734|615991217|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
170451039|NCT00773734|615991218|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
170451040|NCT00773734|615991213|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
170451041|NCT00773734|615991214|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
170451042|NCT00773734|615991215|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
170451043|NCT00773734|615991216|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
170451044|NCT00773734|615991217|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
170451045|NCT00773734|615991218|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
170451046|NCT00773734|615991213|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
170451047|NCT00773734|615991214|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
170451048|NCT00773734|615991215|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
170451049|NCT00773734|615991216|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
170451050|NCT00773734|615991217|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
170451051|NCT00773734|615991218|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
170451052|NCT00773734|615991213|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
170451053|NCT00773734|615991214|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
170451054|NCT00773734|615991215|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
170451055|NCT00773734|615991216|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
170451056|NCT00773734|615991217|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
170451057|NCT00773734|615991218|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
170451058|NCT00773734|615991213|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
170451059|NCT00773734|615991214|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
170451060|NCT00773734|615991215|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
170541270|NCT01078662|616325216|FG003|Overall Study|Protocol Violation|0|||
170786984|NCT01824394|617229602|FG002|Overall Study|Early Termination|3|||
170541271|NCT01078662|616325217|FG004|Overall Study|Protocol Violation|0|||
170541272|NCT01078662|616325213|FG000|Overall Study|Lost to Follow-up|1|||
170541273|NCT01078662|616325214|FG001|Overall Study|Lost to Follow-up|0|||
170541274|NCT01078662|616325215|FG002|Overall Study|Lost to Follow-up|0|||
170541275|NCT01078662|616325216|FG003|Overall Study|Lost to Follow-up|0|||
170541276|NCT01078662|616325217|FG004|Overall Study|Lost to Follow-up|0|||
170541277|NCT01937299|616325219|FG000|Overall Study|Adverse Event|13|||
170786985|NCT01824394|617229600|FG000|Overall Study|Withdrawn due to Study Termination|91|||
170786986|NCT01824394|617229601|FG001|Overall Study|Withdrawn due to Study Termination|83|||
170786987|NCT01824394|617229602|FG002|Overall Study|Withdrawn due to Study Termination|41|||
170786988|NCT01824394|617229600|FG000|Overall Study|Lost to Follow-up|0|||
170786989|NCT01824394|617229601|FG001|Overall Study|Lost to Follow-up|9|||
170786990|NCT01824394|617229602|FG002|Overall Study|Lost to Follow-up|3|||
170786991|NCT01824394|617229600|FG000|Overall Study|Death|3|||
170541278|NCT01937299|616325220|FG001|Overall Study|Adverse Event|0|||
170541279|NCT01937299|616325219|FG000|Overall Study|Lack of Efficacy|0|||
170541280|NCT01937299|616325220|FG001|Overall Study|Lack of Efficacy|4|||
170541281|NCT01937299|616325219|FG000|Overall Study|Withdrawal by Subject|1|||
170541282|NCT01937299|616325220|FG001|Overall Study|Withdrawal by Subject|0|||
170541283|NCT04017962|616325221|FG000|Overall Study|Death|2|||
170541284|NCT04017962|616325222|FG001|Overall Study|Death|0|||
170541285|NCT04017962|616325221|FG000|Overall Study|Lost to Follow-up|2|||
170541286|NCT04017962|616325222|FG001|Overall Study|Lost to Follow-up|0|||
170541287|NCT04017962|616325221|FG000|Overall Study|Physician Decision|1|||
170541288|NCT04017962|616325222|FG001|Overall Study|Physician Decision|0|||
170541289|NCT04017962|616325221|FG000|Overall Study|Discontinued LTV|5|||
170541290|NCT04017962|616325222|FG001|Overall Study|Discontinued LTV|0|||
170541291|NCT05172570|616325223|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
170541292|NCT05172570|616325224|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
170541293|NCT05172570|616325225|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
170541294|NCT05172570|616325223|FG000|Overall Study|PI Decision due to equipment shortages|0|||
170541295|NCT05172570|616325224|FG001|Overall Study|PI Decision due to equipment shortages|0|||
170541296|NCT05172570|616325225|FG002|Overall Study|PI Decision due to equipment shortages|1|||
170541297|NCT00640289|616325226|FG000|Overall Study|Death|3|||
170541298|NCT00640289|616325226|FG000|Overall Study|Withdrawal by Subject|1|||
170541299|NCT00640289|616325226|FG000|Overall Study|Lost to Follow-up|1|||
170541300|NCT00640289|616325226|FG000|Overall Study|Data collected under different amendment|2|||
170541301|NCT00640289|616325226|FG000|Overall Study|Transferred to another center|1|||
170786992|NCT01824394|617229601|FG001|Overall Study|Death|2|||
170786993|NCT01824394|617229602|FG002|Overall Study|Death|4|||
170786994|NCT01824394|617229600|FG000|Overall Study|Discontinued Subjects|1|||
170786995|NCT01824394|617229601|FG001|Overall Study|Discontinued Subjects|1|||
170786996|NCT01824394|617229602|FG002|Overall Study|Discontinued Subjects|2|||
170786997|NCT01824394|617229600|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
170786998|NCT01824394|617229601|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
170786999|NCT01824394|617229602|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
170787000|NCT02619838|617229603|FG000|Overall Study|Lost to Follow-up|9|||
170787001|NCT02619838|617229603|FG000|Overall Study|Withdrawal by Subject|15|||
170787002|NCT04015167|617229607|FG000|Overall Study|Lost to Follow-up|40|||
170787003|NCT04015167|617229607|FG000|Overall Study|Adverse Event|5|||
170787004|NCT04015167|617229607|FG000|Overall Study|Withdrawal by Subject|2|||
170787005|NCT04015167|617229607|FG000|Overall Study|Subject went to jail|1|||
170787006|NCT03474679|617229616|FG000|Overall Study|Death|7|||
170787007|NCT03474679|617229616|FG000|Overall Study|Withdrawal by Subject|1|||
170787008|NCT01539083|617229625|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
170787009|NCT01539083|617229626|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
170787010|NCT01539083|617229627|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
170787011|NCT01539083|617229625|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
170787012|NCT01539083|617229626|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
170787013|NCT01539083|617229627|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
170787014|NCT01539083|617229625|FG000|Before Randomization (VCD Induction)|Death|6|||
170787015|NCT01539083|617229626|FG001|Before Randomization (VCD Induction)|Death|0|||
170787016|NCT01539083|617229627|FG002|Before Randomization (VCD Induction)|Death|0|||
170787017|NCT01539083|617229625|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
170787018|NCT01539083|617229626|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
170787019|NCT01539083|617229627|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
170787020|NCT01539083|617229625|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
170787021|NCT01539083|617229626|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
170787022|NCT01539083|617229627|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
170787023|NCT01539083|617229625|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
170787024|NCT01539083|617229626|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
170887499|NCT00511355|617595975|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
170887500|NCT00511355|617595974|FG000|Overall Study|Withdrawal of informed consent|0|||
170887501|NCT00511355|617595975|FG001|Overall Study|Withdrawal of informed consent|1|||
170887502|NCT00511355|617595974|FG000|Overall Study|Other reason pre-treatment|0|||
170887503|NCT00511355|617595975|FG001|Overall Study|Other reason pre-treatment|1|||
170887504|NCT02289950|617595976|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
170541302|NCT00640289|616325226|FG000|Overall Study|Missing status|5|||
170541303|NCT03550209|616325227|FG000|Overall Study|Lost to Follow-up|1|||
170541304|NCT03550209|616325228|FG001|Overall Study|Lost to Follow-up|0|||
170541305|NCT03550209|616325229|FG002|Overall Study|Lost to Follow-up|1|||
170541306|NCT03550209|616325230|FG003|Overall Study|Lost to Follow-up|0|||
170541307|NCT03550209|616325227|FG000|Overall Study|Withdrawal by Subject|0|||
170787025|NCT01539083|617229627|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
170787026|NCT01539083|617229625|FG000|Before Randomization (VCD Induction)|Other|5|||
170787027|NCT01539083|617229626|FG001|Before Randomization (VCD Induction)|Other|0|||
170787028|NCT01539083|617229627|FG002|Before Randomization (VCD Induction)|Other|0|||
170787029|NCT01539083|617229625|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
170787030|NCT01539083|617229626|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
170787031|NCT01539083|617229627|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
170787032|NCT01539083|617229625|FG000|After Randomization (TP and VTP)|Other|0|||
170787033|NCT01539083|617229626|FG001|After Randomization (TP and VTP)|Other|1|||
170787034|NCT01539083|617229627|FG002|After Randomization (TP and VTP)|Other|1|||
170787035|NCT01539083|617229625|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
170787036|NCT01539083|617229626|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
170787037|NCT01539083|617229627|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
170787038|NCT01539083|617229625|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
170787039|NCT01539083|617229626|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
170787040|NCT01539083|617229627|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
170787041|NCT01539083|617229625|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
170787042|NCT01539083|617229626|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
170787043|NCT01539083|617229627|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
170787044|NCT01539083|617229625|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
170787045|NCT01539083|617229626|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
170787046|NCT01539083|617229627|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
170787047|NCT01539083|617229625|FG000|After Randomization (TP and VTP)|Death|0|||
170787048|NCT01539083|617229626|FG001|After Randomization (TP and VTP)|Death|6|||
170787049|NCT01539083|617229627|FG002|After Randomization (TP and VTP)|Death|11|||
170787050|NCT05794243|617229631|FG000|Overall Study|Withdrawal by Subject|1|||
170787051|NCT05794243|617229632|FG001|Overall Study|Withdrawal by Subject|0|||
170787052|NCT05794243|617229633|FG002|Overall Study|Withdrawal by Subject|1|||
170787053|NCT05794243|617229631|FG000|Overall Study|Physician Decision|0|||
170787054|NCT05794243|617229632|FG001|Overall Study|Physician Decision|3|||
170787055|NCT05794243|617229633|FG002|Overall Study|Physician Decision|1|||
170787056|NCT04111536|617229650|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
170787057|NCT04111536|617229651|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
170787058|NCT04111536|617229650|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
170787059|NCT04111536|617229651|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
170787060|NCT04111536|617229650|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
170787061|NCT04111536|617229651|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
170787062|NCT04111536|617229650|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
170787063|NCT04111536|617229651|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
170787064|NCT05457647|617229656|FG000|Overall Study|Lost to Follow-up|3|||
170787065|NCT03448107|617229657|FG000|Overall Study|Lost to Follow-up|229|||
170787066|NCT03448107|617229658|FG001|Overall Study|Lost to Follow-up|258|||
170787067|NCT03865498|617229659|FG000|Overall Study|Lack of Efficacy|12|||
170787068|NCT03865498|617229660|FG001|Overall Study|Lack of Efficacy|11|||
170787069|NCT03865498|617229659|FG000|Overall Study|Lost to Follow-up|125|||
170787070|NCT03865498|617229660|FG001|Overall Study|Lost to Follow-up|133|||
170787071|NCT03865498|617229659|FG000|Overall Study|Withdrawal by Subject|2|||
170787072|NCT03865498|617229660|FG001|Overall Study|Withdrawal by Subject|4|||
170787073|NCT01648023|617229661|FG000|Overall Study|Screen Fail Post Randomization|1|||
170787074|NCT01648023|617229662|FG001|Overall Study|Screen Fail Post Randomization|2|||
170787075|NCT05084508|617229665|FG000|Overall Study|Lost to Follow-up|6|||
170787076|NCT05084508|617229666|FG001|Overall Study|Lost to Follow-up|3|||
170787077|NCT05084508|617229667|FG002|Overall Study|Lost to Follow-up|7|||
170787078|NCT05084508|617229668|FG003|Overall Study|Lost to Follow-up|3|||
170787079|NCT05084508|617229665|FG000|Overall Study|Withdrawal by Subject|0|||
170787080|NCT05084508|617229666|FG001|Overall Study|Withdrawal by Subject|2|||
170787081|NCT05084508|617229667|FG002|Overall Study|Withdrawal by Subject|3|||
170787082|NCT05084508|617229668|FG003|Overall Study|Withdrawal by Subject|1|||
170787083|NCT05084508|617229665|FG000|Overall Study|Other|0|||
170787084|NCT05084508|617229666|FG001|Overall Study|Other|0|||
170787085|NCT05084508|617229667|FG002|Overall Study|Other|0|||
170787086|NCT05084508|617229668|FG003|Overall Study|Other|1|||
170787087|NCT04137289|617229669|FG000|Overall Study|Death|0|||
170787088|NCT04137289|617229670|FG001|Overall Study|Death|0|||
170787089|NCT04137289|617229671|FG002|Overall Study|Death|0|||
170787090|NCT04137289|617229672|FG003|Overall Study|Death|0|||
170787091|NCT04137289|617229673|FG004|Overall Study|Death|0|||
170787092|NCT04137289|617229674|FG005|Overall Study|Death|0|||
170787093|NCT04137289|617229675|FG006|Overall Study|Death|1|||
170787094|NCT04137289|617229676|FG007|Overall Study|Death|0|||
170787095|NCT04137289|617229677|FG008|Overall Study|Death|0|||
170787096|NCT04137289|617229669|FG000|Overall Study|Clinical disease progression|0|||
170787097|NCT04137289|617229670|FG001|Overall Study|Clinical disease progression|0|||
170787098|NCT04137289|617229671|FG002|Overall Study|Clinical disease progression|0|||
170787099|NCT04137289|617229672|FG003|Overall Study|Clinical disease progression|4|||
170787100|NCT04137289|617229673|FG004|Overall Study|Clinical disease progression|4|||
170887505|NCT02289950|617595977|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
170887506|NCT02289950|617595976|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
170887507|NCT02289950|617595977|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
170887508|NCT02289950|617595976|FG000|Overall Study|Lost to Follow-up|1|||
170887509|NCT02289950|617595977|FG001|Overall Study|Lost to Follow-up|0|||
170887510|NCT02289950|617595976|FG000|Overall Study|Physician Decision|9|||
170887511|NCT02289950|617595977|FG001|Overall Study|Physician Decision|3|||
170887512|NCT02289950|617595976|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
170887513|NCT02289950|617595977|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
170887514|NCT02289950|617595976|FG000|Overall Study|Withdrawal by Subject|1|||
170887515|NCT02289950|617595977|FG001|Overall Study|Withdrawal by Subject|3|||
170887516|NCT02289950|617595976|FG000|Overall Study|Test article held for greater than 28 days|0|||
170887517|NCT02289950|617595977|FG001|Overall Study|Test article held for greater than 28 days|1|||
170887518|NCT02289950|617595976|FG000|Overall Study|Adverse Event|11|||
170887519|NCT02289950|617595977|FG001|Overall Study|Adverse Event|3|||
170451061|NCT00773734|615991216|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
170451062|NCT00773734|615991217|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
170451063|NCT00773734|615991218|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
170451064|NCT00773734|615991213|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
170451065|NCT00773734|615991214|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
170451066|NCT00773734|615991215|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
170451067|NCT00773734|615991216|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
170451068|NCT00773734|615991217|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
170451069|NCT00773734|615991218|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
170451070|NCT00773734|615991213|FG000|Extension: Active Treatment Week 24-52|Other|0|||
170451071|NCT00773734|615991214|FG001|Extension: Active Treatment Week 24-52|Other|0|||
170451072|NCT00773734|615991215|FG002|Extension: Active Treatment Week 24-52|Other|1|||
170451073|NCT00773734|615991216|FG003|Extension: Active Treatment Week 24-52|Other|2|||
170451074|NCT00773734|615991217|FG004|Extension: Active Treatment Week 24-52|Other|0|||
170451075|NCT00773734|615991218|FG005|Extension: Active Treatment Week 24-52|Other|1|||
170451076|NCT00773734|615991213|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
170451077|NCT00773734|615991214|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
170451078|NCT00773734|615991215|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
170451079|NCT00773734|615991216|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
170451080|NCT00773734|615991217|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
170451081|NCT00773734|615991218|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
170887520|NCT02289950|617595976|FG000|Overall Study|Death|1|||
170887521|NCT02289950|617595977|FG001|Overall Study|Death|1|||
170887522|NCT02289950|617595976|FG000|Overall Study|Other|5|||
170887523|NCT02289950|617595977|FG001|Overall Study|Other|2|||
170451082|NCT00773734|615991213|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
170451083|NCT00773734|615991214|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
170451084|NCT00773734|615991215|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
170451085|NCT00773734|615991216|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
170451086|NCT00773734|615991217|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
170451087|NCT00773734|615991218|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
170451088|NCT00773734|615991213|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
170887524|NCT02289950|617595976|FG000|Overall Study|Not Treated|2|||
170451089|NCT00773734|615991214|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
170451090|NCT00773734|615991215|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
170451091|NCT00773734|615991216|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
170451092|NCT00773734|615991217|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
170451093|NCT00773734|615991218|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
170451094|NCT00773734|615991213|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
170451095|NCT00773734|615991214|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
170451096|NCT00773734|615991215|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
170451097|NCT00773734|615991216|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
170451098|NCT00773734|615991217|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
170541308|NCT03550209|616325228|FG001|Overall Study|Withdrawal by Subject|3|||
170541309|NCT03550209|616325229|FG002|Overall Study|Withdrawal by Subject|1|||
170887525|NCT02289950|617595977|FG001|Overall Study|Not Treated|1|||
170887526|NCT04518462|617595978|FG000|Overall Study|Withdrawal by Subject|0|||
170887527|NCT04518462|617595979|FG001|Overall Study|Withdrawal by Subject|0|||
170887528|NCT04518462|617595980|FG002|Overall Study|Withdrawal by Subject|1|||
170887529|NCT04518462|617595978|FG000|Overall Study|Physician Decision|1|||
170541310|NCT03550209|616325230|FG003|Overall Study|Withdrawal by Subject|2|||
170887530|NCT04518462|617595979|FG001|Overall Study|Physician Decision|1|||
170887531|NCT04518462|617595980|FG002|Overall Study|Physician Decision|0|||
170887532|NCT01003210|617595981|FG000|Overall Study|Lost to Follow-up|1|||
170887533|NCT01003210|617595982|FG001|Overall Study|Lost to Follow-up|3|||
170887534|NCT00271817|617595983|FG000|Part 1|Adverse Event|68|||
170451099|NCT00773734|615991218|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
170451100|NCT02177136|615991219|FG000|DB Phase|Withdrawal by Subject|2|||
170451101|NCT02177136|615991220|FG001|DB Phase|Withdrawal by Subject|0|||
170451102|NCT02177136|615991221|FG002|DB Phase|Withdrawal by Subject|0|||
170451103|NCT02177136|615991222|FG003|DB Phase|Withdrawal by Subject|0|||
170451104|NCT02177136|615991219|FG000|DB Phase|Discontinued Due to Pruritus|1|||
170451105|NCT02177136|615991220|FG001|DB Phase|Discontinued Due to Pruritus|3|||
170451106|NCT02177136|615991221|FG002|DB Phase|Discontinued Due to Pruritus|0|||
170451107|NCT02177136|615991222|FG003|DB Phase|Discontinued Due to Pruritus|0|||
170451108|NCT02177136|615991219|FG000|DB Phase|Adverse Event|3|||
170451109|NCT02177136|615991220|FG001|DB Phase|Adverse Event|2|||
170451110|NCT02177136|615991221|FG002|DB Phase|Adverse Event|3|||
170451111|NCT02177136|615991222|FG003|DB Phase|Adverse Event|0|||
170451112|NCT02177136|615991219|FG000|DB Phase|Protocol Violation|0|||
170451113|NCT02177136|615991220|FG001|DB Phase|Protocol Violation|0|||
170451114|NCT02177136|615991221|FG002|DB Phase|Protocol Violation|1|||
170451115|NCT02177136|615991222|FG003|DB Phase|Protocol Violation|0|||
170541311|NCT03550209|616325227|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
170541312|NCT03550209|616325228|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
170541313|NCT03550209|616325229|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
170541314|NCT03550209|616325230|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
170541315|NCT05543174|616326222|FG000|Overall Study|Adverse Event|1|||
170541316|NCT02383173|616326224|FG000|Overall Study|Palliative Care Team withdrew|0|||
170887535|NCT00271817|617595984|FG001|Part 1|Adverse Event|25|||
170887536|NCT00271817|617595985|FG002|Part 1|Adverse Event|156|||
170887537|NCT00271817|617595983|FG000|Part 1|Lost to Follow-up|6|||
170887538|NCT00271817|617595984|FG001|Part 1|Lost to Follow-up|8|||
170887539|NCT00271817|617595985|FG002|Part 1|Lost to Follow-up|24|||
170887540|NCT00271817|617595983|FG000|Part 1|Protocol Violation|5|||
170887541|NCT00271817|617595984|FG001|Part 1|Protocol Violation|4|||
170887542|NCT00271817|617595985|FG002|Part 1|Protocol Violation|7|||
170887543|NCT00271817|617595983|FG000|Part 1|Patient Moved|3|||
170887544|NCT00271817|617595984|FG001|Part 1|Patient Moved|1|||
170887545|NCT00271817|617595985|FG002|Part 1|Patient Moved|5|||
170887546|NCT00271817|617595983|FG000|Part 1|Withdrawal by Subject|23|||
170887547|NCT00271817|617595984|FG001|Part 1|Withdrawal by Subject|17|||
170887548|NCT00271817|617595985|FG002|Part 1|Withdrawal by Subject|45|||
170887549|NCT00271817|617595983|FG000|Part 1|LDL < 50 mg/dL|1|||
170887550|NCT00271817|617595984|FG001|Part 1|LDL < 50 mg/dL|4|||
170887551|NCT00271817|617595985|FG002|Part 1|LDL < 50 mg/dL|48|||
170887552|NCT00271817|617595983|FG000|Part 2|Adverse Event|0|||
170887553|NCT00271817|617595984|FG001|Part 2|Adverse Event|17|||
170887554|NCT00271817|617595985|FG002|Part 2|Adverse Event|33|||
170887555|NCT00271817|617595983|FG000|Part 2|Lack of Efficacy|0|||
170887556|NCT00271817|617595984|FG001|Part 2|Lack of Efficacy|1|||
170887557|NCT00271817|617595985|FG002|Part 2|Lack of Efficacy|6|||
170887558|NCT00271817|617595983|FG000|Part 2|Lost to Follow-up|0|||
170887559|NCT00271817|617595984|FG001|Part 2|Lost to Follow-up|6|||
170887560|NCT00271817|617595985|FG002|Part 2|Lost to Follow-up|18|||
170887561|NCT00271817|617595983|FG000|Part 2|Protocol Violation|0|||
170887562|NCT00271817|617595984|FG001|Part 2|Protocol Violation|3|||
170887563|NCT00271817|617595985|FG002|Part 2|Protocol Violation|5|||
170887564|NCT00271817|617595983|FG000|Part 2|Patient Moved|0|||
170887565|NCT00271817|617595984|FG001|Part 2|Patient Moved|0|||
170887566|NCT00271817|617595985|FG002|Part 2|Patient Moved|5|||
170887567|NCT00271817|617595983|FG000|Part 2|Withdrawal by Subject|0|||
170887568|NCT00271817|617595984|FG001|Part 2|Withdrawal by Subject|2|||
170887569|NCT00271817|617595985|FG002|Part 2|Withdrawal by Subject|13|||
170887570|NCT00271817|617595983|FG000|Part 2|LDL < 50 mg/dL|0|||
170887571|NCT00271817|617595984|FG001|Part 2|LDL < 50 mg/dL|3|||
170887572|NCT00271817|617595985|FG002|Part 2|LDL < 50 mg/dL|4|||
170634384|NCT03023397|616671952|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
170634385|NCT03023397|616671953|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
170634386|NCT03023397|616671954|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
170634387|NCT01216189|616671958|FG000|Overall Study|Lost to Follow-up|21|||
170634388|NCT01216189|616671959|FG001|Overall Study|Lost to Follow-up|3|||
170634389|NCT01216189|616671958|FG000|Overall Study|Death|4|||
170634390|NCT01216189|616671959|FG001|Overall Study|Death|2|||
170887573|NCT01471782|617595990|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
170887574|NCT01471782|617595991|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
170451116|NCT02177136|615991219|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
170451117|NCT02177136|615991220|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
170451118|NCT02177136|615991221|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
170451119|NCT02177136|615991222|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
170541317|NCT02383173|616326225|FG001|Overall Study|Palliative Care Team withdrew|2|||
170541318|NCT04871113|616326226|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170887575|NCT01471782|617595992|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
170887576|NCT01471782|617595993|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
170887577|NCT01471782|617595994|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
170451120|NCT02177136|615991219|FG000|LTSE Phase|Withdrawal by Subject|0|||
170451121|NCT02177136|615991220|FG001|LTSE Phase|Withdrawal by Subject|0|||
170451122|NCT02177136|615991221|FG002|LTSE Phase|Withdrawal by Subject|0|||
170451123|NCT02177136|615991222|FG003|LTSE Phase|Withdrawal by Subject|6|||
170451124|NCT02177136|615991219|FG000|LTSE Phase|Adverse Event|0|||
170451125|NCT02177136|615991220|FG001|LTSE Phase|Adverse Event|0|||
170451126|NCT02177136|615991221|FG002|LTSE Phase|Adverse Event|0|||
170451127|NCT02177136|615991222|FG003|LTSE Phase|Adverse Event|10|||
170634391|NCT01143246|616671960|FG000|Overall Study|Adverse Event|24|||
170634392|NCT01143246|616671961|FG001|Overall Study|Adverse Event|28|||
170634393|NCT01143246|616671960|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
170634394|NCT01143246|616671961|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
170634395|NCT01143246|616671960|FG000|Overall Study|Lost to Follow-up|0|||
170634396|NCT01143246|616671961|FG001|Overall Study|Lost to Follow-up|1|||
170634397|NCT01143246|616671960|FG000|Overall Study|Death|16|||
170634398|NCT01143246|616671961|FG001|Overall Study|Death|15|||
170634399|NCT01143246|616671960|FG000|Overall Study|Reason not Specified|3|||
170634400|NCT01143246|616671961|FG001|Overall Study|Reason not Specified|5|||
170634401|NCT01663103|616671962|FG000|Overall Study|Withdrawal by Subject|1|||
170634402|NCT01663103|616671963|FG001|Overall Study|Withdrawal by Subject|2|||
170634403|NCT01663103|616671962|FG000|Overall Study|Adverse Event|1|||
170634404|NCT01663103|616671963|FG001|Overall Study|Adverse Event|0|||
170634405|NCT01663103|616671962|FG000|Overall Study|dog bite|1|||
170634406|NCT01663103|616671963|FG001|Overall Study|dog bite|0|||
170634407|NCT01656408|616671964|FG000|Overall Study|Adverse Event|0|||
170634408|NCT01656408|616671965|FG001|Overall Study|Adverse Event|0|||
170634409|NCT01656408|616671966|FG002|Overall Study|Adverse Event|1|||
170634410|NCT01656408|616671967|FG003|Overall Study|Adverse Event|0|||
170634411|NCT01656408|616671968|FG004|Overall Study|Adverse Event|0|||
170634412|NCT01656408|616671969|FG005|Overall Study|Adverse Event|1|||
170634413|NCT01656408|616671970|FG006|Overall Study|Adverse Event|1|||
170634414|NCT01656408|616671971|FG007|Overall Study|Adverse Event|0|||
170634415|NCT01656408|616671972|FG008|Overall Study|Adverse Event|1|||
170634416|NCT01656408|616671973|FG009|Overall Study|Adverse Event|0|||
170634417|NCT01656408|616671964|FG000|Overall Study|Physician Decision|1|||
170634418|NCT01656408|616671965|FG001|Overall Study|Physician Decision|0|||
170634419|NCT01656408|616671966|FG002|Overall Study|Physician Decision|1|||
170634420|NCT01656408|616671967|FG003|Overall Study|Physician Decision|0|||
170634421|NCT01656408|616671968|FG004|Overall Study|Physician Decision|1|||
170634422|NCT01656408|616671969|FG005|Overall Study|Physician Decision|1|||
170634423|NCT01656408|616671970|FG006|Overall Study|Physician Decision|0|||
170634424|NCT01656408|616671971|FG007|Overall Study|Physician Decision|1|||
170634425|NCT01656408|616671972|FG008|Overall Study|Physician Decision|1|||
170634426|NCT01656408|616671973|FG009|Overall Study|Physician Decision|3|||
170634427|NCT01146795|616671974|FG000|Overall Study|Withdrawal by Subject|4|||
170634428|NCT01146795|616671974|FG000|Overall Study|Adverse Event|6|||
170634429|NCT01146795|616671974|FG000|Overall Study|Still in treatment at study closure|10|||
170634430|NCT00363480|616671975|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
170634431|NCT00363480|616671975|FG000|Overall Study|Adverse Event|4|||
170634432|NCT00363480|616671975|FG000|Overall Study|Lost to Follow-up|5|||
170634433|NCT00363480|616671975|FG000|Overall Study|Withdrawal by Subject|5|||
170634434|NCT00363480|616671975|FG000|Overall Study|Non-compliance of subject|1|||
170634435|NCT00363480|616671975|FG000|Overall Study|Participant discontinued on its own|1|||
170634436|NCT01457703|616671984|FG000|Overall Study|Screen Failure|5|||
170634437|NCT01457703|616671985|FG001|Overall Study|Screen Failure|7|||
170634438|NCT01457703|616671984|FG000|Overall Study|Withdrawal by Subject|1|||
170787101|NCT04137289|617229674|FG005|Overall Study|Clinical disease progression|2|||
170634439|NCT01457703|616671985|FG001|Overall Study|Withdrawal by Subject|4|||
170634440|NCT01658436|616671986|FG000|Overall Study|Adverse Event|6|||
170634441|NCT01658436|616671987|FG001|Overall Study|Adverse Event|5|||
170451128|NCT02177136|615991219|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
170451129|NCT02177136|615991220|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
170451130|NCT02177136|615991221|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
170451131|NCT02177136|615991222|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
170451132|NCT02177136|615991219|FG000|LTSE Phase|Physician Decision|0|||
170634442|NCT01658436|616671986|FG000|Overall Study|Physician Decision|1|||
170634443|NCT01658436|616671987|FG001|Overall Study|Physician Decision|0|||
170634444|NCT01658436|616671986|FG000|Overall Study|Progressive disease|12|||
170634445|NCT01658436|616671987|FG001|Overall Study|Progressive disease|4|||
170634446|NCT01658436|616671986|FG000|Overall Study|Study terminated by sponsor|0|||
170634447|NCT01658436|616671987|FG001|Overall Study|Study terminated by sponsor|1|||
170787102|NCT04137289|617229675|FG006|Overall Study|Clinical disease progression|5|||
170634448|NCT01658436|616671986|FG000|Overall Study|Subject/guardian decision|0|||
170451133|NCT02177136|615991220|FG001|LTSE Phase|Physician Decision|0|||
170451134|NCT02177136|615991221|FG002|LTSE Phase|Physician Decision|0|||
170451135|NCT02177136|615991222|FG003|LTSE Phase|Physician Decision|2|||
170634449|NCT01658436|616671987|FG001|Overall Study|Subject/guardian decision|1|||
170634450|NCT01658436|616671986|FG000|Overall Study|Death|1|||
170634451|NCT01658436|616671987|FG001|Overall Study|Death|0|||
170541319|NCT04871113|616326227|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170541320|NCT04871113|616326228|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170541321|NCT04871113|616326229|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170541322|NCT04871113|616326230|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170541323|NCT04871113|616326231|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
170541324|NCT04871113|616326232|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170541325|NCT04871113|616326233|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170541326|NCT04871113|616326234|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170541327|NCT04871113|616326235|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
170541328|NCT04871113|616326226|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
170541329|NCT04871113|616326227|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
170541330|NCT04871113|616326228|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
170541331|NCT04871113|616326229|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
170541332|NCT04871113|616326230|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
170541333|NCT04871113|616326231|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
170541334|NCT04871113|616326232|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
170541335|NCT04871113|616326233|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
170541336|NCT04871113|616326234|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
170541337|NCT04871113|616326235|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
170541338|NCT01946802|616326236|FG000|Overall Study|Death|1|||
170541339|NCT01946802|616326236|FG000|Overall Study|Withdrawal by Subject|2|||
170541340|NCT01946802|616326236|FG000|Overall Study|Combined septic shock|1|||
170541341|NCT01946802|616326236|FG000|Overall Study|Protocol Violation|1|||
170634452|NCT00935584|616671993|FG000|Overall Study|Withdrawal by Subject|9|||
170887578|NCT01471782|617595995|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
170887579|NCT01471782|617595990|FG000|Overall Study|Lack of Efficacy|1|||
170887580|NCT01471782|617595991|FG001|Overall Study|Lack of Efficacy|2|||
170887581|NCT01471782|617595992|FG002|Overall Study|Lack of Efficacy|1|||
170887582|NCT01471782|617595993|FG003|Overall Study|Lack of Efficacy|1|||
170887583|NCT01471782|617595994|FG004|Overall Study|Lack of Efficacy|5|||
170887584|NCT01471782|617595995|FG005|Overall Study|Lack of Efficacy|18|||
170887585|NCT01471782|617595990|FG000|Overall Study|Adverse Event|1|||
170887586|NCT01471782|617595991|FG001|Overall Study|Adverse Event|1|||
170887587|NCT01471782|617595992|FG002|Overall Study|Adverse Event|2|||
170887588|NCT01471782|617595993|FG003|Overall Study|Adverse Event|2|||
170887589|NCT01471782|617595994|FG004|Overall Study|Adverse Event|3|||
170887590|NCT01471782|617595995|FG005|Overall Study|Adverse Event|1|||
170887591|NCT01471782|617595990|FG000|Overall Study|Other|0|||
170887592|NCT01471782|617595991|FG001|Overall Study|Other|0|||
170887593|NCT01471782|617595992|FG002|Overall Study|Other|1|||
170887594|NCT01471782|617595993|FG003|Overall Study|Other|1|||
170887595|NCT01471782|617595994|FG004|Overall Study|Other|6|||
170887596|NCT01471782|617595995|FG005|Overall Study|Other|5|||
170887597|NCT01471782|617595990|FG000|Overall Study|Change of Chemotherapy|1|||
170887598|NCT01471782|617595991|FG001|Overall Study|Change of Chemotherapy|1|||
170887599|NCT01471782|617595992|FG002|Overall Study|Change of Chemotherapy|0|||
170887600|NCT01471782|617595993|FG003|Overall Study|Change of Chemotherapy|0|||
170887601|NCT01471782|617595994|FG004|Overall Study|Change of Chemotherapy|1|||
170887602|NCT01471782|617595995|FG005|Overall Study|Change of Chemotherapy|4|||
170887603|NCT01471782|617595990|FG000|Overall Study|Disease Relapse|0|||
170887604|NCT01471782|617595991|FG001|Overall Study|Disease Relapse|0|||
170887605|NCT01471782|617595992|FG002|Overall Study|Disease Relapse|0|||
170887606|NCT01471782|617595993|FG003|Overall Study|Disease Relapse|1|||
170887607|NCT01471782|617595994|FG004|Overall Study|Disease Relapse|2|||
170887608|NCT01471782|617595995|FG005|Overall Study|Disease Relapse|1|||
170887609|NCT01471782|617595990|FG000|Overall Study|Physician Decision|0|||
170887610|NCT01471782|617595991|FG001|Overall Study|Physician Decision|0|||
170887611|NCT01471782|617595992|FG002|Overall Study|Physician Decision|0|||
170887612|NCT01471782|617595993|FG003|Overall Study|Physician Decision|0|||
170887613|NCT01471782|617595994|FG004|Overall Study|Physician Decision|3|||
170887614|NCT01471782|617595995|FG005|Overall Study|Physician Decision|8|||
170887615|NCT01471782|617595990|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170887616|NCT01471782|617595991|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170887617|NCT01471782|617595992|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170887618|NCT01471782|617595993|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170887619|NCT01471782|617595994|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
170887620|NCT01471782|617595995|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
170887621|NCT01471782|617595990|FG000|Overall Study|Death|0|||
170541342|NCT00153920|616326237|FG000|Overall Study|Adverse Event|9|||
170887622|NCT01471782|617595991|FG001|Overall Study|Death|0|||
170887623|NCT01471782|617595992|FG002|Overall Study|Death|0|||
170887624|NCT01471782|617595993|FG003|Overall Study|Death|0|||
170887625|NCT01471782|617595994|FG004|Overall Study|Death|0|||
170887626|NCT01471782|617595995|FG005|Overall Study|Death|1|||
170887627|NCT00264238|617595996|FG000|Overall Study|Protocol Violation|1|||
170451136|NCT02177136|615991219|FG000|LTSE Phase|Lost to Follow-up|0|||
170451137|NCT02177136|615991220|FG001|LTSE Phase|Lost to Follow-up|0|||
170541343|NCT00153920|616326237|FG000|Overall Study|Progressive Disease|9|||
170541344|NCT00153920|616326237|FG000|Overall Study|Physician Decision|3|||
170541345|NCT00153920|616326237|FG000|Overall Study|Lack of Response|3|||
170541346|NCT00153920|616326237|FG000|Overall Study|Death|2|||
170541347|NCT00153920|616326237|FG000|Overall Study|Withdrawal by Subject|1|||
170541348|NCT00153920|616326237|FG000|Overall Study|Non-Protocol Therapy|1|||
170541349|NCT00153920|616326237|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
170541350|NCT00153920|616326237|FG000|Overall Study|Progressive Disease before Trt|1|||
170541351|NCT03370302|616326240|FG000|Dose Escalation Phase|Other|0|||
170541352|NCT03370302|616326241|FG001|Dose Escalation Phase|Other|1|||
170541353|NCT03370302|616326242|FG002|Dose Escalation Phase|Other|1|||
170451138|NCT02177136|615991221|FG002|LTSE Phase|Lost to Follow-up|0|||
170451139|NCT02177136|615991222|FG003|LTSE Phase|Lost to Follow-up|1|||
170451140|NCT02177136|615991219|FG000|LTSE Phase|Participant Moved|0|||
170451141|NCT02177136|615991220|FG001|LTSE Phase|Participant Moved|0|||
170451142|NCT02177136|615991221|FG002|LTSE Phase|Participant Moved|0|||
170451143|NCT02177136|615991222|FG003|LTSE Phase|Participant Moved|1|||
170451144|NCT01286558|615991227|FG000|Overall Study|Adverse Event|1|||
170451145|NCT01286558|615991228|FG001|Overall Study|Adverse Event|1|||
170541354|NCT03370302|616326243|FG003|Dose Escalation Phase|Other|0|||
170541355|NCT03370302|616326244|FG004|Dose Escalation Phase|Other|0|||
170541356|NCT03370302|616326245|FG005|Dose Escalation Phase|Other|0|||
170541357|NCT03370302|616326240|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
170634453|NCT00935584|616671994|FG001|Overall Study|Withdrawal by Subject|0|||
170634454|NCT00935584|616671993|FG000|Overall Study|Death|3|||
170887628|NCT00861744|617595997|FG000|Overall Study|Adverse Event|0|||
170451146|NCT01286558|615991227|FG000|Overall Study|Withdrawal by Subject|0|||
170451147|NCT01286558|615991228|FG001|Overall Study|Withdrawal by Subject|1|||
170451148|NCT01287039|615991232|FG000|Overall Study|Noncompliance with study procedures|0|||
170451149|NCT01287039|615991233|FG001|Overall Study|Noncompliance with study procedures|1|||
170451150|NCT01287039|615991232|FG000|Overall Study|Change of location/residence|0|||
170451151|NCT01287039|615991233|FG001|Overall Study|Change of location/residence|3|||
170451152|NCT01287039|615991232|FG000|Overall Study|Elective surgery|0|||
170451153|NCT01287039|615991233|FG001|Overall Study|Elective surgery|1|||
170451154|NCT01287039|615991232|FG000|Overall Study|Protocol Violation|2|||
170451155|NCT01287039|615991233|FG001|Overall Study|Protocol Violation|3|||
170451156|NCT01287039|615991232|FG000|Overall Study|Excluded medication taken|1|||
170451157|NCT01287039|615991233|FG001|Overall Study|Excluded medication taken|0|||
170451158|NCT01287039|615991232|FG000|Overall Study|Noncompliance with study medication|0|||
170451159|NCT01287039|615991233|FG001|Overall Study|Noncompliance with study medication|1|||
170451160|NCT01287039|615991232|FG000|Overall Study|Problem with travel|0|||
170451161|NCT01287039|615991233|FG001|Overall Study|Problem with travel|1|||
170451162|NCT01287039|615991232|FG000|Overall Study|Death|1|||
170451163|NCT01287039|615991233|FG001|Overall Study|Death|0|||
170451164|NCT01287039|615991232|FG000|Overall Study|Change of residence|1|||
170451165|NCT01287039|615991233|FG001|Overall Study|Change of residence|0|||
170451166|NCT01287039|615991232|FG000|Overall Study|Adverse Event|7|||
170451167|NCT01287039|615991233|FG001|Overall Study|Adverse Event|4|||
170451168|NCT01287039|615991232|FG000|Overall Study|Withdrawal by Subject|14|||
170451169|NCT01287039|615991233|FG001|Overall Study|Withdrawal by Subject|11|||
170451170|NCT01287039|615991232|FG000|Overall Study|Lost to Follow-up|3|||
170451171|NCT01287039|615991233|FG001|Overall Study|Lost to Follow-up|2|||
170451172|NCT01272921|615991235|FG000|Overall Study|Protocol Violation|2|||
170451173|NCT01272921|615991236|FG001|Overall Study|Protocol Violation|1|||
170451174|NCT03265288|615991237|FG000|Overall Study|Adverse Event|0|||
170451175|NCT03265288|615991238|FG001|Overall Study|Adverse Event|1|||
170451176|NCT03265288|615991237|FG000|Overall Study|Withdrawal by Subject|13|||
170634455|NCT00935584|616671994|FG001|Overall Study|Death|0|||
170887629|NCT00861744|617595998|FG001|Overall Study|Adverse Event|0|||
170887630|NCT00861744|617595999|FG002|Overall Study|Adverse Event|0|||
170887631|NCT00861744|617596000|FG003|Overall Study|Adverse Event|1|||
170887632|NCT00861744|617595997|FG000|Overall Study|Lost to Follow-up|7|||
170887633|NCT00861744|617595998|FG001|Overall Study|Lost to Follow-up|19|||
170451177|NCT03265288|615991238|FG001|Overall Study|Withdrawal by Subject|5|||
170451178|NCT03265288|615991237|FG000|Overall Study|Drug Withdrawn|3|||
170451179|NCT03265288|615991238|FG001|Overall Study|Drug Withdrawn|3|||
170451180|NCT03265288|615991237|FG000|Overall Study|Any Other Reason|7|||
170541358|NCT03370302|616326241|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
170541359|NCT03370302|616326242|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
170541360|NCT03370302|616326243|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
170634456|NCT00935584|616671993|FG000|Overall Study|Lost to Follow-up|8|||
170634457|NCT00935584|616671994|FG001|Overall Study|Lost to Follow-up|0|||
170451181|NCT03265288|615991238|FG001|Overall Study|Any Other Reason|3|||
170451182|NCT01360866|615991242|FG000|Overall Study|Lost to Follow-up|11|||
170451183|NCT01360866|615991243|FG001|Overall Study|Lost to Follow-up|28|||
170451184|NCT01360866|615991244|FG002|Overall Study|Lost to Follow-up|41|||
170887634|NCT00861744|617595999|FG002|Overall Study|Lost to Follow-up|17|||
170451185|NCT01360866|615991245|FG003|Overall Study|Lost to Follow-up|0|||
170451186|NCT01360866|615991242|FG000|Overall Study|Adverse Event|56|||
170451187|NCT01360866|615991243|FG001|Overall Study|Adverse Event|61|||
170451188|NCT01360866|615991244|FG002|Overall Study|Adverse Event|134|||
170451189|NCT01360866|615991245|FG003|Overall Study|Adverse Event|6|||
170451190|NCT01360866|615991242|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
170451191|NCT01360866|615991243|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
170451192|NCT01360866|615991244|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
170451193|NCT01360866|615991245|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
170451194|NCT01360866|615991242|FG000|Overall Study|Withdrawn by Investigator|9|||
170451195|NCT01360866|615991243|FG001|Overall Study|Withdrawn by Investigator|8|||
170451196|NCT01360866|615991244|FG002|Overall Study|Withdrawn by Investigator|31|||
170451197|NCT01360866|615991245|FG003|Overall Study|Withdrawn by Investigator|2|||
170451198|NCT01360866|615991242|FG000|Overall Study|Withdrawal by participant|79|||
170451199|NCT01360866|615991243|FG001|Overall Study|Withdrawal by participant|89|||
170451200|NCT01360866|615991244|FG002|Overall Study|Withdrawal by participant|168|||
170451201|NCT01360866|615991245|FG003|Overall Study|Withdrawal by participant|8|||
170451202|NCT01360866|615991242|FG000|Overall Study|Protocol Deviation|25|||
170451203|NCT01360866|615991243|FG001|Overall Study|Protocol Deviation|33|||
170451204|NCT01360866|615991244|FG002|Overall Study|Protocol Deviation|61|||
170451205|NCT01360866|615991245|FG003|Overall Study|Protocol Deviation|2|||
170451206|NCT01360866|615991242|FG000|Overall Study|Lack of Efficacy|30|||
170451207|NCT01360866|615991243|FG001|Overall Study|Lack of Efficacy|40|||
170451208|NCT01360866|615991244|FG002|Overall Study|Lack of Efficacy|30|||
170451209|NCT01360866|615991245|FG003|Overall Study|Lack of Efficacy|4|||
170451210|NCT01117337|615991257|FG000|Overall Study|Lost to Follow-up|4|||
170451211|NCT01117337|615991258|FG001|Overall Study|Lost to Follow-up|0|||
170451212|NCT03575871|615991259|FG000|Overall Study|Adverse Event|5|||
170451213|NCT03575871|615991260|FG001|Overall Study|Adverse Event|5|||
170451214|NCT03575871|615991261|FG002|Overall Study|Adverse Event|8|||
170451215|NCT03575871|615991259|FG000|Overall Study|Death|1|||
170451216|NCT03575871|615991260|FG001|Overall Study|Death|0|||
170451217|NCT03575871|615991261|FG002|Overall Study|Death|0|||
170451218|NCT03575871|615991259|FG000|Overall Study|Lack of Efficacy|5|||
170451219|NCT03575871|615991260|FG001|Overall Study|Lack of Efficacy|4|||
170451220|NCT03575871|615991261|FG002|Overall Study|Lack of Efficacy|7|||
170451221|NCT03575871|615991259|FG000|Overall Study|Lost to Follow-up|1|||
170451222|NCT03575871|615991260|FG001|Overall Study|Lost to Follow-up|1|||
170451223|NCT03575871|615991261|FG002|Overall Study|Lost to Follow-up|1|||
170451224|NCT03575871|615991259|FG000|Overall Study|Protocol Deviation|1|||
170451225|NCT03575871|615991260|FG001|Overall Study|Protocol Deviation|1|||
170451226|NCT03575871|615991261|FG002|Overall Study|Protocol Deviation|1|||
170541361|NCT03370302|616326244|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
170451227|NCT03575871|615991259|FG000|Overall Study|Withdrawal by Subject|6|||
170451228|NCT03575871|615991260|FG001|Overall Study|Withdrawal by Subject|1|||
170451229|NCT03575871|615991261|FG002|Overall Study|Withdrawal by Subject|9|||
170451230|NCT03575871|615991259|FG000|Overall Study|Other than specified|2|||
170451231|NCT03575871|615991260|FG001|Overall Study|Other than specified|2|||
170451232|NCT03575871|615991261|FG002|Overall Study|Other than specified|0|||
170541362|NCT03370302|616326245|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
170541363|NCT03370302|616326240|FG000|Dose Escalation Phase|Adverse Event|1|||
170541364|NCT03370302|616326241|FG001|Dose Escalation Phase|Adverse Event|0|||
170541365|NCT03370302|616326242|FG002|Dose Escalation Phase|Adverse Event|2|||
170541366|NCT03370302|616326243|FG003|Dose Escalation Phase|Adverse Event|0|||
170541367|NCT03370302|616326244|FG004|Dose Escalation Phase|Adverse Event|0|||
170541368|NCT03370302|616326245|FG005|Dose Escalation Phase|Adverse Event|0|||
170541369|NCT03370302|616326240|FG000|Dose Escalation Phase|Progressive Disease|2|||
170541370|NCT03370302|616326241|FG001|Dose Escalation Phase|Progressive Disease|4|||
170541371|NCT03370302|616326242|FG002|Dose Escalation Phase|Progressive Disease|2|||
170541372|NCT03370302|616326243|FG003|Dose Escalation Phase|Progressive Disease|0|||
170541373|NCT03370302|616326244|FG004|Dose Escalation Phase|Progressive Disease|3|||
170541374|NCT03370302|616326245|FG005|Dose Escalation Phase|Progressive Disease|1|||
170541375|NCT03370302|616326240|FG000|Dose Expansion Phase|Progressive Disease|0|||
170541376|NCT03370302|616326241|FG001|Dose Expansion Phase|Progressive Disease|0|||
170541377|NCT03370302|616326242|FG002|Dose Expansion Phase|Progressive Disease|0|||
170541378|NCT03370302|616326243|FG003|Dose Expansion Phase|Progressive Disease|6|||
170541379|NCT03370302|616326244|FG004|Dose Expansion Phase|Progressive Disease|0|||
170541380|NCT03370302|616326245|FG005|Dose Expansion Phase|Progressive Disease|0|||
170541381|NCT00768053|616326256|FG000|Overall Study|Adverse Event|10|||
170541382|NCT00768053|616326256|FG000|Overall Study|Lost to Follow-up|1|||
170541383|NCT01202591|616326259|FG000|Overall Study|Adverse Event|2|||
170541384|NCT01202591|616326260|FG001|Overall Study|Adverse Event|1|||
170541385|NCT01202591|616326261|FG002|Overall Study|Adverse Event|4|||
170541386|NCT01202591|616326262|FG003|Overall Study|Adverse Event|4|||
170541387|NCT01202591|616326263|FG004|Overall Study|Adverse Event|0|||
170634458|NCT00935584|616671993|FG000|Overall Study|No show|9|||
170634459|NCT00935584|616671994|FG001|Overall Study|No show|0|||
170634460|NCT00935584|616671993|FG000|Overall Study|Relocated|3|||
170634461|NCT00935584|616671994|FG001|Overall Study|Relocated|0|||
170634462|NCT00935584|616671993|FG000|Overall Study|Patient changed provider|3|||
170634463|NCT00935584|616671994|FG001|Overall Study|Patient changed provider|0|||
170634464|NCT00935584|616671993|FG000|Overall Study|Provider dropped out of study|14|||
170634465|NCT00935584|616671994|FG001|Overall Study|Provider dropped out of study|4|||
170634466|NCT02129699|616671995|FG000|Overall Study|Did not start treatment|3|||
170634467|NCT02129699|616671996|FG001|Overall Study|Did not start treatment|2|||
170634468|NCT01394016|616671997|FG000|Overall Study|Progressive Disease|2|||
170634469|NCT01394016|616671998|FG001|Overall Study|Progressive Disease|0|||
170634470|NCT01394016|616671999|FG002|Overall Study|Progressive Disease|0|||
170634471|NCT01394016|616672000|FG003|Overall Study|Progressive Disease|0|||
170634472|NCT01394016|616672001|FG004|Overall Study|Progressive Disease|0|||
170634473|NCT01394016|616672002|FG005|Overall Study|Progressive Disease|0|||
170634474|NCT01394016|616672003|FG006|Overall Study|Progressive Disease|0|||
170634475|NCT01394016|616672004|FG007|Overall Study|Progressive Disease|0|||
170634476|NCT01394016|616672005|FG008|Overall Study|Progressive Disease|0|||
170634477|NCT01394016|616672006|FG009|Overall Study|Progressive Disease|0|||
170634478|NCT01394016|616672007|FG010|Overall Study|Progressive Disease|0|||
170634479|NCT01394016|616672008|FG011|Overall Study|Progressive Disease|0|||
170634480|NCT01394016|616672009|FG012|Overall Study|Progressive Disease|0|||
170634481|NCT01394016|616672010|FG013|Overall Study|Progressive Disease|0|||
170634482|NCT01394016|616672011|FG014|Overall Study|Progressive Disease|0|||
170634483|NCT01394016|616672012|FG015|Overall Study|Progressive Disease|0|||
170634484|NCT01394016|616672013|FG016|Overall Study|Progressive Disease|0|||
170634485|NCT01394016|616672014|FG017|Overall Study|Progressive Disease|0|||
170634486|NCT01394016|616672015|FG018|Overall Study|Progressive Disease|0|||
170634487|NCT01394016|616671997|FG000|Overall Study|Withdrawal by Subject|0|||
170634488|NCT01394016|616671998|FG001|Overall Study|Withdrawal by Subject|0|||
170634489|NCT01394016|616671999|FG002|Overall Study|Withdrawal by Subject|0|||
170634490|NCT01394016|616672000|FG003|Overall Study|Withdrawal by Subject|0|||
170634491|NCT01394016|616672001|FG004|Overall Study|Withdrawal by Subject|0|||
170634492|NCT01394016|616672002|FG005|Overall Study|Withdrawal by Subject|0|||
170634493|NCT01394016|616672003|FG006|Overall Study|Withdrawal by Subject|0|||
170634494|NCT01394016|616672004|FG007|Overall Study|Withdrawal by Subject|1|||
170634495|NCT01394016|616672005|FG008|Overall Study|Withdrawal by Subject|1|||
170634496|NCT01394016|616672006|FG009|Overall Study|Withdrawal by Subject|1|||
170887635|NCT00861744|617596000|FG003|Overall Study|Lost to Follow-up|12|||
170451233|NCT05506358|615991262|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
170451234|NCT05506358|615991263|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
170451235|NCT05506358|615991264|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
170451236|NCT05506358|615991265|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
170451237|NCT05506358|615991266|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
170451238|NCT05506358|615991262|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
170451239|NCT05506358|615991263|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
170451240|NCT05506358|615991264|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
170451241|NCT05506358|615991265|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
170451242|NCT05506358|615991266|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
170451243|NCT05506358|615991262|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
170451244|NCT05506358|615991263|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
170451245|NCT05506358|615991264|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
170451246|NCT05506358|615991265|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
170541388|NCT01202591|616326264|FG005|Overall Study|Adverse Event|0|||
170541389|NCT01202591|616326259|FG000|Overall Study|Other reason as per investigator|3|||
170541390|NCT01202591|616326260|FG001|Overall Study|Other reason as per investigator|4|||
170541391|NCT01202591|616326261|FG002|Overall Study|Other reason as per investigator|7|||
170541392|NCT01202591|616326262|FG003|Overall Study|Other reason as per investigator|3|||
170541393|NCT01202591|616326263|FG004|Overall Study|Other reason as per investigator|1|||
170541394|NCT01202591|616326264|FG005|Overall Study|Other reason as per investigator|3|||
170541395|NCT01202591|616326259|FG000|Overall Study|Withdrawal by Subject|0|||
170541396|NCT01202591|616326260|FG001|Overall Study|Withdrawal by Subject|0|||
170541397|NCT01202591|616326261|FG002|Overall Study|Withdrawal by Subject|0|||
170541398|NCT01202591|616326262|FG003|Overall Study|Withdrawal by Subject|0|||
170541399|NCT01202591|616326263|FG004|Overall Study|Withdrawal by Subject|2|||
170541400|NCT01202591|616326264|FG005|Overall Study|Withdrawal by Subject|1|||
170634497|NCT01394016|616672007|FG010|Overall Study|Withdrawal by Subject|4|||
170634498|NCT01394016|616672008|FG011|Overall Study|Withdrawal by Subject|0|||
170634499|NCT01394016|616672009|FG012|Overall Study|Withdrawal by Subject|0|||
170634500|NCT01394016|616672010|FG013|Overall Study|Withdrawal by Subject|3|||
170634501|NCT01394016|616672011|FG014|Overall Study|Withdrawal by Subject|1|||
170887636|NCT00861744|617595997|FG000|Overall Study|Withdrawal by Subject|10|||
170887637|NCT00861744|617595998|FG001|Overall Study|Withdrawal by Subject|6|||
170887638|NCT00861744|617595999|FG002|Overall Study|Withdrawal by Subject|6|||
170887639|NCT00861744|617596000|FG003|Overall Study|Withdrawal by Subject|19|||
170887640|NCT00861744|617595997|FG000|Overall Study|Protocol Violation|0|||
170887641|NCT00861744|617595998|FG001|Overall Study|Protocol Violation|1|||
170887642|NCT00861744|617595999|FG002|Overall Study|Protocol Violation|0|||
170887643|NCT00861744|617596000|FG003|Overall Study|Protocol Violation|0|||
170887644|NCT00861744|617595997|FG000|Overall Study|Migration from study area|0|||
170887645|NCT00861744|617595998|FG001|Overall Study|Migration from study area|3|||
170887646|NCT00861744|617595999|FG002|Overall Study|Migration from study area|1|||
170887647|NCT00861744|617596000|FG003|Overall Study|Migration from study area|0|||
170887648|NCT00861744|617595997|FG000|Overall Study|Blood draws|0|||
170887649|NCT00861744|617595998|FG001|Overall Study|Blood draws|0|||
170887650|NCT00861744|617595999|FG002|Overall Study|Blood draws|0|||
170887651|NCT00861744|617596000|FG003|Overall Study|Blood draws|1|||
170887652|NCT04428424|617596001|FG000|Overall Study|Does not meet entrance criteria|132|||
170887653|NCT04428424|617596001|FG000|Overall Study|Lost to Follow-up|115|||
170887654|NCT05036083|617596009|FG000|Overall Study|Physician Decision|1|||
170887655|NCT05036083|617596009|FG000|Overall Study|Withdrawal by Subject|1|||
170887656|NCT05036083|617596009|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
170887657|NCT05036083|617596009|FG000|Overall Study|IV not sustainable|1|||
170887658|NCT02600494|617596010|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
170887659|NCT02600494|617596011|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
170887660|NCT02600494|617596012|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
170887661|NCT02600494|617596010|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
170887662|NCT02600494|617596011|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
170887663|NCT02600494|617596012|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
170887664|NCT02600494|617596010|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
170887665|NCT02600494|617596011|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
170887666|NCT02600494|617596012|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
170887667|NCT02600494|617596010|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
170887668|NCT02600494|617596011|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
170887669|NCT02600494|617596012|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
170887670|NCT02600494|617596010|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
170887671|NCT02600494|617596011|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
170887672|NCT02600494|617596012|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
170887673|NCT02600494|617596010|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
170887674|NCT02600494|617596011|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
170887675|NCT02600494|617596012|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
170887676|NCT02600494|617596010|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
170541401|NCT01202591|616326259|FG000|Overall Study|Objective Disease Progression|0|||
170541402|NCT01202591|616326260|FG001|Overall Study|Objective Disease Progression|0|||
170541403|NCT01202591|616326261|FG002|Overall Study|Objective Disease Progression|0|||
170541404|NCT01202591|616326262|FG003|Overall Study|Objective Disease Progression|0|||
170541405|NCT01202591|616326263|FG004|Overall Study|Objective Disease Progression|2|||
170541406|NCT01202591|616326264|FG005|Overall Study|Objective Disease Progression|0|||
170541407|NCT00308685|616326265|FG000|Overall Study|Lost to Follow-up|1|||
170887677|NCT02600494|617596011|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
170887678|NCT02600494|617596012|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
170887679|NCT02600494|617596010|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
170887680|NCT02600494|617596011|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
170887681|NCT02600494|617596012|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
170887682|NCT02600494|617596010|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
170887683|NCT02600494|617596011|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
170887684|NCT02600494|617596012|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
170887685|NCT02600494|617596010|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
170887686|NCT02600494|617596011|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
170887687|NCT02600494|617596012|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
170887688|NCT02600494|617596010|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
170887689|NCT02600494|617596011|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
170887690|NCT02600494|617596012|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
170887691|NCT02600494|617596010|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
170887692|NCT02600494|617596011|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
170887693|NCT02600494|617596012|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
170541408|NCT00308685|616326266|FG001|Overall Study|Lost to Follow-up|0|||
170541409|NCT00308685|616326265|FG000|Overall Study|Need to administer prohibited medication|1|||
170787103|NCT04137289|617229676|FG007|Overall Study|Clinical disease progression|1|||
170541410|NCT00308685|616326266|FG001|Overall Study|Need to administer prohibited medication|2|||
170541411|NCT00308685|616326265|FG000|Overall Study|Other than specified|1|||
170541412|NCT00308685|616326266|FG001|Overall Study|Other than specified|3|||
170541413|NCT01121575|616326267|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
170541414|NCT01121575|616326268|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
170541415|NCT01121575|616326269|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
170541416|NCT01121575|616326270|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
170541417|NCT01121575|616326271|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
170541418|NCT01121575|616326272|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
170541419|NCT01121575|616326267|FG000|Overall Study|Unspecified Reasons|8|||
170541420|NCT01121575|616326268|FG001|Overall Study|Unspecified Reasons|6|||
170541421|NCT01121575|616326269|FG002|Overall Study|Unspecified Reasons|7|||
170541422|NCT01121575|616326270|FG003|Overall Study|Unspecified Reasons|5|||
170541423|NCT01121575|616326271|FG004|Overall Study|Unspecified Reasons|13|||
170541424|NCT01121575|616326272|FG005|Overall Study|Unspecified Reasons|10|||
170541425|NCT01121575|616326267|FG000|Overall Study|Death|6|||
170541426|NCT01121575|616326268|FG001|Overall Study|Death|0|||
170541427|NCT01121575|616326269|FG002|Overall Study|Death|0|||
170541428|NCT01121575|616326270|FG003|Overall Study|Death|1|||
170541429|NCT01121575|616326271|FG004|Overall Study|Death|7|||
170541430|NCT01121575|616326272|FG005|Overall Study|Death|1|||
170541431|NCT03901053|616326273|FG000|Overall Study|Lost to Follow-up|6|||
170541432|NCT03901053|616326274|FG001|Overall Study|Lost to Follow-up|2|||
170541433|NCT03901053|616326273|FG000|Overall Study|Withdrawal by Subject|4|||
170541434|NCT03901053|616326274|FG001|Overall Study|Withdrawal by Subject|3|||
170541435|NCT03901053|616326273|FG000|Overall Study|Unsatisfactory Device|1|||
170541436|NCT03901053|616326274|FG001|Overall Study|Unsatisfactory Device|2|||
170541437|NCT03901053|616326273|FG000|Overall Study|No longer meets study criteria|1|||
170541438|NCT03901053|616326274|FG001|Overall Study|No longer meets study criteria|3|||
170541439|NCT03901053|616326273|FG000|Overall Study|Subject's Medical Status|0|||
170541440|NCT03901053|616326274|FG001|Overall Study|Subject's Medical Status|1|||
170541441|NCT03901053|616326273|FG000|Overall Study|Screening Failure|1|||
170541442|NCT03901053|616326274|FG001|Overall Study|Screening Failure|0|||
170541443|NCT02583269|616326275|FG000|Overall Study|Patient hospitalized prior to start|1|||
170541444|NCT02583269|616326276|FG001|Overall Study|Patient hospitalized prior to start|0|||
170541445|NCT02583269|616326277|FG002|Overall Study|Patient hospitalized prior to start|0|||
170541446|NCT02583269|616326278|FG003|Overall Study|Patient hospitalized prior to start|0|||
170541447|NCT02583269|616326279|FG004|Overall Study|Patient hospitalized prior to start|0|||
170634502|NCT01394016|616672012|FG015|Overall Study|Withdrawal by Subject|3|||
170634503|NCT01394016|616672013|FG016|Overall Study|Withdrawal by Subject|1|||
170787104|NCT04137289|617229677|FG008|Overall Study|Clinical disease progression|0|||
170787105|NCT04137289|617229669|FG000|Overall Study|Lost to Follow-up|0|||
170787106|NCT04137289|617229670|FG001|Overall Study|Lost to Follow-up|0|||
170787107|NCT04137289|617229671|FG002|Overall Study|Lost to Follow-up|0|||
170787108|NCT04137289|617229672|FG003|Overall Study|Lost to Follow-up|1|||
170787109|NCT04137289|617229673|FG004|Overall Study|Lost to Follow-up|0|||
170787110|NCT04137289|617229674|FG005|Overall Study|Lost to Follow-up|0|||
170787111|NCT04137289|617229675|FG006|Overall Study|Lost to Follow-up|0|||
170541448|NCT03244189|616326280|FG000|Overall Study|Death|0|||
170541449|NCT03244189|616326281|FG001|Overall Study|Death|2|||
170541450|NCT03244189|616326280|FG000|Overall Study|Lost to Follow-up|92|||
170541451|NCT03244189|616326281|FG001|Overall Study|Lost to Follow-up|107|||
170541452|NCT03244189|616326280|FG000|Overall Study|Physician Decision|4|||
170541453|NCT03244189|616326281|FG001|Overall Study|Physician Decision|2|||
170541454|NCT03244189|616326280|FG000|Overall Study|Pregnancy|7|||
170541455|NCT03244189|616326281|FG001|Overall Study|Pregnancy|5|||
170541456|NCT03244189|616326280|FG000|Overall Study|Protocol Violation|0|||
170541457|NCT03244189|616326281|FG001|Overall Study|Protocol Violation|2|||
170541458|NCT03244189|616326280|FG000|Overall Study|Withdrawal by Subject|45|||
170541459|NCT03244189|616326281|FG001|Overall Study|Withdrawal by Subject|23|||
170541460|NCT03244189|616326280|FG000|Overall Study|Technical Problems|2|||
170541461|NCT03244189|616326281|FG001|Overall Study|Technical Problems|0|||
170541462|NCT06170827|616326282|FG000|Overall Study|Withdrawal by Subject|1|||
170541463|NCT06170827|616326283|FG001|Overall Study|Withdrawal by Subject|1|||
170541464|NCT03553602|616326293|FG000|Overall Study|Death|1|||
170541465|NCT02999477|616326296|FG000|Overall Study|found ineligible after first dose|0|||
170541466|NCT02999477|616326297|FG001|Overall Study|found ineligible after first dose|1|||
170787112|NCT04137289|617229676|FG007|Overall Study|Lost to Follow-up|0|||
170787113|NCT04137289|617229677|FG008|Overall Study|Lost to Follow-up|0|||
170787114|NCT04137289|617229669|FG000|Overall Study|Adverse Event|0|||
170541467|NCT02999477|616326296|FG000|Overall Study|Withdrawal by Subject|1|||
170541468|NCT02999477|616326297|FG001|Overall Study|Withdrawal by Subject|1|||
170541469|NCT02369458|616326298|FG000|Overall Study|Determined to be not eligible|1|||
170541470|NCT02369458|616326299|FG001|Overall Study|Determined to be not eligible|0|||
170541471|NCT02207608|616326302|FG000|Overall Study|Adverse Event|1|||
170541472|NCT02207608|616326303|FG001|Overall Study|Adverse Event|0|||
170787115|NCT04137289|617229670|FG001|Overall Study|Adverse Event|0|||
170451247|NCT05506358|615991266|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
170451248|NCT05506358|615991262|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
170451249|NCT05506358|615991263|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
170451250|NCT05506358|615991264|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
170451251|NCT05506358|615991265|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
170451252|NCT05506358|615991266|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
170451253|NCT05506358|615991262|FG000|Overall Study|HbE trait|0|||
170451254|NCT05506358|615991263|FG001|Overall Study|HbE trait|0|||
170451255|NCT05506358|615991264|FG002|Overall Study|HbE trait|0|||
170451256|NCT05506358|615991265|FG003|Overall Study|HbE trait|1|||
170451257|NCT05506358|615991266|FG004|Overall Study|HbE trait|0|||
170451258|NCT02791893|615991271|FG000|Blinded Phase|Lost to Follow-up|2|||
170451259|NCT02791893|615991272|FG001|Blinded Phase|Lost to Follow-up|2|||
170451260|NCT02791893|615991271|FG000|Blinded Phase|Withdrawal by Subject|1|||
170451261|NCT02791893|615991272|FG001|Blinded Phase|Withdrawal by Subject|2|||
170451262|NCT02791893|615991271|FG000|Open Label Phase|Lost to Follow-up|3|||
170451263|NCT02791893|615991272|FG001|Open Label Phase|Lost to Follow-up|0|||
170451264|NCT02791893|615991271|FG000|Open Label Phase|Withdrawal by Subject|0|||
170451265|NCT02791893|615991272|FG001|Open Label Phase|Withdrawal by Subject|2|||
170451266|NCT00262041|615991273|FG000|Overall Study|Withdrawal by Subject|0|||
170451267|NCT00262041|615991274|FG001|Overall Study|Withdrawal by Subject|3|||
170451268|NCT00262041|615991275|FG002|Overall Study|Withdrawal by Subject|1|||
170451269|NCT00262041|615991273|FG000|Overall Study|Lost to Follow-up|1|||
170451270|NCT00262041|615991274|FG001|Overall Study|Lost to Follow-up|1|||
170451271|NCT00262041|615991275|FG002|Overall Study|Lost to Follow-up|5|||
170451272|NCT00262041|615991273|FG000|Overall Study|Unable to classify|1|||
170451273|NCT00262041|615991274|FG001|Overall Study|Unable to classify|0|||
170451274|NCT00262041|615991275|FG002|Overall Study|Unable to classify|0|||
170451275|NCT03578237|615991276|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
170451276|NCT03578237|615991277|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
170451277|NCT03028740|615991280|FG000|Overall Study|Did not Receive Study Drug|4|||
170451278|NCT03028740|615991281|FG001|Overall Study|Did not Receive Study Drug|5|||
170451279|NCT03028740|615991280|FG000|Overall Study|Adverse Event|8|||
170451280|NCT03028740|615991281|FG001|Overall Study|Adverse Event|26|||
170451281|NCT03028740|615991280|FG000|Overall Study|Lack of Efficacy|0|||
170451282|NCT03028740|615991281|FG001|Overall Study|Lack of Efficacy|1|||
170451283|NCT03028740|615991280|FG000|Overall Study|Withdrawal by Subject|48|||
170451284|NCT03028740|615991281|FG001|Overall Study|Withdrawal by Subject|101|||
170451285|NCT03028740|615991280|FG000|Overall Study|Lost to Follow-up|30|||
170451286|NCT03028740|615991281|FG001|Overall Study|Lost to Follow-up|54|||
170451287|NCT03028740|615991280|FG000|Overall Study|Physician Decision|4|||
170451288|NCT03028740|615991281|FG001|Overall Study|Physician Decision|11|||
170451289|NCT03028740|615991280|FG000|Overall Study|Protocol Violation|4|||
170451290|NCT03028740|615991281|FG001|Overall Study|Protocol Violation|8|||
170451291|NCT03028740|615991280|FG000|Overall Study|Non-compliance with Study Drug|0|||
170451292|NCT03028740|615991281|FG001|Overall Study|Non-compliance with Study Drug|2|||
170451293|NCT03028740|615991280|FG000|Overall Study|Study Terminated by Sponsor|467|||
170451294|NCT03028740|615991281|FG001|Overall Study|Study Terminated by Sponsor|917|||
170451295|NCT03028740|615991280|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
170451296|NCT03028740|615991281|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
170451297|NCT03028740|615991280|FG000|Overall Study|Reason not Specified|1|||
170451298|NCT03028740|615991281|FG001|Overall Study|Reason not Specified|5|||
170451299|NCT00171301|615991282|FG000|Overall Study|Death|1|||
170451300|NCT00171301|615991283|FG001|Overall Study|Death|2|||
170451301|NCT00171301|615991282|FG000|Overall Study|Adverse Event|1|||
170451302|NCT00171301|615991283|FG001|Overall Study|Adverse Event|2|||
170451303|NCT00171301|615991282|FG000|Overall Study|Lost to Follow-up|6|||
170451304|NCT00171301|615991283|FG001|Overall Study|Lost to Follow-up|2|||
170451305|NCT00171301|615991282|FG000|Overall Study|Protocol Violation|0|||
170451306|NCT00171301|615991283|FG001|Overall Study|Protocol Violation|2|||
170634504|NCT01394016|616672014|FG017|Overall Study|Withdrawal by Subject|1|||
170451307|NCT00171301|615991282|FG000|Overall Study|Withdrawal by Subject|0|||
170451308|NCT00171301|615991283|FG001|Overall Study|Withdrawal by Subject|1|||
170451309|NCT00252174|615991284|FG000|Overall Study|Withdrawal by Subject|0|||
170451310|NCT00252174|615991285|FG001|Overall Study|Withdrawal by Subject|1|||
170451311|NCT00252174|615991286|FG002|Overall Study|Withdrawal by Subject|0|||
170451312|NCT01138826|615991287|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
170451313|NCT01138826|615991288|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
170451314|NCT01138826|615991289|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
170451315|NCT01138826|615991290|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
170451316|NCT01138826|615991291|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
170451317|NCT01138826|615991292|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
170541473|NCT00632359|616326304|FG000|Overall Study|Withdrawal by Subject|2|||
170541474|NCT05556616|616328023|FG000|Overall Study|Withdrawal by Subject|1|||
170541475|NCT05556616|616328024|FG001|Overall Study|Withdrawal by Subject|0|||
170541476|NCT05556616|616328025|FG002|Overall Study|Withdrawal by Subject|0|||
170541477|NCT05556616|616328026|FG003|Overall Study|Withdrawal by Subject|0|||
170541478|NCT05556616|616328027|FG004|Overall Study|Withdrawal by Subject|0|||
170541479|NCT05556616|616328028|FG005|Overall Study|Withdrawal by Subject|0|||
170541480|NCT05556616|616328029|FG006|Overall Study|Withdrawal by Subject|0|||
170541481|NCT05556616|616328023|FG000|Overall Study|Death|0|||
170541482|NCT05556616|616328024|FG001|Overall Study|Death|0|||
170541483|NCT05556616|616328025|FG002|Overall Study|Death|2|||
170541484|NCT05556616|616328026|FG003|Overall Study|Death|1|||
170541485|NCT05556616|616328027|FG004|Overall Study|Death|0|||
170541486|NCT05556616|616328028|FG005|Overall Study|Death|0|||
170541487|NCT05556616|616328029|FG006|Overall Study|Death|0|||
170541488|NCT05556616|616328023|FG000|Overall Study|Study Terminated by Sponsor|0|||
170541489|NCT05556616|616328024|FG001|Overall Study|Study Terminated by Sponsor|3|||
170541490|NCT05556616|616328025|FG002|Overall Study|Study Terminated by Sponsor|0|||
170541491|NCT05556616|616328026|FG003|Overall Study|Study Terminated by Sponsor|0|||
170541492|NCT05556616|616328027|FG004|Overall Study|Study Terminated by Sponsor|0|||
170541493|NCT05556616|616328028|FG005|Overall Study|Study Terminated by Sponsor|0|||
170541494|NCT05556616|616328029|FG006|Overall Study|Study Terminated by Sponsor|0|||
170541495|NCT03215030|616328030|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
170541496|NCT03215030|616328031|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
170541497|NCT03215030|616328032|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541498|NCT03215030|616328033|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
170541499|NCT03215030|616328034|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541500|NCT03215030|616328035|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541501|NCT03215030|616328036|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541502|NCT03215030|616328037|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541503|NCT03215030|616328038|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541504|NCT03215030|616328039|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541505|NCT03215030|616328040|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541506|NCT03215030|616328041|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
170541507|NCT03215030|616328030|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
170541508|NCT03215030|616328031|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541509|NCT03215030|616328032|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541510|NCT03215030|616328033|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
170541511|NCT03215030|616328034|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541512|NCT03215030|616328035|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541513|NCT03215030|616328036|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170887694|NCT02600494|617596010|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
170887695|NCT02600494|617596011|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
170887696|NCT02600494|617596012|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
170887697|NCT01844986|617596013|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
170887698|NCT01844986|617596014|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
170887699|NCT01844986|617596013|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
170887700|NCT01844986|617596014|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
170887701|NCT01844986|617596013|FG000|Overall Study (Global Cohort)|Death|55|||
170887702|NCT01844986|617596014|FG001|Overall Study (Global Cohort)|Death|26|||
170887703|NCT01844986|617596013|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
170887704|NCT01844986|617596014|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
170887705|NCT01844986|617596013|FG000|Overall Study (China Cohort)|Death|10|||
170887706|NCT01844986|617596014|FG001|Overall Study (China Cohort)|Death|6|||
170887707|NCT02028455|617596017|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
170541514|NCT03215030|616328037|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541515|NCT03215030|616328038|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541516|NCT03215030|616328039|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541517|NCT03215030|616328040|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541518|NCT03215030|616328041|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170541519|NCT03215030|616328030|FG000|Part 1: Dose Escalation|Death|15|||
170541520|NCT03215030|616328031|FG001|Part 1: Dose Escalation|Death|6|||
170541521|NCT03215030|616328032|FG002|Part 1: Dose Escalation|Death|6|||
170541522|NCT03215030|616328033|FG003|Part 1: Dose Escalation|Death|8|||
170541523|NCT03215030|616328034|FG004|Part 1: Dose Escalation|Death|0|||
170541524|NCT03215030|616328035|FG005|Part 1: Dose Escalation|Death|0|||
170541525|NCT03215030|616328036|FG006|Part 1: Dose Escalation|Death|0|||
170541526|NCT03215030|616328037|FG007|Part 1: Dose Escalation|Death|0|||
170541527|NCT03215030|616328038|FG008|Part 1: Dose Escalation|Death|0|||
170541528|NCT03215030|616328039|FG009|Part 1: Dose Escalation|Death|0|||
170541529|NCT03215030|616328040|FG010|Part 1: Dose Escalation|Death|0|||
170541530|NCT03215030|616328041|FG011|Part 1: Dose Escalation|Death|0|||
170887708|NCT02028455|617596018|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
170887709|NCT02028455|617596019|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
170887710|NCT02028455|617596020|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
170887711|NCT02028455|617596021|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
170887712|NCT02028455|617596022|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
170887713|NCT02028455|617596023|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
170887714|NCT02028455|617596024|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
170887715|NCT02028455|617596017|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
170887716|NCT02028455|617596018|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
170887717|NCT02028455|617596019|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
170887718|NCT02028455|617596020|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
170887719|NCT02028455|617596021|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
170887720|NCT02028455|617596022|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
170887721|NCT02028455|617596023|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
170451318|NCT05560763|615991294|FG000|Overall Study|Withdrawal by Subject|4|||
170451319|NCT04572243|615991296|FG000|Core Study: 14 Weeks|Adverse Event|1|||
170451320|NCT04572243|615991297|FG001|Core Study: 14 Weeks|Adverse Event|2|||
170451321|NCT04572243|615991298|FG002|Core Study: 14 Weeks|Adverse Event|0|||
170451322|NCT04572243|615991299|FG003|Core Study: 14 Weeks|Adverse Event|0|||
170451323|NCT04572243|615991296|FG000|Core Study: 14 Weeks|Subject choice|0|||
170451324|NCT04572243|615991297|FG001|Core Study: 14 Weeks|Subject choice|2|||
170451325|NCT04572243|615991298|FG002|Core Study: 14 Weeks|Subject choice|0|||
170451326|NCT04572243|615991299|FG003|Core Study: 14 Weeks|Subject choice|0|||
170451327|NCT04572243|615991296|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
170451328|NCT04572243|615991297|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
170451329|NCT04572243|615991298|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
170451330|NCT04572243|615991299|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
170451331|NCT04572243|615991296|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
170451332|NCT04572243|615991297|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
170451333|NCT04572243|615991298|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
170451334|NCT04572243|615991299|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
170451335|NCT01661881|615991300|FG000|Overall Study|Disease Progression|1|||
170451336|NCT01790113|615991301|FG000|Overall Study|Adverse Event|2|||
170451337|NCT01790113|615991302|FG001|Overall Study|Adverse Event|7|||
170451338|NCT01790113|615991301|FG000|Overall Study|Study ended due to FDA clearance|1|||
170451339|NCT01790113|615991302|FG001|Overall Study|Study ended due to FDA clearance|68|||
170451340|NCT03847194|615991303|FG000|Overall Study|Lost to Follow-up|2|||
170451341|NCT03847194|615991304|FG001|Overall Study|Lost to Follow-up|5|||
170451342|NCT03847194|615991303|FG000|Overall Study|Withdrawal by Subject|1|||
170451343|NCT03847194|615991304|FG001|Overall Study|Withdrawal by Subject|2|||
170451344|NCT03847194|615991303|FG000|Overall Study|Death|0|||
170451345|NCT03847194|615991304|FG001|Overall Study|Death|1|||
170451346|NCT01341587|615991305|FG000|Overall Study|Lost to Follow-up|2|||
170451347|NCT01341587|615991306|FG001|Overall Study|Lost to Follow-up|0|||
170451348|NCT01341587|615991305|FG000|Overall Study|stopped using the meters|2|||
170451349|NCT01341587|615991306|FG001|Overall Study|stopped using the meters|10|||
170451350|NCT01144403|615991307|FG000|Overall Study|Lost to Follow-up|3|||
170451351|NCT01144403|615991307|FG000|Overall Study|Death|1|||
170451352|NCT01144403|615991307|FG000|Overall Study|Adverse Event|1|||
170451353|NCT03891329|615991308|FG000|Overall Study|Death|5|||
170451354|NCT03891329|615991308|FG000|Overall Study|Lost to Follow-up|4|||
170451355|NCT03891329|615991308|FG000|Overall Study|Physician Decision|4|||
170451356|NCT03891329|615991308|FG000|Overall Study|Device explanted|3|||
170451357|NCT03891329|615991308|FG000|Overall Study|No study device implanted|3|||
170451358|NCT00706355|615991314|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
170451359|NCT00706355|615991315|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
170451360|NCT00706355|615991316|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
170541531|NCT03215030|616328030|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
170541532|NCT03215030|616328031|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
170541533|NCT03215030|616328032|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
170451361|NCT00706355|615991317|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
170451362|NCT00706355|615991314|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
170451363|NCT00706355|615991315|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
170451364|NCT00706355|615991316|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
170451365|NCT00706355|615991317|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
170451366|NCT00706355|615991314|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
170451367|NCT00706355|615991315|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
170451368|NCT00706355|615991316|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
170451369|NCT00706355|615991317|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
170634505|NCT01394016|616672015|FG018|Overall Study|Withdrawal by Subject|2|||
170634506|NCT01394016|616671997|FG000|Overall Study|Adverse Event|0|||
170634507|NCT01394016|616671998|FG001|Overall Study|Adverse Event|0|||
170634508|NCT01394016|616671999|FG002|Overall Study|Adverse Event|0|||
170634509|NCT01394016|616672000|FG003|Overall Study|Adverse Event|0|||
170634510|NCT01394016|616672001|FG004|Overall Study|Adverse Event|0|||
170634511|NCT01394016|616672002|FG005|Overall Study|Adverse Event|0|||
170634512|NCT01394016|616672003|FG006|Overall Study|Adverse Event|0|||
170634513|NCT01394016|616672004|FG007|Overall Study|Adverse Event|0|||
170634514|NCT01394016|616672005|FG008|Overall Study|Adverse Event|0|||
170634515|NCT01394016|616672006|FG009|Overall Study|Adverse Event|1|||
170634516|NCT01394016|616672007|FG010|Overall Study|Adverse Event|0|||
170634517|NCT01394016|616672008|FG011|Overall Study|Adverse Event|0|||
170634518|NCT01394016|616672009|FG012|Overall Study|Adverse Event|0|||
170634519|NCT01394016|616672010|FG013|Overall Study|Adverse Event|0|||
170634520|NCT01394016|616672011|FG014|Overall Study|Adverse Event|0|||
170634521|NCT01394016|616672012|FG015|Overall Study|Adverse Event|0|||
170634522|NCT01394016|616672013|FG016|Overall Study|Adverse Event|1|||
170634523|NCT01394016|616672014|FG017|Overall Study|Adverse Event|1|||
170634524|NCT01394016|616672015|FG018|Overall Study|Adverse Event|0|||
170634525|NCT01394016|616671997|FG000|Overall Study|Sponsor Decision|0|||
170634526|NCT01394016|616671998|FG001|Overall Study|Sponsor Decision|0|||
170634527|NCT01394016|616671999|FG002|Overall Study|Sponsor Decision|0|||
170634528|NCT01394016|616672000|FG003|Overall Study|Sponsor Decision|0|||
170634529|NCT01394016|616672001|FG004|Overall Study|Sponsor Decision|0|||
170634530|NCT01394016|616672002|FG005|Overall Study|Sponsor Decision|0|||
170634531|NCT01394016|616672003|FG006|Overall Study|Sponsor Decision|0|||
170634532|NCT01394016|616672004|FG007|Overall Study|Sponsor Decision|0|||
170634533|NCT01394016|616672005|FG008|Overall Study|Sponsor Decision|0|||
170634534|NCT01394016|616672006|FG009|Overall Study|Sponsor Decision|0|||
170634535|NCT01394016|616672007|FG010|Overall Study|Sponsor Decision|0|||
170634536|NCT01394016|616672008|FG011|Overall Study|Sponsor Decision|0|||
170634537|NCT01394016|616672009|FG012|Overall Study|Sponsor Decision|1|||
170634538|NCT01394016|616672010|FG013|Overall Study|Sponsor Decision|0|||
170634539|NCT01394016|616672011|FG014|Overall Study|Sponsor Decision|0|||
170634540|NCT01394016|616672012|FG015|Overall Study|Sponsor Decision|0|||
170634541|NCT01394016|616672013|FG016|Overall Study|Sponsor Decision|0|||
170634542|NCT01394016|616672014|FG017|Overall Study|Sponsor Decision|0|||
170634543|NCT01394016|616672015|FG018|Overall Study|Sponsor Decision|0|||
170634544|NCT01394016|616671997|FG000|Overall Study|Lost to Follow-up|0|||
170634545|NCT01394016|616671998|FG001|Overall Study|Lost to Follow-up|0|||
170634546|NCT01394016|616671999|FG002|Overall Study|Lost to Follow-up|0|||
170634547|NCT01394016|616672000|FG003|Overall Study|Lost to Follow-up|0|||
170634548|NCT01394016|616672001|FG004|Overall Study|Lost to Follow-up|0|||
170634549|NCT01394016|616672002|FG005|Overall Study|Lost to Follow-up|0|||
170634550|NCT01394016|616672003|FG006|Overall Study|Lost to Follow-up|0|||
170634551|NCT01394016|616672004|FG007|Overall Study|Lost to Follow-up|0|||
170634552|NCT01394016|616672005|FG008|Overall Study|Lost to Follow-up|0|||
170634553|NCT01394016|616672006|FG009|Overall Study|Lost to Follow-up|0|||
170634554|NCT01394016|616672007|FG010|Overall Study|Lost to Follow-up|0|||
170634555|NCT01394016|616672008|FG011|Overall Study|Lost to Follow-up|0|||
170634556|NCT01394016|616672009|FG012|Overall Study|Lost to Follow-up|0|||
170634557|NCT01394016|616672010|FG013|Overall Study|Lost to Follow-up|0|||
170634558|NCT01394016|616672011|FG014|Overall Study|Lost to Follow-up|0|||
170634559|NCT01394016|616672012|FG015|Overall Study|Lost to Follow-up|0|||
170634560|NCT01394016|616672013|FG016|Overall Study|Lost to Follow-up|0|||
170634561|NCT01394016|616672014|FG017|Overall Study|Lost to Follow-up|0|||
170634562|NCT01394016|616672015|FG018|Overall Study|Lost to Follow-up|1|||
170887722|NCT02028455|617596024|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
170887723|NCT02028455|617596017|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
170887724|NCT02028455|617596018|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
170887725|NCT02028455|617596019|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
170887726|NCT02028455|617596020|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
170887727|NCT02028455|617596021|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
170887728|NCT02028455|617596022|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
170634563|NCT03534804|616672016|FG000|Overall Study|Withdrawal by Subject|1|||
170634564|NCT04161157|616672020|FG000|Overall Study|Lost to Follow-up|4|||
170634565|NCT04161157|616672020|FG000|Overall Study|Death|3|||
170634566|NCT04161157|616672020|FG000|Overall Study|Ineligible|2|||
170634567|NCT04161157|616672020|FG000|Overall Study|Withdrawal by Subject|4|||
170634568|NCT01285557|616672022|FG000|Overall Study|Death|173|||
170634569|NCT01285557|616672023|FG001|Overall Study|Death|90|||
170634570|NCT01285557|616672022|FG000|Overall Study|Lost to Follow-up|6|||
170634571|NCT01285557|616672023|FG001|Overall Study|Lost to Follow-up|2|||
170634572|NCT01285557|616672022|FG000|Overall Study|Withdrew Consent|6|||
170634573|NCT01285557|616672023|FG001|Overall Study|Withdrew Consent|1|||
170634574|NCT01285557|616672022|FG000|Overall Study|Sponsor Study Termination|23|||
170634575|NCT01285557|616672023|FG001|Overall Study|Sponsor Study Termination|13|||
170634576|NCT01285557|616672022|FG000|Overall Study|Randomized but not treated|1|||
170451370|NCT00706355|615991314|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
170451371|NCT00706355|615991315|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
170451372|NCT00706355|615991316|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
170451373|NCT00706355|615991317|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
170451374|NCT00706355|615991314|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
170451375|NCT00706355|615991315|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
170451376|NCT00706355|615991316|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
170451377|NCT00706355|615991317|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
170451378|NCT00706355|615991314|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
170451379|NCT00706355|615991315|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
170451380|NCT00706355|615991316|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
170451381|NCT00706355|615991317|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
170451382|NCT00706355|615991314|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
170451383|NCT00706355|615991315|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
170451384|NCT00706355|615991316|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
170451385|NCT00706355|615991317|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
170451386|NCT00706355|615991314|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
170451387|NCT00706355|615991315|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
170451388|NCT00706355|615991316|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
170451389|NCT00706355|615991317|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
170451390|NCT00706355|615991314|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
170451391|NCT00706355|615991315|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
170451392|NCT00706355|615991316|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
170451393|NCT00706355|615991317|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
170451394|NCT02985879|615991320|FG000|Overall Study|Adverse Event|7|||
170451395|NCT02985879|615991321|FG001|Overall Study|Adverse Event|9|||
170451396|NCT02985879|615991322|FG002|Overall Study|Adverse Event|7|||
170451397|NCT02985879|615991320|FG000|Overall Study|Withdrew consent|6|||
170451398|NCT02985879|615991321|FG001|Overall Study|Withdrew consent|8|||
170451399|NCT02985879|615991322|FG002|Overall Study|Withdrew consent|10|||
170451400|NCT02985879|615991320|FG000|Overall Study|Lost to Follow-up|1|||
170451401|NCT02985879|615991321|FG001|Overall Study|Lost to Follow-up|0|||
170451402|NCT02985879|615991322|FG002|Overall Study|Lost to Follow-up|2|||
170451403|NCT02985879|615991320|FG000|Overall Study|Other, not specified|62|||
170451404|NCT02985879|615991321|FG001|Overall Study|Other, not specified|58|||
170451405|NCT02985879|615991322|FG002|Overall Study|Other, not specified|58|||
170451406|NCT01215513|615992688|FG000|Overall Study|Not completed CS42|9|||
170451407|NCT01215513|615992688|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
170451408|NCT01215513|615992688|FG000|Overall Study|Adverse event (CS42A)|2|||
170451409|NCT01215513|615992688|FG000|Overall Study|Physician decision (CS42A)|6|||
170451410|NCT01215513|615992688|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
170451411|NCT01215513|615992688|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
170451412|NCT00821873|615992689|FG000|Overall Study|Lost to Follow-up|4|||
170451413|NCT03861481|615992695|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
170451414|NCT03861481|615992696|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
170451415|NCT03861481|615992695|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
170451416|NCT03861481|615992696|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
170451417|NCT03861481|615992695|FG000|Overall Study|Relapse|1|||
170451418|NCT03861481|615992696|FG001|Overall Study|Relapse|0|||
170451419|NCT03861481|615992695|FG000|Overall Study|Withdrawal by Subject|0|||
170451420|NCT03861481|615992696|FG001|Overall Study|Withdrawal by Subject|1|||
170451421|NCT03861481|615992695|FG000|Overall Study|Lack of Efficacy|4|||
170451422|NCT03861481|615992696|FG001|Overall Study|Lack of Efficacy|5|||
170451423|NCT00856830|615992703|FG000|Irinotecan & Bendamustine|Death|0|||
170451424|NCT00856830|615992704|FG001|Irinotecan & Bendamustine|Death|0|||
170451425|NCT00856830|615992705|FG002|Irinotecan & Bendamustine|Death|0|||
170451426|NCT00856830|615992706|FG003|Irinotecan & Bendamustine|Death|2|||
170451427|NCT00856830|615992703|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
170451428|NCT00856830|615992704|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
170451429|NCT00856830|615992705|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
170451430|NCT00856830|615992706|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
170451431|NCT03768726|615992707|FG000|Treatment Phase|Adverse Event|2|||
170451432|NCT03768726|615992708|FG001|Treatment Phase|Adverse Event|2|||
170451433|NCT03768726|615992707|FG000|Treatment Phase|Lost to Follow-up|1|||
170451434|NCT03768726|615992708|FG001|Treatment Phase|Lost to Follow-up|0|||
170451435|NCT03768726|615992707|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
170451436|NCT03768726|615992708|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
170451437|NCT03768726|615992707|FG000|Treatment Phase|Withdrawal by Subject|3|||
170451438|NCT03768726|615992708|FG001|Treatment Phase|Withdrawal by Subject|1|||
170451439|NCT03768726|615992707|FG000|Follow-Up|Adverse Event|2|||
170451440|NCT03768726|615992708|FG001|Follow-Up|Adverse Event|2|||
170451441|NCT03768726|615992707|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
170634577|NCT01285557|616672023|FG001|Overall Study|Randomized but not treated|1|||
170634578|NCT01285557|616672022|FG000|Overall Study|Study follow-up ongoing|28|||
170634579|NCT01285557|616672023|FG001|Overall Study|Study follow-up ongoing|14|||
170634580|NCT01285557|616672022|FG000|Overall Study|Sponsor Decision|2|||
170634581|NCT01285557|616672023|FG001|Overall Study|Sponsor Decision|1|||
170634582|NCT01588522|616672028|FG000|Overall Study|Withdrawal by Subject|1|||
170634583|NCT01588522|616672029|FG001|Overall Study|Withdrawal by Subject|5|||
170451442|NCT03768726|615992708|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
170451443|NCT03768726|615992707|FG000|Follow-Up|Withdrawal by Subject|2|||
170451444|NCT03768726|615992708|FG001|Follow-Up|Withdrawal by Subject|0|||
170451445|NCT03768726|615992707|FG000|Follow-Up|Other|1|||
170451446|NCT03768726|615992708|FG001|Follow-Up|Other|0|||
170451447|NCT01220297|615992709|FG000|Overall Study|Death|2|||
170451448|NCT01220297|615992709|FG000|Overall Study|Lost to Follow-up|1|||
170451449|NCT01787279|615992710|FG000|Overall Study|Lost to Follow-up|2|||
170451450|NCT01787279|615992710|FG000|Overall Study|Lack of Efficacy|1|||
170451451|NCT02148913|615992716|FG000|Overall Study|Death|0|||
170451452|NCT02148913|615992717|FG001|Overall Study|Death|1|||
170451453|NCT02148913|615992718|FG002|Overall Study|Death|0|||
170451454|NCT02148913|615992719|FG003|Overall Study|Death|0|||
170451455|NCT02119286|615992721|FG000|Overall Study|Adverse Event|9|||
170451456|NCT02119286|615992722|FG001|Overall Study|Adverse Event|7|||
170451457|NCT02119286|615992723|FG002|Overall Study|Adverse Event|2|||
170451458|NCT02119286|615992721|FG000|Overall Study|Lack of Efficacy|11|||
170451459|NCT02119286|615992722|FG001|Overall Study|Lack of Efficacy|3|||
170451460|NCT02119286|615992723|FG002|Overall Study|Lack of Efficacy|4|||
170451461|NCT02119286|615992721|FG000|Overall Study|Lost to Follow-up|2|||
170451462|NCT02119286|615992722|FG001|Overall Study|Lost to Follow-up|0|||
170451463|NCT02119286|615992723|FG002|Overall Study|Lost to Follow-up|1|||
170451464|NCT02119286|615992721|FG000|Overall Study|Withdrawal by Subject|4|||
170451465|NCT02119286|615992722|FG001|Overall Study|Withdrawal by Subject|1|||
170451466|NCT02119286|615992723|FG002|Overall Study|Withdrawal by Subject|0|||
170451467|NCT02694549|615992724|FG000|Overall Study|screen failures|2|||
170451468|NCT01996332|615992725|FG000|Overall Study|Adverse Event|117|||
170451469|NCT01996332|615992725|FG000|Overall Study|Lack of Efficacy|1245|||
170451470|NCT01996332|615992725|FG000|Overall Study|Death|264|||
170451471|NCT01996332|615992725|FG000|Overall Study|Protocol Violation|9|||
170451472|NCT01996332|615992725|FG000|Overall Study|Withdrawal by Subject|71|||
170451473|NCT01996332|615992725|FG000|Overall Study|Other|20|||
170451474|NCT01996332|615992725|FG000|Overall Study|Clinical Deterioration|28|||
170451475|NCT01996332|615992725|FG000|Overall Study|Physician Decision|17|||
170451476|NCT01996332|615992725|FG000|Overall Study|Lost to Follow-up|34|||
170451477|NCT00922272|615992728|FG000|Open-label Phase|Adverse Event|5|||
170451478|NCT00922272|615992729|FG001|Open-label Phase|Adverse Event|0|||
170451479|NCT00922272|615992728|FG000|Open-label Phase|Protocol Violation|1|||
170451480|NCT00922272|615992729|FG001|Open-label Phase|Protocol Violation|0|||
170451481|NCT00922272|615992728|FG000|Open-label Phase|Withdrawal by Subject|11|||
170451482|NCT00922272|615992729|FG001|Open-label Phase|Withdrawal by Subject|0|||
170451483|NCT00922272|615992728|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
170451484|NCT00922272|615992729|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
170451485|NCT00922272|615992728|FG000|Open-label Phase|Withdrawal criteria met|5|||
170451486|NCT00922272|615992729|FG001|Open-label Phase|Withdrawal criteria met|0|||
170451487|NCT00922272|615992728|FG000|Double-blind Phase|Adverse Event|1|||
170451488|NCT00922272|615992729|FG001|Double-blind Phase|Adverse Event|1|||
170451489|NCT00922272|615992728|FG000|Double-blind Phase|Withdrawal by Subject|1|||
170451490|NCT00922272|615992729|FG001|Double-blind Phase|Withdrawal by Subject|1|||
170451491|NCT00922272|615992728|FG000|Double-blind Phase|Lost to Follow-up|2|||
170451492|NCT00922272|615992729|FG001|Double-blind Phase|Lost to Follow-up|1|||
170451493|NCT00922272|615992728|FG000|Double-blind Phase|Withdrawal criteria met|1|||
170451494|NCT00922272|615992729|FG001|Double-blind Phase|Withdrawal criteria met|1|||
170451495|NCT00922272|615992728|FG000|Double-blind Phase|Noncompliance|1|||
170451496|NCT00922272|615992729|FG001|Double-blind Phase|Noncompliance|1|||
170451497|NCT00922272|615992728|FG000|Double-blind Phase|Positive urine drug screen|1|||
170451498|NCT00922272|615992729|FG001|Double-blind Phase|Positive urine drug screen|1|||
170451499|NCT00099268|615992730|FG000|Overall Study|Withdrawal by Subject|46|||
170451500|NCT00099268|615992731|FG001|Overall Study|Withdrawal by Subject|28|||
170451501|NCT00099268|615992730|FG000|Overall Study|Adverse Event|19|||
170451502|NCT00099268|615992731|FG001|Overall Study|Adverse Event|19|||
170451503|NCT00099268|615992730|FG000|Overall Study|Protocol Violation|9|||
170451504|NCT00099268|615992731|FG001|Overall Study|Protocol Violation|8|||
170634584|NCT01588522|616672030|FG002|Overall Study|Withdrawal by Subject|3|||
170634585|NCT01588522|616672031|FG003|Overall Study|Withdrawal by Subject|1|||
170451505|NCT00099268|615992730|FG000|Overall Study|Lost to Follow-up|6|||
170451506|NCT00099268|615992731|FG001|Overall Study|Lost to Follow-up|4|||
170451507|NCT00099268|615992730|FG000|Overall Study|Lack of Efficacy|5|||
170451508|NCT00099268|615992731|FG001|Overall Study|Lack of Efficacy|18|||
170634586|NCT01588522|616672032|FG004|Overall Study|Withdrawal by Subject|2|||
170451509|NCT00099268|615992730|FG000|Overall Study|Administrative problems|4|||
170451510|NCT00099268|615992731|FG001|Overall Study|Administrative problems|4|||
170787116|NCT04137289|617229671|FG002|Overall Study|Adverse Event|1|||
170787117|NCT04137289|617229672|FG003|Overall Study|Adverse Event|0|||
170787118|NCT04137289|617229673|FG004|Overall Study|Adverse Event|0|||
170787119|NCT04137289|617229674|FG005|Overall Study|Adverse Event|1|||
170787120|NCT04137289|617229675|FG006|Overall Study|Adverse Event|0|||
170787121|NCT04137289|617229676|FG007|Overall Study|Adverse Event|0|||
170451511|NCT00099268|615992730|FG000|Overall Study|Death|3|||
170451512|NCT00099268|615992731|FG001|Overall Study|Death|1|||
170451513|NCT05016622|615992732|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
170451514|NCT05016622|615992732|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
170451515|NCT02954159|615992733|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
170451516|NCT02954159|615992734|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
170451517|NCT02954159|615992733|FG000|Overall Study|Withdrawal by Subject|0|||
170451518|NCT02954159|615992734|FG001|Overall Study|Withdrawal by Subject|1|||
170451519|NCT03438396|615992740|FG000|Overall Study|Reason Not Specified|9|||
170451520|NCT03438396|615992740|FG000|Overall Study|Withdrawal by Subject|5|||
170451521|NCT03438396|615992740|FG000|Overall Study|Lost to Follow-up|2|||
170451522|NCT03438396|615992740|FG000|Overall Study|Death|85|||
170451523|NCT03438396|615992740|FG000|Overall Study|Not treated|1|||
170451524|NCT01744093|615992741|FG000|Overall Study|Withdrawal by Subject|6|||
170451525|NCT01744093|615992742|FG001|Overall Study|Withdrawal by Subject|1|||
170451526|NCT03451006|615992743|FG000|Overall Study|Withdrawal by Subject|2|||
170451527|NCT03451006|615992744|FG001|Overall Study|Withdrawal by Subject|2|||
170451528|NCT00775606|615992745|FG000|Overall Study|Study sponsor terminated funding|3|||
170451529|NCT00775606|615992746|FG001|Overall Study|Study sponsor terminated funding|0|||
170451530|NCT00897949|615992747|FG000|Overall Study|Adverse Event|1|||
170451531|NCT00897949|615992748|FG001|Overall Study|Adverse Event|1|||
170451532|NCT00897949|615992749|FG002|Overall Study|Adverse Event|0|||
170451533|NCT00897949|615992747|FG000|Overall Study|Lost to Follow-up|0|||
170451534|NCT00897949|615992748|FG001|Overall Study|Lost to Follow-up|2|||
170451535|NCT00897949|615992749|FG002|Overall Study|Lost to Follow-up|1|||
170451536|NCT00897949|615992747|FG000|Overall Study|Protocol Violation|6|||
170451537|NCT00897949|615992748|FG001|Overall Study|Protocol Violation|3|||
170451538|NCT00897949|615992749|FG002|Overall Study|Protocol Violation|1|||
170451539|NCT00897949|615992747|FG000|Overall Study|Withdrawal by Subject|1|||
170451540|NCT00897949|615992748|FG001|Overall Study|Withdrawal by Subject|2|||
170451541|NCT00897949|615992749|FG002|Overall Study|Withdrawal by Subject|0|||
170451542|NCT00897949|615992747|FG000|Overall Study|Patient Uncoorperative|0|||
170451543|NCT00897949|615992748|FG001|Overall Study|Patient Uncoorperative|2|||
170451544|NCT00897949|615992749|FG002|Overall Study|Patient Uncoorperative|1|||
170451545|NCT00897949|615992747|FG000|Overall Study|Lost to Follow-up|30|||
170451546|NCT00897949|615992748|FG001|Overall Study|Lost to Follow-up|23|||
170451547|NCT00897949|615992749|FG002|Overall Study|Lost to Follow-up|17|||
170451548|NCT00897949|615992747|FG000|Overall Study|Withdrawal by Subject|24|||
170451549|NCT00897949|615992748|FG001|Overall Study|Withdrawal by Subject|31|||
170451550|NCT00897949|615992749|FG002|Overall Study|Withdrawal by Subject|17|||
170451551|NCT00897949|615992747|FG000|Overall Study|Abnormal Prestudy Labs|2|||
170451552|NCT00897949|615992748|FG001|Overall Study|Abnormal Prestudy Labs|3|||
170451553|NCT00897949|615992749|FG002|Overall Study|Abnormal Prestudy Labs|4|||
170451554|NCT00897949|615992747|FG000|Overall Study|Abnormal Baseline ECG|2|||
170451555|NCT00897949|615992748|FG001|Overall Study|Abnormal Baseline ECG|2|||
170451556|NCT00897949|615992749|FG002|Overall Study|Abnormal Baseline ECG|4|||
170451557|NCT00897949|615992747|FG000|Overall Study|Need for Concom. Med.|0|||
170451558|NCT00897949|615992748|FG001|Overall Study|Need for Concom. Med.|1|||
170451559|NCT00897949|615992749|FG002|Overall Study|Need for Concom. Med.|1|||
170451560|NCT00897949|615992747|FG000|Overall Study|Lack of Migraine Attack|29|||
170451561|NCT00897949|615992748|FG001|Overall Study|Lack of Migraine Attack|30|||
170451562|NCT00897949|615992749|FG002|Overall Study|Lack of Migraine Attack|19|||
170451563|NCT00897949|615992747|FG000|Overall Study|Did not take study drug|9|||
170451564|NCT00897949|615992748|FG001|Overall Study|Did not take study drug|3|||
170451565|NCT00897949|615992749|FG002|Overall Study|Did not take study drug|4|||
170451566|NCT06279871|615992751|FG000|Overall Study|Death|0|||
170451567|NCT06279871|615992752|FG001|Overall Study|Death|0|||
170451568|NCT06279871|615992753|FG002|Overall Study|Death|0|||
170451569|NCT06279871|615992754|FG003|Overall Study|Death|0|||
170451570|NCT06279871|615992755|FG004|Overall Study|Death|0|||
170451571|NCT06279871|615992756|FG005|Overall Study|Death|1|||
170451572|NCT06279871|615992757|FG006|Overall Study|Death|0|||
170451573|NCT06279871|615992751|FG000|Overall Study|Other than Specified|1|||
170451574|NCT06279871|615992752|FG001|Overall Study|Other than Specified|0|||
170451575|NCT06279871|615992753|FG002|Overall Study|Other than Specified|4|||
170451576|NCT06279871|615992754|FG003|Overall Study|Other than Specified|0|||
170451577|NCT06279871|615992755|FG004|Overall Study|Other than Specified|0|||
170451578|NCT06279871|615992756|FG005|Overall Study|Other than Specified|0|||
170451579|NCT06279871|615992757|FG006|Overall Study|Other than Specified|0|||
170451580|NCT06279871|615992751|FG000|Overall Study|Withdrawal by Subject|4|||
170787122|NCT04137289|617229677|FG008|Overall Study|Adverse Event|0|||
170634587|NCT01588522|616672033|FG005|Overall Study|Withdrawal by Subject|0|||
170634588|NCT01588522|616672028|FG000|Overall Study|Lack of Efficacy|0|||
170634589|NCT01588522|616672029|FG001|Overall Study|Lack of Efficacy|0|||
170634590|NCT01588522|616672030|FG002|Overall Study|Lack of Efficacy|0|||
170634591|NCT01588522|616672031|FG003|Overall Study|Lack of Efficacy|0|||
170634592|NCT01588522|616672032|FG004|Overall Study|Lack of Efficacy|1|||
170634593|NCT01588522|616672033|FG005|Overall Study|Lack of Efficacy|0|||
170634594|NCT01588522|616672028|FG000|Overall Study|Adverse Event|0|||
170541534|NCT03215030|616328033|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
170541535|NCT03215030|616328034|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
170541536|NCT03215030|616328035|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
170541537|NCT03215030|616328036|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
170541538|NCT03215030|616328037|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
170541539|NCT03215030|616328038|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
170541540|NCT03215030|616328039|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
170541541|NCT03215030|616328040|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
170541542|NCT03215030|616328041|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
170541543|NCT03215030|616328030|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541544|NCT03215030|616328031|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541545|NCT03215030|616328032|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541546|NCT03215030|616328033|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541547|NCT03215030|616328034|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541548|NCT03215030|616328035|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541549|NCT03215030|616328036|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541550|NCT03215030|616328037|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
170541551|NCT03215030|616328038|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541552|NCT03215030|616328039|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541553|NCT03215030|616328040|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170541554|NCT03215030|616328041|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
170634595|NCT01588522|616672029|FG001|Overall Study|Adverse Event|0|||
170787123|NCT04137289|617229669|FG000|Overall Study|Lack of clinical benefit|0|||
170787124|NCT04137289|617229670|FG001|Overall Study|Lack of clinical benefit|0|||
170787125|NCT04137289|617229671|FG002|Overall Study|Lack of clinical benefit|0|||
170787126|NCT04137289|617229672|FG003|Overall Study|Lack of clinical benefit|0|||
170787127|NCT04137289|617229673|FG004|Overall Study|Lack of clinical benefit|0|||
170787128|NCT04137289|617229674|FG005|Overall Study|Lack of clinical benefit|0|||
170787129|NCT04137289|617229675|FG006|Overall Study|Lack of clinical benefit|0|||
170787130|NCT04137289|617229676|FG007|Overall Study|Lack of clinical benefit|0|||
170887729|NCT02028455|617596023|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
170887730|NCT02028455|617596024|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
170887731|NCT02028455|617596017|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
170887732|NCT02028455|617596018|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
170887733|NCT02028455|617596019|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
170887734|NCT02028455|617596020|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
170887735|NCT02028455|617596021|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
170887736|NCT02028455|617596022|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
170887737|NCT02028455|617596023|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
170887738|NCT02028455|617596024|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
170887739|NCT02396589|617596027|FG000|Intervention|Lost to Follow-up|1|||
170887740|NCT02396589|617596028|FG001|Intervention|Lost to Follow-up|0|||
170887741|NCT02396589|617596027|FG000|6 Month Follow-up|change in health status|0|||
170887742|NCT02396589|617596028|FG001|6 Month Follow-up|change in health status|1|||
170887743|NCT02396589|617596027|FG000|9 Month Follow-up|Death|0|||
170887744|NCT02396589|617596028|FG001|9 Month Follow-up|Death|1|||
170887745|NCT02396589|617596027|FG000|12 Month Follow up|Lost to Follow-up|0|||
170887746|NCT02396589|617596028|FG001|12 Month Follow up|Lost to Follow-up|2|||
170887747|NCT04381650|617596029|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887748|NCT04381650|617596030|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887749|NCT04381650|617596031|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887750|NCT04381650|617596032|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
170887751|NCT04381650|617596033|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887752|NCT04381650|617596034|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887753|NCT04381650|617596035|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887754|NCT04381650|617596036|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170541555|NCT03215030|616328030|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170541556|NCT03215030|616328031|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170541557|NCT03215030|616328032|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170634596|NCT01588522|616672030|FG002|Overall Study|Adverse Event|0|||
170787131|NCT04137289|617229677|FG008|Overall Study|Lack of clinical benefit|1|||
170887755|NCT04381650|617596037|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887756|NCT04381650|617596038|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887757|NCT04381650|617596039|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
170887758|NCT04381650|617596029|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887759|NCT04381650|617596030|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887760|NCT04381650|617596031|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887761|NCT04381650|617596032|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
170887762|NCT04381650|617596033|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887763|NCT04381650|617596034|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887764|NCT04381650|617596035|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887765|NCT04381650|617596036|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887766|NCT04381650|617596037|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887767|NCT04381650|617596038|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887768|NCT04381650|617596039|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
170887769|NCT04381650|617596029|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
170887770|NCT04381650|617596030|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
170887771|NCT04381650|617596031|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
170887772|NCT04381650|617596032|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
170887773|NCT04381650|617596033|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
170887774|NCT04381650|617596034|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
170887775|NCT04381650|617596035|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
170887776|NCT04381650|617596036|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
170887777|NCT04381650|617596037|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
170887778|NCT04381650|617596038|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
170887779|NCT04381650|617596039|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
170887780|NCT04381650|617596029|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887781|NCT04381650|617596030|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887782|NCT04381650|617596031|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
170887783|NCT04381650|617596032|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
170887784|NCT04381650|617596033|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887785|NCT04381650|617596034|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887786|NCT04381650|617596035|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887787|NCT04381650|617596036|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887788|NCT04381650|617596037|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887789|NCT04381650|617596038|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887790|NCT04381650|617596039|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
170887791|NCT04381650|617596029|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
170451581|NCT06279871|615992752|FG001|Overall Study|Withdrawal by Subject|8|||
170451582|NCT06279871|615992753|FG002|Overall Study|Withdrawal by Subject|4|||
170451583|NCT06279871|615992754|FG003|Overall Study|Withdrawal by Subject|2|||
170451584|NCT06279871|615992755|FG004|Overall Study|Withdrawal by Subject|0|||
170451585|NCT06279871|615992756|FG005|Overall Study|Withdrawal by Subject|0|||
170451586|NCT06279871|615992757|FG006|Overall Study|Withdrawal by Subject|0|||
170451587|NCT06279871|615992751|FG000|Overall Study|Lost to Follow-up|11|||
170451588|NCT06279871|615992752|FG001|Overall Study|Lost to Follow-up|10|||
170451589|NCT06279871|615992753|FG002|Overall Study|Lost to Follow-up|8|||
170451590|NCT06279871|615992754|FG003|Overall Study|Lost to Follow-up|0|||
170451591|NCT06279871|615992755|FG004|Overall Study|Lost to Follow-up|0|||
170451592|NCT06279871|615992756|FG005|Overall Study|Lost to Follow-up|0|||
170451593|NCT06279871|615992757|FG006|Overall Study|Lost to Follow-up|0|||
170451594|NCT06279871|615992751|FG000|Overall Study|Adverse Event|0|||
170451595|NCT06279871|615992752|FG001|Overall Study|Adverse Event|1|||
170451596|NCT06279871|615992753|FG002|Overall Study|Adverse Event|0|||
170451597|NCT06279871|615992754|FG003|Overall Study|Adverse Event|0|||
170451598|NCT06279871|615992755|FG004|Overall Study|Adverse Event|0|||
170451599|NCT06279871|615992756|FG005|Overall Study|Adverse Event|0|||
170451600|NCT06279871|615992757|FG006|Overall Study|Adverse Event|0|||
170451601|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
170451602|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
170451603|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
170451604|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
170451605|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
170451606|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
170451607|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
170451608|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
170451609|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
170451610|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
170451611|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
170451612|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
170451613|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
170451614|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
170541558|NCT03215030|616328033|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170787132|NCT04137289|617229669|FG000|Overall Study|Objective disease progression|1|||
170787133|NCT04137289|617229670|FG001|Overall Study|Objective disease progression|1|||
170787134|NCT04137289|617229671|FG002|Overall Study|Objective disease progression|6|||
170787135|NCT04137289|617229672|FG003|Overall Study|Objective disease progression|18|||
170451615|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
170451616|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
170451617|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
170451618|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
170451619|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
170451620|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
170451621|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
170451622|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
170451623|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
170451624|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
170451625|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
170451626|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
170451627|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
170451628|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
170451629|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Death|0|||
170451630|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Death|1|||
170451631|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Death|0|||
170451632|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Death|0|||
170451633|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
170451634|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
170451635|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
170451636|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
170451637|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
170451638|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
170451639|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
170451640|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
170451641|NCT02990806|615992761|FG000|Stage 1 (22 Weeks)|Other|1|||
170451642|NCT02990806|615992762|FG001|Stage 1 (22 Weeks)|Other|3|||
170451643|NCT02990806|615992763|FG002|Stage 1 (22 Weeks)|Other|0|||
170451644|NCT02990806|615992764|FG003|Stage 1 (22 Weeks)|Other|0|||
170451645|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
170451646|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
170451647|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
170451648|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
170451649|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Death|1|||
170451650|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Death|0|||
170451651|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Death|0|||
170451652|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Death|0|||
170451653|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
170451654|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
170451655|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
170451656|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
170451657|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
170451658|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
170451659|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
170451660|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
170451661|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
170451662|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
170451663|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
170451664|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
170451665|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
170451666|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
170451667|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
170451668|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
170451669|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
170451670|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
170451671|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
170451672|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
170451673|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
170451674|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
170451675|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
170451676|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
170451677|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
170451678|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
170451679|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
170451680|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
170451681|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
170634597|NCT01588522|616672031|FG003|Overall Study|Adverse Event|1|||
170634598|NCT01588522|616672032|FG004|Overall Study|Adverse Event|0|||
170634599|NCT01588522|616672033|FG005|Overall Study|Adverse Event|0|||
170451682|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
170451683|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
170451684|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
170451685|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
170451686|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
170451687|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
170451688|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
170451689|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Other|3|||
170451690|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Other|0|||
170451691|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Other|4|||
170451692|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Other|1|||
170451693|NCT02990806|615992761|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
170451694|NCT02990806|615992762|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
170451695|NCT02990806|615992763|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
170451696|NCT02990806|615992764|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
170451697|NCT02990806|615992761|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
170451698|NCT02990806|615992762|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
170451699|NCT02990806|615992763|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
170451700|NCT02990806|615992764|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
170451701|NCT02990806|615992761|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
170451702|NCT02990806|615992762|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
170451703|NCT02990806|615992763|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
170451704|NCT02990806|615992764|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
170451705|NCT02990806|615992761|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
170451706|NCT02990806|615992762|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
170451707|NCT02990806|615992763|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
170451708|NCT02990806|615992764|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
170451709|NCT02990806|615992761|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
170451710|NCT02990806|615992762|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
170451711|NCT02990806|615992763|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
170451712|NCT02990806|615992764|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
170451713|NCT02990806|615992761|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
170451714|NCT02990806|615992762|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
170451715|NCT02990806|615992763|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
170451716|NCT02990806|615992764|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
170451717|NCT02990806|615992761|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
170451718|NCT02990806|615992762|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
170451719|NCT02990806|615992763|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
170451720|NCT02990806|615992764|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
170451721|NCT02990806|615992761|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
170451722|NCT02990806|615992762|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
170451723|NCT02990806|615992763|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
170541559|NCT03215030|616328034|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
170541560|NCT03215030|616328035|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
170541561|NCT03215030|616328036|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
170541562|NCT03215030|616328037|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
170541563|NCT03215030|616328038|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170541564|NCT03215030|616328039|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170541565|NCT03215030|616328040|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170541566|NCT03215030|616328041|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170541567|NCT03215030|616328030|FG000|Part 2: Dose Expansion|Death|0|||
170541568|NCT03215030|616328031|FG001|Part 2: Dose Expansion|Death|0|||
170451724|NCT02990806|615992764|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
170451725|NCT02990806|615992761|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
170541569|NCT03215030|616328032|FG002|Part 2: Dose Expansion|Death|0|||
170541570|NCT03215030|616328033|FG003|Part 2: Dose Expansion|Death|0|||
170541571|NCT03215030|616328034|FG004|Part 2: Dose Expansion|Death|3|||
170541572|NCT03215030|616328035|FG005|Part 2: Dose Expansion|Death|1|||
170634600|NCT01588522|616672028|FG000|Overall Study|Grade 2 alopecia|1|||
170451726|NCT02990806|615992762|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
170451727|NCT02990806|615992763|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
170541573|NCT03215030|616328036|FG006|Part 2: Dose Expansion|Death|5|||
170541574|NCT03215030|616328037|FG007|Part 2: Dose Expansion|Death|4|||
170541575|NCT03215030|616328038|FG008|Part 2: Dose Expansion|Death|0|||
170541576|NCT03215030|616328039|FG009|Part 2: Dose Expansion|Death|0|||
170541577|NCT03215030|616328040|FG010|Part 2: Dose Expansion|Death|0|||
170451728|NCT02990806|615992764|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
170451729|NCT01825837|615992768|FG000|PART I|Withdrawal by Subject|0|||
170451730|NCT01825837|615992769|FG001|PART I|Withdrawal by Subject|0|||
170451731|NCT01825837|615992770|FG002|PART I|Withdrawal by Subject|0|||
170451732|NCT01825837|615992771|FG003|PART I|Withdrawal by Subject|6|||
170451733|NCT01825837|615992768|FG000|PART I|Patient non-compliance|0|||
170451734|NCT01825837|615992769|FG001|PART I|Patient non-compliance|0|||
170451735|NCT01825837|615992770|FG002|PART I|Patient non-compliance|0|||
170451736|NCT01825837|615992771|FG003|PART I|Patient non-compliance|1|||
170451737|NCT01825837|615992768|FG000|PART I|Treatment failure|0|||
170451738|NCT01825837|615992769|FG001|PART I|Treatment failure|0|||
170451739|NCT01825837|615992770|FG002|PART I|Treatment failure|0|||
170451740|NCT01825837|615992771|FG003|PART I|Treatment failure|7|||
170451741|NCT01825837|615992768|FG000|PART I|reason unspecified|0|||
170451742|NCT01825837|615992769|FG001|PART I|reason unspecified|0|||
170451743|NCT01825837|615992770|FG002|PART I|reason unspecified|0|||
170451744|NCT01825837|615992771|FG003|PART I|reason unspecified|3|||
170451745|NCT01825837|615992768|FG000|PART II|Withdrawal by Subject|3|||
170451746|NCT01825837|615992769|FG001|PART II|Withdrawal by Subject|3|||
170451747|NCT01825837|615992770|FG002|PART II|Withdrawal by Subject|7|||
170451748|NCT01825837|615992771|FG003|PART II|Withdrawal by Subject|0|||
170451749|NCT01825837|615992768|FG000|PART II|Patient non-compliance|5|||
170451750|NCT01825837|615992769|FG001|PART II|Patient non-compliance|2|||
170451751|NCT01825837|615992770|FG002|PART II|Patient non-compliance|4|||
170451752|NCT01825837|615992771|FG003|PART II|Patient non-compliance|0|||
170451753|NCT01825837|615992768|FG000|PART II|Adverse Event|3|||
170451754|NCT01825837|615992769|FG001|PART II|Adverse Event|3|||
170451755|NCT01825837|615992770|FG002|PART II|Adverse Event|1|||
170451756|NCT01825837|615992771|FG003|PART II|Adverse Event|0|||
170451757|NCT01825837|615992768|FG000|PART II|Treatment failure|6|||
170451758|NCT01825837|615992769|FG001|PART II|Treatment failure|4|||
170451759|NCT01825837|615992770|FG002|PART II|Treatment failure|5|||
170451760|NCT01825837|615992771|FG003|PART II|Treatment failure|0|||
170451761|NCT01825837|615992768|FG000|PART II|reason unspecified|2|||
170451762|NCT01825837|615992769|FG001|PART II|reason unspecified|2|||
170451763|NCT01825837|615992770|FG002|PART II|reason unspecified|2|||
170451764|NCT01825837|615992771|FG003|PART II|reason unspecified|0|||
170451765|NCT01056640|615992772|FG000|Overall Study|Withdrawal by Subject|11|||
170887792|NCT04381650|617596030|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
170451766|NCT01056640|615992773|FG001|Overall Study|Withdrawal by Subject|8|||
170451767|NCT01056640|615992772|FG000|Overall Study|Death|15|||
170451768|NCT01056640|615992773|FG001|Overall Study|Death|4|||
170451769|NCT01803269|615992774|FG000|Overall Study|Withdrawal by Subject|3|||
170451770|NCT01803269|615992775|FG001|Overall Study|Withdrawal by Subject|0|||
170451771|NCT01803269|615992776|FG002|Overall Study|Withdrawal by Subject|0|||
170451772|NCT02696031|615992782|FG000|Up to Week 24|Adverse Event|2|||
170451773|NCT02696031|615992783|FG001|Up to Week 24|Adverse Event|4|||
170451774|NCT02696031|615992784|FG002|Up to Week 24|Adverse Event|2|||
170451775|NCT02696031|615992785|FG003|Up to Week 24|Adverse Event|0|||
170451776|NCT02696031|615992786|FG004|Up to Week 24|Adverse Event|0|||
170451777|NCT02696031|615992787|FG005|Up to Week 24|Adverse Event|0|||
170451778|NCT02696031|615992782|FG000|Up to Week 24|Lack of Efficacy|2|||
170451779|NCT02696031|615992783|FG001|Up to Week 24|Lack of Efficacy|1|||
170451780|NCT02696031|615992784|FG002|Up to Week 24|Lack of Efficacy|2|||
170451781|NCT02696031|615992785|FG003|Up to Week 24|Lack of Efficacy|0|||
170451782|NCT02696031|615992786|FG004|Up to Week 24|Lack of Efficacy|0|||
170451783|NCT02696031|615992787|FG005|Up to Week 24|Lack of Efficacy|0|||
170541578|NCT03215030|616328041|FG011|Part 2: Dose Expansion|Death|0|||
170541579|NCT03215030|616328030|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
170887793|NCT04381650|617596031|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
170887794|NCT04381650|617596032|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
170887795|NCT04381650|617596033|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
170451784|NCT02696031|615992782|FG000|Up to Week 24|Lost to Follow-up|0|||
170451785|NCT02696031|615992783|FG001|Up to Week 24|Lost to Follow-up|1|||
170451786|NCT02696031|615992784|FG002|Up to Week 24|Lost to Follow-up|1|||
170451787|NCT02696031|615992785|FG003|Up to Week 24|Lost to Follow-up|0|||
170541580|NCT03215030|616328031|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
170541581|NCT03215030|616328032|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
170541582|NCT03215030|616328033|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
170541583|NCT03215030|616328034|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
170451788|NCT02696031|615992786|FG004|Up to Week 24|Lost to Follow-up|0|||
170451789|NCT02696031|615992787|FG005|Up to Week 24|Lost to Follow-up|0|||
170451790|NCT02696031|615992782|FG000|Up to Week 24|Physician Decision|1|||
170451791|NCT02696031|615992783|FG001|Up to Week 24|Physician Decision|0|||
170451792|NCT02696031|615992784|FG002|Up to Week 24|Physician Decision|1|||
170451793|NCT02696031|615992785|FG003|Up to Week 24|Physician Decision|0|||
170451794|NCT02696031|615992786|FG004|Up to Week 24|Physician Decision|0|||
170451795|NCT02696031|615992787|FG005|Up to Week 24|Physician Decision|0|||
170451796|NCT02696031|615992782|FG000|Up to Week 24|Protocol Violation|1|||
170451797|NCT02696031|615992783|FG001|Up to Week 24|Protocol Violation|0|||
170451798|NCT02696031|615992784|FG002|Up to Week 24|Protocol Violation|0|||
170451799|NCT02696031|615992785|FG003|Up to Week 24|Protocol Violation|0|||
170451800|NCT02696031|615992786|FG004|Up to Week 24|Protocol Violation|0|||
170451801|NCT02696031|615992787|FG005|Up to Week 24|Protocol Violation|0|||
170451802|NCT02696031|615992782|FG000|Up to Week 24|Withdrawal by Subject|4|||
170451803|NCT02696031|615992783|FG001|Up to Week 24|Withdrawal by Subject|1|||
170451804|NCT02696031|615992784|FG002|Up to Week 24|Withdrawal by Subject|5|||
170451805|NCT02696031|615992785|FG003|Up to Week 24|Withdrawal by Subject|0|||
170451806|NCT02696031|615992786|FG004|Up to Week 24|Withdrawal by Subject|0|||
170451807|NCT02696031|615992787|FG005|Up to Week 24|Withdrawal by Subject|0|||
170451808|NCT02696031|615992782|FG000|Up to Week 52|Adverse Event|4|||
170451809|NCT02696031|615992783|FG001|Up to Week 52|Adverse Event|5|||
170451810|NCT02696031|615992784|FG002|Up to Week 52|Adverse Event|3|||
170451811|NCT02696031|615992785|FG003|Up to Week 52|Adverse Event|0|||
170451812|NCT02696031|615992786|FG004|Up to Week 52|Adverse Event|0|||
170451813|NCT02696031|615992787|FG005|Up to Week 52|Adverse Event|0|||
170451814|NCT02696031|615992782|FG000|Up to Week 52|Lack of Efficacy|10|||
170887796|NCT04381650|617596034|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
170451815|NCT02696031|615992783|FG001|Up to Week 52|Lack of Efficacy|7|||
170451816|NCT02696031|615992784|FG002|Up to Week 52|Lack of Efficacy|11|||
170451817|NCT02696031|615992785|FG003|Up to Week 52|Lack of Efficacy|0|||
170451818|NCT02696031|615992786|FG004|Up to Week 52|Lack of Efficacy|0|||
170451819|NCT02696031|615992787|FG005|Up to Week 52|Lack of Efficacy|0|||
170451820|NCT02696031|615992782|FG000|Up to Week 52|Lost to Follow-up|1|||
170451821|NCT02696031|615992783|FG001|Up to Week 52|Lost to Follow-up|1|||
170451822|NCT02696031|615992784|FG002|Up to Week 52|Lost to Follow-up|1|||
170451823|NCT02696031|615992785|FG003|Up to Week 52|Lost to Follow-up|0|||
170451824|NCT02696031|615992786|FG004|Up to Week 52|Lost to Follow-up|0|||
170451825|NCT02696031|615992787|FG005|Up to Week 52|Lost to Follow-up|0|||
170451826|NCT02696031|615992782|FG000|Up to Week 52|Physician Decision|1|||
170451827|NCT02696031|615992783|FG001|Up to Week 52|Physician Decision|1|||
170451828|NCT02696031|615992784|FG002|Up to Week 52|Physician Decision|2|||
170451829|NCT02696031|615992785|FG003|Up to Week 52|Physician Decision|0|||
170451830|NCT02696031|615992786|FG004|Up to Week 52|Physician Decision|0|||
170451831|NCT02696031|615992787|FG005|Up to Week 52|Physician Decision|0|||
170451832|NCT02696031|615992782|FG000|Up to Week 52|Pregnancy|0|||
170451833|NCT02696031|615992783|FG001|Up to Week 52|Pregnancy|2|||
170451834|NCT02696031|615992784|FG002|Up to Week 52|Pregnancy|0|||
170451835|NCT02696031|615992785|FG003|Up to Week 52|Pregnancy|0|||
170451836|NCT02696031|615992786|FG004|Up to Week 52|Pregnancy|0|||
170451837|NCT02696031|615992787|FG005|Up to Week 52|Pregnancy|0|||
170451838|NCT02696031|615992782|FG000|Up to Week 52|Protocol Violation|1|||
170451839|NCT02696031|615992783|FG001|Up to Week 52|Protocol Violation|0|||
170451840|NCT02696031|615992784|FG002|Up to Week 52|Protocol Violation|0|||
170451841|NCT02696031|615992785|FG003|Up to Week 52|Protocol Violation|0|||
170451842|NCT02696031|615992786|FG004|Up to Week 52|Protocol Violation|0|||
170451843|NCT02696031|615992787|FG005|Up to Week 52|Protocol Violation|0|||
170451844|NCT02696031|615992782|FG000|Up to Week 52|Withdrawal by Subject|12|||
170451845|NCT02696031|615992783|FG001|Up to Week 52|Withdrawal by Subject|3|||
170451846|NCT02696031|615992784|FG002|Up to Week 52|Withdrawal by Subject|9|||
170451847|NCT02696031|615992785|FG003|Up to Week 52|Withdrawal by Subject|0|||
170451848|NCT02696031|615992786|FG004|Up to Week 52|Withdrawal by Subject|0|||
170451849|NCT02696031|615992787|FG005|Up to Week 52|Withdrawal by Subject|0|||
170451850|NCT02696031|615992782|FG000|Up to Week 104|Pregnancy|0|||
170451851|NCT02696031|615992783|FG001|Up to Week 104|Pregnancy|2|||
170451852|NCT02696031|615992784|FG002|Up to Week 104|Pregnancy|1|||
170451853|NCT02696031|615992785|FG003|Up to Week 104|Pregnancy|0|||
170451854|NCT02696031|615992786|FG004|Up to Week 104|Pregnancy|0|||
170451855|NCT02696031|615992787|FG005|Up to Week 104|Pregnancy|0|||
170451856|NCT02696031|615992782|FG000|Up to Week 104|Withdrawal by Subject|15|||
170451857|NCT02696031|615992783|FG001|Up to Week 104|Withdrawal by Subject|10|||
170451858|NCT02696031|615992784|FG002|Up to Week 104|Withdrawal by Subject|16|||
170451859|NCT02696031|615992785|FG003|Up to Week 104|Withdrawal by Subject|0|||
170451860|NCT02696031|615992786|FG004|Up to Week 104|Withdrawal by Subject|0|||
170451861|NCT02696031|615992787|FG005|Up to Week 104|Withdrawal by Subject|0|||
170451862|NCT02696031|615992782|FG000|Up to Week 104|Protocol Violation|1|||
170451863|NCT02696031|615992783|FG001|Up to Week 104|Protocol Violation|0|||
170451864|NCT02696031|615992784|FG002|Up to Week 104|Protocol Violation|0|||
170451865|NCT02696031|615992785|FG003|Up to Week 104|Protocol Violation|0|||
170451866|NCT02696031|615992786|FG004|Up to Week 104|Protocol Violation|0|||
170451867|NCT02696031|615992787|FG005|Up to Week 104|Protocol Violation|0|||
170451868|NCT02696031|615992782|FG000|Up to Week 104|Physician Decision|1|||
170451869|NCT02696031|615992783|FG001|Up to Week 104|Physician Decision|2|||
170451870|NCT02696031|615992784|FG002|Up to Week 104|Physician Decision|3|||
170451871|NCT02696031|615992785|FG003|Up to Week 104|Physician Decision|0|||
170451872|NCT02696031|615992786|FG004|Up to Week 104|Physician Decision|0|||
170451873|NCT02696031|615992787|FG005|Up to Week 104|Physician Decision|0|||
170451874|NCT02696031|615992782|FG000|Up to Week 104|Lost to Follow-up|2|||
170451875|NCT02696031|615992783|FG001|Up to Week 104|Lost to Follow-up|3|||
170451876|NCT02696031|615992784|FG002|Up to Week 104|Lost to Follow-up|1|||
170634601|NCT01588522|616672029|FG001|Overall Study|Grade 2 alopecia|0|||
170634602|NCT01588522|616672030|FG002|Overall Study|Grade 2 alopecia|0|||
170634603|NCT01588522|616672031|FG003|Overall Study|Grade 2 alopecia|0|||
170634604|NCT01588522|616672032|FG004|Overall Study|Grade 2 alopecia|0|||
170634605|NCT01588522|616672033|FG005|Overall Study|Grade 2 alopecia|0|||
170634606|NCT01588522|616672028|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
170634607|NCT01588522|616672029|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
170634608|NCT01588522|616672030|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
170634609|NCT01588522|616672031|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
170634610|NCT01588522|616672032|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
170634611|NCT01588522|616672033|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
170634612|NCT01588522|616672028|FG000|Overall Study|Taken off taxane-based regimen|0|||
170634613|NCT01588522|616672029|FG001|Overall Study|Taken off taxane-based regimen|0|||
170634614|NCT01588522|616672030|FG002|Overall Study|Taken off taxane-based regimen|0|||
170634615|NCT01588522|616672031|FG003|Overall Study|Taken off taxane-based regimen|1|||
170634616|NCT01588522|616672032|FG004|Overall Study|Taken off taxane-based regimen|0|||
170634617|NCT01588522|616672033|FG005|Overall Study|Taken off taxane-based regimen|0|||
170634618|NCT01588522|616672028|FG000|Overall Study|Did not initiate chemotherapy|0|||
170634619|NCT01588522|616672029|FG001|Overall Study|Did not initiate chemotherapy|0|||
170634620|NCT01588522|616672030|FG002|Overall Study|Did not initiate chemotherapy|0|||
170634621|NCT01588522|616672031|FG003|Overall Study|Did not initiate chemotherapy|0|||
170634622|NCT01588522|616672032|FG004|Overall Study|Did not initiate chemotherapy|1|||
170634623|NCT01588522|616672033|FG005|Overall Study|Did not initiate chemotherapy|0|||
170634624|NCT02991768|616672034|FG000|Overall Study|Physician Decision|4|||
170634625|NCT05786651|616672039|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
170634626|NCT02855125|616672040|FG000|Overall Study|Withdrawal by Subject|2|||
170634627|NCT02855125|616672041|FG001|Overall Study|Withdrawal by Subject|2|||
170634628|NCT02855125|616672040|FG000|Overall Study|Clinical Disease Progression|5|||
170634629|NCT02855125|616672041|FG001|Overall Study|Clinical Disease Progression|4|||
170634630|NCT02855125|616672040|FG000|Overall Study|Radiologic Disease Progression|36|||
170634631|NCT02855125|616672041|FG001|Overall Study|Radiologic Disease Progression|39|||
170634632|NCT02855125|616672040|FG000|Overall Study|Adverse Event|11|||
170634633|NCT02855125|616672041|FG001|Overall Study|Adverse Event|7|||
170634634|NCT02855125|616672040|FG000|Overall Study|Physician Decision|1|||
170634635|NCT02855125|616672041|FG001|Overall Study|Physician Decision|0|||
170634636|NCT02855125|616672040|FG000|Overall Study|On Treatment|9|||
170634637|NCT02855125|616672041|FG001|Overall Study|On Treatment|11|||
170634638|NCT02855125|616672040|FG000|Overall Study|Randomized but not treated|0|||
170634639|NCT02855125|616672041|FG001|Overall Study|Randomized but not treated|1|||
170451877|NCT02696031|615992785|FG003|Up to Week 104|Lost to Follow-up|0|||
170451878|NCT02696031|615992786|FG004|Up to Week 104|Lost to Follow-up|0|||
170451879|NCT02696031|615992787|FG005|Up to Week 104|Lost to Follow-up|0|||
170451880|NCT02696031|615992782|FG000|Up to Week 104|Lack of Efficacy|13|||
170451881|NCT02696031|615992783|FG001|Up to Week 104|Lack of Efficacy|12|||
170541584|NCT03215030|616328035|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
170541585|NCT03215030|616328036|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
170541586|NCT03215030|616328037|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
170634640|NCT01442103|616673201|FG000|Overall Study|Lost to Follow-up|2|||
170634641|NCT03207763|616673205|FG000|Overall Study|Lost to Follow-up|1|||
170634642|NCT03207763|616673206|FG001|Overall Study|Lost to Follow-up|0|||
170451882|NCT02696031|615992784|FG002|Up to Week 104|Lack of Efficacy|11|||
170451883|NCT02696031|615992785|FG003|Up to Week 104|Lack of Efficacy|0|||
170451884|NCT02696031|615992786|FG004|Up to Week 104|Lack of Efficacy|0|||
170541587|NCT03215030|616328038|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
170541588|NCT03215030|616328039|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
170541589|NCT03215030|616328040|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
170541590|NCT03215030|616328041|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
170541591|NCT03215030|616328030|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
170634643|NCT02102204|616673207|FG000|Overall Study|Withdrawal by Subject|137|||
170634644|NCT02102204|616673207|FG000|Overall Study|Death|92|||
170541592|NCT03215030|616328031|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
170634645|NCT02102204|616673207|FG000|Overall Study|Lost to Follow-up|65|||
170634646|NCT02102204|616673207|FG000|Overall Study|Sponsor Decision|5|||
170634647|NCT02102204|616673207|FG000|Overall Study|Ongoing|5|||
170541593|NCT03215030|616328032|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
170541594|NCT03215030|616328033|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
170541595|NCT03215030|616328034|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
170787136|NCT04137289|617229673|FG004|Overall Study|Objective disease progression|12|||
170787137|NCT04137289|617229674|FG005|Overall Study|Objective disease progression|20|||
170451885|NCT02696031|615992787|FG005|Up to Week 104|Lack of Efficacy|0|||
170541596|NCT03215030|616328035|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
170541597|NCT03215030|616328036|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
170451886|NCT02696031|615992782|FG000|Up to Week 104|Adverse Event|7|||
170541598|NCT03215030|616328037|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
170634648|NCT02605122|616673208|FG000|Overall Study|Withdrawal by Subject|4|||
170451887|NCT02696031|615992783|FG001|Up to Week 104|Adverse Event|11|||
170451888|NCT02696031|615992784|FG002|Up to Week 104|Adverse Event|5|||
170451889|NCT02696031|615992785|FG003|Up to Week 104|Adverse Event|0|||
170451890|NCT02696031|615992786|FG004|Up to Week 104|Adverse Event|0|||
170451891|NCT02696031|615992787|FG005|Up to Week 104|Adverse Event|0|||
170451892|NCT02696031|615992782|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
170451893|NCT02696031|615992783|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
170451894|NCT02696031|615992784|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
170451895|NCT02696031|615992785|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
170451896|NCT02696031|615992786|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
170451897|NCT02696031|615992787|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
170451898|NCT02696031|615992782|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
170451899|NCT02696031|615992783|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
170451900|NCT02696031|615992784|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
170451901|NCT02696031|615992785|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
170451902|NCT02696031|615992786|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
170451903|NCT02696031|615992787|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
170451904|NCT02696031|615992782|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
170451905|NCT02696031|615992783|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
170451906|NCT02696031|615992784|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
170451907|NCT02696031|615992785|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
170451908|NCT02696031|615992786|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
170451909|NCT02696031|615992787|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
170451910|NCT02696031|615992782|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
170451911|NCT02696031|615992783|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
170451912|NCT02696031|615992784|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
170451913|NCT02696031|615992785|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
170451914|NCT02696031|615992786|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
170451915|NCT02696031|615992787|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
170451916|NCT02696031|615992782|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
170451917|NCT02696031|615992783|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
170451918|NCT02696031|615992784|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
170451919|NCT02696031|615992785|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
170451920|NCT02696031|615992786|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
170451921|NCT02696031|615992787|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
170451922|NCT02696031|615992782|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
170451923|NCT02696031|615992783|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
170451924|NCT02696031|615992784|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
170451925|NCT02696031|615992785|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
170451926|NCT02696031|615992786|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
170451927|NCT02696031|615992787|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
170451928|NCT02696031|615992782|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
170451929|NCT02696031|615992783|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
170451930|NCT02696031|615992784|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
170451931|NCT02696031|615992785|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
170451932|NCT02696031|615992786|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
170451933|NCT02696031|615992787|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
170451934|NCT04403763|615992788|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
170451935|NCT04403763|615992789|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
170451936|NCT04403763|615992790|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
170887797|NCT04381650|617596035|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
170887798|NCT04381650|617596036|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
170451937|NCT04403763|615992791|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
170451938|NCT04403763|615992792|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
170451939|NCT04403763|615992793|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
170451940|NCT04403763|615992794|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
170451941|NCT04403763|615992788|FG000|Stage 1|Early termination due to PK tube failure|0|||
170451942|NCT04403763|615992789|FG001|Stage 1|Early termination due to PK tube failure|0|||
170451943|NCT04403763|615992790|FG002|Stage 1|Early termination due to PK tube failure|1|||
170451944|NCT04403763|615992791|FG003|Stage 1|Early termination due to PK tube failure|0|||
170451945|NCT04403763|615992792|FG004|Stage 1|Early termination due to PK tube failure|0|||
170451946|NCT04403763|615992793|FG005|Stage 1|Early termination due to PK tube failure|0|||
170451947|NCT04403763|615992794|FG006|Stage 1|Early termination due to PK tube failure|0|||
170887799|NCT04381650|617596037|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
170887800|NCT04381650|617596038|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
170451948|NCT04403763|615992788|FG000|Stage 2A|Adverse Event|0|||
170451949|NCT04403763|615992789|FG001|Stage 2A|Adverse Event|0|||
170451950|NCT04403763|615992790|FG002|Stage 2A|Adverse Event|0|||
170451951|NCT04403763|615992791|FG003|Stage 2A|Adverse Event|0|||
170451952|NCT04403763|615992792|FG004|Stage 2A|Adverse Event|0|||
170451953|NCT04403763|615992793|FG005|Stage 2A|Adverse Event|0|||
170451954|NCT04403763|615992794|FG006|Stage 2A|Adverse Event|1|||
170451955|NCT00350402|615992795|FG000|Overall Study|Lost to Follow-up|1|||
170451956|NCT00350402|615992796|FG001|Overall Study|Lost to Follow-up|1|||
170451957|NCT01376310|615992797|FG000|Overall Study|Study closed/terminated|1|||
170451958|NCT01376310|615992798|FG001|Overall Study|Study closed/terminated|2|||
170451959|NCT01376310|615992797|FG000|Overall Study|Withdrawal by Subject|8|||
170451960|NCT01376310|615992798|FG001|Overall Study|Withdrawal by Subject|2|||
170451961|NCT01376310|615992797|FG000|Overall Study|Physician Decision|26|||
170451962|NCT01376310|615992798|FG001|Overall Study|Physician Decision|7|||
170451963|NCT01376310|615992797|FG000|Overall Study|Lost to Follow-up|1|||
170451964|NCT01376310|615992798|FG001|Overall Study|Lost to Follow-up|0|||
170451965|NCT04099641|615992799|FG000|Overall Study|Death|46|||
170451966|NCT04099641|615992800|FG001|Overall Study|Death|12|||
170451967|NCT04099641|615992799|FG000|Overall Study|Lost to Follow-up|1|||
170451968|NCT04099641|615992800|FG001|Overall Study|Lost to Follow-up|0|||
170451969|NCT04099641|615992799|FG000|Overall Study|Withdrawal by Subject|2|||
170451970|NCT04099641|615992800|FG001|Overall Study|Withdrawal by Subject|0|||
170451971|NCT00645944|615992801|FG000|Randomized|Withdrawal by Subject|1|||
170451972|NCT00645944|615992802|FG001|Randomized|Withdrawal by Subject|2|||
170451973|NCT00645944|615992801|FG000|Received Medication|Adverse Event|2|||
170451974|NCT00645944|615992802|FG001|Received Medication|Adverse Event|1|||
170451975|NCT00645944|615992801|FG000|Received Medication|Withdrawal by Subject|1|||
170451976|NCT00645944|615992802|FG001|Received Medication|Withdrawal by Subject|1|||
170451977|NCT00645944|615992801|FG000|Received Medication|Lost to Follow-up|1|||
170451978|NCT00645944|615992802|FG001|Received Medication|Lost to Follow-up|0|||
170451979|NCT00645944|615992801|FG000|Received Medication|Protocol Violation|2|||
170451980|NCT00645944|615992802|FG001|Received Medication|Protocol Violation|1|||
170451981|NCT02339740|615992803|FG000|Overall Study|Death|1|||
170451982|NCT02339740|615992804|FG001|Overall Study|Death|0|||
170787138|NCT04137289|617229675|FG006|Overall Study|Objective disease progression|18|||
170787139|NCT04137289|617229676|FG007|Overall Study|Objective disease progression|7|||
170787140|NCT04137289|617229677|FG008|Overall Study|Objective disease progression|6|||
170787141|NCT05386030|617229680|FG000|Overall Study|Death|1|||
170787142|NCT05386030|617229681|FG001|Overall Study|Death|0|||
170451983|NCT02339740|615992803|FG000|Overall Study|Physician Decision|0|||
170451984|NCT02339740|615992804|FG001|Overall Study|Physician Decision|2|||
170451985|NCT02339740|615992803|FG000|Overall Study|Withdrawal by Subject|5|||
170787143|NCT05386030|617229680|FG000|Overall Study|Physician Decision|2|||
170787144|NCT05386030|617229681|FG001|Overall Study|Physician Decision|1|||
170787145|NCT05386030|617229680|FG000|Overall Study|Lost to Follow-up|19|||
170787146|NCT05386030|617229681|FG001|Overall Study|Lost to Follow-up|7|||
170787147|NCT05386030|617229680|FG000|Overall Study|Withdrawal by Subject|20|||
170787148|NCT05386030|617229681|FG001|Overall Study|Withdrawal by Subject|10|||
170787149|NCT05386030|617229680|FG000|Overall Study|Eligibility criteria violation|1|||
170451986|NCT02339740|615992804|FG001|Overall Study|Withdrawal by Subject|1|||
170451987|NCT02339740|615992803|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
170451988|NCT02339740|615992804|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
170451989|NCT02470091|615992805|FG000|Overall Study|Withdrawal by Subject|1|||
170451990|NCT02470091|615992806|FG001|Overall Study|Withdrawal by Subject|0|||
170451991|NCT02470091|615992805|FG000|Overall Study|Ineligible|0|||
170451992|NCT02470091|615992806|FG001|Overall Study|Ineligible|2|||
170451993|NCT01807117|615992808|FG000|Overall Study|Physician Decision|2|||
170451994|NCT01807117|615992808|FG000|Overall Study|Disease diagnosis not a study disease|1|||
170451995|NCT02610816|615992811|FG000|Phase 1|Withdrawal by Subject|2|||
170451996|NCT02610816|615992812|FG001|Phase 1|Withdrawal by Subject|6|||
170451997|NCT02610816|615992813|FG002|Phase 1|Withdrawal by Subject|0|||
170451998|NCT02610816|615992814|FG003|Phase 1|Withdrawal by Subject|0|||
170451999|NCT02610816|615992811|FG000|Phase 1|Lost to Follow-up|2|||
170452000|NCT02610816|615992812|FG001|Phase 1|Lost to Follow-up|1|||
170452001|NCT02610816|615992813|FG002|Phase 1|Lost to Follow-up|0|||
170452002|NCT02610816|615992814|FG003|Phase 1|Lost to Follow-up|0|||
170452003|NCT02610816|615992811|FG000|Phase 1|Physician Decision|0|||
170452004|NCT02610816|615992812|FG001|Phase 1|Physician Decision|1|||
170452005|NCT02610816|615992813|FG002|Phase 1|Physician Decision|0|||
170452006|NCT02610816|615992814|FG003|Phase 1|Physician Decision|0|||
170452007|NCT02610816|615992811|FG000|Phase 2|Withdrawal by Subject|0|||
170452008|NCT02610816|615992812|FG001|Phase 2|Withdrawal by Subject|0|||
170452009|NCT02610816|615992813|FG002|Phase 2|Withdrawal by Subject|9|||
170452010|NCT02610816|615992814|FG003|Phase 2|Withdrawal by Subject|3|||
170452011|NCT02610816|615992811|FG000|Phase 2|Lost to Follow-up|0|||
170452012|NCT02610816|615992812|FG001|Phase 2|Lost to Follow-up|0|||
170452013|NCT02610816|615992813|FG002|Phase 2|Lost to Follow-up|2|||
170452014|NCT02610816|615992814|FG003|Phase 2|Lost to Follow-up|0|||
170452015|NCT02610816|615992811|FG000|Phase 2|Physician Decision|0|||
170541599|NCT03215030|616328038|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
170541600|NCT03215030|616328039|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
170541601|NCT03215030|616328040|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
170541602|NCT03215030|616328041|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
170541603|NCT03215030|616328030|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170452016|NCT02610816|615992812|FG001|Phase 2|Physician Decision|0|||
170452017|NCT02610816|615992813|FG002|Phase 2|Physician Decision|0|||
170452018|NCT02610816|615992814|FG003|Phase 2|Physician Decision|2|||
170452019|NCT02610816|615992811|FG000|Phase 2|Pregnancy|0|||
170452020|NCT02610816|615992812|FG001|Phase 2|Pregnancy|0|||
170452021|NCT02610816|615992813|FG002|Phase 2|Pregnancy|0|||
170452022|NCT02610816|615992814|FG003|Phase 2|Pregnancy|1|||
170452023|NCT03545191|615992816|FG000|Overall Study|Death|1|||
170452024|NCT03545191|615992817|FG001|Overall Study|Death|0|||
170452025|NCT03545191|615992818|FG002|Overall Study|Death|0|||
170452026|NCT03545191|615992816|FG000|Overall Study|Adverse Event|4|||
170452027|NCT03545191|615992817|FG001|Overall Study|Adverse Event|2|||
170452028|NCT03545191|615992818|FG002|Overall Study|Adverse Event|7|||
170452029|NCT03545191|615992816|FG000|Overall Study|Other reasons|3|||
170452030|NCT03545191|615992817|FG001|Overall Study|Other reasons|11|||
170452031|NCT03545191|615992818|FG002|Overall Study|Other reasons|8|||
170452032|NCT03545191|615992816|FG000|Overall Study|Withdrawal by Subject|13|||
170452033|NCT03545191|615992817|FG001|Overall Study|Withdrawal by Subject|10|||
170452034|NCT03545191|615992818|FG002|Overall Study|Withdrawal by Subject|12|||
170452035|NCT03545191|615992816|FG000|Overall Study|Lost to Follow-up|1|||
170452036|NCT03545191|615992817|FG001|Overall Study|Lost to Follow-up|2|||
170452037|NCT03545191|615992818|FG002|Overall Study|Lost to Follow-up|3|||
170452038|NCT01277718|615992821|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
170452039|NCT01277718|615992822|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
170452040|NCT01277718|615992821|FG000|Period 2 - Second Intervention|Physician Decision|0|||
170452041|NCT01277718|615992822|FG001|Period 2 - Second Intervention|Physician Decision|2|||
170452042|NCT03919162|615992823|FG000|Overall Study|Adverse Event|3|||
170452043|NCT03919162|615992824|FG001|Overall Study|Adverse Event|2|||
170452044|NCT03919162|615992823|FG000|Overall Study|Death|2|||
170452045|NCT03919162|615992824|FG001|Overall Study|Death|0|||
170452046|NCT03919162|615992823|FG000|Overall Study|Lost to Follow-up|1|||
170452047|NCT03919162|615992824|FG001|Overall Study|Lost to Follow-up|0|||
170452048|NCT03919162|615992823|FG000|Overall Study|Withdrawal by Subject|12|||
170541604|NCT03215030|616328031|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170541605|NCT03215030|616328032|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170887801|NCT04381650|617596039|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
170887802|NCT04381650|617596029|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
170452049|NCT03919162|615992824|FG001|Overall Study|Withdrawal by Subject|12|||
170452050|NCT03919162|615992823|FG000|Overall Study|Study terminated by Sponsor|20|||
170452051|NCT03919162|615992824|FG001|Overall Study|Study terminated by Sponsor|24|||
170452052|NCT03919162|615992823|FG000|Overall Study|Screen failure|1|||
170452053|NCT03919162|615992824|FG001|Overall Study|Screen failure|0|||
170452054|NCT03919162|615992823|FG000|Overall Study|Missing|1|||
170452055|NCT03919162|615992824|FG001|Overall Study|Missing|1|||
170452056|NCT02149121|615992825|FG000|Main Study Period|Lack of Efficacy|2|||
170452057|NCT02149121|615992826|FG001|Main Study Period|Lack of Efficacy|2|||
170452058|NCT02149121|615992827|FG002|Main Study Period|Lack of Efficacy|1|||
170452059|NCT02149121|615992828|FG003|Main Study Period|Lack of Efficacy|0|||
170452060|NCT02149121|615992829|FG004|Main Study Period|Lack of Efficacy|0|||
170452061|NCT02149121|615992830|FG005|Main Study Period|Lack of Efficacy|0|||
170452062|NCT02149121|615992831|FG006|Main Study Period|Lack of Efficacy|0|||
170452063|NCT02149121|615992825|FG000|Main Study Period|Withdrawal by Subject|9|||
170452064|NCT02149121|615992826|FG001|Main Study Period|Withdrawal by Subject|5|||
170452065|NCT02149121|615992827|FG002|Main Study Period|Withdrawal by Subject|1|||
170452066|NCT02149121|615992828|FG003|Main Study Period|Withdrawal by Subject|0|||
170452067|NCT02149121|615992829|FG004|Main Study Period|Withdrawal by Subject|0|||
170452068|NCT02149121|615992830|FG005|Main Study Period|Withdrawal by Subject|0|||
170452069|NCT02149121|615992831|FG006|Main Study Period|Withdrawal by Subject|0|||
170452070|NCT02149121|615992825|FG000|Main Study Period|Adverse Event|2|||
170452071|NCT02149121|615992826|FG001|Main Study Period|Adverse Event|5|||
170452072|NCT02149121|615992827|FG002|Main Study Period|Adverse Event|1|||
170452073|NCT02149121|615992828|FG003|Main Study Period|Adverse Event|0|||
170452074|NCT02149121|615992829|FG004|Main Study Period|Adverse Event|0|||
170452075|NCT02149121|615992830|FG005|Main Study Period|Adverse Event|0|||
170452076|NCT02149121|615992831|FG006|Main Study Period|Adverse Event|0|||
170452077|NCT02149121|615992825|FG000|Main Study Period|Protocol Violation|2|||
170452078|NCT02149121|615992826|FG001|Main Study Period|Protocol Violation|0|||
170452079|NCT02149121|615992827|FG002|Main Study Period|Protocol Violation|0|||
170452080|NCT02149121|615992828|FG003|Main Study Period|Protocol Violation|0|||
170452081|NCT02149121|615992829|FG004|Main Study Period|Protocol Violation|0|||
170452082|NCT02149121|615992830|FG005|Main Study Period|Protocol Violation|0|||
170452083|NCT02149121|615992831|FG006|Main Study Period|Protocol Violation|0|||
170452084|NCT02149121|615992825|FG000|Main Study Period|Lost to Follow-up|2|||
170452085|NCT02149121|615992826|FG001|Main Study Period|Lost to Follow-up|1|||
170452086|NCT02149121|615992827|FG002|Main Study Period|Lost to Follow-up|0|||
170452087|NCT02149121|615992828|FG003|Main Study Period|Lost to Follow-up|0|||
170452088|NCT02149121|615992829|FG004|Main Study Period|Lost to Follow-up|0|||
170452089|NCT02149121|615992830|FG005|Main Study Period|Lost to Follow-up|0|||
170452090|NCT02149121|615992831|FG006|Main Study Period|Lost to Follow-up|0|||
170452091|NCT02149121|615992825|FG000|Main Study Period|Death|1|||
170452092|NCT02149121|615992826|FG001|Main Study Period|Death|0|||
170452093|NCT02149121|615992827|FG002|Main Study Period|Death|0|||
170452094|NCT02149121|615992828|FG003|Main Study Period|Death|0|||
170452095|NCT02149121|615992829|FG004|Main Study Period|Death|0|||
170452096|NCT02149121|615992830|FG005|Main Study Period|Death|0|||
170452097|NCT02149121|615992831|FG006|Main Study Period|Death|0|||
170452098|NCT02149121|615992825|FG000|Main Study Period|Physician Decision|1|||
170452099|NCT02149121|615992826|FG001|Main Study Period|Physician Decision|0|||
170452100|NCT02149121|615992827|FG002|Main Study Period|Physician Decision|0|||
170452101|NCT02149121|615992828|FG003|Main Study Period|Physician Decision|0|||
170452102|NCT02149121|615992829|FG004|Main Study Period|Physician Decision|0|||
170452103|NCT02149121|615992830|FG005|Main Study Period|Physician Decision|0|||
170452104|NCT02149121|615992831|FG006|Main Study Period|Physician Decision|0|||
170452105|NCT02149121|615992825|FG000|Main Study Period|Developed any malignancy|0|||
170452106|NCT02149121|615992826|FG001|Main Study Period|Developed any malignancy|1|||
170452107|NCT02149121|615992827|FG002|Main Study Period|Developed any malignancy|1|||
170452108|NCT02149121|615992828|FG003|Main Study Period|Developed any malignancy|0|||
170452109|NCT02149121|615992829|FG004|Main Study Period|Developed any malignancy|0|||
170452110|NCT02149121|615992830|FG005|Main Study Period|Developed any malignancy|0|||
170452111|NCT02149121|615992831|FG006|Main Study Period|Developed any malignancy|0|||
170452112|NCT02149121|615992825|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
170452113|NCT02149121|615992826|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
170452114|NCT02149121|615992827|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
170452115|NCT02149121|615992828|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
170452116|NCT02149121|615992829|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
170452117|NCT02149121|615992830|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
170452118|NCT02149121|615992831|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
170887803|NCT04381650|617596030|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
170887804|NCT04381650|617596031|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
170887805|NCT04381650|617596032|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
170887806|NCT04381650|617596033|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
170887807|NCT04381650|617596034|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
170452119|NCT02149121|615992825|FG000|Main Study Period|Disease progression|0|||
170452120|NCT02149121|615992826|FG001|Main Study Period|Disease progression|1|||
170452121|NCT02149121|615992827|FG002|Main Study Period|Disease progression|0|||
170452122|NCT02149121|615992828|FG003|Main Study Period|Disease progression|0|||
170452123|NCT02149121|615992829|FG004|Main Study Period|Disease progression|0|||
170452124|NCT02149121|615992830|FG005|Main Study Period|Disease progression|0|||
170452125|NCT02149121|615992831|FG006|Main Study Period|Disease progression|0|||
170452126|NCT02149121|615992825|FG000|Extension Study Period|Withdrawal by Subject|0|||
170452127|NCT02149121|615992826|FG001|Extension Study Period|Withdrawal by Subject|0|||
170452128|NCT02149121|615992827|FG002|Extension Study Period|Withdrawal by Subject|0|||
170452129|NCT02149121|615992828|FG003|Extension Study Period|Withdrawal by Subject|1|||
170452130|NCT02149121|615992829|FG004|Extension Study Period|Withdrawal by Subject|0|||
170452131|NCT02149121|615992830|FG005|Extension Study Period|Withdrawal by Subject|2|||
170452132|NCT02149121|615992831|FG006|Extension Study Period|Withdrawal by Subject|0|||
170452133|NCT01244061|615992842|FG000|Overall Study|Death|1|||
170452134|NCT01244061|615992843|FG001|Overall Study|Death|0|||
170452135|NCT01244061|615992842|FG000|Overall Study|Did not meet entrance criteria|1|||
170452136|NCT01244061|615992843|FG001|Overall Study|Did not meet entrance criteria|0|||
170452137|NCT01244061|615992842|FG000|Overall Study|Lack of Efficacy|1|||
170452138|NCT01244061|615992843|FG001|Overall Study|Lack of Efficacy|3|||
170452139|NCT01244061|615992842|FG000|Overall Study|Lost to Follow-up|34|||
170452140|NCT01244061|615992843|FG001|Overall Study|Lost to Follow-up|30|||
170452141|NCT01244061|615992842|FG000|Overall Study|Withdrawal by Subject|29|||
170452142|NCT01244061|615992843|FG001|Overall Study|Withdrawal by Subject|46|||
170452143|NCT01244061|615992842|FG000|Overall Study|Other|8|||
170452144|NCT01244061|615992843|FG001|Overall Study|Other|19|||
170452145|NCT01244061|615992842|FG000|Overall Study|Protocol Violation|1|||
170452146|NCT01244061|615992843|FG001|Overall Study|Protocol Violation|1|||
170452147|NCT01244061|615992842|FG000|Overall Study|Adverse Event|5|||
170452148|NCT01244061|615992843|FG001|Overall Study|Adverse Event|2|||
170452149|NCT01244061|615992842|FG000|Overall Study|Randomized but not treated|2|||
170452150|NCT01244061|615992843|FG001|Overall Study|Randomized but not treated|2|||
170452151|NCT03078478|615992846|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
170452152|NCT03078478|615992847|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
170452153|NCT03078478|615992846|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
170452154|NCT03078478|615992847|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
170452155|NCT03078478|615992846|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
170452156|NCT03078478|615992847|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
170452157|NCT03078478|615992846|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
170452158|NCT03078478|615992847|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
170452159|NCT03078478|615992846|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
170452160|NCT03078478|615992847|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
170452161|NCT03078478|615992846|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
170452162|NCT03078478|615992847|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
170452163|NCT03078478|615992846|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
170452164|NCT03078478|615992847|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
170452165|NCT03078478|615992846|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
170452166|NCT03078478|615992847|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
170452167|NCT02858726|615992848|FG000|Overall Study|Adverse Event|4|||
170452168|NCT02858726|615992849|FG001|Overall Study|Adverse Event|4|||
170452169|NCT02858726|615992850|FG002|Overall Study|Adverse Event|9|||
170452170|NCT02858726|615992851|FG003|Overall Study|Adverse Event|1|||
170452171|NCT02858726|615992848|FG000|Overall Study|Physician Decision|0|||
170452172|NCT02858726|615992849|FG001|Overall Study|Physician Decision|0|||
170452173|NCT02858726|615992850|FG002|Overall Study|Physician Decision|1|||
170452174|NCT02858726|615992851|FG003|Overall Study|Physician Decision|0|||
170452175|NCT02858726|615992848|FG000|Overall Study|Protocol Violation|0|||
170452176|NCT02858726|615992849|FG001|Overall Study|Protocol Violation|0|||
170452177|NCT02858726|615992850|FG002|Overall Study|Protocol Violation|0|||
170452178|NCT02858726|615992851|FG003|Overall Study|Protocol Violation|1|||
170452179|NCT02858726|615992848|FG000|Overall Study|Study Terminated by Sponsor|0|||
170452180|NCT02858726|615992849|FG001|Overall Study|Study Terminated by Sponsor|0|||
170452181|NCT02858726|615992850|FG002|Overall Study|Study Terminated by Sponsor|0|||
170452182|NCT02858726|615992851|FG003|Overall Study|Study Terminated by Sponsor|1|||
170452183|NCT02858726|615992848|FG000|Overall Study|Withdrawal by Subject|1|||
170452184|NCT02858726|615992849|FG001|Overall Study|Withdrawal by Subject|2|||
170452185|NCT02858726|615992850|FG002|Overall Study|Withdrawal by Subject|1|||
170452186|NCT02858726|615992851|FG003|Overall Study|Withdrawal by Subject|0|||
170452187|NCT02858726|615992848|FG000|Overall Study|Noncompliance|0|||
170452188|NCT02858726|615992849|FG001|Overall Study|Noncompliance|1|||
170452189|NCT02858726|615992850|FG002|Overall Study|Noncompliance|0|||
170452190|NCT02858726|615992851|FG003|Overall Study|Noncompliance|0|||
170452191|NCT00233987|615992856|FG000|Overall Study|Withdrawal by Subject|1|||
170452192|NCT00233987|615992856|FG000|Overall Study|Lack of Efficacy|2|||
170452193|NCT00233987|615992856|FG000|Overall Study|Reason Under Review|1|||
170452194|NCT00233987|615992856|FG000|Overall Study|Other - Not Protocol Specified|5|||
170452195|NCT00233987|615992856|FG000|Overall Study|Eligible but No Treatment Received|2|||
170452196|NCT00233987|615992856|FG000|Overall Study|Ineligible|4|||
170452197|NCT02756637|615992859|FG000|Overall Study|Not eligible for initial SWOG study|10|||
170452198|NCT02756637|615992860|FG001|Overall Study|Not eligible for initial SWOG study|10|||
170452199|NCT02756637|615992859|FG000|Overall Study|No available NLR value|44|||
170452200|NCT02756637|615992860|FG001|Overall Study|No available NLR value|44|||
170452201|NCT02756637|615992859|FG000|Overall Study|Did not complete curative therapy|33|||
170452202|NCT02756637|615992860|FG001|Overall Study|Did not complete curative therapy|0|||
170452203|NCT00493246|615994531|FG000|Overall Study|Withdrawal by Subject|0|||
170452204|NCT00493246|615994532|FG001|Overall Study|Withdrawal by Subject|0|||
170452205|NCT00493246|615994533|FG002|Overall Study|Withdrawal by Subject|0|||
170452206|NCT00493246|615994534|FG003|Overall Study|Withdrawal by Subject|0|||
170452207|NCT00493246|615994535|FG004|Overall Study|Withdrawal by Subject|1|||
170452208|NCT00493246|615994536|FG005|Overall Study|Withdrawal by Subject|0|||
170452209|NCT00493246|615994537|FG006|Overall Study|Withdrawal by Subject|0|||
170452210|NCT00493246|615994538|FG007|Overall Study|Withdrawal by Subject|0|||
170452211|NCT00493246|615994531|FG000|Overall Study|No access to draw blood|0|||
170452212|NCT00493246|615994532|FG001|Overall Study|No access to draw blood|0|||
170452213|NCT00493246|615994533|FG002|Overall Study|No access to draw blood|0|||
170452214|NCT00493246|615994534|FG003|Overall Study|No access to draw blood|0|||
170452215|NCT00493246|615994535|FG004|Overall Study|No access to draw blood|0|||
170452216|NCT00493246|615994536|FG005|Overall Study|No access to draw blood|1|||
170452217|NCT00493246|615994537|FG006|Overall Study|No access to draw blood|0|||
170452218|NCT00493246|615994538|FG007|Overall Study|No access to draw blood|0|||
170452219|NCT00493246|615994531|FG000|Overall Study|Lost to Follow-up|0|||
170452220|NCT00493246|615994532|FG001|Overall Study|Lost to Follow-up|0|||
170452221|NCT00493246|615994533|FG002|Overall Study|Lost to Follow-up|0|||
170452222|NCT00493246|615994534|FG003|Overall Study|Lost to Follow-up|0|||
170452223|NCT00493246|615994535|FG004|Overall Study|Lost to Follow-up|0|||
170541606|NCT03215030|616328033|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170452224|NCT00493246|615994536|FG005|Overall Study|Lost to Follow-up|0|||
170452225|NCT00493246|615994537|FG006|Overall Study|Lost to Follow-up|1|||
170452226|NCT00493246|615994538|FG007|Overall Study|Lost to Follow-up|0|||
170452227|NCT00595335|615994540|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
170452228|NCT00595335|615994541|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
170541607|NCT03215030|616328034|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170541608|NCT03215030|616328035|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170541609|NCT03215030|616328036|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170541610|NCT03215030|616328037|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170541611|NCT03215030|616328038|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
170541612|NCT03215030|616328039|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
170541613|NCT03215030|616328040|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170541614|NCT03215030|616328041|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
170541615|NCT03215030|616328030|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541616|NCT03215030|616328031|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541617|NCT03215030|616328032|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541618|NCT03215030|616328033|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541619|NCT03215030|616328034|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541620|NCT03215030|616328035|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541621|NCT03215030|616328036|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
170634649|NCT02605122|616673209|FG001|Overall Study|Withdrawal by Subject|1|||
170787150|NCT05386030|617229681|FG001|Overall Study|Eligibility criteria violation|1|||
170787151|NCT05386030|617229680|FG000|Overall Study|Personal Reasons|1|||
170787152|NCT05386030|617229681|FG001|Overall Study|Personal Reasons|0|||
170787153|NCT03161028|617229682|FG000|Overall Study|Withdrawal by Subject|6|||
170787154|NCT03161028|617229683|FG001|Overall Study|Withdrawal by Subject|4|||
170787155|NCT03161028|617229682|FG000|Overall Study|Adverse Event|5|||
170787156|NCT03161028|617229683|FG001|Overall Study|Adverse Event|1|||
170787157|NCT03161028|617229682|FG000|Overall Study|Study drug side effects|2|||
170787158|NCT03161028|617229683|FG001|Overall Study|Study drug side effects|2|||
170787159|NCT03161028|617229682|FG000|Overall Study|Administrative PD/UP|4|||
170787160|NCT03161028|617229683|FG001|Overall Study|Administrative PD/UP|2|||
170787161|NCT03161028|617229682|FG000|Overall Study|Lost to Follow-up|2|||
170787162|NCT03161028|617229683|FG001|Overall Study|Lost to Follow-up|0|||
170787163|NCT03161028|617229682|FG000|Overall Study|Unable to comply with procedures|1|||
170787164|NCT03161028|617229683|FG001|Overall Study|Unable to comply with procedures|1|||
170787165|NCT00736723|617229684|FG000|Overall Study|Withdrawal by Subject|4|||
170787166|NCT00736723|617229685|FG001|Overall Study|Withdrawal by Subject|3|||
170787167|NCT05704543|617229686|FG000|Overall Study|Withdrawal by Subject|1|||
170787168|NCT05704543|617229687|FG001|Overall Study|Withdrawal by Subject|1|||
170787169|NCT05704543|617229688|FG002|Overall Study|Withdrawal by Subject|0|||
170787170|NCT05704543|617229689|FG003|Overall Study|Withdrawal by Subject|2|||
170887808|NCT04381650|617596035|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
170887809|NCT04381650|617596036|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
170887810|NCT04381650|617596037|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
170887811|NCT04381650|617596038|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
170887812|NCT04381650|617596039|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
170887813|NCT04381650|617596029|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170887814|NCT04381650|617596030|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170887815|NCT04381650|617596031|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170887816|NCT04381650|617596032|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170887817|NCT04381650|617596033|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170887818|NCT04381650|617596034|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170887819|NCT04381650|617596035|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170887820|NCT04381650|617596036|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
170887821|NCT04381650|617596037|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
170887822|NCT04381650|617596038|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
170887823|NCT04381650|617596039|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170887824|NCT04381650|617596029|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
170887825|NCT04381650|617596030|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
170887826|NCT04381650|617596031|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
170887827|NCT04381650|617596032|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
170887828|NCT04381650|617596033|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
170887829|NCT04381650|617596034|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
170887830|NCT04381650|617596035|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
170887831|NCT04381650|617596036|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
170887832|NCT04381650|617596037|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
170887833|NCT04381650|617596038|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
170887834|NCT04381650|617596039|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
170634650|NCT02605122|616673208|FG000|Overall Study|Lost to Follow-up|1|||
170634651|NCT02605122|616673209|FG001|Overall Study|Lost to Follow-up|1|||
170541622|NCT03215030|616328037|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541623|NCT03215030|616328038|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
170541624|NCT03215030|616328039|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
170541625|NCT03215030|616328040|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541626|NCT03215030|616328041|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
170541627|NCT03215030|616328030|FG000|Part 3: Dose Extension|Death|0|||
170541628|NCT03215030|616328031|FG001|Part 3: Dose Extension|Death|0|||
170541629|NCT03215030|616328032|FG002|Part 3: Dose Extension|Death|0|||
170541630|NCT03215030|616328033|FG003|Part 3: Dose Extension|Death|0|||
170541631|NCT03215030|616328034|FG004|Part 3: Dose Extension|Death|0|||
170541632|NCT03215030|616328035|FG005|Part 3: Dose Extension|Death|0|||
170541633|NCT03215030|616328036|FG006|Part 3: Dose Extension|Death|0|||
170541634|NCT03215030|616328037|FG007|Part 3: Dose Extension|Death|0|||
170541635|NCT03215030|616328038|FG008|Part 3: Dose Extension|Death|19|||
170541636|NCT03215030|616328039|FG009|Part 3: Dose Extension|Death|20|||
170541637|NCT03215030|616328040|FG010|Part 3: Dose Extension|Death|0|||
170541638|NCT03215030|616328041|FG011|Part 3: Dose Extension|Death|0|||
170541639|NCT03215030|616328030|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
170541640|NCT03215030|616328031|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
170541641|NCT03215030|616328032|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
170541642|NCT03215030|616328033|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
170541643|NCT03215030|616328034|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
170541644|NCT03215030|616328035|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
170541645|NCT03215030|616328036|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
170541646|NCT03215030|616328037|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
170541647|NCT03215030|616328038|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
170541648|NCT03215030|616328039|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
170541649|NCT03215030|616328040|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
170541650|NCT03215030|616328041|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
170541651|NCT03215030|616328030|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170541652|NCT03215030|616328031|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170541653|NCT03215030|616328032|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170887835|NCT04381650|617596029|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
170887836|NCT04381650|617596030|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
170887837|NCT04381650|617596031|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
170541654|NCT03215030|616328033|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170541655|NCT03215030|616328034|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170541656|NCT03215030|616328035|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170541657|NCT03215030|616328036|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170634652|NCT02331277|616673210|FG000|Overall Study|Withdrawal by Subject|1|||
170887838|NCT04381650|617596032|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
170887839|NCT04381650|617596033|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
170887840|NCT04381650|617596034|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
170887841|NCT04381650|617596035|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
170887842|NCT04381650|617596036|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
170887843|NCT04381650|617596037|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
170887844|NCT04381650|617596038|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
170887845|NCT04381650|617596039|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
170887846|NCT04381650|617596029|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887847|NCT04381650|617596030|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887848|NCT04381650|617596031|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887849|NCT04381650|617596032|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887850|NCT04381650|617596033|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887851|NCT04381650|617596034|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887852|NCT04381650|617596035|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887853|NCT04381650|617596036|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
170887854|NCT04381650|617596037|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887855|NCT04381650|617596038|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887856|NCT04381650|617596039|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
170887857|NCT05416138|617598173|FG000|Overall Study|Withdrawal by Subject|2|||
170887858|NCT05416138|617598174|FG001|Overall Study|Withdrawal by Subject|1|||
170887859|NCT04705051|617598175|FG000|Overall Study|Enrolled but not treated|1|||
170887860|NCT04705051|617598175|FG000|Overall Study|Study terminated by sponsor|23|||
170887861|NCT03686397|617598176|FG000|Overall Study|Lack of Efficacy|3|||
170887862|NCT03686397|617598177|FG001|Overall Study|Lack of Efficacy|5|||
170887863|NCT03686397|617598176|FG000|Overall Study|Adverse Event|0|||
170887864|NCT03686397|617598177|FG001|Overall Study|Adverse Event|1|||
170452229|NCT00595335|615994540|FG000|Baseline to Six Months|Disease Progression|1|||
170452230|NCT00595335|615994541|FG001|Baseline to Six Months|Disease Progression|1|||
170452231|NCT00595335|615994540|FG000|Baseline to Six Months|Adverse Event|1|||
170452232|NCT00595335|615994541|FG001|Baseline to Six Months|Adverse Event|0|||
170452233|NCT00595335|615994540|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
170452234|NCT00595335|615994541|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
170452235|NCT00595335|615994540|FG000|Six Months to Twelve Months|Disease Progression|1|||
170452236|NCT00595335|615994541|FG001|Six Months to Twelve Months|Disease Progression|0|||
170452237|NCT00493779|615994546|FG000|Overall Study|Logistical issue at site|1|||
170452238|NCT01647958|615994547|FG000|Initial Study|Lost to Follow-up|2|||
170452239|NCT01647958|615994548|FG001|Initial Study|Lost to Follow-up|3|||
170452240|NCT01647958|615994547|FG000|Continuation Phase|treatment received during Overall Study|39|||
170452241|NCT01647958|615994548|FG001|Continuation Phase|treatment received during Overall Study|0|||
170452242|NCT01647958|615994547|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
170452243|NCT01647958|615994548|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
170787171|NCT05704543|617229686|FG000|Overall Study|Lost to Follow-up|1|||
170452244|NCT01131299|615994549|FG000|Overall Study|Withdrawal by Subject|4|||
170452245|NCT01131299|615994550|FG001|Overall Study|Withdrawal by Subject|7|||
170452246|NCT01207440|615994558|FG000|Overall Study|Adverse Event|46|||
170452247|NCT01207440|615994559|FG001|Overall Study|Adverse Event|11|||
170541658|NCT03215030|616328037|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170787172|NCT05704543|617229687|FG001|Overall Study|Lost to Follow-up|2|||
170787173|NCT05704543|617229688|FG002|Overall Study|Lost to Follow-up|0|||
170787174|NCT05704543|617229689|FG003|Overall Study|Lost to Follow-up|0|||
170787175|NCT05251909|617231704|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
170787176|NCT05251909|617231705|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
170787177|NCT02677298|617231708|FG000|Double Blind Phase|Adverse Event|2|||
170787178|NCT02677298|617231709|FG001|Double Blind Phase|Adverse Event|1|||
170787179|NCT02677298|617231710|FG002|Double Blind Phase|Adverse Event|0|||
170787180|NCT02677298|617231708|FG000|Double Blind Phase|Physician Decision|5|||
170787181|NCT02677298|617231709|FG001|Double Blind Phase|Physician Decision|0|||
170787182|NCT02677298|617231710|FG002|Double Blind Phase|Physician Decision|0|||
170787183|NCT02677298|617231708|FG000|Double Blind Phase|Lost to Follow-up|11|||
170787184|NCT02677298|617231709|FG001|Double Blind Phase|Lost to Follow-up|7|||
170541659|NCT03215030|616328038|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170541660|NCT03215030|616328039|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
170541661|NCT03215030|616328040|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
170541662|NCT03215030|616328041|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
170787185|NCT02677298|617231710|FG002|Double Blind Phase|Lost to Follow-up|0|||
170887865|NCT03686397|617598176|FG000|Overall Study|Protocol Violation|0|||
170452248|NCT01207440|615994560|FG002|Overall Study|Adverse Event|7|||
170541663|NCT01239745|616328045|FG000|Overall Study|Study terminated by sponsor|45|||
170787186|NCT02677298|617231708|FG000|Double Blind Phase|Withdrawal by Subject|11|||
170452249|NCT01207440|615994561|FG003|Overall Study|Adverse Event|2|||
170787187|NCT02677298|617231709|FG001|Double Blind Phase|Withdrawal by Subject|8|||
170887866|NCT03686397|617598177|FG001|Overall Study|Protocol Violation|1|||
170887867|NCT03686397|617598176|FG000|Overall Study|Withdrawal by Subject|0|||
170887868|NCT03686397|617598177|FG001|Overall Study|Withdrawal by Subject|1|||
170887869|NCT03686397|617598176|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
170887870|NCT03686397|617598177|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
170887871|NCT01178138|617598182|FG000|Overall Study|Lost to Follow-up|8|||
170887872|NCT01178138|617598182|FG000|Overall Study|Withdrawal by Subject|7|||
170887873|NCT01178138|617598182|FG000|Overall Study|Physician Decision|8|||
170887874|NCT01777763|617598183|FG000|Overall Study|Adverse Event|2|||
170887875|NCT01777763|617598184|FG001|Overall Study|Adverse Event|32|||
170887876|NCT01777763|617598183|FG000|Overall Study|Protocol Violation|1|||
170887877|NCT01777763|617598184|FG001|Overall Study|Protocol Violation|7|||
170887878|NCT01777763|617598183|FG000|Overall Study|Withdrawal by Subject|0|||
170887879|NCT01777763|617598184|FG001|Overall Study|Withdrawal by Subject|2|||
170887880|NCT01777763|617598183|FG000|Overall Study|Treatment Failure|1|||
170887881|NCT01777763|617598184|FG001|Overall Study|Treatment Failure|6|||
170887882|NCT02787850|617598194|FG000|Overall Study|Withdrawal by Subject|0|||
170887883|NCT02787850|617598195|FG001|Overall Study|Withdrawal by Subject|1|||
170887884|NCT02615990|617598196|FG000|Overall Study|study terminated|1|||
170887885|NCT02615990|617598197|FG001|Overall Study|study terminated|1|||
170887886|NCT02944448|617598204|FG000|Overall Study|Adverse Event|37|||
170887887|NCT02944448|617598205|FG001|Overall Study|Adverse Event|6|||
170887888|NCT02944448|617598204|FG000|Overall Study|Lack of Efficacy|8|||
170452250|NCT01207440|615994562|FG004|Overall Study|Adverse Event|6|||
170452251|NCT01207440|615994563|FG005|Overall Study|Adverse Event|6|||
170452252|NCT01207440|615994564|FG006|Overall Study|Adverse Event|2|||
170452253|NCT01207440|615994558|FG000|Overall Study|Death|6|||
170452254|NCT01207440|615994559|FG001|Overall Study|Death|3|||
170452255|NCT01207440|615994560|FG002|Overall Study|Death|2|||
170452256|NCT01207440|615994561|FG003|Overall Study|Death|2|||
170452257|NCT01207440|615994562|FG004|Overall Study|Death|7|||
170452258|NCT01207440|615994563|FG005|Overall Study|Death|5|||
170452259|NCT01207440|615994564|FG006|Overall Study|Death|1|||
170452260|NCT01207440|615994558|FG000|Overall Study|Lack of Efficacy|13|||
170452261|NCT01207440|615994559|FG001|Overall Study|Lack of Efficacy|2|||
170452262|NCT01207440|615994560|FG002|Overall Study|Lack of Efficacy|5|||
170452263|NCT01207440|615994561|FG003|Overall Study|Lack of Efficacy|1|||
170887889|NCT02944448|617598205|FG001|Overall Study|Lack of Efficacy|5|||
170452264|NCT01207440|615994562|FG004|Overall Study|Lack of Efficacy|2|||
170452265|NCT01207440|615994563|FG005|Overall Study|Lack of Efficacy|3|||
170452266|NCT01207440|615994564|FG006|Overall Study|Lack of Efficacy|0|||
170452267|NCT01207440|615994558|FG000|Overall Study|Lost to Follow-up|0|||
170452268|NCT01207440|615994559|FG001|Overall Study|Lost to Follow-up|0|||
170452269|NCT01207440|615994560|FG002|Overall Study|Lost to Follow-up|2|||
170452270|NCT01207440|615994561|FG003|Overall Study|Lost to Follow-up|1|||
170452271|NCT01207440|615994562|FG004|Overall Study|Lost to Follow-up|0|||
170452272|NCT01207440|615994563|FG005|Overall Study|Lost to Follow-up|0|||
170452273|NCT01207440|615994564|FG006|Overall Study|Lost to Follow-up|0|||
170452274|NCT01207440|615994558|FG000|Overall Study|Non-compliance with Study Drug|3|||
170452275|NCT01207440|615994559|FG001|Overall Study|Non-compliance with Study Drug|0|||
170452276|NCT01207440|615994560|FG002|Overall Study|Non-compliance with Study Drug|1|||
170452277|NCT01207440|615994561|FG003|Overall Study|Non-compliance with Study Drug|0|||
170452278|NCT01207440|615994562|FG004|Overall Study|Non-compliance with Study Drug|0|||
170452279|NCT01207440|615994563|FG005|Overall Study|Non-compliance with Study Drug|0|||
170452280|NCT01207440|615994564|FG006|Overall Study|Non-compliance with Study Drug|0|||
170452281|NCT01207440|615994558|FG000|Overall Study|Physician Decision|6|||
170452282|NCT01207440|615994559|FG001|Overall Study|Physician Decision|5|||
170452283|NCT01207440|615994560|FG002|Overall Study|Physician Decision|5|||
170452284|NCT01207440|615994561|FG003|Overall Study|Physician Decision|0|||
170452285|NCT01207440|615994562|FG004|Overall Study|Physician Decision|1|||
170452286|NCT01207440|615994563|FG005|Overall Study|Physician Decision|0|||
170452287|NCT01207440|615994564|FG006|Overall Study|Physician Decision|0|||
170452288|NCT01207440|615994558|FG000|Overall Study|Progressive Disease|19|||
170452289|NCT01207440|615994559|FG001|Overall Study|Progressive Disease|10|||
170452290|NCT01207440|615994560|FG002|Overall Study|Progressive Disease|19|||
170452291|NCT01207440|615994561|FG003|Overall Study|Progressive Disease|7|||
170452292|NCT01207440|615994562|FG004|Overall Study|Progressive Disease|23|||
170452293|NCT01207440|615994563|FG005|Overall Study|Progressive Disease|27|||
170452294|NCT01207440|615994564|FG006|Overall Study|Progressive Disease|0|||
170452295|NCT01207440|615994558|FG000|Overall Study|Protocol Violation|2|||
170452296|NCT01207440|615994559|FG001|Overall Study|Protocol Violation|0|||
170452297|NCT01207440|615994560|FG002|Overall Study|Protocol Violation|0|||
170452298|NCT01207440|615994561|FG003|Overall Study|Protocol Violation|0|||
170452299|NCT01207440|615994562|FG004|Overall Study|Protocol Violation|0|||
170452300|NCT01207440|615994563|FG005|Overall Study|Protocol Violation|0|||
170452301|NCT01207440|615994564|FG006|Overall Study|Protocol Violation|0|||
170452302|NCT01207440|615994558|FG000|Overall Study|Site Terminated by Sponsor|69|||
170452303|NCT01207440|615994559|FG001|Overall Study|Site Terminated by Sponsor|19|||
170887890|NCT02944448|617598204|FG000|Overall Study|Lost to Follow-up|3|||
170787188|NCT02677298|617231710|FG002|Double Blind Phase|Withdrawal by Subject|0|||
170541664|NCT01239745|616328045|FG000|Overall Study|Adverse Event|1|||
170541665|NCT00574951|616328050|FG000|Overall Study|Ineligible - improper prior treatment|1|||
170541666|NCT02836769|616328051|FG000|Overall Study|Lost to Follow-up|10|||
170541667|NCT02836769|616328051|FG000|Overall Study|Medical withdrawal|2|||
170787189|NCT02677298|617231708|FG000|Double Blind Phase|No study drug available at site|0|||
170541668|NCT02836769|616328051|FG000|Overall Study|Withdrawal by Subject|3|||
170541669|NCT00376506|616328052|FG000|Overall Study|Death|0|||
170541670|NCT00376506|616328053|FG001|Overall Study|Death|2|||
170541671|NCT05067127|616328054|FG000|Randomized Controlled Period (26 weeks)|Lost to Follow-up|0|||
170541672|NCT05067127|616328055|FG001|Randomized Controlled Period (26 weeks)|Lost to Follow-up|1|||
170541673|NCT05067127|616328056|FG002|Randomized Controlled Period (26 weeks)|Lost to Follow-up|0|||
170541674|NCT05067127|616328057|FG003|Randomized Controlled Period (26 weeks)|Lost to Follow-up|0|||
170787190|NCT02677298|617231709|FG001|Double Blind Phase|No study drug available at site|1|||
170787191|NCT02677298|617231710|FG002|Double Blind Phase|No study drug available at site|0|||
170787192|NCT02677298|617231708|FG000|Open Label Phase|Adverse Event|0|||
170787193|NCT02677298|617231709|FG001|Open Label Phase|Adverse Event|0|||
170787194|NCT02677298|617231710|FG002|Open Label Phase|Adverse Event|4|||
170787195|NCT02677298|617231708|FG000|Open Label Phase|Physician Decision|0|||
170787196|NCT02677298|617231709|FG001|Open Label Phase|Physician Decision|0|||
170787197|NCT02677298|617231710|FG002|Open Label Phase|Physician Decision|1|||
170787198|NCT02677298|617231708|FG000|Open Label Phase|Lost to Follow-up|0|||
170787199|NCT02677298|617231709|FG001|Open Label Phase|Lost to Follow-up|0|||
170787200|NCT02677298|617231710|FG002|Open Label Phase|Lost to Follow-up|17|||
170787201|NCT02677298|617231708|FG000|Open Label Phase|Withdrawal by Subject|0|||
170787202|NCT02677298|617231709|FG001|Open Label Phase|Withdrawal by Subject|0|||
170787203|NCT02677298|617231710|FG002|Open Label Phase|Withdrawal by Subject|38|||
170787204|NCT03611621|617231711|FG000|Overall Study|Graft loss|3|||
170787205|NCT03611621|617231711|FG000|Overall Study|Death|3|||
170787206|NCT03611621|617231711|FG000|Overall Study|Lost to Follow-up|1|||
170787207|NCT01084876|617231716|FG000|Main Study Treatment Period|Adverse Event|12|||
170787208|NCT01084876|617231717|FG001|Main Study Treatment Period|Adverse Event|7|||
170787209|NCT01084876|617231716|FG000|Main Study Treatment Period|Disease Progression|41|||
170787210|NCT01084876|617231717|FG001|Main Study Treatment Period|Disease Progression|24|||
170787211|NCT01084876|617231716|FG000|Main Study Treatment Period|Physician Decision|2|||
170787212|NCT01084876|617231717|FG001|Main Study Treatment Period|Physician Decision|0|||
170787213|NCT01084876|617231716|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
170787214|NCT01084876|617231717|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
170787215|NCT01084876|617231716|FG000|Main Study Treatment Period|Other Reason|0|||
170787216|NCT01084876|617231717|FG001|Main Study Treatment Period|Other Reason|1|||
170787217|NCT01084876|617231716|FG000|Main Study Treatment Period|Other|0|||
170787218|NCT01084876|617231717|FG001|Main Study Treatment Period|Other|1|||
170787219|NCT01084876|617231716|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
170787220|NCT01084876|617231717|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
170787221|NCT01084876|617231716|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
170787222|NCT01084876|617231717|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
170787223|NCT01084876|617231716|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
170787224|NCT01084876|617231717|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
170787225|NCT01084876|617231716|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
170787226|NCT01084876|617231717|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
170787227|NCT01084876|617231716|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
170787228|NCT01084876|617231717|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
170787229|NCT01084876|617231716|FG000|Treatment Period Beyond Cycle 8|Other|6|||
170787230|NCT01084876|617231717|FG001|Treatment Period Beyond Cycle 8|Other|9|||
170787231|NCT03953508|617231725|FG000|Baseline|Lost to Follow-up|3|||
170787232|NCT03953508|617231726|FG001|Baseline|Lost to Follow-up|2|||
170787233|NCT03953508|617231725|FG000|6-month Follow-up|Lost to Follow-up|62|||
170787234|NCT03953508|617231726|FG001|6-month Follow-up|Lost to Follow-up|70|||
170787235|NCT04456517|617231727|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
170787236|NCT04456517|617231728|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
170787237|NCT03869866|617231732|FG000|Overall Study|Protocol Violation|1|||
170787238|NCT03869866|617231732|FG000|Overall Study|Withdrawal by Subject|3|||
170787239|NCT06181227|617231734|FG000|Overall Study|Study terminated by sponsor|7|||
170787240|NCT06181227|617231735|FG001|Overall Study|Study terminated by sponsor|9|||
170787241|NCT01186367|617231736|FG000|Overall Study|Lost to Follow-up|7|||
170634653|NCT02331277|616673211|FG001|Overall Study|Withdrawal by Subject|0|||
170787242|NCT01186367|617231737|FG001|Overall Study|Lost to Follow-up|4|||
170787243|NCT01186367|617231738|FG002|Overall Study|Lost to Follow-up|7|||
170787244|NCT01186367|617231736|FG000|Overall Study|Did not receive study treatment|0|||
170541675|NCT05067127|616328054|FG000|Randomized Controlled Period (26 weeks)|Withdrawal by Subject|0|||
170541676|NCT05067127|616328055|FG001|Randomized Controlled Period (26 weeks)|Withdrawal by Subject|2|||
170787245|NCT01186367|617231737|FG001|Overall Study|Did not receive study treatment|1|||
170887891|NCT02944448|617598205|FG001|Overall Study|Lost to Follow-up|1|||
170887892|NCT02944448|617598204|FG000|Overall Study|Protocol Violation|25|||
170887893|NCT02944448|617598205|FG001|Overall Study|Protocol Violation|7|||
170887894|NCT02944448|617598204|FG000|Overall Study|Withdrawal by Subject|14|||
170887895|NCT02944448|617598205|FG001|Overall Study|Withdrawal by Subject|4|||
170887896|NCT02944448|617598204|FG000|Overall Study|Sponsor did not supply drug in time|0|||
170887897|NCT02944448|617598205|FG001|Overall Study|Sponsor did not supply drug in time|1|||
170887898|NCT02944448|617598204|FG000|Overall Study|Noncompliant with dosing|1|||
170887899|NCT02944448|617598205|FG001|Overall Study|Noncompliant with dosing|0|||
170452304|NCT01207440|615994560|FG002|Overall Study|Site Terminated by Sponsor|12|||
170452305|NCT01207440|615994561|FG003|Overall Study|Site Terminated by Sponsor|2|||
170452306|NCT01207440|615994562|FG004|Overall Study|Site Terminated by Sponsor|3|||
170452307|NCT01207440|615994563|FG005|Overall Study|Site Terminated by Sponsor|0|||
170452308|NCT01207440|615994564|FG006|Overall Study|Site Terminated by Sponsor|2|||
170541677|NCT05067127|616328056|FG002|Randomized Controlled Period (26 weeks)|Withdrawal by Subject|0|||
170541678|NCT05067127|616328057|FG003|Randomized Controlled Period (26 weeks)|Withdrawal by Subject|0|||
170541679|NCT05067127|616328054|FG000|Randomized Controlled Period (26 weeks)|Investigator or Medical Monitor Decision|1|||
170541680|NCT05067127|616328055|FG001|Randomized Controlled Period (26 weeks)|Investigator or Medical Monitor Decision|0|||
170541681|NCT05067127|616328056|FG002|Randomized Controlled Period (26 weeks)|Investigator or Medical Monitor Decision|0|||
170541682|NCT05067127|616328057|FG003|Randomized Controlled Period (26 weeks)|Investigator or Medical Monitor Decision|0|||
170541683|NCT05067127|616328054|FG000|Randomized Controlled Period (26 weeks)|Pregnancy|0|||
170541684|NCT05067127|616328055|FG001|Randomized Controlled Period (26 weeks)|Pregnancy|1|||
170541685|NCT05067127|616328056|FG002|Randomized Controlled Period (26 weeks)|Pregnancy|0|||
170541686|NCT05067127|616328057|FG003|Randomized Controlled Period (26 weeks)|Pregnancy|0|||
170541687|NCT05067127|616328054|FG000|Randomized Controlled Period (26 weeks)|Death|1|||
170541688|NCT05067127|616328055|FG001|Randomized Controlled Period (26 weeks)|Death|0|||
170541689|NCT05067127|616328056|FG002|Randomized Controlled Period (26 weeks)|Death|0|||
170541690|NCT05067127|616328057|FG003|Randomized Controlled Period (26 weeks)|Death|0|||
170541691|NCT05067127|616328054|FG000|Open-Label Period (26 weeks)|Withdrawal by Subject|0|||
170541692|NCT05067127|616328055|FG001|Open-Label Period (26 weeks)|Withdrawal by Subject|0|||
170541693|NCT05067127|616328056|FG002|Open-Label Period (26 weeks)|Withdrawal by Subject|0|||
170541694|NCT05067127|616328057|FG003|Open-Label Period (26 weeks)|Withdrawal by Subject|1|||
170541695|NCT05067127|616328054|FG000|Open-Label Period (26 weeks)|Investigator or Medical Monitor Decision|0|||
170541696|NCT05067127|616328055|FG001|Open-Label Period (26 weeks)|Investigator or Medical Monitor Decision|0|||
170541697|NCT05067127|616328056|FG002|Open-Label Period (26 weeks)|Investigator or Medical Monitor Decision|2|||
170541698|NCT05067127|616328057|FG003|Open-Label Period (26 weeks)|Investigator or Medical Monitor Decision|1|||
170541699|NCT05040971|616328064|FG000|Overall Study|Withdrawal by Subject|0|||
170541700|NCT05040971|616328065|FG001|Overall Study|Withdrawal by Subject|2|||
170541701|NCT05040971|616328064|FG000|Overall Study|Lost to Follow-up|8|||
170541702|NCT05040971|616328065|FG001|Overall Study|Lost to Follow-up|3|||
170541703|NCT05040971|616328064|FG000|Overall Study|Death|2|||
170541704|NCT05040971|616328065|FG001|Overall Study|Death|0|||
170452309|NCT01207440|615994558|FG000|Overall Study|Withdrawal by Subject|29|||
170452310|NCT01207440|615994559|FG001|Overall Study|Withdrawal by Subject|4|||
170452311|NCT01207440|615994560|FG002|Overall Study|Withdrawal by Subject|5|||
170452312|NCT01207440|615994561|FG003|Overall Study|Withdrawal by Subject|3|||
170452313|NCT01207440|615994562|FG004|Overall Study|Withdrawal by Subject|2|||
170452314|NCT01207440|615994563|FG005|Overall Study|Withdrawal by Subject|2|||
170452315|NCT01207440|615994564|FG006|Overall Study|Withdrawal by Subject|0|||
170452316|NCT01207440|615994558|FG000|Overall Study|Reason Not Specified|10|||
170452317|NCT01207440|615994559|FG001|Overall Study|Reason Not Specified|10|||
170452318|NCT01207440|615994560|FG002|Overall Study|Reason Not Specified|7|||
170452319|NCT01207440|615994561|FG003|Overall Study|Reason Not Specified|0|||
170452320|NCT01207440|615994562|FG004|Overall Study|Reason Not Specified|4|||
170452321|NCT01207440|615994563|FG005|Overall Study|Reason Not Specified|3|||
170452322|NCT01207440|615994564|FG006|Overall Study|Reason Not Specified|0|||
170452323|NCT03341000|615994565|FG000|Overall Study|Adverse Event|1|||
170452324|NCT01408563|615994568|FG000|Overall Study|Ineligible after consent/ registration|2|||
170452325|NCT02091141|615994571|FG000|Overall Study|Death|280|||
170452326|NCT02091141|615994572|FG001|Overall Study|Death|118|||
170452327|NCT02091141|615994573|FG002|Overall Study|Death|46|||
170452328|NCT02091141|615994574|FG003|Overall Study|Death|13|||
170634654|NCT03751657|616673212|FG000|Overall Study|Physician Decision|0|||
170452329|NCT02091141|615994575|FG004|Overall Study|Death|31|||
170452330|NCT02091141|615994576|FG005|Overall Study|Death|16|||
170887900|NCT02944448|617598204|FG000|Overall Study|Abnormal laboratory values|1|||
170887901|NCT02944448|617598205|FG001|Overall Study|Abnormal laboratory values|0|||
170452331|NCT02091141|615994577|FG006|Overall Study|Death|12|||
170452332|NCT02091141|615994571|FG000|Overall Study|Withdrawal by Subject|21|||
170452333|NCT02091141|615994572|FG001|Overall Study|Withdrawal by Subject|13|||
170541705|NCT04003805|616328066|FG000|Overall Study|Lost to Follow-up|5|||
170634655|NCT03751657|616673213|FG001|Overall Study|Physician Decision|1|||
170887902|NCT00804687|617598206|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
170887903|NCT00804687|617598207|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
170887904|NCT00804687|617598208|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
170887905|NCT00804687|617598209|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
170887906|NCT00804687|617598210|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
170887907|NCT00804687|617598211|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
170887908|NCT00804687|617598206|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
170887909|NCT00804687|617598207|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
170887910|NCT00804687|617598208|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
170887911|NCT00804687|617598209|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
170887912|NCT00804687|617598210|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
170887913|NCT00804687|617598211|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
170887914|NCT00804687|617598206|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
170887915|NCT00804687|617598207|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
170887916|NCT00804687|617598208|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
170887917|NCT00804687|617598209|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
170887918|NCT00804687|617598210|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
170887919|NCT00804687|617598211|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
170887920|NCT00804687|617598206|FG000|Period 5: Treatment Period|Positive drug test|1|||
170887921|NCT00804687|617598207|FG001|Period 5: Treatment Period|Positive drug test|0|||
170887922|NCT00804687|617598208|FG002|Period 5: Treatment Period|Positive drug test|0|||
170887923|NCT00804687|617598209|FG003|Period 5: Treatment Period|Positive drug test|0|||
170887924|NCT00804687|617598210|FG004|Period 5: Treatment Period|Positive drug test|0|||
170887925|NCT00804687|617598211|FG005|Period 5: Treatment Period|Positive drug test|0|||
170887926|NCT04401267|617598212|FG000|Overall Study|Death|0|||
170887927|NCT04401267|617598213|FG001|Overall Study|Death|1|||
170887928|NCT04401267|617598212|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
170887929|NCT04401267|617598213|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
170887930|NCT04401267|617598212|FG000|Overall Study|Found to be Ineligible|1|||
170887931|NCT04401267|617598213|FG001|Overall Study|Found to be Ineligible|0|||
170887932|NCT01449708|617598223|FG000|Overall Study|Protocol Violation|0|||
170887933|NCT01449708|617598224|FG001|Overall Study|Protocol Violation|1|||
170887934|NCT01449708|617598223|FG000|Overall Study|surgical complication|1|||
170887935|NCT01449708|617598224|FG001|Overall Study|surgical complication|2|||
170887936|NCT01449708|617598223|FG000|Overall Study|respiratory failure|1|||
170887937|NCT01449708|617598224|FG001|Overall Study|respiratory failure|0|||
170887938|NCT02479802|617598227|FG000|Overall Study|Lost to Follow-up|1|||
170887939|NCT02479802|617598227|FG000|Overall Study|Adverse Event|1|||
170887940|NCT02421887|617598228|FG000|Overall Study|Lost to Follow-up|5|||
170887941|NCT02421887|617598229|FG001|Overall Study|Lost to Follow-up|0|||
170887942|NCT02421887|617598228|FG000|Overall Study|Withdrawal by Subject|8|||
170887943|NCT02421887|617598229|FG001|Overall Study|Withdrawal by Subject|5|||
170887944|NCT02421887|617598228|FG000|Overall Study|Physician Decision|2|||
170887945|NCT02421887|617598229|FG001|Overall Study|Physician Decision|4|||
170452334|NCT02091141|615994573|FG002|Overall Study|Withdrawal by Subject|3|||
170452335|NCT02091141|615994574|FG003|Overall Study|Withdrawal by Subject|2|||
170452336|NCT02091141|615994575|FG004|Overall Study|Withdrawal by Subject|2|||
170452337|NCT02091141|615994576|FG005|Overall Study|Withdrawal by Subject|3|||
170452338|NCT02091141|615994577|FG006|Overall Study|Withdrawal by Subject|0|||
170452339|NCT02091141|615994571|FG000|Overall Study|Lost to Follow-up|21|||
170452340|NCT02091141|615994572|FG001|Overall Study|Lost to Follow-up|5|||
170452341|NCT02091141|615994573|FG002|Overall Study|Lost to Follow-up|1|||
170452342|NCT02091141|615994574|FG003|Overall Study|Lost to Follow-up|0|||
170452343|NCT02091141|615994575|FG004|Overall Study|Lost to Follow-up|1|||
170452344|NCT02091141|615994576|FG005|Overall Study|Lost to Follow-up|2|||
170452345|NCT02091141|615994577|FG006|Overall Study|Lost to Follow-up|0|||
170452346|NCT02091141|615994571|FG000|Overall Study|Reason Not Specified|6|||
170452347|NCT02091141|615994572|FG001|Overall Study|Reason Not Specified|5|||
170452348|NCT02091141|615994573|FG002|Overall Study|Reason Not Specified|2|||
170452349|NCT02091141|615994574|FG003|Overall Study|Reason Not Specified|0|||
170452350|NCT02091141|615994575|FG004|Overall Study|Reason Not Specified|0|||
170452351|NCT02091141|615994576|FG005|Overall Study|Reason Not Specified|0|||
170452352|NCT02091141|615994577|FG006|Overall Study|Reason Not Specified|1|||
170452353|NCT02091141|615994571|FG000|Overall Study|Study Ended by Sponsor|1|||
170452354|NCT02091141|615994572|FG001|Overall Study|Study Ended by Sponsor|9|||
170452355|NCT02091141|615994573|FG002|Overall Study|Study Ended by Sponsor|0|||
170452356|NCT02091141|615994574|FG003|Overall Study|Study Ended by Sponsor|0|||
170452357|NCT02091141|615994575|FG004|Overall Study|Study Ended by Sponsor|0|||
170452358|NCT02091141|615994576|FG005|Overall Study|Study Ended by Sponsor|0|||
170887946|NCT02421887|617598228|FG000|Overall Study|Adverse Event|2|||
170887947|NCT02421887|617598229|FG001|Overall Study|Adverse Event|0|||
170634656|NCT03751657|616673212|FG000|Overall Study|Withdrawal by Subject|1|||
170887948|NCT03124784|617598230|FG000|Overall Study|Adverse Event|1|||
170452359|NCT02091141|615994577|FG006|Overall Study|Study Ended by Sponsor|0|||
170887949|NCT03124784|617598230|FG000|Overall Study|Computer/Equip Malfunction|1|||
170887950|NCT05702515|617598231|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
170887951|NCT02162732|617598232|FG000|Overall Study|Biopsy not performed.|18|||
170452360|NCT02091141|615994571|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
170452361|NCT02091141|615994572|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
170634657|NCT03751657|616673213|FG001|Overall Study|Withdrawal by Subject|1|||
170634658|NCT03751657|616673212|FG000|Overall Study|Lost to Follow-up|2|||
170634659|NCT03751657|616673213|FG001|Overall Study|Lost to Follow-up|1|||
170634660|NCT00990704|616673214|FG000|Overall Study|Adverse Event|1|||
170634661|NCT00990704|616673215|FG001|Overall Study|Adverse Event|1|||
170634662|NCT00990704|616673214|FG000|Overall Study|Physician Decision|0|||
170634663|NCT00990704|616673215|FG001|Overall Study|Physician Decision|1|||
170634664|NCT03894813|616673222|FG000|Overall Study|Adverse Event|1|||
170634665|NCT03894813|616673223|FG001|Overall Study|Adverse Event|1|||
170634666|NCT03894813|616673222|FG000|Overall Study|Lack of Efficacy|3|||
170634667|NCT03894813|616673223|FG001|Overall Study|Lack of Efficacy|3|||
170452362|NCT02091141|615994573|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
170452363|NCT02091141|615994574|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
170634668|NCT03894813|616673222|FG000|Overall Study|Lost to Follow-up|1|||
170634669|NCT03894813|616673223|FG001|Overall Study|Lost to Follow-up|0|||
170634670|NCT03894813|616673222|FG000|Overall Study|Pregnancy|2|||
170887952|NCT01396005|617598233|FG000|Overall Study|Withdrawal by Subject|0|||
170887953|NCT01396005|617598234|FG001|Overall Study|Withdrawal by Subject|1|||
170887954|NCT01396005|617598233|FG000|Overall Study|Non-compliance with protocol|0|||
170887955|NCT01396005|617598234|FG001|Overall Study|Non-compliance with protocol|1|||
170887956|NCT01784965|617598235|FG000|Overall Study|Withdrawal by Subject|6|||
170887957|NCT01784965|617598236|FG001|Overall Study|Withdrawal by Subject|3|||
170887958|NCT01784965|617598235|FG000|Overall Study|Adverse Event|0|||
170887959|NCT01784965|617598236|FG001|Overall Study|Adverse Event|8|||
170887960|NCT03757988|617598237|FG000|Overall Study|Withdrawal by Subject|1|||
170887961|NCT04269395|617598241|FG000|Overall Study|Lost to Follow-up|1|||
170887962|NCT04269395|617598242|FG001|Overall Study|Lost to Follow-up|0|||
170887963|NCT04269395|617598241|FG000|Overall Study|Study terminated by Sponsor|13|||
170887964|NCT04269395|617598242|FG001|Overall Study|Study terminated by Sponsor|10|||
170887965|NCT00584233|617598243|FG000|Overall Study|Withdrawal by Subject|5|||
170887966|NCT00584233|617598243|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
170887967|NCT05689047|617598244|FG000|Overall Study|Lost to Follow-up|0|||
170887968|NCT05689047|617598245|FG001|Overall Study|Lost to Follow-up|1|||
170887969|NCT05689047|617598244|FG000|Overall Study|Protocol Deviation|1|||
170887970|NCT05689047|617598245|FG001|Overall Study|Protocol Deviation|0|||
170887971|NCT01391507|617598252|FG000|Overall Study|Death|0|||
170887972|NCT01391507|617598253|FG001|Overall Study|Death|0|||
170887973|NCT01391507|617598254|FG002|Overall Study|Death|0|||
170887974|NCT01391507|617598255|FG003|Overall Study|Death|1|||
170887975|NCT01391507|617598252|FG000|Overall Study|Adverse Event|1|||
170887976|NCT01391507|617598253|FG001|Overall Study|Adverse Event|1|||
170887977|NCT01391507|617598254|FG002|Overall Study|Adverse Event|2|||
170887978|NCT01391507|617598255|FG003|Overall Study|Adverse Event|2|||
170887979|NCT01391507|617598252|FG000|Overall Study|Withdrawal by Subject|1|||
170887980|NCT01391507|617598253|FG001|Overall Study|Withdrawal by Subject|2|||
170887981|NCT01391507|617598254|FG002|Overall Study|Withdrawal by Subject|1|||
170887982|NCT01391507|617598255|FG003|Overall Study|Withdrawal by Subject|1|||
170887983|NCT01391507|617598252|FG000|Overall Study|Lack of Efficacy|0|||
170887984|NCT01391507|617598253|FG001|Overall Study|Lack of Efficacy|0|||
170887985|NCT01391507|617598254|FG002|Overall Study|Lack of Efficacy|0|||
170887986|NCT01391507|617598255|FG003|Overall Study|Lack of Efficacy|1|||
170887987|NCT01391507|617598252|FG000|Overall Study|Protocol Violation|2|||
170887988|NCT01391507|617598253|FG001|Overall Study|Protocol Violation|1|||
170887989|NCT01391507|617598254|FG002|Overall Study|Protocol Violation|1|||
170887990|NCT01391507|617598255|FG003|Overall Study|Protocol Violation|2|||
170887991|NCT04161495|617598258|FG000|Overall Study|Withdrawal by Subject|3|||
170887992|NCT04161495|617598259|FG001|Overall Study|Withdrawal by Subject|0|||
170887993|NCT04161495|617598258|FG000|Overall Study|Protocol Violation|1|||
170887994|NCT04161495|617598259|FG001|Overall Study|Protocol Violation|0|||
170887995|NCT04161495|617598258|FG000|Overall Study|Prohibited concomitant medication|3|||
170634671|NCT03894813|616673223|FG001|Overall Study|Pregnancy|1|||
170634672|NCT03894813|616673222|FG000|Overall Study|Protocol Violation|3|||
170887996|NCT04161495|617598259|FG001|Overall Study|Prohibited concomitant medication|0|||
170887997|NCT04161495|617598258|FG000|Overall Study|Adverse Event|1|||
170887998|NCT04161495|617598259|FG001|Overall Study|Adverse Event|0|||
170887999|NCT04161495|617598258|FG000|Overall Study|Other - Unspecified|1|||
170888000|NCT04161495|617598259|FG001|Overall Study|Other - Unspecified|0|||
170888001|NCT04161495|617598258|FG000|Overall Study|Death|0|||
170888002|NCT04161495|617598259|FG001|Overall Study|Death|1|||
170888003|NCT01562548|617598262|FG000|Overall Study|Lost to Follow-up|0|||
170888004|NCT01562548|617598263|FG001|Overall Study|Lost to Follow-up|0|||
170634673|NCT03894813|616673223|FG001|Overall Study|Protocol Violation|7|||
170888005|NCT01562548|617598264|FG002|Overall Study|Lost to Follow-up|1|||
170888006|NCT01562548|617598265|FG003|Overall Study|Lost to Follow-up|0|||
170888007|NCT00252057|617598266|FG000|Overall Study|Withdrawal by Subject|2|||
170888008|NCT00252057|617598267|FG001|Overall Study|Withdrawal by Subject|5|||
170888009|NCT00252057|617598266|FG000|Overall Study|Death|1|||
170888010|NCT00252057|617598267|FG001|Overall Study|Death|2|||
170888011|NCT00252057|617598266|FG000|Overall Study|Participant previously enrolled|0|||
170888012|NCT00252057|617598267|FG001|Overall Study|Participant previously enrolled|1|||
170888013|NCT03529773|617598268|FG000|Overall Study|Adverse Event|0|||
170888014|NCT03529773|617598269|FG001|Overall Study|Adverse Event|0|||
170888015|NCT03529773|617598270|FG002|Overall Study|Adverse Event|0|||
170888016|NCT03529773|617598271|FG003|Overall Study|Adverse Event|0|||
170888017|NCT03529773|617598272|FG004|Overall Study|Adverse Event|0|||
170888018|NCT03529773|617598273|FG005|Overall Study|Adverse Event|0|||
170888019|NCT03529773|617598274|FG006|Overall Study|Adverse Event|0|||
170888020|NCT03529773|617598275|FG007|Overall Study|Adverse Event|0|||
170888021|NCT03529773|617598276|FG008|Overall Study|Adverse Event|0|||
170888022|NCT03529773|617598277|FG009|Overall Study|Adverse Event|0|||
170888023|NCT03529773|617598278|FG010|Overall Study|Adverse Event|0|||
170888024|NCT03529773|617598279|FG011|Overall Study|Adverse Event|0|||
170888025|NCT03529773|617598280|FG012|Overall Study|Adverse Event|0|||
170888026|NCT03529773|617598281|FG013|Overall Study|Adverse Event|0|||
170888027|NCT03529773|617598282|FG014|Overall Study|Adverse Event|0|||
170888028|NCT03529773|617598283|FG015|Overall Study|Adverse Event|0|||
170634674|NCT03894813|616673222|FG000|Overall Study|Withdrawal by Subject|1|||
170634675|NCT03894813|616673223|FG001|Overall Study|Withdrawal by Subject|3|||
170634676|NCT03894813|616673222|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
170634677|NCT03894813|616673223|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
170634678|NCT00807001|616673226|FG000|Overall Study|Non-compliance|0|||
170634679|NCT00807001|616673227|FG001|Overall Study|Non-compliance|1|||
170634680|NCT00807001|616673228|FG002|Overall Study|Non-compliance|0|||
170634681|NCT00807001|616673229|FG003|Overall Study|Non-compliance|0|||
170634682|NCT00807001|616673230|FG004|Overall Study|Non-compliance|0|||
170634683|NCT02656693|616673231|FG000|Overall Study|Pregnancy|1|||
170634684|NCT02656693|616673232|FG001|Overall Study|Pregnancy|1|||
170634685|NCT02656693|616673233|FG002|Overall Study|Pregnancy|1|||
170634686|NCT02656693|616673231|FG000|Overall Study|Bariatric surgery|0|||
170634687|NCT02656693|616673232|FG001|Overall Study|Bariatric surgery|1|||
170634688|NCT02656693|616673233|FG002|Overall Study|Bariatric surgery|2|||
170634689|NCT01399372|616673235|FG000|Overall Study|Protocol Violation|3|||
170634690|NCT01399372|616673236|FG001|Overall Study|Protocol Violation|1|||
170634691|NCT02269267|616673237|FG000|Overall Study|Death|5|||
170634692|NCT03805659|616673238|FG000|Overall Study|Withdrawal by Subject|0|||
170634693|NCT03805659|616673239|FG001|Overall Study|Withdrawal by Subject|1|||
170634694|NCT02565784|616673242|FG000|First Treatment|Adverse Event|1|||
170634695|NCT02565784|616673242|FG000|First Treatment|Withdrawal by Subject|1|||
170634696|NCT02565784|616673242|FG000|Second Treatment|Withdrawal by Subject|2|||
170634697|NCT02741518|616673245|FG000|Overall Study|Withdrawal by Subject|1|||
170634698|NCT02741518|616673246|FG001|Overall Study|Withdrawal by Subject|1|||
170634699|NCT00476008|616673249|FG000|Overall Study|Adverse Event|4|||
170634700|NCT00476008|616673250|FG001|Overall Study|Adverse Event|4|||
170634701|NCT00476008|616673249|FG000|Overall Study|Placebo concerns|2|||
170634702|NCT00476008|616673250|FG001|Overall Study|Placebo concerns|2|||
170634703|NCT00476008|616673249|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
170634704|NCT00476008|616673250|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
170634705|NCT00476008|616673249|FG000|Overall Study|Withdrawal by Subject|0|||
170634706|NCT00476008|616673250|FG001|Overall Study|Withdrawal by Subject|1|||
170634707|NCT00476008|616673249|FG000|Overall Study|Death|1|||
170634708|NCT00476008|616673250|FG001|Overall Study|Death|0|||
170634709|NCT01788358|616673251|FG000|Overall Study|Other|11|||
170634710|NCT01788358|616673251|FG000|Overall Study|Logistical difficulties|1|||
170634711|NCT01788358|616673251|FG000|Overall Study|Lost to Follow-up|5|||
170634712|NCT01788358|616673251|FG000|Overall Study|Protocol Violation|3|||
170634713|NCT01788358|616673251|FG000|Overall Study|Withdrawal by Subject|26|||
170634714|NCT01788358|616673251|FG000|Overall Study|Lack of Efficacy|1|||
170888029|NCT03529773|617598284|FG016|Overall Study|Adverse Event|0|||
170888030|NCT03529773|617598285|FG017|Overall Study|Adverse Event|0|||
170888031|NCT03529773|617598286|FG018|Overall Study|Adverse Event|0|||
170888032|NCT03529773|617598287|FG019|Overall Study|Adverse Event|0|||
170634715|NCT01788358|616673251|FG000|Overall Study|Adverse Event|51|||
170634716|NCT01227018|616673252|FG000|Overall Study|Disease progression|9|||
170634717|NCT01227018|616673252|FG000|Overall Study|Toxicity|2|||
170634718|NCT01227018|616673252|FG000|Overall Study|Withdrew after beginning treatment|4|||
170634719|NCT02948634|616673257|FG000|Overall Study|Lack of efficacy and study suspended|10|||
170634720|NCT02948634|616673258|FG001|Overall Study|Lack of efficacy and study suspended|2|||
170634721|NCT01229267|616673263|FG000|Overall Study|Adverse Event|4|||
170634722|NCT01229267|616673264|FG001|Overall Study|Adverse Event|6|||
170888033|NCT03529773|617598288|FG020|Overall Study|Adverse Event|0|||
170452364|NCT02091141|615994575|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
170452365|NCT02091141|615994576|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
170452366|NCT02091141|615994577|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
170452367|NCT02132637|615994582|FG000|Study Period 1|Withdrawal by Subject|0|||
170452368|NCT02132637|615994583|FG001|Study Period 1|Withdrawal by Subject|4|||
170888034|NCT03529773|617598289|FG021|Overall Study|Adverse Event|0|||
170888035|NCT03529773|617598290|FG022|Overall Study|Adverse Event|0|||
170888036|NCT03529773|617598291|FG023|Overall Study|Adverse Event|0|||
170888037|NCT03529773|617598292|FG024|Overall Study|Adverse Event|0|||
170888038|NCT03529773|617598293|FG025|Overall Study|Adverse Event|0|||
170888039|NCT03529773|617598294|FG026|Overall Study|Adverse Event|0|||
170888040|NCT03529773|617598295|FG027|Overall Study|Adverse Event|0|||
170888041|NCT03529773|617598296|FG028|Overall Study|Adverse Event|0|||
170888042|NCT03529773|617598297|FG029|Overall Study|Adverse Event|0|||
170888043|NCT03529773|617598298|FG030|Overall Study|Adverse Event|1|||
170888044|NCT03529773|617598299|FG031|Overall Study|Adverse Event|0|||
170888045|NCT03529773|617598300|FG032|Overall Study|Adverse Event|0|||
170888046|NCT03529773|617598301|FG033|Overall Study|Adverse Event|0|||
170888047|NCT03529773|617598302|FG034|Overall Study|Adverse Event|0|||
170888048|NCT03529773|617598303|FG035|Overall Study|Adverse Event|1|||
170888049|NCT03529773|617598304|FG036|Overall Study|Adverse Event|0|||
170888050|NCT03529773|617598305|FG037|Overall Study|Adverse Event|0|||
170888051|NCT03529773|617598306|FG038|Overall Study|Adverse Event|1|||
170888052|NCT03529773|617598307|FG039|Overall Study|Adverse Event|1|||
170888053|NCT03529773|617598268|FG000|Overall Study|Death|0|||
170888054|NCT03529773|617598269|FG001|Overall Study|Death|0|||
170888055|NCT03529773|617598270|FG002|Overall Study|Death|0|||
170888056|NCT03529773|617598271|FG003|Overall Study|Death|0|||
170888057|NCT03529773|617598272|FG004|Overall Study|Death|0|||
170888058|NCT03529773|617598273|FG005|Overall Study|Death|0|||
170888059|NCT03529773|617598274|FG006|Overall Study|Death|0|||
170888060|NCT03529773|617598275|FG007|Overall Study|Death|0|||
170888061|NCT03529773|617598276|FG008|Overall Study|Death|0|||
170888062|NCT03529773|617598277|FG009|Overall Study|Death|0|||
170888063|NCT03529773|617598278|FG010|Overall Study|Death|0|||
170888064|NCT03529773|617598279|FG011|Overall Study|Death|0|||
170888065|NCT03529773|617598280|FG012|Overall Study|Death|1|||
170888066|NCT03529773|617598281|FG013|Overall Study|Death|0|||
170888067|NCT03529773|617598282|FG014|Overall Study|Death|0|||
170888068|NCT03529773|617598283|FG015|Overall Study|Death|0|||
170888069|NCT03529773|617598284|FG016|Overall Study|Death|0|||
170888070|NCT03529773|617598285|FG017|Overall Study|Death|0|||
170888071|NCT03529773|617598286|FG018|Overall Study|Death|0|||
170888072|NCT03529773|617598287|FG019|Overall Study|Death|1|||
170888073|NCT03529773|617598288|FG020|Overall Study|Death|0|||
170888074|NCT03529773|617598289|FG021|Overall Study|Death|0|||
170888075|NCT03529773|617598290|FG022|Overall Study|Death|1|||
170888076|NCT03529773|617598291|FG023|Overall Study|Death|0|||
170888077|NCT03529773|617598292|FG024|Overall Study|Death|0|||
170888078|NCT03529773|617598293|FG025|Overall Study|Death|0|||
170888079|NCT03529773|617598294|FG026|Overall Study|Death|0|||
170888080|NCT03529773|617598295|FG027|Overall Study|Death|0|||
170888081|NCT03529773|617598296|FG028|Overall Study|Death|0|||
170888082|NCT03529773|617598297|FG029|Overall Study|Death|0|||
170888083|NCT03529773|617598298|FG030|Overall Study|Death|0|||
170888084|NCT03529773|617598299|FG031|Overall Study|Death|0|||
170888085|NCT03529773|617598300|FG032|Overall Study|Death|0|||
170888086|NCT03529773|617598301|FG033|Overall Study|Death|1|||
170888087|NCT03529773|617598302|FG034|Overall Study|Death|1|||
170888088|NCT03529773|617598303|FG035|Overall Study|Death|0|||
170888089|NCT03529773|617598304|FG036|Overall Study|Death|1|||
170888090|NCT03529773|617598305|FG037|Overall Study|Death|0|||
170452369|NCT02132637|615994582|FG000|Study Period 1|Physician Decision|1|||
170452370|NCT02132637|615994583|FG001|Study Period 1|Physician Decision|0|||
170452371|NCT02132637|615994582|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
170888091|NCT03529773|617598306|FG038|Overall Study|Death|0|||
170888092|NCT03529773|617598307|FG039|Overall Study|Death|0|||
170888093|NCT03529773|617598268|FG000|Overall Study|Lost to Follow-up|0|||
170888094|NCT03529773|617598269|FG001|Overall Study|Lost to Follow-up|0|||
170888095|NCT03529773|617598270|FG002|Overall Study|Lost to Follow-up|1|||
170888096|NCT03529773|617598271|FG003|Overall Study|Lost to Follow-up|0|||
170888097|NCT03529773|617598272|FG004|Overall Study|Lost to Follow-up|1|||
170452372|NCT02132637|615994583|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
170888098|NCT03529773|617598273|FG005|Overall Study|Lost to Follow-up|1|||
170888099|NCT03529773|617598274|FG006|Overall Study|Lost to Follow-up|0|||
170888100|NCT03529773|617598275|FG007|Overall Study|Lost to Follow-up|0|||
170888101|NCT03529773|617598276|FG008|Overall Study|Lost to Follow-up|0|||
170888102|NCT03529773|617598277|FG009|Overall Study|Lost to Follow-up|0|||
170888103|NCT03529773|617598278|FG010|Overall Study|Lost to Follow-up|0|||
170888104|NCT03529773|617598279|FG011|Overall Study|Lost to Follow-up|0|||
170888105|NCT03529773|617598280|FG012|Overall Study|Lost to Follow-up|0|||
170888106|NCT03529773|617598281|FG013|Overall Study|Lost to Follow-up|1|||
170888107|NCT03529773|617598282|FG014|Overall Study|Lost to Follow-up|4|||
170888108|NCT03529773|617598283|FG015|Overall Study|Lost to Follow-up|1|||
170888109|NCT03529773|617598284|FG016|Overall Study|Lost to Follow-up|1|||
170888110|NCT03529773|617598285|FG017|Overall Study|Lost to Follow-up|0|||
170888111|NCT03529773|617598286|FG018|Overall Study|Lost to Follow-up|1|||
170888112|NCT03529773|617598287|FG019|Overall Study|Lost to Follow-up|1|||
170888113|NCT03529773|617598288|FG020|Overall Study|Lost to Follow-up|2|||
170888114|NCT03529773|617598289|FG021|Overall Study|Lost to Follow-up|4|||
170452373|NCT02132637|615994582|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
170452374|NCT02132637|615994583|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
170452375|NCT02581163|615994591|FG000|Overall Study|Failure to return|15|||
170452376|NCT02581163|615994591|FG000|Overall Study|Insufficient virological response|3|||
170452377|NCT02581163|615994591|FG000|Overall Study|Withdrew consent|1|||
170452378|NCT02581163|615994591|FG000|Overall Study|Death|1|||
170452379|NCT02581163|615994591|FG000|Overall Study|Other, not specified|9|||
170452380|NCT01763918|615994592|FG000|Overall Study|Withdrawal by Subject|2|||
170888115|NCT03529773|617598290|FG022|Overall Study|Lost to Follow-up|3|||
170888116|NCT03529773|617598291|FG023|Overall Study|Lost to Follow-up|4|||
170888117|NCT03529773|617598292|FG024|Overall Study|Lost to Follow-up|3|||
170888118|NCT03529773|617598293|FG025|Overall Study|Lost to Follow-up|5|||
170888119|NCT03529773|617598294|FG026|Overall Study|Lost to Follow-up|5|||
170888120|NCT03529773|617598295|FG027|Overall Study|Lost to Follow-up|0|||
170888121|NCT03529773|617598296|FG028|Overall Study|Lost to Follow-up|0|||
170888122|NCT03529773|617598297|FG029|Overall Study|Lost to Follow-up|0|||
170888123|NCT03529773|617598298|FG030|Overall Study|Lost to Follow-up|1|||
170888124|NCT03529773|617598299|FG031|Overall Study|Lost to Follow-up|0|||
170888125|NCT03529773|617598300|FG032|Overall Study|Lost to Follow-up|0|||
170888126|NCT03529773|617598301|FG033|Overall Study|Lost to Follow-up|1|||
170888127|NCT03529773|617598302|FG034|Overall Study|Lost to Follow-up|1|||
170888128|NCT03529773|617598303|FG035|Overall Study|Lost to Follow-up|0|||
170888129|NCT03529773|617598304|FG036|Overall Study|Lost to Follow-up|0|||
170888130|NCT03529773|617598305|FG037|Overall Study|Lost to Follow-up|3|||
170452381|NCT01763918|615994593|FG001|Overall Study|Withdrawal by Subject|1|||
170452382|NCT01763918|615994594|FG002|Overall Study|Withdrawal by Subject|1|||
170452383|NCT01763918|615994595|FG003|Overall Study|Withdrawal by Subject|2|||
170452384|NCT01763918|615994592|FG000|Overall Study|Sponsor Decision|4|||
170452385|NCT01763918|615994593|FG001|Overall Study|Sponsor Decision|0|||
170452386|NCT01763918|615994594|FG002|Overall Study|Sponsor Decision|9|||
170452387|NCT01763918|615994595|FG003|Overall Study|Sponsor Decision|0|||
170452388|NCT01621191|615994596|FG000|Overall Study|Adverse Event|9|||
170452389|NCT01621191|615994596|FG000|Overall Study|Withdrawal by Subject|8|||
170452390|NCT01621191|615994596|FG000|Overall Study|Lack of Efficacy|6|||
170452391|NCT01621191|615994596|FG000|Overall Study|Lost to Follow-up|1|||
170452392|NCT01621191|615994596|FG000|Overall Study|Site Removed From Study|1|||
170452393|NCT04355663|615994598|FG000|Overall Study|Physician Decision|2|||
170452394|NCT04355663|615994599|FG001|Overall Study|Physician Decision|7|||
170452395|NCT04355663|615994600|FG002|Overall Study|Physician Decision|0|||
170452396|NCT04355663|615994598|FG000|Overall Study|Adverse Event|0|||
170452397|NCT04355663|615994599|FG001|Overall Study|Adverse Event|0|||
170452398|NCT04355663|615994600|FG002|Overall Study|Adverse Event|1|||
170452399|NCT04355663|615994598|FG000|Overall Study|Withdrawal by Subject|0|||
170452400|NCT04355663|615994599|FG001|Overall Study|Withdrawal by Subject|8|||
170888131|NCT03529773|617598306|FG038|Overall Study|Lost to Follow-up|1|||
170888132|NCT03529773|617598307|FG039|Overall Study|Lost to Follow-up|1|||
170888133|NCT03529773|617598268|FG000|Overall Study|No longer meets eligibility criteria|0|||
170888134|NCT03529773|617598269|FG001|Overall Study|No longer meets eligibility criteria|0|||
170888135|NCT03529773|617598270|FG002|Overall Study|No longer meets eligibility criteria|0|||
170888136|NCT03529773|617598271|FG003|Overall Study|No longer meets eligibility criteria|0|||
170888137|NCT03529773|617598272|FG004|Overall Study|No longer meets eligibility criteria|0|||
170452401|NCT04355663|615994600|FG002|Overall Study|Withdrawal by Subject|3|||
170452402|NCT03253744|615994604|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
170452403|NCT03253744|615994605|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
170452404|NCT03253744|615994606|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
170452405|NCT03253744|615994607|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
170452406|NCT03739138|615994611|FG000|Overall Study|Death|0|||
170452407|NCT03739138|615994612|FG001|Overall Study|Death|7|||
170452408|NCT03739138|615994613|FG002|Overall Study|Death|4|||
170452409|NCT03739138|615994614|FG003|Overall Study|Death|13|||
170452410|NCT03739138|615994615|FG004|Overall Study|Death|0|||
170452411|NCT03739138|615994611|FG000|Overall Study|Lost to Follow-up|0|||
170452412|NCT03739138|615994612|FG001|Overall Study|Lost to Follow-up|0|||
170888138|NCT03529773|617598273|FG005|Overall Study|No longer meets eligibility criteria|0|||
170888139|NCT03529773|617598274|FG006|Overall Study|No longer meets eligibility criteria|0|||
170888140|NCT03529773|617598275|FG007|Overall Study|No longer meets eligibility criteria|0|||
170452413|NCT03739138|615994613|FG002|Overall Study|Lost to Follow-up|1|||
170452414|NCT03739138|615994614|FG003|Overall Study|Lost to Follow-up|0|||
170452415|NCT03739138|615994615|FG004|Overall Study|Lost to Follow-up|0|||
170452416|NCT03739138|615994611|FG000|Overall Study|Study Terminated By Sponsor|0|||
170452417|NCT03739138|615994612|FG001|Overall Study|Study Terminated By Sponsor|0|||
170452418|NCT03739138|615994613|FG002|Overall Study|Study Terminated By Sponsor|0|||
170452419|NCT03739138|615994614|FG003|Overall Study|Study Terminated By Sponsor|4|||
170888141|NCT03529773|617598276|FG008|Overall Study|No longer meets eligibility criteria|0|||
170888142|NCT03529773|617598277|FG009|Overall Study|No longer meets eligibility criteria|0|||
170888143|NCT03529773|617598278|FG010|Overall Study|No longer meets eligibility criteria|0|||
170888144|NCT03529773|617598279|FG011|Overall Study|No longer meets eligibility criteria|0|||
170888145|NCT03529773|617598280|FG012|Overall Study|No longer meets eligibility criteria|0|||
170888146|NCT03529773|617598281|FG013|Overall Study|No longer meets eligibility criteria|0|||
170888147|NCT03529773|617598282|FG014|Overall Study|No longer meets eligibility criteria|0|||
170888148|NCT03529773|617598283|FG015|Overall Study|No longer meets eligibility criteria|0|||
170888149|NCT03529773|617598284|FG016|Overall Study|No longer meets eligibility criteria|0|||
170888150|NCT03529773|617598285|FG017|Overall Study|No longer meets eligibility criteria|0|||
170452420|NCT03739138|615994615|FG004|Overall Study|Study Terminated By Sponsor|0|||
170888151|NCT03529773|617598286|FG018|Overall Study|No longer meets eligibility criteria|0|||
170888152|NCT03529773|617598287|FG019|Overall Study|No longer meets eligibility criteria|0|||
170452421|NCT03739138|615994611|FG000|Overall Study|Withdrawal by Subject|0|||
170452422|NCT03739138|615994612|FG001|Overall Study|Withdrawal by Subject|0|||
170452423|NCT03739138|615994613|FG002|Overall Study|Withdrawal by Subject|0|||
170452424|NCT03739138|615994614|FG003|Overall Study|Withdrawal by Subject|1|||
170452425|NCT03739138|615994615|FG004|Overall Study|Withdrawal by Subject|0|||
170452426|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
170452427|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
170888153|NCT03529773|617598288|FG020|Overall Study|No longer meets eligibility criteria|0|||
170888154|NCT03529773|617598289|FG021|Overall Study|No longer meets eligibility criteria|0|||
170888155|NCT03529773|617598290|FG022|Overall Study|No longer meets eligibility criteria|1|||
170888156|NCT03529773|617598291|FG023|Overall Study|No longer meets eligibility criteria|0|||
170888157|NCT03529773|617598292|FG024|Overall Study|No longer meets eligibility criteria|0|||
170888158|NCT03529773|617598293|FG025|Overall Study|No longer meets eligibility criteria|0|||
170634723|NCT01229267|616673265|FG002|Overall Study|Adverse Event|3|||
170634724|NCT01229267|616673266|FG003|Overall Study|Adverse Event|2|||
170634725|NCT01229267|616673267|FG004|Overall Study|Adverse Event|10|||
170634726|NCT01229267|616673263|FG000|Overall Study|Death|40|||
170634727|NCT01229267|616673264|FG001|Overall Study|Death|37|||
170634728|NCT01229267|616673265|FG002|Overall Study|Death|35|||
170634729|NCT01229267|616673266|FG003|Overall Study|Death|13|||
170634730|NCT01229267|616673267|FG004|Overall Study|Death|103|||
170634731|NCT01229267|616673263|FG000|Overall Study|Withdrawal by Subject|23|||
170634732|NCT01229267|616673264|FG001|Overall Study|Withdrawal by Subject|22|||
170634733|NCT01229267|616673265|FG002|Overall Study|Withdrawal by Subject|32|||
170634734|NCT01229267|616673266|FG003|Overall Study|Withdrawal by Subject|14|||
170634735|NCT01229267|616673267|FG004|Overall Study|Withdrawal by Subject|59|||
170634736|NCT01229267|616673263|FG000|Overall Study|Protocol Violation|0|||
170634737|NCT01229267|616673264|FG001|Overall Study|Protocol Violation|1|||
170541706|NCT04003805|616328066|FG000|Overall Study|Physician Decision|11|||
170541707|NCT04003805|616328066|FG000|Overall Study|Withdrawal by Subject|8|||
170541708|NCT04431726|616328067|FG000|Overall Study|Ongoing in the Study|55|||
170541709|NCT03732820|616328068|FG000|Overall Study|Death|168|||
170541710|NCT03732820|616328069|FG001|Overall Study|Death|203|||
170541711|NCT03732820|616328068|FG000|Overall Study|Other|2|||
170541712|NCT03732820|616328069|FG001|Overall Study|Other|2|||
170541713|NCT03732820|616328068|FG000|Overall Study|Failure to meet randomisation criteria|1|||
170541714|NCT03732820|616328069|FG001|Overall Study|Failure to meet randomisation criteria|1|||
170541715|NCT03732820|616328068|FG000|Overall Study|Patient decision|14|||
170541716|NCT03732820|616328069|FG001|Overall Study|Patient decision|10|||
170541717|NCT03732820|616328068|FG000|Overall Study|Screen failure|0|||
170541718|NCT03732820|616328069|FG001|Overall Study|Screen failure|1|||
170888159|NCT03529773|617598294|FG026|Overall Study|No longer meets eligibility criteria|0|||
170888160|NCT03529773|617598295|FG027|Overall Study|No longer meets eligibility criteria|0|||
170888161|NCT03529773|617598296|FG028|Overall Study|No longer meets eligibility criteria|0|||
170634738|NCT01229267|616673265|FG002|Overall Study|Protocol Violation|0|||
170541719|NCT03732820|616328068|FG000|Overall Study|Patients ongoing study at data cut off|210|||
170634739|NCT01229267|616673266|FG003|Overall Study|Protocol Violation|0|||
170634740|NCT01229267|616673267|FG004|Overall Study|Protocol Violation|0|||
170634741|NCT01229267|616673263|FG000|Overall Study|Progressive disease|0|||
170634742|NCT01229267|616673264|FG001|Overall Study|Progressive disease|0|||
170888162|NCT03529773|617598297|FG029|Overall Study|No longer meets eligibility criteria|0|||
170452428|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
170452429|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
170541720|NCT03732820|616328069|FG001|Overall Study|Patients ongoing study at data cut off|178|||
170541721|NCT03732820|616328068|FG000|Overall Study|Lost to Follow-up|4|||
170541722|NCT03732820|616328069|FG001|Overall Study|Lost to Follow-up|2|||
170634743|NCT01229267|616673265|FG002|Overall Study|Progressive disease|0|||
170634744|NCT01229267|616673266|FG003|Overall Study|Progressive disease|0|||
170452430|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
170452431|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
170452432|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
170452433|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
170452434|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
170452435|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
170452436|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Subject decision|1|||
170452437|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Subject decision|1|||
170452438|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
170452439|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
170452440|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
170888163|NCT03529773|617598298|FG030|Overall Study|No longer meets eligibility criteria|0|||
170888164|NCT03529773|617598299|FG031|Overall Study|No longer meets eligibility criteria|0|||
170888165|NCT03529773|617598300|FG032|Overall Study|No longer meets eligibility criteria|0|||
170888166|NCT03529773|617598301|FG033|Overall Study|No longer meets eligibility criteria|0|||
170888167|NCT03529773|617598302|FG034|Overall Study|No longer meets eligibility criteria|0|||
170888168|NCT03529773|617598303|FG035|Overall Study|No longer meets eligibility criteria|0|||
170888169|NCT03529773|617598304|FG036|Overall Study|No longer meets eligibility criteria|0|||
170888170|NCT03529773|617598305|FG037|Overall Study|No longer meets eligibility criteria|0|||
170888171|NCT03529773|617598306|FG038|Overall Study|No longer meets eligibility criteria|1|||
170888172|NCT03529773|617598307|FG039|Overall Study|No longer meets eligibility criteria|0|||
170888173|NCT03529773|617598268|FG000|Overall Study|Other|0|||
170888174|NCT03529773|617598269|FG001|Overall Study|Other|0|||
170888175|NCT03529773|617598270|FG002|Overall Study|Other|0|||
170888176|NCT03529773|617598271|FG003|Overall Study|Other|0|||
170888177|NCT03529773|617598272|FG004|Overall Study|Other|0|||
170888178|NCT03529773|617598273|FG005|Overall Study|Other|0|||
170888179|NCT03529773|617598274|FG006|Overall Study|Other|0|||
170888180|NCT03529773|617598275|FG007|Overall Study|Other|0|||
170888181|NCT03529773|617598276|FG008|Overall Study|Other|0|||
170452441|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
170452442|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
170452443|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
170452444|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
170452445|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
170452446|NCT00518882|615994616|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
170888182|NCT03529773|617598277|FG009|Overall Study|Other|0|||
170452447|NCT00518882|615994617|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
170452448|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
170452449|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
170452450|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
170452451|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
170452452|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
170452453|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
170452454|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
170452455|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
170452456|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
170452457|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
170452458|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
170452459|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
170452460|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
170452461|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
170452462|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
170452463|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
170452464|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
170452465|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
170452466|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
170452467|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
170452468|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
170452469|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
170452470|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
170452471|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
170452472|NCT00518882|615994616|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
170452473|NCT00518882|615994617|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
170452474|NCT04740931|615994618|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
170452475|NCT04740931|615994619|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
170888183|NCT03529773|617598278|FG010|Overall Study|Other|0|||
170888184|NCT03529773|617598279|FG011|Overall Study|Other|0|||
170888185|NCT03529773|617598280|FG012|Overall Study|Other|1|||
170888186|NCT03529773|617598281|FG013|Overall Study|Other|0|||
170888187|NCT03529773|617598282|FG014|Overall Study|Other|2|||
170634745|NCT01229267|616673267|FG004|Overall Study|Progressive disease|1|||
170634746|NCT01229267|616673263|FG000|Overall Study|Physician Decision|8|||
170634747|NCT01229267|616673264|FG001|Overall Study|Physician Decision|11|||
170634748|NCT01229267|616673265|FG002|Overall Study|Physician Decision|8|||
170634749|NCT01229267|616673266|FG003|Overall Study|Physician Decision|3|||
170634750|NCT01229267|616673267|FG004|Overall Study|Physician Decision|25|||
170634751|NCT01229267|616673263|FG000|Overall Study|Lost to Follow-up|6|||
170634752|NCT01229267|616673264|FG001|Overall Study|Lost to Follow-up|5|||
170634753|NCT01229267|616673265|FG002|Overall Study|Lost to Follow-up|8|||
170634754|NCT01229267|616673266|FG003|Overall Study|Lost to Follow-up|3|||
170634755|NCT01229267|616673267|FG004|Overall Study|Lost to Follow-up|22|||
170634756|NCT00808080|616673270|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
170634757|NCT03085797|616673273|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
170634758|NCT03085797|616673274|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
170634759|NCT03085797|616673273|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
170634760|NCT03085797|616673274|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
170634761|NCT03085797|616673273|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
170634762|NCT03085797|616673274|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
170634763|NCT01837823|616673275|FG000|Overall Study|Lost to Follow-up|6|||
170634764|NCT02803580|616673276|FG000|Overall Study|Death|13|||
170634765|NCT02803580|616673276|FG000|Overall Study|Lost to Follow-up|19|||
170634766|NCT02803580|616673276|FG000|Overall Study|Withdrawal by Subject|3|||
170634767|NCT02803580|616673276|FG000|Overall Study|Inclusion in clinical trial|1|||
170634768|NCT03052400|616673277|FG000|Overall Study|Lost to Follow-up|1|||
170634769|NCT03052400|616673278|FG001|Overall Study|Lost to Follow-up|0|||
170634770|NCT03052400|616673277|FG000|Overall Study|Withdrawal by Subject|0|||
170634771|NCT03052400|616673278|FG001|Overall Study|Withdrawal by Subject|1|||
170634772|NCT00831181|616673279|FG000|Overall Study|Adverse Event|12|||
170634773|NCT01411891|616673281|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
170634774|NCT01411891|616673282|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
170634775|NCT04614974|616673283|FG000|Overall Study|Lost to Follow-up|14|||
170634776|NCT04614974|616673284|FG001|Overall Study|Lost to Follow-up|11|||
170634777|NCT03133793|616673286|FG000|Overall Study|Withdrawal by Subject|0|||
170634778|NCT03133793|616673287|FG001|Overall Study|Withdrawal by Subject|4|||
170634779|NCT03133793|616673288|FG002|Overall Study|Withdrawal by Subject|2|||
170634780|NCT03133793|616673289|FG003|Overall Study|Withdrawal by Subject|4|||
170634781|NCT03133793|616673286|FG000|Overall Study|Lost to Follow-up|1|||
170634782|NCT03133793|616673287|FG001|Overall Study|Lost to Follow-up|0|||
170634783|NCT03133793|616673288|FG002|Overall Study|Lost to Follow-up|2|||
170634784|NCT03133793|616673289|FG003|Overall Study|Lost to Follow-up|0|||
170634785|NCT03133793|616673286|FG000|Overall Study|Death|0|||
170634786|NCT03133793|616673287|FG001|Overall Study|Death|0|||
170634787|NCT03133793|616673288|FG002|Overall Study|Death|0|||
170634788|NCT03133793|616673289|FG003|Overall Study|Death|1|||
170634789|NCT00687193|616673290|FG000|Overall Study|Adverse Event|0|||
170634790|NCT00687193|616673291|FG001|Overall Study|Adverse Event|1|||
170634791|NCT00687193|616673292|FG002|Overall Study|Adverse Event|2|||
170634792|NCT00687193|616673293|FG003|Overall Study|Adverse Event|3|||
170634793|NCT00687193|616673294|FG004|Overall Study|Adverse Event|0|||
170787246|NCT01186367|617231738|FG002|Overall Study|Did not receive study treatment|0|||
170787247|NCT05543915|617231740|FG000|Overall Study|Lost to Follow-up|0|||
170787248|NCT05543915|617231741|FG001|Overall Study|Lost to Follow-up|1|||
170787249|NCT06491433|617231742|FG000|Overall Study|Protocol Violation|51|||
170787250|NCT06491433|617231742|FG000|Overall Study|consent withdrawal|2|||
170787251|NCT06491433|617231742|FG000|Overall Study|screen failure|1|||
170787252|NCT04749615|617231743|FG000|Overall Study|Lost to Follow-up|6|||
170787253|NCT04749615|617231744|FG001|Overall Study|Lost to Follow-up|10|||
170787254|NCT03194217|617231745|FG000|Overall Study|Adverse Event|0|||
170787255|NCT03194217|617231746|FG001|Overall Study|Adverse Event|2|||
170787256|NCT03194217|617231747|FG002|Overall Study|Adverse Event|3|||
170787257|NCT03194217|617231748|FG003|Overall Study|Adverse Event|3|||
170787258|NCT03194217|617231745|FG000|Overall Study|Failure to meet randomisation criteria|0|||
170787259|NCT03194217|617231746|FG001|Overall Study|Failure to meet randomisation criteria|0|||
170787260|NCT03194217|617231747|FG002|Overall Study|Failure to meet randomisation criteria|0|||
170787261|NCT03194217|617231748|FG003|Overall Study|Failure to meet randomisation criteria|1|||
170787262|NCT03194217|617231745|FG000|Overall Study|Other|0|||
170787263|NCT03194217|617231746|FG001|Overall Study|Other|1|||
170787264|NCT03194217|617231747|FG002|Overall Study|Other|1|||
170787265|NCT03194217|617231748|FG003|Overall Study|Other|0|||
170787266|NCT02962895|617231749|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
170787267|NCT02962895|617231750|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
170634794|NCT00687193|616673295|FG005|Overall Study|Adverse Event|2|||
170787268|NCT02962895|617231751|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
170787269|NCT02962895|617231752|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
170634795|NCT00687193|616673290|FG000|Overall Study|Lack of Efficacy|1|||
170787270|NCT02962895|617231753|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
170888188|NCT03529773|617598283|FG015|Overall Study|Other|0|||
170888189|NCT03529773|617598284|FG016|Overall Study|Other|0|||
170888190|NCT03529773|617598285|FG017|Overall Study|Other|3|||
170888191|NCT03529773|617598286|FG018|Overall Study|Other|0|||
170888192|NCT03529773|617598287|FG019|Overall Study|Other|0|||
170888193|NCT03529773|617598288|FG020|Overall Study|Other|1|||
170888194|NCT03529773|617598289|FG021|Overall Study|Other|0|||
170888195|NCT03529773|617598290|FG022|Overall Study|Other|1|||
170634796|NCT00687193|616673291|FG001|Overall Study|Lack of Efficacy|1|||
170634797|NCT00687193|616673292|FG002|Overall Study|Lack of Efficacy|0|||
170452476|NCT04740931|615994618|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
170452477|NCT04740931|615994619|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
170452478|NCT04740931|615994618|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
170452479|NCT04740931|615994619|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
170452480|NCT04740931|615994618|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
170452481|NCT04740931|615994619|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
170452482|NCT04740931|615994618|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
170452483|NCT04740931|615994619|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
170452484|NCT04740931|615994618|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
170452485|NCT04740931|615994619|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
170452486|NCT04740931|615994618|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
170452487|NCT04740931|615994619|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
170452488|NCT04740931|615994618|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
170452489|NCT04740931|615994619|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
170452490|NCT04740931|615994618|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
170452491|NCT04740931|615994619|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
170452492|NCT04740931|615994618|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
170452493|NCT04740931|615994619|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
170452494|NCT04740931|615994618|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
170452495|NCT04740931|615994619|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
170452496|NCT04740931|615994618|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
170452497|NCT04740931|615994619|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
170452498|NCT04740931|615994618|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
170452499|NCT04740931|615994619|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
170452500|NCT04740931|615994618|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
170452501|NCT04740931|615994619|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
170452502|NCT04740931|615994618|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
170452503|NCT04740931|615994619|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
170452504|NCT00063882|615994621|FG000|Overall Study|Protocol Violation|3|||
170634798|NCT00687193|616673293|FG003|Overall Study|Lack of Efficacy|0|||
170634799|NCT00687193|616673294|FG004|Overall Study|Lack of Efficacy|0|||
170634800|NCT00687193|616673295|FG005|Overall Study|Lack of Efficacy|2|||
170634801|NCT00687193|616673290|FG000|Overall Study|Protocol Violation|1|||
170452505|NCT00063882|615994622|FG001|Overall Study|Protocol Violation|3|||
170452506|NCT00063882|615994621|FG000|Overall Study|Withdrawal by Subject|2|||
170452507|NCT00063882|615994622|FG001|Overall Study|Withdrawal by Subject|1|||
170452508|NCT01534637|615994623|FG000|Overall Study|Physician Decision|3|||
170452509|NCT01534637|615994623|FG000|Overall Study|Lack of Efficacy|3|||
170452510|NCT01534637|615994623|FG000|Overall Study|Withdrawal by Subject|1|||
170452511|NCT01534637|615994623|FG000|Overall Study|Adverse Event|1|||
170452512|NCT01534637|615994623|FG000|Overall Study|Liver Mets before treatment|1|||
170452513|NCT02903238|615994624|FG000|Overall Study|Lost to Follow-up|4|||
170452514|NCT01298778|615994626|FG000|Overall Study|Lost to Follow-up|2|||
170452515|NCT01298778|615994627|FG001|Overall Study|Lost to Follow-up|3|||
170452516|NCT01298778|615994626|FG000|Overall Study|Incorrect use of VAS|1|||
170452517|NCT01298778|615994627|FG001|Overall Study|Incorrect use of VAS|0|||
170452518|NCT01298778|615994626|FG000|Overall Study|Withdrawal by Subject|0|||
170452519|NCT01298778|615994627|FG001|Overall Study|Withdrawal by Subject|1|||
170452520|NCT01298778|615994626|FG000|Overall Study|Protocol Violation|0|||
170452521|NCT01298778|615994627|FG001|Overall Study|Protocol Violation|1|||
170452522|NCT01298778|615994626|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
170452523|NCT01298778|615994627|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
170452524|NCT02777918|615994633|FG000|Overall Study|Medical reasons|1|||
170452525|NCT02777918|615994634|FG001|Overall Study|Medical reasons|2|||
170452526|NCT02777918|615994633|FG000|Overall Study|Too busy / stressed|1|||
170452527|NCT02777918|615994634|FG001|Overall Study|Too busy / stressed|1|||
170452528|NCT02777918|615994633|FG000|Overall Study|Withdrawal by Subject|1|||
170452529|NCT02777918|615994634|FG001|Overall Study|Withdrawal by Subject|1|||
170452530|NCT00606502|615994637|FG000|Randomization|Randomized but not treated|3|||
170452531|NCT00606502|615994638|FG001|Randomization|Randomized but not treated|0|||
170452532|NCT00606502|615994637|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
170452533|NCT00606502|615994638|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
170634802|NCT00687193|616673291|FG001|Overall Study|Protocol Violation|2|||
170888196|NCT03529773|617598291|FG023|Overall Study|Other|0|||
170888197|NCT03529773|617598292|FG024|Overall Study|Other|3|||
170888198|NCT03529773|617598293|FG025|Overall Study|Other|2|||
170452534|NCT02510014|615994640|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
170452535|NCT02510014|615994641|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
170452536|NCT02510014|615994640|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
170452537|NCT02510014|615994641|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
170452538|NCT02510014|615994640|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
170452539|NCT02510014|615994641|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
170452540|NCT02510014|615994640|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
170452541|NCT02510014|615994641|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
170452542|NCT02510014|615994640|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
170452543|NCT02510014|615994641|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
170452544|NCT02510014|615994640|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
170452545|NCT02510014|615994641|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
170452546|NCT02510014|615994640|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
170452547|NCT02510014|615994641|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
170452548|NCT02510014|615994640|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
170452549|NCT02510014|615994641|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
170452550|NCT02510014|615994640|FG000|Treatment Period|Adverse Event|11|||
170452551|NCT02510014|615994641|FG001|Treatment Period|Adverse Event|4|||
170452552|NCT02510014|615994640|FG000|Treatment Period|Withdrawal symptoms|3|||
170452553|NCT02510014|615994641|FG001|Treatment Period|Withdrawal symptoms|0|||
170452554|NCT02510014|615994640|FG000|Treatment Period|Lost to Follow-up|80|||
170452555|NCT02510014|615994641|FG001|Treatment Period|Lost to Follow-up|19|||
170452556|NCT02510014|615994640|FG000|Treatment Period|Physician Decision|5|||
170452557|NCT02510014|615994641|FG001|Treatment Period|Physician Decision|0|||
170452558|NCT02510014|615994640|FG000|Treatment Period|Withdrawal by Subject|67|||
170452559|NCT02510014|615994641|FG001|Treatment Period|Withdrawal by Subject|24|||
170452560|NCT02510014|615994640|FG000|Treatment Period|Withdrawn by the investigator|7|||
170452561|NCT02510014|615994641|FG001|Treatment Period|Withdrawn by the investigator|1|||
170452562|NCT02510014|615994640|FG000|Treatment Period|Protocol Violation|4|||
170452563|NCT02510014|615994641|FG001|Treatment Period|Protocol Violation|4|||
170452564|NCT02510014|615994640|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
170452565|NCT02510014|615994641|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
170452566|NCT01949116|615994648|FG000|Overall Study|Death|2|||
170452567|NCT01949116|615994649|FG001|Overall Study|Death|0|||
170452568|NCT01949116|615994648|FG000|Overall Study|Lost to Follow-up|1|||
170452569|NCT01949116|615994649|FG001|Overall Study|Lost to Follow-up|3|||
170452570|NCT01949116|615994648|FG000|Overall Study|Withdrawal by Subject|5|||
170452571|NCT01949116|615994649|FG001|Overall Study|Withdrawal by Subject|3|||
170452572|NCT00049842|615994658|FG000|Treatment Phase|Adverse Event|47|||
170452573|NCT00049842|615994659|FG001|Treatment Phase|Adverse Event|12|||
170452574|NCT00049842|615994658|FG000|Treatment Phase|Withdrawal by Subject|35|||
170452575|NCT00049842|615994659|FG001|Treatment Phase|Withdrawal by Subject|46|||
170452576|NCT00049842|615994658|FG000|Treatment Phase|Non-compliance with protocol|7|||
170452577|NCT00049842|615994659|FG001|Treatment Phase|Non-compliance with protocol|8|||
170452578|NCT00049842|615994658|FG000|Treatment Phase|Lost to Follow-up|4|||
170452579|NCT00049842|615994659|FG001|Treatment Phase|Lost to Follow-up|8|||
170452580|NCT00049842|615994658|FG000|Treatment Phase|Administrative|0|||
170452581|NCT00049842|615994659|FG001|Treatment Phase|Administrative|3|||
170452582|NCT00049842|615994658|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
170452583|NCT00049842|615994659|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
170452584|NCT00049842|615994658|FG000|Follow-up Phase|Adverse Event|6|||
170452585|NCT00049842|615994659|FG001|Follow-up Phase|Adverse Event|1|||
170452586|NCT00049842|615994658|FG000|Follow-up Phase|Other|1|||
170452587|NCT00049842|615994659|FG001|Follow-up Phase|Other|4|||
170888199|NCT03529773|617598294|FG026|Overall Study|Other|2|||
170888200|NCT03529773|617598295|FG027|Overall Study|Other|0|||
170888201|NCT03529773|617598296|FG028|Overall Study|Other|0|||
170888202|NCT03529773|617598297|FG029|Overall Study|Other|0|||
170888203|NCT03529773|617598298|FG030|Overall Study|Other|0|||
170888204|NCT03529773|617598299|FG031|Overall Study|Other|0|||
170888205|NCT03529773|617598300|FG032|Overall Study|Other|0|||
170888206|NCT03529773|617598301|FG033|Overall Study|Other|0|||
170888207|NCT03529773|617598302|FG034|Overall Study|Other|1|||
170888208|NCT03529773|617598303|FG035|Overall Study|Other|1|||
170888209|NCT03529773|617598304|FG036|Overall Study|Other|0|||
170452588|NCT00307931|615994663|FG000|Overall Study|Adverse Event|1|||
170452589|NCT00430950|615994664|FG000|Overall Study|Adverse Event|7|||
170452590|NCT00430950|615994665|FG001|Overall Study|Adverse Event|6|||
170541723|NCT03301714|616328070|FG000|Overall Study|Lost to Follow-up|10|||
170541724|NCT03301714|616328071|FG001|Overall Study|Lost to Follow-up|4|||
170888210|NCT03529773|617598305|FG037|Overall Study|Other|0|||
170888211|NCT03529773|617598306|FG038|Overall Study|Other|0|||
170888212|NCT03529773|617598307|FG039|Overall Study|Other|0|||
170888213|NCT03529773|617598268|FG000|Overall Study|Physician Decision|0|||
170452591|NCT00430950|615994664|FG000|Overall Study|Withdrawal by Subject|1|||
170452592|NCT00430950|615994665|FG001|Overall Study|Withdrawal by Subject|0|||
170787271|NCT02962895|617231754|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
170787272|NCT02962895|617231755|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
170787273|NCT02962895|617231749|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
170787274|NCT02962895|617231750|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
170787275|NCT02962895|617231751|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
170787276|NCT02962895|617231752|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
170787277|NCT02962895|617231753|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
170787278|NCT02962895|617231754|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
170787279|NCT02962895|617231755|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
170787280|NCT02962895|617231749|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
170787281|NCT02962895|617231750|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
170787282|NCT02962895|617231751|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
170787283|NCT02962895|617231752|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
170787284|NCT02962895|617231753|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
170787285|NCT02962895|617231754|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
170787286|NCT02962895|617231755|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
170787287|NCT02962895|617231749|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
170787288|NCT02962895|617231750|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
170787289|NCT02962895|617231751|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
170787290|NCT02962895|617231752|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
170787291|NCT02962895|617231753|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
170787292|NCT02962895|617231754|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
170787293|NCT02962895|617231755|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
170787294|NCT02962895|617231749|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
170787295|NCT02962895|617231750|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
170787296|NCT02962895|617231751|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
170787297|NCT02962895|617231752|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
170787298|NCT02962895|617231753|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
170787299|NCT02962895|617231754|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
170787300|NCT02962895|617231755|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
170787301|NCT02962895|617231749|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
170787302|NCT02962895|617231750|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
170787303|NCT02962895|617231751|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
170787304|NCT02962895|617231752|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
170787305|NCT02962895|617231753|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
170787306|NCT02962895|617231754|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
170787307|NCT02962895|617231755|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
170787308|NCT02962895|617231749|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
170787309|NCT02962895|617231750|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
170787310|NCT02962895|617231751|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
170787311|NCT02962895|617231752|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
170787312|NCT02962895|617231753|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
170787313|NCT02962895|617231754|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
170787314|NCT02962895|617231755|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
170787315|NCT02962895|617231749|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
170787316|NCT02962895|617231750|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
170787317|NCT02962895|617231751|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
170787318|NCT02962895|617231752|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
170787319|NCT02962895|617231753|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
170787320|NCT02962895|617231754|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
170787321|NCT02962895|617231755|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
170787322|NCT02962895|617231749|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
170787323|NCT02962895|617231750|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
170787324|NCT02962895|617231751|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
170787325|NCT02962895|617231752|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
170787326|NCT02962895|617231753|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
170787327|NCT02962895|617231754|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
170787328|NCT02962895|617231755|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
170787329|NCT02962895|617231749|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
170452593|NCT00430950|615994664|FG000|Overall Study|concomitant medication,etc.|5|||
170452594|NCT00430950|615994665|FG001|Overall Study|concomitant medication,etc.|7|||
170452595|NCT00831623|615994672|FG000|Overall Study|Withdrawal by Subject|9|||
170452596|NCT00831623|615994672|FG000|Overall Study|Lost to Follow-up|1|||
170452597|NCT00831623|615994672|FG000|Overall Study|Not 2 years post-treatment|12|||
170452598|NCT01138111|615994679|FG000|Overall Study|Withdrawal by Subject|5|||
170452599|NCT01138111|615994679|FG000|Overall Study|Adverse Event|1|||
170452600|NCT01138111|615994679|FG000|Overall Study|Death|1|||
170452601|NCT01138111|615994679|FG000|Overall Study|Lost to Follow-up|2|||
170452602|NCT03069417|615994680|FG000|Overall Study|Lost to Follow-up|2|||
170452603|NCT03069417|615994681|FG001|Overall Study|Lost to Follow-up|0|||
170452604|NCT03069417|615994680|FG000|Overall Study|Reason Unknown|4|||
170452605|NCT03069417|615994681|FG001|Overall Study|Reason Unknown|7|||
170452606|NCT00440115|615994682|FG000|Overall Study|Death|7|||
170452607|NCT00440115|615994683|FG001|Overall Study|Death|9|||
170452608|NCT00440115|615994684|FG002|Overall Study|Death|5|||
170452609|NCT00440115|615994682|FG000|Overall Study|Incarceration|0|||
170452610|NCT00440115|615994683|FG001|Overall Study|Incarceration|2|||
170452611|NCT00440115|615994684|FG002|Overall Study|Incarceration|1|||
170452612|NCT01118117|615994685|FG000|Overall Study|Death|8|||
170452613|NCT01118117|615994686|FG001|Overall Study|Death|0|||
170452614|NCT01118117|615994685|FG000|Overall Study|Lost to Follow-up|6|||
170452615|NCT01118117|615994686|FG001|Overall Study|Lost to Follow-up|0|||
170452616|NCT01118117|615994685|FG000|Overall Study|Missed 12 Month Visit|7|||
170452617|NCT01118117|615994686|FG001|Overall Study|Missed 12 Month Visit|0|||
170452618|NCT02746627|615994689|FG000|Overall Study|Withdrawal by Subject|1|||
170452619|NCT02746627|615994690|FG001|Overall Study|Withdrawal by Subject|1|||
170452620|NCT02746627|615994691|FG002|Overall Study|Withdrawal by Subject|1|||
170452621|NCT01688726|615994692|FG000|Overall Study|Adverse Event|1|||
170452622|NCT01688726|615994693|FG001|Overall Study|Adverse Event|0|||
170452623|NCT01688726|615994692|FG000|Overall Study|Relocated abroad|0|||
170452624|NCT01688726|615994693|FG001|Overall Study|Relocated abroad|1|||
170452625|NCT04553913|615994694|FG000|Overall Study|patient's block resolved prior to PACU|1|||
170452626|NCT04553913|615994694|FG000|Overall Study|did not use the device properly|5|||
170452627|NCT01481324|615994695|FG000|Overall Study|Missing Data|0|||
170787330|NCT02962895|617231750|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
170787331|NCT02962895|617231751|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
170787332|NCT02962895|617231752|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
170787333|NCT02962895|617231753|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
170787334|NCT02962895|617231754|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
170787335|NCT02962895|617231755|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
170787336|NCT02962895|617231749|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
170787337|NCT02962895|617231750|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
170787338|NCT02962895|617231751|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
170787339|NCT02962895|617231752|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
170787340|NCT02962895|617231753|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
170787341|NCT02962895|617231754|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
170787342|NCT02962895|617231755|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
170787343|NCT02962895|617231749|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
170787344|NCT02962895|617231750|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
170787345|NCT02962895|617231751|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
170787346|NCT02962895|617231752|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
170787347|NCT02962895|617231753|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
170787348|NCT02962895|617231754|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
170787349|NCT02962895|617231755|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
170452628|NCT01481324|615994696|FG001|Overall Study|Missing Data|2|||
170452629|NCT01481324|615994697|FG002|Overall Study|Missing Data|2|||
170452630|NCT00710749|615994700|FG000|First Intervention|Withdrawal by Subject|1|||
170452631|NCT00710749|615994701|FG001|First Intervention|Withdrawal by Subject|0|||
170452632|NCT04189445|615995995|FG000|Overall Study|Withdrawal of consent|8|||
170452633|NCT04189445|615995996|FG001|Overall Study|Withdrawal of consent|1|||
170452634|NCT04189445|615995997|FG002|Overall Study|Withdrawal of consent|0|||
170452635|NCT04189445|615995995|FG000|Overall Study|Study Terminated by Sponsor|25|||
170452636|NCT04189445|615995996|FG001|Overall Study|Study Terminated by Sponsor|3|||
170452637|NCT04189445|615995997|FG002|Overall Study|Study Terminated by Sponsor|0|||
170452638|NCT04189445|615995995|FG000|Overall Study|Death|54|||
170452639|NCT04189445|615995996|FG001|Overall Study|Death|24|||
170452640|NCT04189445|615995997|FG002|Overall Study|Death|0|||
170787350|NCT02962895|617231749|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
170452641|NCT03959527|615995998|FG000|Overall Study|Withdrawal by Subject|8|||
170452642|NCT03959527|615995999|FG001|Overall Study|Withdrawal by Subject|3|||
170452643|NCT03959527|615995998|FG000|Overall Study|Lost to Follow-up|31|||
170452644|NCT03959527|615995999|FG001|Overall Study|Lost to Follow-up|15|||
170452645|NCT03959527|615995998|FG000|Overall Study|Did not meet eligibility criteria|1|||
170452646|NCT03959527|615995999|FG001|Overall Study|Did not meet eligibility criteria|1|||
170452647|NCT03959527|615995998|FG000|Overall Study|Protocol Violation|10|||
170888214|NCT03529773|617598269|FG001|Overall Study|Physician Decision|0|||
170452648|NCT03959527|615995999|FG001|Overall Study|Protocol Violation|5|||
170452649|NCT01000610|615996004|FG000|Overall Study|Adverse Event|1|||
170452650|NCT01000610|615996004|FG000|Overall Study|Lost to Follow-up|4|||
170452651|NCT01000610|615996004|FG000|Overall Study|Treatment failure|1|||
170452652|NCT01013649|615996005|FG000|First Step|Withdrawal by Subject|36|||
170452653|NCT01013649|615996006|FG001|First Step|Withdrawal by Subject|19|||
170452654|NCT01013649|615996007|FG002|First Step|Withdrawal by Subject|0|||
170452655|NCT01013649|615996008|FG003|First Step|Withdrawal by Subject|0|||
170452656|NCT01013649|615996005|FG000|First Step|Progression|58|||
170452657|NCT01013649|615996006|FG001|First Step|Progression|23|||
170452658|NCT01013649|615996007|FG002|First Step|Progression|0|||
170452659|NCT01013649|615996008|FG003|First Step|Progression|0|||
170452660|NCT01013649|615996005|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
170452661|NCT01013649|615996006|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
170452662|NCT01013649|615996007|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
170452663|NCT01013649|615996008|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
170452664|NCT01013649|615996005|FG000|First Step|Death|3|||
170452665|NCT01013649|615996006|FG001|First Step|Death|4|||
170452666|NCT01013649|615996007|FG002|First Step|Death|0|||
170452667|NCT01013649|615996008|FG003|First Step|Death|0|||
170452668|NCT01013649|615996005|FG000|First Step|Adverse Event|9|||
170452669|NCT01013649|615996006|FG001|First Step|Adverse Event|5|||
170452670|NCT01013649|615996007|FG002|First Step|Adverse Event|0|||
170452671|NCT01013649|615996008|FG003|First Step|Adverse Event|0|||
170452672|NCT01013649|615996005|FG000|First Step|Other|4|||
170452673|NCT01013649|615996006|FG001|First Step|Other|6|||
170452674|NCT01013649|615996007|FG002|First Step|Other|0|||
170452675|NCT01013649|615996008|FG003|First Step|Other|0|||
170452676|NCT01592721|615996009|FG000|Long-term Follow-up|Death|1|||
170452677|NCT02246439|615996011|FG000|Overall Study|Adverse Event|3|||
170452678|NCT02246439|615996012|FG001|Overall Study|Adverse Event|0|||
170452679|NCT02246439|615996011|FG000|Overall Study|Lost to Follow-up|7|||
170452680|NCT02246439|615996012|FG001|Overall Study|Lost to Follow-up|5|||
170452681|NCT02246439|615996011|FG000|Overall Study|Protocol Violation|0|||
170452682|NCT02246439|615996012|FG001|Overall Study|Protocol Violation|2|||
170452683|NCT02246439|615996011|FG000|Overall Study|Physician Decision|0|||
170452684|NCT02246439|615996012|FG001|Overall Study|Physician Decision|1|||
170452685|NCT02246439|615996011|FG000|Overall Study|Unkonwn|1|||
170452686|NCT02246439|615996012|FG001|Overall Study|Unkonwn|3|||
170452687|NCT02246439|615996011|FG000|Overall Study|Withdrawal by Subject|1|||
170452688|NCT02246439|615996012|FG001|Overall Study|Withdrawal by Subject|0|||
170452689|NCT02698865|615996016|FG000|Overall Study|Other|11|||
170452690|NCT02698865|615996017|FG001|Overall Study|Other|11|||
170452691|NCT02698865|615996016|FG000|Overall Study|Withdrawal by Subject|20|||
170452692|NCT02698865|615996017|FG001|Overall Study|Withdrawal by Subject|16|||
170452693|NCT02698865|615996016|FG000|Overall Study|Physician Decision|0|||
170452694|NCT02698865|615996017|FG001|Overall Study|Physician Decision|4|||
170452695|NCT02698865|615996016|FG000|Overall Study|Lost to Follow-up|4|||
170452696|NCT02698865|615996017|FG001|Overall Study|Lost to Follow-up|2|||
170452697|NCT04109313|615996020|FG000|Overall Study|Pregnancy|1|||
170452698|NCT04109313|615996020|FG000|Overall Study|Adverse Event|11|||
170452699|NCT04109313|615996020|FG000|Overall Study|Lack of Efficacy|11|||
170452700|NCT04109313|615996020|FG000|Overall Study|Lost to Follow-up|1|||
170452701|NCT04109313|615996020|FG000|Overall Study|Physician Decision|2|||
170452702|NCT04109313|615996020|FG000|Overall Study|Subject Decision|13|||
170452703|NCT04109313|615996020|FG000|Overall Study|Covid-19 situation|2|||
170452704|NCT02113189|615996023|FG000|Overall Study|Lost to follow up|2|||
170452705|NCT02113189|615996024|FG001|Overall Study|Lost to follow up|1|||
170452706|NCT02113189|615996025|FG002|Overall Study|Lost to follow up|3|||
170452707|NCT04268316|615996026|FG000|Overall Study|Withdrawal by Subject|2|||
170452708|NCT04268316|615996027|FG001|Overall Study|Withdrawal by Subject|1|||
170452709|NCT04268316|615996028|FG002|Overall Study|Withdrawal by Subject|0|||
170452710|NCT02040779|615996031|FG000|Overall Study|Adverse Event|1|||
170452711|NCT02040779|615996032|FG001|Overall Study|Adverse Event|0|||
170452712|NCT02040779|615996033|FG002|Overall Study|Adverse Event|0|||
170452713|NCT02040779|615996031|FG000|Overall Study|Withdrawal by Subject|4|||
170452714|NCT02040779|615996032|FG001|Overall Study|Withdrawal by Subject|1|||
170452715|NCT02040779|615996033|FG002|Overall Study|Withdrawal by Subject|3|||
170452716|NCT02040779|615996031|FG000|Overall Study|Non-compliance|0|||
170452717|NCT02040779|615996032|FG001|Overall Study|Non-compliance|1|||
170452718|NCT02040779|615996033|FG002|Overall Study|Non-compliance|0|||
170452719|NCT02040779|615996031|FG000|Overall Study|Protocol Violation|2|||
170452720|NCT02040779|615996032|FG001|Overall Study|Protocol Violation|1|||
170452721|NCT02040779|615996033|FG002|Overall Study|Protocol Violation|0|||
170452722|NCT02040779|615996031|FG000|Overall Study|Lost to Follow-up|1|||
170452723|NCT02040779|615996032|FG001|Overall Study|Lost to Follow-up|2|||
170452724|NCT02040779|615996033|FG002|Overall Study|Lost to Follow-up|1|||
170452725|NCT02040779|615996031|FG000|Overall Study|Lack of Efficacy|4|||
170452726|NCT02040779|615996032|FG001|Overall Study|Lack of Efficacy|2|||
170452727|NCT02040779|615996033|FG002|Overall Study|Lack of Efficacy|0|||
170452728|NCT03702049|615996034|FG000|Overall Study|Lost to Follow-up|4|||
170452729|NCT03702049|615996034|FG000|Overall Study|Physician Decision|1|||
170452730|NCT03197558|615996035|FG000|Overall Study|Tubes not placed|1|||
170452731|NCT00866658|615996036|FG000|Overall Study|Adverse Event|5|||
170452732|NCT00866658|615996037|FG001|Overall Study|Adverse Event|14|||
170452733|NCT00866658|615996036|FG000|Overall Study|Lack of Efficacy|2|||
170452734|NCT00866658|615996037|FG001|Overall Study|Lack of Efficacy|1|||
170452735|NCT00866658|615996036|FG000|Overall Study|Withdrawal by Subject|1|||
170452736|NCT00866658|615996037|FG001|Overall Study|Withdrawal by Subject|0|||
170452737|NCT00866658|615996036|FG000|Overall Study|Protocol Violation|1|||
170452738|NCT00866658|615996037|FG001|Overall Study|Protocol Violation|1|||
170452739|NCT00866658|615996036|FG000|Overall Study|Familial and Personal Reasons|4|||
170452740|NCT00866658|615996037|FG001|Overall Study|Familial and Personal Reasons|5|||
170452741|NCT01304693|615996046|FG000|Overall Study|Adverse Event|0|||
170452742|NCT01304693|615996047|FG001|Overall Study|Adverse Event|0|||
170452743|NCT01304693|615996048|FG002|Overall Study|Adverse Event|0|||
170452744|NCT01304693|615996049|FG003|Overall Study|Adverse Event|0|||
170452745|NCT01304693|615996050|FG004|Overall Study|Adverse Event|1|||
170452746|NCT01304693|615996046|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
170452747|NCT01304693|615996047|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
170452748|NCT01304693|615996048|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
170452749|NCT01304693|615996049|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
170452750|NCT01304693|615996050|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
170452751|NCT00931268|615996051|FG000|Overall Study|Lost to Follow-up|6|||
170452752|NCT02072148|615996054|FG000|Overall Study|withdrew prior to surgery|23|||
170452753|NCT02072148|615996055|FG001|Overall Study|withdrew prior to surgery|0|||
170452754|NCT02072148|615996056|FG002|Overall Study|withdrew prior to surgery|0|||
170452755|NCT02072148|615996054|FG000|Overall Study|Death|0|||
170452756|NCT02072148|615996055|FG001|Overall Study|Death|0|||
170541725|NCT03301714|616328072|FG002|Overall Study|Lost to Follow-up|4|||
170541726|NCT03301714|616328070|FG000|Overall Study|Did not receive allocated intervention|0|||
170541727|NCT03301714|616328071|FG001|Overall Study|Did not receive allocated intervention|2|||
170541728|NCT03301714|616328072|FG002|Overall Study|Did not receive allocated intervention|3|||
170541729|NCT03188185|616328073|FG000|Stage 1|Adverse Event|4|||
170541730|NCT03188185|616328074|FG001|Stage 1|Adverse Event|12|||
170541731|NCT03188185|616328075|FG002|Stage 1|Adverse Event|0|||
170541732|NCT03188185|616328076|FG003|Stage 1|Adverse Event|0|||
170541733|NCT03188185|616328073|FG000|Stage 1|Lack of Efficacy|0|||
170541734|NCT03188185|616328074|FG001|Stage 1|Lack of Efficacy|2|||
170541735|NCT03188185|616328075|FG002|Stage 1|Lack of Efficacy|0|||
170541736|NCT03188185|616328076|FG003|Stage 1|Lack of Efficacy|0|||
170541737|NCT03188185|616328073|FG000|Stage 1|Lost to Follow-up|6|||
170541738|NCT03188185|616328074|FG001|Stage 1|Lost to Follow-up|1|||
170541739|NCT03188185|616328075|FG002|Stage 1|Lost to Follow-up|0|||
170541740|NCT03188185|616328076|FG003|Stage 1|Lost to Follow-up|0|||
170541741|NCT03188185|616328073|FG000|Stage 1|Withdrawal by Subject|9|||
170541742|NCT03188185|616328074|FG001|Stage 1|Withdrawal by Subject|0|||
170541743|NCT03188185|616328075|FG002|Stage 1|Withdrawal by Subject|0|||
170541744|NCT03188185|616328076|FG003|Stage 1|Withdrawal by Subject|0|||
170541745|NCT03188185|616328073|FG000|Stage 1|Identified as a professional patient|0|||
170541746|NCT03188185|616328074|FG001|Stage 1|Identified as a professional patient|1|||
170541747|NCT03188185|616328075|FG002|Stage 1|Identified as a professional patient|0|||
170541748|NCT03188185|616328076|FG003|Stage 1|Identified as a professional patient|0|||
170541749|NCT03188185|616328073|FG000|Stage 2|Adverse Event|0|||
170541750|NCT03188185|616328074|FG001|Stage 2|Adverse Event|0|||
170541751|NCT03188185|616328075|FG002|Stage 2|Adverse Event|2|||
170541752|NCT03188185|616328076|FG003|Stage 2|Adverse Event|4|||
170888215|NCT03529773|617598270|FG002|Overall Study|Physician Decision|0|||
170888216|NCT03529773|617598271|FG003|Overall Study|Physician Decision|0|||
170888217|NCT03529773|617598272|FG004|Overall Study|Physician Decision|0|||
170452757|NCT02072148|615996056|FG002|Overall Study|Death|1|||
170452758|NCT02072148|615996054|FG000|Overall Study|Withdrawal by Subject|0|||
170888218|NCT03529773|617598273|FG005|Overall Study|Physician Decision|0|||
170452759|NCT02072148|615996055|FG001|Overall Study|Withdrawal by Subject|13|||
170452760|NCT02072148|615996056|FG002|Overall Study|Withdrawal by Subject|12|||
170452761|NCT00430495|615996057|FG000|Overall Study|Adverse Event|2|||
170452762|NCT00430495|615996058|FG001|Overall Study|Adverse Event|3|||
170452763|NCT00430495|615996059|FG002|Overall Study|Adverse Event|2|||
170452764|NCT00430495|615996060|FG003|Overall Study|Adverse Event|0|||
170541753|NCT03188185|616328073|FG000|Stage 2|Lack of Efficacy|0|||
170541754|NCT03188185|616328074|FG001|Stage 2|Lack of Efficacy|0|||
170541755|NCT03188185|616328075|FG002|Stage 2|Lack of Efficacy|3|||
170541756|NCT03188185|616328076|FG003|Stage 2|Lack of Efficacy|0|||
170541757|NCT03188185|616328073|FG000|Stage 2|Lost to Follow-up|0|||
170541758|NCT03188185|616328074|FG001|Stage 2|Lost to Follow-up|0|||
170541759|NCT03188185|616328075|FG002|Stage 2|Lost to Follow-up|1|||
170888219|NCT03529773|617598274|FG006|Overall Study|Physician Decision|0|||
170888220|NCT03529773|617598275|FG007|Overall Study|Physician Decision|0|||
170888221|NCT03529773|617598276|FG008|Overall Study|Physician Decision|0|||
170452765|NCT00430495|615996057|FG000|Overall Study|Death|0|||
170452766|NCT00430495|615996058|FG001|Overall Study|Death|0|||
170452767|NCT00430495|615996059|FG002|Overall Study|Death|1|||
170452768|NCT00430495|615996060|FG003|Overall Study|Death|0|||
170452769|NCT00430495|615996057|FG000|Overall Study|Lost to Follow-up|0|||
170452770|NCT00430495|615996058|FG001|Overall Study|Lost to Follow-up|1|||
170452771|NCT00430495|615996059|FG002|Overall Study|Lost to Follow-up|4|||
170452772|NCT00430495|615996060|FG003|Overall Study|Lost to Follow-up|0|||
170452773|NCT00430495|615996057|FG000|Overall Study|Protocol Violation|1|||
170452774|NCT00430495|615996058|FG001|Overall Study|Protocol Violation|0|||
170452775|NCT00430495|615996059|FG002|Overall Study|Protocol Violation|1|||
170888222|NCT03529773|617598277|FG009|Overall Study|Physician Decision|0|||
170888223|NCT03529773|617598278|FG010|Overall Study|Physician Decision|0|||
170888224|NCT03529773|617598279|FG011|Overall Study|Physician Decision|0|||
170888225|NCT03529773|617598280|FG012|Overall Study|Physician Decision|0|||
170888226|NCT03529773|617598281|FG013|Overall Study|Physician Decision|0|||
170888227|NCT03529773|617598282|FG014|Overall Study|Physician Decision|0|||
170888228|NCT03529773|617598283|FG015|Overall Study|Physician Decision|0|||
170888229|NCT03529773|617598284|FG016|Overall Study|Physician Decision|0|||
170888230|NCT03529773|617598285|FG017|Overall Study|Physician Decision|0|||
170888231|NCT03529773|617598286|FG018|Overall Study|Physician Decision|0|||
170888232|NCT03529773|617598287|FG019|Overall Study|Physician Decision|1|||
170888233|NCT03529773|617598288|FG020|Overall Study|Physician Decision|1|||
170888234|NCT03529773|617598289|FG021|Overall Study|Physician Decision|0|||
170888235|NCT03529773|617598290|FG022|Overall Study|Physician Decision|0|||
170888236|NCT03529773|617598291|FG023|Overall Study|Physician Decision|0|||
170888237|NCT03529773|617598292|FG024|Overall Study|Physician Decision|0|||
170452776|NCT00430495|615996060|FG003|Overall Study|Protocol Violation|0|||
170452777|NCT00430495|615996057|FG000|Overall Study|Disease Progression|1|||
170452778|NCT00430495|615996058|FG001|Overall Study|Disease Progression|1|||
170452779|NCT00430495|615996059|FG002|Overall Study|Disease Progression|0|||
170452780|NCT00430495|615996060|FG003|Overall Study|Disease Progression|0|||
170888238|NCT03529773|617598293|FG025|Overall Study|Physician Decision|0|||
170888239|NCT03529773|617598294|FG026|Overall Study|Physician Decision|0|||
170888240|NCT03529773|617598295|FG027|Overall Study|Physician Decision|0|||
170888241|NCT03529773|617598296|FG028|Overall Study|Physician Decision|0|||
170888242|NCT03529773|617598297|FG029|Overall Study|Physician Decision|0|||
170888243|NCT03529773|617598298|FG030|Overall Study|Physician Decision|0|||
170888244|NCT03529773|617598299|FG031|Overall Study|Physician Decision|0|||
170888245|NCT03529773|617598300|FG032|Overall Study|Physician Decision|0|||
170888246|NCT03529773|617598301|FG033|Overall Study|Physician Decision|0|||
170888247|NCT03529773|617598302|FG034|Overall Study|Physician Decision|0|||
170888248|NCT03529773|617598303|FG035|Overall Study|Physician Decision|0|||
170888249|NCT03529773|617598304|FG036|Overall Study|Physician Decision|0|||
170888250|NCT03529773|617598305|FG037|Overall Study|Physician Decision|0|||
170888251|NCT03529773|617598306|FG038|Overall Study|Physician Decision|0|||
170888252|NCT03529773|617598307|FG039|Overall Study|Physician Decision|0|||
170888253|NCT03529773|617598268|FG000|Overall Study|Protocol Violation|0|||
170888254|NCT03529773|617598269|FG001|Overall Study|Protocol Violation|0|||
170888255|NCT03529773|617598270|FG002|Overall Study|Protocol Violation|0|||
170452781|NCT00430495|615996057|FG000|Overall Study|Other|8|||
170452782|NCT00430495|615996058|FG001|Overall Study|Other|2|||
170452783|NCT00430495|615996059|FG002|Overall Study|Other|5|||
170541760|NCT03188185|616328076|FG003|Stage 2|Lost to Follow-up|0|||
170541761|NCT03188185|616328073|FG000|Stage 2|Physician Decision|0|||
170541762|NCT03188185|616328074|FG001|Stage 2|Physician Decision|0|||
170541763|NCT03188185|616328075|FG002|Stage 2|Physician Decision|0|||
170541764|NCT03188185|616328076|FG003|Stage 2|Physician Decision|1|||
170541765|NCT03188185|616328073|FG000|Stage 2|Withdrawal by Subject|0|||
170541766|NCT03188185|616328074|FG001|Stage 2|Withdrawal by Subject|0|||
170541767|NCT03188185|616328075|FG002|Stage 2|Withdrawal by Subject|3|||
170541768|NCT03188185|616328076|FG003|Stage 2|Withdrawal by Subject|1|||
170452784|NCT00430495|615996060|FG003|Overall Study|Other|4|||
170541769|NCT02112552|616328079|FG000|Overall Study|Withdrawal by Subject|1|||
170452785|NCT00430495|615996057|FG000|Overall Study|Randomized but not Treated|2|||
170452786|NCT00430495|615996058|FG001|Overall Study|Randomized but not Treated|0|||
170541770|NCT02112552|616328079|FG000|Overall Study|Adverse Event|1|||
170541771|NCT00774748|616328080|FG000|Overall Study|Lost to Follow-up|3|||
170888256|NCT03529773|617598271|FG003|Overall Study|Protocol Violation|0|||
170888257|NCT03529773|617598272|FG004|Overall Study|Protocol Violation|0|||
170888258|NCT03529773|617598273|FG005|Overall Study|Protocol Violation|0|||
170888259|NCT03529773|617598274|FG006|Overall Study|Protocol Violation|0|||
170888260|NCT03529773|617598275|FG007|Overall Study|Protocol Violation|0|||
170888261|NCT03529773|617598276|FG008|Overall Study|Protocol Violation|0|||
170888262|NCT03529773|617598277|FG009|Overall Study|Protocol Violation|0|||
170888263|NCT03529773|617598278|FG010|Overall Study|Protocol Violation|0|||
170888264|NCT03529773|617598279|FG011|Overall Study|Protocol Violation|0|||
170888265|NCT03529773|617598280|FG012|Overall Study|Protocol Violation|0|||
170888266|NCT03529773|617598281|FG013|Overall Study|Protocol Violation|0|||
170888267|NCT03529773|617598282|FG014|Overall Study|Protocol Violation|0|||
170452787|NCT00430495|615996059|FG002|Overall Study|Randomized but not Treated|0|||
170452788|NCT00430495|615996060|FG003|Overall Study|Randomized but not Treated|0|||
170452789|NCT01206816|615996063|FG000|Overall Study|Protocol Violation|0|||
170452790|NCT01206816|615996064|FG001|Overall Study|Protocol Violation|0|||
170452791|NCT01206816|615996065|FG002|Overall Study|Protocol Violation|1|||
170452792|NCT01206816|615996066|FG003|Overall Study|Protocol Violation|0|||
170452793|NCT01206816|615996067|FG004|Overall Study|Protocol Violation|0|||
170452794|NCT01206816|615996068|FG005|Overall Study|Protocol Violation|0|||
170452795|NCT01206816|615996069|FG006|Overall Study|Protocol Violation|0|||
170452796|NCT01206816|615996063|FG000|Overall Study|Withdrawal by Subject|0|||
170452797|NCT01206816|615996064|FG001|Overall Study|Withdrawal by Subject|0|||
170452798|NCT01206816|615996065|FG002|Overall Study|Withdrawal by Subject|1|||
170452799|NCT01206816|615996066|FG003|Overall Study|Withdrawal by Subject|0|||
170452800|NCT01206816|615996067|FG004|Overall Study|Withdrawal by Subject|0|||
170452801|NCT01206816|615996068|FG005|Overall Study|Withdrawal by Subject|0|||
170452802|NCT01206816|615996069|FG006|Overall Study|Withdrawal by Subject|0|||
170452803|NCT01206816|615996063|FG000|Overall Study|Progressive disease|3|||
170452804|NCT01206816|615996064|FG001|Overall Study|Progressive disease|3|||
170452805|NCT01206816|615996065|FG002|Overall Study|Progressive disease|13|||
170452806|NCT01206816|615996066|FG003|Overall Study|Progressive disease|3|||
170452807|NCT01206816|615996067|FG004|Overall Study|Progressive disease|3|||
170541772|NCT03349515|616328086|FG000|Overall Study|Lack of Efficacy|2|||
170541773|NCT03349515|616328087|FG001|Overall Study|Lack of Efficacy|0|||
170541774|NCT03349515|616328086|FG000|Overall Study|Physician Decision|3|||
170541775|NCT03349515|616328087|FG001|Overall Study|Physician Decision|1|||
170541776|NCT02232698|616328094|FG000|Overall Study|Pregnancy|1|||
170787351|NCT02962895|617231750|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
170787352|NCT02962895|617231751|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
170787353|NCT02962895|617231752|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
170787354|NCT02962895|617231753|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
170787355|NCT02962895|617231754|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
170787356|NCT02962895|617231755|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
170787357|NCT02962895|617231749|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
170787358|NCT02962895|617231750|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
170787359|NCT02962895|617231751|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
170787360|NCT02962895|617231752|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
170787361|NCT02962895|617231753|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
170787362|NCT02962895|617231754|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
170787363|NCT02962895|617231755|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
170787364|NCT05894577|617231756|FG000|Overall Study|No receipt of study drug|14|||
170787365|NCT05894577|617231757|FG001|Overall Study|No receipt of study drug|13|||
170787366|NCT05894577|617231756|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
170787367|NCT05894577|617231757|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
170787368|NCT05894577|617231756|FG000|Overall Study|Screen Fail|2|||
170787369|NCT05894577|617231757|FG001|Overall Study|Screen Fail|0|||
170787370|NCT05894577|617231756|FG000|Overall Study|Study drug recall|86|||
170787371|NCT05894577|617231757|FG001|Overall Study|Study drug recall|63|||
170787372|NCT04509674|617231762|FG000|Overall Study|Not treated|33|||
170787373|NCT04509674|617231763|FG001|Overall Study|Not treated|26|||
170787374|NCT04509674|617231762|FG000|Overall Study|Protocol Violation|9|||
170787375|NCT04509674|617231763|FG001|Overall Study|Protocol Violation|10|||
170787376|NCT04509674|617231762|FG000|Overall Study|Lost to Follow-up|31|||
170787377|NCT04509674|617231763|FG001|Overall Study|Lost to Follow-up|39|||
170787378|NCT04509674|617231762|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
170787379|NCT04509674|617231763|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
170787380|NCT04509674|617231762|FG000|Overall Study|Adverse event, serious fatal event|11|||
170787381|NCT04509674|617231763|FG001|Overall Study|Adverse event, serious fatal event|4|||
170787382|NCT04509674|617231762|FG000|Overall Study|Adverse event, non-fatal event|107|||
170787383|NCT04509674|617231763|FG001|Overall Study|Adverse event, non-fatal event|118|||
170787384|NCT04509674|617231762|FG000|Overall Study|Other reason than listed|106|||
170787385|NCT04509674|617231763|FG001|Overall Study|Other reason than listed|95|||
170787386|NCT05292365|617231769|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
170787387|NCT05292365|617231770|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
170452808|NCT01206816|615996068|FG005|Overall Study|Progressive disease|16|||
170452809|NCT01206816|615996069|FG006|Overall Study|Progressive disease|3|||
170452810|NCT01206816|615996063|FG000|Overall Study|Other AE|0|||
170452811|NCT01206816|615996064|FG001|Overall Study|Other AE|0|||
170452812|NCT01206816|615996065|FG002|Overall Study|Other AE|4|||
170452813|NCT01206816|615996066|FG003|Overall Study|Other AE|0|||
170541777|NCT02232698|616328095|FG001|Overall Study|Pregnancy|1|||
170787388|NCT05292365|617231771|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
170787389|NCT05292365|617231772|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
170541778|NCT02232698|616328094|FG000|Overall Study|Met exclusion criteria|1|||
170888268|NCT03529773|617598283|FG015|Overall Study|Protocol Violation|0|||
170888269|NCT03529773|617598284|FG016|Overall Study|Protocol Violation|0|||
170888270|NCT03529773|617598285|FG017|Overall Study|Protocol Violation|0|||
170888271|NCT03529773|617598286|FG018|Overall Study|Protocol Violation|0|||
170888272|NCT03529773|617598287|FG019|Overall Study|Protocol Violation|0|||
170888273|NCT03529773|617598288|FG020|Overall Study|Protocol Violation|0|||
170888274|NCT03529773|617598289|FG021|Overall Study|Protocol Violation|0|||
170888275|NCT03529773|617598290|FG022|Overall Study|Protocol Violation|0|||
170888276|NCT03529773|617598291|FG023|Overall Study|Protocol Violation|0|||
170888277|NCT03529773|617598292|FG024|Overall Study|Protocol Violation|0|||
170888278|NCT03529773|617598293|FG025|Overall Study|Protocol Violation|0|||
170888279|NCT03529773|617598294|FG026|Overall Study|Protocol Violation|0|||
170888280|NCT03529773|617598295|FG027|Overall Study|Protocol Violation|0|||
170888281|NCT03529773|617598296|FG028|Overall Study|Protocol Violation|0|||
170888282|NCT03529773|617598297|FG029|Overall Study|Protocol Violation|0|||
170888283|NCT03529773|617598298|FG030|Overall Study|Protocol Violation|1|||
170888284|NCT03529773|617598299|FG031|Overall Study|Protocol Violation|0|||
170888285|NCT03529773|617598300|FG032|Overall Study|Protocol Violation|0|||
170888286|NCT03529773|617598301|FG033|Overall Study|Protocol Violation|0|||
170888287|NCT03529773|617598302|FG034|Overall Study|Protocol Violation|0|||
170888288|NCT03529773|617598303|FG035|Overall Study|Protocol Violation|0|||
170888289|NCT03529773|617598304|FG036|Overall Study|Protocol Violation|0|||
170888290|NCT03529773|617598305|FG037|Overall Study|Protocol Violation|0|||
170888291|NCT03529773|617598306|FG038|Overall Study|Protocol Violation|0|||
170888292|NCT03529773|617598307|FG039|Overall Study|Protocol Violation|0|||
170888293|NCT03529773|617598268|FG000|Overall Study|Withdrawal by Subject|0|||
170888294|NCT03529773|617598269|FG001|Overall Study|Withdrawal by Subject|0|||
170888295|NCT03529773|617598270|FG002|Overall Study|Withdrawal by Subject|0|||
170888296|NCT03529773|617598271|FG003|Overall Study|Withdrawal by Subject|0|||
170888297|NCT03529773|617598272|FG004|Overall Study|Withdrawal by Subject|0|||
170888298|NCT03529773|617598273|FG005|Overall Study|Withdrawal by Subject|0|||
170888299|NCT03529773|617598274|FG006|Overall Study|Withdrawal by Subject|0|||
170888300|NCT03529773|617598275|FG007|Overall Study|Withdrawal by Subject|1|||
170888301|NCT03529773|617598276|FG008|Overall Study|Withdrawal by Subject|0|||
170888302|NCT03529773|617598277|FG009|Overall Study|Withdrawal by Subject|1|||
170888303|NCT03529773|617598278|FG010|Overall Study|Withdrawal by Subject|1|||
170888304|NCT03529773|617598279|FG011|Overall Study|Withdrawal by Subject|0|||
170888305|NCT03529773|617598280|FG012|Overall Study|Withdrawal by Subject|0|||
170888306|NCT03529773|617598281|FG013|Overall Study|Withdrawal by Subject|0|||
170888307|NCT03529773|617598282|FG014|Overall Study|Withdrawal by Subject|0|||
170541779|NCT02232698|616328095|FG001|Overall Study|Met exclusion criteria|1|||
170541780|NCT02232698|616328094|FG000|Overall Study|Had device-associated symptoms|7|||
170888308|NCT03529773|617598283|FG015|Overall Study|Withdrawal by Subject|3|||
170888309|NCT03529773|617598284|FG016|Overall Study|Withdrawal by Subject|0|||
170541781|NCT02232698|616328095|FG001|Overall Study|Had device-associated symptoms|0|||
170888310|NCT03529773|617598285|FG017|Overall Study|Withdrawal by Subject|2|||
170888311|NCT03529773|617598286|FG018|Overall Study|Withdrawal by Subject|3|||
170888312|NCT03529773|617598287|FG019|Overall Study|Withdrawal by Subject|1|||
170888313|NCT03529773|617598288|FG020|Overall Study|Withdrawal by Subject|3|||
170888314|NCT03529773|617598289|FG021|Overall Study|Withdrawal by Subject|1|||
170888315|NCT03529773|617598290|FG022|Overall Study|Withdrawal by Subject|1|||
170888316|NCT03529773|617598291|FG023|Overall Study|Withdrawal by Subject|2|||
170888317|NCT03529773|617598292|FG024|Overall Study|Withdrawal by Subject|2|||
170888318|NCT03529773|617598293|FG025|Overall Study|Withdrawal by Subject|4|||
170888319|NCT03529773|617598294|FG026|Overall Study|Withdrawal by Subject|2|||
170888320|NCT03529773|617598295|FG027|Overall Study|Withdrawal by Subject|1|||
170888321|NCT03529773|617598296|FG028|Overall Study|Withdrawal by Subject|1|||
170888322|NCT03529773|617598297|FG029|Overall Study|Withdrawal by Subject|0|||
170888323|NCT03529773|617598298|FG030|Overall Study|Withdrawal by Subject|0|||
170888324|NCT03529773|617598299|FG031|Overall Study|Withdrawal by Subject|0|||
170888325|NCT03529773|617598300|FG032|Overall Study|Withdrawal by Subject|0|||
170888326|NCT03529773|617598301|FG033|Overall Study|Withdrawal by Subject|0|||
170888327|NCT03529773|617598302|FG034|Overall Study|Withdrawal by Subject|1|||
170888328|NCT03529773|617598303|FG035|Overall Study|Withdrawal by Subject|2|||
170888329|NCT03529773|617598304|FG036|Overall Study|Withdrawal by Subject|0|||
170888330|NCT03529773|617598305|FG037|Overall Study|Withdrawal by Subject|2|||
170888331|NCT03529773|617598306|FG038|Overall Study|Withdrawal by Subject|1|||
170888332|NCT03529773|617598307|FG039|Overall Study|Withdrawal by Subject|1|||
170888333|NCT03529773|617598268|FG000|Overall Study|Screen Failure|0|||
170888334|NCT03529773|617598269|FG001|Overall Study|Screen Failure|0|||
170888335|NCT03529773|617598270|FG002|Overall Study|Screen Failure|0|||
170888336|NCT03529773|617598271|FG003|Overall Study|Screen Failure|0|||
170888337|NCT03529773|617598272|FG004|Overall Study|Screen Failure|0|||
170888338|NCT03529773|617598273|FG005|Overall Study|Screen Failure|0|||
170888339|NCT03529773|617598274|FG006|Overall Study|Screen Failure|0|||
170888340|NCT03529773|617598275|FG007|Overall Study|Screen Failure|0|||
170888341|NCT03529773|617598276|FG008|Overall Study|Screen Failure|0|||
170888342|NCT03529773|617598277|FG009|Overall Study|Screen Failure|0|||
170634803|NCT00687193|616673292|FG002|Overall Study|Protocol Violation|0|||
170634804|NCT00687193|616673293|FG003|Overall Study|Protocol Violation|1|||
170634805|NCT00687193|616673294|FG004|Overall Study|Protocol Violation|2|||
170634806|NCT00687193|616673295|FG005|Overall Study|Protocol Violation|0|||
170634807|NCT03529422|616673296|FG000|Overall Study|Withdrawal by Subject|1|||
170634808|NCT03529422|616673296|FG000|Overall Study|Protocol Violation|1|||
170634809|NCT03529422|616673296|FG000|Overall Study|Disease progression|2|||
170634810|NCT02017405|616673297|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
170634811|NCT02017405|616673298|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
170634812|NCT02017405|616673299|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
170634813|NCT02017405|616673300|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
170634814|NCT02017405|616673301|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
170634815|NCT02017405|616673302|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
170634816|NCT02017405|616673297|FG000|Open-label Phase|Adverse Event|1|||
170541782|NCT02232698|616328094|FG000|Overall Study|Non-compliance with study device|1|||
170541783|NCT02232698|616328095|FG001|Overall Study|Non-compliance with study device|4|||
170541784|NCT02232698|616328094|FG000|Overall Study|Allocated to control group|0|||
170541785|NCT02232698|616328095|FG001|Overall Study|Allocated to control group|3|||
170541786|NCT02232698|616328094|FG000|Overall Study|Withdrawal by Subject|0|||
170541787|NCT02232698|616328095|FG001|Overall Study|Withdrawal by Subject|11|||
170541788|NCT02393755|616328096|FG000|Overall Study|Withdrawal by Subject|0|||
170541789|NCT02393755|616328097|FG001|Overall Study|Withdrawal by Subject|3|||
170541790|NCT02393755|616328096|FG000|Overall Study|Adverse Event|0|||
170541791|NCT02393755|616328097|FG001|Overall Study|Adverse Event|2|||
170541792|NCT02393755|616328096|FG000|Overall Study|Physician Decision|0|||
170541793|NCT02393755|616328097|FG001|Overall Study|Physician Decision|2|||
170541794|NCT05324371|616328098|FG000|Overall Study|Withdrawal by Subject|1|||
170541795|NCT05324371|616328098|FG000|Overall Study|Death|1|||
170787390|NCT01798498|617231775|FG000|Overall Study|Lost to Follow-up|1|||
170787391|NCT01098812|617231784|FG000|Overall Study|Death|2|||
170787392|NCT01098812|617231785|FG001|Overall Study|Death|0|||
170787393|NCT01098812|617231786|FG002|Overall Study|Death|1|||
170787394|NCT01098812|617231784|FG000|Overall Study|Lost to Follow-up|0|||
170787395|NCT01098812|617231785|FG001|Overall Study|Lost to Follow-up|1|||
170787396|NCT01098812|617231786|FG002|Overall Study|Lost to Follow-up|0|||
170787397|NCT02319759|617231787|FG000|Week 0 - 16|Lack of Efficacy|1|||
170787398|NCT02319759|617231788|FG001|Week 0 - 16|Lack of Efficacy|0|||
170787399|NCT02319759|617231789|FG002|Week 0 - 16|Lack of Efficacy|0|||
170787400|NCT02319759|617231790|FG003|Week 0 - 16|Lack of Efficacy|0|||
170787401|NCT02319759|617231791|FG004|Week 0 - 16|Lack of Efficacy|0|||
170787402|NCT02319759|617231787|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
170787403|NCT02319759|617231788|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
170787404|NCT02319759|617231789|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
170787405|NCT02319759|617231790|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
170787406|NCT02319759|617231791|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
170787407|NCT02319759|617231787|FG000|Week 16 - 24|Lack of Efficacy|1|||
170787408|NCT02319759|617231788|FG001|Week 16 - 24|Lack of Efficacy|0|||
170787409|NCT02319759|617231789|FG002|Week 16 - 24|Lack of Efficacy|1|||
170787410|NCT02319759|617231790|FG003|Week 16 - 24|Lack of Efficacy|0|||
170787411|NCT02319759|617231791|FG004|Week 16 - 24|Lack of Efficacy|0|||
170787412|NCT02319759|617231787|FG000|Week 16 - 24|Lost to Follow-up|1|||
170787413|NCT02319759|617231788|FG001|Week 16 - 24|Lost to Follow-up|0|||
170787414|NCT02319759|617231789|FG002|Week 16 - 24|Lost to Follow-up|0|||
170787415|NCT02319759|617231790|FG003|Week 16 - 24|Lost to Follow-up|0|||
170787416|NCT02319759|617231791|FG004|Week 16 - 24|Lost to Follow-up|0|||
170787417|NCT02319759|617231787|FG000|Week 16 - 24|Withdrawal by Subject|0|||
170787418|NCT02319759|617231788|FG001|Week 16 - 24|Withdrawal by Subject|0|||
170787419|NCT02319759|617231789|FG002|Week 16 - 24|Withdrawal by Subject|2|||
170787420|NCT02319759|617231790|FG003|Week 16 - 24|Withdrawal by Subject|0|||
170787421|NCT02319759|617231791|FG004|Week 16 - 24|Withdrawal by Subject|0|||
170787422|NCT02319759|617231787|FG000|Week 24 - 56|Adverse Event|0|||
170787423|NCT02319759|617231788|FG001|Week 24 - 56|Adverse Event|0|||
170787424|NCT02319759|617231789|FG002|Week 24 - 56|Adverse Event|2|||
170787425|NCT02319759|617231790|FG003|Week 24 - 56|Adverse Event|0|||
170787426|NCT02319759|617231791|FG004|Week 24 - 56|Adverse Event|0|||
170541796|NCT02721732|616328100|FG000|Overall Study|Adverse Event|2|||
170541797|NCT02721732|616328101|FG001|Overall Study|Adverse Event|0|||
170634817|NCT02017405|616673298|FG001|Open-label Phase|Adverse Event|1|||
170634818|NCT02017405|616673299|FG002|Open-label Phase|Adverse Event|0|||
170634819|NCT02017405|616673300|FG003|Open-label Phase|Adverse Event|0|||
170541798|NCT02721732|616328102|FG002|Overall Study|Adverse Event|2|||
170787427|NCT02319759|617231787|FG000|Week 24 - 56|Lack of Efficacy|0|||
170787428|NCT02319759|617231788|FG001|Week 24 - 56|Lack of Efficacy|0|||
170787429|NCT02319759|617231789|FG002|Week 24 - 56|Lack of Efficacy|0|||
170787430|NCT02319759|617231790|FG003|Week 24 - 56|Lack of Efficacy|2|||
170787431|NCT02319759|617231791|FG004|Week 24 - 56|Lack of Efficacy|1|||
170787432|NCT02319759|617231787|FG000|Week 24 - 56|Withdrawal by Subject|0|||
170888343|NCT03529773|617598278|FG010|Overall Study|Screen Failure|0|||
170888344|NCT03529773|617598279|FG011|Overall Study|Screen Failure|0|||
170452814|NCT01206816|615996067|FG004|Overall Study|Other AE|0|||
170452815|NCT01206816|615996068|FG005|Overall Study|Other AE|3|||
170452816|NCT01206816|615996069|FG006|Overall Study|Other AE|2|||
170452817|NCT01206816|615996063|FG000|Overall Study|other than stated above|0|||
170452818|NCT01206816|615996064|FG001|Overall Study|other than stated above|0|||
170452819|NCT01206816|615996065|FG002|Overall Study|other than stated above|1|||
170452820|NCT01206816|615996066|FG003|Overall Study|other than stated above|0|||
170452821|NCT01206816|615996067|FG004|Overall Study|other than stated above|0|||
170452822|NCT01206816|615996068|FG005|Overall Study|other than stated above|0|||
170452823|NCT01206816|615996069|FG006|Overall Study|other than stated above|1|||
170452824|NCT02384941|615996071|FG000|Overall Study|Adverse Event|11|||
170541799|NCT02721732|616328103|FG003|Overall Study|Adverse Event|0|||
170541800|NCT02721732|616328104|FG004|Overall Study|Adverse Event|1|||
170541801|NCT02721732|616328105|FG005|Overall Study|Adverse Event|0|||
170541802|NCT02721732|616328106|FG006|Overall Study|Adverse Event|1|||
170541803|NCT02721732|616328107|FG007|Overall Study|Adverse Event|0|||
170541804|NCT02721732|616328108|FG008|Overall Study|Adverse Event|1|||
170541805|NCT02721732|616328109|FG009|Overall Study|Adverse Event|1|||
170541806|NCT02721732|616328100|FG000|Overall Study|Death|0|||
170787433|NCT02319759|617231788|FG001|Week 24 - 56|Withdrawal by Subject|1|||
170787434|NCT02319759|617231789|FG002|Week 24 - 56|Withdrawal by Subject|0|||
170787435|NCT02319759|617231790|FG003|Week 24 - 56|Withdrawal by Subject|0|||
170787436|NCT02319759|617231791|FG004|Week 24 - 56|Withdrawal by Subject|0|||
170787437|NCT02319759|617231787|FG000|Week 24 - 56|Lost to Follow-up|0|||
170787438|NCT02319759|617231788|FG001|Week 24 - 56|Lost to Follow-up|0|||
170787439|NCT02319759|617231789|FG002|Week 24 - 56|Lost to Follow-up|0|||
170787440|NCT02319759|617231790|FG003|Week 24 - 56|Lost to Follow-up|0|||
170787441|NCT02319759|617231791|FG004|Week 24 - 56|Lost to Follow-up|1|||
170787442|NCT02262728|617231795|FG000|Follow-up Phase (3 Years)|Death|0|||
170787443|NCT02262728|617231796|FG001|Follow-up Phase (3 Years)|Death|1|||
170787444|NCT02262728|617231795|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
170787445|NCT02262728|617231796|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
170787446|NCT02262728|617231795|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
170787447|NCT02262728|617231796|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
170787448|NCT03381196|617231797|FG000|Overall Study|Withdrawal by Subject|7|||
170787449|NCT03381196|617231798|FG001|Overall Study|Withdrawal by Subject|7|||
170787450|NCT03381196|617231797|FG000|Overall Study|Other|0|||
170541807|NCT02721732|616328101|FG001|Overall Study|Death|0|||
170541808|NCT02721732|616328102|FG002|Overall Study|Death|0|||
170541809|NCT02721732|616328103|FG003|Overall Study|Death|0|||
170541810|NCT02721732|616328104|FG004|Overall Study|Death|1|||
170541811|NCT02721732|616328105|FG005|Overall Study|Death|0|||
170541812|NCT02721732|616328106|FG006|Overall Study|Death|1|||
170541813|NCT02721732|616328107|FG007|Overall Study|Death|0|||
170541814|NCT02721732|616328108|FG008|Overall Study|Death|0|||
170541815|NCT02721732|616328109|FG009|Overall Study|Death|1|||
170541816|NCT02721732|616328100|FG000|Overall Study|Lack of Efficacy|12|||
170541817|NCT02721732|616328101|FG001|Overall Study|Lack of Efficacy|11|||
170541818|NCT02721732|616328102|FG002|Overall Study|Lack of Efficacy|18|||
170541819|NCT02721732|616328103|FG003|Overall Study|Lack of Efficacy|5|||
170541820|NCT02721732|616328104|FG004|Overall Study|Lack of Efficacy|21|||
170541821|NCT02721732|616328105|FG005|Overall Study|Lack of Efficacy|2|||
170787451|NCT03381196|617231798|FG001|Overall Study|Other|1|||
170787452|NCT03381196|617231797|FG000|Overall Study|Lost to Follow-up|5|||
170541822|NCT02721732|616328106|FG006|Overall Study|Lack of Efficacy|8|||
170541823|NCT02721732|616328107|FG007|Overall Study|Lack of Efficacy|11|||
170541824|NCT02721732|616328108|FG008|Overall Study|Lack of Efficacy|10|||
170541825|NCT02721732|616328109|FG009|Overall Study|Lack of Efficacy|20|||
170541826|NCT02721732|616328100|FG000|Overall Study|Physician Decision|0|||
170541827|NCT02721732|616328101|FG001|Overall Study|Physician Decision|0|||
170541828|NCT02721732|616328102|FG002|Overall Study|Physician Decision|1|||
170541829|NCT02721732|616328103|FG003|Overall Study|Physician Decision|0|||
170541830|NCT02721732|616328104|FG004|Overall Study|Physician Decision|0|||
170541831|NCT02721732|616328105|FG005|Overall Study|Physician Decision|0|||
170541832|NCT02721732|616328106|FG006|Overall Study|Physician Decision|0|||
170541833|NCT02721732|616328107|FG007|Overall Study|Physician Decision|0|||
170541834|NCT02721732|616328108|FG008|Overall Study|Physician Decision|0|||
170541835|NCT02721732|616328109|FG009|Overall Study|Physician Decision|0|||
170541836|NCT02721732|616328100|FG000|Overall Study|Withdrawal by Subject|1|||
170541837|NCT02721732|616328101|FG001|Overall Study|Withdrawal by Subject|0|||
170541838|NCT02721732|616328102|FG002|Overall Study|Withdrawal by Subject|0|||
170541839|NCT02721732|616328103|FG003|Overall Study|Withdrawal by Subject|0|||
170541840|NCT02721732|616328104|FG004|Overall Study|Withdrawal by Subject|3|||
170787453|NCT03381196|617231798|FG001|Overall Study|Lost to Follow-up|4|||
170787454|NCT03381196|617231797|FG000|Overall Study|Death|0|||
170888345|NCT03529773|617598280|FG012|Overall Study|Screen Failure|0|||
170452825|NCT02384941|615996072|FG001|Overall Study|Adverse Event|13|||
170541841|NCT02721732|616328105|FG005|Overall Study|Withdrawal by Subject|0|||
170452826|NCT02384941|615996073|FG002|Overall Study|Adverse Event|17|||
170452827|NCT02384941|615996071|FG000|Overall Study|Lost to Follow-up|3|||
170452828|NCT02384941|615996072|FG001|Overall Study|Lost to Follow-up|2|||
170452829|NCT02384941|615996073|FG002|Overall Study|Lost to Follow-up|1|||
170452830|NCT02384941|615996071|FG000|Overall Study|Non-Compliance With Study Drug|2|||
170452831|NCT02384941|615996072|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170452832|NCT02384941|615996073|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170452833|NCT02384941|615996071|FG000|Overall Study|Physician Decision|1|||
170452834|NCT02384941|615996072|FG001|Overall Study|Physician Decision|1|||
170452835|NCT02384941|615996073|FG002|Overall Study|Physician Decision|0|||
170452836|NCT02384941|615996071|FG000|Overall Study|Protocol Violation|3|||
170541842|NCT02721732|616328106|FG006|Overall Study|Withdrawal by Subject|1|||
170541843|NCT02721732|616328107|FG007|Overall Study|Withdrawal by Subject|1|||
170541844|NCT02721732|616328108|FG008|Overall Study|Withdrawal by Subject|0|||
170541845|NCT02721732|616328109|FG009|Overall Study|Withdrawal by Subject|1|||
170541846|NCT02721732|616328100|FG000|Overall Study|Participant Choice|1|||
170541847|NCT02721732|616328101|FG001|Overall Study|Participant Choice|0|||
170541848|NCT02721732|616328102|FG002|Overall Study|Participant Choice|0|||
170541849|NCT02721732|616328103|FG003|Overall Study|Participant Choice|0|||
170541850|NCT02721732|616328104|FG004|Overall Study|Participant Choice|0|||
170541851|NCT02721732|616328105|FG005|Overall Study|Participant Choice|0|||
170541852|NCT02721732|616328106|FG006|Overall Study|Participant Choice|0|||
170541853|NCT02721732|616328107|FG007|Overall Study|Participant Choice|0|||
170541854|NCT02721732|616328108|FG008|Overall Study|Participant Choice|0|||
170541855|NCT02721732|616328109|FG009|Overall Study|Participant Choice|1|||
170541856|NCT02721732|616328100|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541857|NCT02721732|616328101|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541858|NCT02721732|616328102|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
170541859|NCT02721732|616328103|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541860|NCT02721732|616328104|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541861|NCT02721732|616328105|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541862|NCT02721732|616328106|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541863|NCT02721732|616328107|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541864|NCT02721732|616328108|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541865|NCT02721732|616328109|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
170541866|NCT02721732|616328100|FG000|Overall Study|Progression and withdrew consent|1|||
170541867|NCT02721732|616328101|FG001|Overall Study|Progression and withdrew consent|1|||
170541868|NCT02721732|616328102|FG002|Overall Study|Progression and withdrew consent|0|||
170541869|NCT02721732|616328103|FG003|Overall Study|Progression and withdrew consent|0|||
170541870|NCT02721732|616328104|FG004|Overall Study|Progression and withdrew consent|0|||
170541871|NCT02721732|616328105|FG005|Overall Study|Progression and withdrew consent|0|||
170541872|NCT02721732|616328106|FG006|Overall Study|Progression and withdrew consent|0|||
170541873|NCT02721732|616328107|FG007|Overall Study|Progression and withdrew consent|0|||
170541874|NCT02721732|616328108|FG008|Overall Study|Progression and withdrew consent|0|||
170541875|NCT02721732|616328109|FG009|Overall Study|Progression and withdrew consent|1|||
170541876|NCT02721732|616328100|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
170541877|NCT02721732|616328101|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
170541878|NCT02721732|616328102|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
170541879|NCT02721732|616328103|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
170541880|NCT02721732|616328104|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
170541881|NCT02721732|616328105|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
170541882|NCT02721732|616328106|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
170541883|NCT02721732|616328107|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
170541884|NCT02721732|616328108|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
170541885|NCT02721732|616328109|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
170541886|NCT00317369|616328110|FG000|Overall Study|Adverse Event|2|||
170541887|NCT00317369|616328111|FG001|Overall Study|Adverse Event|1|||
170541888|NCT00317369|616328112|FG002|Overall Study|Adverse Event|0|||
170541889|NCT00317369|616328110|FG000|Overall Study|Lack of Efficacy|0|||
170541890|NCT00317369|616328111|FG001|Overall Study|Lack of Efficacy|1|||
170541891|NCT00317369|616328112|FG002|Overall Study|Lack of Efficacy|1|||
170541892|NCT00317369|616328110|FG000|Overall Study|Withdrawal by Subject|0|||
170541893|NCT00317369|616328111|FG001|Overall Study|Withdrawal by Subject|0|||
170541894|NCT00317369|616328112|FG002|Overall Study|Withdrawal by Subject|1|||
170541895|NCT03943901|616328113|FG000|Overall Study|On Follow Up|12|||
170541896|NCT03943901|616328113|FG000|Overall Study|deemed not eligible prior to starting treatment|1|||
170541897|NCT04069520|616328114|FG000|Overall Study|Lost to Follow-up|0|||
170452837|NCT02384941|615996072|FG001|Overall Study|Protocol Violation|0|||
170452838|NCT02384941|615996073|FG002|Overall Study|Protocol Violation|0|||
170452839|NCT02384941|615996071|FG000|Overall Study|Withdrawal by Subject|26|||
170787455|NCT03381196|617231798|FG001|Overall Study|Death|1|||
170787456|NCT03381196|617231797|FG000|Overall Study|Adverse Event|1|||
170787457|NCT03381196|617231798|FG001|Overall Study|Adverse Event|0|||
170634820|NCT02017405|616673301|FG004|Open-label Phase|Adverse Event|0|||
170634821|NCT02017405|616673302|FG005|Open-label Phase|Adverse Event|0|||
170452840|NCT02384941|615996072|FG001|Overall Study|Withdrawal by Subject|19|||
170452841|NCT02384941|615996073|FG002|Overall Study|Withdrawal by Subject|20|||
170452842|NCT02384941|615996071|FG000|Overall Study|Pregnancy|0|||
170452843|NCT02384941|615996072|FG001|Overall Study|Pregnancy|0|||
170452844|NCT02384941|615996073|FG002|Overall Study|Pregnancy|1|||
170452845|NCT02384941|615996071|FG000|Overall Study|Other than specified above|4|||
170452846|NCT02384941|615996072|FG001|Overall Study|Other than specified above|0|||
170452847|NCT02384941|615996073|FG002|Overall Study|Other than specified above|1|||
170452848|NCT02493777|615996074|FG000|Overall Study|Lost to Follow-up|0|||
170452849|NCT02493777|615996075|FG001|Overall Study|Lost to Follow-up|1|||
170452850|NCT00468728|615996076|FG000|Treatment|criteria for mITT population|4|||
170452851|NCT00468728|615996077|FG001|Treatment|criteria for mITT population|11|||
170452852|NCT00468728|615996076|FG000|Follow-up|mITT failure|34|||
170452853|NCT00468728|615996077|FG001|Follow-up|mITT failure|31|||
170452854|NCT01705236|615996078|FG000|Overall Study|Lost to Follow-up|1|||
170452855|NCT01705236|615996078|FG000|Overall Study|Administrative problems|2|||
170452856|NCT01705236|615996078|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
170452857|NCT01705236|615996078|FG000|Overall Study|Protocol Violation|3|||
170452858|NCT01705236|615996078|FG000|Overall Study|Abnormal test procedure result(s)|4|||
170452859|NCT01705236|615996078|FG000|Overall Study|Abnormal laboratory value(s)|4|||
170452860|NCT01705236|615996078|FG000|Overall Study|Withdrawal by Subject|5|||
170452861|NCT01705236|615996078|FG000|Overall Study|Adverse Event|5|||
170452862|NCT02025010|615996079|FG000|Overall Study|Symptomatic or radiographic progression|36|||
170452863|NCT02025010|615996079|FG000|Overall Study|Adverse Event|6|||
170634822|NCT01077050|616674701|FG000|Overall Study|Subjects signed ICF could not be located|1|||
170634823|NCT01077050|616674701|FG000|Overall Study|Screen failure|8|||
170634824|NCT02604160|616674702|FG000|Overall Study|Protocol Violation|0|||
170634825|NCT02604160|616674703|FG001|Overall Study|Protocol Violation|1|||
170634826|NCT02604160|616674702|FG000|Overall Study|Physician Decision|0|||
170634827|NCT02604160|616674703|FG001|Overall Study|Physician Decision|1|||
170634828|NCT01168219|616674707|FG000|Overall Study|off study before starting treatment|2|||
170634829|NCT01168219|616674707|FG000|Overall Study|withdrew before transplant|1|||
170634830|NCT01168219|616674707|FG000|Overall Study|ineligible due to CML|2|||
170634831|NCT01027273|616674708|FG000|Overall Study|Lost to Follow-up|57|||
170634832|NCT01027273|616674709|FG001|Overall Study|Lost to Follow-up|31|||
170634833|NCT01027273|616674708|FG000|Overall Study|Death|2|||
170634834|NCT01027273|616674709|FG001|Overall Study|Death|2|||
170634835|NCT01039519|616674712|FG000|Treatment|Progressive disease|20|||
170634836|NCT01039519|616674712|FG000|Treatment|Treatment failure|2|||
170634837|NCT01039519|616674712|FG000|Treatment|Adverse Event|3|||
170634838|NCT01039519|616674712|FG000|Treatment|Physician Decision|2|||
170787458|NCT03381196|617231797|FG000|Overall Study|Randomized, not treated|3|||
170452864|NCT02025010|615996079|FG000|Overall Study|Physician Decision|7|||
170452865|NCT02025010|615996079|FG000|Overall Study|Withdrawal by Subject|3|||
170452866|NCT02025010|615996079|FG000|Overall Study|Intercurrent illness|3|||
170452867|NCT02025010|615996079|FG000|Overall Study|Patients still on treatment|3|||
170452868|NCT02025010|615996079|FG000|Overall Study|Never initiate the treatment|2|||
170452869|NCT01553747|615996087|FG000|Overall Study|Protocol Violation|0|||
170452870|NCT01553747|615996088|FG001|Overall Study|Protocol Violation|2|||
170452871|NCT01553747|615996089|FG002|Overall Study|Protocol Violation|0|||
170452872|NCT01553747|615996087|FG000|Overall Study|Voluntarily withdrew|70|||
170452873|NCT01553747|615996088|FG001|Overall Study|Voluntarily withdrew|66|||
170787459|NCT03381196|617231798|FG001|Overall Study|Randomized, not treated|6|||
170787460|NCT01987895|617231799|FG000|Overall Study|Withdrawal by Subject|12|||
170452874|NCT01553747|615996089|FG002|Overall Study|Voluntarily withdrew|74|||
170452875|NCT01553747|615996087|FG000|Overall Study|Adverse event or SAE|32|||
170452876|NCT01553747|615996088|FG001|Overall Study|Adverse event or SAE|28|||
170452877|NCT01553747|615996089|FG002|Overall Study|Adverse event or SAE|19|||
170452878|NCT01553747|615996087|FG000|Overall Study|Physician decision: other|10|||
170634839|NCT01039519|616674712|FG000|Survival Follow-up|Death|23|||
170634840|NCT01039519|616674712|FG000|Survival Follow-up|Sponsor decision|4|||
170787461|NCT01987895|617231800|FG001|Overall Study|Withdrawal by Subject|7|||
170452879|NCT01553747|615996088|FG001|Overall Study|Physician decision: other|8|||
170452880|NCT01553747|615996089|FG002|Overall Study|Physician decision: other|7|||
170452881|NCT01553747|615996087|FG000|Overall Study|Lost to Follow-up|11|||
170452882|NCT01553747|615996088|FG001|Overall Study|Lost to Follow-up|5|||
170452883|NCT01553747|615996089|FG002|Overall Study|Lost to Follow-up|6|||
170452884|NCT01553747|615996087|FG000|Overall Study|Sponsor decision, specify|7|||
170634841|NCT01255436|616674718|FG000|Overall Study|Lost to Follow-up|178|||
170634842|NCT01255436|616674719|FG001|Overall Study|Lost to Follow-up|191|||
170787462|NCT01987895|617231799|FG000|Overall Study|Physician Decision|8|||
170634843|NCT01255436|616674718|FG000|Overall Study|Death, stroke, or MI|4|||
170634844|NCT01255436|616674719|FG001|Overall Study|Death, stroke, or MI|3|||
170541898|NCT04069520|616328115|FG001|Overall Study|Lost to Follow-up|2|||
170541899|NCT04069520|616328114|FG000|Overall Study|Withdrawal by Subject|0|||
170541900|NCT04069520|616328115|FG001|Overall Study|Withdrawal by Subject|1|||
170541901|NCT04069520|616328114|FG000|Overall Study|Prior Injury|1|||
170541902|NCT04069520|616328115|FG001|Overall Study|Prior Injury|0|||
170541903|NCT04069520|616328114|FG000|Overall Study|Orthodontia|1|||
170541904|NCT04069520|616328115|FG001|Overall Study|Orthodontia|0|||
170541905|NCT04069520|616328114|FG000|Overall Study|Cut from team|0|||
170541906|NCT04069520|616328115|FG001|Overall Study|Cut from team|2|||
170541907|NCT04599062|616328116|FG000|Overall Study|Physician Decision|1|||
170541908|NCT04599062|616328117|FG001|Overall Study|Physician Decision|0|||
170541909|NCT02422381|616328124|FG000|Overall Study|Death|14|||
170541910|NCT04822194|616328125|FG000|Overall Study|Withdrawal by Subject|5|||
170541911|NCT04822194|616328126|FG001|Overall Study|Withdrawal by Subject|4|||
170541912|NCT04822194|616328125|FG000|Overall Study|Technical issues with MR scanner|1|||
170541913|NCT04822194|616328126|FG001|Overall Study|Technical issues with MR scanner|0|||
170541914|NCT04822194|616328125|FG000|Overall Study|Lost to Follow-up|5|||
170541915|NCT04822194|616328126|FG001|Overall Study|Lost to Follow-up|7|||
170541916|NCT04615507|616328128|FG000|Period 1|Covid-19 exposure|2|||
170541917|NCT04615507|616328129|FG001|Period 1|Covid-19 exposure|1|||
170541918|NCT04615507|616328128|FG000|Period 2|Covid-19 exposure|0|||
170541919|NCT04615507|616328129|FG001|Period 2|Covid-19 exposure|1|||
170541920|NCT04615507|616328128|FG000|Period 2|Protocol Violation|1|||
170541921|NCT04615507|616328129|FG001|Period 2|Protocol Violation|0|||
170541922|NCT04615507|616328128|FG000|Period 2|Withdrawal by Subject|1|||
170541923|NCT04615507|616328129|FG001|Period 2|Withdrawal by Subject|0|||
170541924|NCT04615507|616328128|FG000|Period 2|Adverse Event|0|||
170541925|NCT04615507|616328129|FG001|Period 2|Adverse Event|1|||
170541926|NCT04615507|616328128|FG000|Period 3|Covid-19 exposure|0|||
170541927|NCT04615507|616328129|FG001|Period 3|Covid-19 exposure|1|||
170541928|NCT03407482|616328130|FG000|Overall Study|Adverse Event|12|||
170541929|NCT03407482|616328130|FG000|Overall Study|Disease Relapse|1|||
170541930|NCT03407482|616328130|FG000|Overall Study|Lost to Follow-up|1|||
170541931|NCT03407482|616328130|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170541932|NCT03407482|616328130|FG000|Overall Study|Pregnancy|2|||
170541933|NCT03407482|616328130|FG000|Overall Study|Protocol Violation|1|||
170541934|NCT03407482|616328130|FG000|Overall Study|Study Terminated By Sponsor|106|||
170541935|NCT03407482|616328130|FG000|Overall Study|Withdrawal by Subject|6|||
170541936|NCT03407482|616328130|FG000|Overall Study|Data Entry Error|1|||
170541937|NCT02603887|616328136|FG000|Stage 1|Adverse Event|4|||
170541938|NCT02603887|616328136|FG000|Stage 1|Disease progression|1|||
170541939|NCT02603887|616328136|FG000|Stage 2|FDA guidance|1|||
170541940|NCT04770779|616328137|FG000|Overall Study|Randomized, never treated|0|||
170541941|NCT04770779|616328138|FG001|Overall Study|Randomized, never treated|1|||
170541942|NCT04770779|616328137|FG000|Overall Study|Adverse Event|9|||
170541943|NCT04770779|616328138|FG001|Overall Study|Adverse Event|1|||
170541944|NCT04770779|616328137|FG000|Overall Study|Withdrawal by Subject|7|||
170541945|NCT04770779|616328138|FG001|Overall Study|Withdrawal by Subject|1|||
170541946|NCT04770779|616328137|FG000|Overall Study|Pregnancy|0|||
170541947|NCT04770779|616328138|FG001|Overall Study|Pregnancy|1|||
170541948|NCT03091439|616328139|FG000|Overall Study|Study Terminated by the Sponsor|1|||
170541949|NCT03091439|616328140|FG001|Overall Study|Study Terminated by the Sponsor|0|||
170541950|NCT03122106|616328141|FG000|Overall Study|Not enough tissue|1|||
170541951|NCT03122106|616328141|FG000|Overall Study|Disease progression during screening|2|||
170541952|NCT03122106|616328141|FG000|Overall Study|Poor RNA quality for vaccine|1|||
170541953|NCT02347787|616328142|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
170541954|NCT02347787|616328143|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
170541955|NCT02347787|616328142|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
170541956|NCT02347787|616328143|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
170541957|NCT02347787|616328142|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
170541958|NCT02347787|616328143|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
170541959|NCT02347787|616328142|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
170541960|NCT02347787|616328143|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
170541961|NCT02286089|616328147|FG000|Overall Study|Ongoing in Study|1|||
170541962|NCT02286089|616328148|FG001|Overall Study|Ongoing in Study|1|||
170541963|NCT02286089|616328149|FG002|Overall Study|Ongoing in Study|4|||
170541964|NCT02286089|616328150|FG003|Overall Study|Ongoing in Study|10|||
170541965|NCT02286089|616328147|FG000|Overall Study|Withdrawal by Subject|0|||
170888346|NCT03529773|617598281|FG013|Overall Study|Screen Failure|0|||
170541966|NCT02286089|616328148|FG001|Overall Study|Withdrawal by Subject|0|||
170541967|NCT02286089|616328149|FG002|Overall Study|Withdrawal by Subject|2|||
170541968|NCT02286089|616328150|FG003|Overall Study|Withdrawal by Subject|2|||
170541969|NCT03932331|616328155|FG000|Overall Study|Death|0|||
170541970|NCT03932331|616328156|FG001|Overall Study|Death|7|||
170541971|NCT03932331|616328157|FG002|Overall Study|Death|2|||
170541972|NCT03932331|616328155|FG000|Overall Study|Withdrawal by Subject|0|||
170541973|NCT03932331|616328156|FG001|Overall Study|Withdrawal by Subject|3|||
170541974|NCT03932331|616328157|FG002|Overall Study|Withdrawal by Subject|0|||
170888347|NCT03529773|617598282|FG014|Overall Study|Screen Failure|0|||
170452885|NCT01553747|615996088|FG001|Overall Study|Sponsor decision, specify|5|||
170452886|NCT01553747|615996089|FG002|Overall Study|Sponsor decision, specify|0|||
170452887|NCT01553747|615996087|FG000|Overall Study|Physician decision: lack of efficacy|1|||
170452888|NCT01553747|615996088|FG001|Overall Study|Physician decision: lack of efficacy|5|||
170888348|NCT03529773|617598283|FG015|Overall Study|Screen Failure|0|||
170452889|NCT01553747|615996089|FG002|Overall Study|Physician decision: lack of efficacy|3|||
170452890|NCT02787408|615996092|FG000|Overall Study|Death|16|||
170452891|NCT02787408|615996092|FG000|Overall Study|Withdrawal by Subject|1|||
170452892|NCT02787408|615996092|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
170452893|NCT01782482|615996093|FG000|Overall Study|Adverse Event|2|||
170452894|NCT01782482|615996094|FG001|Overall Study|Adverse Event|1|||
170452895|NCT01782482|615996093|FG000|Overall Study|Lost to Follow-up|2|||
170452896|NCT01782482|615996094|FG001|Overall Study|Lost to Follow-up|3|||
170452897|NCT01782482|615996093|FG000|Overall Study|Physician Decision|1|||
170452898|NCT01782482|615996094|FG001|Overall Study|Physician Decision|0|||
170452899|NCT01782482|615996093|FG000|Overall Study|Protocol Violation|1|||
170452900|NCT01782482|615996094|FG001|Overall Study|Protocol Violation|0|||
170452901|NCT01782482|615996093|FG000|Overall Study|Withdrawal by Subject|2|||
170452902|NCT01782482|615996094|FG001|Overall Study|Withdrawal by Subject|3|||
170452903|NCT01782482|615996093|FG000|Overall Study|Randomized in Error|2|||
170452904|NCT01782482|615996094|FG001|Overall Study|Randomized in Error|2|||
170452905|NCT01782482|615996093|FG000|Overall Study|Habitually wearing toric lens OS|0|||
170452906|NCT01782482|615996094|FG001|Overall Study|Habitually wearing toric lens OS|1|||
170452907|NCT05444543|615996095|FG000|Overall Study|Withdrawal by Subject|1|||
170452908|NCT05444543|615996096|FG001|Overall Study|Withdrawal by Subject|0|||
170452909|NCT05444543|615996095|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
170452910|NCT05444543|615996096|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
170452911|NCT05444543|615996095|FG000|Overall Study|Adverse Event|0|||
170452912|NCT05444543|615996096|FG001|Overall Study|Adverse Event|1|||
170452913|NCT05444543|615996095|FG000|Overall Study|Family relocating at a distance from study site|0|||
170452914|NCT05444543|615996096|FG001|Overall Study|Family relocating at a distance from study site|1|||
170452915|NCT02442271|615996101|FG000|Overall Study|Adverse Event|1|||
170452916|NCT02442271|615996101|FG000|Overall Study|Withdrew Consent|1|||
170452917|NCT02442271|615996101|FG000|Overall Study|Lost to Follow-up|1|||
170452918|NCT02442271|615996101|FG000|Overall Study|Other|1|||
170452919|NCT01491035|615996107|FG000|Overall Study|Lost to Follow-up|0|||
170452920|NCT01491035|615996108|FG001|Overall Study|Lost to Follow-up|0|||
170452921|NCT01491035|615996109|FG002|Overall Study|Lost to Follow-up|0|||
170452922|NCT01491035|615996110|FG003|Overall Study|Lost to Follow-up|0|||
170452923|NCT01491035|615996111|FG004|Overall Study|Lost to Follow-up|1|||
170452924|NCT01491035|615996112|FG005|Overall Study|Lost to Follow-up|0|||
170452925|NCT01491035|615996113|FG006|Overall Study|Lost to Follow-up|0|||
170452926|NCT01491035|615996114|FG007|Overall Study|Lost to Follow-up|0|||
170452927|NCT03487848|615996117|FG000|Overall Study|Lost to Follow-up|1|||
170541975|NCT03932331|616328155|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
170541976|NCT03932331|616328156|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
170541977|NCT03932331|616328157|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
170541978|NCT03932331|616328155|FG000|Overall Study|Progressive disease|3|||
170541979|NCT03932331|616328156|FG001|Overall Study|Progressive disease|0|||
170541980|NCT03932331|616328157|FG002|Overall Study|Progressive disease|0|||
170541981|NCT03932331|616328155|FG000|Overall Study|Lung infection|1|||
170541982|NCT03932331|616328156|FG001|Overall Study|Lung infection|0|||
170541983|NCT03932331|616328157|FG002|Overall Study|Lung infection|0|||
170541984|NCT03932331|616328155|FG000|Overall Study|Other|0|||
170541985|NCT03932331|616328156|FG001|Overall Study|Other|0|||
170541986|NCT03932331|616328157|FG002|Overall Study|Other|58|||
170541987|NCT03860584|616328159|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
170541988|NCT03860584|616328160|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
170541989|NCT03860584|616328159|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
170541990|NCT03860584|616328160|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
170541991|NCT03860584|616328159|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
170541992|NCT03860584|616328160|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
170541993|NCT03860584|616328159|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
170452928|NCT00123955|615996118|FG000|Overall Study|Adverse Event|1|||
170452929|NCT00123955|615996119|FG001|Overall Study|Adverse Event|0|||
170452930|NCT00123955|615996118|FG000|Overall Study|Withdrawal by Subject|4|||
170452931|NCT00123955|615996119|FG001|Overall Study|Withdrawal by Subject|3|||
170452932|NCT00123955|615996118|FG000|Overall Study|Death|0|||
170541994|NCT03860584|616328160|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
170541995|NCT04157517|616328161|FG000|Overall Study|Death|1|||
170541996|NCT04157517|616328162|FG001|Overall Study|Death|2|||
170541997|NCT04157517|616328163|FG002|Overall Study|Death|2|||
170541998|NCT04157517|616328164|FG003|Overall Study|Death|3|||
170541999|NCT04157517|616328165|FG004|Overall Study|Death|3|||
170452933|NCT00123955|615996119|FG001|Overall Study|Death|1|||
170452934|NCT05478252|615996122|FG000|Overall Study|Withdrawal by Subject|2|||
170542000|NCT04157517|616328166|FG005|Overall Study|Death|4|||
170542001|NCT04157517|616328167|FG006|Overall Study|Death|1|||
170542002|NCT04157517|616328168|FG007|Overall Study|Death|2|||
170542003|NCT04157517|616328169|FG008|Overall Study|Death|4|||
170542004|NCT04157517|616328170|FG009|Overall Study|Death|0|||
170542005|NCT04157517|616328161|FG000|Overall Study|Withdrawal by Subject|1|||
170542006|NCT04157517|616328162|FG001|Overall Study|Withdrawal by Subject|1|||
170542007|NCT04157517|616328163|FG002|Overall Study|Withdrawal by Subject|1|||
170542008|NCT04157517|616328164|FG003|Overall Study|Withdrawal by Subject|0|||
170634845|NCT04816669|616674721|FG000|Part 1|Adverse Event|1|||
170634846|NCT04816669|616674722|FG001|Part 1|Adverse Event|1|||
170634847|NCT04816669|616674723|FG002|Part 1|Adverse Event|0|||
170888349|NCT03529773|617598284|FG016|Overall Study|Screen Failure|0|||
170634848|NCT04816669|616674724|FG003|Part 1|Adverse Event|0|||
170634849|NCT04816669|616674721|FG000|Part 1|Lost to Follow-up|2|||
170634850|NCT04816669|616674722|FG001|Part 1|Lost to Follow-up|2|||
170634851|NCT04816669|616674723|FG002|Part 1|Lost to Follow-up|0|||
170634852|NCT04816669|616674724|FG003|Part 1|Lost to Follow-up|0|||
170634853|NCT04816669|616674721|FG000|Part 1|Protocol Violation|0|||
170634854|NCT04816669|616674722|FG001|Part 1|Protocol Violation|1|||
170634855|NCT04816669|616674723|FG002|Part 1|Protocol Violation|0|||
170634856|NCT04816669|616674724|FG003|Part 1|Protocol Violation|0|||
170634857|NCT04816669|616674721|FG000|Part 1|Withdrawal by Subject|1|||
170634858|NCT04816669|616674722|FG001|Part 1|Withdrawal by Subject|2|||
170634859|NCT04816669|616674723|FG002|Part 1|Withdrawal by Subject|0|||
170634860|NCT04816669|616674724|FG003|Part 1|Withdrawal by Subject|0|||
170634861|NCT04816669|616674721|FG000|Part 2|Other|0|||
170634862|NCT04816669|616674722|FG001|Part 2|Other|0|||
170634863|NCT04816669|616674723|FG002|Part 2|Other|1|||
170634864|NCT04816669|616674724|FG003|Part 2|Other|0|||
170634865|NCT04816669|616674721|FG000|Part 2|Withdrawal by Subject|0|||
170634866|NCT04816669|616674722|FG001|Part 2|Withdrawal by Subject|0|||
170634867|NCT04816669|616674723|FG002|Part 2|Withdrawal by Subject|0|||
170634868|NCT04816669|616674724|FG003|Part 2|Withdrawal by Subject|1|||
170634869|NCT04816669|616674721|FG000|Part 2|Lost to Follow-up|0|||
170634870|NCT04816669|616674722|FG001|Part 2|Lost to Follow-up|0|||
170634871|NCT04816669|616674723|FG002|Part 2|Lost to Follow-up|1|||
170634872|NCT04816669|616674724|FG003|Part 2|Lost to Follow-up|0|||
170634873|NCT01528969|616674725|FG000|Overall Study|absent from the school at baseline|2|||
170634874|NCT01528969|616674726|FG001|Overall Study|absent from the school at baseline|0|||
170634875|NCT01358721|616674730|FG000|Overall Study|Withdrawal by Subject|0|||
170888350|NCT03529773|617598285|FG017|Overall Study|Screen Failure|0|||
170888351|NCT03529773|617598286|FG018|Overall Study|Screen Failure|0|||
170888352|NCT03529773|617598287|FG019|Overall Study|Screen Failure|0|||
170888353|NCT03529773|617598288|FG020|Overall Study|Screen Failure|0|||
170634876|NCT01358721|616674731|FG001|Overall Study|Withdrawal by Subject|0|||
170634877|NCT01358721|616674732|FG002|Overall Study|Withdrawal by Subject|0|||
170634878|NCT01358721|616674733|FG003|Overall Study|Withdrawal by Subject|1|||
170888354|NCT03529773|617598289|FG021|Overall Study|Screen Failure|0|||
170888355|NCT03529773|617598290|FG022|Overall Study|Screen Failure|0|||
170888356|NCT03529773|617598291|FG023|Overall Study|Screen Failure|0|||
170888357|NCT03529773|617598292|FG024|Overall Study|Screen Failure|0|||
170888358|NCT03529773|617598293|FG025|Overall Study|Screen Failure|0|||
170888359|NCT03529773|617598294|FG026|Overall Study|Screen Failure|0|||
170888360|NCT03529773|617598295|FG027|Overall Study|Screen Failure|0|||
170888361|NCT03529773|617598296|FG028|Overall Study|Screen Failure|0|||
170888362|NCT03529773|617598297|FG029|Overall Study|Screen Failure|0|||
170888363|NCT03529773|617598298|FG030|Overall Study|Screen Failure|0|||
170888364|NCT03529773|617598299|FG031|Overall Study|Screen Failure|0|||
170542009|NCT04157517|616328165|FG004|Overall Study|Withdrawal by Subject|0|||
170542010|NCT04157517|616328166|FG005|Overall Study|Withdrawal by Subject|1|||
170542011|NCT04157517|616328167|FG006|Overall Study|Withdrawal by Subject|0|||
170634879|NCT01358721|616674730|FG000|Overall Study|Death|0|||
170888365|NCT03529773|617598300|FG032|Overall Study|Screen Failure|0|||
170888366|NCT03529773|617598301|FG033|Overall Study|Screen Failure|0|||
170888367|NCT03529773|617598302|FG034|Overall Study|Screen Failure|0|||
170634880|NCT01358721|616674731|FG001|Overall Study|Death|2|||
170634881|NCT01358721|616674732|FG002|Overall Study|Death|0|||
170634882|NCT01358721|616674733|FG003|Overall Study|Death|0|||
170888368|NCT03529773|617598303|FG035|Overall Study|Screen Failure|0|||
170787463|NCT01987895|617231800|FG001|Overall Study|Physician Decision|10|||
170452935|NCT05478252|615996123|FG001|Overall Study|Withdrawal by Subject|3|||
170452936|NCT05478252|615996122|FG000|Overall Study|Lost to Follow-up|4|||
170452937|NCT05478252|615996123|FG001|Overall Study|Lost to Follow-up|2|||
170452938|NCT05478252|615996122|FG000|Overall Study|Physician Decision|1|||
170452939|NCT05478252|615996123|FG001|Overall Study|Physician Decision|1|||
170452940|NCT05478252|615996122|FG000|Overall Study|Death|1|||
170452941|NCT05478252|615996123|FG001|Overall Study|Death|0|||
170452942|NCT04846881|615996124|FG000|Overall Study|Adverse Event|14|||
170452943|NCT04846881|615996125|FG001|Overall Study|Adverse Event|15|||
170452944|NCT04846881|615996124|FG000|Overall Study|Burden of study procedures|7|||
170452945|NCT04846881|615996125|FG001|Overall Study|Burden of study procedures|3|||
170452946|NCT04846881|615996124|FG000|Overall Study|Protocol deviation|6|||
170452947|NCT04846881|615996125|FG001|Overall Study|Protocol deviation|4|||
170452948|NCT04846881|615996124|FG000|Overall Study|Perceived lack of efficacy|5|||
170452949|NCT04846881|615996125|FG001|Overall Study|Perceived lack of efficacy|2|||
170452950|NCT04846881|615996124|FG000|Overall Study|Change of residence|2|||
170452951|NCT04846881|615996125|FG001|Overall Study|Change of residence|0|||
170452952|NCT04846881|615996124|FG000|Overall Study|Technical problems|0|||
170452953|NCT04846881|615996125|FG001|Overall Study|Technical problems|1|||
170452954|NCT04846881|615996124|FG000|Overall Study|Other than listed|3|||
170452955|NCT04846881|615996125|FG001|Overall Study|Other than listed|10|||
170452956|NCT04846881|615996124|FG000|Overall Study|No reason available|1|||
170452957|NCT04846881|615996125|FG001|Overall Study|No reason available|3|||
170452958|NCT04846881|615996124|FG000|Overall Study|Patient randomised in error|1|||
170452959|NCT04846881|615996125|FG001|Overall Study|Patient randomised in error|0|||
170452960|NCT00003138|615998505|FG000|Step 1|Reasons off treatment not documented|60|||
170452961|NCT00003138|615998506|FG001|Step 1|Reasons off treatment not documented|57|||
170452962|NCT00003138|615998505|FG000|Step 1|Never started treatment|1|||
170452963|NCT00003138|615998506|FG001|Step 1|Never started treatment|0|||
170452964|NCT00003138|615998505|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
170452965|NCT00003138|615998506|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
170452966|NCT00003138|615998505|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
170452967|NCT00003138|615998506|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
170452968|NCT00003138|615998505|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
170452969|NCT00003138|615998506|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
170452970|NCT00003138|615998505|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
170452971|NCT00003138|615998506|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
170452972|NCT02960893|615998507|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
170452973|NCT02960893|615998508|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
170452974|NCT02960893|615998509|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
170452975|NCT02960893|615998510|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
170452976|NCT02960893|615998507|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
170452977|NCT02960893|615998508|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
170452978|NCT02960893|615998509|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
170452979|NCT02960893|615998510|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
170452980|NCT02960893|615998507|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
170452981|NCT02960893|615998508|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
170452982|NCT02960893|615998509|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
170452983|NCT02960893|615998510|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
170452984|NCT02960893|615998507|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
170452985|NCT02960893|615998508|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
170452986|NCT02960893|615998509|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
170452987|NCT02960893|615998510|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
170452988|NCT02960893|615998507|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
170452989|NCT02960893|615998508|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
170452990|NCT02960893|615998509|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
170452991|NCT02960893|615998510|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
170452992|NCT02960893|615998507|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
170452993|NCT02960893|615998508|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
170452994|NCT02960893|615998509|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
170452995|NCT02960893|615998510|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
170452996|NCT02960893|615998507|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
170542012|NCT04157517|616328168|FG007|Overall Study|Withdrawal by Subject|0|||
170452997|NCT02960893|615998508|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
170452998|NCT02960893|615998509|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
170452999|NCT02960893|615998510|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
170453000|NCT02960893|615998507|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
170453001|NCT02960893|615998508|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
170542013|NCT04157517|616328169|FG008|Overall Study|Withdrawal by Subject|1|||
170787464|NCT01987895|617231799|FG000|Overall Study|Death|7|||
170453002|NCT02960893|615998509|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
170453003|NCT02960893|615998510|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
170453004|NCT02960893|615998507|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
170453005|NCT02960893|615998508|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
170453006|NCT02960893|615998509|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
170453007|NCT02960893|615998510|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
170453008|NCT02960893|615998507|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
170453009|NCT02960893|615998508|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
170453010|NCT02960893|615998509|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
170453011|NCT02960893|615998510|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
170453012|NCT02631876|615998515|FG000|Overall Study|Death|96|||
170453013|NCT02631876|615998516|FG001|Overall Study|Death|50|||
170453014|NCT02631876|615998515|FG000|Overall Study|Investigator's discretion|1|||
170453015|NCT02631876|615998516|FG001|Overall Study|Investigator's discretion|0|||
170453016|NCT02631876|615998515|FG000|Overall Study|Lost to Follow-up|2|||
170453017|NCT02631876|615998516|FG001|Overall Study|Lost to Follow-up|0|||
170453018|NCT02631876|615998515|FG000|Overall Study|Withdrawal by Subject|16|||
170453019|NCT02631876|615998516|FG001|Overall Study|Withdrawal by Subject|9|||
170453020|NCT02631876|615998515|FG000|Overall Study|Other than specified|4|||
170453021|NCT02631876|615998516|FG001|Overall Study|Other than specified|4|||
170453022|NCT04556552|615998517|FG000|Overall Study|Lost to Follow-up|1|||
170453023|NCT04556552|615998518|FG001|Overall Study|Lost to Follow-up|0|||
170453024|NCT04556552|615998517|FG000|Overall Study|Claustrophobia|0|||
170453025|NCT04556552|615998518|FG001|Overall Study|Claustrophobia|1|||
170453026|NCT04556552|615998517|FG000|Overall Study|Inability to continue|0|||
170453027|NCT04556552|615998518|FG001|Overall Study|Inability to continue|1|||
170453028|NCT03439852|615998519|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
170453029|NCT03439852|615998520|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
170453030|NCT03439852|615998519|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
170453031|NCT03439852|615998520|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
170453032|NCT03439852|615998519|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
170453033|NCT03439852|615998520|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
170453034|NCT04551911|615998521|FG000|Overall Study|Lost to Follow-up|2|||
170453035|NCT04551911|615998522|FG001|Overall Study|Lost to Follow-up|1|||
170453036|NCT04551911|615998521|FG000|Overall Study|Withdrawal by Subject|10|||
170453037|NCT04551911|615998522|FG001|Overall Study|Withdrawal by Subject|10|||
170453038|NCT04551911|615998521|FG000|Overall Study|Did not receive the study drug|3|||
170453039|NCT04551911|615998522|FG001|Overall Study|Did not receive the study drug|4|||
170453040|NCT02054130|615998525|FG000|Overall Study|Withdrawal by Subject|4|||
170453041|NCT02054130|615998526|FG001|Overall Study|Withdrawal by Subject|4|||
170453042|NCT02054130|615998527|FG002|Overall Study|Withdrawal by Subject|7|||
170453043|NCT02054130|615998528|FG003|Overall Study|Withdrawal by Subject|10|||
170453044|NCT02054130|615998525|FG000|Overall Study|Death|0|||
170453045|NCT02054130|615998526|FG001|Overall Study|Death|1|||
170453046|NCT02054130|615998527|FG002|Overall Study|Death|0|||
170453047|NCT02054130|615998528|FG003|Overall Study|Death|0|||
170453048|NCT02054130|615998525|FG000|Overall Study|Lost to Follow-up|0|||
170453049|NCT02054130|615998526|FG001|Overall Study|Lost to Follow-up|0|||
170542014|NCT04157517|616328170|FG009|Overall Study|Withdrawal by Subject|0|||
170542015|NCT04157517|616328161|FG000|Overall Study|Other|1|||
170542016|NCT04157517|616328162|FG001|Overall Study|Other|0|||
170542017|NCT04157517|616328163|FG002|Overall Study|Other|0|||
170542018|NCT04157517|616328164|FG003|Overall Study|Other|0|||
170542019|NCT04157517|616328165|FG004|Overall Study|Other|0|||
170542020|NCT04157517|616328166|FG005|Overall Study|Other|1|||
170453050|NCT02054130|615998527|FG002|Overall Study|Lost to Follow-up|1|||
170453051|NCT02054130|615998528|FG003|Overall Study|Lost to Follow-up|2|||
170542021|NCT04157517|616328167|FG006|Overall Study|Other|2|||
170542022|NCT04157517|616328168|FG007|Overall Study|Other|7|||
170542023|NCT04157517|616328169|FG008|Overall Study|Other|7|||
170634883|NCT01358721|616674730|FG000|Overall Study|Study Drug Toxicity|1|||
170634884|NCT01358721|616674731|FG001|Overall Study|Study Drug Toxicity|3|||
170634885|NCT01358721|616674732|FG002|Overall Study|Study Drug Toxicity|4|||
170634886|NCT01358721|616674733|FG003|Overall Study|Study Drug Toxicity|5|||
170634887|NCT01358721|616674730|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
170634888|NCT01358721|616674731|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
170634889|NCT01358721|616674732|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
170634890|NCT01358721|616674733|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
170634891|NCT01358721|616674730|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
170634892|NCT01358721|616674731|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
170634893|NCT01358721|616674732|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
170634894|NCT01358721|616674733|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
170634895|NCT01358721|616674730|FG000|Overall Study|Adverse Event related to study drug|1|||
170634896|NCT01358721|616674731|FG001|Overall Study|Adverse Event related to study drug|0|||
170634897|NCT01358721|616674732|FG002|Overall Study|Adverse Event related to study drug|0|||
170634898|NCT01358721|616674733|FG003|Overall Study|Adverse Event related to study drug|1|||
170634899|NCT01358721|616674730|FG000|Overall Study|Disease Progression|19|||
170634900|NCT01358721|616674731|FG001|Overall Study|Disease Progression|15|||
170634901|NCT01358721|616674732|FG002|Overall Study|Disease Progression|17|||
170634902|NCT01358721|616674733|FG003|Overall Study|Disease Progression|15|||
170634903|NCT01358721|616674730|FG000|Overall Study|Out of State/Unmet Criteria|0|||
170634904|NCT01358721|616674731|FG001|Overall Study|Out of State/Unmet Criteria|0|||
170634905|NCT01358721|616674732|FG002|Overall Study|Out of State/Unmet Criteria|1|||
170634906|NCT01358721|616674733|FG003|Overall Study|Out of State/Unmet Criteria|0|||
170634907|NCT00001213|616674734|FG000|Overall Study|Death|18|||
170634908|NCT00337675|616674737|FG000|Overall Study|Adverse Event|10|||
170634909|NCT00337675|616674738|FG001|Overall Study|Adverse Event|9|||
170634910|NCT00337675|616674739|FG002|Overall Study|Adverse Event|19|||
170634911|NCT00337675|616674737|FG000|Overall Study|Lack of Efficacy|10|||
170634912|NCT00337675|616674738|FG001|Overall Study|Lack of Efficacy|7|||
170634913|NCT00337675|616674739|FG002|Overall Study|Lack of Efficacy|9|||
170634914|NCT00337675|616674737|FG000|Overall Study|Lost to Follow-up|22|||
170634915|NCT00337675|616674738|FG001|Overall Study|Lost to Follow-up|19|||
170634916|NCT00337675|616674739|FG002|Overall Study|Lost to Follow-up|17|||
170634917|NCT00337675|616674737|FG000|Overall Study|Physician Decision|9|||
170634918|NCT00337675|616674738|FG001|Overall Study|Physician Decision|17|||
170634919|NCT00337675|616674739|FG002|Overall Study|Physician Decision|14|||
170634920|NCT00337675|616674737|FG000|Overall Study|Protocol Violation|21|||
170634921|NCT00337675|616674738|FG001|Overall Study|Protocol Violation|24|||
170634922|NCT00337675|616674739|FG002|Overall Study|Protocol Violation|19|||
170634923|NCT00337675|616674737|FG000|Overall Study|Withdrawal by Subject|25|||
170634924|NCT00337675|616674738|FG001|Overall Study|Withdrawal by Subject|25|||
170634925|NCT00337675|616674739|FG002|Overall Study|Withdrawal by Subject|19|||
170634926|NCT00337675|616674737|FG000|Overall Study|Progressive Disease|0|||
170634927|NCT00337675|616674738|FG001|Overall Study|Progressive Disease|2|||
170634928|NCT00337675|616674739|FG002|Overall Study|Progressive Disease|0|||
170634929|NCT00337675|616674737|FG000|Overall Study|Trial Terminated|0|||
170634930|NCT00337675|616674738|FG001|Overall Study|Trial Terminated|0|||
170634931|NCT00337675|616674739|FG002|Overall Study|Trial Terminated|2|||
170634932|NCT02754440|616674740|FG000|Overall Study|Protocol Violation|3|||
170634933|NCT02754440|616674741|FG001|Overall Study|Protocol Violation|2|||
170634934|NCT02754440|616674742|FG002|Overall Study|Protocol Violation|2|||
170634935|NCT02754440|616674743|FG003|Overall Study|Protocol Violation|6|||
170634936|NCT02754440|616674740|FG000|Overall Study|Adverse Event|3|||
170634937|NCT02754440|616674741|FG001|Overall Study|Adverse Event|1|||
170634938|NCT02754440|616674742|FG002|Overall Study|Adverse Event|0|||
170634939|NCT02754440|616674743|FG003|Overall Study|Adverse Event|9|||
170634940|NCT02754440|616674740|FG000|Overall Study|Withdrawal by Subject|0|||
170634941|NCT02754440|616674741|FG001|Overall Study|Withdrawal by Subject|0|||
170634942|NCT02754440|616674742|FG002|Overall Study|Withdrawal by Subject|0|||
170634943|NCT02754440|616674743|FG003|Overall Study|Withdrawal by Subject|1|||
170787465|NCT01987895|617231800|FG001|Overall Study|Death|7|||
170634944|NCT02754440|616674740|FG000|Overall Study|Equipment failure|0|||
170634945|NCT02754440|616674741|FG001|Overall Study|Equipment failure|5|||
170634946|NCT02754440|616674742|FG002|Overall Study|Equipment failure|5|||
170634947|NCT02754440|616674743|FG003|Overall Study|Equipment failure|7|||
170634948|NCT02754440|616674740|FG000|Overall Study|Subject issues not resulting in AE|0|||
170634949|NCT02754440|616674741|FG001|Overall Study|Subject issues not resulting in AE|0|||
170634950|NCT02754440|616674742|FG002|Overall Study|Subject issues not resulting in AE|0|||
170634951|NCT02754440|616674743|FG003|Overall Study|Subject issues not resulting in AE|12|||
170634952|NCT02558296|616674744|FG000|Completed the Study Through Week 24|Adverse Event|9|||
170634953|NCT02558296|616674745|FG001|Completed the Study Through Week 24|Adverse Event|3|||
170634954|NCT02558296|616674744|FG000|Completed the Study Through Week 24|Death|7|||
170634955|NCT02558296|616674745|FG001|Completed the Study Through Week 24|Death|7|||
170634956|NCT02558296|616674744|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
170787466|NCT01987895|617231799|FG000|Overall Study|Lost to Follow-up|3|||
170787467|NCT01987895|617231800|FG001|Overall Study|Lost to Follow-up|5|||
170453052|NCT02054130|615998525|FG000|Overall Study|Missed dose|4|||
170453053|NCT02054130|615998526|FG001|Overall Study|Missed dose|6|||
170453054|NCT02054130|615998527|FG002|Overall Study|Missed dose|7|||
170453055|NCT02054130|615998528|FG003|Overall Study|Missed dose|10|||
170453056|NCT01386684|615998529|FG000|Overall Study|Lost to Follow-up|51|||
170453057|NCT01386684|615998529|FG000|Overall Study|Other|51|||
170453058|NCT01386684|615998529|FG000|Overall Study|Death|47|||
170453059|NCT01386684|615998529|FG000|Overall Study|Withdrawal of Consent|44|||
170453060|NCT01386684|615998529|FG000|Overall Study|Alternative Therapy Required|37|||
170453061|NCT01386684|615998529|FG000|Overall Study|Disease Progression|28|||
170453062|NCT01386684|615998529|FG000|Overall Study|Adverse Event|20|||
170453063|NCT01386684|615998529|FG000|Overall Study|Noncompliance|8|||
170453064|NCT01386684|615998529|FG000|Overall Study|Protocol Violation|4|||
170453065|NCT01386684|615998529|FG000|Overall Study|Missing|3|||
170453066|NCT01132664|615998530|FG000|Phase lb|Adverse Event|0|||
170453067|NCT01132664|615998531|FG001|Phase lb|Adverse Event|1|||
170453068|NCT01132664|615998532|FG002|Phase lb|Adverse Event|0|||
170453069|NCT01132664|615998533|FG003|Phase lb|Adverse Event|0|||
170453070|NCT01132664|615998534|FG004|Phase lb|Adverse Event|0|||
170453071|NCT01132664|615998530|FG000|Phase lb|Withdrawal by Subject|1|||
170453072|NCT01132664|615998531|FG001|Phase lb|Withdrawal by Subject|2|||
170453073|NCT01132664|615998532|FG002|Phase lb|Withdrawal by Subject|0|||
170453074|NCT01132664|615998533|FG003|Phase lb|Withdrawal by Subject|0|||
170453075|NCT01132664|615998534|FG004|Phase lb|Withdrawal by Subject|0|||
170453076|NCT01132664|615998530|FG000|Phase lb|Disease Progression|4|||
170453077|NCT01132664|615998531|FG001|Phase lb|Disease Progression|9|||
170453078|NCT01132664|615998532|FG002|Phase lb|Disease Progression|0|||
170453079|NCT01132664|615998533|FG003|Phase lb|Disease Progression|0|||
170453080|NCT01132664|615998534|FG004|Phase lb|Disease Progression|0|||
170453081|NCT01132664|615998530|FG000|Phase ll|Death|0|||
170542024|NCT04157517|616328170|FG009|Overall Study|Other|0|||
170542025|NCT04690556|616328171|FG000|Overall Study|Adverse Event|6|||
170542026|NCT04690556|616328172|FG001|Overall Study|Adverse Event|4|||
170542027|NCT04690556|616328171|FG000|Overall Study|Death|3|||
170542028|NCT04690556|616328172|FG001|Overall Study|Death|4|||
170542029|NCT04690556|616328171|FG000|Overall Study|Lost to Follow-up|3|||
170542030|NCT04690556|616328172|FG001|Overall Study|Lost to Follow-up|2|||
170542031|NCT04690556|616328171|FG000|Overall Study|Protocol Violation|1|||
170542032|NCT04690556|616328172|FG001|Overall Study|Protocol Violation|4|||
170542033|NCT04690556|616328171|FG000|Overall Study|Physician Decision|2|||
170453082|NCT01132664|615998531|FG001|Phase ll|Death|0|||
170453083|NCT01132664|615998532|FG002|Phase ll|Death|2|||
170453084|NCT01132664|615998533|FG003|Phase ll|Death|0|||
170542034|NCT04690556|616328172|FG001|Overall Study|Physician Decision|0|||
170542035|NCT04690556|616328171|FG000|Overall Study|Withdrawal by Subject|25|||
170453085|NCT01132664|615998534|FG004|Phase ll|Death|0|||
170453086|NCT01132664|615998530|FG000|Phase ll|Adverse Event|0|||
170634957|NCT02558296|616674745|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
170634958|NCT02558296|616674744|FG000|Completed the Study Through Week 24|Physician Decision|1|||
170634959|NCT02558296|616674745|FG001|Completed the Study Through Week 24|Physician Decision|0|||
170634960|NCT02558296|616674744|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
170634961|NCT02558296|616674745|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
170634962|NCT02558296|616674744|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
170634963|NCT02558296|616674745|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
170634964|NCT02558296|616674744|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
170634965|NCT02558296|616674745|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
170634966|NCT02558296|616674744|FG000|Completed the Study|Adverse Event|14|||
170634967|NCT02558296|616674745|FG001|Completed the Study|Adverse Event|5|||
170634968|NCT02558296|616674744|FG000|Completed the Study|Death|39|||
170634969|NCT02558296|616674745|FG001|Completed the Study|Death|25|||
170634970|NCT02558296|616674744|FG000|Completed the Study|Lost to Follow-up|31|||
170634971|NCT02558296|616674745|FG001|Completed the Study|Lost to Follow-up|23|||
170634972|NCT02558296|616674744|FG000|Completed the Study|Physician Decision|6|||
170634973|NCT02558296|616674745|FG001|Completed the Study|Physician Decision|0|||
170634974|NCT02558296|616674744|FG000|Completed the Study|Protocol Violation|2|||
170634975|NCT02558296|616674745|FG001|Completed the Study|Protocol Violation|1|||
170634976|NCT02558296|616674744|FG000|Completed the Study|Withdrawal by Subject|53|||
170634977|NCT02558296|616674745|FG001|Completed the Study|Withdrawal by Subject|31|||
170634978|NCT02558296|616674744|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
170634979|NCT02558296|616674745|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
170634980|NCT01263197|616674755|FG000|First Intervention (Period 1)|Adverse Event|0|||
170634981|NCT01263197|616674756|FG001|First Intervention (Period 1)|Adverse Event|0|||
170634982|NCT01263197|616674757|FG002|First Intervention (Period 1)|Adverse Event|0|||
170634983|NCT01263197|616674758|FG003|First Intervention (Period 1)|Adverse Event|0|||
170634984|NCT01263197|616674759|FG004|First Intervention (Period 1)|Adverse Event|0|||
170634985|NCT01263197|616674760|FG005|First Intervention (Period 1)|Adverse Event|1|||
170634986|NCT01263197|616674755|FG000|Washout Period 1|Protocol Violation|0|||
170634987|NCT01263197|616674756|FG001|Washout Period 1|Protocol Violation|0|||
170634988|NCT01263197|616674757|FG002|Washout Period 1|Protocol Violation|0|||
170634989|NCT01263197|616674758|FG003|Washout Period 1|Protocol Violation|0|||
170634990|NCT01263197|616674759|FG004|Washout Period 1|Protocol Violation|1|||
170634991|NCT01263197|616674760|FG005|Washout Period 1|Protocol Violation|0|||
170634992|NCT01263197|616674755|FG000|Washout Period 2|Physician Decision|0|||
170634993|NCT01263197|616674756|FG001|Washout Period 2|Physician Decision|0|||
170634994|NCT01263197|616674757|FG002|Washout Period 2|Physician Decision|0|||
170634995|NCT01263197|616674758|FG003|Washout Period 2|Physician Decision|0|||
170634996|NCT01263197|616674759|FG004|Washout Period 2|Physician Decision|0|||
170634997|NCT01263197|616674760|FG005|Washout Period 2|Physician Decision|1|||
170634998|NCT01263197|616674755|FG000|Washout Period 2|Protocol Violation|0|||
170634999|NCT01263197|616674756|FG001|Washout Period 2|Protocol Violation|0|||
170635000|NCT01263197|616674757|FG002|Washout Period 2|Protocol Violation|0|||
170635001|NCT01263197|616674758|FG003|Washout Period 2|Protocol Violation|1|||
170635002|NCT01263197|616674759|FG004|Washout Period 2|Protocol Violation|0|||
170635003|NCT01263197|616674760|FG005|Washout Period 2|Protocol Violation|0|||
170635004|NCT01263197|616674755|FG000|Third Intervention (Period 3)|Adverse Event|0|||
170635005|NCT01263197|616674756|FG001|Third Intervention (Period 3)|Adverse Event|1|||
170635006|NCT01263197|616674757|FG002|Third Intervention (Period 3)|Adverse Event|0|||
170635007|NCT01263197|616674758|FG003|Third Intervention (Period 3)|Adverse Event|0|||
170635008|NCT01263197|616674759|FG004|Third Intervention (Period 3)|Adverse Event|0|||
170635009|NCT01263197|616674760|FG005|Third Intervention (Period 3)|Adverse Event|0|||
170635010|NCT01075685|616674765|FG000|Overall Study|Protocol Violation|9|||
170635011|NCT01075685|616674766|FG001|Overall Study|Protocol Violation|1|||
170635012|NCT01075685|616674765|FG000|Overall Study|Withdrawal by Subject|20|||
170635013|NCT01075685|616674766|FG001|Overall Study|Withdrawal by Subject|5|||
170635014|NCT01075685|616674765|FG000|Overall Study|Lost to Follow-up|563|||
170635015|NCT01075685|616674766|FG001|Overall Study|Lost to Follow-up|220|||
170635016|NCT01967576|616674767|FG000|Overall Study|Withdrawal by Subject|3|||
170635017|NCT01967576|616674767|FG000|Overall Study|Progressed/Removed from treatment|1|||
170635018|NCT01967576|616674767|FG000|Overall Study|Study closing at site|1|||
170635019|NCT01967576|616674767|FG000|Overall Study|Adverse Event|1|||
170635020|NCT01967576|616674767|FG000|Overall Study|Refused further treatment|1|||
170787468|NCT01987895|617231799|FG000|Overall Study|randomized before giving IC|0|||
170787469|NCT01987895|617231800|FG001|Overall Study|randomized before giving IC|1|||
170787470|NCT04971681|617231801|FG000|Followup|Lost to Follow-up|1|||
170635021|NCT02194985|616674770|FG000|Overall Study|Adverse Event|1|||
170787471|NCT04971681|617231802|FG001|Followup|Lost to Follow-up|0|||
170787472|NCT00686335|617231803|FG000|Run-in Period|Adverse Event|1|||
170787473|NCT00686335|617231803|FG000|Run-in Period|asthma exacerbation|1|||
170453087|NCT01132664|615998531|FG001|Phase ll|Adverse Event|0|||
170453088|NCT01132664|615998532|FG002|Phase ll|Adverse Event|10|||
170453089|NCT01132664|615998533|FG003|Phase ll|Adverse Event|0|||
170453090|NCT01132664|615998534|FG004|Phase ll|Adverse Event|0|||
170453091|NCT01132664|615998530|FG000|Phase ll|Withdrawal by Subject|0|||
170453092|NCT01132664|615998531|FG001|Phase ll|Withdrawal by Subject|0|||
170453093|NCT01132664|615998532|FG002|Phase ll|Withdrawal by Subject|3|||
170453094|NCT01132664|615998533|FG003|Phase ll|Withdrawal by Subject|0|||
170453095|NCT01132664|615998534|FG004|Phase ll|Withdrawal by Subject|0|||
170453096|NCT01132664|615998530|FG000|Phase ll|Disease progression|0|||
170453097|NCT01132664|615998531|FG001|Phase ll|Disease progression|0|||
170453098|NCT01132664|615998532|FG002|Phase ll|Disease progression|35|||
170453099|NCT01132664|615998533|FG003|Phase ll|Disease progression|0|||
170453100|NCT01132664|615998534|FG004|Phase ll|Disease progression|0|||
170453101|NCT01132664|615998530|FG000|BM Cohort|Disease progression|0|||
170453102|NCT01132664|615998531|FG001|BM Cohort|Disease progression|0|||
170453103|NCT01132664|615998532|FG002|BM Cohort|Disease progression|0|||
170453104|NCT01132664|615998533|FG003|BM Cohort|Disease progression|3|||
170787474|NCT00686335|617231803|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
170453105|NCT01132664|615998534|FG004|BM Cohort|Disease progression|4|||
170453106|NCT01132664|615998530|FG000|BM Cohort|Adverse Event|0|||
170453107|NCT01132664|615998531|FG001|BM Cohort|Adverse Event|0|||
170453108|NCT01132664|615998532|FG002|BM Cohort|Adverse Event|0|||
170453109|NCT01132664|615998533|FG003|BM Cohort|Adverse Event|0|||
170453110|NCT01132664|615998534|FG004|BM Cohort|Adverse Event|1|||
170453111|NCT01132664|615998530|FG000|BM Cohort|Withdrawal by Subject|0|||
170453112|NCT01132664|615998531|FG001|BM Cohort|Withdrawal by Subject|0|||
170453113|NCT01132664|615998532|FG002|BM Cohort|Withdrawal by Subject|0|||
170453114|NCT01132664|615998533|FG003|BM Cohort|Withdrawal by Subject|0|||
170453115|NCT01132664|615998534|FG004|BM Cohort|Withdrawal by Subject|1|||
170453116|NCT04271735|615998536|FG000|Overall Study|Physician Decision|2|||
170453117|NCT04271735|615998537|FG001|Overall Study|Physician Decision|0|||
170453118|NCT03656874|615998545|FG000|Overall Study|Lost to Follow-up|3|||
170453119|NCT03656874|615998546|FG001|Overall Study|Lost to Follow-up|17|||
170453120|NCT01403064|615998551|FG000|Overall Study|Death|0|||
170453121|NCT01403064|615998552|FG001|Overall Study|Death|0|||
170453122|NCT01403064|615998553|FG002|Overall Study|Death|1|||
170453123|NCT01403064|615998554|FG003|Overall Study|Death|1|||
170453124|NCT01403064|615998551|FG000|Overall Study|Withdrawal by Subject|0|||
170453125|NCT01403064|615998552|FG001|Overall Study|Withdrawal by Subject|0|||
170453126|NCT01403064|615998553|FG002|Overall Study|Withdrawal by Subject|1|||
170453127|NCT01403064|615998554|FG003|Overall Study|Withdrawal by Subject|1|||
170453128|NCT01403064|615998551|FG000|Overall Study|Other|1|||
170453129|NCT01403064|615998552|FG001|Overall Study|Other|0|||
170453130|NCT01403064|615998553|FG002|Overall Study|Other|2|||
170453131|NCT01403064|615998554|FG003|Overall Study|Other|1|||
170453132|NCT02528123|615998555|FG000|Overall Study|Lost to Follow-up|1|||
170453133|NCT01939496|615998556|FG000|Overall Study|Adverse Event|2|||
170453134|NCT01939496|615998557|FG001|Overall Study|Adverse Event|0|||
170453135|NCT01939496|615998558|FG002|Overall Study|Adverse Event|0|||
170453136|NCT01939496|615998556|FG000|Overall Study|Lost to Follow-up|1|||
170453137|NCT01939496|615998557|FG001|Overall Study|Lost to Follow-up|1|||
170453138|NCT01939496|615998558|FG002|Overall Study|Lost to Follow-up|0|||
170453139|NCT01939496|615998556|FG000|Overall Study|Physician Decision|1|||
170453140|NCT01939496|615998557|FG001|Overall Study|Physician Decision|0|||
170453141|NCT01939496|615998558|FG002|Overall Study|Physician Decision|0|||
170453142|NCT01939496|615998556|FG000|Overall Study|Protocol Violation|3|||
170453143|NCT01939496|615998557|FG001|Overall Study|Protocol Violation|0|||
170453144|NCT01939496|615998558|FG002|Overall Study|Protocol Violation|0|||
170453145|NCT01939496|615998556|FG000|Overall Study|Withdrawal by Subject|0|||
170453146|NCT01939496|615998557|FG001|Overall Study|Withdrawal by Subject|1|||
170453147|NCT01939496|615998558|FG002|Overall Study|Withdrawal by Subject|1|||
170453148|NCT01939496|615998556|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
170453149|NCT01939496|615998557|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
170453150|NCT01939496|615998558|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
170453151|NCT01939496|615998556|FG000|Overall Study|Other|2|||
170453152|NCT01939496|615998557|FG001|Overall Study|Other|0|||
170453153|NCT01939496|615998558|FG002|Overall Study|Other|1|||
170453154|NCT03052322|615998559|FG000|Overall Study|Other un-specified|1|||
170453155|NCT03052322|615998560|FG001|Overall Study|Other un-specified|2|||
170453156|NCT03052322|615998559|FG000|Overall Study|Withdrawal by Subject|10|||
170787475|NCT04149704|617231809|FG000|Three Month Follow-up|Death|2|||
170453157|NCT03052322|615998560|FG001|Overall Study|Withdrawal by Subject|9|||
170453158|NCT03052322|615998559|FG000|Overall Study|Death|0|||
170453159|NCT03052322|615998560|FG001|Overall Study|Death|2|||
170453160|NCT03052322|615998559|FG000|Overall Study|Lack of Efficacy|1|||
170453161|NCT03052322|615998560|FG001|Overall Study|Lack of Efficacy|2|||
170453162|NCT03052322|615998559|FG000|Overall Study|Protocol Violation|1|||
170453163|NCT03052322|615998560|FG001|Overall Study|Protocol Violation|0|||
170453164|NCT03052322|615998559|FG000|Overall Study|Lost to Follow-up|2|||
170453165|NCT03052322|615998560|FG001|Overall Study|Lost to Follow-up|4|||
170635022|NCT02194985|616674770|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
170635023|NCT02194985|616674770|FG000|Overall Study|Physician Decision|4|||
170635024|NCT02194985|616674770|FG000|Overall Study|Lost to Follow-up|1|||
170635025|NCT02194985|616674770|FG000|Overall Study|Withdrawal by Subject|2|||
170635026|NCT00131248|616674771|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
170635027|NCT00131248|616674772|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
170635028|NCT03048578|616674773|FG000|Overall Study|Withdrawal by Subject|5|||
170635029|NCT03048578|616674774|FG001|Overall Study|Withdrawal by Subject|6|||
170635030|NCT03048578|616674773|FG000|Overall Study|Lost to Follow-up|22|||
170635031|NCT03048578|616674774|FG001|Overall Study|Lost to Follow-up|10|||
170635032|NCT03048578|616674773|FG000|Overall Study|Adverse Event|1|||
170635033|NCT03048578|616674774|FG001|Overall Study|Adverse Event|2|||
170635034|NCT03048578|616674773|FG000|Overall Study|Terminated|3|||
170635035|NCT03048578|616674774|FG001|Overall Study|Terminated|2|||
170635036|NCT02377817|616674781|FG000|Overall Study|Transportation/childcare barriers.|2|||
170635037|NCT02377817|616674782|FG001|Overall Study|Transportation/childcare barriers.|0|||
170635038|NCT02377817|616674781|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
170635039|NCT02377817|616674782|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
170635040|NCT02565108|616674783|FG000|Overall Study|Adverse Event|1|||
170635041|NCT02565108|616674784|FG001|Overall Study|Adverse Event|0|||
170635042|NCT02565108|616674783|FG000|Overall Study|Withdrew Consent|1|||
170635043|NCT02565108|616674784|FG001|Overall Study|Withdrew Consent|0|||
170635044|NCT01310075|616674801|FG000|Overall Study|Lost to Follow-up|1|||
170635045|NCT01310075|616674802|FG001|Overall Study|Lost to Follow-up|0|||
170635046|NCT01310075|616674801|FG000|Overall Study|Physician Decision|10|||
170635047|NCT01310075|616674802|FG001|Overall Study|Physician Decision|7|||
170635048|NCT01310075|616674801|FG000|Overall Study|Protocol Violation|2|||
170635049|NCT01310075|616674802|FG001|Overall Study|Protocol Violation|2|||
170635050|NCT01310075|616674801|FG000|Overall Study|Withdrawal by Subject|1|||
170635051|NCT01310075|616674802|FG001|Overall Study|Withdrawal by Subject|1|||
170635052|NCT03614156|616674803|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
170635053|NCT03614156|616674804|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
170635054|NCT03614156|616674805|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
170635055|NCT03614156|616674806|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
170635056|NCT03614156|616674803|FG000|Open-Label Treatment Period|Adverse Event|7|||
170635057|NCT03614156|616674804|FG001|Open-Label Treatment Period|Adverse Event|0|||
170635058|NCT03614156|616674805|FG002|Open-Label Treatment Period|Adverse Event|0|||
170635059|NCT03614156|616674806|FG003|Open-Label Treatment Period|Adverse Event|0|||
170635060|NCT03614156|616674803|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
170635061|NCT03614156|616674804|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
170635062|NCT03614156|616674805|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
170635063|NCT03614156|616674806|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
170635064|NCT03614156|616674803|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
170635065|NCT03614156|616674804|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
170635066|NCT03614156|616674805|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
170635067|NCT03614156|616674806|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
170635068|NCT03614156|616674803|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
170635069|NCT03614156|616674804|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
170635070|NCT03614156|616674805|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
170635071|NCT03614156|616674806|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
170635072|NCT03614156|616674803|FG000|Open-Label Treatment Period|Protocol Violation|2|||
170635073|NCT03614156|616674804|FG001|Open-Label Treatment Period|Protocol Violation|0|||
170635074|NCT03614156|616674805|FG002|Open-Label Treatment Period|Protocol Violation|0|||
170635075|NCT03614156|616674806|FG003|Open-Label Treatment Period|Protocol Violation|0|||
170635076|NCT03614156|616674803|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
170635077|NCT03614156|616674804|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
170635078|NCT03614156|616674805|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
170635079|NCT03614156|616674806|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
170635080|NCT03614156|616674803|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
170635081|NCT03614156|616674804|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
170635082|NCT03614156|616674805|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
170635083|NCT03614156|616674806|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
170635084|NCT03614156|616674803|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
170635085|NCT03614156|616674804|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
170635086|NCT03614156|616674805|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
170635087|NCT03614156|616674806|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
170635088|NCT03614156|616674803|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
170635089|NCT03614156|616674804|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
170635090|NCT03614156|616674805|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
170635091|NCT03614156|616674806|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
170635092|NCT03614156|616674803|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170453166|NCT03052322|615998559|FG000|Overall Study|Adverse Event|6|||
170787476|NCT04149704|617231810|FG001|Three Month Follow-up|Death|0|||
170787477|NCT04149704|617231811|FG002|Three Month Follow-up|Death|0|||
170787478|NCT04149704|617231812|FG003|Three Month Follow-up|Death|0|||
170787479|NCT04149704|617231809|FG000|Three Month Follow-up|Lost to Follow-up|1|||
170787480|NCT04149704|617231810|FG001|Three Month Follow-up|Lost to Follow-up|4|||
170453167|NCT03052322|615998560|FG001|Overall Study|Adverse Event|13|||
170453168|NCT02408120|615998567|FG000|Overall Study|Withdrawal by Subject|0|||
170453169|NCT02408120|615998568|FG001|Overall Study|Withdrawal by Subject|1|||
170453170|NCT02408120|615998567|FG000|Overall Study|Treatment Refusal|1|||
170453171|NCT02408120|615998568|FG001|Overall Study|Treatment Refusal|0|||
170453172|NCT02408120|615998567|FG000|Overall Study|Received Steroids|1|||
170453173|NCT02408120|615998568|FG001|Overall Study|Received Steroids|1|||
170453174|NCT02408120|615998567|FG000|Overall Study|Discharged same day|1|||
170453175|NCT02408120|615998568|FG001|Overall Study|Discharged same day|1|||
170453176|NCT02408120|615998567|FG000|Overall Study|Did not receive insulin|1|||
170453177|NCT02408120|615998568|FG001|Overall Study|Did not receive insulin|2|||
170453178|NCT00757848|615998569|FG000|Overall Study|Voluntary discontinuation|1|||
170453179|NCT00757848|615998570|FG001|Overall Study|Voluntary discontinuation|0|||
170453180|NCT00757848|615998569|FG000|Overall Study|Adverse Event|1|||
170453181|NCT00757848|615998570|FG001|Overall Study|Adverse Event|2|||
170453182|NCT00757848|615998569|FG000|Overall Study|Incorrect enrolment|1|||
170453183|NCT00757848|615998570|FG001|Overall Study|Incorrect enrolment|0|||
170453184|NCT00958126|615998571|FG000|Overall Study|Serious Adverse Event|0|||
170453185|NCT00958126|615998572|FG001|Overall Study|Serious Adverse Event|2|||
170453186|NCT00958126|615998573|FG002|Overall Study|Serious Adverse Event|0|||
170453187|NCT00958126|615998574|FG003|Overall Study|Serious Adverse Event|0|||
170453188|NCT00958126|615998575|FG004|Overall Study|Serious Adverse Event|0|||
170453189|NCT00958126|615998576|FG005|Overall Study|Serious Adverse Event|0|||
170453190|NCT00958126|615998577|FG006|Overall Study|Serious Adverse Event|1|||
170453191|NCT00958126|615998578|FG007|Overall Study|Serious Adverse Event|0|||
170453192|NCT00958126|615998571|FG000|Overall Study|Withdrawal by Subject|0|||
170453193|NCT00958126|615998572|FG001|Overall Study|Withdrawal by Subject|2|||
170453194|NCT00958126|615998573|FG002|Overall Study|Withdrawal by Subject|0|||
170453195|NCT00958126|615998574|FG003|Overall Study|Withdrawal by Subject|0|||
170453196|NCT00958126|615998575|FG004|Overall Study|Withdrawal by Subject|0|||
170453197|NCT00958126|615998576|FG005|Overall Study|Withdrawal by Subject|0|||
170453198|NCT00958126|615998577|FG006|Overall Study|Withdrawal by Subject|0|||
170453199|NCT00958126|615998578|FG007|Overall Study|Withdrawal by Subject|0|||
170453200|NCT00958126|615998571|FG000|Overall Study|Moved away from study area|0|||
170453201|NCT00958126|615998572|FG001|Overall Study|Moved away from study area|0|||
170453202|NCT00958126|615998573|FG002|Overall Study|Moved away from study area|1|||
170453203|NCT00958126|615998574|FG003|Overall Study|Moved away from study area|1|||
170453204|NCT00958126|615998575|FG004|Overall Study|Moved away from study area|0|||
170453205|NCT00958126|615998576|FG005|Overall Study|Moved away from study area|0|||
170453206|NCT00958126|615998577|FG006|Overall Study|Moved away from study area|0|||
170453207|NCT00958126|615998578|FG007|Overall Study|Moved away from study area|0|||
170453208|NCT00958126|615998571|FG000|Overall Study|Lost to Follow-up|1|||
170453209|NCT00958126|615998572|FG001|Overall Study|Lost to Follow-up|5|||
170453210|NCT00958126|615998573|FG002|Overall Study|Lost to Follow-up|9|||
170453211|NCT00958126|615998574|FG003|Overall Study|Lost to Follow-up|8|||
170453212|NCT00958126|615998575|FG004|Overall Study|Lost to Follow-up|0|||
170453213|NCT00958126|615998576|FG005|Overall Study|Lost to Follow-up|0|||
170453214|NCT00958126|615998577|FG006|Overall Study|Lost to Follow-up|0|||
170453215|NCT00958126|615998578|FG007|Overall Study|Lost to Follow-up|0|||
170453216|NCT00958126|615998571|FG000|Overall Study|Sponsor/Investigator decision|0|||
170453217|NCT00958126|615998572|FG001|Overall Study|Sponsor/Investigator decision|0|||
170453218|NCT00958126|615998573|FG002|Overall Study|Sponsor/Investigator decision|0|||
170453219|NCT00958126|615998574|FG003|Overall Study|Sponsor/Investigator decision|1|||
170453220|NCT00958126|615998575|FG004|Overall Study|Sponsor/Investigator decision|0|||
170453221|NCT00958126|615998576|FG005|Overall Study|Sponsor/Investigator decision|0|||
170453222|NCT00958126|615998577|FG006|Overall Study|Sponsor/Investigator decision|0|||
170453223|NCT00958126|615998578|FG007|Overall Study|Sponsor/Investigator decision|0|||
170453224|NCT00958126|615998571|FG000|Overall Study|Other Reason|0|||
170453225|NCT00958126|615998572|FG001|Overall Study|Other Reason|0|||
170453226|NCT00958126|615998573|FG002|Overall Study|Other Reason|0|||
170453227|NCT00958126|615998574|FG003|Overall Study|Other Reason|1|||
170453228|NCT00958126|615998575|FG004|Overall Study|Other Reason|0|||
170453229|NCT00958126|615998576|FG005|Overall Study|Other Reason|1|||
170453230|NCT00958126|615998577|FG006|Overall Study|Other Reason|0|||
170453231|NCT00958126|615998578|FG007|Overall Study|Other Reason|0|||
170453232|NCT01020799|615998579|FG000|Overall Study|Adverse Event|4|||
170453233|NCT01020799|615998580|FG001|Overall Study|Adverse Event|3|||
170453234|NCT01020799|615998581|FG002|Overall Study|Adverse Event|2|||
170453235|NCT01020799|615998579|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
170787481|NCT04149704|617231811|FG002|Three Month Follow-up|Lost to Follow-up|5|||
170453236|NCT01020799|615998580|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
170635093|NCT03614156|616674804|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170888369|NCT03529773|617598304|FG036|Overall Study|Screen Failure|1|||
170888370|NCT03529773|617598305|FG037|Overall Study|Screen Failure|1|||
170888371|NCT03529773|617598306|FG038|Overall Study|Screen Failure|0|||
170453237|NCT01020799|615998581|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
170453238|NCT01020799|615998579|FG000|Overall Study|Protocol Violation|3|||
170453239|NCT01020799|615998580|FG001|Overall Study|Protocol Violation|2|||
170453240|NCT01020799|615998581|FG002|Overall Study|Protocol Violation|0|||
170453241|NCT01020799|615998579|FG000|Overall Study|Withdrawal by Subject|2|||
170453242|NCT01020799|615998580|FG001|Overall Study|Withdrawal by Subject|2|||
170453243|NCT01020799|615998581|FG002|Overall Study|Withdrawal by Subject|3|||
170453244|NCT01020799|615998579|FG000|Overall Study|Lost to Follow-up|6|||
170453245|NCT01020799|615998580|FG001|Overall Study|Lost to Follow-up|4|||
170453246|NCT01020799|615998581|FG002|Overall Study|Lost to Follow-up|2|||
170453247|NCT02556307|615998585|FG000|Overall Study|Premature treatment interruption|11|||
170453248|NCT02556307|615998585|FG000|Overall Study|Lost to Follow-up|36|||
170453249|NCT02556307|615998585|FG000|Overall Study|Change to triple therapy|4|||
170453250|NCT02556307|615998585|FG000|Overall Study|Enrolled but not treated|2|||
170453251|NCT03078582|615998586|FG000|Overall Study|Adverse Event|0|||
170453252|NCT03078582|615998587|FG001|Overall Study|Adverse Event|8|||
170453253|NCT01855048|615998588|FG000|Overall Study|Withdrawal by Subject|0|||
170453254|NCT01855048|615998589|FG001|Overall Study|Withdrawal by Subject|1|||
170453255|NCT01855048|615998590|FG002|Overall Study|Withdrawal by Subject|0|||
170453256|NCT01855048|615998591|FG003|Overall Study|Withdrawal by Subject|0|||
170453257|NCT01855048|615998592|FG004|Overall Study|Withdrawal by Subject|1|||
170453258|NCT01855048|615998593|FG005|Overall Study|Withdrawal by Subject|0|||
170453259|NCT02039414|615998594|FG000|Overall Study|Delivered|1|||
170453260|NCT02039414|615998595|FG001|Overall Study|Delivered|1|||
170453261|NCT02039414|615998594|FG000|Overall Study|Lost to Follow-up|2|||
170453262|NCT02039414|615998595|FG001|Overall Study|Lost to Follow-up|0|||
170453263|NCT02039414|615998594|FG000|Overall Study|Protocol Violation|3|||
170453264|NCT02039414|615998595|FG001|Overall Study|Protocol Violation|1|||
170453265|NCT02972502|615998598|FG000|Overall Study|Lost to Follow-up|3|||
170453266|NCT02972502|615998599|FG001|Overall Study|Lost to Follow-up|1|||
170453267|NCT02972502|615998598|FG000|Overall Study|Withdrawal by Subject|1|||
170453268|NCT02972502|615998599|FG001|Overall Study|Withdrawal by Subject|1|||
170542036|NCT04690556|616328172|FG001|Overall Study|Withdrawal by Subject|17|||
170542037|NCT04690556|616328171|FG000|Overall Study|Prohibited medications and other reasons|3|||
170542038|NCT04690556|616328172|FG001|Overall Study|Prohibited medications and other reasons|1|||
170542039|NCT03853798|616328173|FG000|Overall Study|Death|0|||
170542040|NCT03853798|616328174|FG001|Overall Study|Death|0|||
170542041|NCT03853798|616328175|FG002|Overall Study|Death|0|||
170542042|NCT03853798|616328176|FG003|Overall Study|Death|0|||
170542043|NCT03853798|616328177|FG004|Overall Study|Death|0|||
170542044|NCT03853798|616328178|FG005|Overall Study|Death|1|||
170542045|NCT03853798|616328179|FG006|Overall Study|Death|0|||
170542046|NCT03853798|616328180|FG007|Overall Study|Death|0|||
170542047|NCT03853798|616328181|FG008|Overall Study|Death|0|||
170542048|NCT03853798|616328173|FG000|Overall Study|Adverse Event|0|||
170542049|NCT03853798|616328174|FG001|Overall Study|Adverse Event|0|||
170542050|NCT03853798|616328175|FG002|Overall Study|Adverse Event|2|||
170542051|NCT03853798|616328176|FG003|Overall Study|Adverse Event|0|||
170542052|NCT03853798|616328177|FG004|Overall Study|Adverse Event|0|||
170542053|NCT03853798|616328178|FG005|Overall Study|Adverse Event|0|||
170542054|NCT03853798|616328179|FG006|Overall Study|Adverse Event|0|||
170542055|NCT03853798|616328180|FG007|Overall Study|Adverse Event|0|||
170542056|NCT03853798|616328181|FG008|Overall Study|Adverse Event|0|||
170542057|NCT03853798|616328173|FG000|Overall Study|Withdrawal by Subject|0|||
170542058|NCT03853798|616328174|FG001|Overall Study|Withdrawal by Subject|1|||
170542059|NCT03853798|616328175|FG002|Overall Study|Withdrawal by Subject|4|||
170542060|NCT03853798|616328176|FG003|Overall Study|Withdrawal by Subject|0|||
170542061|NCT03853798|616328177|FG004|Overall Study|Withdrawal by Subject|0|||
170542062|NCT03853798|616328178|FG005|Overall Study|Withdrawal by Subject|5|||
170542063|NCT03853798|616328179|FG006|Overall Study|Withdrawal by Subject|0|||
170542064|NCT03853798|616328180|FG007|Overall Study|Withdrawal by Subject|0|||
170542065|NCT03853798|616328181|FG008|Overall Study|Withdrawal by Subject|4|||
170542066|NCT03853798|616328173|FG000|Overall Study|Physician Decision|1|||
170542067|NCT03853798|616328174|FG001|Overall Study|Physician Decision|0|||
170635094|NCT03614156|616674805|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
170542068|NCT03853798|616328175|FG002|Overall Study|Physician Decision|0|||
170542069|NCT03853798|616328176|FG003|Overall Study|Physician Decision|0|||
170542070|NCT03853798|616328177|FG004|Overall Study|Physician Decision|0|||
170888372|NCT03529773|617598307|FG039|Overall Study|Screen Failure|1|||
170453269|NCT03832738|615998600|FG000|Overall Study|Withdrawal by Subject|6|||
170453270|NCT03832738|615998601|FG001|Overall Study|Withdrawal by Subject|7|||
170453271|NCT03832738|615998602|FG002|Overall Study|Withdrawal by Subject|16|||
170542071|NCT03853798|616328178|FG005|Overall Study|Physician Decision|0|||
170542072|NCT03853798|616328179|FG006|Overall Study|Physician Decision|0|||
170542073|NCT03853798|616328180|FG007|Overall Study|Physician Decision|0|||
170453272|NCT03832738|615998600|FG000|Overall Study|Physician Decision|0|||
170453273|NCT03832738|615998601|FG001|Overall Study|Physician Decision|1|||
170453274|NCT03832738|615998602|FG002|Overall Study|Physician Decision|2|||
170453275|NCT03832738|615998600|FG000|Overall Study|Adverse Event|2|||
170453276|NCT03832738|615998601|FG001|Overall Study|Adverse Event|3|||
170453277|NCT03832738|615998602|FG002|Overall Study|Adverse Event|1|||
170453278|NCT03832738|615998600|FG000|Overall Study|Pregnancy|0|||
170453279|NCT03832738|615998601|FG001|Overall Study|Pregnancy|1|||
170453280|NCT03832738|615998602|FG002|Overall Study|Pregnancy|0|||
170453281|NCT03852459|615998603|FG000|Overall Study|Adverse Event|2|||
170453282|NCT03852459|615998604|FG001|Overall Study|Adverse Event|2|||
170453283|NCT03852459|615998603|FG000|Overall Study|Withdrawal by Subject|1|||
170453284|NCT03852459|615998604|FG001|Overall Study|Withdrawal by Subject|1|||
170453285|NCT01813071|615998605|FG000|Overall Study|Protocol Violation|0|||
170453286|NCT01813071|615998606|FG001|Overall Study|Protocol Violation|0|||
170453287|NCT01813071|615998607|FG002|Overall Study|Protocol Violation|0|||
170453288|NCT01813071|615998608|FG003|Overall Study|Protocol Violation|0|||
170453289|NCT01813071|615998609|FG004|Overall Study|Protocol Violation|1|||
170453290|NCT01813071|615998610|FG005|Overall Study|Protocol Violation|4|||
170453291|NCT01813071|615998611|FG006|Overall Study|Protocol Violation|2|||
170453292|NCT01813071|615998612|FG007|Overall Study|Protocol Violation|4|||
170453293|NCT01813071|615998613|FG008|Overall Study|Protocol Violation|2|||
170453294|NCT01813071|615998605|FG000|Overall Study|Withdrawal by Subject|0|||
170453295|NCT01813071|615998606|FG001|Overall Study|Withdrawal by Subject|0|||
170453296|NCT01813071|615998607|FG002|Overall Study|Withdrawal by Subject|0|||
170453297|NCT01813071|615998608|FG003|Overall Study|Withdrawal by Subject|0|||
170453298|NCT01813071|615998609|FG004|Overall Study|Withdrawal by Subject|0|||
170453299|NCT01813071|615998610|FG005|Overall Study|Withdrawal by Subject|1|||
170453300|NCT01813071|615998611|FG006|Overall Study|Withdrawal by Subject|0|||
170453301|NCT01813071|615998612|FG007|Overall Study|Withdrawal by Subject|0|||
170453302|NCT01813071|615998613|FG008|Overall Study|Withdrawal by Subject|0|||
170453303|NCT01813071|615998605|FG000|Overall Study|Adverse Event|0|||
170453304|NCT01813071|615998606|FG001|Overall Study|Adverse Event|0|||
170453305|NCT01813071|615998607|FG002|Overall Study|Adverse Event|0|||
170453306|NCT01813071|615998608|FG003|Overall Study|Adverse Event|0|||
170453307|NCT01813071|615998609|FG004|Overall Study|Adverse Event|0|||
170453308|NCT01813071|615998610|FG005|Overall Study|Adverse Event|1|||
170453309|NCT01813071|615998611|FG006|Overall Study|Adverse Event|0|||
170453310|NCT01813071|615998612|FG007|Overall Study|Adverse Event|0|||
170453311|NCT01813071|615998613|FG008|Overall Study|Adverse Event|0|||
170453312|NCT01813071|615998605|FG000|Overall Study|Physician Decision|0|||
170453313|NCT01813071|615998606|FG001|Overall Study|Physician Decision|0|||
170453314|NCT01813071|615998607|FG002|Overall Study|Physician Decision|0|||
170453315|NCT01813071|615998608|FG003|Overall Study|Physician Decision|0|||
170453316|NCT01813071|615998609|FG004|Overall Study|Physician Decision|0|||
170453317|NCT01813071|615998610|FG005|Overall Study|Physician Decision|0|||
170453318|NCT01813071|615998611|FG006|Overall Study|Physician Decision|1|||
170453319|NCT01813071|615998612|FG007|Overall Study|Physician Decision|0|||
170453320|NCT01813071|615998613|FG008|Overall Study|Physician Decision|0|||
170453321|NCT01813071|615998605|FG000|Overall Study|Met inc/exc criteria|0|||
170453322|NCT01813071|615998606|FG001|Overall Study|Met inc/exc criteria|0|||
170453323|NCT01813071|615998607|FG002|Overall Study|Met inc/exc criteria|0|||
170453324|NCT01813071|615998608|FG003|Overall Study|Met inc/exc criteria|0|||
170453325|NCT01813071|615998609|FG004|Overall Study|Met inc/exc criteria|0|||
170453326|NCT01813071|615998610|FG005|Overall Study|Met inc/exc criteria|1|||
170453327|NCT01813071|615998611|FG006|Overall Study|Met inc/exc criteria|0|||
170453328|NCT01813071|615998612|FG007|Overall Study|Met inc/exc criteria|1|||
170453329|NCT01813071|615998613|FG008|Overall Study|Met inc/exc criteria|1|||
170453330|NCT05486065|615998614|FG000|Overall Study|Withdrawal by Subject|1|||
170453331|NCT05486065|615998615|FG001|Overall Study|Withdrawal by Subject|5|||
170453332|NCT05486065|615998616|FG002|Overall Study|Withdrawal by Subject|4|||
170453333|NCT05486065|615998617|FG003|Overall Study|Withdrawal by Subject|3|||
170453334|NCT05486065|615998614|FG000|Overall Study|Lost to Follow-up|4|||
170453335|NCT05486065|615998615|FG001|Overall Study|Lost to Follow-up|2|||
170453336|NCT05486065|615998616|FG002|Overall Study|Lost to Follow-up|2|||
170453337|NCT05486065|615998617|FG003|Overall Study|Lost to Follow-up|2|||
170888373|NCT03529773|617598268|FG000|Overall Study|Randomized but not vaccinated|0|||
170888374|NCT03529773|617598269|FG001|Overall Study|Randomized but not vaccinated|0|||
170453338|NCT05486065|615998614|FG000|Overall Study|Physician Decision|0|||
170453339|NCT05486065|615998615|FG001|Overall Study|Physician Decision|1|||
170453340|NCT05486065|615998616|FG002|Overall Study|Physician Decision|1|||
170453341|NCT05486065|615998617|FG003|Overall Study|Physician Decision|0|||
170453342|NCT05486065|615998614|FG000|Overall Study|Failure to meet randomization criteria|0|||
170453343|NCT05486065|615998615|FG001|Overall Study|Failure to meet randomization criteria|0|||
170453344|NCT05486065|615998616|FG002|Overall Study|Failure to meet randomization criteria|0|||
170453345|NCT05486065|615998617|FG003|Overall Study|Failure to meet randomization criteria|1|||
170888375|NCT03529773|617598270|FG002|Overall Study|Randomized but not vaccinated|0|||
170453346|NCT03977701|615998618|FG000|Overall Study|COVID-19 pandemic|0|||
170453347|NCT03977701|615998619|FG001|Overall Study|COVID-19 pandemic|0|||
170453348|NCT03977701|615998620|FG002|Overall Study|COVID-19 pandemic|0|||
170453349|NCT03977701|615998621|FG003|Overall Study|COVID-19 pandemic|0|||
170635095|NCT03614156|616674806|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
170635096|NCT03614156|616674803|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
170635097|NCT03614156|616674804|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
170635098|NCT03614156|616674805|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
170635099|NCT03614156|616674806|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
170635100|NCT03614156|616674803|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
170635101|NCT03614156|616674804|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
170635102|NCT03614156|616674805|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
170635103|NCT03614156|616674806|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
170635104|NCT03614156|616674803|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
170635105|NCT03614156|616674804|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
170635106|NCT03614156|616674805|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
170635107|NCT03614156|616674806|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
170635108|NCT03614156|616674803|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
170635109|NCT03614156|616674804|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
170635110|NCT03614156|616674805|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
170635111|NCT03614156|616674806|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
170635112|NCT03614156|616674803|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
170635113|NCT03614156|616674804|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
170635114|NCT03614156|616674805|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
170635115|NCT03614156|616674806|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
170635116|NCT03614156|616674803|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
170453350|NCT03977701|615998622|FG004|Overall Study|COVID-19 pandemic|0|||
170453351|NCT03977701|615998623|FG005|Overall Study|COVID-19 pandemic|1|||
170453352|NCT03977701|615998624|FG006|Overall Study|COVID-19 pandemic|0|||
170453353|NCT03977701|615998625|FG007|Overall Study|COVID-19 pandemic|1|||
170453354|NCT03977701|615998626|FG008|Overall Study|COVID-19 pandemic|0|||
170453355|NCT03977701|615998627|FG009|Overall Study|COVID-19 pandemic|0|||
170453356|NCT02429934|615998629|FG000|Overall Study|Withdrawal by Subject|0|||
170453357|NCT02429934|615998630|FG001|Overall Study|Withdrawal by Subject|2|||
170453358|NCT02429934|615998629|FG000|Overall Study|Adverse Event|2|||
170453359|NCT02429934|615998630|FG001|Overall Study|Adverse Event|0|||
170453360|NCT02429934|615998629|FG000|Overall Study|Lost to Follow-up|1|||
170453361|NCT02429934|615998630|FG001|Overall Study|Lost to Follow-up|1|||
170453362|NCT02429934|615998629|FG000|Overall Study|Physician Decision|1|||
170453363|NCT02429934|615998630|FG001|Overall Study|Physician Decision|0|||
170453364|NCT00869024|615998631|FG000|Overall Study|Death|2|||
170453365|NCT00869024|615998632|FG001|Overall Study|Death|3|||
170453366|NCT00869024|615998631|FG000|Overall Study|Lost to Follow-up|0|||
170453367|NCT00869024|615998632|FG001|Overall Study|Lost to Follow-up|1|||
170453368|NCT00869024|615998631|FG000|Overall Study|Protocol Violation|0|||
170453369|NCT00869024|615998632|FG001|Overall Study|Protocol Violation|1|||
170453370|NCT02687360|615998635|FG000|Overall Study|Withdrawal by Subject|3|||
170453371|NCT02687360|615998636|FG001|Overall Study|Withdrawal by Subject|0|||
170453372|NCT02181296|615998638|FG000|Overall Study|Lost to Follow-up|7|||
170453373|NCT02181296|615998639|FG001|Overall Study|Lost to Follow-up|6|||
170453374|NCT01568866|615998640|FG000|Overall Study|Disease Progression|208|||
170453375|NCT01568866|615998641|FG001|Overall Study|Disease Progression|183|||
170453376|NCT01568866|615998640|FG000|Overall Study|Adverse Event|94|||
170453377|NCT01568866|615998641|FG001|Overall Study|Adverse Event|96|||
170453378|NCT01568866|615998640|FG000|Overall Study|Patient Request|55|||
170453379|NCT01568866|615998641|FG001|Overall Study|Patient Request|71|||
170453380|NCT01568866|615998640|FG000|Overall Study|Physician Decision|40|||
170453381|NCT01568866|615998641|FG001|Overall Study|Physician Decision|32|||
170453382|NCT01568866|615998640|FG000|Overall Study|Withdrawal by Subject|19|||
170453383|NCT01568866|615998641|FG001|Overall Study|Withdrawal by Subject|11|||
170453384|NCT01568866|615998640|FG000|Overall Study|Death|10|||
170453385|NCT01568866|615998641|FG001|Overall Study|Death|18|||
170453386|NCT01568866|615998640|FG000|Overall Study|Protocol Non-compliance|2|||
170453387|NCT01568866|615998641|FG001|Overall Study|Protocol Non-compliance|4|||
170453388|NCT01568866|615998640|FG000|Overall Study|Lost to Follow-up|1|||
170787482|NCT04149704|617231812|FG003|Three Month Follow-up|Lost to Follow-up|5|||
170787483|NCT04149704|617231809|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
170453389|NCT01568866|615998641|FG001|Overall Study|Lost to Follow-up|0|||
170453390|NCT01568866|615998640|FG000|Overall Study|Randomized but Not Dosed|9|||
170787484|NCT04149704|617231810|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
170787485|NCT04149704|617231811|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
170453391|NCT01568866|615998641|FG001|Overall Study|Randomized but Not Dosed|1|||
170453392|NCT03864042|615998642|FG000|DDI Phase|Adverse Event|2|||
170453393|NCT03864042|615998643|FG001|DDI Phase|Adverse Event|0|||
170453394|NCT03864042|615998644|FG002|DDI Phase|Adverse Event|0|||
170453395|NCT03864042|615998642|FG000|DDI Phase|Physician Decision|1|||
170635117|NCT03614156|616674804|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
170635118|NCT03614156|616674805|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
170635119|NCT03614156|616674806|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
170635120|NCT01094119|616674808|FG000|Overall Study|Lack of Efficacy|2|||
170635121|NCT01094119|616674809|FG001|Overall Study|Lack of Efficacy|4|||
170635122|NCT02745119|616674813|FG000|Overall Study|Adverse Event|1|||
170635123|NCT02745119|616674814|FG001|Overall Study|Adverse Event|0|||
170635124|NCT02745119|616674815|FG002|Overall Study|Adverse Event|1|||
170635125|NCT02745119|616674816|FG003|Overall Study|Adverse Event|3|||
170635126|NCT02745119|616674813|FG000|Overall Study|Death|3|||
170635127|NCT02745119|616674814|FG001|Overall Study|Death|3|||
170635128|NCT02745119|616674815|FG002|Overall Study|Death|0|||
170635129|NCT02745119|616674816|FG003|Overall Study|Death|4|||
170635130|NCT02745119|616674813|FG000|Overall Study|Lost to Follow-up|0|||
170635131|NCT02745119|616674814|FG001|Overall Study|Lost to Follow-up|0|||
170635132|NCT02745119|616674815|FG002|Overall Study|Lost to Follow-up|0|||
170635133|NCT02745119|616674816|FG003|Overall Study|Lost to Follow-up|1|||
170635134|NCT02745119|616674813|FG000|Overall Study|Protocol Deviation|0|||
170635135|NCT02745119|616674814|FG001|Overall Study|Protocol Deviation|0|||
170635136|NCT02745119|616674815|FG002|Overall Study|Protocol Deviation|0|||
170635137|NCT02745119|616674816|FG003|Overall Study|Protocol Deviation|1|||
170635138|NCT02745119|616674813|FG000|Overall Study|Withdrawal by Subject|7|||
170635139|NCT02745119|616674814|FG001|Overall Study|Withdrawal by Subject|15|||
170635140|NCT02745119|616674815|FG002|Overall Study|Withdrawal by Subject|8|||
170635141|NCT02745119|616674816|FG003|Overall Study|Withdrawal by Subject|14|||
170635142|NCT02745119|616674813|FG000|Overall Study|Study Terminated by Sponsor|134|||
170635143|NCT02745119|616674814|FG001|Overall Study|Study Terminated by Sponsor|252|||
170635144|NCT02745119|616674815|FG002|Overall Study|Study Terminated by Sponsor|135|||
170635145|NCT02745119|616674816|FG003|Overall Study|Study Terminated by Sponsor|251|||
170635146|NCT02745119|616674813|FG000|Overall Study|Physician Decision|0|||
170635147|NCT02745119|616674814|FG001|Overall Study|Physician Decision|2|||
170635148|NCT02745119|616674815|FG002|Overall Study|Physician Decision|2|||
170635149|NCT02745119|616674816|FG003|Overall Study|Physician Decision|2|||
170635150|NCT02745119|616674813|FG000|Overall Study|Reason Not Specified|0|||
170635151|NCT02745119|616674814|FG001|Overall Study|Reason Not Specified|2|||
170635152|NCT02745119|616674815|FG002|Overall Study|Reason Not Specified|0|||
170635153|NCT02745119|616674816|FG003|Overall Study|Reason Not Specified|1|||
170635154|NCT02536963|616674817|FG000|Overall Study|Withdrawal by Subject|18|||
170635155|NCT02425943|616674818|FG000|Overall Study|Adverse Event|3|||
170635156|NCT02425943|616674819|FG001|Overall Study|Adverse Event|1|||
170635157|NCT02425943|616674818|FG000|Overall Study|Lost to Follow-up|59|||
170635158|NCT02425943|616674819|FG001|Overall Study|Lost to Follow-up|37|||
170635159|NCT02425943|616674818|FG000|Overall Study|Protocol Violation|4|||
170635160|NCT02425943|616674819|FG001|Overall Study|Protocol Violation|1|||
170635161|NCT02425943|616674818|FG000|Overall Study|Withdrawal by Subject|64|||
170635162|NCT02425943|616674819|FG001|Overall Study|Withdrawal by Subject|31|||
170635163|NCT02425943|616674818|FG000|Overall Study|Other|6|||
170888376|NCT03529773|617598271|FG003|Overall Study|Randomized but not vaccinated|0|||
170635164|NCT02425943|616674819|FG001|Overall Study|Other|0|||
170888377|NCT03529773|617598272|FG004|Overall Study|Randomized but not vaccinated|0|||
170888378|NCT03529773|617598273|FG005|Overall Study|Randomized but not vaccinated|0|||
170888379|NCT03529773|617598274|FG006|Overall Study|Randomized but not vaccinated|0|||
170888380|NCT03529773|617598275|FG007|Overall Study|Randomized but not vaccinated|0|||
170888381|NCT03529773|617598276|FG008|Overall Study|Randomized but not vaccinated|0|||
170888382|NCT03529773|617598277|FG009|Overall Study|Randomized but not vaccinated|0|||
170888383|NCT03529773|617598278|FG010|Overall Study|Randomized but not vaccinated|0|||
170888384|NCT03529773|617598279|FG011|Overall Study|Randomized but not vaccinated|0|||
170888385|NCT03529773|617598280|FG012|Overall Study|Randomized but not vaccinated|0|||
170888386|NCT03529773|617598281|FG013|Overall Study|Randomized but not vaccinated|0|||
170888387|NCT03529773|617598282|FG014|Overall Study|Randomized but not vaccinated|0|||
170888388|NCT03529773|617598283|FG015|Overall Study|Randomized but not vaccinated|0|||
170888389|NCT03529773|617598284|FG016|Overall Study|Randomized but not vaccinated|0|||
170888390|NCT03529773|617598285|FG017|Overall Study|Randomized but not vaccinated|1|||
170888391|NCT03529773|617598286|FG018|Overall Study|Randomized but not vaccinated|0|||
170888392|NCT03529773|617598287|FG019|Overall Study|Randomized but not vaccinated|0|||
170888393|NCT03529773|617598288|FG020|Overall Study|Randomized but not vaccinated|0|||
170888394|NCT03529773|617598289|FG021|Overall Study|Randomized but not vaccinated|0|||
170888395|NCT03529773|617598290|FG022|Overall Study|Randomized but not vaccinated|0|||
170888396|NCT03529773|617598291|FG023|Overall Study|Randomized but not vaccinated|0|||
170888397|NCT03529773|617598292|FG024|Overall Study|Randomized but not vaccinated|0|||
170635165|NCT02668393|616674822|FG000|Overall Study|Progressive disease|6|||
170635166|NCT02668393|616674823|FG001|Overall Study|Progressive disease|3|||
170635167|NCT02668393|616674822|FG000|Overall Study|Adverse Event|0|||
170635168|NCT02668393|616674823|FG001|Overall Study|Adverse Event|2|||
170888398|NCT03529773|617598293|FG025|Overall Study|Randomized but not vaccinated|0|||
170635169|NCT02668393|616674822|FG000|Overall Study|Withdrawal from the trial|0|||
170635170|NCT02668393|616674823|FG001|Overall Study|Withdrawal from the trial|1|||
170635171|NCT02668393|616674822|FG000|Overall Study|Lack of benefit and side effects|1|||
170635172|NCT02668393|616674823|FG001|Overall Study|Lack of benefit and side effects|0|||
170635173|NCT02141204|616674824|FG000|Overall Study|Lost to Follow-up|2|||
170635174|NCT02141204|616674825|FG001|Overall Study|Lost to Follow-up|1|||
170635175|NCT02141204|616674824|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
170635176|NCT02141204|616674825|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
170635177|NCT02141204|616674824|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
170635178|NCT02141204|616674825|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
170635179|NCT02141204|616674824|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
170635180|NCT02141204|616674825|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
170635181|NCT01209325|616674826|FG000|Overall Study|Lost to Follow-up|24|||
170635182|NCT01209325|616674826|FG000|Overall Study|Adverse Event|1|||
170635183|NCT01209325|616674826|FG000|Overall Study|Relocated|3|||
170635184|NCT01209325|616674826|FG000|Overall Study|Refusal after starting therapy|8|||
170635185|NCT01209325|616674826|FG000|Overall Study|Protocol Violation|4|||
170635186|NCT01209325|616674826|FG000|Overall Study|Refusal prior to therapy|1|||
170635187|NCT01209325|616674826|FG000|Overall Study|Incarceration|2|||
170635188|NCT01160822|616674827|FG000|Overall Study|Adverse Event|0|||
170635189|NCT01160822|616674828|FG001|Overall Study|Adverse Event|0|||
170635190|NCT01160822|616674829|FG002|Overall Study|Adverse Event|0|||
170635191|NCT01160822|616674830|FG003|Overall Study|Adverse Event|0|||
170635192|NCT01160822|616674831|FG004|Overall Study|Adverse Event|1|||
170635193|NCT01160822|616674832|FG005|Overall Study|Adverse Event|2|||
170635194|NCT01160822|616674833|FG006|Overall Study|Adverse Event|5|||
170635195|NCT01160822|616674827|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170635196|NCT01160822|616674828|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170635197|NCT01160822|616674829|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170635198|NCT01160822|616674830|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
170635199|NCT01160822|616674831|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
170635200|NCT01160822|616674832|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
170635201|NCT01160822|616674833|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
170635202|NCT01160822|616674827|FG000|Overall Study|Withdrawal by Subject|0|||
170635203|NCT01160822|616674828|FG001|Overall Study|Withdrawal by Subject|0|||
170635204|NCT01160822|616674829|FG002|Overall Study|Withdrawal by Subject|0|||
170635205|NCT01160822|616674830|FG003|Overall Study|Withdrawal by Subject|0|||
170635206|NCT01160822|616674831|FG004|Overall Study|Withdrawal by Subject|0|||
170635207|NCT01160822|616674832|FG005|Overall Study|Withdrawal by Subject|0|||
170635208|NCT01160822|616674833|FG006|Overall Study|Withdrawal by Subject|1|||
170635209|NCT01160822|616674827|FG000|Overall Study|Lost to Follow-up|0|||
170635210|NCT01160822|616674828|FG001|Overall Study|Lost to Follow-up|0|||
170635211|NCT01160822|616674829|FG002|Overall Study|Lost to Follow-up|0|||
170635212|NCT01160822|616674830|FG003|Overall Study|Lost to Follow-up|0|||
170635213|NCT01160822|616674831|FG004|Overall Study|Lost to Follow-up|1|||
170635214|NCT01160822|616674832|FG005|Overall Study|Lost to Follow-up|0|||
170542074|NCT03853798|616328181|FG008|Overall Study|Physician Decision|1|||
170542075|NCT03853798|616328173|FG000|Overall Study|Lack of Efficacy|0|||
170542076|NCT03853798|616328174|FG001|Overall Study|Lack of Efficacy|0|||
170542077|NCT03853798|616328175|FG002|Overall Study|Lack of Efficacy|2|||
170542078|NCT03853798|616328176|FG003|Overall Study|Lack of Efficacy|0|||
170542079|NCT03853798|616328177|FG004|Overall Study|Lack of Efficacy|0|||
170542080|NCT03853798|616328178|FG005|Overall Study|Lack of Efficacy|0|||
170542081|NCT03853798|616328179|FG006|Overall Study|Lack of Efficacy|0|||
170542082|NCT03853798|616328180|FG007|Overall Study|Lack of Efficacy|0|||
170542083|NCT03853798|616328181|FG008|Overall Study|Lack of Efficacy|1|||
170542084|NCT03853798|616328173|FG000|Overall Study|Approved Drug Available for Indication|0|||
170542085|NCT03853798|616328174|FG001|Overall Study|Approved Drug Available for Indication|0|||
170542086|NCT03853798|616328175|FG002|Overall Study|Approved Drug Available for Indication|1|||
170542087|NCT03853798|616328176|FG003|Overall Study|Approved Drug Available for Indication|0|||
170542088|NCT03853798|616328177|FG004|Overall Study|Approved Drug Available for Indication|0|||
170635215|NCT01160822|616674833|FG006|Overall Study|Lost to Follow-up|0|||
170635216|NCT01160822|616674827|FG000|Overall Study|Administrative problems|0|||
170635217|NCT01160822|616674828|FG001|Overall Study|Administrative problems|0|||
170635218|NCT01160822|616674829|FG002|Overall Study|Administrative problems|0|||
170635219|NCT01160822|616674830|FG003|Overall Study|Administrative problems|0|||
170635220|NCT01160822|616674831|FG004|Overall Study|Administrative problems|1|||
170635221|NCT01160822|616674832|FG005|Overall Study|Administrative problems|0|||
170453396|NCT03864042|615998643|FG001|DDI Phase|Physician Decision|0|||
170453397|NCT03864042|615998644|FG002|DDI Phase|Physician Decision|0|||
170453398|NCT03864042|615998642|FG000|DDI Phase|Progressive Disease|1|||
170453399|NCT03864042|615998643|FG001|DDI Phase|Progressive Disease|0|||
170453400|NCT03864042|615998644|FG002|DDI Phase|Progressive Disease|0|||
170453401|NCT03864042|615998642|FG000|Post-DDI Phase|Adverse Event|5|||
170453402|NCT03864042|615998643|FG001|Post-DDI Phase|Adverse Event|3|||
170453403|NCT03864042|615998644|FG002|Post-DDI Phase|Adverse Event|2|||
170453404|NCT03864042|615998642|FG000|Post-DDI Phase|Progressive Disease|11|||
170542089|NCT03853798|616328178|FG005|Overall Study|Approved Drug Available for Indication|1|||
170542090|NCT03853798|616328179|FG006|Overall Study|Approved Drug Available for Indication|0|||
170542091|NCT03853798|616328180|FG007|Overall Study|Approved Drug Available for Indication|0|||
170542092|NCT03853798|616328181|FG008|Overall Study|Approved Drug Available for Indication|0|||
170542093|NCT03853798|616328173|FG000|Overall Study|Other un-specified|0|||
170542094|NCT03853798|616328174|FG001|Overall Study|Other un-specified|0|||
170542095|NCT03853798|616328175|FG002|Overall Study|Other un-specified|2|||
170542096|NCT03853798|616328176|FG003|Overall Study|Other un-specified|0|||
170542097|NCT03853798|616328177|FG004|Overall Study|Other un-specified|0|||
170542098|NCT03853798|616328178|FG005|Overall Study|Other un-specified|1|||
170542099|NCT03853798|616328179|FG006|Overall Study|Other un-specified|0|||
170542100|NCT03853798|616328180|FG007|Overall Study|Other un-specified|0|||
170542101|NCT03853798|616328181|FG008|Overall Study|Other un-specified|0|||
170542102|NCT02743494|616328182|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
170542103|NCT02743494|616328183|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
170542104|NCT02743494|616328182|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
170542105|NCT02743494|616328183|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
170542106|NCT02743494|616328182|FG000|Treatment Period|Disease recurrence|152|||
170542107|NCT02743494|616328183|FG001|Treatment Period|Disease recurrence|115|||
170542108|NCT02743494|616328182|FG000|Treatment Period|Study drug toxicity|56|||
170542109|NCT02743494|616328183|FG001|Treatment Period|Study drug toxicity|8|||
170542110|NCT02743494|616328182|FG000|Treatment Period|Death|1|||
170542111|NCT02743494|616328183|FG001|Treatment Period|Death|1|||
170542112|NCT02743494|616328182|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
170542113|NCT02743494|616328183|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
170542114|NCT02743494|616328182|FG000|Treatment Period|Participant request to discontinue treatment|31|||
170542115|NCT02743494|616328183|FG001|Treatment Period|Participant request to discontinue treatment|5|||
170542116|NCT02743494|616328182|FG000|Treatment Period|Participant withdrew consent|11|||
170542117|NCT02743494|616328183|FG001|Treatment Period|Participant withdrew consent|4|||
170542118|NCT02743494|616328182|FG000|Treatment Period|Lost to Follow-up|0|||
170542119|NCT02743494|616328183|FG001|Treatment Period|Lost to Follow-up|1|||
170542120|NCT02743494|616328182|FG000|Treatment Period|Poor/Non-compliance|2|||
170542121|NCT02743494|616328183|FG001|Treatment Period|Poor/Non-compliance|0|||
170542122|NCT02743494|616328182|FG000|Treatment Period|Other reasons|4|||
170542123|NCT02743494|616328183|FG001|Treatment Period|Other reasons|1|||
170542124|NCT03599713|616328184|FG000|Overall Study|Death|38|||
170542125|NCT03599713|616328185|FG001|Overall Study|Death|3|||
170542126|NCT03599713|616328184|FG000|Overall Study|Withdrawal by Subject|17|||
170542127|NCT03599713|616328185|FG001|Overall Study|Withdrawal by Subject|0|||
170542128|NCT03599713|616328184|FG000|Overall Study|Lost to Follow-up|4|||
170542129|NCT03599713|616328185|FG001|Overall Study|Lost to Follow-up|0|||
170542130|NCT03599713|616328184|FG000|Overall Study|Discontinued Due to End of Study|42|||
170542131|NCT03599713|616328185|FG001|Overall Study|Discontinued Due to End of Study|3|||
170542132|NCT02850406|616328188|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
170542133|NCT02850406|616328189|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
170542134|NCT02850406|616328190|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
170542135|NCT02850406|616328191|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
170542136|NCT02850406|616328192|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
170542137|NCT02850406|616328193|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
170542138|NCT02850406|616328194|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
170542139|NCT02850406|616328195|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
170542140|NCT02850406|616328188|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
170542141|NCT02850406|616328189|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
170542142|NCT02850406|616328190|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
170542143|NCT02850406|616328191|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
170542144|NCT02850406|616328192|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
170542145|NCT02850406|616328193|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
170542146|NCT02850406|616328194|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
170542147|NCT02850406|616328195|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
170542148|NCT02850406|616328188|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
170542149|NCT02850406|616328189|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
170542150|NCT02850406|616328190|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
170542151|NCT02850406|616328191|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
170542152|NCT02850406|616328192|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
170542153|NCT02850406|616328193|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
170542154|NCT02850406|616328194|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
170542155|NCT02850406|616328195|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
170542156|NCT02850406|616328188|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
170542157|NCT02850406|616328189|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
170542158|NCT02850406|616328190|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
170542159|NCT02850406|616328191|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
170542160|NCT02850406|616328192|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
170542161|NCT02850406|616328193|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
170542162|NCT02850406|616328194|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
170542163|NCT02850406|616328195|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
170542164|NCT02850406|616328188|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
170542165|NCT02850406|616328189|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
170542166|NCT02850406|616328190|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
170542167|NCT02850406|616328191|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
170542168|NCT02850406|616328192|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
170542169|NCT02850406|616328193|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
170542170|NCT02850406|616328194|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
170542171|NCT02850406|616328195|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
170542172|NCT02850406|616328188|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542173|NCT02850406|616328189|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542174|NCT02850406|616328190|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542175|NCT02850406|616328191|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542176|NCT02850406|616328192|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
170542177|NCT02850406|616328193|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
170542178|NCT02850406|616328194|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542179|NCT02850406|616328195|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542180|NCT02850406|616328188|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
170542181|NCT02850406|616328189|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
170542182|NCT02850406|616328190|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
170542183|NCT02850406|616328191|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
170542184|NCT02850406|616328192|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
170542185|NCT02850406|616328193|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
170542186|NCT02850406|616328194|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
170542187|NCT02850406|616328195|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
170542188|NCT02850406|616328188|FG000|Part C (Up to 52 Weeks)|Other|0|||
170542189|NCT02850406|616328189|FG001|Part C (Up to 52 Weeks)|Other|0|||
170542190|NCT02850406|616328190|FG002|Part C (Up to 52 Weeks)|Other|0|||
170542191|NCT02850406|616328191|FG003|Part C (Up to 52 Weeks)|Other|0|||
170542192|NCT02850406|616328192|FG004|Part C (Up to 52 Weeks)|Other|1|||
170542193|NCT02850406|616328193|FG005|Part C (Up to 52 Weeks)|Other|3|||
170542194|NCT02850406|616328194|FG006|Part C (Up to 52 Weeks)|Other|0|||
170542195|NCT02850406|616328195|FG007|Part C (Up to 52 Weeks)|Other|0|||
170542196|NCT02850406|616328188|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
170542197|NCT02850406|616328189|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
170635222|NCT01160822|616674833|FG006|Overall Study|Administrative problems|0|||
170635223|NCT01160822|616674827|FG000|Overall Study|Protocol deviation|0|||
170635224|NCT01160822|616674828|FG001|Overall Study|Protocol deviation|0|||
170635225|NCT01160822|616674829|FG002|Overall Study|Protocol deviation|0|||
170635226|NCT01160822|616674830|FG003|Overall Study|Protocol deviation|0|||
170635227|NCT01160822|616674831|FG004|Overall Study|Protocol deviation|2|||
170635228|NCT01160822|616674832|FG005|Overall Study|Protocol deviation|0|||
170635229|NCT01160822|616674833|FG006|Overall Study|Protocol deviation|0|||
170635230|NCT00759941|616674841|FG000|Overall Study|Use of medication|1|||
170635231|NCT00759941|616674842|FG001|Overall Study|Use of medication|0|||
170635232|NCT00759941|616674841|FG000|Overall Study|Adverse Event|1|||
170635233|NCT00759941|616674842|FG001|Overall Study|Adverse Event|0|||
170635234|NCT00759941|616674841|FG000|Overall Study|Exited in error by site|1|||
170635235|NCT00759941|616674842|FG001|Overall Study|Exited in error by site|1|||
170635236|NCT00354432|616674843|FG000|Overall Study|Adverse Event|3|||
170635237|NCT00354432|616674844|FG001|Overall Study|Adverse Event|1|||
170635238|NCT00354432|616674845|FG002|Overall Study|Adverse Event|5|||
170635239|NCT00354432|616674846|FG003|Overall Study|Adverse Event|5|||
170635240|NCT00354432|616674843|FG000|Overall Study|Off/Toxicity|3|||
170635241|NCT00354432|616674844|FG001|Overall Study|Off/Toxicity|7|||
170635242|NCT00354432|616674845|FG002|Overall Study|Off/Toxicity|5|||
170635243|NCT00354432|616674846|FG003|Overall Study|Off/Toxicity|5|||
170635244|NCT03863080|616674847|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
170635245|NCT03863080|616674848|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
170635246|NCT03863080|616674849|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
170635247|NCT03863080|616674850|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
170635248|NCT03863080|616674847|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
170635249|NCT03863080|616674848|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
170635250|NCT03863080|616674849|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
170635251|NCT03863080|616674850|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
170635252|NCT03863080|616674847|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
170635253|NCT03863080|616674848|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
170635254|NCT03863080|616674849|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
170635255|NCT03863080|616674850|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
170635256|NCT02000115|616674859|FG000|Overall Study|Death|56|||
170635257|NCT02000115|616674860|FG001|Overall Study|Death|45|||
170635258|NCT02000115|616674861|FG002|Overall Study|Death|0|||
170635259|NCT02000115|616674862|FG003|Overall Study|Death|0|||
170635260|NCT02000115|616674859|FG000|Overall Study|Missed Visit|6|||
170635261|NCT02000115|616674860|FG001|Overall Study|Missed Visit|8|||
170635262|NCT02000115|616674861|FG002|Overall Study|Missed Visit|1|||
170635263|NCT02000115|616674862|FG003|Overall Study|Missed Visit|0|||
170635264|NCT02000115|616674859|FG000|Overall Study|Protocol Violation|2|||
170635265|NCT02000115|616674860|FG001|Overall Study|Protocol Violation|1|||
170635266|NCT02000115|616674861|FG002|Overall Study|Protocol Violation|0|||
170635267|NCT02000115|616674862|FG003|Overall Study|Protocol Violation|0|||
170635268|NCT02000115|616674859|FG000|Overall Study|Physician Decision|2|||
170635269|NCT02000115|616674860|FG001|Overall Study|Physician Decision|0|||
170635270|NCT02000115|616674861|FG002|Overall Study|Physician Decision|0|||
170635271|NCT02000115|616674862|FG003|Overall Study|Physician Decision|0|||
170635272|NCT02000115|616674859|FG000|Overall Study|Withdrawal by Subject|11|||
170635273|NCT02000115|616674860|FG001|Overall Study|Withdrawal by Subject|11|||
170635274|NCT02000115|616674861|FG002|Overall Study|Withdrawal by Subject|0|||
170635275|NCT02000115|616674862|FG003|Overall Study|Withdrawal by Subject|0|||
170635276|NCT02000115|616674859|FG000|Overall Study|Lost to Follow-up|0|||
170635277|NCT02000115|616674860|FG001|Overall Study|Lost to Follow-up|1|||
170635278|NCT02000115|616674861|FG002|Overall Study|Lost to Follow-up|0|||
170635279|NCT02000115|616674862|FG003|Overall Study|Lost to Follow-up|0|||
170635280|NCT02000115|616674859|FG000|Overall Study|Non-compliance|2|||
170635281|NCT02000115|616674860|FG001|Overall Study|Non-compliance|1|||
170635282|NCT02000115|616674861|FG002|Overall Study|Non-compliance|0|||
170635283|NCT02000115|616674862|FG003|Overall Study|Non-compliance|0|||
170635284|NCT02000115|616674859|FG000|Overall Study|Withdrawn on day of randomization|0|||
170635285|NCT02000115|616674860|FG001|Overall Study|Withdrawn on day of randomization|1|||
170635286|NCT02000115|616674861|FG002|Overall Study|Withdrawn on day of randomization|0|||
170635287|NCT02000115|616674862|FG003|Overall Study|Withdrawn on day of randomization|0|||
170635288|NCT02000115|616674859|FG000|Overall Study|Still on Study|0|||
170635289|NCT02000115|616674860|FG001|Overall Study|Still on Study|0|||
170635290|NCT02000115|616674861|FG002|Overall Study|Still on Study|0|||
170635291|NCT02000115|616674862|FG003|Overall Study|Still on Study|53|||
170635292|NCT02484391|616674863|FG000|Overall Study|Lack of Efficacy|15|||
170635293|NCT02484391|616674864|FG001|Overall Study|Lack of Efficacy|14|||
170635294|NCT02484391|616674865|FG002|Overall Study|Lack of Efficacy|3|||
170635295|NCT02484391|616674863|FG000|Overall Study|Lost to Follow-up|0|||
170635296|NCT02484391|616674864|FG001|Overall Study|Lost to Follow-up|0|||
170635297|NCT02484391|616674865|FG002|Overall Study|Lost to Follow-up|2|||
170635298|NCT02484391|616674863|FG000|Overall Study|Physician Decision|1|||
170542198|NCT02850406|616328190|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
170542199|NCT02850406|616328191|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
170542200|NCT02850406|616328192|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
170542201|NCT02850406|616328193|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
170542202|NCT02850406|616328194|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
170542203|NCT02850406|616328195|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
170542204|NCT02850406|616328188|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542205|NCT02850406|616328189|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542206|NCT02850406|616328190|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542207|NCT02850406|616328191|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542208|NCT02850406|616328192|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542209|NCT02850406|616328193|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542210|NCT02850406|616328194|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
170542211|NCT02850406|616328195|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
170542212|NCT02850406|616328188|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
170542213|NCT02850406|616328189|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
170542214|NCT02850406|616328190|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
170542215|NCT02850406|616328191|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
170542216|NCT02850406|616328192|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
170542217|NCT02850406|616328193|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
170542218|NCT02850406|616328194|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
170542219|NCT02850406|616328195|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
170542220|NCT02850406|616328188|FG000|Part D (Up to 52 Weeks)|Other|0|||
170542221|NCT02850406|616328189|FG001|Part D (Up to 52 Weeks)|Other|0|||
170542222|NCT02850406|616328190|FG002|Part D (Up to 52 Weeks)|Other|0|||
170542223|NCT02850406|616328191|FG003|Part D (Up to 52 Weeks)|Other|0|||
170542224|NCT02850406|616328192|FG004|Part D (Up to 52 Weeks)|Other|0|||
170542225|NCT02850406|616328193|FG005|Part D (Up to 52 Weeks)|Other|0|||
170542226|NCT02850406|616328194|FG006|Part D (Up to 52 Weeks)|Other|0|||
170542227|NCT02850406|616328195|FG007|Part D (Up to 52 Weeks)|Other|1|||
170542228|NCT05643794|616329672|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
170542229|NCT05643794|616329673|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
170542230|NCT05643794|616329674|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
170542231|NCT05643794|616329672|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
170542232|NCT05643794|616329673|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170542233|NCT05643794|616329674|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170542234|NCT05643794|616329672|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
170542235|NCT05643794|616329673|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
170542236|NCT05643794|616329674|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
170542237|NCT05643794|616329672|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
170542238|NCT05643794|616329673|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
170542239|NCT05643794|616329674|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
170542240|NCT05643794|616329672|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
170542241|NCT05643794|616329673|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
170542242|NCT05643794|616329674|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
170542243|NCT05643794|616329672|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
170542244|NCT05643794|616329673|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
170542245|NCT05643794|616329674|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
170542246|NCT05399485|616329677|FG000|DBT Phase|Other|6|||
170453405|NCT03864042|615998643|FG001|Post-DDI Phase|Progressive Disease|6|||
170453406|NCT03864042|615998644|FG002|Post-DDI Phase|Progressive Disease|13|||
170453407|NCT03864042|615998642|FG000|Post-DDI Phase|Discretion of investigator|1|||
170453408|NCT03864042|615998643|FG001|Post-DDI Phase|Discretion of investigator|1|||
170453409|NCT03864042|615998644|FG002|Post-DDI Phase|Discretion of investigator|0|||
170453410|NCT03864042|615998642|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
170453411|NCT03864042|615998643|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
170453412|NCT03864042|615998644|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
170453413|NCT03864042|615998642|FG000|Post-DDI Phase|Withdrawal of consent|1|||
170453414|NCT03864042|615998643|FG001|Post-DDI Phase|Withdrawal of consent|2|||
170453415|NCT03864042|615998644|FG002|Post-DDI Phase|Withdrawal of consent|0|||
170453416|NCT00788593|615998647|FG000|Placebo Run-in Phase|Adverse Event|2|||
170453417|NCT00788593|615998648|FG001|Placebo Run-in Phase|Adverse Event|0|||
170453418|NCT00788593|615998649|FG002|Placebo Run-in Phase|Adverse Event|0|||
170453419|NCT00788593|615998647|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
170453420|NCT00788593|615998648|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
170453421|NCT00788593|615998649|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
170453422|NCT00788593|615998647|FG000|Placebo Run-in Phase|Protocol Violation|2|||
170453423|NCT00788593|615998648|FG001|Placebo Run-in Phase|Protocol Violation|0|||
170453424|NCT00788593|615998649|FG002|Placebo Run-in Phase|Protocol Violation|0|||
170453425|NCT00788593|615998647|FG000|First Intervention Period|Adverse Event|0|||
170453426|NCT00788593|615998648|FG001|First Intervention Period|Adverse Event|1|||
170453427|NCT00788593|615998649|FG002|First Intervention Period|Adverse Event|0|||
170453428|NCT00788593|615998647|FG000|Second Intervention Period|Lost to Follow-up|0|||
170453429|NCT00788593|615998648|FG001|Second Intervention Period|Lost to Follow-up|1|||
170453430|NCT00788593|615998649|FG002|Second Intervention Period|Lost to Follow-up|0|||
170542247|NCT05399485|616329678|FG001|DBT Phase|Other|5|||
170542248|NCT05399485|616329677|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
170542249|NCT05399485|616329678|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
170542250|NCT05399485|616329677|FG000|DBT Phase|Withdrawal by Subject|3|||
170542251|NCT05399485|616329678|FG001|DBT Phase|Withdrawal by Subject|2|||
170542252|NCT05399485|616329677|FG000|DBT Phase|Protocol Violation|2|||
170542253|NCT05399485|616329678|FG001|DBT Phase|Protocol Violation|1|||
170542254|NCT05399485|616329677|FG000|DBT Phase|Physician Decision|0|||
170542255|NCT05399485|616329678|FG001|DBT Phase|Physician Decision|1|||
170542256|NCT05399485|616329677|FG000|DBT Phase|Adverse Event|2|||
170542257|NCT05399485|616329678|FG001|DBT Phase|Adverse Event|1|||
170542258|NCT05399485|616329677|FG000|OLE Phase|Protocol deviation|1|||
170542259|NCT05399485|616329678|FG001|OLE Phase|Protocol deviation|0|||
170542260|NCT05399485|616329677|FG000|OLE Phase|Other|5|||
170542261|NCT05399485|616329678|FG001|OLE Phase|Other|5|||
170542262|NCT05399485|616329677|FG000|OLE Phase|Withdrawal by Subject|12|||
170542263|NCT05399485|616329678|FG001|OLE Phase|Withdrawal by Subject|7|||
170542264|NCT05399485|616329677|FG000|OLE Phase|Pregnancy|0|||
170542265|NCT05399485|616329678|FG001|OLE Phase|Pregnancy|2|||
170542266|NCT05399485|616329677|FG000|OLE Phase|Physician Decision|3|||
170542267|NCT05399485|616329678|FG001|OLE Phase|Physician Decision|0|||
170542268|NCT05399485|616329677|FG000|OLE Phase|Adverse Event|2|||
170542269|NCT05399485|616329678|FG001|OLE Phase|Adverse Event|2|||
170542270|NCT04770753|616329681|FG000|Overall Study|Randomized, never treated|1|||
170542271|NCT04770753|616329682|FG001|Overall Study|Randomized, never treated|1|||
170542272|NCT04770753|616329681|FG000|Overall Study|Withdrawal by Subject|3|||
170542273|NCT04770753|616329682|FG001|Overall Study|Withdrawal by Subject|1|||
170542274|NCT04770753|616329681|FG000|Overall Study|Adverse Event|2|||
170542275|NCT04770753|616329682|FG001|Overall Study|Adverse Event|0|||
170542276|NCT04770753|616329681|FG000|Overall Study|Pregnancy|1|||
170542277|NCT04770753|616329682|FG001|Overall Study|Pregnancy|0|||
170453431|NCT00788593|615998647|FG000|Second Intervention Period|Other|0|||
170453432|NCT00788593|615998648|FG001|Second Intervention Period|Other|0|||
170453433|NCT00788593|615998649|FG002|Second Intervention Period|Other|1|||
170542278|NCT04770753|616329681|FG000|Overall Study|Other un-specified|1|||
170542279|NCT04770753|616329682|FG001|Overall Study|Other un-specified|0|||
170542280|NCT03945773|616329683|FG000|Overall Study|Consent Withdrawn|1|||
170542281|NCT03945773|616329684|FG001|Overall Study|Consent Withdrawn|1|||
170542282|NCT03945773|616329683|FG000|Overall Study|Lost to Follow-up|1|||
170542283|NCT03945773|616329684|FG001|Overall Study|Lost to Follow-up|0|||
170542284|NCT03945773|616329683|FG000|Overall Study|Death|46|||
170542285|NCT03945773|616329684|FG001|Overall Study|Death|22|||
170635299|NCT02484391|616674864|FG001|Overall Study|Physician Decision|3|||
170635300|NCT02484391|616674865|FG002|Overall Study|Physician Decision|0|||
170635301|NCT02484391|616674863|FG000|Overall Study|Went to Transplant|5|||
170635302|NCT02484391|616674864|FG001|Overall Study|Went to Transplant|3|||
170635303|NCT02484391|616674865|FG002|Overall Study|Went to Transplant|2|||
170635304|NCT03493464|616674868|FG000|Overall Study|Surgery not performed|1|||
170635305|NCT04922216|616674871|FG000|Overall Study|Withdrawal by Subject|0|||
170635306|NCT04922216|616674872|FG001|Overall Study|Withdrawal by Subject|1|||
170635307|NCT04922216|616674873|FG002|Overall Study|Withdrawal by Subject|0|||
170635308|NCT04922216|616674874|FG003|Overall Study|Withdrawal by Subject|0|||
170635309|NCT04922216|616674875|FG004|Overall Study|Withdrawal by Subject|0|||
170635310|NCT04922216|616674876|FG005|Overall Study|Withdrawal by Subject|0|||
170635311|NCT04922216|616674877|FG006|Overall Study|Withdrawal by Subject|0|||
170635312|NCT04922216|616674878|FG007|Overall Study|Withdrawal by Subject|2|||
170635313|NCT04922216|616674879|FG008|Overall Study|Withdrawal by Subject|0|||
170635314|NCT04922216|616674880|FG009|Overall Study|Withdrawal by Subject|0|||
170635315|NCT04922216|616674881|FG010|Overall Study|Withdrawal by Subject|0|||
170635316|NCT04922216|616674882|FG011|Overall Study|Withdrawal by Subject|0|||
170635317|NCT04922216|616674883|FG012|Overall Study|Withdrawal by Subject|1|||
170635318|NCT04922216|616674884|FG013|Overall Study|Withdrawal by Subject|1|||
170635319|NCT04922216|616674885|FG014|Overall Study|Withdrawal by Subject|1|||
170635320|NCT04922216|616674886|FG015|Overall Study|Withdrawal by Subject|0|||
170635321|NCT04922216|616674887|FG016|Overall Study|Withdrawal by Subject|0|||
170635322|NCT04922216|616674888|FG017|Overall Study|Withdrawal by Subject|1|||
170635323|NCT04922216|616674889|FG018|Overall Study|Withdrawal by Subject|1|||
170635324|NCT04922216|616674890|FG019|Overall Study|Withdrawal by Subject|1|||
170787486|NCT04149704|617231812|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
170787487|NCT04149704|617231809|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
170787488|NCT04149704|617231810|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
170787489|NCT04149704|617231811|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
170787490|NCT04149704|617231812|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
170787491|NCT04652700|617231815|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
170787492|NCT04652700|617231816|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
170635325|NCT04922216|616674891|FG020|Overall Study|Withdrawal by Subject|1|||
170635326|NCT04922216|616674892|FG021|Overall Study|Withdrawal by Subject|0|||
170635327|NCT04922216|616674893|FG022|Overall Study|Withdrawal by Subject|0|||
170635328|NCT04922216|616674894|FG023|Overall Study|Withdrawal by Subject|2|||
170635329|NCT04922216|616674895|FG024|Overall Study|Withdrawal by Subject|0|||
170635330|NCT04922216|616674896|FG025|Overall Study|Withdrawal by Subject|0|||
170635331|NCT04922216|616674897|FG026|Overall Study|Withdrawal by Subject|1|||
170787493|NCT04652700|617231815|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
170787494|NCT04652700|617231816|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
170787495|NCT04652700|617231815|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
170787496|NCT04652700|617231816|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
170787497|NCT04652700|617231815|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
170787498|NCT04652700|617231816|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
170787499|NCT04652700|617231815|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
170787500|NCT04652700|617231816|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
170787501|NCT04652700|617231815|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
170787502|NCT04652700|617231816|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
170787503|NCT04652700|617231815|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
170787504|NCT04652700|617231816|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
170787505|NCT04652700|617231815|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
170453434|NCT00515034|615998650|FG000|Overall Study|Adverse Event|2|||
170453435|NCT00515034|615998651|FG001|Overall Study|Adverse Event|0|||
170453436|NCT00515034|615998652|FG002|Overall Study|Adverse Event|1|||
170453437|NCT00515034|615998653|FG003|Overall Study|Adverse Event|0|||
170453438|NCT00515034|615998650|FG000|Overall Study|Death|4|||
170453439|NCT00515034|615998651|FG001|Overall Study|Death|2|||
170453440|NCT00515034|615998652|FG002|Overall Study|Death|1|||
170453441|NCT00515034|615998653|FG003|Overall Study|Death|3|||
170453442|NCT00515034|615998650|FG000|Overall Study|Withdrawal by Subject|1|||
170453443|NCT00515034|615998651|FG001|Overall Study|Withdrawal by Subject|0|||
170453444|NCT00515034|615998652|FG002|Overall Study|Withdrawal by Subject|3|||
170453445|NCT00515034|615998653|FG003|Overall Study|Withdrawal by Subject|0|||
170453446|NCT00515034|615998650|FG000|Overall Study|Physician Decision|0|||
170453447|NCT00515034|615998651|FG001|Overall Study|Physician Decision|0|||
170453448|NCT00515034|615998652|FG002|Overall Study|Physician Decision|1|||
170453449|NCT00515034|615998653|FG003|Overall Study|Physician Decision|1|||
170635332|NCT04922216|616674898|FG027|Overall Study|Withdrawal by Subject|0|||
170635333|NCT04922216|616674899|FG028|Overall Study|Withdrawal by Subject|0|||
170453450|NCT00515034|615998650|FG000|Overall Study|Other|1|||
170453451|NCT00515034|615998651|FG001|Overall Study|Other|0|||
170453452|NCT00515034|615998652|FG002|Overall Study|Other|2|||
170453453|NCT00515034|615998653|FG003|Overall Study|Other|1|||
170453454|NCT01392326|615998654|FG000|Overall Study|Death|2|||
170453455|NCT01392326|615998655|FG001|Overall Study|Death|0|||
170453456|NCT01392326|615998656|FG002|Overall Study|Death|0|||
170453457|NCT01392326|615998654|FG000|Overall Study|Withdrawal by Subject|12|||
170453458|NCT01392326|615998655|FG001|Overall Study|Withdrawal by Subject|11|||
170453459|NCT01392326|615998656|FG002|Overall Study|Withdrawal by Subject|15|||
170453460|NCT01392326|615998654|FG000|Overall Study|Protocol Violation|2|||
170453461|NCT01392326|615998655|FG001|Overall Study|Protocol Violation|0|||
170453462|NCT01392326|615998656|FG002|Overall Study|Protocol Violation|0|||
170453463|NCT01392326|615998654|FG000|Overall Study|Pregnancy|0|||
170453464|NCT01392326|615998655|FG001|Overall Study|Pregnancy|0|||
170453465|NCT01392326|615998656|FG002|Overall Study|Pregnancy|1|||
170453466|NCT01392326|615998654|FG000|Overall Study|Physician Decision|7|||
170453467|NCT01392326|615998655|FG001|Overall Study|Physician Decision|5|||
170453468|NCT01392326|615998656|FG002|Overall Study|Physician Decision|2|||
170453469|NCT01392326|615998654|FG000|Overall Study|Lost to Follow-up|1|||
170453470|NCT01392326|615998655|FG001|Overall Study|Lost to Follow-up|3|||
170453471|NCT01392326|615998656|FG002|Overall Study|Lost to Follow-up|4|||
170453472|NCT01392326|615998654|FG000|Overall Study|Lack of Efficacy|14|||
170453473|NCT01392326|615998655|FG001|Overall Study|Lack of Efficacy|10|||
170453474|NCT01392326|615998656|FG002|Overall Study|Lack of Efficacy|15|||
170453475|NCT01392326|615998654|FG000|Overall Study|Adverse Event|9|||
170453476|NCT01392326|615998655|FG001|Overall Study|Adverse Event|6|||
170453477|NCT01392326|615998656|FG002|Overall Study|Adverse Event|11|||
170453478|NCT03499119|615998659|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
170453479|NCT03499119|615998660|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
170453480|NCT03499119|615998661|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
170453481|NCT03499119|615998662|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
170542286|NCT03945773|616329683|FG000|Overall Study|Physician Decision|1|||
170542287|NCT03945773|616329684|FG001|Overall Study|Physician Decision|0|||
170542288|NCT03945773|616329683|FG000|Overall Study|Other|1|||
170542289|NCT03945773|616329684|FG001|Overall Study|Other|0|||
170542290|NCT03945773|616329683|FG000|Overall Study|Ongoing at the time of DCO|4|||
170542291|NCT03945773|616329684|FG001|Overall Study|Ongoing at the time of DCO|3|||
170542292|NCT05849922|616329689|FG000|Period A (DB): Up to Week 16|Withdrawal by Subject|1|||
170542293|NCT05849922|616329690|FG001|Period A (DB): Up to Week 16|Withdrawal by Subject|1|||
170542294|NCT05849922|616329691|FG002|Period A (DB): Up to Week 16|Withdrawal by Subject|0|||
170542295|NCT05849922|616329692|FG003|Period A (DB): Up to Week 16|Withdrawal by Subject|0|||
170542296|NCT05849922|616329689|FG000|Period A (DB): Up to Week 16|Other|1|||
170542297|NCT05849922|616329690|FG001|Period A (DB): Up to Week 16|Other|3|||
170542298|NCT05849922|616329691|FG002|Period A (DB): Up to Week 16|Other|0|||
170542299|NCT05849922|616329692|FG003|Period A (DB): Up to Week 16|Other|0|||
170542300|NCT05849922|616329689|FG000|Period A (DB): Up to Week 16|Adverse Event|0|||
170542301|NCT05849922|616329690|FG001|Period A (DB): Up to Week 16|Adverse Event|2|||
170542302|NCT05849922|616329691|FG002|Period A (DB): Up to Week 16|Adverse Event|0|||
170542303|NCT05849922|616329692|FG003|Period A (DB): Up to Week 16|Adverse Event|0|||
170542304|NCT05849922|616329689|FG000|Period B (OLE): From Week 16 to Week 28|Adverse Event|0|||
170542305|NCT05849922|616329690|FG001|Period B (OLE): From Week 16 to Week 28|Adverse Event|0|||
170542306|NCT05849922|616329691|FG002|Period B (OLE): From Week 16 to Week 28|Adverse Event|0|||
170542307|NCT05849922|616329692|FG003|Period B (OLE): From Week 16 to Week 28|Adverse Event|1|||
170542308|NCT05849922|616329689|FG000|Period B (OLE): From Week 16 to Week 28|Non-compliance with study schedule|0|||
170542309|NCT05849922|616329690|FG001|Period B (OLE): From Week 16 to Week 28|Non-compliance with study schedule|0|||
170542310|NCT05849922|616329691|FG002|Period B (OLE): From Week 16 to Week 28|Non-compliance with study schedule|0|||
170542311|NCT05849922|616329692|FG003|Period B (OLE): From Week 16 to Week 28|Non-compliance with study schedule|1|||
170542312|NCT05849922|616329689|FG000|Period B (OLE): From Week 16 to Week 28|Withdrawal by Subject|0|||
170542313|NCT05849922|616329690|FG001|Period B (OLE): From Week 16 to Week 28|Withdrawal by Subject|0|||
170542314|NCT05849922|616329691|FG002|Period B (OLE): From Week 16 to Week 28|Withdrawal by Subject|2|||
170542315|NCT05849922|616329692|FG003|Period B (OLE): From Week 16 to Week 28|Withdrawal by Subject|1|||
170542316|NCT05849922|616329689|FG000|Period B (OLE): From Week 16 to Week 28|Other|0|||
170542317|NCT05849922|616329690|FG001|Period B (OLE): From Week 16 to Week 28|Other|0|||
170542318|NCT05849922|616329691|FG002|Period B (OLE): From Week 16 to Week 28|Other|0|||
170542319|NCT05849922|616329692|FG003|Period B (OLE): From Week 16 to Week 28|Other|2|||
170542320|NCT05849922|616329689|FG000|Period B (OLE): From Week 16 to Week 28|Non-compliance with study drug|0|||
170542321|NCT05849922|616329690|FG001|Period B (OLE): From Week 16 to Week 28|Non-compliance with study drug|0|||
170542322|NCT05849922|616329691|FG002|Period B (OLE): From Week 16 to Week 28|Non-compliance with study drug|0|||
170453482|NCT03499119|615998659|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
170453483|NCT03499119|615998660|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
170453484|NCT03499119|615998661|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
170453485|NCT03499119|615998662|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
170453486|NCT03499119|615998659|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
170453487|NCT03499119|615998660|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
170453488|NCT03499119|615998661|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
170453489|NCT03499119|615998662|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
170453490|NCT03499119|615998659|FG000|Optional Extension Phase|Lost to Follow-up|0|||
170453491|NCT03499119|615998660|FG001|Optional Extension Phase|Lost to Follow-up|0|||
170453492|NCT03499119|615998661|FG002|Optional Extension Phase|Lost to Follow-up|0|||
170453493|NCT03499119|615998662|FG003|Optional Extension Phase|Lost to Follow-up|1|||
170453494|NCT03499119|615998659|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
170453495|NCT03499119|615998660|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
170453496|NCT03499119|615998661|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
170453497|NCT03499119|615998662|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
170453498|NCT03499119|615998659|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
170453499|NCT03499119|615998660|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
170453500|NCT03499119|615998661|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
170453501|NCT03499119|615998662|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
170453502|NCT01558297|615998666|FG000|Overall Study|Withdrawal by Subject|2|||
170453503|NCT01558297|615998667|FG001|Overall Study|Withdrawal by Subject|2|||
170453504|NCT01558297|615998668|FG002|Overall Study|Withdrawal by Subject|1|||
170453505|NCT00094094|615998669|FG000|Overall Study|Death|2|||
170453506|NCT00094094|615998669|FG000|Overall Study|Lack of Efficacy|23|||
170453507|NCT00094094|615998669|FG000|Overall Study|Adverse Event|7|||
170453508|NCT04560998|615998670|FG000|Overall Study|Withdrawal by Subject|18|||
170453509|NCT04560998|615998671|FG001|Overall Study|Withdrawal by Subject|12|||
170453510|NCT04560998|615998670|FG000|Overall Study|Lost to Follow-up|8|||
170453511|NCT04560998|615998671|FG001|Overall Study|Lost to Follow-up|5|||
170453512|NCT04560998|615998670|FG000|Overall Study|Physician Decision|4|||
170453513|NCT04560998|615998671|FG001|Overall Study|Physician Decision|0|||
170453514|NCT04459715|615998675|FG000|Overall Study|Adverse Event|3|||
170453515|NCT04459715|615998676|FG001|Overall Study|Adverse Event|3|||
170453516|NCT04459715|615998675|FG000|Overall Study|Death|111|||
170453517|NCT04459715|615998676|FG001|Overall Study|Death|93|||
170453518|NCT04459715|615998675|FG000|Overall Study|Lost to Follow-up|10|||
170453519|NCT04459715|615998676|FG001|Overall Study|Lost to Follow-up|9|||
170453520|NCT04459715|615998675|FG000|Overall Study|Other Reasons|4|||
170453521|NCT04459715|615998676|FG001|Overall Study|Other Reasons|5|||
170453522|NCT04459715|615998675|FG000|Overall Study|PROTOCOL DEVIATION|0|||
170453523|NCT04459715|615998676|FG001|Overall Study|PROTOCOL DEVIATION|1|||
170453524|NCT04459715|615998675|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
170453525|NCT04459715|615998676|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
170453526|NCT04459715|615998675|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
170453527|NCT04459715|615998676|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
170453528|NCT04459715|615998675|FG000|Overall Study|Withdrawal by Subject|22|||
170453529|NCT04459715|615998676|FG001|Overall Study|Withdrawal by Subject|22|||
170453530|NCT06029959|616000263|FG000|Overall Study|Physician Decision|6|||
170453531|NCT02522403|616000264|FG000|Overall Study|Lost to Follow-up|2|||
170453532|NCT02522403|616000265|FG001|Overall Study|Lost to Follow-up|2|||
170453533|NCT02522403|616000264|FG000|Overall Study|Withdrawal by Subject|2|||
170453534|NCT02522403|616000265|FG001|Overall Study|Withdrawal by Subject|4|||
170453535|NCT02856880|616000269|FG000|Overall Study|Withdrawal of consent|1|||
170453536|NCT03573505|616000270|FG000|Overall Study|Adverse Event|1|||
170453537|NCT03573505|616000271|FG001|Overall Study|Adverse Event|1|||
170453538|NCT03573505|616000270|FG000|Overall Study|Consent withdrawn|0|||
170453539|NCT03573505|616000271|FG001|Overall Study|Consent withdrawn|1|||
170453540|NCT03573505|616000270|FG000|Overall Study|Disease progression|0|||
170453541|NCT03573505|616000271|FG001|Overall Study|Disease progression|1|||
170453542|NCT03573505|616000270|FG000|Overall Study|Site Terminated by Sponsor|1|||
170453543|NCT03573505|616000271|FG001|Overall Study|Site Terminated by Sponsor|1|||
170453544|NCT03573505|616000270|FG000|Overall Study|Study terminated by sponsor|50|||
170453545|NCT03573505|616000271|FG001|Overall Study|Study terminated by sponsor|45|||
170453546|NCT03573505|616000270|FG000|Overall Study|Reason not specified|0|||
170453547|NCT03573505|616000271|FG001|Overall Study|Reason not specified|1|||
170453548|NCT03573505|616000270|FG000|Overall Study|Death|0|||
170453549|NCT03573505|616000271|FG001|Overall Study|Death|4|||
170453550|NCT00515541|616000272|FG000|Overall Study|Physician Decision|0|||
170453551|NCT00515541|616000273|FG001|Overall Study|Physician Decision|2|||
170453552|NCT00515541|616000274|FG002|Overall Study|Physician Decision|0|||
170453553|NCT00515541|616000275|FG003|Overall Study|Physician Decision|1|||
170453554|NCT00515541|616000272|FG000|Overall Study|No show for appointments|0|||
170453555|NCT00515541|616000273|FG001|Overall Study|No show for appointments|1|||
170453556|NCT00515541|616000274|FG002|Overall Study|No show for appointments|0|||
170453557|NCT00515541|616000275|FG003|Overall Study|No show for appointments|2|||
170787506|NCT04652700|617231816|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
170787507|NCT04652700|617231815|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
170453558|NCT00515541|616000272|FG000|Overall Study|Withdrawal by Subject|0|||
170453559|NCT00515541|616000273|FG001|Overall Study|Withdrawal by Subject|2|||
170453560|NCT00515541|616000274|FG002|Overall Study|Withdrawal by Subject|0|||
170453561|NCT00515541|616000275|FG003|Overall Study|Withdrawal by Subject|2|||
170453562|NCT02588950|616000276|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
170453563|NCT02588950|616000277|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
170453564|NCT02588950|616000278|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
170453565|NCT02588950|616000279|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
170453566|NCT02588950|616000276|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
170453567|NCT02588950|616000277|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
170453568|NCT02588950|616000278|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
170453569|NCT02588950|616000279|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
170453570|NCT05855616|616000280|FG000|Overall Study|Lost to Follow-up|1|||
170453571|NCT05855616|616000281|FG001|Overall Study|Lost to Follow-up|2|||
170453572|NCT00652028|616000284|FG000|Overall Study|Adverse Event|1|||
170453573|NCT00652028|616000285|FG001|Overall Study|Adverse Event|0|||
170453574|NCT00652028|616000286|FG002|Overall Study|Adverse Event|0|||
170453575|NCT00652028|616000287|FG003|Overall Study|Adverse Event|0|||
170453576|NCT00652028|616000284|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
170453577|NCT00652028|616000285|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
170453578|NCT00652028|616000286|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
170453579|NCT00652028|616000287|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
170453580|NCT00652028|616000284|FG000|Overall Study|Physician Decision|0|||
170453581|NCT00652028|616000285|FG001|Overall Study|Physician Decision|0|||
170453582|NCT00652028|616000286|FG002|Overall Study|Physician Decision|1|||
170453583|NCT00652028|616000287|FG003|Overall Study|Physician Decision|0|||
170453584|NCT02072824|616000288|FG000|Overall Study|Insufficient clinical response|1|||
170453585|NCT02072824|616000289|FG001|Overall Study|Insufficient clinical response|0|||
170453586|NCT02072824|616000290|FG002|Overall Study|Insufficient clinical response|1|||
170453587|NCT02072824|616000288|FG000|Overall Study|No longer willing to participate|1|||
170453588|NCT02072824|616000289|FG001|Overall Study|No longer willing to participate|0|||
170453589|NCT02072824|616000290|FG002|Overall Study|No longer willing to participate|1|||
170453590|NCT02072824|616000288|FG000|Overall Study|Medication error|0|||
170453591|NCT02072824|616000289|FG001|Overall Study|Medication error|1|||
170453592|NCT02072824|616000290|FG002|Overall Study|Medication error|0|||
170453593|NCT02072824|616000288|FG000|Overall Study|Adverse Event|0|||
170453594|NCT02072824|616000289|FG001|Overall Study|Adverse Event|0|||
170453595|NCT02072824|616000290|FG002|Overall Study|Adverse Event|1|||
170453596|NCT02669940|616000292|FG000|Overall Study|Failure to return|0|||
170453597|NCT02669940|616000293|FG001|Overall Study|Failure to return|3|||
170453598|NCT02669940|616000292|FG000|Overall Study|Insufficient follow-up data|1|||
170453599|NCT02669940|616000293|FG001|Overall Study|Insufficient follow-up data|0|||
170453600|NCT01892657|616000294|FG000|Overall Study|Withdrawal by Subject|6|||
170453601|NCT01892657|616000294|FG000|Overall Study|Protocol Violation|12|||
170453602|NCT05065983|616000295|FG000|Overall Study|Lost to Follow-up|2|||
170453603|NCT00986180|616000296|FG000|Overall Study|Adverse Event|21|||
170453604|NCT00986180|616000297|FG001|Overall Study|Adverse Event|23|||
170453605|NCT00986180|616000296|FG000|Overall Study|Lack of Efficacy|4|||
170453606|NCT00986180|616000297|FG001|Overall Study|Lack of Efficacy|3|||
170453607|NCT00986180|616000296|FG000|Overall Study|Lost to Follow-up|5|||
170453608|NCT00986180|616000297|FG001|Overall Study|Lost to Follow-up|7|||
170453609|NCT00986180|616000296|FG000|Overall Study|Physician Decision|1|||
170453610|NCT00986180|616000297|FG001|Overall Study|Physician Decision|3|||
170453611|NCT00986180|616000296|FG000|Overall Study|Protocol Violation|2|||
170453612|NCT00986180|616000297|FG001|Overall Study|Protocol Violation|0|||
170453613|NCT00986180|616000296|FG000|Overall Study|Withdrawal by Subject|1|||
170453614|NCT00986180|616000297|FG001|Overall Study|Withdrawal by Subject|9|||
170453615|NCT00986180|616000296|FG000|Overall Study|Miscellanies|10|||
170453616|NCT00986180|616000297|FG001|Overall Study|Miscellanies|11|||
170453617|NCT01642914|616000298|FG000|Overall Study|Adverse Event|11|||
170542323|NCT05849922|616329692|FG003|Period B (OLE): From Week 16 to Week 28|Non-compliance with study drug|1|||
170542324|NCT04339972|616329695|FG000|Overall Study|Scheduling Issues|3|||
170453618|NCT01642914|616000299|FG001|Overall Study|Adverse Event|7|||
170453619|NCT01642914|616000300|FG002|Overall Study|Adverse Event|15|||
170453620|NCT01642914|616000298|FG000|Overall Study|Lack of Efficacy|9|||
170453621|NCT01642914|616000299|FG001|Overall Study|Lack of Efficacy|4|||
170453622|NCT01642914|616000300|FG002|Overall Study|Lack of Efficacy|2|||
170453623|NCT01642914|616000298|FG000|Overall Study|Protocol Violation|15|||
170453624|NCT01642914|616000299|FG001|Overall Study|Protocol Violation|13|||
170453625|NCT01642914|616000300|FG002|Overall Study|Protocol Violation|6|||
170453626|NCT01642914|616000298|FG000|Overall Study|Withdrawal by Subject|5|||
170453627|NCT01642914|616000299|FG001|Overall Study|Withdrawal by Subject|5|||
170453628|NCT01642914|616000300|FG002|Overall Study|Withdrawal by Subject|10|||
170453629|NCT01642914|616000298|FG000|Overall Study|Lost to Follow-up|5|||
170635334|NCT04922216|616674900|FG029|Overall Study|Withdrawal by Subject|0|||
170635335|NCT04922216|616674901|FG030|Overall Study|Withdrawal by Subject|1|||
170635336|NCT04922216|616674902|FG031|Overall Study|Withdrawal by Subject|0|||
170635337|NCT04922216|616674871|FG000|Overall Study|Lost to Follow-up|1|||
170635338|NCT04922216|616674872|FG001|Overall Study|Lost to Follow-up|0|||
170635339|NCT04922216|616674873|FG002|Overall Study|Lost to Follow-up|2|||
170635340|NCT04922216|616674874|FG003|Overall Study|Lost to Follow-up|0|||
170635341|NCT04922216|616674875|FG004|Overall Study|Lost to Follow-up|0|||
170635342|NCT04922216|616674876|FG005|Overall Study|Lost to Follow-up|2|||
170635343|NCT04922216|616674877|FG006|Overall Study|Lost to Follow-up|0|||
170635344|NCT04922216|616674878|FG007|Overall Study|Lost to Follow-up|1|||
170635345|NCT04922216|616674879|FG008|Overall Study|Lost to Follow-up|1|||
170635346|NCT04922216|616674880|FG009|Overall Study|Lost to Follow-up|2|||
170635347|NCT04922216|616674881|FG010|Overall Study|Lost to Follow-up|2|||
170635348|NCT04922216|616674882|FG011|Overall Study|Lost to Follow-up|1|||
170635349|NCT04922216|616674883|FG012|Overall Study|Lost to Follow-up|1|||
170635350|NCT04922216|616674884|FG013|Overall Study|Lost to Follow-up|0|||
170635351|NCT04922216|616674885|FG014|Overall Study|Lost to Follow-up|1|||
170635352|NCT04922216|616674886|FG015|Overall Study|Lost to Follow-up|0|||
170635353|NCT04922216|616674887|FG016|Overall Study|Lost to Follow-up|0|||
170635354|NCT04922216|616674888|FG017|Overall Study|Lost to Follow-up|2|||
170635355|NCT04922216|616674889|FG018|Overall Study|Lost to Follow-up|1|||
170635356|NCT04922216|616674890|FG019|Overall Study|Lost to Follow-up|0|||
170635357|NCT04922216|616674891|FG020|Overall Study|Lost to Follow-up|1|||
170635358|NCT04922216|616674892|FG021|Overall Study|Lost to Follow-up|0|||
170635359|NCT04922216|616674893|FG022|Overall Study|Lost to Follow-up|2|||
170635360|NCT04922216|616674894|FG023|Overall Study|Lost to Follow-up|1|||
170635361|NCT04922216|616674895|FG024|Overall Study|Lost to Follow-up|0|||
170635362|NCT04922216|616674896|FG025|Overall Study|Lost to Follow-up|2|||
170635363|NCT04922216|616674897|FG026|Overall Study|Lost to Follow-up|0|||
170635364|NCT04922216|616674898|FG027|Overall Study|Lost to Follow-up|0|||
170635365|NCT04922216|616674899|FG028|Overall Study|Lost to Follow-up|1|||
170635366|NCT04922216|616674900|FG029|Overall Study|Lost to Follow-up|0|||
170635367|NCT04922216|616674901|FG030|Overall Study|Lost to Follow-up|2|||
170635368|NCT04922216|616674902|FG031|Overall Study|Lost to Follow-up|1|||
170635369|NCT02514083|616674907|FG000|Overall Study|Adverse Event|1|||
170635370|NCT02864394|616674909|FG000|Overall Study|Death|184|||
170635371|NCT02864394|616674910|FG001|Overall Study|Death|189|||
170635372|NCT02864394|616674909|FG000|Overall Study|Lost to Follow-up|0|||
170635373|NCT02864394|616674910|FG001|Overall Study|Lost to Follow-up|2|||
170635374|NCT02864394|616674909|FG000|Overall Study|Sponsor Decision|26|||
170635375|NCT02864394|616674910|FG001|Overall Study|Sponsor Decision|11|||
170635376|NCT02864394|616674909|FG000|Overall Study|Withdrawal by Subject|3|||
170635377|NCT02864394|616674910|FG001|Overall Study|Withdrawal by Subject|10|||
170635378|NCT01596062|616676873|FG000|Overall Study|Adverse Event|1|||
170635379|NCT01596062|616676874|FG001|Overall Study|Adverse Event|0|||
170635380|NCT01596062|616676875|FG002|Overall Study|Adverse Event|2|||
170635381|NCT01596062|616676873|FG000|Overall Study|Lack of Efficacy|0|||
170635382|NCT01596062|616676874|FG001|Overall Study|Lack of Efficacy|0|||
170635383|NCT01596062|616676875|FG002|Overall Study|Lack of Efficacy|1|||
170635384|NCT01069900|616676876|FG000|Overall Study|Technical problems|0|||
170635385|NCT01069900|616676877|FG001|Overall Study|Technical problems|1|||
170635386|NCT01069900|616676876|FG000|Overall Study|Lost to Follow-up|7|||
170635387|NCT01069900|616676877|FG001|Overall Study|Lost to Follow-up|1|||
170635388|NCT01069900|616676876|FG000|Overall Study|Withdrawal by Subject|6|||
170635389|NCT01069900|616676877|FG001|Overall Study|Withdrawal by Subject|1|||
170635390|NCT01069900|616676876|FG000|Overall Study|Protocol Violation|4|||
170635391|NCT01069900|616676877|FG001|Overall Study|Protocol Violation|1|||
170635392|NCT01069900|616676876|FG000|Overall Study|Insufficient Therapeutic effect|1|||
170787508|NCT04652700|617231816|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
170635393|NCT01069900|616676877|FG001|Overall Study|Insufficient Therapeutic effect|0|||
170635394|NCT03180840|616676878|FG000|Overall Study|Withdrawal by Subject|1|||
170787509|NCT04187833|617231817|FG000|Overall Study|Withdrawal by Subject|1|||
170635395|NCT00867815|616676884|FG000|Overall Study|Lost to Follow-up|1|||
170635396|NCT01237899|616676885|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
170635397|NCT01237899|616676886|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
170635398|NCT01237899|616676887|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
170635399|NCT01237899|616676888|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
170787510|NCT04209465|617231818|FG000|Overall Study|Adverse Event|0|||
170635400|NCT01237899|616676889|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
170635401|NCT01237899|616676890|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
170635402|NCT01237899|616676891|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
170635403|NCT01237899|616676892|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
170635404|NCT01237899|616676893|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
170635405|NCT01237899|616676894|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
170635406|NCT01237899|616676895|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
170635407|NCT00859456|616676896|FG000|Overall Study|Adverse Event|3|||
170635408|NCT00859456|616676896|FG000|Overall Study|Progressive disease|2|||
170542325|NCT04339972|616329696|FG001|Overall Study|Scheduling Issues|3|||
170542326|NCT04339972|616329695|FG000|Overall Study|dropout|1|||
170542327|NCT04339972|616329696|FG001|Overall Study|dropout|1|||
170542328|NCT04339972|616329695|FG000|Overall Study|Technical issues|1|||
170542329|NCT04339972|616329696|FG001|Overall Study|Technical issues|0|||
170542330|NCT04339972|616329695|FG000|Overall Study|Claustraphobia|0|||
170542331|NCT04339972|616329696|FG001|Overall Study|Claustraphobia|1|||
170542332|NCT04251156|616329699|FG000|Overall Study|Lost to Follow-up|1|||
170542333|NCT04251156|616329700|FG001|Overall Study|Lost to Follow-up|1|||
170542334|NCT04251156|616329699|FG000|Overall Study|Withdrawal by Subject|4|||
170542335|NCT04251156|616329700|FG001|Overall Study|Withdrawal by Subject|4|||
170542336|NCT04606823|616329701|FG000|Overall Study|Delayed surgery, withdrawn|1|||
170542337|NCT05452239|616329702|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
170542338|NCT05452239|616329703|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
170542339|NCT05452239|616329702|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
170542340|NCT05452239|616329703|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
170542341|NCT05452239|616329702|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
170542342|NCT05452239|616329703|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
170542343|NCT05452239|616329702|FG000|Placebo-controlled Period|Randomized but not treated|2|||
170542344|NCT05452239|616329703|FG001|Placebo-controlled Period|Randomized but not treated|2|||
170542345|NCT05452239|616329702|FG000|Placebo-controlled Period|Other than specified|1|||
170542346|NCT05452239|616329703|FG001|Placebo-controlled Period|Other than specified|1|||
170542347|NCT05452239|616329702|FG000|Open-label Period|Withdrawal by Subject|2|||
170542348|NCT05452239|616329703|FG001|Open-label Period|Withdrawal by Subject|1|||
170542349|NCT05452239|616329702|FG000|Open-label Period|Lost to Follow-up|3|||
170542350|NCT05452239|616329703|FG001|Open-label Period|Lost to Follow-up|0|||
170542351|NCT05452239|616329702|FG000|Open-label Period|Other than specified|1|||
170542352|NCT05452239|616329703|FG001|Open-label Period|Other than specified|2|||
170542353|NCT06057168|616329704|FG000|Overall Study|Adverse Event|2|||
170542354|NCT06057168|616329705|FG001|Overall Study|Adverse Event|0|||
170542355|NCT02403271|616329706|FG000|Period 1|Other varied reasons|1|||
170542356|NCT02403271|616329707|FG001|Period 1|Other varied reasons|0|||
170787511|NCT04209465|617231819|FG001|Overall Study|Adverse Event|0|||
170787512|NCT04209465|617231820|FG002|Overall Study|Adverse Event|0|||
170787513|NCT04209465|617231821|FG003|Overall Study|Adverse Event|0|||
170787514|NCT04209465|617231822|FG004|Overall Study|Adverse Event|0|||
170787515|NCT04209465|617231823|FG005|Overall Study|Adverse Event|1|||
170787516|NCT04209465|617231824|FG006|Overall Study|Adverse Event|0|||
170787517|NCT04209465|617231825|FG007|Overall Study|Adverse Event|0|||
170787518|NCT04209465|617231826|FG008|Overall Study|Adverse Event|1|||
170787519|NCT04209465|617231827|FG009|Overall Study|Adverse Event|0|||
170787520|NCT04209465|617231828|FG010|Overall Study|Adverse Event|2|||
170787521|NCT04209465|617231829|FG011|Overall Study|Adverse Event|1|||
170787522|NCT04209465|617231830|FG012|Overall Study|Adverse Event|1|||
170787523|NCT04209465|617231818|FG000|Overall Study|Death|1|||
170787524|NCT04209465|617231819|FG001|Overall Study|Death|0|||
170787525|NCT04209465|617231820|FG002|Overall Study|Death|0|||
170787526|NCT04209465|617231821|FG003|Overall Study|Death|0|||
170787527|NCT04209465|617231822|FG004|Overall Study|Death|2|||
170787528|NCT04209465|617231823|FG005|Overall Study|Death|7|||
170787529|NCT04209465|617231824|FG006|Overall Study|Death|2|||
170787530|NCT04209465|617231825|FG007|Overall Study|Death|2|||
170787531|NCT04209465|617231826|FG008|Overall Study|Death|1|||
170787532|NCT04209465|617231827|FG009|Overall Study|Death|1|||
170787533|NCT04209465|617231828|FG010|Overall Study|Death|1|||
170787534|NCT04209465|617231829|FG011|Overall Study|Death|0|||
170787535|NCT04209465|617231830|FG012|Overall Study|Death|10|||
170787536|NCT04209465|617231818|FG000|Overall Study|Physician Decision|0|||
170787537|NCT04209465|617231819|FG001|Overall Study|Physician Decision|1|||
170787538|NCT04209465|617231820|FG002|Overall Study|Physician Decision|0|||
170787539|NCT04209465|617231821|FG003|Overall Study|Physician Decision|0|||
170787540|NCT04209465|617231822|FG004|Overall Study|Physician Decision|0|||
170787541|NCT04209465|617231823|FG005|Overall Study|Physician Decision|0|||
170787542|NCT04209465|617231824|FG006|Overall Study|Physician Decision|0|||
170787543|NCT04209465|617231825|FG007|Overall Study|Physician Decision|0|||
170787544|NCT04209465|617231826|FG008|Overall Study|Physician Decision|0|||
170787545|NCT04209465|617231827|FG009|Overall Study|Physician Decision|0|||
170888399|NCT03529773|617598294|FG026|Overall Study|Randomized but not vaccinated|0|||
170888400|NCT03529773|617598295|FG027|Overall Study|Randomized but not vaccinated|1|||
170542357|NCT02403271|616329706|FG000|Period 2|Withdrawal by Subject|0|||
170542358|NCT02403271|616329707|FG001|Period 2|Withdrawal by Subject|14|||
170542359|NCT02403271|616329706|FG000|Period 2|Death|0|||
170787546|NCT04209465|617231828|FG010|Overall Study|Physician Decision|0|||
170787547|NCT04209465|617231829|FG011|Overall Study|Physician Decision|0|||
170787548|NCT04209465|617231830|FG012|Overall Study|Physician Decision|0|||
170787549|NCT04209465|617231818|FG000|Overall Study|Progressive Disease|0|||
170787550|NCT04209465|617231819|FG001|Overall Study|Progressive Disease|0|||
170787551|NCT04209465|617231820|FG002|Overall Study|Progressive Disease|1|||
170787552|NCT04209465|617231821|FG003|Overall Study|Progressive Disease|2|||
170542360|NCT02403271|616329707|FG001|Period 2|Death|84|||
170542361|NCT02403271|616329706|FG000|Period 2|Lost to Follow-up|0|||
170542362|NCT02403271|616329707|FG001|Period 2|Lost to Follow-up|2|||
170542363|NCT02403271|616329706|FG000|Period 2|Study Terminated by Sponsor|0|||
170542364|NCT02403271|616329707|FG001|Period 2|Study Terminated by Sponsor|14|||
170542365|NCT02403271|616329706|FG000|Period 2|Other varied reasons|0|||
170542366|NCT02403271|616329707|FG001|Period 2|Other varied reasons|10|||
170542367|NCT05104476|616329708|FG000|Overall Study|Randomized But Not Treated|1|||
170542368|NCT05104476|616329709|FG001|Overall Study|Randomized But Not Treated|2|||
170542369|NCT05104476|616329708|FG000|Overall Study|Adverse Event|2|||
170542370|NCT05104476|616329709|FG001|Overall Study|Adverse Event|2|||
170542371|NCT05104476|616329708|FG000|Overall Study|Withdrawal by Subject|3|||
170542372|NCT05104476|616329709|FG001|Overall Study|Withdrawal by Subject|3|||
170542373|NCT05104476|616329708|FG000|Overall Study|Other Than Specified|0|||
170542374|NCT05104476|616329709|FG001|Overall Study|Other Than Specified|3|||
170542375|NCT04764474|616329715|FG000|Overall Study|Death|1|||
170542376|NCT04764474|616329716|FG001|Overall Study|Death|3|||
170542377|NCT04764474|616329717|FG002|Overall Study|Death|7|||
170542378|NCT04764474|616329718|FG003|Overall Study|Death|5|||
170542379|NCT04764474|616329719|FG004|Overall Study|Death|5|||
170888401|NCT03529773|617598296|FG028|Overall Study|Randomized but not vaccinated|0|||
170888402|NCT03529773|617598297|FG029|Overall Study|Randomized but not vaccinated|0|||
170888403|NCT03529773|617598298|FG030|Overall Study|Randomized but not vaccinated|0|||
170888404|NCT03529773|617598299|FG031|Overall Study|Randomized but not vaccinated|0|||
170888405|NCT03529773|617598300|FG032|Overall Study|Randomized but not vaccinated|0|||
170888406|NCT03529773|617598301|FG033|Overall Study|Randomized but not vaccinated|0|||
170888407|NCT03529773|617598302|FG034|Overall Study|Randomized but not vaccinated|0|||
170888408|NCT03529773|617598303|FG035|Overall Study|Randomized but not vaccinated|0|||
170888409|NCT03529773|617598304|FG036|Overall Study|Randomized but not vaccinated|0|||
170888410|NCT03529773|617598305|FG037|Overall Study|Randomized but not vaccinated|0|||
170888411|NCT03529773|617598306|FG038|Overall Study|Randomized but not vaccinated|0|||
170888412|NCT03529773|617598307|FG039|Overall Study|Randomized but not vaccinated|0|||
170888413|NCT01496066|617598309|FG000|Overall Study|Lost to Follow-up|8|||
170888414|NCT01496066|617598310|FG001|Overall Study|Lost to Follow-up|5|||
170888415|NCT01496066|617598309|FG000|Overall Study|Explant|3|||
170888416|NCT01496066|617598310|FG001|Overall Study|Explant|0|||
170888417|NCT01496066|617598309|FG000|Overall Study|Death|1|||
170888418|NCT01496066|617598310|FG001|Overall Study|Death|4|||
170888419|NCT02926209|617598311|FG000|Study Cohort|Poor Bowel Preparation|1|||
170888420|NCT02926209|617598312|FG001|Study Cohort|Poor Bowel Preparation|0|||
170888421|NCT00253630|617598313|FG000|Overall Study|ineligible|2|||
170888422|NCT01764633|617598314|FG000|Overall Study|Withdrawal by Subject|105|||
170888423|NCT01764633|617598315|FG001|Overall Study|Withdrawal by Subject|88|||
170888424|NCT01764633|617598314|FG000|Overall Study|Lost to Follow-up|13|||
170888425|NCT01764633|617598315|FG001|Overall Study|Lost to Follow-up|5|||
170888426|NCT02268058|617598316|FG000|Overall Study|Protocol Violation|1|||
170888427|NCT02268058|617598317|FG001|Overall Study|Protocol Violation|0|||
170888428|NCT02268058|617598318|FG002|Overall Study|Protocol Violation|0|||
170888429|NCT02268058|617598319|FG003|Overall Study|Protocol Violation|0|||
170888430|NCT01789970|617598324|FG000|Open-label Titration Period|Adverse Event|68|||
170888431|NCT01789970|617598325|FG001|Open-label Titration Period|Adverse Event|0|||
170888432|NCT01789970|617598326|FG002|Open-label Titration Period|Adverse Event|0|||
170888433|NCT01789970|617598324|FG000|Open-label Titration Period|Lack of Efficacy|31|||
170888434|NCT01789970|617598325|FG001|Open-label Titration Period|Lack of Efficacy|0|||
170888435|NCT01789970|617598326|FG002|Open-label Titration Period|Lack of Efficacy|0|||
170888436|NCT01789970|617598324|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
170888437|NCT01789970|617598325|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
170888438|NCT01789970|617598326|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
170888439|NCT01789970|617598324|FG000|Open-label Titration Period|Protocol Violation|18|||
170888440|NCT01789970|617598325|FG001|Open-label Titration Period|Protocol Violation|0|||
170888441|NCT01789970|617598326|FG002|Open-label Titration Period|Protocol Violation|0|||
170888442|NCT01789970|617598324|FG000|Open-label Titration Period|Lost to Follow-up|5|||
170888443|NCT01789970|617598325|FG001|Open-label Titration Period|Lost to Follow-up|0|||
170453630|NCT01642914|616000299|FG001|Overall Study|Lost to Follow-up|3|||
170453631|NCT01642914|616000300|FG002|Overall Study|Lost to Follow-up|7|||
170453632|NCT01642914|616000298|FG000|Overall Study|Other Reason|1|||
170453633|NCT01642914|616000299|FG001|Overall Study|Other Reason|0|||
170453634|NCT01642914|616000300|FG002|Overall Study|Other Reason|0|||
170453635|NCT02923674|616000301|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
170453636|NCT02923674|616000302|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
170453637|NCT02923674|616000303|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
170453638|NCT02923674|616000301|FG000|Overall Study|Lost to Follow-up|7|||
170453639|NCT02923674|616000302|FG001|Overall Study|Lost to Follow-up|12|||
170453640|NCT02923674|616000303|FG002|Overall Study|Lost to Follow-up|7|||
170453641|NCT02923674|616000301|FG000|Overall Study|Problem with intervention|2|||
170453642|NCT02923674|616000302|FG001|Overall Study|Problem with intervention|2|||
170453643|NCT02923674|616000303|FG002|Overall Study|Problem with intervention|1|||
170453644|NCT02923674|616000301|FG000|Overall Study|Adverse Event|3|||
170453645|NCT02923674|616000302|FG001|Overall Study|Adverse Event|1|||
170453646|NCT02923674|616000303|FG002|Overall Study|Adverse Event|1|||
170453647|NCT02923674|616000301|FG000|Overall Study|Withdrawal by Subject|2|||
170453648|NCT02923674|616000302|FG001|Overall Study|Withdrawal by Subject|2|||
170453649|NCT02923674|616000303|FG002|Overall Study|Withdrawal by Subject|2|||
170453650|NCT01249365|616000306|FG000|Overall Study|Lost to Follow-up|1|||
170453651|NCT02712333|616000307|FG000|First Period|Withdrawal by Subject|3|||
170453652|NCT02712333|616000308|FG001|First Period|Withdrawal by Subject|2|||
170453653|NCT00003875|616000309|FG000|Overall Study|Screen Failed|1|||
170453654|NCT06005597|616000310|FG000|Overall Study|Lost to Follow-up|1|||
170453655|NCT06005597|616000311|FG001|Overall Study|Lost to Follow-up|2|||
170453656|NCT06005597|616000312|FG002|Overall Study|Lost to Follow-up|1|||
170453657|NCT06005597|616000313|FG003|Overall Study|Lost to Follow-up|2|||
170453658|NCT06005597|616000310|FG000|Overall Study|Death|1|||
170453659|NCT06005597|616000311|FG001|Overall Study|Death|1|||
170453660|NCT06005597|616000312|FG002|Overall Study|Death|1|||
170453661|NCT06005597|616000313|FG003|Overall Study|Death|0|||
170453662|NCT03463993|616000314|FG000|Overall Study|Lost to Follow-up|7|||
170453663|NCT03463993|616000315|FG001|Overall Study|Lost to Follow-up|8|||
170453664|NCT03463993|616000314|FG000|Overall Study|Withdrawal by Subject|2|||
170453665|NCT03463993|616000315|FG001|Overall Study|Withdrawal by Subject|0|||
170453666|NCT03463993|616000314|FG000|Overall Study|Protocol Violation|4|||
170453667|NCT03463993|616000315|FG001|Overall Study|Protocol Violation|1|||
170453668|NCT03463993|616000314|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
170453669|NCT03463993|616000315|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
170453670|NCT03463993|616000314|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
170453671|NCT03463993|616000315|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
170453672|NCT02224573|616000317|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
170453673|NCT02224573|616000318|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
170453674|NCT02224573|616000317|FG000|Treatment Phase|Started on Other IMP|1|||
170453675|NCT02224573|616000318|FG001|Treatment Phase|Started on Other IMP|0|||
170453676|NCT02224573|616000317|FG000|Treatment Phase|Participant Discontinued IMP|0|||
170453677|NCT02224573|616000318|FG001|Treatment Phase|Participant Discontinued IMP|1|||
170453678|NCT02224573|616000317|FG000|Treatment Phase|Lack of Efficacy|15|||
170453679|NCT02224573|616000318|FG001|Treatment Phase|Lack of Efficacy|8|||
170453680|NCT02224573|616000317|FG000|Treatment Phase|Began Commercial Product|1|||
170453681|NCT02224573|616000318|FG001|Treatment Phase|Began Commercial Product|0|||
170453682|NCT02224573|616000317|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
170453683|NCT02224573|616000318|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
170453684|NCT02224573|616000317|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
170453685|NCT02224573|616000318|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
170453686|NCT02224573|616000317|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
170453687|NCT02224573|616000318|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
170453688|NCT02224573|616000317|FG000|Treatment Phase|Continued Compassionate Use|1|||
170453689|NCT02224573|616000318|FG001|Treatment Phase|Continued Compassionate Use|0|||
170453690|NCT02224573|616000317|FG000|Treatment Phase|Lack of Efficiency|2|||
170453691|NCT02224573|616000318|FG001|Treatment Phase|Lack of Efficiency|1|||
170453692|NCT02224573|616000317|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
170542380|NCT04764474|616329720|FG005|Overall Study|Death|3|||
170453693|NCT02224573|616000318|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
170453694|NCT02224573|616000317|FG000|Treatment Phase|Participant Moved|2|||
170453695|NCT02224573|616000318|FG001|Treatment Phase|Participant Moved|0|||
170453696|NCT02224573|616000317|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
170453697|NCT02224573|616000318|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
170453698|NCT02224573|616000317|FG000|Treatment Phase|Refused Medication|1|||
170453699|NCT02224573|616000318|FG001|Treatment Phase|Refused Medication|1|||
170453700|NCT02224573|616000317|FG000|Treatment Phase|Adverse Event|26|||
170542381|NCT04764474|616329721|FG006|Overall Study|Death|2|||
170635409|NCT00859456|616676896|FG000|Overall Study|Non-compliance|3|||
170635410|NCT02223858|616676897|FG000|Overall Study|Death|1|||
170635411|NCT02223858|616676898|FG001|Overall Study|Death|1|||
170635412|NCT02223858|616676897|FG000|Overall Study|Lost to Follow-up|6|||
170635413|NCT02223858|616676898|FG001|Overall Study|Lost to Follow-up|11|||
170635414|NCT02223858|616676897|FG000|Overall Study|Withdrawal by Subject|8|||
170635415|NCT02223858|616676898|FG001|Overall Study|Withdrawal by Subject|5|||
170635416|NCT02223858|616676897|FG000|Overall Study|Refused|9|||
170635417|NCT02223858|616676898|FG001|Overall Study|Refused|9|||
170635418|NCT00724698|616676899|FG000|Overall Study|Adverse Event|9|||
170635419|NCT00724698|616676899|FG000|Overall Study|Failure of Therapy|4|||
170635420|NCT00724698|616676899|FG000|Overall Study|Poor Compliance|16|||
170635421|NCT00724698|616676899|FG000|Overall Study|Lost to Follow-up|36|||
170635422|NCT00724698|616676899|FG000|Overall Study|No Info|25|||
170787553|NCT04209465|617231822|FG004|Overall Study|Progressive Disease|8|||
170787554|NCT04209465|617231823|FG005|Overall Study|Progressive Disease|5|||
170787555|NCT04209465|617231824|FG006|Overall Study|Progressive Disease|3|||
170787556|NCT04209465|617231825|FG007|Overall Study|Progressive Disease|4|||
170787557|NCT04209465|617231826|FG008|Overall Study|Progressive Disease|1|||
170787558|NCT04209465|617231827|FG009|Overall Study|Progressive Disease|3|||
170787559|NCT04209465|617231828|FG010|Overall Study|Progressive Disease|2|||
170787560|NCT04209465|617231829|FG011|Overall Study|Progressive Disease|1|||
170787561|NCT04209465|617231830|FG012|Overall Study|Progressive Disease|0|||
170787562|NCT04209465|617231818|FG000|Overall Study|Withdrawal by Subject|0|||
170787563|NCT04209465|617231819|FG001|Overall Study|Withdrawal by Subject|0|||
170787564|NCT04209465|617231820|FG002|Overall Study|Withdrawal by Subject|0|||
170787565|NCT04209465|617231821|FG003|Overall Study|Withdrawal by Subject|0|||
170787566|NCT04209465|617231822|FG004|Overall Study|Withdrawal by Subject|0|||
170787567|NCT04209465|617231823|FG005|Overall Study|Withdrawal by Subject|1|||
170787568|NCT04209465|617231824|FG006|Overall Study|Withdrawal by Subject|2|||
170787569|NCT04209465|617231825|FG007|Overall Study|Withdrawal by Subject|0|||
170787570|NCT04209465|617231826|FG008|Overall Study|Withdrawal by Subject|1|||
170787571|NCT04209465|617231827|FG009|Overall Study|Withdrawal by Subject|0|||
170787572|NCT04209465|617231828|FG010|Overall Study|Withdrawal by Subject|0|||
170787573|NCT04209465|617231829|FG011|Overall Study|Withdrawal by Subject|2|||
170787574|NCT04209465|617231830|FG012|Overall Study|Withdrawal by Subject|2|||
170787575|NCT04209465|617231818|FG000|Overall Study|Lost to Follow-up|0|||
170787576|NCT04209465|617231819|FG001|Overall Study|Lost to Follow-up|0|||
170787577|NCT04209465|617231820|FG002|Overall Study|Lost to Follow-up|0|||
170787578|NCT04209465|617231821|FG003|Overall Study|Lost to Follow-up|0|||
170787579|NCT04209465|617231822|FG004|Overall Study|Lost to Follow-up|0|||
170787580|NCT04209465|617231823|FG005|Overall Study|Lost to Follow-up|1|||
170787581|NCT04209465|617231824|FG006|Overall Study|Lost to Follow-up|0|||
170787582|NCT04209465|617231825|FG007|Overall Study|Lost to Follow-up|0|||
170787583|NCT04209465|617231826|FG008|Overall Study|Lost to Follow-up|1|||
170787584|NCT04209465|617231827|FG009|Overall Study|Lost to Follow-up|0|||
170787585|NCT04209465|617231828|FG010|Overall Study|Lost to Follow-up|0|||
170787586|NCT04209465|617231829|FG011|Overall Study|Lost to Follow-up|1|||
170787587|NCT04209465|617231830|FG012|Overall Study|Lost to Follow-up|0|||
170787588|NCT04209465|617231818|FG000|Overall Study|Started new therapy|0|||
170787589|NCT04209465|617231819|FG001|Overall Study|Started new therapy|0|||
170787590|NCT04209465|617231820|FG002|Overall Study|Started new therapy|0|||
170787591|NCT04209465|617231821|FG003|Overall Study|Started new therapy|0|||
170787592|NCT04209465|617231822|FG004|Overall Study|Started new therapy|0|||
170787593|NCT04209465|617231823|FG005|Overall Study|Started new therapy|1|||
170787594|NCT04209465|617231824|FG006|Overall Study|Started new therapy|0|||
170787595|NCT04209465|617231825|FG007|Overall Study|Started new therapy|0|||
170787596|NCT04209465|617231826|FG008|Overall Study|Started new therapy|0|||
170787597|NCT04209465|617231827|FG009|Overall Study|Started new therapy|0|||
170787598|NCT04209465|617231828|FG010|Overall Study|Started new therapy|0|||
170787599|NCT04209465|617231829|FG011|Overall Study|Started new therapy|0|||
170787600|NCT04209465|617231830|FG012|Overall Study|Started new therapy|0|||
170787601|NCT04209465|617231818|FG000|Overall Study|Study terminated early by sponsor|0|||
170787602|NCT04209465|617231819|FG001|Overall Study|Study terminated early by sponsor|0|||
170787603|NCT04209465|617231820|FG002|Overall Study|Study terminated early by sponsor|0|||
170787604|NCT04209465|617231821|FG003|Overall Study|Study terminated early by sponsor|0|||
170787605|NCT04209465|617231822|FG004|Overall Study|Study terminated early by sponsor|0|||
170787606|NCT04209465|617231823|FG005|Overall Study|Study terminated early by sponsor|0|||
170787607|NCT04209465|617231824|FG006|Overall Study|Study terminated early by sponsor|3|||
170787608|NCT04209465|617231825|FG007|Overall Study|Study terminated early by sponsor|0|||
170787609|NCT04209465|617231826|FG008|Overall Study|Study terminated early by sponsor|0|||
170787610|NCT04209465|617231827|FG009|Overall Study|Study terminated early by sponsor|0|||
170787611|NCT04209465|617231828|FG010|Overall Study|Study terminated early by sponsor|0|||
170453701|NCT02224573|616000318|FG001|Treatment Phase|Adverse Event|38|||
170453702|NCT02224573|616000317|FG000|Treatment Phase|Placed in Group Home|0|||
170453703|NCT02224573|616000318|FG001|Treatment Phase|Placed in Group Home|1|||
170453704|NCT02224573|616000317|FG000|Treatment Phase|Pursued Other Trials|1|||
170453705|NCT02224573|616000318|FG001|Treatment Phase|Pursued Other Trials|0|||
170453706|NCT02224573|616000317|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
170453707|NCT02224573|616000318|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
170453708|NCT02224573|616000317|FG000|Treatment Phase|Lost to Follow-up|2|||
170453709|NCT02224573|616000318|FG001|Treatment Phase|Lost to Follow-up|1|||
170453710|NCT02224573|616000317|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
170453711|NCT02224573|616000318|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
170453712|NCT02224573|616000317|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
170453713|NCT02224573|616000318|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
170453714|NCT02224573|616000317|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
170453715|NCT02224573|616000318|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
170453716|NCT02224573|616000317|FG000|Taper Phase|Adverse Event|1|||
170453717|NCT02224573|616000318|FG001|Taper Phase|Adverse Event|1|||
170453718|NCT02546362|616000319|FG000|4-week Treatment Period|Lost to Follow-up|1|||
170453719|NCT02546362|616000319|FG000|4-week Treatment Period|Change in medication|2|||
170453720|NCT02546362|616000319|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
170453721|NCT02546362|616000319|FG000|12-week Treatment Period|Lost to Follow-up|2|||
170453722|NCT02546362|616000319|FG000|12-week Treatment Period|Change in medication|1|||
170453723|NCT03835325|616000325|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
170453724|NCT03835325|616000325|FG000|Overall Study|Selection failure|1|||
170453725|NCT01231373|616000326|FG000|Overall Study|Withdrew consent prior to randomization|2|||
170453726|NCT01231373|616000327|FG001|Overall Study|Withdrew consent prior to randomization|1|||
170453727|NCT01231373|616000328|FG002|Overall Study|Withdrew consent prior to randomization|0|||
170453728|NCT01231373|616000329|FG003|Overall Study|Withdrew consent prior to randomization|0|||
170453729|NCT01231373|616000326|FG000|Overall Study|Lost to Follow-up|0|||
170453730|NCT01231373|616000327|FG001|Overall Study|Lost to Follow-up|0|||
170453731|NCT01231373|616000328|FG002|Overall Study|Lost to Follow-up|0|||
170453732|NCT01231373|616000329|FG003|Overall Study|Lost to Follow-up|1|||
170453733|NCT01231373|616000326|FG000|Overall Study|Withdrew Consent|1|||
170453734|NCT01231373|616000327|FG001|Overall Study|Withdrew Consent|0|||
170453735|NCT01231373|616000328|FG002|Overall Study|Withdrew Consent|0|||
170453736|NCT01231373|616000329|FG003|Overall Study|Withdrew Consent|0|||
170453737|NCT01546649|616000332|FG000|Overall Study|Adverse Event|4|||
170453738|NCT01546649|616000333|FG001|Overall Study|Adverse Event|5|||
170453739|NCT01546649|616000332|FG000|Overall Study|Protocol Violation|1|||
170453740|NCT01546649|616000333|FG001|Overall Study|Protocol Violation|0|||
170453741|NCT01546649|616000332|FG000|Overall Study|Lack of Efficacy|1|||
170453742|NCT01546649|616000333|FG001|Overall Study|Lack of Efficacy|0|||
170453743|NCT01546649|616000332|FG000|Overall Study|Recurrence|1|||
170453744|NCT01546649|616000333|FG001|Overall Study|Recurrence|1|||
170453745|NCT01546649|616000332|FG000|Overall Study|Discovery of secondary cancer|0|||
170453746|NCT01546649|616000333|FG001|Overall Study|Discovery of secondary cancer|1|||
170453747|NCT01546649|616000332|FG000|Overall Study|Withdrawal by Subject|1|||
170453748|NCT01546649|616000333|FG001|Overall Study|Withdrawal by Subject|2|||
170453749|NCT01370213|616000334|FG000|Overall Study|Early Death|1|||
170453750|NCT01370213|616000335|FG001|Overall Study|Early Death|0|||
170453751|NCT01370213|616000336|FG002|Overall Study|Early Death|0|||
170453752|NCT01370213|616000334|FG000|Overall Study|Not evaluable|0|||
170453753|NCT01370213|616000335|FG001|Overall Study|Not evaluable|2|||
170453754|NCT01370213|616000336|FG002|Overall Study|Not evaluable|0|||
170453755|NCT00102687|616000340|FG000|Initial Period|Withdrawal by Subject|6|||
170453756|NCT00102687|616000341|FG001|Initial Period|Withdrawal by Subject|3|||
170453757|NCT00102687|616000342|FG002|Initial Period|Withdrawal by Subject|5|||
170453758|NCT00102687|616000343|FG003|Initial Period|Withdrawal by Subject|0|||
170453759|NCT00102687|616000344|FG004|Initial Period|Withdrawal by Subject|0|||
170453760|NCT00102687|616000340|FG000|Initial Period|Adverse Event|4|||
170542382|NCT04764474|616329722|FG007|Overall Study|Death|4|||
170542383|NCT04764474|616329715|FG000|Overall Study|Sponsor terminated study|0|||
170542384|NCT04764474|616329716|FG001|Overall Study|Sponsor terminated study|0|||
170542385|NCT04764474|616329717|FG002|Overall Study|Sponsor terminated study|4|||
170542386|NCT04764474|616329718|FG003|Overall Study|Sponsor terminated study|1|||
170542387|NCT04764474|616329719|FG004|Overall Study|Sponsor terminated study|1|||
170542388|NCT04764474|616329720|FG005|Overall Study|Sponsor terminated study|0|||
170453761|NCT00102687|616000341|FG001|Initial Period|Adverse Event|7|||
170453762|NCT00102687|616000342|FG002|Initial Period|Adverse Event|9|||
170453763|NCT00102687|616000343|FG003|Initial Period|Adverse Event|0|||
170453764|NCT00102687|616000344|FG004|Initial Period|Adverse Event|0|||
170453765|NCT00102687|616000340|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
170542389|NCT04764474|616329721|FG006|Overall Study|Sponsor terminated study|1|||
170453766|NCT00102687|616000341|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
170453767|NCT00102687|616000342|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
170453768|NCT00102687|616000343|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
170453769|NCT00102687|616000344|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
170453770|NCT00102687|616000340|FG000|Initial Period|Protocol Violation|0|||
170453771|NCT00102687|616000341|FG001|Initial Period|Protocol Violation|0|||
170453772|NCT00102687|616000342|FG002|Initial Period|Protocol Violation|2|||
170453773|NCT00102687|616000343|FG003|Initial Period|Protocol Violation|0|||
170453774|NCT00102687|616000344|FG004|Initial Period|Protocol Violation|0|||
170453775|NCT00102687|616000340|FG000|Initial Period|Physician Decision|2|||
170453776|NCT00102687|616000341|FG001|Initial Period|Physician Decision|9|||
170453777|NCT00102687|616000342|FG002|Initial Period|Physician Decision|6|||
170453778|NCT00102687|616000343|FG003|Initial Period|Physician Decision|0|||
170453779|NCT00102687|616000344|FG004|Initial Period|Physician Decision|0|||
170453780|NCT00102687|616000340|FG000|Initial Period|Sponsor's decision|0|||
170453781|NCT00102687|616000341|FG001|Initial Period|Sponsor's decision|1|||
170453782|NCT00102687|616000342|FG002|Initial Period|Sponsor's decision|1|||
170453783|NCT00102687|616000343|FG003|Initial Period|Sponsor's decision|0|||
170453784|NCT00102687|616000344|FG004|Initial Period|Sponsor's decision|0|||
170453785|NCT00102687|616000340|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
170453786|NCT00102687|616000341|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
170453787|NCT00102687|616000342|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
170453788|NCT00102687|616000343|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
170453789|NCT00102687|616000344|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
170453790|NCT00102687|616000340|FG000|Initial Period|Death|1|||
170453791|NCT00102687|616000341|FG001|Initial Period|Death|1|||
170453792|NCT00102687|616000342|FG002|Initial Period|Death|1|||
170453793|NCT00102687|616000343|FG003|Initial Period|Death|0|||
170453794|NCT00102687|616000344|FG004|Initial Period|Death|0|||
170453795|NCT00102687|616000340|FG000|Maintenance Period|Withdrawal by Subject|4|||
170453796|NCT00102687|616000341|FG001|Maintenance Period|Withdrawal by Subject|0|||
170453797|NCT00102687|616000342|FG002|Maintenance Period|Withdrawal by Subject|2|||
170453798|NCT00102687|616000343|FG003|Maintenance Period|Withdrawal by Subject|3|||
170453799|NCT00102687|616000344|FG004|Maintenance Period|Withdrawal by Subject|1|||
170453800|NCT00102687|616000340|FG000|Maintenance Period|Adverse Event|1|||
170453801|NCT00102687|616000341|FG001|Maintenance Period|Adverse Event|0|||
170453802|NCT00102687|616000342|FG002|Maintenance Period|Adverse Event|0|||
170453803|NCT00102687|616000343|FG003|Maintenance Period|Adverse Event|1|||
170453804|NCT00102687|616000344|FG004|Maintenance Period|Adverse Event|3|||
170453805|NCT00102687|616000340|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
170453806|NCT00102687|616000341|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
170453807|NCT00102687|616000342|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
170542390|NCT04764474|616329722|FG007|Overall Study|Sponsor terminated study|3|||
170542391|NCT04764474|616329715|FG000|Overall Study|Withdrawal of consent|2|||
170542392|NCT04764474|616329716|FG001|Overall Study|Withdrawal of consent|0|||
170453808|NCT00102687|616000343|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
170453809|NCT00102687|616000344|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
170453810|NCT00102687|616000340|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
170453811|NCT00102687|616000341|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
170453812|NCT00102687|616000342|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
170453813|NCT00102687|616000343|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
170453814|NCT00102687|616000344|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
170453815|NCT00102687|616000340|FG000|Maintenance Period|Death|0|||
170542393|NCT04764474|616329717|FG002|Overall Study|Withdrawal of consent|0|||
170542394|NCT04764474|616329718|FG003|Overall Study|Withdrawal of consent|0|||
170542395|NCT04764474|616329719|FG004|Overall Study|Withdrawal of consent|0|||
170542396|NCT04764474|616329720|FG005|Overall Study|Withdrawal of consent|1|||
170542397|NCT04764474|616329721|FG006|Overall Study|Withdrawal of consent|1|||
170542398|NCT04764474|616329722|FG007|Overall Study|Withdrawal of consent|1|||
170542399|NCT04764474|616329715|FG000|Overall Study|Other|0|||
170542400|NCT04764474|616329716|FG001|Overall Study|Other|0|||
170542401|NCT04764474|616329717|FG002|Overall Study|Other|0|||
170542402|NCT04764474|616329718|FG003|Overall Study|Other|1|||
170542403|NCT04764474|616329719|FG004|Overall Study|Other|0|||
170542404|NCT04764474|616329720|FG005|Overall Study|Other|0|||
170542405|NCT04764474|616329721|FG006|Overall Study|Other|0|||
170542406|NCT04764474|616329722|FG007|Overall Study|Other|0|||
170542407|NCT05218499|616329723|FG000|Overall Study|Not treated|1|||
170542408|NCT05218499|616329724|FG001|Overall Study|Not treated|1|||
170542409|NCT05218499|616329725|FG002|Overall Study|Not treated|8|||
170542410|NCT05218499|616329723|FG000|Overall Study|Death|2|||
170542411|NCT05218499|616329724|FG001|Overall Study|Death|0|||
170542412|NCT05218499|616329725|FG002|Overall Study|Death|0|||
170542413|NCT05218499|616329723|FG000|Overall Study|Other than listed|3|||
170542414|NCT05218499|616329724|FG001|Overall Study|Other than listed|7|||
170542415|NCT05218499|616329725|FG002|Overall Study|Other than listed|10|||
170542416|NCT05218499|616329723|FG000|Overall Study|Protocol deviation|5|||
170542417|NCT05218499|616329724|FG001|Overall Study|Protocol deviation|6|||
170542418|NCT05218499|616329725|FG002|Overall Study|Protocol deviation|4|||
170542419|NCT05218499|616329723|FG000|Overall Study|Technical problems|0|||
170542420|NCT05218499|616329724|FG001|Overall Study|Technical problems|1|||
170542421|NCT05218499|616329725|FG002|Overall Study|Technical problems|0|||
170542422|NCT05218499|616329723|FG000|Overall Study|Burden of trial procedures|0|||
170542423|NCT05218499|616329724|FG001|Overall Study|Burden of trial procedures|1|||
170453816|NCT00102687|616000341|FG001|Maintenance Period|Death|0|||
170453817|NCT00102687|616000342|FG002|Maintenance Period|Death|0|||
170453818|NCT00102687|616000343|FG003|Maintenance Period|Death|1|||
170453819|NCT00102687|616000344|FG004|Maintenance Period|Death|1|||
170453820|NCT00102687|616000340|FG000|Maintenance Period|Physician Decision|1|||
170453821|NCT00102687|616000341|FG001|Maintenance Period|Physician Decision|2|||
170453822|NCT00102687|616000342|FG002|Maintenance Period|Physician Decision|3|||
170453823|NCT00102687|616000343|FG003|Maintenance Period|Physician Decision|0|||
170453824|NCT00102687|616000344|FG004|Maintenance Period|Physician Decision|4|||
170453825|NCT01134627|616000348|FG000|Overall Study|Adverse Event|47|||
170453826|NCT01134627|616000349|FG001|Overall Study|Adverse Event|31|||
170453827|NCT01134627|616000348|FG000|Overall Study|Lost to Follow-up|1|||
170453828|NCT01134627|616000349|FG001|Overall Study|Lost to Follow-up|2|||
170453829|NCT01134627|616000348|FG000|Overall Study|Protocol Violation|3|||
170453830|NCT01134627|616000349|FG001|Overall Study|Protocol Violation|5|||
170453831|NCT01134627|616000348|FG000|Overall Study|Lack of Efficacy|2|||
170453832|NCT01134627|616000349|FG001|Overall Study|Lack of Efficacy|12|||
170453833|NCT01134627|616000348|FG000|Overall Study|Withdrawal by Subject|4|||
170453834|NCT01134627|616000349|FG001|Overall Study|Withdrawal by Subject|3|||
170453835|NCT01134627|616000348|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
170453836|NCT01134627|616000349|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
170453837|NCT01134627|616000348|FG000|Overall Study|Other|11|||
170453838|NCT01134627|616000349|FG001|Overall Study|Other|14|||
170453839|NCT00977431|616000350|FG000|Overall Study|Other than listed|1|||
170453840|NCT00977431|616000351|FG001|Overall Study|Other than listed|0|||
170453841|NCT00977431|616000352|FG002|Overall Study|Other than listed|0|||
170453842|NCT00977431|616000353|FG003|Overall Study|Other than listed|0|||
170453843|NCT00977431|616000354|FG004|Overall Study|Other than listed|2|||
170453844|NCT00977431|616000350|FG000|Overall Study|Protocol Violation|0|||
170453845|NCT00977431|616000351|FG001|Overall Study|Protocol Violation|0|||
170453846|NCT00977431|616000352|FG002|Overall Study|Protocol Violation|1|||
170453847|NCT00977431|616000353|FG003|Overall Study|Protocol Violation|0|||
170453848|NCT00977431|616000354|FG004|Overall Study|Protocol Violation|0|||
170453849|NCT00977431|616000350|FG000|Overall Study|Adverse Event|3|||
170453850|NCT00977431|616000351|FG001|Overall Study|Adverse Event|0|||
170453851|NCT00977431|616000352|FG002|Overall Study|Adverse Event|4|||
170453852|NCT00977431|616000353|FG003|Overall Study|Adverse Event|0|||
170453853|NCT00977431|616000354|FG004|Overall Study|Adverse Event|6|||
170453854|NCT00977431|616000350|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
170453855|NCT00977431|616000351|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
170453856|NCT00977431|616000352|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
170453857|NCT00977431|616000353|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
170453858|NCT00977431|616000354|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
170453859|NCT00977431|616000350|FG000|Overall Study|Progressive disease|2|||
170453860|NCT00977431|616000351|FG001|Overall Study|Progressive disease|6|||
170453861|NCT00977431|616000352|FG002|Overall Study|Progressive disease|1|||
170453862|NCT00977431|616000353|FG003|Overall Study|Progressive disease|3|||
170453863|NCT00977431|616000354|FG004|Overall Study|Progressive disease|5|||
170453864|NCT01010750|616000355|FG000|Second Intervention|Adverse Event|0|||
170453865|NCT01010750|616000356|FG001|Second Intervention|Adverse Event|1|||
170453866|NCT01010750|616000357|FG002|Second Intervention|Adverse Event|0|||
170453867|NCT01010750|616000358|FG003|Second Intervention|Adverse Event|0|||
170453868|NCT01010750|616000359|FG004|Second Intervention|Adverse Event|0|||
170453869|NCT01010750|616000360|FG005|Second Intervention|Adverse Event|0|||
170453870|NCT00466726|616000361|FG000|Overall Study|Not evaluable for response|14|||
170453871|NCT00597116|616000362|FG000|Overall Study|Adverse Event|2|||
170453872|NCT00597116|616000363|FG001|Overall Study|Adverse Event|1|||
170453873|NCT00597116|616000362|FG000|Overall Study|Withdrawal by Subject|0|||
170453874|NCT00597116|616000363|FG001|Overall Study|Withdrawal by Subject|2|||
170453875|NCT00597116|616000362|FG000|Overall Study|Physician Decision|0|||
170453876|NCT00597116|616000363|FG001|Overall Study|Physician Decision|1|||
170453877|NCT00597116|616000362|FG000|Overall Study|Death|0|||
170453878|NCT00597116|616000363|FG001|Overall Study|Death|1|||
170888444|NCT01789970|617598326|FG002|Open-label Titration Period|Lost to Follow-up|0|||
170888445|NCT01789970|617598324|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
170888446|NCT01789970|617598325|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
170888447|NCT01789970|617598326|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
170453879|NCT00597116|616000362|FG000|Overall Study|Lost to Follow-up|1|||
170453880|NCT00597116|616000363|FG001|Overall Study|Lost to Follow-up|0|||
170453881|NCT00597116|616000362|FG000|Overall Study|Progressive disease|11|||
170453882|NCT00597116|616000363|FG001|Overall Study|Progressive disease|6|||
170453883|NCT02096588|616000364|FG000|Overall Study|Lack of Efficacy|2|||
170888448|NCT01789970|617598324|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
170453884|NCT02096588|616000365|FG001|Overall Study|Lack of Efficacy|0|||
170453885|NCT02096588|616000364|FG000|Overall Study|Withdrawal by Subject|0|||
170453886|NCT02096588|616000365|FG001|Overall Study|Withdrawal by Subject|1|||
170453887|NCT01258101|616000366|FG000|Overall Study|Adverse Event|5|||
170453888|NCT01258101|616000367|FG001|Overall Study|Adverse Event|6|||
170453889|NCT01258101|616000368|FG002|Overall Study|Adverse Event|0|||
170453890|NCT01258101|616000369|FG003|Overall Study|Adverse Event|0|||
170453891|NCT01258101|616000366|FG000|Overall Study|Extra exclusion criterion amended|2|||
170453892|NCT01258101|616000367|FG001|Overall Study|Extra exclusion criterion amended|1|||
170453893|NCT01258101|616000368|FG002|Overall Study|Extra exclusion criterion amended|1|||
170453894|NCT01258101|616000369|FG003|Overall Study|Extra exclusion criterion amended|1|||
170453895|NCT01258101|616000366|FG000|Overall Study|Informed consent has been withdrawn|2|||
170453896|NCT01258101|616000367|FG001|Overall Study|Informed consent has been withdrawn|2|||
170453897|NCT01258101|616000368|FG002|Overall Study|Informed consent has been withdrawn|1|||
170453898|NCT01258101|616000369|FG003|Overall Study|Informed consent has been withdrawn|1|||
170453899|NCT01258101|616000366|FG000|Overall Study|Patient is not able to attend visits|8|||
170453900|NCT01258101|616000367|FG001|Overall Study|Patient is not able to attend visits|9|||
170453901|NCT01258101|616000368|FG002|Overall Study|Patient is not able to attend visits|7|||
170453902|NCT01258101|616000369|FG003|Overall Study|Patient is not able to attend visits|6|||
170453903|NCT01258101|616000366|FG000|Overall Study|Patient´s compliance|4|||
170453904|NCT01258101|616000367|FG001|Overall Study|Patient´s compliance|3|||
170453905|NCT01258101|616000368|FG002|Overall Study|Patient´s compliance|1|||
170453906|NCT01258101|616000369|FG003|Overall Study|Patient´s compliance|2|||
170453907|NCT01258101|616000366|FG000|Overall Study|Lost to Follow-up|5|||
170453908|NCT01258101|616000367|FG001|Overall Study|Lost to Follow-up|5|||
170453909|NCT01258101|616000368|FG002|Overall Study|Lost to Follow-up|0|||
170453910|NCT01258101|616000369|FG003|Overall Study|Lost to Follow-up|6|||
170453911|NCT01258101|616000366|FG000|Overall Study|PCR positive at week 24|0|||
170453912|NCT01258101|616000367|FG001|Overall Study|PCR positive at week 24|0|||
170453913|NCT01258101|616000368|FG002|Overall Study|PCR positive at week 24|0|||
170453914|NCT01258101|616000369|FG003|Overall Study|PCR positive at week 24|1|||
170453915|NCT01258101|616000366|FG000|Overall Study|Other reason|7|||
170453916|NCT01258101|616000367|FG001|Overall Study|Other reason|8|||
170453917|NCT01258101|616000368|FG002|Overall Study|Other reason|1|||
170453918|NCT01258101|616000369|FG003|Overall Study|Other reason|8|||
170453919|NCT01470612|616000373|FG000|Overall Study|Adverse Event|20|||
170453920|NCT01470612|616000374|FG001|Overall Study|Adverse Event|80|||
170453921|NCT01470612|616000373|FG000|Overall Study|Death|0|||
170453922|NCT01470612|616000374|FG001|Overall Study|Death|1|||
170453923|NCT01470612|616000373|FG000|Overall Study|Lack of Efficacy|20|||
170453924|NCT01470612|616000374|FG001|Overall Study|Lack of Efficacy|326|||
170453925|NCT01470612|616000373|FG000|Overall Study|Lost to Follow-up|2|||
170453926|NCT01470612|616000374|FG001|Overall Study|Lost to Follow-up|5|||
170453927|NCT01470612|616000373|FG000|Overall Study|Did not meet entrance criteria|0|||
170453928|NCT01470612|616000374|FG001|Overall Study|Did not meet entrance criteria|1|||
170453929|NCT01470612|616000373|FG000|Overall Study|Pregnancy|2|||
170453930|NCT01470612|616000374|FG001|Overall Study|Pregnancy|10|||
170453931|NCT01470612|616000373|FG000|Overall Study|Protocol Violation|2|||
170453932|NCT01470612|616000374|FG001|Overall Study|Protocol Violation|7|||
170453933|NCT01470612|616000373|FG000|Overall Study|Withdrawal by Subject|24|||
170453934|NCT01470612|616000374|FG001|Overall Study|Withdrawal by Subject|79|||
170453935|NCT01470612|616000373|FG000|Overall Study|Other|14|||
170453936|NCT01470612|616000374|FG001|Overall Study|Other|156|||
170453937|NCT03438227|616000375|FG000|Overall Study|Withdrawal by Subject|10|||
170453938|NCT03438227|616000376|FG001|Overall Study|Withdrawal by Subject|5|||
170453939|NCT00293202|616000379|FG000|Overall Study|Withdrawal by Subject|1|||
170453940|NCT00293202|616000380|FG001|Overall Study|Withdrawal by Subject|2|||
170453941|NCT00293202|616000379|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
170453942|NCT00293202|616000380|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
170453943|NCT00293202|616000379|FG000|Overall Study|on-hold due to fistula maturation time|1|||
170453944|NCT00293202|616000380|FG001|Overall Study|on-hold due to fistula maturation time|0|||
170453945|NCT01564459|616000384|FG000|Run-In|Adverse Event|7|||
170453946|NCT01564459|616000385|FG001|Run-In|Adverse Event|0|||
170453947|NCT01564459|616000386|FG002|Run-In|Adverse Event|0|||
170453948|NCT01564459|616000384|FG000|Run-In|Lost to Follow-up|1|||
170453949|NCT01564459|616000385|FG001|Run-In|Lost to Follow-up|0|||
170453950|NCT01564459|616000386|FG002|Run-In|Lost to Follow-up|0|||
170453951|NCT01564459|616000384|FG000|Run-In|Non-compliance with study drug|2|||
170453952|NCT01564459|616000385|FG001|Run-In|Non-compliance with study drug|0|||
170453953|NCT01564459|616000386|FG002|Run-In|Non-compliance with study drug|0|||
170453954|NCT01564459|616000384|FG000|Run-In|Protocol Violation|1|||
170453955|NCT01564459|616000385|FG001|Run-In|Protocol Violation|0|||
170453956|NCT01564459|616000386|FG002|Run-In|Protocol Violation|0|||
170453957|NCT01564459|616000384|FG000|Run-In|Withdrawal by Subject|1|||
170453958|NCT01564459|616000385|FG001|Run-In|Withdrawal by Subject|0|||
170453959|NCT01564459|616000386|FG002|Run-In|Withdrawal by Subject|0|||
170453960|NCT01564459|616000384|FG000|Double-blind Treatment|Adverse Event|0|||
170453961|NCT01564459|616000385|FG001|Double-blind Treatment|Adverse Event|0|||
170453962|NCT01564459|616000386|FG002|Double-blind Treatment|Adverse Event|1|||
170453963|NCT00653991|616000391|FG000|3 Month Follow-up|Participant would not respond|150|||
170453964|NCT00653991|616000392|FG001|3 Month Follow-up|Participant would not respond|157|||
170453965|NCT00653991|616000391|FG000|6 Month Follow-up|Participant would not respond|133|||
170635423|NCT00043979|616676900|FG000|Period 1|recipient with progressive disease|7|||
170635424|NCT00043979|616676901|FG001|Period 1|recipient with progressive disease|4|||
170635425|NCT00043979|616676902|FG002|Period 1|recipient with progressive disease|3|||
170635426|NCT00414596|616676903|FG000|Overall Study|Protocol Violation|2|||
170635427|NCT04639258|616676904|FG000|Overall Study|Screen failure|5|||
170635428|NCT04639258|616676904|FG000|Overall Study|Physician Decision|2|||
170635429|NCT04639258|616676904|FG000|Overall Study|Early study termination|3|||
170635430|NCT04639258|616676904|FG000|Overall Study|Withdrawal by Subject|1|||
170635431|NCT02919995|616676908|FG000|Overall Study|Adverse Event|0|||
170888449|NCT01789970|617598325|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
170635432|NCT02919995|616676909|FG001|Overall Study|Adverse Event|0|||
170635433|NCT02919995|616676910|FG002|Overall Study|Adverse Event|0|||
170635434|NCT02919995|616676911|FG003|Overall Study|Adverse Event|0|||
170635435|NCT02919995|616676912|FG004|Overall Study|Adverse Event|0|||
170635436|NCT02919995|616676913|FG005|Overall Study|Adverse Event|1|||
170635437|NCT00297258|616676924|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
170635438|NCT00297258|616676924|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
170635439|NCT00297258|616676924|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
170635440|NCT00297258|616676924|FG000|Overall Study|Intercurrent Illness|3|||
170635441|NCT00297258|616676924|FG000|Overall Study|Intercurrent Death|2|||
170635442|NCT00297258|616676924|FG000|Overall Study|Deteriorization of General Condition|1|||
170635443|NCT00297258|616676924|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
170635444|NCT00297258|616676924|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
170635445|NCT00297258|616676924|FG000|Overall Study|Switch to Commercial Treatment|1|||
170635446|NCT00297258|616676924|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
170888450|NCT01789970|617598326|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
170888451|NCT01789970|617598324|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
170888452|NCT01789970|617598325|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
170888453|NCT01789970|617598326|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
170888454|NCT01789970|617598324|FG000|Open-label Titration Period|Pregnancy|2|||
170888455|NCT01789970|617598325|FG001|Open-label Titration Period|Pregnancy|0|||
170888456|NCT01789970|617598326|FG002|Open-label Titration Period|Pregnancy|0|||
170888457|NCT01789970|617598324|FG000|Open-label Titration Period|Other|76|||
170888458|NCT01789970|617598325|FG001|Open-label Titration Period|Other|0|||
170888459|NCT01789970|617598326|FG002|Open-label Titration Period|Other|0|||
170888460|NCT01789970|617598324|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
170888461|NCT01789970|617598325|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
170888462|NCT01789970|617598326|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
170888463|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
170888464|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
170888465|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
170888466|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
170888467|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
170888468|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
170888469|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170888470|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
170888471|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
170888472|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
170888473|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
170888474|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
170888475|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
170888476|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
170888477|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
170888478|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
170888479|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
170888480|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
170888481|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170888482|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
170888483|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
170888484|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
170888485|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
170635447|NCT02454517|616676925|FG000|Overall Study|Withdrawal by Subject|3|||
170635448|NCT02454517|616676926|FG001|Overall Study|Withdrawal by Subject|0|||
170635449|NCT02454517|616676925|FG000|Overall Study|Lost to Follow-up|4|||
170635450|NCT02454517|616676926|FG001|Overall Study|Lost to Follow-up|7|||
170635451|NCT02454517|616676925|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
170635452|NCT02454517|616676926|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
170453966|NCT00653991|616000392|FG001|6 Month Follow-up|Participant would not respond|141|||
170453967|NCT03166124|616000393|FG000|Treatment Period 1|Adverse Event|0|||
170453968|NCT03166124|616000394|FG001|Treatment Period 1|Adverse Event|0|||
170453969|NCT03166124|616000395|FG002|Treatment Period 1|Adverse Event|1|||
170453970|NCT03166124|616000396|FG003|Treatment Period 1|Adverse Event|0|||
170453971|NCT03166124|616000393|FG000|Wash-out Period|Withdrawal by Subject|0|||
170453972|NCT03166124|616000394|FG001|Wash-out Period|Withdrawal by Subject|1|||
170453973|NCT03166124|616000395|FG002|Wash-out Period|Withdrawal by Subject|0|||
170453974|NCT03166124|616000396|FG003|Wash-out Period|Withdrawal by Subject|1|||
170453975|NCT03166124|616000393|FG000|Wash-out Period|Adverse Event|0|||
170453976|NCT03166124|616000394|FG001|Wash-out Period|Adverse Event|1|||
170453977|NCT03166124|616000395|FG002|Wash-out Period|Adverse Event|1|||
170453978|NCT03166124|616000396|FG003|Wash-out Period|Adverse Event|0|||
170453979|NCT00766831|616000397|FG000|Overall Study|Withdrawal by Subject|4|||
170453980|NCT00766831|616000397|FG000|Overall Study|Lost to Follow-up|3|||
170453981|NCT00766831|616000397|FG000|Overall Study|Adverse Event|20|||
170453982|NCT00766831|616000397|FG000|Overall Study|Protocol Violation|15|||
170453983|NCT00766831|616000397|FG000|Overall Study|Physician Decision|5|||
170453984|NCT00766831|616000397|FG000|Overall Study|Withdrawal of consent|26|||
170453985|NCT00766831|616000397|FG000|Overall Study|Non cooperation by participants|14|||
170453986|NCT00766831|616000397|FG000|Overall Study|Other|28|||
170453987|NCT02340221|616000398|FG000|Overall Study|Death|100|||
170453988|NCT02340221|616000399|FG001|Overall Study|Death|197|||
170453989|NCT02340221|616000398|FG000|Overall Study|Withdrawal by Participant|24|||
170453990|NCT02340221|616000399|FG001|Overall Study|Withdrawal by Participant|37|||
170453991|NCT02340221|616000398|FG000|Overall Study|Lost to Follow-up|4|||
170453992|NCT02340221|616000399|FG001|Overall Study|Lost to Follow-up|15|||
170453993|NCT02340221|616000398|FG000|Overall Study|Reason Not Specified|85|||
170453994|NCT02340221|616000399|FG001|Overall Study|Reason Not Specified|165|||
170453995|NCT02340221|616000398|FG000|Overall Study|Study Terminated by Sponsor|1|||
170453996|NCT02340221|616000399|FG001|Overall Study|Study Terminated by Sponsor|3|||
170453997|NCT00103402|616000400|FG000|Overall Study|Adverse Event|3|||
170453998|NCT00103402|616000401|FG001|Overall Study|Adverse Event|4|||
170453999|NCT00103402|616000400|FG000|Overall Study|Lost to Follow-up|8|||
170454000|NCT00103402|616000401|FG001|Overall Study|Lost to Follow-up|7|||
170454001|NCT00103402|616000400|FG000|Overall Study|Dissatisfied/No longer interested|6|||
170454002|NCT00103402|616000401|FG001|Overall Study|Dissatisfied/No longer interested|6|||
170454003|NCT00103402|616000400|FG000|Overall Study|Personal constraints/Other|5|||
170454004|NCT00103402|616000401|FG001|Overall Study|Personal constraints/Other|0|||
170454005|NCT00952276|616000404|FG000|Overall Study|Withdrawal by Subject|1|||
170454006|NCT00952276|616000405|FG001|Overall Study|Withdrawal by Subject|0|||
170888486|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
170888487|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
170888488|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
170888489|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
170888490|NCT01789970|617598324|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
170888491|NCT01789970|617598325|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
170888492|NCT01789970|617598326|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
170888493|NCT00411554|617598327|FG000|Overall Study|Adverse Event|2|||
170888494|NCT00411554|617598328|FG001|Overall Study|Adverse Event|4|||
170888495|NCT00411554|617598327|FG000|Overall Study|Lack of Efficacy|2|||
170888496|NCT00411554|617598328|FG001|Overall Study|Lack of Efficacy|5|||
170635453|NCT03565497|616676927|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
170635454|NCT03565497|616676928|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
170635455|NCT03565497|616676929|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
170635456|NCT03565497|616676927|FG000|Overall Study|Lost to Follow-up|1|||
170635457|NCT03565497|616676928|FG001|Overall Study|Lost to Follow-up|1|||
170635458|NCT03565497|616676929|FG002|Overall Study|Lost to Follow-up|2|||
170635459|NCT03565497|616676927|FG000|Overall Study|Withdrawal by Subject|1|||
170635460|NCT03565497|616676928|FG001|Overall Study|Withdrawal by Subject|1|||
170635461|NCT03565497|616676929|FG002|Overall Study|Withdrawal by Subject|1|||
170635462|NCT01470326|616676930|FG000|Overall Study|Protocol Violation|32|||
170787612|NCT04209465|617231829|FG011|Overall Study|Study terminated early by sponsor|0|||
170454007|NCT00952276|616000406|FG002|Overall Study|Withdrawal by Subject|0|||
170454008|NCT00952276|616000407|FG003|Overall Study|Withdrawal by Subject|1|||
170787613|NCT04209465|617231830|FG012|Overall Study|Study terminated early by sponsor|3|||
170787614|NCT04209465|617231818|FG000|Overall Study|Other|0|||
170787615|NCT04209465|617231819|FG001|Overall Study|Other|0|||
170635463|NCT01470326|616676930|FG000|Overall Study|No Drug Administration Information|2|||
170635464|NCT01470326|616676930|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
170635465|NCT01166282|616676931|FG000|Open-label Period|Adverse Event|0|||
170787616|NCT04209465|617231820|FG002|Overall Study|Other|0|||
170454009|NCT00952276|616000408|FG004|Overall Study|Withdrawal by Subject|0|||
170454010|NCT02427984|616000412|FG000|Overall Study|Lost to Follow-up|13|||
170454011|NCT02427984|616000413|FG001|Overall Study|Lost to Follow-up|5|||
170454012|NCT02427984|616000414|FG002|Overall Study|Lost to Follow-up|18|||
170454013|NCT04062448|616001630|FG000|Overall Study|Lost to Follow-up|1|||
170454014|NCT04062448|616001630|FG000|Overall Study|Withdrawal by Subject|2|||
170454015|NCT04385277|616001631|FG000|Overall Study|Physician Decision|2|||
170454016|NCT04385277|616001631|FG000|Overall Study|Ineligible|1|||
170454017|NCT04385277|616001631|FG000|Overall Study|Patient/Parent Refusal|2|||
170454018|NCT04905290|616001632|FG000|Overall Study|Adverse Event|4|||
170454019|NCT04905290|616001632|FG000|Overall Study|Death|2|||
170454020|NCT04905290|616001632|FG000|Overall Study|Withdrawal by Subject|4|||
170454021|NCT04905290|616001632|FG000|Overall Study|Physician Decision|2|||
170454022|NCT04905290|616001632|FG000|Overall Study|Lost to Follow-up|2|||
170454023|NCT04905290|616001632|FG000|Overall Study|Screen Failure|2|||
170454024|NCT04905290|616001632|FG000|Overall Study|Unsuccessful Procedure|2|||
170454025|NCT03303625|616001633|FG000|Overall Study|Withdrawal by Subject|2|||
170454026|NCT03303625|616001634|FG001|Overall Study|Withdrawal by Subject|0|||
170454027|NCT03303625|616001635|FG002|Overall Study|Withdrawal by Subject|0|||
170454028|NCT03303625|616001636|FG003|Overall Study|Withdrawal by Subject|0|||
170454029|NCT04285567|616001641|FG000|Overall Study|Death|3|||
170454030|NCT04285567|616001642|FG001|Overall Study|Death|3|||
170454031|NCT04285567|616001641|FG000|Overall Study|Lost to Follow-up|1|||
170454032|NCT04285567|616001642|FG001|Overall Study|Lost to Follow-up|1|||
170454033|NCT04285567|616001641|FG000|Overall Study|Reason Not Specified|1|||
170454034|NCT04285567|616001642|FG001|Overall Study|Reason Not Specified|1|||
170454035|NCT04285567|616001641|FG000|Overall Study|Physician Decision|2|||
170454036|NCT04285567|616001642|FG001|Overall Study|Physician Decision|1|||
170454037|NCT04285567|616001641|FG000|Overall Study|Withdrawal by Subject|2|||
170454038|NCT04285567|616001642|FG001|Overall Study|Withdrawal by Subject|6|||
170454039|NCT04285567|616001641|FG000|Overall Study|Adverse Event|1|||
170454040|NCT04285567|616001642|FG001|Overall Study|Adverse Event|0|||
170454041|NCT04285567|616001641|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
170454042|NCT04285567|616001642|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
170454043|NCT03340064|616001643|FG000|First Period|Adverse Event, non-fatal|2|||
170454044|NCT03340064|616001644|FG001|First Period|Adverse Event, non-fatal|0|||
170454045|NCT03340064|616001643|FG000|First Period|Lack of Efficacy|3|||
170454046|NCT03340064|616001644|FG001|First Period|Lack of Efficacy|0|||
170454047|NCT03340064|616001643|FG000|Second Period|Adverse Event, non-fatal|1|||
170454048|NCT03340064|616001644|FG001|Second Period|Adverse Event, non-fatal|1|||
170454049|NCT03340064|616001643|FG000|Second Period|Lack of Efficacy|11|||
170454050|NCT03340064|616001644|FG001|Second Period|Lack of Efficacy|0|||
170454051|NCT03340064|616001643|FG000|Second Period|Physician Decision|3|||
170454052|NCT03340064|616001644|FG001|Second Period|Physician Decision|0|||
170454053|NCT03340064|616001643|FG000|Second Period|Withdrawal by Subject|2|||
170454054|NCT03340064|616001644|FG001|Second Period|Withdrawal by Subject|1|||
170454055|NCT03340064|616001643|FG000|Second Period|Approved Drug Available For Indication|1|||
170454056|NCT03340064|616001644|FG001|Second Period|Approved Drug Available For Indication|0|||
170454057|NCT03340064|616001643|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
170454058|NCT03340064|616001644|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
170454059|NCT01045421|616001645|FG000|Phase 1|Progressive Disease|0|||
170454060|NCT01045421|616001646|FG001|Phase 1|Progressive Disease|0|||
170454061|NCT01045421|616001647|FG002|Phase 1|Progressive Disease|0|||
170454062|NCT01045421|616001648|FG003|Phase 1|Progressive Disease|0|||
170454063|NCT01045421|616001649|FG004|Phase 1|Progressive Disease|1|||
170454064|NCT01045421|616001650|FG005|Phase 1|Progressive Disease|0|||
170454065|NCT01045421|616001651|FG006|Phase 1|Progressive Disease|0|||
170454066|NCT01045421|616001652|FG007|Phase 1|Progressive Disease|0|||
170454067|NCT01045421|616001653|FG008|Phase 1|Progressive Disease|0|||
170454068|NCT01045421|616001654|FG009|Phase 1|Progressive Disease|0|||
170454069|NCT01045421|616001655|FG010|Phase 1|Progressive Disease|0|||
170454070|NCT01045421|616001645|FG000|Phase 1|Withdrawal by Subject|0|||
170454071|NCT01045421|616001646|FG001|Phase 1|Withdrawal by Subject|0|||
170454072|NCT01045421|616001647|FG002|Phase 1|Withdrawal by Subject|0|||
170454073|NCT01045421|616001648|FG003|Phase 1|Withdrawal by Subject|1|||
170454074|NCT01045421|616001649|FG004|Phase 1|Withdrawal by Subject|0|||
170454075|NCT01045421|616001650|FG005|Phase 1|Withdrawal by Subject|0|||
170454076|NCT01045421|616001651|FG006|Phase 1|Withdrawal by Subject|0|||
170454077|NCT01045421|616001652|FG007|Phase 1|Withdrawal by Subject|0|||
170454078|NCT01045421|616001653|FG008|Phase 1|Withdrawal by Subject|0|||
170454079|NCT01045421|616001654|FG009|Phase 1|Withdrawal by Subject|0|||
170454080|NCT01045421|616001655|FG010|Phase 1|Withdrawal by Subject|0|||
170454081|NCT01045421|616001645|FG000|Phase 2|Progressive Disease|0|||
170454082|NCT01045421|616001646|FG001|Phase 2|Progressive Disease|0|||
170454083|NCT01045421|616001647|FG002|Phase 2|Progressive Disease|0|||
170454084|NCT01045421|616001648|FG003|Phase 2|Progressive Disease|0|||
170454085|NCT01045421|616001649|FG004|Phase 2|Progressive Disease|0|||
170454086|NCT01045421|616001650|FG005|Phase 2|Progressive Disease|0|||
170787617|NCT04209465|617231821|FG003|Overall Study|Other|0|||
170454087|NCT01045421|616001651|FG006|Phase 2|Progressive Disease|0|||
170454088|NCT01045421|616001652|FG007|Phase 2|Progressive Disease|1|||
170454089|NCT01045421|616001653|FG008|Phase 2|Progressive Disease|1|||
170454090|NCT01045421|616001654|FG009|Phase 2|Progressive Disease|1|||
170454091|NCT01045421|616001655|FG010|Phase 2|Progressive Disease|1|||
170787618|NCT04209465|617231822|FG004|Overall Study|Other|0|||
170787619|NCT04209465|617231823|FG005|Overall Study|Other|0|||
170454092|NCT01045421|616001645|FG000|Phase 2|Death|0|||
170454093|NCT01045421|616001646|FG001|Phase 2|Death|0|||
170454094|NCT01045421|616001647|FG002|Phase 2|Death|0|||
170454095|NCT01045421|616001648|FG003|Phase 2|Death|0|||
170454096|NCT01045421|616001649|FG004|Phase 2|Death|0|||
170454097|NCT01045421|616001650|FG005|Phase 2|Death|0|||
170454098|NCT01045421|616001651|FG006|Phase 2|Death|0|||
170454099|NCT01045421|616001652|FG007|Phase 2|Death|1|||
170787620|NCT04209465|617231824|FG006|Overall Study|Other|0|||
170787621|NCT04209465|617231825|FG007|Overall Study|Other|0|||
170454100|NCT01045421|616001653|FG008|Phase 2|Death|1|||
170454101|NCT01045421|616001654|FG009|Phase 2|Death|2|||
170454102|NCT01045421|616001655|FG010|Phase 2|Death|0|||
170454103|NCT01045421|616001645|FG000|Phase 2|Other|0|||
170454104|NCT01045421|616001646|FG001|Phase 2|Other|0|||
170454105|NCT01045421|616001647|FG002|Phase 2|Other|0|||
170454106|NCT01045421|616001648|FG003|Phase 2|Other|0|||
170454107|NCT01045421|616001649|FG004|Phase 2|Other|0|||
170454108|NCT01045421|616001650|FG005|Phase 2|Other|0|||
170454109|NCT01045421|616001651|FG006|Phase 2|Other|0|||
170454110|NCT01045421|616001652|FG007|Phase 2|Other|3|||
170454111|NCT01045421|616001653|FG008|Phase 2|Other|0|||
170454112|NCT01045421|616001654|FG009|Phase 2|Other|0|||
170454113|NCT01045421|616001655|FG010|Phase 2|Other|1|||
170454114|NCT00856973|616001656|FG000|Overall Study|Adverse Event|5|||
170454115|NCT00856973|616001657|FG001|Overall Study|Adverse Event|5|||
170454116|NCT00856973|616001658|FG002|Overall Study|Adverse Event|3|||
170454117|NCT00856973|616001656|FG000|Overall Study|Lost to Follow-up|6|||
170454118|NCT00856973|616001657|FG001|Overall Study|Lost to Follow-up|3|||
170454119|NCT00856973|616001658|FG002|Overall Study|Lost to Follow-up|5|||
170454120|NCT00856973|616001656|FG000|Overall Study|Physician Decision|0|||
170454121|NCT00856973|616001657|FG001|Overall Study|Physician Decision|3|||
170454122|NCT00856973|616001658|FG002|Overall Study|Physician Decision|1|||
170454123|NCT00856973|616001656|FG000|Overall Study|Protocol Violation|1|||
170454124|NCT00856973|616001657|FG001|Overall Study|Protocol Violation|2|||
170454125|NCT00856973|616001658|FG002|Overall Study|Protocol Violation|1|||
170454126|NCT00856973|616001656|FG000|Overall Study|Withdrawal by Subject|13|||
170454127|NCT00856973|616001657|FG001|Overall Study|Withdrawal by Subject|16|||
170454128|NCT00856973|616001658|FG002|Overall Study|Withdrawal by Subject|15|||
170454129|NCT00856973|616001656|FG000|Overall Study|Other|11|||
170454130|NCT00856973|616001657|FG001|Overall Study|Other|12|||
170454131|NCT00856973|616001658|FG002|Overall Study|Other|13|||
170454132|NCT00729248|616001660|FG000|Overall Study|Physician Decision|2|||
170454133|NCT01859130|616001661|FG000|Overall Study|Death|4|||
170454134|NCT01859130|616001661|FG000|Overall Study|Lost to Follow-up|16|||
170454135|NCT01859130|616001661|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
170454136|NCT01859130|616001661|FG000|Overall Study|Physician Decision|6|||
170454137|NCT01859130|616001661|FG000|Overall Study|Withdrawal by Subject|17|||
170454138|NCT01859130|616001661|FG000|Overall Study|Adverse Event|11|||
170454139|NCT01388166|616001662|FG000|Overall Study|Adverse Event|16|||
170454140|NCT01388166|616001662|FG000|Overall Study|Lost to Follow-up|30|||
170454141|NCT01388166|616001662|FG000|Overall Study|Others than specified above|13|||
170454142|NCT00127036|616001667|FG000|Overall Study|Insufficient Data for Analysis|6|||
170454143|NCT00127036|616001668|FG001|Overall Study|Insufficient Data for Analysis|11|||
170454144|NCT00127036|616001667|FG000|Overall Study|Screen Failure|2|||
170454145|NCT00127036|616001668|FG001|Overall Study|Screen Failure|0|||
170454146|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
170454147|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
170454148|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
170454149|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
170454150|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
170454151|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
170454152|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
170454153|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
170454154|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
170454155|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
170454156|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
170454157|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
170454158|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
170454159|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
170454160|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
170454161|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
170454162|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
170454163|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
170454164|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
170454165|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
170454166|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
170454167|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
170454168|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
170454169|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
170454170|NCT01421342|616001669|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
170454171|NCT01421342|616001670|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
170454172|NCT01421342|616001671|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
170454173|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
170454174|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
170635466|NCT01166282|616676932|FG001|Open-label Period|Adverse Event|0|||
170454175|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
170454176|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
170454177|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
170454178|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
170454179|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
170454180|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
170454181|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
170454182|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
170454183|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
170454184|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
170454185|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
170454186|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
170454187|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
170454188|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
170454189|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
170454190|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
170454191|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
170454192|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
170454193|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
170454194|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
170454195|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
170454196|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
170454197|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
170454198|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
170454199|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
170454200|NCT01421342|616001669|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
170454201|NCT01421342|616001670|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
170454202|NCT01421342|616001671|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
170454203|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
170454204|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
170454205|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
170454206|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
170454207|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
170787622|NCT04209465|617231826|FG008|Overall Study|Other|1|||
170787623|NCT04209465|617231827|FG009|Overall Study|Other|0|||
170787624|NCT04209465|617231828|FG010|Overall Study|Other|0|||
170635467|NCT01166282|616676933|FG002|Open-label Period|Adverse Event|6|||
170787625|NCT04209465|617231829|FG011|Overall Study|Other|0|||
170454208|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
170454209|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
170454210|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
170454211|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
170454212|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
170454213|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
170454214|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
170454215|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
170454216|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
170454217|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
170454218|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
170454219|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
170454220|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
170454221|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
170454222|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
170454223|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
170454224|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
170454225|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
170454226|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
170454227|NCT01421342|616001669|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
170454228|NCT01421342|616001670|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
170454229|NCT01421342|616001671|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
170454230|NCT01429051|616001674|FG000|Titration Phase|Death|1|||
170454231|NCT01429051|616001674|FG000|Titration Phase|Withdrawal by Subject|7|||
170454232|NCT01429051|616001674|FG000|Titration Phase|Physician Decision|1|||
170454233|NCT01429051|616001674|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
170454234|NCT01429051|616001674|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
170454235|NCT01429051|616001674|FG000|Efficacy Phase|Adverse Event|1|||
170454236|NCT01429051|616001674|FG000|Efficacy Phase|Death|1|||
170454237|NCT01429051|616001674|FG000|Tolerability Phase|Death|5|||
170454238|NCT01429051|616001674|FG000|Tolerability Phase|Adverse Event|2|||
170454239|NCT01429051|616001674|FG000|Tolerability Phase|Withdrawal by Subject|5|||
170454240|NCT01429051|616001674|FG000|Tolerability Phase|Physician Decision|1|||
170454241|NCT01429051|616001674|FG000|Tolerability Phase|Other|2|||
170454242|NCT04132336|616001675|FG000|Overall Study|Investigator Decision|0|||
170454243|NCT04132336|616001676|FG001|Overall Study|Investigator Decision|1|||
170454244|NCT04132336|616001677|FG002|Overall Study|Investigator Decision|0|||
170454245|NCT04132336|616001678|FG003|Overall Study|Investigator Decision|0|||
170454246|NCT04132336|616001679|FG004|Overall Study|Investigator Decision|0|||
170454247|NCT04132336|616001680|FG005|Overall Study|Investigator Decision|0|||
170454248|NCT04132336|616001681|FG006|Overall Study|Investigator Decision|0|||
170454249|NCT02488330|616001682|FG000|Overall Study|Adverse Event|1|||
170454250|NCT02488330|616001682|FG000|Overall Study|Physician Decision|2|||
170454251|NCT02488330|616001682|FG000|Overall Study|Death|2|||
170454252|NCT02488330|616001682|FG000|Overall Study|Disease Progression|3|||
170454253|NCT02488330|616001682|FG000|Overall Study|Study Termination by Sponsor|4|||
170454254|NCT00307034|616001687|FG000|Overall Study|Adverse Event|1|||
170454255|NCT00307034|616001688|FG001|Overall Study|Adverse Event|2|||
170454256|NCT00307034|616001687|FG000|Overall Study|Withdrawal by Subject|1|||
170454257|NCT00307034|616001688|FG001|Overall Study|Withdrawal by Subject|2|||
170454258|NCT00307034|616001687|FG000|Overall Study|Lost to Follow-up|0|||
170454259|NCT00307034|616001688|FG001|Overall Study|Lost to Follow-up|3|||
170454260|NCT04920916|616001689|FG000|Phase IIa 60 Day Study|Death|2|||
170454261|NCT04920916|616001690|FG001|Phase IIa 60 Day Study|Death|5|||
170454262|NCT04920916|616001689|FG000|1 Year Follow up (Phone Call)|Death|1|||
170454263|NCT04920916|616001690|FG001|1 Year Follow up (Phone Call)|Death|3|||
170454264|NCT04920916|616001689|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
170454265|NCT04920916|616001690|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
170454266|NCT00973765|616001691|FG000|Overall Study|Lost to Follow-up|8|||
170454267|NCT00973765|616001692|FG001|Overall Study|Lost to Follow-up|14|||
170454268|NCT02011113|616001693|FG000|Overall Study|Adverse Event|4|||
170454269|NCT02011113|616001693|FG000|Overall Study|Disease Progression (DP)|16|||
170454270|NCT02011113|616001693|FG000|Overall Study|Death|1|||
170454271|NCT02011113|616001693|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
170454272|NCT02011113|616001693|FG000|Overall Study|Investigator's judgement- DP|3|||
170454273|NCT02011113|616001693|FG000|Overall Study|Study terminated by sponsor|11|||
170454274|NCT02034058|616001696|FG000|Overall Study|Death|3|||
170454275|NCT04505293|616001705|FG000|Overall Study|Lost to Follow-up|2|||
170454276|NCT04505293|616001705|FG000|Overall Study|Withdrawal by Subject|6|||
170454277|NCT04505293|616001705|FG000|Overall Study|CT scan unreadable|277|||
170454278|NCT00506129|616001706|FG000|Overall Study|Disease Progression/Relapse|15|||
170454279|NCT00506129|616001706|FG000|Overall Study|Death|7|||
170454280|NCT04295135|616001707|FG000|Overall Study|Withdrawal by Subject|2|||
170635468|NCT01166282|616676931|FG000|Open-label Period|Withdrawal by Subject|0|||
170454281|NCT04295135|616001708|FG001|Overall Study|Withdrawal by Subject|1|||
170454282|NCT04295135|616001707|FG000|Overall Study|Subject left organization|8|||
170454283|NCT04295135|616001708|FG001|Overall Study|Subject left organization|4|||
170454284|NCT03201250|616001710|FG000|Overall Study|screen failures|3|||
170454285|NCT03201250|616001711|FG001|Overall Study|screen failures|0|||
170454286|NCT03201250|616001712|FG002|Overall Study|screen failures|0|||
170454287|NCT02575911|616001713|FG000|Overall Study|Lost to Follow-up|1|||
170454288|NCT03579966|616001714|FG000|Overall Study|Adverse Event|6|||
170635469|NCT01166282|616676932|FG001|Open-label Period|Withdrawal by Subject|0|||
170888497|NCT00411554|617598327|FG000|Overall Study|Withdrawal by Subject|3|||
170888498|NCT00411554|617598328|FG001|Overall Study|Withdrawal by Subject|0|||
170888499|NCT00411554|617598327|FG000|Overall Study|Patient Moved|1|||
170888500|NCT00411554|617598328|FG001|Overall Study|Patient Moved|0|||
170888501|NCT00293579|617598333|FG000|Overall Study|Withdrawal by Subject|1|||
170888502|NCT03847610|617598334|FG000|Overall Study|Withdrawal by Subject|1|||
170888503|NCT02004873|617598335|FG000|Overall Study|Implant unsuccessful|6|||
170888504|NCT02004873|617598335|FG000|Overall Study|Awaiting 6-month visit|390|||
170888505|NCT02004873|617598335|FG000|Overall Study|Missed 6-month visit|4|||
170888506|NCT02004873|617598335|FG000|Overall Study|Death|23|||
170888507|NCT02004873|617598335|FG000|Overall Study|Withdrawal by Subject|1|||
170888508|NCT02799069|617598340|FG000|Overall Study|Adverse Event|0|||
170888509|NCT02799069|617598341|FG001|Overall Study|Adverse Event|2|||
170888510|NCT02799069|617598342|FG002|Overall Study|Adverse Event|2|||
170888511|NCT02799069|617598340|FG000|Overall Study|Lack of Efficacy|2|||
170888512|NCT02799069|617598341|FG001|Overall Study|Lack of Efficacy|0|||
170888513|NCT02799069|617598342|FG002|Overall Study|Lack of Efficacy|0|||
170888514|NCT02799069|617598340|FG000|Overall Study|Lost to Follow-up|1|||
170888515|NCT02799069|617598341|FG001|Overall Study|Lost to Follow-up|1|||
170888516|NCT02799069|617598342|FG002|Overall Study|Lost to Follow-up|0|||
170888517|NCT02799069|617598340|FG000|Overall Study|Withdrawal by Subject|4|||
170888518|NCT02799069|617598341|FG001|Overall Study|Withdrawal by Subject|4|||
170888519|NCT02799069|617598342|FG002|Overall Study|Withdrawal by Subject|3|||
170888520|NCT02799069|617598340|FG000|Overall Study|Protocol Violation|1|||
170888521|NCT02799069|617598341|FG001|Overall Study|Protocol Violation|0|||
170888522|NCT02799069|617598342|FG002|Overall Study|Protocol Violation|2|||
170888523|NCT05130463|617598347|FG000|Overall Study|Unspecified reasons|2|||
170888524|NCT05130463|617598347|FG000|Overall Study|off-label indication dose|435|||
170888525|NCT00487539|617598349|FG000|Overall Study|Adverse Event|3|||
170888526|NCT00487539|617598350|FG001|Overall Study|Adverse Event|2|||
170888527|NCT00487539|617598351|FG002|Overall Study|Adverse Event|1|||
170888528|NCT00487539|617598352|FG003|Overall Study|Adverse Event|1|||
170888529|NCT00487539|617598349|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170888530|NCT00487539|617598350|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170888531|NCT00487539|617598351|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170888532|NCT00487539|617598352|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
170888533|NCT00487539|617598349|FG000|Overall Study|Other|3|||
170888534|NCT00487539|617598350|FG001|Overall Study|Other|1|||
170888535|NCT00487539|617598351|FG002|Overall Study|Other|2|||
170888536|NCT00487539|617598352|FG003|Overall Study|Other|2|||
170888537|NCT03440814|617598353|FG000|Overall Study|Adverse Event|2|||
170888538|NCT03440814|617598354|FG001|Overall Study|Adverse Event|1|||
170888539|NCT03440814|617598353|FG000|Overall Study|Lost to Follow-up|2|||
170888540|NCT03440814|617598354|FG001|Overall Study|Lost to Follow-up|0|||
170888541|NCT03440814|617598353|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
170888542|NCT03440814|617598354|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
170888543|NCT02695628|617598355|FG000|Overall Study|Withdrawal by Subject|1|||
170888544|NCT02678390|617598356|FG000|AE (1 Day)|Withdrawal by Subject|0|||
170888545|NCT02678390|617598357|FG001|AE (1 Day)|Withdrawal by Subject|1|||
170888546|NCT00852995|617598358|FG000|Overall Study|Adverse Event|1|||
170888547|NCT00852995|617598359|FG001|Overall Study|Adverse Event|0|||
170888548|NCT00852995|617598360|FG002|Overall Study|Adverse Event|4|||
170888549|NCT00852995|617598361|FG003|Overall Study|Adverse Event|0|||
170888550|NCT00852995|617598362|FG004|Overall Study|Adverse Event|0|||
170888551|NCT00852995|617598358|FG000|Overall Study|Lost to Follow-up|0|||
170888552|NCT00852995|617598359|FG001|Overall Study|Lost to Follow-up|1|||
170888553|NCT00852995|617598360|FG002|Overall Study|Lost to Follow-up|1|||
170635470|NCT01166282|616676933|FG002|Open-label Period|Withdrawal by Subject|4|||
170635471|NCT01166282|616676931|FG000|Open-label Period|Lack of Efficacy|0|||
170635472|NCT01166282|616676932|FG001|Open-label Period|Lack of Efficacy|0|||
170635473|NCT01166282|616676933|FG002|Open-label Period|Lack of Efficacy|2|||
170635474|NCT01166282|616676931|FG000|Open-label Period|Remission|0|||
170635475|NCT01166282|616676932|FG001|Open-label Period|Remission|0|||
170635476|NCT01166282|616676933|FG002|Open-label Period|Remission|4|||
170635477|NCT01166282|616676931|FG000|Open-label Period|Irregular Compliance|0|||
170635478|NCT01166282|616676932|FG001|Open-label Period|Irregular Compliance|0|||
170635479|NCT01166282|616676933|FG002|Open-label Period|Irregular Compliance|1|||
170635480|NCT01995838|616676934|FG000|Overall Study|Lost to Follow-up|0|||
170635481|NCT01995838|616676935|FG001|Overall Study|Lost to Follow-up|1|||
170635482|NCT01995838|616676936|FG002|Overall Study|Lost to Follow-up|0|||
170635483|NCT01995838|616676937|FG003|Overall Study|Lost to Follow-up|0|||
170635484|NCT01995838|616676938|FG004|Overall Study|Lost to Follow-up|0|||
170635485|NCT01995838|616676939|FG005|Overall Study|Lost to Follow-up|0|||
170635486|NCT01995838|616676940|FG006|Overall Study|Lost to Follow-up|1|||
170635487|NCT01995838|616676934|FG000|Overall Study|Participant choice|2|||
170635488|NCT01995838|616676935|FG001|Overall Study|Participant choice|0|||
170635489|NCT01995838|616676936|FG002|Overall Study|Participant choice|0|||
170635490|NCT01995838|616676937|FG003|Overall Study|Participant choice|0|||
170635491|NCT01995838|616676938|FG004|Overall Study|Participant choice|0|||
170635492|NCT01995838|616676939|FG005|Overall Study|Participant choice|1|||
170635493|NCT01995838|616676940|FG006|Overall Study|Participant choice|1|||
170635494|NCT01995838|616676934|FG000|Overall Study|Adverse Event|0|||
170635495|NCT01995838|616676935|FG001|Overall Study|Adverse Event|0|||
170635496|NCT01995838|616676936|FG002|Overall Study|Adverse Event|0|||
170635497|NCT01995838|616676937|FG003|Overall Study|Adverse Event|0|||
170635498|NCT01995838|616676938|FG004|Overall Study|Adverse Event|0|||
170635499|NCT01995838|616676939|FG005|Overall Study|Adverse Event|0|||
170635500|NCT01995838|616676940|FG006|Overall Study|Adverse Event|1|||
170635501|NCT01995838|616676934|FG000|Overall Study|Withdrawal by Subject|0|||
170635502|NCT01995838|616676935|FG001|Overall Study|Withdrawal by Subject|0|||
170635503|NCT01995838|616676936|FG002|Overall Study|Withdrawal by Subject|0|||
170635504|NCT01995838|616676937|FG003|Overall Study|Withdrawal by Subject|0|||
170635505|NCT01995838|616676938|FG004|Overall Study|Withdrawal by Subject|1|||
170635506|NCT01995838|616676939|FG005|Overall Study|Withdrawal by Subject|0|||
170635507|NCT01995838|616676940|FG006|Overall Study|Withdrawal by Subject|0|||
170635508|NCT01995838|616676934|FG000|Overall Study|Other|3|||
170635509|NCT01995838|616676935|FG001|Overall Study|Other|1|||
170635510|NCT01995838|616676936|FG002|Overall Study|Other|0|||
170635511|NCT01995838|616676937|FG003|Overall Study|Other|2|||
170635512|NCT01995838|616676938|FG004|Overall Study|Other|1|||
170635513|NCT01995838|616676939|FG005|Overall Study|Other|1|||
170635514|NCT01995838|616676940|FG006|Overall Study|Other|2|||
170635515|NCT01262989|616676941|FG000|Period 1|Lost to Follow-up|1|||
170635516|NCT01262989|616676942|FG001|Period 1|Lost to Follow-up|1|||
170635517|NCT01262989|616676941|FG000|Period 1|Intercurrent disease|0|||
170635518|NCT01262989|616676942|FG001|Period 1|Intercurrent disease|1|||
170635519|NCT01262989|616676941|FG000|Period 1|Positive answer for exclusion criteria|0|||
170635520|NCT01262989|616676942|FG001|Period 1|Positive answer for exclusion criteria|1|||
170635521|NCT01262989|616676941|FG000|Period 2|Intercurrent disease|0|||
170635522|NCT01262989|616676942|FG001|Period 2|Intercurrent disease|1|||
170635523|NCT00573144|616676943|FG000|Overall Study|Withdrawal by Subject|2|||
170888554|NCT00852995|617598361|FG003|Overall Study|Lost to Follow-up|0|||
170454289|NCT03579966|616001714|FG000|Overall Study|Lost to Follow-up|4|||
170454290|NCT03579966|616001714|FG000|Overall Study|Physician Decision|10|||
170454291|NCT03579966|616001714|FG000|Overall Study|Pregnancy|1|||
170454292|NCT03579966|616001714|FG000|Overall Study|Withdrawal by Subject|16|||
170454293|NCT03579966|616001714|FG000|Overall Study|Study terminated by Sponsor|22|||
170454294|NCT03579966|616001714|FG000|Overall Study|Protocol Violation|1|||
170454295|NCT02408068|616001715|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
170454296|NCT02408068|616001716|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
170454297|NCT02408068|616001717|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
170454298|NCT02408068|616001718|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
170454299|NCT02408068|616001719|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
170635524|NCT00573144|616676944|FG001|Overall Study|Withdrawal by Subject|3|||
170635525|NCT00318643|616676945|FG000|Overall Study|Adverse Event|0|||
170635526|NCT00318643|616676946|FG001|Overall Study|Adverse Event|0|||
170635527|NCT00318643|616676947|FG002|Overall Study|Adverse Event|0|||
170635528|NCT00318643|616676948|FG003|Overall Study|Adverse Event|0|||
170635529|NCT00318643|616676949|FG004|Overall Study|Adverse Event|1|||
170635530|NCT00318643|616676945|FG000|Overall Study|Participant's Decision|0|||
170635531|NCT00318643|616676946|FG001|Overall Study|Participant's Decision|0|||
170635532|NCT00318643|616676947|FG002|Overall Study|Participant's Decision|0|||
170635533|NCT00318643|616676948|FG003|Overall Study|Participant's Decision|0|||
170635534|NCT00318643|616676949|FG004|Overall Study|Participant's Decision|1|||
170635535|NCT00318643|616676945|FG000|Overall Study|Investigator's Decision|0|||
170635536|NCT00318643|616676946|FG001|Overall Study|Investigator's Decision|0|||
170454300|NCT02408068|616001720|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
170454301|NCT03484117|616001723|FG000|Overall Study|Lost to Follow-up|1|||
170454302|NCT03484117|616001724|FG001|Overall Study|Lost to Follow-up|3|||
170454303|NCT03484117|616001723|FG000|Overall Study|Declined participation in exit assess|1|||
170454304|NCT03484117|616001724|FG001|Overall Study|Declined participation in exit assess|1|||
170454305|NCT03052959|616001725|FG000|Overall Study|Lost to Follow-up|4|||
170454306|NCT03052959|616001726|FG001|Overall Study|Lost to Follow-up|5|||
170454307|NCT03551496|616001727|FG000|Overall Study|Death|11|||
170454308|NCT03551496|616001728|FG001|Overall Study|Death|7|||
170542424|NCT05218499|616329725|FG002|Overall Study|Burden of trial procedures|2|||
170542425|NCT05218499|616329723|FG000|Overall Study|Clinical disease progression|6|||
170542426|NCT05218499|616329724|FG001|Overall Study|Clinical disease progression|6|||
170542427|NCT05218499|616329725|FG002|Overall Study|Clinical disease progression|11|||
170542428|NCT05218499|616329723|FG000|Overall Study|Objective disease progression|44|||
170542429|NCT05218499|616329724|FG001|Overall Study|Objective disease progression|61|||
170542430|NCT05218499|616329725|FG002|Overall Study|Objective disease progression|42|||
170542431|NCT05218499|616329723|FG000|Overall Study|Adverse Event|11|||
170542432|NCT05218499|616329724|FG001|Overall Study|Adverse Event|36|||
170542433|NCT05218499|616329725|FG002|Overall Study|Adverse Event|9|||
170542434|NCT05218499|616329723|FG000|Overall Study|On treatment at time of snapshot|18|||
170542435|NCT05218499|616329724|FG001|Overall Study|On treatment at time of snapshot|29|||
170787626|NCT04209465|617231830|FG012|Overall Study|Other|0|||
170454309|NCT03551496|616001727|FG000|Overall Study|Withdrawal by Subject|4|||
170454310|NCT03551496|616001728|FG001|Overall Study|Withdrawal by Subject|3|||
170787627|NCT03097549|617231831|FG000|Overall Study|Withdrawal by Subject|1|||
170454311|NCT03551496|616001727|FG000|Overall Study|Other Reasons|1|||
170454312|NCT03551496|616001728|FG001|Overall Study|Other Reasons|0|||
170454313|NCT00886288|616001731|FG000|Overall Study|no respect of the 12 weeks period|657|||
170454314|NCT00886288|616001732|FG001|Overall Study|no respect of the 12 weeks period|227|||
170454315|NCT00886288|616001731|FG000|Overall Study|Lost to Follow-up|86|||
170454316|NCT00886288|616001732|FG001|Overall Study|Lost to Follow-up|0|||
170454317|NCT01070771|616001733|FG000|Overall Study|Adverse Event|2|||
170454318|NCT01070771|616001733|FG000|Overall Study|Protocol Violation|1|||
170454319|NCT01300052|616001734|FG000|Overall Study|Adverse Event|3|||
170454320|NCT01300052|616001735|FG001|Overall Study|Adverse Event|0|||
170454321|NCT01300052|616001734|FG000|Overall Study|Withdrawal by Subject|2|||
170454322|NCT01300052|616001735|FG001|Overall Study|Withdrawal by Subject|2|||
170454323|NCT01300052|616001734|FG000|Overall Study|Protocol Violation|1|||
170454324|NCT01300052|616001735|FG001|Overall Study|Protocol Violation|1|||
170454325|NCT01550744|616001736|FG000|Open-Label|Lost to Follow-up|7|||
170454326|NCT01550744|616001737|FG001|Open-Label|Lost to Follow-up|0|||
170454327|NCT01550744|616001738|FG002|Open-Label|Lost to Follow-up|0|||
170454328|NCT01550744|616001736|FG000|Open-Label|Withdrawal by Subject|13|||
170454329|NCT01550744|616001737|FG001|Open-Label|Withdrawal by Subject|0|||
170454330|NCT01550744|616001738|FG002|Open-Label|Withdrawal by Subject|0|||
170454331|NCT01550744|616001736|FG000|Open-Label|Adverse Event|11|||
170454332|NCT01550744|616001737|FG001|Open-Label|Adverse Event|0|||
170454333|NCT01550744|616001738|FG002|Open-Label|Adverse Event|0|||
170454334|NCT01550744|616001736|FG000|Open-Label|Lack of Efficacy|4|||
170454335|NCT01550744|616001737|FG001|Open-Label|Lack of Efficacy|0|||
170454336|NCT01550744|616001738|FG002|Open-Label|Lack of Efficacy|0|||
170454337|NCT01550744|616001736|FG000|Open-Label|Protocol Violation|4|||
170454338|NCT01550744|616001737|FG001|Open-Label|Protocol Violation|0|||
170454339|NCT01550744|616001738|FG002|Open-Label|Protocol Violation|0|||
170542436|NCT05218499|616329725|FG002|Overall Study|On treatment at time of snapshot|0|||
170542437|NCT04818255|616329727|FG000|Disclosure Sesions|Lost to Follow-up|1|||
170542438|NCT04818255|616329728|FG001|Disclosure Sesions|Lost to Follow-up|0|||
170542439|NCT04818255|616329729|FG002|Disclosure Sesions|Lost to Follow-up|1|||
170542440|NCT04818255|616329730|FG003|Disclosure Sesions|Lost to Follow-up|0|||
170542441|NCT02503865|616329731|FG000|Overall Study|Moved out of area|1|||
170542442|NCT02503865|616329732|FG001|Overall Study|Moved out of area|8|||
170542443|NCT02503865|616329733|FG002|Overall Study|Moved out of area|0|||
170542444|NCT02503865|616329731|FG000|Overall Study|Refused treatment|4|||
170542445|NCT02503865|616329732|FG001|Overall Study|Refused treatment|39|||
170542446|NCT02503865|616329733|FG002|Overall Study|Refused treatment|2|||
170542447|NCT04607408|616329734|FG000|Overall Study|Lost to Follow-up|0|||
170787628|NCT03097549|617231832|FG001|Overall Study|Withdrawal by Subject|0|||
170787629|NCT03097549|617231831|FG000|Overall Study|Lost to Follow-up|1|||
170542448|NCT04607408|616329735|FG001|Overall Study|Lost to Follow-up|0|||
170542449|NCT04607408|616329736|FG002|Overall Study|Lost to Follow-up|0|||
170542450|NCT04607408|616329737|FG003|Overall Study|Lost to Follow-up|1|||
170454340|NCT01550744|616001736|FG000|Open-Label|Not all 3 study drug injections received|2|||
170454341|NCT01550744|616001737|FG001|Open-Label|Not all 3 study drug injections received|0|||
170454342|NCT01550744|616001738|FG002|Open-Label|Not all 3 study drug injections received|0|||
170454343|NCT01550744|616001736|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
170454344|NCT01550744|616001737|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
170454345|NCT01550744|616001738|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
170454346|NCT01550744|616001736|FG000|Open-Label|Other|1|||
170542451|NCT04607408|616329738|FG004|Overall Study|Lost to Follow-up|0|||
170454347|NCT01550744|616001737|FG001|Open-Label|Other|0|||
170454348|NCT01550744|616001738|FG002|Open-Label|Other|0|||
170454349|NCT01550744|616001736|FG000|Double-Blind|Lost to Follow-up|0|||
170454350|NCT01550744|616001737|FG001|Double-Blind|Lost to Follow-up|6|||
170454351|NCT01550744|616001738|FG002|Double-Blind|Lost to Follow-up|12|||
170454352|NCT01550744|616001736|FG000|Double-Blind|Withdrawal by Subject|0|||
170454353|NCT01550744|616001737|FG001|Double-Blind|Withdrawal by Subject|2|||
170454354|NCT01550744|616001738|FG002|Double-Blind|Withdrawal by Subject|15|||
170454355|NCT01550744|616001736|FG000|Double-Blind|Adverse Event|0|||
170454356|NCT01550744|616001737|FG001|Double-Blind|Adverse Event|4|||
170454357|NCT01550744|616001738|FG002|Double-Blind|Adverse Event|15|||
170454358|NCT01550744|616001736|FG000|Double-Blind|Death|0|||
170454359|NCT01550744|616001737|FG001|Double-Blind|Death|1|||
170454360|NCT01550744|616001738|FG002|Double-Blind|Death|0|||
170454361|NCT01550744|616001736|FG000|Double-Blind|Lack of Efficacy|0|||
170454362|NCT01550744|616001737|FG001|Double-Blind|Lack of Efficacy|2|||
170454363|NCT01550744|616001738|FG002|Double-Blind|Lack of Efficacy|8|||
170454364|NCT01550744|616001736|FG000|Double-Blind|Protocol Violation|0|||
170454365|NCT01550744|616001737|FG001|Double-Blind|Protocol Violation|0|||
170454366|NCT01550744|616001738|FG002|Double-Blind|Protocol Violation|4|||
170454367|NCT01550744|616001736|FG000|Double-Blind|Pregnancy|0|||
170454368|NCT01550744|616001737|FG001|Double-Blind|Pregnancy|0|||
170454369|NCT01550744|616001738|FG002|Double-Blind|Pregnancy|3|||
170454370|NCT01550744|616001736|FG000|Double-Blind|Other|0|||
170454371|NCT01550744|616001737|FG001|Double-Blind|Other|2|||
170454372|NCT01550744|616001738|FG002|Double-Blind|Other|10|||
170454373|NCT00706381|616001739|FG000|Overall Study|Lost to Follow-up|0|||
170454374|NCT00706381|616001740|FG001|Overall Study|Lost to Follow-up|1|||
170454375|NCT00706381|616001741|FG002|Overall Study|Lost to Follow-up|1|||
170454376|NCT00706381|616001742|FG003|Overall Study|Lost to Follow-up|0|||
170454377|NCT03401073|616001743|FG000|Overall Study|Lost to Follow-up|1|||
170454378|NCT03401073|616001744|FG001|Overall Study|Lost to Follow-up|2|||
170454379|NCT01901874|616001745|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
170454380|NCT01901874|616001745|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
170454381|NCT01901874|616001745|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
170454382|NCT01901874|616001745|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
170454383|NCT01901874|616001745|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
170454384|NCT01901874|616001745|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
170454385|NCT01698775|616001749|FG000|Phase A|Adverse Event|2|||
170454386|NCT01698775|616001750|FG001|Phase A|Adverse Event|1|||
170454387|NCT01698775|616001749|FG000|Phase A|Death|1|||
170454388|NCT01698775|616001750|FG001|Phase A|Death|1|||
170454389|NCT01698775|616001749|FG000|Phase A|Lack of Efficacy|1|||
170454390|NCT01698775|616001750|FG001|Phase A|Lack of Efficacy|0|||
170454391|NCT01698775|616001749|FG000|Phase A|Lost to Follow-up|1|||
170454392|NCT01698775|616001750|FG001|Phase A|Lost to Follow-up|2|||
170454393|NCT01698775|616001749|FG000|Phase A|Protocol Violation|1|||
170454394|NCT01698775|616001750|FG001|Phase A|Protocol Violation|0|||
170454395|NCT01698775|616001749|FG000|Phase A|Withdrawal by Subject|3|||
170454396|NCT01698775|616001750|FG001|Phase A|Withdrawal by Subject|4|||
170454397|NCT01698775|616001749|FG000|Phase A|Kidney [transplant]|0|||
170454398|NCT01698775|616001750|FG001|Phase A|Kidney [transplant]|1|||
170454399|NCT01698775|616001749|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
170454400|NCT01698775|616001750|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
170454401|NCT01698775|616001749|FG000|Phase B|Adverse Event|6|||
170454402|NCT01698775|616001750|FG001|Phase B|Adverse Event|3|||
170454403|NCT01698775|616001749|FG000|Phase B|Death|0|||
170454404|NCT01698775|616001750|FG001|Phase B|Death|1|||
170454405|NCT01698775|616001749|FG000|Phase B|Lack of Efficacy|0|||
170454406|NCT01698775|616001750|FG001|Phase B|Lack of Efficacy|1|||
170454407|NCT01698775|616001749|FG000|Phase B|Lost to Follow-up|0|||
170454408|NCT01698775|616001750|FG001|Phase B|Lost to Follow-up|1|||
170454409|NCT01698775|616001749|FG000|Phase B|Physician Decision|1|||
170454410|NCT01698775|616001750|FG001|Phase B|Physician Decision|1|||
170454411|NCT01698775|616001749|FG000|Phase B|Protocol Violation|1|||
170454412|NCT01698775|616001750|FG001|Phase B|Protocol Violation|1|||
170454413|NCT01698775|616001749|FG000|Phase B|Withdrawal by Subject|6|||
170454414|NCT01698775|616001750|FG001|Phase B|Withdrawal by Subject|2|||
170454415|NCT01030341|616003419|FG000|Overall Study|Withdrawal by Subject|1|||
170454416|NCT01030341|616003419|FG000|Overall Study|Lost to Follow-up|2|||
170454417|NCT02667288|616003421|FG000|Overall Study|Protocol Violation|5|||
170454418|NCT02667288|616003421|FG000|Overall Study|Lost to Follow-up|3|||
170454419|NCT02667288|616003421|FG000|Overall Study|Withdrawal by Subject|5|||
170454420|NCT00158756|616003422|FG000|Overall Study|Withdrawal by Subject|5|||
170454421|NCT00158756|616003423|FG001|Overall Study|Withdrawal by Subject|0|||
170454422|NCT00158756|616003424|FG002|Overall Study|Withdrawal by Subject|6|||
170454423|NCT00158756|616003425|FG003|Overall Study|Withdrawal by Subject|1|||
170454424|NCT00158756|616003426|FG004|Overall Study|Withdrawal by Subject|3|||
170454425|NCT00158756|616003422|FG000|Overall Study|Adverse Event|0|||
170454426|NCT00158756|616003423|FG001|Overall Study|Adverse Event|0|||
170454427|NCT00158756|616003424|FG002|Overall Study|Adverse Event|1|||
170454428|NCT00158756|616003425|FG003|Overall Study|Adverse Event|0|||
170454429|NCT00158756|616003426|FG004|Overall Study|Adverse Event|0|||
170454430|NCT00158756|616003422|FG000|Overall Study|Serious adverse event|0|||
170454431|NCT00158756|616003423|FG001|Overall Study|Serious adverse event|0|||
170454432|NCT00158756|616003424|FG002|Overall Study|Serious adverse event|1|||
170454433|NCT00158756|616003425|FG003|Overall Study|Serious adverse event|0|||
170635537|NCT00318643|616676947|FG002|Overall Study|Investigator's Decision|0|||
170635538|NCT00318643|616676948|FG003|Overall Study|Investigator's Decision|0|||
170635539|NCT00318643|616676949|FG004|Overall Study|Investigator's Decision|1|||
170635540|NCT02691507|616676952|FG000|Overall Study|Missed Visit 3|0|||
170635541|NCT02691507|616676953|FG001|Overall Study|Missed Visit 3|1|||
170635542|NCT02557139|616676956|FG000|Overall Study|Significant liver elevation|1|||
170454434|NCT00158756|616003426|FG004|Overall Study|Serious adverse event|0|||
170454435|NCT02145026|616003430|FG000|Overall Study|Adverse Event|2|||
170454436|NCT02145026|616003430|FG000|Overall Study|Death|4|||
170454437|NCT02145026|616003430|FG000|Overall Study|Withdrawal by Subject|2|||
170454438|NCT02145026|616003430|FG000|Overall Study|Physician Decision|4|||
170454439|NCT03001219|616003431|FG000|Proof of Concept|Study Termination by Sponsor|0|||
170454440|NCT03001219|616003432|FG001|Proof of Concept|Study Termination by Sponsor|1|||
170454441|NCT03001219|616003431|FG000|Proof of Concept|Withdrawal by Subject|0|||
170454442|NCT03001219|616003432|FG001|Proof of Concept|Withdrawal by Subject|4|||
170454443|NCT03001219|616003431|FG000|Proof of Concept|Protocol Deviation|0|||
170454444|NCT03001219|616003432|FG001|Proof of Concept|Protocol Deviation|1|||
170454445|NCT03001219|616003431|FG000|Proof of Concept|Adverse Event|1|||
170454446|NCT03001219|616003432|FG001|Proof of Concept|Adverse Event|1|||
170454447|NCT03001219|616003431|FG000|Proof of Concept|Physician Decision|1|||
170454448|NCT03001219|616003432|FG001|Proof of Concept|Physician Decision|0|||
170454449|NCT03001219|616003431|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
170542452|NCT04607408|616329734|FG000|Overall Study|Withdrawal by Subject|0|||
170542453|NCT04607408|616329735|FG001|Overall Study|Withdrawal by Subject|1|||
170542454|NCT04607408|616329736|FG002|Overall Study|Withdrawal by Subject|0|||
170542455|NCT04607408|616329737|FG003|Overall Study|Withdrawal by Subject|1|||
170542456|NCT04607408|616329738|FG004|Overall Study|Withdrawal by Subject|0|||
170542457|NCT04465955|616329739|FG000|Overall Study|Withdrew consent|6|||
170542458|NCT04465955|616329740|FG001|Overall Study|Withdrew consent|10|||
170542459|NCT04465955|616329741|FG002|Overall Study|Withdrew consent|7|||
170542460|NCT04465955|616329739|FG000|Overall Study|Adverse Event|6|||
170542461|NCT04465955|616329740|FG001|Overall Study|Adverse Event|5|||
170542462|NCT04465955|616329741|FG002|Overall Study|Adverse Event|1|||
170542463|NCT04465955|616329739|FG000|Overall Study|Lost to Follow-up|2|||
170542464|NCT04465955|616329740|FG001|Overall Study|Lost to Follow-up|0|||
170542465|NCT04465955|616329741|FG002|Overall Study|Lost to Follow-up|3|||
170542466|NCT04465955|616329739|FG000|Overall Study|Other|1|||
170888555|NCT00852995|617598362|FG004|Overall Study|Lost to Follow-up|0|||
170888556|NCT00852995|617598358|FG000|Overall Study|Withdrawal by Subject|4|||
170888557|NCT00852995|617598359|FG001|Overall Study|Withdrawal by Subject|0|||
170888558|NCT00852995|617598360|FG002|Overall Study|Withdrawal by Subject|0|||
170888559|NCT00852995|617598361|FG003|Overall Study|Withdrawal by Subject|1|||
170888560|NCT00852995|617598362|FG004|Overall Study|Withdrawal by Subject|2|||
170888561|NCT00852995|617598358|FG000|Overall Study|Non-Compliance|0|||
170888562|NCT00852995|617598359|FG001|Overall Study|Non-Compliance|0|||
170888563|NCT00852995|617598360|FG002|Overall Study|Non-Compliance|0|||
170454450|NCT03001219|616003432|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
170454451|NCT03001219|616003431|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
170454452|NCT03001219|616003432|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
170542467|NCT04465955|616329740|FG001|Overall Study|Other|1|||
170542468|NCT04465955|616329741|FG002|Overall Study|Other|3|||
170635543|NCT02557139|616676957|FG001|Overall Study|Significant liver elevation|0|||
170454453|NCT03001219|616003431|FG000|Extension Period Analysis|Physician Decision|0|||
170454454|NCT03001219|616003432|FG001|Extension Period Analysis|Physician Decision|1|||
170454455|NCT03001219|616003431|FG000|Extension Period Analysis|Adverse Event|1|||
170454456|NCT03001219|616003432|FG001|Extension Period Analysis|Adverse Event|1|||
170454457|NCT03001219|616003431|FG000|Extension Period Analysis|Protocol Deviation|0|||
170454458|NCT03001219|616003432|FG001|Extension Period Analysis|Protocol Deviation|1|||
170454459|NCT03001219|616003431|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
170454460|NCT03001219|616003432|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
170454461|NCT02303041|616003433|FG000|Overall Study|Adverse Event|1|||
170454462|NCT02303041|616003434|FG001|Overall Study|Adverse Event|2|||
170454463|NCT05420012|616003437|FG000|Overall Study|Lost to Follow-up|0|||
170454464|NCT05420012|616003438|FG001|Overall Study|Lost to Follow-up|1|||
170454465|NCT00038649|616003440|FG000|Overall Study|Adverse Event|9|||
170454466|NCT03395639|616003441|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
170454467|NCT03395639|616003442|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
170454468|NCT03395639|616003443|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
170454469|NCT03395639|616003441|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
170454470|NCT03395639|616003442|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
170454471|NCT03395639|616003443|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
170454472|NCT03395639|616003441|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
170454473|NCT03395639|616003442|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
170454474|NCT03395639|616003443|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
170454475|NCT03395639|616003441|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
170454476|NCT03395639|616003442|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
170454477|NCT03395639|616003443|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
170454478|NCT03395639|616003441|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
170454479|NCT03395639|616003442|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
170454480|NCT03395639|616003443|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
170454481|NCT00942331|616003444|FG000|Overall Study|Did not start treatment|15|||
170454482|NCT00942331|616003445|FG001|Overall Study|Did not start treatment|22|||
170454483|NCT00995085|616003450|FG000|Overall Study|Withdrawal by Subject|5|||
170454484|NCT01194973|616003454|FG000|Screening Period|Screen Failure|3|||
170454485|NCT01194973|616003454|FG000|26 Week Treatment Period|Adverse Event|1|||
170454486|NCT01194973|616003454|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
170454487|NCT01194973|616003454|FG000|26 Week Treatment Period|Pregnancy|1|||
170454488|NCT00767520|616003457|FG000|Overall Study|Participants still on treatment|11|||
170454489|NCT00767520|616003458|FG001|Overall Study|Participants still on treatment|15|||
170454490|NCT00767520|616003457|FG000|Overall Study|Randomized in error and Never treated|0|||
170454491|NCT00767520|616003458|FG001|Overall Study|Randomized in error and Never treated|2|||
170454492|NCT01338987|616003459|FG000|Overall Study|enrolled on new protocol|0|||
170454493|NCT01338987|616003460|FG001|Overall Study|enrolled on new protocol|0|||
170454494|NCT01338987|616003461|FG002|Overall Study|enrolled on new protocol|1|||
170454495|NCT01338987|616003462|FG003|Overall Study|enrolled on new protocol|0|||
170454496|NCT01338987|616003463|FG004|Overall Study|enrolled on new protocol|0|||
170454497|NCT01338987|616003459|FG000|Overall Study|Disease progression on study|2|||
170454498|NCT01338987|616003460|FG001|Overall Study|Disease progression on study|1|||
170454499|NCT01338987|616003461|FG002|Overall Study|Disease progression on study|1|||
170454500|NCT01338987|616003462|FG003|Overall Study|Disease progression on study|0|||
170454501|NCT01338987|616003463|FG004|Overall Study|Disease progression on study|0|||
170454502|NCT00720226|616003476|FG000|Overall Study|Withdrawal by Subject|7|||
170454503|NCT00720226|616003477|FG001|Overall Study|Withdrawal by Subject|4|||
170454504|NCT00733369|616003478|FG000|Overall Study|Lost to Follow-up|2|||
170454505|NCT00733369|616003479|FG001|Overall Study|Lost to Follow-up|1|||
170454506|NCT00733369|616003478|FG000|Overall Study|Adverse Event|4|||
170454507|NCT00733369|616003479|FG001|Overall Study|Adverse Event|4|||
170454508|NCT00733369|616003478|FG000|Overall Study|Protocol Violation|4|||
170454509|NCT00733369|616003479|FG001|Overall Study|Protocol Violation|4|||
170454510|NCT03856593|616003480|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
170454511|NCT03856593|616003481|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
170454512|NCT03407118|616003485|FG000|Period 2|Withdrawal by Subject|1|||
170454513|NCT03407118|616003486|FG001|Period 2|Withdrawal by Subject|0|||
170454514|NCT01347866|616003499|FG000|Overall Study|Death|0|||
170454515|NCT01347866|616003500|FG001|Overall Study|Death|0|||
170454516|NCT01347866|616003501|FG002|Overall Study|Death|0|||
170454517|NCT01347866|616003502|FG003|Overall Study|Death|1|||
170454518|NCT01347866|616003503|FG004|Overall Study|Death|2|||
170454519|NCT01347866|616003504|FG005|Overall Study|Death|2|||
170454520|NCT01347866|616003505|FG006|Overall Study|Death|1|||
170454521|NCT01347866|616003506|FG007|Overall Study|Death|0|||
170454522|NCT01347866|616003507|FG008|Overall Study|Death|4|||
170454523|NCT01347866|616003508|FG009|Overall Study|Death|1|||
170454524|NCT01347866|616003509|FG010|Overall Study|Death|3|||
170454525|NCT01347866|616003510|FG011|Overall Study|Death|1|||
170454526|NCT01347866|616003511|FG012|Overall Study|Death|2|||
170454527|NCT01347866|616003512|FG013|Overall Study|Death|0|||
170454528|NCT01347866|616003513|FG014|Overall Study|Death|0|||
170542469|NCT00021255|616329742|FG000|Overall Study|Death|1|||
170542470|NCT00021255|616329743|FG001|Overall Study|Death|0|||
170542471|NCT00021255|616329744|FG002|Overall Study|Death|2|||
170454529|NCT01347866|616003514|FG015|Overall Study|Death|1|||
170454530|NCT01347866|616003515|FG016|Overall Study|Death|0|||
170454531|NCT01347866|616003499|FG000|Overall Study|Lost to Follow-up|0|||
170454532|NCT01347866|616003500|FG001|Overall Study|Lost to Follow-up|0|||
170454533|NCT01347866|616003501|FG002|Overall Study|Lost to Follow-up|0|||
170454534|NCT01347866|616003502|FG003|Overall Study|Lost to Follow-up|0|||
170454535|NCT01347866|616003503|FG004|Overall Study|Lost to Follow-up|0|||
170454536|NCT01347866|616003504|FG005|Overall Study|Lost to Follow-up|0|||
170454537|NCT01347866|616003505|FG006|Overall Study|Lost to Follow-up|0|||
170454538|NCT01347866|616003506|FG007|Overall Study|Lost to Follow-up|1|||
170454539|NCT01347866|616003507|FG008|Overall Study|Lost to Follow-up|1|||
170454540|NCT01347866|616003508|FG009|Overall Study|Lost to Follow-up|0|||
170454541|NCT01347866|616003509|FG010|Overall Study|Lost to Follow-up|0|||
170454542|NCT01347866|616003510|FG011|Overall Study|Lost to Follow-up|0|||
170454543|NCT01347866|616003511|FG012|Overall Study|Lost to Follow-up|0|||
170454544|NCT01347866|616003512|FG013|Overall Study|Lost to Follow-up|0|||
170454545|NCT01347866|616003513|FG014|Overall Study|Lost to Follow-up|0|||
170454546|NCT01347866|616003514|FG015|Overall Study|Lost to Follow-up|0|||
170454547|NCT01347866|616003515|FG016|Overall Study|Lost to Follow-up|0|||
170454548|NCT01347866|616003499|FG000|Overall Study|Other|3|||
170454549|NCT01347866|616003500|FG001|Overall Study|Other|1|||
170454550|NCT01347866|616003501|FG002|Overall Study|Other|1|||
170454551|NCT01347866|616003502|FG003|Overall Study|Other|4|||
170454552|NCT01347866|616003503|FG004|Overall Study|Other|5|||
170454553|NCT01347866|616003504|FG005|Overall Study|Other|0|||
170454554|NCT01347866|616003505|FG006|Overall Study|Other|5|||
170454555|NCT01347866|616003506|FG007|Overall Study|Other|3|||
170454556|NCT01347866|616003507|FG008|Overall Study|Other|22|||
170454557|NCT01347866|616003508|FG009|Overall Study|Other|5|||
170454558|NCT01347866|616003509|FG010|Overall Study|Other|0|||
170454559|NCT01347866|616003510|FG011|Overall Study|Other|3|||
170454560|NCT01347866|616003511|FG012|Overall Study|Other|4|||
170454561|NCT01347866|616003512|FG013|Overall Study|Other|4|||
170454562|NCT01347866|616003513|FG014|Overall Study|Other|2|||
170454563|NCT01347866|616003514|FG015|Overall Study|Other|3|||
170454564|NCT01347866|616003515|FG016|Overall Study|Other|0|||
170454565|NCT01347866|616003499|FG000|Overall Study|Subject refused further follow-up|2|||
170454566|NCT01347866|616003500|FG001|Overall Study|Subject refused further follow-up|0|||
170454567|NCT01347866|616003501|FG002|Overall Study|Subject refused further follow-up|0|||
170454568|NCT01347866|616003502|FG003|Overall Study|Subject refused further follow-up|2|||
170454569|NCT01347866|616003503|FG004|Overall Study|Subject refused further follow-up|0|||
170454570|NCT01347866|616003504|FG005|Overall Study|Subject refused further follow-up|1|||
170454571|NCT01347866|616003505|FG006|Overall Study|Subject refused further follow-up|0|||
170454572|NCT01347866|616003506|FG007|Overall Study|Subject refused further follow-up|0|||
170454573|NCT01347866|616003507|FG008|Overall Study|Subject refused further follow-up|4|||
170454574|NCT01347866|616003508|FG009|Overall Study|Subject refused further follow-up|1|||
170454575|NCT01347866|616003509|FG010|Overall Study|Subject refused further follow-up|0|||
170454576|NCT01347866|616003510|FG011|Overall Study|Subject refused further follow-up|0|||
170454577|NCT01347866|616003511|FG012|Overall Study|Subject refused further follow-up|1|||
170454578|NCT01347866|616003512|FG013|Overall Study|Subject refused further follow-up|3|||
170454579|NCT01347866|616003513|FG014|Overall Study|Subject refused further follow-up|1|||
170454580|NCT01347866|616003514|FG015|Overall Study|Subject refused further follow-up|0|||
170454581|NCT01347866|616003515|FG016|Overall Study|Subject refused further follow-up|2|||
170454582|NCT00706992|616003518|FG000|Overall Study|Study termination|5|||
170454583|NCT00706992|616003519|FG001|Overall Study|Study termination|5|||
170454584|NCT00706992|616003520|FG002|Overall Study|Study termination|6|||
170454585|NCT00706992|616003521|FG003|Overall Study|Study termination|2|||
170454586|NCT00706992|616003522|FG004|Overall Study|Study termination|3|||
170454587|NCT00706992|616003523|FG005|Overall Study|Study termination|2|||
170454588|NCT00706992|616003524|FG006|Overall Study|Study termination|3|||
170454589|NCT00706992|616003518|FG000|Overall Study|Disease progression before treatment|0|||
170454590|NCT00706992|616003519|FG001|Overall Study|Disease progression before treatment|0|||
170542472|NCT00021255|616329742|FG000|Overall Study|Breast cancer relapse|5|||
170454591|NCT00706992|616003520|FG002|Overall Study|Disease progression before treatment|0|||
170454592|NCT00706992|616003521|FG003|Overall Study|Disease progression before treatment|0|||
170454593|NCT00706992|616003522|FG004|Overall Study|Disease progression before treatment|1|||
170454594|NCT00706992|616003523|FG005|Overall Study|Disease progression before treatment|0|||
170454595|NCT00706992|616003524|FG006|Overall Study|Disease progression before treatment|0|||
170454596|NCT02025751|616003532|FG000|Overall Study|Lost to Follow-up|1|||
170454597|NCT02025751|616003533|FG001|Overall Study|Lost to Follow-up|0|||
170542473|NCT00021255|616329743|FG001|Overall Study|Breast cancer relapse|18|||
170542474|NCT00021255|616329744|FG002|Overall Study|Breast cancer relapse|11|||
170542475|NCT00021255|616329742|FG000|Overall Study|Second primary malignancy|0|||
170542476|NCT00021255|616329743|FG001|Overall Study|Second primary malignancy|4|||
170542477|NCT00021255|616329744|FG002|Overall Study|Second primary malignancy|1|||
170542478|NCT00021255|616329742|FG000|Overall Study|Withdrawal by Subject|41|||
170542479|NCT00021255|616329743|FG001|Overall Study|Withdrawal by Subject|64|||
170542480|NCT00021255|616329744|FG002|Overall Study|Withdrawal by Subject|26|||
170542481|NCT00021255|616329742|FG000|Overall Study|Lost to Follow-up|0|||
170542482|NCT00021255|616329743|FG001|Overall Study|Lost to Follow-up|2|||
170542483|NCT00021255|616329744|FG002|Overall Study|Lost to Follow-up|3|||
170542484|NCT00021255|616329742|FG000|Overall Study|Cardiac toxicity|0|||
170542485|NCT00021255|616329743|FG001|Overall Study|Cardiac toxicity|61|||
170542486|NCT00021255|616329744|FG002|Overall Study|Cardiac toxicity|32|||
170542487|NCT00021255|616329742|FG000|Overall Study|Herceptin toxicity|0|||
170542488|NCT00021255|616329743|FG001|Overall Study|Herceptin toxicity|22|||
170542489|NCT00021255|616329744|FG002|Overall Study|Herceptin toxicity|6|||
170542490|NCT00021255|616329742|FG000|Overall Study|Adverse Event|46|||
170542491|NCT00021255|616329743|FG001|Overall Study|Adverse Event|30|||
170542492|NCT00021255|616329744|FG002|Overall Study|Adverse Event|18|||
170542493|NCT00021255|616329742|FG000|Overall Study|Protocol Violation|0|||
170542494|NCT00021255|616329743|FG001|Overall Study|Protocol Violation|2|||
170542495|NCT00021255|616329744|FG002|Overall Study|Protocol Violation|0|||
170542496|NCT00021255|616329742|FG000|Overall Study|Other than specified above|0|||
170542497|NCT00021255|616329743|FG001|Overall Study|Other than specified above|38|||
170542498|NCT00021255|616329744|FG002|Overall Study|Other than specified above|19|||
170542499|NCT00021255|616329742|FG000|Overall Study|Missing|0|||
170542500|NCT00021255|616329743|FG001|Overall Study|Missing|27|||
170542501|NCT00021255|616329744|FG002|Overall Study|Missing|13|||
170542502|NCT00021255|616329742|FG000|Overall Study|Randomized but not treated|28|||
170542503|NCT00021255|616329743|FG001|Overall Study|Randomized but not treated|2|||
170542504|NCT00021255|616329744|FG002|Overall Study|Randomized but not treated|18|||
170542505|NCT02734004|616329745|FG000|Overall Study|Death|36|||
170542506|NCT02734004|616329746|FG001|Overall Study|Death|24|||
170542507|NCT02734004|616329747|FG002|Overall Study|Death|26|||
170542508|NCT02734004|616329748|FG003|Overall Study|Death|35|||
170542509|NCT02734004|616329749|FG004|Overall Study|Death|13|||
170542510|NCT02734004|616329750|FG005|Overall Study|Death|17|||
170542511|NCT02734004|616329751|FG006|Overall Study|Death|20|||
170542512|NCT02734004|616329745|FG000|Overall Study|Lost to Follow-up|1|||
170542513|NCT02734004|616329746|FG001|Overall Study|Lost to Follow-up|1|||
170542514|NCT02734004|616329747|FG002|Overall Study|Lost to Follow-up|0|||
170542515|NCT02734004|616329748|FG003|Overall Study|Lost to Follow-up|0|||
170542516|NCT02734004|616329749|FG004|Overall Study|Lost to Follow-up|1|||
170542517|NCT02734004|616329750|FG005|Overall Study|Lost to Follow-up|0|||
170542518|NCT02734004|616329751|FG006|Overall Study|Lost to Follow-up|0|||
170542519|NCT02734004|616329745|FG000|Overall Study|Withdrawal by Subject|3|||
170542520|NCT02734004|616329746|FG001|Overall Study|Withdrawal by Subject|1|||
170542521|NCT02734004|616329747|FG002|Overall Study|Withdrawal by Subject|1|||
170542522|NCT02734004|616329748|FG003|Overall Study|Withdrawal by Subject|1|||
170542523|NCT02734004|616329749|FG004|Overall Study|Withdrawal by Subject|3|||
170542524|NCT02734004|616329750|FG005|Overall Study|Withdrawal by Subject|0|||
170542525|NCT02734004|616329751|FG006|Overall Study|Withdrawal by Subject|2|||
170542526|NCT02734004|616329745|FG000|Overall Study|Other|0|||
170542527|NCT02734004|616329746|FG001|Overall Study|Other|8|||
170542528|NCT02734004|616329747|FG002|Overall Study|Other|7|||
170542529|NCT02734004|616329748|FG003|Overall Study|Other|4|||
170542530|NCT02734004|616329749|FG004|Overall Study|Other|34|||
170542531|NCT02734004|616329750|FG005|Overall Study|Other|14|||
170542532|NCT02734004|616329751|FG006|Overall Study|Other|10|||
170542533|NCT03957551|616329753|FG000|Overall Study|Adverse Event|2|||
170542534|NCT03957551|616329754|FG001|Overall Study|Adverse Event|2|||
170542535|NCT03957551|616329755|FG002|Overall Study|Adverse Event|6|||
170542536|NCT03957551|616329753|FG000|Overall Study|Physician Decision|1|||
170542537|NCT03957551|616329754|FG001|Overall Study|Physician Decision|0|||
170542538|NCT03957551|616329755|FG002|Overall Study|Physician Decision|2|||
170542539|NCT03957551|616329753|FG000|Overall Study|Withdrawal by Subject|1|||
170542540|NCT03957551|616329754|FG001|Overall Study|Withdrawal by Subject|0|||
170542541|NCT03957551|616329755|FG002|Overall Study|Withdrawal by Subject|2|||
170635544|NCT02557139|616676958|FG002|Overall Study|Significant liver elevation|1|||
170542542|NCT03957551|616329753|FG000|Overall Study|Disease progression|1|||
170635545|NCT02557139|616676956|FG000|Overall Study|Withdrawal by Subject|1|||
170542543|NCT03957551|616329754|FG001|Overall Study|Disease progression|0|||
170542544|NCT03957551|616329755|FG002|Overall Study|Disease progression|8|||
170542545|NCT04305496|616329762|FG000|Global Cohort|Withdrawal by Subject|13|||
170542546|NCT04305496|616329763|FG001|Global Cohort|Withdrawal by Subject|6|||
170542547|NCT04305496|616329762|FG000|Global Cohort|Physician Decision|1|||
170542548|NCT04305496|616329763|FG001|Global Cohort|Physician Decision|1|||
170542549|NCT04305496|616329762|FG000|Global Cohort|Subjective disease progression|16|||
170542550|NCT04305496|616329763|FG001|Global Cohort|Subjective disease progression|17|||
170635546|NCT02557139|616676957|FG001|Overall Study|Withdrawal by Subject|0|||
170635547|NCT02557139|616676958|FG002|Overall Study|Withdrawal by Subject|0|||
170635548|NCT02557139|616676956|FG000|Overall Study|Illness of prohibited medication|0|||
170635549|NCT02557139|616676957|FG001|Overall Study|Illness of prohibited medication|0|||
170635550|NCT02557139|616676958|FG002|Overall Study|Illness of prohibited medication|1|||
170635551|NCT02592798|616676961|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
170635552|NCT02592798|616676962|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
170635553|NCT02592798|616676961|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
170635554|NCT02592798|616676962|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
170635555|NCT02592798|616676961|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
170635556|NCT02592798|616676962|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
170635557|NCT02592798|616676961|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
170635558|NCT02592798|616676962|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
170635559|NCT02592798|616676961|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
170635560|NCT02592798|616676962|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
170635561|NCT02592798|616676961|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
170635562|NCT02592798|616676962|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
170635563|NCT02592798|616676961|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
170635564|NCT02592798|616676962|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
170635565|NCT02592798|616676961|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
170635566|NCT02592798|616676962|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
170635567|NCT02592798|616676961|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
170635568|NCT02592798|616676962|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
170635569|NCT02592798|616676961|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
170635570|NCT02592798|616676962|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
170635571|NCT02592798|616676961|FG000|Transition From DB2 to OLE|Other reasons|1|||
170635572|NCT02592798|616676962|FG001|Transition From DB2 to OLE|Other reasons|0|||
170635573|NCT02592798|616676961|FG000|Open Label Period (OLE)|Other reasons|0|||
170635574|NCT02592798|616676962|FG001|Open Label Period (OLE)|Other reasons|2|||
170635575|NCT02592798|616676961|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
170635576|NCT02592798|616676962|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
170635577|NCT02592798|616676961|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
170635578|NCT02592798|616676962|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
170635579|NCT02592798|616676961|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
170635580|NCT02592798|616676962|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
170635581|NCT02592798|616676961|FG000|Open Label Period (OLE)|Adverse Event|0|||
170635582|NCT02592798|616676962|FG001|Open Label Period (OLE)|Adverse Event|1|||
170635583|NCT01519921|616676963|FG000|Overall Study|Adverse Event|10|||
170635584|NCT01519921|616676964|FG001|Overall Study|Adverse Event|9|||
170635585|NCT01519921|616676963|FG000|Overall Study|Lack of Efficacy|4|||
170635586|NCT01519921|616676964|FG001|Overall Study|Lack of Efficacy|3|||
170635587|NCT01519921|616676963|FG000|Overall Study|Withdrawal by Subject|3|||
170635588|NCT01519921|616676964|FG001|Overall Study|Withdrawal by Subject|0|||
170635589|NCT01519921|616676963|FG000|Overall Study|Lost to Follow-up|2|||
170635590|NCT01519921|616676964|FG001|Overall Study|Lost to Follow-up|1|||
170635591|NCT01519921|616676963|FG000|Overall Study|Treatment refusal|2|||
170635592|NCT01519921|616676964|FG001|Overall Study|Treatment refusal|1|||
170635593|NCT01519921|616676963|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
170635594|NCT01519921|616676964|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
170635595|NCT00357006|616676965|FG000|Overall Study|Lost to Follow-up|1|||
170635596|NCT00357006|616676966|FG001|Overall Study|Lost to Follow-up|2|||
170635597|NCT00357006|616676967|FG002|Overall Study|Lost to Follow-up|1|||
170635598|NCT00357006|616676965|FG000|Overall Study|Withdrawal by Subject|1|||
170635599|NCT00357006|616676966|FG001|Overall Study|Withdrawal by Subject|3|||
170635600|NCT00357006|616676967|FG002|Overall Study|Withdrawal by Subject|2|||
170635601|NCT05375760|616676969|FG000|Overall Study|Adverse Event|1|||
170635602|NCT05375760|616676970|FG001|Overall Study|Adverse Event|0|||
170635603|NCT05375760|616676969|FG000|Overall Study|Death|0|||
170635604|NCT05375760|616676970|FG001|Overall Study|Death|1|||
170787630|NCT03097549|617231832|FG001|Overall Study|Lost to Follow-up|0|||
170787631|NCT04171999|617231833|FG000|Overall Study|deemed ineligible after randomization|2|||
170787632|NCT04171999|617231834|FG001|Overall Study|deemed ineligible after randomization|1|||
170787633|NCT03092518|617231839|FG000|Overall Study|Ineligible|2|||
170787634|NCT02146378|617231842|FG000|Overall Study|No information of administration|2|||
170635605|NCT05375760|616676969|FG000|Overall Study|Lost to Follow-up|6|||
170635606|NCT05375760|616676970|FG001|Overall Study|Lost to Follow-up|6|||
170635607|NCT05375760|616676969|FG000|Overall Study|Withdrawal by Subject|17|||
170635608|NCT05375760|616676970|FG001|Overall Study|Withdrawal by Subject|19|||
170635609|NCT05375760|616676969|FG000|Overall Study|Dosing halted by FDA|96|||
170635610|NCT05375760|616676970|FG001|Overall Study|Dosing halted by FDA|100|||
170635611|NCT05375760|616676969|FG000|Overall Study|Not compliant with study visit|2|||
170635612|NCT05375760|616676970|FG001|Overall Study|Not compliant with study visit|0|||
170635613|NCT05375760|616676969|FG000|Overall Study|Physician Decision|1|||
170787635|NCT05089019|617231843|FG000|Period 1|Withdrawal by Subject|0|||
170454598|NCT02025751|616003532|FG000|Overall Study|Adverse Event|0|||
170454599|NCT02025751|616003533|FG001|Overall Study|Adverse Event|1|||
170454600|NCT02025751|616003532|FG000|Overall Study|Physician Decision|0|||
170454601|NCT02025751|616003533|FG001|Overall Study|Physician Decision|1|||
170454602|NCT02025751|616003532|FG000|Overall Study|Withdrawal by Subject|0|||
170454603|NCT02025751|616003533|FG001|Overall Study|Withdrawal by Subject|1|||
170454604|NCT00851643|616003536|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
170454605|NCT00851643|616003537|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
170454606|NCT00851643|616003538|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
170454607|NCT00851643|616003539|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
170454608|NCT00851643|616003540|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
170454609|NCT00851643|616003541|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
170454610|NCT00851643|616003536|FG000|Base Study (Up to 12 Months)|Other|0|||
170454611|NCT00851643|616003537|FG001|Base Study (Up to 12 Months)|Other|0|||
170454612|NCT00851643|616003538|FG002|Base Study (Up to 12 Months)|Other|0|||
170454613|NCT00851643|616003539|FG003|Base Study (Up to 12 Months)|Other|0|||
170454614|NCT00851643|616003540|FG004|Base Study (Up to 12 Months)|Other|0|||
170454615|NCT00851643|616003541|FG005|Base Study (Up to 12 Months)|Other|1|||
170454616|NCT00851643|616003536|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
170454617|NCT00851643|616003537|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
170454618|NCT00851643|616003538|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
170454619|NCT00851643|616003539|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
170454620|NCT00851643|616003540|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
170454621|NCT00851643|616003541|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
170454622|NCT00851643|616003536|FG000|Extension Study (Up to 36 Months)|Moved|0|||
170454623|NCT00851643|616003537|FG001|Extension Study (Up to 36 Months)|Moved|2|||
170454624|NCT00851643|616003538|FG002|Extension Study (Up to 36 Months)|Moved|1|||
170454625|NCT00851643|616003539|FG003|Extension Study (Up to 36 Months)|Moved|1|||
170454626|NCT00851643|616003540|FG004|Extension Study (Up to 36 Months)|Moved|0|||
170454627|NCT00851643|616003541|FG005|Extension Study (Up to 36 Months)|Moved|1|||
170454628|NCT00359788|616003542|FG000|Overall Study|Adverse Event|11|||
170454629|NCT00359788|616003543|FG001|Overall Study|Adverse Event|10|||
170454630|NCT00359788|616003542|FG000|Overall Study|Lack of Efficacy|1|||
170454631|NCT00359788|616003543|FG001|Overall Study|Lack of Efficacy|2|||
170454632|NCT00359788|616003542|FG000|Overall Study|Lost to Follow-up|3|||
170454633|NCT00359788|616003543|FG001|Overall Study|Lost to Follow-up|2|||
170454634|NCT00359788|616003542|FG000|Overall Study|Withdrawal by Subject|4|||
170454635|NCT00359788|616003543|FG001|Overall Study|Withdrawal by Subject|1|||
170454636|NCT00359788|616003542|FG000|Overall Study|Protocol Violation|4|||
170454637|NCT00359788|616003543|FG001|Overall Study|Protocol Violation|2|||
170454638|NCT01297322|616003544|FG000|Overall Study|Lost to Follow-up|1|||
170454639|NCT01297322|616003545|FG001|Overall Study|Lost to Follow-up|0|||
170454640|NCT01297322|616003544|FG000|Overall Study|Withdrawal by Subject|0|||
170454641|NCT01297322|616003545|FG001|Overall Study|Withdrawal by Subject|1|||
170454642|NCT01297322|616003544|FG000|Overall Study|Protocol Violation|0|||
170454643|NCT01297322|616003545|FG001|Overall Study|Protocol Violation|3|||
170454644|NCT01111019|616003546|FG000|Overall Study|Withdrew Prematurely|2|||
170454645|NCT01111019|616003546|FG000|Overall Study|Other|1|||
170454646|NCT01902628|616003549|FG000|Overall Study|Withdrawal of participant's consent|7|||
170454647|NCT01902628|616003549|FG000|Overall Study|Adverse Event|41|||
170454648|NCT01902628|616003549|FG000|Overall Study|Lost to Follow-up|35|||
170454649|NCT01232491|616003550|FG000|Overall Study|Adverse Event|13|||
170454650|NCT01232491|616003551|FG001|Overall Study|Adverse Event|8|||
170454651|NCT01232491|616003550|FG000|Overall Study|Lack of Efficacy|1|||
170454652|NCT01232491|616003551|FG001|Overall Study|Lack of Efficacy|5|||
170454653|NCT01232491|616003550|FG000|Overall Study|Protocol Violation|13|||
170454654|NCT01232491|616003551|FG001|Overall Study|Protocol Violation|11|||
170454655|NCT01232491|616003550|FG000|Overall Study|Withdrawal Criteria|12|||
170454656|NCT01232491|616003551|FG001|Overall Study|Withdrawal Criteria|21|||
170454657|NCT01232491|616003550|FG000|Overall Study|Other|21|||
170454658|NCT01232491|616003551|FG001|Overall Study|Other|18|||
170454659|NCT03747601|616005352|FG000|Overall Study|COVID halt to visits|4|||
170454660|NCT00461253|616005353|FG000|Overall Study|Death|985|||
170454661|NCT00461253|616005354|FG001|Overall Study|Death|0|||
170454662|NCT00461253|616005353|FG000|Overall Study|Protocol Violation|613|||
170454663|NCT00461253|616005354|FG001|Overall Study|Protocol Violation|236|||
170454664|NCT00461253|616005353|FG000|Overall Study|no response|2609|||
170454665|NCT00461253|616005354|FG001|Overall Study|no response|11789|||
170542551|NCT04305496|616329762|FG000|Global Cohort|Condition under investigation worsened|209|||
170542552|NCT04305496|616329763|FG001|Global Cohort|Condition under investigation worsened|273|||
170454666|NCT00461253|616005353|FG000|Overall Study|administrative|773|||
170454667|NCT00461253|616005354|FG001|Overall Study|administrative|7773|||
170454668|NCT02297438|616005355|FG000|Overall Study|Death|79|||
170454669|NCT02297438|616005356|FG001|Overall Study|Death|86|||
170454670|NCT02297438|616005355|FG000|Overall Study|Lost to Follow-up|9|||
170454671|NCT02297438|616005356|FG001|Overall Study|Lost to Follow-up|7|||
170542553|NCT04305496|616329762|FG000|Global Cohort|Protocol Violation|2|||
170787636|NCT05089019|617231844|FG001|Period 1|Withdrawal by Subject|1|||
170787637|NCT05089019|617231843|FG000|Washout Period|Adverse Event|3|||
170787638|NCT05089019|617231844|FG001|Washout Period|Adverse Event|4|||
170888564|NCT00852995|617598361|FG003|Overall Study|Non-Compliance|2|||
170454672|NCT02297438|616005355|FG000|Overall Study|Withdrawal by Subject|7|||
170454673|NCT02297438|616005356|FG001|Overall Study|Withdrawal by Subject|0|||
170454674|NCT02297438|616005355|FG000|Overall Study|Other|9|||
170454675|NCT02297438|616005356|FG001|Overall Study|Other|5|||
170454676|NCT02297438|616005355|FG000|Overall Study|Ongoing|65|||
170454677|NCT02297438|616005356|FG001|Overall Study|Ongoing|73|||
170454678|NCT05142566|616005357|FG000|Overall Study|Protocol Violation|1|||
170454679|NCT02221037|616005358|FG000|Overall Study|Physician Decision|0|||
170454680|NCT02221037|616005359|FG001|Overall Study|Physician Decision|0|||
170454681|NCT02221037|616005360|FG002|Overall Study|Physician Decision|1|||
170454682|NCT02221037|616005361|FG003|Overall Study|Physician Decision|0|||
170454683|NCT01553279|616005363|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
170454684|NCT01553279|616005364|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
170454685|NCT01553279|616005363|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
170454686|NCT01553279|616005364|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
170454687|NCT01553279|616005363|FG000|Interim Period|Withdrawal by Subject|2|||
170454688|NCT01553279|616005364|FG001|Interim Period|Withdrawal by Subject|2|||
170454689|NCT01553279|616005363|FG000|Interim Period|Lost to Follow-up|1|||
170454690|NCT01553279|616005364|FG001|Interim Period|Lost to Follow-up|0|||
170542554|NCT04305496|616329763|FG001|Global Cohort|Protocol Violation|0|||
170542555|NCT04305496|616329762|FG000|Global Cohort|Adverse Event|44|||
170542556|NCT04305496|616329763|FG001|Global Cohort|Adverse Event|6|||
170542557|NCT04305496|616329762|FG000|Global Cohort|Death|3|||
170542558|NCT04305496|616329763|FG001|Global Cohort|Death|2|||
170542559|NCT04305496|616329762|FG000|Global Cohort|Any reason not specifically recorded|4|||
170542560|NCT04305496|616329763|FG001|Global Cohort|Any reason not specifically recorded|5|||
170542561|NCT04305496|616329762|FG000|China Cohort|Any reason not specifically recorded|1|||
170542562|NCT04305496|616329763|FG001|China Cohort|Any reason not specifically recorded|1|||
170542563|NCT04305496|616329762|FG000|China Cohort|Adverse Event|8|||
170542564|NCT04305496|616329763|FG001|China Cohort|Adverse Event|2|||
170542565|NCT04305496|616329762|FG000|China Cohort|Condition under investigation worsened|40|||
170542566|NCT04305496|616329763|FG001|China Cohort|Condition under investigation worsened|47|||
170542567|NCT04305496|616329762|FG000|China Cohort|Subjective disease progression|2|||
170542568|NCT04305496|616329763|FG001|China Cohort|Subjective disease progression|2|||
170542569|NCT04305496|616329762|FG000|China Cohort|Withdrawal by Subject|2|||
170542570|NCT04305496|616329763|FG001|China Cohort|Withdrawal by Subject|1|||
170542571|NCT03944629|616329764|FG000|Overall Study|Withdrawal by Subject|1|||
170542572|NCT03944629|616329765|FG001|Overall Study|Withdrawal by Subject|2|||
170542573|NCT02405221|616329766|FG000|Overall Study|Adverse Event|1|||
170542574|NCT02405221|616329767|FG001|Overall Study|Adverse Event|0|||
170542575|NCT02405221|616329766|FG000|Overall Study|Lost to Follow-up|1|||
170542576|NCT02405221|616329767|FG001|Overall Study|Lost to Follow-up|1|||
170542577|NCT04224961|616329768|FG000|Overall Study|Withdrawal by Subject|1|||
170542578|NCT04224961|616329769|FG001|Overall Study|Withdrawal by Subject|1|||
170454691|NCT01553279|616005363|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
170542579|NCT04941898|616331036|FG000|Overall Study|Protocol Violation|1|||
170542580|NCT01653262|616331037|FG000|Overall Study|Lack of Efficacy|1|||
170542581|NCT01653262|616331037|FG000|Overall Study|SAE, non-fatal|1|||
170542582|NCT01653262|616331037|FG000|Overall Study|AE, non-serious non-fatal|1|||
170542583|NCT01112267|616331038|FG000|Overall Study|Adverse Event|24|||
170542584|NCT01112267|616331039|FG001|Overall Study|Adverse Event|6|||
170542585|NCT01112267|616331038|FG000|Overall Study|Withdrawal by Subject|3|||
170542586|NCT01112267|616331039|FG001|Overall Study|Withdrawal by Subject|5|||
170542587|NCT01112267|616331038|FG000|Overall Study|Protocol Violation|5|||
170542588|NCT01112267|616331039|FG001|Overall Study|Protocol Violation|3|||
170542589|NCT01112267|616331038|FG000|Overall Study|Participants not compliant|1|||
170542590|NCT01112267|616331039|FG001|Overall Study|Participants not compliant|2|||
170542591|NCT01112267|616331038|FG000|Overall Study|Participants not receive any study drug|1|||
170542592|NCT01112267|616331039|FG001|Overall Study|Participants not receive any study drug|2|||
170542593|NCT02014103|616331040|FG000|Overall Study|Protocol Violation|7|||
170542594|NCT02014103|616331041|FG001|Overall Study|Protocol Violation|7|||
170542595|NCT02014103|616331040|FG000|Overall Study|Adverse Event|1|||
170542596|NCT02014103|616331041|FG001|Overall Study|Adverse Event|0|||
170542597|NCT02014103|616331040|FG000|Overall Study|Lost venous access|1|||
170542598|NCT02014103|616331041|FG001|Overall Study|Lost venous access|0|||
170542599|NCT02014103|616331040|FG000|Overall Study|Withdrawal by Subject|0|||
170542600|NCT02014103|616331041|FG001|Overall Study|Withdrawal by Subject|2|||
170542601|NCT03641924|616331044|FG000|Overall Study|Withdrawal by Subject|26|||
170542602|NCT03641924|616331044|FG000|Overall Study|Lost to Follow-up|16|||
170542603|NCT03641924|616331044|FG000|Overall Study|Protocol Violation|10|||
170542604|NCT01373229|616331048|FG000|Overall Study|Death|3|||
170542605|NCT01373229|616331048|FG000|Overall Study|Physician Decision|3|||
170542606|NCT00587457|616331049|FG000|Overall Study|Adverse Event|1|||
170454692|NCT01553279|616005364|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
170454693|NCT01553279|616005363|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
170454694|NCT01553279|616005364|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
170454695|NCT00605865|616005365|FG000|Overall Study|Protocol Violation|115|||
170454696|NCT01884311|616005366|FG000|Overall Study|Withdrawal by Subject|3|||
170454697|NCT01884311|616005366|FG000|Overall Study|withdrew consent due to AEs|1|||
170454698|NCT01884311|616005366|FG000|Overall Study|Precautionary measure|1|||
170454699|NCT02307266|616005367|FG000|Overall Study|Adverse Event|3|||
170454700|NCT02307266|616005368|FG001|Overall Study|Adverse Event|1|||
170454701|NCT02307266|616005369|FG002|Overall Study|Adverse Event|5|||
170454702|NCT02307266|616005367|FG000|Overall Study|Withdrawal by Subject|2|||
170454703|NCT02307266|616005368|FG001|Overall Study|Withdrawal by Subject|0|||
170454704|NCT02307266|616005369|FG002|Overall Study|Withdrawal by Subject|1|||
170454705|NCT02307266|616005367|FG000|Overall Study|Lost to Follow-up|3|||
170454706|NCT02307266|616005368|FG001|Overall Study|Lost to Follow-up|0|||
170454707|NCT02307266|616005369|FG002|Overall Study|Lost to Follow-up|0|||
170454708|NCT00573157|616005370|FG000|Overall Study|Adverse Event|3|||
170454709|NCT00573157|616005371|FG001|Overall Study|Adverse Event|1|||
170454710|NCT00573157|616005370|FG000|Overall Study|Other|1|||
170454711|NCT00573157|616005371|FG001|Overall Study|Other|1|||
170454712|NCT02944383|616005372|FG000|Overall Study|Lost to Follow-up|0|||
170454713|NCT02944383|616005373|FG001|Overall Study|Lost to Follow-up|0|||
170454714|NCT02944383|616005374|FG002|Overall Study|Lost to Follow-up|1|||
170454715|NCT02944383|616005372|FG000|Overall Study|Withdrawal by Subject|1|||
170454716|NCT02944383|616005373|FG001|Overall Study|Withdrawal by Subject|0|||
170454717|NCT02944383|616005374|FG002|Overall Study|Withdrawal by Subject|0|||
170454718|NCT00094458|616005375|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
170454719|NCT00094458|616005376|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
170454720|NCT00094458|616005377|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
170454721|NCT00094458|616005378|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
170454722|NCT00094458|616005379|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
170454723|NCT00094458|616005380|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
170454724|NCT00094458|616005375|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
170454725|NCT00094458|616005376|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
170454726|NCT00094458|616005377|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
170454727|NCT00094458|616005378|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
170454728|NCT00094458|616005379|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
170454729|NCT00094458|616005380|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
170454730|NCT00094458|616005375|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
170454731|NCT00094458|616005376|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
170454732|NCT00094458|616005377|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
170635614|NCT05375760|616676970|FG001|Overall Study|Physician Decision|0|||
170787639|NCT05089019|617231843|FG000|Washout Period|Lost to Follow-up|1|||
170454733|NCT00094458|616005378|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
170454734|NCT00094458|616005379|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
170454735|NCT00094458|616005380|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
170454736|NCT00094458|616005375|FG000|Main Study: Through Week 30|Adverse Event|38|||
170454737|NCT00094458|616005376|FG001|Main Study: Through Week 30|Adverse Event|20|||
170454738|NCT00094458|616005377|FG002|Main Study: Through Week 30|Adverse Event|28|||
170454739|NCT00094458|616005378|FG003|Main Study: Through Week 30|Adverse Event|0|||
170454740|NCT00094458|616005379|FG004|Main Study: Through Week 30|Adverse Event|0|||
170454741|NCT00094458|616005380|FG005|Main Study: Through Week 30|Adverse Event|0|||
170454742|NCT00094458|616005375|FG000|Main Study: Through Week 30|Death|1|||
170454743|NCT00094458|616005376|FG001|Main Study: Through Week 30|Death|0|||
170454744|NCT00094458|616005377|FG002|Main Study: Through Week 30|Death|0|||
170454745|NCT00094458|616005378|FG003|Main Study: Through Week 30|Death|0|||
170454746|NCT00094458|616005379|FG004|Main Study: Through Week 30|Death|0|||
170454747|NCT00094458|616005380|FG005|Main Study: Through Week 30|Death|0|||
170454748|NCT00094458|616005375|FG000|Main Study: Through Week 30|Other|19|||
170454749|NCT00094458|616005376|FG001|Main Study: Through Week 30|Other|16|||
170454750|NCT00094458|616005377|FG002|Main Study: Through Week 30|Other|9|||
170454751|NCT00094458|616005378|FG003|Main Study: Through Week 30|Other|0|||
170454752|NCT00094458|616005379|FG004|Main Study: Through Week 30|Other|0|||
170787640|NCT05089019|617231844|FG001|Washout Period|Lost to Follow-up|0|||
170454753|NCT00094458|616005380|FG005|Main Study: Through Week 30|Other|0|||
170454754|NCT00094458|616005375|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
170454755|NCT00094458|616005376|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
170454756|NCT00094458|616005377|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
170454757|NCT00094458|616005378|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
170454758|NCT00094458|616005379|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
170454759|NCT00094458|616005380|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
170454760|NCT00094458|616005375|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
170454761|NCT00094458|616005376|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
170787641|NCT05089019|617231843|FG000|Washout Period|Physician Decision|2|||
170787642|NCT05089019|617231844|FG001|Washout Period|Physician Decision|0|||
170787643|NCT05089019|617231843|FG000|Washout Period|Withdrawal by Subject|6|||
170454762|NCT00094458|616005377|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
170454763|NCT00094458|616005378|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
170454764|NCT00094458|616005379|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
170454765|NCT00094458|616005380|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
170454766|NCT00094458|616005375|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
170454767|NCT00094458|616005376|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
170454768|NCT00094458|616005377|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
170454769|NCT00094458|616005378|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
170454770|NCT00094458|616005379|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
170454771|NCT00094458|616005380|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
170454772|NCT00094458|616005375|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
170454773|NCT00094458|616005376|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
170454774|NCT00094458|616005377|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
170454775|NCT00094458|616005378|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
170454776|NCT00094458|616005379|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
170454777|NCT00094458|616005380|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
170454778|NCT00094458|616005375|FG000|OLE: Open-Label Extension|Adverse Event|0|||
170454779|NCT00094458|616005376|FG001|OLE: Open-Label Extension|Adverse Event|0|||
170454780|NCT00094458|616005377|FG002|OLE: Open-Label Extension|Adverse Event|0|||
170454781|NCT00094458|616005378|FG003|OLE: Open-Label Extension|Adverse Event|0|||
170454782|NCT00094458|616005379|FG004|OLE: Open-Label Extension|Adverse Event|3|||
170454783|NCT00094458|616005380|FG005|OLE: Open-Label Extension|Adverse Event|4|||
170454784|NCT00094458|616005375|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
170454785|NCT00094458|616005376|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
170454786|NCT00094458|616005377|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
170454787|NCT00094458|616005378|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
170454788|NCT00094458|616005379|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
170454789|NCT00094458|616005380|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
170454790|NCT00094458|616005375|FG000|OLE: Open-Label Extension|Patient decision|0|||
170454791|NCT00094458|616005376|FG001|OLE: Open-Label Extension|Patient decision|0|||
170454792|NCT00094458|616005377|FG002|OLE: Open-Label Extension|Patient decision|0|||
170454793|NCT00094458|616005378|FG003|OLE: Open-Label Extension|Patient decision|0|||
170454794|NCT00094458|616005379|FG004|OLE: Open-Label Extension|Patient decision|1|||
170454795|NCT00094458|616005380|FG005|OLE: Open-Label Extension|Patient decision|0|||
170454796|NCT01995266|616005382|FG000|Overall Study|Death|1|||
170454797|NCT01995266|616005382|FG000|Overall Study|Lack of Efficacy|6|||
170454798|NCT01995266|616005382|FG000|Overall Study|Adverse Event|2|||
170454799|NCT03247517|616005383|FG000|Overall Study|Adverse Event|0|||
170454800|NCT03247517|616005384|FG001|Overall Study|Adverse Event|4|||
170454801|NCT03247517|616005385|FG002|Overall Study|Adverse Event|2|||
170454802|NCT03247517|616005383|FG000|Overall Study|Lost to Follow-up|2|||
170454803|NCT03247517|616005384|FG001|Overall Study|Lost to Follow-up|6|||
170454804|NCT03247517|616005385|FG002|Overall Study|Lost to Follow-up|4|||
170454805|NCT03247517|616005383|FG000|Overall Study|Consent withdrawn by caregiver|1|||
170454806|NCT03247517|616005384|FG001|Overall Study|Consent withdrawn by caregiver|4|||
170542607|NCT00587457|616331050|FG001|Overall Study|Adverse Event|2|||
170542608|NCT00587457|616331051|FG002|Overall Study|Adverse Event|1|||
170542609|NCT00587457|616331049|FG000|Overall Study|Disease progression|2|||
170542610|NCT00587457|616331050|FG001|Overall Study|Disease progression|0|||
170542611|NCT00587457|616331051|FG002|Overall Study|Disease progression|2|||
170542612|NCT00587457|616331049|FG000|Overall Study|Initiation of alternative therapy|0|||
170542613|NCT00587457|616331050|FG001|Overall Study|Initiation of alternative therapy|1|||
170542614|NCT00587457|616331051|FG002|Overall Study|Initiation of alternative therapy|0|||
170542615|NCT00587457|616331049|FG000|Overall Study|Undefined|0|||
170542616|NCT00587457|616331050|FG001|Overall Study|Undefined|0|||
170542617|NCT00587457|616331051|FG002|Overall Study|Undefined|1|||
170542618|NCT00587457|616331049|FG000|Overall Study|Development of neutralizing Abs|0|||
170542619|NCT00587457|616331050|FG001|Overall Study|Development of neutralizing Abs|0|||
170542620|NCT00587457|616331051|FG002|Overall Study|Development of neutralizing Abs|1|||
170542621|NCT04439175|616331052|FG000|Overall Study|Never started treatment|4|||
170542622|NCT04439175|616331052|FG000|Overall Study|Ineligible|5|||
170542623|NCT04439175|616331052|FG000|Overall Study|Adverse Event|6|||
170542624|NCT04439175|616331052|FG000|Overall Study|Death|4|||
170542625|NCT04439175|616331052|FG000|Overall Study|Disease progression|44|||
170542626|NCT04439175|616331052|FG000|Overall Study|Withdrawal by Subject|4|||
170542627|NCT04439175|616331052|FG000|Overall Study|Alternative Therapy|1|||
170542628|NCT04439175|616331052|FG000|Overall Study|Other|2|||
170542629|NCT01847209|616331055|FG000|Overall Study|Withdrawal by Subject|1|||
170542630|NCT01847209|616331055|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
170542631|NCT00729586|616331056|FG000|Overall Study|Ineligible|0|||
170542632|NCT00729586|616331057|FG001|Overall Study|Ineligible|1|||
170888565|NCT00852995|617598362|FG004|Overall Study|Non-Compliance|0|||
170454807|NCT03247517|616005385|FG002|Overall Study|Consent withdrawn by caregiver|7|||
170454808|NCT03247517|616005383|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
170454809|NCT03247517|616005384|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
170454810|NCT03247517|616005385|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
170454811|NCT03247517|616005383|FG000|Overall Study|Protocol Violation|0|||
170454812|NCT03247517|616005384|FG001|Overall Study|Protocol Violation|2|||
170454813|NCT03247517|616005385|FG002|Overall Study|Protocol Violation|0|||
170454814|NCT03247517|616005383|FG000|Overall Study|Multiple reasons|3|||
170454815|NCT03247517|616005384|FG001|Overall Study|Multiple reasons|1|||
170454816|NCT03247517|616005385|FG002|Overall Study|Multiple reasons|0|||
170454817|NCT03310411|616005386|FG000|Period 1|Adverse Event|0|||
170454818|NCT03310411|616005387|FG001|Period 1|Adverse Event|0|||
170454819|NCT03310411|616005388|FG002|Period 1|Adverse Event|0|||
170454820|NCT03310411|616005389|FG003|Period 1|Adverse Event|1|||
170454821|NCT00619112|616005390|FG000|Overall Study|Adverse Event|1|||
170454822|NCT00619112|616005391|FG001|Overall Study|Adverse Event|2|||
170454823|NCT03623386|616005394|FG000|Overall Study|Protocol Violation|3|||
170454824|NCT03623386|616005395|FG001|Overall Study|Protocol Violation|2|||
170454825|NCT03623386|616005396|FG002|Overall Study|Protocol Violation|0|||
170454826|NCT03623386|616005394|FG000|Overall Study|Physician Decision|1|||
170454827|NCT03623386|616005395|FG001|Overall Study|Physician Decision|1|||
170454828|NCT03623386|616005396|FG002|Overall Study|Physician Decision|0|||
170454829|NCT03623386|616005394|FG000|Overall Study|Lost to Follow-up|0|||
170454830|NCT03623386|616005395|FG001|Overall Study|Lost to Follow-up|2|||
170454831|NCT03623386|616005396|FG002|Overall Study|Lost to Follow-up|0|||
170454832|NCT03623386|616005394|FG000|Overall Study|COVID-19|0|||
170454833|NCT03623386|616005395|FG001|Overall Study|COVID-19|1|||
170454834|NCT03623386|616005396|FG002|Overall Study|COVID-19|0|||
170454835|NCT00599521|616005401|FG000|Overall Study|Lack of Efficacy|4|||
170454836|NCT00599521|616005402|FG001|Overall Study|Lack of Efficacy|8|||
170454837|NCT00599521|616005401|FG000|Overall Study|Adverse Event|4|||
170454838|NCT00599521|616005402|FG001|Overall Study|Adverse Event|1|||
170454839|NCT00599521|616005401|FG000|Overall Study|Withdrawal by Subject|28|||
170454840|NCT00599521|616005402|FG001|Overall Study|Withdrawal by Subject|34|||
170454841|NCT00599521|616005401|FG000|Overall Study|Protocol Violation|1|||
170454842|NCT00599521|616005402|FG001|Overall Study|Protocol Violation|1|||
170454843|NCT00599521|616005401|FG000|Overall Study|Lost to Follow-up|23|||
170454844|NCT00599521|616005402|FG001|Overall Study|Lost to Follow-up|23|||
170454845|NCT00599521|616005401|FG000|Overall Study|Pregnancy|0|||
170454846|NCT00599521|616005402|FG001|Overall Study|Pregnancy|2|||
170454847|NCT04397445|616005407|FG000|Overall Study|Withdrawal by Subject|1|||
170454848|NCT04397445|616005408|FG001|Overall Study|Withdrawal by Subject|0|||
170454849|NCT04397445|616005409|FG002|Overall Study|Withdrawal by Subject|0|||
170454850|NCT04397445|616005410|FG003|Overall Study|Withdrawal by Subject|0|||
170454851|NCT00891371|616005413|FG000|Pre-assignment|Inclusion/exclusion|5|||
170454852|NCT00891371|616005413|FG000|Pre-assignment|Consent withdrawal|1|||
170454853|NCT00891371|616005413|FG000|Treatment|Lack of Efficacy|5|||
170454854|NCT00891371|616005413|FG000|Treatment|Adverse Event|2|||
170454855|NCT00891371|616005413|FG000|Treatment|Death|1|||
170454856|NCT00891371|616005413|FG000|Treatment|Lost to Follow-up|1|||
170454857|NCT00857792|616005414|FG000|Overall Study|inadequate image quality for analysis|12|||
170454858|NCT01797835|616005415|FG000|Overall Study|Lost to Follow-up|31|||
170454859|NCT01797835|616005416|FG001|Overall Study|Lost to Follow-up|27|||
170454860|NCT03760250|616005417|FG000|Overall Study|Withdrawal by Subject|1|||
170454861|NCT03760250|616005417|FG000|Overall Study|Physician Decision|1|||
170454862|NCT03733210|616005419|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
170454863|NCT03733210|616005420|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
170454864|NCT02621034|616005427|FG000|Overall Study|Lost to Follow-up|3|||
170454865|NCT02621034|616005428|FG001|Overall Study|Lost to Follow-up|2|||
170454866|NCT02621034|616005429|FG002|Overall Study|Lost to Follow-up|5|||
170454867|NCT02963441|616005442|FG000|Overall Study|Protocol violation or withdrawn|8|||
170454868|NCT02963441|616005442|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
170454869|NCT02963441|616005442|FG000|Overall Study|IDx-DR insufficient quality|33|||
170454870|NCT04688931|616005445|FG000|Overall Study|Adverse Event|4|||
170542633|NCT00729586|616331056|FG000|Overall Study|never treated|1|||
170542634|NCT00729586|616331057|FG001|Overall Study|never treated|0|||
170542635|NCT01631188|616331058|FG000|Overall Study|Physician Decision|75|||
170454871|NCT04688931|616005446|FG001|Overall Study|Adverse Event|1|||
170454872|NCT04688931|616005445|FG000|Overall Study|Withdrawal by Subject|5|||
170454873|NCT04688931|616005446|FG001|Overall Study|Withdrawal by Subject|16|||
170454874|NCT04688931|616005445|FG000|Overall Study|Physician Decision|3|||
170454875|NCT04688931|616005446|FG001|Overall Study|Physician Decision|5|||
170454876|NCT04688931|616005445|FG000|Overall Study|Noncompliance|0|||
170454877|NCT04688931|616005446|FG001|Overall Study|Noncompliance|1|||
170454878|NCT04688931|616005445|FG000|Overall Study|Lost to Follow-up|1|||
170454879|NCT04688931|616005446|FG001|Overall Study|Lost to Follow-up|3|||
170454880|NCT04688931|616005445|FG000|Overall Study|Randomization Error|3|||
170454881|NCT04688931|616005446|FG001|Overall Study|Randomization Error|0|||
170542636|NCT02513199|616331062|FG000|Treatment|Death|1|||
170454882|NCT04688931|616005445|FG000|Overall Study|Not Eligible|1|||
170454883|NCT04688931|616005446|FG001|Overall Study|Not Eligible|3|||
170454884|NCT04688931|616005445|FG000|Overall Study|Disease Progression|0|||
170454885|NCT04688931|616005446|FG001|Overall Study|Disease Progression|2|||
170454886|NCT04688931|616005445|FG000|Overall Study|Sponsor Requirement|1|||
170454887|NCT04688931|616005446|FG001|Overall Study|Sponsor Requirement|1|||
170454888|NCT04688931|616005445|FG000|Overall Study|Other Reason|1|||
170454889|NCT04688931|616005446|FG001|Overall Study|Other Reason|2|||
170454890|NCT00974974|616005448|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
170454891|NCT00974974|616005449|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
170454892|NCT00974974|616005448|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
170454893|NCT00974974|616005449|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
170454894|NCT00974974|616005448|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
170454895|NCT00974974|616005449|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
170454896|NCT00974974|616005448|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
170454897|NCT00974974|616005449|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
170454898|NCT00974974|616005448|FG000|IR CD-LD Dose Adjustment|Various|0|||
170454899|NCT00974974|616005449|FG001|IR CD-LD Dose Adjustment|Various|9|||
170454900|NCT00974974|616005448|FG000|IPX066 Dose Conversion|Adverse Event|23|||
170454901|NCT00974974|616005449|FG001|IPX066 Dose Conversion|Adverse Event|0|||
170454902|NCT00974974|616005448|FG000|IPX066 Dose Conversion|Death|2|||
170454903|NCT00974974|616005449|FG001|IPX066 Dose Conversion|Death|0|||
170454904|NCT00974974|616005448|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
170454905|NCT00974974|616005449|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
170454906|NCT00974974|616005448|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
170454907|NCT00974974|616005449|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
170454908|NCT00974974|616005448|FG000|IPX066 Dose Conversion|Various|3|||
170454909|NCT00974974|616005449|FG001|IPX066 Dose Conversion|Various|0|||
170454910|NCT00974974|616005448|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
170454911|NCT00974974|616005449|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
170454912|NCT00974974|616005448|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
170454913|NCT00974974|616005449|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
170635615|NCT05375760|616676969|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
170454914|NCT00974974|616005448|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
170454915|NCT00974974|616005449|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
170454916|NCT00974974|616005448|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
170454917|NCT00974974|616005449|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
170454918|NCT00974974|616005448|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
170454919|NCT00974974|616005449|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
170454920|NCT00974974|616005448|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
170454921|NCT00974974|616005449|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
170454922|NCT00974974|616005448|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
170454923|NCT00974974|616005449|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
170454924|NCT00974974|616005448|FG000|Maintenance - Double Blind Treatment|Various|4|||
170454925|NCT00974974|616005449|FG001|Maintenance - Double Blind Treatment|Various|0|||
170454926|NCT00361335|616005450|FG000|IV Period: Baseline to E0|Adverse Event|9|||
170454927|NCT00361335|616005451|FG001|IV Period: Baseline to E0|Adverse Event|4|||
170454928|NCT00361335|616005452|FG002|IV Period: Baseline to E0|Adverse Event|5|||
170454929|NCT00361335|616005453|FG003|IV Period: Baseline to E0|Adverse Event|9|||
170454930|NCT00361335|616005454|FG004|IV Period: Baseline to E0|Adverse Event|8|||
170454931|NCT00361335|616005455|FG005|IV Period: Baseline to E0|Adverse Event|0|||
170454932|NCT00361335|616005456|FG006|IV Period: Baseline to E0|Adverse Event|0|||
170454933|NCT00361335|616005450|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
170454934|NCT00361335|616005451|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
170454935|NCT00361335|616005452|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
170454936|NCT00361335|616005453|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
170454937|NCT00361335|616005454|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
170454938|NCT00361335|616005455|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
170454939|NCT00361335|616005456|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
170454940|NCT00361335|616005450|FG000|IV Period: Baseline to E0|Death|1|||
170454941|NCT00361335|616005451|FG001|IV Period: Baseline to E0|Death|1|||
170454942|NCT00361335|616005452|FG002|IV Period: Baseline to E0|Death|1|||
170454943|NCT00361335|616005453|FG003|IV Period: Baseline to E0|Death|1|||
170454944|NCT00361335|616005454|FG004|IV Period: Baseline to E0|Death|0|||
170454945|NCT00361335|616005455|FG005|IV Period: Baseline to E0|Death|0|||
170454946|NCT00361335|616005456|FG006|IV Period: Baseline to E0|Death|0|||
170635616|NCT05375760|616676970|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
170454947|NCT00361335|616005450|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
170454948|NCT00361335|616005451|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
170454949|NCT00361335|616005452|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
170454950|NCT00361335|616005453|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
170454951|NCT00361335|616005454|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
170454952|NCT00361335|616005455|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
170454953|NCT00361335|616005456|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
170454954|NCT00361335|616005450|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
170454955|NCT00361335|616005451|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
170454956|NCT00361335|616005452|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
170454957|NCT00361335|616005453|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
170454958|NCT00361335|616005454|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
170454959|NCT00361335|616005455|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
170454960|NCT00361335|616005456|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
170454961|NCT00361335|616005450|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
170454962|NCT00361335|616005451|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
170454963|NCT00361335|616005452|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
170454964|NCT00361335|616005453|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
170454965|NCT00361335|616005454|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
170454966|NCT00361335|616005455|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
170454967|NCT00361335|616005456|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
170454968|NCT00361335|616005450|FG000|IV Period: Baseline to E0|Other|2|||
170454969|NCT00361335|616005451|FG001|IV Period: Baseline to E0|Other|9|||
170454970|NCT00361335|616005452|FG002|IV Period: Baseline to E0|Other|9|||
170454971|NCT00361335|616005453|FG003|IV Period: Baseline to E0|Other|3|||
170454972|NCT00361335|616005454|FG004|IV Period: Baseline to E0|Other|2|||
170454973|NCT00361335|616005455|FG005|IV Period: Baseline to E0|Other|0|||
170454974|NCT00361335|616005456|FG006|IV Period: Baseline to E0|Other|0|||
170454975|NCT00361335|616005450|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
170454976|NCT00361335|616005451|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
170454977|NCT00361335|616005452|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
170454978|NCT00361335|616005453|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
170454979|NCT00361335|616005454|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
170454980|NCT00361335|616005455|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
170454981|NCT00361335|616005456|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
170454982|NCT00361335|616005450|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
170454983|NCT00361335|616005451|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
170454984|NCT00361335|616005452|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
170454985|NCT00361335|616005453|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
170454986|NCT00361335|616005454|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
170454987|NCT00361335|616005455|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
170454988|NCT00361335|616005456|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
170454989|NCT00361335|616005450|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
170454990|NCT00361335|616005451|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
170454991|NCT00361335|616005452|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
170454992|NCT00361335|616005453|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
170454993|NCT00361335|616005454|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
170454994|NCT00361335|616005455|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
170454995|NCT00361335|616005456|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
170454996|NCT00361335|616005450|FG000|SC Period: Week E0 to Week E24|Death|0|||
170454997|NCT00361335|616005451|FG001|SC Period: Week E0 to Week E24|Death|0|||
170454998|NCT00361335|616005452|FG002|SC Period: Week E0 to Week E24|Death|0|||
170454999|NCT00361335|616005453|FG003|SC Period: Week E0 to Week E24|Death|0|||
170455000|NCT00361335|616005454|FG004|SC Period: Week E0 to Week E24|Death|0|||
170455001|NCT00361335|616005455|FG005|SC Period: Week E0 to Week E24|Death|0|||
170455002|NCT00361335|616005456|FG006|SC Period: Week E0 to Week E24|Death|1|||
170455003|NCT00361335|616005450|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
170455004|NCT00361335|616005451|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
170455005|NCT00361335|616005452|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
170455006|NCT00361335|616005453|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
170455007|NCT00361335|616005454|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
170455008|NCT00361335|616005455|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
170455009|NCT00361335|616005456|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
170455010|NCT00361335|616005450|FG000|SC Period: Week E0 to Week E24|Other|1|||
170455011|NCT00361335|616005451|FG001|SC Period: Week E0 to Week E24|Other|0|||
170455012|NCT00361335|616005452|FG002|SC Period: Week E0 to Week E24|Other|0|||
170455013|NCT00361335|616005453|FG003|SC Period: Week E0 to Week E24|Other|1|||
170455014|NCT00361335|616005454|FG004|SC Period: Week E0 to Week E24|Other|0|||
170455015|NCT00361335|616005455|FG005|SC Period: Week E0 to Week E24|Other|1|||
170455016|NCT00361335|616005456|FG006|SC Period: Week E0 to Week E24|Other|2|||
170455017|NCT00361335|616005450|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
170455018|NCT00361335|616005451|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
170455019|NCT00361335|616005452|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
170455020|NCT00361335|616005453|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
170455021|NCT00361335|616005454|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
170455022|NCT00361335|616005455|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
170455023|NCT00361335|616005456|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
170455024|NCT02963311|616005457|FG000|Overall Study|Withdrawal by Subject|1|||
170455025|NCT02963311|616005457|FG000|Overall Study|Screen Failure|4|||
170455026|NCT01765582|616005458|FG000|Overall Study|Other|3|||
170455027|NCT01765582|616005459|FG001|Overall Study|Other|6|||
170455028|NCT01765582|616005460|FG002|Overall Study|Other|9|||
170455029|NCT01765582|616005458|FG000|Overall Study|Lost to Follow-up|2|||
170455030|NCT01765582|616005459|FG001|Overall Study|Lost to Follow-up|2|||
170455031|NCT01765582|616005460|FG002|Overall Study|Lost to Follow-up|1|||
170455032|NCT01765582|616005458|FG000|Overall Study|Death|31|||
170455033|NCT01765582|616005459|FG001|Overall Study|Death|36|||
170455034|NCT01765582|616005460|FG002|Overall Study|Death|33|||
170455035|NCT01765582|616005458|FG000|Overall Study|Sponsor Decision|46|||
170455036|NCT01765582|616005459|FG001|Overall Study|Sponsor Decision|42|||
170542637|NCT02513199|616331062|FG000|Treatment|Lost to Follow-up|1|||
170542638|NCT02513199|616331062|FG000|Follow-Up|Death|11|||
170542639|NCT04349644|616331063|FG000|Allocation/Pretest|Lost to pretest|0|||
170542640|NCT04349644|616331064|FG001|Allocation/Pretest|Lost to pretest|3|||
170542641|NCT04349644|616331063|FG000|Posttest|Lost to posttest|0|||
170542642|NCT04349644|616331064|FG001|Posttest|Lost to posttest|8|||
170542643|NCT04349644|616331063|FG000|Posttest|Discontinued intervention|6|||
170542644|NCT04349644|616331064|FG001|Posttest|Discontinued intervention|0|||
170542645|NCT04349644|616331063|FG000|Follow-up|Lost to Follow-up|0|||
170542646|NCT04349644|616331064|FG001|Follow-up|Lost to Follow-up|2|||
170542647|NCT02582632|616331065|FG000|Overall Study|Other|1|||
170542648|NCT02323334|616331068|FG000|Period 3|Lost to Follow-up|0|||
170542649|NCT02323334|616331069|FG001|Period 3|Lost to Follow-up|0|||
170542650|NCT02323334|616331070|FG002|Period 3|Lost to Follow-up|1|||
170542651|NCT02323334|616331071|FG003|Period 3|Lost to Follow-up|0|||
170542652|NCT02323334|616331072|FG004|Period 3|Lost to Follow-up|0|||
170542653|NCT02323334|616331073|FG005|Period 3|Lost to Follow-up|0|||
170542654|NCT02323334|616331074|FG006|Period 3|Lost to Follow-up|0|||
170542655|NCT02323334|616331075|FG007|Period 3|Lost to Follow-up|0|||
170888566|NCT00852995|617598358|FG000|Overall Study|Progressive Disease|1|||
170888567|NCT00852995|617598359|FG001|Overall Study|Progressive Disease|0|||
170888568|NCT00852995|617598360|FG002|Overall Study|Progressive Disease|0|||
170888569|NCT00852995|617598361|FG003|Overall Study|Progressive Disease|2|||
170888570|NCT00852995|617598362|FG004|Overall Study|Progressive Disease|1|||
170888571|NCT00852995|617598358|FG000|Overall Study|Physician Decision|1|||
170888572|NCT00852995|617598359|FG001|Overall Study|Physician Decision|0|||
170888573|NCT00852995|617598360|FG002|Overall Study|Physician Decision|0|||
170888574|NCT00852995|617598361|FG003|Overall Study|Physician Decision|0|||
170888575|NCT00852995|617598362|FG004|Overall Study|Physician Decision|0|||
170888576|NCT00852995|617598358|FG000|Overall Study|Protocol Violation|0|||
170888577|NCT00852995|617598359|FG001|Overall Study|Protocol Violation|0|||
170888578|NCT00852995|617598360|FG002|Overall Study|Protocol Violation|0|||
170888579|NCT00852995|617598361|FG003|Overall Study|Protocol Violation|0|||
170888580|NCT00852995|617598362|FG004|Overall Study|Protocol Violation|1|||
170888581|NCT00852995|617598358|FG000|Overall Study|Moved Out of Area|1|||
170888582|NCT00852995|617598359|FG001|Overall Study|Moved Out of Area|0|||
170888583|NCT00852995|617598360|FG002|Overall Study|Moved Out of Area|0|||
170888584|NCT00852995|617598361|FG003|Overall Study|Moved Out of Area|0|||
170888585|NCT00852995|617598362|FG004|Overall Study|Moved Out of Area|0|||
170888586|NCT03499028|617598363|FG000|Overall Study|Lost to Follow-up|12|||
170888587|NCT03499028|617598364|FG001|Overall Study|Lost to Follow-up|9|||
170888588|NCT03499028|617598363|FG000|Overall Study|Withdrawal by Subject|5|||
170888589|NCT03499028|617598364|FG001|Overall Study|Withdrawal by Subject|8|||
170888590|NCT03499028|617598363|FG000|Overall Study|Unplanned SNF discharge|5|||
170888591|NCT03499028|617598364|FG001|Overall Study|Unplanned SNF discharge|8|||
170888592|NCT02665286|617598365|FG000|Overall Study|Lost to Follow-up|3|||
170888593|NCT02665286|617598366|FG001|Overall Study|Lost to Follow-up|2|||
170888594|NCT02665286|617598367|FG002|Overall Study|Lost to Follow-up|1|||
170888595|NCT00626093|617598368|FG000|Overall Study|Lost to Follow-up|5|||
170888596|NCT00626093|617598368|FG000|Overall Study|Death|1|||
170888597|NCT00626093|617598368|FG000|Overall Study|Physician Decision|4|||
170888598|NCT00626093|617598368|FG000|Overall Study|Withdrawal by Subject|6|||
170888599|NCT00626093|617598368|FG000|Overall Study|Protocol Violation|1|||
170888600|NCT00626093|617598368|FG000|Overall Study|One of the required devices not implante|6|||
170888601|NCT03892746|617598371|FG000|Overall Study|Withdrawal by Subject|2|||
170888602|NCT03892746|617598372|FG001|Overall Study|Withdrawal by Subject|1|||
170888603|NCT03892746|617598371|FG000|Overall Study|Lost to Follow-up|2|||
170888604|NCT03892746|617598372|FG001|Overall Study|Lost to Follow-up|0|||
170888605|NCT01358864|617598381|FG000|Overall Study|Adverse Event|0|||
170888606|NCT01358864|617598382|FG001|Overall Study|Adverse Event|6|||
170888607|NCT01358864|617598383|FG002|Overall Study|Adverse Event|9|||
170888608|NCT01358864|617598384|FG003|Overall Study|Adverse Event|0|||
170888609|NCT01358864|617598385|FG004|Overall Study|Adverse Event|4|||
170888610|NCT01358864|617598386|FG005|Overall Study|Adverse Event|8|||
170888611|NCT01358864|617598387|FG006|Overall Study|Adverse Event|12|||
170888612|NCT01358864|617598388|FG007|Overall Study|Adverse Event|7|||
170888613|NCT01358864|617598381|FG000|Overall Study|Lack of Efficacy|26|||
170888614|NCT01358864|617598382|FG001|Overall Study|Lack of Efficacy|3|||
170635617|NCT05375760|616676969|FG000|Overall Study|Participant moved|1|||
170635618|NCT05375760|616676970|FG001|Overall Study|Participant moved|0|||
170635619|NCT01733680|616676971|FG000|Overall Study|Withdrawal by Subject|0|||
170635620|NCT01733680|616676972|FG001|Overall Study|Withdrawal by Subject|1|||
170635621|NCT01932437|616676973|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
170635622|NCT01932437|616676974|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
170635623|NCT01932437|616676975|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
170635624|NCT01932437|616676976|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
170635625|NCT01932437|616676977|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
170635626|NCT01932437|616676978|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
170635627|NCT03853109|616676979|FG000|Overall Study|Withdrawal by Subject|0|||
170635628|NCT03853109|616676980|FG001|Overall Study|Withdrawal by Subject|0|||
170635629|NCT03853109|616676981|FG002|Overall Study|Withdrawal by Subject|1|||
170635630|NCT03853109|616676982|FG003|Overall Study|Withdrawal by Subject|2|||
170635631|NCT03853109|616676983|FG004|Overall Study|Withdrawal by Subject|1|||
170635632|NCT03853109|616676984|FG005|Overall Study|Withdrawal by Subject|4|||
170635633|NCT03853109|616676985|FG006|Overall Study|Withdrawal by Subject|5|||
170635634|NCT03853109|616676986|FG007|Overall Study|Withdrawal by Subject|3|||
170635635|NCT03853109|616676979|FG000|Overall Study|Decision by Sponsor|0|||
170635636|NCT03853109|616676980|FG001|Overall Study|Decision by Sponsor|0|||
170635637|NCT03853109|616676981|FG002|Overall Study|Decision by Sponsor|1|||
170635638|NCT03853109|616676982|FG003|Overall Study|Decision by Sponsor|0|||
170635639|NCT03853109|616676983|FG004|Overall Study|Decision by Sponsor|1|||
170455037|NCT01765582|616005460|FG002|Overall Study|Sponsor Decision|42|||
170455038|NCT01765582|616005458|FG000|Overall Study|Withdrawal of Consent|11|||
170455039|NCT01765582|616005459|FG001|Overall Study|Withdrawal of Consent|6|||
170455040|NCT01765582|616005460|FG002|Overall Study|Withdrawal of Consent|10|||
170455041|NCT03251963|616005461|FG000|Overall Study|inappropriate Xa level timing|6|||
170455042|NCT03251963|616005462|FG001|Overall Study|inappropriate Xa level timing|3|||
170455043|NCT03251963|616005461|FG000|Overall Study|no peak Xa level drawn|2|||
170455044|NCT03251963|616005462|FG001|Overall Study|no peak Xa level drawn|0|||
170455045|NCT03251963|616005461|FG000|Overall Study|bled prior to Xa level|1|||
170455046|NCT03251963|616005462|FG001|Overall Study|bled prior to Xa level|2|||
170455047|NCT00616941|616005463|FG000|Overall Study|Progressive Disease|1|||
170455048|NCT00616941|616005464|FG001|Overall Study|Progressive Disease|2|||
170455049|NCT00616941|616005465|FG002|Overall Study|Progressive Disease|1|||
170455050|NCT00616941|616005463|FG000|Overall Study|Adverse Event|0|||
170455051|NCT00616941|616005464|FG001|Overall Study|Adverse Event|1|||
170455052|NCT00616941|616005465|FG002|Overall Study|Adverse Event|1|||
170455053|NCT00616941|616005463|FG000|Overall Study|Subject Non-compliance|0|||
170455054|NCT00616941|616005464|FG001|Overall Study|Subject Non-compliance|0|||
170455055|NCT00616941|616005465|FG002|Overall Study|Subject Non-compliance|1|||
170455056|NCT00616941|616005463|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
170455057|NCT00616941|616005464|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
170455058|NCT00616941|616005465|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
170455059|NCT00616941|616005463|FG000|Overall Study|Vaccination Suspended|0|||
170455060|NCT00616941|616005464|FG001|Overall Study|Vaccination Suspended|0|||
170455061|NCT00616941|616005465|FG002|Overall Study|Vaccination Suspended|3|||
170455062|NCT00714493|616005483|FG000|Overall Study|Adverse Event|11|||
170455063|NCT00714493|616005483|FG000|Overall Study|Death|3|||
170455064|NCT00714493|616005483|FG000|Overall Study|Lack of Efficacy|10|||
170455065|NCT00714493|616005483|FG000|Overall Study|Lost to Follow-up|3|||
170455066|NCT00714493|616005483|FG000|Overall Study|Protocol Violation|12|||
170455067|NCT00714493|616005483|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
170455068|NCT00714493|616005483|FG000|Overall Study|OTHER|2|||
170455069|NCT00076804|616005484|FG000|Overall Study|Death|9|||
170455070|NCT00076804|616005485|FG001|Overall Study|Death|20|||
170455071|NCT00076804|616005484|FG000|Overall Study|Lost to Follow-up|9|||
170455072|NCT00076804|616005485|FG001|Overall Study|Lost to Follow-up|9|||
170455073|NCT00076804|616005484|FG000|Overall Study|Withdrawal by Subject|10|||
170455074|NCT00076804|616005485|FG001|Overall Study|Withdrawal by Subject|8|||
170455075|NCT00076804|616005484|FG000|Overall Study|Early study Closure|32|||
170455076|NCT00076804|616005485|FG001|Overall Study|Early study Closure|32|||
170455077|NCT00354341|616005488|FG000|Overall Study|Adverse Event|1|||
170455078|NCT00354341|616005489|FG001|Overall Study|Adverse Event|0|||
170455079|NCT00354341|616005488|FG000|Overall Study|Death|0|||
170455080|NCT00354341|616005489|FG001|Overall Study|Death|2|||
170455081|NCT00354341|616005488|FG000|Overall Study|Refused treatment|1|||
170455082|NCT00354341|616005489|FG001|Overall Study|Refused treatment|2|||
170455083|NCT00354341|616005488|FG000|Overall Study|Failure to return|0|||
170455084|NCT00354341|616005489|FG001|Overall Study|Failure to return|1|||
170455085|NCT00354341|616005488|FG000|Overall Study|Other|1|||
170635640|NCT03853109|616676984|FG005|Overall Study|Decision by Sponsor|1|||
170635641|NCT03853109|616676985|FG006|Overall Study|Decision by Sponsor|10|||
170635642|NCT03853109|616676986|FG007|Overall Study|Decision by Sponsor|2|||
170635643|NCT03853109|616676979|FG000|Overall Study|Lost to Follow-up|0|||
170635644|NCT03853109|616676980|FG001|Overall Study|Lost to Follow-up|0|||
170888615|NCT01358864|617598383|FG002|Overall Study|Lack of Efficacy|4|||
170888616|NCT01358864|617598384|FG003|Overall Study|Lack of Efficacy|19|||
170888617|NCT01358864|617598385|FG004|Overall Study|Lack of Efficacy|7|||
170888618|NCT01358864|617598386|FG005|Overall Study|Lack of Efficacy|4|||
170888619|NCT01358864|617598387|FG006|Overall Study|Lack of Efficacy|49|||
170888620|NCT01358864|617598388|FG007|Overall Study|Lack of Efficacy|44|||
170888621|NCT01358864|617598381|FG000|Overall Study|Lost to Follow-up|0|||
170888622|NCT01358864|617598382|FG001|Overall Study|Lost to Follow-up|0|||
170888623|NCT01358864|617598383|FG002|Overall Study|Lost to Follow-up|1|||
170888624|NCT01358864|617598384|FG003|Overall Study|Lost to Follow-up|0|||
170455086|NCT00354341|616005489|FG001|Overall Study|Other|2|||
170455087|NCT01400919|616005490|FG000|Overall Study|Withdrawal by Subject|4|||
170455088|NCT01400919|616005490|FG000|Overall Study|Lost to Follow-up|2|||
170455089|NCT01400919|616005490|FG000|Overall Study|Missed visit|2|||
170455090|NCT00251719|616005491|FG000|Overall Study|Adverse Event|14|||
170455091|NCT00251719|616005492|FG001|Overall Study|Adverse Event|8|||
170455092|NCT00251719|616005493|FG002|Overall Study|Adverse Event|7|||
170888625|NCT01358864|617598385|FG004|Overall Study|Lost to Follow-up|0|||
170455093|NCT00251719|616005491|FG000|Overall Study|Protocol Violation|1|||
170455094|NCT00251719|616005492|FG001|Overall Study|Protocol Violation|1|||
170455095|NCT00251719|616005493|FG002|Overall Study|Protocol Violation|1|||
170455096|NCT00251719|616005491|FG000|Overall Study|Lost to Follow-up|5|||
170455097|NCT00251719|616005492|FG001|Overall Study|Lost to Follow-up|11|||
170888626|NCT01358864|617598386|FG005|Overall Study|Lost to Follow-up|0|||
170888627|NCT01358864|617598387|FG006|Overall Study|Lost to Follow-up|0|||
170888628|NCT01358864|617598388|FG007|Overall Study|Lost to Follow-up|1|||
170888629|NCT01358864|617598381|FG000|Overall Study|Withdrawal by Subject|3|||
170888630|NCT01358864|617598382|FG001|Overall Study|Withdrawal by Subject|4|||
170888631|NCT01358864|617598383|FG002|Overall Study|Withdrawal by Subject|2|||
170888632|NCT01358864|617598384|FG003|Overall Study|Withdrawal by Subject|0|||
170888633|NCT01358864|617598385|FG004|Overall Study|Withdrawal by Subject|0|||
170888634|NCT01358864|617598386|FG005|Overall Study|Withdrawal by Subject|1|||
170888635|NCT01358864|617598387|FG006|Overall Study|Withdrawal by Subject|1|||
170888636|NCT01358864|617598388|FG007|Overall Study|Withdrawal by Subject|3|||
170888637|NCT01358864|617598381|FG000|Overall Study|Other reason not defined above|2|||
170888638|NCT01358864|617598382|FG001|Overall Study|Other reason not defined above|0|||
170888639|NCT01358864|617598383|FG002|Overall Study|Other reason not defined above|0|||
170888640|NCT01358864|617598384|FG003|Overall Study|Other reason not defined above|0|||
170888641|NCT01358864|617598385|FG004|Overall Study|Other reason not defined above|0|||
170888642|NCT01358864|617598386|FG005|Overall Study|Other reason not defined above|0|||
170888643|NCT01358864|617598387|FG006|Overall Study|Other reason not defined above|2|||
170542656|NCT02323334|616331076|FG008|Period 3|Lost to Follow-up|0|||
170542657|NCT02323334|616331077|FG009|Period 3|Lost to Follow-up|0|||
170542658|NCT02323334|616331078|FG010|Period 3|Lost to Follow-up|0|||
170542659|NCT02323334|616331079|FG011|Period 3|Lost to Follow-up|0|||
170542660|NCT02323334|616331080|FG012|Period 3|Lost to Follow-up|0|||
170888644|NCT01358864|617598388|FG007|Overall Study|Other reason not defined above|0|||
170888645|NCT01358864|617598381|FG000|Overall Study|Not treated|0|||
170888646|NCT01358864|617598382|FG001|Overall Study|Not treated|0|||
170888647|NCT01358864|617598383|FG002|Overall Study|Not treated|0|||
170888648|NCT01358864|617598384|FG003|Overall Study|Not treated|0|||
170455098|NCT00251719|616005493|FG002|Overall Study|Lost to Follow-up|8|||
170888649|NCT01358864|617598385|FG004|Overall Study|Not treated|0|||
170888650|NCT01358864|617598386|FG005|Overall Study|Not treated|0|||
170455099|NCT00251719|616005491|FG000|Overall Study|Withdrawal by Subject|14|||
170542661|NCT02323334|616331081|FG013|Period 3|Lost to Follow-up|0|||
170888651|NCT01358864|617598387|FG006|Overall Study|Not treated|1|||
170455100|NCT00251719|616005492|FG001|Overall Study|Withdrawal by Subject|12|||
170455101|NCT00251719|616005493|FG002|Overall Study|Withdrawal by Subject|11|||
170455102|NCT00251719|616005491|FG000|Overall Study|Lack of Efficacy|2|||
170455103|NCT00251719|616005492|FG001|Overall Study|Lack of Efficacy|1|||
170455104|NCT00251719|616005493|FG002|Overall Study|Lack of Efficacy|0|||
170787644|NCT05089019|617231844|FG001|Washout Period|Withdrawal by Subject|3|||
170455105|NCT00251719|616005491|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
170455106|NCT00251719|616005492|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
170455107|NCT00251719|616005493|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
170455108|NCT00251719|616005491|FG000|Overall Study|Investigator decision|1|||
170455109|NCT00251719|616005492|FG001|Overall Study|Investigator decision|1|||
170455110|NCT00251719|616005493|FG002|Overall Study|Investigator decision|0|||
170455111|NCT00251719|616005491|FG000|Overall Study|Noncompliance|2|||
170455112|NCT00251719|616005492|FG001|Overall Study|Noncompliance|3|||
170455113|NCT00251719|616005493|FG002|Overall Study|Noncompliance|1|||
170455114|NCT00251719|616005491|FG000|Overall Study|Barrett's esophagus|2|||
170455115|NCT00251719|616005492|FG001|Overall Study|Barrett's esophagus|2|||
170455116|NCT00251719|616005493|FG002|Overall Study|Barrett's esophagus|0|||
170455117|NCT01449279|616005494|FG000|Overall Study|Lack of Efficacy|5|||
170455118|NCT01449279|616005494|FG000|Overall Study|Toxicity|2|||
170455119|NCT01732874|616005495|FG000|Overall Study|Withdrawal by Subject|5|||
170455120|NCT01732874|616005496|FG001|Overall Study|Withdrawal by Subject|1|||
170455121|NCT01732874|616005495|FG000|Overall Study|Death of Infant|3|||
170455122|NCT01732874|616005496|FG001|Overall Study|Death of Infant|2|||
170455123|NCT03709823|616005497|FG000|Overall Study|Adverse Event|0|||
170455124|NCT03709823|616005498|FG001|Overall Study|Adverse Event|0|||
170455125|NCT03709823|616005499|FG002|Overall Study|Adverse Event|1|||
170455126|NCT03709823|616005500|FG003|Overall Study|Adverse Event|0|||
170455127|NCT03709823|616005501|FG004|Overall Study|Adverse Event|0|||
170455128|NCT03709823|616005502|FG005|Overall Study|Adverse Event|0|||
170455129|NCT03709823|616005497|FG000|Overall Study|Lost to Follow-up|2|||
170455130|NCT03709823|616005498|FG001|Overall Study|Lost to Follow-up|2|||
170455131|NCT03709823|616005499|FG002|Overall Study|Lost to Follow-up|2|||
170455132|NCT03709823|616005500|FG003|Overall Study|Lost to Follow-up|1|||
170455133|NCT03709823|616005501|FG004|Overall Study|Lost to Follow-up|1|||
170455134|NCT03709823|616005502|FG005|Overall Study|Lost to Follow-up|0|||
170455135|NCT03709823|616005497|FG000|Overall Study|Withdrawal by Subject|1|||
170455136|NCT03709823|616005498|FG001|Overall Study|Withdrawal by Subject|3|||
170455137|NCT03709823|616005499|FG002|Overall Study|Withdrawal by Subject|0|||
170455138|NCT03709823|616005500|FG003|Overall Study|Withdrawal by Subject|0|||
170455139|NCT03709823|616005501|FG004|Overall Study|Withdrawal by Subject|0|||
170455140|NCT03709823|616005502|FG005|Overall Study|Withdrawal by Subject|0|||
170455141|NCT03709823|616005497|FG000|Overall Study|Other, Not Specified|0|||
170455142|NCT03709823|616005498|FG001|Overall Study|Other, Not Specified|0|||
170455143|NCT03709823|616005499|FG002|Overall Study|Other, Not Specified|0|||
170787645|NCT05089019|617231843|FG000|Period 2|Adverse Event|4|||
170787646|NCT05089019|617231844|FG001|Period 2|Adverse Event|2|||
170787647|NCT05089019|617231843|FG000|Period 2|Lost to Follow-up|1|||
170787648|NCT05089019|617231844|FG001|Period 2|Lost to Follow-up|0|||
170787649|NCT05089019|617231843|FG000|Period 2|Withdrawal by Subject|0|||
170787650|NCT05089019|617231844|FG001|Period 2|Withdrawal by Subject|1|||
170787651|NCT03808818|617231845|FG000|Overall Study|Death|6|||
170787652|NCT03808818|617231846|FG001|Overall Study|Death|6|||
170787653|NCT03808818|617231845|FG000|Overall Study|Withdrawal by Subject|7|||
170787654|NCT03808818|617231846|FG001|Overall Study|Withdrawal by Subject|18|||
170787655|NCT03808818|617231845|FG000|Overall Study|Lost to Follow-up|31|||
170787656|NCT03808818|617231846|FG001|Overall Study|Lost to Follow-up|33|||
170787657|NCT05415722|617231847|FG000|Overall Study|Lost to Follow-up|0|||
170787658|NCT05415722|617231848|FG001|Overall Study|Lost to Follow-up|2|||
170787659|NCT05415722|617231849|FG002|Overall Study|Lost to Follow-up|0|||
170455144|NCT03709823|616005500|FG003|Overall Study|Other, Not Specified|1|||
170455145|NCT03709823|616005501|FG004|Overall Study|Other, Not Specified|0|||
170455146|NCT03709823|616005502|FG005|Overall Study|Other, Not Specified|0|||
170455147|NCT00557076|616005503|FG000|Overall Study|Unblinding|0|||
170455148|NCT00557076|616005504|FG001|Overall Study|Unblinding|1|||
170542662|NCT02323334|616331082|FG014|Period 3|Lost to Follow-up|0|||
170787660|NCT05415722|617231850|FG003|Overall Study|Lost to Follow-up|1|||
170455149|NCT00688376|616005505|FG000|Double-Blind Phase|Adverse Event|4|||
170455150|NCT00688376|616005506|FG001|Double-Blind Phase|Adverse Event|4|||
170455151|NCT00688376|616005505|FG000|Double-Blind Phase|Protocol Violation|1|||
170455152|NCT00688376|616005506|FG001|Double-Blind Phase|Protocol Violation|2|||
170542663|NCT02323334|616331083|FG015|Period 3|Lost to Follow-up|0|||
170787661|NCT05415722|617231851|FG004|Overall Study|Lost to Follow-up|0|||
170787662|NCT05415722|617231852|FG005|Overall Study|Lost to Follow-up|0|||
170787663|NCT05415722|617231853|FG006|Overall Study|Lost to Follow-up|1|||
170787664|NCT05415722|617231847|FG000|Overall Study|Physician Decision|0|||
170455153|NCT00688376|616005505|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
170455154|NCT00688376|616005506|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
170455155|NCT00688376|616005505|FG000|Double-Blind Phase|Not treated|0|||
170455156|NCT00688376|616005506|FG001|Double-Blind Phase|Not treated|1|||
170455157|NCT00688376|616005505|FG000|Blinded Extension Phase|Adverse Event|3|||
170455158|NCT00688376|616005506|FG001|Blinded Extension Phase|Adverse Event|4|||
170455159|NCT00688376|616005505|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
170455160|NCT00688376|616005506|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
170455161|NCT00688376|616005505|FG000|Blinded Extension Phase|Physician Decision|1|||
170455162|NCT00688376|616005506|FG001|Blinded Extension Phase|Physician Decision|0|||
170455163|NCT00688376|616005505|FG000|Blinded Extension Phase|Other|1|||
170455164|NCT00688376|616005506|FG001|Blinded Extension Phase|Other|0|||
170455165|NCT00846521|616005507|FG000|Overall Study|Withdrawal by Subject|5|||
170455166|NCT00846521|616005507|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
170455167|NCT00846521|616005507|FG000|Overall Study|Protocol Violation|1|||
170455168|NCT04392583|616005508|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
170455169|NCT01340768|616005511|FG000|Overall Study|Lost to Follow-up|10|||
170455170|NCT01340768|616005512|FG001|Overall Study|Lost to Follow-up|4|||
170888652|NCT01358864|617598388|FG007|Overall Study|Not treated|0|||
170888653|NCT04042103|617598394|FG000|Overall Study|Lost to Follow-up|1|||
170888654|NCT04042103|617598394|FG000|Overall Study|Withdrawal by Subject|1|||
170888655|NCT04209855|617598395|FG000|Overall Study|Death|161|||
170888656|NCT04209855|617598396|FG001|Overall Study|Death|177|||
170888657|NCT04209855|617598395|FG000|Overall Study|PI Discretion|1|||
170888658|NCT04209855|617598396|FG001|Overall Study|PI Discretion|1|||
170888659|NCT04209855|617598395|FG000|Overall Study|Lost to Follow-up|5|||
170888660|NCT04209855|617598396|FG001|Overall Study|Lost to Follow-up|2|||
170888661|NCT04209855|617598395|FG000|Overall Study|Withdrew consent|10|||
170888662|NCT04209855|617598396|FG001|Overall Study|Withdrew consent|24|||
170888663|NCT04209855|617598395|FG000|Overall Study|Sponsor decision|44|||
170888664|NCT04209855|617598396|FG001|Overall Study|Sponsor decision|18|||
170888665|NCT04209855|617598395|FG000|Overall Study|Other than specified|6|||
170888666|NCT04209855|617598396|FG001|Overall Study|Other than specified|4|||
170888667|NCT03359759|617598397|FG000|Overall Study|Death|3|||
170888668|NCT03359759|617598397|FG000|Overall Study|Lost to Follow-up|2|||
170888669|NCT01411085|617598398|FG000|Overall Study|Physician Decision|1|||
170888670|NCT01411085|617598398|FG000|Overall Study|Protocol Violation|1|||
170888671|NCT01411085|617598398|FG000|Overall Study|Adverse Event|1|||
170455171|NCT01340768|616005511|FG000|Overall Study|Withdrawal by Subject|5|||
170455172|NCT01340768|616005512|FG001|Overall Study|Withdrawal by Subject|1|||
170455173|NCT01340768|616005511|FG000|Overall Study|Other|2|||
170455174|NCT01340768|616005512|FG001|Overall Study|Other|0|||
170455175|NCT02335983|616005518|FG000|Overall Study|Sponsor Decision|0|||
170455176|NCT02335983|616005519|FG001|Overall Study|Sponsor Decision|0|||
170455177|NCT02335983|616005520|FG002|Overall Study|Sponsor Decision|1|||
170455178|NCT02335983|616005521|FG003|Overall Study|Sponsor Decision|1|||
170455179|NCT02335983|616005522|FG004|Overall Study|Sponsor Decision|0|||
170455180|NCT02335983|616005523|FG005|Overall Study|Sponsor Decision|1|||
170455181|NCT02335983|616005518|FG000|Overall Study|Withdrawal by Subject|3|||
170888672|NCT01564862|617598399|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
170888673|NCT01564862|617598400|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
170888674|NCT01564862|617598401|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
170888675|NCT01564862|617598399|FG000|Overall Study|Major Protocol Deviation|3|||
170888676|NCT01564862|617598400|FG001|Overall Study|Major Protocol Deviation|3|||
170888677|NCT01564862|617598401|FG002|Overall Study|Major Protocol Deviation|4|||
170888678|NCT01564862|617598399|FG000|Overall Study|Lost to Follow-up|10|||
170888679|NCT01564862|617598400|FG001|Overall Study|Lost to Follow-up|8|||
170888680|NCT01564862|617598401|FG002|Overall Study|Lost to Follow-up|6|||
170888681|NCT01564862|617598399|FG000|Overall Study|Voluntary Withdrawal|9|||
170888682|NCT01564862|617598400|FG001|Overall Study|Voluntary Withdrawal|6|||
170888683|NCT01564862|617598401|FG002|Overall Study|Voluntary Withdrawal|8|||
170888684|NCT01564862|617598399|FG000|Overall Study|Lack of Efficacy|1|||
170888685|NCT01564862|617598400|FG001|Overall Study|Lack of Efficacy|5|||
170888686|NCT01564862|617598401|FG002|Overall Study|Lack of Efficacy|6|||
170888687|NCT01564862|617598399|FG000|Overall Study|Other reason(s)|1|||
170888688|NCT01564862|617598400|FG001|Overall Study|Other reason(s)|0|||
170888689|NCT01564862|617598401|FG002|Overall Study|Other reason(s)|0|||
170888690|NCT03809611|617598402|FG000|Overall Study|Withdrawal by Subject|1|||
170888691|NCT03809611|617598403|FG001|Overall Study|Withdrawal by Subject|1|||
170888692|NCT02193074|617598404|FG000|Overall Study|Withdrawal by Subject|1|||
170455182|NCT02335983|616005519|FG001|Overall Study|Withdrawal by Subject|2|||
170455183|NCT02335983|616005520|FG002|Overall Study|Withdrawal by Subject|2|||
170455184|NCT02335983|616005521|FG003|Overall Study|Withdrawal by Subject|1|||
170455185|NCT02335983|616005522|FG004|Overall Study|Withdrawal by Subject|3|||
170455186|NCT02335983|616005523|FG005|Overall Study|Withdrawal by Subject|9|||
170455187|NCT02335983|616005518|FG000|Overall Study|Death|0|||
170455188|NCT02335983|616005519|FG001|Overall Study|Death|0|||
170455189|NCT02335983|616005520|FG002|Overall Study|Death|2|||
170888693|NCT02193074|617598405|FG001|Overall Study|Withdrawal by Subject|2|||
170888694|NCT02193074|617598404|FG000|Overall Study|Adverse Event|16|||
170888695|NCT02193074|617598405|FG001|Overall Study|Adverse Event|13|||
170888696|NCT00352534|617600511|FG000|Initial Staging|Ineligible|8|||
170888697|NCT00352534|617600512|FG001|Initial Staging|Ineligible|9|||
170888698|NCT00352534|617600513|FG002|Initial Staging|Ineligible|0|||
170888699|NCT00352534|617600514|FG003|Initial Staging|Ineligible|0|||
170888700|NCT00352534|617600515|FG004|Initial Staging|Ineligible|0|||
170888701|NCT00352534|617600516|FG005|Initial Staging|Ineligible|0|||
170888702|NCT00352534|617600517|FG006|Initial Staging|Ineligible|0|||
170888703|NCT00352534|617600511|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
170888704|NCT00352534|617600512|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
170888705|NCT00352534|617600513|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
170888706|NCT00352534|617600514|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
170888707|NCT00352534|617600515|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
170888708|NCT00352534|617600516|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
170888709|NCT00352534|617600517|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
170888710|NCT00352534|617600511|FG000|Final Risk Group Assignment|Physician Decision|0|||
170888711|NCT00352534|617600512|FG001|Final Risk Group Assignment|Physician Decision|0|||
170888712|NCT00352534|617600513|FG002|Final Risk Group Assignment|Physician Decision|0|||
170888713|NCT00352534|617600514|FG003|Final Risk Group Assignment|Physician Decision|0|||
170888714|NCT00352534|617600515|FG004|Final Risk Group Assignment|Physician Decision|0|||
170888715|NCT00352534|617600516|FG005|Final Risk Group Assignment|Physician Decision|8|||
170888716|NCT00352534|617600517|FG006|Final Risk Group Assignment|Physician Decision|0|||
170888717|NCT00352534|617600511|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
170888718|NCT00352534|617600512|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
170888719|NCT00352534|617600513|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
170888720|NCT00352534|617600514|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
170888721|NCT00352534|617600515|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
170888722|NCT00352534|617600516|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
170888723|NCT00352534|617600517|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
170888724|NCT00352534|617600511|FG000|Final Risk Group Assignment|Ineligible|0|||
170888725|NCT00352534|617600512|FG001|Final Risk Group Assignment|Ineligible|0|||
170888726|NCT00352534|617600513|FG002|Final Risk Group Assignment|Ineligible|3|||
170888727|NCT00352534|617600514|FG003|Final Risk Group Assignment|Ineligible|1|||
170888728|NCT00352534|617600515|FG004|Final Risk Group Assignment|Ineligible|0|||
170888729|NCT00352534|617600516|FG005|Final Risk Group Assignment|Ineligible|13|||
170888730|NCT00352534|617600517|FG006|Final Risk Group Assignment|Ineligible|0|||
170888731|NCT00352534|617600511|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
170888732|NCT00352534|617600512|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
170888733|NCT00352534|617600513|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
170888734|NCT00352534|617600514|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
170888735|NCT00352534|617600515|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
170888736|NCT00352534|617600516|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
170888737|NCT00352534|617600517|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
170888738|NCT00352534|617600511|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
170635645|NCT03853109|616676981|FG002|Overall Study|Lost to Follow-up|0|||
170635646|NCT03853109|616676982|FG003|Overall Study|Lost to Follow-up|0|||
170635647|NCT03853109|616676983|FG004|Overall Study|Lost to Follow-up|1|||
170635648|NCT03853109|616676984|FG005|Overall Study|Lost to Follow-up|3|||
170635649|NCT03853109|616676985|FG006|Overall Study|Lost to Follow-up|0|||
170635650|NCT03853109|616676986|FG007|Overall Study|Lost to Follow-up|0|||
170635651|NCT03853109|616676979|FG000|Overall Study|Death|2|||
170635652|NCT03853109|616676980|FG001|Overall Study|Death|5|||
170635653|NCT03853109|616676981|FG002|Overall Study|Death|8|||
170635654|NCT03853109|616676982|FG003|Overall Study|Death|10|||
170635655|NCT03853109|616676983|FG004|Overall Study|Death|3|||
170635656|NCT03853109|616676984|FG005|Overall Study|Death|20|||
170635657|NCT03853109|616676985|FG006|Overall Study|Death|10|||
170635658|NCT03853109|616676986|FG007|Overall Study|Death|5|||
170635659|NCT04032093|616676989|FG000|Overall Study|Lost to Follow-up|7|||
170635660|NCT04032093|616676990|FG001|Overall Study|Lost to Follow-up|7|||
170635661|NCT04032093|616676991|FG002|Overall Study|Lost to Follow-up|6|||
170888739|NCT00352534|617600512|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
170888740|NCT00352534|617600513|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
170888741|NCT00352534|617600514|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
170888742|NCT00352534|617600515|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
170455190|NCT02335983|616005521|FG003|Overall Study|Death|0|||
170455191|NCT02335983|616005522|FG004|Overall Study|Death|0|||
170455192|NCT02335983|616005523|FG005|Overall Study|Death|0|||
170635662|NCT04032093|616676992|FG003|Overall Study|Lost to Follow-up|10|||
170635663|NCT04032093|616676993|FG004|Overall Study|Lost to Follow-up|13|||
170635664|NCT04032093|616676994|FG005|Overall Study|Lost to Follow-up|7|||
170635665|NCT04032093|616676995|FG006|Overall Study|Lost to Follow-up|7|||
170635666|NCT04032093|616676996|FG007|Overall Study|Lost to Follow-up|5|||
170635667|NCT04032093|616676997|FG008|Overall Study|Lost to Follow-up|9|||
170635668|NCT04032093|616676998|FG009|Overall Study|Lost to Follow-up|12|||
170635669|NCT04032093|616676989|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
170635670|NCT04032093|616676990|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170635671|NCT04032093|616676991|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
170635672|NCT04032093|616676992|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
170635673|NCT04032093|616676993|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
170635674|NCT04032093|616676994|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
170635675|NCT04032093|616676995|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
170635676|NCT04032093|616676996|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
170635677|NCT04032093|616676997|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
170635678|NCT04032093|616676998|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
170635679|NCT04032093|616676989|FG000|Overall Study|Other|1|||
170635680|NCT04032093|616676990|FG001|Overall Study|Other|0|||
170635681|NCT04032093|616676991|FG002|Overall Study|Other|0|||
170635682|NCT04032093|616676992|FG003|Overall Study|Other|1|||
170635683|NCT04032093|616676993|FG004|Overall Study|Other|1|||
170787665|NCT05415722|617231848|FG001|Overall Study|Physician Decision|0|||
170787666|NCT05415722|617231849|FG002|Overall Study|Physician Decision|0|||
170787667|NCT05415722|617231850|FG003|Overall Study|Physician Decision|1|||
170787668|NCT05415722|617231851|FG004|Overall Study|Physician Decision|0|||
170787669|NCT05415722|617231852|FG005|Overall Study|Physician Decision|0|||
170787670|NCT05415722|617231853|FG006|Overall Study|Physician Decision|1|||
170787671|NCT05415722|617231847|FG000|Overall Study|Protocol Violation|0|||
170787672|NCT05415722|617231848|FG001|Overall Study|Protocol Violation|0|||
170787673|NCT05415722|617231849|FG002|Overall Study|Protocol Violation|0|||
170787674|NCT05415722|617231850|FG003|Overall Study|Protocol Violation|1|||
170787675|NCT05415722|617231851|FG004|Overall Study|Protocol Violation|0|||
170787676|NCT05415722|617231852|FG005|Overall Study|Protocol Violation|0|||
170787677|NCT05415722|617231853|FG006|Overall Study|Protocol Violation|0|||
170787678|NCT05415722|617231847|FG000|Overall Study|Sponsor Discretion|0|||
170787679|NCT05415722|617231848|FG001|Overall Study|Sponsor Discretion|0|||
170787680|NCT05415722|617231849|FG002|Overall Study|Sponsor Discretion|0|||
170787681|NCT05415722|617231850|FG003|Overall Study|Sponsor Discretion|0|||
170787682|NCT05415722|617231851|FG004|Overall Study|Sponsor Discretion|1|||
170787683|NCT05415722|617231852|FG005|Overall Study|Sponsor Discretion|1|||
170787684|NCT05415722|617231853|FG006|Overall Study|Sponsor Discretion|0|||
170787685|NCT05415722|617231847|FG000|Overall Study|Withdrawal by Subject|0|||
170787686|NCT05415722|617231848|FG001|Overall Study|Withdrawal by Subject|1|||
170787687|NCT05415722|617231849|FG002|Overall Study|Withdrawal by Subject|0|||
170787688|NCT05415722|617231850|FG003|Overall Study|Withdrawal by Subject|1|||
170787689|NCT05415722|617231851|FG004|Overall Study|Withdrawal by Subject|1|||
170787690|NCT05415722|617231852|FG005|Overall Study|Withdrawal by Subject|0|||
170787691|NCT05415722|617231853|FG006|Overall Study|Withdrawal by Subject|1|||
170787692|NCT03524612|617231854|FG000|Overall Study|Lack of Efficacy|10|||
170787693|NCT03524612|617231854|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
170787694|NCT03524612|617231854|FG000|Overall Study|Adverse Event|10|||
170787695|NCT03524612|617231854|FG000|Overall Study|Withdrawal by Subject|7|||
170787696|NCT03524612|617231854|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
170787697|NCT03524612|617231854|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
170787698|NCT03524612|617231854|FG000|Overall Study|New therapy for study indication|6|||
170787699|NCT03524612|617231854|FG000|Overall Study|Death|3|||
170787700|NCT03524612|617231854|FG000|Overall Study|Lost to Follow-up|2|||
170787701|NCT03524612|617231854|FG000|Overall Study|Protocol Violation|1|||
170787702|NCT04537715|617231856|FG000|Overall Study|Death|3|||
170787703|NCT04537715|617231857|FG001|Overall Study|Death|1|||
170787704|NCT04537715|617231856|FG000|Overall Study|Withdrawal by Subject|3|||
170787705|NCT04537715|617231857|FG001|Overall Study|Withdrawal by Subject|1|||
170787706|NCT04537715|617231856|FG000|Overall Study|Other|4|||
170787707|NCT04537715|617231857|FG001|Overall Study|Other|3|||
170787708|NCT04537715|617231856|FG000|Overall Study|Progressive disease|1|||
170787709|NCT04537715|617231857|FG001|Overall Study|Progressive disease|0|||
170787710|NCT04623671|617231859|FG000|Overall Study|Adverse Event|0|||
170787711|NCT04623671|617231860|FG001|Overall Study|Adverse Event|1|||
170787712|NCT04623671|617231859|FG000|Overall Study|Lost to Follow-up|2|||
170787713|NCT04623671|617231860|FG001|Overall Study|Lost to Follow-up|1|||
170635684|NCT04032093|616676994|FG005|Overall Study|Other|0|||
170635685|NCT04032093|616676995|FG006|Overall Study|Other|0|||
170635686|NCT04032093|616676996|FG007|Overall Study|Other|0|||
170787714|NCT04623671|617231859|FG000|Overall Study|Death|5|||
170787715|NCT04623671|617231860|FG001|Overall Study|Death|5|||
170787716|NCT04025554|617231861|FG000|Overall Study|Adverse Event|3|||
170787717|NCT04338061|617231866|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
170787718|NCT04338061|617231867|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
170787719|NCT04338061|617231866|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
170787720|NCT04338061|617231867|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
170888743|NCT00352534|617600516|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
170888744|NCT00352534|617600517|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
170888745|NCT00352534|617600511|FG000|Final Risk Group Assignment|Death|0|||
170888746|NCT00352534|617600512|FG001|Final Risk Group Assignment|Death|0|||
170888747|NCT00352534|617600513|FG002|Final Risk Group Assignment|Death|0|||
170888748|NCT00352534|617600514|FG003|Final Risk Group Assignment|Death|0|||
170888749|NCT00352534|617600515|FG004|Final Risk Group Assignment|Death|0|||
170888750|NCT00352534|617600516|FG005|Final Risk Group Assignment|Death|2|||
170888751|NCT00352534|617600517|FG006|Final Risk Group Assignment|Death|0|||
170888752|NCT01284114|617600518|FG000|Overall Study|viral infection|1|||
170635687|NCT04032093|616676997|FG008|Overall Study|Other|0|||
170635688|NCT04032093|616676998|FG009|Overall Study|Other|1|||
170635689|NCT04032093|616676989|FG000|Overall Study|Withdrawal by Subject|1|||
170635690|NCT04032093|616676990|FG001|Overall Study|Withdrawal by Subject|3|||
170635691|NCT04032093|616676991|FG002|Overall Study|Withdrawal by Subject|2|||
170635692|NCT04032093|616676992|FG003|Overall Study|Withdrawal by Subject|2|||
170635693|NCT04032093|616676993|FG004|Overall Study|Withdrawal by Subject|3|||
170635694|NCT04032093|616676994|FG005|Overall Study|Withdrawal by Subject|0|||
170635695|NCT04032093|616676995|FG006|Overall Study|Withdrawal by Subject|0|||
170635696|NCT04032093|616676996|FG007|Overall Study|Withdrawal by Subject|0|||
170635697|NCT04032093|616676997|FG008|Overall Study|Withdrawal by Subject|0|||
170635698|NCT04032093|616676998|FG009|Overall Study|Withdrawal by Subject|0|||
170635699|NCT04032093|616676989|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170635700|NCT04032093|616676990|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170635701|NCT04032093|616676991|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170635702|NCT04032093|616676992|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170888753|NCT01284114|617600518|FG000|Overall Study|From the results of ALLTITUDE study|1|||
170888754|NCT01284114|617600518|FG000|Overall Study|Symptomatic hypotension|1|||
170888755|NCT01284114|617600518|FG000|Overall Study|dizziness|1|||
170888756|NCT01241708|617600520|FG000|Overall Study|Withdrawal by Subject|6|||
170888757|NCT01241708|617600520|FG000|Overall Study|Screen Failure|6|||
170888758|NCT01241708|617600520|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
170888759|NCT01241708|617600520|FG000|Overall Study|Lost to Follow-up|5|||
170888760|NCT03718143|617600523|FG000|Overall Study|Death|1|||
170888761|NCT03718143|617600524|FG001|Overall Study|Death|0|||
170888762|NCT03718143|617600525|FG002|Overall Study|Death|0|||
170888763|NCT03718143|617600523|FG000|Overall Study|Progression of Disease|1|||
170888764|NCT03718143|617600524|FG001|Overall Study|Progression of Disease|0|||
170888765|NCT03718143|617600525|FG002|Overall Study|Progression of Disease|0|||
170888766|NCT03718143|617600523|FG000|Overall Study|Withdrawal of Informed Consent|1|||
170888767|NCT03718143|617600524|FG001|Overall Study|Withdrawal of Informed Consent|2|||
170888768|NCT03718143|617600525|FG002|Overall Study|Withdrawal of Informed Consent|1|||
170888769|NCT03733392|617600529|FG000|Overall Study|Withdrawal by Subject|11|||
170888770|NCT03733392|617600530|FG001|Overall Study|Withdrawal by Subject|1|||
170888771|NCT03733392|617600529|FG000|Overall Study|Death|1|||
170888772|NCT03733392|617600530|FG001|Overall Study|Death|0|||
170888773|NCT03733392|617600529|FG000|Overall Study|Lost to Follow-up|5|||
170888774|NCT03733392|617600530|FG001|Overall Study|Lost to Follow-up|0|||
170888775|NCT03733392|617600529|FG000|Overall Study|Protocol Violation|0|||
170888776|NCT03733392|617600530|FG001|Overall Study|Protocol Violation|1|||
170888777|NCT03733392|617600529|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
170888778|NCT03733392|617600530|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
170888779|NCT03733392|617600529|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
170888780|NCT03733392|617600530|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
170888781|NCT03733392|617600529|FG000|Overall Study|Patient Non-Compliance|2|||
170888782|NCT03733392|617600530|FG001|Overall Study|Patient Non-Compliance|1|||
170888783|NCT03733392|617600529|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
170888784|NCT03733392|617600530|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
170888785|NCT03733392|617600529|FG000|Overall Study|Withdrawal prior to procedure|5|||
170888786|NCT03733392|617600530|FG001|Overall Study|Withdrawal prior to procedure|2|||
170888787|NCT02740478|617600531|FG000|Overall Study|Withdrawal by Subject|1|||
170888788|NCT03905863|617600532|FG000|Overall Study|Adverse Event|2|||
170888789|NCT03905863|617600533|FG001|Overall Study|Adverse Event|4|||
170888790|NCT03905863|617600532|FG000|Overall Study|Withdrawal by Subject|2|||
170888791|NCT03905863|617600533|FG001|Overall Study|Withdrawal by Subject|2|||
170888792|NCT03905863|617600532|FG000|Overall Study|Physician Decision|0|||
170888793|NCT03905863|617600533|FG001|Overall Study|Physician Decision|3|||
170888794|NCT03905863|617600532|FG000|Overall Study|Lost to Follow-up|1|||
170888795|NCT03905863|617600533|FG001|Overall Study|Lost to Follow-up|0|||
170888796|NCT03905863|617600532|FG000|Overall Study|Protocol Violation|0|||
170888797|NCT03905863|617600533|FG001|Overall Study|Protocol Violation|2|||
170635703|NCT04032093|616676993|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
170635704|NCT04032093|616676994|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
170635705|NCT04032093|616676995|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
170455193|NCT02335983|616005518|FG000|Overall Study|Lost to Follow-up|0|||
170455194|NCT02335983|616005519|FG001|Overall Study|Lost to Follow-up|0|||
170455195|NCT02335983|616005520|FG002|Overall Study|Lost to Follow-up|0|||
170787721|NCT04338061|617231866|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
170787722|NCT04338061|617231867|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
170787723|NCT04338061|617231866|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
170787724|NCT04338061|617231867|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
170787725|NCT04338061|617231866|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
170787726|NCT04338061|617231867|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
170787727|NCT04338061|617231866|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
170787728|NCT04338061|617231867|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
170787729|NCT04338061|617231866|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
170787730|NCT04338061|617231867|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
170787731|NCT04338061|617231866|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
170787732|NCT04338061|617231867|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
170787733|NCT04338061|617231866|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
170787734|NCT04338061|617231867|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
170787735|NCT04338061|617231866|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
170787736|NCT04338061|617231867|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
170787737|NCT04338061|617231866|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
170787738|NCT04338061|617231867|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
170787739|NCT04338061|617231866|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
170787740|NCT04338061|617231867|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
170787741|NCT04492722|617231868|FG000|Overall Study|Adverse Event|7|||
170787742|NCT04492722|617231869|FG001|Overall Study|Adverse Event|2|||
170787743|NCT04492722|617231870|FG002|Overall Study|Adverse Event|3|||
170787744|NCT04492722|617231871|FG003|Overall Study|Adverse Event|0|||
170787745|NCT04492722|617231868|FG000|Overall Study|Death|0|||
170787746|NCT04492722|617231869|FG001|Overall Study|Death|0|||
170787747|NCT04492722|617231870|FG002|Overall Study|Death|0|||
170787748|NCT04492722|617231871|FG003|Overall Study|Death|1|||
170787749|NCT04492722|617231868|FG000|Overall Study|Lost to Follow-up|0|||
170787750|NCT04492722|617231869|FG001|Overall Study|Lost to Follow-up|1|||
170787751|NCT04492722|617231870|FG002|Overall Study|Lost to Follow-up|0|||
170787752|NCT04492722|617231871|FG003|Overall Study|Lost to Follow-up|1|||
170787753|NCT04492722|617231868|FG000|Overall Study|Physician Decision|0|||
170787754|NCT04492722|617231869|FG001|Overall Study|Physician Decision|3|||
170787755|NCT04492722|617231870|FG002|Overall Study|Physician Decision|1|||
170787756|NCT04492722|617231871|FG003|Overall Study|Physician Decision|1|||
170787757|NCT04492722|617231868|FG000|Overall Study|Withdrawal by Subject|6|||
170787758|NCT04492722|617231869|FG001|Overall Study|Withdrawal by Subject|6|||
170787759|NCT04492722|617231870|FG002|Overall Study|Withdrawal by Subject|0|||
170787760|NCT04492722|617231871|FG003|Overall Study|Withdrawal by Subject|3|||
170787761|NCT04492722|617231868|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
170787762|NCT04492722|617231869|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
170787763|NCT04492722|617231870|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
170787764|NCT04492722|617231871|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
170787765|NCT04492722|617231868|FG000|Overall Study|Due to Covid-19 pandemic|7|||
170787766|NCT04492722|617231869|FG001|Overall Study|Due to Covid-19 pandemic|3|||
170787767|NCT04492722|617231870|FG002|Overall Study|Due to Covid-19 pandemic|7|||
170787768|NCT04492722|617231871|FG003|Overall Study|Due to Covid-19 pandemic|6|||
170787769|NCT04492722|617231868|FG000|Overall Study|Failure to meet randomisation criteria|2|||
170787770|NCT04492722|617231869|FG001|Overall Study|Failure to meet randomisation criteria|3|||
170787771|NCT04492722|617231870|FG002|Overall Study|Failure to meet randomisation criteria|4|||
170787772|NCT04492722|617231871|FG003|Overall Study|Failure to meet randomisation criteria|2|||
170787773|NCT04492722|617231868|FG000|Overall Study|Early termination from the study|54|||
170787774|NCT04492722|617231869|FG001|Overall Study|Early termination from the study|51|||
170787775|NCT04492722|617231870|FG002|Overall Study|Early termination from the study|50|||
170787776|NCT04492722|617231871|FG003|Overall Study|Early termination from the study|50|||
170787777|NCT04492722|617231868|FG000|Overall Study|Missing|3|||
170787778|NCT04492722|617231869|FG001|Overall Study|Missing|0|||
170787779|NCT04492722|617231870|FG002|Overall Study|Missing|0|||
170455196|NCT02335983|616005521|FG003|Overall Study|Lost to Follow-up|0|||
170455197|NCT02335983|616005522|FG004|Overall Study|Lost to Follow-up|0|||
170787780|NCT04492722|617231871|FG003|Overall Study|Missing|5|||
170787781|NCT04492722|617231868|FG000|Overall Study|Participants who did not receive treatment|0|||
170787782|NCT04492722|617231869|FG001|Overall Study|Participants who did not receive treatment|1|||
170787783|NCT04492722|617231870|FG002|Overall Study|Participants who did not receive treatment|4|||
170787784|NCT04492722|617231871|FG003|Overall Study|Participants who did not receive treatment|0|||
170787785|NCT05228457|617231876|FG000|Overall Study|Withdrawal by Subject|1|||
170787786|NCT05228457|617231877|FG001|Overall Study|Withdrawal by Subject|1|||
170787787|NCT03492216|617231884|FG000|Overall Study|Death|1|||
170888798|NCT03905863|617600532|FG000|Overall Study|Death|0|||
170888799|NCT03905863|617600533|FG001|Overall Study|Death|1|||
170888800|NCT00808444|617600538|FG000|Overall Study|Withdrawal by Subject|1|||
170888801|NCT00808444|617600539|FG001|Overall Study|Withdrawal by Subject|0|||
170888802|NCT00808444|617600538|FG000|Overall Study|Lost to Follow-up|0|||
170888803|NCT00808444|617600539|FG001|Overall Study|Lost to Follow-up|1|||
170888804|NCT01461044|617600540|FG000|Overall Study|Death|58|||
170888805|NCT01461044|617600541|FG001|Overall Study|Death|35|||
170888806|NCT01461044|617600540|FG000|Overall Study|Lost to Follow-up|12|||
170888807|NCT01461044|617600541|FG001|Overall Study|Lost to Follow-up|5|||
170888808|NCT00716976|617600542|FG000|Overall Study|Adverse Event|2|||
170888809|NCT00716976|617600543|FG001|Overall Study|Adverse Event|0|||
170888810|NCT00716976|617600542|FG000|Overall Study|Death|1|||
170888811|NCT00716976|617600543|FG001|Overall Study|Death|0|||
170888812|NCT00716976|617600542|FG000|Overall Study|Physician Decision|2|||
170888813|NCT00716976|617600543|FG001|Overall Study|Physician Decision|2|||
170888814|NCT00716976|617600542|FG000|Overall Study|Withdrawal by Subject|5|||
170888815|NCT00716976|617600543|FG001|Overall Study|Withdrawal by Subject|1|||
170888816|NCT00716976|617600542|FG000|Overall Study|Premature discontinuation cisplatin|5|||
170888817|NCT00716976|617600543|FG001|Overall Study|Premature discontinuation cisplatin|4|||
170888818|NCT00716976|617600542|FG000|Overall Study|Radiation during protocol|1|||
170888819|NCT00716976|617600543|FG001|Overall Study|Radiation during protocol|0|||
170888820|NCT00716976|617600542|FG000|Overall Study|Ineligibles|4|||
170888821|NCT00716976|617600543|FG001|Overall Study|Ineligibles|2|||
170888822|NCT02889796|617600544|FG000|Overall Study|Withdrew Consent|18|||
170888823|NCT02889796|617600545|FG001|Overall Study|Withdrew Consent|29|||
170888824|NCT02889796|617600546|FG002|Overall Study|Withdrew Consent|20|||
170888825|NCT02889796|617600547|FG003|Overall Study|Withdrew Consent|1|||
170888826|NCT02889796|617600548|FG004|Overall Study|Withdrew Consent|2|||
170888827|NCT02889796|617600549|FG005|Overall Study|Withdrew Consent|35|||
170888828|NCT02889796|617600544|FG000|Overall Study|Investigator's Discretion|10|||
170888829|NCT02889796|617600545|FG001|Overall Study|Investigator's Discretion|9|||
170888830|NCT02889796|617600546|FG002|Overall Study|Investigator's Discretion|10|||
170888831|NCT02889796|617600547|FG003|Overall Study|Investigator's Discretion|3|||
170888832|NCT02889796|617600548|FG004|Overall Study|Investigator's Discretion|0|||
170888833|NCT02889796|617600549|FG005|Overall Study|Investigator's Discretion|15|||
170888834|NCT02889796|617600544|FG000|Overall Study|Adverse Event|17|||
170888835|NCT02889796|617600545|FG001|Overall Study|Adverse Event|8|||
170888836|NCT02889796|617600546|FG002|Overall Study|Adverse Event|8|||
170888837|NCT02889796|617600547|FG003|Overall Study|Adverse Event|4|||
170888838|NCT02889796|617600548|FG004|Overall Study|Adverse Event|1|||
170888839|NCT02889796|617600549|FG005|Overall Study|Adverse Event|7|||
170888840|NCT02889796|617600544|FG000|Overall Study|Lost to Follow-up|5|||
170888841|NCT02889796|617600545|FG001|Overall Study|Lost to Follow-up|7|||
170888842|NCT02889796|617600546|FG002|Overall Study|Lost to Follow-up|2|||
170888843|NCT02889796|617600547|FG003|Overall Study|Lost to Follow-up|0|||
170888844|NCT02889796|617600548|FG004|Overall Study|Lost to Follow-up|2|||
170888845|NCT02889796|617600549|FG005|Overall Study|Lost to Follow-up|6|||
170888846|NCT02889796|617600544|FG000|Overall Study|Protocol Violation|0|||
170888847|NCT02889796|617600545|FG001|Overall Study|Protocol Violation|1|||
170888848|NCT02889796|617600546|FG002|Overall Study|Protocol Violation|3|||
170888849|NCT02889796|617600547|FG003|Overall Study|Protocol Violation|0|||
170888850|NCT02889796|617600548|FG004|Overall Study|Protocol Violation|0|||
170888851|NCT02889796|617600549|FG005|Overall Study|Protocol Violation|4|||
170888852|NCT02889796|617600544|FG000|Overall Study|Non-compliance With Study Drug|0|||
170888853|NCT02889796|617600545|FG001|Overall Study|Non-compliance With Study Drug|2|||
170888854|NCT02889796|617600546|FG002|Overall Study|Non-compliance With Study Drug|0|||
170888855|NCT02889796|617600547|FG003|Overall Study|Non-compliance With Study Drug|0|||
170888856|NCT02889796|617600548|FG004|Overall Study|Non-compliance With Study Drug|1|||
170888857|NCT02889796|617600549|FG005|Overall Study|Non-compliance With Study Drug|2|||
170888858|NCT02889796|617600544|FG000|Overall Study|Death|1|||
170888859|NCT02889796|617600545|FG001|Overall Study|Death|1|||
170888860|NCT02889796|617600546|FG002|Overall Study|Death|0|||
170888861|NCT02889796|617600547|FG003|Overall Study|Death|1|||
170888862|NCT02889796|617600548|FG004|Overall Study|Death|0|||
170888863|NCT02889796|617600549|FG005|Overall Study|Death|1|||
170888864|NCT02889796|617600544|FG000|Overall Study|Pregnancy|0|||
170888865|NCT02889796|617600545|FG001|Overall Study|Pregnancy|1|||
170888866|NCT02889796|617600546|FG002|Overall Study|Pregnancy|1|||
170888867|NCT02889796|617600547|FG003|Overall Study|Pregnancy|0|||
170888868|NCT02889796|617600548|FG004|Overall Study|Pregnancy|0|||
170888869|NCT02889796|617600549|FG005|Overall Study|Pregnancy|0|||
170888870|NCT02889796|617600544|FG000|Overall Study|Randomized but not Dosed|2|||
170888871|NCT02889796|617600545|FG001|Overall Study|Randomized but not Dosed|0|||
170888872|NCT02889796|617600546|FG002|Overall Study|Randomized but not Dosed|0|||
170888873|NCT02889796|617600547|FG003|Overall Study|Randomized but not Dosed|0|||
170888874|NCT02889796|617600548|FG004|Overall Study|Randomized but not Dosed|0|||
170888875|NCT02889796|617600549|FG005|Overall Study|Randomized but not Dosed|2|||
170888876|NCT02814565|617600550|FG000|Overall Study|Lack of Efficacy|0|||
170888877|NCT02814565|617600551|FG001|Overall Study|Lack of Efficacy|1|||
170888878|NCT02814565|617600550|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
170888879|NCT02814565|617600551|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
170888880|NCT03472560|617600552|FG000|Overall Study|Subject transfer to continuation protocol|0|||
170888881|NCT03472560|617600553|FG001|Overall Study|Subject transfer to continuation protocol|1|||
170888882|NCT03472560|617600552|FG000|Overall Study|Withdrawal by Subject|4|||
170888883|NCT03472560|617600553|FG001|Overall Study|Withdrawal by Subject|0|||
170888884|NCT03472560|617600552|FG000|Overall Study|Progressive disease|24|||
170888885|NCT03472560|617600553|FG001|Overall Study|Progressive disease|8|||
170888886|NCT03472560|617600552|FG000|Overall Study|Physician Decision|1|||
170888887|NCT03472560|617600553|FG001|Overall Study|Physician Decision|0|||
170888888|NCT03472560|617600552|FG000|Overall Study|Death|7|||
170888889|NCT03472560|617600553|FG001|Overall Study|Death|4|||
170888890|NCT03472560|617600552|FG000|Overall Study|Adverse Event|5|||
170888891|NCT03472560|617600553|FG001|Overall Study|Adverse Event|3|||
170888892|NCT03472560|617600552|FG000|Overall Study|Global deterioration of health status|0|||
170888893|NCT03472560|617600553|FG001|Overall Study|Global deterioration of health status|4|||
170888894|NCT01946178|617600554|FG000|Overall Study|Pregnancy|1|||
170888895|NCT01946178|617600554|FG000|Overall Study|Lost to Follow-up|1|||
170888896|NCT01191697|617600555|FG000|Overall Study|Death|1|||
170888897|NCT01191697|617600555|FG000|Overall Study|Physician Decision|2|||
170888898|NCT01191697|617600555|FG000|Overall Study|Pursue chemoradiation|2|||
170888899|NCT01191697|617600555|FG000|Overall Study|Break from chemotherapy|2|||
170542664|NCT02323334|616331084|FG016|Period 3|Lost to Follow-up|0|||
170542665|NCT02323334|616331068|FG000|Period 3|Withdrawal by Subject|1|||
170542666|NCT02323334|616331069|FG001|Period 3|Withdrawal by Subject|0|||
170542667|NCT02323334|616331070|FG002|Period 3|Withdrawal by Subject|0|||
170542668|NCT02323334|616331071|FG003|Period 3|Withdrawal by Subject|0|||
170542669|NCT02323334|616331072|FG004|Period 3|Withdrawal by Subject|0|||
170542670|NCT02323334|616331073|FG005|Period 3|Withdrawal by Subject|0|||
170542671|NCT02323334|616331074|FG006|Period 3|Withdrawal by Subject|0|||
170542672|NCT02323334|616331075|FG007|Period 3|Withdrawal by Subject|0|||
170542673|NCT02323334|616331076|FG008|Period 3|Withdrawal by Subject|0|||
170542674|NCT02323334|616331077|FG009|Period 3|Withdrawal by Subject|0|||
170542675|NCT02323334|616331078|FG010|Period 3|Withdrawal by Subject|0|||
170542676|NCT02323334|616331079|FG011|Period 3|Withdrawal by Subject|0|||
170542677|NCT02323334|616331080|FG012|Period 3|Withdrawal by Subject|0|||
170542678|NCT02323334|616331081|FG013|Period 3|Withdrawal by Subject|0|||
170542679|NCT02323334|616331082|FG014|Period 3|Withdrawal by Subject|0|||
170542680|NCT02323334|616331083|FG015|Period 3|Withdrawal by Subject|0|||
170542681|NCT02323334|616331084|FG016|Period 3|Withdrawal by Subject|0|||
170542682|NCT01617967|616331086|FG000|Overall Study|Protocol Violation|0|||
170542683|NCT01617967|616331087|FG001|Overall Study|Protocol Violation|0|||
170542684|NCT01617967|616331088|FG002|Overall Study|Protocol Violation|0|||
170542685|NCT01617967|616331089|FG003|Overall Study|Protocol Violation|1|||
170542686|NCT01617967|616331090|FG004|Overall Study|Protocol Violation|0|||
170635706|NCT04032093|616676996|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
170635707|NCT04032093|616676997|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
170888900|NCT01191697|617600555|FG000|Overall Study|Withdrawal by Subject|1|||
170888901|NCT01191697|617600555|FG000|Overall Study|Surveillance|1|||
170888902|NCT01191697|617600555|FG000|Overall Study|Adverse Event|2|||
170888903|NCT01191697|617600555|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
170888904|NCT01191697|617600555|FG000|Overall Study|Not completed but analyzed|25|||
170888905|NCT02787863|617600556|FG000|Overall Study|Death|1|||
170888906|NCT02787863|617600557|FG001|Overall Study|Death|0|||
170888907|NCT02787863|617600558|FG002|Overall Study|Death|1|||
170888908|NCT02787863|617600559|FG003|Overall Study|Death|0|||
170888909|NCT02787863|617600560|FG004|Overall Study|Death|0|||
170888910|NCT02787863|617600561|FG005|Overall Study|Death|0|||
170888911|NCT02787863|617600562|FG006|Overall Study|Death|0|||
170888912|NCT02787863|617600563|FG007|Overall Study|Death|0|||
170888913|NCT02787863|617600556|FG000|Overall Study|Withdrawal by Subject|0|||
170888914|NCT02787863|617600557|FG001|Overall Study|Withdrawal by Subject|1|||
170888915|NCT02787863|617600558|FG002|Overall Study|Withdrawal by Subject|1|||
170888916|NCT02787863|617600559|FG003|Overall Study|Withdrawal by Subject|0|||
170888917|NCT02787863|617600560|FG004|Overall Study|Withdrawal by Subject|0|||
170888918|NCT02787863|617600561|FG005|Overall Study|Withdrawal by Subject|0|||
170888919|NCT02787863|617600562|FG006|Overall Study|Withdrawal by Subject|0|||
170888920|NCT02787863|617600563|FG007|Overall Study|Withdrawal by Subject|0|||
170888921|NCT01534676|617600564|FG000|Overall Study|Study closed due to poor enrollment|2|||
170888922|NCT01534676|617600565|FG001|Overall Study|Study closed due to poor enrollment|1|||
170888923|NCT02634580|617600566|FG000|Double-blind Treatment Period|Subject Request|1|||
170888924|NCT02634580|617600567|FG001|Double-blind Treatment Period|Subject Request|0|||
170888925|NCT02634580|617600568|FG002|Double-blind Treatment Period|Subject Request|1|||
170888926|NCT02634580|617600569|FG003|Double-blind Treatment Period|Subject Request|1|||
170888927|NCT02634580|617600566|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
170542687|NCT01617967|616331091|FG005|Overall Study|Protocol Violation|0|||
170542688|NCT01617967|616331086|FG000|Overall Study|Withdrawal by Subject|0|||
170542689|NCT01617967|616331087|FG001|Overall Study|Withdrawal by Subject|0|||
170635708|NCT04032093|616676998|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
170635709|NCT04032093|616676989|FG000|Overall Study|Adverse Event|0|||
170635710|NCT04032093|616676990|FG001|Overall Study|Adverse Event|0|||
170635711|NCT04032093|616676991|FG002|Overall Study|Adverse Event|0|||
170635712|NCT04032093|616676992|FG003|Overall Study|Adverse Event|0|||
170635713|NCT04032093|616676993|FG004|Overall Study|Adverse Event|0|||
170635714|NCT04032093|616676994|FG005|Overall Study|Adverse Event|0|||
170635715|NCT04032093|616676995|FG006|Overall Study|Adverse Event|0|||
170635716|NCT04032093|616676996|FG007|Overall Study|Adverse Event|0|||
170635717|NCT04032093|616676997|FG008|Overall Study|Adverse Event|0|||
170635718|NCT04032093|616676998|FG009|Overall Study|Adverse Event|1|||
170635719|NCT04032093|616676989|FG000|Overall Study|Physician Decision|0|||
170888928|NCT02634580|617600567|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
170455198|NCT02335983|616005523|FG005|Overall Study|Lost to Follow-up|1|||
170455199|NCT02335983|616005518|FG000|Overall Study|Protocol Specified Criteria|5|||
170455200|NCT02335983|616005519|FG001|Overall Study|Protocol Specified Criteria|7|||
170888929|NCT02634580|617600568|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
170888930|NCT02634580|617600569|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
170888931|NCT01882907|617600571|FG000|Overall Study|Adverse Event|3|||
170888932|NCT01882907|617600572|FG001|Overall Study|Adverse Event|1|||
170888933|NCT01882907|617600571|FG000|Overall Study|Lack of Efficacy|0|||
170888934|NCT01882907|617600572|FG001|Overall Study|Lack of Efficacy|3|||
170888935|NCT01882907|617600571|FG000|Overall Study|Lost to Follow-up|1|||
170888936|NCT01882907|617600572|FG001|Overall Study|Lost to Follow-up|4|||
170888937|NCT01882907|617600571|FG000|Overall Study|Protocol Violation|10|||
170888938|NCT01882907|617600572|FG001|Overall Study|Protocol Violation|14|||
170888939|NCT01882907|617600571|FG000|Overall Study|Withdrawal by Subject|0|||
170888940|NCT01882907|617600572|FG001|Overall Study|Withdrawal by Subject|6|||
170888941|NCT02397473|617600577|FG000|Treatment Phase|Adverse Event|1|||
170455201|NCT02335983|616005520|FG002|Overall Study|Protocol Specified Criteria|27|||
170455202|NCT02335983|616005521|FG003|Overall Study|Protocol Specified Criteria|7|||
170455203|NCT02335983|616005522|FG004|Overall Study|Protocol Specified Criteria|5|||
170455204|NCT02335983|616005523|FG005|Overall Study|Protocol Specified Criteria|21|||
170455205|NCT00289874|616005529|FG000|Overall Study|Adverse Event|1|||
170455206|NCT00289874|616005530|FG001|Overall Study|Adverse Event|5|||
170888942|NCT02397473|617600578|FG001|Treatment Phase|Adverse Event|2|||
170635720|NCT04032093|616676990|FG001|Overall Study|Physician Decision|0|||
170635721|NCT04032093|616676991|FG002|Overall Study|Physician Decision|0|||
170635722|NCT04032093|616676992|FG003|Overall Study|Physician Decision|0|||
170888943|NCT02397473|617600577|FG000|Treatment Phase|Lack of Efficacy|8|||
170888944|NCT02397473|617600578|FG001|Treatment Phase|Lack of Efficacy|1|||
170888945|NCT02397473|617600577|FG000|Treatment Phase|Lost to Follow-up|1|||
170888946|NCT02397473|617600578|FG001|Treatment Phase|Lost to Follow-up|0|||
170888947|NCT02397473|617600577|FG000|Treatment Phase|Withdrawal by Subject|2|||
170888948|NCT02397473|617600578|FG001|Treatment Phase|Withdrawal by Subject|1|||
170888949|NCT02397473|617600577|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
170888950|NCT02397473|617600578|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
170888951|NCT02397473|617600577|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
170888952|NCT02397473|617600578|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
170888953|NCT02397473|617600577|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
170888954|NCT02397473|617600578|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
170888955|NCT02397473|617600577|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
170888956|NCT02397473|617600578|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
170888957|NCT02397473|617600577|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
170888958|NCT02397473|617600578|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
170888959|NCT01790048|617600579|FG000|Overall Study|Incorrect Age|9|||
170888960|NCT01790048|617600580|FG001|Overall Study|Incorrect Age|14|||
170888961|NCT01790048|617600579|FG000|Overall Study|data entry error|0|||
170888962|NCT01790048|617600580|FG001|Overall Study|data entry error|1|||
170888963|NCT01790048|617600579|FG000|Overall Study|Other|0|||
170455207|NCT00289874|616005529|FG000|Overall Study|Lost to Follow-up|1|||
170455208|NCT00289874|616005530|FG001|Overall Study|Lost to Follow-up|1|||
170455209|NCT00289874|616005529|FG000|Overall Study|Protocol Violation|3|||
170455210|NCT00289874|616005530|FG001|Overall Study|Protocol Violation|2|||
170455211|NCT00289874|616005529|FG000|Overall Study|Did not meet eligibility|1|||
170888964|NCT01790048|617600580|FG001|Overall Study|Other|2|||
170888965|NCT01790048|617600579|FG000|Overall Study|SAM at Enrollment|2|||
170888966|NCT01790048|617600580|FG001|Overall Study|SAM at Enrollment|0|||
170888967|NCT01790048|617600579|FG000|Overall Study|Measurement error|1|||
170888968|NCT01790048|617600580|FG001|Overall Study|Measurement error|0|||
170888969|NCT01604512|617600581|FG000|Overall Study|Withdrawal by Subject|3|||
170888970|NCT01604512|617600581|FG000|Overall Study|Not treated|4|||
170888971|NCT02847624|617600584|FG000|Overall Study|Lost to Follow-up|28|||
170888972|NCT02847624|617600584|FG000|Overall Study|Protocol Violation|98|||
170455212|NCT00289874|616005530|FG001|Overall Study|Did not meet eligibility|0|||
170635723|NCT04032093|616676993|FG004|Overall Study|Physician Decision|0|||
170635724|NCT04032093|616676994|FG005|Overall Study|Physician Decision|1|||
170635725|NCT04032093|616676995|FG006|Overall Study|Physician Decision|0|||
170542690|NCT01617967|616331088|FG002|Overall Study|Withdrawal by Subject|0|||
170542691|NCT01617967|616331089|FG003|Overall Study|Withdrawal by Subject|0|||
170542692|NCT01617967|616331090|FG004|Overall Study|Withdrawal by Subject|0|||
170542693|NCT01617967|616331091|FG005|Overall Study|Withdrawal by Subject|1|||
170542694|NCT01617967|616331086|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
170542695|NCT01617967|616331087|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
170542696|NCT01617967|616331088|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
170542697|NCT01617967|616331089|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
170542698|NCT01617967|616331090|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
170542699|NCT01617967|616331091|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
170542700|NCT03520569|616331092|FG000|Overall Study|Withdrawal by Subject|1|||
170542701|NCT02453048|616331093|FG000|Overall Study|Only part of initial 6 mo. study|0|||
170542702|NCT02453048|616331094|FG001|Overall Study|Only part of initial 6 mo. study|0|||
170542703|NCT02453048|616331095|FG002|Overall Study|Only part of initial 6 mo. study|0|||
170542704|NCT02453048|616331096|FG003|Overall Study|Only part of initial 6 mo. study|0|||
170542705|NCT02453048|616331097|FG004|Overall Study|Only part of initial 6 mo. study|6|||
170542706|NCT02453048|616331093|FG000|Overall Study|Lost to Follow-up|0|||
170542707|NCT02453048|616331094|FG001|Overall Study|Lost to Follow-up|1|||
170542708|NCT02453048|616331095|FG002|Overall Study|Lost to Follow-up|2|||
170635726|NCT04032093|616676996|FG007|Overall Study|Physician Decision|0|||
170635727|NCT04032093|616676997|FG008|Overall Study|Physician Decision|0|||
170635728|NCT04032093|616676998|FG009|Overall Study|Physician Decision|0|||
170542709|NCT02453048|616331096|FG003|Overall Study|Lost to Follow-up|0|||
170542710|NCT02453048|616331097|FG004|Overall Study|Lost to Follow-up|0|||
170542711|NCT00447278|616331098|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
170542712|NCT00447278|616331099|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
170635729|NCT01654302|616677003|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
170455213|NCT01087489|616005531|FG000|Overall Study|enrolled in another VA study|0|||
170455214|NCT01087489|616005532|FG001|Overall Study|enrolled in another VA study|1|||
170455215|NCT01087489|616005531|FG000|Overall Study|Death|0|||
170455216|NCT01087489|616005532|FG001|Overall Study|Death|1|||
170455217|NCT01087489|616005531|FG000|Overall Study|unable to survey by telephone|0|||
170455218|NCT01087489|616005532|FG001|Overall Study|unable to survey by telephone|1|||
170455219|NCT00567476|616005542|FG000|Overall Study|Adverse Event|2|||
170455220|NCT00567476|616005543|FG001|Overall Study|Adverse Event|0|||
170455221|NCT00567476|616005542|FG000|Overall Study|Pregnancy|1|||
170455222|NCT00567476|616005543|FG001|Overall Study|Pregnancy|0|||
170455223|NCT00567476|616005542|FG000|Overall Study|Protocol Violation|4|||
170455224|NCT00567476|616005543|FG001|Overall Study|Protocol Violation|1|||
170455225|NCT00567476|616005542|FG000|Overall Study|Lost to Follow-up|0|||
170455226|NCT00567476|616005543|FG001|Overall Study|Lost to Follow-up|1|||
170455227|NCT00567476|616005542|FG000|Overall Study|Administrative issues|1|||
170455228|NCT00567476|616005543|FG001|Overall Study|Administrative issues|0|||
170455229|NCT00567476|616005542|FG000|Overall Study|Medical Decision|0|||
170455230|NCT00567476|616005543|FG001|Overall Study|Medical Decision|1|||
170455231|NCT00567476|616005542|FG000|Overall Study|Non-adherence to protocol|0|||
170455232|NCT00567476|616005543|FG001|Overall Study|Non-adherence to protocol|1|||
170455233|NCT01846273|616005548|FG000|Overall Study|Adverse Event|9|||
170455234|NCT01846273|616005549|FG001|Overall Study|Adverse Event|7|||
170787788|NCT03492216|617231885|FG001|Overall Study|Death|0|||
170455235|NCT01846273|616005550|FG002|Overall Study|Adverse Event|0|||
170455236|NCT01846273|616005548|FG000|Overall Study|Subject withdrew consent|5|||
170455237|NCT01846273|616005549|FG001|Overall Study|Subject withdrew consent|8|||
170542713|NCT00447278|616331098|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
170542714|NCT00447278|616331099|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
170542715|NCT00447278|616331098|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
170542716|NCT00447278|616331099|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
170542717|NCT00447278|616331098|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
170542718|NCT00447278|616331099|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
170542719|NCT00447278|616331098|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
170542720|NCT00447278|616331099|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
170542721|NCT00447278|616331098|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
170542722|NCT00447278|616331099|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
170542723|NCT00447278|616331098|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
170542724|NCT00447278|616331099|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
170542725|NCT00447278|616331098|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
170542726|NCT00447278|616331099|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
170542727|NCT00447278|616331098|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
170787789|NCT03492216|617231886|FG002|Overall Study|Death|4|||
170787790|NCT03492216|617231887|FG003|Overall Study|Death|0|||
170787791|NCT03492216|617231884|FG000|Overall Study|Withdrawal by Subject|5|||
170787792|NCT03492216|617231885|FG001|Overall Study|Withdrawal by Subject|3|||
170787793|NCT03492216|617231886|FG002|Overall Study|Withdrawal by Subject|1|||
170787794|NCT03492216|617231887|FG003|Overall Study|Withdrawal by Subject|1|||
170787795|NCT03492216|617231884|FG000|Overall Study|Lost to Follow-up|9|||
170787796|NCT03492216|617231885|FG001|Overall Study|Lost to Follow-up|2|||
170787797|NCT03492216|617231886|FG002|Overall Study|Lost to Follow-up|7|||
170787798|NCT03492216|617231887|FG003|Overall Study|Lost to Follow-up|8|||
170787799|NCT03492216|617231884|FG000|Overall Study|Moved|5|||
170787800|NCT03492216|617231885|FG001|Overall Study|Moved|3|||
170787801|NCT03492216|617231886|FG002|Overall Study|Moved|3|||
170787802|NCT03492216|617231887|FG003|Overall Study|Moved|5|||
170787803|NCT03492216|617231884|FG000|Overall Study|Too ill|0|||
170787804|NCT03492216|617231885|FG001|Overall Study|Too ill|1|||
170787805|NCT03492216|617231886|FG002|Overall Study|Too ill|0|||
170787806|NCT03492216|617231887|FG003|Overall Study|Too ill|0|||
170787807|NCT03492216|617231884|FG000|Overall Study|Incarcerated|0|||
170787808|NCT03492216|617231885|FG001|Overall Study|Incarcerated|0|||
170787809|NCT03492216|617231886|FG002|Overall Study|Incarcerated|2|||
170787810|NCT03492216|617231887|FG003|Overall Study|Incarcerated|0|||
170787811|NCT04256941|617234121|FG000|Overall Study|Withdrawal by Subject|0|||
170787812|NCT04256941|617234122|FG001|Overall Study|Withdrawal by Subject|1|||
170455238|NCT01846273|616005550|FG002|Overall Study|Subject withdrew consent|0|||
170787813|NCT04256941|617234121|FG000|Overall Study|Death|1|||
170787814|NCT04256941|617234122|FG001|Overall Study|Death|0|||
170455239|NCT01846273|616005548|FG000|Overall Study|Lost to Follow-up|2|||
170455240|NCT01846273|616005549|FG001|Overall Study|Lost to Follow-up|1|||
170455241|NCT01846273|616005550|FG002|Overall Study|Lost to Follow-up|0|||
170787815|NCT04256941|617234121|FG000|Overall Study|Disease Progession|0|||
170787816|NCT04256941|617234122|FG001|Overall Study|Disease Progession|2|||
170787817|NCT05282173|617234123|FG000|Overall Study|Missed|3|||
170787818|NCT05282173|617234124|FG001|Overall Study|Missed|2|||
170787819|NCT05282173|617234125|FG002|Overall Study|Missed|4|||
170787820|NCT05453773|617234134|FG000|Overall Study|Withdrawal by Subject|3|||
170455242|NCT01846273|616005548|FG000|Overall Study|Administrative problems|1|||
170455243|NCT01846273|616005549|FG001|Overall Study|Administrative problems|0|||
170455244|NCT01846273|616005550|FG002|Overall Study|Administrative problems|0|||
170455245|NCT01846273|616005548|FG000|Overall Study|Death|2|||
170455246|NCT01846273|616005549|FG001|Overall Study|Death|1|||
170455247|NCT01846273|616005550|FG002|Overall Study|Death|0|||
170455248|NCT01846273|616005548|FG000|Overall Study|Disease Progression|0|||
170455249|NCT01846273|616005549|FG001|Overall Study|Disease Progression|4|||
170455250|NCT01846273|616005550|FG002|Overall Study|Disease Progression|0|||
170455251|NCT01846273|616005548|FG000|Overall Study|Protocol Deviation|2|||
170455252|NCT01846273|616005549|FG001|Overall Study|Protocol Deviation|3|||
170455253|NCT01846273|616005550|FG002|Overall Study|Protocol Deviation|0|||
170455254|NCT01846273|616005548|FG000|Overall Study|Physician Decision|1|||
170455255|NCT01846273|616005549|FG001|Overall Study|Physician Decision|2|||
170455256|NCT01846273|616005550|FG002|Overall Study|Physician Decision|0|||
170455257|NCT00891839|616005551|FG000|Overall Study|Adverse Event|2|||
170455258|NCT00891839|616005551|FG000|Overall Study|Withdrawal by Subject|2|||
170455259|NCT00891839|616005551|FG000|Overall Study|Disease progression|3|||
170455260|NCT02858492|616007937|FG000|Overall Study|Withdrawal by Subject|0|||
170455261|NCT02858492|616007938|FG001|Overall Study|Withdrawal by Subject|1|||
170888973|NCT02847624|617600584|FG000|Overall Study|Case report failures|4|||
170888974|NCT04735653|617600585|FG000|Overall Study|Lost to Follow-up|17|||
170888975|NCT04735653|617600586|FG001|Overall Study|Lost to Follow-up|7|||
170888976|NCT04735653|617600585|FG000|Overall Study|Withdrawal by Subject|8|||
170888977|NCT04735653|617600586|FG001|Overall Study|Withdrawal by Subject|2|||
170888978|NCT04735653|617600585|FG000|Overall Study|Death|0|||
170888979|NCT04735653|617600586|FG001|Overall Study|Death|2|||
170888980|NCT04735653|617600585|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
170888981|NCT04735653|617600586|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
170888982|NCT01415752|617600590|FG000|Induction (Step 1)|Ineligible|4|||
170888983|NCT01415752|617600591|FG001|Induction (Step 1)|Ineligible|3|||
170888984|NCT01415752|617600592|FG002|Induction (Step 1)|Ineligible|4|||
170888985|NCT01415752|617600593|FG003|Induction (Step 1)|Ineligible|4|||
170888986|NCT01415752|617600590|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
170888987|NCT01415752|617600591|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
170888988|NCT01415752|617600592|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
170888989|NCT01415752|617600593|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
170888990|NCT01415752|617600590|FG000|Maintenance (Step 2)|Adverse Event|3|||
170888991|NCT01415752|617600591|FG001|Maintenance (Step 2)|Adverse Event|4|||
170888992|NCT01415752|617600592|FG002|Maintenance (Step 2)|Adverse Event|9|||
170888993|NCT01415752|617600593|FG003|Maintenance (Step 2)|Adverse Event|6|||
170888994|NCT01415752|617600590|FG000|Maintenance (Step 2)|Death|1|||
170888995|NCT01415752|617600591|FG001|Maintenance (Step 2)|Death|1|||
170888996|NCT01415752|617600592|FG002|Maintenance (Step 2)|Death|2|||
170888997|NCT01415752|617600593|FG003|Maintenance (Step 2)|Death|0|||
170888998|NCT01415752|617600590|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
170888999|NCT01415752|617600591|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
170889000|NCT01415752|617600592|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
170889001|NCT01415752|617600593|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
170889002|NCT01415752|617600590|FG000|Maintenance (Step 2)|Alternative therapy|0|||
170889003|NCT01415752|617600591|FG001|Maintenance (Step 2)|Alternative therapy|1|||
170889004|NCT01415752|617600592|FG002|Maintenance (Step 2)|Alternative therapy|0|||
170889005|NCT01415752|617600593|FG003|Maintenance (Step 2)|Alternative therapy|0|||
170455262|NCT02858492|616007939|FG002|Overall Study|Withdrawal by Subject|0|||
170455263|NCT02858492|616007940|FG003|Overall Study|Withdrawal by Subject|1|||
170455264|NCT02858492|616007937|FG000|Overall Study|Adverse Event|0|||
170455265|NCT02858492|616007938|FG001|Overall Study|Adverse Event|0|||
170455266|NCT02858492|616007939|FG002|Overall Study|Adverse Event|0|||
170455267|NCT02858492|616007940|FG003|Overall Study|Adverse Event|3|||
170455268|NCT02858492|616007937|FG000|Overall Study|Lack of Efficacy|0|||
170455269|NCT02858492|616007938|FG001|Overall Study|Lack of Efficacy|0|||
170455270|NCT02858492|616007939|FG002|Overall Study|Lack of Efficacy|0|||
170455271|NCT02858492|616007940|FG003|Overall Study|Lack of Efficacy|1|||
170455272|NCT02858492|616007937|FG000|Overall Study|Protocol defined stopping criteria|0|||
170455273|NCT02858492|616007938|FG001|Overall Study|Protocol defined stopping criteria|0|||
170455274|NCT02858492|616007939|FG002|Overall Study|Protocol defined stopping criteria|0|||
170542728|NCT00447278|616331099|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
170889006|NCT01415752|617600590|FG000|Maintenance (Step 2)|Other reasons|3|||
170455275|NCT02858492|616007940|FG003|Overall Study|Protocol defined stopping criteria|1|||
170889007|NCT01415752|617600591|FG001|Maintenance (Step 2)|Other reasons|6|||
170889008|NCT01415752|617600592|FG002|Maintenance (Step 2)|Other reasons|4|||
170889009|NCT01415752|617600593|FG003|Maintenance (Step 2)|Other reasons|6|||
170455276|NCT01032018|616007941|FG000|Overall Study|Lost to Follow-up|6|||
170455277|NCT01032018|616007942|FG001|Overall Study|Lost to Follow-up|5|||
170455278|NCT01032018|616007941|FG000|Overall Study|Death|0|||
170889010|NCT01415752|617600590|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
170889011|NCT01415752|617600591|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
170455279|NCT01032018|616007942|FG001|Overall Study|Death|1|||
170455280|NCT00858143|616007945|FG000|Overall Study|Adverse Event|16|||
170455281|NCT00858143|616007945|FG000|Overall Study|Lack of Efficacy|4|||
170455282|NCT00858143|616007945|FG000|Overall Study|Death|7|||
170455283|NCT00858143|616007945|FG000|Overall Study|Other|23|||
170455284|NCT03853148|616007946|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
170455285|NCT03853148|616007947|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
170455286|NCT03853148|616007948|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
170455287|NCT03853148|616007949|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
170455288|NCT00090610|616007950|FG000|Overall Study|Withdrawal by Subject|1|||
170455289|NCT00090610|616007951|FG001|Overall Study|Withdrawal by Subject|1|||
170455290|NCT01293539|616007953|FG000|Overall Study|Physician Decision|1|||
170455291|NCT00609518|616007955|FG000|Overall Study|Death from Study Disease|32|||
170455292|NCT00609518|616007956|FG001|Overall Study|Death from Study Disease|32|||
170455293|NCT00609518|616007955|FG000|Overall Study|Withdrawal by Subject|5|||
170455294|NCT00609518|616007956|FG001|Overall Study|Withdrawal by Subject|3|||
170455295|NCT00609518|616007955|FG000|Overall Study|Lost to Follow-up|3|||
170455296|NCT00609518|616007956|FG001|Overall Study|Lost to Follow-up|0|||
170455297|NCT00609518|616007955|FG000|Overall Study|Physician Decision|1|||
170455298|NCT00609518|616007956|FG001|Overall Study|Physician Decision|3|||
170455299|NCT00609518|616007955|FG000|Overall Study|Death from Adverse Event|2|||
170455300|NCT00609518|616007956|FG001|Overall Study|Death from Adverse Event|2|||
170455301|NCT04032158|616007957|FG000|Overall Study|Study Termination|2|||
170455302|NCT04032158|616007958|FG001|Overall Study|Study Termination|1|||
170455303|NCT01700049|616007961|FG000|Overall Study|Withdrawal by Subject|1|||
170455304|NCT04325204|616007962|FG000|Overall Study|Death|0|||
170455305|NCT04325204|616007963|FG001|Overall Study|Death|1|||
170455306|NCT04325204|616007962|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
170455307|NCT04325204|616007963|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
170455308|NCT04325204|616007962|FG000|Overall Study|Lost to Follow-up|8|||
170455309|NCT04325204|616007963|FG001|Overall Study|Lost to Follow-up|8|||
170455310|NCT04325204|616007962|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
170455311|NCT04325204|616007963|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
170455312|NCT04710979|616007964|FG000|Overall Study|Lost to Follow-up|2|||
170455313|NCT04710979|616007965|FG001|Overall Study|Lost to Follow-up|4|||
170455314|NCT04710979|616007964|FG000|Overall Study|Withdrawal by Subject|1|||
170455315|NCT04710979|616007965|FG001|Overall Study|Withdrawal by Subject|0|||
170455316|NCT02751359|616007966|FG000|Overall Study|Lost to Follow-up|1|||
170455317|NCT01196078|616007969|FG000|Overall Study|Withdrawal by Subject|3|||
170455318|NCT01196078|616007970|FG001|Overall Study|Withdrawal by Subject|5|||
170455319|NCT01196078|616007969|FG000|Overall Study|Adverse Event|4|||
170455320|NCT01196078|616007970|FG001|Overall Study|Adverse Event|4|||
170455321|NCT01196078|616007969|FG000|Overall Study|Protocol Violation|2|||
170455322|NCT01196078|616007970|FG001|Overall Study|Protocol Violation|1|||
170455323|NCT01196078|616007969|FG000|Overall Study|Lack of Efficacy|17|||
170455324|NCT01196078|616007970|FG001|Overall Study|Lack of Efficacy|23|||
170455325|NCT01196078|616007969|FG000|Overall Study|Lost to Follow-up|1|||
170455326|NCT01196078|616007970|FG001|Overall Study|Lost to Follow-up|0|||
170455327|NCT01196078|616007969|FG000|Overall Study|Death|6|||
170455328|NCT01196078|616007970|FG001|Overall Study|Death|4|||
170455329|NCT02400671|616007971|FG000|Overall Study|Death|5|||
170455330|NCT02400671|616007972|FG001|Overall Study|Death|3|||
170455331|NCT02400671|616007973|FG002|Overall Study|Death|4|||
170455332|NCT02400671|616007971|FG000|Overall Study|Lost to Follow-up|20|||
170455333|NCT02400671|616007972|FG001|Overall Study|Lost to Follow-up|27|||
170455334|NCT02400671|616007973|FG002|Overall Study|Lost to Follow-up|24|||
170455335|NCT02400671|616007971|FG000|Overall Study|Withdrawal by Subject|2|||
170455336|NCT02400671|616007972|FG001|Overall Study|Withdrawal by Subject|2|||
170455337|NCT02400671|616007973|FG002|Overall Study|Withdrawal by Subject|0|||
170455338|NCT00394524|616007974|FG000|Overall Study|Protocol Violation|2|||
170455339|NCT00394524|616007975|FG001|Overall Study|Protocol Violation|3|||
170455340|NCT00394524|616007974|FG000|Overall Study|Death|1|||
170455341|NCT00394524|616007975|FG001|Overall Study|Death|0|||
170455342|NCT00394524|616007974|FG000|Overall Study|Withdrawal by Subject|0|||
170455343|NCT00394524|616007975|FG001|Overall Study|Withdrawal by Subject|1|||
170455344|NCT03921151|616007976|FG000|Overall Study|Withdrawal by Subject|11|||
170455345|NCT03921151|616007977|FG001|Overall Study|Withdrawal by Subject|16|||
170455346|NCT04421586|616007979|FG000|Overall Study|Death|0|||
170455347|NCT04421586|616007980|FG001|Overall Study|Death|1|||
170455348|NCT04421586|616007979|FG000|Overall Study|Lost to Follow-up|2|||
170455349|NCT04421586|616007980|FG001|Overall Study|Lost to Follow-up|2|||
170455350|NCT04421586|616007979|FG000|Overall Study|Withdrawn by PI|1|||
170455351|NCT04421586|616007980|FG001|Overall Study|Withdrawn by PI|0|||
170455352|NCT04421586|616007979|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
170455353|NCT04421586|616007980|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
170455354|NCT04647721|616007983|FG000|Overall Study|Withdrawal by Subject|0|||
170455355|NCT04647721|616007984|FG001|Overall Study|Withdrawal by Subject|2|||
170455356|NCT04647721|616007983|FG000|Overall Study|Lost to Follow-up|2|||
170455357|NCT04647721|616007984|FG001|Overall Study|Lost to Follow-up|0|||
170455358|NCT05070546|616007985|FG000|Overall Study|Death|0|||
170455359|NCT05070546|616007986|FG001|Overall Study|Death|0|||
170455360|NCT05070546|616007987|FG002|Overall Study|Death|0|||
170455361|NCT05070546|616007988|FG003|Overall Study|Death|0|||
170455362|NCT05070546|616007989|FG004|Overall Study|Death|0|||
170455363|NCT05070546|616007990|FG005|Overall Study|Death|1|||
170455364|NCT05070546|616007985|FG000|Overall Study|Lost to Follow-up|8|||
170455365|NCT05070546|616007986|FG001|Overall Study|Lost to Follow-up|2|||
170455366|NCT05070546|616007987|FG002|Overall Study|Lost to Follow-up|7|||
170455367|NCT05070546|616007988|FG003|Overall Study|Lost to Follow-up|1|||
170455368|NCT05070546|616007989|FG004|Overall Study|Lost to Follow-up|2|||
170455369|NCT05070546|616007990|FG005|Overall Study|Lost to Follow-up|0|||
170455370|NCT05070546|616007985|FG000|Overall Study|Withdrawal by Subject|1|||
170455371|NCT05070546|616007986|FG001|Overall Study|Withdrawal by Subject|1|||
170455372|NCT05070546|616007987|FG002|Overall Study|Withdrawal by Subject|3|||
170455373|NCT05070546|616007988|FG003|Overall Study|Withdrawal by Subject|0|||
170455374|NCT05070546|616007989|FG004|Overall Study|Withdrawal by Subject|0|||
170455375|NCT05070546|616007990|FG005|Overall Study|Withdrawal by Subject|0|||
170455376|NCT05070546|616007985|FG000|Overall Study|Other|0|||
170455377|NCT05070546|616007986|FG001|Overall Study|Other|0|||
170455378|NCT05070546|616007987|FG002|Overall Study|Other|0|||
170455379|NCT05070546|616007988|FG003|Overall Study|Other|0|||
170455380|NCT05070546|616007989|FG004|Overall Study|Other|3|||
170455381|NCT05070546|616007990|FG005|Overall Study|Other|0|||
170455382|NCT05070546|616007985|FG000|Overall Study|Randomized but not vaccinated|1|||
170455383|NCT05070546|616007986|FG001|Overall Study|Randomized but not vaccinated|0|||
170455384|NCT05070546|616007987|FG002|Overall Study|Randomized but not vaccinated|1|||
170455385|NCT05070546|616007988|FG003|Overall Study|Randomized but not vaccinated|1|||
170455386|NCT05070546|616007989|FG004|Overall Study|Randomized but not vaccinated|3|||
170455387|NCT05070546|616007990|FG005|Overall Study|Randomized but not vaccinated|0|||
170455388|NCT02643355|616007991|FG000|Overall Study|Withdrawal by Subject|1|||
170455389|NCT02643355|616007992|FG001|Overall Study|Withdrawal by Subject|3|||
170455390|NCT02643355|616007991|FG000|Overall Study|Protocol Violation|0|||
170455391|NCT02643355|616007992|FG001|Overall Study|Protocol Violation|2|||
170455392|NCT00136318|616007997|FG000|Overall Study|Adverse Event|5|||
170455393|NCT00136318|616007998|FG001|Overall Study|Adverse Event|5|||
170455394|NCT00136318|616007997|FG000|Overall Study|Withdrawal by Subject|2|||
170455395|NCT00136318|616007998|FG001|Overall Study|Withdrawal by Subject|2|||
170455396|NCT02005887|616007999|FG000|Overall Study|Protocol Violation|0|||
170455397|NCT02005887|616008000|FG001|Overall Study|Protocol Violation|2|||
170455398|NCT01615263|616008009|FG000|Overall Study|Post-randomization exclusion|0|||
170455399|NCT01615263|616008010|FG001|Overall Study|Post-randomization exclusion|2|||
170455400|NCT00988065|616008014|FG000|Overall Study|Adverse Event|4|||
170455401|NCT00988065|616008015|FG001|Overall Study|Adverse Event|10|||
170455402|NCT00988065|616008016|FG002|Overall Study|Adverse Event|2|||
170455403|NCT00988065|616008014|FG000|Overall Study|Lost to Follow-up|1|||
170455404|NCT00988065|616008015|FG001|Overall Study|Lost to Follow-up|2|||
170455405|NCT00988065|616008016|FG002|Overall Study|Lost to Follow-up|2|||
170455406|NCT00988065|616008014|FG000|Overall Study|Subject withdrew consent|3|||
170455407|NCT00988065|616008015|FG001|Overall Study|Subject withdrew consent|5|||
170455408|NCT00988065|616008016|FG002|Overall Study|Subject withdrew consent|2|||
170455409|NCT00988065|616008014|FG000|Overall Study|Noncompliance with protocol|5|||
170455410|NCT00988065|616008015|FG001|Overall Study|Noncompliance with protocol|6|||
170455411|NCT00988065|616008016|FG002|Overall Study|Noncompliance with protocol|9|||
170455412|NCT00700817|616008018|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
170787821|NCT05453773|617234134|FG000|Overall Study|Lost to Follow-up|3|||
170455413|NCT00700817|616008019|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
170455414|NCT00700817|616008020|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
170455415|NCT00700817|616008021|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
170455416|NCT00700817|616008022|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
170455417|NCT00700817|616008018|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
170455418|NCT00700817|616008019|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
170455419|NCT00700817|616008020|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
170455420|NCT00700817|616008021|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
170455421|NCT00700817|616008022|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
170455422|NCT00700817|616008018|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
170455423|NCT00700817|616008019|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
170455424|NCT00700817|616008020|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
170542729|NCT00447278|616331098|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
170542730|NCT00447278|616331099|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
170542731|NCT00447278|616331098|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
170787822|NCT05453773|617234134|FG000|Overall Study|Difficult Blood Draw|3|||
170635730|NCT01654302|616677004|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
170635731|NCT02839200|616677009|FG000|Overall Study|Withdrawal by Subject|2|||
170635732|NCT02839200|616677010|FG001|Overall Study|Withdrawal by Subject|0|||
170635733|NCT02839200|616677011|FG002|Overall Study|Withdrawal by Subject|1|||
170635734|NCT02839200|616677012|FG003|Overall Study|Withdrawal by Subject|0|||
170635735|NCT02839200|616677013|FG004|Overall Study|Withdrawal by Subject|0|||
170635736|NCT02839200|616677014|FG005|Overall Study|Withdrawal by Subject|1|||
170635737|NCT02839200|616677009|FG000|Overall Study|Lost to Follow-up|2|||
170635738|NCT02839200|616677010|FG001|Overall Study|Lost to Follow-up|0|||
170635739|NCT02839200|616677011|FG002|Overall Study|Lost to Follow-up|0|||
170635740|NCT02839200|616677012|FG003|Overall Study|Lost to Follow-up|0|||
170635741|NCT02839200|616677013|FG004|Overall Study|Lost to Follow-up|1|||
170635742|NCT02839200|616677014|FG005|Overall Study|Lost to Follow-up|0|||
170635743|NCT02839200|616677009|FG000|Overall Study|Adverse Event|0|||
170635744|NCT02839200|616677010|FG001|Overall Study|Adverse Event|0|||
170635745|NCT02839200|616677011|FG002|Overall Study|Adverse Event|0|||
170635746|NCT02839200|616677012|FG003|Overall Study|Adverse Event|0|||
170635747|NCT02839200|616677013|FG004|Overall Study|Adverse Event|1|||
170635748|NCT02839200|616677014|FG005|Overall Study|Adverse Event|0|||
170635749|NCT02839200|616677009|FG000|Overall Study|Randomized in error|0|||
170635750|NCT02839200|616677010|FG001|Overall Study|Randomized in error|1|||
170635751|NCT02839200|616677011|FG002|Overall Study|Randomized in error|0|||
170635752|NCT02839200|616677012|FG003|Overall Study|Randomized in error|0|||
170635753|NCT02839200|616677013|FG004|Overall Study|Randomized in error|0|||
170635754|NCT02839200|616677014|FG005|Overall Study|Randomized in error|0|||
170635755|NCT02952820|616677015|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
170635756|NCT02952820|616677016|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
170635757|NCT02952820|616677017|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
170635758|NCT02952820|616677015|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
170635759|NCT02952820|616677016|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
170635760|NCT02952820|616677017|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
170635761|NCT02952820|616677015|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
170635762|NCT02952820|616677016|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
170635763|NCT02952820|616677017|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
170635764|NCT02952820|616677015|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
170635765|NCT02952820|616677016|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
170635766|NCT02952820|616677017|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
170635767|NCT02952820|616677015|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
170635768|NCT02952820|616677016|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
170635769|NCT02952820|616677017|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
170635770|NCT02952820|616677015|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
170635771|NCT02952820|616677016|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
170635772|NCT02952820|616677017|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
170635773|NCT02952820|616677015|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
170635774|NCT02952820|616677016|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
170635775|NCT02952820|616677017|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
170635776|NCT02952820|616677015|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
170635777|NCT02952820|616677016|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
170635778|NCT02952820|616677017|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
170635779|NCT02952820|616677015|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
170635780|NCT02952820|616677016|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
170635781|NCT02952820|616677017|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
170635782|NCT02952820|616677015|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
170635783|NCT02952820|616677016|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
170635784|NCT02952820|616677017|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
170635785|NCT02952820|616677015|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
170635786|NCT02952820|616677016|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
170635787|NCT02952820|616677017|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
170635788|NCT02952820|616677015|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
170635789|NCT02952820|616677016|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
170635790|NCT02952820|616677017|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
170635791|NCT02952820|616677015|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
170635792|NCT02952820|616677016|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
170635793|NCT02952820|616677017|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
170635794|NCT02952820|616677015|FG000|Active Treatment Period (6 Months)|Not treated|0|||
170787823|NCT04019873|617234135|FG000|Overall Study|Discontinued from the treatment|1|||
170635795|NCT02952820|616677016|FG001|Active Treatment Period (6 Months)|Not treated|0|||
170635796|NCT02952820|616677017|FG002|Active Treatment Period (6 Months)|Not treated|1|||
170635797|NCT04139018|616677018|FG000|Overall Study|Screen fail|1|||
170635798|NCT04139018|616677019|FG001|Overall Study|Screen fail|0|||
170455425|NCT00700817|616008021|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
170455426|NCT00700817|616008022|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
170455427|NCT00700817|616008018|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
170455428|NCT00700817|616008019|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
170455429|NCT00700817|616008020|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
170455430|NCT00700817|616008021|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
170455431|NCT00700817|616008022|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
170455432|NCT00700817|616008018|FG000|Week 0-26 (Main Period)|Unclassified|14|||
170455433|NCT00700817|616008019|FG001|Week 0-26 (Main Period)|Unclassified|4|||
170455434|NCT00700817|616008020|FG002|Week 0-26 (Main Period)|Unclassified|8|||
170455435|NCT00700817|616008021|FG003|Week 0-26 (Main Period)|Unclassified|0|||
170455436|NCT00700817|616008022|FG004|Week 0-26 (Main Period)|Unclassified|0|||
170455437|NCT00700817|616008018|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
170455438|NCT00700817|616008019|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
170455439|NCT00700817|616008020|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
170455440|NCT00700817|616008021|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
170455441|NCT00700817|616008022|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
170455442|NCT00700817|616008018|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
170455443|NCT00700817|616008019|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
170455444|NCT00700817|616008020|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
170455445|NCT00700817|616008021|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
170455446|NCT00700817|616008022|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
170455447|NCT00700817|616008018|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
170455448|NCT00700817|616008019|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
170455449|NCT00700817|616008020|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
170455450|NCT00700817|616008021|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
170455451|NCT00700817|616008022|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
170455452|NCT00700817|616008018|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
170455453|NCT00700817|616008019|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
170455454|NCT00700817|616008020|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
170455455|NCT00700817|616008021|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
170455456|NCT00700817|616008022|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
170455457|NCT00700817|616008018|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
170455458|NCT00700817|616008019|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
170455459|NCT00700817|616008020|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
170455460|NCT00700817|616008021|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
170455461|NCT00700817|616008022|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
170455462|NCT00700817|616008018|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
170455463|NCT00700817|616008019|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
170455464|NCT00700817|616008020|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
170455465|NCT00700817|616008021|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
170455466|NCT00700817|616008022|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
170455467|NCT00700817|616008018|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
170455468|NCT00700817|616008019|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
170455469|NCT00700817|616008020|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
170455470|NCT00700817|616008021|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
170455471|NCT00700817|616008022|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
170455472|NCT00700817|616008018|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
170455473|NCT00700817|616008019|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
170455474|NCT00700817|616008020|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
170542732|NCT00447278|616331099|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
170542733|NCT00447278|616331098|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
170542734|NCT00447278|616331099|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
170542735|NCT00447278|616331098|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
170542736|NCT00447278|616331099|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
170455475|NCT00700817|616008021|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
170455476|NCT00700817|616008022|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
170455477|NCT00700817|616008018|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
170455478|NCT00700817|616008019|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
170542737|NCT00447278|616331098|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
170542738|NCT00447278|616331099|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
170455479|NCT00700817|616008020|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
170455480|NCT00700817|616008021|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
170455481|NCT00700817|616008022|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
170455482|NCT00700817|616008018|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
170455483|NCT00700817|616008019|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
170455484|NCT00700817|616008020|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
170542739|NCT05161936|616331102|FG000|Overall Study|Study terminated by Sponsor|1|||
170455485|NCT00700817|616008021|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
170455486|NCT00700817|616008022|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
170455487|NCT03096847|616008023|FG000|Overall Study|Other|2|||
170455488|NCT03096847|616008024|FG001|Overall Study|Other|1|||
170455489|NCT03096847|616008025|FG002|Overall Study|Other|2|||
170455490|NCT03096847|616008023|FG000|Overall Study|Lost to Follow-up|1|||
170455491|NCT03096847|616008024|FG001|Overall Study|Lost to Follow-up|0|||
170455492|NCT03096847|616008025|FG002|Overall Study|Lost to Follow-up|1|||
170455493|NCT03096847|616008023|FG000|Overall Study|Death|6|||
170455494|NCT03096847|616008024|FG001|Overall Study|Death|0|||
170455495|NCT03096847|616008025|FG002|Overall Study|Death|2|||
170455496|NCT03096847|616008023|FG000|Overall Study|Protocol Violation|3|||
170455497|NCT03096847|616008024|FG001|Overall Study|Protocol Violation|0|||
170455498|NCT03096847|616008025|FG002|Overall Study|Protocol Violation|6|||
170455499|NCT03096847|616008023|FG000|Overall Study|Physician Decision|12|||
170455500|NCT03096847|616008024|FG001|Overall Study|Physician Decision|2|||
170455501|NCT03096847|616008025|FG002|Overall Study|Physician Decision|8|||
170455502|NCT03096847|616008023|FG000|Overall Study|Withdrawal by Subject|24|||
170455503|NCT03096847|616008024|FG001|Overall Study|Withdrawal by Subject|1|||
170455504|NCT03096847|616008025|FG002|Overall Study|Withdrawal by Subject|12|||
170455505|NCT03096847|616008023|FG000|Overall Study|Adverse Event|72|||
170455506|NCT03096847|616008024|FG001|Overall Study|Adverse Event|6|||
170455507|NCT03096847|616008025|FG002|Overall Study|Adverse Event|28|||
170455508|NCT03096847|616008023|FG000|Overall Study|Progressive disease|97|||
170455509|NCT03096847|616008024|FG001|Overall Study|Progressive disease|10|||
170455510|NCT03096847|616008025|FG002|Overall Study|Progressive disease|78|||
170455511|NCT03096847|616008023|FG000|Overall Study|Non-compliance with study medication|1|||
170455512|NCT03096847|616008024|FG001|Overall Study|Non-compliance with study medication|0|||
170455513|NCT03096847|616008025|FG002|Overall Study|Non-compliance with study medication|0|||
170455514|NCT03096847|616008023|FG000|Overall Study|New therapy for study indication|1|||
170455515|NCT03096847|616008024|FG001|Overall Study|New therapy for study indication|0|||
170455516|NCT03096847|616008025|FG002|Overall Study|New therapy for study indication|1|||
170455517|NCT02595008|616008028|FG000|Overall Study|Enrolled In Error|1|||
170455518|NCT02595008|616008029|FG001|Overall Study|Enrolled In Error|0|||
170455519|NCT03097588|616008030|FG000|Overall Study|Adverse Event|1|||
170455520|NCT01144364|616008031|FG000|Induction Phase|Disease progression|14|||
170455521|NCT01144364|616008032|FG001|Induction Phase|Disease progression|0|||
170455522|NCT01144364|616008033|FG002|Induction Phase|Disease progression|0|||
170455523|NCT01144364|616008031|FG000|Induction Phase|Adverse Event|9|||
170455524|NCT01144364|616008032|FG001|Induction Phase|Adverse Event|0|||
170455525|NCT01144364|616008033|FG002|Induction Phase|Adverse Event|0|||
170455526|NCT01144364|616008031|FG000|Induction Phase|Death|1|||
170542740|NCT05161936|616331103|FG001|Overall Study|Study terminated by Sponsor|0|||
170542741|NCT05161936|616331104|FG002|Overall Study|Study terminated by Sponsor|0|||
170542742|NCT05161936|616331102|FG000|Overall Study|Withdrawal by Subject|0|||
170542743|NCT05161936|616331103|FG001|Overall Study|Withdrawal by Subject|0|||
170542744|NCT05161936|616331104|FG002|Overall Study|Withdrawal by Subject|1|||
170542745|NCT02541903|616331105|FG000|Overall Study|Death|1|||
170542746|NCT00827242|616331112|FG000|Overall Study|Withdrawal by Subject|2|||
170542747|NCT00827242|616331113|FG001|Overall Study|Withdrawal by Subject|4|||
170542748|NCT00827242|616331112|FG000|Overall Study|Protocol Violation|1|||
170542749|NCT00827242|616331113|FG001|Overall Study|Protocol Violation|3|||
170542750|NCT00827242|616331112|FG000|Overall Study|Lost to Follow-up|0|||
170542751|NCT00827242|616331113|FG001|Overall Study|Lost to Follow-up|3|||
170542752|NCT00827242|616331112|FG000|Overall Study|Adverse Event Excluding Death|2|||
170542753|NCT00827242|616331113|FG001|Overall Study|Adverse Event Excluding Death|1|||
170542754|NCT00827242|616331112|FG000|Overall Study|Entry Criteria Not Met|4|||
170542755|NCT00827242|616331113|FG001|Overall Study|Entry Criteria Not Met|1|||
170542756|NCT00827242|616331112|FG000|Overall Study|Physician Decision|2|||
170542757|NCT00827242|616331113|FG001|Overall Study|Physician Decision|0|||
170542758|NCT00827242|616331112|FG000|Overall Study|Death|1|||
170542759|NCT00827242|616331113|FG001|Overall Study|Death|0|||
170542760|NCT00827242|616331112|FG000|Overall Study|Lack of Efficacy|1|||
170542761|NCT00827242|616331113|FG001|Overall Study|Lack of Efficacy|0|||
170542762|NCT05762679|616331114|FG000|Overall Study|Withdrawal by Subject|1|||
170542763|NCT05762679|616331114|FG000|Overall Study|No analyzable imaging data|1|||
170542764|NCT01479530|616331116|FG000|Overall Study|Adverse Event|5|||
170542765|NCT01479530|616331117|FG001|Overall Study|Adverse Event|6|||
170542766|NCT01479530|616331116|FG000|Overall Study|Lack of Efficacy|0|||
170542767|NCT01479530|616331117|FG001|Overall Study|Lack of Efficacy|1|||
170542768|NCT01479530|616331116|FG000|Overall Study|Protocol Violation|2|||
170542769|NCT01479530|616331117|FG001|Overall Study|Protocol Violation|3|||
170542770|NCT01479530|616331116|FG000|Overall Study|Withdrawal of Consent|3|||
170542771|NCT01479530|616331117|FG001|Overall Study|Withdrawal of Consent|2|||
170542772|NCT03158688|616331120|FG000|Overall Study|Withdrawal by Subject|14|||
170542773|NCT03158688|616331121|FG001|Overall Study|Withdrawal by Subject|28|||
170542774|NCT03158688|616331120|FG000|Overall Study|Decision by sponsor|13|||
170542775|NCT03158688|616331121|FG001|Overall Study|Decision by sponsor|37|||
170542776|NCT03158688|616331120|FG000|Overall Study|Lost to Follow-up|4|||
170542777|NCT03158688|616331121|FG001|Overall Study|Lost to Follow-up|3|||
170455527|NCT01144364|616008032|FG001|Induction Phase|Death|0|||
170455528|NCT01144364|616008033|FG002|Induction Phase|Death|0|||
170455529|NCT01144364|616008031|FG000|Induction Phase|Withdrawal by Subject|1|||
170455530|NCT01144364|616008032|FG001|Induction Phase|Withdrawal by Subject|0|||
170455531|NCT01144364|616008033|FG002|Induction Phase|Withdrawal by Subject|0|||
170455532|NCT01144364|616008031|FG000|Induction Phase|Lost to Follow-up|2|||
170455533|NCT01144364|616008032|FG001|Induction Phase|Lost to Follow-up|0|||
170455534|NCT01144364|616008033|FG002|Induction Phase|Lost to Follow-up|0|||
170455535|NCT01144364|616008031|FG000|Induction Phase|Physician Decision|1|||
170455536|NCT01144364|616008032|FG001|Induction Phase|Physician Decision|0|||
170455537|NCT01144364|616008033|FG002|Induction Phase|Physician Decision|0|||
170455538|NCT01144364|616008031|FG000|Induction Phase|Stable disease|2|||
170455539|NCT01144364|616008032|FG001|Induction Phase|Stable disease|0|||
170455540|NCT01144364|616008033|FG002|Induction Phase|Stable disease|0|||
170455541|NCT01144364|616008031|FG000|Induction Phase|Secondary neoplasia|1|||
170455542|NCT01144364|616008032|FG001|Induction Phase|Secondary neoplasia|0|||
170455543|NCT01144364|616008033|FG002|Induction Phase|Secondary neoplasia|0|||
170455544|NCT01144364|616008031|FG000|Induction Phase|Protocol Violation|1|||
170455545|NCT01144364|616008032|FG001|Induction Phase|Protocol Violation|0|||
170455546|NCT01144364|616008033|FG002|Induction Phase|Protocol Violation|0|||
170455547|NCT01144364|616008031|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
170455548|NCT01144364|616008032|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
170635799|NCT04139018|616677018|FG000|Overall Study|Withdrawal by Subject|2|||
170635800|NCT04139018|616677019|FG001|Overall Study|Withdrawal by Subject|0|||
170635801|NCT04139018|616677018|FG000|Overall Study|Lost to Follow-up|0|||
170635802|NCT04139018|616677019|FG001|Overall Study|Lost to Follow-up|1|||
170635803|NCT03857867|616677023|FG000|Overall Study|Physician Decision|1|||
170455549|NCT01144364|616008033|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
170455550|NCT01144364|616008031|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
170455551|NCT01144364|616008032|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
170455552|NCT01144364|616008033|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
170455553|NCT01144364|616008031|FG000|Follow-Up/Maintenance Phase|Death|0|||
170455554|NCT01144364|616008032|FG001|Follow-Up/Maintenance Phase|Death|2|||
170455555|NCT01144364|616008033|FG002|Follow-Up/Maintenance Phase|Death|0|||
170455556|NCT01144364|616008031|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
170455557|NCT01144364|616008032|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
170455558|NCT01144364|616008033|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
170455559|NCT01144364|616008031|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
170455560|NCT01144364|616008032|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
170455561|NCT01144364|616008033|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
170455562|NCT01144364|616008031|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
170455563|NCT01144364|616008032|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
170455564|NCT01144364|616008033|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
170455565|NCT01144364|616008031|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
170455566|NCT01144364|616008032|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
170455567|NCT01144364|616008033|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
170455568|NCT02939014|616008034|FG000|Overall Study|Lost to Follow-up|1|||
170455569|NCT02939014|616008035|FG001|Overall Study|Lost to Follow-up|0|||
170455570|NCT02939014|616008034|FG000|Overall Study|Death|4|||
170455571|NCT02939014|616008035|FG001|Overall Study|Death|3|||
170455572|NCT02192164|616008036|FG000|Overall Study|Other|8|||
170455573|NCT02192164|616008036|FG000|Overall Study|Withdrawal by Subject|1|||
170455574|NCT02192164|616008036|FG000|Overall Study|Physician Decision|4|||
170455575|NCT02192164|616008036|FG000|Overall Study|Did not meet the exclusion criteria|1|||
170455576|NCT02143583|616008039|FG000|Overall Study|Withdrawal by Subject|1|||
170455577|NCT02143583|616008040|FG001|Overall Study|Withdrawal by Subject|0|||
170455578|NCT02143583|616008041|FG002|Overall Study|Withdrawal by Subject|1|||
170455579|NCT02143583|616008039|FG000|Overall Study|husband illness|0|||
170455580|NCT02143583|616008040|FG001|Overall Study|husband illness|0|||
170455581|NCT02143583|616008041|FG002|Overall Study|husband illness|1|||
170455582|NCT01641133|616008042|FG000|Overall Study|Protocol Violation|0|||
170455583|NCT01641133|616008043|FG001|Overall Study|Protocol Violation|1|||
170455584|NCT01641133|616008044|FG002|Overall Study|Protocol Violation|1|||
170455585|NCT01641133|616008042|FG000|Overall Study|Migrated/moved from study area|5|||
170455586|NCT01641133|616008043|FG001|Overall Study|Migrated/moved from study area|3|||
170455587|NCT01641133|616008044|FG002|Overall Study|Migrated/moved from study area|1|||
170455588|NCT01641133|616008042|FG000|Overall Study|Adverse Event|0|||
170455589|NCT01641133|616008043|FG001|Overall Study|Adverse Event|0|||
170455590|NCT01641133|616008044|FG002|Overall Study|Adverse Event|1|||
170455591|NCT01641133|616008042|FG000|Overall Study|Withdrawal by Subject|5|||
170635804|NCT03070964|616677024|FG000|Overall Study|Progressive disease|8|||
170635805|NCT03070964|616677024|FG000|Overall Study|Treatment-unrelated adverse event|2|||
170635806|NCT03070964|616677024|FG000|Overall Study|Never treated|1|||
170455592|NCT01641133|616008043|FG001|Overall Study|Withdrawal by Subject|3|||
170635807|NCT03070964|616677024|FG000|Overall Study|Physician Decision|1|||
170455593|NCT01641133|616008044|FG002|Overall Study|Withdrawal by Subject|3|||
170635808|NCT03070964|616677024|FG000|Overall Study|Withdrawal by Subject|1|||
170455594|NCT01641133|616008042|FG000|Overall Study|Lost to Follow-up|0|||
170455595|NCT01641133|616008043|FG001|Overall Study|Lost to Follow-up|2|||
170455596|NCT01641133|616008044|FG002|Overall Study|Lost to Follow-up|2|||
170455597|NCT03123861|616008045|FG000|Overall Study|Protocol Violation|1|||
170455598|NCT03123861|616008046|FG001|Overall Study|Protocol Violation|1|||
170455599|NCT03123861|616008045|FG000|Overall Study|Withdrawal by Subject|2|||
170455600|NCT03123861|616008046|FG001|Overall Study|Withdrawal by Subject|2|||
170455601|NCT02220725|616008047|FG000|Overall Study|Lost to Follow-up|0|||
170455602|NCT02220725|616008048|FG001|Overall Study|Lost to Follow-up|0|||
170455603|NCT02220725|616008049|FG002|Overall Study|Lost to Follow-up|0|||
170455604|NCT02220725|616008050|FG003|Overall Study|Lost to Follow-up|1|||
170455605|NCT02220725|616008047|FG000|Overall Study|Withdrawal by Subject|0|||
170455606|NCT02220725|616008048|FG001|Overall Study|Withdrawal by Subject|0|||
170455607|NCT02220725|616008049|FG002|Overall Study|Withdrawal by Subject|0|||
170455608|NCT02220725|616008050|FG003|Overall Study|Withdrawal by Subject|1|||
170455609|NCT04932941|616008051|FG000|Overall Study|Lost to Follow-up|3|||
170455610|NCT04932941|616008052|FG001|Overall Study|Lost to Follow-up|1|||
170455611|NCT04932941|616008051|FG000|Overall Study|Withdrawal by Subject|7|||
170455612|NCT04932941|616008052|FG001|Overall Study|Withdrawal by Subject|4|||
170455613|NCT04932941|616008051|FG000|Overall Study|Other|4|||
170455614|NCT04932941|616008052|FG001|Overall Study|Other|2|||
170455615|NCT03351231|616008053|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
170455616|NCT03351231|616008053|FG000|Combination Therapy Period|Disease progression|2|||
170455617|NCT03351231|616008053|FG000|Combination Therapy Period|Study drug toxicity|1|||
170455618|NCT03351231|616008053|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
170455619|NCT03351231|616008053|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
170455620|NCT03351231|616008053|FG000|Safety Follow-Up Period|Other reason|2|||
170455621|NCT02206620|616008058|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
170455622|NCT02206620|616008059|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
170455623|NCT02206620|616008058|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
170455624|NCT02206620|616008059|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
170455625|NCT00518622|616008062|FG000|Overall Study|Lost to Follow-up|0|||
170455626|NCT00518622|616008063|FG001|Overall Study|Lost to Follow-up|0|||
170455627|NCT00518622|616008064|FG002|Overall Study|Lost to Follow-up|1|||
170455628|NCT00518622|616008065|FG003|Overall Study|Lost to Follow-up|0|||
170455629|NCT00518622|616008066|FG004|Overall Study|Lost to Follow-up|0|||
170455630|NCT00518622|616008067|FG005|Overall Study|Lost to Follow-up|0|||
170455631|NCT00518622|616008068|FG006|Overall Study|Lost to Follow-up|0|||
170455632|NCT00518622|616008069|FG007|Overall Study|Lost to Follow-up|0|||
170455633|NCT00518622|616008062|FG000|Overall Study|Study medication taken incorrectly|0|||
170455634|NCT00518622|616008063|FG001|Overall Study|Study medication taken incorrectly|1|||
170455635|NCT00518622|616008064|FG002|Overall Study|Study medication taken incorrectly|0|||
170455636|NCT00518622|616008065|FG003|Overall Study|Study medication taken incorrectly|0|||
170455637|NCT00518622|616008066|FG004|Overall Study|Study medication taken incorrectly|0|||
170455638|NCT00518622|616008067|FG005|Overall Study|Study medication taken incorrectly|0|||
170455639|NCT00518622|616008068|FG006|Overall Study|Study medication taken incorrectly|0|||
170455640|NCT00518622|616008069|FG007|Overall Study|Study medication taken incorrectly|0|||
170455641|NCT05816200|616008070|FG000|Overall Study|Lost to Follow-up|2|||
170455642|NCT05816200|616008071|FG001|Overall Study|Lost to Follow-up|1|||
170455643|NCT02333487|616008072|FG000|Overall Study|Adverse Event|0|||
170455644|NCT02333487|616008073|FG001|Overall Study|Adverse Event|2|||
170455645|NCT02333487|616008074|FG002|Overall Study|Adverse Event|0|||
170455646|NCT01583218|616008075|FG000|Overall Study|Withdrawal by Subject|43|||
170455647|NCT01583218|616008076|FG001|Overall Study|Withdrawal by Subject|29|||
170455648|NCT01583218|616008075|FG000|Overall Study|Death|206|||
170455649|NCT01583218|616008076|FG001|Overall Study|Death|211|||
170455650|NCT01583218|616008075|FG000|Overall Study|Lost to Follow-up|11|||
170787824|NCT04019873|617234136|FG001|Overall Study|Discontinued from the treatment|39|||
170455651|NCT01583218|616008076|FG001|Overall Study|Lost to Follow-up|17|||
170455652|NCT01583218|616008075|FG000|Overall Study|Adverse event or serious adverse event|3|||
170455653|NCT01583218|616008076|FG001|Overall Study|Adverse event or serious adverse event|3|||
170455654|NCT01583218|616008075|FG000|Overall Study|Patient /Family decision|3|||
170455655|NCT01583218|616008076|FG001|Overall Study|Patient /Family decision|0|||
170455656|NCT01583218|616008075|FG000|Overall Study|Cannot contact patient directly|1|||
170455657|NCT01583218|616008076|FG001|Overall Study|Cannot contact patient directly|2|||
170455658|NCT01583218|616008075|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
170455659|NCT01583218|616008076|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
170455660|NCT01583218|616008075|FG000|Overall Study|Patient did not wish to attend visits|0|||
170455661|NCT01583218|616008076|FG001|Overall Study|Patient did not wish to attend visits|1|||
170455662|NCT01583218|616008075|FG000|Overall Study|Patient randomized but not dosed|17|||
170455663|NCT01583218|616008076|FG001|Overall Study|Patient randomized but not dosed|16|||
170455664|NCT01583218|616008075|FG000|Overall Study|Patient was assessed via phone in person|1|||
170455665|NCT01583218|616008076|FG001|Overall Study|Patient was assessed via phone in person|0|||
170455666|NCT01583218|616008075|FG000|Overall Study|Patient deemed ineligible after random|2|||
170455667|NCT01583218|616008076|FG001|Overall Study|Patient deemed ineligible after random|0|||
170455668|NCT01583218|616008075|FG000|Overall Study|Patient was early terminated from study|0|||
170455669|NCT01583218|616008076|FG001|Overall Study|Patient was early terminated from study|1|||
170455670|NCT01583218|616008075|FG000|Overall Study|Patient was randomized due to mistake|1|||
170455671|NCT01583218|616008076|FG001|Overall Study|Patient was randomized due to mistake|0|||
170455672|NCT01583218|616008075|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
170455673|NCT01583218|616008076|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
170455674|NCT01583218|616008075|FG000|Overall Study|Withdraw of consent on day of random|1|||
170455675|NCT01583218|616008076|FG001|Overall Study|Withdraw of consent on day of random|0|||
170455676|NCT02013375|616008079|FG000|Overall Study|Did not engraft|1|||
170455677|NCT02013375|616008079|FG000|Overall Study|Did not engraft|1|||
170455678|NCT00712985|616008080|FG000|Overall Study|1 withdrew prior to start of drug|1|||
170455679|NCT00712985|616008080|FG000|Overall Study|1 patient moved out of state|1|||
170455680|NCT00712985|616008080|FG000|Overall Study|Lack of Efficacy|3|||
170455681|NCT02674061|616008081|FG000|Overall Study|Death|229|||
170455682|NCT02674061|616008082|FG001|Overall Study|Death|77|||
170455683|NCT02674061|616008081|FG000|Overall Study|Lost to Follow-up|3|||
170455684|NCT02674061|616008082|FG001|Overall Study|Lost to Follow-up|3|||
170455685|NCT02674061|616008081|FG000|Overall Study|Withdrawal by Subject|9|||
170455686|NCT02674061|616008082|FG001|Overall Study|Withdrawal by Subject|1|||
170455687|NCT02674061|616008081|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
170455688|NCT02674061|616008082|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
170455689|NCT03334721|616008083|FG000|Overall Study|Withdrawal by Subject|1|||
170455690|NCT03334721|616008084|FG001|Overall Study|Withdrawal by Subject|0|||
170455691|NCT03334721|616008083|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
170455692|NCT03334721|616008084|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
170455693|NCT01663727|616008086|FG000|Overall Study|Death|161|||
170455694|NCT01663727|616008087|FG001|Overall Study|Death|155|||
170455695|NCT01663727|616008086|FG000|Overall Study|Lost to Follow-up|10|||
170455696|NCT01663727|616008087|FG001|Overall Study|Lost to Follow-up|8|||
170455697|NCT01663727|616008086|FG000|Overall Study|Withdrawal by Subject|18|||
170455698|NCT01663727|616008087|FG001|Overall Study|Withdrawal by Subject|25|||
170455699|NCT01663727|616008086|FG000|Overall Study|Study Terminated|51|||
170455700|NCT01663727|616008087|FG001|Overall Study|Study Terminated|50|||
170455701|NCT01663727|616008086|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
170455702|NCT01663727|616008087|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
170455703|NCT01663727|616008086|FG000|Overall Study|Withdrawal prior to dosing.|1|||
170455704|NCT01663727|616008087|FG001|Overall Study|Withdrawal prior to dosing.|0|||
170455705|NCT02932228|616008088|FG000|Overall Study|Death|8|||
170455706|NCT02932228|616008089|FG001|Overall Study|Death|23|||
170455707|NCT02932228|616008088|FG000|Overall Study|not eligible upon chart review|2|||
170455708|NCT02932228|616008089|FG001|Overall Study|not eligible upon chart review|5|||
170455709|NCT01288053|616009295|FG000|Overall Study|Death|1|||
170455710|NCT03955471|616009296|FG000|Overall Study|Death|22|||
170455711|NCT03955471|616009296|FG000|Overall Study|Lost to Follow-up|1|||
170455712|NCT03955471|616009296|FG000|Overall Study|Withdrawal by Subject|6|||
170455713|NCT03955471|616009296|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
170455714|NCT00321828|616009297|FG000|Overall Study|Ineligible|3|||
170455715|NCT00321828|616009297|FG000|Overall Study|No follow up data|1|||
170455716|NCT00793780|616009300|FG000|Overall Study|Withdrawal by Subject|2|||
170455717|NCT00793780|616009301|FG001|Overall Study|Withdrawal by Subject|1|||
170455718|NCT00059787|616009313|FG000|Overall Study|Adverse Event|13|||
170542778|NCT03158688|616331120|FG000|Overall Study|Death|74|||
170455719|NCT00059787|616009313|FG000|Overall Study|disease progression|2|||
170455720|NCT00059787|616009313|FG000|Overall Study|ineligible|1|||
170455721|NCT00059787|616009313|FG000|Overall Study|Other|4|||
170455722|NCT00577395|616009314|FG000|Overall Study|Study was terminated early by Sponsor|7|||
170455723|NCT00577395|616009315|FG001|Overall Study|Study was terminated early by Sponsor|6|||
170455724|NCT04322149|616009316|FG000|Overall Study|Adverse Event|1|||
170455725|NCT04322149|616009317|FG001|Overall Study|Adverse Event|1|||
170455726|NCT04322149|616009318|FG002|Overall Study|Adverse Event|0|||
170455727|NCT04322149|616009319|FG003|Overall Study|Adverse Event|0|||
170455728|NCT04322149|616009316|FG000|Overall Study|Withdrawal by Subject|0|||
170455729|NCT04322149|616009317|FG001|Overall Study|Withdrawal by Subject|0|||
170455730|NCT04322149|616009318|FG002|Overall Study|Withdrawal by Subject|0|||
170455731|NCT04322149|616009319|FG003|Overall Study|Withdrawal by Subject|2|||
170455732|NCT04322149|616009316|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
170455733|NCT04322149|616009317|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
170455734|NCT04322149|616009318|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
170455735|NCT04322149|616009319|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
170455736|NCT00792935|616009322|FG000|Overall Study|Adverse Event|2|||
170455737|NCT00792935|616009323|FG001|Overall Study|Adverse Event|1|||
170455738|NCT00792935|616009322|FG000|Overall Study|Lost to Follow-up|0|||
170455739|NCT00792935|616009323|FG001|Overall Study|Lost to Follow-up|1|||
170455740|NCT00792935|616009322|FG000|Overall Study|Protocol Violation|2|||
170455741|NCT00792935|616009323|FG001|Overall Study|Protocol Violation|0|||
170455742|NCT00792935|616009322|FG000|Overall Study|Withdrawal by Subject|0|||
170455743|NCT00792935|616009323|FG001|Overall Study|Withdrawal by Subject|1|||
170455744|NCT01248013|616009329|FG000|Overall Study|Withdrawal by Subject|14|||
170455745|NCT00841906|616009332|FG000|Overall Study|Withdrawal by Subject|2|||
170455746|NCT00841906|616009333|FG001|Overall Study|Withdrawal by Subject|0|||
170455747|NCT03827564|616009337|FG000|Overall Study|Discontinued due to Study Termination|1|||
170455748|NCT03827564|616009338|FG001|Overall Study|Discontinued due to Study Termination|0|||
170455749|NCT02238626|616009339|FG000|Overall Study|Adverse Event|3|||
170455750|NCT02238626|616009340|FG001|Overall Study|Adverse Event|5|||
170455751|NCT02238626|616009341|FG002|Overall Study|Adverse Event|0|||
170455752|NCT02238626|616009342|FG003|Overall Study|Adverse Event|3|||
170455753|NCT02238626|616009339|FG000|Overall Study|Lost to Follow-up|2|||
170455754|NCT02238626|616009340|FG001|Overall Study|Lost to Follow-up|4|||
170455755|NCT02238626|616009341|FG002|Overall Study|Lost to Follow-up|2|||
170455756|NCT02238626|616009342|FG003|Overall Study|Lost to Follow-up|2|||
170455757|NCT02238626|616009339|FG000|Overall Study|Withdrawal by Subject|0|||
170455758|NCT02238626|616009340|FG001|Overall Study|Withdrawal by Subject|3|||
170455759|NCT02238626|616009341|FG002|Overall Study|Withdrawal by Subject|0|||
170455760|NCT02238626|616009342|FG003|Overall Study|Withdrawal by Subject|1|||
170455761|NCT02238626|616009339|FG000|Overall Study|Death|0|||
170455762|NCT02238626|616009340|FG001|Overall Study|Death|0|||
170455763|NCT02238626|616009341|FG002|Overall Study|Death|1|||
170455764|NCT02238626|616009342|FG003|Overall Study|Death|1|||
170455765|NCT02238626|616009339|FG000|Overall Study|Other|0|||
170455766|NCT02238626|616009340|FG001|Overall Study|Other|2|||
170455767|NCT02238626|616009341|FG002|Overall Study|Other|0|||
170455768|NCT02238626|616009342|FG003|Overall Study|Other|0|||
170455769|NCT01195103|616009343|FG000|Overall Study|Withdrawal by Subject|1|||
170455770|NCT01195103|616009344|FG001|Overall Study|Withdrawal by Subject|0|||
170455771|NCT01195103|616009345|FG002|Overall Study|Withdrawal by Subject|0|||
170455772|NCT01959035|616009349|FG000|Overall Study|Adverse Event|5|||
170455773|NCT01959035|616009349|FG000|Overall Study|Withdrawal by Subject|4|||
170455774|NCT01959035|616009349|FG000|Overall Study|Lost to Follow-up|1|||
170455775|NCT01959035|616009349|FG000|Overall Study|Other (no primary reason given)|1|||
170455776|NCT01691820|616009352|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
170455777|NCT01691820|616009353|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
170455778|NCT01691820|616009352|FG000|Overall Study|Migrated/moved from study area|7|||
170455779|NCT01691820|616009353|FG001|Overall Study|Migrated/moved from study area|4|||
170455780|NCT01691820|616009352|FG000|Overall Study|Lost to Follow-up|6|||
170455781|NCT01691820|616009353|FG001|Overall Study|Lost to Follow-up|17|||
170455782|NCT01691820|616009352|FG000|Overall Study|Other (unspecified)|4|||
170455783|NCT01691820|616009353|FG001|Overall Study|Other (unspecified)|1|||
170455784|NCT04442490|616009357|FG000|Overall Study|Withdrawal by Subject|18|||
170455785|NCT04442490|616009358|FG001|Overall Study|Withdrawal by Subject|10|||
170889012|NCT01415752|617600592|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
170455786|NCT04442490|616009357|FG000|Overall Study|Lost to Follow-up|7|||
170889013|NCT01415752|617600593|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
170889014|NCT01415752|617600590|FG000|Maintenance (Step 2)|ineligible|1|||
170889015|NCT01415752|617600591|FG001|Maintenance (Step 2)|ineligible|1|||
170889016|NCT01415752|617600592|FG002|Maintenance (Step 2)|ineligible|1|||
170889017|NCT01415752|617600593|FG003|Maintenance (Step 2)|ineligible|0|||
170889018|NCT01415752|617600590|FG000|Maintenance (Step 2)|Missing|4|||
170889019|NCT01415752|617600591|FG001|Maintenance (Step 2)|Missing|1|||
170889020|NCT01415752|617600592|FG002|Maintenance (Step 2)|Missing|4|||
170889021|NCT01415752|617600593|FG003|Maintenance (Step 2)|Missing|3|||
170889022|NCT03083886|617600594|FG000|Overall Study|Withdrawal by Subject|51|||
170455787|NCT04442490|616009358|FG001|Overall Study|Lost to Follow-up|7|||
170455788|NCT04442490|616009357|FG000|Overall Study|Adverse Event|2|||
170455789|NCT04442490|616009358|FG001|Overall Study|Adverse Event|6|||
170455790|NCT04442490|616009357|FG000|Overall Study|Noncompliance|3|||
170455791|NCT04442490|616009358|FG001|Overall Study|Noncompliance|1|||
170455792|NCT04442490|616009357|FG000|Overall Study|Physician Decision|2|||
170455793|NCT04442490|616009358|FG001|Overall Study|Physician Decision|1|||
170455794|NCT04442490|616009357|FG000|Overall Study|Reason not Specified|2|||
170455795|NCT04442490|616009358|FG001|Overall Study|Reason not Specified|1|||
170455796|NCT04442490|616009357|FG000|Overall Study|Randomized but not Treated|3|||
170455797|NCT04442490|616009358|FG001|Overall Study|Randomized but not Treated|3|||
170455798|NCT01968694|616009360|FG000|Washout (1 Month)|Lost to Follow-up|0|||
170455799|NCT01968694|616009361|FG001|Washout (1 Month)|Lost to Follow-up|1|||
170455800|NCT02836496|616009362|FG000|Overall Study|Adverse Event|2|||
170455801|NCT02836496|616009363|FG001|Overall Study|Adverse Event|1|||
170455802|NCT02836496|616009362|FG000|Overall Study|Withdrawal by Subject|0|||
170455803|NCT02836496|616009363|FG001|Overall Study|Withdrawal by Subject|1|||
170455804|NCT02792959|616009373|FG000|Overall Study|Protocol Violation|1|||
170455805|NCT00415194|616009374|FG000|Overall Study|Adverse Event|37|||
170455806|NCT00415194|616009375|FG001|Overall Study|Adverse Event|32|||
170455807|NCT00415194|616009374|FG000|Overall Study|Entry Criteria Not Met|4|||
170455808|NCT00415194|616009375|FG001|Overall Study|Entry Criteria Not Met|8|||
170455809|NCT00415194|616009374|FG000|Overall Study|Lost to Follow-up|1|||
170455810|NCT00415194|616009375|FG001|Overall Study|Lost to Follow-up|0|||
170455811|NCT00415194|616009374|FG000|Overall Study|Physician Decision|10|||
170455812|NCT00415194|616009375|FG001|Overall Study|Physician Decision|16|||
170455813|NCT00415194|616009374|FG000|Overall Study|Progressive Disease|180|||
170455814|NCT00415194|616009375|FG001|Overall Study|Progressive Disease|217|||
170455815|NCT00415194|616009374|FG000|Overall Study|Protocol Violation|4|||
170455816|NCT00415194|616009375|FG001|Overall Study|Protocol Violation|2|||
170455817|NCT00415194|616009374|FG000|Overall Study|Withdrawal by Subject|28|||
170455818|NCT00415194|616009375|FG001|Overall Study|Withdrawal by Subject|21|||
170455819|NCT00415194|616009374|FG000|Overall Study|Death Due to Study Disease|26|||
170455820|NCT00415194|616009375|FG001|Overall Study|Death Due to Study Disease|29|||
170455821|NCT00415194|616009374|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
170455822|NCT00415194|616009375|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
170455823|NCT00415194|616009374|FG000|Overall Study|Death Due to Procedural Related AE|0|||
170455824|NCT00415194|616009375|FG001|Overall Study|Death Due to Procedural Related AE|1|||
170455825|NCT00415194|616009374|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
170455826|NCT00415194|616009375|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
170455827|NCT01297465|616009376|FG000|Overall Study|Lack of Ovarian Response|1|||
170455828|NCT01297465|616009377|FG001|Overall Study|Lack of Ovarian Response|1|||
170455829|NCT01297465|616009376|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
170455830|NCT01297465|616009377|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
170455831|NCT01297465|616009376|FG000|Overall Study|No Oocytes Retrieved|1|||
170889023|NCT03083886|617600595|FG001|Overall Study|Withdrawal by Subject|73|||
170455832|NCT01297465|616009377|FG001|Overall Study|No Oocytes Retrieved|1|||
170455833|NCT01297465|616009376|FG000|Overall Study|Poor oocyte quality|0|||
170455834|NCT01297465|616009377|FG001|Overall Study|Poor oocyte quality|1|||
170455835|NCT01297465|616009376|FG000|Overall Study|No Fertilization|6|||
170455836|NCT01297465|616009377|FG001|Overall Study|No Fertilization|4|||
170455837|NCT01297465|616009376|FG000|Overall Study|All Embryos Discarded|0|||
170455838|NCT01297465|616009377|FG001|Overall Study|All Embryos Discarded|1|||
170455839|NCT01297465|616009376|FG000|Overall Study|Intention to Freeze all Embryos|0|||
170455840|NCT01297465|616009377|FG001|Overall Study|Intention to Freeze all Embryos|1|||
170455841|NCT00969540|616009378|FG000|Overall Study|Lost to Follow-up|1|||
170455842|NCT00969540|616009379|FG001|Overall Study|Lost to Follow-up|1|||
170455843|NCT00369655|616009380|FG000|Overall Study|Refusal of further treatment|2|||
170455844|NCT02397408|616009381|FG000|Overall Study|Physician Decision|4|||
170455845|NCT02397408|616009381|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
170455846|NCT00801099|616009382|FG000|Overall Study|Lost to Follow-up|101|||
170455847|NCT03321630|616009385|FG000|Overall Study|Adverse Event|1|||
170455848|NCT03321630|616009385|FG000|Overall Study|Investigator Discretion|2|||
170455849|NCT03321630|616009385|FG000|Overall Study|Withdrawal by Subject|1|||
170455850|NCT00140426|616009386|FG000|Overall Study|Withdrawal by Subject|0|||
170455851|NCT00140426|616009387|FG001|Overall Study|Withdrawal by Subject|3|||
170455852|NCT02149108|616009388|FG000|Overall Study|Not treated|1|||
170455853|NCT02149108|616009389|FG001|Overall Study|Not treated|2|||
170889024|NCT03083886|617600596|FG002|Overall Study|Withdrawal by Subject|104|||
170455854|NCT02149108|616009388|FG000|Overall Study|Progressive Disease (PD)|324|||
170455855|NCT02149108|616009389|FG001|Overall Study|Progressive Disease (PD)|318|||
170455856|NCT02149108|616009388|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
170455857|NCT02149108|616009389|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
170889025|NCT03083886|617600594|FG000|Overall Study|Missing Baseline data|43|||
170455858|NCT02149108|616009388|FG000|Overall Study|Other Adverse Event (AE)|8|||
170455859|NCT02149108|616009389|FG001|Overall Study|Other Adverse Event (AE)|18|||
170455860|NCT02149108|616009388|FG000|Overall Study|Other not defined above|0|||
170455861|NCT02149108|616009389|FG001|Overall Study|Other not defined above|2|||
170455862|NCT02149108|616009388|FG000|Overall Study|Refusal to continue trial medication|15|||
170455863|NCT02149108|616009389|FG001|Overall Study|Refusal to continue trial medication|11|||
170455864|NCT02149108|616009388|FG000|Overall Study|Lost to Follow-up|1|||
170455865|NCT02149108|616009389|FG001|Overall Study|Lost to Follow-up|0|||
170455866|NCT00950963|616009390|FG000|Overall Study|Lost to Follow-up|29|||
170455867|NCT00950963|616009391|FG001|Overall Study|Lost to Follow-up|24|||
170455868|NCT01675661|616009392|FG000|Overall Study|Lost to Follow-up|22|||
170455869|NCT01675661|616009393|FG001|Overall Study|Lost to Follow-up|23|||
170455870|NCT01675661|616009392|FG000|Overall Study|Practical problems|9|||
170455871|NCT01675661|616009393|FG001|Overall Study|Practical problems|5|||
170455872|NCT01675661|616009392|FG000|Overall Study|Moved away|5|||
170455873|NCT01675661|616009393|FG001|Overall Study|Moved away|6|||
170455874|NCT01675661|616009392|FG000|Overall Study|Withdrawal by Subject|3|||
170455875|NCT01675661|616009393|FG001|Overall Study|Withdrawal by Subject|7|||
170455876|NCT01675661|616009392|FG000|Overall Study|Physician Decision|0|||
170455877|NCT01675661|616009393|FG001|Overall Study|Physician Decision|2|||
170455878|NCT01675661|616009392|FG000|Overall Study|Death|0|||
170455879|NCT01675661|616009393|FG001|Overall Study|Death|1|||
170455880|NCT01675661|616009392|FG000|Overall Study|Other reason|1|||
170455881|NCT01675661|616009393|FG001|Overall Study|Other reason|2|||
170455882|NCT00987389|616009394|FG000|Overall Study|Ineligible|0|||
170455883|NCT00987389|616009395|FG001|Overall Study|Ineligible|3|||
170455884|NCT00987389|616009396|FG002|Overall Study|Ineligible|0|||
170455885|NCT00987389|616009397|FG003|Overall Study|Ineligible|0|||
170455886|NCT00987389|616009394|FG000|Overall Study|Lost to Follow-up|4|||
170455887|NCT00987389|616009395|FG001|Overall Study|Lost to Follow-up|1|||
170455888|NCT00987389|616009396|FG002|Overall Study|Lost to Follow-up|3|||
170455889|NCT00987389|616009397|FG003|Overall Study|Lost to Follow-up|1|||
170455890|NCT00987389|616009394|FG000|Overall Study|Withdrawal by Subject|4|||
170455891|NCT00987389|616009395|FG001|Overall Study|Withdrawal by Subject|3|||
170455892|NCT00987389|616009396|FG002|Overall Study|Withdrawal by Subject|2|||
170455893|NCT00987389|616009397|FG003|Overall Study|Withdrawal by Subject|1|||
170455894|NCT00987389|616009394|FG000|Overall Study|Withdrawn from Treatment|0|||
170455895|NCT00987389|616009395|FG001|Overall Study|Withdrawn from Treatment|1|||
170455896|NCT00987389|616009396|FG002|Overall Study|Withdrawn from Treatment|0|||
170455897|NCT00987389|616009397|FG003|Overall Study|Withdrawn from Treatment|0|||
170455898|NCT00987389|616009394|FG000|Overall Study|Multiple different reasons|1|||
170455899|NCT00987389|616009395|FG001|Overall Study|Multiple different reasons|0|||
170455900|NCT00987389|616009396|FG002|Overall Study|Multiple different reasons|3|||
170455901|NCT00987389|616009397|FG003|Overall Study|Multiple different reasons|1|||
170455902|NCT00859586|616009398|FG000|Overall Study|Donors|4|||
170455903|NCT00080938|616009399|FG000|Overall Study|Adverse Event|3|||
170455904|NCT00080938|616009399|FG000|Overall Study|Withdrawal by Subject|6|||
170455905|NCT00080938|616009399|FG000|Overall Study|Death|2|||
170455906|NCT00080938|616009399|FG000|Overall Study|Lack of Efficacy|7|||
170455907|NCT00080938|616009399|FG000|Overall Study|other disease|1|||
170455908|NCT00080938|616009399|FG000|Overall Study|Not started protocol therapy|1|||
170455909|NCT00080938|616009399|FG000|Overall Study|Ineligible|4|||
170455910|NCT02116608|616009401|FG000|Overall Study|Lost to Follow-up|0|||
170455911|NCT02116608|616009402|FG001|Overall Study|Lost to Follow-up|0|||
170455912|NCT02116608|616009403|FG002|Overall Study|Lost to Follow-up|1|||
170455913|NCT02116608|616009401|FG000|Overall Study|Physician Decision|0|||
170455914|NCT02116608|616009402|FG001|Overall Study|Physician Decision|1|||
170455915|NCT02116608|616009403|FG002|Overall Study|Physician Decision|0|||
170455916|NCT02116608|616009401|FG000|Overall Study|Death|0|||
170455917|NCT02116608|616009402|FG001|Overall Study|Death|1|||
170455918|NCT02116608|616009403|FG002|Overall Study|Death|0|||
170455919|NCT00629265|616009404|FG000|Overall Study|Lost to Follow-up|4|||
170455920|NCT00629265|616009405|FG001|Overall Study|Lost to Follow-up|5|||
170455921|NCT00629265|616009404|FG000|Overall Study|Withdrawal by Subject|11|||
170455922|NCT00629265|616009405|FG001|Overall Study|Withdrawal by Subject|8|||
170455923|NCT00629265|616009404|FG000|Overall Study|Death|1|||
170455924|NCT00629265|616009405|FG001|Overall Study|Death|0|||
170889026|NCT03083886|617600595|FG001|Overall Study|Missing Baseline data|42|||
170455925|NCT00629265|616009404|FG000|Overall Study|Adverse Event|2|||
170455926|NCT00629265|616009405|FG001|Overall Study|Adverse Event|0|||
170455927|NCT00629265|616009404|FG000|Overall Study|HNC Recurrence|4|||
170455928|NCT00629265|616009405|FG001|Overall Study|HNC Recurrence|0|||
170455929|NCT00629265|616009404|FG000|Overall Study|Other CA Requiring Treatment|1|||
170455930|NCT00629265|616009405|FG001|Overall Study|Other CA Requiring Treatment|3|||
170455931|NCT00629265|616009404|FG000|Overall Study|Needed Esophageal Dilation|4|||
170455932|NCT00629265|616009405|FG001|Overall Study|Needed Esophageal Dilation|1|||
170455933|NCT00629265|616009404|FG000|Overall Study|Unrelated Medical Complications|3|||
170455934|NCT00629265|616009405|FG001|Overall Study|Unrelated Medical Complications|1|||
170455935|NCT00629265|616009404|FG000|Overall Study|Unknown Reason|2|||
170455936|NCT00629265|616009405|FG001|Overall Study|Unknown Reason|2|||
170455937|NCT04465630|616009406|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
170635809|NCT03070964|616677024|FG000|Overall Study|Adverse Event|1|||
170635810|NCT01286480|616677028|FG000|Overall Study|Withdrawal by Subject|5|||
170635811|NCT01286480|616677029|FG001|Overall Study|Withdrawal by Subject|3|||
170635812|NCT00885534|616677030|FG000|Overall Study|Patient deemed ineligible|1|||
170635813|NCT00536744|616677033|FG000|Overall Study|Adverse Event|13|||
170635814|NCT00536744|616677034|FG001|Overall Study|Adverse Event|10|||
170635815|NCT00536744|616677033|FG000|Overall Study|Death|2|||
170635816|NCT00536744|616677034|FG001|Overall Study|Death|1|||
170635817|NCT00536744|616677033|FG000|Overall Study|Physician Decision|3|||
170635818|NCT00536744|616677034|FG001|Overall Study|Physician Decision|1|||
170635819|NCT00536744|616677033|FG000|Overall Study|Lost to Follow-up|3|||
170635820|NCT00536744|616677034|FG001|Overall Study|Lost to Follow-up|5|||
170635821|NCT00536744|616677033|FG000|Overall Study|Withdrawal by Subject|7|||
170635822|NCT00536744|616677034|FG001|Overall Study|Withdrawal by Subject|8|||
170635823|NCT00536744|616677033|FG000|Overall Study|PI tried alternative treatment|1|||
170635824|NCT00536744|616677034|FG001|Overall Study|PI tried alternative treatment|3|||
170635825|NCT01642589|616677038|FG000|Overall Study|Withdrawal by Subject|1|||
170635826|NCT01642589|616677039|FG001|Overall Study|Withdrawal by Subject|1|||
170635827|NCT00174187|616677040|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
170635828|NCT00174187|616677041|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
170635829|NCT00174187|616677042|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
170635830|NCT00174187|616677040|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
170635831|NCT00174187|616677041|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
170635832|NCT00174187|616677042|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
170635833|NCT00174187|616677040|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
170635834|NCT00174187|616677041|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
170635835|NCT00174187|616677042|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
170635836|NCT00174187|616677040|FG000|Period 1 (up to 3 Years)|Other|0|||
170635837|NCT00174187|616677041|FG001|Period 1 (up to 3 Years)|Other|1|||
170635838|NCT00174187|616677042|FG002|Period 1 (up to 3 Years)|Other|0|||
170635839|NCT00174187|616677040|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
170635840|NCT00174187|616677041|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
170635841|NCT00174187|616677042|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
170635842|NCT00174187|616677040|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
170635843|NCT00174187|616677041|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
170635844|NCT00174187|616677042|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
170787825|NCT04019873|617234137|FG002|Overall Study|Discontinued from the treatment|2|||
170787826|NCT04185298|617234138|FG000|Overall Study|Lost to Follow-up|1|||
170787827|NCT04185298|617234139|FG001|Overall Study|Lost to Follow-up|3|||
170787828|NCT04185298|617234138|FG000|Overall Study|Withdrawal by Subject|0|||
170635845|NCT00174187|616677040|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
170635846|NCT00174187|616677041|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
170635847|NCT00174187|616677042|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
170635848|NCT00174187|616677040|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
170635849|NCT00174187|616677041|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
170635850|NCT00174187|616677042|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
170635851|NCT00174187|616677040|FG000|Period 2 (After 3 Years)|Other|0|||
170635852|NCT00174187|616677041|FG001|Period 2 (After 3 Years)|Other|0|||
170635853|NCT00174187|616677042|FG002|Period 2 (After 3 Years)|Other|5|||
170635854|NCT03126344|616678873|FG000|Overall Study|Lost to Follow-up|0|||
170635855|NCT03126344|616678874|FG001|Overall Study|Lost to Follow-up|0|||
170635856|NCT03126344|616678875|FG002|Overall Study|Lost to Follow-up|5|||
170635857|NCT01715857|616678876|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
170635858|NCT00975689|616678881|FG000|Overall Study|Adverse Event|0|||
170635859|NCT00975689|616678882|FG001|Overall Study|Adverse Event|3|||
170635860|NCT00975689|616678881|FG000|Overall Study|Withdrawal by Subject|1|||
170635861|NCT00975689|616678882|FG001|Overall Study|Withdrawal by Subject|0|||
170635862|NCT00975689|616678881|FG000|Overall Study|Physician Decision|1|||
170635863|NCT00975689|616678882|FG001|Overall Study|Physician Decision|0|||
170635864|NCT00790088|616678885|FG000|Overall Study|Protocol Violation|11|||
170635865|NCT00790088|616678885|FG000|Overall Study|Withdrawal by Subject|17|||
170787829|NCT04185298|617234139|FG001|Overall Study|Withdrawal by Subject|3|||
170635866|NCT00790088|616678885|FG000|Overall Study|Lost to Follow-up|7|||
170635867|NCT00790088|616678885|FG000|Overall Study|Physician Decision|4|||
170635868|NCT02636595|616678886|FG000|Overall Study|Lost to Follow-up|1|||
170787830|NCT04316871|617234147|FG000|Overall Study|Protocol Violation|2|||
170635869|NCT02636595|616678886|FG000|Overall Study|Other|1|||
170635870|NCT05782179|616678891|FG000|Overall Study|Adverse Event|0|||
170635871|NCT05782179|616678892|FG001|Overall Study|Adverse Event|0|||
170635872|NCT05782179|616678893|FG002|Overall Study|Adverse Event|2|||
170455938|NCT04465630|616009406|FG000|Overall Study|Screen failure|8|||
170455939|NCT04465630|616009406|FG000|Overall Study|Baseline failure|16|||
170455940|NCT01732484|616009410|FG000|Overall Study|Death|7|||
170455941|NCT01732484|616009410|FG000|Overall Study|Lost to Follow-up|14|||
170455942|NCT01732484|616009410|FG000|Overall Study|chronical illness|5|||
170455943|NCT02140411|616009411|FG000|Overall Study|Adverse Event|1|||
170455944|NCT01974440|616009420|FG000|Overall Study|Lost to Follow-up|7|||
170455945|NCT01974440|616009421|FG001|Overall Study|Lost to Follow-up|7|||
170455946|NCT01974440|616009420|FG000|Overall Study|Withdrawal by Subject|24|||
170455947|NCT01974440|616009421|FG001|Overall Study|Withdrawal by Subject|20|||
170455948|NCT01974440|616009420|FG000|Overall Study|Sponsor decision|109|||
170455949|NCT01974440|616009421|FG001|Overall Study|Sponsor decision|110|||
170455950|NCT01359644|616009426|FG000|Treatment Period|Lack of Efficacy|0|||
170455951|NCT01359644|616009427|FG001|Treatment Period|Lack of Efficacy|1|||
170455952|NCT01359644|616009428|FG002|Treatment Period|Lack of Efficacy|0|||
170455953|NCT01359644|616009429|FG003|Treatment Period|Lack of Efficacy|0|||
170455954|NCT01359644|616009430|FG004|Treatment Period|Lack of Efficacy|0|||
170455955|NCT01359644|616009431|FG005|Treatment Period|Lack of Efficacy|0|||
170455956|NCT01359644|616009432|FG006|Treatment Period|Lack of Efficacy|0|||
170455957|NCT01359644|616009433|FG007|Treatment Period|Lack of Efficacy|0|||
170455958|NCT01359644|616009434|FG008|Treatment Period|Lack of Efficacy|0|||
170455959|NCT01359644|616009435|FG009|Treatment Period|Lack of Efficacy|0|||
170455960|NCT01359644|616009426|FG000|Treatment Period|Adverse Event|0|||
170455961|NCT01359644|616009427|FG001|Treatment Period|Adverse Event|0|||
170455962|NCT01359644|616009428|FG002|Treatment Period|Adverse Event|1|||
170455963|NCT01359644|616009429|FG003|Treatment Period|Adverse Event|0|||
170455964|NCT01359644|616009430|FG004|Treatment Period|Adverse Event|0|||
170455965|NCT01359644|616009431|FG005|Treatment Period|Adverse Event|1|||
170455966|NCT01359644|616009432|FG006|Treatment Period|Adverse Event|0|||
170455967|NCT01359644|616009433|FG007|Treatment Period|Adverse Event|0|||
170455968|NCT01359644|616009434|FG008|Treatment Period|Adverse Event|0|||
170455969|NCT01359644|616009435|FG009|Treatment Period|Adverse Event|0|||
170455970|NCT01359644|616009426|FG000|Treatment Period|Lost to Follow-up|0|||
170455971|NCT01359644|616009427|FG001|Treatment Period|Lost to Follow-up|0|||
170455972|NCT01359644|616009428|FG002|Treatment Period|Lost to Follow-up|0|||
170455973|NCT01359644|616009429|FG003|Treatment Period|Lost to Follow-up|0|||
170455974|NCT01359644|616009430|FG004|Treatment Period|Lost to Follow-up|0|||
170455975|NCT01359644|616009431|FG005|Treatment Period|Lost to Follow-up|1|||
170455976|NCT01359644|616009432|FG006|Treatment Period|Lost to Follow-up|0|||
170455977|NCT01359644|616009433|FG007|Treatment Period|Lost to Follow-up|0|||
170455978|NCT01359644|616009434|FG008|Treatment Period|Lost to Follow-up|0|||
170455979|NCT01359644|616009435|FG009|Treatment Period|Lost to Follow-up|0|||
170455980|NCT01359644|616009426|FG000|Follow-up Period|Withdrawal by Subject|0|||
170455981|NCT01359644|616009427|FG001|Follow-up Period|Withdrawal by Subject|0|||
170455982|NCT01359644|616009428|FG002|Follow-up Period|Withdrawal by Subject|0|||
170455983|NCT01359644|616009429|FG003|Follow-up Period|Withdrawal by Subject|0|||
170455984|NCT01359644|616009430|FG004|Follow-up Period|Withdrawal by Subject|0|||
170455985|NCT01359644|616009431|FG005|Follow-up Period|Withdrawal by Subject|1|||
170455986|NCT01359644|616009432|FG006|Follow-up Period|Withdrawal by Subject|0|||
170455987|NCT01359644|616009433|FG007|Follow-up Period|Withdrawal by Subject|0|||
170455988|NCT01359644|616009434|FG008|Follow-up Period|Withdrawal by Subject|0|||
170455989|NCT01359644|616009435|FG009|Follow-up Period|Withdrawal by Subject|0|||
170455990|NCT01359644|616009426|FG000|Follow-up Period|Lost to Follow-up|0|||
170455991|NCT01359644|616009427|FG001|Follow-up Period|Lost to Follow-up|0|||
170455992|NCT01359644|616009428|FG002|Follow-up Period|Lost to Follow-up|0|||
170455993|NCT01359644|616009429|FG003|Follow-up Period|Lost to Follow-up|0|||
170455994|NCT01359644|616009430|FG004|Follow-up Period|Lost to Follow-up|0|||
170455995|NCT01359644|616009431|FG005|Follow-up Period|Lost to Follow-up|0|||
170455996|NCT01359644|616009432|FG006|Follow-up Period|Lost to Follow-up|1|||
170455997|NCT01359644|616009433|FG007|Follow-up Period|Lost to Follow-up|2|||
170455998|NCT01359644|616009434|FG008|Follow-up Period|Lost to Follow-up|0|||
170455999|NCT01359644|616009435|FG009|Follow-up Period|Lost to Follow-up|0|||
170456000|NCT00359632|616009448|FG000|Overall Study|Death|2|||
170456001|NCT00359632|616009449|FG001|Overall Study|Death|0|||
170456002|NCT00359632|616009448|FG000|Overall Study|Adverse Event|1|||
170456003|NCT00359632|616009449|FG001|Overall Study|Adverse Event|0|||
170456004|NCT00359632|616009448|FG000|Overall Study|Non-compliance with visit schedule|1|||
170456005|NCT00359632|616009449|FG001|Overall Study|Non-compliance with visit schedule|0|||
170456006|NCT01875471|616009450|FG000|Overall Study|Adverse Event|0|||
170456007|NCT01875471|616009451|FG001|Overall Study|Adverse Event|1|||
170456008|NCT01875471|616009450|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
170456009|NCT01875471|616009451|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
170456010|NCT00975286|616009452|FG000|Overall Study|Adverse Event|9|||
170456011|NCT00975286|616009453|FG001|Overall Study|Adverse Event|19|||
170456012|NCT00975286|616009452|FG000|Overall Study|Protocol Violation|1|||
170456013|NCT00975286|616009453|FG001|Overall Study|Protocol Violation|2|||
170456014|NCT00975286|616009452|FG000|Overall Study|Withdrawal by Subject|0|||
170456015|NCT00975286|616009453|FG001|Overall Study|Withdrawal by Subject|2|||
170456016|NCT00975286|616009452|FG000|Overall Study|Familial and Personal Reasons|2|||
170456017|NCT00975286|616009453|FG001|Overall Study|Familial and Personal Reasons|2|||
170456018|NCT00975286|616009452|FG000|Overall Study|Poor Compliance to Protocol|0|||
170456019|NCT00975286|616009453|FG001|Overall Study|Poor Compliance to Protocol|2|||
170456020|NCT00975286|616009452|FG000|Overall Study|Sponsor Decision|0|||
170456021|NCT00975286|616009453|FG001|Overall Study|Sponsor Decision|2|||
170456022|NCT01462318|616011178|FG000|Main Study / TP-DI Study|Other|2|||
170456023|NCT01462318|616011179|FG001|Main Study / TP-DI Study|Other|0|||
170456024|NCT01462318|616011180|FG002|Main Study / TP-DI Study|Other|0|||
170456025|NCT01462318|616011178|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
170456026|NCT01462318|616011179|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
170456027|NCT01462318|616011180|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
170456028|NCT01462318|616011178|FG000|Main Study / TP-DI Study|Adverse Event|4|||
170456029|NCT01462318|616011179|FG001|Main Study / TP-DI Study|Adverse Event|0|||
170456030|NCT01462318|616011180|FG002|Main Study / TP-DI Study|Adverse Event|0|||
170456031|NCT01462318|616011178|FG000|Extension Phase|Lost to Follow-up|0|||
170456032|NCT01462318|616011179|FG001|Extension Phase|Lost to Follow-up|0|||
170456033|NCT01462318|616011180|FG002|Extension Phase|Lost to Follow-up|1|||
170456034|NCT01462318|616011178|FG000|Extension Phase|Other|0|||
170456035|NCT01462318|616011179|FG001|Extension Phase|Other|0|||
170456036|NCT01462318|616011180|FG002|Extension Phase|Other|1|||
170456037|NCT01462318|616011178|FG000|Extension Phase|Disease Progression|0|||
170456038|NCT01462318|616011179|FG001|Extension Phase|Disease Progression|0|||
170456039|NCT01462318|616011180|FG002|Extension Phase|Disease Progression|1|||
170456040|NCT01462318|616011178|FG000|Extension Phase|Withdrawal by Subject|0|||
170456041|NCT01462318|616011179|FG001|Extension Phase|Withdrawal by Subject|0|||
170456042|NCT01462318|616011180|FG002|Extension Phase|Withdrawal by Subject|15|||
170456043|NCT01462318|616011178|FG000|Extension Phase|Investigator Decision|0|||
170456044|NCT01462318|616011179|FG001|Extension Phase|Investigator Decision|0|||
170456045|NCT01462318|616011180|FG002|Extension Phase|Investigator Decision|5|||
170456046|NCT01462318|616011178|FG000|Extension Phase|Adverse Event|0|||
170456047|NCT01462318|616011179|FG001|Extension Phase|Adverse Event|0|||
170456048|NCT01462318|616011180|FG002|Extension Phase|Adverse Event|22|||
170456049|NCT00270257|616011181|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
170456050|NCT00270257|616011182|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
170456051|NCT00450619|616011187|FG000|Overall Study|refused treatment after randomization|2|||
170456052|NCT00450619|616011188|FG001|Overall Study|refused treatment after randomization|0|||
170456053|NCT00450619|616011187|FG000|Overall Study|did not progress; refused further trmt|1|||
170456054|NCT00450619|616011188|FG001|Overall Study|did not progress; refused further trmt|1|||
170456055|NCT00450619|616011187|FG000|Overall Study|Adverse Event|1|||
170456056|NCT00450619|616011188|FG001|Overall Study|Adverse Event|0|||
170456057|NCT03254602|616011189|FG000|Overall Study|Lost to Follow-up|4|||
170456058|NCT03347422|616011195|FG000|Part A (26 Weeks)|Adverse Event|3|||
170456059|NCT03347422|616011196|FG001|Part A (26 Weeks)|Adverse Event|0|||
170456060|NCT03347422|616011195|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
170456061|NCT03347422|616011196|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
170456062|NCT03347422|616011195|FG000|Part B (149 Weeks)|Adverse Event|0|||
170456063|NCT03347422|616011196|FG001|Part B (149 Weeks)|Adverse Event|1|||
170456064|NCT03347422|616011195|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
170456065|NCT03347422|616011196|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
170456066|NCT03347422|616011195|FG000|Part B (149 Weeks)|Other|1|||
170456067|NCT03347422|616011196|FG001|Part B (149 Weeks)|Other|0|||
170456068|NCT00158600|616011199|FG000|Overall Study|unable to commit time to study|0|||
170456069|NCT00158600|616011200|FG001|Overall Study|unable to commit time to study|1|||
170456070|NCT00158600|616011199|FG000|Overall Study|Adverse Event|2|||
170456071|NCT00158600|616011200|FG001|Overall Study|Adverse Event|1|||
170456072|NCT00158600|616011199|FG000|Overall Study|Death|1|||
170456073|NCT00158600|616011200|FG001|Overall Study|Death|0|||
170456074|NCT00158600|616011199|FG000|Overall Study|Withdrawal by Subject|2|||
170456075|NCT00158600|616011200|FG001|Overall Study|Withdrawal by Subject|2|||
170456076|NCT02570113|616011201|FG000|Overall Study|Withdrawal by Subject|3|||
170456077|NCT00622466|616011202|FG000|Overall Study|Death|1|||
170456078|NCT00622466|616011202|FG000|Overall Study|Adverse Event|1|||
170456079|NCT00622466|616011202|FG000|Overall Study|Withdrawal by Subject|2|||
170456080|NCT01246011|616011205|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
170456081|NCT01246011|616011206|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
170456082|NCT01246011|616011207|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
170456083|NCT01246011|616011205|FG000|Overall Study|Withdrawal by Subject|0|||
170456084|NCT01246011|616011206|FG001|Overall Study|Withdrawal by Subject|0|||
170456085|NCT01246011|616011207|FG002|Overall Study|Withdrawal by Subject|1|||
170456086|NCT01593696|616011214|FG000|Dose Escalation|Progressive Disease|2|||
170456087|NCT01593696|616011215|FG001|Dose Escalation|Progressive Disease|0|||
170456088|NCT01593696|616011216|FG002|Dose Escalation|Progressive Disease|0|||
170456089|NCT01593696|616011217|FG003|Dose Escalation|Progressive Disease|0|||
170456090|NCT01593696|616011214|FG000|Dose Expansion|Fungal infection|0|||
170456091|NCT01593696|616011215|FG001|Dose Expansion|Fungal infection|0|||
170456092|NCT01593696|616011216|FG002|Dose Expansion|Fungal infection|1|||
170456093|NCT01593696|616011217|FG003|Dose Expansion|Fungal infection|0|||
170456094|NCT01683838|616011218|FG000|Overall Study|Adverse Event|12|||
170456095|NCT01683838|616011219|FG001|Overall Study|Adverse Event|2|||
170456096|NCT01683838|616011218|FG000|Overall Study|Protocol Violation|3|||
170542779|NCT03158688|616331121|FG001|Overall Study|Death|142|||
170542780|NCT00471107|616331122|FG000|Overall Study|Technical problems/data loss|3|||
170542781|NCT00471107|616331123|FG001|Overall Study|Technical problems/data loss|1|||
170542782|NCT00471107|616331124|FG002|Overall Study|Technical problems/data loss|3|||
170542783|NCT02942407|616331126|FG000|Overall Study|Lost to Follow-up|3|||
170542784|NCT02942407|616331127|FG001|Overall Study|Lost to Follow-up|2|||
170542785|NCT02942407|616331126|FG000|Overall Study|Withdrawal by Subject|7|||
170542786|NCT02942407|616331127|FG001|Overall Study|Withdrawal by Subject|9|||
170542787|NCT02942407|616331126|FG000|Overall Study|Death|16|||
170542788|NCT02942407|616331127|FG001|Overall Study|Death|13|||
170542789|NCT00933166|616331128|FG000|Overall Study|Lost to Follow-up|4|||
170542790|NCT00933166|616331128|FG000|Overall Study|Lack of Efficacy|9|||
170542791|NCT00933166|616331128|FG000|Overall Study|Unavailable|4|||
170542792|NCT00933166|616331128|FG000|Overall Study|Withdrawal by Subject|1|||
170542793|NCT03369223|616331133|FG000|Overall Study|Lost to Follow-up|0|||
170542794|NCT03369223|616331134|FG001|Overall Study|Lost to Follow-up|0|||
170542795|NCT03369223|616331135|FG002|Overall Study|Lost to Follow-up|0|||
170542796|NCT03369223|616331136|FG003|Overall Study|Lost to Follow-up|0|||
170542797|NCT03369223|616331137|FG004|Overall Study|Lost to Follow-up|0|||
170542798|NCT03369223|616331138|FG005|Overall Study|Lost to Follow-up|0|||
170542799|NCT03369223|616331139|FG006|Overall Study|Lost to Follow-up|0|||
170542800|NCT03369223|616331140|FG007|Overall Study|Lost to Follow-up|0|||
170542801|NCT03369223|616331141|FG008|Overall Study|Lost to Follow-up|0|||
170542802|NCT03369223|616331142|FG009|Overall Study|Lost to Follow-up|0|||
170542803|NCT03369223|616331143|FG010|Overall Study|Lost to Follow-up|0|||
170542804|NCT03369223|616331144|FG011|Overall Study|Lost to Follow-up|0|||
170542805|NCT03369223|616331145|FG012|Overall Study|Lost to Follow-up|0|||
170542806|NCT03369223|616331146|FG013|Overall Study|Lost to Follow-up|0|||
170542807|NCT03369223|616331147|FG014|Overall Study|Lost to Follow-up|0|||
170542808|NCT03369223|616331148|FG015|Overall Study|Lost to Follow-up|0|||
170542809|NCT03369223|616331149|FG016|Overall Study|Lost to Follow-up|0|||
170542810|NCT03369223|616331150|FG017|Overall Study|Lost to Follow-up|0|||
170542811|NCT03369223|616331151|FG018|Overall Study|Lost to Follow-up|2|||
170542812|NCT03369223|616331152|FG019|Overall Study|Lost to Follow-up|1|||
170542813|NCT03369223|616331133|FG000|Overall Study|Participant no longer meets study criteria|0|||
170787831|NCT04316871|617234148|FG001|Overall Study|Protocol Violation|2|||
170787832|NCT04316871|617234149|FG002|Overall Study|Protocol Violation|2|||
170787833|NCT04316871|617234150|FG003|Overall Study|Protocol Violation|2|||
170787834|NCT04650269|617234151|FG000|Overall Study|Death|3|||
170787835|NCT04650269|617234151|FG000|Overall Study|Lost to Follow-up|6|||
170787836|NCT01437709|617234152|FG000|Overall Study|Adverse Event|0|||
170787837|NCT01437709|617234153|FG001|Overall Study|Adverse Event|1|||
170889027|NCT03083886|617600596|FG002|Overall Study|Missing Baseline data|31|||
170889028|NCT03083886|617600594|FG000|Overall Study|Investigator terminated|1|||
170889029|NCT03083886|617600595|FG001|Overall Study|Investigator terminated|6|||
170889030|NCT03083886|617600596|FG002|Overall Study|Investigator terminated|3|||
170889031|NCT01285908|617600597|FG000|Baseline Measurement|unable to insert catheter|1|||
170889032|NCT01285908|617600598|FG001|Baseline Measurement|unable to insert catheter|0|||
170889033|NCT01285908|617600599|FG002|Baseline Measurement|unable to insert catheter|0|||
170889034|NCT01285908|617600597|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
170889035|NCT01285908|617600598|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
170889036|NCT01285908|617600599|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
170889037|NCT01285908|617600597|FG000|Baseline Measurement|unable to tolerate procedure|1|||
170889038|NCT01285908|617600598|FG001|Baseline Measurement|unable to tolerate procedure|0|||
170889039|NCT01285908|617600599|FG002|Baseline Measurement|unable to tolerate procedure|0|||
170787838|NCT01437709|617234154|FG002|Overall Study|Adverse Event|0|||
170889040|NCT03655756|617600600|FG000|Overall Study|Death|1|||
170889041|NCT03237065|617600601|FG000|Overall Study|Adverse Event|0|||
170456097|NCT01683838|616011219|FG001|Overall Study|Protocol Violation|1|||
170456098|NCT01683838|616011218|FG000|Overall Study|Withdrawal by Subject|6|||
170456099|NCT01683838|616011219|FG001|Overall Study|Withdrawal by Subject|5|||
170542814|NCT03369223|616331134|FG001|Overall Study|Participant no longer meets study criteria|0|||
170542815|NCT03369223|616331135|FG002|Overall Study|Participant no longer meets study criteria|0|||
170456100|NCT01683838|616011218|FG000|Overall Study|Lost to Follow-up|1|||
170456101|NCT01683838|616011219|FG001|Overall Study|Lost to Follow-up|1|||
170456102|NCT01683838|616011218|FG000|Overall Study|Other|4|||
170456103|NCT01683838|616011219|FG001|Overall Study|Other|3|||
170456104|NCT01646138|616011220|FG000|Overall Study|Lost to Follow-up|0|||
170456105|NCT01646138|616011221|FG001|Overall Study|Lost to Follow-up|0|||
170889042|NCT03237065|617600602|FG001|Overall Study|Adverse Event|2|||
170456106|NCT01646138|616011222|FG002|Overall Study|Lost to Follow-up|0|||
170456107|NCT01646138|616011223|FG003|Overall Study|Lost to Follow-up|0|||
170456108|NCT01646138|616011224|FG004|Overall Study|Lost to Follow-up|2|||
170456109|NCT04049617|616011225|FG000|Overall Study|Adverse Event|0|||
170456110|NCT04049617|616011226|FG001|Overall Study|Adverse Event|0|||
170456111|NCT04049617|616011227|FG002|Overall Study|Adverse Event|0|||
170456112|NCT04049617|616011228|FG003|Overall Study|Adverse Event|1|||
170456113|NCT04049617|616011229|FG004|Overall Study|Adverse Event|0|||
170456114|NCT04049617|616011230|FG005|Overall Study|Adverse Event|0|||
170456115|NCT04049617|616011225|FG000|Overall Study|Death|0|||
170456116|NCT04049617|616011226|FG001|Overall Study|Death|0|||
170456117|NCT04049617|616011227|FG002|Overall Study|Death|0|||
170456118|NCT04049617|616011228|FG003|Overall Study|Death|0|||
170456119|NCT04049617|616011229|FG004|Overall Study|Death|0|||
170456120|NCT04049617|616011230|FG005|Overall Study|Death|1|||
170456121|NCT04049617|616011225|FG000|Overall Study|Lost to Follow-up|0|||
170456122|NCT04049617|616011226|FG001|Overall Study|Lost to Follow-up|0|||
170456123|NCT04049617|616011227|FG002|Overall Study|Lost to Follow-up|0|||
170456124|NCT04049617|616011228|FG003|Overall Study|Lost to Follow-up|1|||
170456125|NCT04049617|616011229|FG004|Overall Study|Lost to Follow-up|0|||
170456126|NCT04049617|616011230|FG005|Overall Study|Lost to Follow-up|0|||
170456127|NCT04049617|616011225|FG000|Overall Study|Withdrew consent|0|||
170456128|NCT04049617|616011226|FG001|Overall Study|Withdrew consent|0|||
170456129|NCT04049617|616011227|FG002|Overall Study|Withdrew consent|1|||
170456130|NCT04049617|616011228|FG003|Overall Study|Withdrew consent|0|||
170456131|NCT04049617|616011229|FG004|Overall Study|Withdrew consent|0|||
170456132|NCT04049617|616011230|FG005|Overall Study|Withdrew consent|0|||
170456133|NCT01780987|616011231|FG000|Overall Study|Adverse Event|0|||
170456134|NCT01780987|616011232|FG001|Overall Study|Adverse Event|4|||
170456135|NCT01780987|616011231|FG000|Overall Study|Withdrawal by Subject|2|||
170456136|NCT01780987|616011232|FG001|Overall Study|Withdrawal by Subject|0|||
170456137|NCT01780987|616011231|FG000|Overall Study|Request of Changing Hospital|0|||
170456138|NCT01780987|616011232|FG001|Overall Study|Request of Changing Hospital|1|||
170456139|NCT01780987|616011231|FG000|Overall Study|Changing Residence|1|||
170456140|NCT01780987|616011232|FG001|Overall Study|Changing Residence|0|||
170456141|NCT01780987|616011231|FG000|Overall Study|Not Receiving any Study Medication|0|||
170456142|NCT01780987|616011232|FG001|Overall Study|Not Receiving any Study Medication|1|||
170456143|NCT04078126|616011233|FG000|Washout|Study put on hold due to COVID-19|0|||
170456144|NCT04078126|616011234|FG001|Washout|Study put on hold due to COVID-19|2|||
170456145|NCT04078126|616011233|FG000|Period 2|Study put on hold due to COVID-19|1|||
170456146|NCT04078126|616011234|FG001|Period 2|Study put on hold due to COVID-19|1|||
170456147|NCT03402750|616011237|FG000|Overall Study|Lost to Follow-up|2|||
170456148|NCT03402750|616011238|FG001|Overall Study|Lost to Follow-up|1|||
170456149|NCT04168190|616011239|FG000|Overall Study|Lost to Follow-up|0|||
170542816|NCT03369223|616331136|FG003|Overall Study|Participant no longer meets study criteria|0|||
170542817|NCT03369223|616331137|FG004|Overall Study|Participant no longer meets study criteria|0|||
170542818|NCT03369223|616331138|FG005|Overall Study|Participant no longer meets study criteria|0|||
170542819|NCT03369223|616331139|FG006|Overall Study|Participant no longer meets study criteria|0|||
170542820|NCT03369223|616331140|FG007|Overall Study|Participant no longer meets study criteria|0|||
170889043|NCT03237065|617600601|FG000|Overall Study|Protocol Violation|0|||
170889044|NCT03237065|617600602|FG001|Overall Study|Protocol Violation|1|||
170889045|NCT03237065|617600601|FG000|Overall Study|Withdrawal by Subject|3|||
170889046|NCT03237065|617600602|FG001|Overall Study|Withdrawal by Subject|0|||
170889047|NCT03237065|617600601|FG000|Overall Study|Lost to Follow-up|1|||
170889048|NCT03237065|617600602|FG001|Overall Study|Lost to Follow-up|0|||
170889049|NCT03237065|617600601|FG000|Overall Study|Unable to obtain venous access|0|||
170889050|NCT03237065|617600602|FG001|Overall Study|Unable to obtain venous access|1|||
170456150|NCT04168190|616011240|FG001|Overall Study|Lost to Follow-up|1|||
170456151|NCT04168190|616011241|FG002|Overall Study|Lost to Follow-up|0|||
170456152|NCT04168190|616011242|FG003|Overall Study|Lost to Follow-up|7|||
170456153|NCT04168190|616011243|FG004|Overall Study|Lost to Follow-up|5|||
170456154|NCT04168190|616011239|FG000|Overall Study|Withdrawal by Subject|1|||
170456155|NCT04168190|616011240|FG001|Overall Study|Withdrawal by Subject|0|||
170456156|NCT04168190|616011241|FG002|Overall Study|Withdrawal by Subject|0|||
170889051|NCT00197054|617600605|FG000|Overall Study|Withdrawal by Subject|9|||
170456157|NCT04168190|616011242|FG003|Overall Study|Withdrawal by Subject|2|||
170456158|NCT04168190|616011243|FG004|Overall Study|Withdrawal by Subject|4|||
170456159|NCT04168190|616011239|FG000|Overall Study|Death|0|||
170456160|NCT04168190|616011240|FG001|Overall Study|Death|0|||
170456161|NCT04168190|616011241|FG002|Overall Study|Death|0|||
170456162|NCT04168190|616011242|FG003|Overall Study|Death|1|||
170456163|NCT04168190|616011243|FG004|Overall Study|Death|0|||
170456164|NCT02325518|616011244|FG000|Overall Study|Adverse Event|4|||
170456165|NCT02325518|616011245|FG001|Overall Study|Adverse Event|1|||
170456166|NCT02325518|616011244|FG000|Overall Study|Physician Decision|0|||
170456167|NCT02325518|616011245|FG001|Overall Study|Physician Decision|1|||
170456168|NCT02325518|616011244|FG000|Overall Study|Withdrawal by Subject|0|||
170456169|NCT02325518|616011245|FG001|Overall Study|Withdrawal by Subject|1|||
170456170|NCT02534844|616011246|FG000|Part B|Withdrawal by Subject|0|||
170456171|NCT02534844|616011247|FG001|Part B|Withdrawal by Subject|0|||
170456172|NCT02534844|616011248|FG002|Part B|Withdrawal by Subject|0|||
170456173|NCT02534844|616011249|FG003|Part B|Withdrawal by Subject|0|||
170456174|NCT02534844|616011250|FG004|Part B|Withdrawal by Subject|2|||
170456175|NCT02534844|616011251|FG005|Part B|Withdrawal by Subject|1|||
170456176|NCT04765384|616011252|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
170456177|NCT04765384|616011253|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
170456178|NCT04765384|616011254|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
170456179|NCT04765384|616011255|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
170456180|NCT04765384|616011256|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
170456181|NCT04765384|616011257|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
170456182|NCT04765384|616011252|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
170456183|NCT04765384|616011253|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
170456184|NCT04765384|616011254|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
170456185|NCT04765384|616011255|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
170456186|NCT04765384|616011256|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
170456187|NCT04765384|616011257|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
170456188|NCT04765384|616011252|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
170456189|NCT04765384|616011253|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
170456190|NCT04765384|616011254|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
170456191|NCT04765384|616011255|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
170456192|NCT04765384|616011256|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
170456193|NCT04765384|616011257|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
170456194|NCT04765384|616011252|FG000|Post-natal: Neonates and Infants|Death|0|||
170456195|NCT04765384|616011253|FG001|Post-natal: Neonates and Infants|Death|0|||
170456196|NCT04765384|616011254|FG002|Post-natal: Neonates and Infants|Death|0|||
170456197|NCT04765384|616011255|FG003|Post-natal: Neonates and Infants|Death|1|||
170456198|NCT04765384|616011256|FG004|Post-natal: Neonates and Infants|Death|0|||
170456199|NCT04765384|616011257|FG005|Post-natal: Neonates and Infants|Death|0|||
170456200|NCT04765384|616011252|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
170456201|NCT04765384|616011253|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
170456202|NCT04765384|616011254|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
170456203|NCT04765384|616011255|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
170456204|NCT04765384|616011256|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
170456205|NCT04765384|616011257|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
170456206|NCT02992418|616011262|FG000|Overall Study|Withdrawal by Subject|11|||
170456207|NCT02992418|616011263|FG001|Overall Study|Withdrawal by Subject|12|||
170456208|NCT02992418|616011262|FG000|Overall Study|Non-compliance with the protocol|308|||
170456209|NCT02992418|616011263|FG001|Overall Study|Non-compliance with the protocol|308|||
170456210|NCT02992418|616011262|FG000|Overall Study|Lost to Follow-up|27|||
170456211|NCT02992418|616011263|FG001|Overall Study|Lost to Follow-up|22|||
170456212|NCT05297578|616011265|FG000|Overall Study|Lost to Follow-up|1|||
170456213|NCT05297578|616011266|FG001|Overall Study|Lost to Follow-up|1|||
170456214|NCT05297578|616011267|FG002|Overall Study|Lost to Follow-up|2|||
170456215|NCT05297578|616011268|FG003|Overall Study|Lost to Follow-up|1|||
170456216|NCT05297578|616011265|FG000|Overall Study|Death|0|||
170456217|NCT05297578|616011266|FG001|Overall Study|Death|1|||
170456218|NCT05297578|616011267|FG002|Overall Study|Death|0|||
170456219|NCT05297578|616011268|FG003|Overall Study|Death|0|||
170456220|NCT05297578|616011265|FG000|Overall Study|Withdrawal by Subject|0|||
170456221|NCT05297578|616011266|FG001|Overall Study|Withdrawal by Subject|0|||
170456222|NCT05297578|616011267|FG002|Overall Study|Withdrawal by Subject|1|||
170456223|NCT05297578|616011268|FG003|Overall Study|Withdrawal by Subject|0|||
170456224|NCT01169532|616011272|FG000|Overall Study|Withdrawal by Subject|1|||
170456225|NCT03127644|616011273|FG000|Overall Study|Study-specific withdrawal criteria|0|||
170456226|NCT03127644|616011274|FG001|Overall Study|Study-specific withdrawal criteria|0|||
170456227|NCT03127644|616011275|FG002|Overall Study|Study-specific withdrawal criteria|2|||
170456228|NCT02032706|616011276|FG000|Overall Study|Did not qualify|5|||
170456229|NCT02032706|616011276|FG000|Overall Study|Protocol Violation|1|||
170456230|NCT01156142|616011277|FG000|Overall Study|Withdrawal by Subject|8|||
170456231|NCT01156142|616011278|FG001|Overall Study|Withdrawal by Subject|6|||
170787839|NCT01437709|617234152|FG000|Overall Study|Pt trasnferred care|0|||
170456232|NCT01156142|616011277|FG000|Overall Study|Ineligible|0|||
170456233|NCT01156142|616011278|FG001|Overall Study|Ineligible|1|||
170456234|NCT00928707|616011279|FG000|Overall Study|Protocol Violation|1|||
170456235|NCT00928707|616011280|FG001|Overall Study|Protocol Violation|0|||
170456236|NCT00132028|616011281|FG000|Overall Study|Adverse Event|7|||
170456237|NCT00132028|616011281|FG000|Overall Study|Death|2|||
170456238|NCT00132028|616011281|FG000|Overall Study|Lack of Efficacy|11|||
170456239|NCT00132028|616011281|FG000|Overall Study|Withdrawal by Subject|2|||
170456240|NCT00132028|616011281|FG000|Overall Study|not eligible|2|||
170456241|NCT00132028|616011281|FG000|Overall Study|Physician Decision|3|||
170456242|NCT01660334|616011282|FG000|Overall Study|Lost to Follow-up|1|||
170456243|NCT01321008|616011285|FG000|Overall Study|Early Study Termination|1|||
170456244|NCT03978091|616011286|FG000|Overall Study|Lost to Follow-up|0|||
170456245|NCT03978091|616011287|FG001|Overall Study|Lost to Follow-up|0|||
170456246|NCT03978091|616011288|FG002|Overall Study|Lost to Follow-up|1|||
170456247|NCT03978091|616011289|FG003|Overall Study|Lost to Follow-up|0|||
170456248|NCT03978091|616011290|FG004|Overall Study|Lost to Follow-up|0|||
170456249|NCT03978091|616011291|FG005|Overall Study|Lost to Follow-up|0|||
170456250|NCT03978091|616011286|FG000|Overall Study|Withdrawal by Subject|0|||
170456251|NCT03978091|616011287|FG001|Overall Study|Withdrawal by Subject|0|||
170456252|NCT03978091|616011288|FG002|Overall Study|Withdrawal by Subject|0|||
170456253|NCT03978091|616011289|FG003|Overall Study|Withdrawal by Subject|1|||
170456254|NCT03978091|616011290|FG004|Overall Study|Withdrawal by Subject|1|||
170456255|NCT03978091|616011291|FG005|Overall Study|Withdrawal by Subject|0|||
170456256|NCT01843348|616011297|FG000|Overall Study|Withdrawal by Subject|4|||
170456257|NCT01843348|616011298|FG001|Overall Study|Withdrawal by Subject|16|||
170456258|NCT01843348|616011299|FG002|Overall Study|Withdrawal by Subject|18|||
170456259|NCT01843348|616011297|FG000|Overall Study|Lost to Follow-up|5|||
170456260|NCT01843348|616011298|FG001|Overall Study|Lost to Follow-up|4|||
170456261|NCT01843348|616011299|FG002|Overall Study|Lost to Follow-up|2|||
170456262|NCT01843348|616011297|FG000|Overall Study|Death|5|||
170456263|NCT01843348|616011298|FG001|Overall Study|Death|3|||
170456264|NCT01843348|616011299|FG002|Overall Study|Death|4|||
170456265|NCT01843348|616011297|FG000|Overall Study|Graft loss/retransplantation|5|||
170456266|NCT01843348|616011298|FG001|Overall Study|Graft loss/retransplantation|8|||
170456267|NCT01843348|616011299|FG002|Overall Study|Graft loss/retransplantation|11|||
170456268|NCT01843348|616011297|FG000|Overall Study|Various reasons|4|||
170456269|NCT01843348|616011298|FG001|Overall Study|Various reasons|9|||
170456270|NCT01843348|616011299|FG002|Overall Study|Various reasons|6|||
170456271|NCT00251641|616011300|FG000|Overall Study|Adverse Event|80|||
170456272|NCT00251641|616011301|FG001|Overall Study|Adverse Event|8|||
170456273|NCT00251641|616011300|FG000|Overall Study|Lack of Efficacy|2|||
170456274|NCT00251641|616011301|FG001|Overall Study|Lack of Efficacy|1|||
170456275|NCT00251641|616011300|FG000|Overall Study|Progression of Disease|0|||
170456276|NCT00251641|616011301|FG001|Overall Study|Progression of Disease|2|||
170456277|NCT00251641|616011300|FG000|Overall Study|Lost to Follow-up|3|||
170456278|NCT00251641|616011301|FG001|Overall Study|Lost to Follow-up|3|||
170456279|NCT00251641|616011300|FG000|Overall Study|Withdrawal by Subject|6|||
170456280|NCT00251641|616011301|FG001|Overall Study|Withdrawal by Subject|8|||
170456281|NCT00251641|616011300|FG000|Overall Study|Protocol Violation|10|||
170456282|NCT00251641|616011301|FG001|Overall Study|Protocol Violation|2|||
170456283|NCT00251641|616011300|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
170456284|NCT00251641|616011301|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
170456285|NCT00251641|616011300|FG000|Overall Study|Switched Treatment|9|||
170456286|NCT00251641|616011301|FG001|Overall Study|Switched Treatment|63|||
170456287|NCT02093221|616011302|FG000|Overall Study|Adverse Event|1|||
170456288|NCT02093221|616011303|FG001|Overall Study|Adverse Event|0|||
170456289|NCT02093221|616011304|FG002|Overall Study|Adverse Event|0|||
170456290|NCT02093221|616011305|FG003|Overall Study|Adverse Event|0|||
170456291|NCT02093221|616011306|FG004|Overall Study|Adverse Event|0|||
170456292|NCT02093221|616011302|FG000|Overall Study|Withdrawal by Subject|1|||
170456293|NCT02093221|616011303|FG001|Overall Study|Withdrawal by Subject|1|||
170456294|NCT02093221|616011304|FG002|Overall Study|Withdrawal by Subject|4|||
170456295|NCT02093221|616011305|FG003|Overall Study|Withdrawal by Subject|1|||
170456296|NCT02093221|616011306|FG004|Overall Study|Withdrawal by Subject|1|||
170456297|NCT02093221|616011302|FG000|Overall Study|Lost to Follow-up|2|||
170456298|NCT02093221|616011303|FG001|Overall Study|Lost to Follow-up|0|||
170456299|NCT02093221|616011304|FG002|Overall Study|Lost to Follow-up|1|||
170456300|NCT02093221|616011305|FG003|Overall Study|Lost to Follow-up|1|||
170456301|NCT02093221|616011306|FG004|Overall Study|Lost to Follow-up|0|||
170456302|NCT02093221|616011302|FG000|Overall Study|Death|0|||
170456303|NCT02093221|616011303|FG001|Overall Study|Death|1|||
170456304|NCT02093221|616011304|FG002|Overall Study|Death|0|||
170456305|NCT02093221|616011305|FG003|Overall Study|Death|0|||
170456306|NCT02093221|616011306|FG004|Overall Study|Death|0|||
170456307|NCT02093221|616011302|FG000|Overall Study|Protocol Violation|0|||
170456308|NCT02093221|616011303|FG001|Overall Study|Protocol Violation|1|||
170456309|NCT02093221|616011304|FG002|Overall Study|Protocol Violation|0|||
170456310|NCT02093221|616011305|FG003|Overall Study|Protocol Violation|0|||
170456311|NCT02093221|616011306|FG004|Overall Study|Protocol Violation|0|||
170456312|NCT02093221|616011302|FG000|Overall Study|Study termination|6|||
170456313|NCT02093221|616011303|FG001|Overall Study|Study termination|5|||
170456314|NCT02093221|616011304|FG002|Overall Study|Study termination|4|||
170456315|NCT02093221|616011305|FG003|Overall Study|Study termination|6|||
170456316|NCT02093221|616011306|FG004|Overall Study|Study termination|7|||
170787840|NCT01437709|617234153|FG001|Overall Study|Pt trasnferred care|1|||
170787841|NCT01437709|617234154|FG002|Overall Study|Pt trasnferred care|0|||
170787842|NCT04091750|617234155|FG000|Overall Study|Adverse Event|4|||
170787843|NCT04091750|617234155|FG000|Overall Study|Withdrawal by Subject|1|||
170787844|NCT04473222|617234156|FG000|Overall Study|Lost to Follow-up|13|||
170787845|NCT04473222|617234157|FG001|Overall Study|Lost to Follow-up|13|||
170787846|NCT04473222|617234156|FG000|Overall Study|Withdrawal by Subject|0|||
170787847|NCT04473222|617234157|FG001|Overall Study|Withdrawal by Subject|1|||
170787848|NCT04473222|617234156|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
170787849|NCT04473222|617234157|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
170787850|NCT04293055|617234158|FG000|Overall Study|Lost to Follow-up|1|||
170787851|NCT04293055|617234159|FG001|Overall Study|Lost to Follow-up|1|||
170787852|NCT04293055|617234158|FG000|Overall Study|Did not trigger randomization|6|||
170787853|NCT04293055|617234159|FG001|Overall Study|Did not trigger randomization|5|||
170787854|NCT01369355|617234161|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
170787855|NCT01369355|617234162|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
170787856|NCT01369355|617234163|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
170787857|NCT01369355|617234164|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
170787858|NCT01369355|617234165|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
170787859|NCT01369355|617234166|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
170787860|NCT01369355|617234167|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
170787861|NCT01369355|617234168|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
170787862|NCT01369355|617234169|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
170787863|NCT01369355|617234161|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
170787864|NCT01369355|617234162|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
170787865|NCT01369355|617234163|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
170787866|NCT01369355|617234164|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
170787867|NCT01369355|617234165|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
170787868|NCT01369355|617234166|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
170456317|NCT00876018|616011307|FG000|Overall Study|Lost to Follow-up|0|||
170456318|NCT00876018|616011308|FG001|Overall Study|Lost to Follow-up|1|||
170456319|NCT00876018|616011309|FG002|Overall Study|Lost to Follow-up|1|||
170456320|NCT00876018|616011307|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
170456321|NCT00876018|616011308|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
170456322|NCT00876018|616011309|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
170456323|NCT01230892|616011310|FG000|Overall Study|Withdrawal by Subject|1|||
170456324|NCT01230892|616011311|FG001|Overall Study|Withdrawal by Subject|1|||
170456325|NCT01230892|616011310|FG000|Overall Study|Lost to Follow-up|2|||
170456326|NCT01230892|616011311|FG001|Overall Study|Lost to Follow-up|0|||
170456327|NCT00679913|616011312|FG000|Overall Study|Protocol Violation|18|||
170456328|NCT00679913|616011313|FG001|Overall Study|Protocol Violation|13|||
170456329|NCT00062751|616011319|FG000|Overall Study|Disease progression|24|||
170456330|NCT00062751|616011320|FG001|Overall Study|Disease progression|17|||
170456331|NCT00062751|616011321|FG002|Overall Study|Disease progression|24|||
170456332|NCT00062751|616011322|FG003|Overall Study|Disease progression|2|||
170456333|NCT00062751|616011323|FG004|Overall Study|Disease progression|2|||
170456334|NCT00062751|616011319|FG000|Overall Study|Adverse Event|4|||
170456335|NCT00062751|616011320|FG001|Overall Study|Adverse Event|7|||
170456336|NCT00062751|616011321|FG002|Overall Study|Adverse Event|2|||
170456337|NCT00062751|616011322|FG003|Overall Study|Adverse Event|2|||
170456338|NCT00062751|616011323|FG004|Overall Study|Adverse Event|2|||
170456339|NCT00062751|616011319|FG000|Overall Study|Other|2|||
170456340|NCT00062751|616011320|FG001|Overall Study|Other|3|||
170456341|NCT00062751|616011321|FG002|Overall Study|Other|1|||
170456342|NCT00062751|616011322|FG003|Overall Study|Other|0|||
170456343|NCT00062751|616011323|FG004|Overall Study|Other|1|||
170456344|NCT00062751|616011319|FG000|Overall Study|Withdrawal by Subject|1|||
170456345|NCT00062751|616011320|FG001|Overall Study|Withdrawal by Subject|2|||
170456346|NCT00062751|616011321|FG002|Overall Study|Withdrawal by Subject|2|||
170456347|NCT00062751|616011322|FG003|Overall Study|Withdrawal by Subject|1|||
170456348|NCT00062751|616011323|FG004|Overall Study|Withdrawal by Subject|0|||
170456349|NCT00062751|616011319|FG000|Overall Study|Symptomatic deterioration|1|||
170456350|NCT00062751|616011320|FG001|Overall Study|Symptomatic deterioration|1|||
170456351|NCT00062751|616011321|FG002|Overall Study|Symptomatic deterioration|0|||
170456352|NCT00062751|616011322|FG003|Overall Study|Symptomatic deterioration|0|||
170456353|NCT00062751|616011323|FG004|Overall Study|Symptomatic deterioration|1|||
170456354|NCT00062751|616011319|FG000|Overall Study|Death|1|||
170456355|NCT00062751|616011320|FG001|Overall Study|Death|0|||
170456356|NCT00062751|616011321|FG002|Overall Study|Death|1|||
170456357|NCT00062751|616011322|FG003|Overall Study|Death|0|||
170456358|NCT00062751|616011323|FG004|Overall Study|Death|0|||
170456359|NCT01000493|616011324|FG000|Overall Study|Adverse Event|3|||
170456360|NCT01000493|616011325|FG001|Overall Study|Adverse Event|6|||
170456361|NCT01000493|616011324|FG000|Overall Study|Lack of Efficacy|1|||
170456362|NCT01000493|616011325|FG001|Overall Study|Lack of Efficacy|1|||
170456363|NCT01000493|616011324|FG000|Overall Study|Protocol Violation|1|||
170456364|NCT01000493|616011325|FG001|Overall Study|Protocol Violation|8|||
170456365|NCT01000493|616011324|FG000|Overall Study|Study closed/terminated|25|||
170456366|NCT01000493|616011325|FG001|Overall Study|Study closed/terminated|23|||
170456367|NCT01000493|616011324|FG000|Overall Study|Lost to Follow-up|5|||
170456368|NCT01000493|616011325|FG001|Overall Study|Lost to Follow-up|9|||
170456369|NCT01000493|616011324|FG000|Overall Study|Physician Decision|1|||
170456370|NCT01000493|616011325|FG001|Overall Study|Physician Decision|1|||
170456371|NCT01000493|616011324|FG000|Overall Study|Withdrawal by Subject|3|||
170889052|NCT00197054|617600606|FG001|Overall Study|Withdrawal by Subject|3|||
170456372|NCT01000493|616011325|FG001|Overall Study|Withdrawal by Subject|7|||
170456373|NCT03828448|616011338|FG000|Overall Study|Sponsor's Discretion|34|||
170456374|NCT02037165|616011339|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
170456375|NCT02037165|616011340|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
170456376|NCT02037165|616011341|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
170456377|NCT02037165|616011342|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
170456378|NCT02037165|616011343|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
170456379|NCT00456495|616011347|FG000|Overall Study|Physician Decision|2|||
170456380|NCT00673933|616011350|FG000|Overall Study|Withdrawal by Subject|2|||
170456381|NCT00673933|616011350|FG000|Overall Study|Lost to Follow-up|1|||
170456382|NCT02394730|616011351|FG000|Overall Study|Lost to Follow-up|1|||
170456383|NCT02394730|616011352|FG001|Overall Study|Lost to Follow-up|0|||
170456384|NCT02394730|616011351|FG000|Overall Study|Withdrawal by Subject|0|||
170456385|NCT02394730|616011352|FG001|Overall Study|Withdrawal by Subject|1|||
170456386|NCT00588640|616011353|FG000|Overall Study|Physician Decision|1|||
170456387|NCT00588640|616011353|FG000|Overall Study|Ineligible Patient|1|||
170456388|NCT01673698|616011354|FG000|Overall Study|Lost to Follow-up|51|||
170456389|NCT01673698|616011355|FG001|Overall Study|Lost to Follow-up|13|||
170456390|NCT03548064|616013607|FG000|Overall Study|Withdrawal by Subject|0|||
170456391|NCT03548064|616013608|FG001|Overall Study|Withdrawal by Subject|0|||
170456392|NCT03548064|616013609|FG002|Overall Study|Withdrawal by Subject|0|||
170456393|NCT03548064|616013610|FG003|Overall Study|Withdrawal by Subject|1|||
170456394|NCT03548064|616013611|FG004|Overall Study|Withdrawal by Subject|0|||
170456395|NCT03548064|616013612|FG005|Overall Study|Withdrawal by Subject|0|||
170456396|NCT03548064|616013613|FG006|Overall Study|Withdrawal by Subject|0|||
170456397|NCT03548064|616013614|FG007|Overall Study|Withdrawal by Subject|0|||
170456398|NCT03548064|616013607|FG000|Overall Study|Lost to Follow-up|0|||
170456399|NCT03548064|616013608|FG001|Overall Study|Lost to Follow-up|0|||
170456400|NCT03548064|616013609|FG002|Overall Study|Lost to Follow-up|0|||
170456401|NCT03548064|616013610|FG003|Overall Study|Lost to Follow-up|0|||
170456402|NCT03548064|616013611|FG004|Overall Study|Lost to Follow-up|2|||
170456403|NCT03548064|616013612|FG005|Overall Study|Lost to Follow-up|0|||
170456404|NCT03548064|616013613|FG006|Overall Study|Lost to Follow-up|0|||
170456405|NCT03548064|616013614|FG007|Overall Study|Lost to Follow-up|0|||
170456406|NCT03548064|616013607|FG000|Overall Study|Covid-19 Pandemic|0|||
170456407|NCT03548064|616013608|FG001|Overall Study|Covid-19 Pandemic|0|||
170456408|NCT03548064|616013609|FG002|Overall Study|Covid-19 Pandemic|0|||
170456409|NCT03548064|616013610|FG003|Overall Study|Covid-19 Pandemic|0|||
170456410|NCT03548064|616013611|FG004|Overall Study|Covid-19 Pandemic|10|||
170456411|NCT03548064|616013612|FG005|Overall Study|Covid-19 Pandemic|3|||
170456412|NCT03548064|616013613|FG006|Overall Study|Covid-19 Pandemic|0|||
170456413|NCT03548064|616013614|FG007|Overall Study|Covid-19 Pandemic|0|||
170456414|NCT05011123|616013617|FG000|Overall Study|Withdrawal by Subject|4|||
170456415|NCT05011123|616013618|FG001|Overall Study|Withdrawal by Subject|2|||
170456416|NCT05011123|616013617|FG000|Overall Study|Lost to Follow-up|7|||
170456417|NCT05011123|616013618|FG001|Overall Study|Lost to Follow-up|6|||
170456418|NCT05011123|616013617|FG000|Overall Study|Ongoing at the time of DBL date|36|||
170456419|NCT05011123|616013618|FG001|Overall Study|Ongoing at the time of DBL date|10|||
170456420|NCT05011123|616013617|FG000|Overall Study|Randomized but did not receive vaccination|1|||
170456421|NCT05011123|616013618|FG001|Overall Study|Randomized but did not receive vaccination|0|||
170456422|NCT04221789|616013620|FG000|Overall Study|deviation from protoco|22|||
170456423|NCT04221789|616013621|FG001|Overall Study|deviation from protoco|8|||
170456424|NCT03295318|616013632|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
170456425|NCT03295318|616013633|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
170456426|NCT03295318|616013634|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
170456427|NCT03295318|616013632|FG000|Overall Study|Death|1|||
170456428|NCT03295318|616013633|FG001|Overall Study|Death|1|||
170456429|NCT03295318|616013634|FG002|Overall Study|Death|1|||
170456430|NCT03295318|616013632|FG000|Overall Study|Protocol Violation|4|||
170456431|NCT03295318|616013633|FG001|Overall Study|Protocol Violation|3|||
170456432|NCT03295318|616013634|FG002|Overall Study|Protocol Violation|3|||
170456433|NCT03295318|616013632|FG000|Overall Study|Withdrawal by Subject|0|||
170456434|NCT03295318|616013633|FG001|Overall Study|Withdrawal by Subject|0|||
170456435|NCT03295318|616013634|FG002|Overall Study|Withdrawal by Subject|1|||
170456436|NCT03295318|616013632|FG000|Overall Study|Subject discontinued due to travel|0|||
170456437|NCT03295318|616013633|FG001|Overall Study|Subject discontinued due to travel|1|||
170456438|NCT03295318|616013634|FG002|Overall Study|Subject discontinued due to travel|0|||
170456439|NCT04394351|616013635|FG000|Part A (16 Weeks)|Adverse Event|1|||
170456440|NCT04394351|616013636|FG001|Part A (16 Weeks)|Adverse Event|0|||
170456441|NCT04394351|616013637|FG002|Part A (16 Weeks)|Adverse Event|0|||
170456442|NCT04394351|616013638|FG003|Part A (16 Weeks)|Adverse Event|0|||
170456443|NCT04394351|616013639|FG004|Part A (16 Weeks)|Adverse Event|0|||
170456444|NCT04394351|616013640|FG005|Part A (16 Weeks)|Adverse Event|0|||
170456445|NCT04394351|616013641|FG006|Part A (16 Weeks)|Adverse Event|0|||
170456446|NCT04394351|616013642|FG007|Part A (16 Weeks)|Adverse Event|0|||
170456447|NCT04394351|616013635|FG000|Part A (16 Weeks)|Physician Decision|0|||
170456448|NCT04394351|616013636|FG001|Part A (16 Weeks)|Physician Decision|1|||
170456449|NCT04394351|616013637|FG002|Part A (16 Weeks)|Physician Decision|0|||
170456450|NCT04394351|616013638|FG003|Part A (16 Weeks)|Physician Decision|0|||
170456451|NCT04394351|616013639|FG004|Part A (16 Weeks)|Physician Decision|0|||
170456452|NCT04394351|616013640|FG005|Part A (16 Weeks)|Physician Decision|0|||
170456453|NCT04394351|616013641|FG006|Part A (16 Weeks)|Physician Decision|0|||
170456454|NCT04394351|616013642|FG007|Part A (16 Weeks)|Physician Decision|0|||
170456455|NCT04394351|616013635|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
170456456|NCT04394351|616013636|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
170787869|NCT01369355|617234167|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
170456457|NCT04394351|616013637|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
170456458|NCT04394351|616013638|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
170456459|NCT04394351|616013639|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
170456460|NCT04394351|616013640|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
170456461|NCT04394351|616013641|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
170456462|NCT04394351|616013642|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
170456463|NCT04394351|616013635|FG000|Part B (36 Weeks)|Adverse Event|0|||
170635873|NCT05782179|616678894|FG003|Overall Study|Adverse Event|0|||
170456464|NCT04394351|616013636|FG001|Part B (36 Weeks)|Adverse Event|0|||
170456465|NCT04394351|616013637|FG002|Part B (36 Weeks)|Adverse Event|0|||
170456466|NCT04394351|616013638|FG003|Part B (36 Weeks)|Adverse Event|0|||
170456467|NCT04394351|616013639|FG004|Part B (36 Weeks)|Adverse Event|0|||
170456468|NCT04394351|616013640|FG005|Part B (36 Weeks)|Adverse Event|0|||
170889053|NCT00197054|617600607|FG002|Overall Study|Withdrawal by Subject|3|||
170889054|NCT00197054|617600605|FG000|Overall Study|Moved from area|7|||
170889055|NCT00197054|617600606|FG001|Overall Study|Moved from area|14|||
170889056|NCT00197054|617600607|FG002|Overall Study|Moved from area|9|||
170889057|NCT00197054|617600605|FG000|Overall Study|Lost to Follow-up|1|||
170889058|NCT00197054|617600606|FG001|Overall Study|Lost to Follow-up|4|||
170889059|NCT00197054|617600607|FG002|Overall Study|Lost to Follow-up|0|||
170889060|NCT04016311|617600610|FG000|Overall Study|Withdrawal by Subject|1|||
170889061|NCT04016311|617600611|FG001|Overall Study|Withdrawal by Subject|0|||
170889062|NCT02706730|617600615|FG000|Overall Study|Adverse Event|3|||
170889063|NCT02706730|617600615|FG000|Overall Study|Lack of Efficacy|5|||
170889064|NCT02706730|617600615|FG000|Overall Study|Withdrawal by Subject|11|||
170889065|NCT02706730|617600615|FG000|Overall Study|Study Terminated by Sponsor|11|||
170889066|NCT02706730|617600615|FG000|Overall Study|Subject chose not to receive injection|3|||
170889067|NCT00756938|617600616|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
170889068|NCT00756938|617600617|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
170889069|NCT00756938|617600618|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
170889070|NCT00756938|617600619|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
170889071|NCT00756938|617600616|FG000|12-week Base Study|Protocol Violation|0|||
170889072|NCT00756938|617600617|FG001|12-week Base Study|Protocol Violation|0|||
170889073|NCT00756938|617600618|FG002|12-week Base Study|Protocol Violation|1|||
170889074|NCT00756938|617600619|FG003|12-week Base Study|Protocol Violation|0|||
170889075|NCT00756938|617600616|FG000|12-week Base Study|Lost to Follow-up|1|||
170456469|NCT04394351|616013641|FG006|Part B (36 Weeks)|Adverse Event|1|||
170456470|NCT04394351|616013642|FG007|Part B (36 Weeks)|Adverse Event|0|||
170456471|NCT04394351|616013635|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
170456472|NCT04394351|616013636|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
170456473|NCT04394351|616013637|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
170456474|NCT04394351|616013638|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
170456475|NCT04394351|616013639|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
170456476|NCT04394351|616013640|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
170456477|NCT04394351|616013641|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
170456478|NCT04394351|616013642|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
170456479|NCT04394351|616013635|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
170456480|NCT04394351|616013636|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
170456481|NCT04394351|616013637|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
170456482|NCT04394351|616013638|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
170456483|NCT04394351|616013639|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
170456484|NCT04394351|616013640|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
170456485|NCT04394351|616013641|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
170456486|NCT04394351|616013642|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
170456487|NCT04394351|616013635|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
170456488|NCT04394351|616013636|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
170456489|NCT04394351|616013637|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
170456490|NCT04394351|616013638|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
170456491|NCT04394351|616013639|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
170456492|NCT04394351|616013640|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
170456493|NCT04394351|616013641|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
170456494|NCT04394351|616013642|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
170456495|NCT04394351|616013635|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
170456496|NCT04394351|616013636|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
170456497|NCT04394351|616013637|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
170456498|NCT04394351|616013638|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
170456499|NCT04394351|616013639|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
170456500|NCT04394351|616013640|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
170456501|NCT04394351|616013641|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
170456502|NCT04394351|616013642|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
170456503|NCT04319718|616013649|FG000|Overall Study|Adverse Event|0|||
170456504|NCT04319718|616013650|FG001|Overall Study|Adverse Event|2|||
170456505|NCT04319718|616013649|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
170456506|NCT04319718|616013650|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
170456507|NCT03188666|616013651|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
170456508|NCT03188666|616013652|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
170456509|NCT03188666|616013653|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
170456510|NCT03188666|616013654|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
170456511|NCT03188666|616013651|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
170456512|NCT03188666|616013652|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
170456513|NCT03188666|616013653|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
170456514|NCT03188666|616013654|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
170456515|NCT03188666|616013651|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
170456516|NCT03188666|616013652|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
170456517|NCT03188666|616013653|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
170456518|NCT03188666|616013654|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
170456519|NCT03188666|616013651|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
170456520|NCT03188666|616013652|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
170456521|NCT03188666|616013653|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
170456522|NCT03188666|616013654|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
170456523|NCT00144781|616013655|FG000|Overall Study|Adverse Event|0|||
170456524|NCT00144781|616013656|FG001|Overall Study|Adverse Event|1|||
170456525|NCT00144781|616013657|FG002|Overall Study|Adverse Event|0|||
170456526|NCT00144781|616013658|FG003|Overall Study|Adverse Event|0|||
170456527|NCT00144781|616013655|FG000|Overall Study|Non-compliant|0|||
170456528|NCT00144781|616013656|FG001|Overall Study|Non-compliant|1|||
170456529|NCT00144781|616013657|FG002|Overall Study|Non-compliant|0|||
170456530|NCT00144781|616013658|FG003|Overall Study|Non-compliant|0|||
170456531|NCT02068092|616013659|FG000|Overall Study|Physician Decision|2|||
170456532|NCT02068092|616013659|FG000|Overall Study|Adverse Event|2|||
170456533|NCT02068092|616013659|FG000|Overall Study|Lost to Follow-up|4|||
170456534|NCT02068092|616013659|FG000|Overall Study|Withdrawal by Subject|2|||
170456535|NCT03696953|616013660|FG000|Overall Study|Withdrawal by Subject|6|||
170456536|NCT03696953|616013661|FG001|Overall Study|Withdrawal by Subject|1|||
170456537|NCT03696953|616013660|FG000|Overall Study|missed GBS swabs|2|||
170456538|NCT03696953|616013661|FG001|Overall Study|missed GBS swabs|2|||
170456539|NCT03696953|616013660|FG000|Overall Study|lost study bottle containing capsules|2|||
170456540|NCT03696953|616013661|FG001|Overall Study|lost study bottle containing capsules|0|||
170456541|NCT03696953|616013660|FG000|Overall Study|Premature birth|1|||
170456542|NCT03696953|616013661|FG001|Overall Study|Premature birth|4|||
170456543|NCT03696953|616013660|FG000|Overall Study|Gestational hypertension|1|||
170456544|NCT03696953|616013661|FG001|Overall Study|Gestational hypertension|1|||
170456545|NCT03696953|616013660|FG000|Overall Study|Gestational diabetes|2|||
170456546|NCT03696953|616013661|FG001|Overall Study|Gestational diabetes|1|||
170456547|NCT03696953|616013660|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
170456548|NCT03696953|616013661|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
170456549|NCT03696953|616013660|FG000|Overall Study|Changed prenatal provider|1|||
170456550|NCT03696953|616013661|FG001|Overall Study|Changed prenatal provider|1|||
170456551|NCT03502707|616013662|FG000|Overall Study|Adverse Event|0|||
170456552|NCT03502707|616013663|FG001|Overall Study|Adverse Event|0|||
170456553|NCT03502707|616013664|FG002|Overall Study|Adverse Event|0|||
170456554|NCT03502707|616013665|FG003|Overall Study|Adverse Event|0|||
170456555|NCT03502707|616013666|FG004|Overall Study|Adverse Event|0|||
170456556|NCT03502707|616013667|FG005|Overall Study|Adverse Event|0|||
170456557|NCT03502707|616013668|FG006|Overall Study|Adverse Event|0|||
170456558|NCT03502707|616013669|FG007|Overall Study|Adverse Event|0|||
170456559|NCT03502707|616013670|FG008|Overall Study|Adverse Event|0|||
170456560|NCT03502707|616013671|FG009|Overall Study|Adverse Event|0|||
170456561|NCT03502707|616013672|FG010|Overall Study|Adverse Event|0|||
170456562|NCT03502707|616013673|FG011|Overall Study|Adverse Event|0|||
170456563|NCT03502707|616013674|FG012|Overall Study|Adverse Event|0|||
170456564|NCT03502707|616013675|FG013|Overall Study|Adverse Event|0|||
170456565|NCT03502707|616013676|FG014|Overall Study|Adverse Event|0|||
170456566|NCT03502707|616013677|FG015|Overall Study|Adverse Event|1|||
170456567|NCT03502707|616013678|FG016|Overall Study|Adverse Event|5|||
170456568|NCT03502707|616013679|FG017|Overall Study|Adverse Event|0|||
170456569|NCT03502707|616013662|FG000|Overall Study|Death|0|||
170456570|NCT03502707|616013663|FG001|Overall Study|Death|0|||
170456571|NCT03502707|616013664|FG002|Overall Study|Death|0|||
170456572|NCT03502707|616013665|FG003|Overall Study|Death|1|||
170456573|NCT03502707|616013666|FG004|Overall Study|Death|0|||
170542821|NCT03369223|616331141|FG008|Overall Study|Participant no longer meets study criteria|0|||
170542822|NCT03369223|616331142|FG009|Overall Study|Participant no longer meets study criteria|0|||
170542823|NCT03369223|616331143|FG010|Overall Study|Participant no longer meets study criteria|0|||
170542824|NCT03369223|616331144|FG011|Overall Study|Participant no longer meets study criteria|0|||
170542825|NCT03369223|616331145|FG012|Overall Study|Participant no longer meets study criteria|0|||
170889076|NCT00756938|617600617|FG001|12-week Base Study|Lost to Follow-up|0|||
170889077|NCT00756938|617600618|FG002|12-week Base Study|Lost to Follow-up|0|||
170456574|NCT03502707|616013667|FG005|Overall Study|Death|0|||
170889078|NCT00756938|617600619|FG003|12-week Base Study|Lost to Follow-up|0|||
170889079|NCT00756938|617600616|FG000|Optional Extension|Lack of Efficacy|0|||
170889080|NCT00756938|617600617|FG001|Optional Extension|Lack of Efficacy|0|||
170889081|NCT00756938|617600618|FG002|Optional Extension|Lack of Efficacy|0|||
170889082|NCT00756938|617600619|FG003|Optional Extension|Lack of Efficacy|1|||
170889083|NCT00756938|617600616|FG000|Optional Extension|End of Study|0|||
170889084|NCT00756938|617600617|FG001|Optional Extension|End of Study|0|||
170889085|NCT00756938|617600618|FG002|Optional Extension|End of Study|0|||
170889086|NCT00756938|617600619|FG003|Optional Extension|End of Study|11|||
170889087|NCT00756938|617600616|FG000|Optional Extension|Protocol-specific criteria met|0|||
170889088|NCT00756938|617600617|FG001|Optional Extension|Protocol-specific criteria met|0|||
170889089|NCT00756938|617600618|FG002|Optional Extension|Protocol-specific criteria met|0|||
170889090|NCT00756938|617600619|FG003|Optional Extension|Protocol-specific criteria met|9|||
170889091|NCT00756938|617600616|FG000|Optional Extension|Physician Decision|0|||
170889092|NCT00756938|617600617|FG001|Optional Extension|Physician Decision|0|||
170889093|NCT00756938|617600618|FG002|Optional Extension|Physician Decision|0|||
170889094|NCT00756938|617600619|FG003|Optional Extension|Physician Decision|3|||
170889095|NCT00756938|617600616|FG000|Optional Extension|Lost to Follow-up|0|||
170889096|NCT00756938|617600617|FG001|Optional Extension|Lost to Follow-up|0|||
170889097|NCT00756938|617600618|FG002|Optional Extension|Lost to Follow-up|0|||
170889098|NCT00756938|617600619|FG003|Optional Extension|Lost to Follow-up|1|||
170889099|NCT00756938|617600616|FG000|Optional Extension|Protocol Violation|0|||
170889100|NCT00756938|617600617|FG001|Optional Extension|Protocol Violation|0|||
170456575|NCT03502707|616013668|FG006|Overall Study|Death|0|||
170456576|NCT03502707|616013669|FG007|Overall Study|Death|0|||
170456577|NCT03502707|616013670|FG008|Overall Study|Death|1|||
170456578|NCT03502707|616013671|FG009|Overall Study|Death|1|||
170456579|NCT03502707|616013672|FG010|Overall Study|Death|0|||
170456580|NCT03502707|616013673|FG011|Overall Study|Death|0|||
170456581|NCT03502707|616013674|FG012|Overall Study|Death|1|||
170456582|NCT03502707|616013675|FG013|Overall Study|Death|0|||
170456583|NCT03502707|616013676|FG014|Overall Study|Death|0|||
170456584|NCT03502707|616013677|FG015|Overall Study|Death|1|||
170456585|NCT03502707|616013678|FG016|Overall Study|Death|0|||
170456586|NCT03502707|616013679|FG017|Overall Study|Death|0|||
170456587|NCT03502707|616013662|FG000|Overall Study|Lost to Follow-up|0|||
170456588|NCT03502707|616013663|FG001|Overall Study|Lost to Follow-up|0|||
170456589|NCT03502707|616013664|FG002|Overall Study|Lost to Follow-up|0|||
170456590|NCT03502707|616013665|FG003|Overall Study|Lost to Follow-up|0|||
170456591|NCT03502707|616013666|FG004|Overall Study|Lost to Follow-up|0|||
170456592|NCT03502707|616013667|FG005|Overall Study|Lost to Follow-up|0|||
170456593|NCT03502707|616013668|FG006|Overall Study|Lost to Follow-up|0|||
170456594|NCT03502707|616013669|FG007|Overall Study|Lost to Follow-up|5|||
170456595|NCT03502707|616013670|FG008|Overall Study|Lost to Follow-up|0|||
170456596|NCT03502707|616013671|FG009|Overall Study|Lost to Follow-up|2|||
170456597|NCT03502707|616013672|FG010|Overall Study|Lost to Follow-up|1|||
170456598|NCT03502707|616013673|FG011|Overall Study|Lost to Follow-up|2|||
170456599|NCT03502707|616013674|FG012|Overall Study|Lost to Follow-up|1|||
170456600|NCT03502707|616013675|FG013|Overall Study|Lost to Follow-up|1|||
170456601|NCT03502707|616013676|FG014|Overall Study|Lost to Follow-up|0|||
170456602|NCT03502707|616013677|FG015|Overall Study|Lost to Follow-up|4|||
170456603|NCT03502707|616013678|FG016|Overall Study|Lost to Follow-up|9|||
170456604|NCT03502707|616013679|FG017|Overall Study|Lost to Follow-up|2|||
170456605|NCT03502707|616013662|FG000|Overall Study|Physician Decision|0|||
170456606|NCT03502707|616013663|FG001|Overall Study|Physician Decision|0|||
170456607|NCT03502707|616013664|FG002|Overall Study|Physician Decision|0|||
170456608|NCT03502707|616013665|FG003|Overall Study|Physician Decision|0|||
170456609|NCT03502707|616013666|FG004|Overall Study|Physician Decision|0|||
170456610|NCT03502707|616013667|FG005|Overall Study|Physician Decision|0|||
170456611|NCT03502707|616013668|FG006|Overall Study|Physician Decision|0|||
170456612|NCT03502707|616013669|FG007|Overall Study|Physician Decision|0|||
170456613|NCT03502707|616013670|FG008|Overall Study|Physician Decision|2|||
170456614|NCT03502707|616013671|FG009|Overall Study|Physician Decision|1|||
170456615|NCT03502707|616013672|FG010|Overall Study|Physician Decision|0|||
170456616|NCT03502707|616013673|FG011|Overall Study|Physician Decision|0|||
170456617|NCT03502707|616013674|FG012|Overall Study|Physician Decision|0|||
170456618|NCT03502707|616013675|FG013|Overall Study|Physician Decision|0|||
170456619|NCT03502707|616013676|FG014|Overall Study|Physician Decision|1|||
170456620|NCT03502707|616013677|FG015|Overall Study|Physician Decision|3|||
170456621|NCT03502707|616013678|FG016|Overall Study|Physician Decision|0|||
170456622|NCT03502707|616013679|FG017|Overall Study|Physician Decision|0|||
170456623|NCT03502707|616013662|FG000|Overall Study|Protocol Violation|0|||
170456624|NCT03502707|616013663|FG001|Overall Study|Protocol Violation|0|||
170456625|NCT03502707|616013664|FG002|Overall Study|Protocol Violation|0|||
170456626|NCT03502707|616013665|FG003|Overall Study|Protocol Violation|0|||
170456627|NCT03502707|616013666|FG004|Overall Study|Protocol Violation|0|||
170456628|NCT03502707|616013667|FG005|Overall Study|Protocol Violation|0|||
170456629|NCT03502707|616013668|FG006|Overall Study|Protocol Violation|0|||
170456630|NCT03502707|616013669|FG007|Overall Study|Protocol Violation|0|||
170635874|NCT05782179|616678895|FG004|Overall Study|Adverse Event|0|||
170456631|NCT03502707|616013670|FG008|Overall Study|Protocol Violation|0|||
170456632|NCT03502707|616013671|FG009|Overall Study|Protocol Violation|0|||
170456633|NCT03502707|616013672|FG010|Overall Study|Protocol Violation|0|||
170456634|NCT03502707|616013673|FG011|Overall Study|Protocol Violation|0|||
170456635|NCT03502707|616013674|FG012|Overall Study|Protocol Violation|0|||
170456636|NCT03502707|616013675|FG013|Overall Study|Protocol Violation|0|||
170456637|NCT03502707|616013676|FG014|Overall Study|Protocol Violation|0|||
170456638|NCT03502707|616013677|FG015|Overall Study|Protocol Violation|1|||
170456639|NCT03502707|616013678|FG016|Overall Study|Protocol Violation|0|||
170456640|NCT03502707|616013679|FG017|Overall Study|Protocol Violation|0|||
170456641|NCT03502707|616013662|FG000|Overall Study|Withdrawal by Subject|1|||
170456642|NCT03502707|616013663|FG001|Overall Study|Withdrawal by Subject|1|||
170456643|NCT03502707|616013664|FG002|Overall Study|Withdrawal by Subject|0|||
170456644|NCT03502707|616013665|FG003|Overall Study|Withdrawal by Subject|0|||
170456645|NCT03502707|616013666|FG004|Overall Study|Withdrawal by Subject|0|||
170456646|NCT03502707|616013667|FG005|Overall Study|Withdrawal by Subject|2|||
170456647|NCT03502707|616013668|FG006|Overall Study|Withdrawal by Subject|0|||
170456648|NCT03502707|616013669|FG007|Overall Study|Withdrawal by Subject|3|||
170456649|NCT03502707|616013670|FG008|Overall Study|Withdrawal by Subject|1|||
170456650|NCT03502707|616013671|FG009|Overall Study|Withdrawal by Subject|2|||
170456651|NCT03502707|616013672|FG010|Overall Study|Withdrawal by Subject|12|||
170456652|NCT03502707|616013673|FG011|Overall Study|Withdrawal by Subject|23|||
170456653|NCT03502707|616013674|FG012|Overall Study|Withdrawal by Subject|5|||
170889101|NCT00756938|617600618|FG002|Optional Extension|Protocol Violation|0|||
170889102|NCT00756938|617600619|FG003|Optional Extension|Protocol Violation|1|||
170889103|NCT00756938|617600616|FG000|Optional Extension|Withdrawal by Subject|0|||
170456654|NCT03502707|616013675|FG013|Overall Study|Withdrawal by Subject|3|||
170456655|NCT03502707|616013676|FG014|Overall Study|Withdrawal by Subject|3|||
170456656|NCT03502707|616013677|FG015|Overall Study|Withdrawal by Subject|43|||
170456657|NCT03502707|616013678|FG016|Overall Study|Withdrawal by Subject|44|||
170456658|NCT03502707|616013679|FG017|Overall Study|Withdrawal by Subject|18|||
170456659|NCT03502707|616013662|FG000|Overall Study|Sponsor's Decision|1|||
170456660|NCT03502707|616013663|FG001|Overall Study|Sponsor's Decision|0|||
170456661|NCT03502707|616013664|FG002|Overall Study|Sponsor's Decision|0|||
170456662|NCT03502707|616013665|FG003|Overall Study|Sponsor's Decision|0|||
170456663|NCT03502707|616013666|FG004|Overall Study|Sponsor's Decision|0|||
170456664|NCT03502707|616013667|FG005|Overall Study|Sponsor's Decision|0|||
170456665|NCT03502707|616013668|FG006|Overall Study|Sponsor's Decision|0|||
170456666|NCT03502707|616013669|FG007|Overall Study|Sponsor's Decision|0|||
170456667|NCT03502707|616013670|FG008|Overall Study|Sponsor's Decision|0|||
170456668|NCT03502707|616013671|FG009|Overall Study|Sponsor's Decision|1|||
170456669|NCT03502707|616013672|FG010|Overall Study|Sponsor's Decision|0|||
170456670|NCT03502707|616013673|FG011|Overall Study|Sponsor's Decision|0|||
170456671|NCT03502707|616013674|FG012|Overall Study|Sponsor's Decision|0|||
170456672|NCT03502707|616013675|FG013|Overall Study|Sponsor's Decision|0|||
170456673|NCT03502707|616013676|FG014|Overall Study|Sponsor's Decision|0|||
170456674|NCT03502707|616013677|FG015|Overall Study|Sponsor's Decision|2|||
170456675|NCT03502707|616013678|FG016|Overall Study|Sponsor's Decision|1|||
170456676|NCT03502707|616013679|FG017|Overall Study|Sponsor's Decision|0|||
170456677|NCT03502707|616013662|FG000|Overall Study|Initiated Prohibited Medication|0|||
170456678|NCT03502707|616013663|FG001|Overall Study|Initiated Prohibited Medication|0|||
170456679|NCT03502707|616013664|FG002|Overall Study|Initiated Prohibited Medication|0|||
170456680|NCT03502707|616013665|FG003|Overall Study|Initiated Prohibited Medication|0|||
170456681|NCT03502707|616013666|FG004|Overall Study|Initiated Prohibited Medication|0|||
170456682|NCT03502707|616013667|FG005|Overall Study|Initiated Prohibited Medication|0|||
170456683|NCT03502707|616013668|FG006|Overall Study|Initiated Prohibited Medication|0|||
170456684|NCT03502707|616013669|FG007|Overall Study|Initiated Prohibited Medication|0|||
170456685|NCT03502707|616013670|FG008|Overall Study|Initiated Prohibited Medication|0|||
170456686|NCT03502707|616013671|FG009|Overall Study|Initiated Prohibited Medication|0|||
170456687|NCT03502707|616013672|FG010|Overall Study|Initiated Prohibited Medication|0|||
170456688|NCT03502707|616013673|FG011|Overall Study|Initiated Prohibited Medication|0|||
170456689|NCT03502707|616013674|FG012|Overall Study|Initiated Prohibited Medication|0|||
170456690|NCT03502707|616013675|FG013|Overall Study|Initiated Prohibited Medication|0|||
170456691|NCT03502707|616013676|FG014|Overall Study|Initiated Prohibited Medication|0|||
170456692|NCT03502707|616013677|FG015|Overall Study|Initiated Prohibited Medication|0|||
170456693|NCT03502707|616013678|FG016|Overall Study|Initiated Prohibited Medication|1|||
170456694|NCT03502707|616013679|FG017|Overall Study|Initiated Prohibited Medication|0|||
170456695|NCT03502707|616013662|FG000|Overall Study|Other|0|||
170456696|NCT03502707|616013663|FG001|Overall Study|Other|0|||
170456697|NCT03502707|616013664|FG002|Overall Study|Other|0|||
170456698|NCT03502707|616013665|FG003|Overall Study|Other|0|||
170456699|NCT03502707|616013666|FG004|Overall Study|Other|0|||
170456700|NCT03502707|616013667|FG005|Overall Study|Other|0|||
170635875|NCT05782179|616678896|FG005|Overall Study|Adverse Event|0|||
170635876|NCT00241839|616678897|FG000|Overall Study|Withdrawal by Subject|18|||
170635877|NCT00241839|616678898|FG001|Overall Study|Withdrawal by Subject|17|||
170635878|NCT00241839|616678897|FG000|Overall Study|Adverse Event|1|||
170456701|NCT03502707|616013668|FG006|Overall Study|Other|0|||
170456702|NCT03502707|616013669|FG007|Overall Study|Other|0|||
170456703|NCT03502707|616013670|FG008|Overall Study|Other|1|||
170456704|NCT03502707|616013671|FG009|Overall Study|Other|1|||
170456705|NCT03502707|616013672|FG010|Overall Study|Other|2|||
170456706|NCT03502707|616013673|FG011|Overall Study|Other|0|||
170635879|NCT00241839|616678898|FG001|Overall Study|Adverse Event|1|||
170635880|NCT02910986|616678899|FG000|Overall Study|non-Latina|14|||
170635881|NCT02910986|616678900|FG001|Overall Study|non-Latina|13|||
170456707|NCT03502707|616013674|FG012|Overall Study|Other|0|||
170456708|NCT03502707|616013675|FG013|Overall Study|Other|0|||
170456709|NCT03502707|616013676|FG014|Overall Study|Other|0|||
170456710|NCT03502707|616013677|FG015|Overall Study|Other|4|||
170456711|NCT03502707|616013678|FG016|Overall Study|Other|1|||
170456712|NCT03502707|616013679|FG017|Overall Study|Other|0|||
170456713|NCT03502707|616013662|FG000|Overall Study|Randomized but not vaccinated|0|||
170456714|NCT03502707|616013663|FG001|Overall Study|Randomized but not vaccinated|0|||
170456715|NCT03502707|616013664|FG002|Overall Study|Randomized but not vaccinated|0|||
170456716|NCT03502707|616013665|FG003|Overall Study|Randomized but not vaccinated|0|||
170456717|NCT03502707|616013666|FG004|Overall Study|Randomized but not vaccinated|0|||
170456718|NCT03502707|616013667|FG005|Overall Study|Randomized but not vaccinated|0|||
170456719|NCT03502707|616013668|FG006|Overall Study|Randomized but not vaccinated|0|||
170456720|NCT03502707|616013669|FG007|Overall Study|Randomized but not vaccinated|0|||
170456721|NCT03502707|616013670|FG008|Overall Study|Randomized but not vaccinated|0|||
170635882|NCT02910986|616678901|FG002|Overall Study|non-Latina|12|||
170456722|NCT03502707|616013671|FG009|Overall Study|Randomized but not vaccinated|0|||
170635883|NCT02910986|616678899|FG000|Overall Study|Failure to return T! survey|72|||
170456723|NCT03502707|616013672|FG010|Overall Study|Randomized but not vaccinated|0|||
170456724|NCT03502707|616013673|FG011|Overall Study|Randomized but not vaccinated|1|||
170456725|NCT03502707|616013674|FG012|Overall Study|Randomized but not vaccinated|0|||
170456726|NCT03502707|616013675|FG013|Overall Study|Randomized but not vaccinated|0|||
170456727|NCT03502707|616013676|FG014|Overall Study|Randomized but not vaccinated|0|||
170456728|NCT03502707|616013677|FG015|Overall Study|Randomized but not vaccinated|0|||
170456729|NCT03502707|616013678|FG016|Overall Study|Randomized but not vaccinated|0|||
170456730|NCT03502707|616013679|FG017|Overall Study|Randomized but not vaccinated|1|||
170456731|NCT01933113|616013680|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
170456732|NCT02444793|616013685|FG000|Overall Study|Lost to Follow-up|2|||
170456733|NCT02444793|616013686|FG001|Overall Study|Lost to Follow-up|2|||
170787870|NCT01369355|617234168|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
170787871|NCT01369355|617234169|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
170456734|NCT02444793|616013687|FG002|Overall Study|Lost to Follow-up|0|||
170456735|NCT02444793|616013688|FG003|Overall Study|Lost to Follow-up|0|||
170456736|NCT02444793|616013685|FG000|Overall Study|Death|0|||
170456737|NCT02444793|616013686|FG001|Overall Study|Death|3|||
170456738|NCT02444793|616013687|FG002|Overall Study|Death|0|||
170456739|NCT02444793|616013688|FG003|Overall Study|Death|0|||
170456740|NCT02444793|616013685|FG000|Overall Study|Other|0|||
170456741|NCT02444793|616013686|FG001|Overall Study|Other|0|||
170456742|NCT02444793|616013687|FG002|Overall Study|Other|2|||
170456743|NCT02444793|616013688|FG003|Overall Study|Other|0|||
170456744|NCT02444793|616013685|FG000|Overall Study|Objective progression or relapse|9|||
170456745|NCT02444793|616013686|FG001|Overall Study|Objective progression or relapse|1|||
170456746|NCT02444793|616013687|FG002|Overall Study|Objective progression or relapse|2|||
170456747|NCT02444793|616013688|FG003|Overall Study|Objective progression or relapse|3|||
170456748|NCT03222583|616013689|FG000|Overall Study|Withdrawal by Subject|3|||
170456749|NCT03222583|616013690|FG001|Overall Study|Withdrawal by Subject|3|||
170456750|NCT03222583|616013689|FG000|Overall Study|Lost to Follow-up|1|||
170456751|NCT03222583|616013690|FG001|Overall Study|Lost to Follow-up|0|||
170456752|NCT03222583|616013689|FG000|Overall Study|Other|1|||
170456753|NCT03222583|616013690|FG001|Overall Study|Other|3|||
170456754|NCT04280705|616013691|FG000|Overall Study|Enrolled but not treated|4|||
170456755|NCT04280705|616013692|FG001|Overall Study|Enrolled but not treated|10|||
170456756|NCT04280705|616013691|FG000|Overall Study|Physician Decision|1|||
170456757|NCT04280705|616013692|FG001|Overall Study|Physician Decision|0|||
170456758|NCT04280705|616013691|FG000|Overall Study|Withdrawal by Subject|7|||
170456759|NCT04280705|616013692|FG001|Overall Study|Withdrawal by Subject|9|||
170456760|NCT04280705|616013691|FG000|Overall Study|Adverse Event|0|||
170456761|NCT04280705|616013692|FG001|Overall Study|Adverse Event|4|||
170456762|NCT04280705|616013691|FG000|Overall Study|Transferred to another hospital|1|||
170456763|NCT04280705|616013692|FG001|Overall Study|Transferred to another hospital|1|||
170456764|NCT03084367|616013693|FG000|Overall Study|Lost to Follow-up|32|||
170456765|NCT03084367|616013693|FG000|Overall Study|Withdrawal by Subject|4|||
170456766|NCT03084367|616013693|FG000|Overall Study|Other|1|||
170456767|NCT01206101|616013694|FG000|Overall Study|Adverse Event|1|||
170456768|NCT01206101|616013695|FG001|Overall Study|Adverse Event|0|||
170456769|NCT01206101|616013694|FG000|Overall Study|Physician Decision|0|||
170456770|NCT01206101|616013695|FG001|Overall Study|Physician Decision|1|||
170456771|NCT01206101|616013694|FG000|Overall Study|Unclassified|1|||
170456772|NCT01206101|616013695|FG001|Overall Study|Unclassified|0|||
170456773|NCT00368979|616013701|FG000|Overall Study|Adverse Event|9|||
170456774|NCT00368979|616013702|FG001|Overall Study|Adverse Event|16|||
170456775|NCT00368979|616013701|FG000|Overall Study|Lack of Efficacy|5|||
170456776|NCT00368979|616013702|FG001|Overall Study|Lack of Efficacy|3|||
170456777|NCT00368979|616013701|FG000|Overall Study|Other|3|||
170456778|NCT00368979|616013702|FG001|Overall Study|Other|1|||
170456779|NCT00368979|616013701|FG000|Overall Study|Lost to Follow-up|1|||
170456780|NCT00368979|616013702|FG001|Overall Study|Lost to Follow-up|0|||
170456781|NCT00368979|616013701|FG000|Overall Study|Protocol Violation|2|||
170456782|NCT00368979|616013702|FG001|Overall Study|Protocol Violation|1|||
170787872|NCT01369355|617234161|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
170456783|NCT00368979|616013701|FG000|Overall Study|Withdrawal by Subject|5|||
170456784|NCT00368979|616013702|FG001|Overall Study|Withdrawal by Subject|9|||
170456785|NCT00912093|616013703|FG000|The Controlled Phase|Death|0|||
170456786|NCT00912093|616013704|FG001|The Controlled Phase|Death|1|||
170456787|NCT00912093|616013705|FG002|The Controlled Phase|Death|0|||
170456788|NCT00912093|616013706|FG003|The Controlled Phase|Death|0|||
170456789|NCT00912093|616013707|FG004|The Controlled Phase|Death|0|||
170456790|NCT00912093|616013703|FG000|The Controlled Phase|Medical Condition|0|||
170456791|NCT00912093|616013704|FG001|The Controlled Phase|Medical Condition|1|||
170456792|NCT00912093|616013705|FG002|The Controlled Phase|Medical Condition|0|||
170456793|NCT00912093|616013706|FG003|The Controlled Phase|Medical Condition|0|||
170456794|NCT00912093|616013707|FG004|The Controlled Phase|Medical Condition|0|||
170787873|NCT01369355|617234162|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
170787874|NCT01369355|617234163|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
170787875|NCT01369355|617234164|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
170456795|NCT00912093|616013703|FG000|The Controlled Phase|Lost to Follow-up|0|||
170456796|NCT00912093|616013704|FG001|The Controlled Phase|Lost to Follow-up|0|||
170456797|NCT00912093|616013705|FG002|The Controlled Phase|Lost to Follow-up|0|||
170456798|NCT00912093|616013706|FG003|The Controlled Phase|Lost to Follow-up|0|||
170456799|NCT00912093|616013707|FG004|The Controlled Phase|Lost to Follow-up|1|||
170456800|NCT00103311|616013708|FG000|Overall Study|Lost to Follow-up|1|||
170456801|NCT00103311|616013709|FG001|Overall Study|Lost to Follow-up|0|||
170456802|NCT00103311|616013708|FG000|Overall Study|Withdrawal by Subject|2|||
170456803|NCT00103311|616013709|FG001|Overall Study|Withdrawal by Subject|1|||
170456804|NCT00103311|616013708|FG000|Overall Study|Adverse Event|1|||
170456805|NCT00103311|616013709|FG001|Overall Study|Adverse Event|0|||
170456806|NCT03514641|616013713|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
170456807|NCT03514641|616013714|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
170456808|NCT03514641|616013715|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
170456809|NCT03514641|616013716|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
170456810|NCT03514641|616013713|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
170456811|NCT03514641|616013714|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
170456812|NCT03514641|616013715|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
170456813|NCT03514641|616013716|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
170456814|NCT03514641|616013713|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
170456815|NCT03514641|616013714|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
170456816|NCT03514641|616013715|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
170456817|NCT03514641|616013716|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
170456818|NCT03514641|616013713|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
170456819|NCT03514641|616013714|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
170456820|NCT03514641|616013715|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
170456821|NCT03514641|616013716|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
170456822|NCT03514641|616013713|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
170456823|NCT03514641|616013714|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
170456824|NCT03514641|616013715|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
170456825|NCT03514641|616013716|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
170456826|NCT03514641|616013713|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
170456827|NCT03514641|616013714|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
170456828|NCT03514641|616013715|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
170456829|NCT03514641|616013716|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
170456830|NCT03514641|616013713|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
170456831|NCT03514641|616013714|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
170456832|NCT03514641|616013715|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
170456833|NCT03514641|616013716|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
170456834|NCT03514641|616013713|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
170456835|NCT03514641|616013714|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
170456836|NCT03514641|616013715|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
170456837|NCT03514641|616013716|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
170456838|NCT03514641|616013713|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
170456839|NCT03514641|616013714|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
170456840|NCT03514641|616013715|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
170787876|NCT01369355|617234165|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
170456841|NCT03514641|616013716|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
170456842|NCT03514641|616013713|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
170456843|NCT03514641|616013714|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
170456844|NCT03514641|616013715|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
170456845|NCT03514641|616013716|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
170456846|NCT03514641|616013713|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
170456847|NCT03514641|616013714|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
170456848|NCT03514641|616013715|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
170456849|NCT03514641|616013716|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
170456850|NCT03514641|616013713|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
170456851|NCT03514641|616013714|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
170456852|NCT03514641|616013715|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
170456853|NCT03514641|616013716|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
170456854|NCT02981303|616013717|FG000|Overall Study|Progressive Disease|17|||
170456855|NCT02981303|616013718|FG001|Overall Study|Progressive Disease|37|||
170456856|NCT02981303|616013717|FG000|Overall Study|Adverse Event|1|||
170456857|NCT02981303|616013718|FG001|Overall Study|Adverse Event|4|||
170456858|NCT02981303|616013717|FG000|Overall Study|Withdrawal by Subject|0|||
170787877|NCT01369355|617234166|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
170542826|NCT03369223|616331146|FG013|Overall Study|Participant no longer meets study criteria|0|||
170456859|NCT02981303|616013718|FG001|Overall Study|Withdrawal by Subject|1|||
170456860|NCT01259115|616013719|FG000|Period 1|Adverse Event|1|||
170456861|NCT01259115|616013720|FG001|Period 1|Adverse Event|0|||
170456862|NCT01259115|616013719|FG000|Period 1|Protocol Violation|2|||
170456863|NCT01259115|616013720|FG001|Period 1|Protocol Violation|0|||
170456864|NCT01259115|616013719|FG000|Period 1|Lost to Follow-up|0|||
170456865|NCT01259115|616013720|FG001|Period 1|Lost to Follow-up|1|||
170456866|NCT01259115|616013719|FG000|Period 2|Adverse Event|1|||
170456867|NCT01259115|616013720|FG001|Period 2|Adverse Event|0|||
170456868|NCT00848107|616013721|FG000|Overall Study|Lost to Follow-up|2|||
170456869|NCT00848107|616013721|FG000|Overall Study|Withdrawal by Subject|8|||
170456870|NCT00848107|616013721|FG000|Overall Study|Adverse Event|9|||
170456871|NCT00848107|616013721|FG000|Overall Study|Death|1|||
170456872|NCT00848107|616013721|FG000|Overall Study|Pregnancy|1|||
170456873|NCT01831765|616013722|FG000|Overall Study|Lack of Efficacy|1|||
170456874|NCT01831765|616013723|FG001|Overall Study|Lack of Efficacy|0|||
170456875|NCT01831765|616013724|FG002|Overall Study|Lack of Efficacy|0|||
170456876|NCT01831765|616013722|FG000|Overall Study|Other, sponsor withdrew subject|0|||
170456877|NCT01831765|616013723|FG001|Overall Study|Other, sponsor withdrew subject|1|||
170456878|NCT01831765|616013724|FG002|Overall Study|Other, sponsor withdrew subject|0|||
170456879|NCT01831765|616013722|FG000|Overall Study|Pregnancy|1|||
170456880|NCT01831765|616013723|FG001|Overall Study|Pregnancy|1|||
170456881|NCT01831765|616013724|FG002|Overall Study|Pregnancy|2|||
170456882|NCT01831765|616013722|FG000|Overall Study|Death|0|||
170456883|NCT01831765|616013723|FG001|Overall Study|Death|1|||
170456884|NCT01831765|616013724|FG002|Overall Study|Death|1|||
170456885|NCT01831765|616013722|FG000|Overall Study|Other, site closed|1|||
170456886|NCT01831765|616013723|FG001|Overall Study|Other, site closed|1|||
170456887|NCT01831765|616013724|FG002|Overall Study|Other, site closed|0|||
170456888|NCT01831765|616013722|FG000|Overall Study|Adverse Event|5|||
170456889|NCT01831765|616013723|FG001|Overall Study|Adverse Event|3|||
170456890|NCT01831765|616013724|FG002|Overall Study|Adverse Event|3|||
170456891|NCT01831765|616013722|FG000|Overall Study|Withdrawal by Subject|22|||
170456892|NCT01831765|616013723|FG001|Overall Study|Withdrawal by Subject|7|||
170456893|NCT01831765|616013724|FG002|Overall Study|Withdrawal by Subject|17|||
170456894|NCT01831765|616013722|FG000|Overall Study|Withdrawal criteria|12|||
170456895|NCT01831765|616013723|FG001|Overall Study|Withdrawal criteria|10|||
170456896|NCT01831765|616013724|FG002|Overall Study|Withdrawal criteria|16|||
170456897|NCT01831765|616013722|FG000|Overall Study|Lost to Follow-up|2|||
170456898|NCT01831765|616013723|FG001|Overall Study|Lost to Follow-up|3|||
170456899|NCT01831765|616013724|FG002|Overall Study|Lost to Follow-up|3|||
170456900|NCT02605993|616013729|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
170456901|NCT02605993|616013730|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
170456902|NCT02605993|616013731|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
170456903|NCT02605993|616013732|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
170456904|NCT03246126|616013733|FG000|Overall Study|Withdrawal by Subject|0|||
170456905|NCT03246126|616013734|FG001|Overall Study|Withdrawal by Subject|1|||
170456906|NCT01006135|616013737|FG000|Overall Study|Adverse Event|22|||
170456907|NCT01006135|616013737|FG000|Overall Study|Protocol Violation|14|||
170456908|NCT01006135|616013737|FG000|Overall Study|Lost to Follow-up|32|||
170456909|NCT01006135|616013737|FG000|Overall Study|Other|72|||
170787878|NCT01369355|617234167|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
170787879|NCT01369355|617234168|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
170787880|NCT01369355|617234169|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
170456910|NCT00117325|616013738|FG000|Overall Study|Adverse Event|3|||
170456911|NCT00117325|616013739|FG001|Overall Study|Adverse Event|3|||
170456912|NCT00117325|616013738|FG000|Overall Study|Lost to Follow-up|1|||
170456913|NCT00117325|616013739|FG001|Overall Study|Lost to Follow-up|1|||
170456914|NCT00117325|616013738|FG000|Overall Study|Protocol Violation|2|||
170456915|NCT00117325|616013739|FG001|Overall Study|Protocol Violation|3|||
170456916|NCT00117325|616013738|FG000|Overall Study|Withdrawal by Subject|3|||
170456917|NCT00117325|616013739|FG001|Overall Study|Withdrawal by Subject|2|||
170456918|NCT00117325|616013738|FG000|Overall Study|Lack of Efficacy|1|||
170456919|NCT00117325|616013739|FG001|Overall Study|Lack of Efficacy|0|||
170456920|NCT00117325|616013738|FG000|Overall Study|Use of prohibited medicine|1|||
170456921|NCT00117325|616013739|FG001|Overall Study|Use of prohibited medicine|2|||
170456922|NCT00117325|616013738|FG000|Overall Study|Early termination|1|||
170456923|NCT00117325|616013739|FG001|Overall Study|Early termination|1|||
170456924|NCT00117325|616013738|FG000|Overall Study|Admisnitrative|1|||
170456925|NCT00117325|616013739|FG001|Overall Study|Admisnitrative|0|||
170456926|NCT01468818|616013740|FG000|Overall Study|Death during treatment|2|||
170456927|NCT00893737|616013741|FG000|Overall Study|Adverse Event|4|||
170456928|NCT00893737|616013741|FG000|Overall Study|Withdrawal by Subject|2|||
170456929|NCT00893737|616013741|FG000|Overall Study|Lost to Follow-up|6|||
170456930|NCT03981419|616013744|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
170456931|NCT03981419|616013745|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
170787881|NCT01369355|617234161|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
170635884|NCT02910986|616678900|FG001|Overall Study|Failure to return T! survey|84|||
170635885|NCT02910986|616678901|FG002|Overall Study|Failure to return T! survey|72|||
170635886|NCT02910986|616678899|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
170635887|NCT02910986|616678900|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
170635888|NCT02910986|616678901|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
170635889|NCT02910986|616678899|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
170635890|NCT02910986|616678900|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
170635891|NCT02910986|616678901|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
170635892|NCT06170242|616678904|FG000|Overall Study|Lost to Follow-up|0|||
170635893|NCT06170242|616678905|FG001|Overall Study|Lost to Follow-up|0|||
170635894|NCT06170242|616678906|FG002|Overall Study|Lost to Follow-up|1|||
170635895|NCT06170242|616678907|FG003|Overall Study|Lost to Follow-up|1|||
170635896|NCT00927953|616678908|FG000|Overall Study|Death|2|||
170635897|NCT00927953|616678909|FG001|Overall Study|Death|1|||
170635898|NCT02976038|616678910|FG000|Overall Study|Physician Decision|22|||
170635899|NCT02976038|616678910|FG000|Overall Study|Withdrawal by Subject|3|||
170635900|NCT02976038|616678910|FG000|Overall Study|Lost to Follow-up|2|||
170635901|NCT02976038|616678910|FG000|Overall Study|Adverse Event|1|||
170635902|NCT03682770|616678911|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
170635903|NCT03682770|616678912|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
170635904|NCT03682770|616678913|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
170635905|NCT03682770|616678914|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
170635906|NCT03682770|616678915|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
170635907|NCT03682770|616678916|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
170635908|NCT03682770|616678917|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
170635909|NCT03682770|616678911|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
170635910|NCT03682770|616678912|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
170635911|NCT03682770|616678913|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
170635912|NCT03682770|616678914|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
170635913|NCT03682770|616678915|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
170635914|NCT03682770|616678916|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
170635915|NCT03682770|616678917|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
170635916|NCT03682770|616678911|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
170635917|NCT03682770|616678912|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
170635918|NCT03682770|616678913|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
170635919|NCT03682770|616678914|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
170635920|NCT03682770|616678915|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
170635921|NCT03682770|616678916|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
170635922|NCT03682770|616678917|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
170635923|NCT03682770|616678911|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
170635924|NCT03682770|616678912|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
170635925|NCT03682770|616678913|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
170635926|NCT03682770|616678914|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
170635927|NCT03682770|616678915|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
170635928|NCT03682770|616678916|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
170635929|NCT03682770|616678917|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
170635930|NCT03682770|616678911|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
170635931|NCT03682770|616678912|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
170635932|NCT03682770|616678913|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
170635933|NCT03682770|616678914|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
170635934|NCT03682770|616678915|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
170635935|NCT03682770|616678916|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
170635936|NCT03682770|616678917|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
170635937|NCT03682770|616678911|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
170635938|NCT03682770|616678912|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
170635939|NCT03682770|616678913|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
170635940|NCT03682770|616678914|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
170635941|NCT03682770|616678915|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
170635942|NCT03682770|616678916|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
170787882|NCT01369355|617234162|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
170787883|NCT01369355|617234163|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
170787884|NCT01369355|617234164|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
170787885|NCT01369355|617234165|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
170787886|NCT01369355|617234166|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
170787887|NCT01369355|617234167|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
170787888|NCT01369355|617234168|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
170889104|NCT00756938|617600617|FG001|Optional Extension|Withdrawal by Subject|0|||
170889105|NCT00756938|617600618|FG002|Optional Extension|Withdrawal by Subject|0|||
170456932|NCT01330459|616013746|FG000|Overall Study|Physician Decision|0|||
170456933|NCT01330459|616013747|FG001|Overall Study|Physician Decision|2|||
170456934|NCT02272634|616013748|FG000|Overall Study|Adverse Event|1|||
170456935|NCT02272634|616013749|FG001|Overall Study|Adverse Event|0|||
170456936|NCT02272634|616013750|FG002|Overall Study|Adverse Event|0|||
170456937|NCT02272634|616013748|FG000|Overall Study|Protocol Violation|0|||
170456938|NCT02272634|616013749|FG001|Overall Study|Protocol Violation|0|||
170456939|NCT02272634|616013750|FG002|Overall Study|Protocol Violation|1|||
170456940|NCT02272634|616013748|FG000|Overall Study|Withdrawal by Subject|0|||
170456941|NCT02272634|616013749|FG001|Overall Study|Withdrawal by Subject|1|||
170456942|NCT02272634|616013750|FG002|Overall Study|Withdrawal by Subject|0|||
170456943|NCT04620135|616013751|FG000|Study Completion|Adverse Event|2|||
170456944|NCT04620135|616013752|FG001|Study Completion|Adverse Event|3|||
170456945|NCT04620135|616013751|FG000|Study Completion|Withdrawal by Subject|2|||
170456946|NCT04620135|616013752|FG001|Study Completion|Withdrawal by Subject|0|||
170456947|NCT01437943|616013753|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
170456948|NCT01437943|616013754|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
170456949|NCT01437943|616013753|FG000|Overall Study|Subject expressed pregnancy plans|1|||
170456950|NCT01437943|616013754|FG001|Overall Study|Subject expressed pregnancy plans|0|||
170456951|NCT01437943|616013753|FG000|Overall Study|Adverse Event|2|||
170456952|NCT01437943|616013754|FG001|Overall Study|Adverse Event|0|||
170456953|NCT01442688|616013755|FG000|First Intervention|Withdrawal by Subject|1|||
170456954|NCT01442688|616013756|FG001|First Intervention|Withdrawal by Subject|0|||
170456955|NCT01442688|616013755|FG000|First Intervention|subject incarcerated|1|||
170456956|NCT01442688|616013756|FG001|First Intervention|subject incarcerated|0|||
170456957|NCT01442688|616013755|FG000|Second Intervention|Adverse Event|1|||
170456958|NCT01442688|616013756|FG001|Second Intervention|Adverse Event|0|||
170456959|NCT00857259|616013759|FG000|Overall Study|Protocol Violation|1|||
170456960|NCT00857259|616013760|FG001|Overall Study|Protocol Violation|0|||
170456961|NCT00857259|616013761|FG002|Overall Study|Protocol Violation|1|||
170456962|NCT02701413|616013762|FG000|Overall Study|Withdrawal by Subject|7|||
170456963|NCT02701413|616013763|FG001|Overall Study|Withdrawal by Subject|11|||
170456964|NCT02138136|616013764|FG000|Overall Study|Protocol Violation|4|||
170456965|NCT02138136|616013764|FG000|Overall Study|Physician Decision|7|||
170456966|NCT02138136|616013764|FG000|Overall Study|Lack of Efficacy|35|||
170456967|NCT02138136|616013764|FG000|Overall Study|Pregnancy|2|||
170456968|NCT02138136|616013764|FG000|Overall Study|Adverse Event|18|||
170456969|NCT02138136|616013764|FG000|Overall Study|Withdrawal by Subject|36|||
170456970|NCT02138136|616013764|FG000|Overall Study|Lost to Follow-up|32|||
170456971|NCT02138136|616013764|FG000|Overall Study|Withdrawn by Sponsor|5|||
170456972|NCT00311311|616013766|FG000|Overall Study|Adverse Event|3|||
170456973|NCT00311311|616013767|FG001|Overall Study|Adverse Event|2|||
170456974|NCT00311311|616013766|FG000|Overall Study|Withdrawal by Subject|1|||
170456975|NCT00311311|616013767|FG001|Overall Study|Withdrawal by Subject|1|||
170456976|NCT00311311|616013766|FG000|Overall Study|Noncompliance|0|||
170456977|NCT00311311|616013767|FG001|Overall Study|Noncompliance|1|||
170456978|NCT00311311|616013766|FG000|Overall Study|Study Termination by Sponsor|3|||
170456979|NCT00311311|616013767|FG001|Overall Study|Study Termination by Sponsor|4|||
170456980|NCT00311311|616013766|FG000|Overall Study|Death|1|||
170456981|NCT00311311|616013767|FG001|Overall Study|Death|0|||
170456982|NCT00311311|616013766|FG000|Overall Study|Lack of ancillary assistance|0|||
170456983|NCT00311311|616013767|FG001|Overall Study|Lack of ancillary assistance|1|||
170456984|NCT00546572|616013769|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
170456985|NCT00546572|616013770|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
170456986|NCT00546572|616013769|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
170456987|NCT00546572|616013770|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
170456988|NCT00546572|616013769|FG000|Vax 1 / Year 0|Protocol Violation|3|||
170456989|NCT00546572|616013770|FG001|Vax 1 / Year 0|Protocol Violation|4|||
170456990|NCT00546572|616013769|FG000|Vax 1 / Year 0|Death|2|||
170456991|NCT00546572|616013770|FG001|Vax 1 / Year 0|Death|2|||
170456992|NCT00546572|616013769|FG000|Vax 1 / Year 0|Adverse Event|0|||
170456993|NCT00546572|616013770|FG001|Vax 1 / Year 0|Adverse Event|1|||
170456994|NCT00546572|616013769|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
170456995|NCT00546572|616013770|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
170456996|NCT00546572|616013769|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
170456997|NCT00546572|616013770|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
170456998|NCT00546572|616013769|FG000|Vax 2 / Year 1|Other|1|||
170456999|NCT00546572|616013770|FG001|Vax 2 / Year 1|Other|1|||
170457000|NCT00546572|616013769|FG000|Vax 2 / Year 1|Adverse Event|1|||
170457001|NCT00546572|616013770|FG001|Vax 2 / Year 1|Adverse Event|0|||
170457002|NCT00546572|616013769|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
170457003|NCT00546572|616013770|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
170457004|NCT03979820|616013771|FG000|Overall Study|Protocol Violation|1|||
170457005|NCT03979820|616013772|FG001|Overall Study|Protocol Violation|0|||
170457006|NCT03979820|616013773|FG002|Overall Study|Protocol Violation|0|||
170457007|NCT03979820|616013774|FG003|Overall Study|Protocol Violation|0|||
170457008|NCT03979820|616013771|FG000|Overall Study|Withdrawal by Subject|0|||
170457009|NCT03979820|616013772|FG001|Overall Study|Withdrawal by Subject|0|||
170457010|NCT03979820|616013773|FG002|Overall Study|Withdrawal by Subject|1|||
170457011|NCT03979820|616013774|FG003|Overall Study|Withdrawal by Subject|0|||
170457012|NCT03979820|616013771|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
170457013|NCT03979820|616013772|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
170457014|NCT03979820|616013773|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
170457015|NCT03979820|616013774|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
170457016|NCT02685202|616013775|FG000|Overall Study|Lost to Follow-up|9|||
170457017|NCT01229735|616013776|FG000|Overall Study|Lack of Efficacy|8|||
170457018|NCT01229735|616013777|FG001|Overall Study|Lack of Efficacy|8|||
170457019|NCT01229735|616013776|FG000|Overall Study|Protocol Violation|13|||
170457020|NCT01229735|616013777|FG001|Overall Study|Protocol Violation|8|||
170457021|NCT01229735|616013776|FG000|Overall Study|Lost to Follow-up|0|||
170457022|NCT01229735|616013777|FG001|Overall Study|Lost to Follow-up|2|||
170457023|NCT01229735|616013776|FG000|Overall Study|Withdrawal by Subject|18|||
170457024|NCT01229735|616013777|FG001|Overall Study|Withdrawal by Subject|17|||
170457025|NCT01229735|616013776|FG000|Overall Study|Other Reason|13|||
170457026|NCT01229735|616013777|FG001|Overall Study|Other Reason|10|||
170457027|NCT01229735|616013776|FG000|Overall Study|SAE, non-fatal|0|||
170457028|NCT01229735|616013777|FG001|Overall Study|SAE, non-fatal|4|||
170457029|NCT01229735|616013776|FG000|Overall Study|AE, non-serious non-fatal|13|||
170457030|NCT01229735|616013777|FG001|Overall Study|AE, non-serious non-fatal|17|||
170457031|NCT01229735|616013776|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
170457032|NCT01229735|616013777|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
170457033|NCT02130882|616013778|FG000|Overall Study|Withdrawal by Subject|0|||
170457034|NCT02130882|616013779|FG001|Overall Study|Withdrawal by Subject|1|||
170457035|NCT00536263|616013784|FG000|Overall Study|Adverse Event|5|||
170457036|NCT00536263|616013785|FG001|Overall Study|Adverse Event|5|||
170457037|NCT00536263|616013786|FG002|Overall Study|Adverse Event|7|||
170457038|NCT00536263|616013784|FG000|Overall Study|Lost to Follow-up|3|||
170457039|NCT00536263|616013785|FG001|Overall Study|Lost to Follow-up|4|||
170457040|NCT00536263|616013786|FG002|Overall Study|Lost to Follow-up|4|||
170457041|NCT00536263|616013784|FG000|Overall Study|Subject withdrew - not treatment related|2|||
170457042|NCT00536263|616013785|FG001|Overall Study|Subject withdrew - not treatment related|0|||
170457043|NCT00536263|616013786|FG002|Overall Study|Subject withdrew - not treatment related|5|||
170457044|NCT00536263|616013784|FG000|Overall Study|Subject withdrew - treatment related|0|||
170457045|NCT00536263|616013785|FG001|Overall Study|Subject withdrew - treatment related|3|||
170457046|NCT00536263|616013786|FG002|Overall Study|Subject withdrew - treatment related|2|||
170457047|NCT00536263|616013784|FG000|Overall Study|Noncompliance with protocol|0|||
170457048|NCT00536263|616013785|FG001|Overall Study|Noncompliance with protocol|0|||
170457049|NCT00536263|616013786|FG002|Overall Study|Noncompliance with protocol|1|||
170457050|NCT00536263|616013784|FG000|Overall Study|Did not meet protocol eligibility|1|||
170457051|NCT00536263|616013785|FG001|Overall Study|Did not meet protocol eligibility|2|||
170457052|NCT00536263|616013786|FG002|Overall Study|Did not meet protocol eligibility|2|||
170457053|NCT00160641|616013800|FG000|Overall Study|Adverse Event|102|||
170457054|NCT00160641|616013800|FG000|Overall Study|Withdrawal by Subject|87|||
170457055|NCT00160641|616013800|FG000|Overall Study|Lost to Follow-up|8|||
170457056|NCT00160641|616013800|FG000|Overall Study|Lack of Efficacy|12|||
170457057|NCT00160641|616013800|FG000|Overall Study|Protocol Violation|3|||
170457058|NCT00160641|616013800|FG000|Overall Study|Other|9|||
170457059|NCT00985712|616013805|FG000|Overall Study|Adverse Event|0|||
170457060|NCT00985712|616013806|FG001|Overall Study|Adverse Event|1|||
170457061|NCT00985712|616013805|FG000|Overall Study|Lost to Follow-up|2|||
170457062|NCT00985712|616013806|FG001|Overall Study|Lost to Follow-up|2|||
170457063|NCT00985712|616013805|FG000|Overall Study|Protocol Violation|0|||
170457064|NCT00985712|616013806|FG001|Overall Study|Protocol Violation|1|||
170457065|NCT00985712|616013805|FG000|Overall Study|Withdrawal by Subject|4|||
170457066|NCT00985712|616013806|FG001|Overall Study|Withdrawal by Subject|1|||
170457067|NCT00985712|616013805|FG000|Overall Study|Sponsor decision|0|||
170457068|NCT00985712|616013806|FG001|Overall Study|Sponsor decision|2|||
170457069|NCT00058214|616013807|FG000|Overall Study|Adverse Event|1|||
170457070|NCT01640873|616013808|FG000|Overall Study|Protocol Violation|2|||
170457071|NCT01640873|616013809|FG001|Overall Study|Protocol Violation|1|||
170457072|NCT04700280|616013812|FG000|Overall Study|Adverse Event|4|||
170457073|NCT04700280|616013813|FG001|Overall Study|Adverse Event|0|||
170889106|NCT00756938|617600619|FG003|Optional Extension|Withdrawal by Subject|10|||
170457074|NCT04700280|616013812|FG000|Overall Study|Lack of Efficacy|1|||
170457075|NCT04700280|616013813|FG001|Overall Study|Lack of Efficacy|0|||
170457076|NCT04700280|616013812|FG000|Overall Study|Study terminated by sponsor|5|||
170457077|NCT04700280|616013813|FG001|Overall Study|Study terminated by sponsor|3|||
170457078|NCT04700280|616013812|FG000|Overall Study|Other than specified|1|||
170457079|NCT04700280|616013813|FG001|Overall Study|Other than specified|0|||
170457080|NCT02749292|616013814|FG000|Overall Study|Physician Decision|1|||
170457081|NCT02749292|616013815|FG001|Overall Study|Physician Decision|0|||
170457082|NCT02749292|616013814|FG000|Overall Study|Withdrawal by Subject|5|||
170457083|NCT02749292|616013815|FG001|Overall Study|Withdrawal by Subject|7|||
170457084|NCT02749292|616013814|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
170457085|NCT02749292|616013815|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
170457086|NCT02749292|616013814|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
170457087|NCT02749292|616013815|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
170457088|NCT02749292|616013814|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
170457089|NCT02749292|616013815|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
170457090|NCT02749292|616013814|FG000|Overall Study|Adverse Event|4|||
170457091|NCT02749292|616013815|FG001|Overall Study|Adverse Event|1|||
170457092|NCT02749292|616013814|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
170457093|NCT02749292|616013815|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
170457094|NCT02749292|616013814|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
170457095|NCT02749292|616013815|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
170457096|NCT02749292|616013814|FG000|Overall Study|Requiring glucocorticoids|0|||
170457097|NCT02749292|616013815|FG001|Overall Study|Requiring glucocorticoids|3|||
170457098|NCT02749292|616013814|FG000|Overall Study|Cancer|1|||
170457099|NCT02749292|616013815|FG001|Overall Study|Cancer|0|||
170457100|NCT00257920|616013816|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
170457101|NCT00257920|616013817|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
170457102|NCT00257920|616013816|FG000|Period: Second Intervention|Other|2|||
170457103|NCT00257920|616013817|FG001|Period: Second Intervention|Other|1|||
170457104|NCT00770692|616013818|FG000|Overall Study|Withdrawal by Subject|7|||
170457105|NCT00770692|616013819|FG001|Overall Study|Withdrawal by Subject|9|||
170457106|NCT00770692|616013820|FG002|Overall Study|Withdrawal by Subject|9|||
170457107|NCT00770692|616013821|FG003|Overall Study|Withdrawal by Subject|6|||
170457108|NCT00770692|616013818|FG000|Overall Study|Adverse Event|3|||
170457109|NCT00770692|616013819|FG001|Overall Study|Adverse Event|0|||
170457110|NCT00770692|616013820|FG002|Overall Study|Adverse Event|4|||
170457111|NCT00770692|616013821|FG003|Overall Study|Adverse Event|4|||
170457112|NCT00770692|616013818|FG000|Overall Study|Investigator judgment|2|||
170457113|NCT00770692|616013819|FG001|Overall Study|Investigator judgment|0|||
170457114|NCT00770692|616013820|FG002|Overall Study|Investigator judgment|1|||
170457115|NCT00770692|616013821|FG003|Overall Study|Investigator judgment|1|||
170457116|NCT00725621|616013822|FG000|Overall Study|Adverse Event|25|||
170457117|NCT00725621|616013822|FG000|Overall Study|Lack of Efficacy|46|||
170457118|NCT00725621|616013822|FG000|Overall Study|Withdrawal by Subject|57|||
170457119|NCT00725621|616013822|FG000|Overall Study|Physician Decision|19|||
170457120|NCT00725621|616013822|FG000|Overall Study|Lost to Follow-up|52|||
170457121|NCT00725621|616013822|FG000|Overall Study|Non-compliance|8|||
170457122|NCT00725621|616013822|FG000|Overall Study|Continued treatment by other physician|6|||
170457123|NCT00725621|616013822|FG000|Overall Study|Switched to other study|1|||
170457124|NCT00725621|616013822|FG000|Overall Study|Switched to other drug|1|||
170457125|NCT00725621|616013822|FG000|Overall Study|Prepared for elective surgery|1|||
170457126|NCT00725621|616013822|FG000|Overall Study|Reason not specified|55|||
170457127|NCT01189500|616013823|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
170457128|NCT01189500|616013823|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
170457129|NCT03629028|616013824|FG000|Overall Study|Lost to Follow-up|26|||
170457130|NCT03629028|616013825|FG001|Overall Study|Lost to Follow-up|23|||
170457131|NCT03629028|616013824|FG000|Overall Study|Pregnancy|4|||
170457132|NCT03629028|616013825|FG001|Overall Study|Pregnancy|2|||
170457133|NCT03629028|616013824|FG000|Overall Study|intolerance to examination|2|||
170457134|NCT03629028|616013825|FG001|Overall Study|intolerance to examination|0|||
170457135|NCT01301508|616013828|FG000|Overall Study|Withdrawal by Subject|1|||
170457136|NCT01301508|616013829|FG001|Overall Study|Withdrawal by Subject|2|||
170457137|NCT01301508|616013828|FG000|Overall Study|Lost to Follow-up|0|||
170457138|NCT01301508|616013829|FG001|Overall Study|Lost to Follow-up|1|||
170457139|NCT04092894|616016023|FG000|Overall Study|Withdrawal by Subject|2|||
170457140|NCT04092894|616016024|FG001|Overall Study|Withdrawal by Subject|4|||
170457141|NCT04092894|616016023|FG000|Overall Study|Discontinued EEG after randomization|10|||
170457142|NCT04092894|616016024|FG001|Overall Study|Discontinued EEG after randomization|6|||
170457143|NCT01106014|616016025|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
170457144|NCT01106014|616016026|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
170457145|NCT01106014|616016025|FG000|Overall Study|Adverse Event|78|||
170889107|NCT00756938|617600616|FG000|Optional Extension|Adverse Event|0|||
170457146|NCT01106014|616016026|FG001|Overall Study|Adverse Event|42|||
170457147|NCT01106014|616016025|FG000|Overall Study|Withdrawal by Subject|43|||
170457148|NCT01106014|616016026|FG001|Overall Study|Withdrawal by Subject|37|||
170457149|NCT01106014|616016025|FG000|Overall Study|Administrative reason|7|||
170457150|NCT01106014|616016026|FG001|Overall Study|Administrative reason|6|||
170457151|NCT01106014|616016025|FG000|Overall Study|Lost to Follow-up|2|||
170457152|NCT01106014|616016026|FG001|Overall Study|Lost to Follow-up|3|||
170457153|NCT02935686|616016027|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
170457154|NCT02935686|616016028|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
170457155|NCT02935686|616016029|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
170457156|NCT02935686|616016030|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
170542827|NCT03369223|616331147|FG014|Overall Study|Participant no longer meets study criteria|2|||
170542828|NCT03369223|616331148|FG015|Overall Study|Participant no longer meets study criteria|0|||
170542829|NCT03369223|616331149|FG016|Overall Study|Participant no longer meets study criteria|2|||
170542830|NCT03369223|616331150|FG017|Overall Study|Participant no longer meets study criteria|0|||
170542831|NCT03369223|616331151|FG018|Overall Study|Participant no longer meets study criteria|0|||
170542832|NCT03369223|616331152|FG019|Overall Study|Participant no longer meets study criteria|0|||
170542833|NCT03369223|616331133|FG000|Overall Study|Other reasons|0|||
170542834|NCT03369223|616331134|FG001|Overall Study|Other reasons|0|||
170542835|NCT03369223|616331135|FG002|Overall Study|Other reasons|0|||
170542836|NCT03369223|616331136|FG003|Overall Study|Other reasons|0|||
170542837|NCT03369223|616331137|FG004|Overall Study|Other reasons|0|||
170542838|NCT03369223|616331138|FG005|Overall Study|Other reasons|0|||
170542839|NCT03369223|616331139|FG006|Overall Study|Other reasons|0|||
170542840|NCT03369223|616331140|FG007|Overall Study|Other reasons|0|||
170542841|NCT03369223|616331141|FG008|Overall Study|Other reasons|0|||
170542842|NCT03369223|616331142|FG009|Overall Study|Other reasons|0|||
170542843|NCT03369223|616331143|FG010|Overall Study|Other reasons|0|||
170542844|NCT03369223|616331144|FG011|Overall Study|Other reasons|0|||
170542845|NCT03369223|616331145|FG012|Overall Study|Other reasons|0|||
170542846|NCT03369223|616331146|FG013|Overall Study|Other reasons|1|||
170542847|NCT03369223|616331147|FG014|Overall Study|Other reasons|2|||
170542848|NCT03369223|616331148|FG015|Overall Study|Other reasons|0|||
170542849|NCT03369223|616331149|FG016|Overall Study|Other reasons|1|||
170542850|NCT03369223|616331150|FG017|Overall Study|Other reasons|0|||
170542851|NCT03369223|616331151|FG018|Overall Study|Other reasons|0|||
170542852|NCT03369223|616331152|FG019|Overall Study|Other reasons|2|||
170542853|NCT03369223|616331133|FG000|Overall Study|Death|0|||
170542854|NCT03369223|616331134|FG001|Overall Study|Death|0|||
170542855|NCT03369223|616331135|FG002|Overall Study|Death|0|||
170542856|NCT03369223|616331136|FG003|Overall Study|Death|0|||
170542857|NCT03369223|616331137|FG004|Overall Study|Death|0|||
170542858|NCT03369223|616331138|FG005|Overall Study|Death|0|||
170542859|NCT03369223|616331139|FG006|Overall Study|Death|0|||
170542860|NCT03369223|616331140|FG007|Overall Study|Death|0|||
170542861|NCT03369223|616331141|FG008|Overall Study|Death|0|||
170542862|NCT03369223|616331142|FG009|Overall Study|Death|0|||
170542863|NCT03369223|616331143|FG010|Overall Study|Death|0|||
170542864|NCT03369223|616331144|FG011|Overall Study|Death|0|||
170542865|NCT03369223|616331145|FG012|Overall Study|Death|0|||
170542866|NCT03369223|616331146|FG013|Overall Study|Death|1|||
170542867|NCT03369223|616331147|FG014|Overall Study|Death|0|||
170542868|NCT03369223|616331148|FG015|Overall Study|Death|0|||
170542869|NCT03369223|616331149|FG016|Overall Study|Death|0|||
170542870|NCT03369223|616331150|FG017|Overall Study|Death|0|||
170542871|NCT03369223|616331151|FG018|Overall Study|Death|1|||
170542872|NCT03369223|616331152|FG019|Overall Study|Death|0|||
170542873|NCT03369223|616331133|FG000|Overall Study|Adverse event unrelated to study drug|0|||
170542874|NCT03369223|616331134|FG001|Overall Study|Adverse event unrelated to study drug|0|||
170542875|NCT03369223|616331135|FG002|Overall Study|Adverse event unrelated to study drug|0|||
170889108|NCT00756938|617600617|FG001|Optional Extension|Adverse Event|0|||
170889109|NCT00756938|617600618|FG002|Optional Extension|Adverse Event|0|||
170889110|NCT00756938|617600619|FG003|Optional Extension|Adverse Event|1|||
170542876|NCT03369223|616331136|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170542877|NCT03369223|616331137|FG004|Overall Study|Adverse event unrelated to study drug|0|||
170889111|NCT00094055|617600620|FG000|Overall Study|Adverse Event|11|||
170889112|NCT00094055|617600620|FG000|Overall Study|Death|4|||
170889113|NCT00094055|617600620|FG000|Overall Study|Lack of Efficacy|17|||
170889114|NCT00094055|617600620|FG000|Overall Study|Lost to Follow-up|2|||
170889115|NCT00094055|617600620|FG000|Overall Study|progressive disease|2|||
170889116|NCT00094055|617600620|FG000|Overall Study|clinical progression|1|||
170542878|NCT03369223|616331138|FG005|Overall Study|Adverse event unrelated to study drug|0|||
170542879|NCT03369223|616331139|FG006|Overall Study|Adverse event unrelated to study drug|1|||
170542880|NCT03369223|616331140|FG007|Overall Study|Adverse event unrelated to study drug|0|||
170457157|NCT02935686|616016031|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
170457158|NCT02935686|616016027|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
170457159|NCT02935686|616016028|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
170635943|NCT03682770|616678917|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
170635944|NCT03682770|616678911|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
170457160|NCT02935686|616016029|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
170635945|NCT03682770|616678912|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
170457161|NCT02935686|616016030|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
170457162|NCT02935686|616016031|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
170457163|NCT02935686|616016027|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
170635946|NCT03682770|616678913|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
170635947|NCT03682770|616678914|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
170635948|NCT03682770|616678915|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
170635949|NCT03682770|616678916|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
170635950|NCT03682770|616678917|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
170457164|NCT02935686|616016028|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
170457165|NCT02935686|616016029|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
170457166|NCT02935686|616016030|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
170457167|NCT02935686|616016031|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
170457168|NCT02935686|616016027|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
170457169|NCT02935686|616016028|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
170457170|NCT02935686|616016029|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
170457171|NCT02935686|616016030|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
170457172|NCT02935686|616016031|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
170457173|NCT02935686|616016027|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
170457174|NCT02935686|616016028|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
170457175|NCT02935686|616016029|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
170457176|NCT02935686|616016030|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
170457177|NCT02935686|616016031|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
170457178|NCT02935686|616016027|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
170457179|NCT02935686|616016028|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
170457180|NCT02935686|616016029|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
170457181|NCT02935686|616016030|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
170457182|NCT02935686|616016031|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
170457183|NCT02935686|616016027|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
170457184|NCT02935686|616016028|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
170457185|NCT02935686|616016029|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
170457186|NCT02935686|616016030|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
170457187|NCT02935686|616016031|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
170457188|NCT02935686|616016027|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
170457189|NCT02935686|616016028|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
170457190|NCT02935686|616016029|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
170457191|NCT02935686|616016030|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
170457192|NCT02935686|616016031|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
170457193|NCT02935686|616016027|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
170457194|NCT02935686|616016028|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
170457195|NCT02935686|616016029|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
170457196|NCT02935686|616016030|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
170457197|NCT02935686|616016031|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
170457198|NCT02935686|616016027|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
170457199|NCT02935686|616016028|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
170457200|NCT02935686|616016029|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
170457201|NCT02935686|616016030|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
170457202|NCT02935686|616016031|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
170457203|NCT02935686|616016027|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
170457204|NCT02935686|616016028|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
170457205|NCT02935686|616016029|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
170457206|NCT02935686|616016030|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
170457207|NCT02935686|616016031|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
170457208|NCT02128217|616016034|FG000|Overall Study|Lost to Follow-up|0|||
170457209|NCT02128217|616016035|FG001|Overall Study|Lost to Follow-up|1|||
170457210|NCT05071313|616016036|FG000|Overall Study|Lost to Follow-up|17|||
170457211|NCT05071313|616016037|FG001|Overall Study|Lost to Follow-up|10|||
170457212|NCT05071313|616016036|FG000|Overall Study|Physician Decision|1|||
170457213|NCT05071313|616016037|FG001|Overall Study|Physician Decision|6|||
170457214|NCT05071313|616016036|FG000|Overall Study|Death|1|||
170457215|NCT05071313|616016037|FG001|Overall Study|Death|0|||
170457216|NCT05071313|616016036|FG000|Overall Study|Withdrawal by Subject|10|||
170457217|NCT05071313|616016037|FG001|Overall Study|Withdrawal by Subject|15|||
170457218|NCT05071313|616016036|FG000|Overall Study|Other|1|||
170457219|NCT05071313|616016037|FG001|Overall Study|Other|0|||
170457220|NCT05071313|616016036|FG000|Overall Study|Randomized but not vaccinated|4|||
170457221|NCT05071313|616016037|FG001|Overall Study|Randomized but not vaccinated|2|||
170457222|NCT00541970|616016038|FG000|Month 7|Protocol Violation|9|||
170457223|NCT00541970|616016039|FG001|Month 7|Protocol Violation|13|||
170457224|NCT00541970|616016040|FG002|Month 7|Protocol Violation|11|||
170457225|NCT00541970|616016041|FG003|Month 7|Protocol Violation|5|||
170457226|NCT00541970|616016038|FG000|Month 12|Adverse Event|0|||
170457227|NCT00541970|616016039|FG001|Month 12|Adverse Event|1|||
170457228|NCT00541970|616016040|FG002|Month 12|Adverse Event|1|||
170457229|NCT00541970|616016041|FG003|Month 12|Adverse Event|1|||
170457230|NCT00541970|616016038|FG000|Month 12|Protocol Violation|12|||
170457231|NCT00541970|616016039|FG001|Month 12|Protocol Violation|21|||
170457232|NCT00541970|616016040|FG002|Month 12|Protocol Violation|20|||
170457233|NCT00541970|616016041|FG003|Month 12|Protocol Violation|15|||
170457234|NCT00541970|616016038|FG000|Month 18|Adverse Event|0|||
170457235|NCT00541970|616016039|FG001|Month 18|Adverse Event|1|||
170635951|NCT03682770|616678911|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
170457236|NCT00541970|616016040|FG002|Month 18|Adverse Event|1|||
170457237|NCT00541970|616016041|FG003|Month 18|Adverse Event|1|||
170457238|NCT00541970|616016038|FG000|Month 18|Protocol Violation|14|||
170457239|NCT00541970|616016039|FG001|Month 18|Protocol Violation|23|||
170457240|NCT00541970|616016040|FG002|Month 18|Protocol Violation|24|||
170457241|NCT00541970|616016041|FG003|Month 18|Protocol Violation|16|||
170457242|NCT00541970|616016038|FG000|Month 24|Adverse Event|0|||
170457243|NCT00541970|616016039|FG001|Month 24|Adverse Event|1|||
170457244|NCT00541970|616016040|FG002|Month 24|Adverse Event|1|||
170635952|NCT03682770|616678912|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
170457245|NCT00541970|616016041|FG003|Month 24|Adverse Event|1|||
170457246|NCT00541970|616016038|FG000|Month 24|Protocol Violation|29|||
170457247|NCT00541970|616016039|FG001|Month 24|Protocol Violation|31|||
170457248|NCT00541970|616016040|FG002|Month 24|Protocol Violation|31|||
170457249|NCT00541970|616016041|FG003|Month 24|Protocol Violation|21|||
170457250|NCT00541970|616016038|FG000|Month 36|Protocol Violation|61|||
170457251|NCT00541970|616016039|FG001|Month 36|Protocol Violation|66|||
170457252|NCT00541970|616016040|FG002|Month 36|Protocol Violation|66|||
170457253|NCT00541970|616016041|FG003|Month 36|Protocol Violation|60|||
170457254|NCT00541970|616016038|FG000|Month 48|Withdrawal by Subject|2|||
170457255|NCT00541970|616016039|FG001|Month 48|Withdrawal by Subject|4|||
170457256|NCT00541970|616016040|FG002|Month 48|Withdrawal by Subject|4|||
170457257|NCT00541970|616016041|FG003|Month 48|Withdrawal by Subject|2|||
170635953|NCT03682770|616678913|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
170635954|NCT03682770|616678914|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
170787889|NCT01369355|617234169|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
170787890|NCT01369355|617234161|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
170457258|NCT00541970|616016038|FG000|Month 48|Other|3|||
170457259|NCT00541970|616016039|FG001|Month 48|Other|1|||
170457260|NCT00541970|616016040|FG002|Month 48|Other|1|||
170457261|NCT00541970|616016041|FG003|Month 48|Other|0|||
170457262|NCT00541970|616016038|FG000|Month 48|Lost to Follow-up|66|||
170457263|NCT00541970|616016039|FG001|Month 48|Lost to Follow-up|68|||
170457264|NCT00541970|616016040|FG002|Month 48|Lost to Follow-up|68|||
170457265|NCT00541970|616016041|FG003|Month 48|Lost to Follow-up|73|||
170457266|NCT00541970|616016038|FG000|Month 60|Protocol Violation|78|||
170457267|NCT00541970|616016039|FG001|Month 60|Protocol Violation|77|||
170457268|NCT00541970|616016040|FG002|Month 60|Protocol Violation|82|||
170457269|NCT00541970|616016041|FG003|Month 60|Protocol Violation|72|||
170457270|NCT03107026|616016042|FG000|Overall Study|Adverse Event|2|||
170457271|NCT03107026|616016043|FG001|Overall Study|Adverse Event|14|||
170457272|NCT03107026|616016044|FG002|Overall Study|Adverse Event|23|||
170457273|NCT03107026|616016042|FG000|Overall Study|Lost to Follow-up|12|||
170457274|NCT03107026|616016043|FG001|Overall Study|Lost to Follow-up|12|||
170457275|NCT03107026|616016044|FG002|Overall Study|Lost to Follow-up|13|||
170457276|NCT03107026|616016042|FG000|Overall Study|Protocol Violation|1|||
170457277|NCT03107026|616016043|FG001|Overall Study|Protocol Violation|2|||
170787891|NCT01369355|617234162|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
170457278|NCT03107026|616016044|FG002|Overall Study|Protocol Violation|0|||
170457279|NCT03107026|616016042|FG000|Overall Study|Pregnancy|1|||
170457280|NCT03107026|616016043|FG001|Overall Study|Pregnancy|0|||
170457281|NCT03107026|616016044|FG002|Overall Study|Pregnancy|0|||
170457282|NCT03107026|616016042|FG000|Overall Study|Withdrawal by Subject|13|||
170457283|NCT03107026|616016043|FG001|Overall Study|Withdrawal by Subject|5|||
170457284|NCT03107026|616016044|FG002|Overall Study|Withdrawal by Subject|17|||
170457285|NCT03107026|616016042|FG000|Overall Study|non compliance with study visits|1|||
170457286|NCT03107026|616016043|FG001|Overall Study|non compliance with study visits|2|||
170457287|NCT03107026|616016044|FG002|Overall Study|non compliance with study visits|0|||
170635955|NCT03682770|616678915|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
170635956|NCT03682770|616678916|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
170457288|NCT03107026|616016042|FG000|Overall Study|non-compliance with study drug|2|||
170457289|NCT03107026|616016043|FG001|Overall Study|non-compliance with study drug|2|||
170457290|NCT03107026|616016044|FG002|Overall Study|non-compliance with study drug|3|||
170457291|NCT03107026|616016042|FG000|Overall Study|Physician Decision|0|||
170457292|NCT03107026|616016043|FG001|Overall Study|Physician Decision|1|||
170457293|NCT03107026|616016044|FG002|Overall Study|Physician Decision|0|||
170457294|NCT01183221|616016047|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
170457295|NCT01183221|616016048|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
170457296|NCT00807248|616016049|FG000|Overall Study|Adverse Event|1|||
170457297|NCT00807248|616016050|FG001|Overall Study|Adverse Event|2|||
170457298|NCT00807248|616016051|FG002|Overall Study|Adverse Event|2|||
170457299|NCT00807248|616016052|FG003|Overall Study|Adverse Event|6|||
170457300|NCT00807248|616016049|FG000|Overall Study|Lack of Efficacy|14|||
170457301|NCT00807248|616016050|FG001|Overall Study|Lack of Efficacy|4|||
170457302|NCT00807248|616016051|FG002|Overall Study|Lack of Efficacy|8|||
170457303|NCT00807248|616016052|FG003|Overall Study|Lack of Efficacy|3|||
170457304|NCT00807248|616016049|FG000|Overall Study|Protocol Violation|0|||
170457305|NCT00807248|616016050|FG001|Overall Study|Protocol Violation|1|||
170457306|NCT00807248|616016051|FG002|Overall Study|Protocol Violation|1|||
170457307|NCT00807248|616016052|FG003|Overall Study|Protocol Violation|0|||
170457308|NCT00807248|616016049|FG000|Overall Study|Withdrawal of Consent|5|||
170457309|NCT00807248|616016050|FG001|Overall Study|Withdrawal of Consent|5|||
170457310|NCT00807248|616016051|FG002|Overall Study|Withdrawal of Consent|5|||
170457311|NCT00807248|616016052|FG003|Overall Study|Withdrawal of Consent|5|||
170457312|NCT00807248|616016049|FG000|Overall Study|Lost to Follow-up|1|||
170457313|NCT00807248|616016050|FG001|Overall Study|Lost to Follow-up|0|||
170457314|NCT00807248|616016051|FG002|Overall Study|Lost to Follow-up|0|||
170457315|NCT00807248|616016052|FG003|Overall Study|Lost to Follow-up|0|||
170457316|NCT00807248|616016049|FG000|Overall Study|Other Reason|0|||
170457317|NCT00807248|616016050|FG001|Overall Study|Other Reason|0|||
170457318|NCT00807248|616016051|FG002|Overall Study|Other Reason|2|||
170457319|NCT00807248|616016052|FG003|Overall Study|Other Reason|0|||
170457320|NCT02504671|616016055|FG000|Overall Study|Withdrawal by Subject|1|||
170457321|NCT02504671|616016056|FG001|Overall Study|Withdrawal by Subject|5|||
170457322|NCT02504671|616016057|FG002|Overall Study|Withdrawal by Subject|4|||
170457323|NCT02504671|616016058|FG003|Overall Study|Withdrawal by Subject|4|||
170457324|NCT02504671|616016059|FG004|Overall Study|Withdrawal by Subject|5|||
170457325|NCT02504671|616016060|FG005|Overall Study|Withdrawal by Subject|3|||
170457326|NCT02504671|616016055|FG000|Overall Study|Lack of Efficacy|1|||
170457327|NCT02504671|616016056|FG001|Overall Study|Lack of Efficacy|3|||
170457328|NCT02504671|616016057|FG002|Overall Study|Lack of Efficacy|1|||
170457329|NCT02504671|616016058|FG003|Overall Study|Lack of Efficacy|0|||
170457330|NCT02504671|616016059|FG004|Overall Study|Lack of Efficacy|4|||
170457331|NCT02504671|616016060|FG005|Overall Study|Lack of Efficacy|4|||
170457332|NCT02504671|616016055|FG000|Overall Study|Adverse Event|1|||
170457333|NCT02504671|616016056|FG001|Overall Study|Adverse Event|1|||
170457334|NCT02504671|616016057|FG002|Overall Study|Adverse Event|0|||
170457335|NCT02504671|616016058|FG003|Overall Study|Adverse Event|1|||
170457336|NCT02504671|616016059|FG004|Overall Study|Adverse Event|0|||
170457337|NCT02504671|616016060|FG005|Overall Study|Adverse Event|2|||
170457338|NCT02504671|616016055|FG000|Overall Study|Protocol Violation|2|||
170457339|NCT02504671|616016056|FG001|Overall Study|Protocol Violation|1|||
170457340|NCT02504671|616016057|FG002|Overall Study|Protocol Violation|0|||
170457341|NCT02504671|616016058|FG003|Overall Study|Protocol Violation|0|||
170457342|NCT02504671|616016059|FG004|Overall Study|Protocol Violation|0|||
170457343|NCT02504671|616016060|FG005|Overall Study|Protocol Violation|1|||
170457344|NCT02504671|616016055|FG000|Overall Study|Lost to Follow-up|0|||
170457345|NCT02504671|616016056|FG001|Overall Study|Lost to Follow-up|0|||
170457346|NCT02504671|616016057|FG002|Overall Study|Lost to Follow-up|2|||
170457347|NCT02504671|616016058|FG003|Overall Study|Lost to Follow-up|0|||
170457348|NCT02504671|616016059|FG004|Overall Study|Lost to Follow-up|0|||
170457349|NCT02504671|616016060|FG005|Overall Study|Lost to Follow-up|1|||
170457350|NCT02504671|616016055|FG000|Overall Study|Protocol defined stopping criteria|7|||
170457351|NCT02504671|616016056|FG001|Overall Study|Protocol defined stopping criteria|4|||
170457352|NCT02504671|616016057|FG002|Overall Study|Protocol defined stopping criteria|3|||
170457353|NCT02504671|616016058|FG003|Overall Study|Protocol defined stopping criteria|5|||
170457354|NCT02504671|616016059|FG004|Overall Study|Protocol defined stopping criteria|3|||
170457355|NCT02504671|616016060|FG005|Overall Study|Protocol defined stopping criteria|3|||
170457356|NCT00210249|616016061|FG000|Overall Study|Lost to Follow-up|5|||
170457357|NCT00210249|616016061|FG000|Overall Study|Protocol Violation|11|||
170457358|NCT01687478|616016064|FG000|Overall Study|Adverse Event|3|||
170457359|NCT01687478|616016065|FG001|Overall Study|Adverse Event|10|||
170457360|NCT01687478|616016064|FG000|Overall Study|Lost to Follow-up|1|||
170457361|NCT01687478|616016065|FG001|Overall Study|Lost to Follow-up|3|||
170457362|NCT01687478|616016064|FG000|Overall Study|Protocol Violation|0|||
170457363|NCT01687478|616016065|FG001|Overall Study|Protocol Violation|2|||
170457364|NCT01687478|616016064|FG000|Overall Study|Withdrawal by Subject|21|||
170457365|NCT01687478|616016065|FG001|Overall Study|Withdrawal by Subject|19|||
170457366|NCT01687478|616016064|FG000|Overall Study|Physician Decision|1|||
170457367|NCT01687478|616016065|FG001|Overall Study|Physician Decision|3|||
170457368|NCT01687478|616016064|FG000|Overall Study|Entry Criteria Not Met|6|||
170457369|NCT01687478|616016065|FG001|Overall Study|Entry Criteria Not Met|2|||
170457370|NCT01398514|616016066|FG000|Overall Study|Adverse Event|1|||
170457371|NCT01398514|616016067|FG001|Overall Study|Adverse Event|0|||
170457372|NCT01398514|616016066|FG000|Overall Study|Non-compliance with study procedures|2|||
170457373|NCT01398514|616016067|FG001|Overall Study|Non-compliance with study procedures|0|||
170457374|NCT01398514|616016066|FG000|Overall Study|Physiologic non-responsiveness|1|||
170457375|NCT01398514|616016067|FG001|Overall Study|Physiologic non-responsiveness|3|||
170457376|NCT01398514|616016066|FG000|Overall Study|Failure to show a conditioned response|4|||
170457377|NCT01398514|616016067|FG001|Overall Study|Failure to show a conditioned response|3|||
170457378|NCT02746471|616016073|FG000|Overall Study|Death|43|||
170457379|NCT02746471|616016073|FG000|Overall Study|Exited before 36 months|1119|||
170457380|NCT02669758|616016075|FG000|Overall Study|Withdrawal by Subject|43|||
170457381|NCT02669758|616016075|FG000|Overall Study|Lost to Follow-up|19|||
170457382|NCT02669758|616016075|FG000|Overall Study|Adverse Event|16|||
170635957|NCT03682770|616678917|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
170635958|NCT03682770|616678911|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
170787892|NCT01369355|617234163|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
170787893|NCT01369355|617234164|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
170787894|NCT01369355|617234165|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
170787895|NCT01369355|617234166|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
170787896|NCT01369355|617234167|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
170457383|NCT02669758|616016075|FG000|Overall Study|Non-Compliance with Study Drug|8|||
170542881|NCT03369223|616331141|FG008|Overall Study|Adverse event unrelated to study drug|0|||
170889117|NCT00094055|617600620|FG000|Overall Study|roll-over to another study|14|||
170889118|NCT00094055|617600620|FG000|Overall Study|Withdrawal by Subject|9|||
170889119|NCT04823949|617600621|FG000|Overall Study|Withdrawal by Subject|0|||
170889120|NCT04823949|617600622|FG001|Overall Study|Withdrawal by Subject|4|||
170889121|NCT04823949|617600621|FG000|Overall Study|Physician Decision|0|||
170889122|NCT04823949|617600622|FG001|Overall Study|Physician Decision|1|||
170889123|NCT00090545|617600623|FG000|Overall Study|Disease progression on study|21|||
170889124|NCT00090545|617600624|FG001|Overall Study|Disease progression on study|17|||
170889125|NCT00090545|617600623|FG000|Overall Study|Refused further treatment|1|||
170889126|NCT00090545|617600624|FG001|Overall Study|Refused further treatment|4|||
170889127|NCT00090545|617600623|FG000|Overall Study|Death|0|||
170889128|NCT00090545|617600624|FG001|Overall Study|Death|1|||
170889129|NCT00090545|617600623|FG000|Overall Study|Adverse Event|0|||
170889130|NCT00090545|617600624|FG001|Overall Study|Adverse Event|2|||
170889131|NCT01999582|617600625|FG000|Overall Study|Withdrawal by Subject|0|||
170889132|NCT01999582|617600626|FG001|Overall Study|Withdrawal by Subject|0|||
170889133|NCT01999582|617600627|FG002|Overall Study|Withdrawal by Subject|0|||
170889134|NCT01999582|617600628|FG003|Overall Study|Withdrawal by Subject|1|||
170889135|NCT01999582|617600629|FG004|Overall Study|Withdrawal by Subject|0|||
170889136|NCT01999582|617600630|FG005|Overall Study|Withdrawal by Subject|0|||
170889137|NCT01999582|617600625|FG000|Overall Study|Adverse Event|0|||
170889138|NCT01999582|617600626|FG001|Overall Study|Adverse Event|0|||
170889139|NCT01999582|617600627|FG002|Overall Study|Adverse Event|3|||
170889140|NCT01999582|617600628|FG003|Overall Study|Adverse Event|0|||
170889141|NCT01999582|617600629|FG004|Overall Study|Adverse Event|1|||
170889142|NCT01999582|617600630|FG005|Overall Study|Adverse Event|0|||
170889143|NCT01999582|617600625|FG000|Overall Study|Other Reasons|1|||
170889144|NCT01999582|617600626|FG001|Overall Study|Other Reasons|0|||
170889145|NCT01999582|617600627|FG002|Overall Study|Other Reasons|3|||
170889146|NCT01999582|617600628|FG003|Overall Study|Other Reasons|1|||
170889147|NCT01999582|617600629|FG004|Overall Study|Other Reasons|1|||
170889148|NCT01999582|617600630|FG005|Overall Study|Other Reasons|2|||
170889149|NCT01999582|617600625|FG000|Overall Study|Protocol Violation|1|||
170889150|NCT01999582|617600626|FG001|Overall Study|Protocol Violation|0|||
170889151|NCT01999582|617600627|FG002|Overall Study|Protocol Violation|0|||
170889152|NCT01999582|617600628|FG003|Overall Study|Protocol Violation|0|||
170889153|NCT01999582|617600629|FG004|Overall Study|Protocol Violation|0|||
170889154|NCT01999582|617600630|FG005|Overall Study|Protocol Violation|1|||
170889155|NCT01999582|617600625|FG000|Overall Study|Lack of Efficacy|1|||
170889156|NCT01999582|617600626|FG001|Overall Study|Lack of Efficacy|3|||
170889157|NCT01999582|617600627|FG002|Overall Study|Lack of Efficacy|0|||
170889158|NCT01999582|617600628|FG003|Overall Study|Lack of Efficacy|1|||
170889159|NCT01999582|617600629|FG004|Overall Study|Lack of Efficacy|0|||
170889160|NCT01999582|617600630|FG005|Overall Study|Lack of Efficacy|0|||
170889161|NCT00441545|617600631|FG000|First Intervention|Adverse Event|6|||
170889162|NCT00441545|617600632|FG001|First Intervention|Adverse Event|5|||
170889163|NCT00441545|617600631|FG000|First Intervention|Protocol Violation|2|||
170889164|NCT00441545|617600632|FG001|First Intervention|Protocol Violation|2|||
170889165|NCT00441545|617600631|FG000|First Intervention|Withdrawal by Subject|3|||
170889166|NCT00441545|617600632|FG001|First Intervention|Withdrawal by Subject|3|||
170889167|NCT00441545|617600631|FG000|First Intervention|Kidney transplant|1|||
170889168|NCT00441545|617600632|FG001|First Intervention|Kidney transplant|1|||
170889169|NCT00441545|617600631|FG000|First Intervention|Lack of Efficacy|2|||
170889170|NCT00441545|617600632|FG001|First Intervention|Lack of Efficacy|0|||
170889171|NCT00441545|617600631|FG000|First Intervention|Subject exceeded safety criteria|0|||
170889172|NCT00441545|617600632|FG001|First Intervention|Subject exceeded safety criteria|1|||
170889173|NCT00441545|617600631|FG000|First Intervention|Subject met an exclusionary criteria|1|||
170889174|NCT00441545|617600632|FG001|First Intervention|Subject met an exclusionary criteria|0|||
170889175|NCT00441545|617600631|FG000|First Intervention|Extended hospitalization|1|||
170889176|NCT00441545|617600632|FG001|First Intervention|Extended hospitalization|0|||
170889177|NCT00441545|617600631|FG000|First Intervention|Site error|1|||
170889178|NCT00441545|617600632|FG001|First Intervention|Site error|0|||
170889179|NCT00441545|617600631|FG000|First Intervention|Sponsor's request|1|||
170889180|NCT00441545|617600632|FG001|First Intervention|Sponsor's request|0|||
170889181|NCT00441545|617600631|FG000|Second Intervention|Adverse Event|5|||
170889182|NCT00441545|617600632|FG001|Second Intervention|Adverse Event|2|||
170889183|NCT00441545|617600631|FG000|Second Intervention|Protocol Violation|4|||
170889184|NCT00441545|617600632|FG001|Second Intervention|Protocol Violation|1|||
170889185|NCT00441545|617600631|FG000|Second Intervention|Withdrawal by Subject|1|||
170889186|NCT00441545|617600632|FG001|Second Intervention|Withdrawal by Subject|1|||
170889187|NCT00441545|617600631|FG000|Second Intervention|Kidney Transplant|1|||
170889188|NCT00441545|617600632|FG001|Second Intervention|Kidney Transplant|1|||
170889189|NCT00441545|617600631|FG000|Second Intervention|Lack of Efficacy|0|||
170889190|NCT00441545|617600632|FG001|Second Intervention|Lack of Efficacy|1|||
170635959|NCT03682770|616678912|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
170635960|NCT03682770|616678913|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
170635961|NCT03682770|616678914|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
170457384|NCT02669758|616016075|FG000|Overall Study|Lack of Efficacy|5|||
170457385|NCT02669758|616016075|FG000|Overall Study|Pregnancy|1|||
170457386|NCT02669758|616016075|FG000|Overall Study|Study noncompliance|1|||
170457387|NCT02669758|616016075|FG000|Overall Study|Protocol Violation|1|||
170457388|NCT02455050|616016076|FG000|Treatment Period 1|Lost to Follow-up|1|||
170457389|NCT02455050|616016077|FG001|Treatment Period 1|Lost to Follow-up|1|||
170457390|NCT02455050|616016078|FG002|Treatment Period 1|Lost to Follow-up|1|||
170457391|NCT02455050|616016079|FG003|Treatment Period 1|Lost to Follow-up|2|||
170457392|NCT02455050|616016076|FG000|Treatment Period 2|Lost to Follow-up|1|||
170457393|NCT02455050|616016077|FG001|Treatment Period 2|Lost to Follow-up|0|||
170457394|NCT02455050|616016078|FG002|Treatment Period 2|Lost to Follow-up|2|||
170457395|NCT02455050|616016079|FG003|Treatment Period 2|Lost to Follow-up|1|||
170457396|NCT03393806|616016082|FG000|Overall Study|Physician Decision|1|||
170457397|NCT03393806|616016083|FG001|Overall Study|Physician Decision|0|||
170457398|NCT00507130|616016084|FG000|Overall Study|Lost to Follow-up|0|||
170457399|NCT00507130|616016085|FG001|Overall Study|Lost to Follow-up|0|||
170457400|NCT00507130|616016086|FG002|Overall Study|Lost to Follow-up|1|||
170457401|NCT00507130|616016087|FG003|Overall Study|Lost to Follow-up|1|||
170457402|NCT00507130|616016084|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
170457403|NCT00507130|616016085|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
170457404|NCT00507130|616016086|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
170457405|NCT00507130|616016087|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
170457406|NCT02524730|616016088|FG000|Overall Study|Lost to Follow-up|5|||
170457407|NCT02524730|616016088|FG000|Overall Study|Withdrawal by Subject|18|||
170542882|NCT03369223|616331142|FG009|Overall Study|Adverse event unrelated to study drug|1|||
170635962|NCT03682770|616678915|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
170635963|NCT03682770|616678916|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
170635964|NCT03682770|616678917|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
170635965|NCT03682770|616678911|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
170635966|NCT03682770|616678912|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
170635967|NCT03682770|616678913|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
170635968|NCT03682770|616678914|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
170635969|NCT03682770|616678915|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
170635970|NCT03682770|616678916|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
170635971|NCT03682770|616678917|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
170635972|NCT03682770|616678911|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
170635973|NCT03682770|616678912|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
170635974|NCT03682770|616678913|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
170635975|NCT03682770|616678914|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
170635976|NCT03682770|616678915|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
170635977|NCT03682770|616678916|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
170635978|NCT03682770|616678917|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
170787897|NCT01369355|617234168|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
170457408|NCT02524730|616016088|FG000|Overall Study|Death|10|||
170457409|NCT02524730|616016088|FG000|Overall Study|Adverse Event|8|||
170457410|NCT02524730|616016088|FG000|Overall Study|Protocol Violation|1|||
170542883|NCT03369223|616331143|FG010|Overall Study|Adverse event unrelated to study drug|0|||
170542884|NCT03369223|616331144|FG011|Overall Study|Adverse event unrelated to study drug|0|||
170542885|NCT03369223|616331145|FG012|Overall Study|Adverse event unrelated to study drug|0|||
170542886|NCT03369223|616331146|FG013|Overall Study|Adverse event unrelated to study drug|4|||
170542887|NCT03369223|616331147|FG014|Overall Study|Adverse event unrelated to study drug|2|||
170542888|NCT03369223|616331148|FG015|Overall Study|Adverse event unrelated to study drug|0|||
170542889|NCT03369223|616331149|FG016|Overall Study|Adverse event unrelated to study drug|2|||
170542890|NCT03369223|616331150|FG017|Overall Study|Adverse event unrelated to study drug|1|||
170542891|NCT03369223|616331151|FG018|Overall Study|Adverse event unrelated to study drug|3|||
170787898|NCT01369355|617234169|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
170542892|NCT03369223|616331152|FG019|Overall Study|Adverse event unrelated to study drug|2|||
170457411|NCT02524730|616016088|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
170457412|NCT00706511|616016089|FG000|Overall Study|Withdrawal by Subject|1|||
170457413|NCT00706511|616016090|FG001|Overall Study|Withdrawal by Subject|0|||
170457414|NCT00706511|616016091|FG002|Overall Study|Withdrawal by Subject|0|||
170457415|NCT00706511|616016092|FG003|Overall Study|Withdrawal by Subject|0|||
170457416|NCT03493386|616016095|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170457417|NCT03493386|616016096|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
170457418|NCT03493386|616016097|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170457419|NCT03493386|616016098|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170457420|NCT00289536|616016100|FG000|Period 3|Lost to Follow-up|0|||
170457421|NCT00289536|616016101|FG001|Period 3|Lost to Follow-up|0|||
170457422|NCT00289536|616016102|FG002|Period 3|Lost to Follow-up|1|||
170457423|NCT00988442|616016107|FG000|Overall Study|Death|1|||
170457424|NCT00988442|616016108|FG001|Overall Study|Death|2|||
170457425|NCT00988442|616016107|FG000|Overall Study|Lost to Follow-up|0|||
170457426|NCT00988442|616016108|FG001|Overall Study|Lost to Follow-up|1|||
170457427|NCT00988442|616016107|FG000|Overall Study|Early Study Closure|29|||
170457428|NCT00988442|616016108|FG001|Overall Study|Early Study Closure|25|||
170457429|NCT02266134|616016114|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
170457430|NCT02266134|616016115|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
170457431|NCT02266134|616016116|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
170457432|NCT02266134|616016117|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
170457433|NCT02266134|616016114|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
170457434|NCT02266134|616016115|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
170457435|NCT02266134|616016116|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
170457436|NCT02266134|616016117|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
170457437|NCT02266134|616016114|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
170457438|NCT02266134|616016115|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
170457439|NCT02266134|616016116|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
170457440|NCT02266134|616016117|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
170457441|NCT02266134|616016114|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
170457442|NCT02266134|616016115|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
170457443|NCT02266134|616016116|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
170457444|NCT02266134|616016117|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
170457445|NCT02266134|616016114|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
170457446|NCT02266134|616016115|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
170457447|NCT02266134|616016116|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
170457448|NCT02266134|616016117|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
170457449|NCT02266134|616016114|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
170457450|NCT02266134|616016115|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
170457451|NCT02266134|616016116|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
170457452|NCT02266134|616016117|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
170457453|NCT03678285|616016120|FG000|Overall Study|Adverse Event|2|||
170457454|NCT03678285|616016120|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
170457455|NCT03678285|616016120|FG000|Overall Study|Dehydrated prior to start of workout|1|||
170457456|NCT00123474|616016121|FG000|Randomized to Treatment|Randomized, never treated|1|||
170457457|NCT00123474|616016122|FG001|Randomized to Treatment|Randomized, never treated|4|||
170457458|NCT00123474|616016123|FG002|Randomized to Treatment|Randomized, never treated|2|||
170457459|NCT00123474|616016124|FG003|Randomized to Treatment|Randomized, never treated|1|||
170457460|NCT00123474|616016121|FG000|As Treated at Study Closure|not reported when site closed|1|||
170457461|NCT00123474|616016122|FG001|As Treated at Study Closure|not reported when site closed|0|||
170457462|NCT00123474|616016123|FG002|As Treated at Study Closure|not reported when site closed|1|||
170457463|NCT00123474|616016124|FG003|As Treated at Study Closure|not reported when site closed|0|||
170457464|NCT00123474|616016121|FG000|As Treated at Study Closure|Adverse Event|10|||
170457465|NCT00123474|616016122|FG001|As Treated at Study Closure|Adverse Event|4|||
170457466|NCT00123474|616016123|FG002|As Treated at Study Closure|Adverse Event|10|||
170457467|NCT00123474|616016124|FG003|As Treated at Study Closure|Adverse Event|8|||
170457468|NCT00123474|616016121|FG000|As Treated at Study Closure|Disease Progression|35|||
170457469|NCT00123474|616016122|FG001|As Treated at Study Closure|Disease Progression|42|||
170457470|NCT00123474|616016123|FG002|As Treated at Study Closure|Disease Progression|29|||
170457471|NCT00123474|616016124|FG003|As Treated at Study Closure|Disease Progression|27|||
170457472|NCT00123474|616016121|FG000|As Treated at Study Closure|Investigator Request|12|||
170457473|NCT00123474|616016122|FG001|As Treated at Study Closure|Investigator Request|6|||
170457474|NCT00123474|616016123|FG002|As Treated at Study Closure|Investigator Request|7|||
170457475|NCT00123474|616016124|FG003|As Treated at Study Closure|Investigator Request|5|||
170457476|NCT00123474|616016121|FG000|As Treated at Study Closure|non-specified|54|||
170457477|NCT00123474|616016122|FG001|As Treated at Study Closure|non-specified|47|||
170457478|NCT00123474|616016123|FG002|As Treated at Study Closure|non-specified|57|||
170457479|NCT00123474|616016124|FG003|As Treated at Study Closure|non-specified|60|||
170457480|NCT00123474|616016121|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
170457481|NCT00123474|616016122|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
170542893|NCT03369223|616331133|FG000|Overall Study|Disease progression|6|||
170457482|NCT00123474|616016123|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
170457483|NCT00123474|616016124|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
170457484|NCT00123474|616016121|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
170457485|NCT00123474|616016122|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
170457486|NCT00123474|616016123|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
170457487|NCT00123474|616016124|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
170457488|NCT03893565|616016126|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
170889191|NCT00441545|617600631|FG000|Second Intervention|Subject exceeded safety criteria|1|||
170889192|NCT00441545|617600632|FG001|Second Intervention|Subject exceeded safety criteria|0|||
170889193|NCT00441545|617600631|FG000|Second Intervention|Subject moved|0|||
170889194|NCT00441545|617600632|FG001|Second Intervention|Subject moved|1|||
170889195|NCT02347176|617600633|FG000|Overall Study|Lost to Follow-up|2|||
170889196|NCT02347176|617600634|FG001|Overall Study|Lost to Follow-up|3|||
170889197|NCT02347176|617600635|FG002|Overall Study|Lost to Follow-up|1|||
170889198|NCT02347176|617600636|FG003|Overall Study|Lost to Follow-up|1|||
170889199|NCT02347176|617600633|FG000|Overall Study|Withdrawal by Subject|9|||
170889200|NCT02347176|617600634|FG001|Overall Study|Withdrawal by Subject|5|||
170457489|NCT03893565|616016127|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
170457490|NCT03893565|616016128|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
170457491|NCT03893565|616016129|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
170457492|NCT03893565|616016130|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
170457493|NCT03893565|616016131|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
170542894|NCT03369223|616331134|FG001|Overall Study|Disease progression|8|||
170542895|NCT03369223|616331135|FG002|Overall Study|Disease progression|5|||
170542896|NCT03369223|616331136|FG003|Overall Study|Disease progression|1|||
170542897|NCT03369223|616331137|FG004|Overall Study|Disease progression|9|||
170542898|NCT03369223|616331138|FG005|Overall Study|Disease progression|9|||
170542899|NCT03369223|616331139|FG006|Overall Study|Disease progression|4|||
170542900|NCT03369223|616331140|FG007|Overall Study|Disease progression|6|||
170542901|NCT03369223|616331141|FG008|Overall Study|Disease progression|10|||
170542902|NCT03369223|616331142|FG009|Overall Study|Disease progression|7|||
170542903|NCT03369223|616331143|FG010|Overall Study|Disease progression|4|||
170542904|NCT03369223|616331144|FG011|Overall Study|Disease progression|1|||
170542905|NCT03369223|616331145|FG012|Overall Study|Disease progression|1|||
170542906|NCT03369223|616331146|FG013|Overall Study|Disease progression|25|||
170542907|NCT03369223|616331147|FG014|Overall Study|Disease progression|22|||
170542908|NCT03369223|616331148|FG015|Overall Study|Disease progression|2|||
170542909|NCT03369223|616331149|FG016|Overall Study|Disease progression|10|||
170542910|NCT03369223|616331150|FG017|Overall Study|Disease progression|1|||
170542911|NCT03369223|616331151|FG018|Overall Study|Disease progression|18|||
170542912|NCT03369223|616331152|FG019|Overall Study|Disease progression|28|||
170542913|NCT03369223|616331133|FG000|Overall Study|Study drug toxicity|0|||
170542914|NCT03369223|616331134|FG001|Overall Study|Study drug toxicity|1|||
170542915|NCT03369223|616331135|FG002|Overall Study|Study drug toxicity|4|||
170542916|NCT03369223|616331136|FG003|Overall Study|Study drug toxicity|0|||
170542917|NCT03369223|616331137|FG004|Overall Study|Study drug toxicity|1|||
170542918|NCT03369223|616331138|FG005|Overall Study|Study drug toxicity|2|||
170542919|NCT03369223|616331139|FG006|Overall Study|Study drug toxicity|4|||
170542920|NCT03369223|616331140|FG007|Overall Study|Study drug toxicity|2|||
170542921|NCT03369223|616331141|FG008|Overall Study|Study drug toxicity|2|||
170542922|NCT03369223|616331142|FG009|Overall Study|Study drug toxicity|0|||
170542923|NCT03369223|616331143|FG010|Overall Study|Study drug toxicity|6|||
170542924|NCT03369223|616331144|FG011|Overall Study|Study drug toxicity|1|||
170542925|NCT03369223|616331145|FG012|Overall Study|Study drug toxicity|2|||
170542926|NCT03369223|616331146|FG013|Overall Study|Study drug toxicity|19|||
170542927|NCT03369223|616331147|FG014|Overall Study|Study drug toxicity|19|||
170542928|NCT03369223|616331148|FG015|Overall Study|Study drug toxicity|0|||
170542929|NCT03369223|616331149|FG016|Overall Study|Study drug toxicity|18|||
170542930|NCT03369223|616331150|FG017|Overall Study|Study drug toxicity|3|||
170542931|NCT03369223|616331151|FG018|Overall Study|Study drug toxicity|11|||
170542932|NCT03369223|616331152|FG019|Overall Study|Study drug toxicity|7|||
170542933|NCT03369223|616331133|FG000|Overall Study|Participant request to discontinue study treatment|0|||
170542934|NCT03369223|616331134|FG001|Overall Study|Participant request to discontinue study treatment|1|||
170889201|NCT02347176|617600635|FG002|Overall Study|Withdrawal by Subject|5|||
170889202|NCT02347176|617600636|FG003|Overall Study|Withdrawal by Subject|3|||
170457494|NCT03893565|616016132|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
170457495|NCT03893565|616016133|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
170542935|NCT03369223|616331135|FG002|Overall Study|Participant request to discontinue study treatment|0|||
170542936|NCT03369223|616331136|FG003|Overall Study|Participant request to discontinue study treatment|0|||
170542937|NCT03369223|616331137|FG004|Overall Study|Participant request to discontinue study treatment|1|||
170542938|NCT03369223|616331138|FG005|Overall Study|Participant request to discontinue study treatment|1|||
170542939|NCT03369223|616331139|FG006|Overall Study|Participant request to discontinue study treatment|1|||
170542940|NCT03369223|616331140|FG007|Overall Study|Participant request to discontinue study treatment|0|||
170542941|NCT03369223|616331141|FG008|Overall Study|Participant request to discontinue study treatment|0|||
170542942|NCT03369223|616331142|FG009|Overall Study|Participant request to discontinue study treatment|0|||
170457496|NCT03893565|616016134|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
170457497|NCT03893565|616016126|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
170457498|NCT03893565|616016127|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
170457499|NCT03893565|616016128|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
170457500|NCT03893565|616016129|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
170457501|NCT03893565|616016130|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
170457502|NCT03893565|616016131|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
170457503|NCT03893565|616016132|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
170457504|NCT03893565|616016133|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
170457505|NCT03893565|616016134|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
170457506|NCT03893565|616016126|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457507|NCT03893565|616016127|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
170457508|NCT03893565|616016128|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457509|NCT03893565|616016129|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
170457510|NCT03893565|616016130|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457511|NCT03893565|616016131|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457512|NCT03893565|616016132|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457513|NCT03893565|616016133|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457514|NCT03893565|616016134|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457515|NCT03893565|616016126|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
170457516|NCT03893565|616016127|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
170457517|NCT03893565|616016128|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
170457518|NCT03893565|616016129|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
170457519|NCT03893565|616016130|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
170457520|NCT03893565|616016131|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
170457521|NCT03893565|616016132|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
170457522|NCT03893565|616016133|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
170457523|NCT03893565|616016134|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
170457524|NCT03893565|616016126|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
170457525|NCT03893565|616016127|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
170457526|NCT03893565|616016128|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
170457527|NCT03893565|616016129|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457528|NCT03893565|616016130|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
170457529|NCT03893565|616016131|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457530|NCT03893565|616016132|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457531|NCT03893565|616016133|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457532|NCT03893565|616016134|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457533|NCT03893565|616016126|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
170457534|NCT03893565|616016127|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
170457535|NCT03893565|616016128|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
170457536|NCT03893565|616016129|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
170457537|NCT03893565|616016130|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
170457538|NCT03893565|616016131|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
170457539|NCT03893565|616016132|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
170457540|NCT03893565|616016133|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
170457541|NCT03893565|616016134|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
170457542|NCT03893565|616016126|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457543|NCT03893565|616016127|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457544|NCT03893565|616016128|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457545|NCT03893565|616016129|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
170457546|NCT03893565|616016130|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457547|NCT03893565|616016131|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457548|NCT03893565|616016132|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457549|NCT03893565|616016133|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457550|NCT03893565|616016134|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457551|NCT03893565|616016126|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
170457552|NCT03893565|616016127|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
170457553|NCT03893565|616016128|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
170457554|NCT03893565|616016129|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
170635979|NCT03682770|616678911|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
170635980|NCT03682770|616678912|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
170457555|NCT03893565|616016130|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
170457556|NCT03893565|616016131|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
170457557|NCT03893565|616016132|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
170457558|NCT03893565|616016133|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
170457559|NCT03893565|616016134|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
170457560|NCT03893565|616016126|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
170457561|NCT03893565|616016127|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
170457562|NCT03893565|616016128|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
170457563|NCT03893565|616016129|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
170457564|NCT03893565|616016130|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
170457565|NCT03893565|616016131|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
170457566|NCT03893565|616016132|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
170457567|NCT03893565|616016133|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
170457568|NCT03893565|616016134|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
170457569|NCT03893565|616016126|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
170457570|NCT03893565|616016127|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
170457571|NCT03893565|616016128|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
170457572|NCT03893565|616016129|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
170457573|NCT03893565|616016130|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
170457574|NCT03893565|616016131|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
170457575|NCT03893565|616016132|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
170457576|NCT03893565|616016133|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
170457577|NCT03893565|616016134|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
170457578|NCT03893565|616016126|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
170457579|NCT03893565|616016127|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
170457580|NCT03893565|616016128|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
170457581|NCT03893565|616016129|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
170457582|NCT03893565|616016130|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
170457583|NCT03893565|616016131|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
170457584|NCT03893565|616016132|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
170457585|NCT03893565|616016133|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
170457586|NCT03893565|616016134|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
170457587|NCT03893565|616016126|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
170457588|NCT03893565|616016127|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
170457589|NCT03893565|616016128|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
170457590|NCT03893565|616016129|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
170457591|NCT03893565|616016130|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
170457592|NCT03893565|616016131|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
170457593|NCT03893565|616016132|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
170457594|NCT03893565|616016133|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
170457595|NCT03893565|616016134|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
170457596|NCT03893565|616016126|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457597|NCT03893565|616016127|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457598|NCT03893565|616016128|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457599|NCT03893565|616016129|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457600|NCT03893565|616016130|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457601|NCT03893565|616016131|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457602|NCT03893565|616016132|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457603|NCT03893565|616016133|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
170457604|NCT03893565|616016134|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
170457605|NCT03893565|616016126|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457606|NCT03893565|616016127|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457607|NCT03893565|616016128|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457608|NCT03893565|616016129|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457609|NCT03893565|616016130|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170787899|NCT01369355|617234161|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
170457610|NCT03893565|616016131|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457611|NCT03893565|616016132|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457612|NCT03893565|616016133|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
170457613|NCT03893565|616016134|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
170457614|NCT03893565|616016126|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457615|NCT03893565|616016127|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457616|NCT03893565|616016128|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170787900|NCT01369355|617234162|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
170457617|NCT03893565|616016129|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457618|NCT03893565|616016130|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457619|NCT03893565|616016131|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457620|NCT03893565|616016132|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457621|NCT03893565|616016133|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
170457622|NCT03893565|616016134|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
170457623|NCT03893565|616016126|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
170457624|NCT03893565|616016127|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
170457625|NCT03893565|616016128|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
170457626|NCT03893565|616016129|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
170457627|NCT03893565|616016130|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
170457628|NCT03893565|616016131|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
170457629|NCT03893565|616016132|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
170457630|NCT03893565|616016133|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
170457631|NCT03893565|616016134|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
170457632|NCT01715571|616016135|FG000|Overall Study|Lost to Follow-up|8|||
170457633|NCT03870477|616016142|FG000|Overall Study|Early Study Termination|1|||
170457634|NCT00826449|616016143|FG000|Overall Study|Disease Progression|4|||
170457635|NCT00826449|616016143|FG000|Overall Study|Withdrawal by Subject|1|||
170457636|NCT02987959|616016149|FG000|Overall Study|Grantor stopped supply of drugs|6|||
170457637|NCT04453202|616016150|FG000|Overall Study|Adverse Event|0|||
170457638|NCT04453202|616016151|FG001|Overall Study|Adverse Event|0|||
170457639|NCT04453202|616016152|FG002|Overall Study|Adverse Event|0|||
170457640|NCT04453202|616016153|FG003|Overall Study|Adverse Event|0|||
170457641|NCT04453202|616016154|FG004|Overall Study|Adverse Event|0|||
170457642|NCT04453202|616016155|FG005|Overall Study|Adverse Event|0|||
170457643|NCT04453202|616016156|FG006|Overall Study|Adverse Event|1|||
170457644|NCT04453202|616016157|FG007|Overall Study|Adverse Event|0|||
170457645|NCT04453202|616016158|FG008|Overall Study|Adverse Event|0|||
170457646|NCT04453202|616016159|FG009|Overall Study|Adverse Event|0|||
170457647|NCT04453202|616016160|FG010|Overall Study|Adverse Event|0|||
170457648|NCT04453202|616016150|FG000|Overall Study|Death|0|||
170457649|NCT04453202|616016151|FG001|Overall Study|Death|0|||
170457650|NCT04453202|616016152|FG002|Overall Study|Death|0|||
170457651|NCT04453202|616016153|FG003|Overall Study|Death|0|||
170457652|NCT04453202|616016154|FG004|Overall Study|Death|0|||
170457653|NCT04453202|616016155|FG005|Overall Study|Death|0|||
170457654|NCT04453202|616016156|FG006|Overall Study|Death|0|||
170457655|NCT04453202|616016157|FG007|Overall Study|Death|0|||
170457656|NCT04453202|616016158|FG008|Overall Study|Death|0|||
170457657|NCT04453202|616016159|FG009|Overall Study|Death|1|||
170457658|NCT04453202|616016160|FG010|Overall Study|Death|0|||
170457659|NCT04453202|616016150|FG000|Overall Study|Lost to Follow-up|0|||
170457660|NCT04453202|616016151|FG001|Overall Study|Lost to Follow-up|1|||
170457661|NCT04453202|616016152|FG002|Overall Study|Lost to Follow-up|0|||
170457662|NCT04453202|616016153|FG003|Overall Study|Lost to Follow-up|1|||
170457663|NCT04453202|616016154|FG004|Overall Study|Lost to Follow-up|0|||
170457664|NCT04453202|616016155|FG005|Overall Study|Lost to Follow-up|0|||
170542943|NCT03369223|616331143|FG010|Overall Study|Participant request to discontinue study treatment|0|||
170457665|NCT04453202|616016156|FG006|Overall Study|Lost to Follow-up|0|||
170457666|NCT04453202|616016157|FG007|Overall Study|Lost to Follow-up|0|||
170542944|NCT03369223|616331144|FG011|Overall Study|Participant request to discontinue study treatment|0|||
170542945|NCT03369223|616331145|FG012|Overall Study|Participant request to discontinue study treatment|0|||
170542946|NCT03369223|616331146|FG013|Overall Study|Participant request to discontinue study treatment|1|||
170542947|NCT03369223|616331147|FG014|Overall Study|Participant request to discontinue study treatment|1|||
170542948|NCT03369223|616331148|FG015|Overall Study|Participant request to discontinue study treatment|0|||
170542949|NCT03369223|616331149|FG016|Overall Study|Participant request to discontinue study treatment|0|||
170542950|NCT03369223|616331150|FG017|Overall Study|Participant request to discontinue study treatment|0|||
170542951|NCT03369223|616331151|FG018|Overall Study|Participant request to discontinue study treatment|1|||
170542952|NCT03369223|616331152|FG019|Overall Study|Participant request to discontinue study treatment|0|||
170542953|NCT03369223|616331133|FG000|Overall Study|Participant withdrew consent|0|||
170542954|NCT03369223|616331134|FG001|Overall Study|Participant withdrew consent|1|||
170542955|NCT03369223|616331135|FG002|Overall Study|Participant withdrew consent|1|||
170542956|NCT03369223|616331136|FG003|Overall Study|Participant withdrew consent|0|||
170457667|NCT04453202|616016158|FG008|Overall Study|Lost to Follow-up|0|||
170457668|NCT04453202|616016159|FG009|Overall Study|Lost to Follow-up|1|||
170457669|NCT04453202|616016160|FG010|Overall Study|Lost to Follow-up|1|||
170542957|NCT03369223|616331137|FG004|Overall Study|Participant withdrew consent|0|||
170457670|NCT04453202|616016150|FG000|Overall Study|Withdrawal by Subject|1|||
170457671|NCT04453202|616016151|FG001|Overall Study|Withdrawal by Subject|2|||
170542958|NCT03369223|616331138|FG005|Overall Study|Participant withdrew consent|0|||
170542959|NCT03369223|616331139|FG006|Overall Study|Participant withdrew consent|1|||
170457672|NCT04453202|616016152|FG002|Overall Study|Withdrawal by Subject|1|||
170457673|NCT04453202|616016153|FG003|Overall Study|Withdrawal by Subject|2|||
170457674|NCT04453202|616016154|FG004|Overall Study|Withdrawal by Subject|1|||
170457675|NCT04453202|616016155|FG005|Overall Study|Withdrawal by Subject|1|||
170457676|NCT04453202|616016156|FG006|Overall Study|Withdrawal by Subject|0|||
170457677|NCT04453202|616016157|FG007|Overall Study|Withdrawal by Subject|0|||
170457678|NCT04453202|616016158|FG008|Overall Study|Withdrawal by Subject|0|||
170457679|NCT04453202|616016159|FG009|Overall Study|Withdrawal by Subject|1|||
170457680|NCT04453202|616016160|FG010|Overall Study|Withdrawal by Subject|0|||
170457681|NCT04453202|616016150|FG000|Overall Study|Adverse Event|0|||
170457682|NCT04453202|616016151|FG001|Overall Study|Adverse Event|0|||
170457683|NCT04453202|616016152|FG002|Overall Study|Adverse Event|0|||
170457684|NCT04453202|616016153|FG003|Overall Study|Adverse Event|0|||
170457685|NCT04453202|616016154|FG004|Overall Study|Adverse Event|0|||
170457686|NCT04453202|616016155|FG005|Overall Study|Adverse Event|1|||
170457687|NCT04453202|616016156|FG006|Overall Study|Adverse Event|0|||
170457688|NCT04453202|616016157|FG007|Overall Study|Adverse Event|0|||
170457689|NCT04453202|616016158|FG008|Overall Study|Adverse Event|0|||
170457690|NCT04453202|616016159|FG009|Overall Study|Adverse Event|0|||
170457691|NCT04453202|616016160|FG010|Overall Study|Adverse Event|0|||
170457692|NCT01300923|616016161|FG000|Overall Study|Physician Decision|0|||
170457693|NCT01300923|616016162|FG001|Overall Study|Physician Decision|2|||
170457694|NCT05069155|616016165|FG000|Overall Study|Withdrawal by Subject|1|||
170457695|NCT05069155|616016166|FG001|Overall Study|Withdrawal by Subject|3|||
170457696|NCT01346774|616016167|FG000|Overall Study|Did not take a single dose|6|||
170457697|NCT01346774|616016168|FG001|Overall Study|Did not take a single dose|4|||
170457698|NCT01346774|616016167|FG000|Overall Study|Lost to Follow-up|3|||
170457699|NCT01346774|616016168|FG001|Overall Study|Lost to Follow-up|4|||
170457700|NCT01346774|616016167|FG000|Overall Study|Withdrawal by Subject|1|||
170457701|NCT01346774|616016168|FG001|Overall Study|Withdrawal by Subject|4|||
170457702|NCT01346774|616016167|FG000|Overall Study|Protocol Violation|2|||
170457703|NCT01346774|616016168|FG001|Overall Study|Protocol Violation|3|||
170457704|NCT01346774|616016167|FG000|Overall Study|Adverse Event|1|||
170457705|NCT01346774|616016168|FG001|Overall Study|Adverse Event|2|||
170457706|NCT01929031|616016169|FG000|Overall Study|Adverse Event|3|||
170457707|NCT01929031|616016170|FG001|Overall Study|Adverse Event|1|||
170457708|NCT01929031|616016171|FG002|Overall Study|Adverse Event|1|||
170457709|NCT01929031|616016172|FG003|Overall Study|Adverse Event|0|||
170457710|NCT01929031|616016173|FG004|Overall Study|Adverse Event|0|||
170457711|NCT01929031|616016174|FG005|Overall Study|Adverse Event|0|||
170457712|NCT01929031|616016169|FG000|Overall Study|Protocol Violation|1|||
170457713|NCT01929031|616016170|FG001|Overall Study|Protocol Violation|0|||
170457714|NCT01929031|616016171|FG002|Overall Study|Protocol Violation|0|||
170457715|NCT01929031|616016172|FG003|Overall Study|Protocol Violation|0|||
170457716|NCT01929031|616016173|FG004|Overall Study|Protocol Violation|0|||
170457717|NCT01929031|616016174|FG005|Overall Study|Protocol Violation|1|||
170457718|NCT01929031|616016169|FG000|Overall Study|Reason other than specified above|0|||
170457719|NCT01929031|616016170|FG001|Overall Study|Reason other than specified above|1|||
170457720|NCT01929031|616016171|FG002|Overall Study|Reason other than specified above|0|||
170457721|NCT01929031|616016172|FG003|Overall Study|Reason other than specified above|0|||
170457722|NCT01929031|616016173|FG004|Overall Study|Reason other than specified above|1|||
170457723|NCT01929031|616016174|FG005|Overall Study|Reason other than specified above|0|||
170542960|NCT03369223|616331140|FG007|Overall Study|Participant withdrew consent|1|||
170542961|NCT03369223|616331141|FG008|Overall Study|Participant withdrew consent|1|||
170542962|NCT03369223|616331142|FG009|Overall Study|Participant withdrew consent|0|||
170542963|NCT03369223|616331143|FG010|Overall Study|Participant withdrew consent|0|||
170542964|NCT03369223|616331144|FG011|Overall Study|Participant withdrew consent|1|||
170542965|NCT03369223|616331145|FG012|Overall Study|Participant withdrew consent|0|||
170542966|NCT03369223|616331146|FG013|Overall Study|Participant withdrew consent|0|||
170542967|NCT03369223|616331147|FG014|Overall Study|Participant withdrew consent|3|||
170542968|NCT03369223|616331148|FG015|Overall Study|Participant withdrew consent|0|||
170646061|NCT01628029|616717880|FG001|Overall Study|Incomplete primary outcome assessment|1|||
170889203|NCT02347176|617600633|FG000|Overall Study|Other|1|||
170457724|NCT01366443|616016175|FG000|Overall Study|Lost to Follow-up|2|||
170457725|NCT01366443|616016175|FG000|Overall Study|Under 18 yo|1|||
170457726|NCT00369382|616016181|FG000|Overall Study|Death|0|||
170457727|NCT00369382|616016182|FG001|Overall Study|Death|2|||
170457728|NCT00369382|616016181|FG000|Overall Study|Physician Decision|2|||
170457729|NCT00369382|616016182|FG001|Overall Study|Physician Decision|1|||
170457730|NCT00369382|616016181|FG000|Overall Study|Withdrawal by Subject|5|||
170542969|NCT03369223|616331149|FG016|Overall Study|Participant withdrew consent|1|||
170542970|NCT03369223|616331150|FG017|Overall Study|Participant withdrew consent|0|||
170542971|NCT03369223|616331151|FG018|Overall Study|Participant withdrew consent|4|||
170457731|NCT00369382|616016182|FG001|Overall Study|Withdrawal by Subject|0|||
170457732|NCT00369382|616016181|FG000|Overall Study|Randomized, not treated|2|||
170457733|NCT00369382|616016182|FG001|Overall Study|Randomized, not treated|0|||
170457734|NCT00369382|616016181|FG000|Overall Study|Other|1|||
170457735|NCT00369382|616016182|FG001|Overall Study|Other|0|||
170457736|NCT01393730|616016183|FG000|Overall Study|Withdrawal by Subject|3|||
170457737|NCT01393730|616016183|FG000|Overall Study|Other|2|||
170457738|NCT01393730|616016183|FG000|Overall Study|Adverse Event|1|||
170457739|NCT00448136|616016188|FG000|Overall Study|Death|3|||
170457740|NCT00448136|616016189|FG001|Overall Study|Death|8|||
170457741|NCT00448136|616016188|FG000|Overall Study|Investigator's decision (progression)|1|||
170457742|NCT00448136|616016189|FG001|Overall Study|Investigator's decision (progression)|0|||
170457743|NCT00609466|616016190|FG000|Overall Study|Withdrawal by Subject|0|||
170457744|NCT00609466|616016191|FG001|Overall Study|Withdrawal by Subject|1|||
170457745|NCT00609466|616016192|FG002|Overall Study|Withdrawal by Subject|1|||
170457746|NCT00609466|616016190|FG000|Overall Study|Adverse Event|2|||
170457747|NCT00609466|616016191|FG001|Overall Study|Adverse Event|3|||
170457748|NCT00609466|616016192|FG002|Overall Study|Adverse Event|1|||
170457749|NCT00609466|616016190|FG000|Overall Study|Lack of Efficacy|0|||
170457750|NCT00609466|616016191|FG001|Overall Study|Lack of Efficacy|2|||
170457751|NCT00609466|616016192|FG002|Overall Study|Lack of Efficacy|2|||
170457752|NCT03512262|616016193|FG000|Overall Study|Adverse Event|8|||
170457753|NCT03512262|616016194|FG001|Overall Study|Adverse Event|3|||
170457754|NCT03512262|616016193|FG000|Overall Study|Death (non-treatment emergent)|1|||
170457755|NCT03512262|616016194|FG001|Overall Study|Death (non-treatment emergent)|0|||
170457756|NCT03512262|616016193|FG000|Overall Study|Withdrawal by Subject|17|||
170457757|NCT03512262|616016194|FG001|Overall Study|Withdrawal by Subject|9|||
170457758|NCT03512262|616016193|FG000|Overall Study|Lost to Follow-up|7|||
170457759|NCT03512262|616016194|FG001|Overall Study|Lost to Follow-up|1|||
170457760|NCT03512262|616016193|FG000|Overall Study|Other than Specified|2|||
170457761|NCT03512262|616016194|FG001|Overall Study|Other than Specified|2|||
170457762|NCT03407430|616016197|FG000|Washout|Protocol Violation|1|||
170457763|NCT03407430|616016198|FG001|Washout|Protocol Violation|0|||
170457764|NCT00922987|616016200|FG000|Overall Study|Insufficient clinical response|1|||
170457765|NCT00922987|616016200|FG000|Overall Study|Protocol Violation|2|||
170457766|NCT00922987|616016200|FG000|Overall Study|Adverse Event|1|||
170457767|NCT03510182|616016201|FG000|Overall Study|Withdrawal by Subject|2|||
170457768|NCT01334710|616016208|FG000|Overall Study|Trial was terminated|3|||
170457769|NCT00852969|616018570|FG000|Overall Study|Adverse Event|0|||
170457770|NCT00852969|616018571|FG001|Overall Study|Adverse Event|1|||
170457771|NCT00852969|616018570|FG000|Overall Study|Lost to Follow-up|0|||
170457772|NCT00852969|616018571|FG001|Overall Study|Lost to Follow-up|1|||
170457773|NCT00678041|616018572|FG000|Overall Study|Physician Decision|5|||
170457774|NCT00678041|616018573|FG001|Overall Study|Physician Decision|5|||
170457775|NCT02358343|616018574|FG000|Screening Intervention|Death|0|||
170457776|NCT02358343|616018575|FG001|Screening Intervention|Death|2|||
170457777|NCT02358343|616018576|FG002|Screening Intervention|Death|0|||
170457778|NCT02358343|616018577|FG003|Screening Intervention|Death|0|||
170457779|NCT02358343|616018578|FG004|Screening Intervention|Death|0|||
170457780|NCT02358343|616018574|FG000|Screening Intervention|Withdrawal by Subject|1|||
170457781|NCT02358343|616018575|FG001|Screening Intervention|Withdrawal by Subject|0|||
170457782|NCT02358343|616018576|FG002|Screening Intervention|Withdrawal by Subject|0|||
170457783|NCT02358343|616018577|FG003|Screening Intervention|Withdrawal by Subject|0|||
170457784|NCT02358343|616018578|FG004|Screening Intervention|Withdrawal by Subject|0|||
170457785|NCT02358343|616018574|FG000|Screening Intervention|Determined Ineligible|5|||
170457786|NCT02358343|616018575|FG001|Screening Intervention|Determined Ineligible|6|||
170457787|NCT02358343|616018576|FG002|Screening Intervention|Determined Ineligible|0|||
170457788|NCT02358343|616018577|FG003|Screening Intervention|Determined Ineligible|0|||
170457789|NCT02358343|616018578|FG004|Screening Intervention|Determined Ineligible|0|||
170787901|NCT01369355|617234163|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
170787902|NCT01369355|617234164|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
170457790|NCT02358343|616018574|FG000|Comparative Efficacy Trial / Observation|Death|0|||
170457791|NCT02358343|616018575|FG001|Comparative Efficacy Trial / Observation|Death|0|||
170787903|NCT01369355|617234165|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
170787904|NCT01369355|617234166|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
170787905|NCT01369355|617234167|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
170787906|NCT01369355|617234168|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
170457792|NCT02358343|616018576|FG002|Comparative Efficacy Trial / Observation|Death|2|||
170457793|NCT02358343|616018577|FG003|Comparative Efficacy Trial / Observation|Death|0|||
170457794|NCT02358343|616018578|FG004|Comparative Efficacy Trial / Observation|Death|0|||
170457795|NCT02358343|616018574|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
170457796|NCT02358343|616018575|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
170457797|NCT02358343|616018576|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
170457798|NCT02358343|616018577|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
170457799|NCT02358343|616018578|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
170457800|NCT02358343|616018574|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
170787907|NCT01369355|617234169|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
170889204|NCT02347176|617600634|FG001|Overall Study|Other|2|||
170889205|NCT02347176|617600635|FG002|Overall Study|Other|2|||
170457801|NCT02358343|616018575|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
170457802|NCT02358343|616018576|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
170457803|NCT02358343|616018577|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
170457804|NCT02358343|616018578|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
170457805|NCT03596151|616018581|FG000|Overall Study|Withdrawal by Subject|1|||
170457806|NCT04498403|616018583|FG000|Overall Study|Adverse Event|1|||
170457807|NCT04498403|616018584|FG001|Overall Study|Adverse Event|0|||
170457808|NCT04498403|616018583|FG000|Overall Study|Study Terminated By Sponsor|29|||
170457809|NCT04498403|616018584|FG001|Overall Study|Study Terminated By Sponsor|10|||
170457810|NCT01951885|616018585|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
170457811|NCT01951885|616018586|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
170457812|NCT01951885|616018585|FG000|Overall Study|Adverse Event|1|||
170457813|NCT01951885|616018586|FG001|Overall Study|Adverse Event|0|||
170457814|NCT01951885|616018585|FG000|Overall Study|Withdrawal by Subject|0|||
170457815|NCT01951885|616018586|FG001|Overall Study|Withdrawal by Subject|1|||
170457816|NCT01951885|616018585|FG000|Overall Study|ineligible due to a change in donor|0|||
170457817|NCT01951885|616018586|FG001|Overall Study|ineligible due to a change in donor|1|||
170457818|NCT01951885|616018585|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
170457819|NCT01951885|616018586|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
170457820|NCT03986138|616018587|FG000|First MRI Examination|Physician Decision|0|||
170457821|NCT03986138|616018588|FG001|First MRI Examination|Physician Decision|1|||
170457822|NCT03986138|616018587|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
170457823|NCT03986138|616018588|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
170457824|NCT03986138|616018587|FG000|Washout|Withdrawal by Subject|4|||
170457825|NCT03986138|616018588|FG001|Washout|Withdrawal by Subject|5|||
170457826|NCT03986138|616018587|FG000|Washout|Lost to Follow-up|0|||
170457827|NCT03986138|616018588|FG001|Washout|Lost to Follow-up|2|||
170457828|NCT03986138|616018587|FG000|Washout|Adverse Event|1|||
170457829|NCT03986138|616018588|FG001|Washout|Adverse Event|1|||
170457830|NCT03986138|616018587|FG000|Washout|Other reason|5|||
170457831|NCT03986138|616018588|FG001|Washout|Other reason|5|||
170457832|NCT03986138|616018587|FG000|Second MRI Examination|Withdrawal by Subject|0|||
170457833|NCT03986138|616018588|FG001|Second MRI Examination|Withdrawal by Subject|2|||
170457834|NCT02031458|616018590|FG000|May 8, 2015 to January 11, 2019|Death|89|||
170457835|NCT02031458|616018591|FG001|May 8, 2015 to January 11, 2019|Death|193|||
170457836|NCT02031458|616018592|FG002|May 8, 2015 to January 11, 2019|Death|198|||
170457837|NCT02031458|616018590|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
170457838|NCT02031458|616018591|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
170457839|NCT02031458|616018592|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
170457840|NCT02031458|616018590|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
170457841|NCT02031458|616018591|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
170457842|NCT02031458|616018592|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
170457843|NCT02031458|616018590|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
170457844|NCT02031458|616018591|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
170457845|NCT02031458|616018592|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
170457846|NCT02031458|616018590|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
170457847|NCT02031458|616018591|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
170457848|NCT02031458|616018592|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
170457849|NCT02031458|616018590|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
170457850|NCT02031458|616018591|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
170457851|NCT02031458|616018592|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
170457852|NCT02031458|616018590|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
170457853|NCT02031458|616018591|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
170457854|NCT02031458|616018592|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
170457855|NCT02031458|616018590|FG000|Baseline to May 8, 2015|Death|36|||
170457856|NCT02031458|616018591|FG001|Baseline to May 8, 2015|Death|87|||
170457857|NCT02031458|616018592|FG002|Baseline to May 8, 2015|Death|100|||
170457858|NCT02031458|616018590|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
170457859|NCT02031458|616018591|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
170457860|NCT02031458|616018592|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
170457861|NCT02031458|616018590|FG000|Baseline to May 8, 2015|Physician Decision|0|||
170457862|NCT02031458|616018591|FG001|Baseline to May 8, 2015|Physician Decision|1|||
170457863|NCT02031458|616018592|FG002|Baseline to May 8, 2015|Physician Decision|0|||
170457864|NCT02031458|616018590|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
170457865|NCT02031458|616018591|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
170457866|NCT02031458|616018592|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
170457867|NCT02031458|616018590|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
170457868|NCT02031458|616018591|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
170457869|NCT02031458|616018592|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
170457870|NCT02031458|616018590|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
170457871|NCT02031458|616018591|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
170457872|NCT02031458|616018592|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
170457873|NCT02031458|616018590|FG000|Baseline to May 8, 2015|On Treatment|43|||
170457874|NCT02031458|616018591|FG001|Baseline to May 8, 2015|On Treatment|81|||
170457875|NCT02031458|616018592|FG002|Baseline to May 8, 2015|On Treatment|73|||
170457876|NCT02031458|616018590|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
170457877|NCT02031458|616018591|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
170457878|NCT02031458|616018592|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
170457879|NCT04305587|616018593|FG000|Overall Study|Withdrawal by Subject|0|||
170457880|NCT04305587|616018594|FG001|Overall Study|Withdrawal by Subject|0|||
170457881|NCT04305587|616018595|FG002|Overall Study|Withdrawal by Subject|0|||
170457882|NCT04305587|616018596|FG003|Overall Study|Withdrawal by Subject|1|||
170457883|NCT04305587|616018597|FG004|Overall Study|Withdrawal by Subject|0|||
170457884|NCT04305587|616018598|FG005|Overall Study|Withdrawal by Subject|0|||
170457885|NCT04305587|616018599|FG006|Overall Study|Withdrawal by Subject|0|||
170457886|NCT04305587|616018600|FG007|Overall Study|Withdrawal by Subject|0|||
170457887|NCT04305587|616018601|FG008|Overall Study|Withdrawal by Subject|0|||
170457888|NCT02049450|616018603|FG000|Overall Study|Adverse Event|2|||
170457889|NCT02049450|616018603|FG000|Overall Study|Withdrawal by Subject|1|||
170457890|NCT02049450|616018603|FG000|Overall Study|Patients/guardian decision|1|||
170457891|NCT02492880|616018604|FG000|Overall Study|Lost to Follow-up|1|||
170457892|NCT02492880|616018604|FG000|Overall Study|Protocol Violation|1|||
170457893|NCT00292188|616018608|FG000|Single-Blind|Adverse Event|14|||
170457894|NCT00292188|616018609|FG001|Single-Blind|Adverse Event|0|||
170457895|NCT00292188|616018610|FG002|Single-Blind|Adverse Event|0|||
170457896|NCT00292188|616018608|FG000|Single-Blind|Lack of Efficacy|2|||
170457897|NCT00292188|616018609|FG001|Single-Blind|Lack of Efficacy|0|||
170457898|NCT00292188|616018610|FG002|Single-Blind|Lack of Efficacy|0|||
170457899|NCT00292188|616018608|FG000|Single-Blind|Laboratory Abnormality|5|||
170457900|NCT00292188|616018609|FG001|Single-Blind|Laboratory Abnormality|0|||
170457901|NCT00292188|616018610|FG002|Single-Blind|Laboratory Abnormality|0|||
170457902|NCT00292188|616018608|FG000|Single-Blind|Lost to Follow-up|3|||
170457903|NCT00292188|616018609|FG001|Single-Blind|Lost to Follow-up|0|||
170457904|NCT00292188|616018610|FG002|Single-Blind|Lost to Follow-up|0|||
170457905|NCT00292188|616018608|FG000|Single-Blind|Other|77|||
170457906|NCT00292188|616018609|FG001|Single-Blind|Other|0|||
170457907|NCT00292188|616018610|FG002|Single-Blind|Other|0|||
170457908|NCT00292188|616018608|FG000|Single-Blind|Withdrawal by Subject|12|||
170457909|NCT00292188|616018609|FG001|Single-Blind|Withdrawal by Subject|0|||
170457910|NCT00292188|616018610|FG002|Single-Blind|Withdrawal by Subject|0|||
170457911|NCT00292188|616018608|FG000|Single-Blind|Did not receive treatment|1|||
170457912|NCT00292188|616018609|FG001|Single-Blind|Did not receive treatment|0|||
170457913|NCT00292188|616018610|FG002|Single-Blind|Did not receive treatment|0|||
170457914|NCT00292188|616018608|FG000|Double-Blind|Adverse Event|0|||
170457915|NCT00292188|616018609|FG001|Double-Blind|Adverse Event|25|||
170457916|NCT00292188|616018610|FG002|Double-Blind|Adverse Event|9|||
170457917|NCT00292188|616018608|FG000|Double-Blind|Lack of Efficacy|0|||
170457918|NCT00292188|616018609|FG001|Double-Blind|Lack of Efficacy|2|||
170457919|NCT00292188|616018610|FG002|Double-Blind|Lack of Efficacy|12|||
170457920|NCT00292188|616018608|FG000|Double-Blind|Lost to Follow-up|0|||
170457921|NCT00292188|616018609|FG001|Double-Blind|Lost to Follow-up|1|||
170457922|NCT00292188|616018610|FG002|Double-Blind|Lost to Follow-up|0|||
170457923|NCT00292188|616018608|FG000|Double-Blind|Other|0|||
170457924|NCT00292188|616018609|FG001|Double-Blind|Other|3|||
170457925|NCT00292188|616018610|FG002|Double-Blind|Other|4|||
170542972|NCT03369223|616331152|FG019|Overall Study|Participant withdrew consent|2|||
170542973|NCT03369223|616331133|FG000|Overall Study|Randomized but not treated|0|||
170457926|NCT00292188|616018608|FG000|Double-Blind|Withdrawal by Subject|0|||
170457927|NCT00292188|616018609|FG001|Double-Blind|Withdrawal by Subject|0|||
170457928|NCT00292188|616018610|FG002|Double-Blind|Withdrawal by Subject|3|||
170542974|NCT03369223|616331134|FG001|Overall Study|Randomized but not treated|0|||
170542975|NCT03369223|616331135|FG002|Overall Study|Randomized but not treated|0|||
170542976|NCT03369223|616331136|FG003|Overall Study|Randomized but not treated|0|||
170542977|NCT03369223|616331137|FG004|Overall Study|Randomized but not treated|0|||
170542978|NCT03369223|616331138|FG005|Overall Study|Randomized but not treated|0|||
170542979|NCT03369223|616331139|FG006|Overall Study|Randomized but not treated|0|||
170542980|NCT03369223|616331140|FG007|Overall Study|Randomized but not treated|0|||
170457929|NCT00292188|616018608|FG000|Double-Blind|Laboratory Abnormality|0|||
170542981|NCT03369223|616331141|FG008|Overall Study|Randomized but not treated|0|||
170542982|NCT03369223|616331142|FG009|Overall Study|Randomized but not treated|0|||
170457930|NCT00292188|616018609|FG001|Double-Blind|Laboratory Abnormality|0|||
170457931|NCT00292188|616018610|FG002|Double-Blind|Laboratory Abnormality|1|||
170457932|NCT03186781|616018613|FG000|Overall Study|Lost to Follow-up|0|||
170457933|NCT03186781|616018614|FG001|Overall Study|Lost to Follow-up|0|||
170457934|NCT03186781|616018615|FG002|Overall Study|Lost to Follow-up|1|||
170457935|NCT03186781|616018616|FG003|Overall Study|Lost to Follow-up|0|||
170457936|NCT03186781|616018617|FG004|Overall Study|Lost to Follow-up|1|||
170635981|NCT03682770|616678913|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
170635982|NCT03682770|616678914|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
170635983|NCT03682770|616678915|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
170635984|NCT03682770|616678916|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
170635985|NCT03682770|616678917|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
170635986|NCT02863419|616678918|FG000|Overall Study|Lost to Follow-up|0|||
170635987|NCT02863419|616678919|FG001|Overall Study|Lost to Follow-up|1|||
170635988|NCT02863419|616678920|FG002|Overall Study|Lost to Follow-up|4|||
170635989|NCT02863419|616678918|FG000|Overall Study|Withdrawal by Subject|5|||
170635990|NCT02863419|616678919|FG001|Overall Study|Withdrawal by Subject|5|||
170787908|NCT01369355|617234161|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
170787909|NCT01369355|617234162|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
170787910|NCT01369355|617234163|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
170787911|NCT01369355|617234164|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
170787912|NCT01369355|617234165|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
170787913|NCT01369355|617234166|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
170787914|NCT01369355|617234167|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
170787915|NCT01369355|617234168|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
170787916|NCT01369355|617234169|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
170787917|NCT01369355|617234161|FG000|Long-term Extension (Week 44-272)|Death|0|||
170787918|NCT01369355|617234162|FG001|Long-term Extension (Week 44-272)|Death|0|||
170787919|NCT01369355|617234163|FG002|Long-term Extension (Week 44-272)|Death|0|||
170787920|NCT01369355|617234164|FG003|Long-term Extension (Week 44-272)|Death|0|||
170787921|NCT01369355|617234165|FG004|Long-term Extension (Week 44-272)|Death|0|||
170787922|NCT01369355|617234166|FG005|Long-term Extension (Week 44-272)|Death|0|||
170787923|NCT01369355|617234167|FG006|Long-term Extension (Week 44-272)|Death|0|||
170787924|NCT01369355|617234168|FG007|Long-term Extension (Week 44-272)|Death|1|||
170787925|NCT01369355|617234169|FG008|Long-term Extension (Week 44-272)|Death|3|||
170787926|NCT01369355|617234161|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
170787927|NCT01369355|617234162|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
170787928|NCT01369355|617234163|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
170787929|NCT01369355|617234164|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
170787930|NCT01369355|617234165|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
170787931|NCT01369355|617234166|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
170787932|NCT01369355|617234167|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
170787933|NCT01369355|617234168|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
170787934|NCT01369355|617234169|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
170787935|NCT01369355|617234161|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
170787936|NCT01369355|617234162|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
170787937|NCT01369355|617234163|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
170787938|NCT01369355|617234164|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
170787939|NCT01369355|617234165|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
170787940|NCT01369355|617234166|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
170787941|NCT01369355|617234167|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
170787942|NCT01369355|617234168|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
170787943|NCT01369355|617234169|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
170787944|NCT01369355|617234161|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
170787945|NCT01369355|617234162|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
170787946|NCT01369355|617234163|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
170787947|NCT01369355|617234164|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
170787948|NCT01369355|617234165|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
170787949|NCT01369355|617234166|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
170787950|NCT01369355|617234167|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
170787951|NCT01369355|617234168|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
170787952|NCT01369355|617234169|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
170787953|NCT01369355|617234161|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
170787954|NCT01369355|617234162|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
170787955|NCT01369355|617234163|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
170787956|NCT01369355|617234164|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
170787957|NCT01369355|617234165|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
170787958|NCT01369355|617234166|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
170787959|NCT01369355|617234167|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
170787960|NCT01369355|617234168|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
170787961|NCT01369355|617234169|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
170787962|NCT01369355|617234161|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
170787963|NCT01369355|617234162|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
170787964|NCT01369355|617234163|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
170889206|NCT02347176|617600636|FG003|Overall Study|Other|0|||
170457937|NCT03186781|616018618|FG005|Overall Study|Lost to Follow-up|0|||
170457938|NCT03186781|616018613|FG000|Overall Study|Moved from Area|0|||
170457939|NCT03186781|616018614|FG001|Overall Study|Moved from Area|0|||
170457940|NCT03186781|616018615|FG002|Overall Study|Moved from Area|0|||
170457941|NCT03186781|616018616|FG003|Overall Study|Moved from Area|0|||
170457942|NCT03186781|616018617|FG004|Overall Study|Moved from Area|1|||
170457943|NCT03186781|616018618|FG005|Overall Study|Moved from Area|0|||
170457944|NCT03186781|616018613|FG000|Overall Study|Withdrawal by Subject|0|||
170457945|NCT03186781|616018614|FG001|Overall Study|Withdrawal by Subject|0|||
170457946|NCT03186781|616018615|FG002|Overall Study|Withdrawal by Subject|0|||
170457947|NCT03186781|616018616|FG003|Overall Study|Withdrawal by Subject|0|||
170457948|NCT03186781|616018617|FG004|Overall Study|Withdrawal by Subject|1|||
170457949|NCT03186781|616018618|FG005|Overall Study|Withdrawal by Subject|0|||
170457950|NCT00554190|616018619|FG000|Overall Study|Termination forms not completed|10|||
170889207|NCT00939692|617600641|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
170889208|NCT00939692|617600642|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
170889209|NCT00939692|617600641|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
170889210|NCT00939692|617600642|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
170889211|NCT01536860|617600643|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
170889212|NCT01536860|617600644|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
170889213|NCT01536860|617600645|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
170889214|NCT01543087|617600651|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
170889215|NCT01543087|617600652|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
170889216|NCT01543087|617600653|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
170889217|NCT01543087|617600654|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
170457951|NCT04709835|616018620|FG000|Overall Study|Withdrawal by Subject|0|||
170457952|NCT04709835|616018621|FG001|Overall Study|Withdrawal by Subject|1|||
170457953|NCT04709835|616018622|FG002|Overall Study|Withdrawal by Subject|0|||
170542983|NCT03369223|616331143|FG010|Overall Study|Randomized but not treated|0|||
170542984|NCT03369223|616331144|FG011|Overall Study|Randomized but not treated|0|||
170542985|NCT03369223|616331145|FG012|Overall Study|Randomized but not treated|0|||
170542986|NCT03369223|616331146|FG013|Overall Study|Randomized but not treated|1|||
170542987|NCT03369223|616331147|FG014|Overall Study|Randomized but not treated|1|||
170542988|NCT03369223|616331148|FG015|Overall Study|Randomized but not treated|0|||
170542989|NCT03369223|616331149|FG016|Overall Study|Randomized but not treated|0|||
170542990|NCT03369223|616331150|FG017|Overall Study|Randomized but not treated|0|||
170542991|NCT03369223|616331151|FG018|Overall Study|Randomized but not treated|0|||
170542992|NCT03369223|616331152|FG019|Overall Study|Randomized but not treated|0|||
170542993|NCT03692052|616331153|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
170542994|NCT03692052|616331153|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
170542995|NCT03692052|616331153|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
170542996|NCT03692052|616331153|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
170542997|NCT05480943|616331154|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
170542998|NCT05480943|616331154|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
170542999|NCT05480943|616331154|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
170543000|NCT05480943|616331154|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
170543001|NCT05076266|616331155|FG000|Overall Study|Survey not complete - Participant refusal|2|||
170543002|NCT05076266|616331156|FG001|Overall Study|Survey not complete - Participant refusal|0|||
170543003|NCT03974022|616331157|FG000|Overall Study|Death|0|||
170543004|NCT03974022|616331158|FG001|Overall Study|Death|1|||
170543005|NCT03974022|616331159|FG002|Overall Study|Death|0|||
170543006|NCT03974022|616331160|FG003|Overall Study|Death|2|||
170543007|NCT03974022|616331161|FG004|Overall Study|Death|0|||
170543008|NCT03974022|616331162|FG005|Overall Study|Death|1|||
170543009|NCT03974022|616331163|FG006|Overall Study|Death|0|||
170543010|NCT03974022|616331164|FG007|Overall Study|Death|2|||
170543011|NCT03974022|616331165|FG008|Overall Study|Death|1|||
170543012|NCT03974022|616331166|FG009|Overall Study|Death|4|||
170543013|NCT03974022|616331167|FG010|Overall Study|Death|0|||
170543014|NCT03974022|616331168|FG011|Overall Study|Death|0|||
170457954|NCT04711902|616018623|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
170457955|NCT04711902|616018624|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
170543015|NCT03974022|616331169|FG012|Overall Study|Death|0|||
170543016|NCT03974022|616331170|FG013|Overall Study|Death|33|||
170543017|NCT03974022|616331171|FG014|Overall Study|Death|40|||
170543018|NCT03974022|616331157|FG000|Overall Study|Withdrawal by Subject|0|||
170543019|NCT03974022|616331158|FG001|Overall Study|Withdrawal by Subject|0|||
170543020|NCT03974022|616331159|FG002|Overall Study|Withdrawal by Subject|0|||
170543021|NCT03974022|616331160|FG003|Overall Study|Withdrawal by Subject|0|||
170543022|NCT03974022|616331161|FG004|Overall Study|Withdrawal by Subject|0|||
170635991|NCT02863419|616678920|FG002|Overall Study|Withdrawal by Subject|3|||
170635992|NCT02863419|616678918|FG000|Overall Study|Died|3|||
170889218|NCT01543087|617600655|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
170457956|NCT04711902|616018625|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
170457957|NCT04711902|616018626|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
170457958|NCT04711902|616018627|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
170457959|NCT04711902|616018628|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
170457960|NCT03786718|616018629|FG000|Overall Study|Lost to Follow-up|3|||
170457961|NCT03786718|616018629|FG000|Overall Study|Withdrawal by Subject|1|||
170457962|NCT03786718|616018629|FG000|Overall Study|Did not use the intervention|2|||
170457963|NCT03786718|616018629|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
170457964|NCT00372411|616018632|FG000|Overall Study|Withdrawal by Subject|3|||
170457965|NCT00372411|616018633|FG001|Overall Study|Withdrawal by Subject|4|||
170457966|NCT00372411|616018634|FG002|Overall Study|Withdrawal by Subject|1|||
170457967|NCT00372411|616018632|FG000|Overall Study|Death|0|||
170457968|NCT00372411|616018633|FG001|Overall Study|Death|2|||
170457969|NCT00372411|616018634|FG002|Overall Study|Death|1|||
170457970|NCT00372411|616018632|FG000|Overall Study|Lost to Follow-up|1|||
170457971|NCT00372411|616018633|FG001|Overall Study|Lost to Follow-up|1|||
170457972|NCT00372411|616018634|FG002|Overall Study|Lost to Follow-up|1|||
170457973|NCT00372411|616018632|FG000|Overall Study|Adverse Event|1|||
170457974|NCT00372411|616018633|FG001|Overall Study|Adverse Event|1|||
170457975|NCT00372411|616018634|FG002|Overall Study|Adverse Event|0|||
170457976|NCT00667810|616018638|FG000|Overall Study|Adverse Event|13|||
170457977|NCT00667810|616018639|FG001|Overall Study|Adverse Event|14|||
170457978|NCT00667810|616018640|FG002|Overall Study|Adverse Event|19|||
170457979|NCT00667810|616018641|FG003|Overall Study|Adverse Event|1|||
170457980|NCT00667810|616018638|FG000|Overall Study|Death|1|||
170457981|NCT00667810|616018639|FG001|Overall Study|Death|1|||
170457982|NCT00667810|616018640|FG002|Overall Study|Death|3|||
170457983|NCT00667810|616018641|FG003|Overall Study|Death|0|||
170457984|NCT00667810|616018638|FG000|Overall Study|Lack of Efficacy|1|||
170457985|NCT00667810|616018639|FG001|Overall Study|Lack of Efficacy|0|||
170457986|NCT00667810|616018640|FG002|Overall Study|Lack of Efficacy|2|||
170457987|NCT00667810|616018641|FG003|Overall Study|Lack of Efficacy|0|||
170457988|NCT00667810|616018638|FG000|Overall Study|Lost to Follow-up|1|||
170457989|NCT00667810|616018639|FG001|Overall Study|Lost to Follow-up|4|||
170457990|NCT00667810|616018640|FG002|Overall Study|Lost to Follow-up|2|||
170457991|NCT00667810|616018641|FG003|Overall Study|Lost to Follow-up|0|||
170457992|NCT00667810|616018638|FG000|Overall Study|Physician Decision|1|||
170457993|NCT00667810|616018639|FG001|Overall Study|Physician Decision|1|||
170457994|NCT00667810|616018640|FG002|Overall Study|Physician Decision|2|||
170457995|NCT00667810|616018641|FG003|Overall Study|Physician Decision|0|||
170457996|NCT00667810|616018638|FG000|Overall Study|Protocol Violation|0|||
170457997|NCT00667810|616018639|FG001|Overall Study|Protocol Violation|2|||
170457998|NCT00667810|616018640|FG002|Overall Study|Protocol Violation|0|||
170457999|NCT00667810|616018641|FG003|Overall Study|Protocol Violation|0|||
170458000|NCT00667810|616018638|FG000|Overall Study|Withdrawal by Subject|14|||
170458001|NCT00667810|616018639|FG001|Overall Study|Withdrawal by Subject|20|||
170458002|NCT00667810|616018640|FG002|Overall Study|Withdrawal by Subject|29|||
170458003|NCT00667810|616018641|FG003|Overall Study|Withdrawal by Subject|1|||
170635993|NCT02863419|616678919|FG001|Overall Study|Died|4|||
170635994|NCT02863419|616678920|FG002|Overall Study|Died|1|||
170635995|NCT05021978|616678923|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
170635996|NCT05021978|616678924|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
170635997|NCT05021978|616678925|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
170635998|NCT05021978|616678926|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
170635999|NCT05021978|616678923|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
170636000|NCT05021978|616678924|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
170636001|NCT05021978|616678925|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
170636002|NCT05021978|616678926|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
170636003|NCT00196313|616678927|FG000|Overall Study|Protocol Violation|2|||
170636004|NCT00196313|616678928|FG001|Overall Study|Protocol Violation|3|||
170636005|NCT00196313|616678927|FG000|Overall Study|Withdrawal by Subject|3|||
170636006|NCT00196313|616678928|FG001|Overall Study|Withdrawal by Subject|1|||
170458004|NCT00667810|616018638|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
170636007|NCT00196313|616678927|FG000|Overall Study|Adverse Event|3|||
170636008|NCT00196313|616678928|FG001|Overall Study|Adverse Event|1|||
170458005|NCT00667810|616018639|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
170458006|NCT00667810|616018640|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
170458007|NCT00667810|616018641|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
170458008|NCT00667810|616018638|FG000|Overall Study|Failed to Return|0|||
170458009|NCT00667810|616018639|FG001|Overall Study|Failed to Return|0|||
170458010|NCT00667810|616018640|FG002|Overall Study|Failed to Return|2|||
170458011|NCT00667810|616018641|FG003|Overall Study|Failed to Return|0|||
170458012|NCT00667810|616018638|FG000|Overall Study|Loss of Caregiver|0|||
170458013|NCT00667810|616018639|FG001|Overall Study|Loss of Caregiver|1|||
170458014|NCT00667810|616018640|FG002|Overall Study|Loss of Caregiver|3|||
170458015|NCT00667810|616018641|FG003|Overall Study|Loss of Caregiver|0|||
170458016|NCT00667810|616018638|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
170458017|NCT00667810|616018639|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
170636009|NCT00196313|616678927|FG000|Overall Study|Subject Pregnant|1|||
170636010|NCT00196313|616678928|FG001|Overall Study|Subject Pregnant|1|||
170458018|NCT00667810|616018640|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
170458019|NCT00667810|616018641|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
170458020|NCT00667810|616018638|FG000|Overall Study|Other|6|||
170458021|NCT00667810|616018639|FG001|Overall Study|Other|6|||
170458022|NCT00667810|616018640|FG002|Overall Study|Other|5|||
170458023|NCT00667810|616018641|FG003|Overall Study|Other|0|||
170458024|NCT01561430|616018642|FG000|Overall Study|Adverse Event|0|||
170458025|NCT01561430|616018643|FG001|Overall Study|Adverse Event|0|||
170458026|NCT01561430|616018644|FG002|Overall Study|Adverse Event|3|||
170458027|NCT01561430|616018645|FG003|Overall Study|Adverse Event|1|||
170458028|NCT01561430|616018642|FG000|Overall Study|Withdrawal by Subject|0|||
170458029|NCT01561430|616018643|FG001|Overall Study|Withdrawal by Subject|0|||
170458030|NCT01561430|616018644|FG002|Overall Study|Withdrawal by Subject|1|||
170458031|NCT01561430|616018645|FG003|Overall Study|Withdrawal by Subject|0|||
170458032|NCT01561430|616018642|FG000|Overall Study|Physician Decision|0|||
170458033|NCT01561430|616018643|FG001|Overall Study|Physician Decision|1|||
170458034|NCT01561430|616018644|FG002|Overall Study|Physician Decision|0|||
170458035|NCT01561430|616018645|FG003|Overall Study|Physician Decision|0|||
170458036|NCT01561430|616018642|FG000|Overall Study|Sponsor Decision|1|||
170458037|NCT01561430|616018643|FG001|Overall Study|Sponsor Decision|14|||
170458038|NCT01561430|616018644|FG002|Overall Study|Sponsor Decision|13|||
170458039|NCT01561430|616018645|FG003|Overall Study|Sponsor Decision|12|||
170458040|NCT04234984|616018646|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
170458041|NCT04234984|616018646|FG000|Follow-up at the Second Time Point|Death|1|||
170458042|NCT04234984|616018646|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
170458043|NCT01055132|616018647|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
170458044|NCT01055132|616018648|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
170458045|NCT01055132|616018647|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
170458046|NCT01055132|616018648|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
170458047|NCT02038907|616018649|FG000|Overall Study|Protocol Violation|0|||
170458048|NCT02038907|616018650|FG001|Overall Study|Protocol Violation|0|||
170458049|NCT02038907|616018651|FG002|Overall Study|Protocol Violation|0|||
170458050|NCT02038907|616018652|FG003|Overall Study|Protocol Violation|0|||
170458051|NCT02038907|616018653|FG004|Overall Study|Protocol Violation|0|||
170458052|NCT02038907|616018654|FG005|Overall Study|Protocol Violation|0|||
170458053|NCT02038907|616018655|FG006|Overall Study|Protocol Violation|0|||
170458054|NCT02038907|616018656|FG007|Overall Study|Protocol Violation|0|||
170458055|NCT02038907|616018657|FG008|Overall Study|Protocol Violation|0|||
170458056|NCT02038907|616018658|FG009|Overall Study|Protocol Violation|0|||
170458057|NCT02038907|616018659|FG010|Overall Study|Protocol Violation|1|||
170458058|NCT02038907|616018660|FG011|Overall Study|Protocol Violation|0|||
170458059|NCT02038907|616018661|FG012|Overall Study|Protocol Violation|0|||
170458060|NCT02038907|616018662|FG013|Overall Study|Protocol Violation|0|||
170458061|NCT02038907|616018649|FG000|Overall Study|Withdrawal by Subject|0|||
170458062|NCT02038907|616018650|FG001|Overall Study|Withdrawal by Subject|0|||
170458063|NCT02038907|616018651|FG002|Overall Study|Withdrawal by Subject|0|||
170458064|NCT02038907|616018652|FG003|Overall Study|Withdrawal by Subject|0|||
170458065|NCT02038907|616018653|FG004|Overall Study|Withdrawal by Subject|0|||
170458066|NCT02038907|616018654|FG005|Overall Study|Withdrawal by Subject|0|||
170458067|NCT02038907|616018655|FG006|Overall Study|Withdrawal by Subject|0|||
170458068|NCT02038907|616018656|FG007|Overall Study|Withdrawal by Subject|0|||
170458069|NCT02038907|616018657|FG008|Overall Study|Withdrawal by Subject|0|||
170458070|NCT02038907|616018658|FG009|Overall Study|Withdrawal by Subject|0|||
170458071|NCT02038907|616018659|FG010|Overall Study|Withdrawal by Subject|1|||
170458072|NCT02038907|616018660|FG011|Overall Study|Withdrawal by Subject|0|||
170458073|NCT02038907|616018661|FG012|Overall Study|Withdrawal by Subject|0|||
170543023|NCT03974022|616331162|FG005|Overall Study|Withdrawal by Subject|4|||
170543024|NCT03974022|616331163|FG006|Overall Study|Withdrawal by Subject|4|||
170543025|NCT03974022|616331164|FG007|Overall Study|Withdrawal by Subject|2|||
170543026|NCT03974022|616331165|FG008|Overall Study|Withdrawal by Subject|2|||
170543027|NCT03974022|616331166|FG009|Overall Study|Withdrawal by Subject|3|||
170543028|NCT03974022|616331167|FG010|Overall Study|Withdrawal by Subject|0|||
170543029|NCT03974022|616331168|FG011|Overall Study|Withdrawal by Subject|1|||
170543030|NCT03974022|616331169|FG012|Overall Study|Withdrawal by Subject|0|||
170787965|NCT01369355|617234164|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
170458074|NCT02038907|616018662|FG013|Overall Study|Withdrawal by Subject|0|||
170458075|NCT02564211|616018663|FG000|Overall Study|Adverse Event|4|||
170458076|NCT01908816|616018669|FG000|Overall Study|Subject's no longer requires study drug|0|||
170458077|NCT01908816|616018670|FG001|Overall Study|Subject's no longer requires study drug|0|||
170458078|NCT01908816|616018671|FG002|Overall Study|Subject's no longer requires study drug|0|||
170458079|NCT01908816|616018672|FG003|Overall Study|Subject's no longer requires study drug|1|||
170458080|NCT01908816|616018669|FG000|Overall Study|Protocol deviation|1|||
170458081|NCT01908816|616018670|FG001|Overall Study|Protocol deviation|2|||
170543031|NCT03974022|616331170|FG013|Overall Study|Withdrawal by Subject|3|||
170458082|NCT01908816|616018671|FG002|Overall Study|Protocol deviation|1|||
170458083|NCT01908816|616018672|FG003|Overall Study|Protocol deviation|1|||
170889219|NCT01543087|617600656|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
170458084|NCT01908816|616018669|FG000|Overall Study|Withdrawal by Subject|0|||
170458085|NCT01908816|616018670|FG001|Overall Study|Withdrawal by Subject|4|||
170458086|NCT01908816|616018671|FG002|Overall Study|Withdrawal by Subject|2|||
170458087|NCT01908816|616018672|FG003|Overall Study|Withdrawal by Subject|2|||
170458088|NCT01908816|616018669|FG000|Overall Study|Lost to Follow-up|3|||
170458089|NCT01908816|616018670|FG001|Overall Study|Lost to Follow-up|5|||
170458090|NCT01908816|616018671|FG002|Overall Study|Lost to Follow-up|4|||
170458091|NCT01908816|616018672|FG003|Overall Study|Lost to Follow-up|2|||
170458092|NCT01908816|616018669|FG000|Overall Study|Death|1|||
170458093|NCT01908816|616018670|FG001|Overall Study|Death|0|||
170458094|NCT01908816|616018671|FG002|Overall Study|Death|7|||
170458095|NCT01908816|616018672|FG003|Overall Study|Death|1|||
170458096|NCT01908816|616018669|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170458097|NCT01908816|616018670|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
170458098|NCT01908816|616018671|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
170458099|NCT01908816|616018672|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
170458100|NCT01908816|616018669|FG000|Overall Study|Early termination|87|||
170458101|NCT01908816|616018670|FG001|Overall Study|Early termination|60|||
170458102|NCT01908816|616018671|FG002|Overall Study|Early termination|43|||
170458103|NCT01908816|616018672|FG003|Overall Study|Early termination|28|||
170458104|NCT02618408|616018673|FG000|Overall Study|Withdrawal by Subject|1|||
170458105|NCT02618408|616018674|FG001|Overall Study|Withdrawal by Subject|0|||
170458106|NCT02618408|616018675|FG002|Overall Study|Withdrawal by Subject|4|||
170458107|NCT02618408|616018673|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
170458108|NCT02618408|616018674|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
170458109|NCT02618408|616018675|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
170458110|NCT02618408|616018673|FG000|Overall Study|Lost to Follow-up|4|||
170458111|NCT02618408|616018674|FG001|Overall Study|Lost to Follow-up|2|||
170458112|NCT02618408|616018675|FG002|Overall Study|Lost to Follow-up|6|||
170458113|NCT02618408|616018673|FG000|Overall Study|Adverse Event|4|||
170458114|NCT02618408|616018674|FG001|Overall Study|Adverse Event|0|||
170458115|NCT02618408|616018675|FG002|Overall Study|Adverse Event|10|||
170458116|NCT02618408|616018673|FG000|Overall Study|Physician Decision|1|||
170458117|NCT02618408|616018674|FG001|Overall Study|Physician Decision|1|||
170458118|NCT02618408|616018675|FG002|Overall Study|Physician Decision|2|||
170458119|NCT02618408|616018673|FG000|Overall Study|Protocol Violation|1|||
170458120|NCT02618408|616018674|FG001|Overall Study|Protocol Violation|1|||
170458121|NCT02618408|616018675|FG002|Overall Study|Protocol Violation|2|||
170458122|NCT02618408|616018673|FG000|Overall Study|Other, Multiple Categories|0|||
170458123|NCT02618408|616018674|FG001|Overall Study|Other, Multiple Categories|0|||
170458124|NCT02618408|616018675|FG002|Overall Study|Other, Multiple Categories|4|||
170458125|NCT05183217|616018678|FG000|Overall Study|Withdrawal by Subject|1|||
170458126|NCT05183217|616018679|FG001|Overall Study|Withdrawal by Subject|1|||
170458127|NCT03914950|616018682|FG000|Overall Study|Physician Decision|54|||
170458128|NCT01155024|616018683|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
170458129|NCT01155024|616018684|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
170458130|NCT01155024|616018683|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
170458131|NCT01155024|616018684|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
170458132|NCT01155024|616018683|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
170458133|NCT01155024|616018684|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
170458134|NCT04585789|616018685|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
170458135|NCT04585789|616018686|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
170458136|NCT04585789|616018687|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
170458137|NCT04585789|616018685|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
170458138|NCT04585789|616018686|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
170458139|NCT04585789|616018687|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
170458140|NCT03412396|616018691|FG000|Overall Study|Withdrawal by Subject|2|||
170458141|NCT03412396|616018691|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
170458142|NCT03412396|616018691|FG000|Overall Study|Did not undergo RP|2|||
170458143|NCT05083585|616018704|FG000|Overall Study|Death|1|||
170458144|NCT05083585|616018705|FG001|Overall Study|Death|1|||
170458145|NCT05083585|616018704|FG000|Overall Study|Lost to Follow-up|1|||
170458146|NCT05083585|616018705|FG001|Overall Study|Lost to Follow-up|1|||
170458147|NCT05083585|616018704|FG000|Overall Study|Withdrawal by Subject|2|||
170458148|NCT05083585|616018705|FG001|Overall Study|Withdrawal by Subject|0|||
170458149|NCT05083585|616018704|FG000|Overall Study|Randomized but not vaccinated|2|||
170458150|NCT05083585|616018705|FG001|Overall Study|Randomized but not vaccinated|0|||
170458151|NCT01936623|616018706|FG000|Overall Study|Lost to Follow-up|0|||
170458152|NCT01936623|616018707|FG001|Overall Study|Lost to Follow-up|5|||
170458153|NCT01383135|616018708|FG000|Overall Study|Not Scanned / Imaged|1|||
170458154|NCT01383135|616018709|FG001|Overall Study|Not Scanned / Imaged|0|||
170458155|NCT01383135|616018710|FG002|Overall Study|Not Scanned / Imaged|1|||
170458156|NCT01383135|616018711|FG003|Overall Study|Not Scanned / Imaged|0|||
170458157|NCT03167723|616018715|FG000|Overall Study|Protocol Violation|4|||
170787966|NCT01369355|617234165|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
170458158|NCT03167723|616018716|FG001|Overall Study|Protocol Violation|6|||
170458159|NCT01524679|616018718|FG000|Overall Study|Lost to Follow-up|1|||
170458160|NCT01524679|616018719|FG001|Overall Study|Lost to Follow-up|4|||
170458161|NCT01524679|616018718|FG000|Overall Study|Withdrawal by Subject|4|||
170458162|NCT01524679|616018719|FG001|Overall Study|Withdrawal by Subject|4|||
170458163|NCT01524679|616018718|FG000|Overall Study|Adverse Event|9|||
170458164|NCT01524679|616018719|FG001|Overall Study|Adverse Event|0|||
170458165|NCT01524679|616018718|FG000|Overall Study|Protocol Violation|1|||
170458166|NCT01524679|616018719|FG001|Overall Study|Protocol Violation|0|||
170458167|NCT01524679|616018718|FG000|Overall Study|Lack of Efficacy|2|||
170458168|NCT01524679|616018719|FG001|Overall Study|Lack of Efficacy|0|||
170458169|NCT01524679|616018718|FG000|Overall Study|e.g.wish for children, relocation|6|||
170458170|NCT01524679|616018719|FG001|Overall Study|e.g.wish for children, relocation|1|||
170458171|NCT03397771|616018720|FG000|Overall Study|2 erroneously randomized, never treated|3|||
170458172|NCT03397771|616018721|FG001|Overall Study|2 erroneously randomized, never treated|1|||
170458173|NCT03397771|616018720|FG000|Overall Study|Withdrawal by Subject|1|||
170458174|NCT03397771|616018721|FG001|Overall Study|Withdrawal by Subject|3|||
170458175|NCT03397771|616018720|FG000|Overall Study|Protocol Violation|2|||
170458176|NCT03397771|616018721|FG001|Overall Study|Protocol Violation|2|||
170458177|NCT03397771|616018720|FG000|Overall Study|Adverse Event|2|||
170787967|NCT01369355|617234166|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
170787968|NCT01369355|617234167|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
170787969|NCT01369355|617234168|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
170787970|NCT01369355|617234169|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
170787971|NCT01369355|617234161|FG000|Long-term Extension (Week 44-272)|Other|0|||
170787972|NCT01369355|617234162|FG001|Long-term Extension (Week 44-272)|Other|0|||
170787973|NCT01369355|617234163|FG002|Long-term Extension (Week 44-272)|Other|0|||
170787974|NCT01369355|617234164|FG003|Long-term Extension (Week 44-272)|Other|0|||
170787975|NCT01369355|617234165|FG004|Long-term Extension (Week 44-272)|Other|0|||
170787976|NCT01369355|617234166|FG005|Long-term Extension (Week 44-272)|Other|0|||
170787977|NCT01369355|617234167|FG006|Long-term Extension (Week 44-272)|Other|110|||
170787978|NCT01369355|617234168|FG007|Long-term Extension (Week 44-272)|Other|9|||
170787979|NCT01369355|617234169|FG008|Long-term Extension (Week 44-272)|Other|17|||
170787980|NCT03339713|617234173|FG000|Overall Study|Lost to Follow-up|2|||
170787981|NCT03339713|617234174|FG001|Overall Study|Lost to Follow-up|1|||
170787982|NCT03339713|617234173|FG000|Overall Study|Protocol Violation|1|||
170889220|NCT01543087|617600651|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
170889221|NCT01543087|617600652|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
170458178|NCT03397771|616018721|FG001|Overall Study|Adverse Event|1|||
170889222|NCT01543087|617600653|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
170889223|NCT01543087|617600654|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
170889224|NCT01543087|617600655|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
170889225|NCT01543087|617600656|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
170889226|NCT01543087|617600651|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
170889227|NCT01543087|617600652|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
170889228|NCT01543087|617600653|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
170889229|NCT01543087|617600654|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
170889230|NCT01543087|617600655|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
170889231|NCT01543087|617600656|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
170889232|NCT01543087|617600651|FG000|Stage 1 (48 Months)|Other than specified|5|||
170889233|NCT01543087|617600652|FG001|Stage 1 (48 Months)|Other than specified|0|||
170889234|NCT01543087|617600653|FG002|Stage 1 (48 Months)|Other than specified|9|||
170889235|NCT01543087|617600654|FG003|Stage 1 (48 Months)|Other than specified|0|||
170889236|NCT01543087|617600655|FG004|Stage 1 (48 Months)|Other than specified|0|||
170889237|NCT01543087|617600656|FG005|Stage 1 (48 Months)|Other than specified|0|||
170889238|NCT01543087|617600651|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
170889239|NCT01543087|617600652|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
170636011|NCT00196313|616678927|FG000|Overall Study|Lost to Follow-up|2|||
170636012|NCT00196313|616678928|FG001|Overall Study|Lost to Follow-up|2|||
170787983|NCT03339713|617234174|FG001|Overall Study|Protocol Violation|0|||
170787984|NCT03339713|617234173|FG000|Overall Study|Withdrawal by Subject|1|||
170787985|NCT03339713|617234174|FG001|Overall Study|Withdrawal by Subject|1|||
170458181|NCT01971970|616018726|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
170458182|NCT01971970|616018727|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
170458183|NCT01971970|616018726|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
170787986|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
170787987|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
170889240|NCT01543087|617600653|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
170889241|NCT01543087|617600654|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
170889242|NCT01543087|617600655|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
170889243|NCT01543087|617600656|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
170458184|NCT01971970|616018727|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
170458185|NCT01971970|616018726|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
170458186|NCT01971970|616018727|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
170458187|NCT01971970|616018726|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
170458188|NCT01971970|616018727|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
170458189|NCT01971970|616018726|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
170458190|NCT01971970|616018727|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
170458191|NCT01971970|616018726|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
170458192|NCT01971970|616018727|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
170458193|NCT01971970|616018726|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
170458194|NCT01971970|616018727|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
170458195|NCT02256436|616018731|FG000|Overall Study|Adverse Event|9|||
170458196|NCT02256436|616018732|FG001|Overall Study|Adverse Event|14|||
170458197|NCT02256436|616018731|FG000|Overall Study|Death|216|||
170458198|NCT02256436|616018732|FG001|Overall Study|Death|208|||
170458199|NCT02256436|616018731|FG000|Overall Study|Lost to Follow-up|1|||
170458200|NCT02256436|616018732|FG001|Overall Study|Lost to Follow-up|2|||
170458201|NCT02256436|616018731|FG000|Overall Study|Physician Decision|1|||
170458202|NCT02256436|616018732|FG001|Overall Study|Physician Decision|0|||
170458203|NCT02256436|616018731|FG000|Overall Study|Protocol Violation|0|||
170458204|NCT02256436|616018732|FG001|Overall Study|Protocol Violation|1|||
170458205|NCT02256436|616018731|FG000|Overall Study|Withdrawal by Subject|26|||
170458206|NCT02256436|616018732|FG001|Overall Study|Withdrawal by Subject|10|||
170458207|NCT02256436|616018731|FG000|Overall Study|Transferred to Extension Study|11|||
170458208|NCT02256436|616018732|FG001|Overall Study|Transferred to Extension Study|23|||
170458209|NCT02256436|616018731|FG000|Overall Study|Did Not Continue on Extension Study|8|||
170458210|NCT02256436|616018732|FG001|Overall Study|Did Not Continue on Extension Study|12|||
170458211|NCT00762437|616018733|FG000|Overall Study|Lost to Follow-up|7|||
170458212|NCT00762437|616018733|FG000|Overall Study|Missed final study visit|11|||
170458213|NCT00762437|616018733|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
170458214|NCT05961215|616018734|FG000|Overall Study|Withdrawal by Subject|1|||
170458215|NCT00302081|616018738|FG000|Overall Study|Adverse Event|6|||
170458216|NCT00302081|616018739|FG001|Overall Study|Adverse Event|5|||
170458217|NCT00302081|616018740|FG002|Overall Study|Adverse Event|4|||
170458218|NCT00302081|616018738|FG000|Overall Study|Lost to Follow-up|21|||
170458219|NCT00302081|616018739|FG001|Overall Study|Lost to Follow-up|18|||
170458220|NCT00302081|616018740|FG002|Overall Study|Lost to Follow-up|28|||
170458221|NCT00302081|616018738|FG000|Overall Study|Withdrawal by Subject|8|||
170458222|NCT00302081|616018739|FG001|Overall Study|Withdrawal by Subject|12|||
170458223|NCT00302081|616018740|FG002|Overall Study|Withdrawal by Subject|8|||
170458224|NCT00302081|616018738|FG000|Overall Study|Protocol Violation|5|||
170458225|NCT00302081|616018739|FG001|Overall Study|Protocol Violation|1|||
170458226|NCT00302081|616018740|FG002|Overall Study|Protocol Violation|2|||
170458227|NCT00302081|616018738|FG000|Overall Study|Lack of Efficacy|1|||
170458228|NCT00302081|616018739|FG001|Overall Study|Lack of Efficacy|0|||
170458229|NCT00302081|616018740|FG002|Overall Study|Lack of Efficacy|5|||
170458230|NCT00302081|616018738|FG000|Overall Study|Death|2|||
170458231|NCT00302081|616018739|FG001|Overall Study|Death|1|||
170458232|NCT00302081|616018740|FG002|Overall Study|Death|0|||
170458233|NCT00302081|616018738|FG000|Overall Study|Other|13|||
170458234|NCT00302081|616018739|FG001|Overall Study|Other|6|||
170458235|NCT00302081|616018740|FG002|Overall Study|Other|5|||
170458236|NCT04771403|616018741|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
170458237|NCT04771403|616018742|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
170458238|NCT04771403|616018741|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
170458239|NCT04771403|616018742|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
170458240|NCT04771403|616018741|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
170458241|NCT04771403|616018742|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
170458242|NCT04771403|616018741|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
170458243|NCT04771403|616018742|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
170458244|NCT04771403|616018741|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
170458245|NCT04771403|616018742|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
170458246|NCT04771403|616018741|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
170458247|NCT04771403|616018742|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
170543032|NCT03974022|616331171|FG014|Overall Study|Withdrawal by Subject|9|||
170787988|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
170458248|NCT04771403|616018741|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
170458249|NCT04771403|616018742|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
170458250|NCT04771403|616018741|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
170458251|NCT04771403|616018742|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
170458252|NCT04480710|616018743|FG000|Overall Study|Adverse Event|0|||
170458253|NCT04480710|616018744|FG001|Overall Study|Adverse Event|2|||
170458254|NCT04480710|616018745|FG002|Overall Study|Adverse Event|0|||
170458255|NCT04480710|616018746|FG003|Overall Study|Adverse Event|0|||
170458256|NCT04480710|616018743|FG000|Overall Study|Withdrawal by Subject|0|||
170458257|NCT04480710|616018744|FG001|Overall Study|Withdrawal by Subject|1|||
170458258|NCT04480710|616018745|FG002|Overall Study|Withdrawal by Subject|0|||
170458259|NCT04480710|616018746|FG003|Overall Study|Withdrawal by Subject|0|||
170458260|NCT04480710|616018743|FG000|Overall Study|Physician Decision|0|||
170458261|NCT04480710|616018744|FG001|Overall Study|Physician Decision|0|||
170458262|NCT04480710|616018745|FG002|Overall Study|Physician Decision|1|||
170458263|NCT04480710|616018746|FG003|Overall Study|Physician Decision|0|||
170458264|NCT04480021|616018747|FG000|Overall Study|Lost to Follow-up|3|||
170458265|NCT04480021|616018748|FG001|Overall Study|Lost to Follow-up|4|||
170458266|NCT00446199|616018751|FG000|Overall Study|Adverse Event|7|||
170458267|NCT00446199|616018752|FG001|Overall Study|Adverse Event|4|||
170458268|NCT00446199|616018753|FG002|Overall Study|Adverse Event|6|||
170458269|NCT00446199|616018754|FG003|Overall Study|Adverse Event|4|||
170458270|NCT00446199|616018751|FG000|Overall Study|Lost to Follow-up|4|||
170458271|NCT00446199|616018752|FG001|Overall Study|Lost to Follow-up|5|||
170458272|NCT00446199|616018753|FG002|Overall Study|Lost to Follow-up|2|||
170458273|NCT00446199|616018754|FG003|Overall Study|Lost to Follow-up|6|||
170458274|NCT00446199|616018751|FG000|Overall Study|Protocol Violation|1|||
170458275|NCT00446199|616018752|FG001|Overall Study|Protocol Violation|2|||
170458276|NCT00446199|616018753|FG002|Overall Study|Protocol Violation|1|||
170458277|NCT00446199|616018754|FG003|Overall Study|Protocol Violation|3|||
170458278|NCT00446199|616018751|FG000|Overall Study|Withdrawal by Subject|2|||
170458279|NCT00446199|616018752|FG001|Overall Study|Withdrawal by Subject|5|||
170543033|NCT03974022|616331157|FG000|Overall Study|Lost to Follow-up|0|||
170543034|NCT03974022|616331158|FG001|Overall Study|Lost to Follow-up|0|||
170543035|NCT03974022|616331159|FG002|Overall Study|Lost to Follow-up|0|||
170543036|NCT03974022|616331160|FG003|Overall Study|Lost to Follow-up|0|||
170543037|NCT03974022|616331161|FG004|Overall Study|Lost to Follow-up|0|||
170543038|NCT03974022|616331162|FG005|Overall Study|Lost to Follow-up|0|||
170543039|NCT03974022|616331163|FG006|Overall Study|Lost to Follow-up|1|||
170543040|NCT03974022|616331164|FG007|Overall Study|Lost to Follow-up|0|||
170543041|NCT03974022|616331165|FG008|Overall Study|Lost to Follow-up|0|||
170543042|NCT03974022|616331166|FG009|Overall Study|Lost to Follow-up|0|||
170543043|NCT03974022|616331167|FG010|Overall Study|Lost to Follow-up|0|||
170543044|NCT03974022|616331168|FG011|Overall Study|Lost to Follow-up|0|||
170543045|NCT03974022|616331169|FG012|Overall Study|Lost to Follow-up|0|||
170543046|NCT03974022|616331170|FG013|Overall Study|Lost to Follow-up|1|||
170543047|NCT03974022|616331171|FG014|Overall Study|Lost to Follow-up|1|||
170543048|NCT03974022|616331157|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
170543049|NCT03974022|616331158|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
170543050|NCT03974022|616331159|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
170543051|NCT03974022|616331160|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
170543052|NCT03974022|616331161|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
170543053|NCT03974022|616331162|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
170543054|NCT03974022|616331163|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
170543055|NCT03974022|616331164|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
170543056|NCT03974022|616331165|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
170543057|NCT03974022|616331166|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
170543058|NCT03974022|616331167|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
170543059|NCT03974022|616331168|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
170543060|NCT03974022|616331169|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
170543061|NCT03974022|616331170|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
170543062|NCT03974022|616331171|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
170543063|NCT03279692|616331172|FG000|Overall Study|Withdrawal by Subject|1|||
170787989|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
170458280|NCT00446199|616018753|FG002|Overall Study|Withdrawal by Subject|9|||
170787990|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
170787991|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
170787992|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
170787993|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
170787994|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
170787995|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
170458281|NCT00446199|616018754|FG003|Overall Study|Withdrawal by Subject|10|||
170458282|NCT00446199|616018751|FG000|Overall Study|Site termination|2|||
170458283|NCT00446199|616018752|FG001|Overall Study|Site termination|0|||
170458284|NCT00446199|616018753|FG002|Overall Study|Site termination|0|||
170458285|NCT00446199|616018754|FG003|Overall Study|Site termination|1|||
170458286|NCT00446199|616018751|FG000|Overall Study|Randomization in Error|2|||
170458287|NCT00446199|616018752|FG001|Overall Study|Randomization in Error|0|||
170458288|NCT00446199|616018753|FG002|Overall Study|Randomization in Error|1|||
170458289|NCT00446199|616018754|FG003|Overall Study|Randomization in Error|1|||
170458290|NCT00446199|616018751|FG000|Overall Study|Lack of Efficacy|1|||
170458291|NCT00446199|616018752|FG001|Overall Study|Lack of Efficacy|0|||
170458292|NCT00446199|616018753|FG002|Overall Study|Lack of Efficacy|0|||
170458293|NCT00446199|616018754|FG003|Overall Study|Lack of Efficacy|1|||
170458294|NCT00446199|616018751|FG000|Overall Study|Non-compliant with study drug|1|||
170458295|NCT00446199|616018752|FG001|Overall Study|Non-compliant with study drug|0|||
170458296|NCT00446199|616018753|FG002|Overall Study|Non-compliant with study drug|5|||
170458297|NCT00446199|616018754|FG003|Overall Study|Non-compliant with study drug|0|||
170458298|NCT00446199|616018751|FG000|Overall Study|Non-compliant with visit schedule|1|||
170543064|NCT03436056|616331173|FG000|Overall Study|Lack of Efficacy|2|||
170543065|NCT03436056|616331174|FG001|Overall Study|Lack of Efficacy|0|||
170543066|NCT03436056|616331175|FG002|Overall Study|Lack of Efficacy|0|||
170458299|NCT00446199|616018752|FG001|Overall Study|Non-compliant with visit schedule|1|||
170458300|NCT00446199|616018753|FG002|Overall Study|Non-compliant with visit schedule|1|||
170458301|NCT00446199|616018754|FG003|Overall Study|Non-compliant with visit schedule|2|||
170458302|NCT00446199|616018751|FG000|Overall Study|Hormone fear|0|||
170458303|NCT00446199|616018752|FG001|Overall Study|Hormone fear|0|||
170458304|NCT00446199|616018753|FG002|Overall Study|Hormone fear|0|||
170458305|NCT00446199|616018754|FG003|Overall Study|Hormone fear|1|||
170458306|NCT00446199|616018751|FG000|Overall Study|Lost interest in study participation|0|||
170458307|NCT00446199|616018752|FG001|Overall Study|Lost interest in study participation|1|||
170458308|NCT00446199|616018753|FG002|Overall Study|Lost interest in study participation|0|||
170458309|NCT00446199|616018754|FG003|Overall Study|Lost interest in study participation|0|||
170458310|NCT00446199|616018751|FG000|Overall Study|In-/Exclusion criterion violated|2|||
170458311|NCT00446199|616018752|FG001|Overall Study|In-/Exclusion criterion violated|1|||
170458312|NCT00446199|616018753|FG002|Overall Study|In-/Exclusion criterion violated|2|||
170458313|NCT00446199|616018754|FG003|Overall Study|In-/Exclusion criterion violated|1|||
170458314|NCT00446199|616018751|FG000|Overall Study|Move|0|||
170458315|NCT00446199|616018752|FG001|Overall Study|Move|1|||
170458316|NCT00446199|616018753|FG002|Overall Study|Move|0|||
170458317|NCT00446199|616018754|FG003|Overall Study|Move|0|||
170458318|NCT02312063|616018755|FG000|Overall Study|Withdrawal by Subject|0|||
170458319|NCT02312063|616018756|FG001|Overall Study|Withdrawal by Subject|1|||
170458320|NCT00375492|616018757|FG000|Overall Study|Adverse Event|4|||
170458321|NCT00375492|616018758|FG001|Overall Study|Adverse Event|5|||
170458322|NCT00375492|616018757|FG000|Overall Study|Entry Criteria Not Met|0|||
170458323|NCT00375492|616018758|FG001|Overall Study|Entry Criteria Not Met|1|||
170458324|NCT00375492|616018757|FG000|Overall Study|Loss of Glucose Control|0|||
170458325|NCT00375492|616018758|FG001|Overall Study|Loss of Glucose Control|1|||
170458326|NCT00375492|616018757|FG000|Overall Study|Lost to Follow-up|10|||
170458327|NCT00375492|616018758|FG001|Overall Study|Lost to Follow-up|5|||
170458328|NCT00375492|616018757|FG000|Overall Study|Physician Decision|0|||
170458329|NCT00375492|616018758|FG001|Overall Study|Physician Decision|4|||
170458330|NCT00375492|616018757|FG000|Overall Study|Protocol Violation|6|||
170458331|NCT00375492|616018758|FG001|Overall Study|Protocol Violation|3|||
170458332|NCT00375492|616018757|FG000|Overall Study|Sponsor Decision|0|||
170458333|NCT00375492|616018758|FG001|Overall Study|Sponsor Decision|1|||
170458334|NCT00375492|616018757|FG000|Overall Study|Withdrawal by Subject|6|||
170458335|NCT00375492|616018758|FG001|Overall Study|Withdrawal by Subject|6|||
170458336|NCT01079832|616018759|FG000|Overall Study|Withdrawal by Subject|1|||
170543067|NCT05583149|616331181|FG000|Overall Study|Development of concurrent medical condition that interferes with trial participation|1|||
170543068|NCT05583149|616331181|FG000|Overall Study|Physician Decision|1|||
170543069|NCT03419234|616331182|FG000|Overall Study|Disease progression|37|||
170543070|NCT03419234|616331183|FG001|Overall Study|Disease progression|36|||
170543071|NCT03419234|616331182|FG000|Overall Study|Adverse Event|6|||
170543072|NCT03419234|616331183|FG001|Overall Study|Adverse Event|9|||
170543073|NCT03419234|616331182|FG000|Overall Study|Withdrawal by Subject|9|||
170543074|NCT03419234|616331183|FG001|Overall Study|Withdrawal by Subject|7|||
170543075|NCT03419234|616331182|FG000|Overall Study|Death|5|||
170543076|NCT03419234|616331183|FG001|Overall Study|Death|1|||
170543077|NCT03419234|616331182|FG000|Overall Study|Alternative therapy|4|||
170543078|NCT03419234|616331183|FG001|Overall Study|Alternative therapy|2|||
170543079|NCT03419234|616331182|FG000|Overall Study|PSA progression|8|||
170543080|NCT03419234|616331183|FG001|Overall Study|PSA progression|10|||
170543081|NCT03419234|616331182|FG000|Overall Study|Rising PSA and bone issues|3|||
170543082|NCT03419234|616331183|FG001|Overall Study|Rising PSA and bone issues|2|||
170636013|NCT01491607|616678932|FG000|Overall Study|Lost to Follow-up|7|||
170458337|NCT04941729|616020600|FG000|Overall Study|Death|0|||
170458338|NCT04941729|616020601|FG001|Overall Study|Death|1|||
170458339|NCT04941729|616020600|FG000|Overall Study|Study terminated by sponsor|11|||
170458340|NCT04941729|616020601|FG001|Overall Study|Study terminated by sponsor|10|||
170458341|NCT00006721|616020602|FG000|Overall Study|Adverse Event|0|||
170458342|NCT00006721|616020603|FG001|Overall Study|Adverse Event|4|||
170458343|NCT00006721|616020604|FG002|Overall Study|Adverse Event|4|||
170543083|NCT03419234|616331182|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
170889244|NCT01543087|617600651|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
170889245|NCT01543087|617600652|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
170889246|NCT01543087|617600653|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
170458344|NCT00006721|616020602|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
170458345|NCT00006721|616020603|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
170458346|NCT00006721|616020604|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
170458347|NCT00006721|616020602|FG000|Overall Study|Progression/Relapse|0|||
170458348|NCT00006721|616020603|FG001|Overall Study|Progression/Relapse|1|||
170458349|NCT00006721|616020604|FG002|Overall Study|Progression/Relapse|2|||
170458350|NCT00006721|616020602|FG000|Overall Study|Death|0|||
170458351|NCT00006721|616020603|FG001|Overall Study|Death|1|||
170458352|NCT00006721|616020604|FG002|Overall Study|Death|2|||
170458353|NCT00006721|616020602|FG000|Overall Study|Other - Not Protocol Specified|0|||
170458354|NCT00006721|616020603|FG001|Overall Study|Other - Not Protocol Specified|7|||
170458355|NCT00006721|616020604|FG002|Overall Study|Other - Not Protocol Specified|7|||
170458356|NCT00006721|616020602|FG000|Overall Study|Ineligible|2|||
170458357|NCT00006721|616020603|FG001|Overall Study|Ineligible|12|||
170458358|NCT00006721|616020604|FG002|Overall Study|Ineligible|10|||
170458359|NCT00006721|616020602|FG000|Overall Study|Eligible but no Treatment Received|1|||
170458360|NCT00006721|616020603|FG001|Overall Study|Eligible but no Treatment Received|0|||
170458361|NCT00006721|616020604|FG002|Overall Study|Eligible but no Treatment Received|0|||
170458362|NCT06218823|616020605|FG000|Overall Study|Death|3|||
170458363|NCT06218823|616020606|FG001|Overall Study|Death|0|||
170458364|NCT06218823|616020605|FG000|Overall Study|Lost to Follow-up|0|||
170458365|NCT06218823|616020606|FG001|Overall Study|Lost to Follow-up|2|||
170458366|NCT04732221|616020607|FG000|Base Period|Death|2|||
170458367|NCT04732221|616020608|FG001|Base Period|Death|0|||
170458368|NCT04732221|616020609|FG002|Base Period|Death|0|||
170458369|NCT04732221|616020610|FG003|Base Period|Death|0|||
170458370|NCT04732221|616020611|FG004|Base Period|Death|0|||
170458371|NCT04732221|616020612|FG005|Base Period|Death|0|||
170458372|NCT04732221|616020613|FG006|Base Period|Death|0|||
170458373|NCT04732221|616020607|FG000|Base Period|Withdrawal by Subject|0|||
170458374|NCT04732221|616020608|FG001|Base Period|Withdrawal by Subject|1|||
170458375|NCT04732221|616020609|FG002|Base Period|Withdrawal by Subject|1|||
170458376|NCT04732221|616020610|FG003|Base Period|Withdrawal by Subject|0|||
170458377|NCT04732221|616020611|FG004|Base Period|Withdrawal by Subject|0|||
170458378|NCT04732221|616020612|FG005|Base Period|Withdrawal by Subject|0|||
170458379|NCT04732221|616020613|FG006|Base Period|Withdrawal by Subject|0|||
170458380|NCT04732221|616020607|FG000|Extension Period|Adverse Event|0|||
170458381|NCT04732221|616020608|FG001|Extension Period|Adverse Event|0|||
170458382|NCT04732221|616020609|FG002|Extension Period|Adverse Event|0|||
170458383|NCT04732221|616020610|FG003|Extension Period|Adverse Event|0|||
170458384|NCT04732221|616020611|FG004|Extension Period|Adverse Event|0|||
170458385|NCT04732221|616020612|FG005|Extension Period|Adverse Event|1|||
170458386|NCT04732221|616020613|FG006|Extension Period|Adverse Event|0|||
170458387|NCT04732221|616020607|FG000|Extension Period|Death|0|||
170458388|NCT04732221|616020608|FG001|Extension Period|Death|0|||
170458389|NCT04732221|616020609|FG002|Extension Period|Death|0|||
170458390|NCT04732221|616020610|FG003|Extension Period|Death|0|||
170458391|NCT04732221|616020611|FG004|Extension Period|Death|1|||
170458392|NCT04732221|616020612|FG005|Extension Period|Death|0|||
170458393|NCT04732221|616020613|FG006|Extension Period|Death|2|||
170458394|NCT04732221|616020607|FG000|Extension Period|Pregnancy|0|||
170458395|NCT04732221|616020608|FG001|Extension Period|Pregnancy|0|||
170458396|NCT04732221|616020609|FG002|Extension Period|Pregnancy|0|||
170458397|NCT04732221|616020610|FG003|Extension Period|Pregnancy|0|||
170458398|NCT04732221|616020611|FG004|Extension Period|Pregnancy|1|||
170458399|NCT04732221|616020612|FG005|Extension Period|Pregnancy|0|||
170458400|NCT04732221|616020613|FG006|Extension Period|Pregnancy|0|||
170458401|NCT04732221|616020607|FG000|Extension Period|Sponsors Decision|0|||
170458402|NCT04732221|616020608|FG001|Extension Period|Sponsors Decision|0|||
170458403|NCT04732221|616020609|FG002|Extension Period|Sponsors Decision|0|||
170458404|NCT04732221|616020610|FG003|Extension Period|Sponsors Decision|0|||
170458405|NCT04732221|616020611|FG004|Extension Period|Sponsors Decision|41|||
170458406|NCT04732221|616020612|FG005|Extension Period|Sponsors Decision|40|||
170458407|NCT04732221|616020613|FG006|Extension Period|Sponsors Decision|40|||
170458408|NCT04732221|616020607|FG000|Extension Period|Withdrawal by Subject|0|||
170458409|NCT04732221|616020608|FG001|Extension Period|Withdrawal by Subject|0|||
170458410|NCT04732221|616020609|FG002|Extension Period|Withdrawal by Subject|0|||
170458411|NCT04732221|616020610|FG003|Extension Period|Withdrawal by Subject|0|||
170458412|NCT04732221|616020611|FG004|Extension Period|Withdrawal by Subject|1|||
170458413|NCT04732221|616020612|FG005|Extension Period|Withdrawal by Subject|5|||
170458414|NCT04732221|616020613|FG006|Extension Period|Withdrawal by Subject|2|||
170458415|NCT02788045|616020614|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
170458416|NCT02788045|616020615|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
170458417|NCT02788045|616020616|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
170458418|NCT02788045|616020614|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
170458419|NCT02788045|616020615|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
170458420|NCT02788045|616020616|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
170458421|NCT02788045|616020614|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
170458422|NCT02788045|616020615|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
170458423|NCT02788045|616020616|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
170458424|NCT02788045|616020614|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
170458425|NCT02788045|616020615|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
170458426|NCT02788045|616020616|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
170458427|NCT02788045|616020614|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
170458428|NCT02788045|616020615|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
170458429|NCT02788045|616020616|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
170458430|NCT02788045|616020614|FG000|Main Study (Up to Week 72)|Other|3|||
170458431|NCT02788045|616020615|FG001|Main Study (Up to Week 72)|Other|0|||
170458432|NCT02788045|616020616|FG002|Main Study (Up to Week 72)|Other|0|||
170458433|NCT02788045|616020614|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
170458434|NCT02788045|616020615|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
170458435|NCT02788045|616020616|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
170458436|NCT02788045|616020614|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
170458437|NCT02788045|616020615|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
170458438|NCT02788045|616020616|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
170458439|NCT02788045|616020614|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
170458440|NCT02788045|616020615|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
170458441|NCT02788045|616020616|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
170458442|NCT00379340|616020617|FG000|Overall Study|Death|0|||
170458443|NCT00379340|616020618|FG001|Overall Study|Death|0|||
170458444|NCT00379340|616020619|FG002|Overall Study|Death|0|||
170458445|NCT00379340|616020620|FG003|Overall Study|Death|2|||
170458446|NCT00379340|616020621|FG004|Overall Study|Death|0|||
170458447|NCT00379340|616020617|FG000|Overall Study|Lack of Efficacy|6|||
170458448|NCT00379340|616020618|FG001|Overall Study|Lack of Efficacy|1|||
170458449|NCT00379340|616020619|FG002|Overall Study|Lack of Efficacy|0|||
170458450|NCT00379340|616020620|FG003|Overall Study|Lack of Efficacy|4|||
170458451|NCT00379340|616020621|FG004|Overall Study|Lack of Efficacy|3|||
170458452|NCT00379340|616020617|FG000|Overall Study|Physician Decision|6|||
170458453|NCT00379340|616020618|FG001|Overall Study|Physician Decision|2|||
170458454|NCT00379340|616020619|FG002|Overall Study|Physician Decision|1|||
170458455|NCT00379340|616020620|FG003|Overall Study|Physician Decision|2|||
170458456|NCT00379340|616020621|FG004|Overall Study|Physician Decision|3|||
170458457|NCT00379340|616020617|FG000|Overall Study|Withdrawal by Subject|0|||
170458458|NCT00379340|616020618|FG001|Overall Study|Withdrawal by Subject|0|||
170458459|NCT00379340|616020619|FG002|Overall Study|Withdrawal by Subject|0|||
170458460|NCT00379340|616020620|FG003|Overall Study|Withdrawal by Subject|1|||
170458461|NCT00379340|616020621|FG004|Overall Study|Withdrawal by Subject|0|||
170458462|NCT00379340|616020617|FG000|Overall Study|Refusal of further protocol therapy|1|||
170458463|NCT00379340|616020618|FG001|Overall Study|Refusal of further protocol therapy|0|||
170458464|NCT00379340|616020619|FG002|Overall Study|Refusal of further protocol therapy|1|||
170458465|NCT00379340|616020620|FG003|Overall Study|Refusal of further protocol therapy|1|||
170458466|NCT00379340|616020621|FG004|Overall Study|Refusal of further protocol therapy|7|||
170458467|NCT00379340|616020617|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
170458468|NCT00379340|616020618|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
170458469|NCT00379340|616020619|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
170458470|NCT00379340|616020620|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
170458471|NCT00379340|616020621|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
170458472|NCT00379340|616020617|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
170458473|NCT00379340|616020618|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
170458474|NCT00379340|616020619|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
170458475|NCT00379340|616020620|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
170543084|NCT03419234|616331183|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
170458476|NCT00379340|616020621|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
170458477|NCT03047473|616020624|FG000|Overall Study|Lost to Follow-up|2|||
170458478|NCT00062010|616020627|FG000|Overall Study|Ineligible|3|||
170458479|NCT03188718|616020628|FG000|Overall Study|Participant noncompliance|4|||
170458480|NCT03188718|616020628|FG000|Overall Study|Withdrawal by Subject|1|||
170458481|NCT03188718|616020628|FG000|Overall Study|Device failure|3|||
170458482|NCT03283319|616020630|FG000|Overall Study|Lost to Follow-up|5|||
170458483|NCT03283319|616020631|FG001|Overall Study|Lost to Follow-up|4|||
170787996|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
170787997|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
170787998|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
170787999|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
170788000|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
170788001|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
170788002|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
170788003|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
170788004|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
170788005|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
170788006|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
170788007|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
170788008|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
170788009|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
170788010|NCT01715285|617234175|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
170788011|NCT01715285|617234176|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
170788012|NCT01715285|617234177|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
170788013|NCT01715285|617234175|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
170788014|NCT01715285|617234176|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
170788015|NCT01715285|617234177|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
170788016|NCT01715285|617234175|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
170788017|NCT01715285|617234176|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
170788018|NCT01715285|617234177|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
170788019|NCT01715285|617234175|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
170788020|NCT01715285|617234176|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
170788021|NCT01715285|617234177|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
170788022|NCT01715285|617234175|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
170788023|NCT01715285|617234176|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
170788024|NCT01715285|617234177|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
170788025|NCT01715285|617234175|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
170788026|NCT01715285|617234176|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
170788027|NCT01715285|617234177|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
170788028|NCT00227344|617234178|FG000|Overall Study|study terminated early|12|||
170788029|NCT00227344|617234179|FG001|Overall Study|study terminated early|5|||
170788030|NCT03371381|617234180|FG000|Overall Study|Death|5|||
170788031|NCT03371381|617234180|FG000|Overall Study|Study terminated by sponsor|3|||
170788032|NCT03371381|617234180|FG000|Overall Study|Other|4|||
170788033|NCT02979327|617234181|FG000|First Intervention|Protocol Violation|1|||
170788034|NCT02979327|617234182|FG001|First Intervention|Protocol Violation|0|||
170788035|NCT05364671|617234183|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
170788036|NCT05364671|617234184|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
170788037|NCT05364671|617234183|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
170788038|NCT05364671|617234184|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
170788039|NCT05364671|617234183|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
170788040|NCT05364671|617234184|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
170788041|NCT05364671|617234183|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
170788042|NCT05364671|617234184|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
170788043|NCT05364671|617234183|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
170788044|NCT05364671|617234184|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
170788045|NCT04858321|617234186|FG000|Overall Study|Withdrawal by Subject|3|||
170788046|NCT05006872|617234187|FG000|Overall Study|Lost to Follow-up|37|||
170788047|NCT05006872|617234188|FG001|Overall Study|Lost to Follow-up|31|||
170788048|NCT02573493|617234191|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
170788049|NCT02573493|617234192|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
170788050|NCT02573493|617234193|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
170788051|NCT02573493|617234194|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
170788052|NCT04632992|617234198|FG000|Overall Study|Adverse Event|0|||
170788053|NCT04632992|617234199|FG001|Overall Study|Adverse Event|0|||
170788054|NCT04632992|617234200|FG002|Overall Study|Adverse Event|0|||
170458484|NCT03283319|616020632|FG002|Overall Study|Lost to Follow-up|5|||
170788055|NCT04632992|617234201|FG003|Overall Study|Adverse Event|0|||
170788056|NCT04632992|617234202|FG004|Overall Study|Adverse Event|0|||
170788057|NCT04632992|617234203|FG005|Overall Study|Adverse Event|0|||
170458485|NCT03283319|616020633|FG003|Overall Study|Lost to Follow-up|5|||
170788058|NCT04632992|617234204|FG006|Overall Study|Adverse Event|0|||
170788059|NCT04632992|617234205|FG007|Overall Study|Adverse Event|0|||
170788060|NCT04632992|617234206|FG008|Overall Study|Adverse Event|0|||
170788061|NCT04632992|617234207|FG009|Overall Study|Adverse Event|0|||
170788062|NCT04632992|617234208|FG010|Overall Study|Adverse Event|0|||
170788063|NCT04632992|617234209|FG011|Overall Study|Adverse Event|0|||
170788064|NCT04632992|617234210|FG012|Overall Study|Adverse Event|1|||
170788065|NCT04632992|617234211|FG013|Overall Study|Adverse Event|0|||
170788066|NCT04632992|617234198|FG000|Overall Study|Death|17|||
170788067|NCT04632992|617234199|FG001|Overall Study|Death|1|||
170788068|NCT04632992|617234200|FG002|Overall Study|Death|14|||
170788069|NCT04632992|617234201|FG003|Overall Study|Death|14|||
170788070|NCT04632992|617234202|FG004|Overall Study|Death|13|||
170788071|NCT04632992|617234203|FG005|Overall Study|Death|6|||
170788072|NCT04632992|617234204|FG006|Overall Study|Death|7|||
170788073|NCT04632992|617234205|FG007|Overall Study|Death|12|||
170788074|NCT04632992|617234206|FG008|Overall Study|Death|15|||
170788075|NCT04632992|617234207|FG009|Overall Study|Death|20|||
170788076|NCT04632992|617234208|FG010|Overall Study|Death|8|||
170788077|NCT04632992|617234209|FG011|Overall Study|Death|2|||
170788078|NCT04632992|617234210|FG012|Overall Study|Death|10|||
170788079|NCT04632992|617234211|FG013|Overall Study|Death|1|||
170788080|NCT04632992|617234198|FG000|Overall Study|Lost to Follow-up|1|||
170788081|NCT04632992|617234199|FG001|Overall Study|Lost to Follow-up|0|||
170788082|NCT04632992|617234200|FG002|Overall Study|Lost to Follow-up|1|||
170788083|NCT04632992|617234201|FG003|Overall Study|Lost to Follow-up|0|||
170788084|NCT04632992|617234202|FG004|Overall Study|Lost to Follow-up|2|||
170458486|NCT03283319|616020634|FG004|Overall Study|Lost to Follow-up|4|||
170458487|NCT03283319|616020635|FG005|Overall Study|Lost to Follow-up|3|||
170458488|NCT03283319|616020630|FG000|Overall Study|Withdrawal by Subject|2|||
170458489|NCT03283319|616020631|FG001|Overall Study|Withdrawal by Subject|2|||
170458490|NCT03283319|616020632|FG002|Overall Study|Withdrawal by Subject|2|||
170458491|NCT03283319|616020633|FG003|Overall Study|Withdrawal by Subject|1|||
170458492|NCT03283319|616020634|FG004|Overall Study|Withdrawal by Subject|0|||
170458493|NCT03283319|616020635|FG005|Overall Study|Withdrawal by Subject|1|||
170458494|NCT03283319|616020630|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
170636014|NCT01491607|616678932|FG000|Overall Study|Withdrawal by Subject|3|||
170636015|NCT00473382|616678935|FG000|Core Study|Adverse Event|3|||
170636016|NCT00473382|616678936|FG001|Core Study|Adverse Event|1|||
170636017|NCT00473382|616678937|FG002|Core Study|Adverse Event|1|||
170636018|NCT00473382|616678935|FG000|Core Study|Death|3|||
170636019|NCT00473382|616678936|FG001|Core Study|Death|5|||
170636020|NCT00473382|616678937|FG002|Core Study|Death|10|||
170636021|NCT00473382|616678935|FG000|Core Study|Lost to Follow-up|3|||
170458495|NCT03283319|616020631|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
170458496|NCT03283319|616020632|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
170458497|NCT03283319|616020633|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
170458498|NCT03283319|616020634|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
170458499|NCT03283319|616020635|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
170458500|NCT00824616|616020636|FG000|Overall Study|Adverse Event|2|||
170458501|NCT00824616|616020637|FG001|Overall Study|Adverse Event|1|||
170458502|NCT00824616|616020636|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
170458503|NCT00824616|616020637|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
170458504|NCT00824616|616020636|FG000|Overall Study|Hyperglycemia|1|||
170458505|NCT00824616|616020637|FG001|Overall Study|Hyperglycemia|1|||
170458506|NCT00824616|616020636|FG000|Overall Study|Lack of Efficacy|2|||
170458507|NCT00824616|616020637|FG001|Overall Study|Lack of Efficacy|1|||
170636022|NCT00473382|616678936|FG001|Core Study|Lost to Follow-up|3|||
170636023|NCT00473382|616678937|FG002|Core Study|Lost to Follow-up|3|||
170788085|NCT04632992|617234203|FG005|Overall Study|Lost to Follow-up|0|||
170788086|NCT04632992|617234204|FG006|Overall Study|Lost to Follow-up|1|||
170788087|NCT04632992|617234205|FG007|Overall Study|Lost to Follow-up|1|||
170636024|NCT00473382|616678935|FG000|Core Study|Physician Decision|1|||
170788088|NCT04632992|617234206|FG008|Overall Study|Lost to Follow-up|1|||
170788089|NCT04632992|617234207|FG009|Overall Study|Lost to Follow-up|1|||
170788090|NCT04632992|617234208|FG010|Overall Study|Lost to Follow-up|2|||
170788091|NCT04632992|617234209|FG011|Overall Study|Lost to Follow-up|0|||
170788092|NCT04632992|617234210|FG012|Overall Study|Lost to Follow-up|0|||
170788093|NCT04632992|617234211|FG013|Overall Study|Lost to Follow-up|0|||
170788094|NCT04632992|617234198|FG000|Overall Study|Reason not Specified|2|||
170458508|NCT00824616|616020636|FG000|Overall Study|Lost to Follow-up|0|||
170458509|NCT00824616|616020637|FG001|Overall Study|Lost to Follow-up|1|||
170458510|NCT00824616|616020636|FG000|Overall Study|Withdrawal by Subject|1|||
170636025|NCT00473382|616678936|FG001|Core Study|Physician Decision|2|||
170636026|NCT00473382|616678937|FG002|Core Study|Physician Decision|2|||
170636027|NCT00473382|616678935|FG000|Core Study|Subject non-compliance|5|||
170636028|NCT00473382|616678936|FG001|Core Study|Subject non-compliance|2|||
170788095|NCT04632992|617234199|FG001|Overall Study|Reason not Specified|0|||
170788096|NCT04632992|617234200|FG002|Overall Study|Reason not Specified|1|||
170788097|NCT04632992|617234201|FG003|Overall Study|Reason not Specified|1|||
170788098|NCT04632992|617234202|FG004|Overall Study|Reason not Specified|0|||
170788099|NCT04632992|617234203|FG005|Overall Study|Reason not Specified|0|||
170458511|NCT00824616|616020637|FG001|Overall Study|Withdrawal by Subject|1|||
170458512|NCT01570686|616020643|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170458513|NCT01570686|616020644|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170458514|NCT01570686|616020643|FG000|Overall Study|Administrative problems|0|||
170458515|NCT01570686|616020644|FG001|Overall Study|Administrative problems|1|||
170458516|NCT01570686|616020643|FG000|Overall Study|Adverse Event|8|||
170458517|NCT01570686|616020644|FG001|Overall Study|Adverse Event|6|||
170458518|NCT01570686|616020643|FG000|Overall Study|Lost to Follow-up|4|||
170458519|NCT01570686|616020644|FG001|Overall Study|Lost to Follow-up|3|||
170458520|NCT01570686|616020643|FG000|Overall Study|Protocol Deviation|3|||
170458521|NCT01570686|616020644|FG001|Overall Study|Protocol Deviation|0|||
170458522|NCT01570686|616020643|FG000|Overall Study|Withdrawal by Subject|4|||
170543085|NCT03419234|616331182|FG000|Overall Study|Physician Decision|12|||
170543086|NCT03419234|616331183|FG001|Overall Study|Physician Decision|11|||
170543087|NCT03419234|616331182|FG000|Overall Study|Second malignancy|1|||
170543088|NCT03419234|616331183|FG001|Overall Study|Second malignancy|0|||
170543089|NCT03419234|616331182|FG000|Overall Study|Insurance status change/patient could not afford|2|||
170543090|NCT03419234|616331183|FG001|Overall Study|Insurance status change/patient could not afford|1|||
170543091|NCT03419234|616331182|FG000|Overall Study|Non-compliance|1|||
170543092|NCT03419234|616331183|FG001|Overall Study|Non-compliance|3|||
170543093|NCT03419234|616331182|FG000|Overall Study|Mistakenly off treatment|1|||
170543094|NCT03419234|616331183|FG001|Overall Study|Mistakenly off treatment|0|||
170543095|NCT03419234|616331182|FG000|Overall Study|Transition to hospice|1|||
170543096|NCT03419234|616331183|FG001|Overall Study|Transition to hospice|0|||
170543097|NCT03419234|616331182|FG000|Overall Study|Still on treatment|9|||
170543098|NCT03419234|616331183|FG001|Overall Study|Still on treatment|8|||
170543099|NCT03419234|616331182|FG000|Overall Study|Never received protocol therapy|2|||
170543100|NCT03419234|616331183|FG001|Overall Study|Never received protocol therapy|4|||
170543101|NCT03419234|616331182|FG000|Overall Study|Other complicating disease|0|||
170543102|NCT03419234|616331183|FG001|Overall Study|Other complicating disease|1|||
170543103|NCT03419234|616331182|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
170543104|NCT03419234|616331183|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
170543105|NCT04167670|616332784|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
170543106|NCT04167670|616332785|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
170543107|NCT04167670|616332786|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
170543108|NCT04167670|616332784|FG000|Overall Study|Significant protocol deviation|3|||
170543109|NCT04167670|616332785|FG001|Overall Study|Significant protocol deviation|1|||
170543110|NCT04167670|616332786|FG002|Overall Study|Significant protocol deviation|0|||
170543111|NCT04167670|616332784|FG000|Overall Study|Lost to Follow-up|0|||
170543112|NCT04167670|616332785|FG001|Overall Study|Lost to Follow-up|3|||
170543113|NCT04167670|616332786|FG002|Overall Study|Lost to Follow-up|3|||
170543114|NCT04167670|616332784|FG000|Overall Study|Voluntary Withdrawal|0|||
170543115|NCT04167670|616332785|FG001|Overall Study|Voluntary Withdrawal|1|||
170543116|NCT04167670|616332786|FG002|Overall Study|Voluntary Withdrawal|1|||
170543117|NCT04167670|616332784|FG000|Overall Study|Withdrawal of Consent|4|||
170543118|NCT04167670|616332785|FG001|Overall Study|Withdrawal of Consent|1|||
170543119|NCT04167670|616332786|FG002|Overall Study|Withdrawal of Consent|3|||
170543120|NCT04167670|616332784|FG000|Overall Study|Miscellaneous|7|||
170543121|NCT04167670|616332785|FG001|Overall Study|Miscellaneous|5|||
170543122|NCT04167670|616332786|FG002|Overall Study|Miscellaneous|3|||
170543123|NCT04827446|616332787|FG000|Overall Study|Lost to Follow-up|1|||
170543124|NCT04827446|616332788|FG001|Overall Study|Lost to Follow-up|1|||
170543125|NCT04827446|616332787|FG000|Overall Study|Death|2|||
170543126|NCT04827446|616332788|FG001|Overall Study|Death|0|||
170543127|NCT04827446|616332787|FG000|Overall Study|Withdrawal by Subject|2|||
170543128|NCT04827446|616332788|FG001|Overall Study|Withdrawal by Subject|2|||
170788100|NCT04632992|617234204|FG006|Overall Study|Reason not Specified|0|||
170788101|NCT04632992|617234205|FG007|Overall Study|Reason not Specified|0|||
170788102|NCT04632992|617234206|FG008|Overall Study|Reason not Specified|0|||
170788103|NCT04632992|617234207|FG009|Overall Study|Reason not Specified|0|||
170458523|NCT01570686|616020644|FG001|Overall Study|Withdrawal by Subject|4|||
170543129|NCT03554473|616332791|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
170543130|NCT03554473|616332792|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
170543131|NCT03554473|616332793|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
170543132|NCT03554473|616332791|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
170543133|NCT03554473|616332792|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
170543134|NCT03554473|616332793|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
170543135|NCT03554473|616332791|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
170458524|NCT01570686|616020643|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170458525|NCT01570686|616020644|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170458526|NCT00754650|616020645|FG000|Overall Study|Disease Progression|2|||
170458527|NCT02372071|616020650|FG000|Overall Study|Protocol Violation|18|||
170458528|NCT02227147|616020651|FG000|Controlled Treatment Period|Adverse Event|4|||
170458529|NCT02227147|616020652|FG001|Controlled Treatment Period|Adverse Event|3|||
170458530|NCT02227147|616020651|FG000|Controlled Treatment Period|Other|2|||
170458531|NCT02227147|616020652|FG001|Controlled Treatment Period|Other|0|||
170458532|NCT02227147|616020651|FG000|Follow-up Period|Other|3|||
170458533|NCT02227147|616020652|FG001|Follow-up Period|Other|5|||
170458534|NCT04112173|616020653|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
170458535|NCT02628743|616020661|FG000|Overall Study|Other|3|||
170458536|NCT02628743|616020661|FG000|Overall Study|Withdrawal by Subject|50|||
170458537|NCT02628743|616020661|FG000|Overall Study|Study Terminated by Sponsor|76|||
170458538|NCT02628743|616020661|FG000|Overall Study|Physician Decision|2|||
170458539|NCT01359969|616020664|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
170458540|NCT01783548|616020665|FG000|Overall Study|Adverse Event|8|||
170458541|NCT01783548|616020666|FG001|Overall Study|Adverse Event|4|||
170458542|NCT01783548|616020665|FG000|Overall Study|Withdrawal by Subject|11|||
170458543|NCT01783548|616020666|FG001|Overall Study|Withdrawal by Subject|8|||
170458544|NCT01783548|616020665|FG000|Overall Study|Non-compliance|4|||
170458545|NCT01783548|616020666|FG001|Overall Study|Non-compliance|0|||
170458546|NCT01783548|616020665|FG000|Overall Study|Protocol Violation|2|||
170458547|NCT01783548|616020666|FG001|Overall Study|Protocol Violation|2|||
170458548|NCT01783548|616020665|FG000|Overall Study|Lost to Follow-up|8|||
170458549|NCT01783548|616020666|FG001|Overall Study|Lost to Follow-up|3|||
170458550|NCT01783548|616020665|FG000|Overall Study|Lack of Efficacy|1|||
170458551|NCT01783548|616020666|FG001|Overall Study|Lack of Efficacy|1|||
170458552|NCT04283500|616020670|FG000|Overall Study|Lost to Follow-up|8|||
170458553|NCT04283500|616020670|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
170458554|NCT01059539|616020674|FG000|Overall Study|Adverse Event|66|||
170458555|NCT01059539|616020674|FG000|Overall Study|Insufficient Therapeutic Response|26|||
170458556|NCT01059539|616020674|FG000|Overall Study|Protocol Violation|55|||
170458557|NCT01059539|616020674|FG000|Overall Study|Withdrawal of Consent|80|||
170458558|NCT01059539|616020674|FG000|Overall Study|Lost to Follow-up|42|||
170458559|NCT01059539|616020674|FG000|Overall Study|Reason Not Specified|2|||
170458560|NCT05084963|616020676|FG000|Overall Study|Withdrawal by Subject|0|||
170458561|NCT05084963|616020677|FG001|Overall Study|Withdrawal by Subject|0|||
170458562|NCT05084963|616020678|FG002|Overall Study|Withdrawal by Subject|1|||
170458563|NCT03569228|616020679|FG000|Overall Study|Withdrawal by PI|0|||
170458564|NCT03569228|616020680|FG001|Overall Study|Withdrawal by PI|0|||
170458565|NCT03569228|616020681|FG002|Overall Study|Withdrawal by PI|2|||
170458566|NCT03569228|616020682|FG003|Overall Study|Withdrawal by PI|2|||
170458567|NCT03569228|616020683|FG004|Overall Study|Withdrawal by PI|1|||
170458568|NCT03569228|616020684|FG005|Overall Study|Withdrawal by PI|0|||
170458569|NCT03569228|616020685|FG006|Overall Study|Withdrawal by PI|0|||
170458570|NCT03569228|616020686|FG007|Overall Study|Withdrawal by PI|0|||
170458571|NCT03569228|616020687|FG008|Overall Study|Withdrawal by PI|0|||
170458572|NCT03569228|616020679|FG000|Overall Study|Lost to Follow-up|0|||
170458573|NCT03569228|616020680|FG001|Overall Study|Lost to Follow-up|0|||
170458574|NCT03569228|616020681|FG002|Overall Study|Lost to Follow-up|0|||
170458575|NCT03569228|616020682|FG003|Overall Study|Lost to Follow-up|0|||
170458576|NCT03569228|616020683|FG004|Overall Study|Lost to Follow-up|0|||
170458577|NCT03569228|616020684|FG005|Overall Study|Lost to Follow-up|0|||
170458578|NCT03569228|616020685|FG006|Overall Study|Lost to Follow-up|0|||
170543136|NCT03554473|616332792|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
170543137|NCT03554473|616332793|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
170543138|NCT01363076|616332794|FG000|Overall Study|Withdrawal by Subject|0|||
170543139|NCT01363076|616332795|FG001|Overall Study|Withdrawal by Subject|1|||
170543140|NCT04706403|616332796|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
170458579|NCT03569228|616020686|FG007|Overall Study|Lost to Follow-up|0|||
170458580|NCT03569228|616020687|FG008|Overall Study|Lost to Follow-up|1|||
170458581|NCT03569228|616020679|FG000|Overall Study|Screen Fail|2|||
170458582|NCT03569228|616020680|FG001|Overall Study|Screen Fail|2|||
170458583|NCT03569228|616020681|FG002|Overall Study|Screen Fail|1|||
170458584|NCT03569228|616020682|FG003|Overall Study|Screen Fail|1|||
170458585|NCT03569228|616020683|FG004|Overall Study|Screen Fail|1|||
170458586|NCT03569228|616020684|FG005|Overall Study|Screen Fail|3|||
170458587|NCT03569228|616020685|FG006|Overall Study|Screen Fail|1|||
170458588|NCT03569228|616020686|FG007|Overall Study|Screen Fail|5|||
170458589|NCT03569228|616020687|FG008|Overall Study|Screen Fail|2|||
170458590|NCT05442866|616020688|FG000|Overall Study|Death|1|||
170458591|NCT05442866|616020688|FG000|Overall Study|Lost to Follow-up|9|||
170458592|NCT05442866|616020688|FG000|Overall Study|Protocol Violation|1|||
170458593|NCT01394952|616020689|FG000|Overall Study|Lost to Follow-up|0|||
170458594|NCT01394952|616020690|FG001|Overall Study|Lost to Follow-up|5|||
170458595|NCT01394952|616020689|FG000|Overall Study|Withdrawal by Subject|10|||
170458596|NCT01394952|616020690|FG001|Overall Study|Withdrawal by Subject|5|||
170458597|NCT01394952|616020689|FG000|Overall Study|Physician Decision|2|||
170458598|NCT01394952|616020690|FG001|Overall Study|Physician Decision|0|||
170458599|NCT01394952|616020689|FG000|Overall Study|Sponsor Decision|5|||
170458600|NCT01394952|616020690|FG001|Overall Study|Sponsor Decision|7|||
170458601|NCT01986010|616020691|FG000|Overall Study|Adverse Event|0|||
170458602|NCT01986010|616020692|FG001|Overall Study|Adverse Event|1|||
170458603|NCT01986010|616020693|FG002|Overall Study|Adverse Event|0|||
170458604|NCT01986010|616020694|FG003|Overall Study|Adverse Event|0|||
170458605|NCT01986010|616020695|FG004|Overall Study|Adverse Event|0|||
170458606|NCT01986010|616020696|FG005|Overall Study|Adverse Event|0|||
170458607|NCT01986010|616020697|FG006|Overall Study|Adverse Event|0|||
170458608|NCT01986010|616020698|FG007|Overall Study|Adverse Event|0|||
170458609|NCT01986010|616020699|FG008|Overall Study|Adverse Event|0|||
170458610|NCT01986010|616020700|FG009|Overall Study|Adverse Event|0|||
170458611|NCT01986010|616020701|FG010|Overall Study|Adverse Event|0|||
170458612|NCT01986010|616020702|FG011|Overall Study|Adverse Event|0|||
170458613|NCT01986010|616020703|FG012|Overall Study|Adverse Event|0|||
170458614|NCT01986010|616020704|FG013|Overall Study|Adverse Event|0|||
170458615|NCT01986010|616020705|FG014|Overall Study|Adverse Event|0|||
170458616|NCT01986010|616020706|FG015|Overall Study|Adverse Event|1|||
170458617|NCT01986010|616020707|FG016|Overall Study|Adverse Event|0|||
170458618|NCT01986010|616020691|FG000|Overall Study|Lost to Follow-up|2|||
170458619|NCT01986010|616020692|FG001|Overall Study|Lost to Follow-up|1|||
170458620|NCT01986010|616020693|FG002|Overall Study|Lost to Follow-up|2|||
170458621|NCT01986010|616020694|FG003|Overall Study|Lost to Follow-up|2|||
170458622|NCT01986010|616020695|FG004|Overall Study|Lost to Follow-up|2|||
170458623|NCT01986010|616020696|FG005|Overall Study|Lost to Follow-up|2|||
170458624|NCT01986010|616020697|FG006|Overall Study|Lost to Follow-up|0|||
170458625|NCT01986010|616020698|FG007|Overall Study|Lost to Follow-up|0|||
170458626|NCT01986010|616020699|FG008|Overall Study|Lost to Follow-up|4|||
170458627|NCT01986010|616020700|FG009|Overall Study|Lost to Follow-up|2|||
170458628|NCT01986010|616020701|FG010|Overall Study|Lost to Follow-up|0|||
170458629|NCT01986010|616020702|FG011|Overall Study|Lost to Follow-up|1|||
170458630|NCT01986010|616020703|FG012|Overall Study|Lost to Follow-up|1|||
170458631|NCT01986010|616020704|FG013|Overall Study|Lost to Follow-up|1|||
170458632|NCT01986010|616020705|FG014|Overall Study|Lost to Follow-up|2|||
170458633|NCT01986010|616020706|FG015|Overall Study|Lost to Follow-up|0|||
170458634|NCT01986010|616020707|FG016|Overall Study|Lost to Follow-up|0|||
170458635|NCT01986010|616020691|FG000|Overall Study|Physician Decision|0|||
170458636|NCT01986010|616020692|FG001|Overall Study|Physician Decision|0|||
170458637|NCT01986010|616020693|FG002|Overall Study|Physician Decision|0|||
170458638|NCT01986010|616020694|FG003|Overall Study|Physician Decision|0|||
170458639|NCT01986010|616020695|FG004|Overall Study|Physician Decision|0|||
170458640|NCT01986010|616020696|FG005|Overall Study|Physician Decision|0|||
170543141|NCT04706403|616332797|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
170543142|NCT04706403|616332798|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
170543143|NCT04706403|616332799|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
170543144|NCT04706403|616332800|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
170543145|NCT02642679|616332801|FG000|Overall Study|Withdrawal by Subject|1|||
170543146|NCT02642679|616332801|FG000|Overall Study|Physician Decision|1|||
170543147|NCT02642679|616332801|FG000|Overall Study|Physician Decision|1|||
170543148|NCT05206604|616332802|FG000|Overall Study|Non-compliance with study drug|0|||
170543149|NCT05206604|616332803|FG001|Overall Study|Non-compliance with study drug|0|||
170543150|NCT05206604|616332804|FG002|Overall Study|Non-compliance with study drug|0|||
170543151|NCT05206604|616332805|FG003|Overall Study|Non-compliance with study drug|0|||
170543152|NCT05206604|616332806|FG004|Overall Study|Non-compliance with study drug|0|||
170543153|NCT05206604|616332807|FG005|Overall Study|Non-compliance with study drug|1|||
170788104|NCT04632992|617234208|FG010|Overall Study|Reason not Specified|1|||
170788105|NCT04632992|617234209|FG011|Overall Study|Reason not Specified|0|||
170788106|NCT04632992|617234210|FG012|Overall Study|Reason not Specified|0|||
170788107|NCT04632992|617234211|FG013|Overall Study|Reason not Specified|0|||
170788108|NCT04632992|617234198|FG000|Overall Study|Physician Decision|0|||
170458641|NCT01986010|616020697|FG006|Overall Study|Physician Decision|0|||
170458642|NCT01986010|616020698|FG007|Overall Study|Physician Decision|0|||
170458643|NCT01986010|616020699|FG008|Overall Study|Physician Decision|0|||
170458644|NCT01986010|616020700|FG009|Overall Study|Physician Decision|0|||
170458645|NCT01986010|616020701|FG010|Overall Study|Physician Decision|0|||
170543154|NCT05206604|616332808|FG006|Overall Study|Non-compliance with study drug|0|||
170543155|NCT05206604|616332809|FG007|Overall Study|Non-compliance with study drug|0|||
170458646|NCT01986010|616020702|FG011|Overall Study|Physician Decision|0|||
170458647|NCT01986010|616020703|FG012|Overall Study|Physician Decision|0|||
170458648|NCT01986010|616020704|FG013|Overall Study|Physician Decision|0|||
170458649|NCT01986010|616020705|FG014|Overall Study|Physician Decision|1|||
170458650|NCT01986010|616020706|FG015|Overall Study|Physician Decision|0|||
170458651|NCT01986010|616020707|FG016|Overall Study|Physician Decision|0|||
170458652|NCT01986010|616020691|FG000|Overall Study|Withdrawal by Subject|2|||
170458653|NCT01986010|616020692|FG001|Overall Study|Withdrawal by Subject|2|||
170458654|NCT01986010|616020693|FG002|Overall Study|Withdrawal by Subject|3|||
170458655|NCT01986010|616020694|FG003|Overall Study|Withdrawal by Subject|0|||
170458656|NCT01986010|616020695|FG004|Overall Study|Withdrawal by Subject|2|||
170458657|NCT01986010|616020696|FG005|Overall Study|Withdrawal by Subject|4|||
170458658|NCT01986010|616020697|FG006|Overall Study|Withdrawal by Subject|0|||
170458659|NCT01986010|616020698|FG007|Overall Study|Withdrawal by Subject|0|||
170889247|NCT01543087|617600654|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
170889248|NCT01543087|617600655|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
170889249|NCT01543087|617600656|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
170458660|NCT01986010|616020699|FG008|Overall Study|Withdrawal by Subject|0|||
170458661|NCT01986010|616020700|FG009|Overall Study|Withdrawal by Subject|0|||
170458662|NCT01986010|616020701|FG010|Overall Study|Withdrawal by Subject|0|||
170458663|NCT01986010|616020702|FG011|Overall Study|Withdrawal by Subject|2|||
170458664|NCT01986010|616020703|FG012|Overall Study|Withdrawal by Subject|0|||
170458665|NCT01986010|616020704|FG013|Overall Study|Withdrawal by Subject|1|||
170889250|NCT01543087|617600651|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
170458666|NCT01986010|616020705|FG014|Overall Study|Withdrawal by Subject|2|||
170458667|NCT01986010|616020706|FG015|Overall Study|Withdrawal by Subject|0|||
170458668|NCT01986010|616020707|FG016|Overall Study|Withdrawal by Subject|0|||
170458669|NCT01986010|616020691|FG000|Overall Study|Status Not Recorded|2|||
170458670|NCT01986010|616020692|FG001|Overall Study|Status Not Recorded|4|||
170458671|NCT01986010|616020693|FG002|Overall Study|Status Not Recorded|2|||
170458672|NCT01986010|616020694|FG003|Overall Study|Status Not Recorded|0|||
170458673|NCT01986010|616020695|FG004|Overall Study|Status Not Recorded|1|||
170458674|NCT01986010|616020696|FG005|Overall Study|Status Not Recorded|2|||
170458675|NCT01986010|616020697|FG006|Overall Study|Status Not Recorded|0|||
170458676|NCT01986010|616020698|FG007|Overall Study|Status Not Recorded|0|||
170458677|NCT01986010|616020699|FG008|Overall Study|Status Not Recorded|2|||
170458678|NCT01986010|616020700|FG009|Overall Study|Status Not Recorded|1|||
170458679|NCT01986010|616020701|FG010|Overall Study|Status Not Recorded|7|||
170458680|NCT01986010|616020702|FG011|Overall Study|Status Not Recorded|7|||
170458681|NCT01986010|616020703|FG012|Overall Study|Status Not Recorded|9|||
170458682|NCT01986010|616020704|FG013|Overall Study|Status Not Recorded|9|||
170458683|NCT01986010|616020705|FG014|Overall Study|Status Not Recorded|5|||
170458684|NCT01986010|616020706|FG015|Overall Study|Status Not Recorded|10|||
170458685|NCT01986010|616020707|FG016|Overall Study|Status Not Recorded|4|||
170458686|NCT04740814|616020708|FG000|Overall Study|Adverse Event|3|||
170458687|NCT04740814|616020708|FG000|Overall Study|Protocol Violation|2|||
170458688|NCT04740814|616020708|FG000|Overall Study|Lost to Follow-up|2|||
170458689|NCT04740814|616020708|FG000|Overall Study|Withdrawal by Subject|3|||
170458690|NCT02994940|616020714|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
170458691|NCT02994940|616020715|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
170458692|NCT02994940|616020714|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
170458693|NCT02994940|616020715|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
170458694|NCT02994940|616020714|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
170458695|NCT02994940|616020715|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
170458696|NCT01584843|616020716|FG000|First Treatment Period|Adverse Event|0|||
170458697|NCT01584843|616020717|FG001|First Treatment Period|Adverse Event|0|||
170458698|NCT01584843|616020718|FG002|First Treatment Period|Adverse Event|1|||
170458699|NCT01584843|616020719|FG003|First Treatment Period|Adverse Event|0|||
170458700|NCT01584843|616020720|FG004|First Treatment Period|Adverse Event|0|||
170458701|NCT01584843|616020721|FG005|First Treatment Period|Adverse Event|0|||
170458702|NCT01584843|616020716|FG000|First Treatment Period|Protocol Violation|0|||
170458703|NCT01584843|616020717|FG001|First Treatment Period|Protocol Violation|0|||
170458704|NCT01584843|616020718|FG002|First Treatment Period|Protocol Violation|0|||
170458705|NCT01584843|616020719|FG003|First Treatment Period|Protocol Violation|0|||
170458706|NCT01584843|616020720|FG004|First Treatment Period|Protocol Violation|0|||
170458707|NCT01584843|616020721|FG005|First Treatment Period|Protocol Violation|1|||
170458708|NCT01584843|616020716|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
170458709|NCT01584843|616020717|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
170889251|NCT01543087|617600652|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
170889252|NCT01543087|617600653|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
170458710|NCT01584843|616020718|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
170458711|NCT01584843|616020719|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
170458712|NCT01584843|616020720|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
170458713|NCT01584843|616020721|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
170458714|NCT01584843|616020716|FG000|Second Treatment Period|Withdrawal by Subject|0|||
170458715|NCT01584843|616020717|FG001|Second Treatment Period|Withdrawal by Subject|0|||
170889253|NCT01543087|617600654|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
170458716|NCT01584843|616020718|FG002|Second Treatment Period|Withdrawal by Subject|0|||
170458717|NCT01584843|616020719|FG003|Second Treatment Period|Withdrawal by Subject|0|||
170458718|NCT01584843|616020720|FG004|Second Treatment Period|Withdrawal by Subject|0|||
170458719|NCT01584843|616020721|FG005|Second Treatment Period|Withdrawal by Subject|1|||
170458720|NCT01355159|616020730|FG000|Overall Study|Withdrew consent|39|||
170458721|NCT01355159|616020731|FG001|Overall Study|Withdrew consent|47|||
170458722|NCT01355159|616020730|FG000|Overall Study|No primary outcome data|17|||
170458723|NCT01355159|616020731|FG001|Overall Study|No primary outcome data|11|||
170458724|NCT01355159|616020730|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
170458725|NCT01355159|616020731|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
170458726|NCT01355159|616020730|FG000|Overall Study|Early intrauterine fetal death|6|||
170458727|NCT01355159|616020731|FG001|Overall Study|Early intrauterine fetal death|6|||
170458728|NCT03276221|616020732|FG000|Overall Study|Lost to Follow-up|6|||
170458729|NCT03276221|616020733|FG001|Overall Study|Lost to Follow-up|2|||
170458730|NCT03276221|616020734|FG002|Overall Study|Lost to Follow-up|0|||
170458731|NCT03276221|616020732|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
170458732|NCT03276221|616020733|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
170458733|NCT03276221|616020734|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
170458734|NCT00424775|616020736|FG000|Overall Study|Adverse Event|2|||
170458735|NCT00424775|616020737|FG001|Overall Study|Adverse Event|0|||
170458736|NCT00424775|616020736|FG000|Overall Study|Lack of Efficacy|1|||
170458737|NCT00424775|616020737|FG001|Overall Study|Lack of Efficacy|0|||
170458738|NCT00681590|616020738|FG000|Overall Study|Withdrawal by Subject|2|||
170458739|NCT00681590|616020739|FG001|Overall Study|Withdrawal by Subject|12|||
170458740|NCT02458092|616020740|FG000|Overall Study|Withdrawal by Subject|1|||
170458741|NCT02458092|616020741|FG001|Overall Study|Withdrawal by Subject|0|||
170458742|NCT02615171|616020742|FG000|Overall Study|Lost to Follow-up|2|||
170458743|NCT02615171|616020743|FG001|Overall Study|Lost to Follow-up|1|||
170458744|NCT02707861|616020746|FG000|Overall Study|Went onto commercial drug|30|||
170458745|NCT02707861|616020747|FG001|Overall Study|Went onto commercial drug|23|||
170458746|NCT02707861|616020746|FG000|Overall Study|Adverse Event|2|||
170458747|NCT02707861|616020747|FG001|Overall Study|Adverse Event|3|||
170458748|NCT02707861|616020746|FG000|Overall Study|Death|5|||
170458749|NCT02707861|616020747|FG001|Overall Study|Death|2|||
170458750|NCT02707861|616020746|FG000|Overall Study|Lack of Efficacy|0|||
170458751|NCT02707861|616020747|FG001|Overall Study|Lack of Efficacy|2|||
170458752|NCT02707861|616020746|FG000|Overall Study|Physician Decision|1|||
170458753|NCT02707861|616020747|FG001|Overall Study|Physician Decision|4|||
170458754|NCT02707861|616020746|FG000|Overall Study|Withdrawal by Subject|2|||
170458755|NCT02707861|616020747|FG001|Overall Study|Withdrawal by Subject|1|||
170458756|NCT02707861|616020746|FG000|Overall Study|Lost to Follow-up|1|||
170458757|NCT02707861|616020747|FG001|Overall Study|Lost to Follow-up|3|||
170458758|NCT00731549|616020750|FG000|Overall Study|Lost to Follow-up|19|||
170458759|NCT00731549|616020750|FG000|Overall Study|Met withdrawal criteria|24|||
170458760|NCT00731549|616020750|FG000|Overall Study|Physician Decision|16|||
170458761|NCT00731549|616020750|FG000|Overall Study|Withdrawal by Subject|89|||
170458762|NCT00731549|616020750|FG000|Overall Study|Protocol deviation|1|||
170458763|NCT00731549|616020750|FG000|Overall Study|Adverse Event|31|||
170458764|NCT00731549|616020750|FG000|Overall Study|Lack of efficacy with AE|37|||
170458765|NCT00731549|616020750|FG000|Overall Study|Lack of efficacy without AE|6|||
170458766|NCT02384850|616020751|FG000|Overall Study|Withdrawal by Subject|2|||
170458767|NCT02384850|616020752|FG001|Overall Study|Withdrawal by Subject|2|||
170458768|NCT00507546|616020753|FG000|Overall Study|Withdrawal by Subject|1|||
170458769|NCT00507546|616020754|FG001|Overall Study|Withdrawal by Subject|0|||
170458770|NCT00507546|616020753|FG000|Overall Study|Protocol Violation|1|||
170458771|NCT00507546|616020754|FG001|Overall Study|Protocol Violation|0|||
170458772|NCT00507546|616020753|FG000|Overall Study|Physician Decision|0|||
170458773|NCT00507546|616020754|FG001|Overall Study|Physician Decision|1|||
170458774|NCT02435836|616020755|FG000|Overall Study|Lost to Follow-up|21|||
170458775|NCT02435836|616020755|FG000|Overall Study|Lack of Efficacy|1|||
170458776|NCT02435836|616020755|FG000|Overall Study|Withdrawal by Subject|236|||
170458777|NCT02435836|616020755|FG000|Overall Study|Insufficient Clinical Response|26|||
170458778|NCT02435836|616020755|FG000|Overall Study|Adverse Event|44|||
170458779|NCT02435836|616020755|FG000|Overall Study|Sponsor discontinued trial|167|||
170458780|NCT02435836|616020755|FG000|Overall Study|Noncompliance|27|||
170458781|NCT02435836|616020755|FG000|Overall Study|Protocol Violation|6|||
170458782|NCT02435836|616020755|FG000|Overall Study|Met Withdrawal Criteria|7|||
170458783|NCT02435836|616020755|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
170458784|NCT01299805|616020760|FG000|Overall Study|Adverse Event|2|||
170458785|NCT01299805|616020761|FG001|Overall Study|Adverse Event|0|||
170458786|NCT01661179|616020762|FG000|Overall Study|Death|1|||
170458787|NCT01661179|616020762|FG000|Overall Study|Withdrawal by Subject|1|||
170458788|NCT01661179|616020762|FG000|Overall Study|Other Eligibility criteria|4|||
170458789|NCT01946191|616020763|FG000|Allocation|Did not complete orientation|1|||
170458790|NCT01946191|616020764|FG001|Allocation|Did not complete orientation|1|||
170458791|NCT01946191|616020763|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
170458792|NCT01946191|616020764|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
170458793|NCT01946191|616020763|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
170458794|NCT01946191|616020764|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
170458795|NCT01946191|616020763|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
170458796|NCT01946191|616020764|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
170458797|NCT03071094|616020765|FG000|Overall Study|Death|1|||
170458798|NCT03071094|616020766|FG001|Overall Study|Death|1|||
170458799|NCT03071094|616020765|FG000|Overall Study|Adverse Event|1|||
170458800|NCT03071094|616020766|FG001|Overall Study|Adverse Event|0|||
170458801|NCT03845296|616023027|FG000|Overall Study|On Treatment|2|||
170458802|NCT03845296|616023028|FG001|Overall Study|On Treatment|1|||
170458803|NCT03845296|616023027|FG000|Overall Study|Adverse Event|4|||
170458804|NCT03845296|616023028|FG001|Overall Study|Adverse Event|11|||
170458805|NCT03845296|616023027|FG000|Overall Study|Refusal unrelated to adverse event|0|||
170458806|NCT03845296|616023028|FG001|Overall Study|Refusal unrelated to adverse event|1|||
170458807|NCT03845296|616023027|FG000|Overall Study|Progression/relapse|14|||
170458808|NCT03845296|616023028|FG001|Overall Study|Progression/relapse|18|||
170458809|NCT03845296|616023027|FG000|Overall Study|Death|4|||
170458810|NCT03845296|616023028|FG001|Overall Study|Death|0|||
170458811|NCT03845296|616023027|FG000|Overall Study|Other - not protocol specified|1|||
170458812|NCT03845296|616023028|FG001|Overall Study|Other - not protocol specified|3|||
170458813|NCT05424042|616023029|FG000|Overall Study|Withdrawal by Subject|2|||
170458814|NCT05424042|616023030|FG001|Overall Study|Withdrawal by Subject|0|||
170458815|NCT05424042|616023031|FG002|Overall Study|Withdrawal by Subject|4|||
170458816|NCT05424042|616023029|FG000|Overall Study|Lost to Follow-up|0|||
170458817|NCT05424042|616023030|FG001|Overall Study|Lost to Follow-up|0|||
170458818|NCT05424042|616023031|FG002|Overall Study|Lost to Follow-up|1|||
170458819|NCT05091307|616023032|FG000|Overall Study|Death|0|||
170458820|NCT05091307|616023033|FG001|Overall Study|Death|0|||
170458821|NCT05091307|616023034|FG002|Overall Study|Death|1|||
170458822|NCT05091307|616023035|FG003|Overall Study|Death|0|||
170458823|NCT05091307|616023032|FG000|Overall Study|Lost to Follow-up|33|||
170458824|NCT05091307|616023033|FG001|Overall Study|Lost to Follow-up|33|||
170458825|NCT05091307|616023034|FG002|Overall Study|Lost to Follow-up|2|||
170458826|NCT05091307|616023035|FG003|Overall Study|Lost to Follow-up|0|||
170458827|NCT05091307|616023032|FG000|Overall Study|Physician Decision|1|||
170458828|NCT05091307|616023033|FG001|Overall Study|Physician Decision|0|||
170458829|NCT05091307|616023034|FG002|Overall Study|Physician Decision|0|||
170458830|NCT05091307|616023035|FG003|Overall Study|Physician Decision|0|||
170458831|NCT05091307|616023032|FG000|Overall Study|Protocol Violation|1|||
170458832|NCT05091307|616023033|FG001|Overall Study|Protocol Violation|0|||
170458833|NCT05091307|616023034|FG002|Overall Study|Protocol Violation|0|||
170458834|NCT05091307|616023035|FG003|Overall Study|Protocol Violation|0|||
170458835|NCT05091307|616023032|FG000|Overall Study|Withdrawal by Subject|16|||
170458836|NCT05091307|616023033|FG001|Overall Study|Withdrawal by Subject|16|||
170458837|NCT05091307|616023034|FG002|Overall Study|Withdrawal by Subject|0|||
170458838|NCT05091307|616023035|FG003|Overall Study|Withdrawal by Subject|1|||
170458839|NCT05091307|616023032|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
170458840|NCT05091307|616023033|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
170458841|NCT05091307|616023034|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
170458842|NCT05091307|616023035|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
170458843|NCT05091307|616023032|FG000|Overall Study|Initiated Prohibited Medication|1|||
170458844|NCT05091307|616023033|FG001|Overall Study|Initiated Prohibited Medication|0|||
170458845|NCT05091307|616023034|FG002|Overall Study|Initiated Prohibited Medication|0|||
170458846|NCT05091307|616023035|FG003|Overall Study|Initiated Prohibited Medication|0|||
170458847|NCT05091307|616023032|FG000|Overall Study|Other|4|||
170458848|NCT05091307|616023033|FG001|Overall Study|Other|4|||
170458849|NCT05091307|616023034|FG002|Overall Study|Other|0|||
170458850|NCT05091307|616023035|FG003|Overall Study|Other|0|||
170458851|NCT05091307|616023032|FG000|Overall Study|Randomized but not vaccinated|0|||
170458852|NCT05091307|616023033|FG001|Overall Study|Randomized but not vaccinated|2|||
170458853|NCT05091307|616023034|FG002|Overall Study|Randomized but not vaccinated|0|||
170458854|NCT05091307|616023035|FG003|Overall Study|Randomized but not vaccinated|0|||
170458855|NCT03611543|616023038|FG000|Overall Study|Withdrawal by Subject|4|||
170458856|NCT03611543|616023039|FG001|Overall Study|Withdrawal by Subject|4|||
170458857|NCT03611543|616023038|FG000|Overall Study|Physician Decision|1|||
170458858|NCT03611543|616023039|FG001|Overall Study|Physician Decision|1|||
170458859|NCT03611543|616023038|FG000|Overall Study|Protocol Violation|2|||
170458860|NCT03611543|616023039|FG001|Overall Study|Protocol Violation|2|||
170458861|NCT03611543|616023038|FG000|Overall Study|Device failure|2|||
170458862|NCT03611543|616023039|FG001|Overall Study|Device failure|2|||
170458863|NCT03611543|616023038|FG000|Overall Study|Missing information|5|||
170458864|NCT03611543|616023039|FG001|Overall Study|Missing information|5|||
170458865|NCT06077487|616023040|FG000|Overall Study|Withdrawal by Subject|0|||
170636029|NCT00473382|616678937|FG002|Core Study|Subject non-compliance|1|||
170636030|NCT00473382|616678935|FG000|Core Study|Subject needed other treatment|1|||
170636031|NCT00473382|616678936|FG001|Core Study|Subject needed other treatment|3|||
170458866|NCT06077487|616023041|FG001|Overall Study|Withdrawal by Subject|1|||
170458867|NCT02081209|616023042|FG000|Overall Study|Withdrawal by Subject|1|||
170458868|NCT05101486|616023043|FG000|Overall Study|Death|1|||
170458869|NCT05101486|616023044|FG001|Overall Study|Death|0|||
170458870|NCT05101486|616023045|FG002|Overall Study|Death|1|||
170458871|NCT05101486|616023043|FG000|Overall Study|Lost to Follow-up|12|||
170458872|NCT05101486|616023044|FG001|Overall Study|Lost to Follow-up|8|||
170458873|NCT05101486|616023045|FG002|Overall Study|Lost to Follow-up|17|||
170458874|NCT05101486|616023043|FG000|Overall Study|Physician Decision|1|||
170458875|NCT05101486|616023044|FG001|Overall Study|Physician Decision|0|||
170458876|NCT05101486|616023045|FG002|Overall Study|Physician Decision|0|||
170458877|NCT05101486|616023043|FG000|Overall Study|Protocol Violation|0|||
170458878|NCT05101486|616023044|FG001|Overall Study|Protocol Violation|0|||
170458879|NCT05101486|616023045|FG002|Overall Study|Protocol Violation|1|||
170458880|NCT05101486|616023043|FG000|Overall Study|Withdrawal by Subject|5|||
170458881|NCT05101486|616023044|FG001|Overall Study|Withdrawal by Subject|2|||
170458882|NCT05101486|616023045|FG002|Overall Study|Withdrawal by Subject|4|||
170458883|NCT05101486|616023043|FG000|Overall Study|Randomized but not vaccinated|1|||
170458884|NCT05101486|616023044|FG001|Overall Study|Randomized but not vaccinated|1|||
170458885|NCT05101486|616023045|FG002|Overall Study|Randomized but not vaccinated|1|||
170458886|NCT05327816|616023051|FG000|Overall Study|Lost to Follow-up|1|||
170458887|NCT05327816|616023052|FG001|Overall Study|Lost to Follow-up|0|||
170458888|NCT05327816|616023053|FG002|Overall Study|Lost to Follow-up|0|||
170458889|NCT05327816|616023054|FG003|Overall Study|Lost to Follow-up|0|||
170458890|NCT05327816|616023055|FG004|Overall Study|Lost to Follow-up|0|||
170458891|NCT05327816|616023056|FG005|Overall Study|Lost to Follow-up|0|||
170458892|NCT05327816|616023057|FG006|Overall Study|Lost to Follow-up|0|||
170458893|NCT05327816|616023058|FG007|Overall Study|Lost to Follow-up|0|||
170458894|NCT05327816|616023059|FG008|Overall Study|Lost to Follow-up|0|||
170458895|NCT05327816|616023060|FG009|Overall Study|Lost to Follow-up|1|||
170458896|NCT05327816|616023061|FG010|Overall Study|Lost to Follow-up|0|||
170458897|NCT05327816|616023051|FG000|Overall Study|Withdrawal by Subject|0|||
170458898|NCT05327816|616023052|FG001|Overall Study|Withdrawal by Subject|0|||
170458899|NCT05327816|616023053|FG002|Overall Study|Withdrawal by Subject|0|||
170458900|NCT05327816|616023054|FG003|Overall Study|Withdrawal by Subject|0|||
170458901|NCT05327816|616023055|FG004|Overall Study|Withdrawal by Subject|1|||
170458902|NCT05327816|616023056|FG005|Overall Study|Withdrawal by Subject|1|||
170458903|NCT05327816|616023057|FG006|Overall Study|Withdrawal by Subject|0|||
170458904|NCT05327816|616023058|FG007|Overall Study|Withdrawal by Subject|0|||
170458905|NCT05327816|616023059|FG008|Overall Study|Withdrawal by Subject|0|||
170458906|NCT05327816|616023060|FG009|Overall Study|Withdrawal by Subject|0|||
170458907|NCT05327816|616023061|FG010|Overall Study|Withdrawal by Subject|0|||
170458908|NCT05327816|616023051|FG000|Overall Study|Study Terminated by Sponsor|11|||
170458909|NCT05327816|616023052|FG001|Overall Study|Study Terminated by Sponsor|12|||
170458910|NCT05327816|616023053|FG002|Overall Study|Study Terminated by Sponsor|12|||
170458911|NCT05327816|616023054|FG003|Overall Study|Study Terminated by Sponsor|12|||
170458912|NCT05327816|616023055|FG004|Overall Study|Study Terminated by Sponsor|11|||
170458913|NCT05327816|616023056|FG005|Overall Study|Study Terminated by Sponsor|11|||
170458914|NCT05327816|616023057|FG006|Overall Study|Study Terminated by Sponsor|11|||
170458915|NCT05327816|616023058|FG007|Overall Study|Study Terminated by Sponsor|11|||
170458916|NCT05327816|616023059|FG008|Overall Study|Study Terminated by Sponsor|11|||
170458917|NCT05327816|616023060|FG009|Overall Study|Study Terminated by Sponsor|11|||
170458918|NCT05327816|616023061|FG010|Overall Study|Study Terminated by Sponsor|12|||
170458919|NCT05327816|616023051|FG000|Overall Study|Randomized but not treated|0|||
170458920|NCT05327816|616023052|FG001|Overall Study|Randomized but not treated|0|||
170543156|NCT03735498|616332810|FG000|Overall Study|Withdrawal by Subject|3|||
170543157|NCT03735498|616332810|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
170543158|NCT01177410|616332820|FG000|Overall Study|Adverse Event|0|||
170543159|NCT01177410|616332821|FG001|Overall Study|Adverse Event|2|||
170543160|NCT01177410|616332822|FG002|Overall Study|Adverse Event|2|||
170543161|NCT01177410|616332820|FG000|Overall Study|Withdrawal by Subject|1|||
170543162|NCT01177410|616332821|FG001|Overall Study|Withdrawal by Subject|4|||
170543163|NCT01177410|616332822|FG002|Overall Study|Withdrawal by Subject|3|||
170458921|NCT05327816|616023053|FG002|Overall Study|Randomized but not treated|0|||
170458922|NCT05327816|616023054|FG003|Overall Study|Randomized but not treated|0|||
170458923|NCT05327816|616023055|FG004|Overall Study|Randomized but not treated|0|||
170458924|NCT05327816|616023056|FG005|Overall Study|Randomized but not treated|0|||
170458925|NCT05327816|616023057|FG006|Overall Study|Randomized but not treated|1|||
170458926|NCT05327816|616023058|FG007|Overall Study|Randomized but not treated|1|||
170889254|NCT01543087|617600655|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
170458927|NCT05327816|616023059|FG008|Overall Study|Randomized but not treated|1|||
170458928|NCT05327816|616023060|FG009|Overall Study|Randomized but not treated|0|||
170458929|NCT05327816|616023061|FG010|Overall Study|Randomized but not treated|0|||
170458930|NCT02518919|616023062|FG000|Overall Study|Protocol Violation|1|||
170458931|NCT02518919|616023063|FG001|Overall Study|Protocol Violation|1|||
170458932|NCT02518919|616023064|FG002|Overall Study|Protocol Violation|2|||
170458933|NCT01367665|616023066|FG000|Overall Study|Death|102|||
170458934|NCT01367665|616023067|FG001|Overall Study|Death|19|||
170543164|NCT01177410|616332820|FG000|Overall Study|Lost to Follow-up|0|||
170458935|NCT01367665|616023066|FG000|Overall Study|Lost to Follow-up|222|||
170458936|NCT01367665|616023067|FG001|Overall Study|Lost to Follow-up|22|||
170458937|NCT01367665|616023066|FG000|Overall Study|Not Done|118|||
170458938|NCT01367665|616023067|FG001|Overall Study|Not Done|14|||
170458939|NCT02752906|616023068|FG000|Overall Study|Protocol Violation|2|||
170458940|NCT02752906|616023069|FG001|Overall Study|Protocol Violation|1|||
170458941|NCT02752906|616023068|FG000|Overall Study|Withdrawal by Subject|2|||
170458942|NCT02752906|616023069|FG001|Overall Study|Withdrawal by Subject|2|||
170458943|NCT02752906|616023068|FG000|Overall Study|Lost to Follow-up|3|||
170458944|NCT02752906|616023069|FG001|Overall Study|Lost to Follow-up|2|||
170458945|NCT04663295|616023070|FG000|Run-in Period|Withdrawal by Subject|3|||
170458946|NCT04663295|616023070|FG000|Overall Study Period|Pregnancy|1|||
170458947|NCT04663295|616023070|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
170458948|NCT01345175|616023072|FG000|Overall Study|Physician Decision|0|||
170458949|NCT01345175|616023073|FG001|Overall Study|Physician Decision|1|||
170458950|NCT01345175|616023072|FG000|Overall Study|Withdrawal by Subject|1|||
170458951|NCT01345175|616023073|FG001|Overall Study|Withdrawal by Subject|1|||
170458952|NCT01345175|616023072|FG000|Overall Study|Failed to complete BFI|3|||
170458953|NCT01345175|616023073|FG001|Overall Study|Failed to complete BFI|2|||
170458954|NCT01345175|616023072|FG000|Overall Study|Stopped taking medication|2|||
170458955|NCT01345175|616023073|FG001|Overall Study|Stopped taking medication|2|||
170458956|NCT04715932|616023074|FG000|Overall Study|Lost to Follow-up|1|||
170458957|NCT04715932|616023075|FG001|Overall Study|Lost to Follow-up|0|||
170458958|NCT02740699|616023076|FG000|Overall Study|Lost to Follow-up|5|||
170458959|NCT02740699|616023076|FG000|Overall Study|Withdrawal by Subject|14|||
170458960|NCT02740699|616023076|FG000|Overall Study|Physician Decision|5|||
170458961|NCT00655876|616023088|FG000|Overall Study|Protocol Violation|9|||
170458962|NCT00655876|616023089|FG001|Overall Study|Protocol Violation|7|||
170458963|NCT00326963|616023090|FG000|Overall Study|Adverse Event|2|||
170458964|NCT00326963|616023090|FG000|Overall Study|Injection site reaction|1|||
170458965|NCT00326963|616023090|FG000|Overall Study|Death|1|||
170458966|NCT00326963|616023090|FG000|Overall Study|Failure to return|10|||
170458967|NCT00326963|616023090|FG000|Overall Study|Withdrawal by Subject|10|||
170458968|NCT00326963|616023090|FG000|Overall Study|Refused treatment / did not cooperate|5|||
170458969|NCT00326963|616023090|FG000|Overall Study|Violation of selection criteria at entry|2|||
170458970|NCT00326963|616023090|FG000|Overall Study|Other protocol violation|1|||
170458971|NCT00326963|616023090|FG000|Overall Study|Administrative / other|1|||
170458972|NCT00699374|616023094|FG000|Overall Study|Death|93|||
170458973|NCT00699374|616023095|FG001|Overall Study|Death|83|||
170458974|NCT00699374|616023094|FG000|Overall Study|Adverse Event|70|||
170458975|NCT00699374|616023095|FG001|Overall Study|Adverse Event|67|||
170458976|NCT00699374|616023094|FG000|Overall Study|Global deterioration of health status|7|||
170458977|NCT00699374|616023095|FG001|Overall Study|Global deterioration of health status|8|||
170458978|NCT00699374|616023094|FG000|Overall Study|Lost to Follow-up|3|||
170458979|NCT00699374|616023095|FG001|Overall Study|Lost to Follow-up|5|||
170458980|NCT00699374|616023094|FG000|Overall Study|Withdrawal by Subject|34|||
170458981|NCT00699374|616023095|FG001|Overall Study|Withdrawal by Subject|44|||
170458982|NCT00699374|616023094|FG000|Overall Study|Objective progression or relapse|281|||
170458983|NCT00699374|616023095|FG001|Overall Study|Objective progression or relapse|277|||
170458984|NCT00699374|616023094|FG000|Overall Study|Other|18|||
170543165|NCT01177410|616332821|FG001|Overall Study|Lost to Follow-up|1|||
170543166|NCT01177410|616332822|FG002|Overall Study|Lost to Follow-up|0|||
170543167|NCT03142750|616332823|FG000|Overall Study|Lost to Follow-up|4|||
170543168|NCT03142750|616332824|FG001|Overall Study|Lost to Follow-up|1|||
170543169|NCT00303628|616332825|FG000|Overall Study|Disease progression|0|||
170543170|NCT00303628|616332826|FG001|Overall Study|Disease progression|1|||
170543171|NCT00303628|616332825|FG000|Overall Study|Adverse Event|26|||
170543172|NCT00303628|616332826|FG001|Overall Study|Adverse Event|36|||
170543173|NCT00303628|616332825|FG000|Overall Study|Death|0|||
170543174|NCT00303628|616332826|FG001|Overall Study|Death|1|||
170543175|NCT00303628|616332825|FG000|Overall Study|Withdrawal by Subject|11|||
170543176|NCT00303628|616332826|FG001|Overall Study|Withdrawal by Subject|20|||
170543177|NCT00303628|616332825|FG000|Overall Study|Alternative therapy|2|||
170543178|NCT00303628|616332826|FG001|Overall Study|Alternative therapy|0|||
170543179|NCT00303628|616332825|FG000|Overall Study|Other complicating disease|0|||
170543180|NCT00303628|616332826|FG001|Overall Study|Other complicating disease|1|||
170543181|NCT00303628|616332825|FG000|Overall Study|Not start protocol therapy|3|||
170788109|NCT04632992|617234199|FG001|Overall Study|Physician Decision|0|||
170458985|NCT00699374|616023095|FG001|Overall Study|Other|15|||
170458986|NCT00699374|616023094|FG000|Overall Study|Protocol Violation|2|||
170458987|NCT00699374|616023095|FG001|Overall Study|Protocol Violation|6|||
170458988|NCT00699374|616023094|FG000|Overall Study|Study terminated by sponsor|13|||
170458989|NCT00699374|616023095|FG001|Overall Study|Study terminated by sponsor|28|||
170458990|NCT00699374|616023094|FG000|Overall Study|Randomized but not treated|4|||
170458991|NCT00699374|616023095|FG001|Overall Study|Randomized but not treated|2|||
170543182|NCT00303628|616332826|FG001|Overall Study|Not start protocol therapy|5|||
170788110|NCT04632992|617234200|FG002|Overall Study|Physician Decision|0|||
170788111|NCT04632992|617234201|FG003|Overall Study|Physician Decision|2|||
170788112|NCT04632992|617234202|FG004|Overall Study|Physician Decision|1|||
170788113|NCT04632992|617234203|FG005|Overall Study|Physician Decision|0|||
170788114|NCT04632992|617234204|FG006|Overall Study|Physician Decision|0|||
170788115|NCT04632992|617234205|FG007|Overall Study|Physician Decision|0|||
170788116|NCT04632992|617234206|FG008|Overall Study|Physician Decision|0|||
170788117|NCT04632992|617234207|FG009|Overall Study|Physician Decision|0|||
170458992|NCT00699374|616023094|FG000|Overall Study|Died 28 days after last dose|5|||
170458993|NCT00699374|616023095|FG001|Overall Study|Died 28 days after last dose|9|||
170458994|NCT00593736|616023099|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
170458995|NCT00593736|616023100|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
170458996|NCT00593736|616023101|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
170458997|NCT00593736|616023102|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
170458998|NCT00593736|616023099|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
170458999|NCT00593736|616023100|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
170459000|NCT00593736|616023101|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
170459001|NCT00593736|616023102|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
170459002|NCT00593736|616023099|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
170459003|NCT00593736|616023100|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
170459004|NCT00593736|616023101|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
170459005|NCT00593736|616023102|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
170459006|NCT00593736|616023099|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
170459007|NCT00593736|616023100|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
170459008|NCT00593736|616023101|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
170459009|NCT00593736|616023102|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
170459010|NCT00593736|616023099|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
170459011|NCT00593736|616023100|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
170459012|NCT00593736|616023101|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
170459013|NCT00593736|616023102|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
170459014|NCT00593736|616023099|FG000|Screening Period and Placebo Run-in|Various|0|||
170459015|NCT00593736|616023100|FG001|Screening Period and Placebo Run-in|Various|0|||
170459016|NCT00593736|616023101|FG002|Screening Period and Placebo Run-in|Various|0|||
170459017|NCT00593736|616023102|FG003|Screening Period and Placebo Run-in|Various|25|||
170459018|NCT00593736|616023099|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
170459019|NCT00593736|616023100|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
170459020|NCT00593736|616023101|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
170459021|NCT00593736|616023102|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
170459022|NCT00593736|616023099|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
170459023|NCT00593736|616023100|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
170459024|NCT00593736|616023101|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
170459025|NCT00593736|616023102|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
170459026|NCT00593736|616023099|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
170459027|NCT00593736|616023100|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
170459028|NCT00593736|616023101|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
170459029|NCT00593736|616023102|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
170459030|NCT00593736|616023099|FG000|Treatment Period and Placebo Run-out|Various|1|||
170459031|NCT00593736|616023100|FG001|Treatment Period and Placebo Run-out|Various|1|||
170459032|NCT00593736|616023101|FG002|Treatment Period and Placebo Run-out|Various|1|||
170459033|NCT00593736|616023102|FG003|Treatment Period and Placebo Run-out|Various|0|||
170459034|NCT04645966|616023103|FG000|Vaccination Phase|Adverse Event|1|||
170459035|NCT04645966|616023104|FG001|Vaccination Phase|Adverse Event|0|||
170459036|NCT04645966|616023105|FG002|Vaccination Phase|Adverse Event|0|||
170459037|NCT04645966|616023106|FG003|Vaccination Phase|Adverse Event|0|||
170459038|NCT04645966|616023107|FG004|Vaccination Phase|Adverse Event|0|||
170459039|NCT04645966|616023108|FG005|Vaccination Phase|Adverse Event|0|||
170459040|NCT04645966|616023109|FG006|Vaccination Phase|Adverse Event|1|||
170459041|NCT04645966|616023110|FG007|Vaccination Phase|Adverse Event|0|||
170543183|NCT00303628|616332825|FG000|Overall Study|Other|8|||
170543184|NCT00303628|616332826|FG001|Overall Study|Other|9|||
170543185|NCT03928743|616332828|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
170543186|NCT03928743|616332829|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
170543187|NCT03928743|616332830|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
170543188|NCT03928743|616332828|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
170543189|NCT03928743|616332829|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
170543190|NCT03928743|616332830|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
170543191|NCT03928743|616332828|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
170543192|NCT03928743|616332829|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
170543193|NCT03928743|616332830|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
170788118|NCT04632992|617234208|FG010|Overall Study|Physician Decision|0|||
170788119|NCT04632992|617234209|FG011|Overall Study|Physician Decision|0|||
170788120|NCT04632992|617234210|FG012|Overall Study|Physician Decision|3|||
170788121|NCT04632992|617234211|FG013|Overall Study|Physician Decision|0|||
170788122|NCT04632992|617234198|FG000|Overall Study|Progressive Disease|0|||
170788123|NCT04632992|617234199|FG001|Overall Study|Progressive Disease|0|||
170788124|NCT04632992|617234200|FG002|Overall Study|Progressive Disease|0|||
170459042|NCT04645966|616023111|FG008|Vaccination Phase|Adverse Event|0|||
170459043|NCT04645966|616023103|FG000|Vaccination Phase|Death|0|||
170459044|NCT04645966|616023104|FG001|Vaccination Phase|Death|0|||
170459045|NCT04645966|616023105|FG002|Vaccination Phase|Death|0|||
170459046|NCT04645966|616023106|FG003|Vaccination Phase|Death|0|||
170459047|NCT04645966|616023107|FG004|Vaccination Phase|Death|0|||
170459048|NCT04645966|616023108|FG005|Vaccination Phase|Death|1|||
170459049|NCT04645966|616023109|FG006|Vaccination Phase|Death|0|||
170459050|NCT04645966|616023110|FG007|Vaccination Phase|Death|0|||
170459051|NCT04645966|616023111|FG008|Vaccination Phase|Death|0|||
170459052|NCT04645966|616023103|FG000|Vaccination Phase|Protocol Violation|0|||
170459053|NCT04645966|616023104|FG001|Vaccination Phase|Protocol Violation|0|||
170459054|NCT04645966|616023105|FG002|Vaccination Phase|Protocol Violation|0|||
170459055|NCT04645966|616023106|FG003|Vaccination Phase|Protocol Violation|0|||
170459056|NCT04645966|616023107|FG004|Vaccination Phase|Protocol Violation|1|||
170459057|NCT04645966|616023108|FG005|Vaccination Phase|Protocol Violation|0|||
170459058|NCT04645966|616023109|FG006|Vaccination Phase|Protocol Violation|0|||
170459059|NCT04645966|616023110|FG007|Vaccination Phase|Protocol Violation|0|||
170459060|NCT04645966|616023111|FG008|Vaccination Phase|Protocol Violation|0|||
170459061|NCT04645966|616023103|FG000|Vaccination Phase|Study terminated by sponsor|0|||
170459062|NCT04645966|616023104|FG001|Vaccination Phase|Study terminated by sponsor|0|||
170459063|NCT04645966|616023105|FG002|Vaccination Phase|Study terminated by sponsor|14|||
170459064|NCT04645966|616023106|FG003|Vaccination Phase|Study terminated by sponsor|15|||
170459065|NCT04645966|616023107|FG004|Vaccination Phase|Study terminated by sponsor|47|||
170459066|NCT04645966|616023108|FG005|Vaccination Phase|Study terminated by sponsor|43|||
170459067|NCT04645966|616023109|FG006|Vaccination Phase|Study terminated by sponsor|29|||
170459068|NCT04645966|616023110|FG007|Vaccination Phase|Study terminated by sponsor|29|||
170459069|NCT04645966|616023111|FG008|Vaccination Phase|Study terminated by sponsor|12|||
170459070|NCT04645966|616023103|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
170459071|NCT04645966|616023104|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
170459072|NCT04645966|616023105|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
170459073|NCT04645966|616023106|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
170459074|NCT04645966|616023107|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
170459075|NCT04645966|616023108|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
170459076|NCT04645966|616023109|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
170459077|NCT04645966|616023110|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
170459078|NCT04645966|616023111|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
170459079|NCT04645966|616023103|FG000|Vaccination Phase|Other|0|||
170459080|NCT04645966|616023104|FG001|Vaccination Phase|Other|0|||
170459081|NCT04645966|616023105|FG002|Vaccination Phase|Other|0|||
170459082|NCT04645966|616023106|FG003|Vaccination Phase|Other|0|||
170459083|NCT04645966|616023107|FG004|Vaccination Phase|Other|0|||
170459084|NCT04645966|616023108|FG005|Vaccination Phase|Other|2|||
170459085|NCT04645966|616023109|FG006|Vaccination Phase|Other|0|||
170459086|NCT04645966|616023110|FG007|Vaccination Phase|Other|0|||
170459087|NCT04645966|616023111|FG008|Vaccination Phase|Other|0|||
170459088|NCT04645966|616023103|FG000|Vaccination Phase|Lost to Follow-up|0|||
170459089|NCT04645966|616023104|FG001|Vaccination Phase|Lost to Follow-up|0|||
170459090|NCT04645966|616023105|FG002|Vaccination Phase|Lost to Follow-up|0|||
170788125|NCT04632992|617234201|FG003|Overall Study|Progressive Disease|0|||
170788126|NCT04632992|617234202|FG004|Overall Study|Progressive Disease|1|||
170788127|NCT04632992|617234203|FG005|Overall Study|Progressive Disease|0|||
170788128|NCT04632992|617234204|FG006|Overall Study|Progressive Disease|0|||
170788129|NCT04632992|617234205|FG007|Overall Study|Progressive Disease|0|||
170459091|NCT04645966|616023106|FG003|Vaccination Phase|Lost to Follow-up|0|||
170459092|NCT04645966|616023107|FG004|Vaccination Phase|Lost to Follow-up|0|||
170788130|NCT04632992|617234206|FG008|Overall Study|Progressive Disease|0|||
170788131|NCT04632992|617234207|FG009|Overall Study|Progressive Disease|1|||
170788132|NCT04632992|617234208|FG010|Overall Study|Progressive Disease|1|||
170788133|NCT04632992|617234209|FG011|Overall Study|Progressive Disease|0|||
170788134|NCT04632992|617234210|FG012|Overall Study|Progressive Disease|2|||
170788135|NCT04632992|617234211|FG013|Overall Study|Progressive Disease|0|||
170788136|NCT04632992|617234198|FG000|Overall Study|Withdrawal by Subject|4|||
170788137|NCT04632992|617234199|FG001|Overall Study|Withdrawal by Subject|1|||
170459093|NCT04645966|616023108|FG005|Vaccination Phase|Lost to Follow-up|0|||
170459094|NCT04645966|616023109|FG006|Vaccination Phase|Lost to Follow-up|0|||
170459095|NCT04645966|616023110|FG007|Vaccination Phase|Lost to Follow-up|1|||
170459096|NCT04645966|616023111|FG008|Vaccination Phase|Lost to Follow-up|0|||
170788138|NCT04632992|617234200|FG002|Overall Study|Withdrawal by Subject|5|||
170788139|NCT04632992|617234201|FG003|Overall Study|Withdrawal by Subject|4|||
170788140|NCT04632992|617234202|FG004|Overall Study|Withdrawal by Subject|3|||
170788141|NCT04632992|617234203|FG005|Overall Study|Withdrawal by Subject|3|||
170459097|NCT04645966|616023103|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
170459098|NCT04645966|616023104|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
170459099|NCT04645966|616023105|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
170459100|NCT04645966|616023106|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
170459101|NCT04645966|616023107|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
170459102|NCT04645966|616023108|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
170459103|NCT04645966|616023109|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
170459104|NCT04645966|616023110|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
170459105|NCT04645966|616023111|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
170459106|NCT04645966|616023103|FG000|Follow-up Phase|Lost to Follow-up|0|||
170459107|NCT04645966|616023104|FG001|Follow-up Phase|Lost to Follow-up|0|||
170459108|NCT04645966|616023105|FG002|Follow-up Phase|Lost to Follow-up|0|||
170459109|NCT04645966|616023106|FG003|Follow-up Phase|Lost to Follow-up|0|||
170459110|NCT04645966|616023107|FG004|Follow-up Phase|Lost to Follow-up|0|||
170459111|NCT04645966|616023108|FG005|Follow-up Phase|Lost to Follow-up|0|||
170459112|NCT04645966|616023109|FG006|Follow-up Phase|Lost to Follow-up|0|||
170459113|NCT04645966|616023110|FG007|Follow-up Phase|Lost to Follow-up|1|||
170459114|NCT04645966|616023111|FG008|Follow-up Phase|Lost to Follow-up|0|||
170459115|NCT03825341|616023112|FG000|Overall Study|Withdrawal by Subject|0|||
170459116|NCT03825341|616023113|FG001|Overall Study|Withdrawal by Subject|1|||
170459117|NCT00552578|616023120|FG000|Overall Study|Lost to Follow-up|1|||
170459118|NCT00552578|616023121|FG001|Overall Study|Lost to Follow-up|1|||
170459119|NCT00470067|616023122|FG000|Overall Study|Death|1|||
170459120|NCT00470067|616023122|FG000|Overall Study|Disease Progression|6|||
170459121|NCT01460901|616023123|FG000|Overall Study|Withdrawal by Subject|2|||
170459122|NCT04053465|616023130|FG000|Overall Study|Withdrawal by Subject|4|||
170459123|NCT04053465|616023131|FG001|Overall Study|Withdrawal by Subject|4|||
170459124|NCT04729309|616023132|FG000|Period 1|Subject unable to return for Period 2|3|||
170459125|NCT04729309|616023133|FG001|Period 1|Subject unable to return for Period 2|0|||
170459126|NCT04729309|616023132|FG000|Period 1|Lost to Follow-up|1|||
170459127|NCT04729309|616023133|FG001|Period 1|Lost to Follow-up|0|||
170459128|NCT04091659|616023136|FG000|Overall Study|Protocol Violation|3|||
170459129|NCT04091659|616023137|FG001|Overall Study|Protocol Violation|0|||
170459130|NCT04091659|616023136|FG000|Overall Study|Lost to Follow-up|0|||
170459131|NCT04091659|616023137|FG001|Overall Study|Lost to Follow-up|1|||
170459132|NCT00895947|616023138|FG000|Overall Study|Adverse Event|3|||
170459133|NCT00895947|616023139|FG001|Overall Study|Adverse Event|4|||
170459134|NCT00895947|616023138|FG000|Overall Study|Lost to Follow-up|3|||
170459135|NCT00895947|616023139|FG001|Overall Study|Lost to Follow-up|4|||
170459136|NCT00895947|616023138|FG000|Overall Study|Protocol Violation|4|||
170459137|NCT00895947|616023139|FG001|Overall Study|Protocol Violation|2|||
170459138|NCT00895947|616023138|FG000|Overall Study|Withdrawal by Subject|2|||
170459139|NCT00895947|616023139|FG001|Overall Study|Withdrawal by Subject|0|||
170459140|NCT00338455|616023140|FG000|Overall Study|Death|2|||
170459141|NCT00338455|616023141|FG001|Overall Study|Death|1|||
170459142|NCT00338455|616023140|FG000|Overall Study|Physician Decision|1|||
170459143|NCT00338455|616023141|FG001|Overall Study|Physician Decision|0|||
170459144|NCT04015908|616023145|FG000|Overall Study|Lost to Follow-up|0|||
170459145|NCT04015908|616023146|FG001|Overall Study|Lost to Follow-up|1|||
170459146|NCT02792699|616023147|FG000|Overall Study|Adverse Event|1|||
170459147|NCT02792699|616023148|FG001|Overall Study|Adverse Event|2|||
170459148|NCT02792699|616023149|FG002|Overall Study|Adverse Event|4|||
170459149|NCT02792699|616023147|FG000|Overall Study|Withdrawal by Subject|4|||
170459150|NCT02792699|616023148|FG001|Overall Study|Withdrawal by Subject|4|||
170459151|NCT02792699|616023149|FG002|Overall Study|Withdrawal by Subject|3|||
170459152|NCT02792699|616023147|FG000|Overall Study|Lost to Follow-up|0|||
170459153|NCT02792699|616023148|FG001|Overall Study|Lost to Follow-up|1|||
170459154|NCT02792699|616023149|FG002|Overall Study|Lost to Follow-up|2|||
170459155|NCT02792699|616023147|FG000|Overall Study|Physician Decision|2|||
170459156|NCT02792699|616023148|FG001|Overall Study|Physician Decision|0|||
170459157|NCT02792699|616023149|FG002|Overall Study|Physician Decision|0|||
170459158|NCT02792699|616023147|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
170459159|NCT02792699|616023148|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
170459160|NCT02792699|616023149|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
170459161|NCT02792699|616023147|FG000|Overall Study|Other|1|||
170459162|NCT02792699|616023148|FG001|Overall Study|Other|0|||
170459163|NCT02792699|616023149|FG002|Overall Study|Other|0|||
170459164|NCT01335997|616023159|FG000|Period I and II|Adverse Event|63|||
170459165|NCT01335997|616023160|FG001|Period I and II|Adverse Event|43|||
170459166|NCT01335997|616023159|FG000|Period I and II|Noncompliance with Study Drug|1|||
170459167|NCT01335997|616023160|FG001|Period I and II|Noncompliance with Study Drug|1|||
170459168|NCT01335997|616023159|FG000|Period I and II|Lost to Follow-up|3|||
170459169|NCT01335997|616023160|FG001|Period I and II|Lost to Follow-up|5|||
170459170|NCT01335997|616023159|FG000|Period I and II|Withdrawal by Subject|9|||
170459171|NCT01335997|616023160|FG001|Period I and II|Withdrawal by Subject|4|||
170459172|NCT01335997|616023159|FG000|Period I and II|Study Terminated by Sponsor|406|||
170459173|NCT01335997|616023160|FG001|Period I and II|Study Terminated by Sponsor|415|||
170459174|NCT01335997|616023159|FG000|Period I and II|Protocol Violation|9|||
170459175|NCT01335997|616023160|FG001|Period I and II|Protocol Violation|10|||
170459176|NCT01335997|616023159|FG000|Period I and II|Physician Decision|2|||
170459177|NCT01335997|616023160|FG001|Period I and II|Physician Decision|1|||
170459178|NCT01335997|616023159|FG000|Period III|Adverse Event|0|||
170459179|NCT01335997|616023160|FG001|Period III|Adverse Event|2|||
170459180|NCT01335997|616023159|FG000|Period III|Study Terminated by Sponsor|77|||
170459181|NCT01335997|616023160|FG001|Period III|Study Terminated by Sponsor|76|||
170459182|NCT01335997|616023159|FG000|Period III|Protocol Violation|0|||
170459183|NCT01335997|616023160|FG001|Period III|Protocol Violation|1|||
170459184|NCT01335997|616023159|FG000|Period III|Lost to Follow-up|1|||
170459185|NCT01335997|616023160|FG001|Period III|Lost to Follow-up|0|||
170459186|NCT00085423|616023161|FG000|Overall Study|Withdrawal by Subject|1|||
170459187|NCT00085423|616023161|FG000|Overall Study|screen failure|1|||
170459188|NCT01103466|616023162|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
170459189|NCT01103466|616023163|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
170459190|NCT01103466|616023164|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
170459191|NCT01103466|616023162|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
170459192|NCT01103466|616023163|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
170543194|NCT03928743|616332828|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
170543195|NCT03928743|616332829|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
170543196|NCT03928743|616332830|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
170543197|NCT03928743|616332828|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
170543198|NCT03928743|616332829|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
170543199|NCT03928743|616332830|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
170543200|NCT03928743|616332828|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
170543201|NCT03928743|616332829|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
170543202|NCT03928743|616332830|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
170543203|NCT03928743|616332828|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
170543204|NCT03928743|616332829|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
170543205|NCT03928743|616332830|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
170543206|NCT03928743|616332828|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
170543207|NCT03928743|616332829|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
170543208|NCT03928743|616332830|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
170543209|NCT03928743|616332828|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
170543210|NCT03928743|616332829|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
170543211|NCT03928743|616332830|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
170543212|NCT03928743|616332828|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
170543213|NCT03928743|616332829|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
170543214|NCT03928743|616332830|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
170543215|NCT03928743|616332828|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
170543216|NCT03928743|616332829|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
170543217|NCT03928743|616332830|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
170543218|NCT04425018|616332831|FG000|Overall Study|Withdrawal by Subject|1|||
170543219|NCT04425018|616332832|FG001|Overall Study|Withdrawal by Subject|2|||
170543220|NCT01944774|616332835|FG000|Overall Study|Withdrawal by Subject|2|||
170543221|NCT01944774|616332836|FG001|Overall Study|Withdrawal by Subject|3|||
170543222|NCT01944774|616332837|FG002|Overall Study|Withdrawal by Subject|3|||
170543223|NCT01944774|616332835|FG000|Overall Study|Adverse Event|3|||
170543224|NCT01944774|616332836|FG001|Overall Study|Adverse Event|2|||
170543225|NCT01944774|616332837|FG002|Overall Study|Adverse Event|3|||
170543226|NCT01944774|616332835|FG000|Overall Study|Lack of Efficacy|1|||
170543227|NCT01944774|616332836|FG001|Overall Study|Lack of Efficacy|2|||
170543228|NCT01944774|616332837|FG002|Overall Study|Lack of Efficacy|2|||
170543229|NCT01944774|616332835|FG000|Overall Study|Lost to Follow-up|0|||
170543230|NCT01944774|616332836|FG001|Overall Study|Lost to Follow-up|1|||
170543231|NCT01944774|616332837|FG002|Overall Study|Lost to Follow-up|0|||
170543232|NCT03325439|616332838|FG000|Overall Study|Ineligibility|3|||
170543233|NCT02315625|616332841|FG000|First Intervention|Disease Progression|1|||
170543234|NCT02315625|616332842|FG001|First Intervention|Disease Progression|0|||
170543235|NCT02315625|616332841|FG000|Second Intervention|Physician Decision|2|||
170543236|NCT02315625|616332842|FG001|Second Intervention|Physician Decision|1|||
170543237|NCT02315625|616332841|FG000|Second Intervention|Study closure|1|||
170543238|NCT02315625|616332842|FG001|Second Intervention|Study closure|0|||
170543239|NCT02315625|616332841|FG000|Second Intervention|Disease Progression|1|||
170543240|NCT02315625|616332842|FG001|Second Intervention|Disease Progression|0|||
170543241|NCT02337946|616332845|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
170543242|NCT02337946|616332846|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
170459193|NCT01103466|616023164|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
170459194|NCT01103466|616023162|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
170543243|NCT02337946|616332847|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
170543244|NCT02337946|616332845|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
170459195|NCT01103466|616023163|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
170459196|NCT01103466|616023164|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
170459197|NCT01103466|616023162|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
170459198|NCT01103466|616023163|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
170459199|NCT01103466|616023164|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
170459200|NCT01103466|616023162|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
170459201|NCT01103466|616023163|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
170459202|NCT01103466|616023164|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
170459203|NCT01103466|616023162|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
170459204|NCT01103466|616023163|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
170459205|NCT01103466|616023164|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
170459206|NCT02331368|616023169|FG000|Overall Study|Withdrawal by Subject|3|||
170459207|NCT04126213|616023175|FG000|Overall Study|Lost to Follow-up|9|||
170459208|NCT04126213|616023176|FG001|Overall Study|Lost to Follow-up|1|||
170459209|NCT04126213|616023177|FG002|Overall Study|Lost to Follow-up|5|||
170459210|NCT04126213|616023178|FG003|Overall Study|Lost to Follow-up|10|||
170459211|NCT04126213|616023179|FG004|Overall Study|Lost to Follow-up|4|||
170636032|NCT00473382|616678937|FG002|Core Study|Subject needed other treatment|2|||
170636033|NCT00473382|616678935|FG000|Core Study|Subject's decision|12|||
170636034|NCT00473382|616678936|FG001|Core Study|Subject's decision|11|||
170636035|NCT00473382|616678937|FG002|Core Study|Subject's decision|10|||
170636036|NCT00473382|616678935|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
170636037|NCT00473382|616678936|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
170636038|NCT00473382|616678937|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
170543245|NCT02337946|616332846|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
170543246|NCT02337946|616332847|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
170543247|NCT02337946|616332845|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
170543248|NCT02337946|616332846|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
170543249|NCT02337946|616332847|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
170543250|NCT02337946|616332845|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
170543251|NCT02337946|616332846|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
170543252|NCT02337946|616332847|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
170543253|NCT02337946|616332845|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
170543254|NCT02337946|616332846|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
170543255|NCT02337946|616332847|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
170543256|NCT02337946|616332845|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
170543257|NCT02337946|616332846|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
170543258|NCT02337946|616332847|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
170543259|NCT02337946|616332845|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
170543260|NCT02337946|616332846|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
170543261|NCT02337946|616332847|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
170543262|NCT02337946|616332845|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
170543263|NCT02337946|616332846|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
170543264|NCT02337946|616332847|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
170543265|NCT02337946|616332845|FG000|In-between Period|Without Informed Consent|1|||
170543266|NCT02337946|616332846|FG001|In-between Period|Without Informed Consent|0|||
170543267|NCT02337946|616332847|FG002|In-between Period|Without Informed Consent|0|||
170543268|NCT02337946|616332845|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
170543269|NCT02337946|616332846|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
170543270|NCT02337946|616332847|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
170543271|NCT02337946|616332845|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
170543272|NCT02337946|616332846|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
170543273|NCT02337946|616332847|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
170543274|NCT02337946|616332845|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
170543275|NCT02337946|616332846|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
170543276|NCT02337946|616332847|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
170543277|NCT02337946|616332845|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
170543278|NCT02337946|616332846|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
170543279|NCT02337946|616332847|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
170636039|NCT00473382|616678935|FG000|Open-label Extension Through Month 48|Death|1|||
170636040|NCT00473382|616678936|FG001|Open-label Extension Through Month 48|Death|3|||
170636041|NCT00473382|616678937|FG002|Open-label Extension Through Month 48|Death|3|||
170636042|NCT00473382|616678935|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
170636043|NCT00473382|616678936|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
170543280|NCT02337946|616332845|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
170543281|NCT02337946|616332846|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
170636044|NCT00473382|616678937|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
170636045|NCT00473382|616678935|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
170459212|NCT04126213|616023180|FG005|Overall Study|Lost to Follow-up|7|||
170636046|NCT00473382|616678936|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
170636047|NCT00473382|616678937|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
170636048|NCT00473382|616678935|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
170636049|NCT00473382|616678936|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
170636050|NCT00473382|616678937|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
170636051|NCT00473382|616678935|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
170459213|NCT04126213|616023175|FG000|Overall Study|Withdrawal by Subject|3|||
170459214|NCT04126213|616023176|FG001|Overall Study|Withdrawal by Subject|2|||
170459215|NCT04126213|616023177|FG002|Overall Study|Withdrawal by Subject|1|||
170459216|NCT04126213|616023178|FG003|Overall Study|Withdrawal by Subject|1|||
170459217|NCT04126213|616023179|FG004|Overall Study|Withdrawal by Subject|1|||
170459218|NCT04126213|616023180|FG005|Overall Study|Withdrawal by Subject|1|||
170459219|NCT04126213|616023175|FG000|Overall Study|Other|0|||
170459220|NCT04126213|616023176|FG001|Overall Study|Other|0|||
170459221|NCT04126213|616023177|FG002|Overall Study|Other|2|||
170459222|NCT04126213|616023178|FG003|Overall Study|Other|2|||
170459223|NCT04126213|616023179|FG004|Overall Study|Other|0|||
170459224|NCT04126213|616023180|FG005|Overall Study|Other|1|||
170459225|NCT04126213|616023175|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170459226|NCT04126213|616023176|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
170459227|NCT04126213|616023177|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170459228|NCT04126213|616023178|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170459229|NCT04126213|616023179|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170459230|NCT04126213|616023180|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
170459231|NCT02853370|616023181|FG000|Overall Study|Physician Decision|1|||
170459232|NCT02853370|616023181|FG000|Overall Study|Lack of Efficacy|2|||
170459233|NCT02853370|616023181|FG000|Overall Study|Death|1|||
170459234|NCT02853370|616023181|FG000|Overall Study|Adverse Event|4|||
170459235|NCT02853370|616023181|FG000|Overall Study|Withdrawal by Subject|3|||
170459236|NCT02302859|616023182|FG000|Overall Study|Lost Phone|1|||
170459237|NCT02302859|616023183|FG001|Overall Study|Lost Phone|1|||
170459238|NCT02302859|616023182|FG000|Overall Study|Withdrawal by Subject|0|||
170459239|NCT02302859|616023183|FG001|Overall Study|Withdrawal by Subject|1|||
170459240|NCT00643565|616023185|FG000|Overall Study|Death|12|||
170459241|NCT00643565|616023186|FG001|Overall Study|Death|11|||
170459242|NCT00643565|616023185|FG000|Overall Study|Withdrawal by Subject|4|||
170459243|NCT00643565|616023186|FG001|Overall Study|Withdrawal by Subject|1|||
170459244|NCT00643565|616023185|FG000|Overall Study|Lost to Follow-up|0|||
170459245|NCT00643565|616023186|FG001|Overall Study|Lost to Follow-up|6|||
170459246|NCT00643565|616023185|FG000|Overall Study|Other|7|||
170459247|NCT00643565|616023186|FG001|Overall Study|Other|8|||
170459248|NCT00643565|616023185|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
170459249|NCT00643565|616023186|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
170459250|NCT00643565|616023185|FG000|Overall Study|Recurrence of Disease|2|||
170459251|NCT00643565|616023186|FG001|Overall Study|Recurrence of Disease|1|||
170459252|NCT00643565|616023185|FG000|Overall Study|Progression of Disease|18|||
170459253|NCT00643565|616023186|FG001|Overall Study|Progression of Disease|14|||
170459254|NCT00643565|616023185|FG000|Overall Study|Protocol Violation|3|||
170459255|NCT00643565|616023186|FG001|Overall Study|Protocol Violation|0|||
170459256|NCT00643565|616023185|FG000|Overall Study|Did Not Cooperate|0|||
170459257|NCT00643565|616023186|FG001|Overall Study|Did Not Cooperate|1|||
170459258|NCT00643565|616023185|FG000|Overall Study|Administrative|22|||
170459259|NCT00643565|616023186|FG001|Overall Study|Administrative|16|||
170459260|NCT00643565|616023185|FG000|Overall Study|Adverse Event|5|||
170459261|NCT00643565|616023186|FG001|Overall Study|Adverse Event|8|||
170459262|NCT02317614|616023187|FG000|Overall Study|Lost to Follow-up|1|||
170459263|NCT02317614|616023188|FG001|Overall Study|Lost to Follow-up|1|||
170459264|NCT02317614|616023187|FG000|Overall Study|Withdrawal by Subject|1|||
170459265|NCT02317614|616023188|FG001|Overall Study|Withdrawal by Subject|0|||
170459266|NCT02317614|616023187|FG000|Overall Study|Death|1|||
170459267|NCT02317614|616023188|FG001|Overall Study|Death|1|||
170459268|NCT01910389|616023191|FG000|Overall Study|Withdrawal by Subject|2|||
170459269|NCT01910389|616023192|FG001|Overall Study|Withdrawal by Subject|0|||
170459270|NCT01910389|616023191|FG000|Overall Study|Study Closed|13|||
170459271|NCT01910389|616023192|FG001|Overall Study|Study Closed|8|||
170459272|NCT01674647|616023195|FG000|Treatment Period|Death|4|||
170459273|NCT01674647|616023196|FG001|Treatment Period|Death|1|||
170459274|NCT01674647|616023195|FG000|Treatment Period|Efficacy outcome reached|0|||
170459275|NCT01674647|616023196|FG001|Treatment Period|Efficacy outcome reached|1|||
170459276|NCT01674647|616023195|FG000|Treatment Period|Physician Decision|3|||
170459277|NCT01674647|616023196|FG001|Treatment Period|Physician Decision|1|||
170459278|NCT01674647|616023195|FG000|Treatment Period|Adverse Event|60|||
170459279|NCT01674647|616023196|FG001|Treatment Period|Adverse Event|22|||
170459280|NCT01674647|616023195|FG000|Treatment Period|Non-compliance with study drug|3|||
170459281|NCT01674647|616023196|FG001|Treatment Period|Non-compliance with study drug|0|||
170459282|NCT01674647|616023195|FG000|Treatment Period|Lost to Follow-up|1|||
170788142|NCT04632992|617234204|FG006|Overall Study|Withdrawal by Subject|0|||
170788143|NCT04632992|617234205|FG007|Overall Study|Withdrawal by Subject|5|||
170788144|NCT04632992|617234206|FG008|Overall Study|Withdrawal by Subject|0|||
170788145|NCT04632992|617234207|FG009|Overall Study|Withdrawal by Subject|2|||
170459283|NCT01674647|616023196|FG001|Treatment Period|Lost to Follow-up|1|||
170459284|NCT01674647|616023195|FG000|Treatment Period|Withdrawal by Subject|19|||
170459285|NCT01674647|616023196|FG001|Treatment Period|Withdrawal by Subject|16|||
170459286|NCT01674647|616023195|FG000|Treatment Period|Switching to other therapy|5|||
170459287|NCT01674647|616023196|FG001|Treatment Period|Switching to other therapy|2|||
170459288|NCT01674647|616023195|FG000|Treatment Period|Logistical difficulties|5|||
170788146|NCT04632992|617234208|FG010|Overall Study|Withdrawal by Subject|8|||
170788147|NCT04632992|617234209|FG011|Overall Study|Withdrawal by Subject|0|||
170788148|NCT04632992|617234210|FG012|Overall Study|Withdrawal by Subject|1|||
170788149|NCT04632992|617234211|FG013|Overall Study|Withdrawal by Subject|1|||
170788150|NCT04350463|617234216|FG000|Overall Study|Other reason|0|||
170788151|NCT04350463|617234217|FG001|Overall Study|Other reason|0|||
170788152|NCT04350463|617234218|FG002|Overall Study|Other reason|0|||
170788153|NCT04350463|617234219|FG003|Overall Study|Other reason|1|||
170788154|NCT04350463|617234216|FG000|Overall Study|Lost to Follow-up|0|||
170788155|NCT04350463|617234217|FG001|Overall Study|Lost to Follow-up|0|||
170788156|NCT04350463|617234218|FG002|Overall Study|Lost to Follow-up|0|||
170788157|NCT04350463|617234219|FG003|Overall Study|Lost to Follow-up|2|||
170788158|NCT04350463|617234216|FG000|Overall Study|Withdrawal by Subject|4|||
170788159|NCT04350463|617234217|FG001|Overall Study|Withdrawal by Subject|0|||
170788160|NCT04350463|617234218|FG002|Overall Study|Withdrawal by Subject|1|||
170788161|NCT04350463|617234219|FG003|Overall Study|Withdrawal by Subject|4|||
170788162|NCT04350463|617234216|FG000|Overall Study|Adverse Event|0|||
170788163|NCT04350463|617234217|FG001|Overall Study|Adverse Event|0|||
170459289|NCT01674647|616023196|FG001|Treatment Period|Logistical difficulties|8|||
170459290|NCT01674647|616023195|FG000|Treatment Period|Treatment failure|0|||
170459291|NCT01674647|616023196|FG001|Treatment Period|Treatment failure|14|||
170459292|NCT01674647|616023195|FG000|Treatment Period|Protocol Violation|56|||
170459293|NCT01674647|616023196|FG001|Treatment Period|Protocol Violation|36|||
170459294|NCT01674647|616023195|FG000|30-day Safety Follow-up Period|Death|3|||
170459295|NCT01674647|616023196|FG001|30-day Safety Follow-up Period|Death|2|||
170459296|NCT01674647|616023195|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
170459297|NCT01674647|616023196|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
170459298|NCT01674647|616023195|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
170459299|NCT01674647|616023196|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
170459300|NCT01674647|616023195|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
170459301|NCT01674647|616023196|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
170459302|NCT01674647|616023195|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
170459303|NCT01674647|616023196|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
170636052|NCT00473382|616678936|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
170788164|NCT04350463|617234218|FG002|Overall Study|Adverse Event|0|||
170788165|NCT04350463|617234219|FG003|Overall Study|Adverse Event|2|||
170788166|NCT04350463|617234216|FG000|Overall Study|Death|27|||
170788167|NCT04350463|617234217|FG001|Overall Study|Death|2|||
170788168|NCT04350463|617234218|FG002|Overall Study|Death|13|||
170788169|NCT04350463|617234219|FG003|Overall Study|Death|26|||
170788170|NCT06019559|617234222|FG000|Overall Study|Withdrawal by Subject|7|||
170788171|NCT06019559|617234223|FG001|Overall Study|Withdrawal by Subject|6|||
170788172|NCT06019559|617234224|FG002|Overall Study|Withdrawal by Subject|5|||
170459304|NCT01674647|616023195|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
170459305|NCT01674647|616023196|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
170459306|NCT02989168|616023201|FG000|Overall Study|Withdrawal by Subject|2|||
170459307|NCT02989168|616023202|FG001|Overall Study|Withdrawal by Subject|0|||
170459308|NCT02989168|616023201|FG000|Overall Study|Physician Decision|0|||
170459309|NCT02989168|616023202|FG001|Overall Study|Physician Decision|1|||
170459310|NCT02989168|616023201|FG000|Overall Study|Adverse Event|1|||
170459311|NCT02989168|616023202|FG001|Overall Study|Adverse Event|2|||
170459312|NCT02989168|616023201|FG000|Overall Study|Sponsor stopped study.|1|||
170459313|NCT02989168|616023202|FG001|Overall Study|Sponsor stopped study.|0|||
170459314|NCT01941940|616023203|FG000|Overall Study|Adverse Event|11|||
170459315|NCT01941940|616023203|FG000|Overall Study|Lost to Follow-up|2|||
170459316|NCT01941940|616023203|FG000|Overall Study|Physician Decision|2|||
170459317|NCT01941940|616023203|FG000|Overall Study|Withdrawal by Subject|15|||
170788173|NCT06019559|617234222|FG000|Overall Study|Lost to Follow-up|2|||
170788174|NCT06019559|617234223|FG001|Overall Study|Lost to Follow-up|0|||
170788175|NCT06019559|617234224|FG002|Overall Study|Lost to Follow-up|3|||
170788176|NCT01824537|617234225|FG000|Overall Study|Lost to Follow-up|78|||
170788177|NCT01824537|617234226|FG001|Overall Study|Lost to Follow-up|87|||
170788178|NCT02547987|617234227|FG000|Overall Study|Withdrawal by Subject|1|||
170788179|NCT02547987|617234227|FG000|Overall Study|Adverse Event|2|||
170788180|NCT04282148|617234228|FG000|Overall Study|Death|7|||
170788181|NCT04282148|617234228|FG000|Overall Study|Withdrawal by Subject|1|||
170459318|NCT01941940|616023203|FG000|Overall Study|Death|1|||
170459319|NCT01941940|616023203|FG000|Overall Study|Other|1|||
170459320|NCT01941940|616023203|FG000|Overall Study|Other|1|||
170459321|NCT01940497|616023204|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
170459322|NCT01940497|616023205|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
170459323|NCT01940497|616023204|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
170459324|NCT01940497|616023205|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
170459325|NCT01940497|616023204|FG000|Overall Study|Violation of Entry Criteria|1|||
170459326|NCT01940497|616023205|FG001|Overall Study|Violation of Entry Criteria|1|||
170459327|NCT01940497|616023204|FG000|Overall Study|Refused Treatment|1|||
170459328|NCT01940497|616023205|FG001|Overall Study|Refused Treatment|3|||
170459329|NCT01940497|616023204|FG000|Overall Study|Withdrew Consent|6|||
170459330|NCT01940497|616023205|FG001|Overall Study|Withdrew Consent|2|||
170459331|NCT01940497|616023204|FG000|Overall Study|Administrative/Other|1|||
170459332|NCT01940497|616023205|FG001|Overall Study|Administrative/Other|1|||
170459333|NCT04135196|616023209|FG000|Overall Study|Lost to Follow-up|8|||
170459334|NCT04135196|616023210|FG001|Overall Study|Lost to Follow-up|7|||
170459335|NCT04135196|616023211|FG002|Overall Study|Lost to Follow-up|8|||
170459336|NCT04135196|616023212|FG003|Overall Study|Lost to Follow-up|9|||
170459337|NCT04135196|616023213|FG004|Overall Study|Lost to Follow-up|1|||
170459338|NCT04135196|616023209|FG000|Overall Study|Pregnancy|0|||
170459339|NCT04135196|616023210|FG001|Overall Study|Pregnancy|0|||
170459340|NCT04135196|616023211|FG002|Overall Study|Pregnancy|1|||
170459341|NCT04135196|616023212|FG003|Overall Study|Pregnancy|0|||
170459342|NCT04135196|616023213|FG004|Overall Study|Pregnancy|0|||
170459343|NCT04135196|616023209|FG000|Overall Study|Withdrawal by Subject|0|||
170459344|NCT04135196|616023210|FG001|Overall Study|Withdrawal by Subject|0|||
170459345|NCT04135196|616023211|FG002|Overall Study|Withdrawal by Subject|0|||
170459346|NCT04135196|616023212|FG003|Overall Study|Withdrawal by Subject|0|||
170459347|NCT04135196|616023213|FG004|Overall Study|Withdrawal by Subject|1|||
170459348|NCT00290251|616023220|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
170459349|NCT00290251|616023221|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
170459350|NCT00290251|616023222|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
170459351|NCT00290251|616023223|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
170459352|NCT00290251|616023224|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
170459353|NCT00290251|616023225|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
170459354|NCT00290251|616023220|FG000|Treatment 1 (Months 2-4)|headache|0|||
170459355|NCT00290251|616023221|FG001|Treatment 1 (Months 2-4)|headache|0|||
170459356|NCT00290251|616023222|FG002|Treatment 1 (Months 2-4)|headache|0|||
170459357|NCT00290251|616023223|FG003|Treatment 1 (Months 2-4)|headache|0|||
170459358|NCT00290251|616023224|FG004|Treatment 1 (Months 2-4)|headache|1|||
170459359|NCT00290251|616023225|FG005|Treatment 1 (Months 2-4)|headache|0|||
170459360|NCT00290251|616023220|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
170459361|NCT00290251|616023221|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
170459362|NCT00290251|616023222|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
170459363|NCT00290251|616023223|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
170459364|NCT00290251|616023224|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
170459365|NCT00290251|616023225|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
170459366|NCT03190330|616026665|FG000|Overall Study|Adverse Event|2|||
170459367|NCT03190330|616026665|FG000|Overall Study|Death|10|||
170459368|NCT03190330|616026665|FG000|Overall Study|Lost to Follow-up|1|||
170459369|NCT03190330|616026665|FG000|Overall Study|Withdrawal by Subject|6|||
170459370|NCT03190330|616026665|FG000|Overall Study|Progressive Disease|1|||
170459371|NCT01200992|616026669|FG000|Overall Study|Study terminated early|35|||
170459372|NCT01200992|616026670|FG001|Overall Study|Study terminated early|41|||
170459373|NCT01200992|616026669|FG000|Overall Study|Randomized but not treated|2|||
170459374|NCT01200992|616026670|FG001|Overall Study|Randomized but not treated|0|||
170459375|NCT00721630|616026671|FG000|Overall Study|Participant found to be ineligible|1|||
170459376|NCT01502410|616026672|FG000|Overall Study|Adverse Event|1|||
170459377|NCT01502410|616026673|FG001|Overall Study|Adverse Event|2|||
170459378|NCT01502410|616026674|FG002|Overall Study|Adverse Event|0|||
170459379|NCT01502410|616026675|FG003|Overall Study|Adverse Event|0|||
170459380|NCT01502410|616026672|FG000|Overall Study|Lack of Efficacy|7|||
170459381|NCT01502410|616026673|FG001|Overall Study|Lack of Efficacy|7|||
170459382|NCT01502410|616026674|FG002|Overall Study|Lack of Efficacy|0|||
170459383|NCT01502410|616026675|FG003|Overall Study|Lack of Efficacy|0|||
170459384|NCT01502410|616026672|FG000|Overall Study|Physician Decision|0|||
170459385|NCT01502410|616026673|FG001|Overall Study|Physician Decision|1|||
170459386|NCT01502410|616026674|FG002|Overall Study|Physician Decision|0|||
170459387|NCT01502410|616026675|FG003|Overall Study|Physician Decision|0|||
170459388|NCT01502410|616026672|FG000|Overall Study|Withdrawal by Subject|2|||
170459389|NCT01502410|616026673|FG001|Overall Study|Withdrawal by Subject|0|||
170459390|NCT01502410|616026674|FG002|Overall Study|Withdrawal by Subject|0|||
170459391|NCT01502410|616026675|FG003|Overall Study|Withdrawal by Subject|0|||
170459392|NCT00910091|616026686|FG000|Pre-assignment|Withdrawal by Subject|0|||
170459393|NCT00910091|616026687|FG001|Pre-assignment|Withdrawal by Subject|2|||
170459394|NCT00910091|616026686|FG000|Treatment and Survival|Withdrawal by Subject|3|||
170459395|NCT00910091|616026687|FG001|Treatment and Survival|Withdrawal by Subject|4|||
170459396|NCT00910091|616026686|FG000|Treatment and Survival|Adverse Event|1|||
170459397|NCT00910091|616026687|FG001|Treatment and Survival|Adverse Event|0|||
170459398|NCT01007942|616026689|FG000|Overall Study|Adverse Event|29|||
170459399|NCT01007942|616026690|FG001|Overall Study|Adverse Event|14|||
170459400|NCT01007942|616026689|FG000|Overall Study|Abnormal test procedure|0|||
170459401|NCT01007942|616026690|FG001|Overall Study|Abnormal test procedure|1|||
170459402|NCT01007942|616026689|FG000|Overall Study|Disease progression|217|||
170459403|NCT01007942|616026690|FG001|Overall Study|Disease progression|242|||
170459404|NCT01007942|616026689|FG000|Overall Study|New cancer therapy|5|||
170459405|NCT01007942|616026690|FG001|Overall Study|New cancer therapy|1|||
170459406|NCT01007942|616026689|FG000|Overall Study|Protocol Violation|1|||
170459407|NCT01007942|616026690|FG001|Overall Study|Protocol Violation|1|||
170459408|NCT01007942|616026689|FG000|Overall Study|Withdrawal by Subject|19|||
170459409|NCT01007942|616026690|FG001|Overall Study|Withdrawal by Subject|14|||
170459410|NCT01007942|616026689|FG000|Overall Study|Lost to Follow-up|1|||
170459411|NCT01007942|616026690|FG001|Overall Study|Lost to Follow-up|0|||
170459412|NCT01007942|616026689|FG000|Overall Study|Administrative problems|2|||
170459413|NCT01007942|616026690|FG001|Overall Study|Administrative problems|0|||
170459414|NCT01007942|616026689|FG000|Overall Study|Death|3|||
170459415|NCT01007942|616026690|FG001|Overall Study|Death|2|||
170459416|NCT01007942|616026689|FG000|Overall Study|Patients untreated|4|||
170459417|NCT01007942|616026690|FG001|Overall Study|Patients untreated|3|||
170459418|NCT04492020|616026691|FG000|Overall Study|Adverse Event|1|||
170459419|NCT04492020|616026692|FG001|Overall Study|Adverse Event|3|||
170459420|NCT04492020|616026691|FG000|Overall Study|Withdrawal by Subject|4|||
170459421|NCT04492020|616026692|FG001|Overall Study|Withdrawal by Subject|3|||
170459422|NCT04492020|616026691|FG000|Overall Study|Lost to Follow-up|4|||
170459423|NCT04492020|616026692|FG001|Overall Study|Lost to Follow-up|3|||
170459424|NCT04492020|616026691|FG000|Overall Study|Protocol Violation|5|||
170459425|NCT04492020|616026692|FG001|Overall Study|Protocol Violation|2|||
170459426|NCT04492020|616026691|FG000|Overall Study|Lack of Qualifying Event|25|||
170459427|NCT04492020|616026692|FG001|Overall Study|Lack of Qualifying Event|27|||
170459428|NCT04492020|616026691|FG000|Overall Study|Non-compliance with Study Drug|2|||
170459429|NCT04492020|616026692|FG001|Overall Study|Non-compliance with Study Drug|1|||
170459430|NCT01175811|616026693|FG000|Overall Study|Adverse Event|1|||
170459431|NCT01175811|616026694|FG001|Overall Study|Adverse Event|1|||
170459432|NCT01175811|616026693|FG000|Overall Study|Entry criteria not met|3|||
170459433|NCT01175811|616026694|FG001|Overall Study|Entry criteria not met|1|||
170459434|NCT01175811|616026693|FG000|Overall Study|Lack of Efficacy|1|||
170459435|NCT01175811|616026694|FG001|Overall Study|Lack of Efficacy|0|||
170459436|NCT01175811|616026693|FG000|Overall Study|Lost to Follow-up|3|||
170459437|NCT01175811|616026694|FG001|Overall Study|Lost to Follow-up|2|||
170459438|NCT01175811|616026693|FG000|Overall Study|Physician Decision|1|||
170459439|NCT01175811|616026694|FG001|Overall Study|Physician Decision|1|||
170459440|NCT01175811|616026693|FG000|Overall Study|Protocol Violation|1|||
170459441|NCT01175811|616026694|FG001|Overall Study|Protocol Violation|2|||
170788182|NCT04282148|617234228|FG000|Overall Study|Physician Decision|1|||
170788183|NCT06215521|617234237|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
170459442|NCT01175811|616026693|FG000|Overall Study|Withdrawal by Subject|6|||
170459443|NCT01175811|616026694|FG001|Overall Study|Withdrawal by Subject|7|||
170459444|NCT01059344|616026698|FG000|Overall Study|Adverse Event|12|||
170459445|NCT01059344|616026699|FG001|Overall Study|Adverse Event|30|||
170459446|NCT01059344|616026698|FG000|Overall Study|Withdrawal by Subject|6|||
170459447|NCT01059344|616026699|FG001|Overall Study|Withdrawal by Subject|9|||
170459448|NCT01059344|616026698|FG000|Overall Study|Lost to Follow-up|1|||
170459449|NCT01059344|616026699|FG001|Overall Study|Lost to Follow-up|1|||
170459450|NCT01059344|616026698|FG000|Overall Study|Other|3|||
170459451|NCT01059344|616026699|FG001|Overall Study|Other|6|||
170459452|NCT00616629|616026700|FG000|Overall Study|Protocol Violation|1|||
170459453|NCT00616629|616026701|FG001|Overall Study|Protocol Violation|2|||
170459454|NCT00616629|616026702|FG002|Overall Study|Protocol Violation|1|||
170459455|NCT00616629|616026703|FG003|Overall Study|Protocol Violation|0|||
170459456|NCT00616629|616026704|FG004|Overall Study|Protocol Violation|0|||
170459457|NCT00616629|616026700|FG000|Overall Study|AV-block|1|||
170459458|NCT00616629|616026701|FG001|Overall Study|AV-block|0|||
170459459|NCT00616629|616026702|FG002|Overall Study|AV-block|0|||
170459460|NCT00616629|616026703|FG003|Overall Study|AV-block|0|||
170459461|NCT00616629|616026704|FG004|Overall Study|AV-block|0|||
170459462|NCT00742924|616026708|FG000|Overall Study|Adverse Event|0|||
170459463|NCT00742924|616026709|FG001|Overall Study|Adverse Event|0|||
170459464|NCT00742924|616026710|FG002|Overall Study|Adverse Event|1|||
170459465|NCT00742924|616026711|FG003|Overall Study|Adverse Event|1|||
170459466|NCT00742924|616026708|FG000|Overall Study|Lack of Efficacy|5|||
170459467|NCT00742924|616026709|FG001|Overall Study|Lack of Efficacy|1|||
170459468|NCT00742924|616026710|FG002|Overall Study|Lack of Efficacy|2|||
170459469|NCT00742924|616026711|FG003|Overall Study|Lack of Efficacy|4|||
170459470|NCT00742924|616026708|FG000|Overall Study|Physician Decision|0|||
170788184|NCT06215521|617234238|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
170788185|NCT06215521|617234239|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
170459471|NCT00742924|616026709|FG001|Overall Study|Physician Decision|0|||
170459472|NCT00742924|616026710|FG002|Overall Study|Physician Decision|0|||
170459473|NCT00742924|616026711|FG003|Overall Study|Physician Decision|1|||
170459474|NCT00742924|616026708|FG000|Overall Study|Withdrawal by Subject|0|||
170459475|NCT00742924|616026709|FG001|Overall Study|Withdrawal by Subject|1|||
170459476|NCT00742924|616026710|FG002|Overall Study|Withdrawal by Subject|1|||
170459477|NCT00742924|616026711|FG003|Overall Study|Withdrawal by Subject|0|||
170459478|NCT01447420|616026714|FG000|Overall Study|Adverse Event|2|||
170459479|NCT01447420|616026715|FG001|Overall Study|Adverse Event|4|||
170459480|NCT01447420|616026716|FG002|Overall Study|Adverse Event|2|||
170459481|NCT01447420|616026714|FG000|Overall Study|Protocol Violation|3|||
170459482|NCT01447420|616026715|FG001|Overall Study|Protocol Violation|3|||
170459483|NCT01447420|616026716|FG002|Overall Study|Protocol Violation|0|||
170459484|NCT01447420|616026714|FG000|Overall Study|Withdrawal by Subject|4|||
170459485|NCT01447420|616026715|FG001|Overall Study|Withdrawal by Subject|1|||
170459486|NCT01447420|616026716|FG002|Overall Study|Withdrawal by Subject|0|||
170459487|NCT01447420|616026714|FG000|Overall Study|Lack of Efficacy|1|||
170459488|NCT01447420|616026715|FG001|Overall Study|Lack of Efficacy|19|||
170459489|NCT01447420|616026716|FG002|Overall Study|Lack of Efficacy|8|||
170459490|NCT02731326|616026717|FG000|Overall Study|Withdrawal by Subject|4|||
170459491|NCT02731326|616026718|FG001|Overall Study|Withdrawal by Subject|1|||
170459492|NCT02731326|616026717|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
170459493|NCT02731326|616026718|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
170459494|NCT02731326|616026717|FG000|Overall Study|Discharged without AliveCor|10|||
170459495|NCT02731326|616026718|FG001|Overall Study|Discharged without AliveCor|0|||
170459496|NCT02731326|616026717|FG000|Overall Study|Duplicate Participant|1|||
170459497|NCT02731326|616026718|FG001|Overall Study|Duplicate Participant|1|||
170459498|NCT01085201|616026723|FG000|Overall Study|Scheduling conflict|1|||
170459499|NCT01085201|616026724|FG001|Overall Study|Scheduling conflict|0|||
170459500|NCT01085201|616026725|FG002|Overall Study|Scheduling conflict|1|||
170459501|NCT01085201|616026726|FG003|Overall Study|Scheduling conflict|0|||
170459502|NCT01085201|616026727|FG004|Overall Study|Scheduling conflict|0|||
170459503|NCT01085201|616026723|FG000|Overall Study|Unknown- no study drug|2|||
170459504|NCT01085201|616026724|FG001|Overall Study|Unknown- no study drug|0|||
170459505|NCT01085201|616026725|FG002|Overall Study|Unknown- no study drug|0|||
170459506|NCT01085201|616026726|FG003|Overall Study|Unknown- no study drug|0|||
170459507|NCT01085201|616026727|FG004|Overall Study|Unknown- no study drug|0|||
170459508|NCT01085201|616026723|FG000|Overall Study|Fond ineligible after consent|0|||
170459509|NCT01085201|616026724|FG001|Overall Study|Fond ineligible after consent|1|||
170459510|NCT01085201|616026725|FG002|Overall Study|Fond ineligible after consent|1|||
170459511|NCT01085201|616026726|FG003|Overall Study|Fond ineligible after consent|0|||
170459512|NCT01085201|616026727|FG004|Overall Study|Fond ineligible after consent|0|||
170459513|NCT00528411|616026728|FG000|Overall Study|Adverse Event|4|||
170459514|NCT00528411|616026729|FG001|Overall Study|Adverse Event|0|||
170543282|NCT02337946|616332847|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
170543283|NCT02337946|616332845|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
170543284|NCT02337946|616332846|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
170543285|NCT02337946|616332847|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
170543286|NCT01327703|616332848|FG000|Second Treatment Period|Adverse Event|1|||
170543287|NCT01327703|616332849|FG001|Second Treatment Period|Adverse Event|1|||
170543288|NCT01327703|616332848|FG000|Second Treatment Period|Protocol Violation|0|||
170543289|NCT01327703|616332849|FG001|Second Treatment Period|Protocol Violation|1|||
170543290|NCT01131585|616332850|FG000|Overall Study|Adverse Event|0|||
170543291|NCT01131585|616332851|FG001|Overall Study|Adverse Event|2|||
170543292|NCT01131585|616332850|FG000|Overall Study|Abnormal laboratory value|1|||
170543293|NCT01131585|616332851|FG001|Overall Study|Abnormal laboratory value|0|||
170543294|NCT01131585|616332850|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170543295|NCT01131585|616332851|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170543296|NCT01131585|616332850|FG000|Overall Study|Protocol Violation|2|||
170543297|NCT01131585|616332851|FG001|Overall Study|Protocol Violation|1|||
170459515|NCT00528411|616026730|FG002|Overall Study|Adverse Event|1|||
170459516|NCT00528411|616026728|FG000|Overall Study|Incorrect Enrolment|1|||
170459517|NCT00528411|616026729|FG001|Overall Study|Incorrect Enrolment|1|||
170459518|NCT00528411|616026730|FG002|Overall Study|Incorrect Enrolment|0|||
170459519|NCT00528411|616026728|FG000|Overall Study|Severe non-compliance to protocol|0|||
170459520|NCT00528411|616026729|FG001|Overall Study|Severe non-compliance to protocol|1|||
170459521|NCT00528411|616026730|FG002|Overall Study|Severe non-compliance to protocol|0|||
170459522|NCT00528411|616026728|FG000|Overall Study|Prior commitment medication|0|||
170459523|NCT00528411|616026729|FG001|Overall Study|Prior commitment medication|1|||
170459524|NCT00528411|616026730|FG002|Overall Study|Prior commitment medication|0|||
170459525|NCT05005312|616026731|FG000|Overall Study|Enrolled, but not treated|0|||
170459526|NCT05005312|616026732|FG001|Overall Study|Enrolled, but not treated|1|||
170459527|NCT02238795|616026735|FG000|Overall Study|Patient without purpura fulminans|1|||
170543298|NCT01131585|616332850|FG000|Overall Study|Withdrawal by Subject|3|||
170543299|NCT01131585|616332851|FG001|Overall Study|Withdrawal by Subject|3|||
170543300|NCT01131585|616332850|FG000|Overall Study|Lost to Follow-up|0|||
170459528|NCT00077857|616026736|FG000|Overall Study|Adverse Event|30|||
170459529|NCT00077857|616026737|FG001|Overall Study|Adverse Event|32|||
170459530|NCT00077857|616026736|FG000|Overall Study|Death|7|||
170459531|NCT00077857|616026737|FG001|Overall Study|Death|3|||
170459532|NCT00077857|616026736|FG000|Overall Study|Insufficient therapeutic response|112|||
170459533|NCT00077857|616026737|FG001|Overall Study|Insufficient therapeutic response|128|||
170459534|NCT00077857|616026736|FG000|Overall Study|Violation of selection criteria at entry|3|||
170459535|NCT00077857|616026737|FG001|Overall Study|Violation of selection criteria at entry|1|||
170459536|NCT00077857|616026736|FG000|Overall Study|Other protocol violation|0|||
170459537|NCT00077857|616026737|FG001|Overall Study|Other protocol violation|1|||
170459538|NCT00077857|616026736|FG000|Overall Study|Refused treatment|29|||
170459539|NCT00077857|616026737|FG001|Overall Study|Refused treatment|21|||
170459540|NCT00077857|616026736|FG000|Overall Study|Failure to return|5|||
170459541|NCT00077857|616026737|FG001|Overall Study|Failure to return|5|||
170459542|NCT00077857|616026736|FG000|Overall Study|Other|15|||
170459543|NCT00077857|616026737|FG001|Overall Study|Other|13|||
170459544|NCT06354998|616026738|FG000|Overall Study|Withdrawal by Subject|3|||
170459545|NCT06354998|616026739|FG001|Overall Study|Withdrawal by Subject|0|||
170459546|NCT03819049|616026740|FG000|Overall Study|Lost to Follow-up|1|||
170459547|NCT03819049|616026741|FG001|Overall Study|Lost to Follow-up|2|||
170459548|NCT03819049|616026742|FG002|Overall Study|Lost to Follow-up|9|||
170459549|NCT03819049|616026743|FG003|Overall Study|Lost to Follow-up|0|||
170459550|NCT03819049|616026744|FG004|Overall Study|Lost to Follow-up|3|||
170459551|NCT03819049|616026745|FG005|Overall Study|Lost to Follow-up|1|||
170459552|NCT03819049|616026746|FG006|Overall Study|Lost to Follow-up|0|||
170459553|NCT03819049|616026740|FG000|Overall Study|Withdrawal by Subject|0|||
170459554|NCT03819049|616026741|FG001|Overall Study|Withdrawal by Subject|0|||
170459555|NCT03819049|616026742|FG002|Overall Study|Withdrawal by Subject|18|||
170459556|NCT03819049|616026743|FG003|Overall Study|Withdrawal by Subject|0|||
170459557|NCT03819049|616026744|FG004|Overall Study|Withdrawal by Subject|10|||
170459558|NCT03819049|616026745|FG005|Overall Study|Withdrawal by Subject|9|||
170459559|NCT03819049|616026746|FG006|Overall Study|Withdrawal by Subject|1|||
170459560|NCT03819049|616026740|FG000|Overall Study|Ongoing|0|||
170459561|NCT03819049|616026741|FG001|Overall Study|Ongoing|0|||
170459562|NCT03819049|616026742|FG002|Overall Study|Ongoing|75|||
170459563|NCT03819049|616026743|FG003|Overall Study|Ongoing|0|||
170459564|NCT03819049|616026744|FG004|Overall Study|Ongoing|41|||
170459565|NCT03819049|616026745|FG005|Overall Study|Ongoing|0|||
170459566|NCT03819049|616026746|FG006|Overall Study|Ongoing|0|||
170459567|NCT03819049|616026740|FG000|Overall Study|Other|0|||
170459568|NCT03819049|616026741|FG001|Overall Study|Other|0|||
170459569|NCT03819049|616026742|FG002|Overall Study|Other|2|||
170459570|NCT03819049|616026743|FG003|Overall Study|Other|0|||
170459571|NCT03819049|616026744|FG004|Overall Study|Other|0|||
170459572|NCT03819049|616026745|FG005|Overall Study|Other|0|||
170459573|NCT03819049|616026746|FG006|Overall Study|Other|0|||
170459574|NCT03819049|616026740|FG000|Overall Study|Randomized but not vaccinated|0|||
170459575|NCT03819049|616026741|FG001|Overall Study|Randomized but not vaccinated|0|||
170459576|NCT03819049|616026742|FG002|Overall Study|Randomized but not vaccinated|0|||
170459577|NCT03819049|616026743|FG003|Overall Study|Randomized but not vaccinated|1|||
170459578|NCT03819049|616026744|FG004|Overall Study|Randomized but not vaccinated|0|||
170459579|NCT03819049|616026745|FG005|Overall Study|Randomized but not vaccinated|2|||
170459580|NCT03819049|616026746|FG006|Overall Study|Randomized but not vaccinated|1|||
170459581|NCT03819049|616026740|FG000|Overall Study|Physician Decision|0|||
170459582|NCT03819049|616026741|FG001|Overall Study|Physician Decision|0|||
170459583|NCT03819049|616026742|FG002|Overall Study|Physician Decision|0|||
170459584|NCT03819049|616026743|FG003|Overall Study|Physician Decision|0|||
170459585|NCT03819049|616026744|FG004|Overall Study|Physician Decision|0|||
170459586|NCT03819049|616026745|FG005|Overall Study|Physician Decision|0|||
170459587|NCT03819049|616026746|FG006|Overall Study|Physician Decision|1|||
170459588|NCT00816361|616026747|FG000|Overall Study|Withdrawal by Subject|0|||
170459589|NCT00816361|616026748|FG001|Overall Study|Withdrawal by Subject|0|||
170459590|NCT00816361|616026749|FG002|Overall Study|Withdrawal by Subject|0|||
170459591|NCT00816361|616026750|FG003|Overall Study|Withdrawal by Subject|0|||
170459592|NCT00816361|616026751|FG004|Overall Study|Withdrawal by Subject|1|||
170459593|NCT00816361|616026752|FG005|Overall Study|Withdrawal by Subject|2|||
170459594|NCT00816361|616026753|FG006|Overall Study|Withdrawal by Subject|0|||
170459595|NCT00816361|616026754|FG007|Overall Study|Withdrawal by Subject|2|||
170459596|NCT00816361|616026755|FG008|Overall Study|Withdrawal by Subject|1|||
170459597|NCT00816361|616026747|FG000|Overall Study|Death|4|||
170459598|NCT00816361|616026748|FG001|Overall Study|Death|3|||
170459599|NCT00816361|616026749|FG002|Overall Study|Death|3|||
170459600|NCT00816361|616026750|FG003|Overall Study|Death|3|||
170459601|NCT00816361|616026751|FG004|Overall Study|Death|1|||
170459602|NCT00816361|616026752|FG005|Overall Study|Death|1|||
170459603|NCT00816361|616026753|FG006|Overall Study|Death|3|||
170459604|NCT00816361|616026754|FG007|Overall Study|Death|7|||
170459605|NCT00816361|616026755|FG008|Overall Study|Death|8|||
170459606|NCT00816361|616026747|FG000|Overall Study|Other|0|||
170459607|NCT00816361|616026748|FG001|Overall Study|Other|0|||
170459608|NCT00816361|616026749|FG002|Overall Study|Other|0|||
170459609|NCT00816361|616026750|FG003|Overall Study|Other|0|||
170459610|NCT00816361|616026751|FG004|Overall Study|Other|0|||
170459611|NCT00816361|616026752|FG005|Overall Study|Other|0|||
170459612|NCT00816361|616026753|FG006|Overall Study|Other|0|||
170459613|NCT00816361|616026754|FG007|Overall Study|Other|0|||
170459614|NCT00816361|616026755|FG008|Overall Study|Other|1|||
170459615|NCT03285308|616026758|FG000|Overall Study|Adverse Event|3|||
170459616|NCT03285308|616026759|FG001|Overall Study|Adverse Event|7|||
170459617|NCT03285308|616026758|FG000|Overall Study|Withdrawal by Subject|8|||
170459618|NCT03285308|616026759|FG001|Overall Study|Withdrawal by Subject|9|||
170459619|NCT03285308|616026758|FG000|Overall Study|Lost to Follow-up|3|||
170459620|NCT03285308|616026759|FG001|Overall Study|Lost to Follow-up|1|||
170459621|NCT03285308|616026758|FG000|Overall Study|Protocol Deviation|6|||
170459622|NCT03285308|616026759|FG001|Overall Study|Protocol Deviation|5|||
170459623|NCT03285308|616026758|FG000|Overall Study|Reason not Specified|0|||
170459624|NCT03285308|616026759|FG001|Overall Study|Reason not Specified|1|||
170459625|NCT02283983|616026760|FG000|Overall Study|Inclusion criteria not met|0|||
170459626|NCT02283983|616026761|FG001|Overall Study|Inclusion criteria not met|1|||
170459627|NCT02283983|616026760|FG000|Overall Study|Withdrawal by Subject|4|||
170459628|NCT02283983|616026761|FG001|Overall Study|Withdrawal by Subject|2|||
170459629|NCT02283983|616026760|FG000|Overall Study|Protocol Violation|0|||
170459630|NCT02283983|616026761|FG001|Overall Study|Protocol Violation|4|||
170459631|NCT02283983|616026760|FG000|Overall Study|Physician Decision|2|||
170459632|NCT02283983|616026761|FG001|Overall Study|Physician Decision|4|||
170459633|NCT02283983|616026760|FG000|Overall Study|Death|1|||
170459634|NCT02283983|616026761|FG001|Overall Study|Death|0|||
170459635|NCT02283983|616026760|FG000|Overall Study|Adverse Event|1|||
170459636|NCT02283983|616026761|FG001|Overall Study|Adverse Event|0|||
170459637|NCT02283983|616026760|FG000|Overall Study|Lost to Follow-up|9|||
170459638|NCT02283983|616026761|FG001|Overall Study|Lost to Follow-up|8|||
170459639|NCT02283983|616026760|FG000|Overall Study|Relapse|1|||
170459640|NCT02283983|616026761|FG001|Overall Study|Relapse|0|||
170459641|NCT03283761|616026762|FG000|Study Treatment|Patient Non-Compliance|1|||
170459642|NCT03283761|616026762|FG000|Study Treatment|Alternative Cancer Therapy|7|||
170459643|NCT03283761|616026762|FG000|Study Treatment|Disease progression|21|||
170459644|NCT03283761|616026762|FG000|Study Treatment|Adverse Event|3|||
170459645|NCT03283761|616026762|FG000|Study Treatment|Withdrawal by Subject|4|||
170459646|NCT03283761|616026762|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
170459647|NCT03283761|616026762|FG000|Study Treatment|Symptomatic Deterioration|1|||
170459648|NCT03283761|616026762|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
170459649|NCT03283761|616026762|FG000|Follow up|Lost to Follow-up|1|||
170459650|NCT03283761|616026762|FG000|Follow up|Symptomatic Deterioration|1|||
170459651|NCT03283761|616026762|FG000|Follow up|Death|29|||
170459652|NCT03283761|616026762|FG000|Follow up|study terminated|4|||
170459653|NCT03283761|616026762|FG000|Follow up|Primary Investigator Withdrawal|1|||
170459654|NCT03283761|616026762|FG000|Follow up|Switched to alternative therapy|1|||
170459655|NCT03283761|616026762|FG000|Follow up|Subject is now in Hospice|1|||
170459656|NCT03275064|616026763|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
170459657|NCT03275064|616026764|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
170459658|NCT03275064|616026765|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
170459659|NCT03275064|616026766|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
170459660|NCT03275064|616026767|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
170459661|NCT03275064|616026763|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
170636053|NCT00473382|616678937|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
170636054|NCT00473382|616678935|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
170636055|NCT00473382|616678936|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
170636056|NCT00473382|616678937|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
170788186|NCT06215521|617234240|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
170459662|NCT03275064|616026764|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
170788187|NCT06215521|617234241|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
170459663|NCT03275064|616026765|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
170459664|NCT03275064|616026766|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
170459665|NCT03275064|616026767|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
170459666|NCT03275064|616026763|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
170636057|NCT00473382|616678935|FG000|Open-label Extension Through Month 60|Death|1|||
170788188|NCT06215521|617234242|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
170788189|NCT04096040|617234243|FG000|Overall Study|Protocol Violation|12|||
170459667|NCT03275064|616026764|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
170788190|NCT04096040|617234243|FG000|Overall Study|Non-compliant site|4|||
170788191|NCT04973254|617234244|FG000|Overall Study|Not adherent|0|||
170788192|NCT04973254|617234245|FG001|Overall Study|Not adherent|1|||
170788193|NCT04973254|617234246|FG002|Overall Study|Not adherent|0|||
170788194|NCT05170009|617234250|FG000|Overall Study|Physician Decision|0|||
170788195|NCT05170009|617234251|FG001|Overall Study|Physician Decision|1|||
170788196|NCT04925986|617234256|FG000|Overall Study|Death|0|||
170788197|NCT04925986|617234257|FG001|Overall Study|Death|0|||
170788198|NCT04925986|617234258|FG002|Overall Study|Death|2|||
170788199|NCT04925986|617234259|FG003|Overall Study|Death|0|||
170788200|NCT04925986|617234256|FG000|Overall Study|Lack of Efficacy|1|||
170788201|NCT04925986|617234257|FG001|Overall Study|Lack of Efficacy|2|||
170788202|NCT04925986|617234258|FG002|Overall Study|Lack of Efficacy|0|||
170788203|NCT04925986|617234259|FG003|Overall Study|Lack of Efficacy|1|||
170788204|NCT04925986|617234256|FG000|Overall Study|Withdrawal by Subject|0|||
170788205|NCT04925986|617234257|FG001|Overall Study|Withdrawal by Subject|0|||
170788206|NCT04925986|617234258|FG002|Overall Study|Withdrawal by Subject|1|||
170788207|NCT04925986|617234259|FG003|Overall Study|Withdrawal by Subject|2|||
170788208|NCT03858634|617234260|FG000|Overall Study|Withdrawal by Subject|1|||
170788209|NCT03858634|617234261|FG001|Overall Study|Withdrawal by Subject|0|||
170788210|NCT03858634|617234260|FG000|Overall Study|Adverse Event|1|||
170788211|NCT03858634|617234261|FG001|Overall Study|Adverse Event|0|||
170788212|NCT03858634|617234260|FG000|Overall Study|Lost to Follow-up|0|||
170788213|NCT03858634|617234261|FG001|Overall Study|Lost to Follow-up|1|||
170788214|NCT03858634|617234260|FG000|Overall Study|Other, Not Specified|1|||
170788215|NCT03858634|617234261|FG001|Overall Study|Other, Not Specified|1|||
170788216|NCT06181760|617234262|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
170459668|NCT03275064|616026765|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
170459669|NCT03275064|616026766|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
170459670|NCT03275064|616026767|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
170459671|NCT03275064|616026763|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
170459672|NCT03275064|616026764|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
170459673|NCT03275064|616026765|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
170459674|NCT03275064|616026766|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
170459675|NCT03275064|616026767|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
170459676|NCT03275064|616026763|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
170459677|NCT03275064|616026764|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
170459678|NCT03275064|616026765|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
170459679|NCT03275064|616026766|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
170459680|NCT03275064|616026767|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
170459681|NCT00620555|616026769|FG000|Overall Study|Adverse Event|4|||
170459682|NCT00620555|616026769|FG000|Overall Study|Protocol Violation|2|||
170459683|NCT00620555|616026769|FG000|Overall Study|Lack of Efficacy|12|||
170459684|NCT00620555|616026769|FG000|Overall Study|Withdrawal by Subject|1|||
170459685|NCT00620555|616026769|FG000|Overall Study|Choice of other treatment|1|||
170459686|NCT00620555|616026769|FG000|Overall Study|Visit failure against planned|1|||
170459687|NCT01791153|616026772|FG000|Part 1: Blinded Period|Adverse Event|7|||
170459688|NCT01791153|616026773|FG001|Part 1: Blinded Period|Adverse Event|3|||
170459689|NCT01791153|616026774|FG002|Part 1: Blinded Period|Adverse Event|2|||
170459690|NCT01791153|616026775|FG003|Part 1: Blinded Period|Adverse Event|0|||
170459691|NCT01791153|616026776|FG004|Part 1: Blinded Period|Adverse Event|0|||
170459692|NCT01791153|616026777|FG005|Part 1: Blinded Period|Adverse Event|0|||
170459693|NCT01791153|616026778|FG006|Part 1: Blinded Period|Adverse Event|0|||
170459694|NCT01791153|616026779|FG007|Part 1: Blinded Period|Adverse Event|0|||
170459695|NCT01791153|616026772|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
170459696|NCT01791153|616026773|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
170459697|NCT01791153|616026774|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
170459698|NCT01791153|616026775|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
170459699|NCT01791153|616026776|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
170459700|NCT01791153|616026777|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
170459701|NCT01791153|616026778|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
170459702|NCT01791153|616026779|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
170459703|NCT01791153|616026772|FG000|Part 1: Blinded Period|Non-Compliance|1|||
170459704|NCT01791153|616026773|FG001|Part 1: Blinded Period|Non-Compliance|0|||
170459705|NCT01791153|616026774|FG002|Part 1: Blinded Period|Non-Compliance|0|||
170459706|NCT01791153|616026775|FG003|Part 1: Blinded Period|Non-Compliance|0|||
170459707|NCT01791153|616026776|FG004|Part 1: Blinded Period|Non-Compliance|0|||
170459708|NCT01791153|616026777|FG005|Part 1: Blinded Period|Non-Compliance|0|||
170459709|NCT01791153|616026778|FG006|Part 1: Blinded Period|Non-Compliance|0|||
170788217|NCT06181760|617234263|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
170788218|NCT06181760|617234264|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
170788219|NCT06181760|617234265|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
170788220|NCT04629716|617234267|FG000|Overall Study|Lost to Follow-up|7|||
170788221|NCT04629716|617234268|FG001|Overall Study|Lost to Follow-up|3|||
170788222|NCT04938492|617234269|FG000|Overall Study|Lost to Follow-up|17|||
170889255|NCT01543087|617600656|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
170889256|NCT01632566|617600660|FG000|Overall Study|Withdrawal by Subject|0|||
170889257|NCT01632566|617600661|FG001|Overall Study|Withdrawal by Subject|1|||
170889258|NCT01632566|617600662|FG002|Overall Study|Withdrawal by Subject|0|||
170459710|NCT01791153|616026779|FG007|Part 1: Blinded Period|Non-Compliance|0|||
170459711|NCT01791153|616026772|FG000|Part 1: Blinded Period|Physician Decision|0|||
170459712|NCT01791153|616026773|FG001|Part 1: Blinded Period|Physician Decision|0|||
170459713|NCT01791153|616026774|FG002|Part 1: Blinded Period|Physician Decision|0|||
170459714|NCT01791153|616026775|FG003|Part 1: Blinded Period|Physician Decision|1|||
170459715|NCT01791153|616026776|FG004|Part 1: Blinded Period|Physician Decision|0|||
170459716|NCT01791153|616026777|FG005|Part 1: Blinded Period|Physician Decision|0|||
170459717|NCT01791153|616026778|FG006|Part 1: Blinded Period|Physician Decision|0|||
170459718|NCT01791153|616026779|FG007|Part 1: Blinded Period|Physician Decision|0|||
170459719|NCT01791153|616026772|FG000|Part 1: Blinded Period|Protocol Violation|0|||
170459720|NCT01791153|616026773|FG001|Part 1: Blinded Period|Protocol Violation|0|||
170459721|NCT01791153|616026774|FG002|Part 1: Blinded Period|Protocol Violation|0|||
170459722|NCT01791153|616026775|FG003|Part 1: Blinded Period|Protocol Violation|1|||
170459723|NCT01791153|616026776|FG004|Part 1: Blinded Period|Protocol Violation|0|||
170459724|NCT01791153|616026777|FG005|Part 1: Blinded Period|Protocol Violation|0|||
170459725|NCT01791153|616026778|FG006|Part 1: Blinded Period|Protocol Violation|0|||
170459726|NCT01791153|616026779|FG007|Part 1: Blinded Period|Protocol Violation|0|||
170459727|NCT01791153|616026772|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
170459728|NCT01791153|616026773|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
170459729|NCT01791153|616026774|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
170459730|NCT01791153|616026775|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
170459731|NCT01791153|616026776|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
170459732|NCT01791153|616026777|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
170459733|NCT01791153|616026778|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
170459734|NCT01791153|616026779|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
170459735|NCT01791153|616026772|FG000|Part 2: Open-label Period|Adverse Event|0|||
170459736|NCT01791153|616026773|FG001|Part 2: Open-label Period|Adverse Event|0|||
170459737|NCT01791153|616026774|FG002|Part 2: Open-label Period|Adverse Event|0|||
170459738|NCT01791153|616026775|FG003|Part 2: Open-label Period|Adverse Event|0|||
170459739|NCT01791153|616026776|FG004|Part 2: Open-label Period|Adverse Event|0|||
170459740|NCT01791153|616026777|FG005|Part 2: Open-label Period|Adverse Event|1|||
170459741|NCT01791153|616026778|FG006|Part 2: Open-label Period|Adverse Event|1|||
170459742|NCT01791153|616026779|FG007|Part 2: Open-label Period|Adverse Event|2|||
170459743|NCT01791153|616026772|FG000|Part 2: Open-label Period|Death|0|||
170459744|NCT01791153|616026773|FG001|Part 2: Open-label Period|Death|0|||
170459745|NCT01791153|616026774|FG002|Part 2: Open-label Period|Death|0|||
170459746|NCT01791153|616026775|FG003|Part 2: Open-label Period|Death|0|||
170459747|NCT01791153|616026776|FG004|Part 2: Open-label Period|Death|0|||
170459748|NCT01791153|616026777|FG005|Part 2: Open-label Period|Death|1|||
170459749|NCT01791153|616026778|FG006|Part 2: Open-label Period|Death|1|||
170459750|NCT01791153|616026779|FG007|Part 2: Open-label Period|Death|1|||
170459751|NCT01791153|616026772|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
170459752|NCT01791153|616026773|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
170459753|NCT01791153|616026774|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
170459754|NCT01791153|616026775|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
170459755|NCT01791153|616026776|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
170459756|NCT01791153|616026777|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
170459757|NCT01791153|616026778|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
170459758|NCT01791153|616026779|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
170459759|NCT01791153|616026772|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
170459760|NCT01791153|616026773|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
170459761|NCT01791153|616026774|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
170459762|NCT01791153|616026775|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
170459763|NCT01791153|616026776|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
170459764|NCT01791153|616026777|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
170459765|NCT01791153|616026778|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
170459766|NCT01791153|616026779|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
170459767|NCT01791153|616026772|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
170459768|NCT01791153|616026773|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
170459769|NCT01791153|616026774|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
170459770|NCT01791153|616026775|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
170459771|NCT01791153|616026776|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
170459772|NCT01791153|616026777|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
170459773|NCT01791153|616026778|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
170459774|NCT01791153|616026779|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
170459775|NCT01791153|616026772|FG000|Part 2: Open-label Period|Physician Decision|0|||
170459776|NCT01791153|616026773|FG001|Part 2: Open-label Period|Physician Decision|0|||
170889259|NCT01632566|617600663|FG003|Overall Study|Withdrawal by Subject|0|||
170889260|NCT01632566|617600664|FG004|Overall Study|Withdrawal by Subject|0|||
170459777|NCT01791153|616026774|FG002|Part 2: Open-label Period|Physician Decision|0|||
170459778|NCT01791153|616026775|FG003|Part 2: Open-label Period|Physician Decision|0|||
170459779|NCT01791153|616026776|FG004|Part 2: Open-label Period|Physician Decision|1|||
170459780|NCT01791153|616026777|FG005|Part 2: Open-label Period|Physician Decision|1|||
170459781|NCT01791153|616026778|FG006|Part 2: Open-label Period|Physician Decision|0|||
170459782|NCT01791153|616026779|FG007|Part 2: Open-label Period|Physician Decision|0|||
170459783|NCT02562482|616026783|FG000|Overall Study|Enrolled, but did not receive product|4|||
170459784|NCT02562482|616026784|FG001|Overall Study|Enrolled, but did not receive product|0|||
170459785|NCT02562482|616026783|FG000|Overall Study|Lost to Follow-up|9|||
170459786|NCT02562482|616026784|FG001|Overall Study|Lost to Follow-up|6|||
170459787|NCT02562482|616026783|FG000|Overall Study|Moved from area|2|||
170459788|NCT02562482|616026784|FG001|Overall Study|Moved from area|3|||
170459789|NCT02562482|616026783|FG000|Overall Study|Withdrawal by Subject|5|||
170459790|NCT02562482|616026784|FG001|Overall Study|Withdrawal by Subject|3|||
170459791|NCT02562482|616026783|FG000|Overall Study|Physician Decision|1|||
170459792|NCT02562482|616026784|FG001|Overall Study|Physician Decision|3|||
170459793|NCT02562482|616026783|FG000|Overall Study|Illness/Injury unrelated to product|0|||
170459794|NCT02562482|616026784|FG001|Overall Study|Illness/Injury unrelated to product|1|||
170459795|NCT05896202|616026785|FG000|Overall Study|Lost to Follow-up|2|||
170459796|NCT05896202|616026786|FG001|Overall Study|Lost to Follow-up|2|||
170459797|NCT02357342|616026789|FG000|First 6 Months|Death|2|||
170459798|NCT02357342|616026790|FG001|First 6 Months|Death|0|||
170459799|NCT01490866|616026791|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
170459800|NCT01490866|616026791|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
170459801|NCT01490866|616026791|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
170459802|NCT01490866|616026791|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
170459803|NCT01490866|616026791|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
170459804|NCT01490866|616026791|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
170459805|NCT01490866|616026791|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
170459806|NCT01490866|616026791|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
170459807|NCT01490866|616026791|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
170459808|NCT01490866|616026791|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
170459809|NCT01490866|616026791|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
170459810|NCT03923530|616026792|FG000|Overall Study|Withdrawal by Subject|1|||
170459811|NCT03923530|616026792|FG000|Overall Study|screen failure|3|||
170459812|NCT01181271|616026795|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
170459813|NCT01181271|616026795|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
170459814|NCT01181271|616026795|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
170459815|NCT01181271|616026795|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
170459816|NCT01408628|616026796|FG000|Consented|Withdrawal by Subject|12|||
170459817|NCT01408628|616026796|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
170459818|NCT01408628|616026796|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
170459819|NCT01408628|616026796|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
170459820|NCT03456960|616026797|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
170459821|NCT03456960|616026798|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
170459822|NCT03456960|616026799|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
170459823|NCT03456960|616026800|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
170459824|NCT03456960|616026801|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
170459825|NCT03456960|616026802|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
170459826|NCT03456960|616026797|FG000|Period 2 (1 Day)|Adverse Event|1|||
170459827|NCT03456960|616026798|FG001|Period 2 (1 Day)|Adverse Event|0|||
170459828|NCT03456960|616026799|FG002|Period 2 (1 Day)|Adverse Event|0|||
170636058|NCT00473382|616678936|FG001|Open-label Extension Through Month 60|Death|7|||
170636059|NCT00473382|616678937|FG002|Open-label Extension Through Month 60|Death|4|||
170636060|NCT00473382|616678935|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
170636061|NCT00473382|616678936|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
170636062|NCT00473382|616678937|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
170636063|NCT00473382|616678935|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
170636064|NCT00473382|616678936|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
170636065|NCT00473382|616678937|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
170636066|NCT00473382|616678935|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
170636067|NCT00473382|616678936|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
170788223|NCT04938492|617234270|FG001|Overall Study|Lost to Follow-up|18|||
170788224|NCT04542317|617234271|FG000|Overall Study|Care recipients passed away|18|||
170459829|NCT03456960|616026800|FG003|Period 2 (1 Day)|Adverse Event|1|||
170459830|NCT03456960|616026801|FG004|Period 2 (1 Day)|Adverse Event|0|||
170636068|NCT00473382|616678937|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
170788225|NCT04542317|617234272|FG001|Overall Study|Care recipients passed away|13|||
170459831|NCT03456960|616026802|FG005|Period 2 (1 Day)|Adverse Event|0|||
170459832|NCT04669691|616026803|FG000|Overall Study|Death|0|||
170459833|NCT04669691|616026804|FG001|Overall Study|Death|1|||
170459834|NCT04669691|616026805|FG002|Overall Study|Death|0|||
170459835|NCT04669691|616026806|FG003|Overall Study|Death|0|||
170459836|NCT04669691|616026807|FG004|Overall Study|Death|0|||
170459837|NCT04669691|616026808|FG005|Overall Study|Death|0|||
170459838|NCT00532935|616026809|FG000|Overall Study|Adverse Event|11|||
170459839|NCT00532935|616026810|FG001|Overall Study|Adverse Event|12|||
170459840|NCT00532935|616026809|FG000|Overall Study|Lack of Efficacy|0|||
170459841|NCT00532935|616026810|FG001|Overall Study|Lack of Efficacy|3|||
170459842|NCT00532935|616026809|FG000|Overall Study|Lost to Follow-up|10|||
170459843|NCT00532935|616026810|FG001|Overall Study|Lost to Follow-up|6|||
170459844|NCT00532935|616026809|FG000|Overall Study|Physician Decision|4|||
170459845|NCT00532935|616026810|FG001|Overall Study|Physician Decision|5|||
170459846|NCT00532935|616026809|FG000|Overall Study|Pregnancy|1|||
170459847|NCT00532935|616026810|FG001|Overall Study|Pregnancy|0|||
170459848|NCT00532935|616026809|FG000|Overall Study|Protocol Violation|4|||
170459849|NCT00532935|616026810|FG001|Overall Study|Protocol Violation|2|||
170459850|NCT00532935|616026809|FG000|Overall Study|Withdrawal by Subject|10|||
170459851|NCT00532935|616026810|FG001|Overall Study|Withdrawal by Subject|9|||
170459852|NCT00532935|616026809|FG000|Overall Study|Protocol Specific Criteria|11|||
170459853|NCT00532935|616026810|FG001|Overall Study|Protocol Specific Criteria|15|||
170459854|NCT04156620|616026811|FG000|Overall Study|Adverse event - TP 1|5|||
170459855|NCT04156620|616026812|FG001|Overall Study|Adverse event - TP 1|2|||
170459856|NCT04156620|616026811|FG000|Overall Study|Lost to follow-up TP 1|1|||
170459857|NCT04156620|616026812|FG001|Overall Study|Lost to follow-up TP 1|1|||
170459858|NCT04156620|616026811|FG000|Overall Study|Progressive disease - TP 1|0|||
170459859|NCT04156620|616026812|FG001|Overall Study|Progressive disease - TP 1|1|||
170459860|NCT04156620|616026811|FG000|Overall Study|Subject decision - TP 1|3|||
170459861|NCT04156620|616026812|FG001|Overall Study|Subject decision - TP 1|5|||
170459862|NCT04156620|616026811|FG000|Overall Study|Adverse event - TP 2|5|||
170459863|NCT04156620|616026812|FG001|Overall Study|Adverse event - TP 2|6|||
170459864|NCT04156620|616026811|FG000|Overall Study|Death - TP 2|1|||
170459865|NCT04156620|616026812|FG001|Overall Study|Death - TP 2|0|||
170459866|NCT04156620|616026811|FG000|Overall Study|Lost to follow-up - TP 2|5|||
170459867|NCT04156620|616026812|FG001|Overall Study|Lost to follow-up - TP 2|2|||
170459868|NCT04156620|616026811|FG000|Overall Study|Physician decision - TP 2|4|||
170459869|NCT04156620|616026812|FG001|Overall Study|Physician decision - TP 2|2|||
170459870|NCT04156620|616026811|FG000|Overall Study|Pregnancy - TP 2|1|||
170543301|NCT01131585|616332851|FG001|Overall Study|Lost to Follow-up|1|||
170543302|NCT01131585|616332850|FG000|Overall Study|Administrative problems|1|||
170543303|NCT01131585|616332851|FG001|Overall Study|Administrative problems|1|||
170543304|NCT01131585|616332850|FG000|Overall Study|Study termination|78|||
170543305|NCT01131585|616332851|FG001|Overall Study|Study termination|32|||
170543306|NCT00812097|616332852|FG000|Overall Study|Death|3|||
170543307|NCT00812097|616332853|FG001|Overall Study|Death|10|||
170543308|NCT00812097|616332854|FG002|Overall Study|Death|3|||
170543309|NCT00812097|616332855|FG003|Overall Study|Death|3|||
170543310|NCT00812097|616332852|FG000|Overall Study|Withdrawal by Subject|14|||
170543311|NCT00812097|616332853|FG001|Overall Study|Withdrawal by Subject|12|||
170543312|NCT00812097|616332854|FG002|Overall Study|Withdrawal by Subject|8|||
170543313|NCT00812097|616332855|FG003|Overall Study|Withdrawal by Subject|2|||
170543314|NCT00812097|616332852|FG000|Overall Study|Lost to Follow-up|90|||
170543315|NCT00812097|616332853|FG001|Overall Study|Lost to Follow-up|14|||
170543316|NCT00812097|616332854|FG002|Overall Study|Lost to Follow-up|17|||
170543317|NCT00812097|616332855|FG003|Overall Study|Lost to Follow-up|5|||
170543318|NCT00812097|616332852|FG000|Overall Study|Explantation of study device(s)|27|||
170636069|NCT00473382|616678935|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
170636070|NCT00473382|616678936|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
170889261|NCT01632566|617600660|FG000|Overall Study|Sponsor Decision|0|||
170889262|NCT01632566|617600661|FG001|Overall Study|Sponsor Decision|2|||
170889263|NCT01632566|617600662|FG002|Overall Study|Sponsor Decision|9|||
170459871|NCT04156620|616026812|FG001|Overall Study|Pregnancy - TP 2|1|||
170459872|NCT04156620|616026811|FG000|Overall Study|Subject decision - TP 2|11|||
170459873|NCT04156620|616026812|FG001|Overall Study|Subject decision - TP 2|9|||
170459874|NCT04156620|616026811|FG000|Overall Study|New therapy for study indication - TP 2|1|||
170459875|NCT04156620|616026812|FG001|Overall Study|New therapy for study indication - TP 2|0|||
170543319|NCT00812097|616332853|FG001|Overall Study|Explantation of study device(s)|29|||
170636071|NCT00473382|616678937|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
170459876|NCT03212521|616026813|FG000|Overall Study|Adverse Event|1|||
170459877|NCT03212521|616026813|FG000|Overall Study|Lost to Follow-up|4|||
170543320|NCT00812097|616332854|FG002|Overall Study|Explantation of study device(s)|14|||
170543321|NCT00812097|616332855|FG003|Overall Study|Explantation of study device(s)|20|||
170543322|NCT00812097|616332852|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
170543323|NCT00812097|616332853|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
170543324|NCT00812097|616332854|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
170889264|NCT01632566|617600663|FG003|Overall Study|Sponsor Decision|2|||
170459878|NCT03212521|616026813|FG000|Overall Study|Withdrawal by Subject|1|||
170459879|NCT03212521|616026813|FG000|Overall Study|Other|1|||
170889265|NCT01632566|617600664|FG004|Overall Study|Sponsor Decision|2|||
170889266|NCT00454805|617600665|FG000|Overall Study|Withdrawal by Subject|9|||
170889267|NCT00454805|617600666|FG001|Overall Study|Withdrawal by Subject|2|||
170889268|NCT00454805|617600665|FG000|Overall Study|Death|0|||
170889269|NCT00454805|617600666|FG001|Overall Study|Death|2|||
170889270|NCT00454805|617600665|FG000|Overall Study|Disease progression|16|||
170889271|NCT00454805|617600666|FG001|Overall Study|Disease progression|19|||
170889272|NCT00454805|617600665|FG000|Overall Study|In order to begin radiotherapy|1|||
170889273|NCT00454805|617600666|FG001|Overall Study|In order to begin radiotherapy|0|||
170889274|NCT04982250|617600672|FG000|Overall Study|Lost to Follow-up|0|||
170889275|NCT04982250|617600673|FG001|Overall Study|Lost to Follow-up|26|||
170889276|NCT04982250|617600674|FG002|Overall Study|Lost to Follow-up|0|||
170889277|NCT04982250|617600675|FG003|Overall Study|Lost to Follow-up|0|||
170889278|NCT04982250|617600676|FG004|Overall Study|Lost to Follow-up|72|||
170889279|NCT04982250|617600677|FG005|Overall Study|Lost to Follow-up|69|||
170889280|NCT04982250|617600672|FG000|Overall Study|Not Eligible to Enroll|0|||
170889281|NCT04982250|617600673|FG001|Overall Study|Not Eligible to Enroll|0|||
170889282|NCT04982250|617600674|FG002|Overall Study|Not Eligible to Enroll|0|||
170889283|NCT04982250|617600675|FG003|Overall Study|Not Eligible to Enroll|0|||
170889284|NCT04982250|617600676|FG004|Overall Study|Not Eligible to Enroll|10|||
170889285|NCT04982250|617600677|FG005|Overall Study|Not Eligible to Enroll|7|||
170889286|NCT07099521|617600683|FG000|Overall Study|Incompeleted stimulus program|1|||
170889287|NCT07099521|617600684|FG001|Overall Study|Incompeleted stimulus program|0|||
170889288|NCT07099521|617600683|FG000|Overall Study|Non-social anxiety symtpoms|0|||
170889289|NCT07099521|617600684|FG001|Overall Study|Non-social anxiety symtpoms|1|||
170889290|NCT07099521|617600683|FG000|Overall Study|Extreme values|2|||
170889291|NCT07099521|617600684|FG001|Overall Study|Extreme values|4|||
170906124|NCT01097044|617658625|FG000|Overall Study|Withdrawal by Sponsor|0|||
170906125|NCT01097044|617658626|FG001|Overall Study|Withdrawal by Sponsor|1|||
170906126|NCT01682044|617658627|FG000|Overall Study|Death|1|||
170906127|NCT01682044|617658627|FG000|Overall Study|Progression|3|||
170906128|NCT02581995|617658629|FG000|Overall Study|Unspecified other|3|||
170906129|NCT02581995|617658629|FG000|Overall Study|Adverse Event|6|||
170906130|NCT02581995|617658629|FG000|Overall Study|Lost to Follow-up|5|||
170906131|NCT02581995|617658629|FG000|Overall Study|Withdrawal by participant|12|||
170906132|NCT02581995|617658629|FG000|Overall Study|Physician Decision|1|||
170906133|NCT02581995|617658629|FG000|Overall Study|Death|4|||
170906134|NCT06119191|617658630|FG000|Overall Study|Adverse Event|0|||
170906135|NCT06119191|617658631|FG001|Overall Study|Adverse Event|1|||
170906136|NCT06119191|617658630|FG000|Overall Study|Protocol Violation|1|||
170906137|NCT06119191|617658631|FG001|Overall Study|Protocol Violation|0|||
170906138|NCT05738486|617660807|FG000|Overall Study|Continuing Study|194|||
170906139|NCT05738486|617660808|FG001|Overall Study|Continuing Study|196|||
170906140|NCT05738486|617660809|FG002|Overall Study|Continuing Study|193|||
170906141|NCT05738486|617660810|FG003|Overall Study|Continuing Study|191|||
170906142|NCT05738486|617660807|FG000|Overall Study|Withdrawal by Subject|8|||
170906143|NCT05738486|617660808|FG001|Overall Study|Withdrawal by Subject|5|||
170906144|NCT05738486|617660809|FG002|Overall Study|Withdrawal by Subject|7|||
170906145|NCT05738486|617660810|FG003|Overall Study|Withdrawal by Subject|13|||
170906146|NCT05738486|617660807|FG000|Overall Study|Adverse Event|4|||
170906147|NCT05738486|617660808|FG001|Overall Study|Adverse Event|6|||
170906148|NCT05738486|617660809|FG002|Overall Study|Adverse Event|4|||
170906149|NCT05738486|617660810|FG003|Overall Study|Adverse Event|5|||
170906150|NCT05738486|617660807|FG000|Overall Study|Physician Decision|0|||
170906151|NCT05738486|617660808|FG001|Overall Study|Physician Decision|2|||
170906152|NCT05738486|617660809|FG002|Overall Study|Physician Decision|4|||
170906153|NCT05738486|617660810|FG003|Overall Study|Physician Decision|1|||
170906154|NCT05738486|617660807|FG000|Overall Study|Lost to Follow-up|1|||
170906155|NCT05738486|617660808|FG001|Overall Study|Lost to Follow-up|1|||
170906156|NCT05738486|617660809|FG002|Overall Study|Lost to Follow-up|2|||
170906157|NCT05738486|617660810|FG003|Overall Study|Lost to Follow-up|1|||
170906158|NCT05738486|617660807|FG000|Overall Study|Participant was Non-ambulatory|0|||
170906159|NCT05738486|617660808|FG001|Overall Study|Participant was Non-ambulatory|0|||
170906160|NCT05738486|617660809|FG002|Overall Study|Participant was Non-ambulatory|1|||
170906161|NCT05738486|617660810|FG003|Overall Study|Participant was Non-ambulatory|0|||
170906162|NCT05738486|617660807|FG000|Overall Study|Participant had Poor Venous Access|0|||
170906163|NCT05738486|617660808|FG001|Overall Study|Participant had Poor Venous Access|0|||
170906164|NCT05738486|617660809|FG002|Overall Study|Participant had Poor Venous Access|0|||
170906165|NCT05738486|617660810|FG003|Overall Study|Participant had Poor Venous Access|1|||
170906166|NCT05738486|617660807|FG000|Overall Study|Assigned Treatment by Mistake|0|||
170906167|NCT05738486|617660808|FG001|Overall Study|Assigned Treatment by Mistake|0|||
170906168|NCT05738486|617660809|FG002|Overall Study|Assigned Treatment by Mistake|0|||
170906169|NCT05738486|617660810|FG003|Overall Study|Assigned Treatment by Mistake|1|||
170906170|NCT05738486|617660807|FG000|Overall Study|Death|0|||
170906171|NCT05738486|617660808|FG001|Overall Study|Death|0|||
170906172|NCT05738486|617660809|FG002|Overall Study|Death|1|||
170906173|NCT05738486|617660810|FG003|Overall Study|Death|0|||
170906174|NCT05738486|617660807|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
170889292|NCT02392429|617602190|FG000|Screening|Screen failure|15|||
170889293|NCT02392429|617602190|FG000|Enrolled Participants|Ineligible due to disease|3|||
170889294|NCT02392429|617602190|FG000|Enrolled Participants|Withdrawal by Subject|4|||
170889295|NCT02392429|617602190|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
170889296|NCT02392429|617602190|FG000|Evaluable|Death|5|||
170889297|NCT02392429|617602190|FG000|Evaluable|Withdrawal by Subject|1|||
170889298|NCT02392429|617602190|FG000|Evaluable|Adverse Event|1|||
170889299|NCT02392429|617602190|FG000|Evaluable|remission bone marrow biopsy|3|||
170889300|NCT03266016|617602194|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
170889301|NCT03266016|617602195|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
170889302|NCT03266016|617602196|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
170889303|NCT03266016|617602197|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
170889304|NCT03266016|617602194|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
170889305|NCT03266016|617602195|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
170543325|NCT00812097|616332855|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
170543326|NCT00927082|616332856|FG000|Overall Study|Lost to Follow-up|9|||
170543327|NCT00927082|616332857|FG001|Overall Study|Lost to Follow-up|8|||
170788226|NCT04542317|617234271|FG000|Overall Study|No longer a primary caregiver|5|||
170788227|NCT04542317|617234272|FG001|Overall Study|No longer a primary caregiver|1|||
170788228|NCT04542317|617234271|FG000|Overall Study|Withdrawal by Subject|4|||
170788229|NCT04542317|617234272|FG001|Overall Study|Withdrawal by Subject|2|||
170788230|NCT04542317|617234271|FG000|Overall Study|Caregivers passed away|0|||
170788231|NCT04542317|617234272|FG001|Overall Study|Caregivers passed away|2|||
170788232|NCT04700163|617234275|FG000|Overall Study|Lost to Follow-up|0|||
170788233|NCT04700163|617234276|FG001|Overall Study|Lost to Follow-up|0|||
170788234|NCT04700163|617234277|FG002|Overall Study|Lost to Follow-up|0|||
170788235|NCT04700163|617234278|FG003|Overall Study|Lost to Follow-up|0|||
170788236|NCT04700163|617234279|FG004|Overall Study|Lost to Follow-up|0|||
170788237|NCT04700163|617234280|FG005|Overall Study|Lost to Follow-up|1|||
170788238|NCT03848065|617234281|FG000|Overall Study|Death|0|||
170788239|NCT03848065|617234282|FG001|Overall Study|Death|1|||
170788240|NCT03848065|617234283|FG002|Overall Study|Death|0|||
170788241|NCT03848065|617234281|FG000|Overall Study|Lost to Follow-up|0|||
170788242|NCT03848065|617234282|FG001|Overall Study|Lost to Follow-up|0|||
170788243|NCT03848065|617234283|FG002|Overall Study|Lost to Follow-up|1|||
170788244|NCT03848065|617234281|FG000|Overall Study|Physician Decision|0|||
170788245|NCT03848065|617234282|FG001|Overall Study|Physician Decision|0|||
170788246|NCT03848065|617234283|FG002|Overall Study|Physician Decision|1|||
170788247|NCT00613106|617234290|FG000|Overall Study|Adverse Event|3|||
170788248|NCT00613106|617234291|FG001|Overall Study|Adverse Event|1|||
170788249|NCT00613106|617234290|FG000|Overall Study|Withdrawal by Subject|6|||
170788250|NCT00613106|617234291|FG001|Overall Study|Withdrawal by Subject|3|||
170788251|NCT00613106|617234290|FG000|Overall Study|Lost to Follow-up|7|||
170788252|NCT00613106|617234291|FG001|Overall Study|Lost to Follow-up|2|||
170788253|NCT00613106|617234290|FG000|Overall Study|misc|4|||
170788254|NCT00613106|617234291|FG001|Overall Study|misc|3|||
170788255|NCT03496168|617234292|FG000|Overall Study|Other Reasons|1|||
170788256|NCT03496168|617234292|FG000|Overall Study|Adverse Event|1|||
170788257|NCT05543629|617234297|FG000|Overall Study|Death|1|||
170788258|NCT05543629|617234298|FG001|Overall Study|Death|0|||
170788259|NCT05543629|617234299|FG002|Overall Study|Death|1|||
170788260|NCT05543629|617234300|FG003|Overall Study|Death|0|||
170788261|NCT05543629|617234301|FG004|Overall Study|Death|0|||
170788262|NCT05543629|617234302|FG005|Overall Study|Death|1|||
170788263|NCT05543629|617234303|FG006|Overall Study|Death|2|||
170788264|NCT05543629|617234304|FG007|Overall Study|Death|2|||
170788265|NCT05543629|617234297|FG000|Overall Study|Other Reasons|0|||
170788266|NCT05543629|617234298|FG001|Overall Study|Other Reasons|0|||
170788267|NCT05543629|617234299|FG002|Overall Study|Other Reasons|0|||
170788268|NCT05543629|617234300|FG003|Overall Study|Other Reasons|0|||
170788269|NCT05543629|617234301|FG004|Overall Study|Other Reasons|1|||
170788270|NCT05543629|617234302|FG005|Overall Study|Other Reasons|0|||
170788271|NCT05543629|617234303|FG006|Overall Study|Other Reasons|0|||
170788272|NCT05543629|617234304|FG007|Overall Study|Other Reasons|0|||
170788273|NCT05543629|617234297|FG000|Overall Study|Physician Decision|0|||
170889306|NCT03266016|617602196|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
170889307|NCT03266016|617602197|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
170788274|NCT05543629|617234298|FG001|Overall Study|Physician Decision|0|||
170788275|NCT05543629|617234299|FG002|Overall Study|Physician Decision|3|||
170788276|NCT05543629|617234300|FG003|Overall Study|Physician Decision|0|||
170788277|NCT05543629|617234301|FG004|Overall Study|Physician Decision|0|||
170788278|NCT05543629|617234302|FG005|Overall Study|Physician Decision|0|||
170788279|NCT05543629|617234303|FG006|Overall Study|Physician Decision|1|||
170788280|NCT05543629|617234304|FG007|Overall Study|Physician Decision|0|||
170788281|NCT05543629|617234297|FG000|Overall Study|Study terminated by Sponsor|1|||
170788282|NCT05543629|617234298|FG001|Overall Study|Study terminated by Sponsor|0|||
170788283|NCT05543629|617234299|FG002|Overall Study|Study terminated by Sponsor|0|||
170788284|NCT05543629|617234300|FG003|Overall Study|Study terminated by Sponsor|1|||
170543328|NCT00927082|616332858|FG002|Overall Study|Lost to Follow-up|12|||
170543329|NCT00927082|616332859|FG003|Overall Study|Lost to Follow-up|16|||
170543330|NCT00927082|616332856|FG000|Overall Study|Withdrawal by Subject|3|||
170543331|NCT00927082|616332857|FG001|Overall Study|Withdrawal by Subject|2|||
170543332|NCT00927082|616332858|FG002|Overall Study|Withdrawal by Subject|7|||
170543333|NCT00927082|616332859|FG003|Overall Study|Withdrawal by Subject|2|||
170543334|NCT00927082|616332856|FG000|Overall Study|Death|0|||
170543335|NCT00927082|616332857|FG001|Overall Study|Death|0|||
170543336|NCT00927082|616332858|FG002|Overall Study|Death|1|||
170788285|NCT05543629|617234301|FG004|Overall Study|Study terminated by Sponsor|0|||
170543337|NCT00927082|616332859|FG003|Overall Study|Death|0|||
170543338|NCT00927082|616332856|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
170543339|NCT00927082|616332857|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
170543340|NCT00927082|616332858|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
170543341|NCT00927082|616332859|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
170543342|NCT01786109|616332860|FG000|Overall Study|fail manometry barostat tube placement|1|||
170543343|NCT01786109|616332861|FG001|Overall Study|fail manometry barostat tube placement|0|||
170543344|NCT01786109|616332862|FG002|Overall Study|fail manometry barostat tube placement|0|||
170543345|NCT01786109|616332860|FG000|Overall Study|unrelated illness|0|||
170543346|NCT01786109|616332861|FG001|Overall Study|unrelated illness|0|||
170543347|NCT01786109|616332862|FG002|Overall Study|unrelated illness|1|||
170543348|NCT01786109|616332860|FG000|Overall Study|adverse effects colon preparation|0|||
170788286|NCT05543629|617234302|FG005|Overall Study|Study terminated by Sponsor|4|||
170788287|NCT05543629|617234303|FG006|Overall Study|Study terminated by Sponsor|1|||
170788288|NCT05543629|617234304|FG007|Overall Study|Study terminated by Sponsor|0|||
170788289|NCT05543629|617234297|FG000|Overall Study|Withdrawal by Subject|1|||
170788290|NCT05543629|617234298|FG001|Overall Study|Withdrawal by Subject|1|||
170788291|NCT05543629|617234299|FG002|Overall Study|Withdrawal by Subject|0|||
170788292|NCT05543629|617234300|FG003|Overall Study|Withdrawal by Subject|2|||
170788293|NCT05543629|617234301|FG004|Overall Study|Withdrawal by Subject|1|||
170788294|NCT05543629|617234302|FG005|Overall Study|Withdrawal by Subject|1|||
170788295|NCT05543629|617234303|FG006|Overall Study|Withdrawal by Subject|1|||
170788296|NCT05543629|617234304|FG007|Overall Study|Withdrawal by Subject|1|||
170788297|NCT05543629|617234297|FG000|Overall Study|Not Reported|2|||
170788298|NCT05543629|617234298|FG001|Overall Study|Not Reported|2|||
170788299|NCT05543629|617234299|FG002|Overall Study|Not Reported|0|||
170788300|NCT05543629|617234300|FG003|Overall Study|Not Reported|0|||
170788301|NCT05543629|617234301|FG004|Overall Study|Not Reported|1|||
170788302|NCT05543629|617234302|FG005|Overall Study|Not Reported|1|||
170788303|NCT05543629|617234303|FG006|Overall Study|Not Reported|3|||
170788304|NCT05543629|617234304|FG007|Overall Study|Not Reported|0|||
170788305|NCT04568603|617234305|FG000|Overall Study|Physician Decision|1|||
170788306|NCT03270501|617234307|FG000|Overall Study|Screen failure|6|||
170788307|NCT03270501|617234307|FG000|Overall Study|Lost to Follow-up|2|||
170788308|NCT03270501|617234307|FG000|Overall Study|Adverse Event|1|||
170788309|NCT05296525|617234311|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
170788310|NCT05296525|617234312|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
170788311|NCT05296525|617234313|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
170788312|NCT05296525|617234314|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
170788313|NCT02465268|617234320|FG000|Overall Study|Withdrawal by Subject|4|||
170788314|NCT02465268|617234321|FG001|Overall Study|Withdrawal by Subject|3|||
170788315|NCT02465268|617234322|FG002|Overall Study|Withdrawal by Subject|1|||
170788316|NCT02465268|617234320|FG000|Overall Study|Not evaluable per protocol criteria|3|||
170788317|NCT02465268|617234321|FG001|Overall Study|Not evaluable per protocol criteria|2|||
170788318|NCT02465268|617234322|FG002|Overall Study|Not evaluable per protocol criteria|1|||
170788319|NCT02465268|617234320|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
170788320|NCT02465268|617234321|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
170788321|NCT02465268|617234322|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
170788322|NCT02465268|617234320|FG000|Overall Study|Study drug did not pass QA/QC|1|||
170788323|NCT02465268|617234321|FG001|Overall Study|Study drug did not pass QA/QC|0|||
170788324|NCT02465268|617234322|FG002|Overall Study|Study drug did not pass QA/QC|0|||
170543349|NCT01786109|616332861|FG001|Overall Study|adverse effects colon preparation|0|||
170543350|NCT01786109|616332862|FG002|Overall Study|adverse effects colon preparation|1|||
170543351|NCT02513563|616332865|FG000|Overall Study|Death|4|||
170788325|NCT02465268|617234320|FG000|Overall Study|Adverse Event|0|||
170788326|NCT02465268|617234321|FG001|Overall Study|Adverse Event|1|||
170788327|NCT02465268|617234322|FG002|Overall Study|Adverse Event|0|||
170788328|NCT02465268|617234320|FG000|Overall Study|Physician Decision|0|||
170788329|NCT02465268|617234321|FG001|Overall Study|Physician Decision|1|||
170788330|NCT02465268|617234322|FG002|Overall Study|Physician Decision|0|||
170543352|NCT02513563|616332865|FG000|Overall Study|Withdrawal by Subject|4|||
170543353|NCT02513563|616332865|FG000|Overall Study|Physician Decision|1|||
170543354|NCT06132386|616332870|FG000|Overall Study|ineligble laboratory|1|||
170543355|NCT06132386|616332871|FG001|Overall Study|ineligble laboratory|0|||
170889308|NCT00482014|617602198|FG000|Overall Study|Withdrawal by Subject|1|||
170889309|NCT00482014|617602199|FG001|Overall Study|Withdrawal by Subject|2|||
170889310|NCT00482014|617602200|FG002|Overall Study|Withdrawal by Subject|3|||
170889311|NCT00482014|617602201|FG003|Overall Study|Withdrawal by Subject|4|||
170889312|NCT00482014|617602198|FG000|Overall Study|Adverse Event|3|||
170889313|NCT00482014|617602199|FG001|Overall Study|Adverse Event|0|||
170889314|NCT00482014|617602200|FG002|Overall Study|Adverse Event|2|||
170889315|NCT00482014|617602201|FG003|Overall Study|Adverse Event|8|||
170889316|NCT00482014|617602198|FG000|Overall Study|Death|1|||
170889317|NCT00482014|617602199|FG001|Overall Study|Death|2|||
170889318|NCT00482014|617602200|FG002|Overall Study|Death|1|||
170889319|NCT00482014|617602201|FG003|Overall Study|Death|4|||
170889320|NCT00482014|617602198|FG000|Overall Study|Lack of Efficacy|1|||
170889321|NCT00482014|617602199|FG001|Overall Study|Lack of Efficacy|0|||
170889322|NCT00482014|617602200|FG002|Overall Study|Lack of Efficacy|4|||
170889323|NCT00482014|617602201|FG003|Overall Study|Lack of Efficacy|6|||
170889324|NCT00482014|617602198|FG000|Overall Study|Sponsor Decision|1|||
170889325|NCT00482014|617602199|FG001|Overall Study|Sponsor Decision|2|||
170889326|NCT00482014|617602200|FG002|Overall Study|Sponsor Decision|1|||
170889327|NCT00482014|617602201|FG003|Overall Study|Sponsor Decision|1|||
170889328|NCT02527707|617602202|FG000|Overall Study|Adverse Event|1|||
170889329|NCT02527707|617602202|FG000|Overall Study|Adverse Event|1|||
170889330|NCT01299766|617602203|FG000|Overall Study|Death|5|||
170889331|NCT01299766|617602204|FG001|Overall Study|Death|4|||
170889332|NCT01299766|617602203|FG000|Overall Study|Withdrawal by Subject|29|||
170459880|NCT00444457|616026814|FG000|Infant Series|Other|0|||
170459881|NCT00444457|616026815|FG001|Infant Series|Other|1|||
170459882|NCT00444457|616026816|FG002|Infant Series|Other|0|||
170459883|NCT00444457|616026817|FG003|Infant Series|Other|0|||
170459884|NCT00444457|616026814|FG000|Infant Series|Parent or legal guardian request|18|||
170459885|NCT00444457|616026815|FG001|Infant Series|Parent or legal guardian request|29|||
170459886|NCT00444457|616026816|FG002|Infant Series|Parent or legal guardian request|34|||
170459887|NCT00444457|616026817|FG003|Infant Series|Parent or legal guardian request|14|||
170459888|NCT00444457|616026814|FG000|Infant Series|Lost to Follow-up|10|||
170459889|NCT00444457|616026815|FG001|Infant Series|Lost to Follow-up|11|||
170459890|NCT00444457|616026816|FG002|Infant Series|Lost to Follow-up|7|||
170459891|NCT00444457|616026817|FG003|Infant Series|Lost to Follow-up|6|||
170459892|NCT00444457|616026814|FG000|Infant Series|Protocol Violation|16|||
170459893|NCT00444457|616026815|FG001|Infant Series|Protocol Violation|8|||
170459894|NCT00444457|616026816|FG002|Infant Series|Protocol Violation|6|||
170459895|NCT00444457|616026817|FG003|Infant Series|Protocol Violation|3|||
170459896|NCT00444457|616026814|FG000|Infant Series|Failed to return|5|||
170459897|NCT00444457|616026815|FG001|Infant Series|Failed to return|4|||
170459898|NCT00444457|616026816|FG002|Infant Series|Failed to return|4|||
170459899|NCT00444457|616026817|FG003|Infant Series|Failed to return|2|||
170459900|NCT00444457|616026814|FG000|Infant Series|Investigator request|4|||
170459901|NCT00444457|616026815|FG001|Infant Series|Investigator request|3|||
170459902|NCT00444457|616026816|FG002|Infant Series|Investigator request|3|||
170459903|NCT00444457|616026817|FG003|Infant Series|Investigator request|2|||
170459904|NCT00444457|616026814|FG000|Infant Series|Other|0|||
170459905|NCT00444457|616026815|FG001|Infant Series|Other|2|||
170459906|NCT00444457|616026816|FG002|Infant Series|Other|4|||
170459907|NCT00444457|616026817|FG003|Infant Series|Other|0|||
170459908|NCT00444457|616026814|FG000|Infant Series|Adverse Event|1|||
170459909|NCT00444457|616026815|FG001|Infant Series|Adverse Event|2|||
170459910|NCT00444457|616026816|FG002|Infant Series|Adverse Event|2|||
170459911|NCT00444457|616026817|FG003|Infant Series|Adverse Event|0|||
170459912|NCT00444457|616026814|FG000|Infant Series|Death|0|||
170459913|NCT00444457|616026815|FG001|Infant Series|Death|1|||
170459914|NCT00444457|616026816|FG002|Infant Series|Death|1|||
170459915|NCT00444457|616026817|FG003|Infant Series|Death|1|||
170459916|NCT00444457|616026814|FG000|After Infant Series|Other|0|||
170459917|NCT00444457|616026815|FG001|After Infant Series|Other|1|||
170459918|NCT00444457|616026816|FG002|After Infant Series|Other|1|||
170459919|NCT00444457|616026817|FG003|After Infant Series|Other|1|||
170459920|NCT00444457|616026814|FG000|After Infant Series|Parent or legal guardian request|4|||
170459921|NCT00444457|616026815|FG001|After Infant Series|Parent or legal guardian request|11|||
170459922|NCT00444457|616026816|FG002|After Infant Series|Parent or legal guardian request|6|||
170459923|NCT00444457|616026817|FG003|After Infant Series|Parent or legal guardian request|3|||
170636072|NCT01189032|616678938|FG000|Overall Study|Adverse Event|1|||
170889333|NCT01299766|617602204|FG001|Overall Study|Withdrawal by Subject|19|||
170889334|NCT04002310|617602205|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
170889335|NCT04002310|617602206|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
170889336|NCT04002310|617602207|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
170889337|NCT04002310|617602208|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
170889338|NCT04002310|617602209|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
170459924|NCT00444457|616026814|FG000|After Infant Series|Failed to return|7|||
170459925|NCT00444457|616026815|FG001|After Infant Series|Failed to return|6|||
170459926|NCT00444457|616026816|FG002|After Infant Series|Failed to return|5|||
170889339|NCT01916980|617602212|FG000|Overall Study|Adverse Event|4|||
170889340|NCT01916980|617602213|FG001|Overall Study|Adverse Event|2|||
170889341|NCT01916980|617602212|FG000|Overall Study|Lack of Efficacy|2|||
170889342|NCT01916980|617602213|FG001|Overall Study|Lack of Efficacy|2|||
170889343|NCT01916980|617602212|FG000|Overall Study|Withdrawal by Subject|1|||
170889344|NCT01916980|617602213|FG001|Overall Study|Withdrawal by Subject|0|||
170889345|NCT00544869|617602214|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
170889346|NCT00544869|617602215|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
170889347|NCT00544869|617602216|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
170889348|NCT00544869|617602214|FG000|Overall Study|Adverse Event|6|||
170889349|NCT00544869|617602215|FG001|Overall Study|Adverse Event|1|||
170889350|NCT00544869|617602216|FG002|Overall Study|Adverse Event|0|||
170889351|NCT00544869|617602214|FG000|Overall Study|Lack of Efficacy|1|||
170889352|NCT00544869|617602215|FG001|Overall Study|Lack of Efficacy|1|||
170889353|NCT00544869|617602216|FG002|Overall Study|Lack of Efficacy|0|||
170889354|NCT00544869|617602214|FG000|Overall Study|Physician Decision|2|||
170889355|NCT00544869|617602215|FG001|Overall Study|Physician Decision|0|||
170889356|NCT00544869|617602216|FG002|Overall Study|Physician Decision|0|||
170889357|NCT01354028|617602227|FG000|Overall Study|Physician Decision|0|||
170889358|NCT01354028|617602228|FG001|Overall Study|Physician Decision|2|||
170889359|NCT01354028|617602227|FG000|Overall Study|Discharged before study start|2|||
170889360|NCT01354028|617602228|FG001|Overall Study|Discharged before study start|2|||
170889361|NCT01354028|617602227|FG000|Overall Study|No quiet alert state|0|||
170889362|NCT01354028|617602228|FG001|Overall Study|No quiet alert state|1|||
170889363|NCT02894840|617602229|FG000|Overall Study|Lost to Follow-up|1|||
170889364|NCT02894840|617602230|FG001|Overall Study|Lost to Follow-up|0|||
170889365|NCT02894840|617602231|FG002|Overall Study|Lost to Follow-up|3|||
170889366|NCT02894840|617602232|FG003|Overall Study|Lost to Follow-up|0|||
170889367|NCT01072344|617602233|FG000|Overall Study|Relasped-reached end point|7|||
170889368|NCT01072344|617602234|FG001|Overall Study|Relasped-reached end point|12|||
170889369|NCT01072344|617602233|FG000|Overall Study|Protocol Violation|1|||
170889370|NCT01072344|617602234|FG001|Overall Study|Protocol Violation|2|||
170889371|NCT01072344|617602233|FG000|Overall Study|Lost to Follow-up|3|||
170889372|NCT01072344|617602234|FG001|Overall Study|Lost to Follow-up|4|||
170889373|NCT00805740|617602235|FG000|Overall Study|Death|7|||
170889374|NCT00805740|617602236|FG001|Overall Study|Death|4|||
170889375|NCT00805740|617602235|FG000|Overall Study|Withdrawal by Subject|1|||
170889376|NCT00805740|617602236|FG001|Overall Study|Withdrawal by Subject|0|||
170889377|NCT00805740|617602235|FG000|Overall Study|Lost to Follow-up|1|||
170889378|NCT00805740|617602236|FG001|Overall Study|Lost to Follow-up|0|||
170889379|NCT00805740|617602235|FG000|Overall Study|Randomized, but not treated|2|||
170889380|NCT00805740|617602236|FG001|Overall Study|Randomized, but not treated|0|||
170889381|NCT01467492|617602251|FG000|Overall Study|Withdrawal by Subject|6|||
170889382|NCT01467492|617602252|FG001|Overall Study|Withdrawal by Subject|4|||
170889383|NCT01467492|617602251|FG000|Overall Study|Study Terminated by Sponsor|6|||
170889384|NCT01467492|617602252|FG001|Overall Study|Study Terminated by Sponsor|4|||
170889385|NCT01467492|617602251|FG000|Overall Study|Adverse Event|4|||
170889386|NCT01467492|617602252|FG001|Overall Study|Adverse Event|3|||
170889387|NCT01467492|617602251|FG000|Overall Study|Lost to Follow-up|3|||
170889388|NCT01467492|617602252|FG001|Overall Study|Lost to Follow-up|2|||
170889389|NCT01467492|617602251|FG000|Overall Study|Undefined|2|||
170889390|NCT01467492|617602252|FG001|Overall Study|Undefined|0|||
170889391|NCT01467492|617602251|FG000|Overall Study|Enrolled But Not Treated|1|||
170889392|NCT01467492|617602252|FG001|Overall Study|Enrolled But Not Treated|0|||
170889393|NCT00491179|617602253|FG000|Overall Study|Adverse Event|5|||
170889394|NCT00491179|617602254|FG001|Overall Study|Adverse Event|1|||
170889395|NCT00491179|617602253|FG000|Overall Study|Withdrawal by Subject|2|||
170889396|NCT00491179|617602254|FG001|Overall Study|Withdrawal by Subject|1|||
170889397|NCT01491178|617602258|FG000|Overall Study|Adverse Event|1016|||
170543356|NCT06132386|616332872|FG002|Overall Study|ineligble laboratory|0|||
170543357|NCT06132386|616332873|FG003|Overall Study|ineligble laboratory|0|||
170543358|NCT06132386|616332874|FG004|Overall Study|ineligble laboratory|1|||
170543359|NCT06132386|616332875|FG005|Overall Study|ineligble laboratory|0|||
170543360|NCT06132386|616332870|FG000|Overall Study|ineligible vital signs|0|||
170543361|NCT06132386|616332871|FG001|Overall Study|ineligible vital signs|1|||
170543362|NCT06132386|616332872|FG002|Overall Study|ineligible vital signs|0|||
170543363|NCT06132386|616332873|FG003|Overall Study|ineligible vital signs|0|||
170543364|NCT06132386|616332874|FG004|Overall Study|ineligible vital signs|0|||
170543365|NCT06132386|616332875|FG005|Overall Study|ineligible vital signs|0|||
170889398|NCT01491178|617602258|FG000|Overall Study|Improvement of NVAF|210|||
170889399|NCT01491178|617602258|FG000|Overall Study|To conduct invasive treatment|59|||
170889400|NCT01491178|617602258|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
170889401|NCT01491178|617602258|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
170889402|NCT01491178|617602258|FG000|Overall Study|To take a contraindication|20|||
170889403|NCT01491178|617602258|FG000|Overall Study|Other than specified above|657|||
170889404|NCT03132636|617602261|FG000|Overall Study|Adverse Event|1|||
170543366|NCT02949934|616332878|FG000|Natural Drinking Period|Adverse Event|1|||
170636073|NCT01189032|616678939|FG001|Overall Study|Adverse Event|3|||
170889405|NCT03132636|617602262|FG001|Overall Study|Adverse Event|2|||
170889406|NCT03132636|617602261|FG000|Overall Study|Death|4|||
170889407|NCT03132636|617602262|FG001|Overall Study|Death|7|||
170889408|NCT03132636|617602261|FG000|Overall Study|Lost to Follow-up|3|||
170889409|NCT03132636|617602262|FG001|Overall Study|Lost to Follow-up|2|||
170889410|NCT03132636|617602261|FG000|Overall Study|Non compliance with protocol by participant|1|||
170889411|NCT03132636|617602262|FG001|Overall Study|Non compliance with protocol by participant|1|||
170889412|NCT03132636|617602261|FG000|Overall Study|Subject decision|1|||
170889413|NCT03132636|617602262|FG001|Overall Study|Subject decision|9|||
170889414|NCT03132636|617602261|FG000|Overall Study|Sponsor decision|0|||
170889415|NCT03132636|617602262|FG001|Overall Study|Sponsor decision|1|||
170889416|NCT03132636|617602261|FG000|Overall Study|Physician Decision|1|||
170889417|NCT03132636|617602262|FG001|Overall Study|Physician Decision|0|||
170889418|NCT03132636|617602261|FG000|Overall Study|Progressive disease|33|||
170889419|NCT03132636|617602262|FG001|Overall Study|Progressive disease|36|||
170889420|NCT03132636|617602261|FG000|Overall Study|Withdrawal of consent|2|||
170889421|NCT03132636|617602262|FG001|Overall Study|Withdrawal of consent|5|||
170889422|NCT03132636|617602261|FG000|Overall Study|Did not re-consent|1|||
170889423|NCT03132636|617602262|FG001|Overall Study|Did not re-consent|0|||
170889424|NCT03132636|617602261|FG000|Overall Study|Lost insurance coverage|1|||
170889425|NCT03132636|617602262|FG001|Overall Study|Lost insurance coverage|0|||
170889426|NCT03132636|617602261|FG000|Overall Study|Related to radiological outcomes|0|||
170889427|NCT03132636|617602262|FG001|Overall Study|Related to radiological outcomes|1|||
170889428|NCT03132636|617602261|FG000|Overall Study|Unable to come to site for continued visits|0|||
170889429|NCT03132636|617602262|FG001|Overall Study|Unable to come to site for continued visits|1|||
170889430|NCT01453855|617602263|FG000|Overall Study|Adverse Event|3|||
170889431|NCT01453855|617602264|FG001|Overall Study|Adverse Event|4|||
170889432|NCT01453855|617602263|FG000|Overall Study|Lost to Follow-up|2|||
170889433|NCT01453855|617602264|FG001|Overall Study|Lost to Follow-up|1|||
170889434|NCT01453855|617602263|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
170889435|NCT01453855|617602264|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
170889436|NCT01453855|617602263|FG000|Overall Study|Noncompliance|1|||
170889437|NCT01453855|617602264|FG001|Overall Study|Noncompliance|0|||
170889438|NCT01453855|617602263|FG000|Overall Study|Inadequate Control of IOP|1|||
170889439|NCT01453855|617602264|FG001|Overall Study|Inadequate Control of IOP|5|||
170889440|NCT01453855|617602263|FG000|Overall Study|Other|0|||
170889441|NCT01453855|617602264|FG001|Overall Study|Other|1|||
170889442|NCT00209339|617602267|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
170889443|NCT00209339|617602267|FG000|At 12 Months Follow-up|Death|1|||
170889444|NCT00209339|617602267|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
170889445|NCT00209339|617602267|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
170889446|NCT00209339|617602267|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
170889447|NCT00209339|617602267|FG000|At 24 Months Follow-up|Death|1|||
170889448|NCT00209339|617602267|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
170889449|NCT00209339|617602267|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
170889450|NCT00209339|617602267|FG000|At 4 Years Follow-up|Death|1|||
170889451|NCT00209339|617602267|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
170889452|NCT00209339|617602267|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
170889453|NCT00209339|617602267|FG000|At 5 Years Follow-up|Death|1|||
170889454|NCT01587079|617602268|FG000|Overall Study|Protocol-specified criteria|9|||
170889455|NCT01587079|617602268|FG000|Overall Study|Protocol Violation|5|||
170889456|NCT01587079|617602268|FG000|Overall Study|Lost to Follow-up|2|||
170889457|NCT01587079|617602268|FG000|Overall Study|Physician Decision|2|||
170889458|NCT01587079|617602268|FG000|Overall Study|Withdrawal by Subject|7|||
170889459|NCT01587079|617602268|FG000|Overall Study|Adverse Event|14|||
170889460|NCT01239160|617602269|FG000|Overall Study|Lost to Follow-up|3|||
170543367|NCT02949934|616332879|FG001|Natural Drinking Period|Adverse Event|0|||
170543368|NCT02949934|616332880|FG002|Natural Drinking Period|Adverse Event|0|||
170543369|NCT02949934|616332881|FG003|Natural Drinking Period|Adverse Event|1|||
170543370|NCT02949934|616332882|FG004|Natural Drinking Period|Adverse Event|0|||
170543371|NCT02949934|616332883|FG005|Natural Drinking Period|Adverse Event|0|||
170543372|NCT02949934|616332878|FG000|Natural Drinking Period|Lost to Follow-up|0|||
170543373|NCT02949934|616332879|FG001|Natural Drinking Period|Lost to Follow-up|0|||
170889461|NCT01239160|617602270|FG001|Overall Study|Lost to Follow-up|5|||
170889462|NCT01239160|617602271|FG002|Overall Study|Lost to Follow-up|0|||
170889463|NCT01239160|617602269|FG000|Overall Study|Withdrawal by Subject|17|||
170543374|NCT02949934|616332880|FG002|Natural Drinking Period|Lost to Follow-up|0|||
170889464|NCT01239160|617602270|FG001|Overall Study|Withdrawal by Subject|6|||
170889465|NCT01239160|617602271|FG002|Overall Study|Withdrawal by Subject|2|||
170889466|NCT01239160|617602269|FG000|Overall Study|Physician Decision|5|||
170889467|NCT01239160|617602270|FG001|Overall Study|Physician Decision|7|||
170889468|NCT01239160|617602271|FG002|Overall Study|Physician Decision|2|||
170889469|NCT01239160|617602269|FG000|Overall Study|Early Termination Due to Study Closure|0|||
170889470|NCT01239160|617602270|FG001|Overall Study|Early Termination Due to Study Closure|1|||
170889471|NCT01239160|617602271|FG002|Overall Study|Early Termination Due to Study Closure|6|||
170889472|NCT02062658|617602273|FG000|Overall Study|Withdrawal by Subject|1|||
170889473|NCT02062658|617602273|FG000|Overall Study|Lack of Efficacy|1|||
170889474|NCT02499029|617602274|FG000|Overall Study|Lost to Follow-up|2|||
170889475|NCT02499029|617602275|FG001|Overall Study|Lost to Follow-up|2|||
170889476|NCT02499029|617602274|FG000|Overall Study|Physician Decision|2|||
170889477|NCT02499029|617602275|FG001|Overall Study|Physician Decision|1|||
170889478|NCT02499029|617602274|FG000|Overall Study|Death|1|||
170889479|NCT02499029|617602275|FG001|Overall Study|Death|0|||
170889480|NCT02462473|617602276|FG000|Overall Study|Death|1|||
170889481|NCT02462473|617602276|FG000|Overall Study|Other|3|||
170889482|NCT02161211|617602277|FG000|Overall Study|Lost to Follow-up|21|||
170889483|NCT02161211|617602278|FG001|Overall Study|Lost to Follow-up|27|||
170889484|NCT02161211|617602279|FG002|Overall Study|Lost to Follow-up|21|||
170889485|NCT02161211|617602277|FG000|Overall Study|Dropped|12|||
170889486|NCT02161211|617602278|FG001|Overall Study|Dropped|5|||
170889487|NCT02161211|617602279|FG002|Overall Study|Dropped|9|||
170889488|NCT01707693|617602283|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
170889489|NCT01707693|617602284|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
170889490|NCT01707693|617602283|FG000|Overall Study Allocation|Protocol Violation|4|||
170889491|NCT01707693|617602284|FG001|Overall Study Allocation|Protocol Violation|3|||
170889492|NCT01707693|617602283|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
170889493|NCT01707693|617602284|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
170889494|NCT01707693|617602283|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
170889495|NCT01707693|617602284|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
170889496|NCT03115151|617602286|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
170889497|NCT03115151|617602287|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
170889498|NCT03115151|617602286|FG000|Overall Study|Epidural catheter removal|1|||
170889499|NCT03115151|617602287|FG001|Overall Study|Epidural catheter removal|0|||
170889500|NCT03115151|617602286|FG000|Overall Study|Withdrawal by Subject|0|||
170889501|NCT03115151|617602287|FG001|Overall Study|Withdrawal by Subject|1|||
170889502|NCT03115151|617602286|FG000|Overall Study|Intervention not received according to the protocol.|1|||
170889503|NCT03115151|617602287|FG001|Overall Study|Intervention not received according to the protocol.|1|||
170889504|NCT03115151|617602286|FG000|Overall Study|Physician Decision|1|||
170889505|NCT03115151|617602287|FG001|Overall Study|Physician Decision|0|||
170889506|NCT03115151|617602286|FG000|Overall Study|Randomization not applied|1|||
170889507|NCT03115151|617602287|FG001|Overall Study|Randomization not applied|1|||
170889508|NCT00763321|617602290|FG000|Open-label Period|Adverse Event|24|||
170889509|NCT00763321|617602291|FG001|Open-label Period|Adverse Event|0|||
170889510|NCT00763321|617602292|FG002|Open-label Period|Adverse Event|0|||
170889511|NCT00763321|617602290|FG000|Open-label Period|Lost to Follow-up|14|||
170889512|NCT00763321|617602291|FG001|Open-label Period|Lost to Follow-up|0|||
170889513|NCT00763321|617602292|FG002|Open-label Period|Lost to Follow-up|0|||
170889514|NCT00763321|617602290|FG000|Open-label Period|Withdrawal by Subject|7|||
170889515|NCT00763321|617602291|FG001|Open-label Period|Withdrawal by Subject|0|||
170889516|NCT00763321|617602292|FG002|Open-label Period|Withdrawal by Subject|0|||
170889517|NCT00763321|617602290|FG000|Open-label Period|Subject noncompliant|7|||
170889518|NCT00763321|617602291|FG001|Open-label Period|Subject noncompliant|0|||
170889519|NCT00763321|617602292|FG002|Open-label Period|Subject noncompliant|0|||
170889520|NCT00763321|617602290|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
170889521|NCT00763321|617602291|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
170889522|NCT00763321|617602292|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
170889523|NCT00763321|617602290|FG000|Open-label Period|Lack of Efficacy|2|||
170889524|NCT00763321|617602291|FG001|Open-label Period|Lack of Efficacy|0|||
170889525|NCT00763321|617602292|FG002|Open-label Period|Lack of Efficacy|0|||
170889526|NCT00763321|617602290|FG000|Open-label Period|Other|4|||
170889527|NCT00763321|617602291|FG001|Open-label Period|Other|0|||
170889528|NCT00763321|617602292|FG002|Open-label Period|Other|0|||
170889529|NCT00763321|617602290|FG000|Double-blind Period|Lack of Efficacy|0|||
170889530|NCT00763321|617602291|FG001|Double-blind Period|Lack of Efficacy|9|||
170889531|NCT00763321|617602292|FG002|Double-blind Period|Lack of Efficacy|17|||
170543375|NCT02949934|616332881|FG003|Natural Drinking Period|Lost to Follow-up|0|||
170889532|NCT00763321|617602290|FG000|Double-blind Period|Adverse Event|0|||
170889533|NCT00763321|617602291|FG001|Double-blind Period|Adverse Event|4|||
170889534|NCT00763321|617602292|FG002|Double-blind Period|Adverse Event|4|||
170889535|NCT00763321|617602290|FG000|Double-blind Period|Lost to Follow-up|0|||
170543376|NCT02949934|616332882|FG004|Natural Drinking Period|Lost to Follow-up|1|||
170543377|NCT02949934|616332883|FG005|Natural Drinking Period|Lost to Follow-up|0|||
170543378|NCT02949934|616332878|FG000|Neuroimaging|Protocol Violation|2|||
170889536|NCT00763321|617602291|FG001|Double-blind Period|Lost to Follow-up|4|||
170889537|NCT00763321|617602292|FG002|Double-blind Period|Lost to Follow-up|2|||
170889538|NCT00763321|617602290|FG000|Double-blind Period|Withdrawal by Subject|0|||
170889539|NCT00763321|617602291|FG001|Double-blind Period|Withdrawal by Subject|2|||
170889540|NCT00763321|617602292|FG002|Double-blind Period|Withdrawal by Subject|3|||
170889541|NCT00763321|617602290|FG000|Double-blind Period|Other|0|||
170889542|NCT00763321|617602291|FG001|Double-blind Period|Other|2|||
170889543|NCT00763321|617602292|FG002|Double-blind Period|Other|3|||
170889544|NCT02486757|617602293|FG000|Overall Study|Lost to Follow-up|1|||
170889545|NCT04673786|617602294|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
170889546|NCT04673786|617602295|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
170889547|NCT04673786|617602296|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
170889548|NCT04673786|617602294|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
170889549|NCT04673786|617602295|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
170889550|NCT04673786|617602296|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
170889551|NCT04673786|617602294|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
170889552|NCT04673786|617602295|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
170889553|NCT04673786|617602296|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
170889554|NCT04673786|617602294|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
170889555|NCT04673786|617602295|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
170889556|NCT04673786|617602296|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
170889557|NCT04673786|617602294|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
170889558|NCT04673786|617602295|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
170889559|NCT04673786|617602296|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
170889560|NCT04673786|617602294|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
170889561|NCT04673786|617602295|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
170889562|NCT04673786|617602296|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
170889563|NCT00143455|617602297|FG000|Cohort 1|Adverse Event|8|||
170889564|NCT00143455|617602298|FG001|Cohort 1|Adverse Event|4|||
170889565|NCT00143455|617602299|FG002|Cohort 1|Adverse Event|0|||
170889566|NCT00143455|617602300|FG003|Cohort 1|Adverse Event|0|||
170889567|NCT00143455|617602297|FG000|Cohort 1|Death|5|||
170889568|NCT00143455|617602298|FG001|Cohort 1|Death|2|||
170889569|NCT00143455|617602299|FG002|Cohort 1|Death|0|||
170889570|NCT00143455|617602300|FG003|Cohort 1|Death|0|||
170889571|NCT00143455|617602297|FG000|Cohort 1|Progressive Disease|0|||
170889572|NCT00143455|617602298|FG001|Cohort 1|Progressive Disease|6|||
170889573|NCT00143455|617602299|FG002|Cohort 1|Progressive Disease|0|||
170889574|NCT00143455|617602300|FG003|Cohort 1|Progressive Disease|0|||
170459927|NCT00444457|616026817|FG003|After Infant Series|Failed to return|1|||
170459928|NCT00444457|616026814|FG000|After Infant Series|Lost to Follow-up|5|||
170459929|NCT00444457|616026815|FG001|After Infant Series|Lost to Follow-up|5|||
170459930|NCT00444457|616026816|FG002|After Infant Series|Lost to Follow-up|5|||
170459931|NCT00444457|616026817|FG003|After Infant Series|Lost to Follow-up|2|||
170889575|NCT00143455|617602297|FG000|Cohort 1|Withdrawal by Subject|1|||
170889576|NCT00143455|617602298|FG001|Cohort 1|Withdrawal by Subject|4|||
170889577|NCT00143455|617602299|FG002|Cohort 1|Withdrawal by Subject|0|||
170889578|NCT00143455|617602300|FG003|Cohort 1|Withdrawal by Subject|0|||
170889579|NCT00143455|617602297|FG000|Cohort 1|Randomized But Not Treated|0|||
170889580|NCT00143455|617602298|FG001|Cohort 1|Randomized But Not Treated|1|||
170889581|NCT00143455|617602299|FG002|Cohort 1|Randomized But Not Treated|0|||
170889582|NCT00143455|617602300|FG003|Cohort 1|Randomized But Not Treated|0|||
170889583|NCT00143455|617602297|FG000|Cohort 2|Adverse Event|0|||
170889584|NCT00143455|617602298|FG001|Cohort 2|Adverse Event|0|||
170889585|NCT00143455|617602299|FG002|Cohort 2|Adverse Event|42|||
170889586|NCT00143455|617602300|FG003|Cohort 2|Adverse Event|30|||
170889587|NCT00143455|617602297|FG000|Cohort 2|No Longer Required Study Treatment|0|||
170889588|NCT00143455|617602298|FG001|Cohort 2|No Longer Required Study Treatment|0|||
170889589|NCT00143455|617602299|FG002|Cohort 2|No Longer Required Study Treatment|1|||
170889590|NCT00143455|617602300|FG003|Cohort 2|No Longer Required Study Treatment|0|||
170889591|NCT00143455|617602297|FG000|Cohort 2|Protocol Violation|0|||
170889592|NCT00143455|617602298|FG001|Cohort 2|Protocol Violation|0|||
170889593|NCT00143455|617602299|FG002|Cohort 2|Protocol Violation|1|||
170459932|NCT00444457|616026814|FG000|After Infant Series|Protocol Violation|2|||
170459933|NCT00444457|616026815|FG001|After Infant Series|Protocol Violation|4|||
170459934|NCT00444457|616026816|FG002|After Infant Series|Protocol Violation|2|||
170459935|NCT00444457|616026817|FG003|After Infant Series|Protocol Violation|2|||
170459936|NCT00444457|616026814|FG000|After Infant Series|Adverse Event|2|||
170459937|NCT00444457|616026815|FG001|After Infant Series|Adverse Event|2|||
170459938|NCT00444457|616026816|FG002|After Infant Series|Adverse Event|0|||
170459939|NCT00444457|616026817|FG003|After Infant Series|Adverse Event|0|||
170459940|NCT00444457|616026814|FG000|After Infant Series|Investigator request|0|||
170459941|NCT00444457|616026815|FG001|After Infant Series|Investigator request|0|||
170459942|NCT00444457|616026816|FG002|After Infant Series|Investigator request|0|||
170459943|NCT00444457|616026817|FG003|After Infant Series|Investigator request|1|||
170459944|NCT00444457|616026814|FG000|After Infant Series|Other|0|||
170459945|NCT00444457|616026815|FG001|After Infant Series|Other|1|||
170459946|NCT00444457|616026816|FG002|After Infant Series|Other|0|||
170459947|NCT00444457|616026817|FG003|After Infant Series|Other|0|||
170459948|NCT00444457|616026814|FG000|Toddler Dose|Lost to Follow-up|4|||
170459949|NCT00444457|616026815|FG001|Toddler Dose|Lost to Follow-up|1|||
170459950|NCT00444457|616026816|FG002|Toddler Dose|Lost to Follow-up|1|||
170459951|NCT00444457|616026817|FG003|Toddler Dose|Lost to Follow-up|3|||
170459952|NCT00444457|616026814|FG000|Toddler Dose|Failed to return|2|||
170459953|NCT00444457|616026815|FG001|Toddler Dose|Failed to return|2|||
170459954|NCT00444457|616026816|FG002|Toddler Dose|Failed to return|1|||
170459955|NCT00444457|616026817|FG003|Toddler Dose|Failed to return|3|||
170459956|NCT00444457|616026814|FG000|Toddler Dose|Parent or legal guardian request|0|||
170459957|NCT00444457|616026815|FG001|Toddler Dose|Parent or legal guardian request|3|||
170459958|NCT00444457|616026816|FG002|Toddler Dose|Parent or legal guardian request|2|||
170459959|NCT00444457|616026817|FG003|Toddler Dose|Parent or legal guardian request|1|||
170459960|NCT00444457|616026814|FG000|Toddler Dose|Protocol Violation|1|||
170459961|NCT00444457|616026815|FG001|Toddler Dose|Protocol Violation|0|||
170459962|NCT00444457|616026816|FG002|Toddler Dose|Protocol Violation|0|||
170459963|NCT00444457|616026817|FG003|Toddler Dose|Protocol Violation|1|||
170459964|NCT00914459|616026820|FG000|Overall Study|Protocol Violation|0|||
170459965|NCT00914459|616026821|FG001|Overall Study|Protocol Violation|1|||
170459966|NCT00914459|616026820|FG000|Overall Study|Parent/Legal guardian request|1|||
170459967|NCT00914459|616026821|FG001|Overall Study|Parent/Legal guardian request|0|||
170459968|NCT01970865|616026822|FG000|Overall Study|Death|3|||
170459969|NCT01970865|616026823|FG001|Overall Study|Death|2|||
170459970|NCT01970865|616026824|FG002|Overall Study|Death|3|||
170788331|NCT02547363|617234329|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
170788332|NCT02547363|617234330|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
170788333|NCT02547363|617234329|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
170788334|NCT02547363|617234330|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
170788335|NCT02547363|617234329|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
170788336|NCT02547363|617234330|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
170788337|NCT02547363|617234329|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
170889594|NCT00143455|617602300|FG003|Cohort 2|Protocol Violation|1|||
170889595|NCT00143455|617602297|FG000|Cohort 2|Lost to Follow-up|0|||
170889596|NCT00143455|617602298|FG001|Cohort 2|Lost to Follow-up|0|||
170889597|NCT00143455|617602299|FG002|Cohort 2|Lost to Follow-up|1|||
170889598|NCT00143455|617602300|FG003|Cohort 2|Lost to Follow-up|4|||
170889599|NCT00143455|617602297|FG000|Cohort 2|Death|0|||
170889600|NCT00143455|617602298|FG001|Cohort 2|Death|0|||
170889601|NCT00143455|617602299|FG002|Cohort 2|Death|20|||
170889602|NCT00143455|617602300|FG003|Cohort 2|Death|12|||
170889603|NCT00143455|617602297|FG000|Cohort 2|Progressive Disease|0|||
170889604|NCT00143455|617602298|FG001|Cohort 2|Progressive Disease|0|||
170889605|NCT00143455|617602299|FG002|Cohort 2|Progressive Disease|20|||
170889606|NCT00143455|617602300|FG003|Cohort 2|Progressive Disease|27|||
170889607|NCT00143455|617602297|FG000|Cohort 2|Withdrawal by Subject|0|||
170889608|NCT00143455|617602298|FG001|Cohort 2|Withdrawal by Subject|0|||
170889609|NCT00143455|617602299|FG002|Cohort 2|Withdrawal by Subject|13|||
170889610|NCT00143455|617602300|FG003|Cohort 2|Withdrawal by Subject|12|||
170889611|NCT00143455|617602297|FG000|Cohort 2|Other|0|||
170889612|NCT00143455|617602298|FG001|Cohort 2|Other|0|||
170889613|NCT00143455|617602299|FG002|Cohort 2|Other|7|||
170889614|NCT00143455|617602300|FG003|Cohort 2|Other|6|||
170889615|NCT00143455|617602297|FG000|Cohort 2|Randomized But Not Treated|0|||
170889616|NCT00143455|617602298|FG001|Cohort 2|Randomized But Not Treated|0|||
170889617|NCT00143455|617602299|FG002|Cohort 2|Randomized But Not Treated|1|||
170889618|NCT00143455|617602300|FG003|Cohort 2|Randomized But Not Treated|1|||
170889619|NCT02925156|617602313|FG000|Overall Study|Lost to Follow-up|27|||
170889620|NCT02925156|617602314|FG001|Overall Study|Lost to Follow-up|53|||
170889621|NCT02925156|617602315|FG002|Overall Study|Lost to Follow-up|51|||
170889622|NCT02925156|617602316|FG003|Overall Study|Lost to Follow-up|59|||
170889623|NCT02925156|617602317|FG004|Overall Study|Lost to Follow-up|89|||
170889624|NCT02925156|617602318|FG005|Overall Study|Lost to Follow-up|107|||
170889625|NCT02925156|617602319|FG006|Overall Study|Lost to Follow-up|34|||
170889626|NCT02925156|617602320|FG007|Overall Study|Lost to Follow-up|36|||
170889627|NCT02925156|617602321|FG008|Overall Study|Lost to Follow-up|73|||
170889628|NCT02925156|617602322|FG009|Overall Study|Lost to Follow-up|34|||
170889629|NCT00516737|617602324|FG000|Overall Study|Lost to Follow-up|2|||
170889630|NCT00516737|617602325|FG001|Overall Study|Lost to Follow-up|0|||
170889631|NCT00516737|617602324|FG000|Overall Study|Physician Decision|0|||
170889632|NCT00516737|617602325|FG001|Overall Study|Physician Decision|1|||
170889633|NCT00516737|617602324|FG000|Overall Study|Withdrawal by Subject|0|||
170889634|NCT00516737|617602325|FG001|Overall Study|Withdrawal by Subject|1|||
170889635|NCT00516737|617602324|FG000|Overall Study|Lack of Qualifying Event|9|||
170889636|NCT00516737|617602325|FG001|Overall Study|Lack of Qualifying Event|6|||
170889637|NCT00848354|617602326|FG000|Phase 1|Adverse Event|5|||
170889638|NCT00848354|617602327|FG001|Phase 1|Adverse Event|4|||
170889639|NCT00848354|617602326|FG000|Phase 1|Discontinuation of study by sponsor|2|||
170889640|NCT00848354|617602327|FG001|Phase 1|Discontinuation of study by sponsor|1|||
170889641|NCT00848354|617602326|FG000|Phase 1|Failed to return|0|||
170889642|NCT00848354|617602327|FG001|Phase 1|Failed to return|1|||
170889643|NCT00848354|617602326|FG000|Phase 1|Lost to Follow-up|1|||
170889644|NCT00848354|617602327|FG001|Phase 1|Lost to Follow-up|1|||
170889645|NCT00848354|617602326|FG000|Phase 1|Unspecified Reason|1|||
170889646|NCT00848354|617602327|FG001|Phase 1|Unspecified Reason|1|||
170889647|NCT00848354|617602326|FG000|Phase 1|Protocol Violation|1|||
170889648|NCT00848354|617602327|FG001|Phase 1|Protocol Violation|1|||
170889649|NCT00848354|617602326|FG000|Phase 1|Withdrawal by Subject|2|||
170889650|NCT00848354|617602327|FG001|Phase 1|Withdrawal by Subject|4|||
170889651|NCT00848354|617602326|FG000|Phase 1|Lack of Efficacy|0|||
170889652|NCT00848354|617602327|FG001|Phase 1|Lack of Efficacy|1|||
170889653|NCT00848354|617602326|FG000|Phase 2 Year 1|Adverse Event|7|||
170889654|NCT00848354|617602327|FG001|Phase 2 Year 1|Adverse Event|2|||
170889655|NCT00848354|617602326|FG000|Phase 2 Year 1|Death|1|||
170889656|NCT00848354|617602327|FG001|Phase 2 Year 1|Death|0|||
170889657|NCT00848354|617602326|FG000|Phase 2 Year 1|Failed to Return|1|||
170889658|NCT00848354|617602327|FG001|Phase 2 Year 1|Failed to Return|1|||
170889659|NCT00848354|617602326|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
170889660|NCT00848354|617602327|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
170459971|NCT01970865|616026825|FG003|Overall Study|Death|6|||
170459972|NCT01970865|616026826|FG004|Overall Study|Death|9|||
170459973|NCT01970865|616026827|FG005|Overall Study|Death|3|||
170459974|NCT01970865|616026828|FG006|Overall Study|Death|2|||
170459975|NCT01970865|616026829|FG007|Overall Study|Death|3|||
170459976|NCT01970865|616026830|FG008|Overall Study|Death|2|||
170889661|NCT00848354|617602326|FG000|Phase 2 Year 1|Unspecified Reason|3|||
170889662|NCT00848354|617602327|FG001|Phase 2 Year 1|Unspecified Reason|0|||
170889663|NCT00848354|617602326|FG000|Phase 2 Year 1|Protocol Violation|4|||
170459977|NCT01970865|616026831|FG009|Overall Study|Death|2|||
170459978|NCT01970865|616026832|FG010|Overall Study|Death|8|||
170889664|NCT00848354|617602327|FG001|Phase 2 Year 1|Protocol Violation|1|||
170889665|NCT00848354|617602326|FG000|Phase 2 Year 1|Subject Request|1|||
170889666|NCT00848354|617602327|FG001|Phase 2 Year 1|Subject Request|2|||
170889667|NCT00848354|617602326|FG000|Phase 2 Year 2|Adverse Event|12|||
170459979|NCT01970865|616026833|FG011|Overall Study|Death|13|||
170889668|NCT00848354|617602327|FG001|Phase 2 Year 2|Adverse Event|2|||
170889669|NCT00848354|617602326|FG000|Phase 2 Year 2|Death|2|||
170889670|NCT00848354|617602327|FG001|Phase 2 Year 2|Death|0|||
170889671|NCT00848354|617602326|FG000|Phase 2 Year 2|Failed to return|3|||
170889672|NCT00848354|617602327|FG001|Phase 2 Year 2|Failed to return|0|||
170889673|NCT00848354|617602326|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
170459980|NCT01970865|616026834|FG012|Overall Study|Death|25|||
170459981|NCT01970865|616026835|FG013|Overall Study|Death|46|||
170459982|NCT01970865|616026836|FG014|Overall Study|Death|37|||
170459983|NCT01970865|616026837|FG015|Overall Study|Death|22|||
170459984|NCT01970865|616026838|FG016|Overall Study|Death|1|||
170459985|NCT01970865|616026839|FG017|Overall Study|Death|17|||
170459986|NCT01970865|616026822|FG000|Overall Study|Lost to Follow-up|0|||
170459987|NCT01970865|616026823|FG001|Overall Study|Lost to Follow-up|0|||
170459988|NCT01970865|616026824|FG002|Overall Study|Lost to Follow-up|0|||
170459989|NCT01970865|616026825|FG003|Overall Study|Lost to Follow-up|1|||
170459990|NCT01970865|616026826|FG004|Overall Study|Lost to Follow-up|1|||
170459991|NCT01970865|616026827|FG005|Overall Study|Lost to Follow-up|0|||
170543379|NCT02949934|616332879|FG001|Neuroimaging|Protocol Violation|0|||
170543380|NCT02949934|616332880|FG002|Neuroimaging|Protocol Violation|0|||
170543381|NCT02949934|616332881|FG003|Neuroimaging|Protocol Violation|0|||
170543382|NCT02949934|616332882|FG004|Neuroimaging|Protocol Violation|1|||
170543383|NCT02949934|616332883|FG005|Neuroimaging|Protocol Violation|0|||
170543384|NCT02949934|616332878|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
170788338|NCT02547363|617234330|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
170788339|NCT02547363|617234329|FG000|12-month Follow-up|Withdrawal by Subject|4|||
170788340|NCT02547363|617234330|FG001|12-month Follow-up|Withdrawal by Subject|3|||
170788341|NCT02547363|617234329|FG000|12-month Follow-up|Lost to Follow-up|4|||
170788342|NCT02547363|617234330|FG001|12-month Follow-up|Lost to Follow-up|1|||
170788343|NCT02547363|617234329|FG000|12-month Follow-up|Lack of Efficacy|1|||
170788344|NCT02547363|617234330|FG001|12-month Follow-up|Lack of Efficacy|1|||
170788345|NCT02547363|617234329|FG000|12-month Follow-up|Other|1|||
170788346|NCT02547363|617234330|FG001|12-month Follow-up|Other|0|||
170788347|NCT03931174|617234334|FG000|Providers|Staff left organization|26|||
170788348|NCT03931174|617234335|FG001|Providers|Staff left organization|25|||
170788349|NCT03931174|617234334|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
170788350|NCT03931174|617234335|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
170788351|NCT03931174|617234334|FG000|Providers|Lost to Follow-up|4|||
170788352|NCT03931174|617234335|FG001|Providers|Lost to Follow-up|4|||
170788353|NCT03931174|617234334|FG000|Patients|Post-consent screening failure|1|||
170788354|NCT03931174|617234335|FG001|Patients|Post-consent screening failure|1|||
170788355|NCT03931174|617234334|FG000|Patients|Death|1|||
170788356|NCT03931174|617234335|FG001|Patients|Death|1|||
170788357|NCT03931174|617234334|FG000|Patients|Lost to Follow-up|60|||
170788358|NCT03931174|617234335|FG001|Patients|Lost to Follow-up|89|||
170788359|NCT03322267|617234336|FG000|Overall Study|Lack of Efficacy|11|||
170788360|NCT03322267|617234336|FG000|Overall Study|Adverse Event|1|||
170788361|NCT03322267|617234336|FG000|Overall Study|Withdrawal by Subject|2|||
170788362|NCT03213691|617234337|FG000|Overall Study|Adverse Event|2|||
170788363|NCT03213691|617234337|FG000|Overall Study|Death|3|||
170788364|NCT03213691|617234337|FG000|Overall Study|Physician Decision|1|||
170788365|NCT03213691|617234337|FG000|Overall Study|Progressive Disease|14|||
170788366|NCT03213691|617234337|FG000|Overall Study|Ineligible|1|||
170788367|NCT01799265|617234338|FG000|Overall Study|Lost to Follow-up|1|||
170788368|NCT01799265|617234339|FG001|Overall Study|Lost to Follow-up|0|||
170788369|NCT01799265|617234338|FG000|Overall Study|Protocol Violation|2|||
170788370|NCT01799265|617234339|FG001|Overall Study|Protocol Violation|1|||
170788371|NCT01799265|617234338|FG000|Overall Study|inadequate sleep study|0|||
170788372|NCT01799265|617234339|FG001|Overall Study|inadequate sleep study|2|||
170788373|NCT04830800|617234343|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
170788374|NCT04830800|617234344|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
170788375|NCT04830800|617234345|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
170788376|NCT04830800|617234346|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
170788377|NCT04830800|617234347|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
170788378|NCT05579899|617236281|FG000|Overall Study|Lost to Follow-up|3|||
170788379|NCT05579899|617236282|FG001|Overall Study|Lost to Follow-up|1|||
170788380|NCT05579899|617236281|FG000|Overall Study|Adverse Event|0|||
170788381|NCT05579899|617236282|FG001|Overall Study|Adverse Event|3|||
170788382|NCT05579899|617236281|FG000|Overall Study|Pregnancy|0|||
170788383|NCT05579899|617236282|FG001|Overall Study|Pregnancy|1|||
170788384|NCT05579899|617236281|FG000|Overall Study|Withdrawal by Subject|0|||
170788385|NCT05579899|617236282|FG001|Overall Study|Withdrawal by Subject|3|||
170788386|NCT04059484|617236283|FG000|Overall Study|Adverse Event|2|||
170459992|NCT01970865|616026828|FG006|Overall Study|Lost to Follow-up|0|||
170543385|NCT02949934|616332879|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
170543386|NCT02949934|616332880|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
170788387|NCT04059484|617236284|FG001|Overall Study|Adverse Event|5|||
170889674|NCT00848354|617602327|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
170889675|NCT00848354|617602326|FG000|Phase 2 Year 2|Unspecified Reason|1|||
170889676|NCT00848354|617602327|FG001|Phase 2 Year 2|Unspecified Reason|0|||
170459993|NCT01970865|616026829|FG007|Overall Study|Lost to Follow-up|0|||
170459994|NCT01970865|616026830|FG008|Overall Study|Lost to Follow-up|0|||
170459995|NCT01970865|616026831|FG009|Overall Study|Lost to Follow-up|0|||
170459996|NCT01970865|616026832|FG010|Overall Study|Lost to Follow-up|1|||
170459997|NCT01970865|616026833|FG011|Overall Study|Lost to Follow-up|0|||
170459998|NCT01970865|616026834|FG012|Overall Study|Lost to Follow-up|2|||
170459999|NCT01970865|616026835|FG013|Overall Study|Lost to Follow-up|0|||
170460000|NCT01970865|616026836|FG014|Overall Study|Lost to Follow-up|1|||
170460001|NCT01970865|616026837|FG015|Overall Study|Lost to Follow-up|4|||
170460002|NCT01970865|616026838|FG016|Overall Study|Lost to Follow-up|0|||
170460003|NCT01970865|616026839|FG017|Overall Study|Lost to Follow-up|1|||
170460004|NCT01970865|616026822|FG000|Overall Study|Other|0|||
170460005|NCT01970865|616026823|FG001|Overall Study|Other|1|||
170788388|NCT04059484|617236283|FG000|Overall Study|Withdrawal by Subject|5|||
170788389|NCT04059484|617236284|FG001|Overall Study|Withdrawal by Subject|3|||
170788390|NCT04059484|617236283|FG000|Overall Study|Progressive disease|112|||
170788391|NCT04059484|617236284|FG001|Overall Study|Progressive disease|112|||
170788392|NCT04059484|617236283|FG000|Overall Study|Other|8|||
170788393|NCT04059484|617236284|FG001|Overall Study|Other|3|||
170788394|NCT04059484|617236283|FG000|Overall Study|Ongoing|20|||
170788395|NCT04059484|617236284|FG001|Overall Study|Ongoing|20|||
170788396|NCT04719390|617236288|FG000|Overall Study|Withdrawal by Subject|1|||
170788397|NCT00753545|617236289|FG000|Overall Study|Death|98|||
170788398|NCT00753545|617236290|FG001|Overall Study|Death|112|||
170788399|NCT00753545|617236289|FG000|Overall Study|Lost to Follow-up|2|||
170788400|NCT00753545|617236290|FG001|Overall Study|Lost to Follow-up|3|||
170788401|NCT00753545|617236289|FG000|Overall Study|Protocol Violation|1|||
170788402|NCT00753545|617236290|FG001|Overall Study|Protocol Violation|0|||
170788403|NCT00753545|617236289|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
170788404|NCT00753545|617236290|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
170788405|NCT06190691|617236291|FG000|Overall Study|Adverse Event|2|||
170788406|NCT06190691|617236292|FG001|Overall Study|Adverse Event|0|||
170788407|NCT06190691|617236293|FG002|Overall Study|Adverse Event|0|||
170788408|NCT06190691|617236294|FG003|Overall Study|Adverse Event|0|||
170788409|NCT02485938|617236296|FG000|Overall Study|Withdrawal of consent|2|||
170788410|NCT02485938|617236297|FG001|Overall Study|Withdrawal of consent|0|||
170788411|NCT04633122|617236298|FG000|Overall Study|Remained on treatment|19|||
170788412|NCT04633122|617236299|FG001|Overall Study|Remained on treatment|14|||
170788413|NCT04633122|617236298|FG000|Overall Study|Survival follow-up stopped|22|||
170788414|NCT04633122|617236299|FG001|Overall Study|Survival follow-up stopped|25|||
170788415|NCT03016754|617236300|FG000|Overall Study|Death|5|||
170788416|NCT03016754|617236301|FG001|Overall Study|Death|4|||
170788417|NCT03016754|617236302|FG002|Overall Study|Death|5|||
170788418|NCT03016754|617236303|FG003|Overall Study|Death|1|||
170788419|NCT03016754|617236300|FG000|Overall Study|Lost to Follow-up|23|||
170788420|NCT03016754|617236301|FG001|Overall Study|Lost to Follow-up|17|||
170788421|NCT03016754|617236302|FG002|Overall Study|Lost to Follow-up|4|||
170788422|NCT03016754|617236303|FG003|Overall Study|Lost to Follow-up|2|||
170788423|NCT03016754|617236300|FG000|Overall Study|Withdrawal by Subject|6|||
170788424|NCT03016754|617236301|FG001|Overall Study|Withdrawal by Subject|6|||
170788425|NCT03016754|617236302|FG002|Overall Study|Withdrawal by Subject|2|||
170788426|NCT03016754|617236303|FG003|Overall Study|Withdrawal by Subject|2|||
170788427|NCT03016754|617236300|FG000|Overall Study|Other/Unknown|2|||
170788428|NCT03016754|617236301|FG001|Overall Study|Other/Unknown|4|||
170788429|NCT03016754|617236302|FG002|Overall Study|Other/Unknown|2|||
170788430|NCT03016754|617236303|FG003|Overall Study|Other/Unknown|1|||
170788431|NCT03016754|617236300|FG000|Overall Study|Protocol Violation|0|||
170788432|NCT03016754|617236301|FG001|Overall Study|Protocol Violation|0|||
170788433|NCT03016754|617236302|FG002|Overall Study|Protocol Violation|0|||
170788434|NCT03016754|617236303|FG003|Overall Study|Protocol Violation|4|||
170788435|NCT03839940|617236304|FG000|Overall Study|Withdrawal by Subject|3|||
170788436|NCT03839940|617236305|FG001|Overall Study|Withdrawal by Subject|0|||
170788437|NCT03839940|617236304|FG000|Overall Study|Protocol Violation|0|||
170788438|NCT03839940|617236305|FG001|Overall Study|Protocol Violation|1|||
170788439|NCT03839940|617236304|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
170788440|NCT03839940|617236305|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
170788441|NCT03241745|617236306|FG000|Overall Study|Adverse Event|7|||
170788442|NCT03241745|617236306|FG000|Overall Study|Death|1|||
170788443|NCT03241745|617236306|FG000|Overall Study|Withdrawal by Subject|5|||
170460006|NCT01970865|616026824|FG002|Overall Study|Other|0|||
170460007|NCT01970865|616026825|FG003|Overall Study|Other|1|||
170788444|NCT03241745|617236306|FG000|Overall Study|Treatment delay >28 days|2|||
170788445|NCT03241745|617236306|FG000|Overall Study|Lack of Efficacy|14|||
170460008|NCT01970865|616026826|FG004|Overall Study|Other|1|||
170460009|NCT01970865|616026827|FG005|Overall Study|Other|0|||
170543387|NCT02949934|616332881|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
170543388|NCT02949934|616332882|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
170788446|NCT05087992|617236307|FG000|Overall Study|Adverse Event|0|||
170788447|NCT05087992|617236308|FG001|Overall Study|Adverse Event|1|||
170460010|NCT01970865|616026828|FG006|Overall Study|Other|1|||
170460011|NCT01970865|616026829|FG007|Overall Study|Other|0|||
170636074|NCT01189032|616678940|FG002|Overall Study|Adverse Event|4|||
170636075|NCT01189032|616678938|FG000|Overall Study|Lack of Efficacy|2|||
170636076|NCT01189032|616678939|FG001|Overall Study|Lack of Efficacy|3|||
170636077|NCT01189032|616678940|FG002|Overall Study|Lack of Efficacy|0|||
170636078|NCT01189032|616678938|FG000|Overall Study|Withdrawal by Subject|1|||
170889677|NCT00848354|617602326|FG000|Phase 2 Year 2|Protocol Violation|1|||
170889678|NCT00848354|617602327|FG001|Phase 2 Year 2|Protocol Violation|1|||
170889679|NCT00848354|617602326|FG000|Phase 2 Year 2|Subject Request|1|||
170889680|NCT00848354|617602327|FG001|Phase 2 Year 2|Subject Request|1|||
170889681|NCT00848354|617602326|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
170889682|NCT00848354|617602327|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
170889683|NCT00915343|617602328|FG000|Part B - Open Label Period|Treatment switch|0|||
170889684|NCT00915343|617602329|FG001|Part B - Open Label Period|Treatment switch|0|||
170889685|NCT00915343|617602330|FG002|Part B - Open Label Period|Treatment switch|1|||
170889686|NCT00915343|617602328|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
170889687|NCT00915343|617602329|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
170889688|NCT00915343|617602330|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
170889689|NCT01318109|617602331|FG000|Overall Study|Adverse Event|0|||
170889690|NCT01318109|617602332|FG001|Overall Study|Adverse Event|2|||
170889691|NCT01318109|617602333|FG002|Overall Study|Adverse Event|0|||
170889692|NCT01318109|617602331|FG000|Overall Study|Withdrawal by Subject|1|||
170889693|NCT01318109|617602332|FG001|Overall Study|Withdrawal by Subject|0|||
170460012|NCT01970865|616026830|FG008|Overall Study|Other|0|||
170460013|NCT01970865|616026831|FG009|Overall Study|Other|0|||
170460014|NCT01970865|616026832|FG010|Overall Study|Other|2|||
170460015|NCT01970865|616026833|FG011|Overall Study|Other|3|||
170460016|NCT01970865|616026834|FG012|Overall Study|Other|8|||
170460017|NCT01970865|616026835|FG013|Overall Study|Other|3|||
170460018|NCT01970865|616026836|FG014|Overall Study|Other|2|||
170636079|NCT01189032|616678939|FG001|Overall Study|Withdrawal by Subject|0|||
170460019|NCT01970865|616026837|FG015|Overall Study|Other|3|||
170460020|NCT01970865|616026838|FG016|Overall Study|Other|0|||
170460021|NCT01970865|616026839|FG017|Overall Study|Other|2|||
170460022|NCT01970865|616026822|FG000|Overall Study|Participant refused further follow-up|0|||
170460023|NCT01970865|616026823|FG001|Overall Study|Participant refused further follow-up|0|||
170460024|NCT01970865|616026824|FG002|Overall Study|Participant refused further follow-up|0|||
170460025|NCT01970865|616026825|FG003|Overall Study|Participant refused further follow-up|2|||
170460026|NCT01970865|616026826|FG004|Overall Study|Participant refused further follow-up|3|||
170460027|NCT01970865|616026827|FG005|Overall Study|Participant refused further follow-up|0|||
170460028|NCT01970865|616026828|FG006|Overall Study|Participant refused further follow-up|0|||
170460029|NCT01970865|616026829|FG007|Overall Study|Participant refused further follow-up|0|||
170460030|NCT01970865|616026830|FG008|Overall Study|Participant refused further follow-up|0|||
170460031|NCT01970865|616026831|FG009|Overall Study|Participant refused further follow-up|0|||
170460032|NCT01970865|616026832|FG010|Overall Study|Participant refused further follow-up|1|||
170460033|NCT01970865|616026833|FG011|Overall Study|Participant refused further follow-up|4|||
170460034|NCT01970865|616026834|FG012|Overall Study|Participant refused further follow-up|7|||
170460035|NCT01970865|616026835|FG013|Overall Study|Participant refused further follow-up|8|||
170460036|NCT01970865|616026836|FG014|Overall Study|Participant refused further follow-up|3|||
170460037|NCT01970865|616026837|FG015|Overall Study|Participant refused further follow-up|11|||
170460038|NCT01970865|616026838|FG016|Overall Study|Participant refused further follow-up|0|||
170460039|NCT01970865|616026839|FG017|Overall Study|Participant refused further follow-up|6|||
170460040|NCT01083810|616026840|FG000|Overall Study|Lost to Follow-up|23|||
170460041|NCT01083810|616026841|FG001|Overall Study|Lost to Follow-up|11|||
170636080|NCT01189032|616678940|FG002|Overall Study|Withdrawal by Subject|1|||
170788448|NCT05087992|617236309|FG002|Overall Study|Adverse Event|0|||
170788449|NCT05087992|617236307|FG000|Overall Study|Withdrawal by Subject|2|||
170788450|NCT05087992|617236308|FG001|Overall Study|Withdrawal by Subject|0|||
170788451|NCT05087992|617236309|FG002|Overall Study|Withdrawal by Subject|0|||
170788452|NCT05087992|617236307|FG000|Overall Study|clinical disease progression|3|||
170788453|NCT05087992|617236308|FG001|Overall Study|clinical disease progression|1|||
170788454|NCT05087992|617236309|FG002|Overall Study|clinical disease progression|0|||
170788455|NCT05087992|617236307|FG000|Overall Study|objective disease progression|4|||
170788456|NCT05087992|617236308|FG001|Overall Study|objective disease progression|1|||
170788457|NCT05087992|617236309|FG002|Overall Study|objective disease progression|0|||
170788458|NCT01842542|617236310|FG000|Overall Study|Withdrawal by Subject|2|||
170788459|NCT01842542|617236310|FG000|Overall Study|Lack of Efficacy|1|||
170788460|NCT01842542|617236310|FG000|Overall Study|Protocol Non-compliance|2|||
170788461|NCT01842542|617236310|FG000|Overall Study|Lost to Follow-up|1|||
170788462|NCT02919306|617236311|FG000|Overall Study|Withdrawal by Subject|1|||
170788463|NCT02919306|617236312|FG001|Overall Study|Withdrawal by Subject|0|||
170788464|NCT02919306|617236311|FG000|Overall Study|Protocol Violation|1|||
170889694|NCT01318109|617602333|FG002|Overall Study|Withdrawal by Subject|0|||
170889695|NCT01318109|617602331|FG000|Overall Study|Schedule Conflict|0|||
170460042|NCT01083810|616026842|FG002|Overall Study|Lost to Follow-up|4|||
170460043|NCT01083810|616026840|FG000|Overall Study|Adverse Event|15|||
170460044|NCT01083810|616026841|FG001|Overall Study|Adverse Event|11|||
170460045|NCT01083810|616026842|FG002|Overall Study|Adverse Event|4|||
170460046|NCT01083810|616026840|FG000|Overall Study|Withdrawal by Subject|7|||
170460047|NCT01083810|616026841|FG001|Overall Study|Withdrawal by Subject|2|||
170460048|NCT01083810|616026842|FG002|Overall Study|Withdrawal by Subject|4|||
170636081|NCT01189032|616678938|FG000|Overall Study|Protocol Violation|1|||
170788465|NCT02919306|617236312|FG001|Overall Study|Protocol Violation|0|||
170788466|NCT02761057|617236313|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
170788467|NCT02761057|617236314|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
170788468|NCT02761057|617236315|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
170788469|NCT02761057|617236316|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
170788470|NCT02761057|617236313|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
170788471|NCT02761057|617236314|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
170788472|NCT02761057|617236315|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
170788473|NCT02761057|617236316|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
170788474|NCT02761057|617236313|FG000|Overall Study|Currently On Study Treatment|0|||
170788475|NCT02761057|617236314|FG001|Overall Study|Currently On Study Treatment|3|||
170788476|NCT02761057|617236315|FG002|Overall Study|Currently On Study Treatment|0|||
170788477|NCT02761057|617236316|FG003|Overall Study|Currently On Study Treatment|0|||
170788478|NCT02761057|617236313|FG000|Overall Study|Adverse Event|11|||
170788479|NCT02761057|617236314|FG001|Overall Study|Adverse Event|9|||
170788480|NCT02761057|617236315|FG002|Overall Study|Adverse Event|5|||
170788481|NCT02761057|617236316|FG003|Overall Study|Adverse Event|3|||
170788482|NCT02761057|617236313|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
170788483|NCT02761057|617236314|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
170788484|NCT02761057|617236315|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
170788485|NCT02761057|617236316|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
170788486|NCT02761057|617236313|FG000|Overall Study|Progression/Relapse|29|||
170788487|NCT02761057|617236314|FG001|Overall Study|Progression/Relapse|27|||
170788488|NCT02761057|617236315|FG002|Overall Study|Progression/Relapse|20|||
170788489|NCT02761057|617236316|FG003|Overall Study|Progression/Relapse|23|||
170788490|NCT02761057|617236313|FG000|Overall Study|Death|2|||
170788491|NCT02761057|617236314|FG001|Overall Study|Death|2|||
170788492|NCT02761057|617236315|FG002|Overall Study|Death|1|||
170788493|NCT02761057|617236316|FG003|Overall Study|Death|1|||
170788494|NCT02761057|617236313|FG000|Overall Study|Other - Not Protocol Specified|2|||
170788495|NCT02761057|617236314|FG001|Overall Study|Other - Not Protocol Specified|1|||
170788496|NCT02761057|617236315|FG002|Overall Study|Other - Not Protocol Specified|2|||
170788497|NCT02761057|617236316|FG003|Overall Study|Other - Not Protocol Specified|0|||
170788498|NCT04332926|617236317|FG000|Overall Study|Withdrawal by Subject|6|||
170788499|NCT04332926|617236317|FG000|Overall Study|Physician Decision|6|||
170788500|NCT02677805|617236322|FG000|Double Blind Phase|Lost to Follow-up|8|||
170788501|NCT02677805|617236323|FG001|Double Blind Phase|Lost to Follow-up|3|||
170788502|NCT02677805|617236324|FG002|Double Blind Phase|Lost to Follow-up|0|||
170788503|NCT02677805|617236322|FG000|Double Blind Phase|Withdrawal by Subject|5|||
170788504|NCT02677805|617236323|FG001|Double Blind Phase|Withdrawal by Subject|2|||
170788505|NCT02677805|617236324|FG002|Double Blind Phase|Withdrawal by Subject|0|||
170788506|NCT02677805|617236322|FG000|Open Label Phase|Lost to Follow-up|0|||
170788507|NCT02677805|617236323|FG001|Open Label Phase|Lost to Follow-up|0|||
170788508|NCT02677805|617236324|FG002|Open Label Phase|Lost to Follow-up|10|||
170788509|NCT02677805|617236322|FG000|Open Label Phase|Withdrawal by Subject|0|||
170788510|NCT02677805|617236323|FG001|Open Label Phase|Withdrawal by Subject|0|||
170788511|NCT02677805|617236324|FG002|Open Label Phase|Withdrawal by Subject|6|||
170788512|NCT04277442|617236325|FG000|Overall Study|Death|1|||
170788513|NCT05362487|617236326|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
170788514|NCT03115476|617236329|FG000|LP0084-1369|Death|1|||
170788515|NCT03115476|617236330|FG001|LP0084-1369|Death|0|||
170788516|NCT03115476|617236331|FG002|LP0084-1369|Death|2|||
170788517|NCT03115476|617236329|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
170788518|NCT03115476|617236330|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
170788519|NCT03115476|617236331|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
170788520|NCT04016662|617236332|FG000|Run-In Phase|Death|1|||
170788521|NCT04016662|617236332|FG000|Run-In Phase|Withdrawal by Subject|11|||
170788522|NCT04016662|617236332|FG000|Run-In Phase|Not meeting screening eligibility|9|||
170788523|NCT04016662|617236332|FG000|Run-In Phase|Physician Decision|3|||
170788524|NCT04016662|617236332|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
170788525|NCT04016662|617236332|FG000|PLGS (12 Weeks)|Death|1|||
170788526|NCT04016662|617236332|FG000|SAP (12 Weeks)|Death|1|||
170788527|NCT01802788|617236336|FG000|Overall Study|Withdrawal by Subject|102|||
170788528|NCT01802788|617236337|FG001|Overall Study|Withdrawal by Subject|5|||
170788529|NCT01802788|617236336|FG000|Overall Study|Death|382|||
170788530|NCT01802788|617236337|FG001|Overall Study|Death|18|||
170788531|NCT01802788|617236336|FG000|Overall Study|Lost to Follow-up|31|||
170788532|NCT01802788|617236337|FG001|Overall Study|Lost to Follow-up|2|||
170460049|NCT01083810|616026840|FG000|Overall Study|Reason not reported|6|||
170543389|NCT02949934|616332883|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
170543390|NCT02949934|616332878|FG000|Neuroimaging|Not scanned|0|||
170543391|NCT02949934|616332879|FG001|Neuroimaging|Not scanned|0|||
170543392|NCT02949934|616332880|FG002|Neuroimaging|Not scanned|1|||
170543393|NCT02949934|616332881|FG003|Neuroimaging|Not scanned|0|||
170543394|NCT02949934|616332882|FG004|Neuroimaging|Not scanned|0|||
170543395|NCT02949934|616332883|FG005|Neuroimaging|Not scanned|2|||
170788533|NCT01802788|617236336|FG000|Overall Study|Physician Decision|3|||
170788534|NCT01802788|617236337|FG001|Overall Study|Physician Decision|0|||
170788535|NCT01802788|617236336|FG000|Overall Study|Patient Non-Compliance|1|||
170788536|NCT01802788|617236337|FG001|Overall Study|Patient Non-Compliance|0|||
170788537|NCT01802788|617236336|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
170788538|NCT01802788|617236337|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
170788539|NCT01802788|617236336|FG000|Overall Study|Other Reasons|19|||
170788540|NCT01802788|617236337|FG001|Overall Study|Other Reasons|0|||
170788541|NCT05257486|617236338|FG000|Overall Study|Protocol Violation|3|||
170788542|NCT02310646|617236339|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
170788543|NCT02310646|617236340|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
170788544|NCT02310646|617236339|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
170788545|NCT02310646|617236340|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
170788546|NCT03021096|617236341|FG000|Overall Study|Lost to Follow-up|4|||
170788547|NCT03021096|617236341|FG000|Overall Study|Protocol Violation|2|||
170788548|NCT04564742|617236346|FG000|Overall Study|Lost to Follow-up|1|||
170788549|NCT04564742|617236347|FG001|Overall Study|Lost to Follow-up|0|||
170788550|NCT04564742|617236346|FG000|Overall Study|Consent Withdrawal|4|||
170788551|NCT04564742|617236347|FG001|Overall Study|Consent Withdrawal|4|||
170788552|NCT03313076|617236350|FG000|Overall Study|Withdrawal by Subject|2|||
170788553|NCT03313076|617236351|FG001|Overall Study|Withdrawal by Subject|0|||
170788554|NCT03313076|617236352|FG002|Overall Study|Withdrawal by Subject|0|||
170788555|NCT03313076|617236353|FG003|Overall Study|Withdrawal by Subject|0|||
170788556|NCT03313076|617236350|FG000|Overall Study|Lost to Follow-up|0|||
170788557|NCT03313076|617236351|FG001|Overall Study|Lost to Follow-up|2|||
170788558|NCT03313076|617236352|FG002|Overall Study|Lost to Follow-up|2|||
170788559|NCT03313076|617236353|FG003|Overall Study|Lost to Follow-up|2|||
170788560|NCT04137367|617236358|FG000|Overall Study|Lost to Follow-up|8|||
170788561|NCT04137367|617236359|FG001|Overall Study|Lost to Follow-up|6|||
170788562|NCT04137367|617236360|FG002|Overall Study|Lost to Follow-up|4|||
170788563|NCT03907878|617236361|FG000|Treatment Period|Withdrawal by Subject|5|||
170788564|NCT03907878|617236361|FG000|Treatment Period|Adverse Event|4|||
170788565|NCT03907878|617236361|FG000|Treatment Period|Lack of Efficacy|1|||
170788566|NCT03907878|617236361|FG000|Treatment Period|Protocol Violation|1|||
170788567|NCT03907878|617236361|FG000|Follow-up Period|Adverse Event|3|||
170788568|NCT03907878|617236361|FG000|Follow-up Period|Withdrawal by Subject|3|||
170788569|NCT05144009|617236362|FG000|Overall Study|Lost to Follow-up|0|||
170788570|NCT05144009|617236363|FG001|Overall Study|Lost to Follow-up|1|||
170788571|NCT05144009|617236362|FG000|Overall Study|Study Termination by the Sponsor|11|||
170788572|NCT05144009|617236363|FG001|Overall Study|Study Termination by the Sponsor|11|||
170788573|NCT05144009|617236362|FG000|Overall Study|Disease Progression|1|||
170788574|NCT05144009|617236363|FG001|Overall Study|Disease Progression|0|||
170788575|NCT05144009|617236362|FG000|Overall Study|Participant Decision|0|||
170788576|NCT05144009|617236363|FG001|Overall Study|Participant Decision|2|||
170788577|NCT05144009|617236362|FG000|Overall Study|Death|5|||
170788578|NCT05144009|617236363|FG001|Overall Study|Death|10|||
170788579|NCT00764751|617236364|FG000|Overall Study|Adverse Event|1|||
170788580|NCT00764751|617236365|FG001|Overall Study|Adverse Event|1|||
170788581|NCT00764751|617236364|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
170788582|NCT00764751|617236365|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
170788583|NCT02815566|617236368|FG000|Overall Study|Adverse Event|1|||
170788584|NCT02815566|617236369|FG001|Overall Study|Adverse Event|1|||
170788585|NCT02815566|617236368|FG000|Overall Study|Withdrawal by Subject|1|||
170788586|NCT02815566|617236369|FG001|Overall Study|Withdrawal by Subject|0|||
170788587|NCT02815566|617236368|FG000|Overall Study|Lost to Follow-up|0|||
170788588|NCT02815566|617236369|FG001|Overall Study|Lost to Follow-up|1|||
170788589|NCT04074759|617236370|FG000|Overall Study|Withdrawal by Subject|0|||
170788590|NCT04074759|617236371|FG001|Overall Study|Withdrawal by Subject|0|||
170788591|NCT04074759|617236372|FG002|Overall Study|Withdrawal by Subject|0|||
170788592|NCT04074759|617236373|FG003|Overall Study|Withdrawal by Subject|0|||
170889696|NCT01318109|617602332|FG001|Overall Study|Schedule Conflict|1|||
170889697|NCT01318109|617602333|FG002|Overall Study|Schedule Conflict|0|||
170889698|NCT01328951|617602334|FG000|Overall Study|Disease Progression|17|||
170543396|NCT02949934|616332878|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
170543397|NCT02949934|616332879|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
170788593|NCT04074759|617236374|FG004|Overall Study|Withdrawal by Subject|0|||
170788594|NCT04074759|617236375|FG005|Overall Study|Withdrawal by Subject|2|||
170788595|NCT04074759|617236376|FG006|Overall Study|Withdrawal by Subject|0|||
170788596|NCT04074759|617236377|FG007|Overall Study|Withdrawal by Subject|2|||
170889699|NCT01328951|617602335|FG001|Overall Study|Disease Progression|14|||
170460050|NCT01083810|616026841|FG001|Overall Study|Reason not reported|1|||
170460051|NCT01083810|616026842|FG002|Overall Study|Reason not reported|1|||
170460052|NCT01083810|616026840|FG000|Overall Study|Non-compliance|4|||
170460053|NCT01083810|616026841|FG001|Overall Study|Non-compliance|7|||
170460054|NCT01083810|616026842|FG002|Overall Study|Non-compliance|2|||
170460055|NCT01083810|616026840|FG000|Overall Study|Simplification|4|||
170460056|NCT01083810|616026841|FG001|Overall Study|Simplification|1|||
170460057|NCT01083810|616026842|FG002|Overall Study|Simplification|0|||
170460058|NCT01083810|616026840|FG000|Overall Study|Death|2|||
170460059|NCT01083810|616026841|FG001|Overall Study|Death|2|||
170460060|NCT01083810|616026842|FG002|Overall Study|Death|3|||
170460061|NCT01083810|616026840|FG000|Overall Study|Co-morbidities|1|||
170460062|NCT01083810|616026841|FG001|Overall Study|Co-morbidities|0|||
170460063|NCT01083810|616026842|FG002|Overall Study|Co-morbidities|0|||
170460064|NCT01083810|616026840|FG000|Overall Study|Participation in study|1|||
170460065|NCT01083810|616026841|FG001|Overall Study|Participation in study|0|||
170460066|NCT01083810|616026842|FG002|Overall Study|Participation in study|0|||
170460067|NCT01083810|616026840|FG000|Overall Study|Therapy break|1|||
170460068|NCT01083810|616026841|FG001|Overall Study|Therapy break|2|||
170460069|NCT01083810|616026842|FG002|Overall Study|Therapy break|2|||
170460070|NCT01083810|616026840|FG000|Overall Study|Virologic failure|1|||
170543398|NCT02949934|616332880|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
170543399|NCT02949934|616332881|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
170543400|NCT02949934|616332882|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
170543401|NCT02949934|616332883|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
170788597|NCT04074759|617236378|FG008|Overall Study|Withdrawal by Subject|1|||
170788598|NCT04074759|617236379|FG009|Overall Study|Withdrawal by Subject|2|||
170788599|NCT04074759|617236380|FG010|Overall Study|Withdrawal by Subject|9|||
170788600|NCT04074759|617236381|FG011|Overall Study|Withdrawal by Subject|2|||
170788601|NCT04074759|617236382|FG012|Overall Study|Withdrawal by Subject|1|||
170543402|NCT02949934|616332878|FG000|Bar Laboratory|Adverse Event|1|||
170543403|NCT02949934|616332879|FG001|Bar Laboratory|Adverse Event|0|||
170543404|NCT02949934|616332880|FG002|Bar Laboratory|Adverse Event|2|||
170788602|NCT04074759|617236383|FG013|Overall Study|Withdrawal by Subject|3|||
170788603|NCT04074759|617236384|FG014|Overall Study|Withdrawal by Subject|2|||
170788604|NCT04074759|617236385|FG015|Overall Study|Withdrawal by Subject|0|||
170788605|NCT04074759|617236386|FG016|Overall Study|Withdrawal by Subject|0|||
170788606|NCT04074759|617236387|FG017|Overall Study|Withdrawal by Subject|3|||
170788607|NCT04074759|617236388|FG018|Overall Study|Withdrawal by Subject|1|||
170788608|NCT04074759|617236370|FG000|Overall Study|Death|1|||
170788609|NCT04074759|617236371|FG001|Overall Study|Death|0|||
170788610|NCT04074759|617236372|FG002|Overall Study|Death|1|||
170788611|NCT04074759|617236373|FG003|Overall Study|Death|1|||
170788612|NCT04074759|617236374|FG004|Overall Study|Death|2|||
170788613|NCT04074759|617236375|FG005|Overall Study|Death|0|||
170788614|NCT04074759|617236376|FG006|Overall Study|Death|1|||
170788615|NCT04074759|617236377|FG007|Overall Study|Death|0|||
170788616|NCT04074759|617236378|FG008|Overall Study|Death|3|||
170788617|NCT04074759|617236379|FG009|Overall Study|Death|2|||
170788618|NCT04074759|617236380|FG010|Overall Study|Death|4|||
170788619|NCT04074759|617236381|FG011|Overall Study|Death|1|||
170788620|NCT04074759|617236382|FG012|Overall Study|Death|0|||
170788621|NCT04074759|617236383|FG013|Overall Study|Death|2|||
170788622|NCT04074759|617236384|FG014|Overall Study|Death|1|||
170788623|NCT04074759|617236385|FG015|Overall Study|Death|0|||
170788624|NCT04074759|617236386|FG016|Overall Study|Death|1|||
170788625|NCT04074759|617236387|FG017|Overall Study|Death|0|||
170460071|NCT01083810|616026841|FG001|Overall Study|Virologic failure|8|||
170543405|NCT02949934|616332881|FG003|Bar Laboratory|Adverse Event|0|||
170543406|NCT02949934|616332882|FG004|Bar Laboratory|Adverse Event|1|||
170543407|NCT02949934|616332883|FG005|Bar Laboratory|Adverse Event|0|||
170543408|NCT02949934|616332878|FG000|Bar Laboratory|Protocol Violation|0|||
170543409|NCT02949934|616332879|FG001|Bar Laboratory|Protocol Violation|0|||
170543410|NCT02949934|616332880|FG002|Bar Laboratory|Protocol Violation|0|||
170543411|NCT02949934|616332881|FG003|Bar Laboratory|Protocol Violation|1|||
170543412|NCT02949934|616332882|FG004|Bar Laboratory|Protocol Violation|0|||
170543413|NCT02949934|616332883|FG005|Bar Laboratory|Protocol Violation|0|||
170543414|NCT00849472|616332887|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
170543415|NCT00849472|616332887|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
170543416|NCT00849472|616332887|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
170543417|NCT00849472|616332887|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
170788626|NCT04074759|617236388|FG018|Overall Study|Death|1|||
170788627|NCT04074759|617236370|FG000|Overall Study|Lost to Follow-up|0|||
170788628|NCT04074759|617236371|FG001|Overall Study|Lost to Follow-up|0|||
170460072|NCT01083810|616026842|FG002|Overall Study|Virologic failure|0|||
170460073|NCT01855074|616026843|FG000|Overall Study|Adverse Event|1|||
170788629|NCT04074759|617236372|FG002|Overall Study|Lost to Follow-up|0|||
170788630|NCT04074759|617236373|FG003|Overall Study|Lost to Follow-up|0|||
170788631|NCT04074759|617236374|FG004|Overall Study|Lost to Follow-up|0|||
170788632|NCT04074759|617236375|FG005|Overall Study|Lost to Follow-up|0|||
170636082|NCT01189032|616678939|FG001|Overall Study|Protocol Violation|1|||
170636083|NCT01189032|616678940|FG002|Overall Study|Protocol Violation|1|||
170636084|NCT02999672|616678941|FG000|Overall Study|Death|0|||
170636085|NCT02999672|616678942|FG001|Overall Study|Death|1|||
170636086|NCT02999672|616678941|FG000|Overall Study|Study Terminated by Sponsor|0|||
170543418|NCT00849472|616332887|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
170543419|NCT00849472|616332887|FG000|Weekly Paclitaxel|Disease Progression|1|||
170543420|NCT00849472|616332887|FG000|Weekly Paclitaxel|Adverse Event|11|||
170543421|NCT00849472|616332887|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
170543422|NCT00849472|616332887|FG000|Weekly Paclitaxel|Physician Decision|3|||
170543423|NCT00849472|616332887|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
170636087|NCT02999672|616678942|FG001|Overall Study|Study Terminated by Sponsor|1|||
170543424|NCT00849472|616332887|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
170543425|NCT00849472|616332887|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
170543426|NCT00849472|616332887|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
170543427|NCT00849472|616332887|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
170543428|NCT00849472|616332887|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
170636088|NCT02999672|616678941|FG000|Overall Study|Progressive Disease|9|||
170636089|NCT02999672|616678942|FG001|Overall Study|Progressive Disease|5|||
170636090|NCT02999672|616678941|FG000|Overall Study|Adverse Event|4|||
170636091|NCT02999672|616678942|FG001|Overall Study|Adverse Event|0|||
170636092|NCT01012440|616678945|FG000|Overall Study|Withdrawal by Subject|2|||
170636093|NCT00594815|616678946|FG000|Overall Study|Never Treated|3|||
170636094|NCT00594815|616678946|FG000|Overall Study|Withdrawal by Subject|2|||
170636095|NCT00594815|616678946|FG000|Overall Study|Toxicity|4|||
170636096|NCT03599089|616678947|FG000|Overall Study|Lost to Follow-up|1|||
170636097|NCT03599089|616678948|FG001|Overall Study|Lost to Follow-up|0|||
170636098|NCT03599089|616678949|FG002|Overall Study|Lost to Follow-up|0|||
170636099|NCT03599089|616678950|FG003|Overall Study|Lost to Follow-up|0|||
170636100|NCT03599089|616678947|FG000|Overall Study|Withdrawal by Subject|2|||
170636101|NCT03599089|616678948|FG001|Overall Study|Withdrawal by Subject|1|||
170636102|NCT03599089|616678949|FG002|Overall Study|Withdrawal by Subject|0|||
170788633|NCT04074759|617236376|FG006|Overall Study|Lost to Follow-up|0|||
170788634|NCT04074759|617236377|FG007|Overall Study|Lost to Follow-up|0|||
170788635|NCT04074759|617236378|FG008|Overall Study|Lost to Follow-up|0|||
170788636|NCT04074759|617236379|FG009|Overall Study|Lost to Follow-up|0|||
170788637|NCT04074759|617236380|FG010|Overall Study|Lost to Follow-up|1|||
170788638|NCT04074759|617236381|FG011|Overall Study|Lost to Follow-up|0|||
170788639|NCT04074759|617236382|FG012|Overall Study|Lost to Follow-up|0|||
170788640|NCT04074759|617236383|FG013|Overall Study|Lost to Follow-up|0|||
170788641|NCT04074759|617236384|FG014|Overall Study|Lost to Follow-up|0|||
170788642|NCT04074759|617236385|FG015|Overall Study|Lost to Follow-up|0|||
170788643|NCT04074759|617236386|FG016|Overall Study|Lost to Follow-up|1|||
170788644|NCT04074759|617236387|FG017|Overall Study|Lost to Follow-up|0|||
170788645|NCT04074759|617236388|FG018|Overall Study|Lost to Follow-up|1|||
170788646|NCT04074759|617236370|FG000|Overall Study|Other|0|||
170788647|NCT04074759|617236371|FG001|Overall Study|Other|1|||
170788648|NCT04074759|617236372|FG002|Overall Study|Other|1|||
170636103|NCT03599089|616678950|FG003|Overall Study|Withdrawal by Subject|0|||
170636104|NCT03599089|616678947|FG000|Overall Study|Lack of Efficacy|0|||
170636105|NCT03599089|616678948|FG001|Overall Study|Lack of Efficacy|0|||
170636106|NCT03599089|616678949|FG002|Overall Study|Lack of Efficacy|1|||
170788649|NCT04074759|617236373|FG003|Overall Study|Other|0|||
170788650|NCT04074759|617236374|FG004|Overall Study|Other|2|||
170636107|NCT03599089|616678950|FG003|Overall Study|Lack of Efficacy|2|||
170636108|NCT03214666|616678951|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
170636109|NCT03214666|616678952|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
170636110|NCT03214666|616678953|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
170636111|NCT03214666|616678954|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
170636112|NCT03214666|616678955|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
170636113|NCT03214666|616678956|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
170788651|NCT04074759|617236375|FG005|Overall Study|Other|1|||
170788652|NCT04074759|617236376|FG006|Overall Study|Other|2|||
170788653|NCT04074759|617236377|FG007|Overall Study|Other|1|||
170788654|NCT04074759|617236378|FG008|Overall Study|Other|1|||
170788655|NCT04074759|617236379|FG009|Overall Study|Other|4|||
170788656|NCT04074759|617236380|FG010|Overall Study|Other|4|||
170788657|NCT04074759|617236381|FG011|Overall Study|Other|2|||
170788658|NCT04074759|617236382|FG012|Overall Study|Other|0|||
170788659|NCT04074759|617236383|FG013|Overall Study|Other|0|||
170788660|NCT04074759|617236384|FG014|Overall Study|Other|0|||
170788661|NCT04074759|617236385|FG015|Overall Study|Other|1|||
170788662|NCT04074759|617236386|FG016|Overall Study|Other|0|||
170788663|NCT04074759|617236387|FG017|Overall Study|Other|0|||
170788664|NCT04074759|617236388|FG018|Overall Study|Other|0|||
170788665|NCT04074759|617236370|FG000|Overall Study|Missing end of study status|0|||
170788666|NCT04074759|617236371|FG001|Overall Study|Missing end of study status|0|||
170788667|NCT04074759|617236372|FG002|Overall Study|Missing end of study status|0|||
170788668|NCT04074759|617236373|FG003|Overall Study|Missing end of study status|0|||
170788669|NCT04074759|617236374|FG004|Overall Study|Missing end of study status|0|||
170788670|NCT04074759|617236375|FG005|Overall Study|Missing end of study status|0|||
170788671|NCT04074759|617236376|FG006|Overall Study|Missing end of study status|0|||
170788672|NCT04074759|617236377|FG007|Overall Study|Missing end of study status|0|||
170788673|NCT04074759|617236378|FG008|Overall Study|Missing end of study status|0|||
170788674|NCT04074759|617236379|FG009|Overall Study|Missing end of study status|0|||
170788675|NCT04074759|617236380|FG010|Overall Study|Missing end of study status|2|||
170788676|NCT04074759|617236381|FG011|Overall Study|Missing end of study status|0|||
170788677|NCT04074759|617236382|FG012|Overall Study|Missing end of study status|0|||
170788678|NCT04074759|617236383|FG013|Overall Study|Missing end of study status|0|||
170788679|NCT04074759|617236384|FG014|Overall Study|Missing end of study status|0|||
170788680|NCT04074759|617236385|FG015|Overall Study|Missing end of study status|0|||
170788681|NCT04074759|617236386|FG016|Overall Study|Missing end of study status|1|||
170788682|NCT04074759|617236387|FG017|Overall Study|Missing end of study status|0|||
170788683|NCT04074759|617236388|FG018|Overall Study|Missing end of study status|0|||
170788684|NCT03631784|617236389|FG000|Overall Study|Participants Ongoing|1|||
170788685|NCT03631784|617236390|FG001|Overall Study|Participants Ongoing|0|||
170788686|NCT03631784|617236389|FG000|Overall Study|Withdrawal by Subject|3|||
170788687|NCT03631784|617236390|FG001|Overall Study|Withdrawal by Subject|3|||
170788688|NCT03631784|617236389|FG000|Overall Study|Sponsor's Decision|36|||
170788689|NCT03631784|617236390|FG001|Overall Study|Sponsor's Decision|52|||
170788690|NCT03631784|617236389|FG000|Overall Study|Lost to Follow-up|1|||
170788691|NCT03631784|617236390|FG001|Overall Study|Lost to Follow-up|0|||
170788692|NCT03631784|617236389|FG000|Overall Study|Death|71|||
170788693|NCT03631784|617236390|FG001|Overall Study|Death|49|||
170788694|NCT05329220|617236391|FG000|Active Trial Period|Adverse Event|0|||
170788695|NCT05329220|617236392|FG001|Active Trial Period|Adverse Event|0|||
170788696|NCT05329220|617236393|FG002|Active Trial Period|Adverse Event|0|||
170788697|NCT05329220|617236394|FG003|Active Trial Period|Adverse Event|0|||
170788698|NCT05329220|617236395|FG004|Active Trial Period|Adverse Event|1|||
170788699|NCT05329220|617236396|FG005|Active Trial Period|Adverse Event|0|||
170788700|NCT05329220|617236391|FG000|Active Trial Period|Lost to Follow-up|0|||
170788701|NCT05329220|617236392|FG001|Active Trial Period|Lost to Follow-up|0|||
170788702|NCT05329220|617236393|FG002|Active Trial Period|Lost to Follow-up|0|||
170788703|NCT05329220|617236394|FG003|Active Trial Period|Lost to Follow-up|0|||
170788704|NCT05329220|617236395|FG004|Active Trial Period|Lost to Follow-up|32|||
170788705|NCT05329220|617236396|FG005|Active Trial Period|Lost to Follow-up|28|||
170788706|NCT05329220|617236391|FG000|Active Trial Period|Physician Decision|0|||
170788707|NCT05329220|617236392|FG001|Active Trial Period|Physician Decision|0|||
170788708|NCT05329220|617236393|FG002|Active Trial Period|Physician Decision|0|||
170788709|NCT05329220|617236394|FG003|Active Trial Period|Physician Decision|0|||
170788710|NCT05329220|617236395|FG004|Active Trial Period|Physician Decision|2|||
170636114|NCT02207088|616678962|FG000|Overall Study|Adverse Event|2|||
170788711|NCT05329220|617236396|FG005|Active Trial Period|Physician Decision|0|||
170788712|NCT05329220|617236391|FG000|Active Trial Period|Protocol Violation|0|||
170788713|NCT05329220|617236392|FG001|Active Trial Period|Protocol Violation|0|||
170788714|NCT05329220|617236393|FG002|Active Trial Period|Protocol Violation|0|||
170788715|NCT05329220|617236394|FG003|Active Trial Period|Protocol Violation|0|||
170788716|NCT05329220|617236395|FG004|Active Trial Period|Protocol Violation|1|||
170788717|NCT05329220|617236396|FG005|Active Trial Period|Protocol Violation|3|||
170788718|NCT05329220|617236391|FG000|Active Trial Period|Withdrawal by Subject|0|||
170788719|NCT05329220|617236392|FG001|Active Trial Period|Withdrawal by Subject|0|||
170460074|NCT01855074|616026843|FG000|Overall Study|Lost to Follow-up|4|||
170460075|NCT01855074|616026843|FG000|Overall Study|Withdrawal by Subject|8|||
170460076|NCT01855074|616026843|FG000|Overall Study|Started but not treated|1|||
170460077|NCT01602965|616026844|FG000|Overall Study|Lost to Follow-up|4|||
170460078|NCT01602965|616026845|FG001|Overall Study|Lost to Follow-up|2|||
170460079|NCT01629966|616026846|FG000|Overall Study|Pregnancy|0|||
170460080|NCT01629966|616026847|FG001|Overall Study|Pregnancy|1|||
170460081|NCT01629966|616026848|FG002|Overall Study|Pregnancy|0|||
170460082|NCT01629966|616026846|FG000|Overall Study|Lost to Follow-up|10|||
170460083|NCT01629966|616026847|FG001|Overall Study|Lost to Follow-up|13|||
170460084|NCT01629966|616026848|FG002|Overall Study|Lost to Follow-up|9|||
170460085|NCT01629966|616026846|FG000|Overall Study|Withdrawal by Subject|8|||
170460086|NCT01629966|616026847|FG001|Overall Study|Withdrawal by Subject|9|||
170460087|NCT01629966|616026848|FG002|Overall Study|Withdrawal by Subject|16|||
170460088|NCT01629966|616026846|FG000|Overall Study|Protocol Violation|7|||
170460089|NCT01629966|616026847|FG001|Overall Study|Protocol Violation|9|||
170460090|NCT01629966|616026848|FG002|Overall Study|Protocol Violation|7|||
170460091|NCT01629966|616026846|FG000|Overall Study|Lack of Efficacy|5|||
170460092|NCT01629966|616026847|FG001|Overall Study|Lack of Efficacy|2|||
170460093|NCT01629966|616026848|FG002|Overall Study|Lack of Efficacy|4|||
170460094|NCT01629966|616026846|FG000|Overall Study|Adverse Event|11|||
170460095|NCT01629966|616026847|FG001|Overall Study|Adverse Event|18|||
170460096|NCT01629966|616026848|FG002|Overall Study|Adverse Event|30|||
170460097|NCT01150890|616026849|FG000|Overall Study|Other|0|||
170460098|NCT01150890|616026850|FG001|Overall Study|Other|1|||
170460099|NCT01150890|616026851|FG002|Overall Study|Other|0|||
170460100|NCT01150890|616026852|FG003|Overall Study|Other|2|||
170460101|NCT01150890|616026849|FG000|Overall Study|Pregnancy|0|||
170460102|NCT01150890|616026850|FG001|Overall Study|Pregnancy|0|||
170460103|NCT01150890|616026851|FG002|Overall Study|Pregnancy|0|||
170460104|NCT01150890|616026852|FG003|Overall Study|Pregnancy|1|||
170460105|NCT01150890|616026849|FG000|Overall Study|Administrative Decision|4|||
170460106|NCT01150890|616026850|FG001|Overall Study|Administrative Decision|4|||
170460107|NCT01150890|616026851|FG002|Overall Study|Administrative Decision|5|||
170460108|NCT01150890|616026852|FG003|Overall Study|Administrative Decision|6|||
170460109|NCT01150890|616026849|FG000|Overall Study|Ineligibility determined|0|||
170460110|NCT01150890|616026850|FG001|Overall Study|Ineligibility determined|1|||
170460111|NCT01150890|616026851|FG002|Overall Study|Ineligibility determined|0|||
170460112|NCT01150890|616026852|FG003|Overall Study|Ineligibility determined|0|||
170460113|NCT01150890|616026849|FG000|Overall Study|Adverse Event|0|||
170460114|NCT01150890|616026850|FG001|Overall Study|Adverse Event|0|||
170460115|NCT01150890|616026851|FG002|Overall Study|Adverse Event|2|||
170460116|NCT01150890|616026852|FG003|Overall Study|Adverse Event|0|||
170460117|NCT01150890|616026849|FG000|Overall Study|Withdrawal by Subject|0|||
170460118|NCT01150890|616026850|FG001|Overall Study|Withdrawal by Subject|0|||
170460119|NCT01150890|616026851|FG002|Overall Study|Withdrawal by Subject|2|||
170460120|NCT01150890|616026852|FG003|Overall Study|Withdrawal by Subject|1|||
170460121|NCT01150890|616026849|FG000|Overall Study|Disease progression|0|||
170460122|NCT01150890|616026850|FG001|Overall Study|Disease progression|7|||
170460123|NCT01150890|616026851|FG002|Overall Study|Disease progression|3|||
170460124|NCT01150890|616026852|FG003|Overall Study|Disease progression|7|||
170460125|NCT01672970|616026853|FG000|Overall Study|Lack of Efficacy|12|||
170460126|NCT01672970|616026853|FG000|Overall Study|Adverse Event|18|||
170460127|NCT01672970|616026853|FG000|Overall Study|Withdrawal by Subject|2|||
170460128|NCT01672970|616026853|FG000|Overall Study|Lost to Follow-up|5|||
170460129|NCT01672970|616026853|FG000|Overall Study|Other|9|||
170460130|NCT01672970|616026853|FG000|Overall Study|Enrolled but not treated|1|||
170460131|NCT02132754|616026854|FG000|Overall Study|Adverse Event|0|||
170460132|NCT02132754|616026855|FG001|Overall Study|Adverse Event|0|||
170460133|NCT02132754|616026856|FG002|Overall Study|Adverse Event|0|||
170460134|NCT02132754|616026857|FG003|Overall Study|Adverse Event|0|||
170460135|NCT02132754|616026858|FG004|Overall Study|Adverse Event|0|||
170460136|NCT02132754|616026859|FG005|Overall Study|Adverse Event|0|||
170543429|NCT00849472|616332887|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
170543430|NCT00849472|616332887|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
170788720|NCT05329220|617236393|FG002|Active Trial Period|Withdrawal by Subject|0|||
170460137|NCT02132754|616026860|FG006|Overall Study|Adverse Event|0|||
170460138|NCT02132754|616026861|FG007|Overall Study|Adverse Event|0|||
170460139|NCT02132754|616026862|FG008|Overall Study|Adverse Event|0|||
170460140|NCT02132754|616026863|FG009|Overall Study|Adverse Event|0|||
170460141|NCT02132754|616026864|FG010|Overall Study|Adverse Event|0|||
170460142|NCT02132754|616026865|FG011|Overall Study|Adverse Event|0|||
170460143|NCT02132754|616026866|FG012|Overall Study|Adverse Event|0|||
170460144|NCT02132754|616026867|FG013|Overall Study|Adverse Event|0|||
170460145|NCT02132754|616026868|FG014|Overall Study|Adverse Event|0|||
170460146|NCT02132754|616026869|FG015|Overall Study|Adverse Event|0|||
170460147|NCT02132754|616026870|FG016|Overall Study|Adverse Event|0|||
170460148|NCT02132754|616026871|FG017|Overall Study|Adverse Event|1|||
170460149|NCT02132754|616026872|FG018|Overall Study|Adverse Event|0|||
170460150|NCT02132754|616026873|FG019|Overall Study|Adverse Event|0|||
170460151|NCT02132754|616026874|FG020|Overall Study|Adverse Event|0|||
170460152|NCT02132754|616026875|FG021|Overall Study|Adverse Event|0|||
170460153|NCT02132754|616026876|FG022|Overall Study|Adverse Event|0|||
170460154|NCT02132754|616026877|FG023|Overall Study|Adverse Event|0|||
170460155|NCT02132754|616026878|FG024|Overall Study|Adverse Event|0|||
170460156|NCT02132754|616026879|FG025|Overall Study|Adverse Event|1|||
170460157|NCT02132754|616026880|FG026|Overall Study|Adverse Event|1|||
170460158|NCT02132754|616026881|FG027|Overall Study|Adverse Event|0|||
170460159|NCT02132754|616026882|FG028|Overall Study|Adverse Event|0|||
170460160|NCT02132754|616026883|FG029|Overall Study|Adverse Event|0|||
170460161|NCT02132754|616026884|FG030|Overall Study|Adverse Event|1|||
170460162|NCT02132754|616026885|FG031|Overall Study|Adverse Event|0|||
170460163|NCT02132754|616026886|FG032|Overall Study|Adverse Event|1|||
170460164|NCT02132754|616026887|FG033|Overall Study|Adverse Event|1|||
170460165|NCT02132754|616026854|FG000|Overall Study|Clinical Progression|0|||
170460166|NCT02132754|616026855|FG001|Overall Study|Clinical Progression|0|||
170460167|NCT02132754|616026856|FG002|Overall Study|Clinical Progression|0|||
170460168|NCT02132754|616026857|FG003|Overall Study|Clinical Progression|0|||
170460169|NCT02132754|616026858|FG004|Overall Study|Clinical Progression|0|||
170460170|NCT02132754|616026859|FG005|Overall Study|Clinical Progression|0|||
170460171|NCT02132754|616026860|FG006|Overall Study|Clinical Progression|0|||
170460172|NCT02132754|616026861|FG007|Overall Study|Clinical Progression|0|||
170460173|NCT02132754|616026862|FG008|Overall Study|Clinical Progression|0|||
170460174|NCT02132754|616026863|FG009|Overall Study|Clinical Progression|1|||
170460175|NCT02132754|616026864|FG010|Overall Study|Clinical Progression|0|||
170460176|NCT02132754|616026865|FG011|Overall Study|Clinical Progression|0|||
170460177|NCT02132754|616026866|FG012|Overall Study|Clinical Progression|0|||
170460178|NCT02132754|616026867|FG013|Overall Study|Clinical Progression|0|||
170460179|NCT02132754|616026868|FG014|Overall Study|Clinical Progression|0|||
170460180|NCT02132754|616026869|FG015|Overall Study|Clinical Progression|0|||
170460181|NCT02132754|616026870|FG016|Overall Study|Clinical Progression|1|||
170460182|NCT02132754|616026871|FG017|Overall Study|Clinical Progression|1|||
170460183|NCT02132754|616026872|FG018|Overall Study|Clinical Progression|0|||
170460184|NCT02132754|616026873|FG019|Overall Study|Clinical Progression|1|||
170460185|NCT02132754|616026874|FG020|Overall Study|Clinical Progression|0|||
170460186|NCT02132754|616026875|FG021|Overall Study|Clinical Progression|0|||
170460187|NCT02132754|616026876|FG022|Overall Study|Clinical Progression|1|||
170460188|NCT02132754|616026877|FG023|Overall Study|Clinical Progression|0|||
170460189|NCT02132754|616026878|FG024|Overall Study|Clinical Progression|1|||
170460190|NCT02132754|616026879|FG025|Overall Study|Clinical Progression|1|||
170460191|NCT02132754|616026880|FG026|Overall Study|Clinical Progression|0|||
170460192|NCT02132754|616026881|FG027|Overall Study|Clinical Progression|1|||
170460193|NCT02132754|616026882|FG028|Overall Study|Clinical Progression|1|||
170788721|NCT05329220|617236394|FG003|Active Trial Period|Withdrawal by Subject|1|||
170460194|NCT02132754|616026883|FG029|Overall Study|Clinical Progression|0|||
170460195|NCT02132754|616026884|FG030|Overall Study|Clinical Progression|1|||
170460196|NCT02132754|616026885|FG031|Overall Study|Clinical Progression|0|||
170460197|NCT02132754|616026886|FG032|Overall Study|Clinical Progression|0|||
170460198|NCT02132754|616026887|FG033|Overall Study|Clinical Progression|2|||
170460199|NCT02132754|616026854|FG000|Overall Study|Death|0|||
170460200|NCT02132754|616026855|FG001|Overall Study|Death|0|||
170460201|NCT02132754|616026856|FG002|Overall Study|Death|0|||
170460202|NCT02132754|616026857|FG003|Overall Study|Death|0|||
170460203|NCT02132754|616026858|FG004|Overall Study|Death|0|||
170460204|NCT02132754|616026859|FG005|Overall Study|Death|0|||
170460205|NCT02132754|616026860|FG006|Overall Study|Death|0|||
170460206|NCT02132754|616026861|FG007|Overall Study|Death|0|||
170460207|NCT02132754|616026862|FG008|Overall Study|Death|0|||
170460208|NCT02132754|616026863|FG009|Overall Study|Death|0|||
170460209|NCT02132754|616026864|FG010|Overall Study|Death|0|||
170460210|NCT02132754|616026865|FG011|Overall Study|Death|0|||
170460211|NCT02132754|616026866|FG012|Overall Study|Death|0|||
170460212|NCT02132754|616026867|FG013|Overall Study|Death|0|||
170460213|NCT02132754|616026868|FG014|Overall Study|Death|0|||
170460214|NCT02132754|616026869|FG015|Overall Study|Death|1|||
170788722|NCT05329220|617236395|FG004|Active Trial Period|Withdrawal by Subject|12|||
170788723|NCT05329220|617236396|FG005|Active Trial Period|Withdrawal by Subject|13|||
170788724|NCT05329220|617236391|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
170788725|NCT05329220|617236392|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
170788726|NCT05329220|617236393|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
170788727|NCT05329220|617236394|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
170460215|NCT02132754|616026870|FG016|Overall Study|Death|0|||
170460216|NCT02132754|616026871|FG017|Overall Study|Death|0|||
170460217|NCT02132754|616026872|FG018|Overall Study|Death|0|||
170543431|NCT00825175|616332888|FG000|Overall Study|Withdrawal by Subject|0|||
170460218|NCT02132754|616026873|FG019|Overall Study|Death|1|||
170460219|NCT02132754|616026874|FG020|Overall Study|Death|0|||
170460220|NCT02132754|616026875|FG021|Overall Study|Death|1|||
170460221|NCT02132754|616026876|FG022|Overall Study|Death|0|||
170460222|NCT02132754|616026877|FG023|Overall Study|Death|0|||
170460223|NCT02132754|616026878|FG024|Overall Study|Death|0|||
170460224|NCT02132754|616026879|FG025|Overall Study|Death|0|||
170460225|NCT02132754|616026880|FG026|Overall Study|Death|1|||
170460226|NCT02132754|616026881|FG027|Overall Study|Death|0|||
170460227|NCT02132754|616026882|FG028|Overall Study|Death|0|||
170460228|NCT02132754|616026883|FG029|Overall Study|Death|0|||
170460229|NCT02132754|616026884|FG030|Overall Study|Death|0|||
170460230|NCT02132754|616026885|FG031|Overall Study|Death|0|||
170460231|NCT02132754|616026886|FG032|Overall Study|Death|0|||
170460232|NCT02132754|616026887|FG033|Overall Study|Death|2|||
170460233|NCT02132754|616026854|FG000|Overall Study|Excluded Medication|0|||
170460234|NCT02132754|616026855|FG001|Overall Study|Excluded Medication|0|||
170460235|NCT02132754|616026856|FG002|Overall Study|Excluded Medication|0|||
170460236|NCT02132754|616026857|FG003|Overall Study|Excluded Medication|0|||
170460237|NCT02132754|616026858|FG004|Overall Study|Excluded Medication|0|||
170460238|NCT02132754|616026859|FG005|Overall Study|Excluded Medication|0|||
170460239|NCT02132754|616026860|FG006|Overall Study|Excluded Medication|0|||
170460240|NCT02132754|616026861|FG007|Overall Study|Excluded Medication|0|||
170460241|NCT02132754|616026862|FG008|Overall Study|Excluded Medication|0|||
170460242|NCT02132754|616026863|FG009|Overall Study|Excluded Medication|0|||
170460243|NCT02132754|616026864|FG010|Overall Study|Excluded Medication|0|||
170460244|NCT02132754|616026865|FG011|Overall Study|Excluded Medication|0|||
170460245|NCT02132754|616026866|FG012|Overall Study|Excluded Medication|0|||
170460246|NCT02132754|616026867|FG013|Overall Study|Excluded Medication|0|||
170460247|NCT02132754|616026868|FG014|Overall Study|Excluded Medication|0|||
170460248|NCT02132754|616026869|FG015|Overall Study|Excluded Medication|0|||
170460249|NCT02132754|616026870|FG016|Overall Study|Excluded Medication|0|||
170460250|NCT02132754|616026871|FG017|Overall Study|Excluded Medication|0|||
170460251|NCT02132754|616026872|FG018|Overall Study|Excluded Medication|0|||
170460252|NCT02132754|616026873|FG019|Overall Study|Excluded Medication|0|||
170460253|NCT02132754|616026874|FG020|Overall Study|Excluded Medication|1|||
170460254|NCT02132754|616026875|FG021|Overall Study|Excluded Medication|0|||
170460255|NCT02132754|616026876|FG022|Overall Study|Excluded Medication|0|||
170460256|NCT02132754|616026877|FG023|Overall Study|Excluded Medication|0|||
170460257|NCT02132754|616026878|FG024|Overall Study|Excluded Medication|0|||
170460258|NCT02132754|616026879|FG025|Overall Study|Excluded Medication|0|||
170460259|NCT02132754|616026880|FG026|Overall Study|Excluded Medication|0|||
170460260|NCT02132754|616026881|FG027|Overall Study|Excluded Medication|0|||
170460261|NCT02132754|616026882|FG028|Overall Study|Excluded Medication|0|||
170460262|NCT02132754|616026883|FG029|Overall Study|Excluded Medication|0|||
170788728|NCT05329220|617236395|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
170788729|NCT05329220|617236396|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
170788730|NCT05329220|617236391|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
170788731|NCT05329220|617236392|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
170788732|NCT05329220|617236393|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
170788733|NCT05329220|617236394|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
170788734|NCT05329220|617236395|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
170788735|NCT05329220|617236396|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
170788736|NCT05329220|617236391|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
170788737|NCT05329220|617236392|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
170788738|NCT05329220|617236393|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
170788739|NCT05329220|617236394|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
170788740|NCT05329220|617236395|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
170788741|NCT05329220|617236396|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
170788742|NCT05329220|617236391|FG000|Follow-up Period|Adverse Event|0|||
170788743|NCT05329220|617236392|FG001|Follow-up Period|Adverse Event|0|||
170460263|NCT02132754|616026884|FG030|Overall Study|Excluded Medication|0|||
170460264|NCT02132754|616026885|FG031|Overall Study|Excluded Medication|0|||
170460265|NCT02132754|616026886|FG032|Overall Study|Excluded Medication|0|||
170460266|NCT02132754|616026887|FG033|Overall Study|Excluded Medication|1|||
170460267|NCT02132754|616026854|FG000|Overall Study|Physician Decision|0|||
170543432|NCT00825175|616332889|FG001|Overall Study|Withdrawal by Subject|5|||
170543433|NCT02762604|616332890|FG000|Overall Study|Lost to Follow-up|2|||
170788744|NCT05329220|617236393|FG002|Follow-up Period|Adverse Event|0|||
170460268|NCT02132754|616026855|FG001|Overall Study|Physician Decision|0|||
170460269|NCT02132754|616026856|FG002|Overall Study|Physician Decision|0|||
170460270|NCT02132754|616026857|FG003|Overall Study|Physician Decision|0|||
170460271|NCT02132754|616026858|FG004|Overall Study|Physician Decision|0|||
170460272|NCT02132754|616026859|FG005|Overall Study|Physician Decision|0|||
170460273|NCT02132754|616026860|FG006|Overall Study|Physician Decision|0|||
170460274|NCT02132754|616026861|FG007|Overall Study|Physician Decision|0|||
170460275|NCT02132754|616026862|FG008|Overall Study|Physician Decision|0|||
170460276|NCT02132754|616026863|FG009|Overall Study|Physician Decision|1|||
170460277|NCT02132754|616026864|FG010|Overall Study|Physician Decision|0|||
170460278|NCT02132754|616026865|FG011|Overall Study|Physician Decision|1|||
170460279|NCT02132754|616026866|FG012|Overall Study|Physician Decision|1|||
170460280|NCT02132754|616026867|FG013|Overall Study|Physician Decision|0|||
170460281|NCT02132754|616026868|FG014|Overall Study|Physician Decision|0|||
170460282|NCT02132754|616026869|FG015|Overall Study|Physician Decision|1|||
170460283|NCT02132754|616026870|FG016|Overall Study|Physician Decision|0|||
170460284|NCT02132754|616026871|FG017|Overall Study|Physician Decision|0|||
170460285|NCT02132754|616026872|FG018|Overall Study|Physician Decision|0|||
170460286|NCT02132754|616026873|FG019|Overall Study|Physician Decision|0|||
170460287|NCT02132754|616026874|FG020|Overall Study|Physician Decision|0|||
170460288|NCT02132754|616026875|FG021|Overall Study|Physician Decision|0|||
170460289|NCT02132754|616026876|FG022|Overall Study|Physician Decision|0|||
170460290|NCT02132754|616026877|FG023|Overall Study|Physician Decision|0|||
170460291|NCT02132754|616026878|FG024|Overall Study|Physician Decision|1|||
170460292|NCT02132754|616026879|FG025|Overall Study|Physician Decision|0|||
170460293|NCT02132754|616026880|FG026|Overall Study|Physician Decision|0|||
170460294|NCT02132754|616026881|FG027|Overall Study|Physician Decision|0|||
170460295|NCT02132754|616026882|FG028|Overall Study|Physician Decision|0|||
170460296|NCT02132754|616026883|FG029|Overall Study|Physician Decision|0|||
170460297|NCT02132754|616026884|FG030|Overall Study|Physician Decision|0|||
170460298|NCT02132754|616026885|FG031|Overall Study|Physician Decision|1|||
170460299|NCT02132754|616026886|FG032|Overall Study|Physician Decision|0|||
170460300|NCT02132754|616026887|FG033|Overall Study|Physician Decision|3|||
170460301|NCT02132754|616026854|FG000|Overall Study|Progressive Disease|1|||
170460302|NCT02132754|616026855|FG001|Overall Study|Progressive Disease|1|||
170460303|NCT02132754|616026856|FG002|Overall Study|Progressive Disease|1|||
170460304|NCT02132754|616026857|FG003|Overall Study|Progressive Disease|1|||
170460305|NCT02132754|616026858|FG004|Overall Study|Progressive Disease|1|||
170460306|NCT02132754|616026859|FG005|Overall Study|Progressive Disease|1|||
170460307|NCT02132754|616026860|FG006|Overall Study|Progressive Disease|1|||
170460308|NCT02132754|616026861|FG007|Overall Study|Progressive Disease|1|||
170460309|NCT02132754|616026862|FG008|Overall Study|Progressive Disease|1|||
170460310|NCT02132754|616026863|FG009|Overall Study|Progressive Disease|3|||
170460311|NCT02132754|616026864|FG010|Overall Study|Progressive Disease|3|||
170788745|NCT05329220|617236394|FG003|Follow-up Period|Adverse Event|0|||
170788746|NCT05329220|617236395|FG004|Follow-up Period|Adverse Event|2|||
170788747|NCT05329220|617236396|FG005|Follow-up Period|Adverse Event|1|||
170788748|NCT05329220|617236391|FG000|Follow-up Period|Death|0|||
170788749|NCT05329220|617236392|FG001|Follow-up Period|Death|0|||
170788750|NCT05329220|617236393|FG002|Follow-up Period|Death|1|||
170788751|NCT05329220|617236394|FG003|Follow-up Period|Death|1|||
170788752|NCT05329220|617236395|FG004|Follow-up Period|Death|0|||
170788753|NCT05329220|617236396|FG005|Follow-up Period|Death|1|||
170788754|NCT05329220|617236391|FG000|Follow-up Period|Lost to Follow-up|0|||
170788755|NCT05329220|617236392|FG001|Follow-up Period|Lost to Follow-up|1|||
170788756|NCT05329220|617236393|FG002|Follow-up Period|Lost to Follow-up|2|||
170788757|NCT05329220|617236394|FG003|Follow-up Period|Lost to Follow-up|2|||
170788758|NCT05329220|617236395|FG004|Follow-up Period|Lost to Follow-up|113|||
170788759|NCT05329220|617236396|FG005|Follow-up Period|Lost to Follow-up|89|||
170788760|NCT05329220|617236391|FG000|Follow-up Period|Physician Decision|0|||
170788761|NCT05329220|617236392|FG001|Follow-up Period|Physician Decision|0|||
170788762|NCT05329220|617236393|FG002|Follow-up Period|Physician Decision|0|||
170788763|NCT05329220|617236394|FG003|Follow-up Period|Physician Decision|0|||
170788764|NCT05329220|617236395|FG004|Follow-up Period|Physician Decision|2|||
170788765|NCT05329220|617236396|FG005|Follow-up Period|Physician Decision|2|||
170788766|NCT05329220|617236391|FG000|Follow-up Period|Protocol Violation|0|||
170788767|NCT05329220|617236392|FG001|Follow-up Period|Protocol Violation|0|||
170788768|NCT05329220|617236393|FG002|Follow-up Period|Protocol Violation|0|||
170460312|NCT02132754|616026865|FG011|Overall Study|Progressive Disease|2|||
170460313|NCT02132754|616026866|FG012|Overall Study|Progressive Disease|2|||
170460314|NCT02132754|616026867|FG013|Overall Study|Progressive Disease|3|||
170460315|NCT02132754|616026868|FG014|Overall Study|Progressive Disease|2|||
170460316|NCT02132754|616026869|FG015|Overall Study|Progressive Disease|1|||
170460317|NCT02132754|616026870|FG016|Overall Study|Progressive Disease|2|||
170460318|NCT02132754|616026871|FG017|Overall Study|Progressive Disease|1|||
170460319|NCT02132754|616026872|FG018|Overall Study|Progressive Disease|3|||
170460320|NCT02132754|616026873|FG019|Overall Study|Progressive Disease|1|||
170460321|NCT02132754|616026874|FG020|Overall Study|Progressive Disease|1|||
170788769|NCT05329220|617236394|FG003|Follow-up Period|Protocol Violation|0|||
170788770|NCT05329220|617236395|FG004|Follow-up Period|Protocol Violation|0|||
170788771|NCT05329220|617236396|FG005|Follow-up Period|Protocol Violation|1|||
170788772|NCT05329220|617236391|FG000|Follow-up Period|Withdrawal by Subject|0|||
170788773|NCT05329220|617236392|FG001|Follow-up Period|Withdrawal by Subject|0|||
170788774|NCT05329220|617236393|FG002|Follow-up Period|Withdrawal by Subject|1|||
170788775|NCT05329220|617236394|FG003|Follow-up Period|Withdrawal by Subject|1|||
170788776|NCT05329220|617236395|FG004|Follow-up Period|Withdrawal by Subject|34|||
170460322|NCT02132754|616026875|FG021|Overall Study|Progressive Disease|3|||
170460323|NCT02132754|616026876|FG022|Overall Study|Progressive Disease|2|||
170460324|NCT02132754|616026877|FG023|Overall Study|Progressive Disease|3|||
170460325|NCT02132754|616026878|FG024|Overall Study|Progressive Disease|0|||
170460326|NCT02132754|616026879|FG025|Overall Study|Progressive Disease|1|||
170460327|NCT02132754|616026880|FG026|Overall Study|Progressive Disease|2|||
170460328|NCT02132754|616026881|FG027|Overall Study|Progressive Disease|1|||
170460329|NCT02132754|616026882|FG028|Overall Study|Progressive Disease|2|||
170460330|NCT02132754|616026883|FG029|Overall Study|Progressive Disease|3|||
170460331|NCT02132754|616026884|FG030|Overall Study|Progressive Disease|1|||
170460332|NCT02132754|616026885|FG031|Overall Study|Progressive Disease|1|||
170460333|NCT02132754|616026886|FG032|Overall Study|Progressive Disease|3|||
170460334|NCT02132754|616026887|FG033|Overall Study|Progressive Disease|6|||
170460335|NCT02132754|616026854|FG000|Overall Study|Screen Failure|0|||
170460336|NCT02132754|616026855|FG001|Overall Study|Screen Failure|0|||
170460337|NCT02132754|616026856|FG002|Overall Study|Screen Failure|0|||
170460338|NCT02132754|616026857|FG003|Overall Study|Screen Failure|0|||
170460339|NCT02132754|616026858|FG004|Overall Study|Screen Failure|0|||
170460340|NCT02132754|616026859|FG005|Overall Study|Screen Failure|0|||
170460341|NCT02132754|616026860|FG006|Overall Study|Screen Failure|0|||
170460342|NCT02132754|616026861|FG007|Overall Study|Screen Failure|0|||
170460343|NCT02132754|616026862|FG008|Overall Study|Screen Failure|0|||
170460344|NCT02132754|616026863|FG009|Overall Study|Screen Failure|0|||
170460345|NCT02132754|616026864|FG010|Overall Study|Screen Failure|0|||
170460346|NCT02132754|616026865|FG011|Overall Study|Screen Failure|0|||
170460347|NCT02132754|616026866|FG012|Overall Study|Screen Failure|0|||
170460348|NCT02132754|616026867|FG013|Overall Study|Screen Failure|0|||
170788777|NCT05329220|617236396|FG005|Follow-up Period|Withdrawal by Subject|35|||
170788778|NCT05329220|617236391|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
170788779|NCT05329220|617236392|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
170788780|NCT05329220|617236393|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
170788781|NCT05329220|617236394|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
170788782|NCT05329220|617236395|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
170788783|NCT05329220|617236396|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
170788784|NCT05329220|617236391|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
170788785|NCT05329220|617236392|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
170788786|NCT05329220|617236393|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
170788787|NCT05329220|617236394|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
170788788|NCT05329220|617236395|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
170788789|NCT05329220|617236396|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
170788790|NCT05329220|617236391|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
170788791|NCT05329220|617236392|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
170788792|NCT05329220|617236393|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
170788793|NCT05329220|617236394|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
170788794|NCT05329220|617236395|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
170788795|NCT05329220|617236396|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
170788796|NCT05329220|617236391|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
170788797|NCT05329220|617236392|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
170788798|NCT05329220|617236393|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
170788799|NCT05329220|617236394|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
170788800|NCT05329220|617236395|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
170788801|NCT05329220|617236396|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
170788802|NCT05329220|617236391|FG000|Follow-up Period|EARLY TERMINATION|0|||
170788803|NCT05329220|617236392|FG001|Follow-up Period|EARLY TERMINATION|0|||
170788804|NCT05329220|617236393|FG002|Follow-up Period|EARLY TERMINATION|0|||
170788805|NCT05329220|617236394|FG003|Follow-up Period|EARLY TERMINATION|0|||
170788806|NCT05329220|617236395|FG004|Follow-up Period|EARLY TERMINATION|0|||
170788807|NCT05329220|617236396|FG005|Follow-up Period|EARLY TERMINATION|1|||
170788808|NCT05329220|617236391|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
170788809|NCT05329220|617236392|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
170788810|NCT05329220|617236393|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
170788811|NCT05329220|617236394|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
170788812|NCT05329220|617236395|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
170788813|NCT05329220|617236396|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
170788814|NCT05329220|617236391|FG000|Follow-up Period|DROPPED|0|||
170788815|NCT05329220|617236392|FG001|Follow-up Period|DROPPED|0|||
170788816|NCT05329220|617236393|FG002|Follow-up Period|DROPPED|0|||
170788817|NCT05329220|617236394|FG003|Follow-up Period|DROPPED|0|||
170788818|NCT05329220|617236395|FG004|Follow-up Period|DROPPED|0|||
170788819|NCT05329220|617236396|FG005|Follow-up Period|DROPPED|1|||
170788820|NCT05329220|617236391|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
170889700|NCT01328951|617602334|FG000|Overall Study|Adverse Event|2|||
170889701|NCT01328951|617602335|FG001|Overall Study|Adverse Event|0|||
170889702|NCT01328951|617602334|FG000|Overall Study|Death|243|||
170889703|NCT01328951|617602335|FG001|Overall Study|Death|258|||
170889704|NCT01328951|617602334|FG000|Overall Study|Lost to Follow-up|6|||
170889705|NCT01328951|617602335|FG001|Overall Study|Lost to Follow-up|7|||
170460349|NCT02132754|616026868|FG014|Overall Study|Screen Failure|0|||
170460350|NCT02132754|616026869|FG015|Overall Study|Screen Failure|0|||
170460351|NCT02132754|616026870|FG016|Overall Study|Screen Failure|0|||
170460352|NCT02132754|616026871|FG017|Overall Study|Screen Failure|0|||
170460353|NCT02132754|616026872|FG018|Overall Study|Screen Failure|0|||
170460354|NCT02132754|616026873|FG019|Overall Study|Screen Failure|1|||
170460355|NCT02132754|616026874|FG020|Overall Study|Screen Failure|0|||
170460356|NCT02132754|616026875|FG021|Overall Study|Screen Failure|1|||
170460357|NCT02132754|616026876|FG022|Overall Study|Screen Failure|0|||
170460358|NCT02132754|616026877|FG023|Overall Study|Screen Failure|0|||
170460359|NCT02132754|616026878|FG024|Overall Study|Screen Failure|0|||
170460360|NCT02132754|616026879|FG025|Overall Study|Screen Failure|0|||
170460361|NCT02132754|616026880|FG026|Overall Study|Screen Failure|0|||
170460362|NCT02132754|616026881|FG027|Overall Study|Screen Failure|0|||
170460363|NCT02132754|616026882|FG028|Overall Study|Screen Failure|0|||
170460364|NCT02132754|616026883|FG029|Overall Study|Screen Failure|0|||
170460365|NCT02132754|616026884|FG030|Overall Study|Screen Failure|0|||
170460366|NCT02132754|616026885|FG031|Overall Study|Screen Failure|0|||
170460367|NCT02132754|616026886|FG032|Overall Study|Screen Failure|0|||
170460368|NCT02132754|616026887|FG033|Overall Study|Screen Failure|0|||
170460369|NCT02132754|616026854|FG000|Overall Study|Transferred to Extension Study|0|||
170460370|NCT02132754|616026855|FG001|Overall Study|Transferred to Extension Study|0|||
170460371|NCT02132754|616026856|FG002|Overall Study|Transferred to Extension Study|0|||
170460372|NCT02132754|616026857|FG003|Overall Study|Transferred to Extension Study|0|||
170460373|NCT02132754|616026858|FG004|Overall Study|Transferred to Extension Study|0|||
170460374|NCT02132754|616026859|FG005|Overall Study|Transferred to Extension Study|0|||
170460375|NCT02132754|616026860|FG006|Overall Study|Transferred to Extension Study|0|||
170460376|NCT02132754|616026861|FG007|Overall Study|Transferred to Extension Study|0|||
170460377|NCT02132754|616026862|FG008|Overall Study|Transferred to Extension Study|0|||
170460378|NCT02132754|616026863|FG009|Overall Study|Transferred to Extension Study|0|||
170460379|NCT02132754|616026864|FG010|Overall Study|Transferred to Extension Study|0|||
170460380|NCT02132754|616026865|FG011|Overall Study|Transferred to Extension Study|0|||
170460381|NCT02132754|616026866|FG012|Overall Study|Transferred to Extension Study|0|||
170460382|NCT02132754|616026867|FG013|Overall Study|Transferred to Extension Study|0|||
170543434|NCT02762604|616332891|FG001|Overall Study|Lost to Follow-up|7|||
170543435|NCT02762604|616332890|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
170543436|NCT02762604|616332891|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
170788821|NCT05329220|617236392|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
170788822|NCT05329220|617236393|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
170788823|NCT05329220|617236394|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
170788824|NCT05329220|617236395|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
170788825|NCT05329220|617236396|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
170788826|NCT02861300|617236398|FG000|Overall Study|Death|0|||
170788827|NCT02861300|617236399|FG001|Overall Study|Death|0|||
170788828|NCT02861300|617236400|FG002|Overall Study|Death|0|||
170788829|NCT02861300|617236401|FG003|Overall Study|Death|0|||
170788830|NCT02861300|617236402|FG004|Overall Study|Death|0|||
170788831|NCT02861300|617236403|FG005|Overall Study|Death|0|||
170788832|NCT02861300|617236404|FG006|Overall Study|Death|24|||
170788833|NCT02861300|617236398|FG000|Overall Study|Delay in treatment|0|||
170788834|NCT02861300|617236399|FG001|Overall Study|Delay in treatment|0|||
170788835|NCT02861300|617236400|FG002|Overall Study|Delay in treatment|0|||
170460383|NCT02132754|616026868|FG014|Overall Study|Transferred to Extension Study|0|||
170460384|NCT02132754|616026869|FG015|Overall Study|Transferred to Extension Study|0|||
170460385|NCT02132754|616026870|FG016|Overall Study|Transferred to Extension Study|0|||
170543437|NCT03833167|616332892|FG000|Overall Study|Withdrawal by Subject|4|||
170460386|NCT02132754|616026871|FG017|Overall Study|Transferred to Extension Study|0|||
170460387|NCT02132754|616026872|FG018|Overall Study|Transferred to Extension Study|0|||
170460388|NCT02132754|616026873|FG019|Overall Study|Transferred to Extension Study|0|||
170788836|NCT02861300|617236401|FG003|Overall Study|Delay in treatment|0|||
170788837|NCT02861300|617236402|FG004|Overall Study|Delay in treatment|0|||
170788838|NCT02861300|617236403|FG005|Overall Study|Delay in treatment|1|||
170788839|NCT02861300|617236404|FG006|Overall Study|Delay in treatment|0|||
170788840|NCT02861300|617236398|FG000|Overall Study|Disease Progression|0|||
170788841|NCT02861300|617236399|FG001|Overall Study|Disease Progression|1|||
170788842|NCT02861300|617236400|FG002|Overall Study|Disease Progression|0|||
170788843|NCT02861300|617236401|FG003|Overall Study|Disease Progression|0|||
170788844|NCT02861300|617236402|FG004|Overall Study|Disease Progression|0|||
170788845|NCT02861300|617236403|FG005|Overall Study|Disease Progression|0|||
170889706|NCT01328951|617602334|FG000|Overall Study|Withdrawal by Subject|6|||
170460389|NCT02132754|616026874|FG020|Overall Study|Transferred to Extension Study|0|||
170460390|NCT02132754|616026875|FG021|Overall Study|Transferred to Extension Study|0|||
170460391|NCT02132754|616026876|FG022|Overall Study|Transferred to Extension Study|0|||
170460392|NCT02132754|616026877|FG023|Overall Study|Transferred to Extension Study|0|||
170460393|NCT02132754|616026878|FG024|Overall Study|Transferred to Extension Study|0|||
170460394|NCT02132754|616026879|FG025|Overall Study|Transferred to Extension Study|0|||
170460395|NCT02132754|616026880|FG026|Overall Study|Transferred to Extension Study|0|||
170460396|NCT02132754|616026881|FG027|Overall Study|Transferred to Extension Study|0|||
170460397|NCT02132754|616026882|FG028|Overall Study|Transferred to Extension Study|0|||
170460398|NCT02132754|616026883|FG029|Overall Study|Transferred to Extension Study|0|||
170460399|NCT02132754|616026884|FG030|Overall Study|Transferred to Extension Study|0|||
170460400|NCT02132754|616026885|FG031|Overall Study|Transferred to Extension Study|0|||
170460401|NCT02132754|616026886|FG032|Overall Study|Transferred to Extension Study|0|||
170460402|NCT02132754|616026887|FG033|Overall Study|Transferred to Extension Study|6|||
170460403|NCT02132754|616026854|FG000|Overall Study|Withdrawal by Subject|0|||
170460404|NCT02132754|616026855|FG001|Overall Study|Withdrawal by Subject|0|||
170460405|NCT02132754|616026856|FG002|Overall Study|Withdrawal by Subject|0|||
170460406|NCT02132754|616026857|FG003|Overall Study|Withdrawal by Subject|0|||
170460407|NCT02132754|616026858|FG004|Overall Study|Withdrawal by Subject|0|||
170460408|NCT02132754|616026859|FG005|Overall Study|Withdrawal by Subject|0|||
170460409|NCT02132754|616026860|FG006|Overall Study|Withdrawal by Subject|0|||
170460410|NCT02132754|616026861|FG007|Overall Study|Withdrawal by Subject|0|||
170460411|NCT02132754|616026862|FG008|Overall Study|Withdrawal by Subject|0|||
170460412|NCT02132754|616026863|FG009|Overall Study|Withdrawal by Subject|1|||
170460413|NCT02132754|616026864|FG010|Overall Study|Withdrawal by Subject|0|||
170460414|NCT02132754|616026865|FG011|Overall Study|Withdrawal by Subject|0|||
170460415|NCT02132754|616026866|FG012|Overall Study|Withdrawal by Subject|1|||
170460416|NCT02132754|616026867|FG013|Overall Study|Withdrawal by Subject|0|||
170460417|NCT02132754|616026868|FG014|Overall Study|Withdrawal by Subject|1|||
170460418|NCT02132754|616026869|FG015|Overall Study|Withdrawal by Subject|2|||
170460419|NCT02132754|616026870|FG016|Overall Study|Withdrawal by Subject|1|||
170460420|NCT02132754|616026871|FG017|Overall Study|Withdrawal by Subject|0|||
170460421|NCT02132754|616026872|FG018|Overall Study|Withdrawal by Subject|0|||
170460422|NCT02132754|616026873|FG019|Overall Study|Withdrawal by Subject|0|||
170460423|NCT02132754|616026874|FG020|Overall Study|Withdrawal by Subject|1|||
170460424|NCT02132754|616026875|FG021|Overall Study|Withdrawal by Subject|0|||
170460425|NCT02132754|616026876|FG022|Overall Study|Withdrawal by Subject|0|||
170460426|NCT02132754|616026877|FG023|Overall Study|Withdrawal by Subject|0|||
170460427|NCT02132754|616026878|FG024|Overall Study|Withdrawal by Subject|1|||
170460428|NCT02132754|616026879|FG025|Overall Study|Withdrawal by Subject|0|||
170460429|NCT02132754|616026880|FG026|Overall Study|Withdrawal by Subject|0|||
170460430|NCT02132754|616026881|FG027|Overall Study|Withdrawal by Subject|1|||
170460431|NCT02132754|616026882|FG028|Overall Study|Withdrawal by Subject|0|||
170460432|NCT02132754|616026883|FG029|Overall Study|Withdrawal by Subject|0|||
170460433|NCT02132754|616026884|FG030|Overall Study|Withdrawal by Subject|0|||
170460434|NCT02132754|616026885|FG031|Overall Study|Withdrawal by Subject|1|||
170460435|NCT02132754|616026886|FG032|Overall Study|Withdrawal by Subject|0|||
170460436|NCT02132754|616026887|FG033|Overall Study|Withdrawal by Subject|2|||
170460437|NCT04568031|616026894|FG000|Overall Study|Lost to Follow-up|1|||
170460438|NCT04568031|616026895|FG001|Overall Study|Lost to Follow-up|0|||
170460439|NCT04568031|616026896|FG002|Overall Study|Lost to Follow-up|0|||
170460440|NCT04568031|616026897|FG003|Overall Study|Lost to Follow-up|0|||
170460441|NCT04568031|616026894|FG000|Overall Study|Physician Decision|1|||
170460442|NCT04568031|616026895|FG001|Overall Study|Physician Decision|0|||
170460443|NCT04568031|616026896|FG002|Overall Study|Physician Decision|1|||
170460444|NCT04568031|616026897|FG003|Overall Study|Physician Decision|0|||
170460445|NCT04568031|616026894|FG000|Overall Study|Withdrawal by Subject|1|||
170460446|NCT04568031|616026895|FG001|Overall Study|Withdrawal by Subject|0|||
170460447|NCT04568031|616026896|FG002|Overall Study|Withdrawal by Subject|4|||
170460448|NCT04568031|616026897|FG003|Overall Study|Withdrawal by Subject|1|||
170460449|NCT04430855|616026898|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
170460450|NCT04430855|616026899|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
170460451|NCT04430855|616026898|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
170460452|NCT04430855|616026899|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
170460453|NCT04430855|616026898|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
170460454|NCT04430855|616026899|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
170460455|NCT04430855|616026898|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
170460456|NCT04430855|616026899|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
170460457|NCT04430855|616026898|FG000|Period 1 (Weeks 1-12)|Other|0|||
170460458|NCT04430855|616026899|FG001|Period 1 (Weeks 1-12)|Other|1|||
170460459|NCT04430855|616026898|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
170460460|NCT04430855|616026899|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
170460461|NCT04430855|616026898|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
170460462|NCT04430855|616026899|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
170460463|NCT04430855|616026898|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
170460464|NCT04430855|616026899|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
170460465|NCT00186043|616026900|FG000|Overall Study|Lack of Efficacy|1|||
170460466|NCT00186043|616026901|FG001|Overall Study|Lack of Efficacy|3|||
170460467|NCT00186043|616026900|FG000|Overall Study|Lost to Follow-up|4|||
170460468|NCT00186043|616026901|FG001|Overall Study|Lost to Follow-up|6|||
170460469|NCT00186043|616026900|FG000|Overall Study|Withdrawal by Subject|1|||
170460470|NCT00186043|616026901|FG001|Overall Study|Withdrawal by Subject|0|||
170460471|NCT00186043|616026900|FG000|Overall Study|Adverse Event|7|||
170460472|NCT00186043|616026901|FG001|Overall Study|Adverse Event|3|||
170460473|NCT00186043|616026900|FG000|Overall Study|Protocol Violation|2|||
170460474|NCT00186043|616026901|FG001|Overall Study|Protocol Violation|1|||
170460475|NCT00390221|616026912|FG000|Overall Study|Lost to Follow-up|0|||
170460476|NCT00390221|616026913|FG001|Overall Study|Lost to Follow-up|3|||
170460477|NCT00390221|616026914|FG002|Overall Study|Lost to Follow-up|0|||
170460478|NCT00390221|616026912|FG000|Overall Study|Adverse Event|1|||
170460479|NCT00390221|616026913|FG001|Overall Study|Adverse Event|4|||
170460480|NCT00390221|616026914|FG002|Overall Study|Adverse Event|3|||
170460481|NCT00390221|616026912|FG000|Overall Study|Investigator Decision|0|||
170460482|NCT00390221|616026913|FG001|Overall Study|Investigator Decision|0|||
170460483|NCT00390221|616026914|FG002|Overall Study|Investigator Decision|1|||
170460484|NCT00390221|616026912|FG000|Overall Study|Withdrawal by Subject|13|||
170460485|NCT00390221|616026913|FG001|Overall Study|Withdrawal by Subject|9|||
170460486|NCT00390221|616026914|FG002|Overall Study|Withdrawal by Subject|7|||
170460487|NCT00390221|616026912|FG000|Overall Study|Subject Non-compliance|1|||
170460488|NCT00390221|616026913|FG001|Overall Study|Subject Non-compliance|0|||
170636115|NCT00459186|616678963|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
170788846|NCT02861300|617236404|FG006|Overall Study|Disease Progression|2|||
170788847|NCT02861300|617236398|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
170788848|NCT02861300|617236399|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
170788849|NCT02861300|617236400|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
170788850|NCT02861300|617236401|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
170788851|NCT02861300|617236402|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
170788852|NCT02861300|617236403|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
170788853|NCT02861300|617236404|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
170788854|NCT02861300|617236398|FG000|Overall Study|Clinical Complications|0|||
170788855|NCT02861300|617236399|FG001|Overall Study|Clinical Complications|0|||
170788856|NCT02861300|617236400|FG002|Overall Study|Clinical Complications|0|||
170788857|NCT02861300|617236401|FG003|Overall Study|Clinical Complications|0|||
170788858|NCT02861300|617236402|FG004|Overall Study|Clinical Complications|0|||
170788859|NCT02861300|617236403|FG005|Overall Study|Clinical Complications|0|||
170788860|NCT02861300|617236404|FG006|Overall Study|Clinical Complications|1|||
170788861|NCT02993159|617236407|FG000|Overall Study|Withdrawal by Subject|1|||
170788862|NCT02993159|617236408|FG001|Overall Study|Withdrawal by Subject|3|||
170788863|NCT02993159|617236407|FG000|Overall Study|Protocol Violation|1|||
170788864|NCT02993159|617236408|FG001|Overall Study|Protocol Violation|0|||
170788865|NCT02993159|617236407|FG000|Overall Study|Opted out of surgery|2|||
170788866|NCT02993159|617236408|FG001|Overall Study|Opted out of surgery|0|||
170788867|NCT02993159|617236407|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
170788868|NCT02993159|617236408|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
170788869|NCT02993159|617236407|FG000|Overall Study|Physician Decision|0|||
170788870|NCT02993159|617236408|FG001|Overall Study|Physician Decision|1|||
170788871|NCT05576155|617236426|FG000|Overall Study|Withdrawal by Subject|1|||
170788872|NCT05576155|617236427|FG001|Overall Study|Withdrawal by Subject|1|||
170788873|NCT04515849|617236428|FG000|Overall Study|Adverse Event|0|||
170788874|NCT04515849|617236429|FG001|Overall Study|Adverse Event|0|||
170788875|NCT04515849|617236430|FG002|Overall Study|Adverse Event|0|||
170788876|NCT04515849|617236431|FG003|Overall Study|Adverse Event|1|||
170788877|NCT04515849|617236432|FG004|Overall Study|Adverse Event|2|||
170788878|NCT04515849|617236428|FG000|Overall Study|Death|2|||
170788879|NCT04515849|617236429|FG001|Overall Study|Death|0|||
170788880|NCT04515849|617236430|FG002|Overall Study|Death|0|||
170788881|NCT04515849|617236431|FG003|Overall Study|Death|0|||
170788882|NCT04515849|617236432|FG004|Overall Study|Death|0|||
170788883|NCT04515849|617236428|FG000|Overall Study|Other:family emergency|0|||
170788884|NCT04515849|617236429|FG001|Overall Study|Other:family emergency|0|||
170788885|NCT04515849|617236430|FG002|Overall Study|Other:family emergency|0|||
170788886|NCT04515849|617236431|FG003|Overall Study|Other:family emergency|1|||
170460489|NCT00390221|616026914|FG002|Overall Study|Subject Non-compliance|2|||
170460490|NCT00390221|616026912|FG000|Overall Study|Other|3|||
170460491|NCT00390221|616026913|FG001|Overall Study|Other|4|||
170460492|NCT00390221|616026914|FG002|Overall Study|Other|2|||
170460493|NCT01193127|616026917|FG000|Randomized|Surgery Cancelled|0|||
170460494|NCT01193127|616026918|FG001|Randomized|Surgery Cancelled|0|||
170889707|NCT01328951|617602335|FG001|Overall Study|Withdrawal by Subject|6|||
170889708|NCT01328951|617602334|FG000|Overall Study|Study Closed by the Sponsor|36|||
170889709|NCT01328951|617602335|FG001|Overall Study|Study Closed by the Sponsor|31|||
170889710|NCT01328951|617602334|FG000|Overall Study|Other|11|||
170889711|NCT01328951|617602335|FG001|Overall Study|Other|6|||
170889712|NCT04153188|617602346|FG000|Overall Study|Lost to Follow-up|1|||
170889713|NCT04153188|617602347|FG001|Overall Study|Lost to Follow-up|1|||
170889714|NCT04153188|617602346|FG000|Overall Study|Withdrawal by Subject|2|||
170889715|NCT04153188|617602347|FG001|Overall Study|Withdrawal by Subject|0|||
170889716|NCT04153188|617602346|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
170889717|NCT04153188|617602347|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
170889718|NCT04899232|617602348|FG000|Screening Period|Physician Decision|1|||
170889719|NCT04899232|617602349|FG001|Screening Period|Physician Decision|0|||
170889720|NCT04899232|617602350|FG002|Screening Period|Physician Decision|0|||
170889721|NCT04899232|617602348|FG000|Screening Period|Withdrawal by Subject|1|||
170889722|NCT04899232|617602349|FG001|Screening Period|Withdrawal by Subject|0|||
170889723|NCT04899232|617602350|FG002|Screening Period|Withdrawal by Subject|0|||
170889724|NCT04899232|617602348|FG000|Screening Period|Participant discharged before receiving intervention|3|||
170460495|NCT01193127|616026919|FG002|Randomized|Surgery Cancelled|0|||
170460496|NCT01193127|616026920|FG003|Randomized|Surgery Cancelled|1|||
170460497|NCT01193127|616026917|FG000|Treated|Withdrawal by Subject|0|||
170460498|NCT01193127|616026918|FG001|Treated|Withdrawal by Subject|0|||
170460499|NCT01193127|616026919|FG002|Treated|Withdrawal by Subject|0|||
170460500|NCT01193127|616026920|FG003|Treated|Withdrawal by Subject|1|||
170636116|NCT00459186|616678963|FG000|PET Imaging and Assessment|Adverse Event|3|||
170788887|NCT04515849|617236432|FG004|Overall Study|Other:family emergency|0|||
170788888|NCT04515849|617236428|FG000|Overall Study|Other:randomised by error|0|||
170788889|NCT04515849|617236429|FG001|Overall Study|Other:randomised by error|1|||
170788890|NCT04515849|617236430|FG002|Overall Study|Other:randomised by error|0|||
170788891|NCT04515849|617236431|FG003|Overall Study|Other:randomised by error|0|||
170788892|NCT04515849|617236432|FG004|Overall Study|Other:randomised by error|0|||
170788893|NCT04515849|617236428|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
170788894|NCT04515849|617236429|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
170788895|NCT04515849|617236430|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
170788896|NCT04515849|617236431|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
170788897|NCT04515849|617236432|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
170788898|NCT04515849|617236428|FG000|Overall Study|Physician Decision|0|||
170788899|NCT04515849|617236429|FG001|Overall Study|Physician Decision|1|||
170788900|NCT04515849|617236430|FG002|Overall Study|Physician Decision|0|||
170788901|NCT04515849|617236431|FG003|Overall Study|Physician Decision|0|||
170889725|NCT04899232|617602349|FG001|Screening Period|Participant discharged before receiving intervention|0|||
170889726|NCT04899232|617602350|FG002|Screening Period|Participant discharged before receiving intervention|0|||
170889727|NCT00700271|617602351|FG000|Overall Study|Adverse Event|4|||
170889728|NCT00700271|617602352|FG001|Overall Study|Adverse Event|6|||
170889729|NCT00700271|617602351|FG000|Overall Study|Protocol Violation|1|||
170460501|NCT02370329|616029700|FG000|Overall Study|Alternate treatment|1|||
170460502|NCT02370329|616029700|FG000|Overall Study|Adverse Event|1|||
170460503|NCT02370329|616029700|FG000|Overall Study|Disease progression|3|||
170460504|NCT02370329|616029700|FG000|Overall Study|Physician Decision|2|||
170460505|NCT02370329|616029700|FG000|Overall Study|Study closure|4|||
170460506|NCT02022748|616029701|FG000|Overall Study|Adverse Event|1|||
170460507|NCT02022748|616029702|FG001|Overall Study|Adverse Event|1|||
170460508|NCT02022748|616029703|FG002|Overall Study|Adverse Event|0|||
170460509|NCT02022748|616029701|FG000|Overall Study|Withdrawal by Subject|0|||
170460510|NCT02022748|616029702|FG001|Overall Study|Withdrawal by Subject|1|||
170460511|NCT02022748|616029703|FG002|Overall Study|Withdrawal by Subject|0|||
170460512|NCT04347122|616029706|FG000|Overall Study|Physician Decision|0|||
170460513|NCT04347122|616029707|FG001|Overall Study|Physician Decision|3|||
170460514|NCT04347122|616029708|FG002|Overall Study|Physician Decision|3|||
170543438|NCT03833167|616332893|FG001|Overall Study|Withdrawal by Subject|6|||
170543439|NCT03833167|616332892|FG000|Overall Study|Ongoing|186|||
170543440|NCT03833167|616332893|FG001|Overall Study|Ongoing|194|||
170543441|NCT03833167|616332892|FG000|Overall Study|Lost to Follow-up|1|||
170543442|NCT03833167|616332893|FG001|Overall Study|Lost to Follow-up|1|||
170543443|NCT03833167|616332892|FG000|Overall Study|Physician Decision|0|||
170543444|NCT03833167|616332893|FG001|Overall Study|Physician Decision|2|||
170543445|NCT03833167|616332892|FG000|Overall Study|Death|34|||
170543446|NCT03833167|616332893|FG001|Overall Study|Death|22|||
170543447|NCT05128942|616332897|FG000|Overall Study|Withdrawal by Subject|1|||
170543448|NCT05128942|616332898|FG001|Overall Study|Withdrawal by Subject|0|||
170543449|NCT05128942|616332899|FG002|Overall Study|Withdrawal by Subject|1|||
170543450|NCT05128942|616332900|FG003|Overall Study|Withdrawal by Subject|0|||
170543451|NCT05128942|616332901|FG004|Overall Study|Withdrawal by Subject|0|||
170636117|NCT03306173|616678965|FG000|Overall Study|Lost to Follow-up|16|||
170636118|NCT03306173|616678966|FG001|Overall Study|Lost to Follow-up|23|||
170788902|NCT04515849|617236432|FG004|Overall Study|Physician Decision|0|||
170788903|NCT04515849|617236428|FG000|Overall Study|Withdrawal by Subject|1|||
170788904|NCT04515849|617236429|FG001|Overall Study|Withdrawal by Subject|2|||
170788905|NCT04515849|617236430|FG002|Overall Study|Withdrawal by Subject|1|||
170788906|NCT04515849|617236431|FG003|Overall Study|Withdrawal by Subject|0|||
170788907|NCT04515849|617236432|FG004|Overall Study|Withdrawal by Subject|0|||
170788908|NCT03287817|617237981|FG000|Overall Study|Progressive disease|4|||
170788909|NCT03287817|617237982|FG001|Overall Study|Progressive disease|2|||
170788910|NCT03287817|617237983|FG002|Overall Study|Progressive disease|3|||
170788911|NCT03287817|617237984|FG003|Overall Study|Progressive disease|10|||
170788912|NCT03287817|617237985|FG004|Overall Study|Progressive disease|8|||
170788913|NCT03287817|617237981|FG000|Overall Study|Death|0|||
170788914|NCT03287817|617237982|FG001|Overall Study|Death|0|||
170788915|NCT03287817|617237983|FG002|Overall Study|Death|2|||
170788916|NCT03287817|617237984|FG003|Overall Study|Death|3|||
170788917|NCT03287817|617237985|FG004|Overall Study|Death|4|||
170788918|NCT03287817|617237981|FG000|Overall Study|Physician Decision|0|||
170788919|NCT03287817|617237982|FG001|Overall Study|Physician Decision|0|||
170788920|NCT03287817|617237983|FG002|Overall Study|Physician Decision|0|||
170788921|NCT03287817|617237984|FG003|Overall Study|Physician Decision|1|||
170788922|NCT03287817|617237985|FG004|Overall Study|Physician Decision|0|||
170788923|NCT03287817|617237981|FG000|Overall Study|Withdrawal by Subject|0|||
170788924|NCT03287817|617237982|FG001|Overall Study|Withdrawal by Subject|0|||
170788925|NCT03287817|617237983|FG002|Overall Study|Withdrawal by Subject|0|||
170788926|NCT03287817|617237984|FG003|Overall Study|Withdrawal by Subject|0|||
170788927|NCT03287817|617237985|FG004|Overall Study|Withdrawal by Subject|4|||
170788928|NCT05835336|617237986|FG000|Overall Study|Withdrawal by Subject|5|||
170788929|NCT05835336|617237986|FG000|Overall Study|Did not complete the personalization process|3|||
170788930|NCT04489771|617237987|FG000|Overall Study|Death|27|||
170788931|NCT04489771|617237988|FG001|Overall Study|Death|25|||
170788932|NCT04489771|617237987|FG000|Overall Study|Withdrawal by Subject|1|||
170788933|NCT04489771|617237988|FG001|Overall Study|Withdrawal by Subject|0|||
170788934|NCT04489771|617237987|FG000|Overall Study|Participants Ongoing in Study|50|||
170788935|NCT04489771|617237988|FG001|Overall Study|Participants Ongoing in Study|51|||
170788936|NCT00470704|617237989|FG000|Overall Study|Withdrawal by Subject|4|||
170788937|NCT00470704|617237990|FG001|Overall Study|Withdrawal by Subject|3|||
170788938|NCT00470704|617237989|FG000|Overall Study|Relapse/Progression|37|||
170788939|NCT00470704|617237990|FG001|Overall Study|Relapse/Progression|42|||
170788940|NCT00470704|617237989|FG000|Overall Study|toxicity|0|||
170788941|NCT00470704|617237990|FG001|Overall Study|toxicity|1|||
170788942|NCT02561247|617237997|FG000|Overall Study|Protocol Violation|1|||
170788943|NCT02561247|617237997|FG000|Overall Study|Withdrawal by Subject|1|||
170788944|NCT02561247|617237997|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
170788945|NCT04963270|617238000|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
170788946|NCT04963270|617238001|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
170788947|NCT04963270|617238002|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
170788948|NCT04963270|617238003|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
170788949|NCT04963270|617238000|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
170788950|NCT04963270|617238001|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
170788951|NCT04963270|617238002|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
170788952|NCT04963270|617238003|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
170788953|NCT04963270|617238000|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
170788954|NCT04963270|617238001|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
170788955|NCT04963270|617238002|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
170788956|NCT04963270|617238003|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
170788957|NCT04963270|617238000|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
170788958|NCT04963270|617238001|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
170788959|NCT04963270|617238002|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
170788960|NCT04963270|617238003|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
170788961|NCT04963270|617238000|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
170788962|NCT04963270|617238001|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
170788963|NCT04963270|617238002|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
170788964|NCT04963270|617238003|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
170788965|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
170889730|NCT00700271|617602352|FG001|Overall Study|Protocol Violation|0|||
170788966|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
170788967|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
170788968|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
170788969|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
170788970|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
170788971|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
170460515|NCT04347122|616029709|FG003|Overall Study|Physician Decision|6|||
170460516|NCT03510598|616029710|FG000|Overall Study|Withdrawal by Subject|1|||
170460517|NCT04994483|616029712|FG000|Overall Study|Adverse Event|26|||
170460518|NCT04994483|616029713|FG001|Overall Study|Adverse Event|17|||
170460519|NCT04994483|616029712|FG000|Overall Study|Lost to Follow-up|6|||
170460520|NCT04994483|616029713|FG001|Overall Study|Lost to Follow-up|10|||
170460521|NCT04994483|616029712|FG000|Overall Study|Noncompliance with study drug|8|||
170460522|NCT04994483|616029713|FG001|Overall Study|Noncompliance with study drug|5|||
170460523|NCT04994483|616029712|FG000|Overall Study|Physician Decision|5|||
170460524|NCT04994483|616029713|FG001|Overall Study|Physician Decision|0|||
170460525|NCT04994483|616029712|FG000|Overall Study|Withdrawal by Subject|41|||
170543452|NCT05128942|616332902|FG005|Overall Study|Withdrawal by Subject|0|||
170543453|NCT05128942|616332903|FG006|Overall Study|Withdrawal by Subject|0|||
170543454|NCT05128942|616332904|FG007|Overall Study|Withdrawal by Subject|0|||
170543455|NCT05128942|616332905|FG008|Overall Study|Withdrawal by Subject|0|||
170543456|NCT05128942|616332897|FG000|Overall Study|Other|2|||
170543457|NCT05128942|616332898|FG001|Overall Study|Other|0|||
170543458|NCT05128942|616332899|FG002|Overall Study|Other|2|||
170543459|NCT05128942|616332900|FG003|Overall Study|Other|0|||
170543460|NCT05128942|616332901|FG004|Overall Study|Other|0|||
170543461|NCT05128942|616332902|FG005|Overall Study|Other|0|||
170543462|NCT05128942|616332903|FG006|Overall Study|Other|0|||
170543463|NCT05128942|616332904|FG007|Overall Study|Other|0|||
170543464|NCT05128942|616332905|FG008|Overall Study|Other|0|||
170543465|NCT05128942|616332897|FG000|Overall Study|Termination by Sponsor|2|||
170543466|NCT05128942|616332898|FG001|Overall Study|Termination by Sponsor|6|||
170543467|NCT05128942|616332899|FG002|Overall Study|Termination by Sponsor|14|||
170543468|NCT05128942|616332900|FG003|Overall Study|Termination by Sponsor|2|||
170543469|NCT05128942|616332901|FG004|Overall Study|Termination by Sponsor|4|||
170543470|NCT05128942|616332902|FG005|Overall Study|Termination by Sponsor|8|||
170543471|NCT05128942|616332903|FG006|Overall Study|Termination by Sponsor|11|||
170543472|NCT05128942|616332904|FG007|Overall Study|Termination by Sponsor|6|||
170543473|NCT05128942|616332905|FG008|Overall Study|Termination by Sponsor|0|||
170543474|NCT05128942|616332897|FG000|Overall Study|Adverse Event|0|||
170543475|NCT05128942|616332898|FG001|Overall Study|Adverse Event|0|||
170543476|NCT05128942|616332899|FG002|Overall Study|Adverse Event|0|||
170543477|NCT05128942|616332900|FG003|Overall Study|Adverse Event|0|||
170543478|NCT05128942|616332901|FG004|Overall Study|Adverse Event|0|||
170543479|NCT05128942|616332902|FG005|Overall Study|Adverse Event|0|||
170543480|NCT05128942|616332903|FG006|Overall Study|Adverse Event|1|||
170543481|NCT05128942|616332904|FG007|Overall Study|Adverse Event|1|||
170543482|NCT05128942|616332905|FG008|Overall Study|Adverse Event|0|||
170543483|NCT05128942|616332897|FG000|Overall Study|Lost to Follow-up|0|||
170543484|NCT05128942|616332898|FG001|Overall Study|Lost to Follow-up|0|||
170543485|NCT05128942|616332899|FG002|Overall Study|Lost to Follow-up|0|||
170543486|NCT05128942|616332900|FG003|Overall Study|Lost to Follow-up|0|||
170543487|NCT05128942|616332901|FG004|Overall Study|Lost to Follow-up|1|||
170543488|NCT05128942|616332902|FG005|Overall Study|Lost to Follow-up|0|||
170543489|NCT05128942|616332903|FG006|Overall Study|Lost to Follow-up|0|||
170543490|NCT05128942|616332904|FG007|Overall Study|Lost to Follow-up|0|||
170543491|NCT05128942|616332905|FG008|Overall Study|Lost to Follow-up|0|||
170543492|NCT02227199|616332907|FG000|Overall Study|Physician Decision|0|||
170543493|NCT02227199|616332908|FG001|Overall Study|Physician Decision|0|||
170543494|NCT02227199|616332909|FG002|Overall Study|Physician Decision|1|||
170543495|NCT02227199|616332907|FG000|Overall Study|Adverse Event|0|||
170543496|NCT02227199|616332908|FG001|Overall Study|Adverse Event|0|||
170543497|NCT02227199|616332909|FG002|Overall Study|Adverse Event|3|||
170460526|NCT04994483|616029713|FG001|Overall Study|Withdrawal by Subject|38|||
170460527|NCT04994483|616029712|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
170543498|NCT03998462|616332911|FG000|Overall Study|Withdrawal by Subject|10|||
170543499|NCT03998462|616332912|FG001|Overall Study|Withdrawal by Subject|4|||
170543500|NCT03998462|616332911|FG000|Overall Study|Lost to Follow-up|1|||
170543501|NCT03998462|616332912|FG001|Overall Study|Lost to Follow-up|0|||
170543502|NCT03998462|616332911|FG000|Overall Study|Technical Difficulties|1|||
170543503|NCT03998462|616332912|FG001|Overall Study|Technical Difficulties|2|||
170543504|NCT05710224|616332913|FG000|Overall Study|Death|1|||
170543505|NCT05710224|616332914|FG001|Overall Study|Death|0|||
170543506|NCT05710224|616332913|FG000|Overall Study|Lost to Follow-up|16|||
170543507|NCT05710224|616332914|FG001|Overall Study|Lost to Follow-up|7|||
170543508|NCT05710224|616332913|FG000|Overall Study|Withdrawal by Subject|4|||
170543509|NCT05710224|616332914|FG001|Overall Study|Withdrawal by Subject|6|||
170543510|NCT05710224|616332913|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170543511|NCT05710224|616332914|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
170543512|NCT05710224|616332913|FG000|Overall Study|Participants Left The City|0|||
170543513|NCT05710224|616332914|FG001|Overall Study|Participants Left The City|2|||
170543514|NCT01428128|616332915|FG000|Overall Study|Withdrawal by Subject|4|||
170543515|NCT01428128|616332915|FG000|Overall Study|Screen failure by p53|10|||
170543516|NCT01428128|616332915|FG000|Overall Study|Received Neulasta in one cycle|2|||
170636119|NCT03306173|616678965|FG000|Overall Study|Withdrawal by Subject|4|||
170636120|NCT03306173|616678966|FG001|Overall Study|Withdrawal by Subject|3|||
170636121|NCT03306173|616678965|FG000|Overall Study|Discontinued|4|||
170636122|NCT03306173|616678966|FG001|Overall Study|Discontinued|4|||
170636123|NCT05038982|616678969|FG000|Overall Study|Withdrawal by Subject|0|||
170636124|NCT05038982|616678970|FG001|Overall Study|Withdrawal by Subject|2|||
170636125|NCT01469377|616678971|FG000|Overall Study|Protocol Deviation|7|||
170636126|NCT01469377|616678972|FG001|Overall Study|Protocol Deviation|10|||
170636127|NCT01469377|616678973|FG002|Overall Study|Protocol Deviation|10|||
170636128|NCT01469377|616678971|FG000|Overall Study|Lost to Follow-up|3|||
170636129|NCT01469377|616678972|FG001|Overall Study|Lost to Follow-up|2|||
170889731|NCT00700271|617602351|FG000|Overall Study|Administrative Reasons|1|||
170889732|NCT00700271|617602352|FG001|Overall Study|Administrative Reasons|0|||
170889733|NCT00700271|617602351|FG000|Overall Study|Withdrawal by Subject|6|||
170889734|NCT00700271|617602352|FG001|Overall Study|Withdrawal by Subject|4|||
170889735|NCT00700271|617602351|FG000|Overall Study|Lost to Follow-up|2|||
170889736|NCT00700271|617602352|FG001|Overall Study|Lost to Follow-up|2|||
170889737|NCT02406781|617602353|FG000|Overall Study|Protocol Violation|2|||
170889738|NCT02406781|617602354|FG001|Overall Study|Protocol Violation|2|||
170889739|NCT02406781|617602355|FG002|Overall Study|Protocol Violation|2|||
170889740|NCT02406781|617602356|FG003|Overall Study|Protocol Violation|2|||
170889741|NCT02406781|617602357|FG004|Overall Study|Protocol Violation|1|||
170889742|NCT02406781|617602358|FG005|Overall Study|Protocol Violation|5|||
170889743|NCT02406781|617602359|FG006|Overall Study|Protocol Violation|3|||
170889744|NCT02553460|617602360|FG000|Overall Study|Death|3|||
170889745|NCT02553460|617602360|FG000|Overall Study|Withdrawal by Subject|1|||
170889746|NCT02553460|617602360|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
170889747|NCT02553460|617602360|FG000|Overall Study|Relapse or Transplant|14|||
170889748|NCT02553460|617602360|FG000|Overall Study|No response to treatment|2|||
170889749|NCT02553460|617602360|FG000|Overall Study|CAR T cells|2|||
170889750|NCT03505021|617602361|FG000|Overall Study|Protocol Violation|1|||
170889751|NCT03505021|617602362|FG001|Overall Study|Protocol Violation|0|||
170889752|NCT03505021|617602361|FG000|Overall Study|Death|9|||
170889753|NCT03505021|617602362|FG001|Overall Study|Death|8|||
170889754|NCT03505021|617602361|FG000|Overall Study|Consent withdrawn by subject|6|||
170889755|NCT03505021|617602362|FG001|Overall Study|Consent withdrawn by subject|1|||
170889756|NCT03505021|617602361|FG000|Overall Study|Lost to Follow-up|5|||
170889757|NCT03505021|617602362|FG001|Overall Study|Lost to Follow-up|3|||
170889758|NCT03505021|617602361|FG000|Overall Study|Adverse Event|26|||
170889759|NCT03505021|617602362|FG001|Overall Study|Adverse Event|9|||
170889760|NCT03505021|617602361|FG000|Overall Study|Disease progression|33|||
170889761|NCT03505021|617602362|FG001|Overall Study|Disease progression|17|||
170889762|NCT03505021|617602361|FG000|Overall Study|Other|11|||
170889763|NCT03505021|617602362|FG001|Overall Study|Other|5|||
170889764|NCT03505021|617602361|FG000|Overall Study|Personal reason|21|||
170889765|NCT03505021|617602362|FG001|Overall Study|Personal reason|12|||
170889766|NCT03087955|617604049|FG000|Overall Study|Death|4|||
170889767|NCT03087955|617604050|FG001|Overall Study|Death|0|||
170889768|NCT03087955|617604049|FG000|Overall Study|Lack of Efficacy|2|||
170889769|NCT03087955|617604050|FG001|Overall Study|Lack of Efficacy|0|||
170889770|NCT03087955|617604049|FG000|Overall Study|Lost to Follow-up|1|||
170889771|NCT03087955|617604050|FG001|Overall Study|Lost to Follow-up|0|||
170889772|NCT04484285|617604051|FG000|Overall Study|Unable to operate stimulator|3|||
170889773|NCT04484285|617604052|FG001|Overall Study|Unable to operate stimulator|0|||
170889774|NCT06272370|617604053|FG000|Overall Study|Lost to Follow-up|0|||
170889775|NCT06272370|617604054|FG001|Overall Study|Lost to Follow-up|3|||
170889776|NCT06272370|617604055|FG002|Overall Study|Lost to Follow-up|1|||
170636130|NCT01469377|616678973|FG002|Overall Study|Lost to Follow-up|5|||
170636131|NCT01469377|616678971|FG000|Overall Study|Withdrawal of Consent|12|||
170636132|NCT01469377|616678972|FG001|Overall Study|Withdrawal of Consent|14|||
170636133|NCT01469377|616678973|FG002|Overall Study|Withdrawal of Consent|15|||
170889777|NCT06272370|617604056|FG003|Overall Study|Lost to Follow-up|1|||
170889778|NCT00546364|617604061|FG000|Overall Study|Disease progression|5|||
170889779|NCT00546364|617604062|FG001|Overall Study|Disease progression|11|||
170636134|NCT01469377|616678971|FG000|Overall Study|Adverse Event|8|||
170636135|NCT01469377|616678972|FG001|Overall Study|Adverse Event|18|||
170636136|NCT01469377|616678973|FG002|Overall Study|Adverse Event|36|||
170636137|NCT01469377|616678971|FG000|Overall Study|Insufficient Therapeutic Response|3|||
170889780|NCT00546364|617604063|FG002|Overall Study|Disease progression|8|||
170889781|NCT00546364|617604061|FG000|Overall Study|Completed and off treatment|1|||
170889782|NCT00546364|617604062|FG001|Overall Study|Completed and off treatment|0|||
170889783|NCT00546364|617604063|FG002|Overall Study|Completed and off treatment|2|||
170889784|NCT00546364|617604061|FG000|Overall Study|Administrative reason by sponsor|1|||
170889785|NCT00546364|617604062|FG001|Overall Study|Administrative reason by sponsor|0|||
170889786|NCT00546364|617604063|FG002|Overall Study|Administrative reason by sponsor|0|||
170889787|NCT00546364|617604061|FG000|Overall Study|Poor compliance/noncompliance|0|||
170889788|NCT00546364|617604062|FG001|Overall Study|Poor compliance/noncompliance|0|||
170889789|NCT00546364|617604063|FG002|Overall Study|Poor compliance/noncompliance|1|||
170636138|NCT01469377|616678972|FG001|Overall Study|Insufficient Therapeutic Response|4|||
170636139|NCT01469377|616678973|FG002|Overall Study|Insufficient Therapeutic Response|0|||
170636140|NCT01469377|616678971|FG000|Overall Study|Other Miscellaneous Reasons|2|||
170636141|NCT01469377|616678972|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170636142|NCT01469377|616678973|FG002|Overall Study|Other Miscellaneous Reasons|0|||
170636143|NCT04139798|616678976|FG000|Overall Study|Withdrawal by Subject|6|||
170636144|NCT04139798|616678977|FG001|Overall Study|Withdrawal by Subject|5|||
170636145|NCT04139798|616678976|FG000|Overall Study|Lost to Follow-up|2|||
170636146|NCT04139798|616678977|FG001|Overall Study|Lost to Follow-up|5|||
170636147|NCT04139798|616678976|FG000|Overall Study|Discontinued|4|||
170636148|NCT04139798|616678977|FG001|Overall Study|Discontinued|2|||
170636149|NCT04139798|616678976|FG000|Overall Study|Adverse Event|1|||
170636150|NCT04139798|616678977|FG001|Overall Study|Adverse Event|3|||
170636151|NCT04139798|616678976|FG000|Overall Study|Protocol Violation|1|||
170636152|NCT04139798|616678977|FG001|Overall Study|Protocol Violation|0|||
170636153|NCT04269889|616678978|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
170636154|NCT00834093|616678979|FG000|Overall Study|Progressive Disease|3|||
170636155|NCT00834093|616678979|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
170636156|NCT02453711|616678980|FG000|Overall Study|Withdrawal by Subject|5|||
170636157|NCT02453711|616678981|FG001|Overall Study|Withdrawal by Subject|4|||
170636158|NCT02453711|616678982|FG002|Overall Study|Withdrawal by Subject|6|||
170636159|NCT02453711|616678983|FG003|Overall Study|Withdrawal by Subject|4|||
170636160|NCT02453711|616678984|FG004|Overall Study|Withdrawal by Subject|1|||
170636161|NCT02453711|616678985|FG005|Overall Study|Withdrawal by Subject|1|||
170636162|NCT02453711|616678986|FG006|Overall Study|Withdrawal by Subject|0|||
170636163|NCT02453711|616678987|FG007|Overall Study|Withdrawal by Subject|1|||
170636164|NCT02453711|616678988|FG008|Overall Study|Withdrawal by Subject|7|||
170636165|NCT02453711|616678980|FG000|Overall Study|Lost to Follow-up|5|||
170636166|NCT02453711|616678981|FG001|Overall Study|Lost to Follow-up|3|||
170636167|NCT02453711|616678982|FG002|Overall Study|Lost to Follow-up|2|||
170636168|NCT02453711|616678983|FG003|Overall Study|Lost to Follow-up|3|||
170636169|NCT02453711|616678984|FG004|Overall Study|Lost to Follow-up|1|||
170636170|NCT02453711|616678985|FG005|Overall Study|Lost to Follow-up|5|||
170636171|NCT02453711|616678986|FG006|Overall Study|Lost to Follow-up|2|||
170636172|NCT02453711|616678987|FG007|Overall Study|Lost to Follow-up|6|||
170636173|NCT02453711|616678988|FG008|Overall Study|Lost to Follow-up|6|||
170636174|NCT02453711|616678980|FG000|Overall Study|Death|0|||
170636175|NCT02453711|616678981|FG001|Overall Study|Death|0|||
170636176|NCT02453711|616678982|FG002|Overall Study|Death|0|||
170636177|NCT02453711|616678983|FG003|Overall Study|Death|0|||
170636178|NCT02453711|616678984|FG004|Overall Study|Death|0|||
170636179|NCT02453711|616678985|FG005|Overall Study|Death|0|||
170636180|NCT02453711|616678986|FG006|Overall Study|Death|1|||
170636181|NCT02453711|616678987|FG007|Overall Study|Death|0|||
170636182|NCT02453711|616678988|FG008|Overall Study|Death|0|||
170636183|NCT02453711|616678980|FG000|Overall Study|Unclassified|1|||
170636184|NCT02453711|616678981|FG001|Overall Study|Unclassified|0|||
170636185|NCT02453711|616678982|FG002|Overall Study|Unclassified|1|||
170636186|NCT02453711|616678983|FG003|Overall Study|Unclassified|0|||
170636187|NCT02453711|616678984|FG004|Overall Study|Unclassified|0|||
170636188|NCT02453711|616678985|FG005|Overall Study|Unclassified|0|||
170636189|NCT02453711|616678986|FG006|Overall Study|Unclassified|0|||
170636190|NCT02453711|616678987|FG007|Overall Study|Unclassified|0|||
170460528|NCT04994483|616029713|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
170460529|NCT04994483|616029712|FG000|Overall Study|Met stopping criteria|1|||
170460530|NCT04994483|616029713|FG001|Overall Study|Met stopping criteria|0|||
170460531|NCT04994483|616029712|FG000|Overall Study|Randomized in error, not treated|4|||
170460532|NCT04994483|616029713|FG001|Overall Study|Randomized in error, not treated|3|||
170460533|NCT04994483|616029712|FG000|Overall Study|Lack of a reliable study partner|0|||
170460534|NCT04994483|616029713|FG001|Overall Study|Lack of a reliable study partner|1|||
170460535|NCT04994483|616029712|FG000|Overall Study|Met MRI exclusion criteria|0|||
170460536|NCT04994483|616029713|FG001|Overall Study|Met MRI exclusion criteria|1|||
170460537|NCT00759902|616029714|FG000|Overall Study|Adverse Event|0|||
170460538|NCT00759902|616029715|FG001|Overall Study|Adverse Event|1|||
170460539|NCT00112866|616029717|FG000|Overall Study|Protocol Violation|1|||
170460540|NCT00112866|616029718|FG001|Overall Study|Protocol Violation|0|||
170636191|NCT02453711|616678988|FG008|Overall Study|Unclassified|0|||
170636192|NCT01696188|616678989|FG000|Overall Study|Protocol Violation|1|||
170636193|NCT01696188|616678990|FG001|Overall Study|Protocol Violation|1|||
170636194|NCT00960999|616678991|FG000|Overall Study|Withdrawal by Subject|1|||
170636195|NCT00960999|616678992|FG001|Overall Study|Withdrawal by Subject|0|||
170636196|NCT00960999|616678991|FG000|Overall Study|Protocol Violation|5|||
170636197|NCT00960999|616678992|FG001|Overall Study|Protocol Violation|2|||
170460541|NCT00112866|616029717|FG000|Overall Study|did not start treatment post-op|1|||
170636198|NCT00960999|616678991|FG000|Overall Study|RT dose constraints not met|2|||
170636199|NCT00960999|616678992|FG001|Overall Study|RT dose constraints not met|0|||
170636200|NCT01106248|616678993|FG000|Overall Study|Adverse Event|1|||
170636201|NCT01106248|616678993|FG000|Overall Study|Administrative|2|||
170636202|NCT02447003|616678996|FG000|Overall Study|Other|0|||
170636203|NCT02447003|616678997|FG001|Overall Study|Other|4|||
170636204|NCT02447003|616678996|FG000|Overall Study|Site discontinued|0|||
170636205|NCT02447003|616678997|FG001|Overall Study|Site discontinued|2|||
170636206|NCT02447003|616678996|FG000|Overall Study|Physician Decision|0|||
170636207|NCT02447003|616678997|FG001|Overall Study|Physician Decision|1|||
170636208|NCT02447003|616678996|FG000|Overall Study|Withdrawal by Subject|4|||
170636209|NCT02447003|616678997|FG001|Overall Study|Withdrawal by Subject|3|||
170636210|NCT02447003|616678996|FG000|Overall Study|Sponsor Decision|6|||
170636211|NCT02447003|616678997|FG001|Overall Study|Sponsor Decision|11|||
170636212|NCT02447003|616678996|FG000|Overall Study|Progressive Disease|1|||
170636213|NCT02447003|616678997|FG001|Overall Study|Progressive Disease|0|||
170636214|NCT02447003|616678996|FG000|Overall Study|Lost to Follow-up|5|||
170636215|NCT02447003|616678997|FG001|Overall Study|Lost to Follow-up|0|||
170636216|NCT02447003|616678996|FG000|Overall Study|Death|154|||
170636217|NCT02447003|616678997|FG001|Overall Study|Death|63|||
170636218|NCT00750438|616678998|FG000|Overall Study|Protocol Violation|4|||
170636219|NCT00750438|616678999|FG001|Overall Study|Protocol Violation|1|||
170636220|NCT00750438|616678998|FG000|Overall Study|Physician Decision|2|||
170636221|NCT00750438|616678999|FG001|Overall Study|Physician Decision|2|||
170636222|NCT00750438|616678998|FG000|Overall Study|Withdrawal by Subject|1|||
170636223|NCT00750438|616678999|FG001|Overall Study|Withdrawal by Subject|1|||
170636224|NCT02908672|616679000|FG000|Run-in Period|Death|12|||
170636225|NCT02908672|616679001|FG001|Run-in Period|Death|10|||
170636226|NCT02908672|616679002|FG002|Run-in Period|Death|0|||
170636227|NCT02908672|616679003|FG003|Run-in Period|Death|0|||
170636228|NCT02908672|616679000|FG000|Run-in Period|Lost to Follow-up|1|||
170636229|NCT02908672|616679001|FG001|Run-in Period|Lost to Follow-up|1|||
170636230|NCT02908672|616679002|FG002|Run-in Period|Lost to Follow-up|0|||
170636231|NCT02908672|616679003|FG003|Run-in Period|Lost to Follow-up|0|||
170636232|NCT02908672|616679000|FG000|Run-in Period|Reason Not Specified|2|||
170636233|NCT02908672|616679001|FG001|Run-in Period|Reason Not Specified|0|||
170636234|NCT02908672|616679002|FG002|Run-in Period|Reason Not Specified|0|||
170636235|NCT02908672|616679003|FG003|Run-in Period|Reason Not Specified|0|||
170636236|NCT02908672|616679000|FG000|Run-in Period|Protocol Violation|1|||
170636237|NCT02908672|616679001|FG001|Run-in Period|Protocol Violation|1|||
170636238|NCT02908672|616679002|FG002|Run-in Period|Protocol Violation|0|||
170636239|NCT02908672|616679003|FG003|Run-in Period|Protocol Violation|0|||
170636240|NCT02908672|616679000|FG000|Run-in Period|Study Ended by Sponsor|5|||
170636241|NCT02908672|616679001|FG001|Run-in Period|Study Ended by Sponsor|1|||
170636242|NCT02908672|616679002|FG002|Run-in Period|Study Ended by Sponsor|0|||
170636243|NCT02908672|616679003|FG003|Run-in Period|Study Ended by Sponsor|0|||
170636244|NCT02908672|616679000|FG000|Run-in Period|Withdrawal by Subject|3|||
170636245|NCT02908672|616679001|FG001|Run-in Period|Withdrawal by Subject|9|||
170636246|NCT02908672|616679002|FG002|Run-in Period|Withdrawal by Subject|0|||
170636247|NCT02908672|616679003|FG003|Run-in Period|Withdrawal by Subject|0|||
170636248|NCT02908672|616679000|FG000|Triple Combination Period|Death|0|||
170636249|NCT02908672|616679001|FG001|Triple Combination Period|Death|0|||
170636250|NCT02908672|616679002|FG002|Triple Combination Period|Death|150|||
170636251|NCT02908672|616679003|FG003|Triple Combination Period|Death|127|||
170636252|NCT02908672|616679000|FG000|Triple Combination Period|Lost to Follow-up|0|||
170636253|NCT02908672|616679001|FG001|Triple Combination Period|Lost to Follow-up|0|||
170636254|NCT02908672|616679002|FG002|Triple Combination Period|Lost to Follow-up|6|||
170636255|NCT02908672|616679003|FG003|Triple Combination Period|Lost to Follow-up|8|||
170636256|NCT02908672|616679000|FG000|Triple Combination Period|Reason Not Specified|0|||
170636257|NCT02908672|616679001|FG001|Triple Combination Period|Reason Not Specified|0|||
170636258|NCT02908672|616679002|FG002|Triple Combination Period|Reason Not Specified|0|||
170636259|NCT02908672|616679003|FG003|Triple Combination Period|Reason Not Specified|1|||
170636260|NCT02908672|616679000|FG000|Triple Combination Period|Physician Decision|0|||
170636261|NCT02908672|616679001|FG001|Triple Combination Period|Physician Decision|0|||
170636262|NCT02908672|616679002|FG002|Triple Combination Period|Physician Decision|1|||
170636263|NCT02908672|616679003|FG003|Triple Combination Period|Physician Decision|1|||
170636264|NCT02908672|616679000|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
170636265|NCT02908672|616679001|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
170636266|NCT02908672|616679002|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
170636267|NCT02908672|616679003|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
170636268|NCT02908672|616679000|FG000|Triple Combination Period|Withdrawal by Subject|0|||
170636269|NCT02908672|616679001|FG001|Triple Combination Period|Withdrawal by Subject|0|||
170636270|NCT02908672|616679002|FG002|Triple Combination Period|Withdrawal by Subject|13|||
170636271|NCT02908672|616679003|FG003|Triple Combination Period|Withdrawal by Subject|16|||
170636272|NCT01185080|616679004|FG000|Overall Study|Adverse Event|1|||
170636273|NCT01185080|616679005|FG001|Overall Study|Adverse Event|1|||
170636274|NCT01185080|616679006|FG002|Overall Study|Adverse Event|0|||
170636275|NCT01185080|616679004|FG000|Overall Study|Personal reasons|0|||
170636276|NCT01185080|616679005|FG001|Overall Study|Personal reasons|0|||
170636277|NCT01185080|616679006|FG002|Overall Study|Personal reasons|1|||
170636278|NCT05615922|616679008|FG000|Overall Study|Lost to Follow-up|1|||
170460542|NCT00112866|616029718|FG001|Overall Study|did not start treatment post-op|2|||
170460543|NCT02213510|616029722|FG000|Overall Study|Death|0|||
170460544|NCT02213510|616029723|FG001|Overall Study|Death|1|||
170460545|NCT02213510|616029722|FG000|Overall Study|Lost to Follow-up|1|||
170460546|NCT02213510|616029723|FG001|Overall Study|Lost to Follow-up|0|||
170460547|NCT03954834|616029724|FG000|Overall Study|Adverse Event|1|||
170460548|NCT03954834|616029725|FG001|Overall Study|Adverse Event|3|||
170460549|NCT03954834|616029726|FG002|Overall Study|Adverse Event|1|||
170460550|NCT03954834|616029727|FG003|Overall Study|Adverse Event|1|||
170460551|NCT03954834|616029724|FG000|Overall Study|Death|0|||
170460552|NCT03954834|616029725|FG001|Overall Study|Death|0|||
170460553|NCT03954834|616029726|FG002|Overall Study|Death|0|||
170460554|NCT03954834|616029727|FG003|Overall Study|Death|1|||
170460555|NCT03954834|616029724|FG000|Overall Study|Physician Decision|0|||
170460556|NCT03954834|616029725|FG001|Overall Study|Physician Decision|1|||
170460557|NCT03954834|616029726|FG002|Overall Study|Physician Decision|0|||
170460558|NCT03954834|616029727|FG003|Overall Study|Physician Decision|2|||
170460559|NCT03954834|616029724|FG000|Overall Study|Protocol Violation|1|||
170460560|NCT03954834|616029725|FG001|Overall Study|Protocol Violation|0|||
170543517|NCT01428128|616332915|FG000|Overall Study|Adverse Event|1|||
170543518|NCT03003962|616332917|FG000|Overall Study|Withdrawal by Subject|5|||
170543519|NCT03003962|616332918|FG001|Overall Study|Withdrawal by Subject|17|||
170543520|NCT03003962|616332917|FG000|Overall Study|Death|274|||
170543521|NCT03003962|616332918|FG001|Overall Study|Death|277|||
170543522|NCT03003962|616332917|FG000|Overall Study|Participants ongoing at DCO|55|||
170543523|NCT03003962|616332918|FG001|Overall Study|Participants ongoing at DCO|40|||
170543524|NCT05887401|616332919|FG000|Overall Study|Withdrawal by Subject|0|||
170543525|NCT05887401|616332920|FG001|Overall Study|Withdrawal by Subject|0|||
170543526|NCT05887401|616332921|FG002|Overall Study|Withdrawal by Subject|0|||
170543527|NCT05887401|616332922|FG003|Overall Study|Withdrawal by Subject|0|||
170543528|NCT05887401|616332923|FG004|Overall Study|Withdrawal by Subject|0|||
170543529|NCT05887401|616332924|FG005|Overall Study|Withdrawal by Subject|0|||
170543530|NCT05887401|616332925|FG006|Overall Study|Withdrawal by Subject|0|||
170543531|NCT05887401|616332926|FG007|Overall Study|Withdrawal by Subject|0|||
170543532|NCT05887401|616332927|FG008|Overall Study|Withdrawal by Subject|0|||
170543533|NCT05887401|616332928|FG009|Overall Study|Withdrawal by Subject|1|||
170543534|NCT05887401|616332929|FG010|Overall Study|Withdrawal by Subject|0|||
170543535|NCT05887401|616332930|FG011|Overall Study|Withdrawal by Subject|0|||
170543536|NCT05887401|616332931|FG012|Overall Study|Withdrawal by Subject|0|||
170543537|NCT05887401|616332932|FG013|Overall Study|Withdrawal by Subject|0|||
170543538|NCT05887401|616332933|FG014|Overall Study|Withdrawal by Subject|0|||
170543539|NCT05887401|616332934|FG015|Overall Study|Withdrawal by Subject|1|||
170543540|NCT05887401|616332919|FG000|Overall Study|Lost to Follow-up|0|||
170543541|NCT05887401|616332920|FG001|Overall Study|Lost to Follow-up|1|||
170543542|NCT05887401|616332921|FG002|Overall Study|Lost to Follow-up|1|||
170543543|NCT05887401|616332922|FG003|Overall Study|Lost to Follow-up|2|||
170543544|NCT05887401|616332923|FG004|Overall Study|Lost to Follow-up|0|||
170543545|NCT05887401|616332924|FG005|Overall Study|Lost to Follow-up|0|||
170543546|NCT05887401|616332925|FG006|Overall Study|Lost to Follow-up|0|||
170543547|NCT05887401|616332926|FG007|Overall Study|Lost to Follow-up|0|||
170543548|NCT05887401|616332927|FG008|Overall Study|Lost to Follow-up|1|||
170543549|NCT05887401|616332928|FG009|Overall Study|Lost to Follow-up|1|||
170543550|NCT05887401|616332929|FG010|Overall Study|Lost to Follow-up|2|||
170543551|NCT05887401|616332930|FG011|Overall Study|Lost to Follow-up|1|||
170543552|NCT05887401|616332931|FG012|Overall Study|Lost to Follow-up|0|||
170543553|NCT05887401|616332932|FG013|Overall Study|Lost to Follow-up|0|||
170543554|NCT05887401|616332933|FG014|Overall Study|Lost to Follow-up|0|||
170543555|NCT05887401|616332934|FG015|Overall Study|Lost to Follow-up|0|||
170543556|NCT04530526|616332935|FG000|Overall Study|Withdrawal by Subject|6|||
170543557|NCT05937373|616332936|FG000|Overall Study|Out of Window|2|||
170543558|NCT05937373|616332937|FG001|Overall Study|Out of Window|0|||
170543559|NCT05937373|616332936|FG000|Overall Study|Device fell off prior to date of surgery|0|||
170543560|NCT05937373|616332937|FG001|Overall Study|Device fell off prior to date of surgery|2|||
170543561|NCT05942040|616332938|FG000|Overall Study|No longer employed at study site.|0|||
170543562|NCT05942040|616332939|FG001|Overall Study|No longer employed at study site.|0|||
170543563|NCT05942040|616332940|FG002|Overall Study|No longer employed at study site.|3|||
170543564|NCT05259033|616332941|FG000|Overall Study|Withdrawal by Subject|10|||
170543565|NCT05259033|616332942|FG001|Overall Study|Withdrawal by Subject|5|||
170543566|NCT05259033|616332941|FG000|Overall Study|Lost to Follow-up|1|||
170543567|NCT05259033|616332942|FG001|Overall Study|Lost to Follow-up|0|||
170543568|NCT05259033|616332941|FG000|Overall Study|Death|2|||
170543569|NCT05259033|616332942|FG001|Overall Study|Death|0|||
170543570|NCT03442569|616332943|FG000|Overall Study|Subject was ineligible after enrollment|1|||
170543571|NCT06461455|616332944|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
170460561|NCT03954834|616029726|FG002|Overall Study|Protocol Violation|0|||
170460562|NCT03954834|616029727|FG003|Overall Study|Protocol Violation|1|||
170460563|NCT03954834|616029724|FG000|Overall Study|Withdrawal by Subject|2|||
170460564|NCT03954834|616029725|FG001|Overall Study|Withdrawal by Subject|3|||
170460565|NCT03954834|616029726|FG002|Overall Study|Withdrawal by Subject|13|||
170460566|NCT03954834|616029727|FG003|Overall Study|Withdrawal by Subject|6|||
170460567|NCT03954834|616029724|FG000|Overall Study|Participant left the country|0|||
170460568|NCT03954834|616029725|FG001|Overall Study|Participant left the country|0|||
170460569|NCT03954834|616029726|FG002|Overall Study|Participant left the country|1|||
170460570|NCT03954834|616029727|FG003|Overall Study|Participant left the country|0|||
170460571|NCT03954834|616029724|FG000|Overall Study|Lost to Follow-up|3|||
170460572|NCT03954834|616029725|FG001|Overall Study|Lost to Follow-up|2|||
170460573|NCT03954834|616029726|FG002|Overall Study|Lost to Follow-up|3|||
170460574|NCT03954834|616029727|FG003|Overall Study|Lost to Follow-up|5|||
170460575|NCT00000378|616029731|FG000|Overall Study|Lack of Efficacy|16|||
170460576|NCT00000378|616029732|FG001|Overall Study|Lack of Efficacy|14|||
170460577|NCT00505375|616029737|FG000|Overall Study|Death|1|||
170636279|NCT04949490|616679013|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
170636280|NCT04949490|616679014|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
170636281|NCT04949490|616679015|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
170636282|NCT04949490|616679016|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
170636283|NCT04949490|616679017|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
170636284|NCT04949490|616679018|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
170636285|NCT04949490|616679013|FG000|Group A and Group B|Withdrawal by Subject|0|||
170636286|NCT04949490|616679014|FG001|Group A and Group B|Withdrawal by Subject|0|||
170636287|NCT04949490|616679015|FG002|Group A and Group B|Withdrawal by Subject|1|||
170636288|NCT04949490|616679016|FG003|Group A and Group B|Withdrawal by Subject|0|||
170636289|NCT04949490|616679017|FG004|Group A and Group B|Withdrawal by Subject|0|||
170636290|NCT04949490|616679018|FG005|Group A and Group B|Withdrawal by Subject|0|||
170636291|NCT04949490|616679013|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
170636292|NCT04949490|616679014|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
170636293|NCT04949490|616679015|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
170636294|NCT04949490|616679016|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
170636295|NCT04949490|616679017|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
170460578|NCT00505375|616029738|FG001|Overall Study|Death|0|||
170460579|NCT00505375|616029737|FG000|Overall Study|Withdrawal by Subject|2|||
170460580|NCT00505375|616029738|FG001|Overall Study|Withdrawal by Subject|2|||
170636296|NCT04949490|616679018|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
170460581|NCT00505375|616029737|FG000|Overall Study|Lost to Follow-up|0|||
170460582|NCT00505375|616029738|FG001|Overall Study|Lost to Follow-up|2|||
170460583|NCT00505375|616029737|FG000|Overall Study|Pregnancy|1|||
170460584|NCT00505375|616029738|FG001|Overall Study|Pregnancy|0|||
170460585|NCT00505375|616029737|FG000|Overall Study|Travel issues|0|||
170460586|NCT00505375|616029738|FG001|Overall Study|Travel issues|1|||
170460587|NCT02906930|616029739|FG000|Overall Study|Withdrawal by Subject|0|||
170460588|NCT02906930|616029740|FG001|Overall Study|Withdrawal by Subject|5|||
170460589|NCT02906930|616029741|FG002|Overall Study|Withdrawal by Subject|5|||
170460590|NCT02906930|616029742|FG003|Overall Study|Withdrawal by Subject|4|||
170460591|NCT02906930|616029739|FG000|Overall Study|Lost to Follow-up|5|||
170460592|NCT02906930|616029740|FG001|Overall Study|Lost to Follow-up|7|||
170460593|NCT02906930|616029741|FG002|Overall Study|Lost to Follow-up|5|||
170460594|NCT02906930|616029742|FG003|Overall Study|Lost to Follow-up|2|||
170460595|NCT02906930|616029739|FG000|Overall Study|Death|0|||
170460596|NCT02906930|616029740|FG001|Overall Study|Death|0|||
170460597|NCT02906930|616029741|FG002|Overall Study|Death|1|||
170460598|NCT02906930|616029742|FG003|Overall Study|Death|0|||
170460599|NCT02906930|616029739|FG000|Overall Study|Other|1|||
170460600|NCT02906930|616029740|FG001|Overall Study|Other|2|||
170460601|NCT02906930|616029741|FG002|Overall Study|Other|1|||
170460602|NCT02906930|616029742|FG003|Overall Study|Other|2|||
170460603|NCT03537599|616029743|FG000|Overall Study|Disease Progression|2|||
170460604|NCT03537599|616029744|FG001|Overall Study|Disease Progression|1|||
170460605|NCT03537599|616029743|FG000|Overall Study|Death|0|||
170460606|NCT03537599|616029744|FG001|Overall Study|Death|1|||
170460607|NCT00325195|616029745|FG000|Randomized|Not dosed|5|||
170788972|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
170788973|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
170788974|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
170788975|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
170788976|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
170460608|NCT00325195|616029746|FG001|Randomized|Not dosed|5|||
170460609|NCT00325195|616029747|FG002|Randomized|Not dosed|3|||
170460610|NCT00325195|616029745|FG000|Received Intervention: ITT Population|Adverse Event|15|||
170460611|NCT00325195|616029746|FG001|Received Intervention: ITT Population|Adverse Event|17|||
170460612|NCT00325195|616029747|FG002|Received Intervention: ITT Population|Adverse Event|1|||
170460613|NCT00325195|616029745|FG000|Received Intervention: ITT Population|Death|3|||
170543572|NCT06461455|616332945|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
170543573|NCT06461455|616332944|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
170543574|NCT06461455|616332945|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
170543575|NCT06461455|616332944|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
170543576|NCT06461455|616332945|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
170543577|NCT06061952|616332946|FG000|Overall Study|Withdrawal by Subject|1|||
170543578|NCT06061952|616332947|FG001|Overall Study|Withdrawal by Subject|2|||
170543579|NCT06061952|616332946|FG000|Overall Study|Lost to Follow-up|2|||
170543580|NCT06061952|616332947|FG001|Overall Study|Lost to Follow-up|2|||
170543581|NCT00160615|616334749|FG000|Overall Study|Adverse Event|5|||
170543582|NCT00160615|616334750|FG001|Overall Study|Adverse Event|12|||
170543583|NCT00160615|616334749|FG000|Overall Study|Withdrawal by Subject|0|||
170543584|NCT00160615|616334750|FG001|Overall Study|Withdrawal by Subject|2|||
170543585|NCT00160615|616334749|FG000|Overall Study|Lack of Efficacy|11|||
170788977|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
170788978|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
170788979|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
170788980|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
170788981|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
170788982|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
170788983|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
170788984|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
170788985|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
170788986|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
170788987|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
170788988|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
170788989|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
170788990|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
170788991|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
170788992|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
170788993|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
170788994|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
170788995|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
170788996|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
170788997|NCT04963270|617238000|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
170788998|NCT04963270|617238001|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
170788999|NCT04963270|617238002|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
170789000|NCT04963270|617238003|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
170789001|NCT03896789|617238004|FG000|Baseline|Lost to Follow-up|1|||
170789002|NCT03896789|617238005|FG001|Baseline|Lost to Follow-up|2|||
170789003|NCT03896789|617238004|FG000|Baseline|Death|3|||
170789004|NCT03896789|617238005|FG001|Baseline|Death|6|||
170789005|NCT03896789|617238004|FG000|Post-Randomization|Lost to Follow-up|12|||
170789006|NCT03896789|617238005|FG001|Post-Randomization|Lost to Follow-up|11|||
170789007|NCT03896789|617238004|FG000|Post-Randomization|Death|12|||
170789008|NCT03896789|617238005|FG001|Post-Randomization|Death|13|||
170789009|NCT04908722|617238007|FG000|Overall Study|Protocol deviation|1|||
170789010|NCT04908722|617238008|FG001|Overall Study|Protocol deviation|0|||
170789011|NCT04908722|617238009|FG002|Overall Study|Protocol deviation|0|||
170789012|NCT04908722|617238010|FG003|Overall Study|Protocol deviation|0|||
170789013|NCT04908722|617238011|FG004|Overall Study|Protocol deviation|0|||
170789014|NCT04908722|617238012|FG005|Overall Study|Protocol deviation|1|||
170789015|NCT04908722|617238007|FG000|Overall Study|Lost to Follow-up|33|||
170789016|NCT04908722|617238008|FG001|Overall Study|Lost to Follow-up|33|||
170789017|NCT04908722|617238009|FG002|Overall Study|Lost to Follow-up|36|||
170789018|NCT04908722|617238010|FG003|Overall Study|Lost to Follow-up|30|||
170789019|NCT04908722|617238011|FG004|Overall Study|Lost to Follow-up|32|||
170789020|NCT04908722|617238012|FG005|Overall Study|Lost to Follow-up|34|||
170789021|NCT04908722|617238007|FG000|Overall Study|Physician Decision|1|||
170789022|NCT04908722|617238008|FG001|Overall Study|Physician Decision|1|||
170789023|NCT04908722|617238009|FG002|Overall Study|Physician Decision|1|||
170789024|NCT04908722|617238010|FG003|Overall Study|Physician Decision|2|||
170789025|NCT04908722|617238011|FG004|Overall Study|Physician Decision|0|||
170889790|NCT00546364|617604061|FG000|Overall Study|No longer meets study criteria|1|||
170543586|NCT00160615|616334750|FG001|Overall Study|Lack of Efficacy|23|||
170789026|NCT04908722|617238012|FG005|Overall Study|Physician Decision|0|||
170543587|NCT00160615|616334749|FG000|Overall Study|Patient decision|1|||
170789027|NCT04908722|617238007|FG000|Overall Study|Death|1|||
170789028|NCT04908722|617238008|FG001|Overall Study|Death|0|||
170789029|NCT04908722|617238009|FG002|Overall Study|Death|0|||
170789030|NCT04908722|617238010|FG003|Overall Study|Death|0|||
170789031|NCT04908722|617238011|FG004|Overall Study|Death|0|||
170789032|NCT04908722|617238012|FG005|Overall Study|Death|1|||
170789033|NCT04908722|617238007|FG000|Overall Study|Withdrawal by Subject|12|||
170636297|NCT04949490|616679013|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
170636298|NCT04949490|616679014|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
170636299|NCT04949490|616679015|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
170789034|NCT04908722|617238008|FG001|Overall Study|Withdrawal by Subject|8|||
170460614|NCT00325195|616029746|FG001|Received Intervention: ITT Population|Death|1|||
170460615|NCT00325195|616029747|FG002|Received Intervention: ITT Population|Death|0|||
170460616|NCT00325195|616029745|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
170460617|NCT00325195|616029746|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
170460618|NCT00325195|616029747|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
170460619|NCT00325195|616029745|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
170460620|NCT00325195|616029746|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
170460621|NCT00325195|616029747|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
170460622|NCT00325195|616029745|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
170460623|NCT00325195|616029746|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
170460624|NCT00325195|616029747|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
170460625|NCT03469336|616029748|FG000|Overall Study|Adverse Event|1|||
170460626|NCT02393248|616029752|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460627|NCT02393248|616029753|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
170460628|NCT02393248|616029754|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460629|NCT02393248|616029755|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460630|NCT02393248|616029756|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170543588|NCT00160615|616334750|FG001|Overall Study|Patient decision|2|||
170543589|NCT00160615|616334749|FG000|Overall Study|Investigator decision|1|||
170543590|NCT00160615|616334750|FG001|Overall Study|Investigator decision|1|||
170543591|NCT00160615|616334749|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
170543592|NCT00160615|616334750|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
170543593|NCT00160615|616334749|FG000|Overall Study|Switch to surgical treatment|0|||
170543594|NCT00160615|616334750|FG001|Overall Study|Switch to surgical treatment|2|||
170543595|NCT00160615|616334749|FG000|Overall Study|Non-compliance was suspected|0|||
170543596|NCT00160615|616334750|FG001|Overall Study|Non-compliance was suspected|1|||
170543597|NCT00160615|616334749|FG000|Overall Study|Poor compliance|0|||
170543598|NCT00160615|616334750|FG001|Overall Study|Poor compliance|1|||
170543599|NCT05638737|616334751|FG000|Overall Study|Withdrawal by Subject|4|||
170543600|NCT05638737|616334752|FG001|Overall Study|Withdrawal by Subject|7|||
170543601|NCT05417113|616334755|FG000|Overall Study|Lost to Follow-up|2|||
170543602|NCT05417113|616334756|FG001|Overall Study|Lost to Follow-up|2|||
170543603|NCT03928704|616334759|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
170543604|NCT03928704|616334760|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
170543605|NCT03928704|616334761|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
170543606|NCT03928704|616334762|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
170543607|NCT03928704|616334763|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
170543608|NCT03928704|616334764|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
170543609|NCT03928704|616334759|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
170543610|NCT03928704|616334760|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
170543611|NCT03928704|616334761|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
170543612|NCT03928704|616334762|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
170543613|NCT03928704|616334763|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
170543614|NCT03928704|616334764|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
170543615|NCT03928704|616334759|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
170543616|NCT03928704|616334760|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
170543617|NCT03928704|616334761|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
170543618|NCT03928704|616334762|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
170543619|NCT03928704|616334763|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
170543620|NCT03928704|616334764|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
170543621|NCT03928704|616334759|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
170543622|NCT03928704|616334760|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
170543623|NCT03928704|616334761|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
170543624|NCT03928704|616334762|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
170543625|NCT03928704|616334763|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
170543626|NCT03928704|616334764|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
170543627|NCT03928704|616334759|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
170543628|NCT03928704|616334760|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
170543629|NCT03928704|616334761|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
170543630|NCT03928704|616334762|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
170460631|NCT02393248|616029757|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
170460632|NCT02393248|616029758|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
170460633|NCT02393248|616029759|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460634|NCT02393248|616029760|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460635|NCT02393248|616029761|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460636|NCT02393248|616029762|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460637|NCT02393248|616029763|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460638|NCT02393248|616029764|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460639|NCT02393248|616029765|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460640|NCT02393248|616029766|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460641|NCT02393248|616029767|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460642|NCT02393248|616029768|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460643|NCT02393248|616029769|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460644|NCT02393248|616029770|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460645|NCT02393248|616029771|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460646|NCT02393248|616029772|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460647|NCT02393248|616029773|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460648|NCT02393248|616029774|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170543631|NCT03928704|616334763|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
170543632|NCT03928704|616334764|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
170543633|NCT03928704|616334759|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
170543634|NCT03928704|616334760|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
170543635|NCT03928704|616334761|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
170543636|NCT03928704|616334762|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
170543637|NCT03928704|616334763|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
170543638|NCT03928704|616334764|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
170543639|NCT03928704|616334759|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
170543640|NCT03928704|616334760|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
170543641|NCT03928704|616334761|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
170543642|NCT03928704|616334762|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
170543643|NCT03928704|616334763|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
170543644|NCT03928704|616334764|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
170543645|NCT03928704|616334759|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
170543646|NCT03928704|616334760|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
170543647|NCT03928704|616334761|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
170543648|NCT03928704|616334762|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
170543649|NCT03928704|616334763|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
170543650|NCT03928704|616334764|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
170543651|NCT03928704|616334759|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
170543652|NCT03928704|616334760|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
170543653|NCT03928704|616334761|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
170543654|NCT03928704|616334762|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
170543655|NCT03928704|616334763|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
170543656|NCT03928704|616334764|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
170543657|NCT03928704|616334759|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
170543658|NCT03928704|616334760|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
170543659|NCT03928704|616334761|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
170543660|NCT03928704|616334762|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
170543661|NCT03928704|616334763|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
170543662|NCT03928704|616334764|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
170543663|NCT00992836|616334768|FG000|Overall Study|Lost to Follow-up|1|||
170543664|NCT00992836|616334768|FG000|Overall Study|Withdrawal by Subject|2|||
170543665|NCT00992836|616334768|FG000|Overall Study|Protocol Violation|2|||
170543666|NCT00266812|616334769|FG000|Overall Study|Disease Progression|9|||
170543667|NCT00266812|616334770|FG001|Overall Study|Disease Progression|3|||
170543668|NCT00266812|616334769|FG000|Overall Study|Death|5|||
170543669|NCT00266812|616334770|FG001|Overall Study|Death|4|||
170543670|NCT00266812|616334769|FG000|Overall Study|Adverse Event|3|||
170543671|NCT00266812|616334770|FG001|Overall Study|Adverse Event|1|||
170543672|NCT00266812|616334769|FG000|Overall Study|Protocol Violation|0|||
170543673|NCT00266812|616334770|FG001|Overall Study|Protocol Violation|1|||
170543674|NCT00266812|616334769|FG000|Overall Study|Withdrawal by Subject|0|||
170543675|NCT00266812|616334770|FG001|Overall Study|Withdrawal by Subject|2|||
170543676|NCT00266812|616334769|FG000|Overall Study|Discontinued before starting study drug|4|||
170789035|NCT04908722|617238009|FG002|Overall Study|Withdrawal by Subject|7|||
170789036|NCT04908722|617238010|FG003|Overall Study|Withdrawal by Subject|6|||
170789037|NCT04908722|617238011|FG004|Overall Study|Withdrawal by Subject|12|||
170789038|NCT04908722|617238012|FG005|Overall Study|Withdrawal by Subject|14|||
170789039|NCT04908722|617238007|FG000|Overall Study|Other|3|||
170460649|NCT02393248|616029775|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460650|NCT02393248|616029776|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
170460651|NCT02393248|616029752|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460652|NCT02393248|616029753|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
170460653|NCT02393248|616029754|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460654|NCT02393248|616029755|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460655|NCT02393248|616029756|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460656|NCT02393248|616029757|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460657|NCT02393248|616029758|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460658|NCT02393248|616029759|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460659|NCT02393248|616029760|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460660|NCT02393248|616029761|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460661|NCT02393248|616029762|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460662|NCT02393248|616029763|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460663|NCT02393248|616029764|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460664|NCT02393248|616029765|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460665|NCT02393248|616029766|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460666|NCT02393248|616029767|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460667|NCT02393248|616029768|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460668|NCT02393248|616029769|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460669|NCT02393248|616029770|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460670|NCT02393248|616029771|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460671|NCT02393248|616029772|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460672|NCT02393248|616029773|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460673|NCT02393248|616029774|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170789040|NCT04908722|617238008|FG001|Overall Study|Other|1|||
170789041|NCT04908722|617238009|FG002|Overall Study|Other|3|||
170789042|NCT04908722|617238010|FG003|Overall Study|Other|2|||
170789043|NCT04908722|617238011|FG004|Overall Study|Other|4|||
170789044|NCT04908722|617238012|FG005|Overall Study|Other|1|||
170789045|NCT04908722|617238007|FG000|Overall Study|Initiated prohibited medication|0|||
170789046|NCT04908722|617238008|FG001|Overall Study|Initiated prohibited medication|0|||
170789047|NCT04908722|617238009|FG002|Overall Study|Initiated prohibited medication|0|||
170789048|NCT04908722|617238010|FG003|Overall Study|Initiated prohibited medication|1|||
170789049|NCT04908722|617238011|FG004|Overall Study|Initiated prohibited medication|0|||
170789050|NCT04908722|617238012|FG005|Overall Study|Initiated prohibited medication|1|||
170789051|NCT04908722|617238007|FG000|Overall Study|Randomized but not vaccinated|3|||
170789052|NCT04908722|617238008|FG001|Overall Study|Randomized but not vaccinated|1|||
170789053|NCT04908722|617238009|FG002|Overall Study|Randomized but not vaccinated|2|||
170789054|NCT04908722|617238010|FG003|Overall Study|Randomized but not vaccinated|2|||
170789055|NCT04908722|617238011|FG004|Overall Study|Randomized but not vaccinated|3|||
170789056|NCT04908722|617238012|FG005|Overall Study|Randomized but not vaccinated|4|||
170789057|NCT06424236|617238013|FG000|Overall Study|Adverse Event|0|||
170789058|NCT06424236|617238014|FG001|Overall Study|Adverse Event|1|||
170789059|NCT06424236|617238015|FG002|Overall Study|Adverse Event|0|||
170789060|NCT06424236|617238013|FG000|Overall Study|Withdrawal by Subject|3|||
170789061|NCT06424236|617238014|FG001|Overall Study|Withdrawal by Subject|1|||
170789062|NCT06424236|617238015|FG002|Overall Study|Withdrawal by Subject|2|||
170789063|NCT06424236|617238013|FG000|Overall Study|Physician Decision|0|||
170789064|NCT06424236|617238014|FG001|Overall Study|Physician Decision|1|||
170789065|NCT06424236|617238015|FG002|Overall Study|Physician Decision|0|||
170789066|NCT06424236|617238013|FG000|Overall Study|Study Terminated by Sponsor|11|||
170789067|NCT06424236|617238014|FG001|Overall Study|Study Terminated by Sponsor|20|||
170789068|NCT06424236|617238015|FG002|Overall Study|Study Terminated by Sponsor|16|||
170789069|NCT06424236|617238013|FG000|Overall Study|Lost to Follow-up|0|||
170789070|NCT06424236|617238014|FG001|Overall Study|Lost to Follow-up|1|||
170789071|NCT06424236|617238015|FG002|Overall Study|Lost to Follow-up|0|||
170789072|NCT06424236|617238013|FG000|Overall Study|Disease Progression|0|||
170789073|NCT06424236|617238014|FG001|Overall Study|Disease Progression|1|||
170789074|NCT06424236|617238015|FG002|Overall Study|Disease Progression|2|||
170789075|NCT06424236|617238013|FG000|Overall Study|Other|0|||
170789076|NCT06424236|617238014|FG001|Overall Study|Other|0|||
170460674|NCT02393248|616029775|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170460675|NCT02393248|616029776|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
170789077|NCT06424236|617238015|FG002|Overall Study|Other|1|||
170789078|NCT01959425|617238016|FG000|Overall Study|Withdrawal by Subject|5|||
170789079|NCT01959425|617238017|FG001|Overall Study|Withdrawal by Subject|4|||
170789080|NCT01959425|617238016|FG000|Overall Study|Lost to Follow-up|1|||
170789081|NCT01959425|617238017|FG001|Overall Study|Lost to Follow-up|0|||
170789082|NCT01959425|617238016|FG000|Overall Study|Discontinued Subjects|6|||
170789083|NCT01959425|617238017|FG001|Overall Study|Discontinued Subjects|4|||
170789084|NCT05540665|617238018|FG000|Overall Study|Study terminated by sponsor|6|||
170460676|NCT02393248|616029752|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
170460677|NCT02393248|616029753|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
170460678|NCT02393248|616029754|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
170460679|NCT02393248|616029755|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
170460680|NCT02393248|616029756|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
170460681|NCT02393248|616029757|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
170460682|NCT02393248|616029758|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
170460683|NCT02393248|616029759|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
170460684|NCT02393248|616029760|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
170460685|NCT02393248|616029761|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
170460686|NCT02393248|616029762|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
170460687|NCT02393248|616029763|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
170460688|NCT02393248|616029764|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
170460689|NCT02393248|616029765|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
170460690|NCT02393248|616029766|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
170460691|NCT02393248|616029767|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
170460692|NCT02393248|616029768|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
170460693|NCT02393248|616029769|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
170460694|NCT02393248|616029770|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
170460695|NCT02393248|616029771|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
170460696|NCT02393248|616029772|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
170636300|NCT04949490|616679016|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
170636301|NCT04949490|616679017|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
170636302|NCT04949490|616679018|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
170636303|NCT03278249|616679019|FG000|Overall Study|Withdrawal by Subject|2|||
170636304|NCT03278249|616679019|FG000|Overall Study|Lost to Follow-up|1|||
170636305|NCT05232682|616679020|FG000|Overall Study|Lost to Follow-up|2|||
170636306|NCT01006291|616680758|FG000|Overall Study|Adverse Event|2|||
170636307|NCT01006291|616680759|FG001|Overall Study|Adverse Event|1|||
170636308|NCT01006291|616680760|FG002|Overall Study|Adverse Event|2|||
170636309|NCT01006291|616680758|FG000|Overall Study|Lack of Efficacy|2|||
170636310|NCT01006291|616680759|FG001|Overall Study|Lack of Efficacy|2|||
170636311|NCT01006291|616680760|FG002|Overall Study|Lack of Efficacy|1|||
170636312|NCT01006291|616680758|FG000|Overall Study|Protocol Violation|3|||
170636313|NCT01006291|616680759|FG001|Overall Study|Protocol Violation|3|||
170636314|NCT01006291|616680760|FG002|Overall Study|Protocol Violation|3|||
170636315|NCT01006291|616680758|FG000|Overall Study|Withdrawal criteria|5|||
170636316|NCT01006291|616680759|FG001|Overall Study|Withdrawal criteria|4|||
170636317|NCT01006291|616680760|FG002|Overall Study|Withdrawal criteria|4|||
170636318|NCT01006291|616680758|FG000|Overall Study|Other|14|||
170636319|NCT01006291|616680759|FG001|Overall Study|Other|14|||
170636320|NCT01006291|616680760|FG002|Overall Study|Other|17|||
170636321|NCT00702715|616680761|FG000|Overall Study|Lost to Follow-up|1|||
170636322|NCT00702715|616680762|FG001|Overall Study|Lost to Follow-up|0|||
170636323|NCT02563067|616680765|FG000|Overall Study|Subject/guardian decision|14|||
170636324|NCT02563067|616680766|FG001|Overall Study|Subject/guardian decision|20|||
170636325|NCT02563067|616680767|FG002|Overall Study|Subject/guardian decision|16|||
170636326|NCT02563067|616680765|FG000|Overall Study|Physician Decision|0|||
170636327|NCT02563067|616680766|FG001|Overall Study|Physician Decision|1|||
170636328|NCT02563067|616680767|FG002|Overall Study|Physician Decision|3|||
170636329|NCT02563067|616680765|FG000|Overall Study|Lost to Follow-up|1|||
170636330|NCT02563067|616680766|FG001|Overall Study|Lost to Follow-up|2|||
170636331|NCT02563067|616680767|FG002|Overall Study|Lost to Follow-up|0|||
170636332|NCT02563067|616680765|FG000|Overall Study|Technical problems|0|||
170636333|NCT02563067|616680766|FG001|Overall Study|Technical problems|1|||
170636334|NCT02563067|616680767|FG002|Overall Study|Technical problems|0|||
170636335|NCT02563067|616680765|FG000|Overall Study|Lack of Efficacy|1|||
170636336|NCT02563067|616680766|FG001|Overall Study|Lack of Efficacy|0|||
170789085|NCT05540665|617238019|FG001|Overall Study|Study terminated by sponsor|6|||
170789086|NCT05540665|617238020|FG002|Overall Study|Study terminated by sponsor|7|||
170789087|NCT05020249|617238021|FG000|Overall Study|Protocol Violation|1|||
170789088|NCT05020249|617238022|FG001|Overall Study|Protocol Violation|0|||
170789089|NCT03628924|617238030|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
170789090|NCT03628924|617238031|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
170460697|NCT02393248|616029773|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
170460698|NCT02393248|616029774|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
170460699|NCT02393248|616029775|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
170460700|NCT02393248|616029776|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
170460701|NCT02393248|616029752|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
170636337|NCT02563067|616680767|FG002|Overall Study|Lack of Efficacy|0|||
170636338|NCT02563067|616680765|FG000|Overall Study|Death|0|||
170636339|NCT02563067|616680766|FG001|Overall Study|Death|1|||
170636340|NCT02563067|616680767|FG002|Overall Study|Death|1|||
170636341|NCT02563067|616680765|FG000|Overall Study|Adverse Event|2|||
170636342|NCT02563067|616680766|FG001|Overall Study|Adverse Event|1|||
170636343|NCT02563067|616680767|FG002|Overall Study|Adverse Event|0|||
170636344|NCT02563067|616680765|FG000|Overall Study|Death post Treatment/safety period|1|||
170460702|NCT02393248|616029753|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460703|NCT02393248|616029754|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460704|NCT02393248|616029755|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460705|NCT02393248|616029756|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460706|NCT02393248|616029757|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460707|NCT02393248|616029758|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460708|NCT02393248|616029759|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460709|NCT02393248|616029760|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460710|NCT02393248|616029761|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460711|NCT02393248|616029762|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460712|NCT02393248|616029763|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460713|NCT02393248|616029764|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460714|NCT02393248|616029765|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460715|NCT02393248|616029766|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460716|NCT02393248|616029767|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460717|NCT02393248|616029768|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460718|NCT02393248|616029769|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460719|NCT02393248|616029770|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460720|NCT02393248|616029771|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460721|NCT02393248|616029772|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460722|NCT02393248|616029773|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460723|NCT02393248|616029774|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460724|NCT02393248|616029775|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460725|NCT02393248|616029776|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
170460726|NCT02393248|616029752|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460727|NCT02393248|616029753|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460728|NCT02393248|616029754|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460729|NCT02393248|616029755|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460730|NCT02393248|616029756|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460731|NCT02393248|616029757|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
170460732|NCT02393248|616029758|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
170460733|NCT02393248|616029759|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460734|NCT02393248|616029760|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460735|NCT02393248|616029761|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
170460736|NCT02393248|616029762|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460737|NCT02393248|616029763|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460738|NCT02393248|616029764|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460739|NCT02393248|616029765|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460740|NCT02393248|616029766|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460741|NCT02393248|616029767|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460742|NCT02393248|616029768|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460743|NCT02393248|616029769|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460744|NCT02393248|616029770|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460745|NCT02393248|616029771|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460746|NCT02393248|616029772|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460747|NCT02393248|616029773|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460748|NCT02393248|616029774|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460749|NCT02393248|616029775|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460750|NCT02393248|616029776|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
170460751|NCT02393248|616029752|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460752|NCT02393248|616029753|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460753|NCT02393248|616029754|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460754|NCT02393248|616029755|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460755|NCT02393248|616029756|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460756|NCT02393248|616029757|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460757|NCT02393248|616029758|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
170460758|NCT02393248|616029759|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460759|NCT02393248|616029760|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460760|NCT02393248|616029761|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460761|NCT02393248|616029762|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460762|NCT02393248|616029763|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460763|NCT02393248|616029764|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460764|NCT02393248|616029765|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460765|NCT02393248|616029766|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460766|NCT02393248|616029767|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460767|NCT02393248|616029768|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460768|NCT02393248|616029769|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460769|NCT02393248|616029770|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460770|NCT02393248|616029771|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460771|NCT02393248|616029772|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460772|NCT02393248|616029773|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460773|NCT02393248|616029774|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460774|NCT02393248|616029775|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460775|NCT02393248|616029776|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
170460776|NCT02393248|616029752|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460777|NCT02393248|616029753|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460778|NCT02393248|616029754|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460779|NCT02393248|616029755|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460780|NCT02393248|616029756|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460781|NCT02393248|616029757|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460782|NCT02393248|616029758|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460783|NCT02393248|616029759|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460784|NCT02393248|616029760|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460785|NCT02393248|616029761|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460786|NCT02393248|616029762|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460787|NCT02393248|616029763|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
170460788|NCT02393248|616029764|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
170636345|NCT02563067|616680766|FG001|Overall Study|Death post Treatment/safety period|0|||
170636346|NCT02563067|616680767|FG002|Overall Study|Death post Treatment/safety period|0|||
170636347|NCT01330108|616680773|FG000|Overall Study|Withdrawal by Subject|4|||
170636348|NCT00423917|616680776|FG000|Overall Study|Cancel|2|||
170636349|NCT00423917|616680776|FG000|Overall Study|Ineligible|1|||
170636350|NCT00555061|616680777|FG000|Overall Study|Adverse Event|3|||
170636351|NCT00555061|616680777|FG000|Overall Study|Protocol Violation|1|||
170636352|NCT00555061|616680777|FG000|Overall Study|Lost to Follow-up|2|||
170636353|NCT00555061|616680777|FG000|Overall Study|Withdrawal by Subject|2|||
170636354|NCT00555061|616680777|FG000|Overall Study|Participant enrolled, but never treated|1|||
170636355|NCT02015637|616680780|FG000|Overall Study|Lost to Follow-up|3|||
170636356|NCT02015637|616680781|FG001|Overall Study|Lost to Follow-up|5|||
170636357|NCT02015637|616680780|FG000|Overall Study|Adverse Event|3|||
170636358|NCT02015637|616680781|FG001|Overall Study|Adverse Event|0|||
170636359|NCT02015637|616680780|FG000|Overall Study|Did not take study drug|2|||
170636360|NCT02015637|616680781|FG001|Overall Study|Did not take study drug|0|||
170636361|NCT00578292|616680784|FG000|Overall Study|Death|1|||
170636362|NCT00578292|616680784|FG000|Overall Study|Graft failure|2|||
170636363|NCT02586207|616680791|FG000|Overall Study|Physician Decision|1|||
170636364|NCT02586207|616680791|FG000|Overall Study|Withdrawal by Subject|1|||
170636365|NCT04085289|616680792|FG000|Overall Study|Withdrawal by Subject|0|||
170636366|NCT04085289|616680793|FG001|Overall Study|Withdrawal by Subject|0|||
170636367|NCT04085289|616680794|FG002|Overall Study|Withdrawal by Subject|1|||
170636368|NCT01317277|616680795|FG000|Overall Study|Lost to Follow-up|3|||
170636369|NCT01317277|616680796|FG001|Overall Study|Lost to Follow-up|1|||
170636370|NCT01317277|616680795|FG000|Overall Study|Lost MEMS|1|||
170636371|NCT01317277|616680796|FG001|Overall Study|Lost MEMS|1|||
170636372|NCT01317277|616680795|FG000|Overall Study|Unable to comply with intervention|1|||
170636373|NCT01317277|616680796|FG001|Overall Study|Unable to comply with intervention|0|||
170636374|NCT01317277|616680795|FG000|Overall Study|Withdrawal by Subject|1|||
170636375|NCT01317277|616680796|FG001|Overall Study|Withdrawal by Subject|0|||
170636376|NCT01317277|616680795|FG000|Overall Study|Adverse Event|1|||
170636377|NCT01317277|616680796|FG001|Overall Study|Adverse Event|0|||
170636378|NCT01635153|616680797|FG000|Overall Study|Lost to Follow-up|40|||
170636379|NCT01635153|616680798|FG001|Overall Study|Lost to Follow-up|43|||
170636380|NCT02577718|616680799|FG000|Overall Study|Death|6|||
170636381|NCT02577718|616680799|FG000|Overall Study|Withdrawal by Subject|2|||
170636382|NCT02561832|616680800|FG000|Overall Study|Withdrawal by Subject|1|||
170636383|NCT02561832|616680801|FG001|Overall Study|Withdrawal by Subject|1|||
170636384|NCT02561832|616680800|FG000|Overall Study|Adverse Event|3|||
170636385|NCT02561832|616680801|FG001|Overall Study|Adverse Event|0|||
170636386|NCT02561832|616680800|FG000|Overall Study|Disease progression|3|||
170636387|NCT02561832|616680801|FG001|Overall Study|Disease progression|3|||
170636388|NCT02892448|616680808|FG000|Overall Study|Screening failure|2|||
170636389|NCT02892448|616680809|FG001|Overall Study|Screening failure|2|||
170636390|NCT02892448|616680810|FG002|Overall Study|Screening failure|1|||
170636391|NCT02304367|616680811|FG000|Overall Study|Lack of Response to Bruosumab|1|||
170636392|NCT02304367|616680811|FG000|Overall Study|Sponsor Decision|3|||
170636393|NCT02304367|616680811|FG000|Overall Study|Death|2|||
170636394|NCT02304367|616680811|FG000|Overall Study|Physician Decision|1|||
170889791|NCT00546364|617604062|FG001|Overall Study|No longer meets study criteria|1|||
170889792|NCT00546364|617604063|FG002|Overall Study|No longer meets study criteria|0|||
170889793|NCT00546364|617604061|FG000|Overall Study|Withdrawal by Subject|5|||
170889794|NCT00546364|617604062|FG001|Overall Study|Withdrawal by Subject|6|||
170889795|NCT00546364|617604063|FG002|Overall Study|Withdrawal by Subject|3|||
170889796|NCT00546364|617604061|FG000|Overall Study|Prior taxotere|1|||
170889797|NCT00546364|617604062|FG001|Overall Study|Prior taxotere|0|||
170889798|NCT00546364|617604063|FG002|Overall Study|Prior taxotere|0|||
170889799|NCT00546364|617604061|FG000|Overall Study|Mixed response|1|||
170889800|NCT00546364|617604062|FG001|Overall Study|Mixed response|0|||
170889801|NCT00546364|617604063|FG002|Overall Study|Mixed response|0|||
170889802|NCT00546364|617604061|FG000|Overall Study|Palliative treatment|1|||
170889803|NCT00546364|617604062|FG001|Overall Study|Palliative treatment|0|||
170889804|NCT00546364|617604063|FG002|Overall Study|Palliative treatment|1|||
170889805|NCT00546364|617604061|FG000|Overall Study|Target lesions resected|1|||
170889806|NCT00546364|617604062|FG001|Overall Study|Target lesions resected|0|||
170889807|NCT00546364|617604063|FG002|Overall Study|Target lesions resected|0|||
170889808|NCT00546364|617604061|FG000|Overall Study|Physician Decision|0|||
170889809|NCT00546364|617604062|FG001|Overall Study|Physician Decision|0|||
170636395|NCT02304367|616680811|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
170636396|NCT02500797|616680814|FG000|Overall Study|Cancel (rapid disease progression)|0|||
170636397|NCT02500797|616680815|FG001|Overall Study|Cancel (rapid disease progression)|0|||
170636398|NCT02500797|616680816|FG002|Overall Study|Cancel (rapid disease progression)|0|||
170636399|NCT02500797|616680817|FG003|Overall Study|Cancel (rapid disease progression)|0|||
170636400|NCT02500797|616680818|FG004|Overall Study|Cancel (rapid disease progression)|1|||
170636401|NCT02500797|616680819|FG005|Overall Study|Cancel (rapid disease progression)|1|||
170636402|NCT02500797|616680820|FG006|Overall Study|Cancel (rapid disease progression)|0|||
170636403|NCT02500797|616680821|FG007|Overall Study|Cancel (rapid disease progression)|0|||
170636404|NCT02500797|616680814|FG000|Overall Study|Withdrawal by Subject|1|||
170636405|NCT02500797|616680815|FG001|Overall Study|Withdrawal by Subject|0|||
170636406|NCT02500797|616680816|FG002|Overall Study|Withdrawal by Subject|0|||
170789091|NCT03628924|617238032|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
170789092|NCT03628924|617238033|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
170789093|NCT03628924|617238034|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
170789094|NCT03628924|617238035|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
170789095|NCT03628924|617238036|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
170789096|NCT03628924|617238030|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170789097|NCT03628924|617238031|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170789098|NCT03628924|617238032|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
170789099|NCT03628924|617238033|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170789100|NCT03628924|617238034|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170789101|NCT03628924|617238035|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170789102|NCT03628924|617238036|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
170789103|NCT03628924|617238030|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
170789104|NCT03628924|617238031|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
170789105|NCT03628924|617238032|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
170789106|NCT03628924|617238033|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
170789107|NCT03628924|617238034|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
170789108|NCT03628924|617238035|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
170789109|NCT03628924|617238036|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
170789110|NCT03628924|617238030|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
170789111|NCT03628924|617238031|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
170789112|NCT03628924|617238032|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
170789113|NCT03628924|617238033|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
170789114|NCT03628924|617238034|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
170789115|NCT03628924|617238035|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
170789116|NCT03628924|617238036|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
170789117|NCT03628924|617238030|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
170789118|NCT03628924|617238031|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
170789119|NCT03628924|617238032|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
170789120|NCT03628924|617238033|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
170789121|NCT03628924|617238034|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
170789122|NCT03628924|617238035|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
170789123|NCT03628924|617238036|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
170789124|NCT03628924|617238030|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
170789125|NCT03628924|617238031|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
170789126|NCT03628924|617238032|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
170789127|NCT03628924|617238033|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
170789128|NCT03628924|617238034|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
170789129|NCT03628924|617238035|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
170789130|NCT03628924|617238036|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
170789131|NCT03628924|617238030|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
170789132|NCT03628924|617238031|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
170789133|NCT03628924|617238032|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
170789134|NCT03628924|617238033|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
170789135|NCT03628924|617238034|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
170789136|NCT03628924|617238035|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
170789137|NCT03628924|617238036|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
170789138|NCT03628924|617238030|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
170789139|NCT03628924|617238031|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
170789140|NCT03628924|617238032|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
170789141|NCT03628924|617238033|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
170789142|NCT03628924|617238034|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
170789143|NCT03628924|617238035|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
170789144|NCT03628924|617238036|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
170789145|NCT03628924|617238030|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
170789146|NCT03628924|617238031|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
170789147|NCT03628924|617238032|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
170789148|NCT03628924|617238033|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
170789149|NCT03628924|617238034|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
170636407|NCT02500797|616680817|FG003|Overall Study|Withdrawal by Subject|0|||
170460789|NCT02393248|616029765|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
170460790|NCT02393248|616029766|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
170460791|NCT02393248|616029767|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460792|NCT02393248|616029768|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460793|NCT02393248|616029769|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460794|NCT02393248|616029770|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460795|NCT02393248|616029771|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460796|NCT02393248|616029772|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460797|NCT02393248|616029773|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460798|NCT02393248|616029774|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460799|NCT02393248|616029775|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460800|NCT02393248|616029776|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
170460801|NCT02393248|616029752|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460802|NCT02393248|616029753|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460803|NCT02393248|616029754|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460804|NCT02393248|616029755|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460805|NCT02393248|616029756|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460806|NCT02393248|616029757|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460807|NCT02393248|616029758|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460808|NCT02393248|616029759|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460809|NCT02393248|616029760|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460810|NCT02393248|616029761|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460811|NCT02393248|616029762|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
170460812|NCT02393248|616029763|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
170460813|NCT02393248|616029764|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460814|NCT02393248|616029765|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460815|NCT02393248|616029766|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460816|NCT02393248|616029767|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460817|NCT02393248|616029768|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460818|NCT02393248|616029769|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460819|NCT02393248|616029770|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460820|NCT02393248|616029771|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460821|NCT02393248|616029772|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460822|NCT02393248|616029773|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460823|NCT02393248|616029774|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170636408|NCT02500797|616680818|FG004|Overall Study|Withdrawal by Subject|0|||
170636409|NCT02500797|616680819|FG005|Overall Study|Withdrawal by Subject|0|||
170636410|NCT02500797|616680820|FG006|Overall Study|Withdrawal by Subject|0|||
170636411|NCT02500797|616680821|FG007|Overall Study|Withdrawal by Subject|0|||
170636412|NCT02284243|616680826|FG000|Overall Study|Lack of Efficacy|3|||
170636413|NCT02284243|616680827|FG001|Overall Study|Lack of Efficacy|3|||
170636414|NCT02284243|616680826|FG000|Overall Study|Adverse Event|1|||
170636415|NCT02284243|616680827|FG001|Overall Study|Adverse Event|0|||
170636416|NCT03710161|616680828|FG000|Overall Study|Study halted due to COVID pandemic|3|||
170636417|NCT03710161|616680829|FG001|Overall Study|Study halted due to COVID pandemic|2|||
170460824|NCT02393248|616029775|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460825|NCT02393248|616029776|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
170460826|NCT02393248|616029752|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
170460827|NCT02393248|616029753|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
170460828|NCT02393248|616029754|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
170460829|NCT02393248|616029755|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
170460830|NCT02393248|616029756|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
170460831|NCT02393248|616029757|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
170460832|NCT02393248|616029758|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
170460833|NCT02393248|616029759|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
170460834|NCT02393248|616029760|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
170460835|NCT02393248|616029761|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
170460836|NCT02393248|616029762|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
170460837|NCT02393248|616029763|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
170460838|NCT02393248|616029764|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
170460839|NCT02393248|616029765|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
170460840|NCT02393248|616029766|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
170460841|NCT02393248|616029767|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
170460842|NCT02393248|616029768|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
170460843|NCT02393248|616029769|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
170460844|NCT02393248|616029770|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
170460845|NCT02393248|616029771|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
170460846|NCT02393248|616029772|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
170460847|NCT02393248|616029773|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
170636418|NCT02637037|616680832|FG000|Overall Study|Positive drug screen at admission|1|||
170460848|NCT02393248|616029774|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
170460849|NCT02393248|616029775|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
170460850|NCT02393248|616029776|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
170460851|NCT02393248|616029752|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460852|NCT02393248|616029753|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460853|NCT02393248|616029754|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460854|NCT02393248|616029755|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460855|NCT02393248|616029756|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460856|NCT02393248|616029757|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460857|NCT02393248|616029758|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460858|NCT02393248|616029759|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460859|NCT02393248|616029760|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460860|NCT02393248|616029761|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460861|NCT02393248|616029762|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460862|NCT02393248|616029763|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
170460863|NCT02393248|616029764|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460864|NCT02393248|616029765|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
170460865|NCT02393248|616029766|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460866|NCT02393248|616029767|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460867|NCT02393248|616029768|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460868|NCT02393248|616029769|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460869|NCT02393248|616029770|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460870|NCT02393248|616029771|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170543677|NCT00266812|616334770|FG001|Overall Study|Discontinued before starting study drug|0|||
170543678|NCT00530075|616334771|FG000|Overall Study|Adverse Event|1|||
170543679|NCT00530075|616334771|FG000|Overall Study|Death|1|||
170543680|NCT00530075|616334771|FG000|Overall Study|Lack of Efficacy|3|||
170543681|NCT00530075|616334771|FG000|Overall Study|Protocol Violation|1|||
170543682|NCT00530075|616334771|FG000|Overall Study|Withdrawal by Subject|1|||
170543683|NCT01137812|616334778|FG000|Overall Study|Adverse Event|21|||
170543684|NCT01137812|616334779|FG001|Overall Study|Adverse Event|14|||
170543685|NCT01137812|616334778|FG000|Overall Study|Lost to Follow-up|6|||
170543686|NCT01137812|616334779|FG001|Overall Study|Lost to Follow-up|8|||
170543687|NCT01137812|616334778|FG000|Overall Study|Physician Decision|25|||
170543688|NCT01137812|616334779|FG001|Overall Study|Physician Decision|17|||
170543689|NCT01137812|616334778|FG000|Overall Study|Protocol Violation|5|||
170789150|NCT03628924|617238035|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
170789151|NCT03628924|617238036|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
170543690|NCT01137812|616334779|FG001|Overall Study|Protocol Violation|4|||
170543691|NCT01137812|616334778|FG000|Overall Study|Withdrawal by Subject|5|||
170543692|NCT01137812|616334779|FG001|Overall Study|Withdrawal by Subject|13|||
170543693|NCT01137812|616334778|FG000|Overall Study|Death|2|||
170543694|NCT01137812|616334779|FG001|Overall Study|Death|0|||
170543695|NCT01137812|616334778|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
170543696|NCT01137812|616334779|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
170543697|NCT01137812|616334778|FG000|Overall Study|Other|19|||
170543698|NCT01137812|616334779|FG001|Overall Study|Other|27|||
170543699|NCT03677401|616334780|FG000|Overall Study|Adverse Event|4|||
170543700|NCT03677401|616334781|FG001|Overall Study|Adverse Event|14|||
170543701|NCT03677401|616334780|FG000|Overall Study|Lack of Efficacy|3|||
170543702|NCT03677401|616334781|FG001|Overall Study|Lack of Efficacy|1|||
170543703|NCT03677401|616334780|FG000|Overall Study|Withdrawal by Subject|2|||
170543704|NCT03677401|616334781|FG001|Overall Study|Withdrawal by Subject|2|||
170543705|NCT03677401|616334780|FG000|Overall Study|Sponsor decision|0|||
170543706|NCT03677401|616334781|FG001|Overall Study|Sponsor decision|1|||
170543707|NCT03677401|616334780|FG000|Overall Study|Reason Unspecified|1|||
170543708|NCT03677401|616334781|FG001|Overall Study|Reason Unspecified|0|||
170543709|NCT03927157|616334783|FG000|Overall Study|Adverse Event|1|||
170543710|NCT03927157|616334784|FG001|Overall Study|Adverse Event|3|||
170543711|NCT03927157|616334783|FG000|Overall Study|Protocol Violation|1|||
170543712|NCT03927157|616334784|FG001|Overall Study|Protocol Violation|2|||
170543713|NCT03927157|616334783|FG000|Overall Study|Withdrawal by Subject|8|||
170543714|NCT03927157|616334784|FG001|Overall Study|Withdrawal by Subject|21|||
170543715|NCT03927157|616334783|FG000|Overall Study|Due to COVID-19 pandemic|5|||
170543716|NCT03927157|616334784|FG001|Overall Study|Due to COVID-19 pandemic|2|||
170543717|NCT03927157|616334783|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
170543718|NCT03927157|616334784|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
170543719|NCT03927157|616334783|FG000|Overall Study|Other than above|0|||
170543720|NCT03927157|616334784|FG001|Overall Study|Other than above|1|||
170543721|NCT02965716|616334785|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
170789152|NCT03628924|617238030|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
170789153|NCT03628924|617238031|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
170789154|NCT03628924|617238032|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
170789155|NCT03628924|617238033|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
170460871|NCT02393248|616029772|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460872|NCT02393248|616029773|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460873|NCT02393248|616029774|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460874|NCT02393248|616029775|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460875|NCT02393248|616029776|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
170460876|NCT02393248|616029752|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460877|NCT02393248|616029753|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460878|NCT02393248|616029754|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460879|NCT02393248|616029755|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460880|NCT02393248|616029756|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460881|NCT02393248|616029757|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460882|NCT02393248|616029758|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460883|NCT02393248|616029759|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460884|NCT02393248|616029760|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460885|NCT02393248|616029761|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460886|NCT02393248|616029762|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460887|NCT02393248|616029763|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460888|NCT02393248|616029764|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460889|NCT02393248|616029765|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460890|NCT02393248|616029766|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460891|NCT02393248|616029767|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460892|NCT02393248|616029768|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460893|NCT02393248|616029769|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460894|NCT02393248|616029770|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
170460895|NCT02393248|616029771|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460896|NCT02393248|616029772|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
170460897|NCT02393248|616029773|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
170460898|NCT02393248|616029774|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460899|NCT02393248|616029775|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
170460900|NCT02393248|616029776|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
170460901|NCT02393248|616029752|FG000|Part 3: Combination Therapy|Death|0|||
170460902|NCT02393248|616029753|FG001|Part 3: Combination Therapy|Death|0|||
170460903|NCT02393248|616029754|FG002|Part 3: Combination Therapy|Death|0|||
170460904|NCT02393248|616029755|FG003|Part 3: Combination Therapy|Death|0|||
170460905|NCT02393248|616029756|FG004|Part 3: Combination Therapy|Death|0|||
170460906|NCT02393248|616029757|FG005|Part 3: Combination Therapy|Death|0|||
170460907|NCT02393248|616029758|FG006|Part 3: Combination Therapy|Death|0|||
170460908|NCT02393248|616029759|FG007|Part 3: Combination Therapy|Death|0|||
170460909|NCT02393248|616029760|FG008|Part 3: Combination Therapy|Death|0|||
170460910|NCT02393248|616029761|FG009|Part 3: Combination Therapy|Death|0|||
170460911|NCT02393248|616029762|FG010|Part 3: Combination Therapy|Death|0|||
170460912|NCT02393248|616029763|FG011|Part 3: Combination Therapy|Death|0|||
170460913|NCT02393248|616029764|FG012|Part 3: Combination Therapy|Death|0|||
170460914|NCT02393248|616029765|FG013|Part 3: Combination Therapy|Death|0|||
170460915|NCT02393248|616029766|FG014|Part 3: Combination Therapy|Death|0|||
170460916|NCT02393248|616029767|FG015|Part 3: Combination Therapy|Death|1|||
170460917|NCT02393248|616029768|FG016|Part 3: Combination Therapy|Death|7|||
170460918|NCT02393248|616029769|FG017|Part 3: Combination Therapy|Death|5|||
170460919|NCT02393248|616029770|FG018|Part 3: Combination Therapy|Death|5|||
170460920|NCT02393248|616029771|FG019|Part 3: Combination Therapy|Death|3|||
170460921|NCT02393248|616029772|FG020|Part 3: Combination Therapy|Death|7|||
170460922|NCT02393248|616029773|FG021|Part 3: Combination Therapy|Death|5|||
170460923|NCT02393248|616029774|FG022|Part 3: Combination Therapy|Death|6|||
170460924|NCT02393248|616029775|FG023|Part 3: Combination Therapy|Death|3|||
170460925|NCT02393248|616029776|FG024|Part 3: Combination Therapy|Death|0|||
170460926|NCT02393248|616029752|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460927|NCT02393248|616029753|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460928|NCT02393248|616029754|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460929|NCT02393248|616029755|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170543722|NCT02965716|616334786|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
170543723|NCT02965716|616334785|FG000|Overall Study|Progression/Relapse|8|||
170460930|NCT02393248|616029756|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460931|NCT02393248|616029757|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460932|NCT02393248|616029758|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460933|NCT02393248|616029759|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170543724|NCT02965716|616334786|FG001|Overall Study|Progression/Relapse|16|||
170543725|NCT02965716|616334785|FG000|Overall Study|Death|1|||
170889810|NCT00546364|617604063|FG002|Overall Study|Physician Decision|1|||
170460934|NCT02393248|616029760|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170543726|NCT02965716|616334786|FG001|Overall Study|Death|0|||
170889811|NCT00546364|617604061|FG000|Overall Study|Sponsor decision|0|||
170460935|NCT02393248|616029761|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460936|NCT02393248|616029762|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460937|NCT02393248|616029763|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460938|NCT02393248|616029764|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460939|NCT02393248|616029765|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460940|NCT02393248|616029766|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460941|NCT02393248|616029767|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460942|NCT02393248|616029768|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460943|NCT02393248|616029769|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
170460944|NCT02393248|616029770|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
170460945|NCT02393248|616029771|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
170460946|NCT02393248|616029772|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
170460947|NCT02393248|616029773|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
170460948|NCT02393248|616029774|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
170460949|NCT02393248|616029775|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
170460950|NCT02393248|616029776|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
170460951|NCT02393248|616029752|FG000|Part 3: Combination Therapy|Disease Progression|0|||
170460952|NCT02393248|616029753|FG001|Part 3: Combination Therapy|Disease Progression|0|||
170460953|NCT02393248|616029754|FG002|Part 3: Combination Therapy|Disease Progression|0|||
170460954|NCT02393248|616029755|FG003|Part 3: Combination Therapy|Disease Progression|0|||
170460955|NCT02393248|616029756|FG004|Part 3: Combination Therapy|Disease Progression|0|||
170460956|NCT02393248|616029757|FG005|Part 3: Combination Therapy|Disease Progression|0|||
170460957|NCT02393248|616029758|FG006|Part 3: Combination Therapy|Disease Progression|0|||
170460958|NCT02393248|616029759|FG007|Part 3: Combination Therapy|Disease Progression|0|||
170460959|NCT02393248|616029760|FG008|Part 3: Combination Therapy|Disease Progression|0|||
170460960|NCT02393248|616029761|FG009|Part 3: Combination Therapy|Disease Progression|0|||
170460961|NCT02393248|616029762|FG010|Part 3: Combination Therapy|Disease Progression|0|||
170460962|NCT02393248|616029763|FG011|Part 3: Combination Therapy|Disease Progression|0|||
170460963|NCT02393248|616029764|FG012|Part 3: Combination Therapy|Disease Progression|0|||
170460964|NCT02393248|616029765|FG013|Part 3: Combination Therapy|Disease Progression|0|||
170460965|NCT02393248|616029766|FG014|Part 3: Combination Therapy|Disease Progression|0|||
170460966|NCT02393248|616029767|FG015|Part 3: Combination Therapy|Disease Progression|0|||
170460967|NCT02393248|616029768|FG016|Part 3: Combination Therapy|Disease Progression|0|||
170460968|NCT02393248|616029769|FG017|Part 3: Combination Therapy|Disease Progression|0|||
170460969|NCT02393248|616029770|FG018|Part 3: Combination Therapy|Disease Progression|0|||
170460970|NCT02393248|616029771|FG019|Part 3: Combination Therapy|Disease Progression|0|||
170460971|NCT02393248|616029772|FG020|Part 3: Combination Therapy|Disease Progression|2|||
170460972|NCT02393248|616029773|FG021|Part 3: Combination Therapy|Disease Progression|1|||
170460973|NCT02393248|616029774|FG022|Part 3: Combination Therapy|Disease Progression|0|||
170460974|NCT02393248|616029775|FG023|Part 3: Combination Therapy|Disease Progression|0|||
170460975|NCT02393248|616029776|FG024|Part 3: Combination Therapy|Disease Progression|0|||
170460976|NCT02393248|616029752|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
170543727|NCT02965716|616334785|FG000|Overall Study|Not Protocol Specified|1|||
170543728|NCT02965716|616334786|FG001|Overall Study|Not Protocol Specified|3|||
170543729|NCT00726557|616334787|FG000|Overall Study|Screening failure|4|||
170543730|NCT00726557|616334787|FG000|Overall Study|No end of treatment documentation|37|||
170543731|NCT00726557|616334787|FG000|Overall Study|No follow-up documentation available|55|||
170543732|NCT00726557|616334787|FG000|Overall Study|Treatment less than 3 months|17|||
170543733|NCT00726557|616334787|FG000|Overall Study|Inclusion criteria not met|15|||
170543734|NCT02265744|616334790|FG000|Overall Study|Poor/Non-compliance|1|||
170543735|NCT02265744|616334791|FG001|Overall Study|Poor/Non-compliance|1|||
170543736|NCT02265744|616334792|FG002|Overall Study|Poor/Non-compliance|0|||
170543737|NCT02265744|616334793|FG003|Overall Study|Poor/Non-compliance|0|||
170543738|NCT02265744|616334794|FG004|Overall Study|Poor/Non-compliance|2|||
170543739|NCT02265744|616334790|FG000|Overall Study|Lost to Follow-up|0|||
170543740|NCT02265744|616334791|FG001|Overall Study|Lost to Follow-up|0|||
170543741|NCT02265744|616334792|FG002|Overall Study|Lost to Follow-up|0|||
170789156|NCT03628924|617238034|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
170789157|NCT03628924|617238035|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
170789158|NCT03628924|617238036|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
170789159|NCT05499377|617238039|FG000|Overall Study|Withdrawal by Subject|2|||
170789160|NCT05499377|617238040|FG001|Overall Study|Withdrawal by Subject|0|||
170789161|NCT05499377|617238039|FG000|Overall Study|Physician Decision|1|||
170889812|NCT00546364|617604062|FG001|Overall Study|Sponsor decision|0|||
170460977|NCT02393248|616029753|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
170543742|NCT02265744|616334793|FG003|Overall Study|Lost to Follow-up|1|||
170789162|NCT05499377|617238040|FG001|Overall Study|Physician Decision|0|||
170789163|NCT02268253|617238041|FG000|Stage 1|Withdrawal by Subject|1|||
170543743|NCT02265744|616334794|FG004|Overall Study|Lost to Follow-up|0|||
170543744|NCT02265744|616334790|FG000|Overall Study|Death|0|||
170543745|NCT02265744|616334791|FG001|Overall Study|Death|0|||
170460978|NCT02393248|616029754|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460979|NCT02393248|616029755|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460980|NCT02393248|616029756|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460981|NCT02393248|616029757|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460982|NCT02393248|616029758|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460983|NCT02393248|616029759|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460984|NCT02393248|616029760|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460985|NCT02393248|616029761|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460986|NCT02393248|616029762|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460987|NCT02393248|616029763|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460988|NCT02393248|616029764|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460989|NCT02393248|616029765|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460990|NCT02393248|616029766|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
170543746|NCT02265744|616334792|FG002|Overall Study|Death|0|||
170543747|NCT02265744|616334793|FG003|Overall Study|Death|2|||
170543748|NCT02265744|616334794|FG004|Overall Study|Death|0|||
170543749|NCT02265744|616334790|FG000|Overall Study|Withdrawal by Subject|2|||
170543750|NCT02265744|616334791|FG001|Overall Study|Withdrawal by Subject|0|||
170543751|NCT02265744|616334792|FG002|Overall Study|Withdrawal by Subject|0|||
170543752|NCT02265744|616334793|FG003|Overall Study|Withdrawal by Subject|2|||
170543753|NCT02265744|616334794|FG004|Overall Study|Withdrawal by Subject|0|||
170543754|NCT02265744|616334790|FG000|Overall Study|Participant request to discontinue|2|||
170543755|NCT02265744|616334791|FG001|Overall Study|Participant request to discontinue|2|||
170543756|NCT02265744|616334792|FG002|Overall Study|Participant request to discontinue|2|||
170543757|NCT02265744|616334793|FG003|Overall Study|Participant request to discontinue|0|||
170543758|NCT02265744|616334794|FG004|Overall Study|Participant request to discontinue|0|||
170543759|NCT02265744|616334790|FG000|Overall Study|Adverse Event|8|||
170543760|NCT02265744|616334791|FG001|Overall Study|Adverse Event|4|||
170543761|NCT02265744|616334792|FG002|Overall Study|Adverse Event|9|||
170543762|NCT02265744|616334793|FG003|Overall Study|Adverse Event|8|||
170543763|NCT02265744|616334794|FG004|Overall Study|Adverse Event|2|||
170543764|NCT02265744|616334790|FG000|Overall Study|Lack of Efficacy|2|||
170543765|NCT02265744|616334791|FG001|Overall Study|Lack of Efficacy|4|||
170543766|NCT02265744|616334792|FG002|Overall Study|Lack of Efficacy|3|||
170543767|NCT02265744|616334793|FG003|Overall Study|Lack of Efficacy|4|||
170543768|NCT02265744|616334794|FG004|Overall Study|Lack of Efficacy|5|||
170543769|NCT02265744|616334790|FG000|Overall Study|Reason not provided by Investigator|1|||
170543770|NCT02265744|616334791|FG001|Overall Study|Reason not provided by Investigator|0|||
170543771|NCT02265744|616334792|FG002|Overall Study|Reason not provided by Investigator|0|||
170543772|NCT02265744|616334793|FG003|Overall Study|Reason not provided by Investigator|2|||
170543773|NCT02265744|616334794|FG004|Overall Study|Reason not provided by Investigator|0|||
170543774|NCT02265744|616334790|FG000|Overall Study|Administrative reason by sponsor|3|||
170543775|NCT02265744|616334791|FG001|Overall Study|Administrative reason by sponsor|2|||
170543776|NCT02265744|616334792|FG002|Overall Study|Administrative reason by sponsor|2|||
170543777|NCT02265744|616334793|FG003|Overall Study|Administrative reason by sponsor|3|||
170543778|NCT02265744|616334794|FG004|Overall Study|Administrative reason by sponsor|3|||
170543779|NCT02265744|616334790|FG000|Overall Study|Subject no longer meets study criteria|0|||
170543780|NCT02265744|616334791|FG001|Overall Study|Subject no longer meets study criteria|0|||
170543781|NCT02265744|616334792|FG002|Overall Study|Subject no longer meets study criteria|0|||
170543782|NCT02265744|616334793|FG003|Overall Study|Subject no longer meets study criteria|0|||
170543783|NCT02265744|616334794|FG004|Overall Study|Subject no longer meets study criteria|1|||
170543784|NCT02265744|616334790|FG000|Overall Study|Pregnancy|1|||
170543785|NCT02265744|616334791|FG001|Overall Study|Pregnancy|2|||
170543786|NCT02265744|616334792|FG002|Overall Study|Pregnancy|1|||
170543787|NCT02265744|616334793|FG003|Overall Study|Pregnancy|1|||
170636419|NCT02637037|616680833|FG001|Overall Study|Positive drug screen at admission|0|||
170636420|NCT02637037|616680832|FG000|Overall Study|Withdrawal by Subject|2|||
170636421|NCT02637037|616680833|FG001|Overall Study|Withdrawal by Subject|1|||
170636422|NCT02637037|616680832|FG000|Overall Study|Adverse Event|1|||
170543788|NCT02265744|616334794|FG004|Overall Study|Pregnancy|0|||
170543789|NCT06262607|616334795|FG000|Overall Study|Physician Decision|0|||
170543790|NCT06262607|616334796|FG001|Overall Study|Physician Decision|1|||
170543791|NCT06262607|616334795|FG000|Overall Study|Withdrawal by Subject|2|||
170543792|NCT06262607|616334796|FG001|Overall Study|Withdrawal by Subject|0|||
170636423|NCT02637037|616680833|FG001|Overall Study|Adverse Event|0|||
170460991|NCT02393248|616029767|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
170543793|NCT00923702|616334797|FG000|Overall Study|Ongoing enrollment|0|||
170543794|NCT00923702|616334798|FG001|Overall Study|Ongoing enrollment|0|||
170543795|NCT00923702|616334799|FG002|Overall Study|Ongoing enrollment|0|||
170636424|NCT02023697|616680835|FG000|Treatment Period|Radiological progression|13|||
170789164|NCT02268253|617238042|FG001|Stage 1|Withdrawal by Subject|0|||
170789165|NCT02268253|617238043|FG002|Stage 1|Withdrawal by Subject|0|||
170543796|NCT00923702|616334800|FG003|Overall Study|Ongoing enrollment|0|||
170636425|NCT02023697|616680836|FG001|Treatment Period|Radiological progression|17|||
170789166|NCT02268253|617238044|FG003|Stage 1|Withdrawal by Subject|0|||
170460992|NCT02393248|616029768|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460993|NCT02393248|616029769|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460994|NCT02393248|616029770|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460995|NCT02393248|616029771|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460996|NCT02393248|616029772|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
170460997|NCT02393248|616029773|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
170460998|NCT02393248|616029774|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
170460999|NCT02393248|616029775|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
170461000|NCT02393248|616029776|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
170461001|NCT02393248|616029752|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461002|NCT02393248|616029753|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461003|NCT02393248|616029754|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461004|NCT02393248|616029755|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461005|NCT02393248|616029756|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461006|NCT02393248|616029757|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461007|NCT02393248|616029758|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461008|NCT02393248|616029759|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461009|NCT02393248|616029760|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461010|NCT02393248|616029761|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461011|NCT02393248|616029762|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461012|NCT02393248|616029763|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461013|NCT02393248|616029764|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461014|NCT02393248|616029765|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461015|NCT02393248|616029766|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461016|NCT02393248|616029767|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461017|NCT02393248|616029768|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461018|NCT02393248|616029769|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461019|NCT02393248|616029770|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461020|NCT02393248|616029771|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461021|NCT02393248|616029772|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
170461022|NCT02393248|616029773|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461023|NCT02393248|616029774|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461024|NCT02393248|616029775|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461025|NCT02393248|616029776|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
170461026|NCT02393248|616029752|FG000|Part 3: Combination Therapy|Adverse Event|0|||
170461027|NCT02393248|616029753|FG001|Part 3: Combination Therapy|Adverse Event|0|||
170461028|NCT02393248|616029754|FG002|Part 3: Combination Therapy|Adverse Event|0|||
170461029|NCT02393248|616029755|FG003|Part 3: Combination Therapy|Adverse Event|0|||
170461030|NCT02393248|616029756|FG004|Part 3: Combination Therapy|Adverse Event|0|||
170461031|NCT02393248|616029757|FG005|Part 3: Combination Therapy|Adverse Event|0|||
170461032|NCT02393248|616029758|FG006|Part 3: Combination Therapy|Adverse Event|0|||
170461033|NCT02393248|616029759|FG007|Part 3: Combination Therapy|Adverse Event|0|||
170461034|NCT02393248|616029760|FG008|Part 3: Combination Therapy|Adverse Event|0|||
170461035|NCT02393248|616029761|FG009|Part 3: Combination Therapy|Adverse Event|0|||
170461036|NCT02393248|616029762|FG010|Part 3: Combination Therapy|Adverse Event|0|||
170461037|NCT02393248|616029763|FG011|Part 3: Combination Therapy|Adverse Event|0|||
170461038|NCT02393248|616029764|FG012|Part 3: Combination Therapy|Adverse Event|0|||
170461039|NCT02393248|616029765|FG013|Part 3: Combination Therapy|Adverse Event|0|||
170543797|NCT00923702|616334801|FG004|Overall Study|Ongoing enrollment|354|||
170543798|NCT03446573|616334805|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
170543799|NCT03446573|616334806|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
170543800|NCT03446573|616334805|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
170543801|NCT03446573|616334806|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
170543802|NCT03446573|616334805|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
170543803|NCT03446573|616334806|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
170543804|NCT03446573|616334805|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
170543805|NCT03446573|616334806|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
170543806|NCT03446573|616334805|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
170543807|NCT03446573|616334806|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
170543808|NCT03446573|616334805|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
170789167|NCT02268253|617238045|FG004|Stage 1|Withdrawal by Subject|0|||
170789168|NCT02268253|617238046|FG005|Stage 1|Withdrawal by Subject|0|||
170461040|NCT02393248|616029766|FG014|Part 3: Combination Therapy|Adverse Event|0|||
170461041|NCT02393248|616029767|FG015|Part 3: Combination Therapy|Adverse Event|0|||
170461042|NCT02393248|616029768|FG016|Part 3: Combination Therapy|Adverse Event|0|||
170461043|NCT02393248|616029769|FG017|Part 3: Combination Therapy|Adverse Event|0|||
170461044|NCT02393248|616029770|FG018|Part 3: Combination Therapy|Adverse Event|0|||
170461045|NCT02393248|616029771|FG019|Part 3: Combination Therapy|Adverse Event|0|||
170461046|NCT02393248|616029772|FG020|Part 3: Combination Therapy|Adverse Event|0|||
170461047|NCT02393248|616029773|FG021|Part 3: Combination Therapy|Adverse Event|0|||
170789169|NCT02268253|617238047|FG006|Stage 1|Withdrawal by Subject|0|||
170789170|NCT02268253|617238041|FG000|Stage 1|Death|0|||
170461048|NCT02393248|616029774|FG022|Part 3: Combination Therapy|Adverse Event|0|||
170461049|NCT02393248|616029775|FG023|Part 3: Combination Therapy|Adverse Event|1|||
170461050|NCT02393248|616029776|FG024|Part 3: Combination Therapy|Adverse Event|0|||
170461051|NCT02393248|616029752|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461052|NCT02393248|616029753|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461053|NCT02393248|616029754|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461054|NCT02393248|616029755|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461055|NCT02393248|616029756|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461056|NCT02393248|616029757|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461057|NCT02393248|616029758|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461058|NCT02393248|616029759|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461059|NCT02393248|616029760|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461060|NCT02393248|616029761|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461061|NCT02393248|616029762|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461062|NCT02393248|616029763|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461063|NCT02393248|616029764|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461064|NCT02393248|616029765|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461065|NCT02393248|616029766|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461066|NCT02393248|616029767|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461067|NCT02393248|616029768|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461068|NCT02393248|616029769|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461069|NCT02393248|616029770|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461070|NCT02393248|616029771|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461071|NCT02393248|616029772|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461072|NCT02393248|616029773|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461073|NCT02393248|616029774|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461074|NCT02393248|616029775|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
170461075|NCT02393248|616029776|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
170461076|NCT03560986|616029777|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
170461077|NCT03560986|616029778|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
170461078|NCT03560986|616029777|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
170461079|NCT03560986|616029778|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
170461080|NCT03560986|616029777|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
170543809|NCT03446573|616334806|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
170543810|NCT03446573|616334805|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
170543811|NCT03446573|616334806|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
170543812|NCT03446573|616334805|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
170789171|NCT02268253|617238042|FG001|Stage 1|Death|2|||
170789172|NCT02268253|617238043|FG002|Stage 1|Death|2|||
170789173|NCT02268253|617238044|FG003|Stage 1|Death|2|||
170789174|NCT02268253|617238045|FG004|Stage 1|Death|1|||
170789175|NCT02268253|617238046|FG005|Stage 1|Death|1|||
170789176|NCT02268253|617238047|FG006|Stage 1|Death|0|||
170789177|NCT02268253|617238041|FG000|Stage 2|Disease Recurrence/ Progression|0|||
170789178|NCT02268253|617238042|FG001|Stage 2|Disease Recurrence/ Progression|0|||
170789179|NCT02268253|617238043|FG002|Stage 2|Disease Recurrence/ Progression|1|||
170789180|NCT02268253|617238044|FG003|Stage 2|Disease Recurrence/ Progression|0|||
170889813|NCT00546364|617604063|FG002|Overall Study|Sponsor decision|1|||
170889814|NCT00619502|617604064|FG000|Overall Study|Lost to Follow-up|8|||
170889815|NCT00619502|617604065|FG001|Overall Study|Lost to Follow-up|10|||
170789181|NCT02268253|617238045|FG004|Stage 2|Disease Recurrence/ Progression|0|||
170789182|NCT02268253|617238046|FG005|Stage 2|Disease Recurrence/ Progression|0|||
170789183|NCT02268253|617238047|FG006|Stage 2|Disease Recurrence/ Progression|0|||
170789184|NCT02268253|617238041|FG000|Stage 2|Withdrawal by Subject|0|||
170789185|NCT02268253|617238042|FG001|Stage 2|Withdrawal by Subject|0|||
170889816|NCT01641939|617604066|FG000|Overall Study|Death|90|||
170461081|NCT03560986|616029778|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
170461082|NCT03560986|616029777|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
170461083|NCT03560986|616029778|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
170461084|NCT03560986|616029777|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
170461085|NCT03560986|616029778|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
170461086|NCT03560986|616029777|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
170461087|NCT03560986|616029778|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
170461088|NCT03560986|616029777|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
170461089|NCT03560986|616029778|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
170461090|NCT01857271|616029779|FG000|Overall Study|Lost to Follow-up|1|||
170461091|NCT02885181|616029785|FG000|Overall Study|Investigator's Discretion|0|||
170461092|NCT02885181|616029786|FG001|Overall Study|Investigator's Discretion|1|||
170461093|NCT02885181|616029787|FG002|Overall Study|Investigator's Discretion|0|||
170461094|NCT02885181|616029788|FG003|Overall Study|Investigator's Discretion|1|||
170461095|NCT02885181|616029785|FG000|Overall Study|Adverse Event|0|||
170461096|NCT02885181|616029786|FG001|Overall Study|Adverse Event|0|||
170461097|NCT02885181|616029787|FG002|Overall Study|Adverse Event|0|||
170461098|NCT02885181|616029788|FG003|Overall Study|Adverse Event|1|||
170461099|NCT02885181|616029785|FG000|Overall Study|Withdrawal by Subject|0|||
170461100|NCT02885181|616029786|FG001|Overall Study|Withdrawal by Subject|0|||
170461101|NCT02885181|616029787|FG002|Overall Study|Withdrawal by Subject|0|||
170461102|NCT02885181|616029788|FG003|Overall Study|Withdrawal by Subject|1|||
170461103|NCT01517373|616029789|FG000|Run-in Period|Death|1|||
170461104|NCT01517373|616029790|FG001|Run-in Period|Death|0|||
170461105|NCT01517373|616029791|FG002|Run-in Period|Death|0|||
170461106|NCT01517373|616029792|FG003|Run-in Period|Death|0|||
170461107|NCT01517373|616029793|FG004|Run-in Period|Death|0|||
170461108|NCT01517373|616029794|FG005|Run-in Period|Death|0|||
170461109|NCT01517373|616029789|FG000|Run-in Period|Adverse Event|5|||
170461110|NCT01517373|616029790|FG001|Run-in Period|Adverse Event|0|||
170461111|NCT01517373|616029791|FG002|Run-in Period|Adverse Event|0|||
170461112|NCT01517373|616029792|FG003|Run-in Period|Adverse Event|0|||
170461113|NCT01517373|616029793|FG004|Run-in Period|Adverse Event|0|||
170461114|NCT01517373|616029794|FG005|Run-in Period|Adverse Event|0|||
170461115|NCT01517373|616029789|FG000|Run-in Period|Did not meet eligibility criteria|34|||
170461116|NCT01517373|616029790|FG001|Run-in Period|Did not meet eligibility criteria|0|||
170461117|NCT01517373|616029791|FG002|Run-in Period|Did not meet eligibility criteria|0|||
170461118|NCT01517373|616029792|FG003|Run-in Period|Did not meet eligibility criteria|0|||
170461119|NCT01517373|616029793|FG004|Run-in Period|Did not meet eligibility criteria|0|||
170461120|NCT01517373|616029794|FG005|Run-in Period|Did not meet eligibility criteria|0|||
170461121|NCT01517373|616029789|FG000|Run-in Period|Lost to Follow-up|1|||
170461122|NCT01517373|616029790|FG001|Run-in Period|Lost to Follow-up|0|||
170461123|NCT01517373|616029791|FG002|Run-in Period|Lost to Follow-up|0|||
170461124|NCT01517373|616029792|FG003|Run-in Period|Lost to Follow-up|0|||
170461125|NCT01517373|616029793|FG004|Run-in Period|Lost to Follow-up|0|||
170461126|NCT01517373|616029794|FG005|Run-in Period|Lost to Follow-up|0|||
170461127|NCT01517373|616029789|FG000|Run-in Period|Withdrawal by Subject|12|||
170461128|NCT01517373|616029790|FG001|Run-in Period|Withdrawal by Subject|0|||
170461129|NCT01517373|616029791|FG002|Run-in Period|Withdrawal by Subject|0|||
170461130|NCT01517373|616029792|FG003|Run-in Period|Withdrawal by Subject|0|||
170461131|NCT01517373|616029793|FG004|Run-in Period|Withdrawal by Subject|0|||
170461132|NCT01517373|616029794|FG005|Run-in Period|Withdrawal by Subject|0|||
170461133|NCT01517373|616029789|FG000|Run-in Period|Sponsor Decision|3|||
170461134|NCT01517373|616029790|FG001|Run-in Period|Sponsor Decision|0|||
170461135|NCT01517373|616029791|FG002|Run-in Period|Sponsor Decision|0|||
170461136|NCT01517373|616029792|FG003|Run-in Period|Sponsor Decision|0|||
170461137|NCT01517373|616029793|FG004|Run-in Period|Sponsor Decision|0|||
170461138|NCT01517373|616029794|FG005|Run-in Period|Sponsor Decision|0|||
170461139|NCT01517373|616029789|FG000|Run-in Period|Other|1|||
170461140|NCT01517373|616029790|FG001|Run-in Period|Other|0|||
170461141|NCT01517373|616029791|FG002|Run-in Period|Other|0|||
170461142|NCT01517373|616029792|FG003|Run-in Period|Other|0|||
170461143|NCT01517373|616029793|FG004|Run-in Period|Other|0|||
170461144|NCT01517373|616029794|FG005|Run-in Period|Other|0|||
170461145|NCT01517373|616029789|FG000|Treatment Period|Adverse Event|0|||
170461146|NCT01517373|616029790|FG001|Treatment Period|Adverse Event|0|||
170461147|NCT01517373|616029791|FG002|Treatment Period|Adverse Event|0|||
170889817|NCT01641939|617604067|FG001|Overall Study|Death|187|||
170461148|NCT01517373|616029792|FG003|Treatment Period|Adverse Event|0|||
170461149|NCT01517373|616029793|FG004|Treatment Period|Adverse Event|0|||
170461150|NCT01517373|616029794|FG005|Treatment Period|Adverse Event|2|||
170461151|NCT01517373|616029789|FG000|Treatment Period|Lost to Follow-up|0|||
170461152|NCT01517373|616029790|FG001|Treatment Period|Lost to Follow-up|0|||
170461153|NCT01517373|616029791|FG002|Treatment Period|Lost to Follow-up|1|||
170461154|NCT01517373|616029792|FG003|Treatment Period|Lost to Follow-up|1|||
170461155|NCT01517373|616029793|FG004|Treatment Period|Lost to Follow-up|0|||
170889818|NCT01641939|617604068|FG002|Overall Study|Death|61|||
170789186|NCT02268253|617238043|FG002|Stage 2|Withdrawal by Subject|2|||
170789187|NCT02268253|617238044|FG003|Stage 2|Withdrawal by Subject|0|||
170789188|NCT02268253|617238045|FG004|Stage 2|Withdrawal by Subject|0|||
170789189|NCT02268253|617238046|FG005|Stage 2|Withdrawal by Subject|2|||
170789190|NCT02268253|617238047|FG006|Stage 2|Withdrawal by Subject|0|||
170789191|NCT02268253|617238041|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
170789192|NCT02268253|617238042|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
170789193|NCT02268253|617238043|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
170789194|NCT02268253|617238044|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
170789195|NCT02268253|617238045|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
170789196|NCT02268253|617238046|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
170789197|NCT02268253|617238047|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
170789198|NCT02268253|617238041|FG000|Stage 2|Death|0|||
170789199|NCT02268253|617238042|FG001|Stage 2|Death|0|||
170789200|NCT02268253|617238043|FG002|Stage 2|Death|19|||
170789201|NCT02268253|617238044|FG003|Stage 2|Death|0|||
170789202|NCT02268253|617238045|FG004|Stage 2|Death|0|||
170789203|NCT02268253|617238046|FG005|Stage 2|Death|20|||
170789204|NCT02268253|617238047|FG006|Stage 2|Death|1|||
170789205|NCT02268253|617238041|FG000|Stage 2|Lost to Follow-up|0|||
170789206|NCT02268253|617238042|FG001|Stage 2|Lost to Follow-up|0|||
170789207|NCT02268253|617238043|FG002|Stage 2|Lost to Follow-up|0|||
170789208|NCT02268253|617238044|FG003|Stage 2|Lost to Follow-up|0|||
170789209|NCT02268253|617238045|FG004|Stage 2|Lost to Follow-up|0|||
170789210|NCT02268253|617238046|FG005|Stage 2|Lost to Follow-up|4|||
170789211|NCT02268253|617238047|FG006|Stage 2|Lost to Follow-up|0|||
170789212|NCT02268253|617238041|FG000|Stage 2|Transferred to Hospice|0|||
170789213|NCT02268253|617238042|FG001|Stage 2|Transferred to Hospice|0|||
170789214|NCT02268253|617238043|FG002|Stage 2|Transferred to Hospice|0|||
170789215|NCT02268253|617238044|FG003|Stage 2|Transferred to Hospice|0|||
170789216|NCT02268253|617238045|FG004|Stage 2|Transferred to Hospice|0|||
170789217|NCT02268253|617238046|FG005|Stage 2|Transferred to Hospice|2|||
170789218|NCT02268253|617238047|FG006|Stage 2|Transferred to Hospice|0|||
170789219|NCT02268253|617238041|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
170789220|NCT02268253|617238042|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
170789221|NCT02268253|617238043|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
170789222|NCT02268253|617238044|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
170789223|NCT02268253|617238045|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
170789224|NCT02268253|617238046|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
170789225|NCT02268253|617238047|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
170789226|NCT02268253|617238041|FG000|Stage 3A|Withdrawal by Subject|0|||
170789227|NCT02268253|617238042|FG001|Stage 3A|Withdrawal by Subject|0|||
170789228|NCT02268253|617238043|FG002|Stage 3A|Withdrawal by Subject|2|||
170789229|NCT02268253|617238044|FG003|Stage 3A|Withdrawal by Subject|0|||
170789230|NCT02268253|617238045|FG004|Stage 3A|Withdrawal by Subject|0|||
170789231|NCT02268253|617238046|FG005|Stage 3A|Withdrawal by Subject|0|||
170789232|NCT02268253|617238047|FG006|Stage 3A|Withdrawal by Subject|0|||
170461156|NCT01517373|616029794|FG005|Treatment Period|Lost to Follow-up|0|||
170461157|NCT01517373|616029789|FG000|Treatment Period|Withdrawal by Subject|0|||
170461158|NCT01517373|616029790|FG001|Treatment Period|Withdrawal by Subject|3|||
170461159|NCT01517373|616029791|FG002|Treatment Period|Withdrawal by Subject|2|||
170461160|NCT01517373|616029792|FG003|Treatment Period|Withdrawal by Subject|2|||
170461161|NCT01517373|616029793|FG004|Treatment Period|Withdrawal by Subject|2|||
170461162|NCT01517373|616029794|FG005|Treatment Period|Withdrawal by Subject|3|||
170461163|NCT01517373|616029789|FG000|Treatment Period|Other|0|||
170461164|NCT01517373|616029790|FG001|Treatment Period|Other|0|||
170461165|NCT01517373|616029791|FG002|Treatment Period|Other|0|||
170461166|NCT01517373|616029792|FG003|Treatment Period|Other|0|||
170461167|NCT01517373|616029793|FG004|Treatment Period|Other|1|||
170461168|NCT01517373|616029794|FG005|Treatment Period|Other|0|||
170461169|NCT01517373|616029789|FG000|Treatment Period|Protocol Violation|0|||
170789233|NCT02268253|617238041|FG000|Stage 3A|Physician Decision|0|||
170461170|NCT01517373|616029790|FG001|Treatment Period|Protocol Violation|0|||
170461171|NCT01517373|616029791|FG002|Treatment Period|Protocol Violation|0|||
170461172|NCT01517373|616029792|FG003|Treatment Period|Protocol Violation|0|||
170461173|NCT01517373|616029793|FG004|Treatment Period|Protocol Violation|1|||
170461174|NCT01517373|616029794|FG005|Treatment Period|Protocol Violation|0|||
170789234|NCT02268253|617238042|FG001|Stage 3A|Physician Decision|0|||
170789235|NCT02268253|617238043|FG002|Stage 3A|Physician Decision|2|||
170789236|NCT02268253|617238044|FG003|Stage 3A|Physician Decision|0|||
170789237|NCT02268253|617238045|FG004|Stage 3A|Physician Decision|0|||
170789238|NCT02268253|617238046|FG005|Stage 3A|Physician Decision|0|||
170789239|NCT02268253|617238047|FG006|Stage 3A|Physician Decision|0|||
170789240|NCT02268253|617238041|FG000|Stage 3A|Study Terminated by Sponsor|0|||
170789241|NCT02268253|617238042|FG001|Stage 3A|Study Terminated by Sponsor|0|||
170789242|NCT02268253|617238043|FG002|Stage 3A|Study Terminated by Sponsor|2|||
170789243|NCT02268253|617238044|FG003|Stage 3A|Study Terminated by Sponsor|0|||
170789244|NCT02268253|617238045|FG004|Stage 3A|Study Terminated by Sponsor|0|||
170789245|NCT02268253|617238046|FG005|Stage 3A|Study Terminated by Sponsor|0|||
170789246|NCT02268253|617238047|FG006|Stage 3A|Study Terminated by Sponsor|0|||
170789247|NCT02268253|617238041|FG000|Stage 3A|Lost to Follow-up|0|||
170789248|NCT02268253|617238042|FG001|Stage 3A|Lost to Follow-up|0|||
170789249|NCT02268253|617238043|FG002|Stage 3A|Lost to Follow-up|1|||
170789250|NCT02268253|617238044|FG003|Stage 3A|Lost to Follow-up|0|||
170789251|NCT02268253|617238045|FG004|Stage 3A|Lost to Follow-up|0|||
170789252|NCT02268253|617238046|FG005|Stage 3A|Lost to Follow-up|0|||
170789253|NCT02268253|617238047|FG006|Stage 3A|Lost to Follow-up|0|||
170789254|NCT02268253|617238041|FG000|Stage 3A|Death|0|||
170789255|NCT02268253|617238042|FG001|Stage 3A|Death|0|||
170789256|NCT02268253|617238043|FG002|Stage 3A|Death|5|||
170789257|NCT02268253|617238044|FG003|Stage 3A|Death|0|||
170789258|NCT02268253|617238045|FG004|Stage 3A|Death|0|||
170789259|NCT02268253|617238046|FG005|Stage 3A|Death|0|||
170789260|NCT02268253|617238047|FG006|Stage 3A|Death|0|||
170789261|NCT05783102|617238048|FG000|Overall Study|Lost to Follow-up|1|||
170789262|NCT05783102|617238048|FG000|Overall Study|Withdrawal by Subject|2|||
170789263|NCT03461276|617238049|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
170789264|NCT03461276|617238050|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
170789265|NCT03461276|617238049|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
170789266|NCT03461276|617238050|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
170789267|NCT03461276|617238049|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
170789268|NCT03461276|617238050|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
170789269|NCT03461276|617238049|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
170789270|NCT03461276|617238050|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
170789271|NCT03461276|617238049|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
170789272|NCT03461276|617238050|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
170789273|NCT03461276|617238049|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
170789274|NCT03461276|617238050|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
170789275|NCT03461276|617238049|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
170789276|NCT03461276|617238050|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
170789277|NCT03461276|617238049|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
170789278|NCT03461276|617238050|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
170789279|NCT03461276|617238049|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
170789280|NCT03461276|617238050|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
170789281|NCT03461276|617238049|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
170789282|NCT03461276|617238050|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
170789283|NCT01943409|617238051|FG000|Overall Study|resumed oral/entral|24|||
170789284|NCT01943409|617238052|FG001|Overall Study|resumed oral/entral|20|||
170789285|NCT01943409|617238051|FG000|Overall Study|Protocol Violation|14|||
170789286|NCT01943409|617238052|FG001|Overall Study|Protocol Violation|24|||
170789287|NCT01943409|617238051|FG000|Overall Study|Death|3|||
170789288|NCT01943409|617238052|FG001|Overall Study|Death|1|||
170789289|NCT01943409|617238051|FG000|Overall Study|Withdrawal by Subject|4|||
170789290|NCT01943409|617238052|FG001|Overall Study|Withdrawal by Subject|3|||
170789291|NCT02489903|617238053|FG000|Screening|Screen Failure|24|||
170789292|NCT02489903|617238054|FG001|Screening|Screen Failure|0|||
170789293|NCT02489903|617238055|FG002|Screening|Screen Failure|0|||
170789294|NCT02489903|617238056|FG003|Screening|Screen Failure|8|||
170789295|NCT02489903|617238053|FG000|Randomized and Received Treatment|Protocol Violation|0|||
170789296|NCT02489903|617238054|FG001|Randomized and Received Treatment|Protocol Violation|1|||
170789297|NCT02489903|617238055|FG002|Randomized and Received Treatment|Protocol Violation|0|||
170789298|NCT02489903|617238056|FG003|Randomized and Received Treatment|Protocol Violation|0|||
170789299|NCT02489903|617238053|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
170789300|NCT02489903|617238054|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
170789301|NCT02489903|617238055|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
170789302|NCT02489903|617238056|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
170789303|NCT02489903|617238053|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
170789304|NCT02489903|617238054|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
170789305|NCT02489903|617238055|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
170789306|NCT02489903|617238056|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
170789307|NCT02489903|617238053|FG000|Randomized and Received Treatment|Death|10|||
170789308|NCT02489903|617238054|FG001|Randomized and Received Treatment|Death|1|||
170889819|NCT01641939|617604066|FG000|Overall Study|Lost to Follow-up|3|||
170889820|NCT01641939|617604067|FG001|Overall Study|Lost to Follow-up|2|||
170889821|NCT01641939|617604068|FG002|Overall Study|Lost to Follow-up|1|||
170889822|NCT01641939|617604066|FG000|Overall Study|Withdrawal by Subject|14|||
170889823|NCT01641939|617604067|FG001|Overall Study|Withdrawal by Subject|11|||
170889824|NCT01641939|617604068|FG002|Overall Study|Withdrawal by Subject|5|||
170889825|NCT01641939|617604066|FG000|Overall Study|Study Terminated by Sponsor|10|||
170889826|NCT01641939|617604067|FG001|Overall Study|Study Terminated by Sponsor|28|||
170889827|NCT01641939|617604068|FG002|Overall Study|Study Terminated by Sponsor|3|||
170789309|NCT02489903|617238055|FG002|Randomized and Received Treatment|Death|0|||
170889828|NCT04161131|617604069|FG000|Overall Study|Ineligible|2|||
170889829|NCT04161131|617604069|FG000|Overall Study|Lost to Follow-up|4|||
170461175|NCT01517373|616029789|FG000|Treatment Period|Lack of Efficacy|0|||
170461176|NCT01517373|616029790|FG001|Treatment Period|Lack of Efficacy|1|||
170461177|NCT01517373|616029791|FG002|Treatment Period|Lack of Efficacy|1|||
170461178|NCT01517373|616029792|FG003|Treatment Period|Lack of Efficacy|3|||
170461179|NCT01517373|616029793|FG004|Treatment Period|Lack of Efficacy|2|||
170461180|NCT01517373|616029794|FG005|Treatment Period|Lack of Efficacy|0|||
170461181|NCT01517373|616029789|FG000|Treatment Period|Medication error without AEs|0|||
170461182|NCT01517373|616029790|FG001|Treatment Period|Medication error without AEs|0|||
170461183|NCT01517373|616029791|FG002|Treatment Period|Medication error without AEs|2|||
170461184|NCT01517373|616029792|FG003|Treatment Period|Medication error without AEs|1|||
170461185|NCT01517373|616029793|FG004|Treatment Period|Medication error without AEs|0|||
170461186|NCT01517373|616029794|FG005|Treatment Period|Medication error without AEs|2|||
170461187|NCT06077149|616029803|FG000|Overall Study|Death|1|||
170461188|NCT06077149|616029804|FG001|Overall Study|Death|0|||
170461189|NCT06077149|616029803|FG000|Overall Study|Withdrawal by Subject|2|||
170461190|NCT06077149|616029804|FG001|Overall Study|Withdrawal by Subject|0|||
170461191|NCT06077149|616029803|FG000|Overall Study|RSV infection before vaccination|3|||
170461192|NCT06077149|616029804|FG001|Overall Study|RSV infection before vaccination|0|||
170461193|NCT04658095|616029805|FG000|Overall Study|Study terminated|5|||
170461194|NCT04658095|616029806|FG001|Overall Study|Study terminated|1|||
170461195|NCT04658095|616029807|FG002|Overall Study|Study terminated|4|||
170461196|NCT05788289|616029808|FG000|Overall Study|Death|3|||
170461197|NCT04154631|616029810|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
170461198|NCT04154631|616029811|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
170889830|NCT05064059|617604070|FG000|Overall Study|Death|199|||
170889831|NCT05064059|617604071|FG001|Overall Study|Death|196|||
170889832|NCT05064059|617604070|FG000|Overall Study|Physician Decision|4|||
170889833|NCT05064059|617604071|FG001|Overall Study|Physician Decision|2|||
170889834|NCT05064059|617604070|FG000|Overall Study|Sponsor Decision|14|||
170889835|NCT05064059|617604071|FG001|Overall Study|Sponsor Decision|11|||
170889836|NCT05064059|617604070|FG000|Overall Study|Withdrawal by Subject|4|||
170461199|NCT01441947|616029812|FG000|Overall Study|Withdrawal by Subject|3|||
170461200|NCT01441947|616029813|FG001|Overall Study|Withdrawal by Subject|0|||
170461201|NCT05187013|616029814|FG000|Overall Study|Withdrawal by Subject|1|||
170461202|NCT05187013|616029815|FG001|Overall Study|Withdrawal by Subject|1|||
170461203|NCT05187013|616029816|FG002|Overall Study|Withdrawal by Subject|0|||
170461204|NCT05187013|616029814|FG000|Overall Study|Death|0|||
170461205|NCT05187013|616029815|FG001|Overall Study|Death|1|||
170461206|NCT05187013|616029816|FG002|Overall Study|Death|0|||
170461207|NCT05187013|616029814|FG000|Overall Study|Lost to Follow-up|20|||
170461208|NCT05187013|616029815|FG001|Overall Study|Lost to Follow-up|17|||
170461209|NCT05187013|616029816|FG002|Overall Study|Lost to Follow-up|0|||
170461210|NCT05187013|616029814|FG000|Overall Study|Ongoing Participants|3|||
170461211|NCT05187013|616029815|FG001|Overall Study|Ongoing Participants|5|||
170461212|NCT05187013|616029816|FG002|Overall Study|Ongoing Participants|0|||
170461213|NCT01096368|616029817|FG000|Overall Study|Death|0|||
170461214|NCT01096368|616029818|FG001|Overall Study|Death|1|||
170461215|NCT01096368|616029819|FG002|Overall Study|Death|0|||
170461216|NCT01096368|616029820|FG003|Overall Study|Death|0|||
170461217|NCT01096368|616029821|FG004|Overall Study|Death|0|||
170461218|NCT01096368|616029817|FG000|Overall Study|Physician Decision|0|||
170461219|NCT01096368|616029818|FG001|Overall Study|Physician Decision|13|||
170461220|NCT01096368|616029819|FG002|Overall Study|Physician Decision|2|||
170461221|NCT01096368|616029820|FG003|Overall Study|Physician Decision|4|||
170461222|NCT01096368|616029821|FG004|Overall Study|Physician Decision|6|||
170461223|NCT01096368|616029817|FG000|Overall Study|Withdrawal by Subject|0|||
170461224|NCT01096368|616029818|FG001|Overall Study|Withdrawal by Subject|52|||
170461225|NCT01096368|616029819|FG002|Overall Study|Withdrawal by Subject|0|||
170543813|NCT03446573|616334806|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
170543814|NCT03446573|616334805|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
170543815|NCT03446573|616334806|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
170543816|NCT03446573|616334805|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
170543817|NCT03446573|616334806|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
170461226|NCT01096368|616029820|FG003|Overall Study|Withdrawal by Subject|10|||
170461227|NCT01096368|616029821|FG004|Overall Study|Withdrawal by Subject|14|||
170461228|NCT01096368|616029817|FG000|Overall Study|Ineligible|0|||
170461229|NCT01096368|616029818|FG001|Overall Study|Ineligible|3|||
170461230|NCT01096368|616029819|FG002|Overall Study|Ineligible|2|||
170889837|NCT05064059|617604071|FG001|Overall Study|Withdrawal by Subject|11|||
170461231|NCT01096368|616029820|FG003|Overall Study|Ineligible|0|||
170461232|NCT01096368|616029821|FG004|Overall Study|Ineligible|25|||
170461233|NCT01096368|616029817|FG000|Overall Study|Did not start treatment|0|||
170461234|NCT01096368|616029818|FG001|Overall Study|Did not start treatment|4|||
170461235|NCT01096368|616029819|FG002|Overall Study|Did not start treatment|4|||
170461236|NCT01096368|616029820|FG003|Overall Study|Did not start treatment|0|||
170889838|NCT05227690|617604078|FG000|Overall Study|Adverse Event|5|||
170461237|NCT01096368|616029821|FG004|Overall Study|Did not start treatment|0|||
170889839|NCT05227690|617604079|FG001|Overall Study|Adverse Event|6|||
170461238|NCT01096368|616029817|FG000|Overall Study|Progressive disease|0|||
170461239|NCT01096368|616029818|FG001|Overall Study|Progressive disease|6|||
170461240|NCT01096368|616029819|FG002|Overall Study|Progressive disease|0|||
170461241|NCT01096368|616029820|FG003|Overall Study|Progressive disease|10|||
170461242|NCT01096368|616029821|FG004|Overall Study|Progressive disease|3|||
170461243|NCT01096368|616029817|FG000|Overall Study|Other|0|||
170461244|NCT01096368|616029818|FG001|Overall Study|Other|0|||
170461245|NCT01096368|616029819|FG002|Overall Study|Other|1|||
170461246|NCT01096368|616029820|FG003|Overall Study|Other|0|||
170461247|NCT01096368|616029821|FG004|Overall Study|Other|0|||
170461248|NCT01096368|616029817|FG000|Overall Study|Treated with institutional review|0|||
170461249|NCT01096368|616029818|FG001|Overall Study|Treated with institutional review|0|||
170461250|NCT01096368|616029819|FG002|Overall Study|Treated with institutional review|0|||
170461251|NCT01096368|616029820|FG003|Overall Study|Treated with institutional review|0|||
170461252|NCT01096368|616029821|FG004|Overall Study|Treated with institutional review|1|||
170461253|NCT03384654|616029823|FG000|Overall Study|Withdrawal by Subject|0|||
170461254|NCT03384654|616029824|FG001|Overall Study|Withdrawal by Subject|0|||
170461255|NCT03384654|616029825|FG002|Overall Study|Withdrawal by Subject|1|||
170461256|NCT03384654|616029826|FG003|Overall Study|Withdrawal by Subject|0|||
170461257|NCT02500641|616029829|FG000|Overall Study|Adverse Event|0|||
170461258|NCT02500641|616029830|FG001|Overall Study|Adverse Event|2|||
170461259|NCT02500641|616029829|FG000|Overall Study|Withdrawal by Subject|4|||
170461260|NCT02500641|616029830|FG001|Overall Study|Withdrawal by Subject|5|||
170461261|NCT02500641|616029829|FG000|Overall Study|Unable to follow study procedures|3|||
170461262|NCT02500641|616029830|FG001|Overall Study|Unable to follow study procedures|2|||
170461263|NCT02500641|616029829|FG000|Overall Study|Protocol Violation|1|||
170461264|NCT02500641|616029830|FG001|Overall Study|Protocol Violation|2|||
170461265|NCT02500641|616029829|FG000|Overall Study|Lost to Follow-up|1|||
170461266|NCT02500641|616029830|FG001|Overall Study|Lost to Follow-up|0|||
170461267|NCT02500641|616029829|FG000|Overall Study|Sponsor decision|1|||
170461268|NCT02500641|616029830|FG001|Overall Study|Sponsor decision|0|||
170461269|NCT02500641|616029829|FG000|Overall Study|Non compliance to study drug|0|||
170461270|NCT02500641|616029830|FG001|Overall Study|Non compliance to study drug|1|||
170461271|NCT02440568|616029831|FG000|Overall Study|Death|1|||
170461272|NCT02440568|616029832|FG001|Overall Study|Death|3|||
170461273|NCT02440568|616029833|FG002|Overall Study|Death|4|||
170461274|NCT02440568|616029834|FG003|Overall Study|Death|2|||
170461275|NCT02440568|616029831|FG000|Overall Study|Lack of Efficacy|2|||
170461276|NCT02440568|616029832|FG001|Overall Study|Lack of Efficacy|0|||
170461277|NCT02440568|616029833|FG002|Overall Study|Lack of Efficacy|1|||
170461278|NCT02440568|616029834|FG003|Overall Study|Lack of Efficacy|0|||
170461279|NCT02440568|616029831|FG000|Overall Study|Lost to Follow-up|1|||
170461280|NCT02440568|616029832|FG001|Overall Study|Lost to Follow-up|0|||
170461281|NCT02440568|616029833|FG002|Overall Study|Lost to Follow-up|0|||
170461282|NCT02440568|616029834|FG003|Overall Study|Lost to Follow-up|0|||
170461283|NCT03233230|616029835|FG000|Overall Study|Adverse Event|6|||
170461284|NCT03233230|616029836|FG001|Overall Study|Adverse Event|3|||
170461285|NCT03233230|616029837|FG002|Overall Study|Adverse Event|6|||
170461286|NCT03233230|616029838|FG003|Overall Study|Adverse Event|3|||
170461287|NCT03233230|616029835|FG000|Overall Study|Protocol Violation|1|||
170461288|NCT03233230|616029836|FG001|Overall Study|Protocol Violation|2|||
170461289|NCT03233230|616029837|FG002|Overall Study|Protocol Violation|1|||
170461290|NCT03233230|616029838|FG003|Overall Study|Protocol Violation|1|||
170461291|NCT03233230|616029835|FG000|Overall Study|Lack of Efficacy|1|||
170461292|NCT03233230|616029836|FG001|Overall Study|Lack of Efficacy|0|||
170461293|NCT03233230|616029837|FG002|Overall Study|Lack of Efficacy|0|||
170461294|NCT03233230|616029838|FG003|Overall Study|Lack of Efficacy|0|||
170461295|NCT03233230|616029835|FG000|Overall Study|Other|5|||
170461296|NCT03233230|616029836|FG001|Overall Study|Other|5|||
170789310|NCT02489903|617238056|FG003|Randomized and Received Treatment|Death|0|||
170789311|NCT02043678|617238059|FG000|Overall Study|Never treated|11|||
170789312|NCT02043678|617238060|FG001|Overall Study|Never treated|9|||
170461297|NCT03233230|616029837|FG002|Overall Study|Other|5|||
170461298|NCT03233230|616029838|FG003|Overall Study|Other|3|||
170461299|NCT03233230|616029835|FG000|Overall Study|Withdrawal by Subject|2|||
170461300|NCT03233230|616029836|FG001|Overall Study|Withdrawal by Subject|2|||
170543818|NCT03446573|616334805|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
170461301|NCT03233230|616029837|FG002|Overall Study|Withdrawal by Subject|0|||
170461302|NCT03233230|616029838|FG003|Overall Study|Withdrawal by Subject|1|||
170461303|NCT03233230|616029835|FG000|Overall Study|Lost to Follow-up|0|||
170461304|NCT03233230|616029836|FG001|Overall Study|Lost to Follow-up|3|||
170461305|NCT03233230|616029837|FG002|Overall Study|Lost to Follow-up|0|||
170461306|NCT03233230|616029838|FG003|Overall Study|Lost to Follow-up|0|||
170461307|NCT01763684|616029839|FG000|Overall Study|Study terminated early due to low enrollment|126|||
170461308|NCT01763684|616029840|FG001|Overall Study|Study terminated early due to low enrollment|127|||
170461309|NCT01763684|616029839|FG000|Overall Study|Study surgery not performed|7|||
170461310|NCT01763684|616029840|FG001|Overall Study|Study surgery not performed|6|||
170461311|NCT01341782|616029841|FG000|Overall Study|Adverse Event|1|||
170789313|NCT02043678|617238059|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
170789314|NCT02043678|617238060|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
170789315|NCT02043678|617238059|FG000|Overall Study|AE without clinical PD|54|||
170789316|NCT02043678|617238060|FG001|Overall Study|AE without clinical PD|36|||
170789317|NCT02043678|617238059|FG000|Overall Study|Lost to Follow-up|1|||
170789318|NCT02043678|617238060|FG001|Overall Study|Lost to Follow-up|1|||
170789319|NCT02043678|617238059|FG000|Overall Study|Other|10|||
170789320|NCT02043678|617238060|FG001|Overall Study|Other|14|||
170789321|NCT02043678|617238059|FG000|Overall Study|Clinical PD|114|||
170789322|NCT02043678|617238060|FG001|Overall Study|Clinical PD|148|||
170789323|NCT02043678|617238059|FG000|Overall Study|Radiological PD|100|||
170789324|NCT02043678|617238060|FG001|Overall Study|Radiological PD|90|||
170789325|NCT02043678|617238059|FG000|Overall Study|Protocol-driven decision point|59|||
170789326|NCT02043678|617238060|FG001|Overall Study|Protocol-driven decision point|58|||
170789327|NCT02043678|617238059|FG000|Overall Study|Withdrawal by Subject|16|||
170789328|NCT02043678|617238060|FG001|Overall Study|Withdrawal by Subject|20|||
170789329|NCT02043678|617238059|FG000|Overall Study|Protocol Violation|1|||
170789330|NCT02043678|617238060|FG001|Overall Study|Protocol Violation|0|||
170789331|NCT02043678|617238059|FG000|Overall Study|Deterioration of general conditions|1|||
170461312|NCT01341782|616029842|FG001|Overall Study|Adverse Event|1|||
170461313|NCT01341782|616029841|FG000|Overall Study|Withdrawal by Subject|6|||
170461314|NCT01341782|616029842|FG001|Overall Study|Withdrawal by Subject|5|||
170461315|NCT01341782|616029841|FG000|Overall Study|Missed 3 consecutive doses|0|||
170461316|NCT01341782|616029842|FG001|Overall Study|Missed 3 consecutive doses|4|||
170461317|NCT01341782|616029841|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
170461318|NCT01341782|616029842|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
170461319|NCT01341782|616029841|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
170461320|NCT01341782|616029842|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
170461321|NCT01341782|616029841|FG000|Overall Study|Other|5|||
170461322|NCT01341782|616029842|FG001|Overall Study|Other|0|||
170461323|NCT02036775|616029843|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
170461324|NCT02036775|616029844|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
170461325|NCT02036775|616029845|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
170461326|NCT02036775|616029846|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
170461327|NCT02036775|616029847|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
170461328|NCT02036775|616029848|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
170461329|NCT03796039|616029849|FG000|Overall Study|Death|2|||
170461330|NCT03796039|616029850|FG001|Overall Study|Death|1|||
170461331|NCT03796039|616029849|FG000|Overall Study|Withdrawal by Subject|7|||
170461332|NCT03796039|616029850|FG001|Overall Study|Withdrawal by Subject|4|||
170461333|NCT00669071|616029852|FG000|Overall Study|Lost to Follow-up|3|||
170461334|NCT00669071|616029852|FG000|Overall Study|Final visit 40 days out of window|1|||
170461335|NCT01898650|616029853|FG000|Overall Study|the subject would not lie still for imaging|1|||
170461336|NCT02912650|616029854|FG000|Overall Study|Withdrawal by Subject|1|||
170461337|NCT02912650|616029855|FG001|Overall Study|Withdrawal by Subject|0|||
170461338|NCT02912650|616029856|FG002|Overall Study|Withdrawal by Subject|1|||
170461339|NCT02912650|616029857|FG003|Overall Study|Withdrawal by Subject|5|||
170461340|NCT02912650|616029854|FG000|Overall Study|Adverse Event|0|||
170461341|NCT02912650|616029855|FG001|Overall Study|Adverse Event|0|||
170461342|NCT02912650|616029856|FG002|Overall Study|Adverse Event|1|||
170461343|NCT02912650|616029857|FG003|Overall Study|Adverse Event|0|||
170461344|NCT00741936|616029861|FG000|Overall Study|Lost to Follow-up|1|||
170461345|NCT00741936|616029862|FG001|Overall Study|Lost to Follow-up|1|||
170461346|NCT00741936|616029861|FG000|Overall Study|Adverse Event|3|||
170461347|NCT00741936|616029862|FG001|Overall Study|Adverse Event|4|||
170461348|NCT00741936|616029861|FG000|Overall Study|Pregnancy|0|||
170461349|NCT00741936|616029862|FG001|Overall Study|Pregnancy|1|||
170789332|NCT02043678|617238060|FG001|Overall Study|Deterioration of general conditions|1|||
170789333|NCT02043678|617238059|FG000|Overall Study|Logistical difficulties|2|||
170789334|NCT02043678|617238060|FG001|Overall Study|Logistical difficulties|0|||
170789335|NCT02043678|617238059|FG000|Overall Study|Non-compliance with study drug|3|||
170789336|NCT02043678|617238060|FG001|Overall Study|Non-compliance with study drug|1|||
170789337|NCT02043678|617238059|FG000|Overall Study|Physician Decision|4|||
170789338|NCT02043678|617238060|FG001|Overall Study|Physician Decision|3|||
170789339|NCT02043678|617238059|FG000|Overall Study|Subject decision|0|||
170461350|NCT00741936|616029861|FG000|Overall Study|Protocol Violation|2|||
170461351|NCT00741936|616029862|FG001|Overall Study|Protocol Violation|0|||
170461352|NCT00741936|616029861|FG000|Overall Study|Lack of Efficacy|0|||
170461353|NCT00741936|616029862|FG001|Overall Study|Lack of Efficacy|2|||
170461354|NCT00741936|616029861|FG000|Overall Study|Low compliance|3|||
170461355|NCT00741936|616029862|FG001|Overall Study|Low compliance|0|||
170461356|NCT00502801|616029863|FG000|Treatment Period|Withdrawal by Subject|3|||
170461357|NCT00502801|616029863|FG000|Treatment Period|Adverse Event|7|||
170789340|NCT02043678|617238060|FG001|Overall Study|Subject decision|1|||
170789341|NCT02043678|617238059|FG000|Overall Study|Switching to other therapy|3|||
170789342|NCT02043678|617238060|FG001|Overall Study|Switching to other therapy|2|||
170789343|NCT02043678|617238059|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
170461358|NCT00502801|616029863|FG000|Treatment Period|Death|14|||
170461359|NCT00502801|616029863|FG000|Treatment Period|OTHER|30|||
170461360|NCT00502801|616029863|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
170461361|NCT00502801|616029863|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
170461362|NCT00502801|616029863|FG000|End of Therapy to Test of Cure|Death|3|||
170461363|NCT00502801|616029863|FG000|End of Therapy to Test of Cure|OTHER|2|||
170461364|NCT01121666|616029867|FG000|Overall Study|Protocol Violation|29|||
170889840|NCT05227690|617604080|FG002|Overall Study|Adverse Event|10|||
170889841|NCT05227690|617604078|FG000|Overall Study|Lack of Efficacy|2|||
170461365|NCT01121666|616029868|FG001|Overall Study|Protocol Violation|10|||
170461366|NCT03176459|616029869|FG000|Overall Study|Lost to Follow-up|5|||
170461367|NCT03176459|616029870|FG001|Overall Study|Lost to Follow-up|7|||
170461368|NCT02041091|616029871|FG000|Treatment|Adverse Event|3|||
170461369|NCT02041091|616029872|FG001|Treatment|Adverse Event|3|||
170461370|NCT02041091|616029871|FG000|Treatment|Withdrawal by Subject|2|||
170461371|NCT02041091|616029872|FG001|Treatment|Withdrawal by Subject|4|||
170461372|NCT02041091|616029871|FG000|Treatment|Physician Decision|1|||
170461373|NCT02041091|616029872|FG001|Treatment|Physician Decision|0|||
170461374|NCT02041091|616029871|FG000|Treatment|Sponsor Decision|15|||
170461375|NCT02041091|616029872|FG001|Treatment|Sponsor Decision|16|||
170461376|NCT02041091|616029871|FG000|Treatment|Lost to Follow-up|1|||
170461377|NCT02041091|616029872|FG001|Treatment|Lost to Follow-up|0|||
170461378|NCT02041091|616029871|FG000|Optional Safety Extension Period|Adverse Event|4|||
170461379|NCT02041091|616029872|FG001|Optional Safety Extension Period|Adverse Event|2|||
170543819|NCT03446573|616334806|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
170543820|NCT03446573|616334805|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
170889842|NCT05227690|617604079|FG001|Overall Study|Lack of Efficacy|4|||
170889843|NCT05227690|617604080|FG002|Overall Study|Lack of Efficacy|1|||
170889844|NCT05227690|617604078|FG000|Overall Study|Physician Decision|6|||
170889845|NCT05227690|617604079|FG001|Overall Study|Physician Decision|0|||
170889846|NCT05227690|617604080|FG002|Overall Study|Physician Decision|4|||
170889847|NCT05227690|617604078|FG000|Overall Study|Withdrawal of consent|28|||
170889848|NCT05227690|617604079|FG001|Overall Study|Withdrawal of consent|27|||
170889849|NCT05227690|617604080|FG002|Overall Study|Withdrawal of consent|21|||
170889850|NCT05227690|617604078|FG000|Overall Study|Other, not specified|2|||
170889851|NCT05227690|617604079|FG001|Overall Study|Other, not specified|2|||
170889852|NCT05227690|617604080|FG002|Overall Study|Other, not specified|1|||
170543821|NCT03446573|616334806|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
170543822|NCT03446573|616334805|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
170543823|NCT03446573|616334806|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
170543824|NCT05950906|616334809|FG000|Overall Study|Adverse Event|0|||
170543825|NCT05950906|616334810|FG001|Overall Study|Adverse Event|0|||
170543826|NCT05950906|616334811|FG002|Overall Study|Adverse Event|0|||
170543827|NCT05950906|616334812|FG003|Overall Study|Adverse Event|0|||
170543828|NCT05950906|616334813|FG004|Overall Study|Adverse Event|0|||
170543829|NCT05950906|616334814|FG005|Overall Study|Adverse Event|0|||
170543830|NCT05950906|616334815|FG006|Overall Study|Adverse Event|0|||
170543831|NCT05950906|616334816|FG007|Overall Study|Adverse Event|0|||
170543832|NCT05950906|616334817|FG008|Overall Study|Adverse Event|0|||
170543833|NCT05950906|616334818|FG009|Overall Study|Adverse Event|0|||
170543834|NCT05950906|616334819|FG010|Overall Study|Adverse Event|0|||
170543835|NCT05950906|616334820|FG011|Overall Study|Adverse Event|0|||
170543836|NCT05950906|616334821|FG012|Overall Study|Adverse Event|1|||
170543837|NCT05950906|616334822|FG013|Overall Study|Adverse Event|0|||
170543838|NCT05950906|616334809|FG000|Overall Study|Physician Decision|0|||
170543839|NCT05950906|616334810|FG001|Overall Study|Physician Decision|0|||
170543840|NCT05950906|616334811|FG002|Overall Study|Physician Decision|0|||
170543841|NCT05950906|616334812|FG003|Overall Study|Physician Decision|0|||
170543842|NCT05950906|616334813|FG004|Overall Study|Physician Decision|0|||
170543843|NCT05950906|616334814|FG005|Overall Study|Physician Decision|0|||
170461380|NCT02041091|616029871|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
170461381|NCT02041091|616029872|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
170461382|NCT02041091|616029871|FG000|Optional Safety Extension Period|Protocol Violation|2|||
170461383|NCT02041091|616029872|FG001|Optional Safety Extension Period|Protocol Violation|0|||
170461384|NCT02041091|616029871|FG000|Optional Safety Extension Period|Physician Decision|2|||
170461385|NCT02041091|616029872|FG001|Optional Safety Extension Period|Physician Decision|1|||
170543844|NCT05950906|616334815|FG006|Overall Study|Physician Decision|0|||
170543845|NCT05950906|616334816|FG007|Overall Study|Physician Decision|0|||
170543846|NCT05950906|616334817|FG008|Overall Study|Physician Decision|0|||
170543847|NCT05950906|616334818|FG009|Overall Study|Physician Decision|0|||
170543848|NCT05950906|616334819|FG010|Overall Study|Physician Decision|0|||
170889853|NCT00975156|617604081|FG000|Overall Study|Protocol Violation|0|||
170889854|NCT00975156|617604082|FG001|Overall Study|Protocol Violation|1|||
170889855|NCT05499559|617604083|FG000|Overall Study|Lost to Follow-up|467|||
170461386|NCT02041091|616029871|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
170461387|NCT02041091|616029872|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
170889856|NCT02494596|617604084|FG000|Overall Study|Insufficient Therapeutic Response|3|||
170461388|NCT02041091|616029871|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
170461389|NCT02041091|616029872|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
170461390|NCT02991430|616029874|FG000|Treatment Period 1|Adverse Event|1|||
170461391|NCT02991430|616029875|FG001|Treatment Period 1|Adverse Event|0|||
170461392|NCT02991430|616029876|FG002|Treatment Period 1|Adverse Event|2|||
170461393|NCT02991430|616029874|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170461394|NCT02991430|616029875|FG001|Treatment Period 1|Withdrawal by Subject|4|||
170461395|NCT02991430|616029876|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170461396|NCT02991430|616029874|FG000|Treatment Period 2|Study Termination|6|||
170461397|NCT02991430|616029875|FG001|Treatment Period 2|Study Termination|3|||
170461398|NCT02991430|616029876|FG002|Treatment Period 2|Study Termination|3|||
170461399|NCT02991430|616029874|FG000|Treatment Period 2|Lost to Follow-up|0|||
170461400|NCT02991430|616029875|FG001|Treatment Period 2|Lost to Follow-up|0|||
170461401|NCT02991430|616029876|FG002|Treatment Period 2|Lost to Follow-up|1|||
170461402|NCT02991430|616029874|FG000|Post-treatment Observation Period|Study Termination|3|||
170461403|NCT02991430|616029875|FG001|Post-treatment Observation Period|Study Termination|6|||
170461404|NCT02991430|616029876|FG002|Post-treatment Observation Period|Study Termination|5|||
170461405|NCT03118570|616029877|FG000|Overall Study|Adverse Event|2|||
170461406|NCT03118570|616029878|FG001|Overall Study|Adverse Event|0|||
170461407|NCT03118570|616029879|FG002|Overall Study|Adverse Event|0|||
170461408|NCT03118570|616029880|FG003|Overall Study|Adverse Event|0|||
170461409|NCT03118570|616029881|FG004|Overall Study|Adverse Event|3|||
170461410|NCT03118570|616029877|FG000|Overall Study|Withdrawal by Subject|0|||
170461411|NCT03118570|616029878|FG001|Overall Study|Withdrawal by Subject|1|||
170461412|NCT03118570|616029879|FG002|Overall Study|Withdrawal by Subject|4|||
170461413|NCT03118570|616029880|FG003|Overall Study|Withdrawal by Subject|0|||
170461414|NCT03118570|616029881|FG004|Overall Study|Withdrawal by Subject|1|||
170461415|NCT03118570|616029877|FG000|Overall Study|Lost to Follow-up|2|||
170461416|NCT03118570|616029878|FG001|Overall Study|Lost to Follow-up|3|||
170461417|NCT03118570|616029879|FG002|Overall Study|Lost to Follow-up|1|||
170461418|NCT03118570|616029880|FG003|Overall Study|Lost to Follow-up|0|||
170461419|NCT03118570|616029881|FG004|Overall Study|Lost to Follow-up|1|||
170461420|NCT03118570|616029877|FG000|Overall Study|Other, Not Specified|1|||
170461421|NCT03118570|616029878|FG001|Overall Study|Other, Not Specified|3|||
170461422|NCT03118570|616029879|FG002|Overall Study|Other, Not Specified|0|||
170461423|NCT03118570|616029880|FG003|Overall Study|Other, Not Specified|0|||
170461424|NCT03118570|616029881|FG004|Overall Study|Other, Not Specified|0|||
170461425|NCT03970837|616029882|FG000|Overall Study|Adverse Event|23|||
170461426|NCT03970837|616029883|FG001|Overall Study|Adverse Event|20|||
170461427|NCT03970837|616029884|FG002|Overall Study|Adverse Event|16|||
170461428|NCT03970837|616029885|FG003|Overall Study|Adverse Event|6|||
170461429|NCT03970837|616029886|FG004|Overall Study|Adverse Event|4|||
170461430|NCT03970837|616029887|FG005|Overall Study|Adverse Event|5|||
170461431|NCT03970837|616029888|FG006|Overall Study|Adverse Event|1|||
170461432|NCT03970837|616029889|FG007|Overall Study|Adverse Event|5|||
170461433|NCT03970837|616029890|FG008|Overall Study|Adverse Event|0|||
170461434|NCT03970837|616029891|FG009|Overall Study|Adverse Event|0|||
170461435|NCT03970837|616029892|FG010|Overall Study|Adverse Event|1|||
170461436|NCT03970837|616029893|FG011|Overall Study|Adverse Event|1|||
170461437|NCT03970837|616029882|FG000|Overall Study|Lack of Efficacy|14|||
170461438|NCT03970837|616029883|FG001|Overall Study|Lack of Efficacy|12|||
170461439|NCT03970837|616029884|FG002|Overall Study|Lack of Efficacy|1|||
170461440|NCT03970837|616029885|FG003|Overall Study|Lack of Efficacy|2|||
170889857|NCT02494596|617604085|FG001|Overall Study|Insufficient Therapeutic Response|3|||
170889858|NCT02494596|617604086|FG002|Overall Study|Insufficient Therapeutic Response|1|||
170889859|NCT02494596|617604084|FG000|Overall Study|Adverse Event|0|||
170889860|NCT02494596|617604085|FG001|Overall Study|Adverse Event|1|||
170461441|NCT03970837|616029886|FG004|Overall Study|Lack of Efficacy|3|||
170543849|NCT05950906|616334820|FG011|Overall Study|Physician Decision|0|||
170543850|NCT05950906|616334821|FG012|Overall Study|Physician Decision|1|||
170543851|NCT05950906|616334822|FG013|Overall Study|Physician Decision|0|||
170543852|NCT02070991|616334823|FG000|Overall Study|Death|2|||
170461442|NCT03970837|616029887|FG005|Overall Study|Lack of Efficacy|4|||
170461443|NCT03970837|616029888|FG006|Overall Study|Lack of Efficacy|6|||
170461444|NCT03970837|616029889|FG007|Overall Study|Lack of Efficacy|1|||
170461445|NCT03970837|616029890|FG008|Overall Study|Lack of Efficacy|1|||
170461446|NCT03970837|616029891|FG009|Overall Study|Lack of Efficacy|0|||
170461447|NCT03970837|616029892|FG010|Overall Study|Lack of Efficacy|0|||
170889861|NCT02494596|617604086|FG002|Overall Study|Adverse Event|0|||
170889862|NCT02494596|617604084|FG000|Overall Study|Refused Treatment|0|||
170461448|NCT03970837|616029893|FG011|Overall Study|Lack of Efficacy|0|||
170461449|NCT03970837|616029882|FG000|Overall Study|Lost to Follow-up|6|||
170461450|NCT03970837|616029883|FG001|Overall Study|Lost to Follow-up|5|||
170461451|NCT03970837|616029884|FG002|Overall Study|Lost to Follow-up|5|||
170461452|NCT03970837|616029885|FG003|Overall Study|Lost to Follow-up|1|||
170461453|NCT03970837|616029886|FG004|Overall Study|Lost to Follow-up|0|||
170461454|NCT03970837|616029887|FG005|Overall Study|Lost to Follow-up|2|||
170543853|NCT02070991|616334824|FG001|Overall Study|Death|0|||
170461455|NCT03970837|616029888|FG006|Overall Study|Lost to Follow-up|0|||
170461456|NCT03970837|616029889|FG007|Overall Study|Lost to Follow-up|0|||
170461457|NCT03970837|616029890|FG008|Overall Study|Lost to Follow-up|0|||
170461458|NCT03970837|616029891|FG009|Overall Study|Lost to Follow-up|0|||
170461459|NCT03970837|616029892|FG010|Overall Study|Lost to Follow-up|0|||
170461460|NCT03970837|616029893|FG011|Overall Study|Lost to Follow-up|0|||
170461461|NCT03970837|616029882|FG000|Overall Study|Protocol Violation|1|||
170461462|NCT03970837|616029883|FG001|Overall Study|Protocol Violation|0|||
170461463|NCT03970837|616029884|FG002|Overall Study|Protocol Violation|0|||
170461464|NCT03970837|616029885|FG003|Overall Study|Protocol Violation|0|||
170461465|NCT03970837|616029886|FG004|Overall Study|Protocol Violation|0|||
170461466|NCT03970837|616029887|FG005|Overall Study|Protocol Violation|0|||
170461467|NCT03970837|616029888|FG006|Overall Study|Protocol Violation|0|||
170461468|NCT03970837|616029889|FG007|Overall Study|Protocol Violation|0|||
170461469|NCT03970837|616029890|FG008|Overall Study|Protocol Violation|0|||
170461470|NCT03970837|616029891|FG009|Overall Study|Protocol Violation|0|||
170461471|NCT03970837|616029892|FG010|Overall Study|Protocol Violation|0|||
170461472|NCT03970837|616029893|FG011|Overall Study|Protocol Violation|0|||
170461473|NCT03970837|616029882|FG000|Overall Study|Physician Decision|5|||
170461474|NCT03970837|616029883|FG001|Overall Study|Physician Decision|8|||
170461475|NCT03970837|616029884|FG002|Overall Study|Physician Decision|4|||
170461476|NCT03970837|616029885|FG003|Overall Study|Physician Decision|1|||
170461477|NCT03970837|616029886|FG004|Overall Study|Physician Decision|5|||
170461478|NCT03970837|616029887|FG005|Overall Study|Physician Decision|2|||
170461479|NCT03970837|616029888|FG006|Overall Study|Physician Decision|4|||
170461480|NCT03970837|616029889|FG007|Overall Study|Physician Decision|5|||
170461481|NCT03970837|616029890|FG008|Overall Study|Physician Decision|0|||
170461482|NCT03970837|616029891|FG009|Overall Study|Physician Decision|1|||
170461483|NCT03970837|616029892|FG010|Overall Study|Physician Decision|0|||
170461484|NCT03970837|616029893|FG011|Overall Study|Physician Decision|0|||
170461485|NCT03970837|616029882|FG000|Overall Study|Withdrawal by Subject|32|||
170461486|NCT03970837|616029883|FG001|Overall Study|Withdrawal by Subject|35|||
170461487|NCT03970837|616029884|FG002|Overall Study|Withdrawal by Subject|12|||
170461488|NCT03970837|616029885|FG003|Overall Study|Withdrawal by Subject|8|||
170461489|NCT03970837|616029886|FG004|Overall Study|Withdrawal by Subject|6|||
170461490|NCT03970837|616029887|FG005|Overall Study|Withdrawal by Subject|8|||
170461491|NCT03970837|616029888|FG006|Overall Study|Withdrawal by Subject|2|||
170461492|NCT03970837|616029889|FG007|Overall Study|Withdrawal by Subject|3|||
170461493|NCT03970837|616029890|FG008|Overall Study|Withdrawal by Subject|0|||
170461494|NCT03970837|616029891|FG009|Overall Study|Withdrawal by Subject|0|||
170461495|NCT03970837|616029892|FG010|Overall Study|Withdrawal by Subject|0|||
170461496|NCT03970837|616029893|FG011|Overall Study|Withdrawal by Subject|1|||
170461497|NCT03970837|616029882|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
170461498|NCT03970837|616029883|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
170461499|NCT03970837|616029884|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
170461500|NCT03970837|616029885|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
170461501|NCT03970837|616029886|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
170461502|NCT03970837|616029887|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
170461503|NCT03970837|616029888|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
170461504|NCT03970837|616029889|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
170461505|NCT03970837|616029890|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
170461506|NCT03970837|616029891|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
170461507|NCT03970837|616029892|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
170461508|NCT03970837|616029893|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
170461509|NCT03970837|616029882|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
170461510|NCT03970837|616029883|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
170461511|NCT03970837|616029884|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
170461512|NCT03970837|616029885|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
170461513|NCT03970837|616029886|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
170461514|NCT03970837|616029887|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
170461515|NCT03970837|616029888|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
170461516|NCT03970837|616029889|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
170461517|NCT03970837|616029890|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
170461518|NCT03970837|616029891|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
170461519|NCT03970837|616029892|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
170461520|NCT03970837|616029893|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
170461521|NCT01769339|616029900|FG000|Overall Study|Lost to Follow-up|42|||
170461522|NCT01769339|616029900|FG000|Overall Study|Adverse Event|1|||
170461523|NCT01195272|616029901|FG000|Overall Study|Adverse Event|1|||
170461524|NCT01195272|616029901|FG000|Overall Study|Lack of Efficacy|3|||
170461525|NCT04969861|616029902|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
170461526|NCT04969861|616029903|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
170461527|NCT00633243|616031904|FG000|Overall Study|Withdrawal by Subject|0|||
170461528|NCT00633243|616031905|FG001|Overall Study|Withdrawal by Subject|1|||
170461529|NCT00633243|616031904|FG000|Overall Study|incarceration|0|||
170889863|NCT02494596|617604085|FG001|Overall Study|Refused Treatment|1|||
170889864|NCT02494596|617604086|FG002|Overall Study|Refused Treatment|0|||
170889865|NCT00429858|617604089|FG000|Overall Study|Withdrawal by Subject|1|||
170889866|NCT00429858|617604089|FG000|Overall Study|Study Termination|1|||
170889867|NCT04142983|617604090|FG000|Overall Study|Lost to Follow-up|73|||
170889868|NCT04142983|617604090|FG000|Overall Study|Withdrawal by Subject|10|||
170889869|NCT04142983|617604090|FG000|Overall Study|Physician Decision|1|||
170889870|NCT04142983|617604090|FG000|Overall Study|Adverse Event|1|||
170461530|NCT00633243|616031905|FG001|Overall Study|incarceration|2|||
170461531|NCT00633243|616031904|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
170461532|NCT00633243|616031905|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
170461533|NCT00633243|616031904|FG000|Overall Study|Not comfortable with self-injecting|0|||
170461534|NCT00633243|616031905|FG001|Overall Study|Not comfortable with self-injecting|1|||
170461535|NCT00633243|616031904|FG000|Overall Study|Mental Health--Depression|0|||
170461536|NCT00633243|616031905|FG001|Overall Study|Mental Health--Depression|1|||
170461537|NCT00633243|616031904|FG000|Overall Study|Couldn't tolerate side-effects|1|||
170461538|NCT00633243|616031905|FG001|Overall Study|Couldn't tolerate side-effects|1|||
170461539|NCT00658658|616031906|FG000|Overall Study|Withdrawal by Subject|0|||
170461540|NCT00658658|616031907|FG001|Overall Study|Withdrawal by Subject|1|||
170461541|NCT00658658|616031908|FG002|Overall Study|Withdrawal by Subject|0|||
170461542|NCT00658658|616031909|FG003|Overall Study|Withdrawal by Subject|0|||
170461543|NCT00658658|616031910|FG004|Overall Study|Withdrawal by Subject|0|||
170461544|NCT00658658|616031906|FG000|Overall Study|Death|4|||
170461545|NCT00658658|616031907|FG001|Overall Study|Death|0|||
170461546|NCT00658658|616031908|FG002|Overall Study|Death|0|||
170461547|NCT00658658|616031909|FG003|Overall Study|Death|1|||
170461548|NCT00658658|616031910|FG004|Overall Study|Death|1|||
170461549|NCT00658658|616031906|FG000|Overall Study|Disease Progression|0|||
170461550|NCT00658658|616031907|FG001|Overall Study|Disease Progression|1|||
170461551|NCT00658658|616031908|FG002|Overall Study|Disease Progression|0|||
170461552|NCT00658658|616031909|FG003|Overall Study|Disease Progression|1|||
170461553|NCT00658658|616031910|FG004|Overall Study|Disease Progression|3|||
170461554|NCT00658658|616031906|FG000|Overall Study|Protocol-specified Criteria|1|||
170461555|NCT00658658|616031907|FG001|Overall Study|Protocol-specified Criteria|0|||
170461556|NCT00658658|616031908|FG002|Overall Study|Protocol-specified Criteria|0|||
170461557|NCT00658658|616031909|FG003|Overall Study|Protocol-specified Criteria|0|||
170461558|NCT00658658|616031910|FG004|Overall Study|Protocol-specified Criteria|0|||
170461559|NCT00658658|616031906|FG000|Overall Study|Other|0|||
170461560|NCT00658658|616031907|FG001|Overall Study|Other|0|||
170461561|NCT00658658|616031908|FG002|Overall Study|Other|0|||
170461562|NCT00658658|616031909|FG003|Overall Study|Other|0|||
170461563|NCT00658658|616031910|FG004|Overall Study|Other|1|||
170461564|NCT01167257|616031911|FG000|Overall Study|Lost to Follow-up|2|||
170461565|NCT01167257|616031912|FG001|Overall Study|Lost to Follow-up|2|||
170461566|NCT01167257|616031911|FG000|Overall Study|Withdrew consent|1|||
170461567|NCT01167257|616031912|FG001|Overall Study|Withdrew consent|1|||
170461568|NCT02903030|616031913|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
170461569|NCT02903030|616031914|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
170461570|NCT00699283|616031919|FG000|Overall Study|Lack of Efficacy|15|||
170461571|NCT00699283|616031920|FG001|Overall Study|Lack of Efficacy|5|||
170461572|NCT00699283|616031919|FG000|Overall Study|Lost to Follow-up|2|||
170461573|NCT00699283|616031920|FG001|Overall Study|Lost to Follow-up|0|||
170461574|NCT00699283|616031919|FG000|Overall Study|Withdrawal by Subject|1|||
170461575|NCT00699283|616031920|FG001|Overall Study|Withdrawal by Subject|0|||
170461576|NCT00699283|616031919|FG000|Overall Study|Other Reason|5|||
170461577|NCT00699283|616031920|FG001|Overall Study|Other Reason|1|||
170461578|NCT00699283|616031919|FG000|Overall Study|SAE, non-fatal|1|||
170461579|NCT00699283|616031920|FG001|Overall Study|SAE, non-fatal|1|||
170461580|NCT00699283|616031919|FG000|Overall Study|AE, non-serious non-fatal|8|||
170461581|NCT00699283|616031920|FG001|Overall Study|AE, non-serious non-fatal|1|||
170461582|NCT00699283|616031919|FG000|Overall Study|AE of unknown type|1|||
170461583|NCT00699283|616031920|FG001|Overall Study|AE of unknown type|0|||
170461584|NCT04003896|616031923|FG000|Overall Study|Withdrawal by Subject|3|||
170461585|NCT04003896|616031923|FG000|Overall Study|Physician Decision|1|||
170461586|NCT00805675|616031925|FG000|Overall Study|Adverse Event|0|||
170461587|NCT00805675|616031926|FG001|Overall Study|Adverse Event|0|||
170461588|NCT00805675|616031927|FG002|Overall Study|Adverse Event|1|||
170461589|NCT02771795|616031929|FG000|Overall Study|Withdrawal by Subject|47|||
170461590|NCT02771795|616031930|FG001|Overall Study|Withdrawal by Subject|37|||
170461591|NCT02771795|616031929|FG000|Overall Study|Termination by premature discontinuation of study|168|||
170461592|NCT02771795|616031930|FG001|Overall Study|Termination by premature discontinuation of study|185|||
170461593|NCT01957397|616031933|FG000|Test Period 1|sudden leakage/small bag|1|||
170461594|NCT01957397|616031934|FG001|Test Period 1|sudden leakage/small bag|1|||
170461595|NCT01957397|616031933|FG000|Test Period 1|Withdrawal by Subject|1|||
170461596|NCT01957397|616031934|FG001|Test Period 1|Withdrawal by Subject|0|||
170889871|NCT04142983|617604090|FG000|Overall Study|No longer eligible|4|||
170889872|NCT04142983|617604090|FG000|Overall Study|Screen Failure|10|||
170889873|NCT00257010|617604093|FG000|Overall Study|Lack of Efficacy|11|||
170461597|NCT01957397|616031933|FG000|Test Period 2|Adverse Event|0|||
170461598|NCT01957397|616031934|FG001|Test Period 2|Adverse Event|1|||
170461599|NCT01957397|616031933|FG000|Test Period 3|Adverse Event|1|||
170461600|NCT01957397|616031934|FG001|Test Period 3|Adverse Event|2|||
170461601|NCT01957397|616031933|FG000|Test Period 3|the adhesive did not work|1|||
170461602|NCT01957397|616031934|FG001|Test Period 3|the adhesive did not work|0|||
170461603|NCT00540293|616031935|FG000|Overall Study|Adverse event related to study drug|10|||
170461604|NCT00540293|616031935|FG000|Overall Study|Adverse event not related to study drug|7|||
170461605|NCT00540293|616031935|FG000|Overall Study|Withdrawal by Subject|6|||
170461606|NCT00540293|616031935|FG000|Overall Study|Protocol violation, & subject schedule|12|||
170461607|NCT04594707|616031936|FG000|Overall Study|Adverse Event|0|||
170461608|NCT04594707|616031937|FG001|Overall Study|Adverse Event|0|||
170461609|NCT04594707|616031938|FG002|Overall Study|Adverse Event|1|||
170461610|NCT04594707|616031936|FG000|Overall Study|Death|0|||
170461611|NCT04594707|616031937|FG001|Overall Study|Death|2|||
170461612|NCT04594707|616031938|FG002|Overall Study|Death|2|||
170461613|NCT04594707|616031936|FG000|Overall Study|Lung Transplant|0|||
170461614|NCT04594707|616031937|FG001|Overall Study|Lung Transplant|0|||
170461615|NCT04594707|616031938|FG002|Overall Study|Lung Transplant|1|||
170461616|NCT04594707|616031936|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
170461617|NCT04594707|616031937|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
170461618|NCT04594707|616031938|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
170461619|NCT04594707|616031936|FG000|Overall Study|Study Terminated By Sponsor|19|||
170461620|NCT04594707|616031937|FG001|Overall Study|Study Terminated By Sponsor|47|||
170461621|NCT04594707|616031938|FG002|Overall Study|Study Terminated By Sponsor|41|||
170461622|NCT04594707|616031936|FG000|Overall Study|Withdrawal by Subject|1|||
170461623|NCT04594707|616031937|FG001|Overall Study|Withdrawal by Subject|0|||
170461624|NCT04594707|616031938|FG002|Overall Study|Withdrawal by Subject|2|||
170461625|NCT00114166|616031939|FG000|Overall Study|Wrong primary|0|||
170461626|NCT00114166|616031940|FG001|Overall Study|Wrong primary|1|||
170461627|NCT00806286|616031941|FG000|Overall Study|Adverse Event|5|||
170461628|NCT00806286|616031942|FG001|Overall Study|Adverse Event|2|||
170461629|NCT00806286|616031943|FG002|Overall Study|Adverse Event|0|||
170461630|NCT00806286|616031941|FG000|Overall Study|Disease progression|31|||
170461631|NCT00806286|616031942|FG001|Overall Study|Disease progression|38|||
170461632|NCT00806286|616031943|FG002|Overall Study|Disease progression|1|||
170461633|NCT00806286|616031941|FG000|Overall Study|Death|1|||
170461634|NCT00806286|616031942|FG001|Overall Study|Death|6|||
170461635|NCT00806286|616031943|FG002|Overall Study|Death|0|||
170461636|NCT00806286|616031941|FG000|Overall Study|Lost to Follow-up|0|||
170461637|NCT00806286|616031942|FG001|Overall Study|Lost to Follow-up|1|||
170461638|NCT00806286|616031943|FG002|Overall Study|Lost to Follow-up|0|||
170461639|NCT00806286|616031941|FG000|Overall Study|Withdrawal by Subject|8|||
170461640|NCT00806286|616031942|FG001|Overall Study|Withdrawal by Subject|3|||
170461641|NCT00806286|616031943|FG002|Overall Study|Withdrawal by Subject|1|||
170461642|NCT00806286|616031941|FG000|Overall Study|Physician Decision|2|||
170461643|NCT00806286|616031942|FG001|Overall Study|Physician Decision|2|||
170461644|NCT00806286|616031943|FG002|Overall Study|Physician Decision|0|||
170461645|NCT00806286|616031941|FG000|Overall Study|Due to a variety of reasons|7|||
170461646|NCT00806286|616031942|FG001|Overall Study|Due to a variety of reasons|2|||
170461647|NCT00806286|616031943|FG002|Overall Study|Due to a variety of reasons|1|||
170461648|NCT02585934|616031944|FG000|Overall Study|Lost to Follow-up|2|||
170461649|NCT02585934|616031945|FG001|Overall Study|Lost to Follow-up|2|||
170461650|NCT02585934|616031944|FG000|Overall Study|Protocol Violation|14|||
170461651|NCT02585934|616031945|FG001|Overall Study|Protocol Violation|11|||
170461652|NCT02585934|616031944|FG000|Overall Study|Adverse Event|21|||
170461653|NCT02585934|616031945|FG001|Overall Study|Adverse Event|22|||
170461654|NCT02585934|616031944|FG000|Overall Study|Physician Decision|3|||
170461655|NCT02585934|616031945|FG001|Overall Study|Physician Decision|2|||
170461656|NCT02585934|616031944|FG000|Overall Study|Withdrawal by Subject|7|||
170461657|NCT02585934|616031945|FG001|Overall Study|Withdrawal by Subject|21|||
170461658|NCT02585934|616031944|FG000|Overall Study|Lack of Efficacy|2|||
170461659|NCT02585934|616031945|FG001|Overall Study|Lack of Efficacy|1|||
170461660|NCT02585934|616031944|FG000|Overall Study|Death|2|||
170461661|NCT02585934|616031945|FG001|Overall Study|Death|0|||
170461662|NCT02585934|616031944|FG000|Overall Study|Caregiver Withdrew Consent|7|||
170461663|NCT02585934|616031945|FG001|Overall Study|Caregiver Withdrew Consent|7|||
170461664|NCT02585934|616031944|FG000|Overall Study|Sponsor Termination|1|||
170461665|NCT02585934|616031945|FG001|Overall Study|Sponsor Termination|2|||
170461666|NCT02585934|616031944|FG000|Overall Study|Another Reason|10|||
170461667|NCT02585934|616031945|FG001|Overall Study|Another Reason|5|||
170461668|NCT04713553|616031946|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
170461669|NCT04713553|616031947|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
170461670|NCT04713553|616031948|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
170461671|NCT04713553|616031949|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
170461672|NCT04713553|616031950|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
170461673|NCT04713553|616031951|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
170461674|NCT04713553|616031952|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
170461675|NCT04713553|616031946|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
170461676|NCT04713553|616031947|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
170461677|NCT04713553|616031948|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
170461678|NCT04713553|616031949|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
170461679|NCT04713553|616031950|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
170461680|NCT04713553|616031951|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
170461681|NCT04713553|616031952|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
170461682|NCT04713553|616031946|FG000|Primary Study (2 Months)|Other|1|||
170461683|NCT04713553|616031947|FG001|Primary Study (2 Months)|Other|2|||
170461684|NCT04713553|616031948|FG002|Primary Study (2 Months)|Other|0|||
170461685|NCT04713553|616031949|FG003|Primary Study (2 Months)|Other|0|||
170461686|NCT04713553|616031950|FG004|Primary Study (2 Months)|Other|1|||
170461687|NCT04713553|616031951|FG005|Primary Study (2 Months)|Other|0|||
170461688|NCT04713553|616031952|FG006|Primary Study (2 Months)|Other|0|||
170461689|NCT04713553|616031946|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
170461690|NCT04713553|616031947|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
170461691|NCT04713553|616031948|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
170461692|NCT04713553|616031949|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
170461693|NCT04713553|616031950|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
170461694|NCT04713553|616031951|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
170461695|NCT04713553|616031952|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
170461696|NCT04713553|616031946|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
170461697|NCT04713553|616031947|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
170461698|NCT04713553|616031948|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
170461699|NCT04713553|616031949|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
170461700|NCT04713553|616031950|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
170461701|NCT04713553|616031951|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
170461702|NCT04713553|616031952|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
170461703|NCT01682863|616031954|FG000|Overall Study|Subject/guardian decision|19|||
170461704|NCT01682863|616031955|FG001|Overall Study|Subject/guardian decision|12|||
170461705|NCT01682863|616031956|FG002|Overall Study|Subject/guardian decision|10|||
170461706|NCT01682863|616031954|FG000|Overall Study|Lost to Follow-up|5|||
170461707|NCT01682863|616031955|FG001|Overall Study|Lost to Follow-up|1|||
170461708|NCT01682863|616031956|FG002|Overall Study|Lost to Follow-up|6|||
170461709|NCT01682863|616031954|FG000|Overall Study|Death|1|||
170461710|NCT01682863|616031955|FG001|Overall Study|Death|3|||
170461711|NCT01682863|616031956|FG002|Overall Study|Death|4|||
170461712|NCT01682863|616031954|FG000|Overall Study|Protocol deviation|1|||
170461713|NCT01682863|616031955|FG001|Overall Study|Protocol deviation|0|||
170461714|NCT01682863|616031956|FG002|Overall Study|Protocol deviation|1|||
170461715|NCT01682863|616031954|FG000|Overall Study|Technical problems|1|||
170461716|NCT01682863|616031955|FG001|Overall Study|Technical problems|0|||
170461717|NCT01682863|616031956|FG002|Overall Study|Technical problems|0|||
170461718|NCT01682863|616031954|FG000|Overall Study|Adverse Event|0|||
170461719|NCT01682863|616031955|FG001|Overall Study|Adverse Event|1|||
170461720|NCT01682863|616031956|FG002|Overall Study|Adverse Event|2|||
170461721|NCT01682863|616031954|FG000|Overall Study|Physician Decision|0|||
170461722|NCT01682863|616031955|FG001|Overall Study|Physician Decision|0|||
170461723|NCT01682863|616031956|FG002|Overall Study|Physician Decision|1|||
170461724|NCT00977379|616031957|FG000|Overall Study|Withdrawal by Subject|1|||
170461725|NCT00977379|616031958|FG001|Overall Study|Withdrawal by Subject|1|||
170461726|NCT00977379|616031957|FG000|Overall Study|Death|7|||
170461727|NCT00977379|616031958|FG001|Overall Study|Death|9|||
170461728|NCT00977379|616031957|FG000|Overall Study|Premature Study Termination|4|||
170461729|NCT00977379|616031958|FG001|Overall Study|Premature Study Termination|0|||
170461730|NCT00977379|616031957|FG000|Overall Study|Participant Moving House|0|||
170461731|NCT00977379|616031958|FG001|Overall Study|Participant Moving House|1|||
170461732|NCT00977379|616031957|FG000|Overall Study|Randomization Error|0|||
170461733|NCT00977379|616031958|FG001|Overall Study|Randomization Error|1|||
170461734|NCT00918138|616031959|FG000|Overall Study|Subject withdrew consent|1|||
170461735|NCT00918138|616031960|FG001|Overall Study|Subject withdrew consent|1|||
170461736|NCT00918138|616031959|FG000|Overall Study|Death|1|||
170461737|NCT00918138|616031960|FG001|Overall Study|Death|0|||
170461738|NCT02603393|616031961|FG000|Overall Study|Patient/guardian decision|32|||
170461739|NCT02603393|616031962|FG001|Overall Study|Patient/guardian decision|18|||
170461740|NCT02603393|616031961|FG000|Overall Study|Adverse Event|17|||
170461741|NCT02603393|616031962|FG001|Overall Study|Adverse Event|15|||
170543854|NCT02070991|616334823|FG000|Overall Study|Withdrawal by Subject|1|||
170543855|NCT02070991|616334824|FG001|Overall Study|Withdrawal by Subject|0|||
170543856|NCT02639559|616334825|FG000|Overall Study|Mobilization failure|0|||
170543857|NCT02639559|616334826|FG001|Overall Study|Mobilization failure|3|||
170543858|NCT02639559|616334825|FG000|Overall Study|Issues with vascular acess|1|||
170543859|NCT02639559|616334826|FG001|Overall Study|Issues with vascular acess|0|||
170543860|NCT04999020|616334827|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
170543861|NCT04999020|616334828|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
170543862|NCT04999020|616334829|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
170543863|NCT04999020|616334830|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
170543864|NCT04999020|616334827|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
170543865|NCT04999020|616334828|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
170543866|NCT04999020|616334829|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
170543867|NCT04999020|616334830|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
170543868|NCT04999020|616334827|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
170543869|NCT04999020|616334828|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
170543870|NCT04999020|616334829|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
170543871|NCT04999020|616334830|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
170543872|NCT04999020|616334827|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170543873|NCT04999020|616334828|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170543874|NCT04999020|616334829|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
170543875|NCT04999020|616334830|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
170543876|NCT04999020|616334827|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
170543877|NCT04999020|616334828|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
170543878|NCT04999020|616334829|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
170543879|NCT04999020|616334830|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
170543880|NCT04999020|616334827|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
170543881|NCT04999020|616334828|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
170543882|NCT04999020|616334829|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
170543883|NCT04999020|616334830|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
170543884|NCT04999020|616334827|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170543885|NCT04999020|616334828|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170543886|NCT04999020|616334829|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
170543887|NCT04999020|616334830|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170543888|NCT04999020|616334827|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
170543889|NCT04999020|616334828|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
170543890|NCT04999020|616334829|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
170543891|NCT04999020|616334830|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
170543892|NCT02448043|616334831|FG000|Overall Study|Withdrawal by Subject|2|||
170543893|NCT02448043|616334832|FG001|Overall Study|Withdrawal by Subject|2|||
170543894|NCT02448043|616334831|FG000|Overall Study|Protocol Violation|1|||
170543895|NCT02448043|616334832|FG001|Overall Study|Protocol Violation|2|||
170543896|NCT04795323|616334842|FG000|Overall Study|Did not interact with TARA|1|||
170543897|NCT04795323|616334843|FG001|Overall Study|Did not interact with TARA|0|||
170543898|NCT02691663|616334850|FG000|Overall Study|Screen failure after baseline|2|||
170543899|NCT02691663|616334851|FG001|Overall Study|Screen failure after baseline|2|||
170543900|NCT02691663|616334850|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
170543901|NCT02691663|616334851|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
170543902|NCT02691663|616334850|FG000|Overall Study|Withdrawn after Follow up 2|1|||
170543903|NCT02691663|616334851|FG001|Overall Study|Withdrawn after Follow up 2|1|||
170543904|NCT02691663|616334850|FG000|Overall Study|Lost to Follow-up|3|||
170543905|NCT02691663|616334851|FG001|Overall Study|Lost to Follow-up|2|||
170543906|NCT04925934|616334852|FG000|Overall Study|Adverse Event|1|||
170461742|NCT02603393|616031961|FG000|Overall Study|Technical problems|4|||
170461743|NCT02603393|616031962|FG001|Overall Study|Technical problems|7|||
170543907|NCT04925934|616334853|FG001|Overall Study|Adverse Event|0|||
170461744|NCT02603393|616031961|FG000|Overall Study|Lack of Efficacy|7|||
170461745|NCT02603393|616031962|FG001|Overall Study|Lack of Efficacy|2|||
170461746|NCT02603393|616031961|FG000|Overall Study|Death|3|||
170461747|NCT02603393|616031962|FG001|Overall Study|Death|4|||
170789344|NCT02043678|617238060|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
170789345|NCT02043678|617238059|FG000|Overall Study|Missing|1|||
170789346|NCT02043678|617238060|FG001|Overall Study|Missing|0|||
170789347|NCT02043678|617238059|FG000|Overall Study|Adverse Event|0|||
170789348|NCT02043678|617238060|FG001|Overall Study|Adverse Event|1|||
170789349|NCT05869383|617238061|FG000|Overall Study|Withdrawal by Subject|2|||
170461748|NCT02603393|616031961|FG000|Overall Study|Physician Decision|3|||
170461749|NCT02603393|616031962|FG001|Overall Study|Physician Decision|3|||
170461750|NCT02603393|616031961|FG000|Overall Study|Protocol deviation|2|||
170461751|NCT02603393|616031962|FG001|Overall Study|Protocol deviation|3|||
170461752|NCT02603393|616031961|FG000|Overall Study|Lost to Follow-up|1|||
170461753|NCT02603393|616031962|FG001|Overall Study|Lost to Follow-up|2|||
170461754|NCT02603393|616031961|FG000|Overall Study|Non-compliance with study treatment|1|||
170461755|NCT02603393|616031962|FG001|Overall Study|Non-compliance with study treatment|0|||
170461756|NCT02603393|616031961|FG000|Overall Study|Sponsor decision|1|||
170461757|NCT02603393|616031962|FG001|Overall Study|Sponsor decision|0|||
170461758|NCT03972163|616031966|FG000|Overall Study|Death|0|||
170461759|NCT03972163|616031967|FG001|Overall Study|Death|1|||
170461760|NCT01868893|616031968|FG000|Overall Study|Adverse Event|2|||
170461761|NCT01868893|616031968|FG000|Overall Study|Commercial availability of study drug|17|||
170461762|NCT01868893|616031968|FG000|Overall Study|Neutropenia|1|||
170461763|NCT01199471|616031969|FG000|Overall Study|Protocol Violation|4|||
170461764|NCT01199471|616031969|FG000|Overall Study|Withdrawal by Subject|1|||
170461765|NCT01199471|616031969|FG000|Overall Study|Physician Decision|1|||
170461766|NCT02006693|616031970|FG000|Overall Study|No Reason Specified|6|||
170461767|NCT02006693|616031971|FG001|Overall Study|No Reason Specified|8|||
170461768|NCT02006693|616031970|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
170461769|NCT02006693|616031971|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
170461770|NCT02006693|616031970|FG000|Overall Study|XEN Implant Explantation|0|||
170461771|NCT02006693|616031971|FG001|Overall Study|XEN Implant Explantation|1|||
170461772|NCT02006693|616031970|FG000|Overall Study|Death|2|||
170461773|NCT02006693|616031971|FG001|Overall Study|Death|2|||
170461774|NCT02006693|616031970|FG000|Overall Study|Lost to Follow-up|4|||
170461775|NCT02006693|616031971|FG001|Overall Study|Lost to Follow-up|1|||
170461776|NCT02006693|616031970|FG000|Overall Study|Patient Decision|4|||
170461777|NCT02006693|616031971|FG001|Overall Study|Patient Decision|0|||
170461778|NCT03151408|616031972|FG000|Overall Study|Adverse Event|24|||
170461779|NCT03151408|616031973|FG001|Overall Study|Adverse Event|23|||
170461780|NCT03151408|616031972|FG000|Overall Study|Death|46|||
170461781|NCT03151408|616031973|FG001|Overall Study|Death|26|||
170461782|NCT03151408|616031972|FG000|Overall Study|Physician Decision|13|||
170461783|NCT03151408|616031973|FG001|Overall Study|Physician Decision|19|||
170461784|NCT03151408|616031972|FG000|Overall Study|Withdrawal by Subject|16|||
170461785|NCT03151408|616031973|FG001|Overall Study|Withdrawal by Subject|20|||
170461786|NCT03151408|616031972|FG000|Overall Study|Progressive disease|45|||
170461787|NCT03151408|616031973|FG001|Overall Study|Progressive disease|61|||
170461788|NCT03151408|616031972|FG000|Overall Study|non-compliance by patient|1|||
170461789|NCT03151408|616031973|FG001|Overall Study|non-compliance by patient|0|||
170461790|NCT03151408|616031972|FG000|Overall Study|other reasons|56|||
170461791|NCT03151408|616031973|FG001|Overall Study|other reasons|52|||
170461792|NCT03151408|616031972|FG000|Overall Study|randomized and not treated|2|||
170461793|NCT03151408|616031973|FG001|Overall Study|randomized and not treated|2|||
170461794|NCT03400943|616031974|FG000|Treatment Period 1|Adverse Event|0|||
170461795|NCT03400943|616031975|FG001|Treatment Period 1|Adverse Event|0|||
170461796|NCT03400943|616031976|FG002|Treatment Period 1|Adverse Event|0|||
170461797|NCT03400943|616031977|FG003|Treatment Period 1|Adverse Event|1|||
170461798|NCT03400943|616031974|FG000|Treatment Period 1|Lost to Follow-up|1|||
170461799|NCT03400943|616031975|FG001|Treatment Period 1|Lost to Follow-up|0|||
170461800|NCT03400943|616031976|FG002|Treatment Period 1|Lost to Follow-up|0|||
170461801|NCT03400943|616031977|FG003|Treatment Period 1|Lost to Follow-up|0|||
170461802|NCT03400943|616031974|FG000|Treatment Period 1|Protocol Violation|0|||
170461803|NCT03400943|616031975|FG001|Treatment Period 1|Protocol Violation|1|||
170461804|NCT03400943|616031976|FG002|Treatment Period 1|Protocol Violation|1|||
170461805|NCT03400943|616031977|FG003|Treatment Period 1|Protocol Violation|0|||
170461806|NCT03400943|616031974|FG000|Treatment Period 1|Study terminated by sponsor|2|||
170461807|NCT03400943|616031975|FG001|Treatment Period 1|Study terminated by sponsor|0|||
170461808|NCT03400943|616031976|FG002|Treatment Period 1|Study terminated by sponsor|0|||
170461809|NCT03400943|616031977|FG003|Treatment Period 1|Study terminated by sponsor|1|||
170461810|NCT03400943|616031974|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170461811|NCT03400943|616031975|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170461812|NCT03400943|616031976|FG002|Treatment Period 1|Withdrawal by Subject|3|||
170461813|NCT03400943|616031977|FG003|Treatment Period 1|Withdrawal by Subject|1|||
170461814|NCT03400943|616031974|FG000|Treatment Period 1|Other|2|||
170461815|NCT03400943|616031975|FG001|Treatment Period 1|Other|1|||
170461816|NCT03400943|616031976|FG002|Treatment Period 1|Other|2|||
170461817|NCT03400943|616031977|FG003|Treatment Period 1|Other|2|||
170461818|NCT03400943|616031974|FG000|Post-treatment Period 1|Adverse Event|2|||
170789350|NCT05869383|617238062|FG001|Overall Study|Withdrawal by Subject|0|||
170636426|NCT02023697|616680837|FG002|Treatment Period|Radiological progression|26|||
170636427|NCT02023697|616680835|FG000|Treatment Period|Never Treated|5|||
170636428|NCT02023697|616680836|FG001|Treatment Period|Never Treated|6|||
170636429|NCT02023697|616680837|FG002|Treatment Period|Never Treated|10|||
170636430|NCT02023697|616680835|FG000|Treatment Period|Adverse Event|13|||
170636431|NCT02023697|616680836|FG001|Treatment Period|Adverse Event|25|||
170636432|NCT02023697|616680837|FG002|Treatment Period|Adverse Event|23|||
170636433|NCT02023697|616680835|FG000|Treatment Period|Logistical difficulties|1|||
170636434|NCT02023697|616680836|FG001|Treatment Period|Logistical difficulties|1|||
170636435|NCT02023697|616680837|FG002|Treatment Period|Logistical difficulties|1|||
170636436|NCT02023697|616680835|FG000|Treatment Period|Clinical progression|10|||
170636437|NCT02023697|616680836|FG001|Treatment Period|Clinical progression|8|||
170636438|NCT02023697|616680837|FG002|Treatment Period|Clinical progression|28|||
170636439|NCT02023697|616680835|FG000|Treatment Period|Withdrawal by Subject|4|||
170636440|NCT02023697|616680836|FG001|Treatment Period|Withdrawal by Subject|5|||
170636441|NCT02023697|616680837|FG002|Treatment Period|Withdrawal by Subject|13|||
170636442|NCT02023697|616680835|FG000|Treatment Period|Safety outcome reached|0|||
170636443|NCT02023697|616680836|FG001|Treatment Period|Safety outcome reached|1|||
170636444|NCT02023697|616680837|FG002|Treatment Period|Safety outcome reached|0|||
170636445|NCT02023697|616680835|FG000|Treatment Period|Physician Decision|0|||
170636446|NCT02023697|616680836|FG001|Treatment Period|Physician Decision|0|||
170636447|NCT02023697|616680837|FG002|Treatment Period|Physician Decision|1|||
170636448|NCT02023697|616680835|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
170636449|NCT02023697|616680836|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
170636450|NCT02023697|616680837|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
170636451|NCT02023697|616680835|FG000|Active Follow-up Period|Lost to Follow-up|1|||
170636452|NCT02023697|616680836|FG001|Active Follow-up Period|Lost to Follow-up|1|||
170636453|NCT02023697|616680837|FG002|Active Follow-up Period|Lost to Follow-up|1|||
170636454|NCT02023697|616680835|FG000|Active Follow-up Period|Deterioration of general condition|1|||
170636455|NCT02023697|616680836|FG001|Active Follow-up Period|Deterioration of general condition|1|||
170636456|NCT02023697|616680837|FG002|Active Follow-up Period|Deterioration of general condition|1|||
170636457|NCT02023697|616680835|FG000|Active Follow-up Period|Other unspecified|2|||
170636458|NCT02023697|616680836|FG001|Active Follow-up Period|Other unspecified|0|||
170636459|NCT02023697|616680837|FG002|Active Follow-up Period|Other unspecified|1|||
170636460|NCT02023697|616680835|FG000|Active Follow-up Period|Clinical progression|0|||
170636461|NCT02023697|616680836|FG001|Active Follow-up Period|Clinical progression|2|||
170636462|NCT02023697|616680837|FG002|Active Follow-up Period|Clinical progression|1|||
170636463|NCT02023697|616680835|FG000|Active Follow-up Period|Radiological progression|0|||
170636464|NCT02023697|616680836|FG001|Active Follow-up Period|Radiological progression|0|||
170636465|NCT02023697|616680837|FG002|Active Follow-up Period|Radiological progression|1|||
170636466|NCT02023697|616680835|FG000|Active Follow-up Period|Death|83|||
170636467|NCT02023697|616680836|FG001|Active Follow-up Period|Death|82|||
170636468|NCT02023697|616680837|FG002|Active Follow-up Period|Death|87|||
170636469|NCT02023697|616680835|FG000|Long-term Follow-up Period|Death|9|||
170636470|NCT02023697|616680836|FG001|Long-term Follow-up Period|Death|6|||
170636471|NCT02023697|616680837|FG002|Long-term Follow-up Period|Death|4|||
170636472|NCT02023697|616680835|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
170636473|NCT02023697|616680836|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
170636474|NCT02023697|616680837|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
170636475|NCT02023697|616680835|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
170636476|NCT02023697|616680836|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
170636477|NCT02023697|616680837|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
170636478|NCT02023697|616680835|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
170636479|NCT02023697|616680836|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
170636480|NCT02023697|616680837|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
170636481|NCT02023697|616680835|FG000|Long-term Follow-up Period|Technical problems|0|||
170636482|NCT02023697|616680836|FG001|Long-term Follow-up Period|Technical problems|0|||
170636483|NCT02023697|616680837|FG002|Long-term Follow-up Period|Technical problems|1|||
170636484|NCT02023697|616680835|FG000|Long-term Follow-up Period|Other unspecified|6|||
170636485|NCT02023697|616680836|FG001|Long-term Follow-up Period|Other unspecified|3|||
170636486|NCT02023697|616680837|FG002|Long-term Follow-up Period|Other unspecified|5|||
170636487|NCT00541385|616680838|FG000|Overall Study|Adverse Event|6|||
170889874|NCT00257010|617604093|FG000|Overall Study|Lost to Follow-up|53|||
170889875|NCT00257010|617604093|FG000|Overall Study|Withdrawal by Subject|34|||
170889876|NCT00257010|617604093|FG000|Overall Study|Adverse Event|10|||
170636488|NCT00541385|616680839|FG001|Overall Study|Adverse Event|3|||
170636489|NCT00541385|616680838|FG000|Overall Study|Withdrawal by Subject|2|||
170636490|NCT00541385|616680839|FG001|Overall Study|Withdrawal by Subject|2|||
170636491|NCT00541385|616680838|FG000|Overall Study|Lost to Follow-up|6|||
170636492|NCT00541385|616680839|FG001|Overall Study|Lost to Follow-up|1|||
170636493|NCT00541385|616680838|FG000|Overall Study|Parasite reappearance/malaria|67|||
170636494|NCT00541385|616680839|FG001|Overall Study|Parasite reappearance/malaria|32|||
170636495|NCT04939415|616680844|FG000|Overall Study|Withdrawal by Subject|1|||
170889877|NCT00257010|617604093|FG000|Overall Study|various|11|||
170543908|NCT04925934|616334854|FG002|Overall Study|Adverse Event|0|||
170543909|NCT04925934|616334852|FG000|Overall Study|Lost to Follow-up|2|||
170543910|NCT04925934|616334853|FG001|Overall Study|Lost to Follow-up|0|||
170543911|NCT04925934|616334854|FG002|Overall Study|Lost to Follow-up|1|||
170543912|NCT04925934|616334852|FG000|Overall Study|Death|0|||
170543913|NCT04925934|616334853|FG001|Overall Study|Death|1|||
170543914|NCT04925934|616334854|FG002|Overall Study|Death|0|||
170543915|NCT04925934|616334852|FG000|Overall Study|Withdrawal by Subject|8|||
170543916|NCT04925934|616334853|FG001|Overall Study|Withdrawal by Subject|5|||
170543917|NCT04925934|616334854|FG002|Overall Study|Withdrawal by Subject|9|||
170543918|NCT04925934|616334852|FG000|Overall Study|Other|2|||
170543919|NCT04925934|616334853|FG001|Overall Study|Other|2|||
170543920|NCT04925934|616334854|FG002|Overall Study|Other|2|||
170543921|NCT04925934|616334852|FG000|Overall Study|Eastern European Conflict|7|||
170543922|NCT04925934|616334853|FG001|Overall Study|Eastern European Conflict|3|||
170543923|NCT04925934|616334854|FG002|Overall Study|Eastern European Conflict|2|||
170543924|NCT01068912|616334861|FG000|Overall Study|Adverse Event|2|||
170543925|NCT01068912|616334862|FG001|Overall Study|Adverse Event|3|||
170543926|NCT01068912|616334863|FG002|Overall Study|Adverse Event|2|||
170543927|NCT01068912|616334861|FG000|Overall Study|Withdrawal by Subject|5|||
170543928|NCT01068912|616334862|FG001|Overall Study|Withdrawal by Subject|6|||
170543929|NCT01068912|616334863|FG002|Overall Study|Withdrawal by Subject|6|||
170543930|NCT01068912|616334861|FG000|Overall Study|Lost to Follow-up|3|||
170543931|NCT01068912|616334862|FG001|Overall Study|Lost to Follow-up|7|||
170543932|NCT01068912|616334863|FG002|Overall Study|Lost to Follow-up|3|||
170543933|NCT01068912|616334861|FG000|Overall Study|Protocol Violation|0|||
170543934|NCT01068912|616334862|FG001|Overall Study|Protocol Violation|2|||
170543935|NCT01068912|616334863|FG002|Overall Study|Protocol Violation|0|||
170543936|NCT01068912|616334861|FG000|Overall Study|aggravation influenza|1|||
170543937|NCT01068912|616334862|FG001|Overall Study|aggravation influenza|1|||
170543938|NCT01068912|616334863|FG002|Overall Study|aggravation influenza|1|||
170543939|NCT01068912|616334861|FG000|Overall Study|other underlying illness|0|||
170543940|NCT01068912|616334862|FG001|Overall Study|other underlying illness|3|||
170543941|NCT01068912|616334863|FG002|Overall Study|other underlying illness|3|||
170543942|NCT00366535|616334864|FG000|First Phase: 12 Weeks|Adverse Event|1|||
170543943|NCT00366535|616334865|FG001|First Phase: 12 Weeks|Adverse Event|3|||
170543944|NCT00366535|616334864|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
170543945|NCT00366535|616334865|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
170543946|NCT00366535|616334864|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
170543947|NCT00366535|616334865|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
170543948|NCT00366535|616334864|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
170543949|NCT00366535|616334865|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
170543950|NCT03010501|616334866|FG000|Study Week 1|Withdrawal by Subject|2|||
170543951|NCT03010501|616334867|FG001|Study Week 1|Withdrawal by Subject|1|||
170543952|NCT03010501|616334868|FG002|Study Week 1|Withdrawal by Subject|0|||
170543953|NCT03010501|616334869|FG003|Study Week 1|Withdrawal by Subject|2|||
170543954|NCT03010501|616334870|FG004|Study Week 1|Withdrawal by Subject|0|||
170543955|NCT03010501|616334871|FG005|Study Week 1|Withdrawal by Subject|0|||
170543956|NCT03010501|616334866|FG000|Study Week 3|Withdrawal by Subject|0|||
170543957|NCT03010501|616334867|FG001|Study Week 3|Withdrawal by Subject|0|||
170543958|NCT03010501|616334868|FG002|Study Week 3|Withdrawal by Subject|0|||
170543959|NCT03010501|616334869|FG003|Study Week 3|Withdrawal by Subject|1|||
170543960|NCT03010501|616334870|FG004|Study Week 3|Withdrawal by Subject|0|||
170543961|NCT03010501|616334871|FG005|Study Week 3|Withdrawal by Subject|0|||
170789351|NCT04307355|617238068|FG000|Overall Study|Non-Compliance|3|||
170789352|NCT04307355|617238069|FG001|Overall Study|Non-Compliance|3|||
170543962|NCT00544882|616334872|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
170543963|NCT00544882|616334873|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
170543964|NCT00544882|616334874|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
170543965|NCT00544882|616334872|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
170543966|NCT00544882|616334873|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
170543967|NCT00544882|616334874|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
170543968|NCT00544882|616334872|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
170543969|NCT00544882|616334873|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
170543970|NCT00544882|616334874|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
170543971|NCT00544882|616334872|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
170543972|NCT00544882|616334873|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
170543973|NCT00544882|616334874|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
170543974|NCT00544882|616334872|FG000|Cycle 3: Follow-up|Noncompliance|0|||
170543975|NCT00544882|616334873|FG001|Cycle 3: Follow-up|Noncompliance|1|||
170543976|NCT00544882|616334874|FG002|Cycle 3: Follow-up|Noncompliance|0|||
170543977|NCT00544882|616334872|FG000|Cycle 3: Follow-up|Pregnancy|0|||
170543978|NCT00544882|616334873|FG001|Cycle 3: Follow-up|Pregnancy|1|||
170543979|NCT00544882|616334874|FG002|Cycle 3: Follow-up|Pregnancy|0|||
170543980|NCT05865886|616334875|FG000|Overall Study|Serious adverse event|0|||
170543981|NCT05865886|616334876|FG001|Overall Study|Serious adverse event|1|||
170889878|NCT00257010|617604093|FG000|Overall Study|no headache reported|9|||
170889879|NCT01163786|617604101|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
170889880|NCT01163786|617604101|FG000|Treatment With Bortezomib|Adverse Event|2|||
170889881|NCT01163786|617604101|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
170889882|NCT00662792|617604102|FG000|Period 1|Personal Reasons|0|||
170461819|NCT03400943|616031975|FG001|Post-treatment Period 1|Adverse Event|0|||
170461820|NCT03400943|616031976|FG002|Post-treatment Period 1|Adverse Event|0|||
170461821|NCT03400943|616031977|FG003|Post-treatment Period 1|Adverse Event|0|||
170461822|NCT03400943|616031974|FG000|Post-treatment Period 1|Protocol Violation|1|||
170461823|NCT03400943|616031975|FG001|Post-treatment Period 1|Protocol Violation|0|||
170461824|NCT03400943|616031976|FG002|Post-treatment Period 1|Protocol Violation|0|||
170461825|NCT03400943|616031977|FG003|Post-treatment Period 1|Protocol Violation|0|||
170461826|NCT03400943|616031974|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
170461827|NCT03400943|616031975|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
170461828|NCT03400943|616031976|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
170461829|NCT03400943|616031977|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
170461830|NCT03400943|616031974|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
170461831|NCT03400943|616031975|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
170461832|NCT03400943|616031976|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
170461833|NCT03400943|616031977|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
170461834|NCT03400943|616031974|FG000|Post-treatment Period 1|Other|2|||
170461835|NCT03400943|616031975|FG001|Post-treatment Period 1|Other|0|||
170461836|NCT03400943|616031976|FG002|Post-treatment Period 1|Other|4|||
170461837|NCT03400943|616031977|FG003|Post-treatment Period 1|Other|5|||
170461838|NCT03400943|616031974|FG000|Treatment Period 2|Study terminated by sponsor|0|||
170461839|NCT03400943|616031975|FG001|Treatment Period 2|Study terminated by sponsor|1|||
170461840|NCT03400943|616031976|FG002|Treatment Period 2|Study terminated by sponsor|0|||
170543982|NCT05800145|616334879|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
170543983|NCT05800145|616334880|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
170543984|NCT05800145|616334881|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
170543985|NCT05800145|616334882|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
170543986|NCT05800145|616334883|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
170543987|NCT05800145|616334884|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
170543988|NCT05800145|616334879|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
170543989|NCT05800145|616334880|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
170543990|NCT05800145|616334881|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
170543991|NCT05800145|616334882|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
170543992|NCT05800145|616334883|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
170543993|NCT05800145|616334884|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
170543994|NCT05800145|616334879|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
170543995|NCT05800145|616334880|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
170543996|NCT05800145|616334881|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
170543997|NCT05800145|616334882|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
170543998|NCT05800145|616334883|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
170543999|NCT05800145|616334884|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
170565488|NCT04573972|616418535|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
170565489|NCT04573972|616418536|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
170565490|NCT01496287|616418537|FG000|Overall Study|Lost to Follow-up|1|||
170565491|NCT01496287|616418537|FG000|Overall Study|Incomplete anesthesia|5|||
170461841|NCT03400943|616031977|FG003|Treatment Period 2|Study terminated by sponsor|0|||
170461842|NCT03400943|616031974|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170461843|NCT03400943|616031975|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170461844|NCT03400943|616031976|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170565492|NCT01959529|616418538|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
170565493|NCT01959529|616418539|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
170565494|NCT01959529|616418538|FG000|Overall Study|Lost to Follow-up|4|||
170565495|NCT01959529|616418539|FG001|Overall Study|Lost to Follow-up|1|||
170565496|NCT01959529|616418538|FG000|Overall Study|Other|70|||
170565497|NCT01959529|616418539|FG001|Overall Study|Other|68|||
170565498|NCT01959529|616418538|FG000|Overall Study|Hypoglycaemia|1|||
170461845|NCT03400943|616031977|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170461846|NCT03400943|616031974|FG000|Treatment Period 2|Other|1|||
170461847|NCT03400943|616031975|FG001|Treatment Period 2|Other|6|||
170461848|NCT03400943|616031976|FG002|Treatment Period 2|Other|0|||
170461849|NCT03400943|616031977|FG003|Treatment Period 2|Other|0|||
170461850|NCT03400943|616031974|FG000|Follow-up Period|Withdrawal by Subject|1|||
170461851|NCT03400943|616031975|FG001|Follow-up Period|Withdrawal by Subject|0|||
170461852|NCT03400943|616031976|FG002|Follow-up Period|Withdrawal by Subject|0|||
170461853|NCT03400943|616031977|FG003|Follow-up Period|Withdrawal by Subject|0|||
170565499|NCT01959529|616418539|FG001|Overall Study|Hypoglycaemia|1|||
170565500|NCT01959529|616418538|FG000|Overall Study|Lack of glycaemic control|1|||
170889883|NCT00662792|617604103|FG001|Period 1|Personal Reasons|0|||
170461854|NCT01212588|616031978|FG000|Overall Study|Physician Decision|0|||
170461855|NCT01212588|616031979|FG001|Overall Study|Physician Decision|1|||
170461856|NCT01212588|616031978|FG000|Overall Study|Protocol Violation|1|||
170461857|NCT01212588|616031979|FG001|Overall Study|Protocol Violation|1|||
170461858|NCT03317834|616031982|FG000|Overall Study|Death|2|||
170461859|NCT03317834|616031982|FG000|Overall Study|Device Revision|5|||
170461860|NCT03317834|616031982|FG000|Overall Study|Withdrawal by Subject|13|||
170461861|NCT03317834|616031982|FG000|Overall Study|Lost to Follow-up|13|||
170461862|NCT03839823|616031986|FG000|Overall Study|Adverse Event|8|||
170461863|NCT03839823|616031987|FG001|Overall Study|Adverse Event|4|||
170461864|NCT03839823|616031986|FG000|Overall Study|Death|1|||
170461865|NCT03839823|616031987|FG001|Overall Study|Death|0|||
170461866|NCT03839823|616031986|FG000|Overall Study|Physician Decision|1|||
170461867|NCT03839823|616031987|FG001|Overall Study|Physician Decision|5|||
170461868|NCT03839823|616031986|FG000|Overall Study|Progressive Disease (PD)|65|||
170461869|NCT03839823|616031987|FG001|Overall Study|Progressive Disease (PD)|65|||
170461870|NCT03839823|616031986|FG000|Overall Study|Subject Decision|2|||
170461871|NCT03839823|616031987|FG001|Overall Study|Subject Decision|9|||
170461872|NCT03839823|616031986|FG000|Overall Study|Not Treated|0|||
170461873|NCT03839823|616031987|FG001|Overall Study|Not Treated|10|||
170461874|NCT01716715|616031988|FG000|Overall Study|Never Treated|2|||
170461875|NCT01716715|616031989|FG001|Overall Study|Never Treated|4|||
170461876|NCT01739348|616031997|FG000|Part I (Base Study)|Adverse Event|41|||
170461877|NCT01739348|616031998|FG001|Part I (Base Study)|Adverse Event|52|||
170461878|NCT01739348|616031999|FG002|Part I (Base Study)|Adverse Event|8|||
170461879|NCT01739348|616032000|FG003|Part I (Base Study)|Adverse Event|33|||
170461880|NCT01739348|616031997|FG000|Part I (Base Study)|Death|10|||
170461881|NCT01739348|616031998|FG001|Part I (Base Study)|Death|7|||
170461882|NCT01739348|616031999|FG002|Part I (Base Study)|Death|2|||
170461883|NCT01739348|616032000|FG003|Part I (Base Study)|Death|8|||
170461884|NCT01739348|616031997|FG000|Part I (Base Study)|Lack of Efficacy|3|||
170461885|NCT01739348|616031998|FG001|Part I (Base Study)|Lack of Efficacy|8|||
170461886|NCT01739348|616031999|FG002|Part I (Base Study)|Lack of Efficacy|0|||
170461887|NCT01739348|616032000|FG003|Part I (Base Study)|Lack of Efficacy|7|||
170461888|NCT01739348|616031997|FG000|Part I (Base Study)|Lost to Follow-up|4|||
170461889|NCT01739348|616031998|FG001|Part I (Base Study)|Lost to Follow-up|2|||
170461890|NCT01739348|616031999|FG002|Part I (Base Study)|Lost to Follow-up|4|||
170461891|NCT01739348|616032000|FG003|Part I (Base Study)|Lost to Follow-up|4|||
170461892|NCT01739348|616031997|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
170461893|NCT01739348|616031998|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
170461894|NCT01739348|616031999|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
170461895|NCT01739348|616032000|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
170461896|NCT01739348|616031997|FG000|Part I (Base Study)|Physician Decision|10|||
170461897|NCT01739348|616031998|FG001|Part I (Base Study)|Physician Decision|7|||
170461898|NCT01739348|616031999|FG002|Part I (Base Study)|Physician Decision|1|||
170461899|NCT01739348|616032000|FG003|Part I (Base Study)|Physician Decision|4|||
170461900|NCT01739348|616031997|FG000|Part I (Base Study)|Protocol Violation|2|||
170461901|NCT01739348|616031998|FG001|Part I (Base Study)|Protocol Violation|0|||
170461902|NCT01739348|616031999|FG002|Part I (Base Study)|Protocol Violation|1|||
170461903|NCT01739348|616032000|FG003|Part I (Base Study)|Protocol Violation|2|||
170461904|NCT01739348|616031997|FG000|Part I (Base Study)|Screen Failure|2|||
170461905|NCT01739348|616031998|FG001|Part I (Base Study)|Screen Failure|0|||
170461906|NCT01739348|616031999|FG002|Part I (Base Study)|Screen Failure|0|||
170461907|NCT01739348|616032000|FG003|Part I (Base Study)|Screen Failure|0|||
170461908|NCT01739348|616031997|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
170461909|NCT01739348|616031998|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
170461910|NCT01739348|616031999|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
170461911|NCT01739348|616032000|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
170461912|NCT01739348|616031997|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
170461913|NCT01739348|616031998|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
170461914|NCT01739348|616031999|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
170544000|NCT03600350|616335653|FG000|Overall Study|Death|1|||
170544001|NCT03600350|616335653|FG000|Overall Study|On Follow Up|18|||
170544002|NCT04575324|616335656|FG000|Overall Study|Lost to Follow-up|29|||
170461915|NCT01739348|616032000|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
170461916|NCT01739348|616031997|FG000|Part I (Base Study)|Participant Moved|4|||
170461917|NCT01739348|616031998|FG001|Part I (Base Study)|Participant Moved|3|||
170461918|NCT01739348|616031999|FG002|Part I (Base Study)|Participant Moved|1|||
170461919|NCT01739348|616032000|FG003|Part I (Base Study)|Participant Moved|7|||
170544003|NCT04575324|616335657|FG001|Overall Study|Lost to Follow-up|25|||
170544004|NCT04575324|616335656|FG000|Overall Study|Death|1|||
170544005|NCT04575324|616335657|FG001|Overall Study|Death|2|||
170544006|NCT04575324|616335656|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
170544007|NCT04575324|616335657|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
170544008|NCT01105130|616335658|FG000|Overall Study|Withdrawal by Subject|4|||
170544009|NCT01105130|616335659|FG001|Overall Study|Withdrawal by Subject|6|||
170544010|NCT01105130|616335660|FG002|Overall Study|Withdrawal by Subject|2|||
170544011|NCT01105130|616335658|FG000|Overall Study|Never Started|2|||
170544012|NCT01105130|616335659|FG001|Overall Study|Never Started|2|||
170544013|NCT01105130|616335660|FG002|Overall Study|Never Started|4|||
170544014|NCT01105130|616335658|FG000|Overall Study|Toxicity|1|||
170544015|NCT01105130|616335659|FG001|Overall Study|Toxicity|3|||
170544016|NCT01105130|616335660|FG002|Overall Study|Toxicity|2|||
170544017|NCT01105130|616335658|FG000|Overall Study|Multiple Reasons|3|||
170544018|NCT01105130|616335659|FG001|Overall Study|Multiple Reasons|0|||
170544019|NCT01105130|616335660|FG002|Overall Study|Multiple Reasons|2|||
170544020|NCT00327171|616335663|FG000|Overall Study|Did not receive study medication|3|||
170544021|NCT00327171|616335664|FG001|Overall Study|Did not receive study medication|0|||
170544022|NCT00327171|616335663|FG000|Overall Study|Adverse Event|23|||
170544023|NCT00327171|616335664|FG001|Overall Study|Adverse Event|23|||
170544024|NCT00327171|616335663|FG000|Overall Study|Disease progression/lack of efficacy|68|||
170544025|NCT00327171|616335664|FG001|Overall Study|Disease progression/lack of efficacy|69|||
170544026|NCT00327171|616335663|FG000|Overall Study|Investigator/participant request|1|||
170544027|NCT00327171|616335664|FG001|Overall Study|Investigator/participant request|8|||
170544028|NCT00327171|616335663|FG000|Overall Study|Clinical progression|12|||
170544029|NCT00327171|616335664|FG001|Overall Study|Clinical progression|8|||
170544030|NCT00327171|616335663|FG000|Overall Study|Undisclosed history of ischemia|0|||
170544031|NCT00327171|616335664|FG001|Overall Study|Undisclosed history of ischemia|1|||
170544032|NCT00327171|616335663|FG000|Overall Study|Other|1|||
170544033|NCT00327171|616335664|FG001|Overall Study|Other|0|||
170544034|NCT01363440|616335665|FG000|Overall Study|Adverse Event|5|||
170544035|NCT01363440|616335666|FG001|Overall Study|Adverse Event|4|||
170544036|NCT01363440|616335667|FG002|Overall Study|Adverse Event|4|||
170544037|NCT01363440|616335665|FG000|Overall Study|Death|3|||
170544038|NCT01363440|616335666|FG001|Overall Study|Death|7|||
170544039|NCT01363440|616335667|FG002|Overall Study|Death|5|||
170544040|NCT01363440|616335665|FG000|Overall Study|Withdrawal by Subject|9|||
170544041|NCT01363440|616335666|FG001|Overall Study|Withdrawal by Subject|11|||
170544042|NCT01363440|616335667|FG002|Overall Study|Withdrawal by Subject|11|||
170544043|NCT01363440|616335665|FG000|Overall Study|Lost to Follow-up|2|||
170544044|NCT01363440|616335666|FG001|Overall Study|Lost to Follow-up|4|||
170544045|NCT01363440|616335667|FG002|Overall Study|Lost to Follow-up|5|||
170544046|NCT01363440|616335665|FG000|Overall Study|Other|4|||
170544047|NCT01363440|616335666|FG001|Overall Study|Other|5|||
170544048|NCT01363440|616335667|FG002|Overall Study|Other|2|||
170544049|NCT01771913|616335668|FG000|Overall Study|Withdrawal by Subject|1|||
170544050|NCT01771913|616335669|FG001|Overall Study|Withdrawal by Subject|0|||
170544051|NCT04307394|616335670|FG000|Overall Study|Lost to Follow-up|3|||
170544052|NCT04307394|616335670|FG000|Overall Study|Withdrawal by Subject|2|||
170544053|NCT03695094|616335671|FG000|Overall Study|Adverse Event|1|||
170544054|NCT03695094|616335672|FG001|Overall Study|Adverse Event|1|||
170544055|NCT03695094|616335671|FG000|Overall Study|Withdrawal by Subject|1|||
170544056|NCT03695094|616335672|FG001|Overall Study|Withdrawal by Subject|0|||
170544057|NCT00416949|616335673|FG000|Overall Study|Patients refused to participate|5|||
170544058|NCT01166945|616335678|FG000|Randomized|diagnosed with Group A strep|4|||
170544059|NCT01166945|616335679|FG001|Randomized|diagnosed with Group A strep|4|||
170544060|NCT01166945|616335678|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
170544061|NCT01166945|616335679|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
170544062|NCT01166945|616335678|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
170544063|NCT01166945|616335679|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
170544064|NCT01166945|616335678|FG000|Day 30|Lost to Follow-up|4|||
170544065|NCT01166945|616335679|FG001|Day 30|Lost to Follow-up|3|||
170544066|NCT01178411|616335682|FG000|Overall Study|Adverse Event|5|||
170544067|NCT01178411|616335682|FG000|Overall Study|Withdrawal by Subject|4|||
170544068|NCT01178411|616335682|FG000|Overall Study|Protocol Violation|1|||
170544069|NCT01178411|616335682|FG000|Overall Study|Progressive disease per RECIST|32|||
170544070|NCT01178411|616335682|FG000|Overall Study|Progressive disease per clinician|9|||
170544071|NCT01178411|616335682|FG000|Overall Study|Physician Decision|6|||
170544072|NCT01178411|616335682|FG000|Overall Study|Death|1|||
170544073|NCT01178411|616335682|FG000|Overall Study|No reason provided|1|||
170544074|NCT01178411|616335682|FG000|Overall Study|Drug manufacturing ended|1|||
170544075|NCT00784927|616335683|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
170544076|NCT00784927|616335683|FG000|Overall Study|Protocol Violation|1|||
170544077|NCT00784927|616335683|FG000|Overall Study|Ineligible|1|||
170544078|NCT01471574|616335684|FG000|Treatment Period|Lack of Efficacy|12|||
170544079|NCT01471574|616335685|FG001|Treatment Period|Lack of Efficacy|4|||
170544080|NCT01471574|616335686|FG002|Treatment Period|Lack of Efficacy|14|||
170544081|NCT01471574|616335687|FG003|Treatment Period|Lack of Efficacy|1|||
170544082|NCT01471574|616335684|FG000|Treatment Period|Adverse Event|7|||
170544083|NCT01471574|616335685|FG001|Treatment Period|Adverse Event|3|||
170544084|NCT01471574|616335686|FG002|Treatment Period|Adverse Event|6|||
170544085|NCT01471574|616335687|FG003|Treatment Period|Adverse Event|1|||
170544086|NCT01471574|616335684|FG000|Treatment Period|Withdrawal by Subject|5|||
170544087|NCT01471574|616335685|FG001|Treatment Period|Withdrawal by Subject|1|||
170544088|NCT01471574|616335686|FG002|Treatment Period|Withdrawal by Subject|1|||
170544089|NCT01471574|616335687|FG003|Treatment Period|Withdrawal by Subject|0|||
170544090|NCT01471574|616335684|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
170544091|NCT01471574|616335685|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
170544092|NCT01471574|616335686|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
170544093|NCT01471574|616335687|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
170544094|NCT01471574|616335684|FG000|Treatment Period|Lost to Follow-up|1|||
170544095|NCT01471574|616335685|FG001|Treatment Period|Lost to Follow-up|2|||
170544096|NCT01471574|616335686|FG002|Treatment Period|Lost to Follow-up|2|||
170544097|NCT01471574|616335687|FG003|Treatment Period|Lost to Follow-up|0|||
170544098|NCT01471574|616335684|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
170544099|NCT01471574|616335685|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
170544100|NCT01471574|616335686|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
170544101|NCT01471574|616335687|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
170544102|NCT01471574|616335684|FG000|Treatment Period|Other|1|||
170544103|NCT01471574|616335685|FG001|Treatment Period|Other|0|||
170544104|NCT01471574|616335686|FG002|Treatment Period|Other|0|||
170544105|NCT01471574|616335687|FG003|Treatment Period|Other|0|||
170544106|NCT01471574|616335684|FG000|Follow-up Period|Withdrawal by Subject|3|||
170544107|NCT01471574|616335685|FG001|Follow-up Period|Withdrawal by Subject|0|||
170544108|NCT01471574|616335686|FG002|Follow-up Period|Withdrawal by Subject|3|||
170544109|NCT01471574|616335687|FG003|Follow-up Period|Withdrawal by Subject|1|||
170544110|NCT01471574|616335684|FG000|Follow-up Period|Lost to Follow-up|4|||
170544111|NCT01471574|616335685|FG001|Follow-up Period|Lost to Follow-up|1|||
170544112|NCT01471574|616335686|FG002|Follow-up Period|Lost to Follow-up|3|||
170544113|NCT01471574|616335687|FG003|Follow-up Period|Lost to Follow-up|2|||
170544114|NCT01471574|616335684|FG000|Follow-up Period|Death|0|||
170544115|NCT01471574|616335685|FG001|Follow-up Period|Death|0|||
170544116|NCT01471574|616335686|FG002|Follow-up Period|Death|1|||
170544117|NCT01471574|616335687|FG003|Follow-up Period|Death|0|||
170544118|NCT01471574|616335684|FG000|Follow-up Period|Follow-up no longer required|0|||
170544119|NCT01471574|616335685|FG001|Follow-up Period|Follow-up no longer required|1|||
170544120|NCT01471574|616335686|FG002|Follow-up Period|Follow-up no longer required|0|||
170544121|NCT01471574|616335687|FG003|Follow-up Period|Follow-up no longer required|0|||
170544122|NCT01795937|616335688|FG000|Overall Study|Withdrawal by Subject|1|||
170544123|NCT01795937|616335689|FG001|Overall Study|Withdrawal by Subject|0|||
170544124|NCT01795937|616335690|FG002|Overall Study|Withdrawal by Subject|0|||
170544125|NCT01795937|616335688|FG000|Overall Study|Physician Decision|0|||
170544126|NCT01795937|616335689|FG001|Overall Study|Physician Decision|1|||
170544127|NCT01795937|616335690|FG002|Overall Study|Physician Decision|0|||
170544128|NCT01028053|616335691|FG000|Overall Study|Screen Failure|113|||
170544129|NCT01028053|616335691|FG000|Overall Study|Patient Request|11|||
170544130|NCT01028053|616335691|FG000|Overall Study|Protocol Violation|1|||
170544131|NCT01028053|616335691|FG000|Overall Study|Physician Decision|2|||
170544132|NCT01028053|616335691|FG000|Overall Study|Technical Problem|1|||
170544133|NCT01028053|616335691|FG000|Overall Study|Terminated by Sponsor|1|||
170544134|NCT01028053|616335691|FG000|Overall Study|Various reasons|4|||
170544135|NCT00845182|616335692|FG000|Overall Study|Lost to Follow-up|3|||
170544136|NCT00845182|616335693|FG001|Overall Study|Lost to Follow-up|3|||
170544137|NCT00845182|616335694|FG002|Overall Study|Lost to Follow-up|4|||
170544138|NCT00845182|616335692|FG000|Overall Study|Adverse Event|0|||
170544139|NCT00845182|616335693|FG001|Overall Study|Adverse Event|1|||
170544140|NCT00845182|616335694|FG002|Overall Study|Adverse Event|1|||
170544141|NCT00845182|616335692|FG000|Overall Study|Physician Decision|0|||
170544142|NCT00845182|616335693|FG001|Overall Study|Physician Decision|0|||
170544143|NCT00845182|616335694|FG002|Overall Study|Physician Decision|1|||
170544144|NCT00471354|616335697|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
170544145|NCT00471354|616335697|FG000|Overall Study|Adverse Event|13|||
170544146|NCT00471354|616335697|FG000|Overall Study|Protocol Violation|12|||
170544147|NCT00471354|616335697|FG000|Overall Study|Withdrawal by Subject|1|||
170544148|NCT00471354|616335697|FG000|Overall Study|Physician Decision|4|||
170544149|NCT00471354|616335697|FG000|Overall Study|Sponsor Decision|1|||
170544150|NCT00471354|616335697|FG000|Overall Study|Lost to Follow-up|3|||
170544151|NCT00471354|616335697|FG000|Overall Study|Lack of Efficacy|5|||
170544152|NCT00471354|616335697|FG000|Overall Study|Patient/Caregiver Decision|12|||
170544153|NCT01875237|616335698|FG000|Overall Study|GVDH before DLI|1|||
170544154|NCT01875237|616335699|FG001|Overall Study|GVDH before DLI|0|||
170544155|NCT01875237|616335698|FG000|Overall Study|DLI cells could not be produced|1|||
170544156|NCT01875237|616335699|FG001|Overall Study|DLI cells could not be produced|0|||
170544157|NCT03123588|616335700|FG000|Overall Study|Study Terminated by Sponsor|2|||
170544158|NCT03123588|616335701|FG001|Overall Study|Study Terminated by Sponsor|5|||
170544159|NCT03123588|616335700|FG000|Overall Study|Withdrawal by Subject|1|||
170544160|NCT03123588|616335701|FG001|Overall Study|Withdrawal by Subject|0|||
170544161|NCT03123588|616335700|FG000|Overall Study|Adverse Event|1|||
170544162|NCT03123588|616335701|FG001|Overall Study|Adverse Event|0|||
170544163|NCT03123588|616335700|FG000|Overall Study|Physician Decision|2|||
170544164|NCT03123588|616335701|FG001|Overall Study|Physician Decision|1|||
170544165|NCT05887908|616335702|FG000|Overall Study|Adverse Event|6|||
170544166|NCT05887908|616335703|FG001|Overall Study|Adverse Event|1|||
170544167|NCT05887908|616335704|FG002|Overall Study|Adverse Event|1|||
170544168|NCT05887908|616335702|FG000|Overall Study|Physician Decision|4|||
170544169|NCT05887908|616335703|FG001|Overall Study|Physician Decision|1|||
170544170|NCT05887908|616335704|FG002|Overall Study|Physician Decision|0|||
170544171|NCT05887908|616335702|FG000|Overall Study|Withdrawal by Subject|3|||
170544172|NCT05887908|616335703|FG001|Overall Study|Withdrawal by Subject|2|||
170544173|NCT05887908|616335704|FG002|Overall Study|Withdrawal by Subject|3|||
170544174|NCT05887908|616335702|FG000|Overall Study|Ineligibility after the start of the study|4|||
170544175|NCT05887908|616335703|FG001|Overall Study|Ineligibility after the start of the study|1|||
170544176|NCT05887908|616335704|FG002|Overall Study|Ineligibility after the start of the study|0|||
170544177|NCT05887908|616335702|FG000|Overall Study|Subject non-compliance|4|||
170544178|NCT05887908|616335703|FG001|Overall Study|Subject non-compliance|0|||
170544179|NCT05887908|616335704|FG002|Overall Study|Subject non-compliance|4|||
170544180|NCT05887908|616335702|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
170544181|NCT05887908|616335703|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
170544182|NCT05887908|616335704|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
170544183|NCT05887908|616335702|FG000|Overall Study|Pregnancy|0|||
170544184|NCT05887908|616335703|FG001|Overall Study|Pregnancy|1|||
170544185|NCT05887908|616335704|FG002|Overall Study|Pregnancy|0|||
170544186|NCT05887908|616335702|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
170544187|NCT05887908|616335703|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
170544188|NCT05887908|616335704|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
170544189|NCT05887908|616335702|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
170544190|NCT05887908|616335703|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
170544191|NCT05887908|616335704|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
170544192|NCT05887908|616335702|FG000|Overall Study|Other Reason|3|||
170544193|NCT05887908|616335703|FG001|Overall Study|Other Reason|3|||
170544194|NCT05887908|616335704|FG002|Overall Study|Other Reason|3|||
170544195|NCT02697422|616335708|FG000|Overall Study|Declined exit survey|9|||
170544196|NCT02697422|616335709|FG001|Overall Study|Declined exit survey|2|||
170544197|NCT02697422|616335708|FG000|Overall Study|Lost to Follow-up|13|||
170544198|NCT02697422|616335709|FG001|Overall Study|Lost to Follow-up|8|||
170544199|NCT02697422|616335708|FG000|Overall Study|Death|2|||
170544200|NCT02697422|616335709|FG001|Overall Study|Death|1|||
170544201|NCT02697422|616335708|FG000|Overall Study|Withdrawal by Subject|0|||
170544202|NCT02697422|616335709|FG001|Overall Study|Withdrawal by Subject|1|||
170544203|NCT02697422|616335708|FG000|Overall Study|Physician Decision|1|||
170544204|NCT02697422|616335709|FG001|Overall Study|Physician Decision|1|||
170544205|NCT02697422|616335708|FG000|Overall Study|Exit survey data lost|1|||
170544206|NCT02697422|616335709|FG001|Overall Study|Exit survey data lost|0|||
170544207|NCT01947933|616335711|FG000|Overall Study|Withdrawal by Subject|0|||
170544208|NCT01947933|616335712|FG001|Overall Study|Withdrawal by Subject|0|||
170544209|NCT01947933|616335713|FG002|Overall Study|Withdrawal by Subject|1|||
170636496|NCT04939415|616680845|FG001|Overall Study|Withdrawal by Subject|3|||
170544210|NCT01947933|616335714|FG003|Overall Study|Withdrawal by Subject|0|||
170544211|NCT01947933|616335715|FG004|Overall Study|Withdrawal by Subject|0|||
170544212|NCT01947933|616335716|FG005|Overall Study|Withdrawal by Subject|0|||
170544213|NCT01947933|616335717|FG006|Overall Study|Withdrawal by Subject|0|||
170544214|NCT01947933|616335718|FG007|Overall Study|Withdrawal by Subject|0|||
170544215|NCT01947933|616335719|FG008|Overall Study|Withdrawal by Subject|0|||
170544216|NCT01947933|616335711|FG000|Overall Study|Lost to Follow-up|0|||
170544217|NCT01947933|616335712|FG001|Overall Study|Lost to Follow-up|0|||
170544218|NCT01947933|616335713|FG002|Overall Study|Lost to Follow-up|0|||
170544219|NCT01947933|616335714|FG003|Overall Study|Lost to Follow-up|0|||
170544220|NCT01947933|616335715|FG004|Overall Study|Lost to Follow-up|0|||
170544221|NCT01947933|616335716|FG005|Overall Study|Lost to Follow-up|0|||
170544222|NCT01947933|616335717|FG006|Overall Study|Lost to Follow-up|0|||
170544223|NCT01947933|616335718|FG007|Overall Study|Lost to Follow-up|0|||
170544224|NCT01947933|616335719|FG008|Overall Study|Lost to Follow-up|1|||
170544225|NCT05179603|616335723|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
170789353|NCT04307355|617238070|FG002|Overall Study|Non-Compliance|0|||
170789354|NCT05270408|617238073|FG000|Started Treatment|Withdrawal by Subject|0|||
170789355|NCT05270408|617238074|FG001|Started Treatment|Withdrawal by Subject|0|||
170789356|NCT05270408|617238075|FG002|Started Treatment|Withdrawal by Subject|3|||
170789357|NCT05270408|617238073|FG000|Started Treatment|Adverse Event|0|||
170789358|NCT05270408|617238074|FG001|Started Treatment|Adverse Event|0|||
170544226|NCT05179603|616335723|FG000|Overall Study|Withdrawal by Subject|1|||
170544227|NCT05179603|616335723|FG000|Overall Study|Progressive disease|4|||
170789359|NCT05270408|617238075|FG002|Started Treatment|Adverse Event|1|||
170544228|NCT05179603|616335723|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
170544229|NCT06100250|616335724|FG000|Overall Study|Lost to Follow-up|5|||
170544230|NCT01405911|616335726|FG000|Overall Study|Pre-treatment lab AE|0|||
170544231|NCT01405911|616335727|FG001|Overall Study|Pre-treatment lab AE|1|||
170544232|NCT01405911|616335728|FG002|Overall Study|Pre-treatment lab AE|0|||
170544233|NCT01405911|616335726|FG000|Overall Study|Lost to Follow-up|0|||
170544234|NCT01405911|616335727|FG001|Overall Study|Lost to Follow-up|1|||
170544235|NCT01405911|616335728|FG002|Overall Study|Lost to Follow-up|0|||
170544236|NCT01405911|616335726|FG000|Overall Study|Protocol Violation|1|||
170544237|NCT01405911|616335727|FG001|Overall Study|Protocol Violation|0|||
170544238|NCT01405911|616335728|FG002|Overall Study|Protocol Violation|0|||
170544239|NCT01405911|616335726|FG000|Overall Study|Withdrawal by Subject|3|||
170544240|NCT01405911|616335727|FG001|Overall Study|Withdrawal by Subject|1|||
170544241|NCT01405911|616335728|FG002|Overall Study|Withdrawal by Subject|1|||
170544242|NCT06375655|616335729|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
170544243|NCT06375655|616335730|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
170544244|NCT03770455|616335738|FG000|Overall Study|Screen failures|3|||
170544245|NCT01039675|616335739|FG000|Overall Study|Adverse Event|0|||
170544246|NCT01039675|616335740|FG001|Overall Study|Adverse Event|2|||
170544247|NCT01039675|616335739|FG000|Overall Study|Lack of Efficacy|0|||
170544248|NCT01039675|616335740|FG001|Overall Study|Lack of Efficacy|2|||
170544249|NCT01039675|616335739|FG000|Overall Study|Withdrawal by Subject|0|||
170544250|NCT01039675|616335740|FG001|Overall Study|Withdrawal by Subject|1|||
170544251|NCT01039675|616335739|FG000|Overall Study|Lost to Follow-up|0|||
170544252|NCT01039675|616335740|FG001|Overall Study|Lost to Follow-up|1|||
170544253|NCT01039675|616335739|FG000|Overall Study|Physician Decision|0|||
170544254|NCT01039675|616335740|FG001|Overall Study|Physician Decision|1|||
170544255|NCT03514017|616335743|FG000|Overall Study|Death|1|||
170544256|NCT03514017|616335743|FG000|Overall Study|Adverse Event|1|||
170544257|NCT02564978|616335744|FG000|Overall Study|Adverse Event|8|||
170544258|NCT02564978|616335744|FG000|Overall Study|Death|1|||
170544259|NCT02564978|616335744|FG000|Overall Study|Lost to Follow-up|1|||
170544260|NCT02564978|616335744|FG000|Overall Study|Withdrawal by Subject|15|||
170544261|NCT02564978|616335744|FG000|Overall Study|Early Study Closure|2|||
170544262|NCT02564978|616335744|FG000|Overall Study|Other Reason|5|||
170544263|NCT00567580|616337255|FG000|Overall Study|Protocol Violation|28|||
170544264|NCT00567580|616337256|FG001|Overall Study|Protocol Violation|24|||
170544265|NCT00567580|616337257|FG002|Overall Study|Protocol Violation|24|||
170544266|NCT03971422|616337258|FG000|Overall Study|Lost to Follow-up|0|||
170544267|NCT03971422|616337259|FG001|Overall Study|Lost to Follow-up|1|||
170544268|NCT03971422|616337260|FG002|Overall Study|Lost to Follow-up|0|||
170544269|NCT03971422|616337258|FG000|Overall Study|Lack of Efficacy|5|||
170544270|NCT03971422|616337259|FG001|Overall Study|Lack of Efficacy|1|||
170544271|NCT03971422|616337260|FG002|Overall Study|Lack of Efficacy|1|||
170544272|NCT03971422|616337258|FG000|Overall Study|Adverse event, not fatal|2|||
170544273|NCT03971422|616337259|FG001|Overall Study|Adverse event, not fatal|2|||
170544274|NCT03971422|616337260|FG002|Overall Study|Adverse event, not fatal|5|||
170544275|NCT03971422|616337258|FG000|Overall Study|Worsening of MG Symptoms|1|||
170544276|NCT03971422|616337259|FG001|Overall Study|Worsening of MG Symptoms|4|||
170544277|NCT03971422|616337260|FG002|Overall Study|Worsening of MG Symptoms|2|||
170789360|NCT05270408|617238073|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
170789361|NCT05270408|617238074|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
170789362|NCT05270408|617238075|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
170789363|NCT03768505|617238076|FG000|Overall Study|sponsor decision|76|||
170789364|NCT03768505|617238076|FG000|Overall Study|Death|35|||
170789365|NCT03768505|617238076|FG000|Overall Study|Other -Various|30|||
170789366|NCT03768505|617238076|FG000|Overall Study|Withdrawal by Subject|22|||
170544278|NCT03971422|616337258|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
170544279|NCT03971422|616337259|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
170544280|NCT03971422|616337260|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
170544281|NCT03971422|616337258|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
170544282|NCT03971422|616337259|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
170544283|NCT03971422|616337260|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
170544284|NCT03971422|616337258|FG000|Overall Study|Due to COVID-19 pandemic|0|||
170544285|NCT03971422|616337259|FG001|Overall Study|Due to COVID-19 pandemic|1|||
170544286|NCT03971422|616337260|FG002|Overall Study|Due to COVID-19 pandemic|1|||
170544287|NCT01658878|616337261|FG000|Treatment Period|Disease Progression|1|||
170544288|NCT01658878|616337262|FG001|Treatment Period|Disease Progression|3|||
170789367|NCT03768505|617238076|FG000|Overall Study|Lost to Follow-up|6|||
170789368|NCT05034328|617238083|FG000|Overall Study|Protocol Violation|1|||
170789369|NCT05034328|617238084|FG001|Overall Study|Protocol Violation|0|||
170461920|NCT01739348|616031997|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
170461921|NCT01739348|616031998|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
170461922|NCT01739348|616031999|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
170461923|NCT01739348|616032000|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
170461924|NCT01739348|616031997|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
170461925|NCT01739348|616031998|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
170461926|NCT01739348|616031999|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
170461927|NCT01739348|616032000|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
170461928|NCT01739348|616031997|FG000|Part II (Extension Study)|Adverse Event|10|||
170461929|NCT01739348|616031998|FG001|Part II (Extension Study)|Adverse Event|11|||
170461930|NCT01739348|616031999|FG002|Part II (Extension Study)|Adverse Event|7|||
170461931|NCT01739348|616032000|FG003|Part II (Extension Study)|Adverse Event|26|||
170461932|NCT01739348|616031997|FG000|Part II (Extension Study)|Death|3|||
170461933|NCT01739348|616031998|FG001|Part II (Extension Study)|Death|3|||
170461934|NCT01739348|616031999|FG002|Part II (Extension Study)|Death|2|||
170461935|NCT01739348|616032000|FG003|Part II (Extension Study)|Death|6|||
170461936|NCT01739348|616031997|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
170461937|NCT01739348|616031998|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
170461938|NCT01739348|616031999|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
170461939|NCT01739348|616032000|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
170461940|NCT01739348|616031997|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
170461941|NCT01739348|616031998|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
170461942|NCT01739348|616031999|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
170461943|NCT01739348|616032000|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
170461944|NCT01739348|616031997|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
170461945|NCT01739348|616031998|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
170461946|NCT01739348|616031999|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
170461947|NCT01739348|616032000|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
170461948|NCT01739348|616031997|FG000|Part II (Extension Study)|Physician Decision|7|||
170461949|NCT01739348|616031998|FG001|Part II (Extension Study)|Physician Decision|11|||
170461950|NCT01739348|616031999|FG002|Part II (Extension Study)|Physician Decision|6|||
170461951|NCT01739348|616032000|FG003|Part II (Extension Study)|Physician Decision|12|||
170461952|NCT01739348|616031997|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
170461953|NCT01739348|616031998|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
170461954|NCT01739348|616031999|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
170461955|NCT01739348|616032000|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
170461956|NCT01739348|616031997|FG000|Part II (Extension Study)|Participant Moved|3|||
170461957|NCT01739348|616031998|FG001|Part II (Extension Study)|Participant Moved|3|||
170461958|NCT01739348|616031999|FG002|Part II (Extension Study)|Participant Moved|0|||
170461959|NCT01739348|616032000|FG003|Part II (Extension Study)|Participant Moved|3|||
170461960|NCT01739348|616031997|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
170461961|NCT01739348|616031998|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
170461962|NCT01739348|616031999|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
170461963|NCT01739348|616032000|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
170461964|NCT01739348|616031997|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
170461965|NCT01739348|616031998|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
170461966|NCT01739348|616031999|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
170461967|NCT01739348|616032000|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
170461968|NCT00492024|616032014|FG000|Treatment|Adverse Event|3|||
170461969|NCT00492024|616032015|FG001|Treatment|Adverse Event|1|||
170461970|NCT00492024|616032014|FG000|Treatment|Lack of Efficacy|21|||
170461971|NCT00492024|616032015|FG001|Treatment|Lack of Efficacy|20|||
170461972|NCT00492024|616032014|FG000|Treatment|Lost to Follow-up|3|||
170461973|NCT00492024|616032015|FG001|Treatment|Lost to Follow-up|1|||
170461974|NCT00492024|616032014|FG000|Treatment|Withdrawal by Subject|2|||
170461975|NCT00492024|616032015|FG001|Treatment|Withdrawal by Subject|0|||
170461976|NCT00492024|616032014|FG000|Follow up|Lack of Efficacy|0|||
170461977|NCT00492024|616032015|FG001|Follow up|Lack of Efficacy|1|||
170461978|NCT00492024|616032014|FG000|Follow up|Lost to Follow-up|1|||
170461979|NCT00492024|616032015|FG001|Follow up|Lost to Follow-up|1|||
170461980|NCT00936897|616032020|FG000|Overall Study|Withdrawal by Subject|9|||
170461981|NCT00936897|616032021|FG001|Overall Study|Withdrawal by Subject|19|||
170461982|NCT00936897|616032020|FG000|Overall Study|Adverse Event|4|||
170461983|NCT00936897|616032021|FG001|Overall Study|Adverse Event|13|||
170461984|NCT00936897|616032020|FG000|Overall Study|Other|3|||
170789370|NCT05034328|617238083|FG000|Overall Study|Lost to Follow-up|0|||
170461985|NCT00936897|616032021|FG001|Overall Study|Other|9|||
170461986|NCT00936897|616032020|FG000|Overall Study|Lost to Follow-up|1|||
170461987|NCT00936897|616032021|FG001|Overall Study|Lost to Follow-up|10|||
170461988|NCT00936897|616032020|FG000|Overall Study|Administrative Decision|1|||
170461989|NCT00936897|616032021|FG001|Overall Study|Administrative Decision|2|||
170461990|NCT00936897|616032020|FG000|Overall Study|Protocol Violation|1|||
170461991|NCT00936897|616032021|FG001|Overall Study|Protocol Violation|1|||
170461992|NCT00936897|616032020|FG000|Overall Study|Ineligibility Determined|0|||
170461993|NCT00936897|616032021|FG001|Overall Study|Ineligibility Determined|3|||
170461994|NCT00936897|616032020|FG000|Overall Study|Noncompliance|0|||
170461995|NCT00936897|616032021|FG001|Overall Study|Noncompliance|2|||
170461996|NCT00936897|616032020|FG000|Overall Study|Death|0|||
170461997|NCT00936897|616032021|FG001|Overall Study|Death|1|||
170461998|NCT00901576|616032024|FG000|Second Intervention|Withdrawal by Subject|0|||
170461999|NCT00901576|616032025|FG001|Second Intervention|Withdrawal by Subject|0|||
170462000|NCT00901576|616032026|FG002|Second Intervention|Withdrawal by Subject|0|||
170462001|NCT00901576|616032027|FG003|Second Intervention|Withdrawal by Subject|1|||
170462002|NCT00901576|616032028|FG004|Second Intervention|Withdrawal by Subject|0|||
170789371|NCT05034328|617238084|FG001|Overall Study|Lost to Follow-up|10|||
170462003|NCT00901576|616032029|FG005|Second Intervention|Withdrawal by Subject|1|||
170462004|NCT00901576|616032024|FG000|Second Intervention|Physician Decision|1|||
170462005|NCT00901576|616032025|FG001|Second Intervention|Physician Decision|0|||
170789372|NCT05399459|617238087|FG000|Overall Study|Randomized but not treated|29|||
170789373|NCT05399459|617238088|FG001|Overall Study|Randomized but not treated|30|||
170789374|NCT05399459|617238089|FG002|Overall Study|Randomized but not treated|38|||
170462006|NCT00901576|616032026|FG002|Second Intervention|Physician Decision|0|||
170462007|NCT00901576|616032027|FG003|Second Intervention|Physician Decision|0|||
170462008|NCT00901576|616032028|FG004|Second Intervention|Physician Decision|0|||
170462009|NCT00901576|616032029|FG005|Second Intervention|Physician Decision|0|||
170462010|NCT01696279|616032030|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
170462011|NCT01696279|616032031|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
170462012|NCT01696279|616032032|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
170462013|NCT01696279|616032033|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
170462014|NCT01696279|616032030|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
170462015|NCT01696279|616032031|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
170462016|NCT01696279|616032032|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
170462017|NCT01696279|616032033|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
170462018|NCT01696279|616032030|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
170462019|NCT01696279|616032031|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
170462020|NCT01696279|616032032|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
170462021|NCT01696279|616032033|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
170462022|NCT01696279|616032030|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
170462023|NCT01696279|616032031|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
170462024|NCT01696279|616032032|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
170462025|NCT01696279|616032033|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
170462026|NCT01696279|616032030|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
170462027|NCT01696279|616032031|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
170462028|NCT01696279|616032032|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
170462029|NCT01696279|616032033|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
170462030|NCT01696279|616032030|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
170462031|NCT01696279|616032031|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
170462032|NCT01696279|616032032|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
170462033|NCT01696279|616032033|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
170789375|NCT05399459|617238087|FG000|Overall Study|Lost to Follow-up|1|||
170789376|NCT05399459|617238088|FG001|Overall Study|Lost to Follow-up|0|||
170789377|NCT05399459|617238089|FG002|Overall Study|Lost to Follow-up|0|||
170789378|NCT04992520|617238090|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
170789379|NCT04992520|617238091|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
170789380|NCT04992520|617238092|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
170789381|NCT04992520|617238093|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
170789382|NCT04992520|617238094|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
170789383|NCT04992520|617238095|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
170462034|NCT01696279|616032030|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
170462035|NCT01696279|616032031|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
170462036|NCT01696279|616032032|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
170462037|NCT01696279|616032033|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
170462038|NCT01696279|616032030|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
170462039|NCT01696279|616032031|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
170462040|NCT01696279|616032032|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
170462041|NCT01696279|616032033|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
170462042|NCT01696279|616032030|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
170462043|NCT01696279|616032031|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
170636497|NCT04939415|616680844|FG000|Overall Study|Lost to Follow-up|0|||
170462044|NCT01696279|616032032|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
170462045|NCT01696279|616032033|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
170462046|NCT01696279|616032030|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
170462047|NCT01696279|616032031|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
170462048|NCT01696279|616032032|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
170462049|NCT01696279|616032033|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
170462050|NCT01696279|616032030|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
170462051|NCT01696279|616032031|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
170462052|NCT01696279|616032032|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
170462053|NCT01696279|616032033|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
170462054|NCT01661062|616032034|FG000|Overall Study|Completed Treatment Off Study|3|||
170462055|NCT01661062|616032034|FG000|Overall Study|Withdrawal by Subject|2|||
170462056|NCT01346293|616032035|FG000|Overall Study|Protocol Violation|30|||
170462057|NCT01346293|616032036|FG001|Overall Study|Protocol Violation|9|||
170462058|NCT01346293|616032035|FG000|Overall Study|Lost to Follow-up|21|||
170462059|NCT01346293|616032036|FG001|Overall Study|Lost to Follow-up|8|||
170462060|NCT01346293|616032035|FG000|Overall Study|Withdrawal by Subject|15|||
170462061|NCT01346293|616032036|FG001|Overall Study|Withdrawal by Subject|4|||
170462062|NCT01346293|616032035|FG000|Overall Study|Other|1|||
170462063|NCT01346293|616032036|FG001|Overall Study|Other|0|||
170462064|NCT01616953|616032040|FG000|Overall Study|Lost to Follow-up|1|||
170462065|NCT01616953|616032041|FG001|Overall Study|Lost to Follow-up|0|||
170462066|NCT01616953|616032040|FG000|Overall Study|lack of bone and soft tissue|1|||
170462067|NCT01616953|616032041|FG001|Overall Study|lack of bone and soft tissue|0|||
170462068|NCT01568320|616032042|FG000|Overall Study|Death|20|||
170462069|NCT01568320|616032042|FG000|Overall Study|Lost to Follow-up|9|||
170462070|NCT01568320|616032042|FG000|Overall Study|Withdrawal by Subject|10|||
170462071|NCT01568320|616032042|FG000|Overall Study|Conversion to open repair|1|||
170462072|NCT01568320|616032042|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
170462073|NCT02196701|616032044|FG000|Overall Study|Adverse Event|1|||
170462074|NCT02196701|616032044|FG000|Overall Study|Lost to Follow-up|1|||
170462075|NCT02196701|616032044|FG000|Overall Study|Non-adherence to Protocol|1|||
170462076|NCT01140503|616032045|FG000|Overall Study|Withdrawal by Subject|1|||
170462077|NCT00587990|616032048|FG000|Overall Study|Death|0|||
170462078|NCT00587990|616032049|FG001|Overall Study|Death|0|||
170462079|NCT00587990|616032050|FG002|Overall Study|Death|1|||
170462080|NCT01157897|616032054|FG000|Overall Study|Lost to Follow-up|2|||
170462081|NCT01157897|616032055|FG001|Overall Study|Lost to Follow-up|0|||
170462082|NCT01157897|616032056|FG002|Overall Study|Lost to Follow-up|0|||
170462083|NCT01157897|616032057|FG003|Overall Study|Lost to Follow-up|1|||
170462084|NCT01157897|616032054|FG000|Overall Study|Relocated|0|||
170462085|NCT01157897|616032055|FG001|Overall Study|Relocated|2|||
170462086|NCT01157897|616032056|FG002|Overall Study|Relocated|0|||
170462087|NCT01157897|616032057|FG003|Overall Study|Relocated|0|||
170462088|NCT00426361|616032058|FG000|Overall Study|Lost to Follow-up|3|||
170462089|NCT00426361|616032059|FG001|Overall Study|Lost to Follow-up|2|||
170462090|NCT00426361|616032060|FG002|Overall Study|Lost to Follow-up|5|||
170462091|NCT00426361|616032058|FG000|Overall Study|Withdrawal by Subject|1|||
170462092|NCT00426361|616032059|FG001|Overall Study|Withdrawal by Subject|3|||
170462093|NCT00426361|616032060|FG002|Overall Study|Withdrawal by Subject|0|||
170462094|NCT03918109|616032064|FG000|Overall Study|Withdrawal by Subject|0|||
170462095|NCT03918109|616032065|FG001|Overall Study|Withdrawal by Subject|0|||
170462096|NCT03918109|616032066|FG002|Overall Study|Withdrawal by Subject|2|||
170462097|NCT03918109|616032067|FG003|Overall Study|Withdrawal by Subject|1|||
170462098|NCT03918109|616032064|FG000|Overall Study|Lost to Follow-up|0|||
170462099|NCT03918109|616032065|FG001|Overall Study|Lost to Follow-up|0|||
170544289|NCT01658878|616337263|FG002|Treatment Period|Disease Progression|2|||
170544290|NCT01658878|616337264|FG003|Treatment Period|Disease Progression|1|||
170544291|NCT01658878|616337265|FG004|Treatment Period|Disease Progression|13|||
170544292|NCT01658878|616337266|FG005|Treatment Period|Disease Progression|3|||
170889884|NCT00662792|617604104|FG002|Period 1|Personal Reasons|1|||
170889885|NCT00662792|617604105|FG003|Period 1|Personal Reasons|0|||
170462100|NCT03918109|616032066|FG002|Overall Study|Lost to Follow-up|0|||
170462101|NCT03918109|616032067|FG003|Overall Study|Lost to Follow-up|1|||
170462102|NCT02304458|616032070|FG000|Overall Study|Adverse Event|0|||
170462103|NCT02304458|616032071|FG001|Overall Study|Adverse Event|0|||
170462104|NCT02304458|616032072|FG002|Overall Study|Adverse Event|7|||
170462105|NCT02304458|616032073|FG003|Overall Study|Adverse Event|0|||
170462106|NCT02304458|616032074|FG004|Overall Study|Adverse Event|0|||
170462107|NCT02304458|616032075|FG005|Overall Study|Adverse Event|0|||
170462108|NCT02304458|616032076|FG006|Overall Study|Adverse Event|3|||
170462109|NCT02304458|616032077|FG007|Overall Study|Adverse Event|4|||
170462110|NCT02304458|616032070|FG000|Overall Study|Death|0|||
170462111|NCT02304458|616032071|FG001|Overall Study|Death|0|||
170462112|NCT02304458|616032072|FG002|Overall Study|Death|2|||
170462113|NCT02304458|616032073|FG003|Overall Study|Death|0|||
170544293|NCT01658878|616337267|FG006|Treatment Period|Disease Progression|4|||
170462114|NCT02304458|616032074|FG004|Overall Study|Death|0|||
170462115|NCT02304458|616032075|FG005|Overall Study|Death|0|||
170462116|NCT02304458|616032076|FG006|Overall Study|Death|1|||
170462117|NCT02304458|616032077|FG007|Overall Study|Death|0|||
170462118|NCT02304458|616032070|FG000|Overall Study|Lack of Efficacy|4|||
170462119|NCT02304458|616032071|FG001|Overall Study|Lack of Efficacy|6|||
170462120|NCT02304458|616032072|FG002|Overall Study|Lack of Efficacy|38|||
170462121|NCT02304458|616032073|FG003|Overall Study|Lack of Efficacy|5|||
170462122|NCT02304458|616032074|FG004|Overall Study|Lack of Efficacy|6|||
170462123|NCT02304458|616032075|FG005|Overall Study|Lack of Efficacy|6|||
170462124|NCT02304458|616032076|FG006|Overall Study|Lack of Efficacy|21|||
170462125|NCT02304458|616032077|FG007|Overall Study|Lack of Efficacy|4|||
170462126|NCT02304458|616032070|FG000|Overall Study|Physician Decision|2|||
170462127|NCT02304458|616032071|FG001|Overall Study|Physician Decision|0|||
170462128|NCT02304458|616032072|FG002|Overall Study|Physician Decision|16|||
170462129|NCT02304458|616032073|FG003|Overall Study|Physician Decision|1|||
170462130|NCT02304458|616032074|FG004|Overall Study|Physician Decision|0|||
170462131|NCT02304458|616032075|FG005|Overall Study|Physician Decision|0|||
170462132|NCT02304458|616032076|FG006|Overall Study|Physician Decision|3|||
170462133|NCT02304458|616032077|FG007|Overall Study|Physician Decision|0|||
170462134|NCT02304458|616032070|FG000|Overall Study|Protocol Violation|0|||
170462135|NCT02304458|616032071|FG001|Overall Study|Protocol Violation|0|||
170462136|NCT02304458|616032072|FG002|Overall Study|Protocol Violation|1|||
170462137|NCT02304458|616032073|FG003|Overall Study|Protocol Violation|0|||
170462138|NCT02304458|616032074|FG004|Overall Study|Protocol Violation|0|||
170462139|NCT02304458|616032075|FG005|Overall Study|Protocol Violation|0|||
170462140|NCT02304458|616032076|FG006|Overall Study|Protocol Violation|0|||
170462141|NCT02304458|616032077|FG007|Overall Study|Protocol Violation|0|||
170462142|NCT02304458|616032070|FG000|Overall Study|Withdrawal by Subject|1|||
170462143|NCT02304458|616032071|FG001|Overall Study|Withdrawal by Subject|0|||
170462144|NCT02304458|616032072|FG002|Overall Study|Withdrawal by Subject|7|||
170462145|NCT02304458|616032073|FG003|Overall Study|Withdrawal by Subject|0|||
170462146|NCT02304458|616032074|FG004|Overall Study|Withdrawal by Subject|0|||
170462147|NCT02304458|616032075|FG005|Overall Study|Withdrawal by Subject|0|||
170462148|NCT02304458|616032076|FG006|Overall Study|Withdrawal by Subject|1|||
170462149|NCT02304458|616032077|FG007|Overall Study|Withdrawal by Subject|0|||
170462150|NCT04874636|616032078|FG000|Overall Study|Adverse Event|17|||
170462151|NCT04874636|616032079|FG001|Overall Study|Adverse Event|7|||
170462152|NCT04874636|616032078|FG000|Overall Study|Lost to Follow-up|1|||
170462153|NCT04874636|616032079|FG001|Overall Study|Lost to Follow-up|0|||
170462154|NCT04874636|616032078|FG000|Overall Study|Non-Compliance with Study Drug|2|||
170462155|NCT04874636|616032079|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170462156|NCT04874636|616032078|FG000|Overall Study|Physician Decision|1|||
170462157|NCT04874636|616032079|FG001|Overall Study|Physician Decision|0|||
170462158|NCT04874636|616032078|FG000|Overall Study|Withdrawal by Subject|6|||
170462159|NCT04874636|616032079|FG001|Overall Study|Withdrawal by Subject|5|||
170462160|NCT01770392|616032080|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
170462161|NCT04188301|616032081|FG000|Month 3|Lost to Follow-up|0|||
170462162|NCT04188301|616032082|FG001|Month 3|Lost to Follow-up|0|||
170462163|NCT04188301|616032083|FG002|Month 3|Lost to Follow-up|1|||
170462164|NCT04188301|616032081|FG000|Month 12|Lost to Follow-up|0|||
170462165|NCT04188301|616032082|FG001|Month 12|Lost to Follow-up|0|||
170462166|NCT04188301|616032083|FG002|Month 12|Lost to Follow-up|2|||
170462167|NCT04188301|616032081|FG000|Month 12|Death|1|||
170462168|NCT04188301|616032082|FG001|Month 12|Death|1|||
170462169|NCT04188301|616032083|FG002|Month 12|Death|0|||
170462170|NCT04188301|616032081|FG000|Month 18|Lost to Follow-up|6|||
170462171|NCT04188301|616032082|FG001|Month 18|Lost to Follow-up|0|||
170462172|NCT04188301|616032083|FG002|Month 18|Lost to Follow-up|0|||
170462173|NCT00228423|616032084|FG000|Overall Study|Adverse Event|2|||
170462174|NCT00228423|616032085|FG001|Overall Study|Adverse Event|5|||
170462175|NCT00228423|616032084|FG000|Overall Study|Withdrawal by Subject|7|||
170462176|NCT00228423|616032085|FG001|Overall Study|Withdrawal by Subject|3|||
170462177|NCT00228423|616032084|FG000|Overall Study|Protocol Violation|1|||
170462178|NCT00228423|616032085|FG001|Overall Study|Protocol Violation|3|||
170462179|NCT00228423|616032084|FG000|Overall Study|Physician Decision|0|||
170462180|NCT00228423|616032085|FG001|Overall Study|Physician Decision|1|||
170462181|NCT02582866|616032096|FG000|Overall Study|Death|1|||
170462182|NCT02582866|616032096|FG000|Overall Study|Lack of Efficacy|2|||
170462183|NCT02582866|616032096|FG000|Overall Study|Lost to Follow-up|2|||
170462184|NCT02582866|616032096|FG000|Overall Study|Withdrawal by Subject|7|||
170462185|NCT02582866|616032096|FG000|Overall Study|Investigator decision|5|||
170462186|NCT02582866|616032096|FG000|Overall Study|Participant wants to get pregnant|1|||
170462187|NCT02582866|616032096|FG000|Overall Study|Pregnancy|2|||
170462188|NCT02582866|616032096|FG000|Overall Study|Sponsor decision|1|||
170462189|NCT02582866|616032096|FG000|Overall Study|Withdrawal due to personal reasons|1|||
170462190|NCT02011386|616032101|FG000|Overall Study|Non-compliance|2|||
170462191|NCT02011386|616032101|FG000|Overall Study|Lack of Efficacy|3|||
170462192|NCT02799095|616034560|FG000|Part A|Adverse Event|1|||
170462193|NCT02799095|616034561|FG001|Part A|Adverse Event|0|||
170462194|NCT02799095|616034562|FG002|Part A|Adverse Event|1|||
170462195|NCT02799095|616034563|FG003|Part A|Adverse Event|4|||
170462196|NCT02799095|616034564|FG004|Part A|Adverse Event|1|||
170462197|NCT02799095|616034565|FG005|Part A|Adverse Event|0|||
170462198|NCT02799095|616034566|FG006|Part A|Adverse Event|0|||
170889886|NCT00662792|617604102|FG000|Period 1|Refused continuing medication|0|||
170889887|NCT00662792|617604103|FG001|Period 1|Refused continuing medication|1|||
170889888|NCT00662792|617604104|FG002|Period 1|Refused continuing medication|1|||
170889889|NCT00662792|617604105|FG003|Period 1|Refused continuing medication|0|||
170889890|NCT00662792|617604102|FG000|Period 1|Lost to Follow-up|1|||
170889891|NCT00662792|617604103|FG001|Period 1|Lost to Follow-up|0|||
170889892|NCT00662792|617604104|FG002|Period 1|Lost to Follow-up|0|||
170889893|NCT00662792|617604105|FG003|Period 1|Lost to Follow-up|0|||
170889894|NCT00662792|617604102|FG000|Period 1|Other adverse event (AE)|0|||
170889895|NCT00662792|617604103|FG001|Period 1|Other adverse event (AE)|2|||
170889896|NCT00662792|617604104|FG002|Period 1|Other adverse event (AE)|0|||
170889897|NCT00662792|617604105|FG003|Period 1|Other adverse event (AE)|0|||
170889898|NCT00662792|617604102|FG000|Period 1|Worsening of disease under study (AE)|1|||
170889899|NCT00662792|617604103|FG001|Period 1|Worsening of disease under study (AE)|3|||
170889900|NCT00662792|617604104|FG002|Period 1|Worsening of disease under study (AE)|2|||
170889901|NCT00662792|617604105|FG003|Period 1|Worsening of disease under study (AE)|0|||
170889902|NCT00662792|617604102|FG000|Period 1|Not treated|0|||
170889903|NCT00662792|617604103|FG001|Period 1|Not treated|1|||
170889904|NCT00662792|617604104|FG002|Period 1|Not treated|0|||
170889905|NCT00662792|617604105|FG003|Period 1|Not treated|0|||
170889906|NCT00662792|617604102|FG000|Period 2|Worsening of disease under study|1|||
170889907|NCT00662792|617604103|FG001|Period 2|Worsening of disease under study|0|||
170889908|NCT00662792|617604104|FG002|Period 2|Worsening of disease under study|0|||
170889909|NCT00662792|617604105|FG003|Period 2|Worsening of disease under study|3|||
170889910|NCT00662792|617604102|FG000|Period 3|Refused continuing medication|1|||
170889911|NCT00662792|617604103|FG001|Period 3|Refused continuing medication|0|||
170889912|NCT00662792|617604104|FG002|Period 3|Refused continuing medication|1|||
170889913|NCT00662792|617604105|FG003|Period 3|Refused continuing medication|0|||
170889914|NCT00662792|617604102|FG000|Period 3|Other adverse event (AE)|0|||
170889915|NCT00662792|617604103|FG001|Period 3|Other adverse event (AE)|0|||
170889916|NCT00662792|617604104|FG002|Period 3|Other adverse event (AE)|1|||
170889917|NCT00662792|617604105|FG003|Period 3|Other adverse event (AE)|1|||
170889918|NCT00662792|617604102|FG000|Period 4|Refused continuing medication|0|||
170889919|NCT00662792|617604103|FG001|Period 4|Refused continuing medication|1|||
170889920|NCT00662792|617604104|FG002|Period 4|Refused continuing medication|0|||
170889921|NCT00662792|617604105|FG003|Period 4|Refused continuing medication|0|||
170889922|NCT00662792|617604102|FG000|Period 4|Other adverse event (AE)|1|||
170889923|NCT00662792|617604103|FG001|Period 4|Other adverse event (AE)|0|||
170889924|NCT00662792|617604104|FG002|Period 4|Other adverse event (AE)|0|||
170889925|NCT00662792|617604105|FG003|Period 4|Other adverse event (AE)|0|||
170889926|NCT00662792|617604102|FG000|Period 4|Worsening of disease under study (AE)|0|||
170889927|NCT00662792|617604103|FG001|Period 4|Worsening of disease under study (AE)|0|||
170889928|NCT00662792|617604104|FG002|Period 4|Worsening of disease under study (AE)|0|||
170889929|NCT00662792|617604105|FG003|Period 4|Worsening of disease under study (AE)|1|||
170889930|NCT04029519|617604106|FG000|Overall Study|Protocol Violation|1|||
170889931|NCT04029519|617604106|FG000|Overall Study|Withdrawal by Subject|3|||
170889932|NCT04029519|617604106|FG000|Overall Study|Lost to Follow-up|1|||
170889933|NCT01192347|617604112|FG000|Overall Study|Death|3|||
170889934|NCT01192347|617604112|FG000|Overall Study|Lost to Follow-up|3|||
170889935|NCT01192347|617604112|FG000|Overall Study|Withdrawal by Subject|1|||
170889936|NCT01192347|617604112|FG000|Overall Study|Adverse Event|1|||
170889937|NCT01192347|617604112|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
170889938|NCT01192347|617604112|FG000|Overall Study|Patient seen in different hospital|1|||
170889939|NCT01192347|617604112|FG000|Overall Study|Patient not visiting hospital regularly|1|||
170889940|NCT01192347|617604112|FG000|Overall Study|Patient did not show up for visits|1|||
170889941|NCT01703858|617604121|FG000|Overall Study|Withdrawal by Subject|0|||
170889942|NCT01703858|617604122|FG001|Overall Study|Withdrawal by Subject|1|||
170889943|NCT01703858|617604123|FG002|Overall Study|Withdrawal by Subject|0|||
170889944|NCT00927095|617604126|FG000|Overall Study|Adverse Event|3|||
170462199|NCT02799095|616034567|FG007|Part A|Adverse Event|0|||
170462200|NCT02799095|616034568|FG008|Part A|Adverse Event|0|||
170462201|NCT02799095|616034569|FG009|Part A|Adverse Event|0|||
170889945|NCT00927095|617604127|FG001|Overall Study|Adverse Event|1|||
170889946|NCT00927095|617604128|FG002|Overall Study|Adverse Event|0|||
170889947|NCT00927095|617604126|FG000|Overall Study|Withdrawal by Subject|2|||
170889948|NCT00927095|617604127|FG001|Overall Study|Withdrawal by Subject|1|||
170889949|NCT00927095|617604128|FG002|Overall Study|Withdrawal by Subject|1|||
170889950|NCT00927095|617604126|FG000|Overall Study|Physician Decision|1|||
170889951|NCT00927095|617604127|FG001|Overall Study|Physician Decision|2|||
170889952|NCT00927095|617604128|FG002|Overall Study|Physician Decision|1|||
170889953|NCT02556255|617604129|FG000|Overall Study|Lost to Follow-up|4|||
170889954|NCT00993031|617604132|FG000|Overall Study|Death|0|||
170889955|NCT00993031|617604133|FG001|Overall Study|Death|1|||
170889956|NCT00993031|617604132|FG000|Overall Study|Physician Decision|0|||
170462202|NCT02799095|616034570|FG010|Part A|Adverse Event|0|||
170462203|NCT02799095|616034571|FG011|Part A|Adverse Event|0|||
170462204|NCT02799095|616034572|FG012|Part A|Adverse Event|0|||
170462205|NCT02799095|616034573|FG013|Part A|Adverse Event|0|||
170462206|NCT02799095|616034574|FG014|Part A|Adverse Event|0|||
170462207|NCT02799095|616034575|FG015|Part A|Adverse Event|0|||
170462208|NCT02799095|616034576|FG016|Part A|Adverse Event|0|||
170462209|NCT02799095|616034560|FG000|Part A|Death|0|||
170462210|NCT02799095|616034561|FG001|Part A|Death|0|||
170462211|NCT02799095|616034562|FG002|Part A|Death|0|||
170462212|NCT02799095|616034563|FG003|Part A|Death|0|||
170462213|NCT02799095|616034564|FG004|Part A|Death|0|||
170462214|NCT02799095|616034565|FG005|Part A|Death|0|||
170462215|NCT02799095|616034566|FG006|Part A|Death|3|||
170462216|NCT02799095|616034567|FG007|Part A|Death|0|||
170462217|NCT02799095|616034568|FG008|Part A|Death|0|||
170462218|NCT02799095|616034569|FG009|Part A|Death|0|||
170462219|NCT02799095|616034570|FG010|Part A|Death|0|||
170462220|NCT02799095|616034571|FG011|Part A|Death|0|||
170462221|NCT02799095|616034572|FG012|Part A|Death|0|||
170462222|NCT02799095|616034573|FG013|Part A|Death|0|||
170462223|NCT02799095|616034574|FG014|Part A|Death|0|||
170462224|NCT02799095|616034575|FG015|Part A|Death|0|||
170462225|NCT02799095|616034576|FG016|Part A|Death|0|||
170462226|NCT02799095|616034560|FG000|Part A|Lost to Follow-up|0|||
170544294|NCT01658878|616337268|FG007|Treatment Period|Disease Progression|3|||
170544295|NCT01658878|616337269|FG008|Treatment Period|Disease Progression|5|||
170544296|NCT01658878|616337270|FG009|Treatment Period|Disease Progression|3|||
170544297|NCT01658878|616337271|FG010|Treatment Period|Disease Progression|3|||
170544298|NCT01658878|616337272|FG011|Treatment Period|Disease Progression|4|||
170636498|NCT04939415|616680845|FG001|Overall Study|Lost to Follow-up|2|||
170636499|NCT03155841|616680848|FG000|Overall Study|Protocol Violation|3|||
170636500|NCT03155841|616680849|FG001|Overall Study|Protocol Violation|4|||
170636501|NCT01526733|616680850|FG000|Phase 1|Protocol Violation|1|||
170636502|NCT01526733|616680851|FG001|Phase 1|Protocol Violation|0|||
170636503|NCT01526733|616680850|FG000|Phase 1|Withdrawal by Subject|1|||
170636504|NCT01526733|616680851|FG001|Phase 1|Withdrawal by Subject|1|||
170636505|NCT04411667|616680853|FG000|Overall Study|Physician Decision|1|||
170789384|NCT04992520|617238090|FG000|Part A: First Challenge|Non-compliance|0|||
170789385|NCT04992520|617238091|FG001|Part A: First Challenge|Non-compliance|0|||
170544299|NCT01658878|616337273|FG012|Treatment Period|Disease Progression|43|||
170544300|NCT01658878|616337274|FG013|Treatment Period|Disease Progression|48|||
170544301|NCT01658878|616337275|FG014|Treatment Period|Disease Progression|33|||
170544302|NCT01658878|616337276|FG015|Treatment Period|Disease Progression|46|||
170544303|NCT01658878|616337277|FG016|Treatment Period|Disease Progression|41|||
170544304|NCT01658878|616337278|FG017|Treatment Period|Disease Progression|42|||
170544305|NCT01658878|616337279|FG018|Treatment Period|Disease Progression|28|||
170544306|NCT01658878|616337280|FG019|Treatment Period|Disease Progression|37|||
170544307|NCT01658878|616337281|FG020|Treatment Period|Disease Progression|37|||
170544308|NCT01658878|616337282|FG021|Treatment Period|Disease Progression|39|||
170544309|NCT01658878|616337283|FG022|Treatment Period|Disease Progression|27|||
170544310|NCT01658878|616337284|FG023|Treatment Period|Disease Progression|19|||
170544311|NCT01658878|616337261|FG000|Treatment Period|Study Drug Toxicity|0|||
170544312|NCT01658878|616337262|FG001|Treatment Period|Study Drug Toxicity|0|||
170544313|NCT01658878|616337263|FG002|Treatment Period|Study Drug Toxicity|0|||
170544314|NCT01658878|616337264|FG003|Treatment Period|Study Drug Toxicity|1|||
170544315|NCT01658878|616337265|FG004|Treatment Period|Study Drug Toxicity|0|||
170544316|NCT01658878|616337266|FG005|Treatment Period|Study Drug Toxicity|0|||
170544317|NCT01658878|616337267|FG006|Treatment Period|Study Drug Toxicity|0|||
170789386|NCT04992520|617238092|FG002|Part A: First Challenge|Non-compliance|0|||
170789387|NCT04992520|617238093|FG003|Part A: First Challenge|Non-compliance|1|||
170789388|NCT04992520|617238094|FG004|Part A: First Challenge|Non-compliance|0|||
170462227|NCT02799095|616034561|FG001|Part A|Lost to Follow-up|1|||
170544318|NCT01658878|616337268|FG007|Treatment Period|Study Drug Toxicity|0|||
170544319|NCT01658878|616337269|FG008|Treatment Period|Study Drug Toxicity|0|||
170462228|NCT02799095|616034562|FG002|Part A|Lost to Follow-up|0|||
170462229|NCT02799095|616034563|FG003|Part A|Lost to Follow-up|0|||
170462230|NCT02799095|616034564|FG004|Part A|Lost to Follow-up|0|||
170462231|NCT02799095|616034565|FG005|Part A|Lost to Follow-up|0|||
170462232|NCT02799095|616034566|FG006|Part A|Lost to Follow-up|1|||
170462233|NCT02799095|616034567|FG007|Part A|Lost to Follow-up|0|||
170462234|NCT02799095|616034568|FG008|Part A|Lost to Follow-up|0|||
170462235|NCT02799095|616034569|FG009|Part A|Lost to Follow-up|0|||
170462236|NCT02799095|616034570|FG010|Part A|Lost to Follow-up|0|||
170462237|NCT02799095|616034571|FG011|Part A|Lost to Follow-up|0|||
170544320|NCT01658878|616337270|FG009|Treatment Period|Study Drug Toxicity|0|||
170544321|NCT01658878|616337271|FG010|Treatment Period|Study Drug Toxicity|0|||
170544322|NCT01658878|616337272|FG011|Treatment Period|Study Drug Toxicity|0|||
170544323|NCT01658878|616337273|FG012|Treatment Period|Study Drug Toxicity|7|||
170636506|NCT04411667|616680854|FG001|Overall Study|Physician Decision|0|||
170636507|NCT00949702|616680855|FG000|Overall Study|Death|40|||
170636508|NCT00949702|616680855|FG000|Overall Study|Disease progression|7|||
170789389|NCT04992520|617238095|FG005|Part A: First Challenge|Non-compliance|0|||
170544324|NCT01658878|616337274|FG013|Treatment Period|Study Drug Toxicity|1|||
170636509|NCT00949702|616680855|FG000|Overall Study|Withdrawal of consent|1|||
170636510|NCT02699749|616680859|FG000|Overall Study|Other|0|||
170636511|NCT02699749|616680860|FG001|Overall Study|Other|0|||
170636512|NCT02699749|616680861|FG002|Overall Study|Other|2|||
170636513|NCT02699749|616680862|FG003|Overall Study|Other|0|||
170636514|NCT02699749|616680863|FG004|Overall Study|Other|0|||
170636515|NCT02699749|616680864|FG005|Overall Study|Other|1|||
170636516|NCT02699749|616680865|FG006|Overall Study|Other|1|||
170636517|NCT02699749|616680866|FG007|Overall Study|Other|0|||
170636518|NCT02699749|616680867|FG008|Overall Study|Other|0|||
170636519|NCT02699749|616680868|FG009|Overall Study|Other|0|||
170636520|NCT02699749|616680869|FG010|Overall Study|Other|1|||
170636521|NCT02699749|616680870|FG011|Overall Study|Other|0|||
170636522|NCT02699749|616680871|FG012|Overall Study|Other|0|||
170636523|NCT02699749|616680872|FG013|Overall Study|Other|0|||
170636524|NCT02699749|616680859|FG000|Overall Study|Progressive Disease|3|||
170636525|NCT02699749|616680860|FG001|Overall Study|Progressive Disease|3|||
170636526|NCT02699749|616680861|FG002|Overall Study|Progressive Disease|14|||
170636527|NCT02699749|616680862|FG003|Overall Study|Progressive Disease|3|||
170636528|NCT02699749|616680863|FG004|Overall Study|Progressive Disease|3|||
170636529|NCT02699749|616680864|FG005|Overall Study|Progressive Disease|7|||
170636530|NCT02699749|616680865|FG006|Overall Study|Progressive Disease|5|||
170636531|NCT02699749|616680866|FG007|Overall Study|Progressive Disease|5|||
170636532|NCT02699749|616680867|FG008|Overall Study|Progressive Disease|6|||
170636533|NCT02699749|616680868|FG009|Overall Study|Progressive Disease|6|||
170636534|NCT02699749|616680869|FG010|Overall Study|Progressive Disease|5|||
170636535|NCT02699749|616680870|FG011|Overall Study|Progressive Disease|4|||
170636536|NCT02699749|616680871|FG012|Overall Study|Progressive Disease|3|||
170636537|NCT02699749|616680872|FG013|Overall Study|Progressive Disease|5|||
170636538|NCT02699749|616680859|FG000|Overall Study|Death|0|||
170636539|NCT02699749|616680860|FG001|Overall Study|Death|0|||
170636540|NCT02699749|616680861|FG002|Overall Study|Death|0|||
170636541|NCT02699749|616680862|FG003|Overall Study|Death|0|||
170636542|NCT02699749|616680863|FG004|Overall Study|Death|0|||
170636543|NCT02699749|616680864|FG005|Overall Study|Death|0|||
170636544|NCT02699749|616680865|FG006|Overall Study|Death|0|||
170636545|NCT02699749|616680866|FG007|Overall Study|Death|0|||
170636546|NCT02699749|616680867|FG008|Overall Study|Death|0|||
170636547|NCT02699749|616680868|FG009|Overall Study|Death|0|||
170636548|NCT02699749|616680869|FG010|Overall Study|Death|0|||
170889957|NCT00993031|617604133|FG001|Overall Study|Physician Decision|2|||
170544325|NCT01658878|616337275|FG014|Treatment Period|Study Drug Toxicity|5|||
170544326|NCT01658878|616337276|FG015|Treatment Period|Study Drug Toxicity|0|||
170544327|NCT01658878|616337277|FG016|Treatment Period|Study Drug Toxicity|5|||
170544328|NCT01658878|616337278|FG017|Treatment Period|Study Drug Toxicity|10|||
170544329|NCT01658878|616337279|FG018|Treatment Period|Study Drug Toxicity|12|||
170544330|NCT01658878|616337280|FG019|Treatment Period|Study Drug Toxicity|4|||
170544331|NCT01658878|616337281|FG020|Treatment Period|Study Drug Toxicity|2|||
170544332|NCT01658878|616337282|FG021|Treatment Period|Study Drug Toxicity|3|||
170544333|NCT01658878|616337283|FG022|Treatment Period|Study Drug Toxicity|2|||
170544334|NCT01658878|616337284|FG023|Treatment Period|Study Drug Toxicity|6|||
170544335|NCT01658878|616337261|FG000|Treatment Period|Maximum Clinical Benefit|0|||
170544336|NCT01658878|616337262|FG001|Treatment Period|Maximum Clinical Benefit|0|||
170544337|NCT01658878|616337263|FG002|Treatment Period|Maximum Clinical Benefit|1|||
170544338|NCT01658878|616337264|FG003|Treatment Period|Maximum Clinical Benefit|0|||
170544339|NCT01658878|616337265|FG004|Treatment Period|Maximum Clinical Benefit|0|||
170636549|NCT02699749|616680870|FG011|Overall Study|Death|0|||
170636550|NCT02699749|616680871|FG012|Overall Study|Death|0|||
170889958|NCT00993031|617604132|FG000|Overall Study|Withdrawal by Subject|3|||
170889959|NCT00993031|617604133|FG001|Overall Study|Withdrawal by Subject|3|||
170544340|NCT01658878|616337266|FG005|Treatment Period|Maximum Clinical Benefit|0|||
170636551|NCT02699749|616680872|FG013|Overall Study|Death|1|||
170636552|NCT02699749|616680859|FG000|Overall Study|Lost to Follow-up|0|||
170636553|NCT02699749|616680860|FG001|Overall Study|Lost to Follow-up|0|||
170544341|NCT01658878|616337267|FG006|Treatment Period|Maximum Clinical Benefit|0|||
170636554|NCT02699749|616680861|FG002|Overall Study|Lost to Follow-up|0|||
170636555|NCT02699749|616680862|FG003|Overall Study|Lost to Follow-up|0|||
170636556|NCT02699749|616680863|FG004|Overall Study|Lost to Follow-up|0|||
170636557|NCT02699749|616680864|FG005|Overall Study|Lost to Follow-up|1|||
170636558|NCT02699749|616680865|FG006|Overall Study|Lost to Follow-up|0|||
170636559|NCT02699749|616680866|FG007|Overall Study|Lost to Follow-up|1|||
170544342|NCT01658878|616337268|FG007|Treatment Period|Maximum Clinical Benefit|0|||
170544343|NCT01658878|616337269|FG008|Treatment Period|Maximum Clinical Benefit|0|||
170544344|NCT01658878|616337270|FG009|Treatment Period|Maximum Clinical Benefit|0|||
170636560|NCT02699749|616680867|FG008|Overall Study|Lost to Follow-up|0|||
170636561|NCT02699749|616680868|FG009|Overall Study|Lost to Follow-up|0|||
170636562|NCT02699749|616680869|FG010|Overall Study|Lost to Follow-up|0|||
170636563|NCT02699749|616680870|FG011|Overall Study|Lost to Follow-up|0|||
170636564|NCT02699749|616680871|FG012|Overall Study|Lost to Follow-up|0|||
170636565|NCT02699749|616680872|FG013|Overall Study|Lost to Follow-up|0|||
170889960|NCT00993031|617604132|FG000|Overall Study|Lost to Follow-up|19|||
170462238|NCT02799095|616034572|FG012|Part A|Lost to Follow-up|0|||
170462239|NCT02799095|616034573|FG013|Part A|Lost to Follow-up|0|||
170462240|NCT02799095|616034574|FG014|Part A|Lost to Follow-up|0|||
170462241|NCT02799095|616034575|FG015|Part A|Lost to Follow-up|0|||
170462242|NCT02799095|616034576|FG016|Part A|Lost to Follow-up|0|||
170462243|NCT02799095|616034560|FG000|Part A|Progressive Disease|3|||
170462244|NCT02799095|616034561|FG001|Part A|Progressive Disease|3|||
170462245|NCT02799095|616034562|FG002|Part A|Progressive Disease|3|||
170462246|NCT02799095|616034563|FG003|Part A|Progressive Disease|2|||
170462247|NCT02799095|616034564|FG004|Part A|Progressive Disease|2|||
170462248|NCT02799095|616034565|FG005|Part A|Progressive Disease|0|||
170462249|NCT02799095|616034566|FG006|Part A|Progressive Disease|0|||
170462250|NCT02799095|616034567|FG007|Part A|Progressive Disease|0|||
170462251|NCT02799095|616034568|FG008|Part A|Progressive Disease|0|||
170462252|NCT02799095|616034569|FG009|Part A|Progressive Disease|0|||
170462253|NCT02799095|616034570|FG010|Part A|Progressive Disease|0|||
170462254|NCT02799095|616034571|FG011|Part A|Progressive Disease|0|||
170462255|NCT02799095|616034572|FG012|Part A|Progressive Disease|0|||
170462256|NCT02799095|616034573|FG013|Part A|Progressive Disease|0|||
170462257|NCT02799095|616034574|FG014|Part A|Progressive Disease|0|||
170462258|NCT02799095|616034575|FG015|Part A|Progressive Disease|0|||
170462259|NCT02799095|616034576|FG016|Part A|Progressive Disease|0|||
170789390|NCT04992520|617238090|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
170789391|NCT04992520|617238091|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
170789392|NCT04992520|617238092|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
170789393|NCT04992520|617238093|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
170789394|NCT04992520|617238094|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
170789395|NCT04992520|617238095|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
170789396|NCT04992520|617238090|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
170789397|NCT04992520|617238091|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
170462260|NCT02799095|616034560|FG000|Part A|Clinical Progression|1|||
170462261|NCT02799095|616034561|FG001|Part A|Clinical Progression|0|||
170462262|NCT02799095|616034562|FG002|Part A|Clinical Progression|2|||
170462263|NCT02799095|616034563|FG003|Part A|Clinical Progression|1|||
170462264|NCT02799095|616034564|FG004|Part A|Clinical Progression|5|||
170462265|NCT02799095|616034565|FG005|Part A|Clinical Progression|0|||
170462266|NCT02799095|616034566|FG006|Part A|Clinical Progression|0|||
170462267|NCT02799095|616034567|FG007|Part A|Clinical Progression|0|||
170462268|NCT02799095|616034568|FG008|Part A|Clinical Progression|0|||
170462269|NCT02799095|616034569|FG009|Part A|Clinical Progression|0|||
170462270|NCT02799095|616034570|FG010|Part A|Clinical Progression|0|||
170462271|NCT02799095|616034571|FG011|Part A|Clinical Progression|0|||
170462272|NCT02799095|616034572|FG012|Part A|Clinical Progression|0|||
170462273|NCT02799095|616034573|FG013|Part A|Clinical Progression|0|||
170462274|NCT02799095|616034574|FG014|Part A|Clinical Progression|0|||
170462275|NCT02799095|616034575|FG015|Part A|Clinical Progression|0|||
170462276|NCT02799095|616034576|FG016|Part A|Clinical Progression|0|||
170462277|NCT02799095|616034560|FG000|Part A|Protocol Deviation|0|||
170462278|NCT02799095|616034561|FG001|Part A|Protocol Deviation|0|||
170462279|NCT02799095|616034562|FG002|Part A|Protocol Deviation|1|||
170462280|NCT02799095|616034563|FG003|Part A|Protocol Deviation|0|||
170462281|NCT02799095|616034564|FG004|Part A|Protocol Deviation|0|||
170462282|NCT02799095|616034565|FG005|Part A|Protocol Deviation|0|||
170462283|NCT02799095|616034566|FG006|Part A|Protocol Deviation|0|||
170462284|NCT02799095|616034567|FG007|Part A|Protocol Deviation|0|||
170462285|NCT02799095|616034568|FG008|Part A|Protocol Deviation|0|||
170462286|NCT02799095|616034569|FG009|Part A|Protocol Deviation|0|||
170462287|NCT02799095|616034570|FG010|Part A|Protocol Deviation|0|||
170462288|NCT02799095|616034571|FG011|Part A|Protocol Deviation|0|||
170462289|NCT02799095|616034572|FG012|Part A|Protocol Deviation|0|||
170462290|NCT02799095|616034573|FG013|Part A|Protocol Deviation|0|||
170462291|NCT02799095|616034574|FG014|Part A|Protocol Deviation|0|||
170462292|NCT02799095|616034575|FG015|Part A|Protocol Deviation|0|||
170462293|NCT02799095|616034576|FG016|Part A|Protocol Deviation|0|||
170462294|NCT02799095|616034560|FG000|Part A|Withdrawal by Subject|0|||
170462295|NCT02799095|616034561|FG001|Part A|Withdrawal by Subject|0|||
170462296|NCT02799095|616034562|FG002|Part A|Withdrawal by Subject|0|||
170462297|NCT02799095|616034563|FG003|Part A|Withdrawal by Subject|1|||
170462298|NCT02799095|616034564|FG004|Part A|Withdrawal by Subject|3|||
170462299|NCT02799095|616034565|FG005|Part A|Withdrawal by Subject|1|||
170462300|NCT02799095|616034566|FG006|Part A|Withdrawal by Subject|1|||
170462301|NCT02799095|616034567|FG007|Part A|Withdrawal by Subject|0|||
170462302|NCT02799095|616034568|FG008|Part A|Withdrawal by Subject|0|||
170789398|NCT04992520|617238092|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
170462303|NCT02799095|616034569|FG009|Part A|Withdrawal by Subject|0|||
170462304|NCT02799095|616034570|FG010|Part A|Withdrawal by Subject|0|||
170462305|NCT02799095|616034571|FG011|Part A|Withdrawal by Subject|0|||
170462306|NCT02799095|616034572|FG012|Part A|Withdrawal by Subject|0|||
170462307|NCT02799095|616034573|FG013|Part A|Withdrawal by Subject|0|||
170462308|NCT02799095|616034574|FG014|Part A|Withdrawal by Subject|0|||
170462309|NCT02799095|616034575|FG015|Part A|Withdrawal by Subject|0|||
170462310|NCT02799095|616034576|FG016|Part A|Withdrawal by Subject|0|||
170462311|NCT02799095|616034560|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
170462312|NCT02799095|616034561|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
170462313|NCT02799095|616034562|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
170462314|NCT02799095|616034563|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
170462315|NCT02799095|616034564|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
170462316|NCT02799095|616034565|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
170462317|NCT02799095|616034566|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
170462318|NCT02799095|616034567|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
170462319|NCT02799095|616034568|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
170462320|NCT02799095|616034569|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
170462321|NCT02799095|616034570|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
170462322|NCT02799095|616034571|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
170462323|NCT02799095|616034572|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
170462324|NCT02799095|616034573|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
170462325|NCT02799095|616034574|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
170462326|NCT02799095|616034575|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
170462327|NCT02799095|616034576|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
170462328|NCT02799095|616034560|FG000|Part B|Death|0|||
170462329|NCT02799095|616034561|FG001|Part B|Death|0|||
170462330|NCT02799095|616034562|FG002|Part B|Death|0|||
170462331|NCT02799095|616034563|FG003|Part B|Death|0|||
170462332|NCT02799095|616034564|FG004|Part B|Death|0|||
170462333|NCT02799095|616034565|FG005|Part B|Death|0|||
170462334|NCT02799095|616034566|FG006|Part B|Death|0|||
170462335|NCT02799095|616034567|FG007|Part B|Death|7|||
170462336|NCT02799095|616034568|FG008|Part B|Death|7|||
170462337|NCT02799095|616034569|FG009|Part B|Death|0|||
170462338|NCT02799095|616034570|FG010|Part B|Death|0|||
170462339|NCT02799095|616034571|FG011|Part B|Death|0|||
170462340|NCT02799095|616034572|FG012|Part B|Death|0|||
170544345|NCT01658878|616337271|FG010|Treatment Period|Maximum Clinical Benefit|0|||
170544346|NCT01658878|616337272|FG011|Treatment Period|Maximum Clinical Benefit|0|||
170544347|NCT01658878|616337273|FG012|Treatment Period|Maximum Clinical Benefit|0|||
170544348|NCT01658878|616337274|FG013|Treatment Period|Maximum Clinical Benefit|0|||
170544349|NCT01658878|616337275|FG014|Treatment Period|Maximum Clinical Benefit|0|||
170544350|NCT01658878|616337276|FG015|Treatment Period|Maximum Clinical Benefit|0|||
170544351|NCT01658878|616337277|FG016|Treatment Period|Maximum Clinical Benefit|0|||
170544352|NCT01658878|616337278|FG017|Treatment Period|Maximum Clinical Benefit|0|||
170544353|NCT01658878|616337279|FG018|Treatment Period|Maximum Clinical Benefit|1|||
170544354|NCT01658878|616337280|FG019|Treatment Period|Maximum Clinical Benefit|1|||
170544355|NCT01658878|616337281|FG020|Treatment Period|Maximum Clinical Benefit|0|||
170544356|NCT01658878|616337282|FG021|Treatment Period|Maximum Clinical Benefit|0|||
170544357|NCT01658878|616337283|FG022|Treatment Period|Maximum Clinical Benefit|0|||
170544358|NCT01658878|616337284|FG023|Treatment Period|Maximum Clinical Benefit|0|||
170544359|NCT01658878|616337261|FG000|Treatment Period|Other Reasons|0|||
170544360|NCT01658878|616337262|FG001|Treatment Period|Other Reasons|0|||
170544361|NCT01658878|616337263|FG002|Treatment Period|Other Reasons|0|||
170544362|NCT01658878|616337264|FG003|Treatment Period|Other Reasons|1|||
170544363|NCT01658878|616337265|FG004|Treatment Period|Other Reasons|0|||
170544364|NCT01658878|616337266|FG005|Treatment Period|Other Reasons|0|||
170544365|NCT01658878|616337267|FG006|Treatment Period|Other Reasons|0|||
170544366|NCT01658878|616337268|FG007|Treatment Period|Other Reasons|0|||
170544367|NCT01658878|616337269|FG008|Treatment Period|Other Reasons|0|||
170544368|NCT01658878|616337270|FG009|Treatment Period|Other Reasons|0|||
170544369|NCT01658878|616337271|FG010|Treatment Period|Other Reasons|0|||
170544370|NCT01658878|616337272|FG011|Treatment Period|Other Reasons|0|||
170544371|NCT01658878|616337273|FG012|Treatment Period|Other Reasons|2|||
170636566|NCT01147874|616680874|FG000|Overall Study|Adverse Event|5|||
170789399|NCT04992520|617238093|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
170462341|NCT02799095|616034573|FG013|Part B|Death|0|||
170462342|NCT02799095|616034574|FG014|Part B|Death|0|||
170462343|NCT02799095|616034575|FG015|Part B|Death|0|||
170462344|NCT02799095|616034576|FG016|Part B|Death|0|||
170462345|NCT02799095|616034560|FG000|Part B|Progressive Disease|0|||
170462346|NCT02799095|616034561|FG001|Part B|Progressive Disease|0|||
170462347|NCT02799095|616034562|FG002|Part B|Progressive Disease|0|||
170462348|NCT02799095|616034563|FG003|Part B|Progressive Disease|0|||
170462349|NCT02799095|616034564|FG004|Part B|Progressive Disease|0|||
170462350|NCT02799095|616034565|FG005|Part B|Progressive Disease|0|||
170462351|NCT02799095|616034566|FG006|Part B|Progressive Disease|0|||
170462352|NCT02799095|616034567|FG007|Part B|Progressive Disease|1|||
170462353|NCT02799095|616034568|FG008|Part B|Progressive Disease|0|||
170544372|NCT01658878|616337274|FG013|Treatment Period|Other Reasons|0|||
170544373|NCT01658878|616337275|FG014|Treatment Period|Other Reasons|0|||
170544374|NCT01658878|616337276|FG015|Treatment Period|Other Reasons|2|||
170544375|NCT01658878|616337277|FG016|Treatment Period|Other Reasons|1|||
170544376|NCT01658878|616337278|FG017|Treatment Period|Other Reasons|1|||
170544377|NCT01658878|616337279|FG018|Treatment Period|Other Reasons|3|||
170544378|NCT01658878|616337280|FG019|Treatment Period|Other Reasons|1|||
170889961|NCT00993031|617604133|FG001|Overall Study|Lost to Follow-up|13|||
170462354|NCT02799095|616034569|FG009|Part B|Progressive Disease|0|||
170462355|NCT02799095|616034570|FG010|Part B|Progressive Disease|0|||
170462356|NCT02799095|616034571|FG011|Part B|Progressive Disease|0|||
170462357|NCT02799095|616034572|FG012|Part B|Progressive Disease|0|||
170462358|NCT02799095|616034573|FG013|Part B|Progressive Disease|0|||
170462359|NCT02799095|616034574|FG014|Part B|Progressive Disease|0|||
170462360|NCT02799095|616034575|FG015|Part B|Progressive Disease|0|||
170462361|NCT02799095|616034576|FG016|Part B|Progressive Disease|0|||
170462362|NCT02799095|616034560|FG000|Part B|Withdrawal by Subject|0|||
170462363|NCT02799095|616034561|FG001|Part B|Withdrawal by Subject|0|||
170462364|NCT02799095|616034562|FG002|Part B|Withdrawal by Subject|0|||
170462365|NCT02799095|616034563|FG003|Part B|Withdrawal by Subject|0|||
170462366|NCT02799095|616034564|FG004|Part B|Withdrawal by Subject|0|||
170462367|NCT02799095|616034565|FG005|Part B|Withdrawal by Subject|0|||
170462368|NCT02799095|616034566|FG006|Part B|Withdrawal by Subject|0|||
170462369|NCT02799095|616034567|FG007|Part B|Withdrawal by Subject|10|||
170462370|NCT02799095|616034568|FG008|Part B|Withdrawal by Subject|7|||
170462371|NCT02799095|616034569|FG009|Part B|Withdrawal by Subject|0|||
170462372|NCT02799095|616034570|FG010|Part B|Withdrawal by Subject|0|||
170462373|NCT02799095|616034571|FG011|Part B|Withdrawal by Subject|0|||
170462374|NCT02799095|616034572|FG012|Part B|Withdrawal by Subject|0|||
170462375|NCT02799095|616034573|FG013|Part B|Withdrawal by Subject|0|||
170462376|NCT02799095|616034574|FG014|Part B|Withdrawal by Subject|0|||
170462377|NCT02799095|616034575|FG015|Part B|Withdrawal by Subject|0|||
170462378|NCT02799095|616034576|FG016|Part B|Withdrawal by Subject|0|||
170462379|NCT02799095|616034560|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
170462380|NCT02799095|616034561|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
170462381|NCT02799095|616034562|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
170462382|NCT02799095|616034563|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
170462383|NCT02799095|616034564|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
170462384|NCT02799095|616034565|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
170462385|NCT02799095|616034566|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
170462386|NCT02799095|616034567|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
170462387|NCT02799095|616034568|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
170462388|NCT02799095|616034569|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
170462389|NCT02799095|616034570|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
170462390|NCT02799095|616034571|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
170462391|NCT02799095|616034572|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
170462392|NCT02799095|616034573|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
170462393|NCT02799095|616034574|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
170462394|NCT02799095|616034575|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
170462395|NCT02799095|616034576|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
170462396|NCT02799095|616034560|FG000|Part C|Adverse Event|0|||
170462397|NCT02799095|616034561|FG001|Part C|Adverse Event|0|||
170462398|NCT02799095|616034562|FG002|Part C|Adverse Event|0|||
170462399|NCT02799095|616034563|FG003|Part C|Adverse Event|0|||
170462400|NCT02799095|616034564|FG004|Part C|Adverse Event|0|||
170462401|NCT02799095|616034565|FG005|Part C|Adverse Event|0|||
170462402|NCT02799095|616034566|FG006|Part C|Adverse Event|0|||
170462403|NCT02799095|616034567|FG007|Part C|Adverse Event|0|||
170462404|NCT02799095|616034568|FG008|Part C|Adverse Event|0|||
170462405|NCT02799095|616034569|FG009|Part C|Adverse Event|0|||
170462406|NCT02799095|616034570|FG010|Part C|Adverse Event|3|||
170462407|NCT02799095|616034571|FG011|Part C|Adverse Event|1|||
170889962|NCT01834729|617604139|FG000|Overall Study|Did not return bowel diaries|0|||
170889963|NCT01834729|617604140|FG001|Overall Study|Did not return bowel diaries|0|||
170889964|NCT01834729|617604141|FG002|Overall Study|Did not return bowel diaries|3|||
170889965|NCT01834729|617604142|FG003|Overall Study|Did not return bowel diaries|0|||
170889966|NCT01834729|617604139|FG000|Overall Study|Withdrawal by Subject|1|||
170889967|NCT01834729|617604140|FG001|Overall Study|Withdrawal by Subject|1|||
170889968|NCT01834729|617604141|FG002|Overall Study|Withdrawal by Subject|0|||
170889969|NCT01834729|617604142|FG003|Overall Study|Withdrawal by Subject|0|||
170889970|NCT01834729|617604139|FG000|Overall Study|Adverse Event|0|||
170462408|NCT02799095|616034572|FG012|Part C|Adverse Event|0|||
170462409|NCT02799095|616034573|FG013|Part C|Adverse Event|1|||
170462410|NCT02799095|616034574|FG014|Part C|Adverse Event|0|||
170462411|NCT02799095|616034575|FG015|Part C|Adverse Event|0|||
170462412|NCT02799095|616034576|FG016|Part C|Adverse Event|0|||
170462413|NCT02799095|616034560|FG000|Part C|Death|0|||
170462414|NCT02799095|616034561|FG001|Part C|Death|0|||
170462415|NCT02799095|616034562|FG002|Part C|Death|0|||
170462416|NCT02799095|616034563|FG003|Part C|Death|0|||
170462417|NCT02799095|616034564|FG004|Part C|Death|0|||
170462418|NCT02799095|616034565|FG005|Part C|Death|0|||
170462419|NCT02799095|616034566|FG006|Part C|Death|0|||
170462420|NCT02799095|616034567|FG007|Part C|Death|0|||
170462421|NCT02799095|616034568|FG008|Part C|Death|0|||
170462422|NCT02799095|616034569|FG009|Part C|Death|0|||
170462423|NCT02799095|616034570|FG010|Part C|Death|7|||
170462424|NCT02799095|616034571|FG011|Part C|Death|5|||
170462425|NCT02799095|616034572|FG012|Part C|Death|6|||
170789400|NCT04992520|617238094|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
170789401|NCT04992520|617238095|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
170462426|NCT02799095|616034573|FG013|Part C|Death|8|||
170462427|NCT02799095|616034574|FG014|Part C|Death|1|||
170462428|NCT02799095|616034575|FG015|Part C|Death|8|||
170462429|NCT02799095|616034576|FG016|Part C|Death|1|||
170462430|NCT02799095|616034560|FG000|Part C|Lost to Follow-up|0|||
170462431|NCT02799095|616034561|FG001|Part C|Lost to Follow-up|0|||
170462432|NCT02799095|616034562|FG002|Part C|Lost to Follow-up|0|||
170462433|NCT02799095|616034563|FG003|Part C|Lost to Follow-up|0|||
170462434|NCT02799095|616034564|FG004|Part C|Lost to Follow-up|0|||
170462435|NCT02799095|616034565|FG005|Part C|Lost to Follow-up|0|||
170462436|NCT02799095|616034566|FG006|Part C|Lost to Follow-up|0|||
170462437|NCT02799095|616034567|FG007|Part C|Lost to Follow-up|0|||
170462438|NCT02799095|616034568|FG008|Part C|Lost to Follow-up|0|||
170462439|NCT02799095|616034569|FG009|Part C|Lost to Follow-up|0|||
170462440|NCT02799095|616034570|FG010|Part C|Lost to Follow-up|1|||
170462441|NCT02799095|616034571|FG011|Part C|Lost to Follow-up|1|||
170462442|NCT02799095|616034572|FG012|Part C|Lost to Follow-up|1|||
170462443|NCT02799095|616034573|FG013|Part C|Lost to Follow-up|3|||
170462444|NCT02799095|616034574|FG014|Part C|Lost to Follow-up|0|||
170462445|NCT02799095|616034575|FG015|Part C|Lost to Follow-up|0|||
170462446|NCT02799095|616034576|FG016|Part C|Lost to Follow-up|0|||
170462447|NCT02799095|616034560|FG000|Part C|Progressive Disease|0|||
170462448|NCT02799095|616034561|FG001|Part C|Progressive Disease|0|||
170462449|NCT02799095|616034562|FG002|Part C|Progressive Disease|0|||
170462450|NCT02799095|616034563|FG003|Part C|Progressive Disease|0|||
170462451|NCT02799095|616034564|FG004|Part C|Progressive Disease|0|||
170462452|NCT02799095|616034565|FG005|Part C|Progressive Disease|0|||
170462453|NCT02799095|616034566|FG006|Part C|Progressive Disease|0|||
170462454|NCT02799095|616034567|FG007|Part C|Progressive Disease|0|||
170462455|NCT02799095|616034568|FG008|Part C|Progressive Disease|0|||
170462456|NCT02799095|616034569|FG009|Part C|Progressive Disease|2|||
170462457|NCT02799095|616034570|FG010|Part C|Progressive Disease|13|||
170462458|NCT02799095|616034571|FG011|Part C|Progressive Disease|2|||
170462459|NCT02799095|616034572|FG012|Part C|Progressive Disease|0|||
170462460|NCT02799095|616034573|FG013|Part C|Progressive Disease|1|||
170462461|NCT02799095|616034574|FG014|Part C|Progressive Disease|0|||
170462462|NCT02799095|616034575|FG015|Part C|Progressive Disease|0|||
170462463|NCT02799095|616034576|FG016|Part C|Progressive Disease|0|||
170462464|NCT02799095|616034560|FG000|Part C|Clinical Progression|0|||
170462465|NCT02799095|616034561|FG001|Part C|Clinical Progression|0|||
170462466|NCT02799095|616034562|FG002|Part C|Clinical Progression|0|||
170462467|NCT02799095|616034563|FG003|Part C|Clinical Progression|0|||
170462468|NCT02799095|616034564|FG004|Part C|Clinical Progression|0|||
170462469|NCT02799095|616034565|FG005|Part C|Clinical Progression|0|||
170462470|NCT02799095|616034566|FG006|Part C|Clinical Progression|0|||
170462471|NCT02799095|616034567|FG007|Part C|Clinical Progression|0|||
170462472|NCT02799095|616034568|FG008|Part C|Clinical Progression|0|||
170462473|NCT02799095|616034569|FG009|Part C|Clinical Progression|1|||
170462474|NCT02799095|616034570|FG010|Part C|Clinical Progression|3|||
170462475|NCT02799095|616034571|FG011|Part C|Clinical Progression|0|||
170462476|NCT02799095|616034572|FG012|Part C|Clinical Progression|0|||
170462477|NCT02799095|616034573|FG013|Part C|Clinical Progression|1|||
170462478|NCT02799095|616034574|FG014|Part C|Clinical Progression|0|||
170462479|NCT02799095|616034575|FG015|Part C|Clinical Progression|0|||
170462480|NCT02799095|616034576|FG016|Part C|Clinical Progression|0|||
170462481|NCT02799095|616034560|FG000|Part C|Withdrawal by Subject|0|||
170462482|NCT02799095|616034561|FG001|Part C|Withdrawal by Subject|0|||
170789402|NCT02231164|617238099|FG000|Overall Study|Adverse Event|1|||
170789403|NCT02231164|617238100|FG001|Overall Study|Adverse Event|1|||
170789404|NCT02231164|617238099|FG000|Overall Study|Lack of Efficacy|4|||
170789405|NCT02231164|617238100|FG001|Overall Study|Lack of Efficacy|3|||
170462483|NCT02799095|616034562|FG002|Part C|Withdrawal by Subject|0|||
170462484|NCT02799095|616034563|FG003|Part C|Withdrawal by Subject|0|||
170462485|NCT02799095|616034564|FG004|Part C|Withdrawal by Subject|0|||
170462486|NCT02799095|616034565|FG005|Part C|Withdrawal by Subject|0|||
170462487|NCT02799095|616034566|FG006|Part C|Withdrawal by Subject|0|||
170462488|NCT02799095|616034567|FG007|Part C|Withdrawal by Subject|0|||
170462489|NCT02799095|616034568|FG008|Part C|Withdrawal by Subject|0|||
170462490|NCT02799095|616034569|FG009|Part C|Withdrawal by Subject|0|||
170462491|NCT02799095|616034570|FG010|Part C|Withdrawal by Subject|13|||
170462492|NCT02799095|616034571|FG011|Part C|Withdrawal by Subject|15|||
170789406|NCT02231164|617238099|FG000|Overall Study|Withdrawal by Subject|1|||
170789407|NCT02231164|617238100|FG001|Overall Study|Withdrawal by Subject|2|||
170789408|NCT05201079|617238110|FG000|Overall Study|Adverse Event|7|||
170789409|NCT05201079|617238111|FG001|Overall Study|Adverse Event|11|||
170462493|NCT02799095|616034572|FG012|Part C|Withdrawal by Subject|13|||
170462494|NCT02799095|616034573|FG013|Part C|Withdrawal by Subject|21|||
170462495|NCT02799095|616034574|FG014|Part C|Withdrawal by Subject|0|||
170462496|NCT02799095|616034575|FG015|Part C|Withdrawal by Subject|12|||
170462497|NCT02799095|616034576|FG016|Part C|Withdrawal by Subject|1|||
170789410|NCT05201079|617238110|FG000|Overall Study|Death|1|||
170789411|NCT05201079|617238111|FG001|Overall Study|Death|1|||
170789412|NCT05201079|617238110|FG000|Overall Study|Lack of Efficacy|0|||
170789413|NCT05201079|617238111|FG001|Overall Study|Lack of Efficacy|2|||
170789414|NCT05201079|617238110|FG000|Overall Study|Lost to Follow-up|0|||
170789415|NCT05201079|617238111|FG001|Overall Study|Lost to Follow-up|1|||
170789416|NCT05201079|617238110|FG000|Overall Study|Physician Decision|1|||
170889971|NCT01834729|617604140|FG001|Overall Study|Adverse Event|0|||
170889972|NCT01834729|617604141|FG002|Overall Study|Adverse Event|0|||
170889973|NCT01834729|617604142|FG003|Overall Study|Adverse Event|2|||
170889974|NCT00288080|617604143|FG000|Overall Study|Withdrawal by Subject|1|||
170889975|NCT00288080|617604144|FG001|Overall Study|Withdrawal by Subject|3|||
170889976|NCT00288080|617604143|FG000|Overall Study|Protocol Violation|25|||
170889977|NCT00288080|617604144|FG001|Overall Study|Protocol Violation|20|||
170889978|NCT03403192|617604145|FG000|Overall Study|Lost to Follow-up|1|||
170889979|NCT03403192|617604146|FG001|Overall Study|Lost to Follow-up|2|||
170889980|NCT03403192|617604147|FG002|Overall Study|Lost to Follow-up|0|||
170889981|NCT03403192|617604148|FG003|Overall Study|Lost to Follow-up|0|||
170889982|NCT03403192|617604145|FG000|Overall Study|Unable to respond|0|||
170889983|NCT03403192|617604146|FG001|Overall Study|Unable to respond|1|||
170889984|NCT03403192|617604147|FG002|Overall Study|Unable to respond|0|||
170889985|NCT03403192|617604148|FG003|Overall Study|Unable to respond|0|||
170889986|NCT03403192|617604145|FG000|Overall Study|Incomplete|3|||
170889987|NCT03403192|617604146|FG001|Overall Study|Incomplete|1|||
170889988|NCT03403192|617604147|FG002|Overall Study|Incomplete|3|||
170889989|NCT03403192|617604148|FG003|Overall Study|Incomplete|6|||
170889990|NCT02682901|617604149|FG000|Overall Study|Adverse Event|10|||
170889991|NCT02682901|617604150|FG001|Overall Study|Adverse Event|3|||
170889992|NCT02682901|617604149|FG000|Overall Study|Lack of Efficacy|0|||
170889993|NCT02682901|617604150|FG001|Overall Study|Lack of Efficacy|1|||
170889994|NCT01298492|617604151|FG000|Overall Study|Death|2|||
170889995|NCT01298492|617604151|FG000|Overall Study|Insufficient Clinical Response|22|||
170889996|NCT01298492|617604151|FG000|Overall Study|Lost to Follow-up|12|||
170889997|NCT01298492|617604151|FG000|Overall Study|Withdrawal by Subject|47|||
170889998|NCT01298492|617604151|FG000|Overall Study|Other (Unspecified)|7|||
170889999|NCT01298492|617604151|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
170890000|NCT01298492|617604151|FG000|Overall Study|Protocol Violation|2|||
170890001|NCT01298492|617604151|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
170890002|NCT01298492|617604151|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
170890003|NCT03713944|617604152|FG000|Study Treatment|Patient non-compliance|1|||
170890004|NCT03713944|617604152|FG000|Study Treatment|Alternative Cancer Therapy|3|||
170890005|NCT03713944|617604152|FG000|Study Treatment|Disease Progression|18|||
170890006|NCT03713944|617604152|FG000|Study Treatment|AE/Side Effects/Complications|2|||
170890007|NCT03713944|617604152|FG000|Study Treatment|Death|2|||
170890008|NCT03713944|617604152|FG000|Study Treatment|Withdrawal by Subject|1|||
170890009|NCT03713944|617604152|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
170890010|NCT03713944|617604152|FG000|Study Treatment|Symptomatic Deterioration|2|||
170890011|NCT03713944|617604152|FG000|Follow up|Withdrawal by Subject|2|||
170890012|NCT03713944|617604152|FG000|Follow up|Death|11|||
170890013|NCT03713944|617604152|FG000|Follow up|Study Terminated|3|||
170890014|NCT02902120|617604155|FG000|Overall Study|Lack of Efficacy|1|||
170890015|NCT01353703|617604157|FG000|Overall Study|Migrated/moved from study area|1|||
170890016|NCT01353703|617604158|FG001|Overall Study|Migrated/moved from study area|0|||
170890017|NCT03298022|617604159|FG000|Overall Study|Lack of Efficacy|4|||
170890018|NCT03298022|617604159|FG000|Overall Study|Withdrawal by Subject|7|||
170890019|NCT03298022|617604159|FG000|Overall Study|Adverse Event|1|||
170890020|NCT03298022|617604159|FG000|Overall Study|disease relapse|1|||
170890021|NCT03694925|617604162|FG000|Overall Study|Inadequate laboratory testing|0|||
170890022|NCT03694925|617604163|FG001|Overall Study|Inadequate laboratory testing|3|||
170890023|NCT03694925|617604164|FG002|Overall Study|Inadequate laboratory testing|0|||
170890024|NCT01422239|617604165|FG000|Overall Study|Lost to Follow-up|4|||
170462498|NCT02799095|616034560|FG000|Part C|Physician Decision|0|||
170789417|NCT05201079|617238111|FG001|Overall Study|Physician Decision|1|||
170789418|NCT05201079|617238110|FG000|Overall Study|Protocol Violation|1|||
170890025|NCT01422239|617604166|FG001|Overall Study|Lost to Follow-up|3|||
170890026|NCT02301403|617604169|FG000|Overall Study|Withdrawal by Subject|28|||
170890027|NCT02301403|617604170|FG001|Overall Study|Withdrawal by Subject|41|||
170890028|NCT00730639|617604171|FG000|Overall Study|Adverse Event|3|||
170890029|NCT00730639|617604172|FG001|Overall Study|Adverse Event|0|||
170890030|NCT00730639|617604173|FG002|Overall Study|Adverse Event|9|||
170890031|NCT00730639|617604174|FG003|Overall Study|Adverse Event|8|||
170890032|NCT00730639|617604175|FG004|Overall Study|Adverse Event|23|||
170890033|NCT00730639|617604171|FG000|Overall Study|Complete Response|0|||
170890034|NCT00730639|617604172|FG001|Overall Study|Complete Response|0|||
170890035|NCT00730639|617604173|FG002|Overall Study|Complete Response|2|||
170890036|NCT00730639|617604174|FG003|Overall Study|Complete Response|2|||
170890037|NCT00730639|617604175|FG004|Overall Study|Complete Response|1|||
170890038|NCT00730639|617604171|FG000|Overall Study|Completed Maximum Cycles|0|||
170789419|NCT05201079|617238111|FG001|Overall Study|Protocol Violation|0|||
170462499|NCT02799095|616034561|FG001|Part C|Physician Decision|0|||
170462500|NCT02799095|616034562|FG002|Part C|Physician Decision|0|||
170462501|NCT02799095|616034563|FG003|Part C|Physician Decision|0|||
170462502|NCT02799095|616034564|FG004|Part C|Physician Decision|0|||
170462503|NCT02799095|616034565|FG005|Part C|Physician Decision|0|||
170462504|NCT02799095|616034566|FG006|Part C|Physician Decision|0|||
170462505|NCT02799095|616034567|FG007|Part C|Physician Decision|0|||
170462506|NCT02799095|616034568|FG008|Part C|Physician Decision|0|||
170462507|NCT02799095|616034569|FG009|Part C|Physician Decision|0|||
170462508|NCT02799095|616034570|FG010|Part C|Physician Decision|1|||
170462509|NCT02799095|616034571|FG011|Part C|Physician Decision|0|||
170462510|NCT02799095|616034572|FG012|Part C|Physician Decision|0|||
170462511|NCT02799095|616034573|FG013|Part C|Physician Decision|0|||
170462512|NCT02799095|616034574|FG014|Part C|Physician Decision|0|||
170462513|NCT02799095|616034575|FG015|Part C|Physician Decision|0|||
170462514|NCT02799095|616034576|FG016|Part C|Physician Decision|0|||
170462515|NCT02799095|616034560|FG000|Part C|Other|0|||
170462516|NCT02799095|616034561|FG001|Part C|Other|0|||
170462517|NCT02799095|616034562|FG002|Part C|Other|0|||
170462518|NCT02799095|616034563|FG003|Part C|Other|0|||
170462519|NCT02799095|616034564|FG004|Part C|Other|0|||
170462520|NCT02799095|616034565|FG005|Part C|Other|0|||
170462521|NCT02799095|616034566|FG006|Part C|Other|0|||
170462522|NCT02799095|616034567|FG007|Part C|Other|0|||
170462523|NCT02799095|616034568|FG008|Part C|Other|0|||
170462524|NCT02799095|616034569|FG009|Part C|Other|0|||
170462525|NCT02799095|616034570|FG010|Part C|Other|0|||
170462526|NCT02799095|616034571|FG011|Part C|Other|2|||
170462527|NCT02799095|616034572|FG012|Part C|Other|2|||
170462528|NCT02799095|616034573|FG013|Part C|Other|0|||
170462529|NCT02799095|616034574|FG014|Part C|Other|0|||
170462530|NCT02799095|616034575|FG015|Part C|Other|0|||
170462531|NCT02799095|616034576|FG016|Part C|Other|0|||
170462532|NCT01523457|616034577|FG000|Overall Study|Withdrawal by Subject|7|||
170462533|NCT01523457|616034578|FG001|Overall Study|Withdrawal by Subject|2|||
170462534|NCT03700385|616034579|FG000|Overall Study|Lost to Follow-up|1|||
170462535|NCT04241315|616034580|FG000|Overall Study|Withdrawal by Subject|0|||
170462536|NCT04241315|616034581|FG001|Overall Study|Withdrawal by Subject|1|||
170462537|NCT01555671|616034585|FG000|Overall Study|Physician Decision|20|||
170462538|NCT01555671|616034586|FG001|Overall Study|Physician Decision|25|||
170462539|NCT04590040|616034590|FG000|Treatment Period|Lost to Follow-up|2|||
170462540|NCT04590040|616034591|FG001|Treatment Period|Lost to Follow-up|5|||
170462541|NCT04590040|616034592|FG002|Treatment Period|Lost to Follow-up|0|||
170462542|NCT04590040|616034590|FG000|Treatment Period|Physician Decision|0|||
170462543|NCT04590040|616034591|FG001|Treatment Period|Physician Decision|0|||
170462544|NCT04590040|616034592|FG002|Treatment Period|Physician Decision|2|||
170462545|NCT02085135|616034595|FG000|Overall Study|Adverse Event|4|||
170462546|NCT02085135|616034596|FG001|Overall Study|Adverse Event|7|||
170462547|NCT02085135|616034595|FG000|Overall Study|Lost to Follow-up|2|||
170462548|NCT02085135|616034596|FG001|Overall Study|Lost to Follow-up|2|||
170462549|NCT02085135|616034595|FG000|Overall Study|Withdrawal by Subject|3|||
170462550|NCT02085135|616034596|FG001|Overall Study|Withdrawal by Subject|0|||
170462551|NCT02085135|616034595|FG000|Overall Study|Lack of Efficacy|2|||
170462552|NCT02085135|616034596|FG001|Overall Study|Lack of Efficacy|0|||
170462553|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
170789420|NCT05201079|617238110|FG000|Overall Study|Withdrawal by Subject|1|||
170789421|NCT05201079|617238111|FG001|Overall Study|Withdrawal by Subject|0|||
170789422|NCT05201079|617238110|FG000|Overall Study|Forbidden medication|9|||
170789423|NCT05201079|617238111|FG001|Overall Study|Forbidden medication|5|||
170789424|NCT05201079|617238110|FG000|Overall Study|Transfer to another hospital|0|||
170789425|NCT05201079|617238111|FG001|Overall Study|Transfer to another hospital|1|||
170789426|NCT05201079|617238110|FG000|Overall Study|Clinical condition|1|||
170789427|NCT05201079|617238111|FG001|Overall Study|Clinical condition|0|||
170789428|NCT05201079|617238110|FG000|Overall Study|SAE and sepsis|1|||
170789429|NCT05201079|617238111|FG001|Overall Study|SAE and sepsis|0|||
170462554|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
170462555|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
170789430|NCT05808257|617238112|FG000|Overall Study|Lost to Follow-up|8|||
170462556|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
170462557|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
170462558|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
170462559|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
170462560|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
170462561|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
170462562|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
170462563|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Death|1|||
170462564|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Death|0|||
170462565|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Death|0|||
170462566|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Death|0|||
170462567|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Death|0|||
170462568|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
170462569|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
170544379|NCT01658878|616337281|FG020|Treatment Period|Other Reasons|4|||
170544380|NCT01658878|616337282|FG021|Treatment Period|Other Reasons|0|||
170544381|NCT01658878|616337283|FG022|Treatment Period|Other Reasons|0|||
170462570|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
170462571|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
170462572|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
170462573|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
170462574|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
170462575|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
170462576|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
170462577|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
170462578|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
170462579|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
170462580|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
170462581|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
170462582|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
170462583|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
170462584|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
170462585|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
170462586|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
170462587|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
170462588|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
170462589|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
170462590|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
170462591|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
170462592|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
170462593|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Other|4|||
170462594|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Other|4|||
170462595|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Other|3|||
170462596|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Other|1|||
170462597|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Other|0|||
170462598|NCT01081834|616034599|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
170462599|NCT01081834|616034600|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
170462600|NCT01081834|616034601|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
170462601|NCT01081834|616034602|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
170462602|NCT01081834|616034603|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
170462603|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
170462604|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
170462605|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
170462606|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
170462607|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
170462608|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Death|1|||
170462609|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Death|0|||
170462610|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Death|0|||
170462611|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Death|0|||
170462612|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Death|0|||
170462613|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
170462614|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
170462615|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
170462616|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
170462617|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
170462618|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170462619|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
170462620|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170462621|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170462622|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170462623|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
170544382|NCT01658878|616337284|FG023|Treatment Period|Other Reasons|4|||
170462624|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
170462625|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
170462626|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
170462627|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
170544383|NCT01658878|616337261|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170789431|NCT05808257|617238113|FG001|Overall Study|Lost to Follow-up|8|||
170789432|NCT04042233|617238114|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
170789433|NCT04042233|617238115|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
170789434|NCT04042233|617238114|FG000|Overall Study|Protocol Violation|0|||
170789435|NCT04042233|617238115|FG001|Overall Study|Protocol Violation|2|||
170890039|NCT00730639|617604172|FG001|Overall Study|Completed Maximum Cycles|0|||
170890040|NCT00730639|617604173|FG002|Overall Study|Completed Maximum Cycles|11|||
170890041|NCT00730639|617604174|FG003|Overall Study|Completed Maximum Cycles|3|||
170890042|NCT00730639|617604175|FG004|Overall Study|Completed Maximum Cycles|6|||
170890043|NCT00730639|617604171|FG000|Overall Study|Death|0|||
170890044|NCT00730639|617604172|FG001|Overall Study|Death|0|||
170890045|NCT00730639|617604173|FG002|Overall Study|Death|0|||
170890046|NCT00730639|617604174|FG003|Overall Study|Death|0|||
170890047|NCT00730639|617604175|FG004|Overall Study|Death|2|||
170890048|NCT00730639|617604171|FG000|Overall Study|Disease Progression|12|||
170890049|NCT00730639|617604172|FG001|Overall Study|Disease Progression|13|||
170890050|NCT00730639|617604173|FG002|Overall Study|Disease Progression|48|||
170890051|NCT00730639|617604174|FG003|Overall Study|Disease Progression|32|||
170890052|NCT00730639|617604175|FG004|Overall Study|Disease Progression|88|||
170890053|NCT00730639|617604171|FG000|Overall Study|non-specified|0|||
170890054|NCT00730639|617604172|FG001|Overall Study|non-specified|0|||
170890055|NCT00730639|617604173|FG002|Overall Study|non-specified|4|||
170890056|NCT00730639|617604174|FG003|Overall Study|non-specified|2|||
170890057|NCT00730639|617604175|FG004|Overall Study|non-specified|3|||
170890058|NCT00730639|617604171|FG000|Overall Study|Protocol Violation|0|||
170890059|NCT00730639|617604172|FG001|Overall Study|Protocol Violation|0|||
170890060|NCT00730639|617604173|FG002|Overall Study|Protocol Violation|1|||
170890061|NCT00730639|617604174|FG003|Overall Study|Protocol Violation|0|||
170890062|NCT00730639|617604175|FG004|Overall Study|Protocol Violation|0|||
170890063|NCT00730639|617604171|FG000|Overall Study|Withdrawal by Subject|0|||
170462628|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
170462629|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
170462630|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
170462631|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
170462632|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
170462633|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
170636567|NCT01147874|616680874|FG000|Overall Study|Investigator's Request|1|||
170636568|NCT01147874|616680874|FG000|Overall Study|Lost to Follow-up|25|||
170462634|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
170462635|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
170462636|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
170462637|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
170462638|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Other|4|||
170462639|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Other|5|||
170544384|NCT01658878|616337262|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544385|NCT01658878|616337263|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544386|NCT01658878|616337264|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544387|NCT01658878|616337265|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544388|NCT01658878|616337266|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544389|NCT01658878|616337267|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544390|NCT01658878|616337268|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544391|NCT01658878|616337269|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544392|NCT01658878|616337270|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544393|NCT01658878|616337271|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544394|NCT01658878|616337272|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544395|NCT01658878|616337273|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544396|NCT01658878|616337274|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544397|NCT01658878|616337275|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
170544398|NCT01658878|616337276|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544399|NCT01658878|616337277|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544400|NCT01658878|616337278|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
170544401|NCT01658878|616337279|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544402|NCT01658878|616337280|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544403|NCT01658878|616337281|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170636569|NCT01147874|616680874|FG000|Overall Study|Other|5|||
170636570|NCT01147874|616680874|FG000|Overall Study|Protocol Violation|5|||
170890064|NCT00730639|617604172|FG001|Overall Study|Withdrawal by Subject|0|||
170890065|NCT00730639|617604173|FG002|Overall Study|Withdrawal by Subject|6|||
170890066|NCT00730639|617604174|FG003|Overall Study|Withdrawal by Subject|3|||
170890067|NCT00730639|617604175|FG004|Overall Study|Withdrawal by Subject|4|||
170890068|NCT00730639|617604171|FG000|Overall Study|Treatment on-going|2|||
170890069|NCT00730639|617604172|FG001|Overall Study|Treatment on-going|5|||
170890070|NCT00730639|617604173|FG002|Overall Study|Treatment on-going|5|||
170890071|NCT00730639|617604174|FG003|Overall Study|Treatment on-going|4|||
170890072|NCT00730639|617604175|FG004|Overall Study|Treatment on-going|4|||
170462640|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Other|4|||
170462641|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Other|0|||
170462642|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Other|0|||
170462643|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
170462644|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
170462645|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
170462646|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
170462647|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
170462648|NCT01081834|616034599|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
170462649|NCT01081834|616034600|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
170462650|NCT01081834|616034601|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
170462651|NCT01081834|616034602|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
170462652|NCT01081834|616034603|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
170462653|NCT01161407|616034604|FG000|Overall Study|Protocol Violation|3|||
170462654|NCT01161407|616034605|FG001|Overall Study|Protocol Violation|1|||
170462655|NCT01777620|616034606|FG000|Overall Study|Subject Withdrawal|1|||
170462656|NCT01777620|616034607|FG001|Overall Study|Subject Withdrawal|0|||
170462657|NCT01544179|616034608|FG000|Overall Study|Death|50|||
170462658|NCT01544179|616034609|FG001|Overall Study|Death|37|||
170462659|NCT01544179|616034608|FG000|Overall Study|Lost to Follow-up|0|||
170462660|NCT01544179|616034609|FG001|Overall Study|Lost to Follow-up|1|||
170462661|NCT01544179|616034608|FG000|Overall Study|Adverse Event|0|||
170462662|NCT01544179|616034609|FG001|Overall Study|Adverse Event|1|||
170462663|NCT01544179|616034608|FG000|Overall Study|Withdrawal by Subject|12|||
170462664|NCT01544179|616034609|FG001|Overall Study|Withdrawal by Subject|7|||
170462665|NCT01544179|616034608|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
170462666|NCT01544179|616034609|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170462667|NCT02045147|616034610|FG000|Overall Study|Withdrawal by Subject|2|||
170462668|NCT02045147|616034611|FG001|Overall Study|Withdrawal by Subject|0|||
170462669|NCT02045147|616034612|FG002|Overall Study|Withdrawal by Subject|0|||
170462670|NCT02045147|616034613|FG003|Overall Study|Withdrawal by Subject|0|||
170462671|NCT02045147|616034614|FG004|Overall Study|Withdrawal by Subject|0|||
170462672|NCT02045147|616034615|FG005|Overall Study|Withdrawal by Subject|0|||
170462673|NCT02045147|616034616|FG006|Overall Study|Withdrawal by Subject|0|||
170462674|NCT02045147|616034617|FG007|Overall Study|Withdrawal by Subject|1|||
170462675|NCT02045147|616034610|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
170462676|NCT02045147|616034611|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
170462677|NCT02045147|616034612|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
170462678|NCT02045147|616034613|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
170462679|NCT02045147|616034614|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
170462680|NCT02045147|616034615|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
170462681|NCT02045147|616034616|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
170462682|NCT02045147|616034617|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
170462683|NCT00049530|616034618|FG000|Overall Study|Lack of Efficacy|25|||
170462684|NCT00049530|616034618|FG000|Overall Study|Adverse Event|2|||
170462685|NCT00049530|616034618|FG000|Overall Study|Death|1|||
170462686|NCT00049530|616034618|FG000|Overall Study|symptomatic deterioration|1|||
170462687|NCT00049530|616034618|FG000|Overall Study|ineligible|3|||
170462688|NCT01635283|616034622|FG000|Overall Study|Tumor Progression|3|||
170462689|NCT01635283|616034622|FG000|Overall Study|Lost to Follow-up|1|||
170462690|NCT00696787|616034625|FG000|Overall Study|Adverse Event|1|||
170462691|NCT00696787|616034626|FG001|Overall Study|Adverse Event|0|||
170462692|NCT00696787|616034627|FG002|Overall Study|Adverse Event|6|||
170462693|NCT00696787|616034625|FG000|Overall Study|Discontinuation by Sponsor|9|||
170462694|NCT00696787|616034626|FG001|Overall Study|Discontinuation by Sponsor|13|||
170462695|NCT00696787|616034627|FG002|Overall Study|Discontinuation by Sponsor|14|||
170462696|NCT00696787|616034625|FG000|Overall Study|Lack of Efficacy|0|||
170462697|NCT00696787|616034626|FG001|Overall Study|Lack of Efficacy|1|||
170462698|NCT00696787|616034627|FG002|Overall Study|Lack of Efficacy|0|||
170462699|NCT00696787|616034625|FG000|Overall Study|Lost to Follow-up|4|||
170462700|NCT00696787|616034626|FG001|Overall Study|Lost to Follow-up|0|||
170462701|NCT00696787|616034627|FG002|Overall Study|Lost to Follow-up|3|||
170462702|NCT00696787|616034625|FG000|Overall Study|Withdrawal by Subject|0|||
170462703|NCT00696787|616034626|FG001|Overall Study|Withdrawal by Subject|3|||
170462704|NCT00696787|616034627|FG002|Overall Study|Withdrawal by Subject|2|||
170462705|NCT00696787|616034625|FG000|Overall Study|Failed to return|1|||
170462706|NCT00696787|616034626|FG001|Overall Study|Failed to return|3|||
170462707|NCT00696787|616034627|FG002|Overall Study|Failed to return|1|||
170462708|NCT04058067|616034628|FG000|Overall Study|Adverse Event|2|||
170462709|NCT04058067|616034629|FG001|Overall Study|Adverse Event|0|||
170462710|NCT04058067|616034628|FG000|Overall Study|Death|0|||
170462711|NCT04058067|616034629|FG001|Overall Study|Death|1|||
170462712|NCT04058067|616034628|FG000|Overall Study|Physician Decision|3|||
170462713|NCT04058067|616034629|FG001|Overall Study|Physician Decision|1|||
170462714|NCT04058067|616034628|FG000|Overall Study|Protocol Violation|0|||
170462715|NCT04058067|616034629|FG001|Overall Study|Protocol Violation|1|||
170462716|NCT04058067|616034628|FG000|Overall Study|Withdrawal by Subject|7|||
170462717|NCT04058067|616034629|FG001|Overall Study|Withdrawal by Subject|8|||
170462718|NCT01283035|616034631|FG000|Overall Study|Subject later found ineligible|1|||
170462719|NCT00867503|616034632|FG000|Overall Study|Withdrawal by Subject|1|||
170462720|NCT02704403|616034633|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
170462721|NCT02704403|616034634|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
170462722|NCT02704403|616034633|FG000|Overall Study|Administrative reasons by sponsor|1251|||
170462723|NCT02704403|616034634|FG001|Overall Study|Administrative reasons by sponsor|616|||
170462724|NCT02704403|616034633|FG000|Overall Study|Death|4|||
170462725|NCT02704403|616034634|FG001|Overall Study|Death|3|||
170462726|NCT02704403|616034633|FG000|Overall Study|Endpoint event|52|||
170462727|NCT02704403|616034634|FG001|Overall Study|Endpoint event|24|||
170462728|NCT02704403|616034633|FG000|Overall Study|Lost to Follow-up|22|||
170462729|NCT02704403|616034634|FG001|Overall Study|Lost to Follow-up|11|||
170462730|NCT02704403|616034633|FG000|Overall Study|Protocol Violation|15|||
170462731|NCT02704403|616034634|FG001|Overall Study|Protocol Violation|15|||
170462732|NCT02704403|616034633|FG000|Overall Study|Adverse Event|2|||
170462733|NCT02704403|616034634|FG001|Overall Study|Adverse Event|0|||
170462734|NCT02704403|616034633|FG000|Overall Study|Withdrawal by Subject|85|||
170462735|NCT02704403|616034634|FG001|Overall Study|Withdrawal by Subject|45|||
170462736|NCT02704403|616034633|FG000|Overall Study|Investigator decision|1|||
170462737|NCT02704403|616034634|FG001|Overall Study|Investigator decision|1|||
170462738|NCT02704403|616034633|FG000|Overall Study|Follow-up not possible|1|||
170462739|NCT02704403|616034634|FG001|Overall Study|Follow-up not possible|2|||
170462740|NCT00851318|616034635|FG000|Overall Study|Withdrawal by Subject|7|||
170462741|NCT00851318|616034636|FG001|Overall Study|Withdrawal by Subject|1|||
170462742|NCT00851318|616034637|FG002|Overall Study|Withdrawal by Subject|5|||
170462743|NCT00851318|616034638|FG003|Overall Study|Withdrawal by Subject|3|||
170462744|NCT00851318|616034635|FG000|Overall Study|Adverse Event|13|||
170462745|NCT00851318|616034636|FG001|Overall Study|Adverse Event|2|||
170462746|NCT00851318|616034637|FG002|Overall Study|Adverse Event|9|||
170462747|NCT00851318|616034638|FG003|Overall Study|Adverse Event|12|||
170462748|NCT00851318|616034635|FG000|Overall Study|Pregnancy|0|||
170462749|NCT00851318|616034636|FG001|Overall Study|Pregnancy|0|||
170462750|NCT00851318|616034637|FG002|Overall Study|Pregnancy|1|||
170462751|NCT00851318|616034638|FG003|Overall Study|Pregnancy|1|||
170462752|NCT00851318|616034635|FG000|Overall Study|Lack of Efficacy|8|||
170462753|NCT00851318|616034636|FG001|Overall Study|Lack of Efficacy|2|||
170544404|NCT01658878|616337282|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170789436|NCT05977530|617238118|FG000|Overall Study|Withdrawal by Subject|1|||
170636571|NCT01147874|616680874|FG000|Overall Study|Sponsor's Decision|2|||
170636572|NCT01147874|616680874|FG000|Overall Study|Withdrawal by Subject|24|||
170636573|NCT04287517|616680875|FG000|Overall Study|Withdrawal by Subject|1|||
170636574|NCT04287517|616680876|FG001|Overall Study|Withdrawal by Subject|1|||
170636575|NCT01869764|616680877|FG000|Overall Study|Withdrawal by Subject|0|||
170636576|NCT01869764|616680878|FG001|Overall Study|Withdrawal by Subject|2|||
170636577|NCT02175030|616680879|FG000|Overall Study|Failed screen after consent|7|||
170636578|NCT02175030|616680880|FG001|Overall Study|Failed screen after consent|6|||
170636579|NCT02175030|616680879|FG000|Overall Study|Failed IUD Insertion|20|||
170636580|NCT02175030|616680880|FG001|Overall Study|Failed IUD Insertion|21|||
170636581|NCT02175030|616680879|FG000|Overall Study|Physician Decision|1|||
170636582|NCT02175030|616680880|FG001|Overall Study|Physician Decision|1|||
170636583|NCT02175030|616680879|FG000|Overall Study|Lost to Follow-up|6|||
170636584|NCT02175030|616680880|FG001|Overall Study|Lost to Follow-up|6|||
170636585|NCT02175030|616680879|FG000|Overall Study|Withdrawal by Subject|1|||
170636586|NCT02175030|616680880|FG001|Overall Study|Withdrawal by Subject|4|||
170636587|NCT00357903|616680881|FG000|Overall Study|Adverse Event|87|||
170636588|NCT00357903|616680882|FG001|Overall Study|Adverse Event|4|||
170636589|NCT00357903|616680881|FG000|Overall Study|Death|33|||
170636590|NCT00357903|616680882|FG001|Overall Study|Death|0|||
170636591|NCT00357903|616680881|FG000|Overall Study|Lost to Follow-up|23|||
170636592|NCT00357903|616680882|FG001|Overall Study|Lost to Follow-up|4|||
170636593|NCT00357903|616680881|FG000|Overall Study|Physician Decision|39|||
170636594|NCT00357903|616680882|FG001|Overall Study|Physician Decision|5|||
170636595|NCT00357903|616680881|FG000|Overall Study|Withdrawal by Subject|57|||
170636596|NCT00357903|616680882|FG001|Overall Study|Withdrawal by Subject|7|||
170636597|NCT00357903|616680881|FG000|Overall Study|Completed month 12 only|0|||
170636598|NCT00357903|616680882|FG001|Overall Study|Completed month 12 only|1|||
170636599|NCT00357903|616680881|FG000|Overall Study|Protocol issues|14|||
170636600|NCT00357903|616680882|FG001|Overall Study|Protocol issues|3|||
170636601|NCT00357903|616680881|FG000|Overall Study|Response status|61|||
170636602|NCT00357903|616680882|FG001|Overall Study|Response status|9|||
170636603|NCT00357903|616680881|FG000|Overall Study|Other|49|||
170636604|NCT00357903|616680882|FG001|Overall Study|Other|10|||
170636605|NCT00606593|616680883|FG000|Overall Study|Adverse Event|0|||
170636606|NCT00606593|616680884|FG001|Overall Study|Adverse Event|0|||
170636607|NCT00606593|616680885|FG002|Overall Study|Adverse Event|0|||
170636608|NCT00606593|616680886|FG003|Overall Study|Adverse Event|1|||
170636609|NCT00606593|616680887|FG004|Overall Study|Adverse Event|1|||
170636610|NCT00606593|616680888|FG005|Overall Study|Adverse Event|0|||
170636611|NCT00606593|616680889|FG006|Overall Study|Adverse Event|1|||
170636612|NCT00606593|616680890|FG007|Overall Study|Adverse Event|2|||
170636613|NCT00606593|616680891|FG008|Overall Study|Adverse Event|1|||
170636614|NCT00606593|616680892|FG009|Overall Study|Adverse Event|0|||
170462754|NCT00851318|616034637|FG002|Overall Study|Lack of Efficacy|4|||
170462755|NCT00851318|616034638|FG003|Overall Study|Lack of Efficacy|2|||
170462756|NCT00851318|616034635|FG000|Overall Study|Non-compliance with Study Procedures|2|||
170636615|NCT00606593|616680883|FG000|Overall Study|Withdrawal of consent|1|||
170636616|NCT00606593|616680884|FG001|Overall Study|Withdrawal of consent|0|||
170636617|NCT00606593|616680885|FG002|Overall Study|Withdrawal of consent|1|||
170636618|NCT00606593|616680886|FG003|Overall Study|Withdrawal of consent|0|||
170636619|NCT00606593|616680887|FG004|Overall Study|Withdrawal of consent|0|||
170636620|NCT00606593|616680888|FG005|Overall Study|Withdrawal of consent|0|||
170636621|NCT00606593|616680889|FG006|Overall Study|Withdrawal of consent|0|||
170636622|NCT00606593|616680890|FG007|Overall Study|Withdrawal of consent|0|||
170636623|NCT00606593|616680891|FG008|Overall Study|Withdrawal of consent|0|||
170789437|NCT05977530|617238118|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
170636624|NCT00606593|616680892|FG009|Overall Study|Withdrawal of consent|0|||
170636625|NCT00606593|616680883|FG000|Overall Study|Administrative/Other|0|||
170789438|NCT04880863|617238129|FG000|Overall Study|Adverse Event|1|||
170789439|NCT04880863|617238129|FG000|Overall Study|Patient decision|2|||
170789440|NCT04880863|617238129|FG000|Overall Study|Confirmed Disease Progression|15|||
170789441|NCT04880863|617238129|FG000|Overall Study|Death|3|||
170789442|NCT04880863|617238129|FG000|Overall Study|Physician Decision|4|||
170789443|NCT04880863|617238129|FG000|Overall Study|Unconfirmed Disease Progression|4|||
170636626|NCT00606593|616680884|FG001|Overall Study|Administrative/Other|0|||
170636627|NCT00606593|616680885|FG002|Overall Study|Administrative/Other|1|||
170636628|NCT00606593|616680886|FG003|Overall Study|Administrative/Other|0|||
170636629|NCT00606593|616680887|FG004|Overall Study|Administrative/Other|0|||
170789444|NCT04880863|617238129|FG000|Overall Study|Withdrawal by Subject|2|||
170462757|NCT00851318|616034636|FG001|Overall Study|Non-compliance with Study Procedures|0|||
170636630|NCT00606593|616680888|FG005|Overall Study|Administrative/Other|0|||
170636631|NCT00606593|616680889|FG006|Overall Study|Administrative/Other|0|||
170636632|NCT00606593|616680890|FG007|Overall Study|Administrative/Other|0|||
170636633|NCT00606593|616680891|FG008|Overall Study|Administrative/Other|0|||
170636634|NCT00606593|616680892|FG009|Overall Study|Administrative/Other|0|||
170636635|NCT03181529|616680893|FG000|Overall Study|Withdrawal by Subject|1|||
170462758|NCT00851318|616034637|FG002|Overall Study|Non-compliance with Study Procedures|1|||
170462759|NCT00851318|616034638|FG003|Overall Study|Non-compliance with Study Procedures|0|||
170462760|NCT00851318|616034635|FG000|Overall Study|Physician Decision|0|||
170462761|NCT00851318|616034636|FG001|Overall Study|Physician Decision|0|||
170462762|NCT00851318|616034637|FG002|Overall Study|Physician Decision|1|||
170462763|NCT00851318|616034638|FG003|Overall Study|Physician Decision|1|||
170462764|NCT01001988|616034641|FG000|Overall Study|Protocol Violation|84|||
170462765|NCT01001988|616034641|FG000|Overall Study|Withdrawal by Subject|18|||
170462766|NCT01001988|616034641|FG000|Overall Study|Lost to Follow-up|15|||
170462767|NCT00927394|616034644|FG000|Overall Study|Adverse Event|14|||
170462768|NCT00927394|616034645|FG001|Overall Study|Adverse Event|9|||
170462769|NCT00927394|616034644|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
170462770|NCT00927394|616034645|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
170462771|NCT00927394|616034644|FG000|Overall Study|Withdrawal by Subject|20|||
170462772|NCT00927394|616034645|FG001|Overall Study|Withdrawal by Subject|24|||
170462773|NCT00927394|616034644|FG000|Overall Study|Lost to Follow-up|8|||
170462774|NCT00927394|616034645|FG001|Overall Study|Lost to Follow-up|14|||
170462775|NCT00927394|616034644|FG000|Overall Study|Administrative Problem|1|||
170462776|NCT00927394|616034645|FG001|Overall Study|Administrative Problem|0|||
170462777|NCT00927394|616034644|FG000|Overall Study|Death|1|||
170462778|NCT00927394|616034645|FG001|Overall Study|Death|1|||
170462779|NCT00927394|616034644|FG000|Overall Study|Protocol deviation|16|||
170462780|NCT00927394|616034645|FG001|Overall Study|Protocol deviation|13|||
170462781|NCT00927394|616034644|FG000|Overall Study|Randomized in error|0|||
170462782|NCT00927394|616034645|FG001|Overall Study|Randomized in error|1|||
170462783|NCT04628793|616034646|FG000|Overall Study|Study terminated by sponsor|0|||
170462784|NCT04628793|616034647|FG001|Overall Study|Study terminated by sponsor|0|||
170462785|NCT04628793|616034648|FG002|Overall Study|Study terminated by sponsor|8|||
170462786|NCT04628793|616034646|FG000|Overall Study|Withdrawal by Subject|2|||
170462787|NCT04628793|616034647|FG001|Overall Study|Withdrawal by Subject|3|||
170462788|NCT04628793|616034648|FG002|Overall Study|Withdrawal by Subject|0|||
170462789|NCT04628793|616034646|FG000|Overall Study|Lost to Follow-up|0|||
170462790|NCT04628793|616034647|FG001|Overall Study|Lost to Follow-up|1|||
170462791|NCT04628793|616034648|FG002|Overall Study|Lost to Follow-up|0|||
170462792|NCT02695537|616034649|FG000|Overall Study|Adverse Event|3|||
170462793|NCT02695537|616034649|FG000|Overall Study|Lack of Efficacy|28|||
170462794|NCT02695537|616034649|FG000|Overall Study|Withdrawal by Subject|4|||
170462795|NCT02695537|616034649|FG000|Overall Study|Protocol Violation|3|||
170462796|NCT03597529|616034650|FG000|Overall Study|Lost to Follow-up|10|||
170462797|NCT03597529|616034651|FG001|Overall Study|Lost to Follow-up|12|||
170462798|NCT03597529|616034650|FG000|Overall Study|Physician Decision|3|||
170462799|NCT03597529|616034651|FG001|Overall Study|Physician Decision|1|||
170462800|NCT03597529|616034650|FG000|Overall Study|Withdrawal by Subject|6|||
170462801|NCT03597529|616034651|FG001|Overall Study|Withdrawal by Subject|3|||
170462802|NCT03597529|616034650|FG000|Overall Study|Non-compliant with study activities|1|||
170462803|NCT03597529|616034651|FG001|Overall Study|Non-compliant with study activities|2|||
170462804|NCT01755767|616034654|FG000|Overall Study|Progressive Disease|8|||
170462805|NCT01755767|616034655|FG001|Overall Study|Progressive Disease|7|||
170462806|NCT01755767|616034656|FG002|Overall Study|Progressive Disease|91|||
170462807|NCT01755767|616034657|FG003|Overall Study|Progressive Disease|43|||
170462808|NCT01755767|616034654|FG000|Overall Study|Clinical Disease Progression|4|||
170462809|NCT01755767|616034655|FG001|Overall Study|Clinical Disease Progression|2|||
170462810|NCT01755767|616034656|FG002|Overall Study|Clinical Disease Progression|29|||
170462811|NCT01755767|616034657|FG003|Overall Study|Clinical Disease Progression|20|||
170462812|NCT01755767|616034654|FG000|Overall Study|Radiographic Disease Progression|9|||
170462813|NCT01755767|616034655|FG001|Overall Study|Radiographic Disease Progression|4|||
170462814|NCT01755767|616034656|FG002|Overall Study|Radiographic Disease Progression|44|||
170462815|NCT01755767|616034657|FG003|Overall Study|Radiographic Disease Progression|27|||
170462816|NCT01755767|616034654|FG000|Overall Study|Adverse Event|6|||
170462817|NCT01755767|616034655|FG001|Overall Study|Adverse Event|0|||
170462818|NCT01755767|616034656|FG002|Overall Study|Adverse Event|28|||
170462819|NCT01755767|616034657|FG003|Overall Study|Adverse Event|11|||
170462820|NCT01755767|616034654|FG000|Overall Study|Death|1|||
170462821|NCT01755767|616034655|FG001|Overall Study|Death|2|||
170636636|NCT03181529|616680894|FG001|Overall Study|Withdrawal by Subject|1|||
170462822|NCT01755767|616034656|FG002|Overall Study|Death|15|||
170462823|NCT01755767|616034657|FG003|Overall Study|Death|4|||
170462824|NCT01755767|616034654|FG000|Overall Study|Subject Decision|0|||
170462825|NCT01755767|616034655|FG001|Overall Study|Subject Decision|0|||
170462826|NCT01755767|616034656|FG002|Overall Study|Subject Decision|10|||
170462827|NCT01755767|616034657|FG003|Overall Study|Subject Decision|3|||
170462828|NCT01755767|616034654|FG000|Overall Study|Withdrawal by Subject|0|||
170462829|NCT01755767|616034655|FG001|Overall Study|Withdrawal by Subject|0|||
170462830|NCT01755767|616034656|FG002|Overall Study|Withdrawal by Subject|2|||
170462831|NCT01755767|616034657|FG003|Overall Study|Withdrawal by Subject|1|||
170462832|NCT01755767|616034654|FG000|Overall Study|Other|0|||
170462833|NCT01755767|616034655|FG001|Overall Study|Other|0|||
170462834|NCT01755767|616034656|FG002|Overall Study|Other|2|||
170462835|NCT01755767|616034657|FG003|Overall Study|Other|3|||
170462836|NCT01755767|616034654|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
170462837|NCT01755767|616034655|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
170462838|NCT01755767|616034656|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
170462839|NCT01755767|616034657|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
170462840|NCT00191165|616034658|FG000|Overall Study|Adverse Event|2|||
170462841|NCT00191165|616034659|FG001|Overall Study|Adverse Event|0|||
170462842|NCT00191165|616034658|FG000|Overall Study|Protocol Violation|0|||
170462843|NCT00191165|616034659|FG001|Overall Study|Protocol Violation|1|||
170462844|NCT00191165|616034658|FG000|Overall Study|Participant Moved Away|0|||
170462845|NCT00191165|616034659|FG001|Overall Study|Participant Moved Away|1|||
170462846|NCT00715624|616034660|FG000|Overall Study|Adverse Event|12|||
170462847|NCT00715624|616034661|FG001|Overall Study|Adverse Event|37|||
170462848|NCT00715624|616034660|FG000|Overall Study|Lack of Efficacy|11|||
170462849|NCT00715624|616034661|FG001|Overall Study|Lack of Efficacy|11|||
170462850|NCT00715624|616034660|FG000|Overall Study|Lost to Follow-up|1|||
170462851|NCT00715624|616034661|FG001|Overall Study|Lost to Follow-up|2|||
170462852|NCT00715624|616034660|FG000|Overall Study|Protocol Violation|1|||
170462853|NCT00715624|616034661|FG001|Overall Study|Protocol Violation|0|||
170462854|NCT00715624|616034660|FG000|Overall Study|Withdrawal by Subject|11|||
170462855|NCT00715624|616034661|FG001|Overall Study|Withdrawal by Subject|25|||
170462856|NCT00715624|616034660|FG000|Overall Study|Familial and personal reasons|10|||
170462857|NCT00715624|616034661|FG001|Overall Study|Familial and personal reasons|22|||
170462858|NCT00715624|616034660|FG000|Overall Study|Poor compliance|6|||
170462859|NCT00715624|616034661|FG001|Overall Study|Poor compliance|13|||
170462860|NCT00715624|616034660|FG000|Overall Study|Sponsor decision|0|||
170462861|NCT00715624|616034661|FG001|Overall Study|Sponsor decision|4|||
170636637|NCT03181529|616680893|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
170636638|NCT03181529|616680894|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
170636639|NCT00092443|616680899|FG000|Overall Study|Adverse Event|9|||
170636640|NCT00092443|616680900|FG001|Overall Study|Adverse Event|13|||
170636641|NCT00092443|616680899|FG000|Overall Study|Lost to Follow-up|7|||
170636642|NCT00092443|616680900|FG001|Overall Study|Lost to Follow-up|3|||
170636643|NCT00092443|616680899|FG000|Overall Study|Protocol Violation|11|||
170636644|NCT00092443|616680900|FG001|Overall Study|Protocol Violation|9|||
170636645|NCT00092443|616680899|FG000|Overall Study|Withdrawal by Subject|9|||
170636646|NCT00092443|616680900|FG001|Overall Study|Withdrawal by Subject|11|||
170636647|NCT00092443|616680899|FG000|Overall Study|Moved|5|||
170636648|NCT00092443|616680900|FG001|Overall Study|Moved|5|||
170636649|NCT00092443|616680899|FG000|Overall Study|Other|17|||
170636650|NCT00092443|616680900|FG001|Overall Study|Other|13|||
170636651|NCT06083506|616680922|FG000|Overall Study|Physician Decision|2|||
170636652|NCT06083506|616680922|FG000|Overall Study|Lack of Efficacy|1|||
170636653|NCT05307692|616680923|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
170636654|NCT05307692|616680924|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
170636655|NCT05307692|616680925|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
170636656|NCT05307692|616680926|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
170636657|NCT05307692|616680923|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
170636658|NCT05307692|616680924|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
170636659|NCT05307692|616680925|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
170636660|NCT05307692|616680926|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
170636661|NCT05307692|616680923|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
170636662|NCT05307692|616680924|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
170462862|NCT00715624|616034660|FG000|Overall Study|Incorrect randomization (not treated)|0|||
170890073|NCT02302963|617604184|FG000|Overall Study|Withdrawal by Subject|2|||
170890074|NCT02302963|617604185|FG001|Overall Study|Withdrawal by Subject|1|||
170890075|NCT02302963|617604184|FG000|Overall Study|Steroid injection|0|||
170890076|NCT02302963|617604185|FG001|Overall Study|Steroid injection|1|||
170890077|NCT02302963|617604184|FG000|Overall Study|Physician Decision|1|||
170890078|NCT02302963|617604185|FG001|Overall Study|Physician Decision|0|||
170462863|NCT00715624|616034661|FG001|Overall Study|Incorrect randomization (not treated)|1|||
170636663|NCT05307692|616680925|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
170636664|NCT05307692|616680926|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
170636665|NCT05307692|616680923|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
170890079|NCT03434977|617604188|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
170890080|NCT03434977|617604189|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
170462864|NCT00715624|616034660|FG000|Overall Study|Other|0|||
170462865|NCT00715624|616034661|FG001|Overall Study|Other|1|||
170462866|NCT03196635|616034662|FG000|Overall Study|Withdrawal by Subject|1|||
170462867|NCT04524364|616034663|FG000|Overall Study|Physician Decision|3|||
170462868|NCT04524364|616034664|FG001|Overall Study|Physician Decision|6|||
170789445|NCT04880863|617238129|FG000|Overall Study|Study discontinuation by the sponsor|4|||
170789446|NCT04880863|617238129|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
170789447|NCT04880863|617238129|FG000|Overall Study|Not received study drug NAP|2|||
170789448|NCT03459729|617238130|FG000|Overall Study|Physician Decision|2|||
170789449|NCT03396588|617238134|FG000|Overall Study|Physician Decision|2|||
170789450|NCT03396588|617238135|FG001|Overall Study|Physician Decision|3|||
170789451|NCT00812461|617238136|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
170789452|NCT00812461|617238137|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
170789453|NCT00812461|617238136|FG000|All Treated Patients|Adverse Event|8|||
170789454|NCT00812461|617238137|FG001|All Treated Patients|Adverse Event|15|||
170789455|NCT00812461|617238136|FG000|All Treated Patients|Lack of Efficacy|13|||
170789456|NCT00812461|617238137|FG001|All Treated Patients|Lack of Efficacy|7|||
170789457|NCT00812461|617238136|FG000|All Treated Patients|Non-compliance|6|||
170789458|NCT00812461|617238137|FG001|All Treated Patients|Non-compliance|9|||
170789459|NCT00812461|617238136|FG000|All Treated Patients|Protocol Violation|36|||
170789460|NCT00812461|617238137|FG001|All Treated Patients|Protocol Violation|27|||
170789461|NCT00812461|617238136|FG000|All Treated Patients|Withdrawal by Subject|45|||
170789462|NCT00812461|617238137|FG001|All Treated Patients|Withdrawal by Subject|54|||
170789463|NCT00812461|617238136|FG000|All Treated Patients|Lost to Follow-up|11|||
170789464|NCT00812461|617238137|FG001|All Treated Patients|Lost to Follow-up|14|||
170789465|NCT00812461|617238136|FG000|All Treated Patients|Other Reason|13|||
170789466|NCT00812461|617238137|FG001|All Treated Patients|Other Reason|21|||
170789467|NCT05302596|617238139|FG000|Overall Study|Withdrawal by Subject|1|||
170789468|NCT05302596|617238140|FG001|Overall Study|Withdrawal by Subject|1|||
170789469|NCT04764448|617240267|FG000|Overall Study|Study terminated by sponsor|2|||
170789470|NCT04764448|617240268|FG001|Overall Study|Study terminated by sponsor|2|||
170789471|NCT04764448|617240269|FG002|Overall Study|Study terminated by sponsor|5|||
170789472|NCT04764448|617240267|FG000|Overall Study|Withdrawal by Subject|3|||
170789473|NCT04764448|617240268|FG001|Overall Study|Withdrawal by Subject|3|||
170789474|NCT04764448|617240269|FG002|Overall Study|Withdrawal by Subject|1|||
170789475|NCT04728347|617240270|FG000|Overall Study|Sponsor decision|0|||
170789476|NCT04728347|617240271|FG001|Overall Study|Sponsor decision|0|||
170789477|NCT04728347|617240272|FG002|Overall Study|Sponsor decision|1|||
170789478|NCT04728347|617240273|FG003|Overall Study|Sponsor decision|0|||
170789479|NCT06516705|617240277|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
170789480|NCT06516705|617240278|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
170789481|NCT06516705|617240277|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
170789482|NCT06516705|617240278|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
170789483|NCT06516705|617240277|FG000|T3 ( 3 Month After Education)|covid-19|1|||
170789484|NCT06516705|617240278|FG001|T3 ( 3 Month After Education)|covid-19|2|||
170789485|NCT06516705|617240277|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
170789486|NCT06516705|617240278|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
170789487|NCT06516705|617240277|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
170789488|NCT06516705|617240278|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
170789489|NCT06516705|617240277|FG000|T4 ( 6 Month After Education)|covid-19|3|||
170789490|NCT06516705|617240278|FG001|T4 ( 6 Month After Education)|covid-19|2|||
170789491|NCT06516705|617240277|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
170789492|NCT06516705|617240278|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
170789493|NCT04799899|617240280|FG000|Overall Study|Lost to Follow-up|2|||
170789494|NCT04799899|617240281|FG001|Overall Study|Lost to Follow-up|4|||
170789495|NCT04802967|617240282|FG000|Part B|Withdrawal by Subject|0|||
170789496|NCT04802967|617240283|FG001|Part B|Withdrawal by Subject|0|||
170789497|NCT04802967|617240284|FG002|Part B|Withdrawal by Subject|0|||
170789498|NCT04802967|617240285|FG003|Part B|Withdrawal by Subject|0|||
170789499|NCT04802967|617240286|FG004|Part B|Withdrawal by Subject|0|||
170789500|NCT04802967|617240287|FG005|Part B|Withdrawal by Subject|1|||
170789501|NCT04802967|617240288|FG006|Part B|Withdrawal by Subject|0|||
170789502|NCT04802967|617240289|FG007|Part B|Withdrawal by Subject|0|||
170789503|NCT04802967|617240290|FG008|Part B|Withdrawal by Subject|0|||
170789504|NCT04802967|617240291|FG009|Part B|Withdrawal by Subject|0|||
170789505|NCT05459688|617240299|FG000|Overall Study|Lost to Follow-up|6|||
170789506|NCT05459688|617240299|FG000|Overall Study|Physician Decision|1|||
170789507|NCT05459688|617240299|FG000|Overall Study|Withdrawal by Subject|19|||
170789508|NCT05459688|617240299|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
170789509|NCT03462030|617240307|FG000|Overall Study|Withdrawal by Subject|1|||
170789510|NCT03462030|617240308|FG001|Overall Study|Withdrawal by Subject|1|||
170789511|NCT01073566|617240309|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
170789512|NCT01073566|617240310|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
170789513|NCT05780437|617240313|FG000|Overall Study|Withdrawal by Subject|22|||
170789514|NCT05780437|617240314|FG001|Overall Study|Withdrawal by Subject|16|||
170789515|NCT05672069|617240318|FG000|Overall Study|Implant removal|1|||
170789516|NCT05672069|617240318|FG000|Overall Study|Lost to Follow-up|2|||
170789517|NCT03216057|617240319|FG000|Overall Study|Lost to Follow-up|2|||
170462869|NCT04524364|616034663|FG000|Overall Study|Adverse Event|0|||
170462870|NCT04524364|616034664|FG001|Overall Study|Adverse Event|1|||
170462871|NCT04524364|616034663|FG000|Overall Study|Investigational device deficiency|0|||
170462872|NCT04524364|616034664|FG001|Overall Study|Investigational device deficiency|1|||
170462873|NCT04524364|616034663|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
170462874|NCT04524364|616034664|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
170462875|NCT04524364|616034663|FG000|Overall Study|Device unavailability|0|||
170462876|NCT04524364|616034664|FG001|Overall Study|Device unavailability|2|||
170462877|NCT04524364|616034663|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
170462878|NCT04524364|616034664|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
170462879|NCT04524364|616034663|FG000|Overall Study|Low International normalized ratio (INR)|1|||
170462880|NCT04524364|616034664|FG001|Overall Study|Low International normalized ratio (INR)|0|||
170462881|NCT00998309|616034665|FG000|Overall Study|Protocol Violation|4|||
170462882|NCT03421730|616034668|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462883|NCT03421730|616034669|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
170462884|NCT03421730|616034670|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462885|NCT03421730|616034671|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462886|NCT03421730|616034672|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462887|NCT03421730|616034673|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462888|NCT03421730|616034674|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462889|NCT03421730|616034675|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462890|NCT03421730|616034676|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462891|NCT03421730|616034677|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462892|NCT03421730|616034678|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462893|NCT03421730|616034679|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
170462894|NCT03421730|616034668|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462895|NCT03421730|616034669|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462896|NCT03421730|616034670|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462897|NCT03421730|616034671|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462898|NCT03421730|616034672|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
170462899|NCT03421730|616034673|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462900|NCT03421730|616034674|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462901|NCT03421730|616034675|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462902|NCT03421730|616034676|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462903|NCT03421730|616034677|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462904|NCT03421730|616034678|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462905|NCT03421730|616034679|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
170462906|NCT02865460|616034680|FG000|Overall Study|Adverse Event|1|||
170462907|NCT02865460|616034681|FG001|Overall Study|Adverse Event|0|||
170462908|NCT02865460|616034680|FG000|Overall Study|Withdrawal by Subject|1|||
170462909|NCT02865460|616034681|FG001|Overall Study|Withdrawal by Subject|1|||
170462910|NCT02865460|616034680|FG000|Overall Study|Lost to Follow-up|7|||
170462911|NCT02865460|616034681|FG001|Overall Study|Lost to Follow-up|4|||
170462912|NCT02865460|616034680|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
170890081|NCT01145066|617604190|FG000|Overall Study|To resume NSAIDs|2|||
170890082|NCT01145066|617604191|FG001|Overall Study|To resume NSAIDs|2|||
170890083|NCT01145066|617604192|FG002|Overall Study|To resume NSAIDs|1|||
170890084|NCT01145066|617604190|FG000|Overall Study|Non-related surgery|0|||
170890085|NCT01145066|617604191|FG001|Overall Study|Non-related surgery|0|||
170890086|NCT01145066|617604192|FG002|Overall Study|Non-related surgery|1|||
170890087|NCT01145066|617604190|FG000|Overall Study|Withdrawal by Subject|0|||
170890088|NCT01145066|617604191|FG001|Overall Study|Withdrawal by Subject|0|||
170890089|NCT01145066|617604192|FG002|Overall Study|Withdrawal by Subject|2|||
170890090|NCT01145066|617604190|FG000|Overall Study|To start new med|1|||
170890091|NCT01145066|617604191|FG001|Overall Study|To start new med|0|||
170890092|NCT01145066|617604192|FG002|Overall Study|To start new med|0|||
170890093|NCT01145066|617604190|FG000|Overall Study|problems swallowing capsule|1|||
170890094|NCT01145066|617604191|FG001|Overall Study|problems swallowing capsule|0|||
170890095|NCT01145066|617604192|FG002|Overall Study|problems swallowing capsule|0|||
170462913|NCT02865460|616034681|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
170462914|NCT01559389|616034694|FG000|Overall Study|Withdrawal by Subject|20|||
170890096|NCT01145066|617604190|FG000|Overall Study|Abdominal discomfort|0|||
170890097|NCT01145066|617604191|FG001|Overall Study|Abdominal discomfort|1|||
170890098|NCT01145066|617604192|FG002|Overall Study|Abdominal discomfort|0|||
170890099|NCT01145066|617604190|FG000|Overall Study|Low platelet count|0|||
170890100|NCT01145066|617604191|FG001|Overall Study|Low platelet count|1|||
170890101|NCT01145066|617604192|FG002|Overall Study|Low platelet count|0|||
170789518|NCT03216057|617240320|FG001|Overall Study|Lost to Follow-up|2|||
170789519|NCT04065841|617240330|FG000|Overall Study|Adverse Event|4|||
170462915|NCT01559389|616034695|FG001|Overall Study|Withdrawal by Subject|20|||
170462916|NCT02871492|616034696|FG000|Overall Study|Lost to Follow-up|6|||
170462917|NCT02871492|616034697|FG001|Overall Study|Lost to Follow-up|3|||
170462918|NCT02871492|616034698|FG002|Overall Study|Lost to Follow-up|5|||
170462919|NCT02871492|616034696|FG000|Overall Study|Withdrawal by Subject|0|||
170462920|NCT02871492|616034697|FG001|Overall Study|Withdrawal by Subject|0|||
170462921|NCT02871492|616034698|FG002|Overall Study|Withdrawal by Subject|1|||
170462922|NCT04546724|616034699|FG000|Overall Study|Withdrawal by Subject|145|||
170462923|NCT04546724|616034700|FG001|Overall Study|Withdrawal by Subject|41|||
170462924|NCT04546724|616034699|FG000|Overall Study|Adverse Event|1|||
170462925|NCT04546724|616034700|FG001|Overall Study|Adverse Event|1|||
170789520|NCT04065841|617240331|FG001|Overall Study|Adverse Event|2|||
170789521|NCT04065841|617240332|FG002|Overall Study|Adverse Event|10|||
170789522|NCT04065841|617240333|FG003|Overall Study|Adverse Event|1|||
170789523|NCT04065841|617240330|FG000|Overall Study|Lost to Follow-up|1|||
170789524|NCT04065841|617240331|FG001|Overall Study|Lost to Follow-up|2|||
170789525|NCT04065841|617240332|FG002|Overall Study|Lost to Follow-up|2|||
170789526|NCT04065841|617240333|FG003|Overall Study|Lost to Follow-up|2|||
170789527|NCT04065841|617240330|FG000|Overall Study|Physician Decision|1|||
170789528|NCT04065841|617240331|FG001|Overall Study|Physician Decision|0|||
170789529|NCT04065841|617240332|FG002|Overall Study|Physician Decision|0|||
170789530|NCT04065841|617240333|FG003|Overall Study|Physician Decision|0|||
170789531|NCT04065841|617240330|FG000|Overall Study|Protocol Violation|0|||
170789532|NCT04065841|617240331|FG001|Overall Study|Protocol Violation|1|||
170789533|NCT04065841|617240332|FG002|Overall Study|Protocol Violation|0|||
170789534|NCT04065841|617240333|FG003|Overall Study|Protocol Violation|0|||
170789535|NCT04065841|617240330|FG000|Overall Study|Study terminated by Sponsor|22|||
170789536|NCT04065841|617240331|FG001|Overall Study|Study terminated by Sponsor|16|||
170789537|NCT04065841|617240332|FG002|Overall Study|Study terminated by Sponsor|28|||
170789538|NCT04065841|617240333|FG003|Overall Study|Study terminated by Sponsor|17|||
170462926|NCT04546724|616034699|FG000|Overall Study|Lost to Follow-up|186|||
170462927|NCT04546724|616034700|FG001|Overall Study|Lost to Follow-up|63|||
170462928|NCT04546724|616034699|FG000|Overall Study|Physician Decision|8|||
170462929|NCT04546724|616034700|FG001|Overall Study|Physician Decision|2|||
170462930|NCT04546724|616034699|FG000|Overall Study|Death|2|||
170462931|NCT04546724|616034700|FG001|Overall Study|Death|1|||
170462932|NCT04546724|616034699|FG000|Overall Study|subject has been out of town|1|||
170462933|NCT04546724|616034700|FG001|Overall Study|subject has been out of town|0|||
170462934|NCT04546724|616034699|FG000|Overall Study|subject is incarcerated|2|||
170462935|NCT04546724|616034700|FG001|Overall Study|subject is incarcerated|0|||
170462936|NCT04546724|616034699|FG000|Overall Study|subject is relocating|12|||
170462937|NCT04546724|616034700|FG001|Overall Study|subject is relocating|4|||
170462938|NCT04546724|616034699|FG000|Overall Study|Subject in another study|1|||
170462939|NCT04546724|616034700|FG001|Overall Study|Subject in another study|1|||
170462940|NCT00171951|616034701|FG000|Overall Study|Adverse Event|1|||
170462941|NCT00171951|616034701|FG000|Overall Study|Abnormal Laboratory Values|2|||
170462942|NCT00171951|616034701|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170462943|NCT00171951|616034701|FG000|Overall Study|Participants Withdrew Consent|3|||
170462944|NCT00171951|616034701|FG000|Overall Study|New Cancer Therapy|5|||
170462945|NCT00171951|616034701|FG000|Overall Study|Reason not Specified|2|||
170462946|NCT01844505|616034704|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
170462947|NCT01844505|616034705|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
170462948|NCT01844505|616034706|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
170462949|NCT01844505|616034704|FG000|Treatment Period|Other Reasons|120|||
170462950|NCT01844505|616034705|FG001|Treatment Period|Other Reasons|136|||
170789539|NCT04065841|617240330|FG000|Overall Study|Withdrawal by Subject|1|||
170636666|NCT05307692|616680924|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
170636667|NCT05307692|616680925|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
170636668|NCT05307692|616680926|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
170789540|NCT04065841|617240331|FG001|Overall Study|Withdrawal by Subject|1|||
170789541|NCT04065841|617240332|FG002|Overall Study|Withdrawal by Subject|2|||
170789542|NCT04065841|617240333|FG003|Overall Study|Withdrawal by Subject|0|||
170789543|NCT01420237|617240336|FG000|Overall Study|Death|13|||
170462951|NCT01844505|616034706|FG002|Treatment Period|Other Reasons|58|||
170462952|NCT01844505|616034704|FG000|Treatment Period|Lost to Follow-up|9|||
170462953|NCT01844505|616034705|FG001|Treatment Period|Lost to Follow-up|11|||
170789544|NCT01420237|617240336|FG000|Overall Study|Withdrawal by Subject|41|||
170789545|NCT01420237|617240336|FG000|Overall Study|Lost to Follow-up|32|||
170789546|NCT01420237|617240336|FG000|Overall Study|Adverse Event|10|||
170789547|NCT01420237|617240336|FG000|Overall Study|Investigative Site Termination|43|||
170789548|NCT01420237|617240336|FG000|Overall Study|Censored because study device not implanted|21|||
170789549|NCT01420237|617240336|FG000|Overall Study|Censored because surgery not performed|2|||
170462954|NCT01844505|616034706|FG002|Treatment Period|Lost to Follow-up|6|||
170462955|NCT01844505|616034704|FG000|Treatment Period|Death|175|||
170462956|NCT01844505|616034705|FG001|Treatment Period|Death|154|||
170462957|NCT01844505|616034706|FG002|Treatment Period|Death|228|||
170462958|NCT00311402|616034707|FG000|Overall Study|Adverse Event|118|||
170462959|NCT00311402|616034708|FG001|Overall Study|Adverse Event|105|||
170462960|NCT00311402|616034707|FG000|Overall Study|Lost to Follow-up|0|||
170462961|NCT00311402|616034708|FG001|Overall Study|Lost to Follow-up|3|||
170462962|NCT00311402|616034707|FG000|Overall Study|Withdrawal by Subject|17|||
170462963|NCT00311402|616034708|FG001|Overall Study|Withdrawal by Subject|18|||
170462964|NCT00311402|616034707|FG000|Overall Study|Lack of Efficacy|58|||
170462965|NCT00311402|616034708|FG001|Overall Study|Lack of Efficacy|42|||
170462966|NCT00311402|616034707|FG000|Overall Study|Protocol Violation|7|||
170462967|NCT00311402|616034708|FG001|Overall Study|Protocol Violation|6|||
170462968|NCT00311402|616034707|FG000|Overall Study|IRB's rejection etc.|10|||
170462969|NCT00311402|616034708|FG001|Overall Study|IRB's rejection etc.|3|||
170462970|NCT02640053|616034709|FG000|Overall Study|Withdrawal by Subject|2|||
170462971|NCT02640053|616034710|FG001|Overall Study|Withdrawal by Subject|1|||
170462972|NCT02640053|616034709|FG000|Overall Study|Adverse Event|1|||
170462973|NCT02640053|616034710|FG001|Overall Study|Adverse Event|1|||
170462974|NCT02640053|616034709|FG000|Overall Study|Alternative Therapy|1|||
170462975|NCT02640053|616034710|FG001|Overall Study|Alternative Therapy|1|||
170462976|NCT02640053|616034709|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
170462977|NCT02640053|616034710|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
170462978|NCT02927366|616034711|FG000|Overall Study|Adverse Event|1|||
170789550|NCT01420237|617240336|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
170789551|NCT01420237|617240336|FG000|Overall Study|Sponsor terminated study early|127|||
170789552|NCT05269667|617240337|FG000|Overall Study|Study Terminated by Sponsor|4|||
170462979|NCT02927366|616034712|FG001|Overall Study|Adverse Event|0|||
170462980|NCT02927366|616034711|FG000|Overall Study|Patient schedule|1|||
170462981|NCT02927366|616034712|FG001|Overall Study|Patient schedule|0|||
170462982|NCT02754856|616034717|FG000|Overall Study|Withdrawal by Subject|1|||
170462983|NCT03496610|616034718|FG000|Overall Study|Lost to Follow-up|3|||
170636669|NCT05307692|616680923|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
170636670|NCT05307692|616680924|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
170636671|NCT05307692|616680925|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
170636672|NCT05307692|616680926|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
170636673|NCT05307692|616680923|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
170636674|NCT05307692|616680924|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
170789553|NCT04413708|617240338|FG000|Overall Study|Lost to Follow-up|1|||
170789554|NCT04413708|617240339|FG001|Overall Study|Lost to Follow-up|2|||
170789555|NCT04313972|617240340|FG000|Overall Study|Withdrawal by Subject|0|||
170789556|NCT04313972|617240341|FG001|Overall Study|Withdrawal by Subject|1|||
170789557|NCT05877976|617240342|FG000|Overall Study|Lost to Follow-up|31|||
170789558|NCT00248287|617240343|FG000|Overall Study|Adverse Event|11|||
170789559|NCT00248287|617240344|FG001|Overall Study|Adverse Event|10|||
170789560|NCT00248287|617240343|FG000|Overall Study|Death|1|||
170789561|NCT00248287|617240344|FG001|Overall Study|Death|0|||
170789562|NCT00248287|617240343|FG000|Overall Study|Lost to Follow-up|0|||
170789563|NCT00248287|617240344|FG001|Overall Study|Lost to Follow-up|1|||
170789564|NCT00248287|617240343|FG000|Overall Study|Investigator Request|4|||
170789565|NCT00248287|617240344|FG001|Overall Study|Investigator Request|3|||
170890102|NCT03920670|617604193|FG000|Overall Study|Protocol Violation|2|||
170890103|NCT03920670|617604194|FG001|Overall Study|Protocol Violation|2|||
170890104|NCT03920670|617604193|FG000|Overall Study|Adverse Event|1|||
170890105|NCT03920670|617604194|FG001|Overall Study|Adverse Event|0|||
170890106|NCT04820309|617604208|FG000|Overall Study|Adverse Event|96|||
170890107|NCT04820309|617604208|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
170890108|NCT04820309|617604208|FG000|Overall Study|Consent Withdrawn|93|||
170890109|NCT04820309|617604208|FG000|Overall Study|failure to adhere to protocol|32|||
170890110|NCT04820309|617604208|FG000|Overall Study|alcohol or drug use|6|||
170890111|NCT04820309|617604208|FG000|Overall Study|Lost to Follow-up|46|||
170890112|NCT04820309|617604208|FG000|Overall Study|Death|2|||
170890113|NCT04820309|617604208|FG000|Overall Study|Pregnancy|1|||
170890114|NCT04820309|617604208|FG000|Overall Study|Other reasons|12|||
170890115|NCT01250379|617604211|FG000|Overall Study|Death|141|||
170890116|NCT01250379|617604212|FG001|Overall Study|Death|148|||
170890117|NCT01250379|617604211|FG000|Overall Study|Withdrawal by Subject|32|||
170890118|NCT01250379|617604212|FG001|Overall Study|Withdrawal by Subject|20|||
170890119|NCT01250379|617604211|FG000|Overall Study|Physician Decision|11|||
170890120|NCT01250379|617604212|FG001|Overall Study|Physician Decision|3|||
170890121|NCT01250379|617604211|FG000|Overall Study|Protocol Violation|2|||
170890122|NCT01250379|617604212|FG001|Overall Study|Protocol Violation|8|||
170890123|NCT01250379|617604211|FG000|Overall Study|Lost to Follow-up|9|||
170890124|NCT01250379|617604212|FG001|Overall Study|Lost to Follow-up|6|||
170890125|NCT01250379|617604211|FG000|Overall Study|Adverse Event|5|||
170890126|NCT01250379|617604212|FG001|Overall Study|Adverse Event|4|||
170890127|NCT01250379|617604211|FG000|Overall Study|Other|0|||
170890128|NCT01250379|617604212|FG001|Overall Study|Other|4|||
170890129|NCT01250379|617604211|FG000|Overall Study|Participant noncompliance|2|||
170890130|NCT01250379|617604212|FG001|Overall Study|Participant noncompliance|0|||
170890131|NCT03864653|617604213|FG000|Overall Study|Withdrawal by Subject|1|||
170890132|NCT01489527|617604214|FG000|Overall Study|Pregnancy|9|||
170890133|NCT01489527|617604215|FG001|Overall Study|Pregnancy|14|||
170890134|NCT01489527|617604214|FG000|Overall Study|Participant moved|6|||
170890135|NCT01489527|617604215|FG001|Overall Study|Participant moved|7|||
170890136|NCT01489527|617604214|FG000|Overall Study|Withdrawal by Subject|0|||
170890137|NCT01489527|617604215|FG001|Overall Study|Withdrawal by Subject|4|||
170890138|NCT01489527|617604214|FG000|Overall Study|Lost to Follow-up|5|||
170890139|NCT01489527|617604215|FG001|Overall Study|Lost to Follow-up|1|||
170890140|NCT01489527|617604214|FG000|Overall Study|Procedures|1|||
170789566|NCT00248287|617240343|FG000|Overall Study|Patient Request|5|||
170789567|NCT00248287|617240344|FG001|Overall Study|Patient Request|3|||
170789568|NCT00248287|617240343|FG000|Overall Study|Other|3|||
170789569|NCT00248287|617240344|FG001|Overall Study|Other|2|||
170789570|NCT04907851|617240345|FG000|Overall Study|Consent withdrawn|1|||
170789571|NCT04907851|617240346|FG001|Overall Study|Consent withdrawn|2|||
170890141|NCT01489527|617604215|FG001|Overall Study|Procedures|0|||
170890142|NCT01489527|617604214|FG000|Overall Study|Not compliant|1|||
170890143|NCT01489527|617604215|FG001|Overall Study|Not compliant|0|||
170890144|NCT01984268|617604216|FG000|Overall Study|Study Terminated|15|||
170890145|NCT01928381|617604217|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
170890146|NCT01928381|617604218|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
170890147|NCT01928381|617604219|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
170890148|NCT01928381|617604220|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
170890149|NCT01928381|617604221|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
170890150|NCT01928381|617604222|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
170890151|NCT01928381|617604223|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
170890152|NCT01928381|617604217|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
170890153|NCT01928381|617604218|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
170636675|NCT05307692|616680925|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
170636676|NCT05307692|616680926|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
170636677|NCT05307692|616680923|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
170636678|NCT05307692|616680924|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
170636679|NCT05307692|616680925|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
170462984|NCT03496610|616034719|FG001|Overall Study|Lost to Follow-up|2|||
170636680|NCT05307692|616680926|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
170462985|NCT03496610|616034718|FG000|Overall Study|Physician Decision|1|||
170462986|NCT03496610|616034719|FG001|Overall Study|Physician Decision|0|||
170462987|NCT03496610|616034718|FG000|Overall Study|Withdrawal by Subject|1|||
170462988|NCT03496610|616034719|FG001|Overall Study|Withdrawal by Subject|0|||
170462989|NCT00827632|616034720|FG000|Overall Study|Lost to Follow-up|8|||
170462990|NCT00827632|616034721|FG001|Overall Study|Lost to Follow-up|12|||
170462991|NCT00827632|616034720|FG000|Overall Study|Early withdrawal|14|||
170462992|NCT00827632|616034721|FG001|Overall Study|Early withdrawal|11|||
170462993|NCT00750308|616034734|FG000|First Treatment|Adverse Event|0|||
170462994|NCT00750308|616034735|FG001|First Treatment|Adverse Event|1|||
170462995|NCT00750308|616034736|FG002|First Treatment|Adverse Event|0|||
170462996|NCT00750308|616034737|FG003|First Treatment|Adverse Event|0|||
170462997|NCT00750308|616034738|FG004|First Treatment|Adverse Event|0|||
170462998|NCT00750308|616034739|FG005|First Treatment|Adverse Event|0|||
170462999|NCT00750308|616034740|FG006|First Treatment|Adverse Event|0|||
170463000|NCT00750308|616034741|FG007|First Treatment|Adverse Event|0|||
170463001|NCT00750308|616034742|FG008|First Treatment|Adverse Event|0|||
170463002|NCT00750308|616034743|FG009|First Treatment|Adverse Event|0|||
170463003|NCT00750308|616034744|FG010|First Treatment|Adverse Event|1|||
170463004|NCT00750308|616034745|FG011|First Treatment|Adverse Event|1|||
170463005|NCT00750308|616034734|FG000|First Treatment|Withdrawal by Subject|0|||
170463006|NCT00750308|616034735|FG001|First Treatment|Withdrawal by Subject|0|||
170463007|NCT00750308|616034736|FG002|First Treatment|Withdrawal by Subject|0|||
170463008|NCT00750308|616034737|FG003|First Treatment|Withdrawal by Subject|1|||
170463009|NCT00750308|616034738|FG004|First Treatment|Withdrawal by Subject|0|||
170463010|NCT00750308|616034739|FG005|First Treatment|Withdrawal by Subject|0|||
170463011|NCT00750308|616034740|FG006|First Treatment|Withdrawal by Subject|0|||
170463012|NCT00750308|616034741|FG007|First Treatment|Withdrawal by Subject|1|||
170463013|NCT00750308|616034742|FG008|First Treatment|Withdrawal by Subject|0|||
170463014|NCT00750308|616034743|FG009|First Treatment|Withdrawal by Subject|0|||
170463015|NCT00750308|616034744|FG010|First Treatment|Withdrawal by Subject|0|||
170463016|NCT00750308|616034745|FG011|First Treatment|Withdrawal by Subject|0|||
170463017|NCT00750308|616034734|FG000|Second Treatment|Adverse Event|0|||
170463018|NCT00750308|616034735|FG001|Second Treatment|Adverse Event|0|||
170463019|NCT00750308|616034736|FG002|Second Treatment|Adverse Event|0|||
170463020|NCT00750308|616034737|FG003|Second Treatment|Adverse Event|0|||
170463021|NCT00750308|616034738|FG004|Second Treatment|Adverse Event|0|||
170463022|NCT00750308|616034739|FG005|Second Treatment|Adverse Event|1|||
170463023|NCT00750308|616034740|FG006|Second Treatment|Adverse Event|0|||
170463024|NCT00750308|616034741|FG007|Second Treatment|Adverse Event|0|||
170463025|NCT00750308|616034742|FG008|Second Treatment|Adverse Event|1|||
170463026|NCT00750308|616034743|FG009|Second Treatment|Adverse Event|0|||
170463027|NCT00750308|616034744|FG010|Second Treatment|Adverse Event|0|||
170463028|NCT00750308|616034745|FG011|Second Treatment|Adverse Event|0|||
170463029|NCT00750308|616034734|FG000|Second Treatment|Withdrawal by Subject|0|||
170463030|NCT00750308|616034735|FG001|Second Treatment|Withdrawal by Subject|0|||
170463031|NCT00750308|616034736|FG002|Second Treatment|Withdrawal by Subject|0|||
170463032|NCT00750308|616034737|FG003|Second Treatment|Withdrawal by Subject|0|||
170463033|NCT00750308|616034738|FG004|Second Treatment|Withdrawal by Subject|1|||
170463034|NCT00750308|616034739|FG005|Second Treatment|Withdrawal by Subject|0|||
170463035|NCT00750308|616034740|FG006|Second Treatment|Withdrawal by Subject|0|||
170463036|NCT00750308|616034741|FG007|Second Treatment|Withdrawal by Subject|0|||
170463037|NCT00750308|616034742|FG008|Second Treatment|Withdrawal by Subject|0|||
170463038|NCT00750308|616034743|FG009|Second Treatment|Withdrawal by Subject|0|||
170463039|NCT00750308|616034744|FG010|Second Treatment|Withdrawal by Subject|0|||
170463040|NCT00750308|616034745|FG011|Second Treatment|Withdrawal by Subject|0|||
170463041|NCT00750308|616034734|FG000|Third Treatment|Withdrawal by Subject|0|||
170463042|NCT00750308|616034735|FG001|Third Treatment|Withdrawal by Subject|1|||
170463043|NCT00750308|616034736|FG002|Third Treatment|Withdrawal by Subject|0|||
170463044|NCT00750308|616034737|FG003|Third Treatment|Withdrawal by Subject|0|||
170463045|NCT00750308|616034738|FG004|Third Treatment|Withdrawal by Subject|0|||
170463046|NCT00750308|616034739|FG005|Third Treatment|Withdrawal by Subject|0|||
170463047|NCT00750308|616034740|FG006|Third Treatment|Withdrawal by Subject|0|||
170789572|NCT04907851|617240347|FG002|Overall Study|Consent withdrawn|0|||
170789573|NCT04907851|617240345|FG000|Overall Study|Death|5|||
170789574|NCT04907851|617240346|FG001|Overall Study|Death|15|||
170789575|NCT04907851|617240347|FG002|Overall Study|Death|10|||
170463048|NCT00750308|616034741|FG007|Third Treatment|Withdrawal by Subject|0|||
170463049|NCT00750308|616034742|FG008|Third Treatment|Withdrawal by Subject|0|||
170463050|NCT00750308|616034743|FG009|Third Treatment|Withdrawal by Subject|0|||
170789576|NCT05281562|617240352|FG000|Overall Study|Ineligible patient|1|||
170463051|NCT00750308|616034744|FG010|Third Treatment|Withdrawal by Subject|0|||
170463052|NCT00750308|616034745|FG011|Third Treatment|Withdrawal by Subject|0|||
170463053|NCT00513682|616034746|FG000|Washout Phase|Adverse Event|2|||
170463054|NCT02450526|616034747|FG000|DB Period (Cycle 1)|Adverse Event|0|||
170463055|NCT02450526|616034748|FG001|DB Period (Cycle 1)|Adverse Event|0|||
170463056|NCT02450526|616034749|FG002|DB Period (Cycle 1)|Adverse Event|2|||
170463057|NCT02450526|616034750|FG003|DB Period (Cycle 1)|Adverse Event|0|||
170789577|NCT05281562|617240353|FG001|Overall Study|Ineligible patient|0|||
170463058|NCT02450526|616034751|FG004|DB Period (Cycle 1)|Adverse Event|0|||
170463059|NCT02450526|616034747|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
170463060|NCT02450526|616034748|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
170463061|NCT02450526|616034749|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
170463062|NCT02450526|616034750|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
170463063|NCT02450526|616034751|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
170463064|NCT02450526|616034747|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
170463065|NCT02450526|616034748|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
170463066|NCT02450526|616034749|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
170463067|NCT02450526|616034750|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
170463068|NCT02450526|616034751|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
170463069|NCT02450526|616034747|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
170463070|NCT02450526|616034748|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
170463071|NCT02450526|616034749|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
170463072|NCT02450526|616034750|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
170463073|NCT02450526|616034751|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
170463074|NCT02450526|616034747|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
170463075|NCT02450526|616034748|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
170463076|NCT02450526|616034749|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
170463077|NCT02450526|616034750|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
170463078|NCT02450526|616034751|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
170463079|NCT02450526|616034747|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
170463080|NCT02450526|616034748|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
170463081|NCT02450526|616034749|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
170463082|NCT02450526|616034750|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
170463083|NCT02450526|616034751|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
170463084|NCT02450526|616034747|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
170463085|NCT02450526|616034748|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
170463086|NCT02450526|616034749|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
170463087|NCT02450526|616034750|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
170463088|NCT02450526|616034751|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
170463089|NCT02450526|616034747|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
170463090|NCT02450526|616034748|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
170463091|NCT02450526|616034749|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
170463092|NCT02450526|616034750|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
170463093|NCT02450526|616034751|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
170463094|NCT00911807|616034752|FG000|Overall Study|Adverse Event|2|||
170463095|NCT00911807|616034753|FG001|Overall Study|Adverse Event|1|||
170463096|NCT00911807|616034754|FG002|Overall Study|Adverse Event|5|||
170463097|NCT00911807|616034752|FG000|Overall Study|Death|0|||
170463098|NCT00911807|616034753|FG001|Overall Study|Death|0|||
170463099|NCT00911807|616034754|FG002|Overall Study|Death|1|||
170463100|NCT00911807|616034752|FG000|Overall Study|Protocol Violation|6|||
170463101|NCT00911807|616034753|FG001|Overall Study|Protocol Violation|4|||
170463102|NCT00911807|616034754|FG002|Overall Study|Protocol Violation|9|||
170463103|NCT00911807|616034752|FG000|Overall Study|Withdrawal by Subject|8|||
170463104|NCT00911807|616034753|FG001|Overall Study|Withdrawal by Subject|10|||
170463105|NCT00911807|616034754|FG002|Overall Study|Withdrawal by Subject|7|||
170463106|NCT00911807|616034752|FG000|Overall Study|Organizational reasons|1|||
170463107|NCT00911807|616034753|FG001|Overall Study|Organizational reasons|3|||
170463108|NCT00911807|616034754|FG002|Overall Study|Organizational reasons|1|||
170463109|NCT01753336|616034755|FG000|Overall Study|Patient decision|12|||
170463110|NCT01753336|616034755|FG000|Overall Study|Lost to Follow-up|3|||
170463111|NCT01753336|616034755|FG000|Overall Study|Physician Decision|2|||
170463112|NCT01753336|616034755|FG000|Overall Study|Sponsor's decision|2|||
170463113|NCT01753336|616034755|FG000|Overall Study|Withdrawal by Subject|1|||
170463114|NCT00809159|616034756|FG000|Part 1|Adverse Event|1|||
170463115|NCT00809159|616034757|FG001|Part 1|Adverse Event|1|||
170463116|NCT00809159|616034758|FG002|Part 1|Adverse Event|0|||
170463117|NCT00809159|616034759|FG003|Part 1|Adverse Event|0|||
170463118|NCT00809159|616034760|FG004|Part 1|Adverse Event|0|||
170463119|NCT00809159|616034761|FG005|Part 1|Adverse Event|0|||
170463120|NCT00809159|616034756|FG000|Part 1|Lost to Follow-up|1|||
170463121|NCT00809159|616034757|FG001|Part 1|Lost to Follow-up|0|||
170463122|NCT00809159|616034758|FG002|Part 1|Lost to Follow-up|0|||
170463123|NCT00809159|616034759|FG003|Part 1|Lost to Follow-up|0|||
170463124|NCT00809159|616034760|FG004|Part 1|Lost to Follow-up|0|||
170463125|NCT00809159|616034761|FG005|Part 1|Lost to Follow-up|0|||
170463126|NCT00809159|616034756|FG000|Part 1|Withdrawal by Subject|3|||
170463127|NCT00809159|616034757|FG001|Part 1|Withdrawal by Subject|1|||
170463128|NCT00809159|616034758|FG002|Part 1|Withdrawal by Subject|0|||
170463129|NCT00809159|616034759|FG003|Part 1|Withdrawal by Subject|0|||
170463130|NCT00809159|616034760|FG004|Part 1|Withdrawal by Subject|0|||
170890154|NCT01928381|617604219|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
170463131|NCT00809159|616034761|FG005|Part 1|Withdrawal by Subject|0|||
170463132|NCT00809159|616034756|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
170463133|NCT00809159|616034757|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
170463134|NCT00809159|616034758|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
170789578|NCT06457802|617240355|FG000|Overall Study|Early termination of study prior to participant completion|2|||
170789579|NCT06457802|617240356|FG001|Overall Study|Early termination of study prior to participant completion|2|||
170789580|NCT04719832|617240359|FG000|Overall Study|Adverse Event|2|||
170789581|NCT04719832|617240360|FG001|Overall Study|Adverse Event|0|||
170463135|NCT00809159|616034759|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
170789582|NCT04719832|617240359|FG000|Overall Study|Lack of Efficacy|2|||
170463136|NCT00809159|616034760|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
170463137|NCT00809159|616034761|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
170463138|NCT00809159|616034756|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
170463139|NCT00809159|616034757|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
170463140|NCT00809159|616034758|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
170463141|NCT00809159|616034759|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
170463142|NCT00809159|616034760|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
170463143|NCT00809159|616034761|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
170463144|NCT00809159|616034756|FG000|Part 1 and 2|Administrative problems|0|||
170463145|NCT00809159|616034757|FG001|Part 1 and 2|Administrative problems|0|||
170789583|NCT04719832|617240360|FG001|Overall Study|Lack of Efficacy|4|||
170789584|NCT04719832|617240359|FG000|Overall Study|Lost to Follow-up|0|||
170789585|NCT04719832|617240360|FG001|Overall Study|Lost to Follow-up|2|||
170789586|NCT04719832|617240359|FG000|Overall Study|Physician Decision|0|||
170789587|NCT04719832|617240360|FG001|Overall Study|Physician Decision|1|||
170789588|NCT04719832|617240359|FG000|Overall Study|Pregnancy|1|||
170789589|NCT04719832|617240360|FG001|Overall Study|Pregnancy|1|||
170789590|NCT04719832|617240359|FG000|Overall Study|Withdrawal by Subject|5|||
170789591|NCT04719832|617240360|FG001|Overall Study|Withdrawal by Subject|5|||
170789592|NCT04719832|617240359|FG000|Overall Study|Randomized, not treated|0|||
170789593|NCT04719832|617240360|FG001|Overall Study|Randomized, not treated|2|||
170789594|NCT04719832|617240359|FG000|Overall Study|GCP violations|4|||
170789595|NCT04719832|617240360|FG001|Overall Study|GCP violations|7|||
170789596|NCT03819153|617240363|FG000|Overall Study|Withdrawal by Subject|20|||
170789597|NCT03819153|617240364|FG001|Overall Study|Withdrawal by Subject|28|||
170789598|NCT03819153|617240363|FG000|Overall Study|Lost to Follow-up|23|||
170789599|NCT03819153|617240364|FG001|Overall Study|Lost to Follow-up|30|||
170789600|NCT04898673|617240373|FG000|Overall Study|Screenfail|1|||
170890155|NCT01928381|617604220|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
170890156|NCT01928381|617604221|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
170890157|NCT01928381|617604222|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
170890158|NCT01928381|617604223|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
170890159|NCT01928381|617604217|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
170463146|NCT00809159|616034758|FG002|Part 1 and 2|Administrative problems|0|||
170463147|NCT00809159|616034759|FG003|Part 1 and 2|Administrative problems|1|||
170463148|NCT00809159|616034760|FG004|Part 1 and 2|Administrative problems|0|||
170463149|NCT00809159|616034761|FG005|Part 1 and 2|Administrative problems|0|||
170789601|NCT04898673|617240374|FG001|Overall Study|Screenfail|0|||
170789602|NCT05526430|617240378|FG000|Overall Study|Withdrawal by Subject|0|||
170789603|NCT05526430|617240379|FG001|Overall Study|Withdrawal by Subject|2|||
170789604|NCT05526430|617240380|FG002|Overall Study|Withdrawal by Subject|0|||
170789605|NCT05526430|617240381|FG003|Overall Study|Withdrawal by Subject|0|||
170789606|NCT02305888|617240384|FG000|Overall Study|Lost to Follow-up|0|||
170789607|NCT02305888|617240385|FG001|Overall Study|Lost to Follow-up|0|||
170789608|NCT02305888|617240386|FG002|Overall Study|Lost to Follow-up|1|||
170789609|NCT02305888|617240384|FG000|Overall Study|Adverse Event|0|||
170789610|NCT02305888|617240385|FG001|Overall Study|Adverse Event|1|||
170789611|NCT02305888|617240386|FG002|Overall Study|Adverse Event|0|||
170789612|NCT03024437|617240387|FG000|Overall Study|Adverse Event|0|||
170789613|NCT03024437|617240388|FG001|Overall Study|Adverse Event|1|||
170890160|NCT01928381|617604218|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
170890161|NCT01928381|617604219|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
170890162|NCT01928381|617604220|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
170890163|NCT01928381|617604221|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
170890164|NCT01928381|617604222|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
170890165|NCT01928381|617604223|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
170890166|NCT01928381|617604217|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
170890167|NCT01928381|617604218|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
170789614|NCT03024437|617240389|FG002|Overall Study|Adverse Event|3|||
170789615|NCT03024437|617240390|FG003|Overall Study|Adverse Event|5|||
170789616|NCT03024437|617240391|FG004|Overall Study|Adverse Event|0|||
170789617|NCT03024437|617240387|FG000|Overall Study|Physician Decision|1|||
170463150|NCT00809159|616034756|FG000|Part 1 and 2|Adverse Event|0|||
170463151|NCT00809159|616034757|FG001|Part 1 and 2|Adverse Event|0|||
170789618|NCT03024437|617240388|FG001|Overall Study|Physician Decision|0|||
170890168|NCT01928381|617604219|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
170890169|NCT01928381|617604220|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
170890170|NCT01928381|617604221|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
170890171|NCT01928381|617604222|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
170890172|NCT01928381|617604223|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
170463152|NCT00809159|616034758|FG002|Part 1 and 2|Adverse Event|1|||
170463153|NCT00809159|616034759|FG003|Part 1 and 2|Adverse Event|0|||
170463154|NCT00809159|616034760|FG004|Part 1 and 2|Adverse Event|1|||
170463155|NCT00809159|616034761|FG005|Part 1 and 2|Adverse Event|1|||
170463156|NCT00809159|616034756|FG000|Part 1 and 2|Lost to Follow-up|0|||
170463157|NCT00809159|616034757|FG001|Part 1 and 2|Lost to Follow-up|0|||
170463158|NCT00809159|616034758|FG002|Part 1 and 2|Lost to Follow-up|1|||
170463159|NCT00809159|616034759|FG003|Part 1 and 2|Lost to Follow-up|1|||
170463160|NCT00809159|616034760|FG004|Part 1 and 2|Lost to Follow-up|0|||
170463161|NCT00809159|616034761|FG005|Part 1 and 2|Lost to Follow-up|0|||
170463162|NCT00809159|616034756|FG000|Part 1 and 2|Withdrawal by Subject|0|||
170463163|NCT00809159|616034757|FG001|Part 1 and 2|Withdrawal by Subject|0|||
170463164|NCT00809159|616034758|FG002|Part 1 and 2|Withdrawal by Subject|4|||
170463165|NCT00809159|616034759|FG003|Part 1 and 2|Withdrawal by Subject|0|||
170463166|NCT00809159|616034760|FG004|Part 1 and 2|Withdrawal by Subject|0|||
170463167|NCT00809159|616034761|FG005|Part 1 and 2|Withdrawal by Subject|1|||
170463168|NCT03201211|616034762|FG000|Overall Study|Adverse Event|1|||
170463169|NCT03201211|616034763|FG001|Overall Study|Adverse Event|0|||
170463170|NCT03201211|616034764|FG002|Overall Study|Adverse Event|0|||
170463171|NCT03201211|616034762|FG000|Overall Study|Protocol Violation|1|||
170463172|NCT03201211|616034763|FG001|Overall Study|Protocol Violation|0|||
170463173|NCT03201211|616034764|FG002|Overall Study|Protocol Violation|0|||
170463174|NCT03201211|616034762|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170463175|NCT03201211|616034763|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170463176|NCT03201211|616034764|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
170463177|NCT03201211|616034762|FG000|Overall Study|OTHER unknown reasons|0|||
170463178|NCT03201211|616034763|FG001|Overall Study|OTHER unknown reasons|1|||
170463179|NCT03201211|616034764|FG002|Overall Study|OTHER unknown reasons|0|||
170463180|NCT00620659|616034765|FG000|Treatment Period 1|Adverse Event|1|||
170463181|NCT00620659|616034766|FG001|Treatment Period 1|Adverse Event|0|||
170463182|NCT00620659|616034767|FG002|Treatment Period 1|Adverse Event|0|||
170463183|NCT00620659|616034768|FG003|Treatment Period 1|Adverse Event|3|||
170463184|NCT00620659|616034769|FG004|Treatment Period 1|Adverse Event|0|||
170463185|NCT00620659|616034770|FG005|Treatment Period 1|Adverse Event|0|||
170463186|NCT00620659|616034765|FG000|Treatment Period 1|Protocol Violation|1|||
170463187|NCT00620659|616034766|FG001|Treatment Period 1|Protocol Violation|0|||
170463188|NCT00620659|616034767|FG002|Treatment Period 1|Protocol Violation|0|||
170463189|NCT00620659|616034768|FG003|Treatment Period 1|Protocol Violation|0|||
170463190|NCT00620659|616034769|FG004|Treatment Period 1|Protocol Violation|0|||
170463191|NCT00620659|616034770|FG005|Treatment Period 1|Protocol Violation|0|||
170463192|NCT00620659|616034765|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170463193|NCT00620659|616034766|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170463194|NCT00620659|616034767|FG002|Treatment Period 1|Withdrawal by Subject|1|||
170463195|NCT00620659|616034768|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170463196|NCT00620659|616034769|FG004|Treatment Period 1|Withdrawal by Subject|1|||
170463197|NCT00620659|616034770|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170463198|NCT00620659|616034765|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
170463199|NCT00620659|616034766|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
170463200|NCT00620659|616034767|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
170463201|NCT00620659|616034768|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
170463202|NCT00620659|616034769|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
170463203|NCT00620659|616034770|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
170463204|NCT00620659|616034765|FG000|Treatment Period 2|Adverse Event|0|||
170463205|NCT00620659|616034766|FG001|Treatment Period 2|Adverse Event|3|||
170463206|NCT00620659|616034767|FG002|Treatment Period 2|Adverse Event|0|||
170463207|NCT00620659|616034768|FG003|Treatment Period 2|Adverse Event|0|||
170463208|NCT00620659|616034769|FG004|Treatment Period 2|Adverse Event|2|||
170463209|NCT00620659|616034770|FG005|Treatment Period 2|Adverse Event|0|||
170463210|NCT00620659|616034765|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170463211|NCT00620659|616034766|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170463212|NCT00620659|616034767|FG002|Treatment Period 2|Withdrawal by Subject|1|||
170463213|NCT00620659|616034768|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170463214|NCT00620659|616034769|FG004|Treatment Period 2|Withdrawal by Subject|3|||
170463215|NCT00620659|616034770|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170463216|NCT00620659|616034765|FG000|Placebo Washout Period 2|Adverse Event|2|||
170463217|NCT00620659|616034766|FG001|Placebo Washout Period 2|Adverse Event|0|||
170463218|NCT00620659|616034767|FG002|Placebo Washout Period 2|Adverse Event|0|||
170463219|NCT00620659|616034768|FG003|Placebo Washout Period 2|Adverse Event|0|||
170463220|NCT00620659|616034769|FG004|Placebo Washout Period 2|Adverse Event|0|||
170463221|NCT00620659|616034770|FG005|Placebo Washout Period 2|Adverse Event|0|||
170544405|NCT01658878|616337283|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170463222|NCT00620659|616034765|FG000|Treatment Period 3|Adverse Event|0|||
170463223|NCT00620659|616034766|FG001|Treatment Period 3|Adverse Event|2|||
170463224|NCT00620659|616034767|FG002|Treatment Period 3|Adverse Event|0|||
170463225|NCT00620659|616034768|FG003|Treatment Period 3|Adverse Event|0|||
170463226|NCT00620659|616034769|FG004|Treatment Period 3|Adverse Event|0|||
170463227|NCT00620659|616034770|FG005|Treatment Period 3|Adverse Event|0|||
170463228|NCT00620659|616034765|FG000|Treatment Period 3|Withdrawal by Subject|0|||
170463229|NCT00620659|616034766|FG001|Treatment Period 3|Withdrawal by Subject|0|||
170463230|NCT00620659|616034767|FG002|Treatment Period 3|Withdrawal by Subject|0|||
170463231|NCT00620659|616034768|FG003|Treatment Period 3|Withdrawal by Subject|1|||
170463232|NCT00620659|616034769|FG004|Treatment Period 3|Withdrawal by Subject|0|||
170463233|NCT00620659|616034770|FG005|Treatment Period 3|Withdrawal by Subject|0|||
170463234|NCT00758680|616034776|FG000|Overall Study|Adverse Event|0|||
170463235|NCT00758680|616034777|FG001|Overall Study|Adverse Event|0|||
170463236|NCT00758680|616034778|FG002|Overall Study|Adverse Event|0|||
170463237|NCT00758680|616034779|FG003|Overall Study|Adverse Event|0|||
170463238|NCT00758680|616034780|FG004|Overall Study|Adverse Event|0|||
170463239|NCT00758680|616034781|FG005|Overall Study|Adverse Event|0|||
170463240|NCT00758680|616034782|FG006|Overall Study|Adverse Event|0|||
170463241|NCT00758680|616034783|FG007|Overall Study|Adverse Event|1|||
170463242|NCT00758680|616034784|FG008|Overall Study|Adverse Event|0|||
170463243|NCT00758680|616034785|FG009|Overall Study|Adverse Event|1|||
170463244|NCT00758680|616034776|FG000|Overall Study|Laboratory Adverse Event|0|||
170463245|NCT00758680|616034777|FG001|Overall Study|Laboratory Adverse Event|0|||
170463246|NCT00758680|616034778|FG002|Overall Study|Laboratory Adverse Event|0|||
170463247|NCT00758680|616034779|FG003|Overall Study|Laboratory Adverse Event|0|||
170463248|NCT00758680|616034780|FG004|Overall Study|Laboratory Adverse Event|0|||
170463249|NCT00758680|616034781|FG005|Overall Study|Laboratory Adverse Event|0|||
170463250|NCT00758680|616034782|FG006|Overall Study|Laboratory Adverse Event|0|||
170463251|NCT00758680|616034783|FG007|Overall Study|Laboratory Adverse Event|0|||
170463252|NCT00758680|616034784|FG008|Overall Study|Laboratory Adverse Event|1|||
170463253|NCT00758680|616034785|FG009|Overall Study|Laboratory Adverse Event|0|||
170463254|NCT00758680|616034776|FG000|Overall Study|Withdrawal by Subject|0|||
170463255|NCT00758680|616034777|FG001|Overall Study|Withdrawal by Subject|0|||
170463256|NCT00758680|616034778|FG002|Overall Study|Withdrawal by Subject|0|||
170463257|NCT00758680|616034779|FG003|Overall Study|Withdrawal by Subject|0|||
170544406|NCT01658878|616337284|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
170544407|NCT01658878|616337261|FG000|Treatment Period|Poor/Non-compliance|0|||
170463258|NCT00758680|616034780|FG004|Overall Study|Withdrawal by Subject|0|||
170463259|NCT00758680|616034781|FG005|Overall Study|Withdrawal by Subject|0|||
170463260|NCT00758680|616034782|FG006|Overall Study|Withdrawal by Subject|1|||
170463261|NCT00758680|616034783|FG007|Overall Study|Withdrawal by Subject|0|||
170463262|NCT00758680|616034784|FG008|Overall Study|Withdrawal by Subject|1|||
170463263|NCT00758680|616034785|FG009|Overall Study|Withdrawal by Subject|0|||
170463264|NCT00761865|616034786|FG000|Overall Study|Lost to Follow-up|8|||
170463265|NCT00761865|616034787|FG001|Overall Study|Lost to Follow-up|7|||
170463266|NCT03480386|616034788|FG000|Overall Study|Did not complete measures at 3-months|17|||
170463267|NCT03480386|616034789|FG001|Overall Study|Did not complete measures at 3-months|14|||
170463268|NCT03480386|616034788|FG000|Overall Study|No baseline measures|11|||
170463269|NCT03480386|616034789|FG001|Overall Study|No baseline measures|14|||
170463270|NCT03480386|616034788|FG000|Overall Study|Death|0|||
170463271|NCT03480386|616034789|FG001|Overall Study|Death|5|||
170463272|NCT03480386|616034788|FG000|Overall Study|Withdrawal by Subject|12|||
170463273|NCT03480386|616034789|FG001|Overall Study|Withdrawal by Subject|8|||
170463274|NCT03480386|616034788|FG000|Overall Study|Lost to Follow-up|2|||
170463275|NCT03480386|616034789|FG001|Overall Study|Lost to Follow-up|1|||
170463276|NCT03480386|616034788|FG000|Overall Study|Complicating disease|0|||
170463277|NCT03480386|616034789|FG001|Overall Study|Complicating disease|1|||
170463278|NCT03480386|616034788|FG000|Overall Study|Disease progression|3|||
170463279|NCT03480386|616034789|FG001|Overall Study|Disease progression|0|||
170463280|NCT03480386|616034788|FG000|Overall Study|Became ineligible|0|||
170463281|NCT03480386|616034789|FG001|Overall Study|Became ineligible|2|||
170463282|NCT04555720|616034794|FG000|Overall Study|Lost to Follow-up|2|||
170463283|NCT04555720|616034795|FG001|Overall Study|Lost to Follow-up|0|||
170463284|NCT04555720|616034796|FG002|Overall Study|Lost to Follow-up|0|||
170463285|NCT04555720|616034797|FG003|Overall Study|Lost to Follow-up|0|||
170463286|NCT04555720|616034794|FG000|Overall Study|Withdrawal by Subject|4|||
170463287|NCT04555720|616034795|FG001|Overall Study|Withdrawal by Subject|6|||
170463288|NCT04555720|616034796|FG002|Overall Study|Withdrawal by Subject|0|||
170463289|NCT04555720|616034797|FG003|Overall Study|Withdrawal by Subject|0|||
170463290|NCT00968799|616034798|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
170463291|NCT00719849|616034801|FG000|Overall Study|Death|0|||
170463292|NCT00719849|616034802|FG001|Overall Study|Death|1|||
170544408|NCT01658878|616337262|FG001|Treatment Period|Poor/Non-compliance|0|||
170544409|NCT01658878|616337263|FG002|Treatment Period|Poor/Non-compliance|0|||
170544410|NCT01658878|616337264|FG003|Treatment Period|Poor/Non-compliance|0|||
170544411|NCT01658878|616337265|FG004|Treatment Period|Poor/Non-compliance|0|||
170544412|NCT01658878|616337266|FG005|Treatment Period|Poor/Non-compliance|0|||
170544413|NCT01658878|616337267|FG006|Treatment Period|Poor/Non-compliance|0|||
170544414|NCT01658878|616337268|FG007|Treatment Period|Poor/Non-compliance|0|||
170544415|NCT01658878|616337269|FG008|Treatment Period|Poor/Non-compliance|0|||
170544416|NCT01658878|616337270|FG009|Treatment Period|Poor/Non-compliance|0|||
170544417|NCT01658878|616337271|FG010|Treatment Period|Poor/Non-compliance|0|||
170544418|NCT01658878|616337272|FG011|Treatment Period|Poor/Non-compliance|0|||
170544419|NCT01658878|616337273|FG012|Treatment Period|Poor/Non-compliance|0|||
170544420|NCT01658878|616337274|FG013|Treatment Period|Poor/Non-compliance|0|||
170544421|NCT01658878|616337275|FG014|Treatment Period|Poor/Non-compliance|0|||
170544422|NCT01658878|616337276|FG015|Treatment Period|Poor/Non-compliance|1|||
170789619|NCT03024437|617240389|FG002|Overall Study|Physician Decision|0|||
170789620|NCT03024437|617240390|FG003|Overall Study|Physician Decision|1|||
170789621|NCT03024437|617240391|FG004|Overall Study|Physician Decision|0|||
170789622|NCT03024437|617240387|FG000|Overall Study|Disease progression, relapse|1|||
170789623|NCT03024437|617240388|FG001|Overall Study|Disease progression, relapse|0|||
170789624|NCT03024437|617240389|FG002|Overall Study|Disease progression, relapse|0|||
170789625|NCT03024437|617240390|FG003|Overall Study|Disease progression, relapse|3|||
170789626|NCT03024437|617240391|FG004|Overall Study|Disease progression, relapse|0|||
170789627|NCT03024437|617240387|FG000|Overall Study|Disease progression, refractory disease|4|||
170789628|NCT03024437|617240388|FG001|Overall Study|Disease progression, refractory disease|4|||
170789629|NCT03024437|617240389|FG002|Overall Study|Disease progression, refractory disease|2|||
170789630|NCT03024437|617240390|FG003|Overall Study|Disease progression, refractory disease|2|||
170789631|NCT03024437|617240391|FG004|Overall Study|Disease progression, refractory disease|1|||
170789632|NCT03024437|617240387|FG000|Overall Study|Newly diagnosed cancer|0|||
170544423|NCT01658878|616337277|FG016|Treatment Period|Poor/Non-compliance|0|||
170544424|NCT01658878|616337278|FG017|Treatment Period|Poor/Non-compliance|0|||
170544425|NCT01658878|616337279|FG018|Treatment Period|Poor/Non-compliance|0|||
170544426|NCT01658878|616337280|FG019|Treatment Period|Poor/Non-compliance|0|||
170544427|NCT01658878|616337281|FG020|Treatment Period|Poor/Non-compliance|0|||
170544428|NCT01658878|616337282|FG021|Treatment Period|Poor/Non-compliance|0|||
170544429|NCT01658878|616337283|FG022|Treatment Period|Poor/Non-compliance|0|||
170789633|NCT03024437|617240388|FG001|Overall Study|Newly diagnosed cancer|0|||
170789634|NCT03024437|617240389|FG002|Overall Study|Newly diagnosed cancer|0|||
170789635|NCT03024437|617240390|FG003|Overall Study|Newly diagnosed cancer|1|||
170463293|NCT00389831|616034806|FG000|Overall Study|Lack of Efficacy|0|||
170463294|NCT00389831|616034807|FG001|Overall Study|Lack of Efficacy|2|||
170463295|NCT00389831|616034806|FG000|Overall Study|Did not receive treatment.|0|||
170463296|NCT00389831|616034807|FG001|Overall Study|Did not receive treatment.|2|||
170463297|NCT00389831|616034806|FG000|Overall Study|Other reasons|0|||
170544430|NCT01658878|616337284|FG023|Treatment Period|Poor/Non-compliance|0|||
170544431|NCT01658878|616337261|FG000|Treatment Period|Participant Withdrew Consent|0|||
170544432|NCT01658878|616337262|FG001|Treatment Period|Participant Withdrew Consent|0|||
170463298|NCT00389831|616034807|FG001|Overall Study|Other reasons|2|||
170463299|NCT00389831|616034806|FG000|Overall Study|Lost to Follow-up|0|||
170463300|NCT00389831|616034807|FG001|Overall Study|Lost to Follow-up|1|||
170463301|NCT00321737|616034808|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
170463302|NCT00321737|616034809|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
170463303|NCT00321737|616034810|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
170463304|NCT00321737|616034808|FG000|Overall Study|Adverse Event|11|||
170463305|NCT00321737|616034809|FG001|Overall Study|Adverse Event|3|||
170463306|NCT00321737|616034810|FG002|Overall Study|Adverse Event|6|||
170463307|NCT00321737|616034808|FG000|Overall Study|Lost to Follow-up|5|||
170463308|NCT00321737|616034809|FG001|Overall Study|Lost to Follow-up|5|||
170463309|NCT00321737|616034810|FG002|Overall Study|Lost to Follow-up|6|||
170463310|NCT00321737|616034808|FG000|Overall Study|Withdrawal by Subject|19|||
170463311|NCT00321737|616034809|FG001|Overall Study|Withdrawal by Subject|12|||
170463312|NCT00321737|616034810|FG002|Overall Study|Withdrawal by Subject|17|||
170463313|NCT00321737|616034808|FG000|Overall Study|Protocol Violation|0|||
170463314|NCT00321737|616034809|FG001|Overall Study|Protocol Violation|0|||
170463315|NCT00321737|616034810|FG002|Overall Study|Protocol Violation|1|||
170463316|NCT00321737|616034808|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
170463317|NCT00321737|616034809|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
170463318|NCT00321737|616034810|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
170463319|NCT00321737|616034808|FG000|Overall Study|Possible Barrett's Esophagus|2|||
170463320|NCT00321737|616034809|FG001|Overall Study|Possible Barrett's Esophagus|1|||
170463321|NCT00321737|616034810|FG002|Overall Study|Possible Barrett's Esophagus|1|||
170463322|NCT00321737|616034808|FG000|Overall Study|Therapeutic Failure|6|||
170463323|NCT00321737|616034809|FG001|Overall Study|Therapeutic Failure|0|||
170463324|NCT00321737|616034810|FG002|Overall Study|Therapeutic Failure|2|||
170463325|NCT00321737|616034808|FG000|Overall Study|Pregnancy|0|||
170463326|NCT00321737|616034809|FG001|Overall Study|Pregnancy|2|||
170463327|NCT00321737|616034810|FG002|Overall Study|Pregnancy|0|||
170463328|NCT00321737|616034808|FG000|Overall Study|Noncompliance|2|||
170463329|NCT00321737|616034809|FG001|Overall Study|Noncompliance|0|||
170463330|NCT00321737|616034810|FG002|Overall Study|Noncompliance|0|||
170463331|NCT00321737|616034808|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
170463332|NCT00321737|616034809|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
170463333|NCT00321737|616034810|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
170463334|NCT02201290|616034811|FG000|Overall Study|Withdrawal by Subject|2|||
170463335|NCT02201290|616034811|FG000|Overall Study|Lack of Efficacy|2|||
170463336|NCT02201290|616034811|FG000|Overall Study|Adverse Event|1|||
170463337|NCT01136967|616036565|FG000|Overall Study|Adverse Event|9|||
170463338|NCT01136967|616036566|FG001|Overall Study|Adverse Event|12|||
170463339|NCT01136967|616036565|FG000|Overall Study|Participant Choice|8|||
170463340|NCT01136967|616036566|FG001|Overall Study|Participant Choice|3|||
170463341|NCT01136967|616036565|FG000|Overall Study|Lost to Follow-up|0|||
170890173|NCT01928381|617604217|FG000|Part 1 - Pain Training|Protocol Violation|1|||
170890174|NCT01928381|617604218|FG001|Part 1 - Pain Training|Protocol Violation|0|||
170890175|NCT01928381|617604219|FG002|Part 1 - Pain Training|Protocol Violation|0|||
170890176|NCT01928381|617604220|FG003|Part 1 - Pain Training|Protocol Violation|0|||
170890177|NCT01928381|617604221|FG004|Part 1 - Pain Training|Protocol Violation|0|||
170890178|NCT01928381|617604222|FG005|Part 1 - Pain Training|Protocol Violation|0|||
170890179|NCT01928381|617604223|FG006|Part 1 - Pain Training|Protocol Violation|0|||
170890180|NCT01928381|617604217|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
170890181|NCT01928381|617604218|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
170890182|NCT01928381|617604219|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
170890183|NCT01928381|617604220|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
170890184|NCT01928381|617604221|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
170890185|NCT01928381|617604222|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
170890186|NCT01928381|617604223|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
170890187|NCT01928381|617604217|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
170890188|NCT01928381|617604218|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
170890189|NCT01928381|617604219|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
170890190|NCT01928381|617604220|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
170890191|NCT01928381|617604221|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
170890192|NCT01928381|617604222|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
170890193|NCT01928381|617604223|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
170890194|NCT01928381|617604217|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
170890195|NCT01928381|617604218|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
170890196|NCT01928381|617604219|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
170890197|NCT01928381|617604220|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
170890198|NCT01928381|617604221|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
170890199|NCT01928381|617604222|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
170890200|NCT01928381|617604223|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
170890201|NCT01928381|617604217|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
170463342|NCT01136967|616036566|FG001|Overall Study|Lost to Follow-up|1|||
170463343|NCT01136967|616036565|FG000|Overall Study|Withdrawal by Subject|1|||
170463344|NCT01136967|616036566|FG001|Overall Study|Withdrawal by Subject|2|||
170463345|NCT01136967|616036565|FG000|Overall Study|Clinical Progression|3|||
170463346|NCT01136967|616036566|FG001|Overall Study|Clinical Progression|5|||
170463347|NCT01136967|616036565|FG000|Overall Study|Radiation|1|||
170463348|NCT01136967|616036566|FG001|Overall Study|Radiation|0|||
170463349|NCT01136967|616036565|FG000|Overall Study|Non-compliance|1|||
170463350|NCT01136967|616036566|FG001|Overall Study|Non-compliance|0|||
170463351|NCT01136967|616036565|FG000|Overall Study|Investigator's Choice|1|||
170463352|NCT01136967|616036566|FG001|Overall Study|Investigator's Choice|1|||
170463353|NCT01136967|616036565|FG000|Overall Study|Increase in Lesion Size|0|||
170463354|NCT01136967|616036566|FG001|Overall Study|Increase in Lesion Size|2|||
170463355|NCT01136967|616036565|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
170463356|NCT01136967|616036566|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
170463357|NCT04576923|616036567|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
170463358|NCT04562155|616036568|FG000|Overall Study|COVID-19 pandemic|0|||
170463359|NCT04562155|616036569|FG001|Overall Study|COVID-19 pandemic|0|||
170463360|NCT04562155|616036570|FG002|Overall Study|COVID-19 pandemic|0|||
170463361|NCT04562155|616036571|FG003|Overall Study|COVID-19 pandemic|1|||
170463362|NCT04562155|616036568|FG000|Overall Study|Adverse Event|7|||
170463363|NCT04562155|616036569|FG001|Overall Study|Adverse Event|3|||
170463364|NCT04562155|616036570|FG002|Overall Study|Adverse Event|8|||
170463365|NCT04562155|616036571|FG003|Overall Study|Adverse Event|1|||
170463366|NCT04562155|616036568|FG000|Overall Study|Withdrawal by Subject|3|||
170463367|NCT04562155|616036569|FG001|Overall Study|Withdrawal by Subject|6|||
170463368|NCT04562155|616036570|FG002|Overall Study|Withdrawal by Subject|3|||
170463369|NCT04562155|616036571|FG003|Overall Study|Withdrawal by Subject|3|||
170463370|NCT04562155|616036568|FG000|Overall Study|Participant personal reason|1|||
170463371|NCT04562155|616036569|FG001|Overall Study|Participant personal reason|0|||
170463372|NCT04562155|616036570|FG002|Overall Study|Participant personal reason|2|||
170463373|NCT04562155|616036571|FG003|Overall Study|Participant personal reason|1|||
170463374|NCT01473524|616036572|FG000|DB Phase|Adverse Event|4|||
170463375|NCT01473524|616036573|FG001|DB Phase|Adverse Event|8|||
170463376|NCT01473524|616036574|FG002|DB Phase|Adverse Event|2|||
170463377|NCT01473524|616036575|FG003|DB Phase|Adverse Event|0|||
170463378|NCT01473524|616036576|FG004|DB Phase|Adverse Event|0|||
170463379|NCT01473524|616036577|FG005|DB Phase|Adverse Event|0|||
170463380|NCT01473524|616036572|FG000|DB Phase|Death|1|||
170463381|NCT01473524|616036573|FG001|DB Phase|Death|0|||
170463382|NCT01473524|616036574|FG002|DB Phase|Death|0|||
170463383|NCT01473524|616036575|FG003|DB Phase|Death|0|||
170463384|NCT01473524|616036576|FG004|DB Phase|Death|0|||
170463385|NCT01473524|616036577|FG005|DB Phase|Death|0|||
170463386|NCT01473524|616036572|FG000|DB Phase|Withdrawal by Subject|2|||
170463387|NCT01473524|616036573|FG001|DB Phase|Withdrawal by Subject|1|||
170463388|NCT01473524|616036574|FG002|DB Phase|Withdrawal by Subject|1|||
170463389|NCT01473524|616036575|FG003|DB Phase|Withdrawal by Subject|0|||
170463390|NCT01473524|616036576|FG004|DB Phase|Withdrawal by Subject|0|||
170463391|NCT01473524|616036577|FG005|DB Phase|Withdrawal by Subject|0|||
170463392|NCT01473524|616036572|FG000|LTSE Phase|Withdrawal by Subject|0|||
170463393|NCT01473524|616036573|FG001|LTSE Phase|Withdrawal by Subject|0|||
170463394|NCT01473524|616036574|FG002|LTSE Phase|Withdrawal by Subject|0|||
170463395|NCT01473524|616036575|FG003|LTSE Phase|Withdrawal by Subject|3|||
170463396|NCT01473524|616036576|FG004|LTSE Phase|Withdrawal by Subject|3|||
170463397|NCT01473524|616036577|FG005|LTSE Phase|Withdrawal by Subject|6|||
170463398|NCT01473524|616036572|FG000|LTSE Phase|Death|0|||
170463399|NCT01473524|616036573|FG001|LTSE Phase|Death|0|||
170463400|NCT01473524|616036574|FG002|LTSE Phase|Death|0|||
170463401|NCT01473524|616036575|FG003|LTSE Phase|Death|0|||
170463402|NCT01473524|616036576|FG004|LTSE Phase|Death|1|||
170463403|NCT01473524|616036577|FG005|LTSE Phase|Death|0|||
170463404|NCT01473524|616036572|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
170463405|NCT01473524|616036573|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
170463406|NCT01473524|616036574|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
170463407|NCT01473524|616036575|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
170463408|NCT01473524|616036576|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
170463409|NCT01473524|616036577|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
170463410|NCT01473524|616036572|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
170463411|NCT01473524|616036573|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
170463412|NCT01473524|616036574|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
170463413|NCT01473524|616036575|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
170463414|NCT01473524|616036576|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
170463415|NCT01473524|616036577|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
170463416|NCT01473524|616036572|FG000|LTSE Phase|Lost to Follow-up|0|||
170463417|NCT01473524|616036573|FG001|LTSE Phase|Lost to Follow-up|0|||
170463418|NCT01473524|616036574|FG002|LTSE Phase|Lost to Follow-up|0|||
170463419|NCT01473524|616036575|FG003|LTSE Phase|Lost to Follow-up|1|||
170463420|NCT01473524|616036576|FG004|LTSE Phase|Lost to Follow-up|3|||
170463421|NCT01473524|616036577|FG005|LTSE Phase|Lost to Follow-up|2|||
170463422|NCT01473524|616036572|FG000|LTSE Phase|Principal Investigator Decision|0|||
170463423|NCT01473524|616036573|FG001|LTSE Phase|Principal Investigator Decision|0|||
170463424|NCT01473524|616036574|FG002|LTSE Phase|Principal Investigator Decision|0|||
170463425|NCT01473524|616036575|FG003|LTSE Phase|Principal Investigator Decision|1|||
170463426|NCT01473524|616036576|FG004|LTSE Phase|Principal Investigator Decision|1|||
170463427|NCT01473524|616036577|FG005|LTSE Phase|Principal Investigator Decision|3|||
170463428|NCT01473524|616036572|FG000|LTSE Phase|Liver Transplantation|0|||
170463429|NCT01473524|616036573|FG001|LTSE Phase|Liver Transplantation|0|||
170463430|NCT01473524|616036574|FG002|LTSE Phase|Liver Transplantation|0|||
170463431|NCT01473524|616036575|FG003|LTSE Phase|Liver Transplantation|0|||
170463432|NCT01473524|616036576|FG004|LTSE Phase|Liver Transplantation|0|||
170463433|NCT01473524|616036577|FG005|LTSE Phase|Liver Transplantation|1|||
170463434|NCT01473524|616036572|FG000|LTSE Phase|Pregnancy|0|||
170463435|NCT01473524|616036573|FG001|LTSE Phase|Pregnancy|0|||
170463436|NCT01473524|616036574|FG002|LTSE Phase|Pregnancy|0|||
170463437|NCT01473524|616036575|FG003|LTSE Phase|Pregnancy|1|||
170463438|NCT01473524|616036576|FG004|LTSE Phase|Pregnancy|0|||
170463439|NCT01473524|616036577|FG005|LTSE Phase|Pregnancy|0|||
170463440|NCT01473524|616036572|FG000|LTSE Phase|Protocol Violation|0|||
170463441|NCT01473524|616036573|FG001|LTSE Phase|Protocol Violation|0|||
170463442|NCT01473524|616036574|FG002|LTSE Phase|Protocol Violation|0|||
170463443|NCT01473524|616036575|FG003|LTSE Phase|Protocol Violation|0|||
170463444|NCT01473524|616036576|FG004|LTSE Phase|Protocol Violation|0|||
170463445|NCT01473524|616036577|FG005|LTSE Phase|Protocol Violation|1|||
170463446|NCT01475097|616036582|FG000|Overall Study|Protocol Violation|1|||
170463447|NCT01475097|616036583|FG001|Overall Study|Protocol Violation|1|||
170463448|NCT04839692|616036584|FG000|Overall Study|Withdrawal by Subject|0|||
170463449|NCT04839692|616036585|FG001|Overall Study|Withdrawal by Subject|3|||
170463450|NCT04839692|616036584|FG000|Overall Study|Physician Decision|1|||
170463451|NCT04839692|616036585|FG001|Overall Study|Physician Decision|0|||
170463452|NCT04516759|616036586|FG000|Overall Study|Withdrawal by Subject|1|||
170463453|NCT04516759|616036587|FG001|Overall Study|Withdrawal by Subject|1|||
170463454|NCT04516759|616036586|FG000|Overall Study|Other|0|||
170463455|NCT04516759|616036587|FG001|Overall Study|Other|1|||
170463456|NCT03511326|616036590|FG000|Overall Study|Withdrawal by Subject|1|||
170463457|NCT01305044|616036591|FG000|Overall Study|Withdrawal by Subject|3|||
170463458|NCT01305044|616036592|FG001|Overall Study|Withdrawal by Subject|6|||
170463459|NCT02246114|616036595|FG000|Overall Study|miscarriage|1|||
170463460|NCT02246114|616036596|FG001|Overall Study|miscarriage|0|||
170463461|NCT04005352|616036597|FG000|Overall Study|Adverse Event|4|||
170463462|NCT04005352|616036598|FG001|Overall Study|Adverse Event|5|||
170463463|NCT04005352|616036597|FG000|Overall Study|Death|4|||
170463464|NCT04005352|616036598|FG001|Overall Study|Death|2|||
170544433|NCT01658878|616337263|FG002|Treatment Period|Participant Withdrew Consent|0|||
170789636|NCT03024437|617240391|FG004|Overall Study|Newly diagnosed cancer|0|||
170789637|NCT03024437|617240387|FG000|Overall Study|Moved out of state|0|||
170789638|NCT03024437|617240388|FG001|Overall Study|Moved out of state|1|||
170789639|NCT03024437|617240389|FG002|Overall Study|Moved out of state|0|||
170789640|NCT03024437|617240390|FG003|Overall Study|Moved out of state|0|||
170789641|NCT03024437|617240391|FG004|Overall Study|Moved out of state|0|||
170789642|NCT03024437|617240387|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
170789643|NCT03024437|617240388|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
170789644|NCT03024437|617240389|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
170789645|NCT03024437|617240390|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
170789646|NCT03024437|617240391|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
170789647|NCT03085810|617240392|FG000|Main Study|Withdrawal by Subject|77|||
170789648|NCT03085810|617240393|FG001|Main Study|Withdrawal by Subject|0|||
170789649|NCT03085810|617240394|FG002|Main Study|Withdrawal by Subject|0|||
170789650|NCT03085810|617240392|FG000|Main Study|Terminated By Sponsor|14|||
170789651|NCT03085810|617240393|FG001|Main Study|Terminated By Sponsor|0|||
170789652|NCT03085810|617240394|FG002|Main Study|Terminated By Sponsor|0|||
170789653|NCT03085810|617240392|FG000|Main Study|Protocol Violation|15|||
170789654|NCT03085810|617240393|FG001|Main Study|Protocol Violation|0|||
170463465|NCT04005352|616036597|FG000|Overall Study|Lost to Follow-up|6|||
170463466|NCT04005352|616036598|FG001|Overall Study|Lost to Follow-up|2|||
170463467|NCT04005352|616036597|FG000|Overall Study|Physician Decision|7|||
170463468|NCT04005352|616036598|FG001|Overall Study|Physician Decision|13|||
170463469|NCT04005352|616036597|FG000|Overall Study|Protocol Violation|0|||
170463470|NCT04005352|616036598|FG001|Overall Study|Protocol Violation|1|||
170463471|NCT04005352|616036597|FG000|Overall Study|Withdrawal by Subject|28|||
170463472|NCT04005352|616036598|FG001|Overall Study|Withdrawal by Subject|38|||
170789655|NCT03085810|617240394|FG002|Main Study|Protocol Violation|0|||
170463473|NCT00849186|616036600|FG000|Overall Study|Adverse Event|2|||
170463474|NCT00849186|616036600|FG000|Overall Study|Withdrawal by Subject|1|||
170463475|NCT00849186|616036600|FG000|Overall Study|not treated|6|||
170463476|NCT00849186|616036600|FG000|Overall Study|Other|1|||
170463477|NCT01439009|616036604|FG000|Overall Study|Physician Decision|5|||
170463478|NCT01439009|616036605|FG001|Overall Study|Physician Decision|3|||
170463479|NCT01439009|616036604|FG000|Overall Study|Protocol Violation|2|||
170463480|NCT01439009|616036605|FG001|Overall Study|Protocol Violation|0|||
170463481|NCT01439009|616036604|FG000|Overall Study|Deviation of exclusion criteria|1|||
170463482|NCT01439009|616036605|FG001|Overall Study|Deviation of exclusion criteria|0|||
170463483|NCT00926783|616036606|FG000|Overall Study|Incomplete CFAE Procedures|3|||
170463484|NCT00926783|616036607|FG001|Overall Study|Incomplete CFAE Procedures|3|||
170463485|NCT00417170|616036608|FG000|Overall Study|Adverse Event|1|||
170463486|NCT00417170|616036609|FG001|Overall Study|Adverse Event|1|||
170463487|NCT00417170|616036608|FG000|Overall Study|Withdrawal by Subject|1|||
170463488|NCT00417170|616036609|FG001|Overall Study|Withdrawal by Subject|1|||
170463489|NCT00417170|616036608|FG000|Overall Study|Lost to Follow-up|0|||
170463490|NCT00417170|616036609|FG001|Overall Study|Lost to Follow-up|1|||
170463491|NCT01844856|616036616|FG000|Overall Study|Lost to Follow-up|15|||
170463492|NCT01844856|616036617|FG001|Overall Study|Lost to Follow-up|3|||
170463493|NCT01844856|616036616|FG000|Overall Study|Adverse Event|3|||
170463494|NCT01844856|616036617|FG001|Overall Study|Adverse Event|6|||
170463495|NCT01844856|616036616|FG000|Overall Study|Withdrawal by Subject|3|||
170463496|NCT01844856|616036617|FG001|Overall Study|Withdrawal by Subject|2|||
170463497|NCT01844856|616036616|FG000|Overall Study|Noncompliance|2|||
170463498|NCT01844856|616036617|FG001|Overall Study|Noncompliance|3|||
170463499|NCT01844856|616036616|FG000|Overall Study|Enterococcus Resistant|0|||
170463500|NCT01844856|616036617|FG001|Overall Study|Enterococcus Resistant|1|||
170463501|NCT01844856|616036616|FG000|Overall Study|Inadvertently Not Scheduled|1|||
170463502|NCT01844856|616036617|FG001|Overall Study|Inadvertently Not Scheduled|0|||
170463503|NCT01844856|616036616|FG000|Overall Study|Randomized but was a Screen Failure|0|||
170463504|NCT01844856|616036617|FG001|Overall Study|Randomized but was a Screen Failure|1|||
170463505|NCT01221363|616036618|FG000|Overall Study|Pregnancy|1|||
170463506|NCT01221363|616036619|FG001|Overall Study|Pregnancy|0|||
170463507|NCT01221363|616036618|FG000|Overall Study|Withdrawal by Subject|11|||
170463508|NCT01221363|616036619|FG001|Overall Study|Withdrawal by Subject|5|||
170463509|NCT01329549|616036626|FG000|Overall Study|Withdrawal by Subject|1|||
170463510|NCT01329549|616036626|FG000|Overall Study|Adverse Event|1|||
170463511|NCT01756079|616036627|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
170463512|NCT01756079|616036627|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
170463513|NCT01756079|616036627|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
170463514|NCT01756079|616036627|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
170463515|NCT01756079|616036627|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
170463516|NCT03464630|616036628|FG000|Overall Study|Lost to Follow-up|62|||
170463517|NCT03464630|616036629|FG001|Overall Study|Lost to Follow-up|52|||
170463518|NCT03464630|616036628|FG000|Overall Study|Withdrawal by Subject|16|||
170463519|NCT03464630|616036629|FG001|Overall Study|Withdrawal by Subject|10|||
170463520|NCT03464630|616036628|FG000|Overall Study|Passive Disengagement|8|||
170463521|NCT03464630|616036629|FG001|Overall Study|Passive Disengagement|4|||
170463522|NCT00229723|616036630|FG000|Concomitant Phase|Adverse Event|4|||
170463523|NCT00229723|616036631|FG001|Concomitant Phase|Adverse Event|2|||
170463524|NCT00229723|616036632|FG002|Concomitant Phase|Adverse Event|5|||
170463525|NCT00229723|616036633|FG003|Concomitant Phase|Adverse Event|2|||
170463526|NCT00229723|616036634|FG004|Concomitant Phase|Adverse Event|0|||
170463527|NCT00229723|616036635|FG005|Concomitant Phase|Adverse Event|1|||
170463528|NCT00229723|616036636|FG006|Concomitant Phase|Adverse Event|2|||
170463529|NCT00229723|616036630|FG000|Concomitant Phase|Objective disease progression|0|||
170463530|NCT00229723|616036631|FG001|Concomitant Phase|Objective disease progression|0|||
170463531|NCT00229723|616036632|FG002|Concomitant Phase|Objective disease progression|0|||
170463532|NCT00229723|616036633|FG003|Concomitant Phase|Objective disease progression|0|||
170463533|NCT00229723|616036634|FG004|Concomitant Phase|Objective disease progression|0|||
170463534|NCT00229723|616036635|FG005|Concomitant Phase|Objective disease progression|0|||
170463535|NCT00229723|616036636|FG006|Concomitant Phase|Objective disease progression|0|||
170463536|NCT00229723|616036630|FG000|Concomitant Phase|Clinical progression|0|||
170463537|NCT00229723|616036631|FG001|Concomitant Phase|Clinical progression|0|||
170544434|NCT01658878|616337264|FG003|Treatment Period|Participant Withdrew Consent|0|||
170544435|NCT01658878|616337265|FG004|Treatment Period|Participant Withdrew Consent|0|||
170544436|NCT01658878|616337266|FG005|Treatment Period|Participant Withdrew Consent|0|||
170544437|NCT01658878|616337267|FG006|Treatment Period|Participant Withdrew Consent|0|||
170544438|NCT01658878|616337268|FG007|Treatment Period|Participant Withdrew Consent|0|||
170544439|NCT01658878|616337269|FG008|Treatment Period|Participant Withdrew Consent|0|||
170463538|NCT00229723|616036632|FG002|Concomitant Phase|Clinical progression|0|||
170463539|NCT00229723|616036633|FG003|Concomitant Phase|Clinical progression|0|||
170463540|NCT00229723|616036634|FG004|Concomitant Phase|Clinical progression|0|||
170463541|NCT00229723|616036635|FG005|Concomitant Phase|Clinical progression|0|||
170463542|NCT00229723|616036636|FG006|Concomitant Phase|Clinical progression|1|||
170463543|NCT00229723|616036630|FG000|Concomitant Phase|Lost to Follow-up|0|||
170463544|NCT00229723|616036631|FG001|Concomitant Phase|Lost to Follow-up|0|||
170463545|NCT00229723|616036632|FG002|Concomitant Phase|Lost to Follow-up|0|||
170463546|NCT00229723|616036633|FG003|Concomitant Phase|Lost to Follow-up|0|||
170463547|NCT00229723|616036634|FG004|Concomitant Phase|Lost to Follow-up|1|||
170463548|NCT00229723|616036635|FG005|Concomitant Phase|Lost to Follow-up|0|||
170463549|NCT00229723|616036636|FG006|Concomitant Phase|Lost to Follow-up|0|||
170463550|NCT00229723|616036630|FG000|Concomitant Phase|Informed consent withdrawn|3|||
170463551|NCT00229723|616036631|FG001|Concomitant Phase|Informed consent withdrawn|2|||
170463552|NCT00229723|616036632|FG002|Concomitant Phase|Informed consent withdrawn|0|||
170463553|NCT00229723|616036633|FG003|Concomitant Phase|Informed consent withdrawn|2|||
170463554|NCT00229723|616036634|FG004|Concomitant Phase|Informed consent withdrawn|0|||
170463555|NCT00229723|616036635|FG005|Concomitant Phase|Informed consent withdrawn|0|||
170463556|NCT00229723|616036636|FG006|Concomitant Phase|Informed consent withdrawn|0|||
170463557|NCT00229723|616036630|FG000|Concomitant Phase|Severe non-compliance|0|||
170463558|NCT00229723|616036631|FG001|Concomitant Phase|Severe non-compliance|1|||
170463559|NCT00229723|616036632|FG002|Concomitant Phase|Severe non-compliance|0|||
170463560|NCT00229723|616036633|FG003|Concomitant Phase|Severe non-compliance|0|||
170463561|NCT00229723|616036634|FG004|Concomitant Phase|Severe non-compliance|1|||
170463562|NCT00229723|616036635|FG005|Concomitant Phase|Severe non-compliance|0|||
170463563|NCT00229723|616036636|FG006|Concomitant Phase|Severe non-compliance|0|||
170463564|NCT00229723|616036630|FG000|Concomitant Phase|Other|3|||
170463565|NCT00229723|616036631|FG001|Concomitant Phase|Other|0|||
170463566|NCT00229723|616036632|FG002|Concomitant Phase|Other|1|||
170463567|NCT00229723|616036633|FG003|Concomitant Phase|Other|1|||
170463568|NCT00229723|616036634|FG004|Concomitant Phase|Other|0|||
170463569|NCT00229723|616036635|FG005|Concomitant Phase|Other|2|||
170463570|NCT00229723|616036636|FG006|Concomitant Phase|Other|0|||
170463571|NCT00229723|616036630|FG000|Maintenance Phase|Adverse Event|7|||
170463572|NCT00229723|616036631|FG001|Maintenance Phase|Adverse Event|2|||
170463573|NCT00229723|616036632|FG002|Maintenance Phase|Adverse Event|1|||
170463574|NCT00229723|616036633|FG003|Maintenance Phase|Adverse Event|4|||
170463575|NCT00229723|616036634|FG004|Maintenance Phase|Adverse Event|7|||
170463576|NCT00229723|616036635|FG005|Maintenance Phase|Adverse Event|5|||
170463577|NCT00229723|616036636|FG006|Maintenance Phase|Adverse Event|2|||
170463578|NCT00229723|616036630|FG000|Maintenance Phase|Objective disease progression|5|||
170463579|NCT00229723|616036631|FG001|Maintenance Phase|Objective disease progression|5|||
170463580|NCT00229723|616036632|FG002|Maintenance Phase|Objective disease progression|3|||
170463581|NCT00229723|616036633|FG003|Maintenance Phase|Objective disease progression|6|||
170463582|NCT00229723|616036634|FG004|Maintenance Phase|Objective disease progression|2|||
170463583|NCT00229723|616036635|FG005|Maintenance Phase|Objective disease progression|9|||
170463584|NCT00229723|616036636|FG006|Maintenance Phase|Objective disease progression|5|||
170463585|NCT00229723|616036630|FG000|Maintenance Phase|Clinical progression|4|||
170463586|NCT00229723|616036631|FG001|Maintenance Phase|Clinical progression|1|||
170463587|NCT00229723|616036632|FG002|Maintenance Phase|Clinical progression|2|||
170463588|NCT00229723|616036633|FG003|Maintenance Phase|Clinical progression|2|||
170463589|NCT00229723|616036634|FG004|Maintenance Phase|Clinical progression|1|||
170463590|NCT00229723|616036635|FG005|Maintenance Phase|Clinical progression|1|||
170463591|NCT00229723|616036636|FG006|Maintenance Phase|Clinical progression|1|||
170463592|NCT00229723|616036630|FG000|Maintenance Phase|Lost to Follow-up|0|||
170463593|NCT00229723|616036631|FG001|Maintenance Phase|Lost to Follow-up|1|||
170463594|NCT00229723|616036632|FG002|Maintenance Phase|Lost to Follow-up|2|||
170463595|NCT00229723|616036633|FG003|Maintenance Phase|Lost to Follow-up|2|||
170463596|NCT00229723|616036634|FG004|Maintenance Phase|Lost to Follow-up|0|||
170463597|NCT00229723|616036635|FG005|Maintenance Phase|Lost to Follow-up|0|||
170463598|NCT00229723|616036636|FG006|Maintenance Phase|Lost to Follow-up|1|||
170463599|NCT00229723|616036630|FG000|Maintenance Phase|Informed consent withdrawn|1|||
170463600|NCT00229723|616036631|FG001|Maintenance Phase|Informed consent withdrawn|0|||
170463601|NCT00229723|616036632|FG002|Maintenance Phase|Informed consent withdrawn|0|||
170463602|NCT00229723|616036633|FG003|Maintenance Phase|Informed consent withdrawn|1|||
170463603|NCT00229723|616036634|FG004|Maintenance Phase|Informed consent withdrawn|1|||
170463604|NCT00229723|616036635|FG005|Maintenance Phase|Informed consent withdrawn|1|||
170463605|NCT00229723|616036636|FG006|Maintenance Phase|Informed consent withdrawn|0|||
170463606|NCT00229723|616036630|FG000|Maintenance Phase|Severe non-compliance|3|||
170463607|NCT00229723|616036631|FG001|Maintenance Phase|Severe non-compliance|1|||
170463608|NCT00229723|616036632|FG002|Maintenance Phase|Severe non-compliance|0|||
170463609|NCT00229723|616036633|FG003|Maintenance Phase|Severe non-compliance|0|||
170463610|NCT00229723|616036634|FG004|Maintenance Phase|Severe non-compliance|1|||
170463611|NCT00229723|616036635|FG005|Maintenance Phase|Severe non-compliance|0|||
170463612|NCT00229723|616036636|FG006|Maintenance Phase|Severe non-compliance|0|||
170789656|NCT03085810|617240392|FG000|Main Study|Physician Decision|13|||
170463613|NCT00229723|616036630|FG000|Maintenance Phase|Other|5|||
170463614|NCT00229723|616036631|FG001|Maintenance Phase|Other|4|||
170463615|NCT00229723|616036632|FG002|Maintenance Phase|Other|1|||
170463616|NCT00229723|616036633|FG003|Maintenance Phase|Other|2|||
170463617|NCT00229723|616036634|FG004|Maintenance Phase|Other|3|||
170463618|NCT00229723|616036635|FG005|Maintenance Phase|Other|3|||
170463619|NCT00229723|616036636|FG006|Maintenance Phase|Other|1|||
170463620|NCT02309138|616036637|FG000|Overall Study|Withdrawal by Subject|44|||
170463621|NCT02309138|616036638|FG001|Overall Study|Withdrawal by Subject|15|||
170463622|NCT02309138|616036637|FG000|Overall Study|Protocol Violation|4|||
170463623|NCT02309138|616036638|FG001|Overall Study|Protocol Violation|2|||
170463624|NCT02309138|616036637|FG000|Overall Study|delivered before visit 2|0|||
170463625|NCT02309138|616036638|FG001|Overall Study|delivered before visit 2|1|||
170463626|NCT02677714|616036641|FG000|Overall Study|Withdrawal by Subject|2|||
170463627|NCT02677714|616036642|FG001|Overall Study|Withdrawal by Subject|0|||
170463628|NCT00380744|616036643|FG000|Overall Study|Death|0|||
170463629|NCT00380744|616036644|FG001|Overall Study|Death|0|||
170463630|NCT00380744|616036645|FG002|Overall Study|Death|0|||
170463631|NCT00380744|616036646|FG003|Overall Study|Death|0|||
170463632|NCT00380744|616036647|FG004|Overall Study|Death|0|||
170463633|NCT00380744|616036648|FG005|Overall Study|Death|0|||
170463634|NCT00380744|616036649|FG006|Overall Study|Death|1|||
170463635|NCT00380744|616036643|FG000|Overall Study|Withdrawal by Subject|1|||
170463636|NCT00380744|616036644|FG001|Overall Study|Withdrawal by Subject|0|||
170463637|NCT00380744|616036645|FG002|Overall Study|Withdrawal by Subject|0|||
170463638|NCT00380744|616036646|FG003|Overall Study|Withdrawal by Subject|0|||
170463639|NCT00380744|616036647|FG004|Overall Study|Withdrawal by Subject|0|||
170463640|NCT00380744|616036648|FG005|Overall Study|Withdrawal by Subject|0|||
170463641|NCT00380744|616036649|FG006|Overall Study|Withdrawal by Subject|0|||
170463642|NCT00396812|616036654|FG000|Overall Study|Physician Decision|1|||
170463643|NCT03201445|616036657|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
170463644|NCT03201445|616036658|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
170463645|NCT03201445|616036657|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
170463646|NCT03201445|616036658|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
170463647|NCT03201445|616036657|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
170463648|NCT03201445|616036658|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
170463649|NCT03201445|616036657|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
170463650|NCT03201445|616036658|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
170463651|NCT03201445|616036657|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
170463652|NCT03201445|616036658|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
170463653|NCT03201445|616036657|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
170463654|NCT03201445|616036658|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
170463655|NCT03201445|616036657|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
170463656|NCT03201445|616036658|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
170463657|NCT03201445|616036657|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
170463658|NCT03201445|616036658|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
170463659|NCT03201445|616036657|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
170463660|NCT03201445|616036658|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
170463661|NCT03201445|616036657|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
170463662|NCT03201445|616036658|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
170463663|NCT03201445|616036657|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
170463664|NCT03201445|616036658|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
170463665|NCT03201445|616036657|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
170463666|NCT03201445|616036658|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
170463667|NCT03201445|616036657|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
170463668|NCT03201445|616036658|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
170463669|NCT03201445|616036657|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
170636681|NCT05307692|616680923|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
170636682|NCT05307692|616680924|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
170636683|NCT05307692|616680925|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
170636684|NCT05307692|616680926|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
170636685|NCT01648751|616680927|FG000|Overall Study|Withdrawal by Subject|2|||
170636686|NCT01648751|616680928|FG001|Overall Study|Withdrawal by Subject|3|||
170636687|NCT01967238|616680931|FG000|Overall Study|Adverse Event|1|||
170636688|NCT01967238|616680932|FG001|Overall Study|Adverse Event|1|||
170636689|NCT01967238|616680933|FG002|Overall Study|Adverse Event|0|||
170636690|NCT01967238|616680931|FG000|Overall Study|Lost to Follow-up|1|||
170636691|NCT01967238|616680932|FG001|Overall Study|Lost to Follow-up|0|||
170636692|NCT01967238|616680933|FG002|Overall Study|Lost to Follow-up|1|||
170789657|NCT03085810|617240393|FG001|Main Study|Physician Decision|0|||
170789658|NCT03085810|617240394|FG002|Main Study|Physician Decision|0|||
170789659|NCT03085810|617240392|FG000|Main Study|Lost to Follow-up|17|||
170789660|NCT03085810|617240393|FG001|Main Study|Lost to Follow-up|0|||
170463670|NCT03201445|616036658|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
170463671|NCT03201445|616036657|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
170463672|NCT03201445|616036658|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
170463673|NCT03201445|616036657|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
170463674|NCT03201445|616036658|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
170463675|NCT03201445|616036657|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
170890202|NCT01928381|617604218|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
170890203|NCT01928381|617604219|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
170890204|NCT01928381|617604220|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
170890205|NCT01928381|617604221|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
170890206|NCT01928381|617604222|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
170890207|NCT01928381|617604223|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
170890208|NCT01928381|617604217|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
170890209|NCT01928381|617604218|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
170890210|NCT01928381|617604219|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
170890211|NCT01928381|617604220|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
170890212|NCT01928381|617604221|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
170890213|NCT01928381|617604222|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
170890214|NCT01928381|617604223|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
170463676|NCT03201445|616036658|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
170463677|NCT03201445|616036657|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
170463678|NCT03201445|616036658|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
170463679|NCT03201445|616036657|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
170463680|NCT03201445|616036658|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
170463681|NCT03201445|616036657|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
170463682|NCT03201445|616036658|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
170463683|NCT03201445|616036657|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
170463684|NCT03201445|616036658|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
170463685|NCT02730351|616036661|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
170463686|NCT02730351|616036662|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
170463687|NCT02730351|616036661|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
170463688|NCT02730351|616036662|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
170463689|NCT02730351|616036661|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
170463690|NCT02730351|616036662|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
170463691|NCT02730351|616036661|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
170463692|NCT02730351|616036662|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
170463693|NCT02730351|616036661|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
170463694|NCT02730351|616036662|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
170463695|NCT00128830|616036663|FG000|Overall Study|Adverse Event|10|||
170463696|NCT00128830|616036663|FG000|Overall Study|Withdrawal by Subject|14|||
170463697|NCT00128830|616036663|FG000|Overall Study|Lost to Follow-up|4|||
170463698|NCT00128830|616036663|FG000|Overall Study|Reached a virologic endpoint|29|||
170463699|NCT00128830|616036663|FG000|Overall Study|Non-compliant|4|||
170463700|NCT00128830|616036663|FG000|Overall Study|Discontinued or ineligible for study|2|||
170463701|NCT00128830|616036663|FG000|Overall Study|Other|9|||
170463702|NCT04159935|616036664|FG000|Overall Study|Study terminated due to COVID-19|1|||
170463703|NCT04159935|616036665|FG001|Overall Study|Study terminated due to COVID-19|3|||
170463704|NCT03334617|616036670|FG000|Overall Study|Adverse Event|0|||
170463705|NCT03334617|616036671|FG001|Overall Study|Adverse Event|0|||
170463706|NCT03334617|616036672|FG002|Overall Study|Adverse Event|0|||
170463707|NCT03334617|616036673|FG003|Overall Study|Adverse Event|0|||
170463708|NCT03334617|616036674|FG004|Overall Study|Adverse Event|0|||
170463709|NCT03334617|616036675|FG005|Overall Study|Adverse Event|0|||
170463710|NCT03334617|616036676|FG006|Overall Study|Adverse Event|0|||
170463711|NCT03334617|616036677|FG007|Overall Study|Adverse Event|0|||
170463712|NCT03334617|616036678|FG008|Overall Study|Adverse Event|1|||
170463713|NCT03334617|616036679|FG009|Overall Study|Adverse Event|0|||
170463714|NCT03334617|616036680|FG010|Overall Study|Adverse Event|0|||
170463715|NCT03334617|616036681|FG011|Overall Study|Adverse Event|0|||
170463716|NCT03334617|616036682|FG012|Overall Study|Adverse Event|1|||
170463717|NCT03334617|616036683|FG013|Overall Study|Adverse Event|0|||
170463718|NCT03334617|616036684|FG014|Overall Study|Adverse Event|0|||
170463719|NCT03334617|616036685|FG015|Overall Study|Adverse Event|0|||
170463720|NCT03334617|616036686|FG016|Overall Study|Adverse Event|0|||
170463721|NCT03334617|616036687|FG017|Overall Study|Adverse Event|0|||
170463722|NCT03334617|616036688|FG018|Overall Study|Adverse Event|0|||
170890215|NCT01928381|617604217|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
170890216|NCT01928381|617604218|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
170890217|NCT01928381|617604219|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
170890218|NCT01928381|617604220|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
170463723|NCT03334617|616036689|FG019|Overall Study|Adverse Event|0|||
170463724|NCT03334617|616036690|FG020|Overall Study|Adverse Event|0|||
170463725|NCT03334617|616036691|FG021|Overall Study|Adverse Event|0|||
170463726|NCT03334617|616036670|FG000|Overall Study|Death|18|||
170890219|NCT01928381|617604221|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
170463727|NCT03334617|616036671|FG001|Overall Study|Death|18|||
170463728|NCT03334617|616036672|FG002|Overall Study|Death|20|||
170463729|NCT03334617|616036673|FG003|Overall Study|Death|21|||
170463730|NCT03334617|616036674|FG004|Overall Study|Death|20|||
170463731|NCT03334617|616036675|FG005|Overall Study|Death|16|||
170463732|NCT03334617|616036676|FG006|Overall Study|Death|28|||
170463733|NCT03334617|616036677|FG007|Overall Study|Death|35|||
170463734|NCT03334617|616036678|FG008|Overall Study|Death|47|||
170463735|NCT03334617|616036679|FG009|Overall Study|Death|0|||
170463736|NCT03334617|616036680|FG010|Overall Study|Death|19|||
170463737|NCT03334617|616036681|FG011|Overall Study|Death|6|||
170463738|NCT03334617|616036682|FG012|Overall Study|Death|20|||
170463739|NCT03334617|616036683|FG013|Overall Study|Death|22|||
170463740|NCT03334617|616036684|FG014|Overall Study|Death|17|||
170789661|NCT03085810|617240394|FG002|Main Study|Lost to Follow-up|0|||
170789662|NCT03085810|617240392|FG000|Main Study|Adverse Event|25|||
170789663|NCT03085810|617240393|FG001|Main Study|Adverse Event|0|||
170789664|NCT03085810|617240394|FG002|Main Study|Adverse Event|0|||
170463741|NCT03334617|616036685|FG015|Overall Study|Death|18|||
170463742|NCT03334617|616036686|FG016|Overall Study|Death|12|||
170463743|NCT03334617|616036687|FG017|Overall Study|Death|15|||
170789665|NCT03085810|617240392|FG000|Main Study|Pregnancy|7|||
170789666|NCT03085810|617240393|FG001|Main Study|Pregnancy|0|||
170789667|NCT03085810|617240394|FG002|Main Study|Pregnancy|0|||
170789668|NCT03085810|617240392|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
170789669|NCT03085810|617240393|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
170789670|NCT03085810|617240394|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
170789671|NCT03085810|617240392|FG000|Main Study|Lack of Efficacy|10|||
170789672|NCT03085810|617240393|FG001|Main Study|Lack of Efficacy|0|||
170789673|NCT03085810|617240394|FG002|Main Study|Lack of Efficacy|0|||
170789674|NCT03085810|617240392|FG000|Main Study|Death|12|||
170789675|NCT03085810|617240393|FG001|Main Study|Death|0|||
170789676|NCT03085810|617240394|FG002|Main Study|Death|0|||
170789677|NCT03085810|617240392|FG000|Main Study|Disease progression|1|||
170789678|NCT03085810|617240393|FG001|Main Study|Disease progression|0|||
170789679|NCT03085810|617240394|FG002|Main Study|Disease progression|0|||
170789680|NCT03085810|617240392|FG000|Main Study|Site Closure|3|||
170789681|NCT03085810|617240393|FG001|Main Study|Site Closure|0|||
170789682|NCT03085810|617240394|FG002|Main Study|Site Closure|0|||
170789683|NCT03085810|617240392|FG000|Main Study|Planned pregnancy|17|||
170789684|NCT03085810|617240393|FG001|Main Study|Planned pregnancy|0|||
170789685|NCT03085810|617240394|FG002|Main Study|Planned pregnancy|0|||
170789686|NCT03085810|617240392|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
170789687|NCT03085810|617240393|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
170789688|NCT03085810|617240394|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
170789689|NCT03085810|617240392|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
170789690|NCT03085810|617240393|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
170789691|NCT03085810|617240394|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
170789692|NCT03085810|617240392|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
170789693|NCT03085810|617240393|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
170789694|NCT03085810|617240394|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
170789695|NCT03085810|617240392|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
170789696|NCT03085810|617240393|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
170789697|NCT03085810|617240394|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
170789698|NCT02601313|617240395|FG000|Overall Study|Death|2|||
170789699|NCT02601313|617240396|FG001|Overall Study|Death|41|||
170789700|NCT02601313|617240397|FG002|Overall Study|Death|6|||
170789701|NCT02601313|617240395|FG000|Overall Study|Enrolled but never treated|0|||
170789702|NCT02601313|617240396|FG001|Overall Study|Enrolled but never treated|6|||
170789703|NCT02601313|617240397|FG002|Overall Study|Enrolled but never treated|3|||
170789704|NCT02601313|617240395|FG000|Overall Study|Enrolled, did not initiate AC|4|||
170789705|NCT02601313|617240396|FG001|Overall Study|Enrolled, did not initiate AC|0|||
170789706|NCT02601313|617240397|FG002|Overall Study|Enrolled, did not initiate AC|0|||
170789707|NCT02601313|617240395|FG000|Overall Study|Full consent withdrawal|0|||
170789708|NCT02601313|617240396|FG001|Overall Study|Full consent withdrawal|3|||
170789709|NCT02601313|617240397|FG002|Overall Study|Full consent withdrawal|2|||
170789710|NCT02601313|617240395|FG000|Overall Study|Lost to Follow-up|0|||
170789711|NCT02601313|617240396|FG001|Overall Study|Lost to Follow-up|1|||
170789712|NCT02601313|617240397|FG002|Overall Study|Lost to Follow-up|1|||
170463744|NCT03334617|616036688|FG018|Overall Study|Death|16|||
170463745|NCT03334617|616036689|FG019|Overall Study|Death|27|||
170463746|NCT03334617|616036690|FG020|Overall Study|Death|14|||
170463747|NCT03334617|616036691|FG021|Overall Study|Death|27|||
170463748|NCT03334617|616036670|FG000|Overall Study|Lost to Follow-up|0|||
170463749|NCT03334617|616036671|FG001|Overall Study|Lost to Follow-up|0|||
170463750|NCT03334617|616036672|FG002|Overall Study|Lost to Follow-up|0|||
170463751|NCT03334617|616036673|FG003|Overall Study|Lost to Follow-up|1|||
170463752|NCT03334617|616036674|FG004|Overall Study|Lost to Follow-up|0|||
170463753|NCT03334617|616036675|FG005|Overall Study|Lost to Follow-up|1|||
170463754|NCT03334617|616036676|FG006|Overall Study|Lost to Follow-up|0|||
170463755|NCT03334617|616036677|FG007|Overall Study|Lost to Follow-up|0|||
170463756|NCT03334617|616036678|FG008|Overall Study|Lost to Follow-up|1|||
170463757|NCT03334617|616036679|FG009|Overall Study|Lost to Follow-up|0|||
170463758|NCT03334617|616036680|FG010|Overall Study|Lost to Follow-up|0|||
170463759|NCT03334617|616036681|FG011|Overall Study|Lost to Follow-up|0|||
170463760|NCT03334617|616036682|FG012|Overall Study|Lost to Follow-up|0|||
170463761|NCT03334617|616036683|FG013|Overall Study|Lost to Follow-up|0|||
170463762|NCT03334617|616036684|FG014|Overall Study|Lost to Follow-up|0|||
170463763|NCT03334617|616036685|FG015|Overall Study|Lost to Follow-up|0|||
170463764|NCT03334617|616036686|FG016|Overall Study|Lost to Follow-up|0|||
170463765|NCT03334617|616036687|FG017|Overall Study|Lost to Follow-up|0|||
170463766|NCT03334617|616036688|FG018|Overall Study|Lost to Follow-up|0|||
170463767|NCT03334617|616036689|FG019|Overall Study|Lost to Follow-up|0|||
170463768|NCT03334617|616036690|FG020|Overall Study|Lost to Follow-up|0|||
170463769|NCT03334617|616036691|FG021|Overall Study|Lost to Follow-up|0|||
170463770|NCT03334617|616036670|FG000|Overall Study|Withdrawal by Subject|0|||
170463771|NCT03334617|616036671|FG001|Overall Study|Withdrawal by Subject|1|||
170463772|NCT03334617|616036672|FG002|Overall Study|Withdrawal by Subject|0|||
170463773|NCT03334617|616036673|FG003|Overall Study|Withdrawal by Subject|0|||
170463774|NCT03334617|616036674|FG004|Overall Study|Withdrawal by Subject|1|||
170463775|NCT03334617|616036675|FG005|Overall Study|Withdrawal by Subject|1|||
170463776|NCT03334617|616036676|FG006|Overall Study|Withdrawal by Subject|1|||
170463777|NCT03334617|616036677|FG007|Overall Study|Withdrawal by Subject|2|||
170463778|NCT03334617|616036678|FG008|Overall Study|Withdrawal by Subject|0|||
170463779|NCT03334617|616036679|FG009|Overall Study|Withdrawal by Subject|0|||
170463780|NCT03334617|616036680|FG010|Overall Study|Withdrawal by Subject|0|||
170463781|NCT03334617|616036681|FG011|Overall Study|Withdrawal by Subject|1|||
170463782|NCT03334617|616036682|FG012|Overall Study|Withdrawal by Subject|1|||
170463783|NCT03334617|616036683|FG013|Overall Study|Withdrawal by Subject|0|||
170463784|NCT03334617|616036684|FG014|Overall Study|Withdrawal by Subject|2|||
170463785|NCT03334617|616036685|FG015|Overall Study|Withdrawal by Subject|1|||
170463786|NCT03334617|616036686|FG016|Overall Study|Withdrawal by Subject|0|||
170463787|NCT03334617|616036687|FG017|Overall Study|Withdrawal by Subject|1|||
170463788|NCT03334617|616036688|FG018|Overall Study|Withdrawal by Subject|1|||
170463789|NCT03334617|616036689|FG019|Overall Study|Withdrawal by Subject|1|||
170463790|NCT03334617|616036690|FG020|Overall Study|Withdrawal by Subject|0|||
170463791|NCT03334617|616036691|FG021|Overall Study|Withdrawal by Subject|1|||
170463792|NCT03334617|616036670|FG000|Overall Study|Other|1|||
170463793|NCT03334617|616036671|FG001|Overall Study|Other|2|||
170463794|NCT03334617|616036672|FG002|Overall Study|Other|0|||
170463795|NCT03334617|616036673|FG003|Overall Study|Other|1|||
170463796|NCT03334617|616036674|FG004|Overall Study|Other|1|||
170463797|NCT03334617|616036675|FG005|Overall Study|Other|0|||
170463798|NCT03334617|616036676|FG006|Overall Study|Other|2|||
170463799|NCT03334617|616036677|FG007|Overall Study|Other|1|||
170463800|NCT03334617|616036678|FG008|Overall Study|Other|8|||
170463801|NCT03334617|616036679|FG009|Overall Study|Other|0|||
170463802|NCT03334617|616036680|FG010|Overall Study|Other|3|||
170463803|NCT03334617|616036681|FG011|Overall Study|Other|1|||
170463804|NCT03334617|616036682|FG012|Overall Study|Other|3|||
170463805|NCT03334617|616036683|FG013|Overall Study|Other|1|||
170463806|NCT03334617|616036684|FG014|Overall Study|Other|1|||
170463807|NCT03334617|616036685|FG015|Overall Study|Other|3|||
170463808|NCT03334617|616036686|FG016|Overall Study|Other|3|||
170463809|NCT03334617|616036687|FG017|Overall Study|Other|3|||
170463810|NCT03334617|616036688|FG018|Overall Study|Other|7|||
170463811|NCT03334617|616036689|FG019|Overall Study|Other|4|||
170789713|NCT05239455|617240403|FG000|Overall Study|Adverse Event|1|||
170789714|NCT05239455|617240403|FG000|Overall Study|Sponsor Decision|5|||
170789715|NCT05239455|617240403|FG000|Overall Study|Incomplete Blood Collection|1|||
170789716|NCT06182033|617240404|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
170789717|NCT06182033|617240405|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
170789718|NCT06182033|617240404|FG000|Overall Study|Target child relocation|1|||
170789719|NCT06182033|617240405|FG001|Overall Study|Target child relocation|1|||
170463812|NCT03334617|616036690|FG020|Overall Study|Other|1|||
170463813|NCT03334617|616036691|FG021|Overall Study|Other|4|||
170463814|NCT03334617|616036670|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
170463815|NCT03334617|616036671|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
170463816|NCT03334617|616036672|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
170463817|NCT03334617|616036673|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
170463818|NCT03334617|616036674|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
170463819|NCT03334617|616036675|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
170463820|NCT03334617|616036676|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
170789720|NCT06182033|617240404|FG000|Overall Study|Withdrawal by Subject|1|||
170789721|NCT06182033|617240405|FG001|Overall Study|Withdrawal by Subject|0|||
170789722|NCT03084536|617240406|FG000|Overall Study|Determined to be ineligible|0|||
170789723|NCT03084536|617240407|FG001|Overall Study|Determined to be ineligible|0|||
170789724|NCT03084536|617240408|FG002|Overall Study|Determined to be ineligible|16|||
170789725|NCT03084536|617240406|FG000|Overall Study|Withdrawal by Subject|0|||
170789726|NCT03084536|617240407|FG001|Overall Study|Withdrawal by Subject|0|||
170789727|NCT03084536|617240408|FG002|Overall Study|Withdrawal by Subject|4|||
170789728|NCT03084536|617240406|FG000|Overall Study|Physician Decision|0|||
170789729|NCT03084536|617240407|FG001|Overall Study|Physician Decision|0|||
170789730|NCT03084536|617240408|FG002|Overall Study|Physician Decision|3|||
170890220|NCT01928381|617604222|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
170890221|NCT01928381|617604223|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
170463821|NCT03334617|616036677|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
170463822|NCT03334617|616036678|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
170463823|NCT03334617|616036679|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
170463824|NCT03334617|616036680|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
170463825|NCT03334617|616036681|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
170463826|NCT03334617|616036682|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
170463827|NCT03334617|616036683|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
170463828|NCT03334617|616036684|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
170463829|NCT03334617|616036685|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
170463830|NCT03334617|616036686|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
170463831|NCT03334617|616036687|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
170463832|NCT03334617|616036688|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
170463833|NCT03334617|616036689|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
170463834|NCT03334617|616036690|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
170463835|NCT03334617|616036691|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
170463836|NCT03657342|616036693|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
170463837|NCT03657342|616036694|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
170463838|NCT03657342|616036693|FG000|Overall Study|Withdrawal by Subject|4|||
170463839|NCT03657342|616036694|FG001|Overall Study|Withdrawal by Subject|4|||
170463840|NCT03657342|616036693|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
170463841|NCT03657342|616036694|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
170463842|NCT03657342|616036693|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
170463843|NCT03657342|616036694|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
170463844|NCT00407758|616036698|FG000|Overall Study|ineligible -improper prior treatment|1|||
170463845|NCT03050060|616036711|FG000|Overall Study|Adverse Event|7|||
170463846|NCT03050060|616036711|FG000|Overall Study|Withdrawal by Subject|1|||
170463847|NCT03050060|616036711|FG000|Overall Study|Progression|7|||
170463848|NCT03401450|616036712|FG000|Overall Study|Lost to Follow-up|4|||
170463849|NCT03401450|616036713|FG001|Overall Study|Lost to Follow-up|6|||
170463850|NCT03401450|616036712|FG000|Overall Study|Anesthesia plan changed|2|||
170463851|NCT03401450|616036713|FG001|Overall Study|Anesthesia plan changed|2|||
170463852|NCT03401450|616036712|FG000|Overall Study|Did not complete medication diary|4|||
170463853|NCT03401450|616036713|FG001|Overall Study|Did not complete medication diary|2|||
170463854|NCT03401450|616036712|FG000|Overall Study|post surgery medication change|2|||
170463855|NCT03401450|616036713|FG001|Overall Study|post surgery medication change|1|||
170463856|NCT03401450|616036712|FG000|Overall Study|Cancelled surgery|0|||
170463857|NCT03401450|616036713|FG001|Overall Study|Cancelled surgery|2|||
170463858|NCT03258853|616036716|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
170463859|NCT03258853|616036717|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
170463860|NCT03567382|616036718|FG000|Overall Study|Lost to Follow-up|1|||
170463861|NCT03567382|616036719|FG001|Overall Study|Lost to Follow-up|21|||
170463862|NCT03567382|616036720|FG002|Overall Study|Lost to Follow-up|1|||
170463863|NCT03567382|616036721|FG003|Overall Study|Lost to Follow-up|21|||
170463864|NCT03567382|616036718|FG000|Overall Study|Withdrawal by Subject|2|||
170463865|NCT03567382|616036719|FG001|Overall Study|Withdrawal by Subject|14|||
170463866|NCT03567382|616036720|FG002|Overall Study|Withdrawal by Subject|1|||
170789731|NCT03084536|617240406|FG000|Overall Study|Death|0|||
170789732|NCT03084536|617240407|FG001|Overall Study|Death|0|||
170890222|NCT01928381|617604217|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
170890223|NCT01928381|617604218|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
170463867|NCT03567382|616036721|FG003|Overall Study|Withdrawal by Subject|12|||
170789733|NCT03084536|617240408|FG002|Overall Study|Death|1|||
170789734|NCT03084536|617240406|FG000|Overall Study|Lost to Follow-up|0|||
170789735|NCT03084536|617240407|FG001|Overall Study|Lost to Follow-up|0|||
170890224|NCT01928381|617604219|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
170463868|NCT01709838|616036724|FG000|Overall Study|Withdrawal by Subject|21|||
170463869|NCT01709838|616036724|FG000|Overall Study|Lost to Follow-up|16|||
170789736|NCT03084536|617240408|FG002|Overall Study|Lost to Follow-up|1|||
170463870|NCT01709838|616036724|FG000|Overall Study|Pregnancy|10|||
170463871|NCT01709838|616036724|FG000|Overall Study|Subject/guardian decision|8|||
170463872|NCT01709838|616036724|FG000|Overall Study|Adverse Event|4|||
170463873|NCT01709838|616036724|FG000|Overall Study|Physician Decision|4|||
170463874|NCT01709838|616036724|FG000|Overall Study|Death|3|||
170463875|NCT01709838|616036724|FG000|Overall Study|Protocol Violation|1|||
170463876|NCT03246646|616036727|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
170463877|NCT03246646|616036728|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
170463878|NCT03246646|616036727|FG000|Overall Study|Withdrawal by Subject|3|||
170463879|NCT03246646|616036728|FG001|Overall Study|Withdrawal by Subject|0|||
170463880|NCT03246646|616036727|FG000|Overall Study|Lost to Follow-up|7|||
170463881|NCT03246646|616036728|FG001|Overall Study|Lost to Follow-up|0|||
170463882|NCT02352779|616036729|FG000|Overall Study|Personal Issues|1|||
170463883|NCT02352779|616036730|FG001|Overall Study|Personal Issues|1|||
170463884|NCT02352779|616036731|FG002|Overall Study|Personal Issues|0|||
170463885|NCT02352779|616036729|FG000|Overall Study|Too Many Forms|2|||
170463886|NCT02352779|616036730|FG001|Overall Study|Too Many Forms|0|||
170463887|NCT02352779|616036731|FG002|Overall Study|Too Many Forms|0|||
170463888|NCT02352779|616036729|FG000|Overall Study|Feeling Overwhelmed|1|||
170463889|NCT02352779|616036730|FG001|Overall Study|Feeling Overwhelmed|0|||
170463890|NCT02352779|616036731|FG002|Overall Study|Feeling Overwhelmed|0|||
170463891|NCT02352779|616036729|FG000|Overall Study|Disliked Intervention|1|||
170463892|NCT02352779|616036730|FG001|Overall Study|Disliked Intervention|0|||
170463893|NCT02352779|616036731|FG002|Overall Study|Disliked Intervention|0|||
170463894|NCT02352779|616036729|FG000|Overall Study|Changed Mind|1|||
170463895|NCT02352779|616036730|FG001|Overall Study|Changed Mind|0|||
170463896|NCT02352779|616036731|FG002|Overall Study|Changed Mind|0|||
170463897|NCT02352779|616036729|FG000|Overall Study|Study Related Symptoms|1|||
170463898|NCT02352779|616036730|FG001|Overall Study|Study Related Symptoms|0|||
170463899|NCT02352779|616036731|FG002|Overall Study|Study Related Symptoms|0|||
170463900|NCT02352779|616036729|FG000|Overall Study|Absence of Symptoms|1|||
170463901|NCT02352779|616036730|FG001|Overall Study|Absence of Symptoms|0|||
170890225|NCT01928381|617604220|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
170890226|NCT01928381|617604221|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
170890227|NCT01928381|617604222|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
170890228|NCT01928381|617604223|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
170890229|NCT01928381|617604217|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
170890230|NCT01928381|617604218|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
170890231|NCT01928381|617604219|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
170890232|NCT01928381|617604220|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
170890233|NCT01928381|617604221|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
170463902|NCT02352779|616036731|FG002|Overall Study|Absence of Symptoms|0|||
170463903|NCT02352779|616036729|FG000|Overall Study|Other Medical Reason|0|||
170463904|NCT02352779|616036730|FG001|Overall Study|Other Medical Reason|0|||
170463905|NCT02352779|616036731|FG002|Overall Study|Other Medical Reason|1|||
170463906|NCT02352779|616036729|FG000|Overall Study|No Reason|0|||
170463907|NCT02352779|616036730|FG001|Overall Study|No Reason|0|||
170789737|NCT03084536|617240406|FG000|Overall Study|Protocol Violation|0|||
170789738|NCT03084536|617240407|FG001|Overall Study|Protocol Violation|0|||
170789739|NCT03084536|617240408|FG002|Overall Study|Protocol Violation|1|||
170789740|NCT03084536|617240406|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
170789741|NCT03084536|617240407|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
170789742|NCT03084536|617240408|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
170789743|NCT02626533|617240411|FG000|Overall Study|Protocol Violation|14|||
170789744|NCT02626533|617240411|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
170789745|NCT02626533|617240411|FG000|Overall Study|Withdrawal by Subject|1|||
170789746|NCT03785964|617240412|FG000|Overall Study|Adverse Event|14|||
170789747|NCT03785964|617240413|FG001|Overall Study|Adverse Event|1|||
170890234|NCT01928381|617604222|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
170890235|NCT01928381|617604223|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
170890236|NCT01928381|617604217|FG000|Washout First Intervention|Protocol Violation|0|||
170890237|NCT01928381|617604218|FG001|Washout First Intervention|Protocol Violation|0|||
170890238|NCT01928381|617604219|FG002|Washout First Intervention|Protocol Violation|0|||
170463908|NCT02352779|616036731|FG002|Overall Study|No Reason|1|||
170463909|NCT00319982|616036734|FG000|Overall Study|Withdrawal by Subject|1|||
170463910|NCT00319982|616036735|FG001|Overall Study|Withdrawal by Subject|0|||
170463911|NCT04730349|616036736|FG000|Overall Study|Participant withdrew consent|1|||
170463912|NCT04730349|616036737|FG001|Overall Study|Participant withdrew consent|0|||
170463913|NCT04730349|616036736|FG000|Overall Study|Disease progression|6|||
170463914|NCT04730349|616036737|FG001|Overall Study|Disease progression|4|||
170789748|NCT03785964|617240412|FG000|Overall Study|Unqualified Clinical Progression|1|||
170463915|NCT04730349|616036736|FG000|Overall Study|Study drug toxicity|0|||
170463916|NCT04730349|616036737|FG001|Overall Study|Study drug toxicity|1|||
170463917|NCT00594646|616036738|FG000|Overall Study|Withdrawal by Subject|1|||
170463918|NCT00594646|616036738|FG000|Overall Study|Lost to Follow-up|15|||
170463919|NCT03907462|616036739|FG000|Overall Study|Physician Decision|1|||
170463920|NCT03907462|616036740|FG001|Overall Study|Physician Decision|3|||
170463921|NCT03907462|616036741|FG002|Overall Study|Physician Decision|1|||
170463922|NCT03907462|616036739|FG000|Overall Study|Withdrawal by Subject|6|||
170463923|NCT03907462|616036740|FG001|Overall Study|Withdrawal by Subject|3|||
170463924|NCT03907462|616036741|FG002|Overall Study|Withdrawal by Subject|3|||
170463925|NCT03907462|616036739|FG000|Overall Study|Pregnancy|4|||
170463926|NCT03907462|616036740|FG001|Overall Study|Pregnancy|2|||
170463927|NCT03907462|616036741|FG002|Overall Study|Pregnancy|6|||
170463928|NCT03907462|616036739|FG000|Overall Study|Lost to Follow-up|16|||
170463929|NCT03907462|616036740|FG001|Overall Study|Lost to Follow-up|18|||
170463930|NCT03907462|616036741|FG002|Overall Study|Lost to Follow-up|22|||
170463931|NCT04639713|616036745|FG000|Overall Study|Protocol Noncompliance|2|||
170463932|NCT04639713|616036745|FG000|Overall Study|Withdrawal by Subject|1|||
170463933|NCT03395405|616037907|FG000|Overall Study|Death|0|||
170463934|NCT03395405|616037908|FG001|Overall Study|Death|2|||
170463935|NCT03395405|616037907|FG000|Overall Study|Lost to Follow-up|0|||
170463936|NCT03395405|616037908|FG001|Overall Study|Lost to Follow-up|1|||
170463937|NCT03395405|616037907|FG000|Overall Study|Protocol Violation|0|||
170463938|NCT03395405|616037908|FG001|Overall Study|Protocol Violation|1|||
170463939|NCT03395405|616037907|FG000|Overall Study|Withdrawal by Subject|3|||
170463940|NCT03395405|616037908|FG001|Overall Study|Withdrawal by Subject|1|||
170463941|NCT03395405|616037907|FG000|Overall Study|COVID-19 Pandemic|1|||
170463942|NCT03395405|616037908|FG001|Overall Study|COVID-19 Pandemic|0|||
170463943|NCT00070499|616037909|FG000|Overall Study|Adverse Event|6|||
170463944|NCT00070499|616037910|FG001|Overall Study|Adverse Event|6|||
170463945|NCT00070499|616037911|FG002|Overall Study|Adverse Event|19|||
170463946|NCT00070499|616037912|FG003|Overall Study|Adverse Event|15|||
170463947|NCT00070499|616037909|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
170463948|NCT00070499|616037910|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
170544440|NCT01658878|616337270|FG009|Treatment Period|Participant Withdrew Consent|0|||
170544441|NCT01658878|616337271|FG010|Treatment Period|Participant Withdrew Consent|0|||
170544442|NCT01658878|616337272|FG011|Treatment Period|Participant Withdrew Consent|0|||
170544443|NCT01658878|616337273|FG012|Treatment Period|Participant Withdrew Consent|1|||
170544444|NCT01658878|616337274|FG013|Treatment Period|Participant Withdrew Consent|0|||
170544445|NCT01658878|616337275|FG014|Treatment Period|Participant Withdrew Consent|2|||
170544446|NCT01658878|616337276|FG015|Treatment Period|Participant Withdrew Consent|0|||
170544447|NCT01658878|616337277|FG016|Treatment Period|Participant Withdrew Consent|0|||
170544448|NCT01658878|616337278|FG017|Treatment Period|Participant Withdrew Consent|2|||
170544449|NCT01658878|616337279|FG018|Treatment Period|Participant Withdrew Consent|1|||
170544450|NCT01658878|616337280|FG019|Treatment Period|Participant Withdrew Consent|2|||
170544451|NCT01658878|616337281|FG020|Treatment Period|Participant Withdrew Consent|1|||
170544452|NCT01658878|616337282|FG021|Treatment Period|Participant Withdrew Consent|0|||
170544453|NCT01658878|616337283|FG022|Treatment Period|Participant Withdrew Consent|2|||
170544454|NCT01658878|616337284|FG023|Treatment Period|Participant Withdrew Consent|2|||
170544455|NCT01658878|616337261|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544456|NCT01658878|616337262|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544457|NCT01658878|616337263|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544458|NCT01658878|616337264|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544459|NCT01658878|616337265|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544460|NCT01658878|616337266|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544461|NCT01658878|616337267|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544462|NCT01658878|616337268|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544463|NCT01658878|616337269|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544464|NCT01658878|616337270|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170789749|NCT03785964|617240413|FG001|Overall Study|Unqualified Clinical Progression|1|||
170789750|NCT03785964|617240412|FG000|Overall Study|Participant non-compliance|1|||
170789751|NCT03785964|617240413|FG001|Overall Study|Participant non-compliance|1|||
170789752|NCT03785964|617240412|FG000|Overall Study|Not treated|1|||
170789753|NCT03785964|617240413|FG001|Overall Study|Not treated|0|||
170789754|NCT03785964|617240412|FG000|Overall Study|Other reason|5|||
170789755|NCT03785964|617240413|FG001|Overall Study|Other reason|11|||
170789756|NCT03785964|617240412|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
170789757|NCT03785964|617240413|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
170789758|NCT02151981|617240414|FG000|Overall Study|Death|184|||
170789759|NCT02151981|617240415|FG001|Overall Study|Death|88|||
170789760|NCT02151981|617240414|FG000|Overall Study|Lost to Follow-up|7|||
170789761|NCT02151981|617240415|FG001|Overall Study|Lost to Follow-up|1|||
170789762|NCT02151981|617240414|FG000|Overall Study|Withdrawal by Subject|27|||
170789763|NCT02151981|617240415|FG001|Overall Study|Withdrawal by Subject|21|||
170789764|NCT02151981|617240414|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170789765|NCT02151981|617240415|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170544465|NCT01658878|616337271|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544466|NCT01658878|616337272|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544467|NCT01658878|616337273|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
170544468|NCT01658878|616337274|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
170544469|NCT01658878|616337275|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
170544470|NCT01658878|616337276|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
170544471|NCT01658878|616337277|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
170544472|NCT01658878|616337278|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
170544473|NCT01658878|616337279|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544474|NCT01658878|616337280|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
170544475|NCT01658878|616337281|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
170544476|NCT01658878|616337282|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
170544477|NCT01658878|616337283|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
170544478|NCT01658878|616337284|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
170544479|NCT01658878|616337261|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
170544480|NCT01658878|616337262|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
170890239|NCT01928381|617604220|FG003|Washout First Intervention|Protocol Violation|0|||
170890240|NCT01928381|617604221|FG004|Washout First Intervention|Protocol Violation|1|||
170890241|NCT01928381|617604222|FG005|Washout First Intervention|Protocol Violation|0|||
170890242|NCT01928381|617604223|FG006|Washout First Intervention|Protocol Violation|0|||
170890243|NCT01928381|617604217|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
170890244|NCT01928381|617604218|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
170890245|NCT01928381|617604219|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
170890246|NCT01928381|617604220|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
170890247|NCT01928381|617604221|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
170890248|NCT01928381|617604222|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
170890249|NCT01928381|617604223|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
170890250|NCT01928381|617604217|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
170890251|NCT01928381|617604218|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
170890252|NCT01928381|617604219|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
170890253|NCT01928381|617604220|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
170544481|NCT01658878|616337263|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
170544482|NCT01658878|616337264|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
170544483|NCT01658878|616337265|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
170544484|NCT01658878|616337266|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
170544485|NCT01658878|616337267|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
170544486|NCT01658878|616337268|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
170544487|NCT01658878|616337269|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
170544488|NCT01658878|616337270|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
170636693|NCT01967238|616680931|FG000|Overall Study|Withdrawal by Subject|0|||
170636694|NCT01967238|616680932|FG001|Overall Study|Withdrawal by Subject|0|||
170636695|NCT01967238|616680933|FG002|Overall Study|Withdrawal by Subject|1|||
170636696|NCT00684060|616682500|FG000|Overall Study|Lost to Follow-up|1|||
170636697|NCT00684060|616682501|FG001|Overall Study|Lost to Follow-up|0|||
170636698|NCT00684060|616682500|FG000|Overall Study|New stenosis identified|1|||
170636699|NCT00684060|616682501|FG001|Overall Study|New stenosis identified|0|||
170636700|NCT00684060|616682500|FG000|Overall Study|Unable to collect MRI|1|||
170636701|NCT00684060|616682501|FG001|Overall Study|Unable to collect MRI|2|||
170636702|NCT00684060|616682500|FG000|Overall Study|Death|0|||
170636703|NCT00684060|616682501|FG001|Overall Study|Death|1|||
170636704|NCT02923921|616682506|FG000|Overall Study|Sponsor Decision|39|||
170636705|NCT02923921|616682507|FG001|Overall Study|Sponsor Decision|38|||
170636706|NCT02923921|616682506|FG000|Overall Study|Lost to Follow-up|1|||
170636707|NCT02923921|616682507|FG001|Overall Study|Lost to Follow-up|0|||
170636708|NCT02923921|616682506|FG000|Overall Study|Withdrawal by Subject|6|||
170636709|NCT02923921|616682507|FG001|Overall Study|Withdrawal by Subject|13|||
170890254|NCT01928381|617604221|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
170890255|NCT01928381|617604222|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
170890256|NCT01928381|617604223|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
170890257|NCT02531646|617604224|FG000|Overall Study|equip. image processing issue|5|||
170890258|NCT02531646|617604225|FG001|Overall Study|equip. image processing issue|1|||
170890259|NCT02531646|617604226|FG002|Overall Study|equip. image processing issue|0|||
170890260|NCT00429585|617604227|FG000|Overall Study|Death|1|||
170636710|NCT02923921|616682506|FG000|Overall Study|Unknown, Not Collected|7|||
170636711|NCT02923921|616682507|FG001|Overall Study|Unknown, Not Collected|6|||
170890261|NCT00429585|617604228|FG001|Overall Study|Death|0|||
170890262|NCT00429585|617604227|FG000|Overall Study|Lost to Follow-up|27|||
170890263|NCT00429585|617604228|FG001|Overall Study|Lost to Follow-up|20|||
170890264|NCT00429585|617604227|FG000|Overall Study|Physician Decision|2|||
170463949|NCT00070499|616037911|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
170463950|NCT00070499|616037912|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
170463951|NCT00070499|616037909|FG000|Overall Study|Progression/relapse|4|||
170463952|NCT00070499|616037910|FG001|Overall Study|Progression/relapse|2|||
170463953|NCT00070499|616037911|FG002|Overall Study|Progression/relapse|1|||
170463954|NCT00070499|616037912|FG003|Overall Study|Progression/relapse|4|||
170463955|NCT00070499|616037909|FG000|Overall Study|Death|1|||
170463956|NCT00070499|616037910|FG001|Overall Study|Death|1|||
170463957|NCT00070499|616037911|FG002|Overall Study|Death|1|||
170463958|NCT00070499|616037912|FG003|Overall Study|Death|2|||
170789766|NCT02151981|617240414|FG000|Overall Study|Other reasons|1|||
170789767|NCT02151981|617240415|FG001|Overall Study|Other reasons|2|||
170789768|NCT05645757|617240421|FG000|Overall Study|Enrolled but treatment not administered|0|||
170789769|NCT05645757|617240422|FG001|Overall Study|Enrolled but treatment not administered|0|||
170789770|NCT05645757|617240423|FG002|Overall Study|Enrolled but treatment not administered|0|||
170789771|NCT05645757|617240424|FG003|Overall Study|Enrolled but treatment not administered|0|||
170789772|NCT05645757|617240425|FG004|Overall Study|Enrolled but treatment not administered|1|||
170789773|NCT05645757|617240426|FG005|Overall Study|Enrolled but treatment not administered|1|||
170789774|NCT05645757|617240427|FG006|Overall Study|Enrolled but treatment not administered|0|||
170789775|NCT05645757|617240428|FG007|Overall Study|Enrolled but treatment not administered|0|||
170789776|NCT04437615|617240436|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
170789777|NCT04828005|617240437|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
170789778|NCT04828005|617240438|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
170789779|NCT04828005|617240439|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
170789780|NCT04828005|617240440|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
170789781|NCT04828005|617240437|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
170789782|NCT04828005|617240438|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
170789783|NCT04828005|617240439|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
170789784|NCT04828005|617240440|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
170463959|NCT00070499|616037909|FG000|Overall Study|Other - not protocol specified|7|||
170463960|NCT00070499|616037910|FG001|Overall Study|Other - not protocol specified|3|||
170463961|NCT00070499|616037911|FG002|Overall Study|Other - not protocol specified|12|||
170463962|NCT00070499|616037912|FG003|Overall Study|Other - not protocol specified|20|||
170463963|NCT00070499|616037909|FG000|Overall Study|Still on protocol treatment|10|||
170463964|NCT00070499|616037910|FG001|Overall Study|Still on protocol treatment|4|||
170463965|NCT00070499|616037911|FG002|Overall Study|Still on protocol treatment|79|||
170463966|NCT00070499|616037912|FG003|Overall Study|Still on protocol treatment|57|||
170463967|NCT00070499|616037909|FG000|Overall Study|Did not start treatment|1|||
170463968|NCT00070499|616037910|FG001|Overall Study|Did not start treatment|0|||
170463969|NCT00070499|616037911|FG002|Overall Study|Did not start treatment|0|||
170463970|NCT00070499|616037912|FG003|Overall Study|Did not start treatment|2|||
170463971|NCT00070499|616037909|FG000|Overall Study|Not eligible|2|||
170463972|NCT00070499|616037910|FG001|Overall Study|Not eligible|5|||
170463973|NCT00070499|616037911|FG002|Overall Study|Not eligible|3|||
170463974|NCT00070499|616037912|FG003|Overall Study|Not eligible|2|||
170463975|NCT00805467|616037913|FG000|Overall Study|Lack of Efficacy|0|||
170463976|NCT00805467|616037914|FG001|Overall Study|Lack of Efficacy|8|||
170463977|NCT00805467|616037915|FG002|Overall Study|Lack of Efficacy|13|||
170463978|NCT00805467|616037916|FG003|Overall Study|Lack of Efficacy|86|||
170463979|NCT00805467|616037913|FG000|Overall Study|Lost to Follow-up|0|||
170463980|NCT00805467|616037914|FG001|Overall Study|Lost to Follow-up|1|||
170463981|NCT00805467|616037915|FG002|Overall Study|Lost to Follow-up|7|||
170463982|NCT00805467|616037916|FG003|Overall Study|Lost to Follow-up|21|||
170463983|NCT00805467|616037913|FG000|Overall Study|Withdrawal by Subject|0|||
170463984|NCT00805467|616037914|FG001|Overall Study|Withdrawal by Subject|6|||
170463985|NCT00805467|616037915|FG002|Overall Study|Withdrawal by Subject|45|||
170463986|NCT00805467|616037916|FG003|Overall Study|Withdrawal by Subject|50|||
170463987|NCT00805467|616037913|FG000|Overall Study|Protocol Violation|0|||
170463988|NCT00805467|616037914|FG001|Overall Study|Protocol Violation|3|||
170463989|NCT00805467|616037915|FG002|Overall Study|Protocol Violation|0|||
170789785|NCT04828005|617240437|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
170890265|NCT00429585|617604228|FG001|Overall Study|Physician Decision|0|||
170463990|NCT00805467|616037916|FG003|Overall Study|Protocol Violation|5|||
170463991|NCT00805467|616037913|FG000|Overall Study|Adverse Event|0|||
170463992|NCT00805467|616037914|FG001|Overall Study|Adverse Event|13|||
170463993|NCT00805467|616037915|FG002|Overall Study|Adverse Event|26|||
170463994|NCT00805467|616037916|FG003|Overall Study|Adverse Event|57|||
170463995|NCT00805467|616037913|FG000|Overall Study|Death|0|||
170463996|NCT00805467|616037914|FG001|Overall Study|Death|2|||
170463997|NCT00805467|616037915|FG002|Overall Study|Death|7|||
170463998|NCT00805467|616037916|FG003|Overall Study|Death|5|||
170463999|NCT00805467|616037913|FG000|Overall Study|Physician Decision|0|||
170464000|NCT00805467|616037914|FG001|Overall Study|Physician Decision|1|||
170464001|NCT00805467|616037915|FG002|Overall Study|Physician Decision|2|||
170464002|NCT00805467|616037916|FG003|Overall Study|Physician Decision|6|||
170464003|NCT00805467|616037913|FG000|Overall Study|Not reported|0|||
170890266|NCT01582308|617604229|FG000|Period 1|Withdrawal by Subject|0|||
170890267|NCT01582308|617604230|FG001|Period 1|Withdrawal by Subject|0|||
170890268|NCT01582308|617604231|FG002|Period 1|Withdrawal by Subject|0|||
170890269|NCT01582308|617604232|FG003|Period 1|Withdrawal by Subject|0|||
170890270|NCT01582308|617604233|FG004|Period 1|Withdrawal by Subject|0|||
170890271|NCT01582308|617604234|FG005|Period 1|Withdrawal by Subject|0|||
170890272|NCT01582308|617604235|FG006|Period 1|Withdrawal by Subject|1|||
170890273|NCT01582308|617604236|FG007|Period 1|Withdrawal by Subject|0|||
170890274|NCT01582308|617604237|FG008|Period 1|Withdrawal by Subject|0|||
170890275|NCT01582308|617604238|FG009|Period 1|Withdrawal by Subject|0|||
170890276|NCT01582308|617604229|FG000|10-day Washout Following Period 1|Physician Decision|0|||
170890277|NCT01582308|617604230|FG001|10-day Washout Following Period 1|Physician Decision|0|||
170890278|NCT01582308|617604231|FG002|10-day Washout Following Period 1|Physician Decision|0|||
170890279|NCT01582308|617604232|FG003|10-day Washout Following Period 1|Physician Decision|0|||
170890280|NCT01582308|617604233|FG004|10-day Washout Following Period 1|Physician Decision|1|||
170890281|NCT01582308|617604234|FG005|10-day Washout Following Period 1|Physician Decision|0|||
170890282|NCT01582308|617604235|FG006|10-day Washout Following Period 1|Physician Decision|0|||
170890283|NCT01582308|617604236|FG007|10-day Washout Following Period 1|Physician Decision|0|||
170890284|NCT01582308|617604237|FG008|10-day Washout Following Period 1|Physician Decision|0|||
170890285|NCT01582308|617604238|FG009|10-day Washout Following Period 1|Physician Decision|0|||
170890286|NCT01582308|617604229|FG000|Period 4|Physician Decision|1|||
170890287|NCT01582308|617604230|FG001|Period 4|Physician Decision|0|||
170890288|NCT01582308|617604231|FG002|Period 4|Physician Decision|0|||
170890289|NCT01582308|617604232|FG003|Period 4|Physician Decision|0|||
170464004|NCT00805467|616037914|FG001|Overall Study|Not reported|0|||
170464005|NCT00805467|616037915|FG002|Overall Study|Not reported|3|||
170890290|NCT01582308|617604233|FG004|Period 4|Physician Decision|0|||
170890291|NCT01582308|617604234|FG005|Period 4|Physician Decision|1|||
170890292|NCT01582308|617604235|FG006|Period 4|Physician Decision|0|||
170890293|NCT01582308|617604236|FG007|Period 4|Physician Decision|0|||
170890294|NCT01582308|617604237|FG008|Period 4|Physician Decision|0|||
170890295|NCT01582308|617604238|FG009|Period 4|Physician Decision|1|||
170890296|NCT03521791|617606415|FG000|Overall Study|Protocol Violation|7|||
170890297|NCT03521791|617606416|FG001|Overall Study|Protocol Violation|17|||
170890298|NCT03968419|617606420|FG000|Treatment Period|Adverse Event|0|||
170890299|NCT03968419|617606421|FG001|Treatment Period|Adverse Event|0|||
170890300|NCT03968419|617606422|FG002|Treatment Period|Adverse Event|1|||
170890301|NCT03968419|617606420|FG000|Safety Follow-up Period|Death|3|||
170890302|NCT03968419|617606421|FG001|Safety Follow-up Period|Death|2|||
170890303|NCT03968419|617606422|FG002|Safety Follow-up Period|Death|1|||
170890304|NCT03968419|617606420|FG000|Safety Follow-up Period|Subject Decision|2|||
170890305|NCT03968419|617606421|FG001|Safety Follow-up Period|Subject Decision|1|||
170890306|NCT03968419|617606422|FG002|Safety Follow-up Period|Subject Decision|0|||
170890307|NCT00935883|617606425|FG000|Treatment Period|Physician Decision|1|||
170890308|NCT00935883|617606426|FG001|Treatment Period|Physician Decision|0|||
170890309|NCT00935883|617606425|FG000|Treatment Period|Withdrawal by Subject|0|||
170890310|NCT00935883|617606426|FG001|Treatment Period|Withdrawal by Subject|2|||
170890311|NCT02968810|617606427|FG000|Overall Study|Lost to Follow-up|1|||
170890312|NCT02968810|617606428|FG001|Overall Study|Lost to Follow-up|0|||
170890313|NCT02968810|617606427|FG000|Overall Study|Physician Decision|1|||
170890314|NCT02968810|617606428|FG001|Overall Study|Physician Decision|0|||
170890315|NCT02968810|617606427|FG000|Overall Study|Withdrawal by Subject|1|||
170890316|NCT02968810|617606428|FG001|Overall Study|Withdrawal by Subject|3|||
170890317|NCT02968810|617606427|FG000|Overall Study|Disease Progression|0|||
170890318|NCT02968810|617606428|FG001|Overall Study|Disease Progression|1|||
170890319|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
170890320|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
170890321|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
170890322|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
170890323|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
170890324|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
170890325|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
170890326|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
170890327|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
170890328|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
170890329|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
170890330|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
170890331|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
170890332|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
170890333|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
170890334|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
170890335|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
170890336|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
170464006|NCT00805467|616037916|FG003|Overall Study|Not reported|7|||
170464007|NCT03047330|616037923|FG000|Sleep Block 1|Withdrawal by Subject|3|||
170464008|NCT00660907|616037924|FG000|Overall Study|Incorrect Enrollment|1|||
170464009|NCT00660907|616037925|FG001|Overall Study|Incorrect Enrollment|1|||
170464010|NCT00660907|616037924|FG000|Overall Study|Adverse Event|33|||
170464011|NCT00660907|616037925|FG001|Overall Study|Adverse Event|19|||
170464012|NCT00660907|616037924|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
170464013|NCT00660907|616037925|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
170464014|NCT00660907|616037924|FG000|Overall Study|Withdrawal by Subject|23|||
170464015|NCT00660907|616037925|FG001|Overall Study|Withdrawal by Subject|32|||
170464016|NCT00660907|616037924|FG000|Overall Study|Lost to Follow-up|3|||
170464017|NCT00660907|616037925|FG001|Overall Study|Lost to Follow-up|3|||
170464018|NCT00660907|616037924|FG000|Overall Study|Poor/Non-Compliance|5|||
170464019|NCT00660907|616037925|FG001|Overall Study|Poor/Non-Compliance|1|||
170464020|NCT00660907|616037924|FG000|Overall Study|Safety|1|||
170464021|NCT00660907|616037925|FG001|Overall Study|Safety|0|||
170464022|NCT00660907|616037924|FG000|Overall Study|Death|1|||
170464023|NCT00660907|616037925|FG001|Overall Study|Death|3|||
170464024|NCT00660907|616037924|FG000|Overall Study|Various|11|||
170464025|NCT00660907|616037925|FG001|Overall Study|Various|8|||
170464026|NCT01908907|616037926|FG000|Overall Study|Physician Decision|1|||
170464027|NCT01908907|616037927|FG001|Overall Study|Physician Decision|0|||
170464028|NCT01908907|616037926|FG000|Overall Study|Protocol Violation|1|||
170464029|NCT01908907|616037927|FG001|Overall Study|Protocol Violation|0|||
170464030|NCT04975191|616037928|FG000|Overall Study|Protocol Violation|1|||
170464031|NCT04975191|616037929|FG001|Overall Study|Protocol Violation|2|||
170464032|NCT04975191|616037930|FG002|Overall Study|Protocol Violation|2|||
170464033|NCT04975191|616037931|FG003|Overall Study|Protocol Violation|2|||
170464034|NCT04975191|616037928|FG000|Overall Study|Lost to Follow-up|13|||
170464035|NCT04975191|616037929|FG001|Overall Study|Lost to Follow-up|3|||
170464036|NCT04975191|616037930|FG002|Overall Study|Lost to Follow-up|8|||
170464037|NCT04975191|616037931|FG003|Overall Study|Lost to Follow-up|8|||
170464038|NCT01284361|616037940|FG000|Overall Study|Withdrawal by Subject|1|||
170464039|NCT01284361|616037940|FG000|Overall Study|Protocol Violation|5|||
170464040|NCT01284361|616037940|FG000|Overall Study|Adverse Event|1|||
170464041|NCT01284361|616037940|FG000|Overall Study|Lost to Follow-up|2|||
170464042|NCT00663026|616037941|FG000|Overall Study|Lost to Follow-up|1|||
170464043|NCT00663026|616037942|FG001|Overall Study|Lost to Follow-up|0|||
170464044|NCT00663026|616037943|FG002|Overall Study|Lost to Follow-up|0|||
170464045|NCT00663026|616037941|FG000|Overall Study|Other|1|||
170464046|NCT00663026|616037942|FG001|Overall Study|Other|2|||
170464047|NCT00663026|616037943|FG002|Overall Study|Other|0|||
170464048|NCT00663026|616037941|FG000|Overall Study|Adverse Event|0|||
170464049|NCT00663026|616037942|FG001|Overall Study|Adverse Event|2|||
170464050|NCT00663026|616037943|FG002|Overall Study|Adverse Event|3|||
170464051|NCT00663026|616037941|FG000|Overall Study|Caregiver Request|0|||
170464052|NCT00663026|616037942|FG001|Overall Study|Caregiver Request|2|||
170464053|NCT00663026|616037943|FG002|Overall Study|Caregiver Request|0|||
170464054|NCT00663026|616037941|FG000|Overall Study|Withdrawal by Subject|0|||
170464055|NCT00663026|616037942|FG001|Overall Study|Withdrawal by Subject|0|||
170464056|NCT00663026|616037943|FG002|Overall Study|Withdrawal by Subject|1|||
170464057|NCT01392963|616037947|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
170464058|NCT01392963|616037948|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
170464059|NCT01392963|616037947|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
170464060|NCT01392963|616037948|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
170464061|NCT01392963|616037947|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
170464062|NCT01392963|616037948|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
170464063|NCT01564537|616037949|FG000|Overall Study|Site Terminated by Sponsor|1|||
170464064|NCT01564537|616037950|FG001|Overall Study|Site Terminated by Sponsor|0|||
170464065|NCT01564537|616037949|FG000|Overall Study|Withdrawal by Subject|12|||
170464066|NCT01564537|616037950|FG001|Overall Study|Withdrawal by Subject|14|||
170464067|NCT01564537|616037949|FG000|Overall Study|Lost to Follow-up|7|||
170464068|NCT01564537|616037950|FG001|Overall Study|Lost to Follow-up|3|||
170464069|NCT01564537|616037949|FG000|Overall Study|Reason not specified|81|||
170464070|NCT01564537|616037950|FG001|Overall Study|Reason not specified|82|||
170464071|NCT02932306|616037951|FG000|Overall Study|Withdrawal by Subject|16|||
170464072|NCT02932306|616037952|FG001|Overall Study|Withdrawal by Subject|25|||
170464073|NCT02932306|616037951|FG000|Overall Study|Adverse Event|3|||
170464074|NCT02932306|616037952|FG001|Overall Study|Adverse Event|0|||
170464075|NCT02932306|616037951|FG000|Overall Study|Pregnancy|2|||
170464076|NCT02932306|616037952|FG001|Overall Study|Pregnancy|0|||
170464077|NCT02932306|616037951|FG000|Overall Study|Protocol Violation|1|||
170464078|NCT02932306|616037952|FG001|Overall Study|Protocol Violation|1|||
170464079|NCT02932306|616037951|FG000|Overall Study|Noncompliance with Study Drug|1|||
170464080|NCT02932306|616037952|FG001|Overall Study|Noncompliance with Study Drug|1|||
170464081|NCT02932306|616037951|FG000|Overall Study|Lost to Follow-up|36|||
170464082|NCT02932306|616037952|FG001|Overall Study|Lost to Follow-up|40|||
170464083|NCT02932306|616037951|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
170464084|NCT02932306|616037952|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
170464085|NCT02932306|616037951|FG000|Overall Study|Lack of Efficacy|0|||
170464086|NCT02932306|616037952|FG001|Overall Study|Lack of Efficacy|2|||
170464087|NCT02932306|616037951|FG000|Overall Study|Worsening condition|2|||
170464088|NCT02932306|616037952|FG001|Overall Study|Worsening condition|0|||
170464089|NCT02932306|616037951|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
170464090|NCT02932306|616037952|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
170464091|NCT03783039|616037953|FG000|Overall Study|Death|2|||
170464092|NCT03783039|616037954|FG001|Overall Study|Death|1|||
170890337|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
170890338|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
170890339|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
170890340|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
170890341|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
170890342|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
170890343|NCT04660643|617606431|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
170890344|NCT04660643|617606432|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
170890345|NCT04660643|617606433|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
170890346|NCT04660643|617606431|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
170890347|NCT04660643|617606432|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
170890348|NCT04660643|617606433|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
170890349|NCT04660643|617606431|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
170890350|NCT04660643|617606432|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
170890351|NCT04660643|617606433|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
170890352|NCT04660643|617606431|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
170890353|NCT04660643|617606432|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
170890354|NCT04660643|617606433|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
170890355|NCT04660643|617606431|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
170890356|NCT04660643|617606432|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
170890357|NCT04660643|617606433|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
170890358|NCT04660643|617606431|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
170890359|NCT04660643|617606432|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
170890360|NCT04660643|617606433|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
170890361|NCT04660643|617606431|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
170890362|NCT04660643|617606432|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
170890363|NCT04660643|617606433|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
170890364|NCT04660643|617606431|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
170890365|NCT04660643|617606432|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
170890366|NCT04660643|617606433|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
170890367|NCT02322710|617606437|FG000|Overall Study|No efficacy assessment post-baseline|0|||
170890368|NCT02322710|617606438|FG001|Overall Study|No efficacy assessment post-baseline|1|||
170890369|NCT02322710|617606437|FG000|Overall Study|Protocol Violation|20|||
170890370|NCT02322710|617606438|FG001|Overall Study|Protocol Violation|25|||
170890371|NCT05162066|617606443|FG000|Overall Study|Adverse Event|1|||
170890372|NCT05162066|617606444|FG001|Overall Study|Adverse Event|0|||
170890373|NCT05162066|617606445|FG002|Overall Study|Adverse Event|0|||
170890374|NCT05162066|617606443|FG000|Overall Study|Perceived lack of efficacy|1|||
170890375|NCT05162066|617606444|FG001|Overall Study|Perceived lack of efficacy|0|||
170890376|NCT05162066|617606445|FG002|Overall Study|Perceived lack of efficacy|0|||
170890377|NCT01220414|617606446|FG000|Overall Study|Withdrawal by Subject|1|||
170890378|NCT01220414|617606447|FG001|Overall Study|Withdrawal by Subject|0|||
170890379|NCT01220414|617606448|FG002|Overall Study|Withdrawal by Subject|0|||
170890380|NCT01220414|617606449|FG003|Overall Study|Withdrawal by Subject|1|||
170890381|NCT00623831|617606450|FG000|Overall Study|Withdrawal by Subject|1|||
170464093|NCT01119508|616037955|FG000|Overall Study|Adverse Event|56|||
170464094|NCT01119508|616037955|FG000|Overall Study|Withdrawal by Subject|2|||
170464095|NCT01119508|616037955|FG000|Overall Study|Died before tumor response evaluation|1|||
170464096|NCT00265395|616037956|FG000|Overall Study|Adverse Event|3|||
170890382|NCT00623831|617606451|FG001|Overall Study|Withdrawal by Subject|0|||
170890383|NCT00623831|617606450|FG000|Overall Study|Progressive Disease|0|||
170890384|NCT00623831|617606451|FG001|Overall Study|Progressive Disease|1|||
170890385|NCT01276821|617606452|FG000|Overall Study|Protocol Violation|0|||
170890386|NCT01276821|617606453|FG001|Overall Study|Protocol Violation|1|||
170890387|NCT00223496|617606454|FG000|Overall Study|screen failure|9|||
170464097|NCT00265395|616037957|FG001|Overall Study|Adverse Event|6|||
170464098|NCT00265395|616037956|FG000|Overall Study|Lost to Follow-up|2|||
170464099|NCT00265395|616037957|FG001|Overall Study|Lost to Follow-up|1|||
170464100|NCT00265395|616037956|FG000|Overall Study|Withdrawal by Subject|1|||
170464101|NCT00265395|616037957|FG001|Overall Study|Withdrawal by Subject|6|||
170890388|NCT00223496|617606454|FG000|Overall Study|Lost to Follow-up|4|||
170890389|NCT00223496|617606454|FG000|Overall Study|Lack of Efficacy|6|||
170464102|NCT00265395|616037956|FG000|Overall Study|Protocol Violation|2|||
170464103|NCT00265395|616037957|FG001|Overall Study|Protocol Violation|2|||
170464104|NCT00265395|616037956|FG000|Overall Study|Lack of Efficacy|0|||
170464105|NCT00265395|616037957|FG001|Overall Study|Lack of Efficacy|1|||
170464106|NCT00265395|616037956|FG000|Overall Study|Administrative|0|||
170464107|NCT00265395|616037957|FG001|Overall Study|Administrative|1|||
170464108|NCT02315196|616037958|FG000|Overall Study|Withdrew consent|9|||
170464109|NCT00837473|616037961|FG000|Overall Study|Lost to Follow-up|1|||
170464110|NCT00837473|616037961|FG000|Overall Study|Withdrawal by Subject|2|||
170464111|NCT02563106|616037962|FG000|Overall Study|Withdrawal by Subject|7|||
170464112|NCT02563106|616037963|FG001|Overall Study|Withdrawal by Subject|8|||
170464113|NCT02563106|616037962|FG000|Overall Study|Adverse Event|17|||
170464114|NCT02563106|616037963|FG001|Overall Study|Adverse Event|15|||
170464115|NCT02563106|616037962|FG000|Overall Study|Protocol Violation|1|||
170464116|NCT02563106|616037963|FG001|Overall Study|Protocol Violation|0|||
170464117|NCT02563106|616037962|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
170464118|NCT02563106|616037963|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
170464119|NCT02563106|616037962|FG000|Overall Study|Lost to Follow-up|3|||
170464120|NCT02563106|616037963|FG001|Overall Study|Lost to Follow-up|2|||
170464121|NCT02563106|616037962|FG000|Overall Study|Physician Decision|3|||
170464122|NCT02563106|616037963|FG001|Overall Study|Physician Decision|1|||
170464123|NCT02563106|616037962|FG000|Overall Study|Other reason - not specified|2|||
170464124|NCT02563106|616037963|FG001|Overall Study|Other reason - not specified|1|||
170464125|NCT02338193|616037964|FG000|Overall Study|Withdrawal by Subject|0|||
170464126|NCT02338193|616037965|FG001|Overall Study|Withdrawal by Subject|0|||
170464127|NCT02338193|616037966|FG002|Overall Study|Withdrawal by Subject|2|||
170464128|NCT02338193|616037964|FG000|Overall Study|Pregnancy|0|||
170464129|NCT02338193|616037965|FG001|Overall Study|Pregnancy|1|||
170464130|NCT02338193|616037966|FG002|Overall Study|Pregnancy|1|||
170464131|NCT02338193|616037964|FG000|Overall Study|Noncompliant with visits|2|||
170464132|NCT02338193|616037965|FG001|Overall Study|Noncompliant with visits|2|||
170464133|NCT02338193|616037966|FG002|Overall Study|Noncompliant with visits|7|||
170464134|NCT02338193|616037964|FG000|Overall Study|moved out of state|0|||
170464135|NCT02338193|616037965|FG001|Overall Study|moved out of state|1|||
170464136|NCT02338193|616037966|FG002|Overall Study|moved out of state|0|||
170464137|NCT02338193|616037964|FG000|Overall Study|intolerant of side effects|1|||
170464138|NCT02338193|616037965|FG001|Overall Study|intolerant of side effects|0|||
170464139|NCT02338193|616037966|FG002|Overall Study|intolerant of side effects|0|||
170464140|NCT01735955|616037968|FG000|Overall Study|Administrative problems|1|||
170464141|NCT01735955|616037968|FG000|Overall Study|Patient/guardian decision|1|||
170464142|NCT01735955|616037968|FG000|Overall Study|Patient withdrew consent|2|||
170464143|NCT01735955|616037968|FG000|Overall Study|Physician Decision|4|||
170464144|NCT01735955|616037968|FG000|Overall Study|Disease progression|24|||
170464145|NCT01735955|616037968|FG000|Overall Study|Adverse Event|5|||
170464146|NCT00626392|616037969|FG000|Run-in Period|Adverse Event|0|||
170464147|NCT00626392|616037970|FG001|Run-in Period|Adverse Event|0|||
170464148|NCT00626392|616037971|FG002|Run-in Period|Adverse Event|1|||
170464149|NCT00626392|616037972|FG003|Run-in Period|Adverse Event|0|||
170464150|NCT00626392|616037973|FG004|Run-in Period|Adverse Event|1|||
170464151|NCT00626392|616037974|FG005|Run-in Period|Adverse Event|0|||
170464152|NCT00626392|616037969|FG000|Run-in Period|Withdrawal by Subject|0|||
170464153|NCT00626392|616037970|FG001|Run-in Period|Withdrawal by Subject|1|||
170464154|NCT00626392|616037971|FG002|Run-in Period|Withdrawal by Subject|1|||
170464155|NCT00626392|616037972|FG003|Run-in Period|Withdrawal by Subject|1|||
170464156|NCT00626392|616037973|FG004|Run-in Period|Withdrawal by Subject|3|||
170464157|NCT00626392|616037974|FG005|Run-in Period|Withdrawal by Subject|1|||
170464158|NCT00626392|616037969|FG000|Run-in Period|Noncompliance|1|||
170464159|NCT00626392|616037970|FG001|Run-in Period|Noncompliance|0|||
170464160|NCT00626392|616037971|FG002|Run-in Period|Noncompliance|1|||
170544489|NCT01658878|616337271|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
170789786|NCT04828005|617240438|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
170789787|NCT04828005|617240439|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
170789788|NCT04828005|617240440|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
170789789|NCT04828005|617240437|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
170789790|NCT04828005|617240438|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
170789791|NCT04828005|617240439|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
170464161|NCT00626392|616037972|FG003|Run-in Period|Noncompliance|0|||
170464162|NCT00626392|616037973|FG004|Run-in Period|Noncompliance|0|||
170464163|NCT00626392|616037974|FG005|Run-in Period|Noncompliance|0|||
170464164|NCT00626392|616037969|FG000|Coadministration Period|Adverse Event|3|||
170544490|NCT01658878|616337272|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
170789792|NCT04828005|617240440|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
170464165|NCT00626392|616037970|FG001|Coadministration Period|Adverse Event|1|||
170464166|NCT00626392|616037971|FG002|Coadministration Period|Adverse Event|7|||
170464167|NCT00626392|616037972|FG003|Coadministration Period|Adverse Event|4|||
170464168|NCT00626392|616037973|FG004|Coadministration Period|Adverse Event|3|||
170464169|NCT00626392|616037974|FG005|Coadministration Period|Adverse Event|4|||
170464170|NCT00626392|616037969|FG000|Coadministration Period|Withdrawal by Subject|1|||
170464171|NCT00626392|616037970|FG001|Coadministration Period|Withdrawal by Subject|1|||
170464172|NCT00626392|616037971|FG002|Coadministration Period|Withdrawal by Subject|0|||
170464173|NCT00626392|616037972|FG003|Coadministration Period|Withdrawal by Subject|1|||
170464174|NCT00626392|616037973|FG004|Coadministration Period|Withdrawal by Subject|0|||
170464175|NCT00626392|616037974|FG005|Coadministration Period|Withdrawal by Subject|1|||
170464176|NCT00626392|616037969|FG000|Coadministration Period|Protocol Violation|0|||
170464177|NCT00626392|616037970|FG001|Coadministration Period|Protocol Violation|1|||
170464178|NCT00626392|616037971|FG002|Coadministration Period|Protocol Violation|0|||
170464179|NCT00626392|616037972|FG003|Coadministration Period|Protocol Violation|1|||
170464180|NCT00626392|616037973|FG004|Coadministration Period|Protocol Violation|1|||
170544491|NCT01658878|616337273|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
170544492|NCT01658878|616337274|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
170544493|NCT01658878|616337275|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
170544494|NCT01658878|616337276|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
170544495|NCT01658878|616337277|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
170544496|NCT01658878|616337278|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
170544497|NCT01658878|616337279|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
170544498|NCT01658878|616337280|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
170544499|NCT01658878|616337281|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
170544500|NCT01658878|616337282|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
170544501|NCT01658878|616337283|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
170544502|NCT01658878|616337284|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
170544503|NCT01658878|616337261|FG000|Treatment Period|Death|0|||
170544504|NCT01658878|616337262|FG001|Treatment Period|Death|0|||
170544505|NCT01658878|616337263|FG002|Treatment Period|Death|0|||
170544506|NCT01658878|616337264|FG003|Treatment Period|Death|0|||
170544507|NCT01658878|616337265|FG004|Treatment Period|Death|0|||
170544508|NCT01658878|616337266|FG005|Treatment Period|Death|0|||
170544509|NCT01658878|616337267|FG006|Treatment Period|Death|0|||
170544510|NCT01658878|616337268|FG007|Treatment Period|Death|0|||
170544511|NCT01658878|616337269|FG008|Treatment Period|Death|0|||
170544512|NCT01658878|616337270|FG009|Treatment Period|Death|0|||
170544513|NCT01658878|616337271|FG010|Treatment Period|Death|0|||
170544514|NCT01658878|616337272|FG011|Treatment Period|Death|0|||
170544515|NCT01658878|616337273|FG012|Treatment Period|Death|1|||
170544516|NCT01658878|616337274|FG013|Treatment Period|Death|0|||
170544517|NCT01658878|616337275|FG014|Treatment Period|Death|0|||
170544518|NCT01658878|616337276|FG015|Treatment Period|Death|0|||
170789793|NCT04828005|617240437|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
170789794|NCT04828005|617240438|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
170789795|NCT04828005|617240439|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
170789796|NCT04828005|617240440|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
170789797|NCT04828005|617240437|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
170789798|NCT04828005|617240438|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
170789799|NCT04828005|617240439|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
170789800|NCT04828005|617240440|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
170789801|NCT04828005|617240437|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
170789802|NCT04828005|617240438|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
170789803|NCT04828005|617240439|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
170789804|NCT04828005|617240440|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
170789805|NCT04828005|617240437|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
170789806|NCT04828005|617240438|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
170789807|NCT04828005|617240439|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
170789808|NCT04828005|617240440|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
170789809|NCT04828005|617240437|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
170789810|NCT04828005|617240438|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
170789811|NCT04828005|617240439|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
170789812|NCT04828005|617240440|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
170789813|NCT03023410|617242727|FG000|Overall Study|study termination|0|||
170789814|NCT03023410|617242728|FG001|Overall Study|study termination|1|||
170544519|NCT01658878|616337277|FG016|Treatment Period|Death|1|||
170544520|NCT01658878|616337278|FG017|Treatment Period|Death|1|||
170544521|NCT01658878|616337279|FG018|Treatment Period|Death|0|||
170544522|NCT01658878|616337280|FG019|Treatment Period|Death|0|||
170544523|NCT01658878|616337281|FG020|Treatment Period|Death|0|||
170544524|NCT01658878|616337282|FG021|Treatment Period|Death|2|||
170464181|NCT00626392|616037974|FG005|Coadministration Period|Protocol Violation|0|||
170464182|NCT00626392|616037969|FG000|Coadministration Period|Other|0|||
170464183|NCT00626392|616037970|FG001|Coadministration Period|Other|2|||
170464184|NCT00626392|616037971|FG002|Coadministration Period|Other|3|||
170464185|NCT00626392|616037972|FG003|Coadministration Period|Other|1|||
170464186|NCT00626392|616037973|FG004|Coadministration Period|Other|1|||
170464187|NCT00626392|616037974|FG005|Coadministration Period|Other|1|||
170464188|NCT03327792|616037975|FG000|Overall Study|Adverse Event|4|||
170464189|NCT03327792|616037976|FG001|Overall Study|Adverse Event|0|||
170464190|NCT03327792|616037975|FG000|Overall Study|Family/Personal issues|3|||
170464191|NCT03327792|616037976|FG001|Overall Study|Family/Personal issues|2|||
170464192|NCT03327792|616037975|FG000|Overall Study|Lost to Follow-up|0|||
170464193|NCT03327792|616037976|FG001|Overall Study|Lost to Follow-up|1|||
170464194|NCT01085734|616037979|FG000|Overall Study|Adverse Event|0|||
170464195|NCT01085734|616037980|FG001|Overall Study|Adverse Event|2|||
170464196|NCT01085734|616037979|FG000|Overall Study|Death|1|||
170464197|NCT01085734|616037980|FG001|Overall Study|Death|0|||
170464198|NCT01085734|616037979|FG000|Overall Study|Lost to Follow-up|0|||
170464199|NCT01085734|616037980|FG001|Overall Study|Lost to Follow-up|1|||
170464200|NCT01085734|616037979|FG000|Overall Study|Withdrawal by Subject|0|||
170464201|NCT01085734|616037980|FG001|Overall Study|Withdrawal by Subject|1|||
170464202|NCT03323437|616037981|FG000|Overall Study|Withdrawal by Subject|0|||
170464203|NCT03323437|616037982|FG001|Overall Study|Withdrawal by Subject|4|||
170464204|NCT00923273|616037983|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
170464205|NCT00923273|616037984|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
170464206|NCT00923273|616037985|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
170464207|NCT00923273|616037986|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
170464208|NCT00923273|616037987|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
170464209|NCT00923273|616037983|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
170464210|NCT00923273|616037984|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
170464211|NCT00923273|616037985|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
170464212|NCT00923273|616037986|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
170464213|NCT00923273|616037987|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
170464214|NCT00660400|616037990|FG000|Overall Study|Lack of insurance approval|1|||
170464215|NCT00660400|616037990|FG000|Overall Study|Suboptimal organ function|1|||
170464216|NCT00660400|616037990|FG000|Overall Study|Intracranial hemorrhage|1|||
170464217|NCT00660400|616037990|FG000|Overall Study|Withdrawal by Subject|1|||
170464218|NCT03247816|616038001|FG000|Overall Study|Adverse Event|12|||
170464219|NCT03247816|616038001|FG000|Overall Study|Physician Decision|3|||
170464220|NCT03247816|616038001|FG000|Overall Study|Lack of Efficacy|1|||
170464221|NCT03247816|616038001|FG000|Overall Study|Lost to Follow-up|10|||
170464222|NCT03247816|616038001|FG000|Overall Study|Missing Feraccru stop date|3|||
170464223|NCT02227446|616038017|FG000|Overall Study|not eligible post randomization|18|||
170464224|NCT02227446|616038018|FG001|Overall Study|not eligible post randomization|29|||
170464225|NCT02227446|616038017|FG000|Overall Study|Withdrawal by Subject|4|||
170464226|NCT02227446|616038018|FG001|Overall Study|Withdrawal by Subject|5|||
170464227|NCT04623086|616038019|FG000|Overall Study|Withdrawal by Subject|0|||
170464228|NCT04623086|616038020|FG001|Overall Study|Withdrawal by Subject|0|||
170464229|NCT04623086|616038021|FG002|Overall Study|Withdrawal by Subject|10|||
170464230|NCT03200912|616038022|FG000|Overall Study|Adverse Event|3|||
170464231|NCT03200912|616038023|FG001|Overall Study|Adverse Event|0|||
170464232|NCT03200912|616038024|FG002|Overall Study|Adverse Event|0|||
170464233|NCT03200912|616038022|FG000|Overall Study|Withdrawal by Subject|1|||
170464234|NCT03200912|616038023|FG001|Overall Study|Withdrawal by Subject|2|||
170464235|NCT03200912|616038024|FG002|Overall Study|Withdrawal by Subject|4|||
170464236|NCT03200912|616038022|FG000|Overall Study|Non-compliance with study drug|0|||
170464237|NCT03200912|616038023|FG001|Overall Study|Non-compliance with study drug|1|||
170464238|NCT03200912|616038024|FG002|Overall Study|Non-compliance with study drug|0|||
170464239|NCT03583086|616038029|FG000|Overall Study|Death|2|||
170464240|NCT03583086|616038030|FG001|Overall Study|Death|6|||
170464241|NCT03583086|616038031|FG002|Overall Study|Death|12|||
170464242|NCT03583086|616038032|FG003|Overall Study|Death|10|||
170464243|NCT03583086|616038033|FG004|Overall Study|Death|14|||
170464244|NCT03583086|616038034|FG005|Overall Study|Death|14|||
170464245|NCT03583086|616038035|FG006|Overall Study|Death|4|||
170464246|NCT03583086|616038029|FG000|Overall Study|Withdrawal by Subject|0|||
170464247|NCT03583086|616038030|FG001|Overall Study|Withdrawal by Subject|0|||
170464248|NCT03583086|616038031|FG002|Overall Study|Withdrawal by Subject|1|||
170464249|NCT03583086|616038032|FG003|Overall Study|Withdrawal by Subject|0|||
170464250|NCT03583086|616038033|FG004|Overall Study|Withdrawal by Subject|0|||
170464251|NCT03583086|616038034|FG005|Overall Study|Withdrawal by Subject|0|||
170464252|NCT03583086|616038035|FG006|Overall Study|Withdrawal by Subject|1|||
170464253|NCT03583086|616038029|FG000|Overall Study|Refused follow-up|0|||
170464254|NCT03583086|616038030|FG001|Overall Study|Refused follow-up|0|||
170464255|NCT03583086|616038031|FG002|Overall Study|Refused follow-up|1|||
170464256|NCT03583086|616038032|FG003|Overall Study|Refused follow-up|0|||
170464257|NCT03583086|616038033|FG004|Overall Study|Refused follow-up|1|||
170464258|NCT03583086|616038034|FG005|Overall Study|Refused follow-up|0|||
170464259|NCT03583086|616038035|FG006|Overall Study|Refused follow-up|0|||
170464260|NCT03583086|616038029|FG000|Overall Study|Declining Performance Status|0|||
170464261|NCT03583086|616038030|FG001|Overall Study|Declining Performance Status|0|||
170464262|NCT03583086|616038031|FG002|Overall Study|Declining Performance Status|1|||
170464263|NCT03583086|616038032|FG003|Overall Study|Declining Performance Status|0|||
170464264|NCT03583086|616038033|FG004|Overall Study|Declining Performance Status|0|||
170464265|NCT03583086|616038034|FG005|Overall Study|Declining Performance Status|0|||
170464266|NCT03583086|616038035|FG006|Overall Study|Declining Performance Status|0|||
170464267|NCT03583086|616038029|FG000|Overall Study|Still on study|0|||
170464268|NCT03583086|616038030|FG001|Overall Study|Still on study|0|||
170464269|NCT03583086|616038031|FG002|Overall Study|Still on study|0|||
170464270|NCT03583086|616038032|FG003|Overall Study|Still on study|1|||
170464271|NCT03583086|616038033|FG004|Overall Study|Still on study|0|||
170464272|NCT03583086|616038034|FG005|Overall Study|Still on study|0|||
170464273|NCT03583086|616038035|FG006|Overall Study|Still on study|1|||
170464274|NCT03583086|616038029|FG000|Overall Study|Disease progression|0|||
170464275|NCT03583086|616038030|FG001|Overall Study|Disease progression|0|||
170464276|NCT03583086|616038031|FG002|Overall Study|Disease progression|0|||
170464277|NCT03583086|616038032|FG003|Overall Study|Disease progression|0|||
170464278|NCT03583086|616038033|FG004|Overall Study|Disease progression|0|||
170464279|NCT03583086|616038034|FG005|Overall Study|Disease progression|0|||
170464280|NCT03583086|616038035|FG006|Overall Study|Disease progression|1|||
170464281|NCT03583086|616038029|FG000|Overall Study|Undergoing radiation therapy|0|||
170464282|NCT03583086|616038030|FG001|Overall Study|Undergoing radiation therapy|0|||
170464283|NCT03583086|616038031|FG002|Overall Study|Undergoing radiation therapy|0|||
170464284|NCT03583086|616038032|FG003|Overall Study|Undergoing radiation therapy|0|||
170464285|NCT03583086|616038033|FG004|Overall Study|Undergoing radiation therapy|0|||
170464286|NCT03583086|616038034|FG005|Overall Study|Undergoing radiation therapy|0|||
170464287|NCT03583086|616038035|FG006|Overall Study|Undergoing radiation therapy|1|||
170464288|NCT03583086|616038029|FG000|Overall Study|Lost to Follow-up|0|||
170464289|NCT03583086|616038030|FG001|Overall Study|Lost to Follow-up|0|||
170464290|NCT03583086|616038031|FG002|Overall Study|Lost to Follow-up|0|||
170464291|NCT03583086|616038032|FG003|Overall Study|Lost to Follow-up|0|||
170464292|NCT03583086|616038033|FG004|Overall Study|Lost to Follow-up|0|||
170464293|NCT03583086|616038034|FG005|Overall Study|Lost to Follow-up|1|||
170464294|NCT03583086|616038035|FG006|Overall Study|Lost to Follow-up|0|||
170464295|NCT03583086|616038029|FG000|Overall Study|Adverse Event|0|||
170464296|NCT03583086|616038030|FG001|Overall Study|Adverse Event|0|||
170464297|NCT03583086|616038031|FG002|Overall Study|Adverse Event|0|||
170464298|NCT03583086|616038032|FG003|Overall Study|Adverse Event|0|||
170464299|NCT03583086|616038033|FG004|Overall Study|Adverse Event|0|||
170464300|NCT03583086|616038034|FG005|Overall Study|Adverse Event|1|||
170464301|NCT03583086|616038035|FG006|Overall Study|Adverse Event|0|||
170464302|NCT01228019|616038037|FG000|Overall Study|Dose Violation|70|||
170464303|NCT01228019|616038037|FG000|Overall Study|Duplicate enrollment|1|||
170464304|NCT01228019|616038037|FG000|Overall Study|Missing pre-treatment data|72|||
170464305|NCT01228019|616038037|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
170464306|NCT01228019|616038037|FG000|Overall Study|Violation of Entry Criterion|9|||
170464307|NCT01822275|616038045|FG000|Overall Study|Withdrawal by Subject|3|||
170464308|NCT01822275|616038045|FG000|Overall Study|Adverse Event|3|||
170464309|NCT01822275|616038045|FG000|Overall Study|Progression|14|||
170464310|NCT01822275|616038045|FG000|Overall Study|Physician Decision|2|||
170464311|NCT02980874|616038046|FG000|Overall Study|Adverse Event|2|||
170464312|NCT02980874|616038047|FG001|Overall Study|Adverse Event|7|||
170464313|NCT02980874|616038046|FG000|Overall Study|Withdrawal by Subject|7|||
170464314|NCT02980874|616038047|FG001|Overall Study|Withdrawal by Subject|2|||
170464315|NCT02980874|616038046|FG000|Overall Study|Lost to Follow-up|5|||
170464316|NCT02980874|616038047|FG001|Overall Study|Lost to Follow-up|5|||
170464317|NCT02980874|616038046|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
170464318|NCT02980874|616038047|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
170464319|NCT02980874|616038046|FG000|Overall Study|Unknown study completion status|1|||
170464320|NCT02980874|616038047|FG001|Overall Study|Unknown study completion status|0|||
170464321|NCT00855803|616038049|FG000|Overall Study|Death|2|||
170464322|NCT00855803|616038049|FG000|Overall Study|Lost to Follow-up|2|||
170464323|NCT00855803|616038049|FG000|Overall Study|Technical inability to undergo procedure|2|||
170464324|NCT00855803|616038049|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
170464325|NCT00855803|616038049|FG000|Overall Study|Withdrawal by Subject|3|||
170464326|NCT00855803|616038049|FG000|Overall Study|Physician Decision|3|||
170464327|NCT04619992|616038058|FG000|Overall Study|Withdrawal by Subject|1|||
170464328|NCT04619992|616038059|FG001|Overall Study|Withdrawal by Subject|0|||
170464329|NCT00499174|616038060|FG000|Overall Study|Physician Decision|78|||
170464330|NCT00499174|616038061|FG001|Overall Study|Physician Decision|9|||
170464331|NCT03582826|616038062|FG000|Overall Study|Lost to Follow-up|39|||
170636712|NCT03083873|616682508|FG000|Overall Study|Death|6|||
170636713|NCT03083873|616682509|FG001|Overall Study|Death|15|||
170636714|NCT03083873|616682510|FG002|Overall Study|Death|13|||
170636715|NCT03083873|616682511|FG003|Overall Study|Death|9|||
170636716|NCT03083873|616682512|FG004|Overall Study|Death|0|||
170636717|NCT03083873|616682508|FG000|Overall Study|Sponsor Terminated Study|0|||
170636718|NCT03083873|616682509|FG001|Overall Study|Sponsor Terminated Study|1|||
170636719|NCT03083873|616682510|FG002|Overall Study|Sponsor Terminated Study|2|||
170636720|NCT03083873|616682511|FG003|Overall Study|Sponsor Terminated Study|3|||
170636721|NCT03083873|616682512|FG004|Overall Study|Sponsor Terminated Study|0|||
170636722|NCT03083873|616682508|FG000|Overall Study|Lost to Follow-up|0|||
170636723|NCT03083873|616682509|FG001|Overall Study|Lost to Follow-up|1|||
170636724|NCT03083873|616682510|FG002|Overall Study|Lost to Follow-up|1|||
170464332|NCT03582826|616038063|FG001|Overall Study|Lost to Follow-up|0|||
170464333|NCT03582826|616038062|FG000|Overall Study|Withdrawal by Subject|2|||
170464334|NCT03582826|616038063|FG001|Overall Study|Withdrawal by Subject|0|||
170464335|NCT01214915|616038067|FG000|Overall Study|Adverse Event|8|||
170464336|NCT01214915|616038067|FG000|Overall Study|Lack of Efficacy|3|||
170464337|NCT00574912|616038068|FG000|Overall Study|Could not place IV lines.|3|||
170464338|NCT00574912|616038068|FG000|Overall Study|scheduling conflicts|3|||
170464339|NCT00574912|616038068|FG000|Overall Study|Physician Decision|2|||
170464340|NCT02283294|616038070|FG000|Overall Study|Lost to Follow-up|1|||
170464341|NCT02283294|616038071|FG001|Overall Study|Lost to Follow-up|1|||
170464342|NCT02283294|616038070|FG000|Overall Study|Withdrawal by Subject|1|||
170464343|NCT02283294|616038071|FG001|Overall Study|Withdrawal by Subject|6|||
170464344|NCT02283294|616038070|FG000|Overall Study|Protocol Violation|1|||
170464345|NCT02283294|616038071|FG001|Overall Study|Protocol Violation|0|||
170464346|NCT02283294|616038070|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
170464347|NCT02283294|616038071|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
170464348|NCT03589768|616039783|FG000|Overall Study|Death|1|||
170464349|NCT03589768|616039784|FG001|Overall Study|Death|0|||
170464350|NCT03589768|616039785|FG002|Overall Study|Death|8|||
170464351|NCT03589768|616039786|FG003|Overall Study|Death|3|||
170464352|NCT03589768|616039783|FG000|Overall Study|Withdrawal by Subject|2|||
170464353|NCT03589768|616039784|FG001|Overall Study|Withdrawal by Subject|0|||
170464354|NCT03589768|616039785|FG002|Overall Study|Withdrawal by Subject|0|||
170464355|NCT03589768|616039786|FG003|Overall Study|Withdrawal by Subject|0|||
170464356|NCT03589768|616039783|FG000|Overall Study|Protocol Violation|1|||
170464357|NCT03589768|616039784|FG001|Overall Study|Protocol Violation|0|||
170464358|NCT03589768|616039785|FG002|Overall Study|Protocol Violation|0|||
170464359|NCT03589768|616039786|FG003|Overall Study|Protocol Violation|0|||
170464360|NCT00191113|616039795|FG000|Core Study|Withdrawal by Subject|25|||
170464361|NCT00191113|616039796|FG001|Core Study|Withdrawal by Subject|9|||
170464362|NCT00191113|616039795|FG000|Core Study|Protocol Violation|6|||
170636725|NCT03083873|616682511|FG003|Overall Study|Lost to Follow-up|0|||
170636726|NCT03083873|616682512|FG004|Overall Study|Lost to Follow-up|0|||
170636727|NCT03083873|616682508|FG000|Overall Study|Withdrawal by Subject|2|||
170636728|NCT03083873|616682509|FG001|Overall Study|Withdrawal by Subject|0|||
170636729|NCT03083873|616682510|FG002|Overall Study|Withdrawal by Subject|0|||
170636730|NCT03083873|616682511|FG003|Overall Study|Withdrawal by Subject|0|||
170636731|NCT03083873|616682512|FG004|Overall Study|Withdrawal by Subject|0|||
170636732|NCT03083873|616682508|FG000|Overall Study|Did Not Receive TIL|2|||
170464363|NCT00191113|616039796|FG001|Core Study|Protocol Violation|2|||
170464364|NCT00191113|616039795|FG000|Core Study|Lost to Follow-up|3|||
170544525|NCT01658878|616337283|FG022|Treatment Period|Death|0|||
170544526|NCT01658878|616337284|FG023|Treatment Period|Death|0|||
170544527|NCT01658878|616337261|FG000|Treatment Period|Adverse Event|0|||
170544528|NCT01658878|616337262|FG001|Treatment Period|Adverse Event|0|||
170544529|NCT01658878|616337263|FG002|Treatment Period|Adverse Event|0|||
170544530|NCT01658878|616337264|FG003|Treatment Period|Adverse Event|0|||
170544531|NCT01658878|616337265|FG004|Treatment Period|Adverse Event|0|||
170544532|NCT01658878|616337266|FG005|Treatment Period|Adverse Event|0|||
170544533|NCT01658878|616337267|FG006|Treatment Period|Adverse Event|0|||
170544534|NCT01658878|616337268|FG007|Treatment Period|Adverse Event|0|||
170544535|NCT01658878|616337269|FG008|Treatment Period|Adverse Event|0|||
170544536|NCT01658878|616337270|FG009|Treatment Period|Adverse Event|0|||
170544537|NCT01658878|616337271|FG010|Treatment Period|Adverse Event|0|||
170544538|NCT01658878|616337272|FG011|Treatment Period|Adverse Event|0|||
170544539|NCT01658878|616337273|FG012|Treatment Period|Adverse Event|0|||
170544540|NCT01658878|616337274|FG013|Treatment Period|Adverse Event|0|||
170636733|NCT03083873|616682509|FG001|Overall Study|Did Not Receive TIL|5|||
170464365|NCT00191113|616039796|FG001|Core Study|Lost to Follow-up|0|||
170464366|NCT00191113|616039795|FG000|Core Study|Adverse Event|0|||
170464367|NCT00191113|616039796|FG001|Core Study|Adverse Event|2|||
170464368|NCT00191113|616039795|FG000|Core Study|Lack of Efficacy|0|||
170544541|NCT01658878|616337275|FG014|Treatment Period|Adverse Event|0|||
170544542|NCT01658878|616337276|FG015|Treatment Period|Adverse Event|0|||
170544543|NCT01658878|616337277|FG016|Treatment Period|Adverse Event|10|||
170544544|NCT01658878|616337278|FG017|Treatment Period|Adverse Event|3|||
170544545|NCT01658878|616337279|FG018|Treatment Period|Adverse Event|3|||
170789815|NCT05082025|617242733|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
170789816|NCT05714761|617242734|FG000|Overall Study|Lost to Follow-up|3|||
170789817|NCT05714761|617242734|FG000|Overall Study|Withdrawal by Subject|3|||
170789818|NCT05714761|617242734|FG000|Overall Study|unblinding of sensor data|1|||
170789819|NCT05714761|617242734|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
170789820|NCT05714761|617242734|FG000|Overall Study|did not return second CGM sensor|4|||
170789821|NCT02547233|617242735|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
170789822|NCT02547233|617242736|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
170789823|NCT02547233|617242735|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
170789824|NCT02547233|617242736|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
170789825|NCT02547233|617242735|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
170789826|NCT02547233|617242736|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
170789827|NCT02547233|617242735|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
170464369|NCT00191113|616039796|FG001|Core Study|Lack of Efficacy|2|||
170464370|NCT00191113|616039795|FG000|Core Study|Death|1|||
170464371|NCT00191113|616039796|FG001|Core Study|Death|0|||
170464372|NCT05307510|616039797|FG000|Overall Study|Lost to Follow-up|3|||
170464373|NCT05307510|616039798|FG001|Overall Study|Lost to Follow-up|6|||
170464374|NCT05307510|616039797|FG000|Overall Study|Withdrawal by Subject|0|||
170464375|NCT05307510|616039798|FG001|Overall Study|Withdrawal by Subject|1|||
170464376|NCT00631657|616039800|FG000|6-Month Treatment Period|Adverse Event|47|||
170464377|NCT00631657|616039801|FG001|6-Month Treatment Period|Adverse Event|0|||
170464378|NCT00631657|616039802|FG002|6-Month Treatment Period|Adverse Event|7|||
170464379|NCT00631657|616039800|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
170464380|NCT00631657|616039801|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
170464381|NCT00631657|616039802|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
170464382|NCT00631657|616039800|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
170464383|NCT00631657|616039801|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
170464384|NCT00631657|616039802|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
170464385|NCT00631657|616039800|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
170464386|NCT00631657|616039801|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
170464387|NCT00631657|616039802|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
170464388|NCT00631657|616039800|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
170464389|NCT00631657|616039801|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
170464390|NCT00631657|616039802|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
170464391|NCT00631657|616039800|FG000|6-Month Treatment Period|Other|16|||
170464392|NCT00631657|616039801|FG001|6-Month Treatment Period|Other|0|||
170464393|NCT00631657|616039802|FG002|6-Month Treatment Period|Other|4|||
170464394|NCT00631657|616039800|FG000|6-Month Treatment Period|Not Treated|2|||
170464395|NCT00631657|616039801|FG001|6-Month Treatment Period|Not Treated|0|||
170464396|NCT00631657|616039802|FG002|6-Month Treatment Period|Not Treated|1|||
170464397|NCT00631657|616039800|FG000|7-Day Discontinuation Period|Not Treated|1|||
170464398|NCT00631657|616039801|FG001|7-Day Discontinuation Period|Not Treated|1|||
170464399|NCT00631657|616039802|FG002|7-Day Discontinuation Period|Not Treated|1|||
170464400|NCT00631657|616039800|FG000|7-Day Discontinuation Period|Other|1|||
170464401|NCT00631657|616039801|FG001|7-Day Discontinuation Period|Other|0|||
170464402|NCT00631657|616039802|FG002|7-Day Discontinuation Period|Other|0|||
170464403|NCT01056289|616039803|FG000|Open-label Phase|Adverse Event|29|||
170464404|NCT01056289|616039804|FG001|Open-label Phase|Adverse Event|0|||
170464405|NCT01056289|616039805|FG002|Open-label Phase|Adverse Event|0|||
170464406|NCT01056289|616039806|FG003|Open-label Phase|Adverse Event|0|||
170464407|NCT01056289|616039803|FG000|Open-label Phase|Lost to Follow-up|30|||
170464408|NCT01056289|616039804|FG001|Open-label Phase|Lost to Follow-up|0|||
170464409|NCT01056289|616039805|FG002|Open-label Phase|Lost to Follow-up|0|||
170464410|NCT01056289|616039806|FG003|Open-label Phase|Lost to Follow-up|0|||
170464411|NCT01056289|616039803|FG000|Open-label Phase|Other|9|||
170464412|NCT01056289|616039804|FG001|Open-label Phase|Other|0|||
170464413|NCT01056289|616039805|FG002|Open-label Phase|Other|0|||
170464414|NCT01056289|616039806|FG003|Open-label Phase|Other|0|||
170464415|NCT01056289|616039803|FG000|Open-label Phase|Protocol Violation|6|||
170464416|NCT01056289|616039804|FG001|Open-label Phase|Protocol Violation|0|||
170464417|NCT01056289|616039805|FG002|Open-label Phase|Protocol Violation|0|||
170464418|NCT01056289|616039806|FG003|Open-label Phase|Protocol Violation|0|||
170464419|NCT01056289|616039803|FG000|Open-label Phase|Withdrawal by Subject|26|||
170464420|NCT01056289|616039804|FG001|Open-label Phase|Withdrawal by Subject|0|||
170789828|NCT02547233|617242736|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
170464421|NCT01056289|616039805|FG002|Open-label Phase|Withdrawal by Subject|0|||
170464422|NCT01056289|616039806|FG003|Open-label Phase|Withdrawal by Subject|0|||
170464423|NCT01056289|616039803|FG000|Open-label Phase|Lack of Efficacy|18|||
170464424|NCT01056289|616039804|FG001|Open-label Phase|Lack of Efficacy|0|||
170789829|NCT02547233|617242735|FG000|12-month Follow-up|Withdrawal by Subject|10|||
170789830|NCT02547233|617242736|FG001|12-month Follow-up|Withdrawal by Subject|10|||
170789831|NCT02547233|617242735|FG000|12-month Follow-up|Lost to Follow-up|3|||
170789832|NCT02547233|617242736|FG001|12-month Follow-up|Lost to Follow-up|3|||
170636734|NCT03083873|616682510|FG002|Overall Study|Did Not Receive TIL|3|||
170636735|NCT03083873|616682511|FG003|Overall Study|Did Not Receive TIL|1|||
170636736|NCT03083873|616682512|FG004|Overall Study|Did Not Receive TIL|0|||
170636737|NCT01677377|616682513|FG000|Overall Study|Protocol Violation|1|||
170636738|NCT01677377|616682514|FG001|Overall Study|Protocol Violation|0|||
170636739|NCT01677377|616682515|FG002|Overall Study|Protocol Violation|0|||
170636740|NCT01677377|616682513|FG000|Overall Study|Lost to Follow-up|0|||
170636741|NCT01677377|616682514|FG001|Overall Study|Lost to Follow-up|1|||
170636742|NCT01677377|616682515|FG002|Overall Study|Lost to Follow-up|1|||
170464425|NCT01056289|616039805|FG002|Open-label Phase|Lack of Efficacy|0|||
170636743|NCT01677377|616682513|FG000|Overall Study|Withdrawal by Subject|0|||
170636744|NCT01677377|616682514|FG001|Overall Study|Withdrawal by Subject|0|||
170636745|NCT01677377|616682515|FG002|Overall Study|Withdrawal by Subject|3|||
170636746|NCT01677377|616682513|FG000|Overall Study|Lack of Efficacy|0|||
170636747|NCT01677377|616682514|FG001|Overall Study|Lack of Efficacy|0|||
170636748|NCT01677377|616682515|FG002|Overall Study|Lack of Efficacy|1|||
170636749|NCT01677377|616682513|FG000|Overall Study|Pregnancy|0|||
170636750|NCT01677377|616682514|FG001|Overall Study|Pregnancy|0|||
170636751|NCT01677377|616682515|FG002|Overall Study|Pregnancy|1|||
170636752|NCT00479687|616682516|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
170636753|NCT00479687|616682517|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
170636754|NCT00479687|616682518|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
170636755|NCT00479687|616682516|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
170636756|NCT00479687|616682517|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
170636757|NCT00479687|616682518|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
170636758|NCT00479687|616682516|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
170636759|NCT00479687|616682517|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
170636760|NCT00479687|616682518|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
170636761|NCT00479687|616682516|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
170636762|NCT00479687|616682517|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
170636763|NCT00479687|616682518|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
170636764|NCT00479687|616682516|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
170636765|NCT00479687|616682517|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
170636766|NCT00479687|616682518|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
170636767|NCT00479687|616682516|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
170636768|NCT00479687|616682517|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
170636769|NCT00479687|616682518|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
170636770|NCT00479687|616682516|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
170636771|NCT00479687|616682517|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
170636772|NCT00479687|616682518|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
170636773|NCT00479687|616682516|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
170636774|NCT00479687|616682517|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
170636775|NCT00479687|616682518|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
170636776|NCT00479687|616682516|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
170890390|NCT00223496|617606454|FG000|Overall Study|Withdrawal by Subject|1|||
170464426|NCT01056289|616039806|FG003|Open-label Phase|Lack of Efficacy|0|||
170464427|NCT01056289|616039803|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
170464428|NCT01056289|616039804|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
170464429|NCT01056289|616039805|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
170464430|NCT01056289|616039806|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
170464431|NCT01056289|616039803|FG000|Double-blind Phase|Adverse Event|0|||
170464432|NCT01056289|616039804|FG001|Double-blind Phase|Adverse Event|1|||
170464433|NCT01056289|616039805|FG002|Double-blind Phase|Adverse Event|2|||
170464434|NCT01056289|616039806|FG003|Double-blind Phase|Adverse Event|1|||
170464435|NCT01056289|616039803|FG000|Double-blind Phase|Lost to Follow-up|0|||
170464436|NCT01056289|616039804|FG001|Double-blind Phase|Lost to Follow-up|2|||
170464437|NCT01056289|616039805|FG002|Double-blind Phase|Lost to Follow-up|2|||
170464438|NCT01056289|616039806|FG003|Double-blind Phase|Lost to Follow-up|2|||
170464439|NCT01056289|616039803|FG000|Double-blind Phase|Other|0|||
170464440|NCT01056289|616039804|FG001|Double-blind Phase|Other|0|||
170544546|NCT01658878|616337280|FG019|Treatment Period|Adverse Event|2|||
170544547|NCT01658878|616337281|FG020|Treatment Period|Adverse Event|3|||
170544548|NCT01658878|616337282|FG021|Treatment Period|Adverse Event|3|||
170544549|NCT01658878|616337283|FG022|Treatment Period|Adverse Event|4|||
170544550|NCT01658878|616337284|FG023|Treatment Period|Adverse Event|3|||
170544551|NCT01658878|616337261|FG000|Treatment Period|Lost to Follow-up|0|||
170544552|NCT01658878|616337262|FG001|Treatment Period|Lost to Follow-up|0|||
170544553|NCT01658878|616337263|FG002|Treatment Period|Lost to Follow-up|0|||
170544554|NCT01658878|616337264|FG003|Treatment Period|Lost to Follow-up|0|||
170544555|NCT01658878|616337265|FG004|Treatment Period|Lost to Follow-up|0|||
170544556|NCT01658878|616337266|FG005|Treatment Period|Lost to Follow-up|0|||
170544557|NCT01658878|616337267|FG006|Treatment Period|Lost to Follow-up|0|||
170544558|NCT01658878|616337268|FG007|Treatment Period|Lost to Follow-up|0|||
170636777|NCT00479687|616682517|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
170636778|NCT00479687|616682518|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
170636779|NCT02260180|616682519|FG000|Overall Study|Adverse Event|2|||
170636780|NCT02260180|616682520|FG001|Overall Study|Adverse Event|0|||
170636781|NCT02260180|616682521|FG002|Overall Study|Adverse Event|1|||
170636782|NCT00943072|616682526|FG000|Overall Study|Adverse Event|0|||
170636783|NCT00943072|616682527|FG001|Overall Study|Adverse Event|3|||
170636784|NCT00943072|616682526|FG000|Overall Study|Death|0|||
170636785|NCT00943072|616682527|FG001|Overall Study|Death|2|||
170636786|NCT00943072|616682526|FG000|Overall Study|Withdrawal by Subject|3|||
170636787|NCT00943072|616682527|FG001|Overall Study|Withdrawal by Subject|1|||
170636788|NCT00943072|616682526|FG000|Overall Study|Protocol Violation|0|||
170636789|NCT00943072|616682527|FG001|Overall Study|Protocol Violation|1|||
170636790|NCT00943072|616682526|FG000|Overall Study|Lost to Follow-up|1|||
170636791|NCT00943072|616682527|FG001|Overall Study|Lost to Follow-up|2|||
170636792|NCT00943072|616682526|FG000|Overall Study|Lack of Efficacy|0|||
170636793|NCT00943072|616682527|FG001|Overall Study|Lack of Efficacy|4|||
170636794|NCT00943072|616682526|FG000|Overall Study|Other|1|||
170636795|NCT00943072|616682527|FG001|Overall Study|Other|1|||
170636796|NCT01193257|616682528|FG000|Overall Study|Death|202|||
170636797|NCT01193257|616682529|FG001|Overall Study|Death|391|||
170636798|NCT01193257|616682528|FG000|Overall Study|Study termination by sponsor|0|||
170636799|NCT01193257|616682529|FG001|Overall Study|Study termination by sponsor|3|||
170636800|NCT01193257|616682528|FG000|Overall Study|Withdrawal by Subject|26|||
170636801|NCT01193257|616682529|FG001|Overall Study|Withdrawal by Subject|86|||
170636802|NCT01193257|616682528|FG000|Overall Study|Lost to Follow-up|2|||
170636803|NCT01193257|616682529|FG001|Overall Study|Lost to Follow-up|3|||
170636804|NCT01193257|616682528|FG000|Overall Study|Unblinded due to futility|135|||
170636805|NCT01193257|616682529|FG001|Overall Study|Unblinded due to futility|251|||
170464441|NCT01056289|616039805|FG002|Double-blind Phase|Other|1|||
170464442|NCT01056289|616039806|FG003|Double-blind Phase|Other|2|||
170464443|NCT01056289|616039803|FG000|Double-blind Phase|Protocol Violation|0|||
170464444|NCT01056289|616039804|FG001|Double-blind Phase|Protocol Violation|0|||
170464445|NCT01056289|616039805|FG002|Double-blind Phase|Protocol Violation|1|||
170464446|NCT01056289|616039806|FG003|Double-blind Phase|Protocol Violation|1|||
170464447|NCT01056289|616039803|FG000|Double-blind Phase|Withdrawal by Subject|0|||
170464448|NCT01056289|616039804|FG001|Double-blind Phase|Withdrawal by Subject|0|||
170464449|NCT01056289|616039805|FG002|Double-blind Phase|Withdrawal by Subject|4|||
170464450|NCT01056289|616039806|FG003|Double-blind Phase|Withdrawal by Subject|2|||
170464451|NCT01056289|616039803|FG000|Double-blind Phase|Discontinuation symptom|0|||
170464452|NCT01056289|616039804|FG001|Double-blind Phase|Discontinuation symptom|1|||
170464453|NCT01056289|616039805|FG002|Double-blind Phase|Discontinuation symptom|2|||
170464454|NCT01056289|616039806|FG003|Double-blind Phase|Discontinuation symptom|2|||
170464455|NCT01056289|616039803|FG000|Double-blind Phase|Physician Decision|0|||
170464456|NCT01056289|616039804|FG001|Double-blind Phase|Physician Decision|0|||
170464457|NCT01056289|616039805|FG002|Double-blind Phase|Physician Decision|1|||
170636806|NCT00753649|616682544|FG000|Overall Study|Migrated/moved from study area|1|||
170636807|NCT00753649|616682545|FG001|Overall Study|Migrated/moved from study area|0|||
170636808|NCT00753649|616682544|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
170636809|NCT00753649|616682545|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
170636810|NCT00753649|616682544|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
170636811|NCT00753649|616682545|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
170636812|NCT00753649|616682544|FG000|Overall Study|Protocol Violation|2|||
170636813|NCT00753649|616682545|FG001|Overall Study|Protocol Violation|0|||
170636814|NCT03544333|616682550|FG000|Overall Study|Withdrawal by Subject|1|||
170636815|NCT03544333|616682551|FG001|Overall Study|Withdrawal by Subject|0|||
170636816|NCT01175083|616682552|FG000|Primary Epoch|Withdrawal by Subject|0|||
170464458|NCT01056289|616039806|FG003|Double-blind Phase|Physician Decision|0|||
170464459|NCT03301649|616039814|FG000|Overall Study|Need alternate therapy due to live lice|17|||
170464460|NCT03301649|616039815|FG001|Overall Study|Need alternate therapy due to live lice|25|||
170636817|NCT01175083|616682553|FG001|Primary Epoch|Withdrawal by Subject|0|||
170636818|NCT01175083|616682554|FG002|Primary Epoch|Withdrawal by Subject|0|||
170636819|NCT01175083|616682555|FG003|Primary Epoch|Withdrawal by Subject|0|||
170636820|NCT01175083|616682556|FG004|Primary Epoch|Withdrawal by Subject|0|||
170636821|NCT01175083|616682557|FG005|Primary Epoch|Withdrawal by Subject|2|||
170636822|NCT01175083|616682552|FG000|Primary Epoch|Lost to Follow-up|0|||
170789833|NCT02547233|617242735|FG000|12-month Follow-up|Lack of Efficacy|1|||
170789834|NCT02547233|617242736|FG001|12-month Follow-up|Lack of Efficacy|2|||
170464461|NCT03301649|616039816|FG002|Overall Study|Need alternate therapy due to live lice|81|||
170464462|NCT03301649|616039814|FG000|Overall Study|Lost to Follow-up|11|||
170464463|NCT03301649|616039815|FG001|Overall Study|Lost to Follow-up|11|||
170464464|NCT03301649|616039816|FG002|Overall Study|Lost to Follow-up|3|||
170636823|NCT01175083|616682553|FG001|Primary Epoch|Lost to Follow-up|0|||
170636824|NCT01175083|616682554|FG002|Primary Epoch|Lost to Follow-up|0|||
170636825|NCT01175083|616682555|FG003|Primary Epoch|Lost to Follow-up|0|||
170636826|NCT01175083|616682556|FG004|Primary Epoch|Lost to Follow-up|0|||
170464465|NCT03301649|616039814|FG000|Overall Study|Protocol Violation|0|||
170464466|NCT03301649|616039815|FG001|Overall Study|Protocol Violation|1|||
170464467|NCT03301649|616039816|FG002|Overall Study|Protocol Violation|1|||
170464468|NCT03301649|616039814|FG000|Overall Study|Withdrawal by Subject|10|||
170464469|NCT03301649|616039815|FG001|Overall Study|Withdrawal by Subject|4|||
170464470|NCT03301649|616039816|FG002|Overall Study|Withdrawal by Subject|0|||
170464471|NCT03301649|616039814|FG000|Overall Study|Other than specified|5|||
170464472|NCT03301649|616039815|FG001|Overall Study|Other than specified|3|||
170464473|NCT03301649|616039816|FG002|Overall Study|Other than specified|0|||
170464474|NCT01154816|616039817|FG000|Overall Study|Withdrawal by Subject|1|||
170464475|NCT01154816|616039818|FG001|Overall Study|Withdrawal by Subject|0|||
170464476|NCT01154816|616039819|FG002|Overall Study|Withdrawal by Subject|0|||
170464477|NCT01154816|616039820|FG003|Overall Study|Withdrawal by Subject|1|||
170464478|NCT01154816|616039821|FG004|Overall Study|Withdrawal by Subject|0|||
170464479|NCT01154816|616039822|FG005|Overall Study|Withdrawal by Subject|0|||
170464480|NCT01154816|616039823|FG006|Overall Study|Withdrawal by Subject|0|||
170464481|NCT01154816|616039824|FG007|Overall Study|Withdrawal by Subject|0|||
170464482|NCT01154816|616039825|FG008|Overall Study|Withdrawal by Subject|1|||
170464483|NCT01154816|616039826|FG009|Overall Study|Withdrawal by Subject|3|||
170464484|NCT01154816|616039827|FG010|Overall Study|Withdrawal by Subject|0|||
170464485|NCT01154816|616039828|FG011|Overall Study|Withdrawal by Subject|0|||
170464486|NCT01154816|616039817|FG000|Overall Study|Progressive Disease|13|||
170464487|NCT01154816|616039818|FG001|Overall Study|Progressive Disease|8|||
170464488|NCT01154816|616039819|FG002|Overall Study|Progressive Disease|9|||
170464489|NCT01154816|616039820|FG003|Overall Study|Progressive Disease|9|||
170464490|NCT01154816|616039821|FG004|Overall Study|Progressive Disease|8|||
170464491|NCT01154816|616039822|FG005|Overall Study|Progressive Disease|8|||
170464492|NCT01154816|616039823|FG006|Overall Study|Progressive Disease|5|||
170464493|NCT01154816|616039824|FG007|Overall Study|Progressive Disease|6|||
170464494|NCT01154816|616039825|FG008|Overall Study|Progressive Disease|8|||
170464495|NCT01154816|616039826|FG009|Overall Study|Progressive Disease|6|||
170464496|NCT01154816|616039827|FG010|Overall Study|Progressive Disease|10|||
170464497|NCT01154816|616039828|FG011|Overall Study|Progressive Disease|3|||
170464498|NCT01154816|616039817|FG000|Overall Study|Physician Decision|1|||
170464499|NCT01154816|616039818|FG001|Overall Study|Physician Decision|0|||
170464500|NCT01154816|616039819|FG002|Overall Study|Physician Decision|1|||
170464501|NCT01154816|616039820|FG003|Overall Study|Physician Decision|0|||
170464502|NCT01154816|616039821|FG004|Overall Study|Physician Decision|2|||
170464503|NCT01154816|616039822|FG005|Overall Study|Physician Decision|0|||
170464504|NCT01154816|616039823|FG006|Overall Study|Physician Decision|0|||
170464505|NCT01154816|616039824|FG007|Overall Study|Physician Decision|0|||
170464506|NCT01154816|616039825|FG008|Overall Study|Physician Decision|0|||
170464507|NCT01154816|616039826|FG009|Overall Study|Physician Decision|1|||
170464508|NCT01154816|616039827|FG010|Overall Study|Physician Decision|1|||
170464509|NCT01154816|616039828|FG011|Overall Study|Physician Decision|1|||
170464510|NCT01154816|616039817|FG000|Overall Study|Adverse Event|5|||
170464511|NCT01154816|616039818|FG001|Overall Study|Adverse Event|2|||
170464512|NCT01154816|616039819|FG002|Overall Study|Adverse Event|0|||
170464513|NCT01154816|616039820|FG003|Overall Study|Adverse Event|0|||
170464514|NCT01154816|616039821|FG004|Overall Study|Adverse Event|0|||
170464515|NCT01154816|616039822|FG005|Overall Study|Adverse Event|0|||
170464516|NCT01154816|616039823|FG006|Overall Study|Adverse Event|1|||
170464517|NCT01154816|616039824|FG007|Overall Study|Adverse Event|1|||
170464518|NCT01154816|616039825|FG008|Overall Study|Adverse Event|0|||
170544559|NCT01658878|616337269|FG008|Treatment Period|Lost to Follow-up|0|||
170544560|NCT01658878|616337270|FG009|Treatment Period|Lost to Follow-up|0|||
170544561|NCT01658878|616337271|FG010|Treatment Period|Lost to Follow-up|0|||
170544562|NCT01658878|616337272|FG011|Treatment Period|Lost to Follow-up|0|||
170544563|NCT01658878|616337273|FG012|Treatment Period|Lost to Follow-up|0|||
170544564|NCT01658878|616337274|FG013|Treatment Period|Lost to Follow-up|0|||
170544565|NCT01658878|616337275|FG014|Treatment Period|Lost to Follow-up|0|||
170464519|NCT01154816|616039826|FG009|Overall Study|Adverse Event|0|||
170464520|NCT01154816|616039827|FG010|Overall Study|Adverse Event|0|||
170464521|NCT01154816|616039828|FG011|Overall Study|Adverse Event|0|||
170544566|NCT01658878|616337276|FG015|Treatment Period|Lost to Follow-up|0|||
170789835|NCT02547233|617242735|FG000|12-month Follow-up|Protocol Violation|0|||
170464522|NCT00686075|616039829|FG000|Overall Study|Withdrawal by Subject|4|||
170464523|NCT00686075|616039830|FG001|Overall Study|Withdrawal by Subject|3|||
170464524|NCT00686075|616039831|FG002|Overall Study|Withdrawal by Subject|3|||
170464525|NCT00686075|616039832|FG003|Overall Study|Withdrawal by Subject|7|||
170464526|NCT00686075|616039833|FG004|Overall Study|Withdrawal by Subject|1|||
170464527|NCT00686075|616039834|FG005|Overall Study|Withdrawal by Subject|0|||
170464528|NCT00686075|616039835|FG006|Overall Study|Withdrawal by Subject|0|||
170464529|NCT00686075|616039836|FG007|Overall Study|Withdrawal by Subject|2|||
170464530|NCT00686075|616039837|FG008|Overall Study|Withdrawal by Subject|4|||
170464531|NCT00686075|616039838|FG009|Overall Study|Withdrawal by Subject|6|||
170464532|NCT00686075|616039829|FG000|Overall Study|Lost to Follow-up|3|||
170544567|NCT01658878|616337277|FG016|Treatment Period|Lost to Follow-up|1|||
170464533|NCT00686075|616039830|FG001|Overall Study|Lost to Follow-up|6|||
170464534|NCT00686075|616039831|FG002|Overall Study|Lost to Follow-up|3|||
170464535|NCT00686075|616039832|FG003|Overall Study|Lost to Follow-up|2|||
170464536|NCT00686075|616039833|FG004|Overall Study|Lost to Follow-up|3|||
170636827|NCT01175083|616682557|FG005|Primary Epoch|Lost to Follow-up|1|||
170636828|NCT01175083|616682552|FG000|Booster Epoch|Death|0|||
170636829|NCT01175083|616682553|FG001|Booster Epoch|Death|0|||
170636830|NCT01175083|616682554|FG002|Booster Epoch|Death|1|||
170636831|NCT01175083|616682555|FG003|Booster Epoch|Death|0|||
170636832|NCT01175083|616682556|FG004|Booster Epoch|Death|0|||
170636833|NCT01175083|616682557|FG005|Booster Epoch|Death|0|||
170636834|NCT01175083|616682552|FG000|Booster Epoch|Withdrawal by Subject|0|||
170464537|NCT00686075|616039834|FG005|Overall Study|Lost to Follow-up|3|||
170464538|NCT00686075|616039835|FG006|Overall Study|Lost to Follow-up|0|||
170464539|NCT00686075|616039836|FG007|Overall Study|Lost to Follow-up|0|||
170464540|NCT00686075|616039837|FG008|Overall Study|Lost to Follow-up|2|||
170464541|NCT00686075|616039838|FG009|Overall Study|Lost to Follow-up|3|||
170464542|NCT00686075|616039829|FG000|Overall Study|Other|1|||
170464543|NCT00686075|616039830|FG001|Overall Study|Other|1|||
170464544|NCT00686075|616039831|FG002|Overall Study|Other|0|||
170464545|NCT00686075|616039832|FG003|Overall Study|Other|0|||
170464546|NCT00686075|616039833|FG004|Overall Study|Other|0|||
170464547|NCT00686075|616039834|FG005|Overall Study|Other|0|||
170464548|NCT00686075|616039835|FG006|Overall Study|Other|0|||
170464549|NCT00686075|616039836|FG007|Overall Study|Other|0|||
170464550|NCT00686075|616039837|FG008|Overall Study|Other|0|||
170464551|NCT00686075|616039838|FG009|Overall Study|Other|1|||
170464552|NCT00537303|616039847|FG000|Overall Study|Adverse Event|1|||
170464553|NCT00537303|616039848|FG001|Overall Study|Adverse Event|4|||
170464554|NCT00537303|616039847|FG000|Overall Study|Lack of Efficacy|6|||
170464555|NCT00537303|616039848|FG001|Overall Study|Lack of Efficacy|7|||
170464556|NCT00537303|616039847|FG000|Overall Study|Protocol Violation|8|||
170464557|NCT00537303|616039848|FG001|Overall Study|Protocol Violation|4|||
170464558|NCT00537303|616039847|FG000|Overall Study|Withdrawal criteria|3|||
170464559|NCT00537303|616039848|FG001|Overall Study|Withdrawal criteria|3|||
170464560|NCT00537303|616039847|FG000|Overall Study|Unclassified|8|||
170464561|NCT00537303|616039848|FG001|Overall Study|Unclassified|7|||
170464562|NCT03262038|616039849|FG000|Overall Study|Withdrawal by Subject|0|||
170464563|NCT03262038|616039850|FG001|Overall Study|Withdrawal by Subject|1|||
170464564|NCT04933968|616039851|FG000|Overall Study|Adverse Event|0|||
170464565|NCT04933968|616039852|FG001|Overall Study|Adverse Event|0|||
170464566|NCT04933968|616039853|FG002|Overall Study|Adverse Event|1|||
170464567|NCT04933968|616039854|FG003|Overall Study|Adverse Event|1|||
170464568|NCT04933968|616039855|FG004|Overall Study|Adverse Event|0|||
170464569|NCT04933968|616039856|FG005|Overall Study|Adverse Event|0|||
170464570|NCT04933968|616039851|FG000|Overall Study|Lost to Follow-up|1|||
170544568|NCT01658878|616337278|FG017|Treatment Period|Lost to Follow-up|0|||
170544569|NCT01658878|616337279|FG018|Treatment Period|Lost to Follow-up|1|||
170544570|NCT01658878|616337280|FG019|Treatment Period|Lost to Follow-up|1|||
170544571|NCT01658878|616337281|FG020|Treatment Period|Lost to Follow-up|0|||
170544572|NCT01658878|616337282|FG021|Treatment Period|Lost to Follow-up|0|||
170544573|NCT01658878|616337283|FG022|Treatment Period|Lost to Follow-up|1|||
170544574|NCT01658878|616337284|FG023|Treatment Period|Lost to Follow-up|0|||
170636835|NCT01175083|616682553|FG001|Booster Epoch|Withdrawal by Subject|0|||
170636836|NCT01175083|616682554|FG002|Booster Epoch|Withdrawal by Subject|0|||
170636837|NCT01175083|616682555|FG003|Booster Epoch|Withdrawal by Subject|1|||
170636838|NCT01175083|616682556|FG004|Booster Epoch|Withdrawal by Subject|0|||
170636839|NCT01175083|616682557|FG005|Booster Epoch|Withdrawal by Subject|0|||
170636840|NCT00475306|616682558|FG000|Overall Study|Protocol Violation|1|||
170636841|NCT00475306|616682559|FG001|Overall Study|Protocol Violation|1|||
170789836|NCT02547233|617242736|FG001|12-month Follow-up|Protocol Violation|1|||
170464571|NCT04933968|616039852|FG001|Overall Study|Lost to Follow-up|0|||
170464572|NCT04933968|616039853|FG002|Overall Study|Lost to Follow-up|1|||
170464573|NCT04933968|616039854|FG003|Overall Study|Lost to Follow-up|0|||
170464574|NCT04933968|616039855|FG004|Overall Study|Lost to Follow-up|0|||
170464575|NCT04933968|616039856|FG005|Overall Study|Lost to Follow-up|0|||
170464576|NCT04933968|616039851|FG000|Overall Study|Randomized not treated|1|||
170464577|NCT04933968|616039852|FG001|Overall Study|Randomized not treated|0|||
170464578|NCT04933968|616039853|FG002|Overall Study|Randomized not treated|0|||
170464579|NCT04933968|616039854|FG003|Overall Study|Randomized not treated|0|||
170464580|NCT04933968|616039855|FG004|Overall Study|Randomized not treated|0|||
170464581|NCT04933968|616039856|FG005|Overall Study|Randomized not treated|0|||
170464582|NCT04933968|616039851|FG000|Overall Study|Sponsor terminated study|0|||
170464583|NCT04933968|616039852|FG001|Overall Study|Sponsor terminated study|0|||
170544575|NCT00134719|616337286|FG000|Primary Vaccination Phase|Adverse Event|4|||
170544576|NCT00134719|616337287|FG001|Primary Vaccination Phase|Adverse Event|0|||
170636842|NCT00475306|616682560|FG002|Overall Study|Protocol Violation|0|||
170636843|NCT00475306|616682561|FG003|Overall Study|Protocol Violation|1|||
170636844|NCT02881567|616682562|FG000|Overall Study|Adverse Event|1|||
170789837|NCT02547233|617242735|FG000|12-month Follow-up|Other|0|||
170789838|NCT02547233|617242736|FG001|12-month Follow-up|Other|1|||
170789839|NCT05213390|617242738|FG000|Overall Study|Withdrawal by Subject|2|||
170789840|NCT05213390|617242738|FG000|Overall Study|Lost to Follow-up|12|||
170789841|NCT05213390|617242738|FG000|Overall Study|Protocol Violation|9|||
170789842|NCT03603600|617242741|FG000|Overall Study|Withdrawal by Subject|5|||
170789843|NCT03603600|617242742|FG001|Overall Study|Withdrawal by Subject|7|||
170789844|NCT03603600|617242741|FG000|Overall Study|Lost to Follow-up|2|||
170789845|NCT03603600|617242742|FG001|Overall Study|Lost to Follow-up|3|||
170789846|NCT03603600|617242741|FG000|Overall Study|Death|3|||
170789847|NCT03603600|617242742|FG001|Overall Study|Death|1|||
170789848|NCT03603600|617242741|FG000|Overall Study|Physician Decision|2|||
170789849|NCT03603600|617242742|FG001|Overall Study|Physician Decision|1|||
170789850|NCT03603600|617242741|FG000|Overall Study|Other reason|1|||
170789851|NCT03603600|617242742|FG001|Overall Study|Other reason|0|||
170789852|NCT01593917|617242748|FG000|Overall Study|Death|67|||
170789853|NCT01593917|617242748|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
170789854|NCT01593917|617242748|FG000|Overall Study|Withdrawal by Subject|23|||
170789855|NCT01593917|617242748|FG000|Overall Study|Lost to Follow-up|12|||
170789856|NCT01593917|617242748|FG000|Overall Study|Protocol Violation|5|||
170789857|NCT01593917|617242748|FG000|Overall Study|Physician Decision|3|||
170789858|NCT02683447|617242752|FG000|Overall Study|Lost to Follow-up|2|||
170464584|NCT04933968|616039853|FG002|Overall Study|Sponsor terminated study|0|||
170464585|NCT04933968|616039854|FG003|Overall Study|Sponsor terminated study|1|||
170464586|NCT04933968|616039855|FG004|Overall Study|Sponsor terminated study|2|||
170464587|NCT04933968|616039856|FG005|Overall Study|Sponsor terminated study|0|||
170464588|NCT04933968|616039851|FG000|Overall Study|Other|0|||
170464589|NCT04933968|616039852|FG001|Overall Study|Other|0|||
170464590|NCT04933968|616039853|FG002|Overall Study|Other|0|||
170464591|NCT04933968|616039854|FG003|Overall Study|Other|1|||
170464592|NCT04933968|616039855|FG004|Overall Study|Other|0|||
170464593|NCT04933968|616039856|FG005|Overall Study|Other|0|||
170464594|NCT04933968|616039851|FG000|Overall Study|Missing|1|||
170464595|NCT04933968|616039852|FG001|Overall Study|Missing|3|||
170464596|NCT04933968|616039853|FG002|Overall Study|Missing|2|||
170464597|NCT04933968|616039854|FG003|Overall Study|Missing|1|||
170464598|NCT04933968|616039855|FG004|Overall Study|Missing|1|||
170464599|NCT04933968|616039856|FG005|Overall Study|Missing|0|||
170464600|NCT01724489|616039857|FG000|Overall Study|Adverse Event|8|||
170464601|NCT01724489|616039858|FG001|Overall Study|Adverse Event|3|||
170464602|NCT01724489|616039857|FG000|Overall Study|Surgery, medication|1|||
170464603|NCT01724489|616039858|FG001|Overall Study|Surgery, medication|1|||
170464604|NCT01724489|616039857|FG000|Overall Study|Lost to Follow-up|1|||
170464605|NCT01724489|616039858|FG001|Overall Study|Lost to Follow-up|2|||
170464606|NCT01724489|616039857|FG000|Overall Study|Withdrawal by Subject|6|||
170464607|NCT01724489|616039858|FG001|Overall Study|Withdrawal by Subject|6|||
170464608|NCT04228783|616039859|FG000|Overall Study|Adverse Event|1|||
170464609|NCT04228783|616039860|FG001|Overall Study|Adverse Event|0|||
170464610|NCT04228783|616039861|FG002|Overall Study|Adverse Event|2|||
170464611|NCT04228783|616039862|FG003|Overall Study|Adverse Event|0|||
170464612|NCT04228783|616039863|FG004|Overall Study|Adverse Event|0|||
170464613|NCT04228783|616039864|FG005|Overall Study|Adverse Event|1|||
170464614|NCT04228783|616039859|FG000|Overall Study|Death|0|||
170464615|NCT04228783|616039860|FG001|Overall Study|Death|0|||
170464616|NCT04228783|616039861|FG002|Overall Study|Death|0|||
170464617|NCT04228783|616039862|FG003|Overall Study|Death|0|||
170464618|NCT04228783|616039863|FG004|Overall Study|Death|1|||
170464619|NCT04228783|616039864|FG005|Overall Study|Death|0|||
170636845|NCT02881567|616682562|FG000|Overall Study|Lost to Follow-up|3|||
170789859|NCT05126433|617242753|FG000|Overall Study|Withdrawal by Subject|3|||
170636846|NCT02881567|616682562|FG000|Overall Study|Consent withdrawn|1|||
170636847|NCT02881567|616682562|FG000|Overall Study|Investigator decision|1|||
170636848|NCT02881567|616682562|FG000|Overall Study|Study terminated by sponsor|9|||
170636849|NCT02881567|616682562|FG000|Overall Study|Reason not Specified|3|||
170636850|NCT02405442|616682563|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
170636851|NCT02405442|616682564|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
170789860|NCT05126433|617242754|FG001|Overall Study|Withdrawal by Subject|0|||
170789861|NCT05126433|617242755|FG002|Overall Study|Withdrawal by Subject|4|||
170789862|NCT05126433|617242753|FG000|Overall Study|Death|9|||
170789863|NCT05126433|617242754|FG001|Overall Study|Death|3|||
170789864|NCT05126433|617242755|FG002|Overall Study|Death|5|||
170789865|NCT05126433|617242753|FG000|Overall Study|Study Terminated by sponsor|0|||
170789866|NCT05126433|617242754|FG001|Overall Study|Study Terminated by sponsor|1|||
170789867|NCT05126433|617242755|FG002|Overall Study|Study Terminated by sponsor|2|||
170464620|NCT04228783|616039859|FG000|Overall Study|Lost to Follow-up|36|||
170464621|NCT04228783|616039860|FG001|Overall Study|Lost to Follow-up|36|||
170464622|NCT04228783|616039861|FG002|Overall Study|Lost to Follow-up|28|||
170464623|NCT04228783|616039862|FG003|Overall Study|Lost to Follow-up|6|||
170464624|NCT04228783|616039863|FG004|Overall Study|Lost to Follow-up|14|||
170464625|NCT04228783|616039864|FG005|Overall Study|Lost to Follow-up|3|||
170636852|NCT02405442|616682565|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
170890391|NCT00223496|617606454|FG000|Overall Study|Physician Decision|2|||
170636853|NCT02405442|616682566|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
170636854|NCT02405442|616682563|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
170636855|NCT02405442|616682564|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
170636856|NCT02405442|616682565|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
170636857|NCT02405442|616682566|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
170636858|NCT02405442|616682563|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
170636859|NCT02405442|616682564|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
170464626|NCT04228783|616039859|FG000|Overall Study|Physician Decision|1|||
170464627|NCT04228783|616039860|FG001|Overall Study|Physician Decision|2|||
170464628|NCT04228783|616039861|FG002|Overall Study|Physician Decision|0|||
170464629|NCT04228783|616039862|FG003|Overall Study|Physician Decision|0|||
170464630|NCT04228783|616039863|FG004|Overall Study|Physician Decision|0|||
170464631|NCT04228783|616039864|FG005|Overall Study|Physician Decision|0|||
170464632|NCT04228783|616039859|FG000|Overall Study|Protocol Violation|0|||
170464633|NCT04228783|616039860|FG001|Overall Study|Protocol Violation|0|||
170464634|NCT04228783|616039861|FG002|Overall Study|Protocol Violation|0|||
170464635|NCT04228783|616039862|FG003|Overall Study|Protocol Violation|1|||
170464636|NCT04228783|616039863|FG004|Overall Study|Protocol Violation|0|||
170464637|NCT04228783|616039864|FG005|Overall Study|Protocol Violation|0|||
170464638|NCT04228783|616039859|FG000|Overall Study|Withdrawal by Subject|6|||
170464639|NCT04228783|616039860|FG001|Overall Study|Withdrawal by Subject|10|||
170464640|NCT04228783|616039861|FG002|Overall Study|Withdrawal by Subject|19|||
170464641|NCT04228783|616039862|FG003|Overall Study|Withdrawal by Subject|1|||
170464642|NCT04228783|616039863|FG004|Overall Study|Withdrawal by Subject|2|||
170464643|NCT04228783|616039864|FG005|Overall Study|Withdrawal by Subject|0|||
170464644|NCT04228783|616039859|FG000|Overall Study|Other|4|||
170464645|NCT04228783|616039860|FG001|Overall Study|Other|3|||
170464646|NCT04228783|616039861|FG002|Overall Study|Other|2|||
170464647|NCT04228783|616039862|FG003|Overall Study|Other|1|||
170464648|NCT04228783|616039863|FG004|Overall Study|Other|0|||
170544577|NCT00134719|616337288|FG002|Primary Vaccination Phase|Adverse Event|0|||
170544578|NCT00134719|616337286|FG000|Primary Vaccination Phase|Protocol Violation|1|||
170544579|NCT00134719|616337287|FG001|Primary Vaccination Phase|Protocol Violation|0|||
170544580|NCT00134719|616337288|FG002|Primary Vaccination Phase|Protocol Violation|0|||
170544581|NCT00134719|616337286|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
170544582|NCT00134719|616337287|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
170544583|NCT00134719|616337288|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
170544584|NCT00134719|616337286|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
170544585|NCT00134719|616337287|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
170544586|NCT00134719|616337288|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
170544587|NCT00134719|616337286|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
170544588|NCT00134719|616337287|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
170544589|NCT00134719|616337288|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
170544590|NCT00134719|616337286|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
170544591|NCT00134719|616337287|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
170544592|NCT00134719|616337288|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
170544593|NCT01807520|616337289|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
170544594|NCT01807520|616337290|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
170544595|NCT01807520|616337291|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
170544596|NCT01807520|616337292|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
170544597|NCT01807520|616337293|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
170544598|NCT01807520|616337294|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
170544599|NCT01807520|616337295|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
170544600|NCT01807520|616337289|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
170544601|NCT01807520|616337290|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
170544602|NCT01807520|616337291|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
170544603|NCT01807520|616337292|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
170544604|NCT01807520|616337293|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
170544605|NCT01807520|616337294|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
170544606|NCT01807520|616337295|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
170464649|NCT04228783|616039864|FG005|Overall Study|Other|0|||
170636860|NCT02405442|616682565|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
170636861|NCT02405442|616682566|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
170890392|NCT02971202|617606455|FG000|Overall Study|Pregnancy|1|||
170464650|NCT03151811|616039865|FG000|Overall Study|Randomized But Not Treated|18|||
170464651|NCT03151811|616039866|FG001|Overall Study|Randomized But Not Treated|3|||
170464652|NCT03151811|616039865|FG000|Overall Study|Progressive Disease|130|||
170464653|NCT03151811|616039866|FG001|Overall Study|Progressive Disease|170|||
170464654|NCT03151811|616039865|FG000|Overall Study|Adverse Event|49|||
170464655|NCT03151811|616039866|FG001|Overall Study|Adverse Event|40|||
170544607|NCT01807520|616337289|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
170789868|NCT05126433|617242753|FG000|Overall Study|Progressive Disease|1|||
170789869|NCT05126433|617242754|FG001|Overall Study|Progressive Disease|4|||
170789870|NCT05126433|617242755|FG002|Overall Study|Progressive Disease|3|||
170789871|NCT05126433|617242753|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
170789872|NCT05126433|617242754|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
170789873|NCT05126433|617242755|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
170789874|NCT01501955|617242756|FG000|Overall Study|Withdrawal by Subject|1|||
170789875|NCT01501955|617242757|FG001|Overall Study|Withdrawal by Subject|0|||
170789876|NCT01501955|617242756|FG000|Overall Study|Adverse Event|1|||
170789877|NCT01501955|617242757|FG001|Overall Study|Adverse Event|3|||
170789878|NCT03625167|617242758|FG000|Overall Study|Protocol Violation|5|||
170890393|NCT02971202|617606456|FG001|Overall Study|Pregnancy|0|||
170890394|NCT02971202|617606457|FG002|Overall Study|Pregnancy|0|||
170890395|NCT02971202|617606455|FG000|Overall Study|screen fail after consent|1|||
170890396|NCT02971202|617606456|FG001|Overall Study|screen fail after consent|0|||
170789879|NCT03020199|617242759|FG000|Treatment Period|Adverse Event|0|||
170789880|NCT03020199|617242760|FG001|Treatment Period|Adverse Event|2|||
170789881|NCT03020199|617242759|FG000|Treatment Period|Lack of Efficacy|1|||
170789882|NCT03020199|617242760|FG001|Treatment Period|Lack of Efficacy|6|||
170789883|NCT03020199|617242759|FG000|Treatment Period|Lost to Follow-up|1|||
170789884|NCT03020199|617242760|FG001|Treatment Period|Lost to Follow-up|6|||
170789885|NCT03020199|617242759|FG000|Treatment Period|Physician Decision|0|||
170789886|NCT03020199|617242760|FG001|Treatment Period|Physician Decision|1|||
170789887|NCT03020199|617242759|FG000|Treatment Period|Subject/guardian decision|8|||
170789888|NCT03020199|617242760|FG001|Treatment Period|Subject/guardian decision|15|||
170789889|NCT03020199|617242759|FG000|Treatment Period|Subjects not treated|3|||
170789890|NCT03020199|617242760|FG001|Treatment Period|Subjects not treated|4|||
170890397|NCT02971202|617606457|FG002|Overall Study|screen fail after consent|1|||
170890398|NCT00424827|617606460|FG000|Overall Study|Adverse Event|1|||
170890399|NCT05425563|617606463|FG000|Overall Study|Withdrawal by Subject|17|||
170890400|NCT02222714|617606466|FG000|Overall Study|Death|0|||
170890401|NCT02222714|617606467|FG001|Overall Study|Death|2|||
170890402|NCT02222714|617606468|FG002|Overall Study|Death|3|||
170890403|NCT02222714|617606469|FG003|Overall Study|Death|4|||
170890404|NCT02222714|617606470|FG004|Overall Study|Death|6|||
170890405|NCT02222714|617606466|FG000|Overall Study|Withdrawal by Subject|0|||
170890406|NCT02222714|617606467|FG001|Overall Study|Withdrawal by Subject|0|||
170890407|NCT02222714|617606468|FG002|Overall Study|Withdrawal by Subject|1|||
170890408|NCT02222714|617606469|FG003|Overall Study|Withdrawal by Subject|0|||
170890409|NCT02222714|617606470|FG004|Overall Study|Withdrawal by Subject|1|||
170890410|NCT00159432|617606471|FG000|Overall Study|Adverse Event|1|||
170890411|NCT00159432|617606471|FG000|Overall Study|Death|1|||
170890412|NCT00159432|617606471|FG000|Overall Study|Lack of Efficacy|8|||
170890413|NCT04537208|617606472|FG000|Overall Study|Adverse Event|0|||
170890414|NCT04537208|617606473|FG001|Overall Study|Adverse Event|0|||
170890415|NCT04537208|617606474|FG002|Overall Study|Adverse Event|0|||
170890416|NCT04537208|617606475|FG003|Overall Study|Adverse Event|0|||
170890417|NCT04537208|617606476|FG004|Overall Study|Adverse Event|0|||
170890418|NCT04537208|617606477|FG005|Overall Study|Adverse Event|0|||
170789891|NCT03020199|617242759|FG000|Follow-up Period|Disease relapse|32|||
170890419|NCT04537208|617606478|FG006|Overall Study|Adverse Event|0|||
170890420|NCT04537208|617606479|FG007|Overall Study|Adverse Event|0|||
170890421|NCT04537208|617606480|FG008|Overall Study|Adverse Event|1|||
170890422|NCT04537208|617606481|FG009|Overall Study|Adverse Event|0|||
170890423|NCT04537208|617606482|FG010|Overall Study|Adverse Event|0|||
170890424|NCT04537208|617606472|FG000|Overall Study|Protocol deviation|0|||
170890425|NCT04537208|617606473|FG001|Overall Study|Protocol deviation|0|||
170890426|NCT04537208|617606474|FG002|Overall Study|Protocol deviation|2|||
170890427|NCT04537208|617606475|FG003|Overall Study|Protocol deviation|0|||
170890428|NCT04537208|617606476|FG004|Overall Study|Protocol deviation|0|||
170890429|NCT04537208|617606477|FG005|Overall Study|Protocol deviation|2|||
170789892|NCT03020199|617242760|FG001|Follow-up Period|Disease relapse|7|||
170789893|NCT03020199|617242759|FG000|Follow-up Period|Lack of Efficacy|1|||
170789894|NCT03020199|617242760|FG001|Follow-up Period|Lack of Efficacy|2|||
170789895|NCT03020199|617242759|FG000|Follow-up Period|Lost to Follow-up|4|||
170789896|NCT03020199|617242760|FG001|Follow-up Period|Lost to Follow-up|6|||
170890430|NCT04537208|617606478|FG006|Overall Study|Protocol deviation|4|||
170890431|NCT04537208|617606479|FG007|Overall Study|Protocol deviation|0|||
170890432|NCT04537208|617606480|FG008|Overall Study|Protocol deviation|1|||
170890433|NCT04537208|617606481|FG009|Overall Study|Protocol deviation|0|||
170890434|NCT04537208|617606482|FG010|Overall Study|Protocol deviation|2|||
170890435|NCT04537208|617606472|FG000|Overall Study|Withdrawal by Subject|4|||
170890436|NCT04537208|617606473|FG001|Overall Study|Withdrawal by Subject|2|||
170890437|NCT04537208|617606474|FG002|Overall Study|Withdrawal by Subject|1|||
170890438|NCT04537208|617606475|FG003|Overall Study|Withdrawal by Subject|3|||
170890439|NCT04537208|617606476|FG004|Overall Study|Withdrawal by Subject|5|||
170890440|NCT04537208|617606477|FG005|Overall Study|Withdrawal by Subject|1|||
170890441|NCT04537208|617606478|FG006|Overall Study|Withdrawal by Subject|6|||
170636862|NCT02405442|616682563|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
170636863|NCT02405442|616682564|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
170636864|NCT02405442|616682565|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
170636865|NCT02405442|616682566|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
170636866|NCT02405442|616682563|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
170636867|NCT02405442|616682564|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
170636868|NCT02405442|616682565|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
170636869|NCT02405442|616682566|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
170789897|NCT03020199|617242759|FG000|Follow-up Period|Physician Decision|2|||
170789898|NCT03020199|617242760|FG001|Follow-up Period|Physician Decision|2|||
170464656|NCT03151811|616039865|FG000|Overall Study|Lack of Efficacy|6|||
170464657|NCT03151811|616039866|FG001|Overall Study|Lack of Efficacy|8|||
170464658|NCT03151811|616039865|FG000|Overall Study|Physician Decision|21|||
170464659|NCT03151811|616039866|FG001|Overall Study|Physician Decision|9|||
170464660|NCT03151811|616039865|FG000|Overall Study|Withdrawal by Subject|17|||
170464661|NCT03151811|616039866|FG001|Overall Study|Withdrawal by Subject|7|||
170464662|NCT03151811|616039865|FG000|Overall Study|Lost to Follow-up|0|||
170464663|NCT03151811|616039866|FG001|Overall Study|Lost to Follow-up|1|||
170464664|NCT03151811|616039865|FG000|Overall Study|Study Terminated by Sponsor|5|||
170464665|NCT03151811|616039866|FG001|Overall Study|Study Terminated by Sponsor|11|||
170464666|NCT01664130|616039869|FG000|Overall Study|competing secondary disease|2|||
170464667|NCT02679235|616039874|FG000|Overall Study|Withdrawal by Subject|3|||
170464668|NCT02679235|616039874|FG000|Overall Study|Adverse Event|1|||
170464669|NCT02383810|616039875|FG000|Overall Study|Physician Decision|1|||
170464670|NCT02383810|616039876|FG001|Overall Study|Physician Decision|1|||
170464671|NCT02383810|616039877|FG002|Overall Study|Physician Decision|0|||
170464672|NCT02383810|616039878|FG003|Overall Study|Physician Decision|0|||
170464673|NCT02383810|616039879|FG004|Overall Study|Physician Decision|0|||
170464674|NCT02383810|616039880|FG005|Overall Study|Physician Decision|0|||
170464675|NCT02383810|616039881|FG006|Overall Study|Physician Decision|0|||
170464676|NCT02383810|616039882|FG007|Overall Study|Physician Decision|0|||
170464677|NCT02383810|616039875|FG000|Overall Study|Withdrawal by Subject|2|||
170544608|NCT01807520|616337290|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
170544609|NCT01807520|616337291|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
170544610|NCT01807520|616337292|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
170544611|NCT01807520|616337293|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
170544612|NCT01807520|616337294|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
170544613|NCT01807520|616337295|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
170544614|NCT01807520|616337289|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
170544615|NCT01807520|616337290|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
170544616|NCT01807520|616337291|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
170544617|NCT01807520|616337292|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
170544618|NCT01807520|616337293|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
170544619|NCT01807520|616337294|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
170544620|NCT01807520|616337295|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
170544621|NCT01807520|616337289|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
170544622|NCT01807520|616337290|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
170544623|NCT01807520|616337291|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
170544624|NCT01807520|616337292|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
170544625|NCT01807520|616337293|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
170544626|NCT01807520|616337294|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
170544627|NCT01807520|616337295|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
170789899|NCT03020199|617242759|FG000|Follow-up Period|Protocol Violation|1|||
170789900|NCT03020199|617242760|FG001|Follow-up Period|Protocol Violation|2|||
170789901|NCT03020199|617242759|FG000|Follow-up Period|Study terminated by Sponsor|6|||
170789902|NCT03020199|617242760|FG001|Follow-up Period|Study terminated by Sponsor|3|||
170789903|NCT03020199|617242759|FG000|Follow-up Period|Subject/guardian decision|14|||
170789904|NCT03020199|617242760|FG001|Follow-up Period|Subject/guardian decision|9|||
170789905|NCT04314713|617242761|FG000|Overall Study|Lost to Follow-up|0|||
170789906|NCT04314713|617242762|FG001|Overall Study|Lost to Follow-up|0|||
170789907|NCT04314713|617242763|FG002|Overall Study|Lost to Follow-up|0|||
170789908|NCT04314713|617242764|FG003|Overall Study|Lost to Follow-up|1|||
170789909|NCT04314713|617242765|FG004|Overall Study|Lost to Follow-up|0|||
170464678|NCT02383810|616039876|FG001|Overall Study|Withdrawal by Subject|3|||
170464679|NCT02383810|616039877|FG002|Overall Study|Withdrawal by Subject|3|||
170464680|NCT02383810|616039878|FG003|Overall Study|Withdrawal by Subject|3|||
170464681|NCT02383810|616039879|FG004|Overall Study|Withdrawal by Subject|0|||
170464682|NCT02383810|616039880|FG005|Overall Study|Withdrawal by Subject|0|||
170544628|NCT01807520|616337289|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
170544629|NCT01807520|616337290|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
170544630|NCT01807520|616337291|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
170789910|NCT04314713|617242766|FG005|Overall Study|Lost to Follow-up|0|||
170464683|NCT02383810|616039881|FG006|Overall Study|Withdrawal by Subject|0|||
170464684|NCT02383810|616039882|FG007|Overall Study|Withdrawal by Subject|0|||
170464685|NCT02383810|616039875|FG000|Overall Study|Adverse Event|0|||
170464686|NCT02383810|616039876|FG001|Overall Study|Adverse Event|2|||
170464687|NCT02383810|616039877|FG002|Overall Study|Adverse Event|4|||
170464688|NCT02383810|616039878|FG003|Overall Study|Adverse Event|5|||
170464689|NCT02383810|616039879|FG004|Overall Study|Adverse Event|0|||
170464690|NCT02383810|616039880|FG005|Overall Study|Adverse Event|1|||
170464691|NCT02383810|616039881|FG006|Overall Study|Adverse Event|1|||
170464692|NCT02383810|616039882|FG007|Overall Study|Adverse Event|0|||
170464693|NCT02383810|616039875|FG000|Overall Study|Lost to Follow-up|0|||
170464694|NCT02383810|616039876|FG001|Overall Study|Lost to Follow-up|1|||
170464695|NCT02383810|616039877|FG002|Overall Study|Lost to Follow-up|0|||
170464696|NCT02383810|616039878|FG003|Overall Study|Lost to Follow-up|1|||
170464697|NCT02383810|616039879|FG004|Overall Study|Lost to Follow-up|0|||
170464698|NCT02383810|616039880|FG005|Overall Study|Lost to Follow-up|0|||
170464699|NCT02383810|616039881|FG006|Overall Study|Lost to Follow-up|0|||
170464700|NCT02383810|616039882|FG007|Overall Study|Lost to Follow-up|0|||
170464701|NCT02383810|616039875|FG000|Overall Study|other|0|||
170464702|NCT02383810|616039876|FG001|Overall Study|other|0|||
170464703|NCT02383810|616039877|FG002|Overall Study|other|0|||
170464704|NCT02383810|616039878|FG003|Overall Study|other|2|||
170464705|NCT02383810|616039879|FG004|Overall Study|other|0|||
170464706|NCT02383810|616039880|FG005|Overall Study|other|0|||
170464707|NCT02383810|616039881|FG006|Overall Study|other|0|||
170544631|NCT01807520|616337292|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
170544632|NCT01807520|616337293|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
170544633|NCT01807520|616337294|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
170544634|NCT01807520|616337295|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
170544635|NCT01807520|616337289|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
170544636|NCT01807520|616337290|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
170544637|NCT01807520|616337291|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
170544638|NCT01807520|616337292|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
170544639|NCT01807520|616337293|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
170544640|NCT01807520|616337294|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
170544641|NCT01807520|616337295|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
170544642|NCT01807520|616337289|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
170544643|NCT01807520|616337290|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
170544644|NCT01807520|616337291|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
170544645|NCT01807520|616337292|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
170544646|NCT01807520|616337293|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
170544647|NCT01807520|616337294|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
170544648|NCT01807520|616337295|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
170544649|NCT01807520|616337289|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
170544650|NCT01807520|616337290|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
170544651|NCT01807520|616337291|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
170544652|NCT01807520|616337292|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
170544653|NCT01807520|616337293|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
170544654|NCT01807520|616337294|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
170544655|NCT01807520|616337295|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
170544656|NCT01807520|616337289|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
170544657|NCT01807520|616337290|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
170544658|NCT01807520|616337291|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
170544659|NCT01807520|616337292|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
170544660|NCT01807520|616337293|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
170544661|NCT01807520|616337294|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
170544662|NCT01807520|616337295|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
170544663|NCT01807520|616337289|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
170544664|NCT01807520|616337290|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
170544665|NCT01807520|616337291|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
170544666|NCT01807520|616337292|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
170544667|NCT01807520|616337293|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
170544668|NCT01807520|616337294|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
170544669|NCT01807520|616337295|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
170544670|NCT01807520|616337289|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
170464708|NCT02383810|616039882|FG007|Overall Study|other|0|||
170464709|NCT02383810|616039875|FG000|Overall Study|subject did not receive study treatment|0|||
170464710|NCT02383810|616039876|FG001|Overall Study|subject did not receive study treatment|1|||
170544671|NCT01807520|616337290|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
170544672|NCT01807520|616337291|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
170544673|NCT01807520|616337292|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
170464711|NCT02383810|616039877|FG002|Overall Study|subject did not receive study treatment|0|||
170464712|NCT02383810|616039878|FG003|Overall Study|subject did not receive study treatment|0|||
170464713|NCT02383810|616039879|FG004|Overall Study|subject did not receive study treatment|0|||
170464714|NCT02383810|616039880|FG005|Overall Study|subject did not receive study treatment|0|||
170464715|NCT02383810|616039881|FG006|Overall Study|subject did not receive study treatment|0|||
170464716|NCT02383810|616039882|FG007|Overall Study|subject did not receive study treatment|0|||
170464717|NCT02549027|616039886|FG000|Washout After Period 4|Withdrawal by Subject|0|||
170464718|NCT02549027|616039887|FG001|Washout After Period 4|Withdrawal by Subject|1|||
170464719|NCT02549027|616039888|FG002|Washout After Period 4|Withdrawal by Subject|1|||
170464720|NCT02549027|616039889|FG003|Washout After Period 4|Withdrawal by Subject|1|||
170464721|NCT02549027|616039890|FG004|Washout After Period 4|Withdrawal by Subject|0|||
170464722|NCT02549027|616039891|FG005|Washout After Period 4|Withdrawal by Subject|0|||
170464723|NCT02549027|616039886|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
170464724|NCT02549027|616039887|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
170464725|NCT02549027|616039888|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
170464726|NCT02549027|616039889|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
170464727|NCT02549027|616039890|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
170464728|NCT02549027|616039891|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
170464729|NCT02278055|616039892|FG000|Overall Study|Adverse Event|1|||
170464730|NCT02278055|616039892|FG000|Overall Study|Lost to Follow-up|1|||
170464731|NCT02278055|616039892|FG000|Overall Study|Withdrawal by Subject|2|||
170464732|NCT02278055|616039892|FG000|Overall Study|Progressive Disease|4|||
170464733|NCT01994291|616039893|FG000|Overall Study|Adverse Event|4|||
170464734|NCT01994291|616039894|FG001|Overall Study|Adverse Event|1|||
170464735|NCT01994291|616039895|FG002|Overall Study|Adverse Event|3|||
170464736|NCT01994291|616039893|FG000|Overall Study|Lost to Follow-up|1|||
170464737|NCT01994291|616039894|FG001|Overall Study|Lost to Follow-up|1|||
170464738|NCT01994291|616039895|FG002|Overall Study|Lost to Follow-up|0|||
170464739|NCT01994291|616039893|FG000|Overall Study|Does not meet entrance criteria|1|||
170464740|NCT01994291|616039894|FG001|Overall Study|Does not meet entrance criteria|0|||
170464741|NCT01994291|616039895|FG002|Overall Study|Does not meet entrance criteria|0|||
170464742|NCT01994291|616039893|FG000|Overall Study|Medication error without associated AE|1|||
170464743|NCT01994291|616039894|FG001|Overall Study|Medication error without associated AE|0|||
170464744|NCT01994291|616039895|FG002|Overall Study|Medication error without associated AE|1|||
170464745|NCT01994291|616039893|FG000|Overall Study|Protocol Violation|1|||
170464746|NCT01994291|616039894|FG001|Overall Study|Protocol Violation|0|||
170464747|NCT01994291|616039895|FG002|Overall Study|Protocol Violation|0|||
170464748|NCT01994291|616039893|FG000|Overall Study|Withdrawal by Subject|6|||
170464749|NCT01994291|616039894|FG001|Overall Study|Withdrawal by Subject|3|||
170464750|NCT01994291|616039895|FG002|Overall Study|Withdrawal by Subject|5|||
170464751|NCT01994291|616039893|FG000|Overall Study|Other|1|||
170464752|NCT01994291|616039894|FG001|Overall Study|Other|2|||
170464753|NCT01994291|616039895|FG002|Overall Study|Other|0|||
170464754|NCT02368314|616039898|FG000|Overall Study|Withdrawal by Subject|2|||
170464755|NCT02368314|616039899|FG001|Overall Study|Withdrawal by Subject|1|||
170464756|NCT02368314|616039898|FG000|Overall Study|Adverse Event|1|||
170464757|NCT02368314|616039899|FG001|Overall Study|Adverse Event|2|||
170464758|NCT01266031|616039900|FG000|Overall Study|Not treated|0|||
170464759|NCT01266031|616039901|FG001|Overall Study|Not treated|3|||
170464760|NCT01266031|616039902|FG002|Overall Study|Not treated|2|||
170464761|NCT01338870|616039906|FG000|Overall Study|Lost to Follow-up|0|||
170464762|NCT01338870|616039907|FG001|Overall Study|Lost to Follow-up|0|||
170464763|NCT01338870|616039908|FG002|Overall Study|Lost to Follow-up|1|||
170464764|NCT01338870|616039909|FG003|Overall Study|Lost to Follow-up|0|||
170464765|NCT01338870|616039910|FG004|Overall Study|Lost to Follow-up|1|||
170464766|NCT01338870|616039911|FG005|Overall Study|Lost to Follow-up|0|||
170464767|NCT01338870|616039906|FG000|Overall Study|Withdrawal by Subject|2|||
170464768|NCT01338870|616039907|FG001|Overall Study|Withdrawal by Subject|3|||
170464769|NCT01338870|616039908|FG002|Overall Study|Withdrawal by Subject|4|||
170464770|NCT01338870|616039909|FG003|Overall Study|Withdrawal by Subject|0|||
170464771|NCT01338870|616039910|FG004|Overall Study|Withdrawal by Subject|0|||
170464772|NCT01338870|616039911|FG005|Overall Study|Withdrawal by Subject|2|||
170464773|NCT01338870|616039906|FG000|Overall Study|Other|3|||
170464774|NCT01338870|616039907|FG001|Overall Study|Other|3|||
170464775|NCT01338870|616039908|FG002|Overall Study|Other|3|||
170464776|NCT01338870|616039909|FG003|Overall Study|Other|2|||
170464777|NCT01338870|616039910|FG004|Overall Study|Other|0|||
170464778|NCT01338870|616039911|FG005|Overall Study|Other|2|||
170464779|NCT01338870|616039906|FG000|Overall Study|Protocol Violation|0|||
170464780|NCT01338870|616039907|FG001|Overall Study|Protocol Violation|2|||
170464781|NCT01338870|616039908|FG002|Overall Study|Protocol Violation|2|||
170464782|NCT01338870|616039909|FG003|Overall Study|Protocol Violation|2|||
170464783|NCT01338870|616039910|FG004|Overall Study|Protocol Violation|1|||
170464784|NCT01338870|616039911|FG005|Overall Study|Protocol Violation|1|||
170464785|NCT01338870|616039906|FG000|Overall Study|Adverse Event|4|||
170464786|NCT01338870|616039907|FG001|Overall Study|Adverse Event|4|||
170464787|NCT01338870|616039908|FG002|Overall Study|Adverse Event|1|||
170464788|NCT01338870|616039909|FG003|Overall Study|Adverse Event|5|||
170464789|NCT01338870|616039910|FG004|Overall Study|Adverse Event|4|||
170464790|NCT01338870|616039911|FG005|Overall Study|Adverse Event|1|||
170464791|NCT01955083|616039912|FG000|Overall Study|Lost to Follow-up|1|||
170464792|NCT01955083|616039913|FG001|Overall Study|Lost to Follow-up|1|||
170464793|NCT02387983|616039916|FG000|Overall Study|Adverse Event|4|||
170464794|NCT02387983|616039916|FG000|Overall Study|Protocol Violation|1|||
170464795|NCT02387983|616039916|FG000|Overall Study|Withdrawal by Subject|2|||
170464796|NCT01268501|616039918|FG000|Overall Study|Lost to Follow-up|1|||
170464797|NCT01268501|616039918|FG000|Overall Study|Withdrawal by Subject|3|||
170464798|NCT01268501|616039918|FG000|Overall Study|Unacceptable Subjective Vision|3|||
170464799|NCT01268501|616039918|FG000|Overall Study|Handling Difficulties|2|||
170464800|NCT00530218|616039921|FG000|Overall Study|CMV Not Detected|13|||
170464801|NCT00530218|616039921|FG000|Overall Study|Death|12|||
170464802|NCT03477903|616039924|FG000|Overall Study|Study Terminated by Sponsor|1|||
170464803|NCT00206323|616039925|FG000|Overall Study|Lack of Efficacy|4|||
170464804|NCT00206323|616039926|FG001|Overall Study|Lack of Efficacy|1|||
170464805|NCT00206323|616039925|FG000|Overall Study|Adverse Event|1|||
170464806|NCT00206323|616039926|FG001|Overall Study|Adverse Event|1|||
170464807|NCT00206323|616039925|FG000|Overall Study|Lost to Follow-up|1|||
170464808|NCT00206323|616039926|FG001|Overall Study|Lost to Follow-up|1|||
170464809|NCT02910063|616039927|FG000|Phase 2|Withdrawal by Subject|3|||
170464810|NCT02910063|616039928|FG001|Phase 2|Withdrawal by Subject|0|||
170464811|NCT02910063|616039929|FG002|Phase 2|Withdrawal by Subject|0|||
170464812|NCT02910063|616039927|FG000|Phase 2|Lost to Follow-up|1|||
170464813|NCT02910063|616039928|FG001|Phase 2|Lost to Follow-up|0|||
170464814|NCT02910063|616039929|FG002|Phase 2|Lost to Follow-up|0|||
170464815|NCT02910063|616039927|FG000|Phase 2|Death|24|||
170464816|NCT02910063|616039928|FG001|Phase 2|Death|0|||
170464817|NCT02910063|616039929|FG002|Phase 2|Death|0|||
170464818|NCT00474266|616039930|FG000|Overall Study|Withdrawal by Subject|7|||
170464819|NCT00474266|616039931|FG001|Overall Study|Withdrawal by Subject|20|||
170464820|NCT00474266|616039932|FG002|Overall Study|Withdrawal by Subject|4|||
170464821|NCT00474266|616039933|FG003|Overall Study|Withdrawal by Subject|7|||
170464822|NCT06281171|616039936|FG000|Timepoint 2|Lost to Follow-up|6|||
170464823|NCT06281171|616039937|FG001|Timepoint 2|Lost to Follow-up|4|||
170464824|NCT06281171|616039936|FG000|Timepoint 3|Lost to Follow-up|0|||
170464825|NCT06281171|616039937|FG001|Timepoint 3|Lost to Follow-up|5|||
170464826|NCT01671332|616039938|FG000|Overall Study|Withdrawal by Subject|1|||
170464827|NCT01671332|616039939|FG001|Overall Study|Withdrawal by Subject|1|||
170464828|NCT04572893|616039940|FG000|Part A|Adverse Event|1|||
170464829|NCT04572893|616039941|FG001|Part A|Adverse Event|0|||
170464830|NCT04572893|616039942|FG002|Part A|Adverse Event|0|||
170464831|NCT04572893|616039943|FG003|Part A|Adverse Event|0|||
170464832|NCT04572893|616039944|FG004|Part A|Adverse Event|0|||
170464833|NCT04572893|616039945|FG005|Part A|Adverse Event|0|||
170464834|NCT04572893|616039946|FG006|Part A|Adverse Event|0|||
170464835|NCT04572893|616039940|FG000|Part B|Withdrawal by Subject|0|||
170464836|NCT04572893|616039941|FG001|Part B|Withdrawal by Subject|0|||
170464837|NCT04572893|616039942|FG002|Part B|Withdrawal by Subject|0|||
170464838|NCT04572893|616039943|FG003|Part B|Withdrawal by Subject|0|||
170464839|NCT04572893|616039944|FG004|Part B|Withdrawal by Subject|0|||
170464840|NCT04572893|616039945|FG005|Part B|Withdrawal by Subject|1|||
170464841|NCT04572893|616039946|FG006|Part B|Withdrawal by Subject|0|||
170464842|NCT04572893|616039940|FG000|Part B|Study terminated by sponsor|0|||
170464843|NCT04572893|616039941|FG001|Part B|Study terminated by sponsor|0|||
170464844|NCT04572893|616039942|FG002|Part B|Study terminated by sponsor|0|||
170464845|NCT04572893|616039943|FG003|Part B|Study terminated by sponsor|0|||
170464846|NCT04572893|616039944|FG004|Part B|Study terminated by sponsor|7|||
170464847|NCT04572893|616039945|FG005|Part B|Study terminated by sponsor|5|||
170464848|NCT04572893|616039946|FG006|Part B|Study terminated by sponsor|3|||
170464849|NCT04572893|616039940|FG000|Part B|Lost to Follow-up|0|||
170464850|NCT04572893|616039941|FG001|Part B|Lost to Follow-up|0|||
170464851|NCT04572893|616039942|FG002|Part B|Lost to Follow-up|0|||
170464852|NCT04572893|616039943|FG003|Part B|Lost to Follow-up|0|||
170464853|NCT04572893|616039944|FG004|Part B|Lost to Follow-up|0|||
170636870|NCT02405442|616682563|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
170464854|NCT04572893|616039945|FG005|Part B|Lost to Follow-up|0|||
170464855|NCT04572893|616039946|FG006|Part B|Lost to Follow-up|1|||
170464856|NCT04572893|616039940|FG000|Part B|Adverse Event|0|||
170464857|NCT04572893|616039941|FG001|Part B|Adverse Event|0|||
170464858|NCT04572893|616039942|FG002|Part B|Adverse Event|0|||
170464859|NCT04572893|616039943|FG003|Part B|Adverse Event|0|||
170464860|NCT04572893|616039944|FG004|Part B|Adverse Event|1|||
170464861|NCT04572893|616039945|FG005|Part B|Adverse Event|1|||
170636871|NCT02405442|616682564|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
170464862|NCT04572893|616039946|FG006|Part B|Adverse Event|0|||
170464863|NCT00477295|616039948|FG000|Overall Study|Adverse Event|31|||
170464864|NCT00477295|616039949|FG001|Overall Study|Adverse Event|35|||
170464865|NCT00477295|616039948|FG000|Overall Study|Withdrawal by Subject|35|||
170464866|NCT00477295|616039949|FG001|Overall Study|Withdrawal by Subject|24|||
170464867|NCT00477295|616039948|FG000|Overall Study|Lack of Efficacy|23|||
170464868|NCT00477295|616039949|FG001|Overall Study|Lack of Efficacy|23|||
170464869|NCT00477295|616039948|FG000|Overall Study|Protocol Violation|3|||
170464870|NCT00477295|616039949|FG001|Overall Study|Protocol Violation|8|||
170464871|NCT00477295|616039948|FG000|Overall Study|Physician Decision|4|||
170464872|NCT00477295|616039949|FG001|Overall Study|Physician Decision|5|||
170464873|NCT00477295|616039948|FG000|Overall Study|Lost to Follow-up|21|||
170464874|NCT00477295|616039949|FG001|Overall Study|Lost to Follow-up|11|||
170464875|NCT00477295|616039948|FG000|Overall Study|Other|4|||
170464876|NCT00477295|616039949|FG001|Overall Study|Other|3|||
170464877|NCT03276780|616039952|FG000|Overall Study|Withdrawal by Subject|5|||
170544674|NCT01807520|616337293|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
170544675|NCT01807520|616337294|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
170544676|NCT01807520|616337295|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
170544677|NCT01807520|616337289|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
170544678|NCT01807520|616337290|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
170544679|NCT01807520|616337291|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
170544680|NCT01807520|616337292|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
170544681|NCT01807520|616337293|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
170544682|NCT01807520|616337294|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
170544683|NCT01807520|616337295|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
170544684|NCT01807520|616337289|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
170544685|NCT01807520|616337290|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
170544686|NCT01807520|616337291|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
170544687|NCT01807520|616337292|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
170544688|NCT01807520|616337293|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
170544689|NCT01807520|616337294|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
170544690|NCT01807520|616337295|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
170544691|NCT01807520|616337289|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
170544692|NCT01807520|616337290|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
170544693|NCT01807520|616337291|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
170544694|NCT01807520|616337292|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
170544695|NCT01807520|616337293|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
170544696|NCT01807520|616337294|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
170544697|NCT01807520|616337295|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
170544698|NCT01807520|616337289|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
170544699|NCT01807520|616337290|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
170636872|NCT02405442|616682565|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
170636873|NCT02405442|616682566|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
170636874|NCT02405442|616682563|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
170636875|NCT02405442|616682564|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
170636876|NCT02405442|616682565|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
170636877|NCT02405442|616682566|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
170636878|NCT02405442|616682563|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
170636879|NCT02405442|616682564|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
170636880|NCT02405442|616682565|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
170636881|NCT02405442|616682566|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
170636882|NCT02405442|616682563|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
170636883|NCT02405442|616682564|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
170789911|NCT02714257|617242769|FG000|Overall Study|Withdrawal by Subject|6|||
170789912|NCT02714257|617242770|FG001|Overall Study|Withdrawal by Subject|11|||
170789913|NCT02714257|617242769|FG000|Overall Study|Death|3|||
170789914|NCT02714257|617242770|FG001|Overall Study|Death|4|||
170789915|NCT02714257|617242769|FG000|Overall Study|Lost to Follow-up|1|||
170789916|NCT02714257|617242770|FG001|Overall Study|Lost to Follow-up|6|||
170789917|NCT04248725|617242784|FG000|Post-Treatment|Lost to Follow-up|6|||
170789918|NCT04248725|617242785|FG001|Post-Treatment|Lost to Follow-up|5|||
170789919|NCT04248725|617242784|FG000|6-Month Follow Up|Lost to Follow-up|9|||
170789920|NCT04248725|617242785|FG001|6-Month Follow Up|Lost to Follow-up|8|||
170789921|NCT04436276|617242793|FG000|Overall Study|Adverse Event|0|||
170789922|NCT04436276|617242794|FG001|Overall Study|Adverse Event|0|||
170464878|NCT03276780|616039953|FG001|Overall Study|Withdrawal by Subject|3|||
170464879|NCT03276780|616039952|FG000|Overall Study|Lost to Follow-up|3|||
170464880|NCT03276780|616039953|FG001|Overall Study|Lost to Follow-up|5|||
170544700|NCT01807520|616337291|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
170544701|NCT01807520|616337292|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
170636884|NCT02405442|616682565|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
170789923|NCT04436276|617242795|FG002|Overall Study|Adverse Event|0|||
170464881|NCT03276780|616039952|FG000|Overall Study|Moved out of state|1|||
170544702|NCT01807520|616337293|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
170544703|NCT01807520|616337294|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
170544704|NCT01807520|616337295|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
170464882|NCT03276780|616039953|FG001|Overall Study|Moved out of state|1|||
170464883|NCT03276780|616039952|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
170464884|NCT03276780|616039953|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
170464885|NCT03276780|616039952|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
170464886|NCT03276780|616039953|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
170464887|NCT00510289|616039954|FG000|Overall Study|Withdrawal by Subject|7|||
170464888|NCT00510289|616039954|FG000|Overall Study|Refused bone marrow biopsy|2|||
170464889|NCT00510289|616039954|FG000|Overall Study|Lost to Follow-up|1|||
170464890|NCT00510289|616039954|FG000|Overall Study|Progressed prior to starting drug|2|||
170464891|NCT03835221|616039955|FG000|Methafilcon A|Withdrawal by Subject|1|||
170464892|NCT04240392|616041859|FG000|Overall Study|Withdrawal by Subject|13|||
170464893|NCT04240392|616041860|FG001|Overall Study|Withdrawal by Subject|4|||
170464894|NCT04240392|616041859|FG000|Overall Study|Lost to Follow-up|11|||
170464895|NCT04240392|616041860|FG001|Overall Study|Lost to Follow-up|12|||
170464896|NCT04345601|616041868|FG000|Overall Study|Death|0|||
170464897|NCT04345601|616041869|FG001|Overall Study|Death|3|||
170464898|NCT04345601|616041870|FG002|Overall Study|Death|2|||
170464899|NCT04345601|616041868|FG000|Overall Study|Lost to Follow-up|0|||
170464900|NCT04345601|616041869|FG001|Overall Study|Lost to Follow-up|0|||
170464901|NCT04345601|616041870|FG002|Overall Study|Lost to Follow-up|2|||
170464902|NCT00761657|616041871|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
170464903|NCT00761657|616041872|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
170464904|NCT00761657|616041873|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
170464905|NCT00761657|616041874|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
170464906|NCT00761657|616041875|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
170464907|NCT00761657|616041876|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
170464908|NCT00761657|616041877|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
170464909|NCT00761657|616041878|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
170464910|NCT00761657|616041879|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
170464911|NCT00761657|616041871|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
170464912|NCT00761657|616041872|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
170464913|NCT00761657|616041873|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
170464914|NCT00761657|616041874|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
170464915|NCT00761657|616041875|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
170464916|NCT00761657|616041876|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
170464917|NCT00761657|616041877|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
170464918|NCT00761657|616041878|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
170464919|NCT00761657|616041879|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
170464920|NCT00761657|616041871|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
170464921|NCT00761657|616041872|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
170464922|NCT00761657|616041873|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
170464923|NCT00761657|616041874|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
170464924|NCT00761657|616041875|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
170464925|NCT00761657|616041876|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
170464926|NCT00761657|616041877|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
170464927|NCT00761657|616041878|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
170636885|NCT02405442|616682566|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
170636886|NCT02405442|616682563|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
170636887|NCT02405442|616682564|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
170636888|NCT02405442|616682565|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
170636889|NCT02405442|616682566|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
170636890|NCT02405442|616682563|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
170636891|NCT02405442|616682564|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
170636892|NCT02405442|616682565|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
170636893|NCT02405442|616682566|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
170636894|NCT02405442|616682563|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
170636895|NCT02405442|616682564|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
170636896|NCT02405442|616682565|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
170636897|NCT02405442|616682566|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
170636898|NCT02405442|616682563|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
170636899|NCT02405442|616682564|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
170636900|NCT02405442|616682565|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
170636901|NCT02405442|616682566|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
170636902|NCT02405442|616682563|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
170789924|NCT04436276|617242796|FG003|Overall Study|Adverse Event|0|||
170789925|NCT04436276|617242797|FG004|Overall Study|Adverse Event|0|||
170464928|NCT00761657|616041879|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
170464929|NCT00761657|616041871|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
170789926|NCT04436276|617242798|FG005|Overall Study|Adverse Event|0|||
170464930|NCT00761657|616041872|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
170464931|NCT00761657|616041873|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
170464932|NCT00761657|616041874|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
170464933|NCT00761657|616041875|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
170464934|NCT00761657|616041876|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
170464935|NCT00761657|616041877|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
170464936|NCT00761657|616041878|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
170464937|NCT00761657|616041879|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
170464938|NCT00478244|616041883|FG000|Overall Study|Did not receive transplant|1|||
170464939|NCT00402116|616041888|FG000|Overall Study|Jaw infection after surgery-other|1|||
170464940|NCT00402116|616041889|FG001|Overall Study|Jaw infection after surgery-other|0|||
170464941|NCT00402116|616041890|FG002|Overall Study|Jaw infection after surgery-other|0|||
170464942|NCT00402116|616041888|FG000|Overall Study|Withdrawal by Subject|1|||
170464943|NCT00402116|616041889|FG001|Overall Study|Withdrawal by Subject|0|||
170464944|NCT00402116|616041890|FG002|Overall Study|Withdrawal by Subject|5|||
170464945|NCT00402116|616041888|FG000|Overall Study|Treatment completed per protocol|1|||
170464946|NCT00402116|616041889|FG001|Overall Study|Treatment completed per protocol|1|||
170464947|NCT00402116|616041890|FG002|Overall Study|Treatment completed per protocol|2|||
170464948|NCT00402116|616041888|FG000|Overall Study|other complicating disease|0|||
170464949|NCT00402116|616041889|FG001|Overall Study|other complicating disease|0|||
170464950|NCT00402116|616041890|FG002|Overall Study|other complicating disease|2|||
170464951|NCT00402116|616041888|FG000|Overall Study|Disease Progression|0|||
170464952|NCT00402116|616041889|FG001|Overall Study|Disease Progression|4|||
170464953|NCT00402116|616041890|FG002|Overall Study|Disease Progression|38|||
170464954|NCT00402116|616041888|FG000|Overall Study|mistaken thrombocytopenia|0|||
170464955|NCT00402116|616041889|FG001|Overall Study|mistaken thrombocytopenia|0|||
170464956|NCT00402116|616041890|FG002|Overall Study|mistaken thrombocytopenia|1|||
170464957|NCT00402116|616041888|FG000|Overall Study|decline related hyponatremia/tumor|0|||
170464958|NCT00402116|616041889|FG001|Overall Study|decline related hyponatremia/tumor|0|||
170464959|NCT00402116|616041890|FG002|Overall Study|decline related hyponatremia/tumor|1|||
170464960|NCT00402116|616041888|FG000|Overall Study|Adverse Event|0|||
170464961|NCT00402116|616041889|FG001|Overall Study|Adverse Event|1|||
170464962|NCT00402116|616041890|FG002|Overall Study|Adverse Event|6|||
170464963|NCT00270855|616041891|FG000|Overall Study|Withdrawal by Subject|8|||
170464964|NCT00270855|616041892|FG001|Overall Study|Withdrawal by Subject|8|||
170464965|NCT00450801|616041895|FG000|Overall Study|Death|1|||
170464966|NCT00587860|616041898|FG000|Overall Study|Lost to Follow-up|2|||
170464967|NCT00587860|616041899|FG001|Overall Study|Lost to Follow-up|2|||
170464968|NCT00587860|616041898|FG000|Overall Study|Withdrawal by Subject|3|||
170464969|NCT00587860|616041899|FG001|Overall Study|Withdrawal by Subject|3|||
170464970|NCT02618759|616041902|FG000|Overall Study|Lost to Follow-up|0|||
170544705|NCT01807520|616337289|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
170544706|NCT01807520|616337290|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
170544707|NCT01807520|616337291|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
170789927|NCT04436276|617242799|FG006|Overall Study|Adverse Event|0|||
170544708|NCT01807520|616337292|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
170544709|NCT01807520|616337293|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
170544710|NCT01807520|616337294|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
170544711|NCT01807520|616337295|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
170544712|NCT00620035|616337296|FG000|Overall Study|Adverse Event|106|||
170544713|NCT00620035|616337296|FG000|Overall Study|Withdrawal of Informed Consent|1|||
170544714|NCT00620035|616337296|FG000|Overall Study|Other Reason|38|||
170544715|NCT02400736|616337298|FG000|Overall Study|Lost to Follow-up|6|||
170544716|NCT02400736|616337299|FG001|Overall Study|Lost to Follow-up|6|||
170544717|NCT02400736|616337298|FG000|Overall Study|Withdrawal by Subject|2|||
170544718|NCT02400736|616337299|FG001|Overall Study|Withdrawal by Subject|1|||
170544719|NCT02400736|616337298|FG000|Overall Study|Moved from the area|3|||
170544720|NCT02400736|616337299|FG001|Overall Study|Moved from the area|1|||
170544721|NCT01002105|616337300|FG000|Overall Study|Lost to Follow-up|10|||
170544722|NCT01002105|616337301|FG001|Overall Study|Lost to Follow-up|16|||
170544723|NCT01002105|616337300|FG000|Overall Study|non compliance|5|||
170544724|NCT01002105|616337301|FG001|Overall Study|non compliance|3|||
170544725|NCT01002105|616337300|FG000|Overall Study|condition worsened|4|||
170544726|NCT01002105|616337301|FG001|Overall Study|condition worsened|2|||
170544727|NCT00456612|616337302|FG000|Overall Study|Withdrawal by Subject|3|||
170789928|NCT04436276|617242800|FG007|Overall Study|Adverse Event|0|||
170464971|NCT02618759|616041903|FG001|Overall Study|Lost to Follow-up|1|||
170464972|NCT02618759|616041902|FG000|Overall Study|Withdrawal by Subject|1|||
170464973|NCT02618759|616041903|FG001|Overall Study|Withdrawal by Subject|0|||
170464974|NCT02618759|616041902|FG000|Overall Study|Other Reasons|1|||
170464975|NCT02618759|616041903|FG001|Overall Study|Other Reasons|4|||
170464976|NCT02500043|616041904|FG000|Overall Study|Randomized, but not Treated|2|||
170464977|NCT02500043|616041905|FG001|Overall Study|Randomized, but not Treated|2|||
170464978|NCT02500043|616041904|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
170544728|NCT02316613|616337305|FG000|Overall Study|Death|63|||
170544729|NCT02316613|616337305|FG000|Overall Study|Lost to Follow-up|9|||
170544730|NCT02316613|616337305|FG000|Overall Study|Lymphoma transformation|2|||
170789929|NCT04436276|617242801|FG008|Overall Study|Adverse Event|0|||
170464979|NCT02500043|616041905|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
170464980|NCT02500043|616041904|FG000|Overall Study|Adverse Event|33|||
170464981|NCT02500043|616041905|FG001|Overall Study|Adverse Event|11|||
170464982|NCT02500043|616041904|FG000|Overall Study|Clinical Progression|54|||
170464983|NCT02500043|616041905|FG001|Overall Study|Clinical Progression|35|||
170464984|NCT02500043|616041904|FG000|Overall Study|Radiological Progression|192|||
170464985|NCT02500043|616041905|FG001|Overall Study|Radiological Progression|110|||
170464986|NCT02500043|616041904|FG000|Overall Study|Physician's Decision|11|||
170464987|NCT02500043|616041905|FG001|Overall Study|Physician's Decision|3|||
170464988|NCT02500043|616041904|FG000|Overall Study|Withdrawal by Subject|14|||
170464989|NCT02500043|616041905|FG001|Overall Study|Withdrawal by Subject|4|||
170464990|NCT02500043|616041904|FG000|Overall Study|Death|11|||
170464991|NCT02500043|616041905|FG001|Overall Study|Death|2|||
170464992|NCT02500043|616041904|FG000|Overall Study|Protocol Deviation|1|||
170464993|NCT02500043|616041905|FG001|Overall Study|Protocol Deviation|0|||
170464994|NCT02065700|616041909|FG000|Overall Study|Adverse Event|165|||
170464995|NCT02065700|616041910|FG001|Overall Study|Adverse Event|101|||
170464996|NCT02065700|616041909|FG000|Overall Study|Withdrawal by Subject|90|||
170464997|NCT02065700|616041910|FG001|Overall Study|Withdrawal by Subject|29|||
170464998|NCT02065700|616041909|FG000|Overall Study|Lost to Follow-up|12|||
170464999|NCT02065700|616041910|FG001|Overall Study|Lost to Follow-up|9|||
170465000|NCT02065700|616041909|FG000|Overall Study|Physician Decision|2|||
170465001|NCT02065700|616041910|FG001|Overall Study|Physician Decision|0|||
170465002|NCT02065700|616041909|FG000|Overall Study|Sponsor Request|38|||
170465003|NCT02065700|616041910|FG001|Overall Study|Sponsor Request|15|||
170465004|NCT02065700|616041909|FG000|Overall Study|Treatment Failure|3|||
170465005|NCT02065700|616041910|FG001|Overall Study|Treatment Failure|2|||
170465006|NCT02065700|616041909|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
170465007|NCT02065700|616041910|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
170544731|NCT02316613|616337305|FG000|Overall Study|Participant moved/changed medical team|11|||
170544732|NCT02316613|616337305|FG000|Overall Study|No data and duplicate cases|5|||
170544733|NCT02316613|616337305|FG000|Overall Study|Did not met selection criteria|14|||
170544734|NCT01108796|616337306|FG000|Overall Study|Adverse Event|0|||
170544735|NCT01108796|616337307|FG001|Overall Study|Adverse Event|1|||
170544736|NCT01108796|616337306|FG000|Overall Study|Lost to Follow-up|7|||
170544737|NCT01108796|616337307|FG001|Overall Study|Lost to Follow-up|6|||
170544738|NCT02545127|616337308|FG000|Overall Study|Lost to Follow-up|1|||
170544739|NCT02545127|616337309|FG001|Overall Study|Lost to Follow-up|0|||
170544740|NCT03309605|616337312|FG000|Overall Study|Adverse Event|0|||
170544741|NCT03309605|616337313|FG001|Overall Study|Adverse Event|0|||
170544742|NCT03309605|616337314|FG002|Overall Study|Adverse Event|0|||
170544743|NCT03309605|616337315|FG003|Overall Study|Adverse Event|1|||
170544744|NCT03309605|616337316|FG004|Overall Study|Adverse Event|0|||
170544745|NCT03309605|616337317|FG005|Overall Study|Adverse Event|0|||
170544746|NCT03309605|616337318|FG006|Overall Study|Adverse Event|2|||
170544747|NCT03309605|616337319|FG007|Overall Study|Adverse Event|1|||
170544748|NCT03309605|616337312|FG000|Overall Study|Withdrawal by Subject|0|||
170544749|NCT03309605|616337313|FG001|Overall Study|Withdrawal by Subject|0|||
170544750|NCT03309605|616337314|FG002|Overall Study|Withdrawal by Subject|0|||
170544751|NCT03309605|616337315|FG003|Overall Study|Withdrawal by Subject|0|||
170544752|NCT03309605|616337316|FG004|Overall Study|Withdrawal by Subject|1|||
170544753|NCT03309605|616337317|FG005|Overall Study|Withdrawal by Subject|0|||
170544754|NCT03309605|616337318|FG006|Overall Study|Withdrawal by Subject|1|||
170544755|NCT03309605|616337319|FG007|Overall Study|Withdrawal by Subject|1|||
170544756|NCT04828486|616337324|FG000|Overall Study|Adverse Event|2|||
170544757|NCT04828486|616337324|FG000|Overall Study|Death|1|||
170544758|NCT04828486|616337324|FG000|Overall Study|Disease Progression|8|||
170544759|NCT04828486|616337324|FG000|Overall Study|Other Complicating Disease|1|||
170544760|NCT04828486|616337324|FG000|Overall Study|Withdrawal by Subject|1|||
170544761|NCT02063724|616337325|FG000|Overall Study|Disease progression|1|||
170544762|NCT06204887|616337326|FG000|Overall Study|Lost to Follow-up|3|||
170465008|NCT02065700|616041909|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
170465009|NCT02065700|616041910|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
170465010|NCT02065700|616041909|FG000|Overall Study|Non-compliance with Study Procedures|2|||
170465011|NCT02065700|616041910|FG001|Overall Study|Non-compliance with Study Procedures|0|||
170544763|NCT06204887|616337327|FG001|Overall Study|Lost to Follow-up|4|||
170465012|NCT02065700|616041909|FG000|Overall Study|Not Defined|21|||
170544764|NCT06204887|616337328|FG002|Overall Study|Lost to Follow-up|1|||
170544765|NCT06204887|616337329|FG003|Overall Study|Lost to Follow-up|6|||
170544766|NCT03767894|616337330|FG000|Overall Study|Withdrawal by Subject|1|||
170544767|NCT02068599|616337331|FG000|Overall Study|Adverse Event|4|||
170544768|NCT02068599|616337332|FG001|Overall Study|Adverse Event|1|||
170465013|NCT02065700|616041910|FG001|Overall Study|Not Defined|3|||
170544769|NCT02068599|616337333|FG002|Overall Study|Adverse Event|1|||
170544770|NCT02068599|616337331|FG000|Overall Study|Withdrawal by Subject|2|||
170544771|NCT02068599|616337332|FG001|Overall Study|Withdrawal by Subject|7|||
170544772|NCT02068599|616337333|FG002|Overall Study|Withdrawal by Subject|5|||
170544773|NCT02068599|616337331|FG000|Overall Study|Protocol Violation|4|||
170465014|NCT01635218|616041911|FG000|Overall Study|Lost to Follow-up|3|||
170465015|NCT01635218|616041912|FG001|Overall Study|Lost to Follow-up|7|||
170465016|NCT01635218|616041913|FG002|Overall Study|Lost to Follow-up|6|||
170465017|NCT03146962|616041914|FG000|Overall Study|Lost to Follow-up|1|||
170465018|NCT03146962|616041915|FG001|Overall Study|Lost to Follow-up|1|||
170465019|NCT03146962|616041916|FG002|Overall Study|Lost to Follow-up|0|||
170465020|NCT03146962|616041917|FG003|Overall Study|Lost to Follow-up|0|||
170465021|NCT03146962|616041918|FG004|Overall Study|Lost to Follow-up|0|||
170465022|NCT03146962|616041919|FG005|Overall Study|Lost to Follow-up|0|||
170544774|NCT02068599|616337332|FG001|Overall Study|Protocol Violation|2|||
170465023|NCT03146962|616041920|FG006|Overall Study|Lost to Follow-up|0|||
170544775|NCT02068599|616337333|FG002|Overall Study|Protocol Violation|3|||
170544776|NCT02068599|616337331|FG000|Overall Study|Lost to Follow-up|1|||
170544777|NCT02068599|616337332|FG001|Overall Study|Lost to Follow-up|0|||
170544778|NCT02068599|616337333|FG002|Overall Study|Lost to Follow-up|0|||
170544779|NCT02068599|616337331|FG000|Overall Study|Lack of Efficacy|0|||
170544780|NCT02068599|616337332|FG001|Overall Study|Lack of Efficacy|0|||
170544781|NCT02068599|616337333|FG002|Overall Study|Lack of Efficacy|3|||
170544782|NCT02068599|616337331|FG000|Overall Study|Noncompliance|0|||
170544783|NCT02068599|616337332|FG001|Overall Study|Noncompliance|0|||
170544784|NCT02068599|616337333|FG002|Overall Study|Noncompliance|1|||
170544785|NCT03019588|616337334|FG000|Overall Study|Death|44|||
170544786|NCT03019588|616337335|FG001|Overall Study|Death|46|||
170544787|NCT03019588|616337334|FG000|Overall Study|Study terminated by Sponsor|3|||
170544788|NCT03019588|616337335|FG001|Overall Study|Study terminated by Sponsor|1|||
170544789|NCT06042855|616337340|FG000|Overall Study|No Receipt of Study Drug|48|||
170544790|NCT06042855|616337341|FG001|Overall Study|No Receipt of Study Drug|57|||
170544791|NCT06042855|616337340|FG000|Overall Study|Administratively Withdrawn|59|||
170544792|NCT06042855|616337341|FG001|Overall Study|Administratively Withdrawn|59|||
170544793|NCT00294398|616337342|FG000|Overall Study|Lost to Follow-up|21|||
170544794|NCT00294398|616337343|FG001|Overall Study|Lost to Follow-up|26|||
170544795|NCT03753542|616337344|FG000|Overall Study|Lost to Follow-up|9|||
170544796|NCT03753542|616337345|FG001|Overall Study|Lost to Follow-up|14|||
170544797|NCT01685437|616337352|FG000|Overall Study|Withdrawal by Subject|22|||
170544798|NCT01685437|616337352|FG000|Overall Study|Lost to Follow-up|3|||
170544799|NCT01685437|616337352|FG000|Overall Study|Adverse Event|1|||
170544800|NCT01685437|616337352|FG000|Overall Study|Protocol Violation|4|||
170544801|NCT01685437|616337352|FG000|Overall Study|Unable to make visits due to work|1|||
170544802|NCT02114684|616337353|FG000|Overall Study|Death|6|||
170544803|NCT02114684|616337354|FG001|Overall Study|Death|4|||
170544804|NCT02114684|616337353|FG000|Overall Study|Lost to Follow-up|1|||
170544805|NCT02114684|616337354|FG001|Overall Study|Lost to Follow-up|2|||
170544806|NCT02114684|616337353|FG000|Overall Study|Withdrawal by Subject|1|||
170544807|NCT02114684|616337354|FG001|Overall Study|Withdrawal by Subject|2|||
170544808|NCT02114684|616337353|FG000|Overall Study|Relocation|3|||
170544809|NCT02114684|616337354|FG001|Overall Study|Relocation|1|||
170544810|NCT02114684|616337353|FG000|Overall Study|Rifampicin resistant on culture|0|||
170544811|NCT02114684|616337354|FG001|Overall Study|Rifampicin resistant on culture|1|||
170544812|NCT02114684|616337353|FG000|Overall Study|Patient Incarcerated|1|||
170544813|NCT02114684|616337354|FG001|Overall Study|Patient Incarcerated|0|||
170544814|NCT02530242|616337355|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
170544815|NCT02530242|616337356|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
170544816|NCT02665455|616337357|FG000|Overall Study|Withdrawal by Subject|6|||
170544817|NCT02665455|616337357|FG000|Overall Study|Lost to Follow-up|1|||
170544818|NCT02665455|616337357|FG000|Overall Study|Adverse Event|1|||
170544819|NCT02665455|616337357|FG000|Overall Study|Protocol Violation|1|||
170544820|NCT03787212|616339324|FG000|Period 1|Study Termination|2|||
170544821|NCT03787212|616339325|FG001|Period 1|Study Termination|2|||
170544822|NCT01778985|616339331|FG000|Overall Study|Lost to Follow-up|1|||
170544823|NCT01778985|616339332|FG001|Overall Study|Lost to Follow-up|0|||
170544824|NCT01778985|616339331|FG000|Overall Study|Physician Decision|2|||
170465024|NCT03146962|616041921|FG007|Overall Study|Lost to Follow-up|0|||
170465025|NCT03146962|616041922|FG008|Overall Study|Lost to Follow-up|0|||
170544825|NCT01778985|616339332|FG001|Overall Study|Physician Decision|2|||
170544826|NCT01778985|616339331|FG000|Overall Study|Protocol Violation|4|||
170544827|NCT01778985|616339332|FG001|Overall Study|Protocol Violation|1|||
170544828|NCT00088881|616339334|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
170544829|NCT00088881|616339334|FG000|Step 1 - R-CHOP|Adverse Event|1|||
170544830|NCT00088881|616339334|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
170544831|NCT00088881|616339334|FG000|Step 1 - R-CHOP|Physician Decision|1|||
170544832|NCT00088881|616339334|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
170544833|NCT00088881|616339334|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
170465026|NCT03146962|616041923|FG009|Overall Study|Lost to Follow-up|0|||
170465027|NCT03146962|616041914|FG000|Overall Study|Adverse Event|0|||
170465028|NCT03146962|616041915|FG001|Overall Study|Adverse Event|3|||
170544834|NCT00088881|616339334|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
170544835|NCT02370394|616339342|FG000|Overall Study|Lost to Follow-up|2|||
170544836|NCT02370394|616339343|FG001|Overall Study|Lost to Follow-up|1|||
170544837|NCT02370394|616339342|FG000|Overall Study|Withdrawal by Subject|0|||
170465029|NCT03146962|616041916|FG002|Overall Study|Adverse Event|0|||
170465030|NCT03146962|616041917|FG003|Overall Study|Adverse Event|0|||
170465031|NCT03146962|616041918|FG004|Overall Study|Adverse Event|0|||
170465032|NCT03146962|616041919|FG005|Overall Study|Adverse Event|0|||
170465033|NCT03146962|616041920|FG006|Overall Study|Adverse Event|0|||
170465034|NCT03146962|616041921|FG007|Overall Study|Adverse Event|1|||
170465035|NCT03146962|616041922|FG008|Overall Study|Adverse Event|0|||
170465036|NCT03146962|616041923|FG009|Overall Study|Adverse Event|0|||
170465037|NCT03146962|616041914|FG000|Overall Study|Withdrawal by Subject|0|||
170465038|NCT03146962|616041915|FG001|Overall Study|Withdrawal by Subject|0|||
170465039|NCT03146962|616041916|FG002|Overall Study|Withdrawal by Subject|0|||
170465040|NCT03146962|616041917|FG003|Overall Study|Withdrawal by Subject|0|||
170465041|NCT03146962|616041918|FG004|Overall Study|Withdrawal by Subject|1|||
170465042|NCT03146962|616041919|FG005|Overall Study|Withdrawal by Subject|0|||
170465043|NCT03146962|616041920|FG006|Overall Study|Withdrawal by Subject|0|||
170465044|NCT03146962|616041921|FG007|Overall Study|Withdrawal by Subject|0|||
170465045|NCT03146962|616041922|FG008|Overall Study|Withdrawal by Subject|0|||
170465046|NCT03146962|616041923|FG009|Overall Study|Withdrawal by Subject|0|||
170465047|NCT03146962|616041914|FG000|Overall Study|Death|0|||
170465048|NCT03146962|616041915|FG001|Overall Study|Death|1|||
170465049|NCT03146962|616041916|FG002|Overall Study|Death|0|||
170465050|NCT03146962|616041917|FG003|Overall Study|Death|0|||
170465051|NCT03146962|616041918|FG004|Overall Study|Death|0|||
170465052|NCT03146962|616041919|FG005|Overall Study|Death|0|||
170789930|NCT04436276|617242802|FG009|Overall Study|Adverse Event|0|||
170789931|NCT04436276|617242803|FG010|Overall Study|Adverse Event|0|||
170789932|NCT04436276|617242804|FG011|Overall Study|Adverse Event|0|||
170789933|NCT04436276|617242805|FG012|Overall Study|Adverse Event|0|||
170789934|NCT04436276|617242806|FG013|Overall Study|Adverse Event|0|||
170789935|NCT04436276|617242807|FG014|Overall Study|Adverse Event|0|||
170789936|NCT04436276|617242808|FG015|Overall Study|Adverse Event|0|||
170789937|NCT04436276|617242809|FG016|Overall Study|Adverse Event|1|||
170789938|NCT04436276|617242810|FG017|Overall Study|Adverse Event|0|||
170789939|NCT04436276|617242811|FG018|Overall Study|Adverse Event|0|||
170789940|NCT04436276|617242812|FG019|Overall Study|Adverse Event|0|||
170789941|NCT04436276|617242813|FG020|Overall Study|Adverse Event|0|||
170789942|NCT04436276|617242814|FG021|Overall Study|Adverse Event|0|||
170789943|NCT04436276|617242815|FG022|Overall Study|Adverse Event|0|||
170789944|NCT04436276|617242793|FG000|Overall Study|Death|0|||
170789945|NCT04436276|617242794|FG001|Overall Study|Death|0|||
170789946|NCT04436276|617242795|FG002|Overall Study|Death|0|||
170789947|NCT04436276|617242796|FG003|Overall Study|Death|0|||
170789948|NCT04436276|617242797|FG004|Overall Study|Death|0|||
170789949|NCT04436276|617242798|FG005|Overall Study|Death|0|||
170789950|NCT04436276|617242799|FG006|Overall Study|Death|0|||
170789951|NCT04436276|617242800|FG007|Overall Study|Death|0|||
170789952|NCT04436276|617242801|FG008|Overall Study|Death|0|||
170789953|NCT04436276|617242802|FG009|Overall Study|Death|0|||
170789954|NCT04436276|617242803|FG010|Overall Study|Death|0|||
170789955|NCT04436276|617242804|FG011|Overall Study|Death|0|||
170789956|NCT04436276|617242805|FG012|Overall Study|Death|1|||
170789957|NCT04436276|617242806|FG013|Overall Study|Death|0|||
170789958|NCT04436276|617242807|FG014|Overall Study|Death|1|||
170789959|NCT04436276|617242808|FG015|Overall Study|Death|0|||
170789960|NCT04436276|617242809|FG016|Overall Study|Death|0|||
170789961|NCT04436276|617242810|FG017|Overall Study|Death|0|||
170789962|NCT04436276|617242811|FG018|Overall Study|Death|0|||
170789963|NCT04436276|617242812|FG019|Overall Study|Death|2|||
170789964|NCT04436276|617242813|FG020|Overall Study|Death|0|||
170465053|NCT03146962|616041920|FG006|Overall Study|Death|0|||
170465054|NCT03146962|616041921|FG007|Overall Study|Death|0|||
170465055|NCT03146962|616041922|FG008|Overall Study|Death|0|||
170465056|NCT03146962|616041923|FG009|Overall Study|Death|0|||
170465057|NCT03146962|616041914|FG000|Overall Study|COVID Precautions|1|||
170465058|NCT03146962|616041915|FG001|Overall Study|COVID Precautions|0|||
170465059|NCT03146962|616041916|FG002|Overall Study|COVID Precautions|0|||
170890442|NCT04537208|617606479|FG007|Overall Study|Withdrawal by Subject|1|||
170890443|NCT04537208|617606480|FG008|Overall Study|Withdrawal by Subject|7|||
170465060|NCT03146962|616041917|FG003|Overall Study|COVID Precautions|0|||
170465061|NCT03146962|616041918|FG004|Overall Study|COVID Precautions|0|||
170465062|NCT03146962|616041919|FG005|Overall Study|COVID Precautions|0|||
170465063|NCT03146962|616041920|FG006|Overall Study|COVID Precautions|0|||
170465064|NCT03146962|616041921|FG007|Overall Study|COVID Precautions|0|||
170465065|NCT03146962|616041922|FG008|Overall Study|COVID Precautions|0|||
170465066|NCT03146962|616041923|FG009|Overall Study|COVID Precautions|0|||
170465067|NCT03146962|616041914|FG000|Overall Study|Physician Decision|0|||
170789965|NCT04436276|617242814|FG021|Overall Study|Death|1|||
170789966|NCT04436276|617242815|FG022|Overall Study|Death|0|||
170789967|NCT04436276|617242793|FG000|Overall Study|Lost to Follow-up|0|||
170789968|NCT04436276|617242794|FG001|Overall Study|Lost to Follow-up|2|||
170789969|NCT04436276|617242795|FG002|Overall Study|Lost to Follow-up|2|||
170789970|NCT04436276|617242796|FG003|Overall Study|Lost to Follow-up|1|||
170789971|NCT04436276|617242797|FG004|Overall Study|Lost to Follow-up|4|||
170465068|NCT03146962|616041915|FG001|Overall Study|Physician Decision|0|||
170465069|NCT03146962|616041916|FG002|Overall Study|Physician Decision|0|||
170465070|NCT03146962|616041917|FG003|Overall Study|Physician Decision|0|||
170465071|NCT03146962|616041918|FG004|Overall Study|Physician Decision|0|||
170465072|NCT03146962|616041919|FG005|Overall Study|Physician Decision|0|||
170465073|NCT03146962|616041920|FG006|Overall Study|Physician Decision|0|||
170465074|NCT03146962|616041921|FG007|Overall Study|Physician Decision|0|||
170465075|NCT03146962|616041922|FG008|Overall Study|Physician Decision|0|||
170465076|NCT03146962|616041923|FG009|Overall Study|Physician Decision|1|||
170465077|NCT03146962|616041914|FG000|Overall Study|Started New Treatment|0|||
170465078|NCT03146962|616041915|FG001|Overall Study|Started New Treatment|1|||
170465079|NCT03146962|616041916|FG002|Overall Study|Started New Treatment|0|||
170465080|NCT03146962|616041917|FG003|Overall Study|Started New Treatment|0|||
170465081|NCT03146962|616041918|FG004|Overall Study|Started New Treatment|0|||
170465082|NCT03146962|616041919|FG005|Overall Study|Started New Treatment|0|||
170465083|NCT03146962|616041920|FG006|Overall Study|Started New Treatment|0|||
170465084|NCT03146962|616041921|FG007|Overall Study|Started New Treatment|0|||
170465085|NCT03146962|616041922|FG008|Overall Study|Started New Treatment|0|||
170465086|NCT03146962|616041923|FG009|Overall Study|Started New Treatment|0|||
170465087|NCT01934335|616041926|FG000|Overall Study|Withdrawal by Subject|1|||
170465088|NCT01934335|616041927|FG001|Overall Study|Withdrawal by Subject|1|||
170465089|NCT01111825|616041928|FG000|Overall Study|Withdrawal by Subject|0|||
170465090|NCT01111825|616041929|FG001|Overall Study|Withdrawal by Subject|0|||
170465091|NCT01111825|616041930|FG002|Overall Study|Withdrawal by Subject|1|||
170465092|NCT01111825|616041931|FG003|Overall Study|Withdrawal by Subject|0|||
170465093|NCT01111825|616041928|FG000|Overall Study|Lost to Follow-up|0|||
170465094|NCT01111825|616041929|FG001|Overall Study|Lost to Follow-up|0|||
170465095|NCT01111825|616041930|FG002|Overall Study|Lost to Follow-up|3|||
170465096|NCT01111825|616041931|FG003|Overall Study|Lost to Follow-up|1|||
170465097|NCT01111825|616041928|FG000|Overall Study|Adverse Event|2|||
170465098|NCT01111825|616041929|FG001|Overall Study|Adverse Event|1|||
170465099|NCT01111825|616041930|FG002|Overall Study|Adverse Event|4|||
170465100|NCT01111825|616041931|FG003|Overall Study|Adverse Event|0|||
170465101|NCT01111825|616041928|FG000|Overall Study|Disease Progression|1|||
170465102|NCT01111825|616041929|FG001|Overall Study|Disease Progression|0|||
170465103|NCT01111825|616041930|FG002|Overall Study|Disease Progression|0|||
170465104|NCT01111825|616041931|FG003|Overall Study|Disease Progression|0|||
170465105|NCT01111825|616041928|FG000|Overall Study|Discontinuation by Sponsor|0|||
170465106|NCT01111825|616041929|FG001|Overall Study|Discontinuation by Sponsor|0|||
170465107|NCT01111825|616041930|FG002|Overall Study|Discontinuation by Sponsor|0|||
170465108|NCT01111825|616041931|FG003|Overall Study|Discontinuation by Sponsor|20|||
170636903|NCT02405442|616682564|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
170636904|NCT02405442|616682565|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
170636905|NCT02405442|616682566|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
170636906|NCT01499277|616682568|FG000|Overall Study|Adverse Event|3|||
170636907|NCT01499277|616682569|FG001|Overall Study|Adverse Event|6|||
170636908|NCT01499277|616682568|FG000|Overall Study|Death|3|||
170636909|NCT01499277|616682569|FG001|Overall Study|Death|2|||
170636910|NCT01499277|616682568|FG000|Overall Study|Lost to Follow-up|15|||
170465109|NCT00168818|616041932|FG000|Overall Study|Adverse Event|23|||
170465110|NCT00168818|616041933|FG001|Overall Study|Adverse Event|29|||
170465111|NCT00168818|616041934|FG002|Overall Study|Adverse Event|31|||
170465112|NCT00168818|616041932|FG000|Overall Study|Protocol Violation|16|||
170465113|NCT00168818|616041933|FG001|Overall Study|Protocol Violation|11|||
170465114|NCT00168818|616041934|FG002|Overall Study|Protocol Violation|11|||
170465115|NCT00168818|616041932|FG000|Overall Study|Lost to Follow-up|13|||
170465116|NCT00168818|616041933|FG001|Overall Study|Lost to Follow-up|4|||
170465117|NCT00168818|616041934|FG002|Overall Study|Lost to Follow-up|15|||
170465118|NCT00168818|616041932|FG000|Overall Study|Withdrawal by Subject|43|||
170465119|NCT00168818|616041933|FG001|Overall Study|Withdrawal by Subject|41|||
170465120|NCT00168818|616041934|FG002|Overall Study|Withdrawal by Subject|37|||
170465121|NCT00168818|616041932|FG000|Overall Study|Other|22|||
170465122|NCT00168818|616041933|FG001|Overall Study|Other|24|||
170465123|NCT00168818|616041934|FG002|Overall Study|Other|30|||
170465124|NCT00168818|616041932|FG000|Treatment|Adverse Event|77|||
170465125|NCT00168818|616041933|FG001|Treatment|Adverse Event|89|||
170465126|NCT00168818|616041934|FG002|Treatment|Adverse Event|68|||
170789972|NCT04436276|617242798|FG005|Overall Study|Lost to Follow-up|1|||
170789973|NCT04436276|617242799|FG006|Overall Study|Lost to Follow-up|0|||
170465127|NCT00168818|616041932|FG000|Treatment|Protocol Violation|8|||
170465128|NCT00168818|616041933|FG001|Treatment|Protocol Violation|11|||
170465129|NCT00168818|616041934|FG002|Treatment|Protocol Violation|11|||
170465130|NCT00168818|616041932|FG000|Treatment|Lost to Follow-up|0|||
170789974|NCT04436276|617242800|FG007|Overall Study|Lost to Follow-up|0|||
170465131|NCT00168818|616041933|FG001|Treatment|Lost to Follow-up|2|||
170465132|NCT00168818|616041934|FG002|Treatment|Lost to Follow-up|1|||
170465133|NCT00168818|616041932|FG000|Treatment|Withdrawal by Subject|25|||
170465134|NCT00168818|616041933|FG001|Treatment|Withdrawal by Subject|20|||
170636911|NCT01499277|616682569|FG001|Overall Study|Lost to Follow-up|8|||
170465135|NCT00168818|616041934|FG002|Treatment|Withdrawal by Subject|22|||
170789975|NCT04436276|617242801|FG008|Overall Study|Lost to Follow-up|1|||
170789976|NCT04436276|617242802|FG009|Overall Study|Lost to Follow-up|0|||
170789977|NCT04436276|617242803|FG010|Overall Study|Lost to Follow-up|5|||
170789978|NCT04436276|617242804|FG011|Overall Study|Lost to Follow-up|5|||
170789979|NCT04436276|617242805|FG012|Overall Study|Lost to Follow-up|4|||
170465136|NCT00168818|616041932|FG000|Treatment|Other|23|||
170465137|NCT00168818|616041933|FG001|Treatment|Other|29|||
170465138|NCT00168818|616041934|FG002|Treatment|Other|31|||
170465139|NCT00469144|616041935|FG000|Overall Study|Death|0|||
170465140|NCT00469144|616041936|FG001|Overall Study|Death|1|||
170465141|NCT00469144|616041935|FG000|Overall Study|No Response|5|||
170465142|NCT00469144|616041936|FG001|Overall Study|No Response|5|||
170465143|NCT00469144|616041935|FG000|Overall Study|Progressive Disease|1|||
170465144|NCT00469144|616041936|FG001|Overall Study|Progressive Disease|0|||
170465145|NCT01775189|616041937|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170465146|NCT01775189|616041938|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
170789980|NCT04436276|617242806|FG013|Overall Study|Lost to Follow-up|1|||
170789981|NCT04436276|617242807|FG014|Overall Study|Lost to Follow-up|7|||
170465147|NCT01775189|616041939|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170465148|NCT01775189|616041940|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170465149|NCT01775189|616041941|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170465150|NCT01775189|616041942|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170465151|NCT01775189|616041943|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
170465152|NCT01775189|616041937|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170465153|NCT01775189|616041938|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
170465154|NCT01775189|616041939|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170465155|NCT01775189|616041940|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170465156|NCT01775189|616041941|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170465157|NCT01775189|616041942|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170465158|NCT01775189|616041943|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
170465159|NCT01775189|616041937|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
170465160|NCT01775189|616041938|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
170465161|NCT01775189|616041939|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
170465162|NCT01775189|616041940|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
170465163|NCT01775189|616041941|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
170465164|NCT01775189|616041942|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
170465165|NCT01775189|616041943|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
170465166|NCT01775189|616041937|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
170465167|NCT01775189|616041938|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
170465168|NCT01775189|616041939|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
170465169|NCT01775189|616041940|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
170465170|NCT01775189|616041941|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
170465171|NCT01775189|616041942|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
170465172|NCT01775189|616041943|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
170465173|NCT01775189|616041937|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
170465174|NCT01775189|616041938|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
170544838|NCT02370394|616339343|FG001|Overall Study|Withdrawal by Subject|1|||
170544839|NCT00552058|616339346|FG000|Overall Study|Adverse Event|8|||
170544840|NCT00552058|616339347|FG001|Overall Study|Adverse Event|7|||
170544841|NCT00552058|616339346|FG000|Overall Study|Lack of Efficacy|1|||
170544842|NCT00552058|616339347|FG001|Overall Study|Lack of Efficacy|5|||
170544843|NCT00552058|616339346|FG000|Overall Study|Lost to Follow-up|1|||
170544844|NCT00552058|616339347|FG001|Overall Study|Lost to Follow-up|0|||
170544845|NCT00552058|616339346|FG000|Overall Study|Withdrawal by Subject|4|||
170544846|NCT00552058|616339347|FG001|Overall Study|Withdrawal by Subject|4|||
170544847|NCT00552058|616339346|FG000|Overall Study|Other: Protocol Violation|0|||
170544848|NCT00552058|616339347|FG001|Overall Study|Other: Protocol Violation|1|||
170544849|NCT00552058|616339346|FG000|Overall Study|Other: Non Compliance|1|||
170789982|NCT04436276|617242808|FG015|Overall Study|Lost to Follow-up|7|||
170544850|NCT00552058|616339347|FG001|Overall Study|Other: Non Compliance|2|||
170544851|NCT00552058|616339346|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
170789983|NCT04436276|617242809|FG016|Overall Study|Lost to Follow-up|1|||
170789984|NCT04436276|617242810|FG017|Overall Study|Lost to Follow-up|0|||
170789985|NCT04436276|617242811|FG018|Overall Study|Lost to Follow-up|1|||
170465175|NCT01775189|616041939|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
170465176|NCT01775189|616041940|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
170465177|NCT01775189|616041941|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
170465178|NCT01775189|616041942|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
170544852|NCT00552058|616339347|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
170544853|NCT00552058|616339346|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
170544854|NCT00552058|616339347|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
170789986|NCT04436276|617242812|FG019|Overall Study|Lost to Follow-up|1|||
170789987|NCT04436276|617242813|FG020|Overall Study|Lost to Follow-up|2|||
170789988|NCT04436276|617242814|FG021|Overall Study|Lost to Follow-up|1|||
170789989|NCT04436276|617242815|FG022|Overall Study|Lost to Follow-up|1|||
170789990|NCT04436276|617242793|FG000|Overall Study|Physician Decision|1|||
170789991|NCT04436276|617242794|FG001|Overall Study|Physician Decision|0|||
170789992|NCT04436276|617242795|FG002|Overall Study|Physician Decision|2|||
170789993|NCT04436276|617242796|FG003|Overall Study|Physician Decision|1|||
170789994|NCT04436276|617242797|FG004|Overall Study|Physician Decision|0|||
170789995|NCT04436276|617242798|FG005|Overall Study|Physician Decision|0|||
170789996|NCT04436276|617242799|FG006|Overall Study|Physician Decision|0|||
170789997|NCT04436276|617242800|FG007|Overall Study|Physician Decision|0|||
170789998|NCT04436276|617242801|FG008|Overall Study|Physician Decision|0|||
170890444|NCT04537208|617606481|FG009|Overall Study|Withdrawal by Subject|2|||
170890445|NCT04537208|617606482|FG010|Overall Study|Withdrawal by Subject|4|||
170890446|NCT04537208|617606472|FG000|Overall Study|Lost to Follow-up|4|||
170890447|NCT04537208|617606473|FG001|Overall Study|Lost to Follow-up|1|||
170890448|NCT04537208|617606474|FG002|Overall Study|Lost to Follow-up|3|||
170890449|NCT04537208|617606475|FG003|Overall Study|Lost to Follow-up|4|||
170890450|NCT04537208|617606476|FG004|Overall Study|Lost to Follow-up|3|||
170890451|NCT04537208|617606477|FG005|Overall Study|Lost to Follow-up|2|||
170890452|NCT04537208|617606478|FG006|Overall Study|Lost to Follow-up|3|||
170890453|NCT04537208|617606479|FG007|Overall Study|Lost to Follow-up|2|||
170465179|NCT01775189|616041943|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
170465180|NCT01775189|616041937|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
170465181|NCT01775189|616041938|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
170465182|NCT01775189|616041939|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
170465183|NCT01775189|616041940|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
170465184|NCT01775189|616041941|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
170465185|NCT01775189|616041942|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
170465186|NCT01775189|616041943|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
170465187|NCT00735397|616041950|FG000|Overall Study|Adverse Event|194|||
170465188|NCT00735397|616041950|FG000|Overall Study|Lost to Follow-up|33|||
170465189|NCT00735397|616041950|FG000|Overall Study|Participant choice|252|||
170465190|NCT00735397|616041950|FG000|Overall Study|Inadequate therapeutic effect|202|||
170465191|NCT00735397|616041950|FG000|Overall Study|Administrative/Other|502|||
170465192|NCT03016975|616041961|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
170465193|NCT03016975|616041962|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
170465194|NCT03016975|616041963|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
170465195|NCT03016975|616041961|FG000|At 6 Months Follow-up|Death|2|||
170465196|NCT03016975|616041962|FG001|At 6 Months Follow-up|Death|0|||
170465197|NCT03016975|616041963|FG002|At 6 Months Follow-up|Death|0|||
170465198|NCT03016975|616041961|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
170465199|NCT03016975|616041962|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
170465200|NCT03016975|616041963|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
170465201|NCT03016975|616041961|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
170465202|NCT03016975|616041962|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
170465203|NCT03016975|616041963|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
170465204|NCT03016975|616041961|FG000|At 6 Months Follow-up|Aborted implant|1|||
170465205|NCT03016975|616041962|FG001|At 6 Months Follow-up|Aborted implant|0|||
170465206|NCT03016975|616041963|FG002|At 6 Months Follow-up|Aborted implant|0|||
170465207|NCT03016975|616041961|FG000|At 2 Year Follow-up|Death|1|||
170465208|NCT03016975|616041962|FG001|At 2 Year Follow-up|Death|0|||
170465209|NCT03016975|616041963|FG002|At 2 Year Follow-up|Death|0|||
170465210|NCT03016975|616041961|FG000|At 3 Year Follow-up|Death|1|||
170465211|NCT03016975|616041962|FG001|At 3 Year Follow-up|Death|0|||
170465212|NCT03016975|616041963|FG002|At 3 Year Follow-up|Death|0|||
170465213|NCT03016975|616041961|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
170465214|NCT03016975|616041962|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
170465215|NCT03016975|616041963|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
170465216|NCT03016975|616041961|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
170465217|NCT03016975|616041962|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
170465218|NCT03016975|616041963|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
170465219|NCT02901548|616041964|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
170465220|NCT00724048|616041968|FG000|Overall Study|Adverse Event|1|||
170465221|NCT00724048|616041969|FG001|Overall Study|Adverse Event|1|||
170636912|NCT01499277|616682568|FG000|Overall Study|Protocol Violation|2|||
170636913|NCT01499277|616682569|FG001|Overall Study|Protocol Violation|3|||
170636914|NCT01499277|616682568|FG000|Overall Study|Withdrawal by Subject|16|||
170636915|NCT01499277|616682569|FG001|Overall Study|Withdrawal by Subject|6|||
170636916|NCT01499277|616682568|FG000|Overall Study|Lack of therapeutic response and other|8|||
170465222|NCT00724048|616041970|FG002|Overall Study|Adverse Event|1|||
170465223|NCT00724048|616041971|FG003|Overall Study|Adverse Event|0|||
170465224|NCT00724048|616041968|FG000|Overall Study|Lost to Follow-up|0|||
170465225|NCT00724048|616041969|FG001|Overall Study|Lost to Follow-up|1|||
170465226|NCT00724048|616041970|FG002|Overall Study|Lost to Follow-up|0|||
170465227|NCT00724048|616041971|FG003|Overall Study|Lost to Follow-up|0|||
170465228|NCT00724048|616041968|FG000|Overall Study|Withdrawal by Subject|1|||
170465229|NCT00724048|616041969|FG001|Overall Study|Withdrawal by Subject|2|||
170465230|NCT00724048|616041970|FG002|Overall Study|Withdrawal by Subject|1|||
170465231|NCT00724048|616041971|FG003|Overall Study|Withdrawal by Subject|2|||
170789999|NCT04436276|617242802|FG009|Overall Study|Physician Decision|0|||
170790000|NCT04436276|617242803|FG010|Overall Study|Physician Decision|0|||
170790001|NCT04436276|617242804|FG011|Overall Study|Physician Decision|1|||
170790002|NCT04436276|617242805|FG012|Overall Study|Physician Decision|2|||
170790003|NCT04436276|617242806|FG013|Overall Study|Physician Decision|0|||
170790004|NCT04436276|617242807|FG014|Overall Study|Physician Decision|0|||
170790005|NCT04436276|617242808|FG015|Overall Study|Physician Decision|0|||
170790006|NCT04436276|617242809|FG016|Overall Study|Physician Decision|0|||
170465232|NCT00724048|616041968|FG000|Overall Study|Investigator decision|0|||
170465233|NCT00724048|616041969|FG001|Overall Study|Investigator decision|0|||
170465234|NCT00724048|616041970|FG002|Overall Study|Investigator decision|1|||
170465235|NCT00724048|616041971|FG003|Overall Study|Investigator decision|0|||
170465236|NCT00724048|616041968|FG000|Overall Study|Did not tolerate study drug|0|||
170465237|NCT00724048|616041969|FG001|Overall Study|Did not tolerate study drug|0|||
170465238|NCT00724048|616041970|FG002|Overall Study|Did not tolerate study drug|0|||
170636917|NCT01499277|616682569|FG001|Overall Study|Lack of therapeutic response and other|7|||
170790007|NCT04436276|617242810|FG017|Overall Study|Physician Decision|0|||
170790008|NCT04436276|617242811|FG018|Overall Study|Physician Decision|0|||
170790009|NCT04436276|617242812|FG019|Overall Study|Physician Decision|0|||
170790010|NCT04436276|617242813|FG020|Overall Study|Physician Decision|1|||
170790011|NCT04436276|617242814|FG021|Overall Study|Physician Decision|2|||
170465239|NCT00724048|616041971|FG003|Overall Study|Did not tolerate study drug|1|||
170465240|NCT00724048|616041968|FG000|Overall Study|Other than specified|1|||
170465241|NCT00724048|616041969|FG001|Overall Study|Other than specified|1|||
170790012|NCT04436276|617242815|FG022|Overall Study|Physician Decision|0|||
170790013|NCT04436276|617242793|FG000|Overall Study|Protocol Violation|0|||
170790014|NCT04436276|617242794|FG001|Overall Study|Protocol Violation|0|||
170790015|NCT04436276|617242795|FG002|Overall Study|Protocol Violation|0|||
170790016|NCT04436276|617242796|FG003|Overall Study|Protocol Violation|0|||
170790017|NCT04436276|617242797|FG004|Overall Study|Protocol Violation|0|||
170790018|NCT04436276|617242798|FG005|Overall Study|Protocol Violation|0|||
170790019|NCT04436276|617242799|FG006|Overall Study|Protocol Violation|0|||
170790020|NCT04436276|617242800|FG007|Overall Study|Protocol Violation|0|||
170790021|NCT04436276|617242801|FG008|Overall Study|Protocol Violation|0|||
170790022|NCT04436276|617242802|FG009|Overall Study|Protocol Violation|0|||
170790023|NCT04436276|617242803|FG010|Overall Study|Protocol Violation|0|||
170790024|NCT04436276|617242804|FG011|Overall Study|Protocol Violation|0|||
170790025|NCT04436276|617242805|FG012|Overall Study|Protocol Violation|0|||
170790026|NCT04436276|617242806|FG013|Overall Study|Protocol Violation|1|||
170465242|NCT00724048|616041970|FG002|Overall Study|Other than specified|0|||
170465243|NCT00724048|616041971|FG003|Overall Study|Other than specified|0|||
170790027|NCT04436276|617242807|FG014|Overall Study|Protocol Violation|0|||
170790028|NCT04436276|617242808|FG015|Overall Study|Protocol Violation|1|||
170790029|NCT04436276|617242809|FG016|Overall Study|Protocol Violation|0|||
170790030|NCT04436276|617242810|FG017|Overall Study|Protocol Violation|0|||
170790031|NCT04436276|617242811|FG018|Overall Study|Protocol Violation|0|||
170790032|NCT04436276|617242812|FG019|Overall Study|Protocol Violation|0|||
170790033|NCT04436276|617242813|FG020|Overall Study|Protocol Violation|0|||
170790034|NCT04436276|617242814|FG021|Overall Study|Protocol Violation|0|||
170790035|NCT04436276|617242815|FG022|Overall Study|Protocol Violation|0|||
170790036|NCT04436276|617242793|FG000|Overall Study|Withdrawal by Subject|25|||
170790037|NCT04436276|617242794|FG001|Overall Study|Withdrawal by Subject|22|||
170790038|NCT04436276|617242795|FG002|Overall Study|Withdrawal by Subject|24|||
170790039|NCT04436276|617242796|FG003|Overall Study|Withdrawal by Subject|23|||
170790040|NCT04436276|617242797|FG004|Overall Study|Withdrawal by Subject|14|||
170790041|NCT04436276|617242798|FG005|Overall Study|Withdrawal by Subject|0|||
170790042|NCT04436276|617242799|FG006|Overall Study|Withdrawal by Subject|0|||
170790043|NCT04436276|617242800|FG007|Overall Study|Withdrawal by Subject|1|||
170790044|NCT04436276|617242801|FG008|Overall Study|Withdrawal by Subject|0|||
170790045|NCT04436276|617242802|FG009|Overall Study|Withdrawal by Subject|1|||
170790046|NCT04436276|617242803|FG010|Overall Study|Withdrawal by Subject|17|||
170790047|NCT04436276|617242804|FG011|Overall Study|Withdrawal by Subject|7|||
170790048|NCT04436276|617242805|FG012|Overall Study|Withdrawal by Subject|10|||
170790049|NCT04436276|617242806|FG013|Overall Study|Withdrawal by Subject|6|||
170790050|NCT04436276|617242807|FG014|Overall Study|Withdrawal by Subject|20|||
170790051|NCT04436276|617242808|FG015|Overall Study|Withdrawal by Subject|6|||
170790052|NCT04436276|617242809|FG016|Overall Study|Withdrawal by Subject|11|||
170790053|NCT04436276|617242810|FG017|Overall Study|Withdrawal by Subject|4|||
170790054|NCT04436276|617242811|FG018|Overall Study|Withdrawal by Subject|14|||
170790055|NCT04436276|617242812|FG019|Overall Study|Withdrawal by Subject|24|||
170790056|NCT04436276|617242813|FG020|Overall Study|Withdrawal by Subject|24|||
170790057|NCT04436276|617242814|FG021|Overall Study|Withdrawal by Subject|16|||
170790058|NCT04436276|617242815|FG022|Overall Study|Withdrawal by Subject|14|||
170790059|NCT04436276|617242793|FG000|Overall Study|Other|3|||
170790060|NCT04436276|617242794|FG001|Overall Study|Other|2|||
170790061|NCT04436276|617242795|FG002|Overall Study|Other|5|||
170790062|NCT04436276|617242796|FG003|Overall Study|Other|9|||
170790063|NCT04436276|617242797|FG004|Overall Study|Other|23|||
170790064|NCT04436276|617242798|FG005|Overall Study|Other|1|||
170790065|NCT04436276|617242799|FG006|Overall Study|Other|0|||
170890454|NCT04537208|617606480|FG008|Overall Study|Lost to Follow-up|7|||
170790066|NCT04436276|617242800|FG007|Overall Study|Other|0|||
170790067|NCT04436276|617242801|FG008|Overall Study|Other|0|||
170790068|NCT04436276|617242802|FG009|Overall Study|Other|0|||
170890455|NCT04537208|617606481|FG009|Overall Study|Lost to Follow-up|2|||
170790069|NCT04436276|617242803|FG010|Overall Study|Other|3|||
170890456|NCT04537208|617606482|FG010|Overall Study|Lost to Follow-up|2|||
170790070|NCT04436276|617242804|FG011|Overall Study|Other|1|||
170790071|NCT04436276|617242805|FG012|Overall Study|Other|1|||
170890457|NCT01537211|617606483|FG000|Overall Study|Lost to Follow-up|0|||
170790072|NCT04436276|617242806|FG013|Overall Study|Other|2|||
170790073|NCT04436276|617242807|FG014|Overall Study|Other|3|||
170790074|NCT04436276|617242808|FG015|Overall Study|Other|0|||
170790075|NCT04436276|617242809|FG016|Overall Study|Other|0|||
170790076|NCT04436276|617242810|FG017|Overall Study|Other|6|||
170890458|NCT01537211|617606484|FG001|Overall Study|Lost to Follow-up|1|||
170465244|NCT04874155|616041972|FG000|Overall Study|Lost to Follow-up|1|||
170465245|NCT04874155|616041973|FG001|Overall Study|Lost to Follow-up|1|||
170465246|NCT04874155|616041972|FG000|Overall Study|Withdrawal by Subject|2|||
170465247|NCT04874155|616041973|FG001|Overall Study|Withdrawal by Subject|2|||
170465248|NCT02774642|616041974|FG000|Overall Study|Lost to Follow-up|9|||
170465249|NCT02774642|616041975|FG001|Overall Study|Lost to Follow-up|7|||
170890459|NCT00704964|617606485|FG000|Overall Study|Not completed on time|328|||
170890460|NCT02161562|617606487|FG000|Overall Study|Withdrawal by Subject|5|||
170890461|NCT02161562|617606488|FG001|Overall Study|Withdrawal by Subject|8|||
170890462|NCT02161562|617606487|FG000|Overall Study|Protocol Violation|9|||
170890463|NCT02161562|617606488|FG001|Overall Study|Protocol Violation|4|||
170890464|NCT02161562|617606487|FG000|Overall Study|Pregnancy|1|||
170890465|NCT02161562|617606488|FG001|Overall Study|Pregnancy|2|||
170890466|NCT02161562|617606487|FG000|Overall Study|Lost to Follow-up|3|||
170890467|NCT02161562|617606488|FG001|Overall Study|Lost to Follow-up|1|||
170890468|NCT02161562|617606487|FG000|Overall Study|Lack of Efficacy|4|||
170890469|NCT02161562|617606488|FG001|Overall Study|Lack of Efficacy|1|||
170890470|NCT02161562|617606487|FG000|Overall Study|Adverse Event|1|||
170890471|NCT02161562|617606488|FG001|Overall Study|Adverse Event|1|||
170890472|NCT02161562|617606487|FG000|Overall Study|Participant moved back to home country|1|||
170890473|NCT02161562|617606488|FG001|Overall Study|Participant moved back to home country|0|||
170890474|NCT02161562|617606487|FG000|Overall Study|Withdrew due to being out of the country|1|||
170890475|NCT02161562|617606488|FG001|Overall Study|Withdrew due to being out of the country|0|||
170890476|NCT02161562|617606487|FG000|Overall Study|Participant moved out of province|1|||
170890477|NCT02161562|617606488|FG001|Overall Study|Participant moved out of province|0|||
170890478|NCT02475655|617606491|FG000|Overall Study|Lost to Follow-up|0|||
170890479|NCT02475655|617606492|FG001|Overall Study|Lost to Follow-up|1|||
170890480|NCT00643994|617606493|FG000|Overall Study|Death|24|||
170890481|NCT00643994|617606493|FG000|Overall Study|Lost to Follow-up|72|||
170890482|NCT00343512|617606497|FG000|Overall Study|Withdrawal by Subject|2|||
170890483|NCT02574637|617606498|FG000|Double-blind Period|Adverse Event|1|||
170890484|NCT02574637|617606499|FG001|Double-blind Period|Adverse Event|0|||
170890485|NCT02574637|617606500|FG002|Double-blind Period|Adverse Event|0|||
170465250|NCT02290223|616041976|FG000|6 Months|Lost to Follow-up|9|||
170465251|NCT02290223|616041977|FG001|6 Months|Lost to Follow-up|6|||
170465252|NCT02290223|616041976|FG000|6 Months|Withdrawal by Subject|5|||
170465253|NCT02290223|616041977|FG001|6 Months|Withdrawal by Subject|0|||
170465254|NCT02290223|616041976|FG000|6 Months|deceased (not related to study)|2|||
170544855|NCT00552058|616339346|FG000|Overall Study|Other: Positive Stool Result|0|||
170544856|NCT00552058|616339347|FG001|Overall Study|Other: Positive Stool Result|1|||
170544857|NCT00552058|616339346|FG000|Overall Study|Other: Randomized in error|0|||
170544858|NCT00552058|616339347|FG001|Overall Study|Other: Randomized in error|1|||
170544859|NCT00552058|616339346|FG000|Overall Study|Other: Sponsors Decision|0|||
170544860|NCT00552058|616339347|FG001|Overall Study|Other: Sponsors Decision|1|||
170544861|NCT00552058|616339346|FG000|Overall Study|Other: Early Roll Over|1|||
170544862|NCT00552058|616339347|FG001|Overall Study|Other: Early Roll Over|0|||
170544863|NCT05788328|616339351|FG000|Treatment Period 4 (5 Days)|Other|1|||
170544864|NCT05788328|616339351|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
170544865|NCT02082483|616339352|FG000|Overall Study|Lost to Follow-up|1|||
170544866|NCT02082483|616339353|FG001|Overall Study|Lost to Follow-up|1|||
170544867|NCT02082483|616339352|FG000|Overall Study|Withdrawal by Subject|2|||
170544868|NCT02082483|616339353|FG001|Overall Study|Withdrawal by Subject|1|||
170544869|NCT02082483|616339352|FG000|Overall Study|Physician Decision|1|||
170544870|NCT02082483|616339353|FG001|Overall Study|Physician Decision|1|||
170544871|NCT02082483|616339352|FG000|Overall Study|Death|2|||
170544872|NCT02082483|616339353|FG001|Overall Study|Death|3|||
170544873|NCT00422461|616339354|FG000|Overall Study|Adverse Event|1|||
170544874|NCT00422461|616339355|FG001|Overall Study|Adverse Event|2|||
170544875|NCT00422461|616339356|FG002|Overall Study|Adverse Event|1|||
170544876|NCT00422461|616339357|FG003|Overall Study|Adverse Event|1|||
170544877|NCT00422461|616339354|FG000|Overall Study|Other|0|||
170544878|NCT00422461|616339355|FG001|Overall Study|Other|0|||
170544879|NCT00422461|616339356|FG002|Overall Study|Other|0|||
170544880|NCT00422461|616339357|FG003|Overall Study|Other|2|||
170544881|NCT00422461|616339354|FG000|Overall Study|Participants no longer willing to participate in study|1|||
170544882|NCT00422461|616339355|FG001|Overall Study|Participants no longer willing to participate in study|0|||
170544883|NCT00422461|616339356|FG002|Overall Study|Participants no longer willing to participate in study|0|||
170544884|NCT00422461|616339357|FG003|Overall Study|Participants no longer willing to participate in study|0|||
170544885|NCT00422461|616339354|FG000|Overall Study|Randomized but not treated|1|||
170544886|NCT00422461|616339355|FG001|Overall Study|Randomized but not treated|1|||
170890486|NCT02574637|617606501|FG003|Double-blind Period|Adverse Event|0|||
170544887|NCT00422461|616339356|FG002|Overall Study|Randomized but not treated|0|||
170890487|NCT02574637|617606502|FG004|Double-blind Period|Adverse Event|0|||
170890488|NCT02574637|617606503|FG005|Double-blind Period|Adverse Event|0|||
170890489|NCT02574637|617606504|FG006|Double-blind Period|Adverse Event|0|||
170465255|NCT02290223|616041977|FG001|6 Months|deceased (not related to study)|0|||
170465256|NCT02290223|616041976|FG000|12 Months|Lost to Follow-up|16|||
170465257|NCT02290223|616041977|FG001|12 Months|Lost to Follow-up|10|||
170790077|NCT04436276|617242811|FG018|Overall Study|Other|1|||
170790078|NCT04436276|617242812|FG019|Overall Study|Other|0|||
170790079|NCT04436276|617242813|FG020|Overall Study|Other|2|||
170790080|NCT04436276|617242814|FG021|Overall Study|Other|2|||
170790081|NCT04436276|617242815|FG022|Overall Study|Other|60|||
170790082|NCT00324805|617242822|FG000|Overall Study|Adverse Event|62|||
170790083|NCT00324805|617242823|FG001|Overall Study|Adverse Event|203|||
170790084|NCT00324805|617242822|FG000|Overall Study|Progression|7|||
170790085|NCT00324805|617242823|FG001|Overall Study|Progression|35|||
170790086|NCT00324805|617242822|FG000|Overall Study|Withdrawal by Subject|51|||
170890490|NCT02574637|617606505|FG007|Double-blind Period|Adverse Event|0|||
170890491|NCT02574637|617606506|FG008|Double-blind Period|Adverse Event|0|||
170890492|NCT02574637|617606507|FG009|Double-blind Period|Adverse Event|0|||
170890493|NCT02574637|617606498|FG000|Double-blind Period|Lack of Efficacy|0|||
170890494|NCT02574637|617606499|FG001|Double-blind Period|Lack of Efficacy|0|||
170890495|NCT02574637|617606500|FG002|Double-blind Period|Lack of Efficacy|2|||
170890496|NCT02574637|617606501|FG003|Double-blind Period|Lack of Efficacy|0|||
170465258|NCT02290223|616041976|FG000|12 Months|Refusal|0|||
170465259|NCT02290223|616041977|FG001|12 Months|Refusal|1|||
170465260|NCT02329847|616041978|FG000|Overall Study|Death|4|||
170465261|NCT02329847|616041979|FG001|Overall Study|Death|4|||
170465262|NCT02329847|616041980|FG002|Overall Study|Death|22|||
170465263|NCT02329847|616041981|FG003|Overall Study|Death|12|||
170465264|NCT02329847|616041982|FG004|Overall Study|Death|20|||
170465265|NCT02329847|616041983|FG005|Overall Study|Death|13|||
170465266|NCT02329847|616041978|FG000|Overall Study|Lost to Follow-up|0|||
170465267|NCT02329847|616041979|FG001|Overall Study|Lost to Follow-up|0|||
170465268|NCT02329847|616041980|FG002|Overall Study|Lost to Follow-up|2|||
170465269|NCT02329847|616041981|FG003|Overall Study|Lost to Follow-up|3|||
170465270|NCT02329847|616041982|FG004|Overall Study|Lost to Follow-up|0|||
170465271|NCT02329847|616041983|FG005|Overall Study|Lost to Follow-up|1|||
170465272|NCT02329847|616041978|FG000|Overall Study|Physician Decision|0|||
170465273|NCT02329847|616041979|FG001|Overall Study|Physician Decision|0|||
170465274|NCT02329847|616041980|FG002|Overall Study|Physician Decision|0|||
170465275|NCT02329847|616041981|FG003|Overall Study|Physician Decision|0|||
170465276|NCT02329847|616041982|FG004|Overall Study|Physician Decision|1|||
170465277|NCT02329847|616041983|FG005|Overall Study|Physician Decision|0|||
170465278|NCT02329847|616041978|FG000|Overall Study|Withdrawal by Subject|2|||
170465279|NCT02329847|616041979|FG001|Overall Study|Withdrawal by Subject|1|||
170465280|NCT02329847|616041980|FG002|Overall Study|Withdrawal by Subject|5|||
170465281|NCT02329847|616041981|FG003|Overall Study|Withdrawal by Subject|7|||
170465282|NCT02329847|616041982|FG004|Overall Study|Withdrawal by Subject|8|||
170544888|NCT00422461|616339357|FG003|Overall Study|Randomized but not treated|0|||
170544889|NCT02181621|616339358|FG000|Overall Study|Adverse Event|1|||
170790087|NCT00324805|617242823|FG001|Overall Study|Withdrawal by Subject|174|||
170890497|NCT02574637|617606502|FG004|Double-blind Period|Lack of Efficacy|0|||
170465283|NCT02329847|616041983|FG005|Overall Study|Withdrawal by Subject|3|||
170465284|NCT02329847|616041978|FG000|Overall Study|Other|1|||
170465285|NCT02329847|616041979|FG001|Overall Study|Other|2|||
170465286|NCT02329847|616041980|FG002|Overall Study|Other|6|||
170465287|NCT02329847|616041981|FG003|Overall Study|Other|13|||
170465288|NCT02329847|616041982|FG004|Overall Study|Other|10|||
170465289|NCT02329847|616041983|FG005|Overall Study|Other|3|||
170465290|NCT05293639|616041984|FG000|Overall Study|Withdrawal by Subject|1|||
170465291|NCT05293639|616041985|FG001|Overall Study|Withdrawal by Subject|1|||
170465292|NCT05293639|616041986|FG002|Overall Study|Withdrawal by Subject|2|||
170465293|NCT05293639|616041984|FG000|Overall Study|Death|0|||
170465294|NCT05293639|616041985|FG001|Overall Study|Death|1|||
170465295|NCT05293639|616041986|FG002|Overall Study|Death|0|||
170465296|NCT05293639|616041984|FG000|Overall Study|Lost to Follow-up|0|||
170636918|NCT00372593|616682570|FG000|Overall Study|Adverse Event|43|||
170636919|NCT00372593|616682571|FG001|Overall Study|Adverse Event|45|||
170636920|NCT00372593|616682572|FG002|Overall Study|Adverse Event|0|||
170636921|NCT00372593|616682570|FG000|Overall Study|Death|16|||
170636922|NCT00372593|616682571|FG001|Overall Study|Death|20|||
170636923|NCT00372593|616682572|FG002|Overall Study|Death|1|||
170636924|NCT00372593|616682570|FG000|Overall Study|Lack of Efficacy|82|||
170636925|NCT00372593|616682571|FG001|Overall Study|Lack of Efficacy|71|||
170636926|NCT00372593|616682572|FG002|Overall Study|Lack of Efficacy|2|||
170636927|NCT00372593|616682570|FG000|Overall Study|Lost to Follow-up|1|||
170636928|NCT00372593|616682571|FG001|Overall Study|Lost to Follow-up|0|||
170636929|NCT00372593|616682572|FG002|Overall Study|Lost to Follow-up|0|||
170636930|NCT00372593|616682570|FG000|Overall Study|Physician Decision|42|||
170636931|NCT00372593|616682571|FG001|Overall Study|Physician Decision|41|||
170636932|NCT00372593|616682572|FG002|Overall Study|Physician Decision|0|||
170636933|NCT00372593|616682570|FG000|Overall Study|Ineligible|20|||
170636934|NCT00372593|616682571|FG001|Overall Study|Ineligible|21|||
170636935|NCT00372593|616682572|FG002|Overall Study|Ineligible|1|||
170636936|NCT02974543|616682573|FG000|Overall Study|Withdrawal by Subject|1|||
170636937|NCT02974543|616682574|FG001|Overall Study|Withdrawal by Subject|0|||
170636938|NCT00220636|616682575|FG000|Overall Study|Withdrawal by Subject|4|||
170636939|NCT01662102|616682576|FG000|Overall Study|Sponsor's decision|1|||
170636940|NCT01662102|616682577|FG001|Overall Study|Sponsor's decision|0|||
170636941|NCT00060840|616682578|FG000|Overall Study|Change in surgical plan|2|||
170636942|NCT00060840|616682579|FG001|Overall Study|Change in surgical plan|6|||
170636943|NCT00060840|616682578|FG000|Overall Study|Death|0|||
170636944|NCT00060840|616682579|FG001|Overall Study|Death|1|||
170636945|NCT00060840|616682578|FG000|Overall Study|Withdrawal by Subject|0|||
170790088|NCT00324805|617242822|FG000|Overall Study|Death|6|||
170790089|NCT00324805|617242823|FG001|Overall Study|Death|9|||
170790090|NCT00324805|617242822|FG000|Overall Study|Alternative therapy|4|||
170790091|NCT00324805|617242823|FG001|Overall Study|Alternative therapy|8|||
170790092|NCT00324805|617242822|FG000|Overall Study|Other complicating disease|1|||
170790093|NCT00324805|617242823|FG001|Overall Study|Other complicating disease|9|||
170790094|NCT00324805|617242822|FG000|Overall Study|Other reasons|7|||
170790095|NCT00324805|617242823|FG001|Overall Study|Other reasons|26|||
170790096|NCT00324805|617242822|FG000|Overall Study|Other|0|||
170790097|NCT00324805|617242823|FG001|Overall Study|Other|2|||
170790098|NCT00324805|617242822|FG000|Overall Study|Did not start therapy|12|||
170790099|NCT00324805|617242823|FG001|Overall Study|Did not start therapy|17|||
170790100|NCT05792085|617242825|FG000|Overall Study|Death|0|||
170790101|NCT05792085|617242826|FG001|Overall Study|Death|0|||
170790102|NCT05792085|617242827|FG002|Overall Study|Death|0|||
170790103|NCT05792085|617242828|FG003|Overall Study|Death|0|||
170790104|NCT05792085|617242829|FG004|Overall Study|Death|1|||
170790105|NCT05496231|617242838|FG000|Overall Study|Adverse Event|1|||
170790106|NCT05496231|617242839|FG001|Overall Study|Adverse Event|1|||
170790107|NCT05496231|617242840|FG002|Overall Study|Adverse Event|0|||
170790108|NCT05496231|617242841|FG003|Overall Study|Adverse Event|4|||
170790109|NCT05496231|617242838|FG000|Overall Study|Withdrawal by Subject|5|||
170790110|NCT05496231|617242839|FG001|Overall Study|Withdrawal by Subject|5|||
170790111|NCT05496231|617242840|FG002|Overall Study|Withdrawal by Subject|4|||
170790112|NCT05496231|617242841|FG003|Overall Study|Withdrawal by Subject|11|||
170790113|NCT05496231|617242838|FG000|Overall Study|Migrated/moved from the study area|3|||
170790114|NCT05496231|617242839|FG001|Overall Study|Migrated/moved from the study area|5|||
170790115|NCT05496231|617242840|FG002|Overall Study|Migrated/moved from the study area|3|||
170790116|NCT05496231|617242841|FG003|Overall Study|Migrated/moved from the study area|3|||
170790117|NCT05496231|617242838|FG000|Overall Study|Lost to Follow-up|13|||
170790118|NCT05496231|617242839|FG001|Overall Study|Lost to Follow-up|6|||
170790119|NCT05496231|617242840|FG002|Overall Study|Lost to Follow-up|11|||
170790120|NCT05496231|617242841|FG003|Overall Study|Lost to Follow-up|6|||
170465297|NCT05293639|616041985|FG001|Overall Study|Lost to Follow-up|0|||
170790121|NCT05496231|617242838|FG000|Overall Study|Other|9|||
170790122|NCT05496231|617242839|FG001|Overall Study|Other|7|||
170636946|NCT00060840|616682579|FG001|Overall Study|Withdrawal by Subject|1|||
170636947|NCT00060840|616682578|FG000|Overall Study|Subinvestigator unavailable|0|||
170636948|NCT00060840|616682579|FG001|Overall Study|Subinvestigator unavailable|1|||
170790123|NCT05496231|617242840|FG002|Overall Study|Other|7|||
170790124|NCT05496231|617242841|FG003|Overall Study|Other|8|||
170636949|NCT00060840|616682578|FG000|Overall Study|Physician Decision|1|||
170465298|NCT05293639|616041986|FG002|Overall Study|Lost to Follow-up|5|||
170465299|NCT05293639|616041984|FG000|Overall Study|Other|0|||
170636950|NCT00060840|616682579|FG001|Overall Study|Physician Decision|0|||
170636951|NCT00060840|616682578|FG000|Overall Study|Other|1|||
170790125|NCT04524442|617242842|FG000|Overall Study|Subject Decision|1|||
170465300|NCT05293639|616041985|FG001|Overall Study|Other|0|||
170465301|NCT05293639|616041986|FG002|Overall Study|Other|1|||
170465302|NCT01860677|616041992|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
170465303|NCT01860677|616041993|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
170465304|NCT05330468|616041994|FG000|Overall Study|Death|6|||
170465305|NCT05330468|616041994|FG000|Overall Study|Withdrawal by Subject|4|||
170465306|NCT05330468|616041994|FG000|Overall Study|Lost to Follow-up|4|||
170465307|NCT00369317|616041996|FG000|Overall Study|Adverse Event|3|||
170465308|NCT00369317|616041996|FG000|Overall Study|Death|1|||
170465309|NCT00369317|616041996|FG000|Overall Study|Lack of Efficacy|5|||
170465310|NCT00369317|616041996|FG000|Overall Study|Physician Decision|2|||
170636952|NCT00060840|616682579|FG001|Overall Study|Other|0|||
170636953|NCT01388335|616682580|FG000|Period 1|Progressive Disease|1|||
170636954|NCT01388335|616682580|FG000|Period 2|Progressive Disease|2|||
170636955|NCT01388335|616682580|FG000|Period 2|Sponsor Decision|1|||
170636956|NCT01388335|616682580|FG000|Safety Extension|Progressive Disease|7|||
170636957|NCT00125164|616682583|FG000|Overall Study|Adverse Event|0|||
170636958|NCT00125164|616682584|FG001|Overall Study|Adverse Event|0|||
170636959|NCT00125164|616682585|FG002|Overall Study|Adverse Event|2|||
170636960|NCT00125164|616682586|FG003|Overall Study|Adverse Event|4|||
170636961|NCT00125164|616682583|FG000|Overall Study|Lost to Follow-up|0|||
170636962|NCT00125164|616682584|FG001|Overall Study|Lost to Follow-up|0|||
170636963|NCT00125164|616682585|FG002|Overall Study|Lost to Follow-up|1|||
170636964|NCT00125164|616682586|FG003|Overall Study|Lost to Follow-up|1|||
170636965|NCT00125164|616682583|FG000|Overall Study|Withdrawal by Subject|2|||
170636966|NCT00125164|616682584|FG001|Overall Study|Withdrawal by Subject|0|||
170636967|NCT00125164|616682585|FG002|Overall Study|Withdrawal by Subject|1|||
170636968|NCT00125164|616682586|FG003|Overall Study|Withdrawal by Subject|1|||
170636969|NCT00670306|616682587|FG000|Overall Study|Adverse Event|8|||
170790126|NCT01152450|617242845|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
170790127|NCT01152450|617242846|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
170465311|NCT00369317|616041996|FG000|Overall Study|Withdrawal by Subject|8|||
170465312|NCT00369317|616041996|FG000|Overall Study|Ineligible|1|||
170790128|NCT01152450|617242847|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
170790129|NCT01152450|617242848|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
170465313|NCT02365558|616041997|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
170465314|NCT02365558|616041998|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
170465315|NCT02365558|616041997|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
170465316|NCT02365558|616041998|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
170465317|NCT00861198|616042002|FG000|Overall Study|SpyGlass Failed|5|||
170465318|NCT02288182|616042003|FG000|Overall Study|Adverse Event|0|||
170465319|NCT02288182|616042004|FG001|Overall Study|Adverse Event|1|||
170465320|NCT02288182|616042003|FG000|Overall Study|Lost to Follow-up|0|||
170465321|NCT02288182|616042004|FG001|Overall Study|Lost to Follow-up|1|||
170465322|NCT01197755|616042006|FG000|Overall Study|Adverse Event|8|||
170465323|NCT01197755|616042007|FG001|Overall Study|Adverse Event|10|||
170465324|NCT01197755|616042008|FG002|Overall Study|Adverse Event|10|||
170465325|NCT01197755|616042006|FG000|Overall Study|Study-specific discontinuation criteria|2|||
170465326|NCT01197755|616042007|FG001|Overall Study|Study-specific discontinuation criteria|1|||
170465327|NCT01197755|616042008|FG002|Overall Study|Study-specific discontinuation criteria|0|||
170465328|NCT01197755|616042006|FG000|Overall Study|Entered the long-term extension study|18|||
170465329|NCT01197755|616042007|FG001|Overall Study|Entered the long-term extension study|21|||
170465330|NCT01197755|616042008|FG002|Overall Study|Entered the long-term extension study|35|||
170465331|NCT01197755|616042006|FG000|Overall Study|Lack of therapeutic response|0|||
170465332|NCT01197755|616042007|FG001|Overall Study|Lack of therapeutic response|7|||
170465333|NCT01197755|616042008|FG002|Overall Study|Lack of therapeutic response|4|||
170465334|NCT01197755|616042006|FG000|Overall Study|Severe non-compliance to the protocol|2|||
170465335|NCT01197755|616042007|FG001|Overall Study|Severe non-compliance to the protocol|1|||
170465336|NCT01197755|616042008|FG002|Overall Study|Severe non-compliance to the protocol|2|||
170465337|NCT01197755|616042006|FG000|Overall Study|Withdrawal by Subject|1|||
170465338|NCT01197755|616042007|FG001|Overall Study|Withdrawal by Subject|0|||
170465339|NCT01197755|616042008|FG002|Overall Study|Withdrawal by Subject|0|||
170465340|NCT01197755|616042006|FG000|Overall Study|Lost to Follow-up|0|||
170465341|NCT01197755|616042007|FG001|Overall Study|Lost to Follow-up|0|||
170465342|NCT01197755|616042008|FG002|Overall Study|Lost to Follow-up|1|||
170465343|NCT01197755|616042006|FG000|Overall Study|eg, change in circumstances|7|||
170636970|NCT00670306|616682587|FG000|Overall Study|Lack of Efficacy|10|||
170790130|NCT01152450|617242849|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
170790131|NCT01152450|617242850|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
170636971|NCT00670306|616682587|FG000|Overall Study|Withdrawal by Subject|9|||
170636972|NCT00670306|616682587|FG000|Overall Study|Physician Decision|1|||
170790132|NCT01152450|617242845|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
170790133|NCT01152450|617242846|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
170465344|NCT01197755|616042007|FG001|Overall Study|eg, change in circumstances|3|||
170636973|NCT00670306|616682587|FG000|Overall Study|Lost to Follow-up|8|||
170465345|NCT01197755|616042008|FG002|Overall Study|eg, change in circumstances|2|||
170790134|NCT01152450|617242847|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
170636974|NCT00670306|616682587|FG000|Overall Study|incl/excl criterias did not meet|19|||
170636975|NCT01339052|616682591|FG000|Overall Study|Disease progression|13|||
170636976|NCT01339052|616682592|FG001|Overall Study|Disease progression|46|||
170636977|NCT01339052|616682591|FG000|Overall Study|Adverse Event|1|||
170636978|NCT01339052|616682592|FG001|Overall Study|Adverse Event|1|||
170636979|NCT01339052|616682591|FG000|Overall Study|Withdrawal by Subject|0|||
170636980|NCT01339052|616682592|FG001|Overall Study|Withdrawal by Subject|3|||
170636981|NCT01339052|616682591|FG000|Overall Study|Physician Decision|1|||
170636982|NCT01339052|616682592|FG001|Overall Study|Physician Decision|0|||
170636983|NCT03339219|616682593|FG000|Overall Study|Death|12|||
170636984|NCT03339219|616682593|FG000|Overall Study|Site Terminated by Sponsor|22|||
170636985|NCT03339219|616682593|FG000|Overall Study|Withdrawal by Subject|1|||
170636986|NCT01301027|616682595|FG000|Overall Study|Physician Decision|2|||
170636987|NCT01301027|616682596|FG001|Overall Study|Physician Decision|0|||
170636988|NCT01301027|616682595|FG000|Overall Study|Withdrawal by Subject|2|||
170636989|NCT01301027|616682596|FG001|Overall Study|Withdrawal by Subject|3|||
170636990|NCT01301027|616682595|FG000|Overall Study|Adverse Event|0|||
170636991|NCT01301027|616682596|FG001|Overall Study|Adverse Event|2|||
170636992|NCT01301027|616682595|FG000|Overall Study|Fracture|1|||
170636993|NCT01301027|616682596|FG001|Overall Study|Fracture|3|||
170636994|NCT01301027|616682595|FG000|Overall Study|Transplant|0|||
170636995|NCT01301027|616682596|FG001|Overall Study|Transplant|2|||
170636996|NCT01301027|616682595|FG000|Overall Study|Volume Overload|3|||
170636997|NCT01301027|616682596|FG001|Overall Study|Volume Overload|0|||
170465346|NCT03365011|616042009|FG000|Overall Study|Withdrawal by Subject|1|||
170465347|NCT03365011|616042010|FG001|Overall Study|Withdrawal by Subject|2|||
170465348|NCT03866902|616042011|FG000|Overall Study|Lost to Follow-up|98|||
170465349|NCT03866902|616042012|FG001|Overall Study|Lost to Follow-up|82|||
170465350|NCT03866902|616042011|FG000|Overall Study|Pregnancy|18|||
170465351|NCT03866902|616042012|FG001|Overall Study|Pregnancy|24|||
170465352|NCT00638027|616042019|FG000|Overall Study|Adverse Event|0|||
170465353|NCT00638027|616042020|FG001|Overall Study|Adverse Event|2|||
170465354|NCT00371397|616042021|FG000|Session 1|Withdrawal by Subject|1|||
170465355|NCT00371397|616042022|FG001|Session 1|Withdrawal by Subject|0|||
170465356|NCT00371397|616042023|FG002|Session 1|Withdrawal by Subject|0|||
170465357|NCT00371397|616042024|FG003|Session 1|Withdrawal by Subject|0|||
170465358|NCT00371397|616042025|FG004|Session 1|Withdrawal by Subject|0|||
170465359|NCT00371397|616042026|FG005|Session 1|Withdrawal by Subject|0|||
170465360|NCT00371397|616042027|FG006|Session 1|Withdrawal by Subject|0|||
170465361|NCT00371397|616042028|FG007|Session 1|Withdrawal by Subject|1|||
170465362|NCT00371397|616042029|FG008|Session 1|Withdrawal by Subject|0|||
170465363|NCT00371397|616042030|FG009|Session 1|Withdrawal by Subject|0|||
170465364|NCT00371397|616042031|FG010|Session 1|Withdrawal by Subject|0|||
170465365|NCT00371397|616042032|FG011|Session 1|Withdrawal by Subject|0|||
170465366|NCT03753763|616042033|FG000|Overall Study|Adverse Event|2|||
170465367|NCT03753763|616042034|FG001|Overall Study|Adverse Event|0|||
170544890|NCT02181621|616339359|FG001|Overall Study|Adverse Event|0|||
170544891|NCT02181621|616339358|FG000|Overall Study|Previously Enrolled|0|||
170544892|NCT02181621|616339359|FG001|Overall Study|Previously Enrolled|1|||
170544893|NCT02181621|616339358|FG000|Overall Study|Enrollment Hold|1|||
170544894|NCT02181621|616339359|FG001|Overall Study|Enrollment Hold|1|||
170544895|NCT00145327|616339360|FG000|Overall Study|Withdrawal by Subject|77|||
170636998|NCT00074490|616682597|FG000|Overall Study|Progressive malignancy|0|||
170636999|NCT00074490|616682598|FG001|Overall Study|Progressive malignancy|7|||
170465368|NCT03753763|616042033|FG000|Overall Study|Withdrawal by Subject|3|||
170465369|NCT03753763|616042034|FG001|Overall Study|Withdrawal by Subject|1|||
170544896|NCT00145327|616339361|FG001|Overall Study|Withdrawal by Subject|72|||
170544897|NCT00145327|616339362|FG002|Overall Study|Withdrawal by Subject|164|||
170637000|NCT00074490|616682599|FG002|Overall Study|Progressive malignancy|0|||
170637001|NCT00074490|616682600|FG003|Overall Study|Progressive malignancy|0|||
170637002|NCT00074490|616682601|FG004|Overall Study|Progressive malignancy|3|||
170465370|NCT03753763|616042033|FG000|Overall Study|clinical deterioration|1|||
170465371|NCT03753763|616042034|FG001|Overall Study|clinical deterioration|0|||
170465372|NCT01104779|616042035|FG000|Overall Study|Protocol Violation|1|||
170637003|NCT00074490|616682602|FG005|Overall Study|Progressive malignancy|0|||
170637004|NCT04308291|616682604|FG000|Run-In Phase|Withdrawal by Subject|4|||
170637005|NCT04308291|616682604|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
170637006|NCT04308291|616682604|FG000|Study Phase 6-M|Physician Decision|2|||
170637007|NCT04308291|616682604|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
170637008|NCT04308291|616682604|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
170637009|NCT04308291|616682604|FG000|Study Phase 12-M|Physician Decision|2|||
170637010|NCT04308291|616682604|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
170790135|NCT01152450|617242848|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
170465373|NCT01104779|616042036|FG001|Overall Study|Protocol Violation|2|||
170544898|NCT00145327|616339360|FG000|Overall Study|Death|26|||
170544899|NCT00145327|616339361|FG001|Overall Study|Death|18|||
170544900|NCT00145327|616339362|FG002|Overall Study|Death|30|||
170637011|NCT00714870|616682607|FG000|Overall Study|Lost to Follow-up|22|||
170790136|NCT01152450|617242849|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
170637012|NCT00714870|616682608|FG001|Overall Study|Lost to Follow-up|5|||
170637013|NCT00714870|616682607|FG000|Overall Study|patient unable to come b/c back pain|1|||
170637014|NCT00714870|616682608|FG001|Overall Study|patient unable to come b/c back pain|0|||
170637015|NCT00714870|616682607|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
170637016|NCT00714870|616682608|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
170637017|NCT03399552|616682609|FG000|Overall Study|No evidence of disease|1|||
170637018|NCT03399552|616682609|FG000|Overall Study|Unevaluable|1|||
170637019|NCT02506244|616682612|FG000|Overall Study|Did not undergo active monitoring|458|||
170637020|NCT02506244|616682613|FG001|Overall Study|Did not undergo active monitoring|459|||
170637021|NCT02506244|616682614|FG002|Overall Study|Did not undergo active monitoring|0|||
170637022|NCT00314795|616682618|FG000|Overall Study|Adverse Event|8|||
170637023|NCT00314795|616682618|FG000|Overall Study|Death|4|||
170637024|NCT00314795|616682618|FG000|Overall Study|Reason not Specified|3|||
170637025|NCT00314795|616682618|FG000|Overall Study|Renal Transplant|3|||
170637026|NCT00314795|616682618|FG000|Overall Study|Participants Withdrew Consent|2|||
170637027|NCT04717336|616682619|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
170637028|NCT04717336|616682620|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
170637029|NCT04717336|616682619|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
170637030|NCT04717336|616682620|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
170637031|NCT02170077|616682622|FG000|Overall Study|Withdrawal by Subject|3|||
170637032|NCT02170077|616682623|FG001|Overall Study|Withdrawal by Subject|4|||
170637033|NCT02170077|616682624|FG002|Overall Study|Withdrawal by Subject|2|||
170637034|NCT02170077|616682622|FG000|Overall Study|Adverse Event|4|||
170637035|NCT02170077|616682623|FG001|Overall Study|Adverse Event|4|||
170637036|NCT02170077|616682624|FG002|Overall Study|Adverse Event|4|||
170637037|NCT02170077|616682622|FG000|Overall Study|Lost to Follow-up|0|||
170637038|NCT02170077|616682623|FG001|Overall Study|Lost to Follow-up|1|||
170637039|NCT02170077|616682624|FG002|Overall Study|Lost to Follow-up|0|||
170637040|NCT02170077|616682622|FG000|Overall Study|Exclusion criteria|2|||
170637041|NCT02170077|616682623|FG001|Overall Study|Exclusion criteria|2|||
170637042|NCT02170077|616682624|FG002|Overall Study|Exclusion criteria|5|||
170637043|NCT02170077|616682622|FG000|Overall Study|Exacerbation of seizures|0|||
170637044|NCT02170077|616682623|FG001|Overall Study|Exacerbation of seizures|2|||
170637045|NCT02170077|616682624|FG002|Overall Study|Exacerbation of seizures|1|||
170637046|NCT01958164|616682625|FG000|Overall Study|Adverse Event|0|||
170637047|NCT01958164|616682626|FG001|Overall Study|Adverse Event|2|||
170637048|NCT01958164|616682625|FG000|Overall Study|Lost to Follow-up|2|||
170637049|NCT01958164|616682626|FG001|Overall Study|Lost to Follow-up|3|||
170637050|NCT01500720|616682627|FG000|Overall Study|Randomized But Not Treated|1|||
170637051|NCT01500720|616682628|FG001|Overall Study|Randomized But Not Treated|1|||
170637052|NCT01500720|616682627|FG000|Overall Study|Other|4|||
170637053|NCT01500720|616682628|FG001|Overall Study|Other|8|||
170637054|NCT01780974|616682629|FG000|Overall Study|Death|1|||
170637055|NCT01780974|616682630|FG001|Overall Study|Death|0|||
170637056|NCT01780974|616682629|FG000|Overall Study|Adverse Event|1|||
170637057|NCT01780974|616682630|FG001|Overall Study|Adverse Event|3|||
170637058|NCT01724346|616682631|FG000|Overall Study|Death|42|||
170465374|NCT01104779|616042037|FG002|Overall Study|Protocol Violation|2|||
170465375|NCT01104779|616042035|FG000|Overall Study|Lack of Efficacy|26|||
170465376|NCT01104779|616042036|FG001|Overall Study|Lack of Efficacy|12|||
170465377|NCT01104779|616042037|FG002|Overall Study|Lack of Efficacy|13|||
170465378|NCT01104779|616042035|FG000|Overall Study|Adverse Event|13|||
170465379|NCT01104779|616042036|FG001|Overall Study|Adverse Event|14|||
170465380|NCT01104779|616042037|FG002|Overall Study|Adverse Event|13|||
170465381|NCT01104779|616042035|FG000|Overall Study|Did not meet inc/exc criteria|1|||
170465382|NCT01104779|616042036|FG001|Overall Study|Did not meet inc/exc criteria|1|||
170465383|NCT01104779|616042037|FG002|Overall Study|Did not meet inc/exc criteria|1|||
170465384|NCT01104779|616042035|FG000|Overall Study|Other reasons|0|||
170465385|NCT01104779|616042036|FG001|Overall Study|Other reasons|1|||
170465386|NCT01104779|616042037|FG002|Overall Study|Other reasons|0|||
170465387|NCT01104779|616042035|FG000|Overall Study|Lost to Follow-up|2|||
170465388|NCT01104779|616042036|FG001|Overall Study|Lost to Follow-up|0|||
170637059|NCT01724346|616682632|FG001|Overall Study|Death|42|||
170637060|NCT01724346|616682631|FG000|Overall Study|Lost to Follow-up|5|||
170637061|NCT01724346|616682632|FG001|Overall Study|Lost to Follow-up|1|||
170637062|NCT01724346|616682631|FG000|Overall Study|Withdrawal by Subject|27|||
170637063|NCT01724346|616682632|FG001|Overall Study|Withdrawal by Subject|19|||
170637064|NCT01724346|616682631|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
170637065|NCT01724346|616682632|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
170637066|NCT00670748|616682633|FG000|Overall Study|Death during treatment|1|||
170637067|NCT00670748|616682634|FG001|Overall Study|Death during treatment|1|||
170637068|NCT00670748|616682635|FG002|Overall Study|Death during treatment|1|||
170637069|NCT00670748|616682636|FG003|Overall Study|Death during treatment|0|||
170637070|NCT00670748|616682633|FG000|Overall Study|Not off study|2|||
170790137|NCT01152450|617242850|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
170465389|NCT01104779|616042037|FG002|Overall Study|Lost to Follow-up|1|||
170637071|NCT00670748|616682634|FG001|Overall Study|Not off study|1|||
170465390|NCT01104779|616042035|FG000|Overall Study|Withdrawal by Subject|16|||
170465391|NCT01104779|616042036|FG001|Overall Study|Withdrawal by Subject|25|||
170465392|NCT01104779|616042037|FG002|Overall Study|Withdrawal by Subject|32|||
170465393|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
170465394|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
170465395|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170890498|NCT02574637|617606503|FG005|Double-blind Period|Lack of Efficacy|0|||
170465396|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465397|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465398|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465399|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465400|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465401|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465402|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465403|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170890499|NCT02574637|617606504|FG006|Double-blind Period|Lack of Efficacy|0|||
170465404|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465405|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465406|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
170465407|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
170465408|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
170465409|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465410|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465411|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465412|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465413|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465414|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465415|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465416|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465417|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465418|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465419|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465420|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
170465421|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
170465422|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
170465423|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465424|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465425|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465426|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465427|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465428|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465429|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465430|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465431|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465432|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465433|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465434|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
170465435|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
170465436|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
170465437|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465438|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465439|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465440|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465441|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465442|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465443|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465444|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465445|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465446|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465447|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465448|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
170465449|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
170465450|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
170465451|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465452|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465453|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170890500|NCT02574637|617606505|FG007|Double-blind Period|Lack of Efficacy|0|||
170465454|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465455|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465456|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465457|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465458|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465459|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465460|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465461|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465462|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
170465463|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
170465464|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
170790138|NCT01152450|617242845|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
170790139|NCT01152450|617242846|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
170790140|NCT01152450|617242847|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
170790141|NCT01152450|617242848|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
170465465|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465466|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465467|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465468|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465469|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465470|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465471|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465472|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465473|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465474|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465475|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465476|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
170465477|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
170465478|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
170465479|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465480|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465481|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465482|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465483|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465484|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465485|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465486|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465487|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465488|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465489|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465490|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
170465491|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
170465492|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
170465493|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465494|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465495|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465496|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465497|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465498|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465499|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465500|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170544901|NCT00145327|616339360|FG000|Overall Study|Adverse Event|14|||
170544902|NCT00145327|616339361|FG001|Overall Study|Adverse Event|11|||
170544903|NCT00145327|616339362|FG002|Overall Study|Adverse Event|22|||
170544904|NCT00145327|616339360|FG000|Overall Study|Lost to Follow-up|9|||
170544905|NCT00145327|616339361|FG001|Overall Study|Lost to Follow-up|14|||
170544906|NCT00145327|616339362|FG002|Overall Study|Lost to Follow-up|14|||
170544907|NCT00145327|616339360|FG000|Overall Study|Administrative problems|12|||
170544908|NCT00145327|616339361|FG001|Overall Study|Administrative problems|9|||
170544909|NCT00145327|616339362|FG002|Overall Study|Administrative problems|13|||
170544910|NCT00145327|616339360|FG000|Overall Study|Protocol Violation|2|||
170544911|NCT00145327|616339361|FG001|Overall Study|Protocol Violation|0|||
170544912|NCT00145327|616339362|FG002|Overall Study|Protocol Violation|2|||
170544913|NCT00145327|616339360|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170544914|NCT00145327|616339361|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170544915|NCT00145327|616339362|FG002|Overall Study|Abnormal laboratory value(s)|2|||
170544916|NCT00145327|616339360|FG000|Overall Study|Missing - not stated|1|||
170544917|NCT00145327|616339361|FG001|Overall Study|Missing - not stated|0|||
170465501|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465502|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465503|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465504|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
170465505|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
170465506|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
170465507|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465508|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465509|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465510|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465511|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465512|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465513|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465514|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465515|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465516|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465517|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465518|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
170465519|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
170465520|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
170465521|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465522|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465523|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465524|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465525|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465526|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465527|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465528|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465529|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465530|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465531|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465532|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
170465533|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
170465534|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
170465535|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465536|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465537|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465538|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465539|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465540|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465541|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465542|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465543|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465544|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465545|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465546|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
170465547|NCT03982199|616042044|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
170465548|NCT03982199|616042045|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
170465549|NCT03982199|616042046|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465550|NCT03982199|616042047|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465551|NCT03982199|616042048|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465552|NCT03982199|616042049|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465553|NCT03982199|616042050|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465554|NCT03982199|616042051|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465555|NCT03982199|616042052|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465556|NCT03982199|616042053|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465557|NCT03982199|616042054|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465558|NCT03982199|616042055|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465559|NCT03982199|616042056|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465560|NCT03982199|616042057|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
170465561|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170790142|NCT01152450|617242849|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
170790143|NCT01152450|617242850|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
170790144|NCT04797897|617242851|FG000|Overall Study|Study Termination by Sponsor|1|||
170790145|NCT04797897|617242852|FG001|Overall Study|Study Termination by Sponsor|1|||
170637072|NCT00670748|616682635|FG002|Overall Study|Not off study|1|||
170637073|NCT00670748|616682636|FG003|Overall Study|Not off study|1|||
170637074|NCT02876601|616682637|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
170637075|NCT02876601|616682638|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
170637076|NCT02876601|616682639|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
170637077|NCT02876601|616682640|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
170637078|NCT02736578|616682641|FG000|Overall Study|Adverse Event|1|||
170637079|NCT02736578|616682642|FG001|Overall Study|Adverse Event|0|||
170637080|NCT00802945|616682643|FG000|Overall Study|Death|27|||
170790146|NCT05670587|617242853|FG000|Overall Study|Withdrawal by Subject|3|||
170465562|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465563|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465564|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
170465565|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465566|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465567|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465568|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465569|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465570|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465571|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465572|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465573|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465574|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
170465575|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465576|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465577|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
170465578|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465579|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465580|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465581|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465582|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465583|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170544918|NCT00145327|616339362|FG002|Overall Study|Missing - not stated|1|||
170544919|NCT00960856|616339364|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
170544920|NCT00960856|616339365|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
170544921|NCT00960856|616339366|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
170544922|NCT00960856|616339367|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
170544923|NCT00960856|616339364|FG000|Washout Period of 7 Days|Adverse Event|0|||
170544924|NCT00960856|616339365|FG001|Washout Period of 7 Days|Adverse Event|0|||
170544925|NCT00960856|616339366|FG002|Washout Period of 7 Days|Adverse Event|1|||
170544926|NCT00960856|616339367|FG003|Washout Period of 7 Days|Adverse Event|0|||
170544927|NCT04027946|616339368|FG000|Overall Study|Screen failures|3|||
170544928|NCT05938010|616339370|FG000|Overall Study|Lost to Follow-up|2|||
170544929|NCT00985192|616339371|FG000|Overall Study|Withdrawal by Subject|1|||
170544930|NCT00985192|616339371|FG000|Overall Study|Disease Progression|1|||
170544931|NCT00985192|616339371|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
170544932|NCT04621760|616339372|FG000|Overall Study|Lost to Follow-up|2|||
170544933|NCT04621760|616339373|FG001|Overall Study|Lost to Follow-up|4|||
170544934|NCT04621760|616339372|FG000|Overall Study|Withdrawal by Subject|1|||
170544935|NCT04621760|616339373|FG001|Overall Study|Withdrawal by Subject|0|||
170544936|NCT01454063|616339374|FG000|Randomized|Adverse Event|1|||
170544937|NCT01454063|616339375|FG001|Randomized|Adverse Event|1|||
170544938|NCT01454063|616339374|FG000|Randomized|Protocol Violation|0|||
170544939|NCT01454063|616339375|FG001|Randomized|Protocol Violation|1|||
170544940|NCT01562444|616339379|FG000|Overall Study|Did not meet entry criteria|2|||
170544941|NCT01562444|616339380|FG001|Overall Study|Did not meet entry criteria|0|||
170544942|NCT01562444|616339381|FG002|Overall Study|Did not meet entry criteria|3|||
170544943|NCT01562444|616339379|FG000|Overall Study|Did not comply with blood draw schedule|1|||
170544944|NCT01562444|616339380|FG001|Overall Study|Did not comply with blood draw schedule|0|||
170544945|NCT01562444|616339381|FG002|Overall Study|Did not comply with blood draw schedule|1|||
170544946|NCT01562444|616339379|FG000|Overall Study|Unavailable serological results|0|||
170544947|NCT01562444|616339380|FG001|Overall Study|Unavailable serological results|2|||
170637081|NCT00802945|616682644|FG001|Overall Study|Death|23|||
170637082|NCT00802945|616682643|FG000|Overall Study|Terminated by sponsor|8|||
170637083|NCT00802945|616682644|FG001|Overall Study|Terminated by sponsor|12|||
170637084|NCT05673876|616682645|FG000|Overall Study|Death|3|||
170790147|NCT04508309|617242857|FG000|Overall Study|Death|0|||
170465584|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465585|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465586|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465587|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465588|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
170465589|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465590|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465591|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
170465592|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465593|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465594|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465595|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465596|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465597|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465598|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465599|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465600|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465601|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465602|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
170465603|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465604|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465605|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
170465606|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
170465607|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465608|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465609|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465610|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465611|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465612|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465613|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465614|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465615|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465616|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
170465617|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465618|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465619|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465620|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
170544948|NCT01562444|616339381|FG002|Overall Study|Unavailable serological results|2|||
170544949|NCT01562444|616339379|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
170544950|NCT01562444|616339380|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
170544951|NCT01562444|616339381|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
170544952|NCT01562444|616339379|FG000|Overall Study|Protocol forbidden medication|1|||
170544953|NCT01562444|616339380|FG001|Overall Study|Protocol forbidden medication|0|||
170544954|NCT01562444|616339381|FG002|Overall Study|Protocol forbidden medication|0|||
170544955|NCT03055195|616339386|FG000|Overall Study|Lack of Efficacy|1|||
170544956|NCT03055195|616339387|FG001|Overall Study|Lack of Efficacy|0|||
170544957|NCT03055195|616339386|FG000|Overall Study|Withdrawal by Subject|6|||
170544958|NCT03055195|616339387|FG001|Overall Study|Withdrawal by Subject|7|||
170544959|NCT03055195|616339386|FG000|Overall Study|Study Terminated by Sponsor|2|||
170544960|NCT03055195|616339387|FG001|Overall Study|Study Terminated by Sponsor|6|||
170544961|NCT03055195|616339386|FG000|Overall Study|Protocol Violation|2|||
170544962|NCT03055195|616339387|FG001|Overall Study|Protocol Violation|1|||
170544963|NCT03055195|616339386|FG000|Overall Study|Physician Decision|1|||
170544964|NCT03055195|616339387|FG001|Overall Study|Physician Decision|0|||
170544965|NCT00790933|616339391|FG000|Overall Study|Adverse Event|94|||
170544966|NCT00790933|616339392|FG001|Overall Study|Adverse Event|119|||
170544967|NCT00790933|616339393|FG002|Overall Study|Adverse Event|65|||
170544968|NCT00790933|616339394|FG003|Overall Study|Adverse Event|5|||
170544969|NCT00790933|616339395|FG004|Overall Study|Adverse Event|69|||
170544970|NCT00790933|616339391|FG000|Overall Study|Protocol Violation(s)|8|||
170544971|NCT00790933|616339392|FG001|Overall Study|Protocol Violation(s)|18|||
170544972|NCT00790933|616339393|FG002|Overall Study|Protocol Violation(s)|7|||
170544973|NCT00790933|616339394|FG003|Overall Study|Protocol Violation(s)|0|||
170544974|NCT00790933|616339395|FG004|Overall Study|Protocol Violation(s)|12|||
170544975|NCT00790933|616339391|FG000|Overall Study|Lack of Efficacy|192|||
170544976|NCT00790933|616339392|FG001|Overall Study|Lack of Efficacy|176|||
170544977|NCT00790933|616339393|FG002|Overall Study|Lack of Efficacy|130|||
170544978|NCT00790933|616339394|FG003|Overall Study|Lack of Efficacy|1|||
170637085|NCT05673876|616682646|FG001|Overall Study|Death|1|||
170637086|NCT05673876|616682645|FG000|Overall Study|Study Terminated by Sponsor|0|||
170637087|NCT05673876|616682646|FG001|Overall Study|Study Terminated by Sponsor|1|||
170465621|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465622|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465623|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465624|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465625|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465626|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465627|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465628|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465629|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465630|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
170465631|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465632|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465633|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
170465634|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
170465635|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465636|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465637|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465638|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465639|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465640|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465641|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465642|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465643|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465644|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
170465645|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465646|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465647|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465648|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465649|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465650|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465651|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465652|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465653|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
170465654|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465655|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465656|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465657|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465658|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
170465659|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465660|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465661|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465662|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465663|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465664|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465665|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465666|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465667|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
170465668|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465669|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465670|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465671|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170465672|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
170544979|NCT00790933|616339395|FG004|Overall Study|Lack of Efficacy|121|||
170544980|NCT00790933|616339391|FG000|Overall Study|Study Terminated by Sponsor|0|||
170544981|NCT00790933|616339392|FG001|Overall Study|Study Terminated by Sponsor|0|||
170544982|NCT00790933|616339393|FG002|Overall Study|Study Terminated by Sponsor|1|||
170544983|NCT00790933|616339394|FG003|Overall Study|Study Terminated by Sponsor|0|||
170544984|NCT00790933|616339395|FG004|Overall Study|Study Terminated by Sponsor|0|||
170544985|NCT00790933|616339391|FG000|Overall Study|Withdrawal by Subject|123|||
170544986|NCT00790933|616339392|FG001|Overall Study|Withdrawal by Subject|120|||
170544987|NCT00790933|616339393|FG002|Overall Study|Withdrawal by Subject|52|||
170544988|NCT00790933|616339394|FG003|Overall Study|Withdrawal by Subject|6|||
170544989|NCT00790933|616339395|FG004|Overall Study|Withdrawal by Subject|50|||
170465673|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465674|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465675|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465676|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465677|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465678|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465679|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465680|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465681|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
170465682|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465683|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465684|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465685|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465686|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
170465687|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465688|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465689|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465690|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465691|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465692|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465693|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465694|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465695|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
170465696|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465697|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465698|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465699|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465700|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
170465701|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465702|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465703|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465704|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465705|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465706|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465707|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465708|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465709|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
170465710|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465711|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465712|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465713|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465714|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
170465715|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465716|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465717|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465718|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465719|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465720|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
170465721|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465722|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
170465723|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
170465724|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465725|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465726|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465727|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465728|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
170465729|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465730|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465731|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465732|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465733|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465734|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465735|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170790148|NCT04508309|617242858|FG001|Overall Study|Death|0|||
170465736|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465737|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
170790149|NCT04508309|617242859|FG002|Overall Study|Death|0|||
170790150|NCT04508309|617242860|FG003|Overall Study|Death|0|||
170465738|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465739|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465740|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465741|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465742|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
170465743|NCT03982199|616042044|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465744|NCT03982199|616042045|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465745|NCT03982199|616042046|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465746|NCT03982199|616042047|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465747|NCT03982199|616042048|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465748|NCT03982199|616042049|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
170465749|NCT03982199|616042050|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465750|NCT03982199|616042051|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
170465751|NCT03982199|616042052|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
170465752|NCT03982199|616042053|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465753|NCT03982199|616042054|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465754|NCT03982199|616042055|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465755|NCT03982199|616042056|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465756|NCT03982199|616042057|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
170465757|NCT03982199|616042044|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465758|NCT03982199|616042045|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465759|NCT03982199|616042046|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465760|NCT03982199|616042047|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465761|NCT03982199|616042048|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465762|NCT03982199|616042049|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465763|NCT03982199|616042050|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465764|NCT03982199|616042051|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465765|NCT03982199|616042052|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
170465766|NCT03982199|616042053|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
170465767|NCT03982199|616042054|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
170465768|NCT03982199|616042055|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
170465769|NCT03982199|616042056|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
170465770|NCT03982199|616042057|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
170544990|NCT00790933|616339391|FG000|Overall Study|Lost to Follow-up|13|||
170544991|NCT00790933|616339392|FG001|Overall Study|Lost to Follow-up|31|||
170544992|NCT00790933|616339393|FG002|Overall Study|Lost to Follow-up|10|||
170544993|NCT00790933|616339394|FG003|Overall Study|Lost to Follow-up|1|||
170544994|NCT00790933|616339395|FG004|Overall Study|Lost to Follow-up|15|||
170544995|NCT00790933|616339391|FG000|Overall Study|Reason Not Specified|8|||
170544996|NCT00790933|616339392|FG001|Overall Study|Reason Not Specified|16|||
170544997|NCT00790933|616339393|FG002|Overall Study|Reason Not Specified|4|||
170544998|NCT00790933|616339394|FG003|Overall Study|Reason Not Specified|1|||
170544999|NCT00790933|616339395|FG004|Overall Study|Reason Not Specified|9|||
170545000|NCT05558410|616339396|FG000|Overall Study|Adverse Event|1|||
170545001|NCT05558410|616339397|FG001|Overall Study|Adverse Event|2|||
170545002|NCT05558410|616339398|FG002|Overall Study|Adverse Event|0|||
170545003|NCT05558410|616339396|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
170545004|NCT05558410|616339397|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
170545005|NCT05558410|616339398|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
170545006|NCT05558410|616339396|FG000|Overall Study|Lost to Follow-up|10|||
170545007|NCT05558410|616339397|FG001|Overall Study|Lost to Follow-up|17|||
170545008|NCT05558410|616339398|FG002|Overall Study|Lost to Follow-up|19|||
170545009|NCT05558410|616339396|FG000|Overall Study|Death|1|||
170545010|NCT05558410|616339397|FG001|Overall Study|Death|0|||
170545011|NCT05558410|616339398|FG002|Overall Study|Death|0|||
170545012|NCT05558410|616339396|FG000|Overall Study|Other non-compliance|0|||
170790151|NCT04508309|617242861|FG004|Overall Study|Death|1|||
170545013|NCT05558410|616339397|FG001|Overall Study|Other non-compliance|1|||
170545014|NCT05558410|616339398|FG002|Overall Study|Other non-compliance|2|||
170545015|NCT05558410|616339396|FG000|Overall Study|Sponsor Decision|1|||
170545016|NCT05558410|616339397|FG001|Overall Study|Sponsor Decision|0|||
170545017|NCT05558410|616339398|FG002|Overall Study|Sponsor Decision|0|||
170545018|NCT05558410|616339396|FG000|Overall Study|Other|1|||
170465771|NCT03982199|616042044|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465772|NCT03982199|616042045|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465773|NCT03982199|616042046|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465774|NCT03982199|616042047|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465775|NCT03982199|616042048|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465776|NCT03982199|616042049|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465777|NCT03982199|616042050|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465778|NCT03982199|616042051|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465779|NCT03982199|616042052|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465780|NCT03982199|616042053|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
170465781|NCT03982199|616042054|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465782|NCT03982199|616042055|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465783|NCT03982199|616042056|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465784|NCT03982199|616042057|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
170465785|NCT03982199|616042044|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465786|NCT03982199|616042045|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465787|NCT03982199|616042046|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465788|NCT03982199|616042047|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465789|NCT03982199|616042048|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465790|NCT03982199|616042049|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465791|NCT03982199|616042050|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465792|NCT03982199|616042051|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465793|NCT03982199|616042052|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465794|NCT03982199|616042053|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465795|NCT03982199|616042054|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465796|NCT03982199|616042055|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465797|NCT03982199|616042056|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
170465798|NCT03982199|616042057|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
170465799|NCT03982199|616042044|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465800|NCT03982199|616042045|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465801|NCT03982199|616042046|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465802|NCT03982199|616042047|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465803|NCT03982199|616042048|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465804|NCT03982199|616042049|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465805|NCT03982199|616042050|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465806|NCT03982199|616042051|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465807|NCT03982199|616042052|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465808|NCT03982199|616042053|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465809|NCT03982199|616042054|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
170790152|NCT04508309|617242857|FG000|Overall Study|Lost to Follow-up|0|||
170790153|NCT04508309|617242858|FG001|Overall Study|Lost to Follow-up|0|||
170790154|NCT04508309|617242859|FG002|Overall Study|Lost to Follow-up|1|||
170790155|NCT04508309|617242860|FG003|Overall Study|Lost to Follow-up|1|||
170465810|NCT03982199|616042055|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
170465811|NCT03982199|616042056|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
170465812|NCT03982199|616042057|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
170465813|NCT03982199|616042044|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465814|NCT03982199|616042045|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465815|NCT03982199|616042046|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465816|NCT03982199|616042047|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465817|NCT03982199|616042048|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465818|NCT03982199|616042049|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465819|NCT03982199|616042050|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465820|NCT03982199|616042051|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465821|NCT03982199|616042052|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465822|NCT03982199|616042053|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170545019|NCT05558410|616339397|FG001|Overall Study|Other|0|||
170545020|NCT05558410|616339398|FG002|Overall Study|Other|1|||
170545021|NCT05141357|616339401|FG000|Overall Study|Adverse Event|3|||
170545022|NCT05141357|616339401|FG000|Overall Study|Lack of Efficacy|2|||
170545023|NCT00894647|616339402|FG000|Overall Study|Adverse Event|5|||
170545024|NCT00894647|616339403|FG001|Overall Study|Adverse Event|4|||
170790156|NCT04508309|617242861|FG004|Overall Study|Lost to Follow-up|0|||
170790157|NCT04508309|617242857|FG000|Overall Study|Withdrawal by Subject|0|||
170465823|NCT03982199|616042054|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465824|NCT03982199|616042055|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465825|NCT03982199|616042056|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
170465826|NCT03982199|616042057|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
170465827|NCT03982199|616042044|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465828|NCT03982199|616042045|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465829|NCT03982199|616042046|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465830|NCT03982199|616042047|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465831|NCT03982199|616042048|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465832|NCT03982199|616042049|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465833|NCT03982199|616042050|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465834|NCT03982199|616042051|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465835|NCT03982199|616042052|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465836|NCT03982199|616042053|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465837|NCT03982199|616042054|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465838|NCT03982199|616042055|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
170465839|NCT03982199|616042056|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
170465840|NCT03982199|616042057|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
170465841|NCT03982199|616042044|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465842|NCT03982199|616042045|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465843|NCT03982199|616042046|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465844|NCT03982199|616042047|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465845|NCT03982199|616042048|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465846|NCT03982199|616042049|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465847|NCT03982199|616042050|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465848|NCT03982199|616042051|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465849|NCT03982199|616042052|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465850|NCT03982199|616042053|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465851|NCT03982199|616042054|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465852|NCT03982199|616042055|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465853|NCT03982199|616042056|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
170465854|NCT03982199|616042057|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
170465855|NCT01565850|616042058|FG000|Overall Study|Adverse Event|0|||
170465856|NCT01565850|616042059|FG001|Overall Study|Adverse Event|1|||
170465857|NCT01565850|616042058|FG000|Overall Study|Lost to Follow-up|12|||
170465858|NCT01565850|616042059|FG001|Overall Study|Lost to Follow-up|4|||
170465859|NCT01565850|616042058|FG000|Overall Study|Investigator's Discretion|2|||
170465860|NCT01565850|616042059|FG001|Overall Study|Investigator's Discretion|1|||
170465861|NCT01565850|616042058|FG000|Overall Study|Participant noncompliance|2|||
170465862|NCT01565850|616042059|FG001|Overall Study|Participant noncompliance|0|||
170465863|NCT01565850|616042058|FG000|Overall Study|Withdrew Consent|4|||
170465864|NCT01565850|616042059|FG001|Overall Study|Withdrew Consent|2|||
170465865|NCT05065567|616042061|FG000|Overall Study|Lost to Follow-up|10|||
170465866|NCT05065567|616042062|FG001|Overall Study|Lost to Follow-up|9|||
170465867|NCT05065567|616042063|FG002|Overall Study|Lost to Follow-up|6|||
170465868|NCT05529472|616042064|FG000|Overall Study|Withdrawal by Subject|1|||
170465869|NCT05529472|616042065|FG001|Overall Study|Withdrawal by Subject|1|||
170465870|NCT04324073|616044197|FG000|Overall Study|withdrew consent|0|||
170465871|NCT04324073|616044198|FG001|Overall Study|withdrew consent|4|||
170465872|NCT04324073|616044199|FG002|Overall Study|withdrew consent|2|||
170465873|NCT04324073|616044200|FG003|Overall Study|withdrew consent|8|||
170465874|NCT01200069|616044201|FG000|Overall Study|Withdrawal by Subject|0|||
170465875|NCT01200069|616044202|FG001|Overall Study|Withdrawal by Subject|1|||
170465876|NCT03610516|616044212|FG000|Treatment Epoch|Adverse Event|3|||
170465877|NCT03610516|616044213|FG001|Treatment Epoch|Adverse Event|1|||
170465878|NCT03610516|616044212|FG000|Treatment Epoch|Death|1|||
170465879|NCT03610516|616044213|FG001|Treatment Epoch|Death|0|||
170465880|NCT03610516|616044212|FG000|Treatment Epoch|Lack of Efficacy|0|||
170465881|NCT03610516|616044213|FG001|Treatment Epoch|Lack of Efficacy|1|||
170465882|NCT03610516|616044212|FG000|Treatment Epoch|No longer requires treatment|1|||
170465883|NCT03610516|616044213|FG001|Treatment Epoch|No longer requires treatment|0|||
170465884|NCT03610516|616044212|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
170890501|NCT02574637|617606506|FG008|Double-blind Period|Lack of Efficacy|0|||
170465885|NCT03610516|616044213|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
170465886|NCT03610516|616044212|FG000|Treatment Epoch|Physician Decision|8|||
170465887|NCT03610516|616044213|FG001|Treatment Epoch|Physician Decision|5|||
170465888|NCT03610516|616044212|FG000|Treatment Epoch|Protocol Deviation|1|||
170465889|NCT03610516|616044213|FG001|Treatment Epoch|Protocol Deviation|0|||
170465890|NCT03610516|616044212|FG000|Treatment Epoch|Withdrawal by Subject|3|||
170465891|NCT03610516|616044213|FG001|Treatment Epoch|Withdrawal by Subject|1|||
170890502|NCT02574637|617606507|FG009|Double-blind Period|Lack of Efficacy|0|||
170465892|NCT03610516|616044212|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
170465893|NCT03610516|616044213|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
170465894|NCT03610516|616044212|FG000|Post-Treatment Follow-up|Death|1|||
170465895|NCT03610516|616044213|FG001|Post-Treatment Follow-up|Death|0|||
170465896|NCT00213135|616044214|FG000|Overall Study|Adverse Event|9|||
170465897|NCT00213135|616044215|FG001|Overall Study|Adverse Event|5|||
170465898|NCT00213135|616044216|FG002|Overall Study|Adverse Event|5|||
170465899|NCT00213135|616044214|FG000|Overall Study|Lost to Follow-up|11|||
170465900|NCT00213135|616044215|FG001|Overall Study|Lost to Follow-up|8|||
170465901|NCT00213135|616044216|FG002|Overall Study|Lost to Follow-up|4|||
170465902|NCT00213135|616044214|FG000|Overall Study|Protocol Violation|4|||
170465903|NCT00213135|616044215|FG001|Overall Study|Protocol Violation|4|||
170465904|NCT00213135|616044216|FG002|Overall Study|Protocol Violation|10|||
170465905|NCT00213135|616044214|FG000|Overall Study|Death|1|||
170465906|NCT00213135|616044215|FG001|Overall Study|Death|1|||
170465907|NCT00213135|616044216|FG002|Overall Study|Death|2|||
170465908|NCT00213135|616044214|FG000|Overall Study|Disease progression|4|||
170465909|NCT00213135|616044215|FG001|Overall Study|Disease progression|5|||
170465910|NCT00213135|616044216|FG002|Overall Study|Disease progression|21|||
170465911|NCT00213135|616044214|FG000|Overall Study|Other|21|||
170465912|NCT00213135|616044215|FG001|Overall Study|Other|12|||
170465913|NCT00213135|616044216|FG002|Overall Study|Other|15|||
170465914|NCT00359801|616044219|FG000|Overall Study|Lost to Follow-up|72|||
170465915|NCT00359801|616044220|FG001|Overall Study|Lost to Follow-up|58|||
170465916|NCT00359801|616044219|FG000|Overall Study|Withdrawal by Subject|143|||
170465917|NCT00359801|616044220|FG001|Overall Study|Withdrawal by Subject|96|||
170465918|NCT00359801|616044219|FG000|Overall Study|Other|66|||
170465919|NCT00359801|616044220|FG001|Overall Study|Other|46|||
170465920|NCT00359801|616044219|FG000|Overall Study|Final Status Unknown: missing data|7|||
170465921|NCT00359801|616044220|FG001|Overall Study|Final Status Unknown: missing data|4|||
170465922|NCT00359801|616044219|FG000|Overall Study|Sponsor Decision|17|||
170465923|NCT00359801|616044220|FG001|Overall Study|Sponsor Decision|16|||
170465924|NCT02929056|616044224|FG000|Overall Study|Lost to Follow-up|0|||
170465925|NCT02929056|616044225|FG001|Overall Study|Lost to Follow-up|1|||
170465926|NCT02245412|616044228|FG000|Treatment Period|Death|1|||
170465927|NCT02245412|616044229|FG001|Treatment Period|Death|1|||
170465928|NCT02245412|616044230|FG002|Treatment Period|Death|0|||
170465929|NCT02245412|616044228|FG000|Treatment Period|Physician Decision|1|||
170465930|NCT02245412|616044229|FG001|Treatment Period|Physician Decision|1|||
170465931|NCT02245412|616044230|FG002|Treatment Period|Physician Decision|0|||
170465932|NCT02245412|616044228|FG000|Treatment Period|Withdrawal by Subject|2|||
170465933|NCT02245412|616044229|FG001|Treatment Period|Withdrawal by Subject|1|||
170465934|NCT02245412|616044230|FG002|Treatment Period|Withdrawal by Subject|0|||
170465935|NCT02245412|616044228|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
170465936|NCT02245412|616044229|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
170465937|NCT02245412|616044230|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
170465938|NCT02245412|616044228|FG000|Follow-Up Period|Death|4|||
170465939|NCT02245412|616044229|FG001|Follow-Up Period|Death|2|||
170465940|NCT02245412|616044230|FG002|Follow-Up Period|Death|1|||
170465941|NCT02245412|616044228|FG000|Follow-Up Period|Physician Decision|1|||
170465942|NCT02245412|616044229|FG001|Follow-Up Period|Physician Decision|0|||
170465943|NCT02245412|616044230|FG002|Follow-Up Period|Physician Decision|0|||
170465944|NCT02245412|616044228|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
170465945|NCT02245412|616044229|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
170465946|NCT02245412|616044230|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
170465947|NCT00459043|616044235|FG000|Overall Study|Withdrawal by Subject|1|||
170465948|NCT00459043|616044236|FG001|Overall Study|Withdrawal by Subject|0|||
170790158|NCT04508309|617242858|FG001|Overall Study|Withdrawal by Subject|0|||
170465949|NCT02899195|616044239|FG000|Concurrent Durvalumab|Adverse Event|4|||
170465950|NCT02899195|616044239|FG000|Concurrent Durvalumab|Physician Decision|1|||
170465951|NCT02899195|616044239|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
170465952|NCT02899195|616044239|FG000|Concurrent Durvalumab|Progressive Disease|5|||
170465953|NCT02899195|616044239|FG000|Maintenance Durvalumab|Adverse Event|1|||
170465954|NCT02899195|616044239|FG000|Maintenance Durvalumab|Physician Decision|1|||
170465955|NCT02899195|616044239|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
170465956|NCT02899195|616044239|FG000|Maintenance Durvalumab|Progressive Disease|31|||
170465957|NCT03156504|616044241|FG000|Overall Study|Withdrawal by Subject|1|||
170465958|NCT03452137|616044242|FG000|Overall Study|Death|67|||
170465959|NCT03452137|616044243|FG001|Overall Study|Death|70|||
170465960|NCT03452137|616044242|FG000|Overall Study|Lost to Follow-up|4|||
170465961|NCT03452137|616044243|FG001|Overall Study|Lost to Follow-up|2|||
170465962|NCT03452137|616044242|FG000|Overall Study|Physician Decision|0|||
170545025|NCT00894647|616339402|FG000|Overall Study|Withdrawal by Subject|4|||
170545026|NCT00894647|616339403|FG001|Overall Study|Withdrawal by Subject|4|||
170545027|NCT00894647|616339402|FG000|Overall Study|Lost to Follow-up|0|||
170545028|NCT00894647|616339403|FG001|Overall Study|Lost to Follow-up|2|||
170545029|NCT00894647|616339402|FG000|Overall Study|Non-compliance with study procedures|0|||
170545030|NCT00894647|616339403|FG001|Overall Study|Non-compliance with study procedures|2|||
170890503|NCT02574637|617606498|FG000|Double-blind Period|Protocol Deviation|1|||
170890504|NCT02574637|617606499|FG001|Double-blind Period|Protocol Deviation|0|||
170890505|NCT02574637|617606500|FG002|Double-blind Period|Protocol Deviation|0|||
170890506|NCT02574637|617606501|FG003|Double-blind Period|Protocol Deviation|0|||
170890507|NCT02574637|617606502|FG004|Double-blind Period|Protocol Deviation|0|||
170890508|NCT02574637|617606503|FG005|Double-blind Period|Protocol Deviation|0|||
170890509|NCT02574637|617606504|FG006|Double-blind Period|Protocol Deviation|0|||
170890510|NCT02574637|617606505|FG007|Double-blind Period|Protocol Deviation|0|||
170890511|NCT02574637|617606506|FG008|Double-blind Period|Protocol Deviation|0|||
170890512|NCT02574637|617606507|FG009|Double-blind Period|Protocol Deviation|0|||
170890513|NCT02574637|617606498|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
170890514|NCT02574637|617606499|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
170890515|NCT02574637|617606500|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
170890516|NCT02574637|617606501|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
170890517|NCT02574637|617606502|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
170465963|NCT03452137|616044243|FG001|Overall Study|Physician Decision|1|||
170465964|NCT03452137|616044242|FG000|Overall Study|Study Terminated by Sponsor|120|||
170637088|NCT05673876|616682645|FG000|Overall Study|Physician Decision|0|||
170790159|NCT04508309|617242859|FG002|Overall Study|Withdrawal by Subject|0|||
170790160|NCT04508309|617242860|FG003|Overall Study|Withdrawal by Subject|0|||
170790161|NCT04508309|617242861|FG004|Overall Study|Withdrawal by Subject|1|||
170790162|NCT03058289|617242862|FG000|Overall Study|Radiographic Deterioration|0|||
170790163|NCT03058289|617242863|FG001|Overall Study|Radiographic Deterioration|3|||
170790164|NCT03058289|617242864|FG002|Overall Study|Radiographic Deterioration|1|||
170790165|NCT03058289|617242865|FG003|Overall Study|Radiographic Deterioration|2|||
170790166|NCT03058289|617242866|FG004|Overall Study|Radiographic Deterioration|6|||
170790167|NCT03058289|617242867|FG005|Overall Study|Radiographic Deterioration|3|||
170790168|NCT03058289|617242868|FG006|Overall Study|Radiographic Deterioration|0|||
170790169|NCT03058289|617242869|FG007|Overall Study|Radiographic Deterioration|4|||
170790170|NCT03058289|617242870|FG008|Overall Study|Radiographic Deterioration|2|||
170790171|NCT03058289|617242862|FG000|Overall Study|Adverse Event|2|||
170790172|NCT03058289|617242863|FG001|Overall Study|Adverse Event|0|||
170790173|NCT03058289|617242864|FG002|Overall Study|Adverse Event|1|||
170790174|NCT03058289|617242865|FG003|Overall Study|Adverse Event|3|||
170790175|NCT03058289|617242866|FG004|Overall Study|Adverse Event|1|||
170790176|NCT03058289|617242867|FG005|Overall Study|Adverse Event|0|||
170790177|NCT03058289|617242868|FG006|Overall Study|Adverse Event|1|||
170790178|NCT03058289|617242869|FG007|Overall Study|Adverse Event|3|||
170790179|NCT03058289|617242870|FG008|Overall Study|Adverse Event|0|||
170790180|NCT03058289|617242862|FG000|Overall Study|Withdrawal by Subject|0|||
170790181|NCT03058289|617242863|FG001|Overall Study|Withdrawal by Subject|0|||
170790182|NCT03058289|617242864|FG002|Overall Study|Withdrawal by Subject|0|||
170790183|NCT03058289|617242865|FG003|Overall Study|Withdrawal by Subject|2|||
170790184|NCT03058289|617242866|FG004|Overall Study|Withdrawal by Subject|0|||
170790185|NCT03058289|617242867|FG005|Overall Study|Withdrawal by Subject|2|||
170790186|NCT03058289|617242868|FG006|Overall Study|Withdrawal by Subject|0|||
170790187|NCT03058289|617242869|FG007|Overall Study|Withdrawal by Subject|4|||
170790188|NCT03058289|617242870|FG008|Overall Study|Withdrawal by Subject|1|||
170790189|NCT03058289|617242862|FG000|Overall Study|Physician Decision|1|||
170790190|NCT03058289|617242863|FG001|Overall Study|Physician Decision|0|||
170790191|NCT03058289|617242864|FG002|Overall Study|Physician Decision|0|||
170790192|NCT03058289|617242865|FG003|Overall Study|Physician Decision|2|||
170790193|NCT03058289|617242866|FG004|Overall Study|Physician Decision|1|||
170790194|NCT03058289|617242867|FG005|Overall Study|Physician Decision|0|||
170790195|NCT03058289|617242868|FG006|Overall Study|Physician Decision|2|||
170790196|NCT03058289|617242869|FG007|Overall Study|Physician Decision|3|||
170790197|NCT03058289|617242870|FG008|Overall Study|Physician Decision|0|||
170790198|NCT03058289|617242862|FG000|Overall Study|Clinical Deterioration|2|||
170790199|NCT03058289|617242863|FG001|Overall Study|Clinical Deterioration|0|||
170790200|NCT03058289|617242864|FG002|Overall Study|Clinical Deterioration|0|||
170790201|NCT03058289|617242865|FG003|Overall Study|Clinical Deterioration|2|||
170790202|NCT03058289|617242866|FG004|Overall Study|Clinical Deterioration|1|||
170790203|NCT03058289|617242867|FG005|Overall Study|Clinical Deterioration|1|||
170790204|NCT03058289|617242868|FG006|Overall Study|Clinical Deterioration|0|||
170790205|NCT03058289|617242869|FG007|Overall Study|Clinical Deterioration|3|||
170790206|NCT03058289|617242870|FG008|Overall Study|Clinical Deterioration|2|||
170790207|NCT03058289|617242862|FG000|Overall Study|Lost to Follow-up|0|||
170790208|NCT03058289|617242863|FG001|Overall Study|Lost to Follow-up|0|||
170790209|NCT03058289|617242864|FG002|Overall Study|Lost to Follow-up|0|||
170790210|NCT03058289|617242865|FG003|Overall Study|Lost to Follow-up|0|||
170790211|NCT03058289|617242866|FG004|Overall Study|Lost to Follow-up|1|||
170790212|NCT03058289|617242867|FG005|Overall Study|Lost to Follow-up|0|||
170790213|NCT03058289|617242868|FG006|Overall Study|Lost to Follow-up|0|||
170545031|NCT00894647|616339402|FG000|Overall Study|Other, not due to AE|1|||
170545032|NCT00894647|616339403|FG001|Overall Study|Other, not due to AE|2|||
170545033|NCT00245570|616339404|FG000|Washout Between Periods III and IV|Adverse Event|0|||
170545034|NCT00245570|616339405|FG001|Washout Between Periods III and IV|Adverse Event|1|||
170545035|NCT00245570|616339406|FG002|Washout Between Periods III and IV|Adverse Event|0|||
170545036|NCT00245570|616339407|FG003|Washout Between Periods III and IV|Adverse Event|0|||
170545037|NCT00245570|616339408|FG004|Washout Between Periods III and IV|Adverse Event|0|||
170545038|NCT00245570|616339409|FG005|Washout Between Periods III and IV|Adverse Event|0|||
170545039|NCT01028560|616339410|FG000|Overall Study|Lack of Efficacy|3|||
170545040|NCT01028560|616339411|FG001|Overall Study|Lack of Efficacy|6|||
170790214|NCT03058289|617242869|FG007|Overall Study|Lost to Follow-up|0|||
170790215|NCT03058289|617242870|FG008|Overall Study|Lost to Follow-up|0|||
170790216|NCT03058289|617242862|FG000|Overall Study|Refused Further Treatment|0|||
170790217|NCT03058289|617242863|FG001|Overall Study|Refused Further Treatment|0|||
170790218|NCT03058289|617242864|FG002|Overall Study|Refused Further Treatment|1|||
170790219|NCT03058289|617242865|FG003|Overall Study|Refused Further Treatment|0|||
170790220|NCT03058289|617242866|FG004|Overall Study|Refused Further Treatment|1|||
170790221|NCT03058289|617242867|FG005|Overall Study|Refused Further Treatment|0|||
170790222|NCT03058289|617242868|FG006|Overall Study|Refused Further Treatment|0|||
170790223|NCT03058289|617242869|FG007|Overall Study|Refused Further Treatment|0|||
170790224|NCT03058289|617242870|FG008|Overall Study|Refused Further Treatment|0|||
170545041|NCT01028560|616339410|FG000|Overall Study|Withdrawal by Subject|7|||
170545042|NCT01028560|616339411|FG001|Overall Study|Withdrawal by Subject|12|||
170545043|NCT01960842|616339412|FG000|Overall Study|Adverse Event|1|||
170545044|NCT01960842|616339412|FG000|Overall Study|Withdrawal by Subject|2|||
170545045|NCT01336972|616339413|FG000|Overall Study|Adverse Event|1|||
170545046|NCT01336972|616339414|FG001|Overall Study|Adverse Event|1|||
170545047|NCT01336972|616339415|FG002|Overall Study|Adverse Event|0|||
170545048|NCT02441114|616339419|FG000|Washout2|Withdrawal by Subject|4|||
170545049|NCT05278065|616339421|FG000|Overall Study|Withdrawal by Subject|1|||
170545050|NCT05278065|616339422|FG001|Overall Study|Withdrawal by Subject|0|||
170545051|NCT00283959|616339425|FG000|Extension Period|Low Compliance|1|||
170545052|NCT04625972|616339426|FG000|Overall Study|Death|3|||
170545053|NCT04625972|616339427|FG001|Overall Study|Death|2|||
170545054|NCT04625972|616339426|FG000|Overall Study|Lost to Follow-up|82|||
170545055|NCT04625972|616339427|FG001|Overall Study|Lost to Follow-up|38|||
170545056|NCT04625972|616339426|FG000|Overall Study|Physician Decision|2|||
170545057|NCT04625972|616339427|FG001|Overall Study|Physician Decision|0|||
170545058|NCT04625972|616339426|FG000|Overall Study|Protocol Violation|0|||
170545059|NCT04625972|616339427|FG001|Overall Study|Protocol Violation|1|||
170545060|NCT04625972|616339426|FG000|Overall Study|Withdrawal by Subject|37|||
170545061|NCT04625972|616339427|FG001|Overall Study|Withdrawal by Subject|24|||
170545062|NCT04625972|616339426|FG000|Overall Study|Not specified elsewhere|8|||
170545063|NCT04625972|616339427|FG001|Overall Study|Not specified elsewhere|6|||
170545064|NCT00504309|616339430|FG000|Overall Study|Death|0|||
170545065|NCT00504309|616339431|FG001|Overall Study|Death|0|||
170545066|NCT00504309|616339432|FG002|Overall Study|Death|0|||
170545067|NCT00504309|616339433|FG003|Overall Study|Death|0|||
170545068|NCT00504309|616339434|FG004|Overall Study|Death|1|||
170545069|NCT00504309|616339435|FG005|Overall Study|Death|0|||
170545070|NCT00504309|616339430|FG000|Overall Study|Withdrawal by Subject|0|||
170545071|NCT00504309|616339431|FG001|Overall Study|Withdrawal by Subject|0|||
170545072|NCT00504309|616339432|FG002|Overall Study|Withdrawal by Subject|1|||
170545073|NCT00504309|616339433|FG003|Overall Study|Withdrawal by Subject|0|||
170545074|NCT00504309|616339434|FG004|Overall Study|Withdrawal by Subject|0|||
170545075|NCT00504309|616339435|FG005|Overall Study|Withdrawal by Subject|0|||
170545076|NCT03345095|616339436|FG000|Overall Study|Lack of Efficacy|184|||
170545077|NCT03345095|616339437|FG001|Overall Study|Lack of Efficacy|156|||
170545078|NCT03345095|616339436|FG000|Overall Study|Adverse Event|36|||
170545079|NCT03345095|616339437|FG001|Overall Study|Adverse Event|118|||
170545080|NCT03345095|616339436|FG000|Overall Study|Withdrawal by Subject|22|||
170545081|NCT03345095|616339437|FG001|Overall Study|Withdrawal by Subject|59|||
170637089|NCT05673876|616682646|FG001|Overall Study|Physician Decision|1|||
170637090|NCT05006573|616682649|FG000|Double-blind Treatment Period|Physician Decision|2|||
170637091|NCT05006573|616682650|FG001|Double-blind Treatment Period|Physician Decision|0|||
170637092|NCT05006573|616682649|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
170637093|NCT05006573|616682650|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
170637094|NCT05006573|616682649|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
170637095|NCT05006573|616682650|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
170790225|NCT03058289|617242862|FG000|Overall Study|Rapid Progression of Disease|0|||
170790226|NCT03058289|617242863|FG001|Overall Study|Rapid Progression of Disease|0|||
170790227|NCT03058289|617242864|FG002|Overall Study|Rapid Progression of Disease|0|||
170790228|NCT03058289|617242865|FG003|Overall Study|Rapid Progression of Disease|1|||
170790229|NCT03058289|617242866|FG004|Overall Study|Rapid Progression of Disease|0|||
170790230|NCT03058289|617242867|FG005|Overall Study|Rapid Progression of Disease|0|||
170790231|NCT03058289|617242868|FG006|Overall Study|Rapid Progression of Disease|0|||
170790232|NCT03058289|617242869|FG007|Overall Study|Rapid Progression of Disease|0|||
170790233|NCT03058289|617242870|FG008|Overall Study|Rapid Progression of Disease|0|||
170790234|NCT05139810|617242871|FG000|Overall Study|Voluntary Withdrawal|2|||
170790235|NCT05139810|617242872|FG001|Overall Study|Voluntary Withdrawal|1|||
170790236|NCT05139810|617242873|FG002|Overall Study|Voluntary Withdrawal|0|||
170790237|NCT05139810|617242871|FG000|Overall Study|Pregnancy|1|||
170790238|NCT05139810|617242872|FG001|Overall Study|Pregnancy|0|||
170790239|NCT05139810|617242873|FG002|Overall Study|Pregnancy|0|||
170790240|NCT05139810|617242871|FG000|Overall Study|Roll Over to CS7|19|||
170790241|NCT05139810|617242872|FG001|Overall Study|Roll Over to CS7|44|||
170790242|NCT05139810|617242873|FG002|Overall Study|Roll Over to CS7|20|||
170545082|NCT03345095|616339436|FG000|Overall Study|Physician Decision|3|||
170545083|NCT03345095|616339437|FG001|Overall Study|Physician Decision|18|||
170545084|NCT03345095|616339436|FG000|Overall Study|Death|2|||
170545085|NCT03345095|616339437|FG001|Overall Study|Death|4|||
170545086|NCT03345095|616339436|FG000|Overall Study|Other reasons|2|||
170545087|NCT03345095|616339437|FG001|Overall Study|Other reasons|11|||
170545088|NCT03345095|616339436|FG000|Overall Study|Protocol Violation|0|||
170545089|NCT03345095|616339437|FG001|Overall Study|Protocol Violation|1|||
170545090|NCT04937387|616339438|FG000|Overall Study|Adverse Event|1|||
170545091|NCT04937387|616339439|FG001|Overall Study|Adverse Event|0|||
170545092|NCT04937387|616339440|FG002|Overall Study|Adverse Event|2|||
170545093|NCT04937387|616339441|FG003|Overall Study|Adverse Event|0|||
170637096|NCT05006573|616682649|FG000|Double-blind Treatment Period|Protocol Violation|2|||
170890518|NCT02574637|617606503|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
170890519|NCT02574637|617606504|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
170890520|NCT02574637|617606505|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
170890521|NCT02574637|617606506|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
170890522|NCT02574637|617606507|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
170890523|NCT02574637|617606498|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
170465965|NCT03452137|616044243|FG001|Overall Study|Study Terminated by Sponsor|121|||
170637097|NCT05006573|616682650|FG001|Double-blind Treatment Period|Protocol Violation|0|||
170465966|NCT03452137|616044242|FG000|Overall Study|Withdrawal by Subject|12|||
170465967|NCT03452137|616044243|FG001|Overall Study|Withdrawal by Subject|9|||
170637098|NCT05006573|616682649|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
170637099|NCT05006573|616682650|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
170637100|NCT05006573|616682649|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
170465968|NCT05048329|616044244|FG000|Overall Study|Withdrawal by Subject|1|||
170465969|NCT05048329|616044244|FG000|Overall Study|Screenfail|1|||
170465970|NCT02856802|616044245|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
170465971|NCT02856802|616044246|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
170465972|NCT02856802|616044245|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
170465973|NCT02856802|616044246|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
170465974|NCT02856802|616044245|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
170465975|NCT02856802|616044246|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
170465976|NCT02856802|616044245|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
170790243|NCT05940194|617242874|FG000|Overall Study|Adverse Event|0|||
170790244|NCT05940194|617242875|FG001|Overall Study|Adverse Event|1|||
170790245|NCT05940194|617242876|FG002|Overall Study|Adverse Event|0|||
170790246|NCT05940194|617242874|FG000|Overall Study|Migrated/Moved from the study area|2|||
170790247|NCT05940194|617242875|FG001|Overall Study|Migrated/Moved from the study area|2|||
170790248|NCT05940194|617242876|FG002|Overall Study|Migrated/Moved from the study area|4|||
170790249|NCT02838420|617242877|FG000|Overall Study|Ongoing in Study|113|||
170790250|NCT02838420|617242878|FG001|Overall Study|Ongoing in Study|45|||
170790251|NCT02838420|617242877|FG000|Overall Study|Lost to Follow-up|1|||
170790252|NCT02838420|617242878|FG001|Overall Study|Lost to Follow-up|0|||
170790253|NCT02838420|617242877|FG000|Overall Study|Withdrawal by Subject|3|||
170790254|NCT02838420|617242878|FG001|Overall Study|Withdrawal by Subject|4|||
170790255|NCT02838420|617242877|FG000|Overall Study|Death|8|||
170790256|NCT02838420|617242878|FG001|Overall Study|Death|13|||
170790257|NCT03701763|617242879|FG000|Placebo-controlled Phase|Adverse Event|1|||
170790258|NCT03701763|617242880|FG001|Placebo-controlled Phase|Adverse Event|5|||
170790259|NCT03701763|617242881|FG002|Placebo-controlled Phase|Adverse Event|0|||
170790260|NCT03701763|617242882|FG003|Placebo-controlled Phase|Adverse Event|0|||
170790261|NCT03701763|617242879|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
170790262|NCT03701763|617242880|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
170790263|NCT03701763|617242881|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
170790264|NCT03701763|617242882|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
170790265|NCT03701763|617242879|FG000|Placebo-controlled Phase|Miscellaneous|2|||
170790266|NCT03701763|617242880|FG001|Placebo-controlled Phase|Miscellaneous|0|||
170790267|NCT03701763|617242881|FG002|Placebo-controlled Phase|Miscellaneous|0|||
170465977|NCT02856802|616044246|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
170465978|NCT02856802|616044245|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
170465979|NCT02856802|616044246|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
170637101|NCT05006573|616682650|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
170637102|NCT04500158|616682651|FG000|Overall Study|Physician Decision|17|||
170465980|NCT02856802|616044245|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
170637103|NCT04500158|616682652|FG001|Overall Study|Physician Decision|11|||
170790268|NCT03701763|617242882|FG003|Placebo-controlled Phase|Miscellaneous|0|||
170790269|NCT03701763|617242879|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
170890524|NCT02574637|617606499|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
170465981|NCT02856802|616044246|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
170637104|NCT02807402|616682655|FG000|Overall Study|Failure to Return|1|||
170637105|NCT02807402|616682655|FG000|Overall Study|Death|3|||
170637106|NCT02807402|616682655|FG000|Overall Study|Other|2|||
170637107|NCT04774094|616682657|FG000|Overall Study|Other|2|||
170790270|NCT03701763|617242880|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
170790271|NCT03701763|617242881|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
170790272|NCT03701763|617242882|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
170790273|NCT03701763|617242879|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
170790274|NCT03701763|617242880|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
170790275|NCT03701763|617242881|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
170465982|NCT02126826|616044247|FG000|Overall Study|Withdrawal by Subject|0|||
170465983|NCT02126826|616044248|FG001|Overall Study|Withdrawal by Subject|0|||
170465984|NCT02126826|616044249|FG002|Overall Study|Withdrawal by Subject|0|||
170465985|NCT02126826|616044250|FG003|Overall Study|Withdrawal by Subject|1|||
170465986|NCT02126826|616044251|FG004|Overall Study|Withdrawal by Subject|0|||
170465987|NCT02126826|616044252|FG005|Overall Study|Withdrawal by Subject|0|||
170465988|NCT02126826|616044253|FG006|Overall Study|Withdrawal by Subject|0|||
170465989|NCT02152605|616044254|FG000|Overall Study|Adverse Event|6|||
170465990|NCT02152605|616044255|FG001|Overall Study|Adverse Event|8|||
170465991|NCT02152605|616044254|FG000|Overall Study|Lack of Efficacy|7|||
170465992|NCT02152605|616044255|FG001|Overall Study|Lack of Efficacy|4|||
170465993|NCT02152605|616044254|FG000|Overall Study|Protocol deviation|1|||
170465994|NCT02152605|616044255|FG001|Overall Study|Protocol deviation|4|||
170465995|NCT02152605|616044254|FG000|Overall Study|Lost to Follow-up|1|||
170465996|NCT02152605|616044255|FG001|Overall Study|Lost to Follow-up|0|||
170465997|NCT02152605|616044254|FG000|Overall Study|Withdrew consent|4|||
170465998|NCT02152605|616044255|FG001|Overall Study|Withdrew consent|2|||
170465999|NCT03092219|616044262|FG000|Overall Study|Protocol Violation|7|||
170466000|NCT03092219|616044263|FG001|Overall Study|Protocol Violation|4|||
170466001|NCT02094417|616044267|FG000|Overall Study|Adverse Event|0|||
170637108|NCT04774094|616682657|FG000|Overall Study|Withdrawal by Subject|9|||
170637109|NCT04774094|616682657|FG000|Overall Study|Lost to Follow-up|7|||
170637110|NCT04774094|616682657|FG000|Overall Study|Lack of Efficacy|5|||
170637111|NCT04774094|616682657|FG000|Overall Study|Death|17|||
170637112|NCT04774094|616682657|FG000|Overall Study|Adverse Event|4|||
170637113|NCT00905164|616682658|FG000|Period 1|Protocol Violation|0|||
170637114|NCT00905164|616682659|FG001|Period 1|Protocol Violation|1|||
170637115|NCT04730804|616682660|FG000|Overall Study|Physician Decision|0|||
170637116|NCT04730804|616682661|FG001|Overall Study|Physician Decision|0|||
170637117|NCT04730804|616682662|FG002|Overall Study|Physician Decision|0|||
170637118|NCT04730804|616682663|FG003|Overall Study|Physician Decision|0|||
170637119|NCT04730804|616682664|FG004|Overall Study|Physician Decision|0|||
170637120|NCT04730804|616682665|FG005|Overall Study|Physician Decision|1|||
170637121|NCT04730804|616682660|FG000|Overall Study|Withdrawal by Subject|0|||
170637122|NCT04730804|616682661|FG001|Overall Study|Withdrawal by Subject|0|||
170637123|NCT04730804|616682662|FG002|Overall Study|Withdrawal by Subject|0|||
170637124|NCT04730804|616682663|FG003|Overall Study|Withdrawal by Subject|0|||
170637125|NCT04730804|616682664|FG004|Overall Study|Withdrawal by Subject|1|||
170637126|NCT04730804|616682665|FG005|Overall Study|Withdrawal by Subject|2|||
170637127|NCT03079102|616684489|FG000|Overall Study|Physician Decision|0|||
170637128|NCT03079102|616684490|FG001|Overall Study|Physician Decision|1|||
170637129|NCT00854113|616684494|FG000|Overall Study|Adverse Event|0|||
170637130|NCT00854113|616684495|FG001|Overall Study|Adverse Event|0|||
170466002|NCT02094417|616044268|FG001|Overall Study|Adverse Event|0|||
170466003|NCT02094417|616044269|FG002|Overall Study|Adverse Event|0|||
170466004|NCT02094417|616044270|FG003|Overall Study|Adverse Event|1|||
170466005|NCT02094417|616044267|FG000|Overall Study|Eligibility criteria|0|||
170466006|NCT02094417|616044268|FG001|Overall Study|Eligibility criteria|1|||
170466007|NCT02094417|616044269|FG002|Overall Study|Eligibility criteria|0|||
170466008|NCT02094417|616044270|FG003|Overall Study|Eligibility criteria|0|||
170466009|NCT02094417|616044267|FG000|Overall Study|No responder|4|||
170466010|NCT02094417|616044268|FG001|Overall Study|No responder|4|||
170466011|NCT02094417|616044269|FG002|Overall Study|No responder|4|||
170466012|NCT02094417|616044270|FG003|Overall Study|No responder|3|||
170466013|NCT02094417|616044267|FG000|Overall Study|Unable to conduct observations or assess|0|||
170466014|NCT02094417|616044268|FG001|Overall Study|Unable to conduct observations or assess|1|||
170466015|NCT02094417|616044269|FG002|Overall Study|Unable to conduct observations or assess|0|||
170466016|NCT02094417|616044270|FG003|Overall Study|Unable to conduct observations or assess|0|||
170466017|NCT02094417|616044267|FG000|Overall Study|Withdrawal by Subject|1|||
170466018|NCT02094417|616044268|FG001|Overall Study|Withdrawal by Subject|2|||
170466019|NCT02094417|616044269|FG002|Overall Study|Withdrawal by Subject|1|||
170466020|NCT02094417|616044270|FG003|Overall Study|Withdrawal by Subject|3|||
170637131|NCT00854113|616684496|FG002|Overall Study|Adverse Event|0|||
170637132|NCT00854113|616684497|FG003|Overall Study|Adverse Event|0|||
170637133|NCT00854113|616684498|FG004|Overall Study|Adverse Event|0|||
170637134|NCT00854113|616684499|FG005|Overall Study|Adverse Event|0|||
170637135|NCT00854113|616684500|FG006|Overall Study|Adverse Event|0|||
170466021|NCT00580788|616044271|FG000|Overall Study|Adverse Event|0|||
170466022|NCT00580788|616044272|FG001|Overall Study|Adverse Event|0|||
170466023|NCT00580788|616044273|FG002|Overall Study|Adverse Event|0|||
170637136|NCT00854113|616684501|FG007|Overall Study|Adverse Event|2|||
170637137|NCT00854113|616684502|FG008|Overall Study|Adverse Event|0|||
170637138|NCT00854113|616684503|FG009|Overall Study|Adverse Event|0|||
170637139|NCT00854113|616684504|FG010|Overall Study|Adverse Event|0|||
170637140|NCT00854113|616684494|FG000|Overall Study|Withdrawal by Subject|0|||
170466024|NCT00580788|616044274|FG003|Overall Study|Adverse Event|1|||
170466025|NCT01443728|616044275|FG000|Overall Study|Lost to Follow-up|2|||
170466026|NCT01443728|616044276|FG001|Overall Study|Lost to Follow-up|0|||
170466027|NCT01443728|616044275|FG000|Overall Study|Withdrawal by Subject|1|||
170466028|NCT01443728|616044276|FG001|Overall Study|Withdrawal by Subject|1|||
170466029|NCT01443728|616044275|FG000|Overall Study|Adverse Event|0|||
170466030|NCT01443728|616044276|FG001|Overall Study|Adverse Event|2|||
170466031|NCT01403051|616044279|FG000|Overall Study|Protocol Violation|2|||
170466032|NCT01403051|616044280|FG001|Overall Study|Protocol Violation|0|||
170466033|NCT01403051|616044279|FG000|Overall Study|Death|1|||
170466034|NCT01403051|616044280|FG001|Overall Study|Death|0|||
170466035|NCT01403051|616044279|FG000|Overall Study|Withdrawal by Subject|2|||
170466036|NCT01403051|616044280|FG001|Overall Study|Withdrawal by Subject|1|||
170466037|NCT01403051|616044279|FG000|Overall Study|Lost to Follow-up|5|||
170466038|NCT01403051|616044280|FG001|Overall Study|Lost to Follow-up|5|||
170466039|NCT03929757|616044282|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
170466040|NCT03929757|616044283|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
170466041|NCT03929757|616044284|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
170466042|NCT03929757|616044282|FG000|Main Study: Up to Day 365|Other|1|||
170466043|NCT03929757|616044283|FG001|Main Study: Up to Day 365|Other|0|||
170466044|NCT03929757|616044284|FG002|Main Study: Up to Day 365|Other|0|||
170466045|NCT03929757|616044282|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
170466046|NCT03929757|616044283|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
170466047|NCT03929757|616044284|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
170466048|NCT02448706|616044304|FG000|Overall Study|Withdrawal by Subject|4|||
170466049|NCT02448706|616044305|FG001|Overall Study|Withdrawal by Subject|3|||
170466050|NCT02448706|616044304|FG000|Overall Study|Protocol Violation|1|||
170466051|NCT02448706|616044305|FG001|Overall Study|Protocol Violation|1|||
170466052|NCT03559400|616044308|FG000|Overall Study|Lost to Follow-up|9|||
170466053|NCT03559400|616044309|FG001|Overall Study|Lost to Follow-up|7|||
170466054|NCT03559400|616044308|FG000|Overall Study|Death|0|||
170466055|NCT03559400|616044309|FG001|Overall Study|Death|2|||
170466056|NCT00509366|616044310|FG000|Overall Study|Not Treated (Screen Failure)|1|||
170466057|NCT00509366|616044311|FG001|Overall Study|Not Treated (Screen Failure)|1|||
170466058|NCT00509366|616044312|FG002|Overall Study|Not Treated (Screen Failure)|1|||
170466059|NCT00509366|616044313|FG003|Overall Study|Not Treated (Screen Failure)|0|||
170466060|NCT00509366|616044314|FG004|Overall Study|Not Treated (Screen Failure)|0|||
170466061|NCT02119819|616044315|FG000|Overall Study|Adverse Event|3|||
170466062|NCT02119819|616044316|FG001|Overall Study|Adverse Event|1|||
170466063|NCT02119819|616044317|FG002|Overall Study|Adverse Event|2|||
170466064|NCT02119819|616044318|FG003|Overall Study|Adverse Event|3|||
170466065|NCT02119819|616044319|FG004|Overall Study|Adverse Event|0|||
170466066|NCT02119819|616044320|FG005|Overall Study|Adverse Event|1|||
170466067|NCT02119819|616044315|FG000|Overall Study|Lack of Efficacy|0|||
170466068|NCT02119819|616044316|FG001|Overall Study|Lack of Efficacy|0|||
170466069|NCT02119819|616044317|FG002|Overall Study|Lack of Efficacy|0|||
170466070|NCT02119819|616044318|FG003|Overall Study|Lack of Efficacy|0|||
170466071|NCT02119819|616044319|FG004|Overall Study|Lack of Efficacy|0|||
170466072|NCT02119819|616044320|FG005|Overall Study|Lack of Efficacy|1|||
170466073|NCT02119819|616044315|FG000|Overall Study|Lost to Follow-up|0|||
170466074|NCT02119819|616044316|FG001|Overall Study|Lost to Follow-up|0|||
170466075|NCT02119819|616044317|FG002|Overall Study|Lost to Follow-up|1|||
170466076|NCT02119819|616044318|FG003|Overall Study|Lost to Follow-up|2|||
170466077|NCT02119819|616044319|FG004|Overall Study|Lost to Follow-up|1|||
170466078|NCT02119819|616044320|FG005|Overall Study|Lost to Follow-up|2|||
170466079|NCT02119819|616044315|FG000|Overall Study|Physician Decision|1|||
170466080|NCT02119819|616044316|FG001|Overall Study|Physician Decision|1|||
170466081|NCT02119819|616044317|FG002|Overall Study|Physician Decision|0|||
170466082|NCT02119819|616044318|FG003|Overall Study|Physician Decision|0|||
170466083|NCT02119819|616044319|FG004|Overall Study|Physician Decision|0|||
170466084|NCT02119819|616044320|FG005|Overall Study|Physician Decision|1|||
170466085|NCT02119819|616044315|FG000|Overall Study|Withdrawal by Subject|5|||
170466086|NCT02119819|616044316|FG001|Overall Study|Withdrawal by Subject|3|||
170466087|NCT02119819|616044317|FG002|Overall Study|Withdrawal by Subject|0|||
170466088|NCT02119819|616044318|FG003|Overall Study|Withdrawal by Subject|0|||
170466089|NCT02119819|616044319|FG004|Overall Study|Withdrawal by Subject|6|||
170466090|NCT02119819|616044320|FG005|Overall Study|Withdrawal by Subject|10|||
170466091|NCT02119819|616044315|FG000|Overall Study|Jury Duty|0|||
170466092|NCT02119819|616044316|FG001|Overall Study|Jury Duty|0|||
170466093|NCT02119819|616044317|FG002|Overall Study|Jury Duty|1|||
170466094|NCT02119819|616044318|FG003|Overall Study|Jury Duty|0|||
170466095|NCT02119819|616044319|FG004|Overall Study|Jury Duty|0|||
170466096|NCT02119819|616044320|FG005|Overall Study|Jury Duty|0|||
170466097|NCT02119819|616044315|FG000|Overall Study|Protocol Violation|0|||
170466098|NCT02119819|616044316|FG001|Overall Study|Protocol Violation|0|||
170466099|NCT02119819|616044317|FG002|Overall Study|Protocol Violation|0|||
170466100|NCT02119819|616044318|FG003|Overall Study|Protocol Violation|1|||
170466101|NCT02119819|616044319|FG004|Overall Study|Protocol Violation|0|||
170466102|NCT02119819|616044320|FG005|Overall Study|Protocol Violation|0|||
170466103|NCT02119819|616044315|FG000|Overall Study|Left the city to get a job|0|||
170466104|NCT02119819|616044316|FG001|Overall Study|Left the city to get a job|0|||
170466105|NCT02119819|616044317|FG002|Overall Study|Left the city to get a job|0|||
170466106|NCT02119819|616044318|FG003|Overall Study|Left the city to get a job|1|||
170466107|NCT02119819|616044319|FG004|Overall Study|Left the city to get a job|0|||
170466108|NCT02119819|616044320|FG005|Overall Study|Left the city to get a job|0|||
170466109|NCT00282919|616044324|FG000|Overall Study|Lack of Efficacy|4|||
170466110|NCT00282919|616044324|FG000|Overall Study|Withdrawal by Subject|1|||
170466111|NCT00282919|616044324|FG000|Overall Study|Asymptomatic Parasitemia|2|||
170466112|NCT01438996|616044325|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
170466113|NCT01438996|616044326|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
170466114|NCT01438996|616044327|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
170466115|NCT02861014|616044330|FG000|Primary Analysis|Adverse Event|7|||
170466116|NCT02861014|616044330|FG000|Primary Analysis|Death|1|||
170466117|NCT02861014|616044330|FG000|Primary Analysis|Lack of Efficacy|3|||
170466118|NCT02861014|616044330|FG000|Primary Analysis|Physician Decision|2|||
170466119|NCT02861014|616044330|FG000|Primary Analysis|Pregnancy|4|||
170466120|NCT02861014|616044330|FG000|Primary Analysis|Protocol Violation|2|||
170466121|NCT02861014|616044330|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
170466122|NCT02861014|616044330|FG000|Primary Analysis|Withdrawal by Subject|14|||
170466123|NCT02861014|616044330|FG000|Primary Analysis|Commercial ocrelizumab|3|||
170466124|NCT02861014|616044330|FG000|Safety Follow-up|Adverse Event|1|||
170466125|NCT02861014|616044330|FG000|Safety Follow-up|Pregnancy|1|||
170466126|NCT02861014|616044330|FG000|Safety Follow-up|Withdrawal by Subject|9|||
170466127|NCT02861014|616044330|FG000|Safety Follow-up|Study terminated by sponsor|1|||
170466128|NCT02861014|616044330|FG000|Safety Follow-up|Physician Decision|1|||
170466129|NCT02861014|616044330|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
170466130|NCT02861014|616044330|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
170466131|NCT03257865|616044331|FG000|Overall Study|Adverse Event|4|||
170466132|NCT03257865|616044332|FG001|Overall Study|Adverse Event|8|||
170466133|NCT03257865|616044331|FG000|Overall Study|Lack of Efficacy|1|||
170466134|NCT03257865|616044332|FG001|Overall Study|Lack of Efficacy|2|||
170466135|NCT03257865|616044331|FG000|Overall Study|Non-compliance with Study Drug|0|||
170466136|NCT03257865|616044332|FG001|Overall Study|Non-compliance with Study Drug|2|||
170466137|NCT03257865|616044331|FG000|Overall Study|Withdrawal by Subject|23|||
170466138|NCT03257865|616044332|FG001|Overall Study|Withdrawal by Subject|17|||
170466139|NCT03257865|616044331|FG000|Overall Study|Physician Decision|3|||
170466140|NCT03257865|616044332|FG001|Overall Study|Physician Decision|1|||
170466141|NCT03257865|616044331|FG000|Overall Study|Other|0|||
170466142|NCT03257865|616044332|FG001|Overall Study|Other|1|||
170466143|NCT03257865|616044331|FG000|Overall Study|Lost to Follow-up|4|||
170466144|NCT03257865|616044332|FG001|Overall Study|Lost to Follow-up|4|||
170466145|NCT00811928|616044333|FG000|Overall Study|AEs and SAEs Including Death|7|||
170466146|NCT00811928|616044334|FG001|Overall Study|AEs and SAEs Including Death|11|||
170466147|NCT00811928|616044333|FG000|Overall Study|Withdrawal by Subject|18|||
170466148|NCT00811928|616044334|FG001|Overall Study|Withdrawal by Subject|12|||
170466149|NCT00811928|616044333|FG000|Overall Study|Did Not Take Study Drug|3|||
170466150|NCT00811928|616044334|FG001|Overall Study|Did Not Take Study Drug|0|||
170466151|NCT00811928|616044333|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
170466152|NCT00811928|616044334|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
170466153|NCT00811928|616044333|FG000|Overall Study|Investigator Decision|2|||
170545094|NCT04937387|616339438|FG000|Overall Study|Lack of Efficacy|1|||
170545095|NCT04937387|616339439|FG001|Overall Study|Lack of Efficacy|0|||
170545096|NCT04937387|616339440|FG002|Overall Study|Lack of Efficacy|0|||
170545097|NCT04937387|616339441|FG003|Overall Study|Lack of Efficacy|1|||
170545098|NCT04937387|616339438|FG000|Overall Study|Withdrawal by Subject|1|||
170545099|NCT04937387|616339439|FG001|Overall Study|Withdrawal by Subject|0|||
170545100|NCT04937387|616339440|FG002|Overall Study|Withdrawal by Subject|1|||
170545101|NCT04937387|616339441|FG003|Overall Study|Withdrawal by Subject|1|||
170545102|NCT04937387|616339438|FG000|Overall Study|Randomized in error|0|||
170545103|NCT04937387|616339439|FG001|Overall Study|Randomized in error|0|||
170545104|NCT04937387|616339440|FG002|Overall Study|Randomized in error|0|||
170545105|NCT04937387|616339441|FG003|Overall Study|Randomized in error|1|||
170545106|NCT04971837|616340886|FG000|Overall Study|Long Term Illness|1|||
170466154|NCT00811928|616044334|FG001|Overall Study|Investigator Decision|1|||
170466155|NCT00811928|616044333|FG000|Overall Study|Poor Compliance|2|||
170466156|NCT00811928|616044334|FG001|Overall Study|Poor Compliance|5|||
170466157|NCT02910011|616044335|FG000|Overall Study|Physician Decision|2|||
170466158|NCT00920790|616044336|FG000|Overall Study|aggravation of general condition|14|||
170545107|NCT04971837|616340886|FG000|Overall Study|BMI too low|9|||
170545108|NCT04971837|616340886|FG000|Overall Study|geographic location|1|||
170545109|NCT04971837|616340886|FG000|Overall Study|Discontinued scheduling conflict|1|||
170466159|NCT04411914|616044337|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
170466160|NCT04411914|616044338|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
170466161|NCT04106661|616044344|FG000|Overall Study|Protocol Violation|3|||
170466162|NCT04106661|616044345|FG001|Overall Study|Protocol Violation|0|||
170545110|NCT03166631|616340887|FG000|Overall Study|Progressive disease|2|||
170545111|NCT03166631|616340888|FG001|Overall Study|Progressive disease|1|||
170545112|NCT03166631|616340889|FG002|Overall Study|Progressive disease|3|||
170545113|NCT03166631|616340890|FG003|Overall Study|Progressive disease|4|||
170466163|NCT04106661|616044344|FG000|Overall Study|Scheduling difficulties|1|||
170466164|NCT04106661|616044345|FG001|Overall Study|Scheduling difficulties|1|||
170890525|NCT02574637|617606500|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
170890526|NCT02574637|617606501|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
170890527|NCT02574637|617606502|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
170890528|NCT02574637|617606503|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
170890529|NCT02574637|617606504|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
170466165|NCT02639052|616044346|FG000|Overall Study|Lost to Follow-up|1|||
170466166|NCT02655666|616044348|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
170466167|NCT00838435|616044349|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
170466168|NCT00838435|616044349|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
170466169|NCT00838435|616044349|FG000|Part 2 (7 Years)|Adverse Event|2|||
170466170|NCT00838435|616044349|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
170466171|NCT00838435|616044349|FG000|Part 2 (7 Years)|Physician Decision|1|||
170466172|NCT00838435|616044349|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
170466173|NCT00838435|616044349|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
170466174|NCT00895414|616044350|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
170466175|NCT00895414|616044351|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
170466176|NCT00895414|616044350|FG000|First Intervention (14 Days)|Physician Decision|0|||
170466177|NCT00895414|616044351|FG001|First Intervention (14 Days)|Physician Decision|1|||
170466178|NCT02348723|616044352|FG000|Overall Study|No ablation|21|||
170466179|NCT02348723|616044353|FG001|Overall Study|No ablation|20|||
170466180|NCT02348723|616044352|FG000|Overall Study|Non-compliant with Protocol|1|||
170466181|NCT02348723|616044353|FG001|Overall Study|Non-compliant with Protocol|0|||
170466182|NCT02348723|616044352|FG000|Overall Study|Lost to Follow-up|1|||
170466183|NCT02348723|616044353|FG001|Overall Study|Lost to Follow-up|1|||
170466184|NCT02348723|616044352|FG000|Overall Study|Consent withdrawn|1|||
170466185|NCT02348723|616044353|FG001|Overall Study|Consent withdrawn|3|||
170466186|NCT02348723|616044352|FG000|Overall Study|Reason other than specified|1|||
170466187|NCT02348723|616044353|FG001|Overall Study|Reason other than specified|1|||
170466188|NCT02348723|616044352|FG000|Overall Study|Adverse Event|3|||
170466189|NCT02348723|616044353|FG001|Overall Study|Adverse Event|1|||
170466190|NCT00789737|616044354|FG000|Overall Study|Withdrawal by Subject|13|||
170466191|NCT00789737|616044355|FG001|Overall Study|Withdrawal by Subject|22|||
170466192|NCT00789737|616044354|FG000|Overall Study|Lost to Follow-up|10|||
170466193|NCT00789737|616044355|FG001|Overall Study|Lost to Follow-up|14|||
170466194|NCT00789737|616044354|FG000|Overall Study|Adverse Event|8|||
170466195|NCT00789737|616044355|FG001|Overall Study|Adverse Event|8|||
170466196|NCT00789737|616044354|FG000|Overall Study|Protocol Violation|3|||
170466197|NCT00789737|616044355|FG001|Overall Study|Protocol Violation|0|||
170466198|NCT00789737|616044354|FG000|Overall Study|Lack of Efficacy|3|||
170466199|NCT00789737|616044355|FG001|Overall Study|Lack of Efficacy|0|||
170466200|NCT00789737|616044354|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
170466201|NCT00789737|616044355|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
170466202|NCT00789737|616044354|FG000|Overall Study|Other|11|||
170466203|NCT00789737|616044355|FG001|Overall Study|Other|7|||
170466204|NCT00678886|616044356|FG000|Overall Study|Withdrawal by Subject|0|||
170466205|NCT00678886|616044357|FG001|Overall Study|Withdrawal by Subject|0|||
170466206|NCT00678886|616044358|FG002|Overall Study|Withdrawal by Subject|4|||
170466207|NCT00678886|616044359|FG003|Overall Study|Withdrawal by Subject|6|||
170466208|NCT00678886|616044356|FG000|Overall Study|Physician Decision|0|||
170466209|NCT00678886|616044357|FG001|Overall Study|Physician Decision|0|||
170466210|NCT00678886|616044358|FG002|Overall Study|Physician Decision|1|||
170466211|NCT00678886|616044359|FG003|Overall Study|Physician Decision|1|||
170466212|NCT00678886|616044356|FG000|Overall Study|Lost to Follow-up|0|||
170466213|NCT00678886|616044357|FG001|Overall Study|Lost to Follow-up|0|||
170466214|NCT00678886|616044358|FG002|Overall Study|Lost to Follow-up|3|||
170466215|NCT00678886|616044359|FG003|Overall Study|Lost to Follow-up|2|||
170890530|NCT02574637|617606505|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
170890531|NCT02574637|617606506|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
170890532|NCT02574637|617606507|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
170890533|NCT02574637|617606498|FG000|Double-blind Period|Reason Not Specified|0|||
170466216|NCT00678886|616044356|FG000|Overall Study|Other|0|||
170466217|NCT00678886|616044357|FG001|Overall Study|Other|0|||
170466218|NCT00678886|616044358|FG002|Overall Study|Other|1|||
170545114|NCT03166631|616340891|FG004|Overall Study|Progressive disease|2|||
170890534|NCT02574637|617606499|FG001|Double-blind Period|Reason Not Specified|0|||
170466219|NCT00678886|616044359|FG003|Overall Study|Other|0|||
170466220|NCT01147107|616044360|FG000|Overall Study|Lack of Efficacy|5|||
170466221|NCT01147107|616044361|FG001|Overall Study|Lack of Efficacy|0|||
170466222|NCT01147107|616044360|FG000|Overall Study|Withdrawal by Subject|1|||
170466223|NCT01147107|616044361|FG001|Overall Study|Withdrawal by Subject|1|||
170466224|NCT04435184|616044362|FG000|Overall Study|follow-up blood draws missing|3|||
170466225|NCT04435184|616044363|FG001|Overall Study|follow-up blood draws missing|5|||
170466226|NCT04693416|616044364|FG000|Overall Study|Lost to Follow-up|13|||
170466227|NCT04693416|616044365|FG001|Overall Study|Lost to Follow-up|0|||
170545115|NCT03166631|616340892|FG005|Overall Study|Progressive disease|2|||
170466228|NCT01372774|616044370|FG000|Overall Study|Withdrawal prior to treatment|4|||
170466229|NCT01372774|616044371|FG001|Overall Study|Withdrawal prior to treatment|5|||
170466230|NCT00871741|616044372|FG000|Overall Study|Premature study termination|9|||
170466231|NCT00871741|616044373|FG001|Overall Study|Premature study termination|7|||
170466232|NCT03433755|616044374|FG000|Overall Study|Lost to Follow-up|1|||
170466233|NCT03433755|616044375|FG001|Overall Study|Lost to Follow-up|0|||
170466234|NCT03433755|616044376|FG002|Overall Study|Lost to Follow-up|0|||
170637141|NCT00854113|616684495|FG001|Overall Study|Withdrawal by Subject|0|||
170890535|NCT02574637|617606500|FG002|Double-blind Period|Reason Not Specified|0|||
170890536|NCT02574637|617606501|FG003|Double-blind Period|Reason Not Specified|1|||
170890537|NCT02574637|617606502|FG004|Double-blind Period|Reason Not Specified|0|||
170890538|NCT02574637|617606503|FG005|Double-blind Period|Reason Not Specified|0|||
170890539|NCT02574637|617606504|FG006|Double-blind Period|Reason Not Specified|0|||
170890540|NCT02574637|617606505|FG007|Double-blind Period|Reason Not Specified|0|||
170890541|NCT02574637|617606506|FG008|Double-blind Period|Reason Not Specified|0|||
170890542|NCT02574637|617606507|FG009|Double-blind Period|Reason Not Specified|0|||
170890543|NCT02574637|617606498|FG000|Open-label (OL) Period|Adverse Event|0|||
170890544|NCT02574637|617606499|FG001|Open-label (OL) Period|Adverse Event|0|||
170637142|NCT00854113|616684496|FG002|Overall Study|Withdrawal by Subject|0|||
170637143|NCT00854113|616684497|FG003|Overall Study|Withdrawal by Subject|0|||
170637144|NCT00854113|616684498|FG004|Overall Study|Withdrawal by Subject|0|||
170637145|NCT00854113|616684499|FG005|Overall Study|Withdrawal by Subject|0|||
170637146|NCT00854113|616684500|FG006|Overall Study|Withdrawal by Subject|0|||
170637147|NCT00854113|616684501|FG007|Overall Study|Withdrawal by Subject|1|||
170637148|NCT00854113|616684502|FG008|Overall Study|Withdrawal by Subject|1|||
170637149|NCT00854113|616684503|FG009|Overall Study|Withdrawal by Subject|0|||
170637150|NCT00854113|616684504|FG010|Overall Study|Withdrawal by Subject|0|||
170637151|NCT03901469|616684509|FG000|Overall Study|Radiographic Progression|4|||
170637152|NCT03901469|616684510|FG001|Overall Study|Radiographic Progression|6|||
170637153|NCT03901469|616684511|FG002|Overall Study|Radiographic Progression|3|||
170637154|NCT03901469|616684512|FG003|Overall Study|Radiographic Progression|30|||
170637155|NCT03901469|616684513|FG004|Overall Study|Radiographic Progression|7|||
170637156|NCT03901469|616684514|FG005|Overall Study|Radiographic Progression|2|||
170466235|NCT03433755|616044377|FG003|Overall Study|Lost to Follow-up|0|||
170466236|NCT03433755|616044374|FG000|Overall Study|Decision by Sponsor|1|||
170466237|NCT03433755|616044375|FG001|Overall Study|Decision by Sponsor|0|||
170466238|NCT03433755|616044376|FG002|Overall Study|Decision by Sponsor|0|||
170466239|NCT03433755|616044377|FG003|Overall Study|Decision by Sponsor|0|||
170466240|NCT05323123|616044380|FG000|Overall Study|Withdrawal by Subject|2|||
170466241|NCT05323123|616044381|FG001|Overall Study|Withdrawal by Subject|1|||
170466242|NCT05323123|616044380|FG000|Overall Study|Lost to Follow-up|4|||
170466243|NCT05323123|616044381|FG001|Overall Study|Lost to Follow-up|2|||
170466244|NCT05323123|616044380|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
170466245|NCT05323123|616044381|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
170466246|NCT03665441|616046179|FG000|Overall Study|survival follow up ongoing|23|||
170466247|NCT03665441|616046180|FG001|Overall Study|survival follow up ongoing|0|||
170466248|NCT03665441|616046179|FG000|Overall Study|Patients ongoing on treatment|9|||
170466249|NCT03665441|616046180|FG001|Overall Study|Patients ongoing on treatment|6|||
170466250|NCT03665441|616046179|FG000|Overall Study|Randomized but not treated|7|||
170466251|NCT03665441|616046180|FG001|Overall Study|Randomized but not treated|11|||
170466252|NCT02886624|616046187|FG000|12-week Post Treatment Follow-up|Death|1|||
170466253|NCT02886624|616046187|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
170466254|NCT02925403|616046193|FG000|Overall Study|Lost to Follow-up|0|||
170466255|NCT02925403|616046194|FG001|Overall Study|Lost to Follow-up|1|||
170466256|NCT01659125|616046195|FG000|Overall Study|Withdrawal by Subject|2|||
170637157|NCT03901469|616684515|FG006|Overall Study|Radiographic Progression|11|||
170637158|NCT03901469|616684509|FG000|Overall Study|Clinical Progression|0|||
170637159|NCT03901469|616684510|FG001|Overall Study|Clinical Progression|2|||
170890545|NCT02574637|617606500|FG002|Open-label (OL) Period|Adverse Event|0|||
170890546|NCT02574637|617606501|FG003|Open-label (OL) Period|Adverse Event|0|||
170637160|NCT03901469|616684511|FG002|Overall Study|Clinical Progression|0|||
170637161|NCT03901469|616684512|FG003|Overall Study|Clinical Progression|7|||
170637162|NCT03901469|616684513|FG004|Overall Study|Clinical Progression|6|||
170637163|NCT03901469|616684514|FG005|Overall Study|Clinical Progression|0|||
170637164|NCT03901469|616684515|FG006|Overall Study|Clinical Progression|2|||
170890547|NCT02574637|617606502|FG004|Open-label (OL) Period|Adverse Event|0|||
170466257|NCT01659125|616046195|FG000|Overall Study|Lost to Follow-up|7|||
170466258|NCT01659125|616046195|FG000|Overall Study|Technical Problem|1|||
170466259|NCT01659125|616046195|FG000|Overall Study|Time Constraints|2|||
170466260|NCT01659125|616046195|FG000|Overall Study|Failed to Start Treatment|2|||
170890548|NCT02574637|617606503|FG005|Open-label (OL) Period|Adverse Event|0|||
170890549|NCT02574637|617606504|FG006|Open-label (OL) Period|Adverse Event|0|||
170890550|NCT02574637|617606505|FG007|Open-label (OL) Period|Adverse Event|0|||
170890551|NCT02574637|617606506|FG008|Open-label (OL) Period|Adverse Event|1|||
170890552|NCT02574637|617606507|FG009|Open-label (OL) Period|Adverse Event|0|||
170466261|NCT01396512|616046196|FG000|Overall Study|Withdrawal by Subject|0|||
170466262|NCT01396512|616046197|FG001|Overall Study|Withdrawal by Subject|1|||
170790276|NCT03701763|617242882|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
170790277|NCT03701763|617242879|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
170790278|NCT03701763|617242880|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
170466263|NCT01286753|616046198|FG000|Overall Study|Adverse Event|7|||
170466264|NCT01286753|616046199|FG001|Overall Study|Adverse Event|6|||
170466265|NCT01286753|616046198|FG000|Overall Study|Progression|11|||
170466266|NCT01286753|616046199|FG001|Overall Study|Progression|13|||
170466267|NCT01286753|616046198|FG000|Overall Study|Refused Treatment|1|||
170466268|NCT01286753|616046199|FG001|Overall Study|Refused Treatment|0|||
170466269|NCT01286753|616046198|FG000|Overall Study|Withdrawal of Consent|0|||
170466270|NCT01286753|616046199|FG001|Overall Study|Withdrawal of Consent|2|||
170466271|NCT01286753|616046198|FG000|Overall Study|Discontinued to Join Extension Study|6|||
170466272|NCT01286753|616046199|FG001|Overall Study|Discontinued to Join Extension Study|4|||
170466273|NCT01286753|616046198|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
170466274|NCT01286753|616046199|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
170466275|NCT01371747|616046203|FG000|Overall Study|Adverse Event|4|||
170466276|NCT01371747|616046204|FG001|Overall Study|Adverse Event|2|||
170466277|NCT01371747|616046205|FG002|Overall Study|Adverse Event|7|||
170466278|NCT01371747|616046206|FG003|Overall Study|Adverse Event|2|||
170466279|NCT01371747|616046207|FG004|Overall Study|Adverse Event|2|||
170790279|NCT03701763|617242881|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
170790280|NCT03701763|617242882|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
170790281|NCT03701763|617242879|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
170466280|NCT01371747|616046208|FG005|Overall Study|Adverse Event|2|||
170466281|NCT01371747|616046203|FG000|Overall Study|Death|1|||
170466282|NCT01371747|616046204|FG001|Overall Study|Death|0|||
170466283|NCT01371747|616046205|FG002|Overall Study|Death|4|||
170466284|NCT01371747|616046206|FG003|Overall Study|Death|1|||
170466285|NCT01371747|616046207|FG004|Overall Study|Death|2|||
170466286|NCT01371747|616046208|FG005|Overall Study|Death|0|||
170466287|NCT01371747|616046203|FG000|Overall Study|Abnormal Renal Function|0|||
170466288|NCT01371747|616046204|FG001|Overall Study|Abnormal Renal Function|2|||
170466289|NCT01371747|616046205|FG002|Overall Study|Abnormal Renal Function|0|||
170466290|NCT01371747|616046206|FG003|Overall Study|Abnormal Renal Function|1|||
170466291|NCT01371747|616046207|FG004|Overall Study|Abnormal Renal Function|0|||
170466292|NCT01371747|616046208|FG005|Overall Study|Abnormal Renal Function|1|||
170466293|NCT01371747|616046203|FG000|Overall Study|High Serum Potassium Results|1|||
170466294|NCT01371747|616046204|FG001|Overall Study|High Serum Potassium Results|1|||
170466295|NCT01371747|616046205|FG002|Overall Study|High Serum Potassium Results|1|||
170466296|NCT01371747|616046206|FG003|Overall Study|High Serum Potassium Results|2|||
170466297|NCT01371747|616046207|FG004|Overall Study|High Serum Potassium Results|0|||
170466298|NCT01371747|616046208|FG005|Overall Study|High Serum Potassium Results|2|||
170466299|NCT01371747|616046203|FG000|Overall Study|Low Serum Potassium Results|1|||
170466300|NCT01371747|616046204|FG001|Overall Study|Low Serum Potassium Results|1|||
170466301|NCT01371747|616046205|FG002|Overall Study|Low Serum Potassium Results|1|||
170466302|NCT01371747|616046206|FG003|Overall Study|Low Serum Potassium Results|1|||
170466303|NCT01371747|616046207|FG004|Overall Study|Low Serum Potassium Results|0|||
170466304|NCT01371747|616046208|FG005|Overall Study|Low Serum Potassium Results|3|||
170466305|NCT01371747|616046203|FG000|Overall Study|Protocol Violation|0|||
170466306|NCT01371747|616046204|FG001|Overall Study|Protocol Violation|0|||
170466307|NCT01371747|616046205|FG002|Overall Study|Protocol Violation|1|||
170466308|NCT01371747|616046206|FG003|Overall Study|Protocol Violation|0|||
170790282|NCT03701763|617242880|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
170790283|NCT03701763|617242881|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
170466309|NCT01371747|616046207|FG004|Overall Study|Protocol Violation|0|||
170466310|NCT01371747|616046208|FG005|Overall Study|Protocol Violation|0|||
170466311|NCT01371747|616046203|FG000|Overall Study|Non-Compliance|3|||
170466312|NCT01371747|616046204|FG001|Overall Study|Non-Compliance|4|||
170466313|NCT01371747|616046205|FG002|Overall Study|Non-Compliance|3|||
170466314|NCT01371747|616046206|FG003|Overall Study|Non-Compliance|0|||
170466315|NCT01371747|616046207|FG004|Overall Study|Non-Compliance|0|||
170466316|NCT01371747|616046208|FG005|Overall Study|Non-Compliance|1|||
170790284|NCT03701763|617242882|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
170790285|NCT03701763|617242879|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
170790286|NCT03701763|617242880|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
170790287|NCT03701763|617242881|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
170790288|NCT03701763|617242882|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
170466317|NCT01371747|616046203|FG000|Overall Study|Physician Decision|0|||
170466318|NCT01371747|616046204|FG001|Overall Study|Physician Decision|0|||
170466319|NCT01371747|616046205|FG002|Overall Study|Physician Decision|0|||
170466320|NCT01371747|616046206|FG003|Overall Study|Physician Decision|0|||
170466321|NCT01371747|616046207|FG004|Overall Study|Physician Decision|1|||
170466322|NCT01371747|616046208|FG005|Overall Study|Physician Decision|0|||
170466323|NCT01371747|616046203|FG000|Overall Study|Withdrawal by Subject|6|||
170545116|NCT03166631|616340893|FG006|Overall Study|Progressive disease|5|||
170466324|NCT01371747|616046204|FG001|Overall Study|Withdrawal by Subject|12|||
170466325|NCT01371747|616046205|FG002|Overall Study|Withdrawal by Subject|5|||
170466326|NCT01371747|616046206|FG003|Overall Study|Withdrawal by Subject|2|||
170466327|NCT01371747|616046207|FG004|Overall Study|Withdrawal by Subject|2|||
170466328|NCT01371747|616046208|FG005|Overall Study|Withdrawal by Subject|4|||
170466329|NCT01371747|616046203|FG000|Overall Study|Other Reasons|2|||
170466330|NCT01371747|616046204|FG001|Overall Study|Other Reasons|1|||
170466331|NCT01371747|616046205|FG002|Overall Study|Other Reasons|2|||
170466332|NCT01371747|616046206|FG003|Overall Study|Other Reasons|0|||
170466333|NCT01371747|616046207|FG004|Overall Study|Other Reasons|0|||
170466334|NCT01371747|616046208|FG005|Overall Study|Other Reasons|1|||
170466335|NCT05013008|616046212|FG000|Overall Study|Exclusion from mBFAS|5|||
170466336|NCT05013008|616046213|FG001|Overall Study|Exclusion from mBFAS|25|||
170466337|NCT04497948|616046214|FG000|Overall Study|Death|2|||
170466338|NCT00749892|616046218|FG000|Overall Study|Withdrawal by Subject|3|||
170466339|NCT03207243|616046219|FG000|Overall Study|Adverse Event|2|||
170466340|NCT03207243|616046220|FG001|Overall Study|Adverse Event|2|||
170466341|NCT03207243|616046219|FG000|Overall Study|Loss of Asthma Control|47|||
170466342|NCT03207243|616046220|FG001|Overall Study|Loss of Asthma Control|31|||
170466343|NCT03207243|616046219|FG000|Overall Study|Withdrawal by Subject|2|||
170466344|NCT03207243|616046220|FG001|Overall Study|Withdrawal by Subject|4|||
170466345|NCT03207243|616046219|FG000|Overall Study|Physician Decision|1|||
170466346|NCT03207243|616046220|FG001|Overall Study|Physician Decision|1|||
170466347|NCT03207243|616046219|FG000|Overall Study|Lost to Follow-up|0|||
170466348|NCT03207243|616046220|FG001|Overall Study|Lost to Follow-up|1|||
170466349|NCT03207243|616046219|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
170466350|NCT03207243|616046220|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
170466351|NCT03207243|616046219|FG000|Overall Study|Protocol Violation|0|||
170466352|NCT03207243|616046220|FG001|Overall Study|Protocol Violation|3|||
170466353|NCT01377987|616046221|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
170466354|NCT01377987|616046222|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
170466355|NCT00603837|616046225|FG000|Overall Study|Physician Decision|3|||
170466356|NCT00603837|616046226|FG001|Overall Study|Physician Decision|0|||
170466357|NCT04611529|616046227|FG000|2-day Follow up|Lost to Follow-up|5|||
170466358|NCT04611529|616046228|FG001|2-day Follow up|Lost to Follow-up|6|||
170466359|NCT04611529|616046229|FG002|2-day Follow up|Lost to Follow-up|3|||
170466360|NCT03336528|616046233|FG000|Overall Study|Protocol Violation|1|||
170466361|NCT03336528|616046234|FG001|Overall Study|Protocol Violation|1|||
170466362|NCT03336528|616046233|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
170466363|NCT03336528|616046234|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
170466364|NCT03336528|616046233|FG000|Overall Study|Did not receive study medication|1|||
170466365|NCT03336528|616046234|FG001|Overall Study|Did not receive study medication|2|||
170466366|NCT01085357|616046235|FG000|Overall Study|Adverse Event|1|||
170466367|NCT01085357|616046236|FG001|Overall Study|Adverse Event|1|||
170466368|NCT01085357|616046235|FG000|Overall Study|Subject Decision|4|||
170466369|NCT01085357|616046236|FG001|Overall Study|Subject Decision|3|||
170466370|NCT01085357|616046235|FG000|Overall Study|Investigator Decision|1|||
170466371|NCT01085357|616046236|FG001|Overall Study|Investigator Decision|1|||
170466372|NCT01085357|616046235|FG000|Overall Study|Death|11|||
170466373|NCT01085357|616046236|FG001|Overall Study|Death|1|||
170466374|NCT01085357|616046235|FG000|Overall Study|Lost to Follow-up|2|||
170466375|NCT01085357|616046236|FG001|Overall Study|Lost to Follow-up|0|||
170466376|NCT00314951|616046239|FG000|Treatment|Didn't meet criteria for mITT population|16|||
170466377|NCT00314951|616046240|FG001|Treatment|Didn't meet criteria for mITT population|11|||
170466378|NCT00314951|616046239|FG000|Follow-up|mITT failure|44|||
170466379|NCT00314951|616046240|FG001|Follow-up|mITT failure|34|||
170466380|NCT00423319|616046241|FG000|Overall Study|Death|2|||
170466381|NCT00423319|616046242|FG001|Overall Study|Death|0|||
170466382|NCT00423319|616046241|FG000|Overall Study|Adverse Event|93|||
170466383|NCT00423319|616046242|FG001|Overall Study|Adverse Event|112|||
170466384|NCT00423319|616046241|FG000|Overall Study|Withdrawal by Subject|86|||
170637165|NCT03901469|616684509|FG000|Overall Study|Adverse Event|1|||
170637166|NCT03901469|616684510|FG001|Overall Study|Adverse Event|0|||
170466385|NCT00423319|616046242|FG001|Overall Study|Withdrawal by Subject|99|||
170466386|NCT00423319|616046241|FG000|Overall Study|Lost to Follow-up|4|||
170466387|NCT00423319|616046242|FG001|Overall Study|Lost to Follow-up|3|||
170466388|NCT00423319|616046241|FG000|Overall Study|Poor compliance or noncompliance|1|||
170466389|NCT00423319|616046242|FG001|Overall Study|Poor compliance or noncompliance|1|||
170466390|NCT00423319|616046241|FG000|Overall Study|No longer meets study criteria|15|||
170466391|NCT00423319|616046242|FG001|Overall Study|No longer meets study criteria|15|||
170466392|NCT00423319|616046241|FG000|Overall Study|Other|23|||
170466393|NCT00423319|616046242|FG001|Overall Study|Other|22|||
170466394|NCT02087189|616046244|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
170466395|NCT01189487|616046249|FG000|Overall Study|Lack of Efficacy|2|||
170466396|NCT01189487|616046249|FG000|Overall Study|Adverse Event|1|||
170466397|NCT04630158|616046250|FG000|Overall Study|Adverse Event|1|||
170466398|NCT04630158|616046251|FG001|Overall Study|Adverse Event|1|||
170637167|NCT03901469|616684511|FG002|Overall Study|Adverse Event|0|||
170466399|NCT04630158|616046252|FG002|Overall Study|Adverse Event|1|||
170466400|NCT04630158|616046250|FG000|Overall Study|Physician Decision|0|||
170466401|NCT04630158|616046251|FG001|Overall Study|Physician Decision|2|||
170466402|NCT04630158|616046252|FG002|Overall Study|Physician Decision|0|||
170466403|NCT04630158|616046250|FG000|Overall Study|Protocol Violation|1|||
170466404|NCT04630158|616046251|FG001|Overall Study|Protocol Violation|0|||
170466405|NCT04630158|616046252|FG002|Overall Study|Protocol Violation|1|||
170466406|NCT04630158|616046250|FG000|Overall Study|Withdrawal by Subject|2|||
170637168|NCT03901469|616684512|FG003|Overall Study|Adverse Event|0|||
170637169|NCT03901469|616684513|FG004|Overall Study|Adverse Event|0|||
170637170|NCT03901469|616684514|FG005|Overall Study|Adverse Event|0|||
170637171|NCT03901469|616684515|FG006|Overall Study|Adverse Event|9|||
170637172|NCT03901469|616684509|FG000|Overall Study|Physician Decision|0|||
170637173|NCT03901469|616684510|FG001|Overall Study|Physician Decision|0|||
170637174|NCT03901469|616684511|FG002|Overall Study|Physician Decision|0|||
170637175|NCT03901469|616684512|FG003|Overall Study|Physician Decision|1|||
170637176|NCT03901469|616684513|FG004|Overall Study|Physician Decision|0|||
170637177|NCT03901469|616684514|FG005|Overall Study|Physician Decision|0|||
170637178|NCT03901469|616684515|FG006|Overall Study|Physician Decision|0|||
170637179|NCT03901469|616684509|FG000|Overall Study|Withdrawal by Subject|0|||
170637180|NCT03901469|616684510|FG001|Overall Study|Withdrawal by Subject|0|||
170637181|NCT03901469|616684511|FG002|Overall Study|Withdrawal by Subject|0|||
170637182|NCT03901469|616684512|FG003|Overall Study|Withdrawal by Subject|0|||
170637183|NCT03901469|616684513|FG004|Overall Study|Withdrawal by Subject|2|||
170637184|NCT03901469|616684514|FG005|Overall Study|Withdrawal by Subject|0|||
170637185|NCT03901469|616684515|FG006|Overall Study|Withdrawal by Subject|8|||
170637186|NCT03901469|616684509|FG000|Overall Study|Death|0|||
170637187|NCT03901469|616684510|FG001|Overall Study|Death|0|||
170637188|NCT03901469|616684511|FG002|Overall Study|Death|0|||
170637189|NCT03901469|616684512|FG003|Overall Study|Death|3|||
170637190|NCT03901469|616684513|FG004|Overall Study|Death|5|||
170637191|NCT03901469|616684514|FG005|Overall Study|Death|0|||
170637192|NCT03901469|616684515|FG006|Overall Study|Death|1|||
170637193|NCT03901469|616684509|FG000|Overall Study|Termination of study by sponsor|0|||
170637194|NCT03901469|616684510|FG001|Overall Study|Termination of study by sponsor|0|||
170637195|NCT03901469|616684511|FG002|Overall Study|Termination of study by sponsor|0|||
170637196|NCT03901469|616684512|FG003|Overall Study|Termination of study by sponsor|0|||
170637197|NCT03901469|616684513|FG004|Overall Study|Termination of study by sponsor|1|||
170890553|NCT02574637|617606498|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
170890554|NCT02574637|617606499|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
170890555|NCT02574637|617606500|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
170890556|NCT02574637|617606501|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
170890557|NCT02574637|617606502|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
170890558|NCT02574637|617606503|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
170890559|NCT02574637|617606504|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
170890560|NCT02574637|617606505|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
170890561|NCT02574637|617606506|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
170890562|NCT02574637|617606507|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
170890563|NCT02574637|617606498|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
170890564|NCT02574637|617606499|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
170890565|NCT02574637|617606500|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
170890566|NCT02574637|617606501|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
170890567|NCT02574637|617606502|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
170890568|NCT02574637|617606503|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
170890569|NCT02574637|617606504|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
170890570|NCT02574637|617606505|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
170890571|NCT02574637|617606506|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
170890572|NCT02574637|617606507|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
170466407|NCT04630158|616046251|FG001|Overall Study|Withdrawal by Subject|1|||
170466408|NCT04630158|616046252|FG002|Overall Study|Withdrawal by Subject|2|||
170466409|NCT02828241|616046257|FG000|Overall Study|Adverse Event|7|||
170466410|NCT02828241|616046258|FG001|Overall Study|Adverse Event|2|||
170637198|NCT03901469|616684514|FG005|Overall Study|Termination of study by sponsor|1|||
170466411|NCT02828241|616046257|FG000|Overall Study|Protocol Violation|1|||
170466412|NCT02828241|616046258|FG001|Overall Study|Protocol Violation|0|||
170466413|NCT00642278|616046259|FG000|Overall Study|Adverse Event|2|||
170637199|NCT03901469|616684515|FG006|Overall Study|Termination of study by sponsor|0|||
170637200|NCT03901469|616684509|FG000|Overall Study|Not Reported|1|||
170637201|NCT03901469|616684510|FG001|Overall Study|Not Reported|0|||
170637202|NCT03901469|616684511|FG002|Overall Study|Not Reported|0|||
170637203|NCT03901469|616684512|FG003|Overall Study|Not Reported|1|||
170890573|NCT03021642|617606508|FG000|Washout Period (21 Days)|Adverse Event|1|||
170890574|NCT03021642|617606509|FG001|Washout Period (21 Days)|Adverse Event|1|||
170890575|NCT02474082|617606512|FG000|Overall Study|Adverse Event|2|||
170890576|NCT02474082|617606513|FG001|Overall Study|Adverse Event|32|||
170890577|NCT02474082|617606512|FG000|Overall Study|Withdrawal of informed consent|1|||
170890578|NCT02474082|617606513|FG001|Overall Study|Withdrawal of informed consent|11|||
170466414|NCT00642278|616046260|FG001|Overall Study|Adverse Event|1|||
170466415|NCT00642278|616046261|FG002|Overall Study|Adverse Event|3|||
170466416|NCT00642278|616046262|FG003|Overall Study|Adverse Event|1|||
170466417|NCT00642278|616046263|FG004|Overall Study|Adverse Event|2|||
170466418|NCT00642278|616046264|FG005|Overall Study|Adverse Event|2|||
170466419|NCT00642278|616046265|FG006|Overall Study|Adverse Event|0|||
170466420|NCT00642278|616046259|FG000|Overall Study|Lack of Efficacy|0|||
170466421|NCT00642278|616046260|FG001|Overall Study|Lack of Efficacy|1|||
170466422|NCT00642278|616046261|FG002|Overall Study|Lack of Efficacy|0|||
170466423|NCT00642278|616046262|FG003|Overall Study|Lack of Efficacy|0|||
170466424|NCT00642278|616046263|FG004|Overall Study|Lack of Efficacy|0|||
170466425|NCT00642278|616046264|FG005|Overall Study|Lack of Efficacy|0|||
170466426|NCT00642278|616046265|FG006|Overall Study|Lack of Efficacy|0|||
170466427|NCT00642278|616046259|FG000|Overall Study|Lost to Follow-up|5|||
170466428|NCT00642278|616046260|FG001|Overall Study|Lost to Follow-up|1|||
170466429|NCT00642278|616046261|FG002|Overall Study|Lost to Follow-up|0|||
170466430|NCT00642278|616046262|FG003|Overall Study|Lost to Follow-up|1|||
170466431|NCT00642278|616046263|FG004|Overall Study|Lost to Follow-up|0|||
170466432|NCT00642278|616046264|FG005|Overall Study|Lost to Follow-up|1|||
170466433|NCT00642278|616046265|FG006|Overall Study|Lost to Follow-up|1|||
170466434|NCT00642278|616046259|FG000|Overall Study|Physician Decision|0|||
170466435|NCT00642278|616046260|FG001|Overall Study|Physician Decision|0|||
170466436|NCT00642278|616046261|FG002|Overall Study|Physician Decision|0|||
170466437|NCT00642278|616046262|FG003|Overall Study|Physician Decision|1|||
170466438|NCT00642278|616046263|FG004|Overall Study|Physician Decision|0|||
170466439|NCT00642278|616046264|FG005|Overall Study|Physician Decision|0|||
170466440|NCT00642278|616046265|FG006|Overall Study|Physician Decision|0|||
170466441|NCT00642278|616046259|FG000|Overall Study|Protocol Violation|0|||
170466442|NCT00642278|616046260|FG001|Overall Study|Protocol Violation|0|||
170466443|NCT00642278|616046261|FG002|Overall Study|Protocol Violation|1|||
170466444|NCT00642278|616046262|FG003|Overall Study|Protocol Violation|1|||
170466445|NCT00642278|616046263|FG004|Overall Study|Protocol Violation|0|||
170466446|NCT00642278|616046264|FG005|Overall Study|Protocol Violation|1|||
170466447|NCT00642278|616046265|FG006|Overall Study|Protocol Violation|2|||
170466448|NCT00642278|616046259|FG000|Overall Study|Withdrawal by Subject|1|||
170466449|NCT00642278|616046260|FG001|Overall Study|Withdrawal by Subject|1|||
170466450|NCT00642278|616046261|FG002|Overall Study|Withdrawal by Subject|1|||
170466451|NCT00642278|616046262|FG003|Overall Study|Withdrawal by Subject|3|||
170466452|NCT00642278|616046263|FG004|Overall Study|Withdrawal by Subject|6|||
170466453|NCT00642278|616046264|FG005|Overall Study|Withdrawal by Subject|2|||
170545117|NCT03166631|616340894|FG007|Overall Study|Progressive disease|6|||
170545118|NCT03166631|616340895|FG008|Overall Study|Progressive disease|11|||
170890579|NCT02474082|617606512|FG000|Overall Study|Lost to Follow-up|2|||
170890580|NCT02474082|617606513|FG001|Overall Study|Lost to Follow-up|2|||
170890581|NCT02474082|617606512|FG000|Overall Study|Dose tapering not achieved|0|||
170890582|NCT02474082|617606513|FG001|Overall Study|Dose tapering not achieved|4|||
170890583|NCT02474082|617606512|FG000|Overall Study|Participant/guardian decision|1|||
170890584|NCT02474082|617606513|FG001|Overall Study|Participant/guardian decision|2|||
170545119|NCT03166631|616340896|FG009|Overall Study|Progressive disease|5|||
170545120|NCT03166631|616340897|FG010|Overall Study|Progressive disease|7|||
170545121|NCT03166631|616340887|FG000|Overall Study|Physician Decision|0|||
170545122|NCT03166631|616340888|FG001|Overall Study|Physician Decision|0|||
170890585|NCT02474082|617606512|FG000|Overall Study|Non-compliance with study treatment|0|||
170890586|NCT02474082|617606513|FG001|Overall Study|Non-compliance with study treatment|2|||
170890587|NCT02474082|617606512|FG000|Overall Study|Protocol deviation|0|||
170890588|NCT02474082|617606513|FG001|Overall Study|Protocol deviation|1|||
170890589|NCT04317274|617606520|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
170466454|NCT00642278|616046265|FG006|Overall Study|Withdrawal by Subject|2|||
170466455|NCT00642278|616046259|FG000|Overall Study|Noncompliance with study drug regimen|0|||
170466456|NCT00642278|616046260|FG001|Overall Study|Noncompliance with study drug regimen|0|||
170466457|NCT00642278|616046261|FG002|Overall Study|Noncompliance with study drug regimen|0|||
170545123|NCT03166631|616340889|FG002|Overall Study|Physician Decision|0|||
170545124|NCT03166631|616340890|FG003|Overall Study|Physician Decision|0|||
170545125|NCT03166631|616340891|FG004|Overall Study|Physician Decision|0|||
170890590|NCT04317274|617606521|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
170466458|NCT00642278|616046262|FG003|Overall Study|Noncompliance with study drug regimen|1|||
170466459|NCT00642278|616046263|FG004|Overall Study|Noncompliance with study drug regimen|0|||
170466460|NCT00642278|616046264|FG005|Overall Study|Noncompliance with study drug regimen|0|||
170466461|NCT00642278|616046265|FG006|Overall Study|Noncompliance with study drug regimen|0|||
170466462|NCT00642278|616046259|FG000|Overall Study|Other|2|||
170545126|NCT03166631|616340892|FG005|Overall Study|Physician Decision|0|||
170890591|NCT04317274|617606522|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
170890592|NCT04317274|617606523|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
170890593|NCT01262976|617606524|FG000|Up to Month 2|Serious Adverse Event|0|||
170890594|NCT01262976|617606525|FG001|Up to Month 2|Serious Adverse Event|0|||
170890595|NCT01262976|617606526|FG002|Up to Month 2|Serious Adverse Event|1|||
170890596|NCT01262976|617606527|FG003|Up to Month 2|Serious Adverse Event|0|||
170890597|NCT01262976|617606528|FG004|Up to Month 2|Serious Adverse Event|0|||
170890598|NCT01262976|617606529|FG005|Up to Month 2|Serious Adverse Event|0|||
170890599|NCT01262976|617606524|FG000|Up to Month 2|Withdrawal by Subject|1|||
170890600|NCT01262976|617606525|FG001|Up to Month 2|Withdrawal by Subject|0|||
170890601|NCT01262976|617606526|FG002|Up to Month 2|Withdrawal by Subject|0|||
170890602|NCT01262976|617606527|FG003|Up to Month 2|Withdrawal by Subject|0|||
170890603|NCT01262976|617606528|FG004|Up to Month 2|Withdrawal by Subject|0|||
170890604|NCT01262976|617606529|FG005|Up to Month 2|Withdrawal by Subject|0|||
170466463|NCT00642278|616046260|FG001|Overall Study|Other|1|||
170466464|NCT00642278|616046261|FG002|Overall Study|Other|0|||
170466465|NCT00642278|616046262|FG003|Overall Study|Other|1|||
170466466|NCT00642278|616046263|FG004|Overall Study|Other|0|||
170466467|NCT00642278|616046264|FG005|Overall Study|Other|1|||
170466468|NCT00642278|616046265|FG006|Overall Study|Other|0|||
170466469|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
170466470|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
170466471|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
170466472|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
170466473|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
170466474|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
170466475|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
170466476|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
170466477|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
170466478|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
170890605|NCT01262976|617606524|FG000|Up to Month 2|Migrated/moved from study area|0|||
170890606|NCT01262976|617606525|FG001|Up to Month 2|Migrated/moved from study area|1|||
170466479|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
170466480|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
170466481|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
170466482|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
170466483|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
170466484|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
170466485|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
170466486|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
170466487|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
170466488|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
170466489|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
170466490|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
170466491|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
170466492|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
170466493|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
170466494|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
170466495|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
170466496|NCT02552212|616046266|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
170466497|NCT02552212|616046267|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
170466498|NCT02552212|616046268|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
170466499|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
170466500|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
170466501|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
170890607|NCT01262976|617606526|FG002|Up to Month 2|Migrated/moved from study area|0|||
170890608|NCT01262976|617606527|FG003|Up to Month 2|Migrated/moved from study area|0|||
170890609|NCT01262976|617606528|FG004|Up to Month 2|Migrated/moved from study area|1|||
170890610|NCT01262976|617606529|FG005|Up to Month 2|Migrated/moved from study area|1|||
170890611|NCT01262976|617606524|FG000|Up to Month 2|Lost to Follow-up|1|||
170466502|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
170466503|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
170466504|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
170466505|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
170890612|NCT01262976|617606525|FG001|Up to Month 2|Lost to Follow-up|0|||
170890613|NCT01262976|617606526|FG002|Up to Month 2|Lost to Follow-up|0|||
170890614|NCT01262976|617606527|FG003|Up to Month 2|Lost to Follow-up|1|||
170890615|NCT01262976|617606528|FG004|Up to Month 2|Lost to Follow-up|1|||
170466506|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
170466507|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
170466508|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
170466509|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
170466510|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
170466511|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
170466512|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
170466513|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
170466514|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
170466515|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
170466516|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
170466517|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
170466518|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
170466519|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
170466520|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
170466521|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
170466522|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
170466523|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
170466524|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
170466525|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
170466526|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
170466527|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
170466528|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
170466529|NCT02552212|616046266|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
170466530|NCT02552212|616046267|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
170466531|NCT02552212|616046268|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
170466532|NCT02722148|616046271|FG000|Overall Study|Lost to Follow-up|2|||
170466533|NCT02722148|616046271|FG000|Overall Study|Non compliant with treatment regimen|3|||
170466534|NCT01458106|616046272|FG000|Overall Study|Withdrawal by Subject|2|||
170466535|NCT01458106|616046273|FG001|Overall Study|Withdrawal by Subject|0|||
170466536|NCT01458106|616046272|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
170466537|NCT01458106|616046273|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
170466538|NCT01458106|616046272|FG000|Overall Study|Withdrawn Per Protocol|0|||
170466539|NCT01458106|616046273|FG001|Overall Study|Withdrawn Per Protocol|1|||
170466540|NCT00073021|616046274|FG000|Overall Study|Protocol Violation|2|||
170466541|NCT00073021|616046275|FG001|Overall Study|Protocol Violation|1|||
170545127|NCT03166631|616340893|FG006|Overall Study|Physician Decision|1|||
170545128|NCT03166631|616340894|FG007|Overall Study|Physician Decision|0|||
170790289|NCT03701763|617242879|FG000|Apremilast Extension Phase|Adverse Event|0|||
170790290|NCT03701763|617242880|FG001|Apremilast Extension Phase|Adverse Event|0|||
170790291|NCT03701763|617242881|FG002|Apremilast Extension Phase|Adverse Event|3|||
170790292|NCT03701763|617242882|FG003|Apremilast Extension Phase|Adverse Event|1|||
170790293|NCT03701763|617242879|FG000|Apremilast Extension Phase|Miscellaneous|0|||
170790294|NCT03701763|617242880|FG001|Apremilast Extension Phase|Miscellaneous|0|||
170790295|NCT03701763|617242881|FG002|Apremilast Extension Phase|Miscellaneous|2|||
170790296|NCT03701763|617242882|FG003|Apremilast Extension Phase|Miscellaneous|1|||
170790297|NCT03701763|617242879|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
170545129|NCT03166631|616340895|FG008|Overall Study|Physician Decision|1|||
170790298|NCT03701763|617242880|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
170466542|NCT00073021|616046274|FG000|Overall Study|Adverse Event|4|||
170466543|NCT00073021|616046275|FG001|Overall Study|Adverse Event|4|||
170466544|NCT00073021|616046274|FG000|Overall Study|Withdrawal by Subject|6|||
170466545|NCT00073021|616046275|FG001|Overall Study|Withdrawal by Subject|5|||
170466546|NCT00073021|616046274|FG000|Overall Study|Physician Decision|3|||
170466547|NCT00073021|616046275|FG001|Overall Study|Physician Decision|1|||
170466548|NCT00073021|616046274|FG000|Overall Study|Lack of Efficacy|11|||
170466549|NCT00073021|616046275|FG001|Overall Study|Lack of Efficacy|5|||
170466550|NCT00960115|616046279|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
170890616|NCT01262976|617606529|FG005|Up to Month 2|Lost to Follow-up|1|||
170466551|NCT00960115|616046280|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
170466552|NCT02823652|616046281|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
170466553|NCT02823652|616046282|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
170466554|NCT02823652|616046283|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
170466555|NCT02823652|616046281|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
170466556|NCT02823652|616046282|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
170466557|NCT02823652|616046283|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
170466558|NCT02823652|616046281|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
170466559|NCT02823652|616046282|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
170790299|NCT03701763|617242881|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
170790300|NCT03701763|617242882|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
170790301|NCT03701763|617242879|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
170790302|NCT03701763|617242880|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
170890617|NCT01262976|617606524|FG000|Up to Month 2|Other|1|||
170890618|NCT01262976|617606525|FG001|Up to Month 2|Other|0|||
170890619|NCT01262976|617606526|FG002|Up to Month 2|Other|0|||
170890620|NCT01262976|617606527|FG003|Up to Month 2|Other|1|||
170890621|NCT01262976|617606528|FG004|Up to Month 2|Other|0|||
170890622|NCT01262976|617606529|FG005|Up to Month 2|Other|2|||
170890623|NCT01262976|617606524|FG000|Up to Month 7|Serious Adverse Event|0|||
170890624|NCT01262976|617606525|FG001|Up to Month 7|Serious Adverse Event|0|||
170890625|NCT01262976|617606526|FG002|Up to Month 7|Serious Adverse Event|2|||
170890626|NCT01262976|617606527|FG003|Up to Month 7|Serious Adverse Event|0|||
170890627|NCT01262976|617606528|FG004|Up to Month 7|Serious Adverse Event|0|||
170890628|NCT01262976|617606529|FG005|Up to Month 7|Serious Adverse Event|0|||
170890629|NCT01262976|617606524|FG000|Up to Month 7|Withdrawal by Subject|1|||
170890630|NCT01262976|617606525|FG001|Up to Month 7|Withdrawal by Subject|0|||
170890631|NCT01262976|617606526|FG002|Up to Month 7|Withdrawal by Subject|0|||
170890632|NCT01262976|617606527|FG003|Up to Month 7|Withdrawal by Subject|0|||
170890633|NCT01262976|617606528|FG004|Up to Month 7|Withdrawal by Subject|0|||
170890634|NCT01262976|617606529|FG005|Up to Month 7|Withdrawal by Subject|0|||
170890635|NCT01262976|617606524|FG000|Up to Month 7|Migrated/moved from study area|0|||
170790303|NCT03701763|617242881|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
170790304|NCT03701763|617242882|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
170790305|NCT03701763|617242879|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
170890636|NCT01262976|617606525|FG001|Up to Month 7|Migrated/moved from study area|0|||
170890637|NCT01262976|617606526|FG002|Up to Month 7|Migrated/moved from study area|1|||
170890638|NCT01262976|617606527|FG003|Up to Month 7|Migrated/moved from study area|3|||
170890639|NCT01262976|617606528|FG004|Up to Month 7|Migrated/moved from study area|1|||
170466560|NCT02823652|616046283|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
170466561|NCT02823652|616046281|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
170466562|NCT02823652|616046282|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
170790306|NCT03701763|617242880|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
170890640|NCT01262976|617606529|FG005|Up to Month 7|Migrated/moved from study area|1|||
170890641|NCT01262976|617606524|FG000|Up to Month 7|Lost to Follow-up|1|||
170890642|NCT01262976|617606525|FG001|Up to Month 7|Lost to Follow-up|0|||
170890643|NCT01262976|617606526|FG002|Up to Month 7|Lost to Follow-up|1|||
170890644|NCT01262976|617606527|FG003|Up to Month 7|Lost to Follow-up|3|||
170890645|NCT01262976|617606528|FG004|Up to Month 7|Lost to Follow-up|1|||
170890646|NCT01262976|617606529|FG005|Up to Month 7|Lost to Follow-up|3|||
170890647|NCT01262976|617606524|FG000|Up to Month 7|Other|3|||
170890648|NCT01262976|617606525|FG001|Up to Month 7|Other|0|||
170890649|NCT01262976|617606526|FG002|Up to Month 7|Other|2|||
170890650|NCT01262976|617606527|FG003|Up to Month 7|Other|0|||
170890651|NCT01262976|617606528|FG004|Up to Month 7|Other|0|||
170890652|NCT01262976|617606529|FG005|Up to Month 7|Other|0|||
170890653|NCT01262976|617606524|FG000|Up to Year 1|Serious Adverse Event|0|||
170890654|NCT01262976|617606525|FG001|Up to Year 1|Serious Adverse Event|0|||
170890655|NCT01262976|617606526|FG002|Up to Year 1|Serious Adverse Event|2|||
170890656|NCT01262976|617606527|FG003|Up to Year 1|Serious Adverse Event|0|||
170890657|NCT01262976|617606528|FG004|Up to Year 1|Serious Adverse Event|0|||
170890658|NCT01262976|617606529|FG005|Up to Year 1|Serious Adverse Event|0|||
170890659|NCT01262976|617606524|FG000|Up to Year 1|Withdrawal by Subject|1|||
170890660|NCT01262976|617606525|FG001|Up to Year 1|Withdrawal by Subject|0|||
170890661|NCT01262976|617606526|FG002|Up to Year 1|Withdrawal by Subject|0|||
170890662|NCT01262976|617606527|FG003|Up to Year 1|Withdrawal by Subject|0|||
170890663|NCT01262976|617606528|FG004|Up to Year 1|Withdrawal by Subject|0|||
170890664|NCT01262976|617606529|FG005|Up to Year 1|Withdrawal by Subject|0|||
170890665|NCT01262976|617606524|FG000|Up to Year 1|Migrated/moved from study area|1|||
170890666|NCT01262976|617606525|FG001|Up to Year 1|Migrated/moved from study area|0|||
170890667|NCT01262976|617606526|FG002|Up to Year 1|Migrated/moved from study area|0|||
170890668|NCT01262976|617606527|FG003|Up to Year 1|Migrated/moved from study area|3|||
170890669|NCT01262976|617606528|FG004|Up to Year 1|Migrated/moved from study area|3|||
170890670|NCT01262976|617606529|FG005|Up to Year 1|Migrated/moved from study area|2|||
170890671|NCT01262976|617606524|FG000|Up to Year 1|Lost to Follow-up|4|||
170890672|NCT01262976|617606525|FG001|Up to Year 1|Lost to Follow-up|0|||
170890673|NCT01262976|617606526|FG002|Up to Year 1|Lost to Follow-up|0|||
170890674|NCT01262976|617606527|FG003|Up to Year 1|Lost to Follow-up|1|||
170890675|NCT01262976|617606528|FG004|Up to Year 1|Lost to Follow-up|6|||
170890676|NCT01262976|617606529|FG005|Up to Year 1|Lost to Follow-up|5|||
170890677|NCT01262976|617606524|FG000|Up to Year 1|Other|3|||
170890678|NCT01262976|617606525|FG001|Up to Year 1|Other|1|||
170890679|NCT01262976|617606526|FG002|Up to Year 1|Other|0|||
170890680|NCT01262976|617606527|FG003|Up to Year 1|Other|0|||
170890681|NCT01262976|617606528|FG004|Up to Year 1|Other|2|||
170890682|NCT01262976|617606529|FG005|Up to Year 1|Other|1|||
170890683|NCT01262976|617606524|FG000|Up to Year 1|Subjects with unknown completion status|0|||
170890684|NCT01262976|617606525|FG001|Up to Year 1|Subjects with unknown completion status|0|||
170890685|NCT01262976|617606526|FG002|Up to Year 1|Subjects with unknown completion status|1|||
170890686|NCT01262976|617606527|FG003|Up to Year 1|Subjects with unknown completion status|0|||
170890687|NCT01262976|617606528|FG004|Up to Year 1|Subjects with unknown completion status|0|||
170890688|NCT01262976|617606529|FG005|Up to Year 1|Subjects with unknown completion status|1|||
170890689|NCT01262976|617606524|FG000|Up to Year 2|Serious Adverse Event|0|||
170890690|NCT01262976|617606525|FG001|Up to Year 2|Serious Adverse Event|0|||
170890691|NCT01262976|617606526|FG002|Up to Year 2|Serious Adverse Event|2|||
170890692|NCT01262976|617606527|FG003|Up to Year 2|Serious Adverse Event|0|||
170890693|NCT01262976|617606528|FG004|Up to Year 2|Serious Adverse Event|0|||
170890694|NCT01262976|617606529|FG005|Up to Year 2|Serious Adverse Event|0|||
170890695|NCT01262976|617606524|FG000|Up to Year 2|Withdrawal by Subject|1|||
170890696|NCT01262976|617606525|FG001|Up to Year 2|Withdrawal by Subject|0|||
170890697|NCT01262976|617606526|FG002|Up to Year 2|Withdrawal by Subject|0|||
170890698|NCT01262976|617606527|FG003|Up to Year 2|Withdrawal by Subject|0|||
170890699|NCT01262976|617606528|FG004|Up to Year 2|Withdrawal by Subject|0|||
170890700|NCT01262976|617606529|FG005|Up to Year 2|Withdrawal by Subject|0|||
170890701|NCT01262976|617606524|FG000|Up to Year 2|Migrated/moved from study area|0|||
170890702|NCT01262976|617606525|FG001|Up to Year 2|Migrated/moved from study area|0|||
170890703|NCT01262976|617606526|FG002|Up to Year 2|Migrated/moved from study area|0|||
170890704|NCT01262976|617606527|FG003|Up to Year 2|Migrated/moved from study area|2|||
170545130|NCT03166631|616340896|FG009|Overall Study|Physician Decision|0|||
170890705|NCT01262976|617606528|FG004|Up to Year 2|Migrated/moved from study area|1|||
170890706|NCT01262976|617606529|FG005|Up to Year 2|Migrated/moved from study area|2|||
170890707|NCT01262976|617606524|FG000|Up to Year 2|Lost to Follow-up|1|||
170890708|NCT01262976|617606525|FG001|Up to Year 2|Lost to Follow-up|1|||
170890709|NCT01262976|617606526|FG002|Up to Year 2|Lost to Follow-up|2|||
170890710|NCT01262976|617606527|FG003|Up to Year 2|Lost to Follow-up|2|||
170890711|NCT01262976|617606528|FG004|Up to Year 2|Lost to Follow-up|3|||
170890712|NCT01262976|617606529|FG005|Up to Year 2|Lost to Follow-up|3|||
170890713|NCT01262976|617606524|FG000|Up to Year 2|Subjects with unknown completion status|0|||
170890714|NCT01262976|617606525|FG001|Up to Year 2|Subjects with unknown completion status|0|||
170890715|NCT01262976|617606526|FG002|Up to Year 2|Subjects with unknown completion status|1|||
170890716|NCT01262976|617606527|FG003|Up to Year 2|Subjects with unknown completion status|0|||
170890717|NCT01262976|617606528|FG004|Up to Year 2|Subjects with unknown completion status|0|||
170890718|NCT01262976|617606529|FG005|Up to Year 2|Subjects with unknown completion status|0|||
170890719|NCT01262976|617606524|FG000|Up to Year 2|Other|3|||
170890720|NCT01262976|617606525|FG001|Up to Year 2|Other|0|||
170890721|NCT01262976|617606526|FG002|Up to Year 2|Other|0|||
170890722|NCT01262976|617606527|FG003|Up to Year 2|Other|0|||
170890723|NCT01262976|617606528|FG004|Up to Year 2|Other|0|||
170890724|NCT01262976|617606529|FG005|Up to Year 2|Other|0|||
170890725|NCT01262976|617606524|FG000|Up to Year 3|Serious Adverse Event|0|||
170890726|NCT01262976|617606525|FG001|Up to Year 3|Serious Adverse Event|0|||
170890727|NCT01262976|617606526|FG002|Up to Year 3|Serious Adverse Event|2|||
170890728|NCT01262976|617606527|FG003|Up to Year 3|Serious Adverse Event|0|||
170890729|NCT01262976|617606528|FG004|Up to Year 3|Serious Adverse Event|0|||
170890730|NCT01262976|617606529|FG005|Up to Year 3|Serious Adverse Event|0|||
170890731|NCT01262976|617606524|FG000|Up to Year 3|Withdrawal by Subject|1|||
170890732|NCT01262976|617606525|FG001|Up to Year 3|Withdrawal by Subject|0|||
170890733|NCT01262976|617606526|FG002|Up to Year 3|Withdrawal by Subject|0|||
170890734|NCT01262976|617606527|FG003|Up to Year 3|Withdrawal by Subject|0|||
170890735|NCT01262976|617606528|FG004|Up to Year 3|Withdrawal by Subject|0|||
170890736|NCT01262976|617606529|FG005|Up to Year 3|Withdrawal by Subject|0|||
170890737|NCT01262976|617606524|FG000|Up to Year 3|Migrated/moved from study area|0|||
170890738|NCT01262976|617606525|FG001|Up to Year 3|Migrated/moved from study area|0|||
170890739|NCT01262976|617606526|FG002|Up to Year 3|Migrated/moved from study area|0|||
170890740|NCT01262976|617606527|FG003|Up to Year 3|Migrated/moved from study area|2|||
170890741|NCT01262976|617606528|FG004|Up to Year 3|Migrated/moved from study area|1|||
170890742|NCT01262976|617606529|FG005|Up to Year 3|Migrated/moved from study area|1|||
170890743|NCT01262976|617606524|FG000|Up to Year 3|Lost to Follow-up|2|||
170890744|NCT01262976|617606525|FG001|Up to Year 3|Lost to Follow-up|2|||
170890745|NCT01262976|617606526|FG002|Up to Year 3|Lost to Follow-up|4|||
170890746|NCT01262976|617606527|FG003|Up to Year 3|Lost to Follow-up|3|||
170890747|NCT01262976|617606528|FG004|Up to Year 3|Lost to Follow-up|1|||
170890748|NCT01262976|617606529|FG005|Up to Year 3|Lost to Follow-up|3|||
170890749|NCT01262976|617606524|FG000|Up to Year 3|Subjects with unknown completion status|0|||
170890750|NCT01262976|617606525|FG001|Up to Year 3|Subjects with unknown completion status|0|||
170890751|NCT01262976|617606526|FG002|Up to Year 3|Subjects with unknown completion status|1|||
170890752|NCT01262976|617606527|FG003|Up to Year 3|Subjects with unknown completion status|0|||
170890753|NCT01262976|617606528|FG004|Up to Year 3|Subjects with unknown completion status|0|||
170890754|NCT01262976|617606529|FG005|Up to Year 3|Subjects with unknown completion status|0|||
170890755|NCT01262976|617606524|FG000|Up to Year 3|Other|3|||
170890756|NCT01262976|617606525|FG001|Up to Year 3|Other|0|||
170890757|NCT01262976|617606526|FG002|Up to Year 3|Other|0|||
170890758|NCT01262976|617606527|FG003|Up to Year 3|Other|0|||
170890759|NCT01262976|617606528|FG004|Up to Year 3|Other|0|||
170890760|NCT01262976|617606529|FG005|Up to Year 3|Other|0|||
170890761|NCT00699907|617606530|FG000|Overall Study|Withdrawal by Subject|2|||
170890762|NCT00699907|617606531|FG001|Overall Study|Withdrawal by Subject|1|||
170890763|NCT00699907|617606532|FG002|Overall Study|Withdrawal by Subject|0|||
170890764|NCT00699907|617606530|FG000|Overall Study|No usable sample|0|||
170890765|NCT00699907|617606531|FG001|Overall Study|No usable sample|9|||
170890766|NCT00699907|617606532|FG002|Overall Study|No usable sample|8|||
170890767|NCT01164722|617606533|FG000|Overall Study|Adverse Event|0|||
170890768|NCT01164722|617606534|FG001|Overall Study|Adverse Event|1|||
170890769|NCT01164722|617606533|FG000|Overall Study|Withdrawal by Subject|3|||
170890770|NCT01164722|617606534|FG001|Overall Study|Withdrawal by Subject|4|||
170890771|NCT01164722|617606533|FG000|Overall Study|Lost to Follow-up|3|||
170890772|NCT01164722|617606534|FG001|Overall Study|Lost to Follow-up|6|||
170890773|NCT01164722|617606533|FG000|Overall Study|met protocol criteria for non-treatment|11|||
170890774|NCT01164722|617606534|FG001|Overall Study|met protocol criteria for non-treatment|1|||
170545131|NCT03166631|616340897|FG010|Overall Study|Physician Decision|1|||
170545132|NCT03166631|616340887|FG000|Overall Study|Death|0|||
170545133|NCT03166631|616340888|FG001|Overall Study|Death|0|||
170890775|NCT01164722|617606533|FG000|Overall Study|enrolled on other study, concomitant med|1|||
170890776|NCT01164722|617606534|FG001|Overall Study|enrolled on other study, concomitant med|3|||
170890777|NCT02568046|617606535|FG000|Overall Study|Adverse Event|0|||
170890778|NCT02568046|617606536|FG001|Overall Study|Adverse Event|1|||
170890779|NCT02568046|617606535|FG000|Overall Study|Death|2|||
170890780|NCT02568046|617606536|FG001|Overall Study|Death|0|||
170890781|NCT02568046|617606535|FG000|Overall Study|Progressive Disease|1|||
170890782|NCT02568046|617606536|FG001|Overall Study|Progressive Disease|0|||
170466563|NCT02823652|616046283|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
170466564|NCT02071849|616046284|FG000|6-month Primary Endpoint|Did not receive device|4|||
170466565|NCT02071849|616046284|FG000|6-month Primary Endpoint|Adverse Event|1|||
170466566|NCT02071849|616046284|FG000|2-year Extended Follow-up|Adverse Event|1|||
170466567|NCT02351960|616046285|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
170466568|NCT02351960|616046286|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
170466569|NCT02351960|616046285|FG000|Overall Study|Voluntary Withdrawal|5|||
170466570|NCT02351960|616046286|FG001|Overall Study|Voluntary Withdrawal|4|||
170466571|NCT02351960|616046285|FG000|Overall Study|Significant Protocol Deviation|0|||
170466572|NCT02351960|616046286|FG001|Overall Study|Significant Protocol Deviation|5|||
170466573|NCT01094886|616046287|FG000|Overall Study|Adverse Event|2|||
170466574|NCT01094886|616046287|FG000|Overall Study|Withdrawal by Subject|5|||
170466575|NCT00103610|616046288|FG000|Overall Study|Entered Rescue Procedure|10|||
170466576|NCT00103610|616046289|FG001|Overall Study|Entered Rescue Procedure|52|||
170466577|NCT00103610|616046288|FG000|Overall Study|Death|16|||
170466578|NCT00103610|616046289|FG001|Overall Study|Death|12|||
170466579|NCT00103610|616046288|FG000|Overall Study|Elective Withdrawal|4|||
170466580|NCT00103610|616046289|FG001|Overall Study|Elective Withdrawal|0|||
170466581|NCT00103610|616046288|FG000|Overall Study|Lost to Follow-up|3|||
170466582|NCT00103610|616046289|FG001|Overall Study|Lost to Follow-up|1|||
170466583|NCT00103610|616046288|FG000|Overall Study|Adverse Event|2|||
170466584|NCT00103610|616046289|FG001|Overall Study|Adverse Event|2|||
170466585|NCT00103610|616046288|FG000|Overall Study|Other|2|||
170466586|NCT00103610|616046289|FG001|Overall Study|Other|7|||
170466587|NCT00103610|616046288|FG000|Overall Study|Failed mobilization|1|||
170466588|NCT00103610|616046289|FG001|Overall Study|Failed mobilization|5|||
170466589|NCT00103610|616046288|FG000|Overall Study|Noncompliance|0|||
170466590|NCT00103610|616046289|FG001|Overall Study|Noncompliance|1|||
170466591|NCT00658021|616046290|FG000|28-Week Treatment Period|Adverse Event|3|||
170466592|NCT00658021|616046291|FG001|28-Week Treatment Period|Adverse Event|1|||
170466593|NCT00658021|616046292|FG002|28-Week Treatment Period|Adverse Event|0|||
170466594|NCT00658021|616046290|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
170466595|NCT00658021|616046291|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
170466596|NCT00658021|616046292|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
170466597|NCT00658021|616046290|FG000|28-Week Treatment Period|Protocol Violation|0|||
170466598|NCT00658021|616046291|FG001|28-Week Treatment Period|Protocol Violation|2|||
170466599|NCT00658021|616046292|FG002|28-Week Treatment Period|Protocol Violation|1|||
170466600|NCT00658021|616046290|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
170466601|NCT00658021|616046291|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
170466602|NCT00658021|616046292|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
170466603|NCT00658021|616046290|FG000|28-Week Treatment Period|Physician Decision|1|||
170790307|NCT03701763|617242881|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
170790308|NCT03701763|617242882|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
170790309|NCT03701763|617242879|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
170790310|NCT03701763|617242880|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
170790311|NCT03701763|617242881|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
170790312|NCT03701763|617242882|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
170790313|NCT03701763|617242879|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
170790314|NCT03701763|617242880|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
170790315|NCT03701763|617242881|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
170790316|NCT03701763|617242882|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
170790317|NCT03701763|617242879|FG000|14-Week Observational Follow-up Phase|Other|0|||
170790318|NCT03701763|617242880|FG001|14-Week Observational Follow-up Phase|Other|0|||
170790319|NCT03701763|617242881|FG002|14-Week Observational Follow-up Phase|Other|1|||
170790320|NCT03701763|617242882|FG003|14-Week Observational Follow-up Phase|Other|0|||
170790321|NCT03701763|617242879|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
170790322|NCT03701763|617242880|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
170790323|NCT03701763|617242881|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
170790324|NCT03701763|617242882|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
170790325|NCT03701763|617242879|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
170790326|NCT03701763|617242880|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
170790327|NCT03701763|617242881|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
170790328|NCT03701763|617242882|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
170790329|NCT04068181|617242883|FG000|Overall Study|Death|17|||
170466604|NCT00658021|616046291|FG001|28-Week Treatment Period|Physician Decision|2|||
170466605|NCT00658021|616046292|FG002|28-Week Treatment Period|Physician Decision|1|||
170466606|NCT00658021|616046290|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
170466607|NCT00658021|616046291|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
170466608|NCT00658021|616046292|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
170466609|NCT00658021|616046290|FG000|28-Week Treatment Period|Loss of glucose control|1|||
170890783|NCT02568046|617606535|FG000|Overall Study|Withdrawal by Subject|2|||
170890784|NCT02568046|617606536|FG001|Overall Study|Withdrawal by Subject|1|||
170890785|NCT02568046|617606535|FG000|Overall Study|Other Events|0|||
170890786|NCT02568046|617606536|FG001|Overall Study|Other Events|1|||
170890787|NCT01325428|617606537|FG000|Part A|Progressive disease according to RECIST|9|||
170890788|NCT01325428|617606537|FG000|Part A|Clinical signs, symptoms of progression|2|||
170890789|NCT01325428|617606537|FG000|Part A|Other adverse event|1|||
170890790|NCT01325428|617606537|FG000|Part A|Refused continue taking trial medication|2|||
170890791|NCT01325428|617606537|FG000|Part A|Other reason not defined above|2|||
170890792|NCT01325428|617606537|FG000|Part B|Refused continue taking trial medication|2|||
170890793|NCT01325428|617606537|FG000|Part B|Other reason not defined above|1|||
170890794|NCT00725075|617606538|FG000|Overall Study|Use of Excluded Medication|0|||
170890795|NCT00725075|617606539|FG001|Overall Study|Use of Excluded Medication|1|||
170890796|NCT00725075|617606540|FG002|Overall Study|Use of Excluded Medication|0|||
170890797|NCT00725075|617606538|FG000|Overall Study|Protocol Violation|0|||
170890798|NCT00725075|617606539|FG001|Overall Study|Protocol Violation|0|||
170890799|NCT00725075|617606540|FG002|Overall Study|Protocol Violation|1|||
170890800|NCT00725075|617606538|FG000|Overall Study|Lost to Follow-up|1|||
170890801|NCT00725075|617606539|FG001|Overall Study|Lost to Follow-up|0|||
170890802|NCT00725075|617606540|FG002|Overall Study|Lost to Follow-up|0|||
170890803|NCT00725075|617606538|FG000|Overall Study|Withdrawal by Subject|4|||
170890804|NCT00725075|617606539|FG001|Overall Study|Withdrawal by Subject|5|||
170890805|NCT00725075|617606540|FG002|Overall Study|Withdrawal by Subject|4|||
170890806|NCT00725075|617606538|FG000|Overall Study|Adverse Event|2|||
170890807|NCT00725075|617606539|FG001|Overall Study|Adverse Event|1|||
170890808|NCT00725075|617606540|FG002|Overall Study|Adverse Event|1|||
170890809|NCT00725075|617606538|FG000|Overall Study|Worsening of Disease|2|||
170890810|NCT00725075|617606539|FG001|Overall Study|Worsening of Disease|1|||
170890811|NCT00725075|617606540|FG002|Overall Study|Worsening of Disease|2|||
170890812|NCT00725075|617606538|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
170466610|NCT00658021|616046291|FG001|28-Week Treatment Period|Loss of glucose control|1|||
170466611|NCT00658021|616046292|FG002|28-Week Treatment Period|Loss of glucose control|10|||
170466612|NCT00658021|616046290|FG000|28-Week Treatment Period|Other|2|||
170466613|NCT00658021|616046291|FG001|28-Week Treatment Period|Other|3|||
170466614|NCT00658021|616046292|FG002|28-Week Treatment Period|Other|1|||
170466615|NCT00658021|616046290|FG000|28-Week Treatment Period|Did not receive treatment|2|||
170466616|NCT00658021|616046291|FG001|28-Week Treatment Period|Did not receive treatment|0|||
170466617|NCT00658021|616046292|FG002|28-Week Treatment Period|Did not receive treatment|0|||
170466618|NCT00658021|616046290|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
170466619|NCT00658021|616046291|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
170466620|NCT00658021|616046292|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
170466621|NCT00658021|616046290|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
170466622|NCT00658021|616046291|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
170466623|NCT00658021|616046292|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
170466624|NCT02092467|616046293|FG000|Overall Study|Death|49|||
170466625|NCT02092467|616046294|FG001|Overall Study|Death|66|||
170466626|NCT02092467|616046295|FG002|Overall Study|Death|38|||
170466627|NCT02092467|616046293|FG000|Overall Study|Lost to Follow-up|38|||
170890813|NCT00725075|617606539|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
170890814|NCT00725075|617606540|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
170890815|NCT00725075|617606538|FG000|Overall Study|Other|1|||
170890816|NCT00725075|617606539|FG001|Overall Study|Other|0|||
170890817|NCT00725075|617606540|FG002|Overall Study|Other|0|||
170890818|NCT02340663|617606541|FG000|Overall Study|Lost to Follow-up|1|||
170890819|NCT02340663|617606542|FG001|Overall Study|Lost to Follow-up|0|||
170890820|NCT02340663|617606541|FG000|Overall Study|Protocol Violation|1|||
170890821|NCT02340663|617606542|FG001|Overall Study|Protocol Violation|0|||
170890822|NCT02340663|617606541|FG000|Overall Study|Withdrawal by Subject|3|||
170890823|NCT02340663|617606542|FG001|Overall Study|Withdrawal by Subject|1|||
170890824|NCT03033875|617606552|FG000|Overall Study|Withdrawal by Subject|5|||
170890825|NCT03033875|617606553|FG001|Overall Study|Withdrawal by Subject|9|||
170890826|NCT03033875|617606554|FG002|Overall Study|Withdrawal by Subject|4|||
170466628|NCT02092467|616046294|FG001|Overall Study|Lost to Follow-up|35|||
170466629|NCT02092467|616046295|FG002|Overall Study|Lost to Follow-up|40|||
170466630|NCT02092467|616046293|FG000|Overall Study|Global Deterioration of Health Status|1|||
170466631|NCT02092467|616046294|FG001|Overall Study|Global Deterioration of Health Status|0|||
170890827|NCT03033875|617606552|FG000|Overall Study|Other|14|||
170890828|NCT03033875|617606553|FG001|Overall Study|Other|15|||
170890829|NCT03033875|617606554|FG002|Overall Study|Other|8|||
170890830|NCT03595553|617606561|FG000|Overall Study|Withdrawal by Subject|20|||
170890831|NCT03595553|617606562|FG001|Overall Study|Withdrawal by Subject|8|||
170890832|NCT03595553|617606561|FG000|Overall Study|Physician Decision|3|||
170890833|NCT03595553|617606562|FG001|Overall Study|Physician Decision|2|||
170890834|NCT03595553|617606561|FG000|Overall Study|Adverse Event|2|||
170890835|NCT03595553|617606562|FG001|Overall Study|Adverse Event|5|||
170466632|NCT02092467|616046295|FG002|Overall Study|Global Deterioration of Health Status|0|||
170466633|NCT02092467|616046293|FG000|Overall Study|Other|32|||
170466634|NCT02092467|616046294|FG001|Overall Study|Other|30|||
170466635|NCT02092467|616046295|FG002|Overall Study|Other|24|||
170466636|NCT02092467|616046293|FG000|Overall Study|Withdrawal by Subject|282|||
170466637|NCT02092467|616046294|FG001|Overall Study|Withdrawal by Subject|327|||
170466638|NCT02092467|616046295|FG002|Overall Study|Withdrawal by Subject|289|||
170466639|NCT02092467|616046293|FG000|Overall Study|Randomized but not treated|2|||
170466640|NCT02092467|616046294|FG001|Overall Study|Randomized but not treated|1|||
170466641|NCT02092467|616046295|FG002|Overall Study|Randomized but not treated|7|||
170466642|NCT04844762|616046296|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466643|NCT04844762|616046297|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466644|NCT04844762|616046298|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
170466645|NCT04844762|616046299|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466646|NCT04844762|616046300|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466647|NCT04844762|616046301|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466648|NCT04844762|616046296|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
170466649|NCT04844762|616046297|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
170466650|NCT04844762|616046298|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
170466651|NCT04844762|616046299|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
170466652|NCT04844762|616046300|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
170466653|NCT04844762|616046301|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
170466654|NCT04844762|616046296|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466655|NCT04844762|616046297|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170545134|NCT03166631|616340889|FG002|Overall Study|Death|0|||
170545135|NCT03166631|616340890|FG003|Overall Study|Death|0|||
170545136|NCT03166631|616340891|FG004|Overall Study|Death|1|||
170545137|NCT03166631|616340892|FG005|Overall Study|Death|0|||
170545138|NCT03166631|616340893|FG006|Overall Study|Death|1|||
170545139|NCT03166631|616340894|FG007|Overall Study|Death|0|||
170545140|NCT03166631|616340895|FG008|Overall Study|Death|0|||
170545141|NCT03166631|616340896|FG009|Overall Study|Death|0|||
170790330|NCT04068181|617242884|FG001|Overall Study|Death|12|||
170790331|NCT04068181|617242885|FG002|Overall Study|Death|4|||
170466656|NCT04844762|616046298|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
170466657|NCT04844762|616046299|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
170466658|NCT04844762|616046300|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466659|NCT04844762|616046301|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
170790332|NCT04068181|617242886|FG003|Overall Study|Death|7|||
170790333|NCT04068181|617242883|FG000|Overall Study|Lost to Follow-up|1|||
170466660|NCT04844762|616046296|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466661|NCT04844762|616046297|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466662|NCT04844762|616046298|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
170466663|NCT04844762|616046299|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
170466664|NCT04844762|616046300|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
170466665|NCT04844762|616046301|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466666|NCT04844762|616046296|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
170466667|NCT04844762|616046297|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
170466668|NCT04844762|616046298|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466669|NCT04844762|616046299|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466670|NCT04844762|616046300|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466671|NCT04844762|616046301|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466672|NCT04844762|616046296|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
170466673|NCT04844762|616046297|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466674|NCT04844762|616046298|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466675|NCT04844762|616046299|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466676|NCT04844762|616046300|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466677|NCT04844762|616046301|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170790334|NCT04068181|617242884|FG001|Overall Study|Lost to Follow-up|0|||
170790335|NCT04068181|617242885|FG002|Overall Study|Lost to Follow-up|0|||
170790336|NCT04068181|617242886|FG003|Overall Study|Lost to Follow-up|0|||
170790337|NCT04068181|617242883|FG000|Overall Study|Withdrawal of consent from study|3|||
170466678|NCT04844762|616046296|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466679|NCT04844762|616046297|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466680|NCT04844762|616046298|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466681|NCT04844762|616046299|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170545142|NCT03166631|616340897|FG010|Overall Study|Death|0|||
170545143|NCT03166631|616340887|FG000|Overall Study|Adverse Event|1|||
170545144|NCT03166631|616340888|FG001|Overall Study|Adverse Event|0|||
170545145|NCT03166631|616340889|FG002|Overall Study|Adverse Event|0|||
170790338|NCT04068181|617242884|FG001|Overall Study|Withdrawal of consent from study|0|||
170466682|NCT04844762|616046300|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
170466683|NCT04844762|616046301|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
170466684|NCT04844762|616046296|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
170466685|NCT04844762|616046297|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466686|NCT04844762|616046298|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466687|NCT04844762|616046299|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466688|NCT04844762|616046300|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466689|NCT04844762|616046301|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
170466690|NCT04844762|616046296|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
170466691|NCT04844762|616046297|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466692|NCT04844762|616046298|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466693|NCT04844762|616046299|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466694|NCT04844762|616046300|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
170466695|NCT04844762|616046301|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
170466696|NCT04844762|616046296|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
170466697|NCT04844762|616046297|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
170466698|NCT04844762|616046298|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
170466699|NCT04844762|616046299|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
170466700|NCT04844762|616046300|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
170466701|NCT04844762|616046301|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
170466702|NCT04844762|616046296|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
170466703|NCT04844762|616046297|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
170466704|NCT04844762|616046298|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
170466705|NCT04844762|616046299|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
170466706|NCT04844762|616046300|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
170466707|NCT04844762|616046301|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
170466708|NCT02802631|616046302|FG000|Overall Study|Withdrawal by Subject|1|||
170466709|NCT02802631|616046303|FG001|Overall Study|Withdrawal by Subject|0|||
170466710|NCT02802631|616046304|FG002|Overall Study|Withdrawal by Subject|0|||
170466711|NCT02802631|616046305|FG003|Overall Study|Withdrawal by Subject|0|||
170466712|NCT02802631|616046306|FG004|Overall Study|Withdrawal by Subject|0|||
170466713|NCT02802631|616046307|FG005|Overall Study|Withdrawal by Subject|0|||
170466714|NCT02802631|616046308|FG006|Overall Study|Withdrawal by Subject|0|||
170466715|NCT02802631|616046309|FG007|Overall Study|Withdrawal by Subject|0|||
170466716|NCT02802631|616046302|FG000|Overall Study|Physician Decision|1|||
170545146|NCT03166631|616340890|FG003|Overall Study|Adverse Event|0|||
170545147|NCT03166631|616340891|FG004|Overall Study|Adverse Event|0|||
170545148|NCT03166631|616340892|FG005|Overall Study|Adverse Event|1|||
170545149|NCT03166631|616340893|FG006|Overall Study|Adverse Event|1|||
170545150|NCT03166631|616340894|FG007|Overall Study|Adverse Event|0|||
170545151|NCT03166631|616340895|FG008|Overall Study|Adverse Event|1|||
170545152|NCT03166631|616340896|FG009|Overall Study|Adverse Event|2|||
170545153|NCT03166631|616340897|FG010|Overall Study|Adverse Event|1|||
170545154|NCT03166631|616340887|FG000|Overall Study|Withdrawal by Subject|0|||
170545155|NCT03166631|616340888|FG001|Overall Study|Withdrawal by Subject|0|||
170545156|NCT03166631|616340889|FG002|Overall Study|Withdrawal by Subject|0|||
170545157|NCT03166631|616340890|FG003|Overall Study|Withdrawal by Subject|0|||
170545158|NCT03166631|616340891|FG004|Overall Study|Withdrawal by Subject|0|||
170545159|NCT03166631|616340892|FG005|Overall Study|Withdrawal by Subject|0|||
170545160|NCT03166631|616340893|FG006|Overall Study|Withdrawal by Subject|0|||
170545161|NCT03166631|616340894|FG007|Overall Study|Withdrawal by Subject|0|||
170545162|NCT03166631|616340895|FG008|Overall Study|Withdrawal by Subject|1|||
170545163|NCT03166631|616340896|FG009|Overall Study|Withdrawal by Subject|1|||
170545164|NCT03166631|616340897|FG010|Overall Study|Withdrawal by Subject|0|||
170545165|NCT03022630|616340898|FG000|Overall Study|Death|9|||
170545166|NCT03022630|616340899|FG001|Overall Study|Death|7|||
170545167|NCT03022630|616340898|FG000|Overall Study|Withdrawal by Subject|0|||
170890836|NCT03595553|617606561|FG000|Overall Study|Death|24|||
170890837|NCT03595553|617606562|FG001|Overall Study|Death|22|||
170890838|NCT03595553|617606561|FG000|Overall Study|Lost to Follow-up|6|||
170890839|NCT03595553|617606562|FG001|Overall Study|Lost to Follow-up|7|||
170466717|NCT02802631|616046303|FG001|Overall Study|Physician Decision|0|||
170466718|NCT02802631|616046304|FG002|Overall Study|Physician Decision|0|||
170545168|NCT03022630|616340899|FG001|Overall Study|Withdrawal by Subject|5|||
170545169|NCT00382070|616340900|FG000|Overall Study|No follow up data mapped to Other|17|||
170545170|NCT00382070|616340901|FG001|Overall Study|No follow up data mapped to Other|19|||
170545171|NCT00382070|616340900|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
170545172|NCT00382070|616340901|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
170545173|NCT00382070|616340900|FG000|Overall Study|No clinical assessment|9|||
170890840|NCT03595553|617606561|FG000|Overall Study|Other as indicated in CSR|3|||
170890841|NCT03595553|617606562|FG001|Overall Study|Other as indicated in CSR|3|||
170890842|NCT03595553|617606561|FG000|Overall Study|Sponsor Decision|0|||
170637204|NCT03901469|616684513|FG004|Overall Study|Not Reported|0|||
170790339|NCT04068181|617242885|FG002|Overall Study|Withdrawal of consent from study|0|||
170790340|NCT04068181|617242886|FG003|Overall Study|Withdrawal of consent from study|0|||
170790341|NCT02723591|617242887|FG000|Overall Study|Adverse Event|48|||
170790342|NCT02723591|617242888|FG001|Overall Study|Adverse Event|40|||
170790343|NCT02723591|617242887|FG000|Overall Study|Death|2|||
170790344|NCT02723591|617242888|FG001|Overall Study|Death|2|||
170790345|NCT02723591|617242887|FG000|Overall Study|Lack of Efficacy|4|||
170790346|NCT02723591|617242888|FG001|Overall Study|Lack of Efficacy|3|||
170790347|NCT02723591|617242887|FG000|Overall Study|Lost to Follow-up|1|||
170790348|NCT02723591|617242888|FG001|Overall Study|Lost to Follow-up|7|||
170790349|NCT02723591|617242887|FG000|Overall Study|Protocol Violation|20|||
170790350|NCT02723591|617242888|FG001|Overall Study|Protocol Violation|23|||
170790351|NCT02723591|617242887|FG000|Overall Study|Withdrawal by Subject|4|||
170790352|NCT02723591|617242888|FG001|Overall Study|Withdrawal by Subject|8|||
170790353|NCT02723591|617242887|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
170790354|NCT02723591|617242888|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
170790355|NCT02723591|617242887|FG000|Overall Study|Miscellaneous|5|||
170790356|NCT02723591|617242888|FG001|Overall Study|Miscellaneous|6|||
170790357|NCT05070728|617242889|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
170790358|NCT05070728|617242890|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
170790359|NCT03924635|617242891|FG000|Overall Study|Withdrawal by Subject|2|||
170790360|NCT03924635|617242892|FG001|Overall Study|Withdrawal by Subject|4|||
170790361|NCT04568434|617242895|FG000|Overall Study|Voluntary Withdrawal|0|||
170790362|NCT04568434|617242896|FG001|Overall Study|Voluntary Withdrawal|1|||
170790363|NCT04568434|617242897|FG002|Overall Study|Voluntary Withdrawal|1|||
170790364|NCT04568434|617242895|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
170790365|NCT04568434|617242896|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
170790366|NCT04568434|617242897|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
170790367|NCT04568434|617242895|FG000|Overall Study|Investigator Judgement|1|||
170790368|NCT04568434|617242896|FG001|Overall Study|Investigator Judgement|0|||
170790369|NCT04568434|617242897|FG002|Overall Study|Investigator Judgement|0|||
170790370|NCT03905798|617242898|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
170790371|NCT03463044|617242899|FG000|Overall Study|Lost to Follow-up|0|||
170790372|NCT03463044|617242900|FG001|Overall Study|Lost to Follow-up|0|||
170790373|NCT03463044|617242901|FG002|Overall Study|Lost to Follow-up|0|||
170790374|NCT03463044|617242902|FG003|Overall Study|Lost to Follow-up|0|||
170790375|NCT03463044|617242903|FG004|Overall Study|Lost to Follow-up|0|||
170790376|NCT03463044|617242904|FG005|Overall Study|Lost to Follow-up|0|||
170790377|NCT03463044|617242905|FG006|Overall Study|Lost to Follow-up|0|||
170790378|NCT03463044|617242906|FG007|Overall Study|Lost to Follow-up|1|||
170790379|NCT03463044|617242907|FG008|Overall Study|Lost to Follow-up|0|||
170790380|NCT03334630|617242908|FG000|Overall Study|Withdrawal by Subject|7|||
170790381|NCT03334630|617242909|FG001|Overall Study|Withdrawal by Subject|7|||
170790382|NCT03334630|617242908|FG000|Overall Study|Lost to Follow-up|3|||
170790383|NCT03334630|617242909|FG001|Overall Study|Lost to Follow-up|1|||
170790384|NCT03334630|617242908|FG000|Overall Study|Adverse Event|0|||
170790385|NCT03334630|617242909|FG001|Overall Study|Adverse Event|1|||
170790386|NCT03334630|617242908|FG000|Overall Study|Physician Decision|1|||
170790387|NCT03334630|617242909|FG001|Overall Study|Physician Decision|1|||
170790388|NCT03334630|617242908|FG000|Overall Study|Enrollment closed|2|||
170790389|NCT03334630|617242909|FG001|Overall Study|Enrollment closed|1|||
170790390|NCT03334630|617242908|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
170790391|NCT03334630|617242909|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
170790392|NCT03334630|617242908|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
170790393|NCT03334630|617242909|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
170790394|NCT05192109|617242910|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
170790395|NCT05192109|617242911|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
170790396|NCT05192109|617242912|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
170790397|NCT05192109|617242913|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
170790398|NCT05192109|617242910|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
170790399|NCT05192109|617242911|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
170790400|NCT05192109|617242912|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
170790401|NCT05192109|617242913|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
170790402|NCT04081103|617242919|FG000|Overall Study|Adverse Event|1|||
170790403|NCT04081103|617242920|FG001|Overall Study|Adverse Event|1|||
170790404|NCT04081103|617242921|FG002|Overall Study|Adverse Event|1|||
170790405|NCT04081103|617242919|FG000|Overall Study|Physician Decision|0|||
170790406|NCT04081103|617242920|FG001|Overall Study|Physician Decision|0|||
170790407|NCT04081103|617242921|FG002|Overall Study|Physician Decision|1|||
170790408|NCT05623228|617242922|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
170790409|NCT05623228|617242923|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
170790410|NCT05623228|617242924|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
170466719|NCT02802631|616046305|FG003|Overall Study|Physician Decision|0|||
170466720|NCT02802631|616046306|FG004|Overall Study|Physician Decision|0|||
170466721|NCT02802631|616046307|FG005|Overall Study|Physician Decision|0|||
170466722|NCT02802631|616046308|FG006|Overall Study|Physician Decision|1|||
170466723|NCT02802631|616046309|FG007|Overall Study|Physician Decision|0|||
170466724|NCT02802631|616046302|FG000|Overall Study|Adverse Event|0|||
170466725|NCT02802631|616046303|FG001|Overall Study|Adverse Event|2|||
170466726|NCT02802631|616046304|FG002|Overall Study|Adverse Event|0|||
170466727|NCT02802631|616046305|FG003|Overall Study|Adverse Event|1|||
170466728|NCT02802631|616046306|FG004|Overall Study|Adverse Event|6|||
170466729|NCT02802631|616046307|FG005|Overall Study|Adverse Event|1|||
170466730|NCT02802631|616046308|FG006|Overall Study|Adverse Event|4|||
170466731|NCT02802631|616046309|FG007|Overall Study|Adverse Event|0|||
170466732|NCT02802631|616046302|FG000|Overall Study|Sponsor Decision|0|||
170466733|NCT02802631|616046303|FG001|Overall Study|Sponsor Decision|0|||
170466734|NCT02802631|616046304|FG002|Overall Study|Sponsor Decision|6|||
170466735|NCT02802631|616046305|FG003|Overall Study|Sponsor Decision|0|||
170466736|NCT02802631|616046306|FG004|Overall Study|Sponsor Decision|2|||
170466737|NCT02802631|616046307|FG005|Overall Study|Sponsor Decision|0|||
170466738|NCT02802631|616046308|FG006|Overall Study|Sponsor Decision|0|||
170466739|NCT02802631|616046309|FG007|Overall Study|Sponsor Decision|4|||
170466740|NCT02342639|616046312|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
170466741|NCT02342639|616046313|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
170466742|NCT02342639|616046312|FG000|Overall Study|Protocol Violation|0|||
170466743|NCT02342639|616046313|FG001|Overall Study|Protocol Violation|2|||
170466744|NCT03155945|616046314|FG000|Overall Study|Lost to Follow-up|0|||
170790411|NCT05623228|617242925|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
170790412|NCT05623228|617242926|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
170790413|NCT05623228|617242927|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
170790414|NCT05623228|617242928|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
170790415|NCT05623228|617242929|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
170790416|NCT05623228|617242922|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
170790417|NCT05623228|617242923|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
170790418|NCT05623228|617242924|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
170790419|NCT05623228|617242925|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
170790420|NCT05623228|617242926|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
170790421|NCT05623228|617242927|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
170790422|NCT05623228|617242928|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
170790423|NCT05623228|617242929|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
170790424|NCT05693935|617245697|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
170790425|NCT05693935|617245698|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
170466745|NCT03155945|616046315|FG001|Overall Study|Lost to Follow-up|1|||
170466746|NCT03155945|616046314|FG000|Overall Study|Withdrawal by Subject|0|||
170466747|NCT03155945|616046315|FG001|Overall Study|Withdrawal by Subject|1|||
170466748|NCT03155945|616046314|FG000|Overall Study|Other Reason|0|||
170466749|NCT03155945|616046315|FG001|Overall Study|Other Reason|1|||
170466750|NCT02013674|616046319|FG000|Overall Study|Death|0|||
170466751|NCT02013674|616046320|FG001|Overall Study|Death|1|||
170466752|NCT02013674|616046319|FG000|Overall Study|Lost to Follow-up|1|||
170466753|NCT02013674|616046320|FG001|Overall Study|Lost to Follow-up|0|||
170466754|NCT00416884|616046321|FG000|Overall Study|Study terminated due to low accrual|1|||
170466755|NCT00369486|616048064|FG000|4-Week Visit|Missed visit|2|||
170466756|NCT00369486|616048065|FG001|4-Week Visit|Missed visit|2|||
170466757|NCT00369486|616048066|FG002|4-Week Visit|Missed visit|0|||
170466758|NCT00369486|616048067|FG003|4-Week Visit|Missed visit|2|||
170466759|NCT00369486|616048068|FG004|4-Week Visit|Missed visit|1|||
170466760|NCT00369486|616048064|FG000|4-Week Visit|Dropped|0|||
170466761|NCT00369486|616048065|FG001|4-Week Visit|Dropped|0|||
170466762|NCT00369486|616048066|FG002|4-Week Visit|Dropped|1|||
170466763|NCT00369486|616048067|FG003|4-Week Visit|Dropped|0|||
170466764|NCT00369486|616048068|FG004|4-Week Visit|Dropped|0|||
170466765|NCT00369486|616048064|FG000|8-Week Visit|Missed visit|0|||
170466766|NCT00369486|616048065|FG001|8-Week Visit|Missed visit|1|||
170466767|NCT00369486|616048066|FG002|8-Week Visit|Missed visit|0|||
170466768|NCT00369486|616048067|FG003|8-Week Visit|Missed visit|0|||
170466769|NCT00369486|616048068|FG004|8-Week Visit|Missed visit|1|||
170466770|NCT00369486|616048064|FG000|8-Week Visit|Dropped|0|||
170466771|NCT00369486|616048065|FG001|8-Week Visit|Dropped|0|||
170466772|NCT00369486|616048066|FG002|8-Week Visit|Dropped|0|||
170466773|NCT00369486|616048067|FG003|8-Week Visit|Dropped|1|||
170466774|NCT00369486|616048068|FG004|8-Week Visit|Dropped|0|||
170466775|NCT00369486|616048064|FG000|17-Week Visit|Missed visit|0|||
170466776|NCT00369486|616048065|FG001|17-Week Visit|Missed visit|0|||
170466777|NCT00369486|616048066|FG002|17-Week Visit|Missed visit|1|||
170466778|NCT00369486|616048067|FG003|17-Week Visit|Missed visit|1|||
170466779|NCT00369486|616048068|FG004|17-Week Visit|Missed visit|1|||
170466780|NCT00369486|616048064|FG000|34-Week Visit|Dropped|0|||
170466781|NCT00369486|616048065|FG001|34-Week Visit|Dropped|1|||
170466782|NCT00369486|616048066|FG002|34-Week Visit|Dropped|1|||
170466783|NCT00369486|616048067|FG003|34-Week Visit|Dropped|3|||
170466784|NCT00369486|616048068|FG004|34-Week Visit|Dropped|3|||
170466785|NCT03278626|616048069|FG000|Overall Study|Death|2|||
170466786|NCT03278626|616048069|FG000|Overall Study|Toxicity|1|||
170466787|NCT03278626|616048069|FG000|Overall Study|Disease Progression|2|||
170466788|NCT04981717|616048070|FG000|Overall Study|Protocol Violation|0|||
170466789|NCT04981717|616048071|FG001|Overall Study|Protocol Violation|3|||
170466790|NCT04981717|616048070|FG000|Overall Study|Adverse Event|1|||
170466791|NCT04981717|616048071|FG001|Overall Study|Adverse Event|3|||
170466792|NCT04981717|616048070|FG000|Overall Study|Pregnancy|1|||
170466793|NCT04981717|616048071|FG001|Overall Study|Pregnancy|0|||
170466794|NCT04981717|616048070|FG000|Overall Study|Physician Decision|1|||
170466795|NCT04981717|616048071|FG001|Overall Study|Physician Decision|0|||
170466796|NCT04981717|616048070|FG000|Overall Study|Sponsor Request|157|||
170466797|NCT04981717|616048071|FG001|Overall Study|Sponsor Request|172|||
170890843|NCT03595553|617606562|FG001|Overall Study|Sponsor Decision|1|||
170466798|NCT04981717|616048070|FG000|Overall Study|Lost to Follow-up|4|||
170466799|NCT04981717|616048071|FG001|Overall Study|Lost to Follow-up|5|||
170466800|NCT04981717|616048070|FG000|Overall Study|Withdrawal by Subject|50|||
170466801|NCT04981717|616048071|FG001|Overall Study|Withdrawal by Subject|37|||
170466802|NCT00887289|616048072|FG000|Overall Study|Lack of Efficacy|14|||
170466803|NCT00887289|616048072|FG000|Overall Study|Adverse Event|27|||
170466804|NCT00887289|616048072|FG000|Overall Study|Withdrawal by Subject|26|||
170466805|NCT00887289|616048072|FG000|Overall Study|Lost to Follow-up|8|||
170466806|NCT00887289|616048072|FG000|Overall Study|Other|20|||
170466807|NCT00591773|616048073|FG000|Overall Study|Adverse Event|9|||
170466808|NCT00591773|616048074|FG001|Overall Study|Adverse Event|9|||
170466809|NCT00591773|616048075|FG002|Overall Study|Adverse Event|6|||
170466810|NCT00591773|616048073|FG000|Overall Study|Protocol Violation|2|||
170466811|NCT00591773|616048074|FG001|Overall Study|Protocol Violation|3|||
170466812|NCT00591773|616048075|FG002|Overall Study|Protocol Violation|0|||
170890844|NCT03467958|617606563|FG000|Overall Study|Adverse Event|20|||
170466813|NCT00591773|616048073|FG000|Overall Study|Lost to Follow-up|1|||
170466814|NCT00591773|616048074|FG001|Overall Study|Lost to Follow-up|4|||
170466815|NCT00591773|616048075|FG002|Overall Study|Lost to Follow-up|1|||
170466816|NCT00591773|616048073|FG000|Overall Study|Withdrawal by Subject|2|||
170466817|NCT00591773|616048074|FG001|Overall Study|Withdrawal by Subject|5|||
170466818|NCT00591773|616048075|FG002|Overall Study|Withdrawal by Subject|3|||
170890845|NCT03467958|617606564|FG001|Overall Study|Adverse Event|32|||
170890846|NCT03467958|617606565|FG002|Overall Study|Adverse Event|5|||
170466819|NCT00591773|616048073|FG000|Overall Study|Lack of Efficacy|1|||
170466820|NCT00591773|616048074|FG001|Overall Study|Lack of Efficacy|2|||
170466821|NCT00591773|616048075|FG002|Overall Study|Lack of Efficacy|2|||
170466822|NCT00591773|616048073|FG000|Overall Study|Other|1|||
170466823|NCT00591773|616048074|FG001|Overall Study|Other|1|||
170466824|NCT00591773|616048075|FG002|Overall Study|Other|4|||
170466825|NCT02640482|616048077|FG000|Overall Study|Lost to Follow-up|3|||
170466826|NCT02640482|616048078|FG001|Overall Study|Lost to Follow-up|0|||
170466827|NCT00517881|616048079|FG000|Overall Study|Protocol Violation|2|||
170545174|NCT00382070|616340901|FG001|Overall Study|No clinical assessment|11|||
170545175|NCT00504231|616340902|FG000|Overall Study|Discrepant chart documentation re route|0|||
170545176|NCT00504231|616340903|FG001|Overall Study|Discrepant chart documentation re route|0|||
170545177|NCT00504231|616340904|FG002|Overall Study|Discrepant chart documentation re route|1|||
170545178|NCT00504231|616340905|FG003|Overall Study|Discrepant chart documentation re route|0|||
170545179|NCT01629563|616340906|FG000|Overall Study|Adverse Event|16|||
170545180|NCT01629563|616340907|FG001|Overall Study|Adverse Event|16|||
170545181|NCT01629563|616340906|FG000|Overall Study|Death|2|||
170545182|NCT01629563|616340907|FG001|Overall Study|Death|0|||
170545183|NCT01629563|616340906|FG000|Overall Study|Lack of Efficacy|2|||
170545184|NCT01629563|616340907|FG001|Overall Study|Lack of Efficacy|3|||
170545185|NCT01629563|616340906|FG000|Overall Study|Lost to Follow-up|1|||
170545186|NCT01629563|616340907|FG001|Overall Study|Lost to Follow-up|0|||
170890847|NCT03467958|617606566|FG003|Overall Study|Adverse Event|3|||
170890848|NCT03467958|617606567|FG004|Overall Study|Adverse Event|3|||
170890849|NCT03467958|617606568|FG005|Overall Study|Adverse Event|3|||
170890850|NCT03467958|617606569|FG006|Overall Study|Adverse Event|6|||
170890851|NCT03467958|617606570|FG007|Overall Study|Adverse Event|5|||
170545187|NCT01629563|616340906|FG000|Overall Study|Pregnancy|1|||
170545188|NCT01629563|616340907|FG001|Overall Study|Pregnancy|2|||
170890852|NCT03467958|617606571|FG008|Overall Study|Adverse Event|0|||
170890853|NCT03467958|617606563|FG000|Overall Study|Lack of Efficacy|59|||
170890854|NCT03467958|617606564|FG001|Overall Study|Lack of Efficacy|120|||
170890855|NCT03467958|617606565|FG002|Overall Study|Lack of Efficacy|6|||
170890856|NCT03467958|617606566|FG003|Overall Study|Lack of Efficacy|9|||
170890857|NCT03467958|617606567|FG004|Overall Study|Lack of Efficacy|8|||
170890858|NCT03467958|617606568|FG005|Overall Study|Lack of Efficacy|9|||
170890859|NCT03467958|617606569|FG006|Overall Study|Lack of Efficacy|11|||
170890860|NCT03467958|617606570|FG007|Overall Study|Lack of Efficacy|9|||
170890861|NCT03467958|617606571|FG008|Overall Study|Lack of Efficacy|3|||
170890862|NCT03467958|617606563|FG000|Overall Study|Lost to Follow-up|1|||
170890863|NCT03467958|617606564|FG001|Overall Study|Lost to Follow-up|2|||
170890864|NCT03467958|617606565|FG002|Overall Study|Lost to Follow-up|1|||
170890865|NCT03467958|617606566|FG003|Overall Study|Lost to Follow-up|0|||
170890866|NCT03467958|617606567|FG004|Overall Study|Lost to Follow-up|4|||
170890867|NCT03467958|617606568|FG005|Overall Study|Lost to Follow-up|0|||
170890868|NCT03467958|617606569|FG006|Overall Study|Lost to Follow-up|0|||
170890869|NCT03467958|617606570|FG007|Overall Study|Lost to Follow-up|0|||
170890870|NCT03467958|617606571|FG008|Overall Study|Lost to Follow-up|0|||
170890871|NCT03467958|617606563|FG000|Overall Study|Other reasons|8|||
170890872|NCT03467958|617606564|FG001|Overall Study|Other reasons|14|||
170890873|NCT03467958|617606565|FG002|Overall Study|Other reasons|2|||
170890874|NCT03467958|617606566|FG003|Overall Study|Other reasons|1|||
170890875|NCT03467958|617606567|FG004|Overall Study|Other reasons|4|||
170890876|NCT03467958|617606568|FG005|Overall Study|Other reasons|0|||
170890877|NCT03467958|617606569|FG006|Overall Study|Other reasons|1|||
170890878|NCT03467958|617606570|FG007|Overall Study|Other reasons|0|||
170890879|NCT03467958|617606571|FG008|Overall Study|Other reasons|1|||
170890880|NCT03467958|617606563|FG000|Overall Study|Pregnancy|1|||
170890881|NCT03467958|617606564|FG001|Overall Study|Pregnancy|0|||
170890882|NCT03467958|617606565|FG002|Overall Study|Pregnancy|0|||
170890883|NCT03467958|617606566|FG003|Overall Study|Pregnancy|0|||
170890884|NCT03467958|617606567|FG004|Overall Study|Pregnancy|0|||
170890885|NCT03467958|617606568|FG005|Overall Study|Pregnancy|1|||
170890886|NCT03467958|617606569|FG006|Overall Study|Pregnancy|0|||
170890887|NCT03467958|617606570|FG007|Overall Study|Pregnancy|0|||
170890888|NCT03467958|617606571|FG008|Overall Study|Pregnancy|0|||
170890889|NCT03467958|617606563|FG000|Overall Study|Study terminated by sponsor|65|||
170890890|NCT03467958|617606564|FG001|Overall Study|Study terminated by sponsor|117|||
170890891|NCT03467958|617606565|FG002|Overall Study|Study terminated by sponsor|45|||
170890892|NCT03467958|617606566|FG003|Overall Study|Study terminated by sponsor|64|||
170890893|NCT03467958|617606567|FG004|Overall Study|Study terminated by sponsor|66|||
170890894|NCT03467958|617606568|FG005|Overall Study|Study terminated by sponsor|17|||
170890895|NCT03467958|617606569|FG006|Overall Study|Study terminated by sponsor|11|||
170890896|NCT03467958|617606570|FG007|Overall Study|Study terminated by sponsor|5|||
170890897|NCT03467958|617606571|FG008|Overall Study|Study terminated by sponsor|5|||
170890898|NCT03467958|617606563|FG000|Overall Study|Withdrawal by Subject|25|||
170545189|NCT01629563|616340906|FG000|Overall Study|Protocol Violation|0|||
170890899|NCT03467958|617606564|FG001|Overall Study|Withdrawal by Subject|44|||
170890900|NCT03467958|617606565|FG002|Overall Study|Withdrawal by Subject|7|||
170890901|NCT03467958|617606566|FG003|Overall Study|Withdrawal by Subject|8|||
170890902|NCT03467958|617606567|FG004|Overall Study|Withdrawal by Subject|6|||
170890903|NCT03467958|617606568|FG005|Overall Study|Withdrawal by Subject|8|||
170890904|NCT03467958|617606569|FG006|Overall Study|Withdrawal by Subject|4|||
170890905|NCT03467958|617606570|FG007|Overall Study|Withdrawal by Subject|1|||
170890906|NCT03467958|617606571|FG008|Overall Study|Withdrawal by Subject|4|||
170890907|NCT02286947|617606574|FG000|Overall Study|Withdrawal by Subject|2|||
170890908|NCT01687712|617606575|FG000|Cycle 1|Not Biochemically Pregnant|386|||
170890909|NCT01687712|617606576|FG001|Cycle 1|Not Biochemically Pregnant|348|||
170890910|NCT01687712|617606575|FG000|Cycle 1|Early Pregnancy Loss|43|||
170466828|NCT00517881|616048079|FG000|Overall Study|Adverse Event|1|||
170466829|NCT00517881|616048079|FG000|Overall Study|Renal transplantation|2|||
170466830|NCT05776862|616048080|FG000|Overall Study|Adverse Event|0|||
170466831|NCT05776862|616048081|FG001|Overall Study|Adverse Event|1|||
170466832|NCT05776862|616048080|FG000|Overall Study|non-compliance|1|||
170466833|NCT05776862|616048081|FG001|Overall Study|non-compliance|0|||
170466834|NCT00554606|616048082|FG000|Overall Study|Adverse Event|3|||
170466835|NCT00554606|616048082|FG000|Overall Study|Abnormal laboratory values|1|||
170466836|NCT00554606|616048082|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
170466837|NCT00554606|616048082|FG000|Overall Study|Subject withdrew consent|2|||
170466838|NCT00554606|616048082|FG000|Overall Study|Lost to Follow-up|2|||
170466839|NCT00554606|616048082|FG000|Overall Study|Administrative problems|60|||
170466840|NCT00554606|616048082|FG000|Overall Study|Death|1|||
170466841|NCT00554606|616048082|FG000|Overall Study|Protocol deviation|2|||
170466842|NCT00605540|616048084|FG000|Overall Study|Death|15|||
170466843|NCT00605540|616048084|FG000|Overall Study|Lost to Follow-up|23|||
170466844|NCT01696058|616048088|FG000|Overall Study|Adverse Event|21|||
170466845|NCT01696058|616048089|FG001|Overall Study|Adverse Event|11|||
170466846|NCT01696058|616048088|FG000|Overall Study|Lack of Efficacy|2|||
170466847|NCT01696058|616048089|FG001|Overall Study|Lack of Efficacy|3|||
170466848|NCT01696058|616048088|FG000|Overall Study|Protocol Violation|9|||
170466849|NCT01696058|616048089|FG001|Overall Study|Protocol Violation|3|||
170466850|NCT01696058|616048088|FG000|Overall Study|Lost to Follow-up|2|||
170466851|NCT01696058|616048089|FG001|Overall Study|Lost to Follow-up|5|||
170466852|NCT01696058|616048088|FG000|Overall Study|Withdrawal by Subject|4|||
170466853|NCT01696058|616048089|FG001|Overall Study|Withdrawal by Subject|6|||
170466854|NCT01696058|616048088|FG000|Overall Study|Other reason prematurely discontinued|5|||
170466855|NCT01696058|616048089|FG001|Overall Study|Other reason prematurely discontinued|3|||
170466856|NCT00106964|616048096|FG000|Overall Study|Lost to Follow-up|8|||
170466857|NCT00106964|616048097|FG001|Overall Study|Lost to Follow-up|6|||
170466858|NCT00106964|616048098|FG002|Overall Study|Lost to Follow-up|2|||
170466859|NCT00106964|616048096|FG000|Overall Study|Pregnancy|2|||
170466860|NCT00106964|616048097|FG001|Overall Study|Pregnancy|3|||
170466861|NCT00106964|616048098|FG002|Overall Study|Pregnancy|2|||
170466862|NCT00106964|616048096|FG000|Overall Study|Death|1|||
170466863|NCT00106964|616048097|FG001|Overall Study|Death|1|||
170466864|NCT00106964|616048098|FG002|Overall Study|Death|0|||
170466865|NCT00106964|616048096|FG000|Overall Study|Incarceration|0|||
170466866|NCT00106964|616048097|FG001|Overall Study|Incarceration|1|||
170466867|NCT00106964|616048098|FG002|Overall Study|Incarceration|0|||
170466868|NCT00106964|616048096|FG000|Overall Study|Site Funding Terminated|0|||
170466869|NCT00106964|616048097|FG001|Overall Study|Site Funding Terminated|1|||
170466870|NCT00106964|616048098|FG002|Overall Study|Site Funding Terminated|1|||
170466871|NCT00106964|616048096|FG000|Overall Study|Failure to adhere|2|||
170466872|NCT00106964|616048097|FG001|Overall Study|Failure to adhere|0|||
170466873|NCT00106964|616048098|FG002|Overall Study|Failure to adhere|0|||
170466874|NCT00106964|616048096|FG000|Overall Study|Did not meet eligibility criteria|0|||
170466875|NCT00106964|616048097|FG001|Overall Study|Did not meet eligibility criteria|2|||
170466876|NCT00106964|616048098|FG002|Overall Study|Did not meet eligibility criteria|2|||
170466877|NCT00106964|616048096|FG000|Overall Study|Required disallowed medication|0|||
170466878|NCT00106964|616048097|FG001|Overall Study|Required disallowed medication|1|||
170466879|NCT00106964|616048098|FG002|Overall Study|Required disallowed medication|0|||
170466880|NCT04746794|616048099|FG000|Overall Study|Did not complete any study assessment|50303|||
170466881|NCT04746794|616048100|FG001|Overall Study|Did not complete any study assessment|44997|||
170466882|NCT04040192|616048101|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
170466883|NCT04040192|616048102|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
170466884|NCT04040192|616048103|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
170466885|NCT04040192|616048101|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
170466886|NCT04040192|616048102|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
170545190|NCT01629563|616340907|FG001|Overall Study|Protocol Violation|1|||
170545191|NCT01629563|616340906|FG000|Overall Study|Withdrawal by Subject|27|||
170637205|NCT03901469|616684514|FG005|Overall Study|Not Reported|0|||
170466887|NCT04040192|616048103|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
170466888|NCT04040192|616048101|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
170466889|NCT04040192|616048102|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
170466890|NCT04040192|616048103|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
170466891|NCT04040192|616048101|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
170466892|NCT04040192|616048102|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
170466893|NCT04040192|616048103|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
170466894|NCT04040192|616048101|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
170466895|NCT04040192|616048102|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
170466896|NCT04040192|616048103|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
170466897|NCT04040192|616048101|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
170466898|NCT04040192|616048102|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
170545192|NCT01629563|616340907|FG001|Overall Study|Withdrawal by Subject|20|||
170545193|NCT01629563|616340906|FG000|Overall Study|surgery|0|||
170545194|NCT01629563|616340907|FG001|Overall Study|surgery|3|||
170545195|NCT01629563|616340906|FG000|Overall Study|Lack of return of menses|12|||
170637206|NCT03901469|616684515|FG006|Overall Study|Not Reported|1|||
170637207|NCT01415882|616684520|FG000|Overall Study|Ineligible|1|||
170637208|NCT01415882|616684521|FG001|Overall Study|Ineligible|0|||
170637209|NCT01415882|616684522|FG002|Overall Study|Ineligible|0|||
170637210|NCT01415882|616684523|FG003|Overall Study|Ineligible|3|||
170637211|NCT01415882|616684524|FG004|Overall Study|Ineligible|0|||
170637212|NCT01415882|616684520|FG000|Overall Study|Withdrawal by Subject|0|||
170637213|NCT01415882|616684521|FG001|Overall Study|Withdrawal by Subject|1|||
170637214|NCT01415882|616684522|FG002|Overall Study|Withdrawal by Subject|0|||
170545196|NCT01629563|616340907|FG001|Overall Study|Lack of return of menses|7|||
170545197|NCT01629563|616340906|FG000|Overall Study|Protocol Violation|0|||
170637215|NCT01415882|616684523|FG003|Overall Study|Withdrawal by Subject|1|||
170637216|NCT01415882|616684524|FG004|Overall Study|Withdrawal by Subject|0|||
170637217|NCT00976560|616684525|FG000|Overall Study|Adverse Event|5|||
170637218|NCT00976560|616684526|FG001|Overall Study|Adverse Event|5|||
170637219|NCT00976560|616684525|FG000|Overall Study|Lack of Efficacy|3|||
170637220|NCT00976560|616684526|FG001|Overall Study|Lack of Efficacy|5|||
170637221|NCT00976560|616684525|FG000|Overall Study|Protocol Violation|1|||
170637222|NCT00976560|616684526|FG001|Overall Study|Protocol Violation|0|||
170637223|NCT00976560|616684525|FG000|Overall Study|Lost to Follow-up|1|||
170637224|NCT00976560|616684526|FG001|Overall Study|Lost to Follow-up|0|||
170790426|NCT05693935|617245699|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
170545198|NCT01629563|616340907|FG001|Overall Study|Protocol Violation|1|||
170545199|NCT00720083|616340908|FG000|Overall Study|Ineligible|1|||
170545200|NCT00720083|616340909|FG001|Overall Study|Ineligible|2|||
170545201|NCT01913470|616340914|FG000|Overall Study|Lost to Follow-up|0|||
170545202|NCT01913470|616340915|FG001|Overall Study|Lost to Follow-up|1|||
170545203|NCT01913470|616340914|FG000|Overall Study|Physician Decision|0|||
170545204|NCT01913470|616340915|FG001|Overall Study|Physician Decision|1|||
170545205|NCT01913470|616340914|FG000|Overall Study|Withdrawal by Subject|0|||
170545206|NCT01913470|616340915|FG001|Overall Study|Withdrawal by Subject|1|||
170545207|NCT01524705|616340922|FG000|Overall Study|Adverse Event|2|||
170545208|NCT01524705|616340923|FG001|Overall Study|Adverse Event|0|||
170545209|NCT01524705|616340922|FG000|Overall Study|Death|1|||
170545210|NCT01524705|616340923|FG001|Overall Study|Death|0|||
170545211|NCT01524705|616340922|FG000|Overall Study|Lost to Follow-up|0|||
170545212|NCT01524705|616340923|FG001|Overall Study|Lost to Follow-up|1|||
170545213|NCT01524705|616340922|FG000|Overall Study|Withdrawal by Subject|0|||
170545214|NCT01524705|616340923|FG001|Overall Study|Withdrawal by Subject|1|||
170545215|NCT01524705|616340922|FG000|Overall Study|Pancreatic Cancer|0|||
170545216|NCT01524705|616340923|FG001|Overall Study|Pancreatic Cancer|1|||
170545217|NCT02573467|616340928|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
170790427|NCT05693935|617245700|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
170790428|NCT05693935|617245701|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
170790429|NCT05693935|617245702|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
170790430|NCT05693935|617245703|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
170790431|NCT05693935|617245697|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
170790432|NCT05693935|617245698|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
170890911|NCT01687712|617606576|FG001|Cycle 1|Early Pregnancy Loss|60|||
170890912|NCT01687712|617606575|FG000|Cycle 1|Ectopic Pregnancy|5|||
170890913|NCT01687712|617606576|FG001|Cycle 1|Ectopic Pregnancy|5|||
170545218|NCT02573467|616340929|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
170545219|NCT02573467|616340930|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
170545220|NCT02573467|616340931|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
170545221|NCT02573467|616340928|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
170545222|NCT02573467|616340929|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
170545223|NCT02573467|616340930|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
170545224|NCT02573467|616340931|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
170545225|NCT02573467|616340928|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
170545226|NCT02573467|616340929|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
170545227|NCT02573467|616340930|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
170545228|NCT02573467|616340931|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
170545229|NCT02573467|616340928|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
170545230|NCT02573467|616340929|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
170637225|NCT00976560|616684525|FG000|Overall Study|Physician Decision|2|||
170637226|NCT00976560|616684526|FG001|Overall Study|Physician Decision|0|||
170637227|NCT00976560|616684525|FG000|Overall Study|Withdrawal by Subject|2|||
170890914|NCT01687712|617606575|FG000|Cycle 1|Heterotropic Pregnancy|1|||
170890915|NCT01687712|617606576|FG001|Cycle 1|Heterotropic Pregnancy|0|||
170890916|NCT01687712|617606575|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
170637228|NCT00976560|616684526|FG001|Overall Study|Withdrawal by Subject|3|||
170790433|NCT05693935|617245699|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
170890917|NCT01687712|617606576|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
170637229|NCT03350672|616684527|FG000|Overall Study|Withdrawal by Subject|7|||
170637230|NCT03350672|616684528|FG001|Overall Study|Withdrawal by Subject|0|||
170637231|NCT03350672|616684529|FG002|Overall Study|Withdrawal by Subject|0|||
170637232|NCT02991040|616684530|FG000|Overall Study|Withdrawal by Subject|2|||
170637233|NCT02991040|616684530|FG000|Overall Study|Lost to Follow-up|2|||
170637234|NCT00467753|616684531|FG000|Overall Study|Lost to Follow-up|1|||
170637235|NCT00467753|616684532|FG001|Overall Study|Lost to Follow-up|2|||
170637236|NCT00467753|616684531|FG000|Overall Study|Adverse Event|2|||
170637237|NCT00467753|616684532|FG001|Overall Study|Adverse Event|0|||
170637238|NCT02533453|616684533|FG000|Overall Study|Adverse Event|6|||
170637239|NCT02533453|616684533|FG000|Overall Study|Protocol Violation|1|||
170637240|NCT02533453|616684533|FG000|Overall Study|Withdrawal by Subject|2|||
170637241|NCT01587924|616684539|FG000|Overall Study|Adverse Event|0|||
170637242|NCT01587924|616684540|FG001|Overall Study|Adverse Event|2|||
170637243|NCT01587924|616684541|FG002|Overall Study|Adverse Event|0|||
170637244|NCT01587924|616684542|FG003|Overall Study|Adverse Event|0|||
170637245|NCT01587924|616684539|FG000|Overall Study|Protocol Violation|2|||
170637246|NCT01587924|616684540|FG001|Overall Study|Protocol Violation|1|||
170637247|NCT01587924|616684541|FG002|Overall Study|Protocol Violation|2|||
170637248|NCT01587924|616684542|FG003|Overall Study|Protocol Violation|1|||
170637249|NCT01587924|616684539|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
170637250|NCT01587924|616684540|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
170637251|NCT01587924|616684541|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
170637252|NCT01587924|616684542|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
170637253|NCT01587924|616684539|FG000|Overall Study|Withdrawal by Subject|0|||
170637254|NCT01587924|616684540|FG001|Overall Study|Withdrawal by Subject|1|||
170637255|NCT01587924|616684541|FG002|Overall Study|Withdrawal by Subject|1|||
170637256|NCT01587924|616684542|FG003|Overall Study|Withdrawal by Subject|0|||
170637257|NCT04292899|616684543|FG000|Overall Study|Death|21|||
170637258|NCT04292899|616684544|FG001|Overall Study|Death|28|||
170637259|NCT04292899|616684545|FG002|Overall Study|Death|188|||
170637260|NCT04292899|616684546|FG003|Overall Study|Death|371|||
170637261|NCT04292899|616684543|FG000|Overall Study|Lost to Follow-up|8|||
170637262|NCT04292899|616684544|FG001|Overall Study|Lost to Follow-up|4|||
170637263|NCT04292899|616684545|FG002|Overall Study|Lost to Follow-up|22|||
170637264|NCT04292899|616684546|FG003|Overall Study|Lost to Follow-up|235|||
170637265|NCT04292899|616684543|FG000|Overall Study|Withdrew consent|1|||
170637266|NCT04292899|616684544|FG001|Overall Study|Withdrew consent|0|||
170637267|NCT04292899|616684545|FG002|Overall Study|Withdrew consent|11|||
170637268|NCT04292899|616684546|FG003|Overall Study|Withdrew consent|32|||
170637269|NCT04292899|616684543|FG000|Overall Study|Adverse Event|2|||
170637270|NCT04292899|616684544|FG001|Overall Study|Adverse Event|1|||
170637271|NCT04292899|616684545|FG002|Overall Study|Adverse Event|2|||
170637272|NCT04292899|616684546|FG003|Overall Study|Adverse Event|2|||
170637273|NCT04292899|616684543|FG000|Overall Study|Investigator's Discretion|0|||
170637274|NCT04292899|616684544|FG001|Overall Study|Investigator's Discretion|0|||
170637275|NCT04292899|616684545|FG002|Overall Study|Investigator's Discretion|0|||
170637276|NCT04292899|616684546|FG003|Overall Study|Investigator's Discretion|3|||
170637277|NCT04292899|616684543|FG000|Overall Study|Non-compliance With Study Drug|0|||
170637278|NCT04292899|616684544|FG001|Overall Study|Non-compliance With Study Drug|0|||
170637279|NCT04292899|616684545|FG002|Overall Study|Non-compliance With Study Drug|0|||
170637280|NCT04292899|616684546|FG003|Overall Study|Non-compliance With Study Drug|1|||
170637281|NCT04292899|616684543|FG000|Overall Study|Protocol Violation|0|||
170637282|NCT04292899|616684544|FG001|Overall Study|Protocol Violation|0|||
170637283|NCT04292899|616684545|FG002|Overall Study|Protocol Violation|0|||
170637284|NCT04292899|616684546|FG003|Overall Study|Protocol Violation|1|||
170637285|NCT00948441|616684547|FG000|Overall Study|no longer meet inclusion criteria|1|||
170637286|NCT00948441|616684548|FG001|Overall Study|no longer meet inclusion criteria|4|||
170637287|NCT03695367|616684549|FG000|Overall Study|Missed the Day 28 visit.|1|||
170637288|NCT03695367|616684550|FG001|Overall Study|Missed the Day 28 visit.|0|||
170790434|NCT05693935|617245700|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
170790435|NCT05693935|617245701|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
170790436|NCT05693935|617245702|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
170790437|NCT05693935|617245703|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
170790438|NCT05693935|617245697|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
170790439|NCT05693935|617245698|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
170637289|NCT03695367|616684549|FG000|Overall Study|Lost to Follow-up|0|||
170637290|NCT03695367|616684550|FG001|Overall Study|Lost to Follow-up|1|||
170637291|NCT03695367|616684549|FG000|Overall Study|Withdrawal by Subject|0|||
170637292|NCT03695367|616684550|FG001|Overall Study|Withdrawal by Subject|1|||
170637293|NCT03695367|616684549|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
170790440|NCT05693935|617245699|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
170637294|NCT03695367|616684550|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
170637295|NCT01026324|616684551|FG000|Follow up/Survival|Withdrawal by Subject|1|||
170637296|NCT01026324|616684552|FG001|Follow up/Survival|Withdrawal by Subject|0|||
170790441|NCT05693935|617245700|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
170790442|NCT05693935|617245701|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
170466899|NCT04040192|616048103|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
170790443|NCT05693935|617245702|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
170790444|NCT05693935|617245703|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
170790445|NCT05693935|617245697|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
170790446|NCT05693935|617245698|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
170790447|NCT05693935|617245699|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
170790448|NCT05693935|617245700|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
170790449|NCT05693935|617245701|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
170790450|NCT05693935|617245702|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
170790451|NCT05693935|617245703|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
170790452|NCT05693935|617245697|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
170790453|NCT05693935|617245698|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
170790454|NCT05693935|617245699|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
170790455|NCT05693935|617245700|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
170790456|NCT05693935|617245701|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
170790457|NCT05693935|617245702|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
170790458|NCT05693935|617245703|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
170790459|NCT05693935|617245697|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
170790460|NCT05693935|617245698|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
170790461|NCT05693935|617245699|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
170790462|NCT05693935|617245700|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
170790463|NCT05693935|617245701|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
170790464|NCT05693935|617245702|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
170790465|NCT05693935|617245703|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
170790466|NCT05693935|617245697|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
170790467|NCT05693935|617245698|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
170790468|NCT05693935|617245699|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
170790469|NCT05693935|617245700|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
170790470|NCT05693935|617245701|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
170790471|NCT05693935|617245702|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
170790472|NCT05693935|617245703|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
170790473|NCT05693935|617245697|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
170790474|NCT05693935|617245698|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
170790475|NCT05693935|617245699|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
170790476|NCT05693935|617245700|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
170790477|NCT05693935|617245701|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
170466900|NCT04040192|616048101|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
170466901|NCT04040192|616048102|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
170466902|NCT04040192|616048103|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
170466903|NCT04040192|616048101|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
170466904|NCT04040192|616048102|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
170466905|NCT04040192|616048103|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
170466906|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
170466907|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
170466908|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
170466909|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
170466910|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
170466911|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
170466912|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
170466913|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
170466914|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
170466915|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
170466916|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
170466917|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
170466918|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
170466919|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
170466920|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
170466921|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
170466922|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
170466923|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
170466924|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
170466925|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
170466926|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
170466927|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
170466928|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
170466929|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
170466930|NCT04040192|616048101|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
170466931|NCT04040192|616048102|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
170466932|NCT04040192|616048103|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
170466933|NCT02121392|616048110|FG000|Prior to Intervention|Protocol Violation|40|||
170466934|NCT02121392|616048111|FG001|Prior to Intervention|Protocol Violation|35|||
170466935|NCT02121392|616048110|FG000|Prior to Intervention|Withdrawal by Subject|8|||
170466936|NCT02121392|616048111|FG001|Prior to Intervention|Withdrawal by Subject|6|||
170466937|NCT02121392|616048110|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
170466938|NCT02121392|616048111|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
170466939|NCT02121392|616048110|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
170466940|NCT02121392|616048111|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
170466941|NCT01352416|616048112|FG000|Overall Study|Physician Decision|1|||
170890918|NCT01687712|617606575|FG000|Cycle 1|Abortion|3|||
170466942|NCT01352416|616048113|FG001|Overall Study|Physician Decision|2|||
170466943|NCT01352416|616048114|FG002|Overall Study|Physician Decision|2|||
170466944|NCT01352416|616048115|FG003|Overall Study|Physician Decision|1|||
170466945|NCT00253448|616048118|FG000|Overall Study|Withdrawal by Subject|1|||
170466946|NCT02564887|616048121|FG000|Overall Study|Lost to Follow-up|6|||
170466947|NCT02564887|616048122|FG001|Overall Study|Lost to Follow-up|0|||
170466948|NCT02052011|616048123|FG000|Overall Study|Lost to Follow-up|3|||
170466949|NCT02052011|616048124|FG001|Overall Study|Lost to Follow-up|0|||
170466950|NCT02052011|616048123|FG000|Overall Study|Withdrawal by Subject|1|||
170466951|NCT02052011|616048124|FG001|Overall Study|Withdrawal by Subject|2|||
170466952|NCT00000620|616048125|FG000|Overall Study|Death|86|||
170466953|NCT00000620|616048126|FG001|Overall Study|Death|67|||
170466954|NCT00000620|616048127|FG002|Overall Study|Death|112|||
170890919|NCT01687712|617606576|FG001|Cycle 1|Abortion|0|||
170890920|NCT01687712|617606575|FG000|Cycle 1|Intrauterine Fetal Death|0|||
170890921|NCT01687712|617606576|FG001|Cycle 1|Intrauterine Fetal Death|1|||
170466955|NCT00000620|616048128|FG003|Overall Study|Death|126|||
170466956|NCT00000620|616048129|FG004|Overall Study|Death|64|||
170466957|NCT00000620|616048130|FG005|Overall Study|Death|77|||
170545231|NCT02573467|616340930|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
170890922|NCT01687712|617606575|FG000|Cycle 1|Lost to Follow-up|1|||
170466958|NCT00000620|616048131|FG006|Overall Study|Death|91|||
170466959|NCT00000620|616048132|FG007|Overall Study|Death|95|||
170466960|NCT00000620|616048125|FG000|Overall Study|Lost to Follow-up|14|||
170466961|NCT00000620|616048126|FG001|Overall Study|Lost to Follow-up|14|||
170466962|NCT00000620|616048127|FG002|Overall Study|Lost to Follow-up|14|||
170466963|NCT00000620|616048128|FG003|Overall Study|Lost to Follow-up|14|||
170466964|NCT00000620|616048129|FG004|Overall Study|Lost to Follow-up|15|||
170890923|NCT01687712|617606576|FG001|Cycle 1|Lost to Follow-up|1|||
170466965|NCT00000620|616048130|FG005|Overall Study|Lost to Follow-up|15|||
170466966|NCT00000620|616048131|FG006|Overall Study|Lost to Follow-up|13|||
170466967|NCT00000620|616048132|FG007|Overall Study|Lost to Follow-up|14|||
170466968|NCT00000620|616048125|FG000|Overall Study|Withdrawal by Subject|40|||
170466969|NCT00000620|616048126|FG001|Overall Study|Withdrawal by Subject|27|||
170466970|NCT00000620|616048127|FG002|Overall Study|Withdrawal by Subject|28|||
170466971|NCT00000620|616048128|FG003|Overall Study|Withdrawal by Subject|27|||
170466972|NCT00000620|616048129|FG004|Overall Study|Withdrawal by Subject|30|||
170466973|NCT00000620|616048130|FG005|Overall Study|Withdrawal by Subject|32|||
170466974|NCT00000620|616048131|FG006|Overall Study|Withdrawal by Subject|32|||
170466975|NCT00000620|616048132|FG007|Overall Study|Withdrawal by Subject|21|||
170466976|NCT00000620|616048125|FG000|Overall Study|missed closeout visit|22|||
170466977|NCT00000620|616048126|FG001|Overall Study|missed closeout visit|28|||
170466978|NCT00000620|616048127|FG002|Overall Study|missed closeout visit|16|||
170466979|NCT00000620|616048128|FG003|Overall Study|missed closeout visit|11|||
170466980|NCT00000620|616048129|FG004|Overall Study|missed closeout visit|26|||
170466981|NCT00000620|616048130|FG005|Overall Study|missed closeout visit|28|||
170466982|NCT00000620|616048131|FG006|Overall Study|missed closeout visit|13|||
170466983|NCT00000620|616048132|FG007|Overall Study|missed closeout visit|16|||
170466984|NCT01851330|616048133|FG000|Overall Study|Lack of Efficacy|10|||
170466985|NCT01851330|616048134|FG001|Overall Study|Lack of Efficacy|9|||
170466986|NCT01851330|616048135|FG002|Overall Study|Lack of Efficacy|2|||
170466987|NCT01851330|616048133|FG000|Overall Study|Lost to Follow-up|1|||
170466988|NCT01851330|616048134|FG001|Overall Study|Lost to Follow-up|6|||
170466989|NCT01851330|616048135|FG002|Overall Study|Lost to Follow-up|9|||
170466990|NCT01851330|616048133|FG000|Overall Study|Withdrew Consent|2|||
170466991|NCT01851330|616048134|FG001|Overall Study|Withdrew Consent|1|||
170466992|NCT01851330|616048135|FG002|Overall Study|Withdrew Consent|0|||
170466993|NCT01851330|616048133|FG000|Overall Study|Investigator's Discretion|0|||
170466994|NCT01851330|616048134|FG001|Overall Study|Investigator's Discretion|0|||
170466995|NCT01851330|616048135|FG002|Overall Study|Investigator's Discretion|1|||
170466996|NCT01199016|616048136|FG000|Overall Study|No longer meets eligibility criteria|4|||
170466997|NCT01199016|616048136|FG000|Overall Study|Entrance criteria|5|||
170466998|NCT01199016|616048136|FG000|Overall Study|Protocol Violation|9|||
170466999|NCT01199016|616048136|FG000|Overall Study|Other|13|||
170467000|NCT01199016|616048136|FG000|Overall Study|Withdrawal by Subject|21|||
170467001|NCT01199016|616048136|FG000|Overall Study|Lost to Follow-up|25|||
170467002|NCT02960490|616048145|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
170467003|NCT02960490|616048146|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
170467004|NCT02960490|616048147|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
170467005|NCT02960490|616048148|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
170467006|NCT02960490|616048149|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
170467007|NCT02960490|616048150|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
170467008|NCT02960490|616048151|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
170467009|NCT02960490|616048152|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
170467010|NCT02960490|616048153|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
170467011|NCT02960490|616048154|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
170467012|NCT02960490|616048145|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170467013|NCT02960490|616048146|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
170467014|NCT02960490|616048147|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170467015|NCT02960490|616048148|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170467016|NCT02960490|616048149|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170790478|NCT05693935|617245702|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
170790479|NCT05693935|617245703|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
170790480|NCT05693935|617245697|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
170790481|NCT05693935|617245698|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
170790482|NCT05693935|617245699|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
170790483|NCT05693935|617245700|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
170790484|NCT05693935|617245701|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
170790485|NCT05693935|617245702|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
170790486|NCT05693935|617245703|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
170467017|NCT02960490|616048150|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170467018|NCT02960490|616048151|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170467019|NCT02960490|616048152|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170467020|NCT02960490|616048153|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170467021|NCT02960490|616048154|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
170467022|NCT02960490|616048145|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
170467023|NCT02960490|616048146|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
170467024|NCT02960490|616048147|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
170467025|NCT02960490|616048148|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
170467026|NCT02960490|616048149|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
170467027|NCT02960490|616048150|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
170467028|NCT02960490|616048151|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
170467029|NCT02960490|616048152|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
170467030|NCT02960490|616048153|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
170467031|NCT02960490|616048154|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
170467032|NCT02960490|616048145|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
170467033|NCT02960490|616048146|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
170467034|NCT02960490|616048147|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
170467035|NCT02960490|616048148|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
170467036|NCT02960490|616048149|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
170467037|NCT02960490|616048150|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
170467038|NCT02960490|616048151|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
170467039|NCT02960490|616048152|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
170467040|NCT02960490|616048153|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
170467041|NCT02960490|616048154|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
170467042|NCT02960490|616048145|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
170467043|NCT02960490|616048146|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
170467044|NCT02960490|616048147|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
170467045|NCT02960490|616048148|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
170467046|NCT02960490|616048149|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
170467047|NCT02960490|616048150|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
170467048|NCT02960490|616048151|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
170467049|NCT02960490|616048152|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
170467050|NCT02960490|616048153|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
170467051|NCT02960490|616048154|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
170467052|NCT02960490|616048145|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
170467053|NCT02960490|616048146|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
170467054|NCT02960490|616048147|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
170467055|NCT02960490|616048148|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
170467056|NCT02960490|616048149|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
170467057|NCT02960490|616048150|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
170467058|NCT02960490|616048151|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
170467059|NCT02960490|616048152|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
170467060|NCT02960490|616048153|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
170467061|NCT02960490|616048154|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
170467062|NCT02960490|616048145|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
170467063|NCT02960490|616048146|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
170467064|NCT02960490|616048147|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
170467065|NCT02960490|616048148|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
170467066|NCT02960490|616048149|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
170467067|NCT02960490|616048150|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
170467068|NCT02960490|616048151|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
170467069|NCT02960490|616048152|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
170467070|NCT02960490|616048153|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
170467071|NCT02960490|616048154|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
170467072|NCT02960490|616048145|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
170467073|NCT02960490|616048146|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
170467074|NCT02960490|616048147|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
170467075|NCT02960490|616048148|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
170467076|NCT02960490|616048149|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
170467077|NCT02960490|616048150|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
170467078|NCT02960490|616048151|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
170467079|NCT02960490|616048152|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
170467080|NCT02960490|616048153|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
170467081|NCT02960490|616048154|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
170467082|NCT02960490|616048145|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467083|NCT02960490|616048146|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467084|NCT02960490|616048147|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467085|NCT02960490|616048148|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467086|NCT02960490|616048149|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467087|NCT02960490|616048150|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467088|NCT02960490|616048151|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467089|NCT02960490|616048152|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
170467090|NCT02960490|616048153|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467091|NCT02960490|616048154|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
170467092|NCT02960490|616048145|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
170467093|NCT02960490|616048146|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
170467094|NCT02960490|616048147|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
170467095|NCT02960490|616048148|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
170467096|NCT02960490|616048149|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
170467097|NCT02960490|616048150|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
170467098|NCT02960490|616048151|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
170467099|NCT02960490|616048152|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
170467100|NCT02960490|616048153|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
170467101|NCT02960490|616048154|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
170467102|NCT02960490|616048145|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467103|NCT02960490|616048146|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467104|NCT02960490|616048147|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467105|NCT02960490|616048148|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467106|NCT02960490|616048149|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467107|NCT02960490|616048150|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467108|NCT02960490|616048151|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
170467109|NCT02960490|616048152|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467110|NCT02960490|616048153|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467111|NCT02960490|616048154|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
170467112|NCT02960490|616048145|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467113|NCT02960490|616048146|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467114|NCT02960490|616048147|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467115|NCT02960490|616048148|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467116|NCT02960490|616048149|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467117|NCT02960490|616048150|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467118|NCT02960490|616048151|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467119|NCT02960490|616048152|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
170467120|NCT02960490|616048153|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467121|NCT02960490|616048154|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
170467122|NCT01590797|616048155|FG000|Overall Study|Adverse Event|4|||
170467123|NCT01590797|616048156|FG001|Overall Study|Adverse Event|3|||
170467124|NCT01590797|616048155|FG000|Overall Study|Lack of Efficacy|0|||
170467125|NCT01590797|616048156|FG001|Overall Study|Lack of Efficacy|2|||
170467126|NCT01590797|616048155|FG000|Overall Study|Lost to Follow-up|0|||
170467127|NCT01590797|616048156|FG001|Overall Study|Lost to Follow-up|1|||
170467128|NCT01590797|616048155|FG000|Overall Study|Protocol Violation|4|||
170467129|NCT01590797|616048156|FG001|Overall Study|Protocol Violation|1|||
170467130|NCT01590797|616048155|FG000|Overall Study|Withdrawal by Subject|7|||
170467131|NCT01590797|616048156|FG001|Overall Study|Withdrawal by Subject|5|||
170467132|NCT01590797|616048155|FG000|Overall Study|Other Protocol Specified Criteria|2|||
170467133|NCT01590797|616048156|FG001|Overall Study|Other Protocol Specified Criteria|4|||
170467134|NCT04893018|616048157|FG000|Overall Study|Lost to Follow-up|1|||
170467135|NCT04893018|616048158|FG001|Overall Study|Lost to Follow-up|0|||
170467136|NCT04893018|616048157|FG000|Overall Study|Withdrawal by Subject|2|||
170467137|NCT04893018|616048158|FG001|Overall Study|Withdrawal by Subject|0|||
170467138|NCT04893018|616048157|FG000|Overall Study|Study Terminated|1|||
170467139|NCT04893018|616048158|FG001|Overall Study|Study Terminated|2|||
170467140|NCT02047734|616048165|FG000|Overall Study|Adverse Event|18|||
170467141|NCT02047734|616048166|FG001|Overall Study|Adverse Event|13|||
170467142|NCT02047734|616048167|FG002|Overall Study|Adverse Event|13|||
170467143|NCT02047734|616048165|FG000|Overall Study|Lack of Efficacy|4|||
170467144|NCT02047734|616048166|FG001|Overall Study|Lack of Efficacy|5|||
170467145|NCT02047734|616048167|FG002|Overall Study|Lack of Efficacy|1|||
170467146|NCT02047734|616048165|FG000|Overall Study|Protocol Violation|3|||
170467147|NCT02047734|616048166|FG001|Overall Study|Protocol Violation|1|||
170467148|NCT02047734|616048167|FG002|Overall Study|Protocol Violation|1|||
170467149|NCT02047734|616048165|FG000|Overall Study|Lost to Follow-up|1|||
170545232|NCT02573467|616340931|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
170545233|NCT02573467|616340928|FG000|Post-treatment Follow up Epoch|Death|1|||
170467150|NCT02047734|616048166|FG001|Overall Study|Lost to Follow-up|4|||
170467151|NCT02047734|616048167|FG002|Overall Study|Lost to Follow-up|0|||
170467152|NCT02047734|616048165|FG000|Overall Study|Death|0|||
170545234|NCT02573467|616340929|FG001|Post-treatment Follow up Epoch|Death|1|||
170545235|NCT02573467|616340930|FG002|Post-treatment Follow up Epoch|Death|0|||
170545236|NCT02573467|616340931|FG003|Post-treatment Follow up Epoch|Death|1|||
170467153|NCT02047734|616048166|FG001|Overall Study|Death|1|||
170467154|NCT02047734|616048167|FG002|Overall Study|Death|0|||
170467155|NCT02047734|616048165|FG000|Overall Study|Withdrawal by Subject|30|||
170467156|NCT02047734|616048166|FG001|Overall Study|Withdrawal by Subject|31|||
170467157|NCT02047734|616048167|FG002|Overall Study|Withdrawal by Subject|19|||
170467158|NCT02047734|616048165|FG000|Overall Study|Physician Decision|7|||
170467159|NCT02047734|616048166|FG001|Overall Study|Physician Decision|6|||
170467160|NCT02047734|616048167|FG002|Overall Study|Physician Decision|5|||
170467161|NCT02047734|616048165|FG000|Overall Study|Miscellaneous|2|||
170467162|NCT02047734|616048166|FG001|Overall Study|Miscellaneous|4|||
170467163|NCT02047734|616048167|FG002|Overall Study|Miscellaneous|6|||
170467164|NCT02047734|616048165|FG000|Overall Study|Did Not Receive Study Drug|2|||
170467165|NCT02047734|616048166|FG001|Overall Study|Did Not Receive Study Drug|4|||
170467166|NCT02047734|616048167|FG002|Overall Study|Did Not Receive Study Drug|1|||
170467167|NCT01333397|616048168|FG000|Overall Study|Lost to Follow-up|1|||
170467168|NCT01333397|616048169|FG001|Overall Study|Lost to Follow-up|0|||
170467169|NCT01333397|616048170|FG002|Overall Study|Lost to Follow-up|0|||
170467170|NCT01333397|616048171|FG003|Overall Study|Lost to Follow-up|1|||
170467171|NCT01333397|616048172|FG004|Overall Study|Lost to Follow-up|0|||
170467172|NCT01292226|616048178|FG000|Overall Study|Adverse Event|5|||
170467173|NCT01292226|616048178|FG000|Overall Study|Death|1|||
170467174|NCT01292226|616048178|FG000|Overall Study|Graft loss|1|||
170467175|NCT01292226|616048178|FG000|Overall Study|Protocol Violation|3|||
170467176|NCT01292226|616048178|FG000|Overall Study|Withdrawal by Subject|1|||
170467177|NCT01292226|616048178|FG000|Overall Study|Other|2|||
170467178|NCT00468650|616048180|FG000|Overall Study|Lost to Follow-up|4|||
170467179|NCT00468650|616048180|FG000|Overall Study|Withdrawal by Subject|2|||
170467180|NCT00468650|616048180|FG000|Overall Study|Protocol Violation|1|||
170467181|NCT01267994|616048181|FG000|Overall Study|Adverse Event|2|||
170467182|NCT00478426|616048184|FG000|Overall Study|Withdrawal by Subject|1|||
170467183|NCT01210612|616048188|FG000|Overall Study|Withdrawal by Subject|0|||
170467184|NCT01210612|616048189|FG001|Overall Study|Withdrawal by Subject|2|||
170467185|NCT03713619|616048190|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
170467186|NCT03713619|616048191|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
170467187|NCT03713619|616048192|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
170467188|NCT03713619|616048193|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
170467189|NCT03713619|616048194|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
170467190|NCT03713619|616048190|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
170467191|NCT03713619|616048191|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
170467192|NCT03713619|616048192|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
170467193|NCT03713619|616048193|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
170467194|NCT03713619|616048194|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
170467195|NCT03713619|616048190|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
170467196|NCT03713619|616048191|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
170467197|NCT03713619|616048192|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
170467198|NCT03713619|616048193|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
170467199|NCT03713619|616048194|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
170467200|NCT03713619|616048190|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
170467201|NCT03713619|616048191|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
170467202|NCT03713619|616048192|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
170467203|NCT03713619|616048193|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
170467204|NCT03713619|616048194|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
170467205|NCT03713619|616048190|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
170467206|NCT03713619|616048191|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
170467207|NCT03713619|616048192|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
170467208|NCT03713619|616048193|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
170467209|NCT03713619|616048194|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
170467210|NCT03713619|616048190|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
170467211|NCT03713619|616048191|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
170467212|NCT03713619|616048192|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
170467213|NCT03713619|616048193|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
170467214|NCT03713619|616048194|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
170467215|NCT03713619|616048190|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
170467216|NCT03713619|616048191|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
170467217|NCT03713619|616048192|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
170467218|NCT03713619|616048193|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
170467219|NCT03713619|616048194|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
170467220|NCT03713619|616048190|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
170467221|NCT03713619|616048191|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
170467222|NCT03713619|616048192|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
170467223|NCT03713619|616048193|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
170467224|NCT03713619|616048194|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
170467225|NCT03713619|616048190|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
170467226|NCT03713619|616048191|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
170467227|NCT03713619|616048192|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
170467228|NCT03713619|616048193|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
170467229|NCT03713619|616048194|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
170467230|NCT03713619|616048190|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
170467231|NCT03713619|616048191|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
170467232|NCT03713619|616048192|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
170467233|NCT03713619|616048193|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
170467234|NCT03713619|616048194|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
170467235|NCT03713619|616048190|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
170467236|NCT03713619|616048191|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
170467237|NCT03713619|616048192|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
170467238|NCT03713619|616048193|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
170467239|NCT03713619|616048194|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
170467240|NCT03713619|616048190|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
170467241|NCT03713619|616048191|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
170467242|NCT03713619|616048192|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
170467243|NCT03713619|616048193|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
170467244|NCT03713619|616048194|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
170467245|NCT03713619|616048190|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
170467246|NCT03713619|616048191|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
170467247|NCT03713619|616048192|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
170467248|NCT03713619|616048193|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
170467249|NCT03713619|616048194|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
170467250|NCT01284621|616048206|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
170467251|NCT01284621|616048207|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
170467252|NCT01284621|616048208|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
170467253|NCT01284621|616048209|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
170890924|NCT01687712|617606575|FG000|Cycle 2|Not Biochemically Pregnant|74|||
170467254|NCT01284621|616048210|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
170467255|NCT01284621|616048211|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
170467256|NCT05819203|616048212|FG000|Overall Study|Protocol Violation|1|||
170467257|NCT05819203|616048213|FG001|Overall Study|Protocol Violation|2|||
170467258|NCT05819203|616048212|FG000|Overall Study|Withdrawal by Subject|1|||
170467259|NCT05819203|616048213|FG001|Overall Study|Withdrawal by Subject|0|||
170467260|NCT02952898|616048216|FG000|Overall Study|Withdrawal by Subject|10|||
170467261|NCT02952898|616048217|FG001|Overall Study|Withdrawal by Subject|8|||
170467262|NCT02952898|616048218|FG002|Overall Study|Withdrawal by Subject|8|||
170467263|NCT02952898|616048216|FG000|Overall Study|Adverse Event|8|||
170467264|NCT02952898|616048217|FG001|Overall Study|Adverse Event|8|||
170467265|NCT02952898|616048218|FG002|Overall Study|Adverse Event|3|||
170467266|NCT02952898|616048216|FG000|Overall Study|Lost to Follow-up|3|||
170467267|NCT02952898|616048217|FG001|Overall Study|Lost to Follow-up|2|||
170467268|NCT02952898|616048218|FG002|Overall Study|Lost to Follow-up|2|||
170467269|NCT02952898|616048216|FG000|Overall Study|Non-compliance with study drug|1|||
170467270|NCT02952898|616048217|FG001|Overall Study|Non-compliance with study drug|1|||
170467271|NCT02952898|616048218|FG002|Overall Study|Non-compliance with study drug|2|||
170467272|NCT02377427|616048221|FG000|Part A (Up to Week 20)|Physician Decision|1|||
170890925|NCT01687712|617606576|FG001|Cycle 2|Not Biochemically Pregnant|77|||
170890926|NCT01687712|617606575|FG000|Cycle 2|Early Pregnancy Loss|18|||
170890927|NCT01687712|617606576|FG001|Cycle 2|Early Pregnancy Loss|16|||
170467273|NCT02377427|616048222|FG001|Part A (Up to Week 20)|Physician Decision|0|||
170545237|NCT02573467|616340928|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
170545238|NCT02573467|616340929|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
170890928|NCT01687712|617606575|FG000|Cycle 2|Ectopic Pregnancy|0|||
170467274|NCT02377427|616048223|FG002|Part A (Up to Week 20)|Physician Decision|0|||
170467275|NCT02377427|616048224|FG003|Part A (Up to Week 20)|Physician Decision|0|||
170467276|NCT02377427|616048225|FG004|Part A (Up to Week 20)|Physician Decision|0|||
170467277|NCT02377427|616048221|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
170467278|NCT02377427|616048222|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
170467279|NCT02377427|616048223|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
170467280|NCT02377427|616048224|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
170467281|NCT02377427|616048225|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
170467282|NCT02377427|616048221|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
170467283|NCT02377427|616048222|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
170467284|NCT02377427|616048223|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
170467285|NCT02377427|616048224|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
170467286|NCT02377427|616048225|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
170467287|NCT02377427|616048221|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
170467288|NCT02377427|616048222|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
170467289|NCT02377427|616048223|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
170467290|NCT02377427|616048224|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
170467291|NCT02377427|616048225|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
170467292|NCT02293863|616048226|FG000|Overall Study|Death|4|||
170467293|NCT02293863|616048227|FG001|Overall Study|Death|6|||
170467294|NCT02293863|616048228|FG002|Overall Study|Death|4|||
170467295|NCT02293863|616048226|FG000|Overall Study|Lost to Follow-up|2|||
170467296|NCT02293863|616048227|FG001|Overall Study|Lost to Follow-up|2|||
170467297|NCT02293863|616048228|FG002|Overall Study|Lost to Follow-up|2|||
170467298|NCT02293863|616048226|FG000|Overall Study|Withdrawal by Subject|3|||
170467299|NCT02293863|616048227|FG001|Overall Study|Withdrawal by Subject|3|||
170467300|NCT02293863|616048228|FG002|Overall Study|Withdrawal by Subject|1|||
170467301|NCT02293863|616048226|FG000|Overall Study|Reason Not Specified|0|||
170467302|NCT02293863|616048227|FG001|Overall Study|Reason Not Specified|2|||
170467303|NCT02293863|616048228|FG002|Overall Study|Reason Not Specified|2|||
170467304|NCT00477633|616048229|FG000|Overall Study|Did not receive treatment|23|||
170467305|NCT00477633|616048229|FG000|Overall Study|Adverse Event|143|||
170467306|NCT00477633|616048229|FG000|Overall Study|Pregnancy|23|||
170467307|NCT00477633|616048229|FG000|Overall Study|Lost to Follow-up|271|||
170467308|NCT00477633|616048229|FG000|Overall Study|Withdrawal by Subject|149|||
170467309|NCT00477633|616048229|FG000|Overall Study|Protocol Violation|25|||
170467310|NCT00477633|616048229|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
170467311|NCT02968849|616048230|FG000|Overall Study|Death|8|||
170467312|NCT02968849|616048231|FG001|Overall Study|Death|10|||
170467313|NCT02968849|616048230|FG000|Overall Study|Lost to Follow-up|31|||
170467314|NCT02968849|616048231|FG001|Overall Study|Lost to Follow-up|29|||
170467315|NCT02968849|616048230|FG000|Overall Study|Withdrawal by Subject|73|||
170467316|NCT02968849|616048231|FG001|Overall Study|Withdrawal by Subject|64|||
170467317|NCT02968849|616048230|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
170467318|NCT02968849|616048231|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
170467319|NCT02968849|616048230|FG000|Overall Study|Physician Decision|6|||
170467320|NCT02968849|616048231|FG001|Overall Study|Physician Decision|9|||
170467321|NCT02968849|616048230|FG000|Overall Study|Other|16|||
170467322|NCT02968849|616048231|FG001|Overall Study|Other|10|||
170467323|NCT03408639|616050333|FG000|Overall Study|Death|5|||
170467324|NCT03408639|616050334|FG001|Overall Study|Death|5|||
170467325|NCT03408639|616050333|FG000|Overall Study|Lost to Follow-up|1|||
170467326|NCT03408639|616050334|FG001|Overall Study|Lost to Follow-up|4|||
170467327|NCT03408639|616050333|FG000|Overall Study|Withdrawal by Subject|2|||
170467328|NCT03408639|616050334|FG001|Overall Study|Withdrawal by Subject|7|||
170467329|NCT03408639|616050333|FG000|Overall Study|Physician Decision|3|||
170637297|NCT01026324|616684553|FG002|Follow up/Survival|Withdrawal by Subject|0|||
170637298|NCT00068419|616684554|FG000|Overall Study|Adverse Event|3|||
170637299|NCT00068419|616684554|FG000|Overall Study|Lack of Efficacy|24|||
170890929|NCT01687712|617606576|FG001|Cycle 2|Ectopic Pregnancy|1|||
170890930|NCT01687712|617606575|FG000|Cycle 2|Still Birth|1|||
170890931|NCT01687712|617606576|FG001|Cycle 2|Still Birth|0|||
170637300|NCT00068419|616684554|FG000|Overall Study|Lost to Follow-up|1|||
170637301|NCT00068419|616684554|FG000|Overall Study|Physician Decision|7|||
170890932|NCT01687712|617606575|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
170890933|NCT01687712|617606576|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
170890934|NCT01687712|617606575|FG000|Cycle 3|Not Biochemically Pregnant|21|||
170890935|NCT01687712|617606576|FG001|Cycle 3|Not Biochemically Pregnant|22|||
170890936|NCT01687712|617606575|FG000|Cycle 3|Early Pregnancy Loss|1|||
170467330|NCT03408639|616050334|FG001|Overall Study|Physician Decision|6|||
170467331|NCT03996447|616050337|FG000|First MRI Examination|Adverse Event|2|||
170467332|NCT03996447|616050338|FG001|First MRI Examination|Adverse Event|0|||
170467333|NCT03996447|616050337|FG000|First MRI Examination|Withdrawal by Subject|1|||
170467334|NCT03996447|616050338|FG001|First MRI Examination|Withdrawal by Subject|2|||
170467335|NCT03996447|616050337|FG000|First MRI Examination|Protocol Violation|0|||
170467336|NCT03996447|616050338|FG001|First MRI Examination|Protocol Violation|1|||
170637302|NCT00068419|616684554|FG000|Overall Study|Withdrawal by Subject|14|||
170890937|NCT01687712|617606576|FG001|Cycle 3|Early Pregnancy Loss|2|||
170467337|NCT03996447|616050337|FG000|Washout|Adverse Event|2|||
170467338|NCT03996447|616050338|FG001|Washout|Adverse Event|0|||
170467339|NCT03996447|616050337|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
170890938|NCT01687712|617606575|FG000|Cycle 3|Ectopic Pregnancy|1|||
170890939|NCT01687712|617606576|FG001|Cycle 3|Ectopic Pregnancy|0|||
170545239|NCT02573467|616340930|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
170545240|NCT02573467|616340931|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
170545241|NCT02573467|616340928|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
170545242|NCT02573467|616340929|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
170790487|NCT05693935|617245697|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
170790488|NCT05693935|617245698|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
170790489|NCT05693935|617245699|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
170790490|NCT05693935|617245700|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
170790491|NCT05693935|617245701|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
170790492|NCT05693935|617245702|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
170790493|NCT05693935|617245703|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
170790494|NCT05693935|617245697|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
170790495|NCT05693935|617245698|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
170790496|NCT05693935|617245699|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
170790497|NCT05693935|617245700|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
170790498|NCT05693935|617245701|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
170790499|NCT05693935|617245702|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
170790500|NCT05693935|617245703|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
170790501|NCT05693935|617245697|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
170790502|NCT05693935|617245698|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
170790503|NCT05693935|617245699|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
170790504|NCT05693935|617245700|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
170790505|NCT05693935|617245701|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
170790506|NCT05693935|617245702|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
170790507|NCT05693935|617245703|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
170790508|NCT05693935|617245697|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
170790509|NCT05693935|617245698|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
170790510|NCT05693935|617245699|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
170790511|NCT05693935|617245700|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
170790512|NCT05693935|617245701|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
170790513|NCT05693935|617245702|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
170790514|NCT05693935|617245703|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
170790515|NCT03873818|617245705|FG000|Overall Study|Death|9|||
170790516|NCT03873818|617245706|FG001|Overall Study|Death|3|||
170790517|NCT03873818|617245705|FG000|Overall Study|Lost to Follow-up|1|||
170790518|NCT03873818|617245706|FG001|Overall Study|Lost to Follow-up|0|||
170790519|NCT05171855|617245707|FG000|Overall Study|Death|1|||
170790520|NCT05171855|617245708|FG001|Overall Study|Death|0|||
170790521|NCT05171855|617245709|FG002|Overall Study|Death|0|||
170790522|NCT05171855|617245707|FG000|Overall Study|Withdrawal by Subject|2|||
170790523|NCT05171855|617245708|FG001|Overall Study|Withdrawal by Subject|0|||
170790524|NCT05171855|617245709|FG002|Overall Study|Withdrawal by Subject|5|||
170790525|NCT05171855|617245707|FG000|Overall Study|Physician Decision|1|||
170790526|NCT05171855|617245708|FG001|Overall Study|Physician Decision|0|||
170790527|NCT05171855|617245709|FG002|Overall Study|Physician Decision|0|||
170790528|NCT05171855|617245707|FG000|Overall Study|Adverse Event|2|||
170790529|NCT05171855|617245708|FG001|Overall Study|Adverse Event|4|||
170790530|NCT05171855|617245709|FG002|Overall Study|Adverse Event|2|||
170790531|NCT05171855|617245707|FG000|Overall Study|Other|0|||
170790532|NCT05171855|617245708|FG001|Overall Study|Other|0|||
170790533|NCT05171855|617245709|FG002|Overall Study|Other|1|||
170790534|NCT05041257|617245710|FG000|Overall Study|Death|37|||
170790535|NCT05041257|617245710|FG000|Overall Study|Lost to Follow-up|3|||
170790536|NCT05041257|617245710|FG000|Overall Study|Sponsor decision|39|||
170790537|NCT03067480|617245712|FG000|Overall Study|Lost to Follow-up|2|||
170790538|NCT03067480|617245713|FG001|Overall Study|Lost to Follow-up|4|||
170790539|NCT03067480|617245712|FG000|Overall Study|started insulin|1|||
170790540|NCT03067480|617245713|FG001|Overall Study|started insulin|1|||
170790541|NCT03748953|617245722|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
170890940|NCT01687712|617606575|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
170890941|NCT01687712|617606576|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
170890942|NCT03979274|617606577|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170890943|NCT03979274|617606578|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170890944|NCT01844895|617606581|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
170890945|NCT01844895|617606581|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
170890946|NCT01844895|617606581|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
170890947|NCT01844895|617606581|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
170890948|NCT01844895|617606581|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
170890949|NCT01844895|617606581|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
170890950|NCT01844895|617606581|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
170890951|NCT03891901|617606582|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
170790542|NCT03748953|617245723|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
170467340|NCT03996447|616050338|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
170467341|NCT03996447|616050337|FG000|Washout|Withdrawal by Subject|0|||
170890952|NCT03891901|617606583|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
170467342|NCT03996447|616050338|FG001|Washout|Withdrawal by Subject|1|||
170467343|NCT03996447|616050337|FG000|Washout|Other reason|1|||
170467344|NCT03996447|616050338|FG001|Washout|Other reason|1|||
170467345|NCT03701308|616050339|FG000|Overall Study|Ineligible|2|||
170467346|NCT03701308|616050340|FG001|Overall Study|Ineligible|2|||
170467347|NCT01924754|616050342|FG000|Overall Study|Lost to Follow-up|1|||
170467348|NCT01924754|616050343|FG001|Overall Study|Lost to Follow-up|2|||
170467349|NCT01924754|616050344|FG002|Overall Study|Lost to Follow-up|1|||
170467350|NCT01924754|616050342|FG000|Overall Study|Pregnancy|0|||
170467351|NCT01924754|616050343|FG001|Overall Study|Pregnancy|1|||
170467352|NCT01924754|616050344|FG002|Overall Study|Pregnancy|2|||
170467353|NCT03132155|616050345|FG000|Overall Study|Lack of Efficacy|6|||
170467354|NCT03132155|616050345|FG000|Overall Study|Lost to Follow-up|1|||
170467355|NCT03132155|616050345|FG000|Overall Study|Withdrawal by Subject|1|||
170467356|NCT04778904|616050351|FG000|Overall Study|Protocol Violation|1|||
170467357|NCT04778904|616050352|FG001|Overall Study|Protocol Violation|0|||
170467358|NCT04778904|616050353|FG002|Overall Study|Protocol Violation|0|||
170467359|NCT04778904|616050354|FG003|Overall Study|Protocol Violation|0|||
170467360|NCT04778904|616050351|FG000|Overall Study|Withdrawal by Subject|0|||
170467361|NCT04778904|616050352|FG001|Overall Study|Withdrawal by Subject|0|||
170467362|NCT04778904|616050353|FG002|Overall Study|Withdrawal by Subject|1|||
170467363|NCT04778904|616050354|FG003|Overall Study|Withdrawal by Subject|0|||
170890953|NCT03891901|617606584|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
170890954|NCT03891901|617606585|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
170890955|NCT03891901|617606586|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
170467364|NCT00324649|616050361|FG000|Overall Study|Adverse Event|1|||
170467365|NCT00324649|616050362|FG001|Overall Study|Adverse Event|4|||
170467366|NCT00324649|616050361|FG000|Overall Study|Withdrawal by Subject|0|||
170467367|NCT00324649|616050362|FG001|Overall Study|Withdrawal by Subject|1|||
170467368|NCT00324649|616050361|FG000|Overall Study|Noncompliance|1|||
170467369|NCT00324649|616050362|FG001|Overall Study|Noncompliance|0|||
170467370|NCT03772717|616050363|FG000|Overall Study|Withdrawal by Subject|2|||
170467371|NCT01810302|616050364|FG000|Overall Study|Death|1|||
170467372|NCT01810302|616050365|FG001|Overall Study|Death|0|||
170467373|NCT01810302|616050364|FG000|Overall Study|Physician Decision|0|||
170467374|NCT01810302|616050365|FG001|Overall Study|Physician Decision|1|||
170467375|NCT04138043|616050366|FG000|Overall Study|Withdrawal by Subject|0|||
170467376|NCT04138043|616050367|FG001|Overall Study|Withdrawal by Subject|1|||
170467377|NCT00261443|616050368|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
170890956|NCT03891901|617606587|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
170890957|NCT03891901|617606588|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
170890958|NCT03891901|617606589|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
170890959|NCT03891901|617606590|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
170890960|NCT03891901|617606582|FG000|Overall Study|Adverse Event|2|||
170890961|NCT03891901|617606583|FG001|Overall Study|Adverse Event|2|||
170890962|NCT03891901|617606584|FG002|Overall Study|Adverse Event|0|||
170890963|NCT03891901|617606585|FG003|Overall Study|Adverse Event|0|||
170890964|NCT03891901|617606586|FG004|Overall Study|Adverse Event|0|||
170890965|NCT03891901|617606587|FG005|Overall Study|Adverse Event|0|||
170890966|NCT03891901|617606588|FG006|Overall Study|Adverse Event|0|||
170890967|NCT03891901|617606589|FG007|Overall Study|Adverse Event|0|||
170890968|NCT03891901|617606590|FG008|Overall Study|Adverse Event|0|||
170890969|NCT03891901|617606582|FG000|Overall Study|Poor venous access|1|||
170890970|NCT03891901|617606583|FG001|Overall Study|Poor venous access|0|||
170890971|NCT03891901|617606584|FG002|Overall Study|Poor venous access|0|||
170467378|NCT00261443|616050369|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
170467379|NCT00261443|616050370|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
170467380|NCT00261443|616050368|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
170467381|NCT00261443|616050369|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
170467382|NCT00261443|616050370|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
170467383|NCT00261443|616050368|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
170467384|NCT00261443|616050369|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
170467385|NCT00261443|616050370|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
170467386|NCT00261443|616050368|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
170637303|NCT00068419|616684554|FG000|Overall Study|Ineligible|11|||
170890972|NCT03891901|617606585|FG003|Overall Study|Poor venous access|0|||
170890973|NCT03891901|617606586|FG004|Overall Study|Poor venous access|0|||
170890974|NCT03891901|617606587|FG005|Overall Study|Poor venous access|0|||
170890975|NCT03891901|617606588|FG006|Overall Study|Poor venous access|0|||
170890976|NCT03891901|617606589|FG007|Overall Study|Poor venous access|0|||
170890977|NCT03891901|617606590|FG008|Overall Study|Poor venous access|0|||
170890978|NCT03891901|617606582|FG000|Overall Study|Withdrawal by Subject|0|||
170890979|NCT03891901|617606583|FG001|Overall Study|Withdrawal by Subject|2|||
170890980|NCT03891901|617606584|FG002|Overall Study|Withdrawal by Subject|0|||
170890981|NCT03891901|617606585|FG003|Overall Study|Withdrawal by Subject|0|||
170890982|NCT03891901|617606586|FG004|Overall Study|Withdrawal by Subject|0|||
170890983|NCT03891901|617606587|FG005|Overall Study|Withdrawal by Subject|0|||
170890984|NCT03891901|617606588|FG006|Overall Study|Withdrawal by Subject|0|||
170890985|NCT03891901|617606589|FG007|Overall Study|Withdrawal by Subject|0|||
170890986|NCT03891901|617606590|FG008|Overall Study|Withdrawal by Subject|0|||
170890987|NCT00911989|617606591|FG000|Overall Study|Adverse Event|1|||
170890988|NCT04202679|617606592|FG000|Overall Study|Adverse Event|2|||
170890989|NCT04202679|617606593|FG001|Overall Study|Adverse Event|0|||
170890990|NCT04202679|617606592|FG000|Overall Study|Poor compliance to protocol|1|||
170890991|NCT04202679|617606593|FG001|Overall Study|Poor compliance to protocol|0|||
170890992|NCT04202679|617606592|FG000|Overall Study|Withdrawal by Subject|23|||
170890993|NCT04202679|617606593|FG001|Overall Study|Withdrawal by Subject|6|||
170467387|NCT00261443|616050369|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
170467388|NCT00261443|616050370|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
170467389|NCT00261443|616050368|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
170467390|NCT00261443|616050369|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
170467391|NCT00261443|616050370|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
170467392|NCT00261443|616050368|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
170467393|NCT00261443|616050369|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
170467394|NCT00261443|616050370|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
170467395|NCT00261443|616050368|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
170467396|NCT00261443|616050369|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
170467397|NCT00261443|616050370|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
170467398|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
170467399|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
170467400|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
170467401|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
170467402|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
170467403|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
170467404|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
170467405|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
170467406|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
170467407|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
170467408|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
170467409|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
170467410|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
170467411|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
170467412|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
170467413|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
170467414|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
170467415|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
170545243|NCT02573467|616340930|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
170545244|NCT02573467|616340931|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
170545245|NCT01829165|616340932|FG000|Overall Study|Did not complete intervention|2|||
170545246|NCT01829165|616340933|FG001|Overall Study|Did not complete intervention|0|||
170545247|NCT00103506|616340935|FG000|Overall Study|Study closed by sponsor|34|||
170790543|NCT03748953|617245722|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
170790544|NCT03748953|617245723|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
170790545|NCT03748953|617245722|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
170790546|NCT03748953|617245723|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
170790547|NCT03748953|617245722|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
170790548|NCT03748953|617245723|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
170790549|NCT03748953|617245722|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
170790550|NCT03748953|617245723|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
170790551|NCT03544281|617245724|FG000|Main Study Phase|Death|3|||
170790552|NCT03544281|617245725|FG001|Main Study Phase|Death|2|||
170790553|NCT03544281|617245726|FG002|Main Study Phase|Death|6|||
170790554|NCT03544281|617245727|FG003|Main Study Phase|Death|8|||
170890994|NCT01182428|617606596|FG000|Overall Study|Physician Decision|1|||
170890995|NCT01182428|617606597|FG001|Overall Study|Physician Decision|0|||
170890996|NCT01182428|617606596|FG000|Overall Study|Lost to Follow-up|9|||
170890997|NCT01182428|617606597|FG001|Overall Study|Lost to Follow-up|1|||
170890998|NCT01182428|617606596|FG000|Overall Study|Withdrawal by Subject|1|||
170467416|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
170467417|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
170467418|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
170467419|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
170467420|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
170467421|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
170467422|NCT00261443|616050368|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
170467423|NCT00261443|616050369|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
170467424|NCT00261443|616050370|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
170467425|NCT00261443|616050368|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
170467426|NCT00261443|616050369|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
170467427|NCT00261443|616050370|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
170545248|NCT00103506|616340936|FG001|Overall Study|Study closed by sponsor|37|||
170545249|NCT00103506|616340935|FG000|Overall Study|Death|257|||
170545250|NCT00103506|616340936|FG001|Overall Study|Death|253|||
170545251|NCT00103506|616340935|FG000|Overall Study|Lost to Follow-up|13|||
170545252|NCT00103506|616340936|FG001|Overall Study|Lost to Follow-up|13|||
170545253|NCT00103506|616340935|FG000|Overall Study|Withdrawal by Subject|18|||
170545254|NCT00103506|616340936|FG001|Overall Study|Withdrawal by Subject|21|||
170545255|NCT00710970|616340939|FG000|Overall Study|Never took drug|3|||
170545256|NCT02153827|616340940|FG000|Overall Study|Lost to Follow-up|3|||
170545257|NCT02153827|616340941|FG001|Overall Study|Lost to Follow-up|9|||
170545258|NCT00397930|616340946|FG000|Overall Study|Personal reasons|14|||
170545259|NCT00397930|616340947|FG001|Overall Study|Personal reasons|8|||
170545260|NCT00397930|616340946|FG000|Overall Study|Other medical|9|||
170545261|NCT00397930|616340947|FG001|Overall Study|Other medical|4|||
170545262|NCT00397930|616340946|FG000|Overall Study|Unknown reasons|9|||
170545263|NCT00397930|616340947|FG001|Overall Study|Unknown reasons|14|||
170545264|NCT00397930|616340946|FG000|Overall Study|Noncompliant|3|||
170545265|NCT00397930|616340947|FG001|Overall Study|Noncompliant|2|||
170637304|NCT00396253|616684564|FG000|Overall Study|Protocol Violation|1|||
170637305|NCT00396253|616684564|FG000|Overall Study|Withdrawal by Subject|7|||
170637306|NCT00396253|616684564|FG000|Overall Study|Death|3|||
170637307|NCT00396253|616684564|FG000|Overall Study|Physician Decision|1|||
170790555|NCT03544281|617245728|FG004|Main Study Phase|Death|4|||
170790556|NCT03544281|617245729|FG005|Main Study Phase|Death|2|||
170790557|NCT03544281|617245730|FG006|Main Study Phase|Death|4|||
170790558|NCT03544281|617245731|FG007|Main Study Phase|Death|5|||
170790559|NCT03544281|617245732|FG008|Main Study Phase|Death|5|||
170790560|NCT03544281|617245733|FG009|Main Study Phase|Death|8|||
170790561|NCT03544281|617245734|FG010|Main Study Phase|Death|6|||
170790562|NCT03544281|617245735|FG011|Main Study Phase|Death|4|||
170790563|NCT03544281|617245736|FG012|Main Study Phase|Death|0|||
170790564|NCT03544281|617245737|FG013|Main Study Phase|Death|0|||
170790565|NCT03544281|617245738|FG014|Main Study Phase|Death|0|||
170790566|NCT03544281|617245739|FG015|Main Study Phase|Death|0|||
170790567|NCT03544281|617245740|FG016|Main Study Phase|Death|0|||
170790568|NCT03544281|617245741|FG017|Main Study Phase|Death|0|||
170790569|NCT03544281|617245742|FG018|Main Study Phase|Death|0|||
170790570|NCT03544281|617245743|FG019|Main Study Phase|Death|0|||
170790571|NCT03544281|617245744|FG020|Main Study Phase|Death|0|||
170790572|NCT03544281|617245745|FG021|Main Study Phase|Death|0|||
170790573|NCT03544281|617245724|FG000|Main Study Phase|Lost to Follow-up|0|||
170790574|NCT03544281|617245725|FG001|Main Study Phase|Lost to Follow-up|0|||
170790575|NCT03544281|617245726|FG002|Main Study Phase|Lost to Follow-up|0|||
170790576|NCT03544281|617245727|FG003|Main Study Phase|Lost to Follow-up|0|||
170790577|NCT03544281|617245728|FG004|Main Study Phase|Lost to Follow-up|0|||
170790578|NCT03544281|617245729|FG005|Main Study Phase|Lost to Follow-up|0|||
170790579|NCT03544281|617245730|FG006|Main Study Phase|Lost to Follow-up|0|||
170790580|NCT03544281|617245731|FG007|Main Study Phase|Lost to Follow-up|0|||
170467428|NCT00261443|616050368|FG000|3: Assessment of Relapse|Adverse Event|0|||
170467429|NCT00261443|616050369|FG001|3: Assessment of Relapse|Adverse Event|15|||
170545266|NCT00397930|616340946|FG000|Overall Study|Too time-consuming|2|||
170545267|NCT00397930|616340947|FG001|Overall Study|Too time-consuming|9|||
170545268|NCT00397930|616340946|FG000|Overall Study|Started own yoga program|1|||
170637308|NCT00396253|616684564|FG000|Overall Study|Change in eligibility status|1|||
170790581|NCT03544281|617245732|FG008|Main Study Phase|Lost to Follow-up|0|||
170790582|NCT03544281|617245733|FG009|Main Study Phase|Lost to Follow-up|0|||
170545269|NCT00397930|616340947|FG001|Overall Study|Started own yoga program|1|||
170790583|NCT03544281|617245734|FG010|Main Study Phase|Lost to Follow-up|1|||
170790584|NCT03544281|617245735|FG011|Main Study Phase|Lost to Follow-up|0|||
170790585|NCT03544281|617245736|FG012|Main Study Phase|Lost to Follow-up|0|||
170545270|NCT00397930|616340946|FG000|Overall Study|Did not want to be in control group|0|||
170790586|NCT03544281|617245737|FG013|Main Study Phase|Lost to Follow-up|0|||
170790587|NCT03544281|617245738|FG014|Main Study Phase|Lost to Follow-up|0|||
170790588|NCT03544281|617245739|FG015|Main Study Phase|Lost to Follow-up|0|||
170790589|NCT03544281|617245740|FG016|Main Study Phase|Lost to Follow-up|0|||
170467430|NCT00261443|616050370|FG002|3: Assessment of Relapse|Adverse Event|19|||
170467431|NCT00261443|616050368|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
170467432|NCT00261443|616050369|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
170467433|NCT00261443|616050370|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
170467434|NCT00261443|616050368|FG000|3: Assessment of Relapse|Death|0|||
170467435|NCT00261443|616050369|FG001|3: Assessment of Relapse|Death|0|||
170467436|NCT00261443|616050370|FG002|3: Assessment of Relapse|Death|1|||
170467437|NCT00261443|616050368|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
170467438|NCT00261443|616050369|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
170467439|NCT00261443|616050370|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
170467440|NCT00261443|616050368|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
170467441|NCT00261443|616050369|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
170790590|NCT03544281|617245741|FG017|Main Study Phase|Lost to Follow-up|0|||
170790591|NCT03544281|617245742|FG018|Main Study Phase|Lost to Follow-up|0|||
170790592|NCT03544281|617245743|FG019|Main Study Phase|Lost to Follow-up|0|||
170790593|NCT03544281|617245744|FG020|Main Study Phase|Lost to Follow-up|0|||
170790594|NCT03544281|617245745|FG021|Main Study Phase|Lost to Follow-up|0|||
170790595|NCT03544281|617245724|FG000|Main Study Phase|Physician Decision|0|||
170790596|NCT03544281|617245725|FG001|Main Study Phase|Physician Decision|0|||
170790597|NCT03544281|617245726|FG002|Main Study Phase|Physician Decision|0|||
170790598|NCT03544281|617245727|FG003|Main Study Phase|Physician Decision|0|||
170467442|NCT00261443|616050370|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
170467443|NCT00261443|616050368|FG000|3: Assessment of Relapse|Pregnancy|0|||
170467444|NCT00261443|616050369|FG001|3: Assessment of Relapse|Pregnancy|2|||
170467445|NCT00261443|616050370|FG002|3: Assessment of Relapse|Pregnancy|1|||
170467446|NCT00261443|616050368|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
170467447|NCT00261443|616050369|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
170467448|NCT00261443|616050370|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
170467449|NCT00261443|616050368|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
170467450|NCT00261443|616050369|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
170467451|NCT00261443|616050370|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
170467452|NCT00261443|616050368|FG000|3: Assessment of Relapse|Other Reasons|0|||
170467453|NCT00261443|616050369|FG001|3: Assessment of Relapse|Other Reasons|4|||
170467454|NCT00261443|616050370|FG002|3: Assessment of Relapse|Other Reasons|3|||
170467455|NCT00261443|616050368|FG000|4: Extension Phase|Adverse Event|0|||
170467456|NCT00261443|616050369|FG001|4: Extension Phase|Adverse Event|1|||
170467457|NCT00261443|616050370|FG002|4: Extension Phase|Adverse Event|0|||
170467458|NCT00261443|616050368|FG000|4: Extension Phase|Withdrawal by Subject|0|||
170467459|NCT00261443|616050369|FG001|4: Extension Phase|Withdrawal by Subject|1|||
170467460|NCT00261443|616050370|FG002|4: Extension Phase|Withdrawal by Subject|2|||
170467461|NCT00261443|616050368|FG000|4: Extension Phase|Lost to Follow-up|0|||
170467462|NCT00261443|616050369|FG001|4: Extension Phase|Lost to Follow-up|1|||
170467463|NCT00261443|616050370|FG002|4: Extension Phase|Lost to Follow-up|0|||
170467464|NCT02755649|616050371|FG000|Overall Study|Transitioned into OLE study|99|||
170467465|NCT02755649|616050372|FG001|Overall Study|Transitioned into OLE study|98|||
170467466|NCT02755649|616050373|FG002|Overall Study|Transitioned into OLE study|100|||
170467467|NCT02755649|616050371|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
170467468|NCT02755649|616050372|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
170467469|NCT02755649|616050373|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
170467470|NCT02755649|616050371|FG000|Overall Study|Physician Decision|0|||
170467471|NCT02755649|616050372|FG001|Overall Study|Physician Decision|0|||
170467472|NCT02755649|616050373|FG002|Overall Study|Physician Decision|2|||
170467473|NCT02755649|616050371|FG000|Overall Study|Withdrawal by Subject|0|||
170467474|NCT02755649|616050372|FG001|Overall Study|Withdrawal by Subject|1|||
170467475|NCT02755649|616050373|FG002|Overall Study|Withdrawal by Subject|0|||
170467476|NCT02755649|616050371|FG000|Overall Study|Undecided|1|||
170467477|NCT02755649|616050372|FG001|Overall Study|Undecided|0|||
170467478|NCT02755649|616050373|FG002|Overall Study|Undecided|0|||
170467479|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #1|24|||
170467480|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #1|0|||
170467481|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
170467482|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
170467483|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
170467484|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467485|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
170467486|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
170467487|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
170467488|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
170467489|NCT03888066|616050374|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
170790599|NCT03544281|617245728|FG004|Main Study Phase|Physician Decision|0|||
170790600|NCT03544281|617245729|FG005|Main Study Phase|Physician Decision|0|||
170467490|NCT03888066|616050375|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467491|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
170467492|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467493|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
170467494|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
170467495|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
170467496|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467497|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
170467498|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467499|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #2|5|||
170467500|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #2|0|||
170467501|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
170467502|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
170467503|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
170467504|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
170467505|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
170467506|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
170467507|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #3|11|||
170467508|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #3|0|||
170467509|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
170467510|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
170467511|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
170467512|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
170467513|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
170467514|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467515|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #4|3|||
170467516|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #4|0|||
170467517|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
170467518|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
170467519|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
170467520|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
170467521|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
170467522|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
170467523|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
170467524|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
170467525|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
170467526|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467527|NCT03888066|616050374|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
170467528|NCT03888066|616050375|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
170467529|NCT03888066|616050374|FG000|Run-in Phase|AE (Adverse Event)|17|||
170467530|NCT03888066|616050375|FG001|Run-in Phase|AE (Adverse Event)|0|||
170467531|NCT03888066|616050374|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
170467532|NCT03888066|616050375|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
170467533|NCT03888066|616050374|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
170467534|NCT03888066|616050375|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467535|NCT03888066|616050374|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
170467536|NCT03888066|616050375|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170467537|NCT03888066|616050374|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
170467538|NCT03888066|616050375|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
170467539|NCT03888066|616050374|FG000|Run-in Phase|Withdrawal by Subject|43|||
170467540|NCT03888066|616050375|FG001|Run-in Phase|Withdrawal by Subject|0|||
170467541|NCT03888066|616050374|FG000|Run-in Phase|AE; Physician Decision|1|||
170467542|NCT03888066|616050375|FG001|Run-in Phase|AE; Physician Decision|0|||
170467543|NCT03888066|616050374|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
170467544|NCT03888066|616050375|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
170545271|NCT00397930|616340947|FG001|Overall Study|Did not want to be in control group|1|||
170545272|NCT00397930|616340946|FG000|Overall Study|Withdrawal by Subject|0|||
170545273|NCT00397930|616340947|FG001|Overall Study|Withdrawal by Subject|8|||
170545274|NCT00397930|616340946|FG000|Overall Study|Missing data|0|||
170790601|NCT03544281|617245730|FG006|Main Study Phase|Physician Decision|0|||
170790602|NCT03544281|617245731|FG007|Main Study Phase|Physician Decision|1|||
170467545|NCT03888066|616050374|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
170467546|NCT03888066|616050375|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
170467547|NCT03888066|616050374|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
170467548|NCT03888066|616050375|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
170467549|NCT03888066|616050374|FG000|Run-in Phase|Death|1|||
170467550|NCT03888066|616050375|FG001|Run-in Phase|Death|0|||
170467551|NCT03888066|616050374|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
170467552|NCT03888066|616050375|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
170467553|NCT03888066|616050374|FG000|Run-in Phase|Physician Decision|1|||
170467554|NCT03888066|616050375|FG001|Run-in Phase|Physician Decision|0|||
170467555|NCT03888066|616050374|FG000|Run-in Phase|Protocol Violation|13|||
170467556|NCT03888066|616050375|FG001|Run-in Phase|Protocol Violation|0|||
170467557|NCT03888066|616050374|FG000|Run-in Phase|Sponsor Request|34|||
170467558|NCT03888066|616050375|FG001|Run-in Phase|Sponsor Request|0|||
170467559|NCT03888066|616050374|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
170467560|NCT03888066|616050375|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
170467561|NCT03888066|616050374|FG000|Run-in Phase|Withdrawal Of Consent|1|||
170467562|NCT03888066|616050375|FG001|Run-in Phase|Withdrawal Of Consent|0|||
170467563|NCT03888066|616050374|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
170467564|NCT03888066|616050375|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
170467565|NCT03888066|616050374|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
170467566|NCT03888066|616050375|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
170467567|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
170467568|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
170467569|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
170467570|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
170467571|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
170467572|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
170467573|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
170467574|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
170467575|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
170467576|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
170467577|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
170467578|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
170467579|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
170467580|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
170467581|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
170467582|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
170467583|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
170467584|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
170467585|NCT03888066|616050374|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
170467586|NCT03888066|616050375|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
170467587|NCT02856555|616050376|FG000|Overall Study|Adverse Event|1|||
170467588|NCT02856555|616050377|FG001|Overall Study|Adverse Event|0|||
170467589|NCT02856555|616050378|FG002|Overall Study|Adverse Event|0|||
170467590|NCT02856555|616050376|FG000|Overall Study|Lost to Follow-up|1|||
170467591|NCT02856555|616050377|FG001|Overall Study|Lost to Follow-up|3|||
170467592|NCT02856555|616050378|FG002|Overall Study|Lost to Follow-up|0|||
170467593|NCT02856555|616050376|FG000|Overall Study|Withdrawal by Subject|3|||
170467594|NCT02856555|616050377|FG001|Overall Study|Withdrawal by Subject|0|||
170467595|NCT02856555|616050378|FG002|Overall Study|Withdrawal by Subject|0|||
170467596|NCT02856555|616050376|FG000|Overall Study|Randomized but Never Treated|0|||
170467597|NCT02856555|616050377|FG001|Overall Study|Randomized but Never Treated|1|||
170467598|NCT02856555|616050378|FG002|Overall Study|Randomized but Never Treated|0|||
170467599|NCT03333941|616050379|FG000|Overall Study|Lost to Follow-up|10|||
170467600|NCT03333941|616050379|FG000|Overall Study|Death|2|||
170467601|NCT03333941|616050379|FG000|Overall Study|Adverse Event|1|||
170467602|NCT04971187|616050380|FG000|Overall Study|Screen failures|2|||
170467603|NCT02207634|616050386|FG000|Overall Study|Withdrawal by Subject|21|||
170467604|NCT02207634|616050387|FG001|Overall Study|Withdrawal by Subject|31|||
170467605|NCT02207634|616050386|FG000|Overall Study|Lost to Follow-up|1|||
170467606|NCT02207634|616050387|FG001|Overall Study|Lost to Follow-up|0|||
170467607|NCT02077140|616050388|FG000|Overall Study|Lost to Follow-up|4|||
170467608|NCT02077140|616050389|FG001|Overall Study|Lost to Follow-up|1|||
170467609|NCT02077140|616050390|FG002|Overall Study|Lost to Follow-up|2|||
170467610|NCT02077140|616050391|FG003|Overall Study|Lost to Follow-up|2|||
170467611|NCT02077140|616050392|FG004|Overall Study|Lost to Follow-up|3|||
170467612|NCT02077140|616050388|FG000|Overall Study|Withdrawal by Subject|0|||
170467613|NCT02077140|616050389|FG001|Overall Study|Withdrawal by Subject|1|||
170467614|NCT02077140|616050390|FG002|Overall Study|Withdrawal by Subject|0|||
170467615|NCT02077140|616050391|FG003|Overall Study|Withdrawal by Subject|2|||
170637309|NCT00607373|616684565|FG000|Treatment Period|Adverse Event|0|||
170467616|NCT02077140|616050392|FG004|Overall Study|Withdrawal by Subject|2|||
170467617|NCT00974922|616050395|FG000|Overall Study|study terminated|24|||
170467618|NCT02135614|616050396|FG000|Overall Study|Randomized but Not Treated|2|||
170467619|NCT02135614|616050397|FG001|Overall Study|Randomized but Not Treated|1|||
170467620|NCT02135614|616050396|FG000|Overall Study|Adverse Event|0|||
170467621|NCT02135614|616050397|FG001|Overall Study|Adverse Event|1|||
170467622|NCT02135614|616050396|FG000|Overall Study|Death|1|||
170467623|NCT02135614|616050397|FG001|Overall Study|Death|0|||
170467624|NCT02135614|616050396|FG000|Overall Study|Investigator's Discretion|0|||
170467625|NCT02135614|616050397|FG001|Overall Study|Investigator's Discretion|1|||
170467626|NCT02135614|616050396|FG000|Overall Study|Withdrew Consent|2|||
170467627|NCT02135614|616050397|FG001|Overall Study|Withdrew Consent|2|||
170467628|NCT02135614|616050396|FG000|Overall Study|Lost to Follow-up|3|||
170467629|NCT02135614|616050397|FG001|Overall Study|Lost to Follow-up|0|||
170467630|NCT03022084|616050398|FG000|Overall Study|Lost to Follow-up|2|||
170467631|NCT03022084|616050399|FG001|Overall Study|Lost to Follow-up|3|||
170467632|NCT00113763|616050400|FG000|Overall Study|Adverse Event|5|||
170467633|NCT00113763|616050401|FG001|Overall Study|Adverse Event|2|||
170467634|NCT00113763|616050400|FG000|Overall Study|Disease Progression|28|||
170467635|NCT00113763|616050401|FG001|Overall Study|Disease Progression|14|||
170467636|NCT00113763|616050400|FG000|Overall Study|Lost to Follow-up|10|||
170467637|NCT00113763|616050401|FG001|Overall Study|Lost to Follow-up|0|||
170467638|NCT00113763|616050400|FG000|Overall Study|Withdrawal by Subject|1|||
170467639|NCT00113763|616050401|FG001|Overall Study|Withdrawal by Subject|4|||
170467640|NCT00113763|616050400|FG000|Overall Study|Other|27|||
170467641|NCT00113763|616050401|FG001|Overall Study|Other|6|||
170467642|NCT00113763|616050400|FG000|Overall Study|Non-compliance|1|||
170467643|NCT00113763|616050401|FG001|Overall Study|Non-compliance|0|||
170467644|NCT00113763|616050400|FG000|Overall Study|Ongoing|1|||
170467645|NCT00113763|616050401|FG001|Overall Study|Ongoing|0|||
170467646|NCT03743415|616050402|FG000|Overall Study|Death|5|||
170467647|NCT03743415|616050403|FG001|Overall Study|Death|3|||
170467648|NCT03743415|616050404|FG002|Overall Study|Death|1|||
170467649|NCT03743415|616050405|FG003|Overall Study|Death|4|||
170467650|NCT03743415|616050406|FG004|Overall Study|Death|0|||
170467651|NCT03743415|616050407|FG005|Overall Study|Death|0|||
170467652|NCT03743415|616050408|FG006|Overall Study|Death|0|||
170467653|NCT03743415|616050409|FG007|Overall Study|Death|0|||
170467654|NCT03743415|616050410|FG008|Overall Study|Death|1|||
170467655|NCT03743415|616050411|FG009|Overall Study|Death|0|||
170467656|NCT03743415|616050402|FG000|Overall Study|Withdrawal by Subject|1|||
170467657|NCT03743415|616050403|FG001|Overall Study|Withdrawal by Subject|0|||
170467658|NCT03743415|616050404|FG002|Overall Study|Withdrawal by Subject|4|||
170467659|NCT03743415|616050405|FG003|Overall Study|Withdrawal by Subject|5|||
170467660|NCT03743415|616050406|FG004|Overall Study|Withdrawal by Subject|5|||
170467661|NCT03743415|616050407|FG005|Overall Study|Withdrawal by Subject|2|||
170467662|NCT03743415|616050408|FG006|Overall Study|Withdrawal by Subject|2|||
170467663|NCT03743415|616050409|FG007|Overall Study|Withdrawal by Subject|5|||
170467664|NCT03743415|616050410|FG008|Overall Study|Withdrawal by Subject|9|||
170467665|NCT03743415|616050411|FG009|Overall Study|Withdrawal by Subject|10|||
170467666|NCT03743415|616050402|FG000|Overall Study|Lost to Follow-up|2|||
170467667|NCT03743415|616050403|FG001|Overall Study|Lost to Follow-up|0|||
170467668|NCT03743415|616050404|FG002|Overall Study|Lost to Follow-up|2|||
170467669|NCT03743415|616050405|FG003|Overall Study|Lost to Follow-up|1|||
170467670|NCT03743415|616050406|FG004|Overall Study|Lost to Follow-up|1|||
170467671|NCT03743415|616050407|FG005|Overall Study|Lost to Follow-up|0|||
170467672|NCT03743415|616050408|FG006|Overall Study|Lost to Follow-up|1|||
170467673|NCT03743415|616050409|FG007|Overall Study|Lost to Follow-up|4|||
170467674|NCT03743415|616050410|FG008|Overall Study|Lost to Follow-up|13|||
170467675|NCT03743415|616050411|FG009|Overall Study|Lost to Follow-up|13|||
170467676|NCT02847260|616050412|FG000|Overall Study|Adverse Event|3|||
170637310|NCT00607373|616684566|FG001|Treatment Period|Adverse Event|4|||
170790603|NCT03544281|617245732|FG008|Main Study Phase|Physician Decision|0|||
170467677|NCT02847260|616050412|FG000|Overall Study|Withdrawal by Subject|2|||
170467678|NCT02847260|616050412|FG000|Overall Study|Clinical Deterioration|1|||
170467679|NCT02847260|616050412|FG000|Overall Study|Physician Decision|1|||
170467680|NCT03104400|616050413|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
170637311|NCT00607373|616684565|FG000|Treatment Period|Physician Decision|0|||
170637312|NCT00607373|616684566|FG001|Treatment Period|Physician Decision|1|||
170790604|NCT03544281|617245733|FG009|Main Study Phase|Physician Decision|0|||
170467681|NCT03104400|616050414|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
170467682|NCT03104400|616050415|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
170467683|NCT03104400|616050416|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
170467684|NCT03104400|616050417|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
170467685|NCT03104400|616050418|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
170467686|NCT03104400|616050419|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
170467687|NCT03104400|616050420|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
170467688|NCT03104400|616050421|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
170467689|NCT03104400|616050422|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
170467690|NCT03104400|616050413|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
170890999|NCT01182428|617606597|FG001|Overall Study|Withdrawal by Subject|0|||
170891000|NCT01227902|617608144|FG000|Overall Study|Adverse Event|12|||
170891001|NCT01227902|617608145|FG001|Overall Study|Adverse Event|8|||
170891002|NCT01227902|617608146|FG002|Overall Study|Adverse Event|11|||
170891003|NCT01227902|617608147|FG003|Overall Study|Adverse Event|4|||
170891004|NCT01227902|617608144|FG000|Overall Study|Lack of Efficacy|1|||
170891005|NCT01227902|617608145|FG001|Overall Study|Lack of Efficacy|2|||
170891006|NCT01227902|617608146|FG002|Overall Study|Lack of Efficacy|2|||
170891007|NCT01227902|617608147|FG003|Overall Study|Lack of Efficacy|1|||
170891008|NCT01227902|617608144|FG000|Overall Study|Protocol Violation|1|||
170891009|NCT01227902|617608145|FG001|Overall Study|Protocol Violation|0|||
170891010|NCT01227902|617608146|FG002|Overall Study|Protocol Violation|0|||
170891011|NCT01227902|617608147|FG003|Overall Study|Protocol Violation|0|||
170891012|NCT01227902|617608144|FG000|Overall Study|Lost to Follow-up|0|||
170891013|NCT01227902|617608145|FG001|Overall Study|Lost to Follow-up|0|||
170891014|NCT01227902|617608146|FG002|Overall Study|Lost to Follow-up|1|||
170891015|NCT01227902|617608147|FG003|Overall Study|Lost to Follow-up|2|||
170891016|NCT01227902|617608144|FG000|Overall Study|Physician Decision|0|||
170891017|NCT01227902|617608145|FG001|Overall Study|Physician Decision|1|||
170891018|NCT01227902|617608146|FG002|Overall Study|Physician Decision|1|||
170891019|NCT01227902|617608147|FG003|Overall Study|Physician Decision|0|||
170891020|NCT01227902|617608144|FG000|Overall Study|Withdrawal by Subject|4|||
170891021|NCT01227902|617608145|FG001|Overall Study|Withdrawal by Subject|2|||
170891022|NCT01227902|617608146|FG002|Overall Study|Withdrawal by Subject|4|||
170891023|NCT01227902|617608147|FG003|Overall Study|Withdrawal by Subject|3|||
170891024|NCT02363478|617608152|FG000|Overall Study|Lost to Follow-up|4|||
170891025|NCT02363478|617608152|FG000|Overall Study|Adverse Event|4|||
170891026|NCT00930059|617608153|FG000|Overall Study|Death|1|||
170891027|NCT00930059|617608154|FG001|Overall Study|Death|0|||
170891028|NCT00930059|617608153|FG000|Overall Study|Did not meet entrance criteria|1|||
170891029|NCT00930059|617608154|FG001|Overall Study|Did not meet entrance criteria|1|||
170891030|NCT00930059|617608153|FG000|Overall Study|Withdrawal by Subject|3|||
170891031|NCT00930059|617608154|FG001|Overall Study|Withdrawal by Subject|4|||
170891032|NCT00930059|617608153|FG000|Overall Study|Other|1|||
170891033|NCT00930059|617608154|FG001|Overall Study|Other|0|||
170891034|NCT00930059|617608153|FG000|Overall Study|1 site terminated by sponsor|1|||
170891035|NCT00930059|617608154|FG001|Overall Study|1 site terminated by sponsor|1|||
170891036|NCT00930059|617608153|FG000|Overall Study|Adverse Event|1|||
170891037|NCT00930059|617608154|FG001|Overall Study|Adverse Event|6|||
170891038|NCT02554929|617608156|FG000|Overall Study|Lost to Follow-up|4|||
170891039|NCT02554929|617608157|FG001|Overall Study|Lost to Follow-up|4|||
170891040|NCT02554929|617608156|FG000|Overall Study|Withdrawal by Subject|2|||
170891041|NCT02554929|617608157|FG001|Overall Study|Withdrawal by Subject|8|||
170891042|NCT03064763|617608158|FG000|Overall Study|Lost to Follow-up|1|||
170891043|NCT03064763|617608158|FG000|Overall Study|Death|8|||
170891044|NCT02090855|617608159|FG000|Overall Study|no evaluable Standard of Truth results|2|||
170891045|NCT00388947|617608160|FG000|Overall Study|Protocol Violation|47|||
170891046|NCT04187092|617608161|FG000|Overall Study|Lost to Follow-up|1|||
170891047|NCT04187092|617608162|FG001|Overall Study|Lost to Follow-up|1|||
170891048|NCT04187092|617608161|FG000|Overall Study|Withdrawal by Subject|1|||
170891049|NCT04187092|617608162|FG001|Overall Study|Withdrawal by Subject|1|||
170790605|NCT03544281|617245734|FG010|Main Study Phase|Physician Decision|0|||
170790606|NCT03544281|617245735|FG011|Main Study Phase|Physician Decision|0|||
170790607|NCT03544281|617245736|FG012|Main Study Phase|Physician Decision|0|||
170790608|NCT03544281|617245737|FG013|Main Study Phase|Physician Decision|0|||
170790609|NCT03544281|617245738|FG014|Main Study Phase|Physician Decision|0|||
170790610|NCT03544281|617245739|FG015|Main Study Phase|Physician Decision|0|||
170790611|NCT03544281|617245740|FG016|Main Study Phase|Physician Decision|0|||
170790612|NCT03544281|617245741|FG017|Main Study Phase|Physician Decision|0|||
170790613|NCT03544281|617245742|FG018|Main Study Phase|Physician Decision|0|||
170790614|NCT03544281|617245743|FG019|Main Study Phase|Physician Decision|0|||
170790615|NCT03544281|617245744|FG020|Main Study Phase|Physician Decision|0|||
170790616|NCT03544281|617245745|FG021|Main Study Phase|Physician Decision|0|||
170790617|NCT03544281|617245724|FG000|Main Study Phase|Withdrawal by Subject|2|||
170790618|NCT03544281|617245725|FG001|Main Study Phase|Withdrawal by Subject|0|||
170790619|NCT03544281|617245726|FG002|Main Study Phase|Withdrawal by Subject|1|||
170790620|NCT03544281|617245727|FG003|Main Study Phase|Withdrawal by Subject|2|||
170790621|NCT03544281|617245728|FG004|Main Study Phase|Withdrawal by Subject|0|||
170790622|NCT03544281|617245729|FG005|Main Study Phase|Withdrawal by Subject|0|||
170790623|NCT03544281|617245730|FG006|Main Study Phase|Withdrawal by Subject|0|||
170790624|NCT03544281|617245731|FG007|Main Study Phase|Withdrawal by Subject|0|||
170790625|NCT03544281|617245732|FG008|Main Study Phase|Withdrawal by Subject|2|||
170891050|NCT04187092|617608161|FG000|Overall Study|Adverse Event|0|||
170891051|NCT04187092|617608162|FG001|Overall Study|Adverse Event|1|||
170891052|NCT00669617|617608165|FG000|Period 1|Withdrawal by Subject|0|||
170891053|NCT00669617|617608166|FG001|Period 1|Withdrawal by Subject|0|||
170891054|NCT00669617|617608167|FG002|Period 1|Withdrawal by Subject|1|||
170891055|NCT00669617|617608168|FG003|Period 1|Withdrawal by Subject|0|||
170467691|NCT03104400|616050414|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
170467692|NCT03104400|616050415|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
170467693|NCT03104400|616050416|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
170467694|NCT03104400|616050417|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
170467695|NCT03104400|616050418|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
170467696|NCT03104400|616050419|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
170467697|NCT03104400|616050420|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
170467698|NCT03104400|616050421|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
170467699|NCT03104400|616050422|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
170467700|NCT03104400|616050413|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
170467701|NCT03104400|616050414|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
170467702|NCT03104400|616050415|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
170467703|NCT03104400|616050416|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
170467704|NCT03104400|616050417|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
170467705|NCT03104400|616050418|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
170467706|NCT03104400|616050419|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
170467707|NCT03104400|616050420|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
170467708|NCT03104400|616050421|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
170637313|NCT00607373|616684565|FG000|Treatment Period|Withdrawal by Subject|0|||
170790626|NCT03544281|617245733|FG009|Main Study Phase|Withdrawal by Subject|3|||
170790627|NCT03544281|617245734|FG010|Main Study Phase|Withdrawal by Subject|0|||
170790628|NCT03544281|617245735|FG011|Main Study Phase|Withdrawal by Subject|4|||
170790629|NCT03544281|617245736|FG012|Main Study Phase|Withdrawal by Subject|0|||
170790630|NCT03544281|617245737|FG013|Main Study Phase|Withdrawal by Subject|0|||
170790631|NCT03544281|617245738|FG014|Main Study Phase|Withdrawal by Subject|0|||
170790632|NCT03544281|617245739|FG015|Main Study Phase|Withdrawal by Subject|0|||
170790633|NCT03544281|617245740|FG016|Main Study Phase|Withdrawal by Subject|0|||
170790634|NCT03544281|617245741|FG017|Main Study Phase|Withdrawal by Subject|0|||
170790635|NCT03544281|617245742|FG018|Main Study Phase|Withdrawal by Subject|0|||
170790636|NCT03544281|617245743|FG019|Main Study Phase|Withdrawal by Subject|0|||
170790637|NCT03544281|617245744|FG020|Main Study Phase|Withdrawal by Subject|0|||
170790638|NCT03544281|617245745|FG021|Main Study Phase|Withdrawal by Subject|0|||
170790639|NCT03544281|617245724|FG000|Main Study Phase|Ongoing|3|||
170790640|NCT03544281|617245725|FG001|Main Study Phase|Ongoing|1|||
170790641|NCT03544281|617245726|FG002|Main Study Phase|Ongoing|2|||
170790642|NCT03544281|617245727|FG003|Main Study Phase|Ongoing|4|||
170790643|NCT03544281|617245728|FG004|Main Study Phase|Ongoing|2|||
170790644|NCT03544281|617245729|FG005|Main Study Phase|Ongoing|4|||
170790645|NCT03544281|617245730|FG006|Main Study Phase|Ongoing|4|||
170790646|NCT03544281|617245731|FG007|Main Study Phase|Ongoing|0|||
170790647|NCT03544281|617245732|FG008|Main Study Phase|Ongoing|2|||
170790648|NCT03544281|617245733|FG009|Main Study Phase|Ongoing|2|||
170790649|NCT03544281|617245734|FG010|Main Study Phase|Ongoing|1|||
170790650|NCT03544281|617245735|FG011|Main Study Phase|Ongoing|0|||
170790651|NCT03544281|617245736|FG012|Main Study Phase|Ongoing|0|||
170790652|NCT03544281|617245737|FG013|Main Study Phase|Ongoing|0|||
170790653|NCT03544281|617245738|FG014|Main Study Phase|Ongoing|0|||
170790654|NCT03544281|617245739|FG015|Main Study Phase|Ongoing|0|||
170790655|NCT03544281|617245740|FG016|Main Study Phase|Ongoing|0|||
170790656|NCT03544281|617245741|FG017|Main Study Phase|Ongoing|0|||
170790657|NCT03544281|617245742|FG018|Main Study Phase|Ongoing|0|||
170790658|NCT03544281|617245743|FG019|Main Study Phase|Ongoing|0|||
170790659|NCT03544281|617245744|FG020|Main Study Phase|Ongoing|0|||
170790660|NCT03544281|617245745|FG021|Main Study Phase|Ongoing|0|||
170790661|NCT03544281|617245724|FG000|Main Study Phase|Investigator Site Closed|0|||
170790662|NCT03544281|617245725|FG001|Main Study Phase|Investigator Site Closed|0|||
170790663|NCT03544281|617245726|FG002|Main Study Phase|Investigator Site Closed|0|||
170790664|NCT03544281|617245727|FG003|Main Study Phase|Investigator Site Closed|0|||
170790665|NCT03544281|617245728|FG004|Main Study Phase|Investigator Site Closed|0|||
170790666|NCT03544281|617245729|FG005|Main Study Phase|Investigator Site Closed|0|||
170790667|NCT03544281|617245730|FG006|Main Study Phase|Investigator Site Closed|0|||
170790668|NCT03544281|617245731|FG007|Main Study Phase|Investigator Site Closed|0|||
170790669|NCT03544281|617245732|FG008|Main Study Phase|Investigator Site Closed|0|||
170790670|NCT03544281|617245733|FG009|Main Study Phase|Investigator Site Closed|1|||
170467709|NCT03104400|616050422|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
170467710|NCT03104400|616050413|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
170467711|NCT03104400|616050414|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
170790671|NCT03544281|617245734|FG010|Main Study Phase|Investigator Site Closed|0|||
170790672|NCT03544281|617245735|FG011|Main Study Phase|Investigator Site Closed|0|||
170790673|NCT03544281|617245736|FG012|Main Study Phase|Investigator Site Closed|0|||
170790674|NCT03544281|617245737|FG013|Main Study Phase|Investigator Site Closed|0|||
170790675|NCT03544281|617245738|FG014|Main Study Phase|Investigator Site Closed|0|||
170891056|NCT00669617|617608169|FG004|Period 1|Withdrawal by Subject|0|||
170790676|NCT03544281|617245739|FG015|Main Study Phase|Investigator Site Closed|0|||
170891057|NCT00669617|617608165|FG000|Period 1|Protocol Deviation|0|||
170790677|NCT03544281|617245740|FG016|Main Study Phase|Investigator Site Closed|0|||
170790678|NCT03544281|617245741|FG017|Main Study Phase|Investigator Site Closed|0|||
170790679|NCT03544281|617245742|FG018|Main Study Phase|Investigator Site Closed|0|||
170467712|NCT03104400|616050415|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
170467713|NCT03104400|616050416|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
170467714|NCT03104400|616050417|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
170467715|NCT03104400|616050418|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
170467716|NCT03104400|616050419|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
170467717|NCT03104400|616050420|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
170467718|NCT03104400|616050421|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
170467719|NCT03104400|616050422|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
170467720|NCT03104400|616050413|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467721|NCT03104400|616050414|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467722|NCT03104400|616050415|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467723|NCT03104400|616050416|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
170467724|NCT03104400|616050417|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467725|NCT03104400|616050418|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467726|NCT03104400|616050419|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467727|NCT03104400|616050420|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467728|NCT03104400|616050421|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467729|NCT03104400|616050422|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
170467730|NCT03104400|616050413|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
170467731|NCT03104400|616050414|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
170467732|NCT03104400|616050415|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
170467733|NCT03104400|616050416|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
170467734|NCT03104400|616050417|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
170467735|NCT03104400|616050418|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
170467736|NCT03104400|616050419|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
170467737|NCT03104400|616050420|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
170467738|NCT03104400|616050421|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
170467739|NCT03104400|616050422|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
170467740|NCT03104400|616050413|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467741|NCT03104400|616050414|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467742|NCT03104400|616050415|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467743|NCT03104400|616050416|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
170467744|NCT03104400|616050417|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467745|NCT03104400|616050418|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467746|NCT03104400|616050419|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467747|NCT03104400|616050420|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467748|NCT03104400|616050421|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467749|NCT03104400|616050422|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
170467750|NCT03104400|616050413|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
170467751|NCT03104400|616050414|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
170467752|NCT03104400|616050415|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
170467753|NCT03104400|616050416|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
170467754|NCT03104400|616050417|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
170467755|NCT03104400|616050418|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
170467756|NCT03104400|616050419|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
170467757|NCT03104400|616050420|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
170467758|NCT03104400|616050421|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
170467759|NCT03104400|616050422|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
170467760|NCT03104400|616050413|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
170467761|NCT03104400|616050414|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
170467762|NCT03104400|616050415|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
170467763|NCT03104400|616050416|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
170467764|NCT03104400|616050417|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
170467765|NCT03104400|616050418|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
170467766|NCT03104400|616050419|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
170467767|NCT03104400|616050420|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
170467768|NCT03104400|616050421|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
170467769|NCT03104400|616050422|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
170467770|NCT03104400|616050413|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
170467771|NCT03104400|616050414|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
170467772|NCT03104400|616050415|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
170467773|NCT03104400|616050416|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
170467774|NCT03104400|616050417|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
170467775|NCT03104400|616050418|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
170545275|NCT00397930|616340947|FG001|Overall Study|Missing data|4|||
170467776|NCT03104400|616050419|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
170467777|NCT03104400|616050420|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
170467778|NCT03104400|616050421|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
170467779|NCT03104400|616050422|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
170467780|NCT03104400|616050413|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
170545276|NCT02400580|616340957|FG000|Overall Study|Withdrawal by Subject|1|||
170545277|NCT02400580|616340958|FG001|Overall Study|Withdrawal by Subject|1|||
170467781|NCT03104400|616050414|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
170467782|NCT03104400|616050415|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
170467783|NCT03104400|616050416|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
170467784|NCT03104400|616050417|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
170467785|NCT03104400|616050418|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
170467786|NCT03104400|616050419|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
170467787|NCT03104400|616050420|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
170467788|NCT03104400|616050421|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
170467789|NCT03104400|616050422|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
170467790|NCT03104400|616050413|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
170467791|NCT03104400|616050414|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
170467792|NCT03104400|616050415|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
170467793|NCT03104400|616050416|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
170467794|NCT03104400|616050417|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
170467795|NCT03104400|616050418|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
170467796|NCT03104400|616050419|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
170467797|NCT03104400|616050420|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
170467798|NCT03104400|616050421|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
170467799|NCT03104400|616050422|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
170467800|NCT03104400|616050413|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
170467801|NCT03104400|616050414|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
170467802|NCT03104400|616050415|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
170467803|NCT03104400|616050416|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
170467804|NCT03104400|616050417|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
170467805|NCT03104400|616050418|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
170467806|NCT03104400|616050419|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
170467807|NCT03104400|616050420|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
170467808|NCT03104400|616050421|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
170467809|NCT03104400|616050422|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
170467810|NCT03104400|616050413|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
170467811|NCT03104400|616050414|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
170467812|NCT03104400|616050415|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
170467813|NCT03104400|616050416|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
170467814|NCT03104400|616050417|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
170467815|NCT03104400|616050418|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
170467816|NCT03104400|616050419|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
170467817|NCT03104400|616050420|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
170467818|NCT03104400|616050421|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
170467819|NCT03104400|616050422|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
170467820|NCT03104400|616050413|FG000|Period 2 Week 56 - 260)|Other|0|||
170467821|NCT03104400|616050414|FG001|Period 2 Week 56 - 260)|Other|0|||
170467822|NCT03104400|616050415|FG002|Period 2 Week 56 - 260)|Other|0|||
170467823|NCT03104400|616050416|FG003|Period 2 Week 56 - 260)|Other|0|||
170467824|NCT03104400|616050417|FG004|Period 2 Week 56 - 260)|Other|0|||
170467825|NCT03104400|616050418|FG005|Period 2 Week 56 - 260)|Other|0|||
170467826|NCT03104400|616050419|FG006|Period 2 Week 56 - 260)|Other|0|||
170467827|NCT03104400|616050420|FG007|Period 2 Week 56 - 260)|Other|0|||
170790680|NCT03544281|617245743|FG019|Main Study Phase|Investigator Site Closed|0|||
170790681|NCT03544281|617245744|FG020|Main Study Phase|Investigator Site Closed|0|||
170790682|NCT03544281|617245745|FG021|Main Study Phase|Investigator Site Closed|0|||
170790683|NCT03544281|617245724|FG000|Main Study Phase|Did not receive study treatment|0|||
170790684|NCT03544281|617245725|FG001|Main Study Phase|Did not receive study treatment|0|||
170790685|NCT03544281|617245726|FG002|Main Study Phase|Did not receive study treatment|0|||
170790686|NCT03544281|617245727|FG003|Main Study Phase|Did not receive study treatment|0|||
170790687|NCT03544281|617245728|FG004|Main Study Phase|Did not receive study treatment|0|||
170790688|NCT03544281|617245729|FG005|Main Study Phase|Did not receive study treatment|0|||
170790689|NCT03544281|617245730|FG006|Main Study Phase|Did not receive study treatment|1|||
170790690|NCT03544281|617245731|FG007|Main Study Phase|Did not receive study treatment|0|||
170790691|NCT03544281|617245732|FG008|Main Study Phase|Did not receive study treatment|0|||
170790692|NCT03544281|617245733|FG009|Main Study Phase|Did not receive study treatment|0|||
170790693|NCT03544281|617245734|FG010|Main Study Phase|Did not receive study treatment|0|||
170467828|NCT03104400|616050421|FG008|Period 2 Week 56 - 260)|Other|1|||
170467829|NCT03104400|616050422|FG009|Period 2 Week 56 - 260)|Other|1|||
170467830|NCT00094861|616050423|FG000|Overall Study|Adverse Event|5|||
170467831|NCT00094861|616050424|FG001|Overall Study|Adverse Event|2|||
170467832|NCT00094861|616050423|FG000|Overall Study|Withdrawal by Subject|5|||
170467833|NCT00094861|616050424|FG001|Overall Study|Withdrawal by Subject|3|||
170467834|NCT00094861|616050423|FG000|Overall Study|Physician Decision|1|||
170467835|NCT00094861|616050424|FG001|Overall Study|Physician Decision|1|||
170467836|NCT00094861|616050423|FG000|Overall Study|Lost to Follow-up|0|||
170467837|NCT00094861|616050424|FG001|Overall Study|Lost to Follow-up|1|||
170467838|NCT00094861|616050423|FG000|Overall Study|Death|4|||
170790694|NCT03544281|617245735|FG011|Main Study Phase|Did not receive study treatment|0|||
170467839|NCT00094861|616050424|FG001|Overall Study|Death|2|||
170467840|NCT00094861|616050423|FG000|Overall Study|Other|3|||
170467841|NCT00094861|616050424|FG001|Overall Study|Other|0|||
170467842|NCT01433549|616050427|FG000|Phase 2: Second Study Product|Adverse Event|0|||
170467843|NCT01433549|616050428|FG001|Phase 2: Second Study Product|Adverse Event|1|||
170467844|NCT00451204|616050430|FG000|Overall Study|Adverse Event|4|||
170467845|NCT00451204|616050431|FG001|Overall Study|Adverse Event|6|||
170467846|NCT00451204|616050430|FG000|Overall Study|Lack of Efficacy|4|||
170467847|NCT00451204|616050431|FG001|Overall Study|Lack of Efficacy|4|||
170467848|NCT00451204|616050430|FG000|Overall Study|Lost to Follow-up|4|||
170467849|NCT00451204|616050431|FG001|Overall Study|Lost to Follow-up|4|||
170467850|NCT00451204|616050430|FG000|Overall Study|Protocol Violation|1|||
170467851|NCT00451204|616050431|FG001|Overall Study|Protocol Violation|0|||
170467852|NCT00451204|616050430|FG000|Overall Study|Patient refusal|8|||
170467853|NCT00451204|616050431|FG001|Overall Study|Patient refusal|4|||
170467854|NCT00451204|616050430|FG000|Overall Study|Other|1|||
170467855|NCT00451204|616050431|FG001|Overall Study|Other|2|||
170467856|NCT02186834|616050432|FG000|Dose Escalation|Death|0|||
170467857|NCT02186834|616050433|FG001|Dose Escalation|Death|0|||
170467858|NCT02186834|616050434|FG002|Dose Escalation|Death|0|||
170467859|NCT02186834|616050435|FG003|Dose Escalation|Death|1|||
170467860|NCT02186834|616050436|FG004|Dose Escalation|Death|0|||
170467861|NCT02186834|616050437|FG005|Dose Escalation|Death|0|||
170467862|NCT02186834|616050432|FG000|Treatment at RP2D|Died prior to treatment|0|||
170467863|NCT02186834|616050433|FG001|Treatment at RP2D|Died prior to treatment|0|||
170467864|NCT02186834|616050434|FG002|Treatment at RP2D|Died prior to treatment|0|||
170467865|NCT02186834|616050435|FG003|Treatment at RP2D|Died prior to treatment|0|||
170467866|NCT02186834|616050436|FG004|Treatment at RP2D|Died prior to treatment|0|||
170467867|NCT02186834|616050437|FG005|Treatment at RP2D|Died prior to treatment|1|||
170467868|NCT01421511|616050438|FG000|Overall Study|Lost to Follow-up|11|||
170467869|NCT01421511|616050439|FG001|Overall Study|Lost to Follow-up|14|||
170467870|NCT01421511|616050438|FG000|Overall Study|Randomized but didn't receive study drug|1|||
170467871|NCT01421511|616050439|FG001|Overall Study|Randomized but didn't receive study drug|7|||
170467872|NCT01421511|616050438|FG000|Overall Study|Physician Decision|0|||
170467873|NCT01421511|616050439|FG001|Overall Study|Physician Decision|1|||
170467874|NCT01421511|616050438|FG000|Overall Study|Withdrawal by Subject|6|||
170467875|NCT01421511|616050439|FG001|Overall Study|Withdrawal by Subject|5|||
170467876|NCT01421511|616050438|FG000|Overall Study|Death|1|||
170467877|NCT01421511|616050439|FG001|Overall Study|Death|1|||
170467878|NCT02242045|616050440|FG000|Overall Study|Investigator's Discretion|1|||
170467879|NCT02242045|616050440|FG000|Overall Study|Progressive Disease|2|||
170467880|NCT02242045|616050440|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
170467881|NCT02242045|616050440|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
170467882|NCT05384171|616050441|FG000|Overall Study|Lost to Follow-up|9|||
170467883|NCT05384171|616050442|FG001|Overall Study|Lost to Follow-up|9|||
170467884|NCT05384171|616050441|FG000|Overall Study|Withdrawal by Subject|3|||
170467885|NCT05384171|616050442|FG001|Overall Study|Withdrawal by Subject|0|||
170467886|NCT04581369|616050443|FG000|Overall Study|Death|7|||
170467887|NCT04581369|616050444|FG001|Overall Study|Death|6|||
170467888|NCT04581369|616050445|FG002|Overall Study|Death|0|||
170467889|NCT04581369|616050443|FG000|Overall Study|Lost to Follow-up|7|||
170467890|NCT04581369|616050444|FG001|Overall Study|Lost to Follow-up|3|||
170467891|NCT04581369|616050445|FG002|Overall Study|Lost to Follow-up|0|||
170467892|NCT04581369|616050443|FG000|Overall Study|liver transplant|2|||
170467893|NCT04581369|616050444|FG001|Overall Study|liver transplant|2|||
170467894|NCT04581369|616050445|FG002|Overall Study|liver transplant|0|||
170467895|NCT04581369|616050443|FG000|Overall Study|transitioned to hospice care|0|||
170790695|NCT03544281|617245736|FG012|Main Study Phase|Did not receive study treatment|0|||
170790696|NCT03544281|617245737|FG013|Main Study Phase|Did not receive study treatment|0|||
170790697|NCT03544281|617245738|FG014|Main Study Phase|Did not receive study treatment|0|||
170790698|NCT03544281|617245739|FG015|Main Study Phase|Did not receive study treatment|0|||
170467896|NCT04581369|616050444|FG001|Overall Study|transitioned to hospice care|5|||
170467897|NCT04581369|616050445|FG002|Overall Study|transitioned to hospice care|0|||
170467898|NCT02648932|616050455|FG000|Overall Study|No transplant|3|||
170467899|NCT02648932|616050456|FG001|Overall Study|No transplant|1|||
170467900|NCT03106987|616050457|FG000|Overall Study|Death|37|||
170467901|NCT03106987|616050458|FG001|Overall Study|Death|22|||
170467902|NCT03106987|616050459|FG002|Overall Study|Death|12|||
170467903|NCT03106987|616050460|FG003|Overall Study|Death|8|||
170467904|NCT03106987|616050457|FG000|Overall Study|Lost to Follow-up|2|||
170467905|NCT03106987|616050458|FG001|Overall Study|Lost to Follow-up|0|||
170467906|NCT03106987|616050459|FG002|Overall Study|Lost to Follow-up|2|||
170790699|NCT03544281|617245740|FG016|Main Study Phase|Did not receive study treatment|0|||
170467907|NCT03106987|616050460|FG003|Overall Study|Lost to Follow-up|2|||
170467908|NCT03106987|616050457|FG000|Overall Study|Withdrawal by Subject|5|||
170467909|NCT03106987|616050458|FG001|Overall Study|Withdrawal by Subject|1|||
170467910|NCT03106987|616050459|FG002|Overall Study|Withdrawal by Subject|4|||
170467911|NCT03106987|616050460|FG003|Overall Study|Withdrawal by Subject|1|||
170467912|NCT02463357|616050466|FG000|Overall Study|Withdrawal by Subject|1|||
170467913|NCT02463357|616050467|FG001|Overall Study|Withdrawal by Subject|0|||
170467914|NCT02463357|616050468|FG002|Overall Study|Withdrawal by Subject|0|||
170467915|NCT02463357|616050469|FG003|Overall Study|Withdrawal by Subject|0|||
170467916|NCT02463357|616050470|FG004|Overall Study|Withdrawal by Subject|0|||
170467917|NCT02463357|616050466|FG000|Overall Study|Withdrawal by Subject|0|||
170467918|NCT02463357|616050467|FG001|Overall Study|Withdrawal by Subject|0|||
170467919|NCT02463357|616050468|FG002|Overall Study|Withdrawal by Subject|0|||
170467920|NCT02463357|616050469|FG003|Overall Study|Withdrawal by Subject|0|||
170467921|NCT02463357|616050470|FG004|Overall Study|Withdrawal by Subject|1|||
170467922|NCT02460679|616050473|FG000|Overall Study|Investigator Decision|1|||
170467923|NCT02460679|616050473|FG000|Overall Study|Withdrawal by Subject|4|||
170467924|NCT01994850|616050478|FG000|Overall Study|Physician Decision|1|||
170467925|NCT01994850|616050478|FG000|Overall Study|Withdrawal by Subject|1|||
170467926|NCT03503864|616050511|FG000|Overall Study|Protocol Violation|6|||
170467927|NCT03503864|616050511|FG000|Overall Study|Withdrawal by Subject|7|||
170467928|NCT02458287|616050515|FG000|Overall Study|Adverse Event|0|||
170467929|NCT02458287|616050516|FG001|Overall Study|Adverse Event|0|||
170467930|NCT02458287|616050517|FG002|Overall Study|Adverse Event|0|||
170467931|NCT02458287|616050518|FG003|Overall Study|Adverse Event|1|||
170467932|NCT02458287|616050515|FG000|Overall Study|Lost to Follow-up|0|||
170467933|NCT02458287|616050516|FG001|Overall Study|Lost to Follow-up|1|||
170467934|NCT02458287|616050517|FG002|Overall Study|Lost to Follow-up|1|||
170467935|NCT02458287|616050518|FG003|Overall Study|Lost to Follow-up|0|||
170467936|NCT02458287|616050515|FG000|Overall Study|Protocol Violation|0|||
170467937|NCT02458287|616050516|FG001|Overall Study|Protocol Violation|1|||
170467938|NCT02458287|616050517|FG002|Overall Study|Protocol Violation|0|||
170467939|NCT02458287|616050518|FG003|Overall Study|Protocol Violation|0|||
170467940|NCT02458287|616050515|FG000|Overall Study|Withdrawal by Subject|0|||
170467941|NCT02458287|616050516|FG001|Overall Study|Withdrawal by Subject|2|||
170467942|NCT02458287|616050517|FG002|Overall Study|Withdrawal by Subject|2|||
170467943|NCT02458287|616050518|FG003|Overall Study|Withdrawal by Subject|1|||
170790700|NCT03544281|617245741|FG017|Main Study Phase|Did not receive study treatment|0|||
170790701|NCT03544281|617245742|FG018|Main Study Phase|Did not receive study treatment|0|||
170790702|NCT03544281|617245743|FG019|Main Study Phase|Did not receive study treatment|0|||
170790703|NCT03544281|617245744|FG020|Main Study Phase|Did not receive study treatment|0|||
170790704|NCT03544281|617245745|FG021|Main Study Phase|Did not receive study treatment|0|||
170790705|NCT03544281|617245724|FG000|PACT Phase|Adverse Event|0|||
170790706|NCT03544281|617245725|FG001|PACT Phase|Adverse Event|0|||
170790707|NCT03544281|617245726|FG002|PACT Phase|Adverse Event|0|||
170790708|NCT03544281|617245727|FG003|PACT Phase|Adverse Event|0|||
170790709|NCT03544281|617245728|FG004|PACT Phase|Adverse Event|0|||
170790710|NCT03544281|617245729|FG005|PACT Phase|Adverse Event|0|||
170790711|NCT03544281|617245730|FG006|PACT Phase|Adverse Event|0|||
170790712|NCT03544281|617245731|FG007|PACT Phase|Adverse Event|0|||
170790713|NCT03544281|617245732|FG008|PACT Phase|Adverse Event|0|||
170790714|NCT03544281|617245733|FG009|PACT Phase|Adverse Event|0|||
170790715|NCT03544281|617245734|FG010|PACT Phase|Adverse Event|0|||
170790716|NCT03544281|617245735|FG011|PACT Phase|Adverse Event|0|||
170790717|NCT03544281|617245736|FG012|PACT Phase|Adverse Event|1|||
170790718|NCT03544281|617245737|FG013|PACT Phase|Adverse Event|0|||
170790719|NCT03544281|617245738|FG014|PACT Phase|Adverse Event|0|||
170790720|NCT03544281|617245739|FG015|PACT Phase|Adverse Event|0|||
170790721|NCT03544281|617245740|FG016|PACT Phase|Adverse Event|0|||
170790722|NCT03544281|617245741|FG017|PACT Phase|Adverse Event|1|||
170790723|NCT03544281|617245742|FG018|PACT Phase|Adverse Event|1|||
170790724|NCT03544281|617245743|FG019|PACT Phase|Adverse Event|0|||
170790725|NCT03544281|617245744|FG020|PACT Phase|Adverse Event|0|||
170790726|NCT03544281|617245745|FG021|PACT Phase|Adverse Event|0|||
170790727|NCT05949788|617245746|FG000|Overall Study|severe birth deformity|2|||
170790728|NCT05949788|617245747|FG001|Overall Study|severe birth deformity|7|||
170790729|NCT05949788|617245746|FG000|Overall Study|twin-twin transfusion syndrome|2|||
170467944|NCT02458287|616050515|FG000|Overall Study|Relocated Out of State|0|||
170790730|NCT05949788|617245747|FG001|Overall Study|twin-twin transfusion syndrome|7|||
170467945|NCT02458287|616050516|FG001|Overall Study|Relocated Out of State|0|||
170467946|NCT02458287|616050517|FG002|Overall Study|Relocated Out of State|0|||
170467947|NCT02458287|616050518|FG003|Overall Study|Relocated Out of State|1|||
170467948|NCT02752087|616050519|FG000|Washout|Physician Decision|1|||
170467949|NCT02752087|616050520|FG001|Washout|Physician Decision|0|||
170467950|NCT02613182|616050521|FG000|Overall Study|Death|6|||
170467951|NCT02613182|616050521|FG000|Overall Study|Physician Decision|1|||
170467952|NCT02613182|616050521|FG000|Overall Study|Study Terminated by Sponsor|21|||
170790731|NCT05949788|617245746|FG000|Overall Study|neonatal hemolytic disease|3|||
170790732|NCT05949788|617245747|FG001|Overall Study|neonatal hemolytic disease|8|||
170790733|NCT05949788|617245746|FG000|Overall Study|death within 14 days after birth|2|||
170790734|NCT05949788|617245747|FG001|Overall Study|death within 14 days after birth|6|||
170790735|NCT05949788|617245746|FG000|Overall Study|transfer to another hospital|2|||
170790736|NCT05949788|617245747|FG001|Overall Study|transfer to another hospital|6|||
170790737|NCT02191618|617245755|FG000|Overall Study|Withdrawal by Subject|3|||
170467953|NCT02613182|616050521|FG000|Overall Study|Withdrawal by Subject|6|||
170467954|NCT00843635|616050522|FG000|Overall Study|Adverse Event|2|||
170467955|NCT00843635|616050523|FG001|Overall Study|Adverse Event|2|||
170467956|NCT00843635|616050524|FG002|Overall Study|Adverse Event|0|||
170467957|NCT00813800|616050525|FG000|Overall Study|Screen Failure after Consent|2|||
170467958|NCT00813800|616050525|FG000|Overall Study|Adverse Event|1|||
170467959|NCT00813800|616050525|FG000|Overall Study|Worsening of depression|2|||
170467960|NCT00813800|616050525|FG000|Overall Study|Physician Decision|1|||
170467961|NCT01144715|616050526|FG000|Overall Study|Lost to Follow-up|2|||
170467962|NCT01144715|616050527|FG001|Overall Study|Lost to Follow-up|1|||
170467963|NCT01144715|616050526|FG000|Overall Study|Withdrawal by Subject|2|||
170467964|NCT01144715|616050527|FG001|Overall Study|Withdrawal by Subject|1|||
170467965|NCT01144715|616050526|FG000|Overall Study|Adverse Event|0|||
170467966|NCT01144715|616050527|FG001|Overall Study|Adverse Event|1|||
170467967|NCT03553576|616050528|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
170467968|NCT03553576|616050529|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
170467969|NCT03553576|616050528|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
170467970|NCT03553576|616050529|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
170467971|NCT03553576|616050528|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
170467972|NCT03553576|616050529|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
170467973|NCT03553576|616050528|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
170467974|NCT03553576|616050529|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
170467975|NCT03553576|616050528|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
170467976|NCT03553576|616050529|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
170467977|NCT03553576|616050528|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
170467978|NCT03553576|616050529|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
170467979|NCT03553576|616050528|FG000|Overall Study|Physician Decision|2|||
170467980|NCT03553576|616050529|FG001|Overall Study|Physician Decision|5|||
170467981|NCT00121134|616050530|FG000|Overall Study|Progression of Disease|5|||
170467982|NCT00121134|616050531|FG001|Overall Study|Progression of Disease|3|||
170467983|NCT00121134|616050532|FG002|Overall Study|Progression of Disease|4|||
170467984|NCT00121134|616050533|FG003|Overall Study|Progression of Disease|2|||
170467985|NCT00121134|616050530|FG000|Overall Study|Toxicity|4|||
170467986|NCT00121134|616050531|FG001|Overall Study|Toxicity|7|||
170467987|NCT00121134|616050532|FG002|Overall Study|Toxicity|13|||
170467988|NCT00121134|616050533|FG003|Overall Study|Toxicity|5|||
170467989|NCT00121134|616050530|FG000|Overall Study|Physician Decision|6|||
170467990|NCT00121134|616050531|FG001|Overall Study|Physician Decision|4|||
170467991|NCT00121134|616050532|FG002|Overall Study|Physician Decision|4|||
170467992|NCT00121134|616050533|FG003|Overall Study|Physician Decision|1|||
170467993|NCT00121134|616050530|FG000|Overall Study|Treatment Delay|1|||
170790738|NCT02191618|617245755|FG000|Overall Study|Missed Visit|4|||
170790739|NCT03031470|617245756|FG000|Overall Study|Adverse Event|3|||
170891058|NCT00669617|617608166|FG001|Period 1|Protocol Deviation|0|||
170891059|NCT00669617|617608167|FG002|Period 1|Protocol Deviation|0|||
170891060|NCT00669617|617608168|FG003|Period 1|Protocol Deviation|0|||
170891061|NCT00669617|617608169|FG004|Period 1|Protocol Deviation|1|||
170467994|NCT00121134|616050531|FG001|Overall Study|Treatment Delay|0|||
170467995|NCT00121134|616050532|FG002|Overall Study|Treatment Delay|0|||
170790740|NCT03031470|617245757|FG001|Overall Study|Adverse Event|0|||
170790741|NCT03031470|617245756|FG000|Overall Study|Death|3|||
170790742|NCT03031470|617245757|FG001|Overall Study|Death|1|||
170790743|NCT03031470|617245756|FG000|Overall Study|Lost to Follow-up|1|||
170790744|NCT03031470|617245757|FG001|Overall Study|Lost to Follow-up|1|||
170790745|NCT03031470|617245756|FG000|Overall Study|Withdrawal by Subject|1|||
170790746|NCT03031470|617245757|FG001|Overall Study|Withdrawal by Subject|0|||
170790747|NCT03031470|617245756|FG000|Overall Study|Protocol entry criteria not met|0|||
170790748|NCT03031470|617245757|FG001|Overall Study|Protocol entry criteria not met|1|||
170790749|NCT03031470|617245756|FG000|Overall Study|Cancel the operation|0|||
170467996|NCT00121134|616050533|FG003|Overall Study|Treatment Delay|0|||
170467997|NCT00121134|616050530|FG000|Overall Study|Intercurrent Illness|0|||
170467998|NCT00121134|616050531|FG001|Overall Study|Intercurrent Illness|0|||
170467999|NCT00121134|616050532|FG002|Overall Study|Intercurrent Illness|0|||
170468000|NCT00121134|616050533|FG003|Overall Study|Intercurrent Illness|1|||
170468001|NCT00121134|616050530|FG000|Overall Study|Patient Personal Reasons|0|||
170468002|NCT00121134|616050531|FG001|Overall Study|Patient Personal Reasons|1|||
170468003|NCT00121134|616050532|FG002|Overall Study|Patient Personal Reasons|0|||
170790750|NCT03031470|617245757|FG001|Overall Study|Cancel the operation|1|||
170790751|NCT02296125|617245758|FG000|Overall Study|Withdrawal by Subject|18|||
170790752|NCT02296125|617245759|FG001|Overall Study|Withdrawal by Subject|8|||
170790753|NCT02296125|617245760|FG002|Overall Study|Withdrawal by Subject|6|||
170891062|NCT00669617|617608165|FG000|Period 3|Lost to Follow-up|1|||
170790754|NCT02296125|617245761|FG003|Overall Study|Withdrawal by Subject|2|||
170790755|NCT02296125|617245758|FG000|Overall Study|Adverse Event|41|||
170790756|NCT02296125|617245759|FG001|Overall Study|Adverse Event|52|||
170790757|NCT02296125|617245760|FG002|Overall Study|Adverse Event|9|||
170790758|NCT02296125|617245761|FG003|Overall Study|Adverse Event|4|||
170790759|NCT02296125|617245758|FG000|Overall Study|Severe non-compliance to protocol|0|||
170790760|NCT02296125|617245759|FG001|Overall Study|Severe non-compliance to protocol|1|||
170790761|NCT02296125|617245760|FG002|Overall Study|Severe non-compliance to protocol|0|||
170790762|NCT02296125|617245761|FG003|Overall Study|Severe non-compliance to protocol|0|||
170790763|NCT02296125|617245758|FG000|Overall Study|Condition under investigation worsened|153|||
170790764|NCT02296125|617245759|FG001|Overall Study|Condition under investigation worsened|199|||
170790765|NCT02296125|617245760|FG002|Overall Study|Condition under investigation worsened|39|||
170790766|NCT02296125|617245761|FG003|Overall Study|Condition under investigation worsened|56|||
170790767|NCT02296125|617245758|FG000|Overall Study|Any reason not specifically recorded|6|||
170790768|NCT02296125|617245759|FG001|Overall Study|Any reason not specifically recorded|4|||
170790769|NCT02296125|617245760|FG002|Overall Study|Any reason not specifically recorded|2|||
170790770|NCT02296125|617245761|FG003|Overall Study|Any reason not specifically recorded|0|||
170790771|NCT04663737|617245762|FG000|Overall Study|Withdrawal by Subject|2|||
170790772|NCT04663737|617245763|FG001|Overall Study|Withdrawal by Subject|0|||
170790773|NCT03904147|617245767|FG000|Overall Study|Death|15|||
170790774|NCT03904147|617245768|FG001|Overall Study|Death|13|||
170790775|NCT03904147|617245769|FG002|Overall Study|Death|15|||
170790776|NCT03904147|617245767|FG000|Overall Study|Withdrawal by Subject|7|||
170790777|NCT03904147|617245768|FG001|Overall Study|Withdrawal by Subject|12|||
170790778|NCT03904147|617245769|FG002|Overall Study|Withdrawal by Subject|1|||
170790779|NCT03904147|617245767|FG000|Overall Study|1Y visit completed after 365 days|1|||
170790780|NCT03904147|617245768|FG001|Overall Study|1Y visit completed after 365 days|1|||
170790781|NCT03904147|617245769|FG002|Overall Study|1Y visit completed after 365 days|0|||
170790782|NCT04032704|617245770|FG000|Part A|Withdrawal by Subject|0|||
170468004|NCT00121134|616050533|FG003|Overall Study|Patient Personal Reasons|0|||
170468005|NCT01425723|616050534|FG000|Overall Study|Lack of Efficacy|0|||
170468006|NCT01425723|616050535|FG001|Overall Study|Lack of Efficacy|1|||
170468007|NCT01425723|616050534|FG000|Overall Study|Withdrawal by Subject|1|||
170468008|NCT01425723|616050535|FG001|Overall Study|Withdrawal by Subject|4|||
170468009|NCT01425723|616050534|FG000|Overall Study|Lost to Follow-up|0|||
170468010|NCT01425723|616050535|FG001|Overall Study|Lost to Follow-up|3|||
170468011|NCT01425723|616050534|FG000|Overall Study|Physician Decision|2|||
170468012|NCT01425723|616050535|FG001|Overall Study|Physician Decision|0|||
170468013|NCT01425723|616050534|FG000|Overall Study|Other|1|||
170468014|NCT01425723|616050535|FG001|Overall Study|Other|10|||
170468015|NCT00857584|616050540|FG000|Overall Study|Lack of Efficacy|1|||
170468016|NCT00857584|616050541|FG001|Overall Study|Lack of Efficacy|2|||
170468017|NCT00857584|616050540|FG000|Overall Study|Adverse Event|2|||
170468018|NCT00857584|616050541|FG001|Overall Study|Adverse Event|2|||
170468019|NCT00857584|616050540|FG000|Overall Study|Physician Decision|1|||
170468020|NCT00857584|616050541|FG001|Overall Study|Physician Decision|1|||
170468021|NCT02533375|616050542|FG000|Overall Study|Lack of Efficacy|3|||
170468022|NCT02533375|616050542|FG000|Overall Study|Adverse Event|2|||
170468023|NCT01104792|616050547|FG000|Overall Study|Adverse Event|77|||
170468024|NCT01104792|616050547|FG000|Overall Study|Insufficient Therapeutic Response|22|||
170468025|NCT01104792|616050547|FG000|Overall Study|Protocol Violation|45|||
170468026|NCT01104792|616050547|FG000|Overall Study|Withdrawal of Consent|179|||
170790783|NCT04032704|617245771|FG001|Part A|Withdrawal by Subject|0|||
170790784|NCT04032704|617245772|FG002|Part A|Withdrawal by Subject|3|||
170790785|NCT04032704|617245773|FG003|Part A|Withdrawal by Subject|0|||
170790786|NCT04032704|617245774|FG004|Part A|Withdrawal by Subject|1|||
170790787|NCT04032704|617245775|FG005|Part A|Withdrawal by Subject|7|||
170790788|NCT04032704|617245776|FG006|Part A|Withdrawal by Subject|0|||
170790789|NCT04032704|617245777|FG007|Part A|Withdrawal by Subject|0|||
170790790|NCT04032704|617245778|FG008|Part A|Withdrawal by Subject|0|||
170790791|NCT04032704|617245779|FG009|Part A|Withdrawal by Subject|0|||
170790792|NCT04032704|617245780|FG010|Part A|Withdrawal by Subject|0|||
170790793|NCT04032704|617245781|FG011|Part A|Withdrawal by Subject|0|||
170790794|NCT04032704|617245782|FG012|Part A|Withdrawal by Subject|0|||
170790795|NCT04032704|617245783|FG013|Part A|Withdrawal by Subject|0|||
170790796|NCT04032704|617245784|FG014|Part A|Withdrawal by Subject|0|||
170790797|NCT04032704|617245785|FG015|Part A|Withdrawal by Subject|0|||
170790798|NCT04032704|617245786|FG016|Part A|Withdrawal by Subject|0|||
170790799|NCT04032704|617245787|FG017|Part A|Withdrawal by Subject|0|||
170790800|NCT04032704|617245770|FG000|Part A|Lost to Follow-up|1|||
170790801|NCT04032704|617245771|FG001|Part A|Lost to Follow-up|0|||
170790802|NCT04032704|617245772|FG002|Part A|Lost to Follow-up|0|||
170790803|NCT04032704|617245773|FG003|Part A|Lost to Follow-up|0|||
170790804|NCT04032704|617245774|FG004|Part A|Lost to Follow-up|0|||
170790805|NCT04032704|617245775|FG005|Part A|Lost to Follow-up|0|||
170790806|NCT04032704|617245776|FG006|Part A|Lost to Follow-up|0|||
170790807|NCT04032704|617245777|FG007|Part A|Lost to Follow-up|0|||
170790808|NCT04032704|617245778|FG008|Part A|Lost to Follow-up|0|||
170790809|NCT04032704|617245779|FG009|Part A|Lost to Follow-up|0|||
170790810|NCT04032704|617245780|FG010|Part A|Lost to Follow-up|0|||
170790811|NCT04032704|617245781|FG011|Part A|Lost to Follow-up|0|||
170790812|NCT04032704|617245782|FG012|Part A|Lost to Follow-up|0|||
170790813|NCT04032704|617245783|FG013|Part A|Lost to Follow-up|0|||
170790814|NCT04032704|617245784|FG014|Part A|Lost to Follow-up|0|||
170790815|NCT04032704|617245785|FG015|Part A|Lost to Follow-up|0|||
170790816|NCT04032704|617245786|FG016|Part A|Lost to Follow-up|0|||
170790817|NCT04032704|617245787|FG017|Part A|Lost to Follow-up|0|||
170790818|NCT04032704|617245770|FG000|Part A|Death|9|||
170790819|NCT04032704|617245771|FG001|Part A|Death|2|||
170790820|NCT04032704|617245772|FG002|Part A|Death|10|||
170545278|NCT02400580|616340957|FG000|Overall Study|Adverse Event|1|||
170545279|NCT02400580|616340958|FG001|Overall Study|Adverse Event|0|||
170790821|NCT04032704|617245773|FG003|Part A|Death|7|||
170790822|NCT04032704|617245774|FG004|Part A|Death|4|||
170790823|NCT04032704|617245775|FG005|Part A|Death|5|||
170790824|NCT04032704|617245776|FG006|Part A|Death|0|||
170790825|NCT04032704|617245777|FG007|Part A|Death|0|||
170790826|NCT04032704|617245778|FG008|Part A|Death|0|||
170790827|NCT04032704|617245779|FG009|Part A|Death|0|||
170468027|NCT01104792|616050547|FG000|Overall Study|Lost to Follow-up|43|||
170468028|NCT01104792|616050547|FG000|Overall Study|Reasons Not Specified|27|||
170468029|NCT01104792|616050547|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
170468030|NCT01102374|616050548|FG000|Overall Study|Death|9|||
170790828|NCT04032704|617245780|FG010|Part A|Death|0|||
170790829|NCT04032704|617245781|FG011|Part A|Death|0|||
170790830|NCT04032704|617245782|FG012|Part A|Death|0|||
170468031|NCT01102374|616050549|FG001|Overall Study|Death|13|||
170468032|NCT01102374|616050548|FG000|Overall Study|Lost to Follow-up|7|||
170468033|NCT01102374|616050549|FG001|Overall Study|Lost to Follow-up|6|||
170790831|NCT04032704|617245783|FG013|Part A|Death|0|||
170790832|NCT04032704|617245784|FG014|Part A|Death|0|||
170790833|NCT04032704|617245785|FG015|Part A|Death|0|||
170790834|NCT04032704|617245786|FG016|Part A|Death|0|||
170790835|NCT04032704|617245787|FG017|Part A|Death|0|||
170468034|NCT00418821|616050550|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
170468035|NCT04428333|616050551|FG000|Overall Study|Physician Decision|5|||
170468036|NCT04428333|616050552|FG001|Overall Study|Physician Decision|6|||
170468037|NCT04428333|616050551|FG000|Overall Study|Withdrawal by Subject|1|||
170468038|NCT04428333|616050552|FG001|Overall Study|Withdrawal by Subject|3|||
170468039|NCT04428333|616050551|FG000|Overall Study|Study Terminated By Sponsor|14|||
170468040|NCT04428333|616050552|FG001|Overall Study|Study Terminated By Sponsor|16|||
170468041|NCT04853992|616050553|FG000|Treatment Period A|Adverse Event|0|||
170468042|NCT04853992|616050554|FG001|Treatment Period A|Adverse Event|1|||
170468043|NCT04853992|616050553|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
170468044|NCT04853992|616050554|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
170468045|NCT02056392|616050555|FG000|Overall Study|Lost to Follow-up|0|||
170468046|NCT02056392|616050556|FG001|Overall Study|Lost to Follow-up|1|||
170468047|NCT02056392|616050557|FG002|Overall Study|Lost to Follow-up|2|||
170468048|NCT02056392|616050558|FG003|Overall Study|Lost to Follow-up|0|||
170468049|NCT02056392|616050559|FG004|Overall Study|Lost to Follow-up|0|||
170468050|NCT02056392|616050560|FG005|Overall Study|Lost to Follow-up|0|||
170468051|NCT02056392|616050555|FG000|Overall Study|Protocol Violation|1|||
170468052|NCT02056392|616050556|FG001|Overall Study|Protocol Violation|0|||
170891063|NCT00669617|617608166|FG001|Period 3|Lost to Follow-up|0|||
170891064|NCT00669617|617608167|FG002|Period 3|Lost to Follow-up|0|||
170891065|NCT00669617|617608168|FG003|Period 3|Lost to Follow-up|0|||
170891066|NCT00669617|617608169|FG004|Period 3|Lost to Follow-up|0|||
170891067|NCT02939131|617608175|FG000|Overall Study|Unable to get to clinic|6|||
170891068|NCT02939131|617608176|FG001|Overall Study|Unable to get to clinic|4|||
170891069|NCT02939131|617608175|FG000|Overall Study|Lost to Follow-up|2|||
170891070|NCT02939131|617608176|FG001|Overall Study|Lost to Follow-up|4|||
170891071|NCT02939131|617608175|FG000|Overall Study|severe debilitation|1|||
170891072|NCT02939131|617608176|FG001|Overall Study|severe debilitation|0|||
170891073|NCT02939131|617608175|FG000|Overall Study|Other|0|||
170891074|NCT02939131|617608176|FG001|Overall Study|Other|1|||
170891075|NCT02939131|617608175|FG000|Overall Study|not willing to adhere to protocol|2|||
170891076|NCT02939131|617608176|FG001|Overall Study|not willing to adhere to protocol|0|||
170891077|NCT04033367|617608177|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
170891078|NCT04033367|617608178|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
170891079|NCT04033367|617608177|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
170891080|NCT04033367|617608178|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
170891081|NCT04033367|617608177|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
170891082|NCT04033367|617608178|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
170891083|NCT04033367|617608177|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
170891084|NCT04033367|617608178|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
170891085|NCT02723201|617608179|FG000|Second Intervention Period|Protocol Violation|1|||
170891086|NCT02723201|617608180|FG001|Second Intervention Period|Protocol Violation|0|||
170891087|NCT02723201|617608181|FG002|Second Intervention Period|Protocol Violation|0|||
170891088|NCT02723201|617608179|FG000|Second Intervention Period|Adverse Event|1|||
170891089|NCT02723201|617608180|FG001|Second Intervention Period|Adverse Event|0|||
170891090|NCT02723201|617608181|FG002|Second Intervention Period|Adverse Event|0|||
170891091|NCT02908880|617608191|FG000|Overall Study|Lost to Follow-up|4|||
170891092|NCT02908880|617608191|FG000|Overall Study|Explantation of the device|1|||
170891093|NCT02908880|617608191|FG000|Overall Study|Withdrawal by Subject|17|||
170891094|NCT02908880|617608191|FG000|Overall Study|Death|5|||
170891095|NCT03286842|617608192|FG000|Overall Study|Patients rolled over to another study|80|||
170891096|NCT03178487|617608196|FG000|Period 1|Adverse Event|1|||
170891097|NCT03178487|617608197|FG001|Period 1|Adverse Event|2|||
170891098|NCT03178487|617608196|FG000|Period 1|Withdrawal by Subject|2|||
170891099|NCT03178487|617608197|FG001|Period 1|Withdrawal by Subject|1|||
170891100|NCT03178487|617608196|FG000|Period 1|Lost to Follow-up|1|||
170891101|NCT03178487|617608197|FG001|Period 1|Lost to Follow-up|0|||
170891102|NCT03178487|617608196|FG000|Period 1|Other|0|||
170468053|NCT02056392|616050557|FG002|Overall Study|Protocol Violation|1|||
170468054|NCT02056392|616050558|FG003|Overall Study|Protocol Violation|0|||
170545280|NCT00965094|616340959|FG000|Overall Study|Adverse Event|5|||
170545281|NCT00965094|616340960|FG001|Overall Study|Adverse Event|0|||
170891103|NCT03178487|617608197|FG001|Period 1|Other|1|||
170891104|NCT03178487|617608196|FG000|Period 2|Adverse Event|4|||
170891105|NCT03178487|617608197|FG001|Period 2|Adverse Event|4|||
170891106|NCT03178487|617608196|FG000|Period 2|Withdrawal by Subject|6|||
170891107|NCT03178487|617608197|FG001|Period 2|Withdrawal by Subject|6|||
170891108|NCT03178487|617608196|FG000|Period 2|Lost to Follow-up|2|||
170891109|NCT03178487|617608197|FG001|Period 2|Lost to Follow-up|2|||
170891110|NCT03178487|617608196|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
170891111|NCT03178487|617608197|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
170468055|NCT02056392|616050559|FG004|Overall Study|Protocol Violation|0|||
170468056|NCT02056392|616050560|FG005|Overall Study|Protocol Violation|0|||
170468057|NCT02056392|616050555|FG000|Overall Study|Withdrawal by Subject|1|||
170468058|NCT02056392|616050556|FG001|Overall Study|Withdrawal by Subject|0|||
170468059|NCT02056392|616050557|FG002|Overall Study|Withdrawal by Subject|0|||
170468060|NCT02056392|616050558|FG003|Overall Study|Withdrawal by Subject|0|||
170468061|NCT02056392|616050559|FG004|Overall Study|Withdrawal by Subject|1|||
170468062|NCT02056392|616050560|FG005|Overall Study|Withdrawal by Subject|0|||
170468063|NCT00278889|616050561|FG000|Overall Study|Withdrawal by Subject|0|||
170468064|NCT00278889|616050562|FG001|Overall Study|Withdrawal by Subject|5|||
170468065|NCT00278889|616050563|FG002|Overall Study|Withdrawal by Subject|3|||
170468066|NCT00278889|616050561|FG000|Overall Study|Lost to Follow-up|1|||
170468067|NCT00278889|616050562|FG001|Overall Study|Lost to Follow-up|1|||
170468068|NCT00278889|616050563|FG002|Overall Study|Lost to Follow-up|0|||
170468069|NCT00278889|616050561|FG000|Overall Study|Death|24|||
170468070|NCT00278889|616050562|FG001|Overall Study|Death|21|||
170468071|NCT00278889|616050563|FG002|Overall Study|Death|17|||
170468072|NCT00704730|616050564|FG000|Overall Study|Adverse Event|35|||
170468073|NCT00704730|616050565|FG001|Overall Study|Adverse Event|9|||
170468074|NCT00704730|616050564|FG000|Overall Study|Death|11|||
170468075|NCT00704730|616050565|FG001|Overall Study|Death|5|||
170468076|NCT00704730|616050564|FG000|Overall Study|Physician Decision|2|||
170468077|NCT00704730|616050565|FG001|Overall Study|Physician Decision|0|||
170891112|NCT03178487|617608196|FG000|Period 2|Other|8|||
170891113|NCT03178487|617608197|FG001|Period 2|Other|7|||
170891114|NCT01340209|617608200|FG000|Overall Study|Adverse Event|1|||
170891115|NCT01340209|617608201|FG001|Overall Study|Adverse Event|1|||
170891116|NCT01340209|617608202|FG002|Overall Study|Adverse Event|2|||
170891117|NCT01340209|617608200|FG000|Overall Study|Protocol Violation|1|||
170891118|NCT01340209|617608201|FG001|Overall Study|Protocol Violation|2|||
170891119|NCT01340209|617608202|FG002|Overall Study|Protocol Violation|1|||
170891120|NCT01340209|617608200|FG000|Overall Study|Withdrawal by Subject|0|||
170891121|NCT01340209|617608201|FG001|Overall Study|Withdrawal by Subject|0|||
170891122|NCT01340209|617608202|FG002|Overall Study|Withdrawal by Subject|1|||
170891123|NCT01340209|617608200|FG000|Overall Study|Other reason not defined above|3|||
170891124|NCT01340209|617608201|FG001|Overall Study|Other reason not defined above|5|||
170891125|NCT01340209|617608202|FG002|Overall Study|Other reason not defined above|4|||
170891126|NCT03634800|617608207|FG000|Overall Study|Adverse Event|1|||
170891127|NCT03634800|617608207|FG000|Overall Study|Disease Progression|4|||
170891128|NCT03634800|617608207|FG000|Overall Study|Withdrawal by Subject|1|||
170891129|NCT02624492|617608226|FG000|Overall Study|Adverse Event|2|||
170891130|NCT02624492|617608227|FG001|Overall Study|Adverse Event|2|||
170891131|NCT02624492|617608228|FG002|Overall Study|Adverse Event|2|||
170891132|NCT02624492|617608226|FG000|Overall Study|Progressive disease|0|||
170891133|NCT02624492|617608227|FG001|Overall Study|Progressive disease|2|||
170891134|NCT02624492|617608228|FG002|Overall Study|Progressive disease|3|||
170891135|NCT00323557|617608229|FG000|Overall Study|Physician Decision|1|||
170891136|NCT00323557|617608230|FG001|Overall Study|Physician Decision|0|||
170891137|NCT01081795|617608231|FG000|Overall Study|Adverse Event|18|||
170891138|NCT01081795|617608232|FG001|Overall Study|Adverse Event|23|||
170891139|NCT01081795|617608233|FG002|Overall Study|Adverse Event|6|||
170891140|NCT01081795|617608231|FG000|Overall Study|Lack of Efficacy|7|||
170891141|NCT01081795|617608232|FG001|Overall Study|Lack of Efficacy|5|||
170891142|NCT01081795|617608233|FG002|Overall Study|Lack of Efficacy|19|||
170891143|NCT01081795|617608231|FG000|Overall Study|Subject's schedule|1|||
170891144|NCT01081795|617608232|FG001|Overall Study|Subject's schedule|1|||
170891145|NCT01081795|617608233|FG002|Overall Study|Subject's schedule|2|||
170891146|NCT01081795|617608231|FG000|Overall Study|Revocation of informed consent|2|||
170891147|NCT01081795|617608232|FG001|Overall Study|Revocation of informed consent|0|||
170891148|NCT01081795|617608233|FG002|Overall Study|Revocation of informed consent|0|||
170891149|NCT01081795|617608231|FG000|Overall Study|Ineligible for participation|1|||
170891150|NCT01081795|617608232|FG001|Overall Study|Ineligible for participation|0|||
170891151|NCT01081795|617608233|FG002|Overall Study|Ineligible for participation|0|||
170891152|NCT01081795|617608231|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
170891153|NCT01081795|617608232|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
170891154|NCT01081795|617608233|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
170891155|NCT01081795|617608231|FG000|Overall Study|Using drug with restricted days of use|2|||
170468078|NCT00704730|616050564|FG000|Overall Study|Did not receive drug|5|||
170468079|NCT00704730|616050565|FG001|Overall Study|Did not receive drug|2|||
170468080|NCT00704730|616050564|FG000|Overall Study|Disease progression per PI|58|||
170468081|NCT00704730|616050565|FG001|Overall Study|Disease progression per PI|67|||
170468082|NCT00704730|616050564|FG000|Overall Study|data unavailable|1|||
170891156|NCT01081795|617608232|FG001|Overall Study|Using drug with restricted days of use|3|||
170891157|NCT01081795|617608233|FG002|Overall Study|Using drug with restricted days of use|2|||
170891158|NCT01081795|617608231|FG000|Overall Study|Other|1|||
170891159|NCT01081795|617608232|FG001|Overall Study|Other|2|||
170891160|NCT01081795|617608233|FG002|Overall Study|Other|0|||
170891161|NCT00430508|617608239|FG000|Overall Study|Adverse Event|2|||
170891162|NCT00430508|617608240|FG001|Overall Study|Adverse Event|3|||
170468083|NCT00704730|616050565|FG001|Overall Study|data unavailable|0|||
170891163|NCT00430508|617608241|FG002|Overall Study|Adverse Event|5|||
170468084|NCT00704730|616050564|FG000|Overall Study|Withdrawal by Subject|9|||
170468085|NCT00704730|616050565|FG001|Overall Study|Withdrawal by Subject|13|||
170468086|NCT06492226|616052240|FG000|Overall Study|Protocol Violation|1|||
170468087|NCT06492226|616052241|FG001|Overall Study|Protocol Violation|0|||
170468088|NCT06492226|616052242|FG002|Overall Study|Protocol Violation|1|||
170468089|NCT06492226|616052243|FG003|Overall Study|Protocol Violation|0|||
170468090|NCT06492226|616052244|FG004|Overall Study|Protocol Violation|0|||
170468091|NCT06492226|616052245|FG005|Overall Study|Protocol Violation|0|||
170468092|NCT05016960|616052246|FG000|Overall Study|Withdrawal by Subject|1|||
170468093|NCT05016960|616052247|FG001|Overall Study|Withdrawal by Subject|9|||
170468094|NCT04034927|616052248|FG000|Overall Study|Adverse Event|4|||
170468095|NCT04034927|616052249|FG001|Overall Study|Adverse Event|9|||
170468096|NCT04034927|616052248|FG000|Overall Study|Death|0|||
170468097|NCT04034927|616052249|FG001|Overall Study|Death|1|||
170468098|NCT04034927|616052248|FG000|Overall Study|Withdrawal by Subject|0|||
170468099|NCT04034927|616052249|FG001|Overall Study|Withdrawal by Subject|3|||
170468100|NCT04034927|616052248|FG000|Overall Study|Still on Treatment|2|||
170468101|NCT04034927|616052249|FG001|Overall Study|Still on Treatment|1|||
170468102|NCT04034927|616052248|FG000|Overall Study|Other|1|||
170545282|NCT00965094|616340959|FG000|Overall Study|Lost to Follow-up|0|||
170790836|NCT04032704|617245770|FG000|Part B|Other|0|||
170790837|NCT04032704|617245771|FG001|Part B|Other|0|||
170790838|NCT04032704|617245772|FG002|Part B|Other|0|||
170790839|NCT04032704|617245773|FG003|Part B|Other|0|||
170790840|NCT04032704|617245774|FG004|Part B|Other|0|||
170790841|NCT04032704|617245775|FG005|Part B|Other|0|||
170790842|NCT04032704|617245776|FG006|Part B|Other|0|||
170790843|NCT04032704|617245777|FG007|Part B|Other|1|||
170790844|NCT04032704|617245778|FG008|Part B|Other|2|||
170790845|NCT04032704|617245779|FG009|Part B|Other|1|||
170790846|NCT04032704|617245780|FG010|Part B|Other|1|||
170790847|NCT04032704|617245781|FG011|Part B|Other|1|||
170790848|NCT04032704|617245782|FG012|Part B|Other|5|||
170790849|NCT04032704|617245783|FG013|Part B|Other|13|||
170790850|NCT04032704|617245784|FG014|Part B|Other|0|||
170790851|NCT04032704|617245785|FG015|Part B|Other|0|||
170790852|NCT04032704|617245786|FG016|Part B|Other|0|||
170790853|NCT04032704|617245787|FG017|Part B|Other|0|||
170790854|NCT04032704|617245770|FG000|Part B|Study termination by Sponsor|0|||
170790855|NCT04032704|617245771|FG001|Part B|Study termination by Sponsor|0|||
170790856|NCT04032704|617245772|FG002|Part B|Study termination by Sponsor|0|||
170790857|NCT04032704|617245773|FG003|Part B|Study termination by Sponsor|0|||
170790858|NCT04032704|617245774|FG004|Part B|Study termination by Sponsor|0|||
170790859|NCT04032704|617245775|FG005|Part B|Study termination by Sponsor|0|||
170790860|NCT04032704|617245776|FG006|Part B|Study termination by Sponsor|0|||
170790861|NCT04032704|617245777|FG007|Part B|Study termination by Sponsor|0|||
170790862|NCT04032704|617245778|FG008|Part B|Study termination by Sponsor|1|||
170790863|NCT04032704|617245779|FG009|Part B|Study termination by Sponsor|0|||
170790864|NCT04032704|617245780|FG010|Part B|Study termination by Sponsor|0|||
170790865|NCT04032704|617245781|FG011|Part B|Study termination by Sponsor|0|||
170790866|NCT04032704|617245782|FG012|Part B|Study termination by Sponsor|0|||
170790867|NCT04032704|617245783|FG013|Part B|Study termination by Sponsor|0|||
170790868|NCT04032704|617245784|FG014|Part B|Study termination by Sponsor|0|||
170790869|NCT04032704|617245785|FG015|Part B|Study termination by Sponsor|0|||
170790870|NCT04032704|617245786|FG016|Part B|Study termination by Sponsor|0|||
170790871|NCT04032704|617245787|FG017|Part B|Study termination by Sponsor|0|||
170790872|NCT04032704|617245770|FG000|Part B|Withdrawal by Subject|0|||
170790873|NCT04032704|617245771|FG001|Part B|Withdrawal by Subject|0|||
170790874|NCT04032704|617245772|FG002|Part B|Withdrawal by Subject|0|||
170790875|NCT04032704|617245773|FG003|Part B|Withdrawal by Subject|0|||
170790876|NCT04032704|617245774|FG004|Part B|Withdrawal by Subject|0|||
170790877|NCT04032704|617245775|FG005|Part B|Withdrawal by Subject|0|||
170790878|NCT04032704|617245776|FG006|Part B|Withdrawal by Subject|3|||
170790879|NCT04032704|617245777|FG007|Part B|Withdrawal by Subject|2|||
170545283|NCT00965094|616340960|FG001|Overall Study|Lost to Follow-up|1|||
170545284|NCT01060111|616340961|FG000|Overall Study|Adverse Event|9|||
170790880|NCT04032704|617245778|FG008|Part B|Withdrawal by Subject|2|||
170468103|NCT04034927|616052249|FG001|Overall Study|Other|1|||
170468104|NCT00287586|616052250|FG000|Overall Study|Withdrew Consent|19|||
170468105|NCT00287586|616052251|FG001|Overall Study|Withdrew Consent|30|||
170545285|NCT01060111|616340962|FG001|Overall Study|Adverse Event|5|||
170790881|NCT04032704|617245779|FG009|Part B|Withdrawal by Subject|1|||
170790882|NCT04032704|617245780|FG010|Part B|Withdrawal by Subject|4|||
170790883|NCT04032704|617245781|FG011|Part B|Withdrawal by Subject|6|||
170790884|NCT04032704|617245782|FG012|Part B|Withdrawal by Subject|2|||
170790885|NCT04032704|617245783|FG013|Part B|Withdrawal by Subject|1|||
170468106|NCT00287586|616052250|FG000|Overall Study|Lost to Follow-up|5|||
170790886|NCT04032704|617245784|FG014|Part B|Withdrawal by Subject|0|||
170790887|NCT04032704|617245785|FG015|Part B|Withdrawal by Subject|1|||
170790888|NCT04032704|617245786|FG016|Part B|Withdrawal by Subject|0|||
170790889|NCT04032704|617245787|FG017|Part B|Withdrawal by Subject|0|||
170790890|NCT04032704|617245770|FG000|Part B|Lost to Follow-up|0|||
170468107|NCT00287586|616052251|FG001|Overall Study|Lost to Follow-up|4|||
170468108|NCT00287586|616052250|FG000|Overall Study|Death|2|||
170468109|NCT00287586|616052251|FG001|Overall Study|Death|3|||
170468110|NCT00287586|616052250|FG000|Overall Study|Elevated Hematocrit|3|||
170468111|NCT00287586|616052251|FG001|Overall Study|Elevated Hematocrit|0|||
170468112|NCT00287586|616052250|FG000|Overall Study|Rash|3|||
170468113|NCT00287586|616052251|FG001|Overall Study|Rash|0|||
170468114|NCT00287586|616052250|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
170891164|NCT00430508|617608242|FG003|Overall Study|Adverse Event|3|||
170891165|NCT00430508|617608239|FG000|Overall Study|Withdrawal by Subject|0|||
170891166|NCT00430508|617608240|FG001|Overall Study|Withdrawal by Subject|1|||
170891167|NCT00430508|617608241|FG002|Overall Study|Withdrawal by Subject|1|||
170891168|NCT00430508|617608242|FG003|Overall Study|Withdrawal by Subject|1|||
170891169|NCT00430508|617608239|FG000|Overall Study|responder at visit 4|0|||
170891170|NCT00430508|617608240|FG001|Overall Study|responder at visit 4|0|||
170891171|NCT00430508|617608241|FG002|Overall Study|responder at visit 4|2|||
170891172|NCT00430508|617608242|FG003|Overall Study|responder at visit 4|0|||
170891173|NCT00430508|617608239|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
170891174|NCT00430508|617608240|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
170891175|NCT00430508|617608241|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
170891176|NCT00430508|617608242|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
170891177|NCT00430508|617608239|FG000|Overall Study|Other|1|||
170891178|NCT00430508|617608240|FG001|Overall Study|Other|1|||
170891179|NCT00430508|617608241|FG002|Overall Study|Other|3|||
170891180|NCT00430508|617608242|FG003|Overall Study|Other|0|||
170891181|NCT03433781|617608243|FG000|Overall Study|Progression of Disease|1|||
170891182|NCT03433781|617608244|FG001|Overall Study|Progression of Disease|0|||
170891183|NCT03433781|617608245|FG002|Overall Study|Progression of Disease|0|||
170891184|NCT03433781|617608243|FG000|Overall Study|Physician Decision|0|||
170891185|NCT03433781|617608244|FG001|Overall Study|Physician Decision|1|||
170891186|NCT03433781|617608245|FG002|Overall Study|Physician Decision|0|||
170891187|NCT02809833|617608247|FG000|Overall Study|Death|3|||
170468115|NCT00287586|616052251|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
170468116|NCT00287586|616052250|FG000|Overall Study|Stroke|2|||
170468117|NCT00287586|616052251|FG001|Overall Study|Stroke|0|||
170468118|NCT00287586|616052250|FG000|Overall Study|Myocardial Infarction|1|||
170468119|NCT00287586|616052251|FG001|Overall Study|Myocardial Infarction|0|||
170468120|NCT00287586|616052250|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
170468121|NCT00287586|616052251|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
170468122|NCT00287586|616052250|FG000|Overall Study|Cognitive Impairment|1|||
170468123|NCT00287586|616052251|FG001|Overall Study|Cognitive Impairment|0|||
170468124|NCT00287586|616052250|FG000|Overall Study|Pancreatic Cancer|1|||
170468125|NCT00287586|616052251|FG001|Overall Study|Pancreatic Cancer|3|||
170468126|NCT00287586|616052250|FG000|Overall Study|Sleep Apnea|1|||
170468127|NCT00287586|616052251|FG001|Overall Study|Sleep Apnea|0|||
170468128|NCT00287586|616052250|FG000|Overall Study|Shoulder Pain|1|||
170468129|NCT00287586|616052251|FG001|Overall Study|Shoulder Pain|0|||
170468130|NCT00287586|616052250|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
170468131|NCT00287586|616052251|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
170468132|NCT00287586|616052250|FG000|Overall Study|Nonadherence|1|||
170468133|NCT00287586|616052251|FG001|Overall Study|Nonadherence|1|||
170468134|NCT00287586|616052250|FG000|Overall Study|Enrolled in Another Study|1|||
170468135|NCT00287586|616052251|FG001|Overall Study|Enrolled in Another Study|0|||
170468136|NCT00287586|616052250|FG000|Overall Study|Major Depression|0|||
170468137|NCT00287586|616052251|FG001|Overall Study|Major Depression|2|||
170545286|NCT01060111|616340963|FG002|Overall Study|Adverse Event|18|||
170891188|NCT02809833|617608247|FG000|Overall Study|Intolerance|54|||
170891189|NCT02809833|617608247|FG000|Overall Study|Lack of Efficacy|89|||
170891190|NCT02809833|617608247|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
170891191|NCT02809833|617608247|FG000|Overall Study|Noncompliance|1|||
170891192|NCT02809833|617608247|FG000|Overall Study|Withdrawal by Subject|34|||
170891193|NCT02809833|617608247|FG000|Overall Study|Lost to Follow-up|35|||
170468138|NCT00287586|616052250|FG000|Overall Study|Lung Cancer|0|||
170468139|NCT00287586|616052251|FG001|Overall Study|Lung Cancer|2|||
170468140|NCT00287586|616052250|FG000|Overall Study|Elevated IPSS Score|0|||
170468141|NCT00287586|616052251|FG001|Overall Study|Elevated IPSS Score|1|||
170468142|NCT00287586|616052250|FG000|Overall Study|Retroperitoneal Cancer|0|||
170545287|NCT01060111|616340961|FG000|Overall Study|Lack of Efficacy|2|||
170468143|NCT00287586|616052251|FG001|Overall Study|Retroperitoneal Cancer|1|||
170468144|NCT00287586|616052250|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
170468145|NCT00287586|616052251|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
170545288|NCT01060111|616340962|FG001|Overall Study|Lack of Efficacy|1|||
170891194|NCT02809833|617608247|FG000|Overall Study|Adverse Event (AE)|24|||
170891195|NCT02809833|617608247|FG000|Overall Study|Other|5|||
170891196|NCT02809833|617608247|FG000|Overall Study|Missing Information|52|||
170891197|NCT00408694|617608248|FG000|Overall Study|Ineligible|1|||
170891198|NCT00408694|617608248|FG000|Overall Study|No protocol treatment|1|||
170891199|NCT03889639|617608249|FG000|Overall Study|Withdrawal by Subject|0|||
170468146|NCT00287586|616052250|FG000|Overall Study|Mood Swings and Irritability|0|||
170468147|NCT00287586|616052251|FG001|Overall Study|Mood Swings and Irritability|1|||
170468148|NCT00287586|616052250|FG000|Overall Study|Bradycardia|0|||
170468149|NCT00287586|616052251|FG001|Overall Study|Bradycardia|1|||
170468150|NCT00287586|616052250|FG000|Overall Study|Itchy Swollen Eyes|0|||
170468151|NCT00287586|616052251|FG001|Overall Study|Itchy Swollen Eyes|1|||
170468152|NCT00287586|616052250|FG000|Overall Study|Recurrent Melanoma|0|||
170468153|NCT00287586|616052251|FG001|Overall Study|Recurrent Melanoma|1|||
170468154|NCT00856375|616052252|FG000|Overall Study|Other|0|||
170468155|NCT00856375|616052253|FG001|Overall Study|Other|1|||
170468156|NCT00856375|616052252|FG000|Overall Study|Death|32|||
170468157|NCT00856375|616052253|FG001|Overall Study|Death|30|||
170468158|NCT00856375|616052252|FG000|Overall Study|Sponsor Terminated Study|7|||
170468159|NCT00856375|616052253|FG001|Overall Study|Sponsor Terminated Study|7|||
170468160|NCT00856375|616052252|FG000|Overall Study|Withdrawal by Subject|2|||
170468161|NCT00856375|616052253|FG001|Overall Study|Withdrawal by Subject|1|||
170468162|NCT00856375|616052252|FG000|Overall Study|Lost to Follow-up|1|||
170468163|NCT00856375|616052253|FG001|Overall Study|Lost to Follow-up|2|||
170468164|NCT02538965|616052256|FG000|Treatment Period|Other = Death due to disease progression|1|||
170468165|NCT02538965|616052256|FG000|Treatment Period|Adverse Event|2|||
170468166|NCT02538965|616052256|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
170468167|NCT02538965|616052256|FG000|Treatment Period|Treatment Failure|9|||
170468168|NCT02538965|616052256|FG000|Treatment Period|Disease Progression|1|||
170468169|NCT02538965|616052256|FG000|Treatment Period|Physician Decision|2|||
170468170|NCT02538965|616052256|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
170468171|NCT02538965|616052256|FG000|Follow-Up Period|Withdrawal by Parent|4|||
170468172|NCT00875797|616052257|FG000|Overall Study|Protocol Violation|6|||
170468173|NCT00875797|616052258|FG001|Overall Study|Protocol Violation|3|||
170468174|NCT00741286|616052259|FG000|Overall Study|Lost to Follow-up|15|||
170468175|NCT00741286|616052260|FG001|Overall Study|Lost to Follow-up|10|||
170468176|NCT00741286|616052259|FG000|Overall Study|Adverse Event|1|||
170468177|NCT00741286|616052260|FG001|Overall Study|Adverse Event|6|||
170468178|NCT00741286|616052259|FG000|Overall Study|Protocol Violation|3|||
170468179|NCT00741286|616052260|FG001|Overall Study|Protocol Violation|2|||
170468180|NCT00741286|616052259|FG000|Overall Study|Primary Outcome|1|||
170468181|NCT00741286|616052260|FG001|Overall Study|Primary Outcome|1|||
170468182|NCT00425373|616052261|FG000|Overall Study|Adverse Event|2|||
170468183|NCT00425373|616052262|FG001|Overall Study|Adverse Event|2|||
170468184|NCT00425373|616052263|FG002|Overall Study|Adverse Event|0|||
170468185|NCT00425373|616052264|FG003|Overall Study|Adverse Event|1|||
170468186|NCT00425373|616052265|FG004|Overall Study|Adverse Event|4|||
170468187|NCT00425373|616052266|FG005|Overall Study|Adverse Event|6|||
170468188|NCT00425373|616052267|FG006|Overall Study|Adverse Event|2|||
170468189|NCT00425373|616052268|FG007|Overall Study|Adverse Event|3|||
170468190|NCT00425373|616052269|FG008|Overall Study|Adverse Event|8|||
170468191|NCT00425373|616052261|FG000|Overall Study|Lost to Follow-up|0|||
170468192|NCT00425373|616052262|FG001|Overall Study|Lost to Follow-up|1|||
170468193|NCT00425373|616052263|FG002|Overall Study|Lost to Follow-up|0|||
170468194|NCT00425373|616052264|FG003|Overall Study|Lost to Follow-up|0|||
170468195|NCT00425373|616052265|FG004|Overall Study|Lost to Follow-up|1|||
170468196|NCT00425373|616052266|FG005|Overall Study|Lost to Follow-up|0|||
170468197|NCT00425373|616052267|FG006|Overall Study|Lost to Follow-up|0|||
170468198|NCT00425373|616052268|FG007|Overall Study|Lost to Follow-up|0|||
170468199|NCT00425373|616052269|FG008|Overall Study|Lost to Follow-up|0|||
170790891|NCT04032704|617245771|FG001|Part B|Lost to Follow-up|0|||
170790892|NCT04032704|617245772|FG002|Part B|Lost to Follow-up|0|||
170790893|NCT04032704|617245773|FG003|Part B|Lost to Follow-up|0|||
170790894|NCT04032704|617245774|FG004|Part B|Lost to Follow-up|0|||
170790895|NCT04032704|617245775|FG005|Part B|Lost to Follow-up|0|||
170468200|NCT00425373|616052261|FG000|Overall Study|Protocol Violation|1|||
170545289|NCT01060111|616340963|FG002|Overall Study|Lack of Efficacy|0|||
170545290|NCT01060111|616340961|FG000|Overall Study|Inappropriate participant|5|||
170545291|NCT01060111|616340962|FG001|Overall Study|Inappropriate participant|4|||
170790896|NCT04032704|617245776|FG006|Part B|Lost to Follow-up|0|||
170468201|NCT00425373|616052262|FG001|Overall Study|Protocol Violation|0|||
170468202|NCT00425373|616052263|FG002|Overall Study|Protocol Violation|1|||
170468203|NCT00425373|616052264|FG003|Overall Study|Protocol Violation|0|||
170468204|NCT00425373|616052265|FG004|Overall Study|Protocol Violation|0|||
170468205|NCT00425373|616052266|FG005|Overall Study|Protocol Violation|0|||
170468206|NCT00425373|616052267|FG006|Overall Study|Protocol Violation|0|||
170468207|NCT00425373|616052268|FG007|Overall Study|Protocol Violation|5|||
170790897|NCT04032704|617245777|FG007|Part B|Lost to Follow-up|0|||
170468208|NCT00425373|616052269|FG008|Overall Study|Protocol Violation|3|||
170468209|NCT00425373|616052261|FG000|Overall Study|Withdrawal by Subject|2|||
170468210|NCT00425373|616052262|FG001|Overall Study|Withdrawal by Subject|0|||
170468211|NCT00425373|616052263|FG002|Overall Study|Withdrawal by Subject|2|||
170468212|NCT00425373|616052264|FG003|Overall Study|Withdrawal by Subject|1|||
170468213|NCT00425373|616052265|FG004|Overall Study|Withdrawal by Subject|4|||
170468214|NCT00425373|616052266|FG005|Overall Study|Withdrawal by Subject|0|||
170468215|NCT00425373|616052267|FG006|Overall Study|Withdrawal by Subject|2|||
170468216|NCT00425373|616052268|FG007|Overall Study|Withdrawal by Subject|2|||
170468217|NCT00425373|616052269|FG008|Overall Study|Withdrawal by Subject|2|||
170468218|NCT00425373|616052261|FG000|Overall Study|Lack of Efficacy|0|||
170468219|NCT00425373|616052262|FG001|Overall Study|Lack of Efficacy|0|||
170468220|NCT00425373|616052263|FG002|Overall Study|Lack of Efficacy|0|||
170468221|NCT00425373|616052264|FG003|Overall Study|Lack of Efficacy|0|||
170468222|NCT00425373|616052265|FG004|Overall Study|Lack of Efficacy|1|||
170468223|NCT00425373|616052266|FG005|Overall Study|Lack of Efficacy|3|||
170468224|NCT00425373|616052267|FG006|Overall Study|Lack of Efficacy|3|||
170468225|NCT00425373|616052268|FG007|Overall Study|Lack of Efficacy|0|||
170468226|NCT00425373|616052269|FG008|Overall Study|Lack of Efficacy|5|||
170468227|NCT01307111|616052279|FG000|IUD Insertion|Lost to Follow-up|2|||
170468228|NCT01307111|616052280|FG001|IUD Insertion|Lost to Follow-up|0|||
170468229|NCT01307111|616052279|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
170468230|NCT01307111|616052280|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
170468231|NCT02114385|616052282|FG000|Overall Study|Withdrawal by Subject|3|||
170468232|NCT02114385|616052283|FG001|Overall Study|Withdrawal by Subject|2|||
170468233|NCT02114385|616052282|FG000|Overall Study|Lost to Follow-up|0|||
170468234|NCT02114385|616052283|FG001|Overall Study|Lost to Follow-up|6|||
170468235|NCT02842073|616052285|FG000|Overall Study|Withdrawal by Subject|1|||
170468236|NCT00195338|616052286|FG000|Overall Study|Lost to Follow-up|2|||
170468237|NCT00195338|616052286|FG000|Overall Study|Adverse Event|5|||
170468238|NCT00195338|616052286|FG000|Overall Study|Lack of Efficacy|1|||
170468239|NCT00195338|616052286|FG000|Overall Study|Early closure of the site|4|||
170468240|NCT00582010|616052289|FG000|Overall Study|Death|0|||
170468241|NCT00582010|616052290|FG001|Overall Study|Death|1|||
170468242|NCT05320887|616052298|FG000|Overall Study|Lost to Follow-up|0|||
170468243|NCT05320887|616052299|FG001|Overall Study|Lost to Follow-up|3|||
170468244|NCT05320887|616052300|FG002|Overall Study|Lost to Follow-up|0|||
170468245|NCT05320887|616052301|FG003|Overall Study|Lost to Follow-up|0|||
170468246|NCT01371539|616052304|FG000|Period One: One Week|Lost to Follow-up|0|||
170468247|NCT01371539|616052305|FG001|Period One: One Week|Lost to Follow-up|1|||
170468248|NCT01371539|616052304|FG000|Period Two: One Week|Lost to Follow-up|0|||
170468249|NCT01371539|616052305|FG001|Period Two: One Week|Lost to Follow-up|1|||
170468250|NCT01371539|616052304|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
170468251|NCT01371539|616052305|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
170468252|NCT01371539|616052304|FG000|Period Two: One Week|Time/job conflict|0|||
170468253|NCT01371539|616052305|FG001|Period Two: One Week|Time/job conflict|1|||
170790898|NCT04032704|617245778|FG008|Part B|Lost to Follow-up|0|||
170790899|NCT04032704|617245779|FG009|Part B|Lost to Follow-up|0|||
170790900|NCT04032704|617245780|FG010|Part B|Lost to Follow-up|0|||
170790901|NCT04032704|617245781|FG011|Part B|Lost to Follow-up|1|||
170790902|NCT04032704|617245782|FG012|Part B|Lost to Follow-up|0|||
170790903|NCT04032704|617245783|FG013|Part B|Lost to Follow-up|0|||
170790904|NCT04032704|617245784|FG014|Part B|Lost to Follow-up|0|||
170790905|NCT04032704|617245785|FG015|Part B|Lost to Follow-up|0|||
170790906|NCT04032704|617245786|FG016|Part B|Lost to Follow-up|0|||
170790907|NCT04032704|617245787|FG017|Part B|Lost to Follow-up|0|||
170790908|NCT04032704|617245770|FG000|Part B|Death|0|||
170790909|NCT04032704|617245771|FG001|Part B|Death|0|||
170790910|NCT04032704|617245772|FG002|Part B|Death|0|||
170790911|NCT04032704|617245773|FG003|Part B|Death|0|||
170790912|NCT04032704|617245774|FG004|Part B|Death|0|||
170790913|NCT04032704|617245775|FG005|Part B|Death|0|||
170790914|NCT04032704|617245776|FG006|Part B|Death|13|||
170790915|NCT04032704|617245777|FG007|Part B|Death|13|||
170790916|NCT04032704|617245778|FG008|Part B|Death|14|||
170790917|NCT04032704|617245779|FG009|Part B|Death|12|||
170468254|NCT01399658|616052306|FG000|Overall Study|Ineligible|1|||
170468255|NCT01399658|616052306|FG000|Overall Study|Machine Technical Issue|3|||
170468256|NCT01399658|616052306|FG000|Overall Study|Alternative therapy|1|||
170468257|NCT01399658|616052306|FG000|Overall Study|No reason given|1|||
170790918|NCT04032704|617245780|FG010|Part B|Death|12|||
170790919|NCT04032704|617245781|FG011|Part B|Death|13|||
170790920|NCT04032704|617245782|FG012|Part B|Death|7|||
170790921|NCT04032704|617245783|FG013|Part B|Death|17|||
170790922|NCT04032704|617245784|FG014|Part B|Death|2|||
170790923|NCT04032704|617245785|FG015|Part B|Death|1|||
170790924|NCT04032704|617245786|FG016|Part B|Death|2|||
170468258|NCT04315506|616052308|FG000|Overall Study|Lost to Follow-up|74|||
170468259|NCT04315506|616052309|FG001|Overall Study|Lost to Follow-up|82|||
170468260|NCT04315506|616052308|FG000|Overall Study|Withdrawal by Subject|8|||
170468261|NCT04315506|616052309|FG001|Overall Study|Withdrawal by Subject|8|||
170468262|NCT04315506|616052308|FG000|Overall Study|Physician Decision|0|||
170468263|NCT04315506|616052309|FG001|Overall Study|Physician Decision|1|||
170468264|NCT01721317|616052310|FG000|Overall Study|Study Closed / Terminated|2|||
170790925|NCT04032704|617245787|FG017|Part B|Death|2|||
170790926|NCT06103188|617245790|FG000|Overall Study|Lost to Follow-up|1|||
170790927|NCT06103188|617245791|FG001|Overall Study|Lost to Follow-up|6|||
170790928|NCT06103188|617245792|FG002|Overall Study|Lost to Follow-up|4|||
170468265|NCT01721317|616052311|FG001|Overall Study|Study Closed / Terminated|2|||
170468266|NCT01721317|616052310|FG000|Overall Study|Physician Decision|0|||
170468267|NCT01721317|616052311|FG001|Overall Study|Physician Decision|1|||
170468268|NCT01721317|616052310|FG000|Overall Study|Withdrawal by Subject|0|||
170468269|NCT01721317|616052311|FG001|Overall Study|Withdrawal by Subject|1|||
170468270|NCT02661217|616052312|FG000|Overall Study|Physician Decision|12|||
170468271|NCT02661217|616052313|FG001|Overall Study|Physician Decision|15|||
170468272|NCT02661217|616052312|FG000|Overall Study|Lost to Follow-up|1|||
170468273|NCT02661217|616052313|FG001|Overall Study|Lost to Follow-up|4|||
170468274|NCT02661217|616052312|FG000|Overall Study|Protocol Deviation|0|||
170468275|NCT02661217|616052313|FG001|Overall Study|Protocol Deviation|4|||
170468276|NCT02661217|616052312|FG000|Overall Study|Non-compliance with study treatment|5|||
170468277|NCT02661217|616052313|FG001|Overall Study|Non-compliance with study treatment|5|||
170468278|NCT02661217|616052312|FG000|Overall Study|Death|21|||
170468279|NCT02661217|616052313|FG001|Overall Study|Death|15|||
170468280|NCT02661217|616052312|FG000|Overall Study|Adverse Event|10|||
170468281|NCT02661217|616052313|FG001|Overall Study|Adverse Event|8|||
170790929|NCT02969707|617245795|FG000|Overall Study|Withdrawal by Subject|6|||
170790930|NCT02969707|617245796|FG001|Overall Study|Withdrawal by Subject|5|||
170790931|NCT02969707|617245795|FG000|Overall Study|Severe anxiety|0|||
170790932|NCT02969707|617245796|FG001|Overall Study|Severe anxiety|1|||
170790933|NCT02969707|617245795|FG000|Overall Study|Positive toxicology screen|0|||
170790934|NCT02969707|617245796|FG001|Overall Study|Positive toxicology screen|2|||
170790935|NCT02969707|617245795|FG000|Overall Study|Claustrophobia|2|||
170790936|NCT02969707|617245796|FG001|Overall Study|Claustrophobia|2|||
170790937|NCT02969707|617245795|FG000|Overall Study|Non-compliance|1|||
170790938|NCT02969707|617245796|FG001|Overall Study|Non-compliance|2|||
170790939|NCT04298983|617245799|FG000|Overall Study|Adverse Event|4|||
170790940|NCT04298983|617245799|FG000|Overall Study|Lack of Efficacy|3|||
170790941|NCT05583578|617245802|FG000|Overall Study|Withdrawal by Subject|2|||
170790942|NCT05583578|617245803|FG001|Overall Study|Withdrawal by Subject|0|||
170790943|NCT04103580|617245804|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
170790944|NCT04103580|617245805|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
170790945|NCT04103580|617245804|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
170790946|NCT04103580|617245805|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
170790947|NCT04103580|617245804|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
170790948|NCT04103580|617245805|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
170790949|NCT04103580|617245804|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
170790950|NCT04103580|617245805|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
170790951|NCT04103580|617245804|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
170790952|NCT04103580|617245805|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
170790953|NCT04103580|617245804|FG000|Phase 1 Active Caregiving|Other|3|||
170790954|NCT04103580|617245805|FG001|Phase 1 Active Caregiving|Other|3|||
170790955|NCT04103580|617245804|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
170790956|NCT04103580|617245805|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
170790957|NCT04103580|617245804|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
170790958|NCT04103580|617245805|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
170790959|NCT04103580|617245804|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
170790960|NCT04103580|617245805|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
170790961|NCT04103580|617245804|FG000|Phase 2 Bereavement|Other|8|||
170790962|NCT04103580|617245805|FG001|Phase 2 Bereavement|Other|6|||
170891200|NCT03889639|617608250|FG001|Overall Study|Withdrawal by Subject|0|||
170891201|NCT03889639|617608251|FG002|Overall Study|Withdrawal by Subject|0|||
170891202|NCT03889639|617608252|FG003|Overall Study|Withdrawal by Subject|0|||
170891203|NCT03889639|617608253|FG004|Overall Study|Withdrawal by Subject|0|||
170891204|NCT03889639|617608254|FG005|Overall Study|Withdrawal by Subject|0|||
170891205|NCT03889639|617608255|FG006|Overall Study|Withdrawal by Subject|0|||
170891206|NCT03889639|617608256|FG007|Overall Study|Withdrawal by Subject|1|||
170891207|NCT00087646|617608257|FG000|Overall Study|Adverse Event|37|||
170891208|NCT00087646|617608258|FG001|Overall Study|Adverse Event|6|||
170891209|NCT00087646|617608259|FG002|Overall Study|Adverse Event|18|||
170891210|NCT00087646|617608260|FG003|Overall Study|Adverse Event|20|||
170891211|NCT00087646|617608257|FG000|Overall Study|Death|0|||
170891212|NCT00087646|617608258|FG001|Overall Study|Death|1|||
170891213|NCT00087646|617608259|FG002|Overall Study|Death|0|||
170891214|NCT00087646|617608260|FG003|Overall Study|Death|0|||
170891215|NCT00087646|617608257|FG000|Overall Study|Withdrawal by Subject|6|||
170891216|NCT00087646|617608258|FG001|Overall Study|Withdrawal by Subject|1|||
170891217|NCT00087646|617608259|FG002|Overall Study|Withdrawal by Subject|2|||
170891218|NCT00087646|617608260|FG003|Overall Study|Withdrawal by Subject|2|||
170891219|NCT00087646|617608257|FG000|Overall Study|Insufficient therapeutic response|64|||
170891220|NCT00087646|617608258|FG001|Overall Study|Insufficient therapeutic response|24|||
170891221|NCT00087646|617608259|FG002|Overall Study|Insufficient therapeutic response|38|||
170891222|NCT00087646|617608260|FG003|Overall Study|Insufficient therapeutic response|51|||
170891223|NCT00087646|617608257|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
170891224|NCT00087646|617608258|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
170891225|NCT00087646|617608259|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
170891226|NCT00087646|617608260|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
170891227|NCT00087646|617608257|FG000|Overall Study|Failure to Return|5|||
170891228|NCT00087646|617608258|FG001|Overall Study|Failure to Return|2|||
170891229|NCT00087646|617608259|FG002|Overall Study|Failure to Return|2|||
170891230|NCT00087646|617608260|FG003|Overall Study|Failure to Return|3|||
170891231|NCT00087646|617608257|FG000|Overall Study|Administrative/Other|6|||
170891232|NCT00087646|617608258|FG001|Overall Study|Administrative/Other|1|||
170891233|NCT00087646|617608259|FG002|Overall Study|Administrative/Other|1|||
170891234|NCT00087646|617608260|FG003|Overall Study|Administrative/Other|2|||
170891235|NCT00087646|617608257|FG000|Overall Study|Other Protocol Violation|3|||
170891236|NCT00087646|617608258|FG001|Overall Study|Other Protocol Violation|1|||
170891237|NCT00087646|617608259|FG002|Overall Study|Other Protocol Violation|0|||
170891238|NCT00087646|617608260|FG003|Overall Study|Other Protocol Violation|0|||
170891239|NCT00087646|617608257|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
170891240|NCT00087646|617608258|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
170891241|NCT00087646|617608259|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
170891242|NCT00087646|617608260|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
170891243|NCT02883244|617608261|FG000|Overall Study|Lost to Follow-up|0|||
170891244|NCT02883244|617608262|FG001|Overall Study|Lost to Follow-up|1|||
170891245|NCT01665144|617608270|FG000|Core Part|Withdrawal by Subject|96|||
170891246|NCT01665144|617608271|FG001|Core Part|Withdrawal by Subject|77|||
170891247|NCT01665144|617608272|FG002|Core Part|Withdrawal by Subject|0|||
170891248|NCT01665144|617608270|FG000|Core Part|Adverse Event|45|||
170468282|NCT02661217|616052312|FG000|Overall Study|Withdrawal by Subject|15|||
170468283|NCT02661217|616052313|FG001|Overall Study|Withdrawal by Subject|19|||
170468284|NCT02661217|616052312|FG000|Overall Study|Did not enter follow-up epoch|7|||
170468285|NCT02661217|616052313|FG001|Overall Study|Did not enter follow-up epoch|10|||
170468286|NCT02661217|616052312|FG000|Overall Study|Death - no study drug received|1|||
170468287|NCT02661217|616052313|FG001|Overall Study|Death - no study drug received|2|||
170468288|NCT02661217|616052312|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
170468289|NCT02661217|616052313|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
170468290|NCT02892149|616052323|FG000|Overall Study|Death|262|||
170468291|NCT02892149|616052324|FG001|Overall Study|Death|278|||
170468292|NCT02892149|616052323|FG000|Overall Study|Withdrawal by Subject|53|||
170468293|NCT02892149|616052324|FG001|Overall Study|Withdrawal by Subject|47|||
170468294|NCT02892149|616052323|FG000|Overall Study|Lost to Follow-up|37|||
170468295|NCT02892149|616052324|FG001|Overall Study|Lost to Follow-up|31|||
170468296|NCT03066258|616052325|FG000|Overall Study|Death|1|||
170468297|NCT03066258|616052326|FG001|Overall Study|Death|0|||
170468298|NCT03066258|616052327|FG002|Overall Study|Death|0|||
170468299|NCT03066258|616052328|FG003|Overall Study|Death|0|||
170468300|NCT03066258|616052329|FG004|Overall Study|Death|1|||
170468301|NCT02165735|616052330|FG000|Overall Study|Lost to Follow-up|12|||
170468302|NCT02165735|616052331|FG001|Overall Study|Lost to Follow-up|10|||
170468303|NCT02165735|616052330|FG000|Overall Study|Withdrawal by Subject|3|||
170468304|NCT02165735|616052331|FG001|Overall Study|Withdrawal by Subject|0|||
170468305|NCT02165735|616052330|FG000|Overall Study|Participant indicated lack of time|1|||
170891249|NCT01665144|617608271|FG001|Core Part|Adverse Event|18|||
170891250|NCT01665144|617608272|FG002|Core Part|Adverse Event|0|||
170891251|NCT01665144|617608270|FG000|Core Part|Lack of Efficacy|16|||
170891252|NCT01665144|617608271|FG001|Core Part|Lack of Efficacy|11|||
170891253|NCT01665144|617608272|FG002|Core Part|Lack of Efficacy|0|||
170891254|NCT01665144|617608270|FG000|Core Part|Lost to Follow-up|9|||
170891255|NCT01665144|617608271|FG001|Core Part|Lost to Follow-up|8|||
170891256|NCT01665144|617608272|FG002|Core Part|Lost to Follow-up|0|||
170891257|NCT01665144|617608270|FG000|Core Part|Physician Decision|13|||
170891258|NCT01665144|617608271|FG001|Core Part|Physician Decision|1|||
170891259|NCT01665144|617608272|FG002|Core Part|Physician Decision|0|||
170891260|NCT01665144|617608270|FG000|Core Part|Progressive disease|8|||
170891261|NCT01665144|617608271|FG001|Core Part|Progressive disease|4|||
170891262|NCT01665144|617608272|FG002|Core Part|Progressive disease|0|||
170891263|NCT01665144|617608270|FG000|Core Part|Non-compliance with study treatment|5|||
170891264|NCT01665144|617608271|FG001|Core Part|Non-compliance with study treatment|0|||
170891265|NCT01665144|617608272|FG002|Core Part|Non-compliance with study treatment|0|||
170891266|NCT01665144|617608270|FG000|Core Part|Death|3|||
170891267|NCT01665144|617608271|FG001|Core Part|Death|1|||
170891268|NCT01665144|617608272|FG002|Core Part|Death|0|||
170891269|NCT01665144|617608270|FG000|Core Part|Protocol deviation|3|||
170891270|NCT01665144|617608271|FG001|Core Part|Protocol deviation|1|||
170891271|NCT01665144|617608272|FG002|Core Part|Protocol deviation|0|||
170891272|NCT01665144|617608270|FG000|Core Part|New therapy for study indication|2|||
170891273|NCT01665144|617608271|FG001|Core Part|New therapy for study indication|1|||
170891274|NCT01665144|617608272|FG002|Core Part|New therapy for study indication|0|||
170891275|NCT01665144|617608270|FG000|Core Part|Technical problems|2|||
170891276|NCT01665144|617608271|FG001|Core Part|Technical problems|0|||
170891277|NCT01665144|617608272|FG002|Core Part|Technical problems|0|||
170891278|NCT01665144|617608270|FG000|Extension Part|Patient/guardian decision|180|||
170891279|NCT01665144|617608271|FG001|Extension Part|Patient/guardian decision|0|||
170891280|NCT01665144|617608272|FG002|Extension Part|Patient/guardian decision|98|||
170891281|NCT01665144|617608270|FG000|Extension Part|Adverse Event|104|||
170891282|NCT01665144|617608271|FG001|Extension Part|Adverse Event|0|||
170468306|NCT02165735|616052331|FG001|Overall Study|Participant indicated lack of time|3|||
170468307|NCT02165735|616052330|FG000|Overall Study|Protocol Violation|0|||
170468308|NCT02165735|616052331|FG001|Overall Study|Protocol Violation|1|||
170468309|NCT02784795|616052332|FG000|Overall Study|Progressive Disease|2|||
170468310|NCT02784795|616052333|FG001|Overall Study|Progressive Disease|1|||
170468311|NCT02784795|616052334|FG002|Overall Study|Progressive Disease|1|||
170468312|NCT02784795|616052335|FG003|Overall Study|Progressive Disease|0|||
170468313|NCT02784795|616052336|FG004|Overall Study|Progressive Disease|2|||
170468314|NCT02784795|616052337|FG005|Overall Study|Progressive Disease|0|||
170468315|NCT02784795|616052338|FG006|Overall Study|Progressive Disease|2|||
170468316|NCT02784795|616052339|FG007|Overall Study|Progressive Disease|0|||
170468317|NCT02784795|616052340|FG008|Overall Study|Progressive Disease|0|||
170468318|NCT02784795|616052341|FG009|Overall Study|Progressive Disease|0|||
170468319|NCT02784795|616052342|FG010|Overall Study|Progressive Disease|1|||
170468320|NCT02784795|616052343|FG011|Overall Study|Progressive Disease|0|||
170891283|NCT01665144|617608272|FG002|Extension Part|Adverse Event|59|||
170468321|NCT02784795|616052332|FG000|Overall Study|Adverse Event|1|||
170468322|NCT02784795|616052333|FG001|Overall Study|Adverse Event|0|||
170468323|NCT02784795|616052334|FG002|Overall Study|Adverse Event|0|||
170468324|NCT02784795|616052335|FG003|Overall Study|Adverse Event|1|||
170468325|NCT02784795|616052336|FG004|Overall Study|Adverse Event|0|||
170468326|NCT02784795|616052337|FG005|Overall Study|Adverse Event|0|||
170468327|NCT02784795|616052338|FG006|Overall Study|Adverse Event|1|||
170468328|NCT02784795|616052339|FG007|Overall Study|Adverse Event|0|||
170468329|NCT02784795|616052340|FG008|Overall Study|Adverse Event|0|||
170545292|NCT01060111|616340963|FG002|Overall Study|Inappropriate participant|5|||
170545293|NCT01060111|616340961|FG000|Overall Study|Participants' evasion for hospital visit|0|||
170545294|NCT01060111|616340962|FG001|Overall Study|Participants' evasion for hospital visit|3|||
170545295|NCT01060111|616340963|FG002|Overall Study|Participants' evasion for hospital visit|2|||
170891284|NCT01665144|617608270|FG000|Extension Part|Study closed early|42|||
170891285|NCT01665144|617608271|FG001|Extension Part|Study closed early|0|||
170891286|NCT01665144|617608272|FG002|Extension Part|Study closed early|19|||
170891287|NCT01665144|617608270|FG000|Extension Part|Progressive disease|36|||
170891288|NCT01665144|617608271|FG001|Extension Part|Progressive disease|0|||
170891289|NCT01665144|617608272|FG002|Extension Part|Progressive disease|14|||
170545296|NCT01060111|616340961|FG000|Overall Study|Participants' non-cooperation|8|||
170545297|NCT01060111|616340962|FG001|Overall Study|Participants' non-cooperation|6|||
170545298|NCT01060111|616340963|FG002|Overall Study|Participants' non-cooperation|6|||
170545299|NCT01060111|616340961|FG000|Overall Study|Adverse event and insufficient effect|0|||
170545300|NCT01060111|616340962|FG001|Overall Study|Adverse event and insufficient effect|1|||
170790963|NCT04568486|617245806|FG000|Overall Study|Withdrawal by Subject|26|||
170790964|NCT04568486|617245806|FG000|Overall Study|Lost to Follow-up|7|||
170790965|NCT03656510|617245809|FG000|Overall Study|Lost to Follow-up|1|||
170790966|NCT03656510|617245810|FG001|Overall Study|Lost to Follow-up|0|||
170790967|NCT03656510|617245811|FG002|Overall Study|Lost to Follow-up|0|||
170790968|NCT03656510|617245812|FG003|Overall Study|Lost to Follow-up|0|||
170790969|NCT03656510|617245813|FG004|Overall Study|Lost to Follow-up|0|||
170790970|NCT03656510|617245814|FG005|Overall Study|Lost to Follow-up|0|||
170790971|NCT03656510|617245809|FG000|Overall Study|Withdrawal by Subject|1|||
170790972|NCT03656510|617245810|FG001|Overall Study|Withdrawal by Subject|1|||
170790973|NCT03656510|617245811|FG002|Overall Study|Withdrawal by Subject|0|||
170790974|NCT03656510|617245812|FG003|Overall Study|Withdrawal by Subject|1|||
170790975|NCT03656510|617245813|FG004|Overall Study|Withdrawal by Subject|0|||
170790976|NCT03656510|617245814|FG005|Overall Study|Withdrawal by Subject|0|||
170790977|NCT03852472|617245817|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
170790978|NCT03852472|617245818|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
170790979|NCT03852472|617245819|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
170790980|NCT03852472|617245820|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
170790981|NCT03852472|617245821|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
170790982|NCT03852472|617245817|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
170790983|NCT03852472|617245818|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
170790984|NCT03852472|617245819|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
170790985|NCT03852472|617245820|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
170790986|NCT03852472|617245821|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
170790987|NCT03852472|617245817|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
170790988|NCT03852472|617245818|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
170790989|NCT03852472|617245819|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
170790990|NCT03852472|617245820|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
170790991|NCT03852472|617245821|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
170891290|NCT01665144|617608270|FG000|Extension Part|Lack of Efficacy|37|||
170891291|NCT01665144|617608271|FG001|Extension Part|Lack of Efficacy|0|||
170891292|NCT01665144|617608272|FG002|Extension Part|Lack of Efficacy|12|||
170891293|NCT01665144|617608270|FG000|Extension Part|Physician Decision|29|||
170891294|NCT01665144|617608271|FG001|Extension Part|Physician Decision|0|||
170468330|NCT02784795|616052341|FG009|Overall Study|Adverse Event|0|||
170790992|NCT03852472|617245817|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
170790993|NCT03852472|617245818|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
170468331|NCT02784795|616052342|FG010|Overall Study|Adverse Event|0|||
170468332|NCT02784795|616052343|FG011|Overall Study|Adverse Event|2|||
170468333|NCT02784795|616052332|FG000|Overall Study|Withdrawal by Subject|1|||
170468334|NCT02784795|616052333|FG001|Overall Study|Withdrawal by Subject|0|||
170790994|NCT03852472|617245819|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
170468335|NCT02784795|616052334|FG002|Overall Study|Withdrawal by Subject|2|||
170468336|NCT02784795|616052335|FG003|Overall Study|Withdrawal by Subject|1|||
170468337|NCT02784795|616052336|FG004|Overall Study|Withdrawal by Subject|3|||
170468338|NCT02784795|616052337|FG005|Overall Study|Withdrawal by Subject|0|||
170468339|NCT02784795|616052338|FG006|Overall Study|Withdrawal by Subject|0|||
170468340|NCT02784795|616052339|FG007|Overall Study|Withdrawal by Subject|1|||
170468341|NCT02784795|616052340|FG008|Overall Study|Withdrawal by Subject|0|||
170468342|NCT02784795|616052341|FG009|Overall Study|Withdrawal by Subject|0|||
170468343|NCT02784795|616052342|FG010|Overall Study|Withdrawal by Subject|0|||
170468344|NCT02784795|616052343|FG011|Overall Study|Withdrawal by Subject|2|||
170468345|NCT02784795|616052332|FG000|Overall Study|Death|0|||
170468346|NCT02784795|616052333|FG001|Overall Study|Death|0|||
170468347|NCT02784795|616052334|FG002|Overall Study|Death|0|||
170468348|NCT02784795|616052335|FG003|Overall Study|Death|0|||
170468349|NCT02784795|616052336|FG004|Overall Study|Death|1|||
170468350|NCT02784795|616052337|FG005|Overall Study|Death|0|||
170468351|NCT02784795|616052338|FG006|Overall Study|Death|0|||
170468352|NCT02784795|616052339|FG007|Overall Study|Death|0|||
170468353|NCT02784795|616052340|FG008|Overall Study|Death|0|||
170468354|NCT02784795|616052341|FG009|Overall Study|Death|0|||
170468355|NCT02784795|616052342|FG010|Overall Study|Death|0|||
170468356|NCT02784795|616052343|FG011|Overall Study|Death|0|||
170468357|NCT02784795|616052332|FG000|Overall Study|Physician Decision|0|||
170468358|NCT02784795|616052333|FG001|Overall Study|Physician Decision|0|||
170468359|NCT02784795|616052334|FG002|Overall Study|Physician Decision|0|||
170468360|NCT02784795|616052335|FG003|Overall Study|Physician Decision|0|||
170468361|NCT02784795|616052336|FG004|Overall Study|Physician Decision|0|||
170468362|NCT02784795|616052337|FG005|Overall Study|Physician Decision|0|||
170468363|NCT02784795|616052338|FG006|Overall Study|Physician Decision|1|||
170468364|NCT02784795|616052339|FG007|Overall Study|Physician Decision|0|||
170468365|NCT02784795|616052340|FG008|Overall Study|Physician Decision|0|||
170468366|NCT02784795|616052341|FG009|Overall Study|Physician Decision|0|||
170468367|NCT02784795|616052342|FG010|Overall Study|Physician Decision|0|||
170468368|NCT02784795|616052343|FG011|Overall Study|Physician Decision|0|||
170468369|NCT00595309|616052344|FG000|Overall Study|Lost to Follow-up|1|||
170468370|NCT00595309|616052344|FG000|Overall Study|planned vaccination against yellow fever|1|||
170468371|NCT00595309|616052344|FG000|Overall Study|acute infection after V0|1|||
170468372|NCT00595309|616052344|FG000|Overall Study|personal reason|1|||
170468373|NCT00101283|616052345|FG000|Overall Study|Withdrawal by Subject|0|||
170468374|NCT00101283|616052346|FG001|Overall Study|Withdrawal by Subject|1|||
170790995|NCT03852472|617245820|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
170790996|NCT03852472|617245821|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
170790997|NCT03852472|617245817|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
170790998|NCT03852472|617245818|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
170790999|NCT03852472|617245819|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
170791000|NCT03852472|617245820|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
170791001|NCT03852472|617245821|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
170791002|NCT03852472|617245817|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
170791003|NCT03852472|617245818|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
170791004|NCT03852472|617245819|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
170791005|NCT03852472|617245820|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
170791006|NCT03852472|617245821|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
170791007|NCT03852472|617245817|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
170791008|NCT03852472|617245818|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
170791009|NCT03852472|617245819|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
170791010|NCT03852472|617245820|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
170791011|NCT03852472|617245821|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
170791012|NCT03852472|617245817|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
170791013|NCT03852472|617245818|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
170791014|NCT03852472|617245819|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
170791015|NCT03852472|617245820|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
170791016|NCT03852472|617245821|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
170791017|NCT03852472|617245817|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
170791018|NCT03852472|617245818|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
170791019|NCT03852472|617245819|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
170791020|NCT03852472|617245820|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
170791021|NCT03852472|617245821|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
170791022|NCT03852472|617245817|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
170468375|NCT00101283|616052345|FG000|Overall Study|Insurance Refusal|0|||
170468376|NCT00101283|616052346|FG001|Overall Study|Insurance Refusal|1|||
170468377|NCT00101283|616052345|FG000|Overall Study|Prostate Cancer Recurrence|0|||
170468378|NCT00101283|616052346|FG001|Overall Study|Prostate Cancer Recurrence|1|||
170468379|NCT01420965|616052352|FG000|Overall Study|Withdrawal by Subject|1|||
170468380|NCT01420965|616052353|FG001|Overall Study|Withdrawal by Subject|0|||
170468381|NCT01420965|616052354|FG002|Overall Study|Withdrawal by Subject|0|||
170468382|NCT01420965|616052352|FG000|Overall Study|Adverse Event|0|||
170468383|NCT01420965|616052353|FG001|Overall Study|Adverse Event|1|||
170468384|NCT01420965|616052354|FG002|Overall Study|Adverse Event|0|||
170468385|NCT00339144|616052359|FG000|Overall Study|Disease progression|5|||
170468386|NCT00339144|616052360|FG001|Overall Study|Disease progression|2|||
170468387|NCT00339144|616052361|FG002|Overall Study|Disease progression|2|||
170468388|NCT00339144|616052359|FG000|Overall Study|Study drug toxicity|3|||
170468389|NCT00339144|616052360|FG001|Overall Study|Study drug toxicity|1|||
170468390|NCT00339144|616052361|FG002|Overall Study|Study drug toxicity|1|||
170468391|NCT00339144|616052359|FG000|Overall Study|Participant's request to discontinuation|1|||
170468392|NCT00339144|616052360|FG001|Overall Study|Participant's request to discontinuation|0|||
170468393|NCT00339144|616052361|FG002|Overall Study|Participant's request to discontinuation|1|||
170468394|NCT00233402|616052362|FG000|Overall Study|No pathology data|12|||
170468395|NCT00233402|616052363|FG001|Overall Study|No pathology data|9|||
170468396|NCT00233402|616052362|FG000|Overall Study|No Ta/T1|89|||
170468397|NCT00233402|616052363|FG001|Overall Study|No Ta/T1|94|||
170468398|NCT00233402|616052362|FG000|Overall Study|Lost to follow up etc|3|||
170468399|NCT00233402|616052363|FG001|Overall Study|Lost to follow up etc|21|||
170468400|NCT03280381|616052364|FG000|Overall Study|Physician Decision|0|||
170468401|NCT03280381|616052365|FG001|Overall Study|Physician Decision|2|||
170468402|NCT00252239|616052370|FG000|Overall Study|Withdrawal by Subject|1|||
170468403|NCT00252239|616052371|FG001|Overall Study|Withdrawal by Subject|0|||
170468404|NCT00252239|616052372|FG002|Overall Study|Withdrawal by Subject|0|||
170468405|NCT00252239|616052373|FG003|Overall Study|Withdrawal by Subject|1|||
170468406|NCT00252239|616052370|FG000|Overall Study|Lost to Follow-up|0|||
170468407|NCT00252239|616052371|FG001|Overall Study|Lost to Follow-up|0|||
170468408|NCT00252239|616052372|FG002|Overall Study|Lost to Follow-up|2|||
170468409|NCT00252239|616052373|FG003|Overall Study|Lost to Follow-up|0|||
170468410|NCT03136965|616052376|FG000|Overall Study|Lost to Follow-up|0|||
170468411|NCT03136965|616052377|FG001|Overall Study|Lost to Follow-up|1|||
170468412|NCT03136965|616052378|FG002|Overall Study|Lost to Follow-up|0|||
170468413|NCT00197496|616052379|FG000|Baseline to Discharge|not interested|1|||
170468414|NCT00197496|616052380|FG001|Baseline to Discharge|not interested|0|||
170468415|NCT00197496|616052379|FG000|Baseline to Discharge|MRSA|1|||
170468416|NCT00197496|616052380|FG001|Baseline to Discharge|MRSA|0|||
170468417|NCT00197496|616052379|FG000|Baseline to Discharge|Physician Decision|0|||
170468418|NCT00197496|616052380|FG001|Baseline to Discharge|Physician Decision|1|||
170468419|NCT00197496|616052379|FG000|Baseline to Discharge|Protocol Violation|0|||
170468420|NCT00197496|616052380|FG001|Baseline to Discharge|Protocol Violation|1|||
170468421|NCT00197496|616052379|FG000|Follow-up|Lost to Follow-up|2|||
170468422|NCT00197496|616052380|FG001|Follow-up|Lost to Follow-up|1|||
170468423|NCT00673387|616052381|FG000|Overall Study|Withdrawal by Subject|15|||
170468424|NCT00673387|616052382|FG001|Overall Study|Withdrawal by Subject|16|||
170468425|NCT00673387|616052383|FG002|Overall Study|Withdrawal by Subject|20|||
170468426|NCT00673387|616052384|FG003|Overall Study|Withdrawal by Subject|16|||
170468427|NCT00673387|616052385|FG004|Overall Study|Withdrawal by Subject|18|||
170468428|NCT00673387|616052386|FG005|Overall Study|Withdrawal by Subject|21|||
170468429|NCT00673387|616052387|FG006|Overall Study|Withdrawal by Subject|15|||
170468430|NCT00673387|616052388|FG007|Overall Study|Withdrawal by Subject|21|||
170468431|NCT00673387|616052381|FG000|Overall Study|Adverse Event|3|||
170468432|NCT00673387|616052382|FG001|Overall Study|Adverse Event|1|||
170468433|NCT00673387|616052383|FG002|Overall Study|Adverse Event|5|||
170468434|NCT00673387|616052384|FG003|Overall Study|Adverse Event|2|||
170468435|NCT00673387|616052385|FG004|Overall Study|Adverse Event|6|||
170468436|NCT00673387|616052386|FG005|Overall Study|Adverse Event|2|||
170468437|NCT00673387|616052387|FG006|Overall Study|Adverse Event|5|||
170468438|NCT00673387|616052388|FG007|Overall Study|Adverse Event|5|||
170468439|NCT00673387|616052381|FG000|Overall Study|Physician Decision|0|||
170468440|NCT00673387|616052382|FG001|Overall Study|Physician Decision|0|||
170468441|NCT00673387|616052383|FG002|Overall Study|Physician Decision|0|||
170468442|NCT00673387|616052384|FG003|Overall Study|Physician Decision|0|||
170468443|NCT00673387|616052385|FG004|Overall Study|Physician Decision|0|||
170468444|NCT00673387|616052386|FG005|Overall Study|Physician Decision|5|||
170468445|NCT00673387|616052387|FG006|Overall Study|Physician Decision|1|||
170468446|NCT00673387|616052388|FG007|Overall Study|Physician Decision|1|||
170468447|NCT00673387|616052381|FG000|Overall Study|Protocol Violation|3|||
170468448|NCT00673387|616052382|FG001|Overall Study|Protocol Violation|0|||
170468449|NCT00673387|616052383|FG002|Overall Study|Protocol Violation|1|||
170468450|NCT00673387|616052384|FG003|Overall Study|Protocol Violation|2|||
170468451|NCT00673387|616052385|FG004|Overall Study|Protocol Violation|0|||
170468452|NCT00673387|616052386|FG005|Overall Study|Protocol Violation|1|||
170468453|NCT00673387|616052387|FG006|Overall Study|Protocol Violation|1|||
170468454|NCT00673387|616052388|FG007|Overall Study|Protocol Violation|3|||
170468455|NCT00673387|616052381|FG000|Overall Study|Lost to Follow-up|8|||
170468456|NCT00673387|616052382|FG001|Overall Study|Lost to Follow-up|6|||
170468457|NCT00673387|616052383|FG002|Overall Study|Lost to Follow-up|5|||
170468458|NCT00673387|616052384|FG003|Overall Study|Lost to Follow-up|6|||
170468459|NCT00673387|616052385|FG004|Overall Study|Lost to Follow-up|6|||
170468460|NCT00673387|616052386|FG005|Overall Study|Lost to Follow-up|5|||
170468461|NCT00673387|616052387|FG006|Overall Study|Lost to Follow-up|8|||
170468462|NCT00673387|616052388|FG007|Overall Study|Lost to Follow-up|5|||
170468463|NCT02269163|616052390|FG000|Overall Study|Lost to Follow-up|1|||
170468464|NCT02269163|616052391|FG001|Overall Study|Lost to Follow-up|0|||
170468465|NCT02269163|616052390|FG000|Overall Study|Major protocol violation|0|||
170468466|NCT02269163|616052391|FG001|Overall Study|Major protocol violation|1|||
170468467|NCT02269163|616052390|FG000|Overall Study|Other|2|||
170468468|NCT02269163|616052391|FG001|Overall Study|Other|2|||
170468469|NCT02269163|616052390|FG000|Overall Study|Withdrawal by Subject|0|||
170468470|NCT02269163|616052391|FG001|Overall Study|Withdrawal by Subject|3|||
170468471|NCT02269163|616052390|FG000|Overall Study|Physician Decision|0|||
170468472|NCT02269163|616052391|FG001|Overall Study|Physician Decision|1|||
170468473|NCT02099682|616052402|FG000|Overall Study|Data Not Available|51|||
170468474|NCT02099682|616052402|FG000|Overall Study|Lost to Follow-up|31|||
170891295|NCT01665144|617608272|FG002|Extension Part|Physician Decision|13|||
170891296|NCT01665144|617608270|FG000|Extension Part|Technical problems|20|||
170891297|NCT01665144|617608271|FG001|Extension Part|Technical problems|0|||
170891298|NCT01665144|617608272|FG002|Extension Part|Technical problems|8|||
170891299|NCT01665144|617608270|FG000|Extension Part|Death|20|||
170891300|NCT01665144|617608271|FG001|Extension Part|Death|0|||
170891301|NCT01665144|617608272|FG002|Extension Part|Death|4|||
170891302|NCT01665144|617608270|FG000|Extension Part|Missing|12|||
170891303|NCT01665144|617608271|FG001|Extension Part|Missing|0|||
170891304|NCT01665144|617608272|FG002|Extension Part|Missing|6|||
170891305|NCT01665144|617608270|FG000|Extension Part|Lost to Follow-up|9|||
170891306|NCT01665144|617608271|FG001|Extension Part|Lost to Follow-up|0|||
170891307|NCT01665144|617608272|FG002|Extension Part|Lost to Follow-up|5|||
170891308|NCT01665144|617608270|FG000|Extension Part|New therapy for study indication|3|||
170891309|NCT01665144|617608271|FG001|Extension Part|New therapy for study indication|0|||
170891310|NCT01665144|617608272|FG002|Extension Part|New therapy for study indication|2|||
170891311|NCT01665144|617608270|FG000|Extension Part|Protocol deviation|3|||
170891312|NCT01665144|617608271|FG001|Extension Part|Protocol deviation|0|||
170891313|NCT01665144|617608272|FG002|Extension Part|Protocol deviation|0|||
170891314|NCT01060059|617608273|FG000|Overall Study|Adverse Event|1|||
170891315|NCT01060059|617608274|FG001|Overall Study|Adverse Event|1|||
170891316|NCT01060059|617608273|FG000|Overall Study|Death|2|||
170468475|NCT02099682|616052402|FG000|Overall Study|Other|29|||
170468476|NCT02203331|616052403|FG000|Overall Study|Pregnancy|1|||
170468477|NCT02203331|616052404|FG001|Overall Study|Pregnancy|0|||
170468478|NCT02203331|616052405|FG002|Overall Study|Pregnancy|0|||
170468479|NCT02203331|616052406|FG003|Overall Study|Pregnancy|0|||
170468480|NCT02203331|616052407|FG004|Overall Study|Pregnancy|2|||
170468481|NCT02203331|616052408|FG005|Overall Study|Pregnancy|0|||
170468482|NCT02203331|616052403|FG000|Overall Study|Withdrawal by Subject|1|||
170468483|NCT02203331|616052404|FG001|Overall Study|Withdrawal by Subject|0|||
170468484|NCT02203331|616052405|FG002|Overall Study|Withdrawal by Subject|1|||
170468485|NCT02203331|616052406|FG003|Overall Study|Withdrawal by Subject|0|||
170468486|NCT02203331|616052407|FG004|Overall Study|Withdrawal by Subject|0|||
170468487|NCT02203331|616052408|FG005|Overall Study|Withdrawal by Subject|3|||
170468488|NCT02203331|616052403|FG000|Overall Study|Adverse Event|4|||
170468489|NCT02203331|616052404|FG001|Overall Study|Adverse Event|8|||
170468490|NCT02203331|616052405|FG002|Overall Study|Adverse Event|3|||
170468491|NCT02203331|616052406|FG003|Overall Study|Adverse Event|4|||
170468492|NCT02203331|616052407|FG004|Overall Study|Adverse Event|3|||
170468493|NCT02203331|616052408|FG005|Overall Study|Adverse Event|3|||
170468494|NCT02203331|616052403|FG000|Overall Study|Other Reasons|1|||
170468495|NCT02203331|616052404|FG001|Overall Study|Other Reasons|2|||
170468496|NCT02203331|616052405|FG002|Overall Study|Other Reasons|0|||
170468497|NCT02203331|616052406|FG003|Overall Study|Other Reasons|2|||
170468498|NCT02203331|616052407|FG004|Overall Study|Other Reasons|0|||
170468499|NCT02203331|616052408|FG005|Overall Study|Other Reasons|0|||
170468500|NCT02203331|616052403|FG000|Overall Study|Lack of Efficacy|0|||
170468501|NCT02203331|616052404|FG001|Overall Study|Lack of Efficacy|2|||
170468502|NCT02203331|616052405|FG002|Overall Study|Lack of Efficacy|1|||
170545301|NCT01060111|616340963|FG002|Overall Study|Adverse event and insufficient effect|0|||
170891317|NCT01060059|617608274|FG001|Overall Study|Death|3|||
170891318|NCT01060059|617608273|FG000|Overall Study|Lost to Follow-up|18|||
170891319|NCT01060059|617608274|FG001|Overall Study|Lost to Follow-up|34|||
170468503|NCT02203331|616052406|FG003|Overall Study|Lack of Efficacy|0|||
170468504|NCT02203331|616052407|FG004|Overall Study|Lack of Efficacy|0|||
170545302|NCT01060111|616340961|FG000|Overall Study|Participants' non-cooperation|1|||
170545303|NCT01060111|616340962|FG001|Overall Study|Participants' non-cooperation|0|||
170891320|NCT01060059|617608273|FG000|Overall Study|entry criteria not met|4|||
170468505|NCT02203331|616052408|FG005|Overall Study|Lack of Efficacy|1|||
170468506|NCT02203331|616052403|FG000|Overall Study|Protocol Violation|0|||
170891321|NCT01060059|617608274|FG001|Overall Study|entry criteria not met|3|||
170891322|NCT01060059|617608273|FG000|Overall Study|Withdrawal by Subject|35|||
170891323|NCT01060059|617608274|FG001|Overall Study|Withdrawal by Subject|23|||
170891324|NCT01060059|617608273|FG000|Overall Study|lack of glycemic control|2|||
170891325|NCT01060059|617608274|FG001|Overall Study|lack of glycemic control|1|||
170468507|NCT02203331|616052404|FG001|Overall Study|Protocol Violation|2|||
170468508|NCT02203331|616052405|FG002|Overall Study|Protocol Violation|0|||
170468509|NCT02203331|616052406|FG003|Overall Study|Protocol Violation|1|||
170468510|NCT02203331|616052407|FG004|Overall Study|Protocol Violation|1|||
170791023|NCT03852472|617245818|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
170468511|NCT02203331|616052408|FG005|Overall Study|Protocol Violation|0|||
170468512|NCT02203331|616052403|FG000|Overall Study|Lost to Follow-up|0|||
170468513|NCT02203331|616052404|FG001|Overall Study|Lost to Follow-up|0|||
170468514|NCT02203331|616052405|FG002|Overall Study|Lost to Follow-up|0|||
170468515|NCT02203331|616052406|FG003|Overall Study|Lost to Follow-up|0|||
170468516|NCT02203331|616052407|FG004|Overall Study|Lost to Follow-up|1|||
170468517|NCT02203331|616052408|FG005|Overall Study|Lost to Follow-up|0|||
170468518|NCT03597464|616052409|FG000|Overall Study|Withdrawal by Subject|4|||
170468519|NCT03597464|616052410|FG001|Overall Study|Withdrawal by Subject|5|||
170468520|NCT03597464|616052409|FG000|Overall Study|Lost to Follow-up|3|||
170468521|NCT03597464|616052410|FG001|Overall Study|Lost to Follow-up|1|||
170545304|NCT01060111|616340963|FG002|Overall Study|Participants' non-cooperation|0|||
170545305|NCT01060111|616340961|FG000|Overall Study|Other|2|||
170545306|NCT01060111|616340962|FG001|Overall Study|Other|3|||
170545307|NCT01060111|616340963|FG002|Overall Study|Other|4|||
170545308|NCT01433978|616340964|FG000|Core Study|Adverse Event, Non-Fatal|0|||
170545309|NCT01433978|616340965|FG001|Core Study|Adverse Event, Non-Fatal|1|||
170545310|NCT01433978|616340966|FG002|Core Study|Adverse Event, Non-Fatal|0|||
170545311|NCT01433978|616340964|FG000|Core Study|Lack of Efficacy|5|||
170545312|NCT01433978|616340965|FG001|Core Study|Lack of Efficacy|1|||
170545313|NCT01433978|616340966|FG002|Core Study|Lack of Efficacy|0|||
170545314|NCT01433978|616340964|FG000|Core Study|Study Terminated by Sponsor|6|||
170545315|NCT01433978|616340965|FG001|Core Study|Study Terminated by Sponsor|9|||
170545316|NCT01433978|616340966|FG002|Core Study|Study Terminated by Sponsor|0|||
170545317|NCT01433978|616340964|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
170545318|NCT01433978|616340965|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
170545319|NCT01433978|616340966|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
170545320|NCT01433978|616340964|FG000|Extension Phase|Lack of Efficacy|0|||
170791024|NCT03852472|617245819|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
170791025|NCT03852472|617245820|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
170791026|NCT03852472|617245821|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
170791027|NCT03852472|617245817|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
170791028|NCT03852472|617245818|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
170791029|NCT03852472|617245819|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
170791030|NCT03852472|617245820|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
170791031|NCT03852472|617245821|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
170791032|NCT03852472|617245817|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
170791033|NCT03852472|617245818|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
170791034|NCT03852472|617245819|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
170791035|NCT03852472|617245820|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
170791036|NCT03852472|617245821|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
170791037|NCT03852472|617245817|FG000|Period 2 - Week 44|Adverse Event|0|||
170791038|NCT03852472|617245818|FG001|Period 2 - Week 44|Adverse Event|3|||
170791039|NCT03852472|617245819|FG002|Period 2 - Week 44|Adverse Event|1|||
170791040|NCT03852472|617245820|FG003|Period 2 - Week 44|Adverse Event|2|||
170791041|NCT03852472|617245821|FG004|Period 2 - Week 44|Adverse Event|2|||
170791042|NCT03852472|617245817|FG000|Period 2 - Week 44|COVID-19 Related|0|||
170791043|NCT03852472|617245818|FG001|Period 2 - Week 44|COVID-19 Related|0|||
170791044|NCT03852472|617245819|FG002|Period 2 - Week 44|COVID-19 Related|0|||
170791045|NCT03852472|617245820|FG003|Period 2 - Week 44|COVID-19 Related|1|||
170791046|NCT03852472|617245821|FG004|Period 2 - Week 44|COVID-19 Related|0|||
170791047|NCT03852472|617245817|FG000|Period 2 - Week 44|Reason not stated|0|||
170791048|NCT03852472|617245818|FG001|Period 2 - Week 44|Reason not stated|0|||
170791049|NCT03852472|617245819|FG002|Period 2 - Week 44|Reason not stated|0|||
170791050|NCT03852472|617245820|FG003|Period 2 - Week 44|Reason not stated|0|||
170791051|NCT03852472|617245821|FG004|Period 2 - Week 44|Reason not stated|1|||
170468522|NCT03597464|616052409|FG000|Overall Study|Pregnancy|3|||
170468523|NCT03597464|616052410|FG001|Overall Study|Pregnancy|1|||
170468524|NCT03597464|616052409|FG000|Overall Study|Lack of Efficacy|2|||
170468525|NCT03597464|616052410|FG001|Overall Study|Lack of Efficacy|0|||
170468526|NCT03597464|616052409|FG000|Overall Study|Physician Decision|2|||
170545321|NCT01433978|616340965|FG001|Extension Phase|Lack of Efficacy|0|||
170545322|NCT01433978|616340966|FG002|Extension Phase|Lack of Efficacy|1|||
170545323|NCT01433978|616340964|FG000|Extension Phase|Study Terminated by Sponsor|0|||
170545324|NCT01433978|616340965|FG001|Extension Phase|Study Terminated by Sponsor|0|||
170545325|NCT01433978|616340966|FG002|Extension Phase|Study Terminated by Sponsor|4|||
170791052|NCT01919554|617245822|FG000|Overall Study|Withdrawal by Subject|0|||
170791053|NCT01919554|617245823|FG001|Overall Study|Withdrawal by Subject|0|||
170891326|NCT01060059|617608273|FG000|Overall Study|lack of compliance|5|||
170891327|NCT01060059|617608274|FG001|Overall Study|lack of compliance|2|||
170468527|NCT03597464|616052410|FG001|Overall Study|Physician Decision|2|||
170468528|NCT03597464|616052409|FG000|Overall Study|Protocol Violation|1|||
170468529|NCT03597464|616052410|FG001|Overall Study|Protocol Violation|1|||
170468530|NCT03597464|616052409|FG000|Overall Study|Adverse Event|0|||
170468531|NCT03597464|616052410|FG001|Overall Study|Adverse Event|2|||
170468532|NCT03597464|616052409|FG000|Overall Study|Death|0|||
170891328|NCT01614093|617608275|FG000|Overall Study|Withdrawal by Subject|1|||
170891329|NCT01816243|617608276|FG000|Overall Study|Adverse Event|6|||
170468533|NCT03597464|616052410|FG001|Overall Study|Death|3|||
170468534|NCT02542605|616052413|FG000|Part B: Challenge Phase|Sponsor decision|1|||
170468535|NCT02542605|616052414|FG001|Part B: Challenge Phase|Sponsor decision|0|||
170468536|NCT02542605|616052415|FG002|Part B: Challenge Phase|Sponsor decision|0|||
170468537|NCT02542605|616052413|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
170468538|NCT02542605|616052414|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
170468539|NCT02542605|616052415|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
170468540|NCT03377491|616053440|FG000|Overall Study|Death|193|||
170468541|NCT03377491|616053441|FG001|Overall Study|Death|211|||
170468542|NCT03377491|616053440|FG000|Overall Study|Lost to Follow-up|2|||
170468543|NCT03377491|616053441|FG001|Overall Study|Lost to Follow-up|3|||
170468544|NCT03377491|616053440|FG000|Overall Study|Withdrawal by Subject|42|||
170468545|NCT03377491|616053441|FG001|Overall Study|Withdrawal by Subject|26|||
170468546|NCT03377491|616053440|FG000|Overall Study|Study closure|40|||
170468547|NCT03377491|616053441|FG001|Overall Study|Study closure|37|||
170791054|NCT01919554|617245824|FG002|Overall Study|Withdrawal by Subject|1|||
170791055|NCT01919554|617245825|FG003|Overall Study|Withdrawal by Subject|1|||
170791056|NCT03974178|617245826|FG000|Overall Study|Death|0|||
170791057|NCT03974178|617245827|FG001|Overall Study|Death|1|||
170791058|NCT03899259|617245829|FG000|Overall Study|Adverse Event|5|||
170791059|NCT03899259|617245830|FG001|Overall Study|Adverse Event|4|||
170791060|NCT03899259|617245831|FG002|Overall Study|Adverse Event|6|||
170791061|NCT03899259|617245829|FG000|Overall Study|Lack of Efficacy|5|||
170791062|NCT03899259|617245830|FG001|Overall Study|Lack of Efficacy|0|||
170791063|NCT03899259|617245831|FG002|Overall Study|Lack of Efficacy|2|||
170791064|NCT03899259|617245829|FG000|Overall Study|Pregnancy|3|||
170791065|NCT03899259|617245830|FG001|Overall Study|Pregnancy|0|||
170791066|NCT03899259|617245831|FG002|Overall Study|Pregnancy|1|||
170791067|NCT03899259|617245829|FG000|Overall Study|Physician Decision|0|||
170791068|NCT03899259|617245830|FG001|Overall Study|Physician Decision|1|||
170791069|NCT03899259|617245831|FG002|Overall Study|Physician Decision|0|||
170791070|NCT03899259|617245829|FG000|Overall Study|Protocol Deviation|1|||
170791071|NCT03899259|617245830|FG001|Overall Study|Protocol Deviation|1|||
170791072|NCT03899259|617245831|FG002|Overall Study|Protocol Deviation|1|||
170891330|NCT01816243|617608276|FG000|Overall Study|Lost to Follow-up|1|||
170891331|NCT01816243|617608276|FG000|Overall Study|Lack of Efficacy|1|||
170891332|NCT01816243|617608276|FG000|Overall Study|Not eligible for the study|1|||
170891333|NCT01816243|617608276|FG000|Overall Study|Amputation|3|||
170891334|NCT00512798|617608277|FG000|Overall Study|Death|0|||
170468548|NCT03377491|616053440|FG000|Overall Study|Other|8|||
170468549|NCT03377491|616053441|FG001|Overall Study|Other|9|||
170468550|NCT05292183|616053448|FG000|Overall Study|Adverse Event|1|||
170468551|NCT04377932|616053451|FG000|Dose Level 1|Death|7|||
170468552|NCT04377932|616053452|FG001|Dose Level 1|Death|0|||
170468553|NCT04377932|616053453|FG002|Dose Level 1|Death|0|||
170468554|NCT04377932|616053451|FG000|Dose Level 1|On long term follow up|1|||
170468555|NCT04377932|616053452|FG001|Dose Level 1|On long term follow up|0|||
170468556|NCT04377932|616053453|FG002|Dose Level 1|On long term follow up|0|||
170468557|NCT04377932|616053451|FG000|Dose Level 2|Death|0|||
170468558|NCT04377932|616053452|FG001|Dose Level 2|Death|3|||
170637314|NCT00607373|616684566|FG001|Treatment Period|Withdrawal by Subject|1|||
170891335|NCT00512798|617608278|FG001|Overall Study|Death|3|||
170891336|NCT00512798|617608277|FG000|Overall Study|Adverse Event|2|||
170468559|NCT04377932|616053453|FG002|Dose Level 2|Death|0|||
170468560|NCT04377932|616053451|FG000|Dose Level 3|Death|0|||
170468561|NCT04377932|616053452|FG001|Dose Level 3|Death|0|||
170468562|NCT04377932|616053453|FG002|Dose Level 3|Death|2|||
170468563|NCT04377932|616053451|FG000|Dose Level 3|On long term follow up|0|||
170468564|NCT04377932|616053452|FG001|Dose Level 3|On long term follow up|0|||
170637315|NCT00607373|616684565|FG000|Follow-up Period|Other|0|||
170791073|NCT03899259|617245829|FG000|Overall Study|Withdrawal by Subject|8|||
170791074|NCT03899259|617245830|FG001|Overall Study|Withdrawal by Subject|10|||
170468565|NCT04377932|616053453|FG002|Dose Level 3|On long term follow up|1|||
170468566|NCT03729830|616053454|FG000|Overall Study|Active at study close|136|||
170468567|NCT03729830|616053454|FG000|Overall Study|Subject withdrew consent|40|||
170468568|NCT03729830|616053454|FG000|Overall Study|Intent|32|||
170791075|NCT03899259|617245831|FG002|Overall Study|Withdrawal by Subject|12|||
170791076|NCT03899259|617245829|FG000|Overall Study|Lost to Follow-up|5|||
170791077|NCT03899259|617245830|FG001|Overall Study|Lost to Follow-up|6|||
170791078|NCT03899259|617245831|FG002|Overall Study|Lost to Follow-up|2|||
170891337|NCT00512798|617608278|FG001|Overall Study|Adverse Event|4|||
170891338|NCT00512798|617608277|FG000|Overall Study|Progression of disease|14|||
170891339|NCT00512798|617608278|FG001|Overall Study|Progression of disease|20|||
170468569|NCT03729830|616053454|FG000|Overall Study|Lost to Follow-up|31|||
170468570|NCT03729830|616053454|FG000|Overall Study|research facility closed down|9|||
170468571|NCT03729830|616053454|FG000|Overall Study|Death|5|||
170468572|NCT03729830|616053454|FG000|Overall Study|Physician Decision|4|||
170468573|NCT03729830|616053454|FG000|Overall Study|No longer meets protocol criteria|3|||
170468574|NCT03729830|616053454|FG000|Overall Study|Protocol Violation|6|||
170468575|NCT03729830|616053454|FG000|Overall Study|Sponsor withdrew subject|1|||
170468576|NCT02260570|616053455|FG000|Overall Study|Withdrawal by Subject|2|||
170468577|NCT02260570|616053456|FG001|Overall Study|Withdrawal by Subject|1|||
170468578|NCT02260570|616053455|FG000|Overall Study|Physician Decision|1|||
170468579|NCT02260570|616053456|FG001|Overall Study|Physician Decision|1|||
170468580|NCT04035499|616053457|FG000|Overall Study|Death|2|||
170468581|NCT04035499|616053457|FG000|Overall Study|Withdrawal by Subject|1|||
170468582|NCT00264550|616053462|FG000|Overall Study|Death|0|||
170468583|NCT00264550|616053463|FG001|Overall Study|Death|3|||
170468584|NCT00264550|616053464|FG002|Overall Study|Death|0|||
170468585|NCT00264550|616053465|FG003|Overall Study|Death|0|||
170468586|NCT00264550|616053462|FG000|Overall Study|Lost to Follow-up|3|||
170468587|NCT00264550|616053463|FG001|Overall Study|Lost to Follow-up|1|||
170468588|NCT00264550|616053464|FG002|Overall Study|Lost to Follow-up|1|||
170468589|NCT00264550|616053465|FG003|Overall Study|Lost to Follow-up|1|||
170468590|NCT00264550|616053462|FG000|Overall Study|Adverse Event|23|||
170468591|NCT00264550|616053463|FG001|Overall Study|Adverse Event|18|||
170468592|NCT00264550|616053464|FG002|Overall Study|Adverse Event|9|||
170468593|NCT00264550|616053465|FG003|Overall Study|Adverse Event|14|||
170468594|NCT00264550|616053462|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170468595|NCT00264550|616053463|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
170468596|NCT00264550|616053464|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
170468597|NCT00264550|616053465|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
170468598|NCT00264550|616053462|FG000|Overall Study|Discontinued oral study agent|0|||
170468599|NCT00264550|616053463|FG001|Overall Study|Discontinued oral study agent|1|||
170468600|NCT00264550|616053464|FG002|Overall Study|Discontinued oral study agent|0|||
170468601|NCT00264550|616053465|FG003|Overall Study|Discontinued oral study agent|0|||
170468602|NCT00264550|616053462|FG000|Overall Study|Other|13|||
170468603|NCT00264550|616053463|FG001|Overall Study|Other|7|||
170468604|NCT00264550|616053464|FG002|Overall Study|Other|3|||
170468605|NCT00264550|616053465|FG003|Overall Study|Other|9|||
170468606|NCT02129608|616053466|FG000|Overall Study|Lost to Follow-up|0|||
170468607|NCT02129608|616053467|FG001|Overall Study|Lost to Follow-up|1|||
170468608|NCT02129608|616053468|FG002|Overall Study|Lost to Follow-up|1|||
170468609|NCT02129608|616053466|FG000|Overall Study|Withdrawal by Subject|0|||
170468610|NCT02129608|616053467|FG001|Overall Study|Withdrawal by Subject|0|||
170468611|NCT02129608|616053468|FG002|Overall Study|Withdrawal by Subject|2|||
170468612|NCT00129389|616053469|FG000|Overall Study|Adverse Event|19|||
170468613|NCT00129389|616053470|FG001|Overall Study|Adverse Event|87|||
170468614|NCT00129389|616053469|FG000|Overall Study|Death|0|||
170468615|NCT00129389|616053470|FG001|Overall Study|Death|1|||
170468616|NCT00129389|616053469|FG000|Overall Study|Lost to Follow-up|2|||
170468617|NCT00129389|616053470|FG001|Overall Study|Lost to Follow-up|1|||
170468618|NCT00129389|616053469|FG000|Overall Study|Physician Decision|0|||
170468619|NCT00129389|616053470|FG001|Overall Study|Physician Decision|4|||
170468620|NCT00129389|616053469|FG000|Overall Study|Protocol Violation|0|||
170468621|NCT00129389|616053470|FG001|Overall Study|Protocol Violation|6|||
170468622|NCT00129389|616053469|FG000|Overall Study|Withdrawal by Subject|9|||
170468623|NCT00129389|616053470|FG001|Overall Study|Withdrawal by Subject|23|||
170545326|NCT01773889|616340967|FG000|Overall Study|lack of funding|2|||
170545327|NCT02301429|616340969|FG000|Overall Study|not acceptable vascular anatomy|3|||
170545328|NCT04233580|616340970|FG000|Overall Study|Adverse Event|3|||
170545329|NCT04233580|616340971|FG001|Overall Study|Adverse Event|3|||
170891340|NCT00512798|617608277|FG000|Overall Study|Withdrawal by Subject|3|||
170891341|NCT00512798|617608278|FG001|Overall Study|Withdrawal by Subject|0|||
170891342|NCT01920711|617608279|FG000|Overall Study|Death|347|||
170891343|NCT01920711|617608280|FG001|Overall Study|Death|356|||
170891344|NCT01920711|617608279|FG000|Overall Study|Lost to Follow-up|13|||
170891345|NCT01920711|617608280|FG001|Overall Study|Lost to Follow-up|14|||
170891346|NCT01920711|617608279|FG000|Overall Study|Withdrawal by Subject|4|||
170468624|NCT00129389|616053469|FG000|Overall Study|Relapse|1|||
170468625|NCT00129389|616053470|FG001|Overall Study|Relapse|0|||
170468626|NCT00129389|616053469|FG000|Overall Study|Not eligible|1|||
170468627|NCT00129389|616053470|FG001|Overall Study|Not eligible|2|||
170468628|NCT00129389|616053469|FG000|Overall Study|Crossed to the other arm|1|||
170468629|NCT00129389|616053470|FG001|Overall Study|Crossed to the other arm|16|||
170468630|NCT01191944|616053474|FG000|Overall Study|Adverse Event|11|||
170468631|NCT01191944|616053475|FG001|Overall Study|Adverse Event|12|||
170468632|NCT01191944|616053474|FG000|Overall Study|Protocol Violation|1|||
170468633|NCT01191944|616053475|FG001|Overall Study|Protocol Violation|2|||
170545330|NCT04233580|616340970|FG000|Overall Study|Withdrawal by Subject|2|||
170891347|NCT01920711|617608280|FG001|Overall Study|Withdrawal by Subject|3|||
170891348|NCT03551743|617608282|FG000|Overall Study|Adverse Event|1|||
170468634|NCT01191944|616053474|FG000|Overall Study|Withdrawal by Subject|4|||
170468635|NCT01191944|616053475|FG001|Overall Study|Withdrawal by Subject|2|||
170468636|NCT01191944|616053474|FG000|Overall Study|Other|1|||
170468637|NCT01191944|616053475|FG001|Overall Study|Other|3|||
170468638|NCT01422187|616053480|FG000|Overall Study|Personal reason|1|||
170468639|NCT01422187|616053481|FG001|Overall Study|Personal reason|0|||
170468640|NCT01422187|616053482|FG002|Overall Study|Personal reason|0|||
170468641|NCT01422187|616053480|FG000|Overall Study|Lost to Follow-up|0|||
170468642|NCT01422187|616053481|FG001|Overall Study|Lost to Follow-up|1|||
170468643|NCT01422187|616053482|FG002|Overall Study|Lost to Follow-up|0|||
170468644|NCT04602546|616053485|FG000|Overall Study|Training|2|||
170468645|NCT04602546|616053486|FG001|Overall Study|Training|2|||
170468646|NCT04602546|616053487|FG002|Overall Study|Training|1|||
170468647|NCT04602546|616053488|FG003|Overall Study|Training|2|||
170468648|NCT04602546|616053489|FG004|Overall Study|Training|0|||
170468649|NCT04602546|616053485|FG000|Overall Study|Randomized with disqualified data|2|||
170468650|NCT04602546|616053486|FG001|Overall Study|Randomized with disqualified data|0|||
170468651|NCT04602546|616053487|FG002|Overall Study|Randomized with disqualified data|2|||
170468652|NCT04602546|616053488|FG003|Overall Study|Randomized with disqualified data|5|||
170468653|NCT04602546|616053489|FG004|Overall Study|Randomized with disqualified data|3|||
170468654|NCT00182325|616053554|FG000|Overall Study|Lost to Follow-up|7|||
170468655|NCT00182325|616053555|FG001|Overall Study|Lost to Follow-up|7|||
170468656|NCT00182325|616053554|FG000|Overall Study|Miscarriage|5|||
170468657|NCT00182325|616053555|FG001|Overall Study|Miscarriage|3|||
170468658|NCT00182325|616053554|FG000|Overall Study|Did not complete survey|22|||
170468659|NCT00182325|616053555|FG001|Overall Study|Did not complete survey|43|||
170468660|NCT02015065|616053556|FG000|Overall Study|Death on study|1|||
170468661|NCT02015065|616053557|FG001|Overall Study|Death on study|2|||
170468662|NCT02015065|616053558|FG002|Overall Study|Death on study|1|||
170468663|NCT04751383|616053559|FG000|Overall Study|Adverse Event|1|||
170545331|NCT04233580|616340971|FG001|Overall Study|Withdrawal by Subject|1|||
170545332|NCT00625378|616340972|FG000|Overall Study|Adverse Event|22|||
170545333|NCT00625378|616340973|FG001|Overall Study|Adverse Event|0|||
170545334|NCT00625378|616340972|FG000|Overall Study|Withdrawal by Subject|16|||
170545335|NCT00625378|616340973|FG001|Overall Study|Withdrawal by Subject|0|||
170791079|NCT03899259|617245829|FG000|Overall Study|Lack of Adherence|1|||
170791080|NCT03899259|617245830|FG001|Overall Study|Lack of Adherence|0|||
170791081|NCT03899259|617245831|FG002|Overall Study|Lack of Adherence|0|||
170791082|NCT03899259|617245829|FG000|Overall Study|Screen Failure|1|||
170791083|NCT03899259|617245830|FG001|Overall Study|Screen Failure|0|||
170791084|NCT03899259|617245831|FG002|Overall Study|Screen Failure|0|||
170791085|NCT03899259|617245829|FG000|Overall Study|Ongoing Study Participation|127|||
170791086|NCT03899259|617245830|FG001|Overall Study|Ongoing Study Participation|134|||
170791087|NCT03899259|617245831|FG002|Overall Study|Ongoing Study Participation|210|||
170791088|NCT01544114|617245835|FG000|Overall Study|Withdrawal by Subject|0|||
170791089|NCT01544114|617245836|FG001|Overall Study|Withdrawal by Subject|0|||
170791090|NCT01544114|617245837|FG002|Overall Study|Withdrawal by Subject|3|||
170791091|NCT01544114|617245835|FG000|Overall Study|Lost to Follow-up|0|||
170791092|NCT01544114|617245836|FG001|Overall Study|Lost to Follow-up|2|||
170791093|NCT01544114|617245837|FG002|Overall Study|Lost to Follow-up|0|||
170791094|NCT01544114|617245835|FG000|Overall Study|Adverse Event|1|||
170791095|NCT01544114|617245836|FG001|Overall Study|Adverse Event|1|||
170791096|NCT01544114|617245837|FG002|Overall Study|Adverse Event|2|||
170791097|NCT01544114|617245835|FG000|Overall Study|Protocol Violation|0|||
170791098|NCT01544114|617245836|FG001|Overall Study|Protocol Violation|1|||
170791099|NCT01544114|617245837|FG002|Overall Study|Protocol Violation|0|||
170791100|NCT01733316|617245840|FG000|RP103 Phase|Non-compliance|1|||
170791101|NCT01733316|617245840|FG000|Long Term Extension Phase|Adverse Event|1|||
170791102|NCT01733316|617245840|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
170791103|NCT01733316|617245840|FG000|Long Term Extension Phase|Sponsor Decision|2|||
170791104|NCT03800654|617245854|FG000|Overall Study|Time constraints|3|||
170791105|NCT03800654|617245855|FG001|Overall Study|Time constraints|3|||
170791106|NCT03800654|617245856|FG002|Overall Study|Time constraints|3|||
170791107|NCT03800654|617245854|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
170791108|NCT03800654|617245855|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
170791109|NCT03800654|617245856|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
170791110|NCT03800654|617245854|FG000|Overall Study|Lost to Follow-up|2|||
170791111|NCT03800654|617245855|FG001|Overall Study|Lost to Follow-up|1|||
170791112|NCT03800654|617245856|FG002|Overall Study|Lost to Follow-up|6|||
170791113|NCT03800654|617245854|FG000|Overall Study|Medical Health Issue|0|||
170791114|NCT03800654|617245855|FG001|Overall Study|Medical Health Issue|0|||
170468664|NCT04751383|616053560|FG001|Overall Study|Adverse Event|1|||
170468665|NCT04751383|616053561|FG002|Overall Study|Adverse Event|0|||
170791115|NCT03800654|617245856|FG002|Overall Study|Medical Health Issue|1|||
170791116|NCT03800654|617245854|FG000|Overall Study|Personal Issues|0|||
170791117|NCT03800654|617245855|FG001|Overall Study|Personal Issues|2|||
170791118|NCT03800654|617245856|FG002|Overall Study|Personal Issues|0|||
170468666|NCT04751383|616053562|FG003|Overall Study|Adverse Event|0|||
170791119|NCT03800654|617245854|FG000|Overall Study|Protocol Violation|0|||
170468667|NCT04751383|616053563|FG004|Overall Study|Adverse Event|0|||
170468668|NCT04751383|616053564|FG005|Overall Study|Adverse Event|0|||
170468669|NCT04751383|616053559|FG000|Overall Study|Lack of Efficacy|6|||
170468670|NCT04751383|616053560|FG001|Overall Study|Lack of Efficacy|3|||
170468671|NCT04751383|616053561|FG002|Overall Study|Lack of Efficacy|0|||
170468672|NCT04751383|616053562|FG003|Overall Study|Lack of Efficacy|0|||
170468673|NCT04751383|616053563|FG004|Overall Study|Lack of Efficacy|0|||
170468674|NCT04751383|616053564|FG005|Overall Study|Lack of Efficacy|0|||
170468675|NCT04751383|616053559|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170468676|NCT04751383|616053560|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
170468677|NCT04751383|616053561|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170468678|NCT04751383|616053562|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170468679|NCT04751383|616053563|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170468680|NCT04751383|616053564|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170468681|NCT03485365|616053565|FG000|Overall Study|Protocol Violation|0|||
170468682|NCT03485365|616053566|FG001|Overall Study|Protocol Violation|0|||
170468683|NCT03485365|616053567|FG002|Overall Study|Protocol Violation|0|||
170468684|NCT03485365|616053568|FG003|Overall Study|Protocol Violation|1|||
170468685|NCT03485365|616053569|FG004|Overall Study|Protocol Violation|0|||
170468686|NCT03485365|616053570|FG005|Overall Study|Protocol Violation|0|||
170468687|NCT03485365|616053571|FG006|Overall Study|Protocol Violation|1|||
170468688|NCT03485365|616053572|FG007|Overall Study|Protocol Violation|0|||
170468689|NCT03485365|616053573|FG008|Overall Study|Protocol Violation|0|||
170468690|NCT03968978|616053574|FG000|Overall Study|Adverse Event|1|||
170468691|NCT03968978|616053575|FG001|Overall Study|Adverse Event|0|||
170468692|NCT02785952|616053576|FG000|Overall Study|Adverse Event|31|||
170468693|NCT02785952|616053577|FG001|Overall Study|Adverse Event|19|||
170468694|NCT02785952|616053576|FG000|Overall Study|Refusal unrelated to adverse events|10|||
170468695|NCT02785952|616053577|FG001|Overall Study|Refusal unrelated to adverse events|5|||
170468696|NCT02785952|616053576|FG000|Overall Study|Disease progression/relapse|61|||
170468697|NCT02785952|616053577|FG001|Overall Study|Disease progression/relapse|89|||
170468698|NCT02785952|616053576|FG000|Overall Study|Death|11|||
170468699|NCT02785952|616053577|FG001|Overall Study|Death|7|||
170468700|NCT02785952|616053576|FG000|Overall Study|Other- not protocol specified|6|||
170468701|NCT02785952|616053577|FG001|Overall Study|Other- not protocol specified|4|||
170468702|NCT02785952|616053576|FG000|Overall Study|On protocol treatment|6|||
170468703|NCT02785952|616053577|FG001|Overall Study|On protocol treatment|3|||
170468704|NCT00090363|616053578|FG000|Overall Study|Lost to Follow-up|1|||
170468705|NCT00090363|616053579|FG001|Overall Study|Lost to Follow-up|2|||
170468706|NCT00090363|616053580|FG002|Overall Study|Lost to Follow-up|1|||
170468707|NCT00090363|616053578|FG000|Overall Study|Withdrawal by Subject|7|||
170468708|NCT00090363|616053579|FG001|Overall Study|Withdrawal by Subject|7|||
170468709|NCT00090363|616053580|FG002|Overall Study|Withdrawal by Subject|6|||
170468710|NCT00090363|616053578|FG000|Overall Study|Study-specific discontinuation criteria|75|||
170468711|NCT00090363|616053579|FG001|Overall Study|Study-specific discontinuation criteria|74|||
170468712|NCT00090363|616053580|FG002|Overall Study|Study-specific discontinuation criteria|62|||
170468713|NCT00090363|616053578|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170468714|NCT00090363|616053579|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170468715|NCT00090363|616053580|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
170468716|NCT00090363|616053578|FG000|Overall Study|Consent expired|7|||
170468717|NCT00090363|616053579|FG001|Overall Study|Consent expired|10|||
170468718|NCT00090363|616053580|FG002|Overall Study|Consent expired|9|||
170468719|NCT00090363|616053578|FG000|Overall Study|Reasons not specified|2|||
170468720|NCT00090363|616053579|FG001|Overall Study|Reasons not specified|1|||
170468721|NCT00090363|616053580|FG002|Overall Study|Reasons not specified|1|||
170468722|NCT00090363|616053578|FG000|Overall Study|Continuing on study off treatment|14|||
170468723|NCT00090363|616053579|FG001|Overall Study|Continuing on study off treatment|13|||
170468724|NCT00090363|616053580|FG002|Overall Study|Continuing on study off treatment|16|||
170468725|NCT03972488|616053583|FG000|Overall Study|Progressive disease|42|||
170468726|NCT03972488|616053584|FG001|Overall Study|Progressive disease|44|||
170468727|NCT03972488|616053583|FG000|Overall Study|Physician Decision|13|||
170468728|NCT03972488|616053584|FG001|Overall Study|Physician Decision|7|||
170468729|NCT03972488|616053583|FG000|Overall Study|Adverse Event|8|||
170468730|NCT03972488|616053584|FG001|Overall Study|Adverse Event|1|||
170468731|NCT03972488|616053583|FG000|Overall Study|Death|4|||
170468732|NCT03972488|616053584|FG001|Overall Study|Death|4|||
170468733|NCT03972488|616053583|FG000|Overall Study|Withdrawal by Subject|3|||
170468734|NCT03972488|616053584|FG001|Overall Study|Withdrawal by Subject|4|||
170468735|NCT03972488|616053583|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
170468736|NCT03972488|616053584|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
170468737|NCT02408861|616053585|FG000|Overall Study|Death|0|||
170468738|NCT02408861|616053586|FG001|Overall Study|Death|3|||
170468739|NCT02408861|616053587|FG002|Overall Study|Death|1|||
170468740|NCT02408861|616053588|FG003|Overall Study|Death|2|||
170468741|NCT02408861|616053589|FG004|Overall Study|Death|4|||
170468742|NCT02408861|616053590|FG005|Overall Study|Death|1|||
170468743|NCT02408861|616053591|FG006|Overall Study|Death|0|||
170468744|NCT02408861|616053585|FG000|Overall Study|Lost to Follow-up|0|||
170468745|NCT02408861|616053586|FG001|Overall Study|Lost to Follow-up|0|||
170468746|NCT02408861|616053587|FG002|Overall Study|Lost to Follow-up|1|||
170468747|NCT02408861|616053588|FG003|Overall Study|Lost to Follow-up|1|||
170468748|NCT02408861|616053589|FG004|Overall Study|Lost to Follow-up|4|||
170468749|NCT02408861|616053590|FG005|Overall Study|Lost to Follow-up|2|||
170468750|NCT02408861|616053591|FG006|Overall Study|Lost to Follow-up|1|||
170468751|NCT02408861|616053585|FG000|Overall Study|Disease Progression|0|||
170468752|NCT02408861|616053586|FG001|Overall Study|Disease Progression|0|||
170468753|NCT02408861|616053587|FG002|Overall Study|Disease Progression|1|||
170468754|NCT02408861|616053588|FG003|Overall Study|Disease Progression|0|||
170468755|NCT02408861|616053589|FG004|Overall Study|Disease Progression|3|||
170468756|NCT02408861|616053590|FG005|Overall Study|Disease Progression|1|||
170468757|NCT02408861|616053591|FG006|Overall Study|Disease Progression|1|||
170468758|NCT02408861|616053585|FG000|Overall Study|Adverse Event|1|||
170468759|NCT02408861|616053586|FG001|Overall Study|Adverse Event|0|||
170468760|NCT02408861|616053587|FG002|Overall Study|Adverse Event|1|||
170791120|NCT03800654|617245855|FG001|Overall Study|Protocol Violation|1|||
170791121|NCT03800654|617245856|FG002|Overall Study|Protocol Violation|0|||
170468761|NCT02408861|616053588|FG003|Overall Study|Adverse Event|0|||
170468762|NCT02408861|616053589|FG004|Overall Study|Adverse Event|2|||
170468763|NCT02408861|616053590|FG005|Overall Study|Adverse Event|0|||
170468764|NCT02408861|616053591|FG006|Overall Study|Adverse Event|0|||
170468765|NCT02408861|616053585|FG000|Overall Study|Physician Decision|1|||
170468766|NCT02408861|616053586|FG001|Overall Study|Physician Decision|1|||
170468767|NCT02408861|616053587|FG002|Overall Study|Physician Decision|1|||
170468768|NCT02408861|616053588|FG003|Overall Study|Physician Decision|0|||
170468769|NCT02408861|616053589|FG004|Overall Study|Physician Decision|0|||
170468770|NCT02408861|616053590|FG005|Overall Study|Physician Decision|1|||
170468771|NCT02408861|616053591|FG006|Overall Study|Physician Decision|0|||
170468772|NCT02408861|616053585|FG000|Overall Study|Protocol Violation|1|||
170468773|NCT02408861|616053586|FG001|Overall Study|Protocol Violation|0|||
170468774|NCT02408861|616053587|FG002|Overall Study|Protocol Violation|0|||
170468775|NCT02408861|616053588|FG003|Overall Study|Protocol Violation|0|||
170468776|NCT02408861|616053589|FG004|Overall Study|Protocol Violation|0|||
170468777|NCT02408861|616053590|FG005|Overall Study|Protocol Violation|0|||
170468778|NCT02408861|616053591|FG006|Overall Study|Protocol Violation|0|||
170468779|NCT02408861|616053585|FG000|Overall Study|Withdrawal by Subject|0|||
170468780|NCT02408861|616053586|FG001|Overall Study|Withdrawal by Subject|0|||
170545336|NCT00625378|616340972|FG000|Overall Study|Death|38|||
170545337|NCT00625378|616340973|FG001|Overall Study|Death|0|||
170545338|NCT00625378|616340972|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
170545339|NCT00625378|616340973|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
170545340|NCT00625378|616340972|FG000|Overall Study|Lost to Follow-up|17|||
170545341|NCT00625378|616340973|FG001|Overall Study|Lost to Follow-up|0|||
170545342|NCT00625378|616340972|FG000|Overall Study|Non-compliant with study medication|3|||
170545343|NCT00625378|616340973|FG001|Overall Study|Non-compliant with study medication|0|||
170545344|NCT00625378|616340972|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
170545345|NCT00625378|616340973|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
170545346|NCT00625378|616340972|FG000|Overall Study|Medical decision|1|||
170545347|NCT00625378|616340973|FG001|Overall Study|Medical decision|0|||
170545348|NCT00625378|616340972|FG000|Overall Study|Multiple toxicities|1|||
170545349|NCT00625378|616340973|FG001|Overall Study|Multiple toxicities|0|||
170545350|NCT00625378|616340972|FG000|Overall Study|New cancer|1|||
170545351|NCT00625378|616340973|FG001|Overall Study|New cancer|0|||
170545352|NCT00625378|616340972|FG000|Overall Study|PTA program|2|||
170791122|NCT02966873|617245857|FG000|Overall Study|Lost to Follow-up|16|||
170791123|NCT02966873|617245858|FG001|Overall Study|Lost to Follow-up|15|||
170791124|NCT01456949|617245865|FG000|Enrollment|PI death- incomplete data|6|||
170791125|NCT01456949|617245865|FG000|Enrollment|Death|1|||
170468781|NCT02408861|616053587|FG002|Overall Study|Withdrawal by Subject|0|||
170468782|NCT02408861|616053588|FG003|Overall Study|Withdrawal by Subject|0|||
170468783|NCT02408861|616053589|FG004|Overall Study|Withdrawal by Subject|1|||
170468784|NCT02408861|616053590|FG005|Overall Study|Withdrawal by Subject|1|||
170468785|NCT02408861|616053591|FG006|Overall Study|Withdrawal by Subject|0|||
170545353|NCT00625378|616340973|FG001|Overall Study|PTA program|0|||
170545354|NCT00625378|616340972|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
170545355|NCT00625378|616340973|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
170791126|NCT01456949|617245865|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
170468786|NCT02408861|616053585|FG000|Overall Study|Other Treatment|0|||
170468787|NCT02408861|616053586|FG001|Overall Study|Other Treatment|0|||
170791127|NCT01456949|617245865|FG000|Enrollment|Physician Decision|10|||
170468788|NCT02408861|616053587|FG002|Overall Study|Other Treatment|0|||
170468789|NCT02408861|616053588|FG003|Overall Study|Other Treatment|0|||
170468790|NCT02408861|616053589|FG004|Overall Study|Other Treatment|0|||
170468791|NCT02408861|616053590|FG005|Overall Study|Other Treatment|1|||
170468792|NCT02408861|616053591|FG006|Overall Study|Other Treatment|1|||
170545356|NCT00625378|616340972|FG000|Overall Study|Sponsor decision|1|||
170468793|NCT05147662|616053594|FG000|Overall Study|Withdrawal by parent/guardian|3|||
170468794|NCT05147662|616053594|FG000|Overall Study|Assigned to treatment but never treated|1|||
170468795|NCT02478320|616053595|FG000|Overall Study|Adverse Event|2|||
170468796|NCT02478320|616053596|FG001|Overall Study|Adverse Event|0|||
170468797|NCT02478320|616053595|FG000|Overall Study|Death|1|||
170468798|NCT02478320|616053596|FG001|Overall Study|Death|0|||
170468799|NCT02478320|616053595|FG000|Overall Study|Lack of Efficacy|4|||
170468800|NCT02478320|616053596|FG001|Overall Study|Lack of Efficacy|0|||
170468801|NCT02478320|616053595|FG000|Overall Study|Withdrawal by Subject|2|||
170468802|NCT02478320|616053596|FG001|Overall Study|Withdrawal by Subject|0|||
170468803|NCT02478320|616053595|FG000|Overall Study|Screen Failure|3|||
170468804|NCT02478320|616053596|FG001|Overall Study|Screen Failure|0|||
170468805|NCT03185013|616053597|FG000|Overall Study|Withdrawal by Subject|5|||
170637316|NCT00607373|616684566|FG001|Follow-up Period|Other|1|||
170637317|NCT00607373|616684565|FG000|Follow-up Period|Protocol Violation|0|||
170637318|NCT00607373|616684566|FG001|Follow-up Period|Protocol Violation|1|||
170637319|NCT00607373|616684565|FG000|Follow-up Period|Withdrawal by Subject|1|||
170468806|NCT03185013|616053598|FG001|Overall Study|Withdrawal by Subject|3|||
170468807|NCT03185013|616053597|FG000|Overall Study|Adverse Event|1|||
170468808|NCT03185013|616053598|FG001|Overall Study|Adverse Event|0|||
170468809|NCT03185013|616053597|FG000|Overall Study|Progressive Disease|1|||
170468810|NCT03185013|616053598|FG001|Overall Study|Progressive Disease|0|||
170468811|NCT03185013|616053597|FG000|Overall Study|Lost to Follow-up|8|||
170468812|NCT03185013|616053598|FG001|Overall Study|Lost to Follow-up|2|||
170468813|NCT03185013|616053597|FG000|Overall Study|Physician Decision|1|||
170468814|NCT03185013|616053598|FG001|Overall Study|Physician Decision|0|||
170468815|NCT03185013|616053597|FG000|Overall Study|Protocol Deviation|2|||
170637320|NCT00607373|616684566|FG001|Follow-up Period|Withdrawal by Subject|3|||
170637321|NCT01918306|616684569|FG000|Overall Study|progresive disease|4|||
170637322|NCT01918306|616684570|FG001|Overall Study|progresive disease|0|||
170637323|NCT01918306|616684571|FG002|Overall Study|progresive disease|1|||
170637324|NCT01918306|616684572|FG003|Overall Study|progresive disease|1|||
170637325|NCT01918306|616684569|FG000|Overall Study|Withdrawal by Subject|0|||
170468816|NCT03185013|616053598|FG001|Overall Study|Protocol Deviation|0|||
170468817|NCT03185013|616053597|FG000|Overall Study|Reason not Specified|3|||
170637326|NCT01918306|616684570|FG001|Overall Study|Withdrawal by Subject|0|||
170637327|NCT01918306|616684571|FG002|Overall Study|Withdrawal by Subject|0|||
170637328|NCT01918306|616684572|FG003|Overall Study|Withdrawal by Subject|2|||
170637329|NCT01918306|616684569|FG000|Overall Study|neutropenia|1|||
170637330|NCT01918306|616684570|FG001|Overall Study|neutropenia|0|||
170637331|NCT01918306|616684571|FG002|Overall Study|neutropenia|0|||
170637332|NCT01918306|616684572|FG003|Overall Study|neutropenia|0|||
170637333|NCT01918306|616684569|FG000|Overall Study|Lack of Efficacy|1|||
170637334|NCT01918306|616684570|FG001|Overall Study|Lack of Efficacy|0|||
170637335|NCT01918306|616684571|FG002|Overall Study|Lack of Efficacy|0|||
170637336|NCT01918306|616684572|FG003|Overall Study|Lack of Efficacy|0|||
170637337|NCT01918306|616684569|FG000|Overall Study|progress disease, crossover|0|||
170637338|NCT01918306|616684570|FG001|Overall Study|progress disease, crossover|0|||
170637339|NCT01918306|616684571|FG002|Overall Study|progress disease, crossover|1|||
170468818|NCT03185013|616053598|FG001|Overall Study|Reason not Specified|2|||
170468819|NCT03185013|616053597|FG000|Overall Study|Death|1|||
170468820|NCT03185013|616053598|FG001|Overall Study|Death|0|||
170468821|NCT01806506|616053602|FG000|Overall Study|Lost to Follow-up|2|||
170468822|NCT01806506|616053603|FG001|Overall Study|Lost to Follow-up|1|||
170468823|NCT04400682|616053604|FG000|Period 1|Withdrawal by Subject|1|||
170468824|NCT04400682|616053605|FG001|Period 1|Withdrawal by Subject|4|||
170637340|NCT01918306|616684572|FG003|Overall Study|progress disease, crossover|0|||
170637341|NCT01032889|616684573|FG000|Overall Study|Adverse Event|2|||
170637342|NCT01032889|616684574|FG001|Overall Study|Adverse Event|2|||
170637343|NCT01032889|616684575|FG002|Overall Study|Adverse Event|0|||
170637344|NCT01032889|616684573|FG000|Overall Study|Withdrawal of Consent|1|||
170637345|NCT01032889|616684574|FG001|Overall Study|Withdrawal of Consent|2|||
170637346|NCT01032889|616684575|FG002|Overall Study|Withdrawal of Consent|1|||
170637347|NCT01032889|616684573|FG000|Overall Study|Patient Request|0|||
170637348|NCT01032889|616684574|FG001|Overall Study|Patient Request|1|||
170637349|NCT01032889|616684575|FG002|Overall Study|Patient Request|0|||
170637350|NCT01032889|616684573|FG000|Overall Study|Lost to Follow-up|1|||
170637351|NCT01032889|616684574|FG001|Overall Study|Lost to Follow-up|1|||
170637352|NCT01032889|616684575|FG002|Overall Study|Lost to Follow-up|0|||
170637353|NCT01032889|616684573|FG000|Overall Study|Lack of Submental Fat|2|||
170468825|NCT03316547|616053608|FG000|Overall Study|Death|3|||
170468826|NCT03316547|616053609|FG001|Overall Study|Death|1|||
170468827|NCT03316547|616053608|FG000|Overall Study|Lost to Follow-up|6|||
170468828|NCT03316547|616053609|FG001|Overall Study|Lost to Follow-up|6|||
170468829|NCT03316547|616053608|FG000|Overall Study|Withdrawal by Subject|3|||
170468830|NCT03316547|616053609|FG001|Overall Study|Withdrawal by Subject|2|||
170637354|NCT01032889|616684574|FG001|Overall Study|Lack of Submental Fat|8|||
170637355|NCT01032889|616684575|FG002|Overall Study|Lack of Submental Fat|1|||
170637356|NCT01032889|616684573|FG000|Overall Study|Miscellaneous Reasons|2|||
170791128|NCT01456949|617245865|FG000|Enrollment|Withdrawal by Subject|7|||
170468831|NCT03316547|616053608|FG000|Overall Study|Transfer to another hospital|6|||
170468832|NCT03316547|616053609|FG001|Overall Study|Transfer to another hospital|4|||
170468833|NCT01277601|616054451|FG000|Overall Study|Adverse Event|5|||
170468834|NCT01277601|616054452|FG001|Overall Study|Adverse Event|3|||
170468835|NCT01277601|616054453|FG002|Overall Study|Adverse Event|0|||
170468836|NCT01277601|616054454|FG003|Overall Study|Adverse Event|7|||
170468837|NCT01277601|616054451|FG000|Overall Study|Withdrawal by Subject|18|||
170468838|NCT01277601|616054452|FG001|Overall Study|Withdrawal by Subject|21|||
170468839|NCT01277601|616054453|FG002|Overall Study|Withdrawal by Subject|8|||
170468840|NCT01277601|616054454|FG003|Overall Study|Withdrawal by Subject|17|||
170468841|NCT01277601|616054451|FG000|Overall Study|Lost to Follow-up|7|||
170468842|NCT01277601|616054452|FG001|Overall Study|Lost to Follow-up|9|||
170468843|NCT01277601|616054453|FG002|Overall Study|Lost to Follow-up|4|||
170468844|NCT01277601|616054454|FG003|Overall Study|Lost to Follow-up|2|||
170468845|NCT01277601|616054451|FG000|Overall Study|Physician Decision|3|||
170468846|NCT01277601|616054452|FG001|Overall Study|Physician Decision|5|||
170468847|NCT01277601|616054453|FG002|Overall Study|Physician Decision|1|||
170468848|NCT01277601|616054454|FG003|Overall Study|Physician Decision|6|||
170468849|NCT01277601|616054451|FG000|Overall Study|Pregnancy|2|||
170468850|NCT01277601|616054452|FG001|Overall Study|Pregnancy|2|||
170468851|NCT01277601|616054453|FG002|Overall Study|Pregnancy|4|||
170468852|NCT01277601|616054454|FG003|Overall Study|Pregnancy|1|||
170468853|NCT01277601|616054451|FG000|Overall Study|Noncompliance with Study Drug|1|||
170468854|NCT01277601|616054452|FG001|Overall Study|Noncompliance with Study Drug|3|||
170468855|NCT01277601|616054453|FG002|Overall Study|Noncompliance with Study Drug|2|||
170468856|NCT01277601|616054454|FG003|Overall Study|Noncompliance with Study Drug|0|||
170468857|NCT01277601|616054451|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
170468858|NCT01277601|616054452|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
170468859|NCT01277601|616054453|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
170468860|NCT01277601|616054454|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
170468861|NCT01277601|616054451|FG000|Overall Study|Protocol Violation|0|||
170468862|NCT01277601|616054452|FG001|Overall Study|Protocol Violation|2|||
170468863|NCT01277601|616054453|FG002|Overall Study|Protocol Violation|5|||
170468864|NCT01277601|616054454|FG003|Overall Study|Protocol Violation|0|||
170468865|NCT01277601|616054451|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
170468866|NCT01277601|616054452|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
170468867|NCT01277601|616054453|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
170468868|NCT01277601|616054454|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
170468869|NCT03794349|616054455|FG000|Overall Study|Adverse Event|2|||
170468870|NCT03794349|616054456|FG001|Overall Study|Adverse Event|3|||
170468871|NCT03794349|616054455|FG000|Overall Study|Death|0|||
170468872|NCT03794349|616054456|FG001|Overall Study|Death|2|||
170468873|NCT03794349|616054455|FG000|Overall Study|Physician Decision|10|||
170468874|NCT03794349|616054456|FG001|Overall Study|Physician Decision|8|||
170468875|NCT03794349|616054455|FG000|Overall Study|Withdrawal by Subject|1|||
170468876|NCT03794349|616054456|FG001|Overall Study|Withdrawal by Subject|3|||
170468877|NCT03794349|616054455|FG000|Overall Study|Ineligible|2|||
170468878|NCT03794349|616054456|FG001|Overall Study|Ineligible|1|||
170468879|NCT03794349|616054455|FG000|Overall Study|Refusal|2|||
170468880|NCT03794349|616054456|FG001|Overall Study|Refusal|3|||
170468881|NCT03794349|616054455|FG000|Overall Study|Progressive Disease|7|||
170468882|NCT03794349|616054456|FG001|Overall Study|Progressive Disease|10|||
170468883|NCT03794349|616054455|FG000|Overall Study|Stable Disease after 6 Cycles|4|||
170468884|NCT03794349|616054456|FG001|Overall Study|Stable Disease after 6 Cycles|1|||
170468885|NCT03794349|616054455|FG000|Overall Study|Did not meet criteria to start next treatment cycle within 21 days after planned start of next cycle|4|||
170468886|NCT03794349|616054456|FG001|Overall Study|Did not meet criteria to start next treatment cycle within 21 days after planned start of next cycle|1|||
170468887|NCT03794349|616054455|FG000|Overall Study|Repeat eligibility studies before start of protocol therapy outside required eligibility parameters|1|||
170468888|NCT03794349|616054456|FG001|Overall Study|Repeat eligibility studies before start of protocol therapy outside required eligibility parameters|0|||
170468889|NCT05467397|616054460|FG000|Overall Study|One patient became ineligible after undergoing a renal procedure.|1|||
170468890|NCT04933474|616054463|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
170468891|NCT04933474|616054464|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
170468892|NCT04933474|616054463|FG000|Overall Study|Lost to Follow-up|19|||
170468893|NCT04933474|616054464|FG001|Overall Study|Lost to Follow-up|9|||
170468894|NCT04933474|616054463|FG000|Overall Study|Life Burden - unable to participate|6|||
170468895|NCT04933474|616054464|FG001|Overall Study|Life Burden - unable to participate|2|||
170468896|NCT04933474|616054463|FG000|Overall Study|Disease Burden - unable to participate|4|||
170468897|NCT04933474|616054464|FG001|Overall Study|Disease Burden - unable to participate|1|||
170468898|NCT04933474|616054463|FG000|Overall Study|Surgery/Hospitalization|1|||
170468899|NCT04933474|616054464|FG001|Overall Study|Surgery/Hospitalization|2|||
170468900|NCT04933474|616054463|FG000|Overall Study|Dissatisfied with Intervention|1|||
170468901|NCT04933474|616054464|FG001|Overall Study|Dissatisfied with Intervention|1|||
170468902|NCT04933474|616054463|FG000|Overall Study|Withdrew interest in participation|1|||
170468903|NCT04933474|616054464|FG001|Overall Study|Withdrew interest in participation|0|||
170468904|NCT04933474|616054463|FG000|Overall Study|Had previously enrolled in the study|0|||
170468905|NCT04933474|616054464|FG001|Overall Study|Had previously enrolled in the study|1|||
170468906|NCT01762800|616054465|FG000|Overall Study|Adverse Event|8|||
170468907|NCT01762800|616054466|FG001|Overall Study|Adverse Event|13|||
170468908|NCT01762800|616054465|FG000|Overall Study|Lack of Efficacy|3|||
170468909|NCT01762800|616054466|FG001|Overall Study|Lack of Efficacy|2|||
170468910|NCT01762800|616054465|FG000|Overall Study|Study Closed/Terminated|0|||
170468911|NCT01762800|616054466|FG001|Overall Study|Study Closed/Terminated|1|||
170468912|NCT01762800|616054465|FG000|Overall Study|Physician Decision|1|||
170468913|NCT01762800|616054466|FG001|Overall Study|Physician Decision|1|||
170468914|NCT01762800|616054465|FG000|Overall Study|Withdrawal by Subject|7|||
170468915|NCT01762800|616054466|FG001|Overall Study|Withdrawal by Subject|4|||
170468916|NCT01207583|616054467|FG000|Overall Study|Withdrawal by Subject|0|||
170468917|NCT01207583|616054468|FG001|Overall Study|Withdrawal by Subject|3|||
170468918|NCT01207583|616054469|FG002|Overall Study|Withdrawal by Subject|1|||
170468919|NCT01207583|616054467|FG000|Overall Study|Participant failed to return|1|||
170468920|NCT01207583|616054468|FG001|Overall Study|Participant failed to return|0|||
170468921|NCT01207583|616054469|FG002|Overall Study|Participant failed to return|0|||
170468922|NCT01207583|616054467|FG000|Overall Study|Lost to Follow-up|0|||
170468923|NCT01207583|616054468|FG001|Overall Study|Lost to Follow-up|2|||
170468924|NCT01207583|616054469|FG002|Overall Study|Lost to Follow-up|0|||
170468925|NCT02620579|616054471|FG000|Overall Study|Physician Decision|0|||
170468926|NCT02620579|616054472|FG001|Overall Study|Physician Decision|0|||
170468927|NCT02620579|616054473|FG002|Overall Study|Physician Decision|0|||
170468928|NCT02620579|616054474|FG003|Overall Study|Physician Decision|1|||
170468929|NCT02620579|616054471|FG000|Overall Study|Withdrawal by Subject|0|||
170468930|NCT02620579|616054472|FG001|Overall Study|Withdrawal by Subject|1|||
170468931|NCT02620579|616054473|FG002|Overall Study|Withdrawal by Subject|1|||
170468932|NCT02620579|616054474|FG003|Overall Study|Withdrawal by Subject|0|||
170468933|NCT04233424|616054475|FG000|Overall Study|Death|15|||
170468934|NCT04233424|616054476|FG001|Overall Study|Death|16|||
170468935|NCT04233424|616054475|FG000|Overall Study|Withdrawal by Subject|2|||
170468936|NCT04233424|616054476|FG001|Overall Study|Withdrawal by Subject|8|||
170468937|NCT04233424|616054475|FG000|Overall Study|Physician Decision|1|||
170468938|NCT04233424|616054476|FG001|Overall Study|Physician Decision|3|||
170468939|NCT04233424|616054475|FG000|Overall Study|Protocol Violation|3|||
170468940|NCT04233424|616054476|FG001|Overall Study|Protocol Violation|1|||
170468941|NCT04233424|616054475|FG000|Overall Study|Lost to Follow-up|1|||
170468942|NCT04233424|616054476|FG001|Overall Study|Lost to Follow-up|3|||
170468943|NCT04233424|616054475|FG000|Overall Study|subject refuse to visit site|2|||
170468944|NCT04233424|616054476|FG001|Overall Study|subject refuse to visit site|0|||
170468945|NCT00958893|616054478|FG000|Overall Study|Study prematurely terminated|4|||
170468946|NCT00378573|616054480|FG000|Treatment Period|Adverse Event|9|||
170468947|NCT00378573|616054480|FG000|Treatment Period|Physician Decision|1|||
170468948|NCT00378573|616054480|FG000|Treatment Period|Withdrawal by Subject|2|||
170468949|NCT00378573|616054480|FG000|Treatment Period|Disease Progression|4|||
170468950|NCT00378573|616054480|FG000|Treatment Period|Sponsor decision to close study|1|||
170468951|NCT00378573|616054480|FG000|Follow-up|Death|12|||
170468952|NCT00378573|616054480|FG000|Follow-up|Lost to Follow-up|1|||
170468953|NCT00378573|616054480|FG000|Follow-up|Withdrawal by Subject|1|||
170468954|NCT06232018|616054490|FG000|Overall Study|withdrew due to trauma|0|||
170468955|NCT06232018|616054491|FG001|Overall Study|withdrew due to trauma|2|||
170468956|NCT05339087|616054492|FG000|Overall Study|Withdrawal by Subject|1|||
170468957|NCT05339087|616054493|FG001|Overall Study|Withdrawal by Subject|1|||
170468958|NCT05339087|616054492|FG000|Overall Study|Early study termination|0|||
170468959|NCT05339087|616054493|FG001|Overall Study|Early study termination|1|||
170468960|NCT02181790|616054496|FG000|Overall Study|study terminated|2|||
170468961|NCT02181790|616054497|FG001|Overall Study|study terminated|0|||
170468962|NCT03276078|616054498|FG000|Overall Study|Adverse Event|1|||
170468963|NCT01275430|616054501|FG000|Overall Study|Adverse Event|1|||
170545357|NCT00625378|616340973|FG001|Overall Study|Sponsor decision|0|||
170545358|NCT00625378|616340972|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
170468964|NCT01275430|616054501|FG000|Overall Study|No Contrast Injection|6|||
170468965|NCT01275430|616054501|FG000|Overall Study|Device Malfunction|1|||
170468966|NCT01275430|616054501|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
170468967|NCT04988087|616054502|FG000|Overall Study|Adverse Event|4|||
170468968|NCT04988087|616054503|FG001|Overall Study|Adverse Event|0|||
170545359|NCT00625378|616340973|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
170468969|NCT04988087|616054504|FG002|Overall Study|Adverse Event|0|||
170468970|NCT04988087|616054505|FG003|Overall Study|Adverse Event|0|||
170468971|NCT04988087|616054502|FG000|Overall Study|Withdrawal by Subject|1|||
170468972|NCT04988087|616054503|FG001|Overall Study|Withdrawal by Subject|1|||
170468973|NCT04988087|616054504|FG002|Overall Study|Withdrawal by Subject|0|||
170468974|NCT04988087|616054505|FG003|Overall Study|Withdrawal by Subject|0|||
170468975|NCT04988087|616054502|FG000|Overall Study|Technical problems|7|||
170468976|NCT04988087|616054503|FG001|Overall Study|Technical problems|9|||
170468977|NCT04988087|616054504|FG002|Overall Study|Technical problems|1|||
170468978|NCT04988087|616054505|FG003|Overall Study|Technical problems|2|||
170468979|NCT03879577|616054506|FG000|Overall Study|Withdrawal by Subject|4|||
170468980|NCT03879577|616054506|FG000|Overall Study|Declined surgery|2|||
170468981|NCT05938621|616055360|FG000|Overall Study|Lost to Follow-up|1|||
170468982|NCT05938621|616055361|FG001|Overall Study|Lost to Follow-up|5|||
170468983|NCT05938621|616055362|FG002|Overall Study|Lost to Follow-up|2|||
170468984|NCT05938621|616055363|FG003|Overall Study|Lost to Follow-up|2|||
170468985|NCT05833139|616055367|FG000|Study Period 2|Adverse Event|1|||
170468986|NCT03922529|616055369|FG000|Overall Study|Withdrawal by Subject|13|||
170468987|NCT03922529|616055370|FG001|Overall Study|Withdrawal by Subject|12|||
170468988|NCT03922529|616055369|FG000|Overall Study|Death|7|||
170468989|NCT03922529|616055370|FG001|Overall Study|Death|12|||
170468990|NCT03922529|616055369|FG000|Overall Study|Lost to Follow-up|12|||
170468991|NCT03922529|616055370|FG001|Overall Study|Lost to Follow-up|19|||
170468992|NCT03922529|616055369|FG000|Overall Study|Adverse Event|1|||
170468993|NCT03922529|616055370|FG001|Overall Study|Adverse Event|0|||
170468994|NCT03922529|616055369|FG000|Overall Study|Death after withdrawal|1|||
170468995|NCT03922529|616055370|FG001|Overall Study|Death after withdrawal|0|||
170468996|NCT03922529|616055369|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
170468997|NCT03922529|616055370|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
170468998|NCT03922529|616055369|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
170468999|NCT03922529|616055370|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
170469000|NCT02017015|616055371|FG000|Overall Study|Adverse Event|9|||
170469001|NCT02017015|616055371|FG000|Overall Study|Withdrawal by Subject|21|||
170469002|NCT02017015|616055371|FG000|Overall Study|Death|4|||
170469003|NCT02017015|616055371|FG000|Overall Study|Progressive Disease|31|||
170469004|NCT02017015|616055371|FG000|Overall Study|Non-compliance with study drug|2|||
170469005|NCT02017015|616055371|FG000|Overall Study|Physician Decision|2|||
170469006|NCT04158245|616055373|FG000|Overall Study|Lost to Follow-up|1|||
170469007|NCT05101317|616055374|FG000|Week1-13|Adverse Event|0|||
170469008|NCT05101317|616055375|FG001|Week1-13|Adverse Event|1|||
170469009|NCT05101317|616055376|FG002|Week1-13|Adverse Event|0|||
170469010|NCT05101317|616055377|FG003|Week1-13|Adverse Event|0|||
170469011|NCT05101317|616055374|FG000|Week1-13|Withdrawal by Subject|0|||
170469012|NCT05101317|616055375|FG001|Week1-13|Withdrawal by Subject|2|||
170469013|NCT05101317|616055376|FG002|Week1-13|Withdrawal by Subject|0|||
170469014|NCT05101317|616055377|FG003|Week1-13|Withdrawal by Subject|0|||
170469015|NCT05101317|616055374|FG000|Week1-13|Early Withdrawl|0|||
170469016|NCT05101317|616055375|FG001|Week1-13|Early Withdrawl|0|||
170469017|NCT05101317|616055376|FG002|Week1-13|Early Withdrawl|0|||
170469018|NCT05101317|616055377|FG003|Week1-13|Early Withdrawl|1|||
170469019|NCT05101317|616055374|FG000|Week 13-25|Lost to Follow-up|0|||
170469020|NCT05101317|616055375|FG001|Week 13-25|Lost to Follow-up|0|||
170469021|NCT05101317|616055376|FG002|Week 13-25|Lost to Follow-up|1|||
170469022|NCT05101317|616055377|FG003|Week 13-25|Lost to Follow-up|0|||
170469023|NCT05101317|616055374|FG000|Week 13-25|Withdrawal by Subject|1|||
170469024|NCT05101317|616055375|FG001|Week 13-25|Withdrawal by Subject|1|||
170469025|NCT05101317|616055376|FG002|Week 13-25|Withdrawal by Subject|0|||
170469026|NCT05101317|616055377|FG003|Week 13-25|Withdrawal by Subject|0|||
170469027|NCT05101317|616055374|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
170469028|NCT05101317|616055375|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
170469029|NCT05101317|616055376|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
170469030|NCT05101317|616055377|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
170469031|NCT04338893|616055378|FG000|Overall Study|Withdrawal by Subject|10|||
170469032|NCT04338893|616055379|FG001|Overall Study|Withdrawal by Subject|10|||
170469033|NCT04338893|616055378|FG000|Overall Study|Death|0|||
170469034|NCT04338893|616055379|FG001|Overall Study|Death|1|||
170469035|NCT04338893|616055378|FG000|Overall Study|Adverse Event|2|||
170469036|NCT04338893|616055379|FG001|Overall Study|Adverse Event|0|||
170469037|NCT04338893|616055378|FG000|Overall Study|Lost to Follow-up|23|||
170545360|NCT00625378|616340972|FG000|Overall Study|Switch to commercial drug|6|||
170545361|NCT00625378|616340973|FG001|Overall Study|Switch to commercial drug|1|||
170469038|NCT04338893|616055379|FG001|Overall Study|Lost to Follow-up|15|||
170469039|NCT02465398|616055381|FG000|Overall Study|Death|7|||
170469040|NCT02465398|616055381|FG000|Overall Study|Revision|7|||
170469041|NCT02465398|616055381|FG000|Overall Study|did not receive study device|1|||
170469042|NCT02465398|616055381|FG000|Overall Study|Withdrawal by Subject|1|||
170469043|NCT02465398|616055381|FG000|Overall Study|Lost to Follow-up|14|||
170469044|NCT02540850|616055382|FG000|Overall Study|Lost to Follow-up|69|||
170469045|NCT02540850|616055383|FG001|Overall Study|Lost to Follow-up|66|||
170469046|NCT02540850|616055384|FG002|Overall Study|Lost to Follow-up|34|||
170469047|NCT03760185|616055385|FG000|Overall Study|Lost to Follow-up|1|||
170469048|NCT03760185|616055386|FG001|Overall Study|Lost to Follow-up|1|||
170469049|NCT02794246|616055387|FG000|Overall Study|Withdrawal by Subject|2|||
170469050|NCT02794246|616055387|FG000|Overall Study|Physician Decision|4|||
170469051|NCT02640690|616055389|FG000|Overall Study|Lost to Follow-up|7|||
170545362|NCT00625378|616340972|FG000|Overall Study|Missing|2|||
170637357|NCT01032889|616684574|FG001|Overall Study|Miscellaneous Reasons|1|||
170637358|NCT01032889|616684575|FG002|Overall Study|Miscellaneous Reasons|1|||
170637359|NCT02039843|616684577|FG000|Randomization and Observation Period|Adverse Event|2|||
170637360|NCT02039843|616684578|FG001|Randomization and Observation Period|Adverse Event|0|||
170637361|NCT02039843|616684577|FG000|Randomization and Observation Period|Death|1|||
170637362|NCT02039843|616684578|FG001|Randomization and Observation Period|Death|0|||
170637363|NCT02039843|616684577|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
170637364|NCT02039843|616684578|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
170637365|NCT02039843|616684577|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
170637366|NCT02039843|616684578|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
170637367|NCT02039843|616684577|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
170637368|NCT02039843|616684578|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
170637369|NCT02039843|616684577|FG000|Pairing With a Study Dog|Death|1|||
170637370|NCT02039843|616684578|FG001|Pairing With a Study Dog|Death|0|||
170637371|NCT02039843|616684577|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
170637372|NCT02039843|616684578|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
170637373|NCT02039843|616684577|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
170637374|NCT02039843|616684578|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
170637375|NCT02039843|616684577|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
170469052|NCT02640690|616055390|FG001|Overall Study|Lost to Follow-up|7|||
170469053|NCT02640690|616055389|FG000|Overall Study|Withdrawal by Subject|16|||
170469054|NCT02640690|616055390|FG001|Overall Study|Withdrawal by Subject|20|||
170469055|NCT02640690|616055389|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
170469056|NCT02640690|616055390|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
170469057|NCT04642365|616055394|FG000|Overall Study|Death|3|||
170791129|NCT01456949|617245865|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
170791130|NCT01456949|617245865|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
170791131|NCT01456949|617245865|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
170791132|NCT01456949|617245865|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
170791133|NCT01456949|617245865|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
170791134|NCT01456949|617245865|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
170791135|NCT01456949|617245865|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
170791136|NCT01456949|617245865|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
170791137|NCT05907174|617245872|FG000|3-Month Assessment|Withdrawal by Subject|0|||
170791138|NCT05907174|617245873|FG001|3-Month Assessment|Withdrawal by Subject|0|||
170791139|NCT05907174|617245874|FG002|3-Month Assessment|Withdrawal by Subject|0|||
170791140|NCT05907174|617245875|FG003|3-Month Assessment|Withdrawal by Subject|1|||
170791141|NCT05907174|617245872|FG000|3-Month Assessment|Lost to Follow-up|1|||
170791142|NCT05907174|617245873|FG001|3-Month Assessment|Lost to Follow-up|1|||
170791143|NCT05907174|617245874|FG002|3-Month Assessment|Lost to Follow-up|1|||
170791144|NCT05907174|617245875|FG003|3-Month Assessment|Lost to Follow-up|1|||
170469058|NCT04642365|616055395|FG001|Overall Study|Death|2|||
170469059|NCT04642365|616055396|FG002|Overall Study|Death|4|||
170469060|NCT04642365|616055397|FG003|Overall Study|Death|5|||
170469061|NCT04642365|616055398|FG004|Overall Study|Death|5|||
170469062|NCT04642365|616055399|FG005|Overall Study|Death|3|||
170469063|NCT04642365|616055400|FG006|Overall Study|Death|2|||
170469064|NCT04642365|616055401|FG007|Overall Study|Death|1|||
170469065|NCT04642365|616055394|FG000|Overall Study|Physician Decision|1|||
170469066|NCT04642365|616055395|FG001|Overall Study|Physician Decision|0|||
170469067|NCT04642365|616055396|FG002|Overall Study|Physician Decision|0|||
170469068|NCT04642365|616055397|FG003|Overall Study|Physician Decision|0|||
170469069|NCT04642365|616055398|FG004|Overall Study|Physician Decision|0|||
170469070|NCT04642365|616055399|FG005|Overall Study|Physician Decision|0|||
170469071|NCT04642365|616055400|FG006|Overall Study|Physician Decision|0|||
170791145|NCT05907174|617245872|FG000|6-Month Assessment|Death|0|||
170469072|NCT04642365|616055401|FG007|Overall Study|Physician Decision|0|||
170469073|NCT04642365|616055394|FG000|Overall Study|Progressive Disease|1|||
170469074|NCT04642365|616055395|FG001|Overall Study|Progressive Disease|1|||
170469075|NCT04642365|616055396|FG002|Overall Study|Progressive Disease|1|||
170469076|NCT04642365|616055397|FG003|Overall Study|Progressive Disease|0|||
170469077|NCT04642365|616055398|FG004|Overall Study|Progressive Disease|0|||
170469078|NCT04642365|616055399|FG005|Overall Study|Progressive Disease|0|||
170469079|NCT04642365|616055400|FG006|Overall Study|Progressive Disease|1|||
170469080|NCT04642365|616055401|FG007|Overall Study|Progressive Disease|0|||
170469081|NCT04642365|616055394|FG000|Overall Study|Study Terminated By Sponsor|0|||
170469082|NCT04642365|616055395|FG001|Overall Study|Study Terminated By Sponsor|2|||
170469083|NCT04642365|616055396|FG002|Overall Study|Study Terminated By Sponsor|1|||
170469084|NCT04642365|616055397|FG003|Overall Study|Study Terminated By Sponsor|1|||
170469085|NCT04642365|616055398|FG004|Overall Study|Study Terminated By Sponsor|1|||
170469086|NCT04642365|616055399|FG005|Overall Study|Study Terminated By Sponsor|2|||
170469087|NCT04642365|616055400|FG006|Overall Study|Study Terminated By Sponsor|2|||
170469088|NCT04642365|616055401|FG007|Overall Study|Study Terminated By Sponsor|1|||
170469089|NCT04642365|616055394|FG000|Overall Study|Symptomatic Deterioration|1|||
170469090|NCT04642365|616055395|FG001|Overall Study|Symptomatic Deterioration|1|||
170469091|NCT04642365|616055396|FG002|Overall Study|Symptomatic Deterioration|0|||
170469092|NCT04642365|616055397|FG003|Overall Study|Symptomatic Deterioration|0|||
170791146|NCT05907174|617245873|FG001|6-Month Assessment|Death|0|||
170791147|NCT05907174|617245874|FG002|6-Month Assessment|Death|3|||
170791148|NCT05907174|617245875|FG003|6-Month Assessment|Death|0|||
170791149|NCT05907174|617245872|FG000|6-Month Assessment|Withdrawal by Subject|0|||
170791150|NCT05907174|617245873|FG001|6-Month Assessment|Withdrawal by Subject|0|||
170791151|NCT05907174|617245874|FG002|6-Month Assessment|Withdrawal by Subject|1|||
170791152|NCT05907174|617245875|FG003|6-Month Assessment|Withdrawal by Subject|1|||
170791153|NCT05907174|617245872|FG000|6-Month Assessment|Lost to Follow-up|0|||
170469093|NCT04642365|616055398|FG004|Overall Study|Symptomatic Deterioration|0|||
170469094|NCT04642365|616055399|FG005|Overall Study|Symptomatic Deterioration|1|||
170469095|NCT04642365|616055400|FG006|Overall Study|Symptomatic Deterioration|0|||
170469096|NCT04642365|616055401|FG007|Overall Study|Symptomatic Deterioration|0|||
170791154|NCT05907174|617245873|FG001|6-Month Assessment|Lost to Follow-up|1|||
170791155|NCT05907174|617245874|FG002|6-Month Assessment|Lost to Follow-up|1|||
170791156|NCT05907174|617245875|FG003|6-Month Assessment|Lost to Follow-up|1|||
170469097|NCT04642365|616055394|FG000|Overall Study|Withdrawal by Subject|0|||
170469098|NCT04642365|616055395|FG001|Overall Study|Withdrawal by Subject|0|||
170469099|NCT04642365|616055396|FG002|Overall Study|Withdrawal by Subject|1|||
170469100|NCT04642365|616055397|FG003|Overall Study|Withdrawal by Subject|1|||
170469101|NCT04642365|616055398|FG004|Overall Study|Withdrawal by Subject|0|||
170469102|NCT04642365|616055399|FG005|Overall Study|Withdrawal by Subject|0|||
170469103|NCT04642365|616055400|FG006|Overall Study|Withdrawal by Subject|2|||
170791157|NCT04498390|617245876|FG000|Overall Study|Adverse Event|0|||
170791158|NCT04498390|617245877|FG001|Overall Study|Adverse Event|0|||
170791159|NCT04498390|617245878|FG002|Overall Study|Adverse Event|1|||
170791160|NCT04498390|617245879|FG003|Overall Study|Adverse Event|0|||
170791161|NCT04498390|617245880|FG004|Overall Study|Adverse Event|0|||
170791162|NCT04498390|617245876|FG000|Overall Study|Withdrawal by Subject|0|||
170791163|NCT04498390|617245877|FG001|Overall Study|Withdrawal by Subject|0|||
170791164|NCT04498390|617245878|FG002|Overall Study|Withdrawal by Subject|0|||
170791165|NCT04498390|617245879|FG003|Overall Study|Withdrawal by Subject|1|||
170791166|NCT04498390|617245880|FG004|Overall Study|Withdrawal by Subject|0|||
170791167|NCT03910478|617245885|FG000|Overall Study|Death|13|||
170791168|NCT03910478|617245886|FG001|Overall Study|Death|6|||
170791169|NCT03910478|617245885|FG000|Overall Study|Withdrawal by Subject|23|||
170469104|NCT04642365|616055401|FG007|Overall Study|Withdrawal by Subject|0|||
170469105|NCT04642365|616055394|FG000|Overall Study|Adverse Event|0|||
170469106|NCT04642365|616055395|FG001|Overall Study|Adverse Event|0|||
170469107|NCT04642365|616055396|FG002|Overall Study|Adverse Event|0|||
170791170|NCT03910478|617245886|FG001|Overall Study|Withdrawal by Subject|2|||
170791171|NCT03910478|617245885|FG000|Overall Study|Physician Decision|5|||
170791172|NCT03910478|617245886|FG001|Overall Study|Physician Decision|0|||
170791173|NCT03910478|617245885|FG000|Overall Study|Protocol Violation|1|||
170791174|NCT03910478|617245886|FG001|Overall Study|Protocol Violation|0|||
170791175|NCT03910478|617245885|FG000|Overall Study|Failure to meet continuation criteria|2|||
170791176|NCT03910478|617245886|FG001|Overall Study|Failure to meet continuation criteria|0|||
170791177|NCT03910478|617245885|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
170791178|NCT03910478|617245886|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
170791179|NCT03209973|617245887|FG000|Overall Study|Withdrawal by Subject|7|||
170791180|NCT03209973|617245887|FG000|Overall Study|Lost to Follow-up|2|||
170791181|NCT03209973|617245887|FG000|Overall Study|Death|8|||
170791182|NCT03209973|617245887|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
170791183|NCT03209973|617245887|FG000|Overall Study|Sponsor Decision|18|||
170791184|NCT03209973|617245887|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
170791185|NCT03209973|617245887|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
170791186|NCT04800211|617245888|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
170791187|NCT04800211|617245889|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
170791188|NCT04800211|617245890|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
170791189|NCT04800211|617245888|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
170791190|NCT04800211|617245889|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
170791191|NCT04800211|617245890|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
170791192|NCT04800211|617245888|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
170791193|NCT04800211|617245889|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
170791194|NCT04800211|617245890|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
170791195|NCT04800211|617245888|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
170791196|NCT04800211|617245889|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
170791197|NCT04800211|617245890|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
170791198|NCT04800211|617245888|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
170469108|NCT04642365|616055397|FG003|Overall Study|Adverse Event|0|||
170469109|NCT04642365|616055398|FG004|Overall Study|Adverse Event|0|||
170469110|NCT04642365|616055399|FG005|Overall Study|Adverse Event|0|||
170469111|NCT04642365|616055400|FG006|Overall Study|Adverse Event|0|||
170469112|NCT04642365|616055401|FG007|Overall Study|Adverse Event|1|||
170469113|NCT02728843|616055402|FG000|Overall Study|Adverse Event|0|||
170469114|NCT02728843|616055403|FG001|Overall Study|Adverse Event|2|||
170469115|NCT02728843|616055404|FG002|Overall Study|Adverse Event|3|||
170469116|NCT02728843|616055405|FG003|Overall Study|Adverse Event|1|||
170469117|NCT02728843|616055406|FG004|Overall Study|Adverse Event|2|||
170469118|NCT02728843|616055402|FG000|Overall Study|Lack of Efficacy|0|||
170469119|NCT02728843|616055403|FG001|Overall Study|Lack of Efficacy|1|||
170791199|NCT04800211|617245889|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
170791200|NCT04800211|617245890|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
170791201|NCT04800211|617245888|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
170791202|NCT04800211|617245889|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
170791203|NCT04800211|617245890|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
170791204|NCT04800211|617245888|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
170469120|NCT02728843|616055404|FG002|Overall Study|Lack of Efficacy|1|||
170469121|NCT02728843|616055405|FG003|Overall Study|Lack of Efficacy|0|||
170791205|NCT04800211|617245889|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
170791206|NCT04800211|617245890|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
170469122|NCT02728843|616055406|FG004|Overall Study|Lack of Efficacy|0|||
170469123|NCT02728843|616055402|FG000|Overall Study|Protocol Violation|2|||
170469124|NCT02728843|616055403|FG001|Overall Study|Protocol Violation|0|||
170469125|NCT02728843|616055404|FG002|Overall Study|Protocol Violation|4|||
170469126|NCT02728843|616055405|FG003|Overall Study|Protocol Violation|2|||
170469127|NCT02728843|616055406|FG004|Overall Study|Protocol Violation|2|||
170469128|NCT02728843|616055402|FG000|Overall Study|Withdrawal by Subject|1|||
170469129|NCT02728843|616055403|FG001|Overall Study|Withdrawal by Subject|0|||
170469130|NCT02728843|616055404|FG002|Overall Study|Withdrawal by Subject|0|||
170469131|NCT02728843|616055405|FG003|Overall Study|Withdrawal by Subject|1|||
170469132|NCT02728843|616055406|FG004|Overall Study|Withdrawal by Subject|0|||
170469133|NCT02728843|616055402|FG000|Overall Study|Use of rescue medication|0|||
170469134|NCT02728843|616055403|FG001|Overall Study|Use of rescue medication|2|||
170469135|NCT02728843|616055404|FG002|Overall Study|Use of rescue medication|0|||
170469136|NCT02728843|616055405|FG003|Overall Study|Use of rescue medication|2|||
170469137|NCT02728843|616055406|FG004|Overall Study|Use of rescue medication|1|||
170469138|NCT04544995|616055409|FG000|Overall Study|Death|7|||
170469139|NCT04544995|616055410|FG001|Overall Study|Death|3|||
170469140|NCT04544995|616055411|FG002|Overall Study|Death|3|||
170469141|NCT04544995|616055412|FG003|Overall Study|Death|3|||
170469142|NCT04544995|616055413|FG004|Overall Study|Death|1|||
170469143|NCT04544995|616055414|FG005|Overall Study|Death|2|||
170469144|NCT04544995|616055415|FG006|Overall Study|Death|1|||
170545363|NCT00625378|616340973|FG001|Overall Study|Missing|0|||
170545364|NCT00625378|616340972|FG000|Overall Study|End of treatment not available|2|||
170545365|NCT00625378|616340973|FG001|Overall Study|End of treatment not available|0|||
170545366|NCT00625378|616340972|FG000|Overall Study|Never treated|2|||
170545367|NCT00625378|616340973|FG001|Overall Study|Never treated|0|||
170545368|NCT01371565|616340974|FG000|Overall Study|Withdrawal by Subject|1|||
170545369|NCT01371565|616340974|FG000|Overall Study|Death|1|||
170545370|NCT01371565|616340974|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
170545371|NCT02565186|616340975|FG000|Overall Study|Adverse Event|113|||
170545372|NCT02565186|616340976|FG001|Overall Study|Adverse Event|148|||
170545373|NCT02565186|616340975|FG000|Overall Study|Lost to Follow-up|102|||
170545374|NCT02565186|616340976|FG001|Overall Study|Lost to Follow-up|93|||
170545375|NCT02565186|616340975|FG000|Overall Study|Non-Compliance|57|||
170545376|NCT02565186|616340976|FG001|Overall Study|Non-Compliance|55|||
170545377|NCT02565186|616340975|FG000|Overall Study|Withdrawal by Subject|229|||
170545378|NCT02565186|616340976|FG001|Overall Study|Withdrawal by Subject|214|||
170545379|NCT02565186|616340975|FG000|Overall Study|Physician Decision|18|||
170545380|NCT02565186|616340976|FG001|Overall Study|Physician Decision|16|||
170545381|NCT02565186|616340975|FG000|Overall Study|Sponsor Request|5|||
170545382|NCT02565186|616340976|FG001|Overall Study|Sponsor Request|9|||
170545383|NCT02565186|616340975|FG000|Overall Study|Missing|1|||
170545384|NCT02565186|616340976|FG001|Overall Study|Missing|0|||
170545385|NCT02565186|616340975|FG000|Overall Study|Did Not Receive Study Drug|55|||
170545386|NCT02565186|616340976|FG001|Overall Study|Did Not Receive Study Drug|86|||
170545387|NCT02609633|616340977|FG000|Overall Study|Consent Withdrawn|0|||
170545388|NCT02609633|616340978|FG001|Overall Study|Consent Withdrawn|1|||
170545389|NCT02609633|616340977|FG000|Overall Study|Protocol Deviation|1|||
170545390|NCT02609633|616340978|FG001|Overall Study|Protocol Deviation|0|||
170545391|NCT02609633|616340977|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
170545392|NCT02609633|616340978|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
170545393|NCT02609633|616340977|FG000|Overall Study|Reason not Specified|2|||
170545394|NCT02609633|616340978|FG001|Overall Study|Reason not Specified|1|||
170545395|NCT03670628|616340981|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
170545396|NCT03670628|616340982|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
170545397|NCT03670628|616340981|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
170545398|NCT03670628|616340982|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
170545399|NCT00899847|616340986|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
170545400|NCT02287025|616340987|FG000|Overall Study|Not treated|2|||
170545401|NCT02287025|616340988|FG001|Overall Study|Not treated|0|||
170545402|NCT02287025|616340987|FG000|Overall Study|Progression of disease|3|||
170545403|NCT02287025|616340988|FG001|Overall Study|Progression of disease|2|||
170545404|NCT02287025|616340987|FG000|Overall Study|Adverse Event|2|||
170545405|NCT02287025|616340988|FG001|Overall Study|Adverse Event|4|||
170545406|NCT02287025|616340987|FG000|Overall Study|Withdrawal by Subject|2|||
170545407|NCT02287025|616340988|FG001|Overall Study|Withdrawal by Subject|2|||
170545408|NCT02287025|616340987|FG000|Overall Study|Screening failed|1|||
170545409|NCT02287025|616340988|FG001|Overall Study|Screening failed|1|||
170791207|NCT04800211|617245888|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
170469145|NCT04544995|616055409|FG000|Overall Study|Lost to Follow-up|0|||
170469146|NCT04544995|616055410|FG001|Overall Study|Lost to Follow-up|0|||
170469147|NCT04544995|616055411|FG002|Overall Study|Lost to Follow-up|0|||
170469148|NCT04544995|616055412|FG003|Overall Study|Lost to Follow-up|0|||
170545410|NCT01769443|616340989|FG000|Overall Study|Study closure|1|||
170545411|NCT01769443|616340990|FG001|Overall Study|Study closure|0|||
170545412|NCT04996264|616340991|FG000|Overall Study|Lost to Follow-up|0|||
170469149|NCT04544995|616055413|FG004|Overall Study|Lost to Follow-up|1|||
170469150|NCT04544995|616055414|FG005|Overall Study|Lost to Follow-up|0|||
170469151|NCT04544995|616055415|FG006|Overall Study|Lost to Follow-up|0|||
170469152|NCT04544995|616055409|FG000|Overall Study|Physician Decision|0|||
170469153|NCT04544995|616055410|FG001|Overall Study|Physician Decision|0|||
170469154|NCT04544995|616055411|FG002|Overall Study|Physician Decision|0|||
170469155|NCT04544995|616055412|FG003|Overall Study|Physician Decision|0|||
170469156|NCT04544995|616055413|FG004|Overall Study|Physician Decision|5|||
170469157|NCT04544995|616055414|FG005|Overall Study|Physician Decision|0|||
170469158|NCT04544995|616055415|FG006|Overall Study|Physician Decision|0|||
170469159|NCT04544995|616055409|FG000|Overall Study|Withdrawal by Subject|0|||
170469160|NCT04544995|616055410|FG001|Overall Study|Withdrawal by Subject|0|||
170469161|NCT04544995|616055411|FG002|Overall Study|Withdrawal by Subject|0|||
170469162|NCT04544995|616055412|FG003|Overall Study|Withdrawal by Subject|0|||
170469163|NCT04544995|616055413|FG004|Overall Study|Withdrawal by Subject|0|||
170469164|NCT04544995|616055414|FG005|Overall Study|Withdrawal by Subject|1|||
170469165|NCT04544995|616055415|FG006|Overall Study|Withdrawal by Subject|0|||
170469166|NCT04544995|616055409|FG000|Overall Study|Study Terminated by Sponsor|1|||
170469167|NCT04544995|616055410|FG001|Overall Study|Study Terminated by Sponsor|0|||
170469168|NCT04544995|616055411|FG002|Overall Study|Study Terminated by Sponsor|0|||
170469169|NCT04544995|616055412|FG003|Overall Study|Study Terminated by Sponsor|0|||
170469170|NCT04544995|616055413|FG004|Overall Study|Study Terminated by Sponsor|0|||
170469171|NCT04544995|616055414|FG005|Overall Study|Study Terminated by Sponsor|0|||
170469172|NCT04544995|616055415|FG006|Overall Study|Study Terminated by Sponsor|1|||
170469173|NCT04544995|616055409|FG000|Overall Study|Reached protocol-defined stopping criteria|3|||
170469174|NCT04544995|616055410|FG001|Overall Study|Reached protocol-defined stopping criteria|4|||
170469175|NCT04544995|616055411|FG002|Overall Study|Reached protocol-defined stopping criteria|2|||
170469176|NCT04544995|616055412|FG003|Overall Study|Reached protocol-defined stopping criteria|0|||
170469177|NCT04544995|616055413|FG004|Overall Study|Reached protocol-defined stopping criteria|4|||
170469178|NCT04544995|616055414|FG005|Overall Study|Reached protocol-defined stopping criteria|4|||
170469179|NCT04544995|616055415|FG006|Overall Study|Reached protocol-defined stopping criteria|1|||
170469180|NCT05038800|616055416|FG000|Overall Study|Death|1|||
170469181|NCT05038800|616055417|FG001|Overall Study|Death|1|||
170469182|NCT05038800|616055418|FG002|Overall Study|Death|5|||
170469183|NCT05038800|616055419|FG003|Overall Study|Death|3|||
170469184|NCT05038800|616055420|FG004|Overall Study|Death|1|||
170469185|NCT05038800|616055416|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170469186|NCT05038800|616055417|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170469187|NCT05038800|616055418|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170469188|NCT05038800|616055419|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170469189|NCT05038800|616055420|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170469190|NCT05038800|616055416|FG000|Overall Study|Lack of Efficacy|0|||
170469191|NCT05038800|616055417|FG001|Overall Study|Lack of Efficacy|0|||
170469192|NCT05038800|616055418|FG002|Overall Study|Lack of Efficacy|0|||
170469193|NCT05038800|616055419|FG003|Overall Study|Lack of Efficacy|0|||
170469194|NCT05038800|616055420|FG004|Overall Study|Lack of Efficacy|1|||
170469195|NCT03255655|616055421|FG000|Overall Study|Lost to Follow-up|7|||
170469196|NCT03255655|616055422|FG001|Overall Study|Lost to Follow-up|4|||
170469197|NCT02105974|616055423|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
170637376|NCT02039843|616684578|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
170637377|NCT02624986|616684583|FG000|Overall Study|Death|0|||
170469198|NCT02105974|616055424|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
170469199|NCT02105974|616055425|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
170469200|NCT02105974|616055423|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
170637378|NCT02624986|616684584|FG001|Overall Study|Death|1|||
170637379|NCT02624986|616684585|FG002|Overall Study|Death|2|||
170637380|NCT02624986|616684586|FG003|Overall Study|Death|2|||
170637381|NCT02624986|616684587|FG004|Overall Study|Death|2|||
170637382|NCT02624986|616684588|FG005|Overall Study|Death|0|||
170637383|NCT02624986|616684589|FG006|Overall Study|Death|0|||
170637384|NCT02624986|616684590|FG007|Overall Study|Death|1|||
170637385|NCT02624986|616684583|FG000|Overall Study|Study Terminated by Sponsor|1|||
170637386|NCT02624986|616684584|FG001|Overall Study|Study Terminated by Sponsor|1|||
170637387|NCT02624986|616684585|FG002|Overall Study|Study Terminated by Sponsor|0|||
170637388|NCT02624986|616684586|FG003|Overall Study|Study Terminated by Sponsor|1|||
170637389|NCT02624986|616684587|FG004|Overall Study|Study Terminated by Sponsor|2|||
170637390|NCT02624986|616684588|FG005|Overall Study|Study Terminated by Sponsor|2|||
170637391|NCT02624986|616684589|FG006|Overall Study|Study Terminated by Sponsor|4|||
170637392|NCT02624986|616684590|FG007|Overall Study|Study Terminated by Sponsor|3|||
170637393|NCT02624986|616684583|FG000|Overall Study|Progressive Disease|0|||
170637394|NCT02624986|616684584|FG001|Overall Study|Progressive Disease|1|||
170637395|NCT02624986|616684585|FG002|Overall Study|Progressive Disease|0|||
170637396|NCT02624986|616684586|FG003|Overall Study|Progressive Disease|0|||
170637397|NCT02624986|616684587|FG004|Overall Study|Progressive Disease|0|||
170637398|NCT02624986|616684588|FG005|Overall Study|Progressive Disease|0|||
170637399|NCT02624986|616684589|FG006|Overall Study|Progressive Disease|0|||
170637400|NCT02624986|616684590|FG007|Overall Study|Progressive Disease|0|||
170469201|NCT02105974|616055424|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
170469202|NCT02105974|616055425|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
170469203|NCT02105974|616055423|FG000|2 Week Run-in Period|Adverse Event|6|||
170469204|NCT02105974|616055424|FG001|2 Week Run-in Period|Adverse Event|0|||
170469205|NCT02105974|616055425|FG002|2 Week Run-in Period|Adverse Event|0|||
170469206|NCT02105974|616055423|FG000|2 Week Run-in Period|Study closed/terminated|1|||
170469207|NCT02105974|616055424|FG001|2 Week Run-in Period|Study closed/terminated|0|||
170469208|NCT02105974|616055425|FG002|2 Week Run-in Period|Study closed/terminated|0|||
170469209|NCT02105974|616055423|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
170469210|NCT02105974|616055424|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
170469211|NCT02105974|616055425|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
170469212|NCT02105974|616055423|FG000|2 Week Run-in Period|Withdrew consent|23|||
170469213|NCT02105974|616055424|FG001|2 Week Run-in Period|Withdrew consent|0|||
170469214|NCT02105974|616055425|FG002|2 Week Run-in Period|Withdrew consent|0|||
170469215|NCT02105974|616055423|FG000|2 Week Run-in Period|Investigator discretion|8|||
170469216|NCT02105974|616055424|FG001|2 Week Run-in Period|Investigator discretion|0|||
170469217|NCT02105974|616055425|FG002|2 Week Run-in Period|Investigator discretion|0|||
170469218|NCT02105974|616055423|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
170469219|NCT02105974|616055424|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
170469220|NCT02105974|616055425|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
170469221|NCT02105974|616055423|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
170469222|NCT02105974|616055424|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
170469223|NCT02105974|616055425|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
170469224|NCT02105974|616055423|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
170469225|NCT02105974|616055424|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
170469226|NCT02105974|616055425|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
170469227|NCT02105974|616055423|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
170469228|NCT02105974|616055424|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
170637401|NCT02624986|616684583|FG000|Overall Study|Protocol Violation|1|||
170637402|NCT02624986|616684584|FG001|Overall Study|Protocol Violation|0|||
170637403|NCT02624986|616684585|FG002|Overall Study|Protocol Violation|0|||
170637404|NCT02624986|616684586|FG003|Overall Study|Protocol Violation|0|||
170637405|NCT02624986|616684587|FG004|Overall Study|Protocol Violation|0|||
170637406|NCT02624986|616684588|FG005|Overall Study|Protocol Violation|0|||
170637407|NCT02624986|616684589|FG006|Overall Study|Protocol Violation|0|||
170637408|NCT02624986|616684590|FG007|Overall Study|Protocol Violation|0|||
170637409|NCT02624986|616684583|FG000|Overall Study|Withdrawal by Subject|0|||
170637410|NCT02624986|616684584|FG001|Overall Study|Withdrawal by Subject|0|||
170637411|NCT02624986|616684585|FG002|Overall Study|Withdrawal by Subject|0|||
170637412|NCT02624986|616684586|FG003|Overall Study|Withdrawal by Subject|0|||
170637413|NCT02624986|616684587|FG004|Overall Study|Withdrawal by Subject|0|||
170637414|NCT02624986|616684588|FG005|Overall Study|Withdrawal by Subject|0|||
170637415|NCT02624986|616684589|FG006|Overall Study|Withdrawal by Subject|0|||
170637416|NCT02624986|616684590|FG007|Overall Study|Withdrawal by Subject|1|||
170637417|NCT02963506|616684591|FG000|Double-Blind Period|Adverse Event|0|||
170791208|NCT04800211|617245889|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
170791209|NCT04800211|617245890|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
170791210|NCT04800211|617245888|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
170791211|NCT04800211|617245889|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
170637418|NCT02963506|616684592|FG001|Double-Blind Period|Adverse Event|0|||
170637419|NCT02963506|616684593|FG002|Double-Blind Period|Adverse Event|1|||
170469229|NCT02105974|616055425|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
170469230|NCT02105974|616055423|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
170469231|NCT02105974|616055424|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
170469232|NCT02105974|616055425|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
170469233|NCT02105974|616055423|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
170469234|NCT02105974|616055424|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
170469235|NCT02105974|616055425|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
170469236|NCT02105974|616055423|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
170469237|NCT02105974|616055424|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
170469238|NCT02105974|616055425|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
170469239|NCT05985304|616055429|FG000|Overall Study|Protocol Violation|1|||
170469240|NCT05985304|616055430|FG001|Overall Study|Protocol Violation|0|||
170469241|NCT05985304|616055429|FG000|Overall Study|Withdrawal by Subject|0|||
170469242|NCT05985304|616055430|FG001|Overall Study|Withdrawal by Subject|2|||
170469243|NCT05985304|616055429|FG000|Overall Study|Subject was not implanted with the study device|0|||
170469244|NCT05985304|616055430|FG001|Overall Study|Subject was not implanted with the study device|2|||
170469245|NCT04825912|616056972|FG000|Overall Study|Death|3|||
170469246|NCT04825912|616056972|FG000|Overall Study|Withdrawal by Subject|1|||
170469247|NCT00976911|616056978|FG000|Overall Study|Withdrawal by Subject|4|||
170469248|NCT00976911|616056979|FG001|Overall Study|Withdrawal by Subject|6|||
170469249|NCT00976911|616056978|FG000|Overall Study|Death|138|||
170469250|NCT00976911|616056979|FG001|Overall Study|Death|126|||
170469251|NCT00976911|616056978|FG000|Overall Study|Adverse Event|0|||
170469252|NCT00976911|616056979|FG001|Overall Study|Adverse Event|1|||
170469253|NCT00976911|616056978|FG000|Overall Study|Protocol Violation|2|||
170469254|NCT00976911|616056979|FG001|Overall Study|Protocol Violation|0|||
170469255|NCT00976911|616056978|FG000|Overall Study|Other|8|||
170469256|NCT00976911|616056979|FG001|Overall Study|Other|9|||
170469257|NCT00976911|616056978|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
170469258|NCT00976911|616056979|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
170469259|NCT02954991|616056980|FG000|Overall Study|Death|92|||
170469260|NCT02954991|616056981|FG001|Overall Study|Death|11|||
170469261|NCT02954991|616056982|FG002|Overall Study|Death|2|||
170469262|NCT02954991|616056980|FG000|Overall Study|Lost to Follow-up|3|||
170469263|NCT02954991|616056981|FG001|Overall Study|Lost to Follow-up|2|||
170469264|NCT02954991|616056982|FG002|Overall Study|Lost to Follow-up|0|||
170469265|NCT02954991|616056980|FG000|Overall Study|Withdrawal by Subject|9|||
170469266|NCT02954991|616056981|FG001|Overall Study|Withdrawal by Subject|8|||
170469267|NCT02954991|616056982|FG002|Overall Study|Withdrawal by Subject|1|||
170469268|NCT02954991|616056980|FG000|Overall Study|Study Terminated by Sponsor|18|||
170637420|NCT02963506|616684594|FG003|Double-Blind Period|Adverse Event|0|||
170791212|NCT04800211|617245890|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
170637421|NCT02963506|616684595|FG004|Double-Blind Period|Adverse Event|0|||
170637422|NCT02963506|616684596|FG005|Double-Blind Period|Adverse Event|0|||
170637423|NCT02963506|616684597|FG006|Double-Blind Period|Adverse Event|0|||
170791213|NCT04800211|617245888|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
170791214|NCT04800211|617245889|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
170791215|NCT04800211|617245890|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
170791216|NCT04800211|617245888|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
170791217|NCT04800211|617245889|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
170791218|NCT04800211|617245890|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
170791219|NCT05218096|617245902|FG000|Primary Evaluation|Withdrawal by Subject|0|||
170791220|NCT05218096|617245903|FG001|Primary Evaluation|Withdrawal by Subject|0|||
170791221|NCT05218096|617245904|FG002|Primary Evaluation|Withdrawal by Subject|2|||
170791222|NCT05218096|617245905|FG003|Primary Evaluation|Withdrawal by Subject|0|||
170791223|NCT05218096|617245906|FG004|Primary Evaluation|Withdrawal by Subject|0|||
170791224|NCT05218096|617245902|FG000|Primary Evaluation|Physician Decision|1|||
170791225|NCT05218096|617245903|FG001|Primary Evaluation|Physician Decision|0|||
170791226|NCT05218096|617245904|FG002|Primary Evaluation|Physician Decision|0|||
170791227|NCT05218096|617245905|FG003|Primary Evaluation|Physician Decision|0|||
170791228|NCT05218096|617245906|FG004|Primary Evaluation|Physician Decision|0|||
170791229|NCT05218096|617245902|FG000|Extended Treatment|Clinical Deterioration|1|||
170791230|NCT05218096|617245903|FG001|Extended Treatment|Clinical Deterioration|1|||
170891349|NCT03551743|617608283|FG001|Overall Study|Adverse Event|0|||
170891350|NCT03551743|617608284|FG002|Overall Study|Adverse Event|0|||
170469269|NCT02954991|616056981|FG001|Overall Study|Study Terminated by Sponsor|10|||
170469270|NCT02954991|616056982|FG002|Overall Study|Study Terminated by Sponsor|1|||
170469271|NCT02954991|616056980|FG000|Overall Study|Miscellaneous|2|||
170469272|NCT02954991|616056981|FG001|Overall Study|Miscellaneous|1|||
170469273|NCT02954991|616056982|FG002|Overall Study|Miscellaneous|1|||
170469274|NCT00576316|616056983|FG000|Overall Study|Adverse Event|9|||
170469275|NCT00576316|616056983|FG000|Overall Study|Withdrawal by Subject|2|||
170637424|NCT02963506|616684598|FG007|Double-Blind Period|Adverse Event|0|||
170791231|NCT05218096|617245904|FG002|Extended Treatment|Clinical Deterioration|0|||
170891351|NCT03551743|617608285|FG003|Overall Study|Adverse Event|0|||
170469276|NCT00576316|616056983|FG000|Overall Study|Protocol Violation|9|||
170637425|NCT02963506|616684599|FG008|Double-Blind Period|Adverse Event|0|||
170637426|NCT02963506|616684600|FG009|Double-Blind Period|Adverse Event|0|||
170637427|NCT02963506|616684601|FG010|Double-Blind Period|Adverse Event|0|||
170637428|NCT02963506|616684602|FG011|Double-Blind Period|Adverse Event|0|||
170637429|NCT02963506|616684603|FG012|Double-Blind Period|Adverse Event|0|||
170637430|NCT02963506|616684591|FG000|Double-Blind Period|Death|0|||
170637431|NCT02963506|616684592|FG001|Double-Blind Period|Death|0|||
170637432|NCT02963506|616684593|FG002|Double-Blind Period|Death|0|||
170637433|NCT02963506|616684594|FG003|Double-Blind Period|Death|1|||
170637434|NCT02963506|616684595|FG004|Double-Blind Period|Death|0|||
170891352|NCT03551743|617608282|FG000|Overall Study|Withdrawal by Subject|1|||
170891353|NCT03551743|617608283|FG001|Overall Study|Withdrawal by Subject|0|||
170469277|NCT02552303|616056986|FG000|Allocation|Withdrawal by Subject|2|||
170469278|NCT02552303|616056987|FG001|Allocation|Withdrawal by Subject|1|||
170469279|NCT02552303|616056988|FG002|Allocation|Withdrawal by Subject|1|||
170469280|NCT02552303|616056989|FG003|Allocation|Withdrawal by Subject|1|||
170637435|NCT02963506|616684596|FG005|Double-Blind Period|Death|0|||
170637436|NCT02963506|616684597|FG006|Double-Blind Period|Death|0|||
170637437|NCT02963506|616684598|FG007|Double-Blind Period|Death|0|||
170637438|NCT02963506|616684599|FG008|Double-Blind Period|Death|0|||
170637439|NCT02963506|616684600|FG009|Double-Blind Period|Death|0|||
170637440|NCT02963506|616684601|FG010|Double-Blind Period|Death|0|||
170637441|NCT02963506|616684602|FG011|Double-Blind Period|Death|0|||
170637442|NCT02963506|616684603|FG012|Double-Blind Period|Death|0|||
170637443|NCT02963506|616684591|FG000|Double-Blind Period|Lost to Follow-up|0|||
170637444|NCT02963506|616684592|FG001|Double-Blind Period|Lost to Follow-up|1|||
170637445|NCT02963506|616684593|FG002|Double-Blind Period|Lost to Follow-up|0|||
170637446|NCT02963506|616684594|FG003|Double-Blind Period|Lost to Follow-up|0|||
170637447|NCT02963506|616684595|FG004|Double-Blind Period|Lost to Follow-up|0|||
170637448|NCT02963506|616684596|FG005|Double-Blind Period|Lost to Follow-up|0|||
170637449|NCT02963506|616684597|FG006|Double-Blind Period|Lost to Follow-up|0|||
170469281|NCT02552303|616056986|FG000|Allocation|ineligible|1|||
170469282|NCT02552303|616056987|FG001|Allocation|ineligible|1|||
170469283|NCT02552303|616056988|FG002|Allocation|ineligible|0|||
170469284|NCT02552303|616056989|FG003|Allocation|ineligible|0|||
170469285|NCT02552303|616056986|FG000|Follow-Up|Lost to Follow-up|0|||
170469286|NCT02552303|616056987|FG001|Follow-Up|Lost to Follow-up|0|||
170469287|NCT02552303|616056988|FG002|Follow-Up|Lost to Follow-up|1|||
170469288|NCT02552303|616056989|FG003|Follow-Up|Lost to Follow-up|0|||
170469289|NCT02552303|616056986|FG000|Follow-Up|ineligible|0|||
170469290|NCT02552303|616056987|FG001|Follow-Up|ineligible|2|||
170469291|NCT02552303|616056988|FG002|Follow-Up|ineligible|0|||
170637450|NCT02963506|616684598|FG007|Double-Blind Period|Lost to Follow-up|0|||
170637451|NCT02963506|616684599|FG008|Double-Blind Period|Lost to Follow-up|0|||
170637452|NCT02963506|616684600|FG009|Double-Blind Period|Lost to Follow-up|0|||
170791232|NCT05218096|617245905|FG003|Extended Treatment|Clinical Deterioration|0|||
170791233|NCT05218096|617245906|FG004|Extended Treatment|Clinical Deterioration|0|||
170791234|NCT05218096|617245902|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
170791235|NCT05218096|617245903|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
170791236|NCT05218096|617245904|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
170791237|NCT05218096|617245905|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
170791238|NCT05218096|617245906|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
170791239|NCT05218096|617245902|FG000|Extended Treatment|Withdrawal by Subject|1|||
170791240|NCT05218096|617245903|FG001|Extended Treatment|Withdrawal by Subject|3|||
170791241|NCT05218096|617245904|FG002|Extended Treatment|Withdrawal by Subject|0|||
170791242|NCT05218096|617245905|FG003|Extended Treatment|Withdrawal by Subject|2|||
170791243|NCT05218096|617245906|FG004|Extended Treatment|Withdrawal by Subject|2|||
170791244|NCT05218096|617245902|FG000|Extended Treatment|Lack of Efficacy|3|||
170637453|NCT02963506|616684601|FG010|Double-Blind Period|Lost to Follow-up|0|||
170637454|NCT02963506|616684602|FG011|Double-Blind Period|Lost to Follow-up|0|||
170637455|NCT02963506|616684603|FG012|Double-Blind Period|Lost to Follow-up|0|||
170637456|NCT02963506|616684591|FG000|Double-Blind Period|Withdrawal by Subject|0|||
170637457|NCT02963506|616684592|FG001|Double-Blind Period|Withdrawal by Subject|0|||
170637458|NCT02963506|616684593|FG002|Double-Blind Period|Withdrawal by Subject|1|||
170637459|NCT02963506|616684594|FG003|Double-Blind Period|Withdrawal by Subject|1|||
170891354|NCT03551743|617608284|FG002|Overall Study|Withdrawal by Subject|0|||
170891355|NCT03551743|617608285|FG003|Overall Study|Withdrawal by Subject|0|||
170891356|NCT02317562|617608286|FG000|Overall Study|Physician Decision|1|||
170637460|NCT02963506|616684595|FG004|Double-Blind Period|Withdrawal by Subject|0|||
170637461|NCT02963506|616684596|FG005|Double-Blind Period|Withdrawal by Subject|0|||
170637462|NCT02963506|616684597|FG006|Double-Blind Period|Withdrawal by Subject|0|||
170637463|NCT02963506|616684598|FG007|Double-Blind Period|Withdrawal by Subject|0|||
170637464|NCT02963506|616684599|FG008|Double-Blind Period|Withdrawal by Subject|0|||
170637465|NCT02963506|616684600|FG009|Double-Blind Period|Withdrawal by Subject|0|||
170791245|NCT05218096|617245903|FG001|Extended Treatment|Lack of Efficacy|0|||
170791246|NCT05218096|617245904|FG002|Extended Treatment|Lack of Efficacy|0|||
170469292|NCT02552303|616056989|FG003|Follow-Up|ineligible|0|||
170469293|NCT01582152|616056990|FG000|Overall Study|Disease Progression|4|||
170891357|NCT02317562|617608286|FG000|Overall Study|early termination of the study|8|||
170891358|NCT02317562|617608286|FG000|Overall Study|Lack of Efficacy|4|||
170891359|NCT02317562|617608286|FG000|Overall Study|Withdrawal by Subject|1|||
170891360|NCT00603915|617608287|FG000|Overall Study|Physician Decision|1|||
170891361|NCT03064841|617608288|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
170891362|NCT03064841|617608288|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
170891363|NCT03064841|617608288|FG000|Overall Study|Screen failure|2|||
170891364|NCT00772668|617608290|FG000|Overall Study|Physician Decision|3|||
170469294|NCT01582152|616056991|FG001|Overall Study|Disease Progression|5|||
170469295|NCT01582152|616056990|FG000|Overall Study|Adverse Event|2|||
170469296|NCT01582152|616056991|FG001|Overall Study|Adverse Event|1|||
170469297|NCT01831258|616056993|FG000|Overall Study|Withdrawal by Subject|2|||
170469298|NCT01831258|616056994|FG001|Overall Study|Withdrawal by Subject|1|||
170469299|NCT01831258|616056993|FG000|Overall Study|Lost to Follow-up|3|||
170469300|NCT01831258|616056994|FG001|Overall Study|Lost to Follow-up|2|||
170469301|NCT03055624|616056995|FG000|Overall Study|Study closed|9|||
170469302|NCT00230178|616056999|FG000|Overall Study|Adverse Event|1|||
170469303|NCT00230178|616057000|FG001|Overall Study|Adverse Event|5|||
170469304|NCT00230178|616057001|FG002|Overall Study|Adverse Event|2|||
170469305|NCT00230178|616056999|FG000|Overall Study|Withdrawal by Subject|0|||
170469306|NCT00230178|616057000|FG001|Overall Study|Withdrawal by Subject|0|||
170469307|NCT00230178|616057001|FG002|Overall Study|Withdrawal by Subject|1|||
170469308|NCT00230178|616056999|FG000|Overall Study|Various other reasons|3|||
170469309|NCT00230178|616057000|FG001|Overall Study|Various other reasons|2|||
170469310|NCT00230178|616057001|FG002|Overall Study|Various other reasons|4|||
170469311|NCT01753297|616057002|FG000|Overall Study|Lost to Follow-up|7|||
170469312|NCT01753297|616057003|FG001|Overall Study|Lost to Follow-up|2|||
170469313|NCT01753297|616057002|FG000|Overall Study|Withdrawal by Subject|26|||
170469314|NCT01753297|616057003|FG001|Overall Study|Withdrawal by Subject|23|||
170469315|NCT01753297|616057002|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
170469316|NCT01753297|616057003|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
170469317|NCT01753297|616057002|FG000|Overall Study|Death|0|||
170469318|NCT01753297|616057003|FG001|Overall Study|Death|2|||
170469319|NCT01753297|616057002|FG000|Overall Study|Did not attend end of study visit|7|||
170469320|NCT01753297|616057003|FG001|Overall Study|Did not attend end of study visit|8|||
170469321|NCT01275729|616057006|FG000|Overall Study|Death|3|||
170469322|NCT01275729|616057006|FG000|Overall Study|Withdrawal by Subject|1|||
170469323|NCT02252406|616057011|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
170469324|NCT02252406|616057012|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
170469325|NCT02252406|616057011|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
170469326|NCT02252406|616057012|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
170469327|NCT02252406|616057011|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
170469328|NCT02252406|616057012|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
170469329|NCT02252406|616057011|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
170469330|NCT02252406|616057012|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
170469331|NCT02252406|616057011|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
170469332|NCT02252406|616057012|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
170469333|NCT00447876|616057013|FG000|Overall Study|Withdrawal by Subject|1|||
170469334|NCT00447876|616057014|FG001|Overall Study|Withdrawal by Subject|4|||
170469335|NCT00447876|616057013|FG000|Overall Study|Lost to Follow-up|1|||
170545413|NCT04996264|616340992|FG001|Overall Study|Lost to Follow-up|1|||
170545414|NCT04996264|616340991|FG000|Overall Study|Withdrawal by Subject|4|||
170545415|NCT04996264|616340992|FG001|Overall Study|Withdrawal by Subject|3|||
170545416|NCT04996264|616340991|FG000|Overall Study|1 left AMA|0|||
170545417|NCT04996264|616340992|FG001|Overall Study|1 left AMA|1|||
170545418|NCT04996264|616340991|FG000|Overall Study|Subject changed hospitals|0|||
170545419|NCT04996264|616340992|FG001|Overall Study|Subject changed hospitals|1|||
170545420|NCT04996264|616340991|FG000|Overall Study|unable to complete due to work|0|||
170545421|NCT04996264|616340992|FG001|Overall Study|unable to complete due to work|1|||
170545422|NCT00685698|616340993|FG000|Overall Study|Withdrawal by Subject|1|||
170545423|NCT00685698|616340993|FG000|Overall Study|Protocol Violation|6|||
170545424|NCT00685698|616340993|FG000|Overall Study|Adverse Event|3|||
170545425|NCT00685698|616340993|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
170545426|NCT00685698|616340993|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
170545427|NCT00685698|616340993|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
170545428|NCT02030418|616340995|FG000|Overall Study|Death|78|||
170469336|NCT00447876|616057014|FG001|Overall Study|Lost to Follow-up|0|||
170469337|NCT00447876|616057013|FG000|Overall Study|Deterioration of symptomology|1|||
170469338|NCT00447876|616057014|FG001|Overall Study|Deterioration of symptomology|0|||
170469339|NCT02533180|616057015|FG000|Overall Study|Death|0|||
170545429|NCT02030418|616340995|FG000|Overall Study|Missed 12-Month Visit|9|||
170545430|NCT02030418|616340995|FG000|Overall Study|Withdrawn|57|||
170545431|NCT04740567|616340996|FG000|Overall Study|Death|31|||
170545432|NCT04740567|616340997|FG001|Overall Study|Death|43|||
170545433|NCT04740567|616340996|FG000|Overall Study|Lost to Follow-up|2|||
170891365|NCT04341948|617608292|FG000|Overall Study|Adverse Event|0|||
170469340|NCT02533180|616057016|FG001|Overall Study|Death|2|||
170469341|NCT02533180|616057015|FG000|Overall Study|Lost to Follow-up|0|||
170469342|NCT02533180|616057016|FG001|Overall Study|Lost to Follow-up|1|||
170469343|NCT02533180|616057015|FG000|Overall Study|Physician Decision|0|||
170469344|NCT02533180|616057016|FG001|Overall Study|Physician Decision|1|||
170469345|NCT02533180|616057015|FG000|Overall Study|Withdrawal by Subject|2|||
170469346|NCT02533180|616057016|FG001|Overall Study|Withdrawal by Subject|5|||
170469347|NCT02533180|616057015|FG000|Overall Study|Screen Failure|37|||
170469348|NCT02533180|616057016|FG001|Overall Study|Screen Failure|0|||
170469349|NCT02533180|616057015|FG000|Overall Study|Protocol Deviation|0|||
170469350|NCT02533180|616057016|FG001|Overall Study|Protocol Deviation|1|||
170469351|NCT02533180|616057015|FG000|Overall Study|Non-compliance|0|||
170469352|NCT02533180|616057016|FG001|Overall Study|Non-compliance|1|||
170469353|NCT00005957|616057017|FG000|Overall Study|No treated|3|||
170469354|NCT00005957|616057018|FG001|Overall Study|No treated|9|||
170469355|NCT00005957|616057017|FG000|Overall Study|Crossover to the other arm|5|||
170469356|NCT00005957|616057018|FG001|Overall Study|Crossover to the other arm|19|||
170469357|NCT01609023|616057019|FG000|Overall Study|Lack of Efficacy|3|||
170469358|NCT01609023|616057019|FG000|Overall Study|Withdrawal by Subject|4|||
170469359|NCT01609023|616057019|FG000|Overall Study|Lost to Follow-up|8|||
170469360|NCT01609023|616057019|FG000|Overall Study|Toxicity|3|||
170469361|NCT01609023|616057019|FG000|Overall Study|Disease progression|10|||
170469362|NCT01609023|616057019|FG000|Overall Study|Physician Decision|2|||
170469363|NCT01609023|616057019|FG000|Overall Study|Death|2|||
170469364|NCT01609023|616057019|FG000|Overall Study|Personal reasons|1|||
170469365|NCT01174043|616057020|FG000|Overall Study|Disease progression|5|||
170469366|NCT01174043|616057020|FG000|Overall Study|Adverse Event|3|||
170469367|NCT01174043|616057020|FG000|Overall Study|Death|1|||
170469368|NCT01174043|616057020|FG000|Overall Study|Withdrawal by Subject|2|||
170469369|NCT04172597|616057022|FG000|Overall Study|Disease Progression|0|||
170469370|NCT04172597|616057023|FG001|Overall Study|Disease Progression|0|||
170469371|NCT04172597|616057024|FG002|Overall Study|Disease Progression|0|||
170469372|NCT04172597|616057025|FG003|Overall Study|Disease Progression|0|||
170469373|NCT04172597|616057026|FG004|Overall Study|Disease Progression|1|||
170469374|NCT00799825|616057031|FG000|Overall Study|Adverse Event|1|||
170469375|NCT00799825|616057031|FG000|Overall Study|Withdrawal by Subject|6|||
170469376|NCT00799825|616057031|FG000|Overall Study|Lost to Follow-up|38|||
170469377|NCT00799825|616057031|FG000|Overall Study|Pregnancy|3|||
170469378|NCT00794339|616057032|FG000|Overall Study|Withdrawal by Subject|3|||
170469379|NCT00794339|616057032|FG000|Overall Study|Ineligible|4|||
170469380|NCT00794339|616057032|FG000|Overall Study|Tx prior to ATSM|3|||
170469381|NCT00794339|616057032|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
170469382|NCT00794339|616057032|FG000|Overall Study|Tx not per protocol|1|||
170469383|NCT02952586|616057037|FG000|Lead-In Phase (7 Days)|Death|0|||
170469384|NCT02952586|616057038|FG001|Lead-In Phase (7 Days)|Death|1|||
170469385|NCT02952586|616057037|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
170469386|NCT02952586|616057038|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
170469387|NCT02952586|616057037|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
170469388|NCT02952586|616057038|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
170469389|NCT02952586|616057037|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
170469390|NCT02952586|616057038|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
170469391|NCT02952586|616057037|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
170469392|NCT02952586|616057038|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
170545434|NCT04740567|616340997|FG001|Overall Study|Lost to Follow-up|11|||
170545435|NCT04740567|616340996|FG000|Overall Study|Patient declined to participate|13|||
170545436|NCT04740567|616340997|FG001|Overall Study|Patient declined to participate|26|||
170545437|NCT04740567|616340996|FG000|Overall Study|Patient was physically incapable|1|||
170545438|NCT04740567|616340997|FG001|Overall Study|Patient was physically incapable|3|||
170545439|NCT04740567|616340996|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
170545440|NCT04740567|616340997|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
170545441|NCT00724893|616340998|FG000|Overall Study|Adverse Event|76|||
170545442|NCT00724893|616340999|FG001|Overall Study|Adverse Event|142|||
170545443|NCT00724893|616340998|FG000|Overall Study|Withdrawal by Subject|0|||
170545444|NCT00724893|616340999|FG001|Overall Study|Withdrawal by Subject|1|||
170469393|NCT02952586|616057037|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
170469394|NCT02952586|616057038|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
170469395|NCT02952586|616057037|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
170469396|NCT02952586|616057038|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
170469397|NCT02952586|616057037|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
170469398|NCT02952586|616057038|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
170469399|NCT02952586|616057037|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
170469400|NCT02952586|616057038|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
170469401|NCT02952586|616057037|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
170469402|NCT02952586|616057038|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
170545445|NCT00724893|616340998|FG000|Overall Study|Lack of virologic response|94|||
170469403|NCT02952586|616057037|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
170469404|NCT02952586|616057038|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
170469405|NCT02952586|616057037|FG000|CRT for Cisplatin (63 Days)|Death|3|||
170469406|NCT02952586|616057038|FG001|CRT for Cisplatin (63 Days)|Death|8|||
170791247|NCT05218096|617245905|FG003|Extended Treatment|Lack of Efficacy|0|||
170791248|NCT05218096|617245906|FG004|Extended Treatment|Lack of Efficacy|0|||
170791249|NCT05218096|617245902|FG000|Extended Treatment|Physician Decision|0|||
170469407|NCT02952586|616057037|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
170791250|NCT05218096|617245903|FG001|Extended Treatment|Physician Decision|1|||
170791251|NCT05218096|617245904|FG002|Extended Treatment|Physician Decision|0|||
170791252|NCT05218096|617245905|FG003|Extended Treatment|Physician Decision|0|||
170791253|NCT05218096|617245906|FG004|Extended Treatment|Physician Decision|0|||
170791254|NCT05218096|617245902|FG000|Open-label Extension|Adverse Event|1|||
170791255|NCT05218096|617245903|FG001|Open-label Extension|Adverse Event|0|||
170791256|NCT05218096|617245904|FG002|Open-label Extension|Adverse Event|0|||
170791257|NCT05218096|617245905|FG003|Open-label Extension|Adverse Event|0|||
170791258|NCT05218096|617245906|FG004|Open-label Extension|Adverse Event|1|||
170791259|NCT05218096|617245902|FG000|Open-label Extension|Pregnancy|0|||
170791260|NCT05218096|617245903|FG001|Open-label Extension|Pregnancy|0|||
170791261|NCT05218096|617245904|FG002|Open-label Extension|Pregnancy|0|||
170791262|NCT05218096|617245905|FG003|Open-label Extension|Pregnancy|0|||
170791263|NCT05218096|617245906|FG004|Open-label Extension|Pregnancy|1|||
170791264|NCT05218096|617245902|FG000|Open-label Extension|Lack of Efficacy|1|||
170791265|NCT05218096|617245903|FG001|Open-label Extension|Lack of Efficacy|2|||
170791266|NCT05218096|617245904|FG002|Open-label Extension|Lack of Efficacy|0|||
170791267|NCT05218096|617245905|FG003|Open-label Extension|Lack of Efficacy|0|||
170791268|NCT05218096|617245906|FG004|Open-label Extension|Lack of Efficacy|0|||
170791269|NCT05218096|617245902|FG000|Open-label Extension|Lost to Follow-up|1|||
170791270|NCT05218096|617245903|FG001|Open-label Extension|Lost to Follow-up|0|||
170791271|NCT05218096|617245904|FG002|Open-label Extension|Lost to Follow-up|0|||
170791272|NCT05218096|617245905|FG003|Open-label Extension|Lost to Follow-up|0|||
170791273|NCT05218096|617245906|FG004|Open-label Extension|Lost to Follow-up|0|||
170791274|NCT05218096|617245902|FG000|Open-label Extension|Death|0|||
170791275|NCT05218096|617245903|FG001|Open-label Extension|Death|0|||
170791276|NCT05218096|617245904|FG002|Open-label Extension|Death|0|||
170791277|NCT05218096|617245905|FG003|Open-label Extension|Death|1|||
170791278|NCT05218096|617245906|FG004|Open-label Extension|Death|0|||
170791279|NCT05218096|617245902|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
170791280|NCT05218096|617245903|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
170791281|NCT05218096|617245904|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
170791282|NCT05218096|617245905|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
170791283|NCT05218096|617245906|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
170791284|NCT04049643|617245907|FG000|Overall Study|Lack of Efficacy|1|||
170791285|NCT04049643|617245908|FG001|Overall Study|Lack of Efficacy|1|||
170791286|NCT04049643|617245909|FG002|Overall Study|Lack of Efficacy|0|||
170791287|NCT04049643|617245907|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
170791288|NCT04049643|617245908|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
170791289|NCT04049643|617245909|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
170791290|NCT04585815|617245910|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
170791291|NCT04585815|617245911|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
170791292|NCT04585815|617245912|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
170791293|NCT04585815|617245913|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
170791294|NCT04585815|617245914|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
170791295|NCT04585815|617245915|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
170791296|NCT04585815|617245916|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
170791297|NCT04585815|617245910|FG000|Sub-study A- Treatment Phase|Death|0|||
170791298|NCT04585815|617245911|FG001|Sub-study A- Treatment Phase|Death|2|||
170791299|NCT04585815|617245912|FG002|Sub-study A- Treatment Phase|Death|0|||
170791300|NCT04585815|617245913|FG003|Sub-study A- Treatment Phase|Death|0|||
170791301|NCT04585815|617245914|FG004|Sub-study A- Treatment Phase|Death|0|||
170791302|NCT04585815|617245915|FG005|Sub-study A- Treatment Phase|Death|0|||
170891366|NCT04341948|617608293|FG001|Overall Study|Adverse Event|1|||
170891367|NCT04341948|617608292|FG000|Overall Study|Lost to Follow-up|6|||
170791303|NCT04585815|617245916|FG006|Sub-study A- Treatment Phase|Death|0|||
170791304|NCT04585815|617245910|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
170791305|NCT04585815|617245911|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
170791306|NCT04585815|617245912|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
170791307|NCT04585815|617245913|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
170791308|NCT04585815|617245914|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
170791309|NCT04585815|617245915|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
170791310|NCT04585815|617245916|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
170891368|NCT04341948|617608293|FG001|Overall Study|Lost to Follow-up|1|||
170469408|NCT02952586|616057038|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
170545446|NCT00724893|616340999|FG001|Overall Study|Lack of virologic response|202|||
170545447|NCT00724893|616340998|FG000|Overall Study|Reason not specified|193|||
170545448|NCT00724893|616340999|FG001|Overall Study|Reason not specified|7|||
170545449|NCT00724893|616340998|FG000|Overall Study|Patient choice|0|||
170545450|NCT00724893|616340999|FG001|Overall Study|Patient choice|26|||
170545451|NCT00724893|616340998|FG000|Overall Study|Geographic reasons|0|||
170545452|NCT00724893|616340999|FG001|Overall Study|Geographic reasons|11|||
170545453|NCT00724893|616340998|FG000|Overall Study|Incarceration|0|||
170545454|NCT00724893|616340999|FG001|Overall Study|Incarceration|9|||
170545455|NCT00724893|616340998|FG000|Overall Study|Substance abuse|0|||
170545456|NCT00724893|616340999|FG001|Overall Study|Substance abuse|3|||
170545457|NCT00724893|616340998|FG000|Overall Study|Financial reasons|0|||
170545458|NCT00724893|616340999|FG001|Overall Study|Financial reasons|2|||
170545459|NCT00724893|616340998|FG000|Overall Study|Assigned shorter treatment|0|||
170545460|NCT00724893|616340999|FG001|Overall Study|Assigned shorter treatment|2|||
170545461|NCT00724893|616340998|FG000|Overall Study|Lost to Follow-up|0|||
170545462|NCT00724893|616340999|FG001|Overall Study|Lost to Follow-up|52|||
170545463|NCT00724893|616340998|FG000|Overall Study|Unknown, missing data|1|||
170545464|NCT00724893|616340999|FG001|Overall Study|Unknown, missing data|1|||
170637466|NCT02963506|616684601|FG010|Double-Blind Period|Withdrawal by Subject|0|||
170637467|NCT02963506|616684602|FG011|Double-Blind Period|Withdrawal by Subject|0|||
170637468|NCT02963506|616684603|FG012|Double-Blind Period|Withdrawal by Subject|0|||
170637469|NCT02963506|616684591|FG000|Double-Blind Period|No compliance|0|||
170637470|NCT02963506|616684592|FG001|Double-Blind Period|No compliance|1|||
170637471|NCT02963506|616684593|FG002|Double-Blind Period|No compliance|0|||
170637472|NCT02963506|616684594|FG003|Double-Blind Period|No compliance|0|||
170637473|NCT02963506|616684595|FG004|Double-Blind Period|No compliance|0|||
170637474|NCT02963506|616684596|FG005|Double-Blind Period|No compliance|0|||
170791311|NCT04585815|617245910|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
170791312|NCT04585815|617245911|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
170791313|NCT04585815|617245912|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
170791314|NCT04585815|617245913|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
170791315|NCT04585815|617245914|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
170791316|NCT04585815|617245915|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
170791317|NCT04585815|617245916|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
170791318|NCT04585815|617245910|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
170791319|NCT04585815|617245911|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
170791320|NCT04585815|617245912|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
170791321|NCT04585815|617245913|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
170791322|NCT04585815|617245914|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
170791323|NCT04585815|617245915|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
170791324|NCT04585815|617245916|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
170791325|NCT04585815|617245910|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
170791326|NCT04585815|617245911|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
170791327|NCT04585815|617245912|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
170791328|NCT04585815|617245913|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
170791329|NCT04585815|617245914|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
170791330|NCT04585815|617245915|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
170791331|NCT04585815|617245916|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
170791332|NCT04585815|617245910|FG000|Sub-study A- Treatment Phase|Other|1|||
170791333|NCT04585815|617245911|FG001|Sub-study A- Treatment Phase|Other|0|||
170791334|NCT04585815|617245912|FG002|Sub-study A- Treatment Phase|Other|0|||
170791335|NCT04585815|617245913|FG003|Sub-study A- Treatment Phase|Other|0|||
170791336|NCT04585815|617245914|FG004|Sub-study A- Treatment Phase|Other|0|||
170791337|NCT04585815|617245915|FG005|Sub-study A- Treatment Phase|Other|0|||
170791338|NCT04585815|617245916|FG006|Sub-study A- Treatment Phase|Other|0|||
170791339|NCT04585815|617245910|FG000|Sub-study A- Follow-up Phase|Death|0|||
170791340|NCT04585815|617245911|FG001|Sub-study A- Follow-up Phase|Death|1|||
170791341|NCT04585815|617245912|FG002|Sub-study A- Follow-up Phase|Death|0|||
170791342|NCT04585815|617245913|FG003|Sub-study A- Follow-up Phase|Death|0|||
170791343|NCT04585815|617245914|FG004|Sub-study A- Follow-up Phase|Death|0|||
170791344|NCT04585815|617245915|FG005|Sub-study A- Follow-up Phase|Death|0|||
170791345|NCT04585815|617245916|FG006|Sub-study A- Follow-up Phase|Death|0|||
170791346|NCT04585815|617245910|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
170791347|NCT04585815|617245911|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
170791348|NCT04585815|617245912|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
170545465|NCT01179516|616341002|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
170545466|NCT01179516|616341003|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
170637475|NCT02963506|616684597|FG006|Double-Blind Period|No compliance|0|||
170637476|NCT02963506|616684598|FG007|Double-Blind Period|No compliance|0|||
170637477|NCT02963506|616684599|FG008|Double-Blind Period|No compliance|0|||
170545467|NCT01179516|616341004|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
170637478|NCT02963506|616684600|FG009|Double-Blind Period|No compliance|0|||
170637479|NCT02963506|616684601|FG010|Double-Blind Period|No compliance|0|||
170637480|NCT02963506|616684602|FG011|Double-Blind Period|No compliance|0|||
170637481|NCT02963506|616684603|FG012|Double-Blind Period|No compliance|0|||
170637482|NCT02963506|616684591|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637483|NCT02963506|616684592|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
170469409|NCT02952586|616057037|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
170469410|NCT02952586|616057038|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
170637484|NCT02963506|616684593|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637485|NCT02963506|616684594|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637486|NCT02963506|616684595|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637487|NCT02963506|616684596|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637488|NCT02963506|616684597|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637489|NCT02963506|616684598|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637490|NCT02963506|616684599|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637491|NCT02963506|616684600|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637492|NCT02963506|616684601|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637493|NCT02963506|616684602|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637494|NCT02963506|616684603|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
170637495|NCT02963506|616684591|FG000|Dose-Blind Period|Adverse Event|0|||
170637496|NCT02963506|616684592|FG001|Dose-Blind Period|Adverse Event|0|||
170637497|NCT02963506|616684593|FG002|Dose-Blind Period|Adverse Event|0|||
170637498|NCT02963506|616684594|FG003|Dose-Blind Period|Adverse Event|0|||
170637499|NCT02963506|616684595|FG004|Dose-Blind Period|Adverse Event|0|||
170637500|NCT02963506|616684596|FG005|Dose-Blind Period|Adverse Event|1|||
170637501|NCT02963506|616684597|FG006|Dose-Blind Period|Adverse Event|3|||
170637502|NCT02963506|616684598|FG007|Dose-Blind Period|Adverse Event|2|||
170637503|NCT02963506|616684599|FG008|Dose-Blind Period|Adverse Event|2|||
170637504|NCT02963506|616684600|FG009|Dose-Blind Period|Adverse Event|2|||
170637505|NCT02963506|616684601|FG010|Dose-Blind Period|Adverse Event|1|||
170637506|NCT02963506|616684602|FG011|Dose-Blind Period|Adverse Event|1|||
170637507|NCT02963506|616684603|FG012|Dose-Blind Period|Adverse Event|6|||
170637508|NCT02963506|616684591|FG000|Dose-Blind Period|Lack of Efficacy|0|||
170637509|NCT02963506|616684592|FG001|Dose-Blind Period|Lack of Efficacy|0|||
170637510|NCT02963506|616684593|FG002|Dose-Blind Period|Lack of Efficacy|0|||
170637511|NCT02963506|616684594|FG003|Dose-Blind Period|Lack of Efficacy|0|||
170637512|NCT02963506|616684595|FG004|Dose-Blind Period|Lack of Efficacy|0|||
170637513|NCT02963506|616684596|FG005|Dose-Blind Period|Lack of Efficacy|0|||
170637514|NCT02963506|616684597|FG006|Dose-Blind Period|Lack of Efficacy|0|||
170637515|NCT02963506|616684598|FG007|Dose-Blind Period|Lack of Efficacy|1|||
170637516|NCT02963506|616684599|FG008|Dose-Blind Period|Lack of Efficacy|0|||
170637517|NCT02963506|616684600|FG009|Dose-Blind Period|Lack of Efficacy|1|||
170637518|NCT02963506|616684601|FG010|Dose-Blind Period|Lack of Efficacy|0|||
170637519|NCT02963506|616684602|FG011|Dose-Blind Period|Lack of Efficacy|0|||
170637520|NCT02963506|616684603|FG012|Dose-Blind Period|Lack of Efficacy|0|||
170637521|NCT02963506|616684591|FG000|Dose-Blind Period|Lost to Follow-up|0|||
170637522|NCT02963506|616684592|FG001|Dose-Blind Period|Lost to Follow-up|0|||
170637523|NCT02963506|616684593|FG002|Dose-Blind Period|Lost to Follow-up|0|||
170791349|NCT04585815|617245913|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
170791350|NCT04585815|617245914|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
170791351|NCT04585815|617245915|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
170791352|NCT04585815|617245916|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
170791353|NCT04585815|617245910|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
170791354|NCT04585815|617245911|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
170791355|NCT04585815|617245912|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
170791356|NCT04585815|617245913|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
170791357|NCT04585815|617245914|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
170791358|NCT04585815|617245915|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
170791359|NCT04585815|617245916|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
170791360|NCT04585815|617245910|FG000|Sub-study B- Treatment Phase|Death|0|||
170791361|NCT04585815|617245911|FG001|Sub-study B- Treatment Phase|Death|0|||
170791362|NCT04585815|617245912|FG002|Sub-study B- Treatment Phase|Death|0|||
170791363|NCT04585815|617245913|FG003|Sub-study B- Treatment Phase|Death|1|||
170791364|NCT04585815|617245914|FG004|Sub-study B- Treatment Phase|Death|0|||
170791365|NCT04585815|617245915|FG005|Sub-study B- Treatment Phase|Death|0|||
170791366|NCT04585815|617245916|FG006|Sub-study B- Treatment Phase|Death|0|||
170791367|NCT04585815|617245910|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
170637524|NCT02963506|616684594|FG003|Dose-Blind Period|Lost to Follow-up|0|||
170637525|NCT02963506|616684595|FG004|Dose-Blind Period|Lost to Follow-up|0|||
170637526|NCT02963506|616684596|FG005|Dose-Blind Period|Lost to Follow-up|1|||
170637527|NCT02963506|616684597|FG006|Dose-Blind Period|Lost to Follow-up|0|||
170637528|NCT02963506|616684598|FG007|Dose-Blind Period|Lost to Follow-up|0|||
170637529|NCT02963506|616684599|FG008|Dose-Blind Period|Lost to Follow-up|1|||
170469411|NCT02952586|616057037|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
170469412|NCT02952586|616057038|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
170469413|NCT02952586|616057037|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
170469414|NCT02952586|616057038|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
170469415|NCT02952586|616057037|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
170469416|NCT02952586|616057038|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
170469417|NCT02952586|616057037|FG000|CRT for Cisplatin (63 Days)|Other|1|||
170469418|NCT02952586|616057038|FG001|CRT for Cisplatin (63 Days)|Other|1|||
170469419|NCT02952586|616057037|FG000|CRT for IMRT (63 Days)|Death|5|||
170469420|NCT02952586|616057038|FG001|CRT for IMRT (63 Days)|Death|8|||
170469421|NCT02952586|616057037|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
170469422|NCT02952586|616057038|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
170469423|NCT02952586|616057037|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
170469424|NCT02952586|616057038|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
170469425|NCT02952586|616057037|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
170469426|NCT02952586|616057038|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
170469427|NCT02952586|616057037|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
170469428|NCT02952586|616057038|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
170469429|NCT02952586|616057037|FG000|CRT for IMRT (63 Days)|Other|1|||
170469430|NCT02952586|616057038|FG001|CRT for IMRT (63 Days)|Other|0|||
170469431|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Death|17|||
170469432|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Death|11|||
170469433|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
170469434|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
170469435|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
170469436|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
170469437|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
170469438|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
170469439|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
170469440|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
170469441|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
170469442|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
170469443|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
170637530|NCT02963506|616684600|FG009|Dose-Blind Period|Lost to Follow-up|0|||
170469444|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
170469445|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
170469446|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
170469447|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Other|2|||
170469448|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Other|1|||
170469449|NCT02952586|616057037|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
170469450|NCT02952586|616057038|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
170469451|NCT02952586|616057037|FG000|Follow-Up Phase (90 Days)|Death|12|||
170469452|NCT02952586|616057038|FG001|Follow-Up Phase (90 Days)|Death|10|||
170469453|NCT02952586|616057037|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
170469454|NCT02952586|616057038|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
170469455|NCT02952586|616057037|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
170469456|NCT02952586|616057038|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
170469457|NCT02952586|616057037|FG000|Follow-Up Phase (90 Days)|Other|7|||
170469458|NCT02952586|616057038|FG001|Follow-Up Phase (90 Days)|Other|5|||
170469459|NCT02952586|616057037|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
170469460|NCT02952586|616057038|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
170469461|NCT02952586|616057037|FG000|LT Follow-up (up to 45 Months)|Death|51|||
170469462|NCT02952586|616057038|FG001|LT Follow-up (up to 45 Months)|Death|31|||
170469463|NCT02952586|616057037|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
170469464|NCT02952586|616057038|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
170469465|NCT02952586|616057037|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
170469466|NCT02952586|616057038|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
170469467|NCT02952586|616057037|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
170469468|NCT02952586|616057038|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
170469469|NCT00492778|616057039|FG000|Overall Study|Ineligible by Pathology Review|8|||
170469470|NCT00492778|616057040|FG001|Overall Study|Ineligible by Pathology Review|1|||
170469471|NCT03717012|616057057|FG000|Overall Study|Due to trial termination|1|||
170469472|NCT03717012|616057058|FG001|Overall Study|Due to trial termination|2|||
170469473|NCT03717012|616057057|FG000|Overall Study|Protocol Violation|0|||
170469474|NCT03717012|616057058|FG001|Overall Study|Protocol Violation|2|||
170469475|NCT03717012|616057057|FG000|Overall Study|Adverse Event|0|||
170469476|NCT03717012|616057058|FG001|Overall Study|Adverse Event|1|||
170469477|NCT03717012|616057057|FG000|Overall Study|Lung transplant|0|||
170469478|NCT03717012|616057058|FG001|Overall Study|Lung transplant|1|||
170469479|NCT00789035|616057059|FG000|Overall Study|Adverse Event|0|||
170469480|NCT00789035|616057060|FG001|Overall Study|Adverse Event|2|||
170469481|NCT00789035|616057061|FG002|Overall Study|Adverse Event|0|||
170469482|NCT00789035|616057062|FG003|Overall Study|Adverse Event|1|||
170469483|NCT00789035|616057063|FG004|Overall Study|Adverse Event|3|||
170469484|NCT00789035|616057059|FG000|Overall Study|Lack of Efficacy|3|||
170469485|NCT00789035|616057060|FG001|Overall Study|Lack of Efficacy|0|||
170469486|NCT00789035|616057061|FG002|Overall Study|Lack of Efficacy|0|||
170469487|NCT00789035|616057062|FG003|Overall Study|Lack of Efficacy|0|||
170469488|NCT00789035|616057063|FG004|Overall Study|Lack of Efficacy|2|||
170469489|NCT00789035|616057059|FG000|Overall Study|Protocol Violation|1|||
170469490|NCT00789035|616057060|FG001|Overall Study|Protocol Violation|0|||
170469491|NCT00789035|616057061|FG002|Overall Study|Protocol Violation|0|||
170469492|NCT00789035|616057062|FG003|Overall Study|Protocol Violation|0|||
170637531|NCT02963506|616684601|FG010|Dose-Blind Period|Lost to Follow-up|0|||
170637532|NCT02963506|616684602|FG011|Dose-Blind Period|Lost to Follow-up|1|||
170637533|NCT02963506|616684603|FG012|Dose-Blind Period|Lost to Follow-up|0|||
170637534|NCT02963506|616684591|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
170637535|NCT02963506|616684592|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
170637536|NCT02963506|616684593|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
170637537|NCT02963506|616684594|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
170637538|NCT02963506|616684595|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
170791368|NCT04585815|617245911|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
170637539|NCT02963506|616684596|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
170637540|NCT02963506|616684597|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
170637541|NCT02963506|616684598|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
170637542|NCT02963506|616684599|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
170637543|NCT02963506|616684600|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
170637544|NCT02963506|616684601|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
170637545|NCT02963506|616684602|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
170637546|NCT02963506|616684603|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
170791369|NCT04585815|617245912|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
170891369|NCT04341948|617608292|FG000|Overall Study|Physician Decision|1|||
170469493|NCT00789035|616057063|FG004|Overall Study|Protocol Violation|0|||
170469494|NCT00789035|616057059|FG000|Overall Study|Withdrawal by Subject|0|||
170469495|NCT00789035|616057060|FG001|Overall Study|Withdrawal by Subject|2|||
170469496|NCT00789035|616057061|FG002|Overall Study|Withdrawal by Subject|0|||
170637547|NCT02963506|616684591|FG000|Dose-Blind Period|Sponsor decision|0|||
170891370|NCT04341948|617608293|FG001|Overall Study|Physician Decision|2|||
170891371|NCT04341948|617608292|FG000|Overall Study|Withdrawal by Participant|6|||
170891372|NCT04341948|617608293|FG001|Overall Study|Withdrawal by Participant|3|||
170891373|NCT04341948|617608292|FG000|Overall Study|Lack of compliance by Participant|1|||
170891374|NCT04341948|617608293|FG001|Overall Study|Lack of compliance by Participant|0|||
170891375|NCT01748071|617609738|FG000|Overall Study|Adverse Event|2|||
170891376|NCT01748071|617609739|FG001|Overall Study|Adverse Event|2|||
170891377|NCT01748071|617609740|FG002|Overall Study|Adverse Event|0|||
170891378|NCT01668654|617609743|FG000|Overall Study|Study Closed/Terminated|3|||
170891379|NCT01668654|617609743|FG000|Overall Study|Withdrawal by Subject|1|||
170891380|NCT01001702|617609744|FG000|Overall Study|Lost to Follow-up|7|||
170891381|NCT01001702|617609744|FG000|Overall Study|Adverse Event|7|||
170891382|NCT01001702|617609744|FG000|Overall Study|Sponsor Discontinued Study|4|||
170469497|NCT00789035|616057062|FG003|Overall Study|Withdrawal by Subject|0|||
170469498|NCT00789035|616057063|FG004|Overall Study|Withdrawal by Subject|0|||
170469499|NCT00789035|616057059|FG000|Overall Study|Other reason not defined above|2|||
170469500|NCT00789035|616057060|FG001|Overall Study|Other reason not defined above|3|||
170469501|NCT00789035|616057061|FG002|Overall Study|Other reason not defined above|1|||
170469502|NCT00789035|616057062|FG003|Overall Study|Other reason not defined above|0|||
170469503|NCT00789035|616057063|FG004|Overall Study|Other reason not defined above|1|||
170469504|NCT00658879|616057064|FG000|Overall Study|Protocol Violation|1|||
170469505|NCT01118975|616057065|FG000|Overall Study|Adverse Event|0|||
170469506|NCT01118975|616057066|FG001|Overall Study|Adverse Event|1|||
170469507|NCT01645787|616057067|FG000|Washout (2 Weeks)|Adverse Event|1|||
170469508|NCT01645787|616057068|FG001|Washout (2 Weeks)|Adverse Event|0|||
170469509|NCT01098474|616057070|FG000|Active Phase|Other|0|||
170891383|NCT01001702|617609744|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
170469510|NCT01098474|616057071|FG001|Active Phase|Other|0|||
170469511|NCT01098474|616057072|FG002|Active Phase|Other|3|||
170469512|NCT01098474|616057073|FG003|Active Phase|Other|0|||
170469513|NCT01098474|616057074|FG004|Active Phase|Other|0|||
170469514|NCT01098474|616057075|FG005|Active Phase|Other|0|||
170469515|NCT01098474|616057070|FG000|Active Phase|Withdrawal by Subject|1|||
170469516|NCT01098474|616057071|FG001|Active Phase|Withdrawal by Subject|1|||
170469517|NCT01098474|616057072|FG002|Active Phase|Withdrawal by Subject|2|||
170469518|NCT01098474|616057073|FG003|Active Phase|Withdrawal by Subject|0|||
170469519|NCT01098474|616057074|FG004|Active Phase|Withdrawal by Subject|0|||
170469520|NCT01098474|616057075|FG005|Active Phase|Withdrawal by Subject|0|||
170469521|NCT01098474|616057070|FG000|Active Phase|Lost to Follow-up|1|||
170469522|NCT01098474|616057071|FG001|Active Phase|Lost to Follow-up|0|||
170469523|NCT01098474|616057072|FG002|Active Phase|Lost to Follow-up|0|||
170469524|NCT01098474|616057073|FG003|Active Phase|Lost to Follow-up|0|||
170469525|NCT01098474|616057074|FG004|Active Phase|Lost to Follow-up|0|||
170469526|NCT01098474|616057075|FG005|Active Phase|Lost to Follow-up|0|||
170469527|NCT01098474|616057070|FG000|Follow Up Phase|Travelled out of study area|0|||
170469528|NCT01098474|616057071|FG001|Follow Up Phase|Travelled out of study area|0|||
170469529|NCT01098474|616057072|FG002|Follow Up Phase|Travelled out of study area|0|||
170469530|NCT01098474|616057073|FG003|Follow Up Phase|Travelled out of study area|0|||
170469531|NCT01098474|616057074|FG004|Follow Up Phase|Travelled out of study area|1|||
170469532|NCT01098474|616057075|FG005|Follow Up Phase|Travelled out of study area|0|||
170469533|NCT01098474|616057070|FG000|Follow Up Phase|Other|0|||
170469534|NCT01098474|616057071|FG001|Follow Up Phase|Other|0|||
170469535|NCT01098474|616057072|FG002|Follow Up Phase|Other|0|||
170469536|NCT01098474|616057073|FG003|Follow Up Phase|Other|0|||
170469537|NCT01098474|616057074|FG004|Follow Up Phase|Other|0|||
170469538|NCT01098474|616057075|FG005|Follow Up Phase|Other|4|||
170469539|NCT01098474|616057070|FG000|Follow Up Phase|Withdrawal by Subject|0|||
170469540|NCT01098474|616057071|FG001|Follow Up Phase|Withdrawal by Subject|0|||
170469541|NCT01098474|616057072|FG002|Follow Up Phase|Withdrawal by Subject|0|||
170469542|NCT01098474|616057073|FG003|Follow Up Phase|Withdrawal by Subject|2|||
170469543|NCT01098474|616057074|FG004|Follow Up Phase|Withdrawal by Subject|0|||
170891384|NCT01001702|617609744|FG000|Overall Study|Investigator withdrew Subject|10|||
170891385|NCT01001702|617609744|FG000|Overall Study|Withdrawal by Subject|19|||
170469544|NCT01098474|616057075|FG005|Follow Up Phase|Withdrawal by Subject|1|||
170469545|NCT01098474|616057070|FG000|Follow Up Phase|Lost to Follow-up|0|||
170469546|NCT01098474|616057071|FG001|Follow Up Phase|Lost to Follow-up|0|||
170545468|NCT01179516|616341002|FG000|Overall Study|Lack of Efficacy|4|||
170891386|NCT01001702|617609744|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
170891387|NCT02167945|617609747|FG000|Overall Study|Adverse Event|16|||
170891388|NCT02167945|617609747|FG000|Overall Study|Withdrew Consent|42|||
170469547|NCT01098474|616057072|FG002|Follow Up Phase|Lost to Follow-up|0|||
170469548|NCT01098474|616057073|FG003|Follow Up Phase|Lost to Follow-up|0|||
170469549|NCT01098474|616057074|FG004|Follow Up Phase|Lost to Follow-up|1|||
170469550|NCT01098474|616057075|FG005|Follow Up Phase|Lost to Follow-up|0|||
170469551|NCT01372748|616057080|FG000|Overall Study|Lost to Follow-up|16|||
170469552|NCT01372748|616057081|FG001|Overall Study|Lost to Follow-up|34|||
170469553|NCT01372748|616057080|FG000|Overall Study|Withdrawal by Subject|7|||
170891389|NCT02167945|617609747|FG000|Overall Study|Lost to Follow-up|122|||
170469554|NCT01372748|616057081|FG001|Overall Study|Withdrawal by Subject|5|||
170469555|NCT00711880|616057082|FG000|Overall Study|Adverse Event|11|||
170469556|NCT00711880|616057083|FG001|Overall Study|Adverse Event|2|||
170469557|NCT00711880|616057082|FG000|Overall Study|Patient non-compliance|1|||
170469558|NCT00711880|616057083|FG001|Overall Study|Patient non-compliance|0|||
170469559|NCT00711880|616057082|FG000|Overall Study|Lack of Efficacy|1|||
170469560|NCT00711880|616057083|FG001|Overall Study|Lack of Efficacy|5|||
170469561|NCT04238650|616057084|FG000|Overall Study|Withdrawal by Subject|0|||
170469562|NCT04238650|616057085|FG001|Overall Study|Withdrawal by Subject|1|||
170469563|NCT03633825|616057086|FG000|Enrollment|Did not post on network|5066|||
170469564|NCT03633825|616057087|FG001|Enrollment|Did not post on network|5080|||
170469565|NCT03633825|616057086|FG000|Enrollment|Post not classified as crisis|13967|||
170469566|NCT03633825|616057087|FG001|Enrollment|Post not classified as crisis|13757|||
170469567|NCT03633825|616057086|FG000|Follow up|Lost to Follow-up|478|||
170469568|NCT03633825|616057087|FG001|Follow up|Lost to Follow-up|450|||
170469569|NCT02585778|616057088|FG000|Overall Study|Adverse Event|17|||
170469570|NCT02585778|616057089|FG001|Overall Study|Adverse Event|4|||
170469571|NCT02585778|616057088|FG000|Overall Study|Participant did not wish to continue|9|||
170469572|NCT02585778|616057089|FG001|Overall Study|Participant did not wish to continue|4|||
170469573|NCT02585778|616057088|FG000|Overall Study|Poor compliance to study protocol|0|||
170469574|NCT02585778|616057089|FG001|Overall Study|Poor compliance to study protocol|2|||
170469575|NCT02585778|616057088|FG000|Overall Study|Death|0|||
170469576|NCT02585778|616057089|FG001|Overall Study|Death|1|||
170469577|NCT02585778|616057088|FG000|Overall Study|Randomized but not treated|1|||
170469578|NCT02585778|616057089|FG001|Overall Study|Randomized but not treated|2|||
170469579|NCT02585778|616057088|FG000|Overall Study|Other than specified above|6|||
170469580|NCT02585778|616057089|FG001|Overall Study|Other than specified above|2|||
170469581|NCT00356525|616057092|FG000|Overall Study|Progressive Disease|8|||
170469582|NCT00356525|616057093|FG001|Overall Study|Progressive Disease|5|||
170469583|NCT00356525|616057094|FG002|Overall Study|Progressive Disease|4|||
170469584|NCT00356525|616057095|FG003|Overall Study|Progressive Disease|2|||
170469585|NCT00356525|616057092|FG000|Overall Study|Adverse Event|1|||
170469586|NCT00356525|616057093|FG001|Overall Study|Adverse Event|3|||
170469587|NCT00356525|616057094|FG002|Overall Study|Adverse Event|1|||
170469588|NCT00356525|616057095|FG003|Overall Study|Adverse Event|1|||
170469589|NCT00356525|616057092|FG000|Overall Study|Lost to Follow-up|1|||
170469590|NCT00356525|616057093|FG001|Overall Study|Lost to Follow-up|0|||
170469591|NCT00356525|616057094|FG002|Overall Study|Lost to Follow-up|0|||
170469592|NCT00356525|616057095|FG003|Overall Study|Lost to Follow-up|0|||
170469593|NCT00356525|616057092|FG000|Overall Study|Physician Decision|2|||
170469594|NCT00356525|616057093|FG001|Overall Study|Physician Decision|2|||
170469595|NCT00356525|616057094|FG002|Overall Study|Physician Decision|2|||
170469596|NCT00356525|616057095|FG003|Overall Study|Physician Decision|1|||
170469597|NCT00356525|616057092|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
170469598|NCT00356525|616057093|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
170469599|NCT00356525|616057094|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
170469600|NCT00356525|616057095|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
170891390|NCT02167945|617609747|FG000|Overall Study|COVID-19 logistical restrictions|6|||
170891391|NCT02167945|617609747|FG000|Overall Study|Other, not specified|63|||
170891392|NCT02623335|617609751|FG000|Overall Study|Death|8|||
170891393|NCT02623335|617609752|FG001|Overall Study|Death|7|||
170891394|NCT02623335|617609751|FG000|Overall Study|Lost to Follow-up|15|||
170891395|NCT02623335|617609752|FG001|Overall Study|Lost to Follow-up|23|||
170891396|NCT02623335|617609751|FG000|Overall Study|Withdrawal by Subject|2|||
170469601|NCT00356525|616057092|FG000|Overall Study|Withdrawal by Subject|1|||
170469602|NCT00356525|616057093|FG001|Overall Study|Withdrawal by Subject|1|||
170469603|NCT00356525|616057094|FG002|Overall Study|Withdrawal by Subject|0|||
170469604|NCT00356525|616057095|FG003|Overall Study|Withdrawal by Subject|3|||
170469605|NCT00356525|616057092|FG000|Overall Study|Death|0|||
170469606|NCT00356525|616057093|FG001|Overall Study|Death|0|||
170469607|NCT00356525|616057094|FG002|Overall Study|Death|0|||
170469608|NCT00356525|616057095|FG003|Overall Study|Death|1|||
170469609|NCT00356525|616057092|FG000|Overall Study|Sponsor Decision|0|||
170469610|NCT00356525|616057093|FG001|Overall Study|Sponsor Decision|0|||
170469611|NCT00356525|616057094|FG002|Overall Study|Sponsor Decision|0|||
170469612|NCT00356525|616057095|FG003|Overall Study|Sponsor Decision|1|||
170469613|NCT02714426|616057098|FG000|Overall Study|Withdrawal by Subject|2|||
170469614|NCT02714426|616057099|FG001|Overall Study|Withdrawal by Subject|2|||
170469615|NCT02617563|616057100|FG000|4 Weeks|Withdrawal by Subject|2|||
170469616|NCT02617563|616057101|FG001|4 Weeks|Withdrawal by Subject|0|||
170469617|NCT02617563|616057100|FG000|3 Months|Lost to Follow-up|1|||
170469618|NCT02617563|616057101|FG001|3 Months|Lost to Follow-up|0|||
170469619|NCT02617563|616057100|FG000|3 Months|Withdrawal by Subject|0|||
170469620|NCT02617563|616057101|FG001|3 Months|Withdrawal by Subject|1|||
170469621|NCT02617563|616057100|FG000|1 Year|Lost to Follow-up|1|||
170469622|NCT02617563|616057101|FG001|1 Year|Lost to Follow-up|2|||
170469623|NCT02617563|616057100|FG000|2 Year|Death|1|||
170469624|NCT02617563|616057101|FG001|2 Year|Death|0|||
170891397|NCT02623335|617609752|FG001|Overall Study|Withdrawal by Subject|5|||
170469625|NCT02617563|616057100|FG000|2 Year|Lost to Follow-up|2|||
170469626|NCT02617563|616057101|FG001|2 Year|Lost to Follow-up|1|||
170545469|NCT01179516|616341003|FG001|Overall Study|Lack of Efficacy|2|||
170545470|NCT01179516|616341004|FG002|Overall Study|Lack of Efficacy|0|||
170545471|NCT01179516|616341002|FG000|Overall Study|Noncompliance with Study Drug|2|||
170545472|NCT01179516|616341003|FG001|Overall Study|Noncompliance with Study Drug|0|||
170545473|NCT01179516|616341004|FG002|Overall Study|Noncompliance with Study Drug|1|||
170545474|NCT01179516|616341002|FG000|Overall Study|Protocol Deviations|4|||
170545475|NCT01179516|616341003|FG001|Overall Study|Protocol Deviations|3|||
170545476|NCT01179516|616341004|FG002|Overall Study|Protocol Deviations|3|||
170545477|NCT01179516|616341002|FG000|Overall Study|Withdrawal of Consent|2|||
170545478|NCT01179516|616341003|FG001|Overall Study|Withdrawal of Consent|6|||
170545479|NCT01179516|616341004|FG002|Overall Study|Withdrawal of Consent|10|||
170545480|NCT01179516|616341002|FG000|Overall Study|Lost to Follow-up|7|||
170545481|NCT01179516|616341003|FG001|Overall Study|Lost to Follow-up|7|||
170545482|NCT01179516|616341004|FG002|Overall Study|Lost to Follow-up|3|||
170545483|NCT01179516|616341002|FG000|Overall Study|Other|2|||
170545484|NCT01179516|616341003|FG001|Overall Study|Other|0|||
170545485|NCT01179516|616341004|FG002|Overall Study|Other|2|||
170545486|NCT00866320|616341007|FG000|Overall Study|Withdrawal by Subject|4|||
170545487|NCT00866320|616341007|FG000|Overall Study|Death|2|||
170545488|NCT02336503|616341009|FG000|Overall Study|Lost to Follow-up|0|||
170545489|NCT02336503|616341010|FG001|Overall Study|Lost to Follow-up|3|||
170545490|NCT02336503|616341011|FG002|Overall Study|Lost to Follow-up|0|||
170545491|NCT02336503|616341012|FG003|Overall Study|Lost to Follow-up|2|||
170545492|NCT02336503|616341009|FG000|Overall Study|Withdrawal by Subject|2|||
170545493|NCT02336503|616341010|FG001|Overall Study|Withdrawal by Subject|0|||
170545494|NCT02336503|616341011|FG002|Overall Study|Withdrawal by Subject|0|||
170545495|NCT02336503|616341012|FG003|Overall Study|Withdrawal by Subject|4|||
170545496|NCT02336503|616341009|FG000|Overall Study|Adverse Event|0|||
170545497|NCT02336503|616341010|FG001|Overall Study|Adverse Event|0|||
170545498|NCT02336503|616341011|FG002|Overall Study|Adverse Event|1|||
170545499|NCT02336503|616341012|FG003|Overall Study|Adverse Event|0|||
170545500|NCT00896233|616341013|FG000|Overall Study|Claustrophobia during MRI|1|||
170545501|NCT06991803|616341032|FG000|Overall Study|Lost to Follow-up|0|||
170545502|NCT06991803|616341033|FG001|Overall Study|Lost to Follow-up|4|||
170545503|NCT06991803|616341034|FG002|Overall Study|Lost to Follow-up|0|||
170545504|NCT06991803|616341035|FG003|Overall Study|Lost to Follow-up|3|||
170545505|NCT06991803|616341036|FG004|Overall Study|Lost to Follow-up|2|||
170545506|NCT06991803|616341037|FG005|Overall Study|Lost to Follow-up|5|||
170545507|NCT01671059|616341038|FG000|Overall Study|Adverse Event|4|||
170545508|NCT01671059|616341038|FG000|Overall Study|Lack of Efficacy|1|||
170545509|NCT00983957|616341042|FG000|Overall Study|Adverse Event|1|||
170545510|NCT00983957|616341042|FG000|Overall Study|Personal Reasons|1|||
170545511|NCT00884949|616342631|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
170545512|NCT00884949|616342631|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
170545513|NCT04289298|616342632|FG000|Overall Study|Lost to Follow-up|5|||
170545514|NCT04289298|616342633|FG001|Overall Study|Lost to Follow-up|0|||
170545515|NCT04289298|616342632|FG000|Overall Study|Withdrawal by Subject|2|||
170545516|NCT04289298|616342633|FG001|Overall Study|Withdrawal by Subject|0|||
170545517|NCT01734928|616342634|FG000|Randomization|Physician Decision|0|||
170545518|NCT01734928|616342635|FG001|Randomization|Physician Decision|1|||
170545519|NCT01734928|616342634|FG000|Randomization|clinical progression|0|||
170469627|NCT02617563|616057100|FG000|2 Year|Withdrawal by Subject|0|||
170469628|NCT02617563|616057101|FG001|2 Year|Withdrawal by Subject|4|||
170469629|NCT02617563|616057100|FG000|3 Year|Death|2|||
170469630|NCT02617563|616057101|FG001|3 Year|Death|1|||
170469631|NCT02617563|616057100|FG000|3 Year|Lost to Follow-up|1|||
170469632|NCT02617563|616057101|FG001|3 Year|Lost to Follow-up|3|||
170469633|NCT02617563|616057100|FG000|3 Year|Withdrawal by Subject|1|||
170469634|NCT02617563|616057101|FG001|3 Year|Withdrawal by Subject|1|||
170469635|NCT02617563|616057100|FG000|4 Year|Death|1|||
170469636|NCT02617563|616057101|FG001|4 Year|Death|0|||
170469637|NCT02617563|616057100|FG000|4 Year|Lost to Follow-up|3|||
170469638|NCT02617563|616057101|FG001|4 Year|Lost to Follow-up|1|||
170469639|NCT02617563|616057100|FG000|4 Year|Withdrawal by Subject|3|||
170469640|NCT02617563|616057101|FG001|4 Year|Withdrawal by Subject|1|||
170469641|NCT02617563|616057100|FG000|5 Year|Death|0|||
170469642|NCT02617563|616057101|FG001|5 Year|Death|1|||
170469643|NCT02617563|616057100|FG000|5 Year|Lost to Follow-up|9|||
170469644|NCT02617563|616057101|FG001|5 Year|Lost to Follow-up|5|||
170469645|NCT02617563|616057100|FG000|5 Year|Withdrawal by Subject|1|||
170469646|NCT02617563|616057101|FG001|5 Year|Withdrawal by Subject|0|||
170469647|NCT00896480|616057102|FG000|Overall Study|Disease progression/recurrence|21|||
170469648|NCT00205803|616057104|FG000|Infant Series|Lost to Follow-up|10|||
170469649|NCT00205803|616057105|FG001|Infant Series|Lost to Follow-up|4|||
170469650|NCT00205803|616057104|FG000|Infant Series|Withdrawal by Subject|2|||
170469651|NCT00205803|616057105|FG001|Infant Series|Withdrawal by Subject|5|||
170469652|NCT00205803|616057104|FG000|Infant Series|Physician Decision|3|||
170469653|NCT00205803|616057105|FG001|Infant Series|Physician Decision|1|||
170469654|NCT00205803|616057104|FG000|Infant Series|Protocol Violation|1|||
170469655|NCT00205803|616057105|FG001|Infant Series|Protocol Violation|0|||
170469656|NCT00205803|616057104|FG000|Infant Series|Lost Kaiser coverage|0|||
170469657|NCT00205803|616057105|FG001|Infant Series|Lost Kaiser coverage|1|||
170469658|NCT00205803|616057104|FG000|Infant Series|Non-compliant|1|||
170469659|NCT00205803|616057105|FG001|Infant Series|Non-compliant|0|||
170469660|NCT00205803|616057104|FG000|Infant Series|Sponsor request|1|||
170637548|NCT02963506|616684592|FG001|Dose-Blind Period|Sponsor decision|0|||
170637549|NCT02963506|616684593|FG002|Dose-Blind Period|Sponsor decision|0|||
170637550|NCT02963506|616684594|FG003|Dose-Blind Period|Sponsor decision|0|||
170891398|NCT02623335|617609751|FG000|Overall Study|Protocol Violation|2|||
170891399|NCT02623335|617609752|FG001|Overall Study|Protocol Violation|1|||
170469661|NCT00205803|616057105|FG001|Infant Series|Sponsor request|0|||
170469662|NCT00205803|616057104|FG000|After Infant Series|Adverse Event|1|||
170469663|NCT00205803|616057105|FG001|After Infant Series|Adverse Event|1|||
170469664|NCT00205803|616057104|FG000|After Infant Series|Protocol Violation|1|||
170469665|NCT00205803|616057105|FG001|After Infant Series|Protocol Violation|1|||
170469666|NCT00205803|616057104|FG000|After Infant Series|Lost to Follow-up|2|||
170469667|NCT00205803|616057105|FG001|After Infant Series|Lost to Follow-up|1|||
170469668|NCT00205803|616057104|FG000|After Infant Series|Physician Decision|3|||
170469669|NCT00205803|616057105|FG001|After Infant Series|Physician Decision|2|||
170469670|NCT00205803|616057104|FG000|After Infant Series|Withdrawal by Subject|1|||
170469671|NCT00205803|616057105|FG001|After Infant Series|Withdrawal by Subject|4|||
170469672|NCT00205803|616057104|FG000|After Infant Series|Other|10|||
170545520|NCT01734928|616342635|FG001|Randomization|clinical progression|1|||
170545521|NCT01734928|616342634|FG000|Randomization|progressive disease|0|||
170545522|NCT01734928|616342635|FG001|Randomization|progressive disease|2|||
170545523|NCT01734928|616342634|FG000|Randomization|Withdrew informed consent|0|||
170545524|NCT01734928|616342635|FG001|Randomization|Withdrew informed consent|4|||
170545525|NCT01734928|616342634|FG000|Randomization|Death|1|||
170545526|NCT01734928|616342635|FG001|Randomization|Death|0|||
170545527|NCT01734928|616342634|FG000|Randomization|Randomization error|1|||
170545528|NCT01734928|616342635|FG001|Randomization|Randomization error|0|||
170545529|NCT01734928|616342634|FG000|Randomization|Lost to Follow-up|1|||
170545530|NCT01734928|616342635|FG001|Randomization|Lost to Follow-up|0|||
170545531|NCT01734928|616342634|FG000|Treatment Period|Lost to Follow-up|0|||
170545532|NCT01734928|616342635|FG001|Treatment Period|Lost to Follow-up|2|||
170545533|NCT01734928|616342634|FG000|Treatment Period|Progressive Disease|167|||
170891400|NCT00395967|617609754|FG000|Treatment Period|Failed Mobilization|1|||
170891401|NCT00395967|617609754|FG000|Follow-up Period|Death|1|||
170469673|NCT00205803|616057105|FG001|After Infant Series|Other|4|||
170469674|NCT00205803|616057104|FG000|Toddler Dose|Lost to Follow-up|2|||
170469675|NCT00205803|616057105|FG001|Toddler Dose|Lost to Follow-up|3|||
170469676|NCT06865677|616057106|FG000|Overall Study|Screen failure|1|||
170469677|NCT06865677|616057107|FG001|Overall Study|Screen failure|0|||
170469678|NCT06865677|616057106|FG000|Overall Study|Participant no longer eligible before start of conditioning|0|||
170469679|NCT06865677|616057107|FG001|Overall Study|Participant no longer eligible before start of conditioning|1|||
170469680|NCT03014180|616057110|FG000|Overall Study|Protocol Violation|2|||
170545534|NCT01734928|616342635|FG001|Treatment Period|Progressive Disease|165|||
170469681|NCT04784533|616057113|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
170469682|NCT04784533|616057114|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
170891402|NCT00395967|617609754|FG000|Follow-up Period|Lost to Follow-up|1|||
170545535|NCT01734928|616342634|FG000|Treatment Period|Adverse Event|39|||
170545536|NCT01734928|616342635|FG001|Treatment Period|Adverse Event|52|||
170545537|NCT01734928|616342634|FG000|Treatment Period|Withdrawal of Consent|25|||
170545538|NCT01734928|616342635|FG001|Treatment Period|Withdrawal of Consent|22|||
170545539|NCT01734928|616342634|FG000|Treatment Period|Death|20|||
170545540|NCT01734928|616342635|FG001|Treatment Period|Death|9|||
170545541|NCT01734928|616342634|FG000|Treatment Period|Other Reasons|27|||
170469683|NCT04784533|616057115|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
170469684|NCT04784533|616057116|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
170469685|NCT04784533|616057117|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
170469686|NCT04784533|616057118|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
170469687|NCT04784533|616057119|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
170469688|NCT04784533|616057120|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
170469689|NCT04784533|616057121|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
170469690|NCT04784533|616057122|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
170469691|NCT04784533|616057113|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
170469692|NCT04784533|616057114|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
170469693|NCT04784533|616057115|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
170469694|NCT04784533|616057116|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
170469695|NCT04784533|616057117|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
170469696|NCT04784533|616057118|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
170469697|NCT04784533|616057119|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
170469698|NCT04784533|616057120|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
170469699|NCT04784533|616057121|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
170469700|NCT04784533|616057122|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
170469701|NCT04784533|616057113|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469702|NCT04784533|616057114|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
170469703|NCT04784533|616057115|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469704|NCT04784533|616057116|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469705|NCT04784533|616057117|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469706|NCT04784533|616057118|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469707|NCT04784533|616057119|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469708|NCT04784533|616057120|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469709|NCT04784533|616057121|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469710|NCT04784533|616057122|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
170469711|NCT04784533|616057113|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
170469712|NCT04784533|616057114|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469713|NCT04784533|616057115|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469714|NCT04784533|616057116|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469715|NCT04784533|616057117|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469716|NCT04784533|616057118|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469717|NCT04784533|616057119|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469718|NCT04784533|616057120|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469719|NCT04784533|616057121|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469720|NCT04784533|616057122|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
170469721|NCT04784533|616057113|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
170469722|NCT04784533|616057114|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
170469723|NCT04784533|616057115|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
170469724|NCT04784533|616057116|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
170469725|NCT04784533|616057117|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
170469726|NCT04784533|616057118|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
170469727|NCT04784533|616057119|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
170469728|NCT04784533|616057120|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
170469729|NCT04784533|616057121|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
170469730|NCT04784533|616057122|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
170469731|NCT04784533|616057113|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
170469732|NCT04784533|616057114|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
170469733|NCT04784533|616057115|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
170469734|NCT04784533|616057116|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
170469735|NCT04784533|616057117|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
170469736|NCT04784533|616057118|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
170469737|NCT04784533|616057119|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
170469738|NCT04784533|616057120|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
170791370|NCT04585815|617245913|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
170791371|NCT04585815|617245914|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
170791372|NCT04585815|617245915|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
170791373|NCT04585815|617245916|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
170791374|NCT04585815|617245910|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
170791375|NCT04585815|617245911|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
170791376|NCT04585815|617245912|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
170469739|NCT04784533|616057121|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
170469740|NCT04784533|616057122|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
170469741|NCT04784533|616057113|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469742|NCT04784533|616057114|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469743|NCT04784533|616057115|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
170469744|NCT04784533|616057116|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469745|NCT04784533|616057117|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469746|NCT04784533|616057118|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469747|NCT04784533|616057119|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469748|NCT04784533|616057120|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469749|NCT04784533|616057121|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469750|NCT04784533|616057122|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
170469751|NCT04784533|616057113|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469752|NCT04784533|616057114|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469753|NCT04784533|616057115|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469754|NCT04784533|616057116|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469755|NCT04784533|616057117|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469756|NCT04784533|616057118|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469757|NCT04784533|616057119|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469758|NCT04784533|616057120|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469759|NCT04784533|616057121|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
170469760|NCT04784533|616057122|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
170469761|NCT04784533|616057113|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
170469762|NCT04784533|616057114|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
170469763|NCT04784533|616057115|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
170469764|NCT04784533|616057116|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
170469765|NCT04784533|616057117|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
170469766|NCT04784533|616057118|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
170469767|NCT04784533|616057119|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
170469768|NCT04784533|616057120|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
170469769|NCT04784533|616057121|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
170469770|NCT04784533|616057122|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
170469771|NCT02731638|616058758|FG000|Overall Study|Lost to Follow-up|6|||
170469772|NCT02731638|616058759|FG001|Overall Study|Lost to Follow-up|9|||
170469773|NCT02454608|616058760|FG000|Double-Blind Period|Lack of Efficacy|0|||
170469774|NCT02454608|616058761|FG001|Double-Blind Period|Lack of Efficacy|2|||
170469775|NCT02454608|616058762|FG002|Double-Blind Period|Lack of Efficacy|0|||
170469776|NCT02454608|616058760|FG000|Open Label Period|Lost to Follow-up|0|||
170469777|NCT02454608|616058761|FG001|Open Label Period|Lost to Follow-up|0|||
170469778|NCT02454608|616058762|FG002|Open Label Period|Lost to Follow-up|11|||
170469779|NCT02454608|616058760|FG000|Open Label Period|Withdrawal by Subject|0|||
170469780|NCT02454608|616058761|FG001|Open Label Period|Withdrawal by Subject|0|||
170469781|NCT02454608|616058762|FG002|Open Label Period|Withdrawal by Subject|8|||
170469782|NCT04856930|616058763|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
170469783|NCT04856930|616058764|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
170469784|NCT04856930|616058765|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
170469785|NCT04856930|616058763|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
170469786|NCT04856930|616058764|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
170545542|NCT01734928|616342635|FG001|Treatment Period|Other Reasons|19|||
170545543|NCT01734928|616342634|FG000|Treatment Period|Pregnancy|0|||
170545544|NCT01734928|616342635|FG001|Treatment Period|Pregnancy|1|||
170545545|NCT04193176|616342636|FG000|Overall Study|Withdrawal by Subject|6|||
170545546|NCT04193176|616342637|FG001|Overall Study|Withdrawal by Subject|10|||
170545547|NCT03537729|616342646|FG000|Overall Study|Death|2|||
170545548|NCT03537729|616342647|FG001|Overall Study|Death|2|||
170545549|NCT03537729|616342648|FG002|Overall Study|Death|7|||
170545550|NCT03537729|616342646|FG000|Overall Study|Withdrawal by Subject|3|||
170791377|NCT04585815|617245913|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
170791378|NCT04585815|617245914|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
170791379|NCT04585815|617245915|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
170791380|NCT04585815|617245916|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
170791381|NCT04585815|617245910|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
170469787|NCT04856930|616058765|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
170469788|NCT04856930|616058763|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
170469789|NCT04856930|616058764|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
170545551|NCT03537729|616342647|FG001|Overall Study|Withdrawal by Subject|3|||
170545552|NCT03537729|616342648|FG002|Overall Study|Withdrawal by Subject|0|||
170545553|NCT03537729|616342646|FG000|Overall Study|Subject Moved|8|||
170791382|NCT04585815|617245911|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
170791383|NCT04585815|617245912|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
170791384|NCT04585815|617245913|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
170791385|NCT04585815|617245914|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
170469790|NCT04856930|616058765|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
170469791|NCT04856930|616058763|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
170791386|NCT04585815|617245915|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
170791387|NCT04585815|617245916|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
170791388|NCT04585815|617245910|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
170791389|NCT04585815|617245911|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
170791390|NCT04585815|617245912|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
170791391|NCT04585815|617245913|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
170791392|NCT04585815|617245914|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
170791393|NCT04585815|617245915|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
170791394|NCT04585815|617245916|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
170791395|NCT04585815|617245910|FG000|Sub-study B- Follow-up Phase|Death|0|||
170891403|NCT00193063|617609755|FG000|Overall Study|Lack of Efficacy|3|||
170891404|NCT00193063|617609755|FG000|Overall Study|Adverse Event|1|||
170891405|NCT02971670|617609760|FG000|Overall Study|Withdrawal by Subject|4|||
170891406|NCT02971670|617609761|FG001|Overall Study|Withdrawal by Subject|1|||
170891407|NCT02971670|617609762|FG002|Overall Study|Withdrawal by Subject|1|||
170891408|NCT02971670|617609763|FG003|Overall Study|Withdrawal by Subject|2|||
170891409|NCT01127165|617609764|FG000|Overall Study|Adverse Event|2|||
170891410|NCT01127165|617609765|FG001|Overall Study|Adverse Event|2|||
170891411|NCT01127165|617609764|FG000|Overall Study|Lack of Efficacy|10|||
170891412|NCT01127165|617609765|FG001|Overall Study|Lack of Efficacy|8|||
170891413|NCT01127165|617609764|FG000|Overall Study|Lost to Follow-up|3|||
170891414|NCT01127165|617609765|FG001|Overall Study|Lost to Follow-up|5|||
170891415|NCT01127165|617609764|FG000|Overall Study|Withdrawal by Subject|1|||
170891416|NCT01127165|617609765|FG001|Overall Study|Withdrawal by Subject|3|||
170891417|NCT01127165|617609764|FG000|Overall Study|Protocol Violation|0|||
170891418|NCT01127165|617609765|FG001|Overall Study|Protocol Violation|1|||
170891419|NCT00379795|617609766|FG000|Overall Study|Death|31|||
170891420|NCT00379795|617609767|FG001|Overall Study|Death|8|||
170891421|NCT00379795|617609768|FG002|Overall Study|Death|6|||
170891422|NCT00379795|617609769|FG003|Overall Study|Death|4|||
170891423|NCT00379795|617609770|FG004|Overall Study|Death|7|||
170891424|NCT00379795|617609766|FG000|Overall Study|Adverse Event|17|||
170891425|NCT00379795|617609767|FG001|Overall Study|Adverse Event|3|||
170891426|NCT00379795|617609768|FG002|Overall Study|Adverse Event|3|||
170891427|NCT00379795|617609769|FG003|Overall Study|Adverse Event|1|||
170891428|NCT00379795|617609770|FG004|Overall Study|Adverse Event|4|||
170891429|NCT00379795|617609766|FG000|Overall Study|Lost to Follow-up|8|||
170891430|NCT00379795|617609767|FG001|Overall Study|Lost to Follow-up|1|||
170891431|NCT00379795|617609768|FG002|Overall Study|Lost to Follow-up|2|||
170891432|NCT00379795|617609769|FG003|Overall Study|Lost to Follow-up|1|||
170891433|NCT00379795|617609770|FG004|Overall Study|Lost to Follow-up|4|||
170891434|NCT00379795|617609766|FG000|Overall Study|Physician Decision|25|||
170891435|NCT00379795|617609767|FG001|Overall Study|Physician Decision|0|||
170891436|NCT00379795|617609768|FG002|Overall Study|Physician Decision|2|||
170891437|NCT00379795|617609769|FG003|Overall Study|Physician Decision|2|||
170891438|NCT00379795|617609770|FG004|Overall Study|Physician Decision|2|||
170891439|NCT00379795|617609766|FG000|Overall Study|Withdrawal by Subject|94|||
170891440|NCT00379795|617609767|FG001|Overall Study|Withdrawal by Subject|11|||
170891441|NCT00379795|617609768|FG002|Overall Study|Withdrawal by Subject|19|||
170891442|NCT00379795|617609769|FG003|Overall Study|Withdrawal by Subject|7|||
170891443|NCT00379795|617609770|FG004|Overall Study|Withdrawal by Subject|14|||
170891444|NCT00379795|617609766|FG000|Overall Study|Subject non-compliance|7|||
170891445|NCT00379795|617609767|FG001|Overall Study|Subject non-compliance|2|||
170891446|NCT00379795|617609768|FG002|Overall Study|Subject non-compliance|0|||
170891447|NCT00379795|617609769|FG003|Overall Study|Subject non-compliance|0|||
170891448|NCT00379795|617609770|FG004|Overall Study|Subject non-compliance|1|||
170891449|NCT00379795|617609766|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
170891450|NCT00379795|617609767|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
170891451|NCT00379795|617609768|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
170891452|NCT00379795|617609769|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
170891453|NCT00379795|617609770|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
170891454|NCT00379795|617609766|FG000|Overall Study|Subjects condition mandated intervention|34|||
170891455|NCT00379795|617609767|FG001|Overall Study|Subjects condition mandated intervention|9|||
170891456|NCT00379795|617609768|FG002|Overall Study|Subjects condition mandated intervention|7|||
170891457|NCT00379795|617609769|FG003|Overall Study|Subjects condition mandated intervention|5|||
170545554|NCT03537729|616342647|FG001|Overall Study|Subject Moved|5|||
170891458|NCT00379795|617609770|FG004|Overall Study|Subjects condition mandated intervention|7|||
170891459|NCT00379795|617609766|FG000|Overall Study|Sponsor's decision|257|||
170469792|NCT04856930|616058764|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
170469793|NCT04856930|616058765|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
170469794|NCT04856930|616058763|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
170469795|NCT04856930|616058764|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
170469796|NCT04856930|616058765|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
170469797|NCT04856930|616058763|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
170469798|NCT04856930|616058764|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
170469799|NCT04856930|616058765|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
170469800|NCT04856930|616058763|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
170469801|NCT04856930|616058764|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
170469802|NCT04856930|616058765|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
170469803|NCT04856930|616058763|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
170469804|NCT04856930|616058764|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
170469805|NCT04856930|616058765|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
170469806|NCT04856930|616058763|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
170469807|NCT04856930|616058764|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
170469808|NCT04856930|616058765|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
170469809|NCT04856930|616058763|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
170469810|NCT04856930|616058764|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
170469811|NCT04856930|616058765|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
170469812|NCT04856930|616058763|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
170469813|NCT04856930|616058764|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
170469814|NCT04856930|616058765|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
170469815|NCT04856930|616058763|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
170469816|NCT04856930|616058764|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
170469817|NCT04856930|616058765|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
170469818|NCT04856930|616058763|FG000|Extension Period (16 Weeks)|Other than specified|0|||
170469819|NCT04856930|616058764|FG001|Extension Period (16 Weeks)|Other than specified|0|||
170469820|NCT04856930|616058765|FG002|Extension Period (16 Weeks)|Other than specified|1|||
170469821|NCT04856930|616058763|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
170469822|NCT04856930|616058764|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
170469823|NCT04856930|616058765|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
170469824|NCT04856930|616058763|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
170469825|NCT04856930|616058764|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
170469826|NCT04856930|616058765|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
170469827|NCT04856930|616058763|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
170469828|NCT04856930|616058764|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
170469829|NCT04856930|616058765|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
170469830|NCT04856930|616058763|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
170469831|NCT04856930|616058764|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
170469832|NCT04856930|616058765|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
170469833|NCT00678210|616058767|FG000|Overall Study|Adverse Event|1|||
170469834|NCT00678210|616058768|FG001|Overall Study|Adverse Event|2|||
170469835|NCT00678210|616058769|FG002|Overall Study|Adverse Event|3|||
170469836|NCT00678210|616058770|FG003|Overall Study|Adverse Event|3|||
170469837|NCT00678210|616058767|FG000|Overall Study|Lack of Efficacy|2|||
170469838|NCT00678210|616058768|FG001|Overall Study|Lack of Efficacy|3|||
170469839|NCT00678210|616058769|FG002|Overall Study|Lack of Efficacy|1|||
170469840|NCT00678210|616058770|FG003|Overall Study|Lack of Efficacy|9|||
170469841|NCT00678210|616058767|FG000|Overall Study|Lost to Follow-up|4|||
170469842|NCT00678210|616058768|FG001|Overall Study|Lost to Follow-up|2|||
170469843|NCT00678210|616058769|FG002|Overall Study|Lost to Follow-up|0|||
170469844|NCT00678210|616058770|FG003|Overall Study|Lost to Follow-up|1|||
170469845|NCT00678210|616058767|FG000|Overall Study|Withdrawal by Subject|3|||
170469846|NCT00678210|616058768|FG001|Overall Study|Withdrawal by Subject|4|||
170469847|NCT00678210|616058769|FG002|Overall Study|Withdrawal by Subject|1|||
170791396|NCT04585815|617245911|FG001|Sub-study B- Follow-up Phase|Death|0|||
170469848|NCT00678210|616058770|FG003|Overall Study|Withdrawal by Subject|7|||
170469849|NCT00678210|616058767|FG000|Overall Study|Other|1|||
170469850|NCT00678210|616058768|FG001|Overall Study|Other|0|||
170469851|NCT00678210|616058769|FG002|Overall Study|Other|1|||
170469852|NCT00678210|616058770|FG003|Overall Study|Other|0|||
170469853|NCT02806024|616058776|FG000|Overall Study|Night Delivery|1|||
170469854|NCT02806024|616058777|FG001|Overall Study|Night Delivery|1|||
170545555|NCT03537729|616342648|FG002|Overall Study|Subject Moved|4|||
170545556|NCT03537729|616342646|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
170545557|NCT03537729|616342647|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
170545558|NCT03537729|616342648|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
170545559|NCT03537729|616342646|FG000|Overall Study|COVID-19 Site Restrictions|11|||
170545560|NCT03537729|616342647|FG001|Overall Study|COVID-19 Site Restrictions|15|||
170469855|NCT02806024|616058776|FG000|Overall Study|DVT during antepartum admission|0|||
170469856|NCT02806024|616058777|FG001|Overall Study|DVT during antepartum admission|1|||
170469857|NCT00626561|616058778|FG000|Overall Study|Withdrawal by Subject|2|||
170469858|NCT00626561|616058778|FG000|Overall Study|Disease Progression|2|||
170469859|NCT03790657|616058779|FG000|Overall Study|Adverse Event|1|||
170469860|NCT03790657|616058780|FG001|Overall Study|Adverse Event|1|||
170469861|NCT03790657|616058779|FG000|Overall Study|Withdrawal by Subject|1|||
170469862|NCT03790657|616058780|FG001|Overall Study|Withdrawal by Subject|1|||
170469863|NCT03126435|616058781|FG000|Overall Study|Death|90|||
170469864|NCT03126435|616058782|FG001|Overall Study|Death|84|||
170469865|NCT03126435|616058781|FG000|Overall Study|Lost to Follow-up|4|||
170469866|NCT03126435|616058782|FG001|Overall Study|Lost to Follow-up|3|||
170469867|NCT03126435|616058781|FG000|Overall Study|Physician Decision|0|||
170469868|NCT03126435|616058782|FG001|Overall Study|Physician Decision|1|||
170469869|NCT03126435|616058781|FG000|Overall Study|Withdrawal by Subject|6|||
170469870|NCT03126435|616058782|FG001|Overall Study|Withdrawal by Subject|12|||
170469871|NCT03126435|616058781|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
170469872|NCT03126435|616058782|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
170469873|NCT02756208|616058783|FG000|Overall Study|Withdrawal by Subject|1|||
170469874|NCT02756208|616058784|FG001|Overall Study|Withdrawal by Subject|0|||
170469875|NCT02756208|616058785|FG002|Overall Study|Withdrawal by Subject|1|||
170469876|NCT02756208|616058786|FG003|Overall Study|Withdrawal by Subject|3|||
170469877|NCT02756208|616058783|FG000|Overall Study|Lost to Follow-up|3|||
170469878|NCT02756208|616058784|FG001|Overall Study|Lost to Follow-up|1|||
170469879|NCT02756208|616058785|FG002|Overall Study|Lost to Follow-up|1|||
170469880|NCT02756208|616058786|FG003|Overall Study|Lost to Follow-up|1|||
170469881|NCT02756208|616058783|FG000|Overall Study|Physician Decision|1|||
170469882|NCT02756208|616058784|FG001|Overall Study|Physician Decision|0|||
170469883|NCT02756208|616058785|FG002|Overall Study|Physician Decision|0|||
170469884|NCT02756208|616058786|FG003|Overall Study|Physician Decision|0|||
170469885|NCT02756208|616058783|FG000|Overall Study|Protocol Violation|0|||
170469886|NCT02756208|616058784|FG001|Overall Study|Protocol Violation|1|||
170469887|NCT02756208|616058785|FG002|Overall Study|Protocol Violation|0|||
170469888|NCT02756208|616058786|FG003|Overall Study|Protocol Violation|0|||
170469889|NCT04841577|616058787|FG000|Overall Study|Adverse Event|5|||
170469890|NCT04841577|616058788|FG001|Overall Study|Adverse Event|10|||
170469891|NCT04841577|616058787|FG000|Overall Study|Lost to Follow-up|8|||
170469892|NCT04841577|616058788|FG001|Overall Study|Lost to Follow-up|7|||
170469893|NCT04841577|616058787|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
170469894|NCT04841577|616058788|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
170469895|NCT04841577|616058787|FG000|Overall Study|Other|0|||
170469896|NCT04841577|616058788|FG001|Overall Study|Other|1|||
170469897|NCT02370238|616058795|FG000|Overall Study|Death|42|||
170469898|NCT02370238|616058796|FG001|Overall Study|Death|35|||
170637551|NCT02963506|616684595|FG004|Dose-Blind Period|Sponsor decision|0|||
170637552|NCT02963506|616684596|FG005|Dose-Blind Period|Sponsor decision|1|||
170637553|NCT02963506|616684597|FG006|Dose-Blind Period|Sponsor decision|0|||
170637554|NCT02963506|616684598|FG007|Dose-Blind Period|Sponsor decision|0|||
170637555|NCT02963506|616684599|FG008|Dose-Blind Period|Sponsor decision|0|||
170637556|NCT02963506|616684600|FG009|Dose-Blind Period|Sponsor decision|0|||
170891460|NCT00379795|617609767|FG001|Overall Study|Sponsor's decision|17|||
170891461|NCT00379795|617609768|FG002|Overall Study|Sponsor's decision|54|||
170891462|NCT00379795|617609769|FG003|Overall Study|Sponsor's decision|47|||
170891463|NCT00379795|617609770|FG004|Overall Study|Sponsor's decision|10|||
170469899|NCT02370238|616058795|FG000|Overall Study|Lost to Follow-up|1|||
170469900|NCT02370238|616058796|FG001|Overall Study|Lost to Follow-up|3|||
170469901|NCT02370238|616058795|FG000|Overall Study|Withdrawal by Subject|2|||
170469902|NCT02370238|616058796|FG001|Overall Study|Withdrawal by Subject|6|||
170469903|NCT02370238|616058795|FG000|Overall Study|Other|2|||
170637557|NCT02963506|616684601|FG010|Dose-Blind Period|Sponsor decision|0|||
170637558|NCT02963506|616684602|FG011|Dose-Blind Period|Sponsor decision|0|||
170637559|NCT02963506|616684603|FG012|Dose-Blind Period|Sponsor decision|0|||
170469904|NCT02370238|616058796|FG001|Overall Study|Other|1|||
170469905|NCT01937871|616058797|FG000|Overall Study|Adverse Event|6|||
170469906|NCT01937871|616058798|FG001|Overall Study|Adverse Event|6|||
170637560|NCT02963506|616684591|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637561|NCT02963506|616684592|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170891464|NCT02435849|617609771|FG000|Overall Study|Death|23|||
170891465|NCT02435849|617609772|FG001|Overall Study|Death|0|||
170469907|NCT01937871|616058799|FG002|Overall Study|Adverse Event|2|||
170469908|NCT01937871|616058797|FG000|Overall Study|Lost to Follow-up|8|||
170469909|NCT01937871|616058798|FG001|Overall Study|Lost to Follow-up|2|||
170469910|NCT01937871|616058799|FG002|Overall Study|Lost to Follow-up|4|||
170469911|NCT01937871|616058797|FG000|Overall Study|Withdrawal by Subject|9|||
170469912|NCT01937871|616058798|FG001|Overall Study|Withdrawal by Subject|6|||
170469913|NCT01937871|616058799|FG002|Overall Study|Withdrawal by Subject|4|||
170469914|NCT01937871|616058797|FG000|Overall Study|Physician Decision|0|||
170469915|NCT01937871|616058798|FG001|Overall Study|Physician Decision|1|||
170469916|NCT01937871|616058799|FG002|Overall Study|Physician Decision|0|||
170469917|NCT01937871|616058797|FG000|Overall Study|Entry Criteria Not Met|1|||
170469918|NCT01937871|616058798|FG001|Overall Study|Entry Criteria Not Met|2|||
170469919|NCT01937871|616058799|FG002|Overall Study|Entry Criteria Not Met|1|||
170469920|NCT05246670|616058800|FG000|Overall Study|Withdrawal by Subject|2|||
170469921|NCT05246670|616058801|FG001|Overall Study|Withdrawal by Subject|3|||
170469922|NCT05246670|616058802|FG002|Overall Study|Withdrawal by Subject|0|||
170469923|NCT05246670|616058803|FG003|Overall Study|Withdrawal by Subject|1|||
170469924|NCT05246670|616058800|FG000|Overall Study|Adverse Event|0|||
170469925|NCT05246670|616058801|FG001|Overall Study|Adverse Event|0|||
170469926|NCT05246670|616058802|FG002|Overall Study|Adverse Event|1|||
170469927|NCT05246670|616058803|FG003|Overall Study|Adverse Event|0|||
170469928|NCT05246670|616058800|FG000|Overall Study|Physician Decision|1|||
170469929|NCT05246670|616058801|FG001|Overall Study|Physician Decision|0|||
170469930|NCT05246670|616058802|FG002|Overall Study|Physician Decision|0|||
170469931|NCT05246670|616058803|FG003|Overall Study|Physician Decision|0|||
170469932|NCT05246670|616058800|FG000|Overall Study|Protocol Violation|1|||
170469933|NCT05246670|616058801|FG001|Overall Study|Protocol Violation|0|||
170469934|NCT05246670|616058802|FG002|Overall Study|Protocol Violation|0|||
170469935|NCT05246670|616058803|FG003|Overall Study|Protocol Violation|0|||
170469936|NCT00652340|616058809|FG000|Overall Study|Had not progressed.|4|||
170469937|NCT00652340|616058810|FG001|Overall Study|Had not progressed.|3|||
170469938|NCT02652949|616058811|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
170469939|NCT02652949|616058811|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
170469940|NCT02652949|616058811|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
170469941|NCT02652949|616058811|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
170469942|NCT02652949|616058811|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
170469943|NCT02652949|616058811|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
170469944|NCT02652949|616058811|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
170469945|NCT02652949|616058811|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
170469946|NCT02652949|616058811|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
170469947|NCT02652949|616058811|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
170469948|NCT02652949|616058811|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
170469949|NCT02652949|616058811|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
170469950|NCT02652949|616058811|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
170469951|NCT02652949|616058811|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
170469952|NCT02652949|616058811|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
170469953|NCT02652949|616058811|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
170469954|NCT02652949|616058811|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
170469955|NCT03682107|616058812|FG000|Overall Study|Withdrawal by Subject|0|||
170469956|NCT03682107|616058813|FG001|Overall Study|Withdrawal by Subject|1|||
170469957|NCT03682107|616058814|FG002|Overall Study|Withdrawal by Subject|0|||
170469958|NCT03682107|616058815|FG003|Overall Study|Withdrawal by Subject|0|||
170469959|NCT03682107|616058816|FG004|Overall Study|Withdrawal by Subject|0|||
170469960|NCT00214383|616058819|FG000|Overall Study|Lost to Follow-up|16|||
170469961|NCT00214383|616058820|FG001|Overall Study|Lost to Follow-up|26|||
170469962|NCT04152291|616058821|FG000|Overall Study|Covid-19 restrictions|27|||
170469963|NCT04152291|616058821|FG000|Overall Study|Withdrawal by Subject|3|||
170469964|NCT03597295|616058822|FG000|Overall Study|Death|70|||
170469965|NCT03597295|616058822|FG000|Overall Study|Lost to Follow-up|7|||
170469966|NCT00879411|616058823|FG000|Overall Study|lost to follow-up (non-AE)|162|||
170469967|NCT05124691|616058824|FG000|Phase II|Eligibility criteria|0|||
170469968|NCT05124691|616058825|FG001|Phase II|Eligibility criteria|1|||
170469969|NCT05124691|616058826|FG002|Phase II|Eligibility criteria|0|||
170469970|NCT05124691|616058824|FG000|Phase II|Withdrawal by Subject|6|||
170469971|NCT05124691|616058825|FG001|Phase II|Withdrawal by Subject|2|||
170545561|NCT03537729|616342648|FG002|Overall Study|COVID-19 Site Restrictions|18|||
170545562|NCT03537729|616342646|FG000|Overall Study|Decline in Health|5|||
170545563|NCT03537729|616342647|FG001|Overall Study|Decline in Health|9|||
170545564|NCT03537729|616342648|FG002|Overall Study|Decline in Health|4|||
170469972|NCT05124691|616058826|FG002|Phase II|Withdrawal by Subject|3|||
170469973|NCT05124691|616058824|FG000|Phase III|Withdrawal by Subject|6|||
170545565|NCT03537729|616342646|FG000|Overall Study|Determined Ineligible|0|||
170545566|NCT03537729|616342647|FG001|Overall Study|Determined Ineligible|0|||
170545567|NCT03537729|616342648|FG002|Overall Study|Determined Ineligible|1|||
170469974|NCT05124691|616058825|FG001|Phase III|Withdrawal by Subject|4|||
170469975|NCT05124691|616058826|FG002|Phase III|Withdrawal by Subject|4|||
170469976|NCT05124691|616058824|FG000|Phase III|Lost to Follow-up|1|||
170469977|NCT05124691|616058825|FG001|Phase III|Lost to Follow-up|0|||
170469978|NCT05124691|616058826|FG002|Phase III|Lost to Follow-up|0|||
170545568|NCT01129284|616342658|FG000|Overall Study|Adverse Event|2|||
170545569|NCT01129284|616342659|FG001|Overall Study|Adverse Event|0|||
170469979|NCT05211726|616058827|FG000|Overall Study|Withdrawal by Subject|2|||
170469980|NCT05211726|616058828|FG001|Overall Study|Withdrawal by Subject|3|||
170891466|NCT02435849|617609771|FG000|Overall Study|Lack of Efficacy|10|||
170891467|NCT02435849|617609772|FG001|Overall Study|Lack of Efficacy|0|||
170891468|NCT02435849|617609771|FG000|Overall Study|New therapy for study indication|8|||
170891469|NCT02435849|617609772|FG001|Overall Study|New therapy for study indication|0|||
170891470|NCT02435849|617609771|FG000|Overall Study|Subject/guardian decision|5|||
170891471|NCT02435849|617609772|FG001|Overall Study|Subject/guardian decision|1|||
170891472|NCT02435849|617609771|FG000|Overall Study|Lost to Follow-up|1|||
170545570|NCT01129284|616342660|FG002|Overall Study|Adverse Event|1|||
170545571|NCT03197935|616342666|FG000|Overall Study|Death due to any cause|26|||
170545572|NCT03197935|616342667|FG001|Overall Study|Death due to any cause|15|||
170545573|NCT03197935|616342666|FG000|Overall Study|Lost to Follow-up|3|||
170545574|NCT03197935|616342667|FG001|Overall Study|Lost to Follow-up|5|||
170545575|NCT03197935|616342666|FG000|Overall Study|Physician Decision|2|||
170545576|NCT03197935|616342667|FG001|Overall Study|Physician Decision|1|||
170545577|NCT03197935|616342666|FG000|Overall Study|Withdrawal by Subject|16|||
170545578|NCT03197935|616342667|FG001|Overall Study|Withdrawal by Subject|8|||
170545579|NCT03315689|616342673|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
170545580|NCT03315689|616342674|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
170545581|NCT03315689|616342673|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
170545582|NCT03315689|616342674|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
170545583|NCT03315689|616342673|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
170545584|NCT03315689|616342674|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
170545585|NCT01967277|616342675|FG000|Overall Study|Lost to Follow-up|1|||
170545586|NCT01967277|616342676|FG001|Overall Study|Lost to Follow-up|2|||
170545587|NCT01967277|616342675|FG000|Overall Study|Unrelated illness|0|||
170545588|NCT01967277|616342676|FG001|Overall Study|Unrelated illness|1|||
170545589|NCT02056288|616342687|FG000|In-Hospital Data|Surgery cancelled|1|||
170545590|NCT02056288|616342688|FG001|In-Hospital Data|Surgery cancelled|0|||
170891473|NCT02435849|617609772|FG001|Overall Study|Lost to Follow-up|0|||
170891474|NCT02435849|617609771|FG000|Overall Study|Physician Decision|1|||
170891475|NCT02435849|617609772|FG001|Overall Study|Physician Decision|0|||
170891476|NCT01017952|617609773|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
170891477|NCT01017952|617609774|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
170891478|NCT01017952|617609775|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
170891479|NCT01017952|617609776|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
170891480|NCT01017952|617609777|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
170891481|NCT01017952|617609773|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
170891482|NCT01017952|617609774|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
170891483|NCT01017952|617609775|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
170891484|NCT01017952|617609776|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
170891485|NCT01017952|617609777|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
170891486|NCT01017952|617609773|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
170891487|NCT01017952|617609774|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
170891488|NCT01017952|617609775|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
170891489|NCT01017952|617609776|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
170891490|NCT01017952|617609777|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
170891491|NCT01017952|617609773|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
170891492|NCT01017952|617609774|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
170891493|NCT01017952|617609775|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
170891494|NCT01017952|617609776|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
170891495|NCT01017952|617609777|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
170891496|NCT01017952|617609773|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
170891497|NCT01017952|617609774|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
170891498|NCT01017952|617609775|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
170891499|NCT01017952|617609776|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
170891500|NCT01017952|617609777|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
170891501|NCT01017952|617609773|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
170891502|NCT01017952|617609774|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
170891503|NCT01017952|617609775|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
170891504|NCT01017952|617609776|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
170891505|NCT01017952|617609777|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
170891506|NCT01017952|617609773|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
170891507|NCT01017952|617609774|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
170891508|NCT01017952|617609775|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
170891509|NCT01017952|617609776|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
170891510|NCT01017952|617609777|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
170545591|NCT02056288|616342687|FG000|In-Hospital Data|Protocol Violation|3|||
170545592|NCT02056288|616342688|FG001|In-Hospital Data|Protocol Violation|0|||
170545593|NCT02056288|616342687|FG000|In-Hospital Data|Physician Decision|1|||
170637562|NCT02963506|616684593|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170791397|NCT04585815|617245912|FG002|Sub-study B- Follow-up Phase|Death|1|||
170469981|NCT05211726|616058827|FG000|Overall Study|Protocol Violation|0|||
170469982|NCT05211726|616058828|FG001|Overall Study|Protocol Violation|1|||
170469983|NCT00428116|616058829|FG000|Overall Study|Death|1|||
170469984|NCT00428116|616058830|FG001|Overall Study|Death|0|||
170469985|NCT00428116|616058829|FG000|Overall Study|Withdrawal by Subject|1|||
170469986|NCT00428116|616058830|FG001|Overall Study|Withdrawal by Subject|0|||
170469987|NCT00428116|616058829|FG000|Overall Study|Lost to Follow-up|1|||
170469988|NCT00428116|616058830|FG001|Overall Study|Lost to Follow-up|0|||
170469989|NCT01890434|616058831|FG000|Overall Study|Adverse Event|8|||
170469990|NCT01890434|616058831|FG000|Overall Study|PCI at external hospital|1|||
170469991|NCT01890434|616058831|FG000|Overall Study|Assessment discrepancy|1|||
170469992|NCT01890434|616058831|FG000|Overall Study|CRC didn't contact participant for FU|1|||
170469993|NCT01890434|616058831|FG000|Overall Study|Could not get whole set of images|1|||
170469994|NCT01890434|616058831|FG000|Overall Study|Decline to return for GSPECT|1|||
170469995|NCT01890434|616058831|FG000|Overall Study|GSPECT at rest was not done|1|||
170469996|NCT01890434|616058831|FG000|Overall Study|Participant didn't complete MRI|1|||
170469997|NCT01890434|616058831|FG000|Overall Study|Uncontactable by phone|1|||
170469998|NCT01890434|616058831|FG000|Overall Study|Moved out of position|1|||
170469999|NCT01890434|616058831|FG000|Overall Study|Unable to contact|1|||
170470000|NCT01890434|616058831|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
170470001|NCT01038297|616058832|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
170470002|NCT01038297|616058833|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
170470003|NCT01038297|616058834|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
170470004|NCT01973595|616058838|FG000|Washout|Withdrawal by Subject|1|||
170470005|NCT01973595|616058839|FG001|Washout|Withdrawal by Subject|0|||
170470006|NCT01973595|616058840|FG002|Washout|Withdrawal by Subject|1|||
170470007|NCT01973595|616058841|FG003|Washout|Withdrawal by Subject|0|||
170470008|NCT06187909|616058842|FG000|Overall Study|Withdrawal by Subject|2|||
170470009|NCT06187909|616058843|FG001|Overall Study|Withdrawal by Subject|2|||
170470010|NCT04745676|616058846|FG000|Overall Study|Death|1|||
170470011|NCT04745676|616058847|FG001|Overall Study|Death|0|||
170470012|NCT04745676|616058848|FG002|Overall Study|Death|0|||
170470013|NCT00863772|616058857|FG000|Overall Study|Adverse Event|1|||
170470014|NCT00863772|616058858|FG001|Overall Study|Adverse Event|4|||
170545594|NCT02056288|616342688|FG001|In-Hospital Data|Physician Decision|0|||
170545595|NCT02056288|616342687|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
170545596|NCT02056288|616342688|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
170545597|NCT02384460|616342689|FG000|Overall Study|Protocol Violation|0|||
170545598|NCT02384460|616342690|FG001|Overall Study|Protocol Violation|1|||
170545599|NCT02384460|616342689|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
170545600|NCT02384460|616342690|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
170545601|NCT02384460|616342689|FG000|Overall Study|Adverse Event|5|||
170470015|NCT00863772|616058859|FG002|Overall Study|Adverse Event|0|||
170470016|NCT00863772|616058857|FG000|Overall Study|Lack of Efficacy|4|||
170470017|NCT00863772|616058858|FG001|Overall Study|Lack of Efficacy|2|||
170470018|NCT00863772|616058859|FG002|Overall Study|Lack of Efficacy|4|||
170470019|NCT00863772|616058857|FG000|Overall Study|Lost to Follow-up|5|||
170470020|NCT00863772|616058858|FG001|Overall Study|Lost to Follow-up|1|||
170637563|NCT02963506|616684594|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637564|NCT02963506|616684595|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637565|NCT02963506|616684596|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637566|NCT02963506|616684597|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637567|NCT02963506|616684598|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637568|NCT02963506|616684599|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637569|NCT02963506|616684600|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637570|NCT02963506|616684601|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637571|NCT02963506|616684602|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
170637572|NCT02963506|616684603|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
170637573|NCT02527421|616684604|FG000|Overall Study|Withdrawal by Subject|1|||
170637574|NCT02527421|616684605|FG001|Overall Study|Withdrawal by Subject|0|||
170637575|NCT04200352|616684606|FG000|Overall Study|Death|1|||
170637576|NCT04200352|616684606|FG000|Overall Study|Adverse Event|6|||
170637577|NCT04200352|616684606|FG000|Overall Study|Withdrawal by parent/guardian|6|||
170637578|NCT04200352|616684606|FG000|Overall Study|Lack of Efficacy|1|||
170637579|NCT04200352|616684606|FG000|Overall Study|Other than specified|6|||
170637580|NCT02541604|616684607|FG000|Overall Study|Death|6|||
170637581|NCT02541604|616684608|FG001|Overall Study|Death|5|||
170637582|NCT02541604|616684609|FG002|Overall Study|Death|7|||
170637583|NCT02541604|616684610|FG003|Overall Study|Death|2|||
170637584|NCT02541604|616684611|FG004|Overall Study|Death|9|||
170637585|NCT02541604|616684612|FG005|Overall Study|Death|8|||
170637586|NCT02541604|616684613|FG006|Overall Study|Death|9|||
170891511|NCT01017952|617609773|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
170891512|NCT01017952|617609774|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
170891513|NCT01017952|617609775|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
170891514|NCT01017952|617609776|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
170891515|NCT01017952|617609777|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
170891516|NCT01017952|617609773|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
170891517|NCT01017952|617609774|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
170637587|NCT02541604|616684614|FG007|Overall Study|Death|9|||
170637588|NCT02541604|616684615|FG008|Overall Study|Death|3|||
170637589|NCT02541604|616684616|FG009|Overall Study|Death|4|||
170637590|NCT02541604|616684617|FG010|Overall Study|Death|2|||
170637591|NCT02541604|616684618|FG011|Overall Study|Death|3|||
170891518|NCT01017952|617609775|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
170891519|NCT01017952|617609776|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
170891520|NCT01017952|617609777|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
170891521|NCT01017952|617609773|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
170891522|NCT01017952|617609774|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
170891523|NCT01017952|617609775|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
170891524|NCT01017952|617609776|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
170891525|NCT01017952|617609777|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
170891526|NCT01017952|617609773|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
170891527|NCT01017952|617609774|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
170891528|NCT01017952|617609775|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
170891529|NCT01017952|617609776|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
170891530|NCT01017952|617609777|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
170891531|NCT01017952|617609773|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
170891532|NCT01017952|617609774|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
170891533|NCT01017952|617609775|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
170891534|NCT01017952|617609776|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
170891535|NCT01017952|617609777|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
170891536|NCT01017952|617609773|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170891537|NCT01017952|617609774|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
170891538|NCT01017952|617609775|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
170891539|NCT01017952|617609776|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
170891540|NCT01017952|617609777|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
170891541|NCT01017952|617609773|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
170891542|NCT01017952|617609774|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
170637592|NCT02541604|616684607|FG000|Overall Study|Lost to Follow-up|2|||
170637593|NCT02541604|616684608|FG001|Overall Study|Lost to Follow-up|0|||
170637594|NCT02541604|616684609|FG002|Overall Study|Lost to Follow-up|1|||
170637595|NCT02541604|616684610|FG003|Overall Study|Lost to Follow-up|0|||
170637596|NCT02541604|616684611|FG004|Overall Study|Lost to Follow-up|0|||
170637597|NCT02541604|616684612|FG005|Overall Study|Lost to Follow-up|1|||
170637598|NCT02541604|616684613|FG006|Overall Study|Lost to Follow-up|1|||
170637599|NCT02541604|616684614|FG007|Overall Study|Lost to Follow-up|0|||
170637600|NCT02541604|616684615|FG008|Overall Study|Lost to Follow-up|0|||
170637601|NCT02541604|616684616|FG009|Overall Study|Lost to Follow-up|0|||
170637602|NCT02541604|616684617|FG010|Overall Study|Lost to Follow-up|0|||
170637603|NCT02541604|616684618|FG011|Overall Study|Lost to Follow-up|0|||
170637604|NCT02541604|616684607|FG000|Overall Study|Withdrawal by Subject|2|||
170637605|NCT02541604|616684608|FG001|Overall Study|Withdrawal by Subject|0|||
170637606|NCT02541604|616684609|FG002|Overall Study|Withdrawal by Subject|1|||
170637607|NCT02541604|616684610|FG003|Overall Study|Withdrawal by Subject|0|||
170637608|NCT02541604|616684611|FG004|Overall Study|Withdrawal by Subject|1|||
170637609|NCT02541604|616684612|FG005|Overall Study|Withdrawal by Subject|1|||
170637610|NCT02541604|616684613|FG006|Overall Study|Withdrawal by Subject|0|||
170637611|NCT02541604|616684614|FG007|Overall Study|Withdrawal by Subject|0|||
170470021|NCT00863772|616058859|FG002|Overall Study|Lost to Follow-up|1|||
170470022|NCT00863772|616058857|FG000|Overall Study|Protocol Violation|2|||
170470023|NCT00863772|616058858|FG001|Overall Study|Protocol Violation|0|||
170470024|NCT00863772|616058859|FG002|Overall Study|Protocol Violation|2|||
170470025|NCT00863772|616058857|FG000|Overall Study|Withdrawal by Subject|4|||
170470026|NCT00863772|616058858|FG001|Overall Study|Withdrawal by Subject|7|||
170470027|NCT00863772|616058859|FG002|Overall Study|Withdrawal by Subject|5|||
170470028|NCT00863772|616058857|FG000|Overall Study|Study terminated by sponsor|44|||
170470029|NCT00863772|616058858|FG001|Overall Study|Study terminated by sponsor|45|||
170470030|NCT00863772|616058859|FG002|Overall Study|Study terminated by sponsor|36|||
170470031|NCT00863772|616058857|FG000|Overall Study|Entered extension study|6|||
170470032|NCT00863772|616058858|FG001|Overall Study|Entered extension study|4|||
170470033|NCT00863772|616058859|FG002|Overall Study|Entered extension study|9|||
170470034|NCT00863772|616058857|FG000|Overall Study|Other|1|||
170470035|NCT00863772|616058858|FG001|Overall Study|Other|2|||
170470036|NCT00863772|616058859|FG002|Overall Study|Other|4|||
170470037|NCT00863772|616058857|FG000|Overall Study|Randomized but not Treated|1|||
170470038|NCT00863772|616058858|FG001|Overall Study|Randomized but not Treated|0|||
170470039|NCT00863772|616058859|FG002|Overall Study|Randomized but not Treated|0|||
170470040|NCT00908310|616058860|FG000|Overall Study|Death|37|||
170470041|NCT00908310|616058860|FG000|Overall Study|Withdrawal by Subject|7|||
170470042|NCT00908310|616058860|FG000|Overall Study|Lost to Follow-up|7|||
170470043|NCT00908310|616058860|FG000|Overall Study|Screening failure|5|||
170470044|NCT00908310|616058860|FG000|Overall Study|Other reasons|4|||
170470045|NCT00246324|616058861|FG000|Overall Study|Withdrawal by Subject|1|||
170470046|NCT03456453|616058862|FG000|Overall Study|Withdrawal by Subject|2|||
170470047|NCT03456453|616058863|FG001|Overall Study|Withdrawal by Subject|0|||
170470048|NCT03456453|616058862|FG000|Overall Study|Not released to community|1|||
170470049|NCT03456453|616058863|FG001|Overall Study|Not released to community|5|||
170470050|NCT03456453|616058862|FG000|Overall Study|Lost to Follow-up|0|||
170470051|NCT03456453|616058863|FG001|Overall Study|Lost to Follow-up|2|||
170470052|NCT01004003|616058864|FG000|Overall Study|Progressive disease|2|||
170470053|NCT01004003|616058865|FG001|Overall Study|Progressive disease|1|||
170470054|NCT01004003|616058866|FG002|Overall Study|Progressive disease|1|||
170470055|NCT01004003|616058867|FG003|Overall Study|Progressive disease|0|||
170470056|NCT01004003|616058868|FG004|Overall Study|Progressive disease|2|||
170470057|NCT01004003|616058869|FG005|Overall Study|Progressive disease|1|||
170470058|NCT01004003|616058870|FG006|Overall Study|Progressive disease|1|||
170470059|NCT01004003|616058871|FG007|Overall Study|Progressive disease|39|||
170470060|NCT01004003|616058872|FG008|Overall Study|Progressive disease|22|||
170470061|NCT01004003|616058864|FG000|Overall Study|Adverse Event|4|||
170470062|NCT01004003|616058865|FG001|Overall Study|Adverse Event|2|||
170470063|NCT01004003|616058866|FG002|Overall Study|Adverse Event|3|||
170470064|NCT01004003|616058867|FG003|Overall Study|Adverse Event|3|||
170470065|NCT01004003|616058868|FG004|Overall Study|Adverse Event|2|||
170470066|NCT01004003|616058869|FG005|Overall Study|Adverse Event|2|||
170470067|NCT01004003|616058870|FG006|Overall Study|Adverse Event|7|||
170470068|NCT01004003|616058871|FG007|Overall Study|Adverse Event|21|||
170470069|NCT01004003|616058872|FG008|Overall Study|Adverse Event|6|||
170470070|NCT01004003|616058864|FG000|Overall Study|Refused to continue taking trial med.|0|||
170470071|NCT01004003|616058865|FG001|Overall Study|Refused to continue taking trial med.|0|||
170470072|NCT01004003|616058866|FG002|Overall Study|Refused to continue taking trial med.|0|||
170470073|NCT01004003|616058867|FG003|Overall Study|Refused to continue taking trial med.|0|||
170791398|NCT04585815|617245913|FG003|Sub-study B- Follow-up Phase|Death|3|||
170791399|NCT04585815|617245914|FG004|Sub-study B- Follow-up Phase|Death|1|||
170791400|NCT04585815|617245915|FG005|Sub-study B- Follow-up Phase|Death|0|||
170791401|NCT04585815|617245916|FG006|Sub-study B- Follow-up Phase|Death|3|||
170791402|NCT04585815|617245910|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
170791403|NCT04585815|617245911|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
170791404|NCT04585815|617245912|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
170791405|NCT04585815|617245913|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
170791406|NCT04585815|617245914|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
170791407|NCT04585815|617245915|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
170791408|NCT04585815|617245916|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
170791409|NCT04304820|617247876|FG000|Overall Study|Death|1|||
170791410|NCT04304820|617247876|FG000|Overall Study|Lost to Follow-up|1|||
170470074|NCT01004003|616058868|FG004|Overall Study|Refused to continue taking trial med.|0|||
170470075|NCT01004003|616058869|FG005|Overall Study|Refused to continue taking trial med.|0|||
170470076|NCT01004003|616058870|FG006|Overall Study|Refused to continue taking trial med.|0|||
170470077|NCT01004003|616058871|FG007|Overall Study|Refused to continue taking trial med.|0|||
170470078|NCT01004003|616058872|FG008|Overall Study|Refused to continue taking trial med.|2|||
170470079|NCT01004003|616058864|FG000|Overall Study|Other|0|||
170470080|NCT01004003|616058865|FG001|Overall Study|Other|0|||
170470081|NCT01004003|616058866|FG002|Overall Study|Other|0|||
170470082|NCT01004003|616058867|FG003|Overall Study|Other|0|||
170470083|NCT01004003|616058868|FG004|Overall Study|Other|0|||
170470084|NCT01004003|616058869|FG005|Overall Study|Other|1|||
170470085|NCT01004003|616058870|FG006|Overall Study|Other|0|||
170470086|NCT01004003|616058871|FG007|Overall Study|Other|0|||
170470087|NCT01004003|616058872|FG008|Overall Study|Other|0|||
170470088|NCT01589497|616058873|FG000|Overall Study|Withdrawal by Subject|0|||
170470089|NCT01589497|616058874|FG001|Overall Study|Withdrawal by Subject|1|||
170470090|NCT01589497|616058875|FG002|Overall Study|Withdrawal by Subject|0|||
170470091|NCT01589497|616058876|FG003|Overall Study|Withdrawal by Subject|1|||
170470092|NCT01589497|616058873|FG000|Overall Study|Death|1|||
170470093|NCT01589497|616058874|FG001|Overall Study|Death|0|||
170470094|NCT01589497|616058875|FG002|Overall Study|Death|0|||
170470095|NCT01589497|616058876|FG003|Overall Study|Death|0|||
170470096|NCT01589497|616058873|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
170470097|NCT01589497|616058874|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
170470098|NCT01589497|616058875|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
170470099|NCT01589497|616058876|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
170470100|NCT01885195|616058877|FG000|Overall Study|Adverse Event|29|||
170470101|NCT01885195|616058877|FG000|Overall Study|Death|1|||
170470102|NCT01885195|616058877|FG000|Overall Study|Disease Progression|67|||
170470103|NCT01885195|616058877|FG000|Overall Study|Protocol Deviation|2|||
170470104|NCT01885195|616058877|FG000|Overall Study|Physician Decision|3|||
170470105|NCT01885195|616058877|FG000|Overall Study|Patient/guardian decision|8|||
170470106|NCT03390426|616058880|FG000|Overall Study|Protocol Violation|0|||
170470107|NCT03390426|616058881|FG001|Overall Study|Protocol Violation|1|||
170470108|NCT00259272|616058888|FG000|Overall Study|Adverse Event|2|||
170470109|NCT00259272|616058889|FG001|Overall Study|Adverse Event|1|||
170470110|NCT00259272|616058890|FG002|Overall Study|Adverse Event|0|||
170470111|NCT00259272|616058891|FG003|Overall Study|Adverse Event|3|||
170470112|NCT00259272|616058888|FG000|Overall Study|Lack of Efficacy|5|||
170470113|NCT00259272|616058889|FG001|Overall Study|Lack of Efficacy|1|||
170470114|NCT00259272|616058890|FG002|Overall Study|Lack of Efficacy|2|||
170470115|NCT00259272|616058891|FG003|Overall Study|Lack of Efficacy|6|||
170470116|NCT00259272|616058888|FG000|Overall Study|Physician Decision|1|||
170470117|NCT00259272|616058889|FG001|Overall Study|Physician Decision|2|||
170470118|NCT00259272|616058890|FG002|Overall Study|Physician Decision|1|||
170470119|NCT00259272|616058891|FG003|Overall Study|Physician Decision|3|||
170470120|NCT00259272|616058888|FG000|Overall Study|Protocol Violation|2|||
170470121|NCT00259272|616058889|FG001|Overall Study|Protocol Violation|0|||
170470122|NCT00259272|616058890|FG002|Overall Study|Protocol Violation|0|||
170470123|NCT00259272|616058891|FG003|Overall Study|Protocol Violation|1|||
170470124|NCT00259272|616058888|FG000|Overall Study|Sponsor Decision|0|||
170470125|NCT00259272|616058889|FG001|Overall Study|Sponsor Decision|1|||
170470126|NCT00259272|616058890|FG002|Overall Study|Sponsor Decision|0|||
170470127|NCT00259272|616058891|FG003|Overall Study|Sponsor Decision|0|||
170470128|NCT00259272|616058888|FG000|Overall Study|Withdrawal by Subject|4|||
170470129|NCT00259272|616058889|FG001|Overall Study|Withdrawal by Subject|2|||
170470130|NCT00259272|616058890|FG002|Overall Study|Withdrawal by Subject|2|||
170470131|NCT00259272|616058891|FG003|Overall Study|Withdrawal by Subject|7|||
170470132|NCT00259272|616058888|FG000|Overall Study|Lost to Follow-up|1|||
170470133|NCT00259272|616058889|FG001|Overall Study|Lost to Follow-up|0|||
170470134|NCT00259272|616058890|FG002|Overall Study|Lost to Follow-up|0|||
170470135|NCT00259272|616058891|FG003|Overall Study|Lost to Follow-up|1|||
170470136|NCT03301623|616058894|FG000|Overall Study|Death|3|||
170470137|NCT03301623|616058895|FG001|Overall Study|Death|1|||
170470138|NCT03301623|616058894|FG000|Overall Study|Withdrawal by Subject|11|||
170470139|NCT03301623|616058895|FG001|Overall Study|Withdrawal by Subject|13|||
170470140|NCT03301623|616058894|FG000|Overall Study|Lost to Follow-up|3|||
170470141|NCT03301623|616058895|FG001|Overall Study|Lost to Follow-up|1|||
170470142|NCT02516553|616058896|FG000|Overall Study|Progressive disease|2|||
170791411|NCT04304820|617247876|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
170791412|NCT04304820|617247876|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
170470143|NCT02516553|616058897|FG001|Overall Study|Progressive disease|2|||
170470144|NCT02516553|616058898|FG002|Overall Study|Progressive disease|3|||
170470145|NCT02516553|616058899|FG003|Overall Study|Progressive disease|5|||
170470146|NCT02516553|616058900|FG004|Overall Study|Progressive disease|3|||
170470147|NCT02516553|616058901|FG005|Overall Study|Progressive disease|0|||
170470148|NCT02516553|616058902|FG006|Overall Study|Progressive disease|5|||
170470149|NCT02516553|616058903|FG007|Overall Study|Progressive disease|5|||
170470150|NCT02516553|616058904|FG008|Overall Study|Progressive disease|11|||
170791413|NCT04304820|617247876|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
170470151|NCT02516553|616058905|FG009|Overall Study|Progressive disease|3|||
170470152|NCT02516553|616058906|FG010|Overall Study|Progressive disease|10|||
170470153|NCT02516553|616058907|FG011|Overall Study|Progressive disease|8|||
170470154|NCT02516553|616058908|FG012|Overall Study|Progressive disease|8|||
170470155|NCT02516553|616058909|FG013|Overall Study|Progressive disease|2|||
170470156|NCT02516553|616058910|FG014|Overall Study|Progressive disease|2|||
170470157|NCT02516553|616058911|FG015|Overall Study|Progressive disease|2|||
170470158|NCT02516553|616058912|FG016|Overall Study|Progressive disease|1|||
170470159|NCT02516553|616058913|FG017|Overall Study|Progressive disease|9|||
170470160|NCT02516553|616058914|FG018|Overall Study|Progressive disease|12|||
170470161|NCT02516553|616058915|FG019|Overall Study|Progressive disease|7|||
170470162|NCT02516553|616058916|FG020|Overall Study|Progressive disease|16|||
170470163|NCT02516553|616058917|FG021|Overall Study|Progressive disease|18|||
170470164|NCT02516553|616058896|FG000|Overall Study|Dose limiting toxicity|0|||
170470165|NCT02516553|616058897|FG001|Overall Study|Dose limiting toxicity|0|||
170470166|NCT02516553|616058898|FG002|Overall Study|Dose limiting toxicity|0|||
170470167|NCT02516553|616058899|FG003|Overall Study|Dose limiting toxicity|0|||
170470168|NCT02516553|616058900|FG004|Overall Study|Dose limiting toxicity|3|||
170470169|NCT02516553|616058901|FG005|Overall Study|Dose limiting toxicity|1|||
170470170|NCT02516553|616058902|FG006|Overall Study|Dose limiting toxicity|1|||
170470171|NCT02516553|616058903|FG007|Overall Study|Dose limiting toxicity|0|||
170470172|NCT02516553|616058904|FG008|Overall Study|Dose limiting toxicity|1|||
170470173|NCT02516553|616058905|FG009|Overall Study|Dose limiting toxicity|0|||
170470174|NCT02516553|616058906|FG010|Overall Study|Dose limiting toxicity|0|||
170470175|NCT02516553|616058907|FG011|Overall Study|Dose limiting toxicity|1|||
170470176|NCT02516553|616058908|FG012|Overall Study|Dose limiting toxicity|0|||
170470177|NCT02516553|616058909|FG013|Overall Study|Dose limiting toxicity|1|||
170470178|NCT02516553|616058910|FG014|Overall Study|Dose limiting toxicity|0|||
170470179|NCT02516553|616058911|FG015|Overall Study|Dose limiting toxicity|0|||
170470180|NCT02516553|616058912|FG016|Overall Study|Dose limiting toxicity|1|||
170470181|NCT02516553|616058913|FG017|Overall Study|Dose limiting toxicity|1|||
170470182|NCT02516553|616058914|FG018|Overall Study|Dose limiting toxicity|0|||
170470183|NCT02516553|616058915|FG019|Overall Study|Dose limiting toxicity|2|||
170470184|NCT02516553|616058916|FG020|Overall Study|Dose limiting toxicity|0|||
170470185|NCT02516553|616058917|FG021|Overall Study|Dose limiting toxicity|0|||
170470186|NCT02516553|616058896|FG000|Overall Study|Other Adverse Events|0|||
170470187|NCT02516553|616058897|FG001|Overall Study|Other Adverse Events|0|||
170470188|NCT02516553|616058898|FG002|Overall Study|Other Adverse Events|0|||
170470189|NCT02516553|616058899|FG003|Overall Study|Other Adverse Events|1|||
170470190|NCT02516553|616058900|FG004|Overall Study|Other Adverse Events|0|||
170470191|NCT02516553|616058901|FG005|Overall Study|Other Adverse Events|1|||
170470192|NCT02516553|616058902|FG006|Overall Study|Other Adverse Events|0|||
170470193|NCT02516553|616058903|FG007|Overall Study|Other Adverse Events|0|||
170470194|NCT02516553|616058904|FG008|Overall Study|Other Adverse Events|0|||
170470195|NCT02516553|616058905|FG009|Overall Study|Other Adverse Events|1|||
170470196|NCT02516553|616058906|FG010|Overall Study|Other Adverse Events|3|||
170470197|NCT02516553|616058907|FG011|Overall Study|Other Adverse Events|2|||
170470198|NCT02516553|616058908|FG012|Overall Study|Other Adverse Events|0|||
170470199|NCT02516553|616058909|FG013|Overall Study|Other Adverse Events|1|||
170470200|NCT02516553|616058910|FG014|Overall Study|Other Adverse Events|0|||
170470201|NCT02516553|616058911|FG015|Overall Study|Other Adverse Events|0|||
170470202|NCT02516553|616058912|FG016|Overall Study|Other Adverse Events|0|||
170470203|NCT02516553|616058913|FG017|Overall Study|Other Adverse Events|2|||
170470204|NCT02516553|616058914|FG018|Overall Study|Other Adverse Events|1|||
170470205|NCT02516553|616058915|FG019|Overall Study|Other Adverse Events|2|||
170470206|NCT02516553|616058916|FG020|Overall Study|Other Adverse Events|2|||
170470207|NCT02516553|616058917|FG021|Overall Study|Other Adverse Events|1|||
170470208|NCT02516553|616058896|FG000|Overall Study|Refused to continue trial medication|0|||
170470209|NCT02516553|616058897|FG001|Overall Study|Refused to continue trial medication|0|||
170470210|NCT02516553|616058898|FG002|Overall Study|Refused to continue trial medication|0|||
170470211|NCT02516553|616058899|FG003|Overall Study|Refused to continue trial medication|0|||
170470212|NCT02516553|616058900|FG004|Overall Study|Refused to continue trial medication|0|||
170470213|NCT02516553|616058901|FG005|Overall Study|Refused to continue trial medication|0|||
170470214|NCT02516553|616058902|FG006|Overall Study|Refused to continue trial medication|0|||
170470215|NCT02516553|616058903|FG007|Overall Study|Refused to continue trial medication|0|||
170470216|NCT02516553|616058904|FG008|Overall Study|Refused to continue trial medication|0|||
170470217|NCT02516553|616058905|FG009|Overall Study|Refused to continue trial medication|0|||
170470218|NCT02516553|616058906|FG010|Overall Study|Refused to continue trial medication|1|||
170470219|NCT02516553|616058907|FG011|Overall Study|Refused to continue trial medication|0|||
170470220|NCT02516553|616058908|FG012|Overall Study|Refused to continue trial medication|0|||
170791414|NCT05782816|617247877|FG000|Overall Study|Withdrawal by Subject|1|||
170470221|NCT02516553|616058909|FG013|Overall Study|Refused to continue trial medication|0|||
170470222|NCT02516553|616058910|FG014|Overall Study|Refused to continue trial medication|0|||
170470223|NCT02516553|616058911|FG015|Overall Study|Refused to continue trial medication|0|||
170470224|NCT02516553|616058912|FG016|Overall Study|Refused to continue trial medication|0|||
170470225|NCT02516553|616058913|FG017|Overall Study|Refused to continue trial medication|0|||
170470226|NCT02516553|616058914|FG018|Overall Study|Refused to continue trial medication|1|||
170470227|NCT02516553|616058915|FG019|Overall Study|Refused to continue trial medication|0|||
170470228|NCT02516553|616058916|FG020|Overall Study|Refused to continue trial medication|0|||
170470229|NCT02516553|616058917|FG021|Overall Study|Refused to continue trial medication|1|||
170470230|NCT02516553|616058896|FG000|Overall Study|other reasons than listed|0|||
170470231|NCT02516553|616058897|FG001|Overall Study|other reasons than listed|0|||
170470232|NCT02516553|616058898|FG002|Overall Study|other reasons than listed|0|||
170470233|NCT02516553|616058899|FG003|Overall Study|other reasons than listed|0|||
170470234|NCT02516553|616058900|FG004|Overall Study|other reasons than listed|0|||
170470235|NCT02516553|616058901|FG005|Overall Study|other reasons than listed|0|||
170470236|NCT02516553|616058902|FG006|Overall Study|other reasons than listed|0|||
170470237|NCT02516553|616058903|FG007|Overall Study|other reasons than listed|1|||
170470238|NCT02516553|616058904|FG008|Overall Study|other reasons than listed|1|||
170470239|NCT02516553|616058905|FG009|Overall Study|other reasons than listed|0|||
170470240|NCT02516553|616058906|FG010|Overall Study|other reasons than listed|1|||
170470241|NCT02516553|616058907|FG011|Overall Study|other reasons than listed|1|||
170470242|NCT02516553|616058908|FG012|Overall Study|other reasons than listed|0|||
170791415|NCT05782816|617247878|FG001|Overall Study|Withdrawal by Subject|0|||
170791416|NCT04221490|617247879|FG000|At 30 Days Follow-up|Death|7|||
170791417|NCT04221490|617247879|FG000|At 30 Days Follow-up|Physician Decision|1|||
170791418|NCT04221490|617247879|FG000|At 30 Days Follow-up|Missed Visit|4|||
170791419|NCT04221490|617247879|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
170791420|NCT04221490|617247879|FG000|At 6 Months Follow-up|Death|9|||
170791421|NCT04221490|617247879|FG000|At 6 Months Follow-up|Missed Visit|8|||
170791422|NCT04221490|617247879|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
170791423|NCT04221490|617247879|FG000|At 1 Year Follow-up|Death|7|||
170791424|NCT04221490|617247879|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
170791425|NCT04221490|617247879|FG000|At 1 Year Follow-up|Missed Visit|9|||
170791426|NCT04221490|617247879|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
170791427|NCT01824875|617247884|FG000|Overall Study|Disease progression|22|||
170791428|NCT01824875|617247885|FG001|Overall Study|Disease progression|15|||
170791429|NCT01824875|617247884|FG000|Overall Study|Withdrawal by Subject|5|||
170791430|NCT01824875|617247885|FG001|Overall Study|Withdrawal by Subject|4|||
170791431|NCT01824875|617247884|FG000|Overall Study|Adverse Event|4|||
170791432|NCT01824875|617247885|FG001|Overall Study|Adverse Event|10|||
170470243|NCT02516553|616058909|FG013|Overall Study|other reasons than listed|0|||
170470244|NCT02516553|616058910|FG014|Overall Study|other reasons than listed|0|||
170470245|NCT02516553|616058911|FG015|Overall Study|other reasons than listed|0|||
170470246|NCT02516553|616058912|FG016|Overall Study|other reasons than listed|0|||
170470247|NCT02516553|616058913|FG017|Overall Study|other reasons than listed|0|||
170470248|NCT02516553|616058914|FG018|Overall Study|other reasons than listed|0|||
170470249|NCT02516553|616058915|FG019|Overall Study|other reasons than listed|0|||
170470250|NCT02516553|616058916|FG020|Overall Study|other reasons than listed|2|||
170470251|NCT02516553|616058917|FG021|Overall Study|other reasons than listed|2|||
170470252|NCT00315731|616058919|FG000|Overall Study|Lost to Follow-up|1|||
170470253|NCT00315731|616058919|FG000|Overall Study|Death|5|||
170470254|NCT01680497|616058921|FG000|Overall Study|Lost to Follow-up|2|||
170470255|NCT00725205|616058922|FG000|Overall Study|Adverse Event|22|||
170470256|NCT00725205|616058922|FG000|Overall Study|Investigator Discontinued|1|||
170545602|NCT02384460|616342690|FG001|Overall Study|Adverse Event|2|||
170470257|NCT00725205|616058922|FG000|Overall Study|Non-compliance With Protocol|14|||
170470258|NCT00725205|616058922|FG000|Overall Study|Other|8|||
170470259|NCT00725205|616058922|FG000|Overall Study|Protocol Defined Clinical Event|1|||
170470260|NCT00725205|616058922|FG000|Overall Study|Treatment Failure|41|||
170470261|NCT02212379|616058926|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
170470262|NCT02212379|616058926|FG000|From Baseline to Week 48|Adverse Event|7|||
170470263|NCT02212379|616058926|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
170791433|NCT01824875|617247884|FG000|Overall Study|Alternative therapy|3|||
170470264|NCT02212379|616058926|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
170470265|NCT02212379|616058926|FG000|From Week 48 to Week 96|Adverse Event|1|||
170470266|NCT02212379|616058926|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
170470267|NCT01383707|616060937|FG000|Overall Study|Consent withdrawal|6|||
170470268|NCT01383707|616060937|FG000|Overall Study|Death|19|||
170470269|NCT01383707|616060937|FG000|Overall Study|Other|8|||
170470270|NCT01383707|616060937|FG000|Overall Study|Sponsor's decision|2|||
170470271|NCT01383707|616060937|FG000|Overall Study|Adverse Event|14|||
170470272|NCT01383707|616060937|FG000|Overall Study|Progressive disease|23|||
170470273|NCT04414618|616060950|FG000|Overall Study|Death|3|||
170470274|NCT04414618|616060951|FG001|Overall Study|Death|3|||
170470275|NCT04414618|616060950|FG000|Overall Study|Withdrawal by Subject|2|||
170470276|NCT04414618|616060951|FG001|Overall Study|Withdrawal by Subject|1|||
170470277|NCT04414618|616060950|FG000|Overall Study|Lost to Follow-up|2|||
170470278|NCT04414618|616060951|FG001|Overall Study|Lost to Follow-up|3|||
170470279|NCT04414618|616060950|FG000|Overall Study|Physician Decision|1|||
170470280|NCT04414618|616060951|FG001|Overall Study|Physician Decision|0|||
170470281|NCT00362336|616060952|FG000|Overall Study|Serious Adverse Event|1|||
170470282|NCT00362336|616060953|FG001|Overall Study|Serious Adverse Event|0|||
170470283|NCT00362336|616060954|FG002|Overall Study|Serious Adverse Event|1|||
170470284|NCT00362336|616060952|FG000|Overall Study|Protocol Violation|0|||
170470285|NCT00362336|616060953|FG001|Overall Study|Protocol Violation|0|||
170470286|NCT00362336|616060954|FG002|Overall Study|Protocol Violation|1|||
170470287|NCT00362336|616060952|FG000|Overall Study|Lost to Follow-up|6|||
170470288|NCT00362336|616060953|FG001|Overall Study|Lost to Follow-up|4|||
170470289|NCT00362336|616060954|FG002|Overall Study|Lost to Follow-up|0|||
170470290|NCT00362336|616060952|FG000|Overall Study|Withdrawal by Subject|3|||
170470291|NCT00362336|616060953|FG001|Overall Study|Withdrawal by Subject|3|||
170470292|NCT00362336|616060954|FG002|Overall Study|Withdrawal by Subject|1|||
170470293|NCT01520870|616060955|FG000|Overall Study|Withdrawal by Subject|2|||
170470294|NCT02289456|616060956|FG000|Induction Period|Death|2|||
170470295|NCT02289456|616060956|FG000|Induction Period|Adverse Event|11|||
170470296|NCT02289456|616060956|FG000|Induction Period|Progressive Disease (PD)|4|||
170470297|NCT02289456|616060956|FG000|Induction Period|Symptomatic Deterioration|4|||
170470298|NCT02289456|616060956|FG000|Induction Period|Withdrawal by Subject|2|||
170470299|NCT02289456|616060956|FG000|Induction Period|Miscellaneous|1|||
170470300|NCT02289456|616060956|FG000|Monotherapy Period|Death|1|||
170470301|NCT02289456|616060956|FG000|Monotherapy Period|Adverse Event|1|||
170470302|NCT02289456|616060956|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
170470303|NCT02289456|616060956|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
170470304|NCT02289456|616060956|FG000|Monotherapy Period|Withdrawal by Subject|2|||
170470305|NCT02289456|616060956|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
170470306|NCT02289456|616060956|FG000|Monotherapy Period|Miscellaneous|1|||
170470307|NCT02075515|616060960|FG000|Overall Study|Serious Adverse Event|1|||
170470308|NCT02075515|616060961|FG001|Overall Study|Serious Adverse Event|1|||
170470309|NCT02075515|616060962|FG002|Overall Study|Serious Adverse Event|1|||
170470310|NCT02075515|616060960|FG000|Overall Study|Non-Serious Adverse Event|0|||
170470311|NCT02075515|616060961|FG001|Overall Study|Non-Serious Adverse Event|1|||
170470312|NCT02075515|616060962|FG002|Overall Study|Non-Serious Adverse Event|0|||
170470313|NCT02075515|616060960|FG000|Overall Study|Withdrawal by Subject|2|||
170470314|NCT02075515|616060961|FG001|Overall Study|Withdrawal by Subject|0|||
170470315|NCT02075515|616060962|FG002|Overall Study|Withdrawal by Subject|1|||
170470316|NCT02075515|616060960|FG000|Overall Study|Lost to Follow-up|1|||
170470317|NCT02075515|616060961|FG001|Overall Study|Lost to Follow-up|3|||
170470318|NCT02075515|616060962|FG002|Overall Study|Lost to Follow-up|6|||
170545603|NCT02384460|616342689|FG000|Overall Study|Withdrawal by Subject|0|||
170545604|NCT02384460|616342690|FG001|Overall Study|Withdrawal by Subject|3|||
170545605|NCT02384460|616342689|FG000|Overall Study|Elective medical treatment|1|||
170545606|NCT02384460|616342690|FG001|Overall Study|Elective medical treatment|0|||
170545607|NCT02384460|616342689|FG000|Overall Study|Non-compliance|1|||
170545608|NCT02384460|616342690|FG001|Overall Study|Non-compliance|0|||
170545609|NCT01441414|616342695|FG000|Overall Study|Participant died|9|||
170545610|NCT01441414|616342695|FG000|Overall Study|Other reasons|3|||
170545611|NCT01441414|616342695|FG000|Overall Study|Study terminated by sponsor|2|||
170545612|NCT01441414|616342695|FG000|Overall Study|Subject refused further follow-up|1|||
170545613|NCT02365064|616342696|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
170545614|NCT02365064|616342697|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
170545615|NCT02365064|616342696|FG000|Overall Study|Withdrawal by Subject|6|||
170545616|NCT02365064|616342697|FG001|Overall Study|Withdrawal by Subject|9|||
170470319|NCT00606632|616060965|FG000|Overall Study|Withdrawal by Subject|13|||
170470320|NCT00606632|616060965|FG000|Overall Study|Miscellaneous reasons|9|||
170545617|NCT02365064|616342696|FG000|Overall Study|Treatment intolerance|2|||
170545618|NCT02365064|616342697|FG001|Overall Study|Treatment intolerance|4|||
170545619|NCT03954938|616342707|FG000|Overall Study|Withdrawal by Subject|2|||
170470321|NCT00704132|616060966|FG000|Overall Study|Clinical Adverse Experience|1|||
170470322|NCT00704132|616060967|FG001|Overall Study|Clinical Adverse Experience|0|||
170470323|NCT00704132|616060966|FG000|Overall Study|Lack of Efficacy|0|||
170470324|NCT00704132|616060967|FG001|Overall Study|Lack of Efficacy|1|||
170470325|NCT00704132|616060966|FG000|Overall Study|Withdrawal by Subject|0|||
170470326|NCT00704132|616060967|FG001|Overall Study|Withdrawal by Subject|1|||
170470327|NCT00442962|616060968|FG000|Overall Study|Pregnancy|1|||
170470328|NCT00442962|616060968|FG000|Overall Study|Lost to Follow-up|7|||
170470329|NCT05445492|616060969|FG000|Overall Study|Physician Decision|1|||
170470330|NCT04289363|616060971|FG000|Overall Study|Lost to Follow-up|14|||
170470331|NCT04289363|616060972|FG001|Overall Study|Lost to Follow-up|0|||
170470332|NCT03348163|616060973|FG000|Overall Study|Withdrawal by Subject|2|||
170470333|NCT03348163|616060974|FG001|Overall Study|Withdrawal by Subject|0|||
170470334|NCT02125877|616060979|FG000|Overall Study|Physician Decision|1|||
170470335|NCT02125877|616060980|FG001|Overall Study|Physician Decision|0|||
170470336|NCT02125877|616060979|FG000|Overall Study|Death|0|||
170470337|NCT02125877|616060980|FG001|Overall Study|Death|1|||
170470338|NCT02125877|616060979|FG000|Overall Study|Administrative problems|0|||
170470339|NCT02125877|616060980|FG001|Overall Study|Administrative problems|1|||
170470340|NCT02125877|616060979|FG000|Overall Study|Participant/guardian decision|0|||
170470341|NCT02125877|616060980|FG001|Overall Study|Participant/guardian decision|2|||
170470342|NCT02125877|616060979|FG000|Overall Study|Withdrawal by Subject|2|||
170470343|NCT02125877|616060980|FG001|Overall Study|Withdrawal by Subject|1|||
170470344|NCT02125877|616060979|FG000|Overall Study|Protocol deviation|4|||
170470345|NCT02125877|616060980|FG001|Overall Study|Protocol deviation|1|||
170470346|NCT02125877|616060979|FG000|Overall Study|Adverse Event|6|||
170470347|NCT02125877|616060980|FG001|Overall Study|Adverse Event|4|||
170470348|NCT01141205|616060981|FG000|Overall Study|Physician Decision|1|||
170470349|NCT01141205|616060982|FG001|Overall Study|Physician Decision|1|||
170470350|NCT01141205|616060981|FG000|Overall Study|Lost to Follow-up|1|||
170470351|NCT01141205|616060982|FG001|Overall Study|Lost to Follow-up|0|||
170470352|NCT01141205|616060981|FG000|Overall Study|Withdrawal by Subject|1|||
170470353|NCT01141205|616060982|FG001|Overall Study|Withdrawal by Subject|1|||
170470354|NCT04223752|616060986|FG000|Overall Study|Participant enrolled in error|0|||
170470355|NCT04223752|616060987|FG001|Overall Study|Participant enrolled in error|0|||
170470356|NCT04223752|616060988|FG002|Overall Study|Participant enrolled in error|0|||
170470357|NCT04223752|616060989|FG003|Overall Study|Participant enrolled in error|0|||
170470358|NCT04223752|616060990|FG004|Overall Study|Participant enrolled in error|1|||
170470359|NCT04223752|616060986|FG000|Overall Study|Death|0|||
170470360|NCT04223752|616060987|FG001|Overall Study|Death|0|||
170470361|NCT04223752|616060988|FG002|Overall Study|Death|0|||
170470362|NCT04223752|616060989|FG003|Overall Study|Death|2|||
170470363|NCT04223752|616060990|FG004|Overall Study|Death|1|||
170470364|NCT03837743|616060993|FG000|Overall Study|Adverse Event|1|||
170470365|NCT03837743|616060993|FG000|Overall Study|Withdrawal by Subject|2|||
170470366|NCT02257385|616060995|FG000|Overall Study|Adverse Event|12|||
170470367|NCT02257385|616060996|FG001|Overall Study|Adverse Event|8|||
170470368|NCT02257385|616060995|FG000|Overall Study|Lack of Efficacy|1|||
170470369|NCT02257385|616060996|FG001|Overall Study|Lack of Efficacy|2|||
170470370|NCT02257385|616060995|FG000|Overall Study|Protocol Violation|5|||
170470371|NCT02257385|616060996|FG001|Overall Study|Protocol Violation|7|||
170470372|NCT02257385|616060995|FG000|Overall Study|Lost to Follow-up|0|||
170470373|NCT02257385|616060996|FG001|Overall Study|Lost to Follow-up|1|||
170470374|NCT02257385|616060995|FG000|Overall Study|Withdrawal by Subject|4|||
170791434|NCT01824875|617247885|FG001|Overall Study|Alternative therapy|0|||
170791435|NCT01824875|617247884|FG000|Overall Study|Complicating disease|1|||
170791436|NCT01824875|617247885|FG001|Overall Study|Complicating disease|0|||
170791437|NCT01824875|617247884|FG000|Overall Study|Physician Decision|0|||
170791438|NCT01824875|617247885|FG001|Overall Study|Physician Decision|1|||
170470375|NCT02257385|616060996|FG001|Overall Study|Withdrawal by Subject|4|||
170470376|NCT01822366|616061001|FG000|Overall Study|Lost to Follow-up|5|||
170470377|NCT01822366|616061002|FG001|Overall Study|Lost to Follow-up|1|||
170470378|NCT01822366|616061003|FG002|Overall Study|Lost to Follow-up|5|||
170470379|NCT01822366|616061004|FG003|Overall Study|Lost to Follow-up|1|||
170470380|NCT01822366|616061001|FG000|Overall Study|Withdrawal by Subject|0|||
170470381|NCT01822366|616061002|FG001|Overall Study|Withdrawal by Subject|6|||
170470382|NCT01822366|616061003|FG002|Overall Study|Withdrawal by Subject|0|||
170545620|NCT03954938|616342707|FG000|Overall Study|Adverse Event|1|||
170545621|NCT00976391|616342710|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
170545622|NCT00976391|616342711|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
170470383|NCT01822366|616061004|FG003|Overall Study|Withdrawal by Subject|6|||
170470384|NCT01822366|616061001|FG000|Overall Study|Partial Intervention Completion|0|||
170470385|NCT01822366|616061002|FG001|Overall Study|Partial Intervention Completion|15|||
170470386|NCT01822366|616061003|FG002|Overall Study|Partial Intervention Completion|0|||
170470387|NCT01822366|616061004|FG003|Overall Study|Partial Intervention Completion|15|||
170470388|NCT05199090|616061005|FG000|Overall Study|Adverse Event|1|||
170470389|NCT05199090|616061006|FG001|Overall Study|Adverse Event|4|||
170470390|NCT05199090|616061007|FG002|Overall Study|Adverse Event|0|||
170545623|NCT00976391|616342710|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
170791439|NCT01824875|617247884|FG000|Overall Study|Non-compliance|1|||
170470391|NCT05199090|616061008|FG003|Overall Study|Adverse Event|0|||
170470392|NCT05199090|616061009|FG004|Overall Study|Adverse Event|0|||
170470393|NCT05199090|616061010|FG005|Overall Study|Adverse Event|0|||
170470394|NCT05199090|616061005|FG000|Overall Study|Lost to Follow-up|1|||
170470395|NCT05199090|616061006|FG001|Overall Study|Lost to Follow-up|0|||
170470396|NCT05199090|616061007|FG002|Overall Study|Lost to Follow-up|1|||
170470397|NCT05199090|616061008|FG003|Overall Study|Lost to Follow-up|4|||
170470398|NCT05199090|616061009|FG004|Overall Study|Lost to Follow-up|0|||
170470399|NCT05199090|616061010|FG005|Overall Study|Lost to Follow-up|5|||
170470400|NCT05199090|616061005|FG000|Overall Study|Physician Decision|0|||
170470401|NCT05199090|616061006|FG001|Overall Study|Physician Decision|0|||
170470402|NCT05199090|616061007|FG002|Overall Study|Physician Decision|0|||
170470403|NCT05199090|616061008|FG003|Overall Study|Physician Decision|0|||
170470404|NCT05199090|616061009|FG004|Overall Study|Physician Decision|0|||
170470405|NCT05199090|616061010|FG005|Overall Study|Physician Decision|1|||
170470406|NCT05199090|616061005|FG000|Overall Study|Study terminated by sponsor|0|||
170470407|NCT05199090|616061006|FG001|Overall Study|Study terminated by sponsor|6|||
170470408|NCT05199090|616061007|FG002|Overall Study|Study terminated by sponsor|0|||
170470409|NCT05199090|616061008|FG003|Overall Study|Study terminated by sponsor|0|||
170470410|NCT05199090|616061009|FG004|Overall Study|Study terminated by sponsor|0|||
170470411|NCT05199090|616061010|FG005|Overall Study|Study terminated by sponsor|5|||
170470412|NCT05199090|616061005|FG000|Overall Study|Subject decision|0|||
170891543|NCT01017952|617609775|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
170891544|NCT01017952|617609776|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
170891545|NCT01017952|617609777|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
170891546|NCT02793232|617609778|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
170891547|NCT02793232|617609779|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
170891548|NCT02793232|617609780|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
170891549|NCT02793232|617609781|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
170891550|NCT02793232|617609782|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
170891551|NCT02793232|617609783|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
170891552|NCT02793232|617609784|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
170891553|NCT02793232|617609785|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
170891554|NCT02793232|617609786|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
170891555|NCT02387580|617609789|FG000|Overall Study|Withdrawal by Subject|0|||
170891556|NCT02387580|617609790|FG001|Overall Study|Withdrawal by Subject|0|||
170891557|NCT02387580|617609791|FG002|Overall Study|Withdrawal by Subject|0|||
170891558|NCT02387580|617609792|FG003|Overall Study|Withdrawal by Subject|1|||
170470413|NCT05199090|616061006|FG001|Overall Study|Subject decision|4|||
170470414|NCT05199090|616061007|FG002|Overall Study|Subject decision|0|||
170470415|NCT05199090|616061008|FG003|Overall Study|Subject decision|2|||
170470416|NCT05199090|616061009|FG004|Overall Study|Subject decision|5|||
170470417|NCT05199090|616061010|FG005|Overall Study|Subject decision|2|||
170470418|NCT04868968|616061013|FG000|Overall Study|Lost to Follow-up|1|||
170470419|NCT00384930|616061014|FG000|Overall Study|Adverse Event|5|||
170470420|NCT00384930|616061015|FG001|Overall Study|Adverse Event|4|||
170470421|NCT00384930|616061016|FG002|Overall Study|Adverse Event|12|||
170470422|NCT00384930|616061017|FG003|Overall Study|Adverse Event|11|||
170470423|NCT00384930|616061018|FG004|Overall Study|Adverse Event|14|||
170545624|NCT00976391|616342711|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
170545625|NCT00976391|616342710|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
170545626|NCT00976391|616342711|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
170545627|NCT00976391|616342710|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
170545628|NCT00976391|616342711|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
170545629|NCT00976391|616342710|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
170545630|NCT00976391|616342711|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
170545631|NCT00976391|616342710|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
170545632|NCT00976391|616342711|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
170545633|NCT00976391|616342710|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
170545634|NCT00976391|616342711|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
170545635|NCT00976391|616342710|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
170545636|NCT00976391|616342711|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
170545637|NCT00976391|616342710|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
170545638|NCT00976391|616342711|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
170545639|NCT00976391|616342710|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
170470424|NCT00384930|616061014|FG000|Overall Study|Entry Criteria Not Met|2|||
170545640|NCT00976391|616342711|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
170470425|NCT00384930|616061015|FG001|Overall Study|Entry Criteria Not Met|6|||
170470426|NCT00384930|616061016|FG002|Overall Study|Entry Criteria Not Met|7|||
170545641|NCT00976391|616342710|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
170545642|NCT00976391|616342711|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
170470427|NCT00384930|616061017|FG003|Overall Study|Entry Criteria Not Met|8|||
170470428|NCT00384930|616061018|FG004|Overall Study|Entry Criteria Not Met|4|||
170470429|NCT00384930|616061014|FG000|Overall Study|Lack of Efficacy|1|||
170791440|NCT01824875|617247885|FG001|Overall Study|Non-compliance|1|||
170791441|NCT01824875|617247884|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
170791442|NCT01824875|617247885|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
170791443|NCT01824875|617247884|FG000|Overall Study|Administrative issues|0|||
170791444|NCT01824875|617247885|FG001|Overall Study|Administrative issues|2|||
170791445|NCT01824875|617247884|FG000|Overall Study|Ineligible or never started treatment|9|||
170791446|NCT01824875|617247885|FG001|Overall Study|Ineligible or never started treatment|5|||
170791447|NCT01824875|617247884|FG000|Overall Study|Other|0|||
170891559|NCT02387580|617609793|FG004|Overall Study|Withdrawal by Subject|0|||
170891560|NCT02387580|617609794|FG005|Overall Study|Withdrawal by Subject|0|||
170891561|NCT01064167|617609795|FG000|Overall Study|Protocol Violation|14|||
170470430|NCT00384930|616061015|FG001|Overall Study|Lack of Efficacy|1|||
170470431|NCT00384930|616061016|FG002|Overall Study|Lack of Efficacy|2|||
170470432|NCT00384930|616061017|FG003|Overall Study|Lack of Efficacy|1|||
170470433|NCT00384930|616061018|FG004|Overall Study|Lack of Efficacy|2|||
170470434|NCT00384930|616061014|FG000|Overall Study|Lost to Follow-up|5|||
170470435|NCT00384930|616061015|FG001|Overall Study|Lost to Follow-up|3|||
170470436|NCT00384930|616061016|FG002|Overall Study|Lost to Follow-up|0|||
170470437|NCT00384930|616061017|FG003|Overall Study|Lost to Follow-up|4|||
170470438|NCT00384930|616061018|FG004|Overall Study|Lost to Follow-up|6|||
170470439|NCT00384930|616061014|FG000|Overall Study|Physician Decision|0|||
170470440|NCT00384930|616061015|FG001|Overall Study|Physician Decision|1|||
170470441|NCT00384930|616061016|FG002|Overall Study|Physician Decision|1|||
170470442|NCT00384930|616061017|FG003|Overall Study|Physician Decision|0|||
170470443|NCT00384930|616061018|FG004|Overall Study|Physician Decision|1|||
170470444|NCT00384930|616061014|FG000|Overall Study|Protocol Violation|1|||
170470445|NCT00384930|616061015|FG001|Overall Study|Protocol Violation|0|||
170470446|NCT00384930|616061016|FG002|Overall Study|Protocol Violation|1|||
170470447|NCT00384930|616061017|FG003|Overall Study|Protocol Violation|6|||
170470448|NCT00384930|616061018|FG004|Overall Study|Protocol Violation|4|||
170470449|NCT00384930|616061014|FG000|Overall Study|Sponsor Decision|3|||
170470450|NCT00384930|616061015|FG001|Overall Study|Sponsor Decision|4|||
170470451|NCT00384930|616061016|FG002|Overall Study|Sponsor Decision|0|||
170470452|NCT00384930|616061017|FG003|Overall Study|Sponsor Decision|5|||
170470453|NCT00384930|616061018|FG004|Overall Study|Sponsor Decision|0|||
170470454|NCT00384930|616061014|FG000|Overall Study|Withdrawal by Subject|9|||
170470455|NCT00384930|616061015|FG001|Overall Study|Withdrawal by Subject|7|||
170891562|NCT01064167|617609796|FG001|Overall Study|Protocol Violation|15|||
170891563|NCT04849780|617609797|FG000|Period 1|Covid-19 Related|1|||
170891564|NCT04849780|617609798|FG001|Period 1|Covid-19 Related|0|||
170891565|NCT04849780|617609797|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
170891566|NCT04849780|617609798|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
170891567|NCT04849780|617609797|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
170891568|NCT04849780|617609798|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
170891569|NCT03984305|617609800|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
170891570|NCT03984305|617609801|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
170891571|NCT03984305|617609800|FG000|Overall Study|Withdrawal by Subject|3|||
170891572|NCT03984305|617609801|FG001|Overall Study|Withdrawal by Subject|3|||
170891573|NCT03984305|617609800|FG000|Overall Study|Lost to Follow-up|1|||
170891574|NCT03984305|617609801|FG001|Overall Study|Lost to Follow-up|0|||
170891575|NCT02979431|617609804|FG000|Overall Study|Parent/guardian withdrew consent|2|||
170891576|NCT02979431|617609805|FG001|Overall Study|Parent/guardian withdrew consent|1|||
170891577|NCT02979431|617609806|FG002|Overall Study|Parent/guardian withdrew consent|1|||
170891578|NCT02979431|617609807|FG003|Overall Study|Parent/guardian withdrew consent|1|||
170891579|NCT02979431|617609804|FG000|Overall Study|Randomized but received no study drug|1|||
170891580|NCT02979431|617609805|FG001|Overall Study|Randomized but received no study drug|1|||
170891581|NCT02979431|617609806|FG002|Overall Study|Randomized but received no study drug|0|||
170470456|NCT00384930|616061016|FG002|Overall Study|Withdrawal by Subject|7|||
170470457|NCT00384930|616061017|FG003|Overall Study|Withdrawal by Subject|6|||
170545643|NCT00976391|616342710|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
170545644|NCT00976391|616342711|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
170545645|NCT00976391|616342710|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
170545646|NCT00976391|616342711|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
170545647|NCT00976391|616342710|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
170545648|NCT00976391|616342711|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
170545649|NCT00617903|616342712|FG000|Overall Study|Withdrawal by Subject|2|||
170545650|NCT00617903|616342713|FG001|Overall Study|Withdrawal by Subject|3|||
170545651|NCT00617903|616342712|FG000|Overall Study|Lost to Follow-up|1|||
170545652|NCT00617903|616342713|FG001|Overall Study|Lost to Follow-up|1|||
170545653|NCT00617903|616342712|FG000|Overall Study|Lack of Efficacy|0|||
170545654|NCT00617903|616342713|FG001|Overall Study|Lack of Efficacy|1|||
170470458|NCT00384930|616061018|FG004|Overall Study|Withdrawal by Subject|16|||
170470459|NCT00384930|616061014|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
170470460|NCT00384930|616061015|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
170470461|NCT00384930|616061016|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
170470462|NCT00384930|616061017|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
170470463|NCT00384930|616061018|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
170470464|NCT01449370|616061023|FG000|Overall Study|Disease Progression|5|||
170470465|NCT01449370|616061024|FG001|Overall Study|Disease Progression|4|||
170470466|NCT01449370|616061025|FG002|Overall Study|Disease Progression|8|||
170470467|NCT01449370|616061026|FG003|Overall Study|Disease Progression|3|||
170470468|NCT01449370|616061027|FG004|Overall Study|Disease Progression|3|||
170470469|NCT01449370|616061028|FG005|Overall Study|Disease Progression|3|||
170470470|NCT01449370|616061029|FG006|Overall Study|Disease Progression|3|||
170470471|NCT01449370|616061030|FG007|Overall Study|Disease Progression|2|||
170470472|NCT01449370|616061031|FG008|Overall Study|Disease Progression|9|||
170470473|NCT01449370|616061032|FG009|Overall Study|Disease Progression|1|||
170470474|NCT01449370|616061033|FG010|Overall Study|Disease Progression|3|||
170470475|NCT01449370|616061034|FG011|Overall Study|Disease Progression|3|||
170470476|NCT01449370|616061035|FG012|Overall Study|Disease Progression|2|||
170470477|NCT01449370|616061036|FG013|Overall Study|Disease Progression|8|||
170470478|NCT01449370|616061037|FG014|Overall Study|Disease Progression|3|||
170470479|NCT01449370|616061038|FG015|Overall Study|Disease Progression|1|||
170470480|NCT01449370|616061039|FG016|Overall Study|Disease Progression|4|||
170470481|NCT01449370|616061040|FG017|Overall Study|Disease Progression|3|||
170470482|NCT01449370|616061041|FG018|Overall Study|Disease Progression|1|||
170470483|NCT01449370|616061042|FG019|Overall Study|Disease Progression|2|||
170470484|NCT01449370|616061043|FG020|Overall Study|Disease Progression|5|||
170470485|NCT01449370|616061044|FG021|Overall Study|Disease Progression|2|||
170470486|NCT01449370|616061045|FG022|Overall Study|Disease Progression|3|||
170470487|NCT01449370|616061046|FG023|Overall Study|Disease Progression|7|||
170470488|NCT01449370|616061047|FG024|Overall Study|Disease Progression|3|||
170470489|NCT01449370|616061023|FG000|Overall Study|Adverse Event|1|||
170470490|NCT01449370|616061024|FG001|Overall Study|Adverse Event|2|||
170470491|NCT01449370|616061025|FG002|Overall Study|Adverse Event|0|||
170470492|NCT01449370|616061026|FG003|Overall Study|Adverse Event|1|||
170470493|NCT01449370|616061027|FG004|Overall Study|Adverse Event|0|||
170470494|NCT01449370|616061028|FG005|Overall Study|Adverse Event|0|||
170470495|NCT01449370|616061029|FG006|Overall Study|Adverse Event|0|||
170470496|NCT01449370|616061030|FG007|Overall Study|Adverse Event|0|||
170470497|NCT01449370|616061031|FG008|Overall Study|Adverse Event|1|||
170470498|NCT01449370|616061032|FG009|Overall Study|Adverse Event|1|||
170470499|NCT01449370|616061033|FG010|Overall Study|Adverse Event|0|||
170470500|NCT01449370|616061034|FG011|Overall Study|Adverse Event|0|||
170470501|NCT01449370|616061035|FG012|Overall Study|Adverse Event|0|||
170470502|NCT01449370|616061036|FG013|Overall Study|Adverse Event|2|||
170470503|NCT01449370|616061037|FG014|Overall Study|Adverse Event|0|||
170470504|NCT01449370|616061038|FG015|Overall Study|Adverse Event|1|||
170470505|NCT01449370|616061039|FG016|Overall Study|Adverse Event|0|||
170470506|NCT01449370|616061040|FG017|Overall Study|Adverse Event|0|||
170470507|NCT01449370|616061041|FG018|Overall Study|Adverse Event|1|||
170470508|NCT01449370|616061042|FG019|Overall Study|Adverse Event|1|||
170470509|NCT01449370|616061043|FG020|Overall Study|Adverse Event|0|||
170470510|NCT01449370|616061044|FG021|Overall Study|Adverse Event|1|||
170470511|NCT01449370|616061045|FG022|Overall Study|Adverse Event|0|||
170470512|NCT01449370|616061046|FG023|Overall Study|Adverse Event|1|||
170470513|NCT01449370|616061047|FG024|Overall Study|Adverse Event|3|||
170470514|NCT01449370|616061023|FG000|Overall Study|Participant Decision|0|||
170470515|NCT01449370|616061024|FG001|Overall Study|Participant Decision|0|||
170470516|NCT01449370|616061025|FG002|Overall Study|Participant Decision|0|||
170470517|NCT01449370|616061026|FG003|Overall Study|Participant Decision|0|||
170470518|NCT01449370|616061027|FG004|Overall Study|Participant Decision|0|||
170470519|NCT01449370|616061028|FG005|Overall Study|Participant Decision|0|||
170470520|NCT01449370|616061029|FG006|Overall Study|Participant Decision|0|||
170470521|NCT01449370|616061030|FG007|Overall Study|Participant Decision|1|||
170545655|NCT00617903|616342712|FG000|Overall Study|Adverse Event|0|||
170545656|NCT00617903|616342713|FG001|Overall Study|Adverse Event|1|||
170470522|NCT01449370|616061031|FG008|Overall Study|Participant Decision|1|||
170470523|NCT01449370|616061032|FG009|Overall Study|Participant Decision|0|||
170470524|NCT01449370|616061033|FG010|Overall Study|Participant Decision|0|||
170470525|NCT01449370|616061034|FG011|Overall Study|Participant Decision|0|||
170470526|NCT01449370|616061035|FG012|Overall Study|Participant Decision|1|||
170470527|NCT01449370|616061036|FG013|Overall Study|Participant Decision|1|||
170470528|NCT01449370|616061037|FG014|Overall Study|Participant Decision|0|||
170470529|NCT01449370|616061038|FG015|Overall Study|Participant Decision|1|||
170470530|NCT01449370|616061039|FG016|Overall Study|Participant Decision|3|||
170470531|NCT01449370|616061040|FG017|Overall Study|Participant Decision|0|||
170470532|NCT01449370|616061041|FG018|Overall Study|Participant Decision|1|||
170470533|NCT01449370|616061042|FG019|Overall Study|Participant Decision|0|||
170891582|NCT02979431|617609807|FG003|Overall Study|Randomized but received no study drug|0|||
170891583|NCT02979431|617609804|FG000|Overall Study|Adverse Event|0|||
170891584|NCT02979431|617609805|FG001|Overall Study|Adverse Event|0|||
170891585|NCT02979431|617609806|FG002|Overall Study|Adverse Event|1|||
170891586|NCT02979431|617609807|FG003|Overall Study|Adverse Event|0|||
170891587|NCT02979431|617609804|FG000|Overall Study|Subject left country after Day14|1|||
170891588|NCT02979431|617609805|FG001|Overall Study|Subject left country after Day14|0|||
170891589|NCT02979431|617609806|FG002|Overall Study|Subject left country after Day14|0|||
170891590|NCT02979431|617609807|FG003|Overall Study|Subject left country after Day14|0|||
170891591|NCT01405053|617609815|FG000|Overall Study|Adverse Event|3|||
170891592|NCT01405053|617609816|FG001|Overall Study|Adverse Event|0|||
170891593|NCT01405053|617609815|FG000|Overall Study|Lost to Follow-up|0|||
170891594|NCT01405053|617609816|FG001|Overall Study|Lost to Follow-up|1|||
170891595|NCT01405053|617609815|FG000|Overall Study|Participant choice|2|||
170891596|NCT01405053|617609816|FG001|Overall Study|Participant choice|1|||
170891597|NCT01405053|617609815|FG000|Overall Study|Inadequate therapeutic effect|2|||
170891598|NCT01405053|617609816|FG001|Overall Study|Inadequate therapeutic effect|1|||
170891599|NCT01405053|617609815|FG000|Overall Study|Withdrawal by Subject|3|||
170891600|NCT01405053|617609816|FG001|Overall Study|Withdrawal by Subject|4|||
170891601|NCT01405053|617609815|FG000|Overall Study|Other|0|||
170891602|NCT01405053|617609816|FG001|Overall Study|Other|1|||
170891603|NCT03604445|617609818|FG000|Overall Study|Death|0|||
170891604|NCT03604445|617609819|FG001|Overall Study|Death|0|||
170891605|NCT03604445|617609820|FG002|Overall Study|Death|0|||
170891606|NCT03604445|617609821|FG003|Overall Study|Death|0|||
170891607|NCT03604445|617609822|FG004|Overall Study|Death|0|||
170891608|NCT03604445|617609823|FG005|Overall Study|Death|0|||
170891609|NCT03604445|617609824|FG006|Overall Study|Death|0|||
170891610|NCT03604445|617609825|FG007|Overall Study|Death|0|||
170891611|NCT03604445|617609826|FG008|Overall Study|Death|1|||
170891612|NCT03604445|617609818|FG000|Overall Study|Withdrawal by Subject|0|||
170470534|NCT01449370|616061043|FG020|Overall Study|Participant Decision|0|||
170545657|NCT00617903|616342712|FG000|Overall Study|noncompliance|0|||
170470535|NCT01449370|616061044|FG021|Overall Study|Participant Decision|1|||
170470536|NCT01449370|616061045|FG022|Overall Study|Participant Decision|0|||
170470537|NCT01449370|616061046|FG023|Overall Study|Participant Decision|0|||
170470538|NCT01449370|616061047|FG024|Overall Study|Participant Decision|1|||
170470539|NCT01449370|616061023|FG000|Overall Study|Lost to Follow-up|0|||
170470540|NCT01449370|616061024|FG001|Overall Study|Lost to Follow-up|0|||
170470541|NCT01449370|616061025|FG002|Overall Study|Lost to Follow-up|0|||
170470542|NCT01449370|616061026|FG003|Overall Study|Lost to Follow-up|0|||
170470543|NCT01449370|616061027|FG004|Overall Study|Lost to Follow-up|0|||
170470544|NCT01449370|616061028|FG005|Overall Study|Lost to Follow-up|0|||
170470545|NCT01449370|616061029|FG006|Overall Study|Lost to Follow-up|0|||
170470546|NCT01449370|616061030|FG007|Overall Study|Lost to Follow-up|0|||
170470547|NCT01449370|616061031|FG008|Overall Study|Lost to Follow-up|0|||
170470548|NCT01449370|616061032|FG009|Overall Study|Lost to Follow-up|0|||
170470549|NCT01449370|616061033|FG010|Overall Study|Lost to Follow-up|0|||
170470550|NCT01449370|616061034|FG011|Overall Study|Lost to Follow-up|0|||
170470551|NCT01449370|616061035|FG012|Overall Study|Lost to Follow-up|0|||
170470552|NCT01449370|616061036|FG013|Overall Study|Lost to Follow-up|0|||
170470553|NCT01449370|616061037|FG014|Overall Study|Lost to Follow-up|0|||
170470554|NCT01449370|616061038|FG015|Overall Study|Lost to Follow-up|0|||
170470555|NCT01449370|616061039|FG016|Overall Study|Lost to Follow-up|0|||
170470556|NCT01449370|616061040|FG017|Overall Study|Lost to Follow-up|0|||
170470557|NCT01449370|616061041|FG018|Overall Study|Lost to Follow-up|0|||
170470558|NCT01449370|616061042|FG019|Overall Study|Lost to Follow-up|0|||
170470559|NCT01449370|616061043|FG020|Overall Study|Lost to Follow-up|1|||
170470560|NCT01449370|616061044|FG021|Overall Study|Lost to Follow-up|0|||
170470561|NCT01449370|616061045|FG022|Overall Study|Lost to Follow-up|0|||
170470562|NCT01449370|616061046|FG023|Overall Study|Lost to Follow-up|0|||
170891613|NCT03604445|617609819|FG001|Overall Study|Withdrawal by Subject|0|||
170470563|NCT01449370|616061047|FG024|Overall Study|Lost to Follow-up|0|||
170470564|NCT01449370|616061023|FG000|Overall Study|Other|0|||
170470565|NCT01449370|616061024|FG001|Overall Study|Other|0|||
170891614|NCT03604445|617609820|FG002|Overall Study|Withdrawal by Subject|0|||
170891615|NCT03604445|617609821|FG003|Overall Study|Withdrawal by Subject|0|||
170891616|NCT03604445|617609822|FG004|Overall Study|Withdrawal by Subject|0|||
170891617|NCT03604445|617609823|FG005|Overall Study|Withdrawal by Subject|0|||
170891618|NCT03604445|617609824|FG006|Overall Study|Withdrawal by Subject|1|||
170470566|NCT01449370|616061025|FG002|Overall Study|Other|0|||
170470567|NCT01449370|616061026|FG003|Overall Study|Other|0|||
170470568|NCT01449370|616061027|FG004|Overall Study|Other|0|||
170470569|NCT01449370|616061028|FG005|Overall Study|Other|0|||
170470570|NCT01449370|616061029|FG006|Overall Study|Other|0|||
170470571|NCT01449370|616061030|FG007|Overall Study|Other|0|||
170470572|NCT01449370|616061031|FG008|Overall Study|Other|1|||
170470573|NCT01449370|616061032|FG009|Overall Study|Other|1|||
170470574|NCT01449370|616061033|FG010|Overall Study|Other|0|||
170470575|NCT01449370|616061034|FG011|Overall Study|Other|0|||
170470576|NCT01449370|616061035|FG012|Overall Study|Other|0|||
170470577|NCT01449370|616061036|FG013|Overall Study|Other|0|||
170470578|NCT01449370|616061037|FG014|Overall Study|Other|0|||
170470579|NCT01449370|616061038|FG015|Overall Study|Other|0|||
170470580|NCT01449370|616061039|FG016|Overall Study|Other|0|||
170470581|NCT01449370|616061040|FG017|Overall Study|Other|0|||
170470582|NCT01449370|616061041|FG018|Overall Study|Other|0|||
170470583|NCT01449370|616061042|FG019|Overall Study|Other|0|||
170470584|NCT01449370|616061043|FG020|Overall Study|Other|0|||
170470585|NCT01449370|616061044|FG021|Overall Study|Other|0|||
170470586|NCT01449370|616061045|FG022|Overall Study|Other|1|||
170470587|NCT01449370|616061046|FG023|Overall Study|Other|1|||
170470588|NCT01449370|616061047|FG024|Overall Study|Other|0|||
170470589|NCT01449370|616061023|FG000|Overall Study|Medication Prohibited by Protocol|0|||
170470590|NCT01449370|616061024|FG001|Overall Study|Medication Prohibited by Protocol|0|||
170470591|NCT01449370|616061025|FG002|Overall Study|Medication Prohibited by Protocol|0|||
170470592|NCT01449370|616061026|FG003|Overall Study|Medication Prohibited by Protocol|0|||
170470593|NCT01449370|616061027|FG004|Overall Study|Medication Prohibited by Protocol|0|||
170470594|NCT01449370|616061028|FG005|Overall Study|Medication Prohibited by Protocol|0|||
170470595|NCT01449370|616061029|FG006|Overall Study|Medication Prohibited by Protocol|0|||
170470596|NCT01449370|616061030|FG007|Overall Study|Medication Prohibited by Protocol|0|||
170470597|NCT01449370|616061031|FG008|Overall Study|Medication Prohibited by Protocol|0|||
170470598|NCT01449370|616061032|FG009|Overall Study|Medication Prohibited by Protocol|0|||
170470599|NCT01449370|616061033|FG010|Overall Study|Medication Prohibited by Protocol|0|||
170470600|NCT01449370|616061034|FG011|Overall Study|Medication Prohibited by Protocol|0|||
170470601|NCT01449370|616061035|FG012|Overall Study|Medication Prohibited by Protocol|0|||
170470602|NCT01449370|616061036|FG013|Overall Study|Medication Prohibited by Protocol|0|||
170470603|NCT01449370|616061037|FG014|Overall Study|Medication Prohibited by Protocol|0|||
170470604|NCT01449370|616061038|FG015|Overall Study|Medication Prohibited by Protocol|0|||
170470605|NCT01449370|616061039|FG016|Overall Study|Medication Prohibited by Protocol|0|||
170470606|NCT01449370|616061040|FG017|Overall Study|Medication Prohibited by Protocol|0|||
170470607|NCT01449370|616061041|FG018|Overall Study|Medication Prohibited by Protocol|0|||
170470608|NCT01449370|616061042|FG019|Overall Study|Medication Prohibited by Protocol|0|||
170470609|NCT01449370|616061043|FG020|Overall Study|Medication Prohibited by Protocol|0|||
170470610|NCT01449370|616061044|FG021|Overall Study|Medication Prohibited by Protocol|0|||
170470611|NCT01449370|616061045|FG022|Overall Study|Medication Prohibited by Protocol|0|||
170470612|NCT01449370|616061046|FG023|Overall Study|Medication Prohibited by Protocol|1|||
170470613|NCT01449370|616061047|FG024|Overall Study|Medication Prohibited by Protocol|0|||
170470614|NCT01449370|616061023|FG000|Overall Study|Death|0|||
170470615|NCT01449370|616061024|FG001|Overall Study|Death|0|||
170470616|NCT01449370|616061025|FG002|Overall Study|Death|0|||
170470617|NCT01449370|616061026|FG003|Overall Study|Death|0|||
170470618|NCT01449370|616061027|FG004|Overall Study|Death|0|||
170470619|NCT01449370|616061028|FG005|Overall Study|Death|0|||
170470620|NCT01449370|616061029|FG006|Overall Study|Death|0|||
170470621|NCT01449370|616061030|FG007|Overall Study|Death|0|||
170470622|NCT01449370|616061031|FG008|Overall Study|Death|0|||
170470623|NCT01449370|616061032|FG009|Overall Study|Death|0|||
170470624|NCT01449370|616061033|FG010|Overall Study|Death|0|||
170470625|NCT01449370|616061034|FG011|Overall Study|Death|0|||
170470626|NCT01449370|616061035|FG012|Overall Study|Death|0|||
170470627|NCT01449370|616061036|FG013|Overall Study|Death|0|||
170470628|NCT01449370|616061037|FG014|Overall Study|Death|0|||
170470629|NCT01449370|616061038|FG015|Overall Study|Death|0|||
170470630|NCT01449370|616061039|FG016|Overall Study|Death|0|||
170470631|NCT01449370|616061040|FG017|Overall Study|Death|0|||
170470632|NCT01449370|616061041|FG018|Overall Study|Death|0|||
170470633|NCT01449370|616061042|FG019|Overall Study|Death|0|||
170470634|NCT01449370|616061043|FG020|Overall Study|Death|0|||
170470635|NCT01449370|616061044|FG021|Overall Study|Death|0|||
170470636|NCT01449370|616061045|FG022|Overall Study|Death|0|||
170470637|NCT01449370|616061046|FG023|Overall Study|Death|0|||
170545658|NCT00617903|616342713|FG001|Overall Study|noncompliance|1|||
170470638|NCT01449370|616061047|FG024|Overall Study|Death|1|||
170470639|NCT01685840|616061048|FG000|Overall Study|Death|77|||
170470640|NCT01685840|616061049|FG001|Overall Study|Death|66|||
170470641|NCT01685840|616061048|FG000|Overall Study|Lost to Follow-up|27|||
170470642|NCT01685840|616061049|FG001|Overall Study|Lost to Follow-up|25|||
170470643|NCT01685840|616061048|FG000|Overall Study|Physician Decision|3|||
170470644|NCT01685840|616061049|FG001|Overall Study|Physician Decision|7|||
170470645|NCT01685840|616061048|FG000|Overall Study|Withdrawal by Subject|14|||
170470646|NCT01685840|616061049|FG001|Overall Study|Withdrawal by Subject|17|||
170470647|NCT01685840|616061048|FG000|Overall Study|Futility|197|||
170470648|NCT01685840|616061049|FG001|Overall Study|Futility|200|||
170470649|NCT01685840|616061048|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
170470650|NCT01685840|616061049|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
170470651|NCT00086281|616061050|FG000|Phase 1|Adverse Event|0|||
170470652|NCT00086281|616061051|FG001|Phase 1|Adverse Event|0|||
170470653|NCT00086281|616061052|FG002|Phase 1|Adverse Event|0|||
170470654|NCT00086281|616061053|FG003|Phase 1|Adverse Event|0|||
170470655|NCT00086281|616061054|FG004|Phase 1|Adverse Event|0|||
170470656|NCT00086281|616061055|FG005|Phase 1|Adverse Event|0|||
170470657|NCT00086281|616061056|FG006|Phase 1|Adverse Event|0|||
170470658|NCT00086281|616061057|FG007|Phase 1|Adverse Event|0|||
170470659|NCT00086281|616061058|FG008|Phase 1|Adverse Event|0|||
170470660|NCT00086281|616061059|FG009|Phase 1|Adverse Event|1|||
170470661|NCT00086281|616061060|FG010|Phase 1|Adverse Event|2|||
170470662|NCT00086281|616061061|FG011|Phase 1|Adverse Event|1|||
170470663|NCT00086281|616061062|FG012|Phase 1|Adverse Event|1|||
170470664|NCT00086281|616061063|FG013|Phase 1|Adverse Event|1|||
170470665|NCT00086281|616061064|FG014|Phase 1|Adverse Event|2|||
170470666|NCT00086281|616061050|FG000|Phase 1|Protocol Violation|0|||
170470667|NCT00086281|616061051|FG001|Phase 1|Protocol Violation|0|||
170470668|NCT00086281|616061052|FG002|Phase 1|Protocol Violation|0|||
170470669|NCT00086281|616061053|FG003|Phase 1|Protocol Violation|0|||
170470670|NCT00086281|616061054|FG004|Phase 1|Protocol Violation|0|||
170470671|NCT00086281|616061055|FG005|Phase 1|Protocol Violation|0|||
170470672|NCT00086281|616061056|FG006|Phase 1|Protocol Violation|0|||
170470673|NCT00086281|616061057|FG007|Phase 1|Protocol Violation|0|||
170470674|NCT00086281|616061058|FG008|Phase 1|Protocol Violation|0|||
170470675|NCT00086281|616061059|FG009|Phase 1|Protocol Violation|0|||
170470676|NCT00086281|616061060|FG010|Phase 1|Protocol Violation|1|||
170470677|NCT00086281|616061061|FG011|Phase 1|Protocol Violation|0|||
170470678|NCT00086281|616061062|FG012|Phase 1|Protocol Violation|0|||
170470679|NCT00086281|616061063|FG013|Phase 1|Protocol Violation|0|||
170470680|NCT00086281|616061064|FG014|Phase 1|Protocol Violation|0|||
170470681|NCT00086281|616061050|FG000|Phase 1|Serious Adverse Event|0|||
170470682|NCT00086281|616061051|FG001|Phase 1|Serious Adverse Event|0|||
170470683|NCT00086281|616061052|FG002|Phase 1|Serious Adverse Event|0|||
170470684|NCT00086281|616061053|FG003|Phase 1|Serious Adverse Event|0|||
170470685|NCT00086281|616061054|FG004|Phase 1|Serious Adverse Event|0|||
170470686|NCT00086281|616061055|FG005|Phase 1|Serious Adverse Event|0|||
170470687|NCT00086281|616061056|FG006|Phase 1|Serious Adverse Event|0|||
170470688|NCT00086281|616061057|FG007|Phase 1|Serious Adverse Event|0|||
170470689|NCT00086281|616061058|FG008|Phase 1|Serious Adverse Event|0|||
170470690|NCT00086281|616061059|FG009|Phase 1|Serious Adverse Event|0|||
170470691|NCT00086281|616061060|FG010|Phase 1|Serious Adverse Event|0|||
170470692|NCT00086281|616061061|FG011|Phase 1|Serious Adverse Event|0|||
170470693|NCT00086281|616061062|FG012|Phase 1|Serious Adverse Event|0|||
170470694|NCT00086281|616061063|FG013|Phase 1|Serious Adverse Event|0|||
170470695|NCT00086281|616061064|FG014|Phase 1|Serious Adverse Event|1|||
170470696|NCT00086281|616061050|FG000|Phase 2|Adverse Event|0|||
170470697|NCT00086281|616061051|FG001|Phase 2|Adverse Event|0|||
170470698|NCT00086281|616061052|FG002|Phase 2|Adverse Event|0|||
170470699|NCT00086281|616061053|FG003|Phase 2|Adverse Event|0|||
170470700|NCT00086281|616061054|FG004|Phase 2|Adverse Event|0|||
170470701|NCT00086281|616061055|FG005|Phase 2|Adverse Event|0|||
170470702|NCT00086281|616061056|FG006|Phase 2|Adverse Event|0|||
170470703|NCT00086281|616061057|FG007|Phase 2|Adverse Event|0|||
170470704|NCT00086281|616061058|FG008|Phase 2|Adverse Event|0|||
170470705|NCT00086281|616061059|FG009|Phase 2|Adverse Event|0|||
170470706|NCT00086281|616061060|FG010|Phase 2|Adverse Event|0|||
170470707|NCT00086281|616061061|FG011|Phase 2|Adverse Event|0|||
170470708|NCT00086281|616061062|FG012|Phase 2|Adverse Event|1|||
170545659|NCT04676646|616342714|FG000|Open-label Run-in Phase|Adverse Event|3|||
170470709|NCT00086281|616061063|FG013|Phase 2|Adverse Event|1|||
170470710|NCT00086281|616061064|FG014|Phase 2|Adverse Event|0|||
170545660|NCT04676646|616342715|FG001|Open-label Run-in Phase|Adverse Event|0|||
170545661|NCT04676646|616342716|FG002|Open-label Run-in Phase|Adverse Event|0|||
170545662|NCT04676646|616342714|FG000|Open-label Run-in Phase|Death|3|||
170545663|NCT04676646|616342715|FG001|Open-label Run-in Phase|Death|0|||
170545664|NCT04676646|616342716|FG002|Open-label Run-in Phase|Death|0|||
170545665|NCT04676646|616342714|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
170470711|NCT01107197|616061075|FG000|Overall Study|Death|12|||
170470712|NCT01107197|616061076|FG001|Overall Study|Death|10|||
170470713|NCT01107197|616061075|FG000|Overall Study|Lost to Follow-up|5|||
170470714|NCT01107197|616061076|FG001|Overall Study|Lost to Follow-up|8|||
170470715|NCT01107197|616061075|FG000|Overall Study|Withdrawal by Subject|3|||
170470716|NCT01107197|616061076|FG001|Overall Study|Withdrawal by Subject|5|||
170470717|NCT03516513|616061077|FG000|Overall Study|Withdrawal by Subject|2|||
170470718|NCT03516513|616061078|FG001|Overall Study|Withdrawal by Subject|2|||
170470719|NCT03516513|616061079|FG002|Overall Study|Withdrawal by Subject|0|||
170470720|NCT03516513|616061080|FG003|Overall Study|Withdrawal by Subject|0|||
170470721|NCT04697069|616061081|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
170470722|NCT04697069|616061082|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
170470723|NCT04697069|616061081|FG000|Overall Study|Study termination|2|||
170470724|NCT04697069|616061082|FG001|Overall Study|Study termination|1|||
170470725|NCT05180227|616061083|FG000|Overall Study|Hypertension at screening|1|||
170470726|NCT05180227|616061083|FG000|Overall Study|Lost to Follow-up|1|||
170470727|NCT00351533|616061084|FG000|Overall Study|Extubated before first BAL|1|||
170470728|NCT00351533|616061085|FG001|Overall Study|Extubated before first BAL|0|||
170470729|NCT00351533|616061084|FG000|Overall Study|Lost to Follow-up|1|||
170470730|NCT00351533|616061085|FG001|Overall Study|Lost to Follow-up|3|||
170470731|NCT00351533|616061084|FG000|Overall Study|Physician Decision|0|||
170470732|NCT00351533|616061085|FG001|Overall Study|Physician Decision|1|||
170470733|NCT00351533|616061084|FG000|Overall Study|Withdrawal by Subject|0|||
170470734|NCT00351533|616061085|FG001|Overall Study|Withdrawal by Subject|1|||
170470735|NCT02682927|616061090|FG000|Overall Study|Adverse Event|0|||
170470736|NCT02682927|616061091|FG001|Overall Study|Adverse Event|0|||
170470737|NCT02682927|616061092|FG002|Overall Study|Adverse Event|5|||
170470738|NCT02682927|616061093|FG003|Overall Study|Adverse Event|1|||
170470739|NCT02682927|616061094|FG004|Overall Study|Adverse Event|0|||
170470740|NCT02682927|616061095|FG005|Overall Study|Adverse Event|2|||
170470741|NCT02682927|616061090|FG000|Overall Study|Death|0|||
170470742|NCT02682927|616061091|FG001|Overall Study|Death|0|||
170470743|NCT02682927|616061092|FG002|Overall Study|Death|0|||
170470744|NCT02682927|616061093|FG003|Overall Study|Death|1|||
170470745|NCT02682927|616061094|FG004|Overall Study|Death|0|||
170470746|NCT02682927|616061095|FG005|Overall Study|Death|0|||
170470747|NCT02682927|616061090|FG000|Overall Study|Lack of Efficacy|1|||
170470748|NCT02682927|616061091|FG001|Overall Study|Lack of Efficacy|0|||
170470749|NCT02682927|616061092|FG002|Overall Study|Lack of Efficacy|0|||
170470750|NCT02682927|616061093|FG003|Overall Study|Lack of Efficacy|1|||
170470751|NCT02682927|616061094|FG004|Overall Study|Lack of Efficacy|0|||
170470752|NCT02682927|616061095|FG005|Overall Study|Lack of Efficacy|0|||
170470753|NCT02682927|616061090|FG000|Overall Study|Other|0|||
170470754|NCT02682927|616061091|FG001|Overall Study|Other|0|||
170470755|NCT02682927|616061092|FG002|Overall Study|Other|0|||
170470756|NCT02682927|616061093|FG003|Overall Study|Other|2|||
170470757|NCT02682927|616061094|FG004|Overall Study|Other|0|||
170470758|NCT02682927|616061095|FG005|Overall Study|Other|0|||
170470759|NCT02682927|616061090|FG000|Overall Study|Withdrawal by Subject|2|||
170470760|NCT02682927|616061091|FG001|Overall Study|Withdrawal by Subject|0|||
170470761|NCT02682927|616061092|FG002|Overall Study|Withdrawal by Subject|1|||
170470762|NCT02682927|616061093|FG003|Overall Study|Withdrawal by Subject|0|||
170470763|NCT02682927|616061094|FG004|Overall Study|Withdrawal by Subject|1|||
170470764|NCT02682927|616061095|FG005|Overall Study|Withdrawal by Subject|1|||
170470765|NCT04007991|616061096|FG000|Overall Study|Withdrawal by Subject|1|||
170470766|NCT04007991|616061097|FG001|Overall Study|Withdrawal by Subject|1|||
170470767|NCT04007991|616061096|FG000|Overall Study|Physician Decision|1|||
170470768|NCT04007991|616061097|FG001|Overall Study|Physician Decision|1|||
170470769|NCT04007991|616061096|FG000|Overall Study|Non-compliance with Study Drug|0|||
170470770|NCT04007991|616061097|FG001|Overall Study|Non-compliance with Study Drug|1|||
170470771|NCT04007991|616061096|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
170470772|NCT04007991|616061097|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
170637612|NCT02541604|616684615|FG008|Overall Study|Withdrawal by Subject|1|||
170637613|NCT02541604|616684616|FG009|Overall Study|Withdrawal by Subject|0|||
170637614|NCT02541604|616684617|FG010|Overall Study|Withdrawal by Subject|0|||
170637615|NCT02541604|616684618|FG011|Overall Study|Withdrawal by Subject|0|||
170637616|NCT02541604|616684607|FG000|Overall Study|Study Terminated by Sponsor|1|||
170637617|NCT02541604|616684608|FG001|Overall Study|Study Terminated by Sponsor|4|||
170637618|NCT02541604|616684609|FG002|Overall Study|Study Terminated by Sponsor|2|||
170637619|NCT02541604|616684610|FG003|Overall Study|Study Terminated by Sponsor|1|||
170470773|NCT04007991|616061096|FG000|Overall Study|Adverse event, non-fatal|5|||
170470774|NCT04007991|616061097|FG001|Overall Study|Adverse event, non-fatal|0|||
170470775|NCT04007991|616061096|FG000|Overall Study|Lost to Follow-up|2|||
170470776|NCT04007991|616061097|FG001|Overall Study|Lost to Follow-up|1|||
170637620|NCT02541604|616684611|FG004|Overall Study|Study Terminated by Sponsor|0|||
170470777|NCT03654599|616061100|FG000|Overall Study|Lost to Follow-up|14|||
170637621|NCT02541604|616684612|FG005|Overall Study|Study Terminated by Sponsor|0|||
170637622|NCT02541604|616684613|FG006|Overall Study|Study Terminated by Sponsor|0|||
170791448|NCT01824875|617247885|FG001|Overall Study|Other|2|||
170470778|NCT03654599|616061101|FG001|Overall Study|Lost to Follow-up|12|||
170470779|NCT03654599|616061100|FG000|Overall Study|Death|8|||
170470780|NCT03654599|616061101|FG001|Overall Study|Death|6|||
170470781|NCT03654599|616061100|FG000|Overall Study|Withdrawal by Subject|6|||
170470782|NCT03654599|616061101|FG001|Overall Study|Withdrawal by Subject|4|||
170470783|NCT03462459|616061102|FG000|Overall Study|Death|1|||
170470784|NCT03462459|616061103|FG001|Overall Study|Death|0|||
170470785|NCT03462459|616061102|FG000|Overall Study|Lack of Efficacy|2|||
170637623|NCT02541604|616684614|FG007|Overall Study|Study Terminated by Sponsor|0|||
170470786|NCT03462459|616061103|FG001|Overall Study|Lack of Efficacy|4|||
170470787|NCT03462459|616061102|FG000|Overall Study|Lost to Follow-up|1|||
170470788|NCT03462459|616061103|FG001|Overall Study|Lost to Follow-up|3|||
170470789|NCT03462459|616061102|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
170470790|NCT03462459|616061103|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
170470791|NCT03462459|616061102|FG000|Overall Study|Withdrawal by Subject|3|||
170470792|NCT03462459|616061103|FG001|Overall Study|Withdrawal by Subject|2|||
170470793|NCT03462459|616061102|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
170470794|NCT03462459|616061103|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
170470795|NCT05314816|616061105|FG000|Overall Study|Lost to Follow-up|5|||
170470796|NCT05314816|616061106|FG001|Overall Study|Lost to Follow-up|0|||
170470797|NCT05314816|616061107|FG002|Overall Study|Lost to Follow-up|1|||
170470798|NCT05314816|616061105|FG000|Overall Study|Protocol Violation|13|||
170470799|NCT05314816|616061106|FG001|Overall Study|Protocol Violation|8|||
170470800|NCT05314816|616061107|FG002|Overall Study|Protocol Violation|0|||
170470801|NCT04042376|616061108|FG000|Overall Study|Withdrawal by Subject|1|||
170470802|NCT04042376|616061108|FG000|Overall Study|Death|3|||
170470803|NCT04051619|616061109|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
170470804|NCT04051619|616061110|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
170470805|NCT04051619|616061109|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
170470806|NCT04051619|616061110|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
170470807|NCT01290302|616062502|FG000|Overall Study|Adverse Event|2|||
170470808|NCT01290302|616062503|FG001|Overall Study|Adverse Event|0|||
170470809|NCT01290302|616062502|FG000|Overall Study|Withdrawal by Subject|1|||
170470810|NCT01290302|616062503|FG001|Overall Study|Withdrawal by Subject|0|||
170470811|NCT01290302|616062502|FG000|Overall Study|Physician Decision|0|||
170470812|NCT01290302|616062503|FG001|Overall Study|Physician Decision|2|||
170470813|NCT01290302|616062502|FG000|Overall Study|Expiration of time for screening window|1|||
170470814|NCT01290302|616062503|FG001|Overall Study|Expiration of time for screening window|0|||
170470815|NCT02906358|616062504|FG000|Overall Study|Withdrawal by Subject|10|||
170470816|NCT02906358|616062505|FG001|Overall Study|Withdrawal by Subject|7|||
170470817|NCT02906358|616062504|FG000|Overall Study|Lost to Follow-up|12|||
170470818|NCT02906358|616062505|FG001|Overall Study|Lost to Follow-up|15|||
170470819|NCT02699684|616062506|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
170470820|NCT02699684|616062507|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
170470821|NCT02681510|616062513|FG000|Overall Study|Withdrawal by Subject|1|||
170470822|NCT02681510|616062513|FG000|Overall Study|Lost to Follow-up|9|||
170470823|NCT01644617|616062519|FG000|Overall Study|Withdrawal by Subject|3|||
170470824|NCT01644617|616062520|FG001|Overall Study|Withdrawal by Subject|4|||
170470825|NCT01644617|616062521|FG002|Overall Study|Withdrawal by Subject|1|||
170470826|NCT01644617|616062519|FG000|Overall Study|Lost to Follow-up|0|||
170470827|NCT01644617|616062520|FG001|Overall Study|Lost to Follow-up|1|||
170470828|NCT01644617|616062521|FG002|Overall Study|Lost to Follow-up|0|||
170470829|NCT01644617|616062519|FG000|Overall Study|Adverse Event|3|||
170470830|NCT01644617|616062520|FG001|Overall Study|Adverse Event|0|||
170470831|NCT01644617|616062521|FG002|Overall Study|Adverse Event|6|||
170470832|NCT00741338|616062528|FG000|Overall Study|Adverse Event|0|||
170470833|NCT00741338|616062529|FG001|Overall Study|Adverse Event|1|||
170470834|NCT03713632|616062530|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
170470835|NCT03713632|616062531|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
170470836|NCT03713632|616062532|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
170470837|NCT03713632|616062533|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
170470838|NCT03713632|616062534|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
170470839|NCT03713632|616062530|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
170470840|NCT03713632|616062531|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
170470841|NCT03713632|616062532|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
170470842|NCT03713632|616062533|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
170470843|NCT03713632|616062534|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
170470844|NCT03713632|616062530|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
170470845|NCT03713632|616062531|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
170470846|NCT03713632|616062532|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
170470847|NCT03713632|616062533|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
170470848|NCT03713632|616062534|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
170470849|NCT03713632|616062530|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
170791449|NCT03560609|617247886|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
170470850|NCT03713632|616062531|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
170470851|NCT03713632|616062532|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
170470852|NCT03713632|616062533|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
170470853|NCT03713632|616062534|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
170470854|NCT03713632|616062530|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
170470855|NCT03713632|616062531|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
170470856|NCT03713632|616062532|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
170470857|NCT03713632|616062533|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
170470858|NCT03713632|616062534|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
170470859|NCT03713632|616062530|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
170470860|NCT03713632|616062531|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
170470861|NCT03713632|616062532|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
170470862|NCT03713632|616062533|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
170470863|NCT03713632|616062534|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
170470864|NCT03713632|616062530|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
170470865|NCT03713632|616062531|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
170470866|NCT03713632|616062532|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
170470867|NCT03713632|616062533|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
170470868|NCT03713632|616062534|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
170470869|NCT03713632|616062530|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
170470870|NCT03713632|616062531|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
170470871|NCT03713632|616062532|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
170470872|NCT03713632|616062533|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
170470873|NCT03713632|616062534|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
170470874|NCT03713632|616062530|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
170470875|NCT03713632|616062531|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
170470876|NCT03713632|616062532|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
170470877|NCT03713632|616062533|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
170470878|NCT03713632|616062534|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
170470879|NCT03713632|616062530|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
170470880|NCT03713632|616062531|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
170470881|NCT03713632|616062532|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
170470882|NCT03713632|616062533|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
170470883|NCT03713632|616062534|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
170470884|NCT03713632|616062530|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
170470885|NCT03713632|616062531|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
170470886|NCT03713632|616062532|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
170470887|NCT03713632|616062533|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
170470888|NCT03713632|616062534|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
170470889|NCT03713632|616062530|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
170470890|NCT03713632|616062531|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
170470891|NCT03713632|616062532|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
170470892|NCT03713632|616062533|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
170470893|NCT03713632|616062534|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
170470894|NCT03713632|616062530|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
170470895|NCT03713632|616062531|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
170470896|NCT03713632|616062532|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
170470897|NCT03713632|616062533|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
170470898|NCT03713632|616062534|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
170470899|NCT03713632|616062530|FG000|Treatment Period 2 (After Week 16)|Death|0|||
170470900|NCT03713632|616062531|FG001|Treatment Period 2 (After Week 16)|Death|1|||
170470901|NCT03713632|616062532|FG002|Treatment Period 2 (After Week 16)|Death|0|||
170470902|NCT03713632|616062533|FG003|Treatment Period 2 (After Week 16)|Death|0|||
170470903|NCT03713632|616062534|FG004|Treatment Period 2 (After Week 16)|Death|0|||
170470904|NCT03713632|616062530|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
170470905|NCT03713632|616062531|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
170470906|NCT03713632|616062532|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
170470907|NCT03713632|616062533|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
170470908|NCT03713632|616062534|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
170470909|NCT01524978|616062535|FG000|Overall Study|Other|16|||
170891619|NCT03604445|617609825|FG007|Overall Study|Withdrawal by Subject|0|||
170470910|NCT01524978|616062536|FG001|Overall Study|Other|2|||
170470911|NCT01524978|616062537|FG002|Overall Study|Other|1|||
170470912|NCT01524978|616062538|FG003|Overall Study|Other|2|||
170470913|NCT01524978|616062539|FG004|Overall Study|Other|1|||
170470914|NCT01524978|616062540|FG005|Overall Study|Other|3|||
170470915|NCT01524978|616062541|FG006|Overall Study|Other|17|||
170470916|NCT01524978|616062542|FG007|Overall Study|Other|1|||
170470917|NCT01524978|616062543|FG008|Overall Study|Other|2|||
170470918|NCT01524978|616062544|FG009|Overall Study|Other|2|||
170470919|NCT01524978|616062545|FG010|Overall Study|Other|5|||
170470920|NCT01524978|616062535|FG000|Overall Study|Withdrawal by Subject|12|||
170470921|NCT01524978|616062536|FG001|Overall Study|Withdrawal by Subject|0|||
170470922|NCT01524978|616062537|FG002|Overall Study|Withdrawal by Subject|1|||
170470923|NCT01524978|616062538|FG003|Overall Study|Withdrawal by Subject|1|||
170470924|NCT01524978|616062539|FG004|Overall Study|Withdrawal by Subject|3|||
170470925|NCT01524978|616062540|FG005|Overall Study|Withdrawal by Subject|1|||
170637624|NCT02541604|616684615|FG008|Overall Study|Study Terminated by Sponsor|0|||
170637625|NCT02541604|616684616|FG009|Overall Study|Study Terminated by Sponsor|0|||
170637626|NCT02541604|616684617|FG010|Overall Study|Study Terminated by Sponsor|0|||
170637627|NCT02541604|616684618|FG011|Overall Study|Study Terminated by Sponsor|0|||
170637628|NCT02541604|616684607|FG000|Overall Study|Medical condition may jeopardize safety|0|||
170637629|NCT02541604|616684608|FG001|Overall Study|Medical condition may jeopardize safety|0|||
170637630|NCT02541604|616684609|FG002|Overall Study|Medical condition may jeopardize safety|0|||
170637631|NCT02541604|616684610|FG003|Overall Study|Medical condition may jeopardize safety|0|||
170637632|NCT02541604|616684611|FG004|Overall Study|Medical condition may jeopardize safety|0|||
170637633|NCT02541604|616684612|FG005|Overall Study|Medical condition may jeopardize safety|0|||
170637634|NCT02541604|616684613|FG006|Overall Study|Medical condition may jeopardize safety|0|||
170637635|NCT02541604|616684614|FG007|Overall Study|Medical condition may jeopardize safety|1|||
170637636|NCT02541604|616684615|FG008|Overall Study|Medical condition may jeopardize safety|0|||
170637637|NCT02541604|616684616|FG009|Overall Study|Medical condition may jeopardize safety|0|||
170637638|NCT02541604|616684617|FG010|Overall Study|Medical condition may jeopardize safety|0|||
170637639|NCT02541604|616684618|FG011|Overall Study|Medical condition may jeopardize safety|0|||
170637640|NCT00993148|616684619|FG000|Overall Study|Lost to Follow-up|2|||
170637641|NCT00993148|616684619|FG000|Overall Study|never initiated treatment|1|||
170637642|NCT03848728|616684620|FG000|Overall Study|Death|16|||
170470926|NCT01524978|616062541|FG006|Overall Study|Withdrawal by Subject|6|||
170637643|NCT03848728|616684621|FG001|Overall Study|Death|13|||
170637644|NCT03848728|616684620|FG000|Overall Study|Outmigrated to non-study community|98|||
170637645|NCT03848728|616684621|FG001|Overall Study|Outmigrated to non-study community|106|||
170637646|NCT03848728|616684620|FG000|Overall Study|Transfered to non-study clinic|32|||
170637647|NCT03848728|616684621|FG001|Overall Study|Transfered to non-study clinic|48|||
170637648|NCT03848728|616684620|FG000|Overall Study|Withdrawal by Subject|1|||
170637649|NCT03848728|616684621|FG001|Overall Study|Withdrawal by Subject|0|||
170637650|NCT00630838|616684624|FG000|Overall Study|Death|0|||
170470927|NCT01524978|616062542|FG007|Overall Study|Withdrawal by Subject|2|||
170470928|NCT01524978|616062543|FG008|Overall Study|Withdrawal by Subject|4|||
170637651|NCT00630838|616684625|FG001|Overall Study|Death|1|||
170637652|NCT00630838|616684624|FG000|Overall Study|Lost to Follow-up|0|||
170637653|NCT00630838|616684625|FG001|Overall Study|Lost to Follow-up|1|||
170637654|NCT00928408|616684626|FG000|Overall Study|Other|2|||
170637655|NCT00928408|616684626|FG000|Overall Study|Withdrawal by Subject|4|||
170637656|NCT00928408|616684626|FG000|Overall Study|Death|5|||
170637657|NCT00928408|616684626|FG000|Overall Study|Lost to Follow-up|12|||
170637658|NCT00787644|616684627|FG000|Overall Study|Lost to Follow-up|1|||
170470929|NCT01524978|616062544|FG009|Overall Study|Withdrawal by Subject|0|||
170470930|NCT01524978|616062545|FG010|Overall Study|Withdrawal by Subject|5|||
170470931|NCT01524978|616062535|FG000|Overall Study|Lost to Follow-up|0|||
170470932|NCT01524978|616062536|FG001|Overall Study|Lost to Follow-up|0|||
170470933|NCT01524978|616062537|FG002|Overall Study|Lost to Follow-up|3|||
170470934|NCT01524978|616062538|FG003|Overall Study|Lost to Follow-up|0|||
170470935|NCT01524978|616062539|FG004|Overall Study|Lost to Follow-up|1|||
170470936|NCT01524978|616062540|FG005|Overall Study|Lost to Follow-up|1|||
170470937|NCT01524978|616062541|FG006|Overall Study|Lost to Follow-up|2|||
170470938|NCT01524978|616062542|FG007|Overall Study|Lost to Follow-up|0|||
170470939|NCT01524978|616062543|FG008|Overall Study|Lost to Follow-up|1|||
170470940|NCT01524978|616062544|FG009|Overall Study|Lost to Follow-up|1|||
170470941|NCT01524978|616062545|FG010|Overall Study|Lost to Follow-up|1|||
170470942|NCT01524978|616062535|FG000|Overall Study|Death|34|||
170470943|NCT01524978|616062536|FG001|Overall Study|Death|2|||
170470944|NCT01524978|616062537|FG002|Overall Study|Death|5|||
170470945|NCT01524978|616062538|FG003|Overall Study|Death|24|||
170470946|NCT01524978|616062539|FG004|Overall Study|Death|4|||
170470947|NCT01524978|616062540|FG005|Overall Study|Death|4|||
170470948|NCT01524978|616062541|FG006|Overall Study|Death|1|||
170470949|NCT01524978|616062542|FG007|Overall Study|Death|9|||
170470950|NCT01524978|616062543|FG008|Overall Study|Death|5|||
170470951|NCT01524978|616062544|FG009|Overall Study|Death|6|||
170470952|NCT01524978|616062545|FG010|Overall Study|Death|17|||
170470953|NCT02797171|616062551|FG000|Overall Study|Lost to Follow-up|2|||
170470954|NCT02797171|616062552|FG001|Overall Study|Lost to Follow-up|0|||
170470955|NCT02797171|616062553|FG002|Overall Study|Lost to Follow-up|2|||
170470956|NCT02797171|616062554|FG003|Overall Study|Lost to Follow-up|1|||
170470957|NCT02797171|616062555|FG004|Overall Study|Lost to Follow-up|2|||
170470958|NCT02797171|616062556|FG005|Overall Study|Lost to Follow-up|0|||
170470959|NCT02797171|616062551|FG000|Overall Study|Withdrawal by Subject|1|||
170470960|NCT02797171|616062552|FG001|Overall Study|Withdrawal by Subject|1|||
170470961|NCT02797171|616062553|FG002|Overall Study|Withdrawal by Subject|0|||
170470962|NCT02797171|616062554|FG003|Overall Study|Withdrawal by Subject|0|||
170470963|NCT02797171|616062555|FG004|Overall Study|Withdrawal by Subject|0|||
170470964|NCT02797171|616062556|FG005|Overall Study|Withdrawal by Subject|0|||
170470965|NCT02797171|616062551|FG000|Overall Study|Protocol Violation|1|||
170470966|NCT02797171|616062552|FG001|Overall Study|Protocol Violation|0|||
170470967|NCT02797171|616062553|FG002|Overall Study|Protocol Violation|0|||
170470968|NCT02797171|616062554|FG003|Overall Study|Protocol Violation|0|||
170470969|NCT02797171|616062555|FG004|Overall Study|Protocol Violation|0|||
170637659|NCT00787644|616684628|FG001|Overall Study|Lost to Follow-up|1|||
170637660|NCT00787644|616684627|FG000|Overall Study|Withdrawal by Subject|1|||
170891620|NCT03604445|617609826|FG008|Overall Study|Withdrawal by Subject|0|||
170891621|NCT03604445|617609818|FG000|Overall Study|Missing visit|0|||
170891622|NCT03604445|617609819|FG001|Overall Study|Missing visit|0|||
170891623|NCT03604445|617609820|FG002|Overall Study|Missing visit|0|||
170891624|NCT03604445|617609821|FG003|Overall Study|Missing visit|0|||
170891625|NCT03604445|617609822|FG004|Overall Study|Missing visit|0|||
170891626|NCT03604445|617609823|FG005|Overall Study|Missing visit|1|||
170891627|NCT03604445|617609824|FG006|Overall Study|Missing visit|0|||
170891628|NCT03604445|617609825|FG007|Overall Study|Missing visit|1|||
170470970|NCT02797171|616062556|FG005|Overall Study|Protocol Violation|0|||
170470971|NCT02797171|616062551|FG000|Overall Study|Participant unable to adhere|0|||
170470972|NCT02797171|616062552|FG001|Overall Study|Participant unable to adhere|1|||
170470973|NCT02797171|616062553|FG002|Overall Study|Participant unable to adhere|0|||
170470974|NCT02797171|616062554|FG003|Overall Study|Participant unable to adhere|0|||
170470975|NCT02797171|616062555|FG004|Overall Study|Participant unable to adhere|0|||
170637661|NCT00787644|616684628|FG001|Overall Study|Withdrawal by Subject|1|||
170637662|NCT01108185|616684634|FG000|Overall Study|Non-compliance|15|||
170637663|NCT01108185|616684634|FG000|Overall Study|Lost to Follow-up|12|||
170637664|NCT02581410|616684635|FG000|Vaccination Phase|Adverse Event|2|||
170637665|NCT02581410|616684636|FG001|Vaccination Phase|Adverse Event|1|||
170637666|NCT02581410|616684635|FG000|Vaccination Phase|Withdrawal by Subject|0|||
170891629|NCT03604445|617609826|FG008|Overall Study|Missing visit|0|||
170470976|NCT02797171|616062556|FG005|Overall Study|Participant unable to adhere|0|||
170637667|NCT02581410|616684636|FG001|Vaccination Phase|Withdrawal by Subject|1|||
170470977|NCT02797171|616062551|FG000|Overall Study|Not Randomized|0|||
170470978|NCT02797171|616062552|FG001|Overall Study|Not Randomized|0|||
170470979|NCT02797171|616062553|FG002|Overall Study|Not Randomized|0|||
170470980|NCT02797171|616062554|FG003|Overall Study|Not Randomized|0|||
170470981|NCT02797171|616062555|FG004|Overall Study|Not Randomized|0|||
170470982|NCT02797171|616062556|FG005|Overall Study|Not Randomized|1|||
170470983|NCT02540083|616062557|FG000|Overall Study|Withdrawal by Subject|16|||
170470984|NCT00134901|616062558|FG000|Overall Study|Lost to Follow-up|5|||
170470985|NCT00134901|616062559|FG001|Overall Study|Lost to Follow-up|5|||
170470986|NCT00134901|616062558|FG000|Overall Study|discontinued intervention|12|||
170470987|NCT00134901|616062559|FG001|Overall Study|discontinued intervention|10|||
170470988|NCT00185588|616062560|FG000|Overall Study|Adverse Event|3|||
170470989|NCT00185588|616062561|FG001|Overall Study|Adverse Event|1|||
170470990|NCT00185588|616062562|FG002|Overall Study|Adverse Event|4|||
170470991|NCT00185588|616062563|FG003|Overall Study|Adverse Event|2|||
170470992|NCT00185588|616062560|FG000|Overall Study|Lost to Follow-up|0|||
170470993|NCT00185588|616062561|FG001|Overall Study|Lost to Follow-up|0|||
170470994|NCT00185588|616062562|FG002|Overall Study|Lost to Follow-up|1|||
170470995|NCT00185588|616062563|FG003|Overall Study|Lost to Follow-up|2|||
170470996|NCT00185588|616062560|FG000|Overall Study|Withdrawal by Subject|0|||
170470997|NCT00185588|616062561|FG001|Overall Study|Withdrawal by Subject|1|||
170470998|NCT00185588|616062562|FG002|Overall Study|Withdrawal by Subject|0|||
170470999|NCT00185588|616062563|FG003|Overall Study|Withdrawal by Subject|0|||
170471000|NCT00185588|616062560|FG000|Overall Study|Physician Decision|0|||
170637668|NCT02581410|616684635|FG000|Vaccination Phase|Migrated/moved from study area|0|||
170637669|NCT02581410|616684636|FG001|Vaccination Phase|Migrated/moved from study area|1|||
170637670|NCT02581410|616684635|FG000|End of Study Phase|Adverse Event|4|||
170471001|NCT00185588|616062561|FG001|Overall Study|Physician Decision|0|||
170471002|NCT00185588|616062562|FG002|Overall Study|Physician Decision|1|||
170471003|NCT00185588|616062563|FG003|Overall Study|Physician Decision|0|||
170471004|NCT00398866|616062564|FG000|Overall Study|Adverse Event|1|||
170471005|NCT00398866|616062565|FG001|Overall Study|Adverse Event|0|||
170471006|NCT00398866|616062566|FG002|Overall Study|Adverse Event|0|||
170471007|NCT00398866|616062564|FG000|Overall Study|Lack of Efficacy|0|||
170471008|NCT00398866|616062565|FG001|Overall Study|Lack of Efficacy|0|||
170471009|NCT00398866|616062566|FG002|Overall Study|Lack of Efficacy|1|||
170471010|NCT00398866|616062564|FG000|Overall Study|Lost to Follow-up|7|||
170471011|NCT00398866|616062565|FG001|Overall Study|Lost to Follow-up|6|||
170471012|NCT00398866|616062566|FG002|Overall Study|Lost to Follow-up|4|||
170471013|NCT00398866|616062564|FG000|Overall Study|Withdrawal by Subject|5|||
170471014|NCT00398866|616062565|FG001|Overall Study|Withdrawal by Subject|1|||
170471015|NCT00398866|616062566|FG002|Overall Study|Withdrawal by Subject|2|||
170471016|NCT00398866|616062564|FG000|Overall Study|Unable to complete requirements of study|1|||
170471017|NCT00398866|616062565|FG001|Overall Study|Unable to complete requirements of study|1|||
170471018|NCT00398866|616062566|FG002|Overall Study|Unable to complete requirements of study|1|||
170471019|NCT03908437|616062569|FG000|Overall Study|Death|0|||
170471020|NCT03908437|616062570|FG001|Overall Study|Death|1|||
170471021|NCT03908437|616062569|FG000|Overall Study|Lost to Follow-up|31|||
170471022|NCT03908437|616062570|FG001|Overall Study|Lost to Follow-up|24|||
170471023|NCT03971474|616062574|FG000|Overall Study|Adverse Event|11|||
170471024|NCT03971474|616062575|FG001|Overall Study|Adverse Event|7|||
170471025|NCT03971474|616062574|FG000|Overall Study|Refusal unrelated to adverse event|5|||
170471026|NCT03971474|616062575|FG001|Overall Study|Refusal unrelated to adverse event|1|||
170471027|NCT03971474|616062574|FG000|Overall Study|Progression/relapse|40|||
170637671|NCT02581410|616684636|FG001|End of Study Phase|Adverse Event|3|||
170471028|NCT03971474|616062575|FG001|Overall Study|Progression/relapse|47|||
170471029|NCT03971474|616062574|FG000|Overall Study|Death|6|||
170471030|NCT03971474|616062575|FG001|Overall Study|Death|3|||
170471031|NCT03971474|616062574|FG000|Overall Study|Other - not protocol specified|5|||
170471032|NCT03971474|616062575|FG001|Overall Study|Other - not protocol specified|4|||
170637672|NCT02581410|616684635|FG000|End of Study Phase|Withdrawal by Subject|1|||
170637673|NCT02581410|616684636|FG001|End of Study Phase|Withdrawal by Subject|2|||
170637674|NCT02581410|616684635|FG000|End of Study Phase|Migrated/moved from study area|0|||
170471033|NCT03971474|616062574|FG000|Overall Study|On treatment|0|||
170471034|NCT03971474|616062575|FG001|Overall Study|On treatment|7|||
170471035|NCT01023035|616062577|FG000|Treatment Period|Adverse Event|27|||
170471036|NCT01023035|616062578|FG001|Treatment Period|Adverse Event|32|||
170471037|NCT01023035|616062579|FG002|Treatment Period|Adverse Event|50|||
170471038|NCT01023035|616062577|FG000|Treatment Period|Non-Medical Reasons|19|||
170471039|NCT01023035|616062578|FG001|Treatment Period|Non-Medical Reasons|22|||
170471040|NCT01023035|616062579|FG002|Treatment Period|Non-Medical Reasons|44|||
170471041|NCT01023035|616062577|FG000|Treatment Period|Treatment Failure|26|||
170637675|NCT02581410|616684636|FG001|End of Study Phase|Migrated/moved from study area|3|||
170637676|NCT02581410|616684635|FG000|End of Study Phase|Lost to Follow-up|0|||
170637677|NCT02581410|616684636|FG001|End of Study Phase|Lost to Follow-up|2|||
170637678|NCT02581410|616684635|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
170471042|NCT01023035|616062578|FG001|Treatment Period|Treatment Failure|31|||
170471043|NCT01023035|616062579|FG002|Treatment Period|Treatment Failure|24|||
170471044|NCT01023035|616062577|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
170471045|NCT01023035|616062578|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
170471046|NCT01023035|616062579|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
170471047|NCT01023035|616062577|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
170471048|NCT01023035|616062578|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
170471049|NCT01023035|616062579|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
170471050|NCT01699815|616062581|FG000|Overall Study|Protocol Violation|4|||
170471051|NCT01699815|616062582|FG001|Overall Study|Protocol Violation|7|||
170471052|NCT01699815|616062581|FG000|Overall Study|record could not be located|1|||
170471053|NCT01699815|616062582|FG001|Overall Study|record could not be located|0|||
170471054|NCT01699815|616062581|FG000|Overall Study|Adverse Event|0|||
170471055|NCT01699815|616062582|FG001|Overall Study|Adverse Event|1|||
170471056|NCT01295320|616062583|FG000|Overall Study|Adverse Event|2|||
170471057|NCT01295320|616062583|FG000|Overall Study|Lost to Follow-up|4|||
170471058|NCT01295320|616062583|FG000|Overall Study|Withdrawal by Subject|2|||
170471059|NCT01295320|616062583|FG000|Overall Study|Subject was bedridden|1|||
170471060|NCT01295320|616062583|FG000|Overall Study|Unable to travel|1|||
170471061|NCT00699816|616062586|FG000|Overall Study|Protocol Violation|1|||
170471062|NCT00699816|616062587|FG001|Overall Study|Protocol Violation|3|||
170471063|NCT03489109|616062589|FG000|Overall Study|Lost to Follow-up|1|||
170471064|NCT03489109|616062590|FG001|Overall Study|Lost to Follow-up|2|||
170471065|NCT02552732|616062591|FG000|Overall Study|Lost to Follow-up|2|||
170471066|NCT02552732|616062591|FG000|Overall Study|Physician Decision|1|||
170471067|NCT02552732|616062591|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
170471068|NCT02552732|616062591|FG000|Overall Study|Withdrawal by Subject|6|||
170471069|NCT05061420|616062592|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
170471070|NCT05061420|616062593|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
170471071|NCT05061420|616062594|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
170471072|NCT05061420|616062592|FG000|Overall Study|Progressive disease|11|||
170471073|NCT05061420|616062593|FG001|Overall Study|Progressive disease|15|||
170471074|NCT05061420|616062594|FG002|Overall Study|Progressive disease|14|||
170471075|NCT05061420|616062592|FG000|Overall Study|Withdrawal by Subject|2|||
170471076|NCT05061420|616062593|FG001|Overall Study|Withdrawal by Subject|0|||
170471077|NCT05061420|616062594|FG002|Overall Study|Withdrawal by Subject|1|||
170471078|NCT05061420|616062592|FG000|Overall Study|Not related to COVID-19|2|||
170471079|NCT05061420|616062593|FG001|Overall Study|Not related to COVID-19|0|||
170471080|NCT05061420|616062594|FG002|Overall Study|Not related to COVID-19|0|||
170471081|NCT01547130|616062595|FG000|Overall Study|Lost to Follow-up|9|||
170471082|NCT01547130|616062596|FG001|Overall Study|Lost to Follow-up|5|||
170471083|NCT00025259|616062598|FG000|Overall Study|Death|1|||
170471084|NCT00025259|616062599|FG001|Overall Study|Death|3|||
170471085|NCT00025259|616062600|FG002|Overall Study|Death|0|||
170471086|NCT00025259|616062601|FG003|Overall Study|Death|3|||
170471087|NCT00025259|616062602|FG004|Overall Study|Death|0|||
170471088|NCT00025259|616062603|FG005|Overall Study|Death|1|||
170471089|NCT00025259|616062604|FG006|Overall Study|Death|2|||
170471090|NCT00025259|616062598|FG000|Overall Study|Lack of Efficacy|2|||
170471091|NCT00025259|616062599|FG001|Overall Study|Lack of Efficacy|46|||
170471092|NCT00025259|616062600|FG002|Overall Study|Lack of Efficacy|60|||
170471093|NCT00025259|616062601|FG003|Overall Study|Lack of Efficacy|78|||
170471094|NCT00025259|616062602|FG004|Overall Study|Lack of Efficacy|11|||
170471095|NCT00025259|616062603|FG005|Overall Study|Lack of Efficacy|30|||
170471096|NCT00025259|616062604|FG006|Overall Study|Lack of Efficacy|38|||
170471097|NCT00025259|616062598|FG000|Overall Study|Lost to Follow-up|2|||
170471098|NCT00025259|616062599|FG001|Overall Study|Lost to Follow-up|9|||
170471099|NCT00025259|616062600|FG002|Overall Study|Lost to Follow-up|13|||
170471100|NCT00025259|616062601|FG003|Overall Study|Lost to Follow-up|13|||
170791450|NCT03560609|617247887|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
170791451|NCT04195698|617247888|FG000|Overall Study|Adverse Event|4|||
170791452|NCT04195698|617247889|FG001|Overall Study|Adverse Event|11|||
170791453|NCT04195698|617247888|FG000|Overall Study|Withdrawal by Subject|9|||
170791454|NCT04195698|617247889|FG001|Overall Study|Withdrawal by Subject|10|||
170791455|NCT04195698|617247888|FG000|Overall Study|Lost to Follow-up|5|||
170791456|NCT04195698|617247889|FG001|Overall Study|Lost to Follow-up|4|||
170471101|NCT00025259|616062602|FG004|Overall Study|Lost to Follow-up|1|||
170791457|NCT04195698|617247888|FG000|Overall Study|Lack of Efficacy|2|||
170791458|NCT04195698|617247889|FG001|Overall Study|Lack of Efficacy|10|||
170791459|NCT04195698|617247888|FG000|Overall Study|Other|5|||
170471102|NCT00025259|616062603|FG005|Overall Study|Lost to Follow-up|3|||
170471103|NCT00025259|616062604|FG006|Overall Study|Lost to Follow-up|1|||
170471104|NCT00025259|616062598|FG000|Overall Study|Physician Decision|12|||
170471105|NCT00025259|616062599|FG001|Overall Study|Physician Decision|1|||
170471106|NCT00025259|616062600|FG002|Overall Study|Physician Decision|0|||
170471107|NCT00025259|616062601|FG003|Overall Study|Physician Decision|5|||
170471108|NCT00025259|616062602|FG004|Overall Study|Physician Decision|4|||
170471109|NCT00025259|616062603|FG005|Overall Study|Physician Decision|2|||
170471110|NCT00025259|616062604|FG006|Overall Study|Physician Decision|1|||
170471111|NCT00025259|616062598|FG000|Overall Study|Protocol Violation|3|||
170471112|NCT00025259|616062599|FG001|Overall Study|Protocol Violation|2|||
170471113|NCT00025259|616062600|FG002|Overall Study|Protocol Violation|2|||
170471114|NCT00025259|616062601|FG003|Overall Study|Protocol Violation|1|||
170471115|NCT00025259|616062602|FG004|Overall Study|Protocol Violation|2|||
170471116|NCT00025259|616062603|FG005|Overall Study|Protocol Violation|1|||
170471117|NCT00025259|616062604|FG006|Overall Study|Protocol Violation|3|||
170471118|NCT00025259|616062598|FG000|Overall Study|Withdrawal by Subject|9|||
170471119|NCT00025259|616062599|FG001|Overall Study|Withdrawal by Subject|27|||
170471120|NCT00025259|616062600|FG002|Overall Study|Withdrawal by Subject|6|||
170471121|NCT00025259|616062601|FG003|Overall Study|Withdrawal by Subject|14|||
170471122|NCT00025259|616062602|FG004|Overall Study|Withdrawal by Subject|11|||
170471123|NCT00025259|616062603|FG005|Overall Study|Withdrawal by Subject|8|||
170471124|NCT00025259|616062604|FG006|Overall Study|Withdrawal by Subject|3|||
170471125|NCT00025259|616062598|FG000|Overall Study|Ineligible|14|||
170471126|NCT00025259|616062599|FG001|Overall Study|Ineligible|1|||
170471127|NCT00025259|616062600|FG002|Overall Study|Ineligible|0|||
170471128|NCT00025259|616062601|FG003|Overall Study|Ineligible|0|||
170471129|NCT00025259|616062602|FG004|Overall Study|Ineligible|6|||
170471130|NCT00025259|616062603|FG005|Overall Study|Ineligible|0|||
170471131|NCT00025259|616062604|FG006|Overall Study|Ineligible|1|||
170471132|NCT00025259|616062598|FG000|Overall Study|Randomization error|1|||
170471133|NCT00025259|616062599|FG001|Overall Study|Randomization error|0|||
170471134|NCT00025259|616062600|FG002|Overall Study|Randomization error|0|||
170471135|NCT00025259|616062601|FG003|Overall Study|Randomization error|0|||
170471136|NCT00025259|616062602|FG004|Overall Study|Randomization error|1|||
170471137|NCT00025259|616062603|FG005|Overall Study|Randomization error|7|||
170471138|NCT00025259|616062604|FG006|Overall Study|Randomization error|2|||
170471139|NCT00025259|616062598|FG000|Overall Study|Adverse Event|1|||
170471140|NCT00025259|616062599|FG001|Overall Study|Adverse Event|0|||
170471141|NCT00025259|616062600|FG002|Overall Study|Adverse Event|0|||
170471142|NCT00025259|616062601|FG003|Overall Study|Adverse Event|0|||
170471143|NCT00025259|616062602|FG004|Overall Study|Adverse Event|0|||
170471144|NCT00025259|616062603|FG005|Overall Study|Adverse Event|0|||
170471145|NCT00025259|616062604|FG006|Overall Study|Adverse Event|0|||
170791460|NCT04195698|617247889|FG001|Overall Study|Other|4|||
170791461|NCT00433329|617247890|FG000|Overall Study|Adverse Event|9|||
170471146|NCT00710866|616062608|FG000|Overall Study|Protocol Violation|5|||
170791462|NCT00433329|617247890|FG000|Overall Study|Death|4|||
170791463|NCT00433329|617247890|FG000|Overall Study|Withdrew consent|3|||
170791464|NCT00433329|617247890|FG000|Overall Study|Discontinued sildenafil|2|||
170791465|NCT00433329|617247890|FG000|Overall Study|Moved out of state|1|||
170791466|NCT00433329|617247890|FG000|Overall Study|Lost to Follow-up|1|||
170791467|NCT00433329|617247890|FG000|Overall Study|Physician Decision|1|||
170791468|NCT01129102|617247891|FG000|Overall Study|No study drug treatment|2|||
170791469|NCT01129102|617247892|FG001|Overall Study|No study drug treatment|3|||
170791470|NCT01129102|617247893|FG002|Overall Study|No study drug treatment|1|||
170791471|NCT01129102|617247891|FG000|Overall Study|Withdrawal by Subject|2|||
170791472|NCT01129102|617247892|FG001|Overall Study|Withdrawal by Subject|0|||
170791473|NCT01129102|617247893|FG002|Overall Study|Withdrawal by Subject|3|||
170791474|NCT01129102|617247891|FG000|Overall Study|Protocol Violation|0|||
170791475|NCT01129102|617247892|FG001|Overall Study|Protocol Violation|1|||
170791476|NCT01129102|617247893|FG002|Overall Study|Protocol Violation|1|||
170791477|NCT01129102|617247891|FG000|Overall Study|Pregnancy|0|||
170791478|NCT01129102|617247892|FG001|Overall Study|Pregnancy|0|||
170791479|NCT01129102|617247893|FG002|Overall Study|Pregnancy|1|||
170791480|NCT01129102|617247891|FG000|Overall Study|Adverse Event|2|||
170791481|NCT01129102|617247892|FG001|Overall Study|Adverse Event|2|||
170791482|NCT01129102|617247893|FG002|Overall Study|Adverse Event|1|||
170791483|NCT01129102|617247891|FG000|Overall Study|Lost to Follow-up|2|||
170791484|NCT01129102|617247892|FG001|Overall Study|Lost to Follow-up|0|||
170791485|NCT01129102|617247893|FG002|Overall Study|Lost to Follow-up|0|||
170791486|NCT03379675|617247894|FG000|Overall Study|Lost to Follow-up|0|||
170471147|NCT00710866|616062609|FG001|Overall Study|Protocol Violation|4|||
170471148|NCT00710866|616062608|FG000|Overall Study|Withdrawal by Subject|2|||
170471149|NCT00710866|616062609|FG001|Overall Study|Withdrawal by Subject|1|||
170471150|NCT00710866|616062608|FG000|Overall Study|Lost to Follow-up|1|||
170471151|NCT00710866|616062609|FG001|Overall Study|Lost to Follow-up|0|||
170791487|NCT03379675|617247895|FG001|Overall Study|Lost to Follow-up|1|||
170791488|NCT03379675|617247896|FG002|Overall Study|Lost to Follow-up|0|||
170791489|NCT03379675|617247894|FG000|Overall Study|Adverse Event|2|||
170791490|NCT03379675|617247895|FG001|Overall Study|Adverse Event|0|||
170791491|NCT03379675|617247896|FG002|Overall Study|Adverse Event|0|||
170471152|NCT00710866|616062608|FG000|Overall Study|Failed to meet eligibility|1|||
170471153|NCT00710866|616062609|FG001|Overall Study|Failed to meet eligibility|1|||
170471154|NCT03138655|616062611|FG000|Overall Study|Adverse Event|2|||
170471155|NCT03138655|616062612|FG001|Overall Study|Adverse Event|1|||
170791492|NCT03379675|617247894|FG000|Overall Study|Withdrawal by Subject|2|||
170791493|NCT03379675|617247895|FG001|Overall Study|Withdrawal by Subject|1|||
170471156|NCT03138655|616062613|FG002|Overall Study|Adverse Event|2|||
170471157|NCT03138655|616062614|FG003|Overall Study|Adverse Event|1|||
170471158|NCT03138655|616062615|FG004|Overall Study|Adverse Event|1|||
170471159|NCT03138655|616062616|FG005|Overall Study|Adverse Event|4|||
170471160|NCT03138655|616062617|FG006|Overall Study|Adverse Event|2|||
170471161|NCT03138655|616062618|FG007|Overall Study|Adverse Event|2|||
170471162|NCT03138655|616062611|FG000|Overall Study|Withdrawal by Subject|0|||
170471163|NCT03138655|616062612|FG001|Overall Study|Withdrawal by Subject|1|||
170471164|NCT03138655|616062613|FG002|Overall Study|Withdrawal by Subject|0|||
170471165|NCT03138655|616062614|FG003|Overall Study|Withdrawal by Subject|0|||
170471166|NCT03138655|616062615|FG004|Overall Study|Withdrawal by Subject|0|||
170471167|NCT03138655|616062616|FG005|Overall Study|Withdrawal by Subject|0|||
170471168|NCT03138655|616062617|FG006|Overall Study|Withdrawal by Subject|1|||
170471169|NCT03138655|616062618|FG007|Overall Study|Withdrawal by Subject|0|||
170471170|NCT03138655|616062611|FG000|Overall Study|Reason not Specified|1|||
170471171|NCT03138655|616062612|FG001|Overall Study|Reason not Specified|0|||
170471172|NCT03138655|616062613|FG002|Overall Study|Reason not Specified|0|||
170471173|NCT03138655|616062614|FG003|Overall Study|Reason not Specified|2|||
170471174|NCT03138655|616062615|FG004|Overall Study|Reason not Specified|1|||
170471175|NCT03138655|616062616|FG005|Overall Study|Reason not Specified|1|||
170471176|NCT03138655|616062617|FG006|Overall Study|Reason not Specified|0|||
170471177|NCT03138655|616062618|FG007|Overall Study|Reason not Specified|0|||
170471178|NCT02996487|616062621|FG000|Overall Study|Lost to Follow-up|1|||
170471179|NCT02996487|616062622|FG001|Overall Study|Lost to Follow-up|1|||
170471180|NCT02996487|616062623|FG002|Overall Study|Lost to Follow-up|0|||
170471181|NCT02996487|616062621|FG000|Overall Study|Death|0|||
170471182|NCT02996487|616062622|FG001|Overall Study|Death|1|||
170471183|NCT02996487|616062623|FG002|Overall Study|Death|0|||
170471184|NCT02996487|616062621|FG000|Overall Study|Withdrawal by Subject|2|||
170471185|NCT02996487|616062622|FG001|Overall Study|Withdrawal by Subject|3|||
170471186|NCT02996487|616062623|FG002|Overall Study|Withdrawal by Subject|0|||
170471187|NCT02027428|616062624|FG000|Induction|Never treated|7|||
170471188|NCT02027428|616062625|FG001|Induction|Never treated|0|||
170471189|NCT02027428|616062626|FG002|Induction|Never treated|0|||
170471190|NCT02027428|616062624|FG000|Induction|Progressive disease|77|||
170471191|NCT02027428|616062625|FG001|Induction|Progressive disease|0|||
170471192|NCT02027428|616062626|FG002|Induction|Progressive disease|0|||
170471193|NCT02027428|616062624|FG000|Induction|Adverse Event|51|||
170471194|NCT02027428|616062625|FG001|Induction|Adverse Event|0|||
170471195|NCT02027428|616062626|FG002|Induction|Adverse Event|0|||
170471196|NCT02027428|616062624|FG000|Induction|Withdrawal by Subject|22|||
170471197|NCT02027428|616062625|FG001|Induction|Withdrawal by Subject|0|||
170471198|NCT02027428|616062626|FG002|Induction|Withdrawal by Subject|0|||
170471199|NCT02027428|616062624|FG000|Induction|Death|21|||
170471200|NCT02027428|616062625|FG001|Induction|Death|0|||
170471201|NCT02027428|616062626|FG002|Induction|Death|0|||
170471202|NCT02027428|616062624|FG000|Induction|Symptomatic deterioration|16|||
170471203|NCT02027428|616062625|FG001|Induction|Symptomatic deterioration|0|||
170637679|NCT02581410|616684636|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
170471204|NCT02027428|616062626|FG002|Induction|Symptomatic deterioration|0|||
170471205|NCT02027428|616062624|FG000|Induction|Study terminated by sponsor|12|||
170471206|NCT02027428|616062625|FG001|Induction|Study terminated by sponsor|0|||
170471207|NCT02027428|616062626|FG002|Induction|Study terminated by sponsor|0|||
170471208|NCT02027428|616062624|FG000|Induction|Protocol Violation|1|||
170471209|NCT02027428|616062625|FG001|Induction|Protocol Violation|0|||
170471210|NCT02027428|616062626|FG002|Induction|Protocol Violation|0|||
170637680|NCT02840461|616684642|FG000|Overall Study|Adverse Event|1|||
170637681|NCT02840461|616684643|FG001|Overall Study|Adverse Event|5|||
170637682|NCT02840461|616684644|FG002|Overall Study|Adverse Event|3|||
170637683|NCT02840461|616684642|FG000|Overall Study|Lost to Follow-up|10|||
170637684|NCT02840461|616684643|FG001|Overall Study|Lost to Follow-up|7|||
170637685|NCT02840461|616684644|FG002|Overall Study|Lost to Follow-up|6|||
170637686|NCT02840461|616684642|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
170471211|NCT02027428|616062624|FG000|Induction|Miscellaneous|14|||
170471212|NCT02027428|616062625|FG001|Induction|Miscellaneous|0|||
170471213|NCT02027428|616062626|FG002|Induction|Miscellaneous|0|||
170471214|NCT02027428|616062624|FG000|Induction|Induction Treatment Ongoing|4|||
170471215|NCT02027428|616062625|FG001|Induction|Induction Treatment Ongoing|0|||
170471216|NCT02027428|616062626|FG002|Induction|Induction Treatment Ongoing|0|||
170471217|NCT02027428|616062624|FG000|Maintenance|Death|0|||
170471218|NCT02027428|616062625|FG001|Maintenance|Death|3|||
170471219|NCT02027428|616062626|FG002|Maintenance|Death|2|||
170471220|NCT02027428|616062624|FG000|Maintenance|Adverse Event|0|||
170471221|NCT02027428|616062625|FG001|Maintenance|Adverse Event|21|||
170471222|NCT02027428|616062626|FG002|Maintenance|Adverse Event|1|||
170471223|NCT02027428|616062624|FG000|Maintenance|Progressive disease|0|||
170471224|NCT02027428|616062625|FG001|Maintenance|Progressive disease|84|||
170471225|NCT02027428|616062626|FG002|Maintenance|Progressive disease|47|||
170637687|NCT02840461|616684643|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
170637688|NCT02840461|616684644|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
170471226|NCT02027428|616062624|FG000|Maintenance|Symptomatic deterioration|0|||
170471227|NCT02027428|616062625|FG001|Maintenance|Symptomatic deterioration|4|||
170471228|NCT02027428|616062626|FG002|Maintenance|Symptomatic deterioration|1|||
170471229|NCT02027428|616062624|FG000|Maintenance|Withdrawal by Subject|0|||
170471230|NCT02027428|616062625|FG001|Maintenance|Withdrawal by Subject|6|||
170471231|NCT02027428|616062626|FG002|Maintenance|Withdrawal by Subject|5|||
170471232|NCT02027428|616062624|FG000|Maintenance|Protocol Violation|0|||
170471233|NCT02027428|616062625|FG001|Maintenance|Protocol Violation|0|||
170471234|NCT02027428|616062626|FG002|Maintenance|Protocol Violation|1|||
170471235|NCT02027428|616062624|FG000|Maintenance|Other|0|||
170471236|NCT02027428|616062625|FG001|Maintenance|Other|6|||
170471237|NCT02027428|616062626|FG002|Maintenance|Other|3|||
170471238|NCT02027428|616062624|FG000|Survival Follow-up|Death|0|||
170471239|NCT02027428|616062625|FG001|Survival Follow-up|Death|78|||
170471240|NCT02027428|616062626|FG002|Survival Follow-up|Death|45|||
170471241|NCT02027428|616062624|FG000|Survival Follow-up|Lost to Follow-up|0|||
170471242|NCT02027428|616062625|FG001|Survival Follow-up|Lost to Follow-up|1|||
170471243|NCT02027428|616062626|FG002|Survival Follow-up|Lost to Follow-up|1|||
170471244|NCT02859142|616062627|FG000|Overall Study|Adverse Event|1|||
170471245|NCT02859142|616062628|FG001|Overall Study|Adverse Event|2|||
170471246|NCT02859142|616062627|FG000|Overall Study|Lost to Follow-up|1|||
170471247|NCT02859142|616062628|FG001|Overall Study|Lost to Follow-up|4|||
170471248|NCT02859142|616062627|FG000|Overall Study|Withdrawal by Subject|2|||
170471249|NCT02859142|616062628|FG001|Overall Study|Withdrawal by Subject|0|||
170471250|NCT02859142|616062627|FG000|Overall Study|Scheduling difficulties|0|||
170471251|NCT02859142|616062628|FG001|Overall Study|Scheduling difficulties|3|||
170471252|NCT01128543|616062629|FG000|Overall Study|Withdrawal by Subject|3|||
170471253|NCT01128543|616062629|FG000|Overall Study|Protocol Violation|1|||
170471254|NCT03340974|616062630|FG000|Completion of Study -Long Term Follow up|Death|8|||
170471255|NCT03340974|616062631|FG001|Completion of Study -Long Term Follow up|Death|5|||
170471256|NCT03340974|616062632|FG002|Completion of Study -Long Term Follow up|Death|5|||
170471257|NCT03340974|616062633|FG003|Completion of Study -Long Term Follow up|Death|7|||
170471258|NCT03340974|616062630|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
170471259|NCT03340974|616062631|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
170471260|NCT03340974|616062632|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
170471261|NCT03340974|616062633|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
170471262|NCT03340974|616062630|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
170471263|NCT03340974|616062631|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
170471264|NCT03340974|616062632|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
170791494|NCT03379675|617247896|FG002|Overall Study|Withdrawal by Subject|2|||
170791495|NCT02817776|617247897|FG000|Overall Study|Excluded|33|||
170791496|NCT02817776|617247897|FG000|Overall Study|Lost to Follow-up|20|||
170791497|NCT02817776|617247897|FG000|Overall Study|Withdrawal by Subject|33|||
170791498|NCT02817776|617247897|FG000|Overall Study|Death|2|||
170791499|NCT02675751|617247898|FG000|Overall Study|Lost to Follow-up|16|||
170791500|NCT02359890|617247899|FG000|Overall Study|Not meeting eligibility|4|||
170791501|NCT02359890|617247899|FG000|Overall Study|Never treated with study catheter|6|||
170791502|NCT05256017|617247900|FG000|Treatment Period|Withdrawal by Subject|1|||
170791503|NCT05256017|617247901|FG001|Treatment Period|Withdrawal by Subject|1|||
170791504|NCT05256017|617247900|FG000|Follow-up|Lost to Follow-up|7|||
170791505|NCT05256017|617247901|FG001|Follow-up|Lost to Follow-up|1|||
170791506|NCT05256017|617247900|FG000|Follow-up|Withdrawal by Subject|1|||
170791507|NCT05256017|617247901|FG001|Follow-up|Withdrawal by Subject|0|||
170791508|NCT05256017|617247900|FG000|Follow-up|Death|0|||
170791509|NCT05256017|617247901|FG001|Follow-up|Death|1|||
170791510|NCT02442349|617247902|FG000|Overall Study|Death|95|||
170791511|NCT02442349|617247902|FG000|Overall Study|Withdrawal by Subject|27|||
170791512|NCT02442349|617247902|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
170791513|NCT02442349|617247902|FG000|Overall Study|Lost to Follow-up|1|||
170791514|NCT03854227|617247905|FG000|Overall Study|Adverse Event|0|||
170791515|NCT03854227|617247906|FG001|Overall Study|Adverse Event|0|||
170791516|NCT03854227|617247907|FG002|Overall Study|Adverse Event|0|||
170791517|NCT03854227|617247908|FG003|Overall Study|Adverse Event|1|||
170791518|NCT03854227|617247909|FG004|Overall Study|Adverse Event|0|||
170791519|NCT03854227|617247910|FG005|Overall Study|Adverse Event|0|||
170791520|NCT03854227|617247911|FG006|Overall Study|Adverse Event|1|||
170471265|NCT03340974|616062633|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
170471266|NCT03340974|616062630|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
170471267|NCT03340974|616062631|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
170471268|NCT03340974|616062632|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
170471269|NCT03340974|616062633|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
170791521|NCT03854227|617247912|FG007|Overall Study|Adverse Event|0|||
170791522|NCT03854227|617247913|FG008|Overall Study|Adverse Event|0|||
170791523|NCT03854227|617247914|FG009|Overall Study|Adverse Event|3|||
170791524|NCT03854227|617247915|FG010|Overall Study|Adverse Event|0|||
170791525|NCT03854227|617247916|FG011|Overall Study|Adverse Event|1|||
170791526|NCT03854227|617247905|FG000|Overall Study|Death|0|||
170471270|NCT00490841|616062642|FG000|Overall Study|Death|5|||
170471271|NCT00490841|616062642|FG000|Overall Study|Withdrawal by Subject|4|||
170471272|NCT00490841|616062642|FG000|Overall Study|Lost to Follow-up|1|||
170471273|NCT00490841|616062642|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
170471274|NCT04123561|616062648|FG000|Overall Study|Lost to Follow-up|20|||
170471275|NCT04123561|616062649|FG001|Overall Study|Lost to Follow-up|12|||
170471276|NCT04123561|616062650|FG002|Overall Study|Lost to Follow-up|5|||
170471277|NCT04123561|616062648|FG000|Overall Study|Withdrawal by Subject|9|||
170471278|NCT04123561|616062649|FG001|Overall Study|Withdrawal by Subject|7|||
170471279|NCT04123561|616062650|FG002|Overall Study|Withdrawal by Subject|9|||
170471280|NCT04123561|616062648|FG000|Overall Study|Lack of Efficacy|7|||
170471281|NCT04123561|616062649|FG001|Overall Study|Lack of Efficacy|8|||
170471282|NCT04123561|616062650|FG002|Overall Study|Lack of Efficacy|6|||
170471283|NCT04123561|616062648|FG000|Overall Study|Adverse Event|5|||
170471284|NCT04123561|616062649|FG001|Overall Study|Adverse Event|2|||
170471285|NCT04123561|616062650|FG002|Overall Study|Adverse Event|3|||
170471286|NCT04123561|616062648|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
170471287|NCT04123561|616062649|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
170471288|NCT04123561|616062650|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
170471289|NCT04123561|616062648|FG000|Overall Study|Death|0|||
170471290|NCT04123561|616062649|FG001|Overall Study|Death|0|||
170471291|NCT04123561|616062650|FG002|Overall Study|Death|1|||
170471292|NCT04123561|616062648|FG000|Overall Study|Protocol Violation|0|||
170471293|NCT04123561|616062649|FG001|Overall Study|Protocol Violation|1|||
170471294|NCT04123561|616062650|FG002|Overall Study|Protocol Violation|0|||
170471295|NCT02521376|616062651|FG000|Overall Study|Enrolled, But Not Treated|1|||
170471296|NCT02521376|616062652|FG001|Overall Study|Enrolled, But Not Treated|0|||
170471297|NCT02521376|616062653|FG002|Overall Study|Enrolled, But Not Treated|0|||
170471298|NCT02521376|616062654|FG003|Overall Study|Enrolled, But Not Treated|0|||
170471299|NCT01374269|616062656|FG000|Overall Study|Withdrawal by Subject|4|||
170471300|NCT01374269|616062657|FG001|Overall Study|Withdrawal by Subject|0|||
170471301|NCT01374269|616062656|FG000|Overall Study|Lost to Follow-up|1|||
170471302|NCT01374269|616062657|FG001|Overall Study|Lost to Follow-up|3|||
170471303|NCT01374269|616062656|FG000|Overall Study|closed research|1|||
170471304|NCT01374269|616062657|FG001|Overall Study|closed research|2|||
170471305|NCT04803305|616062662|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
170471306|NCT04803305|616062663|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
170471307|NCT04803305|616062662|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
170471308|NCT04803305|616062663|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
170471309|NCT04803305|616062662|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
170471310|NCT04803305|616062663|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
170471311|NCT04803305|616062662|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
170471312|NCT04803305|616062663|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
170471313|NCT04803305|616062662|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
170471314|NCT04803305|616062663|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
170471315|NCT04803305|616062662|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
170471316|NCT04803305|616062663|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
170471317|NCT04803305|616062662|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
170471318|NCT04803305|616062663|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
170471319|NCT04803305|616062662|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
170471320|NCT04803305|616062663|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
170471321|NCT01243775|616062664|FG000|Overall Study|Withdrawal by Subject|2|||
170471322|NCT05026177|616065103|FG000|Overall Study|Adverse Event|33|||
170471323|NCT05026177|616065104|FG001|Overall Study|Adverse Event|33|||
170471324|NCT05026177|616065105|FG002|Overall Study|Adverse Event|17|||
170637689|NCT02840461|616684642|FG000|Overall Study|Protocol Violation|2|||
170637690|NCT02840461|616684643|FG001|Overall Study|Protocol Violation|3|||
170471325|NCT05026177|616065103|FG000|Overall Study|Lost to Follow-up|7|||
170471326|NCT05026177|616065104|FG001|Overall Study|Lost to Follow-up|6|||
170471327|NCT05026177|616065105|FG002|Overall Study|Lost to Follow-up|8|||
170471328|NCT05026177|616065103|FG000|Overall Study|Noncompliance with study drug|6|||
170637691|NCT02840461|616684644|FG002|Overall Study|Protocol Violation|1|||
170637692|NCT02840461|616684642|FG000|Overall Study|Withdrawal by Subject|10|||
170791527|NCT03854227|617247906|FG001|Overall Study|Death|0|||
170791528|NCT03854227|617247907|FG002|Overall Study|Death|0|||
170791529|NCT03854227|617247908|FG003|Overall Study|Death|0|||
170791530|NCT03854227|617247909|FG004|Overall Study|Death|0|||
170471329|NCT05026177|616065104|FG001|Overall Study|Noncompliance with study drug|2|||
170471330|NCT05026177|616065105|FG002|Overall Study|Noncompliance with study drug|1|||
170471331|NCT05026177|616065103|FG000|Overall Study|Physician Decision|4|||
170471332|NCT05026177|616065104|FG001|Overall Study|Physician Decision|1|||
170471333|NCT05026177|616065105|FG002|Overall Study|Physician Decision|0|||
170637693|NCT02840461|616684643|FG001|Overall Study|Withdrawal by Subject|6|||
170791531|NCT03854227|617247910|FG005|Overall Study|Death|1|||
170791532|NCT03854227|617247911|FG006|Overall Study|Death|0|||
170471334|NCT05026177|616065103|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
170471335|NCT05026177|616065104|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
170471336|NCT05026177|616065105|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
170471337|NCT05026177|616065103|FG000|Overall Study|Withdrawal by Subject|53|||
170471338|NCT05026177|616065104|FG001|Overall Study|Withdrawal by Subject|51|||
170471339|NCT05026177|616065105|FG002|Overall Study|Withdrawal by Subject|55|||
170471340|NCT05026177|616065103|FG000|Overall Study|Protocol Violation|0|||
170791533|NCT03854227|617247912|FG007|Overall Study|Death|0|||
170791534|NCT03854227|617247913|FG008|Overall Study|Death|0|||
170791535|NCT03854227|617247914|FG009|Overall Study|Death|1|||
170791536|NCT03854227|617247915|FG010|Overall Study|Death|0|||
170791537|NCT03854227|617247916|FG011|Overall Study|Death|1|||
170791538|NCT03854227|617247905|FG000|Overall Study|Physician Decision|0|||
170791539|NCT03854227|617247906|FG001|Overall Study|Physician Decision|0|||
170791540|NCT03854227|617247907|FG002|Overall Study|Physician Decision|0|||
170791541|NCT03854227|617247908|FG003|Overall Study|Physician Decision|0|||
170791542|NCT03854227|617247909|FG004|Overall Study|Physician Decision|0|||
170791543|NCT03854227|617247910|FG005|Overall Study|Physician Decision|1|||
170791544|NCT03854227|617247911|FG006|Overall Study|Physician Decision|0|||
170471341|NCT05026177|616065104|FG001|Overall Study|Protocol Violation|1|||
170471342|NCT05026177|616065105|FG002|Overall Study|Protocol Violation|0|||
170471343|NCT05026177|616065103|FG000|Overall Study|Study terminated by sponsor|70|||
170471344|NCT05026177|616065104|FG001|Overall Study|Study terminated by sponsor|74|||
170471345|NCT05026177|616065105|FG002|Overall Study|Study terminated by sponsor|67|||
170471346|NCT05026177|616065103|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
170471347|NCT05026177|616065104|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
170471348|NCT05026177|616065105|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
170471349|NCT05026177|616065103|FG000|Overall Study|Starting alternative treatment|0|||
170471350|NCT05026177|616065104|FG001|Overall Study|Starting alternative treatment|1|||
170471351|NCT05026177|616065105|FG002|Overall Study|Starting alternative treatment|1|||
170471352|NCT05026177|616065103|FG000|Overall Study|Noncompliance with study procedures|0|||
170471353|NCT05026177|616065104|FG001|Overall Study|Noncompliance with study procedures|1|||
170471354|NCT05026177|616065105|FG002|Overall Study|Noncompliance with study procedures|1|||
170471355|NCT05026177|616065103|FG000|Overall Study|Met stopping criteria|0|||
170471356|NCT05026177|616065104|FG001|Overall Study|Met stopping criteria|0|||
170471357|NCT05026177|616065105|FG002|Overall Study|Met stopping criteria|1|||
170471358|NCT05026177|616065103|FG000|Overall Study|Health issues preventing continuation|0|||
170471359|NCT05026177|616065104|FG001|Overall Study|Health issues preventing continuation|0|||
170471360|NCT05026177|616065105|FG002|Overall Study|Health issues preventing continuation|1|||
170471361|NCT05026177|616065103|FG000|Overall Study|Randomized in error, not treated|0|||
170471362|NCT05026177|616065104|FG001|Overall Study|Randomized in error, not treated|0|||
170471363|NCT05026177|616065105|FG002|Overall Study|Randomized in error, not treated|2|||
170471364|NCT03816878|616065108|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
170471365|NCT03816878|616065109|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
170471366|NCT03816878|616065108|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
170471367|NCT03816878|616065109|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
170471368|NCT03355469|616065110|FG000|Overall Study|COVID-19|3|||
170471369|NCT03355469|616065111|FG001|Overall Study|COVID-19|2|||
170471370|NCT03355469|616065112|FG002|Overall Study|COVID-19|3|||
170471371|NCT03355469|616065113|FG003|Overall Study|COVID-19|3|||
170471372|NCT03355469|616065110|FG000|Overall Study|Lost to Follow-up|1|||
170471373|NCT03355469|616065111|FG001|Overall Study|Lost to Follow-up|0|||
170471374|NCT03355469|616065112|FG002|Overall Study|Lost to Follow-up|1|||
170471375|NCT03355469|616065113|FG003|Overall Study|Lost to Follow-up|0|||
170471376|NCT03355469|616065110|FG000|Overall Study|Withdrawal by Subject|2|||
170471377|NCT03355469|616065111|FG001|Overall Study|Withdrawal by Subject|1|||
170791545|NCT03854227|617247912|FG007|Overall Study|Physician Decision|0|||
170791546|NCT03854227|617247913|FG008|Overall Study|Physician Decision|1|||
170791547|NCT03854227|617247914|FG009|Overall Study|Physician Decision|1|||
170791548|NCT03854227|617247915|FG010|Overall Study|Physician Decision|0|||
170791549|NCT03854227|617247916|FG011|Overall Study|Physician Decision|1|||
170791550|NCT03854227|617247905|FG000|Overall Study|Progressive disease|1|||
170791551|NCT03854227|617247906|FG001|Overall Study|Progressive disease|1|||
170791552|NCT03854227|617247907|FG002|Overall Study|Progressive disease|1|||
170791553|NCT03854227|617247908|FG003|Overall Study|Progressive disease|2|||
170791554|NCT03854227|617247909|FG004|Overall Study|Progressive disease|3|||
170791555|NCT03854227|617247910|FG005|Overall Study|Progressive disease|1|||
170791556|NCT03854227|617247911|FG006|Overall Study|Progressive disease|2|||
170471378|NCT03355469|616065112|FG002|Overall Study|Withdrawal by Subject|0|||
170471379|NCT03355469|616065113|FG003|Overall Study|Withdrawal by Subject|3|||
170791557|NCT03854227|617247912|FG007|Overall Study|Progressive disease|5|||
170791558|NCT03854227|617247913|FG008|Overall Study|Progressive disease|2|||
170791559|NCT03854227|617247914|FG009|Overall Study|Progressive disease|5|||
170791560|NCT03854227|617247915|FG010|Overall Study|Progressive disease|1|||
170791561|NCT03854227|617247916|FG011|Overall Study|Progressive disease|6|||
170471380|NCT05256134|616065118|FG000|Overall Study|Study Terminated by Sponsor|11|||
170471381|NCT05256134|616065119|FG001|Overall Study|Study Terminated by Sponsor|10|||
170471382|NCT05256134|616065118|FG000|Overall Study|Withdrawal by Subject|1|||
170637694|NCT02840461|616684644|FG002|Overall Study|Withdrawal by Subject|2|||
170471383|NCT05256134|616065119|FG001|Overall Study|Withdrawal by Subject|3|||
170471384|NCT01977417|616065120|FG000|Overall Study|Adverse Event|1|||
170471385|NCT01977417|616065121|FG001|Overall Study|Adverse Event|0|||
170471386|NCT01977417|616065120|FG000|Overall Study|Withdrawal by Subject|2|||
170471387|NCT01977417|616065121|FG001|Overall Study|Withdrawal by Subject|4|||
170471388|NCT01977417|616065120|FG000|Overall Study|Female enrollment goal met|0|||
170471389|NCT01977417|616065121|FG001|Overall Study|Female enrollment goal met|2|||
170471390|NCT02473523|616065124|FG000|Overall Study|Death|1|||
170471391|NCT02473523|616065124|FG000|Overall Study|Lost to Follow-up|1|||
170471392|NCT02111603|616065125|FG000|Overall Study|Withdrawal by Subject|1|||
170471393|NCT01434810|616065131|FG000|Overall Study|Did not receive treatment|11|||
170471394|NCT01434810|616065132|FG001|Overall Study|Did not receive treatment|3|||
170471395|NCT01434810|616065131|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
170471396|NCT01434810|616065132|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
170471397|NCT02794870|616065134|FG000|Overall Study|Withdrawal by Subject|2|||
170471398|NCT02794870|616065135|FG001|Overall Study|Withdrawal by Subject|0|||
170471399|NCT01611857|616065140|FG000|Overall Study|Withdrawal by Subject|0|||
170471400|NCT01611857|616065141|FG001|Overall Study|Withdrawal by Subject|2|||
170471401|NCT04974749|616065142|FG000|Overall Study|Withdrawal by Subject|2|||
170471402|NCT04974749|616065142|FG000|Overall Study|Gestation|1|||
170471403|NCT01625988|616065148|FG000|Overall Study|Lost to Follow-up|5|||
170471404|NCT01625988|616065149|FG001|Overall Study|Lost to Follow-up|6|||
170471405|NCT01625988|616065148|FG000|Overall Study|Withdrawal by Subject|8|||
170471406|NCT01625988|616065149|FG001|Overall Study|Withdrawal by Subject|3|||
170471407|NCT01625988|616065148|FG000|Overall Study|Adverse Event|0|||
170471408|NCT01625988|616065149|FG001|Overall Study|Adverse Event|1|||
170471409|NCT01625988|616065148|FG000|Overall Study|Lack of Efficacy|0|||
170471410|NCT01625988|616065149|FG001|Overall Study|Lack of Efficacy|1|||
170471411|NCT01625988|616065148|FG000|Overall Study|Randomized Inappropriately|1|||
170471412|NCT01625988|616065149|FG001|Overall Study|Randomized Inappropriately|0|||
170471413|NCT01625988|616065148|FG000|Overall Study|Protocol Violation|0|||
170471414|NCT01625988|616065149|FG001|Overall Study|Protocol Violation|2|||
170471415|NCT00796107|616065150|FG000|Overall Study|Lack of Efficacy|1|||
170471416|NCT00796107|616065150|FG000|Overall Study|Progressive Disease|5|||
170471417|NCT02481869|616065155|FG000|Overall Study|Lost to Follow-up|3|||
170471418|NCT02481869|616065156|FG001|Overall Study|Lost to Follow-up|4|||
170471419|NCT02481869|616065155|FG000|Overall Study|Withdrawal by Subject|2|||
170471420|NCT02481869|616065156|FG001|Overall Study|Withdrawal by Subject|0|||
170471421|NCT01482312|616065157|FG000|Period 1, 90 Minutes of Wear|Other|1|||
170471422|NCT01482312|616065158|FG001|Period 1, 90 Minutes of Wear|Other|0|||
170471423|NCT01482312|616065159|FG002|Period 1, 90 Minutes of Wear|Other|0|||
170471424|NCT01482312|616065157|FG000|Period 2, 90 Minutes of Wear|Other|1|||
170471425|NCT01482312|616065158|FG001|Period 2, 90 Minutes of Wear|Other|0|||
170471426|NCT01482312|616065159|FG002|Period 2, 90 Minutes of Wear|Other|0|||
170471427|NCT03154125|616065160|FG000|Overall Study|Lost to Follow-up|11|||
170637695|NCT02840461|616684642|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
170637696|NCT02840461|616684643|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
170637697|NCT02840461|616684644|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
170637698|NCT00256997|616684645|FG000|Overall Study|Protocol Violation|1|||
170637699|NCT00256997|616684646|FG001|Overall Study|Protocol Violation|4|||
170637700|NCT00256997|616684645|FG000|Overall Study|Lack of Efficacy|1|||
170637701|NCT00256997|616684646|FG001|Overall Study|Lack of Efficacy|4|||
170637702|NCT00256997|616684645|FG000|Overall Study|Death|2|||
170637703|NCT00256997|616684646|FG001|Overall Study|Death|0|||
170637704|NCT00256997|616684645|FG000|Overall Study|Adverse Event|4|||
170637705|NCT00256997|616684646|FG001|Overall Study|Adverse Event|0|||
170471428|NCT03154125|616065161|FG001|Overall Study|Lost to Follow-up|11|||
170471429|NCT03154125|616065162|FG002|Overall Study|Lost to Follow-up|0|||
170471430|NCT03154125|616065160|FG000|Overall Study|Withdrawal by Subject|49|||
170471431|NCT03154125|616065161|FG001|Overall Study|Withdrawal by Subject|55|||
170471432|NCT03154125|616065162|FG002|Overall Study|Withdrawal by Subject|8|||
170471433|NCT03154125|616065160|FG000|Overall Study|Physician Decision|13|||
170471434|NCT03154125|616065161|FG001|Overall Study|Physician Decision|6|||
170471435|NCT03154125|616065162|FG002|Overall Study|Physician Decision|0|||
170471436|NCT03154125|616065160|FG000|Overall Study|Protocol Violation|3|||
170471437|NCT03154125|616065161|FG001|Overall Study|Protocol Violation|5|||
170637706|NCT00256997|616684645|FG000|Overall Study|Lost to Follow-up|3|||
170637707|NCT00256997|616684646|FG001|Overall Study|Lost to Follow-up|5|||
170637708|NCT00256997|616684645|FG000|Overall Study|Withdrawal by Subject|13|||
170471438|NCT03154125|616065162|FG002|Overall Study|Protocol Violation|0|||
170471439|NCT00462904|616065163|FG000|Overall Study|Lost to Follow-up|1|||
170471440|NCT00560391|616065164|FG000|Overall Study|Still on treatment|0|||
170471441|NCT00560391|616065165|FG001|Overall Study|Still on treatment|0|||
170637709|NCT00256997|616684646|FG001|Overall Study|Withdrawal by Subject|3|||
170471442|NCT00560391|616065166|FG002|Overall Study|Still on treatment|0|||
170471443|NCT00560391|616065167|FG003|Overall Study|Still on treatment|1|||
170471444|NCT00560391|616065168|FG004|Overall Study|Still on treatment|2|||
170471445|NCT03668808|616065169|FG000|First Intervention|Withdrawal by Subject|2|||
170471446|NCT03668808|616065170|FG001|First Intervention|Withdrawal by Subject|2|||
170471447|NCT01569295|616065173|FG000|Overall Study|Progressive Disease|75|||
170471448|NCT01569295|616065174|FG001|Overall Study|Progressive Disease|139|||
170471449|NCT01569295|616065173|FG000|Overall Study|Adverse Event|39|||
170791562|NCT03854227|617247905|FG000|Overall Study|Study terminated by sponsor|0|||
170471450|NCT01569295|616065174|FG001|Overall Study|Adverse Event|14|||
170471451|NCT01569295|616065173|FG000|Overall Study|Withdrawal by Subject|25|||
170471452|NCT01569295|616065174|FG001|Overall Study|Withdrawal by Subject|12|||
170471453|NCT01569295|616065173|FG000|Overall Study|Death|19|||
170471454|NCT01569295|616065174|FG001|Overall Study|Death|15|||
170471455|NCT01569295|616065173|FG000|Overall Study|Physician Decision|13|||
170471456|NCT01569295|616065174|FG001|Overall Study|Physician Decision|18|||
170471457|NCT01569295|616065173|FG000|Overall Study|Study Terminated by Sponsor|24|||
170471458|NCT01569295|616065174|FG001|Overall Study|Study Terminated by Sponsor|2|||
170471459|NCT01569295|616065173|FG000|Overall Study|Other Reason not Specified|3|||
170471460|NCT01569295|616065174|FG001|Overall Study|Other Reason not Specified|5|||
170471461|NCT01569295|616065173|FG000|Overall Study|Non-Compliance with Study Drug|6|||
170471462|NCT01569295|616065174|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170471463|NCT01569295|616065173|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
170471464|NCT01569295|616065174|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
170471465|NCT01569295|616065173|FG000|Overall Study|Lost to Follow-up|1|||
170471466|NCT01569295|616065174|FG001|Overall Study|Lost to Follow-up|1|||
170471467|NCT00280735|616065175|FG000|Overall Study|Adverse Event|5|||
170471468|NCT00280735|616065175|FG000|Overall Study|Lack of Efficacy|3|||
170471469|NCT00280735|616065175|FG000|Overall Study|Withdrawal by Subject|8|||
170471470|NCT00280735|616065175|FG000|Overall Study|Intercurrent Illness|2|||
170471471|NCT01895777|616065176|FG000|Overall Study|Adverse Event|1|||
170471472|NCT01895777|616065177|FG001|Overall Study|Adverse Event|2|||
170471473|NCT01895777|616065176|FG000|Overall Study|Lost to Follow-up|2|||
170471474|NCT01895777|616065177|FG001|Overall Study|Lost to Follow-up|0|||
170471475|NCT01895777|616065176|FG000|Overall Study|Not treated|1|||
170471476|NCT01895777|616065177|FG001|Overall Study|Not treated|0|||
170471477|NCT01895777|616065176|FG000|Overall Study|Other reasons|3|||
170471478|NCT01895777|616065177|FG001|Overall Study|Other reasons|2|||
170471479|NCT01895777|616065176|FG000|Overall Study|Non-compliance with the CTP|2|||
170471480|NCT01895777|616065177|FG001|Overall Study|Non-compliance with the CTP|1|||
170471481|NCT02064296|616065181|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
170471482|NCT02064296|616065182|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
170471483|NCT02064296|616065183|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
170471484|NCT02064296|616065181|FG000|Intervention|Withdrawal by Subject|0|||
170471485|NCT02064296|616065182|FG001|Intervention|Withdrawal by Subject|1|||
170471486|NCT02064296|616065183|FG002|Intervention|Withdrawal by Subject|2|||
170471487|NCT00396565|616065197|FG000|Overall Study|Physician Decision|3|||
170471488|NCT00396565|616065198|FG001|Overall Study|Physician Decision|1|||
170471489|NCT00396565|616065199|FG002|Overall Study|Physician Decision|2|||
170471490|NCT00396565|616065197|FG000|Overall Study|Adverse Event|5|||
170471491|NCT00396565|616065198|FG001|Overall Study|Adverse Event|13|||
170471492|NCT00396565|616065199|FG002|Overall Study|Adverse Event|3|||
170471493|NCT00396565|616065197|FG000|Overall Study|Withdrawal by Subject|8|||
170471494|NCT00396565|616065198|FG001|Overall Study|Withdrawal by Subject|13|||
170471495|NCT00396565|616065199|FG002|Overall Study|Withdrawal by Subject|1|||
170471496|NCT00396565|616065197|FG000|Overall Study|Lack of Efficacy|32|||
170471497|NCT00396565|616065198|FG001|Overall Study|Lack of Efficacy|64|||
170471498|NCT00396565|616065199|FG002|Overall Study|Lack of Efficacy|11|||
170545666|NCT04676646|616342715|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
170545667|NCT04676646|616342716|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
170791563|NCT03854227|617247906|FG001|Overall Study|Study terminated by sponsor|0|||
170791564|NCT03854227|617247907|FG002|Overall Study|Study terminated by sponsor|0|||
170545668|NCT04676646|616342714|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
170791565|NCT03854227|617247908|FG003|Overall Study|Study terminated by sponsor|0|||
170545669|NCT04676646|616342715|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
170791566|NCT03854227|617247909|FG004|Overall Study|Study terminated by sponsor|0|||
170791567|NCT03854227|617247910|FG005|Overall Study|Study terminated by sponsor|0|||
170791568|NCT03854227|617247911|FG006|Overall Study|Study terminated by sponsor|0|||
170471499|NCT04487067|616065202|FG000|Overall Study|Adverse Event|3|||
170471500|NCT04487067|616065202|FG000|Overall Study|Death Other Than Progressive Disease|60|||
170471501|NCT04487067|616065202|FG000|Overall Study|Death Due To Progressive Disease|40|||
170471502|NCT04487067|616065202|FG000|Overall Study|Lost to Follow-up|3|||
170471503|NCT04487067|616065202|FG000|Overall Study|Progressive Disease|1|||
170471504|NCT04487067|616065202|FG000|Overall Study|Protocol Violation|3|||
170471505|NCT04487067|616065202|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
170471506|NCT04487067|616065202|FG000|Overall Study|Withdrawal by Subject|15|||
170471507|NCT05299528|616065203|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
170471508|NCT05299528|616065204|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
170471509|NCT05299528|616065205|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
170471510|NCT05299528|616065206|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
170471511|NCT05299528|616065207|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
170471512|NCT05299528|616065208|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
170471513|NCT05299528|616065209|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
170471514|NCT05299528|616065203|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
170471515|NCT05299528|616065204|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
170471516|NCT05299528|616065205|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
170471517|NCT05299528|616065206|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
170471518|NCT05299528|616065207|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
170471519|NCT05299528|616065208|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
170471520|NCT05299528|616065209|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
170471521|NCT05299528|616065203|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
170471522|NCT05299528|616065204|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
170471523|NCT05299528|616065205|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
170471524|NCT05299528|616065206|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
170471525|NCT05299528|616065207|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
170471526|NCT05299528|616065208|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
170471527|NCT05299528|616065209|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
170471528|NCT04324021|616065210|FG000|Overall Study|Adverse Event|1|||
170471529|NCT04324021|616065211|FG001|Overall Study|Adverse Event|0|||
170471530|NCT04324021|616065212|FG002|Overall Study|Adverse Event|0|||
170471531|NCT04324021|616065210|FG000|Overall Study|Lack of Efficacy|0|||
170471532|NCT04324021|616065211|FG001|Overall Study|Lack of Efficacy|0|||
170471533|NCT04324021|616065212|FG002|Overall Study|Lack of Efficacy|1|||
170471534|NCT04324021|616065210|FG000|Overall Study|Death|1|||
170471535|NCT04324021|616065211|FG001|Overall Study|Death|1|||
170471536|NCT04324021|616065212|FG002|Overall Study|Death|0|||
170471537|NCT04877457|616065213|FG000|Overall Study|Early termination of study due to low enrollment|2|||
170471538|NCT04877457|616065214|FG001|Overall Study|Early termination of study due to low enrollment|1|||
170471539|NCT00299130|616065215|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
170471540|NCT00299130|616065216|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
170471541|NCT00299130|616065217|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
170471542|NCT00299130|616065215|FG000|Treatment Period (up to 5 Years)|Death|1|||
170471543|NCT00299130|616065216|FG001|Treatment Period (up to 5 Years)|Death|3|||
170471544|NCT00299130|616065217|FG002|Treatment Period (up to 5 Years)|Death|1|||
170471545|NCT00299130|616065215|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
170471546|NCT00299130|616065216|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
170471547|NCT00299130|616065217|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
170471548|NCT00299130|616065215|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
170471549|NCT00299130|616065216|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
170471550|NCT00299130|616065217|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
170471551|NCT00299130|616065215|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
170471552|NCT00299130|616065216|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
170471553|NCT00299130|616065217|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
170471554|NCT00299130|616065215|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
170471555|NCT00299130|616065216|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
170471556|NCT00299130|616065217|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
170471557|NCT00299130|616065215|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
170471558|NCT00299130|616065216|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
170471559|NCT00299130|616065217|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
170471560|NCT00299130|616065215|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
170471561|NCT00299130|616065216|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
170471562|NCT00299130|616065217|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
170471563|NCT00299130|616065215|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
170471564|NCT00299130|616065216|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
170471565|NCT00299130|616065217|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
170471566|NCT00299130|616065215|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
170471567|NCT00299130|616065216|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
170791569|NCT03854227|617247912|FG007|Overall Study|Study terminated by sponsor|0|||
170791570|NCT03854227|617247913|FG008|Overall Study|Study terminated by sponsor|0|||
170791571|NCT03854227|617247914|FG009|Overall Study|Study terminated by sponsor|1|||
170791572|NCT03854227|617247915|FG010|Overall Study|Study terminated by sponsor|0|||
170471568|NCT00299130|616065217|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
170471569|NCT00299130|616065215|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
170471570|NCT00299130|616065216|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
170471571|NCT00299130|616065217|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
170471572|NCT00299130|616065215|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
170471573|NCT00299130|616065216|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
170471574|NCT00299130|616065217|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
170471575|NCT00299130|616065215|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
170471576|NCT00299130|616065216|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
170471577|NCT00299130|616065217|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
170471578|NCT00299130|616065215|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
170471579|NCT00299130|616065216|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
170471580|NCT00299130|616065217|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
170471581|NCT00299130|616065215|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
170471582|NCT00299130|616065216|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
170471583|NCT00299130|616065217|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
170471584|NCT00299130|616065215|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
170471585|NCT00299130|616065216|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
170471586|NCT00299130|616065217|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
170471587|NCT00299130|616065215|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
170471588|NCT00299130|616065216|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
170471589|NCT00299130|616065217|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
170471590|NCT02211417|616065218|FG000|Overall Study|Withdrawal by Subject|11|||
170471591|NCT02211417|616065219|FG001|Overall Study|Withdrawal by Subject|8|||
170471592|NCT02211417|616065218|FG000|Overall Study|Protocol Violation|1|||
170471593|NCT02211417|616065219|FG001|Overall Study|Protocol Violation|0|||
170471594|NCT02211417|616065218|FG000|Overall Study|Pregnancy|0|||
170471595|NCT02211417|616065219|FG001|Overall Study|Pregnancy|1|||
170471596|NCT02211417|616065218|FG000|Overall Study|Lost to Follow-up|2|||
170471597|NCT02211417|616065219|FG001|Overall Study|Lost to Follow-up|3|||
170471598|NCT02211417|616065218|FG000|Overall Study|Adverse Event|1|||
170471599|NCT02211417|616065219|FG001|Overall Study|Adverse Event|4|||
170471600|NCT01198132|616065220|FG000|Overall Study|Withdrawal by Subject|4|||
170471601|NCT01198132|616065221|FG001|Overall Study|Withdrawal by Subject|5|||
170471602|NCT01198132|616065220|FG000|Overall Study|Physician Decision|5|||
170471603|NCT01198132|616065221|FG001|Overall Study|Physician Decision|4|||
170471604|NCT01198132|616065220|FG000|Overall Study|Other Unspecified|3|||
170471605|NCT01198132|616065221|FG001|Overall Study|Other Unspecified|6|||
170471606|NCT01198132|616065220|FG000|Overall Study|Lack of Efficacy|2|||
170471607|NCT01198132|616065221|FG001|Overall Study|Lack of Efficacy|3|||
170471608|NCT01198132|616065220|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
170471609|NCT01198132|616065221|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
170471610|NCT01198132|616065220|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
170471611|NCT01198132|616065221|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
170471612|NCT01198132|616065220|FG000|Overall Study|Adverse Event|0|||
170471613|NCT01198132|616065221|FG001|Overall Study|Adverse Event|1|||
170471614|NCT01198132|616065220|FG000|Overall Study|Protocol Violation|1|||
170471615|NCT01198132|616065221|FG001|Overall Study|Protocol Violation|0|||
170471616|NCT01277211|616065222|FG000|Overall Study|Adverse Event|60|||
170471617|NCT01277211|616065223|FG001|Overall Study|Adverse Event|22|||
170471618|NCT01277211|616065222|FG000|Overall Study|Pregnancy|9|||
170471619|NCT01277211|616065223|FG001|Overall Study|Pregnancy|4|||
170471620|NCT01277211|616065222|FG000|Overall Study|Lost to Follow-up|14|||
170471621|NCT01277211|616065223|FG001|Overall Study|Lost to Follow-up|9|||
170471622|NCT01277211|616065222|FG000|Overall Study|Did not wish to continue|17|||
170471623|NCT01277211|616065223|FG001|Overall Study|Did not wish to continue|0|||
170471624|NCT01277211|616065222|FG000|Overall Study|Withdrew Consent|9|||
170471625|NCT01277211|616065223|FG001|Overall Study|Withdrew Consent|9|||
170471626|NCT01277211|616065222|FG000|Overall Study|Non-compliance with protocol|13|||
170471627|NCT01277211|616065223|FG001|Overall Study|Non-compliance with protocol|4|||
170471628|NCT01277211|616065222|FG000|Overall Study|Did not meet protocol eligibility|1|||
170471629|NCT01277211|616065223|FG001|Overall Study|Did not meet protocol eligibility|0|||
170471630|NCT01277211|616065222|FG000|Overall Study|Administrative|3|||
170471631|NCT01277211|616065223|FG001|Overall Study|Administrative|0|||
170471632|NCT01277211|616065222|FG000|Overall Study|Pregnancy wish|0|||
170471633|NCT01277211|616065223|FG001|Overall Study|Pregnancy wish|2|||
170471634|NCT01277211|616065222|FG000|Overall Study|Discontinued prior to treatment|24|||
170471635|NCT01277211|616065223|FG001|Overall Study|Discontinued prior to treatment|13|||
170471636|NCT01098487|616065224|FG000|Overall Study|Adverse Event|22|||
170471637|NCT01098487|616065224|FG000|Overall Study|Lack of Efficacy|11|||
170471638|NCT01098487|616065224|FG000|Overall Study|Withdrawal by Subject|7|||
170471639|NCT01098487|616065224|FG000|Overall Study|Lost to Follow-up|3|||
170471640|NCT01098487|616065224|FG000|Overall Study|Physician Decision|1|||
170471641|NCT00345631|616065225|FG000|Overall Study|Withdrawal by Subject|1|||
170471642|NCT00345631|616065226|FG001|Overall Study|Withdrawal by Subject|0|||
170471643|NCT00345631|616065227|FG002|Overall Study|Withdrawal by Subject|1|||
170471644|NCT00345631|616065225|FG000|Overall Study|Adverse Event|0|||
170471645|NCT00345631|616065226|FG001|Overall Study|Adverse Event|1|||
170471646|NCT00345631|616065227|FG002|Overall Study|Adverse Event|0|||
170471647|NCT00345631|616065225|FG000|Overall Study|Lost to Follow-up|3|||
170471648|NCT00345631|616065226|FG001|Overall Study|Lost to Follow-up|7|||
170471649|NCT00345631|616065227|FG002|Overall Study|Lost to Follow-up|4|||
170471650|NCT00345631|616065225|FG000|Overall Study|Other reasons|0|||
170471651|NCT00345631|616065226|FG001|Overall Study|Other reasons|0|||
170471652|NCT00345631|616065227|FG002|Overall Study|Other reasons|1|||
170471653|NCT00338728|616065234|FG000|Overall Study|Screen Failure|14|||
170471654|NCT01862484|616065237|FG000|Overall Study|Lack of Efficacy|1|||
170471655|NCT01862484|616065238|FG001|Overall Study|Lack of Efficacy|1|||
170471656|NCT01862484|616065237|FG000|Overall Study|Lost to Follow-up|1|||
170471657|NCT01862484|616065238|FG001|Overall Study|Lost to Follow-up|2|||
170471658|NCT01862484|616065237|FG000|Overall Study|Protocol Violation|0|||
170471659|NCT01862484|616065238|FG001|Overall Study|Protocol Violation|2|||
170471660|NCT01862484|616065237|FG000|Overall Study|Withdrawal by Subject|0|||
170471661|NCT01862484|616065238|FG001|Overall Study|Withdrawal by Subject|3|||
170471662|NCT00996892|616065239|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
170471663|NCT00996892|616065240|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
170471664|NCT00996892|616065241|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
170471665|NCT00996892|616065242|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
170471666|NCT00996892|616065243|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
170471667|NCT00996892|616065244|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
170471668|NCT00996892|616065245|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
170471669|NCT00996892|616065246|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
170471670|NCT00996892|616065247|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
170471671|NCT00996892|616065248|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
170471672|NCT00996892|616065249|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
170471673|NCT00996892|616065250|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
170471674|NCT00996892|616065251|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
170471675|NCT00996892|616065252|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
170471676|NCT00996892|616065253|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
170471677|NCT00996892|616065254|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
170471678|NCT00996892|616065255|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
170471679|NCT00996892|616065256|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
170471680|NCT00996892|616065257|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
170471681|NCT00996892|616065258|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
170471682|NCT00996892|616065239|FG000|Dose-Escalation Stage 1|Death|1|||
170471683|NCT00996892|616065240|FG001|Dose-Escalation Stage 1|Death|0|||
170471684|NCT00996892|616065241|FG002|Dose-Escalation Stage 1|Death|0|||
170471685|NCT00996892|616065242|FG003|Dose-Escalation Stage 1|Death|0|||
170471686|NCT00996892|616065243|FG004|Dose-Escalation Stage 1|Death|0|||
170471687|NCT00996892|616065244|FG005|Dose-Escalation Stage 1|Death|1|||
170471688|NCT00996892|616065245|FG006|Dose-Escalation Stage 1|Death|0|||
170471689|NCT00996892|616065246|FG007|Dose-Escalation Stage 1|Death|0|||
170471690|NCT00996892|616065247|FG008|Dose-Escalation Stage 1|Death|0|||
170471691|NCT00996892|616065248|FG009|Dose-Escalation Stage 1|Death|0|||
170471692|NCT00996892|616065249|FG010|Dose-Escalation Stage 1|Death|0|||
170471693|NCT00996892|616065250|FG011|Dose-Escalation Stage 1|Death|0|||
170637710|NCT00256997|616684645|FG000|Overall Study|Started but not treated|2|||
170637711|NCT00256997|616684646|FG001|Overall Study|Started but not treated|0|||
170791573|NCT03854227|617247916|FG011|Overall Study|Study terminated by sponsor|0|||
170791574|NCT03854227|617247905|FG000|Overall Study|Withdrawal by Subject|0|||
170791575|NCT03854227|617247906|FG001|Overall Study|Withdrawal by Subject|0|||
170791576|NCT03854227|617247907|FG002|Overall Study|Withdrawal by Subject|1|||
170471694|NCT00996892|616065251|FG012|Dose-Escalation Stage 1|Death|0|||
170637712|NCT00256997|616684645|FG000|Overall Study|Other|5|||
170471695|NCT00996892|616065252|FG013|Dose-Escalation Stage 1|Death|0|||
170471696|NCT00996892|616065253|FG014|Dose-Escalation Stage 1|Death|0|||
170471697|NCT00996892|616065254|FG015|Dose-Escalation Stage 1|Death|0|||
170471698|NCT00996892|616065255|FG016|Dose-Escalation Stage 1|Death|0|||
170471699|NCT00996892|616065256|FG017|Dose-Escalation Stage 1|Death|0|||
170471700|NCT00996892|616065257|FG018|Dose-Escalation Stage 1|Death|0|||
170471701|NCT00996892|616065258|FG019|Dose-Escalation Stage 1|Death|0|||
170891630|NCT03604445|617609818|FG000|Overall Study|Adverse Event|0|||
170891631|NCT03604445|617609819|FG001|Overall Study|Adverse Event|0|||
170891632|NCT03604445|617609820|FG002|Overall Study|Adverse Event|0|||
170891633|NCT03604445|617609821|FG003|Overall Study|Adverse Event|1|||
170891634|NCT03604445|617609822|FG004|Overall Study|Adverse Event|0|||
170891635|NCT03604445|617609823|FG005|Overall Study|Adverse Event|0|||
170891636|NCT03604445|617609824|FG006|Overall Study|Adverse Event|0|||
170891637|NCT03604445|617609825|FG007|Overall Study|Adverse Event|0|||
170891638|NCT03604445|617609826|FG008|Overall Study|Adverse Event|1|||
170471702|NCT00996892|616065239|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
170791577|NCT03854227|617247908|FG003|Overall Study|Withdrawal by Subject|0|||
170471703|NCT00996892|616065240|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
170471704|NCT00996892|616065241|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
170471705|NCT00996892|616065242|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
170471706|NCT00996892|616065243|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
170791578|NCT03854227|617247909|FG004|Overall Study|Withdrawal by Subject|0|||
170791579|NCT03854227|617247910|FG005|Overall Study|Withdrawal by Subject|0|||
170471707|NCT00996892|616065244|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
170471708|NCT00996892|616065245|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
170471709|NCT00996892|616065246|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
170471710|NCT00996892|616065247|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
170471711|NCT00996892|616065248|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
170471712|NCT00996892|616065249|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
170471713|NCT00996892|616065250|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
170471714|NCT00996892|616065251|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
170471715|NCT00996892|616065252|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
170471716|NCT00996892|616065253|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
170471717|NCT00996892|616065254|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
170471718|NCT00996892|616065255|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
170471719|NCT00996892|616065256|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
170471720|NCT00996892|616065257|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
170471721|NCT00996892|616065258|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
170471722|NCT00996892|616065239|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471723|NCT00996892|616065240|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
170471724|NCT00996892|616065241|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471725|NCT00996892|616065242|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
170471726|NCT00996892|616065243|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
170471727|NCT00996892|616065244|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
170471728|NCT00996892|616065245|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
170471729|NCT00996892|616065246|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471730|NCT00996892|616065247|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471731|NCT00996892|616065248|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471732|NCT00996892|616065249|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471733|NCT00996892|616065250|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471734|NCT00996892|616065251|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471735|NCT00996892|616065252|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471736|NCT00996892|616065253|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471737|NCT00996892|616065254|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471738|NCT00996892|616065255|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471739|NCT00996892|616065256|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471740|NCT00996892|616065257|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471741|NCT00996892|616065258|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
170471742|NCT00996892|616065239|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
170791580|NCT03854227|617247911|FG006|Overall Study|Withdrawal by Subject|0|||
170471743|NCT00996892|616065240|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
170471744|NCT00996892|616065241|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
170471745|NCT00996892|616065242|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
170471746|NCT00996892|616065243|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
170471747|NCT00996892|616065244|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
170471748|NCT00996892|616065245|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
170471749|NCT00996892|616065246|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
170471750|NCT00996892|616065247|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
170471751|NCT00996892|616065248|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
170471752|NCT00996892|616065249|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
170471753|NCT00996892|616065250|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
170471754|NCT00996892|616065251|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
170791581|NCT03854227|617247912|FG007|Overall Study|Withdrawal by Subject|0|||
170791582|NCT03854227|617247913|FG008|Overall Study|Withdrawal by Subject|0|||
170791583|NCT03854227|617247914|FG009|Overall Study|Withdrawal by Subject|1|||
170791584|NCT03854227|617247915|FG010|Overall Study|Withdrawal by Subject|1|||
170791585|NCT03854227|617247916|FG011|Overall Study|Withdrawal by Subject|0|||
170791586|NCT03854227|617247905|FG000|Overall Study|Disease relapse|0|||
170471755|NCT00996892|616065252|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
170471756|NCT00996892|616065253|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
170471757|NCT00996892|616065254|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
170471758|NCT00996892|616065255|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
170471759|NCT00996892|616065256|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
170471760|NCT00996892|616065257|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
170791587|NCT03854227|617247906|FG001|Overall Study|Disease relapse|0|||
170471761|NCT00996892|616065258|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
170471762|NCT00996892|616065239|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
170471763|NCT00996892|616065240|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
170471764|NCT00996892|616065241|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
170471765|NCT00996892|616065242|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
170471766|NCT00996892|616065243|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
170471767|NCT00996892|616065244|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
170471768|NCT00996892|616065245|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
170471769|NCT00996892|616065246|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
170471770|NCT00996892|616065247|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
170471771|NCT00996892|616065248|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
170471772|NCT00996892|616065249|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
170471773|NCT00996892|616065250|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
170471774|NCT00996892|616065251|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
170471775|NCT00996892|616065252|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
170471776|NCT00996892|616065253|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
170471777|NCT00996892|616065254|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
170471778|NCT00996892|616065255|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
170471779|NCT00996892|616065256|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
170471780|NCT00996892|616065257|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
170471781|NCT00996892|616065258|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
170471782|NCT00996892|616065239|FG000|Dose-Escalation Stage 1A|Death|0|||
170471783|NCT00996892|616065240|FG001|Dose-Escalation Stage 1A|Death|0|||
170471784|NCT00996892|616065241|FG002|Dose-Escalation Stage 1A|Death|0|||
170471785|NCT00996892|616065242|FG003|Dose-Escalation Stage 1A|Death|0|||
170471786|NCT00996892|616065243|FG004|Dose-Escalation Stage 1A|Death|0|||
170471787|NCT00996892|616065244|FG005|Dose-Escalation Stage 1A|Death|0|||
170471788|NCT00996892|616065245|FG006|Dose-Escalation Stage 1A|Death|0|||
170471789|NCT00996892|616065246|FG007|Dose-Escalation Stage 1A|Death|0|||
170471790|NCT00996892|616065247|FG008|Dose-Escalation Stage 1A|Death|0|||
170471791|NCT00996892|616065248|FG009|Dose-Escalation Stage 1A|Death|2|||
170471792|NCT00996892|616065249|FG010|Dose-Escalation Stage 1A|Death|0|||
170471793|NCT00996892|616065250|FG011|Dose-Escalation Stage 1A|Death|1|||
170471794|NCT00996892|616065251|FG012|Dose-Escalation Stage 1A|Death|1|||
170471795|NCT00996892|616065252|FG013|Dose-Escalation Stage 1A|Death|0|||
170471796|NCT00996892|616065253|FG014|Dose-Escalation Stage 1A|Death|0|||
170471797|NCT00996892|616065254|FG015|Dose-Escalation Stage 1A|Death|0|||
170471798|NCT00996892|616065255|FG016|Dose-Escalation Stage 1A|Death|0|||
170471799|NCT00996892|616065256|FG017|Dose-Escalation Stage 1A|Death|0|||
170471800|NCT00996892|616065257|FG018|Dose-Escalation Stage 1A|Death|0|||
170471801|NCT00996892|616065258|FG019|Dose-Escalation Stage 1A|Death|0|||
170471802|NCT00996892|616065239|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
170471803|NCT00996892|616065240|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
170471804|NCT00996892|616065241|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
170471805|NCT00996892|616065242|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
170471806|NCT00996892|616065243|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
170471807|NCT00996892|616065244|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
170471808|NCT00996892|616065245|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
170471809|NCT00996892|616065246|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
170471810|NCT00996892|616065247|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
170471811|NCT00996892|616065248|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
170471812|NCT00996892|616065249|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
170471813|NCT00996892|616065250|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
170471814|NCT00996892|616065251|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
170471815|NCT00996892|616065252|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
170471816|NCT00996892|616065253|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
170471817|NCT00996892|616065254|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
170471818|NCT00996892|616065255|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
170471819|NCT00996892|616065256|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
170471820|NCT00996892|616065257|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
170471821|NCT00996892|616065258|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
170471822|NCT00996892|616065239|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471823|NCT00996892|616065240|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471824|NCT00996892|616065241|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471825|NCT00996892|616065242|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471826|NCT00996892|616065243|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471827|NCT00996892|616065244|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471828|NCT00996892|616065245|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471829|NCT00996892|616065246|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471830|NCT00996892|616065247|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471831|NCT00996892|616065248|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
170471832|NCT00996892|616065249|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
170471833|NCT00996892|616065250|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
170471834|NCT00996892|616065251|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
170471835|NCT00996892|616065252|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471836|NCT00996892|616065253|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471837|NCT00996892|616065254|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471838|NCT00996892|616065255|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471839|NCT00996892|616065256|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471840|NCT00996892|616065257|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471841|NCT00996892|616065258|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
170471842|NCT00996892|616065239|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
170471843|NCT00996892|616065240|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
170471844|NCT00996892|616065241|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
170471845|NCT00996892|616065242|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
170471846|NCT00996892|616065243|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
170471847|NCT00996892|616065244|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
170471848|NCT00996892|616065245|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
170791588|NCT03854227|617247907|FG002|Overall Study|Disease relapse|0|||
170791589|NCT03854227|617247908|FG003|Overall Study|Disease relapse|0|||
170791590|NCT03854227|617247909|FG004|Overall Study|Disease relapse|0|||
170791591|NCT03854227|617247910|FG005|Overall Study|Disease relapse|0|||
170791592|NCT03854227|617247911|FG006|Overall Study|Disease relapse|0|||
170791593|NCT03854227|617247912|FG007|Overall Study|Disease relapse|0|||
170791594|NCT03854227|617247913|FG008|Overall Study|Disease relapse|1|||
170791595|NCT03854227|617247914|FG009|Overall Study|Disease relapse|0|||
170791596|NCT03854227|617247915|FG010|Overall Study|Disease relapse|0|||
170791597|NCT03854227|617247916|FG011|Overall Study|Disease relapse|0|||
170791598|NCT03854227|617247905|FG000|Overall Study|Global deterioration of health status|0|||
170791599|NCT03854227|617247906|FG001|Overall Study|Global deterioration of health status|0|||
170791600|NCT03854227|617247907|FG002|Overall Study|Global deterioration of health status|0|||
170791601|NCT03854227|617247908|FG003|Overall Study|Global deterioration of health status|0|||
170791602|NCT03854227|617247909|FG004|Overall Study|Global deterioration of health status|0|||
170791603|NCT03854227|617247910|FG005|Overall Study|Global deterioration of health status|1|||
170791604|NCT03854227|617247911|FG006|Overall Study|Global deterioration of health status|0|||
170791605|NCT03854227|617247912|FG007|Overall Study|Global deterioration of health status|1|||
170791606|NCT03854227|617247913|FG008|Overall Study|Global deterioration of health status|0|||
170791607|NCT03854227|617247914|FG009|Overall Study|Global deterioration of health status|0|||
170791608|NCT03854227|617247915|FG010|Overall Study|Global deterioration of health status|0|||
170791609|NCT03854227|617247916|FG011|Overall Study|Global deterioration of health status|0|||
170791610|NCT03854227|617247905|FG000|Overall Study|Refused further treatment|0|||
170791611|NCT03854227|617247906|FG001|Overall Study|Refused further treatment|0|||
170791612|NCT03854227|617247907|FG002|Overall Study|Refused further treatment|0|||
170791613|NCT03854227|617247908|FG003|Overall Study|Refused further treatment|0|||
170791614|NCT03854227|617247909|FG004|Overall Study|Refused further treatment|0|||
170791615|NCT03854227|617247910|FG005|Overall Study|Refused further treatment|0|||
170791616|NCT03854227|617247911|FG006|Overall Study|Refused further treatment|0|||
170791617|NCT03854227|617247912|FG007|Overall Study|Refused further treatment|0|||
170791618|NCT03854227|617247913|FG008|Overall Study|Refused further treatment|0|||
170791619|NCT03854227|617247914|FG009|Overall Study|Refused further treatment|1|||
170791620|NCT03854227|617247915|FG010|Overall Study|Refused further treatment|0|||
170791621|NCT03854227|617247916|FG011|Overall Study|Refused further treatment|1|||
170791622|NCT03854227|617247905|FG000|Overall Study|Other|0|||
170791623|NCT03854227|617247906|FG001|Overall Study|Other|0|||
170791624|NCT03854227|617247907|FG002|Overall Study|Other|0|||
170791625|NCT03854227|617247908|FG003|Overall Study|Other|0|||
170891639|NCT00130286|617609827|FG000|Overall Study|Withdrawal by Subject|0|||
170791626|NCT03854227|617247909|FG004|Overall Study|Other|0|||
170791627|NCT03854227|617247910|FG005|Overall Study|Other|0|||
170791628|NCT03854227|617247911|FG006|Overall Study|Other|0|||
170791629|NCT03854227|617247912|FG007|Overall Study|Other|0|||
170791630|NCT03854227|617247913|FG008|Overall Study|Other|1|||
170791631|NCT03854227|617247914|FG009|Overall Study|Other|1|||
170891640|NCT00130286|617609828|FG001|Overall Study|Withdrawal by Subject|1|||
170891641|NCT00130286|617609829|FG002|Overall Study|Withdrawal by Subject|2|||
170471849|NCT00996892|616065246|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
170791632|NCT03854227|617247915|FG010|Overall Study|Other|0|||
170471850|NCT00996892|616065247|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
170637713|NCT00256997|616684646|FG001|Overall Study|Other|8|||
170791633|NCT03854227|617247916|FG011|Overall Study|Other|0|||
170791634|NCT06504862|617247922|FG000|Transition period|Adverse Event|1|||
170791635|NCT06504862|617247923|FG001|Transition period|Adverse Event|0|||
170791636|NCT04676763|617247924|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
170791637|NCT04676763|617247925|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
170891642|NCT00130286|617609830|FG003|Overall Study|Withdrawal by Subject|2|||
170471851|NCT00996892|616065248|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
170471852|NCT00996892|616065249|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
170471853|NCT00996892|616065250|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
170471854|NCT00996892|616065251|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
170471855|NCT00996892|616065252|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
170471856|NCT00996892|616065253|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
170471857|NCT00996892|616065254|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
170471858|NCT00996892|616065255|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
170471859|NCT00996892|616065256|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
170471860|NCT00996892|616065257|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
170637714|NCT00256997|616684645|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
170637715|NCT00256997|616684646|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
170637716|NCT00256997|616684645|FG000|Overall Study|Participant Non-compliant|3|||
170637717|NCT00256997|616684646|FG001|Overall Study|Participant Non-compliant|6|||
170637718|NCT00256997|616684645|FG000|Overall Study|Investigator Withdrew Participant|2|||
170637719|NCT00256997|616684646|FG001|Overall Study|Investigator Withdrew Participant|1|||
170637720|NCT03304249|616684656|FG000|Overall Study|Lost to Follow-up|8|||
170791638|NCT04676763|617247926|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
170791639|NCT04676763|617247924|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
170791640|NCT04676763|617247925|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
170791641|NCT04676763|617247926|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
170791642|NCT04676763|617247924|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
170471861|NCT00996892|616065258|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
170471862|NCT00996892|616065239|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
170471863|NCT00996892|616065240|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
170471864|NCT00996892|616065241|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
170471865|NCT00996892|616065242|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
170471866|NCT00996892|616065243|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
170471867|NCT00996892|616065244|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
170471868|NCT00996892|616065245|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
170471869|NCT00996892|616065246|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
170471870|NCT00996892|616065247|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
170471871|NCT00996892|616065248|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
170471872|NCT00996892|616065249|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
170471873|NCT00996892|616065250|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
170471874|NCT00996892|616065251|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
170471875|NCT00996892|616065252|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
170471876|NCT00996892|616065253|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
170471877|NCT00996892|616065254|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
170471878|NCT00996892|616065255|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
170471879|NCT00996892|616065256|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
170471880|NCT00996892|616065257|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
170471881|NCT00996892|616065258|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
170471882|NCT00996892|616065239|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
170471883|NCT00996892|616065240|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
170471884|NCT00996892|616065241|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
170471885|NCT00996892|616065242|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
170471886|NCT00996892|616065243|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
170471887|NCT00996892|616065244|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
170471888|NCT00996892|616065245|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
170471889|NCT00996892|616065246|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
170471890|NCT00996892|616065247|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
170471891|NCT00996892|616065248|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
170471892|NCT00996892|616065249|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
170471893|NCT00996892|616065250|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
170471894|NCT00996892|616065251|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
170471895|NCT00996892|616065252|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
170471896|NCT00996892|616065253|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
170471897|NCT00996892|616065254|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
170471898|NCT00996892|616065255|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
170471899|NCT00996892|616065256|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
170471900|NCT00996892|616065257|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
170791643|NCT04676763|617247925|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
170791644|NCT04676763|617247926|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
170471901|NCT00996892|616065258|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
170471902|NCT00996892|616065239|FG000|Expansion Stage 2|Adverse Event|0|||
170471903|NCT00996892|616065240|FG001|Expansion Stage 2|Adverse Event|0|||
170471904|NCT00996892|616065241|FG002|Expansion Stage 2|Adverse Event|0|||
170471905|NCT00996892|616065242|FG003|Expansion Stage 2|Adverse Event|0|||
170471906|NCT00996892|616065243|FG004|Expansion Stage 2|Adverse Event|0|||
170637721|NCT03304249|616684657|FG001|Overall Study|Lost to Follow-up|10|||
170471907|NCT00996892|616065244|FG005|Expansion Stage 2|Adverse Event|0|||
170471908|NCT00996892|616065245|FG006|Expansion Stage 2|Adverse Event|0|||
170471909|NCT00996892|616065246|FG007|Expansion Stage 2|Adverse Event|0|||
170471910|NCT00996892|616065247|FG008|Expansion Stage 2|Adverse Event|0|||
170471911|NCT00996892|616065248|FG009|Expansion Stage 2|Adverse Event|0|||
170471912|NCT00996892|616065249|FG010|Expansion Stage 2|Adverse Event|0|||
170471913|NCT00996892|616065250|FG011|Expansion Stage 2|Adverse Event|0|||
170471914|NCT00996892|616065251|FG012|Expansion Stage 2|Adverse Event|0|||
170471915|NCT00996892|616065252|FG013|Expansion Stage 2|Adverse Event|0|||
170471916|NCT00996892|616065253|FG014|Expansion Stage 2|Adverse Event|0|||
170471917|NCT00996892|616065254|FG015|Expansion Stage 2|Adverse Event|0|||
170471918|NCT00996892|616065255|FG016|Expansion Stage 2|Adverse Event|0|||
170471919|NCT00996892|616065256|FG017|Expansion Stage 2|Adverse Event|0|||
170471920|NCT00996892|616065257|FG018|Expansion Stage 2|Adverse Event|3|||
170471921|NCT00996892|616065258|FG019|Expansion Stage 2|Adverse Event|0|||
170471922|NCT00996892|616065239|FG000|Expansion Stage 2|Death|0|||
170471923|NCT00996892|616065240|FG001|Expansion Stage 2|Death|0|||
170471924|NCT00996892|616065241|FG002|Expansion Stage 2|Death|0|||
170471925|NCT00996892|616065242|FG003|Expansion Stage 2|Death|0|||
170471926|NCT00996892|616065243|FG004|Expansion Stage 2|Death|0|||
170471927|NCT00996892|616065244|FG005|Expansion Stage 2|Death|0|||
170471928|NCT00996892|616065245|FG006|Expansion Stage 2|Death|0|||
170471929|NCT00996892|616065246|FG007|Expansion Stage 2|Death|0|||
170471930|NCT00996892|616065247|FG008|Expansion Stage 2|Death|0|||
170471931|NCT00996892|616065248|FG009|Expansion Stage 2|Death|0|||
170471932|NCT00996892|616065249|FG010|Expansion Stage 2|Death|0|||
170471933|NCT00996892|616065250|FG011|Expansion Stage 2|Death|0|||
170471934|NCT00996892|616065251|FG012|Expansion Stage 2|Death|0|||
170471935|NCT00996892|616065252|FG013|Expansion Stage 2|Death|0|||
170471936|NCT00996892|616065253|FG014|Expansion Stage 2|Death|0|||
170471937|NCT00996892|616065254|FG015|Expansion Stage 2|Death|0|||
170471938|NCT00996892|616065255|FG016|Expansion Stage 2|Death|0|||
170471939|NCT00996892|616065256|FG017|Expansion Stage 2|Death|0|||
170471940|NCT00996892|616065257|FG018|Expansion Stage 2|Death|2|||
170471941|NCT00996892|616065258|FG019|Expansion Stage 2|Death|0|||
170471942|NCT00996892|616065239|FG000|Expansion Stage 2|Physician Decision|0|||
170471943|NCT00996892|616065240|FG001|Expansion Stage 2|Physician Decision|0|||
170471944|NCT00996892|616065241|FG002|Expansion Stage 2|Physician Decision|0|||
170471945|NCT00996892|616065242|FG003|Expansion Stage 2|Physician Decision|0|||
170471946|NCT00996892|616065243|FG004|Expansion Stage 2|Physician Decision|0|||
170471947|NCT00996892|616065244|FG005|Expansion Stage 2|Physician Decision|0|||
170471948|NCT00996892|616065245|FG006|Expansion Stage 2|Physician Decision|0|||
170471949|NCT00996892|616065246|FG007|Expansion Stage 2|Physician Decision|0|||
170471950|NCT00996892|616065247|FG008|Expansion Stage 2|Physician Decision|0|||
170471951|NCT00996892|616065248|FG009|Expansion Stage 2|Physician Decision|0|||
170471952|NCT00996892|616065249|FG010|Expansion Stage 2|Physician Decision|0|||
170471953|NCT00996892|616065250|FG011|Expansion Stage 2|Physician Decision|0|||
170471954|NCT00996892|616065251|FG012|Expansion Stage 2|Physician Decision|0|||
170471955|NCT00996892|616065252|FG013|Expansion Stage 2|Physician Decision|0|||
170545670|NCT04676646|616342716|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
170545671|NCT04676646|616342714|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
170545672|NCT04676646|616342715|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
170545673|NCT04676646|616342716|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
170545674|NCT04676646|616342714|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
170545675|NCT04676646|616342715|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
170545676|NCT04676646|616342716|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
170545677|NCT04676646|616342714|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
170545678|NCT04676646|616342715|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
170545679|NCT04676646|616342716|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
170791645|NCT04192266|617247927|FG000|Overall Study|Withdrawal by Subject|3|||
170791646|NCT04192266|617247928|FG001|Overall Study|Withdrawal by Subject|2|||
170791647|NCT04948697|617247929|FG000|Overall Study|Progressive disease|27|||
170791648|NCT04948697|617247930|FG001|Overall Study|Progressive disease|18|||
170471956|NCT00996892|616065253|FG014|Expansion Stage 2|Physician Decision|0|||
170471957|NCT00996892|616065254|FG015|Expansion Stage 2|Physician Decision|0|||
170471958|NCT00996892|616065255|FG016|Expansion Stage 2|Physician Decision|0|||
170471959|NCT00996892|616065256|FG017|Expansion Stage 2|Physician Decision|0|||
170471960|NCT00996892|616065257|FG018|Expansion Stage 2|Physician Decision|1|||
170471961|NCT00996892|616065258|FG019|Expansion Stage 2|Physician Decision|0|||
170471962|NCT00996892|616065239|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
170471963|NCT00996892|616065240|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
170545680|NCT04676646|616342714|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
170545681|NCT04676646|616342715|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
170471964|NCT00996892|616065241|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
170471965|NCT00996892|616065242|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
170471966|NCT00996892|616065243|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
170471967|NCT00996892|616065244|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
170791649|NCT04948697|617247929|FG000|Overall Study|Adverse Event|14|||
170791650|NCT04948697|617247930|FG001|Overall Study|Adverse Event|4|||
170791651|NCT04948697|617247929|FG000|Overall Study|Participant moved to long term extension study|7|||
170791652|NCT04948697|617247930|FG001|Overall Study|Participant moved to long term extension study|4|||
170791653|NCT04948697|617247929|FG000|Overall Study|Withdrawal by Subject|10|||
170791654|NCT04948697|617247930|FG001|Overall Study|Withdrawal by Subject|0|||
170791655|NCT04948697|617247929|FG000|Overall Study|Closed by Sponsor|3|||
170791656|NCT04948697|617247930|FG001|Overall Study|Closed by Sponsor|2|||
170791657|NCT04948697|617247929|FG000|Overall Study|Physician Decision|0|||
170791658|NCT04948697|617247930|FG001|Overall Study|Physician Decision|2|||
170791659|NCT04948697|617247929|FG000|Overall Study|Lost to Follow-up|0|||
170791660|NCT04948697|617247930|FG001|Overall Study|Lost to Follow-up|1|||
170791661|NCT04948697|617247929|FG000|Overall Study|Other-Miscellaneous|1|||
170791662|NCT04948697|617247930|FG001|Overall Study|Other-Miscellaneous|0|||
170791663|NCT04948697|617247929|FG000|Overall Study|Randomized but not treated|0|||
170791664|NCT04948697|617247930|FG001|Overall Study|Randomized but not treated|1|||
170791665|NCT04870515|617247931|FG000|Overall Study|Lost to Follow-up|0|||
170791666|NCT04870515|617247932|FG001|Overall Study|Lost to Follow-up|2|||
170791667|NCT04870515|617247931|FG000|Overall Study|Withdrawal by Subject|0|||
170791668|NCT04870515|617247932|FG001|Overall Study|Withdrawal by Subject|1|||
170791669|NCT04870515|617247931|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
170791670|NCT04870515|617247932|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
170791671|NCT03252847|617247933|FG000|Overall Study|Withdrawal by Subject|0|||
170791672|NCT03252847|617247934|FG001|Overall Study|Withdrawal by Subject|0|||
170791673|NCT03252847|617247935|FG002|Overall Study|Withdrawal by Subject|1|||
170791674|NCT03252847|617247936|FG003|Overall Study|Withdrawal by Subject|0|||
170791675|NCT03252847|617247937|FG004|Overall Study|Withdrawal by Subject|0|||
170791676|NCT03252847|617247938|FG005|Overall Study|Withdrawal by Subject|0|||
170791677|NCT03252847|617247939|FG006|Overall Study|Withdrawal by Subject|0|||
170791678|NCT03252847|617247933|FG000|Overall Study|Other: Patient decision|0|||
170791679|NCT03252847|617247934|FG001|Overall Study|Other: Patient decision|0|||
170791680|NCT03252847|617247935|FG002|Overall Study|Other: Patient decision|0|||
170791681|NCT03252847|617247936|FG003|Overall Study|Other: Patient decision|0|||
170791682|NCT03252847|617247937|FG004|Overall Study|Other: Patient decision|1|||
170791683|NCT03252847|617247938|FG005|Overall Study|Other: Patient decision|0|||
170791684|NCT03252847|617247939|FG006|Overall Study|Other: Patient decision|0|||
170791685|NCT04145440|617247940|FG000|Overall Study|Physician Decision|3|||
170791686|NCT04145440|617247941|FG001|Overall Study|Physician Decision|0|||
170791687|NCT04145440|617247940|FG000|Overall Study|Use of prohibited therapy|2|||
170791688|NCT04145440|617247941|FG001|Overall Study|Use of prohibited therapy|3|||
170791689|NCT02927236|617247946|FG000|Characterization Phase|Physician Decision|0|||
170791690|NCT02927236|617247947|FG001|Characterization Phase|Physician Decision|3|||
170791691|NCT02927236|617247948|FG002|Characterization Phase|Physician Decision|0|||
170791692|NCT02927236|617247949|FG003|Characterization Phase|Physician Decision|2|||
170791693|NCT02927236|617247946|FG000|Characterization Phase|Lost to Follow-up|0|||
170791694|NCT02927236|617247947|FG001|Characterization Phase|Lost to Follow-up|0|||
170791695|NCT02927236|617247948|FG002|Characterization Phase|Lost to Follow-up|0|||
170791696|NCT02927236|617247949|FG003|Characterization Phase|Lost to Follow-up|3|||
170791697|NCT02927236|617247946|FG000|Characterization Phase|Withdrawal by Subject|1|||
170791698|NCT02927236|617247947|FG001|Characterization Phase|Withdrawal by Subject|0|||
170791699|NCT02927236|617247948|FG002|Characterization Phase|Withdrawal by Subject|0|||
170791700|NCT02927236|617247949|FG003|Characterization Phase|Withdrawal by Subject|1|||
170791701|NCT02927236|617247946|FG000|Treatment Phase|Adverse Event|1|||
170791702|NCT02927236|617247947|FG001|Treatment Phase|Adverse Event|0|||
170791703|NCT02927236|617247948|FG002|Treatment Phase|Adverse Event|1|||
170791704|NCT02927236|617247949|FG003|Treatment Phase|Adverse Event|1|||
170791705|NCT02927236|617247946|FG000|Treatment Phase|Protocol Violation|3|||
170791706|NCT02927236|617247947|FG001|Treatment Phase|Protocol Violation|0|||
170791707|NCT02927236|617247948|FG002|Treatment Phase|Protocol Violation|0|||
170791708|NCT02927236|617247949|FG003|Treatment Phase|Protocol Violation|1|||
170891643|NCT00130286|617609827|FG000|Overall Study|Adverse Event|0|||
170471968|NCT00996892|616065245|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
170471969|NCT00996892|616065246|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
170471970|NCT00996892|616065247|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
170471971|NCT00996892|616065248|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
170791709|NCT02927236|617247946|FG000|Treatment Phase|Lost to Follow-up|1|||
170791710|NCT02927236|617247947|FG001|Treatment Phase|Lost to Follow-up|0|||
170791711|NCT02927236|617247948|FG002|Treatment Phase|Lost to Follow-up|0|||
170791712|NCT02927236|617247949|FG003|Treatment Phase|Lost to Follow-up|0|||
170791713|NCT02927236|617247946|FG000|Follow-up Phase|Lost to Follow-up|1|||
170791714|NCT02927236|617247947|FG001|Follow-up Phase|Lost to Follow-up|0|||
170791715|NCT02927236|617247948|FG002|Follow-up Phase|Lost to Follow-up|1|||
170791716|NCT02927236|617247949|FG003|Follow-up Phase|Lost to Follow-up|0|||
170791717|NCT01210807|617247950|FG000|Overall Study|Lost to Follow-up|1|||
170791718|NCT01210807|617247951|FG001|Overall Study|Lost to Follow-up|2|||
170791719|NCT01210807|617247950|FG000|Overall Study|Not implanted bilaterally|2|||
170471972|NCT00996892|616065249|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
170471973|NCT00996892|616065250|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
170471974|NCT00996892|616065251|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
170471975|NCT00996892|616065252|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
170471976|NCT00996892|616065253|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
170471977|NCT00996892|616065254|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
170471978|NCT00996892|616065255|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
170471979|NCT00996892|616065256|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
170471980|NCT00996892|616065257|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
170471981|NCT00996892|616065258|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
170471982|NCT00996892|616065239|FG000|Expansion Stage 2|Disease Progression|0|||
170471983|NCT00996892|616065240|FG001|Expansion Stage 2|Disease Progression|0|||
170471984|NCT00996892|616065241|FG002|Expansion Stage 2|Disease Progression|0|||
170471985|NCT00996892|616065242|FG003|Expansion Stage 2|Disease Progression|0|||
170471986|NCT00996892|616065243|FG004|Expansion Stage 2|Disease Progression|0|||
170471987|NCT00996892|616065244|FG005|Expansion Stage 2|Disease Progression|0|||
170471988|NCT00996892|616065245|FG006|Expansion Stage 2|Disease Progression|0|||
170471989|NCT00996892|616065246|FG007|Expansion Stage 2|Disease Progression|0|||
170471990|NCT00996892|616065247|FG008|Expansion Stage 2|Disease Progression|0|||
170471991|NCT00996892|616065248|FG009|Expansion Stage 2|Disease Progression|0|||
170471992|NCT00996892|616065249|FG010|Expansion Stage 2|Disease Progression|0|||
170471993|NCT00996892|616065250|FG011|Expansion Stage 2|Disease Progression|0|||
170471994|NCT00996892|616065251|FG012|Expansion Stage 2|Disease Progression|0|||
170471995|NCT00996892|616065252|FG013|Expansion Stage 2|Disease Progression|0|||
170471996|NCT00996892|616065253|FG014|Expansion Stage 2|Disease Progression|0|||
170471997|NCT00996892|616065254|FG015|Expansion Stage 2|Disease Progression|0|||
170471998|NCT00996892|616065255|FG016|Expansion Stage 2|Disease Progression|0|||
170471999|NCT00996892|616065256|FG017|Expansion Stage 2|Disease Progression|0|||
170472000|NCT00996892|616065257|FG018|Expansion Stage 2|Disease Progression|28|||
170472001|NCT00996892|616065258|FG019|Expansion Stage 2|Disease Progression|0|||
170472002|NCT00996892|616065239|FG000|Expansion Stage 2A|Adverse Event|0|||
170472003|NCT00996892|616065240|FG001|Expansion Stage 2A|Adverse Event|0|||
170472004|NCT00996892|616065241|FG002|Expansion Stage 2A|Adverse Event|0|||
170472005|NCT00996892|616065242|FG003|Expansion Stage 2A|Adverse Event|0|||
170472006|NCT00996892|616065243|FG004|Expansion Stage 2A|Adverse Event|0|||
170472007|NCT00996892|616065244|FG005|Expansion Stage 2A|Adverse Event|0|||
170472008|NCT00996892|616065245|FG006|Expansion Stage 2A|Adverse Event|0|||
170472009|NCT00996892|616065246|FG007|Expansion Stage 2A|Adverse Event|0|||
170472010|NCT00996892|616065247|FG008|Expansion Stage 2A|Adverse Event|0|||
170472011|NCT00996892|616065248|FG009|Expansion Stage 2A|Adverse Event|0|||
170472012|NCT00996892|616065249|FG010|Expansion Stage 2A|Adverse Event|0|||
170472013|NCT00996892|616065250|FG011|Expansion Stage 2A|Adverse Event|0|||
170472014|NCT00996892|616065251|FG012|Expansion Stage 2A|Adverse Event|0|||
170472015|NCT00996892|616065252|FG013|Expansion Stage 2A|Adverse Event|0|||
170472016|NCT00996892|616065253|FG014|Expansion Stage 2A|Adverse Event|0|||
170472017|NCT00996892|616065254|FG015|Expansion Stage 2A|Adverse Event|0|||
170472018|NCT00996892|616065255|FG016|Expansion Stage 2A|Adverse Event|0|||
170472019|NCT00996892|616065256|FG017|Expansion Stage 2A|Adverse Event|0|||
170472020|NCT00996892|616065257|FG018|Expansion Stage 2A|Adverse Event|0|||
170472021|NCT00996892|616065258|FG019|Expansion Stage 2A|Adverse Event|8|||
170472022|NCT00996892|616065239|FG000|Expansion Stage 2A|Physician Decision|0|||
170472023|NCT00996892|616065240|FG001|Expansion Stage 2A|Physician Decision|0|||
170472024|NCT00996892|616065241|FG002|Expansion Stage 2A|Physician Decision|0|||
170472025|NCT00996892|616065242|FG003|Expansion Stage 2A|Physician Decision|0|||
170472026|NCT00996892|616065243|FG004|Expansion Stage 2A|Physician Decision|0|||
170472027|NCT00996892|616065244|FG005|Expansion Stage 2A|Physician Decision|0|||
170472028|NCT00996892|616065245|FG006|Expansion Stage 2A|Physician Decision|0|||
170472029|NCT00996892|616065246|FG007|Expansion Stage 2A|Physician Decision|0|||
170472030|NCT00996892|616065247|FG008|Expansion Stage 2A|Physician Decision|0|||
170472031|NCT00996892|616065248|FG009|Expansion Stage 2A|Physician Decision|0|||
170472032|NCT00996892|616065249|FG010|Expansion Stage 2A|Physician Decision|0|||
170472033|NCT00996892|616065250|FG011|Expansion Stage 2A|Physician Decision|0|||
170472034|NCT00996892|616065251|FG012|Expansion Stage 2A|Physician Decision|0|||
170545682|NCT04676646|616342716|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
170472035|NCT00996892|616065252|FG013|Expansion Stage 2A|Physician Decision|0|||
170472036|NCT00996892|616065253|FG014|Expansion Stage 2A|Physician Decision|0|||
170472037|NCT00996892|616065254|FG015|Expansion Stage 2A|Physician Decision|0|||
170472038|NCT00996892|616065255|FG016|Expansion Stage 2A|Physician Decision|0|||
170472039|NCT00996892|616065256|FG017|Expansion Stage 2A|Physician Decision|0|||
170472040|NCT00996892|616065257|FG018|Expansion Stage 2A|Physician Decision|0|||
170472041|NCT00996892|616065258|FG019|Expansion Stage 2A|Physician Decision|2|||
170472042|NCT00996892|616065239|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
170472043|NCT00996892|616065240|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
170472044|NCT00996892|616065241|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
170472045|NCT00996892|616065242|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
170472046|NCT00996892|616065243|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
170472047|NCT00996892|616065244|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
170472048|NCT00996892|616065245|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
170472049|NCT00996892|616065246|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
170472050|NCT00996892|616065247|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
170472051|NCT00996892|616065248|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
170472052|NCT00996892|616065249|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
170472053|NCT00996892|616065250|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
170472054|NCT00996892|616065251|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
170472055|NCT00996892|616065252|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
170472056|NCT00996892|616065253|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
170472057|NCT00996892|616065254|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
170472058|NCT00996892|616065255|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
170472059|NCT00996892|616065256|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
170472060|NCT00996892|616065257|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
170472061|NCT00996892|616065258|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
170472062|NCT00996892|616065239|FG000|Expansion Stage 2A|Disease Progression|0|||
170472063|NCT00996892|616065240|FG001|Expansion Stage 2A|Disease Progression|0|||
170472064|NCT00996892|616065241|FG002|Expansion Stage 2A|Disease Progression|0|||
170472065|NCT00996892|616065242|FG003|Expansion Stage 2A|Disease Progression|0|||
170472066|NCT00996892|616065243|FG004|Expansion Stage 2A|Disease Progression|0|||
170472067|NCT00996892|616065244|FG005|Expansion Stage 2A|Disease Progression|0|||
170472068|NCT00996892|616065245|FG006|Expansion Stage 2A|Disease Progression|0|||
170472069|NCT00996892|616065246|FG007|Expansion Stage 2A|Disease Progression|0|||
170472070|NCT00996892|616065247|FG008|Expansion Stage 2A|Disease Progression|0|||
170472071|NCT00996892|616065248|FG009|Expansion Stage 2A|Disease Progression|0|||
170472072|NCT00996892|616065249|FG010|Expansion Stage 2A|Disease Progression|0|||
170472073|NCT00996892|616065250|FG011|Expansion Stage 2A|Disease Progression|0|||
170472074|NCT00996892|616065251|FG012|Expansion Stage 2A|Disease Progression|0|||
170472075|NCT00996892|616065252|FG013|Expansion Stage 2A|Disease Progression|0|||
170472076|NCT00996892|616065253|FG014|Expansion Stage 2A|Disease Progression|0|||
170472077|NCT00996892|616065254|FG015|Expansion Stage 2A|Disease Progression|0|||
170472078|NCT00996892|616065255|FG016|Expansion Stage 2A|Disease Progression|0|||
170472079|NCT00996892|616065256|FG017|Expansion Stage 2A|Disease Progression|0|||
170472080|NCT00996892|616065257|FG018|Expansion Stage 2A|Disease Progression|0|||
170472081|NCT00996892|616065258|FG019|Expansion Stage 2A|Disease Progression|31|||
170472082|NCT00993421|616065259|FG000|Overall Study|Adverse Event|2|||
170472083|NCT00993421|616065260|FG001|Overall Study|Adverse Event|7|||
170472084|NCT00993421|616065261|FG002|Overall Study|Adverse Event|6|||
170472085|NCT00993421|616065262|FG003|Overall Study|Adverse Event|9|||
170472086|NCT00993421|616065263|FG004|Overall Study|Adverse Event|5|||
170472087|NCT00993421|616065264|FG005|Overall Study|Adverse Event|7|||
170472088|NCT00993421|616065265|FG006|Overall Study|Adverse Event|1|||
170472089|NCT00993421|616065259|FG000|Overall Study|Sponsor Decision|36|||
170472090|NCT00993421|616065260|FG001|Overall Study|Sponsor Decision|31|||
170472091|NCT00993421|616065261|FG002|Overall Study|Sponsor Decision|28|||
170472092|NCT00993421|616065262|FG003|Overall Study|Sponsor Decision|30|||
170637722|NCT03304249|616684656|FG000|Overall Study|Withdrawal by Subject|12|||
170472093|NCT00993421|616065263|FG004|Overall Study|Sponsor Decision|38|||
170472094|NCT00993421|616065264|FG005|Overall Study|Sponsor Decision|30|||
170472095|NCT00993421|616065265|FG006|Overall Study|Sponsor Decision|29|||
170472096|NCT00993421|616065259|FG000|Overall Study|Lost to Follow-up|3|||
170472097|NCT00993421|616065260|FG001|Overall Study|Lost to Follow-up|5|||
170472098|NCT00993421|616065261|FG002|Overall Study|Lost to Follow-up|5|||
170472099|NCT00993421|616065262|FG003|Overall Study|Lost to Follow-up|0|||
170472100|NCT00993421|616065263|FG004|Overall Study|Lost to Follow-up|0|||
170472101|NCT00993421|616065264|FG005|Overall Study|Lost to Follow-up|0|||
170472102|NCT00993421|616065265|FG006|Overall Study|Lost to Follow-up|6|||
170637723|NCT03304249|616684657|FG001|Overall Study|Withdrawal by Subject|2|||
170637724|NCT03304249|616684656|FG000|Overall Study|Moved Out of District|4|||
170637725|NCT03304249|616684657|FG001|Overall Study|Moved Out of District|2|||
170637726|NCT04672655|616684659|FG000|Overall Study|Lost to Follow-up|12|||
170637727|NCT04672655|616684660|FG001|Overall Study|Lost to Follow-up|17|||
170637728|NCT04672655|616684659|FG000|Overall Study|Withdrawal by Subject|1|||
170472103|NCT00993421|616065259|FG000|Overall Study|Withdrawal by Subject|3|||
170472104|NCT00993421|616065260|FG001|Overall Study|Withdrawal by Subject|2|||
170472105|NCT00993421|616065261|FG002|Overall Study|Withdrawal by Subject|3|||
170472106|NCT00993421|616065262|FG003|Overall Study|Withdrawal by Subject|3|||
170472107|NCT00993421|616065263|FG004|Overall Study|Withdrawal by Subject|3|||
170472108|NCT00993421|616065264|FG005|Overall Study|Withdrawal by Subject|5|||
170472109|NCT00993421|616065265|FG006|Overall Study|Withdrawal by Subject|3|||
170472110|NCT00993421|616065259|FG000|Overall Study|Death|0|||
170472111|NCT00993421|616065260|FG001|Overall Study|Death|0|||
170472112|NCT00993421|616065261|FG002|Overall Study|Death|0|||
170472113|NCT00993421|616065262|FG003|Overall Study|Death|0|||
170472114|NCT00993421|616065263|FG004|Overall Study|Death|0|||
170472115|NCT00993421|616065264|FG005|Overall Study|Death|0|||
170637729|NCT04672655|616684660|FG001|Overall Study|Withdrawal by Subject|0|||
170637730|NCT04672655|616684659|FG000|Overall Study|Withdrawal by Study|1|||
170472116|NCT00993421|616065265|FG006|Overall Study|Death|1|||
170472117|NCT00993421|616065259|FG000|Overall Study|Entry Criteria Exclusion|0|||
170472118|NCT00993421|616065260|FG001|Overall Study|Entry Criteria Exclusion|0|||
170472119|NCT00993421|616065261|FG002|Overall Study|Entry Criteria Exclusion|1|||
170472120|NCT00993421|616065262|FG003|Overall Study|Entry Criteria Exclusion|3|||
170472121|NCT00993421|616065263|FG004|Overall Study|Entry Criteria Exclusion|0|||
170472122|NCT00993421|616065264|FG005|Overall Study|Entry Criteria Exclusion|1|||
170472123|NCT00993421|616065265|FG006|Overall Study|Entry Criteria Exclusion|0|||
170472124|NCT00993421|616065259|FG000|Overall Study|Physician Decision|0|||
170472125|NCT00993421|616065260|FG001|Overall Study|Physician Decision|0|||
170472126|NCT00993421|616065261|FG002|Overall Study|Physician Decision|0|||
170472127|NCT00993421|616065262|FG003|Overall Study|Physician Decision|0|||
170472128|NCT00993421|616065263|FG004|Overall Study|Physician Decision|0|||
170472129|NCT00993421|616065264|FG005|Overall Study|Physician Decision|1|||
170472130|NCT00993421|616065265|FG006|Overall Study|Physician Decision|1|||
170472131|NCT00993421|616065259|FG000|Overall Study|Protocol Violation|0|||
170472132|NCT00993421|616065260|FG001|Overall Study|Protocol Violation|0|||
170472133|NCT00993421|616065261|FG002|Overall Study|Protocol Violation|0|||
170472134|NCT00993421|616065262|FG003|Overall Study|Protocol Violation|0|||
170472135|NCT00993421|616065263|FG004|Overall Study|Protocol Violation|0|||
170472136|NCT00993421|616065264|FG005|Overall Study|Protocol Violation|2|||
170472137|NCT00993421|616065265|FG006|Overall Study|Protocol Violation|1|||
170472138|NCT01653912|616065266|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
170472139|NCT01653912|616065267|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
170472140|NCT01653912|616065268|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
170472141|NCT01653912|616065269|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
170472142|NCT01653912|616065270|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
170472143|NCT01653912|616065271|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
170472144|NCT01653912|616065266|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
170472145|NCT01653912|616065267|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
170472146|NCT01653912|616065268|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
170472147|NCT01653912|616065269|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
170472148|NCT01653912|616065270|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
170472149|NCT01653912|616065271|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
170472150|NCT01653912|616065266|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
170472151|NCT01653912|616065267|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
170472152|NCT01653912|616065268|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
170472153|NCT01653912|616065269|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
170472154|NCT01653912|616065270|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
170472155|NCT01653912|616065271|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
170472156|NCT01653912|616065266|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472157|NCT01653912|616065267|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472158|NCT01653912|616065268|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472159|NCT01653912|616065269|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
170472160|NCT01653912|616065270|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472161|NCT01653912|616065271|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472162|NCT01653912|616065266|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
170472163|NCT01653912|616065267|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
170472164|NCT01653912|616065268|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
170472165|NCT01653912|616065269|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
170472166|NCT01653912|616065270|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
170472167|NCT01653912|616065271|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
170472168|NCT01653912|616065266|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
170472169|NCT01653912|616065267|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
170472170|NCT01653912|616065268|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
170472171|NCT01653912|616065269|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
170472172|NCT01653912|616065270|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
170472173|NCT01653912|616065271|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
170545683|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
170791720|NCT01210807|617247951|FG001|Overall Study|Not implanted bilaterally|1|||
170472174|NCT01653912|616065266|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472175|NCT01653912|616065267|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472176|NCT01653912|616065268|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472177|NCT01653912|616065269|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472178|NCT01653912|616065270|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
170472179|NCT01653912|616065271|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
170545684|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
170472180|NCT02759692|616065272|FG000|Period 1|Test article no longer available|1|||
170472181|NCT02759692|616065273|FG001|Period 1|Test article no longer available|1|||
170791721|NCT05477186|617247953|FG000|Overall Study|Vaccine not administered|0|||
170791722|NCT05477186|617247954|FG001|Overall Study|Vaccine not administered|2|||
170791723|NCT05477186|617247955|FG002|Overall Study|Vaccine not administered|1|||
170472182|NCT02759692|616065272|FG000|Period 1|No longer meets eligibility criteria.|1|||
170472183|NCT02759692|616065273|FG001|Period 1|No longer meets eligibility criteria.|0|||
170472184|NCT02759692|616065272|FG000|Period 1|Miss-Randomized|1|||
170472185|NCT02759692|616065273|FG001|Period 1|Miss-Randomized|1|||
170472186|NCT02759692|616065272|FG000|Period 2|Lost to Follow-up|1|||
170472187|NCT02759692|616065273|FG001|Period 2|Lost to Follow-up|0|||
170472188|NCT02759692|616065272|FG000|Period 2|Test article no longer available|0|||
170472189|NCT02759692|616065273|FG001|Period 2|Test article no longer available|1|||
170472190|NCT00708227|616065278|FG000|Overall Study|Physician Decision|0|||
170472191|NCT00708227|616065279|FG001|Overall Study|Physician Decision|3|||
170472192|NCT00708227|616065280|FG002|Overall Study|Physician Decision|1|||
170472193|NCT00708227|616065281|FG003|Overall Study|Physician Decision|2|||
170472194|NCT00708227|616065278|FG000|Overall Study|Withdrawal by Subject|1|||
170472195|NCT00708227|616065279|FG001|Overall Study|Withdrawal by Subject|2|||
170472196|NCT00708227|616065280|FG002|Overall Study|Withdrawal by Subject|0|||
170472197|NCT00708227|616065281|FG003|Overall Study|Withdrawal by Subject|1|||
170472198|NCT01987479|616065283|FG000|Overall Study|Protocol Violation|1|||
170472199|NCT01987479|616065283|FG000|Overall Study|Physician Decision|2|||
170472200|NCT01987479|616065283|FG000|Overall Study|Participant/legal guardian decision|1|||
170472201|NCT01987479|616065283|FG000|Overall Study|Other|5|||
170472202|NCT01987479|616065283|FG000|Overall Study|Lost to Follow-up|1|||
170472203|NCT01987479|616065283|FG000|Overall Study|Adverse Event|7|||
170472204|NCT01177059|616065284|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
170472205|NCT01177059|616065284|FG000|Overall Study|Withdrew consent|2|||
170472206|NCT01177059|616065284|FG000|Overall Study|Lost to Follow-up|18|||
170472207|NCT05422625|616065285|FG000|Overall Study|Withdrawal by Subject|1|||
170472208|NCT05422625|616065286|FG001|Overall Study|Withdrawal by Subject|0|||
170472209|NCT01059786|616066775|FG000|Overall Study|Did not receive 6 cycles.|0|||
170472210|NCT01059786|616066776|FG001|Overall Study|Did not receive 6 cycles.|0|||
170472211|NCT01059786|616066777|FG002|Overall Study|Did not receive 6 cycles.|4|||
170472212|NCT01059786|616066778|FG003|Overall Study|Did not receive 6 cycles.|1|||
170472213|NCT01059786|616066779|FG004|Overall Study|Did not receive 6 cycles.|0|||
170472214|NCT04559347|616066780|FG000|Overall Study|Death|1|||
170472215|NCT04559347|616066781|FG001|Overall Study|Death|0|||
170472216|NCT04559347|616066780|FG000|Overall Study|Thoracotomy conversion|1|||
170472217|NCT04559347|616066781|FG001|Overall Study|Thoracotomy conversion|1|||
170472218|NCT04559347|616066780|FG000|Overall Study|Provider unavailable|2|||
170472219|NCT04559347|616066781|FG001|Overall Study|Provider unavailable|1|||
170472220|NCT04559347|616066780|FG000|Overall Study|Other|2|||
170472221|NCT04559347|616066781|FG001|Overall Study|Other|1|||
170472222|NCT03130777|616066782|FG000|Overall Study|Death|0|||
170472223|NCT03130777|616066783|FG001|Overall Study|Death|1|||
170472224|NCT03130777|616066782|FG000|Overall Study|Did not meet eligibility criteria|1|||
170472225|NCT03130777|616066783|FG001|Overall Study|Did not meet eligibility criteria|0|||
170472226|NCT05109611|616066784|FG000|Overall Study|Adverse Event|13|||
170472227|NCT05109611|616066785|FG001|Overall Study|Adverse Event|10|||
170472228|NCT05109611|616066784|FG000|Overall Study|Withdrawal by Subject|1|||
170472229|NCT05109611|616066785|FG001|Overall Study|Withdrawal by Subject|0|||
170472230|NCT05109611|616066784|FG000|Overall Study|Lost to Follow-up|1|||
170472231|NCT05109611|616066785|FG001|Overall Study|Lost to Follow-up|2|||
170472232|NCT05109611|616066784|FG000|Overall Study|Protocol Violation|0|||
170472233|NCT05109611|616066785|FG001|Overall Study|Protocol Violation|4|||
170472234|NCT05109611|616066784|FG000|Overall Study|Information unavailable|1|||
170472235|NCT05109611|616066785|FG001|Overall Study|Information unavailable|1|||
170472236|NCT02291510|616066786|FG000|Overall Study|Adverse Event|0|||
170472237|NCT02291510|616066787|FG001|Overall Study|Adverse Event|0|||
170472238|NCT02291510|616066788|FG002|Overall Study|Adverse Event|0|||
170472239|NCT02291510|616066789|FG003|Overall Study|Adverse Event|1|||
170472240|NCT03203850|616066794|FG000|Overall Study|Subject/guardian decision|4|||
170472241|NCT03203850|616066795|FG001|Overall Study|Subject/guardian decision|3|||
170472242|NCT03203850|616066794|FG000|Overall Study|Adverse Event|3|||
170472243|NCT03203850|616066795|FG001|Overall Study|Adverse Event|0|||
170472244|NCT03203850|616066794|FG000|Overall Study|Death|1|||
170472245|NCT03203850|616066795|FG001|Overall Study|Death|0|||
170472246|NCT02717455|616066796|FG000|Overall Study|Adverse Event|1|||
170472247|NCT02717455|616066797|FG001|Overall Study|Adverse Event|0|||
170472248|NCT02717455|616066798|FG002|Overall Study|Adverse Event|0|||
170472249|NCT02717455|616066799|FG003|Overall Study|Adverse Event|2|||
170472250|NCT02717455|616066800|FG004|Overall Study|Adverse Event|2|||
170472251|NCT02717455|616066801|FG005|Overall Study|Adverse Event|2|||
170472252|NCT02717455|616066796|FG000|Overall Study|Withdrawal by Subject|1|||
170472253|NCT02717455|616066797|FG001|Overall Study|Withdrawal by Subject|1|||
170472254|NCT02717455|616066798|FG002|Overall Study|Withdrawal by Subject|0|||
170472255|NCT02717455|616066799|FG003|Overall Study|Withdrawal by Subject|2|||
170472256|NCT02717455|616066800|FG004|Overall Study|Withdrawal by Subject|2|||
170472257|NCT02717455|616066801|FG005|Overall Study|Withdrawal by Subject|1|||
170472258|NCT02717455|616066796|FG000|Overall Study|Death|1|||
170472259|NCT02717455|616066797|FG001|Overall Study|Death|0|||
170472260|NCT02717455|616066798|FG002|Overall Study|Death|0|||
170472261|NCT02717455|616066799|FG003|Overall Study|Death|0|||
170472262|NCT02717455|616066800|FG004|Overall Study|Death|1|||
170472263|NCT02717455|616066801|FG005|Overall Study|Death|0|||
170472264|NCT02717455|616066796|FG000|Overall Study|Did not receive study drug|0|||
170472265|NCT02717455|616066797|FG001|Overall Study|Did not receive study drug|0|||
170472266|NCT02717455|616066798|FG002|Overall Study|Did not receive study drug|0|||
170472267|NCT02717455|616066799|FG003|Overall Study|Did not receive study drug|1|||
170472268|NCT02717455|616066800|FG004|Overall Study|Did not receive study drug|0|||
170472269|NCT02717455|616066801|FG005|Overall Study|Did not receive study drug|1|||
170472270|NCT02717455|616066796|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
170472271|NCT02717455|616066797|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
170472272|NCT02717455|616066798|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
170472273|NCT02717455|616066799|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
170472274|NCT02717455|616066800|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
170472275|NCT02717455|616066801|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
170472276|NCT02717455|616066796|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
170472277|NCT02717455|616066797|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
170472278|NCT02717455|616066798|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
170472279|NCT02717455|616066799|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
170472280|NCT02717455|616066800|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
170472281|NCT02717455|616066801|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
170472282|NCT01433055|616066802|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
170472283|NCT01433055|616066803|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
170472284|NCT01433055|616066802|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
170472285|NCT01433055|616066803|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
170472286|NCT00733005|616066808|FG000|Overall Study|Adverse Event|0|||
170472287|NCT00733005|616066809|FG001|Overall Study|Adverse Event|1|||
170472288|NCT00733005|616066808|FG000|Overall Study|Treatment Failure|0|||
170472289|NCT00733005|616066809|FG001|Overall Study|Treatment Failure|1|||
170472290|NCT00733005|616066808|FG000|Overall Study|Withdrawal by Subject|0|||
170472291|NCT00733005|616066809|FG001|Overall Study|Withdrawal by Subject|1|||
170472292|NCT00733005|616066808|FG000|Overall Study|Protocol Violation|2|||
170472293|NCT00733005|616066809|FG001|Overall Study|Protocol Violation|0|||
170472294|NCT01769456|616066810|FG000|Overall Study|Lost to Follow-up|19|||
170472295|NCT01769456|616066810|FG000|Overall Study|Withdrawal by Subject|3|||
170472296|NCT01769456|616066810|FG000|Overall Study|Did not receive PCC intervention|6|||
170472297|NCT01769456|616066810|FG000|Overall Study|Moved out of the area|3|||
170472298|NCT01769456|616066810|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
170472299|NCT01769456|616066810|FG000|Overall Study|Parental request to youth to withdraw|1|||
170472300|NCT01009814|616066819|FG000|Overall Study|No longer met study criteria|1|||
170472301|NCT01009814|616066820|FG001|Overall Study|No longer met study criteria|1|||
170472302|NCT01009814|616066821|FG002|Overall Study|No longer met study criteria|0|||
170472303|NCT01009814|616066822|FG003|Overall Study|No longer met study criteria|0|||
170472304|NCT01009814|616066823|FG004|Overall Study|No longer met study criteria|0|||
170472305|NCT00618371|616066824|FG000|Overall Study|Withdrawal by Subject|2|||
170472306|NCT02969382|616066825|FG000|Overall Study|Adverse Event|8|||
170472307|NCT02969382|616066826|FG001|Overall Study|Adverse Event|10|||
170472308|NCT02969382|616066825|FG000|Overall Study|Lack of Efficacy|4|||
170472309|NCT02969382|616066826|FG001|Overall Study|Lack of Efficacy|5|||
170472310|NCT02969382|616066825|FG000|Overall Study|Death|0|||
170472311|NCT02969382|616066826|FG001|Overall Study|Death|1|||
170472312|NCT02969382|616066825|FG000|Overall Study|PROTOCOL DEVIATION|0|||
170472313|NCT02969382|616066826|FG001|Overall Study|PROTOCOL DEVIATION|1|||
170472314|NCT02969382|616066825|FG000|Overall Study|Withdrawal by Subject|14|||
170472315|NCT02969382|616066826|FG001|Overall Study|Withdrawal by Subject|9|||
170472316|NCT01173120|616066827|FG000|Overall Study|Lack of Efficacy|2|||
170472317|NCT01173120|616066827|FG000|Overall Study|Lost to Follow-up|1|||
170545685|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
170545686|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Death|0|||
170545687|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Death|1|||
170545688|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Death|2|||
170545689|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
170545690|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
170545691|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
170472318|NCT01173120|616066827|FG000|Overall Study|Participant Decision|2|||
170472319|NCT01173120|616066827|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
170545692|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
170545693|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
170545694|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
170565501|NCT01959529|616418539|FG001|Overall Study|Lack of glycaemic control|1|||
170472320|NCT01173120|616066827|FG000|Overall Study|Switch-Participant Decision|12|||
170472321|NCT01173120|616066827|FG000|Overall Study|Switch-Difficulty With Device|12|||
170472322|NCT02090725|616066828|FG000|Overall Study|Withdrawal by Subject|1|||
170472323|NCT02090725|616066828|FG000|Overall Study|participants moved from area|3|||
170472324|NCT00886015|616066832|FG000|Overall Study|Death|0|||
170472325|NCT00886015|616066833|FG001|Overall Study|Death|2|||
170472326|NCT01692626|616066834|FG000|Overall Study|Death|0|||
170472327|NCT01692626|616066835|FG001|Overall Study|Death|1|||
170472328|NCT01692626|616066834|FG000|Overall Study|Adverse Event|2|||
170472329|NCT01692626|616066835|FG001|Overall Study|Adverse Event|3|||
170472330|NCT01692626|616066834|FG000|Overall Study|Protocol Violation|1|||
170472331|NCT01692626|616066835|FG001|Overall Study|Protocol Violation|2|||
170472332|NCT01692626|616066834|FG000|Overall Study|Withdrawal by Subject|1|||
170472333|NCT01692626|616066835|FG001|Overall Study|Withdrawal by Subject|0|||
170472334|NCT01145508|616066836|FG000|Overall Study|Adverse Event|1|||
170472335|NCT01145508|616066837|FG001|Overall Study|Adverse Event|0|||
170472336|NCT01145508|616066836|FG000|Overall Study|Death|1|||
170472337|NCT01145508|616066837|FG001|Overall Study|Death|0|||
170472338|NCT01145508|616066836|FG000|Overall Study|Physician Decision|2|||
170472339|NCT01145508|616066837|FG001|Overall Study|Physician Decision|1|||
170472340|NCT01145508|616066836|FG000|Overall Study|Never started treatment|1|||
170472341|NCT01145508|616066837|FG001|Overall Study|Never started treatment|1|||
170472342|NCT02437903|616066845|FG000|Overall Study|Adverse Event|1|||
170472343|NCT02437903|616066845|FG000|Overall Study|Withdrawal by Subject|1|||
170472344|NCT02437903|616066845|FG000|Overall Study|Lost to Follow-up|3|||
170472345|NCT02439970|616066850|FG000|Overall Study|Study Terminated|2|||
170545695|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
170545696|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
170545697|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
170545698|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
170545699|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
170545700|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
170545701|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
170545702|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
170545703|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
170545704|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
170545705|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
170545706|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
170791724|NCT05477186|617247956|FG003|Overall Study|Vaccine not administered|0|||
170791725|NCT05477186|617247957|FG004|Overall Study|Vaccine not administered|1|||
170791726|NCT05477186|617247958|FG005|Overall Study|Vaccine not administered|0|||
170791727|NCT05477186|617247959|FG006|Overall Study|Vaccine not administered|0|||
170791728|NCT05477186|617247953|FG000|Overall Study|Withdrawal by Subject|1|||
170791729|NCT05477186|617247954|FG001|Overall Study|Withdrawal by Subject|0|||
170791730|NCT05477186|617247955|FG002|Overall Study|Withdrawal by Subject|0|||
170791731|NCT05477186|617247956|FG003|Overall Study|Withdrawal by Subject|0|||
170791732|NCT05477186|617247957|FG004|Overall Study|Withdrawal by Subject|0|||
170791733|NCT05477186|617247958|FG005|Overall Study|Withdrawal by Subject|1|||
170791734|NCT05477186|617247959|FG006|Overall Study|Withdrawal by Subject|0|||
170791735|NCT05477186|617247953|FG000|Overall Study|Lost to Follow-up|1|||
170791736|NCT05477186|617247954|FG001|Overall Study|Lost to Follow-up|0|||
170791737|NCT05477186|617247955|FG002|Overall Study|Lost to Follow-up|2|||
170791738|NCT05477186|617247956|FG003|Overall Study|Lost to Follow-up|1|||
170791739|NCT05477186|617247957|FG004|Overall Study|Lost to Follow-up|1|||
170791740|NCT05477186|617247958|FG005|Overall Study|Lost to Follow-up|0|||
170791741|NCT05477186|617247959|FG006|Overall Study|Lost to Follow-up|2|||
170791742|NCT03240016|617247960|FG000|Overall Study|Adverse Event|9|||
170791743|NCT03240016|617247960|FG000|Overall Study|Withdrawal by Subject|7|||
170791744|NCT03240016|617247960|FG000|Overall Study|Death|1|||
170791745|NCT03240016|617247960|FG000|Overall Study|Physician Decision|2|||
170791746|NCT05200403|617247961|FG000|Overall Study|Withdrawal by Subject|4|||
170791747|NCT05200403|617247962|FG001|Overall Study|Withdrawal by Subject|2|||
170791748|NCT05200403|617247963|FG002|Overall Study|Withdrawal by Subject|6|||
170791749|NCT05546411|617247964|FG000|Overall Study|Progressive Disease|1|||
170791750|NCT05546411|617247965|FG001|Overall Study|Progressive Disease|0|||
170472346|NCT02439970|616066851|FG001|Overall Study|Study Terminated|3|||
170472347|NCT01121562|616066852|FG000|Overall Study|Objective progression or relapse|8|||
170472348|NCT01121562|616066852|FG000|Overall Study|Withdrawal by Subject|1|||
170472349|NCT01121562|616066852|FG000|Overall Study|Adverse Event|1|||
170472350|NCT01121562|616066852|FG000|Overall Study|Sponsor Decision|1|||
170472351|NCT01121562|616066852|FG000|Overall Study|Met study discontinuation criteria|1|||
170472352|NCT00616421|616066853|FG000|Overall Study|Withdrawal by Subject|9|||
170472353|NCT00616421|616066854|FG001|Overall Study|Withdrawal by Subject|11|||
170472354|NCT00616421|616066855|FG002|Overall Study|Withdrawal by Subject|8|||
170472355|NCT00616421|616066853|FG000|Overall Study|Lost to Follow-up|12|||
170472356|NCT00616421|616066854|FG001|Overall Study|Lost to Follow-up|26|||
170472357|NCT00616421|616066855|FG002|Overall Study|Lost to Follow-up|30|||
170472358|NCT00616421|616066853|FG000|Overall Study|Inappropriate enrollment|3|||
170472359|NCT00616421|616066854|FG001|Overall Study|Inappropriate enrollment|0|||
170472360|NCT00616421|616066855|FG002|Overall Study|Inappropriate enrollment|1|||
170472361|NCT00616421|616066853|FG000|Overall Study|Administrative reason|1|||
170472362|NCT00616421|616066854|FG001|Overall Study|Administrative reason|0|||
170472363|NCT00616421|616066855|FG002|Overall Study|Administrative reason|0|||
170472364|NCT00616421|616066853|FG000|Overall Study|Protocol Violation|0|||
170472365|NCT00616421|616066854|FG001|Overall Study|Protocol Violation|1|||
170472366|NCT00616421|616066855|FG002|Overall Study|Protocol Violation|2|||
170472367|NCT00616421|616066853|FG000|Overall Study|Unable to classify|1|||
170472368|NCT00616421|616066854|FG001|Overall Study|Unable to classify|0|||
170472369|NCT00616421|616066855|FG002|Overall Study|Unable to classify|0|||
170472370|NCT01495702|616066856|FG000|Randomized Phase|Randomized But Not Treated|1|||
170472371|NCT01495702|616066857|FG001|Randomized Phase|Randomized But Not Treated|4|||
170472372|NCT01495702|616066856|FG000|Randomized Phase|Adverse Event|2|||
170472373|NCT01495702|616066857|FG001|Randomized Phase|Adverse Event|2|||
170472374|NCT01495702|616066856|FG000|Randomized Phase|Death|1|||
170472375|NCT01495702|616066857|FG001|Randomized Phase|Death|0|||
170472376|NCT01495702|616066856|FG000|Randomized Phase|Lack of Efficacy|2|||
170472377|NCT01495702|616066857|FG001|Randomized Phase|Lack of Efficacy|0|||
170472378|NCT01495702|616066856|FG000|Randomized Phase|Investigators Discretion|2|||
170472379|NCT01495702|616066857|FG001|Randomized Phase|Investigators Discretion|0|||
170472380|NCT01495702|616066856|FG000|Randomized Phase|Withdrew Consent|10|||
170472381|NCT01495702|616066857|FG001|Randomized Phase|Withdrew Consent|18|||
170472382|NCT01495702|616066856|FG000|Randomized Phase|Lost to Follow-up|4|||
170472383|NCT01495702|616066857|FG001|Randomized Phase|Lost to Follow-up|3|||
170472384|NCT01495702|616066856|FG000|Randomized Phase|Participant Noncompliance|1|||
170472385|NCT01495702|616066857|FG001|Randomized Phase|Participant Noncompliance|0|||
170472386|NCT01495702|616066856|FG000|Randomized Phase|Protocol Violation|3|||
170472387|NCT01495702|616066857|FG001|Randomized Phase|Protocol Violation|1|||
170472388|NCT04152863|616066858|FG000|Overall Study|Death|13|||
170472389|NCT04152863|616066859|FG001|Overall Study|Death|12|||
170472390|NCT04152863|616066860|FG002|Overall Study|Death|7|||
170472391|NCT04152863|616066858|FG000|Overall Study|Physician Decision|1|||
170472392|NCT04152863|616066859|FG001|Overall Study|Physician Decision|1|||
170472393|NCT04152863|616066860|FG002|Overall Study|Physician Decision|1|||
170472394|NCT04152863|616066858|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
170472395|NCT04152863|616066859|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
170472396|NCT04152863|616066860|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
170472397|NCT04152863|616066858|FG000|Overall Study|Withdrawal by Subject|2|||
170472398|NCT04152863|616066859|FG001|Overall Study|Withdrawal by Subject|1|||
170472399|NCT04152863|616066860|FG002|Overall Study|Withdrawal by Subject|3|||
170472400|NCT03593395|616066863|FG000|Overall Study|Lost to Follow-up|48|||
170472401|NCT03593395|616066864|FG001|Overall Study|Lost to Follow-up|3|||
170472402|NCT03593395|616066863|FG000|Overall Study|Withdrawal by Subject|5|||
170472403|NCT03593395|616066864|FG001|Overall Study|Withdrawal by Subject|24|||
170472404|NCT03593395|616066863|FG000|Overall Study|Death|2|||
170472405|NCT03593395|616066864|FG001|Overall Study|Death|3|||
170472406|NCT03593395|616066863|FG000|Overall Study|Physician Decision|0|||
170472407|NCT03593395|616066864|FG001|Overall Study|Physician Decision|6|||
170472408|NCT03593395|616066863|FG000|Overall Study|Participant Relocated|19|||
170472409|NCT03593395|616066864|FG001|Overall Study|Participant Relocated|3|||
170472410|NCT03593395|616066863|FG000|Overall Study|No Information|1|||
170472411|NCT03593395|616066864|FG001|Overall Study|No Information|7|||
170472412|NCT03022370|616066868|FG000|Overall Study|Death|6|||
170472413|NCT03022370|616066869|FG001|Overall Study|Death|12|||
170472414|NCT03022370|616066868|FG000|Overall Study|Lost to Follow-up|174|||
170472415|NCT03022370|616066869|FG001|Overall Study|Lost to Follow-up|109|||
170472416|NCT03151304|616066873|FG000|Overall Study|Termination of study by Sponsor|23|||
170472417|NCT03151304|616066873|FG000|Overall Study|missing|3|||
170545707|NCT04676646|616342714|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
170545708|NCT04676646|616342715|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
170472418|NCT03151304|616066873|FG000|Overall Study|Withdrawal by Subject|8|||
170472419|NCT03151304|616066873|FG000|Overall Study|multiple reasons|30|||
170472420|NCT04036110|616066877|FG000|Overall Study|Lost to Follow-up|3|||
170472421|NCT04036110|616066878|FG001|Overall Study|Lost to Follow-up|2|||
170472422|NCT04036110|616066879|FG002|Overall Study|Lost to Follow-up|1|||
170472423|NCT04036110|616066877|FG000|Overall Study|Study Suspended|4|||
170472424|NCT04036110|616066878|FG001|Overall Study|Study Suspended|5|||
170472425|NCT04036110|616066879|FG002|Overall Study|Study Suspended|1|||
170472426|NCT00534404|616066880|FG000|Overall Study|Death|0|||
170472427|NCT00534404|616066881|FG001|Overall Study|Death|0|||
170472428|NCT00534404|616066882|FG002|Overall Study|Death|2|||
170472429|NCT00534404|616066880|FG000|Overall Study|Withdrawal by Subject|8|||
170472430|NCT00534404|616066881|FG001|Overall Study|Withdrawal by Subject|2|||
170472431|NCT00534404|616066882|FG002|Overall Study|Withdrawal by Subject|38|||
170472432|NCT00534404|616066880|FG000|Overall Study|Removed by study staff|2|||
170472433|NCT00534404|616066881|FG001|Overall Study|Removed by study staff|3|||
170472434|NCT00534404|616066882|FG002|Overall Study|Removed by study staff|1|||
170472435|NCT00534404|616066880|FG000|Overall Study|Lost to Follow-up|170|||
170472436|NCT00534404|616066881|FG001|Overall Study|Lost to Follow-up|138|||
170472437|NCT00534404|616066882|FG002|Overall Study|Lost to Follow-up|201|||
170472438|NCT04759768|616066885|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
170472439|NCT04759768|616066886|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
170472440|NCT04759768|616066885|FG000|Washout (7 Days)|Physician Decision|0|||
170472441|NCT04759768|616066886|FG001|Washout (7 Days)|Physician Decision|1|||
170472442|NCT02676765|616066887|FG000|Overall Study|Lost to Follow-up|0|||
170472443|NCT02676765|616066888|FG001|Overall Study|Lost to Follow-up|1|||
170472444|NCT02374346|616066889|FG000|Overall Study|operated or discharged during weekend|48|||
170472445|NCT02565511|616066890|FG000|Overall Study|Study terminated by Sponsor|35|||
170472446|NCT02565511|616066891|FG001|Overall Study|Study terminated by Sponsor|22|||
170472447|NCT02565511|616066892|FG002|Overall Study|Study terminated by Sponsor|235|||
170472448|NCT02565511|616066893|FG003|Overall Study|Study terminated by Sponsor|156|||
170472449|NCT02565511|616066890|FG000|Overall Study|Withdrawal by Subject|3|||
170472450|NCT02565511|616066891|FG001|Overall Study|Withdrawal by Subject|0|||
170472451|NCT02565511|616066892|FG002|Overall Study|Withdrawal by Subject|12|||
170472452|NCT02565511|616066893|FG003|Overall Study|Withdrawal by Subject|5|||
170472453|NCT02565511|616066890|FG000|Overall Study|Adverse Event|0|||
170472454|NCT02565511|616066891|FG001|Overall Study|Adverse Event|0|||
170472455|NCT02565511|616066892|FG002|Overall Study|Adverse Event|1|||
170472456|NCT02565511|616066893|FG003|Overall Study|Adverse Event|1|||
170472457|NCT02565511|616066890|FG000|Overall Study|Lost to Follow-up|4|||
170472458|NCT02565511|616066891|FG001|Overall Study|Lost to Follow-up|1|||
170472459|NCT02565511|616066892|FG002|Overall Study|Lost to Follow-up|0|||
170472460|NCT02565511|616066893|FG003|Overall Study|Lost to Follow-up|1|||
170472461|NCT02565511|616066890|FG000|Overall Study|Physician Decision|0|||
170472462|NCT02565511|616066891|FG001|Overall Study|Physician Decision|0|||
170472463|NCT02565511|616066892|FG002|Overall Study|Physician Decision|0|||
170472464|NCT02565511|616066893|FG003|Overall Study|Physician Decision|1|||
170472465|NCT02565511|616066890|FG000|Overall Study|Protocol deviation|0|||
170472466|NCT02565511|616066891|FG001|Overall Study|Protocol deviation|0|||
170472467|NCT02565511|616066892|FG002|Overall Study|Protocol deviation|3|||
170472468|NCT02565511|616066893|FG003|Overall Study|Protocol deviation|0|||
170472469|NCT01941498|616066894|FG000|Overall Study|Relocated out of state|1|||
170472470|NCT00104572|616066896|FG000|Overall Study|Withdrawal by Subject|3|||
170472471|NCT00104572|616066897|FG001|Overall Study|Withdrawal by Subject|3|||
170472472|NCT00104572|616066898|FG002|Overall Study|Withdrawal by Subject|0|||
170472473|NCT03097991|616066899|FG000|Overall Study|Didn't meet study criteria|8|||
170472474|NCT03097991|616066900|FG001|Overall Study|Didn't meet study criteria|0|||
170472475|NCT03097991|616066899|FG000|Overall Study|Withdrawal by Subject|12|||
170472476|NCT03097991|616066900|FG001|Overall Study|Withdrawal by Subject|6|||
170472477|NCT03097991|616066899|FG000|Overall Study|Death of Baby|3|||
170472478|NCT03097991|616066900|FG001|Overall Study|Death of Baby|1|||
170472479|NCT03097991|616066899|FG000|Overall Study|Lost to Follow-up|24|||
170472480|NCT03097991|616066900|FG001|Overall Study|Lost to Follow-up|38|||
170472481|NCT03097991|616066899|FG000|Overall Study|Adverse Event|3|||
170472482|NCT03097991|616066900|FG001|Overall Study|Adverse Event|5|||
170472483|NCT01301729|616066903|FG000|Overall Study|Withdrawal by Subject|2|||
170472484|NCT01301729|616066903|FG000|Overall Study|Participant did not Return for Treatment|1|||
170472485|NCT01301729|616066903|FG000|Overall Study|Violated Selection Criteria|1|||
170472486|NCT03371459|616066904|FG000|Washout|Lost to Follow-up|0|||
170472487|NCT03371459|616066905|FG001|Washout|Lost to Follow-up|1|||
170472488|NCT00447993|616066908|FG000|Overall Study|Lost to Follow-up|0|||
170472489|NCT00447993|616066909|FG001|Overall Study|Lost to Follow-up|0|||
170472490|NCT00447993|616066910|FG002|Overall Study|Lost to Follow-up|2|||
170472491|NCT00447993|616066911|FG003|Overall Study|Lost to Follow-up|2|||
170472492|NCT00447993|616066908|FG000|Overall Study|Withdrawal by Subject|0|||
170472493|NCT00447993|616066909|FG001|Overall Study|Withdrawal by Subject|0|||
170472494|NCT00447993|616066910|FG002|Overall Study|Withdrawal by Subject|2|||
170472495|NCT00447993|616066911|FG003|Overall Study|Withdrawal by Subject|2|||
170472496|NCT02924727|616066912|FG000|Overall Study|Withdrawal by Subject|2|||
170472497|NCT02924727|616066913|FG001|Overall Study|Withdrawal by Subject|4|||
170472498|NCT02924727|616066912|FG000|Overall Study|Lost to Follow-up|2|||
170472499|NCT02924727|616066913|FG001|Overall Study|Lost to Follow-up|5|||
170472500|NCT02924727|616066912|FG000|Overall Study|Death|221|||
170472501|NCT02924727|616066913|FG001|Overall Study|Death|247|||
170472502|NCT02924727|616066912|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
170545709|NCT04676646|616342716|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
170791751|NCT05546411|617247964|FG000|Overall Study|Adverse Event|0|||
170791752|NCT05546411|617247965|FG001|Overall Study|Adverse Event|1|||
170472503|NCT02924727|616066913|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
170472504|NCT03694327|616066914|FG000|Overall Study|Lost to Follow-up|13|||
170472505|NCT03694327|616066915|FG001|Overall Study|Lost to Follow-up|23|||
170472506|NCT02185053|616066916|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
170472507|NCT02185053|616066917|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
170472508|NCT02185053|616066918|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
170472509|NCT02185053|616066916|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
170472510|NCT02185053|616066917|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
170472511|NCT02185053|616066918|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
170472512|NCT02185053|616066916|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
170472513|NCT02185053|616066917|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
170472514|NCT02185053|616066918|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
170472515|NCT02185053|616066916|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
170472516|NCT02185053|616066917|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
170472517|NCT02185053|616066918|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
170472518|NCT02185053|616066916|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
170472519|NCT02185053|616066917|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
170472520|NCT02185053|616066918|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
170472521|NCT02185053|616066916|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
170472522|NCT02185053|616066917|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
170472523|NCT02185053|616066918|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
170472524|NCT02185053|616066916|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
170472525|NCT02185053|616066917|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
170472526|NCT02185053|616066918|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
170472527|NCT02185053|616066916|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
170472528|NCT02185053|616066917|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
170472529|NCT02185053|616066918|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
170472530|NCT01954745|616066920|FG000|Overall Study|Radiological Progression|11|||
170472531|NCT01954745|616066920|FG000|Overall Study|Clinical Progression|5|||
170472532|NCT01954745|616066920|FG000|Overall Study|Adverse Event|2|||
170472533|NCT01954745|616066920|FG000|Overall Study|Death|1|||
170472534|NCT00352417|616066923|FG000|Overall Study|Adverse Event|1|||
170472535|NCT00352417|616066924|FG001|Overall Study|Adverse Event|0|||
170472536|NCT00352417|616066923|FG000|Overall Study|Protocol Violation|0|||
170472537|NCT00352417|616066924|FG001|Overall Study|Protocol Violation|2|||
170472538|NCT00352417|616066923|FG000|Overall Study|Withdrawal by Subject|1|||
170472539|NCT00352417|616066924|FG001|Overall Study|Withdrawal by Subject|2|||
170472540|NCT00352417|616066923|FG000|Overall Study|Lost to Follow-up|1|||
170472541|NCT00352417|616066924|FG001|Overall Study|Lost to Follow-up|0|||
170472542|NCT00352417|616066923|FG000|Overall Study|Schedule Change|2|||
170472543|NCT00352417|616066924|FG001|Overall Study|Schedule Change|1|||
170472544|NCT04205812|616069309|FG000|Randomized Treatment Period|Ongoing|28|||
170472545|NCT04205812|616069310|FG001|Randomized Treatment Period|Ongoing|138|||
170472546|NCT04205812|616069309|FG000|Randomized Treatment Period|Death|94|||
170472547|NCT04205812|616069310|FG001|Randomized Treatment Period|Death|226|||
170472548|NCT04205812|616069309|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
170472549|NCT04205812|616069310|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
170472550|NCT04205812|616069309|FG000|Randomized Treatment Period|Physician Decision|1|||
170472551|NCT04205812|616069310|FG001|Randomized Treatment Period|Physician Decision|4|||
170472552|NCT04205812|616069309|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
170472553|NCT04205812|616069310|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
170472554|NCT04205812|616069309|FG000|Randomized Treatment Period|Progressive Disease|0|||
170472555|NCT04205812|616069310|FG001|Randomized Treatment Period|Progressive Disease|1|||
170472556|NCT04205812|616069309|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
170472557|NCT04205812|616069310|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
170472558|NCT04205812|616069309|FG000|Monotherapy Treatment Period|Ongoing|17|||
170472559|NCT04205812|616069310|FG001|Monotherapy Treatment Period|Ongoing|0|||
170472560|NCT04205812|616069309|FG000|Monotherapy Treatment Period|Death|39|||
170472561|NCT04205812|616069310|FG001|Monotherapy Treatment Period|Death|0|||
170472562|NCT04205812|616069309|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
170472563|NCT04205812|616069310|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
170472564|NCT04205812|616069309|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
170472565|NCT04205812|616069310|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
170472566|NCT03573830|616069316|FG000|Overall Study|Dropped without completing treatment|0|||
170472567|NCT03573830|616069317|FG001|Overall Study|Dropped without completing treatment|7|||
170472568|NCT03573830|616069316|FG000|Overall Study|Lost to Follow-up|4|||
170472569|NCT03573830|616069317|FG001|Overall Study|Lost to Follow-up|0|||
170472570|NCT05244122|616069322|FG000|Overall Study|Withdrawal by Subject|318|||
170472571|NCT03284723|616069327|FG000|Overall Study|Death|0|||
170472572|NCT03284723|616069328|FG001|Overall Study|Death|0|||
170891644|NCT00130286|617609828|FG001|Overall Study|Adverse Event|0|||
170891645|NCT00130286|617609829|FG002|Overall Study|Adverse Event|2|||
170891646|NCT00130286|617609830|FG003|Overall Study|Adverse Event|0|||
170891647|NCT00130286|617609827|FG000|Overall Study|Missing lab specimens|0|||
170891648|NCT00130286|617609828|FG001|Overall Study|Missing lab specimens|2|||
170891649|NCT00130286|617609829|FG002|Overall Study|Missing lab specimens|0|||
170891650|NCT00130286|617609830|FG003|Overall Study|Missing lab specimens|0|||
170891651|NCT02817087|617609836|FG000|Overall Study|Withdrawal by Subject|2|||
170472573|NCT03284723|616069329|FG002|Overall Study|Death|0|||
170472574|NCT03284723|616069330|FG003|Overall Study|Death|1|||
170472575|NCT03284723|616069331|FG004|Overall Study|Death|0|||
170472576|NCT03284723|616069332|FG005|Overall Study|Death|0|||
170472577|NCT03284723|616069333|FG006|Overall Study|Death|1|||
170472578|NCT03284723|616069334|FG007|Overall Study|Death|0|||
170472579|NCT03284723|616069335|FG008|Overall Study|Death|0|||
170472580|NCT03284723|616069336|FG009|Overall Study|Death|2|||
170472581|NCT03284723|616069337|FG010|Overall Study|Death|1|||
170472582|NCT03284723|616069338|FG011|Overall Study|Death|0|||
170472583|NCT03284723|616069327|FG000|Overall Study|Lost to Follow-up|0|||
170472584|NCT03284723|616069328|FG001|Overall Study|Lost to Follow-up|0|||
170472585|NCT03284723|616069329|FG002|Overall Study|Lost to Follow-up|0|||
170472586|NCT03284723|616069330|FG003|Overall Study|Lost to Follow-up|0|||
170472587|NCT03284723|616069331|FG004|Overall Study|Lost to Follow-up|0|||
170472588|NCT03284723|616069332|FG005|Overall Study|Lost to Follow-up|2|||
170472589|NCT03284723|616069333|FG006|Overall Study|Lost to Follow-up|1|||
170472590|NCT03284723|616069334|FG007|Overall Study|Lost to Follow-up|0|||
170472591|NCT03284723|616069335|FG008|Overall Study|Lost to Follow-up|0|||
170472592|NCT03284723|616069336|FG009|Overall Study|Lost to Follow-up|2|||
170472593|NCT03284723|616069337|FG010|Overall Study|Lost to Follow-up|0|||
170472594|NCT03284723|616069338|FG011|Overall Study|Lost to Follow-up|0|||
170472595|NCT03284723|616069327|FG000|Overall Study|Study Terminated By Sponsor|0|||
170472596|NCT03284723|616069328|FG001|Overall Study|Study Terminated By Sponsor|0|||
170472597|NCT03284723|616069329|FG002|Overall Study|Study Terminated By Sponsor|0|||
170472598|NCT03284723|616069330|FG003|Overall Study|Study Terminated By Sponsor|0|||
170472599|NCT03284723|616069331|FG004|Overall Study|Study Terminated By Sponsor|1|||
170472600|NCT03284723|616069332|FG005|Overall Study|Study Terminated By Sponsor|0|||
170472601|NCT03284723|616069333|FG006|Overall Study|Study Terminated By Sponsor|0|||
170472602|NCT03284723|616069334|FG007|Overall Study|Study Terminated By Sponsor|0|||
170472603|NCT03284723|616069335|FG008|Overall Study|Study Terminated By Sponsor|1|||
170472604|NCT03284723|616069336|FG009|Overall Study|Study Terminated By Sponsor|1|||
170472605|NCT03284723|616069337|FG010|Overall Study|Study Terminated By Sponsor|1|||
170472606|NCT03284723|616069338|FG011|Overall Study|Study Terminated By Sponsor|1|||
170472607|NCT03284723|616069327|FG000|Overall Study|Withdrawal by Subject|0|||
170891652|NCT02817087|617609837|FG001|Overall Study|Withdrawal by Subject|0|||
170472608|NCT03284723|616069328|FG001|Overall Study|Withdrawal by Subject|0|||
170472609|NCT03284723|616069329|FG002|Overall Study|Withdrawal by Subject|0|||
170472610|NCT03284723|616069330|FG003|Overall Study|Withdrawal by Subject|0|||
170472611|NCT03284723|616069331|FG004|Overall Study|Withdrawal by Subject|5|||
170891653|NCT01818726|617609840|FG000|Overall Study|Administrative reasons|5|||
170472612|NCT03284723|616069332|FG005|Overall Study|Withdrawal by Subject|3|||
170472613|NCT03284723|616069333|FG006|Overall Study|Withdrawal by Subject|1|||
170472614|NCT03284723|616069334|FG007|Overall Study|Withdrawal by Subject|0|||
170472615|NCT03284723|616069335|FG008|Overall Study|Withdrawal by Subject|6|||
170472616|NCT03284723|616069336|FG009|Overall Study|Withdrawal by Subject|0|||
170472617|NCT03284723|616069337|FG010|Overall Study|Withdrawal by Subject|3|||
170472618|NCT03284723|616069338|FG011|Overall Study|Withdrawal by Subject|1|||
170472619|NCT03284723|616069327|FG000|Overall Study|Other|1|||
170791753|NCT05546411|617247964|FG000|Overall Study|Metastatic disease|1|||
170791754|NCT05546411|617247965|FG001|Overall Study|Metastatic disease|0|||
170791755|NCT02606422|617247966|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
170791756|NCT02606422|617247967|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
170472620|NCT03284723|616069328|FG001|Overall Study|Other|0|||
170472621|NCT03284723|616069329|FG002|Overall Study|Other|1|||
170791757|NCT02606422|617247966|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
170791758|NCT02606422|617247967|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
170791759|NCT02606422|617247966|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
170791760|NCT02606422|617247967|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
170791761|NCT02606422|617247966|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
170791762|NCT02606422|617247967|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
170791763|NCT04625465|617247968|FG000|Overall Study|Lost to Follow-up|2|||
170791764|NCT04625465|617247969|FG001|Overall Study|Lost to Follow-up|2|||
170791765|NCT04625465|617247970|FG002|Overall Study|Lost to Follow-up|1|||
170791766|NCT04625465|617247971|FG003|Overall Study|Lost to Follow-up|0|||
170791767|NCT04625465|617247972|FG004|Overall Study|Lost to Follow-up|0|||
170791768|NCT04625465|617247973|FG005|Overall Study|Lost to Follow-up|2|||
170472622|NCT03284723|616069330|FG003|Overall Study|Other|0|||
170791769|NCT04625465|617247974|FG006|Overall Study|Lost to Follow-up|0|||
170791770|NCT04625465|617247975|FG007|Overall Study|Lost to Follow-up|0|||
170791771|NCT04625465|617247968|FG000|Overall Study|Death|1|||
170791772|NCT04625465|617247969|FG001|Overall Study|Death|0|||
170791773|NCT04625465|617247970|FG002|Overall Study|Death|0|||
170791774|NCT04625465|617247971|FG003|Overall Study|Death|0|||
170791775|NCT04625465|617247972|FG004|Overall Study|Death|0|||
170791776|NCT04625465|617247973|FG005|Overall Study|Death|0|||
170791777|NCT04625465|617247974|FG006|Overall Study|Death|0|||
170791778|NCT04625465|617247975|FG007|Overall Study|Death|0|||
170791779|NCT04625465|617247968|FG000|Overall Study|Withdrawal by Subject|1|||
170791780|NCT04625465|617247969|FG001|Overall Study|Withdrawal by Subject|0|||
170791781|NCT04625465|617247970|FG002|Overall Study|Withdrawal by Subject|4|||
170791782|NCT04625465|617247971|FG003|Overall Study|Withdrawal by Subject|4|||
170791783|NCT04625465|617247972|FG004|Overall Study|Withdrawal by Subject|4|||
170791784|NCT04625465|617247973|FG005|Overall Study|Withdrawal by Subject|0|||
170791785|NCT04625465|617247974|FG006|Overall Study|Withdrawal by Subject|0|||
170791786|NCT04625465|617247975|FG007|Overall Study|Withdrawal by Subject|0|||
170472623|NCT03284723|616069331|FG004|Overall Study|Other|1|||
170472624|NCT03284723|616069332|FG005|Overall Study|Other|0|||
170472625|NCT03284723|616069333|FG006|Overall Study|Other|0|||
170472626|NCT03284723|616069334|FG007|Overall Study|Other|0|||
170472627|NCT03284723|616069335|FG008|Overall Study|Other|0|||
170472628|NCT03284723|616069336|FG009|Overall Study|Other|0|||
170472629|NCT03284723|616069337|FG010|Overall Study|Other|1|||
170472630|NCT03284723|616069338|FG011|Overall Study|Other|0|||
170472631|NCT03284723|616069327|FG000|Overall Study|Adverse Event|0|||
170791787|NCT05566639|617247979|FG000|Overall Study|Adverse Event|1|||
170791788|NCT05566639|617247980|FG001|Overall Study|Adverse Event|1|||
170791789|NCT05566639|617247979|FG000|Overall Study|Serious Adverse Event|1|||
170791790|NCT05566639|617247980|FG001|Overall Study|Serious Adverse Event|3|||
170791791|NCT05566639|617247979|FG000|Overall Study|Death|44|||
170791792|NCT05566639|617247980|FG001|Overall Study|Death|45|||
170791793|NCT05566639|617247979|FG000|Overall Study|Lost to Follow-up|467|||
170791794|NCT05566639|617247980|FG001|Overall Study|Lost to Follow-up|461|||
170791795|NCT05566639|617247979|FG000|Overall Study|Physician Decision|45|||
170791796|NCT05566639|617247980|FG001|Overall Study|Physician Decision|44|||
170791797|NCT05566639|617247979|FG000|Overall Study|Protocol Deviation|4|||
170791798|NCT05566639|617247980|FG001|Overall Study|Protocol Deviation|4|||
170791799|NCT05566639|617247979|FG000|Overall Study|Withdrawal by Subject|277|||
170791800|NCT05566639|617247980|FG001|Overall Study|Withdrawal by Subject|271|||
170791801|NCT05566639|617247979|FG000|Overall Study|Other Than Specified|52|||
170791802|NCT05566639|617247980|FG001|Overall Study|Other Than Specified|64|||
170791803|NCT05374798|617247981|FG000|Overall Study|Lost to Follow-up|2|||
170791804|NCT05374798|617247981|FG000|Overall Study|Withdrawal by Subject|2|||
170791805|NCT05374798|617247981|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
170472632|NCT03284723|616069328|FG001|Overall Study|Adverse Event|0|||
170472633|NCT03284723|616069329|FG002|Overall Study|Adverse Event|0|||
170472634|NCT03284723|616069330|FG003|Overall Study|Adverse Event|0|||
170472635|NCT03284723|616069331|FG004|Overall Study|Adverse Event|0|||
170472636|NCT03284723|616069332|FG005|Overall Study|Adverse Event|0|||
170472637|NCT03284723|616069333|FG006|Overall Study|Adverse Event|0|||
170472638|NCT03284723|616069334|FG007|Overall Study|Adverse Event|0|||
170472639|NCT03284723|616069335|FG008|Overall Study|Adverse Event|1|||
170472640|NCT03284723|616069336|FG009|Overall Study|Adverse Event|0|||
170472641|NCT03284723|616069337|FG010|Overall Study|Adverse Event|0|||
170472642|NCT03284723|616069338|FG011|Overall Study|Adverse Event|0|||
170472643|NCT00615199|616069339|FG000|Overall Study|Adverse Event|3|||
170472644|NCT00615199|616069340|FG001|Overall Study|Adverse Event|1|||
170472645|NCT00615199|616069341|FG002|Overall Study|Adverse Event|1|||
170472646|NCT00615199|616069342|FG003|Overall Study|Adverse Event|0|||
170472647|NCT00615199|616069339|FG000|Overall Study|Lack of Efficacy|2|||
170472648|NCT00615199|616069340|FG001|Overall Study|Lack of Efficacy|0|||
170472649|NCT00615199|616069341|FG002|Overall Study|Lack of Efficacy|0|||
170472650|NCT00615199|616069342|FG003|Overall Study|Lack of Efficacy|1|||
170472651|NCT00615199|616069339|FG000|Overall Study|Lost to Follow-up|1|||
170472652|NCT00615199|616069340|FG001|Overall Study|Lost to Follow-up|0|||
170472653|NCT00615199|616069341|FG002|Overall Study|Lost to Follow-up|0|||
170472654|NCT00615199|616069342|FG003|Overall Study|Lost to Follow-up|0|||
170472655|NCT00615199|616069339|FG000|Overall Study|Other|0|||
170472656|NCT00615199|616069340|FG001|Overall Study|Other|0|||
170472657|NCT00615199|616069341|FG002|Overall Study|Other|0|||
170472658|NCT00615199|616069342|FG003|Overall Study|Other|1|||
170472659|NCT00615199|616069339|FG000|Overall Study|Withdrawal by Subject|2|||
170472660|NCT00615199|616069340|FG001|Overall Study|Withdrawal by Subject|1|||
170472661|NCT00615199|616069341|FG002|Overall Study|Withdrawal by Subject|0|||
170472662|NCT00615199|616069342|FG003|Overall Study|Withdrawal by Subject|0|||
170472663|NCT00459355|616069345|FG000|Overall Study|Subject no longer met inc criteria|20|||
170472664|NCT00459355|616069346|FG001|Overall Study|Subject no longer met inc criteria|18|||
170472665|NCT02653625|616069353|FG000|Overall Study|Adverse Event|1|||
170472666|NCT02653625|616069353|FG000|Overall Study|Non-compliance with Study Drug|1|||
170472667|NCT02653625|616069353|FG000|Overall Study|Protocol Violation|1|||
170472668|NCT02653625|616069353|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
170472669|NCT03965689|616069354|FG000|Overall Study|Too sick to get study intervention|2|||
170472670|NCT00064987|616069355|FG000|Overall Study|Physician Decision|3|||
170472671|NCT00064987|616069356|FG001|Overall Study|Physician Decision|0|||
170472672|NCT00764881|616069358|FG000|Overall Study|Adverse Event|5|||
170472673|NCT00764881|616069359|FG001|Overall Study|Adverse Event|1|||
170472674|NCT00764881|616069358|FG000|Overall Study|Withdrawal by Subject|1|||
170472675|NCT00764881|616069359|FG001|Overall Study|Withdrawal by Subject|3|||
170472676|NCT00764881|616069358|FG000|Overall Study|Protocol Violation|2|||
170472677|NCT00764881|616069359|FG001|Overall Study|Protocol Violation|2|||
170472678|NCT00764881|616069358|FG000|Overall Study|Lost to Follow-up|2|||
170472679|NCT00764881|616069359|FG001|Overall Study|Lost to Follow-up|0|||
170472680|NCT00764881|616069358|FG000|Overall Study|Noncompliant|1|||
170472681|NCT00764881|616069359|FG001|Overall Study|Noncompliant|0|||
170472682|NCT00764881|616069358|FG000|Overall Study|Accidentally discontinued study drug|1|||
170472683|NCT00764881|616069359|FG001|Overall Study|Accidentally discontinued study drug|0|||
170472684|NCT00764881|616069358|FG000|Overall Study|Wished to become pregnant|1|||
170472685|NCT00764881|616069359|FG001|Overall Study|Wished to become pregnant|0|||
170472686|NCT00764881|616069358|FG000|Overall Study|Carcinoma detected|1|||
170472687|NCT00764881|616069359|FG001|Overall Study|Carcinoma detected|0|||
170472688|NCT00764881|616069358|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
170472689|NCT00764881|616069359|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
170545710|NCT04270760|616342717|FG000|Overall Study|Withdrawal by Subject|0|||
170545711|NCT04270760|616342718|FG001|Overall Study|Withdrawal by Subject|1|||
170545712|NCT04270760|616342719|FG002|Overall Study|Withdrawal by Subject|3|||
170545713|NCT04270760|616342720|FG003|Overall Study|Withdrawal by Subject|0|||
170545714|NCT04270760|616342721|FG004|Overall Study|Withdrawal by Subject|0|||
170545715|NCT04270760|616342717|FG000|Overall Study|Lost to Follow-up|1|||
170545716|NCT04270760|616342718|FG001|Overall Study|Lost to Follow-up|2|||
170545717|NCT04270760|616342719|FG002|Overall Study|Lost to Follow-up|1|||
170545718|NCT04270760|616342720|FG003|Overall Study|Lost to Follow-up|0|||
170545719|NCT04270760|616342721|FG004|Overall Study|Lost to Follow-up|0|||
170637731|NCT04672655|616684660|FG001|Overall Study|Withdrawal by Study|0|||
170637732|NCT01326104|616684661|FG000|Overall Study|progressed prior to vaccine|0|||
170472690|NCT00764881|616069358|FG000|Overall Study|no treatment or no observation|2|||
170472691|NCT00764881|616069359|FG001|Overall Study|no treatment or no observation|2|||
170472692|NCT01473407|616069365|FG000|Overall Study|Physician Decision|1|||
170472693|NCT01473407|616069366|FG001|Overall Study|Physician Decision|4|||
170472694|NCT01473407|616069365|FG000|Overall Study|Lost to Follow-up|10|||
170472695|NCT01473407|616069366|FG001|Overall Study|Lost to Follow-up|4|||
170472696|NCT01473407|616069365|FG000|Overall Study|Adverse Event|8|||
170472697|NCT01473407|616069366|FG001|Overall Study|Adverse Event|8|||
170472698|NCT01473407|616069365|FG000|Overall Study|Randomization Error|3|||
170472699|NCT01473407|616069366|FG001|Overall Study|Randomization Error|1|||
170472700|NCT01473407|616069365|FG000|Overall Study|Withdrawal by Subject|4|||
170545720|NCT04270760|616342717|FG000|Overall Study|Death|0|||
170545721|NCT04270760|616342718|FG001|Overall Study|Death|0|||
170545722|NCT04270760|616342719|FG002|Overall Study|Death|0|||
170637733|NCT01326104|616684662|FG001|Overall Study|progressed prior to vaccine|2|||
170637734|NCT01326104|616684661|FG000|Overall Study|unable to make vaccine|0|||
170637735|NCT01326104|616684662|FG001|Overall Study|unable to make vaccine|2|||
170637736|NCT01287741|616684663|FG000|Overall Study|Withdrawal by Subject|35|||
170637737|NCT01287741|616684664|FG001|Overall Study|Withdrawal by Subject|38|||
170637738|NCT01287741|616684663|FG000|Overall Study|Protocol Violation|2|||
170472701|NCT01473407|616069366|FG001|Overall Study|Withdrawal by Subject|7|||
170472702|NCT01473407|616069365|FG000|Overall Study|Kidney Transplant|7|||
170472703|NCT01473407|616069366|FG001|Overall Study|Kidney Transplant|6|||
170472704|NCT01473407|616069365|FG000|Overall Study|Vacation/Travel|1|||
170472705|NCT01473407|616069366|FG001|Overall Study|Vacation/Travel|1|||
170472706|NCT01473407|616069365|FG000|Overall Study|Elevated Hemoglobin|1|||
170472707|NCT01473407|616069366|FG001|Overall Study|Elevated Hemoglobin|0|||
170472708|NCT01473407|616069365|FG000|Overall Study|Patient Received Aranesp|1|||
170472709|NCT01473407|616069366|FG001|Overall Study|Patient Received Aranesp|0|||
170472710|NCT01473407|616069365|FG000|Overall Study|Patient Lost Green Card Status|1|||
170472711|NCT01473407|616069366|FG001|Overall Study|Patient Lost Green Card Status|0|||
170472712|NCT01473407|616069365|FG000|Overall Study|Temperature Excursion|2|||
170472713|NCT01473407|616069366|FG001|Overall Study|Temperature Excursion|3|||
170472714|NCT01473407|616069365|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
170472715|NCT01473407|616069366|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
170472716|NCT01473407|616069365|FG000|Overall Study|Sponsor's Decision|10|||
170472717|NCT01473407|616069366|FG001|Overall Study|Sponsor's Decision|10|||
170472718|NCT01473407|616069365|FG000|Overall Study|Site Closure|1|||
170472719|NCT01473407|616069366|FG001|Overall Study|Site Closure|0|||
170472720|NCT05223920|616069367|FG000|Overall Study|Adverse Event|6|||
170472721|NCT05223920|616069368|FG001|Overall Study|Adverse Event|3|||
170472722|NCT05223920|616069367|FG000|Overall Study|Death|2|||
170472723|NCT05223920|616069368|FG001|Overall Study|Death|0|||
170472724|NCT05223920|616069367|FG000|Overall Study|Disease Progression|1|||
170472725|NCT05223920|616069368|FG001|Overall Study|Disease Progression|2|||
170472726|NCT05223920|616069367|FG000|Overall Study|Physician Decision|1|||
170472727|NCT05223920|616069368|FG001|Overall Study|Physician Decision|2|||
170472728|NCT05223920|616069367|FG000|Overall Study|Sponsor decision|11|||
170472729|NCT05223920|616069368|FG001|Overall Study|Sponsor decision|9|||
170472730|NCT05223920|616069367|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
170472731|NCT05223920|616069368|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
170472732|NCT05223920|616069367|FG000|Overall Study|Subject decision|1|||
170472733|NCT05223920|616069368|FG001|Overall Study|Subject decision|0|||
170472734|NCT05223920|616069367|FG000|Overall Study|Withdrawal by Subject|1|||
170472735|NCT05223920|616069368|FG001|Overall Study|Withdrawal by Subject|6|||
170472736|NCT02301390|616069371|FG000|Overall Study|Withdrawal by Subject|3|||
170472737|NCT02301390|616069372|FG001|Overall Study|Withdrawal by Subject|5|||
170472738|NCT02301390|616069371|FG000|Overall Study|Protocol Violation|1|||
170472739|NCT02301390|616069372|FG001|Overall Study|Protocol Violation|0|||
170472740|NCT02301390|616069371|FG000|Overall Study|Physician Decision|1|||
170472741|NCT02301390|616069372|FG001|Overall Study|Physician Decision|0|||
170472742|NCT02301390|616069371|FG000|Overall Study|Lost to Follow-up|0|||
170472743|NCT02301390|616069372|FG001|Overall Study|Lost to Follow-up|1|||
170472744|NCT02301390|616069371|FG000|Overall Study|Death|2|||
170472745|NCT02301390|616069372|FG001|Overall Study|Death|2|||
170472746|NCT02301390|616069371|FG000|Overall Study|Procedure not completed|0|||
170472747|NCT02301390|616069372|FG001|Overall Study|Procedure not completed|4|||
170472748|NCT02301390|616069371|FG000|Overall Study|Missed multiple visits|1|||
170472749|NCT02301390|616069372|FG001|Overall Study|Missed multiple visits|1|||
170472750|NCT02301390|616069371|FG000|Overall Study|study terminated|2|||
170472751|NCT02301390|616069372|FG001|Overall Study|study terminated|0|||
170472752|NCT02862730|616069375|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
170637739|NCT01287741|616684664|FG001|Overall Study|Protocol Violation|0|||
170637740|NCT01287741|616684663|FG000|Overall Study|Physician Decision|15|||
170637741|NCT01287741|616684664|FG001|Overall Study|Physician Decision|23|||
170637742|NCT01287741|616684663|FG000|Overall Study|Non-compliance|8|||
170637743|NCT01287741|616684664|FG001|Overall Study|Non-compliance|6|||
170637744|NCT01287741|616684663|FG000|Overall Study|Lost to Follow-up|10|||
170637745|NCT01287741|616684664|FG001|Overall Study|Lost to Follow-up|8|||
170472753|NCT02862730|616069376|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
170472754|NCT02862730|616069377|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
170472755|NCT02862730|616069378|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
170472756|NCT02862730|616069379|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
170472757|NCT02862730|616069380|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
170472758|NCT02862730|616069381|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
170472759|NCT02862730|616069375|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
170472760|NCT02862730|616069376|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
170472761|NCT02862730|616069377|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
170472762|NCT02862730|616069378|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
170637746|NCT01287741|616684663|FG000|Overall Study|Death|32|||
170637747|NCT01287741|616684664|FG001|Overall Study|Death|44|||
170472763|NCT02862730|616069379|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
170472764|NCT02862730|616069380|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
170472765|NCT02862730|616069381|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
170472766|NCT02862730|616069375|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
170472767|NCT02862730|616069376|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
170472768|NCT02862730|616069377|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
170472769|NCT02862730|616069378|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
170472770|NCT02862730|616069379|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
170472771|NCT02862730|616069380|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
170472772|NCT02862730|616069381|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
170472773|NCT02862730|616069375|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
170472774|NCT02862730|616069376|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
170472775|NCT02862730|616069377|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
170472776|NCT02862730|616069378|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
170472777|NCT02862730|616069379|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
170472778|NCT02862730|616069380|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
170472779|NCT02862730|616069381|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
170472780|NCT01807065|616069382|FG000|Overall Study|Receive no sip-T due to IV access|1|||
170472781|NCT01807065|616069383|FG001|Overall Study|Receive no sip-T due to IV access|1|||
170472782|NCT01153425|616069384|FG000|Overall Study|Withdrawal by Subject|3|||
170472783|NCT01153425|616069385|FG001|Overall Study|Withdrawal by Subject|3|||
170472784|NCT00445432|616069386|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
170472785|NCT00445432|616069387|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
170472786|NCT00445432|616069388|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
170472787|NCT00445432|616069389|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
170472788|NCT00445432|616069386|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
170472789|NCT00445432|616069387|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
170472790|NCT00445432|616069388|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
170472791|NCT00445432|616069389|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
170472792|NCT00445432|616069386|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
170472793|NCT00445432|616069387|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
170472794|NCT00445432|616069388|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
170472795|NCT00445432|616069389|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
170472796|NCT00445432|616069386|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
170472797|NCT00445432|616069387|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
170472798|NCT00445432|616069388|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
170472799|NCT00445432|616069389|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
170472800|NCT00445432|616069386|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
170472801|NCT00445432|616069387|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
170472802|NCT00445432|616069388|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
170472803|NCT00445432|616069389|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
170472804|NCT00445432|616069386|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
170472805|NCT00445432|616069387|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
170472806|NCT00445432|616069388|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
170472807|NCT00445432|616069389|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
170472808|NCT00445432|616069386|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
170472809|NCT00445432|616069387|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
170472810|NCT00445432|616069388|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
170472811|NCT00445432|616069389|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
170472812|NCT02789137|616069390|FG000|Overall Study|Dropped out/Died|58|||
170472813|NCT00911300|616069391|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
170472814|NCT00911300|616069392|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
170472815|NCT00911300|616069391|FG000|Overall Study|Death|1|||
170472816|NCT00911300|616069392|FG001|Overall Study|Death|0|||
170472817|NCT00911300|616069391|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
170472818|NCT00911300|616069392|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
170472819|NCT00911300|616069391|FG000|Overall Study|Adverse Event|14|||
170472820|NCT00911300|616069392|FG001|Overall Study|Adverse Event|6|||
170472821|NCT00911300|616069391|FG000|Overall Study|Protocol Violation|3|||
170472822|NCT00911300|616069392|FG001|Overall Study|Protocol Violation|2|||
170472823|NCT00911300|616069391|FG000|Overall Study|Consent Withdrawn|4|||
170472824|NCT00911300|616069392|FG001|Overall Study|Consent Withdrawn|12|||
170472825|NCT00911300|616069391|FG000|Overall Study|Coronary Angiography Performed|1|||
170472826|NCT00911300|616069392|FG001|Overall Study|Coronary Angiography Performed|0|||
170472827|NCT00911300|616069391|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
170545723|NCT04270760|616342720|FG003|Overall Study|Death|0|||
170472828|NCT00911300|616069392|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
170472829|NCT00911300|616069391|FG000|Overall Study|Received Commercial Treatment|1|||
170472830|NCT00911300|616069392|FG001|Overall Study|Received Commercial Treatment|0|||
170472831|NCT00911300|616069391|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
170472832|NCT00911300|616069392|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
170472833|NCT00911300|616069391|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
170472834|NCT00911300|616069392|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
170472835|NCT00911300|616069391|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
170472836|NCT00911300|616069392|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
170472837|NCT00911300|616069391|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
170472838|NCT00911300|616069392|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
170472839|NCT00911300|616069391|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
170472840|NCT00911300|616069392|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
170472841|NCT00911300|616069391|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
170472842|NCT00911300|616069392|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
170472843|NCT00911300|616069391|FG000|Overall Study|International Normalized Ratio Too High|0|||
170472844|NCT00911300|616069392|FG001|Overall Study|International Normalized Ratio Too High|1|||
170472845|NCT00911300|616069391|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
170472846|NCT00911300|616069392|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
170472847|NCT00911300|616069391|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
170472848|NCT00911300|616069392|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
170472849|NCT00911300|616069391|FG000|Overall Study|Physician Decision|0|||
170472850|NCT00911300|616069392|FG001|Overall Study|Physician Decision|1|||
170472851|NCT00911300|616069391|FG000|Overall Study|Treatment Stopped by Mistake|0|||
170472852|NCT00911300|616069392|FG001|Overall Study|Treatment Stopped by Mistake|1|||
170472853|NCT00911300|616069391|FG000|Overall Study|Randomized; No Study Medication Received|0|||
170472854|NCT00911300|616069392|FG001|Overall Study|Randomized; No Study Medication Received|2|||
170472855|NCT01526655|616069393|FG000|Overall Study|Withdrawal by Subject|0|||
170472856|NCT01526655|616069394|FG001|Overall Study|Withdrawal by Subject|1|||
170472857|NCT04753216|616069395|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
170472858|NCT04753216|616069395|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
170472859|NCT04753216|616069395|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
170472860|NCT02001987|616069397|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
170472861|NCT02001987|616069397|FG000|Core Study Period (24 Weeks)|Death|1|||
170472862|NCT02001987|616069397|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
170472863|NCT02001987|616069397|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
170472864|NCT02001987|616069397|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
170472865|NCT02001987|616069397|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
170472866|NCT02001987|616069397|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
170472867|NCT02001987|616069397|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
170472868|NCT02001987|616069397|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
170472869|NCT02001987|616069397|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
170472870|NCT02001987|616069397|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
170472871|NCT02001987|616069397|FG000|LTE Period (52 Weeks)|Other|3|||
170472872|NCT01965860|616069398|FG000|Overall Study|Pregnancy|1|||
170472873|NCT01965860|616069399|FG001|Overall Study|Pregnancy|0|||
170472874|NCT01965860|616069400|FG002|Overall Study|Pregnancy|1|||
170472875|NCT01965860|616069398|FG000|Overall Study|Logistics|1|||
170472876|NCT01965860|616069399|FG001|Overall Study|Logistics|0|||
170472877|NCT01965860|616069400|FG002|Overall Study|Logistics|0|||
170472878|NCT03571828|616069407|FG000|Overall Study|Withdrawal by Subject|1|||
170472879|NCT03571828|616069408|FG001|Overall Study|Withdrawal by Subject|0|||
170472880|NCT03571828|616069407|FG000|Overall Study|Decision by sponsor|5|||
170472881|NCT03571828|616069408|FG001|Overall Study|Decision by sponsor|1|||
170545724|NCT04270760|616342721|FG004|Overall Study|Death|1|||
170545725|NCT05156125|616342722|FG000|Overall Study|Lack of Efficacy|1|||
170545726|NCT05156125|616342723|FG001|Overall Study|Lack of Efficacy|1|||
170545727|NCT05156125|616342724|FG002|Overall Study|Lack of Efficacy|1|||
170545728|NCT05156125|616342722|FG000|Overall Study|Physician Decision|0|||
170472882|NCT03571828|616069407|FG000|Overall Study|Death|2|||
170545729|NCT05156125|616342723|FG001|Overall Study|Physician Decision|0|||
170545730|NCT05156125|616342724|FG002|Overall Study|Physician Decision|1|||
170545731|NCT05156125|616342722|FG000|Overall Study|Non-compliance|0|||
170545732|NCT05156125|616342723|FG001|Overall Study|Non-compliance|1|||
170545733|NCT05156125|616342724|FG002|Overall Study|Non-compliance|1|||
170545734|NCT05156125|616342722|FG000|Overall Study|Withdrawal by Subject|0|||
170545735|NCT05156125|616342723|FG001|Overall Study|Withdrawal by Subject|0|||
170545736|NCT05156125|616342724|FG002|Overall Study|Withdrawal by Subject|1|||
170545737|NCT05156125|616342722|FG000|Overall Study|Adverse Event|2|||
170545738|NCT05156125|616342723|FG001|Overall Study|Adverse Event|1|||
170472883|NCT03571828|616069408|FG001|Overall Study|Death|0|||
170472884|NCT00666328|616069409|FG000|Overall Study|Death|2|||
170472885|NCT00666328|616069409|FG000|Overall Study|Lost to Follow-up|2|||
170472886|NCT00666328|616069409|FG000|Overall Study|No longer met eligibility criteria|1|||
170472887|NCT02288325|616069412|FG000|Run-in Period|Adverse Event|48|||
170472888|NCT02288325|616069413|FG001|Run-in Period|Adverse Event|0|||
170545739|NCT05156125|616342724|FG002|Overall Study|Adverse Event|0|||
170472889|NCT02288325|616069414|FG002|Run-in Period|Adverse Event|0|||
170472890|NCT02288325|616069412|FG000|Run-in Period|Lack of Efficacy|16|||
170472891|NCT02288325|616069413|FG001|Run-in Period|Lack of Efficacy|0|||
170472892|NCT02288325|616069414|FG002|Run-in Period|Lack of Efficacy|0|||
170472893|NCT02288325|616069412|FG000|Run-in Period|Withdrawal of Consent|28|||
170472894|NCT02288325|616069413|FG001|Run-in Period|Withdrawal of Consent|0|||
170472895|NCT02288325|616069414|FG002|Run-in Period|Withdrawal of Consent|0|||
170472896|NCT02288325|616069412|FG000|Run-in Period|Lost to Follow-up|25|||
170472897|NCT02288325|616069413|FG001|Run-in Period|Lost to Follow-up|0|||
170472898|NCT02288325|616069414|FG002|Run-in Period|Lost to Follow-up|0|||
170472899|NCT02288325|616069412|FG000|Run-in Period|Protocol Violation|17|||
170637748|NCT01287741|616684663|FG000|Overall Study|Adverse Event|4|||
170637749|NCT01287741|616684664|FG001|Overall Study|Adverse Event|6|||
170637750|NCT01287741|616684663|FG000|Overall Study|Study terminated by Sponsor|307|||
170637751|NCT01287741|616684664|FG001|Overall Study|Study terminated by Sponsor|315|||
170637752|NCT01287741|616684663|FG000|Overall Study|Progressive disease|190|||
170637753|NCT01287741|616684664|FG001|Overall Study|Progressive disease|166|||
170637754|NCT01287741|616684663|FG000|Overall Study|Reason not specified|23|||
170637755|NCT01287741|616684664|FG001|Overall Study|Reason not specified|9|||
170637756|NCT03467750|616684668|FG000|Overall Study|Surgery canceled|1|||
170637757|NCT03467750|616684669|FG001|Overall Study|Surgery canceled|0|||
170472900|NCT02288325|616069413|FG001|Run-in Period|Protocol Violation|0|||
170472901|NCT02288325|616069414|FG002|Run-in Period|Protocol Violation|0|||
170472902|NCT02288325|616069412|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
170472903|NCT02288325|616069413|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
170472904|NCT02288325|616069414|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
170472905|NCT02288325|616069412|FG000|Run-in Period|Reason not Specified|8|||
170472906|NCT02288325|616069413|FG001|Run-in Period|Reason not Specified|0|||
170472907|NCT02288325|616069414|FG002|Run-in Period|Reason not Specified|0|||
170472908|NCT02288325|616069412|FG000|Stabilization Period|Adverse Event|13|||
170472909|NCT02288325|616069413|FG001|Stabilization Period|Adverse Event|0|||
170472910|NCT02288325|616069414|FG002|Stabilization Period|Adverse Event|0|||
170472911|NCT02288325|616069412|FG000|Stabilization Period|Lack of Efficacy|22|||
170472912|NCT02288325|616069413|FG001|Stabilization Period|Lack of Efficacy|0|||
170472913|NCT02288325|616069414|FG002|Stabilization Period|Lack of Efficacy|0|||
170472914|NCT02288325|616069412|FG000|Stabilization Period|Withdrawal of Consent|23|||
170472915|NCT02288325|616069413|FG001|Stabilization Period|Withdrawal of Consent|0|||
170472916|NCT02288325|616069414|FG002|Stabilization Period|Withdrawal of Consent|0|||
170472917|NCT02288325|616069412|FG000|Stabilization Period|Lost to Follow-up|12|||
170472918|NCT02288325|616069413|FG001|Stabilization Period|Lost to Follow-up|0|||
170472919|NCT02288325|616069414|FG002|Stabilization Period|Lost to Follow-up|0|||
170472920|NCT02288325|616069412|FG000|Stabilization Period|Protocol Violation|8|||
170472921|NCT02288325|616069413|FG001|Stabilization Period|Protocol Violation|0|||
170472922|NCT02288325|616069414|FG002|Stabilization Period|Protocol Violation|0|||
170791806|NCT04471246|617247982|FG000|Overall Study|Lost to Follow-up|2|||
170791807|NCT04471246|617247983|FG001|Overall Study|Lost to Follow-up|2|||
170472923|NCT02288325|616069412|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
170472924|NCT02288325|616069413|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
170472925|NCT02288325|616069414|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
170472926|NCT02288325|616069412|FG000|Stabilization Period|Reason not Specified|15|||
170472927|NCT02288325|616069413|FG001|Stabilization Period|Reason not Specified|0|||
170472928|NCT02288325|616069414|FG002|Stabilization Period|Reason not Specified|0|||
170472929|NCT02288325|616069412|FG000|Double-blind Treatment Period|Adverse Event|0|||
170472930|NCT02288325|616069413|FG001|Double-blind Treatment Period|Adverse Event|2|||
170472931|NCT02288325|616069414|FG002|Double-blind Treatment Period|Adverse Event|5|||
170472932|NCT02288325|616069412|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
170472933|NCT02288325|616069413|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
170472934|NCT02288325|616069414|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
170472935|NCT02288325|616069412|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
170545740|NCT05436288|616342727|FG000|Overall Study|Lost to Follow-up|1|||
170545741|NCT05436288|616342727|FG000|Overall Study|Adverse Event|1|||
170545742|NCT04149353|616342733|FG000|Overall Study|Study terminated|1|||
170545743|NCT00887588|616342736|FG000|Core Period|Death|1|||
170545744|NCT00887588|616342737|FG001|Core Period|Death|1|||
170545745|NCT00887588|616342736|FG000|Core Period|Lost to Follow-up|3|||
170545746|NCT00887588|616342737|FG001|Core Period|Lost to Follow-up|1|||
170545747|NCT00887588|616342736|FG000|Core Period|Withdrawal by Subject|6|||
170545748|NCT00887588|616342737|FG001|Core Period|Withdrawal by Subject|8|||
170545749|NCT00887588|616342736|FG000|Core Period|Adverse Event|9|||
170545750|NCT00887588|616342737|FG001|Core Period|Adverse Event|11|||
170545751|NCT00887588|616342736|FG000|Extension Period|Adverse Event|4|||
170545752|NCT00887588|616342737|FG001|Extension Period|Adverse Event|4|||
170545753|NCT00887588|616342736|FG000|Extension Period|Death|0|||
170545754|NCT00887588|616342737|FG001|Extension Period|Death|1|||
170472936|NCT02288325|616069413|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
170472937|NCT02288325|616069414|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
170472938|NCT02288325|616069412|FG000|Double-blind Treatment Period|Protocol Violation|0|||
170472939|NCT02288325|616069413|FG001|Double-blind Treatment Period|Protocol Violation|1|||
170472940|NCT02288325|616069414|FG002|Double-blind Treatment Period|Protocol Violation|2|||
170472941|NCT02288325|616069412|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
170472942|NCT02288325|616069413|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
170472943|NCT02288325|616069414|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
170472944|NCT02288325|616069412|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
170472945|NCT02288325|616069413|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
170472946|NCT02288325|616069414|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
170472947|NCT00769379|616069415|FG000|Overall Study|No follow up data mapped to Other.|3|||
170472948|NCT00769379|616069416|FG001|Overall Study|No follow up data mapped to Other.|13|||
170472949|NCT01884337|616069417|FG000|Treatment|Adverse Event|2|||
170472950|NCT01884337|616069418|FG001|Treatment|Adverse Event|2|||
170472951|NCT01884337|616069417|FG000|Treatment|Subj. request to discont. treatment|2|||
170472952|NCT01884337|616069418|FG001|Treatment|Subj. request to discont. treatment|0|||
170472953|NCT01884337|616069417|FG000|Follow-up Period|Lost to Follow-up|1|||
170472954|NCT01884337|616069418|FG001|Follow-up Period|Lost to Follow-up|1|||
170472955|NCT04186845|616069430|FG000|Overall Study|Death|2|||
170472956|NCT04186845|616069430|FG000|Overall Study|Lost to Follow-up|1|||
170472957|NCT04186845|616069430|FG000|Overall Study|Physician Decision|1|||
170472958|NCT04186845|616069430|FG000|Overall Study|Protocol Violation|1|||
170472959|NCT04186845|616069430|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
170472960|NCT04186845|616069430|FG000|Overall Study|Biopsy ordered but not done|1|||
170472961|NCT04186845|616069430|FG000|Overall Study|It was previously confirmed|1|||
170472962|NCT04186845|616069430|FG000|Overall Study|Patient cancelled scheduled scans|2|||
170472963|NCT04186845|616069430|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
170472964|NCT04186845|616069430|FG000|Overall Study|Subject refused confirmatory imaging|1|||
170472965|NCT04186845|616069430|FG000|Overall Study|Too small to biopsy|1|||
170472966|NCT01814553|616069431|FG000|Overall Study|PD per clinical progression|6|||
170472967|NCT01814553|616069432|FG001|Overall Study|PD per clinical progression|8|||
170472968|NCT01814553|616069431|FG000|Overall Study|Other Adverse Event|4|||
170472969|NCT01814553|616069432|FG001|Overall Study|Other Adverse Event|5|||
170472970|NCT01814553|616069431|FG000|Overall Study|Withdrawal by Subject|1|||
170472971|NCT01814553|616069432|FG001|Overall Study|Withdrawal by Subject|1|||
170472972|NCT01814553|616069431|FG000|Overall Study|Other than stated|7|||
170472973|NCT01814553|616069432|FG001|Overall Study|Other than stated|8|||
170791808|NCT04826471|617247984|FG000|Overall Study|Lost to Follow-up|2|||
170791809|NCT04826471|617247984|FG000|Overall Study|Protocol Violation|3|||
170791810|NCT04826471|617247984|FG000|Overall Study|Withdrawal by Subject|1|||
170791811|NCT05293171|617247990|FG000|Washout 5 to 7 Days|Adverse Event|1|||
170791812|NCT05293171|617247991|FG001|Washout 5 to 7 Days|Adverse Event|1|||
170791813|NCT05293171|617247992|FG002|Washout 5 to 7 Days|Adverse Event|0|||
170791814|NCT05293171|617247993|FG003|Washout 5 to 7 Days|Adverse Event|0|||
170791815|NCT05293171|617247994|FG004|Washout 5 to 7 Days|Adverse Event|0|||
170791816|NCT05293171|617247995|FG005|Washout 5 to 7 Days|Adverse Event|0|||
170791817|NCT05293171|617247996|FG006|Washout 5 to 7 Days|Adverse Event|0|||
170791818|NCT05293171|617247997|FG007|Washout 5 to 7 Days|Adverse Event|0|||
170791819|NCT05293171|617247998|FG008|Washout 5 to 7 Days|Adverse Event|0|||
170791820|NCT05293171|617247999|FG009|Washout 5 to 7 Days|Adverse Event|0|||
170791821|NCT05293171|617248000|FG010|Washout 5 to 7 Days|Adverse Event|0|||
170791822|NCT05293171|617248001|FG011|Washout 5 to 7 Days|Adverse Event|0|||
170791823|NCT05293171|617247990|FG000|Washout 5 to 7 Days|Adverse Event|0|||
170791824|NCT05293171|617247991|FG001|Washout 5 to 7 Days|Adverse Event|0|||
170791825|NCT05293171|617247992|FG002|Washout 5 to 7 Days|Adverse Event|0|||
170791826|NCT05293171|617247993|FG003|Washout 5 to 7 Days|Adverse Event|0|||
170791827|NCT05293171|617247994|FG004|Washout 5 to 7 Days|Adverse Event|0|||
170791828|NCT05293171|617247995|FG005|Washout 5 to 7 Days|Adverse Event|1|||
170791829|NCT05293171|617247996|FG006|Washout 5 to 7 Days|Adverse Event|0|||
170791830|NCT05293171|617247997|FG007|Washout 5 to 7 Days|Adverse Event|0|||
170791831|NCT05293171|617247998|FG008|Washout 5 to 7 Days|Adverse Event|0|||
170791832|NCT05293171|617247999|FG009|Washout 5 to 7 Days|Adverse Event|0|||
170791833|NCT05293171|617248000|FG010|Washout 5 to 7 Days|Adverse Event|0|||
170791834|NCT05293171|617248001|FG011|Washout 5 to 7 Days|Adverse Event|0|||
170791835|NCT04066205|617248002|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
170791836|NCT04066205|617248003|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
170472974|NCT04138823|616069433|FG000|Overall Study|Clinical disease progression|0|||
170472975|NCT04138823|616069434|FG001|Overall Study|Clinical disease progression|0|||
170472976|NCT04138823|616069435|FG002|Overall Study|Clinical disease progression|1|||
170472977|NCT04138823|616069433|FG000|Overall Study|Objective disease progression|3|||
170472978|NCT04138823|616069434|FG001|Overall Study|Objective disease progression|2|||
170472979|NCT04138823|616069435|FG002|Overall Study|Objective disease progression|5|||
170791837|NCT04066205|617248002|FG000|T2 Immediate Post-Intervention|did not respond|5|||
170791838|NCT04066205|617248003|FG001|T2 Immediate Post-Intervention|did not respond|3|||
170472980|NCT02800642|616069436|FG000|Overall Study|Death|3|||
170472981|NCT02800642|616069436|FG000|Overall Study|Other|10|||
170472982|NCT02800642|616069436|FG000|Overall Study|Physician Decision|2|||
170472983|NCT02800642|616069436|FG000|Overall Study|Adverse Event|6|||
170472984|NCT02800642|616069436|FG000|Overall Study|Withdrawal by Subject|3|||
170472985|NCT02800642|616069436|FG000|Overall Study|Lost to Follow-up|1|||
170472986|NCT04868500|616069437|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
170472987|NCT04868500|616069438|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
170472988|NCT04868500|616069437|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
170472989|NCT04868500|616069438|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
170472990|NCT01332292|616069442|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
170472991|NCT01332292|616069443|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
170472992|NCT01332292|616069442|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
170472993|NCT01332292|616069443|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
170472994|NCT01332292|616069442|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
170472995|NCT01332292|616069443|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
170472996|NCT00098774|616069444|FG000|Overall Study|Adverse Event|2|||
170472997|NCT00098774|616069444|FG000|Overall Study|Disease Progression|9|||
170472998|NCT00098774|616069444|FG000|Overall Study|Withdrawal by Subject|1|||
170472999|NCT00098774|616069444|FG000|Overall Study|Failed (to respond) during induction|4|||
170473000|NCT00098774|616069444|FG000|Overall Study|Physician Decision|2|||
170473001|NCT03452943|616069445|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
170473002|NCT03452943|616069446|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
170473003|NCT03452943|616069445|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
170473004|NCT03452943|616069446|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
170473005|NCT03452943|616069445|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
170473006|NCT03452943|616069446|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
170473007|NCT03452943|616069445|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
170473008|NCT03452943|616069446|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
170473009|NCT03452943|616069445|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
170473010|NCT03452943|616069446|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
170473011|NCT03452943|616069445|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
170473012|NCT03452943|616069446|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
170473013|NCT01330303|616069451|FG000|Period 1|Adverse Event|1|||
170473014|NCT01330303|616069452|FG001|Period 1|Adverse Event|0|||
170473015|NCT01330303|616069451|FG000|Period 1|Protocol Violation|0|||
170473016|NCT01330303|616069452|FG001|Period 1|Protocol Violation|1|||
170473017|NCT01330303|616069451|FG000|Period 1|Withdrawal by Subject|0|||
170473018|NCT01330303|616069452|FG001|Period 1|Withdrawal by Subject|1|||
170473019|NCT00796757|616069453|FG000|Overall Study|Withdrawal by Subject|14|||
170473020|NCT00796757|616069453|FG000|Overall Study|Death|61|||
170473021|NCT00796757|616069453|FG000|Overall Study|Protocol Violation|1|||
170473022|NCT00796757|616069453|FG000|Overall Study|Participant noncompliance|1|||
170473023|NCT00796757|616069453|FG000|Overall Study|Investigator's decision|2|||
170473024|NCT00796757|616069453|FG000|Overall Study|Other|7|||
170473025|NCT04614246|616069455|FG000|Overall Study|Adverse Event|0|||
170473026|NCT04614246|616069456|FG001|Overall Study|Adverse Event|1|||
170791839|NCT02052882|617248004|FG000|Overall Study|Not treated|11|||
170791840|NCT02052882|617248004|FG000|Overall Study|Protocol Violation|1|||
170791841|NCT02052882|617248004|FG000|Overall Study|Inadequate testing|1|||
170791842|NCT01275677|617248007|FG000|Overall Study|Not at risk for recurrence.|1|||
170791843|NCT01275677|617248008|FG001|Overall Study|Not at risk for recurrence.|1|||
170791844|NCT01275677|617248007|FG000|Overall Study|No follow-up|26|||
170791845|NCT01275677|617248008|FG001|Overall Study|No follow-up|37|||
170791846|NCT01275677|617248007|FG000|Overall Study|No clinical follow up.|1|||
170791847|NCT01275677|617248008|FG001|Overall Study|No clinical follow up.|4|||
170791848|NCT03734679|617248020|FG000|Overall Study|Missed Visit|1|||
170473027|NCT04614246|616069457|FG002|Overall Study|Adverse Event|1|||
170473028|NCT04614246|616069458|FG003|Overall Study|Adverse Event|2|||
170473029|NCT04614246|616069459|FG004|Overall Study|Adverse Event|1|||
170473030|NCT04614246|616069455|FG000|Overall Study|Lost to Follow-up|0|||
170473031|NCT04614246|616069456|FG001|Overall Study|Lost to Follow-up|1|||
170473032|NCT04614246|616069457|FG002|Overall Study|Lost to Follow-up|0|||
170473033|NCT04614246|616069458|FG003|Overall Study|Lost to Follow-up|1|||
170473034|NCT04614246|616069459|FG004|Overall Study|Lost to Follow-up|3|||
170473035|NCT04614246|616069455|FG000|Overall Study|Other reason|0|||
170473036|NCT04614246|616069456|FG001|Overall Study|Other reason|1|||
170473037|NCT04614246|616069457|FG002|Overall Study|Other reason|2|||
170473038|NCT04614246|616069458|FG003|Overall Study|Other reason|0|||
170473039|NCT04614246|616069459|FG004|Overall Study|Other reason|0|||
170791849|NCT01854775|617248040|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
170473040|NCT04614246|616069455|FG000|Overall Study|Withdrawal by Subject|4|||
170473041|NCT04614246|616069456|FG001|Overall Study|Withdrawal by Subject|2|||
170473042|NCT04614246|616069457|FG002|Overall Study|Withdrawal by Subject|4|||
170473043|NCT04614246|616069458|FG003|Overall Study|Withdrawal by Subject|3|||
170473044|NCT04614246|616069459|FG004|Overall Study|Withdrawal by Subject|4|||
170473045|NCT04614246|616069455|FG000|Overall Study|Physician Decision|0|||
170473046|NCT04614246|616069456|FG001|Overall Study|Physician Decision|2|||
170473047|NCT04614246|616069457|FG002|Overall Study|Physician Decision|1|||
170473048|NCT04614246|616069458|FG003|Overall Study|Physician Decision|0|||
170473049|NCT04614246|616069459|FG004|Overall Study|Physician Decision|0|||
170473050|NCT04614246|616069455|FG000|Overall Study|Study terminated by sponsor|10|||
170473051|NCT04614246|616069456|FG001|Overall Study|Study terminated by sponsor|15|||
170473052|NCT04614246|616069457|FG002|Overall Study|Study terminated by sponsor|12|||
170473053|NCT04614246|616069458|FG003|Overall Study|Study terminated by sponsor|13|||
170473054|NCT04614246|616069459|FG004|Overall Study|Study terminated by sponsor|9|||
170473055|NCT04614246|616069455|FG000|Overall Study|Pregnancy|2|||
170473056|NCT04614246|616069456|FG001|Overall Study|Pregnancy|0|||
170473057|NCT04614246|616069457|FG002|Overall Study|Pregnancy|1|||
170473058|NCT04614246|616069458|FG003|Overall Study|Pregnancy|0|||
170473059|NCT04614246|616069459|FG004|Overall Study|Pregnancy|0|||
170473060|NCT01464931|616069460|FG000|Overall Study|Withdrawal by Subject|1|||
170473061|NCT01464931|616069461|FG001|Overall Study|Withdrawal by Subject|0|||
170473062|NCT00340678|616069474|FG000|Overall Study|Lost to Follow-up|1|||
170473063|NCT00340678|616069475|FG001|Overall Study|Lost to Follow-up|0|||
170473064|NCT00340678|616069476|FG002|Overall Study|Lost to Follow-up|0|||
170473065|NCT00340678|616069477|FG003|Overall Study|Lost to Follow-up|0|||
170473066|NCT04380961|616069480|FG000|Overall Study|Lost to Follow-up|17|||
170473067|NCT04380961|616069481|FG001|Overall Study|Lost to Follow-up|11|||
170473068|NCT04380961|616069480|FG000|Overall Study|Withdrawal by Subject|3|||
170473069|NCT04380961|616069481|FG001|Overall Study|Withdrawal by Subject|0|||
170473070|NCT04380961|616069480|FG000|Overall Study|Death|22|||
170473071|NCT04380961|616069481|FG001|Overall Study|Death|16|||
170473072|NCT04380961|616069480|FG000|Overall Study|Other|1|||
170473073|NCT04380961|616069481|FG001|Overall Study|Other|0|||
170473074|NCT04380961|616069480|FG000|Overall Study|Randomized but Not Treated|1|||
170473075|NCT04380961|616069481|FG001|Overall Study|Randomized but Not Treated|2|||
170473076|NCT02551666|616069482|FG000|Overall Study|Withdrawal by Subject|1|||
170473077|NCT02551666|616069483|FG001|Overall Study|Withdrawal by Subject|3|||
170473078|NCT00912912|616069484|FG000|Overall Study|Withdrawal by Subject|1|||
170473079|NCT00912912|616069484|FG000|Overall Study|Disease Progression|3|||
170473080|NCT00306995|616069485|FG000|Study Part I|Withdrawal by Subject|0|||
170473081|NCT00306995|616069486|FG001|Study Part I|Withdrawal by Subject|0|||
170473082|NCT00306995|616069487|FG002|Study Part I|Withdrawal by Subject|0|||
170473083|NCT00306995|616069488|FG003|Study Part I|Withdrawal by Subject|0|||
170473084|NCT00306995|616069489|FG004|Study Part I|Withdrawal by Subject|0|||
170473085|NCT00306995|616069490|FG005|Study Part I|Withdrawal by Subject|0|||
170473086|NCT00306995|616069491|FG006|Study Part I|Withdrawal by Subject|1|||
170473087|NCT00306995|616069485|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
170473088|NCT00306995|616069486|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
170473089|NCT00306995|616069487|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
170473090|NCT00306995|616069488|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
170473091|NCT00306995|616069489|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
170473092|NCT00306995|616069490|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
170473093|NCT00306995|616069491|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
170473094|NCT02603146|616071350|FG000|Overall Study|Lost to Follow-up|5|||
170473095|NCT02603146|616071351|FG001|Overall Study|Lost to Follow-up|6|||
170473096|NCT02603146|616071350|FG000|Overall Study|Withdrawal by Subject|8|||
170473097|NCT02603146|616071351|FG001|Overall Study|Withdrawal by Subject|10|||
170473098|NCT02603146|616071350|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
170473099|NCT02603146|616071351|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
170637758|NCT03467750|616684668|FG000|Overall Study|Protocol Violation|1|||
170637759|NCT03467750|616684669|FG001|Overall Study|Protocol Violation|1|||
170637760|NCT03467750|616684668|FG000|Overall Study|Withdrawal by Subject|0|||
170637761|NCT03467750|616684669|FG001|Overall Study|Withdrawal by Subject|1|||
170473100|NCT02603146|616071350|FG000|Overall Study|Participant moved|2|||
170473101|NCT02603146|616071351|FG001|Overall Study|Participant moved|0|||
170473102|NCT02603146|616071350|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
170473103|NCT02603146|616071351|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
170473104|NCT05221320|616071354|FG000|Overall Study|Lack of Efficacy|3|||
170473105|NCT05221320|616071355|FG001|Overall Study|Lack of Efficacy|7|||
170473106|NCT05221320|616071356|FG002|Overall Study|Lack of Efficacy|10|||
170473107|NCT05221320|616071357|FG003|Overall Study|Lack of Efficacy|1|||
170473108|NCT05221320|616071358|FG004|Overall Study|Lack of Efficacy|0|||
170473109|NCT05221320|616071359|FG005|Overall Study|Lack of Efficacy|0|||
170473110|NCT05221320|616071354|FG000|Overall Study|Physician Decision|1|||
170473111|NCT05221320|616071355|FG001|Overall Study|Physician Decision|0|||
170473112|NCT05221320|616071356|FG002|Overall Study|Physician Decision|3|||
170473113|NCT05221320|616071357|FG003|Overall Study|Physician Decision|1|||
170473114|NCT05221320|616071358|FG004|Overall Study|Physician Decision|0|||
170637762|NCT02930018|616684674|FG000|Overall Study|Lost to Follow-up|1|||
170473115|NCT05221320|616071359|FG005|Overall Study|Physician Decision|0|||
170473116|NCT05221320|616071354|FG000|Overall Study|Withdrawal by Subject|0|||
170473117|NCT05221320|616071355|FG001|Overall Study|Withdrawal by Subject|3|||
170473118|NCT05221320|616071356|FG002|Overall Study|Withdrawal by Subject|1|||
170473119|NCT05221320|616071357|FG003|Overall Study|Withdrawal by Subject|0|||
170473120|NCT05221320|616071358|FG004|Overall Study|Withdrawal by Subject|0|||
170473121|NCT05221320|616071359|FG005|Overall Study|Withdrawal by Subject|0|||
170473122|NCT05221320|616071354|FG000|Overall Study|Death|0|||
170473123|NCT05221320|616071355|FG001|Overall Study|Death|5|||
170473124|NCT05221320|616071356|FG002|Overall Study|Death|6|||
170473125|NCT05221320|616071357|FG003|Overall Study|Death|0|||
170473126|NCT05221320|616071358|FG004|Overall Study|Death|1|||
170473127|NCT05221320|616071359|FG005|Overall Study|Death|0|||
170473128|NCT06473519|616071360|FG000|Overall Study|Lost to Follow-up|2|||
170473129|NCT06473519|616071361|FG001|Overall Study|Lost to Follow-up|5|||
170473130|NCT06473519|616071360|FG000|Overall Study|Withdrawal by Subject|1|||
170473131|NCT06473519|616071361|FG001|Overall Study|Withdrawal by Subject|4|||
170473132|NCT06473519|616071360|FG000|Overall Study|Randomized but not vaccinated|1|||
170473133|NCT06473519|616071361|FG001|Overall Study|Randomized but not vaccinated|2|||
170473134|NCT00371033|616071365|FG000|Overall Study|Lost to Follow-up|3|||
170473135|NCT00371033|616071366|FG001|Overall Study|Lost to Follow-up|2|||
170473136|NCT00371033|616071365|FG000|Overall Study|No longer interested|2|||
170473137|NCT00371033|616071366|FG001|Overall Study|No longer interested|0|||
170473138|NCT00371033|616071365|FG000|Overall Study|Uknown|3|||
170473139|NCT00371033|616071366|FG001|Overall Study|Uknown|1|||
170473140|NCT02514447|616071367|FG000|Overall Study|Withdrawal by Subject|3|||
170473141|NCT02514447|616071368|FG001|Overall Study|Withdrawal by Subject|1|||
170473142|NCT02514447|616071369|FG002|Overall Study|Withdrawal by Subject|1|||
170473143|NCT02514447|616071370|FG003|Overall Study|Withdrawal by Subject|0|||
170473144|NCT02514447|616071371|FG004|Overall Study|Withdrawal by Subject|0|||
170473145|NCT02514447|616071372|FG005|Overall Study|Withdrawal by Subject|0|||
170473146|NCT02514447|616071373|FG006|Overall Study|Withdrawal by Subject|0|||
170473147|NCT02514447|616071374|FG007|Overall Study|Withdrawal by Subject|1|||
170473148|NCT02514447|616071375|FG008|Overall Study|Withdrawal by Subject|1|||
170473149|NCT02514447|616071367|FG000|Overall Study|Death|24|||
170473150|NCT02514447|616071368|FG001|Overall Study|Death|28|||
170473151|NCT02514447|616071369|FG002|Overall Study|Death|29|||
170473152|NCT02514447|616071370|FG003|Overall Study|Death|0|||
170473153|NCT02514447|616071371|FG004|Overall Study|Death|3|||
170473154|NCT02514447|616071372|FG005|Overall Study|Death|4|||
170473155|NCT02514447|616071373|FG006|Overall Study|Death|8|||
170473156|NCT02514447|616071374|FG007|Overall Study|Death|6|||
170473157|NCT02514447|616071375|FG008|Overall Study|Death|5|||
170473158|NCT02514447|616071367|FG000|Overall Study|Lost to Follow-up|1|||
170473159|NCT02514447|616071368|FG001|Overall Study|Lost to Follow-up|0|||
170473160|NCT02514447|616071369|FG002|Overall Study|Lost to Follow-up|0|||
170473161|NCT02514447|616071370|FG003|Overall Study|Lost to Follow-up|0|||
170473162|NCT02514447|616071371|FG004|Overall Study|Lost to Follow-up|0|||
170473163|NCT02514447|616071372|FG005|Overall Study|Lost to Follow-up|0|||
170473164|NCT02514447|616071373|FG006|Overall Study|Lost to Follow-up|0|||
170473165|NCT02514447|616071374|FG007|Overall Study|Lost to Follow-up|0|||
170473166|NCT02514447|616071375|FG008|Overall Study|Lost to Follow-up|1|||
170473167|NCT02514447|616071367|FG000|Overall Study|Sponsor Termination of Study|0|||
170473168|NCT02514447|616071368|FG001|Overall Study|Sponsor Termination of Study|1|||
170473169|NCT02514447|616071369|FG002|Overall Study|Sponsor Termination of Study|1|||
170473170|NCT02514447|616071370|FG003|Overall Study|Sponsor Termination of Study|0|||
170473171|NCT02514447|616071371|FG004|Overall Study|Sponsor Termination of Study|0|||
170473172|NCT02514447|616071372|FG005|Overall Study|Sponsor Termination of Study|0|||
170473173|NCT02514447|616071373|FG006|Overall Study|Sponsor Termination of Study|0|||
170473174|NCT02514447|616071374|FG007|Overall Study|Sponsor Termination of Study|0|||
170473175|NCT02514447|616071375|FG008|Overall Study|Sponsor Termination of Study|0|||
170473176|NCT02514447|616071367|FG000|Overall Study|Study completion per Investigator|1|||
170473177|NCT02514447|616071368|FG001|Overall Study|Study completion per Investigator|0|||
170473178|NCT02514447|616071369|FG002|Overall Study|Study completion per Investigator|1|||
170473179|NCT02514447|616071370|FG003|Overall Study|Study completion per Investigator|2|||
170473180|NCT02514447|616071371|FG004|Overall Study|Study completion per Investigator|0|||
170473181|NCT02514447|616071372|FG005|Overall Study|Study completion per Investigator|0|||
170473182|NCT02514447|616071373|FG006|Overall Study|Study completion per Investigator|0|||
170473183|NCT02514447|616071374|FG007|Overall Study|Study completion per Investigator|0|||
170473184|NCT02514447|616071375|FG008|Overall Study|Study completion per Investigator|1|||
170473185|NCT06419907|616071377|FG000|Overall Study|Protocol Violation|0|||
170473186|NCT06419907|616071378|FG001|Overall Study|Protocol Violation|3|||
170473187|NCT06419907|616071379|FG002|Overall Study|Protocol Violation|0|||
170473188|NCT06419907|616071380|FG003|Overall Study|Protocol Violation|1|||
170473189|NCT06419907|616071377|FG000|Overall Study|Lost to Follow-up|0|||
170473190|NCT06419907|616071378|FG001|Overall Study|Lost to Follow-up|0|||
170473191|NCT06419907|616071379|FG002|Overall Study|Lost to Follow-up|2|||
170473192|NCT06419907|616071380|FG003|Overall Study|Lost to Follow-up|1|||
170473193|NCT05929651|616071384|FG000|Overall Study|Protocol Deviation|1|||
170545755|NCT00887588|616342736|FG000|Extension Period|Protocol deviation|1|||
170473194|NCT05929651|616071384|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
170473195|NCT02586688|616071385|FG000|Overall Study|Lost to Follow-up|2|||
170473196|NCT02586688|616071386|FG001|Overall Study|Lost to Follow-up|1|||
170473197|NCT02586688|616071385|FG000|Overall Study|Withdrawal by Subject|1|||
170473198|NCT02586688|616071386|FG001|Overall Study|Withdrawal by Subject|1|||
170473199|NCT02586688|616071385|FG000|Overall Study|Adverse Event|3|||
170473200|NCT02586688|616071386|FG001|Overall Study|Adverse Event|1|||
170473201|NCT04856917|616071387|FG000|Overall Study|Withdrawal by Subject|4|||
170473202|NCT04856917|616071388|FG001|Overall Study|Withdrawal by Subject|3|||
170473203|NCT04856917|616071389|FG002|Overall Study|Withdrawal by Subject|1|||
170473204|NCT04856917|616071387|FG000|Overall Study|Lost to Follow-up|3|||
170473205|NCT04856917|616071388|FG001|Overall Study|Lost to Follow-up|1|||
170473206|NCT04856917|616071389|FG002|Overall Study|Lost to Follow-up|1|||
170473207|NCT04856917|616071387|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
170473208|NCT04856917|616071388|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
170473209|NCT04856917|616071389|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
170473210|NCT04856917|616071387|FG000|Overall Study|Other|1|||
170473211|NCT04856917|616071388|FG001|Overall Study|Other|1|||
170473212|NCT04856917|616071389|FG002|Overall Study|Other|0|||
170473213|NCT02498613|616071390|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
170473214|NCT02498613|616071391|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
170473215|NCT02498613|616071392|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
170473216|NCT02498613|616071393|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
170473217|NCT02498613|616071390|FG000|Overall Study|Withdrawal by Subject|3|||
170473218|NCT02498613|616071391|FG001|Overall Study|Withdrawal by Subject|1|||
170473219|NCT02498613|616071392|FG002|Overall Study|Withdrawal by Subject|0|||
170473220|NCT02498613|616071393|FG003|Overall Study|Withdrawal by Subject|0|||
170473221|NCT05168202|616071394|FG000|Overall Study|Progressive Disease|4|||
170473222|NCT05168202|616071395|FG001|Overall Study|Progressive Disease|4|||
170473223|NCT05168202|616071396|FG002|Overall Study|Progressive Disease|2|||
170473224|NCT05168202|616071397|FG003|Overall Study|Progressive Disease|3|||
170473225|NCT05168202|616071398|FG004|Overall Study|Progressive Disease|2|||
170473226|NCT05168202|616071399|FG005|Overall Study|Progressive Disease|3|||
170473227|NCT05168202|616071400|FG006|Overall Study|Progressive Disease|2|||
170473228|NCT05168202|616071394|FG000|Overall Study|Adverse Event|2|||
170473229|NCT05168202|616071395|FG001|Overall Study|Adverse Event|1|||
170473230|NCT05168202|616071396|FG002|Overall Study|Adverse Event|4|||
170473231|NCT05168202|616071397|FG003|Overall Study|Adverse Event|4|||
170473232|NCT05168202|616071398|FG004|Overall Study|Adverse Event|3|||
170473233|NCT05168202|616071399|FG005|Overall Study|Adverse Event|2|||
170473234|NCT05168202|616071400|FG006|Overall Study|Adverse Event|0|||
170473235|NCT05168202|616071394|FG000|Overall Study|Lack of Efficacy|0|||
170473236|NCT05168202|616071395|FG001|Overall Study|Lack of Efficacy|1|||
170473237|NCT05168202|616071396|FG002|Overall Study|Lack of Efficacy|1|||
170473238|NCT05168202|616071397|FG003|Overall Study|Lack of Efficacy|0|||
170473239|NCT05168202|616071398|FG004|Overall Study|Lack of Efficacy|1|||
170473240|NCT05168202|616071399|FG005|Overall Study|Lack of Efficacy|2|||
170473241|NCT05168202|616071400|FG006|Overall Study|Lack of Efficacy|2|||
170473242|NCT05168202|616071394|FG000|Overall Study|Withdrawal by Subject|0|||
170473243|NCT05168202|616071395|FG001|Overall Study|Withdrawal by Subject|0|||
170473244|NCT05168202|616071396|FG002|Overall Study|Withdrawal by Subject|1|||
170473245|NCT05168202|616071397|FG003|Overall Study|Withdrawal by Subject|1|||
170473246|NCT05168202|616071398|FG004|Overall Study|Withdrawal by Subject|1|||
170473247|NCT05168202|616071399|FG005|Overall Study|Withdrawal by Subject|1|||
170473248|NCT05168202|616071400|FG006|Overall Study|Withdrawal by Subject|0|||
170473249|NCT05168202|616071394|FG000|Overall Study|Disease Relapse|0|||
170545756|NCT00887588|616342737|FG001|Extension Period|Protocol deviation|0|||
170473250|NCT05168202|616071395|FG001|Overall Study|Disease Relapse|1|||
170473251|NCT05168202|616071396|FG002|Overall Study|Disease Relapse|0|||
170473252|NCT05168202|616071397|FG003|Overall Study|Disease Relapse|1|||
170473253|NCT05168202|616071398|FG004|Overall Study|Disease Relapse|1|||
170473254|NCT05168202|616071399|FG005|Overall Study|Disease Relapse|0|||
170473255|NCT05168202|616071400|FG006|Overall Study|Disease Relapse|0|||
170473256|NCT05168202|616071394|FG000|Overall Study|Other Reasons|0|||
170473257|NCT05168202|616071395|FG001|Overall Study|Other Reasons|0|||
170545757|NCT00887588|616342736|FG000|Extension Period|Lost to Follow-up|1|||
170545758|NCT00887588|616342737|FG001|Extension Period|Lost to Follow-up|0|||
170791850|NCT01854775|617248041|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
170473258|NCT05168202|616071396|FG002|Overall Study|Other Reasons|0|||
170473259|NCT05168202|616071397|FG003|Overall Study|Other Reasons|0|||
170473260|NCT05168202|616071398|FG004|Overall Study|Other Reasons|0|||
170473261|NCT05168202|616071399|FG005|Overall Study|Other Reasons|2|||
170473262|NCT05168202|616071400|FG006|Overall Study|Other Reasons|1|||
170473263|NCT05168202|616071394|FG000|Overall Study|Physician Decision|0|||
170473264|NCT05168202|616071395|FG001|Overall Study|Physician Decision|1|||
170473265|NCT05168202|616071396|FG002|Overall Study|Physician Decision|1|||
170473266|NCT05168202|616071397|FG003|Overall Study|Physician Decision|0|||
170473267|NCT05168202|616071398|FG004|Overall Study|Physician Decision|0|||
170473268|NCT05168202|616071399|FG005|Overall Study|Physician Decision|0|||
170473269|NCT05168202|616071400|FG006|Overall Study|Physician Decision|0|||
170473270|NCT05168202|616071394|FG000|Overall Study|Study Terminated by Sponsor|0|||
170473271|NCT05168202|616071395|FG001|Overall Study|Study Terminated by Sponsor|0|||
170473272|NCT05168202|616071396|FG002|Overall Study|Study Terminated by Sponsor|0|||
170473273|NCT05168202|616071397|FG003|Overall Study|Study Terminated by Sponsor|1|||
170473274|NCT05168202|616071398|FG004|Overall Study|Study Terminated by Sponsor|0|||
170473275|NCT05168202|616071399|FG005|Overall Study|Study Terminated by Sponsor|0|||
170473276|NCT05168202|616071400|FG006|Overall Study|Study Terminated by Sponsor|0|||
170473277|NCT04011722|616071404|FG000|30 Days|Death|5|||
170473278|NCT04011722|616071405|FG001|30 Days|Death|1|||
170473279|NCT04011722|616071404|FG000|1 Year|Death|13|||
170473280|NCT04011722|616071405|FG001|1 Year|Death|5|||
170473281|NCT04011722|616071404|FG000|1 Year|Withdrawal by Subject|8|||
170473282|NCT04011722|616071405|FG001|1 Year|Withdrawal by Subject|2|||
170473283|NCT04011722|616071404|FG000|1 Year|Missed Visit|6|||
170473284|NCT04011722|616071405|FG001|1 Year|Missed Visit|1|||
170473285|NCT04011722|616071404|FG000|1 Year|Pending Visit|0|||
170473286|NCT04011722|616071405|FG001|1 Year|Pending Visit|11|||
170473287|NCT04011722|616071404|FG000|1 Year|Not Yet Due|0|||
170473288|NCT04011722|616071405|FG001|1 Year|Not Yet Due|9|||
170473289|NCT04011722|616071404|FG000|2 Year|Death|16|||
170473290|NCT04011722|616071405|FG001|2 Year|Death|1|||
170473291|NCT04011722|616071404|FG000|2 Year|Withdrawal by Subject|10|||
170473292|NCT04011722|616071405|FG001|2 Year|Withdrawal by Subject|1|||
170473293|NCT04011722|616071404|FG000|2 Year|Missed Visit|9|||
170473294|NCT04011722|616071405|FG001|2 Year|Missed Visit|0|||
170473295|NCT04011722|616071404|FG000|2 Year|Visit Pending|1|||
170473296|NCT04011722|616071405|FG001|2 Year|Visit Pending|3|||
170473297|NCT04011722|616071404|FG000|2 Year|Not Yet Due|43|||
170473298|NCT04011722|616071405|FG001|2 Year|Not Yet Due|54|||
170473299|NCT04011722|616071404|FG000|3 Year|Death|10|||
170473300|NCT04011722|616071405|FG001|3 Year|Death|0|||
170473301|NCT04011722|616071404|FG000|3 Year|Withdrawal by Subject|2|||
170473302|NCT04011722|616071405|FG001|3 Year|Withdrawal by Subject|0|||
170473303|NCT04011722|616071404|FG000|3 Year|Missed Visit|2|||
170473304|NCT04011722|616071405|FG001|3 Year|Missed Visit|0|||
170473305|NCT04011722|616071404|FG000|3 Year|Pending Visit|34|||
170473306|NCT04011722|616071405|FG001|3 Year|Pending Visit|0|||
170473307|NCT04011722|616071404|FG000|3 Year|Not Yet Due|99|||
170473308|NCT04011722|616071405|FG001|3 Year|Not Yet Due|0|||
170473309|NCT05061134|616071408|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
170545759|NCT02958527|616342738|FG000|Overall Study|Not collected CRFs|12|||
170545760|NCT00567112|616342741|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
170545761|NCT00567112|616342742|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
170791851|NCT01854775|617248042|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
170791852|NCT01854775|617248040|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
170791853|NCT01854775|617248041|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
170791854|NCT01854775|617248042|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
170791855|NCT01854775|617248040|FG000|Extension Phase|Pregnancy|1|||
170791856|NCT01854775|617248041|FG001|Extension Phase|Pregnancy|0|||
170791857|NCT01854775|617248042|FG002|Extension Phase|Pregnancy|0|||
170791858|NCT01854775|617248040|FG000|Extension Phase|Investigator's Discretion|1|||
170473310|NCT05061134|616071409|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
170473311|NCT05061134|616071410|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
170473312|NCT05061134|616071408|FG000|Overall Study|Subject not treated|0|||
170473313|NCT05061134|616071409|FG001|Overall Study|Subject not treated|0|||
170473314|NCT05061134|616071410|FG002|Overall Study|Subject not treated|2|||
170473315|NCT05061134|616071408|FG000|Overall Study|Other|0|||
170473316|NCT05061134|616071409|FG001|Overall Study|Other|0|||
170473317|NCT05061134|616071410|FG002|Overall Study|Other|9|||
170473318|NCT05061134|616071408|FG000|Overall Study|Withdrawal by Subject|9|||
170545762|NCT00567112|616342743|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
170473319|NCT05061134|616071409|FG001|Overall Study|Withdrawal by Subject|8|||
170473320|NCT05061134|616071410|FG002|Overall Study|Withdrawal by Subject|5|||
170473321|NCT05061134|616071408|FG000|Overall Study|Study Terminated by Sponsor|22|||
170473322|NCT05061134|616071409|FG001|Overall Study|Study Terminated by Sponsor|14|||
170473323|NCT05061134|616071410|FG002|Overall Study|Study Terminated by Sponsor|7|||
170473324|NCT05061134|616071408|FG000|Overall Study|Progressive Disease|1|||
170473325|NCT05061134|616071409|FG001|Overall Study|Progressive Disease|2|||
170473326|NCT05061134|616071410|FG002|Overall Study|Progressive Disease|0|||
170473327|NCT05061134|616071408|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
170473328|NCT05061134|616071409|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
170473329|NCT05061134|616071410|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
170473330|NCT05061134|616071408|FG000|Overall Study|Lost to Follow-up|1|||
170473331|NCT05061134|616071409|FG001|Overall Study|Lost to Follow-up|0|||
170473332|NCT05061134|616071410|FG002|Overall Study|Lost to Follow-up|0|||
170473333|NCT05061134|616071408|FG000|Overall Study|Physician Decision|1|||
170473334|NCT05061134|616071409|FG001|Overall Study|Physician Decision|1|||
170473335|NCT05061134|616071410|FG002|Overall Study|Physician Decision|0|||
170473336|NCT05061134|616071408|FG000|Overall Study|Disease progression|1|||
170473337|NCT05061134|616071409|FG001|Overall Study|Disease progression|0|||
170473338|NCT05061134|616071410|FG002|Overall Study|Disease progression|0|||
170473339|NCT05061134|616071408|FG000|Overall Study|Death|43|||
170473340|NCT05061134|616071409|FG001|Overall Study|Death|23|||
170473341|NCT05061134|616071410|FG002|Overall Study|Death|14|||
170473342|NCT05061134|616071408|FG000|Overall Study|Database lock|2|||
170473343|NCT05061134|616071409|FG001|Overall Study|Database lock|0|||
170473344|NCT05061134|616071410|FG002|Overall Study|Database lock|0|||
170473345|NCT05626231|616071411|FG000|Provider Enrollment|Worked part-time|4|||
170473346|NCT05626231|616071411|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
170473347|NCT05626231|616071411|FG000|Provider Enrollment|Non-clinical employee|1|||
170473348|NCT05626231|616071411|FG000|Provider Enrollment|Provider does not see clients|3|||
170473349|NCT05626231|616071411|FG000|Provider Enrollment|Other|5|||
170473350|NCT06195930|616071412|FG000|Overall Study|Adverse Event|4|||
170473351|NCT03765788|616071413|FG000|Overall Study|Subject decision|2|||
170473352|NCT03765788|616071414|FG001|Overall Study|Subject decision|3|||
170473353|NCT03765788|616071413|FG000|Overall Study|Physician Decision|2|||
170473354|NCT03765788|616071414|FG001|Overall Study|Physician Decision|4|||
170473355|NCT03765788|616071413|FG000|Overall Study|Death|0|||
170473356|NCT03765788|616071414|FG001|Overall Study|Death|1|||
170473357|NCT03765788|616071413|FG000|Overall Study|Lost to Follow-up|1|||
170473358|NCT03765788|616071414|FG001|Overall Study|Lost to Follow-up|0|||
170473359|NCT00233948|616071421|FG000|Overall Study|Adverse Event|1|||
170473360|NCT00233948|616071422|FG001|Overall Study|Adverse Event|0|||
170473361|NCT00233948|616071423|FG002|Overall Study|Adverse Event|0|||
170473362|NCT00233948|616071424|FG003|Overall Study|Adverse Event|0|||
170473363|NCT00233948|616071425|FG004|Overall Study|Adverse Event|0|||
170473364|NCT00233948|616071426|FG005|Overall Study|Adverse Event|0|||
170473365|NCT00266630|616071427|FG000|Overall Study|Adverse Event|8|||
170473366|NCT00266630|616071428|FG001|Overall Study|Adverse Event|6|||
170473367|NCT00266630|616071427|FG000|Overall Study|Lack of Efficacy|1|||
170473368|NCT00266630|616071428|FG001|Overall Study|Lack of Efficacy|4|||
170473369|NCT00266630|616071427|FG000|Overall Study|Entry Criteria not met|1|||
170473370|NCT00266630|616071428|FG001|Overall Study|Entry Criteria not met|0|||
170473371|NCT00266630|616071427|FG000|Overall Study|Protocol Violation|1|||
170473372|NCT00266630|616071428|FG001|Overall Study|Protocol Violation|3|||
170473373|NCT00266630|616071427|FG000|Overall Study|Physician Decision|1|||
170473374|NCT00266630|616071428|FG001|Overall Study|Physician Decision|2|||
170473375|NCT00266630|616071427|FG000|Overall Study|Withdrawal by Subject|10|||
170473376|NCT00266630|616071428|FG001|Overall Study|Withdrawal by Subject|2|||
170545763|NCT00567112|616342741|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
170545764|NCT00567112|616342742|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
170545765|NCT00567112|616342743|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
170545766|NCT00567112|616342741|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
170545767|NCT00567112|616342742|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
170545768|NCT00567112|616342743|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
170545769|NCT06038643|616342744|FG000|Overall Study|Withdrawal by Subject|9|||
170545770|NCT06038643|616342745|FG001|Overall Study|Withdrawal by Subject|4|||
170637763|NCT02930018|616684675|FG001|Overall Study|Lost to Follow-up|1|||
170473377|NCT00266630|616071427|FG000|Overall Study|Lost to Follow-up|1|||
170473378|NCT00266630|616071428|FG001|Overall Study|Lost to Follow-up|0|||
170473379|NCT00266630|616071427|FG000|Overall Study|Other|19|||
170473380|NCT00266630|616071428|FG001|Overall Study|Other|11|||
170473381|NCT05377749|616071429|FG000|3 Weeks|Lost to Follow-up|2|||
170473382|NCT05377749|616071430|FG001|3 Weeks|Lost to Follow-up|4|||
170473383|NCT05377749|616071429|FG000|3 Weeks|Withdrawal by Subject|1|||
170473384|NCT05377749|616071430|FG001|3 Weeks|Withdrawal by Subject|1|||
170473385|NCT01214655|616071431|FG000|Part A|Progressive Disease|7|||
170473386|NCT01214655|616071432|FG001|Part A|Progressive Disease|0|||
170473387|NCT01214655|616071433|FG002|Part A|Progressive Disease|0|||
170473388|NCT01214655|616071431|FG000|Part A|Physician Decision|1|||
170473389|NCT01214655|616071432|FG001|Part A|Physician Decision|0|||
170473390|NCT01214655|616071433|FG002|Part A|Physician Decision|0|||
170473391|NCT01214655|616071431|FG000|Part B|Progressive disease|0|||
170473392|NCT01214655|616071432|FG001|Part B|Progressive disease|10|||
170473393|NCT01214655|616071433|FG002|Part B|Progressive disease|0|||
170473394|NCT01214655|616071431|FG000|Part B|Death|0|||
170473395|NCT01214655|616071432|FG001|Part B|Death|1|||
170473396|NCT01214655|616071433|FG002|Part B|Death|0|||
170473397|NCT01214655|616071431|FG000|Part B|Withdrawal by Subject|0|||
170473398|NCT01214655|616071432|FG001|Part B|Withdrawal by Subject|2|||
170473399|NCT01214655|616071433|FG002|Part B|Withdrawal by Subject|0|||
170473400|NCT01214655|616071431|FG000|Part C|Progressive Disease|0|||
170473401|NCT01214655|616071432|FG001|Part C|Progressive Disease|0|||
170473402|NCT01214655|616071433|FG002|Part C|Progressive Disease|5|||
170473403|NCT01214655|616071431|FG000|Part C|Death|0|||
170473404|NCT01214655|616071432|FG001|Part C|Death|0|||
170473405|NCT01214655|616071433|FG002|Part C|Death|1|||
170473406|NCT01214655|616071431|FG000|Part C|Physician Decision|0|||
170473407|NCT01214655|616071432|FG001|Part C|Physician Decision|0|||
170473408|NCT01214655|616071433|FG002|Part C|Physician Decision|1|||
170473409|NCT01499095|616071434|FG000|Overall Study|Randomized But Not Treated|1|||
170473410|NCT01499095|616071435|FG001|Overall Study|Randomized But Not Treated|1|||
170473411|NCT01499095|616071434|FG000|Overall Study|Adverse Event|12|||
170473412|NCT01499095|616071435|FG001|Overall Study|Adverse Event|7|||
170473413|NCT01499095|616071434|FG000|Overall Study|Lack of Efficacy|2|||
170473414|NCT01499095|616071435|FG001|Overall Study|Lack of Efficacy|1|||
170473415|NCT01499095|616071434|FG000|Overall Study|Protocol Violation|6|||
170473416|NCT01499095|616071435|FG001|Overall Study|Protocol Violation|7|||
170473417|NCT01499095|616071434|FG000|Overall Study|Received Rescue Therapy|32|||
170473418|NCT01499095|616071435|FG001|Overall Study|Received Rescue Therapy|40|||
170473419|NCT01499095|616071434|FG000|Overall Study|Diverse Reasons|22|||
170473420|NCT01499095|616071435|FG001|Overall Study|Diverse Reasons|25|||
170473421|NCT01499095|616071434|FG000|Overall Study|Lost to Follow-up|6|||
170473422|NCT01499095|616071435|FG001|Overall Study|Lost to Follow-up|4|||
170473423|NCT01499095|616071434|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
170473424|NCT01499095|616071435|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
170473425|NCT01499095|616071434|FG000|Overall Study|Hypoglycemia|3|||
170473426|NCT01499095|616071435|FG001|Overall Study|Hypoglycemia|1|||
170473427|NCT01499095|616071434|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
170473428|NCT01499095|616071435|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
170473429|NCT01499095|616071434|FG000|Overall Study|Change in Injection Schedule|2|||
170473430|NCT01499095|616071435|FG001|Overall Study|Change in Injection Schedule|0|||
170473431|NCT01499095|616071434|FG000|Overall Study|Perceived Lack of Efficacy|1|||
170473432|NCT01499095|616071435|FG001|Overall Study|Perceived Lack of Efficacy|1|||
170473433|NCT01368497|616071436|FG000|Overall Study|Lost to Follow-up|2|||
170473434|NCT01567462|616071443|FG000|Overall Study|Withdrawal by Subject|4|||
170473435|NCT01567462|616071444|FG001|Overall Study|Withdrawal by Subject|7|||
170473436|NCT00443729|616071451|FG000|Overall Study|Never Treated|0|||
170473437|NCT00443729|616071452|FG001|Overall Study|Never Treated|1|||
170473438|NCT00443729|616071451|FG000|Overall Study|Lack of Efficacy|4|||
170473439|NCT00443729|616071452|FG001|Overall Study|Lack of Efficacy|2|||
170473440|NCT00443729|616071451|FG000|Overall Study|Lost to Follow-up|0|||
170473441|NCT00443729|616071452|FG001|Overall Study|Lost to Follow-up|1|||
170473442|NCT00443729|616071451|FG000|Overall Study|Physician Decision|2|||
170473443|NCT00443729|616071452|FG001|Overall Study|Physician Decision|1|||
170473444|NCT00443729|616071451|FG000|Overall Study|Protocol Violation|1|||
170473445|NCT00443729|616071452|FG001|Overall Study|Protocol Violation|1|||
170473446|NCT00443729|616071451|FG000|Overall Study|Withdrawal by Subject|3|||
170473447|NCT00443729|616071452|FG001|Overall Study|Withdrawal by Subject|1|||
170473448|NCT02013817|616071453|FG000|Overall Study|Adverse Event|12|||
170473449|NCT02013817|616071453|FG000|Overall Study|Withdrawal by Subject|4|||
170473450|NCT02013817|616071453|FG000|Overall Study|Death|2|||
170473451|NCT02013817|616071453|FG000|Overall Study|Other|9|||
170473452|NCT00782626|616071457|FG000|Overall Study|Adverse Event|1|||
170473453|NCT00782626|616071457|FG000|Overall Study|Progressive Disease|5|||
170473454|NCT00782626|616071457|FG000|Overall Study|Other Complicating Disease|1|||
170473455|NCT00855894|616071458|FG000|Overall Study|Death|31|||
170473456|NCT00855894|616071458|FG000|Overall Study|Patient's decision|1|||
170473457|NCT00855894|616071458|FG000|Overall Study|Disease progression|1|||
170473458|NCT00077207|616071460|FG000|Overall Study|Adverse Event|5|||
170473459|NCT00077207|616071460|FG000|Overall Study|Lack of Efficacy|12|||
170473460|NCT00077207|616071460|FG000|Overall Study|Physician Decision|6|||
170473461|NCT00077207|616071460|FG000|Overall Study|Withdrawal by Subject|6|||
170473462|NCT00077207|616071460|FG000|Overall Study|Ineligible|1|||
170473463|NCT02548156|616071464|FG000|Washout Period 1|Lost to Follow-up|0|||
170473464|NCT02548156|616071465|FG001|Washout Period 1|Lost to Follow-up|0|||
170473465|NCT02548156|616071466|FG002|Washout Period 1|Lost to Follow-up|0|||
170473466|NCT02548156|616071467|FG003|Washout Period 1|Lost to Follow-up|0|||
170473467|NCT02548156|616071468|FG004|Washout Period 1|Lost to Follow-up|1|||
170473468|NCT02548156|616071469|FG005|Washout Period 1|Lost to Follow-up|0|||
170473469|NCT03052751|616071470|FG000|Dosing Period 1|Adverse Event|0|||
170473470|NCT03052751|616071471|FG001|Dosing Period 1|Adverse Event|1|||
170473471|NCT03052751|616071472|FG002|Dosing Period 1|Adverse Event|0|||
170473472|NCT03052751|616071473|FG003|Dosing Period 1|Adverse Event|0|||
170473473|NCT03052751|616071474|FG004|Dosing Period 1|Adverse Event|0|||
170473474|NCT03052751|616071475|FG005|Dosing Period 1|Adverse Event|0|||
170473475|NCT03052751|616071470|FG000|Dosing Period 2|Adverse Event|0|||
170473476|NCT03052751|616071471|FG001|Dosing Period 2|Adverse Event|0|||
170473477|NCT03052751|616071472|FG002|Dosing Period 2|Adverse Event|3|||
170637764|NCT02930018|616684674|FG000|Overall Study|Withdrawal by Subject|5|||
170637765|NCT02930018|616684675|FG001|Overall Study|Withdrawal by Subject|2|||
170637766|NCT01104311|616684676|FG000|Overall Study|Withdrawal by Subject|6|||
170473478|NCT03052751|616071473|FG003|Dosing Period 2|Adverse Event|0|||
170473479|NCT03052751|616071474|FG004|Dosing Period 2|Adverse Event|0|||
170473480|NCT03052751|616071475|FG005|Dosing Period 2|Adverse Event|0|||
170473481|NCT03052751|616071470|FG000|Observation Period|Adverse Event|0|||
170473482|NCT03052751|616071471|FG001|Observation Period|Adverse Event|0|||
170473483|NCT03052751|616071472|FG002|Observation Period|Adverse Event|0|||
170473484|NCT03052751|616071473|FG003|Observation Period|Adverse Event|0|||
170473485|NCT03052751|616071474|FG004|Observation Period|Adverse Event|1|||
170473486|NCT03052751|616071475|FG005|Observation Period|Adverse Event|0|||
170473487|NCT00444587|616071486|FG000|Overall Study|Death|2|||
170473488|NCT00444587|616071487|FG001|Overall Study|Death|1|||
170473489|NCT00444587|616071486|FG000|Overall Study|Progression of the disease|73|||
170473490|NCT00444587|616071487|FG001|Overall Study|Progression of the disease|8|||
170473491|NCT00444587|616071486|FG000|Overall Study|Refused treatment/did not cooperate|4|||
170473492|NCT00444587|616071487|FG001|Overall Study|Refused treatment/did not cooperate|1|||
170473493|NCT00444587|616071486|FG000|Overall Study|Investigator decision|3|||
170473494|NCT00444587|616071487|FG001|Overall Study|Investigator decision|0|||
170473495|NCT00444587|616071486|FG000|Overall Study|Protocol Violation|1|||
170473496|NCT00444587|616071487|FG001|Overall Study|Protocol Violation|0|||
170473497|NCT00444587|616071486|FG000|Overall Study|Missing|0|||
170473498|NCT00444587|616071487|FG001|Overall Study|Missing|5|||
170473499|NCT00196326|616071488|FG000|Overall Study|Did not meet protocol requirements|64|||
170473500|NCT00196326|616071488|FG000|Overall Study|Non-compliance with the protocol|81|||
170473501|NCT00196326|616071488|FG000|Overall Study|Physician Decision|3|||
170473502|NCT00196326|616071488|FG000|Overall Study|Withdrawal by Subject|225|||
170473503|NCT00196326|616071488|FG000|Overall Study|Adverse Event|253|||
170473504|NCT00196326|616071488|FG000|Overall Study|Pregnancy|34|||
170473505|NCT00196326|616071488|FG000|Overall Study|Lost to Follow-up|304|||
170473506|NCT00196326|616071488|FG000|Overall Study|Other|22|||
170473507|NCT01427608|616071491|FG000|Overall Study|Death|1|||
170473508|NCT01427608|616071492|FG001|Overall Study|Death|0|||
170473509|NCT01427608|616071491|FG000|Overall Study|Withdrawal by Subject|7|||
170473510|NCT01427608|616071492|FG001|Overall Study|Withdrawal by Subject|3|||
170473511|NCT01427608|616071491|FG000|Overall Study|Relapsed-all cause|13|||
170473512|NCT01427608|616071492|FG001|Overall Study|Relapsed-all cause|34|||
170473513|NCT01427608|616071491|FG000|Overall Study|Events not attributed to study meds|0|||
170473514|NCT01427608|616071492|FG001|Overall Study|Events not attributed to study meds|1|||
170473515|NCT00810511|616071493|FG000|Overall Study|Protocol Violation|0|||
170473516|NCT00810511|616071494|FG001|Overall Study|Protocol Violation|1|||
170473517|NCT00810511|616071493|FG000|Overall Study|Lack of Efficacy|9|||
170473518|NCT00810511|616071494|FG001|Overall Study|Lack of Efficacy|1|||
170473519|NCT00810511|616071493|FG000|Overall Study|death in the family|0|||
170473520|NCT00810511|616071494|FG001|Overall Study|death in the family|1|||
170637767|NCT01104311|616684677|FG001|Overall Study|Withdrawal by Subject|6|||
170637768|NCT01104311|616684676|FG000|Overall Study|Protocol Violation|0|||
170473521|NCT00810511|616071493|FG000|Overall Study|Lost to Follow-up|1|||
170473522|NCT00810511|616071494|FG001|Overall Study|Lost to Follow-up|0|||
170473523|NCT00810511|616071493|FG000|Overall Study|deposits on contact lens|0|||
170473524|NCT00810511|616071494|FG001|Overall Study|deposits on contact lens|1|||
170473525|NCT05219448|616071495|FG000|Overall Study|Lost to Follow-up|9|||
170473526|NCT05219448|616071496|FG001|Overall Study|Lost to Follow-up|0|||
170473527|NCT04342819|616071497|FG000|Overall Study|Declined|4|||
170473528|NCT04342819|616071497|FG000|Overall Study|Not meeeting selection criteria|1|||
170473529|NCT00668317|616071501|FG000|Overall Study|Adverse Event|2|||
170473530|NCT01755091|616071502|FG000|Overall Study|Withdrawal by Subject|6|||
170473531|NCT01755091|616071503|FG001|Overall Study|Withdrawal by Subject|1|||
170637769|NCT01104311|616684677|FG001|Overall Study|Protocol Violation|1|||
170473532|NCT01755091|616071504|FG002|Overall Study|Withdrawal by Subject|3|||
170473533|NCT01755091|616071502|FG000|Overall Study|Adverse Event|1|||
170473534|NCT01755091|616071503|FG001|Overall Study|Adverse Event|1|||
170473535|NCT01755091|616071504|FG002|Overall Study|Adverse Event|1|||
170473536|NCT01755091|616071502|FG000|Overall Study|Lost to Follow-up|1|||
170473537|NCT01755091|616071503|FG001|Overall Study|Lost to Follow-up|0|||
170473538|NCT01755091|616071504|FG002|Overall Study|Lost to Follow-up|1|||
170473539|NCT01755091|616071502|FG000|Overall Study|Physician Decision|1|||
170473540|NCT01755091|616071503|FG001|Overall Study|Physician Decision|1|||
170473541|NCT01755091|616071504|FG002|Overall Study|Physician Decision|2|||
170473542|NCT03164616|616071515|FG000|Overall Study|Death|250|||
170473543|NCT03164616|616071516|FG001|Overall Study|Death|264|||
170473544|NCT03164616|616071517|FG002|Overall Study|Death|279|||
170637770|NCT01104311|616684676|FG000|Overall Study|Physician Decision|2|||
170473545|NCT03164616|616071515|FG000|Overall Study|Lost to Follow-up|2|||
170637771|NCT01104311|616684677|FG001|Overall Study|Physician Decision|2|||
170473546|NCT03164616|616071516|FG001|Overall Study|Lost to Follow-up|2|||
170473547|NCT03164616|616071517|FG002|Overall Study|Lost to Follow-up|2|||
170473548|NCT03164616|616071515|FG000|Overall Study|Withdrawal by Subject|6|||
170473549|NCT03164616|616071516|FG001|Overall Study|Withdrawal by Subject|7|||
170473550|NCT03164616|616071517|FG002|Overall Study|Withdrawal by Subject|16|||
170473551|NCT03548337|616071518|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
170473552|NCT03548337|616071519|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
170473553|NCT03548337|616071518|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
170473554|NCT03548337|616071519|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
170473555|NCT03548337|616071518|FG000|Infant Series|Lost to Follow-up|2|||
170473556|NCT03548337|616071519|FG001|Infant Series|Lost to Follow-up|1|||
170473557|NCT03548337|616071518|FG000|Infant Series|Adverse Event|0|||
170473558|NCT03548337|616071519|FG001|Infant Series|Adverse Event|2|||
170473559|NCT03548337|616071518|FG000|Infant Series|Randomized but Not Vaccinated|1|||
170473560|NCT03548337|616071519|FG001|Infant Series|Randomized but Not Vaccinated|0|||
170473561|NCT03548337|616071518|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
170473562|NCT03548337|616071519|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
170473563|NCT01130597|616071520|FG000|Overall Study|Protocol-specified (High K+)|1|||
170473564|NCT01130597|616071520|FG000|Overall Study|Adverse Event|4|||
170473565|NCT01130597|616071520|FG000|Overall Study|Death|1|||
170473566|NCT01130597|616071520|FG000|Overall Study|Protocol Violation|1|||
170473567|NCT03071276|616071521|FG000|Overall Study|Adverse Event|1|||
170473568|NCT03071276|616071521|FG000|Overall Study|Lack of Efficacy|14|||
170473569|NCT05794503|616071522|FG000|Overall Study|Operation Cancelled|2|||
170473570|NCT05794503|616071523|FG001|Overall Study|Operation Cancelled|0|||
170473571|NCT05794503|616071522|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
170473572|NCT05794503|616071523|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
170473573|NCT05794503|616071522|FG000|Overall Study|Protocol Violation|1|||
170473574|NCT05794503|616071523|FG001|Overall Study|Protocol Violation|0|||
170473575|NCT03052127|616071524|FG000|Overall Study|Withdrawal by Subject|0|||
170473576|NCT03052127|616071525|FG001|Overall Study|Withdrawal by Subject|0|||
170473577|NCT03052127|616071526|FG002|Overall Study|Withdrawal by Subject|0|||
170473578|NCT03052127|616071527|FG003|Overall Study|Withdrawal by Subject|0|||
170473579|NCT03052127|616071528|FG004|Overall Study|Withdrawal by Subject|0|||
170473580|NCT03052127|616071529|FG005|Overall Study|Withdrawal by Subject|0|||
170473581|NCT03052127|616071530|FG006|Overall Study|Withdrawal by Subject|0|||
170473582|NCT03052127|616071531|FG007|Overall Study|Withdrawal by Subject|1|||
170473583|NCT03052127|616071532|FG008|Overall Study|Withdrawal by Subject|1|||
170473584|NCT03052127|616071533|FG009|Overall Study|Withdrawal by Subject|1|||
170473585|NCT03052127|616071534|FG010|Overall Study|Withdrawal by Subject|0|||
170473586|NCT03052127|616071535|FG011|Overall Study|Withdrawal by Subject|0|||
170473587|NCT03052127|616071524|FG000|Overall Study|Discontinuation by Sponsor|0|||
170473588|NCT03052127|616071525|FG001|Overall Study|Discontinuation by Sponsor|0|||
170473589|NCT03052127|616071526|FG002|Overall Study|Discontinuation by Sponsor|0|||
170473590|NCT03052127|616071527|FG003|Overall Study|Discontinuation by Sponsor|0|||
170473591|NCT03052127|616071528|FG004|Overall Study|Discontinuation by Sponsor|0|||
170473592|NCT03052127|616071529|FG005|Overall Study|Discontinuation by Sponsor|0|||
170473593|NCT03052127|616071530|FG006|Overall Study|Discontinuation by Sponsor|0|||
170473594|NCT03052127|616071531|FG007|Overall Study|Discontinuation by Sponsor|0|||
170473595|NCT03052127|616071532|FG008|Overall Study|Discontinuation by Sponsor|4|||
170473596|NCT03052127|616071533|FG009|Overall Study|Discontinuation by Sponsor|2|||
170473597|NCT03052127|616071534|FG010|Overall Study|Discontinuation by Sponsor|5|||
170473598|NCT03052127|616071535|FG011|Overall Study|Discontinuation by Sponsor|13|||
170473599|NCT03052127|616071524|FG000|Overall Study|Inability to comply with trial requirements|0|||
170473600|NCT03052127|616071525|FG001|Overall Study|Inability to comply with trial requirements|0|||
170473601|NCT03052127|616071526|FG002|Overall Study|Inability to comply with trial requirements|1|||
170473602|NCT03052127|616071527|FG003|Overall Study|Inability to comply with trial requirements|0|||
170473603|NCT03052127|616071528|FG004|Overall Study|Inability to comply with trial requirements|0|||
170473604|NCT03052127|616071529|FG005|Overall Study|Inability to comply with trial requirements|0|||
170473605|NCT03052127|616071530|FG006|Overall Study|Inability to comply with trial requirements|0|||
170473606|NCT03052127|616071531|FG007|Overall Study|Inability to comply with trial requirements|0|||
170473607|NCT03052127|616071532|FG008|Overall Study|Inability to comply with trial requirements|0|||
170473608|NCT03052127|616071533|FG009|Overall Study|Inability to comply with trial requirements|0|||
170473609|NCT03052127|616071534|FG010|Overall Study|Inability to comply with trial requirements|0|||
170473610|NCT03052127|616071535|FG011|Overall Study|Inability to comply with trial requirements|0|||
170473611|NCT03052127|616071524|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
170473612|NCT03052127|616071525|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
170473613|NCT03052127|616071526|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
170637772|NCT01104311|616684676|FG000|Overall Study|low compliance|1|||
170473614|NCT03052127|616071527|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
170473615|NCT03052127|616071528|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
170637773|NCT01104311|616684677|FG001|Overall Study|low compliance|1|||
170637774|NCT01104311|616684676|FG000|Overall Study|Adverse Event|1|||
170473616|NCT03052127|616071529|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
170473617|NCT03052127|616071530|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
170473618|NCT03052127|616071531|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
170473619|NCT03052127|616071532|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
170473620|NCT03052127|616071533|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
170473621|NCT03052127|616071534|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
170473622|NCT03052127|616071535|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
170473623|NCT00307437|616071538|FG000|Controlled Period|Adverse Event|7|||
170473624|NCT00307437|616071539|FG001|Controlled Period|Adverse Event|2|||
170473625|NCT00307437|616071540|FG002|Controlled Period|Adverse Event|5|||
170473626|NCT00307437|616071541|FG003|Controlled Period|Adverse Event|0|||
170473627|NCT00307437|616071542|FG004|Controlled Period|Adverse Event|0|||
170473628|NCT00307437|616071543|FG005|Controlled Period|Adverse Event|0|||
170473629|NCT00307437|616071544|FG006|Controlled Period|Adverse Event|0|||
170473630|NCT00307437|616071538|FG000|Controlled Period|Death|0|||
170473631|NCT00307437|616071539|FG001|Controlled Period|Death|0|||
170473632|NCT00307437|616071540|FG002|Controlled Period|Death|1|||
170473633|NCT00307437|616071541|FG003|Controlled Period|Death|0|||
170473634|NCT00307437|616071542|FG004|Controlled Period|Death|0|||
170473635|NCT00307437|616071543|FG005|Controlled Period|Death|0|||
170473636|NCT00307437|616071544|FG006|Controlled Period|Death|0|||
170473637|NCT00307437|616071538|FG000|Controlled Period|Lack of Efficacy|2|||
170473638|NCT00307437|616071539|FG001|Controlled Period|Lack of Efficacy|0|||
170473639|NCT00307437|616071540|FG002|Controlled Period|Lack of Efficacy|0|||
170473640|NCT00307437|616071541|FG003|Controlled Period|Lack of Efficacy|0|||
170473641|NCT00307437|616071542|FG004|Controlled Period|Lack of Efficacy|0|||
170473642|NCT00307437|616071543|FG005|Controlled Period|Lack of Efficacy|0|||
170473643|NCT00307437|616071544|FG006|Controlled Period|Lack of Efficacy|0|||
170473644|NCT00307437|616071538|FG000|Controlled Period|Lost to Follow-up|2|||
170473645|NCT00307437|616071539|FG001|Controlled Period|Lost to Follow-up|3|||
170473646|NCT00307437|616071540|FG002|Controlled Period|Lost to Follow-up|0|||
170473647|NCT00307437|616071541|FG003|Controlled Period|Lost to Follow-up|0|||
170473648|NCT00307437|616071542|FG004|Controlled Period|Lost to Follow-up|0|||
170473649|NCT00307437|616071543|FG005|Controlled Period|Lost to Follow-up|0|||
170473650|NCT00307437|616071544|FG006|Controlled Period|Lost to Follow-up|0|||
170473651|NCT00307437|616071538|FG000|Controlled Period|Other|5|||
170473652|NCT00307437|616071539|FG001|Controlled Period|Other|1|||
170473653|NCT00307437|616071540|FG002|Controlled Period|Other|3|||
170473654|NCT00307437|616071541|FG003|Controlled Period|Other|0|||
170473655|NCT00307437|616071542|FG004|Controlled Period|Other|0|||
170473656|NCT00307437|616071543|FG005|Controlled Period|Other|0|||
170473657|NCT00307437|616071544|FG006|Controlled Period|Other|0|||
170473658|NCT00307437|616071538|FG000|After Controlled Period|Adverse Event|0|||
170473659|NCT00307437|616071539|FG001|After Controlled Period|Adverse Event|0|||
170473660|NCT00307437|616071540|FG002|After Controlled Period|Adverse Event|0|||
170473661|NCT00307437|616071541|FG003|After Controlled Period|Adverse Event|18|||
170473662|NCT00307437|616071542|FG004|After Controlled Period|Adverse Event|16|||
170473663|NCT00307437|616071543|FG005|After Controlled Period|Adverse Event|31|||
170473664|NCT00307437|616071544|FG006|After Controlled Period|Adverse Event|40|||
170473665|NCT00307437|616071538|FG000|After Controlled Period|Death|0|||
170473666|NCT00307437|616071539|FG001|After Controlled Period|Death|0|||
170473667|NCT00307437|616071540|FG002|After Controlled Period|Death|0|||
170473668|NCT00307437|616071541|FG003|After Controlled Period|Death|3|||
170473669|NCT00307437|616071542|FG004|After Controlled Period|Death|1|||
170473670|NCT00307437|616071543|FG005|After Controlled Period|Death|1|||
170473671|NCT00307437|616071544|FG006|After Controlled Period|Death|3|||
170473672|NCT00307437|616071538|FG000|After Controlled Period|Lack of Efficacy|0|||
170473673|NCT00307437|616071539|FG001|After Controlled Period|Lack of Efficacy|0|||
170473674|NCT00307437|616071540|FG002|After Controlled Period|Lack of Efficacy|0|||
170473675|NCT00307437|616071541|FG003|After Controlled Period|Lack of Efficacy|15|||
170473676|NCT00307437|616071542|FG004|After Controlled Period|Lack of Efficacy|17|||
170473677|NCT00307437|616071543|FG005|After Controlled Period|Lack of Efficacy|37|||
170473678|NCT00307437|616071544|FG006|After Controlled Period|Lack of Efficacy|24|||
170473679|NCT00307437|616071538|FG000|After Controlled Period|Lost to Follow-up|0|||
170473680|NCT00307437|616071539|FG001|After Controlled Period|Lost to Follow-up|0|||
170473681|NCT00307437|616071540|FG002|After Controlled Period|Lost to Follow-up|0|||
170473682|NCT00307437|616071541|FG003|After Controlled Period|Lost to Follow-up|7|||
170473683|NCT00307437|616071542|FG004|After Controlled Period|Lost to Follow-up|12|||
170473684|NCT00307437|616071543|FG005|After Controlled Period|Lost to Follow-up|13|||
170791859|NCT01854775|617248041|FG001|Extension Phase|Investigator's Discretion|0|||
170473685|NCT00307437|616071544|FG006|After Controlled Period|Lost to Follow-up|18|||
170473686|NCT00307437|616071538|FG000|After Controlled Period|Other|0|||
170473687|NCT00307437|616071539|FG001|After Controlled Period|Other|0|||
170473688|NCT00307437|616071540|FG002|After Controlled Period|Other|0|||
170473689|NCT00307437|616071541|FG003|After Controlled Period|Other|15|||
170473690|NCT00307437|616071542|FG004|After Controlled Period|Other|9|||
170473691|NCT00307437|616071543|FG005|After Controlled Period|Other|40|||
170473692|NCT00307437|616071544|FG006|After Controlled Period|Other|28|||
170473693|NCT03729596|616073631|FG000|Overall Study|Death|3|||
170473694|NCT03729596|616073632|FG001|Overall Study|Death|5|||
170473695|NCT03729596|616073633|FG002|Overall Study|Death|4|||
170473696|NCT03729596|616073634|FG003|Overall Study|Death|1|||
170473697|NCT03729596|616073635|FG004|Overall Study|Death|0|||
170473698|NCT03729596|616073636|FG005|Overall Study|Death|34|||
170473699|NCT03729596|616073637|FG006|Overall Study|Death|18|||
170473700|NCT03729596|616073638|FG007|Overall Study|Death|14|||
170473701|NCT03729596|616073639|FG008|Overall Study|Death|19|||
170473702|NCT03729596|616073640|FG009|Overall Study|Death|9|||
170473703|NCT03729596|616073631|FG000|Overall Study|Lost to Follow-up|0|||
170473704|NCT03729596|616073632|FG001|Overall Study|Lost to Follow-up|0|||
170473705|NCT03729596|616073633|FG002|Overall Study|Lost to Follow-up|0|||
170473706|NCT03729596|616073634|FG003|Overall Study|Lost to Follow-up|0|||
170473707|NCT03729596|616073635|FG004|Overall Study|Lost to Follow-up|0|||
170473708|NCT03729596|616073636|FG005|Overall Study|Lost to Follow-up|0|||
170473709|NCT03729596|616073637|FG006|Overall Study|Lost to Follow-up|1|||
170473710|NCT03729596|616073638|FG007|Overall Study|Lost to Follow-up|0|||
170473711|NCT03729596|616073639|FG008|Overall Study|Lost to Follow-up|0|||
170473712|NCT03729596|616073640|FG009|Overall Study|Lost to Follow-up|1|||
170473713|NCT03729596|616073631|FG000|Overall Study|protocol amendment|0|||
170473714|NCT03729596|616073632|FG001|Overall Study|protocol amendment|1|||
170473715|NCT03729596|616073633|FG002|Overall Study|protocol amendment|3|||
170473716|NCT03729596|616073634|FG003|Overall Study|protocol amendment|6|||
170473717|NCT03729596|616073635|FG004|Overall Study|protocol amendment|5|||
170473718|NCT03729596|616073636|FG005|Overall Study|protocol amendment|0|||
170473719|NCT03729596|616073637|FG006|Overall Study|protocol amendment|0|||
170473720|NCT03729596|616073638|FG007|Overall Study|protocol amendment|0|||
170473721|NCT03729596|616073639|FG008|Overall Study|protocol amendment|0|||
170473722|NCT03729596|616073640|FG009|Overall Study|protocol amendment|0|||
170473723|NCT03729596|616073631|FG000|Overall Study|Withdrawal by Subject|0|||
170473724|NCT03729596|616073632|FG001|Overall Study|Withdrawal by Subject|0|||
170473725|NCT03729596|616073633|FG002|Overall Study|Withdrawal by Subject|0|||
170473726|NCT03729596|616073634|FG003|Overall Study|Withdrawal by Subject|0|||
170473727|NCT03729596|616073635|FG004|Overall Study|Withdrawal by Subject|0|||
170473728|NCT03729596|616073636|FG005|Overall Study|Withdrawal by Subject|4|||
170473729|NCT03729596|616073637|FG006|Overall Study|Withdrawal by Subject|2|||
170473730|NCT03729596|616073638|FG007|Overall Study|Withdrawal by Subject|3|||
170473731|NCT03729596|616073639|FG008|Overall Study|Withdrawal by Subject|2|||
170473732|NCT03729596|616073640|FG009|Overall Study|Withdrawal by Subject|3|||
170473733|NCT03729596|616073631|FG000|Overall Study|study terminated by sponsor|0|||
170473734|NCT03729596|616073632|FG001|Overall Study|study terminated by sponsor|0|||
170473735|NCT03729596|616073633|FG002|Overall Study|study terminated by sponsor|0|||
170473736|NCT03729596|616073634|FG003|Overall Study|study terminated by sponsor|0|||
170473737|NCT03729596|616073635|FG004|Overall Study|study terminated by sponsor|1|||
170473738|NCT03729596|616073636|FG005|Overall Study|study terminated by sponsor|3|||
170473739|NCT03729596|616073637|FG006|Overall Study|study terminated by sponsor|0|||
170473740|NCT03729596|616073638|FG007|Overall Study|study terminated by sponsor|1|||
170473741|NCT03729596|616073639|FG008|Overall Study|study terminated by sponsor|0|||
170473742|NCT03729596|616073640|FG009|Overall Study|study terminated by sponsor|0|||
170473743|NCT05126693|616073641|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
170473744|NCT05126693|616073642|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
170473745|NCT05126693|616073641|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
170473746|NCT05126693|616073642|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
170473747|NCT05126693|616073641|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
170473748|NCT05126693|616073642|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
170473749|NCT03999996|616073646|FG000|Prior to Booster|Adverse Event|2|||
170473750|NCT03999996|616073647|FG001|Prior to Booster|Adverse Event|0|||
170791860|NCT01854775|617248042|FG002|Extension Phase|Investigator's Discretion|0|||
170473751|NCT03999996|616073648|FG002|Prior to Booster|Adverse Event|0|||
170473752|NCT03999996|616073649|FG003|Prior to Booster|Adverse Event|0|||
170473753|NCT03999996|616073646|FG000|Prior to Booster|Lost to Follow-up|17|||
170473754|NCT03999996|616073647|FG001|Prior to Booster|Lost to Follow-up|22|||
170791861|NCT01854775|617248040|FG000|Extension Phase|Non-Compliance with study drug|1|||
170473755|NCT03999996|616073648|FG002|Prior to Booster|Lost to Follow-up|0|||
170791862|NCT01854775|617248041|FG001|Extension Phase|Non-Compliance with study drug|0|||
170791863|NCT01854775|617248042|FG002|Extension Phase|Non-Compliance with study drug|0|||
170791864|NCT01854775|617248040|FG000|Extension Phase|Lost to Follow-up|1|||
170473756|NCT03999996|616073649|FG003|Prior to Booster|Lost to Follow-up|0|||
170473757|NCT03999996|616073646|FG000|Prior to Booster|Withdrawal of Consent|51|||
170473758|NCT03999996|616073647|FG001|Prior to Booster|Withdrawal of Consent|8|||
170473759|NCT03999996|616073648|FG002|Prior to Booster|Withdrawal of Consent|0|||
170473760|NCT03999996|616073649|FG003|Prior to Booster|Withdrawal of Consent|0|||
170473761|NCT03999996|616073646|FG000|Prior to Booster|Death|0|||
170473762|NCT03999996|616073647|FG001|Prior to Booster|Death|1|||
170473763|NCT03999996|616073648|FG002|Prior to Booster|Death|0|||
170473764|NCT03999996|616073649|FG003|Prior to Booster|Death|0|||
170473765|NCT03999996|616073646|FG000|Prior to Booster|Reason Not Specified|27|||
170473766|NCT03999996|616073647|FG001|Prior to Booster|Reason Not Specified|4|||
170473767|NCT03999996|616073648|FG002|Prior to Booster|Reason Not Specified|0|||
170473768|NCT03999996|616073649|FG003|Prior to Booster|Reason Not Specified|0|||
170473769|NCT03999996|616073646|FG000|Booster Phase|Lost to Follow-up|0|||
170473770|NCT03999996|616073647|FG001|Booster Phase|Lost to Follow-up|0|||
170473771|NCT03999996|616073648|FG002|Booster Phase|Lost to Follow-up|3|||
170473772|NCT03999996|616073649|FG003|Booster Phase|Lost to Follow-up|3|||
170473773|NCT03999996|616073646|FG000|Booster Phase|Withdrawal of Consent|0|||
170473774|NCT03999996|616073647|FG001|Booster Phase|Withdrawal of Consent|0|||
170473775|NCT03999996|616073648|FG002|Booster Phase|Withdrawal of Consent|0|||
170473776|NCT03999996|616073649|FG003|Booster Phase|Withdrawal of Consent|1|||
170473777|NCT03999996|616073646|FG000|Booster Phase|Reason Not Specified|0|||
170473778|NCT03999996|616073647|FG001|Booster Phase|Reason Not Specified|0|||
170473779|NCT03999996|616073648|FG002|Booster Phase|Reason Not Specified|0|||
170473780|NCT03999996|616073649|FG003|Booster Phase|Reason Not Specified|1|||
170473781|NCT03690388|616073650|FG000|Overall Study|Adverse Event|8|||
170473782|NCT03690388|616073651|FG001|Overall Study|Adverse Event|1|||
170473783|NCT03690388|616073650|FG000|Overall Study|Radiographic Progression|14|||
170473784|NCT03690388|616073651|FG001|Overall Study|Radiographic Progression|29|||
170473785|NCT03690388|616073650|FG000|Overall Study|Clinical deterioration|10|||
170473786|NCT03690388|616073651|FG001|Overall Study|Clinical deterioration|6|||
170473787|NCT03690388|616073650|FG000|Overall Study|Withdrawal by Subject|2|||
170473788|NCT03690388|616073651|FG001|Overall Study|Withdrawal by Subject|0|||
170473789|NCT03690388|616073650|FG000|Overall Study|Lack of Efficacy|1|||
170473790|NCT03690388|616073651|FG001|Overall Study|Lack of Efficacy|0|||
170473791|NCT03690388|616073650|FG000|Overall Study|Lost to Follow-up|1|||
170473792|NCT03690388|616073651|FG001|Overall Study|Lost to Follow-up|0|||
170473793|NCT00001521|616073652|FG000|Overall Study|Withdrawal by Subject|3|||
170473794|NCT00001521|616073653|FG001|Overall Study|Withdrawal by Subject|3|||
170473795|NCT00001521|616073652|FG000|Overall Study|Physician Decision|1|||
170473796|NCT00001521|616073653|FG001|Overall Study|Physician Decision|1|||
170473797|NCT00001521|616073652|FG000|Overall Study|Noncompliant|6|||
170473798|NCT00001521|616073653|FG001|Overall Study|Noncompliant|3|||
170473799|NCT03176134|616073654|FG000|Overall Study|Lost to Follow-up|0|||
170473800|NCT03176134|616073655|FG001|Overall Study|Lost to Follow-up|2|||
170473801|NCT03176134|616073656|FG002|Overall Study|Lost to Follow-up|0|||
170473802|NCT03176134|616073657|FG003|Overall Study|Lost to Follow-up|0|||
170473803|NCT03176134|616073658|FG004|Overall Study|Lost to Follow-up|0|||
170473804|NCT03176134|616073659|FG005|Overall Study|Lost to Follow-up|0|||
170473805|NCT03176134|616073660|FG006|Overall Study|Lost to Follow-up|0|||
170473806|NCT03176134|616073661|FG007|Overall Study|Lost to Follow-up|0|||
170473807|NCT03176134|616073654|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
170473808|NCT03176134|616073655|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170473809|NCT03176134|616073656|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
170473810|NCT03176134|616073657|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170473811|NCT03176134|616073658|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
170473812|NCT03176134|616073659|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
170473813|NCT03176134|616073660|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
170473814|NCT03176134|616073661|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
170473815|NCT03410056|616073664|FG000|Overall Study|Decision by Sponsor|0|||
170473816|NCT03410056|616073665|FG001|Overall Study|Decision by Sponsor|0|||
170473817|NCT03410056|616073666|FG002|Overall Study|Decision by Sponsor|3|||
170473818|NCT03410056|616073667|FG003|Overall Study|Decision by Sponsor|0|||
170473819|NCT03410056|616073668|FG004|Overall Study|Decision by Sponsor|0|||
170473820|NCT03410056|616073669|FG005|Overall Study|Decision by Sponsor|0|||
170473821|NCT03410056|616073670|FG006|Overall Study|Decision by Sponsor|0|||
170473822|NCT03410056|616073664|FG000|Overall Study|Withdrawal by Subject|0|||
170473823|NCT03410056|616073665|FG001|Overall Study|Withdrawal by Subject|2|||
170473824|NCT03410056|616073666|FG002|Overall Study|Withdrawal by Subject|5|||
170473825|NCT03410056|616073667|FG003|Overall Study|Withdrawal by Subject|5|||
170473826|NCT03410056|616073668|FG004|Overall Study|Withdrawal by Subject|0|||
170791865|NCT01854775|617248041|FG001|Extension Phase|Lost to Follow-up|0|||
170791866|NCT01854775|617248042|FG002|Extension Phase|Lost to Follow-up|0|||
170473827|NCT03410056|616073669|FG005|Overall Study|Withdrawal by Subject|0|||
170473828|NCT03410056|616073670|FG006|Overall Study|Withdrawal by Subject|0|||
170473829|NCT01130532|616073674|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
170473830|NCT01130532|616073675|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
170473831|NCT01130532|616073676|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
170473832|NCT01130532|616073677|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
170473833|NCT01130532|616073674|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
170473834|NCT01130532|616073675|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
170473835|NCT01130532|616073676|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
170473836|NCT01130532|616073677|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
170473837|NCT01130532|616073674|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
170473838|NCT01130532|616073675|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
170473839|NCT01130532|616073676|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
170637775|NCT01104311|616684677|FG001|Overall Study|Adverse Event|2|||
170637776|NCT01865552|616686635|FG000|Period 1|Adverse Event|1|||
170637777|NCT01865552|616686636|FG001|Period 1|Adverse Event|0|||
170637778|NCT01865552|616686637|FG002|Period 1|Adverse Event|0|||
170637779|NCT01865552|616686638|FG003|Period 1|Adverse Event|1|||
170637780|NCT01865552|616686639|FG004|Period 1|Adverse Event|1|||
170637781|NCT01865552|616686640|FG005|Period 1|Adverse Event|1|||
170637782|NCT01865552|616686635|FG000|Period 1|Pathological lab|0|||
170637783|NCT01865552|616686636|FG001|Period 1|Pathological lab|0|||
170637784|NCT01865552|616686637|FG002|Period 1|Pathological lab|0|||
170637785|NCT01865552|616686638|FG003|Period 1|Pathological lab|0|||
170637786|NCT01865552|616686639|FG004|Period 1|Pathological lab|1|||
170637787|NCT01865552|616686640|FG005|Period 1|Pathological lab|0|||
170637788|NCT01865552|616686635|FG000|Period 1|Other|0|||
170637789|NCT01865552|616686636|FG001|Period 1|Other|0|||
170637790|NCT01865552|616686637|FG002|Period 1|Other|0|||
170637791|NCT01865552|616686638|FG003|Period 1|Other|0|||
170637792|NCT01865552|616686639|FG004|Period 1|Other|1|||
170637793|NCT01865552|616686640|FG005|Period 1|Other|0|||
170637794|NCT01243242|616686645|FG000|Overall Study|Adverse Event|1|||
170637795|NCT01243242|616686646|FG001|Overall Study|Adverse Event|1|||
170637796|NCT01243242|616686645|FG000|Overall Study|Withdrawal by Subject|1|||
170637797|NCT01243242|616686646|FG001|Overall Study|Withdrawal by Subject|1|||
170637798|NCT01243242|616686645|FG000|Overall Study|Physician Decision|0|||
170637799|NCT01243242|616686646|FG001|Overall Study|Physician Decision|1|||
170637800|NCT01243242|616686645|FG000|Overall Study|sponsor decision|0|||
170637801|NCT01243242|616686646|FG001|Overall Study|sponsor decision|1|||
170637802|NCT01243242|616686645|FG000|Overall Study|non compliance|1|||
170637803|NCT01243242|616686646|FG001|Overall Study|non compliance|0|||
170637804|NCT01250145|616686651|FG000|Overall Study|Adverse Event|2|||
170637805|NCT01250145|616686652|FG001|Overall Study|Adverse Event|1|||
170637806|NCT01250145|616686651|FG000|Overall Study|Withdrawal by Subject|0|||
170637807|NCT01250145|616686652|FG001|Overall Study|Withdrawal by Subject|4|||
170891654|NCT01818726|617609841|FG001|Overall Study|Administrative reasons|1|||
170891655|NCT01818726|617609840|FG000|Overall Study|Withdrawal by Subject|0|||
170891656|NCT01818726|617609841|FG001|Overall Study|Withdrawal by Subject|1|||
170891657|NCT01818726|617609840|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
170891658|NCT01818726|617609841|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
170891659|NCT02551159|617609846|FG000|Overall Study|Death|352|||
170891660|NCT02551159|617609847|FG001|Overall Study|Death|174|||
170891661|NCT02551159|617609848|FG002|Overall Study|Death|161|||
170891662|NCT02551159|617609846|FG000|Overall Study|Withdrawal by Subject|8|||
170891663|NCT02551159|617609847|FG001|Overall Study|Withdrawal by Subject|5|||
170891664|NCT02551159|617609848|FG002|Overall Study|Withdrawal by Subject|16|||
170891665|NCT02551159|617609846|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
170891666|NCT02551159|617609847|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
170891667|NCT02551159|617609848|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
170891668|NCT06098729|617609849|FG000|Overall Study|Withdrawal by Subject|1|||
170637808|NCT02687191|616686653|FG000|Overall Study|Death|0|||
170637809|NCT02687191|616686654|FG001|Overall Study|Death|1|||
170637810|NCT02687191|616686655|FG002|Overall Study|Death|1|||
170637811|NCT02687191|616686656|FG003|Overall Study|Death|0|||
170637812|NCT02687191|616686657|FG004|Overall Study|Death|1|||
170637813|NCT02687191|616686658|FG005|Overall Study|Death|1|||
170637814|NCT02687191|616686653|FG000|Overall Study|Withdrawal by Subject|0|||
170637815|NCT02687191|616686654|FG001|Overall Study|Withdrawal by Subject|0|||
170637816|NCT02687191|616686655|FG002|Overall Study|Withdrawal by Subject|0|||
170637817|NCT02687191|616686656|FG003|Overall Study|Withdrawal by Subject|1|||
170637818|NCT02687191|616686657|FG004|Overall Study|Withdrawal by Subject|0|||
170637819|NCT02687191|616686658|FG005|Overall Study|Withdrawal by Subject|0|||
170637820|NCT01349049|616686659|FG000|Overall Study|Disease progression|3|||
170637821|NCT01349049|616686660|FG001|Overall Study|Disease progression|5|||
170637822|NCT01349049|616686661|FG002|Overall Study|Disease progression|3|||
170637823|NCT01349049|616686662|FG003|Overall Study|Disease progression|2|||
170637824|NCT01349049|616686663|FG004|Overall Study|Disease progression|2|||
170637825|NCT01349049|616686664|FG005|Overall Study|Disease progression|2|||
170637826|NCT01349049|616686665|FG006|Overall Study|Disease progression|3|||
170637827|NCT01349049|616686666|FG007|Overall Study|Disease progression|2|||
170637828|NCT01349049|616686667|FG008|Overall Study|Disease progression|33|||
170637829|NCT01349049|616686659|FG000|Overall Study|Adverse Event|0|||
170891669|NCT00993928|617609850|FG000|Overall Study|Withdrawal by Subject|4|||
170637830|NCT01349049|616686660|FG001|Overall Study|Adverse Event|1|||
170637831|NCT01349049|616686661|FG002|Overall Study|Adverse Event|0|||
170891670|NCT00993928|617609851|FG001|Overall Study|Withdrawal by Subject|7|||
170891671|NCT00993928|617609850|FG000|Overall Study|ineligible|1|||
170637832|NCT01349049|616686662|FG003|Overall Study|Adverse Event|0|||
170637833|NCT01349049|616686663|FG004|Overall Study|Adverse Event|0|||
170637834|NCT01349049|616686664|FG005|Overall Study|Adverse Event|3|||
170637835|NCT01349049|616686665|FG006|Overall Study|Adverse Event|1|||
170637836|NCT01349049|616686666|FG007|Overall Study|Adverse Event|0|||
170637837|NCT01349049|616686667|FG008|Overall Study|Adverse Event|4|||
170473840|NCT01130532|616073677|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
170473841|NCT01130532|616073674|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
170473842|NCT01130532|616073675|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
170473843|NCT01130532|616073676|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
170473844|NCT01130532|616073677|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
170473845|NCT01130532|616073674|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
170473846|NCT01130532|616073675|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
170473847|NCT01130532|616073676|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
170473848|NCT01130532|616073677|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
170473849|NCT01130532|616073674|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
170473850|NCT01130532|616073675|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
170473851|NCT01130532|616073676|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
170473852|NCT01130532|616073677|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
170473853|NCT01130532|616073674|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
170473854|NCT01130532|616073675|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
170473855|NCT01130532|616073676|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
170473856|NCT01130532|616073677|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
170473857|NCT01130532|616073674|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
170473858|NCT01130532|616073675|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
170473859|NCT01130532|616073676|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
170473860|NCT01130532|616073677|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
170473861|NCT01130532|616073674|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
170473862|NCT01130532|616073675|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
170473863|NCT01130532|616073676|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
170473864|NCT01130532|616073677|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
170473865|NCT01130532|616073674|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
170473866|NCT01130532|616073675|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
170473867|NCT01130532|616073676|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
170473868|NCT01130532|616073677|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
170473869|NCT01130532|616073674|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
170473870|NCT01130532|616073675|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
170473871|NCT01130532|616073676|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
170473872|NCT01130532|616073677|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
170473873|NCT02762929|616073678|FG000|Overall Study|Adverse Event|0|||
170473874|NCT02762929|616073679|FG001|Overall Study|Adverse Event|0|||
170473875|NCT02762929|616073680|FG002|Overall Study|Adverse Event|0|||
170473876|NCT02762929|616073681|FG003|Overall Study|Adverse Event|1|||
170473877|NCT02762929|616073682|FG004|Overall Study|Adverse Event|0|||
170473878|NCT02762929|616073683|FG005|Overall Study|Adverse Event|0|||
170473879|NCT02762929|616073678|FG000|Overall Study|Lost to Follow-up|1|||
170473880|NCT02762929|616073679|FG001|Overall Study|Lost to Follow-up|2|||
170473881|NCT02762929|616073680|FG002|Overall Study|Lost to Follow-up|0|||
170473882|NCT02762929|616073681|FG003|Overall Study|Lost to Follow-up|1|||
170473883|NCT02762929|616073682|FG004|Overall Study|Lost to Follow-up|0|||
170473884|NCT02762929|616073683|FG005|Overall Study|Lost to Follow-up|0|||
170473885|NCT02762929|616073678|FG000|Overall Study|Withdrawal by Subject|0|||
170473886|NCT02762929|616073679|FG001|Overall Study|Withdrawal by Subject|1|||
170473887|NCT02762929|616073680|FG002|Overall Study|Withdrawal by Subject|0|||
170473888|NCT02762929|616073681|FG003|Overall Study|Withdrawal by Subject|0|||
170473889|NCT02762929|616073682|FG004|Overall Study|Withdrawal by Subject|0|||
170473890|NCT02762929|616073683|FG005|Overall Study|Withdrawal by Subject|0|||
170473891|NCT02762929|616073678|FG000|Overall Study|exclusionary medication disclosed late|0|||
170473892|NCT02762929|616073679|FG001|Overall Study|exclusionary medication disclosed late|0|||
170473893|NCT02762929|616073680|FG002|Overall Study|exclusionary medication disclosed late|0|||
170473894|NCT02762929|616073681|FG003|Overall Study|exclusionary medication disclosed late|1|||
170473895|NCT02762929|616073682|FG004|Overall Study|exclusionary medication disclosed late|0|||
170473896|NCT02762929|616073683|FG005|Overall Study|exclusionary medication disclosed late|0|||
170473897|NCT02656303|616073684|FG000|Overall Study|Adverse Event|3|||
170473898|NCT02656303|616073685|FG001|Overall Study|Adverse Event|2|||
170473899|NCT02656303|616073686|FG002|Overall Study|Adverse Event|0|||
170473900|NCT02656303|616073684|FG000|Overall Study|Death|12|||
170473901|NCT02656303|616073685|FG001|Overall Study|Death|4|||
170473902|NCT02656303|616073686|FG002|Overall Study|Death|1|||
170473903|NCT02656303|616073684|FG000|Overall Study|Lack of Efficacy|1|||
170473904|NCT02656303|616073685|FG001|Overall Study|Lack of Efficacy|0|||
170473905|NCT02656303|616073686|FG002|Overall Study|Lack of Efficacy|0|||
170473906|NCT02656303|616073684|FG000|Overall Study|Non-Compliance with Study|1|||
170473907|NCT02656303|616073685|FG001|Overall Study|Non-Compliance with Study|1|||
170473908|NCT02656303|616073686|FG002|Overall Study|Non-Compliance with Study|0|||
170473909|NCT02656303|616073684|FG000|Overall Study|Investigator Decision|2|||
170473910|NCT02656303|616073685|FG001|Overall Study|Investigator Decision|1|||
170473911|NCT02656303|616073686|FG002|Overall Study|Investigator Decision|0|||
170473912|NCT02656303|616073684|FG000|Overall Study|Progressive Disease|25|||
170473913|NCT02656303|616073685|FG001|Overall Study|Progressive Disease|14|||
170473914|NCT02656303|616073686|FG002|Overall Study|Progressive Disease|10|||
170473915|NCT02656303|616073684|FG000|Overall Study|Study Terminated by Sponsor|20|||
170473916|NCT02656303|616073685|FG001|Overall Study|Study Terminated by Sponsor|7|||
170473917|NCT02656303|616073686|FG002|Overall Study|Study Terminated by Sponsor|5|||
170473918|NCT02656303|616073684|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
170473919|NCT02656303|616073685|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
170473920|NCT02656303|616073686|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
170473921|NCT02656303|616073684|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
170473922|NCT02656303|616073685|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
170473923|NCT02656303|616073686|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
170473924|NCT02656303|616073684|FG000|Overall Study|Reason not Specified|1|||
170473925|NCT02656303|616073685|FG001|Overall Study|Reason not Specified|1|||
170473926|NCT02656303|616073686|FG002|Overall Study|Reason not Specified|2|||
170473927|NCT02422797|616073689|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
170473928|NCT02422797|616073690|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
170473929|NCT02422797|616073689|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
170473930|NCT02422797|616073690|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
170473931|NCT02422797|616073689|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
170473932|NCT02422797|616073690|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
170473933|NCT02422797|616073689|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
170473934|NCT02422797|616073690|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
170473935|NCT02422797|616073689|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
170473936|NCT02422797|616073690|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
170473937|NCT02422797|616073689|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
170473938|NCT02422797|616073690|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
170473939|NCT02422797|616073689|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
170473940|NCT02422797|616073690|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
170473941|NCT02422797|616073689|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
170473942|NCT02422797|616073690|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
170473943|NCT02422797|616073689|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
170473944|NCT02422797|616073690|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
170473945|NCT02422797|616073689|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
170473946|NCT02422797|616073690|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
170473947|NCT02422797|616073689|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
170473948|NCT02422797|616073690|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
170473949|NCT02422797|616073689|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
170473950|NCT02422797|616073690|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
170473951|NCT02422797|616073689|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
170473952|NCT02422797|616073690|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
170473953|NCT02422797|616073689|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
170473954|NCT02422797|616073690|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
170473955|NCT02422797|616073689|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
170473956|NCT02422797|616073690|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
170473957|NCT02422797|616073689|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
170473958|NCT02422797|616073690|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
170473959|NCT02422797|616073689|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
170473960|NCT02422797|616073690|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
170473961|NCT02422797|616073689|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
170473962|NCT02422797|616073690|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
170473963|NCT02422797|616073689|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
170473964|NCT02422797|616073690|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
170473965|NCT02422797|616073689|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
170473966|NCT02422797|616073690|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
170473967|NCT02422797|616073689|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
170473968|NCT02422797|616073690|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
170473969|NCT04071405|616073691|FG000|Overall Study|Protocol Violation|3|||
170473970|NCT01027702|616073694|FG000|Overall Study|Received subsequent therapy|1|||
170473971|NCT01027702|616073695|FG001|Overall Study|Received subsequent therapy|2|||
170473972|NCT01027702|616073696|FG002|Overall Study|Received subsequent therapy|0|||
170473973|NCT01027702|616073697|FG003|Overall Study|Received subsequent therapy|4|||
170473974|NCT01027702|616073698|FG004|Overall Study|Received subsequent therapy|1|||
170545771|NCT06038643|616342744|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
170545772|NCT06038643|616342745|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
170545773|NCT03573882|616342746|FG000|Overall Study|Study Terminated by Sponsor|22|||
170791867|NCT01854775|617248040|FG000|Extension Phase|Withdrew consent|0|||
170473975|NCT01027702|616073699|FG005|Overall Study|Received subsequent therapy|0|||
170473976|NCT01027702|616073700|FG006|Overall Study|Received subsequent therapy|1|||
170473977|NCT01027702|616073694|FG000|Overall Study|Death|0|||
170473978|NCT01027702|616073695|FG001|Overall Study|Death|0|||
170473979|NCT01027702|616073696|FG002|Overall Study|Death|1|||
170473980|NCT01027702|616073697|FG003|Overall Study|Death|0|||
170473981|NCT01027702|616073698|FG004|Overall Study|Death|0|||
170473982|NCT01027702|616073699|FG005|Overall Study|Death|0|||
170473983|NCT01027702|616073700|FG006|Overall Study|Death|0|||
170473984|NCT00403585|616073701|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
170473985|NCT00403585|616073701|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
170473986|NCT00403585|616073701|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
170473987|NCT03685344|616073702|FG000|Overall Study|Withdrawal by Subject|1|||
170473988|NCT03685344|616073703|FG001|Overall Study|Withdrawal by Subject|1|||
170473989|NCT03685344|616073704|FG002|Overall Study|Withdrawal by Subject|2|||
170473990|NCT03685344|616073705|FG003|Overall Study|Withdrawal by Subject|0|||
170473991|NCT03685344|616073702|FG000|Overall Study|Physician Decision|1|||
170473992|NCT03685344|616073703|FG001|Overall Study|Physician Decision|1|||
170473993|NCT03685344|616073704|FG002|Overall Study|Physician Decision|5|||
170473994|NCT03685344|616073705|FG003|Overall Study|Physician Decision|0|||
170473995|NCT03685344|616073702|FG000|Overall Study|Death|1|||
170473996|NCT03685344|616073703|FG001|Overall Study|Death|1|||
170473997|NCT03685344|616073704|FG002|Overall Study|Death|0|||
170473998|NCT03685344|616073705|FG003|Overall Study|Death|0|||
170473999|NCT02121652|616073708|FG000|Overall Study|Lost to Follow-up|2|||
170474000|NCT02121652|616073709|FG001|Overall Study|Lost to Follow-up|1|||
170474001|NCT02121652|616073708|FG000|Overall Study|Death|1|||
170474002|NCT02121652|616073709|FG001|Overall Study|Death|0|||
170474003|NCT02121652|616073708|FG000|Overall Study|Withdrawal by Subject|3|||
170474004|NCT02121652|616073709|FG001|Overall Study|Withdrawal by Subject|3|||
170474005|NCT02276807|616073710|FG000|Overall Study|Withdrawal by Subject|8|||
170474006|NCT02276807|616073711|FG001|Overall Study|Withdrawal by Subject|7|||
170474007|NCT02276807|616073710|FG000|Overall Study|Lost to Follow-up|10|||
170474008|NCT02276807|616073711|FG001|Overall Study|Lost to Follow-up|10|||
170474009|NCT00261950|616073712|FG000|Overall Study|Lost to Follow-up|2|||
170474010|NCT00261950|616073712|FG000|Overall Study|Death|6|||
170474011|NCT00261950|616073712|FG000|Overall Study|Withdrawal by Subject|5|||
170474012|NCT00261950|616073712|FG000|Overall Study|Other|1|||
170474013|NCT00261950|616073712|FG000|Overall Study|Physician Decision|1|||
170474014|NCT00261950|616073712|FG000|Overall Study|Protocol specified Criteria|11|||
170474015|NCT01090414|616073715|FG000|Study 101-99|Progressive Disease|28|||
170474016|NCT01090414|616073716|FG001|Study 101-99|Progressive Disease|48|||
170474017|NCT01090414|616073717|FG002|Study 101-99|Progressive Disease|10|||
170474018|NCT01090414|616073718|FG003|Study 101-99|Progressive Disease|4|||
170474019|NCT01090414|616073715|FG000|Study 101-99|Adverse Event|10|||
170474020|NCT01090414|616073716|FG001|Study 101-99|Adverse Event|28|||
170474021|NCT01090414|616073717|FG002|Study 101-99|Adverse Event|18|||
170474022|NCT01090414|616073718|FG003|Study 101-99|Adverse Event|0|||
170474023|NCT01090414|616073715|FG000|Study 101-99|Investigator Request|1|||
170637838|NCT01349049|616686659|FG000|Overall Study|Physician Decision|0|||
170637839|NCT01349049|616686660|FG001|Overall Study|Physician Decision|1|||
170545774|NCT03573882|616342747|FG001|Overall Study|Study Terminated by Sponsor|17|||
170545775|NCT03573882|616342748|FG002|Overall Study|Study Terminated by Sponsor|18|||
170545776|NCT03573882|616342746|FG000|Overall Study|Withdrawal by Subject|6|||
170545777|NCT03573882|616342747|FG001|Overall Study|Withdrawal by Subject|11|||
170545778|NCT03573882|616342748|FG002|Overall Study|Withdrawal by Subject|7|||
170545779|NCT03573882|616342746|FG000|Overall Study|Adverse Event|7|||
170545780|NCT03573882|616342747|FG001|Overall Study|Adverse Event|5|||
170545781|NCT03573882|616342748|FG002|Overall Study|Adverse Event|6|||
170545782|NCT03573882|616342746|FG000|Overall Study|Lost to Follow-up|2|||
170545783|NCT03573882|616342747|FG001|Overall Study|Lost to Follow-up|5|||
170545784|NCT03573882|616342748|FG002|Overall Study|Lost to Follow-up|3|||
170545785|NCT03573882|616342746|FG000|Overall Study|Physician Decision|4|||
170545786|NCT03573882|616342747|FG001|Overall Study|Physician Decision|3|||
170474024|NCT01090414|616073716|FG001|Study 101-99|Investigator Request|11|||
170474025|NCT01090414|616073717|FG002|Study 101-99|Investigator Request|4|||
170637840|NCT01349049|616686661|FG002|Overall Study|Physician Decision|0|||
170637841|NCT01349049|616686662|FG003|Overall Study|Physician Decision|0|||
170637842|NCT01349049|616686663|FG004|Overall Study|Physician Decision|0|||
170474026|NCT01090414|616073718|FG003|Study 101-99|Investigator Request|0|||
170474027|NCT01090414|616073715|FG000|Study 101-99|Death|3|||
170474028|NCT01090414|616073716|FG001|Study 101-99|Death|8|||
170474029|NCT01090414|616073717|FG002|Study 101-99|Death|1|||
170474030|NCT01090414|616073718|FG003|Study 101-99|Death|0|||
170474031|NCT01090414|616073715|FG000|Study 101-99|Sponsor Discontinued Study|0|||
170474032|NCT01090414|616073716|FG001|Study 101-99|Sponsor Discontinued Study|7|||
170474033|NCT01090414|616073717|FG002|Study 101-99|Sponsor Discontinued Study|5|||
170474034|NCT01090414|616073718|FG003|Study 101-99|Sponsor Discontinued Study|0|||
170545787|NCT03573882|616342748|FG002|Overall Study|Physician Decision|2|||
170545788|NCT03573882|616342746|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
170791868|NCT01854775|617248041|FG001|Extension Phase|Withdrew consent|1|||
170474035|NCT01090414|616073715|FG000|Study 101-99|Other (Unknown Reasons)|3|||
170637843|NCT01349049|616686664|FG005|Overall Study|Physician Decision|0|||
170637844|NCT01349049|616686665|FG006|Overall Study|Physician Decision|0|||
170637845|NCT01349049|616686666|FG007|Overall Study|Physician Decision|0|||
170637846|NCT01349049|616686667|FG008|Overall Study|Physician Decision|2|||
170637847|NCT01349049|616686659|FG000|Overall Study|Protocol Violation|0|||
170791869|NCT01854775|617248042|FG002|Extension Phase|Withdrew consent|0|||
170791870|NCT04032847|617248043|FG000|Overall Study|Study termination by sponsor|8|||
170791871|NCT04032847|617248044|FG001|Overall Study|Study termination by sponsor|0|||
170791872|NCT04032847|617248045|FG002|Overall Study|Study termination by sponsor|4|||
170791873|NCT04032847|617248043|FG000|Overall Study|Death|12|||
170791874|NCT04032847|617248044|FG001|Overall Study|Death|0|||
170791875|NCT04032847|617248045|FG002|Overall Study|Death|0|||
170791876|NCT04032847|617248043|FG000|Overall Study|Progressive disease|2|||
170791877|NCT04032847|617248044|FG001|Overall Study|Progressive disease|0|||
170791878|NCT04032847|617248045|FG002|Overall Study|Progressive disease|1|||
170791879|NCT02068885|617248046|FG000|Overall Study|Withdrew|3|||
170791880|NCT02068885|617248047|FG001|Overall Study|Withdrew|5|||
170791881|NCT02068885|617248048|FG002|Overall Study|Withdrew|8|||
170791882|NCT03100149|617248049|FG000|Overall Study|Adverse Event|0|||
170791883|NCT03100149|617248050|FG001|Overall Study|Adverse Event|1|||
170791884|NCT03100149|617248051|FG002|Overall Study|Adverse Event|0|||
170791885|NCT03100149|617248049|FG000|Overall Study|Participant Moved out of Country|0|||
170637848|NCT01349049|616686660|FG001|Overall Study|Protocol Violation|0|||
170637849|NCT01349049|616686661|FG002|Overall Study|Protocol Violation|0|||
170637850|NCT01349049|616686662|FG003|Overall Study|Protocol Violation|0|||
170637851|NCT01349049|616686663|FG004|Overall Study|Protocol Violation|0|||
170637852|NCT01349049|616686664|FG005|Overall Study|Protocol Violation|0|||
170637853|NCT01349049|616686665|FG006|Overall Study|Protocol Violation|0|||
170637854|NCT01349049|616686666|FG007|Overall Study|Protocol Violation|0|||
170637855|NCT01349049|616686667|FG008|Overall Study|Protocol Violation|1|||
170637856|NCT01349049|616686659|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
170637857|NCT01349049|616686660|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
170637858|NCT01349049|616686661|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
170637859|NCT01349049|616686662|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
170637860|NCT01349049|616686663|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
170637861|NCT01349049|616686664|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
170637862|NCT01349049|616686665|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
170637863|NCT01349049|616686666|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
170637864|NCT01349049|616686667|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
170637865|NCT01349049|616686659|FG000|Overall Study|Other|0|||
170637866|NCT01349049|616686660|FG001|Overall Study|Other|0|||
170791886|NCT03100149|617248050|FG001|Overall Study|Participant Moved out of Country|0|||
170791887|NCT03100149|617248051|FG002|Overall Study|Participant Moved out of Country|1|||
170791888|NCT03100149|617248049|FG000|Overall Study|Withdrawal by Subject|0|||
170791889|NCT03100149|617248050|FG001|Overall Study|Withdrawal by Subject|3|||
170637867|NCT01349049|616686661|FG002|Overall Study|Other|0|||
170637868|NCT01349049|616686662|FG003|Overall Study|Other|0|||
170637869|NCT01349049|616686663|FG004|Overall Study|Other|0|||
170637870|NCT01349049|616686664|FG005|Overall Study|Other|1|||
170637871|NCT01349049|616686665|FG006|Overall Study|Other|0|||
170791890|NCT03100149|617248051|FG002|Overall Study|Withdrawal by Subject|1|||
170637872|NCT01349049|616686666|FG007|Overall Study|Other|0|||
170637873|NCT01349049|616686667|FG008|Overall Study|Other|4|||
170637874|NCT01349049|616686659|FG000|Overall Study|Death|0|||
170637875|NCT01349049|616686660|FG001|Overall Study|Death|0|||
170637876|NCT01349049|616686661|FG002|Overall Study|Death|0|||
170637877|NCT01349049|616686662|FG003|Overall Study|Death|0|||
170791891|NCT03697876|617248052|FG000|Overall Study|Lost to Follow-up|0|||
170791892|NCT03697876|617248053|FG001|Overall Study|Lost to Follow-up|1|||
170791893|NCT03697876|617248052|FG000|Overall Study|Adverse Event|1|||
170791894|NCT03697876|617248053|FG001|Overall Study|Adverse Event|0|||
170637878|NCT01349049|616686663|FG004|Overall Study|Death|0|||
170637879|NCT01349049|616686664|FG005|Overall Study|Death|0|||
170637880|NCT01349049|616686665|FG006|Overall Study|Death|0|||
170474036|NCT01090414|616073716|FG001|Study 101-99|Other (Unknown Reasons)|3|||
170474037|NCT01090414|616073717|FG002|Study 101-99|Other (Unknown Reasons)|0|||
170474038|NCT01090414|616073718|FG003|Study 101-99|Other (Unknown Reasons)|0|||
170474039|NCT01090414|616073715|FG000|Study 101-99|Withdrew Consent|0|||
170474040|NCT01090414|616073716|FG001|Study 101-99|Withdrew Consent|2|||
170474041|NCT01090414|616073717|FG002|Study 101-99|Withdrew Consent|3|||
170474042|NCT01090414|616073718|FG003|Study 101-99|Withdrew Consent|1|||
170474043|NCT01090414|616073715|FG000|Study 101-99|Participant Request|3|||
170637881|NCT01349049|616686666|FG007|Overall Study|Death|1|||
170637882|NCT01349049|616686667|FG008|Overall Study|Death|5|||
170791895|NCT04721977|617248054|FG000|Overall Study|Death|15|||
170637883|NCT01349049|616686659|FG000|Overall Study|Non-compliance|0|||
170637884|NCT01349049|616686660|FG001|Overall Study|Non-compliance|0|||
170637885|NCT01349049|616686661|FG002|Overall Study|Non-compliance|0|||
170637886|NCT01349049|616686662|FG003|Overall Study|Non-compliance|1|||
170791896|NCT04721977|617248054|FG000|Overall Study|Ongoing|51|||
170791897|NCT05321082|617248057|FG000|Overall Study|Other than listed|40|||
170791898|NCT05321082|617248058|FG001|Overall Study|Other than listed|26|||
170791899|NCT05321082|617248059|FG002|Overall Study|Other than listed|27|||
170791900|NCT05321082|617248057|FG000|Overall Study|Lost to Follow-up|0|||
170791901|NCT05321082|617248058|FG001|Overall Study|Lost to Follow-up|1|||
170791902|NCT05321082|617248059|FG002|Overall Study|Lost to Follow-up|0|||
170791903|NCT05321082|617248057|FG000|Overall Study|Withdrawal by Subject|30|||
170791904|NCT05321082|617248058|FG001|Overall Study|Withdrawal by Subject|34|||
170791905|NCT05321082|617248059|FG002|Overall Study|Withdrawal by Subject|42|||
170791906|NCT05321082|617248057|FG000|Overall Study|Protocol Violation|0|||
170791907|NCT05321082|617248058|FG001|Overall Study|Protocol Violation|0|||
170791908|NCT05321082|617248059|FG002|Overall Study|Protocol Violation|1|||
170791909|NCT05321082|617248057|FG000|Overall Study|Adverse Event|49|||
170791910|NCT05321082|617248058|FG001|Overall Study|Adverse Event|49|||
170791911|NCT05321082|617248059|FG002|Overall Study|Adverse Event|48|||
170474044|NCT01090414|616073716|FG001|Study 101-99|Participant Request|1|||
170474045|NCT01090414|616073717|FG002|Study 101-99|Participant Request|0|||
170474046|NCT01090414|616073718|FG003|Study 101-99|Participant Request|0|||
170474047|NCT03594071|616073723|FG000|Overall Study|Re-operation|3|||
170474048|NCT03594071|616073723|FG000|Overall Study|Missed visit|2|||
170474049|NCT01750190|616073724|FG000|Overall Study|Adverse Event|47|||
170474050|NCT01750190|616073725|FG001|Overall Study|Adverse Event|19|||
170474051|NCT01750190|616073724|FG000|Overall Study|Death|38|||
170474052|NCT01750190|616073725|FG001|Overall Study|Death|11|||
170474053|NCT01750190|616073724|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
170474054|NCT01750190|616073725|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
170637887|NCT01349049|616686663|FG004|Overall Study|Non-compliance|0|||
170637888|NCT01349049|616686664|FG005|Overall Study|Non-compliance|0|||
170637889|NCT01349049|616686665|FG006|Overall Study|Non-compliance|0|||
170791912|NCT05321082|617248057|FG000|Overall Study|Lack of Efficacy|2|||
170791913|NCT05321082|617248058|FG001|Overall Study|Lack of Efficacy|0|||
170791914|NCT05321082|617248059|FG002|Overall Study|Lack of Efficacy|1|||
170791915|NCT05321082|617248057|FG000|Overall Study|Not treated|1|||
170791916|NCT05321082|617248058|FG001|Overall Study|Not treated|0|||
170474055|NCT01750190|616073724|FG000|Overall Study|Lost to Follow-up|28|||
170637890|NCT01349049|616686666|FG007|Overall Study|Non-compliance|0|||
170791917|NCT05321082|617248059|FG002|Overall Study|Not treated|1|||
170791918|NCT03474107|617249345|FG000|Overall Study|Adverse Event|42|||
170791919|NCT03474107|617249346|FG001|Overall Study|Adverse Event|46|||
170791920|NCT03474107|617249345|FG000|Overall Study|Death|2|||
170791921|NCT03474107|617249346|FG001|Overall Study|Death|2|||
170791922|NCT03474107|617249345|FG000|Overall Study|Lost to Follow-up|0|||
170791923|NCT03474107|617249346|FG001|Overall Study|Lost to Follow-up|1|||
170791924|NCT03474107|617249345|FG000|Overall Study|Progressive Disease|177|||
170791925|NCT03474107|617249346|FG001|Overall Study|Progressive Disease|180|||
170791926|NCT03474107|617249345|FG000|Overall Study|Protocol Violation|1|||
170791927|NCT03474107|617249346|FG001|Overall Study|Protocol Violation|1|||
170791928|NCT03474107|617249345|FG000|Overall Study|Withdrawal by Subject|15|||
170791929|NCT03474107|617249346|FG001|Overall Study|Withdrawal by Subject|27|||
170791930|NCT03474107|617249345|FG000|Overall Study|Physician Decision|7|||
170791931|NCT03474107|617249346|FG001|Overall Study|Physician Decision|22|||
170791932|NCT03474107|617249345|FG000|Overall Study|Miscellaneous|1|||
170637891|NCT01349049|616686667|FG008|Overall Study|Non-compliance|0|||
170637892|NCT01349049|616686659|FG000|Overall Study|Withdrawal by Subject|0|||
170637893|NCT01349049|616686660|FG001|Overall Study|Withdrawal by Subject|0|||
170637894|NCT01349049|616686661|FG002|Overall Study|Withdrawal by Subject|0|||
170637895|NCT01349049|616686662|FG003|Overall Study|Withdrawal by Subject|0|||
170891672|NCT00993928|617609851|FG001|Overall Study|ineligible|0|||
170474056|NCT01750190|616073725|FG001|Overall Study|Lost to Follow-up|7|||
170474057|NCT01750190|616073724|FG000|Overall Study|Physician Decision|16|||
170474058|NCT01750190|616073725|FG001|Overall Study|Physician Decision|17|||
170474059|NCT01750190|616073724|FG000|Overall Study|Protocol Violation|6|||
170474060|NCT01750190|616073725|FG001|Overall Study|Protocol Violation|5|||
170474061|NCT01750190|616073724|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
170474062|NCT01750190|616073725|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
170474063|NCT01750190|616073724|FG000|Overall Study|Withdrawal by Subject|83|||
170474064|NCT01750190|616073725|FG001|Overall Study|Withdrawal by Subject|89|||
170474065|NCT01750190|616073724|FG000|Overall Study|Kidney Transplant|8|||
170474066|NCT01750190|616073725|FG001|Overall Study|Kidney Transplant|4|||
170474067|NCT01750190|616073724|FG000|Overall Study|Dialysis|22|||
170474068|NCT01750190|616073725|FG001|Overall Study|Dialysis|8|||
170474069|NCT01750190|616073724|FG000|Overall Study|Other than Specified|13|||
170474070|NCT01750190|616073725|FG001|Overall Study|Other than Specified|4|||
170474071|NCT02906670|616073726|FG000|Cohort 1, QW|Radiological Progression|1|||
170474072|NCT02906670|616073727|FG001|Cohort 1, QW|Radiological Progression|0|||
170474073|NCT02906670|616073728|FG002|Cohort 1, QW|Radiological Progression|0|||
170474074|NCT02906670|616073729|FG003|Cohort 1, QW|Radiological Progression|0|||
170474075|NCT02906670|616073730|FG004|Cohort 1, QW|Radiological Progression|0|||
170474076|NCT02906670|616073731|FG005|Cohort 1, QW|Radiological Progression|0|||
170474077|NCT02906670|616073732|FG006|Cohort 1, QW|Radiological Progression|0|||
170474078|NCT02906670|616073733|FG007|Cohort 1, QW|Radiological Progression|0|||
170474079|NCT02906670|616073734|FG008|Cohort 1, QW|Radiological Progression|0|||
170474080|NCT02906670|616073735|FG009|Cohort 1, QW|Radiological Progression|0|||
170474081|NCT02906670|616073726|FG000|Cohort 2, QW|Radiological Progression|0|||
170474082|NCT02906670|616073727|FG001|Cohort 2, QW|Radiological Progression|1|||
170474083|NCT02906670|616073728|FG002|Cohort 2, QW|Radiological Progression|0|||
170474084|NCT02906670|616073729|FG003|Cohort 2, QW|Radiological Progression|0|||
170474085|NCT02906670|616073730|FG004|Cohort 2, QW|Radiological Progression|0|||
170474086|NCT02906670|616073731|FG005|Cohort 2, QW|Radiological Progression|0|||
170474087|NCT02906670|616073732|FG006|Cohort 2, QW|Radiological Progression|0|||
170474088|NCT02906670|616073733|FG007|Cohort 2, QW|Radiological Progression|0|||
170474089|NCT02906670|616073734|FG008|Cohort 2, QW|Radiological Progression|0|||
170474090|NCT02906670|616073735|FG009|Cohort 2, QW|Radiological Progression|0|||
170474091|NCT02906670|616073726|FG000|Cohort 3, QW|Radiological Progression|0|||
170474092|NCT02906670|616073727|FG001|Cohort 3, QW|Radiological Progression|0|||
170474093|NCT02906670|616073728|FG002|Cohort 3, QW|Radiological Progression|2|||
170474094|NCT02906670|616073729|FG003|Cohort 3, QW|Radiological Progression|0|||
170474095|NCT02906670|616073730|FG004|Cohort 3, QW|Radiological Progression|0|||
170474096|NCT02906670|616073731|FG005|Cohort 3, QW|Radiological Progression|0|||
170474097|NCT02906670|616073732|FG006|Cohort 3, QW|Radiological Progression|0|||
170474098|NCT02906670|616073733|FG007|Cohort 3, QW|Radiological Progression|0|||
170474099|NCT02906670|616073734|FG008|Cohort 3, QW|Radiological Progression|0|||
170474100|NCT02906670|616073735|FG009|Cohort 3, QW|Radiological Progression|0|||
170474101|NCT02906670|616073726|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
170474102|NCT02906670|616073727|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
170474103|NCT02906670|616073728|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
170474104|NCT02906670|616073729|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
170474105|NCT02906670|616073730|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
170474106|NCT02906670|616073731|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
170474107|NCT02906670|616073732|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
170474108|NCT02906670|616073733|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
170474109|NCT02906670|616073734|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
170891673|NCT00573794|617609853|FG000|Overall Study|Adverse Event|81|||
170474110|NCT02906670|616073735|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
170474111|NCT02906670|616073726|FG000|Cohort 4, Q2W|Radiological Progression|0|||
170474112|NCT02906670|616073727|FG001|Cohort 4, Q2W|Radiological Progression|0|||
170637896|NCT01349049|616686663|FG004|Overall Study|Withdrawal by Subject|0|||
170637897|NCT01349049|616686664|FG005|Overall Study|Withdrawal by Subject|0|||
170474113|NCT02906670|616073728|FG002|Cohort 4, Q2W|Radiological Progression|0|||
170474114|NCT02906670|616073729|FG003|Cohort 4, Q2W|Radiological Progression|0|||
170474115|NCT02906670|616073730|FG004|Cohort 4, Q2W|Radiological Progression|0|||
170474116|NCT02906670|616073731|FG005|Cohort 4, Q2W|Radiological Progression|1|||
170891674|NCT00573794|617609853|FG000|Overall Study|Withdrew Consent|90|||
170474117|NCT02906670|616073732|FG006|Cohort 4, Q2W|Radiological Progression|0|||
170474118|NCT02906670|616073733|FG007|Cohort 4, Q2W|Radiological Progression|0|||
170474119|NCT02906670|616073734|FG008|Cohort 4, Q2W|Radiological Progression|0|||
170474120|NCT02906670|616073735|FG009|Cohort 4, Q2W|Radiological Progression|0|||
170891675|NCT00573794|617609853|FG000|Overall Study|Lost to Follow-up|13|||
170474121|NCT02906670|616073726|FG000|Cohort 4, Q2W|Clinical Progression|0|||
170474122|NCT02906670|616073727|FG001|Cohort 4, Q2W|Clinical Progression|0|||
170474123|NCT02906670|616073728|FG002|Cohort 4, Q2W|Clinical Progression|0|||
170474124|NCT02906670|616073729|FG003|Cohort 4, Q2W|Clinical Progression|0|||
170474125|NCT02906670|616073730|FG004|Cohort 4, Q2W|Clinical Progression|0|||
170474126|NCT02906670|616073731|FG005|Cohort 4, Q2W|Clinical Progression|2|||
170474127|NCT02906670|616073732|FG006|Cohort 4, Q2W|Clinical Progression|0|||
170474128|NCT02906670|616073733|FG007|Cohort 4, Q2W|Clinical Progression|0|||
170474129|NCT02906670|616073734|FG008|Cohort 4, Q2W|Clinical Progression|0|||
170474130|NCT02906670|616073735|FG009|Cohort 4, Q2W|Clinical Progression|0|||
170474131|NCT02906670|616073726|FG000|Cohort 5, Q2W|Radiological Progression|0|||
170474132|NCT02906670|616073727|FG001|Cohort 5, Q2W|Radiological Progression|0|||
170474133|NCT02906670|616073728|FG002|Cohort 5, Q2W|Radiological Progression|0|||
170474134|NCT02906670|616073729|FG003|Cohort 5, Q2W|Radiological Progression|0|||
170474135|NCT02906670|616073730|FG004|Cohort 5, Q2W|Radiological Progression|0|||
170474136|NCT02906670|616073731|FG005|Cohort 5, Q2W|Radiological Progression|0|||
170474137|NCT02906670|616073732|FG006|Cohort 5, Q2W|Radiological Progression|4|||
170474138|NCT02906670|616073733|FG007|Cohort 5, Q2W|Radiological Progression|0|||
170474139|NCT02906670|616073734|FG008|Cohort 5, Q2W|Radiological Progression|0|||
170474140|NCT02906670|616073735|FG009|Cohort 5, Q2W|Radiological Progression|0|||
170474141|NCT02906670|616073726|FG000|Cohort 5, Q2W|Clinical Progression|0|||
170474142|NCT02906670|616073727|FG001|Cohort 5, Q2W|Clinical Progression|0|||
170474143|NCT02906670|616073728|FG002|Cohort 5, Q2W|Clinical Progression|0|||
170474144|NCT02906670|616073729|FG003|Cohort 5, Q2W|Clinical Progression|0|||
170474145|NCT02906670|616073730|FG004|Cohort 5, Q2W|Clinical Progression|0|||
170474146|NCT02906670|616073731|FG005|Cohort 5, Q2W|Clinical Progression|0|||
170474147|NCT02906670|616073732|FG006|Cohort 5, Q2W|Clinical Progression|1|||
170474148|NCT02906670|616073733|FG007|Cohort 5, Q2W|Clinical Progression|0|||
170474149|NCT02906670|616073734|FG008|Cohort 5, Q2W|Clinical Progression|0|||
170474150|NCT02906670|616073735|FG009|Cohort 5, Q2W|Clinical Progression|0|||
170474151|NCT02906670|616073726|FG000|Cohort 5, Q2W|Adverse Event|0|||
170474152|NCT02906670|616073727|FG001|Cohort 5, Q2W|Adverse Event|0|||
170474153|NCT02906670|616073728|FG002|Cohort 5, Q2W|Adverse Event|0|||
170474154|NCT02906670|616073729|FG003|Cohort 5, Q2W|Adverse Event|0|||
170474155|NCT02906670|616073730|FG004|Cohort 5, Q2W|Adverse Event|0|||
170474156|NCT02906670|616073731|FG005|Cohort 5, Q2W|Adverse Event|0|||
170474157|NCT02906670|616073732|FG006|Cohort 5, Q2W|Adverse Event|1|||
170474158|NCT02906670|616073733|FG007|Cohort 5, Q2W|Adverse Event|0|||
170474159|NCT02906670|616073734|FG008|Cohort 5, Q2W|Adverse Event|0|||
170474160|NCT02906670|616073735|FG009|Cohort 5, Q2W|Adverse Event|0|||
170474161|NCT02906670|616073726|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474162|NCT02906670|616073727|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474163|NCT02906670|616073728|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474164|NCT02906670|616073729|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474165|NCT02906670|616073730|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474166|NCT02906670|616073731|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474167|NCT02906670|616073732|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
170474168|NCT02906670|616073733|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474169|NCT02906670|616073734|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474170|NCT02906670|616073735|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
170474171|NCT02906670|616073726|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
170474172|NCT02906670|616073727|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
170474173|NCT02906670|616073728|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
170474174|NCT02906670|616073729|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
170474175|NCT02906670|616073730|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
170474176|NCT02906670|616073731|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
170474177|NCT02906670|616073732|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
170474178|NCT02906670|616073733|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
170474179|NCT02906670|616073734|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
170474180|NCT02906670|616073735|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
170474181|NCT02906670|616073726|FG000|Cohort 5P, Q2W|Adverse Event|0|||
170474182|NCT02906670|616073727|FG001|Cohort 5P, Q2W|Adverse Event|0|||
170474183|NCT02906670|616073728|FG002|Cohort 5P, Q2W|Adverse Event|0|||
170474184|NCT02906670|616073729|FG003|Cohort 5P, Q2W|Adverse Event|0|||
170474185|NCT02906670|616073730|FG004|Cohort 5P, Q2W|Adverse Event|0|||
170474186|NCT02906670|616073731|FG005|Cohort 5P, Q2W|Adverse Event|0|||
170474187|NCT02906670|616073732|FG006|Cohort 5P, Q2W|Adverse Event|0|||
170474188|NCT02906670|616073733|FG007|Cohort 5P, Q2W|Adverse Event|1|||
170474189|NCT02906670|616073734|FG008|Cohort 5P, Q2W|Adverse Event|0|||
170474190|NCT02906670|616073735|FG009|Cohort 5P, Q2W|Adverse Event|0|||
170474191|NCT02906670|616073726|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
170474192|NCT02906670|616073727|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
170474193|NCT02906670|616073728|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
170474194|NCT02906670|616073729|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
170474195|NCT02906670|616073730|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
170474196|NCT02906670|616073731|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
170474197|NCT02906670|616073732|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
170474198|NCT02906670|616073733|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
170474199|NCT02906670|616073734|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
170474200|NCT02906670|616073735|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
170474201|NCT02906670|616073726|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
170474202|NCT02906670|616073727|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
170474203|NCT02906670|616073728|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
170474204|NCT02906670|616073729|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
170474205|NCT02906670|616073730|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
170474206|NCT02906670|616073731|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
170474207|NCT02906670|616073732|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
170474208|NCT02906670|616073733|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
170474209|NCT02906670|616073734|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
170474210|NCT02906670|616073735|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
170474211|NCT02906670|616073726|FG000|Cohort 4P, QW|Radiological Progression|0|||
170474212|NCT02906670|616073727|FG001|Cohort 4P, QW|Radiological Progression|0|||
170474213|NCT02906670|616073728|FG002|Cohort 4P, QW|Radiological Progression|0|||
170474214|NCT02906670|616073729|FG003|Cohort 4P, QW|Radiological Progression|3|||
170474215|NCT02906670|616073730|FG004|Cohort 4P, QW|Radiological Progression|0|||
170474216|NCT02906670|616073731|FG005|Cohort 4P, QW|Radiological Progression|0|||
170474217|NCT02906670|616073732|FG006|Cohort 4P, QW|Radiological Progression|0|||
170474218|NCT02906670|616073733|FG007|Cohort 4P, QW|Radiological Progression|0|||
170474219|NCT02906670|616073734|FG008|Cohort 4P, QW|Radiological Progression|0|||
170474220|NCT02906670|616073735|FG009|Cohort 4P, QW|Radiological Progression|0|||
170474221|NCT02906670|616073726|FG000|Cohort 7P, Q2W|Adverse Event|0|||
170474222|NCT02906670|616073727|FG001|Cohort 7P, Q2W|Adverse Event|0|||
170474223|NCT02906670|616073728|FG002|Cohort 7P, Q2W|Adverse Event|0|||
170474224|NCT02906670|616073729|FG003|Cohort 7P, Q2W|Adverse Event|0|||
170474225|NCT02906670|616073730|FG004|Cohort 7P, Q2W|Adverse Event|0|||
170474226|NCT02906670|616073731|FG005|Cohort 7P, Q2W|Adverse Event|0|||
170474227|NCT02906670|616073732|FG006|Cohort 7P, Q2W|Adverse Event|0|||
170474228|NCT02906670|616073733|FG007|Cohort 7P, Q2W|Adverse Event|0|||
170474229|NCT02906670|616073734|FG008|Cohort 7P, Q2W|Adverse Event|0|||
170474230|NCT02906670|616073735|FG009|Cohort 7P, Q2W|Adverse Event|1|||
170474231|NCT02906670|616073726|FG000|Cohort 7P, Q2W|Physician Decision|0|||
170474232|NCT02906670|616073727|FG001|Cohort 7P, Q2W|Physician Decision|0|||
170474233|NCT02906670|616073728|FG002|Cohort 7P, Q2W|Physician Decision|0|||
170474234|NCT02906670|616073729|FG003|Cohort 7P, Q2W|Physician Decision|0|||
170474235|NCT02906670|616073730|FG004|Cohort 7P, Q2W|Physician Decision|0|||
170474236|NCT02906670|616073731|FG005|Cohort 7P, Q2W|Physician Decision|0|||
170474237|NCT02906670|616073732|FG006|Cohort 7P, Q2W|Physician Decision|0|||
170474238|NCT02906670|616073733|FG007|Cohort 7P, Q2W|Physician Decision|0|||
170474239|NCT02906670|616073734|FG008|Cohort 7P, Q2W|Physician Decision|0|||
170474240|NCT02906670|616073735|FG009|Cohort 7P, Q2W|Physician Decision|1|||
170474241|NCT02906670|616073726|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170474242|NCT02906670|616073727|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170791933|NCT03474107|617249346|FG001|Overall Study|Miscellaneous|6|||
170791934|NCT04987320|617249348|FG000|Overall Study|Withdrawal by Subject|0|||
170791935|NCT04987320|617249349|FG001|Overall Study|Withdrawal by Subject|1|||
170791936|NCT00085735|617249350|FG000|Overall Study|Adverse Event|1|||
170791937|NCT00085735|617249351|FG001|Overall Study|Adverse Event|0|||
170791938|NCT00085735|617249352|FG002|Overall Study|Adverse Event|0|||
170791939|NCT00085735|617249353|FG003|Overall Study|Adverse Event|0|||
170791940|NCT00085735|617249354|FG004|Overall Study|Adverse Event|0|||
170891676|NCT00573794|617609853|FG000|Overall Study|Protocol Violation|6|||
170474243|NCT02906670|616073728|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170474244|NCT02906670|616073729|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170474245|NCT02906670|616073730|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170474246|NCT02906670|616073731|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170791941|NCT00085735|617249355|FG005|Overall Study|Adverse Event|0|||
170791942|NCT00085735|617249350|FG000|Overall Study|Lack of Efficacy|2|||
170791943|NCT00085735|617249351|FG001|Overall Study|Lack of Efficacy|4|||
170791944|NCT00085735|617249352|FG002|Overall Study|Lack of Efficacy|6|||
170791945|NCT00085735|617249353|FG003|Overall Study|Lack of Efficacy|3|||
170791946|NCT00085735|617249354|FG004|Overall Study|Lack of Efficacy|4|||
170791947|NCT00085735|617249355|FG005|Overall Study|Lack of Efficacy|3|||
170791948|NCT00085735|617249350|FG000|Overall Study|Lost to Follow-up|0|||
170474247|NCT02906670|616073732|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170474248|NCT02906670|616073733|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170474249|NCT02906670|616073734|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
170474250|NCT02906670|616073735|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
170474251|NCT02906670|616073726|FG000|Cohort 5P, QW|Radiological Progression|0|||
170474252|NCT02906670|616073727|FG001|Cohort 5P, QW|Radiological Progression|0|||
170474253|NCT02906670|616073728|FG002|Cohort 5P, QW|Radiological Progression|0|||
170791949|NCT00085735|617249351|FG001|Overall Study|Lost to Follow-up|1|||
170791950|NCT00085735|617249352|FG002|Overall Study|Lost to Follow-up|0|||
170474254|NCT02906670|616073729|FG003|Cohort 5P, QW|Radiological Progression|0|||
170474255|NCT02906670|616073730|FG004|Cohort 5P, QW|Radiological Progression|3|||
170474256|NCT02906670|616073731|FG005|Cohort 5P, QW|Radiological Progression|0|||
170474257|NCT02906670|616073732|FG006|Cohort 5P, QW|Radiological Progression|0|||
170474258|NCT02906670|616073733|FG007|Cohort 5P, QW|Radiological Progression|0|||
170474259|NCT02906670|616073734|FG008|Cohort 5P, QW|Radiological Progression|0|||
170474260|NCT02906670|616073735|FG009|Cohort 5P, QW|Radiological Progression|0|||
170474261|NCT04759703|616073742|FG000|Overall Study|Withdrawal by Subject|4|||
170474262|NCT04759703|616073743|FG001|Overall Study|Withdrawal by Subject|9|||
170474263|NCT04759703|616073742|FG000|Overall Study|Adverse Event|1|||
170474264|NCT04759703|616073743|FG001|Overall Study|Adverse Event|0|||
170474265|NCT04759703|616073742|FG000|Overall Study|Lost to Follow-up|2|||
170474266|NCT04759703|616073743|FG001|Overall Study|Lost to Follow-up|0|||
170474267|NCT00535405|616073746|FG000|Overall Study|Adverse Event|6|||
170474268|NCT00535405|616073747|FG001|Overall Study|Adverse Event|8|||
170474269|NCT00535405|616073748|FG002|Overall Study|Adverse Event|3|||
170474270|NCT00535405|616073749|FG003|Overall Study|Adverse Event|8|||
170474271|NCT00535405|616073750|FG004|Overall Study|Adverse Event|6|||
170474272|NCT00535405|616073746|FG000|Overall Study|Lost to Follow-up|1|||
170474273|NCT00535405|616073747|FG001|Overall Study|Lost to Follow-up|3|||
170474274|NCT00535405|616073748|FG002|Overall Study|Lost to Follow-up|3|||
170474275|NCT00535405|616073749|FG003|Overall Study|Lost to Follow-up|2|||
170474276|NCT00535405|616073750|FG004|Overall Study|Lost to Follow-up|1|||
170474277|NCT00535405|616073746|FG000|Overall Study|Physician Decision|3|||
170474278|NCT00535405|616073747|FG001|Overall Study|Physician Decision|2|||
170474279|NCT00535405|616073748|FG002|Overall Study|Physician Decision|0|||
170474280|NCT00535405|616073749|FG003|Overall Study|Physician Decision|1|||
170474281|NCT00535405|616073750|FG004|Overall Study|Physician Decision|1|||
170474282|NCT00535405|616073746|FG000|Overall Study|Protocol Violation|2|||
170474283|NCT00535405|616073747|FG001|Overall Study|Protocol Violation|2|||
170474284|NCT00535405|616073748|FG002|Overall Study|Protocol Violation|2|||
170474285|NCT00535405|616073749|FG003|Overall Study|Protocol Violation|1|||
170474286|NCT00535405|616073750|FG004|Overall Study|Protocol Violation|0|||
170474287|NCT00535405|616073746|FG000|Overall Study|Withdrawal by Subject|5|||
170474288|NCT00535405|616073747|FG001|Overall Study|Withdrawal by Subject|11|||
170474289|NCT00535405|616073748|FG002|Overall Study|Withdrawal by Subject|10|||
170474290|NCT00535405|616073749|FG003|Overall Study|Withdrawal by Subject|10|||
170474291|NCT00535405|616073750|FG004|Overall Study|Withdrawal by Subject|8|||
170474292|NCT02466685|616073751|FG000|Overall Study|Adverse Event|5|||
170474293|NCT02466685|616073752|FG001|Overall Study|Adverse Event|2|||
170474294|NCT02466685|616073751|FG000|Overall Study|Lost to Follow-up|1|||
170474295|NCT02466685|616073752|FG001|Overall Study|Lost to Follow-up|1|||
170474296|NCT02466685|616073751|FG000|Overall Study|Withdrawal by Subject|1|||
170474297|NCT02466685|616073752|FG001|Overall Study|Withdrawal by Subject|0|||
170474298|NCT02466685|616073751|FG000|Overall Study|Physician Decision|1|||
170474299|NCT02466685|616073752|FG001|Overall Study|Physician Decision|1|||
170474300|NCT03910673|616073754|FG000|Overall Study|Adverse Event|0|||
170474301|NCT03910673|616073755|FG001|Overall Study|Adverse Event|0|||
170474302|NCT03910673|616073756|FG002|Overall Study|Adverse Event|0|||
170474303|NCT03910673|616073757|FG003|Overall Study|Adverse Event|2|||
170474304|NCT03910673|616073758|FG004|Overall Study|Adverse Event|0|||
170474305|NCT02006732|616073759|FG000|Overall Study|Adverse Event|10|||
170474306|NCT02006732|616073760|FG001|Overall Study|Adverse Event|7|||
170474307|NCT02006732|616073761|FG002|Overall Study|Adverse Event|4|||
170474308|NCT02006732|616073762|FG003|Overall Study|Adverse Event|2|||
170474309|NCT02006732|616073759|FG000|Overall Study|Lack of Efficacy|6|||
170474310|NCT02006732|616073760|FG001|Overall Study|Lack of Efficacy|3|||
170474311|NCT02006732|616073761|FG002|Overall Study|Lack of Efficacy|1|||
170474312|NCT02006732|616073762|FG003|Overall Study|Lack of Efficacy|1|||
170474313|NCT02006732|616073759|FG000|Overall Study|Protocol Violation|1|||
170474314|NCT02006732|616073760|FG001|Overall Study|Protocol Violation|1|||
170474315|NCT02006732|616073761|FG002|Overall Study|Protocol Violation|0|||
170474316|NCT02006732|616073762|FG003|Overall Study|Protocol Violation|0|||
170474317|NCT02006732|616073759|FG000|Overall Study|Lost to Follow-up|0|||
170474318|NCT02006732|616073760|FG001|Overall Study|Lost to Follow-up|1|||
170474319|NCT02006732|616073761|FG002|Overall Study|Lost to Follow-up|0|||
170474320|NCT02006732|616073762|FG003|Overall Study|Lost to Follow-up|0|||
170474321|NCT02006732|616073759|FG000|Overall Study|Withdrawal by Subject|3|||
170474322|NCT02006732|616073760|FG001|Overall Study|Withdrawal by Subject|0|||
170474323|NCT02006732|616073761|FG002|Overall Study|Withdrawal by Subject|4|||
170474324|NCT02006732|616073762|FG003|Overall Study|Withdrawal by Subject|1|||
170474325|NCT02016183|616073763|FG000|Overall Study|Case Report Forms Uncollected|13|||
170474326|NCT02016183|616073763|FG000|Overall Study|Protocol Violation|52|||
170474327|NCT02969044|616073764|FG000|Overall Study|Withdrawal by Subject|2|||
170474328|NCT02969044|616073765|FG001|Overall Study|Withdrawal by Subject|6|||
170474329|NCT02969044|616073764|FG000|Overall Study|Adverse Event|3|||
170474330|NCT02969044|616073765|FG001|Overall Study|Adverse Event|0|||
170474331|NCT02593110|616073766|FG000|Overall Study|Withdrawal by Subject|0|||
170474332|NCT02593110|616073767|FG001|Overall Study|Withdrawal by Subject|3|||
170474333|NCT02593110|616073768|FG002|Overall Study|Withdrawal by Subject|3|||
170474334|NCT02593110|616073769|FG003|Overall Study|Withdrawal by Subject|2|||
170474335|NCT02593110|616073766|FG000|Overall Study|Death|0|||
170474336|NCT02593110|616073767|FG001|Overall Study|Death|0|||
170474337|NCT02593110|616073768|FG002|Overall Study|Death|1|||
170474338|NCT02593110|616073769|FG003|Overall Study|Death|0|||
170474339|NCT04604795|616073770|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
170474340|NCT04604795|616073771|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
170474341|NCT04604795|616073772|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
170474342|NCT04604795|616073773|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
170474343|NCT04604795|616073774|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
170474344|NCT04604795|616073775|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
170474345|NCT04604795|616073776|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
170474346|NCT04604795|616073777|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
170474347|NCT04604795|616073778|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
170474348|NCT04604795|616073779|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
170474349|NCT04604795|616073770|FG000|Part B: Up to Day 14|Adverse Event|0|||
170474350|NCT04604795|616073771|FG001|Part B: Up to Day 14|Adverse Event|0|||
170791951|NCT00085735|617249353|FG003|Overall Study|Lost to Follow-up|0|||
170791952|NCT00085735|617249354|FG004|Overall Study|Lost to Follow-up|1|||
170791953|NCT00085735|617249355|FG005|Overall Study|Lost to Follow-up|0|||
170791954|NCT00085735|617249350|FG000|Overall Study|Physician Decision|2|||
170791955|NCT00085735|617249351|FG001|Overall Study|Physician Decision|3|||
170791956|NCT00085735|617249352|FG002|Overall Study|Physician Decision|2|||
170791957|NCT00085735|617249353|FG003|Overall Study|Physician Decision|3|||
170474351|NCT04604795|616073772|FG002|Part B: Up to Day 14|Adverse Event|0|||
170474352|NCT04604795|616073773|FG003|Part B: Up to Day 14|Adverse Event|0|||
170474353|NCT04604795|616073774|FG004|Part B: Up to Day 14|Adverse Event|2|||
170474354|NCT04604795|616073775|FG005|Part B: Up to Day 14|Adverse Event|1|||
170474355|NCT04604795|616073776|FG006|Part B: Up to Day 14|Adverse Event|0|||
170474356|NCT04604795|616073777|FG007|Part B: Up to Day 14|Adverse Event|0|||
170474357|NCT04604795|616073778|FG008|Part B: Up to Day 14|Adverse Event|0|||
170474358|NCT04604795|616073779|FG009|Part B: Up to Day 14|Adverse Event|0|||
170474359|NCT04604795|616073770|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474360|NCT04604795|616073771|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474361|NCT04604795|616073772|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474362|NCT04604795|616073773|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474363|NCT04604795|616073774|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474364|NCT04604795|616073775|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474365|NCT04604795|616073776|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474366|NCT04604795|616073777|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474367|NCT04604795|616073778|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
170474368|NCT04604795|616073779|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
170474369|NCT04604795|616073770|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474370|NCT04604795|616073771|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474371|NCT04604795|616073772|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474372|NCT04604795|616073773|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474373|NCT04604795|616073774|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474374|NCT04604795|616073775|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474375|NCT04604795|616073776|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474376|NCT04604795|616073777|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474377|NCT04604795|616073778|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
170474378|NCT04604795|616073779|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
170474379|NCT04604795|616073770|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170474380|NCT04604795|616073771|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170474381|NCT04604795|616073772|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170474382|NCT04604795|616073773|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170474383|NCT04604795|616073774|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170474384|NCT04604795|616073775|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170474385|NCT04604795|616073776|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170474386|NCT04604795|616073777|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170791958|NCT00085735|617249354|FG004|Overall Study|Physician Decision|11|||
170474387|NCT04604795|616073778|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
170474388|NCT04604795|616073779|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
170791959|NCT00085735|617249355|FG005|Overall Study|Physician Decision|8|||
170637898|NCT01349049|616686665|FG006|Overall Study|Withdrawal by Subject|0|||
170637899|NCT01349049|616686666|FG007|Overall Study|Withdrawal by Subject|0|||
170637900|NCT01349049|616686667|FG008|Overall Study|Withdrawal by Subject|6|||
170637901|NCT03887702|616686670|FG000|Overall Study|Study terminated|0|||
170474389|NCT04604795|616073770|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474390|NCT04604795|616073771|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474391|NCT04604795|616073772|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474392|NCT04604795|616073773|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474393|NCT04604795|616073774|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474394|NCT04604795|616073775|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474395|NCT04604795|616073776|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474396|NCT04604795|616073777|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474397|NCT04604795|616073778|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
170637902|NCT03887702|616686671|FG001|Overall Study|Study terminated|0|||
170637903|NCT03887702|616686672|FG002|Overall Study|Study terminated|2|||
170791960|NCT00085735|617249350|FG000|Overall Study|Protocol Violation|1|||
170474398|NCT04604795|616073779|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
170474399|NCT02359994|616073783|FG000|Overall Population Study|Adverse Event|1|||
170474400|NCT02359994|616073784|FG001|Overall Population Study|Adverse Event|1|||
170474401|NCT02359994|616073783|FG000|Overall Population Study|Death|1|||
170474402|NCT02359994|616073784|FG001|Overall Population Study|Death|5|||
170474403|NCT02359994|616073783|FG000|Overall Population Study|Lost to Follow-up|1|||
170474404|NCT02359994|616073784|FG001|Overall Population Study|Lost to Follow-up|1|||
170474405|NCT02359994|616073783|FG000|Overall Population Study|Withdrawal by Subject|1|||
170474406|NCT02359994|616073784|FG001|Overall Population Study|Withdrawal by Subject|0|||
170474407|NCT02359994|616073783|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
170474408|NCT02359994|616073784|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
170474409|NCT02359994|616073783|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
170474410|NCT02359994|616073784|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
170474411|NCT02359994|616073783|FG000|Extended Oncology 24-Month Survival|Death|19|||
170474412|NCT02359994|616073784|FG001|Extended Oncology 24-Month Survival|Death|21|||
170474413|NCT02359994|616073783|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
170474414|NCT02359994|616073784|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
170474415|NCT00985491|616073786|FG000|Overall Study|Adverse Event|8|||
170474416|NCT00985491|616073786|FG000|Overall Study|device migration|7|||
170474417|NCT00985491|616073786|FG000|Overall Study|Withdrawal by Subject|1|||
170474418|NCT00985491|616073786|FG000|Overall Study|implant failure|3|||
170474419|NCT01893346|616073787|FG000|Overall Study|Lost to Follow-up|0|||
170474420|NCT01893346|616073788|FG001|Overall Study|Lost to Follow-up|1|||
170474421|NCT01893346|616073789|FG002|Overall Study|Lost to Follow-up|0|||
170474422|NCT01893346|616073790|FG003|Overall Study|Lost to Follow-up|0|||
170474423|NCT01893346|616073787|FG000|Overall Study|Protocol Violation|1|||
170474424|NCT01893346|616073788|FG001|Overall Study|Protocol Violation|0|||
170474425|NCT01893346|616073789|FG002|Overall Study|Protocol Violation|0|||
170474426|NCT01893346|616073790|FG003|Overall Study|Protocol Violation|0|||
170474427|NCT01893346|616073787|FG000|Overall Study|Withdrawal by Subject|2|||
170474428|NCT01893346|616073788|FG001|Overall Study|Withdrawal by Subject|0|||
170474429|NCT01893346|616073789|FG002|Overall Study|Withdrawal by Subject|0|||
170474430|NCT01893346|616073790|FG003|Overall Study|Withdrawal by Subject|0|||
170474431|NCT00489827|616073794|FG000|Overall Study|Intraoperative exclusion criteria|1|||
170474432|NCT00489827|616073795|FG001|Overall Study|Intraoperative exclusion criteria|1|||
170474433|NCT00489827|616073794|FG000|Overall Study|Intraoperative exclusion criteria|1|||
170474434|NCT00489827|616073795|FG001|Overall Study|Intraoperative exclusion criteria|1|||
170474435|NCT02766283|616073796|FG000|Overall Study|Lost to Follow-up|27|||
170474436|NCT00721227|616073797|FG000|Overall Study|Lost to Follow-up|3|||
170474437|NCT00721227|616073798|FG001|Overall Study|Lost to Follow-up|0|||
170474438|NCT00721227|616073797|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
170474439|NCT00721227|616073798|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
170474440|NCT03736031|616073813|FG000|Overall Study|Death|2|||
170474441|NCT03736031|616073814|FG001|Overall Study|Death|4|||
170474442|NCT03736031|616073813|FG000|Overall Study|Lost to Follow-up|21|||
170474443|NCT03736031|616073814|FG001|Overall Study|Lost to Follow-up|2|||
170474444|NCT03736031|616073813|FG000|Overall Study|Withdrawal by Subject|9|||
170474445|NCT03736031|616073814|FG001|Overall Study|Withdrawal by Subject|0|||
170474446|NCT03300817|616075609|FG000|Overall Study|Withdrawal by Subject|1|||
170474447|NCT03300817|616075609|FG000|Overall Study|Adverse Event|1|||
170474448|NCT03300817|616075609|FG000|Overall Study|Subject Found to be Ineligible|2|||
170474449|NCT03041311|616075612|FG000|Overall Study|Death|39|||
170474450|NCT03041311|616075613|FG001|Overall Study|Death|42|||
170474451|NCT03041311|616075612|FG000|Overall Study|Lost to Follow-up|0|||
170474452|NCT03041311|616075613|FG001|Overall Study|Lost to Follow-up|1|||
170474453|NCT03041311|616075612|FG000|Overall Study|Withdrawal by Subject|8|||
170474454|NCT03041311|616075613|FG001|Overall Study|Withdrawal by Subject|5|||
170545789|NCT03573882|616342747|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
170545790|NCT03573882|616342748|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
170545791|NCT03573882|616342746|FG000|Overall Study|Pregnancy|1|||
170545792|NCT03573882|616342747|FG001|Overall Study|Pregnancy|2|||
170545793|NCT03573882|616342748|FG002|Overall Study|Pregnancy|0|||
170637904|NCT03887702|616686673|FG003|Overall Study|Study terminated|2|||
170637905|NCT01643772|616686674|FG000|Overall Study|Protocol Violation|0|||
170637906|NCT01643772|616686675|FG001|Overall Study|Protocol Violation|0|||
170637907|NCT01643772|616686676|FG002|Overall Study|Protocol Violation|0|||
170637908|NCT01643772|616686677|FG003|Overall Study|Protocol Violation|1|||
170637909|NCT01643772|616686674|FG000|Overall Study|Adverse Event|0|||
170637910|NCT01643772|616686675|FG001|Overall Study|Adverse Event|0|||
170637911|NCT01643772|616686676|FG002|Overall Study|Adverse Event|0|||
170637912|NCT01643772|616686677|FG003|Overall Study|Adverse Event|1|||
170637913|NCT01675544|616686678|FG000|Overall Study|Withdrawal by Subject|2|||
170637914|NCT03860818|616686679|FG000|Overall Study|Death|144|||
170637915|NCT03860818|616686680|FG001|Overall Study|Death|195|||
170474455|NCT03041311|616075612|FG000|Overall Study|Sponsor Terminated Study|2|||
170474456|NCT03041311|616075613|FG001|Overall Study|Sponsor Terminated Study|4|||
170474457|NCT03041311|616075612|FG000|Overall Study|Disease Progression|3|||
170474458|NCT03041311|616075613|FG001|Overall Study|Disease Progression|1|||
170474459|NCT03041311|616075612|FG000|Overall Study|Randomized in error, did not receive drug|2|||
170474460|NCT03041311|616075613|FG001|Overall Study|Randomized in error, did not receive drug|0|||
170474461|NCT04909853|616075614|FG000|Part 1|Assigned but not treated|0|||
170474462|NCT04909853|616075615|FG001|Part 1|Assigned but not treated|0|||
170474463|NCT04909853|616075616|FG002|Part 1|Assigned but not treated|1|||
170474464|NCT04909853|616075617|FG003|Part 1|Assigned but not treated|0|||
170637916|NCT03860818|616686679|FG000|Overall Study|Graft Loss|32|||
170637917|NCT03860818|616686680|FG001|Overall Study|Graft Loss|45|||
170637918|NCT00505778|616686681|FG000|Overall Study|Adverse Event|2|||
170637919|NCT00505778|616686682|FG001|Overall Study|Adverse Event|7|||
170474465|NCT04909853|616075614|FG000|Part 2|Adverse Event|0|||
170474466|NCT04909853|616075615|FG001|Part 2|Adverse Event|0|||
170474467|NCT04909853|616075616|FG002|Part 2|Adverse Event|0|||
170474468|NCT04909853|616075617|FG003|Part 2|Adverse Event|1|||
170474469|NCT02366689|616075624|FG000|Overall Study|Withdrawal by Subject|1|||
170474470|NCT02366689|616075625|FG001|Overall Study|Withdrawal by Subject|0|||
170474471|NCT02366689|616075626|FG002|Overall Study|Withdrawal by Subject|1|||
170474472|NCT02366689|616075624|FG000|Overall Study|Lost to Follow-up|3|||
170474473|NCT02366689|616075625|FG001|Overall Study|Lost to Follow-up|2|||
170474474|NCT02366689|616075626|FG002|Overall Study|Lost to Follow-up|0|||
170474475|NCT02366689|616075624|FG000|Overall Study|Pregnancy|0|||
170474476|NCT02366689|616075625|FG001|Overall Study|Pregnancy|1|||
170474477|NCT02366689|616075626|FG002|Overall Study|Pregnancy|1|||
170474478|NCT03718832|616075627|FG000|Analysis Sample|Withdrawal by Subject|18|||
170474479|NCT03718832|616075628|FG001|Analysis Sample|Withdrawal by Subject|15|||
170474480|NCT03718832|616075627|FG000|Analysis Sample|Legal hold on data|1|||
170474481|NCT03718832|616075628|FG001|Analysis Sample|Legal hold on data|0|||
170474482|NCT03718832|616075627|FG000|Analysis Sample|Participant from treated household|0|||
170474483|NCT03718832|616075628|FG001|Analysis Sample|Participant from treated household|1|||
170637920|NCT00505778|616686681|FG000|Overall Study|Physician Decision|8|||
170637921|NCT00505778|616686682|FG001|Overall Study|Physician Decision|14|||
170637922|NCT00505778|616686681|FG000|Overall Study|Lost to Follow-up|17|||
170637923|NCT00505778|616686682|FG001|Overall Study|Lost to Follow-up|23|||
170637924|NCT00505778|616686681|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
170637925|NCT00505778|616686682|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
170637926|NCT00505778|616686681|FG000|Overall Study|Protocol Violation|7|||
170637927|NCT00505778|616686682|FG001|Overall Study|Protocol Violation|9|||
170637928|NCT00505778|616686681|FG000|Overall Study|Withdrawal by Subject|29|||
170474484|NCT03718832|616075627|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
170545794|NCT03573882|616342746|FG000|Overall Study|Other|4|||
170545795|NCT03573882|616342747|FG001|Overall Study|Other|2|||
170545796|NCT03573882|616342748|FG002|Overall Study|Other|2|||
170545797|NCT02691572|616342749|FG000|Overall Study|Withdrawal by Subject|1|||
170545798|NCT02691572|616342750|FG001|Overall Study|Withdrawal by Subject|0|||
170637929|NCT00505778|616686682|FG001|Overall Study|Withdrawal by Subject|14|||
170474485|NCT03718832|616075628|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
170474486|NCT01996241|616075629|FG000|Overall Study|Lost to Follow-up|252|||
170474487|NCT01996241|616075630|FG001|Overall Study|Lost to Follow-up|235|||
170474488|NCT01068262|616075634|FG000|Overall Study|Adverse Event|2|||
170474489|NCT01068262|616075635|FG001|Overall Study|Adverse Event|0|||
170474490|NCT01068262|616075636|FG002|Overall Study|Adverse Event|1|||
170545799|NCT02691572|616342749|FG000|Overall Study|Protocol Violation|0|||
170545800|NCT02691572|616342750|FG001|Overall Study|Protocol Violation|1|||
170545801|NCT00699751|616342751|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
170545802|NCT00699751|616342752|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
170637930|NCT00505778|616686681|FG000|Overall Study|Relapse|65|||
170637931|NCT00505778|616686682|FG001|Overall Study|Relapse|65|||
170637932|NCT00505778|616686681|FG000|Overall Study|Took No Study Drug|2|||
170474491|NCT01068262|616075637|FG003|Overall Study|Adverse Event|0|||
170474492|NCT01068262|616075634|FG000|Overall Study|Protocol Violation|1|||
170474493|NCT01068262|616075635|FG001|Overall Study|Protocol Violation|0|||
170474494|NCT01068262|616075636|FG002|Overall Study|Protocol Violation|0|||
170474495|NCT01068262|616075637|FG003|Overall Study|Protocol Violation|0|||
170474496|NCT01068262|616075634|FG000|Overall Study|Withdrawal by Subject|0|||
170474497|NCT01068262|616075635|FG001|Overall Study|Withdrawal by Subject|1|||
170474498|NCT01068262|616075636|FG002|Overall Study|Withdrawal by Subject|0|||
170474499|NCT01068262|616075637|FG003|Overall Study|Withdrawal by Subject|0|||
170474500|NCT00369941|616075638|FG000|Overall Study|Never Treated|1|||
170474501|NCT00369941|616075639|FG001|Overall Study|Never Treated|2|||
170474502|NCT00369941|616075638|FG000|Overall Study|Adverse Event|14|||
170474503|NCT00369941|616075639|FG001|Overall Study|Adverse Event|28|||
170474504|NCT00369941|616075638|FG000|Overall Study|Lack of Efficacy|6|||
170474505|NCT00369941|616075639|FG001|Overall Study|Lack of Efficacy|10|||
170474506|NCT00369941|616075638|FG000|Overall Study|Lost to Follow-up|12|||
170474507|NCT00369941|616075639|FG001|Overall Study|Lost to Follow-up|22|||
170474508|NCT00369941|616075638|FG000|Overall Study|Protocol Violation|5|||
170474509|NCT00369941|616075639|FG001|Overall Study|Protocol Violation|3|||
170474510|NCT00369941|616075638|FG000|Overall Study|Withdrawal by Subject|5|||
170474511|NCT00369941|616075639|FG001|Overall Study|Withdrawal by Subject|18|||
170474512|NCT00369941|616075638|FG000|Overall Study|Pregnancy|4|||
170474513|NCT00369941|616075639|FG001|Overall Study|Pregnancy|2|||
170474514|NCT00369941|616075638|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
170474515|NCT00369941|616075639|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
170474516|NCT00369941|616075638|FG000|Overall Study|Moved|11|||
170474517|NCT00369941|616075639|FG001|Overall Study|Moved|5|||
170474518|NCT00369941|616075638|FG000|Overall Study|Treatment with Prohibited Medication|3|||
170474519|NCT00369941|616075639|FG001|Overall Study|Treatment with Prohibited Medication|1|||
170474520|NCT00369941|616075638|FG000|Overall Study|Employment Interfered with Study Visits|1|||
170474521|NCT00369941|616075639|FG001|Overall Study|Employment Interfered with Study Visits|0|||
170474522|NCT00369941|616075638|FG000|Overall Study|Study Site Terminated|2|||
170474523|NCT00369941|616075639|FG001|Overall Study|Study Site Terminated|0|||
170474524|NCT00369941|616075638|FG000|Overall Study|Miscellaneous|3|||
170474525|NCT00369941|616075639|FG001|Overall Study|Miscellaneous|3|||
170474526|NCT02604407|616075640|FG000|Overall Study|Adverse Event|0|||
170474527|NCT02604407|616075641|FG001|Overall Study|Adverse Event|7|||
170791961|NCT00085735|617249351|FG001|Overall Study|Protocol Violation|0|||
170791962|NCT00085735|617249352|FG002|Overall Study|Protocol Violation|0|||
170791963|NCT00085735|617249353|FG003|Overall Study|Protocol Violation|0|||
170791964|NCT00085735|617249354|FG004|Overall Study|Protocol Violation|0|||
170791965|NCT00085735|617249355|FG005|Overall Study|Protocol Violation|0|||
170791966|NCT00085735|617249350|FG000|Overall Study|Withdrawal by Subject|1|||
170791967|NCT00085735|617249351|FG001|Overall Study|Withdrawal by Subject|0|||
170791968|NCT00085735|617249352|FG002|Overall Study|Withdrawal by Subject|4|||
170791969|NCT00085735|617249353|FG003|Overall Study|Withdrawal by Subject|5|||
170791970|NCT00085735|617249354|FG004|Overall Study|Withdrawal by Subject|7|||
170791971|NCT00085735|617249355|FG005|Overall Study|Withdrawal by Subject|8|||
170791972|NCT00085735|617249350|FG000|Overall Study|Patient ineligible|1|||
170791973|NCT00085735|617249351|FG001|Overall Study|Patient ineligible|0|||
170791974|NCT00085735|617249352|FG002|Overall Study|Patient ineligible|3|||
170791975|NCT00085735|617249353|FG003|Overall Study|Patient ineligible|7|||
170791976|NCT00085735|617249354|FG004|Overall Study|Patient ineligible|17|||
170791977|NCT00085735|617249355|FG005|Overall Study|Patient ineligible|8|||
170791978|NCT00085735|617249350|FG000|Overall Study|Excess residual disease|2|||
170791979|NCT00085735|617249351|FG001|Overall Study|Excess residual disease|2|||
170791980|NCT00085735|617249352|FG002|Overall Study|Excess residual disease|1|||
170791981|NCT00085735|617249353|FG003|Overall Study|Excess residual disease|1|||
170791982|NCT00085735|617249354|FG004|Overall Study|Excess residual disease|1|||
170791983|NCT00085735|617249355|FG005|Overall Study|Excess residual disease|4|||
170791984|NCT00085735|617249350|FG000|Overall Study|Reason not documented|1|||
170791985|NCT00085735|617249351|FG001|Overall Study|Reason not documented|0|||
170791986|NCT00085735|617249352|FG002|Overall Study|Reason not documented|1|||
170791987|NCT00085735|617249353|FG003|Overall Study|Reason not documented|0|||
170791988|NCT00085735|617249354|FG004|Overall Study|Reason not documented|1|||
170791989|NCT00085735|617249355|FG005|Overall Study|Reason not documented|0|||
170791990|NCT00085735|617249350|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
170791991|NCT00085735|617249351|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
170474528|NCT02604407|616075642|FG002|Overall Study|Adverse Event|5|||
170791992|NCT00085735|617249352|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
170474529|NCT02604407|616075640|FG000|Overall Study|Protocol Violation|2|||
170474530|NCT02604407|616075641|FG001|Overall Study|Protocol Violation|0|||
170474531|NCT02604407|616075642|FG002|Overall Study|Protocol Violation|0|||
170474532|NCT02604407|616075640|FG000|Overall Study|Withdrawal by Subject|3|||
170791993|NCT00085735|617249353|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
170791994|NCT00085735|617249354|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
170791995|NCT00085735|617249355|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
170474533|NCT02604407|616075641|FG001|Overall Study|Withdrawal by Subject|3|||
170474534|NCT02604407|616075642|FG002|Overall Study|Withdrawal by Subject|5|||
170474535|NCT02604407|616075640|FG000|Overall Study|Lost to Follow-up|2|||
170474536|NCT02604407|616075641|FG001|Overall Study|Lost to Follow-up|1|||
170474537|NCT02604407|616075642|FG002|Overall Study|Lost to Follow-up|2|||
170474538|NCT02604407|616075640|FG000|Overall Study|Lack of Efficacy|1|||
170474539|NCT02604407|616075641|FG001|Overall Study|Lack of Efficacy|0|||
170474540|NCT02604407|616075642|FG002|Overall Study|Lack of Efficacy|0|||
170474541|NCT02604407|616075640|FG000|Overall Study|Other|3|||
170474542|NCT02604407|616075641|FG001|Overall Study|Other|1|||
170474543|NCT02604407|616075642|FG002|Overall Study|Other|4|||
170474544|NCT00661193|616075643|FG000|Overall Study|Adverse Event|2|||
170474545|NCT00661193|616075644|FG001|Overall Study|Adverse Event|1|||
170474546|NCT00661193|616075643|FG000|Overall Study|Withdrawal by Subject|3|||
170474547|NCT00661193|616075644|FG001|Overall Study|Withdrawal by Subject|1|||
170474548|NCT00661193|616075643|FG000|Overall Study|Progression|27|||
170474549|NCT00661193|616075644|FG001|Overall Study|Progression|24|||
170474550|NCT00661193|616075643|FG000|Overall Study|Not protocol specified|1|||
170474551|NCT00661193|616075644|FG001|Overall Study|Not protocol specified|0|||
170474552|NCT02964312|616075645|FG000|Overall Study|Lost to Follow-up|28|||
170474553|NCT02964312|616075645|FG000|Overall Study|Withdrawal by Subject|11|||
170474554|NCT02964312|616075645|FG000|Overall Study|Lack of Efficacy|10|||
170474555|NCT02964312|616075645|FG000|Overall Study|Did not consent to long-term FU|14|||
170474556|NCT02964312|616075645|FG000|Overall Study|Death|1|||
170474557|NCT00191191|616075654|FG000|Overall Study|Entry Criteria Exclusion|2|||
170474558|NCT00191191|616075655|FG001|Overall Study|Entry Criteria Exclusion|0|||
170474559|NCT00191191|616075654|FG000|Overall Study|Treated with Another Systemic Agent|1|||
170474560|NCT00191191|616075655|FG001|Overall Study|Treated with Another Systemic Agent|1|||
170474561|NCT00191191|616075654|FG000|Overall Study|Adverse Event|11|||
170474562|NCT00191191|616075655|FG001|Overall Study|Adverse Event|21|||
170474563|NCT00191191|616075654|FG000|Overall Study|Progressive Disease|84|||
170545803|NCT00699751|616342751|FG000|Period 1: Without/Before Drug Switch|Death|28|||
170545804|NCT00699751|616342752|FG001|Period 1: Without/Before Drug Switch|Death|29|||
170545805|NCT00699751|616342751|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
170545806|NCT00699751|616342752|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
170545807|NCT00699751|616342751|FG000|Period 1: Without/Before Drug Switch|Other|30|||
170545808|NCT00699751|616342752|FG001|Period 1: Without/Before Drug Switch|Other|20|||
170545809|NCT00699751|616342751|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
170545810|NCT00699751|616342752|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
170545811|NCT00699751|616342751|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
170545812|NCT00699751|616342752|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
170545813|NCT00699751|616342751|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
170545814|NCT00699751|616342752|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
170545815|NCT00699751|616342751|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
170545816|NCT00699751|616342752|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
170545817|NCT02939781|616342758|FG000|Overall Study|Protocol Violation|8|||
170545818|NCT02939781|616342758|FG000|Overall Study|Withdrawal by Subject|1|||
170545819|NCT05537571|616342764|FG000|Overall Study|Withdrawal by Subject|1|||
170545820|NCT05537571|616342765|FG001|Overall Study|Withdrawal by Subject|1|||
170545821|NCT05537571|616342766|FG002|Overall Study|Withdrawal by Subject|0|||
170545822|NCT05537571|616342767|FG003|Overall Study|Withdrawal by Subject|0|||
170545823|NCT05537571|616342768|FG004|Overall Study|Withdrawal by Subject|0|||
170637933|NCT00505778|616686682|FG001|Overall Study|Took No Study Drug|2|||
170637934|NCT01621802|616686683|FG000|Overall Study|Protocol Violation|0|||
170637935|NCT01621802|616686684|FG001|Overall Study|Protocol Violation|0|||
170637936|NCT01621802|616686685|FG002|Overall Study|Protocol Violation|0|||
170474564|NCT00191191|616075655|FG001|Overall Study|Progressive Disease|72|||
170474565|NCT00191191|616075654|FG000|Overall Study|Toxicity After Dose Reduction|7|||
170474566|NCT00191191|616075655|FG001|Overall Study|Toxicity After Dose Reduction|8|||
170474567|NCT00191191|616075654|FG000|Overall Study|Family/Caregiver Decision|5|||
170474568|NCT00191191|616075655|FG001|Overall Study|Family/Caregiver Decision|7|||
170474569|NCT00191191|616075654|FG000|Overall Study|Lost to Follow-up|1|||
170474570|NCT00191191|616075655|FG001|Overall Study|Lost to Follow-up|0|||
170545824|NCT05537571|616342764|FG000|Overall Study|Adverse Event|2|||
170545825|NCT05537571|616342765|FG001|Overall Study|Adverse Event|0|||
170545826|NCT05537571|616342766|FG002|Overall Study|Adverse Event|0|||
170545827|NCT05537571|616342767|FG003|Overall Study|Adverse Event|0|||
170545828|NCT05537571|616342768|FG004|Overall Study|Adverse Event|0|||
170545829|NCT05537571|616342764|FG000|Overall Study|Hepatitis A screening result|2|||
170545830|NCT05537571|616342765|FG001|Overall Study|Hepatitis A screening result|0|||
170545831|NCT05537571|616342766|FG002|Overall Study|Hepatitis A screening result|0|||
170545832|NCT05537571|616342767|FG003|Overall Study|Hepatitis A screening result|0|||
170545833|NCT05537571|616342768|FG004|Overall Study|Hepatitis A screening result|0|||
170545834|NCT05537571|616342764|FG000|Overall Study|Lost to Follow-up|0|||
170637937|NCT01621802|616686686|FG003|Overall Study|Protocol Violation|0|||
170474571|NCT00191191|616075654|FG000|Overall Study|Physician Decision|3|||
170474572|NCT00191191|616075655|FG001|Overall Study|Physician Decision|2|||
170474573|NCT00191191|616075654|FG000|Overall Study|Good Clinical Practice Violation|0|||
170474574|NCT00191191|616075655|FG001|Overall Study|Good Clinical Practice Violation|1|||
170474575|NCT03288714|616075661|FG000|Overall Study|Lost to Follow-up|2|||
170474576|NCT03288714|616075662|FG001|Overall Study|Lost to Follow-up|1|||
170474577|NCT03288714|616075661|FG000|Overall Study|Non-compliance with study schedule|2|||
170474578|NCT03288714|616075662|FG001|Overall Study|Non-compliance with study schedule|0|||
170474579|NCT03288714|616075661|FG000|Overall Study|Withdrawal by Subject|3|||
170474580|NCT03288714|616075662|FG001|Overall Study|Withdrawal by Subject|1|||
170474581|NCT03288714|616075661|FG000|Overall Study|Clinical Worsening|2|||
170474582|NCT03288714|616075662|FG001|Overall Study|Clinical Worsening|1|||
170474583|NCT03288714|616075661|FG000|Overall Study|Adverse Event|1|||
170474584|NCT03288714|616075662|FG001|Overall Study|Adverse Event|0|||
170474585|NCT03280264|616075663|FG000|Overall Study|Adverse Event|1|||
170474586|NCT03280264|616075663|FG000|Overall Study|Physician Decision|1|||
170474587|NCT03280264|616075663|FG000|Overall Study|Withdrawal by Subject|1|||
170474588|NCT00524420|616075673|FG000|Overall Study|Lack of Efficacy|1|||
170474589|NCT00524420|616075674|FG001|Overall Study|Lack of Efficacy|0|||
170474590|NCT00577863|616075675|FG000|Overall Study|Adverse Event|4|||
170474591|NCT00577863|616075676|FG001|Overall Study|Adverse Event|2|||
170474592|NCT00577863|616075675|FG000|Overall Study|Death|1|||
170474593|NCT00577863|616075676|FG001|Overall Study|Death|0|||
170474594|NCT00577863|616075675|FG000|Overall Study|Lost to Follow-up|2|||
170474595|NCT00577863|616075676|FG001|Overall Study|Lost to Follow-up|2|||
170474596|NCT00577863|616075675|FG000|Overall Study|Entry Criteria Exclusion|1|||
170474597|NCT00577863|616075676|FG001|Overall Study|Entry Criteria Exclusion|0|||
170474598|NCT00577863|616075675|FG000|Overall Study|Withdrawal by Subject|0|||
170474599|NCT00577863|616075676|FG001|Overall Study|Withdrawal by Subject|2|||
170474600|NCT00577863|616075675|FG000|Overall Study|Sponsor Decision|2|||
170474601|NCT00577863|616075676|FG001|Overall Study|Sponsor Decision|7|||
170474602|NCT00577863|616075675|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
170474603|NCT00577863|616075676|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
170474604|NCT02738138|616075678|FG000|Overall Study|Adverse Event|0|||
170474605|NCT02738138|616075679|FG001|Overall Study|Adverse Event|1|||
170474606|NCT02738138|616075678|FG000|Overall Study|Lost to Follow-up|2|||
170474607|NCT02738138|616075679|FG001|Overall Study|Lost to Follow-up|0|||
170474608|NCT02738138|616075678|FG000|Overall Study|Other - not further specified|1|||
170474609|NCT02738138|616075679|FG001|Overall Study|Other - not further specified|0|||
170474610|NCT01232452|616075690|FG000|Overall Study|Adverse Event|17|||
170474611|NCT01232452|616075691|FG001|Overall Study|Adverse Event|15|||
170474612|NCT01232452|616075690|FG000|Overall Study|Withdrawal by Subject|11|||
170474613|NCT01232452|616075691|FG001|Overall Study|Withdrawal by Subject|8|||
170474614|NCT01232452|616075690|FG000|Overall Study|Physician Decision|8|||
170474615|NCT01232452|616075691|FG001|Overall Study|Physician Decision|12|||
170474616|NCT01232452|616075690|FG000|Overall Study|Protocol entry criterion not met|0|||
170474617|NCT01232452|616075691|FG001|Overall Study|Protocol entry criterion not met|2|||
170474618|NCT01232452|616075690|FG000|Overall Study|Sponsor Decision|3|||
170474619|NCT01232452|616075691|FG001|Overall Study|Sponsor Decision|1|||
170474620|NCT01232452|616075690|FG000|Overall Study|Protocol Violation|0|||
170474621|NCT01232452|616075691|FG001|Overall Study|Protocol Violation|1|||
170474622|NCT00247676|616075692|FG000|Overall Study|Death|5|||
170474623|NCT00247676|616075692|FG000|Overall Study|Adverse Event|11|||
170474624|NCT00247676|616075692|FG000|Overall Study|Lack of Efficacy|15|||
170474625|NCT00247676|616075692|FG000|Overall Study|Other|3|||
170474626|NCT00247676|616075692|FG000|Overall Study|Withdrawal by Subject|2|||
170474627|NCT00662649|616075693|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
170474628|NCT00662649|616075694|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
170474629|NCT00662649|616075695|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
170474630|NCT00662649|616075696|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
170474631|NCT00662649|616075697|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
170791996|NCT02598388|617249356|FG000|Overall Study|Lost to Follow-up|1|||
170474632|NCT00662649|616075693|FG000|Core Study (24 Months)|Adverse Event|22|||
170474633|NCT00662649|616075694|FG001|Core Study (24 Months)|Adverse Event|13|||
170474634|NCT00662649|616075695|FG002|Core Study (24 Months)|Adverse Event|18|||
170474635|NCT00662649|616075696|FG003|Core Study (24 Months)|Adverse Event|0|||
170474636|NCT00662649|616075697|FG004|Core Study (24 Months)|Adverse Event|0|||
170474637|NCT00662649|616075693|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
170474638|NCT00662649|616075694|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
170474639|NCT00662649|616075695|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
170474640|NCT00662649|616075696|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
170474641|NCT00662649|616075697|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
170474642|NCT00662649|616075693|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
170474643|NCT00662649|616075694|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
170474644|NCT00662649|616075695|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
170474645|NCT00662649|616075696|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
170474646|NCT00662649|616075697|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
170474647|NCT00662649|616075693|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
170474648|NCT00662649|616075694|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
170474649|NCT00662649|616075695|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
170474650|NCT00662649|616075696|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
170474651|NCT00662649|616075697|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
170474652|NCT00662649|616075693|FG000|Core Study (24 Months)|Protocol Violation|5|||
170474653|NCT00662649|616075694|FG001|Core Study (24 Months)|Protocol Violation|5|||
170474654|NCT00662649|616075695|FG002|Core Study (24 Months)|Protocol Violation|4|||
170474655|NCT00662649|616075696|FG003|Core Study (24 Months)|Protocol Violation|0|||
170474656|NCT00662649|616075697|FG004|Core Study (24 Months)|Protocol Violation|0|||
170474657|NCT00662649|616075693|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
170474658|NCT00662649|616075694|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
170474659|NCT00662649|616075695|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
170474660|NCT00662649|616075696|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
170791997|NCT02598388|617249357|FG001|Overall Study|Lost to Follow-up|0|||
170474661|NCT00662649|616075697|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
170474662|NCT00662649|616075693|FG000|Core Study (24 Months)|Death|1|||
170474663|NCT00662649|616075694|FG001|Core Study (24 Months)|Death|0|||
170474664|NCT00662649|616075695|FG002|Core Study (24 Months)|Death|2|||
170474665|NCT00662649|616075696|FG003|Core Study (24 Months)|Death|0|||
170474666|NCT00662649|616075697|FG004|Core Study (24 Months)|Death|0|||
170474667|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
170474668|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
170474669|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
170474670|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
170474671|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
170474672|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
170474673|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
170474674|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
170474675|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
170474676|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
170474677|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
170545835|NCT05537571|616342765|FG001|Overall Study|Lost to Follow-up|0|||
170545836|NCT05537571|616342766|FG002|Overall Study|Lost to Follow-up|1|||
170545837|NCT05537571|616342767|FG003|Overall Study|Lost to Follow-up|0|||
170545838|NCT05537571|616342768|FG004|Overall Study|Lost to Follow-up|1|||
170545839|NCT04210375|616342772|FG000|Overall Study|Death|0|||
170545840|NCT04210375|616342773|FG001|Overall Study|Death|1|||
170474678|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
170474679|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
170474680|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
170474681|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
170474682|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
170474683|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
170474684|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
170474685|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
170545841|NCT04210375|616342774|FG002|Overall Study|Death|0|||
170545842|NCT04210375|616342775|FG003|Overall Study|Death|0|||
170545843|NCT04439123|616342776|FG000|Overall Study|Adverse Event|11|||
170545844|NCT04439123|616342776|FG000|Overall Study|Death|1|||
170545845|NCT04439123|616342776|FG000|Overall Study|Disease progression|19|||
170545846|NCT04439123|616342776|FG000|Overall Study|Withdrawal by Subject|2|||
170545847|NCT04439123|616342776|FG000|Overall Study|Still on treatment|2|||
170545848|NCT04337021|616342777|FG000|Overall Study|Lost to Follow-up|54|||
170545849|NCT04337021|616342778|FG001|Overall Study|Lost to Follow-up|66|||
170545850|NCT05752487|616342781|FG000|Overall Study|Enrolled, not treated|9|||
170545851|NCT05752487|616342781|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
170545852|NCT05752487|616342781|FG000|Overall Study|Withdrawal by Subject|2|||
170545853|NCT00424008|616342783|FG000|Overall Study|Adverse Event|8|||
170545854|NCT00424008|616342784|FG001|Overall Study|Adverse Event|6|||
170545855|NCT00424008|616342783|FG000|Overall Study|Lack of Efficacy|40|||
170545856|NCT00424008|616342784|FG001|Overall Study|Lack of Efficacy|34|||
170545857|NCT00424008|616342783|FG000|Overall Study|Lost to Follow-up|1|||
170545858|NCT00424008|616342784|FG001|Overall Study|Lost to Follow-up|2|||
170545859|NCT00424008|616342783|FG000|Overall Study|Withdrawal by Subject|5|||
170545860|NCT00424008|616342784|FG001|Overall Study|Withdrawal by Subject|8|||
170545861|NCT00424008|616342783|FG000|Overall Study|Noncompliance with protocol|13|||
170545862|NCT00424008|616342784|FG001|Overall Study|Noncompliance with protocol|7|||
170545863|NCT00424008|616342783|FG000|Overall Study|Did not meet protocol eligibility|16|||
170545864|NCT00424008|616342784|FG001|Overall Study|Did not meet protocol eligibility|21|||
170545865|NCT00424008|616342783|FG000|Overall Study|Administrative|266|||
170545866|NCT00424008|616342784|FG001|Overall Study|Administrative|257|||
170474686|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
170474687|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
170474688|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
170474689|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
170474690|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
170474691|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
170474692|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
170474693|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
170474694|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
170474695|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
170474696|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
170474697|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
170474698|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
170474699|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
170474700|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
170474701|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
170474702|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
170474703|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
170474704|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
170474705|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
170474706|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
170474707|NCT00662649|616075693|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
170474708|NCT00662649|616075694|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
170474709|NCT00662649|616075695|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
170474710|NCT00662649|616075696|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
170474711|NCT00662649|616075697|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
170474712|NCT01350271|616075699|FG000|Overall Study|Lost to Follow-up|21|||
170474713|NCT01350271|616075700|FG001|Overall Study|Lost to Follow-up|17|||
170474714|NCT01350271|616075701|FG002|Overall Study|Lost to Follow-up|26|||
170474715|NCT01349192|616075702|FG000|Overall Study|Protocol Violation|0|||
170474716|NCT01349192|616075703|FG001|Overall Study|Protocol Violation|1|||
170474717|NCT01349192|616075702|FG000|Overall Study|Withdrawal by Subject|0|||
170474718|NCT01349192|616075703|FG001|Overall Study|Withdrawal by Subject|2|||
170474719|NCT01349192|616075702|FG000|Overall Study|Lost to Follow-up|1|||
170474720|NCT01349192|616075703|FG001|Overall Study|Lost to Follow-up|3|||
170474721|NCT01349192|616075702|FG000|Overall Study|Failure to adhere to Protocol|2|||
170474722|NCT01349192|616075703|FG001|Overall Study|Failure to adhere to Protocol|0|||
170474723|NCT02262325|616075705|FG000|Overall Study|Death|16|||
170474724|NCT02262325|616075705|FG000|Overall Study|Lost to Follow-up|1|||
170474725|NCT00958828|616075709|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
170474726|NCT00958828|616075710|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
170474727|NCT00958828|616075709|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
170474728|NCT00958828|616075710|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
170474729|NCT02414958|616075711|FG000|Overall Study|Adverse Event|6|||
170474730|NCT02414958|616075712|FG001|Overall Study|Adverse Event|6|||
170474731|NCT02414958|616075713|FG002|Overall Study|Adverse Event|3|||
170474732|NCT02414958|616075711|FG000|Overall Study|Protocol Violation|10|||
170474733|NCT02414958|616075712|FG001|Overall Study|Protocol Violation|3|||
170474734|NCT02414958|616075713|FG002|Overall Study|Protocol Violation|1|||
170474735|NCT02414958|616075711|FG000|Overall Study|Lost to Follow-up|7|||
170474736|NCT02414958|616075712|FG001|Overall Study|Lost to Follow-up|4|||
170474737|NCT02414958|616075713|FG002|Overall Study|Lost to Follow-up|0|||
170474738|NCT02414958|616075711|FG000|Overall Study|Withdrawal by Subject|5|||
170474739|NCT02414958|616075712|FG001|Overall Study|Withdrawal by Subject|3|||
170474740|NCT02414958|616075713|FG002|Overall Study|Withdrawal by Subject|5|||
170474741|NCT02414958|616075711|FG000|Overall Study|Other than specified|4|||
170474742|NCT02414958|616075712|FG001|Overall Study|Other than specified|4|||
170474743|NCT02414958|616075713|FG002|Overall Study|Other than specified|5|||
170474744|NCT02232984|616075719|FG000|Overall Study|Withdrawal by Subject|5|||
170474745|NCT02232984|616075719|FG000|Overall Study|Death|1|||
170891677|NCT00573794|617609853|FG000|Overall Study|Lack of Efficacy|94|||
170474746|NCT02232984|616075719|FG000|Overall Study|Investigator withdrawal|10|||
170474747|NCT02232984|616075719|FG000|Overall Study|Device implant unsuccessful|53|||
170474748|NCT02232984|616075719|FG000|Overall Study|not disclosed by site|7|||
170474749|NCT02232984|616075719|FG000|Overall Study|Protocol Violation|1|||
170474750|NCT03607487|616075720|FG000|Overall Study|Withdrawal by Subject|2|||
170474751|NCT03607487|616075721|FG001|Overall Study|Withdrawal by Subject|0|||
170474752|NCT03607487|616075722|FG002|Overall Study|Withdrawal by Subject|0|||
170474753|NCT03607487|616075723|FG003|Overall Study|Withdrawal by Subject|1|||
170474754|NCT02455518|616075724|FG000|Overall Study|Protocol Violation|0|||
170891678|NCT00573794|617609853|FG000|Overall Study|Other|46|||
170637938|NCT01621802|616686687|FG004|Overall Study|Protocol Violation|0|||
170637939|NCT01621802|616686688|FG005|Overall Study|Protocol Violation|1|||
170637940|NCT01621802|616686683|FG000|Overall Study|Withdrawal by Subject|8|||
170637941|NCT01621802|616686684|FG001|Overall Study|Withdrawal by Subject|4|||
170637942|NCT01621802|616686685|FG002|Overall Study|Withdrawal by Subject|4|||
170637943|NCT01621802|616686686|FG003|Overall Study|Withdrawal by Subject|2|||
170637944|NCT01621802|616686687|FG004|Overall Study|Withdrawal by Subject|2|||
170637945|NCT01621802|616686688|FG005|Overall Study|Withdrawal by Subject|0|||
170637946|NCT01621802|616686683|FG000|Overall Study|Migrated/moved from study area|0|||
170637947|NCT01621802|616686684|FG001|Overall Study|Migrated/moved from study area|0|||
170637948|NCT01621802|616686685|FG002|Overall Study|Migrated/moved from study area|2|||
170637949|NCT01621802|616686686|FG003|Overall Study|Migrated/moved from study area|0|||
170637950|NCT01621802|616686687|FG004|Overall Study|Migrated/moved from study area|1|||
170637951|NCT01621802|616686688|FG005|Overall Study|Migrated/moved from study area|0|||
170637952|NCT01621802|616686683|FG000|Overall Study|Others|3|||
170637953|NCT01621802|616686684|FG001|Overall Study|Others|3|||
170637954|NCT01621802|616686685|FG002|Overall Study|Others|3|||
170637955|NCT01621802|616686686|FG003|Overall Study|Others|2|||
170637956|NCT01621802|616686687|FG004|Overall Study|Others|1|||
170637957|NCT01621802|616686688|FG005|Overall Study|Others|0|||
170637958|NCT01621802|616686683|FG000|Overall Study|Lost to Follow-up|36|||
170637959|NCT01621802|616686684|FG001|Overall Study|Lost to Follow-up|16|||
170637960|NCT01621802|616686685|FG002|Overall Study|Lost to Follow-up|24|||
170637961|NCT01621802|616686686|FG003|Overall Study|Lost to Follow-up|7|||
170637962|NCT01621802|616686687|FG004|Overall Study|Lost to Follow-up|31|||
170637963|NCT01621802|616686688|FG005|Overall Study|Lost to Follow-up|11|||
170791998|NCT02598388|617249358|FG002|Overall Study|Lost to Follow-up|1|||
170474755|NCT02455518|616075725|FG001|Overall Study|Protocol Violation|1|||
170474756|NCT02455518|616075726|FG002|Overall Study|Protocol Violation|1|||
170474757|NCT02455518|616075727|FG003|Overall Study|Protocol Violation|3|||
170474758|NCT02508935|616075730|FG000|Overall Study|Withdrawal by Subject|1|||
170474759|NCT02508935|616075730|FG000|Overall Study|Withdrawal by Caregiver|8|||
170474760|NCT02508935|616075730|FG000|Overall Study|Pain Score <4|1|||
170474761|NCT02508935|616075730|FG000|Overall Study|Emesis|3|||
170474762|NCT02508935|616075730|FG000|Overall Study|Adverse Event|3|||
170474763|NCT02508935|616075730|FG000|Overall Study|Protocol Violation|1|||
170474764|NCT02508935|616075730|FG000|Overall Study|Physician Decision|1|||
170474765|NCT02508935|616075730|FG000|Overall Study|Trial terminated by sponsor|5|||
170474766|NCT02673775|616075735|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
170474767|NCT02673775|616075736|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
170474768|NCT02673775|616075735|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
170474769|NCT02673775|616075736|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
170474770|NCT02673775|616075735|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
170474771|NCT02673775|616075736|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
170474772|NCT02673775|616075735|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
170474773|NCT02673775|616075736|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
170474774|NCT04650204|616075741|FG000|Overall Study|Study was Terminated|2|||
170474775|NCT04650204|616075742|FG001|Overall Study|Study was Terminated|1|||
170474776|NCT02536846|616075743|FG000|Overall Study|Withdrawal by Subject|1|||
170474777|NCT02503787|616075755|FG000|Enrollment|Withdrawal by Subject|6|||
170474778|NCT02503787|616075755|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
170474779|NCT02503787|616075755|FG000|Enrollment|Physician Decision|2|||
170474780|NCT02503787|616075755|FG000|Enrollment|Insurance issue|2|||
170474781|NCT02503787|616075755|FG000|Enrollment|Lost to Follow-up|1|||
170474782|NCT02503787|616075755|FG000|Enrollment|Study closure|1|||
170474783|NCT02503787|616075755|FG000|Enrollment|Adverse Event|1|||
170474784|NCT02503787|616075755|FG000|Enrollment|Protocol Violation|1|||
170474785|NCT02503787|616075755|FG000|Enrollment|Inability to implant system|1|||
170474786|NCT02503787|616075755|FG000|Enrollment|Unable to be programmed|1|||
170474787|NCT02503787|616075755|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
170474788|NCT02503787|616075755|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
170474789|NCT02503787|616075755|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
170474790|NCT02503787|616075755|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
170474791|NCT02503787|616075755|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
170474792|NCT02503787|616075755|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
170474793|NCT04787627|616075756|FG000|Overall Study|Withdrawal by Subject|3|||
170474794|NCT04787627|616075757|FG001|Overall Study|Withdrawal by Subject|0|||
170474795|NCT04787627|616075756|FG000|Overall Study|Physician Decision|2|||
170474796|NCT04787627|616075757|FG001|Overall Study|Physician Decision|0|||
170474797|NCT04787627|616075756|FG000|Overall Study|Excluded|0|||
170474798|NCT04787627|616075757|FG001|Overall Study|Excluded|1|||
170474799|NCT00548093|616075758|FG000|Overall Study|Death|33|||
170637964|NCT03790696|616686689|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
170637965|NCT03790696|616686690|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
170637966|NCT01149148|616686691|FG000|Overall Study|Lost to Follow-up|1|||
170474800|NCT00548093|616075759|FG001|Overall Study|Death|13|||
170474801|NCT00548093|616075758|FG000|Overall Study|Lost to Follow-up|3|||
170474802|NCT00548093|616075759|FG001|Overall Study|Lost to Follow-up|1|||
170474803|NCT00548093|616075758|FG000|Overall Study|Objective progression or relapse|1|||
170474804|NCT00548093|616075759|FG001|Overall Study|Objective progression or relapse|1|||
170474805|NCT00548093|616075758|FG000|Overall Study|Other|11|||
170474806|NCT00548093|616075759|FG001|Overall Study|Other|1|||
170474807|NCT00548093|616075758|FG000|Overall Study|Withdrawal by Subject|1|||
170474808|NCT00548093|616075759|FG001|Overall Study|Withdrawal by Subject|0|||
170474809|NCT00548093|616075758|FG000|Overall Study|Completed post-treatment follow-up|1|||
170474810|NCT00548093|616075759|FG001|Overall Study|Completed post-treatment follow-up|0|||
170474811|NCT01982812|616075762|FG000|Overall Study|Death|1|||
170474812|NCT01982812|616075763|FG001|Overall Study|Death|5|||
170474813|NCT01982812|616075762|FG000|Overall Study|Adverse Event|0|||
170474814|NCT01982812|616075763|FG001|Overall Study|Adverse Event|5|||
170474815|NCT00174954|616075764|FG000|Overall Study|Adverse Event|2|||
170474816|NCT00174954|616075764|FG000|Overall Study|No tophi found in MRI|1|||
170474817|NCT00174954|616075764|FG000|Overall Study|Physician Decision|1|||
170474818|NCT00839254|616075765|FG000|Overall Study|Protocol Violation|0|||
170474819|NCT00839254|616075766|FG001|Overall Study|Protocol Violation|1|||
170474820|NCT00839254|616075767|FG002|Overall Study|Protocol Violation|1|||
170474821|NCT00839254|616075768|FG003|Overall Study|Protocol Violation|1|||
170474822|NCT00839254|616075769|FG004|Overall Study|Protocol Violation|0|||
170474823|NCT00839254|616075770|FG005|Overall Study|Protocol Violation|0|||
170474824|NCT00839254|616075771|FG006|Overall Study|Protocol Violation|1|||
170474825|NCT00839254|616075772|FG007|Overall Study|Protocol Violation|2|||
170474826|NCT00839254|616075765|FG000|Overall Study|Physician Decision|0|||
170474827|NCT00839254|616075766|FG001|Overall Study|Physician Decision|1|||
170474828|NCT00839254|616075767|FG002|Overall Study|Physician Decision|0|||
170474829|NCT00839254|616075768|FG003|Overall Study|Physician Decision|0|||
170474830|NCT00839254|616075769|FG004|Overall Study|Physician Decision|0|||
170474831|NCT00839254|616075770|FG005|Overall Study|Physician Decision|0|||
170474832|NCT00839254|616075771|FG006|Overall Study|Physician Decision|0|||
170474833|NCT00839254|616075772|FG007|Overall Study|Physician Decision|1|||
170474834|NCT00839254|616075765|FG000|Overall Study|Wrong treatment number allocation|0|||
170474835|NCT00839254|616075766|FG001|Overall Study|Wrong treatment number allocation|1|||
170474836|NCT00839254|616075767|FG002|Overall Study|Wrong treatment number allocation|0|||
170474837|NCT00839254|616075768|FG003|Overall Study|Wrong treatment number allocation|0|||
170474838|NCT00839254|616075769|FG004|Overall Study|Wrong treatment number allocation|0|||
170474839|NCT00839254|616075770|FG005|Overall Study|Wrong treatment number allocation|1|||
170474840|NCT00839254|616075771|FG006|Overall Study|Wrong treatment number allocation|0|||
170791999|NCT02598388|617249359|FG003|Overall Study|Lost to Follow-up|0|||
170792000|NCT02598388|617249360|FG004|Overall Study|Lost to Follow-up|5|||
170792001|NCT02598388|617249361|FG005|Overall Study|Lost to Follow-up|1|||
170474841|NCT00839254|616075772|FG007|Overall Study|Wrong treatment number allocation|0|||
170474842|NCT00839254|616075765|FG000|Overall Study|Adverse Event|12|||
170474843|NCT00839254|616075766|FG001|Overall Study|Adverse Event|6|||
170474844|NCT00839254|616075767|FG002|Overall Study|Adverse Event|3|||
170474845|NCT00839254|616075768|FG003|Overall Study|Adverse Event|5|||
170474846|NCT00839254|616075769|FG004|Overall Study|Adverse Event|2|||
170474847|NCT00839254|616075770|FG005|Overall Study|Adverse Event|1|||
170474848|NCT00839254|616075771|FG006|Overall Study|Adverse Event|0|||
170474849|NCT00839254|616075772|FG007|Overall Study|Adverse Event|1|||
170474850|NCT00839254|616075765|FG000|Overall Study|Withdrawal by Subject|87|||
170474851|NCT00839254|616075766|FG001|Overall Study|Withdrawal by Subject|53|||
170474852|NCT00839254|616075767|FG002|Overall Study|Withdrawal by Subject|54|||
170474853|NCT00839254|616075768|FG003|Overall Study|Withdrawal by Subject|32|||
170474854|NCT00839254|616075769|FG004|Overall Study|Withdrawal by Subject|27|||
170474855|NCT00839254|616075770|FG005|Overall Study|Withdrawal by Subject|15|||
170474856|NCT00839254|616075771|FG006|Overall Study|Withdrawal by Subject|22|||
170474857|NCT00839254|616075772|FG007|Overall Study|Withdrawal by Subject|9|||
170474858|NCT00839254|616075765|FG000|Overall Study|Wrong group allocation|0|||
170474859|NCT00839254|616075766|FG001|Overall Study|Wrong group allocation|0|||
170474860|NCT00839254|616075767|FG002|Overall Study|Wrong group allocation|0|||
170474861|NCT00839254|616075768|FG003|Overall Study|Wrong group allocation|0|||
170474862|NCT00839254|616075769|FG004|Overall Study|Wrong group allocation|0|||
170792002|NCT02598388|617249362|FG006|Overall Study|Lost to Follow-up|2|||
170474863|NCT00839254|616075770|FG005|Overall Study|Wrong group allocation|0|||
170474864|NCT00839254|616075771|FG006|Overall Study|Wrong group allocation|1|||
170474865|NCT00839254|616075772|FG007|Overall Study|Wrong group allocation|0|||
170474866|NCT00839254|616075765|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
170474867|NCT00839254|616075766|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
170474868|NCT00839254|616075767|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
170474869|NCT00839254|616075768|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
170474870|NCT00839254|616075769|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
170474871|NCT00839254|616075770|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
170474872|NCT00839254|616075771|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
170474873|NCT00839254|616075772|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
170474874|NCT00839254|616075765|FG000|Overall Study|Withdrawn due to non-compliance|2|||
170474875|NCT00839254|616075766|FG001|Overall Study|Withdrawn due to non-compliance|0|||
170474876|NCT00839254|616075767|FG002|Overall Study|Withdrawn due to non-compliance|0|||
170474877|NCT00839254|616075768|FG003|Overall Study|Withdrawn due to non-compliance|0|||
170474878|NCT00839254|616075769|FG004|Overall Study|Withdrawn due to non-compliance|0|||
170474879|NCT00839254|616075770|FG005|Overall Study|Withdrawn due to non-compliance|0|||
170474880|NCT00839254|616075771|FG006|Overall Study|Withdrawn due to non-compliance|0|||
170474881|NCT00839254|616075772|FG007|Overall Study|Withdrawn due to non-compliance|0|||
170474882|NCT00839254|616075765|FG000|Overall Study|Lost to Follow-up|51|||
170474883|NCT00839254|616075766|FG001|Overall Study|Lost to Follow-up|30|||
170474884|NCT00839254|616075767|FG002|Overall Study|Lost to Follow-up|32|||
170474885|NCT00839254|616075768|FG003|Overall Study|Lost to Follow-up|24|||
170474886|NCT00839254|616075769|FG004|Overall Study|Lost to Follow-up|8|||
170474887|NCT00839254|616075770|FG005|Overall Study|Lost to Follow-up|8|||
170474888|NCT00839254|616075771|FG006|Overall Study|Lost to Follow-up|4|||
170474889|NCT00839254|616075772|FG007|Overall Study|Lost to Follow-up|2|||
170474890|NCT03017612|616075773|FG000|Overall Study|Adverse Event|2|||
170474891|NCT01320150|616075774|FG000|Overall Study|Protocol Violation|15|||
170474892|NCT01320150|616075774|FG000|Overall Study|Withdrawal by Subject|5|||
170474893|NCT01320150|616075774|FG000|Overall Study|Death|2|||
170474894|NCT01320150|616075774|FG000|Overall Study|Lost to Follow-up|44|||
170474895|NCT00143247|616075780|FG000|Overall Study|Death|8|||
170474896|NCT00143247|616075780|FG000|Overall Study|Adverse Event|19|||
170474897|NCT00143247|616075780|FG000|Overall Study|Lack of Efficacy|3|||
170474898|NCT00143247|616075780|FG000|Overall Study|Withdrawal by Subject|55|||
170474899|NCT00143247|616075780|FG000|Overall Study|Study terminated by sponsor|31|||
170474900|NCT00143247|616075780|FG000|Overall Study|Protocol Violation|15|||
170474901|NCT00143247|616075780|FG000|Overall Study|Lost to Follow-up|12|||
170474902|NCT00143247|616075780|FG000|Overall Study|following inaccurate lab adverse event|1|||
170474903|NCT00143247|616075780|FG000|Overall Study|Other|12|||
170474904|NCT02933255|616075781|FG000|Overall Study|Discontinued due to study closure.|1|||
170474905|NCT02933255|616075782|FG001|Overall Study|Discontinued due to study closure.|0|||
170474906|NCT02215967|616075783|FG000|Overall Study|Patient became ineligible for treatment|0|||
170474907|NCT02215967|616075784|FG001|Overall Study|Patient became ineligible for treatment|0|||
170474908|NCT02215967|616075785|FG002|Overall Study|Patient became ineligible for treatment|0|||
170474909|NCT02215967|616075786|FG003|Overall Study|Patient became ineligible for treatment|3|||
170474910|NCT02215967|616075783|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
170474911|NCT02215967|616075784|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
170474912|NCT02215967|616075785|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
170474913|NCT02215967|616075786|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
170474914|NCT03620708|616077578|FG000|Overall Study|Lost to Follow-up|1|||
170474915|NCT03620708|616077579|FG001|Overall Study|Lost to Follow-up|1|||
170474916|NCT03620708|616077580|FG002|Overall Study|Lost to Follow-up|2|||
170474917|NCT03620708|616077578|FG000|Overall Study|Withdrawal by Subject|0|||
170474918|NCT03620708|616077579|FG001|Overall Study|Withdrawal by Subject|0|||
170474919|NCT03620708|616077580|FG002|Overall Study|Withdrawal by Subject|1|||
170474920|NCT06082843|616077581|FG000|Overall Study|Withdrawal by Subject|0|||
170474921|NCT06082843|616077582|FG001|Overall Study|Withdrawal by Subject|2|||
170474922|NCT06082843|616077581|FG000|Overall Study|Study terminated by sponsor|12|||
170474923|NCT06082843|616077582|FG001|Overall Study|Study terminated by sponsor|8|||
170474924|NCT04182490|616077583|FG000|Overall Study|Withdrawal by Subject|3|||
170474925|NCT04182490|616077584|FG001|Overall Study|Withdrawal by Subject|3|||
170474926|NCT04182490|616077583|FG000|Overall Study|Lost to Follow-up|0|||
170474927|NCT04182490|616077584|FG001|Overall Study|Lost to Follow-up|1|||
170474928|NCT04182490|616077583|FG000|Overall Study|Physician Decision|0|||
170474929|NCT04182490|616077584|FG001|Overall Study|Physician Decision|1|||
170474930|NCT01720225|616077593|FG000|Overall Study|Withdrawal by Subject|0|||
170637967|NCT01149148|616686692|FG001|Overall Study|Lost to Follow-up|2|||
170474931|NCT01720225|616077594|FG001|Overall Study|Withdrawal by Subject|1|||
170474932|NCT01720225|616077593|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
170474933|NCT01720225|616077594|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
170474934|NCT00799058|616077604|FG000|Overall Study|Withdrawal by Subject|2|||
170637968|NCT01149148|616686691|FG000|Overall Study|Death|1|||
170637969|NCT01149148|616686692|FG001|Overall Study|Death|0|||
170474935|NCT00799058|616077605|FG001|Overall Study|Withdrawal by Subject|2|||
170474936|NCT00799058|616077606|FG002|Overall Study|Withdrawal by Subject|2|||
170474937|NCT00799058|616077604|FG000|Overall Study|Lost to Follow-up|1|||
170474938|NCT00799058|616077605|FG001|Overall Study|Lost to Follow-up|2|||
170474939|NCT00799058|616077606|FG002|Overall Study|Lost to Follow-up|1|||
170474940|NCT00799058|616077604|FG000|Overall Study|Adverse Event|0|||
170474941|NCT00799058|616077605|FG001|Overall Study|Adverse Event|2|||
170474942|NCT00799058|616077606|FG002|Overall Study|Adverse Event|0|||
170474943|NCT00799058|616077604|FG000|Overall Study|Pregnancy|1|||
170474944|NCT00799058|616077605|FG001|Overall Study|Pregnancy|0|||
170637970|NCT03436082|616686693|FG000|Overall Study|Did not undergo procedure|1|||
170637971|NCT03436082|616686694|FG001|Overall Study|Did not undergo procedure|0|||
170637972|NCT00373113|616686695|FG000|Overall Study|Death|1|||
170637973|NCT00373113|616686696|FG001|Overall Study|Death|7|||
170637974|NCT00373113|616686695|FG000|Overall Study|Adverse Event|38|||
170637975|NCT00373113|616686696|FG001|Overall Study|Adverse Event|24|||
170637976|NCT00373113|616686695|FG000|Overall Study|Study terminated by sponsor|9|||
170637977|NCT00373113|616686696|FG001|Overall Study|Study terminated by sponsor|1|||
170637978|NCT00373113|616686695|FG000|Overall Study|Global deterioration of health status|10|||
170637979|NCT00373113|616686696|FG001|Overall Study|Global deterioration of health status|7|||
170637980|NCT00373113|616686695|FG000|Overall Study|Lost to Follow-up|1|||
170637981|NCT00373113|616686696|FG001|Overall Study|Lost to Follow-up|3|||
170891679|NCT02154087|617609854|FG000|Overall Study|Study Termination|1|||
170891680|NCT02183519|617609864|FG000|Overall Study|computer error|3|||
170891681|NCT02183519|617609865|FG001|Overall Study|computer error|0|||
170891682|NCT02183519|617609864|FG000|Overall Study|Did not respond to cough inducter|0|||
170891683|NCT02183519|617609865|FG001|Overall Study|Did not respond to cough inducter|3|||
170891684|NCT04949841|617609866|FG000|Overall Study|Adverse Event|7|||
170891685|NCT04949841|617609866|FG000|Overall Study|Death|1|||
170891686|NCT04949841|617609866|FG000|Overall Study|Withdrawal by Subject|52|||
170891687|NCT04949841|617609866|FG000|Overall Study|Pregnancy|4|||
170891688|NCT04949841|617609866|FG000|Overall Study|Lost to Follow-up|9|||
170474945|NCT00799058|616077606|FG002|Overall Study|Pregnancy|0|||
170474946|NCT00799058|616077604|FG000|Overall Study|Not adherent|3|||
170474947|NCT00799058|616077605|FG001|Overall Study|Not adherent|2|||
170474948|NCT00799058|616077606|FG002|Overall Study|Not adherent|1|||
170474949|NCT00799058|616077604|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
170474950|NCT00799058|616077605|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
170474951|NCT00799058|616077606|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
170637982|NCT00373113|616686695|FG000|Overall Study|Objective progression or relapse|150|||
170637983|NCT00373113|616686696|FG001|Overall Study|Objective progression or relapse|169|||
170891689|NCT04949841|617609866|FG000|Overall Study|Lack of Efficacy|55|||
170891690|NCT04949841|617609866|FG000|Overall Study|Various reasons|9|||
170474952|NCT00799058|616077604|FG000|Overall Study|IP dispensing error|1|||
170474953|NCT00799058|616077605|FG001|Overall Study|IP dispensing error|0|||
170474954|NCT00799058|616077606|FG002|Overall Study|IP dispensing error|0|||
170474955|NCT00799058|616077604|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
170474956|NCT00799058|616077605|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
170474957|NCT00799058|616077606|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
170474958|NCT00799058|616077604|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
170474959|NCT00799058|616077605|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
170474960|NCT00799058|616077606|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
170474961|NCT00799058|616077604|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
170474962|NCT00799058|616077605|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
170474963|NCT00799058|616077606|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
170474964|NCT00799058|616077604|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
170474965|NCT00799058|616077605|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
170474966|NCT00799058|616077606|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
170474967|NCT03639779|616077613|FG000|Overall Study|Lost to Follow-up|1|||
170474968|NCT02088697|616077618|FG000|Period I|Physician Decision|1|||
170474969|NCT02088697|616077619|FG001|Period I|Physician Decision|4|||
170474970|NCT02088697|616077618|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
170474971|NCT02088697|616077619|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
170474972|NCT02932462|616077620|FG000|Overall Study|Adverse Event|1|||
170474973|NCT02932462|616077621|FG001|Overall Study|Adverse Event|2|||
170474974|NCT02932462|616077620|FG000|Overall Study|Lost to Follow-up|4|||
170474975|NCT02932462|616077621|FG001|Overall Study|Lost to Follow-up|1|||
170474976|NCT02932462|616077620|FG000|Overall Study|Protocol Violation|0|||
170474977|NCT02932462|616077621|FG001|Overall Study|Protocol Violation|5|||
170474978|NCT02932462|616077620|FG000|Overall Study|Withdrawal by Subject|1|||
170474979|NCT02932462|616077621|FG001|Overall Study|Withdrawal by Subject|4|||
170474980|NCT02932462|616077620|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170474981|NCT02932462|616077621|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170474982|NCT02932462|616077620|FG000|Overall Study|Progressive Disease|1|||
170474983|NCT02932462|616077621|FG001|Overall Study|Progressive Disease|0|||
170474984|NCT02413229|616077622|FG000|Overall Study|Adverse Event|0|||
170474985|NCT02413229|616077623|FG001|Overall Study|Adverse Event|0|||
170474986|NCT02413229|616077624|FG002|Overall Study|Adverse Event|0|||
170474987|NCT02413229|616077625|FG003|Overall Study|Adverse Event|1|||
170474988|NCT02413229|616077626|FG004|Overall Study|Adverse Event|0|||
170637984|NCT00373113|616686695|FG000|Overall Study|Other|14|||
170891691|NCT05702736|617609867|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
170891692|NCT05702736|617609868|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
170891693|NCT05702736|617609867|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
170891694|NCT05702736|617609868|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
170891695|NCT01462266|617609872|FG000|Overall Study|Adverse Event|7|||
170891696|NCT01462266|617609873|FG001|Overall Study|Adverse Event|6|||
170891697|NCT01462266|617609872|FG000|Overall Study|Death|2|||
170891698|NCT01462266|617609873|FG001|Overall Study|Death|1|||
170474989|NCT02413229|616077627|FG005|Overall Study|Adverse Event|0|||
170474990|NCT02413229|616077628|FG006|Overall Study|Adverse Event|0|||
170474991|NCT02413229|616077629|FG007|Overall Study|Adverse Event|1|||
170474992|NCT02413229|616077622|FG000|Overall Study|Lost to Follow-up|0|||
170474993|NCT02413229|616077623|FG001|Overall Study|Lost to Follow-up|0|||
170474994|NCT02413229|616077624|FG002|Overall Study|Lost to Follow-up|1|||
170474995|NCT02413229|616077625|FG003|Overall Study|Lost to Follow-up|0|||
170474996|NCT02413229|616077626|FG004|Overall Study|Lost to Follow-up|2|||
170474997|NCT02413229|616077627|FG005|Overall Study|Lost to Follow-up|0|||
170474998|NCT02413229|616077628|FG006|Overall Study|Lost to Follow-up|0|||
170545867|NCT02593864|616342785|FG000|Overall Study|Withdrawal by Subject|3|||
170545868|NCT02593864|616342785|FG000|Overall Study|Lost to Follow-up|3|||
170545869|NCT03828383|616342793|FG000|Overall Study|Lost to Follow-up|3|||
170545870|NCT03828383|616342794|FG001|Overall Study|Lost to Follow-up|2|||
170545871|NCT03828383|616342793|FG000|Overall Study|Withdrawal by Subject|4|||
170545872|NCT03828383|616342794|FG001|Overall Study|Withdrawal by Subject|5|||
170545873|NCT00441896|616342799|FG000|Overall Study|Withdrawal by Subject|0|||
170545874|NCT00441896|616342800|FG001|Overall Study|Withdrawal by Subject|0|||
170545875|NCT00441896|616342801|FG002|Overall Study|Withdrawal by Subject|0|||
170545876|NCT00441896|616342802|FG003|Overall Study|Withdrawal by Subject|1|||
170545877|NCT00441896|616342803|FG004|Overall Study|Withdrawal by Subject|0|||
170545878|NCT00441896|616342804|FG005|Overall Study|Withdrawal by Subject|0|||
170545879|NCT00441896|616342805|FG006|Overall Study|Withdrawal by Subject|0|||
170545880|NCT00441896|616342806|FG007|Overall Study|Withdrawal by Subject|0|||
170545881|NCT00441896|616342807|FG008|Overall Study|Withdrawal by Subject|0|||
170545882|NCT00441896|616342808|FG009|Overall Study|Withdrawal by Subject|0|||
170545883|NCT00441896|616342799|FG000|Overall Study|Other|0|||
170545884|NCT00441896|616342800|FG001|Overall Study|Other|0|||
170545885|NCT00441896|616342801|FG002|Overall Study|Other|0|||
170545886|NCT00441896|616342802|FG003|Overall Study|Other|0|||
170545887|NCT00441896|616342803|FG004|Overall Study|Other|1|||
170545888|NCT00441896|616342804|FG005|Overall Study|Other|0|||
170545889|NCT00441896|616342805|FG006|Overall Study|Other|0|||
170545890|NCT00441896|616342806|FG007|Overall Study|Other|0|||
170545891|NCT00441896|616342807|FG008|Overall Study|Other|0|||
170545892|NCT00441896|616342808|FG009|Overall Study|Other|0|||
170545893|NCT01033071|616342809|FG000|Overall Study|Adverse Event|28|||
170545894|NCT01033071|616342810|FG001|Overall Study|Adverse Event|51|||
170545895|NCT01033071|616342811|FG002|Overall Study|Adverse Event|26|||
170545896|NCT01033071|616342809|FG000|Overall Study|Protocol Violation|0|||
170545897|NCT01033071|616342810|FG001|Overall Study|Protocol Violation|2|||
170545898|NCT01033071|616342811|FG002|Overall Study|Protocol Violation|1|||
170545899|NCT01033071|616342809|FG000|Overall Study|Lost to Follow-up|4|||
170545900|NCT01033071|616342810|FG001|Overall Study|Lost to Follow-up|5|||
170545901|NCT01033071|616342811|FG002|Overall Study|Lost to Follow-up|5|||
170545902|NCT01033071|616342809|FG000|Overall Study|Withdrawal by Subject|17|||
170545903|NCT01033071|616342810|FG001|Overall Study|Withdrawal by Subject|14|||
170545904|NCT01033071|616342811|FG002|Overall Study|Withdrawal by Subject|11|||
170545905|NCT01033071|616342809|FG000|Overall Study|Lack of Efficacy|0|||
170545906|NCT01033071|616342810|FG001|Overall Study|Lack of Efficacy|1|||
170545907|NCT01033071|616342811|FG002|Overall Study|Lack of Efficacy|1|||
170545908|NCT01033071|616342809|FG000|Overall Study|Other|6|||
170545909|NCT01033071|616342810|FG001|Overall Study|Other|4|||
170545910|NCT01033071|616342811|FG002|Overall Study|Other|3|||
170474999|NCT02413229|616077629|FG007|Overall Study|Lost to Follow-up|0|||
170475000|NCT02413229|616077622|FG000|Overall Study|Withdrawal by Subject|1|||
170545911|NCT01027416|616343918|FG000|Overall Study|Withdrawal by Subject|0|||
170545912|NCT01027416|616343919|FG001|Overall Study|Withdrawal by Subject|1|||
170545913|NCT01027416|616343918|FG000|Overall Study|Physician Decision|1|||
170545914|NCT01027416|616343919|FG001|Overall Study|Physician Decision|4|||
170545915|NCT00421733|616343920|FG000|Overall Study|Adverse Event|4|||
170545916|NCT00421733|616343921|FG001|Overall Study|Adverse Event|9|||
170545917|NCT00421733|616343922|FG002|Overall Study|Adverse Event|2|||
170545918|NCT00421733|616343920|FG000|Overall Study|Lost to Follow-up|1|||
170545919|NCT00421733|616343921|FG001|Overall Study|Lost to Follow-up|2|||
170545920|NCT00421733|616343922|FG002|Overall Study|Lost to Follow-up|4|||
170545921|NCT00421733|616343920|FG000|Overall Study|Withdrawal by Subject|1|||
170545922|NCT00421733|616343921|FG001|Overall Study|Withdrawal by Subject|2|||
170545923|NCT00421733|616343922|FG002|Overall Study|Withdrawal by Subject|7|||
170545924|NCT00421733|616343920|FG000|Overall Study|Death|0|||
170545925|NCT00421733|616343921|FG001|Overall Study|Death|3|||
170545926|NCT00421733|616343922|FG002|Overall Study|Death|0|||
170475001|NCT02413229|616077623|FG001|Overall Study|Withdrawal by Subject|1|||
170475002|NCT02413229|616077624|FG002|Overall Study|Withdrawal by Subject|0|||
170475003|NCT02413229|616077625|FG003|Overall Study|Withdrawal by Subject|0|||
170475004|NCT02413229|616077626|FG004|Overall Study|Withdrawal by Subject|1|||
170475005|NCT02413229|616077627|FG005|Overall Study|Withdrawal by Subject|0|||
170475006|NCT02413229|616077628|FG006|Overall Study|Withdrawal by Subject|0|||
170475007|NCT02413229|616077629|FG007|Overall Study|Withdrawal by Subject|2|||
170475008|NCT02413229|616077622|FG000|Overall Study|Progressive Disease|0|||
170475009|NCT02413229|616077623|FG001|Overall Study|Progressive Disease|0|||
170475010|NCT02413229|616077624|FG002|Overall Study|Progressive Disease|0|||
170475011|NCT02413229|616077625|FG003|Overall Study|Progressive Disease|0|||
170475012|NCT02413229|616077626|FG004|Overall Study|Progressive Disease|0|||
170475013|NCT02413229|616077627|FG005|Overall Study|Progressive Disease|0|||
170475014|NCT02413229|616077628|FG006|Overall Study|Progressive Disease|0|||
170475015|NCT02413229|616077629|FG007|Overall Study|Progressive Disease|1|||
170475016|NCT01995513|616077630|FG000|Period 1: First Open Label Treatment|Other|34|||
170475017|NCT01995513|616077631|FG001|Period 1: First Open Label Treatment|Other|0|||
170475018|NCT01995513|616077632|FG002|Period 1: First Open Label Treatment|Other|0|||
170475019|NCT01995513|616077633|FG003|Period 1: First Open Label Treatment|Other|0|||
170475020|NCT01995513|616077630|FG000|Period 1: First Open Label Treatment|Death|14|||
170475021|NCT01995513|616077631|FG001|Period 1: First Open Label Treatment|Death|0|||
170475022|NCT01995513|616077632|FG002|Period 1: First Open Label Treatment|Death|0|||
170475023|NCT01995513|616077633|FG003|Period 1: First Open Label Treatment|Death|0|||
170475024|NCT01995513|616077630|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
170475025|NCT01995513|616077631|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
170475026|NCT01995513|616077632|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
170475027|NCT01995513|616077633|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
170475028|NCT01995513|616077630|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
170475029|NCT01995513|616077631|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
170475030|NCT01995513|616077632|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
170475031|NCT01995513|616077633|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
170475032|NCT01995513|616077630|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
170475033|NCT01995513|616077631|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
170475034|NCT01995513|616077632|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
170475035|NCT01995513|616077633|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
170475036|NCT01995513|616077630|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
170475037|NCT01995513|616077631|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
170475038|NCT01995513|616077632|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
170475039|NCT01995513|616077633|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
170475040|NCT01995513|616077630|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
170475041|NCT01995513|616077631|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
170475042|NCT01995513|616077632|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
170475043|NCT01995513|616077633|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
170475044|NCT01995513|616077630|FG000|Period 1: Second Open Label Treatment|Other|0|||
170475045|NCT01995513|616077631|FG001|Period 1: Second Open Label Treatment|Other|2|||
170475046|NCT01995513|616077632|FG002|Period 1: Second Open Label Treatment|Other|0|||
170475047|NCT01995513|616077633|FG003|Period 1: Second Open Label Treatment|Other|0|||
170475048|NCT01995513|616077630|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
170475049|NCT01995513|616077631|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
170475050|NCT01995513|616077632|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
170475051|NCT01995513|616077633|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
170475052|NCT01995513|616077630|FG000|Period 2: Double Blind Treatment|Death|0|||
170475053|NCT01995513|616077631|FG001|Period 2: Double Blind Treatment|Death|0|||
170475054|NCT01995513|616077632|FG002|Period 2: Double Blind Treatment|Death|0|||
170475055|NCT01995513|616077633|FG003|Period 2: Double Blind Treatment|Death|1|||
170475056|NCT01995513|616077630|FG000|Period 2: Double Blind Treatment|Other|0|||
170475057|NCT01995513|616077631|FG001|Period 2: Double Blind Treatment|Other|0|||
170545927|NCT00421733|616343920|FG000|Overall Study|Required dialysis|1|||
170545928|NCT00421733|616343921|FG001|Overall Study|Required dialysis|0|||
170545929|NCT00421733|616343922|FG002|Overall Study|Required dialysis|0|||
170545930|NCT00421733|616343920|FG000|Overall Study|Administrative|2|||
170545931|NCT00421733|616343921|FG001|Overall Study|Administrative|0|||
170792003|NCT02598388|617249363|FG007|Overall Study|Lost to Follow-up|1|||
170792004|NCT02598388|617249364|FG008|Overall Study|Lost to Follow-up|0|||
170792005|NCT02598388|617249365|FG009|Overall Study|Lost to Follow-up|0|||
170792006|NCT02598388|617249366|FG010|Overall Study|Lost to Follow-up|1|||
170792007|NCT02598388|617249367|FG011|Overall Study|Lost to Follow-up|0|||
170792008|NCT02598388|617249356|FG000|Overall Study|Withdrawal by Subject|0|||
170792009|NCT02598388|617249357|FG001|Overall Study|Withdrawal by Subject|0|||
170792010|NCT02598388|617249358|FG002|Overall Study|Withdrawal by Subject|0|||
170891699|NCT01462266|617609872|FG000|Overall Study|Lack of Efficacy|0|||
170637985|NCT00373113|616686696|FG001|Overall Study|Other|17|||
170637986|NCT00373113|616686695|FG000|Overall Study|Protocol Violation|5|||
170475058|NCT01995513|616077632|FG002|Period 2: Double Blind Treatment|Other|3|||
170475059|NCT01995513|616077633|FG003|Period 2: Double Blind Treatment|Other|3|||
170475060|NCT01995513|616077630|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
170475061|NCT01995513|616077631|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
170475062|NCT01995513|616077632|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
170475063|NCT01995513|616077633|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
170475064|NCT01995513|616077630|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
170475065|NCT01995513|616077631|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
170637987|NCT00373113|616686696|FG001|Overall Study|Protocol Violation|1|||
170637988|NCT00373113|616686695|FG000|Overall Study|Withdrawal by Subject|10|||
170637989|NCT00373113|616686696|FG001|Overall Study|Withdrawal by Subject|15|||
170637990|NCT03275350|616686697|FG000|Overall Study|Lost to Follow-up|4|||
170637991|NCT03275350|616686698|FG001|Overall Study|Lost to Follow-up|6|||
170637992|NCT03275350|616686697|FG000|Overall Study|Death|2|||
170637993|NCT03275350|616686698|FG001|Overall Study|Death|1|||
170637994|NCT03275350|616686697|FG000|Overall Study|Physician Decision|1|||
170637995|NCT03275350|616686698|FG001|Overall Study|Physician Decision|0|||
170637996|NCT03275350|616686697|FG000|Overall Study|Incarcerated|1|||
170637997|NCT03275350|616686698|FG001|Overall Study|Incarcerated|1|||
170637998|NCT03830892|616686699|FG000|Overall Study|Physician Decision|2|||
170637999|NCT03830892|616686700|FG001|Overall Study|Physician Decision|3|||
170638000|NCT03830892|616686699|FG000|Overall Study|Study terminated due to COVID|4|||
170638001|NCT03830892|616686700|FG001|Overall Study|Study terminated due to COVID|0|||
170638002|NCT03830892|616686699|FG000|Overall Study|Protocol Violation|0|||
170638003|NCT03830892|616686700|FG001|Overall Study|Protocol Violation|1|||
170638004|NCT03830892|616686699|FG000|Overall Study|Withdrawal by Subject|0|||
170638005|NCT03830892|616686700|FG001|Overall Study|Withdrawal by Subject|2|||
170638006|NCT03656562|616686703|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
170638007|NCT03656562|616686704|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
170638008|NCT03656562|616686705|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
170638009|NCT03656562|616686706|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
170638010|NCT03656562|616686703|FG000|Overall Study|Physician Decision|1|||
170638011|NCT03656562|616686704|FG001|Overall Study|Physician Decision|2|||
170638012|NCT03656562|616686705|FG002|Overall Study|Physician Decision|0|||
170638013|NCT03656562|616686706|FG003|Overall Study|Physician Decision|0|||
170638014|NCT03656562|616686703|FG000|Overall Study|Subject Decision|3|||
170638015|NCT03656562|616686704|FG001|Overall Study|Subject Decision|5|||
170638016|NCT03656562|616686705|FG002|Overall Study|Subject Decision|0|||
170638017|NCT03656562|616686706|FG003|Overall Study|Subject Decision|2|||
170638018|NCT04335136|616686707|FG000|Overall Study|Death|8|||
170638019|NCT04335136|616686708|FG001|Overall Study|Death|4|||
170638020|NCT04335136|616686707|FG000|Overall Study|Lost to Follow-up|2|||
170638021|NCT04335136|616686708|FG001|Overall Study|Lost to Follow-up|0|||
170638022|NCT04335136|616686707|FG000|Overall Study|Protocol Violation|1|||
170638023|NCT04335136|616686708|FG001|Overall Study|Protocol Violation|0|||
170638024|NCT04335136|616686707|FG000|Overall Study|Withdrawal by Subject|1|||
170638025|NCT04335136|616686708|FG001|Overall Study|Withdrawal by Subject|1|||
170638026|NCT04335136|616686707|FG000|Overall Study|Health-threatening condition|0|||
170638027|NCT04335136|616686708|FG001|Overall Study|Health-threatening condition|1|||
170638028|NCT04335136|616686707|FG000|Overall Study|Adverse Event|0|||
170638029|NCT04335136|616686708|FG001|Overall Study|Adverse Event|1|||
170638030|NCT04335136|616686707|FG000|Overall Study|Erroneously randomized|2|||
170638031|NCT04335136|616686708|FG001|Overall Study|Erroneously randomized|0|||
170638032|NCT01396447|616686709|FG000|Overall Study|Did Not Receive Treatment|3|||
170638033|NCT01396447|616686710|FG001|Overall Study|Did Not Receive Treatment|2|||
170638034|NCT01396447|616686711|FG002|Overall Study|Did Not Receive Treatment|1|||
170638035|NCT01396447|616686712|FG003|Overall Study|Did Not Receive Treatment|0|||
170638036|NCT01396447|616686709|FG000|Overall Study|Adverse Event|15|||
170792011|NCT02598388|617249359|FG003|Overall Study|Withdrawal by Subject|0|||
170792012|NCT02598388|617249360|FG004|Overall Study|Withdrawal by Subject|2|||
170792013|NCT02598388|617249361|FG005|Overall Study|Withdrawal by Subject|0|||
170792014|NCT02598388|617249362|FG006|Overall Study|Withdrawal by Subject|2|||
170638037|NCT01396447|616686710|FG001|Overall Study|Adverse Event|12|||
170638038|NCT01396447|616686711|FG002|Overall Study|Adverse Event|12|||
170638039|NCT01396447|616686712|FG003|Overall Study|Adverse Event|17|||
170638040|NCT01396447|616686709|FG000|Overall Study|Insufficient Therapeutic Response|5|||
170638041|NCT01396447|616686710|FG001|Overall Study|Insufficient Therapeutic Response|5|||
170638042|NCT01396447|616686711|FG002|Overall Study|Insufficient Therapeutic Response|2|||
170792015|NCT02598388|617249363|FG007|Overall Study|Withdrawal by Subject|0|||
170792016|NCT02598388|617249364|FG008|Overall Study|Withdrawal by Subject|0|||
170792017|NCT02598388|617249365|FG009|Overall Study|Withdrawal by Subject|1|||
170891700|NCT01462266|617609873|FG001|Overall Study|Lack of Efficacy|2|||
170475066|NCT01995513|616077632|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
170638043|NCT01396447|616686712|FG003|Overall Study|Insufficient Therapeutic Response|4|||
170545932|NCT00421733|616343922|FG002|Overall Study|Administrative|0|||
170545933|NCT00421733|616343920|FG000|Overall Study|Did not satisfy entry criteria|1|||
170545934|NCT00421733|616343921|FG001|Overall Study|Did not satisfy entry criteria|3|||
170545935|NCT00421733|616343922|FG002|Overall Study|Did not satisfy entry criteria|2|||
170545936|NCT00421733|616343920|FG000|Overall Study|Sponsor request|1|||
170545937|NCT00421733|616343921|FG001|Overall Study|Sponsor request|0|||
170545938|NCT00421733|616343922|FG002|Overall Study|Sponsor request|3|||
170545939|NCT00421733|616343920|FG000|Overall Study|Protocol deviation|4|||
170545940|NCT00421733|616343921|FG001|Overall Study|Protocol deviation|7|||
170545941|NCT00421733|616343922|FG002|Overall Study|Protocol deviation|2|||
170545942|NCT02502383|616343925|FG000|Overall Study|Lost to Follow-up|130|||
170545943|NCT02502383|616343926|FG001|Overall Study|Lost to Follow-up|131|||
170545944|NCT02502383|616343925|FG000|Overall Study|Withdrawal by Subject|31|||
170545945|NCT02502383|616343926|FG001|Overall Study|Withdrawal by Subject|24|||
170545946|NCT00676052|616343927|FG000|Overall Study|Adverse Event|0|||
170545947|NCT00676052|616343928|FG001|Overall Study|Adverse Event|1|||
170545948|NCT00676052|616343929|FG002|Overall Study|Adverse Event|1|||
170545949|NCT00676052|616343930|FG003|Overall Study|Adverse Event|2|||
170545950|NCT00676052|616343931|FG004|Overall Study|Adverse Event|2|||
170545951|NCT00676052|616343932|FG005|Overall Study|Adverse Event|2|||
170545952|NCT00676052|616343927|FG000|Overall Study|Lack of Efficacy|2|||
170545953|NCT00676052|616343928|FG001|Overall Study|Lack of Efficacy|2|||
170545954|NCT00676052|616343929|FG002|Overall Study|Lack of Efficacy|1|||
170545955|NCT00676052|616343930|FG003|Overall Study|Lack of Efficacy|1|||
170545956|NCT00676052|616343931|FG004|Overall Study|Lack of Efficacy|2|||
170545957|NCT00676052|616343932|FG005|Overall Study|Lack of Efficacy|1|||
170545958|NCT00676052|616343927|FG000|Overall Study|Protocol Violation|5|||
170545959|NCT00676052|616343928|FG001|Overall Study|Protocol Violation|3|||
170545960|NCT00676052|616343929|FG002|Overall Study|Protocol Violation|2|||
170545961|NCT00676052|616343930|FG003|Overall Study|Protocol Violation|2|||
170545962|NCT00676052|616343931|FG004|Overall Study|Protocol Violation|1|||
170545963|NCT00676052|616343932|FG005|Overall Study|Protocol Violation|2|||
170545964|NCT00676052|616343927|FG000|Overall Study|Lost to Follow-up|0|||
170545965|NCT00676052|616343928|FG001|Overall Study|Lost to Follow-up|0|||
170545966|NCT00676052|616343929|FG002|Overall Study|Lost to Follow-up|0|||
170545967|NCT00676052|616343930|FG003|Overall Study|Lost to Follow-up|0|||
170545968|NCT00676052|616343931|FG004|Overall Study|Lost to Follow-up|1|||
170545969|NCT00676052|616343932|FG005|Overall Study|Lost to Follow-up|0|||
170545970|NCT00676052|616343927|FG000|Overall Study|Physician Decision|1|||
170545971|NCT00676052|616343928|FG001|Overall Study|Physician Decision|1|||
170545972|NCT00676052|616343929|FG002|Overall Study|Physician Decision|1|||
170545973|NCT00676052|616343930|FG003|Overall Study|Physician Decision|0|||
170545974|NCT00676052|616343931|FG004|Overall Study|Physician Decision|0|||
170638044|NCT01396447|616686709|FG000|Overall Study|Protocol Violation|5|||
170638045|NCT01396447|616686710|FG001|Overall Study|Protocol Violation|2|||
170638046|NCT01396447|616686711|FG002|Overall Study|Protocol Violation|3|||
170545975|NCT00676052|616343932|FG005|Overall Study|Physician Decision|1|||
170545976|NCT00676052|616343927|FG000|Overall Study|Withdrawal by Subject|1|||
170545977|NCT00676052|616343928|FG001|Overall Study|Withdrawal by Subject|0|||
170545978|NCT00676052|616343929|FG002|Overall Study|Withdrawal by Subject|1|||
170545979|NCT00676052|616343930|FG003|Overall Study|Withdrawal by Subject|0|||
170545980|NCT00676052|616343931|FG004|Overall Study|Withdrawal by Subject|0|||
170545981|NCT00676052|616343932|FG005|Overall Study|Withdrawal by Subject|0|||
170545982|NCT00875667|616343935|FG000|Overall Study|Adverse Event|29|||
170545983|NCT00875667|616343936|FG001|Overall Study|Adverse Event|10|||
170545984|NCT00875667|616343935|FG000|Overall Study|Withdrawal by Subject|17|||
170545985|NCT00875667|616343936|FG001|Overall Study|Withdrawal by Subject|5|||
170545986|NCT00875667|616343935|FG000|Overall Study|Death|7|||
170545987|NCT00875667|616343936|FG001|Overall Study|Death|2|||
170545988|NCT00875667|616343935|FG000|Overall Study|Protocol Violation|2|||
170545989|NCT00875667|616343936|FG001|Overall Study|Protocol Violation|0|||
170545990|NCT00875667|616343935|FG000|Overall Study|Disease Progression|100|||
170545991|NCT00875667|616343936|FG001|Overall Study|Disease Progression|49|||
170545992|NCT00875667|616343935|FG000|Overall Study|Miscellaneous|12|||
170545993|NCT00875667|616343936|FG001|Overall Study|Miscellaneous|6|||
170545994|NCT00875667|616343935|FG000|Overall Study|Randomized but no Study Drug Given|3|||
170545995|NCT00875667|616343936|FG001|Overall Study|Randomized but no Study Drug Given|1|||
170545996|NCT00120250|616343937|FG000|Overall Study|Lost to Follow-up|1|||
170545997|NCT00120250|616343938|FG001|Overall Study|Lost to Follow-up|1|||
170545998|NCT00120250|616343937|FG000|Overall Study|Protocol Violation|0|||
170545999|NCT00120250|616343938|FG001|Overall Study|Protocol Violation|1|||
170546000|NCT01964560|616343941|FG000|Overall Study|Adverse Event|23|||
170546001|NCT01964560|616343941|FG000|Overall Study|Lack of Efficacy|46|||
170546002|NCT01964560|616343941|FG000|Overall Study|Protocol deviation|2|||
170546003|NCT01964560|616343941|FG000|Overall Study|Lost to Follow-up|4|||
170546004|NCT01964560|616343941|FG000|Overall Study|Withdrawal by Subject|64|||
170546005|NCT01964560|616343941|FG000|Overall Study|Surgery-hemispherotomy|1|||
170546006|NCT01964560|616343941|FG000|Overall Study|Surgery|1|||
170638047|NCT01396447|616686712|FG003|Overall Study|Protocol Violation|7|||
170638048|NCT01396447|616686709|FG000|Overall Study|Withdrawal of Consent|11|||
170638049|NCT01396447|616686710|FG001|Overall Study|Withdrawal of Consent|9|||
170638050|NCT01396447|616686711|FG002|Overall Study|Withdrawal of Consent|4|||
170638051|NCT01396447|616686712|FG003|Overall Study|Withdrawal of Consent|15|||
170638052|NCT01396447|616686709|FG000|Overall Study|Lost to Follow-up|4|||
170638053|NCT01396447|616686710|FG001|Overall Study|Lost to Follow-up|8|||
170638054|NCT01396447|616686711|FG002|Overall Study|Lost to Follow-up|7|||
170638055|NCT01396447|616686712|FG003|Overall Study|Lost to Follow-up|9|||
170638056|NCT01396447|616686709|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170638057|NCT01396447|616686710|FG001|Overall Study|Other Miscellaneous Reasons|2|||
170638058|NCT01396447|616686711|FG002|Overall Study|Other Miscellaneous Reasons|1|||
170638059|NCT01396447|616686712|FG003|Overall Study|Other Miscellaneous Reasons|0|||
170638060|NCT01402102|616686715|FG000|Overall Study|Protocol Violation|1|||
170475067|NCT01995513|616077633|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
170475068|NCT01995513|616077630|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
170475069|NCT01995513|616077631|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
170475070|NCT01995513|616077632|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
170475071|NCT01995513|616077633|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
170475072|NCT01995513|616077630|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
170475073|NCT01995513|616077631|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
170475074|NCT01995513|616077632|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
170475075|NCT01995513|616077633|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
170475076|NCT04108299|616077635|FG000|Overall Study|Not interested in participating|2|||
170475077|NCT04108299|616077636|FG001|Overall Study|Not interested in participating|1|||
170475078|NCT04108299|616077637|FG002|Overall Study|Not interested in participating|2|||
170475079|NCT04108299|616077638|FG003|Overall Study|Not interested in participating|1|||
170475080|NCT05024747|616077642|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
170475081|NCT05024747|616077643|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
170475082|NCT05024747|616077642|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
170475083|NCT05024747|616077643|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
170475084|NCT05024747|616077642|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
170475085|NCT05024747|616077643|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
170475086|NCT02287922|616077650|FG000|Overall Study|Adverse Event|1|||
170475087|NCT02287922|616077651|FG001|Overall Study|Adverse Event|1|||
170475088|NCT02287922|616077652|FG002|Overall Study|Adverse Event|3|||
170475089|NCT02287922|616077653|FG003|Overall Study|Adverse Event|4|||
170475090|NCT02287922|616077650|FG000|Overall Study|Withdrawal by Subject|1|||
170475091|NCT02287922|616077651|FG001|Overall Study|Withdrawal by Subject|1|||
170475092|NCT02287922|616077652|FG002|Overall Study|Withdrawal by Subject|1|||
170475093|NCT02287922|616077653|FG003|Overall Study|Withdrawal by Subject|2|||
170475094|NCT02287922|616077650|FG000|Overall Study|Lost to Follow-up|0|||
170475095|NCT02287922|616077651|FG001|Overall Study|Lost to Follow-up|0|||
170475096|NCT02287922|616077652|FG002|Overall Study|Lost to Follow-up|1|||
170475097|NCT02287922|616077653|FG003|Overall Study|Lost to Follow-up|0|||
170475098|NCT02287922|616077650|FG000|Overall Study|Sponsor's decision|0|||
170475099|NCT02287922|616077651|FG001|Overall Study|Sponsor's decision|0|||
170475100|NCT02287922|616077652|FG002|Overall Study|Sponsor's decision|0|||
170475101|NCT02287922|616077653|FG003|Overall Study|Sponsor's decision|1|||
170475102|NCT02287922|616077650|FG000|Overall Study|Other|1|||
170475103|NCT02287922|616077651|FG001|Overall Study|Other|0|||
170475104|NCT02287922|616077652|FG002|Overall Study|Other|2|||
170475105|NCT02287922|616077653|FG003|Overall Study|Other|0|||
170475106|NCT00322712|616077658|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
170475107|NCT01342081|616077659|FG000|Overall Study|Did not receive allocated intervention|0|||
170475108|NCT01342081|616077660|FG001|Overall Study|Did not receive allocated intervention|0|||
170475109|NCT01342081|616077661|FG002|Overall Study|Did not receive allocated intervention|1|||
170475110|NCT01342081|616077659|FG000|Overall Study|Adverse Event|1|||
170475111|NCT01342081|616077660|FG001|Overall Study|Adverse Event|0|||
170475112|NCT01342081|616077661|FG002|Overall Study|Adverse Event|0|||
170475113|NCT01342081|616077659|FG000|Overall Study|Physician Decision|0|||
170475114|NCT01342081|616077660|FG001|Overall Study|Physician Decision|1|||
170475115|NCT01342081|616077661|FG002|Overall Study|Physician Decision|0|||
170475116|NCT01342081|616077659|FG000|Overall Study|Withdrawal by Subject|1|||
170475117|NCT01342081|616077660|FG001|Overall Study|Withdrawal by Subject|1|||
170475118|NCT01342081|616077661|FG002|Overall Study|Withdrawal by Subject|0|||
170475119|NCT01431079|616077663|FG000|Overall Study|Lost to Follow-up|35|||
170475120|NCT01431079|616077664|FG001|Overall Study|Lost to Follow-up|39|||
170475121|NCT04688671|616077668|FG000|Overall Study|Adverse Event|3|||
170475122|NCT04688671|616077669|FG001|Overall Study|Adverse Event|1|||
170475123|NCT04688671|616077668|FG000|Overall Study|Withdrawal by Subject|3|||
170475124|NCT04688671|616077669|FG001|Overall Study|Withdrawal by Subject|1|||
170475125|NCT04688671|616077668|FG000|Overall Study|Lack of Efficacy|1|||
170638061|NCT01402102|616686716|FG001|Overall Study|Protocol Violation|0|||
170792018|NCT02598388|617249366|FG010|Overall Study|Withdrawal by Subject|0|||
170792019|NCT02598388|617249367|FG011|Overall Study|Withdrawal by Subject|0|||
170792020|NCT02598388|617249356|FG000|Overall Study|Other|0|||
170792021|NCT02598388|617249357|FG001|Overall Study|Other|0|||
170792022|NCT02598388|617249358|FG002|Overall Study|Other|1|||
170792023|NCT02598388|617249359|FG003|Overall Study|Other|0|||
170792024|NCT02598388|617249360|FG004|Overall Study|Other|3|||
170792025|NCT02598388|617249361|FG005|Overall Study|Other|0|||
170792026|NCT02598388|617249362|FG006|Overall Study|Other|1|||
170792027|NCT02598388|617249363|FG007|Overall Study|Other|0|||
170792028|NCT02598388|617249364|FG008|Overall Study|Other|0|||
170792029|NCT02598388|617249365|FG009|Overall Study|Other|0|||
170792030|NCT02598388|617249366|FG010|Overall Study|Other|0|||
170792031|NCT02598388|617249367|FG011|Overall Study|Other|0|||
170792032|NCT04914676|617249379|FG000|Overall Study|Study termination|3|||
170792033|NCT04914676|617249380|FG001|Overall Study|Study termination|0|||
170792034|NCT04054193|617249381|FG000|Cycle 1|Physician Decision|1|||
170792035|NCT04054193|617249381|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
170792036|NCT04054193|617249381|FG000|Cycle 1|Allocated but not treated|3|||
170792037|NCT04054193|617249381|FG000|Cycles 2-3|Physician Decision|2|||
170792038|NCT04054193|617249381|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
170792039|NCT04054193|617249381|FG000|Cycles 2-3|Various reasons|17|||
170792040|NCT03235544|617249382|FG000|Overall Study|Death|11|||
170792041|NCT03235544|617249383|FG001|Overall Study|Death|31|||
170792042|NCT03235544|617249384|FG002|Overall Study|Death|19|||
170792043|NCT03235544|617249385|FG003|Overall Study|Death|34|||
170792044|NCT03235544|617249382|FG000|Overall Study|Lost to Follow-up|0|||
170792045|NCT03235544|617249383|FG001|Overall Study|Lost to Follow-up|1|||
170792046|NCT03235544|617249384|FG002|Overall Study|Lost to Follow-up|1|||
170792047|NCT03235544|617249385|FG003|Overall Study|Lost to Follow-up|1|||
170792048|NCT03235544|617249382|FG000|Overall Study|Withdrawal by Subject|0|||
170792049|NCT03235544|617249383|FG001|Overall Study|Withdrawal by Subject|3|||
170792050|NCT03235544|617249384|FG002|Overall Study|Withdrawal by Subject|1|||
170792051|NCT03235544|617249385|FG003|Overall Study|Withdrawal by Subject|5|||
170792052|NCT03235544|617249382|FG000|Overall Study|Disease Progression|0|||
170792053|NCT03235544|617249383|FG001|Overall Study|Disease Progression|1|||
170792054|NCT03235544|617249384|FG002|Overall Study|Disease Progression|0|||
170792055|NCT03235544|617249385|FG003|Overall Study|Disease Progression|2|||
170792056|NCT03235544|617249382|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
170792057|NCT03235544|617249383|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
170792058|NCT03235544|617249384|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
170792059|NCT03235544|617249385|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
170475126|NCT04688671|616077669|FG001|Overall Study|Lack of Efficacy|1|||
170475127|NCT04688671|616077668|FG000|Overall Study|Protocol Violation|1|||
170475128|NCT04688671|616077669|FG001|Overall Study|Protocol Violation|0|||
170475129|NCT04688671|616077668|FG000|Overall Study|Lost to Follow-up|0|||
170475130|NCT04688671|616077669|FG001|Overall Study|Lost to Follow-up|1|||
170475131|NCT04720053|616077670|FG000|Overall Study|Lost to Follow-up|12|||
170475132|NCT01942993|616077671|FG000|Overall Study|Lost to Follow-up|1|||
170475133|NCT01942993|616077671|FG000|Overall Study|Physician Decision|1|||
170792060|NCT03235544|617249382|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
170792061|NCT03235544|617249383|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
170792062|NCT03235544|617249384|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
170792063|NCT03235544|617249385|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
170792064|NCT00950742|617249386|FG000|Overall Study|Other Adverse Event|1|||
170792065|NCT00950742|617249387|FG001|Overall Study|Other Adverse Event|0|||
170792066|NCT00950742|617249386|FG000|Overall Study|Withdrawal by Subject|3|||
170792067|NCT00950742|617249387|FG001|Overall Study|Withdrawal by Subject|0|||
170792068|NCT00950742|617249386|FG000|Overall Study|Progressive Disease|6|||
170792069|NCT00950742|617249387|FG001|Overall Study|Progressive Disease|2|||
170792070|NCT00950742|617249386|FG000|Overall Study|Dose limiting toxicity|6|||
170792071|NCT00950742|617249387|FG001|Overall Study|Dose limiting toxicity|0|||
170475134|NCT03749330|616077675|FG000|Overall Study|Clinicians left work in the CICU|0|||
170792072|NCT00696111|617249388|FG000|Overall Study|Withdrawal by Subject|17|||
170792073|NCT05436262|617249389|FG000|Pre-Randomization|Withdrawal by Subject|1|||
170792074|NCT05436262|617249390|FG001|Pre-Randomization|Withdrawal by Subject|0|||
170792075|NCT05436262|617249391|FG002|Pre-Randomization|Withdrawal by Subject|0|||
170792076|NCT05436262|617249389|FG000|Randomization|Withdrawal by Subject|0|||
170792077|NCT05436262|617249390|FG001|Randomization|Withdrawal by Subject|1|||
170792078|NCT05436262|617249391|FG002|Randomization|Withdrawal by Subject|0|||
170792079|NCT05299073|617249392|FG000|Overall Study|Withdrawal by Subject|0|||
170475135|NCT03749330|616077676|FG001|Overall Study|Clinicians left work in the CICU|2|||
170792080|NCT05299073|617249393|FG001|Overall Study|Withdrawal by Subject|0|||
170792081|NCT05299073|617249394|FG002|Overall Study|Withdrawal by Subject|1|||
170638062|NCT01402102|616686715|FG000|Overall Study|Insufficiency of compliance|1|||
170638063|NCT01402102|616686716|FG001|Overall Study|Insufficiency of compliance|1|||
170638064|NCT01402102|616686715|FG000|Overall Study|Withdrawal by Subject|0|||
170638065|NCT01402102|616686716|FG001|Overall Study|Withdrawal by Subject|2|||
170475136|NCT03749330|616077677|FG002|Overall Study|Clinicians left work in the CICU|0|||
170475137|NCT03749330|616077678|FG003|Overall Study|Clinicians left work in the CICU|0|||
170475138|NCT03749330|616077679|FG004|Overall Study|Clinicians left work in the CICU|0|||
170475139|NCT03749330|616077680|FG005|Overall Study|Clinicians left work in the CICU|0|||
170475140|NCT01973439|616077681|FG000|Overall Study|Lost samples from one PK Day|2|||
170475141|NCT01973439|616077681|FG000|Overall Study|Vomiting after commencing once daily|1|||
170475142|NCT01973439|616077681|FG000|Overall Study|PK curve incomplete|2|||
170475143|NCT02038010|616077685|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
170475144|NCT02038010|616077686|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
170475145|NCT02038010|616077687|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
170475146|NCT02038010|616077688|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
170475147|NCT02038010|616077685|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
170475148|NCT02038010|616077686|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
170475149|NCT02038010|616077687|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
170475150|NCT02038010|616077688|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
170475151|NCT02038010|616077685|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
170475152|NCT02038010|616077686|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
170475153|NCT02038010|616077687|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
170475154|NCT02038010|616077688|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
170475155|NCT02038010|616077685|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
170475156|NCT02038010|616077686|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
170475157|NCT02038010|616077687|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
170475158|NCT02038010|616077688|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
170475159|NCT02038010|616077685|FG000|Follow Up|Death|4|||
170475160|NCT02038010|616077686|FG001|Follow Up|Death|3|||
170475161|NCT02038010|616077687|FG002|Follow Up|Death|0|||
170475162|NCT02038010|616077688|FG003|Follow Up|Death|0|||
170475163|NCT02038010|616077685|FG000|Follow Up|Other|3|||
170475164|NCT02038010|616077686|FG001|Follow Up|Other|0|||
170475165|NCT02038010|616077687|FG002|Follow Up|Other|0|||
170475166|NCT02038010|616077688|FG003|Follow Up|Other|0|||
170475167|NCT02105467|616077689|FG000|Period 1|Lost to Follow-up|1|||
170475168|NCT02105467|616077690|FG001|Period 1|Lost to Follow-up|0|||
170475169|NCT02105467|616077689|FG000|Period 1|Death|1|||
170475170|NCT02105467|616077690|FG001|Period 1|Death|0|||
170475171|NCT02105467|616077689|FG000|Period 2|Lost to Follow-up|1|||
170475172|NCT02105467|616077690|FG001|Period 2|Lost to Follow-up|0|||
170475173|NCT02105467|616077689|FG000|Period 2|Death|1|||
170475174|NCT02105467|616077690|FG001|Period 2|Death|0|||
170475175|NCT02105467|616077689|FG000|Period 2|Withdrawal by Subject|0|||
170475176|NCT02105467|616077690|FG001|Period 2|Withdrawal by Subject|2|||
170475177|NCT02105467|616077689|FG000|Period 3|Lost to Follow-up|0|||
170475178|NCT02105467|616077690|FG001|Period 3|Lost to Follow-up|1|||
170475179|NCT03908125|616077691|FG000|Overall Study|Withdrawal by Subject|92|||
170475180|NCT03908125|616077691|FG000|Overall Study|Lost to Follow-up|8|||
170475181|NCT02815995|616077692|FG000|Overall Study|Disease Progression|3|||
170475182|NCT02815995|616077693|FG001|Overall Study|Disease Progression|7|||
170475183|NCT02815995|616077694|FG002|Overall Study|Disease Progression|2|||
170475184|NCT02815995|616077695|FG003|Overall Study|Disease Progression|4|||
170475185|NCT02815995|616077696|FG004|Overall Study|Disease Progression|3|||
170475186|NCT02815995|616077697|FG005|Overall Study|Disease Progression|9|||
170475187|NCT02815995|616077698|FG006|Overall Study|Disease Progression|3|||
170475188|NCT02815995|616077699|FG007|Overall Study|Disease Progression|1|||
170475189|NCT02815995|616077692|FG000|Overall Study|Adverse Event|1|||
170475190|NCT02815995|616077693|FG001|Overall Study|Adverse Event|2|||
170475191|NCT02815995|616077694|FG002|Overall Study|Adverse Event|2|||
170475192|NCT02815995|616077695|FG003|Overall Study|Adverse Event|0|||
170638066|NCT03534180|616686717|FG000|Overall Study|Withdrawal by Subject|1|||
170638067|NCT00330967|616686718|FG000|Overall Study|Withdrawal by Subject|0|||
170475193|NCT02815995|616077696|FG004|Overall Study|Adverse Event|0|||
170475194|NCT02815995|616077697|FG005|Overall Study|Adverse Event|1|||
170475195|NCT02815995|616077698|FG006|Overall Study|Adverse Event|0|||
170475196|NCT02815995|616077699|FG007|Overall Study|Adverse Event|0|||
170475197|NCT02815995|616077692|FG000|Overall Study|Pregnancy|0|||
170475198|NCT02815995|616077693|FG001|Overall Study|Pregnancy|0|||
170475199|NCT02815995|616077694|FG002|Overall Study|Pregnancy|0|||
170475200|NCT02815995|616077695|FG003|Overall Study|Pregnancy|0|||
170475201|NCT02815995|616077696|FG004|Overall Study|Pregnancy|0|||
170475202|NCT02815995|616077697|FG005|Overall Study|Pregnancy|0|||
170475203|NCT02815995|616077698|FG006|Overall Study|Pregnancy|1|||
170475204|NCT02815995|616077699|FG007|Overall Study|Pregnancy|0|||
170475205|NCT01071915|616077700|FG000|Overall Study|Adverse Event|3|||
170475206|NCT01071915|616077700|FG000|Overall Study|Physician Decision|2|||
170475207|NCT01071915|616077700|FG000|Overall Study|Withdrawal by Subject|2|||
170475208|NCT01071915|616077700|FG000|Overall Study|Miscellaneous Reasons|2|||
170475209|NCT00811733|616077705|FG000|Overall Study|Investigator Discretion|10|||
170475210|NCT00811733|616077706|FG001|Overall Study|Investigator Discretion|8|||
170475211|NCT00811733|616077705|FG000|Overall Study|Withdrawal by Subject|1|||
170475212|NCT00811733|616077706|FG001|Overall Study|Withdrawal by Subject|2|||
170475213|NCT00793871|616077707|FG000|Overall Study|Death|50|||
170475214|NCT00793871|616077707|FG000|Overall Study|Lost to Follow-up|3|||
170475215|NCT00793871|616077707|FG000|Overall Study|Study terminated by the Sponsor|7|||
170475216|NCT02500589|616077708|FG000|Overall Study|Withdrawal by Subject|11|||
170475217|NCT02500589|616077709|FG001|Overall Study|Withdrawal by Subject|14|||
170475218|NCT02500589|616077708|FG000|Overall Study|Lost to Follow-up|10|||
170475219|NCT02500589|616077709|FG001|Overall Study|Lost to Follow-up|12|||
170475220|NCT02500589|616077708|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
170475221|NCT02500589|616077709|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
170475222|NCT02500589|616077708|FG000|Overall Study|Death|7|||
170475223|NCT02500589|616077709|FG001|Overall Study|Death|5|||
170475224|NCT00344448|616077718|FG000|Screening|Withdrawal by Subject|0|||
170475225|NCT00344448|616077719|FG001|Screening|Withdrawal by Subject|1|||
170475226|NCT00344448|616077718|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
170475227|NCT00344448|616077719|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
170475228|NCT00344448|616077718|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
170475229|NCT00344448|616077719|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
170475230|NCT00344448|616077718|FG000|Open Label|Withdrawal by Subject|1|||
170475231|NCT00344448|616077719|FG001|Open Label|Withdrawal by Subject|1|||
170546007|NCT01964560|616343941|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
170546008|NCT01964560|616343941|FG000|Overall Study|Patient and Investigator choice|1|||
170546009|NCT01964560|616343941|FG000|Overall Study|Patient was prescribed CBD|1|||
170546010|NCT01964560|616343941|FG000|Overall Study|Participant moved to another country|1|||
170546011|NCT02217982|616343947|FG000|Overall Study|Trial discontinued|1|||
170546012|NCT02217982|616343948|FG001|Overall Study|Trial discontinued|0|||
170546013|NCT02217982|616343947|FG000|Overall Study|Adverse Event|0|||
170546014|NCT02217982|616343948|FG001|Overall Study|Adverse Event|1|||
170546015|NCT03791060|616343951|FG000|Overall Study|Withdrawal by Subject|1|||
170546016|NCT00997126|616343952|FG000|Overall Study|Physician Decision|7|||
170546017|NCT00997126|616343953|FG001|Overall Study|Physician Decision|11|||
170546018|NCT01011283|616343954|FG000|Overall Study|Adverse Event|4|||
170546019|NCT01011283|616343955|FG001|Overall Study|Adverse Event|2|||
170546020|NCT01011283|616343954|FG000|Overall Study|Progressive Disease|0|||
170546021|NCT01011283|616343955|FG001|Overall Study|Progressive Disease|2|||
170546022|NCT01011283|616343954|FG000|Overall Study|Terminated by Sponsor|5|||
170546023|NCT01011283|616343955|FG001|Overall Study|Terminated by Sponsor|5|||
170546024|NCT01011283|616343954|FG000|Overall Study|Other|2|||
170546025|NCT01011283|616343955|FG001|Overall Study|Other|2|||
170546026|NCT01755637|616343957|FG000|Period 1|Adverse Event|0|||
170546027|NCT01755637|616343958|FG001|Period 1|Adverse Event|1|||
170546028|NCT01814332|616343959|FG000|Overall Study|Adverse Event|8|||
170546029|NCT01814332|616343960|FG001|Overall Study|Adverse Event|3|||
170546030|NCT01814332|616343959|FG000|Overall Study|Withdrawal by Subject|3|||
170546031|NCT01814332|616343960|FG001|Overall Study|Withdrawal by Subject|8|||
170546032|NCT01814332|616343959|FG000|Overall Study|Protocol Violation|0|||
170546033|NCT01814332|616343960|FG001|Overall Study|Protocol Violation|4|||
170546034|NCT01814332|616343959|FG000|Overall Study|Lost to Follow-up|5|||
170546035|NCT01814332|616343960|FG001|Overall Study|Lost to Follow-up|1|||
170546036|NCT04389671|616343963|FG000|Overall Study|Death|7|||
170546037|NCT03338023|616343964|FG000|Overall Study|Withdrawal by Subject|3|||
170546038|NCT03338023|616343965|FG001|Overall Study|Withdrawal by Subject|4|||
170546039|NCT03338023|616343964|FG000|Overall Study|Protocol Violation|3|||
170546040|NCT03338023|616343965|FG001|Overall Study|Protocol Violation|3|||
170546041|NCT03338023|616343964|FG000|Overall Study|Lost to Follow-up|2|||
170792082|NCT05299073|617249392|FG000|Overall Study|Adverse Event|0|||
170792083|NCT05299073|617249393|FG001|Overall Study|Adverse Event|1|||
170546042|NCT03338023|616343965|FG001|Overall Study|Lost to Follow-up|1|||
170792084|NCT05299073|617249394|FG002|Overall Study|Adverse Event|0|||
170792085|NCT05299073|617249392|FG000|Overall Study|Lost to Follow-up|0|||
170792086|NCT05299073|617249393|FG001|Overall Study|Lost to Follow-up|1|||
170475232|NCT00344448|616077718|FG000|Open Label|Study terminated|1|||
170546043|NCT03338023|616343964|FG000|Overall Study|Physician Decision|1|||
170546044|NCT03338023|616343965|FG001|Overall Study|Physician Decision|2|||
170546045|NCT01279200|616343966|FG000|Overall Study|Withdrawal by Subject|1|||
170546046|NCT01279200|616343967|FG001|Overall Study|Withdrawal by Subject|3|||
170546047|NCT01279200|616343966|FG000|Overall Study|Patient withdrawal due to high cost|0|||
170475233|NCT00344448|616077719|FG001|Open Label|Study terminated|0|||
170475234|NCT03762239|616077720|FG000|Overall Study|Appointment to the doctor|1|||
170475235|NCT03762239|616077721|FG001|Overall Study|Appointment to the doctor|1|||
170475236|NCT03519087|616077722|FG000|Clinic Evaluation|Physician Decision|15|||
170546048|NCT01279200|616343967|FG001|Overall Study|Patient withdrawal due to high cost|1|||
170792087|NCT05299073|617249394|FG002|Overall Study|Lost to Follow-up|0|||
170475237|NCT03519087|616077723|FG001|Clinic Evaluation|Physician Decision|18|||
170475238|NCT03519087|616077724|FG002|Clinic Evaluation|Physician Decision|0|||
170475239|NCT03519087|616077725|FG003|Clinic Evaluation|Physician Decision|0|||
170475240|NCT03519087|616077726|FG004|Clinic Evaluation|Physician Decision|0|||
170475241|NCT03519087|616077722|FG000|Clinic Evaluation|Protocol Violation|1|||
170475242|NCT03519087|616077723|FG001|Clinic Evaluation|Protocol Violation|0|||
170475243|NCT03519087|616077724|FG002|Clinic Evaluation|Protocol Violation|0|||
170475244|NCT03519087|616077725|FG003|Clinic Evaluation|Protocol Violation|0|||
170475245|NCT03519087|616077726|FG004|Clinic Evaluation|Protocol Violation|0|||
170475246|NCT03519087|616077722|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
170475247|NCT03519087|616077723|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
170475248|NCT03519087|616077724|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
170475249|NCT03519087|616077725|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
170475250|NCT03519087|616077726|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
170475251|NCT03519087|616077722|FG000|Re-randomization for Treatment|Not appropriate|2|||
170475252|NCT03519087|616077723|FG001|Re-randomization for Treatment|Not appropriate|3|||
170475253|NCT03519087|616077724|FG002|Re-randomization for Treatment|Not appropriate|0|||
170475254|NCT03519087|616077725|FG003|Re-randomization for Treatment|Not appropriate|0|||
170475255|NCT03519087|616077726|FG004|Re-randomization for Treatment|Not appropriate|0|||
170475256|NCT03519087|616077722|FG000|Laboratory Testing|Lost to Follow-up|0|||
170475257|NCT03519087|616077723|FG001|Laboratory Testing|Lost to Follow-up|0|||
170475258|NCT03519087|616077724|FG002|Laboratory Testing|Lost to Follow-up|2|||
170475259|NCT03519087|616077725|FG003|Laboratory Testing|Lost to Follow-up|3|||
170475260|NCT03519087|616077726|FG004|Laboratory Testing|Lost to Follow-up|6|||
170475261|NCT03519087|616077722|FG000|Laboratory Testing|Protocol Violation|0|||
170475262|NCT03519087|616077723|FG001|Laboratory Testing|Protocol Violation|0|||
170475263|NCT03519087|616077724|FG002|Laboratory Testing|Protocol Violation|0|||
170475264|NCT03519087|616077725|FG003|Laboratory Testing|Protocol Violation|1|||
170475265|NCT03519087|616077726|FG004|Laboratory Testing|Protocol Violation|0|||
170475266|NCT01137071|616077727|FG000|Overall Study|Disease Progression|11|||
170475267|NCT01137071|616077727|FG000|Overall Study|Withdrawal by Subject|2|||
170475268|NCT01137071|616077727|FG000|Overall Study|Wrongly Included|1|||
170475269|NCT04807400|616077728|FG000|Overall Study|Adverse Event|2|||
170475270|NCT04807400|616077729|FG001|Overall Study|Adverse Event|3|||
170475271|NCT04807400|616077730|FG002|Overall Study|Adverse Event|3|||
170475272|NCT04807400|616077728|FG000|Overall Study|Death|2|||
170638068|NCT00330967|616686719|FG001|Overall Study|Withdrawal by Subject|5|||
170638069|NCT00330967|616686718|FG000|Overall Study|Physician Decision|0|||
170638070|NCT00330967|616686719|FG001|Overall Study|Physician Decision|9|||
170638071|NCT00905645|616686720|FG000|Overall Study|Death (not device related)|10|||
170638072|NCT00905645|616686721|FG001|Overall Study|Death (not device related)|4|||
170638073|NCT00905645|616686722|FG002|Overall Study|Death (not device related)|15|||
170638074|NCT00905645|616686723|FG003|Overall Study|Death (not device related)|8|||
170638075|NCT00905645|616686720|FG000|Overall Study|Explantation of study device(s)|78|||
170638076|NCT00905645|616686721|FG001|Overall Study|Explantation of study device(s)|47|||
170638077|NCT00905645|616686722|FG002|Overall Study|Explantation of study device(s)|28|||
170638078|NCT00905645|616686723|FG003|Overall Study|Explantation of study device(s)|21|||
170638079|NCT00905645|616686720|FG000|Overall Study|Subject Request|41|||
170638080|NCT00905645|616686721|FG001|Overall Study|Subject Request|17|||
170638081|NCT00905645|616686722|FG002|Overall Study|Subject Request|13|||
170638082|NCT00905645|616686723|FG003|Overall Study|Subject Request|11|||
170638083|NCT00905645|616686720|FG000|Overall Study|Lost to Follow-up|299|||
170638084|NCT00905645|616686721|FG001|Overall Study|Lost to Follow-up|103|||
170638085|NCT00905645|616686722|FG002|Overall Study|Lost to Follow-up|51|||
170638086|NCT00905645|616686723|FG003|Overall Study|Lost to Follow-up|12|||
170638087|NCT01386970|616686724|FG000|Overall Study|Withdrawal by Subject|0|||
170638088|NCT01386970|616686725|FG001|Overall Study|Withdrawal by Subject|1|||
170638089|NCT01386970|616686724|FG000|Overall Study|Adverse Event|4|||
170638090|NCT01386970|616686725|FG001|Overall Study|Adverse Event|1|||
170638091|NCT02423902|616686726|FG000|Overall Study|Disease progression|1|||
170638092|NCT02423902|616686727|FG001|Overall Study|Disease progression|4|||
170638093|NCT02136069|616686728|FG000|Overall Study|UC flare-up|1|||
170638094|NCT02136069|616686729|FG001|Overall Study|UC flare-up|0|||
170638095|NCT02136069|616686728|FG000|Overall Study|Adverse Event|6|||
170638096|NCT02136069|616686729|FG001|Overall Study|Adverse Event|8|||
170638097|NCT02136069|616686728|FG000|Overall Study|Death|0|||
170638098|NCT02136069|616686729|FG001|Overall Study|Death|1|||
170891701|NCT01462266|617609872|FG000|Overall Study|Lost to Follow-up|4|||
170891702|NCT01462266|617609873|FG001|Overall Study|Lost to Follow-up|3|||
170475273|NCT04807400|616077729|FG001|Overall Study|Death|0|||
170638099|NCT02136069|616686728|FG000|Overall Study|Lack of Efficacy|10|||
170638100|NCT02136069|616686729|FG001|Overall Study|Lack of Efficacy|4|||
170638101|NCT02136069|616686728|FG000|Overall Study|Lost to Follow-up|1|||
170475274|NCT04807400|616077730|FG002|Overall Study|Death|0|||
170475275|NCT04807400|616077728|FG000|Overall Study|Lost to Follow-up|8|||
170475276|NCT04807400|616077729|FG001|Overall Study|Lost to Follow-up|6|||
170638102|NCT02136069|616686729|FG001|Overall Study|Lost to Follow-up|0|||
170638103|NCT02136069|616686728|FG000|Overall Study|Non-Compliance|1|||
170638104|NCT02136069|616686729|FG001|Overall Study|Non-Compliance|0|||
170638105|NCT02136069|616686728|FG000|Overall Study|Physician Decision|5|||
170638106|NCT02136069|616686729|FG001|Overall Study|Physician Decision|4|||
170638107|NCT02136069|616686728|FG000|Overall Study|Withdrawal by Subject|10|||
170638108|NCT02136069|616686729|FG001|Overall Study|Withdrawal by Subject|11|||
170638109|NCT04269265|616686730|FG000|Overall Study|Physician Decision|1|||
170638110|NCT04269265|616686730|FG000|Overall Study|Withdrawal by Subject|1|||
170638111|NCT04269265|616686730|FG000|Overall Study|Overenrolled (sample size reached)|4|||
170638112|NCT04439136|616686731|FG000|Overall Study|Ineligible|1|||
170638113|NCT04439136|616686731|FG000|Overall Study|Never Started Treatment|2|||
170638114|NCT04439136|616686731|FG000|Overall Study|Adverse Event|4|||
170638115|NCT04439136|616686731|FG000|Overall Study|Death|3|||
170638116|NCT04439136|616686731|FG000|Overall Study|Disease Progression|27|||
170638117|NCT04439136|616686731|FG000|Overall Study|Alternative Therapy|1|||
170638118|NCT04439136|616686731|FG000|Overall Study|Increased Tumor Burden|1|||
170638119|NCT04439136|616686731|FG000|Overall Study|Symptomatic Detrioration|1|||
170638120|NCT04693234|616686732|FG000|Overall Study|Death|79|||
170638121|NCT04693234|616686733|FG001|Overall Study|Death|19|||
170638122|NCT04693234|616686732|FG000|Overall Study|Sponsor Ended Study|47|||
170638123|NCT04693234|616686733|FG001|Overall Study|Sponsor Ended Study|18|||
170638124|NCT04693234|616686732|FG000|Overall Study|Withdrawal by Subject|10|||
170638125|NCT04693234|616686733|FG001|Overall Study|Withdrawal by Subject|2|||
170638126|NCT04693234|616686732|FG000|Overall Study|Lost to Follow-up|2|||
170638127|NCT04693234|616686733|FG001|Overall Study|Lost to Follow-up|1|||
170638128|NCT04838626|616686736|FG000|Overall Study|Adverse Event|2|||
170638129|NCT04838626|616686736|FG000|Overall Study|Physician Decision|6|||
170638130|NCT04838626|616686736|FG000|Overall Study|Protocol Violation|3|||
170638131|NCT04838626|616686736|FG000|Overall Study|Withdrawal by Subject|9|||
170638132|NCT04838626|616686736|FG000|Overall Study|Technical Problems|2|||
170638133|NCT02578706|616686737|FG000|Overall Study|Withdrawal by Subject|1|||
170638134|NCT02578706|616686738|FG001|Overall Study|Withdrawal by Subject|0|||
170638135|NCT02578706|616686739|FG002|Overall Study|Withdrawal by Subject|0|||
170638136|NCT02578706|616686737|FG000|Overall Study|Lost to Follow-up|0|||
170638137|NCT02578706|616686738|FG001|Overall Study|Lost to Follow-up|4|||
170638138|NCT02578706|616686739|FG002|Overall Study|Lost to Follow-up|0|||
170638139|NCT02578706|616686737|FG000|Overall Study|Physician Decision|0|||
170638140|NCT02578706|616686738|FG001|Overall Study|Physician Decision|1|||
170638141|NCT02578706|616686739|FG002|Overall Study|Physician Decision|0|||
170638142|NCT04849559|616686742|FG000|Overall Study|Withdrawal by Subject|2|||
170638143|NCT04849559|616686743|FG001|Overall Study|Withdrawal by Subject|1|||
170638144|NCT02362282|616686752|FG000|Overall Study|Withdrawal by Subject|1|||
170638145|NCT02362282|616686753|FG001|Overall Study|Withdrawal by Subject|0|||
170638146|NCT02004093|616686754|FG000|Overall Study|Death|2|||
170638147|NCT02004093|616686755|FG001|Overall Study|Death|1|||
170638148|NCT02004093|616686754|FG000|Overall Study|Lack of Efficacy|66|||
170475277|NCT04807400|616077730|FG002|Overall Study|Lost to Follow-up|6|||
170475278|NCT04807400|616077728|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170475279|NCT04807400|616077729|FG001|Overall Study|Non-Compliance With Study Drug|4|||
170475280|NCT04807400|616077730|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170475281|NCT04807400|616077728|FG000|Overall Study|Participant Decision|20|||
170475282|NCT04807400|616077729|FG001|Overall Study|Participant Decision|19|||
170475283|NCT04807400|616077730|FG002|Overall Study|Participant Decision|26|||
170475284|NCT04807400|616077728|FG000|Overall Study|Physician Decision|0|||
170475285|NCT04807400|616077729|FG001|Overall Study|Physician Decision|1|||
170475286|NCT04807400|616077730|FG002|Overall Study|Physician Decision|0|||
170475287|NCT04807400|616077728|FG000|Overall Study|Protocol Violation|4|||
170475288|NCT04807400|616077729|FG001|Overall Study|Protocol Violation|3|||
170475289|NCT04807400|616077730|FG002|Overall Study|Protocol Violation|7|||
170475290|NCT04807400|616077728|FG000|Overall Study|Withdrawal by Subject|13|||
170475291|NCT04807400|616077729|FG001|Overall Study|Withdrawal by Subject|9|||
170475292|NCT04807400|616077730|FG002|Overall Study|Withdrawal by Subject|20|||
170475293|NCT04807400|616077728|FG000|Overall Study|Mis-randomized|1|||
170475294|NCT04807400|616077729|FG001|Overall Study|Mis-randomized|0|||
170475295|NCT04807400|616077730|FG002|Overall Study|Mis-randomized|0|||
170475296|NCT04194645|616077731|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475297|NCT04194645|616077732|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475298|NCT04194645|616077733|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475299|NCT04194645|616077734|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475300|NCT04194645|616077735|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475301|NCT04194645|616077736|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475302|NCT04194645|616077737|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475303|NCT04194645|616077738|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475304|NCT04194645|616077739|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475305|NCT04194645|616077740|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
170475306|NCT04194645|616077741|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170638149|NCT02004093|616686755|FG001|Overall Study|Lack of Efficacy|62|||
170638150|NCT02004093|616686754|FG000|Overall Study|Protocol Violation|0|||
170638151|NCT02004093|616686755|FG001|Overall Study|Protocol Violation|1|||
170638152|NCT02004093|616686754|FG000|Overall Study|Lost to Follow-up|0|||
170638153|NCT02004093|616686755|FG001|Overall Study|Lost to Follow-up|1|||
170792088|NCT03952338|617249395|FG000|Overall Study|Lost to Follow-up|11|||
170792089|NCT03952338|617249396|FG001|Overall Study|Lost to Follow-up|17|||
170792090|NCT03952338|617249395|FG000|Overall Study|Withdrawal by Subject|1|||
170792091|NCT03952338|617249396|FG001|Overall Study|Withdrawal by Subject|1|||
170792092|NCT03952338|617249395|FG000|Overall Study|Protocol Violation|1|||
170792093|NCT03952338|617249396|FG001|Overall Study|Protocol Violation|0|||
170792094|NCT04753697|617249397|FG000|Induction Phase|Withdrawal by Subject|12|||
170792095|NCT04753697|617249398|FG001|Induction Phase|Withdrawal by Subject|5|||
170792096|NCT04753697|617249399|FG002|Induction Phase|Withdrawal by Subject|6|||
170792097|NCT04753697|617249397|FG000|Induction Phase|Physician Decision|1|||
170792098|NCT04753697|617249398|FG001|Induction Phase|Physician Decision|0|||
170792099|NCT04753697|617249399|FG002|Induction Phase|Physician Decision|0|||
170792100|NCT04753697|617249397|FG000|Induction Phase|Lost to Follow-up|2|||
170792101|NCT04753697|617249398|FG001|Induction Phase|Lost to Follow-up|2|||
170792102|NCT04753697|617249399|FG002|Induction Phase|Lost to Follow-up|1|||
170792103|NCT04753697|617249397|FG000|Induction Phase|Lack of Efficacy|1|||
170792104|NCT04753697|617249398|FG001|Induction Phase|Lack of Efficacy|0|||
170792105|NCT04753697|617249399|FG002|Induction Phase|Lack of Efficacy|0|||
170792106|NCT04753697|617249397|FG000|Maintenance Phase|Physician Decision|0|||
170792107|NCT04753697|617249398|FG001|Maintenance Phase|Physician Decision|0|||
170792108|NCT04753697|617249399|FG002|Maintenance Phase|Physician Decision|1|||
170792109|NCT04753697|617249397|FG000|Maintenance Phase|Withdrawal by Subject|3|||
170792110|NCT04753697|617249398|FG001|Maintenance Phase|Withdrawal by Subject|4|||
170792111|NCT04753697|617249399|FG002|Maintenance Phase|Withdrawal by Subject|6|||
170792112|NCT04753697|617249397|FG000|Maintenance Phase|Lost to Follow-up|2|||
170792113|NCT04753697|617249398|FG001|Maintenance Phase|Lost to Follow-up|2|||
170792114|NCT04753697|617249399|FG002|Maintenance Phase|Lost to Follow-up|0|||
170792115|NCT04753697|617249397|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
170792116|NCT04753697|617249398|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
170792117|NCT04753697|617249399|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
170792118|NCT04753697|617249397|FG000|Maintenance Phase|Adverse Event|0|||
170792119|NCT04753697|617249398|FG001|Maintenance Phase|Adverse Event|1|||
170475307|NCT04194645|616077742|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475308|NCT04194645|616077743|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475309|NCT04194645|616077744|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170638154|NCT02004093|616686754|FG000|Overall Study|Withdrawal by Subject|3|||
170638155|NCT02004093|616686755|FG001|Overall Study|Withdrawal by Subject|7|||
170638156|NCT02004093|616686754|FG000|Overall Study|Other|3|||
170638157|NCT02004093|616686755|FG001|Overall Study|Other|1|||
170638158|NCT00774566|616686756|FG000|Overall Study|Protocol Violation|18|||
170638159|NCT00774566|616686757|FG001|Overall Study|Protocol Violation|15|||
170638160|NCT00392769|616686758|FG000|Overall Study|Clinical Deterioration|9|||
170638161|NCT00392769|616686758|FG000|Overall Study|Adverse Event|1|||
170638162|NCT04154189|616686759|FG000|Overall Study|Withdrawal by Subject|4|||
170638163|NCT04154189|616686760|FG001|Overall Study|Withdrawal by Subject|6|||
170638164|NCT04154189|616686759|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
170638165|NCT04154189|616686760|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
170638166|NCT04154189|616686759|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
170638167|NCT04154189|616686760|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
170638168|NCT04154189|616686759|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
170638169|NCT04154189|616686760|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
170638170|NCT04154189|616686759|FG000|Overall Study|Death|25|||
170638171|NCT04154189|616686760|FG001|Overall Study|Death|25|||
170792120|NCT04753697|617249399|FG002|Maintenance Phase|Adverse Event|1|||
170792121|NCT04753697|617249397|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
170792122|NCT04753697|617249398|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
170792123|NCT04753697|617249399|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
170792124|NCT04200456|617249402|FG000|Overall Study|Physician Decision|0|||
170792125|NCT04200456|617249403|FG001|Overall Study|Physician Decision|1|||
170792126|NCT04200456|617249402|FG000|Overall Study|Withdrawal by Subject|2|||
170792127|NCT04200456|617249403|FG001|Overall Study|Withdrawal by Subject|2|||
170792128|NCT04200456|617249402|FG000|Overall Study|Lack of Efficacy|1|||
170792129|NCT04200456|617249403|FG001|Overall Study|Lack of Efficacy|1|||
170638172|NCT04380519|616686761|FG000|Overall Study|Withdrawal by Subject|4|||
170792130|NCT04200456|617249402|FG000|Overall Study|Adverse event, non-fatal|0|||
170792131|NCT04200456|617249403|FG001|Overall Study|Adverse event, non-fatal|1|||
170792132|NCT04200456|617249402|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
170638173|NCT04380519|616686762|FG001|Overall Study|Withdrawal by Subject|0|||
170638174|NCT04380519|616686763|FG002|Overall Study|Withdrawal by Subject|1|||
170792133|NCT04200456|617249403|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
170475310|NCT04194645|616077745|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
170475311|NCT03656744|616077746|FG000|Overall Study|Adverse Event|1|||
170638175|NCT04380519|616686761|FG000|Overall Study|Death|14|||
170638176|NCT04380519|616686762|FG001|Overall Study|Death|9|||
170638177|NCT04380519|616686763|FG002|Overall Study|Death|6|||
170638178|NCT04380519|616686761|FG000|Overall Study|Adverse Event|0|||
170638179|NCT04380519|616686762|FG001|Overall Study|Adverse Event|1|||
170638180|NCT04380519|616686763|FG002|Overall Study|Adverse Event|0|||
170638181|NCT04380519|616686761|FG000|Overall Study|relatives' decision|0|||
170638182|NCT04380519|616686762|FG001|Overall Study|relatives' decision|1|||
170638183|NCT04380519|616686763|FG002|Overall Study|relatives' decision|0|||
170638184|NCT00470275|616686764|FG000|Overall Study|Death|1|||
170638185|NCT00470275|616686764|FG000|Overall Study|Lack of Efficacy|7|||
170638186|NCT00470275|616686764|FG000|Overall Study|Withdrawal by Subject|2|||
170638187|NCT01191762|616686765|FG000|Overall Study|Adverse Event|1|||
170638188|NCT01191762|616686766|FG001|Overall Study|Adverse Event|0|||
170638189|NCT01587014|616686767|FG000|Overall Study|Death|2|||
170638190|NCT04995419|616686773|FG000|Overall Study|Withdrawal by Subject|3|||
170638191|NCT04995419|616686773|FG000|Overall Study|Progressive Disease|19|||
170638192|NCT04995419|616686773|FG000|Overall Study|Adverse Event|2|||
170638193|NCT04995419|616686773|FG000|Overall Study|Ongoing|16|||
170638194|NCT03801031|616686774|FG000|Overall Study|Lost to Follow-up|1|||
170638195|NCT03801031|616686775|FG001|Overall Study|Lost to Follow-up|0|||
170638196|NCT03801031|616686774|FG000|Overall Study|Unable to comply|1|||
170638197|NCT03801031|616686775|FG001|Overall Study|Unable to comply|0|||
170638198|NCT03801031|616686774|FG000|Overall Study|Withdrawal by Subject|0|||
170638199|NCT03801031|616686775|FG001|Overall Study|Withdrawal by Subject|1|||
170638200|NCT02948088|616686776|FG000|Overall Study|Lost to Follow-up|8|||
170638201|NCT02948088|616686776|FG000|Overall Study|Death|1|||
170638202|NCT02948088|616686776|FG000|Overall Study|Withdrawal by Subject|4|||
170638203|NCT02948088|616686776|FG000|Overall Study|Other|2|||
170638204|NCT01409811|616686777|FG000|Overall Study|Insurance denial|1|||
170638205|NCT00634101|616686778|FG000|Overall Study|Study Terminated|3|||
170638206|NCT00634101|616686779|FG001|Overall Study|Study Terminated|3|||
170638207|NCT00634101|616686778|FG000|Overall Study|Lost to Follow-up|2|||
170638208|NCT00634101|616686779|FG001|Overall Study|Lost to Follow-up|0|||
170638209|NCT01077076|616686780|FG000|First Intervention|Withdrawal by Subject|1|||
170638210|NCT01077076|616686781|FG001|First Intervention|Withdrawal by Subject|0|||
170638211|NCT01077076|616686782|FG002|First Intervention|Withdrawal by Subject|0|||
170638212|NCT01077076|616686783|FG003|First Intervention|Withdrawal by Subject|0|||
170638213|NCT01077076|616686784|FG004|First Intervention|Withdrawal by Subject|0|||
170638214|NCT01077076|616686785|FG005|First Intervention|Withdrawal by Subject|0|||
170792134|NCT00592852|617249404|FG000|Overall Study|Non-compliance|1|||
170792135|NCT00592852|617249404|FG000|Overall Study|Adverse Event|3|||
170792136|NCT00592852|617249404|FG000|Overall Study|Found ineligible|1|||
170792137|NCT00592852|617249404|FG000|Overall Study|Withdrawal by Subject|1|||
170792138|NCT05002088|617249405|FG000|Overall Study|Withdrawal by Subject|9|||
170792139|NCT05002088|617249406|FG001|Overall Study|Withdrawal by Subject|0|||
170792140|NCT05002088|617249405|FG000|Overall Study|Lost to Follow-up|0|||
170792141|NCT05002088|617249406|FG001|Overall Study|Lost to Follow-up|1|||
170792142|NCT05002088|617249405|FG000|Overall Study|Death|16|||
170792143|NCT05002088|617249406|FG001|Overall Study|Death|2|||
170792144|NCT05002088|617249405|FG000|Overall Study|Protocol Violation|25|||
170792145|NCT05002088|617249406|FG001|Overall Study|Protocol Violation|7|||
170792146|NCT02589795|617249417|FG000|Overall Study|Lost to Follow-up|1|||
170792147|NCT02589795|617249418|FG001|Overall Study|Lost to Follow-up|0|||
170792148|NCT02589795|617249419|FG002|Overall Study|Lost to Follow-up|0|||
170792149|NCT02589795|617249417|FG000|Overall Study|Withdrawal by Subject|0|||
170792150|NCT02589795|617249418|FG001|Overall Study|Withdrawal by Subject|0|||
170792151|NCT02589795|617249419|FG002|Overall Study|Withdrawal by Subject|2|||
170792152|NCT02589795|617249417|FG000|Overall Study|Protocol Violation|0|||
170792153|NCT02589795|617249418|FG001|Overall Study|Protocol Violation|0|||
170792154|NCT02589795|617249419|FG002|Overall Study|Protocol Violation|1|||
170792155|NCT03599661|617249421|FG000|Overall Study|Lost to Follow-up|9|||
170792156|NCT04811040|617249422|FG000|Overall Study|Lost to Follow-up|2|||
170638215|NCT01077076|616686780|FG000|Third Intervention|Death in the participant's family|0|||
170638216|NCT01077076|616686781|FG001|Third Intervention|Death in the participant's family|0|||
170638217|NCT01077076|616686782|FG002|Third Intervention|Death in the participant's family|0|||
170638218|NCT01077076|616686783|FG003|Third Intervention|Death in the participant's family|0|||
170638219|NCT01077076|616686784|FG004|Third Intervention|Death in the participant's family|0|||
170792157|NCT04811040|617249423|FG001|Overall Study|Lost to Follow-up|0|||
170792158|NCT04811040|617249424|FG002|Overall Study|Lost to Follow-up|0|||
170792159|NCT04811040|617249425|FG003|Overall Study|Lost to Follow-up|0|||
170792160|NCT04811040|617249422|FG000|Overall Study|Withdrew consent|1|||
170891703|NCT01462266|617609872|FG000|Overall Study|Non-compliance with study drug|3|||
170475312|NCT03656744|616077747|FG001|Overall Study|Adverse Event|4|||
170638220|NCT01077076|616686785|FG005|Third Intervention|Death in the participant's family|1|||
170638221|NCT01578486|616686802|FG000|Overall Study|Physician Decision|3|||
170792161|NCT04811040|617249423|FG001|Overall Study|Withdrew consent|1|||
170638222|NCT01578486|616686802|FG000|Overall Study|Withdrawal by Subject|2|||
170638223|NCT01273519|616686803|FG000|Overall Study|Adverse Event|3|||
170638224|NCT01273519|616686804|FG001|Overall Study|Adverse Event|0|||
170638225|NCT01273519|616686805|FG002|Overall Study|Adverse Event|0|||
170638226|NCT01273519|616686803|FG000|Overall Study|Lost to Follow-up|2|||
170638227|NCT01273519|616686804|FG001|Overall Study|Lost to Follow-up|1|||
170638228|NCT01273519|616686805|FG002|Overall Study|Lost to Follow-up|3|||
170638229|NCT01273519|616686803|FG000|Overall Study|Lack of Efficacy|8|||
170638230|NCT01273519|616686804|FG001|Overall Study|Lack of Efficacy|3|||
170638231|NCT01273519|616686805|FG002|Overall Study|Lack of Efficacy|4|||
170638232|NCT01273519|616686803|FG000|Overall Study|Other|6|||
170638233|NCT01273519|616686804|FG001|Overall Study|Other|1|||
170638234|NCT01273519|616686805|FG002|Overall Study|Other|1|||
170638235|NCT00740857|616686806|FG000|Overall Study|Withdrawal by Subject|1|||
170638236|NCT00740857|616686807|FG001|Overall Study|Withdrawal by Subject|0|||
170638237|NCT00740857|616686808|FG002|Overall Study|Withdrawal by Subject|0|||
170638238|NCT03532451|616686812|FG000|Overall Study|Withdrawal by Subject|0|||
170638239|NCT03532451|616686813|FG001|Overall Study|Withdrawal by Subject|1|||
170475313|NCT03656744|616077748|FG002|Overall Study|Adverse Event|1|||
170475314|NCT03656744|616077746|FG000|Overall Study|Protocol Violation|1|||
170475315|NCT03656744|616077747|FG001|Overall Study|Protocol Violation|0|||
170475316|NCT03656744|616077748|FG002|Overall Study|Protocol Violation|0|||
170475317|NCT03656744|616077746|FG000|Overall Study|Lost to Follow-up|2|||
170475318|NCT03656744|616077747|FG001|Overall Study|Lost to Follow-up|2|||
170475319|NCT03656744|616077748|FG002|Overall Study|Lost to Follow-up|0|||
170475320|NCT03656744|616077746|FG000|Overall Study|Withdrawal by Subject|0|||
170475321|NCT03656744|616077747|FG001|Overall Study|Withdrawal by Subject|1|||
170475322|NCT03656744|616077748|FG002|Overall Study|Withdrawal by Subject|0|||
170475323|NCT03656744|616077746|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
170475324|NCT03656744|616077747|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
170475325|NCT03656744|616077748|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
170475326|NCT02290405|616077749|FG000|Overall Study|Withdrawal by Subject|1|||
170475327|NCT02290405|616077750|FG001|Overall Study|Withdrawal by Subject|0|||
170475328|NCT00996489|616077751|FG000|Overall Study|Device failure|45|||
170475329|NCT00996489|616077751|FG000|Overall Study|Discontinued|116|||
170475330|NCT03142191|616077752|FG000|Placebo Controlled Period|Death|0|||
170475331|NCT03142191|616077753|FG001|Placebo Controlled Period|Death|1|||
170475332|NCT03142191|616077754|FG002|Placebo Controlled Period|Death|1|||
170475333|NCT03142191|616077755|FG003|Placebo Controlled Period|Death|0|||
170475334|NCT03142191|616077756|FG004|Placebo Controlled Period|Death|0|||
170475335|NCT03142191|616077752|FG000|Placebo Controlled Period|Adverse Event|4|||
170475336|NCT03142191|616077753|FG001|Placebo Controlled Period|Adverse Event|5|||
170475337|NCT03142191|616077754|FG002|Placebo Controlled Period|Adverse Event|1|||
170475338|NCT03142191|616077755|FG003|Placebo Controlled Period|Adverse Event|0|||
170475339|NCT03142191|616077756|FG004|Placebo Controlled Period|Adverse Event|0|||
170475340|NCT03142191|616077752|FG000|Placebo Controlled Period|Progressive Disease|1|||
170475341|NCT03142191|616077753|FG001|Placebo Controlled Period|Progressive Disease|0|||
170475342|NCT03142191|616077754|FG002|Placebo Controlled Period|Progressive Disease|1|||
170475343|NCT03142191|616077755|FG003|Placebo Controlled Period|Progressive Disease|0|||
170475344|NCT03142191|616077756|FG004|Placebo Controlled Period|Progressive Disease|0|||
170475345|NCT03142191|616077752|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
170475346|NCT03142191|616077753|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
170475347|NCT03142191|616077754|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
170475348|NCT03142191|616077755|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
170475349|NCT03142191|616077756|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
170475350|NCT03142191|616077752|FG000|Placebo Controlled Period|Other Reasons|1|||
170475351|NCT03142191|616077753|FG001|Placebo Controlled Period|Other Reasons|0|||
170475352|NCT03142191|616077754|FG002|Placebo Controlled Period|Other Reasons|0|||
170475353|NCT03142191|616077755|FG003|Placebo Controlled Period|Other Reasons|0|||
170475354|NCT03142191|616077756|FG004|Placebo Controlled Period|Other Reasons|0|||
170475355|NCT03142191|616077752|FG000|Active Treatment Extension Period|Death|2|||
170475356|NCT03142191|616077753|FG001|Active Treatment Extension Period|Death|1|||
170475357|NCT03142191|616077754|FG002|Active Treatment Extension Period|Death|1|||
170475358|NCT03142191|616077755|FG003|Active Treatment Extension Period|Death|1|||
170475359|NCT03142191|616077756|FG004|Active Treatment Extension Period|Death|0|||
170638240|NCT03532451|616686812|FG000|Overall Study|Did not undergo surgery|1|||
170475360|NCT03142191|616077752|FG000|Active Treatment Extension Period|Adverse Event|6|||
170475361|NCT03142191|616077753|FG001|Active Treatment Extension Period|Adverse Event|5|||
170475362|NCT03142191|616077754|FG002|Active Treatment Extension Period|Adverse Event|4|||
170475363|NCT03142191|616077755|FG003|Active Treatment Extension Period|Adverse Event|1|||
170475364|NCT03142191|616077756|FG004|Active Treatment Extension Period|Adverse Event|0|||
170638241|NCT03532451|616686813|FG001|Overall Study|Did not undergo surgery|1|||
170638242|NCT00828204|616686814|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
170475365|NCT03142191|616077752|FG000|Active Treatment Extension Period|Progressive Disease|10|||
170475366|NCT03142191|616077753|FG001|Active Treatment Extension Period|Progressive Disease|5|||
170475367|NCT03142191|616077754|FG002|Active Treatment Extension Period|Progressive Disease|4|||
170475368|NCT03142191|616077755|FG003|Active Treatment Extension Period|Progressive Disease|1|||
170475369|NCT03142191|616077756|FG004|Active Treatment Extension Period|Progressive Disease|2|||
170475370|NCT03142191|616077752|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
170475371|NCT03142191|616077753|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
170475372|NCT03142191|616077754|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
170475373|NCT03142191|616077755|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
170475374|NCT03142191|616077756|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
170475375|NCT03142191|616077752|FG000|Active Treatment Extension Period|Physician Decision|2|||
170475376|NCT03142191|616077753|FG001|Active Treatment Extension Period|Physician Decision|0|||
170475377|NCT03142191|616077754|FG002|Active Treatment Extension Period|Physician Decision|0|||
170475378|NCT03142191|616077755|FG003|Active Treatment Extension Period|Physician Decision|0|||
170475379|NCT03142191|616077756|FG004|Active Treatment Extension Period|Physician Decision|0|||
170475380|NCT03142191|616077752|FG000|Active Treatment Extension Period|Other Reasons|3|||
170475381|NCT03142191|616077753|FG001|Active Treatment Extension Period|Other Reasons|3|||
170475382|NCT03142191|616077754|FG002|Active Treatment Extension Period|Other Reasons|3|||
170475383|NCT03142191|616077755|FG003|Active Treatment Extension Period|Other Reasons|8|||
170475384|NCT03142191|616077756|FG004|Active Treatment Extension Period|Other Reasons|3|||
170475385|NCT03142191|616077752|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
170475386|NCT03142191|616077753|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
170475387|NCT03142191|616077754|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
170475388|NCT03142191|616077755|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
170475389|NCT03142191|616077756|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
170475390|NCT00770328|616077759|FG000|Overall Study|Adverse Event|11|||
170475391|NCT00770328|616077760|FG001|Overall Study|Adverse Event|2|||
170475392|NCT00770328|616077759|FG000|Overall Study|Lost to Follow-up|2|||
170475393|NCT00770328|616077760|FG001|Overall Study|Lost to Follow-up|2|||
170475394|NCT01130493|616077761|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
170475395|NCT01130493|616077762|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
170475396|NCT01130493|616077763|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
170475397|NCT01130493|616077761|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
170475398|NCT01130493|616077762|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
170475399|NCT01130493|616077763|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
170475400|NCT01130493|616077761|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
170475401|NCT01130493|616077762|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
170475402|NCT01130493|616077763|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
170475403|NCT01130493|616077761|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
170475404|NCT01130493|616077762|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
170475405|NCT01130493|616077763|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
170475406|NCT01130493|616077761|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
170475407|NCT01130493|616077762|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
170475408|NCT01130493|616077763|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
170475409|NCT01130493|616077761|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
170475410|NCT01130493|616077762|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
170475411|NCT01130493|616077763|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
170475412|NCT01130493|616077761|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
170475413|NCT01130493|616077762|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
170475414|NCT01130493|616077763|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
170475415|NCT01130493|616077761|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
170475416|NCT01130493|616077762|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
170475417|NCT01130493|616077763|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
170475418|NCT01130493|616077761|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
170475419|NCT01130493|616077762|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
170475420|NCT01130493|616077763|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
170475421|NCT01130493|616077761|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
170475422|NCT01130493|616077762|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
170475423|NCT01130493|616077763|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
170546049|NCT01279200|616343966|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
170546050|NCT01279200|616343967|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
170546051|NCT01279200|616343966|FG000|Overall Study|ultrasound screening failure|0|||
170475424|NCT01130493|616077761|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
170475425|NCT01130493|616077762|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
170475426|NCT01130493|616077763|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
170546052|NCT01279200|616343967|FG001|Overall Study|ultrasound screening failure|1|||
170638243|NCT00828204|616686815|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
170638244|NCT00828204|616686814|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
170638245|NCT00828204|616686815|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
170638246|NCT00828204|616686814|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
170638247|NCT00828204|616686815|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
170638248|NCT00828204|616686814|FG000|Main Study: After Study Restart|Adverse Event|0|||
170638249|NCT00828204|616686815|FG001|Main Study: After Study Restart|Adverse Event|2|||
170638250|NCT00828204|616686814|FG000|Main Study: After Study Restart|Noncompliance|0|||
170638251|NCT00828204|616686815|FG001|Main Study: After Study Restart|Noncompliance|1|||
170638252|NCT00828204|616686814|FG000|Extension Study|Lost to Follow-up|0|||
170638253|NCT00828204|616686815|FG001|Extension Study|Lost to Follow-up|1|||
170638254|NCT00828204|616686814|FG000|Extension Study|Physician Decision|0|||
170638255|NCT00828204|616686815|FG001|Extension Study|Physician Decision|2|||
170638256|NCT00912197|616686818|FG000|Overall Study|Withdrawal by Subject|3|||
170638257|NCT00912197|616686819|FG001|Overall Study|Withdrawal by Subject|3|||
170638258|NCT04163016|616686827|FG000|Enrollment|Adverse Event|1|||
170638259|NCT04163016|616686828|FG001|Enrollment|Adverse Event|0|||
170638260|NCT04163016|616686829|FG002|Enrollment|Adverse Event|0|||
170638261|NCT04163016|616686830|FG003|Enrollment|Adverse Event|0|||
170638262|NCT04163016|616686827|FG000|Treatment|Adverse Event|0|||
170638263|NCT04163016|616686828|FG001|Treatment|Adverse Event|1|||
170638264|NCT04163016|616686829|FG002|Treatment|Adverse Event|0|||
170638265|NCT04163016|616686830|FG003|Treatment|Adverse Event|0|||
170638266|NCT04163016|616686827|FG000|Treatment|Withdrawal by Subject|0|||
170638267|NCT04163016|616686828|FG001|Treatment|Withdrawal by Subject|2|||
170638268|NCT04163016|616686829|FG002|Treatment|Withdrawal by Subject|0|||
170638269|NCT04163016|616686830|FG003|Treatment|Withdrawal by Subject|0|||
170638270|NCT04163016|616686827|FG000|Treatment|Indeterminate TB-test|0|||
170638271|NCT04163016|616686828|FG001|Treatment|Indeterminate TB-test|0|||
170638272|NCT04163016|616686829|FG002|Treatment|Indeterminate TB-test|0|||
170638273|NCT04163016|616686830|FG003|Treatment|Indeterminate TB-test|1|||
170638274|NCT04163016|616686827|FG000|Treatment|Participant did not want to continue in study|0|||
170638275|NCT04163016|616686828|FG001|Treatment|Participant did not want to continue in study|0|||
170638276|NCT04163016|616686829|FG002|Treatment|Participant did not want to continue in study|0|||
170638277|NCT04163016|616686830|FG003|Treatment|Participant did not want to continue in study|1|||
170638278|NCT00560352|616686833|FG000|Overall Study|Adverse event unrelated to study drug|2|||
170638279|NCT00560352|616686834|FG001|Overall Study|Adverse event unrelated to study drug|1|||
170638280|NCT00560352|616686835|FG002|Overall Study|Adverse event unrelated to study drug|1|||
170638281|NCT00560352|616686833|FG000|Overall Study|Study drug toxicity|3|||
170638282|NCT00560352|616686834|FG001|Overall Study|Study drug toxicity|0|||
170638283|NCT00560352|616686835|FG002|Overall Study|Study drug toxicity|1|||
170638284|NCT00560352|616686833|FG000|Overall Study|Disease progression|0|||
170638285|NCT00560352|616686834|FG001|Overall Study|Disease progression|1|||
170638286|NCT00560352|616686835|FG002|Overall Study|Disease progression|1|||
170638287|NCT00560352|616686833|FG000|Overall Study|Withdrawal by Subject|1|||
170638288|NCT00560352|616686834|FG001|Overall Study|Withdrawal by Subject|1|||
170638289|NCT00560352|616686835|FG002|Overall Study|Withdrawal by Subject|1|||
170638290|NCT00560352|616686833|FG000|Overall Study|Maximum clinical benefit|1|||
170638291|NCT00560352|616686834|FG001|Overall Study|Maximum clinical benefit|0|||
170638292|NCT00560352|616686835|FG002|Overall Study|Maximum clinical benefit|0|||
170638293|NCT00122980|616688201|FG000|Overall Study|Death|0|||
170638294|NCT00122980|616688202|FG001|Overall Study|Death|1|||
170638295|NCT00122980|616688201|FG000|Overall Study|Physician Decision|2|||
170638296|NCT00122980|616688202|FG001|Overall Study|Physician Decision|0|||
170638297|NCT00122980|616688201|FG000|Overall Study|Protocol Violation|5|||
170638298|NCT00122980|616688202|FG001|Overall Study|Protocol Violation|1|||
170638299|NCT00122980|616688201|FG000|Overall Study|Withdrawal by Subject|2|||
170638300|NCT00122980|616688202|FG001|Overall Study|Withdrawal by Subject|3|||
170638301|NCT00122980|616688201|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
170638302|NCT00122980|616688202|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
170638303|NCT00122980|616688201|FG000|Overall Study|Study termination|27|||
170638304|NCT00122980|616688202|FG001|Overall Study|Study termination|35|||
170638305|NCT00796419|616688203|FG000|Overall Study|Death|0|||
170638306|NCT00796419|616688204|FG001|Overall Study|Death|1|||
170638307|NCT00539864|616688205|FG000|Overall Study|Lost to Follow-up|0|||
170638308|NCT00539864|616688206|FG001|Overall Study|Lost to Follow-up|1|||
170638309|NCT00539864|616688205|FG000|Overall Study|Withdrawal by Subject|1|||
170638310|NCT00539864|616688206|FG001|Overall Study|Withdrawal by Subject|1|||
170638311|NCT02840799|616688209|FG000|Phase 1|Physician Decision|1|||
170638312|NCT02840799|616688210|FG001|Phase 1|Physician Decision|3|||
170638313|NCT02840799|616688209|FG000|Phase 1|Withdrawal by Subject|4|||
170638314|NCT02840799|616688210|FG001|Phase 1|Withdrawal by Subject|0|||
170638315|NCT02840799|616688209|FG000|Phase 2 (Crossover)|Adverse Event|0|||
170638316|NCT02840799|616688210|FG001|Phase 2 (Crossover)|Adverse Event|1|||
170638317|NCT02840799|616688209|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
170638318|NCT02840799|616688210|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
170638319|NCT01256294|616688216|FG000|Overall Study|Adverse Event|1|||
170638320|NCT01256294|616688217|FG001|Overall Study|Adverse Event|0|||
170638321|NCT01256294|616688216|FG000|Overall Study|Withdrawal by Subject|1|||
170638322|NCT01256294|616688217|FG001|Overall Study|Withdrawal by Subject|1|||
170638323|NCT01256294|616688216|FG000|Overall Study|Protocol deviation|2|||
170638324|NCT01256294|616688217|FG001|Overall Study|Protocol deviation|1|||
170638325|NCT04681352|616688218|FG000|Overall Study|Lost to Follow-up|2|||
170638326|NCT04681352|616688218|FG000|Overall Study|Withdrawal by Subject|22|||
170638327|NCT00439517|616688219|FG000|Overall Study|Subject on treatment|1|||
170638328|NCT00439517|616688220|FG001|Overall Study|Subject on treatment|0|||
170638329|NCT00439517|616688219|FG000|Overall Study|Subject in survival follow-up|1|||
170638330|NCT00439517|616688220|FG001|Overall Study|Subject in survival follow-up|0|||
170638331|NCT03527732|616688223|FG000|Overall Study|Lost to Follow-up|21|||
170638332|NCT03527732|616688224|FG001|Overall Study|Lost to Follow-up|23|||
170638333|NCT03527732|616688225|FG002|Overall Study|Lost to Follow-up|80|||
170638334|NCT03527732|616688226|FG003|Overall Study|Lost to Follow-up|62|||
170638335|NCT03527732|616688227|FG004|Overall Study|Lost to Follow-up|12|||
170638336|NCT03527732|616688228|FG005|Overall Study|Lost to Follow-up|20|||
170638337|NCT02474069|616688229|FG000|Selection Phase (SP)|Adverse Event|8|||
170638338|NCT02474069|616688230|FG001|Selection Phase (SP)|Adverse Event|0|||
170638339|NCT02474069|616688231|FG002|Selection Phase (SP)|Adverse Event|0|||
170638340|NCT02474069|616688229|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
170638341|NCT02474069|616688230|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
170638342|NCT02474069|616688231|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
170638343|NCT02474069|616688229|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
170638344|NCT02474069|616688230|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
170638345|NCT02474069|616688231|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
170638346|NCT02474069|616688229|FG000|Selection Phase (SP)|Physician Decision|1|||
170638347|NCT02474069|616688230|FG001|Selection Phase (SP)|Physician Decision|0|||
170638348|NCT02474069|616688231|FG002|Selection Phase (SP)|Physician Decision|0|||
170638349|NCT02474069|616688229|FG000|Selection Phase (SP)|Protocol Violation|1|||
170638350|NCT02474069|616688230|FG001|Selection Phase (SP)|Protocol Violation|0|||
170638351|NCT02474069|616688231|FG002|Selection Phase (SP)|Protocol Violation|0|||
170638352|NCT02474069|616688229|FG000|Selection Phase (SP)|No longer requires treatment|1|||
170638353|NCT02474069|616688230|FG001|Selection Phase (SP)|No longer requires treatment|0|||
170638354|NCT02474069|616688231|FG002|Selection Phase (SP)|No longer requires treatment|0|||
170638355|NCT02474069|616688229|FG000|Selection Phase (SP)|Technical Problem|1|||
170638356|NCT02474069|616688230|FG001|Selection Phase (SP)|Technical Problem|0|||
170638357|NCT02474069|616688231|FG002|Selection Phase (SP)|Technical Problem|0|||
170638358|NCT02474069|616688229|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
170475427|NCT01130493|616077761|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
170475428|NCT01130493|616077762|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
170475429|NCT01130493|616077763|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
170475430|NCT01130493|616077761|FG000|Part 2: OLE|Adverse Event|0|||
170475431|NCT01130493|616077762|FG001|Part 2: OLE|Adverse Event|2|||
170475432|NCT01130493|616077763|FG002|Part 2: OLE|Adverse Event|1|||
170475433|NCT01130493|616077761|FG000|Part 2: OLE|Withdrawal by Subject|0|||
170475434|NCT01130493|616077762|FG001|Part 2: OLE|Withdrawal by Subject|1|||
170475435|NCT01130493|616077763|FG002|Part 2: OLE|Withdrawal by Subject|4|||
170475436|NCT03541317|616077768|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
170475437|NCT03541317|616077769|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
170475438|NCT03541317|616077770|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
170475439|NCT03541317|616077771|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
170792162|NCT04811040|617249424|FG002|Overall Study|Withdrew consent|0|||
170792163|NCT04811040|617249425|FG003|Overall Study|Withdrew consent|0|||
170792164|NCT03687086|617249426|FG000|Overall Study|Withdrawal by Subject|3|||
170792165|NCT03687086|617249427|FG001|Overall Study|Withdrawal by Subject|4|||
170792166|NCT03687086|617249426|FG000|Overall Study|Lost to Follow-up|1|||
170792167|NCT03687086|617249427|FG001|Overall Study|Lost to Follow-up|1|||
170792168|NCT03687086|617249426|FG000|Overall Study|Death|1|||
170792169|NCT03687086|617249427|FG001|Overall Study|Death|0|||
170792170|NCT03687086|617249426|FG000|Overall Study|Incomplete assessment|0|||
170792171|NCT03687086|617249427|FG001|Overall Study|Incomplete assessment|2|||
170792172|NCT01928394|617249428|FG000|Treatment Period|Disease progression|17|||
170792173|NCT01928394|617249429|FG001|Treatment Period|Disease progression|2|||
170792174|NCT01928394|617249430|FG002|Treatment Period|Disease progression|12|||
170792175|NCT01928394|617249431|FG003|Treatment Period|Disease progression|48|||
170792176|NCT01928394|617249432|FG004|Treatment Period|Disease progression|3|||
170475440|NCT03541317|616077772|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
170638359|NCT02474069|616688230|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
170638360|NCT02474069|616688231|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
170638361|NCT02474069|616688229|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
170475441|NCT03541317|616077773|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
170475442|NCT00879086|616077774|FG000|Overall Study|Adverse Event|3|||
170638362|NCT02474069|616688230|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
170792177|NCT01928394|617249433|FG005|Treatment Period|Disease progression|25|||
170638363|NCT02474069|616688231|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
170638364|NCT02474069|616688229|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
170638365|NCT02474069|616688230|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
170638366|NCT02474069|616688231|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
170638367|NCT02474069|616688229|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
170638368|NCT02474069|616688230|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
170891704|NCT01462266|617609873|FG001|Overall Study|Non-compliance with study drug|0|||
170891705|NCT01462266|617609872|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
170891706|NCT01462266|617609873|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
170891707|NCT01462266|617609872|FG000|Overall Study|Physician Decision|2|||
170891708|NCT01462266|617609873|FG001|Overall Study|Physician Decision|5|||
170891709|NCT01462266|617609872|FG000|Overall Study|Protocol Violation|1|||
170891710|NCT01462266|617609873|FG001|Overall Study|Protocol Violation|3|||
170891711|NCT01462266|617609872|FG000|Overall Study|Withdrawal by Subject|7|||
170891712|NCT01462266|617609873|FG001|Overall Study|Withdrawal by Subject|2|||
170891713|NCT01462266|617609872|FG000|Overall Study|Screen failure|1|||
170891714|NCT01462266|617609873|FG001|Overall Study|Screen failure|1|||
170891715|NCT05902364|617609889|FG000|Overall Study|Adverse Event|1|||
170891716|NCT05902364|617609890|FG001|Overall Study|Adverse Event|0|||
170891717|NCT02270242|617609891|FG000|Overall Study|Withdrawal by Subject|18|||
170891718|NCT02270242|617609892|FG001|Overall Study|Withdrawal by Subject|25|||
170891719|NCT02270242|617609891|FG000|Overall Study|Lost to Follow-up|41|||
170891720|NCT02270242|617609892|FG001|Overall Study|Lost to Follow-up|27|||
170891721|NCT02270242|617609891|FG000|Overall Study|Physician Decision|0|||
170891722|NCT02270242|617609892|FG001|Overall Study|Physician Decision|1|||
170891723|NCT02321436|617609893|FG000|Overall Study|Withdrawal by Subject|1|||
170891724|NCT02321436|617609894|FG001|Overall Study|Withdrawal by Subject|0|||
170891725|NCT02321436|617609893|FG000|Overall Study|Lost to Follow-up|0|||
170891726|NCT02321436|617609894|FG001|Overall Study|Lost to Follow-up|1|||
170891727|NCT01877083|617609901|FG000|Treatment Phase|Disease Progression|10|||
170891728|NCT01877083|617609901|FG000|Treatment Phase|Clinical Progression|1|||
170891729|NCT01877083|617609901|FG000|Treatment Phase|Adverse Event|6|||
170891730|NCT01877083|617609901|FG000|Treatment Phase|Withdrawal by Subject|2|||
170891731|NCT01877083|617609901|FG000|Treatment Phase|Lost to Follow-up|1|||
170891732|NCT01877083|617609901|FG000|Extension Phase|Disease Progression|3|||
170891733|NCT01877083|617609901|FG000|Extension Phase|Adverse Event|2|||
170891734|NCT03631706|617609902|FG000|Overall Study|Randomized, not treated|1|||
170891735|NCT03631706|617609903|FG001|Overall Study|Randomized, not treated|0|||
170891736|NCT00684957|617609906|FG000|Overall Study|Withdrawal by Subject|1|||
170891737|NCT00684957|617609907|FG001|Overall Study|Withdrawal by Subject|1|||
170891738|NCT00684957|617609906|FG000|Overall Study|Lost to Follow-up|1|||
170891739|NCT00684957|617609907|FG001|Overall Study|Lost to Follow-up|0|||
170891740|NCT02949128|617611826|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
170891741|NCT02949128|617611826|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
170891742|NCT02949128|617611826|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
170891743|NCT02949128|617611826|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
170891744|NCT02949128|617611826|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
170891745|NCT02949128|617611826|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
170891746|NCT02949128|617611826|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
170891747|NCT02949128|617611826|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
170891748|NCT02949128|617611826|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
170891749|NCT02949128|617611826|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
170891750|NCT02324270|617611827|FG000|Overall Study|Withdrawal by Subject|0|||
170891751|NCT02324270|617611828|FG001|Overall Study|Withdrawal by Subject|1|||
170891752|NCT02324270|617611829|FG002|Overall Study|Withdrawal by Subject|0|||
170891753|NCT02324270|617611827|FG000|Overall Study|Lost to Follow-up|4|||
170891754|NCT02324270|617611828|FG001|Overall Study|Lost to Follow-up|3|||
170891755|NCT02324270|617611829|FG002|Overall Study|Lost to Follow-up|4|||
170891756|NCT02324270|617611827|FG000|Overall Study|Protocol Violation|0|||
170891757|NCT02324270|617611828|FG001|Overall Study|Protocol Violation|1|||
170891758|NCT02324270|617611829|FG002|Overall Study|Protocol Violation|1|||
170891759|NCT02324270|617611827|FG000|Overall Study|Non Compliance with Study Drug|1|||
170891760|NCT02324270|617611828|FG001|Overall Study|Non Compliance with Study Drug|2|||
170638369|NCT02474069|616688231|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
170638370|NCT02474069|616688229|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
170891761|NCT02324270|617611829|FG002|Overall Study|Non Compliance with Study Drug|0|||
170891762|NCT03038308|617611831|FG000|Overall Study|Surgical resection|1|||
170891763|NCT03038308|617611831|FG000|Overall Study|Withdrawal by Subject|2|||
170638371|NCT02474069|616688230|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
170638372|NCT02474069|616688231|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
170638373|NCT02474069|616688229|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
170638374|NCT02474069|616688230|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
170638375|NCT02474069|616688231|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
170638376|NCT04173494|616688232|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
170638377|NCT04173494|616688233|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
170638378|NCT04173494|616688232|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
170638379|NCT04173494|616688233|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
170638380|NCT04173494|616688232|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
170638381|NCT04173494|616688233|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
170638382|NCT04173494|616688232|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
170638383|NCT04173494|616688233|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
170638384|NCT04173494|616688232|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
170638385|NCT04173494|616688233|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
170638386|NCT04173494|616688232|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
170638387|NCT04173494|616688233|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
170638388|NCT04173494|616688232|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
170638389|NCT04173494|616688233|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
170638390|NCT04173494|616688232|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
170638391|NCT04173494|616688233|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
170638392|NCT04173494|616688232|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
170638393|NCT04173494|616688233|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
170638394|NCT04173494|616688232|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
170638395|NCT04173494|616688233|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
170638396|NCT04173494|616688232|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
170638397|NCT04173494|616688233|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
170638398|NCT04173494|616688232|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
170638399|NCT04173494|616688233|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
170638400|NCT04173494|616688232|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
170638401|NCT04173494|616688233|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
170638402|NCT04173494|616688232|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
170638403|NCT04173494|616688233|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
170638404|NCT04173494|616688232|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
170638405|NCT04173494|616688233|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
170638406|NCT04173494|616688232|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
170638407|NCT04173494|616688233|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
170638408|NCT02920242|616688234|FG000|Overall Study|Withdrawal by Subject|1|||
170638409|NCT02920242|616688235|FG001|Overall Study|Withdrawal by Subject|0|||
170638410|NCT02920242|616688236|FG002|Overall Study|Withdrawal by Subject|1|||
170638411|NCT02920242|616688234|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
170638412|NCT02920242|616688235|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
170638413|NCT02920242|616688236|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
170638414|NCT03776812|616688237|FG000|Overall Study|Death|53|||
170638415|NCT03776812|616688238|FG001|Overall Study|Death|49|||
170638416|NCT03776812|616688239|FG002|Overall Study|Death|56|||
170638417|NCT03776812|616688237|FG000|Overall Study|Withdrawal by Subject|1|||
170638418|NCT03776812|616688238|FG001|Overall Study|Withdrawal by Subject|7|||
170638419|NCT03776812|616688239|FG002|Overall Study|Withdrawal by Subject|2|||
170638420|NCT03776812|616688237|FG000|Overall Study|Lost to Follow-up|1|||
170638421|NCT03776812|616688238|FG001|Overall Study|Lost to Follow-up|1|||
170638422|NCT03776812|616688239|FG002|Overall Study|Lost to Follow-up|0|||
170638423|NCT03776812|616688237|FG000|Overall Study|Did not enter long-term follow-up|3|||
170638424|NCT03776812|616688238|FG001|Overall Study|Did not enter long-term follow-up|3|||
170638425|NCT03776812|616688239|FG002|Overall Study|Did not enter long-term follow-up|2|||
170638426|NCT03610269|616688244|FG000|Overall Study|Physician Decision|10|||
170638427|NCT03610269|616688244|FG000|Overall Study|Protocol Violation|1|||
170638428|NCT03610269|616688244|FG000|Overall Study|Unable to draw blood|1|||
170638429|NCT03610269|616688244|FG000|Overall Study|Screen fail|4|||
170792178|NCT01928394|617249434|FG006|Treatment Period|Disease progression|38|||
170792179|NCT01928394|617249435|FG007|Treatment Period|Disease progression|16|||
170475443|NCT00879086|616077775|FG001|Overall Study|Adverse Event|15|||
170475444|NCT00879086|616077774|FG000|Overall Study|Participant choice|2|||
170475445|NCT00879086|616077775|FG001|Overall Study|Participant choice|2|||
170638430|NCT00067002|616688245|FG000|Overall Study|Early Death|1|||
170792180|NCT01928394|617249436|FG008|Treatment Period|Disease progression|3|||
170792181|NCT01928394|617249437|FG009|Treatment Period|Disease progression|11|||
170792182|NCT01928394|617249438|FG010|Treatment Period|Disease progression|22|||
170475446|NCT00879086|616077774|FG000|Overall Study|Progression of disease|40|||
170475447|NCT00879086|616077775|FG001|Overall Study|Progression of disease|26|||
170475448|NCT00879086|616077774|FG000|Overall Study|Withdrawal of consent|2|||
170475449|NCT00879086|616077775|FG001|Overall Study|Withdrawal of consent|1|||
170475450|NCT00879086|616077774|FG000|Overall Study|Other|4|||
170475451|NCT00879086|616077775|FG001|Overall Study|Other|6|||
170475452|NCT00879086|616077774|FG000|Overall Study|Death|1|||
170475453|NCT00879086|616077775|FG001|Overall Study|Death|2|||
170475454|NCT01911273|616077776|FG000|Overall Study|Progression of Disease|1|||
170475455|NCT01911273|616077777|FG001|Overall Study|Progression of Disease|0|||
170475456|NCT01911273|616077776|FG000|Overall Study|Withdrawal by Subject|0|||
170475457|NCT01911273|616077777|FG001|Overall Study|Withdrawal by Subject|2|||
170475458|NCT04597632|616077778|FG000|Overall Study|Withdrawal by Subject|10|||
170475459|NCT04597632|616077778|FG000|Overall Study|Lost to Follow-up|1|||
170475460|NCT04597632|616077778|FG000|Overall Study|Death|1|||
170475461|NCT04597632|616077778|FG000|Overall Study|Adverse Event|5|||
170475462|NCT00509795|616077779|FG000|Overall Study|Adverse Event|4|||
170475463|NCT00509795|616077780|FG001|Overall Study|Adverse Event|3|||
170475464|NCT00509795|616077781|FG002|Overall Study|Adverse Event|5|||
170475465|NCT00509795|616077782|FG003|Overall Study|Adverse Event|4|||
170475466|NCT00509795|616077779|FG000|Overall Study|Death|3|||
170475467|NCT00509795|616077780|FG001|Overall Study|Death|1|||
170546053|NCT01279200|616343966|FG000|Overall Study|Lost to Follow-up|0|||
170546054|NCT01279200|616343967|FG001|Overall Study|Lost to Follow-up|1|||
170546055|NCT01279200|616343966|FG000|Overall Study|Adverse Event|1|||
170546056|NCT01279200|616343967|FG001|Overall Study|Adverse Event|0|||
170546057|NCT01399099|616343968|FG000|Overall Study|Lost to Follow-up|14|||
170546058|NCT01399099|616343968|FG000|Overall Study|Physician Decision|1|||
170546059|NCT01399099|616343968|FG000|Overall Study|Protocol Violation|1|||
170546060|NCT01399099|616343968|FG000|Overall Study|Skin Irritation|13|||
170546061|NCT01399099|616343968|FG000|Overall Study|Infection|1|||
170546062|NCT01399099|616343968|FG000|Overall Study|Miscellaneous|4|||
170546063|NCT01668537|616343969|FG000|Overall Study|Request to Discontinue Prematurely|1|||
170546064|NCT01668537|616343970|FG001|Overall Study|Request to Discontinue Prematurely|1|||
170546065|NCT01668537|616343969|FG000|Overall Study|Subject unwilling/unable to comply|5|||
170546066|NCT01668537|616343970|FG001|Overall Study|Subject unwilling/unable to comply|0|||
170546067|NCT01668537|616343969|FG000|Overall Study|Reason Precludes Participation|1|||
170546068|NCT01668537|616343970|FG001|Overall Study|Reason Precludes Participation|0|||
170546069|NCT01668537|616343969|FG000|Overall Study|Lost to Follow-up|13|||
170546070|NCT01668537|616343970|FG001|Overall Study|Lost to Follow-up|6|||
170546071|NCT01668537|616343969|FG000|Overall Study|Other|2|||
170546072|NCT01668537|616343970|FG001|Overall Study|Other|3|||
170546073|NCT01149538|616343973|FG000|Overall Study|Lost to Follow-up|0|||
170546074|NCT01149538|616343974|FG001|Overall Study|Lost to Follow-up|1|||
170546075|NCT01149538|616343973|FG000|Overall Study|Withdrawal by Subject|5|||
170546076|NCT01149538|616343974|FG001|Overall Study|Withdrawal by Subject|3|||
170546077|NCT00888849|616343977|FG000|Overall Study|Death|4|||
170546078|NCT00888849|616343978|FG001|Overall Study|Death|7|||
170546079|NCT00888849|616343977|FG000|Overall Study|Lost to Follow-up|1|||
170546080|NCT00888849|616343978|FG001|Overall Study|Lost to Follow-up|2|||
170546081|NCT05064800|616343979|FG000|Period 3|Withdrawal by Subject|0|||
170546082|NCT05064800|616343980|FG001|Period 3|Withdrawal by Subject|0|||
170546083|NCT05064800|616343981|FG002|Period 3|Withdrawal by Subject|0|||
170546084|NCT05064800|616343982|FG003|Period 3|Withdrawal by Subject|0|||
170546085|NCT05064800|616343983|FG004|Period 3|Withdrawal by Subject|1|||
170546086|NCT05064800|616343984|FG005|Period 3|Withdrawal by Subject|0|||
170546087|NCT00629239|616343987|FG000|Overall Study|Adverse Event|7|||
170546088|NCT00629239|616343988|FG001|Overall Study|Adverse Event|4|||
170546089|NCT00629239|616343987|FG000|Overall Study|Physician Decision|1|||
170475468|NCT00509795|616077781|FG002|Overall Study|Death|2|||
170475469|NCT00509795|616077782|FG003|Overall Study|Death|7|||
170475470|NCT00509795|616077779|FG000|Overall Study|Lack of Efficacy|0|||
170475471|NCT00509795|616077780|FG001|Overall Study|Lack of Efficacy|0|||
170546090|NCT00629239|616343988|FG001|Overall Study|Physician Decision|0|||
170546091|NCT01871727|616343990|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
170546092|NCT01871727|616343991|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
170546093|NCT01871727|616343992|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
170546094|NCT01871727|616343993|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
170546095|NCT01871727|616343994|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
170546096|NCT01871727|616343990|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
170546097|NCT01871727|616343991|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
170546098|NCT01871727|616343992|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
170546099|NCT01871727|616343993|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
170475472|NCT00509795|616077781|FG002|Overall Study|Lack of Efficacy|2|||
170475473|NCT00509795|616077782|FG003|Overall Study|Lack of Efficacy|2|||
170475474|NCT00509795|616077779|FG000|Overall Study|Lost to Follow-up|1|||
170546100|NCT01871727|616343994|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
170546101|NCT01871727|616343990|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
170638431|NCT00067002|616688246|FG001|Overall Study|Early Death|2|||
170475475|NCT00509795|616077780|FG001|Overall Study|Lost to Follow-up|2|||
170475476|NCT00509795|616077781|FG002|Overall Study|Lost to Follow-up|4|||
170638432|NCT00067002|616688245|FG000|Overall Study|Delayed|1|||
170638433|NCT00067002|616688246|FG001|Overall Study|Delayed|1|||
170638434|NCT00067002|616688245|FG000|Overall Study|Graft Failure|5|||
170638435|NCT00067002|616688246|FG001|Overall Study|Graft Failure|6|||
170638436|NCT00478023|616688249|FG000|Overall Study|Adverse Event|11|||
170638437|NCT00478023|616688250|FG001|Overall Study|Adverse Event|7|||
170638438|NCT00478023|616688251|FG002|Overall Study|Adverse Event|8|||
170638439|NCT00478023|616688252|FG003|Overall Study|Adverse Event|14|||
170638440|NCT00478023|616688253|FG004|Overall Study|Adverse Event|6|||
170638441|NCT00478023|616688249|FG000|Overall Study|Death|1|||
170638442|NCT00478023|616688250|FG001|Overall Study|Death|0|||
170638443|NCT00478023|616688251|FG002|Overall Study|Death|0|||
170638444|NCT00478023|616688252|FG003|Overall Study|Death|0|||
170638445|NCT00478023|616688253|FG004|Overall Study|Death|0|||
170638446|NCT00478023|616688249|FG000|Overall Study|Lack of Efficacy|11|||
170638447|NCT00478023|616688250|FG001|Overall Study|Lack of Efficacy|10|||
170638448|NCT00478023|616688251|FG002|Overall Study|Lack of Efficacy|4|||
170638449|NCT00478023|616688252|FG003|Overall Study|Lack of Efficacy|5|||
170891764|NCT03038308|617611831|FG000|Overall Study|Lost to Follow-up|1|||
170891765|NCT01475734|617611832|FG000|Overall Study|Withdrawal by Subject|1|||
170638450|NCT00478023|616688253|FG004|Overall Study|Lack of Efficacy|41|||
170638451|NCT00478023|616688249|FG000|Overall Study|Lost to Follow-up|3|||
170638452|NCT00478023|616688250|FG001|Overall Study|Lost to Follow-up|1|||
170638453|NCT00478023|616688251|FG002|Overall Study|Lost to Follow-up|1|||
170638454|NCT00478023|616688252|FG003|Overall Study|Lost to Follow-up|1|||
170638455|NCT00478023|616688253|FG004|Overall Study|Lost to Follow-up|0|||
170638456|NCT00478023|616688249|FG000|Overall Study|Withdrawal by Subject|2|||
170638457|NCT00478023|616688250|FG001|Overall Study|Withdrawal by Subject|3|||
170638458|NCT00478023|616688251|FG002|Overall Study|Withdrawal by Subject|2|||
170638459|NCT00478023|616688252|FG003|Overall Study|Withdrawal by Subject|4|||
170638460|NCT00478023|616688253|FG004|Overall Study|Withdrawal by Subject|5|||
170638461|NCT00478023|616688249|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
170638462|NCT00478023|616688250|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
170638463|NCT00478023|616688251|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
170638464|NCT00478023|616688252|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
170638465|NCT00478023|616688253|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
170638466|NCT03895840|616688256|FG000|Overall Study|Withdrawal by Subject|21|||
170638467|NCT01931566|616688257|FG000|Overall Study|Randomized But Not Treated|6|||
170638468|NCT01931566|616688258|FG001|Overall Study|Randomized But Not Treated|9|||
170638469|NCT01931566|616688259|FG002|Overall Study|Randomized But Not Treated|14|||
170638470|NCT01931566|616688257|FG000|Overall Study|Adverse Event|37|||
170638471|NCT01931566|616688258|FG001|Overall Study|Adverse Event|167|||
170638472|NCT01931566|616688259|FG002|Overall Study|Adverse Event|132|||
170638473|NCT01931566|616688257|FG000|Overall Study|Major Protocol Deviation|5|||
170638474|NCT01931566|616688258|FG001|Overall Study|Major Protocol Deviation|14|||
170638475|NCT01931566|616688259|FG002|Overall Study|Major Protocol Deviation|21|||
170638476|NCT01931566|616688257|FG000|Overall Study|Lost to Follow-up|3|||
170638477|NCT01931566|616688258|FG001|Overall Study|Lost to Follow-up|26|||
170638478|NCT01931566|616688259|FG002|Overall Study|Lost to Follow-up|23|||
170638479|NCT01931566|616688257|FG000|Overall Study|Voluntary Withdrawal|78|||
170638480|NCT01931566|616688258|FG001|Overall Study|Voluntary Withdrawal|245|||
170638481|NCT01931566|616688259|FG002|Overall Study|Voluntary Withdrawal|225|||
170638482|NCT01931566|616688257|FG000|Overall Study|Study Termination|289|||
170546102|NCT01871727|616343991|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
170546103|NCT01871727|616343992|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
170546104|NCT01871727|616343993|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
170546105|NCT01871727|616343994|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
170546106|NCT01871727|616343990|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
170546107|NCT01871727|616343991|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
170638483|NCT01931566|616688258|FG001|Overall Study|Study Termination|968|||
170638484|NCT01931566|616688259|FG002|Overall Study|Study Termination|1037|||
170638485|NCT01931566|616688257|FG000|Overall Study|Reason Not Specified|11|||
170638486|NCT01931566|616688258|FG001|Overall Study|Reason Not Specified|47|||
170638487|NCT01931566|616688259|FG002|Overall Study|Reason Not Specified|53|||
170638488|NCT01931566|616688257|FG000|Overall Study|Missing|0|||
170638489|NCT01931566|616688258|FG001|Overall Study|Missing|0|||
170638490|NCT01931566|616688259|FG002|Overall Study|Missing|1|||
170638491|NCT00611026|616688260|FG000|Randomized to Double-blind Treatment|Not treated|2|||
170638492|NCT00611026|616688261|FG001|Randomized to Double-blind Treatment|Not treated|1|||
170891766|NCT01475734|617611833|FG001|Overall Study|Withdrawal by Subject|0|||
170891767|NCT01475734|617611832|FG000|Overall Study|Protocol Violation|1|||
170546108|NCT01871727|616343992|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
170638493|NCT00611026|616688262|FG002|Randomized to Double-blind Treatment|Not treated|3|||
170638494|NCT00611026|616688260|FG000|Double-blind Treatment Period|Death|1|||
170638495|NCT00611026|616688261|FG001|Double-blind Treatment Period|Death|0|||
170891768|NCT01475734|617611833|FG001|Overall Study|Protocol Violation|0|||
170891769|NCT01475734|617611832|FG000|Overall Study|Physician Decision|0|||
170475477|NCT00509795|616077782|FG003|Overall Study|Lost to Follow-up|4|||
170475478|NCT00509795|616077779|FG000|Overall Study|OTHER|1|||
170475479|NCT00509795|616077780|FG001|Overall Study|OTHER|0|||
170475480|NCT00509795|616077781|FG002|Overall Study|OTHER|4|||
170475481|NCT00509795|616077782|FG003|Overall Study|OTHER|1|||
170475482|NCT00509795|616077779|FG000|Overall Study|Protocol Violation|3|||
170475483|NCT00509795|616077780|FG001|Overall Study|Protocol Violation|0|||
170475484|NCT00509795|616077781|FG002|Overall Study|Protocol Violation|3|||
170475485|NCT00509795|616077782|FG003|Overall Study|Protocol Violation|1|||
170475486|NCT00509795|616077779|FG000|Overall Study|Withdrawal by Subject|10|||
170475487|NCT00509795|616077780|FG001|Overall Study|Withdrawal by Subject|5|||
170475488|NCT00509795|616077781|FG002|Overall Study|Withdrawal by Subject|7|||
170475489|NCT00509795|616077782|FG003|Overall Study|Withdrawal by Subject|8|||
170475490|NCT00919854|616077783|FG000|Overall Study|Adverse Event|1|||
170475491|NCT00451178|616077784|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
170475492|NCT00451178|616077785|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
170475493|NCT00451178|616077784|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
170475494|NCT00451178|616077785|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
170475495|NCT00451178|616077784|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
170475496|NCT00451178|616077785|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
170475497|NCT00451178|616077784|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
170475498|NCT00451178|616077785|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
170475499|NCT00451178|616077784|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
170475500|NCT00451178|616077785|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
170475501|NCT00451178|616077784|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
170475502|NCT00451178|616077785|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
170475503|NCT00451178|616077784|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
170475504|NCT00451178|616077785|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
170475505|NCT00451178|616077784|FG000|Prior to Maintenance Therapy|PD|2|||
170475506|NCT00451178|616077785|FG001|Prior to Maintenance Therapy|PD|0|||
170475507|NCT00451178|616077784|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
170475508|NCT00451178|616077785|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
170475509|NCT00451178|616077784|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
170475510|NCT00451178|616077785|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
170475511|NCT00451178|616077784|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
170546109|NCT01871727|616343993|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
170546110|NCT01871727|616343994|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
170546111|NCT01871727|616343990|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
170546112|NCT01871727|616343991|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
170546113|NCT01871727|616343992|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
170546114|NCT01871727|616343993|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
170546115|NCT01871727|616343994|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
170546116|NCT01871727|616343990|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
170546117|NCT01871727|616343991|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
170546118|NCT01871727|616343992|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
170546119|NCT01871727|616343993|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
170546120|NCT01871727|616343994|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
170546121|NCT01871727|616343990|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
170546122|NCT01871727|616343991|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
170546123|NCT01871727|616343992|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
170546124|NCT01871727|616343993|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
170546125|NCT01871727|616343994|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
170546126|NCT01263028|616343995|FG000|Overall Study|Withdrawal by Subject|1|||
170546127|NCT01263028|616343995|FG000|Overall Study|Adverse Event|1|||
170546128|NCT01263028|616343995|FG000|Overall Study|Study terminated due to low enrollment.|4|||
170546129|NCT00250718|616343996|FG000|Overall Study|Death|1|||
170546130|NCT00250718|616343996|FG000|Overall Study|Adverse Event|1|||
170546131|NCT00250718|616343996|FG000|Overall Study|Withdrawal by Subject|1|||
170546132|NCT00086307|616343997|FG000|Overall Study|Lack of Efficacy|1|||
170546133|NCT00086307|616343998|FG001|Overall Study|Lack of Efficacy|1|||
170546134|NCT00086307|616343999|FG002|Overall Study|Lack of Efficacy|2|||
170546135|NCT00086307|616343997|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
170546136|NCT00086307|616343998|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
170546137|NCT00086307|616343999|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
170546138|NCT00086307|616343997|FG000|Overall Study|Nausea and headaches|0|||
170546139|NCT00086307|616343998|FG001|Overall Study|Nausea and headaches|0|||
170546140|NCT00086307|616343999|FG002|Overall Study|Nausea and headaches|1|||
170546141|NCT00086307|616343997|FG000|Overall Study|Constipation and sleepiness|0|||
170546142|NCT00086307|616343998|FG001|Overall Study|Constipation and sleepiness|0|||
170546143|NCT00086307|616343999|FG002|Overall Study|Constipation and sleepiness|1|||
170475512|NCT00451178|616077785|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
170475513|NCT00451178|616077784|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
170475514|NCT00451178|616077785|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
170475515|NCT00451178|616077784|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
170475516|NCT00451178|616077785|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
170475517|NCT00451178|616077784|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
170475518|NCT00451178|616077785|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
170475519|NCT00451178|616077784|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
170475520|NCT00451178|616077785|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
170475521|NCT02447744|616077786|FG000|Overall Study|Withdrawal by Subject|3|||
170475522|NCT02447744|616077787|FG001|Overall Study|Withdrawal by Subject|1|||
170475523|NCT02447744|616077786|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
170475524|NCT02447744|616077787|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
170475525|NCT04467840|616080016|FG000|Overall Study|Death|35|||
170475526|NCT04467840|616080017|FG001|Overall Study|Death|39|||
170475527|NCT04467840|616080016|FG000|Overall Study|Withdrawal by Subject|8|||
170475528|NCT04467840|616080017|FG001|Overall Study|Withdrawal by Subject|4|||
170475529|NCT04467840|616080016|FG000|Overall Study|Adverse Event|2|||
170475530|NCT04467840|616080017|FG001|Overall Study|Adverse Event|0|||
170475531|NCT04467840|616080016|FG000|Overall Study|Lost to Follow-up|1|||
170475532|NCT04467840|616080017|FG001|Overall Study|Lost to Follow-up|3|||
170475533|NCT04467840|616080016|FG000|Overall Study|Physician Decision|1|||
170475534|NCT04467840|616080017|FG001|Overall Study|Physician Decision|0|||
170475535|NCT04467840|616080016|FG000|Overall Study|Other|1|||
170475536|NCT04467840|616080017|FG001|Overall Study|Other|5|||
170475537|NCT04467840|616080016|FG000|Overall Study|Missing study completion status|3|||
170475538|NCT04467840|616080017|FG001|Overall Study|Missing study completion status|1|||
170475539|NCT04653454|616080021|FG000|Overall Study|Withdrawal by Subject|1|||
170475540|NCT04653454|616080021|FG000|Overall Study|Physician Decision|40|||
170475541|NCT03560037|616080022|FG000|Overall Study|Protocol Violation|1|||
170475542|NCT03560037|616080023|FG001|Overall Study|Protocol Violation|0|||
170475543|NCT03560037|616080022|FG000|Overall Study|Physician Decision|0|||
170475544|NCT03560037|616080023|FG001|Overall Study|Physician Decision|1|||
170546144|NCT00086307|616343997|FG000|Overall Study|Suicidal ideation|0|||
170546145|NCT00086307|616343998|FG001|Overall Study|Suicidal ideation|0|||
170546146|NCT00086307|616343999|FG002|Overall Study|Suicidal ideation|1|||
170546147|NCT00086307|616343997|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
170546148|NCT00086307|616343998|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
170546149|NCT00086307|616343999|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
170546150|NCT00086307|616343997|FG000|Overall Study|Withdrawal by Subject|0|||
170546151|NCT00086307|616343998|FG001|Overall Study|Withdrawal by Subject|0|||
170546152|NCT00086307|616343999|FG002|Overall Study|Withdrawal by Subject|2|||
170546153|NCT03158311|616344002|FG000|Overall Study|Subject/Guardian Decision|10|||
170546154|NCT03158311|616344003|FG001|Overall Study|Subject/Guardian Decision|6|||
170546155|NCT03158311|616344004|FG002|Overall Study|Subject/Guardian Decision|11|||
170546156|NCT03158311|616344002|FG000|Overall Study|Adverse Event|5|||
170546157|NCT03158311|616344003|FG001|Overall Study|Adverse Event|3|||
170546158|NCT03158311|616344004|FG002|Overall Study|Adverse Event|3|||
170546159|NCT03158311|616344002|FG000|Overall Study|Techinical Problems|3|||
170546160|NCT03158311|616344003|FG001|Overall Study|Techinical Problems|1|||
170546161|NCT03158311|616344004|FG002|Overall Study|Techinical Problems|5|||
170546162|NCT03158311|616344002|FG000|Overall Study|Physician Decision|2|||
170546163|NCT03158311|616344003|FG001|Overall Study|Physician Decision|3|||
170546164|NCT03158311|616344004|FG002|Overall Study|Physician Decision|7|||
170546165|NCT03158311|616344002|FG000|Overall Study|Lost to Follow-up|1|||
170546166|NCT03158311|616344003|FG001|Overall Study|Lost to Follow-up|1|||
170546167|NCT03158311|616344004|FG002|Overall Study|Lost to Follow-up|1|||
170475545|NCT04515147|616080025|FG000|Overall Study|Withdrawal by Subject|1|||
170475546|NCT04515147|616080026|FG001|Overall Study|Withdrawal by Subject|0|||
170475547|NCT04515147|616080027|FG002|Overall Study|Withdrawal by Subject|10|||
170475548|NCT04515147|616080028|FG003|Overall Study|Withdrawal by Subject|18|||
170546168|NCT03158311|616344002|FG000|Overall Study|Sponsor decision|1|||
170638496|NCT00611026|616688262|FG002|Double-blind Treatment Period|Death|0|||
170475549|NCT04515147|616080029|FG004|Overall Study|Withdrawal by Subject|1|||
170475550|NCT04515147|616080030|FG005|Overall Study|Withdrawal by Subject|8|||
170475551|NCT04515147|616080025|FG000|Overall Study|Lost to Follow-up|0|||
170475552|NCT04515147|616080026|FG001|Overall Study|Lost to Follow-up|1|||
170475553|NCT04515147|616080027|FG002|Overall Study|Lost to Follow-up|5|||
170475554|NCT04515147|616080028|FG003|Overall Study|Lost to Follow-up|6|||
170475555|NCT04515147|616080029|FG004|Overall Study|Lost to Follow-up|2|||
170546169|NCT03158311|616344003|FG001|Overall Study|Sponsor decision|0|||
170475556|NCT04515147|616080030|FG005|Overall Study|Lost to Follow-up|1|||
170475557|NCT04515147|616080025|FG000|Overall Study|Adverse Event|0|||
170546170|NCT03158311|616344004|FG002|Overall Study|Sponsor decision|0|||
170546171|NCT03158311|616344002|FG000|Overall Study|Pregnancy|0|||
170546172|NCT03158311|616344003|FG001|Overall Study|Pregnancy|2|||
170546173|NCT03158311|616344004|FG002|Overall Study|Pregnancy|0|||
170792183|NCT01928394|617249439|FG011|Treatment Period|Disease progression|73|||
170792184|NCT01928394|617249440|FG012|Treatment Period|Disease progression|38|||
170792185|NCT01928394|617249441|FG013|Treatment Period|Disease progression|118|||
170792186|NCT01928394|617249442|FG014|Treatment Period|Disease progression|59|||
170792187|NCT01928394|617249443|FG015|Treatment Period|Disease progression|1|||
170792188|NCT01928394|617249444|FG016|Treatment Period|Disease progression|43|||
170792189|NCT01928394|617249445|FG017|Treatment Period|Disease progression|56|||
170792190|NCT01928394|617249446|FG018|Treatment Period|Disease progression|50|||
170792191|NCT01928394|617249447|FG019|Treatment Period|Disease progression|71|||
170792192|NCT01928394|617249448|FG020|Treatment Period|Disease progression|30|||
170792193|NCT01928394|617249449|FG021|Treatment Period|Disease progression|31|||
170792194|NCT01928394|617249450|FG022|Treatment Period|Disease progression|31|||
170792195|NCT01928394|617249428|FG000|Treatment Period|Study drug toxicity|1|||
170792196|NCT01928394|617249429|FG001|Treatment Period|Study drug toxicity|1|||
170792197|NCT01928394|617249430|FG002|Treatment Period|Study drug toxicity|3|||
170792198|NCT01928394|617249431|FG003|Treatment Period|Study drug toxicity|3|||
170792199|NCT01928394|617249432|FG004|Treatment Period|Study drug toxicity|0|||
170792200|NCT01928394|617249433|FG005|Treatment Period|Study drug toxicity|9|||
170792201|NCT01928394|617249434|FG006|Treatment Period|Study drug toxicity|7|||
170792202|NCT01928394|617249435|FG007|Treatment Period|Study drug toxicity|1|||
170792203|NCT01928394|617249436|FG008|Treatment Period|Study drug toxicity|0|||
170792204|NCT01928394|617249437|FG009|Treatment Period|Study drug toxicity|5|||
170792205|NCT01928394|617249438|FG010|Treatment Period|Study drug toxicity|2|||
170475558|NCT04515147|616080026|FG001|Overall Study|Adverse Event|0|||
170475559|NCT04515147|616080027|FG002|Overall Study|Adverse Event|0|||
170475560|NCT04515147|616080028|FG003|Overall Study|Adverse Event|2|||
170475561|NCT04515147|616080029|FG004|Overall Study|Adverse Event|0|||
170475562|NCT04515147|616080030|FG005|Overall Study|Adverse Event|0|||
170475563|NCT04515147|616080025|FG000|Overall Study|Miscellaneous|0|||
170475564|NCT04515147|616080026|FG001|Overall Study|Miscellaneous|0|||
170475565|NCT04515147|616080027|FG002|Overall Study|Miscellaneous|0|||
170475566|NCT04515147|616080028|FG003|Overall Study|Miscellaneous|1|||
170475567|NCT04515147|616080029|FG004|Overall Study|Miscellaneous|0|||
170475568|NCT04515147|616080030|FG005|Overall Study|Miscellaneous|1|||
170475569|NCT01811472|616080038|FG000|Overall Study|Adverse Event|1|||
170475570|NCT01811472|616080039|FG001|Overall Study|Adverse Event|0|||
170475571|NCT01811472|616080040|FG002|Overall Study|Adverse Event|4|||
170475572|NCT01811472|616080038|FG000|Overall Study|Lost to Follow-up|0|||
170475573|NCT01811472|616080039|FG001|Overall Study|Lost to Follow-up|0|||
170475574|NCT01811472|616080040|FG002|Overall Study|Lost to Follow-up|1|||
170475575|NCT01811472|616080038|FG000|Overall Study|Subject/guardian decision|1|||
170475576|NCT01811472|616080039|FG001|Overall Study|Subject/guardian decision|0|||
170475577|NCT01811472|616080040|FG002|Overall Study|Subject/guardian decision|0|||
170475578|NCT04882241|616080041|FG000|Overall Study|Ongoing in study|46|||
170475579|NCT04882241|616080042|FG001|Overall Study|Ongoing in study|48|||
170475580|NCT04882241|616080043|FG002|Overall Study|Ongoing in study|0|||
170475581|NCT04882241|616080044|FG003|Overall Study|Ongoing in study|0|||
170475582|NCT04882241|616080041|FG000|Overall Study|Death|13|||
170475583|NCT04882241|616080042|FG001|Overall Study|Death|13|||
170475584|NCT04882241|616080043|FG002|Overall Study|Death|0|||
170475585|NCT04882241|616080044|FG003|Overall Study|Death|0|||
170475586|NCT02719184|616080047|FG000|Overall Study|Other than listed|1|||
170475587|NCT02719184|616080048|FG001|Overall Study|Other than listed|12|||
170475588|NCT02719184|616080049|FG002|Overall Study|Other than listed|13|||
170475589|NCT02719184|616080050|FG003|Overall Study|Other than listed|22|||
170792206|NCT01928394|617249439|FG011|Treatment Period|Study drug toxicity|3|||
170792207|NCT01928394|617249440|FG012|Treatment Period|Study drug toxicity|7|||
170792208|NCT01928394|617249441|FG013|Treatment Period|Study drug toxicity|5|||
170792209|NCT01928394|617249442|FG014|Treatment Period|Study drug toxicity|12|||
170792210|NCT01928394|617249443|FG015|Treatment Period|Study drug toxicity|0|||
170792211|NCT01928394|617249444|FG016|Treatment Period|Study drug toxicity|3|||
170792212|NCT01928394|617249445|FG017|Treatment Period|Study drug toxicity|3|||
170792213|NCT01928394|617249446|FG018|Treatment Period|Study drug toxicity|12|||
170792214|NCT01928394|617249447|FG019|Treatment Period|Study drug toxicity|15|||
170475590|NCT02719184|616080051|FG004|Overall Study|Other than listed|9|||
170475591|NCT02719184|616080047|FG000|Overall Study|Withdrawal by Subject|5|||
170475592|NCT02719184|616080048|FG001|Overall Study|Withdrawal by Subject|3|||
170475593|NCT02719184|616080049|FG002|Overall Study|Withdrawal by Subject|6|||
170792215|NCT01928394|617249448|FG020|Treatment Period|Study drug toxicity|4|||
170792216|NCT01928394|617249449|FG021|Treatment Period|Study drug toxicity|7|||
170792217|NCT01928394|617249450|FG022|Treatment Period|Study drug toxicity|4|||
170475594|NCT02719184|616080050|FG003|Overall Study|Withdrawal by Subject|6|||
170475595|NCT02719184|616080051|FG004|Overall Study|Withdrawal by Subject|0|||
170475596|NCT02719184|616080047|FG000|Overall Study|Lost to Follow-up|0|||
170475597|NCT02719184|616080048|FG001|Overall Study|Lost to Follow-up|4|||
170475598|NCT02719184|616080049|FG002|Overall Study|Lost to Follow-up|1|||
170475599|NCT02719184|616080050|FG003|Overall Study|Lost to Follow-up|3|||
170475600|NCT02719184|616080051|FG004|Overall Study|Lost to Follow-up|0|||
170546174|NCT03158311|616344002|FG000|Overall Study|Randomized in error|0|||
170546175|NCT03158311|616344003|FG001|Overall Study|Randomized in error|0|||
170546176|NCT03158311|616344004|FG002|Overall Study|Randomized in error|1|||
170546177|NCT01184118|616344005|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
170546178|NCT01184118|616344005|FG000|Overall Study|No physiologic confirmation of asthma|8|||
170546179|NCT01184118|616344005|FG000|Overall Study|FEV1 <60% predicted|2|||
170546180|NCT01184118|616344005|FG000|Overall Study|Exclusionary medical condition|2|||
170546181|NCT01184118|616344005|FG000|Overall Study|Withdrawal by Subject|5|||
170546182|NCT01928771|616344011|FG000|Overall Study|Adverse Event|6|||
170546183|NCT01928771|616344012|FG001|Overall Study|Adverse Event|5|||
170546184|NCT01928771|616344013|FG002|Overall Study|Adverse Event|1|||
170546185|NCT01928771|616344011|FG000|Overall Study|Death|2|||
170546186|NCT01928771|616344012|FG001|Overall Study|Death|2|||
170546187|NCT01928771|616344013|FG002|Overall Study|Death|2|||
170546188|NCT01928771|616344011|FG000|Overall Study|Lost to Follow-up|5|||
170546189|NCT01928771|616344012|FG001|Overall Study|Lost to Follow-up|6|||
170546190|NCT01928771|616344013|FG002|Overall Study|Lost to Follow-up|3|||
170546191|NCT01928771|616344011|FG000|Overall Study|Withdrawal by Subject|20|||
170546192|NCT01928771|616344012|FG001|Overall Study|Withdrawal by Subject|15|||
170546193|NCT01928771|616344013|FG002|Overall Study|Withdrawal by Subject|17|||
170546194|NCT01928771|616344011|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
170546195|NCT01928771|616344012|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
170546196|NCT01928771|616344013|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
170546197|NCT01928771|616344011|FG000|Overall Study|Other Reasons|9|||
170546198|NCT01928771|616344012|FG001|Overall Study|Other Reasons|9|||
170546199|NCT01928771|616344013|FG002|Overall Study|Other Reasons|14|||
170546200|NCT01928771|616344011|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
170546201|NCT01928771|616344012|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
170546202|NCT01928771|616344013|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
170546203|NCT01560416|616344016|FG000|Randomized Phase|Crossover Participants|7|||
170546204|NCT01560416|616344017|FG001|Randomized Phase|Crossover Participants|0|||
170546205|NCT01030900|616344018|FG000|Overall Study|Not treated due to congestive heart failure|1|||
170546206|NCT01030900|616344018|FG000|Overall Study|Not treated due to rapid disease|1|||
170546207|NCT00004859|616344024|FG000|Overall Study|Lack of Efficacy|43|||
170546208|NCT00004859|616344025|FG001|Overall Study|Lack of Efficacy|113|||
170546209|NCT00004859|616344024|FG000|Overall Study|Adverse Event|31|||
170546210|NCT00004859|616344025|FG001|Overall Study|Adverse Event|93|||
170546211|NCT00004859|616344024|FG000|Overall Study|Death|5|||
170546212|NCT00004859|616344025|FG001|Overall Study|Death|5|||
170546213|NCT00004859|616344024|FG000|Overall Study|Withdrawal by Subject|7|||
170546214|NCT00004859|616344025|FG001|Overall Study|Withdrawal by Subject|33|||
170546215|NCT00004859|616344024|FG000|Overall Study|Protocol Violation|2|||
170546216|NCT00004859|616344025|FG001|Overall Study|Protocol Violation|2|||
170546217|NCT00004859|616344024|FG000|Overall Study|other disease|0|||
170546218|NCT00004859|616344025|FG001|Overall Study|other disease|3|||
170546219|NCT00004859|616344024|FG000|Overall Study|error|3|||
170546220|NCT00004859|616344025|FG001|Overall Study|error|1|||
170546221|NCT00004859|616344024|FG000|Overall Study|missing data|14|||
170546222|NCT00004859|616344025|FG001|Overall Study|missing data|11|||
170546223|NCT00004859|616344024|FG000|Overall Study|Other|13|||
170638497|NCT00611026|616688260|FG000|Double-blind Treatment Period|Adverse Event|9|||
170638498|NCT00611026|616688261|FG001|Double-blind Treatment Period|Adverse Event|28|||
170546224|NCT00004859|616344025|FG001|Overall Study|Other|21|||
170546225|NCT04073407|616344026|FG000|Part 1|Withdrawal by Subject|1|||
170546226|NCT04073407|616344027|FG001|Part 1|Withdrawal by Subject|0|||
170546227|NCT04073407|616344026|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
170546228|NCT04073407|616344027|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
170546229|NCT04073407|616344026|FG000|Part 2|Withdrawal by Subject|0|||
170546230|NCT04073407|616344027|FG001|Part 2|Withdrawal by Subject|1|||
170546231|NCT00944645|616345793|FG000|Period 2|Adverse Event|1|||
170546232|NCT00944645|616345794|FG001|Period 2|Adverse Event|0|||
170546233|NCT00944645|616345793|FG000|Period 2|Lost to Follow-up|0|||
170546234|NCT00944645|616345794|FG001|Period 2|Lost to Follow-up|3|||
170546235|NCT00944645|616345793|FG000|Period 2|Withdrawal by Subject|7|||
170546236|NCT00944645|616345794|FG001|Period 2|Withdrawal by Subject|6|||
170546237|NCT03684057|616345795|FG000|Overall Study|Withdrawal by Subject|4|||
170546238|NCT03684057|616345796|FG001|Overall Study|Withdrawal by Subject|5|||
170546239|NCT04621786|616345802|FG000|Overall Study|Lost to Follow-up|9|||
170546240|NCT04621786|616345802|FG000|Overall Study|Protocol Violation|3|||
170546241|NCT00710554|616345803|FG000|Overall Study|Adverse Event|24|||
170546242|NCT00710554|616345804|FG001|Overall Study|Adverse Event|7|||
170546243|NCT00710554|616345803|FG000|Overall Study|Withdrawal by Subject|7|||
170546244|NCT00710554|616345804|FG001|Overall Study|Withdrawal by Subject|3|||
170546245|NCT00710554|616345803|FG000|Overall Study|Lost to Follow-up|7|||
170546246|NCT00710554|616345804|FG001|Overall Study|Lost to Follow-up|1|||
170546247|NCT00710554|616345803|FG000|Overall Study|Lack of Efficacy|11|||
170546248|NCT00710554|616345804|FG001|Overall Study|Lack of Efficacy|12|||
170891770|NCT01475734|617611833|FG001|Overall Study|Physician Decision|1|||
170891771|NCT00483327|617611834|FG000|Overall Study|Adverse Event|1|||
170891772|NCT00483327|617611834|FG000|Overall Study|Withdrawal by Subject|3|||
170475601|NCT02719184|616080047|FG000|Overall Study|Protocol Violation|0|||
170475602|NCT02719184|616080048|FG001|Overall Study|Protocol Violation|3|||
170475603|NCT02719184|616080049|FG002|Overall Study|Protocol Violation|0|||
170475604|NCT02719184|616080050|FG003|Overall Study|Protocol Violation|2|||
170475605|NCT02719184|616080051|FG004|Overall Study|Protocol Violation|0|||
170475606|NCT02719184|616080047|FG000|Overall Study|Adverse Event|0|||
170475607|NCT02719184|616080048|FG001|Overall Study|Adverse Event|0|||
170475608|NCT02719184|616080049|FG002|Overall Study|Adverse Event|0|||
170475609|NCT02719184|616080050|FG003|Overall Study|Adverse Event|3|||
170475610|NCT02719184|616080051|FG004|Overall Study|Adverse Event|0|||
170475611|NCT02955212|616080052|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
170475612|NCT02955212|616080053|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
170475613|NCT02955212|616080052|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
170475614|NCT02955212|616080053|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
170475615|NCT02955212|616080052|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
170475616|NCT02955212|616080053|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
170475617|NCT02955212|616080052|FG000|Period 1: Double-blind Treatment Period|Other|3|||
170475618|NCT02955212|616080053|FG001|Period 1: Double-blind Treatment Period|Other|2|||
170475619|NCT02955212|616080052|FG000|Period 2: Open-label Extension|Adverse Event|11|||
170475620|NCT02955212|616080053|FG001|Period 2: Open-label Extension|Adverse Event|7|||
170475621|NCT02955212|616080052|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
170475622|NCT02955212|616080053|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
170475623|NCT02955212|616080052|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
170475624|NCT02955212|616080053|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
170475625|NCT02955212|616080052|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
170546249|NCT00710554|616345803|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
170546250|NCT00710554|616345804|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
170546251|NCT01093885|616345805|FG000|Overall Study|Adverse Event|4|||
170546252|NCT01093885|616345805|FG000|Overall Study|Lost to Follow-up|1|||
170891773|NCT00483327|617611834|FG000|Overall Study|Lost to Follow-up|4|||
170891774|NCT00483327|617611834|FG000|Overall Study|Patient Non Compliance|2|||
170891775|NCT03609619|617611837|FG000|Overall Study|Adverse Event|1|||
170891776|NCT03609619|617611838|FG001|Overall Study|Adverse Event|0|||
170891777|NCT03609619|617611837|FG000|Overall Study|Lack of Efficacy|1|||
170891778|NCT03609619|617611838|FG001|Overall Study|Lack of Efficacy|2|||
170891779|NCT03609619|617611837|FG000|Overall Study|Protocol Violation|5|||
170891780|NCT03609619|617611838|FG001|Overall Study|Protocol Violation|0|||
170891781|NCT03609619|617611837|FG000|Overall Study|Withdrawal by Subject|2|||
170891782|NCT03609619|617611838|FG001|Overall Study|Withdrawal by Subject|3|||
170891783|NCT03609619|617611837|FG000|Overall Study|Lost to Follow-up|1|||
170891784|NCT03609619|617611838|FG001|Overall Study|Lost to Follow-up|1|||
170891785|NCT00568555|617611839|FG000|Overall Study|Withdrawal by Subject|1|||
170891786|NCT00568555|617611840|FG001|Overall Study|Withdrawal by Subject|1|||
170475626|NCT02955212|616080053|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
170475627|NCT02955212|616080052|FG000|Period 2: Open-label Extension|Other|2|||
170475628|NCT02955212|616080053|FG001|Period 2: Open-label Extension|Other|4|||
170475629|NCT02454933|616080058|FG000|Overall Study|Progressive disease|10|||
170475630|NCT02454933|616080059|FG001|Overall Study|Progressive disease|7|||
170546253|NCT00292370|616345810|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
170546254|NCT00292370|616345811|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
170546255|NCT00292370|616345812|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
170546256|NCT00292370|616345810|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
170546257|NCT00292370|616345811|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
170546258|NCT00292370|616345812|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
170546259|NCT00292370|616345810|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
170546260|NCT00292370|616345811|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
170891787|NCT01231555|617611841|FG000|Overall Study|Study terminated|8|||
170891788|NCT01231555|617611842|FG001|Overall Study|Study terminated|5|||
170891789|NCT01231555|617611843|FG002|Overall Study|Study terminated|8|||
170891790|NCT01231555|617611841|FG000|Overall Study|Withdrawal by Subject|0|||
170891791|NCT01231555|617611842|FG001|Overall Study|Withdrawal by Subject|2|||
170475631|NCT02454933|616080058|FG000|Overall Study|Adverse Event|1|||
170891792|NCT01231555|617611843|FG002|Overall Study|Withdrawal by Subject|0|||
170891793|NCT03068325|617611847|FG000|Overall Study|Lost to Follow-up|5|||
170891794|NCT03588741|617611848|FG000|Overall Study|Withdrawal by Subject|1|||
170891795|NCT01445535|617611849|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
170891796|NCT01445535|617611850|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
170891797|NCT01445535|617611851|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
170891798|NCT01445535|617611852|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
170475632|NCT02454933|616080059|FG001|Overall Study|Adverse Event|1|||
170475633|NCT02454933|616080058|FG000|Overall Study|Withdrawal by Subject|0|||
170475634|NCT02454933|616080059|FG001|Overall Study|Withdrawal by Subject|3|||
170475635|NCT02454933|616080058|FG000|Overall Study|Lost to Follow-up|1|||
170475636|NCT02454933|616080059|FG001|Overall Study|Lost to Follow-up|0|||
170475637|NCT02515331|616080069|FG000|Overall Study|Withdrawal by Subject|0|||
170475638|NCT02515331|616080070|FG001|Overall Study|Withdrawal by Subject|0|||
170475639|NCT02515331|616080071|FG002|Overall Study|Withdrawal by Subject|1|||
170475640|NCT02515331|616080069|FG000|Overall Study|Protocol deviation|0|||
170475641|NCT02515331|616080070|FG001|Overall Study|Protocol deviation|0|||
170475642|NCT02515331|616080071|FG002|Overall Study|Protocol deviation|3|||
170475643|NCT02515331|616080069|FG000|Overall Study|Adverse Event|2|||
170475644|NCT02515331|616080070|FG001|Overall Study|Adverse Event|0|||
170475645|NCT02515331|616080071|FG002|Overall Study|Adverse Event|0|||
170475646|NCT02071225|616080072|FG000|Overall Study|Withdrawal of Consent|2|||
170475647|NCT02071225|616080072|FG000|Overall Study|Protocol Deviation|1|||
170475648|NCT02071225|616080072|FG000|Overall Study|Lost to Follow-up|2|||
170475649|NCT02071225|616080072|FG000|Overall Study|Death|25|||
170475650|NCT00758524|616080075|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
170475651|NCT00758524|616080076|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
170475652|NCT00758524|616080077|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
170475653|NCT00758524|616080078|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475654|NCT00758524|616080079|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
170475655|NCT00758524|616080080|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
170475656|NCT00758524|616080081|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475657|NCT00758524|616080082|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475658|NCT00758524|616080083|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475659|NCT00758524|616080084|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475660|NCT00758524|616080085|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475661|NCT00758524|616080086|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475662|NCT00758524|616080087|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475663|NCT00758524|616080088|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475664|NCT00758524|616080089|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475665|NCT00758524|616080090|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475666|NCT00758524|616080091|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
170475667|NCT00758524|616080075|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
170475668|NCT00758524|616080076|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475669|NCT00758524|616080077|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
170475670|NCT00758524|616080078|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
170475671|NCT00758524|616080079|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
170546261|NCT00292370|616345812|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
170546262|NCT00292370|616345810|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
170792218|NCT01928394|617249428|FG000|Treatment Period|AE unrelated to study drug|0|||
170792219|NCT01928394|617249429|FG001|Treatment Period|AE unrelated to study drug|0|||
170792220|NCT01928394|617249430|FG002|Treatment Period|AE unrelated to study drug|2|||
170792221|NCT01928394|617249431|FG003|Treatment Period|AE unrelated to study drug|3|||
170792222|NCT01928394|617249432|FG004|Treatment Period|AE unrelated to study drug|0|||
170792223|NCT01928394|617249433|FG005|Treatment Period|AE unrelated to study drug|5|||
170792224|NCT01928394|617249434|FG006|Treatment Period|AE unrelated to study drug|1|||
170792225|NCT01928394|617249435|FG007|Treatment Period|AE unrelated to study drug|0|||
170546263|NCT00292370|616345811|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
170546264|NCT00292370|616345812|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
170546265|NCT00292370|616345810|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
170546266|NCT00292370|616345811|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
170546267|NCT00292370|616345812|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
170546268|NCT00292370|616345810|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
170546269|NCT00292370|616345811|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
170546270|NCT00292370|616345812|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
170792226|NCT01928394|617249436|FG008|Treatment Period|AE unrelated to study drug|0|||
170475672|NCT00758524|616080080|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
170475673|NCT00758524|616080081|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475674|NCT00758524|616080082|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475675|NCT00758524|616080083|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475676|NCT00758524|616080084|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475677|NCT00758524|616080085|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170546271|NCT01301001|616345813|FG000|First Intervention|Lost to Follow-up|4|||
170546272|NCT01301001|616345814|FG001|First Intervention|Lost to Follow-up|4|||
170475678|NCT00758524|616080086|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475679|NCT00758524|616080087|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475680|NCT00758524|616080088|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170546273|NCT01301001|616345813|FG000|First Intervention|Withdrawal by Subject|1|||
170475681|NCT00758524|616080089|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475682|NCT00758524|616080090|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475683|NCT00758524|616080091|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
170475684|NCT00758524|616080075|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
170475685|NCT00758524|616080076|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
170475686|NCT00758524|616080077|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
170475687|NCT00758524|616080078|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
170475688|NCT00758524|616080079|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
170475689|NCT00758524|616080080|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
170475690|NCT00758524|616080081|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475691|NCT00758524|616080082|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475692|NCT00758524|616080083|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475693|NCT00758524|616080084|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475694|NCT00758524|616080085|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475695|NCT00758524|616080086|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475696|NCT00758524|616080087|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475697|NCT00758524|616080088|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475698|NCT00758524|616080089|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475699|NCT00758524|616080090|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475700|NCT00758524|616080091|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
170475701|NCT00758524|616080075|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475702|NCT00758524|616080076|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
170475703|NCT00758524|616080077|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
170475704|NCT00758524|616080078|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475705|NCT00758524|616080079|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
170475706|NCT00758524|616080080|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
170475707|NCT00758524|616080081|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475708|NCT00758524|616080082|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475709|NCT00758524|616080083|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475710|NCT00758524|616080084|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475711|NCT00758524|616080085|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475712|NCT00758524|616080086|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475713|NCT00758524|616080087|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475714|NCT00758524|616080088|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475715|NCT00758524|616080089|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475716|NCT00758524|616080090|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475717|NCT00758524|616080091|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
170475718|NCT00758524|616080075|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475719|NCT00758524|616080076|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475720|NCT00758524|616080077|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
170475721|NCT00758524|616080078|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
170475722|NCT00758524|616080079|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475723|NCT00758524|616080080|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475724|NCT00758524|616080081|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475725|NCT00758524|616080082|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170546274|NCT01301001|616345814|FG001|First Intervention|Withdrawal by Subject|4|||
170546275|NCT01301001|616345813|FG000|First Intervention|Adverse Event|5|||
170546276|NCT01301001|616345814|FG001|First Intervention|Adverse Event|0|||
170475726|NCT00758524|616080083|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475727|NCT00758524|616080084|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475728|NCT00758524|616080085|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475729|NCT00758524|616080086|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475730|NCT00758524|616080087|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475731|NCT00758524|616080088|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475732|NCT00758524|616080089|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475733|NCT00758524|616080090|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475734|NCT00758524|616080091|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
170475735|NCT00758524|616080075|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475736|NCT00758524|616080076|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170546277|NCT01301001|616345813|FG000|First Intervention|Protocol Violation|0|||
170546278|NCT01301001|616345814|FG001|First Intervention|Protocol Violation|1|||
170475737|NCT00758524|616080077|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475738|NCT00758524|616080078|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475739|NCT00758524|616080079|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
170475740|NCT00758524|616080080|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475741|NCT00758524|616080081|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475742|NCT00758524|616080082|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475743|NCT00758524|616080083|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475744|NCT00758524|616080084|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475745|NCT00758524|616080085|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475746|NCT00758524|616080086|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475747|NCT00758524|616080087|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475748|NCT00758524|616080088|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475749|NCT00758524|616080089|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475750|NCT00758524|616080090|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475751|NCT00758524|616080091|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
170475752|NCT00758524|616080075|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475753|NCT00758524|616080076|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
170475754|NCT00758524|616080077|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475755|NCT00758524|616080078|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475756|NCT00758524|616080079|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475757|NCT00758524|616080080|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475758|NCT00758524|616080081|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475759|NCT00758524|616080082|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475760|NCT00758524|616080083|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475761|NCT00758524|616080084|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475762|NCT00758524|616080085|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475763|NCT00758524|616080086|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475764|NCT00758524|616080087|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475765|NCT00758524|616080088|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475766|NCT00758524|616080089|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475767|NCT00758524|616080090|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475768|NCT00758524|616080091|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
170475769|NCT00758524|616080075|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475770|NCT00758524|616080076|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
170475771|NCT00758524|616080077|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475772|NCT00758524|616080078|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475773|NCT00758524|616080079|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475774|NCT00758524|616080080|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475775|NCT00758524|616080081|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475776|NCT00758524|616080082|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475777|NCT00758524|616080083|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475778|NCT00758524|616080084|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475779|NCT00758524|616080085|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475780|NCT00758524|616080086|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475781|NCT00758524|616080087|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475782|NCT00758524|616080088|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475783|NCT00758524|616080089|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475784|NCT00758524|616080090|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475785|NCT00758524|616080091|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
170475786|NCT00758524|616080075|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475787|NCT00758524|616080076|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170546279|NCT01301001|616345813|FG000|Second Intervention|Adverse Event|2|||
170546280|NCT01301001|616345814|FG001|Second Intervention|Adverse Event|0|||
170546281|NCT01301001|616345813|FG000|Second Intervention|Withdrawal by Subject|2|||
170475788|NCT00758524|616080077|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475789|NCT00758524|616080078|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475790|NCT00758524|616080079|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475791|NCT00758524|616080080|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475792|NCT00758524|616080081|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475793|NCT00758524|616080082|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170546282|NCT01301001|616345814|FG001|Second Intervention|Withdrawal by Subject|0|||
170546283|NCT01158404|616345815|FG000|Overall Study|Withdrawal by Subject|0|||
170546284|NCT01158404|616345816|FG001|Overall Study|Withdrawal by Subject|1|||
170475794|NCT00758524|616080083|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
170891799|NCT01445535|617611849|FG000|Overall Study|Disease progression|1|||
170891800|NCT01445535|617611850|FG001|Overall Study|Disease progression|0|||
170891801|NCT01445535|617611851|FG002|Overall Study|Disease progression|1|||
170891802|NCT01445535|617611852|FG003|Overall Study|Disease progression|0|||
170891803|NCT01445535|617611849|FG000|Overall Study|PI discretion|0|||
170891804|NCT01445535|617611850|FG001|Overall Study|PI discretion|0|||
170475795|NCT00758524|616080084|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475796|NCT00758524|616080085|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475797|NCT00758524|616080086|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475798|NCT00758524|616080087|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475799|NCT00758524|616080088|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475800|NCT00758524|616080089|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475801|NCT00758524|616080090|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475802|NCT00758524|616080091|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
170475803|NCT00758524|616080075|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475804|NCT00758524|616080076|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475805|NCT00758524|616080077|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475806|NCT00758524|616080078|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475807|NCT00758524|616080079|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475808|NCT00758524|616080080|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475809|NCT00758524|616080081|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
170475810|NCT00758524|616080082|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475811|NCT00758524|616080083|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475812|NCT00758524|616080084|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475813|NCT00758524|616080085|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475814|NCT00758524|616080086|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475815|NCT00758524|616080087|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475816|NCT00758524|616080088|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475817|NCT00758524|616080089|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170546285|NCT01158404|616345817|FG002|Overall Study|Withdrawal by Subject|0|||
170546286|NCT01158404|616345818|FG003|Overall Study|Withdrawal by Subject|0|||
170546287|NCT01158404|616345819|FG004|Overall Study|Withdrawal by Subject|3|||
170546288|NCT01158404|616345820|FG005|Overall Study|Withdrawal by Subject|1|||
170546289|NCT01158404|616345821|FG006|Overall Study|Withdrawal by Subject|0|||
170546290|NCT01158404|616345822|FG007|Overall Study|Withdrawal by Subject|1|||
170546291|NCT01158404|616345815|FG000|Overall Study|Physician Decision|0|||
170546292|NCT01158404|616345816|FG001|Overall Study|Physician Decision|0|||
170546293|NCT01158404|616345817|FG002|Overall Study|Physician Decision|0|||
170546294|NCT01158404|616345818|FG003|Overall Study|Physician Decision|0|||
170546295|NCT01158404|616345819|FG004|Overall Study|Physician Decision|0|||
170546296|NCT01158404|616345820|FG005|Overall Study|Physician Decision|0|||
170546297|NCT01158404|616345821|FG006|Overall Study|Physician Decision|0|||
170546298|NCT01158404|616345822|FG007|Overall Study|Physician Decision|1|||
170546299|NCT01158404|616345815|FG000|Overall Study|Progressive Disease|0|||
170546300|NCT01158404|616345816|FG001|Overall Study|Progressive Disease|0|||
170546301|NCT01158404|616345817|FG002|Overall Study|Progressive Disease|0|||
170546302|NCT01158404|616345818|FG003|Overall Study|Progressive Disease|0|||
170546303|NCT01158404|616345819|FG004|Overall Study|Progressive Disease|0|||
170546304|NCT01158404|616345820|FG005|Overall Study|Progressive Disease|0|||
170546305|NCT01158404|616345821|FG006|Overall Study|Progressive Disease|1|||
170546306|NCT01158404|616345822|FG007|Overall Study|Progressive Disease|0|||
170546307|NCT01560988|616345828|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
170546308|NCT01560988|616345829|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
170546309|NCT01560988|616345828|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
170546310|NCT01560988|616345829|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
170546311|NCT01560988|616345828|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
170546312|NCT01560988|616345829|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
170546313|NCT00500110|616345832|FG000|Overall Study|Withdrawal by Subject|3|||
170546314|NCT00605657|616345833|FG000|Overall Study|Adverse Event|1|||
170546315|NCT00605657|616345833|FG000|Overall Study|Protocol Violation|1|||
170546316|NCT02018887|616345834|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
170546317|NCT02018887|616345835|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170546318|NCT02018887|616345836|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170891805|NCT01445535|617611851|FG002|Overall Study|PI discretion|0|||
170891806|NCT01445535|617611852|FG003|Overall Study|PI discretion|1|||
170891807|NCT03569202|617611856|FG000|Part 3|Physician Decision|1|||
170891808|NCT03569202|617611857|FG001|Part 3|Physician Decision|0|||
170891809|NCT03569202|617611856|FG000|Part 3|Other|1|||
170891810|NCT03569202|617611857|FG001|Part 3|Other|1|||
170546319|NCT02018887|616345837|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170546320|NCT02018887|616345838|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170475818|NCT00758524|616080090|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475819|NCT00758524|616080091|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
170475820|NCT01960257|616080092|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
170475821|NCT01960257|616080093|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
170475822|NCT01960257|616080094|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
170475823|NCT01960257|616080092|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
170546321|NCT02018887|616345839|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170792227|NCT01928394|617249437|FG009|Treatment Period|AE unrelated to study drug|2|||
170792228|NCT01928394|617249438|FG010|Treatment Period|AE unrelated to study drug|0|||
170792229|NCT01928394|617249439|FG011|Treatment Period|AE unrelated to study drug|12|||
170792230|NCT01928394|617249440|FG012|Treatment Period|AE unrelated to study drug|6|||
170792231|NCT01928394|617249441|FG013|Treatment Period|AE unrelated to study drug|13|||
170792232|NCT01928394|617249442|FG014|Treatment Period|AE unrelated to study drug|6|||
170792233|NCT01928394|617249443|FG015|Treatment Period|AE unrelated to study drug|1|||
170792234|NCT01928394|617249444|FG016|Treatment Period|AE unrelated to study drug|1|||
170792235|NCT01928394|617249445|FG017|Treatment Period|AE unrelated to study drug|6|||
170792236|NCT01928394|617249446|FG018|Treatment Period|AE unrelated to study drug|3|||
170792237|NCT01928394|617249447|FG019|Treatment Period|AE unrelated to study drug|5|||
170792238|NCT01928394|617249448|FG020|Treatment Period|AE unrelated to study drug|1|||
170891811|NCT00420511|617611858|FG000|Overall Study|Adverse Event|1|||
170475824|NCT01960257|616080093|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
170475825|NCT01960257|616080094|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
170475826|NCT01960257|616080092|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
170475827|NCT01960257|616080093|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
170475828|NCT01960257|616080094|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
170475829|NCT02676882|616080097|FG000|Overall Study|Adverse Event|1|||
170475830|NCT02676882|616080098|FG001|Overall Study|Adverse Event|0|||
170475831|NCT02676882|616080097|FG000|Overall Study|Lost to Follow-up|1|||
170475832|NCT02676882|616080098|FG001|Overall Study|Lost to Follow-up|0|||
170475833|NCT02676882|616080097|FG000|Overall Study|Withdrawal by Subject|1|||
170475834|NCT02676882|616080098|FG001|Overall Study|Withdrawal by Subject|2|||
170475835|NCT03076775|616080099|FG000|Overall Study|Lost to Follow-up|1|||
170475836|NCT03076775|616080100|FG001|Overall Study|Lost to Follow-up|0|||
170475837|NCT01783886|616080101|FG000|Overall Study|Lost to Follow-up|0|||
170475838|NCT01783886|616080102|FG001|Overall Study|Lost to Follow-up|3|||
170475839|NCT01783886|616080103|FG002|Overall Study|Lost to Follow-up|0|||
170475840|NCT01783886|616080101|FG000|Overall Study|Protocol deviation|0|||
170475841|NCT01783886|616080102|FG001|Overall Study|Protocol deviation|0|||
170475842|NCT01783886|616080103|FG002|Overall Study|Protocol deviation|2|||
170475843|NCT01783886|616080101|FG000|Overall Study|Withdrawal of consent by participant|1|||
170475844|NCT01783886|616080102|FG001|Overall Study|Withdrawal of consent by participant|3|||
170475845|NCT01783886|616080103|FG002|Overall Study|Withdrawal of consent by participant|4|||
170475846|NCT01783886|616080101|FG000|Overall Study|Adverse Event|4|||
170475847|NCT01783886|616080102|FG001|Overall Study|Adverse Event|5|||
170475848|NCT01783886|616080103|FG002|Overall Study|Adverse Event|4|||
170475849|NCT00940316|616080104|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
170475850|NCT00940316|616080105|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
170475851|NCT00940316|616080106|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
170475852|NCT00940316|616080104|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
170475853|NCT00940316|616080105|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
170475854|NCT00940316|616080106|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
170475855|NCT00940316|616080104|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
170475856|NCT00940316|616080105|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
170475857|NCT00940316|616080106|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
170475858|NCT00940316|616080104|FG000|Treated After Cycle 5|Adverse Event|0|||
170475859|NCT00940316|616080105|FG001|Treated After Cycle 5|Adverse Event|0|||
170475860|NCT00940316|616080106|FG002|Treated After Cycle 5|Adverse Event|1|||
170475861|NCT00940316|616080104|FG000|Treated After Cycle 5|Progressive disease|0|||
170475862|NCT00940316|616080105|FG001|Treated After Cycle 5|Progressive disease|1|||
170475863|NCT00940316|616080106|FG002|Treated After Cycle 5|Progressive disease|0|||
170475864|NCT04728802|616080117|FG000|Overall Study|Withdrawal by Subject|4|||
170475865|NCT04728802|616080118|FG001|Overall Study|Withdrawal by Subject|20|||
170475866|NCT04728802|616080117|FG000|Overall Study|Physician Decision|7|||
170475867|NCT04728802|616080118|FG001|Overall Study|Physician Decision|7|||
170475868|NCT04728802|616080117|FG000|Overall Study|Protocol Violation|10|||
170475869|NCT04728802|616080118|FG001|Overall Study|Protocol Violation|4|||
170475870|NCT04728802|616080117|FG000|Overall Study|Transfer|1|||
170475871|NCT04728802|616080118|FG001|Overall Study|Transfer|0|||
170475872|NCT04728802|616080117|FG000|Overall Study|Death|4|||
170546322|NCT02018887|616345840|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170475873|NCT04728802|616080118|FG001|Overall Study|Death|5|||
170546323|NCT02018887|616345841|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170475874|NCT04728802|616080117|FG000|Overall Study|Other|3|||
170475875|NCT04728802|616080118|FG001|Overall Study|Other|0|||
170475876|NCT02286843|616080119|FG000|Overall Study|Not Treated|4|||
170638499|NCT00611026|616688262|FG002|Double-blind Treatment Period|Adverse Event|46|||
170638500|NCT00611026|616688260|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
170638501|NCT00611026|616688261|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
170638502|NCT00611026|616688262|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
170638503|NCT00611026|616688260|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
170638504|NCT00611026|616688261|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
170638505|NCT00611026|616688262|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
170638506|NCT00611026|616688260|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
170638507|NCT00611026|616688261|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
170638508|NCT00611026|616688262|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
170638509|NCT00611026|616688260|FG000|Double-blind Treatment Period|Other|13|||
170638510|NCT00611026|616688261|FG001|Double-blind Treatment Period|Other|20|||
170638511|NCT00611026|616688262|FG002|Double-blind Treatment Period|Other|18|||
170638512|NCT00760617|616688263|FG000|Overall Study|Adverse Event|5|||
170638513|NCT00760617|616688264|FG001|Overall Study|Adverse Event|2|||
170638514|NCT00760617|616688265|FG002|Overall Study|Adverse Event|0|||
170638515|NCT00760617|616688263|FG000|Overall Study|Lost to Follow-up|0|||
170638516|NCT00760617|616688264|FG001|Overall Study|Lost to Follow-up|0|||
170638517|NCT00760617|616688265|FG002|Overall Study|Lost to Follow-up|5|||
170638518|NCT01192191|616688270|FG000|Overall Study|Adverse Event|7|||
170638519|NCT01192191|616688271|FG001|Overall Study|Adverse Event|12|||
170638520|NCT01192191|616688270|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
170638521|NCT01192191|616688271|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
170638522|NCT01192191|616688270|FG000|Overall Study|Lost to Follow-up|0|||
170638523|NCT01192191|616688271|FG001|Overall Study|Lost to Follow-up|1|||
170638524|NCT01192191|616688270|FG000|Overall Study|Withdrawal by Subject|1|||
170638525|NCT01192191|616688271|FG001|Overall Study|Withdrawal by Subject|6|||
170638526|NCT01047553|616688272|FG000|Overall Study|Adverse Event|10|||
170638527|NCT01047553|616688273|FG001|Overall Study|Adverse Event|5|||
170638528|NCT01047553|616688272|FG000|Overall Study|Withdrawal by Subject|4|||
170638529|NCT01047553|616688273|FG001|Overall Study|Withdrawal by Subject|2|||
170638530|NCT01047553|616688272|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
170638531|NCT01047553|616688273|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
170638532|NCT01047553|616688272|FG000|Overall Study|Lost to Follow-up|1|||
170638533|NCT01047553|616688273|FG001|Overall Study|Lost to Follow-up|0|||
170638534|NCT01047553|616688272|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
170891812|NCT00420511|617611859|FG001|Overall Study|Adverse Event|1|||
170891813|NCT00420511|617611858|FG000|Overall Study|Lost to Follow-up|1|||
170638535|NCT01047553|616688273|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
170638536|NCT01047553|616688272|FG000|Overall Study|PI's decision|0|||
170638537|NCT01047553|616688273|FG001|Overall Study|PI's decision|1|||
170638538|NCT02817464|616688274|FG000|Overall Study|Lost to Follow-up|1|||
170891814|NCT00420511|617611859|FG001|Overall Study|Lost to Follow-up|0|||
170891815|NCT02415712|617611860|FG000|Overall Study|Protocol Violation|16|||
170638539|NCT02817464|616688275|FG001|Overall Study|Lost to Follow-up|0|||
170638540|NCT02817464|616688274|FG000|Overall Study|Discontinued early due to personal decision|1|||
170638541|NCT02817464|616688275|FG001|Overall Study|Discontinued early due to personal decision|1|||
170638542|NCT05340478|616688278|FG000|Overall Study|Scheduling Issues|10|||
170638543|NCT05340478|616688279|FG001|Overall Study|Scheduling Issues|4|||
170638544|NCT05340478|616688278|FG000|Overall Study|Neither member of dyad started treatment|2|||
170638545|NCT05340478|616688279|FG001|Overall Study|Neither member of dyad started treatment|2|||
170638546|NCT05340478|616688278|FG000|Overall Study|Withdrawn from study|2|||
170638547|NCT05340478|616688279|FG001|Overall Study|Withdrawn from study|2|||
170638548|NCT05340478|616688278|FG000|Overall Study|Lost to Follow-up|1|||
170891816|NCT00454779|617611861|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
170891817|NCT00454779|617611862|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
170891818|NCT00454779|617611861|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
170891819|NCT00454779|617611862|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
170891820|NCT00454779|617611861|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
170891821|NCT00454779|617611862|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
170891822|NCT00454779|617611861|FG000|First-line Treatment Phase|Protocol Violation|0|||
170891823|NCT00454779|617611862|FG001|First-line Treatment Phase|Protocol Violation|1|||
170891824|NCT00454779|617611861|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
170891825|NCT00454779|617611862|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
170891826|NCT00454779|617611861|FG000|First-line Treatment Phase|Ongoing|1|||
170891827|NCT00454779|617611862|FG001|First-line Treatment Phase|Ongoing|0|||
170891828|NCT00454779|617611861|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
170638549|NCT05340478|616688279|FG001|Overall Study|Lost to Follow-up|4|||
170638550|NCT02116205|616688280|FG000|Overall Study|Withdrawal by Subject|2|||
170638551|NCT02116205|616688281|FG001|Overall Study|Withdrawal by Subject|4|||
170638552|NCT02116205|616688282|FG002|Overall Study|Withdrawal by Subject|1|||
170638553|NCT02116205|616688283|FG003|Overall Study|Withdrawal by Subject|3|||
170638554|NCT02116205|616688280|FG000|Overall Study|Lost to Follow-up|0|||
170638555|NCT02116205|616688281|FG001|Overall Study|Lost to Follow-up|2|||
170475877|NCT02286843|616080119|FG000|Overall Study|Protocol Violation|1|||
170475878|NCT02286843|616080119|FG000|Overall Study|Withdrawal by Subject|1|||
170475879|NCT04388553|616080122|FG000|Overall Study|Protocol Violation|1|||
170475880|NCT04388553|616080123|FG001|Overall Study|Protocol Violation|0|||
170891829|NCT00454779|617611862|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
170891830|NCT00454779|617611861|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
170891831|NCT00454779|617611862|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
170891832|NCT00454779|617611861|FG000|Second-line Treatment Phase|Ongoing|0|||
170891833|NCT00454779|617611862|FG001|Second-line Treatment Phase|Ongoing|1|||
170891834|NCT01337973|617611864|FG000|Overall Study|Lost to Follow-up|2|||
170891835|NCT01337973|617611865|FG001|Overall Study|Lost to Follow-up|4|||
170891836|NCT01337973|617611866|FG002|Overall Study|Lost to Follow-up|3|||
170891837|NCT01337973|617611864|FG000|Overall Study|Death|1|||
170891838|NCT01337973|617611865|FG001|Overall Study|Death|2|||
170891839|NCT01337973|617611866|FG002|Overall Study|Death|1|||
170891840|NCT01337973|617611864|FG000|Overall Study|Withdrawal by Subject|10|||
170891841|NCT01337973|617611865|FG001|Overall Study|Withdrawal by Subject|8|||
170891842|NCT01337973|617611866|FG002|Overall Study|Withdrawal by Subject|4|||
170891843|NCT01337973|617611864|FG000|Overall Study|missing data on primary outcome|3|||
170891844|NCT01337973|617611865|FG001|Overall Study|missing data on primary outcome|1|||
170891845|NCT01337973|617611866|FG002|Overall Study|missing data on primary outcome|3|||
170891846|NCT01688050|617611867|FG000|Overall Study|Death|7|||
170891847|NCT01688050|617611867|FG000|Overall Study|Conversion to open repair|1|||
170891848|NCT01688050|617611867|FG000|Overall Study|Lost to Follow-up|13|||
170891849|NCT01688050|617611867|FG000|Overall Study|Withdrawal by Subject|10|||
170891850|NCT00684515|617611868|FG000|Overall Study|Adverse Event|3|||
170891851|NCT00684515|617611869|FG001|Overall Study|Adverse Event|3|||
170891852|NCT00684515|617611870|FG002|Overall Study|Adverse Event|1|||
170891853|NCT00684515|617611868|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
170891854|NCT00684515|617611869|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
170891855|NCT00684515|617611870|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
170891856|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
170891857|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
170891858|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
170891859|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
170891860|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
170891861|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
170891862|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
170891863|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
170891864|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
170891865|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
170891866|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
170891867|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
170891868|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
170891869|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
170891870|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
170891871|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
170891872|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
170891873|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
170891874|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
170891875|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
170891876|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
170891877|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
170891878|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
170891879|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
170891880|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Death|2|||
170891881|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Death|1|||
170891882|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Death|2|||
170891883|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Graft loss|0|||
170891884|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Graft loss|2|||
170891885|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Graft loss|0|||
170891886|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
170891887|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
170891888|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
170475881|NCT00111241|616080128|FG000|Overall Study|Lost to Follow-up|1|||
170475882|NCT00111241|616080129|FG001|Overall Study|Lost to Follow-up|0|||
170638556|NCT02116205|616688282|FG002|Overall Study|Lost to Follow-up|1|||
170475883|NCT00111241|616080128|FG000|Overall Study|Withdrawal by Subject|4|||
170475884|NCT00111241|616080129|FG001|Overall Study|Withdrawal by Subject|0|||
170638557|NCT02116205|616688283|FG003|Overall Study|Lost to Follow-up|2|||
170475885|NCT00111241|616080128|FG000|Overall Study|Protocol Violation|9|||
170475886|NCT00111241|616080129|FG001|Overall Study|Protocol Violation|8|||
170475887|NCT00111241|616080128|FG000|Overall Study|Adverse Event|1|||
170475888|NCT00111241|616080129|FG001|Overall Study|Adverse Event|0|||
170475889|NCT04502212|616080130|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
170475890|NCT04502212|616080130|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
170475891|NCT05724589|616080132|FG000|Overall Study|Lost to Follow-up|1|||
170475892|NCT01070953|616080135|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
170638558|NCT02116205|616688280|FG000|Overall Study|Physician Decision|0|||
170638559|NCT02116205|616688281|FG001|Overall Study|Physician Decision|1|||
170638560|NCT02116205|616688282|FG002|Overall Study|Physician Decision|1|||
170638561|NCT02116205|616688283|FG003|Overall Study|Physician Decision|1|||
170638562|NCT02116205|616688280|FG000|Overall Study|Exclusion criteria|0|||
170638563|NCT02116205|616688281|FG001|Overall Study|Exclusion criteria|0|||
170638564|NCT02116205|616688282|FG002|Overall Study|Exclusion criteria|1|||
170638565|NCT02116205|616688283|FG003|Overall Study|Exclusion criteria|0|||
170638566|NCT00525161|616688286|FG000|Overall Study|Adverse Event|1|||
170638567|NCT01076361|616688287|FG000|Overall Study|22 leads were excluded from analysis|21|||
170638568|NCT04421027|616688293|FG000|Treatment Period|Adverse Event|5|||
170638569|NCT04421027|616688294|FG001|Treatment Period|Adverse Event|3|||
170638570|NCT04421027|616688295|FG002|Treatment Period|Adverse Event|0|||
170638571|NCT04421027|616688296|FG003|Treatment Period|Adverse Event|0|||
170638572|NCT04421027|616688293|FG000|Treatment Period|Death|98|||
170638573|NCT04421027|616688294|FG001|Treatment Period|Death|61|||
170638574|NCT04421027|616688295|FG002|Treatment Period|Death|0|||
170638575|NCT04421027|616688296|FG003|Treatment Period|Death|0|||
170638576|NCT04421027|616688293|FG000|Treatment Period|Lost to Follow-up|22|||
170638577|NCT04421027|616688294|FG001|Treatment Period|Lost to Follow-up|20|||
170638578|NCT04421027|616688295|FG002|Treatment Period|Lost to Follow-up|0|||
170638579|NCT04421027|616688296|FG003|Treatment Period|Lost to Follow-up|0|||
170638580|NCT04421027|616688293|FG000|Treatment Period|Other-Unknown|15|||
170638581|NCT04421027|616688294|FG001|Treatment Period|Other-Unknown|9|||
170638582|NCT04421027|616688295|FG002|Treatment Period|Other-Unknown|0|||
170638583|NCT04421027|616688296|FG003|Treatment Period|Other-Unknown|0|||
170638584|NCT04421027|616688293|FG000|Treatment Period|Physician Decision|1|||
170638585|NCT04421027|616688294|FG001|Treatment Period|Physician Decision|1|||
170638586|NCT04421027|616688295|FG002|Treatment Period|Physician Decision|0|||
170638587|NCT04421027|616688296|FG003|Treatment Period|Physician Decision|0|||
170638588|NCT04421027|616688293|FG000|Treatment Period|Withdrawal by Subject|7|||
170638589|NCT04421027|616688294|FG001|Treatment Period|Withdrawal by Subject|12|||
170638590|NCT04421027|616688295|FG002|Treatment Period|Withdrawal by Subject|0|||
170638591|NCT04421027|616688296|FG003|Treatment Period|Withdrawal by Subject|0|||
170638592|NCT04421027|616688293|FG000|Treatment Period|Randomized Not Dosed|9|||
170638593|NCT04421027|616688294|FG001|Treatment Period|Randomized Not Dosed|14|||
170638594|NCT04421027|616688295|FG002|Treatment Period|Randomized Not Dosed|0|||
170792239|NCT01928394|617249449|FG021|Treatment Period|AE unrelated to study drug|1|||
170792240|NCT01928394|617249450|FG022|Treatment Period|AE unrelated to study drug|0|||
170792241|NCT01928394|617249428|FG000|Treatment Period|Participant request to stop therapy|0|||
170792242|NCT01928394|617249429|FG001|Treatment Period|Participant request to stop therapy|0|||
170792243|NCT01928394|617249430|FG002|Treatment Period|Participant request to stop therapy|0|||
170792244|NCT01928394|617249431|FG003|Treatment Period|Participant request to stop therapy|0|||
170792245|NCT01928394|617249432|FG004|Treatment Period|Participant request to stop therapy|0|||
170792246|NCT01928394|617249433|FG005|Treatment Period|Participant request to stop therapy|3|||
170792247|NCT01928394|617249434|FG006|Treatment Period|Participant request to stop therapy|3|||
170792248|NCT01928394|617249435|FG007|Treatment Period|Participant request to stop therapy|0|||
170792249|NCT01928394|617249436|FG008|Treatment Period|Participant request to stop therapy|0|||
170792250|NCT01928394|617249437|FG009|Treatment Period|Participant request to stop therapy|0|||
170792251|NCT01928394|617249438|FG010|Treatment Period|Participant request to stop therapy|3|||
170792252|NCT01928394|617249439|FG011|Treatment Period|Participant request to stop therapy|2|||
170792253|NCT01928394|617249440|FG012|Treatment Period|Participant request to stop therapy|1|||
170792254|NCT01928394|617249441|FG013|Treatment Period|Participant request to stop therapy|2|||
170792255|NCT01928394|617249442|FG014|Treatment Period|Participant request to stop therapy|4|||
170792256|NCT01928394|617249443|FG015|Treatment Period|Participant request to stop therapy|0|||
170792257|NCT01928394|617249444|FG016|Treatment Period|Participant request to stop therapy|1|||
170792258|NCT01928394|617249445|FG017|Treatment Period|Participant request to stop therapy|3|||
170891889|NCT01114529|617611871|FG000|Completed Study Medication at Month 24|Missing|2|||
170891890|NCT01114529|617611872|FG001|Completed Study Medication at Month 24|Missing|0|||
170638595|NCT04421027|616688296|FG003|Treatment Period|Randomized Not Dosed|0|||
170638596|NCT04421027|616688293|FG000|Follow-Up Period|Adverse Event|0|||
170638597|NCT04421027|616688294|FG001|Follow-Up Period|Adverse Event|0|||
170638598|NCT04421027|616688295|FG002|Follow-Up Period|Adverse Event|0|||
170638599|NCT04421027|616688296|FG003|Follow-Up Period|Adverse Event|3|||
170475893|NCT01070953|616080135|FG000|Participants for Safety Evaluation|Off-label use|283|||
170475894|NCT01070953|616080135|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
170475895|NCT01070953|616080135|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
170475896|NCT01070953|616080135|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
170475897|NCT01070953|616080135|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
170475898|NCT01070953|616080135|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
170475899|NCT01070953|616080135|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
170475900|NCT01070953|616080135|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
170475901|NCT01070953|616080135|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
170546324|NCT02018887|616345842|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170546325|NCT02018887|616345843|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170546326|NCT02018887|616345844|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
170546327|NCT02018887|616345834|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
170546328|NCT02018887|616345835|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
170546329|NCT02018887|616345836|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
170546330|NCT02018887|616345837|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
170546331|NCT02018887|616345838|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
170546332|NCT02018887|616345839|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
170546333|NCT02018887|616345840|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
170546334|NCT02018887|616345841|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
170546335|NCT02018887|616345842|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
170546336|NCT02018887|616345843|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
170891891|NCT01114529|617611873|FG002|Completed Study Medication at Month 24|Missing|0|||
170891892|NCT01114529|617611871|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
170475902|NCT01957176|616080141|FG000|Overall Study|Adverse Event|2|||
170475903|NCT01957176|616080142|FG001|Overall Study|Adverse Event|0|||
170475904|NCT01957176|616080141|FG000|Overall Study|Physician Decision|2|||
170475905|NCT01957176|616080142|FG001|Overall Study|Physician Decision|1|||
170475906|NCT01957176|616080141|FG000|Overall Study|Withdrawal by Subject|1|||
170475907|NCT01957176|616080142|FG001|Overall Study|Withdrawal by Subject|0|||
170475908|NCT01823835|616080143|FG000|Overall Study|Adverse Event|0|||
170475909|NCT01823835|616080144|FG001|Overall Study|Adverse Event|0|||
170475910|NCT01823835|616080145|FG002|Overall Study|Adverse Event|0|||
170475911|NCT01823835|616080146|FG003|Overall Study|Adverse Event|0|||
170475912|NCT01823835|616080147|FG004|Overall Study|Adverse Event|1|||
170475913|NCT01823835|616080148|FG005|Overall Study|Adverse Event|0|||
170475914|NCT01823835|616080149|FG006|Overall Study|Adverse Event|1|||
170475915|NCT01823835|616080150|FG007|Overall Study|Adverse Event|0|||
170475916|NCT01823835|616080151|FG008|Overall Study|Adverse Event|0|||
170475917|NCT01823835|616080152|FG009|Overall Study|Adverse Event|0|||
170546337|NCT02018887|616345844|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
170546338|NCT02018887|616345834|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
170546339|NCT02018887|616345835|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
170546340|NCT02018887|616345836|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
170546341|NCT02018887|616345837|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
170546342|NCT02018887|616345838|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
170546343|NCT02018887|616345839|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
170546344|NCT02018887|616345840|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
170891893|NCT01114529|617611872|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
170546345|NCT02018887|616345841|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
170546346|NCT02018887|616345842|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
170546347|NCT02018887|616345843|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
170546348|NCT02018887|616345844|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
170546349|NCT02018887|616345834|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
170546350|NCT02018887|616345835|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
170546351|NCT02018887|616345836|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
170546352|NCT02018887|616345837|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
170546353|NCT02018887|616345838|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
170546354|NCT02018887|616345839|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
170546355|NCT02018887|616345840|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
170546356|NCT02018887|616345841|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
170546357|NCT02018887|616345842|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
170546358|NCT02018887|616345843|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
170546359|NCT02018887|616345844|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
170546360|NCT00981175|616345845|FG000|Primary Dose Vaccination|Adverse Event|1|||
170546361|NCT00981175|616345846|FG001|Primary Dose Vaccination|Adverse Event|0|||
170546362|NCT00981175|616345845|FG000|Primary Dose Vaccination|Protocol Violation|0|||
170546363|NCT00981175|616345846|FG001|Primary Dose Vaccination|Protocol Violation|1|||
170546364|NCT00981175|616345845|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
170546365|NCT00981175|616345846|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
170546366|NCT00981175|616345845|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
170546367|NCT00981175|616345846|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
170546368|NCT04477486|616345849|FG000|Overall Study|Death|2|||
170546369|NCT04477486|616345849|FG000|Overall Study|Ongoing at Time of Analysis|11|||
170546370|NCT01851369|616345850|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546371|NCT01851369|616345851|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546372|NCT01851369|616345852|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546373|NCT01851369|616345853|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170891894|NCT01114529|617611873|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
170891895|NCT01114529|617611871|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
170475918|NCT01823835|616080153|FG010|Overall Study|Adverse Event|1|||
170475919|NCT01823835|616080154|FG011|Overall Study|Adverse Event|2|||
170475920|NCT01823835|616080155|FG012|Overall Study|Adverse Event|0|||
170475921|NCT01823835|616080156|FG013|Overall Study|Adverse Event|0|||
170475922|NCT01823835|616080157|FG014|Overall Study|Adverse Event|0|||
170546374|NCT01851369|616345854|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546375|NCT01851369|616345855|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
170546376|NCT01851369|616345856|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546377|NCT01851369|616345857|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546378|NCT01851369|616345858|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170638600|NCT04421027|616688293|FG000|Follow-Up Period|Death|0|||
170475923|NCT01823835|616080143|FG000|Overall Study|Physician Decision|0|||
170475924|NCT01823835|616080144|FG001|Overall Study|Physician Decision|0|||
170475925|NCT01823835|616080145|FG002|Overall Study|Physician Decision|0|||
170638601|NCT04421027|616688294|FG001|Follow-Up Period|Death|0|||
170638602|NCT04421027|616688295|FG002|Follow-Up Period|Death|16|||
170638603|NCT04421027|616688296|FG003|Follow-Up Period|Death|17|||
170638604|NCT04421027|616688293|FG000|Follow-Up Period|Lost to Follow-up|0|||
170638605|NCT04421027|616688294|FG001|Follow-Up Period|Lost to Follow-up|0|||
170638606|NCT04421027|616688295|FG002|Follow-Up Period|Lost to Follow-up|7|||
170638607|NCT04421027|616688296|FG003|Follow-Up Period|Lost to Follow-up|7|||
170638608|NCT04421027|616688293|FG000|Follow-Up Period|Protocol Deviation|0|||
170638609|NCT04421027|616688294|FG001|Follow-Up Period|Protocol Deviation|0|||
170638610|NCT04421027|616688295|FG002|Follow-Up Period|Protocol Deviation|1|||
170638611|NCT04421027|616688296|FG003|Follow-Up Period|Protocol Deviation|0|||
170792259|NCT01928394|617249446|FG018|Treatment Period|Participant request to stop therapy|1|||
170475926|NCT01823835|616080146|FG003|Overall Study|Physician Decision|0|||
170475927|NCT01823835|616080147|FG004|Overall Study|Physician Decision|0|||
170475928|NCT01823835|616080148|FG005|Overall Study|Physician Decision|0|||
170475929|NCT01823835|616080149|FG006|Overall Study|Physician Decision|0|||
170475930|NCT01823835|616080150|FG007|Overall Study|Physician Decision|0|||
170475931|NCT01823835|616080151|FG008|Overall Study|Physician Decision|0|||
170475932|NCT01823835|616080152|FG009|Overall Study|Physician Decision|0|||
170475933|NCT01823835|616080153|FG010|Overall Study|Physician Decision|0|||
170475934|NCT01823835|616080154|FG011|Overall Study|Physician Decision|2|||
170792260|NCT01928394|617249447|FG019|Treatment Period|Participant request to stop therapy|1|||
170475935|NCT01823835|616080155|FG012|Overall Study|Physician Decision|0|||
170475936|NCT01823835|616080156|FG013|Overall Study|Physician Decision|0|||
170475937|NCT01823835|616080157|FG014|Overall Study|Physician Decision|0|||
170475938|NCT01823835|616080143|FG000|Overall Study|Progressive Disease|3|||
170475939|NCT01823835|616080144|FG001|Overall Study|Progressive Disease|4|||
170475940|NCT01823835|616080145|FG002|Overall Study|Progressive Disease|3|||
170475941|NCT01823835|616080146|FG003|Overall Study|Progressive Disease|6|||
170475942|NCT01823835|616080147|FG004|Overall Study|Progressive Disease|4|||
170475943|NCT01823835|616080148|FG005|Overall Study|Progressive Disease|6|||
170475944|NCT01823835|616080149|FG006|Overall Study|Progressive Disease|5|||
170638612|NCT04421027|616688293|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
170638613|NCT04421027|616688294|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
170792261|NCT01928394|617249448|FG020|Treatment Period|Participant request to stop therapy|3|||
170792262|NCT01928394|617249449|FG021|Treatment Period|Participant request to stop therapy|1|||
170792263|NCT01928394|617249450|FG022|Treatment Period|Participant request to stop therapy|3|||
170792264|NCT01928394|617249428|FG000|Treatment Period|Participant withdrew consent|0|||
170792265|NCT01928394|617249429|FG001|Treatment Period|Participant withdrew consent|0|||
170792266|NCT01928394|617249430|FG002|Treatment Period|Participant withdrew consent|1|||
170792267|NCT01928394|617249431|FG003|Treatment Period|Participant withdrew consent|1|||
170792268|NCT01928394|617249432|FG004|Treatment Period|Participant withdrew consent|0|||
170792269|NCT01928394|617249433|FG005|Treatment Period|Participant withdrew consent|1|||
170792270|NCT01928394|617249434|FG006|Treatment Period|Participant withdrew consent|0|||
170792271|NCT01928394|617249435|FG007|Treatment Period|Participant withdrew consent|1|||
170792272|NCT01928394|617249436|FG008|Treatment Period|Participant withdrew consent|0|||
170792273|NCT01928394|617249437|FG009|Treatment Period|Participant withdrew consent|0|||
170792274|NCT01928394|617249438|FG010|Treatment Period|Participant withdrew consent|1|||
170792275|NCT01928394|617249439|FG011|Treatment Period|Participant withdrew consent|1|||
170792276|NCT01928394|617249440|FG012|Treatment Period|Participant withdrew consent|1|||
170792277|NCT01928394|617249441|FG013|Treatment Period|Participant withdrew consent|0|||
170792278|NCT01928394|617249442|FG014|Treatment Period|Participant withdrew consent|2|||
170792279|NCT01928394|617249443|FG015|Treatment Period|Participant withdrew consent|0|||
170792280|NCT01928394|617249444|FG016|Treatment Period|Participant withdrew consent|2|||
170792281|NCT01928394|617249445|FG017|Treatment Period|Participant withdrew consent|1|||
170792282|NCT01928394|617249446|FG018|Treatment Period|Participant withdrew consent|1|||
170792283|NCT01928394|617249447|FG019|Treatment Period|Participant withdrew consent|1|||
170792284|NCT01928394|617249448|FG020|Treatment Period|Participant withdrew consent|0|||
170792285|NCT01928394|617249449|FG021|Treatment Period|Participant withdrew consent|2|||
170792286|NCT01928394|617249450|FG022|Treatment Period|Participant withdrew consent|0|||
170792287|NCT01928394|617249428|FG000|Treatment Period|Poor/non-compliance|0|||
170792288|NCT01928394|617249429|FG001|Treatment Period|Poor/non-compliance|0|||
170475945|NCT01823835|616080150|FG007|Overall Study|Progressive Disease|3|||
170475946|NCT01823835|616080151|FG008|Overall Study|Progressive Disease|3|||
170475947|NCT01823835|616080152|FG009|Overall Study|Progressive Disease|18|||
170475948|NCT01823835|616080153|FG010|Overall Study|Progressive Disease|8|||
170475949|NCT01823835|616080154|FG011|Overall Study|Progressive Disease|46|||
170475950|NCT01823835|616080155|FG012|Overall Study|Progressive Disease|18|||
170475951|NCT01823835|616080156|FG013|Overall Study|Progressive Disease|4|||
170475952|NCT01823835|616080157|FG014|Overall Study|Progressive Disease|6|||
170475953|NCT01823835|616080143|FG000|Overall Study|Study Termination|0|||
170475954|NCT01823835|616080144|FG001|Overall Study|Study Termination|0|||
170475955|NCT01823835|616080145|FG002|Overall Study|Study Termination|0|||
170475956|NCT01823835|616080146|FG003|Overall Study|Study Termination|0|||
170475957|NCT01823835|616080147|FG004|Overall Study|Study Termination|1|||
170475958|NCT01823835|616080148|FG005|Overall Study|Study Termination|0|||
170475959|NCT01823835|616080149|FG006|Overall Study|Study Termination|0|||
170475960|NCT01823835|616080150|FG007|Overall Study|Study Termination|0|||
170475961|NCT01823835|616080151|FG008|Overall Study|Study Termination|0|||
170475962|NCT01823835|616080152|FG009|Overall Study|Study Termination|0|||
170475963|NCT01823835|616080153|FG010|Overall Study|Study Termination|0|||
170475964|NCT01823835|616080154|FG011|Overall Study|Study Termination|1|||
170475965|NCT01823835|616080155|FG012|Overall Study|Study Termination|0|||
170475966|NCT01823835|616080156|FG013|Overall Study|Study Termination|0|||
170475967|NCT01823835|616080157|FG014|Overall Study|Study Termination|0|||
170475968|NCT01823835|616080143|FG000|Overall Study|Withdrawal by Subject|0|||
170475969|NCT01823835|616080144|FG001|Overall Study|Withdrawal by Subject|0|||
170546379|NCT01851369|616345859|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546380|NCT01851369|616345860|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170792289|NCT01928394|617249430|FG002|Treatment Period|Poor/non-compliance|0|||
170792290|NCT01928394|617249431|FG003|Treatment Period|Poor/non-compliance|1|||
170792291|NCT01928394|617249432|FG004|Treatment Period|Poor/non-compliance|0|||
170792292|NCT01928394|617249433|FG005|Treatment Period|Poor/non-compliance|0|||
170792293|NCT01928394|617249434|FG006|Treatment Period|Poor/non-compliance|0|||
170792294|NCT01928394|617249435|FG007|Treatment Period|Poor/non-compliance|0|||
170475970|NCT01823835|616080145|FG002|Overall Study|Withdrawal by Subject|1|||
170475971|NCT01823835|616080146|FG003|Overall Study|Withdrawal by Subject|0|||
170475972|NCT01823835|616080147|FG004|Overall Study|Withdrawal by Subject|0|||
170475973|NCT01823835|616080148|FG005|Overall Study|Withdrawal by Subject|0|||
170475974|NCT01823835|616080149|FG006|Overall Study|Withdrawal by Subject|0|||
170475975|NCT01823835|616080150|FG007|Overall Study|Withdrawal by Subject|0|||
170475976|NCT01823835|616080151|FG008|Overall Study|Withdrawal by Subject|0|||
170546381|NCT01851369|616345861|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546382|NCT01851369|616345862|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
170546383|NCT03412890|616345863|FG000|Overall Study|Adverse Event|5|||
170546384|NCT03412890|616345864|FG001|Overall Study|Adverse Event|5|||
170546385|NCT03412890|616345865|FG002|Overall Study|Adverse Event|9|||
170546386|NCT03412890|616345863|FG000|Overall Study|Protocol deviation|2|||
170546387|NCT03412890|616345864|FG001|Overall Study|Protocol deviation|1|||
170792295|NCT01928394|617249436|FG008|Treatment Period|Poor/non-compliance|0|||
170792296|NCT01928394|617249437|FG009|Treatment Period|Poor/non-compliance|0|||
170792297|NCT01928394|617249438|FG010|Treatment Period|Poor/non-compliance|0|||
170792298|NCT01928394|617249439|FG011|Treatment Period|Poor/non-compliance|0|||
170792299|NCT01928394|617249440|FG012|Treatment Period|Poor/non-compliance|1|||
170792300|NCT01928394|617249441|FG013|Treatment Period|Poor/non-compliance|0|||
170792301|NCT01928394|617249442|FG014|Treatment Period|Poor/non-compliance|1|||
170792302|NCT01928394|617249443|FG015|Treatment Period|Poor/non-compliance|0|||
170792303|NCT01928394|617249444|FG016|Treatment Period|Poor/non-compliance|0|||
170792304|NCT01928394|617249445|FG017|Treatment Period|Poor/non-compliance|1|||
170792305|NCT01928394|617249446|FG018|Treatment Period|Poor/non-compliance|0|||
170792306|NCT01928394|617249447|FG019|Treatment Period|Poor/non-compliance|1|||
170792307|NCT01928394|617249448|FG020|Treatment Period|Poor/non-compliance|0|||
170792308|NCT01928394|617249449|FG021|Treatment Period|Poor/non-compliance|0|||
170792309|NCT01928394|617249450|FG022|Treatment Period|Poor/non-compliance|0|||
170546388|NCT03412890|616345865|FG002|Overall Study|Protocol deviation|2|||
170792310|NCT01928394|617249428|FG000|Treatment Period|other reason|0|||
170792311|NCT01928394|617249429|FG001|Treatment Period|other reason|0|||
170792312|NCT01928394|617249430|FG002|Treatment Period|other reason|0|||
170792313|NCT01928394|617249431|FG003|Treatment Period|other reason|0|||
170792314|NCT01928394|617249432|FG004|Treatment Period|other reason|0|||
170792315|NCT01928394|617249433|FG005|Treatment Period|other reason|0|||
170792316|NCT01928394|617249434|FG006|Treatment Period|other reason|0|||
170792317|NCT01928394|617249435|FG007|Treatment Period|other reason|0|||
170546389|NCT03412890|616345863|FG000|Overall Study|Lost to Follow-up|7|||
170546390|NCT03412890|616345864|FG001|Overall Study|Lost to Follow-up|10|||
170546391|NCT03412890|616345865|FG002|Overall Study|Lost to Follow-up|10|||
170546392|NCT03412890|616345863|FG000|Overall Study|Withdrawal by Subject|9|||
170546393|NCT03412890|616345864|FG001|Overall Study|Withdrawal by Subject|12|||
170546394|NCT03412890|616345865|FG002|Overall Study|Withdrawal by Subject|11|||
170546395|NCT03412890|616345863|FG000|Overall Study|Lack of Efficacy|2|||
170546396|NCT03412890|616345864|FG001|Overall Study|Lack of Efficacy|7|||
170546397|NCT03412890|616345865|FG002|Overall Study|Lack of Efficacy|5|||
170546398|NCT03412890|616345863|FG000|Overall Study|Other|5|||
170546399|NCT03412890|616345864|FG001|Overall Study|Other|6|||
170792318|NCT01928394|617249436|FG008|Treatment Period|other reason|0|||
170792319|NCT01928394|617249437|FG009|Treatment Period|other reason|0|||
170792320|NCT01928394|617249438|FG010|Treatment Period|other reason|1|||
170792321|NCT01928394|617249439|FG011|Treatment Period|other reason|1|||
170792322|NCT01928394|617249440|FG012|Treatment Period|other reason|1|||
170475977|NCT01823835|616080152|FG009|Overall Study|Withdrawal by Subject|1|||
170475978|NCT01823835|616080153|FG010|Overall Study|Withdrawal by Subject|1|||
170475979|NCT01823835|616080154|FG011|Overall Study|Withdrawal by Subject|2|||
170475980|NCT01823835|616080155|FG012|Overall Study|Withdrawal by Subject|1|||
170475981|NCT01823835|616080156|FG013|Overall Study|Withdrawal by Subject|0|||
170475982|NCT01823835|616080157|FG014|Overall Study|Withdrawal by Subject|0|||
170475983|NCT04895982|616080158|FG000|Overall Study|Withdrawal by Subject|0|||
170475984|NCT04895982|616080159|FG001|Overall Study|Withdrawal by Subject|0|||
170638614|NCT04421027|616688295|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
170638615|NCT04421027|616688296|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
170638616|NCT04421027|616688293|FG000|Follow-Up Period|Left message, participant did not call back|0|||
170638617|NCT04421027|616688294|FG001|Follow-Up Period|Left message, participant did not call back|0|||
170638618|NCT04421027|616688295|FG002|Follow-Up Period|Left message, participant did not call back|0|||
170638619|NCT04421027|616688296|FG003|Follow-Up Period|Left message, participant did not call back|1|||
170638620|NCT04421027|616688293|FG000|Follow-Up Period|Participant died|0|||
170638621|NCT04421027|616688294|FG001|Follow-Up Period|Participant died|0|||
170638622|NCT04421027|616688295|FG002|Follow-Up Period|Participant died|0|||
170638623|NCT04421027|616688296|FG003|Follow-Up Period|Participant died|1|||
170638624|NCT04421027|616688293|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
170638625|NCT04421027|616688294|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
170638626|NCT04421027|616688295|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
170638627|NCT04421027|616688296|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
170638628|NCT03843541|616688297|FG000|Overall Study|Adverse Event|4|||
170638629|NCT03843541|616688298|FG001|Overall Study|Adverse Event|2|||
170638630|NCT03843541|616688299|FG002|Overall Study|Adverse Event|3|||
170638631|NCT03843541|616688297|FG000|Overall Study|Death|1|||
170638632|NCT03843541|616688298|FG001|Overall Study|Death|0|||
170638633|NCT03843541|616688299|FG002|Overall Study|Death|0|||
170638634|NCT03843541|616688297|FG000|Overall Study|Lack of adherence to study medication|0|||
170638635|NCT03843541|616688298|FG001|Overall Study|Lack of adherence to study medication|0|||
170475985|NCT04895982|616080160|FG002|Overall Study|Withdrawal by Subject|0|||
170638636|NCT03843541|616688299|FG002|Overall Study|Lack of adherence to study medication|1|||
170638637|NCT03843541|616688297|FG000|Overall Study|Physician Decision|1|||
170638638|NCT03843541|616688298|FG001|Overall Study|Physician Decision|2|||
170638639|NCT03843541|616688299|FG002|Overall Study|Physician Decision|2|||
170638640|NCT03843541|616688297|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
170638641|NCT03843541|616688298|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
170792323|NCT01928394|617249441|FG013|Treatment Period|other reason|0|||
170792324|NCT01928394|617249442|FG014|Treatment Period|other reason|1|||
170792325|NCT01928394|617249443|FG015|Treatment Period|other reason|0|||
170792326|NCT01928394|617249444|FG016|Treatment Period|other reason|0|||
170792327|NCT01928394|617249445|FG017|Treatment Period|other reason|0|||
170792328|NCT01928394|617249446|FG018|Treatment Period|other reason|2|||
170792329|NCT01928394|617249447|FG019|Treatment Period|other reason|2|||
170792330|NCT01928394|617249448|FG020|Treatment Period|other reason|0|||
170792331|NCT01928394|617249449|FG021|Treatment Period|other reason|0|||
170792332|NCT01928394|617249450|FG022|Treatment Period|other reason|0|||
170792333|NCT01928394|617249428|FG000|Treatment Period|Maximum clinical benefit|0|||
170792334|NCT01928394|617249429|FG001|Treatment Period|Maximum clinical benefit|0|||
170792335|NCT01928394|617249430|FG002|Treatment Period|Maximum clinical benefit|0|||
170792336|NCT01928394|617249431|FG003|Treatment Period|Maximum clinical benefit|0|||
170792337|NCT01928394|617249432|FG004|Treatment Period|Maximum clinical benefit|0|||
170792338|NCT01928394|617249433|FG005|Treatment Period|Maximum clinical benefit|0|||
170792339|NCT01928394|617249434|FG006|Treatment Period|Maximum clinical benefit|0|||
170792340|NCT01928394|617249435|FG007|Treatment Period|Maximum clinical benefit|0|||
170792341|NCT01928394|617249436|FG008|Treatment Period|Maximum clinical benefit|0|||
170792342|NCT01928394|617249437|FG009|Treatment Period|Maximum clinical benefit|0|||
170792343|NCT01928394|617249438|FG010|Treatment Period|Maximum clinical benefit|1|||
170792344|NCT01928394|617249439|FG011|Treatment Period|Maximum clinical benefit|1|||
170792345|NCT01928394|617249440|FG012|Treatment Period|Maximum clinical benefit|0|||
170475986|NCT04895982|616080161|FG003|Overall Study|Withdrawal by Subject|0|||
170475987|NCT04895982|616080162|FG004|Overall Study|Withdrawal by Subject|0|||
170638642|NCT03843541|616688299|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
170792346|NCT01928394|617249441|FG013|Treatment Period|Maximum clinical benefit|0|||
170792347|NCT01928394|617249442|FG014|Treatment Period|Maximum clinical benefit|1|||
170792348|NCT01928394|617249443|FG015|Treatment Period|Maximum clinical benefit|0|||
170792349|NCT01928394|617249444|FG016|Treatment Period|Maximum clinical benefit|0|||
170792350|NCT01928394|617249445|FG017|Treatment Period|Maximum clinical benefit|1|||
170792351|NCT01928394|617249446|FG018|Treatment Period|Maximum clinical benefit|1|||
170792352|NCT01928394|617249447|FG019|Treatment Period|Maximum clinical benefit|0|||
170792353|NCT01928394|617249448|FG020|Treatment Period|Maximum clinical benefit|2|||
170475988|NCT04895982|616080163|FG005|Overall Study|Withdrawal by Subject|1|||
170546400|NCT03412890|616345865|FG002|Overall Study|Other|5|||
170546401|NCT03412890|616345863|FG000|Overall Study|Participants who did not receive any study drug|0|||
170546402|NCT03412890|616345864|FG001|Overall Study|Participants who did not receive any study drug|1|||
170546403|NCT03412890|616345865|FG002|Overall Study|Participants who did not receive any study drug|0|||
170546404|NCT01543503|616345867|FG000|Overall Study|Lost to Follow-up|32|||
170546405|NCT01543503|616345868|FG001|Overall Study|Lost to Follow-up|36|||
170546406|NCT01543503|616345867|FG000|Overall Study|Adverse Event|9|||
170546407|NCT01543503|616345868|FG001|Overall Study|Adverse Event|13|||
170546408|NCT01543503|616345867|FG000|Overall Study|Lack of Efficacy|4|||
170546409|NCT01543503|616345868|FG001|Overall Study|Lack of Efficacy|16|||
170546410|NCT01543503|616345867|FG000|Overall Study|Participant withdrew informed consent|8|||
170546411|NCT01543503|616345868|FG001|Overall Study|Participant withdrew informed consent|10|||
170546412|NCT01543503|616345867|FG000|Overall Study|Change of jobs|0|||
170546413|NCT01543503|616345868|FG001|Overall Study|Change of jobs|1|||
170546414|NCT01543503|616345867|FG000|Overall Study|Intolerance to the biologic treatment|0|||
170546415|NCT01543503|616345868|FG001|Overall Study|Intolerance to the biologic treatment|1|||
170546416|NCT01543503|616345867|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
170546417|NCT01543503|616345868|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
170546418|NCT01543503|616345867|FG000|Overall Study|Participant did not complete last visit|0|||
170546419|NCT01543503|616345868|FG001|Overall Study|Participant did not complete last visit|2|||
170546420|NCT01543503|616345867|FG000|Overall Study|Refused to continue treatment|7|||
170546421|NCT01543503|616345868|FG001|Overall Study|Refused to continue treatment|0|||
170546422|NCT01543503|616345867|FG000|Overall Study|Incorrect medication received|1|||
170546423|NCT01543503|616345868|FG001|Overall Study|Incorrect medication received|0|||
170546424|NCT01543503|616345867|FG000|Overall Study|Participant moved to another city|2|||
170546425|NCT01543503|616345868|FG001|Overall Study|Participant moved to another city|0|||
170546426|NCT01543503|616345867|FG000|Overall Study|Participant will not return for visits|0|||
170546427|NCT01543503|616345868|FG001|Overall Study|Participant will not return for visits|2|||
170546428|NCT01543503|616345867|FG000|Overall Study|Participant transferred to another city|1|||
170546429|NCT01543503|616345868|FG001|Overall Study|Participant transferred to another city|0|||
170546430|NCT01543503|616345867|FG000|Overall Study|Participant moved to Scotland|1|||
170546431|NCT01543503|616345868|FG001|Overall Study|Participant moved to Scotland|0|||
170546432|NCT01543503|616345867|FG000|Overall Study|Participant decision to stop treatment|1|||
170546433|NCT01543503|616345868|FG001|Overall Study|Participant decision to stop treatment|0|||
170546434|NCT01543503|616345867|FG000|Overall Study|Investigator did not wish to participate|1|||
170546435|NCT01543503|616345868|FG001|Overall Study|Investigator did not wish to participate|1|||
170546436|NCT01543503|616345867|FG000|Overall Study|Participant recruited after closing date|0|||
170546437|NCT01543503|616345868|FG001|Overall Study|Participant recruited after closing date|1|||
170546438|NCT01543503|616345867|FG000|Overall Study|Site stopped participation|5|||
170546439|NCT01543503|616345868|FG001|Overall Study|Site stopped participation|1|||
170546440|NCT01543503|616345867|FG000|Overall Study|Participant did not attend a visit|1|||
170546441|NCT01543503|616345868|FG001|Overall Study|Participant did not attend a visit|0|||
170546442|NCT01543503|616345867|FG000|Overall Study|Moved to other rheumatologic site|0|||
170546443|NCT01543503|616345868|FG001|Overall Study|Moved to other rheumatologic site|1|||
170546444|NCT01543503|616345867|FG000|Overall Study|Participant consented to another study|0|||
170546445|NCT01543503|616345868|FG001|Overall Study|Participant consented to another study|2|||
170546446|NCT01543503|616345867|FG000|Overall Study|Participant went to United States|1|||
170792354|NCT01928394|617249449|FG021|Treatment Period|Maximum clinical benefit|0|||
170792355|NCT01928394|617249450|FG022|Treatment Period|Maximum clinical benefit|0|||
170792356|NCT01928394|617249428|FG000|Treatment Period|Lost to Follow-up|0|||
170792357|NCT01928394|617249429|FG001|Treatment Period|Lost to Follow-up|0|||
170792358|NCT01928394|617249430|FG002|Treatment Period|Lost to Follow-up|0|||
170792359|NCT01928394|617249431|FG003|Treatment Period|Lost to Follow-up|0|||
170792360|NCT01928394|617249432|FG004|Treatment Period|Lost to Follow-up|0|||
170792361|NCT01928394|617249433|FG005|Treatment Period|Lost to Follow-up|0|||
170546447|NCT01543503|616345868|FG001|Overall Study|Participant went to United States|0|||
170546448|NCT01543503|616345867|FG000|Overall Study|Screen failure|1|||
170546449|NCT01543503|616345868|FG001|Overall Study|Screen failure|0|||
170546450|NCT01936974|616345869|FG000|Overall Study|Physician Decision|2|||
170546451|NCT01936974|616345870|FG001|Overall Study|Physician Decision|5|||
170546452|NCT04584554|616345871|FG000|Overall Study|Withdrawal by Subject|2|||
170792362|NCT01928394|617249434|FG006|Treatment Period|Lost to Follow-up|0|||
170475989|NCT04895982|616080164|FG006|Overall Study|Withdrawal by Subject|1|||
170475990|NCT04895982|616080165|FG007|Overall Study|Withdrawal by Subject|0|||
170475991|NCT04895982|616080166|FG008|Overall Study|Withdrawal by Subject|0|||
170475992|NCT04895982|616080167|FG009|Overall Study|Withdrawal by Subject|1|||
170475993|NCT04895982|616080168|FG010|Overall Study|Withdrawal by Subject|0|||
170475994|NCT04895982|616080169|FG011|Overall Study|Withdrawal by Subject|1|||
170792363|NCT01928394|617249435|FG007|Treatment Period|Lost to Follow-up|0|||
170792364|NCT01928394|617249436|FG008|Treatment Period|Lost to Follow-up|0|||
170792365|NCT01928394|617249437|FG009|Treatment Period|Lost to Follow-up|0|||
170792366|NCT01928394|617249438|FG010|Treatment Period|Lost to Follow-up|0|||
170792367|NCT01928394|617249439|FG011|Treatment Period|Lost to Follow-up|0|||
170792368|NCT01928394|617249440|FG012|Treatment Period|Lost to Follow-up|0|||
170792369|NCT01928394|617249441|FG013|Treatment Period|Lost to Follow-up|0|||
170792370|NCT01928394|617249442|FG014|Treatment Period|Lost to Follow-up|0|||
170792371|NCT01928394|617249443|FG015|Treatment Period|Lost to Follow-up|0|||
170792372|NCT01928394|617249444|FG016|Treatment Period|Lost to Follow-up|0|||
170475995|NCT04895982|616080158|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170475996|NCT04895982|616080159|FG001|Overall Study|Withdrawal by parent/guardian|3|||
170475997|NCT04895982|616080160|FG002|Overall Study|Withdrawal by parent/guardian|3|||
170475998|NCT04895982|616080161|FG003|Overall Study|Withdrawal by parent/guardian|1|||
170475999|NCT04895982|616080162|FG004|Overall Study|Withdrawal by parent/guardian|3|||
170476000|NCT04895982|616080163|FG005|Overall Study|Withdrawal by parent/guardian|2|||
170476001|NCT04895982|616080164|FG006|Overall Study|Withdrawal by parent/guardian|1|||
170476002|NCT04895982|616080165|FG007|Overall Study|Withdrawal by parent/guardian|0|||
170476003|NCT04895982|616080166|FG008|Overall Study|Withdrawal by parent/guardian|3|||
170476004|NCT04895982|616080167|FG009|Overall Study|Withdrawal by parent/guardian|0|||
170546453|NCT04584554|616345872|FG001|Overall Study|Withdrawal by Subject|2|||
170546454|NCT00063999|616345873|FG000|Overall Study|Withdrawal by Subject|1|||
170546455|NCT00063999|616345874|FG001|Overall Study|Withdrawal by Subject|0|||
170546456|NCT00063999|616345873|FG000|Overall Study|Ineligible|44|||
170546457|NCT00063999|616345874|FG001|Overall Study|Ineligible|24|||
170546458|NCT02583477|616345876|FG000|Overall Study|Adverse Event|0|||
170546459|NCT02583477|616345877|FG001|Overall Study|Adverse Event|2|||
170546460|NCT02583477|616345876|FG000|Overall Study|Death|1|||
170546461|NCT02583477|616345877|FG001|Overall Study|Death|16|||
170546462|NCT02583477|616345876|FG000|Overall Study|Study terminated|2|||
170546463|NCT02583477|616345877|FG001|Overall Study|Study terminated|2|||
170546464|NCT05507450|616345878|FG000|Overall Study|Death|0|||
170546465|NCT05507450|616345879|FG001|Overall Study|Death|0|||
170546466|NCT05507450|616345880|FG002|Overall Study|Death|1|||
170546467|NCT05507450|616345881|FG003|Overall Study|Death|0|||
170546468|NCT05507450|616345878|FG000|Overall Study|Lost to Follow-up|22|||
170546469|NCT05507450|616345879|FG001|Overall Study|Lost to Follow-up|20|||
170546470|NCT05507450|616345880|FG002|Overall Study|Lost to Follow-up|20|||
170546471|NCT05507450|616345881|FG003|Overall Study|Lost to Follow-up|7|||
170546472|NCT05507450|616345878|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170546473|NCT05507450|616345879|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
170546474|NCT05507450|616345880|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170546475|NCT05507450|616345881|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170546476|NCT05507450|616345878|FG000|Overall Study|Withdrawal by Subject|4|||
170546477|NCT05507450|616345879|FG001|Overall Study|Withdrawal by Subject|11|||
170546478|NCT05507450|616345880|FG002|Overall Study|Withdrawal by Subject|7|||
170546479|NCT05507450|616345881|FG003|Overall Study|Withdrawal by Subject|3|||
170546480|NCT05507450|616345878|FG000|Overall Study|Participant left the country|0|||
170546481|NCT05507450|616345879|FG001|Overall Study|Participant left the country|0|||
170546482|NCT05507450|616345880|FG002|Overall Study|Participant left the country|1|||
170546483|NCT05507450|616345881|FG003|Overall Study|Participant left the country|0|||
170546484|NCT00514917|616345882|FG000|Overall Study|Death|4|||
170546485|NCT00514917|616345883|FG001|Overall Study|Death|10|||
170546486|NCT00514917|616345882|FG000|Overall Study|Protocol Violation|1|||
170546487|NCT00514917|616345883|FG001|Overall Study|Protocol Violation|0|||
170792373|NCT01928394|617249445|FG017|Treatment Period|Lost to Follow-up|0|||
170792374|NCT01928394|617249446|FG018|Treatment Period|Lost to Follow-up|0|||
170792375|NCT01928394|617249447|FG019|Treatment Period|Lost to Follow-up|0|||
170792376|NCT01928394|617249448|FG020|Treatment Period|Lost to Follow-up|0|||
170476005|NCT04895982|616080168|FG010|Overall Study|Withdrawal by parent/guardian|0|||
170476006|NCT04895982|616080169|FG011|Overall Study|Withdrawal by parent/guardian|0|||
170476007|NCT04895982|616080158|FG000|Overall Study|Other|0|||
170476008|NCT04895982|616080159|FG001|Overall Study|Other|0|||
170476009|NCT04895982|616080160|FG002|Overall Study|Other|1|||
170476010|NCT04895982|616080161|FG003|Overall Study|Other|1|||
170476011|NCT04895982|616080162|FG004|Overall Study|Other|0|||
170546488|NCT00514917|616345882|FG000|Overall Study|Lost to Follow-up|4|||
170546489|NCT00514917|616345883|FG001|Overall Study|Lost to Follow-up|3|||
170546490|NCT00514917|616345882|FG000|Overall Study|Withdrawal by Subject|18|||
170546491|NCT00514917|616345883|FG001|Overall Study|Withdrawal by Subject|16|||
170792377|NCT01928394|617249449|FG021|Treatment Period|Lost to Follow-up|0|||
170792378|NCT01928394|617249450|FG022|Treatment Period|Lost to Follow-up|1|||
170792379|NCT01928394|617249428|FG000|Treatment Period|Death|0|||
170792380|NCT01928394|617249429|FG001|Treatment Period|Death|0|||
170792381|NCT01928394|617249430|FG002|Treatment Period|Death|0|||
170792382|NCT01928394|617249431|FG003|Treatment Period|Death|0|||
170792383|NCT01928394|617249432|FG004|Treatment Period|Death|0|||
170792384|NCT01928394|617249433|FG005|Treatment Period|Death|0|||
170792385|NCT01928394|617249434|FG006|Treatment Period|Death|0|||
170792386|NCT01928394|617249435|FG007|Treatment Period|Death|0|||
170792387|NCT01928394|617249436|FG008|Treatment Period|Death|0|||
170792388|NCT01928394|617249437|FG009|Treatment Period|Death|0|||
170792389|NCT01928394|617249438|FG010|Treatment Period|Death|0|||
170792390|NCT01928394|617249439|FG011|Treatment Period|Death|0|||
170792391|NCT01928394|617249440|FG012|Treatment Period|Death|0|||
170792392|NCT01928394|617249441|FG013|Treatment Period|Death|1|||
170792393|NCT01928394|617249442|FG014|Treatment Period|Death|2|||
170792394|NCT01928394|617249443|FG015|Treatment Period|Death|0|||
170891896|NCT01114529|617611872|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
170891897|NCT01114529|617611873|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
170891898|NCT01114529|617611871|FG000|Completed Study Phase at Month 24|Death|8|||
170891899|NCT01114529|617611872|FG001|Completed Study Phase at Month 24|Death|5|||
170891900|NCT01114529|617611873|FG002|Completed Study Phase at Month 24|Death|4|||
170891901|NCT01114529|617611871|FG000|Completed Study Phase at Month 24|Other|2|||
170891902|NCT01114529|617611872|FG001|Completed Study Phase at Month 24|Other|0|||
170891903|NCT01114529|617611873|FG002|Completed Study Phase at Month 24|Other|0|||
170891904|NCT01114529|617611871|FG000|Completed Study Phase at Month 24|Missing|2|||
170891905|NCT01114529|617611872|FG001|Completed Study Phase at Month 24|Missing|0|||
170891906|NCT01114529|617611873|FG002|Completed Study Phase at Month 24|Missing|0|||
170891907|NCT02450578|617611874|FG000|Overall Study|ECG abnormality so not treated|1|||
170891908|NCT02450578|617611875|FG001|Overall Study|ECG abnormality so not treated|0|||
170891909|NCT02450578|617611876|FG002|Overall Study|ECG abnormality so not treated|0|||
170891910|NCT02450578|617611877|FG003|Overall Study|ECG abnormality so not treated|0|||
170891911|NCT04428411|617611878|FG000|Overall Study|Lost to Follow-up|114|||
170891912|NCT00634569|617611879|FG000|Overall Study|Withdrawal by Subject|0|||
170891913|NCT00634569|617611880|FG001|Overall Study|Withdrawal by Subject|4|||
170891914|NCT00634569|617611879|FG000|Overall Study|Physician Decision|0|||
170891915|NCT00634569|617611880|FG001|Overall Study|Physician Decision|1|||
170891916|NCT02918019|617611881|FG000|Overall Study|Death|0|||
170546492|NCT00514917|616345882|FG000|Overall Study|Discontinued due to study closure|88|||
170546493|NCT00514917|616345883|FG001|Overall Study|Discontinued due to study closure|81|||
170546494|NCT00514917|616345882|FG000|Overall Study|Undefined|11|||
170546495|NCT00514917|616345883|FG001|Overall Study|Undefined|5|||
170546496|NCT00387127|616345884|FG000|Overall Study|Lost to Follow-up|0|||
170546497|NCT00387127|616345885|FG001|Overall Study|Lost to Follow-up|4|||
170546498|NCT00387127|616345884|FG000|Overall Study|Death|16|||
170546499|NCT00387127|616345885|FG001|Overall Study|Death|16|||
170546500|NCT00387127|616345884|FG000|Overall Study|Physician Decision|0|||
170546501|NCT00387127|616345885|FG001|Overall Study|Physician Decision|1|||
170546502|NCT00387127|616345884|FG000|Overall Study|Withdrawal by Subject|3|||
170546503|NCT00387127|616345885|FG001|Overall Study|Withdrawal by Subject|2|||
170546504|NCT00387127|616345884|FG000|Overall Study|Required by Protocol Amendment #4|12|||
170546505|NCT00387127|616345885|FG001|Overall Study|Required by Protocol Amendment #4|10|||
170546506|NCT00387127|616345884|FG000|Overall Study|Serious Adverse Event|1|||
170546507|NCT00387127|616345885|FG001|Overall Study|Serious Adverse Event|1|||
170546508|NCT00387127|616345884|FG000|Overall Study|Sponsor Unblinded|1|||
170546509|NCT00387127|616345885|FG001|Overall Study|Sponsor Unblinded|0|||
170546510|NCT01436500|616345886|FG000|Overall Study|Death|1|||
170546511|NCT01436500|616345887|FG001|Overall Study|Death|0|||
170546512|NCT01436500|616345888|FG002|Overall Study|Death|0|||
170546513|NCT01436500|616345889|FG003|Overall Study|Death|0|||
170546514|NCT01436500|616345890|FG004|Overall Study|Death|0|||
170546515|NCT01436500|616345886|FG000|Overall Study|Adverse Event|0|||
170546516|NCT01436500|616345887|FG001|Overall Study|Adverse Event|2|||
170792395|NCT01928394|617249444|FG016|Treatment Period|Death|0|||
170792396|NCT01928394|617249445|FG017|Treatment Period|Death|0|||
170891917|NCT02918019|617611882|FG001|Overall Study|Death|0|||
170891918|NCT02918019|617611883|FG002|Overall Study|Death|1|||
170546517|NCT01436500|616345888|FG002|Overall Study|Adverse Event|2|||
170546518|NCT01436500|616345889|FG003|Overall Study|Adverse Event|0|||
170546519|NCT01436500|616345890|FG004|Overall Study|Adverse Event|1|||
170546520|NCT01436500|616345886|FG000|Overall Study|Withdrawal by Subject|0|||
170792397|NCT01928394|617249446|FG018|Treatment Period|Death|0|||
170891919|NCT02918019|617611884|FG003|Overall Study|Death|0|||
170891920|NCT02918019|617611881|FG000|Overall Study|Lost to Follow-up|1|||
170891921|NCT02918019|617611882|FG001|Overall Study|Lost to Follow-up|1|||
170546521|NCT01436500|616345887|FG001|Overall Study|Withdrawal by Subject|0|||
170792398|NCT01928394|617249447|FG019|Treatment Period|Death|0|||
170792399|NCT01928394|617249448|FG020|Treatment Period|Death|0|||
170792400|NCT01928394|617249449|FG021|Treatment Period|Death|0|||
170792401|NCT01928394|617249450|FG022|Treatment Period|Death|0|||
170891922|NCT02918019|617611883|FG002|Overall Study|Lost to Follow-up|0|||
170891923|NCT02918019|617611884|FG003|Overall Study|Lost to Follow-up|1|||
170891924|NCT02918019|617611881|FG000|Overall Study|Principal investigator request|0|||
170891925|NCT02918019|617611882|FG001|Overall Study|Principal investigator request|0|||
170891926|NCT02918019|617611883|FG002|Overall Study|Principal investigator request|0|||
170891927|NCT02918019|617611884|FG003|Overall Study|Principal investigator request|1|||
170891928|NCT02918019|617611881|FG000|Overall Study|Physician Decision|1|||
170891929|NCT02918019|617611882|FG001|Overall Study|Physician Decision|3|||
170891930|NCT02918019|617611883|FG002|Overall Study|Physician Decision|2|||
170476012|NCT04895982|616080163|FG005|Overall Study|Other|0|||
170476013|NCT04895982|616080164|FG006|Overall Study|Other|0|||
170476014|NCT04895982|616080165|FG007|Overall Study|Other|0|||
170476015|NCT04895982|616080166|FG008|Overall Study|Other|0|||
170476016|NCT04895982|616080167|FG009|Overall Study|Other|1|||
170476017|NCT04895982|616080168|FG010|Overall Study|Other|0|||
170476018|NCT04895982|616080169|FG011|Overall Study|Other|0|||
170476019|NCT04895982|616080158|FG000|Overall Study|Protocol Violation|0|||
170476020|NCT04895982|616080159|FG001|Overall Study|Protocol Violation|0|||
170476021|NCT04895982|616080160|FG002|Overall Study|Protocol Violation|1|||
170476022|NCT04895982|616080161|FG003|Overall Study|Protocol Violation|1|||
170476023|NCT04895982|616080162|FG004|Overall Study|Protocol Violation|1|||
170476024|NCT04895982|616080163|FG005|Overall Study|Protocol Violation|0|||
170476025|NCT04895982|616080164|FG006|Overall Study|Protocol Violation|0|||
170476026|NCT04895982|616080165|FG007|Overall Study|Protocol Violation|1|||
170476027|NCT04895982|616080166|FG008|Overall Study|Protocol Violation|0|||
170476028|NCT04895982|616080167|FG009|Overall Study|Protocol Violation|0|||
170476029|NCT04895982|616080168|FG010|Overall Study|Protocol Violation|0|||
170476030|NCT04895982|616080169|FG011|Overall Study|Protocol Violation|0|||
170476031|NCT04895982|616080158|FG000|Overall Study|Lost to Follow-up|0|||
170476032|NCT04895982|616080159|FG001|Overall Study|Lost to Follow-up|0|||
170476033|NCT04895982|616080160|FG002|Overall Study|Lost to Follow-up|1|||
170476034|NCT04895982|616080161|FG003|Overall Study|Lost to Follow-up|0|||
170546522|NCT01436500|616345888|FG002|Overall Study|Withdrawal by Subject|2|||
170891931|NCT02918019|617611884|FG003|Overall Study|Physician Decision|0|||
170546523|NCT01436500|616345889|FG003|Overall Study|Withdrawal by Subject|0|||
170891932|NCT02918019|617611881|FG000|Overall Study|Protocol deviation|1|||
170476035|NCT04895982|616080162|FG004|Overall Study|Lost to Follow-up|0|||
170476036|NCT04895982|616080163|FG005|Overall Study|Lost to Follow-up|1|||
170476037|NCT04895982|616080164|FG006|Overall Study|Lost to Follow-up|0|||
170891933|NCT02918019|617611882|FG001|Overall Study|Protocol deviation|1|||
170638643|NCT03843541|616688297|FG000|Overall Study|Withdrawal by Subject|6|||
170638644|NCT03843541|616688298|FG001|Overall Study|Withdrawal by Subject|9|||
170638645|NCT03843541|616688299|FG002|Overall Study|Withdrawal by Subject|7|||
170638646|NCT03843541|616688297|FG000|Overall Study|Administration of rescue mucolytic|0|||
170638647|NCT03843541|616688298|FG001|Overall Study|Administration of rescue mucolytic|0|||
170638648|NCT03843541|616688299|FG002|Overall Study|Administration of rescue mucolytic|1|||
170638649|NCT03843541|616688297|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
170638650|NCT03843541|616688298|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
170638651|NCT03843541|616688299|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
170638652|NCT02374450|616688313|FG000|Overall Study|Protocol Violation|0|||
170638653|NCT02374450|616688314|FG001|Overall Study|Protocol Violation|1|||
170638654|NCT02374450|616688315|FG002|Overall Study|Protocol Violation|0|||
170638655|NCT02374450|616688313|FG000|Overall Study|Withdrawal by Subject|91|||
170638656|NCT02374450|616688314|FG001|Overall Study|Withdrawal by Subject|110|||
170638657|NCT02374450|616688315|FG002|Overall Study|Withdrawal by Subject|4|||
170638658|NCT02374450|616688313|FG000|Overall Study|Lost to Follow-up|168|||
170638659|NCT02374450|616688314|FG001|Overall Study|Lost to Follow-up|194|||
170638660|NCT02374450|616688315|FG002|Overall Study|Lost to Follow-up|138|||
170638661|NCT02374450|616688313|FG000|Overall Study|Death|173|||
170638662|NCT02374450|616688314|FG001|Overall Study|Death|185|||
170638663|NCT02374450|616688315|FG002|Overall Study|Death|81|||
170638664|NCT02374450|616688313|FG000|Overall Study|Migrated from the study area|538|||
170638665|NCT02374450|616688314|FG001|Overall Study|Migrated from the study area|648|||
170638666|NCT02374450|616688315|FG002|Overall Study|Migrated from the study area|181|||
170638667|NCT02374450|616688313|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
170638668|NCT02374450|616688314|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
170638669|NCT02374450|616688315|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
170638670|NCT02374450|616688313|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
170638671|NCT02374450|616688314|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
170638672|NCT02374450|616688315|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
170638673|NCT02374450|616688313|FG000|Overall Study|Other|0|||
170638674|NCT02374450|616688314|FG001|Overall Study|Other|21|||
170638675|NCT02374450|616688315|FG002|Overall Study|Other|79|||
170638676|NCT03568461|616688320|FG000|Overall Study|Death|7|||
170638677|NCT03568461|616688320|FG000|Overall Study|Physician Decision|5|||
170638678|NCT03568461|616688320|FG000|Overall Study|Subject decision|5|||
170638679|NCT03568461|616688320|FG000|Overall Study|Lost to Follow-up|1|||
170638680|NCT03387085|616688321|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
170638681|NCT04193189|616688328|FG000|Overall Study|Lost to Follow-up|9|||
170638682|NCT04193189|616688329|FG001|Overall Study|Lost to Follow-up|7|||
170638683|NCT04193189|616688330|FG002|Overall Study|Lost to Follow-up|9|||
170638684|NCT04193189|616688331|FG003|Overall Study|Lost to Follow-up|0|||
170638685|NCT04193189|616688328|FG000|Overall Study|Withdrawal by Subject|1|||
170638686|NCT04193189|616688329|FG001|Overall Study|Withdrawal by Subject|2|||
170638687|NCT04193189|616688330|FG002|Overall Study|Withdrawal by Subject|2|||
170638688|NCT04193189|616688331|FG003|Overall Study|Withdrawal by Subject|0|||
170638689|NCT04193189|616688328|FG000|Overall Study|Death|1|||
170638690|NCT04193189|616688329|FG001|Overall Study|Death|1|||
170638691|NCT04193189|616688330|FG002|Overall Study|Death|0|||
170638692|NCT04193189|616688331|FG003|Overall Study|Death|0|||
170638693|NCT04193189|616688328|FG000|Overall Study|Protocol Violation|0|||
170638694|NCT04193189|616688329|FG001|Overall Study|Protocol Violation|0|||
170638695|NCT04193189|616688330|FG002|Overall Study|Protocol Violation|0|||
170638696|NCT04193189|616688331|FG003|Overall Study|Protocol Violation|1|||
170638697|NCT00295880|616689388|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
170891934|NCT02918019|617611883|FG002|Overall Study|Protocol deviation|0|||
170891935|NCT02918019|617611884|FG003|Overall Study|Protocol deviation|2|||
170891936|NCT02918019|617611881|FG000|Overall Study|Withdrawal by Subject|3|||
170891937|NCT02918019|617611882|FG001|Overall Study|Withdrawal by Subject|4|||
170891938|NCT02918019|617611883|FG002|Overall Study|Withdrawal by Subject|6|||
170891939|NCT02918019|617611884|FG003|Overall Study|Withdrawal by Subject|4|||
170476038|NCT04895982|616080165|FG007|Overall Study|Lost to Follow-up|0|||
170638698|NCT00295880|616689388|FG000|Overall Study|Unit randomization did not occur|1|||
170638699|NCT00792571|616689389|FG000|Overall Study|Death|1|||
170638700|NCT00792571|616689389|FG000|Overall Study|Adverse Event|4|||
170638701|NCT00792571|616689389|FG000|Overall Study|Withdrawal by Subject|1|||
170638702|NCT00792571|616689389|FG000|Overall Study|Other|4|||
170638703|NCT02600819|616689390|FG000|GEN Phase|Adverse Event|2|||
170476039|NCT04895982|616080166|FG008|Overall Study|Lost to Follow-up|1|||
170638704|NCT02600819|616689391|FG001|GEN Phase|Adverse Event|0|||
170638705|NCT02600819|616689390|FG000|GEN Phase|Death|2|||
170638706|NCT02600819|616689391|FG001|GEN Phase|Death|0|||
170638707|NCT02600819|616689390|FG000|GEN Phase|Investigator's Discretion|4|||
170638708|NCT02600819|616689391|FG001|GEN Phase|Investigator's Discretion|0|||
170891940|NCT02918019|617611881|FG000|Overall Study|Adverse Event|0|||
170638709|NCT02600819|616689390|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
170891941|NCT02918019|617611882|FG001|Overall Study|Adverse Event|1|||
170891942|NCT02918019|617611883|FG002|Overall Study|Adverse Event|0|||
170891943|NCT02918019|617611884|FG003|Overall Study|Adverse Event|1|||
170891944|NCT01212185|617611886|FG000|Overall Study|Protocol Violation|2|||
170891945|NCT01212185|617611887|FG001|Overall Study|Protocol Violation|1|||
170891946|NCT03555266|617611888|FG000|Overall Study|Protocol Violation|6|||
170891947|NCT03555266|617611889|FG001|Overall Study|Protocol Violation|4|||
170891948|NCT02614079|617611890|FG000|Overall Study|Withdrawal by Subject|1|||
170891949|NCT01699087|617611891|FG000|Overall Study|Lost to Follow-up|7|||
170891950|NCT01699087|617611891|FG000|Overall Study|Screen failure (prior to treatment)|15|||
170891951|NCT01699087|617611891|FG000|Overall Study|Unable to make future visits|2|||
170891952|NCT03370770|617611892|FG000|Overall Study|Patient was followed in another hospital center|1|||
170891953|NCT03370770|617611892|FG000|Overall Study|Progressive Disease|98|||
170891954|NCT03370770|617611892|FG000|Overall Study|Adverse Event|2|||
170891955|NCT03370770|617611892|FG000|Overall Study|Death|5|||
170891956|NCT00132730|617611893|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
170891957|NCT00132730|617611894|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
170891958|NCT00132730|617611895|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
170891959|NCT00132730|617611896|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
170891960|NCT00132730|617611897|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
170891961|NCT00132730|617611898|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
170891962|NCT00132730|617611893|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
170891963|NCT00132730|617611894|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
170891964|NCT00132730|617611895|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
170891965|NCT00132730|617611896|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
170891966|NCT00132730|617611897|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
170891967|NCT00132730|617611898|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
170546524|NCT01436500|616345890|FG004|Overall Study|Withdrawal by Subject|2|||
170546525|NCT01436500|616345886|FG000|Overall Study|Physician Decision|0|||
170546526|NCT01436500|616345887|FG001|Overall Study|Physician Decision|0|||
170546527|NCT01436500|616345888|FG002|Overall Study|Physician Decision|1|||
170546528|NCT01436500|616345889|FG003|Overall Study|Physician Decision|0|||
170546529|NCT01436500|616345890|FG004|Overall Study|Physician Decision|0|||
170546530|NCT01436500|616345886|FG000|Overall Study|liver transplant|1|||
170546531|NCT01436500|616345887|FG001|Overall Study|liver transplant|0|||
170546532|NCT01436500|616345888|FG002|Overall Study|liver transplant|0|||
170546533|NCT01436500|616345889|FG003|Overall Study|liver transplant|0|||
170546534|NCT01436500|616345890|FG004|Overall Study|liver transplant|0|||
170546535|NCT01436500|616345886|FG000|Overall Study|initiation of dialysis|0|||
170546536|NCT01436500|616345887|FG001|Overall Study|initiation of dialysis|0|||
170546537|NCT01436500|616345888|FG002|Overall Study|initiation of dialysis|0|||
170546538|NCT01436500|616345889|FG003|Overall Study|initiation of dialysis|0|||
170546539|NCT01436500|616345890|FG004|Overall Study|initiation of dialysis|1|||
170546540|NCT01436500|616345886|FG000|Overall Study|discontinued study drug|1|||
170546541|NCT01436500|616345887|FG001|Overall Study|discontinued study drug|0|||
170546542|NCT01436500|616345888|FG002|Overall Study|discontinued study drug|0|||
170546543|NCT01436500|616345889|FG003|Overall Study|discontinued study drug|0|||
170546544|NCT01436500|616345890|FG004|Overall Study|discontinued study drug|0|||
170546545|NCT01436500|616345886|FG000|Overall Study|Other|0|||
170546546|NCT01436500|616345887|FG001|Overall Study|Other|1|||
170546547|NCT01436500|616345888|FG002|Overall Study|Other|0|||
170546548|NCT01436500|616345889|FG003|Overall Study|Other|1|||
170891968|NCT00132730|617611893|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
170891969|NCT00132730|617611894|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
170891970|NCT00132730|617611895|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
170546549|NCT01436500|616345890|FG004|Overall Study|Other|0|||
170546550|NCT01489358|616345891|FG000|Overall Study|Lost to Follow-up|0|||
170546551|NCT01489358|616345892|FG001|Overall Study|Lost to Follow-up|0|||
170546552|NCT01489358|616345893|FG002|Overall Study|Lost to Follow-up|2|||
170546553|NCT01873833|616345902|FG000|Overall Study|Withdrawal by Subject|1|||
170891971|NCT00132730|617611896|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
170891972|NCT00132730|617611897|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
170891973|NCT00132730|617611898|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
170891974|NCT00132730|617611893|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
170891975|NCT00132730|617611894|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
170891976|NCT00132730|617611895|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
170891977|NCT00132730|617611896|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
170891978|NCT00132730|617611897|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
170891979|NCT00132730|617611898|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
170891980|NCT00132730|617611893|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
170891981|NCT00132730|617611894|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
170891982|NCT00132730|617611895|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
170891983|NCT00132730|617611896|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
170891984|NCT00132730|617611897|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
170891985|NCT00132730|617611898|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
170891986|NCT00132730|617611893|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
170891987|NCT00132730|617611894|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
170891988|NCT00132730|617611895|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
170891989|NCT00132730|617611896|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
170891990|NCT00132730|617611897|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
170891991|NCT00132730|617611898|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
170891992|NCT00132730|617611893|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
170891993|NCT00132730|617611894|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
170891994|NCT00132730|617611895|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
170891995|NCT00132730|617611896|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
170891996|NCT00132730|617611897|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
170891997|NCT00132730|617611898|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
170891998|NCT00132730|617611893|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
170891999|NCT00132730|617611894|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
170892000|NCT00132730|617611895|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
170892001|NCT00132730|617611896|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
170892002|NCT00132730|617611897|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
170892003|NCT00132730|617611898|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
170892004|NCT00132730|617611893|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
170892005|NCT00132730|617611894|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
170892006|NCT00132730|617611895|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
170892007|NCT00132730|617611896|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
170892008|NCT00132730|617611897|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
170892009|NCT00132730|617611898|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
170892010|NCT00132730|617611893|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
170892011|NCT00132730|617611894|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
170892012|NCT00132730|617611895|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
170892013|NCT00132730|617611896|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
170892014|NCT00132730|617611897|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
170892015|NCT00132730|617611898|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
170892016|NCT00132730|617611893|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
170892017|NCT00132730|617611894|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
170892018|NCT00132730|617611895|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
170892019|NCT00132730|617611896|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
170892020|NCT00132730|617611897|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
170892021|NCT00132730|617611898|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
170892022|NCT00132730|617611893|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
170476040|NCT04895982|616080167|FG009|Overall Study|Lost to Follow-up|0|||
170476041|NCT04895982|616080168|FG010|Overall Study|Lost to Follow-up|0|||
170476042|NCT04895982|616080169|FG011|Overall Study|Lost to Follow-up|0|||
170476043|NCT04895982|616080158|FG000|Overall Study|Refused further study procedures|0|||
170476044|NCT04895982|616080159|FG001|Overall Study|Refused further study procedures|0|||
170476045|NCT04895982|616080160|FG002|Overall Study|Refused further study procedures|1|||
170476046|NCT04895982|616080161|FG003|Overall Study|Refused further study procedures|0|||
170476047|NCT04895982|616080162|FG004|Overall Study|Refused further study procedures|0|||
170476048|NCT04895982|616080163|FG005|Overall Study|Refused further study procedures|0|||
170476049|NCT04895982|616080164|FG006|Overall Study|Refused further study procedures|0|||
170638710|NCT02600819|616689391|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
170638711|NCT02600819|616689390|FG000|GEN Phase|Withdrew Consent|5|||
170476050|NCT04895982|616080165|FG007|Overall Study|Refused further study procedures|0|||
170476051|NCT04895982|616080166|FG008|Overall Study|Refused further study procedures|0|||
170476052|NCT04895982|616080167|FG009|Overall Study|Refused further study procedures|0|||
170476053|NCT04895982|616080168|FG010|Overall Study|Refused further study procedures|0|||
170476054|NCT04895982|616080169|FG011|Overall Study|Refused further study procedures|0|||
170476055|NCT01449812|616080170|FG000|Overall Study|Migrated/moved from study area|1|||
170476056|NCT01449812|616080171|FG001|Overall Study|Migrated/moved from study area|0|||
170476057|NCT01449812|616080172|FG002|Overall Study|Migrated/moved from study area|0|||
170476058|NCT01449812|616080170|FG000|Overall Study|Withdrawal by Subject|0|||
170476059|NCT01449812|616080171|FG001|Overall Study|Withdrawal by Subject|0|||
170476060|NCT01449812|616080172|FG002|Overall Study|Withdrawal by Subject|1|||
170476061|NCT01449812|616080170|FG000|Overall Study|Lost to Follow-up|1|||
170476062|NCT01449812|616080171|FG001|Overall Study|Lost to Follow-up|0|||
170476063|NCT01449812|616080172|FG002|Overall Study|Lost to Follow-up|0|||
170476064|NCT02517463|616080177|FG000|Overall Study|Lost to Follow-up|5|||
170476065|NCT02517463|616080178|FG001|Overall Study|Lost to Follow-up|2|||
170476066|NCT01632280|616080179|FG000|Overall Study|Withdrawal by Subject|1|||
170476067|NCT01632280|616080180|FG001|Overall Study|Withdrawal by Subject|0|||
170476068|NCT03086551|616080183|FG000|First Intervention|Failure to meet inclusion criterion|1|||
170476069|NCT03086551|616080184|FG001|First Intervention|Failure to meet inclusion criterion|0|||
170476070|NCT03086551|616080183|FG000|First Intervention|Lost to Follow-up|0|||
170476071|NCT03086551|616080184|FG001|First Intervention|Lost to Follow-up|1|||
170476072|NCT03086551|616080183|FG000|Washout|Lost to Follow-up|1|||
170476073|NCT03086551|616080184|FG001|Washout|Lost to Follow-up|2|||
170476074|NCT03086551|616080183|FG000|Washout|Withdrawal by Subject|2|||
170476075|NCT03086551|616080184|FG001|Washout|Withdrawal by Subject|1|||
170476076|NCT03180645|616080188|FG000|Overall Study|Adverse Event|0|||
170476077|NCT03180645|616080189|FG001|Overall Study|Adverse Event|1|||
170476078|NCT03180645|616080190|FG002|Overall Study|Adverse Event|2|||
170546554|NCT03983109|616345903|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
170546555|NCT03983109|616345904|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
170546556|NCT05085405|616345905|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
170546557|NCT05085405|616345906|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
170546558|NCT05085405|616345907|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
170546559|NCT05085405|616345908|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
170546560|NCT05085405|616345909|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
170546561|NCT05085405|616345910|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
170546562|NCT05085405|616345905|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
170546563|NCT05085405|616345906|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
170546564|NCT05085405|616345907|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
170546565|NCT05085405|616345908|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
170546566|NCT05085405|616345909|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
170546567|NCT05085405|616345910|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
170546568|NCT01860404|616345911|FG000|Overall Study|Lost to Follow-up|3|||
170546569|NCT01860404|616345912|FG001|Overall Study|Lost to Follow-up|4|||
170546570|NCT01860404|616345913|FG002|Overall Study|Lost to Follow-up|1|||
170546571|NCT01860404|616345914|FG003|Overall Study|Lost to Follow-up|6|||
170546572|NCT01860404|616345915|FG004|Overall Study|Lost to Follow-up|4|||
170792402|NCT01928394|617249428|FG000|Follow-up Period|Participant withdrew consent|3|||
170792403|NCT01928394|617249429|FG001|Follow-up Period|Participant withdrew consent|0|||
170792404|NCT01928394|617249430|FG002|Follow-up Period|Participant withdrew consent|1|||
170792405|NCT01928394|617249431|FG003|Follow-up Period|Participant withdrew consent|4|||
170792406|NCT01928394|617249432|FG004|Follow-up Period|Participant withdrew consent|0|||
170792407|NCT01928394|617249433|FG005|Follow-up Period|Participant withdrew consent|2|||
170792408|NCT01928394|617249434|FG006|Follow-up Period|Participant withdrew consent|5|||
170792409|NCT01928394|617249435|FG007|Follow-up Period|Participant withdrew consent|1|||
170792410|NCT01928394|617249436|FG008|Follow-up Period|Participant withdrew consent|0|||
170792411|NCT01928394|617249437|FG009|Follow-up Period|Participant withdrew consent|0|||
170792412|NCT01928394|617249438|FG010|Follow-up Period|Participant withdrew consent|5|||
170792413|NCT01928394|617249439|FG011|Follow-up Period|Participant withdrew consent|8|||
170792414|NCT01928394|617249440|FG012|Follow-up Period|Participant withdrew consent|2|||
170792415|NCT01928394|617249441|FG013|Follow-up Period|Participant withdrew consent|12|||
170792416|NCT01928394|617249442|FG014|Follow-up Period|Participant withdrew consent|7|||
170476079|NCT01512160|616080193|FG000|Overall Study|Lost to Follow-up|1|||
170476080|NCT01512160|616080194|FG001|Overall Study|Lost to Follow-up|0|||
170476081|NCT01512160|616080195|FG002|Overall Study|Lost to Follow-up|0|||
170892023|NCT00132730|617611894|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
170892024|NCT00132730|617611895|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
170892025|NCT00132730|617611896|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
170892026|NCT00132730|617611897|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
170476082|NCT01512160|616080196|FG003|Overall Study|Lost to Follow-up|0|||
170476083|NCT01512160|616080193|FG000|Overall Study|Withdrawal by Subject|1|||
170476084|NCT01512160|616080194|FG001|Overall Study|Withdrawal by Subject|0|||
170476085|NCT01512160|616080195|FG002|Overall Study|Withdrawal by Subject|0|||
170476086|NCT01512160|616080196|FG003|Overall Study|Withdrawal by Subject|1|||
170476087|NCT03207867|616080197|FG000|Overall Study|Adverse Event|1|||
170476088|NCT03207867|616080198|FG001|Overall Study|Adverse Event|0|||
170476089|NCT03207867|616080199|FG002|Overall Study|Adverse Event|1|||
170892027|NCT00132730|617611898|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
170892028|NCT00094757|617611899|FG000|Overall Study|Adverse Event|11|||
170892029|NCT00094757|617611900|FG001|Overall Study|Adverse Event|9|||
170892030|NCT00094757|617611901|FG002|Overall Study|Adverse Event|6|||
170892031|NCT00094757|617611899|FG000|Overall Study|Lack of Efficacy|11|||
170892032|NCT00094757|617611900|FG001|Overall Study|Lack of Efficacy|15|||
170892033|NCT00094757|617611901|FG002|Overall Study|Lack of Efficacy|8|||
170892034|NCT00094757|617611899|FG000|Overall Study|Lost to Follow-up|3|||
170892035|NCT00094757|617611900|FG001|Overall Study|Lost to Follow-up|5|||
170892036|NCT00094757|617611901|FG002|Overall Study|Lost to Follow-up|6|||
170892037|NCT00094757|617611899|FG000|Overall Study|Patient Moved|2|||
170892038|NCT00094757|617611900|FG001|Overall Study|Patient Moved|1|||
170892039|NCT00094757|617611901|FG002|Overall Study|Patient Moved|1|||
170892040|NCT00094757|617611899|FG000|Overall Study|Protocol Violation|8|||
170892041|NCT00094757|617611900|FG001|Overall Study|Protocol Violation|5|||
170892042|NCT00094757|617611901|FG002|Overall Study|Protocol Violation|3|||
170892043|NCT00094757|617611899|FG000|Overall Study|Withdrawal by Subject|14|||
170892044|NCT00094757|617611900|FG001|Overall Study|Withdrawal by Subject|21|||
170892045|NCT00094757|617611901|FG002|Overall Study|Withdrawal by Subject|5|||
170476090|NCT03207867|616080200|FG003|Overall Study|Adverse Event|0|||
170546573|NCT01860404|616345911|FG000|Overall Study|Withdrawal by Subject|0|||
170546574|NCT01860404|616345912|FG001|Overall Study|Withdrawal by Subject|0|||
170546575|NCT01860404|616345913|FG002|Overall Study|Withdrawal by Subject|4|||
170546576|NCT01860404|616345914|FG003|Overall Study|Withdrawal by Subject|0|||
170546577|NCT01860404|616345915|FG004|Overall Study|Withdrawal by Subject|0|||
170546578|NCT00356421|616345917|FG000|Overall Study|Lack of Efficacy|3|||
170546579|NCT00356421|616345918|FG001|Overall Study|Lack of Efficacy|0|||
170546580|NCT00356421|616345917|FG000|Overall Study|Withdrawal by Subject|9|||
170546581|NCT00356421|616345918|FG001|Overall Study|Withdrawal by Subject|2|||
170546582|NCT00356421|616345917|FG000|Overall Study|Related to study drug|15|||
170546583|NCT00356421|616345918|FG001|Overall Study|Related to study drug|12|||
170546584|NCT00356421|616345917|FG000|Overall Study|Not related to study drug|5|||
170546585|NCT00356421|616345918|FG001|Overall Study|Not related to study drug|3|||
170546586|NCT01666314|616345923|FG000|Overall Study|Adverse Event|3|||
170546587|NCT01666314|616345924|FG001|Overall Study|Adverse Event|13|||
170546588|NCT01666314|616345925|FG002|Overall Study|Adverse Event|7|||
170546589|NCT01666314|616345926|FG003|Overall Study|Adverse Event|7|||
170546590|NCT01666314|616345923|FG000|Overall Study|Progressive Disease|11|||
170546591|NCT01666314|616345924|FG001|Overall Study|Progressive Disease|9|||
170546592|NCT01666314|616345925|FG002|Overall Study|Progressive Disease|19|||
170546593|NCT01666314|616345926|FG003|Overall Study|Progressive Disease|20|||
170546594|NCT01666314|616345923|FG000|Overall Study|Symptomatic Deterioration|1|||
170546595|NCT01666314|616345924|FG001|Overall Study|Symptomatic Deterioration|0|||
170546596|NCT01666314|616345925|FG002|Overall Study|Symptomatic Deterioration|2|||
170546597|NCT01666314|616345926|FG003|Overall Study|Symptomatic Deterioration|0|||
170546598|NCT01666314|616345923|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
170546599|NCT01666314|616345924|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
170546600|NCT01666314|616345925|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
170546601|NCT01666314|616345926|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
170546602|NCT01666314|616345923|FG000|Overall Study|Withdrawal by Subject|1|||
170892046|NCT00094757|617611899|FG000|Overall Study|Other|3|||
170892047|NCT00094757|617611900|FG001|Overall Study|Other|3|||
170476091|NCT03207867|616080201|FG004|Overall Study|Adverse Event|0|||
170476092|NCT03207867|616080202|FG005|Overall Study|Adverse Event|2|||
170546603|NCT01666314|616345924|FG001|Overall Study|Withdrawal by Subject|1|||
170546604|NCT01666314|616345925|FG002|Overall Study|Withdrawal by Subject|2|||
170546605|NCT01666314|616345926|FG003|Overall Study|Withdrawal by Subject|3|||
170546606|NCT01666314|616345923|FG000|Overall Study|Reason not Specified|10|||
170546607|NCT01666314|616345924|FG001|Overall Study|Reason not Specified|7|||
170892048|NCT00094757|617611901|FG002|Overall Study|Other|1|||
170892049|NCT00094757|617611899|FG000|Overall Study|Protocol specified discontinuation|1|||
170892050|NCT00094757|617611900|FG001|Overall Study|Protocol specified discontinuation|3|||
170892051|NCT00094757|617611901|FG002|Overall Study|Protocol specified discontinuation|0|||
170892052|NCT01463098|617611902|FG000|Part A (11 Days)|Participant Choice|2|||
170638712|NCT02600819|616689391|FG001|GEN Phase|Withdrew Consent|0|||
170638713|NCT02600819|616689390|FG000|GEN Phase|Lost to Follow-up|2|||
170638714|NCT02600819|616689391|FG001|GEN Phase|Lost to Follow-up|0|||
170638715|NCT01296672|616689397|FG000|Overall Study|Lost to Follow-up|73|||
170638716|NCT01296672|616689398|FG001|Overall Study|Lost to Follow-up|18|||
170638717|NCT02078960|616689399|FG000|Treatment Period|Other|0|||
170638718|NCT02078960|616689400|FG001|Treatment Period|Other|0|||
170638719|NCT02078960|616689401|FG002|Treatment Period|Other|1|||
170638720|NCT02078960|616689399|FG000|Treatment Period|Lack of Efficacy|0|||
170638721|NCT02078960|616689400|FG001|Treatment Period|Lack of Efficacy|1|||
170638722|NCT02078960|616689401|FG002|Treatment Period|Lack of Efficacy|0|||
170638723|NCT02078960|616689399|FG000|Treatment Period|Disease progression - accelerated phase|0|||
170638724|NCT02078960|616689400|FG001|Treatment Period|Disease progression - accelerated phase|1|||
170638725|NCT02078960|616689401|FG002|Treatment Period|Disease progression - accelerated phase|0|||
170638726|NCT02078960|616689399|FG000|Treatment Period|Disease progression - blast phase|1|||
170638727|NCT02078960|616689400|FG001|Treatment Period|Disease progression - blast phase|0|||
170638728|NCT02078960|616689401|FG002|Treatment Period|Disease progression - blast phase|0|||
170638729|NCT02078960|616689399|FG000|Treatment Period|Withdrawal by Subject|0|||
170638730|NCT02078960|616689400|FG001|Treatment Period|Withdrawal by Subject|1|||
170638731|NCT02078960|616689401|FG002|Treatment Period|Withdrawal by Subject|1|||
170638732|NCT02078960|616689399|FG000|Treatment Period|Adverse Event|1|||
170638733|NCT02078960|616689400|FG001|Treatment Period|Adverse Event|0|||
170638734|NCT02078960|616689401|FG002|Treatment Period|Adverse Event|0|||
170638735|NCT02078960|616689399|FG000|Treatment Period|Death|0|||
170638736|NCT02078960|616689400|FG001|Treatment Period|Death|0|||
170638737|NCT02078960|616689401|FG002|Treatment Period|Death|1|||
170638738|NCT02078960|616689399|FG000|Follow-up Period|Death|2|||
170638739|NCT02078960|616689400|FG001|Follow-up Period|Death|0|||
170638740|NCT02078960|616689401|FG002|Follow-up Period|Death|0|||
170638741|NCT02078960|616689399|FG000|Follow-up Period|Lost to Follow-up|0|||
170638742|NCT02078960|616689400|FG001|Follow-up Period|Lost to Follow-up|1|||
170638743|NCT02078960|616689401|FG002|Follow-up Period|Lost to Follow-up|0|||
170638744|NCT04248491|616689402|FG000|Overall Study|Lost to Follow-up|1|||
170638745|NCT04248491|616689403|FG001|Overall Study|Lost to Follow-up|0|||
170638746|NCT04605991|616689405|FG000|Overall Study|Adverse Event|5|||
170638747|NCT04605991|616689405|FG000|Overall Study|Lack of Efficacy|1|||
170638748|NCT04605991|616689405|FG000|Overall Study|Lost to Follow-up|8|||
170638749|NCT04605991|616689405|FG000|Overall Study|Physician Decision|4|||
170638750|NCT04605991|616689405|FG000|Overall Study|Withdrawal by Subject|14|||
170638751|NCT04605991|616689405|FG000|Overall Study|Non-compliance with study|1|||
170638752|NCT01311024|616689406|FG000|Overall Study|Protocol Violation|35|||
170638753|NCT01311024|616689407|FG001|Overall Study|Protocol Violation|22|||
170638754|NCT04661579|616689408|FG000|Overall Study|Lost to Follow-up|19|||
170638755|NCT04661579|616689409|FG001|Overall Study|Lost to Follow-up|10|||
170638756|NCT04661579|616689410|FG002|Overall Study|Lost to Follow-up|2|||
170638757|NCT04661579|616689411|FG003|Overall Study|Lost to Follow-up|7|||
170638758|NCT04661579|616689412|FG004|Overall Study|Lost to Follow-up|11|||
170638759|NCT04661579|616689408|FG000|Overall Study|Physician Decision|2|||
170638760|NCT04661579|616689409|FG001|Overall Study|Physician Decision|0|||
170638761|NCT04661579|616689410|FG002|Overall Study|Physician Decision|0|||
170638762|NCT04661579|616689411|FG003|Overall Study|Physician Decision|1|||
170638763|NCT04661579|616689412|FG004|Overall Study|Physician Decision|0|||
170638764|NCT04661579|616689408|FG000|Overall Study|Withdrawal by Subject|1|||
170638765|NCT04661579|616689409|FG001|Overall Study|Withdrawal by Subject|4|||
170638766|NCT04661579|616689410|FG002|Overall Study|Withdrawal by Subject|0|||
170638767|NCT04661579|616689411|FG003|Overall Study|Withdrawal by Subject|2|||
170638768|NCT04661579|616689412|FG004|Overall Study|Withdrawal by Subject|0|||
170638769|NCT04661579|616689408|FG000|Overall Study|Death|1|||
170638770|NCT04661579|616689409|FG001|Overall Study|Death|0|||
170638771|NCT04661579|616689410|FG002|Overall Study|Death|0|||
170638772|NCT04661579|616689411|FG003|Overall Study|Death|0|||
170638773|NCT04661579|616689412|FG004|Overall Study|Death|0|||
170638774|NCT04661579|616689408|FG000|Overall Study|Other|1|||
170792417|NCT01928394|617249443|FG015|Follow-up Period|Participant withdrew consent|0|||
170792418|NCT01928394|617249444|FG016|Follow-up Period|Participant withdrew consent|5|||
170638775|NCT04661579|616689409|FG001|Overall Study|Other|2|||
170638776|NCT04661579|616689410|FG002|Overall Study|Other|1|||
170638777|NCT04661579|616689411|FG003|Overall Study|Other|1|||
170638778|NCT04661579|616689412|FG004|Overall Study|Other|1|||
170638779|NCT04661579|616689408|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
170638780|NCT04661579|616689409|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
170792419|NCT01928394|617249445|FG017|Follow-up Period|Participant withdrew consent|3|||
170638781|NCT04661579|616689410|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
170638782|NCT04661579|616689411|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
170638783|NCT04661579|616689412|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
170638784|NCT00771953|616689414|FG000|Overall Study|Adverse Event|5|||
170638785|NCT00771953|616689415|FG001|Overall Study|Adverse Event|3|||
170792420|NCT01928394|617249446|FG018|Follow-up Period|Participant withdrew consent|2|||
170638786|NCT00771953|616689414|FG000|Overall Study|Death|2|||
170638787|NCT00771953|616689415|FG001|Overall Study|Death|2|||
170638788|NCT00771953|616689414|FG000|Overall Study|Progression before active Tx|1|||
170638789|NCT00771953|616689415|FG001|Overall Study|Progression before active Tx|2|||
170638790|NCT00771953|616689414|FG000|Overall Study|Sponsor decision|1|||
170638791|NCT00771953|616689415|FG001|Overall Study|Sponsor decision|0|||
170638792|NCT00771953|616689414|FG000|Overall Study|Other complicating disease|1|||
170638793|NCT00771953|616689415|FG001|Overall Study|Other complicating disease|0|||
170638794|NCT00771953|616689414|FG000|Overall Study|Withdrawal by Subject|0|||
170638795|NCT00771953|616689415|FG001|Overall Study|Withdrawal by Subject|3|||
170638796|NCT04896073|616689416|FG000|Overall Study|Screen failure|0|||
170638797|NCT04896073|616689417|FG001|Overall Study|Screen failure|2|||
170638798|NCT04896073|616689416|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
170638799|NCT04896073|616689417|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
170638800|NCT00811018|616689419|FG000|Overall Study|Additional Chronic Treatment|31|||
170638801|NCT00811018|616689419|FG000|Overall Study|Adverse Event|79|||
170638802|NCT00811018|616689419|FG000|Overall Study|Death|147|||
170638803|NCT00811018|616689419|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
170638804|NCT00811018|616689419|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
170638805|NCT00811018|616689419|FG000|Overall Study|Investigator Decision|57|||
170638806|NCT00811018|616689419|FG000|Overall Study|Lost to Follow-up|19|||
170638807|NCT00811018|616689419|FG000|Overall Study|Pregnancy|6|||
170638808|NCT00811018|616689419|FG000|Overall Study|Sponsor Decision|450|||
170638809|NCT00811018|616689419|FG000|Overall Study|Withdrawal by Subject|70|||
170638810|NCT00811018|616689419|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
170638811|NCT00811018|616689419|FG000|Overall Study|Other|26|||
170638812|NCT00393861|616689420|FG000|Overall Study|Adverse Event|2|||
170638813|NCT00393861|616689420|FG000|Overall Study|Disease Progression|24|||
170638814|NCT01727024|616689421|FG000|Period 1|Lost to Follow-up|1|||
170638815|NCT01727024|616689422|FG001|Period 1|Lost to Follow-up|1|||
170638816|NCT01727024|616689421|FG000|Period 1|Withdrawal by Subject|2|||
170638817|NCT01727024|616689422|FG001|Period 1|Withdrawal by Subject|3|||
170638818|NCT00139477|616689423|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
170638819|NCT00139477|616689424|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
170638820|NCT00139477|616689423|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
170638821|NCT00139477|616689424|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
170638822|NCT00139477|616689423|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
170638823|NCT00139477|616689424|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
170638824|NCT00139477|616689423|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
170638825|NCT00139477|616689424|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
170476093|NCT03207867|616080203|FG006|Overall Study|Adverse Event|1|||
170476094|NCT03207867|616080204|FG007|Overall Study|Adverse Event|1|||
170476095|NCT03207867|616080205|FG008|Overall Study|Adverse Event|2|||
170476096|NCT03207867|616080206|FG009|Overall Study|Adverse Event|2|||
170476097|NCT03207867|616080207|FG010|Overall Study|Adverse Event|0|||
170476098|NCT03207867|616080208|FG011|Overall Study|Adverse Event|0|||
170476099|NCT03207867|616080209|FG012|Overall Study|Adverse Event|0|||
170892053|NCT01463098|617611903|FG001|Part A (11 Days)|Participant Choice|0|||
170892054|NCT01463098|617611904|FG002|Part A (11 Days)|Participant Choice|0|||
170892055|NCT01463098|617611905|FG003|Part A (11 Days)|Participant Choice|0|||
170892056|NCT01463098|617611906|FG004|Part A (11 Days)|Participant Choice|0|||
170892057|NCT01463098|617611907|FG005|Part A (11 Days)|Participant Choice|0|||
170892058|NCT01463098|617611908|FG006|Part A (11 Days)|Participant Choice|0|||
170892059|NCT01463098|617611909|FG007|Part A (11 Days)|Participant Choice|0|||
170892060|NCT01463098|617611910|FG008|Part A (11 Days)|Participant Choice|1|||
170892061|NCT01463098|617611911|FG009|Part A (11 Days)|Participant Choice|0|||
170892062|NCT01463098|617611912|FG010|Part A (11 Days)|Participant Choice|0|||
170892063|NCT01463098|617611913|FG011|Part A (11 Days)|Participant Choice|0|||
170892064|NCT01463098|617611914|FG012|Part A (11 Days)|Participant Choice|0|||
170892065|NCT01463098|617611915|FG013|Part A (11 Days)|Participant Choice|0|||
170892066|NCT01463098|617611902|FG000|Part A (11 Days)|Lost to Follow-up|0|||
170892067|NCT01463098|617611903|FG001|Part A (11 Days)|Lost to Follow-up|0|||
170892068|NCT01463098|617611904|FG002|Part A (11 Days)|Lost to Follow-up|0|||
170892069|NCT01463098|617611905|FG003|Part A (11 Days)|Lost to Follow-up|0|||
170892070|NCT01463098|617611906|FG004|Part A (11 Days)|Lost to Follow-up|1|||
170892071|NCT01463098|617611907|FG005|Part A (11 Days)|Lost to Follow-up|0|||
170892072|NCT01463098|617611908|FG006|Part A (11 Days)|Lost to Follow-up|0|||
170892073|NCT01463098|617611909|FG007|Part A (11 Days)|Lost to Follow-up|0|||
170892074|NCT01463098|617611910|FG008|Part A (11 Days)|Lost to Follow-up|0|||
170892075|NCT01463098|617611911|FG009|Part A (11 Days)|Lost to Follow-up|0|||
170892076|NCT01463098|617611912|FG010|Part A (11 Days)|Lost to Follow-up|0|||
170892077|NCT01463098|617611913|FG011|Part A (11 Days)|Lost to Follow-up|0|||
170892078|NCT01463098|617611914|FG012|Part A (11 Days)|Lost to Follow-up|0|||
170892079|NCT01463098|617611915|FG013|Part A (11 Days)|Lost to Follow-up|0|||
170892080|NCT01463098|617611902|FG000|Part B (11 Days)|Participant Choice|0|||
170892081|NCT01463098|617611903|FG001|Part B (11 Days)|Participant Choice|0|||
170892082|NCT01463098|617611904|FG002|Part B (11 Days)|Participant Choice|0|||
170892083|NCT01463098|617611905|FG003|Part B (11 Days)|Participant Choice|0|||
170892084|NCT01463098|617611906|FG004|Part B (11 Days)|Participant Choice|0|||
170892085|NCT01463098|617611907|FG005|Part B (11 Days)|Participant Choice|0|||
170892086|NCT01463098|617611908|FG006|Part B (11 Days)|Participant Choice|0|||
170892087|NCT01463098|617611909|FG007|Part B (11 Days)|Participant Choice|0|||
170892088|NCT01463098|617611910|FG008|Part B (11 Days)|Participant Choice|0|||
170892089|NCT01463098|617611911|FG009|Part B (11 Days)|Participant Choice|0|||
170892090|NCT01463098|617611912|FG010|Part B (11 Days)|Participant Choice|0|||
170892091|NCT01463098|617611913|FG011|Part B (11 Days)|Participant Choice|1|||
170892092|NCT01463098|617611914|FG012|Part B (11 Days)|Participant Choice|0|||
170892093|NCT01463098|617611915|FG013|Part B (11 Days)|Participant Choice|0|||
170892094|NCT01528787|617611916|FG000|Overall Study|Withdrawal by Subject|0|||
170892095|NCT01528787|617611917|FG001|Overall Study|Withdrawal by Subject|0|||
170892096|NCT01528787|617611918|FG002|Overall Study|Withdrawal by Subject|0|||
170892097|NCT01528787|617611919|FG003|Overall Study|Withdrawal by Subject|1|||
170892098|NCT01528787|617611916|FG000|Overall Study|Family Emergency|0|||
170892099|NCT01528787|617611917|FG001|Overall Study|Family Emergency|0|||
170892100|NCT01528787|617611918|FG002|Overall Study|Family Emergency|1|||
170892101|NCT01528787|617611919|FG003|Overall Study|Family Emergency|0|||
170892102|NCT00797823|617611922|FG000|First Period (Initial Randomization)|Physician Decision|1|||
170892103|NCT00797823|617611923|FG001|First Period (Initial Randomization)|Physician Decision|0|||
170892104|NCT00797823|617611924|FG002|First Period (Initial Randomization)|Physician Decision|0|||
170892105|NCT02400255|617611925|FG000|Overall Study|Relapse|4|||
170892106|NCT02400255|617611926|FG001|Overall Study|Relapse|1|||
170892107|NCT02400255|617611927|FG002|Overall Study|Relapse|1|||
170892108|NCT02400255|617611928|FG003|Overall Study|Relapse|2|||
170892109|NCT02400255|617611925|FG000|Overall Study|Adverse Event|6|||
170892110|NCT02400255|617611926|FG001|Overall Study|Adverse Event|3|||
170892111|NCT02400255|617611927|FG002|Overall Study|Adverse Event|0|||
170892112|NCT02400255|617611928|FG003|Overall Study|Adverse Event|0|||
170892113|NCT02400255|617611925|FG000|Overall Study|Physician Decision|6|||
170892114|NCT02400255|617611926|FG001|Overall Study|Physician Decision|0|||
170892115|NCT02400255|617611927|FG002|Overall Study|Physician Decision|0|||
170892116|NCT02400255|617611928|FG003|Overall Study|Physician Decision|0|||
170892117|NCT02400255|617611925|FG000|Overall Study|Loss of insurance|1|||
170892118|NCT02400255|617611926|FG001|Overall Study|Loss of insurance|0|||
170892119|NCT02400255|617611927|FG002|Overall Study|Loss of insurance|0|||
170892120|NCT02400255|617611928|FG003|Overall Study|Loss of insurance|0|||
170892121|NCT00523991|617611931|FG000|Overall Study|Adverse Event|6|||
170476100|NCT03207867|616080210|FG013|Overall Study|Adverse Event|0|||
170476101|NCT03207867|616080211|FG014|Overall Study|Adverse Event|0|||
170476102|NCT03207867|616080212|FG015|Overall Study|Adverse Event|0|||
170476103|NCT03207867|616080213|FG016|Overall Study|Adverse Event|3|||
170476104|NCT03207867|616080214|FG017|Overall Study|Adverse Event|1|||
170476105|NCT03207867|616080215|FG018|Overall Study|Adverse Event|2|||
170476106|NCT03207867|616080216|FG019|Overall Study|Adverse Event|1|||
170476107|NCT03207867|616080217|FG020|Overall Study|Adverse Event|0|||
170476108|NCT03207867|616080218|FG021|Overall Study|Adverse Event|0|||
170476109|NCT03207867|616080219|FG022|Overall Study|Adverse Event|0|||
170476110|NCT03207867|616080220|FG023|Overall Study|Adverse Event|0|||
170476111|NCT03207867|616080197|FG000|Overall Study|Death|0|||
170476112|NCT03207867|616080198|FG001|Overall Study|Death|0|||
170476113|NCT03207867|616080199|FG002|Overall Study|Death|0|||
170476114|NCT03207867|616080200|FG003|Overall Study|Death|0|||
170476115|NCT03207867|616080201|FG004|Overall Study|Death|0|||
170476116|NCT03207867|616080202|FG005|Overall Study|Death|1|||
170476117|NCT03207867|616080203|FG006|Overall Study|Death|0|||
170476118|NCT03207867|616080204|FG007|Overall Study|Death|3|||
170476119|NCT03207867|616080205|FG008|Overall Study|Death|1|||
170476120|NCT03207867|616080206|FG009|Overall Study|Death|2|||
170638826|NCT00139477|616689423|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
170638827|NCT00139477|616689424|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
170638828|NCT00139477|616689423|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
170638829|NCT00139477|616689424|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
170792421|NCT01928394|617249447|FG019|Follow-up Period|Participant withdrew consent|7|||
170792422|NCT01928394|617249448|FG020|Follow-up Period|Participant withdrew consent|4|||
170792423|NCT01928394|617249449|FG021|Follow-up Period|Participant withdrew consent|6|||
170792424|NCT01928394|617249450|FG022|Follow-up Period|Participant withdrew consent|2|||
170792425|NCT01928394|617249428|FG000|Follow-up Period|Death|0|||
170792426|NCT01928394|617249429|FG001|Follow-up Period|Death|0|||
170792427|NCT01928394|617249430|FG002|Follow-up Period|Death|2|||
170792428|NCT01928394|617249431|FG003|Follow-up Period|Death|6|||
170792429|NCT01928394|617249432|FG004|Follow-up Period|Death|0|||
170792430|NCT01928394|617249433|FG005|Follow-up Period|Death|6|||
170892122|NCT00523991|617611932|FG001|Overall Study|Adverse Event|5|||
170892123|NCT00523991|617611931|FG000|Overall Study|Protocol Violation|1|||
170892124|NCT00523991|617611932|FG001|Overall Study|Protocol Violation|4|||
170892125|NCT00523991|617611931|FG000|Overall Study|Lost to Follow-up|4|||
170892126|NCT00523991|617611932|FG001|Overall Study|Lost to Follow-up|1|||
170892127|NCT00523991|617611931|FG000|Overall Study|Withdrawal by Subject|7|||
170892128|NCT00523991|617611932|FG001|Overall Study|Withdrawal by Subject|17|||
170892129|NCT00523991|617611931|FG000|Overall Study|Other reason (not specified)|3|||
170892130|NCT00523991|617611932|FG001|Overall Study|Other reason (not specified)|0|||
170892131|NCT03261531|617611934|FG000|Overall Study|Withdrawal by Subject|4|||
170892132|NCT01700192|617611935|FG000|Overall Study|Adverse Event|73|||
170892133|NCT01700192|617611936|FG001|Overall Study|Adverse Event|18|||
170892134|NCT01700192|617611935|FG000|Overall Study|Lack of Efficacy|1|||
170892135|NCT01700192|617611936|FG001|Overall Study|Lack of Efficacy|0|||
170892136|NCT01700192|617611935|FG000|Overall Study|Lost to Follow-up|42|||
170892137|NCT01700192|617611936|FG001|Overall Study|Lost to Follow-up|29|||
170892138|NCT01700192|617611935|FG000|Overall Study|Noncompliance with study drug|0|||
170476121|NCT03207867|616080207|FG010|Overall Study|Death|0|||
170476122|NCT03207867|616080208|FG011|Overall Study|Death|1|||
170792431|NCT01928394|617249434|FG006|Follow-up Period|Death|6|||
170792432|NCT01928394|617249435|FG007|Follow-up Period|Death|2|||
170792433|NCT01928394|617249436|FG008|Follow-up Period|Death|1|||
170792434|NCT01928394|617249437|FG009|Follow-up Period|Death|2|||
170792435|NCT01928394|617249438|FG010|Follow-up Period|Death|4|||
170792436|NCT01928394|617249439|FG011|Follow-up Period|Death|12|||
170792437|NCT01928394|617249440|FG012|Follow-up Period|Death|11|||
170792438|NCT01928394|617249441|FG013|Follow-up Period|Death|25|||
170792439|NCT01928394|617249442|FG014|Follow-up Period|Death|18|||
170792440|NCT01928394|617249443|FG015|Follow-up Period|Death|0|||
170792441|NCT01928394|617249444|FG016|Follow-up Period|Death|6|||
170792442|NCT01928394|617249445|FG017|Follow-up Period|Death|5|||
170476123|NCT03207867|616080209|FG012|Overall Study|Death|0|||
170476124|NCT03207867|616080210|FG013|Overall Study|Death|1|||
170476125|NCT03207867|616080211|FG014|Overall Study|Death|0|||
170476126|NCT03207867|616080212|FG015|Overall Study|Death|0|||
170476127|NCT03207867|616080213|FG016|Overall Study|Death|0|||
170476128|NCT03207867|616080214|FG017|Overall Study|Death|2|||
170476129|NCT03207867|616080215|FG018|Overall Study|Death|0|||
170476130|NCT03207867|616080216|FG019|Overall Study|Death|1|||
170476131|NCT03207867|616080217|FG020|Overall Study|Death|0|||
170476132|NCT03207867|616080218|FG021|Overall Study|Death|0|||
170476133|NCT03207867|616080219|FG022|Overall Study|Death|0|||
170476134|NCT03207867|616080220|FG023|Overall Study|Death|0|||
170476135|NCT03207867|616080197|FG000|Overall Study|Physician Decision|3|||
170476136|NCT03207867|616080198|FG001|Overall Study|Physician Decision|5|||
170792443|NCT01928394|617249446|FG018|Follow-up Period|Death|13|||
170792444|NCT01928394|617249447|FG019|Follow-up Period|Death|13|||
170892139|NCT01700192|617611936|FG001|Overall Study|Noncompliance with study drug|5|||
170638830|NCT00139477|616689423|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
170638831|NCT00139477|616689424|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
170638832|NCT00441064|616689427|FG000|Overall Study|Adverse Event|1|||
170638833|NCT00441064|616689428|FG001|Overall Study|Adverse Event|0|||
170638834|NCT00441064|616689427|FG000|Overall Study|Abnormal laboratory values|0|||
170638835|NCT00441064|616689428|FG001|Overall Study|Abnormal laboratory values|2|||
170638836|NCT00441064|616689427|FG000|Overall Study|Abnormal test procedure results|0|||
170638837|NCT00441064|616689428|FG001|Overall Study|Abnormal test procedure results|1|||
170638838|NCT00441064|616689427|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170638839|NCT00441064|616689428|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170638840|NCT00441064|616689427|FG000|Overall Study|Protocol Deviation|3|||
170638841|NCT00441064|616689428|FG001|Overall Study|Protocol Deviation|2|||
170638842|NCT00441064|616689427|FG000|Overall Study|Patient withdrew consent|5|||
170638843|NCT00441064|616689428|FG001|Overall Study|Patient withdrew consent|2|||
170638844|NCT03051178|616689429|FG000|Overall Study|Withdrawal by Subject|5|||
170638845|NCT00953056|616689430|FG000|Overall Study|Withdrew Consent|0|||
170638846|NCT00953056|616689431|FG001|Overall Study|Withdrew Consent|0|||
170638847|NCT00953056|616689432|FG002|Overall Study|Withdrew Consent|0|||
170638848|NCT00953056|616689433|FG003|Overall Study|Withdrew Consent|0|||
170638849|NCT00953056|616689434|FG004|Overall Study|Withdrew Consent|2|||
170638850|NCT00953056|616689435|FG005|Overall Study|Withdrew Consent|3|||
170638851|NCT00953056|616689430|FG000|Overall Study|Serious Adverse Event|0|||
170638852|NCT00953056|616689431|FG001|Overall Study|Serious Adverse Event|0|||
170638853|NCT00953056|616689432|FG002|Overall Study|Serious Adverse Event|0|||
170638854|NCT00953056|616689433|FG003|Overall Study|Serious Adverse Event|0|||
170638855|NCT00953056|616689434|FG004|Overall Study|Serious Adverse Event|0|||
170638856|NCT00953056|616689435|FG005|Overall Study|Serious Adverse Event|1|||
170638857|NCT00845897|616689436|FG000|Overall Study|Lost to Follow-up|1|||
170638858|NCT00845897|616689437|FG001|Overall Study|Lost to Follow-up|1|||
170638859|NCT00845897|616689438|FG002|Overall Study|Lost to Follow-up|0|||
170638860|NCT00845897|616689436|FG000|Overall Study|Withdrawal by Subject|0|||
170638861|NCT00845897|616689437|FG001|Overall Study|Withdrawal by Subject|3|||
170638862|NCT00845897|616689438|FG002|Overall Study|Withdrawal by Subject|2|||
170792445|NCT01928394|617249448|FG020|Follow-up Period|Death|5|||
170476137|NCT03207867|616080199|FG002|Overall Study|Physician Decision|0|||
170476138|NCT03207867|616080200|FG003|Overall Study|Physician Decision|3|||
170476139|NCT03207867|616080201|FG004|Overall Study|Physician Decision|2|||
170476140|NCT03207867|616080202|FG005|Overall Study|Physician Decision|0|||
170476141|NCT03207867|616080203|FG006|Overall Study|Physician Decision|0|||
170476142|NCT03207867|616080204|FG007|Overall Study|Physician Decision|0|||
170476143|NCT03207867|616080205|FG008|Overall Study|Physician Decision|4|||
170476144|NCT03207867|616080206|FG009|Overall Study|Physician Decision|2|||
170476145|NCT03207867|616080207|FG010|Overall Study|Physician Decision|0|||
170476146|NCT03207867|616080208|FG011|Overall Study|Physician Decision|4|||
170476147|NCT03207867|616080209|FG012|Overall Study|Physician Decision|0|||
170476148|NCT03207867|616080210|FG013|Overall Study|Physician Decision|0|||
170476149|NCT03207867|616080211|FG014|Overall Study|Physician Decision|2|||
170546608|NCT01666314|616345925|FG002|Overall Study|Reason not Specified|5|||
170546609|NCT01666314|616345926|FG003|Overall Study|Reason not Specified|5|||
170546610|NCT03462563|616345928|FG000|Overall Study|Death|1|||
170546611|NCT03462563|616345929|FG001|Overall Study|Death|1|||
170546612|NCT03462563|616345928|FG000|Overall Study|Termination of study|2|||
170546613|NCT03462563|616345929|FG001|Overall Study|Termination of study|1|||
170546614|NCT03462563|616345928|FG000|Overall Study|Adverse Event|1|||
170546615|NCT03462563|616345929|FG001|Overall Study|Adverse Event|3|||
170546616|NCT03462563|616345928|FG000|Overall Study|Unspecified reason|10|||
170546617|NCT03462563|616345929|FG001|Overall Study|Unspecified reason|12|||
170546618|NCT03462563|616345928|FG000|Overall Study|Physician Decision|1|||
170546619|NCT03462563|616345929|FG001|Overall Study|Physician Decision|0|||
170546620|NCT05089357|616345932|FG000|Overall Study|Withdrawal by Subject|23|||
170546621|NCT05089357|616345932|FG000|Overall Study|Lost to Follow-up|6|||
170546622|NCT05089357|616345932|FG000|Overall Study|Medical reason|1|||
170546623|NCT05089357|616345932|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
170546624|NCT05089357|616345932|FG000|Overall Study|Pregnancy|2|||
170546625|NCT02021318|616345933|FG000|Overall Study|Adverse Event|2|||
170546626|NCT02021318|616345934|FG001|Overall Study|Adverse Event|1|||
170546627|NCT02021318|616345933|FG000|Overall Study|Death|33|||
170546628|NCT02021318|616345934|FG001|Overall Study|Death|34|||
170546629|NCT02021318|616345933|FG000|Overall Study|Lost to Follow-up|3|||
170546630|NCT02021318|616345934|FG001|Overall Study|Lost to Follow-up|3|||
170546631|NCT02021318|616345933|FG000|Overall Study|Progressive Disease|0|||
170546632|NCT02021318|616345934|FG001|Overall Study|Progressive Disease|1|||
170546633|NCT02021318|616345933|FG000|Overall Study|Withdrawal by Subject|30|||
170546634|NCT02021318|616345934|FG001|Overall Study|Withdrawal by Subject|18|||
170546635|NCT02021318|616345933|FG000|Overall Study|Physician Decision|3|||
170546636|NCT02021318|616345934|FG001|Overall Study|Physician Decision|3|||
170546637|NCT02021318|616345933|FG000|Overall Study|Miscellaneous|2|||
170546638|NCT02021318|616345934|FG001|Overall Study|Miscellaneous|3|||
170638863|NCT00845897|616689436|FG000|Overall Study|Ulcer did not heal|1|||
170638864|NCT00845897|616689437|FG001|Overall Study|Ulcer did not heal|0|||
170638865|NCT00845897|616689438|FG002|Overall Study|Ulcer did not heal|1|||
170638866|NCT00845897|616689436|FG000|Overall Study|Too ill to participate|0|||
170638867|NCT00845897|616689437|FG001|Overall Study|Too ill to participate|1|||
170638868|NCT00845897|616689438|FG002|Overall Study|Too ill to participate|0|||
170638869|NCT02722499|616689439|FG000|Overall Study|Lost to Follow-up|2|||
170638870|NCT02722499|616689440|FG001|Overall Study|Lost to Follow-up|0|||
170638871|NCT02722499|616689441|FG002|Overall Study|Lost to Follow-up|1|||
170638872|NCT05626322|616689442|FG000|Overall Study|Death|2|||
170638873|NCT05626322|616689443|FG001|Overall Study|Death|0|||
170638874|NCT05626322|616689444|FG002|Overall Study|Death|0|||
170638875|NCT05626322|616689442|FG000|Overall Study|Physician Decision|1|||
170638876|NCT05626322|616689443|FG001|Overall Study|Physician Decision|0|||
170638877|NCT05626322|616689444|FG002|Overall Study|Physician Decision|0|||
170638878|NCT05626322|616689442|FG000|Overall Study|Progressive Disease|0|||
170638879|NCT05626322|616689443|FG001|Overall Study|Progressive Disease|1|||
170638880|NCT05626322|616689444|FG002|Overall Study|Progressive Disease|1|||
170638881|NCT05626322|616689442|FG000|Overall Study|Study terminated by sponsor|0|||
170638882|NCT05626322|616689443|FG001|Overall Study|Study terminated by sponsor|1|||
170638883|NCT05626322|616689444|FG002|Overall Study|Study terminated by sponsor|0|||
170638884|NCT02357368|616689445|FG000|Overall Study|Lost to Follow-up|0|||
170638885|NCT02357368|616689446|FG001|Overall Study|Lost to Follow-up|0|||
170638886|NCT02357368|616689447|FG002|Overall Study|Lost to Follow-up|0|||
170638887|NCT02357368|616689448|FG003|Overall Study|Lost to Follow-up|1|||
170638888|NCT02357368|616689445|FG000|Overall Study|Pregnancy|3|||
170638889|NCT02357368|616689446|FG001|Overall Study|Pregnancy|2|||
170638890|NCT02357368|616689447|FG002|Overall Study|Pregnancy|0|||
170638891|NCT02357368|616689448|FG003|Overall Study|Pregnancy|0|||
170638892|NCT02357368|616689445|FG000|Overall Study|Withdrawal by Subject|3|||
170638893|NCT02357368|616689446|FG001|Overall Study|Withdrawal by Subject|1|||
170638894|NCT02357368|616689447|FG002|Overall Study|Withdrawal by Subject|1|||
170638895|NCT02357368|616689448|FG003|Overall Study|Withdrawal by Subject|2|||
170792446|NCT01928394|617249449|FG021|Follow-up Period|Death|3|||
170476150|NCT03207867|616080212|FG015|Overall Study|Physician Decision|1|||
170476151|NCT03207867|616080213|FG016|Overall Study|Physician Decision|1|||
170476152|NCT03207867|616080214|FG017|Overall Study|Physician Decision|2|||
170476153|NCT03207867|616080215|FG018|Overall Study|Physician Decision|1|||
170476154|NCT03207867|616080216|FG019|Overall Study|Physician Decision|3|||
170476155|NCT03207867|616080217|FG020|Overall Study|Physician Decision|0|||
170476156|NCT03207867|616080218|FG021|Overall Study|Physician Decision|0|||
170476157|NCT03207867|616080219|FG022|Overall Study|Physician Decision|0|||
170476158|NCT03207867|616080220|FG023|Overall Study|Physician Decision|0|||
170476159|NCT03207867|616080197|FG000|Overall Study|Progressive Disease|7|||
170792447|NCT01928394|617249450|FG022|Follow-up Period|Death|2|||
170792448|NCT01928394|617249428|FG000|Follow-up Period|other reason|0|||
170792449|NCT01928394|617249429|FG001|Follow-up Period|other reason|0|||
170792450|NCT01928394|617249430|FG002|Follow-up Period|other reason|0|||
170792451|NCT01928394|617249431|FG003|Follow-up Period|other reason|0|||
170792452|NCT01928394|617249432|FG004|Follow-up Period|other reason|0|||
170792453|NCT01928394|617249433|FG005|Follow-up Period|other reason|0|||
170792454|NCT01928394|617249434|FG006|Follow-up Period|other reason|1|||
170792455|NCT01928394|617249435|FG007|Follow-up Period|other reason|3|||
170792456|NCT01928394|617249436|FG008|Follow-up Period|other reason|0|||
170792457|NCT01928394|617249437|FG009|Follow-up Period|other reason|0|||
170792458|NCT01928394|617249438|FG010|Follow-up Period|other reason|2|||
170792459|NCT01928394|617249439|FG011|Follow-up Period|other reason|1|||
170792460|NCT01928394|617249440|FG012|Follow-up Period|other reason|0|||
170792461|NCT01928394|617249441|FG013|Follow-up Period|other reason|1|||
170792462|NCT01928394|617249442|FG014|Follow-up Period|other reason|4|||
170792463|NCT01928394|617249443|FG015|Follow-up Period|other reason|0|||
170792464|NCT01928394|617249444|FG016|Follow-up Period|other reason|2|||
170792465|NCT01928394|617249445|FG017|Follow-up Period|other reason|0|||
170792466|NCT01928394|617249446|FG018|Follow-up Period|other reason|1|||
170792467|NCT01928394|617249447|FG019|Follow-up Period|other reason|1|||
170792468|NCT01928394|617249448|FG020|Follow-up Period|other reason|0|||
170476160|NCT03207867|616080198|FG001|Overall Study|Progressive Disease|7|||
170638896|NCT02395081|616689449|FG000|Overall Study|Withdrawal by Subject|1|||
170638897|NCT02395081|616689450|FG001|Overall Study|Withdrawal by Subject|1|||
170792469|NCT01928394|617249449|FG021|Follow-up Period|other reason|0|||
170792470|NCT01928394|617249450|FG022|Follow-up Period|other reason|1|||
170792471|NCT01928394|617249428|FG000|Follow-up Period|Lost to Follow-up|0|||
170476161|NCT03207867|616080199|FG002|Overall Study|Progressive Disease|9|||
170638898|NCT02395081|616689451|FG002|Overall Study|Withdrawal by Subject|0|||
170638899|NCT02395081|616689449|FG000|Overall Study|Moved where blood couldn't be collected|4|||
170638900|NCT02395081|616689450|FG001|Overall Study|Moved where blood couldn't be collected|1|||
170476162|NCT03207867|616080200|FG003|Overall Study|Progressive Disease|10|||
170638901|NCT02395081|616689451|FG002|Overall Study|Moved where blood couldn't be collected|3|||
170792472|NCT01928394|617249429|FG001|Follow-up Period|Lost to Follow-up|0|||
170792473|NCT01928394|617249430|FG002|Follow-up Period|Lost to Follow-up|0|||
170476163|NCT03207867|616080201|FG004|Overall Study|Progressive Disease|11|||
170476164|NCT03207867|616080202|FG005|Overall Study|Progressive Disease|10|||
170476165|NCT03207867|616080203|FG006|Overall Study|Progressive Disease|9|||
170476166|NCT03207867|616080204|FG007|Overall Study|Progressive Disease|8|||
170476167|NCT03207867|616080205|FG008|Overall Study|Progressive Disease|19|||
170476168|NCT03207867|616080206|FG009|Overall Study|Progressive Disease|23|||
170476169|NCT03207867|616080207|FG010|Overall Study|Progressive Disease|2|||
170476170|NCT03207867|616080208|FG011|Overall Study|Progressive Disease|24|||
170476171|NCT03207867|616080209|FG012|Overall Study|Progressive Disease|3|||
170476172|NCT03207867|616080210|FG013|Overall Study|Progressive Disease|11|||
170476173|NCT03207867|616080211|FG014|Overall Study|Progressive Disease|9|||
170476174|NCT03207867|616080212|FG015|Overall Study|Progressive Disease|5|||
170476175|NCT03207867|616080213|FG016|Overall Study|Progressive Disease|10|||
170476176|NCT03207867|616080214|FG017|Overall Study|Progressive Disease|14|||
170476177|NCT03207867|616080215|FG018|Overall Study|Progressive Disease|13|||
170476178|NCT03207867|616080216|FG019|Overall Study|Progressive Disease|14|||
170476179|NCT03207867|616080217|FG020|Overall Study|Progressive Disease|6|||
170476180|NCT03207867|616080218|FG021|Overall Study|Progressive Disease|3|||
170476181|NCT03207867|616080219|FG022|Overall Study|Progressive Disease|3|||
170792474|NCT01928394|617249431|FG003|Follow-up Period|Lost to Follow-up|0|||
170792475|NCT01928394|617249432|FG004|Follow-up Period|Lost to Follow-up|0|||
170476182|NCT03207867|616080220|FG023|Overall Study|Progressive Disease|3|||
170476183|NCT03207867|616080197|FG000|Overall Study|Patient/guardian Decision|0|||
170792476|NCT01928394|617249433|FG005|Follow-up Period|Lost to Follow-up|0|||
170476184|NCT03207867|616080198|FG001|Overall Study|Patient/guardian Decision|0|||
170476185|NCT03207867|616080199|FG002|Overall Study|Patient/guardian Decision|1|||
170476186|NCT03207867|616080200|FG003|Overall Study|Patient/guardian Decision|1|||
170476187|NCT03207867|616080201|FG004|Overall Study|Patient/guardian Decision|1|||
170476188|NCT03207867|616080202|FG005|Overall Study|Patient/guardian Decision|2|||
170476189|NCT03207867|616080203|FG006|Overall Study|Patient/guardian Decision|1|||
170476190|NCT03207867|616080204|FG007|Overall Study|Patient/guardian Decision|0|||
170476191|NCT03207867|616080205|FG008|Overall Study|Patient/guardian Decision|1|||
170476192|NCT03207867|616080206|FG009|Overall Study|Patient/guardian Decision|0|||
170476193|NCT03207867|616080207|FG010|Overall Study|Patient/guardian Decision|0|||
170476194|NCT03207867|616080208|FG011|Overall Study|Patient/guardian Decision|1|||
170476195|NCT03207867|616080209|FG012|Overall Study|Patient/guardian Decision|0|||
170476196|NCT03207867|616080210|FG013|Overall Study|Patient/guardian Decision|1|||
170476197|NCT03207867|616080211|FG014|Overall Study|Patient/guardian Decision|2|||
170476198|NCT03207867|616080212|FG015|Overall Study|Patient/guardian Decision|0|||
170476199|NCT03207867|616080213|FG016|Overall Study|Patient/guardian Decision|1|||
170476200|NCT03207867|616080214|FG017|Overall Study|Patient/guardian Decision|3|||
170476201|NCT03207867|616080215|FG018|Overall Study|Patient/guardian Decision|4|||
170476202|NCT03207867|616080216|FG019|Overall Study|Patient/guardian Decision|1|||
170476203|NCT03207867|616080217|FG020|Overall Study|Patient/guardian Decision|0|||
170476204|NCT03207867|616080218|FG021|Overall Study|Patient/guardian Decision|0|||
170476205|NCT03207867|616080219|FG022|Overall Study|Patient/guardian Decision|0|||
170792477|NCT01928394|617249434|FG006|Follow-up Period|Lost to Follow-up|0|||
170792478|NCT01928394|617249435|FG007|Follow-up Period|Lost to Follow-up|0|||
170792479|NCT01928394|617249436|FG008|Follow-up Period|Lost to Follow-up|0|||
170792480|NCT01928394|617249437|FG009|Follow-up Period|Lost to Follow-up|0|||
170792481|NCT01928394|617249438|FG010|Follow-up Period|Lost to Follow-up|0|||
170792482|NCT01928394|617249439|FG011|Follow-up Period|Lost to Follow-up|1|||
170792483|NCT01928394|617249440|FG012|Follow-up Period|Lost to Follow-up|1|||
170792484|NCT01928394|617249441|FG013|Follow-up Period|Lost to Follow-up|0|||
170792485|NCT01928394|617249442|FG014|Follow-up Period|Lost to Follow-up|1|||
170792486|NCT01928394|617249443|FG015|Follow-up Period|Lost to Follow-up|0|||
170792487|NCT01928394|617249444|FG016|Follow-up Period|Lost to Follow-up|1|||
170792488|NCT01928394|617249445|FG017|Follow-up Period|Lost to Follow-up|0|||
170792489|NCT01928394|617249446|FG018|Follow-up Period|Lost to Follow-up|0|||
170792490|NCT01928394|617249447|FG019|Follow-up Period|Lost to Follow-up|0|||
170792491|NCT01928394|617249448|FG020|Follow-up Period|Lost to Follow-up|0|||
170792492|NCT01928394|617249449|FG021|Follow-up Period|Lost to Follow-up|0|||
170792493|NCT01928394|617249450|FG022|Follow-up Period|Lost to Follow-up|1|||
170792494|NCT05764525|617249455|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
170792495|NCT05764525|617249456|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
170792496|NCT05764525|617249455|FG000|Overall Study|Withdrawal by Subject|4|||
170792497|NCT05764525|617249456|FG001|Overall Study|Withdrawal by Subject|8|||
170792498|NCT05764525|617249455|FG000|Overall Study|Physician Decision|1|||
170792499|NCT05764525|617249456|FG001|Overall Study|Physician Decision|0|||
170792500|NCT04079218|617249457|FG000|Overall Study|Death|1|||
170792501|NCT04079218|617249458|FG001|Overall Study|Death|0|||
170792502|NCT04079218|617249457|FG000|Overall Study|Withdrawal by Subject|3|||
170792503|NCT04079218|617249458|FG001|Overall Study|Withdrawal by Subject|0|||
170792504|NCT04079218|617249457|FG000|Overall Study|Physician Decision|4|||
170476206|NCT03207867|616080220|FG023|Overall Study|Patient/guardian Decision|0|||
170476207|NCT00265759|616082351|FG000|Overall Study|Withdrawal by Subject|0|||
170476208|NCT00265759|616082352|FG001|Overall Study|Withdrawal by Subject|1|||
170476209|NCT00265759|616082353|FG002|Overall Study|Withdrawal by Subject|2|||
170476210|NCT00265759|616082354|FG003|Overall Study|Withdrawal by Subject|2|||
170476211|NCT00265759|616082351|FG000|Overall Study|Cancel|0|||
170476212|NCT00265759|616082352|FG001|Overall Study|Cancel|0|||
170476213|NCT00265759|616082353|FG002|Overall Study|Cancel|0|||
170476214|NCT00265759|616082354|FG003|Overall Study|Cancel|3|||
170476215|NCT00265759|616082351|FG000|Overall Study|Ineligible|0|||
170476216|NCT00265759|616082352|FG001|Overall Study|Ineligible|0|||
170476217|NCT00265759|616082353|FG002|Overall Study|Ineligible|0|||
170476218|NCT00265759|616082354|FG003|Overall Study|Ineligible|1|||
170476219|NCT00265759|616082351|FG000|Overall Study|Bilateral disease|0|||
170476220|NCT00265759|616082352|FG001|Overall Study|Bilateral disease|0|||
170476221|NCT00265759|616082353|FG002|Overall Study|Bilateral disease|0|||
170476222|NCT00265759|616082354|FG003|Overall Study|Bilateral disease|2|||
170476223|NCT00265759|616082351|FG000|Overall Study|Discontinued due to intolerability|0|||
170476224|NCT00265759|616082352|FG001|Overall Study|Discontinued due to intolerability|0|||
170476225|NCT00265759|616082353|FG002|Overall Study|Discontinued due to intolerability|0|||
170476226|NCT00265759|616082354|FG003|Overall Study|Discontinued due to intolerability|1|||
170476227|NCT05525520|616082356|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
170476228|NCT05525520|616082357|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
170476229|NCT05525520|616082356|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
170792505|NCT04079218|617249458|FG001|Overall Study|Physician Decision|0|||
170476230|NCT05525520|616082357|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
170476231|NCT02115269|616082360|FG000|Overall Study|Lost to Follow-up|43|||
170476232|NCT02115269|616082360|FG000|Overall Study|Did not complete patient diary|3|||
170476233|NCT02115269|616082360|FG000|Overall Study|Moved to another city|7|||
170476234|NCT02115269|616082360|FG000|Overall Study|Withdrawal by Subject|2|||
170792506|NCT04079218|617249457|FG000|Overall Study|Lost to Follow-up|0|||
170792507|NCT04079218|617249458|FG001|Overall Study|Lost to Follow-up|1|||
170476235|NCT02115269|616082360|FG000|Overall Study|Didn't take study drug|2|||
170476236|NCT01842438|616082361|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
170476237|NCT01842438|616082362|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
170476238|NCT01842438|616082361|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
170476239|NCT01842438|616082362|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
170476240|NCT01842438|616082361|FG000|T2: 6month Follow-up|Death|0|||
170476241|NCT01842438|616082362|FG001|T2: 6month Follow-up|Death|1|||
170476242|NCT03989102|616082363|FG000|Year 1|Withdrawal by Subject|6|||
170892140|NCT01700192|617611935|FG000|Overall Study|Physician Decision|2|||
170892141|NCT01700192|617611936|FG001|Overall Study|Physician Decision|3|||
170892142|NCT01700192|617611935|FG000|Overall Study|Pregnancy|1|||
170892143|NCT01700192|617611936|FG001|Overall Study|Pregnancy|4|||
170892144|NCT01700192|617611935|FG000|Overall Study|Progressive disease|1|||
170892145|NCT01700192|617611936|FG001|Overall Study|Progressive disease|0|||
170892146|NCT01700192|617611935|FG000|Overall Study|Protocol Violation|3|||
170892147|NCT01700192|617611936|FG001|Overall Study|Protocol Violation|4|||
170892148|NCT01700192|617611935|FG000|Overall Study|Technical problems|0|||
170892149|NCT01700192|617611936|FG001|Overall Study|Technical problems|1|||
170892150|NCT01700192|617611935|FG000|Overall Study|Withdrawal by Subject|56|||
170892151|NCT01700192|617611936|FG001|Overall Study|Withdrawal by Subject|64|||
170892152|NCT01700192|617611935|FG000|Overall Study|Never received study drug|1|||
170476243|NCT03989102|616082364|FG001|Year 1|Withdrawal by Subject|2|||
170476244|NCT03989102|616082365|FG002|Year 1|Withdrawal by Subject|7|||
170476245|NCT03989102|616082363|FG000|Year 1|Lost to Follow-up|5|||
170476246|NCT03989102|616082364|FG001|Year 1|Lost to Follow-up|2|||
170476247|NCT03989102|616082365|FG002|Year 1|Lost to Follow-up|5|||
170546639|NCT00689052|616345935|FG000|Overall Study|Adverse Event|4|||
170546640|NCT00689052|616345936|FG001|Overall Study|Adverse Event|6|||
170546641|NCT00689052|616345935|FG000|Overall Study|Protocol Violation|1|||
170546642|NCT00689052|616345936|FG001|Overall Study|Protocol Violation|0|||
170546643|NCT00689052|616345935|FG000|Overall Study|Lost to Follow-up|2|||
170546644|NCT00689052|616345936|FG001|Overall Study|Lost to Follow-up|0|||
170546645|NCT00689052|616345935|FG000|Overall Study|Withdrawal by Subject|2|||
170546646|NCT00689052|616345936|FG001|Overall Study|Withdrawal by Subject|0|||
170546647|NCT00689052|616345935|FG000|Overall Study|Early termination of the trial|22|||
170546648|NCT00689052|616345936|FG001|Overall Study|Early termination of the trial|24|||
170546649|NCT01068249|616345937|FG000|Overall Study|Death|1|||
170546650|NCT01068249|616345937|FG000|Overall Study|Withdrawal by Subject|3|||
170546651|NCT04180696|616345938|FG000|Overall Study|Death|5|||
170792508|NCT01868997|617249462|FG000|Overall Study|Adverse Event|2|||
170792509|NCT01868997|617249463|FG001|Overall Study|Adverse Event|5|||
170792510|NCT01868997|617249462|FG000|Overall Study|Lack of Efficacy|2|||
170792511|NCT01868997|617249463|FG001|Overall Study|Lack of Efficacy|0|||
170792512|NCT01868997|617249462|FG000|Overall Study|Other|3|||
170792513|NCT01868997|617249463|FG001|Overall Study|Other|1|||
170792514|NCT02733159|617249474|FG000|Overall Study|Adverse Event|1|||
170792515|NCT02733159|617249474|FG000|Overall Study|Lack of disease progression|1|||
170792516|NCT02670525|617249477|FG000|Overall Study|Death|94|||
170792517|NCT02670525|617249478|FG001|Overall Study|Death|14|||
170792518|NCT02670525|617249477|FG000|Overall Study|Lost to Follow-up|4|||
170792519|NCT02670525|617249478|FG001|Overall Study|Lost to Follow-up|1|||
170792520|NCT02670525|617249477|FG000|Overall Study|Subject withdrew consent|1|||
170792521|NCT02670525|617249478|FG001|Overall Study|Subject withdrew consent|0|||
170792522|NCT02670525|617249477|FG000|Overall Study|Unknown, data entry delayed|123|||
170792523|NCT02670525|617249478|FG001|Overall Study|Unknown, data entry delayed|78|||
170792524|NCT04622046|617249479|FG000|Intervention Period|Adverse Event|1|||
170792525|NCT04622046|617249479|FG000|Intervention Period|Withdrawal by Subject|2|||
170792526|NCT04622046|617249479|FG000|Extension Period|Ongoing in the Extension Period|21|||
170792527|NCT05809453|617251723|FG000|Overall Study|Withdrawal by Subject|1|||
170792528|NCT05809453|617251724|FG001|Overall Study|Withdrawal by Subject|0|||
170792529|NCT05809453|617251725|FG002|Overall Study|Withdrawal by Subject|0|||
170792530|NCT05809453|617251726|FG003|Overall Study|Withdrawal by Subject|0|||
170792531|NCT03668236|617251729|FG000|90-day Follow-up|Withdrawal by Subject|3|||
170792532|NCT03668236|617251730|FG001|90-day Follow-up|Withdrawal by Subject|2|||
170792533|NCT03668236|617251729|FG000|90-day Follow-up|Lost to Follow-up|3|||
170792534|NCT03668236|617251730|FG001|90-day Follow-up|Lost to Follow-up|1|||
170792535|NCT03668236|617251729|FG000|Baseline Characteristics|Lost to Follow-up|9|||
170792536|NCT03668236|617251730|FG001|Baseline Characteristics|Lost to Follow-up|5|||
170792537|NCT03668236|617251729|FG000|1-year Follow-up|Withdrawal by Subject|17|||
170792538|NCT03668236|617251730|FG001|1-year Follow-up|Withdrawal by Subject|15|||
170792539|NCT06132282|617251731|FG000|Overall Study|Lost to Follow-up|31|||
170792540|NCT04171141|617251736|FG000|Overall Study|Adverse Event|0|||
170792541|NCT04171141|617251737|FG001|Overall Study|Adverse Event|0|||
170792542|NCT04171141|617251738|FG002|Overall Study|Adverse Event|2|||
170476248|NCT03989102|616082363|FG000|Year 1|Subject met withdrawal criteria|1|||
170546652|NCT04180696|616345939|FG001|Overall Study|Death|6|||
170546653|NCT04180696|616345938|FG000|Overall Study|Lost to Follow-up|1|||
170546654|NCT04180696|616345939|FG001|Overall Study|Lost to Follow-up|0|||
170638902|NCT02395081|616689449|FG000|Overall Study|Fetal Loss|2|||
170638903|NCT02395081|616689450|FG001|Overall Study|Fetal Loss|3|||
170638904|NCT02395081|616689451|FG002|Overall Study|Fetal Loss|1|||
170638905|NCT04625101|616689452|FG000|Overall Study|Withdrawal by Subject|0|||
170638906|NCT04625101|616689453|FG001|Overall Study|Withdrawal by Subject|1|||
170638907|NCT04625101|616689452|FG000|Overall Study|Protocol Deviation|1|||
170638908|NCT04625101|616689453|FG001|Overall Study|Protocol Deviation|0|||
170638909|NCT02721966|616689454|FG000|Overall Study|Protocol Violation|1|||
170638910|NCT02721966|616689455|FG001|Overall Study|Protocol Violation|0|||
170638911|NCT02721966|616689456|FG002|Overall Study|Protocol Violation|0|||
170638912|NCT02721966|616689457|FG003|Overall Study|Protocol Violation|0|||
170638913|NCT02721966|616689458|FG004|Overall Study|Protocol Violation|0|||
170638914|NCT02721966|616689454|FG000|Overall Study|Withdrawal by Subject|9|||
170638915|NCT02721966|616689455|FG001|Overall Study|Withdrawal by Subject|2|||
170638916|NCT02721966|616689456|FG002|Overall Study|Withdrawal by Subject|3|||
170638917|NCT02721966|616689457|FG003|Overall Study|Withdrawal by Subject|7|||
170638918|NCT02721966|616689458|FG004|Overall Study|Withdrawal by Subject|0|||
170638919|NCT02721966|616689454|FG000|Overall Study|Adverse Event|4|||
170638920|NCT02721966|616689455|FG001|Overall Study|Adverse Event|4|||
170638921|NCT02721966|616689456|FG002|Overall Study|Adverse Event|3|||
170638922|NCT02721966|616689457|FG003|Overall Study|Adverse Event|0|||
170638923|NCT02721966|616689458|FG004|Overall Study|Adverse Event|0|||
170638924|NCT02721966|616689454|FG000|Overall Study|Death|1|||
170638925|NCT02721966|616689455|FG001|Overall Study|Death|0|||
170638926|NCT02721966|616689456|FG002|Overall Study|Death|0|||
170638927|NCT02721966|616689457|FG003|Overall Study|Death|0|||
170638928|NCT02721966|616689458|FG004|Overall Study|Death|0|||
170638929|NCT02721966|616689454|FG000|Overall Study|Lack of Efficacy|7|||
170638930|NCT02721966|616689455|FG001|Overall Study|Lack of Efficacy|4|||
170638931|NCT02721966|616689456|FG002|Overall Study|Lack of Efficacy|0|||
170638932|NCT02721966|616689457|FG003|Overall Study|Lack of Efficacy|0|||
170638933|NCT02721966|616689458|FG004|Overall Study|Lack of Efficacy|0|||
170638934|NCT02721966|616689454|FG000|Overall Study|Lost to Follow-up|0|||
170638935|NCT02721966|616689455|FG001|Overall Study|Lost to Follow-up|0|||
170638936|NCT02721966|616689456|FG002|Overall Study|Lost to Follow-up|3|||
170638937|NCT02721966|616689457|FG003|Overall Study|Lost to Follow-up|0|||
170638938|NCT02721966|616689458|FG004|Overall Study|Lost to Follow-up|0|||
170638939|NCT02721966|616689454|FG000|Overall Study|Physician Decision|1|||
170638940|NCT02721966|616689455|FG001|Overall Study|Physician Decision|1|||
170638941|NCT02721966|616689456|FG002|Overall Study|Physician Decision|0|||
170638942|NCT02721966|616689457|FG003|Overall Study|Physician Decision|0|||
170638943|NCT02721966|616689458|FG004|Overall Study|Physician Decision|0|||
170638944|NCT02721966|616689454|FG000|Overall Study|Pregnancy|1|||
170638945|NCT02721966|616689455|FG001|Overall Study|Pregnancy|0|||
170638946|NCT02721966|616689456|FG002|Overall Study|Pregnancy|0|||
170638947|NCT02721966|616689457|FG003|Overall Study|Pregnancy|0|||
170638948|NCT02721966|616689458|FG004|Overall Study|Pregnancy|0|||
170638949|NCT02721966|616689454|FG000|Overall Study|Did not continue to period 2|5|||
170638950|NCT02721966|616689455|FG001|Overall Study|Did not continue to period 2|12|||
170638951|NCT02721966|616689456|FG002|Overall Study|Did not continue to period 2|0|||
170638952|NCT02721966|616689457|FG003|Overall Study|Did not continue to period 2|0|||
170638953|NCT02721966|616689458|FG004|Overall Study|Did not continue to period 2|5|||
170638954|NCT02504216|616689461|FG000|Overall Study|Lost to Follow-up|3|||
170638955|NCT02504216|616689462|FG001|Overall Study|Lost to Follow-up|3|||
170638956|NCT02504216|616689461|FG000|Overall Study|Withdrawal by Subject|8|||
170638957|NCT02504216|616689462|FG001|Overall Study|Withdrawal by Subject|12|||
170638958|NCT00223080|616689463|FG000|Overall Study|Withdrawal by Subject|253|||
170638959|NCT00223080|616689464|FG001|Overall Study|Withdrawal by Subject|232|||
170638960|NCT00223080|616689463|FG000|Overall Study|Required contraindicated med|0|||
170638961|NCT00223080|616689464|FG001|Overall Study|Required contraindicated med|1|||
170638962|NCT00223080|616689463|FG000|Overall Study|Non-compliant|7|||
170638963|NCT00223080|616689464|FG001|Overall Study|Non-compliant|7|||
170638964|NCT00223080|616689463|FG000|Overall Study|Moved from study area|37|||
170638965|NCT00223080|616689464|FG001|Overall Study|Moved from study area|47|||
170638966|NCT00223080|616689463|FG000|Overall Study|Lost to Follow-up|259|||
170638967|NCT00223080|616689464|FG001|Overall Study|Lost to Follow-up|284|||
170638968|NCT00223080|616689463|FG000|Overall Study|Death|85|||
170638969|NCT00223080|616689464|FG001|Overall Study|Death|74|||
170638970|NCT00223080|616689463|FG000|Overall Study|Other|14|||
170638971|NCT00223080|616689464|FG001|Overall Study|Other|11|||
170638972|NCT00223080|616689463|FG000|Overall Study|Reason not provided|141|||
170638973|NCT00223080|616689464|FG001|Overall Study|Reason not provided|140|||
170638974|NCT00223080|616689463|FG000|Overall Study|Adverse Event|0|||
170638975|NCT00223080|616689464|FG001|Overall Study|Adverse Event|1|||
170638976|NCT02792829|616689472|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
170638977|NCT02792829|616689473|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
170638978|NCT02792829|616689474|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
170638979|NCT02792829|616689475|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
170638980|NCT02792829|616689476|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
170792543|NCT04171141|617251739|FG003|Overall Study|Adverse Event|0|||
170792544|NCT04171141|617251740|FG004|Overall Study|Adverse Event|0|||
170792545|NCT04171141|617251741|FG005|Overall Study|Adverse Event|0|||
170792546|NCT04171141|617251742|FG006|Overall Study|Adverse Event|0|||
170792547|NCT04171141|617251743|FG007|Overall Study|Adverse Event|0|||
170792548|NCT04171141|617251744|FG008|Overall Study|Adverse Event|0|||
170792549|NCT04171141|617251745|FG009|Overall Study|Adverse Event|0|||
170792550|NCT04171141|617251746|FG010|Overall Study|Adverse Event|0|||
170546655|NCT04180696|616345938|FG000|Overall Study|Withdrawal by Subject|0|||
170792551|NCT04171141|617251747|FG011|Overall Study|Adverse Event|0|||
170792552|NCT04171141|617251748|FG012|Overall Study|Adverse Event|0|||
170792553|NCT04171141|617251749|FG013|Overall Study|Adverse Event|2|||
170476249|NCT03989102|616082364|FG001|Year 1|Subject met withdrawal criteria|0|||
170476250|NCT03989102|616082365|FG002|Year 1|Subject met withdrawal criteria|1|||
170476251|NCT03989102|616082363|FG000|Year 2|Lost to Follow-up|7|||
170546656|NCT04180696|616345939|FG001|Overall Study|Withdrawal by Subject|1|||
170546657|NCT04124965|616345942|FG000|Overall Study|Adverse event, non-fatal|3|||
170546658|NCT04124965|616345943|FG001|Overall Study|Adverse event, non-fatal|1|||
170546659|NCT04124965|616345942|FG000|Overall Study|Withdrawal by Subject|1|||
170546660|NCT04124965|616345943|FG001|Overall Study|Withdrawal by Subject|1|||
170546661|NCT04124965|616345942|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
170546662|NCT04124965|616345943|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
170546663|NCT04124965|616345942|FG000|Overall Study|Pregnancy|1|||
170546664|NCT04124965|616345943|FG001|Overall Study|Pregnancy|0|||
170546665|NCT04124965|616345942|FG000|Overall Study|Sponsor and participant decision|0|||
170546666|NCT04124965|616345943|FG001|Overall Study|Sponsor and participant decision|1|||
170546667|NCT04124965|616345942|FG000|Overall Study|Personal surgery|0|||
170546668|NCT04124965|616345943|FG001|Overall Study|Personal surgery|1|||
170546669|NCT04124965|616345942|FG000|Overall Study|Physician Decision|0|||
170546670|NCT04124965|616345943|FG001|Overall Study|Physician Decision|1|||
170546671|NCT00002874|616345944|FG000|Overall Study|Withdrawal by Subject|1|||
170546672|NCT00002874|616345945|FG001|Overall Study|Withdrawal by Subject|1|||
170546673|NCT00002874|616345944|FG000|Overall Study|Protocol Violation|44|||
170546674|NCT00002874|616345945|FG001|Overall Study|Protocol Violation|34|||
170546675|NCT02405962|616345948|FG000|Overall Study|Lost to Follow-up|1|||
170546676|NCT02405962|616345949|FG001|Overall Study|Lost to Follow-up|4|||
170546677|NCT02405962|616345948|FG000|Overall Study|A participant has moved to another place|0|||
170546678|NCT02405962|616345949|FG001|Overall Study|A participant has moved to another place|1|||
170546679|NCT01214720|616345952|FG000|Overall Study|Alive and still on treatment|34|||
170546680|NCT01214720|616345953|FG001|Overall Study|Alive and still on treatment|18|||
170546681|NCT01214720|616345952|FG000|Overall Study|Alive and in follow-up|45|||
170546682|NCT01214720|616345953|FG001|Overall Study|Alive and in follow-up|48|||
170546683|NCT01214720|616345952|FG000|Overall Study|Lost to Follow-up|6|||
170546684|NCT01214720|616345953|FG001|Overall Study|Lost to Follow-up|2|||
170546685|NCT01980888|616345954|FG000|Overall Study|Study Terminated by Sponsor|116|||
170476252|NCT03989102|616082364|FG001|Year 2|Lost to Follow-up|3|||
170476253|NCT03989102|616082365|FG002|Year 2|Lost to Follow-up|4|||
170476254|NCT03989102|616082363|FG000|Year 2|Withdrawal by Subject|3|||
170476255|NCT03989102|616082364|FG001|Year 2|Withdrawal by Subject|1|||
170476256|NCT03989102|616082365|FG002|Year 2|Withdrawal by Subject|2|||
170476257|NCT03989102|616082363|FG000|Year 2|Subject non-compliant|3|||
170476258|NCT03989102|616082364|FG001|Year 2|Subject non-compliant|2|||
170476259|NCT03989102|616082365|FG002|Year 2|Subject non-compliant|0|||
170476260|NCT03989102|616082363|FG000|Year 2|Travel|1|||
170476261|NCT03989102|616082364|FG001|Year 2|Travel|0|||
170476262|NCT03989102|616082365|FG002|Year 2|Travel|1|||
170476263|NCT03989102|616082363|FG000|Year 2|P16 missing|4|||
170476264|NCT03989102|616082364|FG001|Year 2|P16 missing|2|||
170476265|NCT03989102|616082365|FG002|Year 2|P16 missing|1|||
170476266|NCT03989102|616082363|FG000|Year 2|P11 missing|1|||
170546686|NCT01980888|616345955|FG001|Overall Study|Study Terminated by Sponsor|122|||
170546687|NCT01980888|616345954|FG000|Overall Study|Withdrew Consent|17|||
170546688|NCT01980888|616345955|FG001|Overall Study|Withdrew Consent|6|||
170546689|NCT01980888|616345954|FG000|Overall Study|Investigator's Discretion|8|||
170546690|NCT01980888|616345955|FG001|Overall Study|Investigator's Discretion|3|||
170546691|NCT01980888|616345954|FG000|Overall Study|Non-Compliance with Study Drug|3|||
170546692|NCT01980888|616345955|FG001|Overall Study|Non-Compliance with Study Drug|2|||
170546693|NCT05591755|616345956|FG000|Overall Study|Screen Failure|1|||
170546694|NCT05591755|616345957|FG001|Overall Study|Screen Failure|0|||
170638981|NCT02792829|616689477|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
170792554|NCT04171141|617251750|FG014|Overall Study|Adverse Event|0|||
170476267|NCT03989102|616082364|FG001|Year 2|P11 missing|3|||
170476268|NCT03989102|616082365|FG002|Year 2|P11 missing|7|||
170546695|NCT05591755|616345958|FG002|Overall Study|Screen Failure|0|||
170546696|NCT05591755|616345959|FG003|Overall Study|Screen Failure|0|||
170546697|NCT05591755|616345956|FG000|Overall Study|Protocol Violation|0|||
170546698|NCT05591755|616345957|FG001|Overall Study|Protocol Violation|0|||
170546699|NCT05591755|616345958|FG002|Overall Study|Protocol Violation|2|||
170546700|NCT05591755|616345959|FG003|Overall Study|Protocol Violation|0|||
170546701|NCT05591755|616345956|FG000|Overall Study|Withdrawal by Subject|0|||
170638982|NCT02792829|616689478|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
170638983|NCT02792829|616689479|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
170638984|NCT02792829|616689472|FG000|Treatment Period 2|Adverse Event|0|||
170638985|NCT02792829|616689473|FG001|Treatment Period 2|Adverse Event|0|||
170638986|NCT02792829|616689474|FG002|Treatment Period 2|Adverse Event|0|||
170638987|NCT02792829|616689475|FG003|Treatment Period 2|Adverse Event|0|||
170638988|NCT02792829|616689476|FG004|Treatment Period 2|Adverse Event|1|||
170638989|NCT02792829|616689477|FG005|Treatment Period 2|Adverse Event|0|||
170638990|NCT02792829|616689478|FG006|Treatment Period 2|Adverse Event|1|||
170638991|NCT02792829|616689479|FG007|Treatment Period 2|Adverse Event|1|||
170638992|NCT02792829|616689472|FG000|Treatment Period 2|Use of proscribed medications|0|||
170638993|NCT02792829|616689473|FG001|Treatment Period 2|Use of proscribed medications|0|||
170638994|NCT02792829|616689474|FG002|Treatment Period 2|Use of proscribed medications|0|||
170638995|NCT02792829|616689475|FG003|Treatment Period 2|Use of proscribed medications|0|||
170638996|NCT02792829|616689476|FG004|Treatment Period 2|Use of proscribed medications|0|||
170638997|NCT02792829|616689477|FG005|Treatment Period 2|Use of proscribed medications|0|||
170638998|NCT02792829|616689478|FG006|Treatment Period 2|Use of proscribed medications|0|||
170638999|NCT02792829|616689479|FG007|Treatment Period 2|Use of proscribed medications|1|||
170639000|NCT01262820|616689482|FG000|Overall Study|Adverse Event|5|||
170639001|NCT01262820|616689482|FG000|Overall Study|Lack of Efficacy|9|||
170639002|NCT01262820|616689482|FG000|Overall Study|Drug held for 21+ days|1|||
170639003|NCT02442804|616689487|FG000|Overall Study|Withdrawal by Subject|0|||
170639004|NCT02442804|616689488|FG001|Overall Study|Withdrawal by Subject|1|||
170639005|NCT02442804|616689487|FG000|Overall Study|Adverse Event|1|||
170546702|NCT05591755|616345957|FG001|Overall Study|Withdrawal by Subject|1|||
170546703|NCT05591755|616345958|FG002|Overall Study|Withdrawal by Subject|0|||
170546704|NCT05591755|616345959|FG003|Overall Study|Withdrawal by Subject|0|||
170546705|NCT00165698|616345960|FG000|Overall Study|Adverse Event|2|||
170546706|NCT00165698|616345961|FG001|Overall Study|Adverse Event|10|||
170639006|NCT02442804|616689488|FG001|Overall Study|Adverse Event|0|||
170639007|NCT01387542|616689489|FG000|Overall Study|Adverse Event|3|||
170639008|NCT01387542|616689489|FG000|Overall Study|Withdrawal by Subject|1|||
170639009|NCT01387542|616689489|FG000|Overall Study|Changed diagnosis|1|||
170639010|NCT01387542|616689489|FG000|Overall Study|Insufficient response|1|||
170639011|NCT01387542|616689489|FG000|Overall Study|Non-compliant|1|||
170639012|NCT01387542|616689489|FG000|Overall Study|Lost to Follow-up|1|||
170639013|NCT01010867|616689490|FG000|Overall Study|< 50% adherence to probiotic|1|||
170546707|NCT00165698|616345960|FG000|Overall Study|Lost to Follow-up|2|||
170546708|NCT00165698|616345961|FG001|Overall Study|Lost to Follow-up|2|||
170546709|NCT00165698|616345960|FG000|Overall Study|Withdrawal by Subject|2|||
170546710|NCT00165698|616345961|FG001|Overall Study|Withdrawal by Subject|1|||
170546711|NCT00165698|616345960|FG000|Overall Study|Protocol Violation|1|||
170546712|NCT00165698|616345961|FG001|Overall Study|Protocol Violation|0|||
170546713|NCT00165698|616345960|FG000|Overall Study|Not Taken/Lost the medicine|1|||
170546714|NCT00165698|616345961|FG001|Overall Study|Not Taken/Lost the medicine|2|||
170546715|NCT00433290|616345962|FG000|Overall Study|Adverse Event|24|||
170546716|NCT00433290|616345963|FG001|Overall Study|Adverse Event|7|||
170546717|NCT00433290|616345962|FG000|Overall Study|Lack of Efficacy|1|||
170546718|NCT00433290|616345963|FG001|Overall Study|Lack of Efficacy|5|||
170546719|NCT00433290|616345962|FG000|Overall Study|Withdrawal by Subject|4|||
170546720|NCT00433290|616345963|FG001|Overall Study|Withdrawal by Subject|2|||
170546721|NCT00433290|616345962|FG000|Overall Study|Protocol Violation|3|||
170546722|NCT00433290|616345963|FG001|Overall Study|Protocol Violation|2|||
170546723|NCT00433290|616345962|FG000|Overall Study|Physician Decision|2|||
170546724|NCT00433290|616345963|FG001|Overall Study|Physician Decision|0|||
170639014|NCT01668589|616689493|FG000|Overall Study|Lost to Follow-up|29|||
170792555|NCT04171141|617251751|FG015|Overall Study|Adverse Event|0|||
170792556|NCT04171141|617251736|FG000|Overall Study|Physician Decision|0|||
170792557|NCT04171141|617251737|FG001|Overall Study|Physician Decision|0|||
170792558|NCT04171141|617251738|FG002|Overall Study|Physician Decision|0|||
170792559|NCT04171141|617251739|FG003|Overall Study|Physician Decision|0|||
170792560|NCT04171141|617251740|FG004|Overall Study|Physician Decision|1|||
170792561|NCT04171141|617251741|FG005|Overall Study|Physician Decision|0|||
170546725|NCT00433290|616345962|FG000|Overall Study|Entry Criteria Not Met|0|||
170792562|NCT04171141|617251742|FG006|Overall Study|Physician Decision|0|||
170639015|NCT01668589|616689494|FG001|Overall Study|Lost to Follow-up|37|||
170639016|NCT01668589|616689495|FG002|Overall Study|Lost to Follow-up|15|||
170639017|NCT01668589|616689496|FG003|Overall Study|Lost to Follow-up|5|||
170639018|NCT01668589|616689493|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
170639019|NCT01668589|616689494|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
170639020|NCT01668589|616689495|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
170792563|NCT04171141|617251743|FG007|Overall Study|Physician Decision|0|||
170546726|NCT00433290|616345963|FG001|Overall Study|Entry Criteria Not Met|1|||
170546727|NCT00433290|616345962|FG000|Overall Study|Lost to Follow-up|1|||
170546728|NCT00433290|616345963|FG001|Overall Study|Lost to Follow-up|0|||
170546729|NCT01397747|616345969|FG000|Overall Study|Multitarget DNA test excluded|689|||
170792564|NCT04171141|617251744|FG008|Overall Study|Physician Decision|0|||
170476269|NCT03989102|616082363|FG000|Year 2|Definitive displacement outside the study site|0|||
170476270|NCT03989102|616082364|FG001|Year 2|Definitive displacement outside the study site|1|||
170476271|NCT03989102|616082365|FG002|Year 2|Definitive displacement outside the study site|0|||
170476272|NCT03989102|616082363|FG000|Year 2|Subject missed last study visit|0|||
170476273|NCT03989102|616082364|FG001|Year 2|Subject missed last study visit|1|||
170476274|NCT03989102|616082365|FG002|Year 2|Subject missed last study visit|0|||
170476275|NCT03989102|616082363|FG000|Year 2|Death|0|||
170476276|NCT03989102|616082364|FG001|Year 2|Death|1|||
170476277|NCT03989102|616082365|FG002|Year 2|Death|0|||
170476278|NCT03989102|616082363|FG000|Year 2|Subject not reachable|0|||
170476279|NCT03989102|616082364|FG001|Year 2|Subject not reachable|0|||
170476280|NCT03989102|616082365|FG002|Year 2|Subject not reachable|1|||
170476281|NCT03989102|616082363|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
170476282|NCT03989102|616082364|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
170476283|NCT03989102|616082365|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
170546730|NCT01397747|616345969|FG000|Overall Study|Colonoscopy excluded|304|||
170546731|NCT01397747|616345969|FG000|Overall Study|FIT excluded|34|||
170546732|NCT01018953|616345971|FG000|Overall Study|Adverse Event|2|||
170546733|NCT01018953|616345971|FG000|Overall Study|Withdrawal by Subject|1|||
170546734|NCT01018953|616345971|FG000|Overall Study|Study termination by sponsor|5|||
170546735|NCT00724503|616345972|FG000|Overall Study|Lost to Follow-up|4|||
170546736|NCT00724503|616345973|FG001|Overall Study|Lost to Follow-up|8|||
170546737|NCT00724503|616345972|FG000|Overall Study|Withdrawal by Subject|11|||
170546738|NCT00724503|616345973|FG001|Overall Study|Withdrawal by Subject|23|||
170546739|NCT00724503|616345972|FG000|Overall Study|Death|190|||
170546740|NCT00724503|616345973|FG001|Overall Study|Death|182|||
170546741|NCT00724503|616345972|FG000|Overall Study|Adverse Event|1|||
170546742|NCT00724503|616345973|FG001|Overall Study|Adverse Event|0|||
170546743|NCT00724503|616345972|FG000|Overall Study|Not otherwise specified|4|||
170546744|NCT00724503|616345973|FG001|Overall Study|Not otherwise specified|7|||
170546745|NCT01186419|616345974|FG000|Overall Study|Withdrawal by Subject|5|||
170792565|NCT04171141|617251745|FG009|Overall Study|Physician Decision|0|||
170792566|NCT04171141|617251746|FG010|Overall Study|Physician Decision|0|||
170792567|NCT04171141|617251747|FG011|Overall Study|Physician Decision|0|||
170792568|NCT04171141|617251748|FG012|Overall Study|Physician Decision|0|||
170792569|NCT04171141|617251749|FG013|Overall Study|Physician Decision|0|||
170792570|NCT04171141|617251750|FG014|Overall Study|Physician Decision|0|||
170792571|NCT04171141|617251751|FG015|Overall Study|Physician Decision|1|||
170792572|NCT04171141|617251736|FG000|Overall Study|Progressive disease|2|||
170792573|NCT04171141|617251737|FG001|Overall Study|Progressive disease|3|||
170792574|NCT04171141|617251738|FG002|Overall Study|Progressive disease|4|||
170792575|NCT04171141|617251739|FG003|Overall Study|Progressive disease|7|||
170792576|NCT04171141|617251740|FG004|Overall Study|Progressive disease|1|||
170792577|NCT04171141|617251741|FG005|Overall Study|Progressive disease|8|||
170792578|NCT04171141|617251742|FG006|Overall Study|Progressive disease|4|||
170792579|NCT04171141|617251743|FG007|Overall Study|Progressive disease|6|||
170792580|NCT04171141|617251744|FG008|Overall Study|Progressive disease|7|||
170792581|NCT04171141|617251745|FG009|Overall Study|Progressive disease|3|||
170792582|NCT04171141|617251746|FG010|Overall Study|Progressive disease|4|||
170792583|NCT04171141|617251747|FG011|Overall Study|Progressive disease|3|||
170792584|NCT04171141|617251748|FG012|Overall Study|Progressive disease|4|||
170792585|NCT04171141|617251749|FG013|Overall Study|Progressive disease|2|||
170792586|NCT04171141|617251750|FG014|Overall Study|Progressive disease|4|||
170792587|NCT04171141|617251751|FG015|Overall Study|Progressive disease|1|||
170792588|NCT04171141|617251736|FG000|Overall Study|Withdrawal by Subject|0|||
170792589|NCT04171141|617251737|FG001|Overall Study|Withdrawal by Subject|0|||
170792590|NCT04171141|617251738|FG002|Overall Study|Withdrawal by Subject|0|||
170792591|NCT04171141|617251739|FG003|Overall Study|Withdrawal by Subject|1|||
170792592|NCT04171141|617251740|FG004|Overall Study|Withdrawal by Subject|0|||
170792593|NCT04171141|617251741|FG005|Overall Study|Withdrawal by Subject|0|||
170792594|NCT04171141|617251742|FG006|Overall Study|Withdrawal by Subject|1|||
170792595|NCT04171141|617251743|FG007|Overall Study|Withdrawal by Subject|0|||
170792596|NCT04171141|617251744|FG008|Overall Study|Withdrawal by Subject|0|||
170792597|NCT04171141|617251745|FG009|Overall Study|Withdrawal by Subject|1|||
170792598|NCT04171141|617251746|FG010|Overall Study|Withdrawal by Subject|0|||
170476284|NCT03989102|616082363|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
170546746|NCT01186419|616345975|FG001|Overall Study|Withdrawal by Subject|3|||
170792599|NCT04171141|617251747|FG011|Overall Study|Withdrawal by Subject|0|||
170792600|NCT04171141|617251748|FG012|Overall Study|Withdrawal by Subject|0|||
170546747|NCT01186419|616345974|FG000|Overall Study|Adverse Event|1|||
170546748|NCT01186419|616345975|FG001|Overall Study|Adverse Event|2|||
170792601|NCT04171141|617251749|FG013|Overall Study|Withdrawal by Subject|0|||
170792602|NCT04171141|617251750|FG014|Overall Study|Withdrawal by Subject|0|||
170792603|NCT04171141|617251751|FG015|Overall Study|Withdrawal by Subject|0|||
170546749|NCT01186419|616345974|FG000|Overall Study|Physician Decision|0|||
170546750|NCT01186419|616345975|FG001|Overall Study|Physician Decision|3|||
170546751|NCT01186419|616345974|FG000|Overall Study|Other|1|||
170476285|NCT03989102|616082364|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
170476286|NCT03989102|616082365|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
170476287|NCT03989102|616082363|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
170476288|NCT03989102|616082364|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
170476289|NCT03989102|616082365|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
170476290|NCT03989102|616082363|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
170476291|NCT03989102|616082364|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
170476292|NCT03989102|616082365|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
170476293|NCT03989102|616082363|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
170476294|NCT03989102|616082364|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
170476295|NCT03989102|616082365|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
170476296|NCT03989102|616082363|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
170476297|NCT03989102|616082364|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
170476298|NCT03989102|616082365|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
170476299|NCT04054765|616082366|FG000|Baseline|Withdrawal by Subject|5|||
170476300|NCT04054765|616082367|FG001|Baseline|Withdrawal by Subject|3|||
170476301|NCT04054765|616082366|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
170476302|NCT04054765|616082367|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
170476303|NCT04054765|616082366|FG000|3-month Follow up|Withdrawal by Subject|0|||
170476304|NCT04054765|616082367|FG001|3-month Follow up|Withdrawal by Subject|3|||
170476305|NCT04054765|616082366|FG000|6-month Follow up|Lost to Follow-up|32|||
170476306|NCT04054765|616082367|FG001|6-month Follow up|Lost to Follow-up|32|||
170476307|NCT01290068|616082368|FG000|Overall Study|Adverse Event|1|||
170476308|NCT01290068|616082369|FG001|Overall Study|Adverse Event|3|||
170476309|NCT01290068|616082368|FG000|Overall Study|Lost to Follow-up|3|||
170476310|NCT01290068|616082369|FG001|Overall Study|Lost to Follow-up|0|||
170476311|NCT01290068|616082368|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
170476312|NCT01290068|616082369|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
170476313|NCT01290068|616082368|FG000|Overall Study|Other|3|||
170476314|NCT01290068|616082369|FG001|Overall Study|Other|1|||
170476315|NCT02009722|616082372|FG000|Overall Study|Protocol Violation|1|||
170476316|NCT02009722|616082373|FG001|Overall Study|Protocol Violation|2|||
170476317|NCT02009722|616082372|FG000|Overall Study|Did not receive intervention|0|||
170476318|NCT02009722|616082373|FG001|Overall Study|Did not receive intervention|1|||
170476319|NCT00545714|616082374|FG000|Induction Phase (6 Months)|Physician Decision|3|||
170476320|NCT00545714|616082374|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
170476321|NCT00545714|616082374|FG000|Induction Phase (6 Months)|Disease Progression|1|||
170476322|NCT00545714|616082374|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
170476323|NCT00545714|616082374|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
170546752|NCT01186419|616345975|FG001|Overall Study|Other|1|||
170546753|NCT03882801|616347458|FG000|Period 1|Adverse Event|0|||
170546754|NCT03882801|616347459|FG001|Period 1|Adverse Event|1|||
170546755|NCT03882801|616347458|FG000|Period 1|Non-compliance with study drug|1|||
170546756|NCT03882801|616347459|FG001|Period 1|Non-compliance with study drug|1|||
170546757|NCT03882801|616347458|FG000|Period 1|Never treated with study drug|1|||
170546758|NCT03882801|616347459|FG001|Period 1|Never treated with study drug|0|||
170546759|NCT03882801|616347458|FG000|Washout Period|Physician Decision|0|||
170546760|NCT03882801|616347459|FG001|Washout Period|Physician Decision|1|||
170546761|NCT03882801|616347458|FG000|Period 2|Non-compliance with study drug|0|||
170546762|NCT03882801|616347459|FG001|Period 2|Non-compliance with study drug|1|||
170546763|NCT01569763|616347460|FG000|Overall Study|Lack of Efficacy|2|||
170546764|NCT01569763|616347461|FG001|Overall Study|Lack of Efficacy|7|||
170546765|NCT01569763|616347460|FG000|Overall Study|Adverse Event|1|||
170546766|NCT01569763|616347461|FG001|Overall Study|Adverse Event|0|||
170546767|NCT01793129|616347462|FG000|Overall Study|Lost to Follow-up|3|||
170546768|NCT01793129|616347463|FG001|Overall Study|Lost to Follow-up|7|||
170546769|NCT01793129|616347462|FG000|Overall Study|Withdrawal by Subject|0|||
170792604|NCT04171141|617251736|FG000|Overall Study|Global deterioration of health status|0|||
170792605|NCT04171141|617251737|FG001|Overall Study|Global deterioration of health status|0|||
170792606|NCT04171141|617251738|FG002|Overall Study|Global deterioration of health status|0|||
170792607|NCT04171141|617251739|FG003|Overall Study|Global deterioration of health status|1|||
170792608|NCT04171141|617251740|FG004|Overall Study|Global deterioration of health status|0|||
170792609|NCT04171141|617251741|FG005|Overall Study|Global deterioration of health status|2|||
170792610|NCT04171141|617251742|FG006|Overall Study|Global deterioration of health status|1|||
170792611|NCT04171141|617251743|FG007|Overall Study|Global deterioration of health status|0|||
170792612|NCT04171141|617251744|FG008|Overall Study|Global deterioration of health status|1|||
170792613|NCT04171141|617251745|FG009|Overall Study|Global deterioration of health status|0|||
170792614|NCT04171141|617251746|FG010|Overall Study|Global deterioration of health status|0|||
170792615|NCT04171141|617251747|FG011|Overall Study|Global deterioration of health status|0|||
170546770|NCT01793129|616347463|FG001|Overall Study|Withdrawal by Subject|2|||
170546771|NCT03004183|616347466|FG000|Overall Study|Adverse Event|7|||
170546772|NCT03004183|616347466|FG000|Overall Study|Lost to Follow-up|1|||
170792616|NCT04171141|617251748|FG012|Overall Study|Global deterioration of health status|0|||
170476324|NCT00545714|616082374|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
170546773|NCT03004183|616347466|FG000|Overall Study|Physician Decision|40|||
170546774|NCT03004183|616347466|FG000|Overall Study|Withdrawal by Subject|1|||
170546775|NCT03004183|616347466|FG000|Overall Study|COVID-19|1|||
170546776|NCT01567085|616347467|FG000|Overall Study|Death|6|||
170546777|NCT01567085|616347467|FG000|Overall Study|Adverse Event|6|||
170546778|NCT01567085|616347467|FG000|Overall Study|Lost to Follow-up|3|||
170476325|NCT00545714|616082374|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
170476326|NCT00545714|616082374|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
170476327|NCT00545714|616082374|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
170476328|NCT00545714|616082374|FG000|Maintenance Phase (36 Months)|Death|2|||
170476329|NCT02556801|616082381|FG000|Overall Study|Lost to Follow-up|1|||
170476330|NCT02556801|616082382|FG001|Overall Study|Lost to Follow-up|0|||
170476331|NCT02556801|616082383|FG002|Overall Study|Lost to Follow-up|2|||
170476332|NCT02556801|616082384|FG003|Overall Study|Lost to Follow-up|0|||
170476333|NCT02556801|616082381|FG000|Overall Study|Withdrawal by Subject|1|||
170476334|NCT02556801|616082382|FG001|Overall Study|Withdrawal by Subject|1|||
170476335|NCT02556801|616082383|FG002|Overall Study|Withdrawal by Subject|1|||
170476336|NCT02556801|616082384|FG003|Overall Study|Withdrawal by Subject|0|||
170476337|NCT02556801|616082381|FG000|Overall Study|Protocol Violation|0|||
170476338|NCT02556801|616082382|FG001|Overall Study|Protocol Violation|3|||
170476339|NCT02556801|616082383|FG002|Overall Study|Protocol Violation|1|||
170476340|NCT02556801|616082384|FG003|Overall Study|Protocol Violation|1|||
170476341|NCT02556801|616082381|FG000|Overall Study|Adverse Event|0|||
170476342|NCT02556801|616082382|FG001|Overall Study|Adverse Event|2|||
170476343|NCT02556801|616082383|FG002|Overall Study|Adverse Event|0|||
170476344|NCT02556801|616082384|FG003|Overall Study|Adverse Event|3|||
170476345|NCT02556801|616082381|FG000|Overall Study|Pregnancy|0|||
170476346|NCT02556801|616082382|FG001|Overall Study|Pregnancy|1|||
170476347|NCT02556801|616082383|FG002|Overall Study|Pregnancy|0|||
170476348|NCT02556801|616082384|FG003|Overall Study|Pregnancy|0|||
170476349|NCT02556801|616082381|FG000|Overall Study|Personal reasons patient|0|||
170476350|NCT02556801|616082382|FG001|Overall Study|Personal reasons patient|0|||
170476351|NCT02556801|616082383|FG002|Overall Study|Personal reasons patient|0|||
170476352|NCT02556801|616082384|FG003|Overall Study|Personal reasons patient|1|||
170476353|NCT00124748|616082385|FG000|Overall Study|Adverse Event|8|||
170476354|NCT00124748|616082386|FG001|Overall Study|Adverse Event|39|||
170476355|NCT00124748|616082385|FG000|Overall Study|Abnormal laboratory Value|2|||
170476356|NCT00124748|616082386|FG001|Overall Study|Abnormal laboratory Value|2|||
170476357|NCT00124748|616082385|FG000|Overall Study|Abnormal Procedure|0|||
170476358|NCT00124748|616082386|FG001|Overall Study|Abnormal Procedure|1|||
170476359|NCT00124748|616082385|FG000|Overall Study|Lack of Efficacy|20|||
170476360|NCT00124748|616082386|FG001|Overall Study|Lack of Efficacy|41|||
170476361|NCT00124748|616082385|FG000|Overall Study|No longer requires study drug|1|||
170476362|NCT00124748|616082386|FG001|Overall Study|No longer requires study drug|1|||
170476363|NCT00124748|616082385|FG000|Overall Study|Protocol Violation|3|||
170476364|NCT00124748|616082386|FG001|Overall Study|Protocol Violation|1|||
170476365|NCT00124748|616082385|FG000|Overall Study|Withdrawal by Subject|5|||
170476366|NCT00124748|616082386|FG001|Overall Study|Withdrawal by Subject|15|||
170476367|NCT00124748|616082385|FG000|Overall Study|Lost to Follow-up|2|||
170476368|NCT00124748|616082386|FG001|Overall Study|Lost to Follow-up|7|||
170476369|NCT00124748|616082385|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
170476370|NCT00124748|616082386|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
170476371|NCT00124748|616082385|FG000|Overall Study|Death|1|||
170476372|NCT00124748|616082386|FG001|Overall Study|Death|3|||
170476373|NCT04176250|616082389|FG000|Overall Study|Adverse Event|0|||
170476374|NCT04176250|616082390|FG001|Overall Study|Adverse Event|1|||
170476375|NCT04176250|616082391|FG002|Overall Study|Adverse Event|0|||
170476376|NCT04176250|616082392|FG003|Overall Study|Adverse Event|1|||
170476377|NCT04176250|616082393|FG004|Overall Study|Adverse Event|0|||
170476378|NCT04176250|616082394|FG005|Overall Study|Adverse Event|1|||
170476379|NCT04176250|616082389|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
170476380|NCT04176250|616082390|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
170546779|NCT01567085|616347467|FG000|Overall Study|Graft loss|2|||
170546780|NCT01567085|616347467|FG000|Overall Study|Renal transplantectomy|1|||
170546781|NCT01567085|616347467|FG000|Overall Study|Returned to chronic dialysis|1|||
170546782|NCT01567085|616347467|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
170792617|NCT04171141|617251749|FG013|Overall Study|Global deterioration of health status|0|||
170792618|NCT04171141|617251750|FG014|Overall Study|Global deterioration of health status|1|||
170476381|NCT04176250|616082391|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
170476382|NCT04176250|616082392|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
170546783|NCT00284934|616347472|FG000|Overall Study|Adverse Event|1|||
170546784|NCT00284934|616347473|FG001|Overall Study|Adverse Event|2|||
170546785|NCT00284934|616347472|FG000|Overall Study|Other reasons|3|||
170476383|NCT04176250|616082393|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
170476384|NCT04176250|616082394|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
170792619|NCT04171141|617251751|FG015|Overall Study|Global deterioration of health status|1|||
170792620|NCT04858451|617251754|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
170792621|NCT04858451|617251755|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
170792622|NCT04858451|617251756|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
170476385|NCT04176250|616082389|FG000|Overall Study|Withdrawal by Subject|0|||
170476386|NCT04176250|616082390|FG001|Overall Study|Withdrawal by Subject|0|||
170476387|NCT04176250|616082391|FG002|Overall Study|Withdrawal by Subject|0|||
170476388|NCT04176250|616082392|FG003|Overall Study|Withdrawal by Subject|0|||
170476389|NCT04176250|616082393|FG004|Overall Study|Withdrawal by Subject|0|||
170792623|NCT04858451|617251757|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
170792624|NCT04858451|617251758|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
170792625|NCT04858451|617251759|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
170792626|NCT04858451|617251760|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
170792627|NCT04858451|617251761|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
170792628|NCT04858451|617251762|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
170792629|NCT04858451|617251754|FG000|Part 2|Discontinued|0|||
170792630|NCT04858451|617251755|FG001|Part 2|Discontinued|0|||
170792631|NCT04858451|617251756|FG002|Part 2|Discontinued|0|||
170476390|NCT04176250|616082394|FG005|Overall Study|Withdrawal by Subject|1|||
170476391|NCT04176250|616082389|FG000|Overall Study|Randomized in error|0|||
170476392|NCT04176250|616082390|FG001|Overall Study|Randomized in error|0|||
170476393|NCT04176250|616082391|FG002|Overall Study|Randomized in error|0|||
170476394|NCT04176250|616082392|FG003|Overall Study|Randomized in error|0|||
170476395|NCT04176250|616082393|FG004|Overall Study|Randomized in error|1|||
170476396|NCT04176250|616082394|FG005|Overall Study|Randomized in error|0|||
170476397|NCT04660331|616082402|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
170476398|NCT04660331|616082403|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
170476399|NCT04660331|616082404|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
170476400|NCT02635984|616082405|FG000|Overall Study|Lost to Follow-up|2|||
170476401|NCT02635984|616082406|FG001|Overall Study|Lost to Follow-up|4|||
170476402|NCT02635984|616082405|FG000|Overall Study|Study Arm Closed|1|||
170476403|NCT02635984|616082406|FG001|Overall Study|Study Arm Closed|0|||
170476404|NCT01640249|616082407|FG000|Period 1|Withdrawal by Subject|1|||
170476405|NCT01640249|616082408|FG001|Period 1|Withdrawal by Subject|0|||
170476406|NCT01640249|616082409|FG002|Period 1|Withdrawal by Subject|0|||
170476407|NCT01640249|616082410|FG003|Period 1|Withdrawal by Subject|0|||
170476408|NCT01640249|616082411|FG004|Period 1|Withdrawal by Subject|0|||
170476409|NCT01640249|616082412|FG005|Period 1|Withdrawal by Subject|1|||
170476410|NCT01640249|616082413|FG006|Period 1|Withdrawal by Subject|0|||
170476411|NCT02308124|616082414|FG000|Overall Study|Lost to Follow-up|6|||
170476412|NCT02308124|616082415|FG001|Overall Study|Lost to Follow-up|6|||
170792632|NCT04858451|617251757|FG003|Part 2|Discontinued|0|||
170792633|NCT04858451|617251758|FG004|Part 2|Discontinued|0|||
170792634|NCT04858451|617251759|FG005|Part 2|Discontinued|0|||
170792635|NCT04858451|617251760|FG006|Part 2|Discontinued|0|||
170792636|NCT04858451|617251761|FG007|Part 2|Discontinued|0|||
170476413|NCT02308124|616082416|FG002|Overall Study|Lost to Follow-up|6|||
170476414|NCT02308124|616082414|FG000|Overall Study|Adverse Event|0|||
170476415|NCT02308124|616082415|FG001|Overall Study|Adverse Event|2|||
170476416|NCT02308124|616082416|FG002|Overall Study|Adverse Event|2|||
170476417|NCT04700137|616082417|FG000|Overall Study|Lost to Follow-up|1|||
170476418|NCT04700137|616082418|FG001|Overall Study|Lost to Follow-up|6|||
170476419|NCT04700137|616082419|FG002|Overall Study|Lost to Follow-up|1|||
170476420|NCT04700137|616082420|FG003|Overall Study|Lost to Follow-up|1|||
170476421|NCT04700137|616082417|FG000|Overall Study|Withdrawal by Subject|0|||
170476422|NCT04700137|616082418|FG001|Overall Study|Withdrawal by Subject|0|||
170792637|NCT04858451|617251762|FG008|Part 2|Discontinued|63|||
170792638|NCT03314454|617251763|FG000|Overall Study|Protocol Violation|1|||
170792639|NCT04119843|617251764|FG000|Overall Study|Adverse Event|3|||
170476423|NCT04700137|616082419|FG002|Overall Study|Withdrawal by Subject|1|||
170476424|NCT04700137|616082420|FG003|Overall Study|Withdrawal by Subject|0|||
170476425|NCT04700137|616082417|FG000|Overall Study|Death|0|||
170792640|NCT04119843|617251764|FG000|Overall Study|Death|1|||
170792641|NCT04499924|617251765|FG000|Overall Study|Study termination by sponsor|4|||
170476426|NCT04700137|616082418|FG001|Overall Study|Death|0|||
170476427|NCT04700137|616082419|FG002|Overall Study|Death|1|||
170476428|NCT04700137|616082420|FG003|Overall Study|Death|0|||
170476429|NCT02445963|616082421|FG000|Overall Study|Lost to Follow-up|1|||
170476430|NCT02445963|616082422|FG001|Overall Study|Lost to Follow-up|0|||
170476431|NCT02445963|616082423|FG002|Overall Study|Lost to Follow-up|0|||
170476432|NCT02445963|616082424|FG003|Overall Study|Lost to Follow-up|0|||
170639021|NCT01668589|616689496|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
170639022|NCT01668589|616689493|FG000|Overall Study|Death|12|||
170639023|NCT01668589|616689494|FG001|Overall Study|Death|3|||
170639024|NCT01668589|616689495|FG002|Overall Study|Death|2|||
170639025|NCT01668589|616689496|FG003|Overall Study|Death|11|||
170639026|NCT01668589|616689493|FG000|Overall Study|Other|44|||
170639027|NCT01668589|616689494|FG001|Overall Study|Other|10|||
170639028|NCT01668589|616689495|FG002|Overall Study|Other|7|||
170639029|NCT01668589|616689496|FG003|Overall Study|Other|15|||
170639030|NCT02954172|616689497|FG000|Overall Study|Protocol Violation|3|||
170639031|NCT02954172|616689498|FG001|Overall Study|Protocol Violation|0|||
170639032|NCT02954172|616689497|FG000|Overall Study|allergic reaction|2|||
170639033|NCT02954172|616689498|FG001|Overall Study|allergic reaction|1|||
170639034|NCT02954172|616689497|FG000|Overall Study|non-measurable lesions at baseline|1|||
170639035|NCT02954172|616689498|FG001|Overall Study|non-measurable lesions at baseline|2|||
170639036|NCT00806819|616689499|FG000|Overall Study|progressive disease (modified RECIST )|217|||
170639037|NCT00806819|616689500|FG001|Overall Study|progressive disease (modified RECIST )|216|||
170639038|NCT00806819|616689499|FG000|Overall Study|Worsening or AE of underlying disease|18|||
170639039|NCT00806819|616689500|FG001|Overall Study|Worsening or AE of underlying disease|25|||
170639040|NCT00806819|616689499|FG000|Overall Study|Other AE|38|||
170639041|NCT00806819|616689500|FG001|Overall Study|Other AE|40|||
170639042|NCT00806819|616689499|FG000|Overall Study|Protocol Violation|9|||
170639043|NCT00806819|616689500|FG001|Overall Study|Protocol Violation|4|||
170639044|NCT00806819|616689499|FG000|Overall Study|Lost to Follow-up|1|||
170639045|NCT00806819|616689500|FG001|Overall Study|Lost to Follow-up|0|||
170639046|NCT00806819|616689499|FG000|Overall Study|Withdrawal by Subject|32|||
170639047|NCT00806819|616689500|FG001|Overall Study|Withdrawal by Subject|29|||
170639048|NCT00806819|616689499|FG000|Overall Study|Not treated|6|||
170639049|NCT00806819|616689500|FG001|Overall Study|Not treated|3|||
170639050|NCT00806819|616689499|FG000|Overall Study|Reasons other than stated above|25|||
170639051|NCT00806819|616689500|FG001|Overall Study|Reasons other than stated above|41|||
170639052|NCT00233064|616689503|FG000|Overall Study|Lost to Follow-up|7|||
170639053|NCT00233064|616689504|FG001|Overall Study|Lost to Follow-up|7|||
170639054|NCT00233064|616689503|FG000|Overall Study|Withdrawal by Subject|5|||
170639055|NCT00233064|616689504|FG001|Overall Study|Withdrawal by Subject|3|||
170639056|NCT00233064|616689503|FG000|Overall Study|Death|0|||
170639057|NCT00233064|616689504|FG001|Overall Study|Death|1|||
170639058|NCT00233064|616689503|FG000|Overall Study|Relocation|0|||
170639059|NCT00233064|616689504|FG001|Overall Study|Relocation|1|||
170639060|NCT00233064|616689503|FG000|Overall Study|Protocol Violation|1|||
170639061|NCT00233064|616689504|FG001|Overall Study|Protocol Violation|0|||
170476433|NCT02445963|616082421|FG000|Overall Study|Change in employment|1|||
170476434|NCT02445963|616082422|FG001|Overall Study|Change in employment|0|||
170476435|NCT02445963|616082423|FG002|Overall Study|Change in employment|0|||
170476436|NCT02445963|616082424|FG003|Overall Study|Change in employment|0|||
170476437|NCT02445963|616082421|FG000|Overall Study|Symptoms post-vaccination|0|||
170476438|NCT02445963|616082422|FG001|Overall Study|Symptoms post-vaccination|0|||
170476439|NCT02445963|616082423|FG002|Overall Study|Symptoms post-vaccination|1|||
170476440|NCT02445963|616082424|FG003|Overall Study|Symptoms post-vaccination|0|||
170476441|NCT00952731|616082428|FG000|Overall Study|Drug supply expired|1|||
170476442|NCT00952731|616082429|FG001|Overall Study|Drug supply expired|0|||
170476443|NCT02296931|616082432|FG000|Overall Study|Protocol Violation|0|||
170476444|NCT02296931|616082433|FG001|Overall Study|Protocol Violation|2|||
170476445|NCT04386616|616082434|FG000|Overall Study|Death|22|||
170476446|NCT04386616|616082435|FG001|Overall Study|Death|22|||
170476447|NCT04386616|616082436|FG002|Overall Study|Death|21|||
170476448|NCT04386616|616082434|FG000|Overall Study|Lost to Follow-up|5|||
170476449|NCT04386616|616082435|FG001|Overall Study|Lost to Follow-up|8|||
170476450|NCT04386616|616082436|FG002|Overall Study|Lost to Follow-up|6|||
170639062|NCT00233064|616689503|FG000|Overall Study|Moved to Dom. Republic|1|||
170639063|NCT00233064|616689504|FG001|Overall Study|Moved to Dom. Republic|0|||
170639064|NCT02302339|616689505|FG000|Overall Study|Lost to Follow-up|1|||
170639065|NCT02302339|616689506|FG001|Overall Study|Lost to Follow-up|0|||
170476451|NCT04386616|616082434|FG000|Overall Study|Withdrawal by Subject|2|||
170476452|NCT04386616|616082435|FG001|Overall Study|Withdrawal by Subject|4|||
170639066|NCT02302339|616689507|FG002|Overall Study|Lost to Follow-up|0|||
170476453|NCT04386616|616082436|FG002|Overall Study|Withdrawal by Subject|1|||
170476454|NCT04386616|616082434|FG000|Overall Study|Adverse Event|1|||
170639067|NCT02302339|616689508|FG003|Overall Study|Lost to Follow-up|0|||
170639068|NCT02302339|616689505|FG000|Overall Study|Withdrawal by Subject|0|||
170639069|NCT02302339|616689506|FG001|Overall Study|Withdrawal by Subject|2|||
170639070|NCT02302339|616689507|FG002|Overall Study|Withdrawal by Subject|1|||
170639071|NCT02302339|616689508|FG003|Overall Study|Withdrawal by Subject|0|||
170639072|NCT04434937|616689513|FG000|Overall Study|Death|4|||
170639073|NCT04434937|616689513|FG000|Overall Study|Withdrawal by Subject|1|||
170639074|NCT04434937|616689513|FG000|Overall Study|Transitioned to Rollover Study|19|||
170639075|NCT04434937|616689513|FG000|Overall Study|Progressive Disease|18|||
170639076|NCT04236141|616691180|FG000|Overall Study|Death|18|||
170639077|NCT04236141|616691181|FG001|Overall Study|Death|10|||
170639078|NCT04236141|616691180|FG000|Overall Study|Withdrawal by Participant|1|||
170639079|NCT04236141|616691181|FG001|Overall Study|Withdrawal by Participant|0|||
170639080|NCT04236141|616691180|FG000|Overall Study|Reason not Specified|1|||
170639081|NCT04236141|616691181|FG001|Overall Study|Reason not Specified|0|||
170639082|NCT04236141|616691180|FG000|Overall Study|Study terminated by Sponsor|8|||
170639083|NCT04236141|616691181|FG001|Overall Study|Study terminated by Sponsor|4|||
170639084|NCT01474239|616691184|FG000|Overall Study|Disease Progression|37|||
170639085|NCT01474239|616691185|FG001|Overall Study|Disease Progression|25|||
170639086|NCT01474239|616691184|FG000|Overall Study|Adverse Event|12|||
170639087|NCT01474239|616691185|FG001|Overall Study|Adverse Event|3|||
170639088|NCT01474239|616691184|FG000|Overall Study|Withdrawal by Subject|1|||
170639089|NCT01474239|616691185|FG001|Overall Study|Withdrawal by Subject|2|||
170639090|NCT01474239|616691184|FG000|Overall Study|Death|1|||
170639091|NCT01474239|616691185|FG001|Overall Study|Death|1|||
170639092|NCT01474239|616691184|FG000|Overall Study|Clinical Disease Progression|7|||
170639093|NCT01474239|616691185|FG001|Overall Study|Clinical Disease Progression|1|||
170639094|NCT01474239|616691184|FG000|Overall Study|Withdrawal for Economic Reason|1|||
170639095|NCT01474239|616691185|FG001|Overall Study|Withdrawal for Economic Reason|0|||
170639096|NCT02175199|616691192|FG000|Overall Study|Withdrawal by Subject|1|||
170639097|NCT02175199|616691193|FG001|Overall Study|Withdrawal by Subject|5|||
170639098|NCT02175199|616691192|FG000|Overall Study|Randomized in Error|1|||
170639099|NCT02175199|616691193|FG001|Overall Study|Randomized in Error|0|||
170639100|NCT02175199|616691192|FG000|Overall Study|Sponsor Decision|1|||
170639101|NCT02175199|616691193|FG001|Overall Study|Sponsor Decision|0|||
170639102|NCT00552188|616691194|FG000|Overall Study|Adverse Event|0|||
170639103|NCT00552188|616691195|FG001|Overall Study|Adverse Event|2|||
170639104|NCT00552188|616691194|FG000|Overall Study|Lost to Follow-up|2|||
170639105|NCT00552188|616691195|FG001|Overall Study|Lost to Follow-up|1|||
170639106|NCT00552188|616691194|FG000|Overall Study|Withdrawal of consent|0|||
170639107|NCT00552188|616691195|FG001|Overall Study|Withdrawal of consent|1|||
170639108|NCT00552188|616691194|FG000|Overall Study|Subject returned to home country|0|||
170639109|NCT00552188|616691195|FG001|Overall Study|Subject returned to home country|1|||
170639110|NCT00798759|616691196|FG000|Overall Study|Adverse Event|3|||
170639111|NCT00798759|616691197|FG001|Overall Study|Adverse Event|3|||
170639112|NCT00798759|616691196|FG000|Overall Study|Lost to Follow-up|1|||
170639113|NCT00798759|616691197|FG001|Overall Study|Lost to Follow-up|1|||
170639114|NCT00798759|616691196|FG000|Overall Study|Protocol Violation|4|||
170639115|NCT00798759|616691197|FG001|Overall Study|Protocol Violation|8|||
170639116|NCT00798759|616691196|FG000|Overall Study|Other|0|||
170639117|NCT00798759|616691197|FG001|Overall Study|Other|1|||
170639118|NCT00724711|616691198|FG000|Overall Study|Adverse Event|7|||
170639119|NCT00724711|616691199|FG001|Overall Study|Adverse Event|3|||
170639120|NCT00724711|616691198|FG000|Overall Study|Pregnancy|0|||
170639121|NCT00724711|616691199|FG001|Overall Study|Pregnancy|1|||
170639122|NCT00724711|616691198|FG000|Overall Study|Lack of Efficacy|0|||
170639123|NCT00724711|616691199|FG001|Overall Study|Lack of Efficacy|1|||
170639124|NCT00724711|616691198|FG000|Overall Study|Physician Decision|0|||
170639125|NCT00724711|616691199|FG001|Overall Study|Physician Decision|3|||
170639126|NCT00724711|616691198|FG000|Overall Study|Withdrawal by Subject|5|||
170476455|NCT04386616|616082435|FG001|Overall Study|Adverse Event|1|||
170476456|NCT04386616|616082436|FG002|Overall Study|Adverse Event|0|||
170476457|NCT01377012|616082437|FG000|Core Study|Study terminated by Sponsor|47|||
170476458|NCT01377012|616082438|FG001|Core Study|Study terminated by Sponsor|54|||
170476459|NCT01377012|616082439|FG002|Core Study|Study terminated by Sponsor|46|||
170476460|NCT01377012|616082437|FG000|Core Study|Technical problems|1|||
170476461|NCT01377012|616082438|FG001|Core Study|Technical problems|0|||
170476462|NCT01377012|616082439|FG002|Core Study|Technical problems|0|||
170476463|NCT01377012|616082437|FG000|Core Study|Withdrawal by Subject|15|||
170639127|NCT00724711|616691199|FG001|Overall Study|Withdrawal by Subject|4|||
170639128|NCT00724711|616691198|FG000|Overall Study|Lost to Follow-up|4|||
170476464|NCT01377012|616082438|FG001|Core Study|Withdrawal by Subject|23|||
170639129|NCT00724711|616691199|FG001|Overall Study|Lost to Follow-up|5|||
170639130|NCT00724711|616691198|FG000|Overall Study|Protocol Violation|1|||
170639131|NCT00724711|616691199|FG001|Overall Study|Protocol Violation|0|||
170639132|NCT00745849|616691200|FG000|First Intervention|Withdrawal by Subject|0|||
170639133|NCT00745849|616691201|FG001|First Intervention|Withdrawal by Subject|1|||
170639134|NCT00745849|616691200|FG000|First Intervention|Lost to Follow-up|1|||
170639135|NCT00745849|616691201|FG001|First Intervention|Lost to Follow-up|1|||
170639136|NCT00745849|616691200|FG000|Second Intervention|Lost to Follow-up|2|||
170639137|NCT00745849|616691201|FG001|Second Intervention|Lost to Follow-up|1|||
170476465|NCT01377012|616082439|FG002|Core Study|Withdrawal by Subject|18|||
170476466|NCT01377012|616082437|FG000|Core Study|Protocol Violation|7|||
170639138|NCT01139008|616691202|FG000|Overall Study|Withdrawal by Subject|5|||
170476467|NCT01377012|616082438|FG001|Core Study|Protocol Violation|3|||
170476468|NCT01377012|616082439|FG002|Core Study|Protocol Violation|2|||
170476469|NCT01377012|616082437|FG000|Core Study|Pregnancy|0|||
170476470|NCT01377012|616082438|FG001|Core Study|Pregnancy|0|||
170476471|NCT01377012|616082439|FG002|Core Study|Pregnancy|1|||
170476472|NCT01377012|616082437|FG000|Core Study|Physician Decision|5|||
170476473|NCT01377012|616082438|FG001|Core Study|Physician Decision|4|||
170476474|NCT01377012|616082439|FG002|Core Study|Physician Decision|10|||
170476475|NCT01377012|616082437|FG000|Core Study|Non-Compliant with study treatment|0|||
170476476|NCT01377012|616082438|FG001|Core Study|Non-Compliant with study treatment|0|||
170476477|NCT01377012|616082439|FG002|Core Study|Non-Compliant with study treatment|1|||
170476478|NCT01377012|616082437|FG000|Core Study|No Longer require treatment|0|||
170476479|NCT01377012|616082438|FG001|Core Study|No Longer require treatment|0|||
170476480|NCT01377012|616082439|FG002|Core Study|No Longer require treatment|1|||
170476481|NCT01377012|616082437|FG000|Core Study|Lost to Follow-up|7|||
170476482|NCT01377012|616082438|FG001|Core Study|Lost to Follow-up|5|||
170476483|NCT01377012|616082439|FG002|Core Study|Lost to Follow-up|4|||
170476484|NCT01377012|616082437|FG000|Core Study|Lack of Efficacy|41|||
170476485|NCT01377012|616082438|FG001|Core Study|Lack of Efficacy|28|||
170476486|NCT01377012|616082439|FG002|Core Study|Lack of Efficacy|37|||
170476487|NCT01377012|616082437|FG000|Core Study|Death|1|||
170476488|NCT01377012|616082438|FG001|Core Study|Death|1|||
170476489|NCT01377012|616082439|FG002|Core Study|Death|1|||
170476490|NCT01377012|616082437|FG000|Core Study|Adverse Event|10|||
170476491|NCT01377012|616082438|FG001|Core Study|Adverse Event|14|||
170476492|NCT01377012|616082439|FG002|Core Study|Adverse Event|13|||
170476493|NCT01377012|616082437|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
170476494|NCT01377012|616082438|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
170476495|NCT01377012|616082439|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
170476496|NCT01377012|616082437|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
170476497|NCT01377012|616082438|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
170476498|NCT01377012|616082439|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
170476499|NCT01377012|616082437|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
170476500|NCT01377012|616082438|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
170476501|NCT01377012|616082439|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
170476502|NCT01377012|616082437|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
170476503|NCT01377012|616082438|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
170476504|NCT01377012|616082439|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
170476505|NCT01377012|616082437|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
170476506|NCT01377012|616082438|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
170476507|NCT01377012|616082439|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
170476508|NCT01377012|616082437|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
170476509|NCT01377012|616082438|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
170476510|NCT01377012|616082439|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
170476511|NCT03449446|616082440|FG000|Overall Study|Randomized but Never Treated|0|||
170476512|NCT03449446|616082441|FG001|Overall Study|Randomized but Never Treated|0|||
170476513|NCT03449446|616082442|FG002|Overall Study|Randomized but Never Treated|1|||
170476514|NCT03449446|616082443|FG003|Overall Study|Randomized but Never Treated|1|||
170476515|NCT03449446|616082444|FG004|Overall Study|Randomized but Never Treated|1|||
170476516|NCT03449446|616082445|FG005|Overall Study|Randomized but Never Treated|0|||
170476517|NCT03449446|616082446|FG006|Overall Study|Randomized but Never Treated|0|||
170476518|NCT03449446|616082440|FG000|Overall Study|Unknown Reason|33|||
170476519|NCT03449446|616082441|FG001|Overall Study|Unknown Reason|1|||
170476520|NCT03449446|616082442|FG002|Overall Study|Unknown Reason|1|||
170476521|NCT03449446|616082443|FG003|Overall Study|Unknown Reason|1|||
170476522|NCT03449446|616082444|FG004|Overall Study|Unknown Reason|2|||
170476523|NCT03449446|616082445|FG005|Overall Study|Unknown Reason|2|||
170476524|NCT03449446|616082446|FG006|Overall Study|Unknown Reason|0|||
170476525|NCT03449446|616082440|FG000|Overall Study|Withdrew Consent|1|||
170476526|NCT03449446|616082441|FG001|Overall Study|Withdrew Consent|3|||
170476527|NCT03449446|616082442|FG002|Overall Study|Withdrew Consent|1|||
170476528|NCT03449446|616082443|FG003|Overall Study|Withdrew Consent|4|||
170476529|NCT03449446|616082444|FG004|Overall Study|Withdrew Consent|4|||
170476530|NCT03449446|616082445|FG005|Overall Study|Withdrew Consent|4|||
170476531|NCT03449446|616082446|FG006|Overall Study|Withdrew Consent|1|||
170476532|NCT03449446|616082440|FG000|Overall Study|Adverse Event|1|||
170476533|NCT03449446|616082441|FG001|Overall Study|Adverse Event|2|||
170476534|NCT03449446|616082442|FG002|Overall Study|Adverse Event|1|||
170476535|NCT03449446|616082443|FG003|Overall Study|Adverse Event|0|||
170476536|NCT03449446|616082444|FG004|Overall Study|Adverse Event|0|||
170476537|NCT03449446|616082445|FG005|Overall Study|Adverse Event|2|||
170546786|NCT00284934|616347473|FG001|Overall Study|Other reasons|1|||
170476538|NCT03449446|616082446|FG006|Overall Study|Adverse Event|0|||
170476539|NCT03449446|616082440|FG000|Overall Study|Lost to Follow-up|0|||
170476540|NCT03449446|616082441|FG001|Overall Study|Lost to Follow-up|0|||
170476541|NCT03449446|616082442|FG002|Overall Study|Lost to Follow-up|2|||
170546787|NCT00758043|616347474|FG000|Overall Study|Adverse Event|1|||
170476542|NCT03449446|616082443|FG003|Overall Study|Lost to Follow-up|1|||
170476543|NCT03449446|616082444|FG004|Overall Study|Lost to Follow-up|3|||
170476544|NCT03449446|616082445|FG005|Overall Study|Lost to Follow-up|0|||
170476545|NCT03449446|616082446|FG006|Overall Study|Lost to Follow-up|0|||
170476546|NCT03449446|616082440|FG000|Overall Study|Investigator's Discretion|0|||
170476547|NCT03449446|616082441|FG001|Overall Study|Investigator's Discretion|1|||
170476548|NCT03449446|616082442|FG002|Overall Study|Investigator's Discretion|1|||
170476549|NCT03449446|616082443|FG003|Overall Study|Investigator's Discretion|2|||
170476550|NCT03449446|616082444|FG004|Overall Study|Investigator's Discretion|0|||
170476551|NCT03449446|616082445|FG005|Overall Study|Investigator's Discretion|0|||
170476552|NCT03449446|616082446|FG006|Overall Study|Investigator's Discretion|0|||
170476553|NCT03449446|616082440|FG000|Overall Study|Non Compliance with Study Drug|1|||
170476554|NCT03449446|616082441|FG001|Overall Study|Non Compliance with Study Drug|0|||
170476555|NCT03449446|616082442|FG002|Overall Study|Non Compliance with Study Drug|0|||
170476556|NCT03449446|616082443|FG003|Overall Study|Non Compliance with Study Drug|0|||
170476557|NCT03449446|616082444|FG004|Overall Study|Non Compliance with Study Drug|0|||
170476558|NCT03449446|616082445|FG005|Overall Study|Non Compliance with Study Drug|0|||
170476559|NCT03449446|616082446|FG006|Overall Study|Non Compliance with Study Drug|0|||
170476560|NCT03449446|616082440|FG000|Overall Study|Protocol Violation|0|||
170476561|NCT03449446|616082441|FG001|Overall Study|Protocol Violation|0|||
170476562|NCT03449446|616082442|FG002|Overall Study|Protocol Violation|0|||
170476563|NCT03449446|616082443|FG003|Overall Study|Protocol Violation|0|||
170476564|NCT03449446|616082444|FG004|Overall Study|Protocol Violation|1|||
170476565|NCT03449446|616082445|FG005|Overall Study|Protocol Violation|1|||
170476566|NCT03449446|616082446|FG006|Overall Study|Protocol Violation|0|||
170476567|NCT03449446|616082440|FG000|Overall Study|Death|0|||
170476568|NCT03449446|616082441|FG001|Overall Study|Death|0|||
170476569|NCT03449446|616082442|FG002|Overall Study|Death|0|||
170476570|NCT03449446|616082443|FG003|Overall Study|Death|0|||
170476571|NCT03449446|616082444|FG004|Overall Study|Death|1|||
170476572|NCT03449446|616082445|FG005|Overall Study|Death|0|||
170476573|NCT03449446|616082446|FG006|Overall Study|Death|0|||
170476574|NCT00805961|616082451|FG000|Modality Therapy|Withdrawal by Subject|1|||
170476575|NCT00805961|616082451|FG000|Modality Therapy|Adverse Event|1|||
170476576|NCT00805961|616082451|FG000|Modality Therapy|Disease Progression|2|||
170476577|NCT00805961|616082451|FG000|Treatment-Free Interval|Adverse Event|3|||
170476578|NCT00805961|616082451|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
170476579|NCT00805961|616082451|FG000|Treatment-Free Interval|Physician Decision|1|||
170476580|NCT00805961|616082451|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
170476581|NCT00805961|616082451|FG000|Maintenance Treatment|Lack of Efficacy|13|||
170476582|NCT00805961|616082451|FG000|Maintenance Treatment|Intercurrent Illness|7|||
170476583|NCT00805961|616082451|FG000|Maintenance Treatment|Adverse Event|6|||
170476584|NCT00805961|616082451|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
170476585|NCT00805961|616082451|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
170476586|NCT00805961|616082451|FG000|Maintenance Treatment|Withdrawn Consent|1|||
170476587|NCT00243412|616082462|FG000|Overall Study|Death|0|||
170476588|NCT00243412|616082463|FG001|Overall Study|Death|1|||
170476589|NCT00243412|616082462|FG000|Overall Study|Adverse Event|4|||
170476590|NCT00243412|616082463|FG001|Overall Study|Adverse Event|2|||
170476591|NCT00243412|616082462|FG000|Overall Study|Lost to Follow-up|0|||
170476592|NCT00243412|616082463|FG001|Overall Study|Lost to Follow-up|1|||
170476593|NCT00243412|616082462|FG000|Overall Study|Physician Decision|1|||
170476594|NCT00243412|616082463|FG001|Overall Study|Physician Decision|1|||
170476595|NCT00243412|616082462|FG000|Overall Study|Withdrawal by Subject|4|||
170476596|NCT00243412|616082463|FG001|Overall Study|Withdrawal by Subject|5|||
170476597|NCT00243412|616082462|FG000|Overall Study|Other|1|||
170476598|NCT00243412|616082463|FG001|Overall Study|Other|1|||
170476599|NCT00143390|616082464|FG000|Overall Study|Death|2|||
170476600|NCT00143390|616082465|FG001|Overall Study|Death|0|||
170476601|NCT00143390|616082464|FG000|Overall Study|Not meeting entry criteria|2|||
170476602|NCT00143390|616082465|FG001|Overall Study|Not meeting entry criteria|5|||
170476603|NCT00143390|616082464|FG000|Overall Study|Withdrawal by Subject|4|||
170476604|NCT00143390|616082465|FG001|Overall Study|Withdrawal by Subject|4|||
170476605|NCT00143390|616082464|FG000|Overall Study|Progressive disease|119|||
170476606|NCT00143390|616082465|FG001|Overall Study|Progressive disease|115|||
170476607|NCT00143390|616082464|FG000|Overall Study|Protocol Violation|2|||
170476608|NCT00143390|616082465|FG001|Overall Study|Protocol Violation|0|||
170476609|NCT00143390|616082464|FG000|Overall Study|Study termination|10|||
170476610|NCT00143390|616082465|FG001|Overall Study|Study termination|15|||
170476611|NCT00143390|616082464|FG000|Overall Study|Adverse Event|9|||
170476612|NCT00143390|616082465|FG001|Overall Study|Adverse Event|8|||
170476613|NCT00143390|616082464|FG000|Overall Study|Other|1|||
170476614|NCT00143390|616082465|FG001|Overall Study|Other|2|||
170476615|NCT00041132|616082466|FG000|Overall Study|Adverse Event|19|||
170476616|NCT00041132|616082466|FG000|Overall Study|Death|1|||
170476617|NCT00041132|616082466|FG000|Overall Study|Not Eligible|7|||
170476618|NCT00041132|616082466|FG000|Overall Study|Withdrawal by Subject|1|||
170476619|NCT00041132|616082466|FG000|Overall Study|Physician Decision|2|||
170476620|NCT02764151|616082467|FG000|Overall Study|Subject refused further follow-up|0|||
170476621|NCT02764151|616082468|FG001|Overall Study|Subject refused further follow-up|0|||
170476622|NCT02764151|616082469|FG002|Overall Study|Subject refused further follow-up|0|||
170476623|NCT02764151|616082470|FG003|Overall Study|Subject refused further follow-up|1|||
170476624|NCT02764151|616082467|FG000|Overall Study|Other|0|||
170476625|NCT02764151|616082468|FG001|Overall Study|Other|0|||
170476626|NCT02764151|616082469|FG002|Overall Study|Other|0|||
170476627|NCT02764151|616082470|FG003|Overall Study|Other|2|||
170476628|NCT04208750|616082471|FG000|Overall Study|Lost to Follow-up|16|||
170476629|NCT04208750|616082472|FG001|Overall Study|Lost to Follow-up|15|||
170476630|NCT02201277|616082476|FG000|Overall Study|Death|3|||
170476631|NCT02201277|616082477|FG001|Overall Study|Death|4|||
170476632|NCT02201277|616082476|FG000|Overall Study|Lost to Follow-up|2|||
170476633|NCT02201277|616082477|FG001|Overall Study|Lost to Follow-up|1|||
170476634|NCT02201277|616082476|FG000|Overall Study|Failed retrieval|1|||
170476635|NCT02201277|616082477|FG001|Overall Study|Failed retrieval|0|||
170476636|NCT02201277|616082476|FG000|Overall Study|Physician Decision|1|||
170476637|NCT02201277|616082477|FG001|Overall Study|Physician Decision|0|||
170476638|NCT05022212|616082480|FG000|Overall Study|Lost to Follow-up|0|||
170476639|NCT05022212|616082481|FG001|Overall Study|Lost to Follow-up|2|||
170476640|NCT02905032|616082482|FG000|Overall Study|Withdrawal by Subject|2|||
170476641|NCT02905032|616082483|FG001|Overall Study|Withdrawal by Subject|0|||
170476642|NCT02905032|616082484|FG002|Overall Study|Withdrawal by Subject|0|||
170476643|NCT02905032|616082482|FG000|Overall Study|Protocol Violation|6|||
170476644|NCT02905032|616082483|FG001|Overall Study|Protocol Violation|12|||
170476645|NCT02905032|616082484|FG002|Overall Study|Protocol Violation|0|||
170476646|NCT02729909|616082485|FG000|Overall Study|Lost to Follow-up|0|||
170476647|NCT02729909|616082486|FG001|Overall Study|Lost to Follow-up|1|||
170476648|NCT02729909|616082485|FG000|Overall Study|Lack of Efficacy|0|||
170476649|NCT02729909|616082486|FG001|Overall Study|Lack of Efficacy|2|||
170476650|NCT02729909|616082485|FG000|Overall Study|Significant Protocol Deviation|0|||
170476651|NCT02729909|616082486|FG001|Overall Study|Significant Protocol Deviation|2|||
170476652|NCT02729909|616082485|FG000|Overall Study|Voluntary Withdrawal|1|||
170476653|NCT02729909|616082486|FG001|Overall Study|Voluntary Withdrawal|0|||
170476654|NCT00739063|616082490|FG000|Overall Study|Screen failures|8|||
170476655|NCT04779879|616082492|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
170476656|NCT04779879|616082493|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
170476657|NCT04779879|616082494|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
170476658|NCT04779879|616082495|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
170476659|NCT04779879|616082496|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
170476660|NCT04779879|616082497|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
170476661|NCT04779879|616082492|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
170476662|NCT04779879|616082493|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
170476663|NCT04779879|616082494|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
170476664|NCT04779879|616082495|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
170476665|NCT04779879|616082496|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
170476666|NCT04779879|616082497|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
170476667|NCT04779879|616082492|FG000|Part C: Up to Week 36|Death|0|||
170476668|NCT04779879|616082493|FG001|Part C: Up to Week 36|Death|0|||
170476669|NCT04779879|616082494|FG002|Part C: Up to Week 36|Death|0|||
170476670|NCT04779879|616082495|FG003|Part C: Up to Week 36|Death|0|||
170476671|NCT04779879|616082496|FG004|Part C: Up to Week 36|Death|0|||
170476672|NCT04779879|616082497|FG005|Part C: Up to Week 36|Death|1|||
170476673|NCT04779879|616082492|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
170476674|NCT04779879|616082493|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
170476675|NCT04779879|616082494|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
170476676|NCT04779879|616082495|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
170476677|NCT04779879|616082496|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
170476678|NCT04779879|616082497|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
170476679|NCT02854527|616082498|FG000|Overall Study|Adverse Event|0|||
170476680|NCT02854527|616082499|FG001|Overall Study|Adverse Event|0|||
170476681|NCT02854527|616082500|FG002|Overall Study|Adverse Event|0|||
170546788|NCT00758043|616347475|FG001|Overall Study|Adverse Event|20|||
170546789|NCT00758043|616347476|FG002|Overall Study|Adverse Event|12|||
170476682|NCT02854527|616082501|FG003|Overall Study|Adverse Event|0|||
170476683|NCT02854527|616082502|FG004|Overall Study|Adverse Event|1|||
170476684|NCT02854527|616082503|FG005|Overall Study|Adverse Event|0|||
170476685|NCT02854527|616082504|FG006|Overall Study|Adverse Event|0|||
170476686|NCT02854527|616082505|FG007|Overall Study|Adverse Event|0|||
170476687|NCT02854527|616082506|FG008|Overall Study|Adverse Event|0|||
170476688|NCT02854527|616082507|FG009|Overall Study|Adverse Event|0|||
170476689|NCT02854527|616082498|FG000|Overall Study|Lost to Follow-up|0|||
170476690|NCT02854527|616082499|FG001|Overall Study|Lost to Follow-up|0|||
170476691|NCT02854527|616082500|FG002|Overall Study|Lost to Follow-up|0|||
170476692|NCT02854527|616082501|FG003|Overall Study|Lost to Follow-up|1|||
170476693|NCT02854527|616082502|FG004|Overall Study|Lost to Follow-up|0|||
170476694|NCT02854527|616082503|FG005|Overall Study|Lost to Follow-up|0|||
170476695|NCT02854527|616082504|FG006|Overall Study|Lost to Follow-up|0|||
170476696|NCT02854527|616082505|FG007|Overall Study|Lost to Follow-up|0|||
170476697|NCT02854527|616082506|FG008|Overall Study|Lost to Follow-up|0|||
170476698|NCT02854527|616082507|FG009|Overall Study|Lost to Follow-up|0|||
170476699|NCT00866359|616082508|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
170792642|NCT04499924|617251766|FG001|Overall Study|Study termination by sponsor|6|||
170792643|NCT04499924|617251765|FG000|Overall Study|Withdrawal by Subject|1|||
170792644|NCT04499924|617251766|FG001|Overall Study|Withdrawal by Subject|3|||
170792645|NCT02841579|617251775|FG000|Overall Study|Death|1|||
170792646|NCT02841579|617251775|FG000|Overall Study|Adverse Event|1|||
170792647|NCT02841579|617251775|FG000|Overall Study|Lack of Efficacy|9|||
170476700|NCT00866359|616082509|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
170476701|NCT00866359|616082510|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
170476702|NCT00866359|616082511|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
170476703|NCT00866359|616082508|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
170476704|NCT00866359|616082509|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
170476705|NCT00866359|616082510|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
170476706|NCT00866359|616082511|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
170476707|NCT00866359|616082508|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
170476708|NCT00866359|616082509|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
170476709|NCT00866359|616082510|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
170476710|NCT00866359|616082511|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
170476711|NCT00866359|616082508|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
170476712|NCT00866359|616082509|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
170476713|NCT00866359|616082510|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
170476714|NCT00866359|616082511|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
170476715|NCT00866359|616082508|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
170476716|NCT00866359|616082509|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
170476717|NCT00866359|616082510|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
170476718|NCT00866359|616082511|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
170476719|NCT00866359|616082508|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
170476720|NCT00866359|616082509|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
170476721|NCT00866359|616082510|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
170476722|NCT00866359|616082511|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
170476723|NCT02163057|616082512|FG000|Overall Study|Participant Refusal to Continue|2|||
170476724|NCT02163057|616082513|FG001|Overall Study|Participant Refusal to Continue|2|||
170476725|NCT02163057|616082512|FG000|Overall Study|Participant Significant Noncompliance|0|||
170476726|NCT02163057|616082513|FG001|Overall Study|Participant Significant Noncompliance|1|||
170476727|NCT02163057|616082512|FG000|Overall Study|Progression of Disease|1|||
170476728|NCT02163057|616082513|FG001|Overall Study|Progression of Disease|2|||
170476729|NCT01625091|616082514|FG000|Intervention|Death|1|||
170476730|NCT01625091|616082515|FG001|Intervention|Death|1|||
170476731|NCT01625091|616082514|FG000|Intervention|Withdrawal by Subject|4|||
170476732|NCT01625091|616082515|FG001|Intervention|Withdrawal by Subject|1|||
170476733|NCT01625091|616082514|FG000|Intervention|Adverse Event|0|||
170476734|NCT01625091|616082515|FG001|Intervention|Adverse Event|2|||
170476735|NCT01625091|616082514|FG000|Intervention|Lost to Follow-up|4|||
170476736|NCT01625091|616082515|FG001|Intervention|Lost to Follow-up|4|||
170476737|NCT01625091|616082514|FG000|Intervention|Study termination|2|||
170476738|NCT01625091|616082515|FG001|Intervention|Study termination|3|||
170476739|NCT01625091|616082514|FG000|Post-intervention|Death|0|||
170476740|NCT01625091|616082515|FG001|Post-intervention|Death|1|||
170476741|NCT01625091|616082514|FG000|Post-intervention|Lost to Follow-up|2|||
170476742|NCT01625091|616082515|FG001|Post-intervention|Lost to Follow-up|0|||
170476743|NCT01625091|616082514|FG000|Post-intervention|Study termination|2|||
170476744|NCT01625091|616082515|FG001|Post-intervention|Study termination|1|||
170476745|NCT01547390|616082522|FG000|Overall Study|Withdrawal by Subject|10|||
170476746|NCT01547390|616082523|FG001|Overall Study|Withdrawal by Subject|7|||
170476747|NCT01547390|616082522|FG000|Overall Study|termination of pregnancy|0|||
170476748|NCT01547390|616082523|FG001|Overall Study|termination of pregnancy|1|||
170792648|NCT02998268|617251776|FG000|Overall Study|Adverse Event|0|||
170792649|NCT02998268|617251777|FG001|Overall Study|Adverse Event|2|||
170476749|NCT01547390|616082522|FG000|Overall Study|Lost to Follow-up|0|||
170476750|NCT01547390|616082523|FG001|Overall Study|Lost to Follow-up|2|||
170476751|NCT01547390|616082522|FG000|Overall Study|Adverse Event|3|||
170792650|NCT02998268|617251776|FG000|Overall Study|Withdrawal by Subject|0|||
170792651|NCT02998268|617251777|FG001|Overall Study|Withdrawal by Subject|1|||
170476752|NCT01547390|616082523|FG001|Overall Study|Adverse Event|0|||
170476753|NCT01959295|616082527|FG000|Overall Study|Adverse Event|2|||
170476754|NCT01959295|616082528|FG001|Overall Study|Adverse Event|0|||
170476755|NCT01959295|616082527|FG000|Overall Study|Lost to Follow-up|0|||
170476756|NCT01959295|616082528|FG001|Overall Study|Lost to Follow-up|2|||
170476757|NCT01959295|616082527|FG000|Overall Study|Physician Decision|2|||
170476758|NCT01959295|616082528|FG001|Overall Study|Physician Decision|3|||
170792652|NCT04225273|617251778|FG000|Overall Study|Lost to Follow-up|3|||
170476759|NCT01959295|616082527|FG000|Overall Study|Protocol Violation|16|||
170476760|NCT01959295|616082528|FG001|Overall Study|Protocol Violation|5|||
170476761|NCT01959295|616082527|FG000|Overall Study|Withdrawal by Subject|3|||
170476762|NCT01959295|616082528|FG001|Overall Study|Withdrawal by Subject|1|||
170476763|NCT01959295|616082527|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
170476764|NCT01959295|616082528|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
170476765|NCT04576507|616084503|FG000|Overall Study|Adverse Event|4|||
170476766|NCT04576507|616084503|FG000|Overall Study|Withdrawal by Subject|1|||
170476767|NCT05878093|616084504|FG000|Overall Study|Withdrawal by Subject|3|||
170476768|NCT05878093|616084505|FG001|Overall Study|Withdrawal by Subject|1|||
170476769|NCT04100018|616084509|FG000|Pre-Treatment Period|Not Reported|0|||
170476770|NCT04100018|616084510|FG001|Pre-Treatment Period|Not Reported|4|||
170476771|NCT04100018|616084509|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
170476772|NCT04100018|616084510|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
170476773|NCT04100018|616084509|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
170476774|NCT04100018|616084510|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
170476775|NCT04100018|616084509|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
170476776|NCT04100018|616084510|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
170476777|NCT04100018|616084509|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
170476778|NCT04100018|616084510|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
170476779|NCT04100018|616084509|FG000|Treatment Period|Ongoing Treatment|1|||
170476780|NCT04100018|616084510|FG001|Treatment Period|Ongoing Treatment|0|||
170546790|NCT00758043|616347477|FG003|Overall Study|Adverse Event|62|||
170546791|NCT00758043|616347474|FG000|Overall Study|Lack of Efficacy|0|||
170546792|NCT00758043|616347475|FG001|Overall Study|Lack of Efficacy|6|||
170546793|NCT00758043|616347476|FG002|Overall Study|Lack of Efficacy|18|||
170546794|NCT00758043|616347477|FG003|Overall Study|Lack of Efficacy|12|||
170546795|NCT00758043|616347474|FG000|Overall Study|Refused Further Treatment|0|||
170546796|NCT00758043|616347475|FG001|Overall Study|Refused Further Treatment|11|||
170546797|NCT00758043|616347476|FG002|Overall Study|Refused Further Treatment|5|||
170546798|NCT00758043|616347477|FG003|Overall Study|Refused Further Treatment|8|||
170546799|NCT00758043|616347474|FG000|Overall Study|Lost to Follow-up|0|||
170546800|NCT00758043|616347475|FG001|Overall Study|Lost to Follow-up|2|||
170546801|NCT00758043|616347476|FG002|Overall Study|Lost to Follow-up|2|||
170546802|NCT00758043|616347477|FG003|Overall Study|Lost to Follow-up|5|||
170546803|NCT00758043|616347474|FG000|Overall Study|Withdrawal by Subject|0|||
170546804|NCT00758043|616347475|FG001|Overall Study|Withdrawal by Subject|1|||
170546805|NCT00758043|616347476|FG002|Overall Study|Withdrawal by Subject|1|||
170546806|NCT00758043|616347477|FG003|Overall Study|Withdrawal by Subject|4|||
170546807|NCT00758043|616347474|FG000|Overall Study|Required Prohibited Medication|0|||
170546808|NCT00758043|616347475|FG001|Overall Study|Required Prohibited Medication|0|||
170546809|NCT00758043|616347476|FG002|Overall Study|Required Prohibited Medication|1|||
170546810|NCT00758043|616347477|FG003|Overall Study|Required Prohibited Medication|3|||
170546811|NCT00758043|616347474|FG000|Overall Study|Non-Compliant With study Drug|0|||
170546812|NCT00758043|616347475|FG001|Overall Study|Non-Compliant With study Drug|0|||
170546813|NCT00758043|616347476|FG002|Overall Study|Non-Compliant With study Drug|0|||
170546814|NCT00758043|616347477|FG003|Overall Study|Non-Compliant With study Drug|1|||
170546815|NCT00758043|616347474|FG000|Overall Study|Other Reasons|0|||
170546816|NCT00758043|616347475|FG001|Overall Study|Other Reasons|1|||
170546817|NCT00758043|616347476|FG002|Overall Study|Other Reasons|0|||
170546818|NCT00758043|616347477|FG003|Overall Study|Other Reasons|5|||
170546819|NCT03422718|616347481|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
170546820|NCT03422718|616347482|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
170546821|NCT03422718|616347483|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
170546822|NCT03422718|616347484|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
170546823|NCT03422718|616347485|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
170639139|NCT01139008|616691202|FG000|Overall Study|Non-compliant, lost product|1|||
170639140|NCT00813943|616691208|FG000|Overall Study|Ongoing at cut-off date|5|||
170546824|NCT03422718|616347486|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
170639141|NCT00813943|616691209|FG001|Overall Study|Ongoing at cut-off date|5|||
170639142|NCT00813943|616691210|FG002|Overall Study|Ongoing at cut-off date|3|||
170546825|NCT03422718|616347487|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
170546826|NCT03422718|616347488|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
170639143|NCT04896086|616691211|FG000|Overall Study|Lost to Follow-up|0|||
170476781|NCT04100018|616084509|FG000|Treatment Period|Other Reason|26|||
170476782|NCT04100018|616084510|FG001|Treatment Period|Other Reason|37|||
170476783|NCT04100018|616084509|FG000|Treatment Period|Completed treatment as per protocol|1|||
170546827|NCT03422718|616347481|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
170546828|NCT03422718|616347482|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
170546829|NCT03422718|616347483|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
170546830|NCT03422718|616347484|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
170546831|NCT03422718|616347485|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
170476784|NCT04100018|616084510|FG001|Treatment Period|Completed treatment as per protocol|2|||
170476785|NCT04100018|616084509|FG000|Treatment Period|Maximum clinical benefit|3|||
170476786|NCT04100018|616084510|FG001|Treatment Period|Maximum clinical benefit|0|||
170476787|NCT04100018|616084509|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
170476788|NCT04100018|616084510|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
170476789|NCT04100018|616084509|FG000|Treatment Period|Study drug toxicity|67|||
170476790|NCT04100018|616084510|FG001|Treatment Period|Study drug toxicity|28|||
170476791|NCT04100018|616084509|FG000|Treatment Period|Disease Progression|284|||
170476792|NCT04100018|616084510|FG001|Treatment Period|Disease Progression|327|||
170476793|NCT04100018|616084509|FG000|Treatment Period|Administrative reasons by sponsor|16|||
170476794|NCT04100018|616084510|FG001|Treatment Period|Administrative reasons by sponsor|30|||
170476795|NCT04100018|616084509|FG000|Treatment Period|Poor/Non-Compliance|1|||
170476796|NCT04100018|616084510|FG001|Treatment Period|Poor/Non-Compliance|0|||
170476797|NCT04100018|616084509|FG000|Treatment Period|Lost to Follow-up|2|||
170476798|NCT04100018|616084510|FG001|Treatment Period|Lost to Follow-up|2|||
170546832|NCT03422718|616347486|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
170546833|NCT03422718|616347487|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
170546834|NCT03422718|616347488|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
170546835|NCT03422718|616347481|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
170546836|NCT03422718|616347482|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
170546837|NCT03422718|616347483|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
170546838|NCT03422718|616347484|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
170546839|NCT03422718|616347485|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
170546840|NCT03422718|616347486|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
170546841|NCT03422718|616347487|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
170546842|NCT03422718|616347488|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
170546843|NCT03422718|616347481|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
170546844|NCT03422718|616347482|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
170546845|NCT03422718|616347483|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
170546846|NCT03422718|616347484|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
170546847|NCT03422718|616347485|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
170546848|NCT03422718|616347486|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
170546849|NCT03422718|616347487|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
170546850|NCT03422718|616347488|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
170546851|NCT03422718|616347481|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
170546852|NCT03422718|616347482|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
170546853|NCT03422718|616347483|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
170546854|NCT03422718|616347484|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
170546855|NCT03422718|616347485|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
170546856|NCT03422718|616347486|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
170546857|NCT03422718|616347487|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
170546858|NCT03422718|616347488|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
170546859|NCT03422718|616347481|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
170546860|NCT03422718|616347482|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
170546861|NCT03422718|616347483|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
170546862|NCT03422718|616347484|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
170546863|NCT03422718|616347485|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
170546864|NCT03422718|616347486|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
170546865|NCT03422718|616347487|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
170546866|NCT03422718|616347488|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
170546867|NCT00864513|616347492|FG000|Overall Study|Withdrawal by Subject|3|||
170546868|NCT00762788|616347493|FG000|Overall Study|Lost to Follow-up|26|||
170546869|NCT00762788|616347494|FG001|Overall Study|Lost to Follow-up|37|||
170546870|NCT00762788|616347495|FG002|Overall Study|Lost to Follow-up|21|||
170546871|NCT00762788|616347496|FG003|Overall Study|Lost to Follow-up|26|||
170546872|NCT00762788|616347497|FG004|Overall Study|Lost to Follow-up|13|||
170546873|NCT00762788|616347498|FG005|Overall Study|Lost to Follow-up|21|||
170546874|NCT03073109|616347499|FG000|Overall Study|Adverse Event|0|||
170546875|NCT03073109|616347500|FG001|Overall Study|Adverse Event|1|||
170546876|NCT03073109|616347499|FG000|Overall Study|Other|2|||
170476799|NCT04100018|616084509|FG000|Treatment Period|Death|16|||
170476800|NCT04100018|616084510|FG001|Treatment Period|Death|11|||
170476801|NCT04100018|616084509|FG000|Treatment Period|Participant withdrew consent|10|||
170476802|NCT04100018|616084510|FG001|Treatment Period|Participant withdrew consent|10|||
170476803|NCT04100018|616084509|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
170476804|NCT04100018|616084510|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
170546877|NCT03073109|616347500|FG001|Overall Study|Other|0|||
170546878|NCT03073109|616347499|FG000|Overall Study|Lost to Follow-up|8|||
170546879|NCT03073109|616347500|FG001|Overall Study|Lost to Follow-up|1|||
170476805|NCT04100018|616084509|FG000|Treatment Period|Adverse Event|14|||
170476806|NCT04100018|616084510|FG001|Treatment Period|Adverse Event|6|||
170476807|NCT04100018|616084509|FG000|Treatment Period|Lack of Efficacy|4|||
170476808|NCT04100018|616084510|FG001|Treatment Period|Lack of Efficacy|2|||
170476809|NCT00696423|616084511|FG000|Overall Study|Lost to Follow-up|0|||
170476810|NCT00696423|616084512|FG001|Overall Study|Lost to Follow-up|5|||
170476811|NCT02760004|616084515|FG000|Overall Study|Lost to Follow-up|13|||
170476812|NCT02760004|616084516|FG001|Overall Study|Lost to Follow-up|22|||
170476813|NCT01050530|616084517|FG000|Overall Study|Adverse Event|6|||
170476814|NCT01050530|616084518|FG001|Overall Study|Adverse Event|3|||
170476815|NCT01050530|616084517|FG000|Overall Study|Lack of Efficacy|1|||
170476816|NCT01050530|616084518|FG001|Overall Study|Lack of Efficacy|4|||
170476817|NCT01050530|616084517|FG000|Overall Study|Withdrawal by Subject|0|||
170476818|NCT01050530|616084518|FG001|Overall Study|Withdrawal by Subject|3|||
170476819|NCT01050530|616084517|FG000|Overall Study|Protocol Violation|1|||
170476820|NCT01050530|616084518|FG001|Overall Study|Protocol Violation|0|||
170476821|NCT05767905|616084521|FG000|Overall Study|Adverse Event|0|||
170476822|NCT05767905|616084522|FG001|Overall Study|Adverse Event|0|||
170476823|NCT05767905|616084523|FG002|Overall Study|Adverse Event|1|||
170476824|NCT04542057|616084526|FG000|Overall Study|Death|3|||
170476825|NCT04542057|616084527|FG001|Overall Study|Death|1|||
170476826|NCT04542057|616084526|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
170476827|NCT04542057|616084527|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
170476828|NCT04542057|616084526|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
170476829|NCT04542057|616084527|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
170476830|NCT04542057|616084526|FG000|Overall Study|Adverse Event|15|||
170476831|NCT04542057|616084527|FG001|Overall Study|Adverse Event|6|||
170476832|NCT04542057|616084526|FG000|Overall Study|COVID-19 adverse event|6|||
170476833|NCT04542057|616084527|FG001|Overall Study|COVID-19 adverse event|4|||
170476834|NCT04542057|616084526|FG000|Overall Study|Lack of Efficacy|2|||
170476835|NCT04542057|616084527|FG001|Overall Study|Lack of Efficacy|5|||
170476836|NCT04542057|616084526|FG000|Overall Study|Study terminated by sponsor|1|||
170476837|NCT04542057|616084527|FG001|Overall Study|Study terminated by sponsor|0|||
170476838|NCT04542057|616084526|FG000|Overall Study|Investigator discretion|2|||
170476839|NCT04542057|616084527|FG001|Overall Study|Investigator discretion|1|||
170476840|NCT04542057|616084526|FG000|Overall Study|Withdrawal by Subject|52|||
170476841|NCT04542057|616084527|FG001|Overall Study|Withdrawal by Subject|30|||
170476842|NCT04542057|616084526|FG000|Overall Study|Lost to Follow-up|8|||
170476843|NCT04542057|616084527|FG001|Overall Study|Lost to Follow-up|11|||
170476844|NCT04542057|616084526|FG000|Overall Study|Other|2|||
170476845|NCT04542057|616084527|FG001|Overall Study|Other|2|||
170476846|NCT02324582|616084529|FG000|Overall Study|Screen Failures|0|||
170476847|NCT02324582|616084530|FG001|Overall Study|Screen Failures|5|||
170476848|NCT01841593|616084531|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
170476849|NCT01841593|616084532|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
170476850|NCT01841593|616084531|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
170476851|NCT01841593|616084532|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
170476852|NCT00065156|616084536|FG000|Overall Study|Adverse Event|37|||
170476853|NCT00065156|616084536|FG000|Overall Study|Lack of Efficacy|52|||
170476854|NCT00065156|616084536|FG000|Overall Study|Withdrawal by Subject|8|||
170476855|NCT00065156|616084536|FG000|Overall Study|Lost to Follow-up|1|||
170476856|NCT00065156|616084536|FG000|Overall Study|Death|11|||
170476857|NCT00065156|616084536|FG000|Overall Study|Study Closed by Sponsor|2|||
170476858|NCT00065156|616084536|FG000|Overall Study|Disease Progression|7|||
170476859|NCT00065156|616084536|FG000|Overall Study|Investigator Decision|2|||
170476860|NCT00065156|616084536|FG000|Overall Study|Non-Compliance|2|||
170476861|NCT00065156|616084536|FG000|Overall Study|Loss of Response|1|||
170476862|NCT00065156|616084536|FG000|Overall Study|Secondary Malign Disease|1|||
170792653|NCT04231149|617251779|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
170792654|NCT04231149|617251780|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
170792655|NCT04231149|617251781|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
170792656|NCT04231149|617251782|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
170792657|NCT04231149|617251783|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
170792658|NCT04979442|617251789|FG000|Overall Study|Death|43|||
170476863|NCT04583735|616084537|FG000|Double-masked Treatment Period|Adverse Event|0|||
170476864|NCT04583735|616084538|FG001|Double-masked Treatment Period|Adverse Event|1|||
170476865|NCT04583735|616084537|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
170476866|NCT04583735|616084538|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
170476867|NCT04583735|616084537|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
170476868|NCT04583735|616084538|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
170476869|NCT04583735|616084537|FG000|Open-label Treatment Period|Adverse Event|1|||
170476870|NCT04583735|616084538|FG001|Open-label Treatment Period|Adverse Event|1|||
170476871|NCT04583735|616084537|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
170476872|NCT04583735|616084538|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
170476873|NCT04583735|616084537|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
170476874|NCT04583735|616084538|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
170476875|NCT01176513|616084539|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
170476876|NCT03518008|616084540|FG000|Period 2, Second Week of Wear|Family emergency|0|||
170476877|NCT03518008|616084541|FG001|Period 2, Second Week of Wear|Family emergency|1|||
170476878|NCT01215136|616084542|FG000|Overall Study|Adverse Event|2|||
170476879|NCT01215136|616084543|FG001|Overall Study|Adverse Event|9|||
170476880|NCT01215136|616084542|FG000|Overall Study|Disease Progression|3|||
170476881|NCT01215136|616084543|FG001|Overall Study|Disease Progression|14|||
170476882|NCT01215136|616084542|FG000|Overall Study|Symptomatic Deterioration|1|||
170476883|NCT01215136|616084543|FG001|Overall Study|Symptomatic Deterioration|1|||
170476884|NCT01215136|616084542|FG000|Overall Study|Death|0|||
170476885|NCT01215136|616084543|FG001|Overall Study|Death|2|||
170476886|NCT01215136|616084542|FG000|Overall Study|Withdrawal by Subject|0|||
170639144|NCT04896086|616691212|FG001|Overall Study|Lost to Follow-up|2|||
170639145|NCT04896086|616691213|FG002|Overall Study|Lost to Follow-up|1|||
170639146|NCT04896086|616691214|FG003|Overall Study|Lost to Follow-up|0|||
170792659|NCT04979442|617251790|FG001|Overall Study|Death|30|||
170476887|NCT01215136|616084543|FG001|Overall Study|Withdrawal by Subject|1|||
170476888|NCT01125917|616084548|FG000|Overall Study|Adverse Event|43|||
170476889|NCT01125917|616084548|FG000|Overall Study|Lost to Follow-up|23|||
170476890|NCT01125917|616084548|FG000|Overall Study|Withdrawal by Subject|31|||
170476891|NCT01125917|616084548|FG000|Overall Study|Administrative|223|||
170476892|NCT01125917|616084548|FG000|Overall Study|Lack of Efficacy|19|||
170476893|NCT04421131|616084552|FG000|Overall Study|Lost to Follow-up|1|||
170476894|NCT04421131|616084552|FG000|Overall Study|Protocol Violation|2|||
170476895|NCT04421131|616084552|FG000|Overall Study|App crashed|5|||
170476896|NCT02501928|616084553|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
170476897|NCT02501928|616084554|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
170476898|NCT02501928|616084555|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
170476899|NCT02501928|616084556|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
170476900|NCT02501928|616084557|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
170476901|NCT02501928|616084558|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
170476902|NCT00838526|616084562|FG000|Overall Study|Adverse Event|3|||
170476903|NCT00838526|616084563|FG001|Overall Study|Adverse Event|12|||
170476904|NCT00838526|616084562|FG000|Overall Study|Lost to Follow-up|4|||
170476905|NCT00838526|616084563|FG001|Overall Study|Lost to Follow-up|12|||
170476906|NCT00838526|616084562|FG000|Overall Study|Withdrawal by Subject|4|||
170476907|NCT00838526|616084563|FG001|Overall Study|Withdrawal by Subject|5|||
170476908|NCT00838526|616084562|FG000|Overall Study|Lack of Efficacy|2|||
170476909|NCT00838526|616084563|FG001|Overall Study|Lack of Efficacy|3|||
170476910|NCT00838526|616084562|FG000|Overall Study|Other|11|||
170476911|NCT00838526|616084563|FG001|Overall Study|Other|7|||
170476912|NCT01526057|616084564|FG000|Overall Study|Withdrawal by Subject|3|||
170476913|NCT01526057|616084565|FG001|Overall Study|Withdrawal by Subject|2|||
170476914|NCT01526057|616084566|FG002|Overall Study|Withdrawal by Subject|2|||
170476915|NCT01526057|616084564|FG000|Overall Study|Adverse Event|3|||
170476916|NCT01526057|616084565|FG001|Overall Study|Adverse Event|1|||
170476917|NCT01526057|616084566|FG002|Overall Study|Adverse Event|1|||
170476918|NCT01526057|616084564|FG000|Overall Study|Death|1|||
170476919|NCT01526057|616084565|FG001|Overall Study|Death|0|||
170476920|NCT01526057|616084566|FG002|Overall Study|Death|0|||
170476921|NCT01526057|616084564|FG000|Overall Study|Lost to Follow-up|1|||
170476922|NCT01526057|616084565|FG001|Overall Study|Lost to Follow-up|0|||
170476923|NCT01526057|616084566|FG002|Overall Study|Lost to Follow-up|1|||
170476924|NCT01526057|616084564|FG000|Overall Study|Other|1|||
170476925|NCT01526057|616084565|FG001|Overall Study|Other|0|||
170476926|NCT01526057|616084566|FG002|Overall Study|Other|1|||
170476927|NCT01526057|616084564|FG000|Overall Study|Protocol Violation|0|||
170476928|NCT01526057|616084565|FG001|Overall Study|Protocol Violation|0|||
170476929|NCT01526057|616084566|FG002|Overall Study|Protocol Violation|1|||
170476930|NCT00610129|616084577|FG000|Overall Study|Not treated since patients ineligible|3|||
170792660|NCT04979442|617251789|FG000|Overall Study|Withdrawal by Subject|8|||
170476931|NCT02273388|616084579|FG000|Overall Study|Adverse Event|0|||
170639147|NCT04896086|616691215|FG004|Overall Study|Lost to Follow-up|0|||
170792661|NCT04979442|617251790|FG001|Overall Study|Withdrawal by Subject|13|||
170792662|NCT04979442|617251789|FG000|Overall Study|Physician Decision|1|||
170476932|NCT02273388|616084580|FG001|Overall Study|Adverse Event|0|||
170476933|NCT02273388|616084581|FG002|Overall Study|Adverse Event|0|||
170476934|NCT02273388|616084582|FG003|Overall Study|Adverse Event|0|||
170476935|NCT02273388|616084583|FG004|Overall Study|Adverse Event|0|||
170476936|NCT02273388|616084584|FG005|Overall Study|Adverse Event|0|||
170476937|NCT02273388|616084585|FG006|Overall Study|Adverse Event|1|||
170476938|NCT02273388|616084586|FG007|Overall Study|Adverse Event|2|||
170476939|NCT02273388|616084587|FG008|Overall Study|Adverse Event|0|||
170476940|NCT02273388|616084588|FG009|Overall Study|Adverse Event|0|||
170476941|NCT02273388|616084589|FG010|Overall Study|Adverse Event|0|||
170476942|NCT02273388|616084590|FG011|Overall Study|Adverse Event|0|||
170476943|NCT02273388|616084579|FG000|Overall Study|Adverse Event study disease worse|4|||
170476944|NCT02273388|616084580|FG001|Overall Study|Adverse Event study disease worse|3|||
170476945|NCT02273388|616084581|FG002|Overall Study|Adverse Event study disease worse|3|||
170476946|NCT02273388|616084582|FG003|Overall Study|Adverse Event study disease worse|2|||
170476947|NCT02273388|616084583|FG004|Overall Study|Adverse Event study disease worse|4|||
170476948|NCT02273388|616084584|FG005|Overall Study|Adverse Event study disease worse|3|||
170476949|NCT02273388|616084585|FG006|Overall Study|Adverse Event study disease worse|14|||
170476950|NCT02273388|616084586|FG007|Overall Study|Adverse Event study disease worse|6|||
170476951|NCT02273388|616084587|FG008|Overall Study|Adverse Event study disease worse|6|||
170639148|NCT04896086|616691211|FG000|Overall Study|Physician Decision|0|||
170639149|NCT04896086|616691212|FG001|Overall Study|Physician Decision|1|||
170639150|NCT04896086|616691213|FG002|Overall Study|Physician Decision|0|||
170639151|NCT04896086|616691214|FG003|Overall Study|Physician Decision|0|||
170639152|NCT04896086|616691215|FG004|Overall Study|Physician Decision|0|||
170639153|NCT04896086|616691211|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
170639154|NCT04896086|616691212|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
170639155|NCT04896086|616691213|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
170639156|NCT04896086|616691214|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
170639157|NCT04896086|616691215|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
170639158|NCT04896086|616691211|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
170476952|NCT02273388|616084588|FG009|Overall Study|Adverse Event study disease worse|5|||
170476953|NCT02273388|616084589|FG010|Overall Study|Adverse Event study disease worse|10|||
170476954|NCT02273388|616084590|FG011|Overall Study|Adverse Event study disease worse|1|||
170476955|NCT02273388|616084579|FG000|Overall Study|Sponsor decision|0|||
170476956|NCT02273388|616084580|FG001|Overall Study|Sponsor decision|0|||
170476957|NCT02273388|616084581|FG002|Overall Study|Sponsor decision|0|||
170476958|NCT02273388|616084582|FG003|Overall Study|Sponsor decision|0|||
170476959|NCT02273388|616084583|FG004|Overall Study|Sponsor decision|0|||
170476960|NCT02273388|616084584|FG005|Overall Study|Sponsor decision|0|||
170476961|NCT02273388|616084585|FG006|Overall Study|Sponsor decision|0|||
170476962|NCT02273388|616084586|FG007|Overall Study|Sponsor decision|0|||
170476963|NCT02273388|616084587|FG008|Overall Study|Sponsor decision|0|||
170476964|NCT02273388|616084588|FG009|Overall Study|Sponsor decision|0|||
170476965|NCT02273388|616084589|FG010|Overall Study|Sponsor decision|0|||
170476966|NCT02273388|616084590|FG011|Overall Study|Sponsor decision|1|||
170476967|NCT04331808|616084591|FG000|Overall Study|Withdrew consent|1|||
170476968|NCT04331808|616084592|FG001|Overall Study|Withdrew consent|0|||
170476969|NCT04331808|616084593|FG002|Overall Study|Withdrew consent|2|||
170476970|NCT04331808|616084594|FG003|Overall Study|Withdrew consent|3|||
170476971|NCT01590277|616084599|FG000|Overall Study|Withdrawal by Subject|3|||
170476972|NCT01590277|616084599|FG000|Overall Study|Withdrawal by Subject|2|||
170476973|NCT01590277|616084599|FG000|Overall Study|Withdrawal by Subject|1|||
170476974|NCT01590277|616084599|FG000|Overall Study|Withdrawal by Subject|1|||
170476975|NCT04233073|616084604|FG000|Overall Study|Death|5|||
170476976|NCT03172494|616084605|FG000|Overall Study|Adverse Event|5|||
170476977|NCT03172494|616084606|FG001|Overall Study|Adverse Event|1|||
170476978|NCT03172494|616084607|FG002|Overall Study|Adverse Event|15|||
170476979|NCT03172494|616084605|FG000|Overall Study|Protocol Violation|3|||
170476980|NCT03172494|616084606|FG001|Overall Study|Protocol Violation|2|||
170476981|NCT03172494|616084607|FG002|Overall Study|Protocol Violation|1|||
170476982|NCT03172494|616084605|FG000|Overall Study|Lack of Efficacy|0|||
170476983|NCT03172494|616084606|FG001|Overall Study|Lack of Efficacy|0|||
170476984|NCT03172494|616084607|FG002|Overall Study|Lack of Efficacy|4|||
170476985|NCT03172494|616084605|FG000|Overall Study|Pregnancy|0|||
170476986|NCT03172494|616084606|FG001|Overall Study|Pregnancy|1|||
170476987|NCT03172494|616084607|FG002|Overall Study|Pregnancy|0|||
170476988|NCT03172494|616084605|FG000|Overall Study|Withdrawal by Subject|10|||
170476989|NCT03172494|616084606|FG001|Overall Study|Withdrawal by Subject|8|||
170476990|NCT03172494|616084607|FG002|Overall Study|Withdrawal by Subject|8|||
170476991|NCT03172494|616084605|FG000|Overall Study|Severe hypoglycaemic episode|0|||
170476992|NCT03172494|616084606|FG001|Overall Study|Severe hypoglycaemic episode|0|||
170476993|NCT03172494|616084607|FG002|Overall Study|Severe hypoglycaemic episode|1|||
170476994|NCT03172494|616084605|FG000|Overall Study|Non-compliance towards treatment|2|||
170476995|NCT03172494|616084606|FG001|Overall Study|Non-compliance towards treatment|0|||
170476996|NCT03172494|616084607|FG002|Overall Study|Non-compliance towards treatment|0|||
170476997|NCT01450683|616084611|FG000|Overall Study|Adverse Event|2|||
170476998|NCT00625872|616084612|FG000|Overall Study|Withdrawal by Subject|1|||
170476999|NCT00625872|616084613|FG001|Overall Study|Withdrawal by Subject|0|||
170477000|NCT00625872|616084612|FG000|Overall Study|Does not meet inclusion criteria|1|||
170477001|NCT00625872|616084613|FG001|Overall Study|Does not meet inclusion criteria|0|||
170477002|NCT00625872|616084612|FG000|Overall Study|Terminated by sponsor|2|||
170477003|NCT00625872|616084613|FG001|Overall Study|Terminated by sponsor|5|||
170477004|NCT00625872|616084612|FG000|Overall Study|Randomized but not treated|0|||
170477005|NCT00625872|616084613|FG001|Overall Study|Randomized but not treated|1|||
170477006|NCT05101343|616084614|FG000|Overall Study|Withdrawal by Subject|2|||
170477007|NCT05101343|616084615|FG001|Overall Study|Withdrawal by Subject|1|||
170477008|NCT04917861|616084616|FG000|Main Study (196 Days)|Adverse Event|0|||
170477009|NCT04917861|616084617|FG001|Main Study (196 Days)|Adverse Event|1|||
170477010|NCT04917861|616084618|FG002|Main Study (196 Days)|Adverse Event|0|||
170477011|NCT04917861|616084619|FG003|Main Study (196 Days)|Adverse Event|0|||
170477012|NCT04917861|616084616|FG000|Main Study (196 Days)|Death|0|||
170477013|NCT04917861|616084617|FG001|Main Study (196 Days)|Death|0|||
170477014|NCT04917861|616084618|FG002|Main Study (196 Days)|Death|0|||
170477015|NCT04917861|616084619|FG003|Main Study (196 Days)|Death|1|||
170477016|NCT04917861|616084616|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
170477017|NCT04917861|616084617|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
170477018|NCT04917861|616084618|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
170477019|NCT04917861|616084619|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
170477020|NCT04917861|616084616|FG000|Main Study (196 Days)|Physician Decision|0|||
170477021|NCT04917861|616084617|FG001|Main Study (196 Days)|Physician Decision|0|||
170477022|NCT04917861|616084618|FG002|Main Study (196 Days)|Physician Decision|0|||
170477023|NCT04917861|616084619|FG003|Main Study (196 Days)|Physician Decision|1|||
170477024|NCT04917861|616084616|FG000|Main Study (196 Days)|Pregnancy|1|||
170477025|NCT04917861|616084617|FG001|Main Study (196 Days)|Pregnancy|1|||
170477026|NCT04917861|616084618|FG002|Main Study (196 Days)|Pregnancy|0|||
170477027|NCT04917861|616084619|FG003|Main Study (196 Days)|Pregnancy|0|||
170477028|NCT04917861|616084616|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
170477029|NCT04917861|616084617|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
170477030|NCT04917861|616084618|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
170477031|NCT04917861|616084619|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
170477032|NCT04917861|616084616|FG000|Main Study (196 Days)|Other Than Specified|1|||
170477033|NCT04917861|616084617|FG001|Main Study (196 Days)|Other Than Specified|0|||
170477034|NCT04917861|616084618|FG002|Main Study (196 Days)|Other Than Specified|1|||
170477035|NCT04917861|616084619|FG003|Main Study (196 Days)|Other Than Specified|2|||
170477036|NCT04917861|616084616|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
170477037|NCT04917861|616084617|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
170477038|NCT04917861|616084618|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
170477039|NCT04917861|616084619|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
170477040|NCT04917861|616084616|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
170477041|NCT04917861|616084617|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
170477042|NCT04917861|616084618|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
170477043|NCT04917861|616084619|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
170477044|NCT04917861|616084616|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
170477045|NCT04917861|616084617|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
170477046|NCT04917861|616084618|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
170477047|NCT04917861|616084619|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
170477048|NCT04917861|616084616|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
170477049|NCT04917861|616084617|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
170477050|NCT04917861|616084618|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
170477051|NCT04917861|616084619|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
170477052|NCT04917861|616084616|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
170477053|NCT04917861|616084617|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
170477054|NCT04917861|616084618|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
170477055|NCT04917861|616084619|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
170477056|NCT04917861|616084616|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
170477057|NCT04917861|616084617|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
170477058|NCT04917861|616084618|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
170477059|NCT04917861|616084619|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
170477060|NCT01128179|616084620|FG000|Overall Study|Death|1|||
170477061|NCT01128179|616084621|FG001|Overall Study|Death|0|||
170477062|NCT01128179|616084620|FG000|Overall Study|Protocol Violation|1|||
170546880|NCT01783015|616347503|FG000|Blinded Treatment|Adverse Event|0|||
170546881|NCT01783015|616347504|FG001|Blinded Treatment|Adverse Event|1|||
170546882|NCT01783015|616347505|FG002|Blinded Treatment|Adverse Event|0|||
170477063|NCT01128179|616084621|FG001|Overall Study|Protocol Violation|0|||
170477064|NCT01682811|616084622|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
170477065|NCT01682811|616084623|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
170477066|NCT01682811|616084624|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
170477067|NCT01682811|616084625|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
170477068|NCT01682811|616084626|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
170477069|NCT01682811|616084627|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
170477070|NCT01682811|616084628|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
170477071|NCT01682811|616084622|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
170477072|NCT01682811|616084623|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
170477073|NCT01682811|616084624|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
170477074|NCT01682811|616084625|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
170477075|NCT01682811|616084626|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
170477076|NCT01682811|616084627|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
170477077|NCT01682811|616084628|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
170477078|NCT01682811|616084622|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
170792663|NCT04979442|617251790|FG001|Overall Study|Physician Decision|1|||
170477079|NCT01682811|616084623|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
170477080|NCT01682811|616084624|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
170477081|NCT01682811|616084625|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
170477082|NCT01682811|616084626|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
170477083|NCT01682811|616084627|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
170477084|NCT01682811|616084628|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
170477085|NCT01682811|616084622|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
170477086|NCT01682811|616084623|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
170477087|NCT01682811|616084624|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
170477088|NCT01682811|616084625|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
170477089|NCT01682811|616084626|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
170477090|NCT01682811|616084627|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
170477091|NCT01682811|616084628|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
170477092|NCT01260701|616084633|FG000|Overall Study|Adverse Event|9|||
170477093|NCT01260701|616084633|FG000|Overall Study|Withdrawal by Subject|2|||
170477094|NCT01260701|616084633|FG000|Overall Study|Progression|53|||
170477095|NCT01260701|616084633|FG000|Overall Study|Death|2|||
170477096|NCT01260701|616084633|FG000|Overall Study|Not protocol specified|3|||
170477097|NCT01260701|616084633|FG000|Overall Study|Under review|1|||
170477098|NCT01260701|616084633|FG000|Overall Study|Ineligible|4|||
170477099|NCT01260701|616084633|FG000|Overall Study|Did not begin protocol therapy|1|||
170477100|NCT00720382|616084635|FG000|Overall Study|Adverse Event|54|||
170477101|NCT00720382|616084636|FG001|Overall Study|Adverse Event|17|||
170477102|NCT00720382|616084635|FG000|Overall Study|Lack of Efficacy|18|||
170477103|NCT00720382|616084636|FG001|Overall Study|Lack of Efficacy|7|||
170477104|NCT00720382|616084635|FG000|Overall Study|Non-Compliance|15|||
170477105|NCT00720382|616084636|FG001|Overall Study|Non-Compliance|5|||
170477106|NCT00720382|616084635|FG000|Overall Study|Withdrawal by Subject|47|||
170477107|NCT00720382|616084636|FG001|Overall Study|Withdrawal by Subject|11|||
170477108|NCT00720382|616084635|FG000|Overall Study|Lost to Follow-up|28|||
170477109|NCT00720382|616084636|FG001|Overall Study|Lost to Follow-up|14|||
170477110|NCT00720382|616084635|FG000|Overall Study|administrative|14|||
170477111|NCT00720382|616084636|FG001|Overall Study|administrative|5|||
170477112|NCT05192889|616084637|FG000|Block 1: All Eligible Patients|Death|2|||
170477113|NCT05192889|616084638|FG001|Block 1: All Eligible Patients|Death|0|||
170477114|NCT05192889|616084639|FG002|Block 1: All Eligible Patients|Death|0|||
170477115|NCT05192889|616084637|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
170477116|NCT05192889|616084638|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
170477117|NCT05192889|616084639|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
170477118|NCT05192889|616084637|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
170477119|NCT05192889|616084638|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
170477120|NCT05192889|616084639|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
170477121|NCT05655546|616085857|FG000|Overall Study|Withdrawal by Subject|2|||
170477122|NCT05655546|616085858|FG001|Overall Study|Withdrawal by Subject|4|||
170477123|NCT03493685|616085859|FG000|Overall Study|Death|4|||
170477124|NCT03493685|616085860|FG001|Overall Study|Death|3|||
170477125|NCT03493685|616085859|FG000|Overall Study|Lost to Follow-up|3|||
170477126|NCT03493685|616085860|FG001|Overall Study|Lost to Follow-up|2|||
170477127|NCT03493685|616085859|FG000|Overall Study|Physician Decision|2|||
170477128|NCT03493685|616085860|FG001|Overall Study|Physician Decision|0|||
170792664|NCT04979442|617251789|FG000|Overall Study|Lost to Follow-up|0|||
170477129|NCT03493685|616085859|FG000|Overall Study|Withdrawal by Subject|7|||
170477130|NCT03493685|616085860|FG001|Overall Study|Withdrawal by Subject|11|||
170477131|NCT00725283|616085861|FG000|Overall Study|Missing Code|3|||
170477132|NCT00725283|616085861|FG000|Overall Study|Death|5|||
170477133|NCT00725283|616085861|FG000|Overall Study|Other|6|||
170477134|NCT00725283|616085861|FG000|Overall Study|Withdrawal by Subject|10|||
170792665|NCT04979442|617251790|FG001|Overall Study|Lost to Follow-up|2|||
170477135|NCT03103087|616085862|FG000|Overall Study|Did not receive any study drug|1|||
170477136|NCT03103087|616085863|FG001|Overall Study|Did not receive any study drug|0|||
170477137|NCT03103087|616085864|FG002|Overall Study|Did not receive any study drug|0|||
170477138|NCT03103087|616085862|FG000|Overall Study|Protocol Violation|1|||
170477139|NCT03103087|616085863|FG001|Overall Study|Protocol Violation|2|||
170477140|NCT03103087|616085864|FG002|Overall Study|Protocol Violation|1|||
170477141|NCT03103087|616085862|FG000|Overall Study|Lack of Efficacy|2|||
170477142|NCT03103087|616085863|FG001|Overall Study|Lack of Efficacy|1|||
170477143|NCT03103087|616085864|FG002|Overall Study|Lack of Efficacy|1|||
170477144|NCT03103087|616085862|FG000|Overall Study|Pregnancy|0|||
170477145|NCT03103087|616085863|FG001|Overall Study|Pregnancy|0|||
170477146|NCT03103087|616085864|FG002|Overall Study|Pregnancy|1|||
170477147|NCT03103087|616085862|FG000|Overall Study|Adverse Event|2|||
170477148|NCT03103087|616085863|FG001|Overall Study|Adverse Event|15|||
170477149|NCT03103087|616085864|FG002|Overall Study|Adverse Event|6|||
170477150|NCT03103087|616085862|FG000|Overall Study|Withdrawal by Subject|13|||
170792666|NCT04979442|617251789|FG000|Overall Study|do not want to continue|0|||
170477151|NCT03103087|616085863|FG001|Overall Study|Withdrawal by Subject|6|||
170639159|NCT04896086|616691212|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
170639160|NCT04896086|616691213|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
170639161|NCT04896086|616691214|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
170639162|NCT04896086|616691215|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
170639163|NCT03583385|616691222|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170639164|NCT03583385|616691223|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170639165|NCT03583385|616691222|FG000|Treatment Period 2|Adverse Event|1|||
170639166|NCT03583385|616691223|FG001|Treatment Period 2|Adverse Event|0|||
170639167|NCT02934503|616691226|FG000|Overall Study|progression of disease|3|||
170639168|NCT02934503|616691226|FG000|Overall Study|Withdrawal by Subject|1|||
170639169|NCT00724867|616691227|FG000|Overall Study|Adverse Event|25|||
170639170|NCT00724867|616691227|FG000|Overall Study|Lack of Efficacy|14|||
170639171|NCT00724867|616691227|FG000|Overall Study|Lost to Follow-up|12|||
170639172|NCT00724867|616691227|FG000|Overall Study|Non-compliance with study drug|6|||
170639173|NCT00724867|616691227|FG000|Overall Study|Physician Decision|17|||
170639174|NCT00724867|616691227|FG000|Overall Study|Protocol Violation|1|||
170639175|NCT00724867|616691227|FG000|Overall Study|Withdrawal by Subject|31|||
170639176|NCT00724867|616691227|FG000|Overall Study|Sponsor decision to end study|14|||
170639177|NCT00724867|616691227|FG000|Overall Study|Subject incarcerated|1|||
170639178|NCT00724867|616691227|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
170639179|NCT00724867|616691227|FG000|Overall Study|Subject moved out of state|1|||
170639180|NCT00724867|616691227|FG000|Overall Study|Elected to exit due to site closure|2|||
170639181|NCT01864603|616691228|FG000|Stage 2|DSMB design modification|86056|||
170639182|NCT01864603|616691229|FG001|Stage 2|DSMB design modification|92558|||
170477152|NCT03103087|616085864|FG002|Overall Study|Withdrawal by Subject|6|||
170639183|NCT00485134|616691234|FG000|Overall Study|Lost to Follow-up|1|||
170639184|NCT00485134|616691235|FG001|Overall Study|Lost to Follow-up|0|||
170639185|NCT00485134|616691236|FG002|Overall Study|Lost to Follow-up|0|||
170639186|NCT00485134|616691237|FG003|Overall Study|Lost to Follow-up|0|||
170639187|NCT00485134|616691238|FG004|Overall Study|Lost to Follow-up|0|||
170639188|NCT00485134|616691239|FG005|Overall Study|Lost to Follow-up|0|||
170639189|NCT00485134|616691240|FG006|Overall Study|Lost to Follow-up|0|||
170639190|NCT00485134|616691241|FG007|Overall Study|Lost to Follow-up|0|||
170639191|NCT00485134|616691234|FG000|Overall Study|Withdrawal by Subject|0|||
170639192|NCT00485134|616691235|FG001|Overall Study|Withdrawal by Subject|1|||
170639193|NCT00485134|616691236|FG002|Overall Study|Withdrawal by Subject|0|||
170639194|NCT00485134|616691237|FG003|Overall Study|Withdrawal by Subject|0|||
170639195|NCT00485134|616691238|FG004|Overall Study|Withdrawal by Subject|0|||
170639196|NCT00485134|616691239|FG005|Overall Study|Withdrawal by Subject|0|||
170639197|NCT00485134|616691240|FG006|Overall Study|Withdrawal by Subject|0|||
170639198|NCT00485134|616691241|FG007|Overall Study|Withdrawal by Subject|0|||
170639199|NCT00485134|616691234|FG000|Overall Study|Change in health status|0|||
170639200|NCT00485134|616691235|FG001|Overall Study|Change in health status|1|||
170639201|NCT00485134|616691236|FG002|Overall Study|Change in health status|2|||
170639202|NCT00485134|616691237|FG003|Overall Study|Change in health status|1|||
170477153|NCT03103087|616085862|FG000|Overall Study|Lost to Follow-up|4|||
170477154|NCT03103087|616085863|FG001|Overall Study|Lost to Follow-up|2|||
170477155|NCT03103087|616085864|FG002|Overall Study|Lost to Follow-up|7|||
170477156|NCT03103087|616085862|FG000|Overall Study|Other reason not reported|1|||
170477157|NCT03103087|616085863|FG001|Overall Study|Other reason not reported|3|||
170477158|NCT03103087|616085864|FG002|Overall Study|Other reason not reported|5|||
170477159|NCT05989672|616085865|FG000|Overall Study|Adverse Event|3|||
170477160|NCT05989672|616085866|FG001|Overall Study|Adverse Event|0|||
170639203|NCT00485134|616691238|FG004|Overall Study|Change in health status|0|||
170639204|NCT00485134|616691239|FG005|Overall Study|Change in health status|1|||
170639205|NCT00485134|616691240|FG006|Overall Study|Change in health status|0|||
170639206|NCT00485134|616691241|FG007|Overall Study|Change in health status|0|||
170639207|NCT00485134|616691234|FG000|Overall Study|Withdrew for adverse event|0|||
170477161|NCT05989672|616085867|FG002|Overall Study|Adverse Event|0|||
170477162|NCT04123405|616085868|FG000|Overall Study|Adverse Event|1|||
170477163|NCT04123405|616085869|FG001|Overall Study|Adverse Event|2|||
170477164|NCT04123405|616085870|FG002|Overall Study|Adverse Event|3|||
170639208|NCT00485134|616691235|FG001|Overall Study|Withdrew for adverse event|0|||
170639209|NCT00485134|616691236|FG002|Overall Study|Withdrew for adverse event|1|||
170639210|NCT00485134|616691237|FG003|Overall Study|Withdrew for adverse event|0|||
170639211|NCT00485134|616691238|FG004|Overall Study|Withdrew for adverse event|0|||
170639212|NCT00485134|616691239|FG005|Overall Study|Withdrew for adverse event|0|||
170639213|NCT00485134|616691240|FG006|Overall Study|Withdrew for adverse event|0|||
170639214|NCT00485134|616691241|FG007|Overall Study|Withdrew for adverse event|0|||
170477165|NCT04123405|616085871|FG003|Overall Study|Adverse Event|3|||
170639215|NCT00485134|616691234|FG000|Overall Study|Positive drug test|0|||
170639216|NCT00485134|616691235|FG001|Overall Study|Positive drug test|0|||
170639217|NCT00485134|616691236|FG002|Overall Study|Positive drug test|0|||
170639218|NCT00485134|616691237|FG003|Overall Study|Positive drug test|0|||
170477166|NCT04123405|616085868|FG000|Overall Study|Exclusion criteria met|1|||
170477167|NCT04123405|616085869|FG001|Overall Study|Exclusion criteria met|2|||
170477168|NCT04123405|616085870|FG002|Overall Study|Exclusion criteria met|0|||
170477169|NCT04123405|616085871|FG003|Overall Study|Exclusion criteria met|2|||
170546883|NCT01783015|616347503|FG000|Blinded Treatment|Protocol Violation|0|||
170546884|NCT01783015|616347504|FG001|Blinded Treatment|Protocol Violation|1|||
170546885|NCT01783015|616347505|FG002|Blinded Treatment|Protocol Violation|0|||
170546886|NCT01783015|616347503|FG000|Blinded Treatment|Withdrawal by Subject|0|||
170546887|NCT01783015|616347504|FG001|Blinded Treatment|Withdrawal by Subject|1|||
170546888|NCT01783015|616347505|FG002|Blinded Treatment|Withdrawal by Subject|0|||
170546889|NCT01783015|616347503|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
170546890|NCT01783015|616347504|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
170546891|NCT01783015|616347505|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
170546892|NCT01783015|616347503|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
170546893|NCT01783015|616347504|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
170546894|NCT01783015|616347505|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
170546895|NCT01230814|616347506|FG000|Overall Study|Lost to Follow-up|11|||
170546896|NCT01230814|616347507|FG001|Overall Study|Lost to Follow-up|3|||
170546897|NCT01230814|616347506|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
170546898|NCT01230814|616347507|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
170639219|NCT00485134|616691238|FG004|Overall Study|Positive drug test|2|||
170639220|NCT00485134|616691239|FG005|Overall Study|Positive drug test|1|||
170639221|NCT00485134|616691240|FG006|Overall Study|Positive drug test|0|||
170639222|NCT00485134|616691241|FG007|Overall Study|Positive drug test|0|||
170639223|NCT00485134|616691234|FG000|Overall Study|Non-compliance|0|||
170639224|NCT00485134|616691235|FG001|Overall Study|Non-compliance|0|||
170639225|NCT00485134|616691236|FG002|Overall Study|Non-compliance|0|||
170639226|NCT00485134|616691237|FG003|Overall Study|Non-compliance|0|||
170639227|NCT00485134|616691238|FG004|Overall Study|Non-compliance|1|||
170639228|NCT00485134|616691239|FG005|Overall Study|Non-compliance|2|||
170639229|NCT00485134|616691240|FG006|Overall Study|Non-compliance|2|||
170639230|NCT00485134|616691241|FG007|Overall Study|Non-compliance|0|||
170639231|NCT00485134|616691234|FG000|Overall Study|Unable to comply with study schedule|0|||
170892153|NCT01700192|617611936|FG001|Overall Study|Never received study drug|0|||
170892154|NCT00744874|617611938|FG000|Overall Study|Lost to Follow-up|1|||
170639232|NCT00485134|616691235|FG001|Overall Study|Unable to comply with study schedule|0|||
170639233|NCT00485134|616691236|FG002|Overall Study|Unable to comply with study schedule|0|||
170639234|NCT00485134|616691237|FG003|Overall Study|Unable to comply with study schedule|0|||
170892155|NCT00744874|617611938|FG000|Overall Study|Withdrawal by Subject|1|||
170892156|NCT00744874|617611938|FG000|Overall Study|Study Device not available at procedure|1|||
170477170|NCT04123405|616085868|FG000|Overall Study|Withdrawal by Subject|1|||
170477171|NCT04123405|616085869|FG001|Overall Study|Withdrawal by Subject|3|||
170477172|NCT04123405|616085870|FG002|Overall Study|Withdrawal by Subject|0|||
170477173|NCT04123405|616085871|FG003|Overall Study|Withdrawal by Subject|2|||
170477174|NCT04123405|616085868|FG000|Overall Study|Contact to subject lost|0|||
170477175|NCT04123405|616085869|FG001|Overall Study|Contact to subject lost|0|||
170477176|NCT04123405|616085870|FG002|Overall Study|Contact to subject lost|0|||
170477177|NCT04123405|616085871|FG003|Overall Study|Contact to subject lost|1|||
170477178|NCT04123405|616085868|FG000|Overall Study|screening failure|1|||
170477179|NCT04123405|616085869|FG001|Overall Study|screening failure|0|||
170477180|NCT04123405|616085870|FG002|Overall Study|screening failure|0|||
170477181|NCT04123405|616085871|FG003|Overall Study|screening failure|0|||
170477182|NCT03889886|616085872|FG000|Overall Study|Other|0|||
170477183|NCT03889886|616085873|FG001|Overall Study|Other|1|||
170477184|NCT03889886|616085874|FG002|Overall Study|Other|0|||
170477185|NCT03889886|616085875|FG003|Overall Study|Other|1|||
170477186|NCT03889886|616085872|FG000|Overall Study|Withdrawal by Subject|0|||
170477187|NCT03889886|616085873|FG001|Overall Study|Withdrawal by Subject|0|||
170477188|NCT03889886|616085874|FG002|Overall Study|Withdrawal by Subject|1|||
170477189|NCT03889886|616085875|FG003|Overall Study|Withdrawal by Subject|0|||
170546899|NCT01297244|616347510|FG000|Overall Study|Progressive disease|22|||
170546900|NCT01297244|616347511|FG001|Overall Study|Progressive disease|3|||
170546901|NCT01297244|616347510|FG000|Overall Study|Adverse Event|9|||
170639235|NCT00485134|616691238|FG004|Overall Study|Unable to comply with study schedule|0|||
170477190|NCT03889886|616085872|FG000|Overall Study|Adverse Event|0|||
170477191|NCT03889886|616085873|FG001|Overall Study|Adverse Event|0|||
170477192|NCT03889886|616085874|FG002|Overall Study|Adverse Event|0|||
170477193|NCT03889886|616085875|FG003|Overall Study|Adverse Event|6|||
170546902|NCT01297244|616347511|FG001|Overall Study|Adverse Event|1|||
170639236|NCT00485134|616691239|FG005|Overall Study|Unable to comply with study schedule|0|||
170639237|NCT00485134|616691240|FG006|Overall Study|Unable to comply with study schedule|0|||
170639238|NCT00485134|616691241|FG007|Overall Study|Unable to comply with study schedule|1|||
170639239|NCT00485134|616691234|FG000|Overall Study|Pregnancy|0|||
170892157|NCT00744874|617611938|FG000|Overall Study|Unable to accomodate schedule|1|||
170477194|NCT01626690|616085883|FG000|Overall Study|Protocol Violation|1|||
170477195|NCT01626690|616085884|FG001|Overall Study|Protocol Violation|0|||
170546903|NCT01297244|616347510|FG000|Overall Study|Death|1|||
170546904|NCT01297244|616347511|FG001|Overall Study|Death|1|||
170639240|NCT00485134|616691235|FG001|Overall Study|Pregnancy|0|||
170892158|NCT03175549|617611939|FG000|Overall Study|Lost to Follow-up|2|||
170892159|NCT03175549|617611940|FG001|Overall Study|Lost to Follow-up|2|||
170892160|NCT03175549|617611939|FG000|Overall Study|Medication non-compliance|2|||
170892161|NCT03175549|617611940|FG001|Overall Study|Medication non-compliance|2|||
170892162|NCT01656434|617611941|FG000|Overall Study|Adverse Event|199|||
170892163|NCT01656434|617611942|FG001|Overall Study|Adverse Event|63|||
170477196|NCT01626690|616085883|FG000|Overall Study|Adverse Event|1|||
170477197|NCT01626690|616085884|FG001|Overall Study|Adverse Event|0|||
170639241|NCT00485134|616691236|FG002|Overall Study|Pregnancy|0|||
170639242|NCT00485134|616691237|FG003|Overall Study|Pregnancy|0|||
170639243|NCT00485134|616691238|FG004|Overall Study|Pregnancy|0|||
170639244|NCT00485134|616691239|FG005|Overall Study|Pregnancy|0|||
170639245|NCT00485134|616691240|FG006|Overall Study|Pregnancy|1|||
170639246|NCT00485134|616691241|FG007|Overall Study|Pregnancy|0|||
170639247|NCT03539549|616691242|FG000|Overall Study|Adverse Event|12|||
170639248|NCT03539549|616691242|FG000|Overall Study|Lost to Follow-up|1|||
170639249|NCT03539549|616691242|FG000|Overall Study|Death|2|||
170639250|NCT03539549|616691242|FG000|Overall Study|Progressive Disease|1|||
170639251|NCT03539549|616691242|FG000|Overall Study|Reason not Specified|1|||
170639252|NCT00436345|616691243|FG000|Overall Study|ICU resident beyond follow-up period|3|||
170639253|NCT00436345|616691244|FG001|Overall Study|ICU resident beyond follow-up period|0|||
170639254|NCT00481091|616691245|FG000|Overall Study|Withdrawal by Subject|0|||
170639255|NCT00481091|616691246|FG001|Overall Study|Withdrawal by Subject|1|||
170639256|NCT00481091|616691247|FG002|Overall Study|Withdrawal by Subject|1|||
170639257|NCT00481091|616691248|FG003|Overall Study|Withdrawal by Subject|0|||
170639258|NCT00481091|616691249|FG004|Overall Study|Withdrawal by Subject|0|||
170639259|NCT00481091|616691250|FG005|Overall Study|Withdrawal by Subject|0|||
170639260|NCT00481091|616691251|FG006|Overall Study|Withdrawal by Subject|0|||
170639261|NCT00481091|616691252|FG007|Overall Study|Withdrawal by Subject|0|||
170639262|NCT00481091|616691253|FG008|Overall Study|Withdrawal by Subject|1|||
170639263|NCT00481091|616691254|FG009|Overall Study|Withdrawal by Subject|6|||
170639264|NCT00481091|616691245|FG000|Overall Study|Other, Not Specified|0|||
170639265|NCT00481091|616691246|FG001|Overall Study|Other, Not Specified|1|||
170639266|NCT00481091|616691247|FG002|Overall Study|Other, Not Specified|1|||
170639267|NCT00481091|616691248|FG003|Overall Study|Other, Not Specified|0|||
170639268|NCT00481091|616691249|FG004|Overall Study|Other, Not Specified|0|||
170639269|NCT00481091|616691250|FG005|Overall Study|Other, Not Specified|1|||
170639270|NCT00481091|616691251|FG006|Overall Study|Other, Not Specified|0|||
170639271|NCT00481091|616691252|FG007|Overall Study|Other, Not Specified|0|||
170639272|NCT00481091|616691253|FG008|Overall Study|Other, Not Specified|0|||
170639273|NCT00481091|616691254|FG009|Overall Study|Other, Not Specified|4|||
170639274|NCT00481091|616691245|FG000|Overall Study|Adverse Event|1|||
170639275|NCT00481091|616691246|FG001|Overall Study|Adverse Event|2|||
170639276|NCT00481091|616691247|FG002|Overall Study|Adverse Event|0|||
170639277|NCT00481091|616691248|FG003|Overall Study|Adverse Event|1|||
170639278|NCT00481091|616691249|FG004|Overall Study|Adverse Event|1|||
170639279|NCT00481091|616691250|FG005|Overall Study|Adverse Event|1|||
170639280|NCT00481091|616691251|FG006|Overall Study|Adverse Event|2|||
170639281|NCT00481091|616691252|FG007|Overall Study|Adverse Event|1|||
170639282|NCT00481091|616691253|FG008|Overall Study|Adverse Event|1|||
170639283|NCT00481091|616691254|FG009|Overall Study|Adverse Event|6|||
170639284|NCT00481091|616691245|FG000|Overall Study|Progressive disease clinical|0|||
170639285|NCT00481091|616691246|FG001|Overall Study|Progressive disease clinical|0|||
170639286|NCT00481091|616691247|FG002|Overall Study|Progressive disease clinical|0|||
170477198|NCT00942357|616085886|FG000|Overall Study|Ineligible|37|||
170477199|NCT00942357|616085887|FG001|Overall Study|Ineligible|40|||
170477200|NCT01998919|616085890|FG000|Overall Study|Death|2|||
170477201|NCT01998919|616085891|FG001|Overall Study|Death|2|||
170639287|NCT00481091|616691248|FG003|Overall Study|Progressive disease clinical|0|||
170639288|NCT00481091|616691249|FG004|Overall Study|Progressive disease clinical|0|||
170892164|NCT01656434|617611941|FG000|Overall Study|Enrollment terminated at trial site|2|||
170892165|NCT01656434|617611942|FG001|Overall Study|Enrollment terminated at trial site|0|||
170892166|NCT01656434|617611941|FG000|Overall Study|Lost to Follow-up|309|||
170892167|NCT01656434|617611942|FG001|Overall Study|Lost to Follow-up|76|||
170477202|NCT01998919|616085890|FG000|Overall Study|Adverse Event|0|||
170477203|NCT01998919|616085891|FG001|Overall Study|Adverse Event|5|||
170477204|NCT01998919|616085890|FG000|Overall Study|Disease progression|31|||
170639289|NCT00481091|616691250|FG005|Overall Study|Progressive disease clinical|0|||
170639290|NCT00481091|616691251|FG006|Overall Study|Progressive disease clinical|0|||
170639291|NCT00481091|616691252|FG007|Overall Study|Progressive disease clinical|0|||
170639292|NCT00481091|616691253|FG008|Overall Study|Progressive disease clinical|1|||
170639293|NCT00481091|616691254|FG009|Overall Study|Progressive disease clinical|7|||
170639294|NCT00481091|616691245|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
170639295|NCT00481091|616691246|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
170892168|NCT01656434|617611941|FG000|Overall Study|Site discontinued study participation|24|||
170477205|NCT01998919|616085891|FG001|Overall Study|Disease progression|22|||
170639296|NCT00481091|616691247|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
170639297|NCT00481091|616691248|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
170639298|NCT00481091|616691249|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
170639299|NCT00481091|616691250|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
170639300|NCT00481091|616691251|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
170639301|NCT00481091|616691252|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
170639302|NCT00481091|616691253|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
170639303|NCT00481091|616691254|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
170639304|NCT00481091|616691245|FG000|Overall Study|Progressive disease other|1|||
170639305|NCT00481091|616691246|FG001|Overall Study|Progressive disease other|1|||
170639306|NCT00481091|616691247|FG002|Overall Study|Progressive disease other|0|||
170477206|NCT01998919|616085890|FG000|Overall Study|Withdrawal by Subject|2|||
170477207|NCT01998919|616085891|FG001|Overall Study|Withdrawal by Subject|4|||
170477208|NCT01998919|616085890|FG000|Overall Study|Lost to Follow-up|2|||
170477209|NCT01998919|616085891|FG001|Overall Study|Lost to Follow-up|0|||
170477210|NCT01998919|616085890|FG000|Overall Study|Other|5|||
170477211|NCT01998919|616085891|FG001|Overall Study|Other|2|||
170477212|NCT00116779|616085892|FG000|Overall Study|Adverse Event|4|||
170477213|NCT00116779|616085893|FG001|Overall Study|Adverse Event|2|||
170639307|NCT00481091|616691248|FG003|Overall Study|Progressive disease other|1|||
170639308|NCT00481091|616691249|FG004|Overall Study|Progressive disease other|1|||
170639309|NCT00481091|616691250|FG005|Overall Study|Progressive disease other|1|||
170639310|NCT00481091|616691251|FG006|Overall Study|Progressive disease other|0|||
170477214|NCT00116779|616085892|FG000|Overall Study|Protocol Violation|1|||
170477215|NCT00116779|616085893|FG001|Overall Study|Protocol Violation|4|||
170477216|NCT00116779|616085892|FG000|Overall Study|Withdrawal by Subject|4|||
170477217|NCT00116779|616085893|FG001|Overall Study|Withdrawal by Subject|1|||
170477218|NCT00116779|616085892|FG000|Overall Study|Inadequate testosterone suppression|7|||
170639311|NCT00481091|616691252|FG007|Overall Study|Progressive disease other|2|||
170639312|NCT00481091|616691253|FG008|Overall Study|Progressive disease other|0|||
170639313|NCT00481091|616691254|FG009|Overall Study|Progressive disease other|0|||
170639314|NCT00481091|616691245|FG000|Overall Study|No reason given|0|||
170639315|NCT00481091|616691246|FG001|Overall Study|No reason given|0|||
170792667|NCT04979442|617251790|FG001|Overall Study|do not want to continue|1|||
170792668|NCT02116530|617251794|FG000|Overall Study|Withdrawal by Subject|1|||
170792669|NCT02116530|617251795|FG001|Overall Study|Withdrawal by Subject|2|||
170477219|NCT00116779|616085893|FG001|Overall Study|Inadequate testosterone suppression|9|||
170477220|NCT00116779|616085892|FG000|Overall Study|Physician Decision|3|||
170792670|NCT02116530|617251794|FG000|Overall Study|Adverse Event|4|||
170792671|NCT02116530|617251795|FG001|Overall Study|Adverse Event|0|||
170477221|NCT00116779|616085893|FG001|Overall Study|Physician Decision|1|||
170477222|NCT00116779|616085892|FG000|Overall Study|Elevated PSA levels|2|||
170477223|NCT00116779|616085893|FG001|Overall Study|Elevated PSA levels|2|||
170477224|NCT02687451|616085895|FG000|Overall Study|Withdrawal by Subject|1|||
170477225|NCT02687451|616085896|FG001|Overall Study|Withdrawal by Subject|0|||
170477226|NCT02687451|616085897|FG002|Overall Study|Withdrawal by Subject|0|||
170477227|NCT02687451|616085898|FG003|Overall Study|Withdrawal by Subject|0|||
170477228|NCT02687451|616085899|FG004|Overall Study|Withdrawal by Subject|0|||
170639316|NCT00481091|616691247|FG002|Overall Study|No reason given|1|||
170639317|NCT00481091|616691248|FG003|Overall Study|No reason given|1|||
170792672|NCT02116530|617251794|FG000|Overall Study|Physician Decision|1|||
170792673|NCT02116530|617251795|FG001|Overall Study|Physician Decision|0|||
170792674|NCT02116530|617251794|FG000|Overall Study|Lost to Follow-up|1|||
170792675|NCT02116530|617251795|FG001|Overall Study|Lost to Follow-up|0|||
170792676|NCT02116530|617251794|FG000|Overall Study|Other Medical Problems|2|||
170792677|NCT02116530|617251795|FG001|Overall Study|Other Medical Problems|2|||
170792678|NCT02844465|617251799|FG000|Overall Study|Screen Failure|36|||
170792679|NCT02844465|617251799|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
170792680|NCT02844465|617251799|FG000|Overall Study|Withdrawal by Subject|5|||
170792681|NCT02844465|617251799|FG000|Overall Study|Lost to Follow-up|1|||
170792682|NCT02844465|617251799|FG000|Overall Study|Retreatment|1|||
170792683|NCT05297565|617251800|FG000|Overall Study|Other Reasons|0|||
170792684|NCT05297565|617251801|FG001|Overall Study|Other Reasons|1|||
170792685|NCT05297565|617251800|FG000|Overall Study|Physician Decision|0|||
170792686|NCT05297565|617251801|FG001|Overall Study|Physician Decision|1|||
170792687|NCT05297565|617251800|FG000|Overall Study|Disease recurrence|1|||
170792688|NCT05297565|617251801|FG001|Overall Study|Disease recurrence|0|||
170477229|NCT02687451|616085900|FG005|Overall Study|Withdrawal by Subject|1|||
170477230|NCT01778530|616085902|FG000|Overall Study|Progression on study|1|||
170477231|NCT01778530|616085902|FG000|Overall Study|Adverse event/side effect|1|||
170477232|NCT01199939|616085903|FG000|Overall Study|Adverse Event|4|||
170477233|NCT01199939|616085903|FG000|Overall Study|Protocol Violation|3|||
170792689|NCT05671653|617251802|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
170792690|NCT05671653|617251803|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
170792691|NCT05671653|617251804|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
170792692|NCT05671653|617251805|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
170792693|NCT05671653|617251806|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
170792694|NCT05671653|617251807|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
170477234|NCT01199939|616085903|FG000|Overall Study|Lost to Follow-up|2|||
170477235|NCT01199939|616085903|FG000|Overall Study|Reached a virologic endpoint|4|||
170477236|NCT03472014|616085904|FG000|Overall Study|Lost to Follow-up|4|||
170477237|NCT00110396|616085905|FG000|Overall Study|Adverse Event|15|||
170477238|NCT00110396|616085905|FG000|Overall Study|Lost to Follow-up|1|||
170477239|NCT00110396|616085905|FG000|Overall Study|Administration of plasmapheresis|1|||
170477240|NCT00110396|616085905|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
170477241|NCT00110396|616085905|FG000|Overall Study|Lack of Efficacy|1|||
170477242|NCT00110396|616085905|FG000|Overall Study|Decided not to continue treatment|1|||
170477243|NCT00110396|616085905|FG000|Overall Study|Patient non-compliance|1|||
170477244|NCT00110396|616085905|FG000|Overall Study|Patient refused to continue|1|||
170477245|NCT00110396|616085905|FG000|Overall Study|Patient refused to participate|1|||
170477246|NCT00110396|616085905|FG000|Overall Study|Patient will|1|||
170546905|NCT01297244|616347510|FG000|Overall Study|Clinical progression|1|||
170546906|NCT01297244|616347511|FG001|Overall Study|Clinical progression|1|||
170546907|NCT01297244|616347510|FG000|Overall Study|Withdrawal by Subject|2|||
170546908|NCT01297244|616347511|FG001|Overall Study|Withdrawal by Subject|0|||
170546909|NCT01348698|616347512|FG000|Overall Study|Does not meet lesion size criteria|1|||
170546910|NCT01348698|616347512|FG000|Overall Study|Death|3|||
170546911|NCT01348698|616347512|FG000|Overall Study|PI decision to close study|68|||
170546912|NCT02595749|616347513|FG000|Overall Study|Withdrawal by Subject|12|||
170546913|NCT02595749|616347514|FG001|Overall Study|Withdrawal by Subject|7|||
170546914|NCT00669331|616347515|FG000|Randomisation to First Dose|Adverse Event|1|||
170546915|NCT00669331|616347516|FG001|Randomisation to First Dose|Adverse Event|0|||
170546916|NCT00669331|616347515|FG000|Randomisation to First Dose|Protocol Violation|1|||
170546917|NCT00669331|616347516|FG001|Randomisation to First Dose|Protocol Violation|0|||
170546918|NCT00669331|616347515|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
170546919|NCT00669331|616347516|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
170546920|NCT00669331|616347515|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
170546921|NCT00669331|616347516|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
170546922|NCT00669331|616347515|FG000|Randomisation to First Dose|Death|1|||
170546923|NCT00669331|616347516|FG001|Randomisation to First Dose|Death|0|||
170546924|NCT00669331|616347515|FG000|Randomisation to First Dose|Sponsor decision|0|||
170546925|NCT00669331|616347516|FG001|Randomisation to First Dose|Sponsor decision|1|||
170546926|NCT00669331|616347515|FG000|Randomisation to First Dose|Randomised in error|3|||
170546927|NCT00669331|616347516|FG001|Randomisation to First Dose|Randomised in error|10|||
170546928|NCT00669331|616347515|FG000|Blinded Treatment Period|Adverse Event|16|||
170546929|NCT00669331|616347516|FG001|Blinded Treatment Period|Adverse Event|10|||
170546930|NCT00669331|616347515|FG000|Blinded Treatment Period|Protocol Violation|1|||
170546931|NCT00669331|616347516|FG001|Blinded Treatment Period|Protocol Violation|1|||
170546932|NCT00669331|616347515|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
170546933|NCT00669331|616347516|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
170546934|NCT00669331|616347515|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
170546935|NCT00669331|616347516|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
170546936|NCT00669331|616347515|FG000|Blinded Treatment Period|Death|0|||
170546937|NCT00669331|616347516|FG001|Blinded Treatment Period|Death|2|||
170546938|NCT00669331|616347515|FG000|Blinded Treatment Period|Physician Decision|3|||
170546939|NCT00669331|616347516|FG001|Blinded Treatment Period|Physician Decision|3|||
170546940|NCT00669331|616347515|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
170546941|NCT00669331|616347516|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
170546942|NCT03387046|616347517|FG000|Overall Study|Adverse Event|1|||
170546943|NCT03387046|616347518|FG001|Overall Study|Adverse Event|1|||
170546944|NCT03558672|616347519|FG000|Overall Study|Study Early Termination|10|||
170546945|NCT00509600|616347520|FG000|Overall Study|Adverse Event|1|||
170546946|NCT03607695|616347523|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
170546947|NCT03607695|616347523|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
170546948|NCT00986232|616347524|FG000|Overall Study|Adverse Event|1|||
170546949|NCT00986232|616347525|FG001|Overall Study|Adverse Event|2|||
170546950|NCT00986232|616347526|FG002|Overall Study|Adverse Event|3|||
170792695|NCT05671653|617251808|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
170792696|NCT05671653|617251809|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
170792697|NCT05671653|617251810|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
170792698|NCT05671653|617251811|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
170477247|NCT00110396|616085905|FG000|Overall Study|Patient's decision|1|||
170546951|NCT00986232|616347527|FG003|Overall Study|Adverse Event|0|||
170792699|NCT05671653|617251812|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
170546952|NCT00986232|616347524|FG000|Overall Study|Lost to Follow-up|19|||
170546953|NCT00986232|616347525|FG001|Overall Study|Lost to Follow-up|12|||
170546954|NCT00986232|616347526|FG002|Overall Study|Lost to Follow-up|12|||
170546955|NCT00986232|616347527|FG003|Overall Study|Lost to Follow-up|7|||
170546956|NCT00986232|616347524|FG000|Overall Study|Protocol Violation|2|||
170892169|NCT01656434|617611942|FG001|Overall Study|Site discontinued study participation|9|||
170477248|NCT00110396|616085905|FG000|Overall Study|Participation in MS vaccine study|1|||
170477249|NCT00110396|616085905|FG000|Overall Study|Pregnancy|1|||
170477250|NCT00110396|616085905|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
170477251|NCT00110396|616085905|FG000|Overall Study|Protocol Violation|2|||
170477252|NCT00110396|616085905|FG000|Overall Study|Patient refused to come back|1|||
170477253|NCT00110396|616085905|FG000|Overall Study|The patient has refused|2|||
170477254|NCT00110396|616085905|FG000|Overall Study|The patient has refused to visit site|1|||
170477255|NCT00110396|616085905|FG000|Overall Study|Patient is to be administered copaxone|1|||
170477256|NCT02792517|616085906|FG000|Overall Study|Withdrawal by Subject|10|||
170477257|NCT02792517|616085906|FG000|Overall Study|Decision by Sponsor|7|||
170477258|NCT02792517|616085906|FG000|Overall Study|Lost to Follow-up|3|||
170477259|NCT01269918|616085907|FG000|Overall Study|Did not receive study drug|0|||
170477260|NCT01269918|616085908|FG001|Overall Study|Did not receive study drug|3|||
170477261|NCT00245466|616085913|FG000|Overall Study|Adverse Event|2|||
170477262|NCT00245466|616085914|FG001|Overall Study|Adverse Event|8|||
170477263|NCT00245466|616085915|FG002|Overall Study|Adverse Event|4|||
170477264|NCT00245466|616085913|FG000|Overall Study|Low prostate specific antigen suppr|16|||
170477265|NCT00245466|616085914|FG001|Overall Study|Low prostate specific antigen suppr|14|||
170477266|NCT00245466|616085915|FG002|Overall Study|Low prostate specific antigen suppr|5|||
170477267|NCT00245466|616085913|FG000|Overall Study|Insufficient testosterone suppr|12|||
170477268|NCT00245466|616085914|FG001|Overall Study|Insufficient testosterone suppr|12|||
170477269|NCT00245466|616085915|FG002|Overall Study|Insufficient testosterone suppr|21|||
170477270|NCT00245466|616085913|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
170477271|NCT00245466|616085914|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
170477272|NCT00245466|616085915|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
170477273|NCT00245466|616085913|FG000|Overall Study|Withdrawal by Subject|2|||
170477274|NCT00245466|616085914|FG001|Overall Study|Withdrawal by Subject|2|||
170477275|NCT00245466|616085915|FG002|Overall Study|Withdrawal by Subject|1|||
170477276|NCT00245466|616085913|FG000|Overall Study|Lost to Follow-up|3|||
170477277|NCT00245466|616085914|FG001|Overall Study|Lost to Follow-up|0|||
170477278|NCT00245466|616085915|FG002|Overall Study|Lost to Follow-up|0|||
170477279|NCT00245466|616085913|FG000|Overall Study|Disease progression|0|||
170477280|NCT00245466|616085914|FG001|Overall Study|Disease progression|3|||
170477281|NCT00245466|616085915|FG002|Overall Study|Disease progression|1|||
170477282|NCT00245466|616085913|FG000|Overall Study|Protocol Violation|1|||
170477283|NCT00245466|616085914|FG001|Overall Study|Protocol Violation|2|||
170477284|NCT00245466|616085915|FG002|Overall Study|Protocol Violation|2|||
170477285|NCT00245466|616085913|FG000|Overall Study|Death|0|||
170477286|NCT00245466|616085914|FG001|Overall Study|Death|2|||
170477287|NCT00245466|616085915|FG002|Overall Study|Death|0|||
170477288|NCT00245466|616085913|FG000|Overall Study|Administrative reasons|0|||
170477289|NCT00245466|616085914|FG001|Overall Study|Administrative reasons|1|||
170477290|NCT00245466|616085915|FG002|Overall Study|Administrative reasons|0|||
170477291|NCT03885661|616085916|FG000|Overall Study|Withdrawal by Subject|0|||
170477292|NCT03885661|616085917|FG001|Overall Study|Withdrawal by Subject|1|||
170477293|NCT03885661|616085916|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
170477294|NCT03885661|616085917|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
170477295|NCT00856193|616085918|FG000|Period 2|Abnormal test procedure results|0|||
170477296|NCT00856193|616085919|FG001|Period 2|Abnormal test procedure results|1|||
170477297|NCT00856193|616085918|FG000|Period 2|Lost to Follow-up|0|||
170477298|NCT00856193|616085919|FG001|Period 2|Lost to Follow-up|1|||
170477299|NCT05064397|616085920|FG000|Overall Study|Adverse Event|4|||
170477300|NCT05064397|616085920|FG000|Overall Study|Lack of Efficacy|12|||
170477301|NCT05064397|616085920|FG000|Overall Study|Withdrawal by Subject|3|||
170477302|NCT05064397|616085920|FG000|Overall Study|Lost to Follow-up|1|||
170477303|NCT05064397|616085920|FG000|Overall Study|Other reasons|3|||
170477304|NCT03652051|616085921|FG000|Stage 1|Adverse Event|0|||
170546957|NCT00986232|616347525|FG001|Overall Study|Protocol Violation|3|||
170546958|NCT00986232|616347526|FG002|Overall Study|Protocol Violation|0|||
170546959|NCT00986232|616347527|FG003|Overall Study|Protocol Violation|1|||
170546960|NCT00986232|616347524|FG000|Overall Study|Withdrawal by Subject|13|||
170477305|NCT03652051|616085922|FG001|Stage 1|Adverse Event|5|||
170477306|NCT03652051|616085923|FG002|Stage 1|Adverse Event|7|||
170477307|NCT03652051|616085924|FG003|Stage 1|Adverse Event|1|||
170477308|NCT03652051|616085921|FG000|Stage 1|Withdrawal by Subject|0|||
170477309|NCT03652051|616085922|FG001|Stage 1|Withdrawal by Subject|0|||
170477310|NCT03652051|616085923|FG002|Stage 1|Withdrawal by Subject|1|||
170477311|NCT03652051|616085924|FG003|Stage 1|Withdrawal by Subject|0|||
170477312|NCT03652051|616085921|FG000|Stage 2|Adverse Event|0|||
170477313|NCT03652051|616085922|FG001|Stage 2|Adverse Event|2|||
170546961|NCT00986232|616347525|FG001|Overall Study|Withdrawal by Subject|16|||
170546962|NCT00986232|616347526|FG002|Overall Study|Withdrawal by Subject|12|||
170477314|NCT03652051|616085923|FG002|Stage 2|Adverse Event|1|||
170477315|NCT03652051|616085924|FG003|Stage 2|Adverse Event|0|||
170477316|NCT03652051|616085921|FG000|Stage 2|Protocol Violation|0|||
170546963|NCT00986232|616347527|FG003|Overall Study|Withdrawal by Subject|3|||
170639318|NCT00481091|616691249|FG004|Overall Study|No reason given|1|||
170639319|NCT00481091|616691250|FG005|Overall Study|No reason given|0|||
170639320|NCT00481091|616691251|FG006|Overall Study|No reason given|1|||
170639321|NCT00481091|616691252|FG007|Overall Study|No reason given|1|||
170639322|NCT00481091|616691253|FG008|Overall Study|No reason given|1|||
170639323|NCT00481091|616691254|FG009|Overall Study|No reason given|4|||
170639324|NCT04294680|616691255|FG000|Overall Study|Withdrawal by Subject|2|||
170639325|NCT04294680|616691256|FG001|Overall Study|Withdrawal by Subject|1|||
170639326|NCT04294680|616691255|FG000|Overall Study|Follow-up visits completed outside of window|1|||
170639327|NCT04294680|616691256|FG001|Overall Study|Follow-up visits completed outside of window|0|||
170639328|NCT04881942|616691259|FG000|Overall Study|Adverse Event|0|||
170639329|NCT04881942|616691260|FG001|Overall Study|Adverse Event|0|||
170639330|NCT04881942|616691261|FG002|Overall Study|Adverse Event|0|||
170639331|NCT04881942|616691262|FG003|Overall Study|Adverse Event|0|||
170639332|NCT04881942|616691263|FG004|Overall Study|Adverse Event|1|||
170639333|NCT04881942|616691259|FG000|Overall Study|Alternates|0|||
170639334|NCT04881942|616691260|FG001|Overall Study|Alternates|0|||
170639335|NCT04881942|616691261|FG002|Overall Study|Alternates|0|||
170639336|NCT04881942|616691262|FG003|Overall Study|Alternates|0|||
170639337|NCT04881942|616691263|FG004|Overall Study|Alternates|2|||
170639338|NCT00947193|616691264|FG000|Overall Study|Lost to Follow-up|1|||
170639339|NCT00947193|616691265|FG001|Overall Study|Lost to Follow-up|0|||
170639340|NCT00947193|616691264|FG000|Overall Study|Withdrawal by Subject|1|||
170639341|NCT00947193|616691265|FG001|Overall Study|Withdrawal by Subject|0|||
170639342|NCT00947193|616691264|FG000|Overall Study|Factor VIII >1%|1|||
170639343|NCT00947193|616691265|FG001|Overall Study|Factor VIII >1%|0|||
170639344|NCT04364984|616691266|FG000|Overall Study|Death|2|||
170639345|NCT04364984|616691267|FG001|Overall Study|Death|2|||
170639346|NCT04364984|616691268|FG002|Overall Study|Death|0|||
170639347|NCT01349959|616691269|FG000|Overall Study|Adverse Event|7|||
170639348|NCT02105961|616691270|FG000|Overall Study|Adverse Event|18|||
170639349|NCT02105961|616691271|FG001|Overall Study|Adverse Event|7|||
170639350|NCT02105961|616691272|FG002|Overall Study|Adverse Event|13|||
170639351|NCT02105961|616691270|FG000|Overall Study|Lack of Efficacy|3|||
170639352|NCT02105961|616691271|FG001|Overall Study|Lack of Efficacy|0|||
170639353|NCT02105961|616691272|FG002|Overall Study|Lack of Efficacy|3|||
170639354|NCT02105961|616691270|FG000|Overall Study|Lost to Follow-up|2|||
170639355|NCT02105961|616691271|FG001|Overall Study|Lost to Follow-up|0|||
170639356|NCT02105961|616691272|FG002|Overall Study|Lost to Follow-up|1|||
170639357|NCT02105961|616691270|FG000|Overall Study|Physician Decision|3|||
170639358|NCT02105961|616691271|FG001|Overall Study|Physician Decision|3|||
170639359|NCT02105961|616691272|FG002|Overall Study|Physician Decision|2|||
170477317|NCT03652051|616085922|FG001|Stage 2|Protocol Violation|1|||
170477318|NCT03652051|616085923|FG002|Stage 2|Protocol Violation|6|||
170477319|NCT03652051|616085924|FG003|Stage 2|Protocol Violation|0|||
170477320|NCT03652051|616085921|FG000|Stage 2|Lost to Follow-up|0|||
170792700|NCT05671653|617251813|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
170792701|NCT05671653|617251814|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
170792702|NCT05671653|617251802|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170792703|NCT05671653|617251803|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170792704|NCT05671653|617251804|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170477321|NCT03652051|616085922|FG001|Stage 2|Lost to Follow-up|2|||
170477322|NCT03652051|616085923|FG002|Stage 2|Lost to Follow-up|0|||
170477323|NCT03652051|616085924|FG003|Stage 2|Lost to Follow-up|3|||
170477324|NCT03652051|616085921|FG000|Stage 2|Withdrawal by Subject|0|||
170639360|NCT02105961|616691270|FG000|Overall Study|Withdrawal by Subject|15|||
170639361|NCT02105961|616691271|FG001|Overall Study|Withdrawal by Subject|7|||
170639362|NCT02105961|616691272|FG002|Overall Study|Withdrawal by Subject|11|||
170639363|NCT00934362|616691273|FG000|Overall Study|Adverse Event|1|||
170792705|NCT05671653|617251805|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170477325|NCT03652051|616085922|FG001|Stage 2|Withdrawal by Subject|11|||
170639364|NCT00934362|616691274|FG001|Overall Study|Adverse Event|0|||
170639365|NCT02147561|616691279|FG000|Overall Study|Lost to Follow-up|3|||
170792706|NCT05671653|617251806|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170477326|NCT03652051|616085923|FG002|Stage 2|Withdrawal by Subject|9|||
170477327|NCT03652051|616085924|FG003|Stage 2|Withdrawal by Subject|3|||
170477328|NCT03442751|616085927|FG000|Overall Study|Withdrawal by Subject|3|||
170477329|NCT03442751|616085928|FG001|Overall Study|Withdrawal by Subject|1|||
170792707|NCT05671653|617251807|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
170477330|NCT03442751|616085927|FG000|Overall Study|Lost to Follow-up|3|||
170477331|NCT03442751|616085928|FG001|Overall Study|Lost to Follow-up|0|||
170477332|NCT03934541|616085929|FG000|Overall Study|Study Terminated by Sponsor|0|||
170639366|NCT02147561|616691279|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
170639367|NCT03023813|616691280|FG000|Overall Study|Lost to Follow-up|1|||
170639368|NCT03023813|616691281|FG001|Overall Study|Lost to Follow-up|2|||
170477333|NCT03934541|616085930|FG001|Overall Study|Study Terminated by Sponsor|1|||
170639369|NCT03023813|616691282|FG002|Overall Study|Lost to Follow-up|0|||
170639370|NCT02813577|616691286|FG000|Overall Study|Study terminated|4|||
170639371|NCT04999852|616691287|FG000|Overall Study|Withdrawal by Subject|11|||
170792708|NCT05671653|617251808|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170792709|NCT05671653|617251809|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170477334|NCT03934541|616085931|FG002|Overall Study|Study Terminated by Sponsor|0|||
170477335|NCT03934541|616085932|FG003|Overall Study|Study Terminated by Sponsor|0|||
170477336|NCT01308424|616085933|FG000|Baseline Eligibility|Screen Failures|71|||
170477337|NCT01308424|616085934|FG001|Baseline Eligibility|Screen Failures|0|||
170477338|NCT01308424|616085935|FG002|Baseline Eligibility|Screen Failures|0|||
170477339|NCT01308424|616085933|FG000|Randomization|Adverse Event|0|||
170477340|NCT01308424|616085934|FG001|Randomization|Adverse Event|1|||
170477341|NCT01308424|616085935|FG002|Randomization|Adverse Event|1|||
170477342|NCT01308424|616085933|FG000|Randomization|Lost to Follow-up|0|||
170477343|NCT01308424|616085934|FG001|Randomization|Lost to Follow-up|1|||
170477344|NCT01308424|616085935|FG002|Randomization|Lost to Follow-up|0|||
170477345|NCT01308424|616085933|FG000|Randomization|Physician Decision|0|||
170477346|NCT01308424|616085934|FG001|Randomization|Physician Decision|1|||
170477347|NCT01308424|616085935|FG002|Randomization|Physician Decision|1|||
170477348|NCT00948155|616085936|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
170477349|NCT00948155|616085937|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
170477350|NCT00948155|616085936|FG000|Washout 14 Days|Lost to Follow-up|1|||
170477351|NCT00948155|616085937|FG001|Washout 14 Days|Lost to Follow-up|2|||
170477352|NCT04620746|616085938|FG000|Overall Study|Adverse Event|2|||
170477353|NCT04620746|616085939|FG001|Overall Study|Adverse Event|0|||
170477354|NCT04620746|616085938|FG000|Overall Study|Uniterpretable skin test|1|||
170477355|NCT04620746|616085939|FG001|Overall Study|Uniterpretable skin test|0|||
170477356|NCT04620746|616085938|FG000|Overall Study|Withdrawal by Subject|0|||
170477357|NCT04620746|616085939|FG001|Overall Study|Withdrawal by Subject|1|||
170477358|NCT03535740|616085944|FG000|Overall Study|Death|44|||
170477359|NCT03535740|616085944|FG000|Overall Study|Lost to Follow-up|1|||
170477360|NCT03535740|616085944|FG000|Overall Study|Withdrawal by Subject|13|||
170477361|NCT03535740|616085944|FG000|Overall Study|Site terminated by Sponsor|45|||
170477362|NCT00129545|616085952|FG000|Overall Study|Death|5|||
170477363|NCT00129545|616085953|FG001|Overall Study|Death|60|||
170477364|NCT00129545|616085954|FG002|Overall Study|Death|44|||
170477365|NCT00129545|616085952|FG000|Overall Study|Withdrawal by Subject|3|||
170477366|NCT00129545|616085953|FG001|Overall Study|Withdrawal by Subject|18|||
170477367|NCT00129545|616085954|FG002|Overall Study|Withdrawal by Subject|44|||
170477368|NCT00129545|616085952|FG000|Overall Study|Lost to Follow-up|2|||
170477369|NCT00129545|616085953|FG001|Overall Study|Lost to Follow-up|22|||
170477370|NCT00129545|616085954|FG002|Overall Study|Lost to Follow-up|13|||
170477371|NCT00129545|616085952|FG000|Overall Study|Physician Decision|0|||
170477372|NCT00129545|616085953|FG001|Overall Study|Physician Decision|3|||
170477373|NCT00129545|616085954|FG002|Overall Study|Physician Decision|10|||
170477374|NCT00129545|616085952|FG000|Overall Study|Device not implanted|16|||
170477375|NCT00129545|616085953|FG001|Overall Study|Device not implanted|61|||
170477376|NCT00129545|616085954|FG002|Overall Study|Device not implanted|0|||
170477377|NCT03624192|616085955|FG000|Overall Study|Lost to Follow-up|1|||
170477378|NCT03624192|616085956|FG001|Overall Study|Lost to Follow-up|1|||
170477379|NCT00307086|616085957|FG000|Overall Study|ineligible|5|||
170477380|NCT01487525|616085958|FG000|Overall Study|Withdrawal by Subject|0|||
170477381|NCT01487525|616085959|FG001|Overall Study|Withdrawal by Subject|1|||
170477382|NCT05317312|616085960|FG000|Overall Study|Withdrawal by Subject|0|||
170477383|NCT05317312|616085961|FG001|Overall Study|Withdrawal by Subject|1|||
170477384|NCT05317312|616085962|FG002|Overall Study|Withdrawal by Subject|0|||
170477385|NCT05317312|616085963|FG003|Overall Study|Withdrawal by Subject|0|||
170477386|NCT05317312|616085960|FG000|Overall Study|Lost to Follow-up|0|||
170477387|NCT05317312|616085961|FG001|Overall Study|Lost to Follow-up|0|||
170477388|NCT05317312|616085962|FG002|Overall Study|Lost to Follow-up|0|||
170477389|NCT05317312|616085963|FG003|Overall Study|Lost to Follow-up|1|||
170477390|NCT05317312|616085960|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
170477391|NCT05317312|616085961|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
170477392|NCT05317312|616085962|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
170477393|NCT05317312|616085963|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
170477394|NCT00312338|616085964|FG000|Overall Study|Adverse Event|7|||
170477395|NCT00312338|616085965|FG001|Overall Study|Adverse Event|2|||
170546964|NCT00986232|616347524|FG000|Overall Study|Missed one or more bleeds|13|||
170546965|NCT00986232|616347525|FG001|Overall Study|Missed one or more bleeds|10|||
170546966|NCT00986232|616347526|FG002|Overall Study|Missed one or more bleeds|6|||
170546967|NCT00986232|616347527|FG003|Overall Study|Missed one or more bleeds|7|||
170546968|NCT00986232|616347524|FG000|Overall Study|Incomplete safety follow-up|3|||
170792710|NCT05671653|617251810|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170792711|NCT05671653|617251811|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170477396|NCT00312338|616085964|FG000|Overall Study|Lost to Follow-up|9|||
170477397|NCT00312338|616085965|FG001|Overall Study|Lost to Follow-up|1|||
170477398|NCT00312338|616085964|FG000|Overall Study|Withdrawal by Subject|4|||
170477399|NCT00312338|616085965|FG001|Overall Study|Withdrawal by Subject|0|||
170477400|NCT00312338|616085964|FG000|Overall Study|Subsequent infection|2|||
170477401|NCT00312338|616085965|FG001|Overall Study|Subsequent infection|0|||
170477402|NCT00100828|616085966|FG000|Overall Study|Physician Decision|6|||
170477403|NCT02096744|616085968|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
170477404|NCT02096744|616085969|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
170477405|NCT02096744|616085968|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
170477406|NCT02096744|616085969|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
170477407|NCT02096744|616085968|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
170477408|NCT02096744|616085969|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
170477409|NCT00786409|616085975|FG000|Overall Study|Withdrawal by Subject|2|||
170477410|NCT00786409|616085975|FG000|Overall Study|Adverse Event|2|||
170477411|NCT00786409|616085975|FG000|Overall Study|Pregnancy|2|||
170477412|NCT00786409|616085975|FG000|Overall Study|Lost to Follow-up|1|||
170477413|NCT01855828|616085978|FG000|Overall Study|Adverse Event|1|||
170477414|NCT01855828|616085978|FG000|Overall Study|Withdrawal by Subject|1|||
170477415|NCT01256502|616085984|FG000|Overall Study|Had scaffold removed|4|||
170477416|NCT01256502|616085984|FG000|Overall Study|Personal reasons|5|||
170477417|NCT01256502|616085984|FG000|Overall Study|Protocol deviation|1|||
170477418|NCT00852202|616085985|FG000|Overall Study|Adverse Event|2|||
170477419|NCT00852202|616085986|FG001|Overall Study|Adverse Event|3|||
170477420|NCT00852202|616085987|FG002|Overall Study|Adverse Event|7|||
170477421|NCT00852202|616085985|FG000|Overall Study|Lack of Efficacy|4|||
170477422|NCT00852202|616085986|FG001|Overall Study|Lack of Efficacy|1|||
170477423|NCT00852202|616085987|FG002|Overall Study|Lack of Efficacy|2|||
170477424|NCT00852202|616085985|FG000|Overall Study|Protocol Violation|2|||
170477425|NCT00852202|616085986|FG001|Overall Study|Protocol Violation|2|||
170477426|NCT00852202|616085987|FG002|Overall Study|Protocol Violation|7|||
170477427|NCT00852202|616085985|FG000|Overall Study|Withdrawal by Subject|3|||
170477428|NCT00852202|616085986|FG001|Overall Study|Withdrawal by Subject|1|||
170477429|NCT00852202|616085987|FG002|Overall Study|Withdrawal by Subject|2|||
170477430|NCT00852202|616085985|FG000|Overall Study|Lost to Follow-up|5|||
170477431|NCT00852202|616085986|FG001|Overall Study|Lost to Follow-up|5|||
170477432|NCT00852202|616085987|FG002|Overall Study|Lost to Follow-up|6|||
170477433|NCT00852202|616085985|FG000|Overall Study|pregnancy,moving away and surgery|1|||
170477434|NCT00852202|616085986|FG001|Overall Study|pregnancy,moving away and surgery|0|||
170477435|NCT00852202|616085987|FG002|Overall Study|pregnancy,moving away and surgery|2|||
170477436|NCT04075487|616088139|FG000|Overall Study|Withdrawal by Subject|1|||
170477437|NCT04452669|616088142|FG000|Overall Study|Death|1|||
170477438|NCT04452669|616088143|FG001|Overall Study|Death|4|||
170477439|NCT02848001|616088149|FG000|Overall Study|other reasons|0|||
170477440|NCT02848001|616088150|FG001|Overall Study|other reasons|0|||
170477441|NCT02848001|616088151|FG002|Overall Study|other reasons|1|||
170477442|NCT02848001|616088152|FG003|Overall Study|other reasons|0|||
170477443|NCT02848001|616088153|FG004|Overall Study|other reasons|4|||
170477444|NCT02848001|616088154|FG005|Overall Study|other reasons|1|||
170477445|NCT02848001|616088155|FG006|Overall Study|other reasons|0|||
170477446|NCT02848001|616088156|FG007|Overall Study|other reasons|2|||
170477447|NCT02848001|616088157|FG008|Overall Study|other reasons|2|||
170477448|NCT02848001|616088158|FG009|Overall Study|other reasons|3|||
170477449|NCT02848001|616088159|FG010|Overall Study|other reasons|0|||
170477450|NCT02848001|616088160|FG011|Overall Study|other reasons|1|||
170477451|NCT02848001|616088161|FG012|Overall Study|other reasons|1|||
170477452|NCT02848001|616088162|FG013|Overall Study|other reasons|0|||
170477453|NCT02848001|616088163|FG014|Overall Study|other reasons|0|||
170477454|NCT02848001|616088164|FG015|Overall Study|other reasons|2|||
170477455|NCT02848001|616088165|FG016|Overall Study|other reasons|1|||
170477456|NCT02848001|616088149|FG000|Overall Study|Lack of Efficacy|0|||
170546969|NCT00986232|616347525|FG001|Overall Study|Incomplete safety follow-up|7|||
170546970|NCT00986232|616347526|FG002|Overall Study|Incomplete safety follow-up|2|||
170792712|NCT05671653|617251812|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170792713|NCT05671653|617251813|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170792714|NCT05671653|617251814|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
170792715|NCT05671653|617251802|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792716|NCT05671653|617251803|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792717|NCT05671653|617251804|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792718|NCT05671653|617251805|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792719|NCT05671653|617251806|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170477457|NCT02848001|616088150|FG001|Overall Study|Lack of Efficacy|1|||
170477458|NCT02848001|616088151|FG002|Overall Study|Lack of Efficacy|1|||
170477459|NCT02848001|616088152|FG003|Overall Study|Lack of Efficacy|2|||
170477460|NCT02848001|616088153|FG004|Overall Study|Lack of Efficacy|3|||
170477461|NCT02848001|616088154|FG005|Overall Study|Lack of Efficacy|0|||
170477462|NCT02848001|616088155|FG006|Overall Study|Lack of Efficacy|1|||
170477463|NCT02848001|616088156|FG007|Overall Study|Lack of Efficacy|0|||
170477464|NCT02848001|616088157|FG008|Overall Study|Lack of Efficacy|0|||
170477465|NCT02848001|616088158|FG009|Overall Study|Lack of Efficacy|1|||
170477466|NCT02848001|616088159|FG010|Overall Study|Lack of Efficacy|0|||
170477467|NCT02848001|616088160|FG011|Overall Study|Lack of Efficacy|2|||
170546971|NCT00986232|616347527|FG003|Overall Study|Incomplete safety follow-up|2|||
170477468|NCT02848001|616088161|FG012|Overall Study|Lack of Efficacy|0|||
170477469|NCT02848001|616088162|FG013|Overall Study|Lack of Efficacy|2|||
170477470|NCT02848001|616088163|FG014|Overall Study|Lack of Efficacy|2|||
170477471|NCT02848001|616088164|FG015|Overall Study|Lack of Efficacy|0|||
170477472|NCT02848001|616088165|FG016|Overall Study|Lack of Efficacy|0|||
170477473|NCT02848001|616088149|FG000|Overall Study|Progressive Disease|2|||
170477474|NCT02848001|616088150|FG001|Overall Study|Progressive Disease|1|||
170477475|NCT02848001|616088151|FG002|Overall Study|Progressive Disease|0|||
170477476|NCT02848001|616088152|FG003|Overall Study|Progressive Disease|4|||
170477477|NCT02848001|616088153|FG004|Overall Study|Progressive Disease|3|||
170477478|NCT02848001|616088154|FG005|Overall Study|Progressive Disease|0|||
170477479|NCT02848001|616088155|FG006|Overall Study|Progressive Disease|4|||
170477480|NCT02848001|616088156|FG007|Overall Study|Progressive Disease|1|||
170477481|NCT02848001|616088157|FG008|Overall Study|Progressive Disease|0|||
170477482|NCT02848001|616088158|FG009|Overall Study|Progressive Disease|2|||
170477483|NCT02848001|616088159|FG010|Overall Study|Progressive Disease|3|||
170477484|NCT02848001|616088160|FG011|Overall Study|Progressive Disease|2|||
170477485|NCT02848001|616088161|FG012|Overall Study|Progressive Disease|1|||
170477486|NCT02848001|616088162|FG013|Overall Study|Progressive Disease|0|||
170477487|NCT02848001|616088163|FG014|Overall Study|Progressive Disease|2|||
170477488|NCT02848001|616088164|FG015|Overall Study|Progressive Disease|4|||
170477489|NCT02848001|616088165|FG016|Overall Study|Progressive Disease|0|||
170477490|NCT02848001|616088149|FG000|Overall Study|Adverse Event|0|||
170477491|NCT02848001|616088150|FG001|Overall Study|Adverse Event|0|||
170477492|NCT02848001|616088151|FG002|Overall Study|Adverse Event|0|||
170477493|NCT02848001|616088152|FG003|Overall Study|Adverse Event|0|||
170477494|NCT02848001|616088153|FG004|Overall Study|Adverse Event|2|||
170477495|NCT02848001|616088154|FG005|Overall Study|Adverse Event|0|||
170477496|NCT02848001|616088155|FG006|Overall Study|Adverse Event|0|||
170477497|NCT02848001|616088156|FG007|Overall Study|Adverse Event|0|||
170477498|NCT02848001|616088157|FG008|Overall Study|Adverse Event|0|||
170477499|NCT02848001|616088158|FG009|Overall Study|Adverse Event|1|||
170477500|NCT02848001|616088159|FG010|Overall Study|Adverse Event|0|||
170477501|NCT02848001|616088160|FG011|Overall Study|Adverse Event|1|||
170477502|NCT02848001|616088161|FG012|Overall Study|Adverse Event|1|||
170477503|NCT02848001|616088162|FG013|Overall Study|Adverse Event|0|||
170477504|NCT02848001|616088163|FG014|Overall Study|Adverse Event|2|||
170477505|NCT02848001|616088164|FG015|Overall Study|Adverse Event|0|||
170477506|NCT02848001|616088165|FG016|Overall Study|Adverse Event|0|||
170477507|NCT02848001|616088149|FG000|Overall Study|Death|0|||
170477508|NCT02848001|616088150|FG001|Overall Study|Death|0|||
170477509|NCT02848001|616088151|FG002|Overall Study|Death|0|||
170477510|NCT02848001|616088152|FG003|Overall Study|Death|1|||
170477511|NCT02848001|616088153|FG004|Overall Study|Death|3|||
170477512|NCT02848001|616088154|FG005|Overall Study|Death|1|||
170477513|NCT02848001|616088155|FG006|Overall Study|Death|2|||
170477514|NCT02848001|616088156|FG007|Overall Study|Death|3|||
170477515|NCT02848001|616088157|FG008|Overall Study|Death|4|||
170477516|NCT02848001|616088158|FG009|Overall Study|Death|1|||
170477517|NCT02848001|616088159|FG010|Overall Study|Death|0|||
170477518|NCT02848001|616088160|FG011|Overall Study|Death|1|||
170477519|NCT02848001|616088161|FG012|Overall Study|Death|3|||
170477520|NCT02848001|616088162|FG013|Overall Study|Death|0|||
170477521|NCT02848001|616088163|FG014|Overall Study|Death|2|||
170477522|NCT02848001|616088164|FG015|Overall Study|Death|3|||
170477523|NCT02848001|616088165|FG016|Overall Study|Death|0|||
170477524|NCT02848001|616088149|FG000|Overall Study|Physician Decision|0|||
170477525|NCT02848001|616088150|FG001|Overall Study|Physician Decision|0|||
170477526|NCT02848001|616088151|FG002|Overall Study|Physician Decision|0|||
170477527|NCT02848001|616088152|FG003|Overall Study|Physician Decision|0|||
170477528|NCT02848001|616088153|FG004|Overall Study|Physician Decision|0|||
170477529|NCT02848001|616088154|FG005|Overall Study|Physician Decision|0|||
170477530|NCT02848001|616088155|FG006|Overall Study|Physician Decision|0|||
170477531|NCT02848001|616088156|FG007|Overall Study|Physician Decision|0|||
170477532|NCT02848001|616088157|FG008|Overall Study|Physician Decision|1|||
170477533|NCT02848001|616088158|FG009|Overall Study|Physician Decision|1|||
170477534|NCT02848001|616088159|FG010|Overall Study|Physician Decision|0|||
170477535|NCT02848001|616088160|FG011|Overall Study|Physician Decision|0|||
170477536|NCT02848001|616088161|FG012|Overall Study|Physician Decision|2|||
170477537|NCT02848001|616088162|FG013|Overall Study|Physician Decision|0|||
170477538|NCT02848001|616088163|FG014|Overall Study|Physician Decision|0|||
170477539|NCT02848001|616088164|FG015|Overall Study|Physician Decision|0|||
170477540|NCT02848001|616088165|FG016|Overall Study|Physician Decision|0|||
170477541|NCT02848001|616088149|FG000|Overall Study|Withdrawal by Subject|0|||
170477542|NCT02848001|616088150|FG001|Overall Study|Withdrawal by Subject|0|||
170477543|NCT02848001|616088151|FG002|Overall Study|Withdrawal by Subject|0|||
170477544|NCT02848001|616088152|FG003|Overall Study|Withdrawal by Subject|0|||
170477545|NCT02848001|616088153|FG004|Overall Study|Withdrawal by Subject|0|||
170477546|NCT02848001|616088154|FG005|Overall Study|Withdrawal by Subject|1|||
170477547|NCT02848001|616088155|FG006|Overall Study|Withdrawal by Subject|1|||
170477548|NCT02848001|616088156|FG007|Overall Study|Withdrawal by Subject|1|||
170639372|NCT04999852|616691288|FG001|Overall Study|Withdrawal by Subject|1|||
170639373|NCT04999852|616691287|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
170477549|NCT02848001|616088157|FG008|Overall Study|Withdrawal by Subject|0|||
170477550|NCT02848001|616088158|FG009|Overall Study|Withdrawal by Subject|0|||
170639374|NCT04999852|616691288|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
170639375|NCT04758637|616691289|FG000|Overall Study|Lost to Follow-up|0|||
170639376|NCT04758637|616691290|FG001|Overall Study|Lost to Follow-up|1|||
170639377|NCT04758637|616691291|FG002|Overall Study|Lost to Follow-up|0|||
170639378|NCT04758637|616691292|FG003|Overall Study|Lost to Follow-up|0|||
170639379|NCT01599637|616691295|FG000|Overall Study|administrative problems|0|||
170639380|NCT01599637|616691296|FG001|Overall Study|administrative problems|2|||
170639381|NCT01599637|616691297|FG002|Overall Study|administrative problems|0|||
170639382|NCT01599637|616691295|FG000|Overall Study|Adverse Event|1|||
170477551|NCT02848001|616088159|FG010|Overall Study|Withdrawal by Subject|0|||
170477552|NCT02848001|616088160|FG011|Overall Study|Withdrawal by Subject|0|||
170477553|NCT02848001|616088161|FG012|Overall Study|Withdrawal by Subject|0|||
170477554|NCT02848001|616088162|FG013|Overall Study|Withdrawal by Subject|0|||
170477555|NCT02848001|616088163|FG014|Overall Study|Withdrawal by Subject|0|||
170477556|NCT02848001|616088164|FG015|Overall Study|Withdrawal by Subject|0|||
170477557|NCT02848001|616088165|FG016|Overall Study|Withdrawal by Subject|0|||
170477558|NCT04358081|616088166|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
170477559|NCT04358081|616088167|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
170477560|NCT04358081|616088168|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
170477561|NCT04358081|616088166|FG000|Treatment Phase of Study|Adverse Event|1|||
170477562|NCT04358081|616088167|FG001|Treatment Phase of Study|Adverse Event|0|||
170477563|NCT04358081|616088168|FG002|Treatment Phase of Study|Adverse Event|1|||
170477564|NCT04358081|616088166|FG000|Treatment Phase of Study|Physician Decision|2|||
170477565|NCT04358081|616088167|FG001|Treatment Phase of Study|Physician Decision|0|||
170477566|NCT04358081|616088168|FG002|Treatment Phase of Study|Physician Decision|1|||
170477567|NCT04358081|616088166|FG000|Treatment Phase of Study|Protocol Violation|1|||
170477568|NCT04358081|616088167|FG001|Treatment Phase of Study|Protocol Violation|0|||
170477569|NCT04358081|616088168|FG002|Treatment Phase of Study|Protocol Violation|0|||
170477570|NCT04358081|616088166|FG000|Study Completion Phase|Death|0|||
170477571|NCT04358081|616088167|FG001|Study Completion Phase|Death|0|||
170477572|NCT04358081|616088168|FG002|Study Completion Phase|Death|1|||
170477573|NCT04358081|616088166|FG000|Study Completion Phase|Lost to Follow-up|1|||
170477574|NCT04358081|616088167|FG001|Study Completion Phase|Lost to Follow-up|0|||
170477575|NCT04358081|616088168|FG002|Study Completion Phase|Lost to Follow-up|1|||
170477576|NCT00118157|616088172|FG000|Overall Study|Adverse Event|2|||
170477577|NCT00118157|616088172|FG000|Overall Study|Death|8|||
170639383|NCT01599637|616691296|FG001|Overall Study|Adverse Event|0|||
170639384|NCT01599637|616691297|FG002|Overall Study|Adverse Event|0|||
170639385|NCT00048074|616691298|FG000|Overall Study|Adverse Event|46|||
170639386|NCT00048074|616691299|FG001|Overall Study|Adverse Event|41|||
170639387|NCT00048074|616691300|FG002|Overall Study|Adverse Event|53|||
170639388|NCT00048074|616691298|FG000|Overall Study|Death|3|||
170639389|NCT00048074|616691299|FG001|Overall Study|Death|3|||
170639390|NCT00048074|616691300|FG002|Overall Study|Death|2|||
170639391|NCT00048074|616691298|FG000|Overall Study|Lost to Follow-up|2|||
170639392|NCT00048074|616691299|FG001|Overall Study|Lost to Follow-up|6|||
170639393|NCT00048074|616691300|FG002|Overall Study|Lost to Follow-up|6|||
170639394|NCT00048074|616691298|FG000|Overall Study|Withdrawal by Subject|28|||
170639395|NCT00048074|616691299|FG001|Overall Study|Withdrawal by Subject|30|||
170639396|NCT00048074|616691300|FG002|Overall Study|Withdrawal by Subject|35|||
170639397|NCT00048074|616691298|FG000|Overall Study|Protocol Violation|1|||
170639398|NCT00048074|616691299|FG001|Overall Study|Protocol Violation|3|||
170639399|NCT00048074|616691300|FG002|Overall Study|Protocol Violation|0|||
170639400|NCT00048074|616691298|FG000|Overall Study|Study participation was terminated|0|||
170639401|NCT00048074|616691299|FG001|Overall Study|Study participation was terminated|1|||
170639402|NCT00048074|616691300|FG002|Overall Study|Study participation was terminated|0|||
170639403|NCT00048074|616691298|FG000|Overall Study|Husband ill|0|||
170639404|NCT00048074|616691299|FG001|Overall Study|Husband ill|1|||
170639405|NCT00048074|616691300|FG002|Overall Study|Husband ill|0|||
170639406|NCT00048074|616691298|FG000|Overall Study|Poor compliance|0|||
170639407|NCT00048074|616691299|FG001|Overall Study|Poor compliance|1|||
170639408|NCT00048074|616691300|FG002|Overall Study|Poor compliance|0|||
170639409|NCT00048074|616691298|FG000|Overall Study|Out of station|0|||
170477578|NCT00118157|616088172|FG000|Overall Study|Withdrawal by Subject|2|||
170477579|NCT00413699|616088173|FG000|Initial Period|Death|25|||
170477580|NCT00413699|616088174|FG001|Initial Period|Death|30|||
170477581|NCT00413699|616088175|FG002|Initial Period|Death|0|||
170477582|NCT00413699|616088173|FG000|Initial Period|Lack of Efficacy|59|||
170639410|NCT00048074|616691299|FG001|Overall Study|Out of station|1|||
170639411|NCT00048074|616691300|FG002|Overall Study|Out of station|1|||
170639412|NCT00048074|616691298|FG000|Overall Study|Social reasons|1|||
170639413|NCT00048074|616691299|FG001|Overall Study|Social reasons|0|||
170639414|NCT00048074|616691300|FG002|Overall Study|Social reasons|0|||
170792720|NCT05671653|617251807|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
170792721|NCT05671653|617251808|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792722|NCT05671653|617251809|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792723|NCT05671653|617251810|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792724|NCT05671653|617251811|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792725|NCT05671653|617251812|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792726|NCT05671653|617251813|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792727|NCT05671653|617251814|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
170792728|NCT05671653|617251802|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792729|NCT05671653|617251803|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792730|NCT05671653|617251804|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792731|NCT05671653|617251805|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792732|NCT05671653|617251806|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792733|NCT05671653|617251807|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792734|NCT05671653|617251808|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792735|NCT05671653|617251809|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792736|NCT05671653|617251810|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
170792737|NCT05671653|617251811|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792738|NCT05671653|617251812|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792739|NCT05671653|617251813|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792740|NCT05671653|617251814|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
170792741|NCT05671653|617251802|FG000|Cohort 2 Period 2|Adverse Event|0|||
170792742|NCT05671653|617251803|FG001|Cohort 2 Period 2|Adverse Event|0|||
170639415|NCT05019521|616691301|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
170639416|NCT05019521|616691302|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
170639417|NCT05019521|616691303|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
170639418|NCT05019521|616691304|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
170639419|NCT05019521|616691305|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
170639420|NCT05019521|616691306|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
170639421|NCT05019521|616691307|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
170639422|NCT05019521|616691301|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
170639423|NCT05019521|616691302|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
170639424|NCT05019521|616691303|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
170639425|NCT05019521|616691304|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
170639426|NCT05019521|616691305|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
170639427|NCT05019521|616691306|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
170639428|NCT05019521|616691307|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
170639429|NCT05019521|616691301|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
170639430|NCT05019521|616691302|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
170639431|NCT05019521|616691303|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
170639432|NCT05019521|616691304|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
170639433|NCT05019521|616691305|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
170639434|NCT05019521|616691306|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
170639435|NCT05019521|616691307|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
170639436|NCT05019521|616691301|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
170639437|NCT05019521|616691302|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
170639438|NCT05019521|616691303|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
170639439|NCT05019521|616691304|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
170639440|NCT05019521|616691305|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
170639441|NCT05019521|616691306|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
170639442|NCT05019521|616691307|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
170639443|NCT05019521|616691301|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
170792743|NCT05671653|617251804|FG002|Cohort 2 Period 2|Adverse Event|0|||
170792744|NCT05671653|617251805|FG003|Cohort 2 Period 2|Adverse Event|0|||
170792745|NCT05671653|617251806|FG004|Cohort 2 Period 2|Adverse Event|0|||
170792746|NCT05671653|617251807|FG005|Cohort 2 Period 2|Adverse Event|0|||
170792747|NCT05671653|617251808|FG006|Cohort 2 Period 2|Adverse Event|0|||
170792748|NCT05671653|617251809|FG007|Cohort 2 Period 2|Adverse Event|0|||
170792749|NCT05671653|617251810|FG008|Cohort 2 Period 2|Adverse Event|0|||
170639444|NCT05019521|616691302|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
170639445|NCT05019521|616691303|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
170639446|NCT05019521|616691304|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
170792750|NCT05671653|617251811|FG009|Cohort 2 Period 2|Adverse Event|0|||
170792751|NCT05671653|617251812|FG010|Cohort 2 Period 2|Adverse Event|1|||
170792752|NCT05671653|617251813|FG011|Cohort 2 Period 2|Adverse Event|0|||
170792753|NCT05671653|617251814|FG012|Cohort 2 Period 2|Adverse Event|0|||
170792754|NCT05671653|617251802|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
170792755|NCT05671653|617251803|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
170792756|NCT05671653|617251804|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
170792757|NCT05671653|617251805|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
170792758|NCT05671653|617251806|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
170477583|NCT00413699|616088174|FG001|Initial Period|Lack of Efficacy|115|||
170477584|NCT00413699|616088175|FG002|Initial Period|Lack of Efficacy|0|||
170477585|NCT00413699|616088173|FG000|Initial Period|Lost to Follow-up|31|||
170477586|NCT00413699|616088174|FG001|Initial Period|Lost to Follow-up|101|||
170792759|NCT05671653|617251807|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
170477587|NCT00413699|616088175|FG002|Initial Period|Lost to Follow-up|0|||
170477588|NCT00413699|616088173|FG000|Initial Period|Protocol Violation|38|||
170477589|NCT00413699|616088174|FG001|Initial Period|Protocol Violation|89|||
170477590|NCT00413699|616088175|FG002|Initial Period|Protocol Violation|0|||
170477591|NCT00413699|616088173|FG000|Initial Period|Pregnancy|10|||
170477592|NCT00413699|616088174|FG001|Initial Period|Pregnancy|8|||
170477593|NCT00413699|616088175|FG002|Initial Period|Pregnancy|0|||
170477594|NCT00413699|616088173|FG000|Initial Period|Did not meet entrance criteria|2|||
170477595|NCT00413699|616088174|FG001|Initial Period|Did not meet entrance criteria|2|||
170477596|NCT00413699|616088175|FG002|Initial Period|Did not meet entrance criteria|0|||
170477597|NCT00413699|616088173|FG000|Initial Period|Medication error without adverse event|0|||
170477598|NCT00413699|616088174|FG001|Initial Period|Medication error without adverse event|1|||
170477599|NCT00413699|616088175|FG002|Initial Period|Medication error without adverse event|0|||
170477600|NCT00413699|616088173|FG000|Initial Period|Study terminated by Sponsor|0|||
170477601|NCT00413699|616088174|FG001|Initial Period|Study terminated by Sponsor|1|||
170477602|NCT00413699|616088175|FG002|Initial Period|Study terminated by Sponsor|0|||
170477603|NCT00413699|616088173|FG000|Initial Period|Other|67|||
170477604|NCT00413699|616088174|FG001|Initial Period|Other|211|||
170477605|NCT00413699|616088175|FG002|Initial Period|Other|0|||
170477606|NCT00413699|616088173|FG000|Initial Period|Adverse event related to study drug|178|||
170477607|NCT00413699|616088174|FG001|Initial Period|Adverse event related to study drug|527|||
170477608|NCT00413699|616088175|FG002|Initial Period|Adverse event related to study drug|0|||
170477609|NCT00413699|616088173|FG000|Initial Period|Adverse event not related to study drug|113|||
170477610|NCT00413699|616088174|FG001|Initial Period|Adverse event not related to study drug|248|||
170477611|NCT00413699|616088175|FG002|Initial Period|Adverse event not related to study drug|0|||
170477612|NCT00413699|616088173|FG000|Initial Period|Missing end of study page|0|||
170477613|NCT00413699|616088174|FG001|Initial Period|Missing end of study page|4|||
170477614|NCT00413699|616088175|FG002|Initial Period|Missing end of study page|0|||
170477615|NCT00413699|616088173|FG000|Initial Period|No longer willing to participate|116|||
170477616|NCT00413699|616088174|FG001|Initial Period|No longer willing to participate|368|||
170477617|NCT00413699|616088175|FG002|Initial Period|No longer willing to participate|0|||
170477618|NCT00413699|616088173|FG000|Extension Period|No Longer Willing to Participate|0|||
170477619|NCT00413699|616088174|FG001|Extension Period|No Longer Willing to Participate|0|||
170477620|NCT00413699|616088175|FG002|Extension Period|No Longer Willing to Participate|2|||
170477621|NCT00413699|616088173|FG000|Extension Period|Protocol Violation|0|||
170477622|NCT00413699|616088174|FG001|Extension Period|Protocol Violation|0|||
170477623|NCT00413699|616088175|FG002|Extension Period|Protocol Violation|1|||
170477624|NCT00413699|616088173|FG000|Extension Period|Adverse Event|0|||
170477625|NCT00413699|616088174|FG001|Extension Period|Adverse Event|0|||
170477626|NCT00413699|616088175|FG002|Extension Period|Adverse Event|2|||
170477627|NCT02810457|616088177|FG000|Overall Study|Randomised but no treatment received|2|||
170477628|NCT02810457|616088178|FG001|Overall Study|Randomised but no treatment received|1|||
170477629|NCT02810457|616088177|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
170546972|NCT02568423|616347528|FG000|Overall Study|Lost to Follow-up|0|||
170546973|NCT02568423|616347529|FG001|Overall Study|Lost to Follow-up|2|||
170546974|NCT02568423|616347530|FG002|Overall Study|Lost to Follow-up|0|||
170792760|NCT05671653|617251808|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
170792761|NCT05671653|617251809|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
170792762|NCT05671653|617251810|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
170792763|NCT05671653|617251811|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
170792764|NCT05671653|617251812|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
170792765|NCT05671653|617251813|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
170792766|NCT05671653|617251814|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
170792767|NCT05671653|617251802|FG000|Cohort 2 Period 2|Pregnancy|0|||
170477630|NCT02810457|616088178|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
170477631|NCT02810457|616088177|FG000|Overall Study|Adverse Event|37|||
170477632|NCT02810457|616088178|FG001|Overall Study|Adverse Event|43|||
170477633|NCT02810457|616088177|FG000|Overall Study|Patient decision|31|||
170477634|NCT02810457|616088178|FG001|Overall Study|Patient decision|35|||
170477635|NCT02810457|616088177|FG000|Overall Study|Patient lost to follow-up|2|||
170477636|NCT02810457|616088178|FG001|Overall Study|Patient lost to follow-up|2|||
170477637|NCT02810457|616088177|FG000|Overall Study|Death|39|||
170477638|NCT02810457|616088178|FG001|Overall Study|Death|28|||
170477639|NCT02810457|616088177|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
170792768|NCT05671653|617251803|FG001|Cohort 2 Period 2|Pregnancy|0|||
170892170|NCT01656434|617611941|FG000|Overall Study|Screen failure|2|||
170477640|NCT02810457|616088178|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
170546975|NCT02568423|616347531|FG003|Overall Study|Lost to Follow-up|0|||
170477641|NCT02810457|616088177|FG000|Overall Study|Clinical progression|15|||
170477642|NCT02810457|616088178|FG001|Overall Study|Clinical progression|16|||
170477643|NCT02810457|616088177|FG000|Overall Study|Investigator decision|3|||
170477644|NCT02810457|616088178|FG001|Overall Study|Investigator decision|2|||
170477645|NCT02810457|616088177|FG000|Overall Study|Patient ineligibility|3|||
170477646|NCT02810457|616088178|FG001|Overall Study|Patient ineligibility|0|||
170477647|NCT02810457|616088177|FG000|Overall Study|Miscalculated PD|1|||
170477648|NCT02810457|616088178|FG001|Overall Study|Miscalculated PD|0|||
170477649|NCT02810457|616088177|FG000|Overall Study|Physician Decision|0|||
170477650|NCT02810457|616088178|FG001|Overall Study|Physician Decision|1|||
170477651|NCT01962103|616088182|FG000|Phase 1|Adverse Event|4|||
170477652|NCT01962103|616088183|FG001|Phase 1|Adverse Event|0|||
170477653|NCT01962103|616088184|FG002|Phase 1|Adverse Event|2|||
170477654|NCT01962103|616088185|FG003|Phase 1|Adverse Event|1|||
170477655|NCT01962103|616088186|FG004|Phase 1|Adverse Event|2|||
170477656|NCT01962103|616088187|FG005|Phase 1|Adverse Event|2|||
170477657|NCT01962103|616088188|FG006|Phase 1|Adverse Event|0|||
170477658|NCT01962103|616088189|FG007|Phase 1|Adverse Event|0|||
170477659|NCT01962103|616088190|FG008|Phase 1|Adverse Event|0|||
170477660|NCT01962103|616088182|FG000|Phase 1|Progressive Disease|8|||
170477661|NCT01962103|616088183|FG001|Phase 1|Progressive Disease|6|||
170477662|NCT01962103|616088184|FG002|Phase 1|Progressive Disease|8|||
170477663|NCT01962103|616088185|FG003|Phase 1|Progressive Disease|4|||
170477664|NCT01962103|616088186|FG004|Phase 1|Progressive Disease|5|||
170477665|NCT01962103|616088187|FG005|Phase 1|Progressive Disease|4|||
170477666|NCT01962103|616088188|FG006|Phase 1|Progressive Disease|0|||
170477667|NCT01962103|616088189|FG007|Phase 1|Progressive Disease|0|||
170477668|NCT01962103|616088190|FG008|Phase 1|Progressive Disease|0|||
170477669|NCT01962103|616088182|FG000|Phase 1|Withdrawal by Subject|0|||
170477670|NCT01962103|616088183|FG001|Phase 1|Withdrawal by Subject|0|||
170477671|NCT01962103|616088184|FG002|Phase 1|Withdrawal by Subject|0|||
170477672|NCT01962103|616088185|FG003|Phase 1|Withdrawal by Subject|2|||
170477673|NCT01962103|616088186|FG004|Phase 1|Withdrawal by Subject|0|||
170477674|NCT01962103|616088187|FG005|Phase 1|Withdrawal by Subject|0|||
170477675|NCT01962103|616088188|FG006|Phase 1|Withdrawal by Subject|0|||
170477676|NCT01962103|616088189|FG007|Phase 1|Withdrawal by Subject|0|||
170477677|NCT01962103|616088190|FG008|Phase 1|Withdrawal by Subject|0|||
170477678|NCT01962103|616088182|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
170477679|NCT01962103|616088183|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
170477680|NCT01962103|616088184|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
170477681|NCT01962103|616088185|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
170477682|NCT01962103|616088186|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
170477683|NCT01962103|616088187|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
170477684|NCT01962103|616088188|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
170477685|NCT01962103|616088189|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
170477686|NCT01962103|616088190|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
170477687|NCT01962103|616088182|FG000|Phase 1|Physician Decision|0|||
170477688|NCT01962103|616088183|FG001|Phase 1|Physician Decision|0|||
170477689|NCT01962103|616088184|FG002|Phase 1|Physician Decision|0|||
170477690|NCT01962103|616088185|FG003|Phase 1|Physician Decision|1|||
170477691|NCT01962103|616088186|FG004|Phase 1|Physician Decision|0|||
170477692|NCT01962103|616088187|FG005|Phase 1|Physician Decision|0|||
170477693|NCT01962103|616088188|FG006|Phase 1|Physician Decision|0|||
170477694|NCT01962103|616088189|FG007|Phase 1|Physician Decision|0|||
170477695|NCT01962103|616088190|FG008|Phase 1|Physician Decision|0|||
170477696|NCT01962103|616088182|FG000|Phase 1|Symptomatic Deterioration|3|||
170477697|NCT01962103|616088183|FG001|Phase 1|Symptomatic Deterioration|2|||
170477698|NCT01962103|616088184|FG002|Phase 1|Symptomatic Deterioration|2|||
170477699|NCT01962103|616088185|FG003|Phase 1|Symptomatic Deterioration|2|||
170477700|NCT01962103|616088186|FG004|Phase 1|Symptomatic Deterioration|1|||
170639447|NCT05019521|616691305|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
170639448|NCT05019521|616691306|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
170477701|NCT01962103|616088187|FG005|Phase 1|Symptomatic Deterioration|1|||
170477702|NCT01962103|616088188|FG006|Phase 1|Symptomatic Deterioration|0|||
170477703|NCT01962103|616088189|FG007|Phase 1|Symptomatic Deterioration|0|||
170477704|NCT01962103|616088190|FG008|Phase 1|Symptomatic Deterioration|0|||
170477705|NCT01962103|616088182|FG000|Phase 1|Miscellaneous|1|||
170477706|NCT01962103|616088183|FG001|Phase 1|Miscellaneous|0|||
170477707|NCT01962103|616088184|FG002|Phase 1|Miscellaneous|0|||
170477708|NCT01962103|616088185|FG003|Phase 1|Miscellaneous|0|||
170477709|NCT01962103|616088186|FG004|Phase 1|Miscellaneous|0|||
170477710|NCT01962103|616088187|FG005|Phase 1|Miscellaneous|0|||
170477711|NCT01962103|616088188|FG006|Phase 1|Miscellaneous|0|||
170477712|NCT01962103|616088189|FG007|Phase 1|Miscellaneous|0|||
170792769|NCT05671653|617251804|FG002|Cohort 2 Period 2|Pregnancy|0|||
170477713|NCT01962103|616088190|FG008|Phase 1|Miscellaneous|0|||
170477714|NCT01962103|616088182|FG000|Phase 2|Adverse Event|0|||
170477715|NCT01962103|616088183|FG001|Phase 2|Adverse Event|0|||
170477716|NCT01962103|616088184|FG002|Phase 2|Adverse Event|0|||
170477717|NCT01962103|616088185|FG003|Phase 2|Adverse Event|0|||
170477718|NCT01962103|616088186|FG004|Phase 2|Adverse Event|0|||
170477719|NCT01962103|616088187|FG005|Phase 2|Adverse Event|0|||
170639449|NCT05019521|616691307|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
170639450|NCT05019521|616691301|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
170639451|NCT05019521|616691302|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639452|NCT05019521|616691303|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639453|NCT05019521|616691304|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639454|NCT05019521|616691305|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639455|NCT05019521|616691306|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639456|NCT05019521|616691307|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639457|NCT05019521|616691301|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
170639458|NCT05019521|616691302|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
170477720|NCT01962103|616088188|FG006|Phase 2|Adverse Event|1|||
170477721|NCT01962103|616088189|FG007|Phase 2|Adverse Event|0|||
170477722|NCT01962103|616088190|FG008|Phase 2|Adverse Event|3|||
170477723|NCT01962103|616088182|FG000|Phase 2|Progressive Disease|0|||
170477724|NCT01962103|616088183|FG001|Phase 2|Progressive Disease|0|||
170477725|NCT01962103|616088184|FG002|Phase 2|Progressive Disease|0|||
170477726|NCT01962103|616088185|FG003|Phase 2|Progressive Disease|0|||
170477727|NCT01962103|616088186|FG004|Phase 2|Progressive Disease|0|||
170477728|NCT01962103|616088187|FG005|Phase 2|Progressive Disease|0|||
170477729|NCT01962103|616088188|FG006|Phase 2|Progressive Disease|11|||
170477730|NCT01962103|616088189|FG007|Phase 2|Progressive Disease|12|||
170477731|NCT01962103|616088190|FG008|Phase 2|Progressive Disease|11|||
170477732|NCT01962103|616088182|FG000|Phase 2|Symptomatic Deterioration|0|||
170477733|NCT01962103|616088183|FG001|Phase 2|Symptomatic Deterioration|0|||
170477734|NCT01962103|616088184|FG002|Phase 2|Symptomatic Deterioration|0|||
170477735|NCT01962103|616088185|FG003|Phase 2|Symptomatic Deterioration|0|||
170477736|NCT01962103|616088186|FG004|Phase 2|Symptomatic Deterioration|0|||
170477737|NCT01962103|616088187|FG005|Phase 2|Symptomatic Deterioration|0|||
170477738|NCT01962103|616088188|FG006|Phase 2|Symptomatic Deterioration|2|||
170477739|NCT01962103|616088189|FG007|Phase 2|Symptomatic Deterioration|2|||
170477740|NCT01962103|616088190|FG008|Phase 2|Symptomatic Deterioration|0|||
170477741|NCT01321749|616088193|FG000|Overall Study|Lost to Follow-up|4|||
170477742|NCT01321749|616088194|FG001|Overall Study|Lost to Follow-up|11|||
170477743|NCT01321749|616088193|FG000|Overall Study|Protocol Violation|4|||
170477744|NCT01321749|616088194|FG001|Overall Study|Protocol Violation|7|||
170477745|NCT01321749|616088193|FG000|Overall Study|Withdrawal by Subject|5|||
170477746|NCT01321749|616088194|FG001|Overall Study|Withdrawal by Subject|4|||
170477747|NCT02750618|616088198|FG000|Overall Study|Withdrawal by Subject|1|||
170477748|NCT04179838|616088199|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
170477749|NCT04179838|616088200|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
170477750|NCT04179838|616088199|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
170477751|NCT04179838|616088200|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
170477752|NCT02763046|616088207|FG000|Overall Study|Adverse Event|5|||
170477753|NCT02763046|616088208|FG001|Overall Study|Adverse Event|4|||
170477754|NCT02763046|616088209|FG002|Overall Study|Adverse Event|0|||
170477755|NCT02763046|616088207|FG000|Overall Study|Lack of Efficacy|1|||
170477756|NCT02763046|616088208|FG001|Overall Study|Lack of Efficacy|1|||
170477757|NCT02763046|616088209|FG002|Overall Study|Lack of Efficacy|3|||
170477758|NCT02763046|616088207|FG000|Overall Study|Physician Decision|1|||
170477759|NCT02763046|616088208|FG001|Overall Study|Physician Decision|0|||
170477760|NCT02763046|616088209|FG002|Overall Study|Physician Decision|1|||
170477761|NCT02763046|616088207|FG000|Overall Study|Subject/guardian decision|2|||
170477762|NCT02763046|616088208|FG001|Overall Study|Subject/guardian decision|0|||
170477763|NCT02763046|616088209|FG002|Overall Study|Subject/guardian decision|4|||
170477764|NCT03283566|616088212|FG000|Overall Study|Lost to Follow-up|1|||
170477765|NCT03283566|616088213|FG001|Overall Study|Lost to Follow-up|2|||
170477766|NCT00818766|616088214|FG000|Overall Study|Could not be Contacted on Day 28|11|||
170477767|NCT00818766|616088215|FG001|Overall Study|Could not be Contacted on Day 28|10|||
170477768|NCT00818766|616088214|FG000|Overall Study|Death|1|||
170477769|NCT00818766|616088215|FG001|Overall Study|Death|0|||
170477770|NCT00818766|616088214|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
170477771|NCT00818766|616088215|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
170477772|NCT02439216|616088218|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
170546976|NCT02568423|616347532|FG004|Overall Study|Lost to Follow-up|0|||
170546977|NCT02568423|616347533|FG005|Overall Study|Lost to Follow-up|0|||
170546978|NCT02568423|616347534|FG006|Overall Study|Lost to Follow-up|0|||
170546979|NCT02568423|616347535|FG007|Overall Study|Lost to Follow-up|0|||
170546980|NCT02568423|616347528|FG000|Overall Study|Physician Decision|0|||
170546981|NCT02568423|616347529|FG001|Overall Study|Physician Decision|0|||
170546982|NCT02568423|616347530|FG002|Overall Study|Physician Decision|0|||
170546983|NCT02568423|616347531|FG003|Overall Study|Physician Decision|0|||
170546984|NCT02568423|616347532|FG004|Overall Study|Physician Decision|0|||
170546985|NCT02568423|616347533|FG005|Overall Study|Physician Decision|1|||
170546986|NCT02568423|616347534|FG006|Overall Study|Physician Decision|0|||
170792770|NCT05671653|617251805|FG003|Cohort 2 Period 2|Pregnancy|0|||
170792771|NCT05671653|617251806|FG004|Cohort 2 Period 2|Pregnancy|0|||
170792772|NCT05671653|617251807|FG005|Cohort 2 Period 2|Pregnancy|0|||
170792773|NCT05671653|617251808|FG006|Cohort 2 Period 2|Pregnancy|0|||
170792774|NCT05671653|617251809|FG007|Cohort 2 Period 2|Pregnancy|0|||
170792775|NCT05671653|617251810|FG008|Cohort 2 Period 2|Pregnancy|0|||
170792776|NCT05671653|617251811|FG009|Cohort 2 Period 2|Pregnancy|0|||
170792777|NCT05671653|617251812|FG010|Cohort 2 Period 2|Pregnancy|1|||
170792778|NCT05671653|617251813|FG011|Cohort 2 Period 2|Pregnancy|0|||
170792779|NCT05671653|617251814|FG012|Cohort 2 Period 2|Pregnancy|0|||
170792780|NCT05671653|617251802|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
170792781|NCT05671653|617251803|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
170792782|NCT05671653|617251804|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
170792783|NCT05671653|617251805|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
170477773|NCT02439216|616088219|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
170477774|NCT02439216|616088220|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
170477775|NCT02439216|616088221|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
170477776|NCT02439216|616088222|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
170477777|NCT02439216|616088223|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
170477778|NCT02439216|616088224|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
170477779|NCT02439216|616088225|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
170477780|NCT02439216|616088226|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
170477781|NCT02439216|616088218|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
170477782|NCT02439216|616088219|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
170477783|NCT02439216|616088220|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
170477784|NCT02439216|616088221|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
170477785|NCT02439216|616088222|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
170477786|NCT02439216|616088223|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
170477787|NCT02439216|616088224|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
170477788|NCT02439216|616088225|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
170477789|NCT02439216|616088226|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
170477790|NCT02439216|616088218|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
170477791|NCT02439216|616088219|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
170477792|NCT02439216|616088220|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
170546987|NCT02568423|616347535|FG007|Overall Study|Physician Decision|0|||
170546988|NCT03794544|616347536|FG000|Overall Study|Withdrawal by Subject|1|||
170546989|NCT03794544|616347537|FG001|Overall Study|Withdrawal by Subject|1|||
170546990|NCT03794544|616347538|FG002|Overall Study|Withdrawal by Subject|0|||
170546991|NCT03794544|616347539|FG003|Overall Study|Withdrawal by Subject|0|||
170546992|NCT03794544|616347536|FG000|Overall Study|Death|0|||
170546993|NCT03794544|616347537|FG001|Overall Study|Death|0|||
170546994|NCT03794544|616347538|FG002|Overall Study|Death|0|||
170546995|NCT03794544|616347539|FG003|Overall Study|Death|1|||
170546996|NCT03794544|616347536|FG000|Overall Study|Lost to Follow-up|0|||
170546997|NCT03794544|616347537|FG001|Overall Study|Lost to Follow-up|1|||
170546998|NCT03794544|616347538|FG002|Overall Study|Lost to Follow-up|1|||
170546999|NCT03794544|616347539|FG003|Overall Study|Lost to Follow-up|0|||
170547000|NCT03794544|616347536|FG000|Overall Study|Other|0|||
170547001|NCT03794544|616347537|FG001|Overall Study|Other|1|||
170547002|NCT03794544|616347538|FG002|Overall Study|Other|0|||
170547003|NCT03794544|616347539|FG003|Overall Study|Other|0|||
170547004|NCT02741193|616347540|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
170547005|NCT02741193|616347540|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
170547006|NCT01428713|616347542|FG000|Overall Study|Non-compliance|2|||
170547007|NCT01428713|616347543|FG001|Overall Study|Non-compliance|2|||
170547008|NCT01428713|616347542|FG000|Overall Study|Withdrawal by Subject|1|||
170547009|NCT01428713|616347543|FG001|Overall Study|Withdrawal by Subject|1|||
170547010|NCT01428713|616347542|FG000|Overall Study|Adverse Event|0|||
170547011|NCT01428713|616347543|FG001|Overall Study|Adverse Event|2|||
170547012|NCT00585585|616347548|FG000|Overall Study|Adverse Event|1|||
170547013|NCT00604383|616347558|FG000|Overall Study|Withdrawal by Subject|33|||
170547014|NCT00604383|616347559|FG001|Overall Study|Withdrawal by Subject|31|||
170547015|NCT00604383|616347558|FG000|Overall Study|Lost to Follow-up|24|||
170547016|NCT00604383|616347559|FG001|Overall Study|Lost to Follow-up|19|||
170547017|NCT00604383|616347558|FG000|Overall Study|Death|14|||
170547018|NCT00604383|616347559|FG001|Overall Study|Death|22|||
170547019|NCT00604383|616347558|FG000|Overall Study|Adverse Event|16|||
170547020|NCT00604383|616347559|FG001|Overall Study|Adverse Event|9|||
170547021|NCT00604383|616347558|FG000|Overall Study|Physician Decision|0|||
170547022|NCT00604383|616347559|FG001|Overall Study|Physician Decision|3|||
170547023|NCT01698008|616347560|FG000|Overall Study|Withdrawal by Subject|1|||
170547024|NCT01698008|616347561|FG001|Overall Study|Withdrawal by Subject|2|||
170547025|NCT02619812|616347562|FG000|Overall Study|Withdrawal by Subject|0|||
170547026|NCT02619812|616347563|FG001|Overall Study|Withdrawal by Subject|0|||
170639459|NCT05019521|616691303|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
170639460|NCT05019521|616691304|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
170639461|NCT05019521|616691305|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
170639462|NCT05019521|616691306|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
170639463|NCT05019521|616691307|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
170639464|NCT05019521|616691301|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
170639465|NCT05019521|616691302|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
170792784|NCT05671653|617251806|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
170792785|NCT05671653|617251807|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
170792786|NCT05671653|617251808|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
170477793|NCT02439216|616088221|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
170477794|NCT02439216|616088222|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
170477795|NCT02439216|616088223|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
170477796|NCT02439216|616088224|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
170477797|NCT02439216|616088225|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
170477798|NCT02439216|616088226|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
170477799|NCT02439216|616088218|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
170477800|NCT02439216|616088219|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
170477801|NCT02439216|616088220|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
170477802|NCT02439216|616088221|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
170547027|NCT02619812|616347564|FG002|Overall Study|Withdrawal by Subject|1|||
170547028|NCT02619812|616347565|FG003|Overall Study|Withdrawal by Subject|2|||
170547029|NCT05987540|616347566|FG000|Overall Study|Withdrawal by Subject|2|||
170547030|NCT05987540|616347566|FG000|Overall Study|Death|1|||
170547031|NCT05987540|616347566|FG000|Overall Study|Study Termination|1|||
170547032|NCT05987540|616347566|FG000|Overall Study|Adverse Event|2|||
170547033|NCT00122187|616347567|FG000|Overall Study|Withdrew because of resource limitations|2|||
170547034|NCT00122187|616347568|FG001|Overall Study|Withdrew because of resource limitations|2|||
170547035|NCT02061592|616347569|FG000|Period 1|Withdrawal by Subject|1|||
170547036|NCT02061592|616347570|FG001|Period 1|Withdrawal by Subject|0|||
170547037|NCT02061592|616347569|FG000|Period 1|Protocol Violation|1|||
170547038|NCT02061592|616347570|FG001|Period 1|Protocol Violation|0|||
170547039|NCT02061592|616347569|FG000|Period 2|Lost to Follow-up|0|||
170547040|NCT02061592|616347570|FG001|Period 2|Lost to Follow-up|1|||
170547041|NCT04433975|616347571|FG000|1-month Follow Up|Withdrawal by Subject|1|||
170547042|NCT04433975|616347572|FG001|1-month Follow Up|Withdrawal by Subject|1|||
170547043|NCT04433975|616347571|FG000|1-month Follow Up|Lost to Follow-up|21|||
170547044|NCT04433975|616347572|FG001|1-month Follow Up|Lost to Follow-up|25|||
170547045|NCT04433975|616347571|FG000|3-month Follow Up|Lost to Follow-up|20|||
170547046|NCT04433975|616347572|FG001|3-month Follow Up|Lost to Follow-up|24|||
170547047|NCT04433975|616347571|FG000|3-month Follow Up|Death|1|||
170547048|NCT04433975|616347572|FG001|3-month Follow Up|Death|0|||
170547049|NCT04433975|616347571|FG000|3-month Follow Up|Withdrawal by Subject|2|||
170547050|NCT04433975|616347572|FG001|3-month Follow Up|Withdrawal by Subject|0|||
170547051|NCT04433975|616347571|FG000|6-month Follow Up|Lost to Follow-up|23|||
170547052|NCT04433975|616347572|FG001|6-month Follow Up|Lost to Follow-up|28|||
170547053|NCT04433975|616347571|FG000|6-month Follow Up|Withdrawal by Subject|1|||
170547054|NCT04433975|616347572|FG001|6-month Follow Up|Withdrawal by Subject|1|||
170547055|NCT04433975|616347571|FG000|9-month Follow Up|Lost to Follow-up|27|||
170547056|NCT04433975|616347572|FG001|9-month Follow Up|Lost to Follow-up|36|||
170547057|NCT04433975|616347571|FG000|9-month Follow Up|Death|0|||
170547058|NCT04433975|616347572|FG001|9-month Follow Up|Death|1|||
170547059|NCT04433975|616347571|FG000|12-month Follow Up|Lost to Follow-up|27|||
170547060|NCT04433975|616347572|FG001|12-month Follow Up|Lost to Follow-up|31|||
170547061|NCT04882215|616347573|FG000|Overall Study|Withdrawal by Subject|5|||
170547062|NCT04882215|616347574|FG001|Overall Study|Withdrawal by Subject|0|||
170547063|NCT04263532|616347575|FG000|Overall Study|Withdrawal by Subject|2|||
170547064|NCT04263532|616347576|FG001|Overall Study|Withdrawal by Subject|0|||
170547065|NCT01290731|616347577|FG000|Overall Study|Withdrawal by Subject|1|||
170547066|NCT02181738|616347580|FG000|Overall Study|Participant Withdrew Consent|2|||
170547067|NCT02181738|616347581|FG001|Overall Study|Participant Withdrew Consent|1|||
170547068|NCT02181738|616347582|FG002|Overall Study|Participant Withdrew Consent|1|||
170547069|NCT02181738|616347583|FG003|Overall Study|Participant Withdrew Consent|1|||
170547070|NCT02181738|616347580|FG000|Overall Study|Lost to Follow-up|1|||
170547071|NCT02181738|616347581|FG001|Overall Study|Lost to Follow-up|2|||
170547072|NCT02181738|616347582|FG002|Overall Study|Lost to Follow-up|1|||
170547073|NCT02181738|616347583|FG003|Overall Study|Lost to Follow-up|1|||
170639466|NCT05019521|616691303|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
170792787|NCT05671653|617251809|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
170547074|NCT02181738|616347580|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
170547075|NCT02181738|616347581|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
170547076|NCT02181738|616347582|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
170792788|NCT05671653|617251810|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
170477803|NCT02439216|616088222|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
170477804|NCT02439216|616088223|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
170477805|NCT02439216|616088224|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
170477806|NCT02439216|616088225|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
170477807|NCT02439216|616088226|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
170477808|NCT02439216|616088218|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
170477809|NCT02439216|616088219|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
170477810|NCT02439216|616088220|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
170477811|NCT02439216|616088221|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
170477812|NCT02439216|616088222|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
170477813|NCT02439216|616088223|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
170477814|NCT02439216|616088224|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
170477815|NCT02439216|616088225|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
170477816|NCT02439216|616088226|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
170477817|NCT02094300|616088230|FG000|Overall Study|Death|7|||
170477818|NCT02094300|616088230|FG000|Overall Study|Lost to Follow-up|10|||
170477819|NCT02094300|616088230|FG000|Overall Study|Still be eligible for follow-up|3|||
170477820|NCT00725491|616088237|FG000|Overall Study|Adverse Event|3|||
170477821|NCT00725491|616088238|FG001|Overall Study|Adverse Event|2|||
170477822|NCT00725491|616088237|FG000|Overall Study|Pregnancy|0|||
170477823|NCT00725491|616088238|FG001|Overall Study|Pregnancy|3|||
170477824|NCT00725491|616088237|FG000|Overall Study|Risk for hyperstimulation|2|||
170477825|NCT00725491|616088238|FG001|Overall Study|Risk for hyperstimulation|9|||
170477826|NCT00725491|616088237|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
170477827|NCT00725491|616088238|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
170477828|NCT00725491|616088237|FG000|Overall Study|Fertilization failure|0|||
170477829|NCT00725491|616088238|FG001|Overall Study|Fertilization failure|1|||
170477830|NCT00725491|616088237|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
170477831|NCT00725491|616088238|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
170477832|NCT04428034|616088239|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
170477833|NCT01495000|616088240|FG000|Overall Study|Lost to Follow-up|2|||
170477834|NCT01495000|616088241|FG001|Overall Study|Lost to Follow-up|2|||
170477835|NCT01495000|616088240|FG000|Overall Study|Protocol Violation|1|||
170477836|NCT01495000|616088241|FG001|Overall Study|Protocol Violation|0|||
170477837|NCT01495000|616088240|FG000|Overall Study|Withdrawal by Subject|10|||
170477838|NCT01495000|616088241|FG001|Overall Study|Withdrawal by Subject|10|||
170477839|NCT02070965|616088242|FG000|Overall Study|Lost to Follow-up|0|||
170477840|NCT02070965|616088243|FG001|Overall Study|Lost to Follow-up|1|||
170477841|NCT02070965|616088244|FG002|Overall Study|Lost to Follow-up|0|||
170477842|NCT02070965|616088242|FG000|Overall Study|Withdrawal by Subject|1|||
170477843|NCT02070965|616088243|FG001|Overall Study|Withdrawal by Subject|1|||
170477844|NCT02070965|616088244|FG002|Overall Study|Withdrawal by Subject|1|||
170477845|NCT02070965|616088242|FG000|Overall Study|Subject moved|1|||
170477846|NCT02070965|616088243|FG001|Overall Study|Subject moved|0|||
170477847|NCT02070965|616088244|FG002|Overall Study|Subject moved|0|||
170477848|NCT00276484|616088246|FG000|Overall Study|Adverse Event|4|||
170477849|NCT00276484|616088247|FG001|Overall Study|Adverse Event|7|||
170477850|NCT00276484|616088246|FG000|Overall Study|Lost to Follow-up|1|||
170477851|NCT00276484|616088247|FG001|Overall Study|Lost to Follow-up|1|||
170477852|NCT00276484|616088246|FG000|Overall Study|Protocol Violation|0|||
170477853|NCT00276484|616088247|FG001|Overall Study|Protocol Violation|1|||
170477854|NCT00276484|616088246|FG000|Overall Study|Withdrawal by Subject|4|||
170477855|NCT00276484|616088247|FG001|Overall Study|Withdrawal by Subject|3|||
170477856|NCT00276484|616088246|FG000|Overall Study|Could not take time off work|0|||
170477857|NCT00276484|616088247|FG001|Overall Study|Could not take time off work|1|||
170477858|NCT02790437|616088257|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
170477859|NCT02790437|616088258|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
170477860|NCT02790437|616088257|FG000|Overall Study|Adverse Event|1|||
170477861|NCT02790437|616088258|FG001|Overall Study|Adverse Event|0|||
170477862|NCT02790437|616088257|FG000|Overall Study|Withdrawal by Subject|1|||
170477863|NCT02790437|616088258|FG001|Overall Study|Withdrawal by Subject|0|||
170477864|NCT01202175|616088259|FG000|Overall Study|Lost to Follow-up|2|||
170477865|NCT01202175|616088259|FG000|Overall Study|Withdrawal by Subject|1|||
170477866|NCT01202175|616088259|FG000|Overall Study|Adverse Event|2|||
170477867|NCT03347110|616088262|FG000|Overall Study|Other (Participant is incarcerated)|1|||
170547077|NCT02181738|616347583|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
170547078|NCT02181738|616347580|FG000|Overall Study|Poor/Non-Compliance|1|||
170547079|NCT02181738|616347581|FG001|Overall Study|Poor/Non-Compliance|0|||
170547080|NCT02181738|616347582|FG002|Overall Study|Poor/Non-Compliance|2|||
170547081|NCT02181738|616347583|FG003|Overall Study|Poor/Non-Compliance|1|||
170547082|NCT02181738|616347580|FG000|Overall Study|Disease Progression|28|||
170477868|NCT03347110|616088262|FG000|Overall Study|Withdrawal by Subject|9|||
170547083|NCT02181738|616347581|FG001|Overall Study|Disease Progression|35|||
170792789|NCT05671653|617251811|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
170792790|NCT05671653|617251812|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
170792791|NCT05671653|617251813|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
170792792|NCT05671653|617251814|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
170477869|NCT03347110|616088262|FG000|Overall Study|Lost to Follow-up|1|||
170477870|NCT03347110|616088262|FG000|Overall Study|Lack of Efficacy|2|||
170477871|NCT03347110|616088262|FG000|Overall Study|Adverse Event, non-fatal|9|||
170477872|NCT01321879|616088263|FG000|Overall Study|Lack of Efficacy|5|||
170477873|NCT01321879|616088263|FG000|Overall Study|Adverse Event|5|||
170477874|NCT01321879|616088263|FG000|Overall Study|Death|3|||
170477875|NCT01321879|616088263|FG000|Overall Study|Withdrawal by Subject|1|||
170477876|NCT01125189|616088270|FG000|Treatment Period|Lack of Efficacy|15|||
170477877|NCT01125189|616088271|FG001|Treatment Period|Lack of Efficacy|18|||
170477878|NCT01125189|616088272|FG002|Treatment Period|Lack of Efficacy|25|||
170477879|NCT01125189|616088270|FG000|Treatment Period|Adverse Event|7|||
170477880|NCT01125189|616088271|FG001|Treatment Period|Adverse Event|8|||
170477881|NCT01125189|616088272|FG002|Treatment Period|Adverse Event|8|||
170477882|NCT01125189|616088270|FG000|Treatment Period|Withdrawal by Subject|3|||
170477883|NCT01125189|616088271|FG001|Treatment Period|Withdrawal by Subject|1|||
170477884|NCT01125189|616088272|FG002|Treatment Period|Withdrawal by Subject|1|||
170477885|NCT01125189|616088270|FG000|Treatment Period|Death|1|||
170477886|NCT01125189|616088271|FG001|Treatment Period|Death|0|||
170477887|NCT01125189|616088272|FG002|Treatment Period|Death|0|||
170477888|NCT01125189|616088270|FG000|Treatment Period|Lost to Follow-up|1|||
170477889|NCT01125189|616088271|FG001|Treatment Period|Lost to Follow-up|2|||
170477890|NCT01125189|616088272|FG002|Treatment Period|Lost to Follow-up|1|||
170477891|NCT01125189|616088270|FG000|Treatment Period|Poor compliance/noncompliance|0|||
170477892|NCT01125189|616088271|FG001|Treatment Period|Poor compliance/noncompliance|1|||
170477893|NCT01125189|616088272|FG002|Treatment Period|Poor compliance/noncompliance|0|||
170477894|NCT01125189|616088270|FG000|Treatment Period|Participants requested to discontinue|1|||
170477895|NCT01125189|616088271|FG001|Treatment Period|Participants requested to discontinue|3|||
170477896|NCT01125189|616088272|FG002|Treatment Period|Participants requested to discontinue|4|||
170477897|NCT01125189|616088270|FG000|Treatment Period|Other reasons|1|||
170477898|NCT01125189|616088271|FG001|Treatment Period|Other reasons|1|||
170477899|NCT01125189|616088272|FG002|Treatment Period|Other reasons|0|||
170477900|NCT01125189|616088270|FG000|Treatment Period|Completed 24 week treatment period only|2|||
170477901|NCT01125189|616088271|FG001|Treatment Period|Completed 24 week treatment period only|1|||
170477902|NCT01125189|616088272|FG002|Treatment Period|Completed 24 week treatment period only|2|||
170477903|NCT01125189|616088270|FG000|Follow up Period|Withdrawal by Subject|3|||
170477904|NCT01125189|616088271|FG001|Follow up Period|Withdrawal by Subject|2|||
170477905|NCT01125189|616088272|FG002|Follow up Period|Withdrawal by Subject|5|||
170477906|NCT01125189|616088270|FG000|Follow up Period|Death|1|||
170477907|NCT01125189|616088271|FG001|Follow up Period|Death|0|||
170477908|NCT01125189|616088272|FG002|Follow up Period|Death|0|||
170477909|NCT01125189|616088270|FG000|Follow up Period|Lost to Follow-up|12|||
170792793|NCT05671653|617251802|FG000|Cohort 2 Period 2|Other|0|||
170792794|NCT05671653|617251803|FG001|Cohort 2 Period 2|Other|0|||
170477910|NCT01125189|616088271|FG001|Follow up Period|Lost to Follow-up|9|||
170477911|NCT01125189|616088272|FG002|Follow up Period|Lost to Follow-up|6|||
170477912|NCT01125189|616088270|FG000|Follow up Period|Other reasons|4|||
170477913|NCT01125189|616088271|FG001|Follow up Period|Other reasons|4|||
170477914|NCT01125189|616088272|FG002|Follow up Period|Other reasons|5|||
170477915|NCT00114140|616088273|FG000|Overall Study|Protocol Violation|7|||
170547084|NCT02181738|616347582|FG002|Overall Study|Disease Progression|40|||
170547085|NCT02181738|616347583|FG003|Overall Study|Disease Progression|0|||
170547086|NCT02181738|616347580|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
170547087|NCT02181738|616347581|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
170547088|NCT02181738|616347582|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
170547089|NCT02181738|616347583|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
170547090|NCT02181738|616347580|FG000|Overall Study|Study Drug Toxicity|6|||
170547091|NCT02181738|616347581|FG001|Overall Study|Study Drug Toxicity|11|||
170547092|NCT02181738|616347582|FG002|Overall Study|Study Drug Toxicity|8|||
170547093|NCT02181738|616347583|FG003|Overall Study|Study Drug Toxicity|1|||
170547094|NCT02181738|616347580|FG000|Overall Study|Other Reasons|14|||
170639467|NCT05019521|616691304|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
170639468|NCT05019521|616691305|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
170792795|NCT05671653|617251804|FG002|Cohort 2 Period 2|Other|0|||
170792796|NCT05671653|617251805|FG003|Cohort 2 Period 2|Other|0|||
170792797|NCT05671653|617251806|FG004|Cohort 2 Period 2|Other|0|||
170792798|NCT05671653|617251807|FG005|Cohort 2 Period 2|Other|0|||
170477916|NCT01518322|616088274|FG000|Overall Study|FeNO measurement was missing|13|||
170477917|NCT01641640|616088275|FG000|Overall Study|Enrolled but not treated|1|||
170477918|NCT01641640|616088275|FG000|Overall Study|Efficacy failure|29|||
170477919|NCT01641640|616088275|FG000|Overall Study|Lost to Follow-up|3|||
170477920|NCT01641640|616088275|FG000|Overall Study|Withdrawal by Subject|2|||
170477921|NCT01641640|616088275|FG000|Overall Study|Adverse Event|1|||
170477922|NCT03238651|616088285|FG000|Overall Study|Other|0|||
170792799|NCT05671653|617251808|FG006|Cohort 2 Period 2|Other|0|||
170477923|NCT03238651|616088286|FG001|Overall Study|Other|0|||
170477924|NCT03238651|616088287|FG002|Overall Study|Other|0|||
170477925|NCT03238651|616088288|FG003|Overall Study|Other|0|||
170477926|NCT03238651|616088289|FG004|Overall Study|Other|1|||
170477927|NCT03238651|616088285|FG000|Overall Study|Progressive Disease|2|||
170477928|NCT03238651|616088286|FG001|Overall Study|Progressive Disease|2|||
170477929|NCT03238651|616088287|FG002|Overall Study|Progressive Disease|2|||
170477930|NCT03238651|616088288|FG003|Overall Study|Progressive Disease|2|||
170477931|NCT03238651|616088289|FG004|Overall Study|Progressive Disease|0|||
170477932|NCT03238651|616088285|FG000|Overall Study|Withdrawal by Subject|0|||
170477933|NCT03238651|616088286|FG001|Overall Study|Withdrawal by Subject|1|||
170477934|NCT03238651|616088287|FG002|Overall Study|Withdrawal by Subject|0|||
170477935|NCT03238651|616088288|FG003|Overall Study|Withdrawal by Subject|1|||
170477936|NCT03238651|616088289|FG004|Overall Study|Withdrawal by Subject|0|||
170477937|NCT03238651|616088285|FG000|Overall Study|Adverse Event|1|||
170477938|NCT03238651|616088286|FG001|Overall Study|Adverse Event|3|||
170477939|NCT03238651|616088287|FG002|Overall Study|Adverse Event|2|||
170477940|NCT03238651|616088288|FG003|Overall Study|Adverse Event|0|||
170477941|NCT03238651|616088289|FG004|Overall Study|Adverse Event|0|||
170477942|NCT01930162|616088290|FG000|Overall Study|Abnormal test procedure result(s)|4|||
170477943|NCT01930162|616088290|FG000|Overall Study|Death|1|||
170477944|NCT00428246|616088291|FG000|Overall Study|Withdrawal by Subject|0|||
170477945|NCT00428246|616088292|FG001|Overall Study|Withdrawal by Subject|0|||
170477946|NCT00428246|616088293|FG002|Overall Study|Withdrawal by Subject|1|||
170477947|NCT00428246|616088291|FG000|Overall Study|Adverse Event|1|||
170477948|NCT00428246|616088292|FG001|Overall Study|Adverse Event|0|||
170477949|NCT00428246|616088293|FG002|Overall Study|Adverse Event|0|||
170477950|NCT05198518|616088296|FG000|Screening Visit|Deemed unable to participate|58|||
170477951|NCT05198518|616088297|FG001|Screening Visit|Deemed unable to participate|0|||
170477952|NCT05198518|616088298|FG002|Screening Visit|Deemed unable to participate|0|||
170477953|NCT01870778|616088305|FG000|Overall Study|Withdrawal by Subject|8|||
170477954|NCT01870778|616088306|FG001|Overall Study|Withdrawal by Subject|7|||
170477955|NCT01870778|616088305|FG000|Overall Study|Lost to Follow-up|0|||
170477956|NCT01870778|616088306|FG001|Overall Study|Lost to Follow-up|2|||
170477957|NCT00124917|616088307|FG000|Overall Study|Physician Decision|3|||
170477958|NCT01197911|616088312|FG000|Overall Study|Adverse Event|0|||
170477959|NCT01197911|616088313|FG001|Overall Study|Adverse Event|0|||
170477960|NCT01197911|616088314|FG002|Overall Study|Adverse Event|1|||
170477961|NCT04338022|616088315|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
170477962|NCT04338022|616088316|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
170477963|NCT04338022|616088315|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
170477964|NCT04338022|616088316|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
170477965|NCT04338022|616088315|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
170477966|NCT04338022|616088316|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
170477967|NCT04338022|616088315|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
170477968|NCT04338022|616088316|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
170477969|NCT04338022|616088315|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
170477970|NCT04338022|616088316|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
170477971|NCT04338022|616088315|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
170477972|NCT04338022|616088316|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
170477973|NCT04338022|616088315|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
170477974|NCT04338022|616088316|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
170477975|NCT04338022|616088315|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
170477976|NCT04338022|616088316|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
170477977|NCT04338022|616088315|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
170477978|NCT04338022|616088316|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
170477979|NCT04338022|616088315|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
170477980|NCT04338022|616088316|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
170477981|NCT04338022|616088315|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
170477982|NCT04338022|616088316|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
170477983|NCT04338022|616088315|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
170477984|NCT04338022|616088316|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
170477985|NCT04338022|616088315|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
170547095|NCT02181738|616347581|FG001|Overall Study|Other Reasons|16|||
170547096|NCT02181738|616347582|FG002|Overall Study|Other Reasons|28|||
170547097|NCT02181738|616347583|FG003|Overall Study|Other Reasons|0|||
170547098|NCT02181738|616347580|FG000|Overall Study|Maximum Clinical Benefit|3|||
170547099|NCT02181738|616347581|FG001|Overall Study|Maximum Clinical Benefit|0|||
170547100|NCT02181738|616347582|FG002|Overall Study|Maximum Clinical Benefit|1|||
170547101|NCT02181738|616347583|FG003|Overall Study|Maximum Clinical Benefit|0|||
170547102|NCT02181738|616347580|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
170547103|NCT02181738|616347581|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
170477986|NCT04338022|616088316|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
170477987|NCT04338022|616088315|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
170477988|NCT04338022|616088316|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
170477989|NCT01808573|616088318|FG000|Overall Study|Death|212|||
170477990|NCT01808573|616088319|FG001|Overall Study|Death|240|||
170477991|NCT01808573|616088318|FG000|Overall Study|Withdrawal by Subject|12|||
170477992|NCT01808573|616088319|FG001|Overall Study|Withdrawal by Subject|10|||
170477993|NCT01808573|616088318|FG000|Overall Study|Lost to Follow-up|3|||
170477994|NCT01808573|616088319|FG001|Overall Study|Lost to Follow-up|0|||
170477995|NCT01808573|616088318|FG000|Overall Study|Discontinuation of study by sponsor|79|||
170477996|NCT01808573|616088319|FG001|Overall Study|Discontinuation of study by sponsor|64|||
170477997|NCT01808573|616088318|FG000|Overall Study|Randomized in Error|1|||
170477998|NCT01808573|616088319|FG001|Overall Study|Randomized in Error|0|||
170477999|NCT00489255|616088322|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
170478000|NCT00489255|616088323|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
170478001|NCT00489255|616088322|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
170478002|NCT00489255|616088323|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
170478003|NCT00489255|616088322|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
170478004|NCT00489255|616088323|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
170478005|NCT00489255|616088322|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
170478006|NCT00489255|616088323|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
170478007|NCT00489255|616088322|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
170478008|NCT00489255|616088323|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
170478009|NCT00489255|616088322|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
170478010|NCT00489255|616088323|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
170478011|NCT00489255|616088322|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
170478012|NCT00489255|616088323|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
170547104|NCT02181738|616347582|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
170547105|NCT02181738|616347583|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
170547106|NCT00114777|616347587|FG000|Randomization to Month 36|Death|10|||
170547107|NCT00114777|616347588|FG001|Randomization to Month 36|Death|4|||
170547108|NCT00114777|616347589|FG002|Randomization to Month 36|Death|3|||
170547109|NCT00114777|616347587|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
170547110|NCT00114777|616347588|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
170547111|NCT00114777|616347589|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
170547112|NCT00114777|616347587|FG000|Randomization to Month 36|Lack of Efficacy|19|||
170547113|NCT00114777|616347588|FG001|Randomization to Month 36|Lack of Efficacy|15|||
170547114|NCT00114777|616347589|FG002|Randomization to Month 36|Lack of Efficacy|17|||
170547115|NCT00114777|616347587|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
170547116|NCT00114777|616347588|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
170547117|NCT00114777|616347589|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
170547118|NCT00114777|616347587|FG000|Randomization to Month 36|Adverse Event|34|||
170547119|NCT00114777|616347588|FG001|Randomization to Month 36|Adverse Event|35|||
170547120|NCT00114777|616347589|FG002|Randomization to Month 36|Adverse Event|44|||
170547121|NCT00114777|616347587|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
170547122|NCT00114777|616347588|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
170547123|NCT00114777|616347589|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
170547124|NCT00114777|616347587|FG000|Randomization to Month 36|Other|9|||
170547125|NCT00114777|616347588|FG001|Randomization to Month 36|Other|3|||
170547126|NCT00114777|616347589|FG002|Randomization to Month 36|Other|12|||
170547127|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|Death|8|||
170547128|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|Death|13|||
170547129|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|Death|7|||
170547130|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
170547131|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
170547132|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
170547133|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
170547134|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
170547135|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
170547136|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
170547137|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
170547138|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
170547139|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
170547140|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
170547141|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
170547142|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
170547143|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
170547144|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
170547145|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
170547146|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
170478013|NCT00489255|616088322|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
170478014|NCT00489255|616088323|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
170478015|NCT00489255|616088322|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
170478016|NCT00489255|616088323|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
170478017|NCT00489255|616088322|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
170478018|NCT00489255|616088323|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
170478019|NCT03629184|616088325|FG000|Overall Study|Withdrawal by Subject|2|||
170478020|NCT03629184|616088326|FG001|Overall Study|Withdrawal by Subject|1|||
170478021|NCT03629184|616088325|FG000|Overall Study|Physician Decision|1|||
170478022|NCT03629184|616088326|FG001|Overall Study|Physician Decision|0|||
170478023|NCT02694328|616088327|FG000|Overall Study|Adverse Event|27|||
170478024|NCT02694328|616088328|FG001|Overall Study|Adverse Event|33|||
170478025|NCT02694328|616088327|FG000|Overall Study|Withdrawal by Subject|27|||
170478026|NCT02694328|616088328|FG001|Overall Study|Withdrawal by Subject|23|||
170478027|NCT02694328|616088327|FG000|Overall Study|Lost to Follow-up|26|||
170478028|NCT02694328|616088328|FG001|Overall Study|Lost to Follow-up|22|||
170478029|NCT02694328|616088327|FG000|Overall Study|Noncompliant with study drug|11|||
170478030|NCT02694328|616088328|FG001|Overall Study|Noncompliant with study drug|8|||
170478031|NCT02694328|616088327|FG000|Overall Study|Incarceration|1|||
170478032|NCT02694328|616088328|FG001|Overall Study|Incarceration|1|||
170478033|NCT02694328|616088327|FG000|Overall Study|Lack of Efficacy|1|||
170478034|NCT02694328|616088328|FG001|Overall Study|Lack of Efficacy|2|||
170478035|NCT02694328|616088327|FG000|Overall Study|Pregnancy|1|||
170478036|NCT02694328|616088328|FG001|Overall Study|Pregnancy|1|||
170478037|NCT02694328|616088327|FG000|Overall Study|Protocol Violation|6|||
170478038|NCT02694328|616088328|FG001|Overall Study|Protocol Violation|5|||
170478039|NCT02694328|616088327|FG000|Overall Study|Abnormal Laboratory Value|0|||
170478040|NCT02694328|616088328|FG001|Overall Study|Abnormal Laboratory Value|3|||
170478041|NCT02243605|616090443|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
170478042|NCT02243605|616090444|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
170478043|NCT02243605|616090443|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
170478044|NCT02243605|616090444|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
170478045|NCT02243605|616090443|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
170478046|NCT02243605|616090444|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
170478047|NCT02243605|616090443|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
170478048|NCT02243605|616090444|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
170478049|NCT02243605|616090443|FG000|Stage 2 - Final Analysis Population|Progression|0|||
170478050|NCT02243605|616090444|FG001|Stage 2 - Final Analysis Population|Progression|1|||
170478051|NCT03511105|616090445|FG000|Overall Study|Adverse Event|1|||
170478052|NCT03511105|616090446|FG001|Overall Study|Adverse Event|0|||
170478053|NCT03511105|616090445|FG000|Overall Study|Withdrew consent|1|||
170478054|NCT03511105|616090446|FG001|Overall Study|Withdrew consent|0|||
170478055|NCT01557504|616090447|FG000|Overall Study|Physician Decision|1|||
170547147|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
170547148|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
170547149|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
170547150|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
170547151|NCT00114777|616347587|FG000|Long-Term Extension to Month 84|Other|2|||
170547152|NCT00114777|616347588|FG001|Long-Term Extension to Month 84|Other|0|||
170547153|NCT00114777|616347589|FG002|Long-Term Extension to Month 84|Other|2|||
170547154|NCT00183391|616347590|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
170547155|NCT00183391|616347591|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
170547156|NCT00183391|616347590|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
170547157|NCT00183391|616347591|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
170547158|NCT01078545|616347597|FG000|Overall Study|Lost to Follow-up|13|||
170547159|NCT01078545|616347597|FG000|Overall Study|Physician Decision|6|||
170547160|NCT01078545|616347597|FG000|Overall Study|Withdrawal by Subject|3|||
170547161|NCT01078545|616347597|FG000|Overall Study|Death|3|||
170547162|NCT01078545|616347597|FG000|Overall Study|Participant moved to another physician|1|||
170547163|NCT02497755|616347599|FG000|Overall Study|Protocol Violation|1|||
170547164|NCT02497755|616347600|FG001|Overall Study|Protocol Violation|0|||
170547165|NCT01774370|616347603|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
170547166|NCT01774370|616347603|FG000|Overall Study|Administered prior to the contract date|4|||
170547167|NCT01774370|616347603|FG000|Overall Study|Subjects of contraindications|34|||
170547168|NCT01774370|616347603|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
170547169|NCT01774370|616347603|FG000|Overall Study|Follow-up failure|34|||
170547170|NCT04243837|616347609|FG000|Overall Study|Adverse Event|2|||
170478056|NCT01557504|616090448|FG001|Overall Study|Physician Decision|0|||
170478057|NCT01173523|616090455|FG000|Overall Study|Clinical Progression|1|||
170478058|NCT01173523|616090456|FG001|Overall Study|Clinical Progression|1|||
170478059|NCT01173523|616090455|FG000|Overall Study|Progressive Disease|10|||
170478060|NCT01173523|616090456|FG001|Overall Study|Progressive Disease|8|||
170478061|NCT01173523|616090455|FG000|Overall Study|Other|2|||
170478062|NCT01173523|616090456|FG001|Overall Study|Other|3|||
170478063|NCT01067105|616090457|FG000|Overall Study|Adverse Event|14|||
170478064|NCT01067105|616090457|FG000|Overall Study|Protocol Violation|48|||
170639469|NCT05019521|616691306|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
170639470|NCT05019521|616691307|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
170478065|NCT01067105|616090457|FG000|Overall Study|Withdrawal by Subject|36|||
170478066|NCT01067105|616090457|FG000|Overall Study|Lost to Follow-up|6|||
170478067|NCT01067105|616090457|FG000|Overall Study|Physician Decision|6|||
170478068|NCT01067105|616090457|FG000|Overall Study|Other|31|||
170478069|NCT00853099|616090458|FG000|Double-blind Period|Adverse Event|7|||
170478070|NCT00853099|616090459|FG001|Double-blind Period|Adverse Event|9|||
170478071|NCT00853099|616090460|FG002|Double-blind Period|Adverse Event|13|||
170478072|NCT00853099|616090461|FG003|Double-blind Period|Adverse Event|0|||
170478073|NCT00853099|616090458|FG000|Double-blind Period|Withdrawal by Subject|2|||
170478074|NCT00853099|616090459|FG001|Double-blind Period|Withdrawal by Subject|3|||
170639471|NCT05019521|616691301|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
170639472|NCT05019521|616691302|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
170639473|NCT05019521|616691303|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
170639474|NCT05019521|616691304|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
170639475|NCT05019521|616691305|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
170639476|NCT05019521|616691306|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
170639477|NCT05019521|616691307|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
170639478|NCT05019521|616691301|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
170639479|NCT05019521|616691302|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
170639480|NCT05019521|616691303|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
170478075|NCT00853099|616090460|FG002|Double-blind Period|Withdrawal by Subject|0|||
170478076|NCT00853099|616090461|FG003|Double-blind Period|Withdrawal by Subject|0|||
170478077|NCT00853099|616090458|FG000|Double-blind Period|Lack of Efficacy|14|||
170478078|NCT00853099|616090459|FG001|Double-blind Period|Lack of Efficacy|17|||
170478079|NCT00853099|616090460|FG002|Double-blind Period|Lack of Efficacy|16|||
170478080|NCT00853099|616090461|FG003|Double-blind Period|Lack of Efficacy|0|||
170478081|NCT00853099|616090458|FG000|Double-blind Period|Other|0|||
170478082|NCT00853099|616090459|FG001|Double-blind Period|Other|0|||
170478083|NCT00853099|616090460|FG002|Double-blind Period|Other|1|||
170478084|NCT00853099|616090461|FG003|Double-blind Period|Other|0|||
170478085|NCT00853099|616090458|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
170478086|NCT00853099|616090459|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
170478087|NCT00853099|616090460|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
170478088|NCT00853099|616090461|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
170478089|NCT00853099|616090458|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
170478090|NCT00853099|616090459|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
170478091|NCT00853099|616090460|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
170478092|NCT00853099|616090461|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
170478093|NCT00853099|616090458|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
170478094|NCT00853099|616090459|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
170478095|NCT00853099|616090460|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
170478096|NCT00853099|616090461|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
170478097|NCT00853099|616090458|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
170639481|NCT05019521|616691304|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
170639482|NCT05019521|616691305|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
170639483|NCT05019521|616691306|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
170639484|NCT05019521|616691307|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
170639485|NCT05019521|616691301|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
170639486|NCT05019521|616691302|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
170639487|NCT05019521|616691303|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
170639488|NCT05019521|616691304|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
170639489|NCT05019521|616691305|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
170639490|NCT05019521|616691306|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
170639491|NCT05019521|616691307|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
170639492|NCT05019521|616691301|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
170639493|NCT05019521|616691302|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
170639494|NCT05019521|616691303|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
170478098|NCT00853099|616090459|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
170478099|NCT00853099|616090460|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
170478100|NCT00853099|616090461|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
170478101|NCT00853099|616090458|FG000|Double-blind + Open-label Periods|Other|0|||
170478102|NCT00853099|616090459|FG001|Double-blind + Open-label Periods|Other|0|||
170478103|NCT00853099|616090460|FG002|Double-blind + Open-label Periods|Other|0|||
170478104|NCT00853099|616090461|FG003|Double-blind + Open-label Periods|Other|6|||
170478105|NCT05017246|616090463|FG000|Overall Study|Withdrawal by Subject|5|||
170478106|NCT05017246|616090464|FG001|Overall Study|Withdrawal by Subject|3|||
170478107|NCT05017246|616090463|FG000|Overall Study|Determined to be ineligible|0|||
170478108|NCT05017246|616090464|FG001|Overall Study|Determined to be ineligible|1|||
170478109|NCT05017246|616090463|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
170478110|NCT05017246|616090464|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
170478111|NCT05017246|616090463|FG000|Overall Study|Technical failure|1|||
170478112|NCT05017246|616090464|FG001|Overall Study|Technical failure|3|||
170478113|NCT00470535|616090465|FG000|Overall Study|Disease Progression|13|||
170478114|NCT00470535|616090465|FG000|Overall Study|Withdrawal by Subject|1|||
170478115|NCT00470535|616090465|FG000|Overall Study|Adverse Event|1|||
170478116|NCT00470535|616090465|FG000|Overall Study|Death|1|||
170478117|NCT00470535|616090465|FG000|Overall Study|Other|2|||
170478118|NCT00709995|616090466|FG000|Overall Study|Adverse Event|4|||
170478119|NCT00709995|616090467|FG001|Overall Study|Adverse Event|2|||
170478120|NCT00709995|616090466|FG000|Overall Study|Withdrawal by Subject|1|||
170478121|NCT00709995|616090467|FG001|Overall Study|Withdrawal by Subject|3|||
170478122|NCT01276041|616090468|FG000|Overall Study|Adverse Event|2|||
170478123|NCT01276041|616090468|FG000|Overall Study|Protocol Violation|1|||
170478124|NCT00638508|616090471|FG000|Overall Study|Physician Decision|5|||
170478125|NCT00638508|616090472|FG001|Overall Study|Physician Decision|2|||
170478126|NCT00654095|616090473|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
170478127|NCT00654095|616090473|FG000|Overall Study|Elevated triglyceride level (2)|1|||
170478128|NCT00654095|616090473|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
170478129|NCT00654095|616090473|FG000|Overall Study|Adverse Event|11|||
170547171|NCT04243837|616347610|FG001|Overall Study|Adverse Event|1|||
170547172|NCT04243837|616347609|FG000|Overall Study|Withdrawal by Subject|4|||
170547173|NCT04243837|616347610|FG001|Overall Study|Withdrawal by Subject|2|||
170547174|NCT04243837|616347609|FG000|Overall Study|Covid-19 lock down|1|||
170547175|NCT04243837|616347610|FG001|Overall Study|Covid-19 lock down|0|||
170892171|NCT01656434|617611942|FG001|Overall Study|Screen failure|0|||
170892172|NCT01656434|617611941|FG000|Overall Study|Protocol Violation|7|||
170892173|NCT01656434|617611942|FG001|Overall Study|Protocol Violation|0|||
170892174|NCT01656434|617611941|FG000|Overall Study|Pregnancy wish|18|||
170892175|NCT01656434|617611942|FG001|Overall Study|Pregnancy wish|6|||
170892176|NCT01656434|617611941|FG000|Overall Study|Pregnancy|45|||
170892177|NCT01656434|617611942|FG001|Overall Study|Pregnancy|10|||
170892178|NCT01656434|617611941|FG000|Overall Study|Physician Decision|7|||
170892179|NCT01656434|617611942|FG001|Overall Study|Physician Decision|2|||
170892180|NCT01656434|617611941|FG000|Overall Study|Non-compliance with study drug|48|||
170892181|NCT01656434|617611942|FG001|Overall Study|Non-compliance with study drug|9|||
170892182|NCT01656434|617611941|FG000|Overall Study|Study terminated by sponsor|1501|||
170892183|NCT01656434|617611942|FG001|Overall Study|Study terminated by sponsor|348|||
170892184|NCT01656434|617611941|FG000|Overall Study|Participant discontinued; drug related|13|||
170892185|NCT01656434|617611942|FG001|Overall Study|Participant discontinued; drug related|4|||
170892186|NCT01656434|617611941|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
170892187|NCT01656434|617611942|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
170892188|NCT01656434|617611941|FG000|Overall Study|Non-compliance with protocol|39|||
170892189|NCT01656434|617611942|FG001|Overall Study|Non-compliance with protocol|15|||
170892190|NCT01656434|617611941|FG000|Overall Study|Participant moved|40|||
170892191|NCT01656434|617611942|FG001|Overall Study|Participant moved|12|||
170892192|NCT01656434|617611941|FG000|Overall Study|Participant withdrew consent|28|||
170892193|NCT01656434|617611942|FG001|Overall Study|Participant withdrew consent|9|||
170892194|NCT01656434|617611941|FG000|Overall Study|Withdrawal by Subject|64|||
170547176|NCT04243837|616347609|FG000|Overall Study|Study Terminated by Sponsor|11|||
170547177|NCT04243837|616347610|FG001|Overall Study|Study Terminated by Sponsor|12|||
170547178|NCT01740427|616347611|FG000|Overall Study|Objective Progression or Relapse|286|||
170547179|NCT01740427|616347612|FG001|Overall Study|Objective Progression or Relapse|172|||
170639495|NCT05019521|616691304|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
170892195|NCT01656434|617611942|FG001|Overall Study|Withdrawal by Subject|7|||
170892196|NCT02026063|617611948|FG000|Overall Study|Physician Decision|0|||
170892197|NCT02026063|617611949|FG001|Overall Study|Physician Decision|10|||
170892198|NCT02026063|617611948|FG000|Overall Study|Noncompliance with Study Drug|1|||
170892199|NCT02026063|617611949|FG001|Overall Study|Noncompliance with Study Drug|1|||
170892200|NCT02026063|617611948|FG000|Overall Study|Withdrawal of Consent|1|||
170892201|NCT02026063|617611949|FG001|Overall Study|Withdrawal of Consent|6|||
170892202|NCT02026063|617611948|FG000|Overall Study|Adverse Event|5|||
170892203|NCT02026063|617611949|FG001|Overall Study|Adverse Event|20|||
170892204|NCT02026063|617611948|FG000|Overall Study|Lack of Efficacy|0|||
170892205|NCT02026063|617611949|FG001|Overall Study|Lack of Efficacy|4|||
170892206|NCT02026063|617611948|FG000|Overall Study|Lost to Follow-up|0|||
170892207|NCT02026063|617611949|FG001|Overall Study|Lost to Follow-up|1|||
170478130|NCT00654095|616090473|FG000|Overall Study|Withdrawal by Subject|5|||
170478131|NCT00654095|616090473|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
170478132|NCT00654095|616090473|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
170478133|NCT00654095|616090473|FG000|Overall Study|Did not meet inclusion criteria|1|||
170478134|NCT00595621|616090474|FG000|Open Label Run in|Adverse Event|1|||
170478135|NCT00595621|616090475|FG001|Open Label Run in|Adverse Event|0|||
170547180|NCT01740427|616347611|FG000|Overall Study|Adverse Event|32|||
170892208|NCT02026063|617611948|FG000|Overall Study|Reason not Specified|2|||
170892209|NCT02026063|617611949|FG001|Overall Study|Reason not Specified|7|||
170892210|NCT03687502|617611950|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
170892211|NCT03687502|617611950|FG000|Overall Study|Lumason not available|1|||
170892212|NCT01724528|617611951|FG000|Overall Study|Death|3|||
170892213|NCT01724528|617611952|FG001|Overall Study|Death|0|||
170892214|NCT01724528|617611951|FG000|Overall Study|Withdrawal by Subject|0|||
170892215|NCT01724528|617611952|FG001|Overall Study|Withdrawal by Subject|2|||
170892216|NCT01724528|617611951|FG000|Overall Study|Protocol Violation|0|||
170892217|NCT01724528|617611952|FG001|Overall Study|Protocol Violation|1|||
170892218|NCT01724528|617611951|FG000|Overall Study|Patient refused to attend last visit|1|||
170892219|NCT01724528|617611952|FG001|Overall Study|Patient refused to attend last visit|0|||
170892220|NCT05574062|617611958|FG000|Pre Run-In|Screening failure|3|||
170892221|NCT05574062|617611959|FG001|Pre Run-In|Screening failure|0|||
170892222|NCT05574062|617611960|FG002|Pre Run-In|Screening failure|0|||
170892223|NCT05574062|617611961|FG003|Pre Run-In|Screening failure|0|||
170892224|NCT05574062|617611962|FG004|Pre Run-In|Screening failure|0|||
170892225|NCT05574062|617611958|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
170892226|NCT05574062|617611959|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
170892227|NCT05574062|617611960|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
170892228|NCT05574062|617611961|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
170892229|NCT05574062|617611962|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
170892230|NCT05574062|617611958|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
170892231|NCT05574062|617611959|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
170547181|NCT01740427|616347612|FG001|Overall Study|Adverse Event|9|||
170547182|NCT01740427|616347611|FG000|Overall Study|Global Deterioration of Health Status|28|||
170547183|NCT01740427|616347612|FG001|Overall Study|Global Deterioration of Health Status|12|||
170547184|NCT01740427|616347611|FG000|Overall Study|Participant Refused Continued Treatment|27|||
170547185|NCT01740427|616347612|FG001|Overall Study|Participant Refused Continued Treatment|15|||
170547186|NCT01740427|616347611|FG000|Overall Study|Unspecified reasons|52|||
170547187|NCT01740427|616347612|FG001|Overall Study|Unspecified reasons|8|||
170547188|NCT01740427|616347611|FG000|Overall Study|Death|10|||
170547189|NCT01740427|616347612|FG001|Overall Study|Death|3|||
170547190|NCT01740427|616347611|FG000|Overall Study|Protocol Violation|5|||
170547191|NCT01740427|616347612|FG001|Overall Study|Protocol Violation|3|||
170547192|NCT01740427|616347611|FG000|Overall Study|Lost to Follow-up|3|||
170547193|NCT01740427|616347612|FG001|Overall Study|Lost to Follow-up|0|||
170547194|NCT01740427|616347611|FG000|Overall Study|Site Terminated by Sponsor|1|||
170547195|NCT01740427|616347612|FG001|Overall Study|Site Terminated by Sponsor|0|||
170547196|NCT02184156|616347614|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
170547197|NCT02184156|616347615|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
170547198|NCT02184156|616347614|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
170547199|NCT02184156|616347615|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
170547200|NCT01695772|616347617|FG000|Overall Study|Withdrawal by Subject|18|||
170547201|NCT01695772|616347617|FG000|Overall Study|Progressive Disease|8|||
170547202|NCT01695772|616347617|FG000|Overall Study|Investigator Decision|5|||
170547203|NCT01695772|616347617|FG000|Overall Study|Lost to Follow-up|4|||
170547204|NCT01695772|616347617|FG000|Overall Study|Protocol Violation|2|||
170547205|NCT01695772|616347617|FG000|Overall Study|Unspecified Reason|1|||
170547206|NCT02724644|616350091|FG000|Overall Study|Adverse Event|7|||
170547207|NCT02724644|616350092|FG001|Overall Study|Adverse Event|1|||
170547208|NCT02724644|616350091|FG000|Overall Study|Lost to Follow-up|6|||
170547209|NCT02724644|616350092|FG001|Overall Study|Lost to Follow-up|2|||
170547210|NCT02724644|616350091|FG000|Overall Study|Withdrawal by Subject|7|||
170547211|NCT02724644|616350092|FG001|Overall Study|Withdrawal by Subject|1|||
170547212|NCT02724644|616350091|FG000|Overall Study|Administrative|1|||
170547213|NCT02724644|616350092|FG001|Overall Study|Administrative|0|||
170547214|NCT02698787|616350093|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
170547215|NCT02698787|616350094|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
170547216|NCT03312114|616350096|FG000|Overall Study|All the five enrolled dropped out of the|5|||
170547217|NCT02469961|616350103|FG000|Overall Study|Physician Decision|4|||
170547218|NCT02469961|616350104|FG001|Overall Study|Physician Decision|1|||
170547219|NCT00454142|616350106|FG000|Overall Study|Withdrawal by Subject|1|||
170547220|NCT03548415|616350107|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
170547221|NCT03548415|616350108|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
170547222|NCT03548415|616350109|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
170547223|NCT03548415|616350110|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
170547224|NCT03548415|616350111|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
170547225|NCT00903344|616350112|FG000|Overall Study|Pregnancy|2|||
170547226|NCT00903344|616350113|FG001|Overall Study|Pregnancy|3|||
170547227|NCT00903344|616350112|FG000|Overall Study|Lost to Follow-up|3|||
170547228|NCT00903344|616350113|FG001|Overall Study|Lost to Follow-up|0|||
170547229|NCT00585169|616350114|FG000|Overall Study|Withdrawal by Subject|1|||
170547230|NCT00527748|616350116|FG000|Overall Study|Other|3|||
170547231|NCT03055221|616350117|FG000|Overall Study|Adverse Event|2|||
170792800|NCT05671653|617251809|FG007|Cohort 2 Period 2|Other|0|||
170792801|NCT05671653|617251810|FG008|Cohort 2 Period 2|Other|0|||
170792802|NCT05671653|617251811|FG009|Cohort 2 Period 2|Other|0|||
170792803|NCT05671653|617251812|FG010|Cohort 2 Period 2|Other|1|||
170792804|NCT05671653|617251813|FG011|Cohort 2 Period 2|Other|0|||
170792805|NCT05671653|617251814|FG012|Cohort 2 Period 2|Other|0|||
170792806|NCT05671653|617251802|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792807|NCT05671653|617251803|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792808|NCT05671653|617251804|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792809|NCT05671653|617251805|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792810|NCT05671653|617251806|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792811|NCT05671653|617251807|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792812|NCT05671653|617251808|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792813|NCT05671653|617251809|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792814|NCT05671653|617251810|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792815|NCT05671653|617251811|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792816|NCT05671653|617251812|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792817|NCT05671653|617251813|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
170792818|NCT05671653|617251814|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
170792819|NCT06232590|617251818|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
170792820|NCT06232590|617251819|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
170792821|NCT04770402|617251820|FG000|Overall Study|Lost to Follow-up|1|||
170792822|NCT04770402|617251821|FG001|Overall Study|Lost to Follow-up|2|||
170792823|NCT04770402|617251820|FG000|Overall Study|Non-compliance|1|||
170792824|NCT04770402|617251821|FG001|Overall Study|Non-compliance|0|||
170792825|NCT04770402|617251820|FG000|Overall Study|Withdrawal by Subject|0|||
170792826|NCT04770402|617251821|FG001|Overall Study|Withdrawal by Subject|1|||
170792827|NCT02505984|617251824|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
170792828|NCT02505984|617251825|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
170792829|NCT02505984|617251824|FG000|Overall Study|Unreliable self-report data|1|||
170792830|NCT02505984|617251825|FG001|Overall Study|Unreliable self-report data|0|||
170792831|NCT02505984|617251824|FG000|Overall Study|Study blind opened during assessment|0|||
170792832|NCT02505984|617251825|FG001|Overall Study|Study blind opened during assessment|1|||
170792833|NCT02505984|617251824|FG000|Overall Study|Noncompliance with study protocol|0|||
170792834|NCT02505984|617251825|FG001|Overall Study|Noncompliance with study protocol|1|||
170792835|NCT03511664|617251830|FG000|Overall Study|Death|457|||
170792836|NCT03511664|617251831|FG001|Overall Study|Death|201|||
170792837|NCT03511664|617251832|FG002|Overall Study|Death|21|||
170792838|NCT03511664|617251830|FG000|Overall Study|Withdrew consent|40|||
170792839|NCT03511664|617251831|FG001|Overall Study|Withdrew consent|63|||
170792840|NCT03511664|617251832|FG002|Overall Study|Withdrew consent|3|||
170792841|NCT03511664|617251830|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
170792842|NCT03511664|617251831|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
170792843|NCT03511664|617251832|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
170792844|NCT03511664|617251830|FG000|Overall Study|Lost to Follow-up|8|||
170792845|NCT03511664|617251831|FG001|Overall Study|Lost to Follow-up|5|||
170792846|NCT03511664|617251832|FG002|Overall Study|Lost to Follow-up|0|||
170792847|NCT03511664|617251830|FG000|Overall Study|Physician Decision|2|||
170792848|NCT03511664|617251831|FG001|Overall Study|Physician Decision|1|||
170792849|NCT03511664|617251832|FG002|Overall Study|Physician Decision|0|||
170792850|NCT03511664|617251830|FG000|Overall Study|Patient non-compliance|1|||
170792851|NCT03511664|617251831|FG001|Overall Study|Patient non-compliance|0|||
170792852|NCT03511664|617251832|FG002|Overall Study|Patient non-compliance|0|||
170792853|NCT05934942|617251834|FG000|Run-in Period|Not treated|1|||
170792854|NCT05934942|617251834|FG000|Run-in Period|Withdrawal by Subject|1|||
170792855|NCT05469464|617251849|FG000|Overall Study|Withdrawal by Subject|8|||
170792856|NCT05469464|617251850|FG001|Overall Study|Withdrawal by Subject|7|||
170792857|NCT05469464|617251851|FG002|Overall Study|Withdrawal by Subject|4|||
170792858|NCT05469464|617251852|FG003|Overall Study|Withdrawal by Subject|5|||
170792859|NCT05469464|617251849|FG000|Overall Study|Adverse Event|8|||
170792860|NCT05469464|617251850|FG001|Overall Study|Adverse Event|14|||
170792861|NCT05469464|617251851|FG002|Overall Study|Adverse Event|13|||
170792862|NCT05469464|617251852|FG003|Overall Study|Adverse Event|2|||
170792863|NCT05469464|617251849|FG000|Overall Study|Lost to Follow-up|2|||
170792864|NCT05469464|617251850|FG001|Overall Study|Lost to Follow-up|5|||
170792865|NCT05469464|617251851|FG002|Overall Study|Lost to Follow-up|3|||
170792866|NCT05469464|617251852|FG003|Overall Study|Lost to Follow-up|3|||
170792867|NCT05469464|617251849|FG000|Overall Study|Lack of Efficacy|4|||
170792868|NCT05469464|617251850|FG001|Overall Study|Lack of Efficacy|1|||
170792869|NCT05469464|617251851|FG002|Overall Study|Lack of Efficacy|2|||
170792870|NCT05469464|617251852|FG003|Overall Study|Lack of Efficacy|2|||
170792871|NCT05469464|617251849|FG000|Overall Study|Physician Decision|0|||
170792872|NCT05469464|617251850|FG001|Overall Study|Physician Decision|0|||
170892232|NCT05574062|617611960|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
170892233|NCT05574062|617611961|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
170892234|NCT05574062|617611962|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
170892235|NCT05574062|617611958|FG000|Continuation Phase Period 1|Physician Decision|1|||
170892236|NCT05574062|617611959|FG001|Continuation Phase Period 1|Physician Decision|0|||
170892237|NCT05574062|617611960|FG002|Continuation Phase Period 1|Physician Decision|0|||
170892238|NCT05574062|617611961|FG003|Continuation Phase Period 1|Physician Decision|0|||
170892239|NCT05574062|617611962|FG004|Continuation Phase Period 1|Physician Decision|0|||
170892240|NCT05574062|617611958|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
170892241|NCT05574062|617611959|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
170892242|NCT05574062|617611960|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
170892243|NCT05574062|617611961|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
170892244|NCT05574062|617611962|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
170892245|NCT05574062|617611958|FG000|Continuation Phase Period 1|Adverse Event|1|||
170892246|NCT05574062|617611959|FG001|Continuation Phase Period 1|Adverse Event|0|||
170892247|NCT05574062|617611960|FG002|Continuation Phase Period 1|Adverse Event|0|||
170892248|NCT05574062|617611961|FG003|Continuation Phase Period 1|Adverse Event|0|||
170892249|NCT05574062|617611962|FG004|Continuation Phase Period 1|Adverse Event|0|||
170892250|NCT05574062|617611958|FG000|Continuation Phase Period 1|Death|1|||
170892251|NCT05574062|617611959|FG001|Continuation Phase Period 1|Death|0|||
170892252|NCT05574062|617611960|FG002|Continuation Phase Period 1|Death|0|||
170892253|NCT05574062|617611961|FG003|Continuation Phase Period 1|Death|0|||
170892254|NCT05574062|617611962|FG004|Continuation Phase Period 1|Death|0|||
170892255|NCT05574062|617611958|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
170892256|NCT05574062|617611959|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
170892257|NCT05574062|617611960|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
170892258|NCT05574062|617611961|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
170892259|NCT05574062|617611962|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
170892260|NCT00695565|617611968|FG000|Overall Study|Lost to Follow-up|4|||
170892261|NCT00695565|617611969|FG001|Overall Study|Lost to Follow-up|4|||
170892262|NCT00695565|617611968|FG000|Overall Study|Adverse Event|3|||
170639496|NCT05019521|616691305|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
170792873|NCT05469464|617251851|FG002|Overall Study|Physician Decision|0|||
170792874|NCT05469464|617251852|FG003|Overall Study|Physician Decision|1|||
170792875|NCT04076618|617251853|FG000|Overall Study|Lost to Follow-up|2|||
170792876|NCT04076618|617251854|FG001|Overall Study|Lost to Follow-up|1|||
170792877|NCT04076618|617251855|FG002|Overall Study|Lost to Follow-up|3|||
170792878|NCT04076618|617251853|FG000|Overall Study|Withdrawal by Subject|3|||
170792879|NCT04076618|617251854|FG001|Overall Study|Withdrawal by Subject|1|||
170792880|NCT04076618|617251855|FG002|Overall Study|Withdrawal by Subject|2|||
170792881|NCT04076618|617251853|FG000|Overall Study|Relocated out of state|0|||
170792882|NCT04076618|617251854|FG001|Overall Study|Relocated out of state|2|||
170792883|NCT04076618|617251855|FG002|Overall Study|Relocated out of state|0|||
170792884|NCT04076618|617251853|FG000|Overall Study|COVID concerns|0|||
170792885|NCT04076618|617251854|FG001|Overall Study|COVID concerns|1|||
170792886|NCT04076618|617251855|FG002|Overall Study|COVID concerns|0|||
170792887|NCT04076618|617251853|FG000|Overall Study|Adverse Event|0|||
170792888|NCT04076618|617251854|FG001|Overall Study|Adverse Event|0|||
170792889|NCT04076618|617251855|FG002|Overall Study|Adverse Event|2|||
170792890|NCT06473662|617251858|FG000|Overall Study|Withdrawal by Subject|1|||
170792891|NCT06473662|617251859|FG001|Overall Study|Withdrawal by Subject|6|||
170792892|NCT06473662|617251860|FG002|Overall Study|Withdrawal by Subject|5|||
170792893|NCT06473662|617251858|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
170792894|NCT06473662|617251859|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
170792895|NCT06473662|617251860|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
170792896|NCT06473662|617251858|FG000|Overall Study|Starting HbA1c below 7%|0|||
170792897|NCT06473662|617251859|FG001|Overall Study|Starting HbA1c below 7%|1|||
170792898|NCT06473662|617251860|FG002|Overall Study|Starting HbA1c below 7%|1|||
170792899|NCT06473662|617251858|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
170792900|NCT06473662|617251859|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
170639497|NCT05019521|616691306|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
170792901|NCT06473662|617251860|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
170792902|NCT06473662|617251858|FG000|Overall Study|Did not take medication|2|||
170792903|NCT06473662|617251859|FG001|Overall Study|Did not take medication|3|||
170792904|NCT06473662|617251860|FG002|Overall Study|Did not take medication|2|||
170792905|NCT03478956|617251876|FG000|Randomized Treatment Period|Adverse Event|1|||
170792906|NCT03478956|617251877|FG001|Randomized Treatment Period|Adverse Event|0|||
170792907|NCT03478956|617251878|FG002|Randomized Treatment Period|Adverse Event|0|||
170892263|NCT00695565|617611969|FG001|Overall Study|Adverse Event|1|||
170892264|NCT00695565|617611968|FG000|Overall Study|Protocol Violation|3|||
170892265|NCT00695565|617611969|FG001|Overall Study|Protocol Violation|1|||
170892266|NCT00695565|617611968|FG000|Overall Study|Withdrawal by Subject|1|||
170892267|NCT00695565|617611969|FG001|Overall Study|Withdrawal by Subject|1|||
170892268|NCT00695565|617611968|FG000|Overall Study|Lack of Efficacy|1|||
170792908|NCT03478956|617251879|FG003|Randomized Treatment Period|Adverse Event|0|||
170639498|NCT05019521|616691307|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
170639499|NCT05019521|616691301|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639500|NCT05019521|616691302|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170892269|NCT00695565|617611969|FG001|Overall Study|Lack of Efficacy|1|||
170892270|NCT00695565|617611968|FG000|Overall Study|Subject did not follow instructions|1|||
170892271|NCT00695565|617611969|FG001|Overall Study|Subject did not follow instructions|1|||
170892272|NCT01106846|617611970|FG000|Overall Study|Change in surgical procedure|0|||
170892273|NCT01106846|617611971|FG001|Overall Study|Change in surgical procedure|1|||
170892274|NCT04811716|617611972|FG000|Overall Study|Withdrawal by Subject|2|||
170892275|NCT04811716|617611973|FG001|Overall Study|Withdrawal by Subject|0|||
170892276|NCT01314716|617611974|FG000|Double-Blind Phase|Randomized but not treated|1|||
170892277|NCT01314716|617611975|FG001|Double-Blind Phase|Randomized but not treated|1|||
170892278|NCT01314716|617611974|FG000|Double-Blind Phase|Adverse Event|10|||
170892279|NCT01314716|617611975|FG001|Double-Blind Phase|Adverse Event|4|||
170892280|NCT01314716|617611974|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
170892281|NCT01314716|617611975|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
170892282|NCT01314716|617611974|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170892283|NCT01314716|617611975|FG001|Double-Blind Phase|Lost to Follow-up|1|||
170892284|NCT01314716|617611974|FG000|Double-Blind Phase|Sponsor request|1|||
170892285|NCT01314716|617611975|FG001|Double-Blind Phase|Sponsor request|2|||
170892286|NCT01314716|617611974|FG000|Double-Blind Phase|Physician Decision|0|||
170892287|NCT01314716|617611975|FG001|Double-Blind Phase|Physician Decision|1|||
170892288|NCT01314716|617611974|FG000|Open-Label Phase|Adverse Event|4|||
170892289|NCT01314716|617611975|FG001|Open-Label Phase|Adverse Event|6|||
170892290|NCT01314716|617611974|FG000|Open-Label Phase|Withdrawal by Subject|1|||
170892291|NCT01314716|617611975|FG001|Open-Label Phase|Withdrawal by Subject|2|||
170892292|NCT01314716|617611974|FG000|Open-Label Phase|Physician Decision|5|||
170892293|NCT01314716|617611975|FG001|Open-Label Phase|Physician Decision|4|||
170892294|NCT02320487|617611980|FG000|Overall Study|Reason not Specified|1|||
170892295|NCT02320487|617611980|FG000|Overall Study|Physician Decision|5|||
170892296|NCT02320487|617611980|FG000|Overall Study|Withdrawal by Subject|1|||
170892297|NCT02320487|617611980|FG000|Overall Study|Death|3|||
170892298|NCT02320487|617611980|FG000|Overall Study|Adverse Event|11|||
170892299|NCT03344003|617611981|FG000|Overall Study|Switched to alternative treatment|1|||
170892300|NCT03344003|617611982|FG001|Overall Study|Switched to alternative treatment|0|||
170892301|NCT03344003|617611981|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
170892302|NCT03344003|617611982|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
170892303|NCT00670007|617613185|FG000|Overall Study|Drug abuse|1|||
170892304|NCT00670007|617613185|FG000|Overall Study|Lung transplant|1|||
170892305|NCT00670007|617613185|FG000|Overall Study|Travel/Vacation|1|||
170892306|NCT00670007|617613185|FG000|Overall Study|Adverse event, serious fatal|1|||
170639501|NCT05019521|616691303|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639502|NCT05019521|616691304|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639503|NCT05019521|616691305|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639504|NCT05019521|616691306|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
170639505|NCT05019521|616691307|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
170639506|NCT05019521|616691301|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
170639507|NCT05019521|616691302|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
170639508|NCT05019521|616691303|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
170639509|NCT05019521|616691304|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
170639510|NCT05019521|616691305|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
170639511|NCT05019521|616691306|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
170639512|NCT05019521|616691307|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
170639513|NCT05019521|616691301|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
170639514|NCT05019521|616691302|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
170639515|NCT05019521|616691303|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
170639516|NCT05019521|616691304|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
170639517|NCT05019521|616691305|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
170639518|NCT05019521|616691306|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
170892307|NCT00670007|617613185|FG000|Overall Study|Adverse Event|1|||
170892308|NCT00670007|617613185|FG000|Overall Study|Withdrawal by Subject|4|||
170892309|NCT00200057|617613186|FG000|Overall Study|Lack of Efficacy|3|||
170892310|NCT00200057|617613186|FG000|Overall Study|Exited due to terminal illness of PI|2|||
170892311|NCT00200057|617613186|FG000|Overall Study|Withdrawal by Subject|1|||
170892312|NCT00200057|617613186|FG000|Overall Study|Change in medical condition|1|||
170892313|NCT00200057|617613186|FG000|Overall Study|Infection|1|||
170892314|NCT00200057|617613186|FG000|Overall Study|Death|1|||
170892315|NCT00778830|617613188|FG000|Overall Study|Ongoing at data cut-off|0|||
170892316|NCT00778830|617613189|FG001|Overall Study|Ongoing at data cut-off|1|||
170892317|NCT03593915|617613190|FG000|Overall Study|Adverse Event|0|||
170892318|NCT03593915|617613191|FG001|Overall Study|Adverse Event|0|||
170892319|NCT03593915|617613192|FG002|Overall Study|Adverse Event|0|||
170892320|NCT03593915|617613193|FG003|Overall Study|Adverse Event|1|||
170892321|NCT03593915|617613194|FG004|Overall Study|Adverse Event|0|||
170892322|NCT03593915|617613195|FG005|Overall Study|Adverse Event|0|||
170892323|NCT03593915|617613190|FG000|Overall Study|Physician Decision|0|||
170892324|NCT03593915|617613191|FG001|Overall Study|Physician Decision|0|||
170892325|NCT03593915|617613192|FG002|Overall Study|Physician Decision|0|||
170892326|NCT03593915|617613193|FG003|Overall Study|Physician Decision|0|||
170892327|NCT03593915|617613194|FG004|Overall Study|Physician Decision|0|||
170892328|NCT03593915|617613195|FG005|Overall Study|Physician Decision|1|||
170892329|NCT01246206|617613196|FG000|Overall Study|Patient did not receive study regiments.|1|||
170892330|NCT02002975|617613197|FG000|Overall Study|Case Report Forms Uncollected|135|||
170892331|NCT02002975|617613197|FG000|Overall Study|Protocol Deviation|437|||
170892332|NCT03523351|617613200|FG000|Overall Study|Death|13|||
170892333|NCT03523351|617613201|FG001|Overall Study|Death|11|||
170892334|NCT03523351|617613200|FG000|Overall Study|Lost to Follow-up|2|||
170892335|NCT03523351|617613201|FG001|Overall Study|Lost to Follow-up|3|||
170892336|NCT03523351|617613200|FG000|Overall Study|Withdrawal by Subject|4|||
170892337|NCT03523351|617613201|FG001|Overall Study|Withdrawal by Subject|0|||
170892338|NCT03523351|617613200|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
170892339|NCT03523351|617613201|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
170892340|NCT01940484|617613204|FG000|Overall Study|Withdrawal by Subject|3|||
170892341|NCT01940484|617613204|FG000|Overall Study|Underwent transplantation|4|||
170892342|NCT01940484|617613204|FG000|Overall Study|Death|2|||
170892343|NCT01940484|617613204|FG000|Overall Study|Adverse Event|1|||
170892344|NCT04652804|617613205|FG000|Overall Study|Ineligible post randomization|1|||
170892345|NCT04652804|617613206|FG001|Overall Study|Ineligible post randomization|0|||
170892346|NCT04652804|617613207|FG002|Overall Study|Ineligible post randomization|1|||
170892347|NCT04652804|617613208|FG003|Overall Study|Ineligible post randomization|0|||
170892348|NCT04652804|617613209|FG004|Overall Study|Ineligible post randomization|1|||
170892349|NCT04652804|617613210|FG005|Overall Study|Ineligible post randomization|1|||
170892350|NCT04652804|617613205|FG000|Overall Study|Missing SVR lab results|2|||
170892351|NCT04652804|617613206|FG001|Overall Study|Missing SVR lab results|0|||
170892352|NCT04652804|617613207|FG002|Overall Study|Missing SVR lab results|0|||
170892353|NCT04652804|617613208|FG003|Overall Study|Missing SVR lab results|0|||
170892354|NCT04652804|617613209|FG004|Overall Study|Missing SVR lab results|0|||
170892355|NCT04652804|617613210|FG005|Overall Study|Missing SVR lab results|0|||
170892356|NCT00927368|617613211|FG000|Overall Study|enrollment in another study|1|||
170892357|NCT00927368|617613212|FG001|Overall Study|enrollment in another study|1|||
170892358|NCT00927368|617613213|FG002|Overall Study|enrollment in another study|2|||
170892359|NCT00927368|617613211|FG000|Overall Study|Lost to Follow-up|4|||
170892360|NCT00927368|617613212|FG001|Overall Study|Lost to Follow-up|0|||
170892361|NCT00927368|617613213|FG002|Overall Study|Lost to Follow-up|0|||
170892362|NCT00927368|617613211|FG000|Overall Study|equipment failure|1|||
170892363|NCT00927368|617613212|FG001|Overall Study|equipment failure|0|||
170892364|NCT00927368|617613213|FG002|Overall Study|equipment failure|0|||
170892365|NCT00927368|617613211|FG000|Overall Study|ineligible post randomization|0|||
170892366|NCT00927368|617613212|FG001|Overall Study|ineligible post randomization|3|||
170892367|NCT00927368|617613213|FG002|Overall Study|ineligible post randomization|1|||
170892368|NCT00927368|617613211|FG000|Overall Study|cancellation of surgery|0|||
170892369|NCT00927368|617613212|FG001|Overall Study|cancellation of surgery|1|||
170892370|NCT00927368|617613213|FG002|Overall Study|cancellation of surgery|2|||
170892371|NCT00352105|617613216|FG000|Overall Study|Death|5|||
170892372|NCT00352105|617613216|FG000|Overall Study|Withdrawal by Subject|5|||
170892373|NCT00352105|617613216|FG000|Overall Study|Lack of Efficacy|9|||
170892374|NCT00352105|617613216|FG000|Overall Study|Adverse Event|19|||
170892375|NCT00352105|617613216|FG000|Overall Study|Protocol Violation|2|||
170892376|NCT02435914|617613217|FG000|Overall Study|Ocular Adverse Event|1|||
170892377|NCT02435914|617613218|FG001|Overall Study|Ocular Adverse Event|0|||
170892378|NCT02435914|617613219|FG002|Overall Study|Ocular Adverse Event|0|||
170892379|NCT02435914|617613220|FG003|Overall Study|Ocular Adverse Event|0|||
170892380|NCT02435914|617613217|FG000|Overall Study|Withdrawal by Subject|0|||
170892381|NCT02435914|617613218|FG001|Overall Study|Withdrawal by Subject|1|||
170892382|NCT02435914|617613219|FG002|Overall Study|Withdrawal by Subject|0|||
170892383|NCT02435914|617613220|FG003|Overall Study|Withdrawal by Subject|0|||
170892384|NCT02435914|617613217|FG000|Overall Study|Other Miscellaneous Reason|0|||
170892385|NCT02435914|617613218|FG001|Overall Study|Other Miscellaneous Reason|0|||
170892386|NCT02435914|617613219|FG002|Overall Study|Other Miscellaneous Reason|1|||
170892387|NCT02435914|617613220|FG003|Overall Study|Other Miscellaneous Reason|0|||
170792909|NCT03478956|617251876|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
170792910|NCT03478956|617251877|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
170792911|NCT03478956|617251878|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
170792912|NCT03478956|617251879|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
170792913|NCT03478956|617251876|FG000|Open Label Extension Period|Adverse Event|0|||
170792914|NCT03478956|617251877|FG001|Open Label Extension Period|Adverse Event|0|||
170792915|NCT03478956|617251878|FG002|Open Label Extension Period|Adverse Event|4|||
170792916|NCT03478956|617251879|FG003|Open Label Extension Period|Adverse Event|0|||
170792917|NCT03478956|617251876|FG000|Open Label Extension Period|Lack of Efficacy|0|||
170792918|NCT03478956|617251877|FG001|Open Label Extension Period|Lack of Efficacy|0|||
170792919|NCT03478956|617251878|FG002|Open Label Extension Period|Lack of Efficacy|8|||
170792920|NCT03478956|617251879|FG003|Open Label Extension Period|Lack of Efficacy|0|||
170792921|NCT03478956|617251876|FG000|Open Label Extension Period|Reason Not Provided|0|||
170792922|NCT03478956|617251877|FG001|Open Label Extension Period|Reason Not Provided|0|||
170792923|NCT03478956|617251878|FG002|Open Label Extension Period|Reason Not Provided|1|||
170792924|NCT03478956|617251879|FG003|Open Label Extension Period|Reason Not Provided|0|||
170792925|NCT03478956|617251876|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
170792926|NCT03478956|617251877|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
170792927|NCT03478956|617251878|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
170792928|NCT03478956|617251879|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
170792929|NCT03478956|617251876|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
170792930|NCT03478956|617251877|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
170792931|NCT03478956|617251878|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
170792932|NCT03478956|617251879|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
170792933|NCT03478956|617251876|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
170792934|NCT03478956|617251877|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
170792935|NCT03478956|617251878|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
170792936|NCT03478956|617251879|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
170792937|NCT05170841|617251880|FG000|Single Dose Phase|Adverse Event|1|||
170792938|NCT05170841|617251881|FG001|Single Dose Phase|Adverse Event|2|||
170792939|NCT05170841|617251882|FG002|Single Dose Phase|Adverse Event|0|||
170792940|NCT05170841|617251883|FG003|Single Dose Phase|Adverse Event|2|||
170792941|NCT05170841|617251880|FG000|Multiple Dose Phase|Adverse Event|1|||
170792942|NCT05170841|617251881|FG001|Multiple Dose Phase|Adverse Event|2|||
170792943|NCT05170841|617251882|FG002|Multiple Dose Phase|Adverse Event|1|||
170792944|NCT05170841|617251883|FG003|Multiple Dose Phase|Adverse Event|4|||
170792945|NCT05170841|617251880|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
170792946|NCT05170841|617251881|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
170792947|NCT05170841|617251882|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
170792948|NCT05170841|617251883|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
170792949|NCT05123586|617251886|FG000|Overall Study|Physician Decision|1|||
170792950|NCT05123586|617251887|FG001|Overall Study|Physician Decision|1|||
170792951|NCT05123586|617251886|FG000|Overall Study|Withdrawal by Subject|0|||
170792952|NCT05123586|617251887|FG001|Overall Study|Withdrawal by Subject|3|||
170792953|NCT06122194|617251892|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
170792954|NCT06122194|617251893|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
170792955|NCT06122194|617251894|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
170792956|NCT06122194|617251895|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
170792957|NCT02315703|617251896|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
170792958|NCT02315703|617251897|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
170792959|NCT02315703|617251898|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
170792960|NCT02315703|617251899|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
170792961|NCT02315703|617251900|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
170792962|NCT02315703|617251901|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
170792963|NCT02315703|617251902|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
170792964|NCT02315703|617251903|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
170792965|NCT02315703|617251896|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
170892388|NCT01486199|617613221|FG000|Two Year Period Between Study Days|Physician Decision|1|||
170892389|NCT01486199|617613222|FG001|Two Year Period Between Study Days|Physician Decision|0|||
170892390|NCT02154425|617613223|FG000|Screening Period|Adverse Event|1|||
170892391|NCT00480857|617613226|FG000|Overall Study|Lack of Efficacy|2|||
170892392|NCT00611247|617613227|FG000|Overall Study|Death|1|||
170892393|NCT00611247|617613228|FG001|Overall Study|Death|5|||
170892394|NCT00611247|617613227|FG000|Overall Study|Lack of Efficacy|1|||
170892395|NCT00611247|617613228|FG001|Overall Study|Lack of Efficacy|16|||
170892396|NCT00243659|617613229|FG000|Overall Study|Withdrawal by Subject|1|||
170892397|NCT00243659|617613230|FG001|Overall Study|Withdrawal by Subject|1|||
170892398|NCT00243659|617613229|FG000|Overall Study|Protocol Violation|1|||
170892399|NCT00243659|617613230|FG001|Overall Study|Protocol Violation|2|||
170892400|NCT00357500|617613231|FG000|Overall Study|Adverse Event|3|||
170892401|NCT00357500|617613231|FG000|Overall Study|Withdrawal by Subject|5|||
170892402|NCT00357500|617613231|FG000|Overall Study|Progressive Disease|65|||
170892403|NCT00357500|617613231|FG000|Overall Study|Not Started Protocol Therapy|4|||
170892404|NCT01890421|617613232|FG000|Overall Study|Adverse Event|1|||
170892405|NCT01890421|617613232|FG000|Overall Study|Other reason|10|||
170892406|NCT04871711|617613233|FG000|Overall Study|Withdrawal by Subject|11|||
170892407|NCT04871711|617613234|FG001|Overall Study|Withdrawal by Subject|5|||
170892408|NCT04871711|617613233|FG000|Overall Study|Lack of Efficacy|5|||
170892409|NCT04871711|617613234|FG001|Overall Study|Lack of Efficacy|7|||
170892410|NCT04871711|617613233|FG000|Overall Study|Adverse Event|2|||
170892411|NCT04871711|617613234|FG001|Overall Study|Adverse Event|6|||
170892412|NCT04871711|617613233|FG000|Overall Study|Various reasons|2|||
170892413|NCT04871711|617613234|FG001|Overall Study|Various reasons|1|||
170892414|NCT04871711|617613233|FG000|Overall Study|Lost to Follow-up|0|||
170892415|NCT04871711|617613234|FG001|Overall Study|Lost to Follow-up|2|||
170892416|NCT01913483|617613235|FG000|Overall Study|Withdrawal by Subject|1|||
170892417|NCT01913483|617613236|FG001|Overall Study|Withdrawal by Subject|2|||
170892418|NCT01913483|617613235|FG000|Overall Study|Lost to Follow-up|6|||
170892419|NCT01913483|617613236|FG001|Overall Study|Lost to Follow-up|3|||
170892420|NCT01913483|617613235|FG000|Overall Study|Death|14|||
170892421|NCT01913483|617613236|FG001|Overall Study|Death|17|||
170547232|NCT03055221|616350117|FG000|Overall Study|Withdrawal by Subject|4|||
170547233|NCT03055221|616350117|FG000|Overall Study|Death|6|||
170547234|NCT03055221|616350117|FG000|Overall Study|Physician Decision|1|||
170547235|NCT03055221|616350117|FG000|Overall Study|Study terminated by Sponsor|3|||
170547236|NCT03055221|616350117|FG000|Overall Study|Lost to Follow-up|4|||
170547237|NCT01243424|616350118|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
170547238|NCT01243424|616350119|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
170547239|NCT01243424|616350118|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
170547240|NCT01243424|616350119|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
170547241|NCT01243424|616350118|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
170547242|NCT01243424|616350119|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
170547243|NCT01243424|616350118|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
170547244|NCT01243424|616350119|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
170547245|NCT01243424|616350118|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
170547246|NCT01243424|616350119|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
170547247|NCT01243424|616350118|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
170547248|NCT01243424|616350119|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
170547249|NCT01243424|616350118|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
170547250|NCT01243424|616350119|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
170547251|NCT01243424|616350118|FG000|Discontinuation From Treatment|Not treated|5|||
170547252|NCT01243424|616350119|FG001|Discontinuation From Treatment|Not treated|4|||
170547253|NCT01243424|616350118|FG000|Discontinuation From Treatment|Adverse Event|457|||
170547254|NCT01243424|616350119|FG001|Discontinuation From Treatment|Adverse Event|523|||
170639519|NCT05019521|616691307|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
170892422|NCT03969888|617613237|FG000|Overall Study|Never Received Study Drug|0|||
170892423|NCT03969888|617613238|FG001|Overall Study|Never Received Study Drug|0|||
170639520|NCT02873377|616691308|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
170892424|NCT03969888|617613239|FG002|Overall Study|Never Received Study Drug|1|||
170892425|NCT03969888|617613240|FG003|Overall Study|Never Received Study Drug|0|||
170892426|NCT03969888|617613241|FG004|Overall Study|Never Received Study Drug|0|||
170892427|NCT03969888|617613242|FG005|Overall Study|Never Received Study Drug|0|||
170547255|NCT01243424|616350118|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
170792966|NCT02315703|617251897|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
170792967|NCT02315703|617251898|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
170792968|NCT02315703|617251899|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
170792969|NCT02315703|617251900|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
170792970|NCT02315703|617251901|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
170792971|NCT02315703|617251902|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
170792972|NCT02315703|617251903|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
170792973|NCT02315703|617251896|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
170792974|NCT02315703|617251897|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
170792975|NCT02315703|617251898|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
170792976|NCT02315703|617251899|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
170792977|NCT02315703|617251900|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
170792978|NCT02315703|617251901|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
170792979|NCT02315703|617251902|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
170792980|NCT02315703|617251903|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
170792981|NCT02315703|617251896|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
170792982|NCT02315703|617251897|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
170792983|NCT02315703|617251898|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
170792984|NCT02315703|617251899|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
170792985|NCT02315703|617251900|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
170792986|NCT02315703|617251901|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
170792987|NCT02315703|617251902|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
170792988|NCT02315703|617251903|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
170792989|NCT02315703|617251896|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
170792990|NCT02315703|617251897|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
170792991|NCT02315703|617251898|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
170792992|NCT02315703|617251899|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
170792993|NCT02315703|617251900|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
170792994|NCT02315703|617251901|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
170792995|NCT02315703|617251902|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
170792996|NCT02315703|617251903|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
170792997|NCT02315703|617251896|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
170792998|NCT02315703|617251897|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
170792999|NCT02315703|617251898|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
170793000|NCT02315703|617251899|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
170793001|NCT02315703|617251900|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
170793002|NCT02315703|617251901|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
170793003|NCT02315703|617251902|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
170793004|NCT02315703|617251903|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
170793005|NCT02315703|617251896|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
170793006|NCT02315703|617251897|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
170793007|NCT02315703|617251898|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
170793008|NCT02315703|617251899|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
170793009|NCT02315703|617251900|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
170793010|NCT02315703|617251901|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
170793011|NCT02315703|617251902|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
170793012|NCT02315703|617251903|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
170793013|NCT02315703|617251896|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
170793014|NCT02315703|617251897|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
170793015|NCT02315703|617251898|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
170793016|NCT02315703|617251899|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
170793017|NCT02315703|617251900|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
170793018|NCT02315703|617251901|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
170793019|NCT02315703|617251902|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
170793020|NCT02315703|617251903|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
170793021|NCT02315703|617251896|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
170793022|NCT02315703|617251897|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
170793023|NCT02315703|617251898|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
170793024|NCT02315703|617251899|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
170892428|NCT03969888|617613243|FG006|Overall Study|Never Received Study Drug|1|||
170892429|NCT03969888|617613244|FG007|Overall Study|Never Received Study Drug|0|||
170892430|NCT03969888|617613237|FG000|Overall Study|Reason Not Specified|0|||
170892431|NCT03969888|617613238|FG001|Overall Study|Reason Not Specified|0|||
170892432|NCT03969888|617613239|FG002|Overall Study|Reason Not Specified|0|||
170892433|NCT03969888|617613240|FG003|Overall Study|Reason Not Specified|0|||
170892434|NCT03969888|617613241|FG004|Overall Study|Reason Not Specified|0|||
170892435|NCT03969888|617613242|FG005|Overall Study|Reason Not Specified|0|||
170892436|NCT03969888|617613243|FG006|Overall Study|Reason Not Specified|0|||
170892437|NCT03969888|617613244|FG007|Overall Study|Reason Not Specified|1|||
170892438|NCT00464178|617613245|FG000|Overall Study|Protocol Violation|1|||
170892439|NCT00464178|617613245|FG000|Overall Study|Withdrawal by Subject|1|||
170892440|NCT01972074|617613252|FG000|Overall Study|Adverse Event|4|||
170892441|NCT01972074|617613253|FG001|Overall Study|Adverse Event|1|||
170892442|NCT01972074|617613254|FG002|Overall Study|Adverse Event|0|||
170892443|NCT01972074|617613252|FG000|Overall Study|Lack of Efficacy|1|||
170892444|NCT01972074|617613253|FG001|Overall Study|Lack of Efficacy|1|||
170892445|NCT01972074|617613254|FG002|Overall Study|Lack of Efficacy|0|||
170892446|NCT01972074|617613252|FG000|Overall Study|Lost to Follow-up|0|||
170892447|NCT01972074|617613253|FG001|Overall Study|Lost to Follow-up|1|||
170892448|NCT01972074|617613254|FG002|Overall Study|Lost to Follow-up|1|||
170892449|NCT01972074|617613252|FG000|Overall Study|Withdrawal by Subject|1|||
170892450|NCT01972074|617613253|FG001|Overall Study|Withdrawal by Subject|1|||
170892451|NCT01972074|617613254|FG002|Overall Study|Withdrawal by Subject|1|||
170892452|NCT01972074|617613252|FG000|Overall Study|Scanner Unavailable|0|||
170892453|NCT01972074|617613253|FG001|Overall Study|Scanner Unavailable|0|||
170892454|NCT01972074|617613254|FG002|Overall Study|Scanner Unavailable|1|||
170892455|NCT02319044|617613255|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
170892456|NCT02319044|617613256|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
170892457|NCT02319044|617613257|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
170892458|NCT02319044|617613255|FG000|Overall Study|Withdrawal by Subject|3|||
170892459|NCT02319044|617613256|FG001|Overall Study|Withdrawal by Subject|3|||
170892460|NCT02319044|617613257|FG002|Overall Study|Withdrawal by Subject|6|||
170892461|NCT02319044|617613255|FG000|Overall Study|Condition under investigation worsened|100|||
170892462|NCT02319044|617613256|FG001|Overall Study|Condition under investigation worsened|50|||
170892463|NCT02319044|617613257|FG002|Overall Study|Condition under investigation worsened|46|||
170892464|NCT02319044|617613255|FG000|Overall Study|Adverse Event|17|||
170892465|NCT02319044|617613256|FG001|Overall Study|Adverse Event|2|||
170892466|NCT02319044|617613257|FG002|Overall Study|Adverse Event|8|||
170892467|NCT02319044|617613255|FG000|Overall Study|Study specific discontinuation criteria|2|||
170892468|NCT02319044|617613256|FG001|Overall Study|Study specific discontinuation criteria|2|||
170892469|NCT02319044|617613257|FG002|Overall Study|Study specific discontinuation criteria|1|||
170892470|NCT02319044|617613255|FG000|Overall Study|Not treated|0|||
170892471|NCT02319044|617613256|FG001|Overall Study|Not treated|2|||
170892472|NCT02319044|617613257|FG002|Overall Study|Not treated|2|||
170892473|NCT04556617|617613264|FG000|Overall Study|progressive disease|0|||
170892474|NCT04556617|617613265|FG001|Overall Study|progressive disease|2|||
170892475|NCT04556617|617613266|FG002|Overall Study|progressive disease|2|||
170892476|NCT04556617|617613267|FG003|Overall Study|progressive disease|1|||
170892477|NCT04556617|617613268|FG004|Overall Study|progressive disease|1|||
170892478|NCT04556617|617613264|FG000|Overall Study|Physician Decision|0|||
170892479|NCT04556617|617613265|FG001|Overall Study|Physician Decision|0|||
170892480|NCT04556617|617613266|FG002|Overall Study|Physician Decision|2|||
170892481|NCT04556617|617613267|FG003|Overall Study|Physician Decision|0|||
170892482|NCT04556617|617613268|FG004|Overall Study|Physician Decision|0|||
170892483|NCT04556617|617613264|FG000|Overall Study|Adverse Event|0|||
170892484|NCT04556617|617613265|FG001|Overall Study|Adverse Event|0|||
170892485|NCT04556617|617613266|FG002|Overall Study|Adverse Event|2|||
170892486|NCT04556617|617613267|FG003|Overall Study|Adverse Event|3|||
170892487|NCT04556617|617613268|FG004|Overall Study|Adverse Event|0|||
170892488|NCT04556617|617613264|FG000|Overall Study|Withdrawal by Subject|0|||
170892489|NCT04556617|617613265|FG001|Overall Study|Withdrawal by Subject|2|||
170547256|NCT01243424|616350119|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
170547257|NCT01243424|616350118|FG000|Discontinuation From Treatment|Protocol Violation|46|||
170547258|NCT01243424|616350119|FG001|Discontinuation From Treatment|Protocol Violation|47|||
170892490|NCT04556617|617613266|FG002|Overall Study|Withdrawal by Subject|1|||
170892491|NCT04556617|617613267|FG003|Overall Study|Withdrawal by Subject|1|||
170547259|NCT01243424|616350118|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
170892492|NCT04556617|617613268|FG004|Overall Study|Withdrawal by Subject|0|||
170892493|NCT04556617|617613264|FG000|Overall Study|PSA increase|0|||
170892494|NCT04556617|617613265|FG001|Overall Study|PSA increase|1|||
170892495|NCT04556617|617613266|FG002|Overall Study|PSA increase|0|||
170892496|NCT04556617|617613267|FG003|Overall Study|PSA increase|0|||
170892497|NCT04556617|617613268|FG004|Overall Study|PSA increase|0|||
170892498|NCT04556617|617613264|FG000|Overall Study|Sponsor study termination|1|||
170892499|NCT04556617|617613265|FG001|Overall Study|Sponsor study termination|0|||
170892500|NCT04556617|617613266|FG002|Overall Study|Sponsor study termination|0|||
170892501|NCT04556617|617613267|FG003|Overall Study|Sponsor study termination|0|||
170892502|NCT04556617|617613268|FG004|Overall Study|Sponsor study termination|0|||
170892503|NCT01777581|617613269|FG000|Overall Study|Lost to Follow-up|1|||
170892504|NCT01777581|617613270|FG001|Overall Study|Lost to Follow-up|1|||
170892505|NCT01777581|617613269|FG000|Overall Study|Adverse Event|2|||
170892506|NCT01777581|617613270|FG001|Overall Study|Adverse Event|0|||
170892507|NCT01777581|617613269|FG000|Overall Study|Lack of Efficacy|0|||
170892508|NCT01777581|617613270|FG001|Overall Study|Lack of Efficacy|1|||
170892509|NCT02887521|617613271|FG000|Overall Study|Withdrawal by Subject|0|||
170892510|NCT02887521|617613272|FG001|Overall Study|Withdrawal by Subject|3|||
170892511|NCT03110900|617613273|FG000|Overall Study|Sponsor withdrew|1|||
170892512|NCT03110900|617613274|FG001|Overall Study|Sponsor withdrew|1|||
170892513|NCT00644787|617613275|FG000|Period 1: Titration Phase|Adverse Event|11|||
170892514|NCT00644787|617613276|FG001|Period 1: Titration Phase|Adverse Event|0|||
170892515|NCT00644787|617613277|FG002|Period 1: Titration Phase|Adverse Event|0|||
170892516|NCT00644787|617613275|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
170892517|NCT00644787|617613276|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
170892518|NCT00644787|617613277|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
170892519|NCT00644787|617613275|FG000|Period 1: Titration Phase|Physician Decision|1|||
170892520|NCT00644787|617613276|FG001|Period 1: Titration Phase|Physician Decision|0|||
170892521|NCT00644787|617613277|FG002|Period 1: Titration Phase|Physician Decision|0|||
170892522|NCT00644787|617613275|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
170892523|NCT00644787|617613276|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
170892524|NCT00644787|617613277|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
170892525|NCT00644787|617613275|FG000|Period 1: Titration Phase|Worsening of complications|1|||
170892526|NCT00644787|617613276|FG001|Period 1: Titration Phase|Worsening of complications|0|||
170892527|NCT00644787|617613277|FG002|Period 1: Titration Phase|Worsening of complications|0|||
170892528|NCT00644787|617613275|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
170892529|NCT00644787|617613276|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
170892530|NCT00644787|617613277|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
170892531|NCT00644787|617613275|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
170892532|NCT00644787|617613276|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
170892533|NCT00644787|617613277|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
170892534|NCT00644787|617613275|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
170892535|NCT00644787|617613276|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
170892536|NCT00644787|617613277|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
170892537|NCT00644787|617613275|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
170892538|NCT00644787|617613276|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
170892539|NCT00644787|617613277|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
170892540|NCT00644787|617613275|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
170892541|NCT00644787|617613276|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
170892542|NCT00644787|617613277|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
170892543|NCT00644787|617613275|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
170892544|NCT00644787|617613276|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
170892545|NCT00644787|617613277|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
170892546|NCT00644787|617613275|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
170892547|NCT00644787|617613276|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
170892548|NCT00644787|617613277|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
170892549|NCT03355300|617613278|FG000|Overall Study|Physician Decision|0|||
170892550|NCT03355300|617613279|FG001|Overall Study|Physician Decision|1|||
170892551|NCT03355300|617613278|FG000|Overall Study|Lack of Efficacy|2|||
170892552|NCT03355300|617613279|FG001|Overall Study|Lack of Efficacy|1|||
170892553|NCT03355300|617613278|FG000|Overall Study|Other reason|1|||
170892554|NCT03355300|617613279|FG001|Overall Study|Other reason|0|||
170892555|NCT00546052|617613280|FG000|Overall Study|Adverse Event|47|||
170892556|NCT00546052|617613280|FG000|Overall Study|Lost to Follow-up|144|||
170892557|NCT00546052|617613280|FG000|Overall Study|Protocol Violation|9|||
170892558|NCT00546052|617613280|FG000|Overall Study|Withdrawal by Subject|20|||
170892559|NCT00546052|617613280|FG000|Overall Study|Non Compliance|7|||
170892560|NCT03048422|617613281|FG000|Overall Study|Death|1|||
170892561|NCT03048422|617613282|FG001|Overall Study|Death|0|||
170892562|NCT03048422|617613283|FG002|Overall Study|Death|0|||
170892563|NCT03048422|617613281|FG000|Overall Study|Lost to Follow-up|5|||
170892564|NCT03048422|617613282|FG001|Overall Study|Lost to Follow-up|0|||
170892565|NCT03048422|617613283|FG002|Overall Study|Lost to Follow-up|1|||
170639521|NCT02873377|616691309|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
170892566|NCT03048422|617613281|FG000|Overall Study|Withdrawal by Subject|5|||
170892567|NCT03048422|617613282|FG001|Overall Study|Withdrawal by Subject|7|||
170892568|NCT03048422|617613283|FG002|Overall Study|Withdrawal by Subject|4|||
170892569|NCT03048422|617613281|FG000|Overall Study|Moved|3|||
170892570|NCT03048422|617613282|FG001|Overall Study|Moved|2|||
170892571|NCT03048422|617613283|FG002|Overall Study|Moved|2|||
170892572|NCT03048422|617613281|FG000|Overall Study|Noncompliant with Study Requirements|2|||
170892573|NCT03048422|617613282|FG001|Overall Study|Noncompliant with Study Requirements|1|||
170892574|NCT03048422|617613283|FG002|Overall Study|Noncompliant with Study Requirements|2|||
170892575|NCT03048422|617613281|FG000|Overall Study|Not Able to Get to Clinic|1|||
170892576|NCT03048422|617613282|FG001|Overall Study|Not Able to Get to Clinic|0|||
170892577|NCT03048422|617613283|FG002|Overall Study|Not Able to Get to Clinic|0|||
170892578|NCT02482129|617613284|FG000|Overall Study|Adverse Event-prior to treatment|0|||
170892579|NCT02482129|617613285|FG001|Overall Study|Adverse Event-prior to treatment|1|||
170892580|NCT02482129|617613284|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
170892581|NCT02482129|617613285|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
170892582|NCT02482129|617613284|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
170892583|NCT02482129|617613285|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
170892584|NCT02482129|617613284|FG000|Overall Study|Criteria not met-prior to treatment|1|||
170892585|NCT02482129|617613285|FG001|Overall Study|Criteria not met-prior to treatment|0|||
170892586|NCT02482129|617613284|FG000|Overall Study|Adverse Event|1|||
170892587|NCT02482129|617613285|FG001|Overall Study|Adverse Event|0|||
170892588|NCT02482129|617613284|FG000|Overall Study|Withdrawal by Subject|2|||
170892589|NCT02482129|617613285|FG001|Overall Study|Withdrawal by Subject|0|||
170892590|NCT02482129|617613284|FG000|Overall Study|Criteria not met|1|||
170892591|NCT02482129|617613285|FG001|Overall Study|Criteria not met|0|||
170892592|NCT01738971|617613286|FG000|Overall Study|Lost to Follow-up|19|||
170892593|NCT01738971|617613287|FG001|Overall Study|Lost to Follow-up|30|||
170892594|NCT01738971|617613288|FG002|Overall Study|Lost to Follow-up|17|||
170892595|NCT01031446|617613289|FG000|Overall Study|Disease Progression|38|||
170892596|NCT01031446|617613289|FG000|Overall Study|Adverse Event|9|||
170892597|NCT01031446|617613289|FG000|Overall Study|Physician Decision|4|||
170892598|NCT01031446|617613289|FG000|Overall Study|Withdrawal by Subject|3|||
170892599|NCT01031446|617613289|FG000|Overall Study|Still on treatment|1|||
170892600|NCT04698629|617613301|FG000|Overall Study|Adverse Event|1|||
170892601|NCT05900115|617615286|FG000|Overall Study|Lost to Follow-up|129|||
170892602|NCT05900115|617615287|FG001|Overall Study|Lost to Follow-up|98|||
170892603|NCT00880750|617615291|FG000|First Intervention|Adverse Event|1|||
170892604|NCT00880750|617615292|FG001|First Intervention|Adverse Event|0|||
170892605|NCT00880750|617615291|FG000|First Intervention|Unable to collect urine|4|||
170892606|NCT00880750|617615292|FG001|First Intervention|Unable to collect urine|0|||
170547260|NCT01243424|616350119|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
170547261|NCT01243424|616350118|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
170547262|NCT01243424|616350119|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
170892607|NCT00880750|617615291|FG000|First Intervention|Non-compliance with meals|0|||
170892608|NCT00880750|617615292|FG001|First Intervention|Non-compliance with meals|1|||
170892609|NCT00880750|617615291|FG000|First Intervention|Withdrawal by Subject|2|||
170892610|NCT00880750|617615292|FG001|First Intervention|Withdrawal by Subject|0|||
170892611|NCT00880750|617615291|FG000|First Intervention|Lost to Follow-up|2|||
170892612|NCT00880750|617615292|FG001|First Intervention|Lost to Follow-up|0|||
170892613|NCT00880750|617615291|FG000|Second Intervention|Withdrawal by Subject|2|||
170892614|NCT00880750|617615292|FG001|Second Intervention|Withdrawal by Subject|2|||
170892615|NCT00880750|617615291|FG000|Second Intervention|Protocol Violation|1|||
170892616|NCT00880750|617615292|FG001|Second Intervention|Protocol Violation|0|||
170892617|NCT00880750|617615291|FG000|Second Intervention|Unable to collect urine|1|||
170892618|NCT00880750|617615292|FG001|Second Intervention|Unable to collect urine|0|||
170892619|NCT00667576|617615297|FG000|Overall Study|Withdrawal by Subject|1|||
170892620|NCT00667576|617615298|FG001|Overall Study|Withdrawal by Subject|0|||
170892621|NCT00667576|617615299|FG002|Overall Study|Withdrawal by Subject|1|||
170892622|NCT00667576|617615300|FG003|Overall Study|Withdrawal by Subject|1|||
170892623|NCT00667576|617615301|FG004|Overall Study|Withdrawal by Subject|1|||
170892624|NCT00667576|617615297|FG000|Overall Study|Adverse Event|1|||
170892625|NCT00667576|617615298|FG001|Overall Study|Adverse Event|1|||
170892626|NCT00667576|617615299|FG002|Overall Study|Adverse Event|0|||
170892627|NCT00667576|617615300|FG003|Overall Study|Adverse Event|0|||
170892628|NCT00667576|617615301|FG004|Overall Study|Adverse Event|0|||
170892629|NCT00667576|617615297|FG000|Overall Study|Lost to Follow-up|0|||
170892630|NCT00667576|617615298|FG001|Overall Study|Lost to Follow-up|0|||
170547263|NCT01243424|616350118|FG000|Discontinuation From Treatment|Other than listed above|230|||
170547264|NCT01243424|616350119|FG001|Discontinuation From Treatment|Other than listed above|211|||
170892631|NCT00667576|617615299|FG002|Overall Study|Lost to Follow-up|1|||
170892632|NCT00667576|617615300|FG003|Overall Study|Lost to Follow-up|0|||
170892633|NCT00667576|617615301|FG004|Overall Study|Lost to Follow-up|0|||
170892634|NCT00667576|617615297|FG000|Overall Study|Protocol Violation|0|||
170892635|NCT00667576|617615298|FG001|Overall Study|Protocol Violation|0|||
170892636|NCT00667576|617615299|FG002|Overall Study|Protocol Violation|0|||
170892637|NCT00667576|617615300|FG003|Overall Study|Protocol Violation|1|||
170892638|NCT00667576|617615301|FG004|Overall Study|Protocol Violation|0|||
170892639|NCT00667576|617615297|FG000|Overall Study|Physician Decision|0|||
170892640|NCT00667576|617615298|FG001|Overall Study|Physician Decision|0|||
170892641|NCT00667576|617615299|FG002|Overall Study|Physician Decision|0|||
170892642|NCT00667576|617615300|FG003|Overall Study|Physician Decision|1|||
170892643|NCT00667576|617615301|FG004|Overall Study|Physician Decision|0|||
170892644|NCT00667576|617615297|FG000|Overall Study|Missed Visit|0|||
170892645|NCT00667576|617615298|FG001|Overall Study|Missed Visit|0|||
170892646|NCT00667576|617615299|FG002|Overall Study|Missed Visit|0|||
170892647|NCT00667576|617615300|FG003|Overall Study|Missed Visit|1|||
170892648|NCT00667576|617615301|FG004|Overall Study|Missed Visit|0|||
170892649|NCT01059448|617615305|FG000|Overall Study|Adverse Event|1|||
170892650|NCT01059448|617615306|FG001|Overall Study|Adverse Event|3|||
170892651|NCT01059448|617615307|FG002|Overall Study|Adverse Event|0|||
170892652|NCT01059448|617615308|FG003|Overall Study|Adverse Event|1|||
170892653|NCT01059448|617615305|FG000|Overall Study|Withdrawal by Subject|2|||
170892654|NCT01059448|617615306|FG001|Overall Study|Withdrawal by Subject|0|||
170892655|NCT01059448|617615307|FG002|Overall Study|Withdrawal by Subject|2|||
170892656|NCT01059448|617615308|FG003|Overall Study|Withdrawal by Subject|4|||
170892657|NCT01059448|617615305|FG000|Overall Study|Disease Progression|2|||
170892658|NCT01059448|617615306|FG001|Overall Study|Disease Progression|1|||
170892659|NCT01059448|617615307|FG002|Overall Study|Disease Progression|4|||
170892660|NCT01059448|617615308|FG003|Overall Study|Disease Progression|2|||
170892661|NCT01059448|617615305|FG000|Overall Study|Administrative Decision|43|||
170892662|NCT01059448|617615306|FG001|Overall Study|Administrative Decision|49|||
170892663|NCT01059448|617615307|FG002|Overall Study|Administrative Decision|45|||
170892664|NCT01059448|617615308|FG003|Overall Study|Administrative Decision|46|||
170892665|NCT01059448|617615305|FG000|Overall Study|Lost to Follow-up|0|||
170892666|NCT01059448|617615306|FG001|Overall Study|Lost to Follow-up|0|||
170892667|NCT01059448|617615307|FG002|Overall Study|Lost to Follow-up|2|||
170892668|NCT01059448|617615308|FG003|Overall Study|Lost to Follow-up|0|||
170892669|NCT01059448|617615305|FG000|Overall Study|Death|0|||
170892670|NCT01059448|617615306|FG001|Overall Study|Death|1|||
170892671|NCT01059448|617615307|FG002|Overall Study|Death|0|||
170892672|NCT01059448|617615308|FG003|Overall Study|Death|0|||
170892673|NCT01059448|617615305|FG000|Overall Study|Other|1|||
170892674|NCT01059448|617615306|FG001|Overall Study|Other|1|||
170892675|NCT01059448|617615307|FG002|Overall Study|Other|0|||
170892676|NCT01059448|617615308|FG003|Overall Study|Other|1|||
170892677|NCT01390389|617615309|FG000|Overall Study|Withdrawal by Subject|2|||
170892678|NCT01390389|617615310|FG001|Overall Study|Withdrawal by Subject|0|||
170892679|NCT01390389|617615309|FG000|Overall Study|Screen Fail|2|||
170892680|NCT01390389|617615310|FG001|Overall Study|Screen Fail|1|||
170892681|NCT05512949|617615311|FG000|Overall Study|Lost to Follow-up|4|||
170892682|NCT05512949|617615312|FG001|Overall Study|Lost to Follow-up|6|||
170892683|NCT05512949|617615313|FG002|Overall Study|Lost to Follow-up|2|||
170892684|NCT05512949|617615311|FG000|Overall Study|Protocol Violation|0|||
170892685|NCT05512949|617615312|FG001|Overall Study|Protocol Violation|0|||
170892686|NCT05512949|617615313|FG002|Overall Study|Protocol Violation|1|||
170892687|NCT05512949|617615311|FG000|Overall Study|Withdrawal by Subject|1|||
170892688|NCT05512949|617615312|FG001|Overall Study|Withdrawal by Subject|1|||
170892689|NCT05512949|617615313|FG002|Overall Study|Withdrawal by Subject|2|||
170892690|NCT05512949|617615311|FG000|Overall Study|Completion status unknown|1|||
170892691|NCT05512949|617615312|FG001|Overall Study|Completion status unknown|3|||
170892692|NCT05512949|617615313|FG002|Overall Study|Completion status unknown|0|||
170892693|NCT01583179|617615314|FG000|Overall Study|Screen failure|1|||
170892694|NCT01583179|617615315|FG001|Overall Study|Screen failure|2|||
170892695|NCT03988907|617615316|FG000|Overall Study|Unable to complete visit|0|||
170892696|NCT03988907|617615317|FG001|Overall Study|Unable to complete visit|1|||
170892697|NCT02810964|617615318|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
170892698|NCT02810964|617615319|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
170892699|NCT02810964|617615318|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
170892700|NCT02810964|617615319|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
170892701|NCT02810964|617615318|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
170892702|NCT02810964|617615319|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
170892703|NCT02810964|617615318|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
170478136|NCT00595621|616090474|FG000|Open Label Run in|Physician Decision|1|||
170892704|NCT02810964|617615319|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
170892705|NCT01871090|617615322|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
170892706|NCT01871090|617615323|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
170892707|NCT01871090|617615322|FG000|Overall Study|Interrogation not completed correctly|1|||
170892708|NCT01871090|617615323|FG001|Overall Study|Interrogation not completed correctly|0|||
170892709|NCT01871090|617615322|FG000|Overall Study|Subject Non-Compliance|0|||
170892710|NCT01871090|617615323|FG001|Overall Study|Subject Non-Compliance|1|||
170892711|NCT01307033|617615324|FG000|8-week Double-blind Period|Adverse Event|2|||
170892712|NCT01307033|617615325|FG001|8-week Double-blind Period|Adverse Event|0|||
170478137|NCT00595621|616090475|FG001|Open Label Run in|Physician Decision|0|||
170478138|NCT00595621|616090474|FG000|Open Label Run in|Withdrawal by Subject|1|||
170892713|NCT01307033|617615326|FG002|8-week Double-blind Period|Adverse Event|0|||
170892714|NCT01307033|617615327|FG003|8-week Double-blind Period|Adverse Event|0|||
170892715|NCT01307033|617615324|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
170892716|NCT01307033|617615325|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
170892717|NCT01307033|617615326|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
170892718|NCT01307033|617615327|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
170892719|NCT01307033|617615324|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
170892720|NCT01307033|617615325|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
170892721|NCT01307033|617615326|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
170892722|NCT01307033|617615327|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
170892723|NCT01307033|617615324|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
170892724|NCT01307033|617615325|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
170892725|NCT01307033|617615326|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
170892726|NCT01307033|617615327|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
170892727|NCT01307033|617615324|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
170892728|NCT01307033|617615325|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
170892729|NCT01307033|617615326|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
170892730|NCT01307033|617615327|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
170892731|NCT01307033|617615324|FG000|44-week Open-label Extension|Adverse Event|0|||
170892732|NCT01307033|617615325|FG001|44-week Open-label Extension|Adverse Event|0|||
170892733|NCT01307033|617615326|FG002|44-week Open-label Extension|Adverse Event|2|||
170892734|NCT01307033|617615327|FG003|44-week Open-label Extension|Adverse Event|1|||
170892735|NCT01307033|617615324|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
170892736|NCT01307033|617615325|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
170892737|NCT01307033|617615326|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
170892738|NCT01307033|617615327|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
170892739|NCT01307033|617615324|FG000|44-week Open-label Extension|Physician Decision|0|||
170892740|NCT01307033|617615325|FG001|44-week Open-label Extension|Physician Decision|0|||
170892741|NCT01307033|617615326|FG002|44-week Open-label Extension|Physician Decision|1|||
170892742|NCT01307033|617615327|FG003|44-week Open-label Extension|Physician Decision|0|||
170892743|NCT01307033|617615324|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
170892744|NCT01307033|617615325|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
170892745|NCT01307033|617615326|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
170892746|NCT01307033|617615327|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
170892747|NCT01307033|617615324|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
170892748|NCT01307033|617615325|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
170892749|NCT01307033|617615326|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
170892750|NCT01307033|617615327|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
170892751|NCT01307033|617615324|FG000|44-week Open-label Extension|Death|0|||
170892752|NCT01307033|617615325|FG001|44-week Open-label Extension|Death|0|||
170892753|NCT01307033|617615326|FG002|44-week Open-label Extension|Death|0|||
170892754|NCT01307033|617615327|FG003|44-week Open-label Extension|Death|1|||
170892755|NCT01793792|617615330|FG000|Overall Study|Death|5|||
170892756|NCT01793792|617615330|FG000|Overall Study|Lost to Follow-up|5|||
170892757|NCT01793792|617615330|FG000|Overall Study|Withdrawal by Subject|1|||
170892758|NCT01793792|617615330|FG000|Overall Study|Device Not Implanted|1|||
170892759|NCT01773421|617615332|FG000|Treatment Phase|Other|0|||
170892760|NCT01773421|617615333|FG001|Treatment Phase|Other|0|||
170892761|NCT01773421|617615334|FG002|Treatment Phase|Other|2|||
170892762|NCT01773421|617615335|FG003|Treatment Phase|Other|0|||
170892763|NCT01773421|617615336|FG004|Treatment Phase|Other|0|||
170892764|NCT01773421|617615337|FG005|Treatment Phase|Other|0|||
170892765|NCT01773421|617615338|FG006|Treatment Phase|Other|0|||
170892766|NCT01773421|617615332|FG000|Treatment Phase|Adverse Event|0|||
170892767|NCT01773421|617615333|FG001|Treatment Phase|Adverse Event|0|||
170892768|NCT01773421|617615334|FG002|Treatment Phase|Adverse Event|3|||
170892769|NCT01773421|617615335|FG003|Treatment Phase|Adverse Event|1|||
170892770|NCT01773421|617615336|FG004|Treatment Phase|Adverse Event|0|||
170892771|NCT01773421|617615337|FG005|Treatment Phase|Adverse Event|0|||
170892772|NCT01773421|617615338|FG006|Treatment Phase|Adverse Event|0|||
170892773|NCT01773421|617615332|FG000|Treatment Phase|Withdrawal by Subject|0|||
170892774|NCT01773421|617615333|FG001|Treatment Phase|Withdrawal by Subject|0|||
170892775|NCT01773421|617615334|FG002|Treatment Phase|Withdrawal by Subject|1|||
170892776|NCT01773421|617615335|FG003|Treatment Phase|Withdrawal by Subject|1|||
170892777|NCT01773421|617615336|FG004|Treatment Phase|Withdrawal by Subject|0|||
170892778|NCT01773421|617615337|FG005|Treatment Phase|Withdrawal by Subject|0|||
170547265|NCT00662038|616350120|FG000|Overall Study|Reason not specified|3|||
170547266|NCT00662038|616350120|FG000|Overall Study|Withdrawn consent|22|||
170892779|NCT01773421|617615338|FG006|Treatment Phase|Withdrawal by Subject|0|||
170892780|NCT01773421|617615332|FG000|Extension Phase|Other|0|||
170892781|NCT01773421|617615333|FG001|Extension Phase|Other|0|||
170793025|NCT02315703|617251900|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
170793026|NCT02315703|617251901|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
170793027|NCT02315703|617251902|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
170793028|NCT02315703|617251903|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
170793029|NCT03088878|617251906|FG000|Overall Study|Adverse Event|0|||
170793030|NCT03088878|617251907|FG001|Overall Study|Adverse Event|0|||
170793031|NCT03088878|617251908|FG002|Overall Study|Adverse Event|0|||
170793032|NCT03088878|617251909|FG003|Overall Study|Adverse Event|0|||
170793033|NCT03088878|617251910|FG004|Overall Study|Adverse Event|4|||
170793034|NCT03088878|617251911|FG005|Overall Study|Adverse Event|2|||
170793035|NCT03088878|617251912|FG006|Overall Study|Adverse Event|1|||
170793036|NCT03088878|617251913|FG007|Overall Study|Adverse Event|0|||
170793037|NCT03088878|617251914|FG008|Overall Study|Adverse Event|0|||
170793038|NCT03088878|617251915|FG009|Overall Study|Adverse Event|0|||
170793039|NCT03088878|617251916|FG010|Overall Study|Adverse Event|0|||
170793040|NCT03088878|617251917|FG011|Overall Study|Adverse Event|0|||
170793041|NCT03088878|617251918|FG012|Overall Study|Adverse Event|5|||
170793042|NCT03088878|617251919|FG013|Overall Study|Adverse Event|3|||
170793043|NCT03088878|617251906|FG000|Overall Study|Clinical Progression|0|||
170793044|NCT03088878|617251907|FG001|Overall Study|Clinical Progression|0|||
170793045|NCT03088878|617251908|FG002|Overall Study|Clinical Progression|0|||
170793046|NCT03088878|617251909|FG003|Overall Study|Clinical Progression|0|||
170793047|NCT03088878|617251910|FG004|Overall Study|Clinical Progression|2|||
170793048|NCT03088878|617251911|FG005|Overall Study|Clinical Progression|0|||
170793049|NCT03088878|617251912|FG006|Overall Study|Clinical Progression|0|||
170793050|NCT03088878|617251913|FG007|Overall Study|Clinical Progression|0|||
170793051|NCT03088878|617251914|FG008|Overall Study|Clinical Progression|0|||
170793052|NCT03088878|617251915|FG009|Overall Study|Clinical Progression|0|||
170793053|NCT03088878|617251916|FG010|Overall Study|Clinical Progression|0|||
170793054|NCT03088878|617251917|FG011|Overall Study|Clinical Progression|0|||
170793055|NCT03088878|617251918|FG012|Overall Study|Clinical Progression|0|||
170793056|NCT03088878|617251919|FG013|Overall Study|Clinical Progression|0|||
170793057|NCT03088878|617251906|FG000|Overall Study|Death|0|||
170793058|NCT03088878|617251907|FG001|Overall Study|Death|0|||
170793059|NCT03088878|617251908|FG002|Overall Study|Death|0|||
170793060|NCT03088878|617251909|FG003|Overall Study|Death|0|||
170793061|NCT03088878|617251910|FG004|Overall Study|Death|2|||
170793062|NCT03088878|617251911|FG005|Overall Study|Death|0|||
170793063|NCT03088878|617251912|FG006|Overall Study|Death|0|||
170793064|NCT03088878|617251913|FG007|Overall Study|Death|0|||
170793065|NCT03088878|617251914|FG008|Overall Study|Death|0|||
170793066|NCT03088878|617251915|FG009|Overall Study|Death|0|||
170793067|NCT03088878|617251916|FG010|Overall Study|Death|0|||
170793068|NCT03088878|617251917|FG011|Overall Study|Death|1|||
170793069|NCT03088878|617251918|FG012|Overall Study|Death|0|||
170793070|NCT03088878|617251919|FG013|Overall Study|Death|0|||
170793071|NCT03088878|617251906|FG000|Overall Study|Disease Progression|1|||
170793072|NCT03088878|617251907|FG001|Overall Study|Disease Progression|2|||
170793073|NCT03088878|617251908|FG002|Overall Study|Disease Progression|3|||
170793074|NCT03088878|617251909|FG003|Overall Study|Disease Progression|0|||
170793075|NCT03088878|617251910|FG004|Overall Study|Disease Progression|3|||
170793076|NCT03088878|617251911|FG005|Overall Study|Disease Progression|0|||
170793077|NCT03088878|617251912|FG006|Overall Study|Disease Progression|0|||
170793078|NCT03088878|617251913|FG007|Overall Study|Disease Progression|0|||
170793079|NCT03088878|617251914|FG008|Overall Study|Disease Progression|0|||
170793080|NCT03088878|617251915|FG009|Overall Study|Disease Progression|0|||
170793081|NCT03088878|617251916|FG010|Overall Study|Disease Progression|0|||
170793082|NCT03088878|617251917|FG011|Overall Study|Disease Progression|0|||
170793083|NCT03088878|617251918|FG012|Overall Study|Disease Progression|1|||
170793084|NCT03088878|617251919|FG013|Overall Study|Disease Progression|1|||
170793085|NCT03088878|617251906|FG000|Overall Study|Initiation of Alternative Treatment|0|||
170793086|NCT03088878|617251907|FG001|Overall Study|Initiation of Alternative Treatment|0|||
170793087|NCT03088878|617251908|FG002|Overall Study|Initiation of Alternative Treatment|0|||
170793088|NCT03088878|617251909|FG003|Overall Study|Initiation of Alternative Treatment|1|||
170793089|NCT03088878|617251910|FG004|Overall Study|Initiation of Alternative Treatment|0|||
170793090|NCT03088878|617251911|FG005|Overall Study|Initiation of Alternative Treatment|0|||
170793091|NCT03088878|617251912|FG006|Overall Study|Initiation of Alternative Treatment|0|||
170793092|NCT03088878|617251913|FG007|Overall Study|Initiation of Alternative Treatment|1|||
170793093|NCT03088878|617251914|FG008|Overall Study|Initiation of Alternative Treatment|1|||
170793094|NCT03088878|617251915|FG009|Overall Study|Initiation of Alternative Treatment|0|||
170793095|NCT03088878|617251916|FG010|Overall Study|Initiation of Alternative Treatment|0|||
170793096|NCT03088878|617251917|FG011|Overall Study|Initiation of Alternative Treatment|0|||
170793097|NCT03088878|617251918|FG012|Overall Study|Initiation of Alternative Treatment|0|||
170793098|NCT03088878|617251919|FG013|Overall Study|Initiation of Alternative Treatment|0|||
170793099|NCT03088878|617251906|FG000|Overall Study|Withdrawal by Subject|0|||
170793100|NCT03088878|617251907|FG001|Overall Study|Withdrawal by Subject|0|||
170793101|NCT03088878|617251908|FG002|Overall Study|Withdrawal by Subject|0|||
170793102|NCT03088878|617251909|FG003|Overall Study|Withdrawal by Subject|1|||
170892782|NCT01773421|617615334|FG002|Extension Phase|Other|0|||
170892783|NCT01773421|617615335|FG003|Extension Phase|Other|0|||
170892784|NCT01773421|617615336|FG004|Extension Phase|Other|1|||
170892785|NCT01773421|617615337|FG005|Extension Phase|Other|2|||
170892786|NCT01773421|617615338|FG006|Extension Phase|Other|0|||
170892787|NCT01773421|617615332|FG000|Extension Phase|Adverse Event|0|||
170892788|NCT01773421|617615333|FG001|Extension Phase|Adverse Event|0|||
170892789|NCT01773421|617615334|FG002|Extension Phase|Adverse Event|0|||
170892790|NCT01773421|617615335|FG003|Extension Phase|Adverse Event|0|||
170892791|NCT01773421|617615336|FG004|Extension Phase|Adverse Event|2|||
170892792|NCT01773421|617615337|FG005|Extension Phase|Adverse Event|0|||
170892793|NCT01773421|617615338|FG006|Extension Phase|Adverse Event|0|||
170892794|NCT00688909|617615339|FG000|Overall Study|Adverse Event|28|||
170892795|NCT00688909|617615339|FG000|Overall Study|Patient withdrew consent|2|||
170892796|NCT00688909|617615339|FG000|Overall Study|Administrative problems|1|||
170892797|NCT00688909|617615339|FG000|Overall Study|Protocol Violation|2|||
170892798|NCT02472847|617615340|FG000|Overall Study|Withdrawal by Subject|1|||
170892799|NCT02472847|617615341|FG001|Overall Study|Withdrawal by Subject|5|||
170892800|NCT00700180|617615343|FG000|Overall Study|Death|99|||
170892801|NCT00700180|617615344|FG001|Overall Study|Death|114|||
170892802|NCT00700180|617615343|FG000|Overall Study|Alive on treatment|5|||
170892803|NCT00700180|617615344|FG001|Overall Study|Alive on treatment|3|||
170892804|NCT00700180|617615343|FG000|Overall Study|Alive in follow-up|46|||
170892805|NCT00700180|617615344|FG001|Overall Study|Alive in follow-up|27|||
170892806|NCT00700180|617615343|FG000|Overall Study|Lost to Follow-up|4|||
170892807|NCT00700180|617615344|FG001|Overall Study|Lost to Follow-up|5|||
170892808|NCT01613326|617615345|FG000|Overall Study|Adverse Event|7|||
170892809|NCT01613326|617615346|FG001|Overall Study|Adverse Event|5|||
170892810|NCT01613326|617615345|FG000|Overall Study|Withdrawal by Subject|3|||
170892811|NCT01613326|617615346|FG001|Overall Study|Withdrawal by Subject|4|||
170547267|NCT00662038|616350120|FG000|Overall Study|Withdrawal by Subject|83|||
170547268|NCT00662038|616350120|FG000|Overall Study|Sponsor decision|1|||
170547269|NCT00662038|616350120|FG000|Overall Study|Physician Decision|19|||
170547270|NCT00662038|616350120|FG000|Overall Study|Lung transplantation|44|||
170547271|NCT00662038|616350120|FG000|Overall Study|Lost to Follow-up|1|||
170547272|NCT00662038|616350120|FG000|Overall Study|Death|95|||
170547273|NCT00662038|616350120|FG000|Overall Study|Adverse Event|358|||
170547274|NCT00662038|616350120|FG000|Overall Study|Continued treatment|5|||
170547275|NCT00397046|616350121|FG000|Overall Study|Disease Progression|3|||
170547276|NCT00397046|616350122|FG001|Overall Study|Disease Progression|3|||
170547277|NCT00397046|616350123|FG002|Overall Study|Disease Progression|10|||
170892812|NCT01613326|617615345|FG000|Overall Study|Abnormal test procedure result(s)|2|||
170892813|NCT01613326|617615346|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170892814|NCT01613326|617615345|FG000|Overall Study|inability to use device|1|||
170892815|NCT01613326|617615346|FG001|Overall Study|inability to use device|0|||
170892816|NCT01613326|617615345|FG000|Overall Study|Lack of Efficacy|0|||
170892817|NCT01613326|617615346|FG001|Overall Study|Lack of Efficacy|1|||
170547278|NCT00397046|616350124|FG003|Overall Study|Disease Progression|5|||
170547279|NCT02105012|616350126|FG000|Overall Study|Withdrawal by Subject|11|||
170547280|NCT02105012|616350126|FG000|Overall Study|Protocol Specified Criteria|9|||
170547281|NCT02105012|616350126|FG000|Overall Study|Lost to Follow-up|4|||
170547282|NCT02105012|616350126|FG000|Overall Study|Protocol Violation|4|||
170892818|NCT01613326|617615345|FG000|Overall Study|Lost to Follow-up|0|||
170892819|NCT01613326|617615346|FG001|Overall Study|Lost to Follow-up|1|||
170892820|NCT01613326|617615345|FG000|Overall Study|Administrative|0|||
170892821|NCT01613326|617615346|FG001|Overall Study|Administrative|2|||
170892822|NCT01613326|617615345|FG000|Overall Study|Protocol Violation|0|||
170892823|NCT01613326|617615346|FG001|Overall Study|Protocol Violation|1|||
170892824|NCT00793793|617615349|FG000|Overall Study|Adverse Event|0|||
170892825|NCT00793793|617615350|FG001|Overall Study|Adverse Event|0|||
170892826|NCT00793793|617615351|FG002|Overall Study|Adverse Event|1|||
170892827|NCT00793793|617615352|FG003|Overall Study|Adverse Event|1|||
170892828|NCT00793793|617615353|FG004|Overall Study|Adverse Event|0|||
170892829|NCT00793793|617615354|FG005|Overall Study|Adverse Event|1|||
170892830|NCT00793793|617615355|FG006|Overall Study|Adverse Event|2|||
170892831|NCT00793793|617615356|FG007|Overall Study|Adverse Event|0|||
170892832|NCT00793793|617615357|FG008|Overall Study|Adverse Event|0|||
170892833|NCT00793793|617615358|FG009|Overall Study|Adverse Event|0|||
170892834|NCT00793793|617615359|FG010|Overall Study|Adverse Event|0|||
170892835|NCT00793793|617615360|FG011|Overall Study|Adverse Event|2|||
170892836|NCT00793793|617615349|FG000|Overall Study|Protocol Violation|0|||
170892837|NCT00793793|617615350|FG001|Overall Study|Protocol Violation|0|||
170892838|NCT00793793|617615351|FG002|Overall Study|Protocol Violation|0|||
170892839|NCT00793793|617615352|FG003|Overall Study|Protocol Violation|1|||
170892840|NCT00793793|617615353|FG004|Overall Study|Protocol Violation|0|||
170547283|NCT02105012|616350126|FG000|Overall Study|Physician Decision|3|||
170547284|NCT02105012|616350126|FG000|Overall Study|Adverse Event|1|||
170547285|NCT02105012|616350126|FG000|Overall Study|Lack of Efficacy|1|||
170892841|NCT00793793|617615354|FG005|Overall Study|Protocol Violation|0|||
170892842|NCT00793793|617615355|FG006|Overall Study|Protocol Violation|0|||
170892843|NCT00793793|617615356|FG007|Overall Study|Protocol Violation|0|||
170892844|NCT00793793|617615357|FG008|Overall Study|Protocol Violation|0|||
170892845|NCT00793793|617615358|FG009|Overall Study|Protocol Violation|0|||
170892846|NCT00793793|617615359|FG010|Overall Study|Protocol Violation|0|||
170892847|NCT00793793|617615360|FG011|Overall Study|Protocol Violation|0|||
170892848|NCT00793793|617615349|FG000|Overall Study|Lost to Follow-up|0|||
170892849|NCT00793793|617615350|FG001|Overall Study|Lost to Follow-up|0|||
170892850|NCT00793793|617615351|FG002|Overall Study|Lost to Follow-up|1|||
170892851|NCT00793793|617615352|FG003|Overall Study|Lost to Follow-up|0|||
170892852|NCT00793793|617615353|FG004|Overall Study|Lost to Follow-up|0|||
170892853|NCT00793793|617615354|FG005|Overall Study|Lost to Follow-up|0|||
170892854|NCT00793793|617615355|FG006|Overall Study|Lost to Follow-up|0|||
170892855|NCT00793793|617615356|FG007|Overall Study|Lost to Follow-up|0|||
170892856|NCT00793793|617615357|FG008|Overall Study|Lost to Follow-up|1|||
170892857|NCT00793793|617615358|FG009|Overall Study|Lost to Follow-up|3|||
170892858|NCT00793793|617615359|FG010|Overall Study|Lost to Follow-up|1|||
170892859|NCT00793793|617615360|FG011|Overall Study|Lost to Follow-up|0|||
170892860|NCT00793793|617615349|FG000|Overall Study|Withdrawal by Subject|0|||
170892861|NCT00793793|617615350|FG001|Overall Study|Withdrawal by Subject|0|||
170892862|NCT00793793|617615351|FG002|Overall Study|Withdrawal by Subject|0|||
170892863|NCT00793793|617615352|FG003|Overall Study|Withdrawal by Subject|0|||
170892864|NCT00793793|617615353|FG004|Overall Study|Withdrawal by Subject|1|||
170892865|NCT00793793|617615354|FG005|Overall Study|Withdrawal by Subject|0|||
170892866|NCT00793793|617615355|FG006|Overall Study|Withdrawal by Subject|0|||
170892867|NCT00793793|617615356|FG007|Overall Study|Withdrawal by Subject|0|||
170892868|NCT00793793|617615357|FG008|Overall Study|Withdrawal by Subject|1|||
170892869|NCT00793793|617615358|FG009|Overall Study|Withdrawal by Subject|0|||
170892870|NCT00793793|617615359|FG010|Overall Study|Withdrawal by Subject|0|||
170892871|NCT00793793|617615360|FG011|Overall Study|Withdrawal by Subject|0|||
170892872|NCT00793793|617615349|FG000|Overall Study|reason not specified|0|||
170892873|NCT00793793|617615350|FG001|Overall Study|reason not specified|1|||
170892874|NCT00793793|617615351|FG002|Overall Study|reason not specified|0|||
170892875|NCT00793793|617615352|FG003|Overall Study|reason not specified|1|||
170892876|NCT00793793|617615353|FG004|Overall Study|reason not specified|1|||
170892877|NCT00793793|617615354|FG005|Overall Study|reason not specified|1|||
170892878|NCT00793793|617615355|FG006|Overall Study|reason not specified|2|||
170892879|NCT00793793|617615356|FG007|Overall Study|reason not specified|0|||
170892880|NCT00793793|617615357|FG008|Overall Study|reason not specified|7|||
170892881|NCT00793793|617615358|FG009|Overall Study|reason not specified|6|||
170892882|NCT00793793|617615359|FG010|Overall Study|reason not specified|2|||
170892883|NCT00793793|617615360|FG011|Overall Study|reason not specified|4|||
170892884|NCT01505894|617615361|FG000|Overall Study|Adverse Event|1|||
170892885|NCT01505894|617615362|FG001|Overall Study|Adverse Event|0|||
170892886|NCT01505894|617615363|FG002|Overall Study|Adverse Event|0|||
170892887|NCT01505894|617615364|FG003|Overall Study|Adverse Event|0|||
170892888|NCT01505894|617615365|FG004|Overall Study|Adverse Event|0|||
170892889|NCT01505894|617615366|FG005|Overall Study|Adverse Event|0|||
170892890|NCT01505894|617615367|FG006|Overall Study|Adverse Event|0|||
170892891|NCT01505894|617615368|FG007|Overall Study|Adverse Event|0|||
170892892|NCT01505894|617615369|FG008|Overall Study|Adverse Event|0|||
170892893|NCT01505894|617615361|FG000|Overall Study|Other than specified|0|||
170892894|NCT01505894|617615362|FG001|Overall Study|Other than specified|0|||
170892895|NCT01505894|617615363|FG002|Overall Study|Other than specified|0|||
170639522|NCT02873377|616691308|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
170892896|NCT01505894|617615364|FG003|Overall Study|Other than specified|0|||
170892897|NCT01505894|617615365|FG004|Overall Study|Other than specified|1|||
170892898|NCT01505894|617615366|FG005|Overall Study|Other than specified|0|||
170892899|NCT01505894|617615367|FG006|Overall Study|Other than specified|0|||
170892900|NCT01505894|617615368|FG007|Overall Study|Other than specified|0|||
170892901|NCT01505894|617615369|FG008|Overall Study|Other than specified|0|||
170892902|NCT00254566|617615370|FG000|Overall Study|Death|1|||
170892903|NCT00254566|617615371|FG001|Overall Study|Death|0|||
170892904|NCT00254566|617615370|FG000|Overall Study|Adverse Event|5|||
170892905|NCT00254566|617615371|FG001|Overall Study|Adverse Event|4|||
170892906|NCT00254566|617615370|FG000|Overall Study|Lack of Efficacy|12|||
170892907|NCT00254566|617615371|FG001|Overall Study|Lack of Efficacy|9|||
170892908|NCT00254566|617615370|FG000|Overall Study|Other|1|||
170892909|NCT00254566|617615371|FG001|Overall Study|Other|5|||
170892910|NCT00254566|617615370|FG000|Overall Study|Withdrawal by Subject|5|||
170892911|NCT00254566|617615371|FG001|Overall Study|Withdrawal by Subject|6|||
170892912|NCT00254566|617615370|FG000|Overall Study|Lost to Follow-up|7|||
170892913|NCT00254566|617615371|FG001|Overall Study|Lost to Follow-up|2|||
170892914|NCT03106779|617615372|FG000|Overall Study|Lack of Efficacy|33|||
170892915|NCT03106779|617615373|FG001|Overall Study|Lack of Efficacy|24|||
170892916|NCT03106779|617615372|FG000|Overall Study|Adverse Event|8|||
170892917|NCT03106779|617615373|FG001|Overall Study|Adverse Event|16|||
170892918|NCT03106779|617615372|FG000|Overall Study|Physician Decision|10|||
170892919|NCT03106779|617615373|FG001|Overall Study|Physician Decision|6|||
170892920|NCT03106779|617615372|FG000|Overall Study|Patient/guardian decision|4|||
170892921|NCT03106779|617615373|FG001|Overall Study|Patient/guardian decision|3|||
170892922|NCT03106779|617615372|FG000|Overall Study|Progressive disease|1|||
170892923|NCT03106779|617615373|FG001|Overall Study|Progressive disease|3|||
170892924|NCT03106779|617615372|FG000|Overall Study|Lost to Follow-up|1|||
170892925|NCT03106779|617615373|FG001|Overall Study|Lost to Follow-up|2|||
170892926|NCT03106779|617615372|FG000|Overall Study|Death|1|||
170892927|NCT03106779|617615373|FG001|Overall Study|Death|0|||
170892928|NCT03106779|617615372|FG000|Overall Study|Protocol Violation|1|||
170892929|NCT03106779|617615373|FG001|Overall Study|Protocol Violation|0|||
170892930|NCT03106779|617615372|FG000|Overall Study|Not treated|1|||
170892931|NCT03106779|617615373|FG001|Overall Study|Not treated|0|||
170892932|NCT02288247|617615374|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
170892933|NCT02288247|617615375|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
170892934|NCT02288247|617615374|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
170892935|NCT02288247|617615375|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
170892936|NCT02288247|617615374|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
170892937|NCT02288247|617615375|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
170892938|NCT02288247|617615374|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
170892939|NCT02288247|617615375|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
170892940|NCT02288247|617615374|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
170892941|NCT02288247|617615375|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
170892942|NCT02288247|617615374|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
170892943|NCT02288247|617615375|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
170892944|NCT02288247|617615374|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
170892945|NCT02288247|617615375|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
170892946|NCT02288247|617615374|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
170892947|NCT02288247|617615375|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
170892948|NCT02288247|617615374|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
170892949|NCT02288247|617615375|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
170892950|NCT02288247|617615374|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
170892951|NCT02288247|617615375|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
170892952|NCT02288247|617615374|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
170892953|NCT02288247|617615375|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
170892954|NCT02288247|617615374|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
170892955|NCT02288247|617615375|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
170892956|NCT02288247|617615374|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
170892957|NCT02288247|617615375|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
170892958|NCT02288247|617615374|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
170892959|NCT02288247|617615375|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
170892960|NCT02288247|617615374|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
170892961|NCT02288247|617615375|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
170892962|NCT02288247|617615374|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
170892963|NCT02288247|617615375|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
170892964|NCT00191451|617615377|FG000|Overall Study|Withdrawal by Subject|2|||
170892965|NCT00191451|617615378|FG001|Overall Study|Withdrawal by Subject|3|||
170892966|NCT00191451|617615379|FG002|Overall Study|Withdrawal by Subject|5|||
170892967|NCT00191451|617615377|FG000|Overall Study|Physician Decision|2|||
170892968|NCT00191451|617615378|FG001|Overall Study|Physician Decision|9|||
170892969|NCT00191451|617615379|FG002|Overall Study|Physician Decision|6|||
170892970|NCT00191451|617615377|FG000|Overall Study|Sponsor Decision|1|||
170892971|NCT00191451|617615378|FG001|Overall Study|Sponsor Decision|0|||
170892972|NCT00191451|617615379|FG002|Overall Study|Sponsor Decision|0|||
170892973|NCT00191451|617615377|FG000|Overall Study|Ineligible|0|||
170892974|NCT00191451|617615378|FG001|Overall Study|Ineligible|1|||
170892975|NCT00191451|617615379|FG002|Overall Study|Ineligible|0|||
170892976|NCT00191451|617615377|FG000|Overall Study|Reason Not Specified|2|||
170892977|NCT00191451|617615378|FG001|Overall Study|Reason Not Specified|1|||
170892978|NCT00191451|617615379|FG002|Overall Study|Reason Not Specified|3|||
170793103|NCT03088878|617251910|FG004|Overall Study|Withdrawal by Subject|4|||
170793104|NCT03088878|617251911|FG005|Overall Study|Withdrawal by Subject|1|||
170793105|NCT03088878|617251912|FG006|Overall Study|Withdrawal by Subject|1|||
170793106|NCT03088878|617251913|FG007|Overall Study|Withdrawal by Subject|0|||
170793107|NCT03088878|617251914|FG008|Overall Study|Withdrawal by Subject|1|||
170793108|NCT03088878|617251915|FG009|Overall Study|Withdrawal by Subject|2|||
170793109|NCT03088878|617251916|FG010|Overall Study|Withdrawal by Subject|0|||
170793110|NCT03088878|617251917|FG011|Overall Study|Withdrawal by Subject|2|||
170793111|NCT03088878|617251918|FG012|Overall Study|Withdrawal by Subject|1|||
170793112|NCT03088878|617251919|FG013|Overall Study|Withdrawal by Subject|0|||
170793113|NCT03088878|617251906|FG000|Overall Study|Terminated by Sponsor|2|||
170793114|NCT03088878|617251907|FG001|Overall Study|Terminated by Sponsor|1|||
170793115|NCT03088878|617251908|FG002|Overall Study|Terminated by Sponsor|0|||
170793116|NCT03088878|617251909|FG003|Overall Study|Terminated by Sponsor|1|||
170793117|NCT03088878|617251910|FG004|Overall Study|Terminated by Sponsor|6|||
170793118|NCT03088878|617251911|FG005|Overall Study|Terminated by Sponsor|0|||
170793119|NCT03088878|617251912|FG006|Overall Study|Terminated by Sponsor|0|||
170793120|NCT03088878|617251913|FG007|Overall Study|Terminated by Sponsor|0|||
170793121|NCT03088878|617251914|FG008|Overall Study|Terminated by Sponsor|0|||
170793122|NCT03088878|617251915|FG009|Overall Study|Terminated by Sponsor|0|||
170793123|NCT03088878|617251916|FG010|Overall Study|Terminated by Sponsor|3|||
170793124|NCT03088878|617251917|FG011|Overall Study|Terminated by Sponsor|13|||
170793125|NCT03088878|617251918|FG012|Overall Study|Terminated by Sponsor|2|||
170793126|NCT03088878|617251919|FG013|Overall Study|Terminated by Sponsor|1|||
170793127|NCT03088878|617251906|FG000|Overall Study|Completed 2 years of Treatment|0|||
170793128|NCT03088878|617251907|FG001|Overall Study|Completed 2 years of Treatment|0|||
170793129|NCT03088878|617251908|FG002|Overall Study|Completed 2 years of Treatment|0|||
170793130|NCT03088878|617251909|FG003|Overall Study|Completed 2 years of Treatment|0|||
170793131|NCT03088878|617251910|FG004|Overall Study|Completed 2 years of Treatment|0|||
170793132|NCT03088878|617251911|FG005|Overall Study|Completed 2 years of Treatment|0|||
170793133|NCT03088878|617251912|FG006|Overall Study|Completed 2 years of Treatment|1|||
170793134|NCT03088878|617251913|FG007|Overall Study|Completed 2 years of Treatment|0|||
170793135|NCT03088878|617251914|FG008|Overall Study|Completed 2 years of Treatment|0|||
170793136|NCT03088878|617251915|FG009|Overall Study|Completed 2 years of Treatment|1|||
170793137|NCT03088878|617251916|FG010|Overall Study|Completed 2 years of Treatment|0|||
170793138|NCT03088878|617251917|FG011|Overall Study|Completed 2 years of Treatment|0|||
170793139|NCT03088878|617251918|FG012|Overall Study|Completed 2 years of Treatment|8|||
170793140|NCT03088878|617251919|FG013|Overall Study|Completed 2 years of Treatment|3|||
170793141|NCT03088878|617251906|FG000|Overall Study|Physician Decision|0|||
170793142|NCT03088878|617251907|FG001|Overall Study|Physician Decision|0|||
170793143|NCT03088878|617251908|FG002|Overall Study|Physician Decision|0|||
170793144|NCT03088878|617251909|FG003|Overall Study|Physician Decision|0|||
170793145|NCT03088878|617251910|FG004|Overall Study|Physician Decision|0|||
170793146|NCT03088878|617251911|FG005|Overall Study|Physician Decision|0|||
170793147|NCT03088878|617251912|FG006|Overall Study|Physician Decision|0|||
170793148|NCT03088878|617251913|FG007|Overall Study|Physician Decision|2|||
170793149|NCT03088878|617251914|FG008|Overall Study|Physician Decision|1|||
170793150|NCT03088878|617251915|FG009|Overall Study|Physician Decision|0|||
170793151|NCT03088878|617251916|FG010|Overall Study|Physician Decision|0|||
170793152|NCT03088878|617251917|FG011|Overall Study|Physician Decision|0|||
170793153|NCT03088878|617251918|FG012|Overall Study|Physician Decision|0|||
170793154|NCT03088878|617251919|FG013|Overall Study|Physician Decision|1|||
170793155|NCT03088878|617251906|FG000|Overall Study|COVID Related noncompliance|0|||
170793156|NCT03088878|617251907|FG001|Overall Study|COVID Related noncompliance|0|||
170793157|NCT03088878|617251908|FG002|Overall Study|COVID Related noncompliance|0|||
170793158|NCT03088878|617251909|FG003|Overall Study|COVID Related noncompliance|0|||
170793159|NCT03088878|617251910|FG004|Overall Study|COVID Related noncompliance|0|||
170793160|NCT03088878|617251911|FG005|Overall Study|COVID Related noncompliance|0|||
170793161|NCT03088878|617251912|FG006|Overall Study|COVID Related noncompliance|0|||
170793162|NCT03088878|617251913|FG007|Overall Study|COVID Related noncompliance|0|||
170793163|NCT03088878|617251914|FG008|Overall Study|COVID Related noncompliance|0|||
170793164|NCT03088878|617251915|FG009|Overall Study|COVID Related noncompliance|0|||
170793165|NCT03088878|617251916|FG010|Overall Study|COVID Related noncompliance|0|||
170793166|NCT03088878|617251917|FG011|Overall Study|COVID Related noncompliance|0|||
170793167|NCT03088878|617251918|FG012|Overall Study|COVID Related noncompliance|0|||
170793168|NCT03088878|617251919|FG013|Overall Study|COVID Related noncompliance|1|||
170793169|NCT03088878|617251906|FG000|Overall Study|Drug or Study Noncompliance|0|||
170793170|NCT03088878|617251907|FG001|Overall Study|Drug or Study Noncompliance|0|||
170793171|NCT03088878|617251908|FG002|Overall Study|Drug or Study Noncompliance|0|||
170793172|NCT03088878|617251909|FG003|Overall Study|Drug or Study Noncompliance|0|||
170793173|NCT03088878|617251910|FG004|Overall Study|Drug or Study Noncompliance|0|||
170793174|NCT03088878|617251911|FG005|Overall Study|Drug or Study Noncompliance|0|||
170793175|NCT03088878|617251912|FG006|Overall Study|Drug or Study Noncompliance|0|||
170793176|NCT03088878|617251913|FG007|Overall Study|Drug or Study Noncompliance|0|||
170793177|NCT03088878|617251914|FG008|Overall Study|Drug or Study Noncompliance|0|||
170793178|NCT03088878|617251915|FG009|Overall Study|Drug or Study Noncompliance|0|||
170793179|NCT03088878|617251916|FG010|Overall Study|Drug or Study Noncompliance|0|||
170793180|NCT03088878|617251917|FG011|Overall Study|Drug or Study Noncompliance|0|||
170793181|NCT03088878|617251918|FG012|Overall Study|Drug or Study Noncompliance|1|||
170793182|NCT03088878|617251919|FG013|Overall Study|Drug or Study Noncompliance|0|||
170892979|NCT00331409|617615384|FG000|Overall Study|Lack of Efficacy|4|||
170892980|NCT01482910|617615386|FG000|Overall Study|Adverse Event|6|||
170892981|NCT01482910|617615387|FG001|Overall Study|Adverse Event|5|||
170892982|NCT01482910|617615386|FG000|Overall Study|Lost to Follow-up|0|||
170793183|NCT05216406|617251920|FG000|Overall Study|Lost to Follow-up|8|||
170793184|NCT05216406|617251921|FG001|Overall Study|Lost to Follow-up|9|||
170793185|NCT04068311|617251926|FG000|Overall Study|Death|3|||
170793186|NCT04068311|617251927|FG001|Overall Study|Death|3|||
170793187|NCT04068311|617251926|FG000|Overall Study|Lost to Follow-up|24|||
170892983|NCT01482910|617615387|FG001|Overall Study|Lost to Follow-up|1|||
170892984|NCT01482910|617615386|FG000|Overall Study|Protocol Violation|1|||
170892985|NCT01482910|617615387|FG001|Overall Study|Protocol Violation|1|||
170892986|NCT01482910|617615386|FG000|Overall Study|Withdrawal by Subject|7|||
170892987|NCT01482910|617615387|FG001|Overall Study|Withdrawal by Subject|2|||
170892988|NCT01482910|617615386|FG000|Overall Study|Death|1|||
170892989|NCT01482910|617615387|FG001|Overall Study|Death|0|||
170892990|NCT00179959|617615388|FG000|Overall Study|Lost to Follow-up|3|||
170892991|NCT00179959|617615389|FG001|Overall Study|Lost to Follow-up|1|||
170892992|NCT00179959|617615388|FG000|Overall Study|Withdrawal by Subject|3|||
170892993|NCT00179959|617615389|FG001|Overall Study|Withdrawal by Subject|2|||
170892994|NCT01552681|617615394|FG000|Overall Study|Withdrawal by Subject|4|||
170892995|NCT01552681|617615395|FG001|Overall Study|Withdrawal by Subject|0|||
170892996|NCT01552681|617615394|FG000|Overall Study|Physician Decision|1|||
170892997|NCT01552681|617615395|FG001|Overall Study|Physician Decision|0|||
170892998|NCT01552681|617615394|FG000|Overall Study|Subject moved away|0|||
170892999|NCT01552681|617615395|FG001|Overall Study|Subject moved away|1|||
170893000|NCT02772757|617615397|FG000|Overall Study|Withdrawal by Subject|1|||
170893001|NCT02772757|617615398|FG001|Overall Study|Withdrawal by Subject|0|||
170893002|NCT02772757|617615399|FG002|Overall Study|Withdrawal by Subject|1|||
170893003|NCT02772757|617615397|FG000|Overall Study|Protocol Violation|0|||
170893004|NCT02772757|617615398|FG001|Overall Study|Protocol Violation|0|||
170893005|NCT02772757|617615399|FG002|Overall Study|Protocol Violation|1|||
170893006|NCT02772757|617615397|FG000|Overall Study|Physician Decision|0|||
170893007|NCT02772757|617615398|FG001|Overall Study|Physician Decision|3|||
170893008|NCT02772757|617615399|FG002|Overall Study|Physician Decision|3|||
170893009|NCT00510276|617615400|FG000|Acute Double-Blind Phase|Adverse Event|21|||
170893010|NCT00510276|617615401|FG001|Acute Double-Blind Phase|Adverse Event|6|||
170893011|NCT00510276|617615400|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
170893012|NCT00510276|617615401|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
170893013|NCT00510276|617615400|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
170893014|NCT00510276|617615401|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
170893015|NCT00510276|617615400|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
170893016|NCT00510276|617615401|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
170893017|NCT00510276|617615400|FG000|Acute Double-Blind Phase|Physician Decision|0|||
170893018|NCT00510276|617615401|FG001|Acute Double-Blind Phase|Physician Decision|3|||
170893019|NCT00510276|617615400|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
170893020|NCT00510276|617615401|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
170893021|NCT00510276|617615400|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
170893022|NCT00510276|617615401|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
170893023|NCT00510276|617615400|FG000|Acute Double-Blind Phase|Subject Decision|26|||
170893024|NCT00510276|617615401|FG001|Acute Double-Blind Phase|Subject Decision|28|||
170893025|NCT00510276|617615400|FG000|Extension Open-Label Phase|Adverse Event|9|||
170893026|NCT00510276|617615401|FG001|Extension Open-Label Phase|Adverse Event|18|||
170893027|NCT00510276|617615400|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
170893028|NCT00510276|617615401|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
170893029|NCT00510276|617615400|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
170893030|NCT00510276|617615401|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
170893031|NCT00510276|617615400|FG000|Extension Open-Label Phase|Physician Decision|2|||
170893032|NCT00510276|617615401|FG001|Extension Open-Label Phase|Physician Decision|3|||
170893033|NCT00510276|617615400|FG000|Extension Open-Label Phase|Protocol Violation|0|||
170893034|NCT00510276|617615401|FG001|Extension Open-Label Phase|Protocol Violation|1|||
170893035|NCT00510276|617615400|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
170893036|NCT00510276|617615401|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
170893037|NCT00510276|617615400|FG000|Extension Open-Label Phase|Subject Decision|7|||
170893038|NCT00510276|617615401|FG001|Extension Open-Label Phase|Subject Decision|9|||
170893039|NCT01580397|617615404|FG000|Overall Study|Lack of Efficacy|14|||
170893040|NCT01727258|617615405|FG000|Overall Study|Adverse Event|0|||
170547286|NCT01975285|616350129|FG000|Overall Study|Failed Block and follow up|2|||
170893041|NCT01727258|617615406|FG001|Overall Study|Adverse Event|2|||
170893042|NCT01727258|617615407|FG002|Overall Study|Adverse Event|0|||
170893043|NCT01727258|617615405|FG000|Overall Study|Noncompliance with Study Drug|0|||
170893044|NCT01727258|617615406|FG001|Overall Study|Noncompliance with Study Drug|0|||
170893045|NCT01727258|617615407|FG002|Overall Study|Noncompliance with Study Drug|1|||
170547287|NCT01975285|616350130|FG001|Overall Study|Failed Block and follow up|2|||
170547288|NCT04535362|616350131|FG000|Overall Study|Lost to Follow-up|3|||
170893046|NCT01727258|617615405|FG000|Overall Study|Withdrawal by Subject|1|||
170893047|NCT01727258|617615406|FG001|Overall Study|Withdrawal by Subject|1|||
170893048|NCT01727258|617615407|FG002|Overall Study|Withdrawal by Subject|0|||
170893049|NCT01727258|617615405|FG000|Overall Study|Lost to Follow-up|1|||
170893050|NCT01727258|617615406|FG001|Overall Study|Lost to Follow-up|0|||
170893051|NCT01727258|617615407|FG002|Overall Study|Lost to Follow-up|0|||
170893052|NCT00820755|617615408|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
170893053|NCT00820755|617615409|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
170893054|NCT00820755|617615410|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
170893055|NCT00820755|617615408|FG000|Period 1: Combination Therapy Phase|Death|28|||
170893056|NCT00820755|617615409|FG001|Period 1: Combination Therapy Phase|Death|0|||
170893057|NCT00820755|617615410|FG002|Period 1: Combination Therapy Phase|Death|0|||
170893058|NCT00820755|617615408|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
170893059|NCT00820755|617615409|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
170893060|NCT00820755|617615410|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
170893061|NCT00820755|617615408|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
170893062|NCT00820755|617615409|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
170893063|NCT00820755|617615410|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
170893064|NCT00820755|617615408|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
170893065|NCT00820755|617615409|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
170893066|NCT00820755|617615410|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
170893067|NCT00820755|617615408|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
170893068|NCT00820755|617615409|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
170893069|NCT00820755|617615410|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
170893070|NCT00820755|617615408|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
170893071|NCT00820755|617615409|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
170893072|NCT00820755|617615410|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
170893073|NCT00820755|617615408|FG000|Period 1: Combination Therapy Phase|Other|11|||
170893074|NCT00820755|617615409|FG001|Period 1: Combination Therapy Phase|Other|0|||
170893075|NCT00820755|617615410|FG002|Period 1: Combination Therapy Phase|Other|0|||
170893076|NCT00820755|617615408|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
170893077|NCT00820755|617615409|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
170893078|NCT00820755|617615410|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
170893079|NCT01573910|617615414|FG000|Overall Study|Adverse Event|4|||
170893080|NCT01573910|617615415|FG001|Overall Study|Adverse Event|4|||
170893081|NCT01573910|617615414|FG000|Overall Study|Lost to Follow-up|2|||
170893082|NCT01573910|617615415|FG001|Overall Study|Lost to Follow-up|1|||
170893083|NCT01573910|617615414|FG000|Overall Study|Withdrawal by Subject|0|||
170893084|NCT01573910|617615415|FG001|Overall Study|Withdrawal by Subject|1|||
170893085|NCT01573910|617615414|FG000|Overall Study|Protocol Violation|3|||
170893086|NCT01573910|617615415|FG001|Overall Study|Protocol Violation|0|||
170893087|NCT01573910|617615414|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
170893088|NCT01573910|617615415|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
170893089|NCT02251912|617615416|FG000|Overall Study|Withdrawal by Subject|2|||
170893090|NCT02251912|617615417|FG001|Overall Study|Withdrawal by Subject|3|||
170893091|NCT02251912|617615416|FG000|Overall Study|Adverse Event|0|||
170893092|NCT02251912|617615417|FG001|Overall Study|Adverse Event|2|||
170893093|NCT00268242|617615424|FG000|Overall Study|Death|1|||
170893094|NCT02175680|617615425|FG000|Overall Study|non-compliance|1|||
170893095|NCT02175680|617615425|FG000|Overall Study|other non-medical reason|1|||
170893096|NCT04506294|617615428|FG000|Overall Study|Lost to Follow-up|70|||
170893097|NCT04506294|617615429|FG001|Overall Study|Lost to Follow-up|20|||
170893098|NCT04506294|617615428|FG000|Overall Study|Withdrawal by Subject|16|||
170893099|NCT04506294|617615429|FG001|Overall Study|Withdrawal by Subject|2|||
170893100|NCT01469000|617615434|FG000|Overall Study|Withdrawal by Subject|16|||
170893101|NCT01469000|617615435|FG001|Overall Study|Withdrawal by Subject|3|||
170893102|NCT01469000|617615434|FG000|Overall Study|Sponsor Decision|4|||
170893103|NCT01469000|617615435|FG001|Overall Study|Sponsor Decision|1|||
170893104|NCT00769119|617615445|FG000|Overall Study|Voluntary discontinuation|0|||
170893105|NCT00769119|617615446|FG001|Overall Study|Voluntary discontinuation|2|||
170893106|NCT00769119|617615445|FG000|Overall Study|Adverse Event|1|||
170893107|NCT00769119|617615446|FG001|Overall Study|Adverse Event|1|||
170893108|NCT00769119|617615445|FG000|Overall Study|Disallowed medication|1|||
170893109|NCT00769119|617615446|FG001|Overall Study|Disallowed medication|0|||
170893110|NCT01116544|617615449|FG000|Overall Study|Protocol Violation|1|||
170893111|NCT01116544|617615450|FG001|Overall Study|Protocol Violation|0|||
170547289|NCT04535362|616350132|FG001|Overall Study|Lost to Follow-up|1|||
170893112|NCT01116544|617615449|FG000|Overall Study|Withdrawal by Subject|1|||
170893113|NCT01116544|617615450|FG001|Overall Study|Withdrawal by Subject|1|||
170893114|NCT00486278|617615451|FG000|Overall Study|Adverse Event|5|||
170893115|NCT00486278|617615451|FG000|Overall Study|Withdrawal by Subject|2|||
170893116|NCT00486278|617615451|FG000|Overall Study|Physician Decision|2|||
170893117|NCT01725750|617615452|FG000|Overall Study|Adverse Event|1|||
170547290|NCT03774810|616350136|FG000|Phase 1|Lack of Efficacy|21|||
170893118|NCT01725750|617615453|FG001|Overall Study|Adverse Event|0|||
170893119|NCT01725750|617615452|FG000|Overall Study|Lost to Follow-up|1|||
170893120|NCT01725750|617615453|FG001|Overall Study|Lost to Follow-up|1|||
170893121|NCT01725750|617615452|FG000|Overall Study|Withdrawal by Subject|0|||
170893122|NCT01725750|617615453|FG001|Overall Study|Withdrawal by Subject|9|||
170893123|NCT05168267|617615458|FG000|Overall Study|Withdrawal by Subject|2|||
170893124|NCT05168267|617615459|FG001|Overall Study|Withdrawal by Subject|1|||
170893125|NCT05168267|617615458|FG000|Overall Study|Withdrawn by Therapist|1|||
170893126|NCT05168267|617615459|FG001|Overall Study|Withdrawn by Therapist|1|||
170893127|NCT05168267|617615458|FG000|Overall Study|Left Facility|1|||
170893128|NCT05168267|617615459|FG001|Overall Study|Left Facility|0|||
170893129|NCT02937350|617615460|FG000|Overall Study|Withdrawal by Subject|0|||
170893130|NCT02937350|617615461|FG001|Overall Study|Withdrawal by Subject|1|||
170893131|NCT02937350|617615462|FG002|Overall Study|Withdrawal by Subject|0|||
170893132|NCT02419508|617615463|FG000|Overall Study|Adverse Event|9|||
170893133|NCT02419508|617615464|FG001|Overall Study|Adverse Event|3|||
170893134|NCT02419508|617615463|FG000|Overall Study|Withdrawal by Subject|1|||
170893135|NCT02419508|617615464|FG001|Overall Study|Withdrawal by Subject|0|||
170893136|NCT02419508|617615463|FG000|Overall Study|Other - Reason not specified|0|||
170793188|NCT04068311|617251927|FG001|Overall Study|Lost to Follow-up|68|||
170793189|NCT04068311|617251926|FG000|Overall Study|Withdrawal by Subject|5|||
170793190|NCT04068311|617251927|FG001|Overall Study|Withdrawal by Subject|0|||
170793191|NCT03056573|617251928|FG000|Overall Study|Death|2|||
170793192|NCT03056573|617251929|FG001|Overall Study|Death|4|||
170793193|NCT03056573|617251928|FG000|Overall Study|Withdrawal by Subject|2|||
170793194|NCT03056573|617251929|FG001|Overall Study|Withdrawal by Subject|0|||
170793195|NCT03056573|617251928|FG000|Overall Study|Lost to Follow-up|1|||
170793196|NCT03056573|617251929|FG001|Overall Study|Lost to Follow-up|1|||
170793197|NCT04428203|617251930|FG000|Overall Study|Adverse Event|1|||
170793198|NCT04428203|617251931|FG001|Overall Study|Adverse Event|0|||
170793199|NCT04428203|617251932|FG002|Overall Study|Adverse Event|0|||
170793200|NCT04428203|617251930|FG000|Overall Study|Withdrawal by Subject|1|||
170793201|NCT04428203|617251931|FG001|Overall Study|Withdrawal by Subject|0|||
170793202|NCT04428203|617251932|FG002|Overall Study|Withdrawal by Subject|1|||
170793203|NCT03257410|617253989|FG000|Overall Study|Adverse Event|2|||
170793204|NCT03257410|617253990|FG001|Overall Study|Adverse Event|3|||
170793205|NCT03257410|617253989|FG000|Overall Study|Protocol Violation|1|||
170793206|NCT03257410|617253990|FG001|Overall Study|Protocol Violation|2|||
170793207|NCT03257410|617253989|FG000|Overall Study|Lost to Follow-up|1|||
170793208|NCT03257410|617253990|FG001|Overall Study|Lost to Follow-up|0|||
170793209|NCT03257410|617253989|FG000|Overall Study|Withdrawal by Subject|1|||
170793210|NCT03257410|617253990|FG001|Overall Study|Withdrawal by Subject|2|||
170793211|NCT03257410|617253989|FG000|Overall Study|Physician Decision|1|||
170793212|NCT03257410|617253990|FG001|Overall Study|Physician Decision|1|||
170793213|NCT03257410|617253989|FG000|Overall Study|Renal transplantation|2|||
170793214|NCT03257410|617253990|FG001|Overall Study|Renal transplantation|0|||
170793215|NCT03257410|617253989|FG000|Overall Study|Switch to peritoneal dialysis|1|||
170793216|NCT03257410|617253990|FG001|Overall Study|Switch to peritoneal dialysis|0|||
170793217|NCT03257410|617253989|FG000|Overall Study|Death|3|||
170793218|NCT03257410|617253990|FG001|Overall Study|Death|2|||
170793219|NCT03257410|617253989|FG000|Overall Study|Change to another dialysis center|2|||
170793220|NCT03257410|617253990|FG001|Overall Study|Change to another dialysis center|2|||
170793221|NCT03257410|617253989|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
170793222|NCT03257410|617253990|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
170793223|NCT03257410|617253989|FG000|Overall Study|Miscellaneous|2|||
170793224|NCT03257410|617253990|FG001|Overall Study|Miscellaneous|2|||
170793225|NCT03257410|617253989|FG000|Overall Study|Other|0|||
170793226|NCT03257410|617253990|FG001|Overall Study|Other|1|||
170793227|NCT03652389|617253991|FG000|Overall Study|Lost to Follow-up|1|||
170793228|NCT03652389|617253992|FG001|Overall Study|Lost to Follow-up|5|||
170793229|NCT03652389|617253991|FG000|Overall Study|Withdrawal by Subject|5|||
170793230|NCT03652389|617253992|FG001|Overall Study|Withdrawal by Subject|1|||
170793231|NCT03652389|617253991|FG000|Overall Study|New diagnosis|2|||
170793232|NCT03652389|617253992|FG001|Overall Study|New diagnosis|0|||
170793233|NCT04183283|617253993|FG000|Period 1|Withdrawal by Subject|0|||
170793234|NCT04183283|617253994|FG001|Period 1|Withdrawal by Subject|1|||
170793235|NCT04183283|617253995|FG002|Period 1|Withdrawal by Subject|0|||
170793236|NCT04183283|617253996|FG003|Period 1|Withdrawal by Subject|0|||
170793237|NCT04183283|617253993|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
170793238|NCT04183283|617253994|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
170793239|NCT04183283|617253995|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
170793240|NCT04183283|617253996|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
170793241|NCT04005794|617253997|FG000|Overall Study|Lost to Follow-up|0|||
170793242|NCT04005794|617253998|FG001|Overall Study|Lost to Follow-up|4|||
170793243|NCT04005794|617253999|FG002|Overall Study|Lost to Follow-up|0|||
170893137|NCT02419508|617615464|FG001|Overall Study|Other - Reason not specified|1|||
170893138|NCT06228586|617615471|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
170793244|NCT00104676|617254000|FG000|Overall Study|Death|3|||
170793245|NCT00104676|617254001|FG001|Overall Study|Death|2|||
170793246|NCT00104676|617254000|FG000|Overall Study|Withdrawal by Subject|0|||
170793247|NCT00104676|617254001|FG001|Overall Study|Withdrawal by Subject|2|||
170793248|NCT00104676|617254000|FG000|Overall Study|treatment interruption|4|||
170793249|NCT00104676|617254001|FG001|Overall Study|treatment interruption|10|||
170793250|NCT01197378|617254007|FG000|Overall Study|Adverse Event|3|||
170893139|NCT06228586|617615472|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
170893140|NCT01602341|617617343|FG000|Overall Study|Adverse Event|0|||
170893141|NCT01602341|617617344|FG001|Overall Study|Adverse Event|1|||
170893142|NCT02152345|617617345|FG000|Overall Study|Case Cancellations|2|||
170893143|NCT02152345|617617346|FG001|Overall Study|Case Cancellations|4|||
170893144|NCT02152345|617617345|FG000|Overall Study|Withdrawal by Subject|2|||
170893145|NCT02152345|617617346|FG001|Overall Study|Withdrawal by Subject|1|||
170893146|NCT00680836|617617347|FG000|Overall Study|Withdrawal by Subject|3|||
170893147|NCT00680836|617617348|FG001|Overall Study|Withdrawal by Subject|0|||
170893148|NCT00680836|617617347|FG000|Overall Study|Lost to Follow-up|3|||
170893149|NCT00680836|617617348|FG001|Overall Study|Lost to Follow-up|1|||
170893150|NCT00680836|617617347|FG000|Overall Study|Physician Decision|2|||
170793251|NCT01197378|617254007|FG000|Overall Study|Withdrawal by Subject|1|||
170793252|NCT01197378|617254007|FG000|Overall Study|Physician Decision|1|||
170793253|NCT01197378|617254007|FG000|Overall Study|Other|2|||
170793254|NCT05299723|617254011|FG000|Overall Study|Withdrawal by Subject|0|||
170793255|NCT05299723|617254012|FG001|Overall Study|Withdrawal by Subject|2|||
170793256|NCT05299723|617254013|FG002|Overall Study|Withdrawal by Subject|0|||
170793257|NCT01959607|617254014|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
170793258|NCT01959607|617254015|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
170793259|NCT01959607|617254016|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
170793260|NCT01959607|617254017|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
170793261|NCT03913442|617254018|FG000|Overall Study|Adverse Event|0|||
170793262|NCT03913442|617254019|FG001|Overall Study|Adverse Event|3|||
170793263|NCT03913442|617254018|FG000|Overall Study|Withdrawal by Subject|5|||
170793264|NCT03913442|617254019|FG001|Overall Study|Withdrawal by Subject|5|||
170793265|NCT03913442|617254018|FG000|Overall Study|Terminations|2|||
170793266|NCT03913442|617254019|FG001|Overall Study|Terminations|1|||
170793267|NCT03913442|617254018|FG000|Overall Study|Lost to Follow-up|2|||
170793268|NCT03913442|617254019|FG001|Overall Study|Lost to Follow-up|2|||
170793269|NCT02460458|617254020|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
170793270|NCT02460458|617254020|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
170793271|NCT02460458|617254020|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
170793272|NCT02460458|617254020|FG000|First Prospective Phase|Lost to Follow-up|84|||
170793273|NCT02460458|617254020|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
170793274|NCT02433379|617254024|FG000|Overall Study|Screen Failures|55|||
170793275|NCT02433379|617254024|FG000|Overall Study|Death|57|||
170793276|NCT02433379|617254024|FG000|Overall Study|Total Withdrawals|209|||
170793277|NCT04850898|617254025|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
170793278|NCT04850898|617254026|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
170793279|NCT04117347|617254033|FG000|Overall Study|Adverse Event|0|||
170793280|NCT04117347|617254034|FG001|Overall Study|Adverse Event|0|||
170793281|NCT04117347|617254035|FG002|Overall Study|Adverse Event|1|||
170793282|NCT04117347|617254033|FG000|Overall Study|No time for study|0|||
170793283|NCT04117347|617254034|FG001|Overall Study|No time for study|2|||
170793284|NCT04117347|617254035|FG002|Overall Study|No time for study|0|||
170793285|NCT04117347|617254033|FG000|Overall Study|Family emergency|1|||
170793286|NCT04117347|617254034|FG001|Overall Study|Family emergency|0|||
170793287|NCT04117347|617254035|FG002|Overall Study|Family emergency|0|||
170793288|NCT03691935|617254036|FG000|Overall Study|Physician Decision|2|||
170793289|NCT03691935|617254037|FG001|Overall Study|Physician Decision|1|||
170793290|NCT03691935|617254036|FG000|Overall Study|Adverse Event|3|||
170793291|NCT03691935|617254037|FG001|Overall Study|Adverse Event|0|||
170793292|NCT05446168|617254046|FG000|Overall Study|Physician Decision|0|||
170793293|NCT05446168|617254047|FG001|Overall Study|Physician Decision|1|||
170793294|NCT01946789|617254049|FG000|Overall Study|Death|0|||
170793295|NCT01946789|617254050|FG001|Overall Study|Death|2|||
170793296|NCT01946789|617254051|FG002|Overall Study|Death|1|||
170793297|NCT01946789|617254052|FG003|Overall Study|Death|1|||
170793298|NCT01946789|617254053|FG004|Overall Study|Death|1|||
170793299|NCT01946789|617254054|FG005|Overall Study|Death|1|||
170793300|NCT01946789|617254055|FG006|Overall Study|Death|3|||
170793301|NCT01946789|617254056|FG007|Overall Study|Death|1|||
170793302|NCT01946789|617254057|FG008|Overall Study|Death|2|||
170793303|NCT01946789|617254049|FG000|Overall Study|Progressive Disease|0|||
170793304|NCT01946789|617254050|FG001|Overall Study|Progressive Disease|0|||
170793305|NCT01946789|617254051|FG002|Overall Study|Progressive Disease|1|||
170793306|NCT01946789|617254052|FG003|Overall Study|Progressive Disease|0|||
170793307|NCT01946789|617254053|FG004|Overall Study|Progressive Disease|0|||
170793308|NCT01946789|617254054|FG005|Overall Study|Progressive Disease|2|||
170893151|NCT00680836|617617348|FG001|Overall Study|Physician Decision|1|||
170893152|NCT03786432|617617349|FG000|Overall Study|Screen Failure after consent|1|||
170793309|NCT01946789|617254055|FG006|Overall Study|Progressive Disease|0|||
170793310|NCT01946789|617254056|FG007|Overall Study|Progressive Disease|0|||
170793311|NCT01946789|617254057|FG008|Overall Study|Progressive Disease|0|||
170793312|NCT01946789|617254049|FG000|Overall Study|Withdrawal by Subject|0|||
170793313|NCT01946789|617254050|FG001|Overall Study|Withdrawal by Subject|0|||
170893153|NCT03786432|617617349|FG000|Overall Study|Lost to Follow-up|4|||
170893154|NCT03786432|617617349|FG000|Overall Study|did not complete 12 month CT scan|1|||
170893155|NCT00771472|617617353|FG000|Overall Study|Physician Decision|2|||
170893156|NCT00771472|617617354|FG001|Overall Study|Physician Decision|3|||
170893157|NCT00771472|617617353|FG000|Overall Study|Progressive Disease|3|||
170893158|NCT00771472|617617354|FG001|Overall Study|Progressive Disease|1|||
170893159|NCT00771472|617617353|FG000|Overall Study|Protocol Violation|1|||
170893160|NCT00771472|617617354|FG001|Overall Study|Protocol Violation|0|||
170893161|NCT00618722|617617355|FG000|Overall Study|Refusal of Treatment|0|||
170893162|NCT00618722|617617356|FG001|Overall Study|Refusal of Treatment|0|||
170893163|NCT00618722|617617357|FG002|Overall Study|Refusal of Treatment|1|||
170893164|NCT00618722|617617358|FG003|Overall Study|Refusal of Treatment|0|||
170893165|NCT00618722|617617355|FG000|Overall Study|Patient Request|1|||
170893166|NCT00618722|617617356|FG001|Overall Study|Patient Request|1|||
170893167|NCT00618722|617617357|FG002|Overall Study|Patient Request|1|||
170893168|NCT00618722|617617358|FG003|Overall Study|Patient Request|1|||
170893169|NCT00618722|617617355|FG000|Overall Study|Inability to Complete Study Procedure|0|||
170893170|NCT00618722|617617356|FG001|Overall Study|Inability to Complete Study Procedure|1|||
170893171|NCT00618722|617617357|FG002|Overall Study|Inability to Complete Study Procedure|0|||
170893172|NCT00618722|617617358|FG003|Overall Study|Inability to Complete Study Procedure|0|||
170893173|NCT00618722|617617355|FG000|Overall Study|Lost to Follow-up|2|||
170893174|NCT00618722|617617356|FG001|Overall Study|Lost to Follow-up|0|||
170893175|NCT00618722|617617357|FG002|Overall Study|Lost to Follow-up|0|||
170893176|NCT00618722|617617358|FG003|Overall Study|Lost to Follow-up|2|||
170893177|NCT00618722|617617355|FG000|Overall Study|Miscellaneous Reasons|0|||
170893178|NCT00618722|617617356|FG001|Overall Study|Miscellaneous Reasons|0|||
170893179|NCT00618722|617617357|FG002|Overall Study|Miscellaneous Reasons|1|||
170893180|NCT00618722|617617358|FG003|Overall Study|Miscellaneous Reasons|1|||
170893181|NCT00925600|617617359|FG000|Overall Study|Withdrawal by Subject|16|||
170893182|NCT00925600|617617360|FG001|Overall Study|Withdrawal by Subject|14|||
170893183|NCT00925600|617617359|FG000|Overall Study|Death|4|||
170893184|NCT00925600|617617360|FG001|Overall Study|Death|3|||
170893185|NCT00925600|617617359|FG000|Overall Study|Lost to Follow-up|2|||
170893186|NCT00925600|617617360|FG001|Overall Study|Lost to Follow-up|2|||
170893187|NCT00925600|617617359|FG000|Overall Study|Disease Progression|1|||
170893188|NCT00925600|617617360|FG001|Overall Study|Disease Progression|3|||
170893189|NCT00925600|617617359|FG000|Overall Study|Administrative Decision|1|||
170893190|NCT00925600|617617360|FG001|Overall Study|Administrative Decision|1|||
170893191|NCT00925600|617617359|FG000|Overall Study|Noncompliance|2|||
170893192|NCT00925600|617617360|FG001|Overall Study|Noncompliance|0|||
170893193|NCT00925600|617617359|FG000|Overall Study|Ineligibility Determined|2|||
170893194|NCT00925600|617617360|FG001|Overall Study|Ineligibility Determined|0|||
170893195|NCT00925600|617617359|FG000|Overall Study|Protocol Deviation|0|||
170893196|NCT00925600|617617360|FG001|Overall Study|Protocol Deviation|1|||
170893197|NCT00925600|617617359|FG000|Overall Study|Requirement for Alternative Therapy|0|||
170893198|NCT00925600|617617360|FG001|Overall Study|Requirement for Alternative Therapy|1|||
170893199|NCT00925600|617617359|FG000|Overall Study|Other|3|||
170893200|NCT00925600|617617360|FG001|Overall Study|Other|1|||
170893201|NCT00925600|617617359|FG000|Overall Study|Adverse Event|1|||
170893202|NCT00925600|617617360|FG001|Overall Study|Adverse Event|2|||
170893203|NCT00127127|617617365|FG000|Overall Study|Adverse Event|0|||
170893204|NCT00127127|617617366|FG001|Overall Study|Adverse Event|2|||
170893205|NCT00127127|617617367|FG002|Overall Study|Adverse Event|0|||
170893206|NCT00127127|617617368|FG003|Overall Study|Adverse Event|1|||
170893207|NCT00127127|617617365|FG000|Overall Study|Lack of Efficacy|1|||
170893208|NCT00127127|617617366|FG001|Overall Study|Lack of Efficacy|3|||
170547291|NCT03774810|616350137|FG001|Phase 1|Lack of Efficacy|0|||
170893209|NCT00127127|617617367|FG002|Overall Study|Lack of Efficacy|0|||
170893210|NCT00127127|617617368|FG003|Overall Study|Lack of Efficacy|2|||
170893211|NCT01891643|617617369|FG000|Overall Study|Adverse event unrelated to study drug|2|||
170893212|NCT01891643|617617370|FG001|Overall Study|Adverse event unrelated to study drug|5|||
170893213|NCT01891643|617617369|FG000|Overall Study|Disease Progression|4|||
170547292|NCT03774810|616350138|FG002|Phase 1|Lack of Efficacy|0|||
170893214|NCT01891643|617617370|FG001|Overall Study|Disease Progression|3|||
170893215|NCT01891643|617617369|FG000|Overall Study|Study Drug Toxicity|3|||
170893216|NCT01891643|617617370|FG001|Overall Study|Study Drug Toxicity|0|||
170893217|NCT01891643|617617369|FG000|Overall Study|Maximum Clinical Benefit|0|||
170893218|NCT01891643|617617370|FG001|Overall Study|Maximum Clinical Benefit|1|||
170893219|NCT01891643|617617369|FG000|Overall Study|Poor/Non-compliance|0|||
170893220|NCT01891643|617617370|FG001|Overall Study|Poor/Non-compliance|1|||
170893221|NCT01891643|617617369|FG000|Overall Study|Participant request to discontinue|1|||
170893222|NCT01891643|617617370|FG001|Overall Study|Participant request to discontinue|0|||
170893223|NCT02327260|617617381|FG000|Overall Study|Lost to Follow-up|2|||
170893224|NCT02327260|617617382|FG001|Overall Study|Lost to Follow-up|3|||
170893225|NCT02327260|617617383|FG002|Overall Study|Lost to Follow-up|2|||
170893226|NCT02327260|617617381|FG000|Overall Study|invalid phone number|1|||
170893227|NCT02327260|617617382|FG001|Overall Study|invalid phone number|1|||
170893228|NCT02327260|617617383|FG002|Overall Study|invalid phone number|0|||
170893229|NCT02327260|617617381|FG000|Overall Study|non-adherence to protocol|2|||
170893230|NCT02327260|617617382|FG001|Overall Study|non-adherence to protocol|0|||
170893231|NCT02327260|617617383|FG002|Overall Study|non-adherence to protocol|0|||
170893232|NCT02327260|617617381|FG000|Overall Study|cognitive concerns|1|||
170893233|NCT02327260|617617382|FG001|Overall Study|cognitive concerns|0|||
170893234|NCT02327260|617617383|FG002|Overall Study|cognitive concerns|0|||
170893235|NCT03502330|617617384|FG000|Overall Study|Adverse Event|2|||
170893236|NCT03502330|617617385|FG001|Overall Study|Adverse Event|1|||
170893237|NCT03502330|617617386|FG002|Overall Study|Adverse Event|0|||
170893238|NCT03502330|617617387|FG003|Overall Study|Adverse Event|0|||
170893239|NCT03502330|617617388|FG004|Overall Study|Adverse Event|1|||
170893240|NCT03502330|617617389|FG005|Overall Study|Adverse Event|0|||
170893241|NCT03502330|617617390|FG006|Overall Study|Adverse Event|1|||
170893242|NCT03502330|617617391|FG007|Overall Study|Adverse Event|1|||
170893243|NCT03502330|617617392|FG008|Overall Study|Adverse Event|0|||
170893244|NCT03502330|617617384|FG000|Overall Study|Lack of Efficacy|1|||
170893245|NCT03502330|617617385|FG001|Overall Study|Lack of Efficacy|5|||
170893246|NCT03502330|617617386|FG002|Overall Study|Lack of Efficacy|3|||
170893247|NCT03502330|617617387|FG003|Overall Study|Lack of Efficacy|5|||
170793314|NCT01946789|617254051|FG002|Overall Study|Withdrawal by Subject|0|||
170793315|NCT01946789|617254052|FG003|Overall Study|Withdrawal by Subject|2|||
170793316|NCT01946789|617254053|FG004|Overall Study|Withdrawal by Subject|1|||
170793317|NCT01946789|617254054|FG005|Overall Study|Withdrawal by Subject|0|||
170793318|NCT01946789|617254055|FG006|Overall Study|Withdrawal by Subject|1|||
170793319|NCT01946789|617254056|FG007|Overall Study|Withdrawal by Subject|0|||
170893248|NCT03502330|617617388|FG004|Overall Study|Lack of Efficacy|1|||
170893249|NCT03502330|617617389|FG005|Overall Study|Lack of Efficacy|5|||
170893250|NCT03502330|617617390|FG006|Overall Study|Lack of Efficacy|5|||
170893251|NCT03502330|617617391|FG007|Overall Study|Lack of Efficacy|6|||
170893252|NCT03502330|617617392|FG008|Overall Study|Lack of Efficacy|0|||
170893253|NCT03502330|617617384|FG000|Overall Study|Physician Decision|0|||
170893254|NCT03502330|617617385|FG001|Overall Study|Physician Decision|0|||
170893255|NCT03502330|617617386|FG002|Overall Study|Physician Decision|0|||
170893256|NCT03502330|617617387|FG003|Overall Study|Physician Decision|0|||
170893257|NCT03502330|617617388|FG004|Overall Study|Physician Decision|1|||
170793320|NCT01946789|617254057|FG008|Overall Study|Withdrawal by Subject|0|||
170793321|NCT01828099|617254058|FG000|Treatment Period|Adverse Event|24|||
170793322|NCT01828099|617254059|FG001|Treatment Period|Adverse Event|23|||
170793323|NCT01828099|617254058|FG000|Treatment Period|Death|10|||
170793324|NCT01828099|617254059|FG001|Treatment Period|Death|12|||
170793325|NCT01828099|617254058|FG000|Treatment Period|Lost to Follow-up|2|||
170793326|NCT01828099|617254059|FG001|Treatment Period|Lost to Follow-up|1|||
170893258|NCT03502330|617617389|FG005|Overall Study|Physician Decision|0|||
170893259|NCT03502330|617617390|FG006|Overall Study|Physician Decision|0|||
170893260|NCT03502330|617617391|FG007|Overall Study|Physician Decision|0|||
170893261|NCT03502330|617617392|FG008|Overall Study|Physician Decision|0|||
170893262|NCT03502330|617617384|FG000|Overall Study|Withdrawal by Subject|0|||
170893263|NCT03502330|617617385|FG001|Overall Study|Withdrawal by Subject|0|||
170893264|NCT03502330|617617386|FG002|Overall Study|Withdrawal by Subject|0|||
170893265|NCT03502330|617617387|FG003|Overall Study|Withdrawal by Subject|0|||
170893266|NCT03502330|617617388|FG004|Overall Study|Withdrawal by Subject|0|||
170893267|NCT03502330|617617389|FG005|Overall Study|Withdrawal by Subject|1|||
170893268|NCT03502330|617617390|FG006|Overall Study|Withdrawal by Subject|0|||
170893269|NCT03502330|617617391|FG007|Overall Study|Withdrawal by Subject|1|||
170793327|NCT01828099|617254058|FG000|Treatment Period|Non-compliance with study treatment|1|||
170893270|NCT03502330|617617392|FG008|Overall Study|Withdrawal by Subject|0|||
170893271|NCT03502330|617617384|FG000|Overall Study|Death|0|||
170893272|NCT03502330|617617385|FG001|Overall Study|Death|0|||
170893273|NCT03502330|617617386|FG002|Overall Study|Death|0|||
170547293|NCT03774810|616350139|FG003|Phase 1|Lack of Efficacy|0|||
170547294|NCT03774810|616350140|FG004|Phase 1|Lack of Efficacy|0|||
170547295|NCT03774810|616350136|FG000|Phase 1|Withdrawal by Subject|9|||
170547296|NCT03774810|616350137|FG001|Phase 1|Withdrawal by Subject|0|||
170793328|NCT01828099|617254059|FG001|Treatment Period|Non-compliance with study treatment|0|||
170793329|NCT01828099|617254058|FG000|Treatment Period|Physician Decision|17|||
170793330|NCT01828099|617254059|FG001|Treatment Period|Physician Decision|16|||
170793331|NCT01828099|617254058|FG000|Treatment Period|Progressive disease|99|||
170793332|NCT01828099|617254059|FG001|Treatment Period|Progressive disease|107|||
170793333|NCT01828099|617254058|FG000|Treatment Period|Subject/guardian decision|22|||
170793334|NCT01828099|617254059|FG001|Treatment Period|Subject/guardian decision|26|||
170793335|NCT01828099|617254058|FG000|Treatment Period|Study terminated by Sponsor|13|||
170793336|NCT01828099|617254059|FG001|Treatment Period|Study terminated by Sponsor|1|||
170793337|NCT01828099|617254058|FG000|Treatment Period|Protocol deviation|1|||
170793338|NCT01828099|617254059|FG001|Treatment Period|Protocol deviation|0|||
170793339|NCT01828099|617254058|FG000|Treatment Period|No longer requires treatment|0|||
170793340|NCT01828099|617254059|FG001|Treatment Period|No longer requires treatment|1|||
170793341|NCT01828099|617254058|FG000|Extension-treatment Phase|Adverse Event|0|||
170793342|NCT01828099|617254059|FG001|Extension-treatment Phase|Adverse Event|17|||
170793343|NCT01828099|617254058|FG000|Extension-treatment Phase|Death|0|||
170793344|NCT01828099|617254059|FG001|Extension-treatment Phase|Death|11|||
170793345|NCT01828099|617254058|FG000|Extension-treatment Phase|Physician Decision|0|||
170793346|NCT01828099|617254059|FG001|Extension-treatment Phase|Physician Decision|5|||
170793347|NCT01828099|617254058|FG000|Extension-treatment Phase|Progressive disease|0|||
170793348|NCT01828099|617254059|FG001|Extension-treatment Phase|Progressive disease|54|||
170793349|NCT01828099|617254058|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
170793350|NCT01828099|617254059|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
170793351|NCT01828099|617254058|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
170793352|NCT01828099|617254059|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
170793353|NCT04362254|617254064|FG000|Overall Study|Adverse Event|1|||
170793354|NCT04362254|617254064|FG000|Overall Study|Protocol Violation|1|||
170793355|NCT04362254|617254064|FG000|Overall Study|Due to early termination of the trial|10|||
170793356|NCT00321048|617254065|FG000|Overall Study|Withdrawal by Subject|6|||
170793357|NCT00321048|617254066|FG001|Overall Study|Withdrawal by Subject|8|||
170793358|NCT04707625|617254067|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
170793359|NCT02038777|617254068|FG000|Overall Study|Death|0|||
170793360|NCT02038777|617254069|FG001|Overall Study|Death|2|||
170793361|NCT02038777|617254070|FG002|Overall Study|Death|0|||
170793362|NCT02038777|617254071|FG003|Overall Study|Death|1|||
170793363|NCT02038777|617254072|FG004|Overall Study|Death|2|||
170793364|NCT02038777|617254073|FG005|Overall Study|Death|4|||
170793365|NCT02038777|617254074|FG006|Overall Study|Death|0|||
170793366|NCT02038777|617254075|FG007|Overall Study|Death|11|||
170793367|NCT02038777|617254068|FG000|Overall Study|Lost to Follow-up|0|||
170793368|NCT02038777|617254069|FG001|Overall Study|Lost to Follow-up|0|||
170793369|NCT02038777|617254070|FG002|Overall Study|Lost to Follow-up|0|||
170793370|NCT02038777|617254071|FG003|Overall Study|Lost to Follow-up|1|||
170793371|NCT02038777|617254072|FG004|Overall Study|Lost to Follow-up|0|||
170793372|NCT02038777|617254073|FG005|Overall Study|Lost to Follow-up|0|||
170793373|NCT02038777|617254074|FG006|Overall Study|Lost to Follow-up|0|||
170793374|NCT02038777|617254075|FG007|Overall Study|Lost to Follow-up|0|||
170793375|NCT02038777|617254068|FG000|Overall Study|Other|0|||
170793376|NCT02038777|617254069|FG001|Overall Study|Other|1|||
170793377|NCT02038777|617254070|FG002|Overall Study|Other|0|||
170793378|NCT02038777|617254071|FG003|Overall Study|Other|2|||
170793379|NCT02038777|617254072|FG004|Overall Study|Other|1|||
170793380|NCT02038777|617254073|FG005|Overall Study|Other|0|||
170793381|NCT02038777|617254074|FG006|Overall Study|Other|0|||
170793382|NCT02038777|617254075|FG007|Overall Study|Other|0|||
170793383|NCT02038777|617254068|FG000|Overall Study|Randomized but not treated|0|||
170793384|NCT02038777|617254069|FG001|Overall Study|Randomized but not treated|1|||
170793385|NCT02038777|617254070|FG002|Overall Study|Randomized but not treated|0|||
170793386|NCT02038777|617254071|FG003|Overall Study|Randomized but not treated|0|||
170793387|NCT02038777|617254072|FG004|Overall Study|Randomized but not treated|0|||
170793388|NCT02038777|617254073|FG005|Overall Study|Randomized but not treated|0|||
170793389|NCT02038777|617254074|FG006|Overall Study|Randomized but not treated|0|||
170793390|NCT02038777|617254075|FG007|Overall Study|Randomized but not treated|0|||
170793391|NCT02038777|617254068|FG000|Overall Study|Started Chemotherapy|1|||
170793392|NCT02038777|617254069|FG001|Overall Study|Started Chemotherapy|0|||
170793393|NCT02038777|617254070|FG002|Overall Study|Started Chemotherapy|3|||
170793394|NCT02038777|617254071|FG003|Overall Study|Started Chemotherapy|0|||
170793395|NCT02038777|617254072|FG004|Overall Study|Started Chemotherapy|0|||
170793396|NCT02038777|617254073|FG005|Overall Study|Started Chemotherapy|0|||
170793397|NCT02038777|617254074|FG006|Overall Study|Started Chemotherapy|0|||
170793398|NCT02038777|617254075|FG007|Overall Study|Started Chemotherapy|0|||
170793399|NCT02038777|617254068|FG000|Overall Study|participation terminated by sponsor|0|||
170547297|NCT03774810|616350138|FG002|Phase 1|Withdrawal by Subject|0|||
170893274|NCT03502330|617617387|FG003|Overall Study|Death|0|||
170893275|NCT03502330|617617388|FG004|Overall Study|Death|0|||
170893276|NCT03502330|617617389|FG005|Overall Study|Death|0|||
170893277|NCT03502330|617617390|FG006|Overall Study|Death|2|||
170893278|NCT03502330|617617391|FG007|Overall Study|Death|0|||
170893279|NCT03502330|617617392|FG008|Overall Study|Death|0|||
170893280|NCT02804763|617617396|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
170893281|NCT02804763|617617397|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
170893282|NCT02804763|617617398|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
170893283|NCT02804763|617617399|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
170893284|NCT02804763|617617396|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
170893285|NCT02804763|617617397|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
170893286|NCT02804763|617617398|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
170893287|NCT02804763|617617399|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
170893288|NCT02804763|617617396|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
170893289|NCT02804763|617617397|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
170893290|NCT02804763|617617398|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
170893291|NCT02804763|617617399|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
170893292|NCT02804763|617617396|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
170893293|NCT02804763|617617397|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
170893294|NCT02804763|617617398|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
170893295|NCT02804763|617617399|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
170893296|NCT02804763|617617396|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
170893297|NCT02804763|617617397|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
170893298|NCT02804763|617617398|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
170893299|NCT02804763|617617399|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
170893300|NCT02804763|617617396|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
170893301|NCT02804763|617617397|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
170893302|NCT02804763|617617398|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
170893303|NCT02804763|617617399|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
170893304|NCT01400932|617617404|FG000|Overall Study|Adverse Event|10|||
170893305|NCT01400932|617617405|FG001|Overall Study|Adverse Event|5|||
170893306|NCT01400932|617617404|FG000|Overall Study|Lack of Efficacy|0|||
170893307|NCT01400932|617617405|FG001|Overall Study|Lack of Efficacy|3|||
170893308|NCT01400932|617617404|FG000|Overall Study|Withdrawal by Subject|2|||
170893309|NCT01400932|617617405|FG001|Overall Study|Withdrawal by Subject|6|||
170893310|NCT01400932|617617404|FG000|Overall Study|Lost to Follow-up|1|||
170893311|NCT01400932|617617405|FG001|Overall Study|Lost to Follow-up|0|||
170893312|NCT01400932|617617404|FG000|Overall Study|Protocol Deviation|0|||
170893313|NCT01400932|617617405|FG001|Overall Study|Protocol Deviation|1|||
170547298|NCT03774810|616350139|FG003|Phase 1|Withdrawal by Subject|0|||
170547299|NCT03774810|616350140|FG004|Phase 1|Withdrawal by Subject|0|||
170547300|NCT03774810|616350136|FG000|Phase 1|Lost to Follow-up|2|||
170547301|NCT03774810|616350137|FG001|Phase 1|Lost to Follow-up|0|||
170547302|NCT03774810|616350138|FG002|Phase 1|Lost to Follow-up|0|||
170547303|NCT03774810|616350139|FG003|Phase 1|Lost to Follow-up|0|||
170547304|NCT03774810|616350140|FG004|Phase 1|Lost to Follow-up|0|||
170547305|NCT03774810|616350136|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
170547306|NCT03774810|616350137|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
170547307|NCT03774810|616350138|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
170547308|NCT03774810|616350139|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
170547309|NCT03774810|616350140|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
170547310|NCT03774810|616350136|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
170547311|NCT03774810|616350137|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
170893314|NCT01400932|617617404|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
170893315|NCT01400932|617617405|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
170893316|NCT04656990|617617408|FG000|Baseline|pandemic|20|||
170893317|NCT04656990|617617409|FG001|Baseline|pandemic|24|||
170893318|NCT04656990|617617408|FG000|Follow Up Period|Lost to Follow-up|61|||
170893319|NCT04656990|617617409|FG001|Follow Up Period|Lost to Follow-up|73|||
170893320|NCT03244059|617617410|FG000|Specific Aim 1|Physician Decision|1|||
170893321|NCT03244059|617617411|FG001|Specific Aim 1|Physician Decision|0|||
170893322|NCT03244059|617617410|FG000|Specific Aim 2|Physician Decision|1|||
170893323|NCT03244059|617617411|FG001|Specific Aim 2|Physician Decision|0|||
170893324|NCT05499520|617617415|FG000|Overall Study|Lost to Follow-up|0|||
170893325|NCT05499520|617617416|FG001|Overall Study|Lost to Follow-up|0|||
170893326|NCT05499520|617617417|FG002|Overall Study|Lost to Follow-up|38|||
170893327|NCT05499520|617617418|FG003|Overall Study|Lost to Follow-up|41|||
170547312|NCT03774810|616350138|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
170547313|NCT03774810|616350139|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
170547314|NCT03774810|616350140|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
170547315|NCT03774810|616350136|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
170547316|NCT03774810|616350137|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
170547317|NCT03774810|616350138|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
170547318|NCT03774810|616350139|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
170893328|NCT05499520|617617419|FG004|Overall Study|Lost to Follow-up|46|||
170893329|NCT05499520|617617420|FG005|Overall Study|Lost to Follow-up|0|||
170893330|NCT05499520|617617421|FG006|Overall Study|Lost to Follow-up|31|||
170893331|NCT05499520|617617422|FG007|Overall Study|Lost to Follow-up|45|||
170893332|NCT05499520|617617423|FG008|Overall Study|Lost to Follow-up|42|||
170893333|NCT05499520|617617424|FG009|Overall Study|Lost to Follow-up|0|||
170893334|NCT05499520|617617425|FG010|Overall Study|Lost to Follow-up|0|||
170893335|NCT05499520|617617426|FG011|Overall Study|Lost to Follow-up|37|||
170893336|NCT05499520|617617427|FG012|Overall Study|Lost to Follow-up|53|||
170893337|NCT05499520|617617428|FG013|Overall Study|Lost to Follow-up|49|||
170893338|NCT05499520|617617429|FG014|Overall Study|Lost to Follow-up|0|||
170893339|NCT05499520|617617430|FG015|Overall Study|Lost to Follow-up|36|||
170893340|NCT05499520|617617431|FG016|Overall Study|Lost to Follow-up|58|||
170893341|NCT05499520|617617432|FG017|Overall Study|Lost to Follow-up|53|||
170893342|NCT03706365|617617433|FG000|Overall Study|Lost to Follow-up|7|||
170893343|NCT03706365|617617434|FG001|Overall Study|Lost to Follow-up|0|||
170893344|NCT03706365|617617433|FG000|Overall Study|Withdrawal by Subject|17|||
170893345|NCT03706365|617617434|FG001|Overall Study|Withdrawal by Subject|15|||
170893346|NCT03706365|617617433|FG000|Overall Study|On Study Treatment|51|||
170893347|NCT03706365|617617434|FG001|Overall Study|On Study Treatment|51|||
170893348|NCT00605267|617617435|FG000|Overall Study|Adverse Event|0|||
170893349|NCT00605267|617617436|FG001|Overall Study|Adverse Event|1|||
170893350|NCT00605267|617617435|FG000|Overall Study|Lack of Efficacy|1|||
170893351|NCT00605267|617617436|FG001|Overall Study|Lack of Efficacy|5|||
170893352|NCT00605267|617617435|FG000|Overall Study|Withdrawal by Subject|2|||
170893353|NCT00605267|617617436|FG001|Overall Study|Withdrawal by Subject|3|||
170893354|NCT00840827|617617438|FG000|Overall Study|Adverse Event|1|||
170893355|NCT00840827|617617438|FG000|Overall Study|Lack of Efficacy|4|||
170893356|NCT00840827|617617438|FG000|Overall Study|Physician Decision|1|||
170893357|NCT04557384|617617439|FG000|Overall Study|Study Terminated by Sponsor|1|||
170893358|NCT04557384|617617439|FG000|Overall Study|Death|1|||
170893359|NCT00059202|617617440|FG000|Overall Study|Withdrawal by Subject|5|||
170893360|NCT00059202|617617441|FG001|Overall Study|Withdrawal by Subject|9|||
170893361|NCT00059202|617617440|FG000|Overall Study|Protocol Violation|1|||
170893362|NCT00059202|617617441|FG001|Overall Study|Protocol Violation|3|||
170893363|NCT00059202|617617440|FG000|Overall Study|drug toxicity|0|||
170893364|NCT00059202|617617441|FG001|Overall Study|drug toxicity|3|||
170893365|NCT01705691|617617444|FG000|Overall Study|Death|1|||
170893366|NCT01705691|617617445|FG001|Overall Study|Death|2|||
170893367|NCT01705691|617617444|FG000|Overall Study|Withdrawal by Subject|1|||
170893368|NCT01705691|617617445|FG001|Overall Study|Withdrawal by Subject|2|||
170893369|NCT01705691|617617444|FG000|Overall Study|Lost to Follow-up|1|||
170893370|NCT01705691|617617445|FG001|Overall Study|Lost to Follow-up|1|||
170893371|NCT01705691|617617444|FG000|Overall Study|Other|0|||
170893372|NCT01705691|617617445|FG001|Overall Study|Other|1|||
170893373|NCT02658448|617617446|FG000|Overall Study|Lost to Follow-up|1|||
170893374|NCT04233229|617617447|FG000|Overall Study|Withdrawal by Subject|0|||
170893375|NCT04233229|617617448|FG001|Overall Study|Withdrawal by Subject|1|||
170893376|NCT04233229|617617447|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
170893377|NCT04233229|617617448|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
170893378|NCT04233229|617617447|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
170893379|NCT04233229|617617448|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
170893380|NCT00584194|617617449|FG000|Overall Study|Other|135|||
170893381|NCT04093531|617617450|FG000|Overall Study|failed screening|4|||
170893382|NCT00400400|617617451|FG000|Overall Study|Adverse Event|9|||
170893383|NCT00400400|617617452|FG001|Overall Study|Adverse Event|8|||
170893384|NCT00400400|617617451|FG000|Overall Study|Protocol Violation|2|||
170893385|NCT00400400|617617452|FG001|Overall Study|Protocol Violation|0|||
170893386|NCT00400400|617617451|FG000|Overall Study|Withdrawal by Subject|1|||
170893387|NCT00400400|617617452|FG001|Overall Study|Withdrawal by Subject|3|||
170893388|NCT00400400|617617451|FG000|Overall Study|Administrative Problem|1|||
170893389|NCT00400400|617617452|FG001|Overall Study|Administrative Problem|0|||
170893390|NCT00400400|617617451|FG000|Overall Study|Lost to Follow-up|0|||
170893391|NCT00400400|617617452|FG001|Overall Study|Lost to Follow-up|1|||
170893392|NCT00400400|617617451|FG000|Overall Study|Did not receive study drug|1|||
170893393|NCT00400400|617617452|FG001|Overall Study|Did not receive study drug|3|||
170893394|NCT00354601|617617453|FG000|Overall Study|Protocol Violation|1|||
170893395|NCT00354601|617617453|FG000|Overall Study|progression|1|||
170893396|NCT03157531|617617457|FG000|Overall Study|Death|2|||
170893397|NCT03157531|617617457|FG000|Overall Study|Lost to Follow-up|4|||
170893398|NCT01235962|617617459|FG000|Overall Study|Withdrawal by Subject|20|||
170893399|NCT01235962|617617460|FG001|Overall Study|Withdrawal by Subject|19|||
170893400|NCT01235962|617617461|FG002|Overall Study|Withdrawal by Subject|62|||
170893401|NCT01235962|617617462|FG003|Overall Study|Withdrawal by Subject|49|||
170893402|NCT01235962|617617459|FG000|Overall Study|Lost to Follow-up|21|||
170893403|NCT01235962|617617460|FG001|Overall Study|Lost to Follow-up|16|||
170893404|NCT01235962|617617461|FG002|Overall Study|Lost to Follow-up|47|||
170893405|NCT01235962|617617462|FG003|Overall Study|Lost to Follow-up|32|||
170893406|NCT01235962|617617459|FG000|Overall Study|Physician Decision|5|||
170893407|NCT01235962|617617460|FG001|Overall Study|Physician Decision|0|||
170893408|NCT01235962|617617461|FG002|Overall Study|Physician Decision|9|||
170893409|NCT01235962|617617462|FG003|Overall Study|Physician Decision|5|||
170893410|NCT02471716|617617465|FG000|Overall Study|Withdrawal by Subject|0|||
170893411|NCT02471716|617617466|FG001|Overall Study|Withdrawal by Subject|1|||
170893412|NCT02471716|617617467|FG002|Overall Study|Withdrawal by Subject|0|||
170893413|NCT02471716|617617468|FG003|Overall Study|Withdrawal by Subject|2|||
170893414|NCT02471716|617617469|FG004|Overall Study|Withdrawal by Subject|5|||
170893415|NCT02471716|617617465|FG000|Overall Study|Study Terminiated by sponsor|0|||
170893416|NCT02471716|617617466|FG001|Overall Study|Study Terminiated by sponsor|0|||
170893417|NCT02471716|617617467|FG002|Overall Study|Study Terminiated by sponsor|0|||
170893418|NCT02471716|617617468|FG003|Overall Study|Study Terminiated by sponsor|1|||
170893419|NCT02471716|617617469|FG004|Overall Study|Study Terminiated by sponsor|0|||
170893420|NCT02471716|617617465|FG000|Overall Study|Lost to Follow-up|0|||
170893421|NCT02471716|617617466|FG001|Overall Study|Lost to Follow-up|0|||
170893422|NCT02471716|617617467|FG002|Overall Study|Lost to Follow-up|0|||
170893423|NCT02471716|617617468|FG003|Overall Study|Lost to Follow-up|3|||
170893424|NCT02471716|617617469|FG004|Overall Study|Lost to Follow-up|2|||
170893425|NCT02471716|617617465|FG000|Overall Study|Death|0|||
170893426|NCT02471716|617617466|FG001|Overall Study|Death|0|||
170547319|NCT03774810|616350140|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
170547320|NCT03774810|616350136|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
170547321|NCT03774810|616350137|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
170547322|NCT03774810|616350138|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
170547323|NCT03774810|616350139|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
170893427|NCT02471716|617617467|FG002|Overall Study|Death|0|||
170893428|NCT02471716|617617468|FG003|Overall Study|Death|1|||
170893429|NCT02471716|617617469|FG004|Overall Study|Death|0|||
170893430|NCT02471716|617617465|FG000|Overall Study|Other|0|||
170893431|NCT02471716|617617466|FG001|Overall Study|Other|0|||
170893432|NCT02471716|617617467|FG002|Overall Study|Other|0|||
170893433|NCT02471716|617617468|FG003|Overall Study|Other|8|||
170547324|NCT03774810|616350140|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
170893434|NCT02471716|617617469|FG004|Overall Study|Other|9|||
170893435|NCT02211261|617617481|FG000|Overall Study|Withdrawal by Subject|0|||
170893436|NCT02211261|617617482|FG001|Overall Study|Withdrawal by Subject|0|||
170893437|NCT02211261|617617483|FG002|Overall Study|Withdrawal by Subject|1|||
170893438|NCT02211261|617617484|FG003|Overall Study|Withdrawal by Subject|0|||
170893439|NCT02211261|617617485|FG004|Overall Study|Withdrawal by Subject|2|||
170893440|NCT02211261|617617486|FG005|Overall Study|Withdrawal by Subject|0|||
170893441|NCT02211261|617617487|FG006|Overall Study|Withdrawal by Subject|0|||
170893442|NCT02211261|617617488|FG007|Overall Study|Withdrawal by Subject|0|||
170893443|NCT02211261|617617489|FG008|Overall Study|Withdrawal by Subject|0|||
170893444|NCT02211261|617617490|FG009|Overall Study|Withdrawal by Subject|0|||
170893445|NCT02211261|617617491|FG010|Overall Study|Withdrawal by Subject|0|||
170893446|NCT02211261|617617481|FG000|Overall Study|Other|0|||
170893447|NCT02211261|617617482|FG001|Overall Study|Other|0|||
170893448|NCT02211261|617617483|FG002|Overall Study|Other|0|||
170893449|NCT02211261|617617484|FG003|Overall Study|Other|0|||
170893450|NCT02211261|617617485|FG004|Overall Study|Other|0|||
170893451|NCT02211261|617617486|FG005|Overall Study|Other|1|||
170893452|NCT02211261|617617487|FG006|Overall Study|Other|0|||
170893453|NCT02211261|617617488|FG007|Overall Study|Other|0|||
170893454|NCT02211261|617617489|FG008|Overall Study|Other|0|||
170893455|NCT02211261|617617490|FG009|Overall Study|Other|2|||
170893456|NCT02211261|617617491|FG010|Overall Study|Other|0|||
170893457|NCT02211261|617617481|FG000|Overall Study|Lost to Follow-up|0|||
170893458|NCT02211261|617617482|FG001|Overall Study|Lost to Follow-up|0|||
170893459|NCT02211261|617617483|FG002|Overall Study|Lost to Follow-up|0|||
170893460|NCT02211261|617617484|FG003|Overall Study|Lost to Follow-up|0|||
170893461|NCT02211261|617617485|FG004|Overall Study|Lost to Follow-up|0|||
170893462|NCT02211261|617617486|FG005|Overall Study|Lost to Follow-up|0|||
170893463|NCT02211261|617617487|FG006|Overall Study|Lost to Follow-up|0|||
170893464|NCT02211261|617617488|FG007|Overall Study|Lost to Follow-up|1|||
170893465|NCT02211261|617617489|FG008|Overall Study|Lost to Follow-up|0|||
170893466|NCT02211261|617617490|FG009|Overall Study|Lost to Follow-up|0|||
170893467|NCT02211261|617617491|FG010|Overall Study|Lost to Follow-up|0|||
170893468|NCT04062214|617617494|FG000|Week 12|Death|1|||
170893469|NCT04062214|617617495|FG001|Week 12|Death|1|||
170893470|NCT04062214|617617494|FG000|Week 12|Withdrawal by Subject|14|||
170893471|NCT04062214|617617495|FG001|Week 12|Withdrawal by Subject|13|||
170893472|NCT04062214|617617494|FG000|Week 12|Lost to Follow-up|55|||
170893473|NCT04062214|617617495|FG001|Week 12|Lost to Follow-up|68|||
170893474|NCT04062214|617617494|FG000|Week 12|Intermittent missing|31|||
170893475|NCT04062214|617617495|FG001|Week 12|Intermittent missing|29|||
170893476|NCT04062214|617617494|FG000|Week 36|Withdrawal by Subject|4|||
170893477|NCT04062214|617617495|FG001|Week 36|Withdrawal by Subject|5|||
170893478|NCT04062214|617617494|FG000|Week 36|Lost to Follow-up|50|||
170893479|NCT04062214|617617495|FG001|Week 36|Lost to Follow-up|46|||
170893480|NCT04062214|617617494|FG000|Week 36|Death|0|||
170893481|NCT04062214|617617495|FG001|Week 36|Death|1|||
170893482|NCT00865020|617617501|FG000|Overall Study|Withdrawal by Subject|22|||
170893483|NCT00865020|617617502|FG001|Overall Study|Withdrawal by Subject|16|||
170893484|NCT00865020|617617501|FG000|Overall Study|Adverse Event|9|||
170893485|NCT00865020|617617502|FG001|Overall Study|Adverse Event|14|||
170893486|NCT00865020|617617501|FG000|Overall Study|Abnormal test procedure result(s)|6|||
170893487|NCT00865020|617617502|FG001|Overall Study|Abnormal test procedure result(s)|8|||
170893488|NCT00865020|617617501|FG000|Overall Study|Lost to Follow-up|6|||
170893489|NCT00865020|617617502|FG001|Overall Study|Lost to Follow-up|4|||
170893490|NCT00865020|617617501|FG000|Overall Study|Protocol deviation|4|||
170547325|NCT03774810|616350136|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
170547326|NCT03774810|616350137|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
170547327|NCT03774810|616350138|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
170547328|NCT03774810|616350139|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
170547329|NCT03774810|616350140|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
170547330|NCT03774810|616350136|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
170893491|NCT00865020|617617502|FG001|Overall Study|Protocol deviation|1|||
170893492|NCT00865020|617617501|FG000|Overall Study|Administrative problems|0|||
170893493|NCT00865020|617617502|FG001|Overall Study|Administrative problems|2|||
170893494|NCT00865020|617617501|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170893495|NCT00865020|617617502|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170893496|NCT00865020|617617501|FG000|Overall Study|Death|0|||
170893497|NCT00865020|617617502|FG001|Overall Study|Death|1|||
170893498|NCT00865020|617617501|FG000|Overall Study|Randomized but discontinued|2|||
170893499|NCT00865020|617617502|FG001|Overall Study|Randomized but discontinued|4|||
170893500|NCT03406897|617617503|FG000|Overall Study|Lost to Follow-up|1|||
170893501|NCT03406897|617617504|FG001|Overall Study|Lost to Follow-up|2|||
170893502|NCT03406897|617617503|FG000|Overall Study|Withdrawal by Subject|4|||
170893503|NCT03406897|617617504|FG001|Overall Study|Withdrawal by Subject|4|||
170893504|NCT03406897|617617503|FG000|Overall Study|Physician Decision|0|||
170893505|NCT03406897|617617504|FG001|Overall Study|Physician Decision|1|||
170547331|NCT03774810|616350137|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
170547332|NCT03774810|616350138|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
170547333|NCT03774810|616350139|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
170547334|NCT03774810|616350140|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
170547335|NCT02460380|616350142|FG000|Overall Study|Withdrawal by Subject|10|||
170547336|NCT02460380|616350143|FG001|Overall Study|Withdrawal by Subject|5|||
170547337|NCT00395512|616350144|FG000|Overall Study|Adverse Event|3|||
170893506|NCT04047797|617619864|FG000|Overall Study|Progressive Disease|1|||
170893507|NCT01430442|617619865|FG000|Overall Study|Subject Withdrew Consent|3|||
170893508|NCT01430442|617619866|FG001|Overall Study|Subject Withdrew Consent|0|||
170893509|NCT01430442|617619867|FG002|Overall Study|Subject Withdrew Consent|1|||
170893510|NCT01430442|617619868|FG003|Overall Study|Subject Withdrew Consent|0|||
170893511|NCT01430442|617619869|FG004|Overall Study|Subject Withdrew Consent|2|||
170893512|NCT01430442|617619870|FG005|Overall Study|Subject Withdrew Consent|1|||
170893513|NCT01430442|617619871|FG006|Overall Study|Subject Withdrew Consent|5|||
170893514|NCT01430442|617619872|FG007|Overall Study|Subject Withdrew Consent|2|||
170893515|NCT01430442|617619865|FG000|Overall Study|Lost to Follow-up|2|||
170893516|NCT01430442|617619866|FG001|Overall Study|Lost to Follow-up|0|||
170893517|NCT01430442|617619867|FG002|Overall Study|Lost to Follow-up|1|||
170893518|NCT01430442|617619868|FG003|Overall Study|Lost to Follow-up|2|||
170893519|NCT01430442|617619869|FG004|Overall Study|Lost to Follow-up|2|||
170893520|NCT01430442|617619870|FG005|Overall Study|Lost to Follow-up|1|||
170893521|NCT01430442|617619871|FG006|Overall Study|Lost to Follow-up|5|||
170893522|NCT01430442|617619872|FG007|Overall Study|Lost to Follow-up|1|||
170893523|NCT01430442|617619865|FG000|Overall Study|Pregnancy|1|||
170893524|NCT01430442|617619866|FG001|Overall Study|Pregnancy|0|||
170893525|NCT01430442|617619867|FG002|Overall Study|Pregnancy|0|||
170893526|NCT01430442|617619868|FG003|Overall Study|Pregnancy|0|||
170893527|NCT01430442|617619869|FG004|Overall Study|Pregnancy|0|||
170893528|NCT01430442|617619870|FG005|Overall Study|Pregnancy|1|||
170893529|NCT01430442|617619871|FG006|Overall Study|Pregnancy|0|||
170893530|NCT01430442|617619872|FG007|Overall Study|Pregnancy|0|||
170893531|NCT01430442|617619865|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
170893532|NCT01430442|617619866|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
170893533|NCT01430442|617619867|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
170893534|NCT01430442|617619868|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
170893535|NCT01430442|617619869|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
170893536|NCT01430442|617619870|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
170893537|NCT01430442|617619871|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
170893538|NCT01430442|617619872|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
170893539|NCT01171820|617619880|FG000|Overall Study|Death|3|||
170893540|NCT01171820|617619881|FG001|Overall Study|Death|3|||
170893541|NCT01171820|617619880|FG000|Overall Study|Lost to Follow-up|0|||
170893542|NCT01171820|617619881|FG001|Overall Study|Lost to Follow-up|1|||
170893543|NCT01171820|617619880|FG000|Overall Study|Withdrawal by Subject|2|||
170893544|NCT01171820|617619881|FG001|Overall Study|Withdrawal by Subject|0|||
170893545|NCT01171820|617619880|FG000|Overall Study|Physician Decision|0|||
170547338|NCT00395512|616350145|FG001|Overall Study|Adverse Event|8|||
170547339|NCT00395512|616350146|FG002|Overall Study|Adverse Event|6|||
170793400|NCT02038777|617254069|FG001|Overall Study|participation terminated by sponsor|0|||
170893546|NCT01171820|617619881|FG001|Overall Study|Physician Decision|1|||
170893547|NCT01171820|617619880|FG000|Overall Study|1-Year Missed Visit|1|||
170893548|NCT01171820|617619881|FG001|Overall Study|1-Year Missed Visit|1|||
170893549|NCT03969875|617619882|FG000|Overall Study|did not receive allocated intervention|3|||
170893550|NCT03969875|617619883|FG001|Overall Study|did not receive allocated intervention|3|||
170893551|NCT03969875|617619884|FG002|Overall Study|did not receive allocated intervention|4|||
170893552|NCT03969875|617619882|FG000|Overall Study|Protocol Violation|4|||
170793401|NCT02038777|617254070|FG002|Overall Study|participation terminated by sponsor|0|||
170793402|NCT02038777|617254071|FG003|Overall Study|participation terminated by sponsor|0|||
170793403|NCT02038777|617254072|FG004|Overall Study|participation terminated by sponsor|0|||
170793404|NCT02038777|617254073|FG005|Overall Study|participation terminated by sponsor|0|||
170793405|NCT02038777|617254074|FG006|Overall Study|participation terminated by sponsor|1|||
170793406|NCT02038777|617254075|FG007|Overall Study|participation terminated by sponsor|1|||
170793407|NCT04299464|617254076|FG000|Overall Study|Adverse Event|1|||
170893553|NCT03969875|617619883|FG001|Overall Study|Protocol Violation|2|||
170893554|NCT03969875|617619884|FG002|Overall Study|Protocol Violation|2|||
170893555|NCT00167245|617619885|FG000|Overall Study|Lost to Follow-up|20|||
170893556|NCT00167245|617619886|FG001|Overall Study|Lost to Follow-up|31|||
170893557|NCT00167245|617619885|FG000|Overall Study|Withdrawal by Subject|5|||
170893558|NCT00167245|617619886|FG001|Overall Study|Withdrawal by Subject|8|||
170893559|NCT00167245|617619885|FG000|Overall Study|Incarcerated|3|||
170893560|NCT00167245|617619886|FG001|Overall Study|Incarcerated|2|||
170893561|NCT00167245|617619885|FG000|Overall Study|Drowsy|1|||
170893562|NCT00167245|617619886|FG001|Overall Study|Drowsy|0|||
170893563|NCT02911688|617619889|FG000|Washout|Lost to Follow-up|1|||
170893564|NCT02911688|617619890|FG001|Washout|Lost to Follow-up|1|||
170893565|NCT02911688|617619889|FG000|Washout|Withdrawal by Subject|0|||
170893566|NCT02911688|617619890|FG001|Washout|Withdrawal by Subject|1|||
170893567|NCT00947531|617619891|FG000|Overall Study|Withdrawal by Subject|10|||
170893568|NCT00947531|617619892|FG001|Overall Study|Withdrawal by Subject|7|||
170893569|NCT00947531|617619891|FG000|Overall Study|Administrative Reason|0|||
170893570|NCT00947531|617619892|FG001|Overall Study|Administrative Reason|1|||
170893571|NCT00947531|617619891|FG000|Overall Study|Adverse Event|2|||
170893572|NCT00947531|617619892|FG001|Overall Study|Adverse Event|2|||
170893573|NCT00947531|617619891|FG000|Overall Study|Lack of Efficacy|1|||
170893574|NCT00947531|617619892|FG001|Overall Study|Lack of Efficacy|0|||
170893575|NCT00947531|617619891|FG000|Overall Study|Other|1|||
170893576|NCT00947531|617619892|FG001|Overall Study|Other|1|||
170893577|NCT00851903|617619893|FG000|Overall Study|Withdrawal by Subject|2|||
170893578|NCT00270894|617619894|FG000|Overall Study|Adverse Event|1|||
170893579|NCT00270894|617619894|FG000|Overall Study|Withdrawal by Subject|1|||
170893580|NCT01070329|617619895|FG000|Overall Study|Adverse Event|13|||
170893581|NCT01070329|617619896|FG001|Overall Study|Adverse Event|10|||
170893582|NCT01070329|617619895|FG000|Overall Study|Lost to Follow-up|22|||
170547340|NCT00395512|616350147|FG003|Overall Study|Adverse Event|6|||
170547341|NCT00395512|616350144|FG000|Overall Study|Protocol Violation|2|||
170547342|NCT00395512|616350145|FG001|Overall Study|Protocol Violation|3|||
170547343|NCT00395512|616350146|FG002|Overall Study|Protocol Violation|6|||
170547344|NCT00395512|616350147|FG003|Overall Study|Protocol Violation|7|||
170547345|NCT00395512|616350144|FG000|Overall Study|Lost to Follow-up|2|||
170547346|NCT00395512|616350145|FG001|Overall Study|Lost to Follow-up|6|||
170547347|NCT00395512|616350146|FG002|Overall Study|Lost to Follow-up|5|||
170547348|NCT00395512|616350147|FG003|Overall Study|Lost to Follow-up|5|||
170547349|NCT00395512|616350144|FG000|Overall Study|Withdrawal by Subject|6|||
170547350|NCT00395512|616350145|FG001|Overall Study|Withdrawal by Subject|5|||
170547351|NCT00395512|616350146|FG002|Overall Study|Withdrawal by Subject|5|||
170547352|NCT00395512|616350147|FG003|Overall Study|Withdrawal by Subject|12|||
170547353|NCT00395512|616350144|FG000|Overall Study|Physician Decision|6|||
170547354|NCT00395512|616350145|FG001|Overall Study|Physician Decision|4|||
170547355|NCT00395512|616350146|FG002|Overall Study|Physician Decision|2|||
170547356|NCT00395512|616350147|FG003|Overall Study|Physician Decision|2|||
170547357|NCT00395512|616350144|FG000|Overall Study|Other|1|||
170547358|NCT00395512|616350145|FG001|Overall Study|Other|1|||
170547359|NCT00395512|616350146|FG002|Overall Study|Other|0|||
170547360|NCT00395512|616350147|FG003|Overall Study|Other|0|||
170547361|NCT00395512|616350144|FG000|Overall Study|Hyperglycemic Rescue|18|||
170547362|NCT00395512|616350145|FG001|Overall Study|Hyperglycemic Rescue|10|||
170547363|NCT00395512|616350146|FG002|Overall Study|Hyperglycemic Rescue|4|||
170547364|NCT00395512|616350147|FG003|Overall Study|Hyperglycemic Rescue|6|||
170547365|NCT01986751|616350148|FG000|Overall Study|improperly consented|10|||
170547366|NCT01986751|616350149|FG001|Overall Study|improperly consented|2|||
170547367|NCT01478087|616350154|FG000|Overall Study|due to sponsor closing study|1|||
170547368|NCT03501277|616350163|FG000|Intervention Period 1 (4 Days)|Other|0|||
170547369|NCT03501277|616350164|FG001|Intervention Period 1 (4 Days)|Other|0|||
170547370|NCT03501277|616350165|FG002|Intervention Period 1 (4 Days)|Other|1|||
170547371|NCT03501277|616350166|FG003|Intervention Period 1 (4 Days)|Other|0|||
170547372|NCT03501277|616350163|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
170547373|NCT03501277|616350164|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
170547374|NCT03501277|616350165|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
170547375|NCT03501277|616350166|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
170893583|NCT01070329|617619896|FG001|Overall Study|Lost to Follow-up|12|||
170893584|NCT01070329|617619895|FG000|Overall Study|Withdrawal by Subject|9|||
170893585|NCT01070329|617619896|FG001|Overall Study|Withdrawal by Subject|11|||
170893586|NCT01070329|617619895|FG000|Overall Study|Protocol Violation|3|||
170893587|NCT01070329|617619896|FG001|Overall Study|Protocol Violation|8|||
170893588|NCT01070329|617619895|FG000|Overall Study|Lack of Efficacy|2|||
170893589|NCT01070329|617619896|FG001|Overall Study|Lack of Efficacy|6|||
170893590|NCT01070329|617619895|FG000|Overall Study|Physician Decision|2|||
170893591|NCT01070329|617619896|FG001|Overall Study|Physician Decision|1|||
170893592|NCT01070329|617619895|FG000|Overall Study|Entry Criteria Not Met|1|||
170893593|NCT01070329|617619896|FG001|Overall Study|Entry Criteria Not Met|0|||
170547376|NCT03501277|616350163|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
170547377|NCT03501277|616350164|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
170547378|NCT03501277|616350165|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
170893594|NCT01070329|617619895|FG000|Overall Study|Sponsor Decision|0|||
170893595|NCT01070329|617619896|FG001|Overall Study|Sponsor Decision|1|||
170547379|NCT03501277|616350166|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
170547380|NCT03501277|616350163|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
170547381|NCT03501277|616350164|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
170793408|NCT04299464|617254077|FG001|Overall Study|Adverse Event|0|||
170793409|NCT04299464|617254078|FG002|Overall Study|Adverse Event|2|||
170793410|NCT04299464|617254076|FG000|Overall Study|Non-compliance with Study Drug|1|||
170793411|NCT04299464|617254077|FG001|Overall Study|Non-compliance with Study Drug|0|||
170793412|NCT04299464|617254078|FG002|Overall Study|Non-compliance with Study Drug|0|||
170793413|NCT04299464|617254076|FG000|Overall Study|Reason not Specified|0|||
170793414|NCT04299464|617254077|FG001|Overall Study|Reason not Specified|1|||
170793415|NCT04299464|617254078|FG002|Overall Study|Reason not Specified|3|||
170793416|NCT04299464|617254076|FG000|Overall Study|Physician Decision|0|||
170793417|NCT04299464|617254077|FG001|Overall Study|Physician Decision|1|||
170793418|NCT04299464|617254078|FG002|Overall Study|Physician Decision|1|||
170793419|NCT04299464|617254076|FG000|Overall Study|Withdrawal by Subject|0|||
170793420|NCT04299464|617254077|FG001|Overall Study|Withdrawal by Subject|2|||
170793421|NCT04299464|617254078|FG002|Overall Study|Withdrawal by Subject|1|||
170793422|NCT03676192|617254079|FG000|Induction Study Period|Adverse Event|21|||
170793423|NCT03676192|617254080|FG001|Induction Study Period|Adverse Event|20|||
170793424|NCT03676192|617254079|FG000|Induction Study Period|Death|23|||
170793425|NCT03676192|617254080|FG001|Induction Study Period|Death|20|||
170793426|NCT03676192|617254079|FG000|Induction Study Period|Lost to Follow-up|3|||
170793427|NCT03676192|617254080|FG001|Induction Study Period|Lost to Follow-up|3|||
170793428|NCT03676192|617254079|FG000|Induction Study Period|Physician Decision|6|||
170793429|NCT03676192|617254080|FG001|Induction Study Period|Physician Decision|3|||
170793430|NCT03676192|617254079|FG000|Induction Study Period|Progressive Disease|32|||
170793431|NCT03676192|617254080|FG001|Induction Study Period|Progressive Disease|21|||
170793432|NCT03676192|617254079|FG000|Induction Study Period|Protocol Violation|1|||
170793433|NCT03676192|617254080|FG001|Induction Study Period|Protocol Violation|2|||
170793434|NCT03676192|617254079|FG000|Induction Study Period|Withdrawal by Subject|20|||
170793435|NCT03676192|617254080|FG001|Induction Study Period|Withdrawal by Subject|15|||
170793436|NCT03386578|617254082|FG000|PK Component|Lost to Follow-up|0|||
170793437|NCT03386578|617254083|FG001|PK Component|Lost to Follow-up|1|||
170793438|NCT03386578|617254084|FG002|PK Component|Lost to Follow-up|0|||
170793439|NCT03386578|617254085|FG003|PK Component|Lost to Follow-up|0|||
170793440|NCT03386578|617254086|FG004|PK Component|Lost to Follow-up|0|||
170793441|NCT03386578|617254087|FG005|PK Component|Lost to Follow-up|0|||
170793442|NCT03386578|617254088|FG006|PK Component|Lost to Follow-up|1|||
170793443|NCT03386578|617254089|FG007|PK Component|Lost to Follow-up|0|||
170793444|NCT03386578|617254090|FG008|PK Component|Lost to Follow-up|0|||
170793445|NCT03386578|617254091|FG009|PK Component|Lost to Follow-up|0|||
170793446|NCT03386578|617254082|FG000|PK Component|Stillbirth/Abortion|0|||
170793447|NCT03386578|617254083|FG001|PK Component|Stillbirth/Abortion|0|||
170793448|NCT03386578|617254084|FG002|PK Component|Stillbirth/Abortion|0|||
170793449|NCT03386578|617254085|FG003|PK Component|Stillbirth/Abortion|0|||
170793450|NCT03386578|617254086|FG004|PK Component|Stillbirth/Abortion|0|||
170793451|NCT03386578|617254087|FG005|PK Component|Stillbirth/Abortion|2|||
170793452|NCT03386578|617254088|FG006|PK Component|Stillbirth/Abortion|0|||
170793453|NCT03386578|617254089|FG007|PK Component|Stillbirth/Abortion|0|||
170793454|NCT03386578|617254090|FG008|PK Component|Stillbirth/Abortion|0|||
170793455|NCT03386578|617254091|FG009|PK Component|Stillbirth/Abortion|0|||
170793456|NCT03386578|617254082|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
170793457|NCT03386578|617254083|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
170793458|NCT03386578|617254084|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
170793459|NCT03386578|617254085|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
170793460|NCT03386578|617254086|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
170793461|NCT03386578|617254087|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
170793462|NCT03386578|617254088|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
170793463|NCT03386578|617254089|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
170793464|NCT03386578|617254090|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
170793465|NCT03386578|617254091|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
170793466|NCT03386578|617254082|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
170793467|NCT03386578|617254083|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
170793468|NCT03386578|617254084|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
170793469|NCT03386578|617254085|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
170793470|NCT03386578|617254086|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
170793471|NCT03386578|617254087|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
170793472|NCT03386578|617254088|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
170793473|NCT03386578|617254089|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
170793474|NCT03386578|617254090|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
170793475|NCT03386578|617254091|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
170639523|NCT02873377|616691309|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
170639524|NCT01583296|616691312|FG000|Overall Study|Withdrawal by Subject|11|||
170639525|NCT01583296|616691313|FG001|Overall Study|Withdrawal by Subject|10|||
170639526|NCT01063283|616691314|FG000|Cycle 1|Adverse Event|2|||
170639527|NCT01063283|616691315|FG001|Cycle 1|Adverse Event|0|||
170639528|NCT01063283|616691316|FG002|Cycle 1|Adverse Event|0|||
170639529|NCT01063283|616691314|FG000|Cycle 1|Technical failure in data collection|1|||
170639530|NCT01063283|616691315|FG001|Cycle 1|Technical failure in data collection|0|||
170639531|NCT01063283|616691316|FG002|Cycle 1|Technical failure in data collection|0|||
170639532|NCT01737502|616691321|FG000|Phase I|Disease progression|2|||
170639533|NCT01737502|616691322|FG001|Phase I|Disease progression|3|||
170639534|NCT01737502|616691321|FG000|Phase I|Complicating disease|1|||
170639535|NCT01737502|616691322|FG001|Phase I|Complicating disease|0|||
170639536|NCT01737502|616691321|FG000|Phase II|Adverse Event|0|||
170639537|NCT01737502|616691322|FG001|Phase II|Adverse Event|3|||
170639538|NCT01737502|616691321|FG000|Phase II|Disease progression|0|||
170639539|NCT01737502|616691322|FG001|Phase II|Disease progression|18|||
170793476|NCT03386578|617254082|FG000|PrEP Comparison Component Step 1|Death|0|||
170793477|NCT03386578|617254083|FG001|PrEP Comparison Component Step 1|Death|0|||
170793478|NCT03386578|617254084|FG002|PrEP Comparison Component Step 1|Death|1|||
170793479|NCT03386578|617254085|FG003|PrEP Comparison Component Step 1|Death|0|||
170793480|NCT03386578|617254086|FG004|PrEP Comparison Component Step 1|Death|0|||
170793481|NCT03386578|617254087|FG005|PrEP Comparison Component Step 1|Death|0|||
170793482|NCT03386578|617254088|FG006|PrEP Comparison Component Step 1|Death|0|||
170793483|NCT03386578|617254089|FG007|PrEP Comparison Component Step 1|Death|9|||
170793484|NCT03386578|617254090|FG008|PrEP Comparison Component Step 1|Death|5|||
170793485|NCT03386578|617254091|FG009|PrEP Comparison Component Step 1|Death|0|||
170793486|NCT03386578|617254082|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
170793487|NCT03386578|617254083|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
170793488|NCT03386578|617254084|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
170793489|NCT03386578|617254085|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
170793490|NCT03386578|617254086|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
170793491|NCT03386578|617254087|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
170793492|NCT03386578|617254088|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
170793493|NCT03386578|617254089|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
170793494|NCT03386578|617254090|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
170793495|NCT03386578|617254091|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
170793496|NCT03386578|617254082|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
170793497|NCT03386578|617254083|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
170793498|NCT03386578|617254084|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
170793499|NCT03386578|617254085|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
170793500|NCT03386578|617254086|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
170793501|NCT03386578|617254087|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
170793502|NCT03386578|617254088|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
170793503|NCT03386578|617254089|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
170793504|NCT03386578|617254090|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
170793505|NCT03386578|617254091|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
170793506|NCT03386578|617254082|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
170793507|NCT03386578|617254083|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
170793508|NCT03386578|617254084|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
170793509|NCT03386578|617254085|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
170793510|NCT03386578|617254086|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
170793511|NCT03386578|617254087|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
170793512|NCT03386578|617254088|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
170793513|NCT03386578|617254089|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
170793514|NCT03386578|617254090|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
170793515|NCT03386578|617254091|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
170793516|NCT02424617|617254092|FG000|Overall Study|Adverse Event|0|||
170793517|NCT02424617|617254093|FG001|Overall Study|Adverse Event|1|||
170793518|NCT02424617|617254094|FG002|Overall Study|Adverse Event|0|||
170793519|NCT02424617|617254095|FG003|Overall Study|Adverse Event|0|||
170793520|NCT02424617|617254092|FG000|Overall Study|Investigator Decision|0|||
170793521|NCT02424617|617254093|FG001|Overall Study|Investigator Decision|0|||
170793522|NCT02424617|617254094|FG002|Overall Study|Investigator Decision|0|||
170478139|NCT00595621|616090475|FG001|Open Label Run in|Withdrawal by Subject|0|||
170639540|NCT01737502|616691321|FG000|Phase II|Death|0|||
170639541|NCT01737502|616691322|FG001|Phase II|Death|1|||
170639542|NCT01737502|616691321|FG000|Phase II|Transition to hospice care|0|||
170639543|NCT01737502|616691322|FG001|Phase II|Transition to hospice care|1|||
170639544|NCT04073225|616691323|FG000|Overall Study|Lost to Follow-up|4|||
170893596|NCT05742984|617619897|FG000|Overall Study|Adverse Event|0|||
170893597|NCT05742984|617619898|FG001|Overall Study|Adverse Event|0|||
170893598|NCT05742984|617619899|FG002|Overall Study|Adverse Event|1|||
170893599|NCT05742984|617619900|FG003|Overall Study|Adverse Event|0|||
170893600|NCT05742984|617619901|FG004|Overall Study|Adverse Event|1|||
170893601|NCT05742984|617619902|FG005|Overall Study|Adverse Event|1|||
170893602|NCT05742984|617619897|FG000|Overall Study|Withdrawal by Subject|0|||
170893603|NCT05742984|617619898|FG001|Overall Study|Withdrawal by Subject|1|||
170893604|NCT05742984|617619899|FG002|Overall Study|Withdrawal by Subject|0|||
170893605|NCT05742984|617619900|FG003|Overall Study|Withdrawal by Subject|0|||
170893606|NCT05742984|617619901|FG004|Overall Study|Withdrawal by Subject|0|||
170893607|NCT05742984|617619902|FG005|Overall Study|Withdrawal by Subject|2|||
170893608|NCT03980938|617619910|FG000|Treatment Period 1|Study Terminated|1|||
170893609|NCT03980938|617619911|FG001|Treatment Period 1|Study Terminated|1|||
170893610|NCT03980938|617619910|FG000|Treatment Period 2|Study Terminated|2|||
170893611|NCT03980938|617619911|FG001|Treatment Period 2|Study Terminated|2|||
170893612|NCT03116113|617619912|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
170547382|NCT03501277|616350165|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
170793523|NCT02424617|617254095|FG003|Overall Study|Investigator Decision|1|||
170793524|NCT02424617|617254092|FG000|Overall Study|Withdrawal by Subject|1|||
170793525|NCT02424617|617254093|FG001|Overall Study|Withdrawal by Subject|1|||
170793526|NCT02424617|617254094|FG002|Overall Study|Withdrawal by Subject|0|||
170793527|NCT02424617|617254095|FG003|Overall Study|Withdrawal by Subject|1|||
170793528|NCT02424617|617254092|FG000|Overall Study|Progressive Disease|7|||
170793529|NCT02424617|617254093|FG001|Overall Study|Progressive Disease|6|||
170793530|NCT02424617|617254094|FG002|Overall Study|Progressive Disease|11|||
170793531|NCT02424617|617254095|FG003|Overall Study|Progressive Disease|10|||
170793532|NCT02424617|617254092|FG000|Overall Study|Other|0|||
170793533|NCT02424617|617254093|FG001|Overall Study|Other|0|||
170793534|NCT02424617|617254094|FG002|Overall Study|Other|0|||
170793535|NCT02424617|617254095|FG003|Overall Study|Other|1|||
170793536|NCT05370040|617254098|FG000|Overall Study|Lost to Follow-up|0|||
170793537|NCT05370040|617254099|FG001|Overall Study|Lost to Follow-up|0|||
170793538|NCT05370040|617254100|FG002|Overall Study|Lost to Follow-up|1|||
170793539|NCT05370040|617254101|FG003|Overall Study|Lost to Follow-up|0|||
170793540|NCT05370040|617254102|FG004|Overall Study|Lost to Follow-up|1|||
170793541|NCT05370040|617254103|FG005|Overall Study|Lost to Follow-up|0|||
170793542|NCT04314778|617254114|FG000|Overall Study|Lost to Follow-up|5|||
170793543|NCT04314778|617254115|FG001|Overall Study|Lost to Follow-up|3|||
170793544|NCT05646355|617254118|FG000|Overall Study|Lost to Follow-up|1|||
170793545|NCT05646355|617254119|FG001|Overall Study|Lost to Follow-up|0|||
170793546|NCT05646355|617254118|FG000|Overall Study|translated materials not available for pilot|2|||
170793547|NCT05646355|617254119|FG001|Overall Study|translated materials not available for pilot|0|||
170793548|NCT05646355|617254118|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
170793549|NCT05646355|617254119|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
170793550|NCT03523572|617254120|FG000|Dose Escalation|Progressive disease|1|||
170793551|NCT03523572|617254121|FG001|Dose Escalation|Progressive disease|0|||
170793552|NCT03523572|617254122|FG002|Dose Escalation|Progressive disease|0|||
170793553|NCT03523572|617254123|FG003|Dose Escalation|Progressive disease|0|||
170793554|NCT03523572|617254124|FG004|Dose Escalation|Progressive disease|0|||
170793555|NCT03523572|617254125|FG005|Dose Escalation|Progressive disease|0|||
170793556|NCT03523572|617254120|FG000|Dose Escalation|Clinical Progression|0|||
170793557|NCT03523572|617254121|FG001|Dose Escalation|Clinical Progression|1|||
170793558|NCT03523572|617254122|FG002|Dose Escalation|Clinical Progression|0|||
170793559|NCT03523572|617254123|FG003|Dose Escalation|Clinical Progression|0|||
170793560|NCT03523572|617254124|FG004|Dose Escalation|Clinical Progression|0|||
170547383|NCT03501277|616350166|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
170547384|NCT02280499|616350168|FG000|Overall Study|Death|14|||
170547385|NCT02280499|616350168|FG000|Overall Study|Lost to Follow-up|42|||
170547386|NCT02280499|616350168|FG000|Overall Study|Adverse Event|5|||
170547387|NCT01968785|616350172|FG000|Overall Study|Withdrawal by Subject|1|||
170547388|NCT01968785|616350173|FG001|Overall Study|Withdrawal by Subject|0|||
170547389|NCT00098293|616350174|FG000|Double-blind (DB) Phase|Adverse Event|14|||
170793561|NCT03523572|617254125|FG005|Dose Escalation|Clinical Progression|0|||
170547390|NCT00098293|616350175|FG001|Double-blind (DB) Phase|Adverse Event|27|||
170547391|NCT00098293|616350176|FG002|Double-blind (DB) Phase|Adverse Event|60|||
170793562|NCT03523572|617254120|FG000|Dose Escalation|Adverse Event|2|||
170793563|NCT03523572|617254121|FG001|Dose Escalation|Adverse Event|0|||
170793564|NCT03523572|617254122|FG002|Dose Escalation|Adverse Event|0|||
170793565|NCT03523572|617254123|FG003|Dose Escalation|Adverse Event|0|||
170793566|NCT03523572|617254124|FG004|Dose Escalation|Adverse Event|0|||
170793567|NCT03523572|617254125|FG005|Dose Escalation|Adverse Event|0|||
170793568|NCT03523572|617254120|FG000|Dose Escalation|Physician Decision|1|||
170793569|NCT03523572|617254121|FG001|Dose Escalation|Physician Decision|1|||
170793570|NCT03523572|617254122|FG002|Dose Escalation|Physician Decision|0|||
170893613|NCT03116113|617619913|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
170547392|NCT00098293|616350177|FG003|Double-blind (DB) Phase|Adverse Event|0|||
170547393|NCT00098293|616350178|FG004|Double-blind (DB) Phase|Adverse Event|0|||
170547394|NCT00098293|616350174|FG000|Double-blind (DB) Phase|Pregnancy|0|||
170547395|NCT00098293|616350175|FG001|Double-blind (DB) Phase|Pregnancy|7|||
170547396|NCT00098293|616350176|FG002|Double-blind (DB) Phase|Pregnancy|9|||
170547397|NCT00098293|616350177|FG003|Double-blind (DB) Phase|Pregnancy|0|||
170547398|NCT00098293|616350178|FG004|Double-blind (DB) Phase|Pregnancy|0|||
170547399|NCT00098293|616350174|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
170547400|NCT00098293|616350175|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
170547401|NCT00098293|616350176|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
170547402|NCT00098293|616350177|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
170547403|NCT00098293|616350178|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
170547404|NCT00098293|616350174|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
170547405|NCT00098293|616350175|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
170547406|NCT00098293|616350176|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
170547407|NCT00098293|616350177|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
170547408|NCT00098293|616350178|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
170547409|NCT00098293|616350174|FG000|Double-blind (DB) Phase|Death|1|||
170547410|NCT00098293|616350175|FG001|Double-blind (DB) Phase|Death|2|||
170547411|NCT00098293|616350176|FG002|Double-blind (DB) Phase|Death|2|||
170547412|NCT00098293|616350177|FG003|Double-blind (DB) Phase|Death|0|||
170547413|NCT00098293|616350178|FG004|Double-blind (DB) Phase|Death|0|||
170793571|NCT03523572|617254123|FG003|Dose Escalation|Physician Decision|0|||
170793572|NCT03523572|617254124|FG004|Dose Escalation|Physician Decision|0|||
170793573|NCT03523572|617254125|FG005|Dose Escalation|Physician Decision|0|||
170793574|NCT03523572|617254120|FG000|Dose Expansion|Progressive Disease|0|||
170793575|NCT03523572|617254121|FG001|Dose Expansion|Progressive Disease|0|||
170793576|NCT03523572|617254122|FG002|Dose Expansion|Progressive Disease|9|||
170793577|NCT03523572|617254123|FG003|Dose Expansion|Progressive Disease|11|||
170793578|NCT03523572|617254124|FG004|Dose Expansion|Progressive Disease|15|||
170793579|NCT03523572|617254125|FG005|Dose Expansion|Progressive Disease|2|||
170793580|NCT03523572|617254120|FG000|Dose Expansion|Clinical Progression|0|||
170793581|NCT03523572|617254121|FG001|Dose Expansion|Clinical Progression|0|||
170793582|NCT03523572|617254122|FG002|Dose Expansion|Clinical Progression|2|||
170793583|NCT03523572|617254123|FG003|Dose Expansion|Clinical Progression|2|||
170793584|NCT03523572|617254124|FG004|Dose Expansion|Clinical Progression|2|||
170793585|NCT03523572|617254125|FG005|Dose Expansion|Clinical Progression|0|||
170793586|NCT03523572|617254120|FG000|Dose Expansion|Adverse Event|0|||
170793587|NCT03523572|617254121|FG001|Dose Expansion|Adverse Event|0|||
170793588|NCT03523572|617254122|FG002|Dose Expansion|Adverse Event|10|||
170793589|NCT03523572|617254123|FG003|Dose Expansion|Adverse Event|1|||
170793590|NCT03523572|617254124|FG004|Dose Expansion|Adverse Event|5|||
170793591|NCT03523572|617254125|FG005|Dose Expansion|Adverse Event|2|||
170793592|NCT03523572|617254120|FG000|Dose Expansion|Withdrawal by Subject|0|||
170793593|NCT03523572|617254121|FG001|Dose Expansion|Withdrawal by Subject|0|||
170793594|NCT03523572|617254122|FG002|Dose Expansion|Withdrawal by Subject|1|||
170793595|NCT03523572|617254123|FG003|Dose Expansion|Withdrawal by Subject|1|||
170793596|NCT03523572|617254124|FG004|Dose Expansion|Withdrawal by Subject|0|||
170793597|NCT03523572|617254125|FG005|Dose Expansion|Withdrawal by Subject|0|||
170793598|NCT03523572|617254120|FG000|Dose Expansion|Physician Decision|0|||
170793599|NCT03523572|617254121|FG001|Dose Expansion|Physician Decision|0|||
170793600|NCT03523572|617254122|FG002|Dose Expansion|Physician Decision|1|||
170793601|NCT03523572|617254123|FG003|Dose Expansion|Physician Decision|0|||
170793602|NCT03523572|617254124|FG004|Dose Expansion|Physician Decision|1|||
170793603|NCT03523572|617254125|FG005|Dose Expansion|Physician Decision|0|||
170793604|NCT03523572|617254120|FG000|Dose Expansion|Miscellaneous|0|||
170793605|NCT03523572|617254121|FG001|Dose Expansion|Miscellaneous|0|||
170793606|NCT03523572|617254122|FG002|Dose Expansion|Miscellaneous|0|||
170793607|NCT03523572|617254123|FG003|Dose Expansion|Miscellaneous|0|||
170793608|NCT03523572|617254124|FG004|Dose Expansion|Miscellaneous|3|||
170793609|NCT03523572|617254125|FG005|Dose Expansion|Miscellaneous|0|||
170793610|NCT02240238|617254129|FG000|Phase 1|Adverse Event|0|||
170793611|NCT02240238|617254130|FG001|Phase 1|Adverse Event|0|||
170793612|NCT02240238|617254131|FG002|Phase 1|Adverse Event|0|||
170793613|NCT02240238|617254132|FG003|Phase 1|Adverse Event|0|||
170793614|NCT02240238|617254133|FG004|Phase 1|Adverse Event|0|||
170793615|NCT02240238|617254134|FG005|Phase 1|Adverse Event|0|||
170793616|NCT02240238|617254135|FG006|Phase 1|Adverse Event|3|||
170793617|NCT02240238|617254136|FG007|Phase 1|Adverse Event|1|||
170793618|NCT02240238|617254137|FG008|Phase 1|Adverse Event|0|||
170793619|NCT02240238|617254138|FG009|Phase 1|Adverse Event|0|||
170793620|NCT02240238|617254139|FG010|Phase 1|Adverse Event|0|||
170547414|NCT00098293|616350174|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
170547415|NCT00098293|616350175|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
170793621|NCT02240238|617254140|FG011|Phase 1|Adverse Event|0|||
170793622|NCT02240238|617254129|FG000|Phase 1|Death|0|||
170793623|NCT02240238|617254130|FG001|Phase 1|Death|0|||
170547416|NCT00098293|616350176|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
170793624|NCT02240238|617254131|FG002|Phase 1|Death|0|||
170893614|NCT03116113|617619914|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
170893615|NCT03116113|617619915|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
170893616|NCT03116113|617619916|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
170893617|NCT03116113|617619917|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
170893618|NCT03116113|617619918|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
170893619|NCT03116113|617619919|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
170893620|NCT03116113|617619920|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
170893621|NCT05195528|617619921|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
170893622|NCT05195528|617619922|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
170893623|NCT05195528|617619923|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
170893624|NCT05195528|617619924|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
170893625|NCT05195528|617619925|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
170893626|NCT05195528|617619921|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
170893627|NCT05195528|617619922|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
170893628|NCT05195528|617619923|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
170893629|NCT05195528|617619924|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
170893630|NCT05195528|617619925|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
170893631|NCT05195528|617619921|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
170893632|NCT05195528|617619922|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
170893633|NCT05195528|617619923|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
170893634|NCT05195528|617619924|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
170893635|NCT05195528|617619925|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
170893636|NCT05195528|617619921|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
170893637|NCT05195528|617619922|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
170893638|NCT05195528|617619923|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
170893639|NCT05195528|617619924|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
170893640|NCT05195528|617619925|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
170893641|NCT05195528|617619921|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
170893642|NCT05195528|617619922|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
170893643|NCT05195528|617619923|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
170893644|NCT05195528|617619924|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
170893645|NCT05195528|617619925|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
170893646|NCT05195528|617619921|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
170893647|NCT05195528|617619922|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
170893648|NCT05195528|617619923|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
170893649|NCT05195528|617619924|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
170893650|NCT05195528|617619925|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
170893651|NCT05195528|617619921|FG000|Placebo-controlled Treatment Period|Other|0|||
170893652|NCT05195528|617619922|FG001|Placebo-controlled Treatment Period|Other|0|||
170893653|NCT05195528|617619923|FG002|Placebo-controlled Treatment Period|Other|1|||
170893654|NCT05195528|617619924|FG003|Placebo-controlled Treatment Period|Other|0|||
170893655|NCT05195528|617619925|FG004|Placebo-controlled Treatment Period|Other|0|||
170893656|NCT05195528|617619921|FG000|Extension Period|PTE or AE or SAE|0|||
170893657|NCT05195528|617619922|FG001|Extension Period|PTE or AE or SAE|4|||
170893658|NCT05195528|617619923|FG002|Extension Period|PTE or AE or SAE|5|||
170893659|NCT05195528|617619924|FG003|Extension Period|PTE or AE or SAE|4|||
170893660|NCT05195528|617619925|FG004|Extension Period|PTE or AE or SAE|4|||
170893661|NCT05195528|617619921|FG000|Extension Period|Protocol Violation|0|||
170893662|NCT05195528|617619922|FG001|Extension Period|Protocol Violation|2|||
170893663|NCT05195528|617619923|FG002|Extension Period|Protocol Violation|1|||
170893664|NCT05195528|617619924|FG003|Extension Period|Protocol Violation|0|||
170893665|NCT05195528|617619925|FG004|Extension Period|Protocol Violation|1|||
170893666|NCT05195528|617619921|FG000|Extension Period|Lost to Follow-up|0|||
170893667|NCT05195528|617619922|FG001|Extension Period|Lost to Follow-up|6|||
170893668|NCT05195528|617619923|FG002|Extension Period|Lost to Follow-up|13|||
170893669|NCT05195528|617619924|FG003|Extension Period|Lost to Follow-up|3|||
170893670|NCT05195528|617619925|FG004|Extension Period|Lost to Follow-up|7|||
170547417|NCT00098293|616350177|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
170547418|NCT00098293|616350178|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
170547419|NCT00098293|616350174|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
170893671|NCT05195528|617619921|FG000|Extension Period|Withdrawal by Subject|0|||
170893672|NCT05195528|617619922|FG001|Extension Period|Withdrawal by Subject|12|||
170893673|NCT05195528|617619923|FG002|Extension Period|Withdrawal by Subject|9|||
170893674|NCT05195528|617619924|FG003|Extension Period|Withdrawal by Subject|6|||
170547420|NCT00098293|616350175|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
170893675|NCT05195528|617619925|FG004|Extension Period|Withdrawal by Subject|5|||
170893676|NCT05195528|617619921|FG000|Extension Period|Lack of Efficacy|0|||
170893677|NCT05195528|617619922|FG001|Extension Period|Lack of Efficacy|3|||
170893678|NCT05195528|617619923|FG002|Extension Period|Lack of Efficacy|0|||
170893679|NCT05195528|617619924|FG003|Extension Period|Lack of Efficacy|0|||
170893680|NCT05195528|617619925|FG004|Extension Period|Lack of Efficacy|2|||
170893681|NCT05195528|617619921|FG000|Extension Period|Not Treated|0|||
170893682|NCT05195528|617619922|FG001|Extension Period|Not Treated|0|||
170893683|NCT05195528|617619923|FG002|Extension Period|Not Treated|2|||
170893684|NCT05195528|617619924|FG003|Extension Period|Not Treated|3|||
170893685|NCT05195528|617619925|FG004|Extension Period|Not Treated|0|||
170893686|NCT05195528|617619921|FG000|Extension Period|Other|0|||
170547421|NCT00098293|616350176|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
170547422|NCT00098293|616350177|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
170547423|NCT00098293|616350178|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
170547424|NCT00098293|616350174|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
170547425|NCT00098293|616350175|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
170547426|NCT00098293|616350176|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
170547427|NCT00098293|616350177|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
170547428|NCT00098293|616350178|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
170547429|NCT00098293|616350174|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
170547430|NCT00098293|616350175|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
170547431|NCT00098293|616350176|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
170547432|NCT00098293|616350177|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
170547433|NCT00098293|616350178|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
170547434|NCT00098293|616350174|FG000|Open-label (OL) Phase|Adverse Event|0|||
170547435|NCT00098293|616350175|FG001|Open-label (OL) Phase|Adverse Event|3|||
170547436|NCT00098293|616350176|FG002|Open-label (OL) Phase|Adverse Event|7|||
170547437|NCT00098293|616350177|FG003|Open-label (OL) Phase|Adverse Event|6|||
170547438|NCT00098293|616350178|FG004|Open-label (OL) Phase|Adverse Event|0|||
170547439|NCT00098293|616350174|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
170547440|NCT00098293|616350175|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
170547441|NCT00098293|616350176|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
170547442|NCT00098293|616350177|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
170547443|NCT00098293|616350178|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
170547444|NCT00098293|616350174|FG000|Open-label (OL) Phase|Pregnancy|0|||
170547445|NCT00098293|616350175|FG001|Open-label (OL) Phase|Pregnancy|1|||
170547446|NCT00098293|616350176|FG002|Open-label (OL) Phase|Pregnancy|0|||
170547447|NCT00098293|616350177|FG003|Open-label (OL) Phase|Pregnancy|3|||
170547448|NCT00098293|616350178|FG004|Open-label (OL) Phase|Pregnancy|0|||
170547449|NCT00098293|616350174|FG000|Open-label (OL) Phase|Protocol Violation|0|||
170547450|NCT00098293|616350175|FG001|Open-label (OL) Phase|Protocol Violation|6|||
170547451|NCT00098293|616350176|FG002|Open-label (OL) Phase|Protocol Violation|13|||
170547452|NCT00098293|616350177|FG003|Open-label (OL) Phase|Protocol Violation|16|||
170547453|NCT00098293|616350178|FG004|Open-label (OL) Phase|Protocol Violation|0|||
170547454|NCT00098293|616350174|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
170547455|NCT00098293|616350175|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
170547456|NCT00098293|616350176|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
170547457|NCT00098293|616350177|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
170547458|NCT00098293|616350178|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
170547459|NCT00098293|616350174|FG000|Open-label (OL) Phase|Death|0|||
170547460|NCT00098293|616350175|FG001|Open-label (OL) Phase|Death|2|||
170547461|NCT00098293|616350176|FG002|Open-label (OL) Phase|Death|3|||
170547462|NCT00098293|616350177|FG003|Open-label (OL) Phase|Death|0|||
170793625|NCT02240238|617254132|FG003|Phase 1|Death|0|||
170793626|NCT02240238|617254133|FG004|Phase 1|Death|0|||
170793627|NCT02240238|617254134|FG005|Phase 1|Death|1|||
170793628|NCT02240238|617254135|FG006|Phase 1|Death|0|||
170793629|NCT02240238|617254136|FG007|Phase 1|Death|0|||
170793630|NCT02240238|617254137|FG008|Phase 1|Death|0|||
170793631|NCT02240238|617254138|FG009|Phase 1|Death|0|||
170793632|NCT02240238|617254139|FG010|Phase 1|Death|0|||
170793633|NCT02240238|617254140|FG011|Phase 1|Death|0|||
170793634|NCT02240238|617254129|FG000|Phase 1|Sponsor termination|0|||
170793635|NCT02240238|617254130|FG001|Phase 1|Sponsor termination|0|||
170793636|NCT02240238|617254131|FG002|Phase 1|Sponsor termination|0|||
170793637|NCT02240238|617254132|FG003|Phase 1|Sponsor termination|0|||
170793638|NCT02240238|617254133|FG004|Phase 1|Sponsor termination|0|||
170793639|NCT02240238|617254134|FG005|Phase 1|Sponsor termination|1|||
170793640|NCT02240238|617254135|FG006|Phase 1|Sponsor termination|0|||
170793641|NCT02240238|617254136|FG007|Phase 1|Sponsor termination|0|||
170793642|NCT02240238|617254137|FG008|Phase 1|Sponsor termination|0|||
170547463|NCT00098293|616350178|FG004|Open-label (OL) Phase|Death|0|||
170547464|NCT00098293|616350174|FG000|Supplemental Phase (SP)|Death|0|||
170793643|NCT02240238|617254138|FG009|Phase 1|Sponsor termination|0|||
170793644|NCT02240238|617254139|FG010|Phase 1|Sponsor termination|0|||
170793645|NCT02240238|617254140|FG011|Phase 1|Sponsor termination|0|||
170893687|NCT05195528|617619922|FG001|Extension Period|Other|1|||
170478140|NCT00595621|616090474|FG000|Randomization and Study|Adverse Event|2|||
170478141|NCT00595621|616090475|FG001|Randomization and Study|Adverse Event|0|||
170478142|NCT00595621|616090474|FG000|Randomization and Study|Withdrawal by Subject|0|||
170478143|NCT00595621|616090475|FG001|Randomization and Study|Withdrawal by Subject|1|||
170478144|NCT02440464|616090476|FG000|Overall Study|Withdrawal by Subject|3|||
170478145|NCT02440464|616090477|FG001|Overall Study|Withdrawal by Subject|2|||
170478146|NCT00324987|616090478|FG000|Overall Study|Adverse Event|2|||
170478147|NCT00324987|616090479|FG001|Overall Study|Adverse Event|1|||
170478148|NCT00324987|616090478|FG000|Overall Study|Withdrawal by Subject|1|||
170478149|NCT00324987|616090479|FG001|Overall Study|Withdrawal by Subject|1|||
170478150|NCT00324987|616090478|FG000|Overall Study|Progression|1|||
170478151|NCT00324987|616090479|FG001|Overall Study|Progression|1|||
170478152|NCT00324987|616090478|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
170478153|NCT00324987|616090479|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
170478154|NCT04747470|616090480|FG000|Overall Study|Death|0|||
170478155|NCT04747470|616090481|FG001|Overall Study|Death|3|||
170478156|NCT04747470|616090482|FG002|Overall Study|Death|2|||
170478157|NCT04747470|616090483|FG003|Overall Study|Death|2|||
170478158|NCT04747470|616090484|FG004|Overall Study|Death|2|||
170478159|NCT04747470|616090485|FG005|Overall Study|Death|0|||
170478160|NCT04747470|616090486|FG006|Overall Study|Death|0|||
170478161|NCT04747470|616090487|FG007|Overall Study|Death|0|||
170478162|NCT04747470|616090488|FG008|Overall Study|Death|0|||
170478163|NCT04747470|616090489|FG009|Overall Study|Death|0|||
170478164|NCT04747470|616090490|FG010|Overall Study|Death|0|||
170478165|NCT04747470|616090480|FG000|Overall Study|Withdrew Consent|0|||
170478166|NCT04747470|616090481|FG001|Overall Study|Withdrew Consent|0|||
170478167|NCT04747470|616090482|FG002|Overall Study|Withdrew Consent|0|||
170478168|NCT04747470|616090483|FG003|Overall Study|Withdrew Consent|1|||
170478169|NCT04747470|616090484|FG004|Overall Study|Withdrew Consent|0|||
170478170|NCT04747470|616090485|FG005|Overall Study|Withdrew Consent|0|||
170478171|NCT04747470|616090486|FG006|Overall Study|Withdrew Consent|0|||
170478172|NCT04747470|616090487|FG007|Overall Study|Withdrew Consent|0|||
170478173|NCT04747470|616090488|FG008|Overall Study|Withdrew Consent|0|||
170478174|NCT04747470|616090489|FG009|Overall Study|Withdrew Consent|0|||
170478175|NCT04747470|616090490|FG010|Overall Study|Withdrew Consent|0|||
170478176|NCT04747470|616090480|FG000|Overall Study|Study Terminated by Sponsor|0|||
170478177|NCT04747470|616090481|FG001|Overall Study|Study Terminated by Sponsor|0|||
170478178|NCT04747470|616090482|FG002|Overall Study|Study Terminated by Sponsor|1|||
170478179|NCT04747470|616090483|FG003|Overall Study|Study Terminated by Sponsor|0|||
170478180|NCT04747470|616090484|FG004|Overall Study|Study Terminated by Sponsor|2|||
170478181|NCT04747470|616090485|FG005|Overall Study|Study Terminated by Sponsor|0|||
170478182|NCT04747470|616090486|FG006|Overall Study|Study Terminated by Sponsor|0|||
170478183|NCT04747470|616090487|FG007|Overall Study|Study Terminated by Sponsor|0|||
170478184|NCT04747470|616090488|FG008|Overall Study|Study Terminated by Sponsor|0|||
170478185|NCT04747470|616090489|FG009|Overall Study|Study Terminated by Sponsor|0|||
170478186|NCT04747470|616090490|FG010|Overall Study|Study Terminated by Sponsor|0|||
170478187|NCT02968576|616090492|FG000|Overall Study|Pregnancy|0|||
170478188|NCT02968576|616090493|FG001|Overall Study|Pregnancy|1|||
170478189|NCT02058069|616090496|FG000|Overall Study|Exclusion due to implant size|5|||
170478190|NCT02058069|616090496|FG000|Overall Study|Withdrawal by Subject|6|||
170478191|NCT02222922|616090497|FG000|Overall Study|Death|0|||
170478192|NCT02222922|616090498|FG001|Overall Study|Death|0|||
170478193|NCT02222922|616090499|FG002|Overall Study|Death|0|||
170478194|NCT02222922|616090500|FG003|Overall Study|Death|0|||
170478195|NCT02222922|616090501|FG004|Overall Study|Death|13|||
170478196|NCT02222922|616090502|FG005|Overall Study|Death|0|||
170478197|NCT02222922|616090503|FG006|Overall Study|Death|0|||
170478198|NCT02222922|616090504|FG007|Overall Study|Death|0|||
170478199|NCT02222922|616090505|FG008|Overall Study|Death|2|||
170478200|NCT02222922|616090497|FG000|Overall Study|Lost to Follow-up|0|||
170478201|NCT02222922|616090498|FG001|Overall Study|Lost to Follow-up|0|||
170478202|NCT02222922|616090499|FG002|Overall Study|Lost to Follow-up|1|||
170478203|NCT02222922|616090500|FG003|Overall Study|Lost to Follow-up|0|||
170478204|NCT02222922|616090501|FG004|Overall Study|Lost to Follow-up|9|||
170478205|NCT02222922|616090502|FG005|Overall Study|Lost to Follow-up|1|||
170478206|NCT02222922|616090503|FG006|Overall Study|Lost to Follow-up|0|||
170478207|NCT02222922|616090504|FG007|Overall Study|Lost to Follow-up|0|||
170478208|NCT02222922|616090505|FG008|Overall Study|Lost to Follow-up|0|||
170478209|NCT02222922|616090497|FG000|Overall Study|Other|0|||
170478210|NCT02222922|616090498|FG001|Overall Study|Other|0|||
170478211|NCT02222922|616090499|FG002|Overall Study|Other|0|||
170478212|NCT02222922|616090500|FG003|Overall Study|Other|2|||
170478213|NCT02222922|616090501|FG004|Overall Study|Other|10|||
170478214|NCT02222922|616090502|FG005|Overall Study|Other|2|||
170478215|NCT02222922|616090503|FG006|Overall Study|Other|2|||
170478216|NCT02222922|616090504|FG007|Overall Study|Other|4|||
170478217|NCT02222922|616090505|FG008|Overall Study|Other|1|||
170478218|NCT02222922|616090497|FG000|Overall Study|Participant refused further follow-up|1|||
170478219|NCT02222922|616090498|FG001|Overall Study|Participant refused further follow-up|0|||
170478220|NCT02222922|616090499|FG002|Overall Study|Participant refused further follow-up|0|||
170793646|NCT02240238|617254129|FG000|Phase 1|Withdrawal by Subject|0|||
170793647|NCT02240238|617254130|FG001|Phase 1|Withdrawal by Subject|0|||
170478221|NCT02222922|616090500|FG003|Overall Study|Participant refused further follow-up|1|||
170478222|NCT02222922|616090501|FG004|Overall Study|Participant refused further follow-up|6|||
170478223|NCT02222922|616090502|FG005|Overall Study|Participant refused further follow-up|0|||
170478224|NCT02222922|616090503|FG006|Overall Study|Participant refused further follow-up|0|||
170478225|NCT02222922|616090504|FG007|Overall Study|Participant refused further follow-up|0|||
170478226|NCT02222922|616090505|FG008|Overall Study|Participant refused further follow-up|3|||
170478227|NCT02568072|616090511|FG000|Overall Study|Unavailable for appointment|23|||
170478228|NCT02568072|616090511|FG000|Overall Study|Unable to contact|3|||
170478229|NCT02568072|616090511|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
170478230|NCT02568072|616090511|FG000|Overall Study|Withdrawal by Subject|1|||
170478231|NCT02568072|616090511|FG000|Overall Study|Sustained injury, marathon not run|24|||
170478232|NCT00897715|616090512|FG000|Overall Study|Lost to Follow-up|0|||
170478233|NCT00897715|616090513|FG001|Overall Study|Lost to Follow-up|1|||
170793648|NCT02240238|617254131|FG002|Phase 1|Withdrawal by Subject|0|||
170793649|NCT02240238|617254132|FG003|Phase 1|Withdrawal by Subject|0|||
170478234|NCT00897715|616090512|FG000|Overall Study|Physician Decision|1|||
170478235|NCT00897715|616090513|FG001|Overall Study|Physician Decision|0|||
170478236|NCT00897715|616090512|FG000|Overall Study|increased risk of infection|1|||
170478237|NCT00897715|616090513|FG001|Overall Study|increased risk of infection|0|||
170478238|NCT00927589|616090515|FG000|Overall Study|Death|1|||
170478239|NCT00927589|616090515|FG000|Overall Study|Physician Decision|1|||
170478240|NCT00927589|616090515|FG000|Overall Study|Withdrawal by Subject|3|||
170793650|NCT02240238|617254133|FG004|Phase 1|Withdrawal by Subject|0|||
170793651|NCT02240238|617254134|FG005|Phase 1|Withdrawal by Subject|2|||
170793652|NCT02240238|617254135|FG006|Phase 1|Withdrawal by Subject|0|||
170793653|NCT02240238|617254136|FG007|Phase 1|Withdrawal by Subject|0|||
170793654|NCT02240238|617254137|FG008|Phase 1|Withdrawal by Subject|0|||
170793655|NCT02240238|617254138|FG009|Phase 1|Withdrawal by Subject|0|||
170793656|NCT02240238|617254139|FG010|Phase 1|Withdrawal by Subject|0|||
170793657|NCT02240238|617254140|FG011|Phase 1|Withdrawal by Subject|0|||
170793658|NCT02240238|617254129|FG000|Phase 1|Physician Decision|0|||
170793659|NCT02240238|617254130|FG001|Phase 1|Physician Decision|0|||
170793660|NCT02240238|617254131|FG002|Phase 1|Physician Decision|0|||
170478241|NCT00927589|616090515|FG000|Overall Study|Adverse Event|2|||
170793661|NCT02240238|617254132|FG003|Phase 1|Physician Decision|0|||
170793662|NCT02240238|617254133|FG004|Phase 1|Physician Decision|0|||
170893688|NCT05195528|617619923|FG002|Extension Period|Other|1|||
170893689|NCT05195528|617619924|FG003|Extension Period|Other|0|||
170893690|NCT05195528|617619925|FG004|Extension Period|Other|0|||
170893691|NCT01552902|617619926|FG000|Overall Study|Adverse Event|1|||
170893692|NCT01552902|617619927|FG001|Overall Study|Adverse Event|15|||
170893693|NCT01552902|617619928|FG002|Overall Study|Adverse Event|14|||
170893694|NCT01552902|617619926|FG000|Overall Study|Protocol Violation|3|||
170893695|NCT01552902|617619927|FG001|Overall Study|Protocol Violation|3|||
170893696|NCT01552902|617619928|FG002|Overall Study|Protocol Violation|3|||
170893697|NCT01552902|617619926|FG000|Overall Study|Lack of Efficacy|4|||
170893698|NCT01552902|617619927|FG001|Overall Study|Lack of Efficacy|3|||
170893699|NCT01552902|617619928|FG002|Overall Study|Lack of Efficacy|1|||
170893700|NCT01552902|617619926|FG000|Overall Study|Withdrawal by Subject|1|||
170893701|NCT01552902|617619927|FG001|Overall Study|Withdrawal by Subject|9|||
170893702|NCT01552902|617619928|FG002|Overall Study|Withdrawal by Subject|6|||
170893703|NCT01552902|617619926|FG000|Overall Study|Lost to Follow-up|1|||
170893704|NCT01552902|617619927|FG001|Overall Study|Lost to Follow-up|3|||
170893705|NCT01552902|617619928|FG002|Overall Study|Lost to Follow-up|6|||
170893706|NCT01552902|617619926|FG000|Overall Study|Other|3|||
170893707|NCT01552902|617619927|FG001|Overall Study|Other|4|||
170893708|NCT01552902|617619928|FG002|Overall Study|Other|3|||
170893709|NCT02487108|617619931|FG000|Overall Study|Adverse Event|1|||
170893710|NCT02487108|617619932|FG001|Overall Study|Adverse Event|6|||
170893711|NCT02487108|617619933|FG002|Overall Study|Adverse Event|12|||
170893712|NCT02487108|617619934|FG003|Overall Study|Adverse Event|6|||
170893713|NCT02487108|617619931|FG000|Overall Study|Withdrawal by Subject|8|||
170893714|NCT02487108|617619932|FG001|Overall Study|Withdrawal by Subject|5|||
170893715|NCT02487108|617619933|FG002|Overall Study|Withdrawal by Subject|5|||
170893716|NCT02487108|617619934|FG003|Overall Study|Withdrawal by Subject|0|||
170893717|NCT02487108|617619931|FG000|Overall Study|Non-compliance to study medication|3|||
170893718|NCT02487108|617619932|FG001|Overall Study|Non-compliance to study medication|2|||
170893719|NCT02487108|617619933|FG002|Overall Study|Non-compliance to study medication|5|||
170893720|NCT02487108|617619934|FG003|Overall Study|Non-compliance to study medication|4|||
170893721|NCT02487108|617619931|FG000|Overall Study|Protocol Violation|1|||
170893722|NCT02487108|617619932|FG001|Overall Study|Protocol Violation|1|||
170893723|NCT02487108|617619933|FG002|Overall Study|Protocol Violation|2|||
170893724|NCT02487108|617619934|FG003|Overall Study|Protocol Violation|0|||
170893725|NCT02487108|617619931|FG000|Overall Study|Non-compliance to study procedures|0|||
170893726|NCT02487108|617619932|FG001|Overall Study|Non-compliance to study procedures|0|||
170893727|NCT02487108|617619933|FG002|Overall Study|Non-compliance to study procedures|0|||
170893728|NCT02487108|617619934|FG003|Overall Study|Non-compliance to study procedures|1|||
170893729|NCT02487108|617619931|FG000|Overall Study|Other than specified|3|||
170893730|NCT02487108|617619932|FG001|Overall Study|Other than specified|2|||
170893731|NCT02487108|617619933|FG002|Overall Study|Other than specified|2|||
170893732|NCT02487108|617619934|FG003|Overall Study|Other than specified|0|||
170893733|NCT02367521|617619935|FG000|Overall Study|severe headache after intervention|2|||
170893734|NCT02367521|617619936|FG001|Overall Study|severe headache after intervention|0|||
170893735|NCT02367521|617619935|FG000|Overall Study|unable to find transportation|2|||
170893736|NCT02367521|617619936|FG001|Overall Study|unable to find transportation|0|||
170893737|NCT00469612|617619937|FG000|Overall Study|Study terminated before data collected|2|||
170893738|NCT00469612|617619938|FG001|Overall Study|Study terminated before data collected|0|||
170893739|NCT02720757|617619939|FG000|Overall Study|Other reason|5|||
170893740|NCT02720757|617619939|FG000|Overall Study|Loss of contact|4|||
170893741|NCT02720757|617619939|FG000|Overall Study|Informed consent withdrawal|1|||
170893742|NCT02720757|617619939|FG000|Overall Study|Patients wish to withdraw|2|||
170893743|NCT02720757|617619939|FG000|Overall Study|Missing|3|||
170893744|NCT02720757|617619939|FG000|Overall Study|General exclusion|3|||
170893745|NCT00883493|617619940|FG000|Overall Study|Adverse Event|11|||
170893746|NCT00883493|617619941|FG001|Overall Study|Adverse Event|12|||
170893747|NCT00883493|617619940|FG000|Overall Study|Lack of Efficacy|4|||
170893748|NCT00883493|617619941|FG001|Overall Study|Lack of Efficacy|3|||
170893749|NCT00883493|617619940|FG000|Overall Study|Lost to Follow-up|7|||
170893750|NCT00883493|617619941|FG001|Overall Study|Lost to Follow-up|6|||
170893751|NCT00883493|617619940|FG000|Overall Study|Withdrawal by Subject|11|||
170893752|NCT00883493|617619941|FG001|Overall Study|Withdrawal by Subject|20|||
170893753|NCT00883493|617619940|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
170893754|NCT00883493|617619941|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
170893755|NCT00883493|617619940|FG000|Overall Study|Study specific disc. criteria|2|||
170893756|NCT00883493|617619941|FG001|Overall Study|Study specific disc. criteria|0|||
170893757|NCT00883493|617619940|FG000|Overall Study|Other|5|||
170893758|NCT00883493|617619941|FG001|Overall Study|Other|3|||
170893759|NCT02522767|617619943|FG000|Double-blind|Withdrawal by Subject|8|||
170893760|NCT02522767|617619944|FG001|Double-blind|Withdrawal by Subject|11|||
170893761|NCT02522767|617619943|FG000|Double-blind|Lost to Follow-up|1|||
170793663|NCT02240238|617254134|FG005|Phase 1|Physician Decision|2|||
170793664|NCT02240238|617254135|FG006|Phase 1|Physician Decision|0|||
170793665|NCT02240238|617254136|FG007|Phase 1|Physician Decision|0|||
170793666|NCT02240238|617254137|FG008|Phase 1|Physician Decision|0|||
170793667|NCT02240238|617254138|FG009|Phase 1|Physician Decision|0|||
170793668|NCT02240238|617254139|FG010|Phase 1|Physician Decision|0|||
170793669|NCT02240238|617254140|FG011|Phase 1|Physician Decision|0|||
170793670|NCT02240238|617254129|FG000|Phase 2|Adverse Event|0|||
170793671|NCT02240238|617254130|FG001|Phase 2|Adverse Event|0|||
170793672|NCT02240238|617254131|FG002|Phase 2|Adverse Event|0|||
170793673|NCT02240238|617254132|FG003|Phase 2|Adverse Event|0|||
170793674|NCT02240238|617254133|FG004|Phase 2|Adverse Event|0|||
170793675|NCT02240238|617254134|FG005|Phase 2|Adverse Event|0|||
170793676|NCT02240238|617254135|FG006|Phase 2|Adverse Event|0|||
170793677|NCT02240238|617254136|FG007|Phase 2|Adverse Event|0|||
170793678|NCT02240238|617254137|FG008|Phase 2|Adverse Event|0|||
170793679|NCT02240238|617254138|FG009|Phase 2|Adverse Event|7|||
170793680|NCT02240238|617254139|FG010|Phase 2|Adverse Event|14|||
170793681|NCT02240238|617254140|FG011|Phase 2|Adverse Event|2|||
170793682|NCT02240238|617254129|FG000|Phase 2|Death|0|||
170793683|NCT02240238|617254130|FG001|Phase 2|Death|0|||
170793684|NCT02240238|617254131|FG002|Phase 2|Death|0|||
170793685|NCT02240238|617254132|FG003|Phase 2|Death|0|||
170793686|NCT02240238|617254133|FG004|Phase 2|Death|0|||
170793687|NCT02240238|617254134|FG005|Phase 2|Death|0|||
170793688|NCT02240238|617254135|FG006|Phase 2|Death|0|||
170793689|NCT02240238|617254136|FG007|Phase 2|Death|0|||
170793690|NCT02240238|617254137|FG008|Phase 2|Death|0|||
170793691|NCT02240238|617254138|FG009|Phase 2|Death|3|||
170793692|NCT02240238|617254139|FG010|Phase 2|Death|2|||
170793693|NCT02240238|617254140|FG011|Phase 2|Death|1|||
170793694|NCT02240238|617254129|FG000|Phase 2|Disease progression|0|||
170793695|NCT02240238|617254130|FG001|Phase 2|Disease progression|0|||
170793696|NCT02240238|617254131|FG002|Phase 2|Disease progression|0|||
170793697|NCT02240238|617254132|FG003|Phase 2|Disease progression|0|||
170793698|NCT02240238|617254133|FG004|Phase 2|Disease progression|0|||
170793699|NCT02240238|617254134|FG005|Phase 2|Disease progression|0|||
170793700|NCT02240238|617254135|FG006|Phase 2|Disease progression|0|||
170793701|NCT02240238|617254136|FG007|Phase 2|Disease progression|0|||
170793702|NCT02240238|617254137|FG008|Phase 2|Disease progression|0|||
170793703|NCT02240238|617254138|FG009|Phase 2|Disease progression|5|||
170793704|NCT02240238|617254139|FG010|Phase 2|Disease progression|11|||
170793705|NCT02240238|617254140|FG011|Phase 2|Disease progression|1|||
170793706|NCT02240238|617254129|FG000|Phase 2|Withdrawal by Subject|0|||
170793707|NCT02240238|617254130|FG001|Phase 2|Withdrawal by Subject|0|||
170793708|NCT02240238|617254131|FG002|Phase 2|Withdrawal by Subject|0|||
170793709|NCT02240238|617254132|FG003|Phase 2|Withdrawal by Subject|0|||
170793710|NCT02240238|617254133|FG004|Phase 2|Withdrawal by Subject|0|||
170793711|NCT02240238|617254134|FG005|Phase 2|Withdrawal by Subject|0|||
170793712|NCT02240238|617254135|FG006|Phase 2|Withdrawal by Subject|0|||
170793713|NCT02240238|617254136|FG007|Phase 2|Withdrawal by Subject|0|||
170793714|NCT02240238|617254137|FG008|Phase 2|Withdrawal by Subject|0|||
170793715|NCT02240238|617254138|FG009|Phase 2|Withdrawal by Subject|1|||
170793716|NCT02240238|617254139|FG010|Phase 2|Withdrawal by Subject|1|||
170793717|NCT02240238|617254140|FG011|Phase 2|Withdrawal by Subject|0|||
170793718|NCT02240238|617254129|FG000|Phase 2|Physician Decision|0|||
170793719|NCT02240238|617254130|FG001|Phase 2|Physician Decision|0|||
170478242|NCT00927589|616090515|FG000|Overall Study|Disease Progression|8|||
170478243|NCT00927589|616090515|FG000|Overall Study|Non-compliance|1|||
170478244|NCT00707239|616090516|FG000|Overall Study|Adverse Event|5|||
170478245|NCT00707239|616090517|FG001|Overall Study|Adverse Event|3|||
170478246|NCT00707239|616090518|FG002|Overall Study|Adverse Event|2|||
170478247|NCT00707239|616090516|FG000|Overall Study|Death|3|||
170478248|NCT00707239|616090517|FG001|Overall Study|Death|1|||
170478249|NCT00707239|616090518|FG002|Overall Study|Death|3|||
170478250|NCT00707239|616090516|FG000|Overall Study|Physician Decision|1|||
170478251|NCT00707239|616090517|FG001|Overall Study|Physician Decision|1|||
170478252|NCT00707239|616090518|FG002|Overall Study|Physician Decision|2|||
170478253|NCT00707239|616090516|FG000|Overall Study|Protocol Violation|0|||
170478254|NCT00707239|616090517|FG001|Overall Study|Protocol Violation|0|||
170478255|NCT00707239|616090518|FG002|Overall Study|Protocol Violation|1|||
170478256|NCT00707239|616090516|FG000|Overall Study|Lack of Efficacy|1|||
170478257|NCT00707239|616090517|FG001|Overall Study|Lack of Efficacy|2|||
170478258|NCT00707239|616090518|FG002|Overall Study|Lack of Efficacy|0|||
170478259|NCT00707239|616090516|FG000|Overall Study|Randomized, but not treated|1|||
170478260|NCT00707239|616090517|FG001|Overall Study|Randomized, but not treated|1|||
170478261|NCT00707239|616090518|FG002|Overall Study|Randomized, but not treated|1|||
170478262|NCT00707239|616090516|FG000|Overall Study|Other|8|||
170478263|NCT00707239|616090517|FG001|Overall Study|Other|3|||
170478264|NCT00707239|616090518|FG002|Overall Study|Other|5|||
170478265|NCT03875508|616090519|FG000|Overall Study|Adverse Event|1|||
170478266|NCT03875508|616090519|FG000|Overall Study|Lost to Follow-up|8|||
170478267|NCT03875508|616090519|FG000|Overall Study|Lack of Efficacy|1|||
170478268|NCT03875508|616090519|FG000|Overall Study|Other, not specified|2|||
170478269|NCT00711087|616090520|FG000|Overall Study|Lost to Follow-up|1|||
170478270|NCT00711087|616090521|FG001|Overall Study|Lost to Follow-up|0|||
170478271|NCT02394600|616090522|FG000|Overall Study|Adverse Event|3|||
170478272|NCT02394600|616090523|FG001|Overall Study|Adverse Event|0|||
170478273|NCT02394600|616090522|FG000|Overall Study|Lost to Follow-up|0|||
170478274|NCT02394600|616090523|FG001|Overall Study|Lost to Follow-up|1|||
170478275|NCT02394600|616090522|FG000|Overall Study|Withdrawal by Subject|0|||
170478276|NCT02394600|616090523|FG001|Overall Study|Withdrawal by Subject|1|||
170478277|NCT02394600|616090522|FG000|Overall Study|Protocol Violation|1|||
170478278|NCT02394600|616090523|FG001|Overall Study|Protocol Violation|0|||
170478279|NCT02569801|616090524|FG000|Overall Study|Withdrawal by Subject|9|||
170478280|NCT02569801|616090525|FG001|Overall Study|Withdrawal by Subject|9|||
170478281|NCT02569801|616090524|FG000|Overall Study|Sponsor Decision|13|||
170478282|NCT02569801|616090525|FG001|Overall Study|Sponsor Decision|14|||
170478283|NCT02569801|616090524|FG000|Overall Study|Progressive Disease|2|||
170478284|NCT02569801|616090525|FG001|Overall Study|Progressive Disease|7|||
170478285|NCT02569801|616090524|FG000|Overall Study|Lost to Follow-up|0|||
170478286|NCT02569801|616090525|FG001|Overall Study|Lost to Follow-up|1|||
170478287|NCT02569801|616090524|FG000|Overall Study|Death|12|||
170478288|NCT02569801|616090525|FG001|Overall Study|Death|4|||
170478289|NCT01928472|616090531|FG000|Overall Study|Death|0|||
170478290|NCT01928472|616090532|FG001|Overall Study|Death|0|||
170478291|NCT01928472|616090533|FG002|Overall Study|Death|1|||
170478292|NCT01928472|616090534|FG003|Overall Study|Death|0|||
170478293|NCT01928472|616090531|FG000|Overall Study|Withdrawal by Subject|4|||
170478294|NCT01928472|616090532|FG001|Overall Study|Withdrawal by Subject|4|||
170478295|NCT01928472|616090533|FG002|Overall Study|Withdrawal by Subject|1|||
170478296|NCT01928472|616090534|FG003|Overall Study|Withdrawal by Subject|2|||
170478297|NCT01928472|616090531|FG000|Overall Study|Lost to Follow-up|2|||
170478298|NCT01928472|616090532|FG001|Overall Study|Lost to Follow-up|3|||
170478299|NCT01928472|616090533|FG002|Overall Study|Lost to Follow-up|4|||
170478300|NCT01928472|616090534|FG003|Overall Study|Lost to Follow-up|0|||
170478301|NCT01928472|616090531|FG000|Overall Study|Administrative Reason|2|||
170478302|NCT01928472|616090532|FG001|Overall Study|Administrative Reason|1|||
170478303|NCT01928472|616090533|FG002|Overall Study|Administrative Reason|0|||
170478304|NCT01928472|616090534|FG003|Overall Study|Administrative Reason|0|||
170478305|NCT01928472|616090531|FG000|Overall Study|Unclassified|0|||
170478306|NCT01928472|616090532|FG001|Overall Study|Unclassified|0|||
170478307|NCT01928472|616090533|FG002|Overall Study|Unclassified|1|||
170478308|NCT01928472|616090534|FG003|Overall Study|Unclassified|0|||
170478309|NCT00613171|616090539|FG000|Overall Study|Adverse Event|7|||
170478310|NCT00613171|616090539|FG000|Overall Study|Withdrawal by Subject|3|||
170478311|NCT00613171|616090539|FG000|Overall Study|Reason not Specified|4|||
170893762|NCT02522767|617619944|FG001|Double-blind|Lost to Follow-up|0|||
170893763|NCT02522767|617619943|FG000|Double-blind|Adverse Event|1|||
170893764|NCT02522767|617619944|FG001|Double-blind|Adverse Event|10|||
170893765|NCT02522767|617619943|FG000|Double-blind|Protocol Violation|0|||
170893766|NCT02522767|617619944|FG001|Double-blind|Protocol Violation|1|||
170893767|NCT02522767|617619943|FG000|Double-blind|Lack of Efficacy|0|||
170893768|NCT02522767|617619944|FG001|Double-blind|Lack of Efficacy|2|||
170893769|NCT02522767|617619943|FG000|Double-blind|Protocol Deviation|1|||
170893770|NCT02522767|617619944|FG001|Double-blind|Protocol Deviation|0|||
170893771|NCT02522767|617619943|FG000|Open-label|Withdrawal by Subject|2|||
170893772|NCT02522767|617619944|FG001|Open-label|Withdrawal by Subject|3|||
170893773|NCT02522767|617619943|FG000|Open-label|Lost to Follow-up|0|||
170893774|NCT02522767|617619944|FG001|Open-label|Lost to Follow-up|1|||
170893775|NCT02522767|617619943|FG000|Open-label|Adverse Event|2|||
170893776|NCT02522767|617619944|FG001|Open-label|Adverse Event|1|||
170893777|NCT02522767|617619943|FG000|Open-label|Lack of Efficacy|1|||
170893778|NCT02522767|617619944|FG001|Open-label|Lack of Efficacy|1|||
170893779|NCT02522767|617619943|FG000|Open-label|Protocol Violation|0|||
170893780|NCT02522767|617619944|FG001|Open-label|Protocol Violation|1|||
170893781|NCT00434967|617619945|FG000|Overall Study|Adverse Event|2|||
170893782|NCT00434967|617619946|FG001|Overall Study|Adverse Event|4|||
170893783|NCT00434967|617619947|FG002|Overall Study|Adverse Event|3|||
170893784|NCT00434967|617619948|FG003|Overall Study|Adverse Event|3|||
170793720|NCT02240238|617254131|FG002|Phase 2|Physician Decision|0|||
170793721|NCT02240238|617254132|FG003|Phase 2|Physician Decision|0|||
170793722|NCT02240238|617254133|FG004|Phase 2|Physician Decision|0|||
170793723|NCT02240238|617254134|FG005|Phase 2|Physician Decision|0|||
170793724|NCT02240238|617254135|FG006|Phase 2|Physician Decision|0|||
170793725|NCT02240238|617254136|FG007|Phase 2|Physician Decision|0|||
170793726|NCT02240238|617254137|FG008|Phase 2|Physician Decision|0|||
170793727|NCT02240238|617254138|FG009|Phase 2|Physician Decision|1|||
170793728|NCT02240238|617254139|FG010|Phase 2|Physician Decision|3|||
170793729|NCT02240238|617254140|FG011|Phase 2|Physician Decision|0|||
170793730|NCT02240238|617254129|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793731|NCT02240238|617254130|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793732|NCT02240238|617254131|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793733|NCT02240238|617254132|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170893785|NCT00434967|617619945|FG000|Overall Study|Lost to Follow-up|0|||
170893786|NCT00434967|617619946|FG001|Overall Study|Lost to Follow-up|0|||
170893787|NCT00434967|617619947|FG002|Overall Study|Lost to Follow-up|1|||
170893788|NCT00434967|617619948|FG003|Overall Study|Lost to Follow-up|0|||
170893789|NCT00434967|617619945|FG000|Overall Study|Withdrawal by Subject|2|||
170478312|NCT04870710|616090545|FG000|Overall Study|Lost to Follow-up|3|||
170478313|NCT00476190|616090546|FG000|Overall Study|Ineligible|1|||
170478314|NCT00476190|616090547|FG001|Overall Study|Ineligible|1|||
170478315|NCT00476190|616090546|FG000|Overall Study|Induction Death|2|||
170478316|NCT00476190|616090547|FG001|Overall Study|Induction Death|0|||
170478317|NCT00476190|616090546|FG000|Overall Study|Induction Failure|2|||
170478318|NCT00476190|616090547|FG001|Overall Study|Induction Failure|4|||
170478319|NCT00476190|616090546|FG000|Overall Study|Lost to Follow-up|1|||
170478320|NCT00476190|616090547|FG001|Overall Study|Lost to Follow-up|0|||
170478321|NCT00476190|616090546|FG000|Overall Study|Relapse/Progression|5|||
170478322|NCT00476190|616090547|FG001|Overall Study|Relapse/Progression|2|||
170478323|NCT00476190|616090546|FG000|Overall Study|Remission Death|0|||
170478324|NCT00476190|616090547|FG001|Overall Study|Remission Death|1|||
170478325|NCT00476190|616090546|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
170478326|NCT00476190|616090547|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
170478327|NCT00476190|616090546|FG000|Overall Study|Withdrawal by Subject|6|||
170478328|NCT00476190|616090547|FG001|Overall Study|Withdrawal by Subject|2|||
170478329|NCT00476190|616090546|FG000|Overall Study|Other|9|||
170478330|NCT00476190|616090547|FG001|Overall Study|Other|10|||
170478331|NCT02860546|616090548|FG000|Overall Study|Clinical Progression|6|||
170478332|NCT02860546|616090548|FG000|Overall Study|Radiological Progression|12|||
170478333|NCT02553772|616090549|FG000|Overall Study|Adverse Event|2|||
170478334|NCT02553772|616090550|FG001|Overall Study|Adverse Event|3|||
170478335|NCT02553772|616090549|FG000|Overall Study|Lost to Follow-up|2|||
170478336|NCT02553772|616090550|FG001|Overall Study|Lost to Follow-up|1|||
170478337|NCT02553772|616090549|FG000|Overall Study|Withdrawal of Consent|1|||
170478338|NCT02553772|616090550|FG001|Overall Study|Withdrawal of Consent|1|||
170478339|NCT02553772|616090549|FG000|Overall Study|Lack of Efficacy|1|||
170478340|NCT02553772|616090550|FG001|Overall Study|Lack of Efficacy|0|||
170893790|NCT00434967|617619946|FG001|Overall Study|Withdrawal by Subject|2|||
170478341|NCT02553772|616090549|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170478342|NCT02553772|616090550|FG001|Overall Study|Other Miscellaneous Reasons|1|||
170478343|NCT02466321|616090551|FG000|Overall Study|Death|26|||
170478344|NCT02466321|616090551|FG000|Overall Study|Revision|6|||
170478345|NCT02466321|616090551|FG000|Overall Study|Lost to Follow-up|60|||
170893791|NCT00434967|617619947|FG002|Overall Study|Withdrawal by Subject|4|||
170793734|NCT02240238|617254133|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793735|NCT02240238|617254134|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793736|NCT02240238|617254135|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793737|NCT02240238|617254136|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793738|NCT02240238|617254137|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793739|NCT02240238|617254138|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
170793740|NCT02240238|617254139|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793741|NCT02240238|617254140|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
170793742|NCT02240238|617254129|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793743|NCT02240238|617254130|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793744|NCT02240238|617254131|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793745|NCT02240238|617254132|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793746|NCT02240238|617254133|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793747|NCT02240238|617254134|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793748|NCT02240238|617254135|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793749|NCT02240238|617254136|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793750|NCT02240238|617254137|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793751|NCT02240238|617254138|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
170793752|NCT02240238|617254139|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793753|NCT02240238|617254140|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
170793754|NCT02240238|617254129|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793755|NCT02240238|617254130|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793756|NCT02240238|617254131|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793757|NCT02240238|617254132|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793758|NCT02240238|617254133|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793759|NCT02240238|617254134|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793760|NCT02240238|617254135|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793761|NCT02240238|617254136|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793762|NCT02240238|617254137|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793763|NCT02240238|617254138|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793764|NCT02240238|617254139|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
170793765|NCT02240238|617254140|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
170793766|NCT02240238|617254129|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793767|NCT02240238|617254130|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793768|NCT02240238|617254131|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170478346|NCT02466321|616090551|FG000|Overall Study|Did not receive study device|1|||
170478347|NCT01042093|616090552|FG000|Overall Study|Protocol Violation|2|||
170793769|NCT02240238|617254132|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793770|NCT02240238|617254133|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793771|NCT02240238|617254134|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170478348|NCT01042093|616090553|FG001|Overall Study|Protocol Violation|2|||
170478349|NCT01042093|616090554|FG002|Overall Study|Protocol Violation|2|||
170478350|NCT01042093|616090555|FG003|Overall Study|Protocol Violation|3|||
170478351|NCT01042093|616090552|FG000|Overall Study|Withdrawal by Subject|0|||
170478352|NCT01042093|616090553|FG001|Overall Study|Withdrawal by Subject|0|||
170478353|NCT01042093|616090554|FG002|Overall Study|Withdrawal by Subject|0|||
170478354|NCT01042093|616090555|FG003|Overall Study|Withdrawal by Subject|1|||
170478355|NCT01329900|616090558|FG000|Overall Study|Elevated creatinine/renal function|1|||
170478356|NCT04239027|616090559|FG000|Overall Study|Adverse Event|4|||
170478357|NCT04239027|616090559|FG000|Overall Study|Withdrawal by Subject|9|||
170478358|NCT04239027|616090559|FG000|Overall Study|Death|1|||
170547465|NCT00098293|616350175|FG001|Supplemental Phase (SP)|Death|0|||
170793772|NCT02240238|617254135|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793773|NCT02240238|617254136|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793774|NCT02240238|617254137|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793775|NCT02240238|617254138|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793776|NCT02240238|617254139|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
170793777|NCT02240238|617254140|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
170793778|NCT02240238|617254129|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793779|NCT02240238|617254130|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793780|NCT02240238|617254131|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170478359|NCT04239027|616090559|FG000|Overall Study|Physician Decision|9|||
170478360|NCT04239027|616090559|FG000|Overall Study|Lost to Follow-up|2|||
170478361|NCT04239027|616090559|FG000|Overall Study|Lack of Efficacy|1|||
170478362|NCT01184079|616090568|FG000|Overall Study|Lost to Follow-up|14|||
170893792|NCT00434967|617619948|FG003|Overall Study|Withdrawal by Subject|6|||
170478363|NCT01184079|616090569|FG001|Overall Study|Lost to Follow-up|2|||
170478364|NCT01876446|616090572|FG000|Overall Study|Death|0|||
170478365|NCT01876446|616090573|FG001|Overall Study|Death|1|||
170478366|NCT01876446|616090572|FG000|Overall Study|Withdrawal by Subject|1|||
170478367|NCT01876446|616090573|FG001|Overall Study|Withdrawal by Subject|2|||
170478368|NCT01876446|616090572|FG000|Overall Study|Physician Decision|1|||
170478369|NCT01876446|616090573|FG001|Overall Study|Physician Decision|3|||
170478370|NCT02108912|616090574|FG000|Overall Study|Lost to Follow-up|1|||
170478371|NCT02108912|616090575|FG001|Overall Study|Lost to Follow-up|1|||
170478372|NCT02108912|616090574|FG000|Overall Study|lack of transportation|1|||
170478373|NCT02108912|616090575|FG001|Overall Study|lack of transportation|0|||
170478374|NCT02108912|616090574|FG000|Overall Study|high blood pressure|1|||
170478375|NCT02108912|616090575|FG001|Overall Study|high blood pressure|0|||
170478376|NCT01523002|616090578|FG000|Period 1|Withdrawal by Subject|1|||
170478377|NCT01523002|616090579|FG001|Period 1|Withdrawal by Subject|3|||
170478378|NCT01523002|616090578|FG000|Period 1|Lost to Follow-up|1|||
170478379|NCT01523002|616090579|FG001|Period 1|Lost to Follow-up|0|||
170478380|NCT01523002|616090578|FG000|Period 1|Adverse Event|0|||
170478381|NCT01523002|616090579|FG001|Period 1|Adverse Event|8|||
170478382|NCT01523002|616090578|FG000|Period 2|Withdrawal by Subject|4|||
170478383|NCT01523002|616090579|FG001|Period 2|Withdrawal by Subject|1|||
170478384|NCT01523002|616090578|FG000|Period 2|Adverse Event|2|||
170478385|NCT01523002|616090579|FG001|Period 2|Adverse Event|5|||
170478386|NCT01523002|616090578|FG000|Period 3|Withdrawal by Subject|1|||
170478387|NCT01523002|616090579|FG001|Period 3|Withdrawal by Subject|0|||
170478388|NCT01523002|616090578|FG000|Period 3|Adverse Event|3|||
170478389|NCT01523002|616090579|FG001|Period 3|Adverse Event|0|||
170478390|NCT03953612|616090580|FG000|Overall Study|Randomized but did not start|1|||
170478391|NCT03953612|616090581|FG001|Overall Study|Randomized but did not start|1|||
170478392|NCT03953612|616090582|FG002|Overall Study|Randomized but did not start|1|||
170478393|NCT03953612|616090580|FG000|Overall Study|Withdrawal by Subject|2|||
170478394|NCT03953612|616090581|FG001|Overall Study|Withdrawal by Subject|1|||
170893793|NCT00434967|617619945|FG000|Overall Study|Randomized in error|0|||
170893794|NCT00434967|617619946|FG001|Overall Study|Randomized in error|0|||
170478395|NCT03953612|616090582|FG002|Overall Study|Withdrawal by Subject|0|||
170478396|NCT03485352|616090583|FG000|Overall Study|Lost to Follow-up|9|||
170478397|NCT01998841|616090590|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
170478398|NCT01998841|616090591|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
170478399|NCT01998841|616090592|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
170478400|NCT01998841|616090593|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
170478401|NCT01998841|616090594|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
170478402|NCT01998841|616090590|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
170478403|NCT01998841|616090591|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
170478404|NCT01998841|616090592|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
170478405|NCT01998841|616090593|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
170478406|NCT01998841|616090594|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
170478407|NCT02552121|616090595|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
170478408|NCT02552121|616090596|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
170478409|NCT02552121|616090597|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
170478410|NCT02552121|616090598|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
170478411|NCT02552121|616090599|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
170478412|NCT02552121|616090600|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
170478413|NCT02552121|616090601|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
170478414|NCT02552121|616090602|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
170478415|NCT02552121|616090595|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
170478416|NCT02552121|616090596|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
170478417|NCT02552121|616090597|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
170478418|NCT02552121|616090598|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
170478419|NCT02552121|616090599|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
170478420|NCT02552121|616090600|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
170478421|NCT02552121|616090601|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
170478422|NCT02552121|616090602|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
170478423|NCT02552121|616090595|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
170478424|NCT02552121|616090596|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
170478425|NCT02552121|616090597|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
170478426|NCT02552121|616090598|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
170893795|NCT00434967|617619947|FG002|Overall Study|Randomized in error|0|||
170478427|NCT02552121|616090599|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
170478428|NCT02552121|616090600|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
170478429|NCT02552121|616090601|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
170478430|NCT02552121|616090602|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
170478431|NCT02552121|616090595|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
170478432|NCT02552121|616090596|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
170478433|NCT02552121|616090597|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
170478434|NCT02552121|616090598|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
170478435|NCT02552121|616090599|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
170478436|NCT02552121|616090600|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
170478437|NCT02552121|616090601|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
170478438|NCT02552121|616090602|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
170893796|NCT00434967|617619948|FG003|Overall Study|Randomized in error|1|||
170893797|NCT00434967|617619945|FG000|Overall Study|Protocol Violation|0|||
170893798|NCT00434967|617619946|FG001|Overall Study|Protocol Violation|1|||
170893799|NCT00434967|617619947|FG002|Overall Study|Protocol Violation|0|||
170893800|NCT00434967|617619948|FG003|Overall Study|Protocol Violation|1|||
170893801|NCT00434967|617619945|FG000|Overall Study|Physician Decision|1|||
170893802|NCT00434967|617619946|FG001|Overall Study|Physician Decision|1|||
170893803|NCT00434967|617619947|FG002|Overall Study|Physician Decision|1|||
170893804|NCT00434967|617619948|FG003|Overall Study|Physician Decision|0|||
170893805|NCT00434967|617619945|FG000|Overall Study|Patient Disposition Challenges|2|||
170893806|NCT00434967|617619946|FG001|Overall Study|Patient Disposition Challenges|0|||
170893807|NCT00434967|617619947|FG002|Overall Study|Patient Disposition Challenges|0|||
170893808|NCT00434967|617619948|FG003|Overall Study|Patient Disposition Challenges|3|||
170893809|NCT03502187|617619953|FG000|Overall Study|Withdrawal by Subject|4|||
170893810|NCT03502187|617619954|FG001|Overall Study|Withdrawal by Subject|3|||
170893811|NCT03502187|617619955|FG002|Overall Study|Withdrawal by Subject|3|||
170893812|NCT03502187|617619953|FG000|Overall Study|Lost to Follow-up|5|||
170893813|NCT03502187|617619954|FG001|Overall Study|Lost to Follow-up|4|||
170893814|NCT03502187|617619955|FG002|Overall Study|Lost to Follow-up|5|||
170893815|NCT04088409|617619956|FG000|Part A|Withdrawal by Subject|2|||
170893816|NCT04088409|617619957|FG001|Part A|Withdrawal by Subject|1|||
170893817|NCT04088409|617619956|FG000|Part A|Did Not Meet Randomization Criteria|2|||
170893818|NCT04088409|617619957|FG001|Part A|Did Not Meet Randomization Criteria|0|||
170893819|NCT04088409|617619956|FG000|Part A|Lack of Efficacy|9|||
170893820|NCT04088409|617619957|FG001|Part A|Lack of Efficacy|0|||
170893821|NCT04088409|617619956|FG000|Part A|Lost to Follow-up|1|||
170893822|NCT04088409|617619957|FG001|Part A|Lost to Follow-up|0|||
170893823|NCT04088409|617619956|FG000|Part A|Adverse Event|1|||
170893824|NCT04088409|617619957|FG001|Part A|Adverse Event|0|||
170893825|NCT04088409|617619956|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
170893826|NCT04088409|617619957|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
170893827|NCT04088409|617619956|FG000|Part B|Ongoing Treatment|10|||
170893828|NCT04088409|617619957|FG001|Part B|Ongoing Treatment|0|||
170893829|NCT00841763|617619958|FG000|Overall Study|Withdrawal by Subject|60|||
170893830|NCT00841763|617619959|FG001|Overall Study|Withdrawal by Subject|17|||
170893831|NCT00841763|617619960|FG002|Overall Study|Withdrawal by Subject|4|||
170893832|NCT00841763|617619961|FG003|Overall Study|Withdrawal by Subject|1|||
170893833|NCT00841763|617619958|FG000|Overall Study|Adverse Event|9|||
170893834|NCT00841763|617619959|FG001|Overall Study|Adverse Event|10|||
170893835|NCT00841763|617619960|FG002|Overall Study|Adverse Event|3|||
170893836|NCT00841763|617619961|FG003|Overall Study|Adverse Event|2|||
170478439|NCT02552121|616090595|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
170893837|NCT00841763|617619958|FG000|Overall Study|Lost to Follow-up|63|||
170893838|NCT00841763|617619959|FG001|Overall Study|Lost to Follow-up|25|||
170893839|NCT00841763|617619960|FG002|Overall Study|Lost to Follow-up|0|||
170478440|NCT02552121|616090596|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
170478441|NCT02552121|616090597|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
170478442|NCT02552121|616090598|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
170478443|NCT02552121|616090599|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
170478444|NCT02552121|616090600|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
170478445|NCT02552121|616090601|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
170478446|NCT02552121|616090602|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
170478447|NCT02552121|616090595|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
170478448|NCT02552121|616090596|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
170478449|NCT02552121|616090597|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
170547466|NCT00098293|616350176|FG002|Supplemental Phase (SP)|Death|0|||
170893840|NCT00841763|617619961|FG003|Overall Study|Lost to Follow-up|0|||
170893841|NCT00841763|617619958|FG000|Overall Study|Protocol Violation|20|||
170893842|NCT00841763|617619959|FG001|Overall Study|Protocol Violation|3|||
170893843|NCT00841763|617619960|FG002|Overall Study|Protocol Violation|1|||
170893844|NCT00841763|617619961|FG003|Overall Study|Protocol Violation|0|||
170893845|NCT00841763|617619958|FG000|Overall Study|Administrative Reasons|3|||
170893846|NCT00841763|617619959|FG001|Overall Study|Administrative Reasons|1|||
170893847|NCT00841763|617619960|FG002|Overall Study|Administrative Reasons|0|||
170893848|NCT00841763|617619961|FG003|Overall Study|Administrative Reasons|0|||
170893849|NCT00841763|617619958|FG000|Overall Study|Unable to Classify|7|||
170893850|NCT00841763|617619959|FG001|Overall Study|Unable to Classify|1|||
170893851|NCT00841763|617619960|FG002|Overall Study|Unable to Classify|0|||
170478450|NCT02552121|616090598|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
170478451|NCT02552121|616090599|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
170478452|NCT02552121|616090600|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
170478453|NCT02552121|616090601|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
170478454|NCT02552121|616090602|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
170478455|NCT02552121|616090595|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
170478456|NCT02552121|616090596|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
170478457|NCT02552121|616090597|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
170478458|NCT02552121|616090598|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
170478459|NCT02552121|616090599|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
170478460|NCT02552121|616090600|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
170478461|NCT02552121|616090601|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
170478462|NCT02552121|616090602|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
170478463|NCT02552121|616090595|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
170478464|NCT02552121|616090596|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
170478465|NCT02552121|616090597|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
170478466|NCT02552121|616090598|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
170478467|NCT02552121|616090599|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
170478468|NCT02552121|616090600|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
170478469|NCT02552121|616090601|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
170478470|NCT02552121|616090602|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
170478471|NCT02552121|616090595|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
170478472|NCT02552121|616090596|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
170478473|NCT02552121|616090597|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
170478474|NCT02552121|616090598|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
170478475|NCT02552121|616090599|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
170478476|NCT02552121|616090600|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
170478477|NCT02552121|616090601|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
170478478|NCT02552121|616090602|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
170478479|NCT02552121|616090595|FG000|Part 2: Cohort Expansion|Death|0|||
170478480|NCT02552121|616090596|FG001|Part 2: Cohort Expansion|Death|0|||
170478481|NCT02552121|616090597|FG002|Part 2: Cohort Expansion|Death|1|||
170478482|NCT02552121|616090598|FG003|Part 2: Cohort Expansion|Death|0|||
170478483|NCT02552121|616090599|FG004|Part 2: Cohort Expansion|Death|0|||
170478484|NCT02552121|616090600|FG005|Part 2: Cohort Expansion|Death|0|||
170478485|NCT02552121|616090601|FG006|Part 2: Cohort Expansion|Death|0|||
170478486|NCT02552121|616090602|FG007|Part 2: Cohort Expansion|Death|0|||
170478487|NCT01417156|616092214|FG000|Overall Study|Adverse Event|12|||
170478488|NCT01417156|616092214|FG000|Overall Study|Protocol Violation|2|||
170478489|NCT00086684|616092219|FG000|Overall Study|Adverse Event|12|||
170478490|NCT00086684|616092220|FG001|Overall Study|Adverse Event|17|||
170478491|NCT00086684|616092221|FG002|Overall Study|Adverse Event|14|||
170478492|NCT00086684|616092219|FG000|Overall Study|Lack of Efficacy|6|||
170478493|NCT00086684|616092220|FG001|Overall Study|Lack of Efficacy|6|||
170478494|NCT00086684|616092221|FG002|Overall Study|Lack of Efficacy|5|||
170478495|NCT00086684|616092219|FG000|Overall Study|Lost to Follow-up|15|||
170478496|NCT00086684|616092220|FG001|Overall Study|Lost to Follow-up|8|||
170478497|NCT00086684|616092221|FG002|Overall Study|Lost to Follow-up|10|||
170478498|NCT00086684|616092219|FG000|Overall Study|Protocol Violation|8|||
170478499|NCT00086684|616092220|FG001|Overall Study|Protocol Violation|3|||
170478500|NCT00086684|616092221|FG002|Overall Study|Protocol Violation|0|||
170478501|NCT00086684|616092219|FG000|Overall Study|Withdrawal by Subject|0|||
170793781|NCT02240238|617254132|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793782|NCT02240238|617254133|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793783|NCT02240238|617254134|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793784|NCT02240238|617254135|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793785|NCT02240238|617254136|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793786|NCT02240238|617254137|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793787|NCT02240238|617254138|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793788|NCT02240238|617254139|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
170793789|NCT02240238|617254140|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
170793790|NCT02240238|617254129|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793791|NCT02240238|617254130|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793792|NCT02240238|617254131|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170893852|NCT00841763|617619961|FG003|Overall Study|Unable to Classify|0|||
170478502|NCT00086684|616092220|FG001|Overall Study|Withdrawal by Subject|4|||
170478503|NCT00086684|616092221|FG002|Overall Study|Withdrawal by Subject|10|||
170478504|NCT00086684|616092219|FG000|Overall Study|NONCOMPLIANCE|5|||
170478505|NCT00086684|616092220|FG001|Overall Study|NONCOMPLIANCE|7|||
170478506|NCT00086684|616092221|FG002|Overall Study|NONCOMPLIANCE|6|||
170478507|NCT00086684|616092219|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
170478508|NCT00086684|616092220|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
170478509|NCT00086684|616092221|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
170478510|NCT00086684|616092219|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
170478511|NCT00086684|616092220|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
170478512|NCT00086684|616092221|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
170478513|NCT00086684|616092219|FG000|Overall Study|Other|4|||
170478514|NCT00086684|616092220|FG001|Overall Study|Other|2|||
170478515|NCT00086684|616092221|FG002|Overall Study|Other|3|||
170478516|NCT02547428|616092222|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
170478517|NCT02547428|616092223|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
170478518|NCT02547428|616092222|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
170478519|NCT02547428|616092223|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
170478520|NCT02547428|616092222|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
170478521|NCT02547428|616092223|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
170478522|NCT02547428|616092222|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
170478523|NCT02547428|616092223|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
170478524|NCT02547428|616092222|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
170478525|NCT02547428|616092223|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
170478526|NCT02547428|616092222|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
170478527|NCT02547428|616092223|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
170478528|NCT02547428|616092222|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
170478529|NCT02547428|616092223|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
170478530|NCT02547428|616092222|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
170478531|NCT02547428|616092223|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
170478532|NCT01103180|616092224|FG000|Overall Study|Withdrawal by Subject|8|||
170478533|NCT01103180|616092225|FG001|Overall Study|Withdrawal by Subject|13|||
170478534|NCT01103180|616092224|FG000|Overall Study|Lost to Follow-up|13|||
170478535|NCT01103180|616092225|FG001|Overall Study|Lost to Follow-up|7|||
170478536|NCT01103180|616092224|FG000|Overall Study|Physician Decision|1|||
170478537|NCT01103180|616092225|FG001|Overall Study|Physician Decision|0|||
170478538|NCT01103180|616092224|FG000|Overall Study|Protocol Violation|0|||
170478539|NCT01103180|616092225|FG001|Overall Study|Protocol Violation|1|||
170478540|NCT00882518|616092226|FG000|Overall Study|Adverse Event|9|||
170478541|NCT00882518|616092227|FG001|Overall Study|Adverse Event|18|||
170478542|NCT00882518|616092226|FG000|Overall Study|Withdrawal by Subject|9|||
170478543|NCT00882518|616092227|FG001|Overall Study|Withdrawal by Subject|13|||
170478544|NCT00882518|616092226|FG000|Overall Study|Lack of Efficacy|12|||
170478545|NCT00882518|616092227|FG001|Overall Study|Lack of Efficacy|9|||
170478546|NCT00882518|616092226|FG000|Overall Study|Severe non-compliance to protocol|3|||
170478547|NCT00882518|616092227|FG001|Overall Study|Severe non-compliance to protocol|1|||
170478548|NCT00882518|616092226|FG000|Overall Study|Incorrect enrolment|4|||
170478549|NCT00882518|616092227|FG001|Overall Study|Incorrect enrolment|2|||
170478550|NCT00882518|616092226|FG000|Overall Study|Central lab closure for National day|1|||
170478551|NCT00882518|616092227|FG001|Overall Study|Central lab closure for National day|0|||
170478552|NCT00882518|616092226|FG000|Overall Study|Allocating random number by mistake|0|||
170478553|NCT00882518|616092227|FG001|Overall Study|Allocating random number by mistake|1|||
170478554|NCT02137252|616092231|FG000|Overall Study|trial terminated early|2|||
170793793|NCT02240238|617254132|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793794|NCT02240238|617254133|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793795|NCT02240238|617254134|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793796|NCT02240238|617254135|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793797|NCT02240238|617254136|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793798|NCT02240238|617254137|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793799|NCT02240238|617254138|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793800|NCT02240238|617254139|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
170793801|NCT02240238|617254140|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
170793802|NCT02240238|617254129|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793803|NCT02240238|617254130|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170478555|NCT02137252|616092232|FG001|Overall Study|trial terminated early|1|||
170478556|NCT01958437|616092235|FG000|Overall Study|Incidental MRI findings|0|||
170547467|NCT00098293|616350177|FG003|Supplemental Phase (SP)|Death|0|||
170547468|NCT00098293|616350178|FG004|Supplemental Phase (SP)|Death|1|||
170547469|NCT00098293|616350174|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
170547470|NCT00098293|616350175|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
170478557|NCT01958437|616092236|FG001|Overall Study|Incidental MRI findings|0|||
170478558|NCT01958437|616092237|FG002|Overall Study|Incidental MRI findings|1|||
170478559|NCT01958437|616092238|FG003|Overall Study|Incidental MRI findings|1|||
170478560|NCT01113892|616092239|FG000|Overall Study|Lost to Follow-up|2|||
170547471|NCT00098293|616350176|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
170547472|NCT00098293|616350177|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
170478561|NCT01113892|616092240|FG001|Overall Study|Lost to Follow-up|2|||
170893853|NCT03222349|617619962|FG000|Overall Study|Treatment B not done|5|||
170893854|NCT03222349|617619963|FG001|Overall Study|Treatment B not done|0|||
170478562|NCT01113892|616092239|FG000|Overall Study|Withdrawal by Subject|1|||
170478563|NCT01113892|616092240|FG001|Overall Study|Withdrawal by Subject|1|||
170478564|NCT01113892|616092239|FG000|Overall Study|Death|2|||
170478565|NCT01113892|616092240|FG001|Overall Study|Death|4|||
170478566|NCT01113892|616092239|FG000|Overall Study|Graft no longer evaluable|9|||
170478567|NCT01113892|616092240|FG001|Overall Study|Graft no longer evaluable|9|||
170478568|NCT03404674|616092249|FG000|Overall Study|Inability to Attend Future Visits|0|||
170478569|NCT03404674|616092250|FG001|Overall Study|Inability to Attend Future Visits|1|||
170478570|NCT03404674|616092251|FG002|Overall Study|Inability to Attend Future Visits|1|||
170478571|NCT03404674|616092252|FG003|Overall Study|Inability to Attend Future Visits|0|||
170478572|NCT03404674|616092253|FG004|Overall Study|Inability to Attend Future Visits|0|||
170478573|NCT03404674|616092254|FG005|Overall Study|Inability to Attend Future Visits|0|||
170478574|NCT03404674|616092249|FG000|Overall Study|Behavioral Problems|0|||
170478575|NCT03404674|616092250|FG001|Overall Study|Behavioral Problems|0|||
170478576|NCT03404674|616092251|FG002|Overall Study|Behavioral Problems|1|||
170478577|NCT03404674|616092252|FG003|Overall Study|Behavioral Problems|0|||
170478578|NCT03404674|616092253|FG004|Overall Study|Behavioral Problems|0|||
170478579|NCT03404674|616092254|FG005|Overall Study|Behavioral Problems|0|||
170478580|NCT03404674|616092249|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
170478581|NCT03404674|616092250|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
170478582|NCT03404674|616092251|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
170478583|NCT03404674|616092252|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
170478584|NCT03404674|616092253|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
170478585|NCT03404674|616092254|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
170478586|NCT02123446|616092262|FG000|Washout Period (1 Day)|Physician Decision|1|||
170478587|NCT02123446|616092263|FG001|Washout Period (1 Day)|Physician Decision|0|||
170478588|NCT01169350|616092264|FG000|Overall Study|Physician Decision|3|||
170478589|NCT01169350|616092264|FG000|Overall Study|Lost to Follow-up|2|||
170478590|NCT02291237|616092265|FG000|Overall Study|Study Terminated by Sponsor|72|||
170478591|NCT02291237|616092266|FG001|Overall Study|Study Terminated by Sponsor|67|||
170478592|NCT02291237|616092265|FG000|Overall Study|Adverse Event|1|||
170478593|NCT02291237|616092266|FG001|Overall Study|Adverse Event|3|||
170478594|NCT02291237|616092265|FG000|Overall Study|Investigator's Discretion|0|||
170478595|NCT02291237|616092266|FG001|Overall Study|Investigator's Discretion|3|||
170478596|NCT02291237|616092265|FG000|Overall Study|Withdrew Consent|11|||
170478597|NCT02291237|616092266|FG001|Overall Study|Withdrew Consent|11|||
170478598|NCT02291237|616092265|FG000|Overall Study|Lost to Follow-up|0|||
170478599|NCT02291237|616092266|FG001|Overall Study|Lost to Follow-up|2|||
170478600|NCT02291237|616092265|FG000|Overall Study|Subject Required Prohibited Medication|2|||
170478601|NCT02291237|616092266|FG001|Overall Study|Subject Required Prohibited Medication|0|||
170478602|NCT01866098|616092267|FG000|Overall Study|Lost to Follow-up|11|||
170478603|NCT01866098|616092268|FG001|Overall Study|Lost to Follow-up|18|||
170478604|NCT01866098|616092269|FG002|Overall Study|Lost to Follow-up|13|||
170478605|NCT01866098|616092267|FG000|Overall Study|Physician Decision|0|||
170478606|NCT01866098|616092268|FG001|Overall Study|Physician Decision|1|||
170478607|NCT01866098|616092269|FG002|Overall Study|Physician Decision|2|||
170478608|NCT01866098|616092267|FG000|Overall Study|Adverse Event|1|||
170478609|NCT01866098|616092268|FG001|Overall Study|Adverse Event|5|||
170478610|NCT01866098|616092269|FG002|Overall Study|Adverse Event|4|||
170478611|NCT01866098|616092267|FG000|Overall Study|Protocol Violation|1|||
170478612|NCT01866098|616092268|FG001|Overall Study|Protocol Violation|0|||
170478613|NCT01866098|616092269|FG002|Overall Study|Protocol Violation|0|||
170478614|NCT01866098|616092267|FG000|Overall Study|Withdrawal by Subject|1|||
170478615|NCT01866098|616092268|FG001|Overall Study|Withdrawal by Subject|2|||
170478616|NCT01866098|616092269|FG002|Overall Study|Withdrawal by Subject|0|||
170478617|NCT01866098|616092267|FG000|Overall Study|Unrelated Hospitalization|2|||
170478618|NCT01866098|616092268|FG001|Overall Study|Unrelated Hospitalization|0|||
170478619|NCT01866098|616092269|FG002|Overall Study|Unrelated Hospitalization|1|||
170478620|NCT01866098|616092267|FG000|Overall Study|Non-compliance|1|||
170478621|NCT01866098|616092268|FG001|Overall Study|Non-compliance|0|||
170478622|NCT01866098|616092269|FG002|Overall Study|Non-compliance|1|||
170478623|NCT01866098|616092267|FG000|Overall Study|Pregnancy|2|||
170478624|NCT01866098|616092268|FG001|Overall Study|Pregnancy|0|||
170478625|NCT01866098|616092269|FG002|Overall Study|Pregnancy|0|||
170478626|NCT01866098|616092267|FG000|Overall Study|Death|0|||
170478627|NCT01866098|616092268|FG001|Overall Study|Death|1|||
170478628|NCT01866098|616092269|FG002|Overall Study|Death|0|||
170478629|NCT00995774|616092271|FG000|Training Period 2|Withdrawal by Subject|2|||
170478630|NCT00995774|616092272|FG001|Training Period 2|Withdrawal by Subject|0|||
170893855|NCT03222349|617619962|FG000|Overall Study|Lost to Follow-up|1|||
170478631|NCT00456300|616092275|FG000|Overall Study|Adverse Event|1|||
170478632|NCT00456300|616092276|FG001|Overall Study|Adverse Event|0|||
170478633|NCT02586155|616092293|FG000|Overall Study|Adverse Event|2|||
170893856|NCT03222349|617619963|FG001|Overall Study|Lost to Follow-up|2|||
170547473|NCT00098293|616350178|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
170547474|NCT00098293|616350174|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
170547475|NCT00098293|616350175|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
170793804|NCT02240238|617254131|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170547476|NCT00098293|616350176|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
170547477|NCT00098293|616350177|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
170547478|NCT00098293|616350178|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
170547479|NCT00098293|616350174|FG000|Supplemental Phase (SP)|Other|0|||
170547480|NCT00098293|616350175|FG001|Supplemental Phase (SP)|Other|0|||
170547481|NCT00098293|616350176|FG002|Supplemental Phase (SP)|Other|0|||
170547482|NCT00098293|616350177|FG003|Supplemental Phase (SP)|Other|0|||
170793805|NCT02240238|617254132|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793806|NCT02240238|617254133|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793807|NCT02240238|617254134|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793808|NCT02240238|617254135|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793809|NCT02240238|617254136|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793810|NCT02240238|617254137|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793811|NCT02240238|617254138|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793812|NCT02240238|617254139|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
170793813|NCT02240238|617254140|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
170793814|NCT02240238|617254129|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793815|NCT02240238|617254130|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793816|NCT02240238|617254131|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793817|NCT02240238|617254132|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793818|NCT02240238|617254133|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793819|NCT02240238|617254134|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793820|NCT02240238|617254135|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793821|NCT02240238|617254136|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793822|NCT02240238|617254137|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793823|NCT02240238|617254138|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793824|NCT02240238|617254139|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
170793825|NCT02240238|617254140|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
170547483|NCT00098293|616350178|FG004|Supplemental Phase (SP)|Other|22|||
170547484|NCT04560309|616350188|FG000|Overall Study|Meet drop out criteria|1|||
170547485|NCT04560309|616350189|FG001|Overall Study|Meet drop out criteria|1|||
170547486|NCT04146909|616350190|FG000|Overall Study|Withdrawal by Subject|3|||
170547487|NCT04146909|616350190|FG000|Overall Study|Did not qualify after consented|1|||
170478634|NCT02586155|616092294|FG001|Overall Study|Adverse Event|3|||
170478635|NCT02586155|616092293|FG000|Overall Study|Withdrawal by Subject|31|||
170478636|NCT02586155|616092294|FG001|Overall Study|Withdrawal by Subject|24|||
170478637|NCT02586155|616092293|FG000|Overall Study|Lost to Follow-up|7|||
170478638|NCT02586155|616092294|FG001|Overall Study|Lost to Follow-up|13|||
170478639|NCT02586155|616092293|FG000|Overall Study|Death|61|||
170478640|NCT02586155|616092294|FG001|Overall Study|Death|72|||
170478641|NCT02586155|616092293|FG000|Overall Study|Other reasons|26|||
170478642|NCT02586155|616092294|FG001|Overall Study|Other reasons|15|||
170478643|NCT00972595|616092295|FG000|Period 1|Adverse Event|1|||
170478644|NCT00972595|616092296|FG001|Period 1|Adverse Event|0|||
170478645|NCT01461538|616092297|FG000|Overall Study|Death|15|||
170478646|NCT01461538|616092298|FG001|Overall Study|Death|6|||
170478647|NCT01461538|616092299|FG002|Overall Study|Death|2|||
170478648|NCT01461538|616092297|FG000|Overall Study|Study Stopped by Sponsor|2|||
170478649|NCT01461538|616092298|FG001|Overall Study|Study Stopped by Sponsor|1|||
170478650|NCT01461538|616092299|FG002|Overall Study|Study Stopped by Sponsor|0|||
170478651|NCT01461538|616092297|FG000|Overall Study|Withdrawal by Subject|1|||
170478652|NCT01461538|616092298|FG001|Overall Study|Withdrawal by Subject|1|||
170478653|NCT01461538|616092299|FG002|Overall Study|Withdrawal by Subject|0|||
170478654|NCT00141778|616092300|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
170478655|NCT00141778|616092301|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
170478656|NCT00141778|616092302|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
170478657|NCT00141778|616092300|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
170478658|NCT00141778|616092301|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
170478659|NCT00141778|616092302|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
170478660|NCT00141778|616092300|FG000|Started Study Medication|Withdrawal by Subject|0|||
170478661|NCT00141778|616092301|FG001|Started Study Medication|Withdrawal by Subject|2|||
170478662|NCT00141778|616092302|FG002|Started Study Medication|Withdrawal by Subject|0|||
170478663|NCT00141778|616092300|FG000|Started Study Medication|Difficulty Swallowing|0|||
170478664|NCT00141778|616092301|FG001|Started Study Medication|Difficulty Swallowing|1|||
170478665|NCT00141778|616092302|FG002|Started Study Medication|Difficulty Swallowing|0|||
170478666|NCT00141778|616092300|FG000|Started Study Medication|Chest Discomfort|0|||
170478667|NCT00141778|616092301|FG001|Started Study Medication|Chest Discomfort|0|||
170478668|NCT00141778|616092302|FG002|Started Study Medication|Chest Discomfort|1|||
170478669|NCT04052620|616092304|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
170478670|NCT04052620|616092305|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
170478671|NCT04052620|616092304|FG000|Overall Study|Withdrawal by Subject|1|||
170478672|NCT04052620|616092305|FG001|Overall Study|Withdrawal by Subject|0|||
170478673|NCT04052620|616092304|FG000|Overall Study|Lost to Follow-up|1|||
170478674|NCT04052620|616092305|FG001|Overall Study|Lost to Follow-up|1|||
170478675|NCT04052620|616092304|FG000|Overall Study|Adverse Event|1|||
170478676|NCT04052620|616092305|FG001|Overall Study|Adverse Event|0|||
170478677|NCT04052620|616092304|FG000|Overall Study|Subject did not meet study Criteria|0|||
170478678|NCT04052620|616092305|FG001|Overall Study|Subject did not meet study Criteria|1|||
170478679|NCT04052620|616092304|FG000|Overall Study|Screened failure, randomized by mistake|0|||
170478680|NCT04052620|616092305|FG001|Overall Study|Screened failure, randomized by mistake|1|||
170478681|NCT04052620|616092304|FG000|Overall Study|Personal reasons|2|||
170478682|NCT04052620|616092305|FG001|Overall Study|Personal reasons|4|||
170478683|NCT04052620|616092304|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
170478684|NCT04052620|616092305|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
170478685|NCT01406574|616092306|FG000|Overall Study|Adverse Event|0|||
170478686|NCT01406574|616092307|FG001|Overall Study|Adverse Event|0|||
170478687|NCT01406574|616092308|FG002|Overall Study|Adverse Event|1|||
170478688|NCT01406574|616092309|FG003|Overall Study|Adverse Event|3|||
170478689|NCT01406574|616092306|FG000|Overall Study|Physician Decision|0|||
170478690|NCT01406574|616092307|FG001|Overall Study|Physician Decision|0|||
170478691|NCT01406574|616092308|FG002|Overall Study|Physician Decision|0|||
170478692|NCT01406574|616092309|FG003|Overall Study|Physician Decision|1|||
170478693|NCT01406574|616092306|FG000|Overall Study|Withdrawal by Subject|0|||
170478694|NCT01406574|616092307|FG001|Overall Study|Withdrawal by Subject|1|||
170478695|NCT01406574|616092308|FG002|Overall Study|Withdrawal by Subject|0|||
170478696|NCT01406574|616092309|FG003|Overall Study|Withdrawal by Subject|0|||
170478697|NCT01406574|616092306|FG000|Overall Study|Definite progression of primary disease|1|||
170478698|NCT01406574|616092307|FG001|Overall Study|Definite progression of primary disease|0|||
170478699|NCT01406574|616092308|FG002|Overall Study|Definite progression of primary disease|0|||
170478700|NCT01406574|616092309|FG003|Overall Study|Definite progression of primary disease|0|||
170478701|NCT03552380|616092311|FG000|Study Treatment|Disease Progression|3|||
170478702|NCT03552380|616092312|FG001|Study Treatment|Disease Progression|4|||
170478703|NCT03552380|616092311|FG000|Study Treatment|Adverse Event|2|||
170478704|NCT03552380|616092312|FG001|Study Treatment|Adverse Event|2|||
170478705|NCT03552380|616092311|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
170547488|NCT00345592|616350191|FG000|Overall Study|Death|14|||
170478706|NCT03552380|616092312|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
170478707|NCT03552380|616092311|FG000|Follow up|Death|3|||
170478708|NCT03552380|616092312|FG001|Follow up|Death|4|||
170478709|NCT03552380|616092311|FG000|Follow up|Site IRB terminated|0|||
170478710|NCT03552380|616092312|FG001|Follow up|Site IRB terminated|1|||
170478711|NCT02201784|616092313|FG000|Overall Study|Failure to achieve adequate block|2|||
170478712|NCT02201784|616092314|FG001|Overall Study|Failure to achieve adequate block|0|||
170478713|NCT03447743|616092315|FG000|Overall Study|Withdrawal by Subject|2|||
170478714|NCT03447743|616092315|FG000|Overall Study|Lost to Follow-up|3|||
170478715|NCT03447743|616092315|FG000|Overall Study|Adverse Event|1|||
170478716|NCT03447743|616092315|FG000|Overall Study|Did not meet criteria to continue|1|||
170893857|NCT03222349|617619962|FG000|Overall Study|Withdrawal by Subject|1|||
170893858|NCT03222349|617619963|FG001|Overall Study|Withdrawal by Subject|0|||
170893859|NCT03222349|617619962|FG000|Overall Study|Treatment A not done|0|||
170893860|NCT03222349|617619963|FG001|Overall Study|Treatment A not done|5|||
170893861|NCT03222349|617619962|FG000|Overall Study|Study terminated by sponsor|1|||
170893862|NCT03222349|617619963|FG001|Overall Study|Study terminated by sponsor|0|||
170893863|NCT01554579|617619964|FG000|Overall Study|Adverse Event|6|||
170893864|NCT01554579|617619965|FG001|Overall Study|Adverse Event|25|||
170893865|NCT01554579|617619964|FG000|Overall Study|Lack of Efficacy|2|||
170893866|NCT01554579|617619965|FG001|Overall Study|Lack of Efficacy|1|||
170893867|NCT01554579|617619964|FG000|Overall Study|Withdrawal by Subject|2|||
170893868|NCT01554579|617619965|FG001|Overall Study|Withdrawal by Subject|1|||
170893869|NCT01808612|617619968|FG000|Treatment Period|Adverse Event|8|||
170893870|NCT01808612|617619969|FG001|Treatment Period|Adverse Event|4|||
170893871|NCT01808612|617619970|FG002|Treatment Period|Adverse Event|3|||
170893872|NCT01808612|617619968|FG000|Treatment Period|Lost to Follow-up|2|||
170893873|NCT01808612|617619969|FG001|Treatment Period|Lost to Follow-up|2|||
170893874|NCT01808612|617619970|FG002|Treatment Period|Lost to Follow-up|1|||
170893875|NCT01808612|617619968|FG000|Treatment Period|Protocol Violation|1|||
170478717|NCT00473590|616092316|FG000|Overall Study|Adverse Event|3|||
170478718|NCT00473590|616092317|FG001|Overall Study|Adverse Event|3|||
170478719|NCT00473590|616092316|FG000|Overall Study|Death|4|||
170478720|NCT00473590|616092317|FG001|Overall Study|Death|2|||
170478721|NCT00473590|616092316|FG000|Overall Study|Progression not resulting in death|24|||
170478722|NCT00473590|616092317|FG001|Overall Study|Progression not resulting in death|20|||
170478723|NCT00473590|616092316|FG000|Overall Study|Non-protocol-specified therapy|7|||
170478724|NCT00473590|616092317|FG001|Overall Study|Non-protocol-specified therapy|5|||
170478725|NCT00473590|616092316|FG000|Overall Study|Physician Decision|2|||
170478726|NCT00473590|616092317|FG001|Overall Study|Physician Decision|4|||
170478727|NCT00473590|616092316|FG000|Overall Study|Withdrawal by Subject|5|||
170478728|NCT00473590|616092317|FG001|Overall Study|Withdrawal by Subject|3|||
170478729|NCT00473590|616092316|FG000|Overall Study|Other|0|||
170478730|NCT00473590|616092317|FG001|Overall Study|Other|1|||
170478731|NCT01112059|616092318|FG000|Overall Study|Withdrawal by Subject|1|||
170478732|NCT01112059|616092319|FG001|Overall Study|Withdrawal by Subject|0|||
170478733|NCT01245283|616092322|FG000|Overall Study|Lost to Follow-up|14|||
170478734|NCT01245283|616092323|FG001|Overall Study|Lost to Follow-up|11|||
170478735|NCT01245283|616092324|FG002|Overall Study|Lost to Follow-up|11|||
170478736|NCT03567980|616092329|FG000|Overall Study|Adverse Event|1|||
170478737|NCT01610492|616092330|FG000|Overall Study|Adverse Event|1|||
170478738|NCT01610492|616092330|FG000|Overall Study|Lack of Efficacy|3|||
170478739|NCT01610492|616092330|FG000|Overall Study|Other: Reached stopping criteria|1|||
170478740|NCT01610492|616092330|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
170893876|NCT01808612|617619969|FG001|Treatment Period|Protocol Violation|0|||
170893877|NCT01808612|617619970|FG002|Treatment Period|Protocol Violation|0|||
170893878|NCT01808612|617619968|FG000|Treatment Period|Withdrawal by Subject|1|||
170893879|NCT01808612|617619969|FG001|Treatment Period|Withdrawal by Subject|0|||
170893880|NCT01808612|617619970|FG002|Treatment Period|Withdrawal by Subject|4|||
170478741|NCT01982955|616092331|FG000|Overall Study|Randomized but not treated|0|||
170478742|NCT01982955|616092332|FG001|Overall Study|Randomized but not treated|0|||
170478743|NCT01982955|616092333|FG002|Overall Study|Randomized but not treated|0|||
170478744|NCT01982955|616092334|FG003|Overall Study|Randomized but not treated|1|||
170478745|NCT01982955|616092335|FG004|Overall Study|Randomized but not treated|0|||
170478746|NCT03093259|616092337|FG000|Overall Study|Adverse Event|1|||
170547489|NCT00345592|616350192|FG001|Overall Study|Death|16|||
170547490|NCT00345592|616350191|FG000|Overall Study|Withdrawal by Subject|11|||
170547491|NCT00345592|616350192|FG001|Overall Study|Withdrawal by Subject|8|||
170893881|NCT01808612|617619968|FG000|Treatment Period|Physician Decision|1|||
170893882|NCT01808612|617619969|FG001|Treatment Period|Physician Decision|0|||
170893883|NCT01808612|617619970|FG002|Treatment Period|Physician Decision|4|||
170478747|NCT03093259|616092338|FG001|Overall Study|Adverse Event|0|||
170893884|NCT01808612|617619968|FG000|Treatment Period|Sponsor Decision|1|||
170478748|NCT03093259|616092337|FG000|Overall Study|Withdrawal by Subject|1|||
170478749|NCT03093259|616092338|FG001|Overall Study|Withdrawal by Subject|0|||
170893885|NCT01808612|617619969|FG001|Treatment Period|Sponsor Decision|0|||
170893886|NCT01808612|617619970|FG002|Treatment Period|Sponsor Decision|0|||
170478750|NCT02575833|616092339|FG000|Overall Study|Withdrawal by Subject|0|||
170478751|NCT02575833|616092340|FG001|Overall Study|Withdrawal by Subject|1|||
170478752|NCT02575833|616092339|FG000|Overall Study|Lost to Follow-up|1|||
170478753|NCT02575833|616092340|FG001|Overall Study|Lost to Follow-up|0|||
170478754|NCT01757275|616092341|FG000|Overall Study|Lost to Follow-up|1|||
170478755|NCT01757275|616092342|FG001|Overall Study|Lost to Follow-up|2|||
170478756|NCT01757275|616092341|FG000|Overall Study|Adverse Event|3|||
170478757|NCT01757275|616092342|FG001|Overall Study|Adverse Event|3|||
170478758|NCT01757275|616092341|FG000|Overall Study|Withdrawal by Subject|2|||
170478759|NCT01757275|616092342|FG001|Overall Study|Withdrawal by Subject|4|||
170478760|NCT01757275|616092341|FG000|Overall Study|Not treated|3|||
170478761|NCT01757275|616092342|FG001|Overall Study|Not treated|4|||
170478762|NCT01821807|616092345|FG000|Overall Study|Lost to Follow-up|3|||
170478763|NCT01821807|616092346|FG001|Overall Study|Lost to Follow-up|1|||
170478764|NCT01401452|616092350|FG000|Overall Study|Adverse reaction|9|||
170478765|NCT01401452|616092350|FG000|Overall Study|Lost to Follow-up|12|||
170478766|NCT01401452|616092350|FG000|Overall Study|Lack of Efficacy|30|||
170478767|NCT01401452|616092350|FG000|Overall Study|Participant developed breast cancer|1|||
170547492|NCT04689009|616350193|FG000|Overall Study|Adverse Event|1|||
170478768|NCT01401452|616092350|FG000|Overall Study|Tx stopped due to financial reasons|1|||
170478769|NCT01401452|616092350|FG000|Overall Study|Tx stopped by psychiatrist|1|||
170478770|NCT01401452|616092350|FG000|Overall Study|No more visits within the 36 wk followup|4|||
170478771|NCT01401452|616092350|FG000|Overall Study|Subject did not come to follow up visits|2|||
170478772|NCT01401452|616092350|FG000|Overall Study|Subject didn't return for routine visits|1|||
170547493|NCT04689009|616350194|FG001|Overall Study|Adverse Event|0|||
170547494|NCT04689009|616350193|FG000|Overall Study|Lost to Follow-up|1|||
170547495|NCT04689009|616350194|FG001|Overall Study|Lost to Follow-up|2|||
170547496|NCT04689009|616350193|FG000|Overall Study|Withdrawal by Subject|4|||
170547497|NCT04689009|616350194|FG001|Overall Study|Withdrawal by Subject|3|||
170547498|NCT04689009|616350193|FG000|Overall Study|Protocol Violation|1|||
170547499|NCT04689009|616350194|FG001|Overall Study|Protocol Violation|0|||
170547500|NCT03467945|616350195|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170547501|NCT03467945|616350196|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170547502|NCT03467945|616350197|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170547503|NCT03467945|616350198|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170547504|NCT03467945|616350195|FG000|Treatment Period 3|Withdrawal by Subject|1|||
170547505|NCT03467945|616350196|FG001|Treatment Period 3|Withdrawal by Subject|0|||
170547506|NCT03467945|616350197|FG002|Treatment Period 3|Withdrawal by Subject|2|||
170547507|NCT03467945|616350198|FG003|Treatment Period 3|Withdrawal by Subject|1|||
170547508|NCT04595370|616350211|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
170547509|NCT04595370|616350212|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
170547510|NCT04595370|616350213|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
170547511|NCT04595370|616350214|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
170547512|NCT04595370|616350215|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
170547513|NCT04595370|616350216|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
170547514|NCT04595370|616350211|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
170547515|NCT04595370|616350212|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
170547516|NCT04595370|616350213|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
170547517|NCT04595370|616350214|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
170547518|NCT04595370|616350215|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
170793826|NCT03476343|617254142|FG000|Overall Study|Clinical exam moved to another scanner|7|||
170793827|NCT03476343|617254142|FG000|Overall Study|Clinical order cancelled|4|||
170793828|NCT03476343|617254142|FG000|Overall Study|Neonate did not settle down for the scan|1|||
170793829|NCT05863156|617254143|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
170793830|NCT05863156|617254144|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
170793831|NCT05863156|617254145|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
170793832|NCT01346540|617254146|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
170793833|NCT01346540|617254147|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
170793834|NCT01346540|617254146|FG000|Overall Study|Adverse Event|0|||
170793835|NCT01346540|617254147|FG001|Overall Study|Adverse Event|4|||
170793836|NCT04690582|617254153|FG000|Overall Study|Withdrawal by Subject|6|||
170793837|NCT04690582|617254154|FG001|Overall Study|Withdrawal by Subject|4|||
170793838|NCT04270942|617254156|FG000|Overall Study|Death|1|||
170793839|NCT05147116|617254158|FG000|Overall Study|Withdrawal by Subject|0|||
170478773|NCT01401452|616092350|FG000|Overall Study|Subject moved to another city|1|||
170478774|NCT01401452|616092350|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
170478775|NCT01401452|616092350|FG000|Overall Study|Psoriatic arthritis|1|||
170793840|NCT05147116|617254159|FG001|Overall Study|Withdrawal by Subject|1|||
170478776|NCT01401452|616092350|FG000|Overall Study|Participant stopped Tx|2|||
170478777|NCT01401452|616092350|FG000|Overall Study|Discontinuation for personal reasons|1|||
170478778|NCT01401452|616092350|FG000|Overall Study|Treatment failure|1|||
170478779|NCT01401452|616092350|FG000|Overall Study|Unsatisfactory output|1|||
170478780|NCT01401452|616092350|FG000|Overall Study|Subject withdrew because of Tx success|1|||
170478781|NCT01401452|616092350|FG000|Overall Study|Subject chose to discontinue treatment|1|||
170478782|NCT01401452|616092350|FG000|Overall Study|Participant withdrew consent|1|||
170478783|NCT00550459|616092351|FG000|Overall Study|Adverse Event|0|||
170478784|NCT00550459|616092352|FG001|Overall Study|Adverse Event|2|||
170478785|NCT00550459|616092351|FG000|Overall Study|Withdrawal by Subject|1|||
170478786|NCT00550459|616092352|FG001|Overall Study|Withdrawal by Subject|1|||
170478787|NCT02633787|616092353|FG000|Overall Study|Withdrawal by Subject|1|||
170478788|NCT00584454|616092354|FG000|Overall Study|Adverse Event|1|||
170478789|NCT00584454|616092354|FG000|Overall Study|Relocation|1|||
170478790|NCT00584454|616092354|FG000|Overall Study|Clinical Hold|2|||
170478791|NCT01742897|616092355|FG000|Overall Study|Adverse Event|3|||
170478792|NCT01742897|616092355|FG000|Overall Study|Withdrawal by Subject|1|||
170478793|NCT01742897|616092355|FG000|Overall Study|Other|1|||
170478794|NCT02404805|616092356|FG000|Overall Study|Withdrawal by Subject|1|||
170478795|NCT02404805|616092357|FG001|Overall Study|Withdrawal by Subject|0|||
170478796|NCT02404805|616092358|FG002|Overall Study|Withdrawal by Subject|0|||
170478797|NCT02404805|616092359|FG003|Overall Study|Withdrawal by Subject|0|||
170478798|NCT02404805|616092360|FG004|Overall Study|Withdrawal by Subject|0|||
170478799|NCT02404805|616092361|FG005|Overall Study|Withdrawal by Subject|0|||
170478800|NCT00768248|616092362|FG000|Overall Study|Research coordinator didn't collect data|1|||
170478801|NCT00768248|616092363|FG001|Overall Study|Research coordinator didn't collect data|1|||
170478802|NCT01459783|616092368|FG000|Baseline to 6 Months|Death|1|||
170478803|NCT01459783|616092369|FG001|Baseline to 6 Months|Death|0|||
170478804|NCT01459783|616092368|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
170478805|NCT01459783|616092369|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
170478806|NCT01459783|616092368|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
170478807|NCT01459783|616092369|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
170478808|NCT01459783|616092368|FG000|6 Months to 12 Months|Death|0|||
170478809|NCT01459783|616092369|FG001|6 Months to 12 Months|Death|1|||
170478810|NCT01459783|616092368|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
170478811|NCT01459783|616092369|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
170478812|NCT01459783|616092368|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
170478813|NCT01459783|616092369|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
170478814|NCT01459783|616092368|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
170478815|NCT01459783|616092369|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
170478816|NCT04211831|616092370|FG000|Overall Study|Withdrawal by Subject|4|||
170478817|NCT04211831|616092371|FG001|Overall Study|Withdrawal by Subject|1|||
170478818|NCT04211831|616092372|FG002|Overall Study|Withdrawal by Subject|1|||
170478819|NCT04211831|616092370|FG000|Overall Study|Protocol Violation|0|||
170478820|NCT04211831|616092371|FG001|Overall Study|Protocol Violation|0|||
170478821|NCT04211831|616092372|FG002|Overall Study|Protocol Violation|1|||
170478822|NCT04211831|616092370|FG000|Overall Study|Adverse Event|0|||
170478823|NCT04211831|616092371|FG001|Overall Study|Adverse Event|1|||
170547519|NCT04595370|616350216|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
170547520|NCT04595370|616350211|FG000|Overall Study|Adverse Event|0|||
170547521|NCT04595370|616350212|FG001|Overall Study|Adverse Event|4|||
170547522|NCT04595370|616350213|FG002|Overall Study|Adverse Event|3|||
170547523|NCT04595370|616350214|FG003|Overall Study|Adverse Event|1|||
170547524|NCT04595370|616350215|FG004|Overall Study|Adverse Event|1|||
170547525|NCT04595370|616350216|FG005|Overall Study|Adverse Event|1|||
170547526|NCT04595370|616350211|FG000|Overall Study|Withdrawal of Consent|1|||
170793841|NCT03625115|617254160|FG000|Overall Study|Withdrawal by Subject|4|||
170793842|NCT03625115|617254161|FG001|Overall Study|Withdrawal by Subject|7|||
170793843|NCT03625115|617254160|FG000|Overall Study|Lost to Follow-up|17|||
170478824|NCT04211831|616092372|FG002|Overall Study|Adverse Event|0|||
170478825|NCT04211831|616092370|FG000|Overall Study|Lack of Efficacy|0|||
170478826|NCT04211831|616092371|FG001|Overall Study|Lack of Efficacy|0|||
170547527|NCT04595370|616350212|FG001|Overall Study|Withdrawal of Consent|1|||
170547528|NCT04595370|616350213|FG002|Overall Study|Withdrawal of Consent|1|||
170547529|NCT04595370|616350214|FG003|Overall Study|Withdrawal of Consent|0|||
170547530|NCT04595370|616350215|FG004|Overall Study|Withdrawal of Consent|0|||
170793844|NCT03625115|617254161|FG001|Overall Study|Lost to Follow-up|24|||
170478827|NCT04211831|616092372|FG002|Overall Study|Lack of Efficacy|1|||
170478828|NCT04211831|616092370|FG000|Overall Study|Lost to Follow-up|0|||
170478829|NCT04211831|616092371|FG001|Overall Study|Lost to Follow-up|0|||
170478830|NCT04211831|616092372|FG002|Overall Study|Lost to Follow-up|2|||
170478831|NCT04211831|616092370|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
170478832|NCT04211831|616092371|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
170478833|NCT04211831|616092372|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
170793845|NCT04577963|617254162|FG000|Part 2|Death|0|||
170793846|NCT04577963|617254163|FG001|Part 2|Death|1|||
170478834|NCT04211831|616092370|FG000|Overall Study|Other|0|||
170478835|NCT04211831|616092371|FG001|Overall Study|Other|1|||
170478836|NCT04211831|616092372|FG002|Overall Study|Other|0|||
170478837|NCT00967330|616092373|FG000|Overall Study|Protocol Violation|3|||
170478838|NCT00967330|616092374|FG001|Overall Study|Protocol Violation|4|||
170478839|NCT00967330|616092373|FG000|Overall Study|Regular|10|||
170478840|NCT00967330|616092374|FG001|Overall Study|Regular|3|||
170478841|NCT00967330|616092373|FG000|Overall Study|Withdrawal by Subject|6|||
170478842|NCT00967330|616092374|FG001|Overall Study|Withdrawal by Subject|0|||
170478843|NCT00967330|616092373|FG000|Overall Study|Lost to Follow-up|1|||
170478844|NCT00967330|616092374|FG001|Overall Study|Lost to Follow-up|1|||
170478845|NCT00967330|616092373|FG000|Overall Study|Death|102|||
170478846|NCT00967330|616092374|FG001|Overall Study|Death|51|||
170478847|NCT00967330|616092373|FG000|Overall Study|Severe protocol deviation|0|||
170478848|NCT00967330|616092374|FG001|Overall Study|Severe protocol deviation|1|||
170478849|NCT02548143|616092375|FG000|Overall Study|Adverse Event|1|||
170478850|NCT02548143|616092376|FG001|Overall Study|Adverse Event|0|||
170478851|NCT02548143|616092375|FG000|Overall Study|Withdrawal by Subject|0|||
170478852|NCT02548143|616092376|FG001|Overall Study|Withdrawal by Subject|1|||
170478853|NCT01127256|616094215|FG000|Overall Study|Adverse Event|13|||
170478854|NCT01127256|616094216|FG001|Overall Study|Adverse Event|13|||
170478855|NCT01127256|616094215|FG000|Overall Study|Lack of Efficacy|4|||
170478856|NCT01127256|616094216|FG001|Overall Study|Lack of Efficacy|0|||
170478857|NCT01127256|616094215|FG000|Overall Study|Lost to Follow-up|16|||
170478858|NCT01127256|616094216|FG001|Overall Study|Lost to Follow-up|17|||
170478859|NCT01127256|616094215|FG000|Overall Study|Withdrawal by Subject|5|||
170478860|NCT01127256|616094216|FG001|Overall Study|Withdrawal by Subject|9|||
170478861|NCT01127256|616094215|FG000|Overall Study|Protocol Violation|1|||
170478862|NCT01127256|616094216|FG001|Overall Study|Protocol Violation|0|||
170478863|NCT00679211|616094217|FG000|Overall Study|Progressive disease|82|||
170478864|NCT00679211|616094217|FG000|Overall Study|Adverse Event|7|||
170478865|NCT00679211|616094217|FG000|Overall Study|Withdrawal by Subject|2|||
170478866|NCT00679211|616094217|FG000|Overall Study|Physician Decision|5|||
170478867|NCT00679211|616094217|FG000|Overall Study|Refused to undergo protocol procedures|1|||
170478868|NCT00679211|616094217|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
170478869|NCT00679211|616094217|FG000|Overall Study|Other|1|||
170478870|NCT00931528|616094220|FG000|Overall Study|Protocol Violation|9|||
170478871|NCT00931528|616094221|FG001|Overall Study|Protocol Violation|12|||
170478872|NCT00931528|616094220|FG000|Overall Study|Withdrawal by Subject|4|||
170478873|NCT00931528|616094221|FG001|Overall Study|Withdrawal by Subject|12|||
170547531|NCT04595370|616350216|FG005|Overall Study|Withdrawal of Consent|0|||
170547532|NCT04595370|616350211|FG000|Overall Study|Death|0|||
170547533|NCT04595370|616350212|FG001|Overall Study|Death|1|||
170547534|NCT04595370|616350213|FG002|Overall Study|Death|0|||
170547535|NCT04595370|616350214|FG003|Overall Study|Death|0|||
170547536|NCT04595370|616350215|FG004|Overall Study|Death|1|||
170547537|NCT04595370|616350216|FG005|Overall Study|Death|0|||
170547538|NCT04595370|616350211|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170547539|NCT04595370|616350212|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170547540|NCT04595370|616350213|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
170547541|NCT04595370|616350214|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170547542|NCT04595370|616350215|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170547543|NCT04595370|616350216|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170793847|NCT04577963|617254164|FG002|Part 2|Death|8|||
170793848|NCT04577963|617254165|FG003|Part 2|Death|0|||
170793849|NCT04577963|617254166|FG004|Part 2|Death|20|||
170793850|NCT04577963|617254162|FG000|Part 2|Lost to Follow-up|0|||
170793851|NCT04577963|617254163|FG001|Part 2|Lost to Follow-up|0|||
170893887|NCT01808612|617619968|FG000|Treatment Period|Lack of Efficacy|1|||
170893888|NCT01808612|617619969|FG001|Treatment Period|Lack of Efficacy|1|||
170793852|NCT04577963|617254164|FG002|Part 2|Lost to Follow-up|0|||
170793853|NCT04577963|617254165|FG003|Part 2|Lost to Follow-up|0|||
170793854|NCT04577963|617254166|FG004|Part 2|Lost to Follow-up|2|||
170793855|NCT04577963|617254162|FG000|Part 2|Withdrawal by Subject|0|||
170893889|NCT01808612|617619970|FG002|Treatment Period|Lack of Efficacy|2|||
170893890|NCT01808612|617619968|FG000|Discontinuation Period|Adverse Event|1|||
170893891|NCT01808612|617619969|FG001|Discontinuation Period|Adverse Event|0|||
170478874|NCT00931528|616094220|FG000|Overall Study|Lost to Follow-up|6|||
170478875|NCT00931528|616094221|FG001|Overall Study|Lost to Follow-up|13|||
170478876|NCT00931528|616094220|FG000|Overall Study|Assessment outside of Time Frame|22|||
170478877|NCT00931528|616094221|FG001|Overall Study|Assessment outside of Time Frame|23|||
170478878|NCT00813150|616094222|FG000|Treatment Period|Adverse Event|16|||
170478879|NCT00813150|616094223|FG001|Treatment Period|Adverse Event|15|||
170793856|NCT04577963|617254163|FG001|Part 2|Withdrawal by Subject|0|||
170478880|NCT00813150|616094222|FG000|Treatment Period|Death|2|||
170478881|NCT00813150|616094223|FG001|Treatment Period|Death|0|||
170793857|NCT04577963|617254164|FG002|Part 2|Withdrawal by Subject|0|||
170793858|NCT04577963|617254165|FG003|Part 2|Withdrawal by Subject|0|||
170793859|NCT04577963|617254166|FG004|Part 2|Withdrawal by Subject|10|||
170893892|NCT01808612|617619970|FG002|Discontinuation Period|Adverse Event|0|||
170478882|NCT00813150|616094222|FG000|Treatment Period|Progressive disease|1|||
170478883|NCT00813150|616094223|FG001|Treatment Period|Progressive disease|0|||
170478884|NCT00813150|616094222|FG000|Treatment Period|Complete response|0|||
170478885|NCT00813150|616094223|FG001|Treatment Period|Complete response|1|||
170478886|NCT00813150|616094222|FG000|Treatment Period|Stable disease|1|||
170478887|NCT00813150|616094223|FG001|Treatment Period|Stable disease|2|||
170478888|NCT00813150|616094222|FG000|Treatment Period|Protocol Violation|3|||
170478889|NCT00813150|616094223|FG001|Treatment Period|Protocol Violation|4|||
170478890|NCT00813150|616094222|FG000|Treatment Period|Withdrawal by Subject|5|||
170478891|NCT00813150|616094223|FG001|Treatment Period|Withdrawal by Subject|3|||
170478892|NCT00813150|616094222|FG000|Treatment Period|Non compliance|0|||
170478893|NCT00813150|616094223|FG001|Treatment Period|Non compliance|1|||
170478894|NCT00813150|616094222|FG000|Treatment Period|Reason not specified|3|||
170478895|NCT00813150|616094223|FG001|Treatment Period|Reason not specified|4|||
170478896|NCT00813150|616094222|FG000|Treatment Period|Data not available|1|||
170478897|NCT00813150|616094223|FG001|Treatment Period|Data not available|2|||
170478898|NCT00813150|616094222|FG000|Long Term Follow-up|Death|0|||
170478899|NCT00813150|616094223|FG001|Long Term Follow-up|Death|4|||
170478900|NCT00813150|616094222|FG000|Long Term Follow-up|Other|0|||
170478901|NCT00813150|616094223|FG001|Long Term Follow-up|Other|3|||
170478902|NCT00813150|616094222|FG000|Long Term Follow-up|Lost to Follow-up|2|||
170478903|NCT00813150|616094223|FG001|Long Term Follow-up|Lost to Follow-up|0|||
170478904|NCT00813150|616094222|FG000|Long Term Follow-up|Progression/Relapse|22|||
170478905|NCT00813150|616094223|FG001|Long Term Follow-up|Progression/Relapse|24|||
170478906|NCT05085834|616094224|FG000|Overall Study|Lost to Follow-up|9|||
170478907|NCT05085834|616094225|FG001|Overall Study|Lost to Follow-up|2|||
170478908|NCT05085834|616094224|FG000|Overall Study|Adverse Event|6|||
170478909|NCT05085834|616094225|FG001|Overall Study|Adverse Event|0|||
170478910|NCT05085834|616094224|FG000|Overall Study|Death|1|||
170478911|NCT05085834|616094225|FG001|Overall Study|Death|0|||
170478912|NCT05085834|616094224|FG000|Overall Study|Inability to swallow the pill|0|||
170478913|NCT05085834|616094225|FG001|Overall Study|Inability to swallow the pill|1|||
170478914|NCT05842967|616094226|FG000|Period 1: SSA|Adverse Event|1|||
170478915|NCT05842967|616094227|FG001|Period 1: SSA|Adverse Event|1|||
170478916|NCT05842967|616094228|FG002|Period 1: SSA|Adverse Event|0|||
170478917|NCT05842967|616094229|FG003|Period 1: SSA|Adverse Event|0|||
170478918|NCT05842967|616094226|FG000|Period 1: SSA|Death|1|||
170478919|NCT05842967|616094227|FG001|Period 1: SSA|Death|0|||
170478920|NCT05842967|616094228|FG002|Period 1: SSA|Death|0|||
170478921|NCT05842967|616094229|FG003|Period 1: SSA|Death|0|||
170478922|NCT05842967|616094226|FG000|Period 1: SSA|Lost to Follow-up|16|||
170478923|NCT05842967|616094227|FG001|Period 1: SSA|Lost to Follow-up|4|||
170478924|NCT05842967|616094228|FG002|Period 1: SSA|Lost to Follow-up|0|||
170478925|NCT05842967|616094229|FG003|Period 1: SSA|Lost to Follow-up|0|||
170478926|NCT05842967|616094226|FG000|Period 1: SSA|Physician Decision|1|||
170478927|NCT05842967|616094227|FG001|Period 1: SSA|Physician Decision|0|||
170478928|NCT05842967|616094228|FG002|Period 1: SSA|Physician Decision|0|||
170478929|NCT05842967|616094229|FG003|Period 1: SSA|Physician Decision|0|||
170478930|NCT05842967|616094226|FG000|Period 1: SSA|Withdrawal by Subject|2|||
170478931|NCT05842967|616094227|FG001|Period 1: SSA|Withdrawal by Subject|2|||
170478932|NCT05842967|616094228|FG002|Period 1: SSA|Withdrawal by Subject|0|||
170478933|NCT05842967|616094229|FG003|Period 1: SSA|Withdrawal by Subject|0|||
170478934|NCT05842967|616094226|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
170478935|NCT05842967|616094227|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
170478936|NCT05842967|616094228|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
170478937|NCT05842967|616094229|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
170478938|NCT05842967|616094226|FG000|Period 2: SSB|Adverse Event|0|||
170478939|NCT05842967|616094227|FG001|Period 2: SSB|Adverse Event|0|||
170478940|NCT05842967|616094228|FG002|Period 2: SSB|Adverse Event|2|||
170478941|NCT05842967|616094229|FG003|Period 2: SSB|Adverse Event|0|||
170478942|NCT05842967|616094226|FG000|Period 2: SSB|Lost to Follow-up|0|||
170478943|NCT05842967|616094227|FG001|Period 2: SSB|Lost to Follow-up|0|||
170478944|NCT05842967|616094228|FG002|Period 2: SSB|Lost to Follow-up|4|||
170478945|NCT05842967|616094229|FG003|Period 2: SSB|Lost to Follow-up|3|||
170478946|NCT05842967|616094226|FG000|Period 2: SSB|Withdrawal by Subject|0|||
170478947|NCT05842967|616094227|FG001|Period 2: SSB|Withdrawal by Subject|0|||
170478948|NCT05842967|616094228|FG002|Period 2: SSB|Withdrawal by Subject|1|||
170478949|NCT05842967|616094229|FG003|Period 2: SSB|Withdrawal by Subject|0|||
170478950|NCT05842967|616094226|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
170478951|NCT05842967|616094227|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
170478952|NCT05842967|616094228|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
170478953|NCT05842967|616094229|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
170478954|NCT05842967|616094226|FG000|Period 2: SSB|Protocol Violation|0|||
170478955|NCT05842967|616094227|FG001|Period 2: SSB|Protocol Violation|0|||
170478956|NCT05842967|616094228|FG002|Period 2: SSB|Protocol Violation|0|||
170478957|NCT05842967|616094229|FG003|Period 2: SSB|Protocol Violation|1|||
170478958|NCT02572570|616094237|FG000|Overall Study|Study Terminated|27|||
170478959|NCT01217112|616094238|FG000|Overall Study|Adverse Event|0|||
170478960|NCT01217112|616094239|FG001|Overall Study|Adverse Event|2|||
170478961|NCT01217112|616094240|FG002|Overall Study|Adverse Event|0|||
170478962|NCT01217112|616094241|FG003|Overall Study|Adverse Event|2|||
170478963|NCT01217112|616094242|FG004|Overall Study|Adverse Event|0|||
170478964|NCT01217112|616094238|FG000|Overall Study|Withdrawal by Subject|0|||
170478965|NCT01217112|616094239|FG001|Overall Study|Withdrawal by Subject|0|||
170478966|NCT01217112|616094240|FG002|Overall Study|Withdrawal by Subject|1|||
170478967|NCT01217112|616094241|FG003|Overall Study|Withdrawal by Subject|0|||
170478968|NCT01217112|616094242|FG004|Overall Study|Withdrawal by Subject|0|||
170478969|NCT01217112|616094238|FG000|Overall Study|Physician Decision|0|||
170478970|NCT01217112|616094239|FG001|Overall Study|Physician Decision|0|||
170478971|NCT01217112|616094240|FG002|Overall Study|Physician Decision|0|||
170478972|NCT01217112|616094241|FG003|Overall Study|Physician Decision|0|||
170478973|NCT01217112|616094242|FG004|Overall Study|Physician Decision|1|||
170478974|NCT02157935|616094245|FG000|Overall Study|Withdrawal by Subject|25|||
170478975|NCT02157935|616094246|FG001|Overall Study|Withdrawal by Subject|39|||
170478976|NCT02157935|616094245|FG000|Overall Study|Screen failure|1|||
170478977|NCT02157935|616094246|FG001|Overall Study|Screen failure|2|||
170478978|NCT02157935|616094245|FG000|Overall Study|Protocol Violation|1|||
170478979|NCT02157935|616094246|FG001|Overall Study|Protocol Violation|0|||
170478980|NCT02157935|616094245|FG000|Overall Study|Progressive disease|0|||
170478981|NCT02157935|616094246|FG001|Overall Study|Progressive disease|2|||
170478982|NCT02157935|616094245|FG000|Overall Study|Other|5|||
170478983|NCT02157935|616094246|FG001|Overall Study|Other|12|||
170478984|NCT02157935|616094245|FG000|Overall Study|Lack of Efficacy|0|||
170478985|NCT02157935|616094246|FG001|Overall Study|Lack of Efficacy|1|||
170478986|NCT02157935|616094245|FG000|Overall Study|Death|4|||
170478987|NCT02157935|616094246|FG001|Overall Study|Death|4|||
170478988|NCT02157935|616094245|FG000|Overall Study|Adverse Event|3|||
170478989|NCT02157935|616094246|FG001|Overall Study|Adverse Event|5|||
170478990|NCT01401361|616094247|FG000|Overall Study|Withdrawal by Subject|16|||
170478991|NCT01401361|616094247|FG000|Overall Study|Lack of Efficacy|6|||
170478992|NCT01401361|616094247|FG000|Overall Study|Physician Decision|1|||
170478993|NCT01401361|616094247|FG000|Overall Study|Lost to Follow-up|3|||
170478994|NCT01401361|616094247|FG000|Overall Study|Subject/family decision post procedure|2|||
170478995|NCT00595920|616094250|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
170478996|NCT00611923|616094251|FG000|Overall Study|Withdrawal by Subject|2|||
170478997|NCT00611923|616094252|FG001|Overall Study|Withdrawal by Subject|2|||
170478998|NCT04565145|616094253|FG000|Overall Study|Withdrawal by Subject|1|||
170478999|NCT04565145|616094254|FG001|Overall Study|Withdrawal by Subject|1|||
170479000|NCT01892501|616094257|FG000|Overall Study|Protocol Violation|2|||
170479001|NCT01892501|616094257|FG000|Overall Study|Puncture not carried out|9|||
170479002|NCT01892501|616094257|FG000|Overall Study|Radiological monitoring not carried out|5|||
170479003|NCT01892501|616094257|FG000|Overall Study|Non-contributory histological result|12|||
170479004|NCT04335123|616094258|FG000|Overall Study|Withdrawal by Subject|2|||
170479005|NCT04335123|616094259|FG001|Overall Study|Withdrawal by Subject|0|||
170479006|NCT04335123|616094258|FG000|Overall Study|Physician Decision|2|||
170479007|NCT04335123|616094259|FG001|Overall Study|Physician Decision|0|||
170479008|NCT02302833|616094264|FG000|Overall Study|Lost to Follow-up|3|||
170479009|NCT04429503|616094265|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
170479010|NCT04429503|616094266|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
170479011|NCT04429503|616094267|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
170479012|NCT04429503|616094268|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
170479013|NCT04429503|616094269|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
170479014|NCT04429503|616094270|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
170479015|NCT04429503|616094265|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
170479016|NCT04429503|616094266|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
170893893|NCT01808612|617619968|FG000|Discontinuation Period|Physician Decision|1|||
170893894|NCT01808612|617619969|FG001|Discontinuation Period|Physician Decision|0|||
170893895|NCT01808612|617619970|FG002|Discontinuation Period|Physician Decision|0|||
170893896|NCT01808612|617619968|FG000|Discontinuation Period|Lost to Follow-up|0|||
170893897|NCT01808612|617619969|FG001|Discontinuation Period|Lost to Follow-up|1|||
170893898|NCT01808612|617619970|FG002|Discontinuation Period|Lost to Follow-up|0|||
170893899|NCT03739528|617619971|FG000|Overall Study|Not treated|8|||
170893900|NCT03739528|617619972|FG001|Overall Study|Not treated|12|||
170893901|NCT03739528|617619971|FG000|Overall Study|Treatment and study discontinued|6|||
170479017|NCT04429503|616094267|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
170479018|NCT04429503|616094268|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
170479019|NCT04429503|616094269|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
170479020|NCT04429503|616094270|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
170479021|NCT04429503|616094265|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
170479022|NCT04429503|616094266|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
170479023|NCT04429503|616094267|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
170893902|NCT03739528|617619972|FG001|Overall Study|Treatment and study discontinued|2|||
170479024|NCT04429503|616094268|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
170479025|NCT04429503|616094269|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
170479026|NCT04429503|616094270|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
170479027|NCT04429503|616094265|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
170479028|NCT04429503|616094266|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
170479029|NCT04429503|616094267|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
170479030|NCT04429503|616094268|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
170479031|NCT04429503|616094269|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
170479032|NCT04429503|616094270|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
170479033|NCT04429503|616094265|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
170479034|NCT04429503|616094266|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
170479035|NCT04429503|616094267|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
170479036|NCT04429503|616094268|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
170479037|NCT04429503|616094269|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
170479038|NCT04429503|616094270|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
170479039|NCT04429503|616094265|FG000|Main Study (Up to Wk 96)|Death|9|||
170479040|NCT04429503|616094266|FG001|Main Study (Up to Wk 96)|Death|18|||
170479041|NCT04429503|616094267|FG002|Main Study (Up to Wk 96)|Death|5|||
170479042|NCT04429503|616094268|FG003|Main Study (Up to Wk 96)|Death|0|||
170479043|NCT04429503|616094269|FG004|Main Study (Up to Wk 96)|Death|0|||
170479044|NCT04429503|616094270|FG005|Main Study (Up to Wk 96)|Death|0|||
170479045|NCT04429503|616094265|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
170479046|NCT04429503|616094266|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
170479047|NCT04429503|616094267|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
170479048|NCT04429503|616094268|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
170479049|NCT04429503|616094269|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
170479050|NCT04429503|616094270|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
170479051|NCT04429503|616094265|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
170479052|NCT04429503|616094266|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
170479053|NCT04429503|616094267|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
170479054|NCT04429503|616094268|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
170479055|NCT04429503|616094269|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
170479056|NCT04429503|616094270|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
170479057|NCT04429503|616094265|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
170479058|NCT04429503|616094266|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
170479059|NCT04429503|616094267|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
170479060|NCT04429503|616094268|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
170479061|NCT04429503|616094269|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
170479062|NCT04429503|616094270|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
170479063|NCT04429503|616094265|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
170479064|NCT04429503|616094266|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
170479065|NCT04429503|616094267|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
170479066|NCT04429503|616094268|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
170479067|NCT04429503|616094269|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
170479068|NCT04429503|616094270|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
170479069|NCT04429503|616094265|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
170479070|NCT04429503|616094266|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
170479071|NCT04429503|616094267|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
170479072|NCT04429503|616094268|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
170479073|NCT04429503|616094269|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
170479074|NCT04429503|616094270|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
170479075|NCT04429503|616094265|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
170479076|NCT04429503|616094266|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
170893903|NCT03739528|617619971|FG000|Overall Study|Treatment discontinued + study completed|1|||
170893904|NCT03739528|617619972|FG001|Overall Study|Treatment discontinued + study completed|3|||
170893905|NCT03072160|617619973|FG000|Overall Study|Adverse Event|3|||
170893906|NCT03072160|617619974|FG001|Overall Study|Adverse Event|1|||
170479077|NCT04429503|616094267|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
170479078|NCT04429503|616094268|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
170479079|NCT04429503|616094269|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
170479080|NCT04429503|616094270|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
170479081|NCT02717507|616094275|FG000|Overall Study|Lost to Follow-up|5|||
170479082|NCT02717507|616094276|FG001|Overall Study|Lost to Follow-up|8|||
170893907|NCT03072160|617619973|FG000|Overall Study|Refused further treatment|6|||
170893908|NCT03072160|617619974|FG001|Overall Study|Refused further treatment|1|||
170893909|NCT03072160|617619973|FG000|Overall Study|Physician Decision|1|||
170479083|NCT02717507|616094275|FG000|Overall Study|Pregnancy|1|||
170479084|NCT02717507|616094276|FG001|Overall Study|Pregnancy|1|||
170893910|NCT03072160|617619974|FG001|Overall Study|Physician Decision|0|||
170893911|NCT03072160|617619973|FG000|Overall Study|Disease progression on study|1|||
170479085|NCT02717507|616094275|FG000|Overall Study|Protocol Violation|2|||
170479086|NCT02717507|616094276|FG001|Overall Study|Protocol Violation|2|||
170479087|NCT02717507|616094275|FG000|Overall Study|Withdrawal by Subject|20|||
170479088|NCT02717507|616094276|FG001|Overall Study|Withdrawal by Subject|20|||
170479089|NCT02717507|616094275|FG000|Overall Study|Relapse|1|||
170479090|NCT02717507|616094276|FG001|Overall Study|Relapse|1|||
170479091|NCT02717507|616094275|FG000|Overall Study|Cardiac Event|2|||
170479092|NCT02717507|616094276|FG001|Overall Study|Cardiac Event|6|||
170479093|NCT00970593|616094277|FG000|Overall Study|Adverse Event|1|||
170479094|NCT00970593|616094278|FG001|Overall Study|Adverse Event|1|||
170479095|NCT00970593|616094279|FG002|Overall Study|Adverse Event|0|||
170479096|NCT00970593|616094280|FG003|Overall Study|Adverse Event|0|||
170479097|NCT00970593|616094281|FG004|Overall Study|Adverse Event|0|||
170479098|NCT00970593|616094282|FG005|Overall Study|Adverse Event|0|||
170479099|NCT00970593|616094283|FG006|Overall Study|Adverse Event|0|||
170479100|NCT00970593|616094277|FG000|Overall Study|Discontinuation of study by sponsor|0|||
170479101|NCT00970593|616094278|FG001|Overall Study|Discontinuation of study by sponsor|0|||
170479102|NCT00970593|616094279|FG002|Overall Study|Discontinuation of study by sponsor|5|||
170479103|NCT00970593|616094280|FG003|Overall Study|Discontinuation of study by sponsor|0|||
170479104|NCT00970593|616094281|FG004|Overall Study|Discontinuation of study by sponsor|0|||
170479105|NCT00970593|616094282|FG005|Overall Study|Discontinuation of study by sponsor|0|||
170479106|NCT00970593|616094283|FG006|Overall Study|Discontinuation of study by sponsor|2|||
170479107|NCT00970593|616094277|FG000|Overall Study|Withdrawal by Subject|0|||
170479108|NCT00970593|616094278|FG001|Overall Study|Withdrawal by Subject|0|||
170479109|NCT00970593|616094279|FG002|Overall Study|Withdrawal by Subject|1|||
170479110|NCT00970593|616094280|FG003|Overall Study|Withdrawal by Subject|0|||
170479111|NCT00970593|616094281|FG004|Overall Study|Withdrawal by Subject|0|||
170479112|NCT00970593|616094282|FG005|Overall Study|Withdrawal by Subject|0|||
170479113|NCT00970593|616094283|FG006|Overall Study|Withdrawal by Subject|0|||
170479114|NCT02203357|616094284|FG000|Overall Study|Lost to Follow-up|58|||
170479115|NCT02203357|616094285|FG001|Overall Study|Lost to Follow-up|66|||
170479116|NCT02203357|616094286|FG002|Overall Study|Lost to Follow-up|70|||
170479117|NCT01866826|616094293|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
170479118|NCT01866826|616094294|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
170479119|NCT01866826|616094293|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
170479120|NCT01866826|616094294|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
170479121|NCT01866826|616094293|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
170479122|NCT01866826|616094294|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
170479123|NCT02493660|616094295|FG000|Overall Study|Physician Decision|0|||
170479124|NCT02493660|616094296|FG001|Overall Study|Physician Decision|1|||
170479125|NCT02493660|616094295|FG000|Overall Study|Adverse Event|4|||
170479126|NCT02493660|616094296|FG001|Overall Study|Adverse Event|2|||
170479127|NCT02493660|616094295|FG000|Overall Study|Withdrawal by Subject|2|||
170479128|NCT02493660|616094296|FG001|Overall Study|Withdrawal by Subject|3|||
170479129|NCT02493660|616094295|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
170479130|NCT02493660|616094296|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
170479131|NCT02493660|616094295|FG000|Overall Study|Protocol Violation|0|||
170479132|NCT02493660|616094296|FG001|Overall Study|Protocol Violation|1|||
170479133|NCT02493660|616094295|FG000|Overall Study|Death|0|||
170479134|NCT02493660|616094296|FG001|Overall Study|Death|1|||
170479135|NCT02493660|616094295|FG000|Overall Study|Lost to Follow-up|2|||
170479136|NCT02493660|616094296|FG001|Overall Study|Lost to Follow-up|4|||
170479137|NCT00742209|616094302|FG000|Overall Study|Adverse Event|11|||
170893912|NCT03072160|617619974|FG001|Overall Study|Disease progression on study|1|||
170893913|NCT03072160|617619973|FG000|Overall Study|No contact|0|||
170893914|NCT03072160|617619974|FG001|Overall Study|No contact|1|||
170793860|NCT04577963|617254162|FG000|Part 2|Progressive disease|0|||
170793861|NCT04577963|617254163|FG001|Part 2|Progressive disease|0|||
170793862|NCT04577963|617254164|FG002|Part 2|Progressive disease|0|||
170793863|NCT04577963|617254165|FG003|Part 2|Progressive disease|0|||
170793864|NCT04577963|617254166|FG004|Part 2|Progressive disease|2|||
170793865|NCT04577963|617254162|FG000|Part 2|Investigator decision|0|||
170793866|NCT04577963|617254163|FG001|Part 2|Investigator decision|0|||
170793867|NCT04577963|617254164|FG002|Part 2|Investigator decision|0|||
170479138|NCT00742209|616094303|FG001|Overall Study|Adverse Event|4|||
170479139|NCT00742209|616094304|FG002|Overall Study|Adverse Event|17|||
170893915|NCT01046695|617619975|FG000|Overall Study|Subject had a pacemaker|0|||
170479140|NCT00742209|616094305|FG003|Overall Study|Adverse Event|16|||
170479141|NCT00742209|616094306|FG004|Overall Study|Adverse Event|13|||
170479142|NCT00742209|616094302|FG000|Overall Study|Participant Withdrew Consent|8|||
170893916|NCT01046695|617619976|FG001|Overall Study|Subject had a pacemaker|1|||
170479143|NCT00742209|616094303|FG001|Overall Study|Participant Withdrew Consent|4|||
170479144|NCT00742209|616094304|FG002|Overall Study|Participant Withdrew Consent|14|||
170479145|NCT00742209|616094305|FG003|Overall Study|Participant Withdrew Consent|7|||
170793868|NCT04577963|617254165|FG003|Part 2|Investigator decision|0|||
170793869|NCT04577963|617254166|FG004|Part 2|Investigator decision|1|||
170479146|NCT00742209|616094306|FG004|Overall Study|Participant Withdrew Consent|4|||
170479147|NCT00742209|616094302|FG000|Overall Study|Protocol Violation|6|||
170479148|NCT00742209|616094303|FG001|Overall Study|Protocol Violation|5|||
170479149|NCT00742209|616094304|FG002|Overall Study|Protocol Violation|4|||
170479150|NCT00742209|616094305|FG003|Overall Study|Protocol Violation|5|||
170479151|NCT00742209|616094306|FG004|Overall Study|Protocol Violation|3|||
170479152|NCT00742209|616094302|FG000|Overall Study|Lost to Follow-up|3|||
170479153|NCT00742209|616094303|FG001|Overall Study|Lost to Follow-up|4|||
170479154|NCT00742209|616094304|FG002|Overall Study|Lost to Follow-up|5|||
170479155|NCT00742209|616094305|FG003|Overall Study|Lost to Follow-up|5|||
170479156|NCT00742209|616094306|FG004|Overall Study|Lost to Follow-up|3|||
170479157|NCT00742209|616094302|FG000|Overall Study|Lack of Efficacy|6|||
170479158|NCT00742209|616094303|FG001|Overall Study|Lack of Efficacy|1|||
170479159|NCT00742209|616094304|FG002|Overall Study|Lack of Efficacy|1|||
170479160|NCT00742209|616094305|FG003|Overall Study|Lack of Efficacy|3|||
170479161|NCT00742209|616094306|FG004|Overall Study|Lack of Efficacy|1|||
170479162|NCT00742209|616094302|FG000|Overall Study|Investigator Discretion|0|||
170479163|NCT00742209|616094303|FG001|Overall Study|Investigator Discretion|0|||
170479164|NCT00742209|616094304|FG002|Overall Study|Investigator Discretion|5|||
170479165|NCT00742209|616094305|FG003|Overall Study|Investigator Discretion|1|||
170479166|NCT00742209|616094306|FG004|Overall Study|Investigator Discretion|1|||
170479167|NCT02003209|616094307|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
170479168|NCT02003209|616094308|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
170479169|NCT00485264|616094309|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
170479170|NCT00485264|616094310|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
170479171|NCT00485264|616094311|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
170479172|NCT00485264|616094312|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
170479173|NCT00485264|616094313|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
170479174|NCT00485264|616094314|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
170479175|NCT00485264|616094309|FG000|Overall Study|Death|1|||
170479176|NCT00485264|616094310|FG001|Overall Study|Death|0|||
170479177|NCT00485264|616094311|FG002|Overall Study|Death|0|||
170479178|NCT00485264|616094312|FG003|Overall Study|Death|0|||
170479179|NCT00485264|616094313|FG004|Overall Study|Death|1|||
170479180|NCT00485264|616094314|FG005|Overall Study|Death|0|||
170479181|NCT00485264|616094309|FG000|Overall Study|Adverse Event|1|||
170479182|NCT00485264|616094310|FG001|Overall Study|Adverse Event|0|||
170479183|NCT00485264|616094311|FG002|Overall Study|Adverse Event|2|||
170479184|NCT00485264|616094312|FG003|Overall Study|Adverse Event|3|||
170479185|NCT00485264|616094313|FG004|Overall Study|Adverse Event|1|||
170479186|NCT00485264|616094314|FG005|Overall Study|Adverse Event|3|||
170479187|NCT00485264|616094309|FG000|Overall Study|Pregnancy|4|||
170479188|NCT00485264|616094310|FG001|Overall Study|Pregnancy|0|||
170479189|NCT00485264|616094311|FG002|Overall Study|Pregnancy|0|||
170479190|NCT00485264|616094312|FG003|Overall Study|Pregnancy|0|||
170479191|NCT00485264|616094313|FG004|Overall Study|Pregnancy|0|||
170479192|NCT00485264|616094314|FG005|Overall Study|Pregnancy|0|||
170479193|NCT00485264|616094309|FG000|Overall Study|Disallowed Medication|0|||
170479194|NCT00485264|616094310|FG001|Overall Study|Disallowed Medication|0|||
170479195|NCT00485264|616094311|FG002|Overall Study|Disallowed Medication|0|||
170479196|NCT00485264|616094312|FG003|Overall Study|Disallowed Medication|0|||
170479197|NCT00485264|616094313|FG004|Overall Study|Disallowed Medication|0|||
170479198|NCT00485264|616094314|FG005|Overall Study|Disallowed Medication|1|||
170479199|NCT00485264|616094309|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
170479200|NCT00485264|616094310|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
170479201|NCT00485264|616094311|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
170479202|NCT00485264|616094312|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
170479203|NCT00485264|616094313|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
170479204|NCT00485264|616094314|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
170479205|NCT00485264|616094309|FG000|Overall Study|Lack of Efficacy|0|||
170893917|NCT01046695|617619975|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
170893918|NCT01046695|617619976|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
170893919|NCT04426695|617619977|FG000|Overall Study|Death|2|||
170479206|NCT00485264|616094310|FG001|Overall Study|Lack of Efficacy|1|||
170479207|NCT00485264|616094311|FG002|Overall Study|Lack of Efficacy|0|||
170479208|NCT00485264|616094312|FG003|Overall Study|Lack of Efficacy|0|||
170479209|NCT00485264|616094313|FG004|Overall Study|Lack of Efficacy|0|||
170479210|NCT00485264|616094314|FG005|Overall Study|Lack of Efficacy|0|||
170479211|NCT00485264|616094309|FG000|Overall Study|Guardian Consent Withdrawn|1|||
170479212|NCT00485264|616094310|FG001|Overall Study|Guardian Consent Withdrawn|0|||
170893920|NCT04426695|617619978|FG001|Overall Study|Death|0|||
170893921|NCT04426695|617619979|FG002|Overall Study|Death|1|||
170479213|NCT00485264|616094311|FG002|Overall Study|Guardian Consent Withdrawn|0|||
170479214|NCT00485264|616094312|FG003|Overall Study|Guardian Consent Withdrawn|0|||
170479215|NCT00485264|616094313|FG004|Overall Study|Guardian Consent Withdrawn|1|||
170479216|NCT00485264|616094314|FG005|Overall Study|Guardian Consent Withdrawn|0|||
170479217|NCT00485264|616094309|FG000|Overall Study|Physician Decision|0|||
170479218|NCT00485264|616094310|FG001|Overall Study|Physician Decision|2|||
170479219|NCT00485264|616094311|FG002|Overall Study|Physician Decision|0|||
170479220|NCT00485264|616094312|FG003|Overall Study|Physician Decision|0|||
170479221|NCT00485264|616094313|FG004|Overall Study|Physician Decision|0|||
170479222|NCT00485264|616094314|FG005|Overall Study|Physician Decision|0|||
170479223|NCT00485264|616094309|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
170479224|NCT00485264|616094310|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
170479225|NCT00485264|616094311|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
170479226|NCT00485264|616094312|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
170479227|NCT00485264|616094313|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
170479228|NCT00485264|616094314|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
170479229|NCT00485264|616094309|FG000|Overall Study|Not Able to Attend Clinic|5|||
170479230|NCT00485264|616094310|FG001|Overall Study|Not Able to Attend Clinic|0|||
170479231|NCT00485264|616094311|FG002|Overall Study|Not Able to Attend Clinic|0|||
170479232|NCT00485264|616094312|FG003|Overall Study|Not Able to Attend Clinic|1|||
170479233|NCT00485264|616094313|FG004|Overall Study|Not Able to Attend Clinic|1|||
170479234|NCT00485264|616094314|FG005|Overall Study|Not Able to Attend Clinic|2|||
170479235|NCT00485264|616094309|FG000|Overall Study|Non-Compliant|17|||
170479236|NCT00485264|616094310|FG001|Overall Study|Non-Compliant|2|||
170479237|NCT00485264|616094311|FG002|Overall Study|Non-Compliant|1|||
170479238|NCT00485264|616094312|FG003|Overall Study|Non-Compliant|0|||
170479239|NCT00485264|616094313|FG004|Overall Study|Non-Compliant|1|||
170479240|NCT00485264|616094314|FG005|Overall Study|Non-Compliant|0|||
170479241|NCT00485264|616094309|FG000|Overall Study|Lost to Follow-up|2|||
170479242|NCT00485264|616094310|FG001|Overall Study|Lost to Follow-up|1|||
170479243|NCT00485264|616094311|FG002|Overall Study|Lost to Follow-up|1|||
170479244|NCT00485264|616094312|FG003|Overall Study|Lost to Follow-up|0|||
170479245|NCT00485264|616094313|FG004|Overall Study|Lost to Follow-up|0|||
170479246|NCT00485264|616094314|FG005|Overall Study|Lost to Follow-up|1|||
170479247|NCT00485264|616094309|FG000|Overall Study|Other Reason|3|||
170479248|NCT00485264|616094310|FG001|Overall Study|Other Reason|0|||
170479249|NCT00485264|616094311|FG002|Overall Study|Other Reason|0|||
170479250|NCT00485264|616094312|FG003|Overall Study|Other Reason|0|||
170479251|NCT00485264|616094313|FG004|Overall Study|Other Reason|0|||
170479252|NCT00485264|616094314|FG005|Overall Study|Other Reason|0|||
170479253|NCT03500198|616094315|FG000|Overall Study|Lost to Follow-up|0|||
170479254|NCT03500198|616094316|FG001|Overall Study|Lost to Follow-up|1|||
170479255|NCT01514461|616094317|FG000|Overall Study|Adverse Event|2|||
170479256|NCT01514461|616094318|FG001|Overall Study|Adverse Event|1|||
170479257|NCT01514461|616094319|FG002|Overall Study|Adverse Event|3|||
170479258|NCT01514461|616094317|FG000|Overall Study|Physician Decision|1|||
170479259|NCT01514461|616094318|FG001|Overall Study|Physician Decision|1|||
170479260|NCT01514461|616094319|FG002|Overall Study|Physician Decision|0|||
170479261|NCT01514461|616094317|FG000|Overall Study|Patient/guardian decision|1|||
170479262|NCT01514461|616094318|FG001|Overall Study|Patient/guardian decision|1|||
170479263|NCT01514461|616094319|FG002|Overall Study|Patient/guardian decision|1|||
170479264|NCT01514461|616094317|FG000|Overall Study|Death|1|||
170479265|NCT01514461|616094318|FG001|Overall Study|Death|0|||
170479266|NCT01514461|616094319|FG002|Overall Study|Death|0|||
170479267|NCT00513240|616094326|FG000|Overall Study|Did not have intended surgery|3|||
170479268|NCT00513240|616094327|FG001|Overall Study|Did not have intended surgery|0|||
170479269|NCT00513240|616094326|FG000|Overall Study|Death|3|||
170479270|NCT00513240|616094327|FG001|Overall Study|Death|3|||
170479271|NCT00513240|616094326|FG000|Overall Study|Withdrawal by Subject|7|||
170479272|NCT00513240|616094327|FG001|Overall Study|Withdrawal by Subject|4|||
170479273|NCT05263908|616094328|FG000|Overall Study|No informed consent for publication of study results|397|||
170479274|NCT05263908|616094328|FG000|Overall Study|CRF not collected|1|||
170479275|NCT03743051|616094329|FG000|Overall Study|Adverse Event|5|||
170479276|NCT03743051|616094330|FG001|Overall Study|Adverse Event|9|||
170479277|NCT03743051|616094329|FG000|Overall Study|Death|27|||
170479278|NCT03743051|616094330|FG001|Overall Study|Death|26|||
170479279|NCT03743051|616094329|FG000|Overall Study|Lost to Follow-up|4|||
170479280|NCT03743051|616094330|FG001|Overall Study|Lost to Follow-up|8|||
170479281|NCT03743051|616094329|FG000|Overall Study|Withdrawal by Subject|32|||
170479282|NCT03743051|616094330|FG001|Overall Study|Withdrawal by Subject|19|||
170479283|NCT03743051|616094329|FG000|Overall Study|Physician Decision|10|||
170479284|NCT03743051|616094330|FG001|Overall Study|Physician Decision|15|||
170479285|NCT03743051|616094329|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
170479286|NCT03743051|616094330|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
170479287|NCT00840749|616094331|FG000|Overall Study|Death|1|||
170479288|NCT00840749|616094332|FG001|Overall Study|Death|2|||
170479289|NCT00840749|616094331|FG000|Overall Study|not treated on study arm|11|||
170479290|NCT00840749|616094332|FG001|Overall Study|not treated on study arm|11|||
170479291|NCT00840749|616094331|FG000|Overall Study|study closed|19|||
170479292|NCT00840749|616094332|FG001|Overall Study|study closed|14|||
170479293|NCT02550561|616094333|FG000|Overall Study|Lost to Follow-up|5|||
170479294|NCT02550561|616094333|FG000|Overall Study|Withdrawal by Subject|1|||
170479295|NCT03473925|616094336|FG000|Overall Study|Death|48|||
170479296|NCT03473925|616094337|FG001|Overall Study|Death|44|||
170479297|NCT03473925|616094336|FG000|Overall Study|Sponsor Decision|2|||
170479298|NCT03473925|616094337|FG001|Overall Study|Sponsor Decision|7|||
170479299|NCT03473925|616094336|FG000|Overall Study|Withdrawal by Subject|1|||
170479300|NCT03473925|616094337|FG001|Overall Study|Withdrawal by Subject|3|||
170479301|NCT03473925|616094336|FG000|Overall Study|Not Treated|1|||
170479302|NCT03473925|616094337|FG001|Overall Study|Not Treated|1|||
170479303|NCT03411863|616094338|FG000|Overall Study|Withdrawal by Subject|3|||
170479304|NCT03411863|616094339|FG001|Overall Study|Withdrawal by Subject|1|||
170479305|NCT03411863|616094338|FG000|Overall Study|Physician Decision|0|||
170479306|NCT03411863|616094339|FG001|Overall Study|Physician Decision|1|||
170479307|NCT02766335|616094340|FG000|Initial Registration|Adverse Event|6|||
170479308|NCT02766335|616094341|FG001|Initial Registration|Adverse Event|3|||
170479309|NCT02766335|616094342|FG002|Initial Registration|Adverse Event|0|||
170479310|NCT02766335|616094340|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
170479311|NCT02766335|616094341|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
170479312|NCT02766335|616094342|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
170479313|NCT02766335|616094340|FG000|Initial Registration|Progression/relapse|49|||
170479314|NCT02766335|616094341|FG001|Initial Registration|Progression/relapse|15|||
170479315|NCT02766335|616094342|FG002|Initial Registration|Progression/relapse|0|||
170479316|NCT02766335|616094340|FG000|Initial Registration|Death|1|||
170479317|NCT02766335|616094341|FG001|Initial Registration|Death|3|||
170479318|NCT02766335|616094342|FG002|Initial Registration|Death|0|||
170479319|NCT02766335|616094340|FG000|Initial Registration|not protocol specified|1|||
170479320|NCT02766335|616094341|FG001|Initial Registration|not protocol specified|9|||
170479321|NCT02766335|616094342|FG002|Initial Registration|not protocol specified|0|||
170479322|NCT02766335|616094340|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
170479323|NCT02766335|616094341|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
170479324|NCT02766335|616094342|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
170479325|NCT02766335|616094340|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
170479326|NCT02766335|616094341|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
170479327|NCT02766335|616094342|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
170479328|NCT02756611|616094343|FG000|Overall Study|Death|70|||
170479329|NCT02756611|616094343|FG000|Overall Study|Withdrawal by Subject|2|||
170479330|NCT02756611|616094343|FG000|Overall Study|Lost to Follow-up|3|||
170479331|NCT02756611|616094343|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
170479332|NCT02756611|616094343|FG000|Overall Study|Other|10|||
170479333|NCT03125798|616094345|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
170479334|NCT03125798|616094346|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
170479335|NCT03125798|616094345|FG000|Overall Study|Conversion to thoracotomy|7|||
170479336|NCT03125798|616094346|FG001|Overall Study|Conversion to thoracotomy|7|||
170479337|NCT00262028|616094350|FG000|Overall Study|Withdrawal by Subject|6|||
170479338|NCT00262028|616094351|FG001|Overall Study|Withdrawal by Subject|3|||
170479339|NCT00262028|616094352|FG002|Overall Study|Withdrawal by Subject|6|||
170479340|NCT00262028|616094353|FG003|Overall Study|Withdrawal by Subject|5|||
170479341|NCT00262028|616094354|FG004|Overall Study|Withdrawal by Subject|2|||
170479342|NCT00262028|616094355|FG005|Overall Study|Withdrawal by Subject|3|||
170479343|NCT00262028|616094356|FG006|Overall Study|Withdrawal by Subject|5|||
170479344|NCT00262028|616094357|FG007|Overall Study|Withdrawal by Subject|7|||
170479345|NCT00262028|616094358|FG008|Overall Study|Withdrawal by Subject|2|||
170479346|NCT00262028|616094350|FG000|Overall Study|Lost to Follow-up|7|||
170479347|NCT00262028|616094351|FG001|Overall Study|Lost to Follow-up|7|||
170479348|NCT00262028|616094352|FG002|Overall Study|Lost to Follow-up|5|||
170479349|NCT00262028|616094353|FG003|Overall Study|Lost to Follow-up|5|||
170479350|NCT00262028|616094354|FG004|Overall Study|Lost to Follow-up|4|||
170479351|NCT00262028|616094355|FG005|Overall Study|Lost to Follow-up|3|||
170479352|NCT00262028|616094356|FG006|Overall Study|Lost to Follow-up|3|||
170479353|NCT00262028|616094357|FG007|Overall Study|Lost to Follow-up|5|||
170479354|NCT00262028|616094358|FG008|Overall Study|Lost to Follow-up|6|||
170479355|NCT00262028|616094350|FG000|Overall Study|Administrative Reason|11|||
170479356|NCT00262028|616094351|FG001|Overall Study|Administrative Reason|14|||
170479357|NCT00262028|616094352|FG002|Overall Study|Administrative Reason|9|||
170479358|NCT00262028|616094353|FG003|Overall Study|Administrative Reason|12|||
170479359|NCT00262028|616094354|FG004|Overall Study|Administrative Reason|6|||
170479360|NCT00262028|616094355|FG005|Overall Study|Administrative Reason|7|||
170479361|NCT00262028|616094356|FG006|Overall Study|Administrative Reason|4|||
170479362|NCT00262028|616094357|FG007|Overall Study|Administrative Reason|6|||
170479363|NCT00262028|616094358|FG008|Overall Study|Administrative Reason|10|||
170479364|NCT00262028|616094350|FG000|Overall Study|Protocol Violation|0|||
170479365|NCT00262028|616094351|FG001|Overall Study|Protocol Violation|0|||
170479366|NCT00262028|616094352|FG002|Overall Study|Protocol Violation|0|||
170479367|NCT00262028|616094353|FG003|Overall Study|Protocol Violation|1|||
170479368|NCT00262028|616094354|FG004|Overall Study|Protocol Violation|0|||
170479369|NCT00262028|616094355|FG005|Overall Study|Protocol Violation|0|||
170479370|NCT00262028|616094356|FG006|Overall Study|Protocol Violation|0|||
170479371|NCT00262028|616094357|FG007|Overall Study|Protocol Violation|0|||
170479372|NCT00262028|616094358|FG008|Overall Study|Protocol Violation|0|||
170479373|NCT00262028|616094350|FG000|Overall Study|Unable to classify|0|||
170479374|NCT00262028|616094351|FG001|Overall Study|Unable to classify|3|||
170479375|NCT00262028|616094352|FG002|Overall Study|Unable to classify|0|||
170479376|NCT00262028|616094353|FG003|Overall Study|Unable to classify|0|||
170479377|NCT00262028|616094354|FG004|Overall Study|Unable to classify|0|||
170479378|NCT00262028|616094355|FG005|Overall Study|Unable to classify|0|||
170479379|NCT00262028|616094356|FG006|Overall Study|Unable to classify|0|||
170479380|NCT00262028|616094357|FG007|Overall Study|Unable to classify|0|||
170479381|NCT00262028|616094358|FG008|Overall Study|Unable to classify|1|||
170479382|NCT01515423|616094359|FG000|Open Label Phase|Adverse Event|57|||
170479383|NCT01515423|616094360|FG001|Open Label Phase|Adverse Event|0|||
170479384|NCT01515423|616094361|FG002|Open Label Phase|Adverse Event|0|||
170479385|NCT01515423|616094359|FG000|Open Label Phase|Death|2|||
170479386|NCT01515423|616094360|FG001|Open Label Phase|Death|0|||
170479387|NCT01515423|616094361|FG002|Open Label Phase|Death|0|||
170479388|NCT01515423|616094359|FG000|Open Label Phase|Lack of Efficacy|117|||
170479389|NCT01515423|616094360|FG001|Open Label Phase|Lack of Efficacy|0|||
170479390|NCT01515423|616094361|FG002|Open Label Phase|Lack of Efficacy|0|||
170479391|NCT01515423|616094359|FG000|Open Label Phase|Lost to Follow-up|21|||
170479392|NCT01515423|616094360|FG001|Open Label Phase|Lost to Follow-up|0|||
170479393|NCT01515423|616094361|FG002|Open Label Phase|Lost to Follow-up|0|||
170479394|NCT01515423|616094359|FG000|Open Label Phase|Withdrawal by Subject|118|||
170479395|NCT01515423|616094360|FG001|Open Label Phase|Withdrawal by Subject|0|||
170479396|NCT01515423|616094361|FG002|Open Label Phase|Withdrawal by Subject|0|||
170479397|NCT01515423|616094359|FG000|Open Label Phase|excluded from DB Phase|70|||
170479398|NCT01515423|616094360|FG001|Open Label Phase|excluded from DB Phase|0|||
170479399|NCT01515423|616094361|FG002|Open Label Phase|excluded from DB Phase|0|||
170479400|NCT01515423|616094359|FG000|Open Label Phase|Other|28|||
170479401|NCT01515423|616094360|FG001|Open Label Phase|Other|0|||
170479402|NCT01515423|616094361|FG002|Open Label Phase|Other|0|||
170479403|NCT01515423|616094359|FG000|DOUBLE BLIND|Adverse Event|0|||
170479404|NCT01515423|616094360|FG001|DOUBLE BLIND|Adverse Event|15|||
170479405|NCT01515423|616094361|FG002|DOUBLE BLIND|Adverse Event|13|||
170893922|NCT04426695|617619980|FG003|Overall Study|Death|27|||
170893923|NCT04426695|617619981|FG004|Overall Study|Death|25|||
170893924|NCT04426695|617619982|FG005|Overall Study|Death|21|||
170893925|NCT04426695|617619983|FG006|Overall Study|Death|42|||
170893926|NCT04426695|617619984|FG007|Overall Study|Death|23|||
170893927|NCT04426695|617619985|FG008|Overall Study|Death|37|||
170893928|NCT04426695|617619986|FG009|Overall Study|Death|14|||
170893929|NCT04426695|617619987|FG010|Overall Study|Death|8|||
170893930|NCT04426695|617619988|FG011|Overall Study|Death|7|||
170893931|NCT04426695|617619989|FG012|Overall Study|Death|13|||
170893932|NCT04426695|617619990|FG013|Overall Study|Death|25|||
170893933|NCT04426695|617619991|FG014|Overall Study|Death|19|||
170893934|NCT04426695|617619992|FG015|Overall Study|Death|7|||
170893935|NCT04426695|617619993|FG016|Overall Study|Death|8|||
170893936|NCT04426695|617619994|FG017|Overall Study|Death|4|||
170893937|NCT04426695|617619977|FG000|Overall Study|Lost to Follow-up|2|||
170893938|NCT04426695|617619978|FG001|Overall Study|Lost to Follow-up|4|||
170893939|NCT04426695|617619979|FG002|Overall Study|Lost to Follow-up|1|||
170893940|NCT04426695|617619980|FG003|Overall Study|Lost to Follow-up|19|||
170893941|NCT04426695|617619981|FG004|Overall Study|Lost to Follow-up|10|||
170893942|NCT04426695|617619982|FG005|Overall Study|Lost to Follow-up|14|||
170893943|NCT04426695|617619983|FG006|Overall Study|Lost to Follow-up|5|||
170893944|NCT04426695|617619984|FG007|Overall Study|Lost to Follow-up|14|||
170893945|NCT04426695|617619985|FG008|Overall Study|Lost to Follow-up|10|||
170893946|NCT04426695|617619986|FG009|Overall Study|Lost to Follow-up|11|||
170893947|NCT04426695|617619987|FG010|Overall Study|Lost to Follow-up|12|||
170893948|NCT04426695|617619988|FG011|Overall Study|Lost to Follow-up|6|||
170479406|NCT01515423|616094359|FG000|DOUBLE BLIND|Death|0|||
170479407|NCT01515423|616094360|FG001|DOUBLE BLIND|Death|1|||
170479408|NCT01515423|616094361|FG002|DOUBLE BLIND|Death|2|||
170479409|NCT01515423|616094359|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
170479410|NCT01515423|616094360|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
170479411|NCT01515423|616094361|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
170479412|NCT01515423|616094359|FG000|DOUBLE BLIND|Pregnancy|0|||
170479413|NCT01515423|616094360|FG001|DOUBLE BLIND|Pregnancy|2|||
170893949|NCT04426695|617619989|FG012|Overall Study|Lost to Follow-up|2|||
170893950|NCT04426695|617619990|FG013|Overall Study|Lost to Follow-up|2|||
170479414|NCT01515423|616094361|FG002|DOUBLE BLIND|Pregnancy|0|||
170893951|NCT04426695|617619991|FG014|Overall Study|Lost to Follow-up|2|||
170479415|NCT01515423|616094359|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
170479416|NCT01515423|616094360|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
170479417|NCT01515423|616094361|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
170479418|NCT01515423|616094359|FG000|DOUBLE BLIND|Other|0|||
170893952|NCT04426695|617619992|FG015|Overall Study|Lost to Follow-up|0|||
170893953|NCT04426695|617619993|FG016|Overall Study|Lost to Follow-up|0|||
170893954|NCT04426695|617619994|FG017|Overall Study|Lost to Follow-up|0|||
170639545|NCT04073225|616691324|FG001|Overall Study|Lost to Follow-up|3|||
170639546|NCT03892967|616691329|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
170639547|NCT03892967|616691330|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
170639548|NCT03892967|616691331|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
170639549|NCT03892967|616691332|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
170639550|NCT03892967|616691333|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
170639551|NCT03892967|616691329|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
170639552|NCT03892967|616691330|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
170639553|NCT03892967|616691331|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
170639554|NCT03892967|616691332|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
170639555|NCT03892967|616691333|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
170639556|NCT03892967|616691329|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
170639557|NCT03892967|616691330|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
170639558|NCT03892967|616691331|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
170639559|NCT03892967|616691332|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
170639560|NCT03892967|616691333|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
170639561|NCT03892967|616691329|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
170639562|NCT03892967|616691330|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
170639563|NCT03892967|616691331|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
170639564|NCT03892967|616691332|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
170639565|NCT03892967|616691333|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
170639566|NCT03892967|616691329|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
170639567|NCT03892967|616691330|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
170639568|NCT03892967|616691331|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
170639569|NCT03892967|616691332|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
170639570|NCT03892967|616691333|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
170793870|NCT04577963|617254162|FG000|Part 2|Sponsor terminated study|0|||
170793871|NCT04577963|617254163|FG001|Part 2|Sponsor terminated study|0|||
170793872|NCT04577963|617254164|FG002|Part 2|Sponsor terminated study|3|||
170793873|NCT04577963|617254165|FG003|Part 2|Sponsor terminated study|1|||
170793874|NCT04577963|617254166|FG004|Part 2|Sponsor terminated study|4|||
170793875|NCT04862416|617254172|FG000|Overall Study|Withdrawal by Subject|0|||
170793876|NCT04862416|617254173|FG001|Overall Study|Withdrawal by Subject|1|||
170793877|NCT04862416|617254174|FG002|Overall Study|Withdrawal by Subject|0|||
170793878|NCT04862416|617254175|FG003|Overall Study|Withdrawal by Subject|1|||
170793879|NCT04862416|617254176|FG004|Overall Study|Withdrawal by Subject|0|||
170793880|NCT04862416|617254177|FG005|Overall Study|Withdrawal by Subject|0|||
170793881|NCT04862416|617254178|FG006|Overall Study|Withdrawal by Subject|0|||
170793882|NCT04862416|617254179|FG007|Overall Study|Withdrawal by Subject|0|||
170793883|NCT04141891|617254180|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
170793884|NCT04141891|617254181|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
170793885|NCT04141891|617254180|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
170793886|NCT04141891|617254181|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
170793887|NCT04141891|617254180|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
170793888|NCT04141891|617254181|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
170793889|NCT04141891|617254180|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
170793890|NCT04141891|617254181|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
170793891|NCT04141891|617254180|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
170793892|NCT04141891|617254181|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
170793893|NCT04141891|617254180|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
170639571|NCT03892967|616691329|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
170639572|NCT03892967|616691330|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
170793894|NCT04141891|617254181|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
170793895|NCT04141891|617254180|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
170479419|NCT01515423|616094360|FG001|DOUBLE BLIND|Other|6|||
170479420|NCT01515423|616094361|FG002|DOUBLE BLIND|Other|12|||
170479421|NCT01515423|616094359|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
170479422|NCT01515423|616094360|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
170479423|NCT01515423|616094361|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
170479424|NCT01422213|616094366|FG000|Overall Study|Adverse Event|8|||
170479425|NCT01422213|616094367|FG001|Overall Study|Adverse Event|7|||
170479426|NCT01422213|616094368|FG002|Overall Study|Adverse Event|11|||
170479427|NCT01422213|616094366|FG000|Overall Study|Lack of Efficacy|10|||
170479428|NCT01422213|616094367|FG001|Overall Study|Lack of Efficacy|2|||
170479429|NCT01422213|616094368|FG002|Overall Study|Lack of Efficacy|2|||
170479430|NCT01422213|616094366|FG000|Overall Study|Non-compliance with study drug|0|||
170479431|NCT01422213|616094367|FG001|Overall Study|Non-compliance with study drug|1|||
170479432|NCT01422213|616094368|FG002|Overall Study|Non-compliance with study drug|0|||
170479433|NCT01422213|616094366|FG000|Overall Study|Protocol Violation|0|||
170479434|NCT01422213|616094367|FG001|Overall Study|Protocol Violation|2|||
170479435|NCT01422213|616094368|FG002|Overall Study|Protocol Violation|4|||
170479436|NCT01422213|616094366|FG000|Overall Study|Withdrawal of Consent|7|||
170479437|NCT01422213|616094367|FG001|Overall Study|Withdrawal of Consent|3|||
170479438|NCT01422213|616094368|FG002|Overall Study|Withdrawal of Consent|5|||
170793896|NCT04141891|617254181|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
170793897|NCT04141891|617254180|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
170793898|NCT04141891|617254181|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
170793899|NCT04141891|617254180|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
170793900|NCT04141891|617254181|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
170793901|NCT04141891|617254180|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
170793902|NCT04141891|617254181|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
170793903|NCT04141891|617254180|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
170793904|NCT04141891|617254181|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
170793905|NCT04141891|617254180|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
170793906|NCT04141891|617254181|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
170793907|NCT04141891|617254180|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
170793908|NCT04141891|617254181|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
170793909|NCT04141891|617254180|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
170793910|NCT04141891|617254181|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
170793911|NCT04737330|617254184|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
170793912|NCT04737330|617254185|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
170793913|NCT04737330|617254184|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
170793914|NCT04737330|617254185|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
170793915|NCT04737330|617254184|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
170793916|NCT04737330|617254185|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
170793917|NCT04737330|617254184|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
170479439|NCT01422213|616094366|FG000|Overall Study|Lost to Follow-up|3|||
170479440|NCT01422213|616094367|FG001|Overall Study|Lost to Follow-up|3|||
170479441|NCT01422213|616094368|FG002|Overall Study|Lost to Follow-up|5|||
170479442|NCT01422213|616094366|FG000|Overall Study|Administrative or Other Reason(s)|5|||
170479443|NCT01422213|616094367|FG001|Overall Study|Administrative or Other Reason(s)|4|||
170479444|NCT01422213|616094368|FG002|Overall Study|Administrative or Other Reason(s)|2|||
170479445|NCT00951496|616094369|FG000|Overall Study|Did not initiate study treatment|10|||
170479446|NCT00951496|616094370|FG001|Overall Study|Did not initiate study treatment|8|||
170479447|NCT00951496|616094371|FG002|Overall Study|Did not initiate study treatment|13|||
170479448|NCT04782076|616094382|FG000|Overall Study|Family Emergency|1|||
170639573|NCT03892967|616691331|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
170639574|NCT03892967|616691332|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
170639575|NCT03892967|616691333|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
170639576|NCT04549545|616693668|FG000|Initial Period|Withdrawal by Subject|4|||
170639577|NCT04549545|616693669|FG001|Initial Period|Withdrawal by Subject|0|||
170479457|NCT02189837|616094388|FG000|Overall Study|Withdrawal by Subject|2|||
170479458|NCT02189837|616094389|FG001|Overall Study|Withdrawal by Subject|1|||
170479459|NCT02189837|616094390|FG002|Overall Study|Withdrawal by Subject|3|||
170479460|NCT02189837|616094391|FG003|Overall Study|Withdrawal by Subject|1|||
170479461|NCT02189837|616094388|FG000|Overall Study|Sponsor Decision|0|||
170479462|NCT02189837|616094389|FG001|Overall Study|Sponsor Decision|0|||
170479463|NCT02189837|616094390|FG002|Overall Study|Sponsor Decision|0|||
170479464|NCT02189837|616094391|FG003|Overall Study|Sponsor Decision|1|||
170479465|NCT04199104|616097136|FG000|Overall Study|Death|148|||
170479466|NCT04199104|616097137|FG001|Overall Study|Death|134|||
170479467|NCT04199104|616097136|FG000|Overall Study|Lost to Follow-up|1|||
170479468|NCT04199104|616097137|FG001|Overall Study|Lost to Follow-up|1|||
170479469|NCT04199104|616097136|FG000|Overall Study|Withdrawal by Subject|4|||
170479470|NCT04199104|616097137|FG001|Overall Study|Withdrawal by Subject|4|||
170479471|NCT04199104|616097136|FG000|Overall Study|Participants Ongoing|103|||
170479472|NCT04199104|616097137|FG001|Overall Study|Participants Ongoing|116|||
170479473|NCT04563754|616097142|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
170479474|NCT04563754|616097143|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
170479475|NCT04563754|616097144|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
170547544|NCT04595370|616350211|FG000|Overall Study|Withdrawal by Subject|0|||
170479476|NCT04563754|616097142|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
170479477|NCT04563754|616097143|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
170479478|NCT04563754|616097144|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
170479479|NCT04563754|616097142|FG000|Follow up|Lost to Follow-up|61|||
170479480|NCT04563754|616097143|FG001|Follow up|Lost to Follow-up|23|||
170479481|NCT04563754|616097144|FG002|Follow up|Lost to Follow-up|5|||
170479482|NCT04563754|616097142|FG000|Follow up|Death|0|||
170479483|NCT04563754|616097143|FG001|Follow up|Death|2|||
170479484|NCT04563754|616097144|FG002|Follow up|Death|0|||
170479485|NCT04563754|616097142|FG000|Follow up|Ongoing|0|||
170479486|NCT04563754|616097143|FG001|Follow up|Ongoing|28|||
170479487|NCT04563754|616097144|FG002|Follow up|Ongoing|0|||
170479488|NCT00070564|616097145|FG000|Overall Study|Progression|2|||
170479489|NCT00070564|616097146|FG001|Overall Study|Progression|4|||
170479490|NCT00070564|616097147|FG002|Overall Study|Progression|7|||
170479491|NCT00070564|616097148|FG003|Overall Study|Progression|7|||
170479492|NCT00070564|616097149|FG004|Overall Study|Progression|1|||
170479493|NCT00070564|616097150|FG005|Overall Study|Progression|0|||
170479494|NCT00070564|616097145|FG000|Overall Study|Delinquent|1|||
170479495|NCT00070564|616097146|FG001|Overall Study|Delinquent|4|||
170479496|NCT00070564|616097147|FG002|Overall Study|Delinquent|2|||
170479497|NCT00070564|616097148|FG003|Overall Study|Delinquent|0|||
170479498|NCT00070564|616097149|FG004|Overall Study|Delinquent|0|||
170479499|NCT00070564|616097150|FG005|Overall Study|Delinquent|0|||
170479500|NCT00070564|616097145|FG000|Overall Study|Adverse Event|150|||
170479501|NCT00070564|616097146|FG001|Overall Study|Adverse Event|142|||
170479502|NCT00070564|616097147|FG002|Overall Study|Adverse Event|120|||
170479503|NCT00070564|616097148|FG003|Overall Study|Adverse Event|108|||
170479504|NCT00070564|616097149|FG004|Overall Study|Adverse Event|63|||
170479505|NCT00070564|616097150|FG005|Overall Study|Adverse Event|36|||
170479506|NCT00070564|616097145|FG000|Overall Study|Death|4|||
170479507|NCT00070564|616097146|FG001|Overall Study|Death|1|||
170479508|NCT00070564|616097147|FG002|Overall Study|Death|5|||
170479509|NCT00070564|616097148|FG003|Overall Study|Death|3|||
170479510|NCT00070564|616097149|FG004|Overall Study|Death|0|||
170479511|NCT00070564|616097150|FG005|Overall Study|Death|1|||
170479512|NCT00070564|616097145|FG000|Overall Study|Other, not protocol specified|17|||
170479513|NCT00070564|616097146|FG001|Overall Study|Other, not protocol specified|15|||
170479514|NCT00070564|616097147|FG002|Overall Study|Other, not protocol specified|14|||
170479515|NCT00070564|616097148|FG003|Overall Study|Other, not protocol specified|19|||
170479516|NCT00070564|616097149|FG004|Overall Study|Other, not protocol specified|6|||
170479517|NCT00070564|616097150|FG005|Overall Study|Other, not protocol specified|7|||
170479518|NCT00070564|616097145|FG000|Overall Study|Withdrawal by Subject|26|||
170479519|NCT00070564|616097146|FG001|Overall Study|Withdrawal by Subject|37|||
170479520|NCT00070564|616097147|FG002|Overall Study|Withdrawal by Subject|23|||
170479521|NCT00070564|616097148|FG003|Overall Study|Withdrawal by Subject|30|||
170479522|NCT00070564|616097149|FG004|Overall Study|Withdrawal by Subject|8|||
170479523|NCT00070564|616097150|FG005|Overall Study|Withdrawal by Subject|8|||
170479524|NCT00070564|616097145|FG000|Overall Study|Not reported|0|||
170479525|NCT00070564|616097146|FG001|Overall Study|Not reported|0|||
170479526|NCT00070564|616097147|FG002|Overall Study|Not reported|0|||
170479527|NCT00070564|616097148|FG003|Overall Study|Not reported|0|||
170479528|NCT00070564|616097149|FG004|Overall Study|Not reported|1|||
170479529|NCT00070564|616097150|FG005|Overall Study|Not reported|0|||
170479530|NCT04023396|616097151|FG000|Overall Study|Adverse Event|16|||
170479531|NCT04023396|616097151|FG000|Overall Study|Death|1|||
170479532|NCT04023396|616097151|FG000|Overall Study|Lost to Follow-up|1|||
170479533|NCT04023396|616097151|FG000|Overall Study|Withdrawal by Subject|14|||
170479534|NCT04023396|616097151|FG000|Overall Study|Pregnancy|4|||
170479535|NCT04023396|616097151|FG000|Overall Study|Lack of Efficacy|3|||
170893955|NCT04426695|617619977|FG000|Overall Study|Participant Decision|1|||
170893956|NCT04426695|617619978|FG001|Overall Study|Participant Decision|2|||
170893957|NCT04426695|617619979|FG002|Overall Study|Participant Decision|2|||
170893958|NCT04426695|617619980|FG003|Overall Study|Participant Decision|12|||
170893959|NCT04426695|617619981|FG004|Overall Study|Participant Decision|18|||
170893960|NCT04426695|617619982|FG005|Overall Study|Participant Decision|22|||
170893961|NCT04426695|617619983|FG006|Overall Study|Participant Decision|13|||
170479536|NCT04023396|616097151|FG000|Overall Study|Physician Decision|4|||
170479537|NCT04023396|616097151|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
170479538|NCT04796961|616097154|FG000|Overall Study|Lost to Follow-up|10|||
170893962|NCT04426695|617619984|FG007|Overall Study|Participant Decision|13|||
170479539|NCT04796961|616097154|FG000|Overall Study|Withdrawal by Subject|3|||
170479540|NCT04796961|616097154|FG000|Overall Study|Left Organization|10|||
170479541|NCT02325973|616097157|FG000|Overall Study|Death|5|||
170479542|NCT02325973|616097157|FG000|Overall Study|Withdrawal by subject or investigator|16|||
170479543|NCT04075825|616097158|FG000|Overall Study|Withdrawal by Subject|6|||
170479544|NCT04075825|616097159|FG001|Overall Study|Withdrawal by Subject|8|||
170479545|NCT04075825|616097158|FG000|Overall Study|Physician Decision|3|||
170479546|NCT04075825|616097159|FG001|Overall Study|Physician Decision|1|||
170479547|NCT04075825|616097158|FG000|Overall Study|Lost to Follow-up|5|||
170893963|NCT04426695|617619985|FG008|Overall Study|Participant Decision|10|||
170479548|NCT04075825|616097159|FG001|Overall Study|Lost to Follow-up|1|||
170479549|NCT04075825|616097158|FG000|Overall Study|Participation in New Clinical Trial|1|||
170479550|NCT04075825|616097159|FG001|Overall Study|Participation in New Clinical Trial|1|||
170479551|NCT04075825|616097158|FG000|Overall Study|Reason Not Specified|2|||
170479552|NCT04075825|616097159|FG001|Overall Study|Reason Not Specified|2|||
170479553|NCT02513160|616097160|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
170479554|NCT02513160|616097161|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
170479555|NCT02513160|616097162|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
170479556|NCT02513160|616097163|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
170479557|NCT02513160|616097160|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
170479558|NCT02513160|616097161|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
170479559|NCT02513160|616097162|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
170479560|NCT02513160|616097163|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
170479561|NCT02513160|616097160|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
170479562|NCT02513160|616097161|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
170479563|NCT02513160|616097162|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
170479564|NCT02513160|616097163|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
170479565|NCT02513160|616097160|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
170479566|NCT02513160|616097161|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
170479567|NCT02513160|616097162|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
170479568|NCT02513160|616097163|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
170479569|NCT02513160|616097160|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
170479570|NCT02513160|616097161|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
170479571|NCT02513160|616097162|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
170479572|NCT02513160|616097163|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
170479573|NCT02513160|616097160|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
170479574|NCT02513160|616097161|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
170479575|NCT02513160|616097162|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
170479576|NCT02513160|616097163|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
170479577|NCT02513160|616097160|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
170479578|NCT02513160|616097161|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
170479579|NCT02513160|616097162|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
170479580|NCT02513160|616097163|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
170479581|NCT02513160|616097160|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
170479582|NCT02513160|616097161|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
170479583|NCT02513160|616097162|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
170479584|NCT02513160|616097163|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
170479585|NCT02513160|616097160|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
170479586|NCT02513160|616097161|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
170479587|NCT02513160|616097162|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
170479588|NCT02513160|616097163|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
170479589|NCT02513160|616097160|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
170479590|NCT02513160|616097161|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
170479591|NCT02513160|616097162|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
170479592|NCT02513160|616097163|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
170479593|NCT02513160|616097160|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
170479594|NCT02513160|616097161|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
170479595|NCT02513160|616097162|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
170479596|NCT02513160|616097163|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
170793918|NCT04737330|617254185|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
170793919|NCT04737330|617254184|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
170793920|NCT04737330|617254185|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
170793921|NCT04737330|617254184|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
170793922|NCT04737330|617254185|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
170793923|NCT05267470|617254187|FG000|Overall Study|Decision by sponsor|0|||
170793924|NCT05267470|617254188|FG001|Overall Study|Decision by sponsor|3|||
170793925|NCT05267470|617254189|FG002|Overall Study|Decision by sponsor|19|||
170793926|NCT05267470|617254190|FG003|Overall Study|Decision by sponsor|7|||
170793927|NCT05267470|617254191|FG004|Overall Study|Decision by sponsor|3|||
170793928|NCT05267470|617254187|FG000|Overall Study|Withdrawal by Subject|1|||
170793929|NCT05267470|617254188|FG001|Overall Study|Withdrawal by Subject|1|||
170793930|NCT05267470|617254189|FG002|Overall Study|Withdrawal by Subject|2|||
170793931|NCT05267470|617254190|FG003|Overall Study|Withdrawal by Subject|2|||
170793932|NCT05267470|617254191|FG004|Overall Study|Withdrawal by Subject|0|||
170793933|NCT05267470|617254187|FG000|Overall Study|Death|3|||
170793934|NCT05267470|617254188|FG001|Overall Study|Death|5|||
170793935|NCT05267470|617254189|FG002|Overall Study|Death|8|||
170479597|NCT02513160|616097160|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
170479598|NCT02513160|616097161|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
170479599|NCT02513160|616097162|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
170479600|NCT02513160|616097163|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
170479601|NCT01168232|616097164|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
170479602|NCT01168232|616097164|FG000|Overall Study|Ineligible- Wrong cell type|6|||
170479603|NCT01168232|616097164|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
170479604|NCT04021914|616097170|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
170479605|NCT03349060|616097171|FG000|Overall Study|Adverse Event|9|||
170479606|NCT03349060|616097172|FG001|Overall Study|Adverse Event|9|||
170479607|NCT03349060|616097173|FG002|Overall Study|Adverse Event|7|||
170479608|NCT03349060|616097171|FG000|Overall Study|Lack of Efficacy|1|||
170479609|NCT03349060|616097172|FG001|Overall Study|Lack of Efficacy|0|||
170479610|NCT03349060|616097173|FG002|Overall Study|Lack of Efficacy|2|||
170479611|NCT03349060|616097171|FG000|Overall Study|Lost to Follow-up|2|||
170479612|NCT03349060|616097172|FG001|Overall Study|Lost to Follow-up|1|||
170479613|NCT03349060|616097173|FG002|Overall Study|Lost to Follow-up|1|||
170479614|NCT03349060|616097171|FG000|Overall Study|Protocol Violation|2|||
170479615|NCT03349060|616097172|FG001|Overall Study|Protocol Violation|2|||
170479616|NCT03349060|616097173|FG002|Overall Study|Protocol Violation|1|||
170479617|NCT03349060|616097171|FG000|Overall Study|Withdrawal by Subject|5|||
170479618|NCT03349060|616097172|FG001|Overall Study|Withdrawal by Subject|3|||
170479619|NCT03349060|616097173|FG002|Overall Study|Withdrawal by Subject|4|||
170479620|NCT03349060|616097171|FG000|Overall Study|Medication error,no linked adverse event|0|||
170479621|NCT03349060|616097172|FG001|Overall Study|Medication error,no linked adverse event|0|||
170479622|NCT03349060|616097173|FG002|Overall Study|Medication error,no linked adverse event|1|||
170479623|NCT03349060|616097171|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
170479624|NCT03349060|616097172|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
170479625|NCT03349060|616097173|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
170479626|NCT03349060|616097171|FG000|Overall Study|Other|2|||
170479627|NCT03349060|616097172|FG001|Overall Study|Other|1|||
170479628|NCT03349060|616097173|FG002|Overall Study|Other|0|||
170479629|NCT00803790|616097178|FG000|Period 1|Adverse Event|0|||
170479630|NCT00803790|616097179|FG001|Period 1|Adverse Event|1|||
170479631|NCT00803790|616097180|FG002|Period 1|Adverse Event|0|||
170479632|NCT00803790|616097181|FG003|Period 1|Adverse Event|0|||
170479633|NCT00803790|616097178|FG000|Period 1|Lost to Follow-up|1|||
170479634|NCT00803790|616097179|FG001|Period 1|Lost to Follow-up|2|||
170479635|NCT00803790|616097180|FG002|Period 1|Lost to Follow-up|0|||
170479636|NCT00803790|616097181|FG003|Period 1|Lost to Follow-up|0|||
170479637|NCT00803790|616097178|FG000|Period 1|Withdrawal by Subject|8|||
170479638|NCT00803790|616097179|FG001|Period 1|Withdrawal by Subject|6|||
170479639|NCT00803790|616097180|FG002|Period 1|Withdrawal by Subject|0|||
170479640|NCT00803790|616097181|FG003|Period 1|Withdrawal by Subject|0|||
170479641|NCT00803790|616097178|FG000|Period 1|positive drug screen or personal reasons|0|||
170479642|NCT00803790|616097179|FG001|Period 1|positive drug screen or personal reasons|3|||
170479643|NCT00803790|616097180|FG002|Period 1|positive drug screen or personal reasons|0|||
170479644|NCT00803790|616097181|FG003|Period 1|positive drug screen or personal reasons|4|||
170479645|NCT00803790|616097178|FG000|Period 1|Protocol Violation|0|||
170479646|NCT00803790|616097179|FG001|Period 1|Protocol Violation|0|||
170479647|NCT00803790|616097180|FG002|Period 1|Protocol Violation|1|||
170479648|NCT00803790|616097181|FG003|Period 1|Protocol Violation|0|||
170479649|NCT00803790|616097178|FG000|Period 2|Adverse Event|0|||
170479650|NCT00803790|616097179|FG001|Period 2|Adverse Event|0|||
170893964|NCT04426695|617619986|FG009|Overall Study|Participant Decision|15|||
170479651|NCT00803790|616097180|FG002|Period 2|Adverse Event|1|||
170479652|NCT00803790|616097181|FG003|Period 2|Adverse Event|1|||
170479653|NCT00803790|616097178|FG000|Period 2|Withdrawal by Subject|1|||
170479654|NCT00803790|616097179|FG001|Period 2|Withdrawal by Subject|0|||
170479655|NCT00803790|616097180|FG002|Period 2|Withdrawal by Subject|0|||
170479656|NCT00803790|616097181|FG003|Period 2|Withdrawal by Subject|0|||
170479657|NCT00803790|616097178|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
170479658|NCT00803790|616097179|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
170479659|NCT00803790|616097180|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
170479660|NCT00803790|616097181|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
170893965|NCT04426695|617619987|FG010|Overall Study|Participant Decision|16|||
170479661|NCT04581824|616097183|FG000|Overall Study|Lost to Follow-up|1|||
170479662|NCT04581824|616097184|FG001|Overall Study|Lost to Follow-up|0|||
170479663|NCT04581824|616097183|FG000|Overall Study|Withdrawal by Subject|2|||
170893966|NCT04426695|617619988|FG011|Overall Study|Participant Decision|17|||
170893967|NCT04426695|617619989|FG012|Overall Study|Participant Decision|2|||
170479664|NCT04581824|616097184|FG001|Overall Study|Withdrawal by Subject|7|||
170479665|NCT04581824|616097183|FG000|Overall Study|Study terminated by sponsor|37|||
170479666|NCT04581824|616097184|FG001|Overall Study|Study terminated by sponsor|23|||
170479667|NCT03879135|616097187|FG000|Overall Study|Physician Decision|0|||
170893968|NCT04426695|617619990|FG013|Overall Study|Participant Decision|1|||
170479668|NCT03879135|616097188|FG001|Overall Study|Physician Decision|0|||
170479669|NCT03879135|616097189|FG002|Overall Study|Physician Decision|0|||
170479670|NCT03879135|616097190|FG003|Overall Study|Physician Decision|1|||
170479671|NCT03879135|616097191|FG004|Overall Study|Physician Decision|0|||
170479672|NCT03879135|616097192|FG005|Overall Study|Physician Decision|0|||
170479673|NCT03879135|616097187|FG000|Overall Study|Withdrawal by Subject|0|||
170479674|NCT03879135|616097188|FG001|Overall Study|Withdrawal by Subject|0|||
170479675|NCT03879135|616097189|FG002|Overall Study|Withdrawal by Subject|0|||
170479676|NCT03879135|616097190|FG003|Overall Study|Withdrawal by Subject|0|||
170479677|NCT03879135|616097191|FG004|Overall Study|Withdrawal by Subject|0|||
170479678|NCT03879135|616097192|FG005|Overall Study|Withdrawal by Subject|1|||
170479679|NCT03879135|616097187|FG000|Overall Study|Site Closed by Sponsor|0|||
170479680|NCT03879135|616097188|FG001|Overall Study|Site Closed by Sponsor|0|||
170479681|NCT03879135|616097189|FG002|Overall Study|Site Closed by Sponsor|0|||
170479682|NCT03879135|616097190|FG003|Overall Study|Site Closed by Sponsor|1|||
170479683|NCT03879135|616097191|FG004|Overall Study|Site Closed by Sponsor|1|||
170479684|NCT03879135|616097192|FG005|Overall Study|Site Closed by Sponsor|0|||
170479685|NCT05201794|616097193|FG000|Overall Study|Withdrawal by Subject|13|||
170479686|NCT05201794|616097194|FG001|Overall Study|Withdrawal by Subject|12|||
170479687|NCT05201794|616097195|FG002|Overall Study|Withdrawal by Subject|14|||
170479688|NCT05201794|616097196|FG003|Overall Study|Withdrawal by Subject|0|||
170479689|NCT05201794|616097193|FG000|Overall Study|Adverse Event|5|||
170479690|NCT05201794|616097194|FG001|Overall Study|Adverse Event|5|||
170479691|NCT05201794|616097195|FG002|Overall Study|Adverse Event|4|||
170479692|NCT05201794|616097196|FG003|Overall Study|Adverse Event|0|||
170479693|NCT05201794|616097193|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
170479694|NCT05201794|616097194|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
170479695|NCT05201794|616097195|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
170479696|NCT05201794|616097196|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170479697|NCT05201794|616097193|FG000|Overall Study|Non-Compliance With Study Drug|2|||
170479698|NCT05201794|616097194|FG001|Overall Study|Non-Compliance With Study Drug|3|||
170479699|NCT05201794|616097195|FG002|Overall Study|Non-Compliance With Study Drug|3|||
170479700|NCT05201794|616097196|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170479701|NCT05201794|616097193|FG000|Overall Study|Physician Decision|1|||
170479702|NCT05201794|616097194|FG001|Overall Study|Physician Decision|3|||
170479703|NCT05201794|616097195|FG002|Overall Study|Physician Decision|2|||
170479704|NCT05201794|616097196|FG003|Overall Study|Physician Decision|0|||
170479705|NCT05201794|616097193|FG000|Overall Study|Lost to Follow-up|2|||
170479706|NCT05201794|616097194|FG001|Overall Study|Lost to Follow-up|2|||
170479707|NCT05201794|616097195|FG002|Overall Study|Lost to Follow-up|0|||
170479708|NCT05201794|616097196|FG003|Overall Study|Lost to Follow-up|0|||
170479709|NCT05201794|616097193|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
170479710|NCT05201794|616097194|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
170479711|NCT05201794|616097195|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
170479712|NCT05201794|616097196|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
170479713|NCT05201794|616097193|FG000|Overall Study|Protocol Violation|2|||
170479714|NCT05201794|616097194|FG001|Overall Study|Protocol Violation|0|||
170479715|NCT05201794|616097195|FG002|Overall Study|Protocol Violation|1|||
170479716|NCT05201794|616097196|FG003|Overall Study|Protocol Violation|0|||
170479717|NCT05201794|616097193|FG000|Overall Study|Death|1|||
170479718|NCT05201794|616097194|FG001|Overall Study|Death|0|||
170479719|NCT05201794|616097195|FG002|Overall Study|Death|0|||
170479720|NCT05201794|616097196|FG003|Overall Study|Death|0|||
170479721|NCT05201794|616097193|FG000|Overall Study|Site Terminated By Sponsor|0|||
170479722|NCT05201794|616097194|FG001|Overall Study|Site Terminated By Sponsor|1|||
170479723|NCT05201794|616097195|FG002|Overall Study|Site Terminated By Sponsor|0|||
170479724|NCT05201794|616097196|FG003|Overall Study|Site Terminated By Sponsor|0|||
170479725|NCT05201794|616097193|FG000|Overall Study|Other|3|||
170479726|NCT05201794|616097194|FG001|Overall Study|Other|3|||
170479727|NCT05201794|616097195|FG002|Overall Study|Other|3|||
170479728|NCT05201794|616097196|FG003|Overall Study|Other|0|||
170479729|NCT05201794|616097193|FG000|Overall Study|Randomized But Not Treated|1|||
170479730|NCT05201794|616097194|FG001|Overall Study|Randomized But Not Treated|2|||
170479731|NCT05201794|616097195|FG002|Overall Study|Randomized But Not Treated|1|||
170479732|NCT05201794|616097196|FG003|Overall Study|Randomized But Not Treated|0|||
170479733|NCT03428958|616097197|FG000|Overall Study|Adverse Event|0|||
170479734|NCT03428958|616097198|FG001|Overall Study|Adverse Event|0|||
170479735|NCT03428958|616097199|FG002|Overall Study|Adverse Event|0|||
170479736|NCT03428958|616097200|FG003|Overall Study|Adverse Event|1|||
170479737|NCT03428958|616097201|FG004|Overall Study|Adverse Event|0|||
170479738|NCT03428958|616097202|FG005|Overall Study|Adverse Event|2|||
170479739|NCT03428958|616097203|FG006|Overall Study|Adverse Event|1|||
170479740|NCT03428958|616097204|FG007|Overall Study|Adverse Event|0|||
170479741|NCT03428958|616097205|FG008|Overall Study|Adverse Event|0|||
170479742|NCT03428958|616097206|FG009|Overall Study|Adverse Event|0|||
170479743|NCT03428958|616097207|FG010|Overall Study|Adverse Event|0|||
170479744|NCT03428958|616097208|FG011|Overall Study|Adverse Event|0|||
170479745|NCT03428958|616097209|FG012|Overall Study|Adverse Event|0|||
170479746|NCT03428958|616097210|FG013|Overall Study|Adverse Event|0|||
170479747|NCT03428958|616097211|FG014|Overall Study|Adverse Event|0|||
170479748|NCT03428958|616097212|FG015|Overall Study|Adverse Event|0|||
170479749|NCT03428958|616097213|FG016|Overall Study|Adverse Event|0|||
170479750|NCT03428958|616097197|FG000|Overall Study|Clinical Progression|2|||
170479751|NCT03428958|616097198|FG001|Overall Study|Clinical Progression|3|||
170479752|NCT03428958|616097199|FG002|Overall Study|Clinical Progression|2|||
170479753|NCT03428958|616097200|FG003|Overall Study|Clinical Progression|1|||
170479754|NCT03428958|616097201|FG004|Overall Study|Clinical Progression|0|||
170479755|NCT03428958|616097202|FG005|Overall Study|Clinical Progression|2|||
170479756|NCT03428958|616097203|FG006|Overall Study|Clinical Progression|0|||
170479757|NCT03428958|616097204|FG007|Overall Study|Clinical Progression|0|||
170479758|NCT03428958|616097205|FG008|Overall Study|Clinical Progression|0|||
170479759|NCT03428958|616097206|FG009|Overall Study|Clinical Progression|0|||
170479760|NCT03428958|616097207|FG010|Overall Study|Clinical Progression|0|||
170479761|NCT03428958|616097208|FG011|Overall Study|Clinical Progression|0|||
170479762|NCT03428958|616097209|FG012|Overall Study|Clinical Progression|0|||
170479763|NCT03428958|616097210|FG013|Overall Study|Clinical Progression|0|||
170479764|NCT03428958|616097211|FG014|Overall Study|Clinical Progression|0|||
170479765|NCT03428958|616097212|FG015|Overall Study|Clinical Progression|0|||
170479766|NCT03428958|616097213|FG016|Overall Study|Clinical Progression|0|||
170479767|NCT03428958|616097197|FG000|Overall Study|Progression per RECIST|6|||
170479768|NCT03428958|616097198|FG001|Overall Study|Progression per RECIST|6|||
170479769|NCT03428958|616097199|FG002|Overall Study|Progression per RECIST|7|||
170479770|NCT03428958|616097200|FG003|Overall Study|Progression per RECIST|4|||
170479771|NCT03428958|616097201|FG004|Overall Study|Progression per RECIST|0|||
170479772|NCT03428958|616097202|FG005|Overall Study|Progression per RECIST|7|||
170479773|NCT03428958|616097203|FG006|Overall Study|Progression per RECIST|8|||
170479774|NCT03428958|616097204|FG007|Overall Study|Progression per RECIST|0|||
170479775|NCT03428958|616097205|FG008|Overall Study|Progression per RECIST|0|||
170479776|NCT03428958|616097206|FG009|Overall Study|Progression per RECIST|0|||
170479777|NCT03428958|616097207|FG010|Overall Study|Progression per RECIST|0|||
170479778|NCT03428958|616097208|FG011|Overall Study|Progression per RECIST|0|||
170479779|NCT03428958|616097209|FG012|Overall Study|Progression per RECIST|1|||
170479780|NCT03428958|616097210|FG013|Overall Study|Progression per RECIST|0|||
170479781|NCT03428958|616097211|FG014|Overall Study|Progression per RECIST|0|||
170479782|NCT03428958|616097212|FG015|Overall Study|Progression per RECIST|0|||
170479783|NCT03428958|616097213|FG016|Overall Study|Progression per RECIST|0|||
170479784|NCT03428958|616097197|FG000|Overall Study|Death|2|||
170479785|NCT03428958|616097198|FG001|Overall Study|Death|2|||
170479786|NCT03428958|616097199|FG002|Overall Study|Death|0|||
170479787|NCT03428958|616097200|FG003|Overall Study|Death|0|||
170479788|NCT03428958|616097201|FG004|Overall Study|Death|0|||
170479789|NCT03428958|616097202|FG005|Overall Study|Death|7|||
170479790|NCT03428958|616097203|FG006|Overall Study|Death|9|||
170479791|NCT03428958|616097204|FG007|Overall Study|Death|6|||
170479792|NCT03428958|616097205|FG008|Overall Study|Death|0|||
170479793|NCT03428958|616097206|FG009|Overall Study|Death|0|||
170479794|NCT03428958|616097207|FG010|Overall Study|Death|3|||
170479795|NCT03428958|616097208|FG011|Overall Study|Death|0|||
170479796|NCT03428958|616097209|FG012|Overall Study|Death|4|||
170479797|NCT03428958|616097210|FG013|Overall Study|Death|0|||
170479798|NCT03428958|616097211|FG014|Overall Study|Death|0|||
170479799|NCT03428958|616097212|FG015|Overall Study|Death|0|||
170479800|NCT03428958|616097213|FG016|Overall Study|Death|0|||
170479801|NCT03428958|616097197|FG000|Overall Study|Lost to Follow-up|0|||
170479802|NCT03428958|616097198|FG001|Overall Study|Lost to Follow-up|0|||
170479803|NCT03428958|616097199|FG002|Overall Study|Lost to Follow-up|0|||
170479804|NCT03428958|616097200|FG003|Overall Study|Lost to Follow-up|0|||
170793936|NCT05267470|617254190|FG003|Overall Study|Death|18|||
170793937|NCT05267470|617254191|FG004|Overall Study|Death|1|||
170793938|NCT05267470|617254187|FG000|Overall Study|Lost to Follow-up|0|||
170793939|NCT05267470|617254188|FG001|Overall Study|Lost to Follow-up|0|||
170479805|NCT03428958|616097201|FG004|Overall Study|Lost to Follow-up|0|||
170479806|NCT03428958|616097202|FG005|Overall Study|Lost to Follow-up|1|||
170479807|NCT03428958|616097203|FG006|Overall Study|Lost to Follow-up|1|||
170479808|NCT03428958|616097204|FG007|Overall Study|Lost to Follow-up|0|||
170479809|NCT03428958|616097205|FG008|Overall Study|Lost to Follow-up|0|||
170479810|NCT03428958|616097206|FG009|Overall Study|Lost to Follow-up|0|||
170479811|NCT03428958|616097207|FG010|Overall Study|Lost to Follow-up|0|||
170793940|NCT05267470|617254189|FG002|Overall Study|Lost to Follow-up|0|||
170479812|NCT03428958|616097208|FG011|Overall Study|Lost to Follow-up|0|||
170479813|NCT03428958|616097209|FG012|Overall Study|Lost to Follow-up|0|||
170479814|NCT03428958|616097210|FG013|Overall Study|Lost to Follow-up|0|||
170479815|NCT03428958|616097211|FG014|Overall Study|Lost to Follow-up|0|||
170479816|NCT03428958|616097212|FG015|Overall Study|Lost to Follow-up|0|||
170479817|NCT03428958|616097213|FG016|Overall Study|Lost to Follow-up|0|||
170793941|NCT05267470|617254190|FG003|Overall Study|Lost to Follow-up|1|||
170479818|NCT03428958|616097197|FG000|Overall Study|Physician/Sponsor Decision|1|||
170479819|NCT03428958|616097198|FG001|Overall Study|Physician/Sponsor Decision|0|||
170479820|NCT03428958|616097199|FG002|Overall Study|Physician/Sponsor Decision|1|||
170479821|NCT03428958|616097200|FG003|Overall Study|Physician/Sponsor Decision|0|||
170479822|NCT03428958|616097201|FG004|Overall Study|Physician/Sponsor Decision|0|||
170479823|NCT03428958|616097202|FG005|Overall Study|Physician/Sponsor Decision|2|||
170479824|NCT03428958|616097203|FG006|Overall Study|Physician/Sponsor Decision|2|||
170479825|NCT03428958|616097204|FG007|Overall Study|Physician/Sponsor Decision|2|||
170479826|NCT03428958|616097205|FG008|Overall Study|Physician/Sponsor Decision|0|||
170479827|NCT03428958|616097206|FG009|Overall Study|Physician/Sponsor Decision|0|||
170479828|NCT03428958|616097207|FG010|Overall Study|Physician/Sponsor Decision|2|||
170479829|NCT03428958|616097208|FG011|Overall Study|Physician/Sponsor Decision|0|||
170479830|NCT03428958|616097209|FG012|Overall Study|Physician/Sponsor Decision|4|||
170479831|NCT03428958|616097210|FG013|Overall Study|Physician/Sponsor Decision|0|||
170479832|NCT03428958|616097211|FG014|Overall Study|Physician/Sponsor Decision|0|||
170479833|NCT03428958|616097212|FG015|Overall Study|Physician/Sponsor Decision|0|||
170479834|NCT03428958|616097213|FG016|Overall Study|Physician/Sponsor Decision|0|||
170479835|NCT03428958|616097197|FG000|Overall Study|Withdrawal by Subject|0|||
170479836|NCT03428958|616097198|FG001|Overall Study|Withdrawal by Subject|0|||
170479837|NCT03428958|616097199|FG002|Overall Study|Withdrawal by Subject|2|||
170479838|NCT03428958|616097200|FG003|Overall Study|Withdrawal by Subject|0|||
170479839|NCT03428958|616097201|FG004|Overall Study|Withdrawal by Subject|0|||
170479840|NCT03428958|616097202|FG005|Overall Study|Withdrawal by Subject|2|||
170479841|NCT03428958|616097203|FG006|Overall Study|Withdrawal by Subject|4|||
170479842|NCT03428958|616097204|FG007|Overall Study|Withdrawal by Subject|1|||
170479843|NCT03428958|616097205|FG008|Overall Study|Withdrawal by Subject|0|||
170479844|NCT03428958|616097206|FG009|Overall Study|Withdrawal by Subject|0|||
170479845|NCT03428958|616097207|FG010|Overall Study|Withdrawal by Subject|0|||
170479846|NCT03428958|616097208|FG011|Overall Study|Withdrawal by Subject|0|||
170479847|NCT03428958|616097209|FG012|Overall Study|Withdrawal by Subject|0|||
170479848|NCT03428958|616097210|FG013|Overall Study|Withdrawal by Subject|0|||
170479849|NCT03428958|616097211|FG014|Overall Study|Withdrawal by Subject|0|||
170479850|NCT03428958|616097212|FG015|Overall Study|Withdrawal by Subject|0|||
170479851|NCT03428958|616097213|FG016|Overall Study|Withdrawal by Subject|0|||
170479852|NCT03874117|616097214|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
170479853|NCT03874117|616097215|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
170479854|NCT03874117|616097214|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
170479855|NCT03874117|616097215|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
170479856|NCT03874117|616097214|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
170479857|NCT03874117|616097215|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170479858|NCT03874117|616097214|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
170479859|NCT03874117|616097215|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
170479860|NCT03874117|616097214|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
170479861|NCT03874117|616097215|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
170479862|NCT03985800|616097216|FG000|Overall Study|Death|1|||
170479863|NCT03985800|616097217|FG001|Overall Study|Death|2|||
170479864|NCT03985800|616097216|FG000|Overall Study|Withdrawal by Subject|3|||
170479865|NCT03985800|616097217|FG001|Overall Study|Withdrawal by Subject|6|||
170479866|NCT03985800|616097216|FG000|Overall Study|Protocol Violation|2|||
170479867|NCT03985800|616097217|FG001|Overall Study|Protocol Violation|0|||
170479868|NCT05012098|616097218|FG000|Overall Study|Disease progression|5|||
170479869|NCT05012098|616097219|FG001|Overall Study|Disease progression|2|||
170479870|NCT05012098|616097218|FG000|Overall Study|Adverse Event|1|||
170479871|NCT05012098|616097219|FG001|Overall Study|Adverse Event|0|||
170893969|NCT04426695|617619991|FG014|Overall Study|Participant Decision|2|||
170893970|NCT04426695|617619992|FG015|Overall Study|Participant Decision|0|||
170893971|NCT04426695|617619993|FG016|Overall Study|Participant Decision|0|||
170893972|NCT04426695|617619994|FG017|Overall Study|Participant Decision|0|||
170893973|NCT04426695|617619977|FG000|Overall Study|Adverse Event|0|||
170479872|NCT05012098|616097218|FG000|Overall Study|Withdrawal by Subject|1|||
170479873|NCT05012098|616097219|FG001|Overall Study|Withdrawal by Subject|0|||
170479874|NCT05012098|616097218|FG000|Overall Study|Discontinuation per protocol|1|||
170479875|NCT05012098|616097219|FG001|Overall Study|Discontinuation per protocol|0|||
170479876|NCT05573464|616097220|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
170479877|NCT05573464|616097221|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
170479878|NCT05573464|616097220|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
170479879|NCT05573464|616097221|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
170479880|NCT05573464|616097220|FG000|12-week Treatment Period|Protocol Violation|3|||
170479881|NCT05573464|616097221|FG001|12-week Treatment Period|Protocol Violation|1|||
170479882|NCT05573464|616097220|FG000|12-week Treatment Period|Physician Decision|1|||
170479883|NCT05573464|616097221|FG001|12-week Treatment Period|Physician Decision|2|||
170479884|NCT05573464|616097220|FG000|12-week Treatment Period|Lost to Follow-up|2|||
170893974|NCT04426695|617619978|FG001|Overall Study|Adverse Event|0|||
170479885|NCT05573464|616097221|FG001|12-week Treatment Period|Lost to Follow-up|0|||
170479886|NCT05573464|616097220|FG000|12-week Treatment Period|Adverse Event|20|||
170479887|NCT05573464|616097221|FG001|12-week Treatment Period|Adverse Event|9|||
170479888|NCT05573464|616097220|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
170479889|NCT05573464|616097221|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
170479890|NCT05573464|616097220|FG000|12-week Treatment Period|Randomised, not treated|0|||
170479891|NCT05573464|616097221|FG001|12-week Treatment Period|Randomised, not treated|1|||
170479892|NCT05573464|616097220|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
170479893|NCT05573464|616097221|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
170479894|NCT05573464|616097220|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
170479895|NCT05573464|616097221|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
170479896|NCT05573464|616097220|FG000|52-week Treatment Period|Protocol Violation|1|||
170479897|NCT05573464|616097221|FG001|52-week Treatment Period|Protocol Violation|1|||
170479898|NCT05573464|616097220|FG000|52-week Treatment Period|Physician Decision|2|||
170479899|NCT05573464|616097221|FG001|52-week Treatment Period|Physician Decision|2|||
170479900|NCT05573464|616097220|FG000|52-week Treatment Period|Lost to Follow-up|1|||
170479901|NCT05573464|616097221|FG001|52-week Treatment Period|Lost to Follow-up|1|||
170479902|NCT05573464|616097220|FG000|52-week Treatment Period|Adverse Event|11|||
170479903|NCT05573464|616097221|FG001|52-week Treatment Period|Adverse Event|8|||
170479904|NCT05573464|616097220|FG000|52-week Treatment Period|Death|1|||
170479905|NCT05573464|616097221|FG001|52-week Treatment Period|Death|1|||
170479906|NCT05734157|616097223|FG000|Overall Study|Death|3|||
170479907|NCT05734157|616097223|FG000|Overall Study|Withdrawal by Subject|2|||
170479908|NCT05734157|616097223|FG000|Overall Study|Lost to Follow-up|1|||
170479909|NCT05734157|616097223|FG000|Overall Study|Telephone call|3|||
170479910|NCT01490086|616097224|FG000|Overall Study|Consent withdrawn|4|||
170479911|NCT01490086|616097225|FG001|Overall Study|Consent withdrawn|4|||
170479912|NCT01490086|616097226|FG002|Overall Study|Consent withdrawn|3|||
170479913|NCT01490086|616097227|FG003|Overall Study|Consent withdrawn|0|||
170479914|NCT01490086|616097228|FG004|Overall Study|Consent withdrawn|1|||
170479915|NCT01490086|616097224|FG000|Overall Study|Non-compliance|0|||
170479916|NCT01490086|616097225|FG001|Overall Study|Non-compliance|1|||
170479917|NCT01490086|616097226|FG002|Overall Study|Non-compliance|0|||
170479918|NCT01490086|616097227|FG003|Overall Study|Non-compliance|0|||
170479919|NCT01490086|616097228|FG004|Overall Study|Non-compliance|0|||
170479920|NCT01490086|616097224|FG000|Overall Study|Abnormal laboratory findings|1|||
170479921|NCT01490086|616097225|FG001|Overall Study|Abnormal laboratory findings|0|||
170479922|NCT01490086|616097226|FG002|Overall Study|Abnormal laboratory findings|0|||
170479923|NCT01490086|616097227|FG003|Overall Study|Abnormal laboratory findings|0|||
170479924|NCT01490086|616097228|FG004|Overall Study|Abnormal laboratory findings|0|||
170479925|NCT01490086|616097224|FG000|Overall Study|Lost to Follow-up|0|||
170479926|NCT01490086|616097225|FG001|Overall Study|Lost to Follow-up|0|||
170479927|NCT01490086|616097226|FG002|Overall Study|Lost to Follow-up|0|||
170479928|NCT01490086|616097227|FG003|Overall Study|Lost to Follow-up|0|||
170479929|NCT01490086|616097228|FG004|Overall Study|Lost to Follow-up|1|||
170479930|NCT01490086|616097224|FG000|Overall Study|Physician Decision|3|||
170479931|NCT01490086|616097225|FG001|Overall Study|Physician Decision|4|||
170479932|NCT01490086|616097226|FG002|Overall Study|Physician Decision|2|||
170479933|NCT01490086|616097227|FG003|Overall Study|Physician Decision|3|||
170479934|NCT01490086|616097228|FG004|Overall Study|Physician Decision|1|||
170479935|NCT01490086|616097224|FG000|Overall Study|Adverse Event|0|||
170479936|NCT01490086|616097225|FG001|Overall Study|Adverse Event|0|||
170479937|NCT01490086|616097226|FG002|Overall Study|Adverse Event|1|||
170479938|NCT01490086|616097227|FG003|Overall Study|Adverse Event|2|||
170479939|NCT01490086|616097228|FG004|Overall Study|Adverse Event|0|||
170479940|NCT01490086|616097224|FG000|Overall Study|Lack of Efficacy|0|||
170479941|NCT01490086|616097225|FG001|Overall Study|Lack of Efficacy|3|||
170479942|NCT01490086|616097226|FG002|Overall Study|Lack of Efficacy|1|||
170479943|NCT01490086|616097227|FG003|Overall Study|Lack of Efficacy|0|||
170479944|NCT01490086|616097228|FG004|Overall Study|Lack of Efficacy|8|||
170479945|NCT01490086|616097224|FG000|Overall Study|Worsening of symptoms|0|||
170479946|NCT01490086|616097225|FG001|Overall Study|Worsening of symptoms|1|||
170479947|NCT01490086|616097226|FG002|Overall Study|Worsening of symptoms|0|||
170479948|NCT01490086|616097227|FG003|Overall Study|Worsening of symptoms|1|||
170639578|NCT04549545|616693668|FG000|Initial Period|Additional ENT Procedure|3|||
170479949|NCT01490086|616097228|FG004|Overall Study|Worsening of symptoms|0|||
170479950|NCT01490086|616097224|FG000|Overall Study|Subject uncontrollable and abusive|0|||
170479951|NCT01490086|616097225|FG001|Overall Study|Subject uncontrollable and abusive|1|||
170479952|NCT01490086|616097226|FG002|Overall Study|Subject uncontrollable and abusive|0|||
170479953|NCT01490086|616097227|FG003|Overall Study|Subject uncontrollable and abusive|0|||
170479954|NCT01490086|616097228|FG004|Overall Study|Subject uncontrollable and abusive|0|||
170479955|NCT01490086|616097224|FG000|Overall Study|Subject left hospital|0|||
170479956|NCT01490086|616097225|FG001|Overall Study|Subject left hospital|1|||
170479957|NCT01490086|616097226|FG002|Overall Study|Subject left hospital|0|||
170639579|NCT04549545|616693669|FG001|Initial Period|Additional ENT Procedure|0|||
170479958|NCT01490086|616097227|FG003|Overall Study|Subject left hospital|1|||
170479959|NCT01490086|616097228|FG004|Overall Study|Subject left hospital|0|||
170479960|NCT04815083|616097229|FG000|Overall Study|Physician Decision|1|||
170479961|NCT04815083|616097229|FG000|Overall Study|Study pause|2|||
170479962|NCT04815083|616097229|FG000|Overall Study|Screening failure|4|||
170479963|NCT06025721|616097230|FG000|Overall Study|Physician Decision|1|||
170479964|NCT06025721|616097230|FG000|Overall Study|Protocol Violation|1|||
170479965|NCT06025721|616097230|FG000|Overall Study|Incarceration|1|||
170479966|NCT04510090|616097231|FG000|FE-HS|Withdrawal by Subject|0|||
170479967|NCT04510090|616097232|FG001|FE-HS|Withdrawal by Subject|0|||
170479968|NCT04510090|616097233|FG002|FE-HS|Withdrawal by Subject|0|||
170479969|NCT04510090|616097234|FG003|FE-HS|Withdrawal by Subject|0|||
170479970|NCT04510090|616097235|FG004|FE-HS|Withdrawal by Subject|1|||
170479971|NCT04510090|616097236|FG005|FE-HS|Withdrawal by Subject|0|||
170479972|NCT04510090|616097237|FG006|FE-HS|Withdrawal by Subject|0|||
170479973|NCT04510090|616097238|FG007|FE-HS|Withdrawal by Subject|0|||
170479974|NCT05825404|616097239|FG000|First Intervention (Weeks 2-5)|Death|0|||
170479975|NCT05825404|616097240|FG001|First Intervention (Weeks 2-5)|Death|1|||
170479976|NCT05825404|616097239|FG000|Second Intervention (Weeks 8-11)|Death|0|||
170479977|NCT05825404|616097240|FG001|Second Intervention (Weeks 8-11)|Death|1|||
170479978|NCT01749826|616097241|FG000|Overall Study|Study Terminated|20|||
170479979|NCT01749826|616097242|FG001|Overall Study|Study Terminated|0|||
170479980|NCT01922037|616097243|FG000|Overall Study|Withdrawal by Subject|2|||
170479981|NCT01922037|616097244|FG001|Overall Study|Withdrawal by Subject|44|||
170479982|NCT01922037|616097243|FG000|Overall Study|Adverse Event|1|||
170479983|NCT01922037|616097244|FG001|Overall Study|Adverse Event|7|||
170479984|NCT01922037|616097243|FG000|Overall Study|Death|0|||
170479985|NCT01922037|616097244|FG001|Overall Study|Death|5|||
170479986|NCT01922037|616097243|FG000|Overall Study|Pregnancy|0|||
170479987|NCT01922037|616097244|FG001|Overall Study|Pregnancy|2|||
170479988|NCT01922037|616097243|FG000|Overall Study|Participant non-compliance|4|||
170479989|NCT01922037|616097244|FG001|Overall Study|Participant non-compliance|46|||
170479990|NCT01922037|616097243|FG000|Overall Study|Investigator/Sponsor decision|1|||
170479991|NCT01922037|616097244|FG001|Overall Study|Investigator/Sponsor decision|4|||
170479992|NCT01922037|616097243|FG000|Overall Study|Other unspecified|2|||
170479993|NCT01922037|616097244|FG001|Overall Study|Other unspecified|66|||
170479994|NCT01730053|616097245|FG000|Overall Study|Participant moved|0|||
170479995|NCT01730053|616097246|FG001|Overall Study|Participant moved|0|||
170479996|NCT01730053|616097247|FG002|Overall Study|Participant moved|1|||
170479997|NCT01730053|616097248|FG003|Overall Study|Participant moved|0|||
170479998|NCT01730053|616097249|FG004|Overall Study|Participant moved|0|||
170479999|NCT01730053|616097250|FG005|Overall Study|Participant moved|0|||
170480000|NCT01730053|616097245|FG000|Overall Study|Physician Decision|0|||
170480001|NCT01730053|616097246|FG001|Overall Study|Physician Decision|0|||
170480002|NCT01730053|616097247|FG002|Overall Study|Physician Decision|0|||
170480003|NCT01730053|616097248|FG003|Overall Study|Physician Decision|1|||
170480004|NCT01730053|616097249|FG004|Overall Study|Physician Decision|0|||
170480005|NCT01730053|616097250|FG005|Overall Study|Physician Decision|0|||
170480006|NCT01730053|616097245|FG000|Overall Study|Adverse Event|2|||
170480007|NCT01730053|616097246|FG001|Overall Study|Adverse Event|6|||
170480008|NCT01730053|616097247|FG002|Overall Study|Adverse Event|3|||
170480009|NCT01730053|616097248|FG003|Overall Study|Adverse Event|3|||
170480010|NCT01730053|616097249|FG004|Overall Study|Adverse Event|2|||
170480011|NCT01730053|616097250|FG005|Overall Study|Adverse Event|2|||
170480012|NCT01730053|616097245|FG000|Overall Study|Poor compliance to protocol|1|||
170480013|NCT01730053|616097246|FG001|Overall Study|Poor compliance to protocol|2|||
170480014|NCT01730053|616097247|FG002|Overall Study|Poor compliance to protocol|2|||
170480015|NCT01730053|616097248|FG003|Overall Study|Poor compliance to protocol|0|||
170547545|NCT04595370|616350212|FG001|Overall Study|Withdrawal by Subject|0|||
170547546|NCT04595370|616350213|FG002|Overall Study|Withdrawal by Subject|1|||
170480016|NCT01730053|616097249|FG004|Overall Study|Poor compliance to protocol|0|||
170480017|NCT01730053|616097250|FG005|Overall Study|Poor compliance to protocol|2|||
170480018|NCT01730053|616097245|FG000|Overall Study|Other than specified|2|||
170480019|NCT01730053|616097246|FG001|Overall Study|Other than specified|6|||
170480020|NCT01730053|616097247|FG002|Overall Study|Other than specified|5|||
170480021|NCT01730053|616097248|FG003|Overall Study|Other than specified|4|||
170480022|NCT01730053|616097249|FG004|Overall Study|Other than specified|7|||
170547547|NCT04595370|616350214|FG003|Overall Study|Withdrawal by Subject|0|||
170547548|NCT04595370|616350215|FG004|Overall Study|Withdrawal by Subject|2|||
170547549|NCT04595370|616350216|FG005|Overall Study|Withdrawal by Subject|0|||
170547550|NCT04595370|616350211|FG000|Overall Study|Lost to Follow-up|0|||
170547551|NCT04595370|616350212|FG001|Overall Study|Lost to Follow-up|0|||
170547552|NCT04595370|616350213|FG002|Overall Study|Lost to Follow-up|0|||
170480023|NCT01730053|616097250|FG005|Overall Study|Other than specified|9|||
170480024|NCT00351468|616097251|FG000|Overall Study|Adverse Event|42|||
170547553|NCT04595370|616350214|FG003|Overall Study|Lost to Follow-up|0|||
170480025|NCT00351468|616097251|FG000|Overall Study|Withdrawal by Subject|39|||
170480026|NCT00351468|616097251|FG000|Overall Study|Various -follow up w clinical team|39|||
170480027|NCT00351468|616097251|FG000|Overall Study|Lack of Efficacy|32|||
170480028|NCT00351468|616097251|FG000|Overall Study|Non-compliance|8|||
170480029|NCT00351468|616097251|FG000|Overall Study|Lost to Follow-up|4|||
170480030|NCT00351468|616097251|FG000|Overall Study|Protocol Violation|3|||
170480031|NCT03588910|616097252|FG000|Overall Study|Withdrawal by Subject|1|||
170480032|NCT03588910|616097253|FG001|Overall Study|Withdrawal by Subject|0|||
170480033|NCT03588910|616097252|FG000|Overall Study|Allergy|2|||
170480034|NCT03588910|616097253|FG001|Overall Study|Allergy|0|||
170480035|NCT03588910|616097252|FG000|Overall Study|Protocol Violation|0|||
170480036|NCT03588910|616097253|FG001|Overall Study|Protocol Violation|3|||
170480037|NCT03588910|616097252|FG000|Overall Study|Did not complete Day 1 Survey|5|||
170480038|NCT03588910|616097253|FG001|Overall Study|Did not complete Day 1 Survey|10|||
170480039|NCT03588910|616097252|FG000|Overall Study|Did not complete Day 7 Survey|5|||
170480040|NCT03588910|616097253|FG001|Overall Study|Did not complete Day 7 Survey|2|||
170480041|NCT03096314|616097254|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
170480042|NCT03096314|616097255|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
170480043|NCT00471822|616097256|FG000|Overall Study|Protocol Violation|2|||
170480044|NCT03318861|616097257|FG000|Overall Study|Death|2|||
170480045|NCT03318861|616097258|FG001|Overall Study|Death|3|||
170480046|NCT03318861|616097259|FG002|Overall Study|Death|3|||
170480047|NCT03318861|616097260|FG003|Overall Study|Death|2|||
170480048|NCT03318861|616097261|FG004|Overall Study|Death|2|||
170480049|NCT03318861|616097257|FG000|Overall Study|Enrolled But Never Treated|0|||
170480050|NCT03318861|616097258|FG001|Overall Study|Enrolled But Never Treated|1|||
170480051|NCT03318861|616097259|FG002|Overall Study|Enrolled But Never Treated|0|||
170480052|NCT03318861|616097260|FG003|Overall Study|Enrolled But Never Treated|1|||
170480053|NCT03318861|616097261|FG004|Overall Study|Enrolled But Never Treated|1|||
170480054|NCT03318861|616097257|FG000|Overall Study|Informed Consent Withdraw|0|||
170480055|NCT03318861|616097258|FG001|Overall Study|Informed Consent Withdraw|0|||
170480056|NCT03318861|616097259|FG002|Overall Study|Informed Consent Withdraw|0|||
170480057|NCT03318861|616097260|FG003|Overall Study|Informed Consent Withdraw|1|||
170480058|NCT03318861|616097261|FG004|Overall Study|Informed Consent Withdraw|0|||
170480059|NCT03318861|616097257|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
170480060|NCT03318861|616097258|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
170480061|NCT03318861|616097259|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
170480062|NCT03318861|616097260|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
170480063|NCT03318861|616097261|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
170480064|NCT05516108|616097264|FG000|Overall Study|Time Commitment|3|||
170480065|NCT05516108|616097265|FG001|Overall Study|Time Commitment|1|||
170480066|NCT05516108|616097264|FG000|Overall Study|Reason Unknown|2|||
170480067|NCT05516108|616097265|FG001|Overall Study|Reason Unknown|4|||
170480068|NCT03664232|616097266|FG000|Overall Study|Withdrawal by Subject|0|||
170480069|NCT03664232|616097267|FG001|Overall Study|Withdrawal by Subject|1|||
170480070|NCT03664232|616097268|FG002|Overall Study|Withdrawal by Subject|0|||
170480071|NCT03664232|616097269|FG003|Overall Study|Withdrawal by Subject|1|||
170480072|NCT03664232|616097266|FG000|Overall Study|Adverse Event|0|||
170480073|NCT03664232|616097267|FG001|Overall Study|Adverse Event|0|||
170480074|NCT03664232|616097268|FG002|Overall Study|Adverse Event|1|||
170480075|NCT03664232|616097269|FG003|Overall Study|Adverse Event|0|||
170480076|NCT03664232|616097266|FG000|Overall Study|Other-Non-compliance with study drug|0|||
170480077|NCT03664232|616097267|FG001|Overall Study|Other-Non-compliance with study drug|1|||
170480078|NCT03664232|616097268|FG002|Overall Study|Other-Non-compliance with study drug|0|||
170480079|NCT03664232|616097269|FG003|Overall Study|Other-Non-compliance with study drug|2|||
170480080|NCT03664232|616097266|FG000|Overall Study|Other-Unspecified|0|||
170480081|NCT03664232|616097267|FG001|Overall Study|Other-Unspecified|3|||
170480082|NCT03664232|616097268|FG002|Overall Study|Other-Unspecified|0|||
170480083|NCT03664232|616097269|FG003|Overall Study|Other-Unspecified|1|||
170480084|NCT03664232|616097266|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
170480085|NCT03664232|616097267|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
170480086|NCT03664232|616097268|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
170480087|NCT03664232|616097269|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
170480088|NCT02288312|616097272|FG000|Overall Study|Pregnancy|1|||
170480089|NCT02288312|616097273|FG001|Overall Study|Pregnancy|0|||
170480090|NCT02288312|616097274|FG002|Overall Study|Pregnancy|0|||
170480091|NCT02548832|616097277|FG000|Overall Study|Lost to Follow-up|2|||
170480092|NCT02548832|616097278|FG001|Overall Study|Lost to Follow-up|2|||
170480093|NCT02548832|616097279|FG002|Overall Study|Lost to Follow-up|2|||
170480094|NCT03565900|616097280|FG000|Overall Study|Disposition Unknown|4|||
170793942|NCT05267470|617254191|FG004|Overall Study|Lost to Follow-up|0|||
170793943|NCT02823145|617254192|FG000|Enrollment|Other|1|||
170480095|NCT03565900|616097281|FG001|Overall Study|Disposition Unknown|1|||
170480096|NCT03565900|616097280|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
170480097|NCT03565900|616097281|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
170480098|NCT03565900|616097280|FG000|Overall Study|Withdrawal by Subject|4|||
170480099|NCT03565900|616097281|FG001|Overall Study|Withdrawal by Subject|5|||
170480100|NCT03565900|616097280|FG000|Overall Study|Randomized By Mistake|0|||
170547554|NCT04595370|616350215|FG004|Overall Study|Lost to Follow-up|1|||
170480101|NCT03565900|616097281|FG001|Overall Study|Randomized By Mistake|2|||
170480102|NCT03565900|616097280|FG000|Overall Study|Physician Decision|7|||
170480103|NCT03565900|616097281|FG001|Overall Study|Physician Decision|11|||
170480104|NCT03565900|616097280|FG000|Overall Study|Death|9|||
170480105|NCT03565900|616097281|FG001|Overall Study|Death|7|||
170480106|NCT01254643|616097282|FG000|Overall Study|Withdrawal by Subject|1|||
170480107|NCT00942084|616097285|FG000|Overall Study|Death|2|||
170480108|NCT01037218|616097288|FG000|Overall Study|Adverse Event|4|||
170480109|NCT01037218|616097289|FG001|Overall Study|Adverse Event|2|||
170480110|NCT01037218|616097290|FG002|Overall Study|Adverse Event|2|||
170480111|NCT01037218|616097291|FG003|Overall Study|Adverse Event|1|||
170480112|NCT01037218|616097288|FG000|Overall Study|Lack of Efficacy|0|||
170480113|NCT01037218|616097289|FG001|Overall Study|Lack of Efficacy|2|||
170480114|NCT01037218|616097290|FG002|Overall Study|Lack of Efficacy|1|||
170480115|NCT01037218|616097291|FG003|Overall Study|Lack of Efficacy|5|||
170480116|NCT01037218|616097288|FG000|Overall Study|Lost to Follow-up|3|||
170480117|NCT01037218|616097289|FG001|Overall Study|Lost to Follow-up|5|||
170480118|NCT01037218|616097290|FG002|Overall Study|Lost to Follow-up|4|||
170547555|NCT04595370|616350216|FG005|Overall Study|Lost to Follow-up|0|||
170547556|NCT04595370|616350211|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
170547557|NCT04595370|616350212|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
170547558|NCT04595370|616350213|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
170547559|NCT04595370|616350214|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
170547560|NCT04595370|616350215|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
170547561|NCT04595370|616350216|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
170547562|NCT02187055|616350217|FG000|Overall Study|Lack of Efficacy|10|||
170547563|NCT02187055|616350218|FG001|Overall Study|Lack of Efficacy|3|||
170547564|NCT02187055|616350219|FG002|Overall Study|Lack of Efficacy|7|||
170639580|NCT04549545|616693668|FG000|Initial Period|Lost to Follow-up|3|||
170793944|NCT02823145|617254193|FG001|Enrollment|Other|0|||
170793945|NCT02823145|617254192|FG000|Treatment|Adverse Event|0|||
170793946|NCT02823145|617254193|FG001|Treatment|Adverse Event|11|||
170793947|NCT02823145|617254192|FG000|Treatment|Death|0|||
170793948|NCT02823145|617254193|FG001|Treatment|Death|3|||
170793949|NCT02823145|617254192|FG000|Treatment|Family Decision|0|||
170793950|NCT02823145|617254193|FG001|Treatment|Family Decision|1|||
170793951|NCT02823145|617254192|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
170793952|NCT02823145|617254193|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
170793953|NCT02823145|617254192|FG000|Treatment|Lack of Efficacy|0|||
170793954|NCT02823145|617254193|FG001|Treatment|Lack of Efficacy|48|||
170793955|NCT02823145|617254192|FG000|Treatment|Non-Compliance With E-Diary|0|||
170793956|NCT02823145|617254193|FG001|Treatment|Non-Compliance With E-Diary|1|||
170793957|NCT02823145|617254192|FG000|Treatment|Physician Decision|0|||
170793958|NCT02823145|617254193|FG001|Treatment|Physician Decision|2|||
170793959|NCT02823145|617254192|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
170793960|NCT02823145|617254193|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
170793961|NCT02823145|617254192|FG000|Treatment|Subject needed to take prohibited medication|0|||
170793962|NCT02823145|617254193|FG001|Treatment|Subject needed to take prohibited medication|1|||
170793963|NCT02823145|617254192|FG000|Treatment|Subject transferred to direct access programme|0|||
170793964|NCT02823145|617254193|FG001|Treatment|Subject transferred to direct access programme|1|||
170793965|NCT02823145|617254192|FG000|Treatment|Switching to commercially available drug|0|||
170793966|NCT02823145|617254193|FG001|Treatment|Switching to commercially available drug|11|||
170793967|NCT02823145|617254192|FG000|Treatment|Transitioned to commercial supply of medication|0|||
170793968|NCT02823145|617254193|FG001|Treatment|Transitioned to commercial supply of medication|1|||
170793969|NCT02823145|617254192|FG000|Treatment|Withdrawal By Caregiver|0|||
170793970|NCT02823145|617254193|FG001|Treatment|Withdrawal By Caregiver|1|||
170793971|NCT02823145|617254192|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
170793972|NCT02823145|617254193|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
170893975|NCT04426695|617619979|FG002|Overall Study|Adverse Event|0|||
170893976|NCT04426695|617619980|FG003|Overall Study|Adverse Event|0|||
170893977|NCT04426695|617619981|FG004|Overall Study|Adverse Event|0|||
170893978|NCT04426695|617619982|FG005|Overall Study|Adverse Event|0|||
170893979|NCT04426695|617619983|FG006|Overall Study|Adverse Event|0|||
170480119|NCT01037218|616097291|FG003|Overall Study|Lost to Follow-up|2|||
170480120|NCT01037218|616097288|FG000|Overall Study|Withdrawal by Subject|6|||
170480121|NCT01037218|616097289|FG001|Overall Study|Withdrawal by Subject|7|||
170480122|NCT01037218|616097290|FG002|Overall Study|Withdrawal by Subject|7|||
170793973|NCT02823145|617254192|FG000|Treatment|Withdrawal by Subject|0|||
170793974|NCT02823145|617254193|FG001|Treatment|Withdrawal by Subject|16|||
170793975|NCT02823145|617254192|FG000|Treatment|Reason unknown|0|||
170793976|NCT02823145|617254193|FG001|Treatment|Reason unknown|1|||
170793977|NCT02852655|617254199|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
170893980|NCT04426695|617619984|FG007|Overall Study|Adverse Event|1|||
170893981|NCT04426695|617619985|FG008|Overall Study|Adverse Event|0|||
170893982|NCT04426695|617619986|FG009|Overall Study|Adverse Event|0|||
170480123|NCT01037218|616097291|FG003|Overall Study|Withdrawal by Subject|4|||
170480124|NCT01037218|616097288|FG000|Overall Study|Partner Withdrew Consent|0|||
170793978|NCT02852655|617254200|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
170793979|NCT02852655|617254201|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
170793980|NCT02852655|617254199|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
170793981|NCT02852655|617254200|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
170793982|NCT02852655|617254201|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
170793983|NCT02852655|617254199|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
170793984|NCT02852655|617254200|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
170793985|NCT02852655|617254201|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
170793986|NCT02852655|617254199|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
170793987|NCT02852655|617254200|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
170793988|NCT02852655|617254201|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
170793989|NCT02852655|617254199|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
170793990|NCT02852655|617254200|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
170793991|NCT02852655|617254201|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
170793992|NCT02852655|617254199|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
170793993|NCT02852655|617254200|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
170793994|NCT02852655|617254201|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
170793995|NCT02852655|617254199|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
170793996|NCT02852655|617254200|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
170793997|NCT02852655|617254201|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
170793998|NCT02852655|617254199|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
170793999|NCT02852655|617254200|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
170794000|NCT02852655|617254201|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
170794001|NCT02852655|617254199|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
170794002|NCT02852655|617254200|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
170794003|NCT02852655|617254201|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
170794004|NCT03011333|617255931|FG000|Overall Study|Lost to Follow-up|0|||
170794005|NCT03011333|617255932|FG001|Overall Study|Lost to Follow-up|1|||
170794006|NCT03011333|617255933|FG002|Overall Study|Lost to Follow-up|0|||
170794007|NCT03011333|617255934|FG003|Overall Study|Lost to Follow-up|1|||
170794008|NCT03011333|617255935|FG004|Overall Study|Lost to Follow-up|4|||
170794009|NCT03011333|617255936|FG005|Overall Study|Lost to Follow-up|4|||
170794010|NCT03011333|617255937|FG006|Overall Study|Lost to Follow-up|5|||
170794011|NCT04233216|617255938|FG000|Overall Study|Lost to Follow-up|1|||
170794012|NCT04233216|617255939|FG001|Overall Study|Lost to Follow-up|0|||
170794013|NCT04233216|617255940|FG002|Overall Study|Lost to Follow-up|2|||
170794014|NCT04233216|617255941|FG003|Overall Study|Lost to Follow-up|0|||
170794015|NCT04233216|617255938|FG000|Overall Study|Physician Decision|0|||
170794016|NCT04233216|617255939|FG001|Overall Study|Physician Decision|3|||
170794017|NCT04233216|617255940|FG002|Overall Study|Physician Decision|0|||
170794018|NCT04233216|617255941|FG003|Overall Study|Physician Decision|2|||
170794019|NCT04233216|617255938|FG000|Overall Study|Withdrawal by Subject|0|||
170794020|NCT04233216|617255939|FG001|Overall Study|Withdrawal by Subject|2|||
170794021|NCT04233216|617255940|FG002|Overall Study|Withdrawal by Subject|1|||
170794022|NCT04233216|617255941|FG003|Overall Study|Withdrawal by Subject|0|||
170794023|NCT05622812|617255944|FG000|Overall Study|Withdrawal by Subject|1|||
170794024|NCT05622812|617255945|FG001|Overall Study|Withdrawal by Subject|4|||
170794025|NCT05622812|617255944|FG000|Overall Study|Lost to Follow-up|2|||
170794026|NCT05622812|617255945|FG001|Overall Study|Lost to Follow-up|1|||
170794027|NCT04433208|617255946|FG000|Overall Study|Withdrawal by Subject|0|||
170794028|NCT04433208|617255947|FG001|Overall Study|Withdrawal by Subject|1|||
170794029|NCT04433208|617255948|FG002|Overall Study|Withdrawal by Subject|1|||
170794030|NCT04433208|617255949|FG003|Overall Study|Withdrawal by Subject|0|||
170794031|NCT04433208|617255950|FG004|Overall Study|Withdrawal by Subject|2|||
170794032|NCT04433208|617255951|FG005|Overall Study|Withdrawal by Subject|1|||
170794033|NCT04433208|617255946|FG000|Overall Study|Lost to Follow-up|0|||
170794034|NCT04433208|617255947|FG001|Overall Study|Lost to Follow-up|0|||
170794035|NCT04433208|617255948|FG002|Overall Study|Lost to Follow-up|0|||
170794036|NCT04433208|617255949|FG003|Overall Study|Lost to Follow-up|0|||
170794037|NCT04433208|617255950|FG004|Overall Study|Lost to Follow-up|0|||
170794038|NCT04433208|617255951|FG005|Overall Study|Lost to Follow-up|1|||
170794039|NCT05093842|617255952|FG000|Overall Study|Pregnancy loss|1|||
170794040|NCT05093842|617255953|FG001|Overall Study|Pregnancy loss|1|||
170794041|NCT05093842|617255952|FG000|Overall Study|Lost to Follow-up|6|||
170794042|NCT05093842|617255953|FG001|Overall Study|Lost to Follow-up|0|||
170794043|NCT05093842|617255952|FG000|Overall Study|Physician Decision|0|||
170794044|NCT05093842|617255953|FG001|Overall Study|Physician Decision|1|||
170794045|NCT04971109|617255954|FG000|Overall Study|Adverse Event|4|||
170794046|NCT04971109|617255955|FG001|Overall Study|Adverse Event|3|||
170794047|NCT04971109|617255954|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
170893983|NCT04426695|617619987|FG010|Overall Study|Adverse Event|1|||
170893984|NCT04426695|617619988|FG011|Overall Study|Adverse Event|1|||
170893985|NCT04426695|617619989|FG012|Overall Study|Adverse Event|0|||
170893986|NCT04426695|617619990|FG013|Overall Study|Adverse Event|0|||
170893987|NCT04426695|617619991|FG014|Overall Study|Adverse Event|0|||
170893988|NCT04426695|617619992|FG015|Overall Study|Adverse Event|0|||
170893989|NCT04426695|617619993|FG016|Overall Study|Adverse Event|0|||
170893990|NCT04426695|617619994|FG017|Overall Study|Adverse Event|0|||
170893991|NCT04426695|617619977|FG000|Overall Study|Sponsor Request|0|||
170893992|NCT04426695|617619978|FG001|Overall Study|Sponsor Request|0|||
170893993|NCT04426695|617619979|FG002|Overall Study|Sponsor Request|0|||
170893994|NCT04426695|617619980|FG003|Overall Study|Sponsor Request|0|||
170893995|NCT04426695|617619981|FG004|Overall Study|Sponsor Request|0|||
170893996|NCT04426695|617619982|FG005|Overall Study|Sponsor Request|0|||
170893997|NCT04426695|617619983|FG006|Overall Study|Sponsor Request|1|||
170893998|NCT04426695|617619984|FG007|Overall Study|Sponsor Request|0|||
170893999|NCT04426695|617619985|FG008|Overall Study|Sponsor Request|0|||
170894000|NCT04426695|617619986|FG009|Overall Study|Sponsor Request|0|||
170894001|NCT04426695|617619987|FG010|Overall Study|Sponsor Request|0|||
170894002|NCT04426695|617619988|FG011|Overall Study|Sponsor Request|0|||
170894003|NCT04426695|617619989|FG012|Overall Study|Sponsor Request|0|||
170894004|NCT04426695|617619990|FG013|Overall Study|Sponsor Request|0|||
170894005|NCT04426695|617619991|FG014|Overall Study|Sponsor Request|0|||
170894006|NCT04426695|617619992|FG015|Overall Study|Sponsor Request|0|||
170894007|NCT04426695|617619993|FG016|Overall Study|Sponsor Request|0|||
170894008|NCT04426695|617619994|FG017|Overall Study|Sponsor Request|0|||
170894009|NCT04426695|617619977|FG000|Overall Study|Physician Decision|0|||
170894010|NCT04426695|617619978|FG001|Overall Study|Physician Decision|0|||
170894011|NCT04426695|617619979|FG002|Overall Study|Physician Decision|0|||
170894012|NCT04426695|617619980|FG003|Overall Study|Physician Decision|0|||
170894013|NCT04426695|617619981|FG004|Overall Study|Physician Decision|0|||
170894014|NCT04426695|617619982|FG005|Overall Study|Physician Decision|0|||
170894015|NCT04426695|617619983|FG006|Overall Study|Physician Decision|0|||
170894016|NCT04426695|617619984|FG007|Overall Study|Physician Decision|0|||
170894017|NCT04426695|617619985|FG008|Overall Study|Physician Decision|0|||
170894018|NCT04426695|617619986|FG009|Overall Study|Physician Decision|1|||
170894019|NCT04426695|617619987|FG010|Overall Study|Physician Decision|0|||
170894020|NCT04426695|617619988|FG011|Overall Study|Physician Decision|0|||
170894021|NCT04426695|617619989|FG012|Overall Study|Physician Decision|1|||
170894022|NCT04426695|617619990|FG013|Overall Study|Physician Decision|0|||
170894023|NCT04426695|617619991|FG014|Overall Study|Physician Decision|0|||
170894024|NCT04426695|617619992|FG015|Overall Study|Physician Decision|0|||
170894025|NCT04426695|617619993|FG016|Overall Study|Physician Decision|0|||
170894026|NCT04426695|617619994|FG017|Overall Study|Physician Decision|0|||
170894027|NCT04426695|617619977|FG000|Overall Study|Randomized but Never Treated|3|||
170894028|NCT04426695|617619978|FG001|Overall Study|Randomized but Never Treated|1|||
170894029|NCT04426695|617619979|FG002|Overall Study|Randomized but Never Treated|0|||
170894030|NCT04426695|617619980|FG003|Overall Study|Randomized but Never Treated|4|||
170894031|NCT04426695|617619981|FG004|Overall Study|Randomized but Never Treated|5|||
170894032|NCT04426695|617619982|FG005|Overall Study|Randomized but Never Treated|5|||
170894033|NCT04426695|617619983|FG006|Overall Study|Randomized but Never Treated|4|||
170894034|NCT04426695|617619984|FG007|Overall Study|Randomized but Never Treated|6|||
170894035|NCT04426695|617619985|FG008|Overall Study|Randomized but Never Treated|6|||
170894036|NCT04426695|617619986|FG009|Overall Study|Randomized but Never Treated|3|||
170894037|NCT04426695|617619987|FG010|Overall Study|Randomized but Never Treated|3|||
170480125|NCT01037218|616097289|FG001|Overall Study|Partner Withdrew Consent|3|||
170480126|NCT01037218|616097290|FG002|Overall Study|Partner Withdrew Consent|2|||
170480127|NCT01037218|616097291|FG003|Overall Study|Partner Withdrew Consent|1|||
170480128|NCT01037218|616097288|FG000|Overall Study|Protocol Violation|0|||
170480129|NCT01037218|616097289|FG001|Overall Study|Protocol Violation|0|||
170639581|NCT04549545|616693669|FG001|Initial Period|Lost to Follow-up|1|||
170639582|NCT04549545|616693668|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
170894038|NCT04426695|617619988|FG011|Overall Study|Randomized but Never Treated|6|||
170894039|NCT04426695|617619989|FG012|Overall Study|Randomized but Never Treated|1|||
170894040|NCT04426695|617619990|FG013|Overall Study|Randomized but Never Treated|2|||
170894041|NCT04426695|617619991|FG014|Overall Study|Randomized but Never Treated|0|||
170894042|NCT04426695|617619992|FG015|Overall Study|Randomized but Never Treated|0|||
170894043|NCT04426695|617619993|FG016|Overall Study|Randomized but Never Treated|0|||
170894044|NCT04426695|617619994|FG017|Overall Study|Randomized but Never Treated|0|||
170894045|NCT00559273|617619995|FG000|Correction Period (20 Weeks)|Death|3|||
170894046|NCT00559273|617619996|FG001|Correction Period (20 Weeks)|Death|4|||
170894047|NCT00559273|617619995|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
170894048|NCT00559273|617619996|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
170894049|NCT00559273|617619995|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
170894050|NCT00559273|617619996|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
170894051|NCT00559273|617619995|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
170894052|NCT00559273|617619996|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
170894053|NCT00559273|617619995|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
170894054|NCT00559273|617619996|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
170894055|NCT00559273|617619995|FG000|Evaluation Period (8 Weeks)|Death|1|||
170894056|NCT00559273|617619996|FG001|Evaluation Period (8 Weeks)|Death|3|||
170894057|NCT00559273|617619995|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
170894058|NCT00559273|617619996|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
170894059|NCT00559273|617619995|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
170894060|NCT00559273|617619996|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
170894061|NCT00559273|617619995|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
170894062|NCT00559273|617619996|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
170894063|NCT01109940|617619998|FG000|Overall Study|Administrative problems|2|||
170894064|NCT01109940|617619999|FG001|Overall Study|Administrative problems|0|||
170894065|NCT01109940|617620000|FG002|Overall Study|Administrative problems|0|||
170894066|NCT01109940|617620001|FG003|Overall Study|Administrative problems|0|||
170894067|NCT01109940|617619998|FG000|Overall Study|Serious Adverse Event|2|||
170894068|NCT01109940|617619999|FG001|Overall Study|Serious Adverse Event|1|||
170894069|NCT01109940|617620000|FG002|Overall Study|Serious Adverse Event|0|||
170894070|NCT01109940|617620001|FG003|Overall Study|Serious Adverse Event|0|||
170894071|NCT01109940|617619998|FG000|Overall Study|Lost to Follow-up|1|||
170894072|NCT01109940|617619999|FG001|Overall Study|Lost to Follow-up|0|||
170894073|NCT01109940|617620000|FG002|Overall Study|Lost to Follow-up|0|||
170894074|NCT01109940|617620001|FG003|Overall Study|Lost to Follow-up|0|||
170894075|NCT01109940|617619998|FG000|Overall Study|Patient withdrew consent|1|||
170894076|NCT01109940|617619999|FG001|Overall Study|Patient withdrew consent|1|||
170894077|NCT01109940|617620000|FG002|Overall Study|Patient withdrew consent|0|||
170894078|NCT01109940|617620001|FG003|Overall Study|Patient withdrew consent|0|||
170894079|NCT01109940|617619998|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170894080|NCT01109940|617619999|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170894081|NCT01109940|617620000|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
170894082|NCT01109940|617620001|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
170894083|NCT04451330|617620002|FG000|Overall Study|Adverse Event|1|||
170894084|NCT04451330|617620003|FG001|Overall Study|Adverse Event|2|||
170894085|NCT04451330|617620002|FG000|Overall Study|Lost to Follow-up|5|||
170894086|NCT04451330|617620003|FG001|Overall Study|Lost to Follow-up|0|||
170894087|NCT04451330|617620002|FG000|Overall Study|Withdrawal by Subject|3|||
170894088|NCT04451330|617620003|FG001|Overall Study|Withdrawal by Subject|1|||
170894089|NCT04451330|617620002|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170894090|NCT04451330|617620003|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170794048|NCT04971109|617255955|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
170794049|NCT04971109|617255954|FG000|Overall Study|Lost to Follow-up|8|||
170794050|NCT04971109|617255955|FG001|Overall Study|Lost to Follow-up|2|||
170794051|NCT04971109|617255954|FG000|Overall Study|Physician Decision|5|||
170794052|NCT04971109|617255955|FG001|Overall Study|Physician Decision|0|||
170794053|NCT04971109|617255954|FG000|Overall Study|Protocol Violation|0|||
170794054|NCT04971109|617255955|FG001|Overall Study|Protocol Violation|1|||
170794055|NCT04971109|617255954|FG000|Overall Study|Withdrawal by Subject|18|||
170794056|NCT04971109|617255955|FG001|Overall Study|Withdrawal by Subject|3|||
170794057|NCT04971109|617255954|FG000|Overall Study|Subject was randomized in error|1|||
170794058|NCT04971109|617255955|FG001|Overall Study|Subject was randomized in error|0|||
170794059|NCT04778397|617255958|FG000|Overall Study|Death|59|||
170894091|NCT04451330|617620002|FG000|Overall Study|Other than specified|0|||
170894092|NCT04451330|617620003|FG001|Overall Study|Other than specified|1|||
170894093|NCT01299727|617620004|FG000|Overall Study|Withdrawal by Subject|1|||
170480130|NCT01037218|616097290|FG002|Overall Study|Protocol Violation|2|||
170480131|NCT01037218|616097291|FG003|Overall Study|Protocol Violation|2|||
170480132|NCT01037218|616097288|FG000|Overall Study|Various|3|||
170480133|NCT01037218|616097289|FG001|Overall Study|Various|2|||
170480134|NCT01037218|616097290|FG002|Overall Study|Various|3|||
170480135|NCT01037218|616097291|FG003|Overall Study|Various|1|||
170480136|NCT01068860|616097292|FG000|Overall Study|Withdrawal by Subject|0|||
170480137|NCT01068860|616097293|FG001|Overall Study|Withdrawal by Subject|0|||
170480138|NCT01068860|616097294|FG002|Overall Study|Withdrawal by Subject|0|||
170894094|NCT01299727|617620005|FG001|Overall Study|Withdrawal by Subject|0|||
170894095|NCT01299727|617620006|FG002|Overall Study|Withdrawal by Subject|0|||
170894096|NCT01299727|617620004|FG000|Overall Study|Adverse Event|0|||
170894097|NCT01299727|617620005|FG001|Overall Study|Adverse Event|0|||
170894098|NCT01299727|617620006|FG002|Overall Study|Adverse Event|1|||
170894099|NCT01299727|617620004|FG000|Overall Study|Completed the Treatment Period|3|||
170480139|NCT01068860|616097295|FG003|Overall Study|Withdrawal by Subject|0|||
170794060|NCT04778397|617255959|FG001|Overall Study|Death|54|||
170794061|NCT04778397|617255960|FG002|Overall Study|Death|11|||
170794062|NCT04778397|617255961|FG003|Overall Study|Death|9|||
170894100|NCT01299727|617620005|FG001|Overall Study|Completed the Treatment Period|4|||
170894101|NCT01299727|617620006|FG002|Overall Study|Completed the Treatment Period|3|||
170480140|NCT01068860|616097296|FG004|Overall Study|Withdrawal by Subject|0|||
170480141|NCT01068860|616097297|FG005|Overall Study|Withdrawal by Subject|2|||
170480142|NCT01068860|616097298|FG006|Overall Study|Withdrawal by Subject|0|||
170480143|NCT01068860|616097299|FG007|Overall Study|Withdrawal by Subject|0|||
170480144|NCT01068860|616097300|FG008|Overall Study|Withdrawal by Subject|0|||
170480145|NCT01068860|616097301|FG009|Overall Study|Withdrawal by Subject|3|||
170480146|NCT01068860|616097292|FG000|Overall Study|Administrative problems; misrandomized|0|||
170480147|NCT01068860|616097293|FG001|Overall Study|Administrative problems; misrandomized|0|||
170480148|NCT01068860|616097294|FG002|Overall Study|Administrative problems; misrandomized|0|||
170480149|NCT01068860|616097295|FG003|Overall Study|Administrative problems; misrandomized|1|||
170480150|NCT01068860|616097296|FG004|Overall Study|Administrative problems; misrandomized|0|||
170480151|NCT01068860|616097297|FG005|Overall Study|Administrative problems; misrandomized|0|||
170480152|NCT01068860|616097298|FG006|Overall Study|Administrative problems; misrandomized|0|||
170480153|NCT01068860|616097299|FG007|Overall Study|Administrative problems; misrandomized|0|||
170480154|NCT01068860|616097300|FG008|Overall Study|Administrative problems; misrandomized|0|||
170480155|NCT01068860|616097301|FG009|Overall Study|Administrative problems; misrandomized|1|||
170480156|NCT01068860|616097292|FG000|Overall Study|Lost to Follow-up|0|||
170480157|NCT01068860|616097293|FG001|Overall Study|Lost to Follow-up|1|||
170480158|NCT01068860|616097294|FG002|Overall Study|Lost to Follow-up|0|||
170480159|NCT01068860|616097295|FG003|Overall Study|Lost to Follow-up|0|||
170480160|NCT01068860|616097296|FG004|Overall Study|Lost to Follow-up|0|||
170547565|NCT02187055|616350217|FG000|Overall Study|Lost to Follow-up|2|||
170547566|NCT02187055|616350218|FG001|Overall Study|Lost to Follow-up|7|||
170547567|NCT02187055|616350219|FG002|Overall Study|Lost to Follow-up|3|||
170547568|NCT02187055|616350217|FG000|Overall Study|No longer meets eligibility criteria|0|||
170547569|NCT02187055|616350218|FG001|Overall Study|No longer meets eligibility criteria|2|||
170547570|NCT02187055|616350219|FG002|Overall Study|No longer meets eligibility criteria|0|||
170547571|NCT02187055|616350217|FG000|Overall Study|No longer willing to participate|6|||
170547572|NCT02187055|616350218|FG001|Overall Study|No longer willing to participate|8|||
170547573|NCT02187055|616350219|FG002|Overall Study|No longer willing to participate|10|||
170547574|NCT02187055|616350217|FG000|Overall Study|Other|5|||
170547575|NCT02187055|616350218|FG001|Overall Study|Other|6|||
170547576|NCT02187055|616350219|FG002|Overall Study|Other|3|||
170547577|NCT02187055|616350217|FG000|Overall Study|Protocol Violation|9|||
170547578|NCT02187055|616350218|FG001|Overall Study|Protocol Violation|9|||
170547579|NCT02187055|616350219|FG002|Overall Study|Protocol Violation|4|||
170547580|NCT02187055|616350217|FG000|Overall Study|Pregnancy|3|||
170547581|NCT02187055|616350218|FG001|Overall Study|Pregnancy|1|||
170547582|NCT02187055|616350219|FG002|Overall Study|Pregnancy|0|||
170547583|NCT02187055|616350217|FG000|Overall Study|Withdrawal by Subject|11|||
170547584|NCT02187055|616350218|FG001|Overall Study|Withdrawal by Subject|11|||
170547585|NCT02187055|616350219|FG002|Overall Study|Withdrawal by Subject|11|||
170547586|NCT02187055|616350217|FG000|Overall Study|Adverse Event|21|||
170547587|NCT02187055|616350218|FG001|Overall Study|Adverse Event|26|||
170547588|NCT02187055|616350219|FG002|Overall Study|Adverse Event|36|||
170547589|NCT02187055|616350217|FG000|Overall Study|Death|2|||
170547590|NCT02187055|616350218|FG001|Overall Study|Death|0|||
170547591|NCT02187055|616350219|FG002|Overall Study|Death|0|||
170547592|NCT03336866|616350220|FG000|Overall Study|Lost to Follow-up|2|||
170547593|NCT03336866|616350221|FG001|Overall Study|Lost to Follow-up|0|||
170547594|NCT03336866|616350222|FG002|Overall Study|Lost to Follow-up|3|||
170547595|NCT03336866|616350220|FG000|Overall Study|Withdrawal by Subject|1|||
170547596|NCT03336866|616350221|FG001|Overall Study|Withdrawal by Subject|1|||
170547597|NCT03336866|616350222|FG002|Overall Study|Withdrawal by Subject|0|||
170794063|NCT04778397|617255958|FG000|Overall Study|Study Terminated by Sponsor|34|||
170794064|NCT04778397|617255959|FG001|Overall Study|Study Terminated by Sponsor|42|||
170794065|NCT04778397|617255960|FG002|Overall Study|Study Terminated by Sponsor|15|||
170794066|NCT04778397|617255961|FG003|Overall Study|Study Terminated by Sponsor|12|||
170794067|NCT04778397|617255958|FG000|Overall Study|Withdrew Consent|5|||
170794068|NCT04778397|617255959|FG001|Overall Study|Withdrew Consent|4|||
170794069|NCT04778397|617255960|FG002|Overall Study|Withdrew Consent|1|||
170794070|NCT04778397|617255961|FG003|Overall Study|Withdrew Consent|1|||
170794071|NCT04778397|617255958|FG000|Overall Study|Reason Not Specified|1|||
170794072|NCT04778397|617255959|FG001|Overall Study|Reason Not Specified|3|||
170794073|NCT04778397|617255960|FG002|Overall Study|Reason Not Specified|0|||
170794074|NCT04778397|617255961|FG003|Overall Study|Reason Not Specified|2|||
170794075|NCT04778397|617255958|FG000|Overall Study|Lost to Follow-up|2|||
170794076|NCT04778397|617255959|FG001|Overall Study|Lost to Follow-up|1|||
170794077|NCT04778397|617255960|FG002|Overall Study|Lost to Follow-up|0|||
170794078|NCT04778397|617255961|FG003|Overall Study|Lost to Follow-up|1|||
170480161|NCT01068860|616097297|FG005|Overall Study|Lost to Follow-up|0|||
170547598|NCT03336866|616350220|FG000|Overall Study|Noncompliance with clinic house rules|0|||
170794079|NCT03987022|617255964|FG000|Overall Study|Lost to Follow-up|2|||
170794080|NCT03987022|617255965|FG001|Overall Study|Lost to Follow-up|2|||
170794081|NCT03987022|617255964|FG000|Overall Study|Withdrawal by Subject|1|||
170794082|NCT03987022|617255965|FG001|Overall Study|Withdrawal by Subject|0|||
170894102|NCT03882424|617620007|FG000|Overall Study|Lost to Follow-up|3|||
170894103|NCT03882424|617620008|FG001|Overall Study|Lost to Follow-up|0|||
170894104|NCT03882424|617620009|FG002|Overall Study|Lost to Follow-up|0|||
170894105|NCT03882424|617620007|FG000|Overall Study|schedule conflict|1|||
170894106|NCT03882424|617620008|FG001|Overall Study|schedule conflict|0|||
170894107|NCT03882424|617620009|FG002|Overall Study|schedule conflict|0|||
170894108|NCT00236080|617620010|FG000|Overall Study|Adverse Event|0|||
170894109|NCT00236080|617620011|FG001|Overall Study|Adverse Event|0|||
170894110|NCT00236080|617620012|FG002|Overall Study|Adverse Event|3|||
170894111|NCT00236080|617620013|FG003|Overall Study|Adverse Event|1|||
170894112|NCT00236080|617620014|FG004|Overall Study|Adverse Event|0|||
170894113|NCT00236080|617620010|FG000|Overall Study|Lost to Follow-up|0|||
170894114|NCT00236080|617620011|FG001|Overall Study|Lost to Follow-up|1|||
170894115|NCT00236080|617620012|FG002|Overall Study|Lost to Follow-up|0|||
170894116|NCT00236080|617620013|FG003|Overall Study|Lost to Follow-up|0|||
170894117|NCT00236080|617620014|FG004|Overall Study|Lost to Follow-up|0|||
170894118|NCT00236080|617620010|FG000|Overall Study|Physician Decision|1|||
170894119|NCT00236080|617620011|FG001|Overall Study|Physician Decision|0|||
170894120|NCT00236080|617620012|FG002|Overall Study|Physician Decision|1|||
170894121|NCT00236080|617620013|FG003|Overall Study|Physician Decision|1|||
170894122|NCT00236080|617620014|FG004|Overall Study|Physician Decision|1|||
170894123|NCT00236080|617620010|FG000|Overall Study|Withdrawal by Subject|1|||
170894124|NCT00236080|617620011|FG001|Overall Study|Withdrawal by Subject|0|||
170894125|NCT00236080|617620012|FG002|Overall Study|Withdrawal by Subject|0|||
170894126|NCT00236080|617620013|FG003|Overall Study|Withdrawal by Subject|0|||
170894127|NCT00236080|617620014|FG004|Overall Study|Withdrawal by Subject|0|||
170894128|NCT00236080|617620010|FG000|Overall Study|Miscellaneous|0|||
170894129|NCT00236080|617620011|FG001|Overall Study|Miscellaneous|0|||
170894130|NCT00236080|617620012|FG002|Overall Study|Miscellaneous|1|||
170894131|NCT00236080|617620013|FG003|Overall Study|Miscellaneous|0|||
170894132|NCT00236080|617620014|FG004|Overall Study|Miscellaneous|0|||
170894133|NCT01214044|617620015|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
170894134|NCT01214044|617620015|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
170894135|NCT01214044|617620015|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
170894136|NCT01214044|617620015|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
170894137|NCT01214044|617620015|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
170894138|NCT01214044|617620015|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
170894139|NCT04698525|617620018|FG000|Overall Study|Lost to Follow-up|1|||
170894140|NCT04698525|617620019|FG001|Overall Study|Lost to Follow-up|2|||
170894141|NCT04698525|617620018|FG000|Overall Study|Three suffered of Covid-19|2|||
170894142|NCT04698525|617620019|FG001|Overall Study|Three suffered of Covid-19|1|||
170894143|NCT01961544|617620023|FG000|Overall Study|Protocol Violation|1|||
170894144|NCT01961544|617620023|FG000|Overall Study|Withdrawal by Subject|7|||
170894145|NCT01961544|617620023|FG000|Overall Study|Adverse Event|1|||
170894146|NCT01961544|617620023|FG000|Overall Study|Physician Decision|2|||
170894147|NCT01961544|617620023|FG000|Overall Study|Poor Tolerance|1|||
170894148|NCT01961544|617620023|FG000|Overall Study|Aggravation of Steral Pain|1|||
170894149|NCT01500057|617620026|FG000|Overall Study|Lost to Follow-up|6|||
170894150|NCT01500057|617620027|FG001|Overall Study|Lost to Follow-up|4|||
170894151|NCT00441792|617620028|FG000|Overall Study|Lost to Follow-up|0|||
170894152|NCT00441792|617620029|FG001|Overall Study|Lost to Follow-up|2|||
170894153|NCT01731678|617620030|FG000|Overall Study|Withdrawal by Subject|3|||
170894154|NCT01731678|617620030|FG000|Overall Study|Did not meet inclusion criteria|1|||
170894155|NCT01731678|617620030|FG000|Overall Study|RMT too high, making TMS difficult|3|||
170894156|NCT03665285|617620035|FG000|Overall Study|Started New Anticancer Treatment|1|||
170894157|NCT03665285|617620036|FG001|Overall Study|Started New Anticancer Treatment|1|||
170894158|NCT03665285|617620037|FG002|Overall Study|Started New Anticancer Treatment|2|||
170894159|NCT03665285|617620038|FG003|Overall Study|Started New Anticancer Treatment|4|||
170894160|NCT03665285|617620039|FG004|Overall Study|Started New Anticancer Treatment|1|||
170894161|NCT03665285|617620040|FG005|Overall Study|Started New Anticancer Treatment|1|||
170894162|NCT03665285|617620041|FG006|Overall Study|Started New Anticancer Treatment|2|||
170894163|NCT03665285|617620042|FG007|Overall Study|Started New Anticancer Treatment|15|||
170894164|NCT03665285|617620043|FG008|Overall Study|Started New Anticancer Treatment|1|||
170894165|NCT03665285|617620035|FG000|Overall Study|Disease Progression|0|||
170894166|NCT03665285|617620036|FG001|Overall Study|Disease Progression|0|||
170894167|NCT03665285|617620037|FG002|Overall Study|Disease Progression|3|||
170894168|NCT03665285|617620038|FG003|Overall Study|Disease Progression|1|||
170894169|NCT03665285|617620039|FG004|Overall Study|Disease Progression|0|||
170894170|NCT03665285|617620040|FG005|Overall Study|Disease Progression|0|||
170894171|NCT03665285|617620041|FG006|Overall Study|Disease Progression|0|||
170894172|NCT03665285|617620042|FG007|Overall Study|Disease Progression|7|||
170894173|NCT03665285|617620043|FG008|Overall Study|Disease Progression|1|||
170894174|NCT03665285|617620035|FG000|Overall Study|Hospice|0|||
170894175|NCT03665285|617620036|FG001|Overall Study|Hospice|0|||
170894176|NCT03665285|617620037|FG002|Overall Study|Hospice|0|||
170894177|NCT03665285|617620038|FG003|Overall Study|Hospice|0|||
170894178|NCT03665285|617620039|FG004|Overall Study|Hospice|0|||
170894179|NCT03665285|617620040|FG005|Overall Study|Hospice|0|||
170894180|NCT03665285|617620041|FG006|Overall Study|Hospice|0|||
170894181|NCT03665285|617620042|FG007|Overall Study|Hospice|2|||
170894182|NCT03665285|617620043|FG008|Overall Study|Hospice|0|||
170894183|NCT03665285|617620035|FG000|Overall Study|Withdrawal by Subject|0|||
170894184|NCT03665285|617620036|FG001|Overall Study|Withdrawal by Subject|0|||
170894185|NCT03665285|617620037|FG002|Overall Study|Withdrawal by Subject|0|||
170894186|NCT03665285|617620038|FG003|Overall Study|Withdrawal by Subject|0|||
170894187|NCT03665285|617620039|FG004|Overall Study|Withdrawal by Subject|1|||
170894188|NCT03665285|617620040|FG005|Overall Study|Withdrawal by Subject|0|||
170894189|NCT03665285|617620041|FG006|Overall Study|Withdrawal by Subject|0|||
170894190|NCT03665285|617620042|FG007|Overall Study|Withdrawal by Subject|2|||
170480162|NCT01068860|616097298|FG006|Overall Study|Lost to Follow-up|0|||
170480163|NCT01068860|616097299|FG007|Overall Study|Lost to Follow-up|0|||
170480164|NCT01068860|616097300|FG008|Overall Study|Lost to Follow-up|0|||
170480165|NCT01068860|616097301|FG009|Overall Study|Lost to Follow-up|0|||
170480166|NCT02714218|616097305|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170480167|NCT02714218|616097306|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
170480168|NCT02714218|616097307|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170480169|NCT02714218|616097305|FG000|Pre-Treatment Period|Other reasons|0|||
170480170|NCT02714218|616097306|FG001|Pre-Treatment Period|Other reasons|1|||
170480171|NCT02714218|616097307|FG002|Pre-Treatment Period|Other reasons|0|||
170480172|NCT02714218|616097305|FG000|Treatment Period|Disease Progression|55|||
170480173|NCT02714218|616097306|FG001|Treatment Period|Disease Progression|52|||
170480174|NCT02714218|616097307|FG002|Treatment Period|Disease Progression|14|||
170480175|NCT02714218|616097305|FG000|Treatment Period|Study drug toxicity|46|||
170480176|NCT02714218|616097306|FG001|Treatment Period|Study drug toxicity|70|||
170480177|NCT02714218|616097307|FG002|Treatment Period|Study drug toxicity|6|||
170480178|NCT02714218|616097305|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
170480179|NCT02714218|616097306|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
170480180|NCT02714218|616097307|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
170480181|NCT02714218|616097305|FG000|Treatment Period|Request to discontinue treatment|1|||
170480182|NCT02714218|616097306|FG001|Treatment Period|Request to discontinue treatment|4|||
170480183|NCT02714218|616097307|FG002|Treatment Period|Request to discontinue treatment|1|||
170480184|NCT02714218|616097305|FG000|Treatment Period|Participant withdrew consent|2|||
170480185|NCT02714218|616097306|FG001|Treatment Period|Participant withdrew consent|2|||
170480186|NCT02714218|616097307|FG002|Treatment Period|Participant withdrew consent|0|||
170480187|NCT02714218|616097305|FG000|Treatment Period|Maximum clinical benefit|4|||
170480188|NCT02714218|616097306|FG001|Treatment Period|Maximum clinical benefit|2|||
170480189|NCT02714218|616097307|FG002|Treatment Period|Maximum clinical benefit|0|||
170480190|NCT02714218|616097305|FG000|Treatment Period|Administrative reason by sponsor|2|||
170480191|NCT02714218|616097306|FG001|Treatment Period|Administrative reason by sponsor|1|||
170480192|NCT02714218|616097307|FG002|Treatment Period|Administrative reason by sponsor|0|||
170480193|NCT02714218|616097305|FG000|Treatment Period|Other reasons|6|||
170480194|NCT02714218|616097306|FG001|Treatment Period|Other reasons|6|||
170894191|NCT03665285|617620043|FG008|Overall Study|Withdrawal by Subject|0|||
170894192|NCT03665285|617620035|FG000|Overall Study|Physician Decision|0|||
170894193|NCT03665285|617620036|FG001|Overall Study|Physician Decision|0|||
170894194|NCT03665285|617620037|FG002|Overall Study|Physician Decision|0|||
170894195|NCT03665285|617620038|FG003|Overall Study|Physician Decision|0|||
170894196|NCT03665285|617620039|FG004|Overall Study|Physician Decision|0|||
170894197|NCT03665285|617620040|FG005|Overall Study|Physician Decision|0|||
170894198|NCT03665285|617620041|FG006|Overall Study|Physician Decision|0|||
170894199|NCT03665285|617620042|FG007|Overall Study|Physician Decision|2|||
170894200|NCT03665285|617620043|FG008|Overall Study|Physician Decision|0|||
170480195|NCT02714218|616097307|FG002|Treatment Period|Other reasons|0|||
170480196|NCT02714218|616097305|FG000|Treatment Period|Completed treatment as per protocol|36|||
170639583|NCT04549545|616693669|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
170894201|NCT00888355|617620044|FG000|Overall Study|Adverse Event|10|||
170894202|NCT00888355|617620045|FG001|Overall Study|Adverse Event|0|||
170894203|NCT00888355|617620046|FG002|Overall Study|Adverse Event|3|||
170894204|NCT00888355|617620047|FG003|Overall Study|Adverse Event|3|||
170894205|NCT00888355|617620044|FG000|Overall Study|Lack of Efficacy|9|||
170894206|NCT00888355|617620045|FG001|Overall Study|Lack of Efficacy|2|||
170894207|NCT00888355|617620046|FG002|Overall Study|Lack of Efficacy|5|||
170894208|NCT00888355|617620047|FG003|Overall Study|Lack of Efficacy|2|||
170894209|NCT00888355|617620044|FG000|Overall Study|Lost to Follow-up|0|||
170894210|NCT00888355|617620045|FG001|Overall Study|Lost to Follow-up|2|||
170894211|NCT00888355|617620046|FG002|Overall Study|Lost to Follow-up|2|||
170894212|NCT00888355|617620047|FG003|Overall Study|Lost to Follow-up|0|||
170894213|NCT00888355|617620044|FG000|Overall Study|Protocol Violation|3|||
170794083|NCT01627574|617255966|FG000|Overall Study|Withdrawal by Subject|8|||
170794084|NCT01627574|617255967|FG001|Overall Study|Withdrawal by Subject|5|||
170794085|NCT01627574|617255966|FG000|Overall Study|Lost to Follow-up|13|||
170794086|NCT01627574|617255967|FG001|Overall Study|Lost to Follow-up|13|||
170794087|NCT04730739|617255968|FG000|Overall Study|Death|1|||
170794088|NCT03308877|617255970|FG000|Overall Study|Lost to Follow-up|32|||
170794089|NCT03308877|617255971|FG001|Overall Study|Lost to Follow-up|28|||
170794090|NCT04685135|617255984|FG000|Overall Study|Death|126|||
170794091|NCT04685135|617255985|FG001|Overall Study|Death|53|||
170794092|NCT04685135|617255984|FG000|Overall Study|Withdrawal by Subject|12|||
170794093|NCT04685135|617255985|FG001|Overall Study|Withdrawal by Subject|16|||
170547599|NCT03336866|616350221|FG001|Overall Study|Noncompliance with clinic house rules|0|||
170794094|NCT03362476|617255999|FG000|Overall Study|Withdrawal by Subject|0|||
170794095|NCT03362476|617256000|FG001|Overall Study|Withdrawal by Subject|1|||
170794096|NCT03672916|617256005|FG000|Overall Study|Death|6|||
170794097|NCT03672916|617256005|FG000|Overall Study|Lost to Follow-up|29|||
170794098|NCT03672916|617256005|FG000|Overall Study|Adverse Event|6|||
170794099|NCT03672916|617256005|FG000|Overall Study|Withdrawal by Subject|11|||
170794100|NCT05868382|617256007|FG000|Overall Study|Lost to Follow-up|5|||
170794101|NCT05868382|617256008|FG001|Overall Study|Lost to Follow-up|0|||
170794102|NCT05868382|617256009|FG002|Overall Study|Lost to Follow-up|6|||
170794103|NCT05868382|617256010|FG003|Overall Study|Lost to Follow-up|4|||
170794104|NCT05868382|617256011|FG004|Overall Study|Lost to Follow-up|2|||
170794105|NCT05868382|617256012|FG005|Overall Study|Lost to Follow-up|6|||
170794106|NCT05868382|617256007|FG000|Overall Study|Withdrawal by Subject|1|||
170794107|NCT05868382|617256008|FG001|Overall Study|Withdrawal by Subject|0|||
170794108|NCT05868382|617256009|FG002|Overall Study|Withdrawal by Subject|0|||
170794109|NCT05868382|617256010|FG003|Overall Study|Withdrawal by Subject|0|||
170794110|NCT05868382|617256011|FG004|Overall Study|Withdrawal by Subject|1|||
170794111|NCT05868382|617256012|FG005|Overall Study|Withdrawal by Subject|0|||
170794112|NCT03655028|617256015|FG000|12-weeks Follow up|Death|1|||
170794113|NCT03655028|617256016|FG001|12-weeks Follow up|Death|0|||
170794114|NCT03655028|617256015|FG000|12-weeks Follow up|Physician Decision|3|||
170794115|NCT03655028|617256016|FG001|12-weeks Follow up|Physician Decision|3|||
170794116|NCT03655028|617256015|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
170794117|NCT03655028|617256016|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
170794118|NCT03655028|617256015|FG000|12-weeks Follow up|Lost to Follow-up|4|||
170794119|NCT03655028|617256016|FG001|12-weeks Follow up|Lost to Follow-up|4|||
170794120|NCT03655028|617256015|FG000|24-weeks|Lost to Follow-up|1|||
170794121|NCT03655028|617256016|FG001|24-weeks|Lost to Follow-up|1|||
170794122|NCT03655028|617256015|FG000|24-weeks|Death|0|||
170794123|NCT03655028|617256016|FG001|24-weeks|Death|1|||
170794124|NCT02709161|617256017|FG000|Overall Study|Withdrawal by Subject|1|||
170894214|NCT00888355|617620045|FG001|Overall Study|Protocol Violation|2|||
170894215|NCT00888355|617620046|FG002|Overall Study|Protocol Violation|1|||
170894216|NCT00888355|617620047|FG003|Overall Study|Protocol Violation|2|||
170894217|NCT00888355|617620044|FG000|Overall Study|Withdrawal by Subject|0|||
170894218|NCT00888355|617620045|FG001|Overall Study|Withdrawal by Subject|3|||
170894219|NCT00888355|617620046|FG002|Overall Study|Withdrawal by Subject|1|||
170894220|NCT00888355|617620047|FG003|Overall Study|Withdrawal by Subject|3|||
170894221|NCT02318784|617620048|FG000|Overall Study|Adverse Event|13|||
170894222|NCT02318784|617620048|FG000|Overall Study|Death|2|||
170894223|NCT02318784|617620048|FG000|Overall Study|Progressive Disease|37|||
170894224|NCT02318784|617620048|FG000|Overall Study|Withdrawal by Subject|10|||
170894225|NCT03543410|617620056|FG000|Overall Study|Adverse Event|10|||
170894226|NCT03543410|617620057|FG001|Overall Study|Adverse Event|8|||
170894227|NCT03543410|617620058|FG002|Overall Study|Adverse Event|2|||
170894228|NCT03543410|617620056|FG000|Overall Study|Lack of Efficacy|0|||
170894229|NCT03543410|617620057|FG001|Overall Study|Lack of Efficacy|1|||
170894230|NCT03543410|617620058|FG002|Overall Study|Lack of Efficacy|0|||
170894231|NCT03543410|617620056|FG000|Overall Study|Lost to Follow-up|0|||
170894232|NCT03543410|617620057|FG001|Overall Study|Lost to Follow-up|1|||
170894233|NCT03543410|617620058|FG002|Overall Study|Lost to Follow-up|0|||
170894234|NCT03543410|617620056|FG000|Overall Study|Withdrawal by Subject|5|||
170894235|NCT03543410|617620057|FG001|Overall Study|Withdrawal by Subject|2|||
170894236|NCT03543410|617620058|FG002|Overall Study|Withdrawal by Subject|8|||
170794125|NCT02709161|617256018|FG001|Overall Study|Withdrawal by Subject|0|||
170794126|NCT04059185|617256023|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
170794127|NCT04059185|617256024|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
170794128|NCT04059185|617256025|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
170794129|NCT04059185|617256023|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
170794130|NCT04059185|617256024|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
170794131|NCT04059185|617256025|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
170794132|NCT04059185|617256023|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
170794133|NCT04059185|617256024|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
170794134|NCT04059185|617256025|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
170794135|NCT04059185|617256023|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
170894237|NCT03543410|617620056|FG000|Overall Study|Protocol Violation|0|||
170894238|NCT03543410|617620057|FG001|Overall Study|Protocol Violation|1|||
170894239|NCT03543410|617620058|FG002|Overall Study|Protocol Violation|0|||
170894240|NCT03543410|617620056|FG000|Overall Study|Due to COVID-19|4|||
170894241|NCT03543410|617620057|FG001|Overall Study|Due to COVID-19|0|||
170894242|NCT03543410|617620058|FG002|Overall Study|Due to COVID-19|2|||
170894243|NCT03543410|617620056|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
170894244|NCT03543410|617620057|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
170894245|NCT03543410|617620058|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
170894246|NCT03543410|617620056|FG000|Overall Study|Not Due to COVID-19|2|||
170894247|NCT03543410|617620057|FG001|Overall Study|Not Due to COVID-19|0|||
170894248|NCT03543410|617620058|FG002|Overall Study|Not Due to COVID-19|1|||
170894249|NCT01318122|617620059|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170894250|NCT01318122|617620060|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170894251|NCT01318122|617620061|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
170894252|NCT01318122|617620062|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
170894253|NCT01318122|617620059|FG000|Enrolled - Long-Term Extension Study|Other|1|||
170894254|NCT01318122|617620060|FG001|Enrolled - Long-Term Extension Study|Other|0|||
170894255|NCT01318122|617620061|FG002|Enrolled - Long-Term Extension Study|Other|0|||
170894256|NCT01318122|617620062|FG003|Enrolled - Long-Term Extension Study|Other|0|||
170894257|NCT01318122|617620059|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
170894258|NCT01318122|617620060|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
170894259|NCT01318122|617620061|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
170894260|NCT01318122|617620062|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
170894261|NCT01318122|617620059|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
170894262|NCT01318122|617620060|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170894263|NCT01318122|617620061|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170894264|NCT01318122|617620062|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170894265|NCT01318122|617620059|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
170894266|NCT01318122|617620060|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
170894267|NCT01318122|617620061|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
170894268|NCT01318122|617620062|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
170894269|NCT01318122|617620059|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
170894270|NCT01318122|617620060|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
170894271|NCT01318122|617620061|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
170894272|NCT01318122|617620062|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
170894273|NCT02591615|617621865|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
170894274|NCT02591615|617621866|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
170894275|NCT02591615|617621867|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
170894276|NCT02591615|617621868|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
170894277|NCT02591615|617621865|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
170894278|NCT02591615|617621866|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
170894279|NCT02591615|617621867|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
170894280|NCT02591615|617621868|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
170894281|NCT02591615|617621865|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
170894282|NCT02591615|617621866|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
170894283|NCT02591615|617621867|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
170894284|NCT02591615|617621868|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
170894285|NCT02591615|617621865|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
170894286|NCT02591615|617621866|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
170894287|NCT02591615|617621867|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
170894288|NCT02591615|617621868|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
170894289|NCT02591615|617621865|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
170894290|NCT02591615|617621866|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
170894291|NCT02591615|617621867|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
170894292|NCT02591615|617621868|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
170480197|NCT02714218|616097306|FG001|Treatment Period|Completed treatment as per protocol|27|||
170480198|NCT02714218|616097307|FG002|Treatment Period|Completed treatment as per protocol|3|||
170480199|NCT02714218|616097305|FG000|Treatment Period|Not reported|9|||
170480200|NCT02714218|616097306|FG001|Treatment Period|Not reported|6|||
170480201|NCT02714218|616097307|FG002|Treatment Period|Not reported|0|||
170894293|NCT02591615|617621865|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
170894294|NCT02591615|617621866|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
170894295|NCT02591615|617621867|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
170894296|NCT02591615|617621868|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
170894297|NCT02591615|617621865|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
170894298|NCT02591615|617621866|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
170480202|NCT01433471|616097310|FG000|Overall Study|Withdrawal by Subject|0|||
170480203|NCT01433471|616097311|FG001|Overall Study|Withdrawal by Subject|1|||
170894299|NCT02591615|617621867|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
170894300|NCT02591615|617621868|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
170894301|NCT02591615|617621865|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
170894302|NCT02591615|617621866|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
170894303|NCT02591615|617621867|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
170894304|NCT02591615|617621868|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
170894305|NCT02591615|617621865|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
170894306|NCT02591615|617621866|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
170894307|NCT02591615|617621867|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
170894308|NCT02591615|617621868|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
170894309|NCT02591615|617621865|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
170894310|NCT02591615|617621866|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
170894311|NCT02591615|617621867|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
170894312|NCT02591615|617621868|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
170894313|NCT02591615|617621865|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
170894314|NCT02591615|617621866|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
170894315|NCT02591615|617621867|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
170894316|NCT02591615|617621868|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
170894317|NCT02591615|617621865|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
170894318|NCT02591615|617621866|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
170894319|NCT02591615|617621867|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
170894320|NCT02591615|617621868|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
170894321|NCT02591615|617621865|FG000|Maintenance MK-3475|Adverse Event|0|||
170894322|NCT02591615|617621866|FG001|Maintenance MK-3475|Adverse Event|3|||
170894323|NCT02591615|617621867|FG002|Maintenance MK-3475|Adverse Event|1|||
170894324|NCT02591615|617621868|FG003|Maintenance MK-3475|Adverse Event|2|||
170894325|NCT02591615|617621865|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
170894326|NCT02591615|617621866|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
170894327|NCT02591615|617621867|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
170894328|NCT02591615|617621868|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
170894329|NCT02591615|617621865|FG000|Maintenance MK-3475|Death|0|||
170894330|NCT02591615|617621866|FG001|Maintenance MK-3475|Death|1|||
170894331|NCT02591615|617621867|FG002|Maintenance MK-3475|Death|1|||
170894332|NCT02591615|617621868|FG003|Maintenance MK-3475|Death|0|||
170894333|NCT02591615|617621865|FG000|Maintenance MK-3475|Physician discretion|0|||
170894334|NCT02591615|617621866|FG001|Maintenance MK-3475|Physician discretion|0|||
170894335|NCT02591615|617621867|FG002|Maintenance MK-3475|Physician discretion|1|||
170894336|NCT02591615|617621868|FG003|Maintenance MK-3475|Physician discretion|0|||
170894337|NCT02591615|617621865|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
170894338|NCT02591615|617621866|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
170894339|NCT02591615|617621867|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
170894340|NCT02591615|617621868|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
170894341|NCT02591615|617621865|FG000|Maintenance MK-3475|In active treatment|2|||
170894342|NCT02591615|617621866|FG001|Maintenance MK-3475|In active treatment|0|||
170894343|NCT02591615|617621867|FG002|Maintenance MK-3475|In active treatment|0|||
170894344|NCT02591615|617621868|FG003|Maintenance MK-3475|In active treatment|1|||
170894345|NCT00772629|617621872|FG000|Overall Study|Subject was not vaccinated|1|||
170894346|NCT00772629|617621873|FG001|Overall Study|Subject was not vaccinated|0|||
170894347|NCT00132041|617621874|FG000|Baseline|Ineligible|6|||
170894348|NCT00132041|617621874|FG000|3 Months Post Ablation|Transplant|1|||
170894349|NCT00132041|617621874|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
170894350|NCT00132041|617621874|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
170894351|NCT00132041|617621874|FG000|6 Months Post Ablation|Death|2|||
170894352|NCT00132041|617621874|FG000|6 Months Post Ablation|Transplant|6|||
170894353|NCT00132041|617621874|FG000|9 Months Post Ablation|Death|1|||
170894354|NCT00132041|617621874|FG000|9 Months Post Ablation|Transplant|1|||
170894355|NCT00132041|617621874|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
170480204|NCT02626026|616097312|FG000|Overall Study|Randomized but Never Treated|0|||
170480205|NCT02626026|616097313|FG001|Overall Study|Randomized but Never Treated|0|||
170480206|NCT02626026|616097314|FG002|Overall Study|Randomized but Never Treated|0|||
170480207|NCT02626026|616097315|FG003|Overall Study|Randomized but Never Treated|0|||
170480208|NCT02626026|616097316|FG004|Overall Study|Randomized but Never Treated|1|||
170480209|NCT02626026|616097317|FG005|Overall Study|Randomized but Never Treated|0|||
170480210|NCT01778855|616097318|FG000|Overall Study|Death|0|||
170480211|NCT01778855|616097319|FG001|Overall Study|Death|1|||
170480212|NCT00191477|616097320|FG000|Overall Study|Tumor Recurrence|49|||
170480213|NCT00191477|616097321|FG001|Overall Study|Tumor Recurrence|48|||
170894356|NCT00132041|617621874|FG000|12 Months Post Ablation|Death|1|||
170894357|NCT00132041|617621874|FG000|12 Months Post Ablation|Transplant|1|||
170894358|NCT00132041|617621874|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
170894359|NCT00132041|617621874|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
170480214|NCT00191477|616097320|FG000|Overall Study|Death, Study Disease|1|||
170894360|NCT00132041|617621874|FG000|15 Months Post Ablation|Death|1|||
170894361|NCT00132041|617621874|FG000|15 Months Post Ablation|Transplant|5|||
170894362|NCT00132041|617621874|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
170894363|NCT00132041|617621874|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
170894364|NCT00132041|617621874|FG000|18 Months Post Ablation|Transplant|1|||
170894365|NCT00132041|617621874|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
170894366|NCT00132041|617621874|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
170894367|NCT00860158|617621877|FG000|Overall Study|Study Terminated|1|||
170894368|NCT02357420|617621880|FG000|Overall Study|Adverse Event|3|||
170894369|NCT02357420|617621881|FG001|Overall Study|Adverse Event|3|||
170894370|NCT02357420|617621882|FG002|Overall Study|Adverse Event|8|||
170894371|NCT02357420|617621883|FG003|Overall Study|Adverse Event|9|||
170894372|NCT02357420|617621880|FG000|Overall Study|Investigator Decision|1|||
170894373|NCT02357420|617621881|FG001|Overall Study|Investigator Decision|0|||
170894374|NCT02357420|617621882|FG002|Overall Study|Investigator Decision|0|||
170894375|NCT02357420|617621883|FG003|Overall Study|Investigator Decision|0|||
170894376|NCT02357420|617621880|FG000|Overall Study|Prohibited Medication|1|||
170894377|NCT02357420|617621881|FG001|Overall Study|Prohibited Medication|1|||
170894378|NCT02357420|617621882|FG002|Overall Study|Prohibited Medication|0|||
170894379|NCT02357420|617621883|FG003|Overall Study|Prohibited Medication|0|||
170894380|NCT02357420|617621880|FG000|Overall Study|Protocol Non-compliance|0|||
170894381|NCT02357420|617621881|FG001|Overall Study|Protocol Non-compliance|0|||
170894382|NCT02357420|617621882|FG002|Overall Study|Protocol Non-compliance|0|||
170894383|NCT02357420|617621883|FG003|Overall Study|Protocol Non-compliance|1|||
170894384|NCT02357420|617621880|FG000|Overall Study|Withdrawn Consent|4|||
170894385|NCT02357420|617621881|FG001|Overall Study|Withdrawn Consent|8|||
170894386|NCT02357420|617621882|FG002|Overall Study|Withdrawn Consent|6|||
170894387|NCT02357420|617621883|FG003|Overall Study|Withdrawn Consent|6|||
170894388|NCT02357420|617621880|FG000|Overall Study|Lost to Follow-up|3|||
170894389|NCT02357420|617621881|FG001|Overall Study|Lost to Follow-up|0|||
170894390|NCT02357420|617621882|FG002|Overall Study|Lost to Follow-up|2|||
170894391|NCT02357420|617621883|FG003|Overall Study|Lost to Follow-up|3|||
170894392|NCT00214461|617621884|FG000|Overall Study|Adverse Event|0|||
170894393|NCT00214461|617621885|FG001|Overall Study|Adverse Event|0|||
170894394|NCT00214461|617621886|FG002|Overall Study|Adverse Event|1|||
170894395|NCT00214461|617621887|FG003|Overall Study|Adverse Event|1|||
170894396|NCT00214461|617621884|FG000|Overall Study|Withdrawal by Subject|0|||
170894397|NCT00214461|617621885|FG001|Overall Study|Withdrawal by Subject|0|||
170894398|NCT00214461|617621886|FG002|Overall Study|Withdrawal by Subject|1|||
170894399|NCT00214461|617621887|FG003|Overall Study|Withdrawal by Subject|0|||
170894400|NCT00648167|617621889|FG000|Overall Study|Adverse Event|6|||
170894401|NCT00648167|617621889|FG000|Overall Study|unable to swallow tablets|1|||
170894402|NCT01848145|617621890|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
170894403|NCT01848145|617621890|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
170894404|NCT01848145|617621890|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
170894405|NCT01848145|617621890|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
170894406|NCT01848145|617621890|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
170894407|NCT01848145|617621890|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
170894408|NCT01848145|617621890|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
170894409|NCT00364689|617621891|FG000|Overall Study|Lost to Follow-up|1|||
170894410|NCT00272987|617621899|FG000|Overall Study|Adverse Event|1|||
170894411|NCT00272987|617621900|FG001|Overall Study|Adverse Event|0|||
170894412|NCT00272987|617621901|FG002|Overall Study|Adverse Event|0|||
170894413|NCT00272987|617621899|FG000|Overall Study|Lost to Follow-up|3|||
170894414|NCT00272987|617621900|FG001|Overall Study|Lost to Follow-up|1|||
170894415|NCT00272987|617621901|FG002|Overall Study|Lost to Follow-up|1|||
170547600|NCT03336866|616350222|FG002|Overall Study|Noncompliance with clinic house rules|1|||
170547601|NCT00985790|616350223|FG000|Overall Study|Withdrawal by Subject|1|||
170547602|NCT00985790|616350224|FG001|Overall Study|Withdrawal by Subject|1|||
170547603|NCT00985790|616350223|FG000|Overall Study|Lost to Follow-up|6|||
170547604|NCT00985790|616350224|FG001|Overall Study|Lost to Follow-up|7|||
170547605|NCT04518410|616350227|FG000|Overall Study|Lost to Follow-up|1|||
170547606|NCT04518410|616350228|FG001|Overall Study|Lost to Follow-up|1|||
170547607|NCT04518410|616350229|FG002|Overall Study|Lost to Follow-up|8|||
170894416|NCT00272987|617621899|FG000|Overall Study|Withdrawal by Subject|1|||
170547608|NCT04518410|616350230|FG003|Overall Study|Lost to Follow-up|5|||
170894417|NCT00272987|617621900|FG001|Overall Study|Withdrawal by Subject|0|||
170547609|NCT04518410|616350231|FG004|Overall Study|Lost to Follow-up|92|||
170547610|NCT04518410|616350232|FG005|Overall Study|Lost to Follow-up|25|||
170894418|NCT00272987|617621901|FG002|Overall Study|Withdrawal by Subject|3|||
170894419|NCT00272987|617621899|FG000|Overall Study|Sponsor Terminated study|0|||
170894420|NCT00272987|617621900|FG001|Overall Study|Sponsor Terminated study|1|||
170894421|NCT00272987|617621901|FG002|Overall Study|Sponsor Terminated study|1|||
170894422|NCT00272987|617621899|FG000|Overall Study|Disease progression|1|||
170894423|NCT00272987|617621900|FG001|Overall Study|Disease progression|1|||
170894424|NCT00272987|617621901|FG002|Overall Study|Disease progression|2|||
170894425|NCT00272987|617621899|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
170894426|NCT00272987|617621900|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
170894427|NCT00272987|617621901|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
170894428|NCT00272987|617621899|FG000|Overall Study|Death|1|||
170894429|NCT00272987|617621900|FG001|Overall Study|Death|0|||
170894430|NCT00272987|617621901|FG002|Overall Study|Death|0|||
170894431|NCT00234039|617621908|FG000|Overall Study|Adverse Event|2|||
170894432|NCT00234039|617621908|FG000|Overall Study|Progression/relapse|34|||
170894433|NCT00234039|617621908|FG000|Overall Study|Other - Not Protocol Specified|3|||
170894434|NCT00234039|617621908|FG000|Overall Study|Ineligible|9|||
170547611|NCT04518410|616350233|FG006|Overall Study|Lost to Follow-up|25|||
170547612|NCT04518410|616350234|FG007|Overall Study|Lost to Follow-up|3|||
170547613|NCT04518410|616350235|FG008|Overall Study|Lost to Follow-up|2|||
170547614|NCT04518410|616350236|FG009|Overall Study|Lost to Follow-up|13|||
170547615|NCT04518410|616350237|FG010|Overall Study|Lost to Follow-up|9|||
170547616|NCT04518410|616350238|FG011|Overall Study|Lost to Follow-up|13|||
170547617|NCT04518410|616350239|FG012|Overall Study|Lost to Follow-up|9|||
170894435|NCT00234039|617621908|FG000|Overall Study|No Protocol Treatment Received|2|||
170894436|NCT03683394|617621909|FG000|Overall Study|Withdrawal by Subject|4|||
170894437|NCT03683394|617621910|FG001|Overall Study|Withdrawal by Subject|8|||
170894438|NCT03683394|617621909|FG000|Overall Study|Lost to Follow-up|7|||
170894439|NCT03683394|617621910|FG001|Overall Study|Lost to Follow-up|0|||
170894440|NCT03683394|617621909|FG000|Overall Study|Death|3|||
170894441|NCT03683394|617621910|FG001|Overall Study|Death|1|||
170894442|NCT02239263|617621913|FG000|Overall Study|Protocol Violation|6|||
170894443|NCT04303000|617621914|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
170894444|NCT04303000|617621915|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
170894445|NCT04303000|617621916|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
170894446|NCT01058096|617621917|FG000|Double-blind Treatment Phase|Adverse Event|11|||
170894447|NCT01058096|617621918|FG001|Double-blind Treatment Phase|Adverse Event|15|||
170794136|NCT04059185|617256024|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
170794137|NCT04059185|617256025|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
170794138|NCT04059185|617256023|FG000|Longitudinal Assessment-Adults Only|Death|4|||
170794139|NCT04059185|617256024|FG001|Longitudinal Assessment-Adults Only|Death|4|||
170894448|NCT01058096|617621917|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
170894449|NCT01058096|617621918|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
170894450|NCT01058096|617621917|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
170894451|NCT01058096|617621918|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
170894452|NCT01058096|617621917|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
170894453|NCT01058096|617621918|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
170547618|NCT04518410|616350240|FG013|Overall Study|Lost to Follow-up|13|||
170547619|NCT04518410|616350241|FG014|Overall Study|Lost to Follow-up|8|||
170547620|NCT04518410|616350242|FG015|Overall Study|Lost to Follow-up|10|||
170794140|NCT04059185|617256025|FG002|Longitudinal Assessment-Adults Only|Death|3|||
170794141|NCT05207956|617256040|FG000|Overall Study|Lost to follow up|1|||
170794142|NCT05207956|617256041|FG001|Overall Study|Lost to follow up|2|||
170794143|NCT01009788|617256044|FG000|Overall Study|Withdrawal by Subject|1|||
170794144|NCT01009788|617256045|FG001|Overall Study|Withdrawal by Subject|0|||
170794145|NCT04587453|617256046|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
170794146|NCT04587453|617256047|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
170794147|NCT03571581|617256050|FG000|Overall Study|Death|2|||
170794148|NCT03571581|617256050|FG000|Overall Study|Withdrawal by Subject|2|||
170794149|NCT04625725|617256053|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
170794150|NCT04625725|617256054|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
170794151|NCT04625725|617256055|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
170794152|NCT04625725|617256056|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
170794153|NCT04625725|617256057|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
170794154|NCT04625725|617256058|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
170794155|NCT04625725|617256053|FG000|Provent Main Study|Withdrawal by Subject|242|||
170547621|NCT04518410|616350243|FG016|Overall Study|Lost to Follow-up|6|||
170547622|NCT04518410|616350244|FG017|Overall Study|Lost to Follow-up|13|||
170547623|NCT04518410|616350245|FG018|Overall Study|Lost to Follow-up|21|||
170547624|NCT04518410|616350246|FG019|Overall Study|Lost to Follow-up|6|||
170639584|NCT04549545|616693668|FG000|Crossover Period|Additional ENT Procedure|0|||
170794156|NCT04625725|617256054|FG001|Provent Main Study|Withdrawal by Subject|144|||
170894454|NCT01058096|617621917|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
170894455|NCT01058096|617621918|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
170894456|NCT01058096|617621917|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
170894457|NCT01058096|617621918|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
170894458|NCT05655377|617621919|FG000|Overall Study|Withdrawal by Subject|2|||
170547625|NCT04518410|616350247|FG020|Overall Study|Lost to Follow-up|7|||
170794157|NCT04625725|617256055|FG002|Provent Main Study|Withdrawal by Subject|0|||
170547626|NCT04518410|616350248|FG021|Overall Study|Lost to Follow-up|21|||
170547627|NCT04518410|616350249|FG022|Overall Study|Lost to Follow-up|1|||
170547628|NCT04518410|616350250|FG023|Overall Study|Lost to Follow-up|7|||
170547629|NCT04518410|616350251|FG024|Overall Study|Lost to Follow-up|6|||
170547630|NCT04518410|616350227|FG000|Overall Study|Withdrawal by Subject|1|||
170547631|NCT04518410|616350228|FG001|Overall Study|Withdrawal by Subject|2|||
170547632|NCT04518410|616350229|FG002|Overall Study|Withdrawal by Subject|2|||
170547633|NCT04518410|616350230|FG003|Overall Study|Withdrawal by Subject|3|||
170547634|NCT04518410|616350231|FG004|Overall Study|Withdrawal by Subject|20|||
170547635|NCT04518410|616350232|FG005|Overall Study|Withdrawal by Subject|20|||
170547636|NCT04518410|616350233|FG006|Overall Study|Withdrawal by Subject|25|||
170547637|NCT04518410|616350234|FG007|Overall Study|Withdrawal by Subject|6|||
170547638|NCT04518410|616350235|FG008|Overall Study|Withdrawal by Subject|1|||
170547639|NCT04518410|616350236|FG009|Overall Study|Withdrawal by Subject|12|||
170547640|NCT04518410|616350237|FG010|Overall Study|Withdrawal by Subject|5|||
170547641|NCT04518410|616350238|FG011|Overall Study|Withdrawal by Subject|7|||
170547642|NCT04518410|616350239|FG012|Overall Study|Withdrawal by Subject|2|||
170547643|NCT04518410|616350240|FG013|Overall Study|Withdrawal by Subject|13|||
170547644|NCT04518410|616350241|FG014|Overall Study|Withdrawal by Subject|4|||
170547645|NCT04518410|616350242|FG015|Overall Study|Withdrawal by Subject|9|||
170547646|NCT04518410|616350243|FG016|Overall Study|Withdrawal by Subject|0|||
170547647|NCT04518410|616350244|FG017|Overall Study|Withdrawal by Subject|15|||
170547648|NCT04518410|616350245|FG018|Overall Study|Withdrawal by Subject|12|||
170547649|NCT04518410|616350246|FG019|Overall Study|Withdrawal by Subject|9|||
170547650|NCT04518410|616350247|FG020|Overall Study|Withdrawal by Subject|14|||
170547651|NCT04518410|616350248|FG021|Overall Study|Withdrawal by Subject|3|||
170547652|NCT04518410|616350249|FG022|Overall Study|Withdrawal by Subject|2|||
170547653|NCT04518410|616350250|FG023|Overall Study|Withdrawal by Subject|9|||
170547654|NCT04518410|616350251|FG024|Overall Study|Withdrawal by Subject|8|||
170547655|NCT04518410|616350227|FG000|Overall Study|Other|1|||
170547656|NCT04518410|616350228|FG001|Overall Study|Other|0|||
170547657|NCT04518410|616350229|FG002|Overall Study|Other|0|||
170547658|NCT04518410|616350230|FG003|Overall Study|Other|1|||
170547659|NCT04518410|616350231|FG004|Overall Study|Other|6|||
170547660|NCT04518410|616350232|FG005|Overall Study|Other|6|||
170547661|NCT04518410|616350233|FG006|Overall Study|Other|5|||
170547662|NCT04518410|616350234|FG007|Overall Study|Other|2|||
170547663|NCT04518410|616350235|FG008|Overall Study|Other|0|||
170547664|NCT04518410|616350236|FG009|Overall Study|Other|1|||
170547665|NCT04518410|616350237|FG010|Overall Study|Other|0|||
170547666|NCT04518410|616350238|FG011|Overall Study|Other|2|||
170547667|NCT04518410|616350239|FG012|Overall Study|Other|0|||
170547668|NCT04518410|616350240|FG013|Overall Study|Other|0|||
170547669|NCT04518410|616350241|FG014|Overall Study|Other|0|||
170547670|NCT04518410|616350242|FG015|Overall Study|Other|3|||
170547671|NCT04518410|616350243|FG016|Overall Study|Other|1|||
170547672|NCT04518410|616350244|FG017|Overall Study|Other|1|||
170547673|NCT04518410|616350245|FG018|Overall Study|Other|1|||
170547674|NCT04518410|616350246|FG019|Overall Study|Other|0|||
170547675|NCT04518410|616350247|FG020|Overall Study|Other|1|||
170547676|NCT04518410|616350248|FG021|Overall Study|Other|0|||
170547677|NCT04518410|616350249|FG022|Overall Study|Other|1|||
170547678|NCT04518410|616350250|FG023|Overall Study|Other|2|||
170547679|NCT04518410|616350251|FG024|Overall Study|Other|2|||
170794158|NCT04625725|617256056|FG003|Provent Main Study|Withdrawal by Subject|0|||
170794159|NCT04625725|617256057|FG004|Provent Main Study|Withdrawal by Subject|0|||
170794160|NCT04625725|617256058|FG005|Provent Main Study|Withdrawal by Subject|0|||
170794161|NCT04625725|617256053|FG000|Provent Main Study|Physician Decision|5|||
170794162|NCT04625725|617256054|FG001|Provent Main Study|Physician Decision|0|||
170794163|NCT04625725|617256055|FG002|Provent Main Study|Physician Decision|0|||
170794164|NCT04625725|617256056|FG003|Provent Main Study|Physician Decision|0|||
170794165|NCT04625725|617256057|FG004|Provent Main Study|Physician Decision|0|||
170794166|NCT04625725|617256058|FG005|Provent Main Study|Physician Decision|0|||
170794167|NCT04625725|617256053|FG000|Provent Main Study|Protocol Violation|1|||
170794168|NCT04625725|617256054|FG001|Provent Main Study|Protocol Violation|0|||
170794169|NCT04625725|617256055|FG002|Provent Main Study|Protocol Violation|0|||
170794170|NCT04625725|617256056|FG003|Provent Main Study|Protocol Violation|0|||
170894459|NCT03653390|617621924|FG000|Overall Study|Lost to Follow-up|12|||
170547680|NCT04518410|616350227|FG000|Overall Study|Protocol Violation|0|||
170547681|NCT04518410|616350228|FG001|Overall Study|Protocol Violation|0|||
170547682|NCT04518410|616350229|FG002|Overall Study|Protocol Violation|0|||
170547683|NCT04518410|616350230|FG003|Overall Study|Protocol Violation|2|||
170547684|NCT04518410|616350231|FG004|Overall Study|Protocol Violation|17|||
170547685|NCT04518410|616350232|FG005|Overall Study|Protocol Violation|1|||
170547686|NCT04518410|616350233|FG006|Overall Study|Protocol Violation|2|||
170547687|NCT04518410|616350234|FG007|Overall Study|Protocol Violation|1|||
170547688|NCT04518410|616350235|FG008|Overall Study|Protocol Violation|0|||
170794171|NCT04625725|617256057|FG004|Provent Main Study|Protocol Violation|0|||
170794172|NCT04625725|617256058|FG005|Provent Main Study|Protocol Violation|0|||
170794173|NCT04625725|617256053|FG000|Provent Main Study|Lost to Follow-up|357|||
170894460|NCT03653390|617621925|FG001|Overall Study|Lost to Follow-up|8|||
170894461|NCT03653390|617621926|FG002|Overall Study|Lost to Follow-up|7|||
170894462|NCT03653390|617621924|FG000|Overall Study|Withdrawal by Subject|6|||
170894463|NCT03653390|617621925|FG001|Overall Study|Withdrawal by Subject|1|||
170894464|NCT03653390|617621926|FG002|Overall Study|Withdrawal by Subject|1|||
170894465|NCT03653390|617621924|FG000|Overall Study|Death|1|||
170894466|NCT03653390|617621925|FG001|Overall Study|Death|0|||
170894467|NCT03653390|617621926|FG002|Overall Study|Death|0|||
170894468|NCT03653390|617621924|FG000|Overall Study|Paper Survey Lost|1|||
170894469|NCT03653390|617621925|FG001|Overall Study|Paper Survey Lost|0|||
170894470|NCT03653390|617621926|FG002|Overall Study|Paper Survey Lost|0|||
170894471|NCT03118947|617621927|FG000|Overall Study|Adverse Event|7|||
170894472|NCT03118947|617621927|FG000|Overall Study|Death|3|||
170894473|NCT03118947|617621927|FG000|Overall Study|Lack of Efficacy|4|||
170894474|NCT03118947|617621927|FG000|Overall Study|Non-compliance with study drug|1|||
170894475|NCT03118947|617621927|FG000|Overall Study|Protocol Violation|2|||
170894476|NCT03118947|617621927|FG000|Overall Study|Withdrawal by Subject|3|||
170894477|NCT03118947|617621927|FG000|Overall Study|Withdrawal by caregiver|3|||
170894478|NCT03118947|617621927|FG000|Overall Study|Change in patient's living situation|4|||
170894479|NCT03118947|617621927|FG000|Overall Study|Lost to Follow-up|2|||
170894480|NCT02769624|617621930|FG000|Overall Study|Lost to Follow-up|0|||
170894481|NCT02769624|617621931|FG001|Overall Study|Lost to Follow-up|1|||
170894482|NCT05099640|617621932|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
170894483|NCT05099640|617621933|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
170894484|NCT05099640|617621934|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
170894485|NCT05099640|617621932|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
170894486|NCT05099640|617621933|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
170894487|NCT05099640|617621934|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
170894488|NCT05099640|617621932|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
170894489|NCT05099640|617621933|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
170894490|NCT05099640|617621934|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
170894491|NCT05099640|617621932|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
170894492|NCT05099640|617621933|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
170894493|NCT05099640|617621934|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
170894494|NCT05099640|617621932|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
170894495|NCT05099640|617621933|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
170894496|NCT05099640|617621934|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
170894497|NCT05099640|617621932|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
170894498|NCT05099640|617621933|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
170894499|NCT05099640|617621934|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
170894500|NCT01987908|617621944|FG000|Placebo Lead-in Period|Adverse Event|2|||
170894501|NCT01987908|617621945|FG001|Placebo Lead-in Period|Adverse Event|0|||
170894502|NCT01987908|617621946|FG002|Placebo Lead-in Period|Adverse Event|0|||
170894503|NCT01987908|617621944|FG000|Placebo Lead-in Period|Physician Decision|2|||
170894504|NCT01987908|617621945|FG001|Placebo Lead-in Period|Physician Decision|0|||
170894505|NCT01987908|617621946|FG002|Placebo Lead-in Period|Physician Decision|0|||
170894506|NCT01987908|617621944|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
170894507|NCT01987908|617621945|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
170894508|NCT01987908|617621946|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
170894509|NCT01987908|617621944|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
170894510|NCT01987908|617621945|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
170894511|NCT01987908|617621946|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
170894512|NCT01987908|617621944|FG000|Treatment Period|Adverse Event|0|||
170894513|NCT01987908|617621945|FG001|Treatment Period|Adverse Event|1|||
170894514|NCT01987908|617621946|FG002|Treatment Period|Adverse Event|1|||
170894515|NCT01987908|617621944|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
170894516|NCT01987908|617621945|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
170894517|NCT01987908|617621946|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
170894518|NCT01987908|617621944|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
170894519|NCT01987908|617621945|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
170894520|NCT01987908|617621946|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
170894521|NCT01262625|617621947|FG000|Overall Study|Administrative Error|1|||
170894522|NCT01262625|617621948|FG001|Overall Study|Administrative Error|1|||
170894523|NCT01262625|617621947|FG000|Overall Study|Site Closed|1|||
170894524|NCT01262625|617621948|FG001|Overall Study|Site Closed|0|||
170894525|NCT01869348|617621949|FG000|Overall Study|Withdrawal by Subject|1|||
170894526|NCT01869348|617621950|FG001|Overall Study|Withdrawal by Subject|1|||
170894527|NCT01728779|617621952|FG000|Overall Study|Withdrawal by Subject|1|||
170480215|NCT00191477|616097321|FG001|Overall Study|Death, Study Disease|1|||
170480216|NCT00191477|616097320|FG000|Overall Study|Death, Other Cause|3|||
170480217|NCT00191477|616097321|FG001|Overall Study|Death, Other Cause|6|||
170480218|NCT00191477|616097320|FG000|Overall Study|Lost to Follow-up|23|||
170894528|NCT02789657|617621953|FG000|Overall Study|Withdrawal by Subject|2|||
170894529|NCT02789657|617621954|FG001|Overall Study|Withdrawal by Subject|0|||
170639585|NCT04549545|616693669|FG001|Crossover Period|Additional ENT Procedure|6|||
170894530|NCT02789657|617621955|FG002|Overall Study|Withdrawal by Subject|0|||
170894531|NCT02789657|617621956|FG003|Overall Study|Withdrawal by Subject|0|||
170894532|NCT00448708|617621957|FG000|Overall Study|Death|21|||
170894533|NCT00448708|617621958|FG001|Overall Study|Death|17|||
170794174|NCT04625725|617256054|FG001|Provent Main Study|Lost to Follow-up|200|||
170894534|NCT00448708|617621957|FG000|Overall Study|Withdrawal by Subject|8|||
170894535|NCT00448708|617621958|FG001|Overall Study|Withdrawal by Subject|4|||
170894536|NCT00448708|617621957|FG000|Overall Study|Lost to Follow-up|6|||
170894537|NCT00448708|617621958|FG001|Overall Study|Lost to Follow-up|8|||
170894538|NCT00448708|617621957|FG000|Overall Study|not listed|0|||
170794175|NCT04625725|617256055|FG002|Provent Main Study|Lost to Follow-up|0|||
170794176|NCT04625725|617256056|FG003|Provent Main Study|Lost to Follow-up|0|||
170794177|NCT04625725|617256057|FG004|Provent Main Study|Lost to Follow-up|0|||
170794178|NCT04625725|617256058|FG005|Provent Main Study|Lost to Follow-up|0|||
170794179|NCT04625725|617256053|FG000|Provent Main Study|Death|22|||
170794180|NCT04625725|617256054|FG001|Provent Main Study|Death|10|||
170794181|NCT04625725|617256055|FG002|Provent Main Study|Death|0|||
170794182|NCT04625725|617256056|FG003|Provent Main Study|Death|0|||
170794183|NCT04625725|617256057|FG004|Provent Main Study|Death|0|||
170794184|NCT04625725|617256058|FG005|Provent Main Study|Death|0|||
170794185|NCT04625725|617256053|FG000|Provent Main Study|Adverse Event|2|||
170794186|NCT04625725|617256054|FG001|Provent Main Study|Adverse Event|1|||
170794187|NCT04625725|617256055|FG002|Provent Main Study|Adverse Event|0|||
170794188|NCT04625725|617256056|FG003|Provent Main Study|Adverse Event|0|||
170794189|NCT04625725|617256057|FG004|Provent Main Study|Adverse Event|0|||
170794190|NCT04625725|617256058|FG005|Provent Main Study|Adverse Event|0|||
170794191|NCT04625725|617256053|FG000|Provent Main Study|Participants dosed in sub-study|310|||
170794192|NCT04625725|617256054|FG001|Provent Main Study|Participants dosed in sub-study|193|||
170794193|NCT04625725|617256055|FG002|Provent Main Study|Participants dosed in sub-study|0|||
170794194|NCT04625725|617256056|FG003|Provent Main Study|Participants dosed in sub-study|0|||
170794195|NCT04625725|617256057|FG004|Provent Main Study|Participants dosed in sub-study|0|||
170794196|NCT04625725|617256058|FG005|Provent Main Study|Participants dosed in sub-study|0|||
170794197|NCT04625725|617256053|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
170794198|NCT04625725|617256054|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
170794199|NCT04625725|617256055|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
170794200|NCT04625725|617256056|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
170794201|NCT04625725|617256057|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
170794202|NCT04625725|617256058|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
170794203|NCT04625725|617256053|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
170894539|NCT00448708|617621958|FG001|Overall Study|not listed|2|||
170894540|NCT01925209|617621959|FG000|Treatment Epoch|Physician Decision|1|||
170894541|NCT01925209|617621960|FG001|Treatment Epoch|Physician Decision|0|||
170894542|NCT01925209|617621961|FG002|Treatment Epoch|Physician Decision|0|||
170894543|NCT01925209|617621962|FG003|Treatment Epoch|Physician Decision|0|||
170894544|NCT01925209|617621959|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
170894545|NCT01925209|617621960|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
170894546|NCT01925209|617621961|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
170894547|NCT01925209|617621962|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
170894548|NCT01925209|617621959|FG000|Treatment Epoch|Death|1|||
170894549|NCT01925209|617621960|FG001|Treatment Epoch|Death|0|||
170894550|NCT01925209|617621961|FG002|Treatment Epoch|Death|0|||
170894551|NCT01925209|617621962|FG003|Treatment Epoch|Death|0|||
170894552|NCT01925209|617621959|FG000|Treatment Epoch|Protocol deviation|0|||
170894553|NCT01925209|617621960|FG001|Treatment Epoch|Protocol deviation|0|||
170894554|NCT01925209|617621961|FG002|Treatment Epoch|Protocol deviation|1|||
170894555|NCT01925209|617621962|FG003|Treatment Epoch|Protocol deviation|1|||
170894556|NCT01925209|617621959|FG000|Treatment Epoch|Withdrawal by Subject|4|||
170894557|NCT01925209|617621960|FG001|Treatment Epoch|Withdrawal by Subject|3|||
170639586|NCT04549545|616693668|FG000|Crossover Period|Lost to Follow-up|0|||
170794204|NCT04625725|617256054|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
170894558|NCT01925209|617621961|FG002|Treatment Epoch|Withdrawal by Subject|3|||
170894559|NCT01925209|617621962|FG003|Treatment Epoch|Withdrawal by Subject|2|||
170894560|NCT01925209|617621959|FG000|Treatment Epoch|Adverse Event|3|||
170794205|NCT04625725|617256055|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
170794206|NCT04625725|617256056|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
170894561|NCT01925209|617621960|FG001|Treatment Epoch|Adverse Event|5|||
170794207|NCT04625725|617256057|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
170794208|NCT04625725|617256058|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
170894562|NCT01925209|617621961|FG002|Treatment Epoch|Adverse Event|3|||
170894563|NCT01925209|617621962|FG003|Treatment Epoch|Adverse Event|1|||
170894564|NCT01925209|617621959|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
170894565|NCT01925209|617621960|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
170894566|NCT01925209|617621961|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
170894567|NCT01925209|617621962|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
170894568|NCT01925209|617621959|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
170894569|NCT01925209|617621960|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
170894570|NCT01925209|617621961|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
170894571|NCT01925209|617621962|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
170894572|NCT01925209|617621959|FG000|Follow-up|Adverse Event|1|||
170894573|NCT01925209|617621960|FG001|Follow-up|Adverse Event|4|||
170794209|NCT04625725|617256053|FG000|Provent Main Study|INCARCERATION|3|||
170794210|NCT04625725|617256054|FG001|Provent Main Study|INCARCERATION|0|||
170794211|NCT04625725|617256055|FG002|Provent Main Study|INCARCERATION|0|||
170794212|NCT04625725|617256056|FG003|Provent Main Study|INCARCERATION|0|||
170794213|NCT04625725|617256057|FG004|Provent Main Study|INCARCERATION|0|||
170794214|NCT04625725|617256058|FG005|Provent Main Study|INCARCERATION|0|||
170794215|NCT04625725|617256053|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
170794216|NCT04625725|617256054|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
170794217|NCT04625725|617256055|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
170794218|NCT04625725|617256056|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
170794219|NCT04625725|617256057|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
170794220|NCT04625725|617256058|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
170794221|NCT04625725|617256053|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
170794222|NCT04625725|617256054|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
170794223|NCT04625725|617256055|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
170794224|NCT04625725|617256056|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
170794225|NCT04625725|617256057|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
170794226|NCT04625725|617256058|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
170794227|NCT04625725|617256053|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
170794228|NCT04625725|617256054|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
170794229|NCT04625725|617256055|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
170794230|NCT04625725|617256056|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
170794231|NCT04625725|617256057|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
170794232|NCT04625725|617256058|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
170794233|NCT04625725|617256053|FG000|Provent Main Study|MISSING REASON|0|||
170794234|NCT04625725|617256054|FG001|Provent Main Study|MISSING REASON|1|||
170794235|NCT04625725|617256055|FG002|Provent Main Study|MISSING REASON|0|||
170794236|NCT04625725|617256056|FG003|Provent Main Study|MISSING REASON|0|||
170794237|NCT04625725|617256057|FG004|Provent Main Study|MISSING REASON|0|||
170794238|NCT04625725|617256058|FG005|Provent Main Study|MISSING REASON|0|||
170794239|NCT04625725|617256053|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
170794240|NCT04625725|617256054|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
170794241|NCT04625725|617256055|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
170794242|NCT04625725|617256056|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
170794243|NCT04625725|617256057|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
170794244|NCT04625725|617256058|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
170794245|NCT04625725|617256053|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
170794246|NCT04625725|617256054|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
170794247|NCT04625725|617256055|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
170794248|NCT04625725|617256056|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
170794249|NCT04625725|617256057|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
170794250|NCT04625725|617256058|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
170794251|NCT04625725|617256053|FG000|Provent Sub Study|Lost to Follow-up|0|||
170794252|NCT04625725|617256054|FG001|Provent Sub Study|Lost to Follow-up|0|||
170794253|NCT04625725|617256055|FG002|Provent Sub Study|Lost to Follow-up|20|||
170794254|NCT04625725|617256056|FG003|Provent Sub Study|Lost to Follow-up|10|||
170794255|NCT04625725|617256057|FG004|Provent Sub Study|Lost to Follow-up|6|||
170794256|NCT04625725|617256058|FG005|Provent Sub Study|Lost to Follow-up|4|||
170794257|NCT04625725|617256053|FG000|Provent Sub Study|Death|0|||
170794258|NCT04625725|617256054|FG001|Provent Sub Study|Death|0|||
170894574|NCT01925209|617621961|FG002|Follow-up|Adverse Event|0|||
170894575|NCT01925209|617621962|FG003|Follow-up|Adverse Event|1|||
170894576|NCT01925209|617621959|FG000|Follow-up|Physician Decision|0|||
170794259|NCT04625725|617256055|FG002|Provent Sub Study|Death|8|||
170794260|NCT04625725|617256056|FG003|Provent Sub Study|Death|5|||
170794261|NCT04625725|617256057|FG004|Provent Sub Study|Death|0|||
170794262|NCT04625725|617256058|FG005|Provent Sub Study|Death|1|||
170794263|NCT04625725|617256053|FG000|Provent Sub Study|Adverse Event|0|||
170894577|NCT01925209|617621960|FG001|Follow-up|Physician Decision|0|||
170894578|NCT01925209|617621961|FG002|Follow-up|Physician Decision|1|||
170794264|NCT04625725|617256054|FG001|Provent Sub Study|Adverse Event|0|||
170794265|NCT04625725|617256055|FG002|Provent Sub Study|Adverse Event|0|||
170894579|NCT01925209|617621962|FG003|Follow-up|Physician Decision|0|||
170894580|NCT01925209|617621959|FG000|Follow-up|Non-compliance with study treatment|0|||
170894581|NCT01925209|617621960|FG001|Follow-up|Non-compliance with study treatment|0|||
170894582|NCT01925209|617621961|FG002|Follow-up|Non-compliance with study treatment|0|||
170894583|NCT01925209|617621962|FG003|Follow-up|Non-compliance with study treatment|1|||
170894584|NCT01925209|617621959|FG000|Follow-up|Withdrawal by Subject|0|||
170894585|NCT01925209|617621960|FG001|Follow-up|Withdrawal by Subject|2|||
170894586|NCT01925209|617621961|FG002|Follow-up|Withdrawal by Subject|0|||
170894587|NCT01925209|617621962|FG003|Follow-up|Withdrawal by Subject|2|||
170894588|NCT03075163|617621963|FG000|Overall Study|not eligible for treatment limb|138|||
170894589|NCT03075163|617621964|FG001|Overall Study|not eligible for treatment limb|138|||
170894590|NCT02532855|617621976|FG000|Overall Study|Lost to Follow-up|4|||
170894591|NCT02532855|617621977|FG001|Overall Study|Lost to Follow-up|3|||
170894592|NCT02532855|617621976|FG000|Overall Study|Withdrawal by Subject|4|||
170894593|NCT02532855|617621977|FG001|Overall Study|Withdrawal by Subject|8|||
170894594|NCT00666926|617621978|FG000|Overall Study|Adverse Event|0|||
170894595|NCT00666926|617621979|FG001|Overall Study|Adverse Event|0|||
170894596|NCT00666926|617621980|FG002|Overall Study|Adverse Event|0|||
170894597|NCT00666926|617621981|FG003|Overall Study|Adverse Event|0|||
170894598|NCT00666926|617621982|FG004|Overall Study|Adverse Event|0|||
170894599|NCT00666926|617621983|FG005|Overall Study|Adverse Event|0|||
170894600|NCT00666926|617621984|FG006|Overall Study|Adverse Event|0|||
170894601|NCT00666926|617621985|FG007|Overall Study|Adverse Event|0|||
170894602|NCT00666926|617621986|FG008|Overall Study|Adverse Event|0|||
170894603|NCT00666926|617621987|FG009|Overall Study|Adverse Event|2|||
170894604|NCT00666926|617621988|FG010|Overall Study|Adverse Event|2|||
170894605|NCT00666926|617621989|FG011|Overall Study|Adverse Event|2|||
170894606|NCT00666926|617621990|FG012|Overall Study|Adverse Event|0|||
170894607|NCT00666926|617621991|FG013|Overall Study|Adverse Event|1|||
170894608|NCT00666926|617621992|FG014|Overall Study|Adverse Event|0|||
170894609|NCT00666926|617621993|FG015|Overall Study|Adverse Event|0|||
170894610|NCT00666926|617621978|FG000|Overall Study|Laboratory abnormality|0|||
170894611|NCT00666926|617621979|FG001|Overall Study|Laboratory abnormality|0|||
170894612|NCT00666926|617621980|FG002|Overall Study|Laboratory abnormality|0|||
170894613|NCT00666926|617621981|FG003|Overall Study|Laboratory abnormality|0|||
170894614|NCT00666926|617621982|FG004|Overall Study|Laboratory abnormality|0|||
170894615|NCT00666926|617621983|FG005|Overall Study|Laboratory abnormality|0|||
170894616|NCT00666926|617621984|FG006|Overall Study|Laboratory abnormality|0|||
170894617|NCT00666926|617621985|FG007|Overall Study|Laboratory abnormality|0|||
170894618|NCT00666926|617621986|FG008|Overall Study|Laboratory abnormality|0|||
170894619|NCT00666926|617621987|FG009|Overall Study|Laboratory abnormality|0|||
170894620|NCT00666926|617621988|FG010|Overall Study|Laboratory abnormality|1|||
170894621|NCT00666926|617621989|FG011|Overall Study|Laboratory abnormality|0|||
170894622|NCT00666926|617621990|FG012|Overall Study|Laboratory abnormality|0|||
170894623|NCT00666926|617621991|FG013|Overall Study|Laboratory abnormality|0|||
170894624|NCT00666926|617621992|FG014|Overall Study|Laboratory abnormality|0|||
170894625|NCT00666926|617621993|FG015|Overall Study|Laboratory abnormality|1|||
170894626|NCT00666926|617621978|FG000|Overall Study|Lack of Efficacy|0|||
170894627|NCT00666926|617621979|FG001|Overall Study|Lack of Efficacy|0|||
170894628|NCT00666926|617621980|FG002|Overall Study|Lack of Efficacy|0|||
170894629|NCT00666926|617621981|FG003|Overall Study|Lack of Efficacy|0|||
170894630|NCT00666926|617621982|FG004|Overall Study|Lack of Efficacy|0|||
170894631|NCT00666926|617621983|FG005|Overall Study|Lack of Efficacy|1|||
170894632|NCT00666926|617621984|FG006|Overall Study|Lack of Efficacy|0|||
170894633|NCT00666926|617621985|FG007|Overall Study|Lack of Efficacy|0|||
170894634|NCT00666926|617621986|FG008|Overall Study|Lack of Efficacy|0|||
170894635|NCT00666926|617621987|FG009|Overall Study|Lack of Efficacy|0|||
170894636|NCT00666926|617621988|FG010|Overall Study|Lack of Efficacy|0|||
170894637|NCT00666926|617621989|FG011|Overall Study|Lack of Efficacy|1|||
170894638|NCT00666926|617621990|FG012|Overall Study|Lack of Efficacy|0|||
170894639|NCT00666926|617621991|FG013|Overall Study|Lack of Efficacy|0|||
170894640|NCT00666926|617621992|FG014|Overall Study|Lack of Efficacy|0|||
170894641|NCT00666926|617621993|FG015|Overall Study|Lack of Efficacy|0|||
170894642|NCT00666926|617621978|FG000|Overall Study|Lost to Follow-up|0|||
170894643|NCT00666926|617621979|FG001|Overall Study|Lost to Follow-up|0|||
170894644|NCT00666926|617621980|FG002|Overall Study|Lost to Follow-up|0|||
170894645|NCT00666926|617621981|FG003|Overall Study|Lost to Follow-up|1|||
170894646|NCT00666926|617621982|FG004|Overall Study|Lost to Follow-up|0|||
170894647|NCT00666926|617621983|FG005|Overall Study|Lost to Follow-up|0|||
170894648|NCT00666926|617621984|FG006|Overall Study|Lost to Follow-up|0|||
170894649|NCT00666926|617621985|FG007|Overall Study|Lost to Follow-up|0|||
170894650|NCT00666926|617621986|FG008|Overall Study|Lost to Follow-up|0|||
170894651|NCT00666926|617621987|FG009|Overall Study|Lost to Follow-up|0|||
170894652|NCT00666926|617621988|FG010|Overall Study|Lost to Follow-up|0|||
170894653|NCT00666926|617621989|FG011|Overall Study|Lost to Follow-up|0|||
170894654|NCT00666926|617621990|FG012|Overall Study|Lost to Follow-up|0|||
170894655|NCT00666926|617621991|FG013|Overall Study|Lost to Follow-up|0|||
170894656|NCT00666926|617621992|FG014|Overall Study|Lost to Follow-up|0|||
170894657|NCT00666926|617621993|FG015|Overall Study|Lost to Follow-up|0|||
170894658|NCT00666926|617621978|FG000|Overall Study|Other|2|||
170894659|NCT00666926|617621979|FG001|Overall Study|Other|4|||
170894660|NCT00666926|617621980|FG002|Overall Study|Other|3|||
170894661|NCT00666926|617621981|FG003|Overall Study|Other|3|||
170894662|NCT00666926|617621982|FG004|Overall Study|Other|3|||
170894663|NCT00666926|617621983|FG005|Overall Study|Other|3|||
170894664|NCT00666926|617621984|FG006|Overall Study|Other|4|||
170894665|NCT00666926|617621985|FG007|Overall Study|Other|0|||
170894666|NCT00666926|617621986|FG008|Overall Study|Other|3|||
170894667|NCT00666926|617621987|FG009|Overall Study|Other|5|||
170894668|NCT00666926|617621988|FG010|Overall Study|Other|3|||
170894669|NCT00666926|617621989|FG011|Overall Study|Other|26|||
170894670|NCT00666926|617621990|FG012|Overall Study|Other|3|||
170894671|NCT00666926|617621991|FG013|Overall Study|Other|2|||
170894672|NCT00666926|617621992|FG014|Overall Study|Other|4|||
170894673|NCT00666926|617621993|FG015|Overall Study|Other|4|||
170894674|NCT00666926|617621978|FG000|Overall Study|Withdrawal by Subject|0|||
170894675|NCT00666926|617621979|FG001|Overall Study|Withdrawal by Subject|0|||
170894676|NCT00666926|617621980|FG002|Overall Study|Withdrawal by Subject|0|||
170894677|NCT00666926|617621981|FG003|Overall Study|Withdrawal by Subject|0|||
170894678|NCT00666926|617621982|FG004|Overall Study|Withdrawal by Subject|0|||
170894679|NCT00666926|617621983|FG005|Overall Study|Withdrawal by Subject|0|||
170894680|NCT00666926|617621984|FG006|Overall Study|Withdrawal by Subject|0|||
170894681|NCT00666926|617621985|FG007|Overall Study|Withdrawal by Subject|1|||
170894682|NCT00666926|617621986|FG008|Overall Study|Withdrawal by Subject|0|||
170894683|NCT00666926|617621987|FG009|Overall Study|Withdrawal by Subject|3|||
170894684|NCT00666926|617621988|FG010|Overall Study|Withdrawal by Subject|0|||
170894685|NCT00666926|617621989|FG011|Overall Study|Withdrawal by Subject|3|||
170894686|NCT00666926|617621990|FG012|Overall Study|Withdrawal by Subject|0|||
170894687|NCT00666926|617621991|FG013|Overall Study|Withdrawal by Subject|1|||
170894688|NCT00666926|617621992|FG014|Overall Study|Withdrawal by Subject|3|||
170894689|NCT00666926|617621993|FG015|Overall Study|Withdrawal by Subject|3|||
170894690|NCT00666926|617621978|FG000|Overall Study|Death|0|||
170894691|NCT00666926|617621979|FG001|Overall Study|Death|0|||
170894692|NCT00666926|617621980|FG002|Overall Study|Death|0|||
170794266|NCT04625725|617256056|FG003|Provent Sub Study|Adverse Event|0|||
170794267|NCT04625725|617256057|FG004|Provent Sub Study|Adverse Event|0|||
170794268|NCT04625725|617256058|FG005|Provent Sub Study|Adverse Event|1|||
170794269|NCT04625725|617256053|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
170794270|NCT04625725|617256054|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
170794271|NCT04625725|617256055|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
170894693|NCT00666926|617621981|FG003|Overall Study|Death|0|||
170894694|NCT00666926|617621982|FG004|Overall Study|Death|0|||
170894695|NCT00666926|617621983|FG005|Overall Study|Death|0|||
170894696|NCT00666926|617621984|FG006|Overall Study|Death|0|||
170894697|NCT00666926|617621985|FG007|Overall Study|Death|0|||
170894698|NCT00666926|617621986|FG008|Overall Study|Death|0|||
170894699|NCT00666926|617621987|FG009|Overall Study|Death|0|||
170894700|NCT00666926|617621988|FG010|Overall Study|Death|0|||
170894701|NCT00666926|617621989|FG011|Overall Study|Death|1|||
170894702|NCT00666926|617621990|FG012|Overall Study|Death|0|||
170894703|NCT00666926|617621991|FG013|Overall Study|Death|0|||
170894704|NCT00666926|617621992|FG014|Overall Study|Death|0|||
170894705|NCT00666926|617621993|FG015|Overall Study|Death|0|||
170894706|NCT01838044|617622000|FG000|Overall Study|Adverse Event|4|||
170894707|NCT01838044|617622001|FG001|Overall Study|Adverse Event|6|||
170894708|NCT01838044|617622000|FG000|Overall Study|Protocol Violation|3|||
170894709|NCT01838044|617622001|FG001|Overall Study|Protocol Violation|3|||
170894710|NCT01838044|617622000|FG000|Overall Study|Withdrawal by Subject|0|||
170894711|NCT01838044|617622001|FG001|Overall Study|Withdrawal by Subject|2|||
170894712|NCT01838044|617622000|FG000|Overall Study|Insufficient clinical response|1|||
170894713|NCT01838044|617622001|FG001|Overall Study|Insufficient clinical response|2|||
170894714|NCT01838044|617622000|FG000|Overall Study|Medication error without associated AE|0|||
170894715|NCT01838044|617622001|FG001|Overall Study|Medication error without associated AE|1|||
170894716|NCT01838044|617622000|FG000|Overall Study|Lost to Follow-up|0|||
170894717|NCT01838044|617622001|FG001|Overall Study|Lost to Follow-up|2|||
170894718|NCT00330187|617622002|FG000|Overall Study|Lost to Follow-up|12|||
170894719|NCT00330187|617622003|FG001|Overall Study|Lost to Follow-up|13|||
170894720|NCT00330187|617622004|FG002|Overall Study|Lost to Follow-up|14|||
170894721|NCT00330187|617622005|FG003|Overall Study|Lost to Follow-up|10|||
170894722|NCT00330187|617622002|FG000|Overall Study|Withdrawal by Subject|8|||
170894723|NCT00330187|617622003|FG001|Overall Study|Withdrawal by Subject|5|||
170894724|NCT00330187|617622004|FG002|Overall Study|Withdrawal by Subject|4|||
170894725|NCT00330187|617622005|FG003|Overall Study|Withdrawal by Subject|4|||
170894726|NCT01162421|617622006|FG000|Overall Study|Did not receive study drug|2|||
170894727|NCT01162421|617622007|FG001|Overall Study|Did not receive study drug|1|||
170547689|NCT04518410|616350236|FG009|Overall Study|Protocol Violation|0|||
170894728|NCT01162421|617622006|FG000|Overall Study|Adverse Event|2|||
170894729|NCT01162421|617622007|FG001|Overall Study|Adverse Event|5|||
170894730|NCT01162421|617622006|FG000|Overall Study|Lost to Follow-up|0|||
170894731|NCT01162421|617622007|FG001|Overall Study|Lost to Follow-up|2|||
170894732|NCT01162421|617622006|FG000|Overall Study|Lack of Efficacy|2|||
170894733|NCT01162421|617622007|FG001|Overall Study|Lack of Efficacy|2|||
170894734|NCT01162421|617622006|FG000|Overall Study|Other|2|||
170894735|NCT01162421|617622007|FG001|Overall Study|Other|3|||
170894736|NCT01850615|617622008|FG000|Overall Study|Protocol Violation|4|||
170894737|NCT01850615|617622009|FG001|Overall Study|Protocol Violation|1|||
170894738|NCT01850615|617622008|FG000|Overall Study|Adverse Event|2|||
170894739|NCT01850615|617622009|FG001|Overall Study|Adverse Event|1|||
170894740|NCT01850615|617622008|FG000|Overall Study|Withdrawal by Subject|3|||
170894741|NCT01850615|617622009|FG001|Overall Study|Withdrawal by Subject|1|||
170894742|NCT01850615|617622008|FG000|Overall Study|Lost to Follow-up|0|||
170894743|NCT01850615|617622009|FG001|Overall Study|Lost to Follow-up|1|||
170894744|NCT01850615|617622008|FG000|Overall Study|Unclassified|0|||
170894745|NCT01850615|617622009|FG001|Overall Study|Unclassified|1|||
170894746|NCT00706628|617622010|FG000|Overall Study|Other Adverse Event|16|||
170894747|NCT00706628|617622011|FG001|Overall Study|Other Adverse Event|5|||
170639587|NCT04549545|616693669|FG001|Crossover Period|Lost to Follow-up|1|||
170894748|NCT00706628|617622012|FG002|Overall Study|Other Adverse Event|5|||
170894749|NCT00706628|617622013|FG003|Overall Study|Other Adverse Event|2|||
170480219|NCT00191477|616097321|FG001|Overall Study|Lost to Follow-up|21|||
170894750|NCT00706628|617622010|FG000|Overall Study|Non compliant with protocol|0|||
170894751|NCT00706628|617622011|FG001|Overall Study|Non compliant with protocol|1|||
170894752|NCT00706628|617622012|FG002|Overall Study|Non compliant with protocol|0|||
170894753|NCT00706628|617622013|FG003|Overall Study|Non compliant with protocol|0|||
170894754|NCT00706628|617622010|FG000|Overall Study|Consent withdrawn|6|||
170894755|NCT00706628|617622011|FG001|Overall Study|Consent withdrawn|1|||
170894756|NCT00706628|617622012|FG002|Overall Study|Consent withdrawn|3|||
170894757|NCT00706628|617622013|FG003|Overall Study|Consent withdrawn|0|||
170894758|NCT00706628|617622010|FG000|Overall Study|Progressive disease|20|||
170894759|NCT00706628|617622011|FG001|Overall Study|Progressive disease|13|||
170894760|NCT00706628|617622012|FG002|Overall Study|Progressive disease|8|||
170894761|NCT00706628|617622013|FG003|Overall Study|Progressive disease|1|||
170894762|NCT00706628|617622010|FG000|Overall Study|Other than those stated above|4|||
170894763|NCT00706628|617622011|FG001|Overall Study|Other than those stated above|0|||
170894764|NCT00706628|617622012|FG002|Overall Study|Other than those stated above|0|||
170894765|NCT00706628|617622013|FG003|Overall Study|Other than those stated above|0|||
170894766|NCT00706628|617622010|FG000|Overall Study|Not treated|1|||
170894767|NCT00706628|617622011|FG001|Overall Study|Not treated|1|||
170894768|NCT00706628|617622012|FG002|Overall Study|Not treated|0|||
170894769|NCT00706628|617622013|FG003|Overall Study|Not treated|0|||
170894770|NCT02921425|617622014|FG000|Overall Study|Protocol Violation|9|||
170894771|NCT01948830|617622020|FG000|Overall Study|Physician Decision|1|||
170894772|NCT01948830|617622021|FG001|Overall Study|Physician Decision|3|||
170894773|NCT01948830|617622020|FG000|Overall Study|Protocol deviation|1|||
170894774|NCT01948830|617622021|FG001|Overall Study|Protocol deviation|2|||
170894775|NCT01948830|617622020|FG000|Overall Study|Lost to Follow-up|5|||
170894776|NCT01948830|617622021|FG001|Overall Study|Lost to Follow-up|4|||
170894777|NCT01948830|617622020|FG000|Overall Study|Withdrawal by Subject|14|||
170894778|NCT01948830|617622021|FG001|Overall Study|Withdrawal by Subject|17|||
170894779|NCT01948830|617622020|FG000|Overall Study|Adverse Event|9|||
170894780|NCT01948830|617622021|FG001|Overall Study|Adverse Event|2|||
170894781|NCT01948830|617622020|FG000|Overall Study|Death|3|||
170894782|NCT01948830|617622021|FG001|Overall Study|Death|4|||
170894783|NCT02526550|617622024|FG000|Overall Study|Lost to Follow-up|1|||
170894784|NCT00091832|617622027|FG000|Overall Study|Physician Decision|1|||
170894785|NCT00091832|617622028|FG001|Overall Study|Physician Decision|0|||
170894786|NCT00091832|617622029|FG002|Overall Study|Physician Decision|0|||
170894787|NCT00091832|617622030|FG003|Overall Study|Physician Decision|0|||
170894788|NCT00091832|617622031|FG004|Overall Study|Physician Decision|0|||
170894789|NCT00091832|617622032|FG005|Overall Study|Physician Decision|0|||
170894790|NCT00091832|617622027|FG000|Overall Study|Adverse Event|0|||
170894791|NCT00091832|617622028|FG001|Overall Study|Adverse Event|0|||
170894792|NCT00091832|617622029|FG002|Overall Study|Adverse Event|0|||
170894793|NCT00091832|617622030|FG003|Overall Study|Adverse Event|1|||
170894794|NCT00091832|617622031|FG004|Overall Study|Adverse Event|3|||
170894795|NCT00091832|617622032|FG005|Overall Study|Adverse Event|0|||
170894796|NCT00091832|617622027|FG000|Overall Study|Withdrawal by Subject|4|||
170894797|NCT00091832|617622028|FG001|Overall Study|Withdrawal by Subject|5|||
170894798|NCT00091832|617622029|FG002|Overall Study|Withdrawal by Subject|0|||
170894799|NCT00091832|617622030|FG003|Overall Study|Withdrawal by Subject|1|||
170894800|NCT00091832|617622031|FG004|Overall Study|Withdrawal by Subject|3|||
170894801|NCT00091832|617622032|FG005|Overall Study|Withdrawal by Subject|1|||
170894802|NCT00091832|617622027|FG000|Overall Study|Death|6|||
170894803|NCT00091832|617622028|FG001|Overall Study|Death|4|||
170894804|NCT00091832|617622029|FG002|Overall Study|Death|5|||
170894805|NCT00091832|617622030|FG003|Overall Study|Death|8|||
170894806|NCT00091832|617622031|FG004|Overall Study|Death|5|||
170894807|NCT00091832|617622032|FG005|Overall Study|Death|6|||
170894808|NCT00091832|617622027|FG000|Overall Study|Disease Progression|2|||
170480220|NCT00191477|616097320|FG000|Overall Study|Protocol Violation|1|||
170480221|NCT00191477|616097321|FG001|Overall Study|Protocol Violation|1|||
170480222|NCT00191477|616097320|FG000|Overall Study|Treatment Change|2|||
170480223|NCT00191477|616097321|FG001|Overall Study|Treatment Change|0|||
170480224|NCT00191477|616097320|FG000|Overall Study|Withdrawal by Subject|2|||
170480225|NCT00191477|616097321|FG001|Overall Study|Withdrawal by Subject|0|||
170480226|NCT00191477|616097320|FG000|Overall Study|Other|2|||
170894809|NCT00091832|617622028|FG001|Overall Study|Disease Progression|0|||
170894810|NCT00091832|617622029|FG002|Overall Study|Disease Progression|0|||
170894811|NCT00091832|617622030|FG003|Overall Study|Disease Progression|1|||
170894812|NCT00091832|617622031|FG004|Overall Study|Disease Progression|1|||
170894813|NCT00091832|617622032|FG005|Overall Study|Disease Progression|2|||
170894814|NCT00091832|617622027|FG000|Overall Study|Ineligibility Determined|0|||
170894815|NCT00091832|617622028|FG001|Overall Study|Ineligibility Determined|0|||
170894816|NCT00091832|617622029|FG002|Overall Study|Ineligibility Determined|1|||
170894817|NCT00091832|617622030|FG003|Overall Study|Ineligibility Determined|0|||
170894818|NCT00091832|617622031|FG004|Overall Study|Ineligibility Determined|1|||
170894819|NCT00091832|617622032|FG005|Overall Study|Ineligibility Determined|0|||
170894820|NCT00091832|617622027|FG000|Overall Study|Lost to Follow-up|1|||
170894821|NCT00091832|617622028|FG001|Overall Study|Lost to Follow-up|0|||
170894822|NCT00091832|617622029|FG002|Overall Study|Lost to Follow-up|3|||
170894823|NCT00091832|617622030|FG003|Overall Study|Lost to Follow-up|3|||
170894824|NCT00091832|617622031|FG004|Overall Study|Lost to Follow-up|2|||
170894825|NCT00091832|617622032|FG005|Overall Study|Lost to Follow-up|1|||
170894826|NCT00091832|617622027|FG000|Overall Study|Noncompliance|0|||
170894827|NCT00091832|617622028|FG001|Overall Study|Noncompliance|1|||
170894828|NCT00091832|617622029|FG002|Overall Study|Noncompliance|0|||
170894829|NCT00091832|617622030|FG003|Overall Study|Noncompliance|0|||
170894830|NCT00091832|617622031|FG004|Overall Study|Noncompliance|0|||
170894831|NCT00091832|617622032|FG005|Overall Study|Noncompliance|0|||
170894832|NCT00091832|617622027|FG000|Overall Study|Other|0|||
170894833|NCT00091832|617622028|FG001|Overall Study|Other|1|||
170894834|NCT00091832|617622029|FG002|Overall Study|Other|2|||
170894835|NCT00091832|617622030|FG003|Overall Study|Other|0|||
170894836|NCT00091832|617622031|FG004|Overall Study|Other|0|||
170894837|NCT00091832|617622032|FG005|Overall Study|Other|0|||
170894838|NCT00091832|617622027|FG000|Overall Study|Protocol Violation|0|||
170894839|NCT00091832|617622028|FG001|Overall Study|Protocol Violation|0|||
170894840|NCT00091832|617622029|FG002|Overall Study|Protocol Violation|1|||
170894841|NCT00091832|617622030|FG003|Overall Study|Protocol Violation|0|||
170639588|NCT04549545|616693668|FG000|Crossover Period|Withdrawal by Subject|0|||
170639589|NCT04549545|616693669|FG001|Crossover Period|Withdrawal by Subject|4|||
170639590|NCT03844945|616693674|FG000|Overall Study|Adverse Event|1|||
170639591|NCT03844945|616693675|FG001|Overall Study|Adverse Event|1|||
170639592|NCT03844945|616693676|FG002|Overall Study|Adverse Event|4|||
170639593|NCT03844945|616693677|FG003|Overall Study|Adverse Event|0|||
170639594|NCT03844945|616693674|FG000|Overall Study|Withdrawal by Subject|0|||
170639595|NCT03844945|616693675|FG001|Overall Study|Withdrawal by Subject|0|||
170639596|NCT03844945|616693676|FG002|Overall Study|Withdrawal by Subject|1|||
170639597|NCT03844945|616693677|FG003|Overall Study|Withdrawal by Subject|0|||
170794272|NCT04625725|617256056|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
170794273|NCT04625725|617256057|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
170794274|NCT04625725|617256058|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
170794275|NCT04625725|617256053|FG000|Provent Sub Study|Withdrawal by Subject|0|||
170794276|NCT04625725|617256054|FG001|Provent Sub Study|Withdrawal by Subject|0|||
170794277|NCT04625725|617256055|FG002|Provent Sub Study|Withdrawal by Subject|11|||
170894842|NCT00091832|617622031|FG004|Overall Study|Protocol Violation|0|||
170894843|NCT00091832|617622032|FG005|Overall Study|Protocol Violation|1|||
170894844|NCT00946309|617622033|FG000|Overall Study|Protocol Violation|1|||
170894845|NCT00946309|617622034|FG001|Overall Study|Protocol Violation|0|||
170894846|NCT00946309|617622033|FG000|Overall Study|Lost to Follow-up|0|||
170894847|NCT00946309|617622034|FG001|Overall Study|Lost to Follow-up|1|||
170894848|NCT00946309|617622033|FG000|Overall Study|Procedure cancelled/discontinued|0|||
170894849|NCT00946309|617622034|FG001|Overall Study|Procedure cancelled/discontinued|3|||
170894850|NCT00578643|617622035|FG000|Overall Study|Death|1|||
170894851|NCT00578643|617622035|FG000|Overall Study|Lost to Follow-up|1|||
170894852|NCT01356589|617622037|FG000|Overall Study|Enrolled, but not treated|3|||
170894853|NCT01356589|617622037|FG000|Overall Study|Dose data not recorded|2|||
170894854|NCT01634555|617622038|FG000|Overall Study|Adverse Event|3|||
170639598|NCT03844945|616693674|FG000|Overall Study|Lack of Efficacy|0|||
170639599|NCT03844945|616693675|FG001|Overall Study|Lack of Efficacy|0|||
170639600|NCT03844945|616693676|FG002|Overall Study|Lack of Efficacy|0|||
170639601|NCT03844945|616693677|FG003|Overall Study|Lack of Efficacy|1|||
170639602|NCT03983317|616693678|FG000|Overall Study|Physician Decision|5|||
170639603|NCT01761162|616693679|FG000|Overall Study|Withdrawal by Subject|3|||
170639604|NCT02160899|616693680|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
170639605|NCT02160899|616693681|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
170894855|NCT01634555|617622038|FG000|Overall Study|Physician Decision|1|||
170894856|NCT02447848|617622042|FG000|Overall Study|Patient discharged|3|||
170894857|NCT02447848|617622042|FG000|Overall Study|Lack of Efficacy|4|||
170894858|NCT02447848|617622042|FG000|Overall Study|Withdrawal by Subject|4|||
170794278|NCT04625725|617256056|FG003|Provent Sub Study|Withdrawal by Subject|13|||
170894859|NCT01506882|617622043|FG000|Overall Study|Lack of Efficacy|4|||
170894860|NCT01506882|617622044|FG001|Overall Study|Lack of Efficacy|3|||
170894861|NCT01506882|617622043|FG000|Overall Study|Lost to Follow-up|1|||
170894862|NCT01506882|617622044|FG001|Overall Study|Lost to Follow-up|0|||
170894863|NCT01506882|617622043|FG000|Overall Study|Withdrawal by Subject|9|||
170894864|NCT01506882|617622044|FG001|Overall Study|Withdrawal by Subject|3|||
170894865|NCT01506882|617622043|FG000|Overall Study|SAE, non-fatal|2|||
170894866|NCT01506882|617622044|FG001|Overall Study|SAE, non-fatal|0|||
170894867|NCT01506882|617622043|FG000|Overall Study|AE, non-serious non-fatal|3|||
170894868|NCT01506882|617622044|FG001|Overall Study|AE, non-serious non-fatal|1|||
170894869|NCT01506882|617622043|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
170894870|NCT01506882|617622044|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
170894871|NCT01506882|617622043|FG000|Overall Study|Other Reason|2|||
170894872|NCT01506882|617622044|FG001|Overall Study|Other Reason|0|||
170894873|NCT04025632|617624151|FG000|Overall Study|Adverse Event|1|||
170894874|NCT04025632|617624152|FG001|Overall Study|Adverse Event|1|||
170894875|NCT04025632|617624151|FG000|Overall Study|Withdrawal by Subject|1|||
170894876|NCT04025632|617624152|FG001|Overall Study|Withdrawal by Subject|1|||
170894877|NCT04025632|617624151|FG000|Overall Study|Study Terminated by Sponsor|10|||
170894878|NCT04025632|617624152|FG001|Overall Study|Study Terminated by Sponsor|9|||
170894879|NCT04025632|617624151|FG000|Overall Study|Physician Decision|3|||
170894880|NCT04025632|617624152|FG001|Overall Study|Physician Decision|1|||
170894881|NCT00376961|617624153|FG000|Initial Registration|Adverse Event|1|||
170894882|NCT00376961|617624154|FG001|Initial Registration|Adverse Event|0|||
170894883|NCT00376961|617624153|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
170894884|NCT00376961|617624154|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
170894885|NCT00376961|617624153|FG000|Initial Registration|Progression/relapse|1|||
170894886|NCT00376961|617624154|FG001|Initial Registration|Progression/relapse|0|||
170894887|NCT00376961|617624153|FG000|Initial Registration|Ineligible|3|||
170894888|NCT00376961|617624154|FG001|Initial Registration|Ineligible|0|||
170894889|NCT00376961|617624153|FG000|Maintenance|Adverse Event|0|||
170894890|NCT00376961|617624154|FG001|Maintenance|Adverse Event|1|||
170894891|NCT00376961|617624153|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
170894892|NCT00376961|617624154|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
170894893|NCT00376961|617624153|FG000|Maintenance|Progression/relapse|0|||
170894894|NCT00376961|617624154|FG001|Maintenance|Progression/relapse|18|||
170894895|NCT00376961|617624153|FG000|Maintenance|Ineligible|0|||
170894896|NCT00376961|617624154|FG001|Maintenance|Ineligible|3|||
170894897|NCT01097629|617624163|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
170894898|NCT01097629|617624164|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
170894899|NCT01097629|617624165|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
170894900|NCT01097629|617624166|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170480227|NCT00191477|616097321|FG001|Overall Study|Other|0|||
170480228|NCT00191477|616097320|FG000|Overall Study|Not Eligible|41|||
170480229|NCT00191477|616097321|FG001|Overall Study|Not Eligible|38|||
170480230|NCT00191477|616097320|FG000|Overall Study|Pathological Specimen Lost|1|||
170480231|NCT00191477|616097321|FG001|Overall Study|Pathological Specimen Lost|0|||
170480232|NCT00191477|616097320|FG000|Overall Study|Discontinued Prior to Instillation|13|||
170480233|NCT00191477|616097321|FG001|Overall Study|Discontinued Prior to Instillation|14|||
170480234|NCT05921903|616097324|FG000|Overall Study|Unsolicited non-SAE|0|||
170480235|NCT05921903|616097325|FG001|Overall Study|Unsolicited non-SAE|1|||
170480236|NCT05921903|616097326|FG002|Overall Study|Unsolicited non-SAE|0|||
170480237|NCT05921903|616097324|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
170480238|NCT05921903|616097325|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
170480239|NCT05921903|616097326|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
170480240|NCT05921903|616097324|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
170480241|NCT05921903|616097325|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
170480242|NCT05921903|616097326|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
170480243|NCT00789854|616097327|FG000|Overall Study|Adverse Event|28|||
170480244|NCT00789854|616097328|FG001|Overall Study|Adverse Event|23|||
170480245|NCT00789854|616097329|FG002|Overall Study|Adverse Event|18|||
170480246|NCT00789854|616097327|FG000|Overall Study|Lost to Follow-up|1|||
170480247|NCT00789854|616097328|FG001|Overall Study|Lost to Follow-up|1|||
170480248|NCT00789854|616097329|FG002|Overall Study|Lost to Follow-up|4|||
170480249|NCT00789854|616097327|FG000|Overall Study|Withdrawal by Subject|9|||
170480250|NCT00789854|616097328|FG001|Overall Study|Withdrawal by Subject|6|||
170547690|NCT04518410|616350237|FG010|Overall Study|Protocol Violation|0|||
170894901|NCT01097629|617624167|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170894902|NCT01097629|617624168|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170480251|NCT00789854|616097329|FG002|Overall Study|Withdrawal by Subject|17|||
170480252|NCT00789854|616097327|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
170894903|NCT01097629|617624169|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170894904|NCT01097629|617624170|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170894905|NCT01097629|617624163|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
170894906|NCT01097629|617624164|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
170894907|NCT01097629|617624165|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
170894908|NCT01097629|617624166|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170480253|NCT00789854|616097328|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
170480254|NCT00789854|616097329|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
170794279|NCT04625725|617256057|FG004|Provent Sub Study|Withdrawal by Subject|5|||
170794280|NCT04625725|617256058|FG005|Provent Sub Study|Withdrawal by Subject|6|||
170794281|NCT04625725|617256053|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
170794282|NCT04625725|617256054|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
170794283|NCT04625725|617256055|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
170794284|NCT04625725|617256056|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
170794285|NCT04625725|617256057|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
170794286|NCT04625725|617256058|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
170794287|NCT03295721|617256065|FG000|Overall Study|Adverse Event|1|||
170794288|NCT03295721|617256066|FG001|Overall Study|Adverse Event|0|||
170794289|NCT03295721|617256067|FG002|Overall Study|Adverse Event|0|||
170794290|NCT03295721|617256065|FG000|Overall Study|Lost to Follow-up|1|||
170794291|NCT03295721|617256066|FG001|Overall Study|Lost to Follow-up|1|||
170794292|NCT03295721|617256067|FG002|Overall Study|Lost to Follow-up|1|||
170794293|NCT03295721|617256065|FG000|Overall Study|Withdrawal by Subject|1|||
170794294|NCT03295721|617256066|FG001|Overall Study|Withdrawal by Subject|0|||
170794295|NCT03295721|617256067|FG002|Overall Study|Withdrawal by Subject|1|||
170794296|NCT03295721|617256065|FG000|Overall Study|Death|0|||
170794297|NCT03295721|617256066|FG001|Overall Study|Death|0|||
170794298|NCT03295721|617256067|FG002|Overall Study|Death|1|||
170794299|NCT00429364|617256070|FG000|Overall Study|Withdrawal by Subject|11|||
170794300|NCT00429364|617256071|FG001|Overall Study|Withdrawal by Subject|5|||
170794301|NCT00429364|617256070|FG000|Overall Study|Physician Decision|4|||
170794302|NCT00429364|617256071|FG001|Overall Study|Physician Decision|2|||
170794303|NCT00429364|617256070|FG000|Overall Study|Lost to Follow-up|7|||
170794304|NCT00429364|617256071|FG001|Overall Study|Lost to Follow-up|6|||
170794305|NCT00429364|617256070|FG000|Overall Study|Death|0|||
170794306|NCT00429364|617256071|FG001|Overall Study|Death|1|||
170794307|NCT00429364|617256070|FG000|Overall Study|Underwent aortic root surgery|10|||
170794308|NCT00429364|617256071|FG001|Overall Study|Underwent aortic root surgery|18|||
170794309|NCT00429364|617256070|FG000|Overall Study|Pregnancy|0|||
170794310|NCT00429364|617256071|FG001|Overall Study|Pregnancy|1|||
170794311|NCT03325985|617256072|FG000|Overall Study|Lost to Follow-up|122|||
170794312|NCT03325985|617256073|FG001|Overall Study|Lost to Follow-up|26|||
170794313|NCT03325985|617256074|FG002|Overall Study|Lost to Follow-up|141|||
170794314|NCT03325985|617256075|FG003|Overall Study|Lost to Follow-up|28|||
170794315|NCT03325985|617256072|FG000|Overall Study|Death|99|||
170794316|NCT03325985|617256073|FG001|Overall Study|Death|36|||
170794317|NCT03325985|617256074|FG002|Overall Study|Death|94|||
170794318|NCT03325985|617256075|FG003|Overall Study|Death|32|||
170794319|NCT03213665|617256076|FG000|Overall Study|Adverse Event|1|||
170794320|NCT03213665|617256076|FG000|Overall Study|Physician Decision|2|||
170794321|NCT03213665|617256076|FG000|Overall Study|Withdrawal by Subject|3|||
170794322|NCT03213665|617256076|FG000|Overall Study|Progressive Disease|13|||
170794323|NCT03034356|617256077|FG000|Baseline|Lost to Follow-up|2|||
170794324|NCT03034356|617256078|FG001|Baseline|Lost to Follow-up|4|||
170794325|NCT03034356|617256077|FG000|Baseline|Withdrawal by Subject|2|||
170794326|NCT03034356|617256078|FG001|Baseline|Withdrawal by Subject|0|||
170794327|NCT03034356|617256077|FG000|Baseline|Physician Decision|0|||
170794328|NCT03034356|617256078|FG001|Baseline|Physician Decision|1|||
170794329|NCT03034356|617256077|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
170794330|NCT03034356|617256078|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
170794331|NCT03034356|617256077|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
170794332|NCT03034356|617256078|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
170794333|NCT03034356|617256077|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
170480255|NCT00789854|616097327|FG000|Overall Study|Severe non-compliance to the protocol|3|||
170480256|NCT00789854|616097328|FG001|Overall Study|Severe non-compliance to the protocol|0|||
170480257|NCT00789854|616097329|FG002|Overall Study|Severe non-compliance to the protocol|0|||
170794334|NCT03034356|617256078|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
170794335|NCT03034356|617256077|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
170794336|NCT03034356|617256078|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
170794337|NCT05873556|617256079|FG000|Overall Study|Lost to Follow-up|4|||
170794338|NCT05873556|617256080|FG001|Overall Study|Lost to Follow-up|1|||
170794339|NCT02684227|617256082|FG000|Overall Study|Adverse Event|1|||
170794340|NCT02684227|617256083|FG001|Overall Study|Adverse Event|7|||
170794341|NCT02684227|617256082|FG000|Overall Study|Death|0|||
170794342|NCT02684227|617256083|FG001|Overall Study|Death|2|||
170794343|NCT02684227|617256082|FG000|Overall Study|Withdrawal by Subject|0|||
170794344|NCT02684227|617256083|FG001|Overall Study|Withdrawal by Subject|1|||
170794345|NCT02684227|617256082|FG000|Overall Study|Progressive Disease|0|||
170794346|NCT02684227|617256083|FG001|Overall Study|Progressive Disease|2|||
170794347|NCT04862234|617256086|FG000|Overall Study|Surgery cancellation|1|||
170794348|NCT04862234|617256087|FG001|Overall Study|Surgery cancellation|2|||
170794349|NCT04862234|617256086|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
170794350|NCT04862234|617256087|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
170639606|NCT02160899|616693682|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
170639607|NCT02160899|616693683|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
170639608|NCT02160899|616693684|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
170639609|NCT02160899|616693685|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
170639610|NCT03387111|616693686|FG000|Overall Study|Progressive Disease|3|||
170639611|NCT03387111|616693686|FG000|Overall Study|Other|1|||
170639612|NCT01945710|616693687|FG000|Overall Study|Progressive Disease|5|||
170639613|NCT01945710|616693688|FG001|Overall Study|Progressive Disease|4|||
170639614|NCT01945710|616693689|FG002|Overall Study|Progressive Disease|3|||
170639615|NCT01945710|616693690|FG003|Overall Study|Progressive Disease|2|||
170639616|NCT01945710|616693691|FG004|Overall Study|Progressive Disease|7|||
170639617|NCT01945710|616693692|FG005|Overall Study|Progressive Disease|3|||
170639618|NCT01945710|616693693|FG006|Overall Study|Progressive Disease|19|||
170639619|NCT01945710|616693687|FG000|Overall Study|Adverse Event|0|||
170639620|NCT01945710|616693688|FG001|Overall Study|Adverse Event|1|||
170639621|NCT01945710|616693689|FG002|Overall Study|Adverse Event|0|||
170639622|NCT01945710|616693690|FG003|Overall Study|Adverse Event|0|||
170639623|NCT01945710|616693691|FG004|Overall Study|Adverse Event|0|||
170639624|NCT01945710|616693692|FG005|Overall Study|Adverse Event|0|||
170639625|NCT01945710|616693693|FG006|Overall Study|Adverse Event|0|||
170639626|NCT01945710|616693687|FG000|Overall Study|Other|2|||
170639627|NCT01945710|616693688|FG001|Overall Study|Other|0|||
170639628|NCT01945710|616693689|FG002|Overall Study|Other|3|||
170639629|NCT01945710|616693690|FG003|Overall Study|Other|1|||
170639630|NCT01945710|616693691|FG004|Overall Study|Other|1|||
170639631|NCT01945710|616693692|FG005|Overall Study|Other|0|||
170639632|NCT01945710|616693693|FG006|Overall Study|Other|4|||
170639633|NCT01945710|616693687|FG000|Overall Study|Withdrawal by Subject|0|||
170639634|NCT01945710|616693688|FG001|Overall Study|Withdrawal by Subject|1|||
170639635|NCT01945710|616693689|FG002|Overall Study|Withdrawal by Subject|1|||
170639636|NCT01945710|616693690|FG003|Overall Study|Withdrawal by Subject|0|||
170639637|NCT01945710|616693691|FG004|Overall Study|Withdrawal by Subject|1|||
170639638|NCT01945710|616693692|FG005|Overall Study|Withdrawal by Subject|0|||
170639639|NCT01945710|616693693|FG006|Overall Study|Withdrawal by Subject|0|||
170639640|NCT02730195|616693696|FG000|Overall Study|Withdrawal by Subject|1|||
170639641|NCT01368562|616693697|FG000|Overall Study|Adverse Event|1|||
170639642|NCT01368562|616693697|FG000|Overall Study|Disease progression|1|||
170639643|NCT01368562|616693697|FG000|Overall Study|Lost to Follow-up|1|||
170639644|NCT01368562|616693697|FG000|Overall Study|Death|6|||
170639645|NCT01368562|616693697|FG000|Overall Study|Unresponsive to treatment|5|||
170639646|NCT01368562|616693697|FG000|Overall Study|Other|3|||
170639647|NCT01368562|616693697|FG000|Overall Study|Other than specified|2|||
170639648|NCT03390101|616693699|FG000|Weeks 0-12|Withdrawal by Subject|0|||
170639649|NCT03390101|616693700|FG001|Weeks 0-12|Withdrawal by Subject|1|||
170639650|NCT03390101|616693701|FG002|Weeks 0-12|Withdrawal by Subject|1|||
170639651|NCT03390101|616693699|FG000|Weeks 0-12|Lost to Follow-up|0|||
170639652|NCT03390101|616693700|FG001|Weeks 0-12|Lost to Follow-up|1|||
170639653|NCT03390101|616693701|FG002|Weeks 0-12|Lost to Follow-up|0|||
170639654|NCT03390101|616693699|FG000|Weeks 12-54|Withdrawal by Subject|0|||
170480258|NCT00789854|616097327|FG000|Overall Study|Safety reasons|0|||
170480259|NCT00789854|616097328|FG001|Overall Study|Safety reasons|0|||
170480260|NCT00789854|616097329|FG002|Overall Study|Safety reasons|2|||
170480261|NCT00789854|616097327|FG000|Overall Study|Other|6|||
170480262|NCT00789854|616097328|FG001|Overall Study|Other|0|||
170480263|NCT00789854|616097329|FG002|Overall Study|Other|5|||
170480264|NCT02224157|616097330|FG000|Overall Study|Severe non-compliance to protocol|2|||
170480265|NCT02224157|616097331|FG001|Overall Study|Severe non-compliance to protocol|2|||
170480266|NCT02224157|616097330|FG000|Overall Study|Other|13|||
170639655|NCT03390101|616693700|FG001|Weeks 12-54|Withdrawal by Subject|3|||
170639656|NCT03390101|616693701|FG002|Weeks 12-54|Withdrawal by Subject|1|||
170794351|NCT04862234|617256086|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
170794352|NCT04862234|617256087|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
170639657|NCT03390101|616693699|FG000|Weeks 12-54|Pregnancy|1|||
170639658|NCT03390101|616693700|FG001|Weeks 12-54|Pregnancy|0|||
170639659|NCT03390101|616693701|FG002|Weeks 12-54|Pregnancy|0|||
170639660|NCT03390101|616693699|FG000|Weeks 12-54|Adverse Event|2|||
170639661|NCT03390101|616693700|FG001|Weeks 12-54|Adverse Event|1|||
170639662|NCT03390101|616693701|FG002|Weeks 12-54|Adverse Event|1|||
170639663|NCT04590248|616693702|FG000|Overall Study|Lost to Follow-up|1|||
170639664|NCT04590248|616693702|FG000|Overall Study|Withdrawal by Subject|16|||
170639665|NCT04590248|616693702|FG000|Overall Study|Other|2|||
170639666|NCT02052414|616693703|FG000|Overall Study|Adverse Event|12|||
170639667|NCT02052414|616693703|FG000|Overall Study|Lack of Efficacy|2|||
170639668|NCT02052414|616693703|FG000|Overall Study|Withdrawal by Subject|3|||
170639669|NCT04838977|616693709|FG000|Overall Study|Lost to Follow-up|2|||
170480267|NCT02224157|616097331|FG001|Overall Study|Other|10|||
170480268|NCT02224157|616097330|FG000|Overall Study|Subject decision|58|||
170480269|NCT02224157|616097331|FG001|Overall Study|Subject decision|50|||
170639670|NCT04838977|616693710|FG001|Overall Study|Lost to Follow-up|3|||
170639671|NCT04838977|616693709|FG000|Overall Study|Withdrawal by Subject|1|||
170794353|NCT03733925|617256093|FG000|Overall Study|Lost to Follow-up|1|||
170794354|NCT03733925|617256093|FG000|Overall Study|Withdrawal by Subject|2|||
170794355|NCT03733925|617256093|FG000|Overall Study|Adverse Event|2|||
170794356|NCT03733925|617256093|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170794357|NCT04571619|617256094|FG000|Phase 1|Death|22|||
170794358|NCT04571619|617256095|FG001|Phase 1|Death|18|||
170794359|NCT04571619|617256094|FG000|Phase 1|Withdrawal by Subject|7|||
170794360|NCT04571619|617256095|FG001|Phase 1|Withdrawal by Subject|2|||
170794361|NCT04571619|617256094|FG000|Phase 2|Death|13|||
170794362|NCT04571619|617256095|FG001|Phase 2|Death|16|||
170794363|NCT04571619|617256094|FG000|Phase 2|Withdrawal by Subject|6|||
170794364|NCT04571619|617256095|FG001|Phase 2|Withdrawal by Subject|4|||
170794365|NCT05683340|617256096|FG000|Overall Study|Adverse Event|1|||
170794366|NCT05683340|617256097|FG001|Overall Study|Adverse Event|1|||
170794367|NCT05683340|617256096|FG000|Overall Study|Protocol Violation|1|||
170794368|NCT05683340|617256097|FG001|Overall Study|Protocol Violation|0|||
170794369|NCT05683340|617256096|FG000|Overall Study|Withdrawal by Subject|0|||
170794370|NCT05683340|617256097|FG001|Overall Study|Withdrawal by Subject|2|||
170794371|NCT03505008|617256098|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
170794372|NCT03505008|617256099|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
170794373|NCT03505008|617256100|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
170794374|NCT03505008|617256101|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
170794375|NCT03505008|617256098|FG000|Before Week 24 Randomization|Adverse Event|10|||
170794376|NCT03505008|617256099|FG001|Before Week 24 Randomization|Adverse Event|0|||
170794377|NCT03505008|617256100|FG002|Before Week 24 Randomization|Adverse Event|0|||
170794378|NCT03505008|617256101|FG003|Before Week 24 Randomization|Adverse Event|0|||
170794379|NCT03505008|617256098|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
170794380|NCT03505008|617256099|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
170794381|NCT03505008|617256100|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
170794382|NCT03505008|617256101|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
170794383|NCT03505008|617256098|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
170794384|NCT03505008|617256099|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
170794385|NCT03505008|617256100|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
170794386|NCT03505008|617256101|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
170547691|NCT04518410|616350238|FG011|Overall Study|Protocol Violation|0|||
170547692|NCT04518410|616350239|FG012|Overall Study|Protocol Violation|0|||
170547693|NCT04518410|616350240|FG013|Overall Study|Protocol Violation|0|||
170547694|NCT04518410|616350241|FG014|Overall Study|Protocol Violation|0|||
170547695|NCT04518410|616350242|FG015|Overall Study|Protocol Violation|0|||
170547696|NCT04518410|616350243|FG016|Overall Study|Protocol Violation|1|||
170547697|NCT04518410|616350244|FG017|Overall Study|Protocol Violation|1|||
170547698|NCT04518410|616350245|FG018|Overall Study|Protocol Violation|0|||
170547699|NCT04518410|616350246|FG019|Overall Study|Protocol Violation|0|||
170547700|NCT04518410|616350247|FG020|Overall Study|Protocol Violation|1|||
170547701|NCT04518410|616350248|FG021|Overall Study|Protocol Violation|2|||
170547702|NCT04518410|616350249|FG022|Overall Study|Protocol Violation|0|||
170547703|NCT04518410|616350250|FG023|Overall Study|Protocol Violation|3|||
170547704|NCT04518410|616350251|FG024|Overall Study|Protocol Violation|0|||
170547705|NCT04518410|616350227|FG000|Overall Study|Death|0|||
170547706|NCT04518410|616350228|FG001|Overall Study|Death|0|||
170547707|NCT04518410|616350229|FG002|Overall Study|Death|0|||
170547708|NCT04518410|616350230|FG003|Overall Study|Death|0|||
170547709|NCT04518410|616350231|FG004|Overall Study|Death|12|||
170547710|NCT04518410|616350232|FG005|Overall Study|Death|2|||
170547711|NCT04518410|616350233|FG006|Overall Study|Death|11|||
170547712|NCT04518410|616350234|FG007|Overall Study|Death|0|||
170547713|NCT04518410|616350235|FG008|Overall Study|Death|1|||
170547714|NCT04518410|616350236|FG009|Overall Study|Death|0|||
170794387|NCT03505008|617256098|FG000|Before Week 24 Randomization|Physician Decision|2|||
170794388|NCT03505008|617256099|FG001|Before Week 24 Randomization|Physician Decision|0|||
170794389|NCT03505008|617256100|FG002|Before Week 24 Randomization|Physician Decision|0|||
170547715|NCT04518410|616350237|FG010|Overall Study|Death|0|||
170547716|NCT04518410|616350238|FG011|Overall Study|Death|0|||
170547717|NCT04518410|616350239|FG012|Overall Study|Death|0|||
170547718|NCT04518410|616350240|FG013|Overall Study|Death|1|||
170547719|NCT04518410|616350241|FG014|Overall Study|Death|1|||
170547720|NCT04518410|616350242|FG015|Overall Study|Death|0|||
170794390|NCT03505008|617256101|FG003|Before Week 24 Randomization|Physician Decision|0|||
170794391|NCT03505008|617256098|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
170547721|NCT04518410|616350243|FG016|Overall Study|Death|0|||
170547722|NCT04518410|616350244|FG017|Overall Study|Death|1|||
170547723|NCT04518410|616350245|FG018|Overall Study|Death|4|||
170547724|NCT04518410|616350246|FG019|Overall Study|Death|4|||
170547725|NCT04518410|616350247|FG020|Overall Study|Death|1|||
170794392|NCT03505008|617256099|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
170794393|NCT03505008|617256100|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
170794394|NCT03505008|617256101|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
170794395|NCT03505008|617256098|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
170794396|NCT03505008|617256099|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
170794397|NCT03505008|617256100|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
170794398|NCT03505008|617256101|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
170794399|NCT03505008|617256098|FG000|Before Week 24 Randomization|Complication|1|||
170794400|NCT03505008|617256099|FG001|Before Week 24 Randomization|Complication|0|||
170794401|NCT03505008|617256100|FG002|Before Week 24 Randomization|Complication|0|||
170794402|NCT03505008|617256101|FG003|Before Week 24 Randomization|Complication|0|||
170794403|NCT03505008|617256098|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
170794404|NCT03505008|617256099|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
170794405|NCT03505008|617256100|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
170794406|NCT03505008|617256101|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
170794407|NCT03505008|617256098|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
170794408|NCT03505008|617256099|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
170794409|NCT03505008|617256100|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
170794410|NCT03505008|617256101|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
170794411|NCT03505008|617256098|FG000|After Week 24 Randomization|Adverse Event|0|||
170794412|NCT03505008|617256099|FG001|After Week 24 Randomization|Adverse Event|1|||
170794413|NCT03505008|617256100|FG002|After Week 24 Randomization|Adverse Event|2|||
170794414|NCT03505008|617256101|FG003|After Week 24 Randomization|Adverse Event|2|||
170794415|NCT03505008|617256098|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
170794416|NCT03505008|617256099|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
170794417|NCT03505008|617256100|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
170794418|NCT03505008|617256101|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
170794419|NCT03505008|617256098|FG000|After Week 24 Randomization|Protocol Violation|0|||
170794420|NCT03505008|617256099|FG001|After Week 24 Randomization|Protocol Violation|0|||
170794421|NCT03505008|617256100|FG002|After Week 24 Randomization|Protocol Violation|1|||
170794422|NCT03505008|617256101|FG003|After Week 24 Randomization|Protocol Violation|0|||
170794423|NCT04741776|617256102|FG000|Overall Study|Withdrawal by Subject|7|||
170794424|NCT04741776|617256103|FG001|Overall Study|Withdrawal by Subject|10|||
170794425|NCT04741776|617256104|FG002|Overall Study|Withdrawal by Subject|10|||
170794426|NCT04741776|617256105|FG003|Overall Study|Withdrawal by Subject|17|||
170794427|NCT04741776|617256102|FG000|Overall Study|Death|0|||
170794428|NCT04741776|617256103|FG001|Overall Study|Death|0|||
170794429|NCT04741776|617256104|FG002|Overall Study|Death|1|||
170794430|NCT04741776|617256105|FG003|Overall Study|Death|0|||
170794431|NCT03663569|617257812|FG000|Overall Study|Discontinuation of study|11|||
170794432|NCT03663569|617257812|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
170794433|NCT03663569|617257812|FG000|Overall Study|Deceased patient|6|||
170794434|NCT03663569|617257812|FG000|Overall Study|Lost to Follow-up|18|||
170794435|NCT03663569|617257812|FG000|Overall Study|Withdrawal of consent|5|||
170794436|NCT03663569|617257812|FG000|Overall Study|Patient's request|11|||
170794437|NCT03663569|617257812|FG000|Overall Study|Adverse Event|4|||
170794438|NCT03663569|617257812|FG000|Overall Study|Not come to second visit|3|||
170794439|NCT03663569|617257812|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
170794440|NCT03663569|617257812|FG000|Overall Study|Serious adverse event|1|||
170794441|NCT03916185|617257814|FG000|Overall Study|Lost to Follow-up|0|||
170794442|NCT03916185|617257815|FG001|Overall Study|Lost to Follow-up|1|||
170794443|NCT03916185|617257816|FG002|Overall Study|Lost to Follow-up|0|||
170794444|NCT03916185|617257817|FG003|Overall Study|Lost to Follow-up|0|||
170794445|NCT03916185|617257814|FG000|Overall Study|Moved|1|||
170794446|NCT03916185|617257815|FG001|Overall Study|Moved|0|||
170794447|NCT03916185|617257816|FG002|Overall Study|Moved|0|||
170794448|NCT03916185|617257817|FG003|Overall Study|Moved|1|||
170794449|NCT03916185|617257814|FG000|Overall Study|Not Able to Get to Clinic|1|||
170794450|NCT03916185|617257815|FG001|Overall Study|Not Able to Get to Clinic|0|||
170794451|NCT03916185|617257816|FG002|Overall Study|Not Able to Get to Clinic|0|||
170794452|NCT03916185|617257817|FG003|Overall Study|Not Able to Get to Clinic|0|||
170794453|NCT03766685|617257818|FG000|Overall Study|Lost to Follow-up|1|||
170794454|NCT03766685|617257819|FG001|Overall Study|Lost to Follow-up|1|||
170794455|NCT03766685|617257820|FG002|Overall Study|Lost to Follow-up|0|||
170794456|NCT03766685|617257821|FG003|Overall Study|Lost to Follow-up|0|||
170794457|NCT03766685|617257818|FG000|Overall Study|Adverse Event, not fatal|0|||
170794458|NCT03766685|617257819|FG001|Overall Study|Adverse Event, not fatal|1|||
170894909|NCT01097629|617624167|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170547726|NCT04518410|616350248|FG021|Overall Study|Death|0|||
170794459|NCT03766685|617257820|FG002|Overall Study|Adverse Event, not fatal|0|||
170794460|NCT03766685|617257821|FG003|Overall Study|Adverse Event, not fatal|1|||
170547727|NCT04518410|616350249|FG022|Overall Study|Death|0|||
170794461|NCT03766685|617257818|FG000|Overall Study|Withdrawal by Subject|0|||
170794462|NCT03766685|617257819|FG001|Overall Study|Withdrawal by Subject|2|||
170794463|NCT03766685|617257820|FG002|Overall Study|Withdrawal by Subject|0|||
170794464|NCT03766685|617257821|FG003|Overall Study|Withdrawal by Subject|0|||
170794465|NCT03766685|617257818|FG000|Overall Study|Protocol Violation|0|||
170794466|NCT03766685|617257819|FG001|Overall Study|Protocol Violation|1|||
170794467|NCT03766685|617257820|FG002|Overall Study|Protocol Violation|0|||
170894910|NCT01097629|617624168|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170894911|NCT01097629|617624169|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170894912|NCT01097629|617624170|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170894913|NCT01097629|617624163|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
170894914|NCT01097629|617624164|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
170894915|NCT01097629|617624165|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
170894916|NCT01097629|617624166|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170639672|NCT04838977|616693710|FG001|Overall Study|Withdrawal by Subject|1|||
170639673|NCT05367492|616693711|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
170639674|NCT05367492|616693712|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
170639675|NCT05367492|616693713|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
170639676|NCT05367492|616693711|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
170639677|NCT05367492|616693712|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
170639678|NCT05367492|616693713|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
170639679|NCT05367492|616693711|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
170639680|NCT05367492|616693712|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
170639681|NCT05367492|616693713|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
170639682|NCT05367492|616693711|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
170639683|NCT05367492|616693712|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
170794468|NCT03766685|617257821|FG003|Overall Study|Protocol Violation|0|||
170794469|NCT03766685|617257818|FG000|Overall Study|Non-compliance|0|||
170794470|NCT03766685|617257819|FG001|Overall Study|Non-compliance|2|||
170794471|NCT03766685|617257820|FG002|Overall Study|Non-compliance|0|||
170794472|NCT03766685|617257821|FG003|Overall Study|Non-compliance|0|||
170794473|NCT04550221|617257825|FG000|Overall Study|Lost to Follow-up|0|||
170794474|NCT04550221|617257826|FG001|Overall Study|Lost to Follow-up|4|||
170794475|NCT04550221|617257825|FG000|Overall Study|Withdrawn|3|||
170794476|NCT04550221|617257826|FG001|Overall Study|Withdrawn|0|||
170794477|NCT04550221|617257825|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
170794478|NCT04550221|617257826|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
170794479|NCT05485779|617257827|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794480|NCT05485779|617257828|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794481|NCT05485779|617257829|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794482|NCT05485779|617257830|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794483|NCT05485779|617257831|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794484|NCT05485779|617257832|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794485|NCT05485779|617257833|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794486|NCT05485779|617257834|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
170794487|NCT05485779|617257835|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
170794488|NCT05485779|617257836|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794489|NCT05485779|617257837|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
170794490|NCT05485779|617257827|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794491|NCT05485779|617257828|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794492|NCT05485779|617257829|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794493|NCT05485779|617257830|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794494|NCT05485779|617257831|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794495|NCT05485779|617257832|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794496|NCT05485779|617257833|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794497|NCT05485779|617257834|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794498|NCT05485779|617257835|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794499|NCT05485779|617257836|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
170794500|NCT05485779|617257837|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
170794501|NCT05485779|617257827|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794502|NCT05485779|617257828|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794503|NCT05485779|617257829|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794504|NCT05485779|617257830|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
170794505|NCT05485779|617257831|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794506|NCT05485779|617257832|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794507|NCT05485779|617257833|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794508|NCT05485779|617257834|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794509|NCT05485779|617257835|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794510|NCT05485779|617257836|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170794511|NCT05485779|617257837|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
170894917|NCT01097629|617624167|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170794512|NCT02694822|617257838|FG000|Phase 1|Death|2|||
170794513|NCT02694822|617257839|FG001|Phase 1|Death|1|||
170794514|NCT02694822|617257840|FG002|Phase 1|Death|6|||
170794515|NCT02694822|617257841|FG003|Phase 1|Death|6|||
170794516|NCT02694822|617257842|FG004|Phase 1|Death|3|||
170794517|NCT02694822|617257843|FG005|Phase 1|Death|0|||
170794518|NCT02694822|617257838|FG000|Phase 1|Withdrawal by Subject|2|||
170794519|NCT02694822|617257839|FG001|Phase 1|Withdrawal by Subject|2|||
170794520|NCT02694822|617257840|FG002|Phase 1|Withdrawal by Subject|4|||
170794521|NCT02694822|617257841|FG003|Phase 1|Withdrawal by Subject|8|||
170794522|NCT02694822|617257842|FG004|Phase 1|Withdrawal by Subject|1|||
170794523|NCT02694822|617257843|FG005|Phase 1|Withdrawal by Subject|0|||
170794524|NCT02694822|617257838|FG000|Phase 2|Death|0|||
170794525|NCT02694822|617257839|FG001|Phase 2|Death|0|||
170794526|NCT02694822|617257840|FG002|Phase 2|Death|0|||
170794527|NCT02694822|617257841|FG003|Phase 2|Death|0|||
170794528|NCT02694822|617257842|FG004|Phase 2|Death|0|||
170794529|NCT02694822|617257843|FG005|Phase 2|Death|26|||
170794530|NCT02694822|617257838|FG000|Phase 2|Withdrawal by Subject|0|||
170794531|NCT02694822|617257839|FG001|Phase 2|Withdrawal by Subject|0|||
170794532|NCT02694822|617257840|FG002|Phase 2|Withdrawal by Subject|0|||
170794533|NCT02694822|617257841|FG003|Phase 2|Withdrawal by Subject|0|||
170794534|NCT02694822|617257842|FG004|Phase 2|Withdrawal by Subject|0|||
170794535|NCT02694822|617257843|FG005|Phase 2|Withdrawal by Subject|13|||
170794536|NCT02694822|617257838|FG000|Phase 2|Administrative Study Closure|0|||
170794537|NCT02694822|617257839|FG001|Phase 2|Administrative Study Closure|0|||
170794538|NCT02694822|617257840|FG002|Phase 2|Administrative Study Closure|0|||
170794539|NCT02694822|617257841|FG003|Phase 2|Administrative Study Closure|0|||
170794540|NCT02694822|617257842|FG004|Phase 2|Administrative Study Closure|0|||
170794541|NCT02694822|617257843|FG005|Phase 2|Administrative Study Closure|2|||
170794542|NCT02694822|617257838|FG000|Phase 2|Lost to Follow-up|0|||
170794543|NCT02694822|617257839|FG001|Phase 2|Lost to Follow-up|0|||
170794544|NCT02694822|617257840|FG002|Phase 2|Lost to Follow-up|0|||
170794545|NCT02694822|617257841|FG003|Phase 2|Lost to Follow-up|0|||
170794546|NCT02694822|617257842|FG004|Phase 2|Lost to Follow-up|0|||
170794547|NCT02694822|617257843|FG005|Phase 2|Lost to Follow-up|1|||
170794548|NCT02694822|617257838|FG000|Phase 2|Participant Transferred to Another Site|0|||
170794549|NCT02694822|617257839|FG001|Phase 2|Participant Transferred to Another Site|0|||
170794550|NCT02694822|617257840|FG002|Phase 2|Participant Transferred to Another Site|0|||
170794551|NCT02694822|617257841|FG003|Phase 2|Participant Transferred to Another Site|0|||
170794552|NCT02694822|617257842|FG004|Phase 2|Participant Transferred to Another Site|0|||
170794553|NCT02694822|617257843|FG005|Phase 2|Participant Transferred to Another Site|1|||
170794554|NCT04766892|617257844|FG000|Overall Study|Withdrawal by Subject|1|||
170794555|NCT04766892|617257844|FG000|Overall Study|Lost to Follow-up|1|||
170794556|NCT04766892|617257844|FG000|Overall Study|Adverse Event|3|||
170794557|NCT04766892|617257844|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
170794558|NCT05906784|617257845|FG000|Overall Study|Lost to Follow-up|2|||
170794559|NCT05906784|617257846|FG001|Overall Study|Lost to Follow-up|1|||
170794560|NCT05906784|617257847|FG002|Overall Study|Lost to Follow-up|1|||
170794561|NCT05906784|617257848|FG003|Overall Study|Lost to Follow-up|1|||
170794562|NCT03249090|617257851|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
170794563|NCT03249090|617257852|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
170794564|NCT03249090|617257851|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
170794565|NCT03249090|617257852|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
170794566|NCT03249090|617257851|FG000|3 Month Time Point|Voluntary withdrawal|6|||
170794567|NCT03249090|617257852|FG001|3 Month Time Point|Voluntary withdrawal|3|||
170794568|NCT03249090|617257851|FG000|3 Month Time Point|Changed oncology practice|4|||
170794569|NCT03249090|617257852|FG001|3 Month Time Point|Changed oncology practice|2|||
170794570|NCT03249090|617257851|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
170794571|NCT03249090|617257852|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
170794572|NCT03249090|617257851|FG000|12 Month Time Point|Voluntary withdrawal|35|||
170547728|NCT04518410|616350250|FG023|Overall Study|Death|0|||
170794573|NCT03249090|617257852|FG001|12 Month Time Point|Voluntary withdrawal|4|||
170794574|NCT03249090|617257851|FG000|12 Month Time Point|Changed oncology practice|20|||
170794575|NCT03249090|617257852|FG001|12 Month Time Point|Changed oncology practice|9|||
170794576|NCT02724969|617257858|FG000|Overall Study|Lost to Follow-up|12|||
170794577|NCT02724969|617257859|FG001|Overall Study|Lost to Follow-up|6|||
170794578|NCT02724969|617257858|FG000|Overall Study|Withdrawal by Subject|3|||
170794579|NCT02724969|617257859|FG001|Overall Study|Withdrawal by Subject|3|||
170794580|NCT02724969|617257858|FG000|Overall Study|Infant demise|0|||
170794581|NCT02724969|617257859|FG001|Overall Study|Infant demise|2|||
170794582|NCT05974501|617257860|FG000|Overall Study|Physician Decision|0|||
170794583|NCT05974501|617257861|FG001|Overall Study|Physician Decision|1|||
170794584|NCT02497950|617257862|FG000|Overall Study|Death|209|||
170794585|NCT02497950|617257862|FG000|Overall Study|Transplanted|85|||
170794586|NCT02497950|617257862|FG000|Overall Study|Explanted|8|||
170794587|NCT02497950|617257862|FG000|Overall Study|Device Permanently Deactivated|4|||
170794588|NCT02497950|617257862|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
170794589|NCT02497950|617257862|FG000|Overall Study|Lost to Follow-up|6|||
170894918|NCT01097629|617624168|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170894919|NCT01097629|617624169|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170894920|NCT01097629|617624170|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170894921|NCT01097629|617624163|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
170894922|NCT01097629|617624164|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
170894923|NCT01097629|617624165|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
170894924|NCT01097629|617624166|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170894925|NCT01097629|617624167|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170639684|NCT05367492|616693713|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
170639685|NCT01088048|616693717|FG000|Overall Study|Adverse Event|7|||
170639686|NCT01088048|616693718|FG001|Overall Study|Adverse Event|9|||
170639687|NCT01088048|616693719|FG002|Overall Study|Adverse Event|7|||
170639688|NCT01088048|616693720|FG003|Overall Study|Adverse Event|5|||
170639689|NCT01088048|616693721|FG004|Overall Study|Adverse Event|6|||
170639690|NCT01088048|616693722|FG005|Overall Study|Adverse Event|3|||
170639691|NCT01088048|616693723|FG006|Overall Study|Adverse Event|3|||
170894926|NCT01097629|617624168|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170894927|NCT01097629|617624169|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170894928|NCT01097629|617624170|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170894929|NCT01097629|617624163|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
170894930|NCT01097629|617624164|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
170894931|NCT01097629|617624165|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
170894932|NCT01097629|617624166|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170894933|NCT01097629|617624167|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170894934|NCT01097629|617624168|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170894935|NCT01097629|617624169|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170894936|NCT01097629|617624170|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170894937|NCT01097629|617624163|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
170894938|NCT01097629|617624164|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
170894939|NCT01097629|617624165|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170894940|NCT01097629|617624166|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170894941|NCT01097629|617624167|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170894942|NCT01097629|617624168|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170894943|NCT01097629|617624169|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170894944|NCT01097629|617624170|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170894945|NCT01097629|617624163|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
170894946|NCT01097629|617624164|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
170894947|NCT01097629|617624165|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
170894948|NCT01097629|617624166|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170480270|NCT02224157|616097330|FG000|Overall Study|Prematurely closed site|4|||
170480271|NCT02224157|616097331|FG001|Overall Study|Prematurely closed site|2|||
170480272|NCT02224157|616097330|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
170480273|NCT02224157|616097331|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
170639692|NCT01088048|616693724|FG007|Overall Study|Adverse Event|0|||
170639693|NCT01088048|616693725|FG008|Overall Study|Adverse Event|2|||
170639694|NCT01088048|616693726|FG009|Overall Study|Adverse Event|2|||
170639695|NCT01088048|616693717|FG000|Overall Study|Withdrew Consent|1|||
170639696|NCT01088048|616693718|FG001|Overall Study|Withdrew Consent|1|||
170639697|NCT01088048|616693719|FG002|Overall Study|Withdrew Consent|1|||
170639698|NCT01088048|616693720|FG003|Overall Study|Withdrew Consent|1|||
170639699|NCT01088048|616693721|FG004|Overall Study|Withdrew Consent|2|||
170639700|NCT01088048|616693722|FG005|Overall Study|Withdrew Consent|1|||
170639701|NCT01088048|616693723|FG006|Overall Study|Withdrew Consent|0|||
170639702|NCT01088048|616693724|FG007|Overall Study|Withdrew Consent|2|||
170639703|NCT01088048|616693725|FG008|Overall Study|Withdrew Consent|2|||
170639704|NCT01088048|616693726|FG009|Overall Study|Withdrew Consent|1|||
170639705|NCT01088048|616693717|FG000|Overall Study|Concomitant Medication Prohibited|1|||
170639706|NCT01088048|616693718|FG001|Overall Study|Concomitant Medication Prohibited|0|||
170639707|NCT01088048|616693719|FG002|Overall Study|Concomitant Medication Prohibited|0|||
170639708|NCT01088048|616693720|FG003|Overall Study|Concomitant Medication Prohibited|0|||
170639709|NCT01088048|616693721|FG004|Overall Study|Concomitant Medication Prohibited|0|||
170639710|NCT01088048|616693722|FG005|Overall Study|Concomitant Medication Prohibited|0|||
170639711|NCT01088048|616693723|FG006|Overall Study|Concomitant Medication Prohibited|0|||
170639712|NCT01088048|616693724|FG007|Overall Study|Concomitant Medication Prohibited|0|||
170639713|NCT01088048|616693725|FG008|Overall Study|Concomitant Medication Prohibited|0|||
170639714|NCT01088048|616693726|FG009|Overall Study|Concomitant Medication Prohibited|0|||
170639715|NCT01088048|616693717|FG000|Overall Study|Investigator Request|2|||
170639716|NCT01088048|616693718|FG001|Overall Study|Investigator Request|2|||
170639717|NCT01088048|616693719|FG002|Overall Study|Investigator Request|0|||
170639718|NCT01088048|616693720|FG003|Overall Study|Investigator Request|0|||
170639719|NCT01088048|616693721|FG004|Overall Study|Investigator Request|3|||
170639720|NCT01088048|616693722|FG005|Overall Study|Investigator Request|1|||
170639721|NCT01088048|616693723|FG006|Overall Study|Investigator Request|1|||
170639722|NCT01088048|616693724|FG007|Overall Study|Investigator Request|0|||
170639723|NCT01088048|616693725|FG008|Overall Study|Investigator Request|0|||
170639724|NCT01088048|616693726|FG009|Overall Study|Investigator Request|0|||
170639725|NCT01088048|616693717|FG000|Overall Study|Patient Non-compliance|0|||
170639726|NCT01088048|616693718|FG001|Overall Study|Patient Non-compliance|1|||
170639727|NCT01088048|616693719|FG002|Overall Study|Patient Non-compliance|0|||
170639728|NCT01088048|616693720|FG003|Overall Study|Patient Non-compliance|0|||
170639729|NCT01088048|616693721|FG004|Overall Study|Patient Non-compliance|0|||
170639730|NCT01088048|616693722|FG005|Overall Study|Patient Non-compliance|0|||
170639731|NCT01088048|616693723|FG006|Overall Study|Patient Non-compliance|0|||
170639732|NCT01088048|616693724|FG007|Overall Study|Patient Non-compliance|0|||
170639733|NCT01088048|616693725|FG008|Overall Study|Patient Non-compliance|0|||
170639734|NCT01088048|616693726|FG009|Overall Study|Patient Non-compliance|0|||
170639735|NCT01088048|616693717|FG000|Overall Study|Disease Progression|7|||
170639736|NCT01088048|616693718|FG001|Overall Study|Disease Progression|4|||
170639737|NCT01088048|616693719|FG002|Overall Study|Disease Progression|3|||
170639738|NCT01088048|616693720|FG003|Overall Study|Disease Progression|5|||
170639739|NCT01088048|616693721|FG004|Overall Study|Disease Progression|3|||
170639740|NCT01088048|616693722|FG005|Overall Study|Disease Progression|3|||
170639741|NCT01088048|616693723|FG006|Overall Study|Disease Progression|2|||
170639742|NCT01088048|616693724|FG007|Overall Study|Disease Progression|1|||
170639743|NCT01088048|616693725|FG008|Overall Study|Disease Progression|0|||
170639744|NCT01088048|616693726|FG009|Overall Study|Disease Progression|0|||
170639745|NCT01088048|616693717|FG000|Overall Study|Death|1|||
170639746|NCT01088048|616693718|FG001|Overall Study|Death|5|||
170639747|NCT01088048|616693719|FG002|Overall Study|Death|3|||
170639748|NCT01088048|616693720|FG003|Overall Study|Death|3|||
170639749|NCT01088048|616693721|FG004|Overall Study|Death|1|||
170639750|NCT01088048|616693722|FG005|Overall Study|Death|3|||
170639751|NCT01088048|616693723|FG006|Overall Study|Death|0|||
170639752|NCT01088048|616693724|FG007|Overall Study|Death|0|||
170639753|NCT01088048|616693725|FG008|Overall Study|Death|3|||
170639754|NCT01088048|616693726|FG009|Overall Study|Death|1|||
170639755|NCT01088048|616693717|FG000|Overall Study|Other|3|||
170639756|NCT01088048|616693718|FG001|Overall Study|Other|5|||
170639757|NCT01088048|616693719|FG002|Overall Study|Other|0|||
170639758|NCT01088048|616693720|FG003|Overall Study|Other|0|||
170639759|NCT01088048|616693721|FG004|Overall Study|Other|2|||
170639760|NCT01088048|616693722|FG005|Overall Study|Other|0|||
170639761|NCT01088048|616693723|FG006|Overall Study|Other|0|||
170639762|NCT01088048|616693724|FG007|Overall Study|Other|2|||
170639763|NCT01088048|616693725|FG008|Overall Study|Other|0|||
170639764|NCT01088048|616693726|FG009|Overall Study|Other|0|||
170639765|NCT00950859|616693732|FG000|Overall Study|Adverse Event|3|||
170639766|NCT00950859|616693733|FG001|Overall Study|Adverse Event|3|||
170639767|NCT00950859|616693732|FG000|Overall Study|Insufficient Viral Load Response|12|||
170639768|NCT00950859|616693733|FG001|Overall Study|Insufficient Viral Load Response|3|||
170639769|NCT00950859|616693732|FG000|Overall Study|Protocol Violation|1|||
170894949|NCT01097629|617624167|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170894950|NCT01097629|617624168|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170894951|NCT01097629|617624169|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170894952|NCT01097629|617624170|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170894953|NCT01097629|617624163|FG000|DB RO Phase|Withdrawal by Subject|0|||
170894954|NCT01097629|617624164|FG001|DB RO Phase|Withdrawal by Subject|0|||
170894955|NCT01097629|617624165|FG002|DB RO Phase|Withdrawal by Subject|0|||
170894956|NCT01097629|617624166|FG003|DB RO Phase|Withdrawal by Subject|0|||
170894957|NCT01097629|617624167|FG004|DB RO Phase|Withdrawal by Subject|0|||
170894958|NCT01097629|617624168|FG005|DB RO Phase|Withdrawal by Subject|0|||
170639770|NCT00950859|616693733|FG001|Overall Study|Protocol Violation|1|||
170639771|NCT00950859|616693732|FG000|Overall Study|Lost to Follow-up|0|||
170639772|NCT00950859|616693733|FG001|Overall Study|Lost to Follow-up|3|||
170639773|NCT02249832|616693734|FG000|Overall Study|Withdrawal by Subject|3|||
170639774|NCT02249832|616693734|FG000|Overall Study|Lost to Follow-up|10|||
170639775|NCT00265148|616693735|FG000|Overall Study|Adverse Event|2|||
170894959|NCT01097629|617624169|FG006|DB RO Phase|Withdrawal by Subject|0|||
170639776|NCT00265148|616693736|FG001|Overall Study|Adverse Event|2|||
170639777|NCT00265148|616693735|FG000|Overall Study|Lack of Efficacy|0|||
170639778|NCT00265148|616693736|FG001|Overall Study|Lack of Efficacy|2|||
170639779|NCT00265148|616693735|FG000|Overall Study|Protocol Violation|3|||
170639780|NCT00265148|616693736|FG001|Overall Study|Protocol Violation|2|||
170639781|NCT00265148|616693735|FG000|Overall Study|Lost to Follow-up|0|||
170639782|NCT00265148|616693736|FG001|Overall Study|Lost to Follow-up|1|||
170639783|NCT00265148|616693735|FG000|Overall Study|Withdrawal by Subject|2|||
170639784|NCT00265148|616693736|FG001|Overall Study|Withdrawal by Subject|1|||
170894960|NCT01097629|617624170|FG007|DB RO Phase|Withdrawal by Subject|1|||
170894961|NCT01097629|617624163|FG000|DB RO Phase|Protocol Violation|0|||
170894962|NCT01097629|617624164|FG001|DB RO Phase|Protocol Violation|0|||
170894963|NCT01097629|617624165|FG002|DB RO Phase|Protocol Violation|0|||
170894964|NCT01097629|617624166|FG003|DB RO Phase|Protocol Violation|1|||
170894965|NCT01097629|617624167|FG004|DB RO Phase|Protocol Violation|0|||
170894966|NCT01097629|617624168|FG005|DB RO Phase|Protocol Violation|1|||
170894967|NCT01097629|617624169|FG006|DB RO Phase|Protocol Violation|1|||
170894968|NCT01097629|617624170|FG007|DB RO Phase|Protocol Violation|0|||
170894969|NCT01097629|617624163|FG000|DB RO Phase|Lost to Follow-up|0|||
170894970|NCT01097629|617624164|FG001|DB RO Phase|Lost to Follow-up|0|||
170894971|NCT01097629|617624165|FG002|DB RO Phase|Lost to Follow-up|0|||
170894972|NCT01097629|617624166|FG003|DB RO Phase|Lost to Follow-up|0|||
170894973|NCT01097629|617624167|FG004|DB RO Phase|Lost to Follow-up|0|||
170894974|NCT01097629|617624168|FG005|DB RO Phase|Lost to Follow-up|0|||
170894975|NCT01097629|617624169|FG006|DB RO Phase|Lost to Follow-up|2|||
170894976|NCT01097629|617624170|FG007|DB RO Phase|Lost to Follow-up|0|||
170894977|NCT02663895|617624171|FG000|Overall Study|Adverse Event|3|||
170894978|NCT02663895|617624171|FG000|Overall Study|Physician Decision|2|||
170894979|NCT02663895|617624171|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
170894980|NCT02663895|617624171|FG000|Overall Study|Withdrawal by Subject|1|||
170894981|NCT00809328|617624172|FG000|Overall Study|Lack of Efficacy|18|||
170894982|NCT00809328|617624172|FG000|Overall Study|Adverse Event|6|||
170894983|NCT00809328|617624172|FG000|Overall Study|Protocol Violation|3|||
170894984|NCT00809328|617624172|FG000|Overall Study|Withdrawal by Subject|2|||
170894985|NCT00686127|617624175|FG000|Overall Study|Withdrawal by Subject|14|||
170894986|NCT00686127|617624176|FG001|Overall Study|Withdrawal by Subject|6|||
170547729|NCT04518410|616350251|FG024|Overall Study|Death|0|||
170547730|NCT04518410|616350227|FG000|Overall Study|Requirement to start alternative therapy|0|||
170547731|NCT04518410|616350228|FG001|Overall Study|Requirement to start alternative therapy|0|||
170547732|NCT04518410|616350229|FG002|Overall Study|Requirement to start alternative therapy|1|||
170547733|NCT04518410|616350230|FG003|Overall Study|Requirement to start alternative therapy|0|||
170547734|NCT04518410|616350231|FG004|Overall Study|Requirement to start alternative therapy|0|||
170794590|NCT02497950|617257862|FG000|Overall Study|Withdrawal by Subject|2|||
170794591|NCT02497950|617257862|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
170794592|NCT02497950|617257862|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
170794593|NCT03513302|617257865|FG000|First Intervention (14 Days)|Screen failure|15|||
170794594|NCT03513302|617257866|FG001|First Intervention (14 Days)|Screen failure|16|||
170794595|NCT01236781|617257867|FG000|Overall Study|Ineligible|2|||
170794596|NCT01236781|617257868|FG001|Overall Study|Ineligible|1|||
170794597|NCT01236781|617257867|FG000|Overall Study|Did not complete study imaging|5|||
170794598|NCT01236781|617257868|FG001|Overall Study|Did not complete study imaging|0|||
170794599|NCT05256654|617257869|FG000|Overall Study|Adverse Event|0|||
170794600|NCT05256654|617257870|FG001|Overall Study|Adverse Event|0|||
170794601|NCT05256654|617257871|FG002|Overall Study|Adverse Event|1|||
170794602|NCT05256654|617257872|FG003|Overall Study|Adverse Event|0|||
170794603|NCT05256654|617257869|FG000|Overall Study|Lost to Follow-up|0|||
170794604|NCT05256654|617257870|FG001|Overall Study|Lost to Follow-up|0|||
170794605|NCT05256654|617257871|FG002|Overall Study|Lost to Follow-up|0|||
170794606|NCT05256654|617257872|FG003|Overall Study|Lost to Follow-up|1|||
170794607|NCT05256654|617257869|FG000|Overall Study|Withdrawal by Subject|1|||
170794608|NCT05256654|617257870|FG001|Overall Study|Withdrawal by Subject|2|||
170794609|NCT05256654|617257871|FG002|Overall Study|Withdrawal by Subject|1|||
170794610|NCT05256654|617257872|FG003|Overall Study|Withdrawal by Subject|3|||
170794611|NCT05256654|617257869|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
170794612|NCT05256654|617257870|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
170794613|NCT05256654|617257871|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
170894987|NCT03312218|617624177|FG000|Overall Study|Never signed in to access the app|54|||
170894988|NCT03312218|617624178|FG001|Overall Study|Never signed in to access the app|58|||
170894989|NCT02159807|617624179|FG000|Overall Study|Adverse Event|0|||
170547735|NCT04518410|616350232|FG005|Overall Study|Requirement to start alternative therapy|0|||
170547736|NCT04518410|616350233|FG006|Overall Study|Requirement to start alternative therapy|0|||
170547737|NCT04518410|616350234|FG007|Overall Study|Requirement to start alternative therapy|0|||
170547738|NCT04518410|616350235|FG008|Overall Study|Requirement to start alternative therapy|0|||
170547739|NCT04518410|616350236|FG009|Overall Study|Requirement to start alternative therapy|0|||
170547740|NCT04518410|616350237|FG010|Overall Study|Requirement to start alternative therapy|0|||
170547741|NCT04518410|616350238|FG011|Overall Study|Requirement to start alternative therapy|0|||
170547742|NCT04518410|616350239|FG012|Overall Study|Requirement to start alternative therapy|0|||
170547743|NCT04518410|616350240|FG013|Overall Study|Requirement to start alternative therapy|0|||
170547744|NCT04518410|616350241|FG014|Overall Study|Requirement to start alternative therapy|0|||
170794614|NCT05256654|617257872|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
170894990|NCT02159807|617624180|FG001|Overall Study|Adverse Event|0|||
170894991|NCT02159807|617624181|FG002|Overall Study|Adverse Event|1|||
170894992|NCT02159807|617624179|FG000|Overall Study|No CSF|1|||
170894993|NCT02159807|617624180|FG001|Overall Study|No CSF|1|||
170794615|NCT05256654|617257869|FG000|Overall Study|Other|0|||
170794616|NCT05256654|617257870|FG001|Overall Study|Other|0|||
170794617|NCT05256654|617257871|FG002|Overall Study|Other|0|||
170794618|NCT05256654|617257872|FG003|Overall Study|Other|1|||
170794619|NCT01221948|617257879|FG000|Overall Study|Physician Decision|5|||
170794620|NCT01221948|617257879|FG000|Overall Study|Withdrawal by Subject|2|||
170894994|NCT02159807|617624181|FG002|Overall Study|No CSF|1|||
170894995|NCT02159807|617624179|FG000|Overall Study|elevated blood pressure|0|||
170894996|NCT02159807|617624180|FG001|Overall Study|elevated blood pressure|0|||
170894997|NCT02159807|617624181|FG002|Overall Study|elevated blood pressure|1|||
170894998|NCT00600171|617624182|FG000|Overall Study|Adverse Event|0|||
170894999|NCT00600171|617624183|FG001|Overall Study|Adverse Event|1|||
170895000|NCT00600171|617624184|FG002|Overall Study|Adverse Event|0|||
170895001|NCT00600171|617624185|FG003|Overall Study|Adverse Event|0|||
170895002|NCT00600171|617624186|FG004|Overall Study|Adverse Event|1|||
170895003|NCT00600171|617624187|FG005|Overall Study|Adverse Event|0|||
170895004|NCT00600171|617624182|FG000|Overall Study|Lack of Efficacy|9|||
170895005|NCT00600171|617624183|FG001|Overall Study|Lack of Efficacy|12|||
170895006|NCT00600171|617624184|FG002|Overall Study|Lack of Efficacy|3|||
170895007|NCT00600171|617624185|FG003|Overall Study|Lack of Efficacy|5|||
170895008|NCT00600171|617624186|FG004|Overall Study|Lack of Efficacy|4|||
170895009|NCT00600171|617624187|FG005|Overall Study|Lack of Efficacy|0|||
170895010|NCT00600171|617624182|FG000|Overall Study|Protocol Violation|1|||
170895011|NCT00600171|617624183|FG001|Overall Study|Protocol Violation|2|||
170895012|NCT00600171|617624184|FG002|Overall Study|Protocol Violation|0|||
170895013|NCT00600171|617624185|FG003|Overall Study|Protocol Violation|1|||
170895014|NCT00600171|617624186|FG004|Overall Study|Protocol Violation|0|||
170895015|NCT00600171|617624187|FG005|Overall Study|Protocol Violation|0|||
170895016|NCT00600171|617624182|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
170895017|NCT00600171|617624183|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
170895018|NCT00600171|617624184|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
170895019|NCT00600171|617624185|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
170895020|NCT00600171|617624186|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
170895021|NCT00600171|617624187|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
170895022|NCT00600171|617624182|FG000|Overall Study|Withdrawal by Subject|3|||
170895023|NCT00600171|617624183|FG001|Overall Study|Withdrawal by Subject|0|||
170895024|NCT00600171|617624184|FG002|Overall Study|Withdrawal by Subject|0|||
170895025|NCT00600171|617624185|FG003|Overall Study|Withdrawal by Subject|1|||
170547745|NCT04518410|616350242|FG015|Overall Study|Requirement to start alternative therapy|0|||
170547746|NCT04518410|616350243|FG016|Overall Study|Requirement to start alternative therapy|0|||
170547747|NCT04518410|616350244|FG017|Overall Study|Requirement to start alternative therapy|0|||
170547748|NCT04518410|616350245|FG018|Overall Study|Requirement to start alternative therapy|0|||
170547749|NCT04518410|616350246|FG019|Overall Study|Requirement to start alternative therapy|0|||
170794621|NCT01221948|617257879|FG000|Overall Study|not disclosed|2|||
170794622|NCT01221948|617257879|FG000|Overall Study|Death|1|||
170547750|NCT04518410|616350247|FG020|Overall Study|Requirement to start alternative therapy|0|||
170547751|NCT04518410|616350248|FG021|Overall Study|Requirement to start alternative therapy|0|||
170547752|NCT04518410|616350249|FG022|Overall Study|Requirement to start alternative therapy|0|||
170547753|NCT04518410|616350250|FG023|Overall Study|Requirement to start alternative therapy|0|||
170794623|NCT01221948|617257879|FG000|Overall Study|Protocol Violation|4|||
170794624|NCT00746096|617257880|FG000|Overall Study|Adverse Event|1|||
170794625|NCT00746096|617257881|FG001|Overall Study|Adverse Event|0|||
170794626|NCT00746096|617257880|FG000|Overall Study|Withdrawal by Subject|5|||
170895026|NCT00600171|617624186|FG004|Overall Study|Withdrawal by Subject|1|||
170895027|NCT00600171|617624187|FG005|Overall Study|Withdrawal by Subject|1|||
170895028|NCT00600171|617624182|FG000|Overall Study|Physician Decision|0|||
170895029|NCT00600171|617624183|FG001|Overall Study|Physician Decision|1|||
170895030|NCT00600171|617624184|FG002|Overall Study|Physician Decision|0|||
170895031|NCT00600171|617624185|FG003|Overall Study|Physician Decision|1|||
170895032|NCT00600171|617624186|FG004|Overall Study|Physician Decision|0|||
170895033|NCT00600171|617624187|FG005|Overall Study|Physician Decision|2|||
170895034|NCT00600171|617624182|FG000|Overall Study|Lost to Follow-up|0|||
170895035|NCT00600171|617624183|FG001|Overall Study|Lost to Follow-up|0|||
170895036|NCT00600171|617624184|FG002|Overall Study|Lost to Follow-up|0|||
170895037|NCT00600171|617624185|FG003|Overall Study|Lost to Follow-up|1|||
170895038|NCT00600171|617624186|FG004|Overall Study|Lost to Follow-up|0|||
170895039|NCT00600171|617624187|FG005|Overall Study|Lost to Follow-up|0|||
170895040|NCT00103012|617624191|FG000|Overall Study|Withdrawal by Subject|2|||
170895041|NCT00103012|617624192|FG001|Overall Study|Withdrawal by Subject|1|||
170794627|NCT00746096|617257881|FG001|Overall Study|Withdrawal by Subject|1|||
170895042|NCT00103012|617624193|FG002|Overall Study|Withdrawal by Subject|2|||
170895043|NCT00103012|617624191|FG000|Overall Study|Pregnancy|1|||
170895044|NCT00103012|617624192|FG001|Overall Study|Pregnancy|0|||
170794628|NCT00746096|617257880|FG000|Overall Study|Lost to Follow-up|2|||
170794629|NCT00746096|617257881|FG001|Overall Study|Lost to Follow-up|1|||
170794630|NCT00746096|617257880|FG000|Overall Study|Protocol Violation|1|||
170794631|NCT00746096|617257881|FG001|Overall Study|Protocol Violation|0|||
170794632|NCT00746096|617257880|FG000|Overall Study|No study drug treatment|1|||
170794633|NCT00746096|617257881|FG001|Overall Study|No study drug treatment|1|||
170794634|NCT03756662|617257882|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
170794635|NCT01254864|617257890|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
170794636|NCT01254864|617257891|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
170794637|NCT01254864|617257892|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
170794638|NCT01254864|617257890|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
170794639|NCT01254864|617257891|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
170794640|NCT01254864|617257892|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
170794641|NCT01254864|617257890|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
170794642|NCT01254864|617257891|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
170794643|NCT01254864|617257892|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
170794644|NCT01254864|617257890|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
170794645|NCT01254864|617257891|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
170794646|NCT01254864|617257892|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
170794647|NCT01254864|617257890|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
170794648|NCT01254864|617257891|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
170794649|NCT01254864|617257892|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
170794650|NCT01254864|617257890|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
170794651|NCT01254864|617257891|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
170794652|NCT01254864|617257892|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
170794653|NCT01254864|617257890|FG000|Randomization Phase|Adverse Event|0|||
170794654|NCT01254864|617257891|FG001|Randomization Phase|Adverse Event|5|||
170794655|NCT01254864|617257892|FG002|Randomization Phase|Adverse Event|17|||
170794656|NCT01254864|617257890|FG000|Randomization Phase|Death|0|||
170794657|NCT01254864|617257891|FG001|Randomization Phase|Death|1|||
170794658|NCT01254864|617257892|FG002|Randomization Phase|Death|0|||
170794659|NCT01254864|617257890|FG000|Randomization Phase|Lost to Follow-up|0|||
170794660|NCT01254864|617257891|FG001|Randomization Phase|Lost to Follow-up|0|||
170794661|NCT01254864|617257892|FG002|Randomization Phase|Lost to Follow-up|1|||
170794662|NCT01254864|617257890|FG000|Randomization Phase|Physician Decision|0|||
170794663|NCT01254864|617257891|FG001|Randomization Phase|Physician Decision|20|||
170794664|NCT01254864|617257892|FG002|Randomization Phase|Physician Decision|25|||
170794665|NCT01254864|617257890|FG000|Randomization Phase|Withdrawal by Subject|0|||
170794666|NCT01254864|617257891|FG001|Randomization Phase|Withdrawal by Subject|4|||
170794667|NCT01254864|617257892|FG002|Randomization Phase|Withdrawal by Subject|2|||
170794668|NCT01254864|617257890|FG000|Randomization Phase|Non-Compliance|0|||
170794669|NCT01254864|617257891|FG001|Randomization Phase|Non-Compliance|1|||
170794670|NCT01254864|617257892|FG002|Randomization Phase|Non-Compliance|0|||
170794671|NCT01254864|617257890|FG000|Randomization Phase|Comorbidities|0|||
170794672|NCT01254864|617257891|FG001|Randomization Phase|Comorbidities|2|||
170794673|NCT01254864|617257892|FG002|Randomization Phase|Comorbidities|1|||
170794674|NCT03626220|617257896|FG000|Overall Study|Withdrawal by Subject|2|||
170794675|NCT03626220|617257897|FG001|Overall Study|Withdrawal by Subject|0|||
170794676|NCT04136912|617257898|FG000|Overall Study|Operational reasons|0|||
170794677|NCT04136912|617257899|FG001|Overall Study|Operational reasons|0|||
170794678|NCT04136912|617257900|FG002|Overall Study|Operational reasons|2|||
170794679|NCT04689256|617257901|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
170794680|NCT04689256|617257902|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
170794681|NCT05104463|617257903|FG000|Overall Study|Adverse Event|1|||
170794682|NCT05104463|617257904|FG001|Overall Study|Adverse Event|1|||
170794683|NCT05104463|617257903|FG000|Overall Study|Lost to Follow-up|1|||
170794684|NCT05104463|617257904|FG001|Overall Study|Lost to Follow-up|1|||
170794685|NCT05104463|617257903|FG000|Overall Study|Physician Decision|1|||
170794686|NCT05104463|617257904|FG001|Overall Study|Physician Decision|0|||
170794687|NCT05104463|617257903|FG000|Overall Study|Protocol Violation|0|||
170794688|NCT05104463|617257904|FG001|Overall Study|Protocol Violation|2|||
170794689|NCT05104463|617257903|FG000|Overall Study|Withdrawal by Subject|1|||
170794690|NCT05104463|617257904|FG001|Overall Study|Withdrawal by Subject|1|||
170794691|NCT03292484|617257905|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
170794692|NCT03292484|617257905|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
170480274|NCT02224157|616097330|FG000|Overall Study|Lost to Follow-up|27|||
170480275|NCT02224157|616097331|FG001|Overall Study|Lost to Follow-up|35|||
170480276|NCT02224157|616097330|FG000|Overall Study|Death|1|||
170480277|NCT02224157|616097331|FG001|Overall Study|Death|1|||
170480278|NCT02224157|616097330|FG000|Overall Study|Adverse Event|1|||
170480279|NCT02224157|616097331|FG001|Overall Study|Adverse Event|3|||
170480280|NCT03164551|616097334|FG000|Overall Study|Imaging discontinued prior completion|8|||
170794693|NCT03292484|617257905|FG000|Overall Study|Protocol Violation|2|||
170794694|NCT03292484|617257905|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
170794695|NCT03292484|617257905|FG000|Overall Study|Sponsor decision|349|||
170794696|NCT03292484|617257905|FG000|Overall Study|Lost to Follow-up|7|||
170794697|NCT03292484|617257905|FG000|Overall Study|Coronavirus Disease 2019|1|||
170794698|NCT03292484|617257905|FG000|Overall Study|Other|20|||
170794699|NCT05828017|617257908|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
170794700|NCT05012163|617257909|FG000|Overall Study|Protocol Violation|0|||
170794701|NCT05012163|617257910|FG001|Overall Study|Protocol Violation|0|||
170794702|NCT05012163|617257911|FG002|Overall Study|Protocol Violation|1|||
170794703|NCT05012163|617257912|FG003|Overall Study|Protocol Violation|1|||
170794704|NCT05425420|617257917|FG000|Overall Study|Physician Decision|1|||
170794705|NCT05425420|617257917|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
170794706|NCT05524402|617257918|FG000|Overall Study|Withdrawal by Subject|3|||
170794707|NCT05524402|617257919|FG001|Overall Study|Withdrawal by Subject|1|||
170794708|NCT05524402|617257918|FG000|Overall Study|Lost to Follow-up|2|||
170794709|NCT05524402|617257919|FG001|Overall Study|Lost to Follow-up|1|||
170794710|NCT03381586|617257920|FG000|Overall Study|Adverse Event|1|||
170794711|NCT03381586|617257921|FG001|Overall Study|Adverse Event|1|||
170794712|NCT03381586|617257920|FG000|Overall Study|Protocol Violation|1|||
170794713|NCT03381586|617257921|FG001|Overall Study|Protocol Violation|0|||
170794714|NCT03381586|617257920|FG000|Overall Study|Withdrawal by Subject|1|||
170794715|NCT03381586|617257921|FG001|Overall Study|Withdrawal by Subject|2|||
170794716|NCT05838027|617257924|FG000|Overall Study|Lost to Follow-up|5|||
170794717|NCT05838027|617257925|FG001|Overall Study|Lost to Follow-up|1|||
170794718|NCT05838027|617257924|FG000|Overall Study|Withdrawal by Subject|1|||
170794719|NCT05838027|617257925|FG001|Overall Study|Withdrawal by Subject|0|||
170794720|NCT03714815|617257926|FG000|Overall Study|Physician Decision|2|||
170794721|NCT03714815|617257926|FG000|Overall Study|Withdrawal by Subject|2|||
170794722|NCT03714815|617257926|FG000|Overall Study|Death|11|||
170794723|NCT04056611|617257932|FG000|Overall Study|Physician Decision|1|||
170794724|NCT02224144|617257935|FG000|Overall Study|Lost to Follow-up|3|||
170794725|NCT02224144|617257936|FG001|Overall Study|Lost to Follow-up|1|||
170794726|NCT02224144|617257935|FG000|Overall Study|Death|2|||
170794727|NCT02224144|617257936|FG001|Overall Study|Death|0|||
170639785|NCT00265148|616693735|FG000|Overall Study|Physician Decision|1|||
170639786|NCT00265148|616693736|FG001|Overall Study|Physician Decision|0|||
170639787|NCT00265148|616693735|FG000|Overall Study|Increasing frailty|0|||
170639788|NCT00265148|616693736|FG001|Overall Study|Increasing frailty|1|||
170639789|NCT00265148|616693735|FG000|Overall Study|Subject chose to change of the dose|1|||
170639790|NCT00265148|616693736|FG001|Overall Study|Subject chose to change of the dose|0|||
170639791|NCT01463007|616693737|FG000|Overall Study|Physician Decision|1|||
170639792|NCT00243269|616693738|FG000|Overall Study|Protocol Violation|2|||
170639793|NCT00243269|616693739|FG001|Overall Study|Protocol Violation|1|||
170639794|NCT00243269|616693740|FG002|Overall Study|Protocol Violation|0|||
170639795|NCT00243269|616693741|FG003|Overall Study|Protocol Violation|1|||
170639796|NCT00243269|616693738|FG000|Overall Study|Lost to Follow-up|1|||
170639797|NCT00243269|616693739|FG001|Overall Study|Lost to Follow-up|0|||
170639798|NCT00243269|616693740|FG002|Overall Study|Lost to Follow-up|1|||
170639799|NCT00243269|616693741|FG003|Overall Study|Lost to Follow-up|3|||
170639800|NCT00545272|616693743|FG000|Overall Study|Protocol deviation|0|||
170639801|NCT00545272|616693744|FG001|Overall Study|Protocol deviation|1|||
170639802|NCT00545272|616693745|FG002|Overall Study|Protocol deviation|0|||
170794728|NCT02224144|617257935|FG000|Overall Study|Withdrawal by Subject|0|||
170794729|NCT02224144|617257936|FG001|Overall Study|Withdrawal by Subject|1|||
170794730|NCT00323856|617257949|FG000|Overall Study|Withdrawal by Subject|1|||
170794731|NCT00323856|617257949|FG000|Overall Study|Was uncooperative and noncompliant|1|||
170794732|NCT00323856|617257949|FG000|Overall Study|Reason not specified|1|||
170794733|NCT00323856|617257949|FG000|Overall Study|Missing|2|||
170794734|NCT04451772|617257951|FG000|Overall Study|Adverse Event|1|||
170794735|NCT04451772|617257952|FG001|Overall Study|Adverse Event|0|||
170794736|NCT04451772|617257953|FG002|Overall Study|Adverse Event|1|||
170794737|NCT04451772|617257954|FG003|Overall Study|Adverse Event|1|||
170794738|NCT04451772|617257955|FG004|Overall Study|Adverse Event|0|||
170794739|NCT04451772|617257956|FG005|Overall Study|Adverse Event|3|||
170794740|NCT04451772|617257951|FG000|Overall Study|Withdrawal by Subject|2|||
170794741|NCT04451772|617257952|FG001|Overall Study|Withdrawal by Subject|7|||
170794742|NCT04451772|617257953|FG002|Overall Study|Withdrawal by Subject|2|||
170794743|NCT04451772|617257954|FG003|Overall Study|Withdrawal by Subject|1|||
170794744|NCT04451772|617257955|FG004|Overall Study|Withdrawal by Subject|1|||
170794745|NCT04451772|617257956|FG005|Overall Study|Withdrawal by Subject|0|||
170794746|NCT04451772|617257951|FG000|Overall Study|Other, not specified|1|||
170639803|NCT00545272|616693746|FG003|Overall Study|Protocol deviation|1|||
170639804|NCT00545272|616693747|FG004|Overall Study|Protocol deviation|0|||
170639805|NCT00545272|616693748|FG005|Overall Study|Protocol deviation|1|||
170639806|NCT00545272|616693743|FG000|Overall Study|Adverse Event|0|||
170639807|NCT00545272|616693744|FG001|Overall Study|Adverse Event|0|||
170639808|NCT00545272|616693745|FG002|Overall Study|Adverse Event|1|||
170480281|NCT03164551|616097335|FG001|Overall Study|Imaging discontinued prior completion|0|||
170480282|NCT03164551|616097334|FG000|Overall Study|Participant was non-compliant|1|||
170480283|NCT03164551|616097335|FG001|Overall Study|Participant was non-compliant|0|||
170480284|NCT03164551|616097334|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
170480285|NCT03164551|616097335|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
170480286|NCT03164551|616097334|FG000|Overall Study|Other|8|||
170480287|NCT03164551|616097335|FG001|Overall Study|Other|2|||
170480288|NCT02857816|616097336|FG000|Overall Study|Screen Failure|33|||
170480289|NCT02857816|616097336|FG000|Overall Study|Withdrawal by Subject|4|||
170480290|NCT02857816|616097336|FG000|Overall Study|Lost to Follow-up|1|||
170480291|NCT00765102|616097337|FG000|Overall Study|Progressive disease|18|||
170480292|NCT00765102|616097337|FG000|Overall Study|Adverse Event|6|||
170480293|NCT00765102|616097337|FG000|Overall Study|Physician Decision|4|||
170480294|NCT00765102|616097337|FG000|Overall Study|Withdrawal by Subject|2|||
170480295|NCT00765102|616097337|FG000|Overall Study|Protocol Violation|1|||
170480296|NCT00470470|616097338|FG000|Overall Study|Adverse Event|2|||
170480297|NCT00470470|616097338|FG000|Overall Study|Death|2|||
170480298|NCT00470470|616097338|FG000|Overall Study|Not treated|1|||
170480299|NCT02546986|616099292|FG000|Treatment Period|Progressive Disease|20|||
170480300|NCT02546986|616099293|FG001|Treatment Period|Progressive Disease|22|||
170480301|NCT02546986|616099292|FG000|Treatment Period|Adverse Event|14|||
170480302|NCT02546986|616099293|FG001|Treatment Period|Adverse Event|6|||
170480303|NCT02546986|616099292|FG000|Treatment Period|Symptomatic Deterioration|4|||
170639809|NCT00545272|616693746|FG003|Overall Study|Adverse Event|0|||
170794747|NCT04451772|617257952|FG001|Overall Study|Other, not specified|2|||
170794748|NCT04451772|617257953|FG002|Overall Study|Other, not specified|1|||
170794749|NCT04451772|617257954|FG003|Overall Study|Other, not specified|0|||
170794750|NCT04451772|617257955|FG004|Overall Study|Other, not specified|0|||
170794751|NCT04451772|617257956|FG005|Overall Study|Other, not specified|1|||
170794752|NCT04451772|617257951|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
170794753|NCT04451772|617257952|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
170794754|NCT04451772|617257953|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
170794755|NCT04451772|617257954|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
170794756|NCT04451772|617257955|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
170794757|NCT04451772|617257956|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
170794758|NCT04167553|617257957|FG000|Overall Study|Withdrawal by Subject|1|||
170794759|NCT04167553|617257958|FG001|Overall Study|Withdrawal by Subject|0|||
170794760|NCT04167553|617257959|FG002|Overall Study|Withdrawal by Subject|1|||
170794761|NCT04167553|617257960|FG003|Overall Study|Withdrawal by Subject|2|||
170794762|NCT04167553|617257961|FG004|Overall Study|Withdrawal by Subject|1|||
170794763|NCT04167553|617257962|FG005|Overall Study|Withdrawal by Subject|0|||
170794764|NCT04167553|617257963|FG006|Overall Study|Withdrawal by Subject|0|||
170794765|NCT04167553|617257957|FG000|Overall Study|Physician Decision|0|||
170794766|NCT04167553|617257958|FG001|Overall Study|Physician Decision|0|||
170794767|NCT04167553|617257959|FG002|Overall Study|Physician Decision|0|||
170794768|NCT04167553|617257960|FG003|Overall Study|Physician Decision|0|||
170794769|NCT04167553|617257961|FG004|Overall Study|Physician Decision|2|||
170794770|NCT04167553|617257962|FG005|Overall Study|Physician Decision|2|||
170794771|NCT04167553|617257963|FG006|Overall Study|Physician Decision|0|||
170794772|NCT04167553|617257957|FG000|Overall Study|Lost to Follow-up|0|||
170794773|NCT04167553|617257958|FG001|Overall Study|Lost to Follow-up|0|||
170794774|NCT04167553|617257959|FG002|Overall Study|Lost to Follow-up|2|||
170794775|NCT04167553|617257960|FG003|Overall Study|Lost to Follow-up|0|||
170794776|NCT04167553|617257961|FG004|Overall Study|Lost to Follow-up|0|||
170794777|NCT04167553|617257962|FG005|Overall Study|Lost to Follow-up|0|||
170794778|NCT04167553|617257963|FG006|Overall Study|Lost to Follow-up|0|||
170794779|NCT02828358|617257966|FG000|Overall Study|Physician Decision|7|||
170794780|NCT02828358|617257967|FG001|Overall Study|Physician Decision|1|||
170794781|NCT02828358|617257966|FG000|Overall Study|Treatment Failure|6|||
170794782|NCT02828358|617257967|FG001|Overall Study|Treatment Failure|0|||
170794783|NCT02828358|617257966|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
170794784|NCT02828358|617257967|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
170794785|NCT02828358|617257966|FG000|Overall Study|Refusal of further protocol therapy|2|||
170794786|NCT02828358|617257967|FG001|Overall Study|Refusal of further protocol therapy|0|||
170794787|NCT02828358|617257966|FG000|Overall Study|Relapse|25|||
170794788|NCT02828358|617257967|FG001|Overall Study|Relapse|0|||
170794789|NCT02828358|617257966|FG000|Overall Study|Still on therapy|5|||
170794790|NCT02828358|617257967|FG001|Overall Study|Still on therapy|0|||
170794791|NCT04479761|617257980|FG000|Overall Study|could not perform the balance tasks|1|||
170794792|NCT04479761|617257981|FG001|Overall Study|could not perform the balance tasks|0|||
170794793|NCT04479761|617257982|FG002|Overall Study|could not perform the balance tasks|0|||
170794794|NCT04479761|617257980|FG000|Overall Study|Adverse Event|1|||
170794795|NCT04479761|617257981|FG001|Overall Study|Adverse Event|0|||
170794796|NCT04479761|617257982|FG002|Overall Study|Adverse Event|0|||
170794797|NCT04479761|617257980|FG000|Overall Study|one control did not meet screening criteria|0|||
170639810|NCT00545272|616693747|FG004|Overall Study|Adverse Event|0|||
170639811|NCT00545272|616693748|FG005|Overall Study|Adverse Event|1|||
170639812|NCT00545272|616693743|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170639813|NCT00545272|616693744|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170639814|NCT00545272|616693745|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170639815|NCT00545272|616693746|FG003|Overall Study|Abnormal laboratory value(s)|0|||
170639816|NCT00545272|616693747|FG004|Overall Study|Abnormal laboratory value(s)|0|||
170639817|NCT00545272|616693748|FG005|Overall Study|Abnormal laboratory value(s)|1|||
170639818|NCT00545272|616693743|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170639819|NCT00545272|616693744|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170639820|NCT00545272|616693745|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170639821|NCT00545272|616693746|FG003|Overall Study|Abnormal test procedure result(s)|0|||
170639822|NCT00545272|616693747|FG004|Overall Study|Abnormal test procedure result(s)|1|||
170639823|NCT00545272|616693748|FG005|Overall Study|Abnormal test procedure result(s)|0|||
170639824|NCT00545272|616693743|FG000|Overall Study|Lost to Follow-up|0|||
170639825|NCT00545272|616693744|FG001|Overall Study|Lost to Follow-up|0|||
170639826|NCT00545272|616693745|FG002|Overall Study|Lost to Follow-up|0|||
170639827|NCT00545272|616693746|FG003|Overall Study|Lost to Follow-up|0|||
170639828|NCT00545272|616693747|FG004|Overall Study|Lost to Follow-up|1|||
170639829|NCT00545272|616693748|FG005|Overall Study|Lost to Follow-up|0|||
170639830|NCT00970684|616693750|FG000|Overall Study|Lack of Efficacy|5|||
170639831|NCT00970684|616693750|FG000|Overall Study|Adverse Event|4|||
170639832|NCT00970684|616693750|FG000|Overall Study|Withdrawal by Subject|1|||
170639833|NCT02527200|616693754|FG000|Overall Study|Withdrawal by Subject|3|||
170639834|NCT02527200|616693755|FG001|Overall Study|Withdrawal by Subject|2|||
170639835|NCT02527200|616693756|FG002|Overall Study|Withdrawal by Subject|1|||
170639836|NCT02527200|616693757|FG003|Overall Study|Withdrawal by Subject|0|||
170639837|NCT02527200|616693754|FG000|Overall Study|Unclassified|0|||
170639838|NCT02527200|616693755|FG001|Overall Study|Unclassified|1|||
170639839|NCT02527200|616693756|FG002|Overall Study|Unclassified|0|||
170639840|NCT02527200|616693757|FG003|Overall Study|Unclassified|0|||
170639841|NCT02527200|616693754|FG000|Overall Study|Lost to Follow-up|0|||
170639842|NCT02527200|616693755|FG001|Overall Study|Lost to Follow-up|0|||
170639843|NCT02527200|616693756|FG002|Overall Study|Lost to Follow-up|1|||
170639844|NCT02527200|616693757|FG003|Overall Study|Lost to Follow-up|0|||
170639845|NCT01652469|616693758|FG000|Overall Study|Withdrawal by Subject|1|||
170639846|NCT01652469|616693759|FG001|Overall Study|Withdrawal by Subject|4|||
170639847|NCT01652469|616693758|FG000|Overall Study|Lost to Follow-up|0|||
170639848|NCT01652469|616693759|FG001|Overall Study|Lost to Follow-up|2|||
170639849|NCT00859638|616693761|FG000|Overall Study|Lost to Follow-up|6|||
170639850|NCT00859638|616693762|FG001|Overall Study|Lost to Follow-up|1|||
170639851|NCT00859638|616693761|FG000|Overall Study|Withdrawal by Subject|3|||
170639852|NCT00859638|616693762|FG001|Overall Study|Withdrawal by Subject|2|||
170639853|NCT00859638|616693761|FG000|Overall Study|Ill health|1|||
170639854|NCT00859638|616693762|FG001|Overall Study|Ill health|1|||
170639855|NCT04643158|616693766|FG000|Overall Study|Study terminated by sponsor|0|||
170639856|NCT04643158|616693767|FG001|Overall Study|Study terminated by sponsor|0|||
170639857|NCT04643158|616693768|FG002|Overall Study|Study terminated by sponsor|1|||
170639858|NCT04643158|616693769|FG003|Overall Study|Study terminated by sponsor|0|||
170639859|NCT04643158|616693770|FG004|Overall Study|Study terminated by sponsor|0|||
170639860|NCT04643158|616693771|FG005|Overall Study|Study terminated by sponsor|1|||
170639861|NCT04643158|616693772|FG006|Overall Study|Study terminated by sponsor|0|||
170639862|NCT04643158|616693766|FG000|Overall Study|Global/country situation|0|||
170639863|NCT04643158|616693767|FG001|Overall Study|Global/country situation|0|||
170639864|NCT04643158|616693768|FG002|Overall Study|Global/country situation|1|||
170639865|NCT04643158|616693769|FG003|Overall Study|Global/country situation|0|||
170639866|NCT04643158|616693770|FG004|Overall Study|Global/country situation|0|||
170794798|NCT04479761|617257981|FG001|Overall Study|one control did not meet screening criteria|0|||
170794799|NCT04479761|617257982|FG002|Overall Study|one control did not meet screening criteria|1|||
170794800|NCT04479761|617257980|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
170895045|NCT00103012|617624193|FG002|Overall Study|Pregnancy|0|||
170639867|NCT04643158|616693771|FG005|Overall Study|Global/country situation|0|||
170639868|NCT04643158|616693772|FG006|Overall Study|Global/country situation|0|||
170639869|NCT04643158|616693766|FG000|Overall Study|Withdrawal by Subject|0|||
170639870|NCT04643158|616693767|FG001|Overall Study|Withdrawal by Subject|0|||
170639871|NCT04643158|616693768|FG002|Overall Study|Withdrawal by Subject|0|||
170639872|NCT04643158|616693769|FG003|Overall Study|Withdrawal by Subject|0|||
170639873|NCT04643158|616693770|FG004|Overall Study|Withdrawal by Subject|0|||
170639874|NCT04643158|616693771|FG005|Overall Study|Withdrawal by Subject|1|||
170639875|NCT04643158|616693772|FG006|Overall Study|Withdrawal by Subject|0|||
170639876|NCT00622440|616693773|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
170639877|NCT00622440|616693774|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
170639878|NCT00622440|616693773|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
170639879|NCT00622440|616693774|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
170895046|NCT00103012|617624191|FG000|Overall Study|Adverse Event|0|||
170547754|NCT04518410|616350251|FG024|Overall Study|Requirement to start alternative therapy|0|||
170794801|NCT04479761|617257981|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
170794802|NCT04479761|617257982|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
170794803|NCT05209152|617257983|FG000|Overall Study|Sponsor decision|1|||
170794804|NCT05209152|617257984|FG001|Overall Study|Sponsor decision|2|||
170794805|NCT05209152|617257983|FG000|Overall Study|Death|3|||
170794806|NCT05209152|617257984|FG001|Overall Study|Death|1|||
170794807|NCT05029622|617259960|FG000|Overall Study|Lost to Follow-up|1|||
170547755|NCT04518410|616350227|FG000|Overall Study|Randomized but not treated|0|||
170547756|NCT04518410|616350228|FG001|Overall Study|Randomized but not treated|0|||
170547757|NCT04518410|616350229|FG002|Overall Study|Randomized but not treated|0|||
170547758|NCT04518410|616350230|FG003|Overall Study|Randomized but not treated|2|||
170547759|NCT04518410|616350231|FG004|Overall Study|Randomized but not treated|6|||
170547760|NCT04518410|616350232|FG005|Overall Study|Randomized but not treated|4|||
170547761|NCT04518410|616350233|FG006|Overall Study|Randomized but not treated|3|||
170547762|NCT04518410|616350234|FG007|Overall Study|Randomized but not treated|3|||
170547763|NCT04518410|616350235|FG008|Overall Study|Randomized but not treated|0|||
170547764|NCT04518410|616350236|FG009|Overall Study|Randomized but not treated|4|||
170547765|NCT04518410|616350237|FG010|Overall Study|Randomized but not treated|0|||
170547766|NCT04518410|616350238|FG011|Overall Study|Randomized but not treated|0|||
170547767|NCT04518410|616350239|FG012|Overall Study|Randomized but not treated|1|||
170547768|NCT04518410|616350240|FG013|Overall Study|Randomized but not treated|3|||
170547769|NCT04518410|616350241|FG014|Overall Study|Randomized but not treated|3|||
170547770|NCT04518410|616350242|FG015|Overall Study|Randomized but not treated|3|||
170547771|NCT04518410|616350243|FG016|Overall Study|Randomized but not treated|4|||
170547772|NCT04518410|616350244|FG017|Overall Study|Randomized but not treated|5|||
170547773|NCT04518410|616350245|FG018|Overall Study|Randomized but not treated|4|||
170547774|NCT04518410|616350246|FG019|Overall Study|Randomized but not treated|0|||
170547775|NCT04518410|616350247|FG020|Overall Study|Randomized but not treated|0|||
170547776|NCT04518410|616350248|FG021|Overall Study|Randomized but not treated|5|||
170547777|NCT04518410|616350249|FG022|Overall Study|Randomized but not treated|0|||
170547778|NCT04518410|616350250|FG023|Overall Study|Randomized but not treated|3|||
170547779|NCT04518410|616350251|FG024|Overall Study|Randomized but not treated|1|||
170547780|NCT04518410|616350227|FG000|Overall Study|Screen Fail but Randomized|0|||
170547781|NCT04518410|616350228|FG001|Overall Study|Screen Fail but Randomized|0|||
170547782|NCT04518410|616350229|FG002|Overall Study|Screen Fail but Randomized|0|||
170547783|NCT04518410|616350230|FG003|Overall Study|Screen Fail but Randomized|0|||
170547784|NCT04518410|616350231|FG004|Overall Study|Screen Fail but Randomized|2|||
170547785|NCT04518410|616350232|FG005|Overall Study|Screen Fail but Randomized|0|||
170547786|NCT04518410|616350233|FG006|Overall Study|Screen Fail but Randomized|0|||
170547787|NCT04518410|616350234|FG007|Overall Study|Screen Fail but Randomized|0|||
170547788|NCT04518410|616350235|FG008|Overall Study|Screen Fail but Randomized|0|||
170547789|NCT04518410|616350236|FG009|Overall Study|Screen Fail but Randomized|0|||
170547790|NCT04518410|616350237|FG010|Overall Study|Screen Fail but Randomized|0|||
170547791|NCT04518410|616350238|FG011|Overall Study|Screen Fail but Randomized|0|||
170547792|NCT04518410|616350239|FG012|Overall Study|Screen Fail but Randomized|0|||
170547793|NCT04518410|616350240|FG013|Overall Study|Screen Fail but Randomized|0|||
170547794|NCT04518410|616350241|FG014|Overall Study|Screen Fail but Randomized|0|||
170547795|NCT04518410|616350242|FG015|Overall Study|Screen Fail but Randomized|0|||
170547796|NCT04518410|616350243|FG016|Overall Study|Screen Fail but Randomized|0|||
170547797|NCT04518410|616350244|FG017|Overall Study|Screen Fail but Randomized|0|||
170547798|NCT04518410|616350245|FG018|Overall Study|Screen Fail but Randomized|0|||
170547799|NCT04518410|616350246|FG019|Overall Study|Screen Fail but Randomized|0|||
170547800|NCT04518410|616350247|FG020|Overall Study|Screen Fail but Randomized|0|||
170547801|NCT04518410|616350248|FG021|Overall Study|Screen Fail but Randomized|0|||
170547802|NCT04518410|616350249|FG022|Overall Study|Screen Fail but Randomized|0|||
170547803|NCT04518410|616350250|FG023|Overall Study|Screen Fail but Randomized|0|||
170547804|NCT04518410|616350251|FG024|Overall Study|Screen Fail but Randomized|0|||
170547805|NCT04518410|616350227|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
170547806|NCT04518410|616350228|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
170547807|NCT04518410|616350229|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
170547808|NCT04518410|616350230|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
170547809|NCT04518410|616350231|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
170547810|NCT04518410|616350232|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
170547811|NCT04518410|616350233|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
170565502|NCT00325143|616418549|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
170794808|NCT04909801|617259963|FG000|Overall Study|Lack of Efficacy|2|||
170565503|NCT00325143|616418549|FG000|Overall Study|Migrated/moved from study area|1|||
170565504|NCT00325143|616418549|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
170480304|NCT02546986|616099293|FG001|Treatment Period|Symptomatic Deterioration|3|||
170794809|NCT04909801|617259964|FG001|Overall Study|Lack of Efficacy|1|||
170794810|NCT04909801|617259963|FG000|Overall Study|Adverse Event|1|||
170794811|NCT04909801|617259964|FG001|Overall Study|Adverse Event|2|||
170794812|NCT04909801|617259963|FG000|Overall Study|Participant request to discontinue study treatment|1|||
170794813|NCT04909801|617259964|FG001|Overall Study|Participant request to discontinue study treatment|2|||
170794814|NCT04909801|617259963|FG000|Overall Study|Withdrawal by Subject|2|||
170794815|NCT04909801|617259964|FG001|Overall Study|Withdrawal by Subject|1|||
170794816|NCT04909801|617259963|FG000|Overall Study|other reasons|1|||
170794817|NCT04909801|617259964|FG001|Overall Study|other reasons|1|||
170794818|NCT05274074|617259965|FG000|Overall Study|Lost to Follow-up|2|||
170794819|NCT05274074|617259966|FG001|Overall Study|Lost to Follow-up|3|||
170794820|NCT05274074|617259965|FG000|Overall Study|Withdrawal by Subject|1|||
170794821|NCT05274074|617259966|FG001|Overall Study|Withdrawal by Subject|2|||
170794822|NCT05194956|617259967|FG000|Washout Period|Withdrawal by Subject|0|||
170794823|NCT05194956|617259968|FG001|Washout Period|Withdrawal by Subject|2|||
170794824|NCT05452460|617259969|FG000|Overall Study|Lost to Follow-up|3|||
170794825|NCT05452460|617259970|FG001|Overall Study|Lost to Follow-up|3|||
170794826|NCT05452460|617259969|FG000|Overall Study|Did not receive intervention|1|||
170794827|NCT05452460|617259970|FG001|Overall Study|Did not receive intervention|0|||
170794828|NCT04447040|617259972|FG000|Overall Study|Lost to Follow-up|2|||
170794829|NCT04447040|617259973|FG001|Overall Study|Lost to Follow-up|1|||
170794830|NCT04447040|617259974|FG002|Overall Study|Lost to Follow-up|3|||
170794831|NCT04447040|617259975|FG003|Overall Study|Lost to Follow-up|3|||
170794832|NCT04447040|617259976|FG004|Overall Study|Lost to Follow-up|1|||
170794833|NCT04447040|617259977|FG005|Overall Study|Lost to Follow-up|3|||
170794834|NCT04447040|617259972|FG000|Overall Study|Withdrawal by Subject|0|||
170794835|NCT04447040|617259973|FG001|Overall Study|Withdrawal by Subject|1|||
170794836|NCT04447040|617259974|FG002|Overall Study|Withdrawal by Subject|1|||
170794837|NCT04447040|617259975|FG003|Overall Study|Withdrawal by Subject|1|||
170794838|NCT04447040|617259976|FG004|Overall Study|Withdrawal by Subject|0|||
170794839|NCT04447040|617259977|FG005|Overall Study|Withdrawal by Subject|0|||
170794840|NCT04359654|617259981|FG000|Overall Study|Withdrawal by Subject|1|||
170794841|NCT04359654|617259982|FG001|Overall Study|Withdrawal by Subject|0|||
170794842|NCT04359654|617259981|FG000|Overall Study|Adverse Event|0|||
170794843|NCT04359654|617259982|FG001|Overall Study|Adverse Event|1|||
170794844|NCT04797195|617260003|FG000|Overall Study|Death|8|||
170794845|NCT04797195|617260004|FG001|Overall Study|Death|15|||
170794846|NCT04797195|617260003|FG000|Overall Study|Change from PD|15|||
170794847|NCT04797195|617260004|FG001|Overall Study|Change from PD|15|||
170794848|NCT04797195|617260003|FG000|Overall Study|Withdrawal by Subject|3|||
170794849|NCT04797195|617260004|FG001|Overall Study|Withdrawal by Subject|2|||
170794850|NCT04197336|617260005|FG000|Overall Study|Withdrawal by Subject|1|||
170794851|NCT04101357|617260006|FG000|Overall Study|Death|1|||
170794852|NCT04101357|617260007|FG001|Overall Study|Death|1|||
170794853|NCT04101357|617260008|FG002|Overall Study|Death|1|||
170794854|NCT04101357|617260009|FG003|Overall Study|Death|2|||
170794855|NCT04101357|617260010|FG004|Overall Study|Death|4|||
170794856|NCT04101357|617260011|FG005|Overall Study|Death|11|||
170794857|NCT04101357|617260012|FG006|Overall Study|Death|4|||
170794858|NCT04101357|617260013|FG007|Overall Study|Death|4|||
170794859|NCT04101357|617260014|FG008|Overall Study|Death|5|||
170794860|NCT04101357|617260015|FG009|Overall Study|Death|2|||
170794861|NCT04101357|617260016|FG010|Overall Study|Death|3|||
170794862|NCT04101357|617260006|FG000|Overall Study|Trial closure|0|||
170794863|NCT04101357|617260007|FG001|Overall Study|Trial closure|0|||
170794864|NCT04101357|617260008|FG002|Overall Study|Trial closure|0|||
170794865|NCT04101357|617260009|FG003|Overall Study|Trial closure|0|||
170794866|NCT04101357|617260010|FG004|Overall Study|Trial closure|0|||
170794867|NCT04101357|617260011|FG005|Overall Study|Trial closure|2|||
170794868|NCT04101357|617260012|FG006|Overall Study|Trial closure|2|||
170794869|NCT04101357|617260013|FG007|Overall Study|Trial closure|0|||
170794870|NCT04101357|617260014|FG008|Overall Study|Trial closure|0|||
170794871|NCT04101357|617260015|FG009|Overall Study|Trial closure|0|||
170794872|NCT04101357|617260016|FG010|Overall Study|Trial closure|1|||
170794873|NCT04101357|617260006|FG000|Overall Study|Lost to Follow-up|0|||
170794874|NCT04101357|617260007|FG001|Overall Study|Lost to Follow-up|0|||
170794875|NCT04101357|617260008|FG002|Overall Study|Lost to Follow-up|0|||
170794876|NCT04101357|617260009|FG003|Overall Study|Lost to Follow-up|1|||
170794877|NCT04101357|617260010|FG004|Overall Study|Lost to Follow-up|0|||
170794878|NCT04101357|617260011|FG005|Overall Study|Lost to Follow-up|0|||
170794879|NCT04101357|617260012|FG006|Overall Study|Lost to Follow-up|0|||
170794880|NCT04101357|617260013|FG007|Overall Study|Lost to Follow-up|1|||
170794881|NCT04101357|617260014|FG008|Overall Study|Lost to Follow-up|0|||
170794882|NCT04101357|617260015|FG009|Overall Study|Lost to Follow-up|0|||
170794883|NCT04101357|617260016|FG010|Overall Study|Lost to Follow-up|0|||
170794884|NCT04101357|617260006|FG000|Overall Study|Withdrawal by Subject|1|||
170794885|NCT04101357|617260007|FG001|Overall Study|Withdrawal by Subject|0|||
170794886|NCT04101357|617260008|FG002|Overall Study|Withdrawal by Subject|0|||
170895047|NCT00103012|617624192|FG001|Overall Study|Adverse Event|0|||
170480305|NCT02546986|616099292|FG000|Treatment Period|Death|3|||
170480306|NCT02546986|616099293|FG001|Treatment Period|Death|4|||
170480307|NCT02546986|616099292|FG000|Treatment Period|Physician Decision|1|||
170480308|NCT02546986|616099293|FG001|Treatment Period|Physician Decision|2|||
170480309|NCT02546986|616099292|FG000|Treatment Period|Protocol Violation|1|||
170480310|NCT02546986|616099293|FG001|Treatment Period|Protocol Violation|0|||
170480311|NCT02546986|616099292|FG000|Treatment Period|Withdrawal by Subject|1|||
170480312|NCT02546986|616099293|FG001|Treatment Period|Withdrawal by Subject|1|||
170480313|NCT02546986|616099292|FG000|Treatment Period|Non-compliance with Study Drug|0|||
170480314|NCT02546986|616099293|FG001|Treatment Period|Non-compliance with Study Drug|1|||
170480315|NCT02546986|616099292|FG000|Treatment Period|Study Terminated by Sponsor|0|||
170480316|NCT02546986|616099293|FG001|Treatment Period|Study Terminated by Sponsor|1|||
170794887|NCT04101357|617260009|FG003|Overall Study|Withdrawal by Subject|0|||
170794888|NCT04101357|617260010|FG004|Overall Study|Withdrawal by Subject|0|||
170794889|NCT04101357|617260011|FG005|Overall Study|Withdrawal by Subject|0|||
170794890|NCT04101357|617260012|FG006|Overall Study|Withdrawal by Subject|0|||
170794891|NCT04101357|617260013|FG007|Overall Study|Withdrawal by Subject|0|||
170794892|NCT04101357|617260014|FG008|Overall Study|Withdrawal by Subject|1|||
170794893|NCT04101357|617260015|FG009|Overall Study|Withdrawal by Subject|1|||
170794894|NCT04101357|617260016|FG010|Overall Study|Withdrawal by Subject|0|||
170794895|NCT04101357|617260006|FG000|Overall Study|Other|0|||
170794896|NCT04101357|617260007|FG001|Overall Study|Other|0|||
170794897|NCT04101357|617260008|FG002|Overall Study|Other|0|||
170794898|NCT04101357|617260009|FG003|Overall Study|Other|0|||
170794899|NCT04101357|617260010|FG004|Overall Study|Other|0|||
170794900|NCT04101357|617260011|FG005|Overall Study|Other|1|||
170794901|NCT04101357|617260012|FG006|Overall Study|Other|2|||
170794902|NCT04101357|617260013|FG007|Overall Study|Other|1|||
170794903|NCT04101357|617260014|FG008|Overall Study|Other|0|||
170794904|NCT04101357|617260015|FG009|Overall Study|Other|0|||
170794905|NCT04101357|617260016|FG010|Overall Study|Other|0|||
170794906|NCT04101357|617260006|FG000|Overall Study|Enrolled but not treated|0|||
170794907|NCT04101357|617260007|FG001|Overall Study|Enrolled but not treated|0|||
170794908|NCT04101357|617260008|FG002|Overall Study|Enrolled but not treated|0|||
170794909|NCT04101357|617260009|FG003|Overall Study|Enrolled but not treated|0|||
170794910|NCT04101357|617260010|FG004|Overall Study|Enrolled but not treated|0|||
170794911|NCT04101357|617260011|FG005|Overall Study|Enrolled but not treated|1|||
170794912|NCT04101357|617260012|FG006|Overall Study|Enrolled but not treated|1|||
170794913|NCT04101357|617260013|FG007|Overall Study|Enrolled but not treated|0|||
170794914|NCT04101357|617260014|FG008|Overall Study|Enrolled but not treated|0|||
170794915|NCT04101357|617260015|FG009|Overall Study|Enrolled but not treated|0|||
170794916|NCT04101357|617260016|FG010|Overall Study|Enrolled but not treated|0|||
170794917|NCT04295512|617260023|FG000|Overall Study|Lack of family response to schedule assessment|0|||
170794918|NCT04295512|617260024|FG001|Overall Study|Lack of family response to schedule assessment|0|||
170794919|NCT04295512|617260025|FG002|Overall Study|Lack of family response to schedule assessment|0|||
170794920|NCT04295512|617260026|FG003|Overall Study|Lack of family response to schedule assessment|2|||
170794921|NCT04295512|617260023|FG000|Overall Study|Therapist did not refer eligible family|7|||
170794922|NCT04295512|617260024|FG001|Overall Study|Therapist did not refer eligible family|7|||
170794923|NCT04295512|617260025|FG002|Overall Study|Therapist did not refer eligible family|0|||
170794924|NCT04295512|617260026|FG003|Overall Study|Therapist did not refer eligible family|0|||
170794925|NCT01309672|617260027|FG000|Overall Study|Lack of Efficacy|20|||
170794926|NCT01309672|617260027|FG000|Overall Study|Other|9|||
170794927|NCT01309672|617260027|FG000|Overall Study|Adverse Event|5|||
170794928|NCT01309672|617260027|FG000|Overall Study|Withdrawal by Subject|3|||
170794929|NCT05090683|617260028|FG000|Overall Study|Lost to Follow-up|10|||
170794930|NCT05090683|617260029|FG001|Overall Study|Lost to Follow-up|2|||
170794931|NCT05090683|617260028|FG000|Overall Study|Withdrawal by Subject|15|||
170794932|NCT05090683|617260029|FG001|Overall Study|Withdrawal by Subject|0|||
170794933|NCT05184452|617260030|FG000|Overall Study|Lost to Follow-up|0|||
170794934|NCT05184452|617260031|FG001|Overall Study|Lost to Follow-up|0|||
170794935|NCT05184452|617260032|FG002|Overall Study|Lost to Follow-up|0|||
170794936|NCT05184452|617260033|FG003|Overall Study|Lost to Follow-up|0|||
170794937|NCT05184452|617260034|FG004|Overall Study|Lost to Follow-up|0|||
170794938|NCT05184452|617260035|FG005|Overall Study|Lost to Follow-up|2|||
170480317|NCT02546986|616099292|FG000|Treatment Period|Miscellaneous|7|||
170480318|NCT02546986|616099293|FG001|Treatment Period|Miscellaneous|9|||
170480319|NCT02546986|616099292|FG000|Survival Follow-Up Phase|Missing Status|3|||
170480320|NCT02546986|616099293|FG001|Survival Follow-Up Phase|Missing Status|5|||
170794939|NCT05184452|617260036|FG006|Overall Study|Lost to Follow-up|0|||
170794940|NCT05184452|617260037|FG007|Overall Study|Lost to Follow-up|0|||
170794941|NCT05184452|617260038|FG008|Overall Study|Lost to Follow-up|0|||
170794942|NCT05184452|617260039|FG009|Overall Study|Lost to Follow-up|1|||
170794943|NCT05184452|617260030|FG000|Overall Study|Withdrawal by Subject|0|||
170794944|NCT05184452|617260031|FG001|Overall Study|Withdrawal by Subject|0|||
170794945|NCT05184452|617260032|FG002|Overall Study|Withdrawal by Subject|0|||
170794946|NCT05184452|617260033|FG003|Overall Study|Withdrawal by Subject|0|||
170794947|NCT05184452|617260034|FG004|Overall Study|Withdrawal by Subject|0|||
170794948|NCT05184452|617260035|FG005|Overall Study|Withdrawal by Subject|1|||
170794949|NCT05184452|617260036|FG006|Overall Study|Withdrawal by Subject|0|||
170794950|NCT05184452|617260037|FG007|Overall Study|Withdrawal by Subject|0|||
170794951|NCT05184452|617260038|FG008|Overall Study|Withdrawal by Subject|0|||
170794952|NCT05184452|617260039|FG009|Overall Study|Withdrawal by Subject|1|||
170794953|NCT05586490|617260040|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
170895048|NCT00103012|617624193|FG002|Overall Study|Adverse Event|1|||
170895049|NCT00103012|617624191|FG000|Overall Study|Subject non-compliant with medications|0|||
170895050|NCT00103012|617624192|FG001|Overall Study|Subject non-compliant with medications|0|||
170895051|NCT00103012|617624193|FG002|Overall Study|Subject non-compliant with medications|1|||
170895052|NCT00393718|617624201|FG000|Overall Study|Adverse Event|20|||
170895053|NCT00393718|617624202|FG001|Overall Study|Adverse Event|8|||
170895054|NCT00393718|617624201|FG000|Overall Study|Protocol Violation|1|||
170895055|NCT00393718|617624202|FG001|Overall Study|Protocol Violation|2|||
170895056|NCT00393718|617624201|FG000|Overall Study|Lack of Efficacy|10|||
170895057|NCT00393718|617624202|FG001|Overall Study|Lack of Efficacy|9|||
170895058|NCT00393718|617624201|FG000|Overall Study|Hypoglycaemia|3|||
170895059|NCT00393718|617624202|FG001|Overall Study|Hypoglycaemia|2|||
170895060|NCT00393718|617624201|FG000|Overall Study|Subject decision|5|||
170895061|NCT00393718|617624202|FG001|Overall Study|Subject decision|0|||
170895062|NCT00393718|617624201|FG000|Overall Study|Withdrawal of consent|2|||
170895063|NCT00393718|617624202|FG001|Overall Study|Withdrawal of consent|1|||
170895064|NCT00393718|617624201|FG000|Overall Study|Missed measurement|1|||
170895065|NCT00393718|617624202|FG001|Overall Study|Missed measurement|0|||
170895066|NCT00393718|617624201|FG000|Overall Study|Move|1|||
170895067|NCT00393718|617624202|FG001|Overall Study|Move|0|||
170895068|NCT01084551|617624204|FG000|Overall Study|Adverse Event|2|||
170895069|NCT01084551|617624205|FG001|Overall Study|Adverse Event|9|||
170895070|NCT01084551|617624206|FG002|Overall Study|Adverse Event|4|||
170895071|NCT01084551|617624204|FG000|Overall Study|Lack of Efficacy|2|||
170895072|NCT01084551|617624205|FG001|Overall Study|Lack of Efficacy|0|||
170895073|NCT01084551|617624206|FG002|Overall Study|Lack of Efficacy|1|||
170895074|NCT01084551|617624204|FG000|Overall Study|Withdrawal by Subject|2|||
170895075|NCT01084551|617624205|FG001|Overall Study|Withdrawal by Subject|1|||
170895076|NCT01084551|617624206|FG002|Overall Study|Withdrawal by Subject|0|||
170895077|NCT01084551|617624204|FG000|Overall Study|Protocol Violation|2|||
170895078|NCT01084551|617624205|FG001|Overall Study|Protocol Violation|4|||
170895079|NCT01084551|617624206|FG002|Overall Study|Protocol Violation|0|||
170895080|NCT01084551|617624204|FG000|Overall Study|Lost to Follow-up|0|||
170895081|NCT01084551|617624205|FG001|Overall Study|Lost to Follow-up|0|||
170895082|NCT01084551|617624206|FG002|Overall Study|Lost to Follow-up|3|||
170895083|NCT01084551|617624204|FG000|Overall Study|Physician Decision|1|||
170895084|NCT01084551|617624205|FG001|Overall Study|Physician Decision|0|||
170895085|NCT01084551|617624206|FG002|Overall Study|Physician Decision|0|||
170895086|NCT03902080|617624207|FG000|Overall Study|Adverse Event|17|||
170895087|NCT03902080|617624208|FG001|Overall Study|Adverse Event|15|||
170895088|NCT03902080|617624207|FG000|Overall Study|Withdrawal by Subject|28|||
170895089|NCT03902080|617624208|FG001|Overall Study|Withdrawal by Subject|35|||
170895090|NCT03902080|617624207|FG000|Overall Study|Lost to Follow-up|6|||
170895091|NCT03902080|617624208|FG001|Overall Study|Lost to Follow-up|7|||
170895092|NCT03902080|617624207|FG000|Overall Study|Other|3|||
170480321|NCT02546986|616099292|FG000|Survival Follow-Up Phase|Death|18|||
170480322|NCT02546986|616099293|FG001|Survival Follow-Up Phase|Death|12|||
170794954|NCT05586490|617260041|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
170895093|NCT03902080|617624208|FG001|Overall Study|Other|5|||
170895094|NCT03902080|617624207|FG000|Overall Study|Non compliance|4|||
170895095|NCT03902080|617624208|FG001|Overall Study|Non compliance|3|||
170895096|NCT03902080|617624207|FG000|Overall Study|Physician Decision|5|||
170895097|NCT03902080|617624208|FG001|Overall Study|Physician Decision|1|||
170895098|NCT03902080|617624207|FG000|Overall Study|Protocol Violation|3|||
170895099|NCT03902080|617624208|FG001|Overall Study|Protocol Violation|3|||
170480323|NCT02546986|616099292|FG000|Survival Follow-Up Phase|Alive|13|||
170794955|NCT05586490|617260042|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
170794956|NCT05586490|617260043|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
170794957|NCT05586490|617260044|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
170794958|NCT05586490|617260040|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
170794959|NCT05586490|617260041|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
170895100|NCT03902080|617624207|FG000|Overall Study|Lack of Efficacy|1|||
170895101|NCT03902080|617624208|FG001|Overall Study|Lack of Efficacy|3|||
170895102|NCT03902080|617624207|FG000|Overall Study|Withdrawn prior to dosing|0|||
170895103|NCT03902080|617624208|FG001|Overall Study|Withdrawn prior to dosing|1|||
170895104|NCT00168831|617624210|FG000|Overall Study|Adverse Event|36|||
170895105|NCT00168831|617624211|FG001|Overall Study|Adverse Event|47|||
170895106|NCT00168831|617624212|FG002|Overall Study|Adverse Event|74|||
170895107|NCT00168831|617624210|FG000|Overall Study|Lost to Follow-up|5|||
170895108|NCT00168831|617624211|FG001|Overall Study|Lost to Follow-up|6|||
170895109|NCT00168831|617624212|FG002|Overall Study|Lost to Follow-up|4|||
170794960|NCT05586490|617260042|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
170794961|NCT05586490|617260043|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
170794962|NCT05586490|617260044|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
170794963|NCT05586490|617260040|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
170794964|NCT05586490|617260041|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
170794965|NCT05586490|617260042|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
170794966|NCT05586490|617260043|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
170794967|NCT05586490|617260044|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
170794968|NCT03556293|617260045|FG000|Overall Study|Ineligible for analysis|1904|||
170794969|NCT03556293|617260046|FG001|Overall Study|Ineligible for analysis|1471|||
170794970|NCT03556293|617260047|FG002|Overall Study|Ineligible for analysis|1091|||
170794971|NCT03556293|617260048|FG003|Overall Study|Ineligible for analysis|1269|||
170794972|NCT05290493|617260055|FG000|Overall Study|Withdrawal by Subject|2|||
170794973|NCT05290493|617260056|FG001|Overall Study|Withdrawal by Subject|2|||
170794974|NCT05290493|617260055|FG000|Overall Study|Adverse Event|1|||
170794975|NCT05290493|617260056|FG001|Overall Study|Adverse Event|0|||
170480324|NCT02546986|616099293|FG001|Survival Follow-Up Phase|Alive|16|||
170480325|NCT02546986|616099292|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
170480326|NCT02546986|616099293|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
170480327|NCT02068508|616099294|FG000|Overall Study|Case report forms uncollected|27|||
170794976|NCT04999111|617260061|FG000|Overall Study|Lost to Follow-up|21|||
170794977|NCT04999111|617260062|FG001|Overall Study|Lost to Follow-up|16|||
170794978|NCT04999111|617260063|FG002|Overall Study|Lost to Follow-up|2|||
170794979|NCT04999111|617260064|FG003|Overall Study|Lost to Follow-up|26|||
170794980|NCT04999111|617260065|FG004|Overall Study|Lost to Follow-up|30|||
170794981|NCT04999111|617260066|FG005|Overall Study|Lost to Follow-up|6|||
170794982|NCT04999111|617260061|FG000|Overall Study|Physician Decision|1|||
170794983|NCT04999111|617260062|FG001|Overall Study|Physician Decision|3|||
170794984|NCT04999111|617260063|FG002|Overall Study|Physician Decision|0|||
170794985|NCT04999111|617260064|FG003|Overall Study|Physician Decision|1|||
170794986|NCT04999111|617260065|FG004|Overall Study|Physician Decision|2|||
170794987|NCT04999111|617260066|FG005|Overall Study|Physician Decision|0|||
170794988|NCT04999111|617260061|FG000|Overall Study|Withdrawal by Subject|23|||
170794989|NCT04999111|617260062|FG001|Overall Study|Withdrawal by Subject|29|||
170794990|NCT04999111|617260063|FG002|Overall Study|Withdrawal by Subject|15|||
170794991|NCT04999111|617260064|FG003|Overall Study|Withdrawal by Subject|30|||
170794992|NCT04999111|617260065|FG004|Overall Study|Withdrawal by Subject|35|||
170794993|NCT04999111|617260066|FG005|Overall Study|Withdrawal by Subject|10|||
170794994|NCT04999111|617260061|FG000|Overall Study|Other|6|||
170794995|NCT04999111|617260062|FG001|Overall Study|Other|6|||
170794996|NCT04999111|617260063|FG002|Overall Study|Other|3|||
170794997|NCT04999111|617260064|FG003|Overall Study|Other|8|||
170794998|NCT04999111|617260065|FG004|Overall Study|Other|8|||
170794999|NCT04999111|617260066|FG005|Overall Study|Other|5|||
170795000|NCT04999111|617260061|FG000|Overall Study|Non-compliance with study schedule|1|||
170795001|NCT04999111|617260062|FG001|Overall Study|Non-compliance with study schedule|0|||
170795002|NCT04999111|617260063|FG002|Overall Study|Non-compliance with study schedule|0|||
170795003|NCT04999111|617260064|FG003|Overall Study|Non-compliance with study schedule|1|||
170795004|NCT04999111|617260065|FG004|Overall Study|Non-compliance with study schedule|1|||
170795005|NCT04999111|617260066|FG005|Overall Study|Non-compliance with study schedule|1|||
170795006|NCT04999111|617260061|FG000|Overall Study|Randomized but not vaccinated|1|||
170795007|NCT04999111|617260062|FG001|Overall Study|Randomized but not vaccinated|2|||
170795008|NCT04999111|617260063|FG002|Overall Study|Randomized but not vaccinated|0|||
170795009|NCT04999111|617260064|FG003|Overall Study|Randomized but not vaccinated|3|||
170795010|NCT04999111|617260065|FG004|Overall Study|Randomized but not vaccinated|3|||
170795011|NCT04999111|617260066|FG005|Overall Study|Randomized but not vaccinated|0|||
170795012|NCT04999111|617260061|FG000|Overall Study|Adverse Event|1|||
170795013|NCT04999111|617260062|FG001|Overall Study|Adverse Event|1|||
170795014|NCT04999111|617260063|FG002|Overall Study|Adverse Event|0|||
170795015|NCT04999111|617260064|FG003|Overall Study|Adverse Event|0|||
170795016|NCT04999111|617260065|FG004|Overall Study|Adverse Event|0|||
170795017|NCT04999111|617260066|FG005|Overall Study|Adverse Event|0|||
170480328|NCT02068508|616099294|FG000|Overall Study|Patient did not visit the study site|1|||
170480329|NCT02068508|616099294|FG000|Overall Study|Protocol Violation|4|||
170480330|NCT01470248|616099295|FG000|Overall Study|Withdrawal by Subject|1|||
170795018|NCT04999111|617260061|FG000|Overall Study|Initiated prohibited medication|0|||
170795019|NCT04999111|617260062|FG001|Overall Study|Initiated prohibited medication|0|||
170795020|NCT04999111|617260063|FG002|Overall Study|Initiated prohibited medication|0|||
170795021|NCT04999111|617260064|FG003|Overall Study|Initiated prohibited medication|0|||
170795022|NCT04999111|617260065|FG004|Overall Study|Initiated prohibited medication|1|||
170795023|NCT04999111|617260066|FG005|Overall Study|Initiated prohibited medication|0|||
170795024|NCT02631746|617260073|FG000|Overall Study|Lack of Efficacy|3|||
170795025|NCT02361216|617260075|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
170795026|NCT02361216|617260076|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
170895110|NCT00168831|617624210|FG000|Overall Study|Withdrawal by Subject|7|||
170895111|NCT00168831|617624211|FG001|Overall Study|Withdrawal by Subject|14|||
170895112|NCT00168831|617624212|FG002|Overall Study|Withdrawal by Subject|19|||
170895113|NCT00168831|617624210|FG000|Overall Study|Protocol Violation|6|||
170895114|NCT00168831|617624211|FG001|Overall Study|Protocol Violation|11|||
170895115|NCT00168831|617624212|FG002|Overall Study|Protocol Violation|11|||
170895116|NCT00168831|617624210|FG000|Overall Study|Other|6|||
170895117|NCT00168831|617624211|FG001|Overall Study|Other|3|||
170895118|NCT00168831|617624212|FG002|Overall Study|Other|6|||
170895119|NCT01622569|617624214|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
170895120|NCT01622569|617624215|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
170895121|NCT01622569|617624216|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
170895122|NCT01622569|617624217|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
170895123|NCT01622569|617624214|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
170895124|NCT01622569|617624215|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
170895125|NCT01622569|617624216|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
170895126|NCT01622569|617624217|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
170895127|NCT01622569|617624214|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
170895128|NCT01622569|617624215|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
170895129|NCT01622569|617624216|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
170895130|NCT01622569|617624217|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
170895131|NCT01622569|617624214|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
170895132|NCT01622569|617624215|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
170895133|NCT01622569|617624216|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
170895134|NCT01622569|617624217|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
170895135|NCT01622569|617624214|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
170895136|NCT01622569|617624215|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
170895137|NCT01622569|617624216|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
170480331|NCT00711243|616099296|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
170480332|NCT00711243|616099297|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
170480333|NCT00711243|616099298|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
170480334|NCT00711243|616099299|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
170480335|NCT00711243|616099300|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
170480336|NCT00711243|616099301|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
170480337|NCT00711243|616099296|FG000|Reached First Response/4 Cycles|Death|0|||
170480338|NCT00711243|616099297|FG001|Reached First Response/4 Cycles|Death|0|||
170480339|NCT00711243|616099298|FG002|Reached First Response/4 Cycles|Death|0|||
170480340|NCT00711243|616099299|FG003|Reached First Response/4 Cycles|Death|0|||
170480341|NCT00711243|616099300|FG004|Reached First Response/4 Cycles|Death|0|||
170480342|NCT00711243|616099301|FG005|Reached First Response/4 Cycles|Death|2|||
170480343|NCT00711243|616099296|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
170480344|NCT00711243|616099297|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
170480345|NCT00711243|616099298|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
170480346|NCT00711243|616099299|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
170480347|NCT00711243|616099300|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
170480348|NCT00711243|616099301|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
170480349|NCT00711243|616099296|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
170547812|NCT04518410|616350234|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
170480350|NCT00711243|616099297|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
170480351|NCT00711243|616099298|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
170480352|NCT00711243|616099299|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
170547813|NCT04518410|616350235|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
170547814|NCT04518410|616350236|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
170547815|NCT04518410|616350237|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
170895138|NCT01622569|617624217|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
170895139|NCT01622569|617624214|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
170895140|NCT01622569|617624215|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
170895141|NCT01622569|617624216|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
170895142|NCT01622569|617624217|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
170895143|NCT01622569|617624214|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
170895144|NCT01622569|617624215|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
170895145|NCT01622569|617624216|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
170480353|NCT00711243|616099300|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
170480354|NCT00711243|616099301|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
170480355|NCT00711243|616099296|FG000|Treated Cycle 5 After First Response|Death|0|||
170480356|NCT00711243|616099297|FG001|Treated Cycle 5 After First Response|Death|0|||
170895146|NCT01622569|617624217|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
170895147|NCT01622569|617624214|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
170895148|NCT01622569|617624215|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
170895149|NCT01622569|617624216|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
170895150|NCT01622569|617624217|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
170895151|NCT04173741|617624218|FG000|Overall Study|IVC measurement cannot be done|1|||
170895152|NCT04173741|617624219|FG001|Overall Study|IVC measurement cannot be done|1|||
170895153|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895154|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
170895155|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895156|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895157|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895158|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
170895159|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
170895160|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
170895161|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
170895162|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
170895163|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
170895164|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
170895165|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
170895166|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
170895167|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
170895168|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
170895169|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
170895170|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
170895171|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
170895172|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
170895173|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895174|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895175|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895176|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
170895177|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895178|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
170895179|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
170895180|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
170895181|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
170895182|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
170895183|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
170895184|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
170895185|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
170895186|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
170895187|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
170895188|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
170895189|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
170895190|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
170895191|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
170895192|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
170895193|NCT00289913|617624220|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
170895194|NCT00289913|617624221|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
170480357|NCT00711243|616099298|FG002|Treated Cycle 5 After First Response|Death|0|||
170480358|NCT00711243|616099299|FG003|Treated Cycle 5 After First Response|Death|0|||
170480359|NCT00711243|616099300|FG004|Treated Cycle 5 After First Response|Death|0|||
170480360|NCT00711243|616099301|FG005|Treated Cycle 5 After First Response|Death|2|||
170480361|NCT00711243|616099296|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
170480362|NCT00711243|616099297|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
170480363|NCT00711243|616099298|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
170565505|NCT00325143|616418549|FG000|Overall Study|Withdrawal by Subject|8|||
170480364|NCT00711243|616099299|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
170565506|NCT02286895|616418550|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
170480365|NCT00711243|616099300|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
170480366|NCT00711243|616099301|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
170480367|NCT00711243|616099296|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
170480368|NCT00711243|616099297|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
170480369|NCT00711243|616099298|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
170480370|NCT00711243|616099299|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
170480371|NCT00711243|616099300|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
170480372|NCT00711243|616099301|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
170480373|NCT01823328|616099302|FG000|Overall Study|Withdrawal by Subject|8|||
170480374|NCT01823328|616099303|FG001|Overall Study|Withdrawal by Subject|6|||
170480375|NCT04173507|616099304|FG000|Overall Study|On Treatment|3|||
170480376|NCT04173507|616099304|FG000|Overall Study|Adverse Event|3|||
170480377|NCT04173507|616099304|FG000|Overall Study|Progression/Relapse|34|||
170480378|NCT04173507|616099304|FG000|Overall Study|Death|2|||
170480379|NCT01402570|616099305|FG000|Overall Study|Adverse Event|1|||
170480380|NCT02832687|616099308|FG000|Overall Study|Adverse Event|0|||
170480381|NCT02832687|616099309|FG001|Overall Study|Adverse Event|2|||
170480382|NCT01662635|616099310|FG000|Overall Study|scarce samples for evaluation|30|||
170480383|NCT02019472|616099311|FG000|Overall Study|Adverse Event|14|||
170480384|NCT02019472|616099312|FG001|Overall Study|Adverse Event|23|||
170480385|NCT02019472|616099313|FG002|Overall Study|Adverse Event|17|||
170480386|NCT02019472|616099311|FG000|Overall Study|Death|0|||
170480387|NCT02019472|616099312|FG001|Overall Study|Death|1|||
170480388|NCT02019472|616099313|FG002|Overall Study|Death|1|||
170480389|NCT02019472|616099311|FG000|Overall Study|Lack of Efficacy|7|||
170480390|NCT02019472|616099312|FG001|Overall Study|Lack of Efficacy|4|||
170480391|NCT02019472|616099313|FG002|Overall Study|Lack of Efficacy|4|||
170480392|NCT02019472|616099311|FG000|Overall Study|Lost to Follow-up|0|||
170480393|NCT02019472|616099312|FG001|Overall Study|Lost to Follow-up|2|||
170480394|NCT02019472|616099313|FG002|Overall Study|Lost to Follow-up|1|||
170480395|NCT02019472|616099311|FG000|Overall Study|Physician Decision|1|||
170480396|NCT02019472|616099312|FG001|Overall Study|Physician Decision|2|||
170480397|NCT02019472|616099313|FG002|Overall Study|Physician Decision|0|||
170480398|NCT02019472|616099311|FG000|Overall Study|Pregnancy|1|||
170480399|NCT02019472|616099312|FG001|Overall Study|Pregnancy|2|||
170480400|NCT02019472|616099313|FG002|Overall Study|Pregnancy|2|||
170480401|NCT02019472|616099311|FG000|Overall Study|Withdrawal by Subject|11|||
170480402|NCT02019472|616099312|FG001|Overall Study|Withdrawal by Subject|10|||
170480403|NCT02019472|616099313|FG002|Overall Study|Withdrawal by Subject|11|||
170480404|NCT02019472|616099311|FG000|Overall Study|Other|3|||
170480405|NCT02019472|616099312|FG001|Overall Study|Other|8|||
170480406|NCT02019472|616099313|FG002|Overall Study|Other|6|||
170480407|NCT00513695|616099316|FG000|Overall Study|Discontinued therapy|2|||
170480408|NCT00513695|616099316|FG000|Overall Study|Progression prior to surgery|3|||
170480409|NCT03192488|616099317|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
170480410|NCT03192488|616099318|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
170639880|NCT00622440|616693773|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
170480411|NCT03192488|616099319|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
170480412|NCT03192488|616099320|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
170480413|NCT03192488|616099321|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
170480414|NCT03192488|616099322|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
170480415|NCT03192488|616099317|FG000|Third Intervention (d1)|Adverse Event|0|||
170480416|NCT03192488|616099318|FG001|Third Intervention (d1)|Adverse Event|0|||
170480417|NCT03192488|616099319|FG002|Third Intervention (d1)|Adverse Event|0|||
170480418|NCT03192488|616099320|FG003|Third Intervention (d1)|Adverse Event|0|||
170480419|NCT03192488|616099321|FG004|Third Intervention (d1)|Adverse Event|1|||
170480420|NCT03192488|616099322|FG005|Third Intervention (d1)|Adverse Event|0|||
170480421|NCT00318474|616099323|FG000|Overall Study|Adverse Event|1|||
170480422|NCT00318474|616099324|FG001|Overall Study|Adverse Event|1|||
170480423|NCT00318474|616099323|FG000|Overall Study|Lost to Follow-up|0|||
170480424|NCT00318474|616099324|FG001|Overall Study|Lost to Follow-up|1|||
170480425|NCT00318474|616099323|FG000|Overall Study|Pregnancy|0|||
170480426|NCT00318474|616099324|FG001|Overall Study|Pregnancy|2|||
170480427|NCT00318474|616099323|FG000|Overall Study|Protocol Violation|1|||
170480428|NCT00318474|616099324|FG001|Overall Study|Protocol Violation|0|||
170480429|NCT00318474|616099323|FG000|Overall Study|Withdrawal by Subject|3|||
170480430|NCT00318474|616099324|FG001|Overall Study|Withdrawal by Subject|2|||
170480431|NCT00318474|616099323|FG000|Overall Study|Fall in GFR|3|||
170480432|NCT00318474|616099324|FG001|Overall Study|Fall in GFR|3|||
170480433|NCT00318474|616099323|FG000|Overall Study|Post-therapy hyperflycemia|0|||
170480434|NCT00318474|616099324|FG001|Overall Study|Post-therapy hyperflycemia|1|||
170480435|NCT00318474|616099323|FG000|Overall Study|Trial terminated|10|||
170480436|NCT00318474|616099324|FG001|Overall Study|Trial terminated|7|||
170480437|NCT02844933|616099325|FG000|Overall Study|Discontinued due to premature termination of study|3|||
170480438|NCT02844933|616099326|FG001|Overall Study|Discontinued due to premature termination of study|2|||
170480439|NCT01479465|616099327|FG000|Overall Study|Disease Progression|9|||
170480440|NCT01479465|616099328|FG001|Overall Study|Disease Progression|61|||
170480441|NCT01479465|616099329|FG002|Overall Study|Disease Progression|65|||
170480442|NCT01479465|616099330|FG003|Overall Study|Disease Progression|70|||
170480443|NCT01479465|616099327|FG000|Overall Study|Study Discontinued by Sponsor|0|||
170480444|NCT01479465|616099328|FG001|Overall Study|Study Discontinued by Sponsor|7|||
170480445|NCT01479465|616099329|FG002|Overall Study|Study Discontinued by Sponsor|5|||
170480446|NCT01479465|616099330|FG003|Overall Study|Study Discontinued by Sponsor|3|||
170480447|NCT01479465|616099327|FG000|Overall Study|Adverse Event|0|||
170480448|NCT01479465|616099328|FG001|Overall Study|Adverse Event|3|||
170480449|NCT01479465|616099329|FG002|Overall Study|Adverse Event|6|||
170480450|NCT01479465|616099330|FG003|Overall Study|Adverse Event|4|||
170480451|NCT01479465|616099327|FG000|Overall Study|Investigator Discretion|1|||
170480452|NCT01479465|616099328|FG001|Overall Study|Investigator Discretion|4|||
170480453|NCT01479465|616099329|FG002|Overall Study|Investigator Discretion|2|||
170480454|NCT01479465|616099330|FG003|Overall Study|Investigator Discretion|4|||
170480455|NCT01479465|616099327|FG000|Overall Study|Subject Request|1|||
170480456|NCT01479465|616099328|FG001|Overall Study|Subject Request|3|||
170480457|NCT01479465|616099329|FG002|Overall Study|Subject Request|4|||
170480458|NCT01479465|616099330|FG003|Overall Study|Subject Request|2|||
170480459|NCT01479465|616099327|FG000|Overall Study|Subject Withdrew Consent|0|||
170480460|NCT01479465|616099328|FG001|Overall Study|Subject Withdrew Consent|5|||
170480461|NCT01479465|616099329|FG002|Overall Study|Subject Withdrew Consent|2|||
170480462|NCT01479465|616099330|FG003|Overall Study|Subject Withdrew Consent|1|||
170480463|NCT01479465|616099327|FG000|Overall Study|Protocol Violation|0|||
170480464|NCT01479465|616099328|FG001|Overall Study|Protocol Violation|1|||
170480465|NCT01479465|616099329|FG002|Overall Study|Protocol Violation|1|||
170480466|NCT01479465|616099330|FG003|Overall Study|Protocol Violation|0|||
170480467|NCT01479465|616099327|FG000|Overall Study|Death|0|||
170480468|NCT01479465|616099328|FG001|Overall Study|Death|0|||
170480469|NCT01479465|616099329|FG002|Overall Study|Death|0|||
170480470|NCT01479465|616099330|FG003|Overall Study|Death|1|||
170480471|NCT01479465|616099327|FG000|Overall Study|Lost to Follow-up|0|||
170480472|NCT01479465|616099328|FG001|Overall Study|Lost to Follow-up|0|||
170480473|NCT01479465|616099329|FG002|Overall Study|Lost to Follow-up|1|||
170480474|NCT01479465|616099330|FG003|Overall Study|Lost to Follow-up|0|||
170480475|NCT02502149|616099332|FG000|Intermediate|Discontinued prematurely|1|||
170480476|NCT02502149|616099333|FG001|Intermediate|Discontinued prematurely|0|||
170547816|NCT04518410|616350238|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
170547817|NCT04518410|616350239|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
170547818|NCT04518410|616350240|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
170547819|NCT04518410|616350241|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
170547820|NCT04518410|616350242|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
170639881|NCT00622440|616693774|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
170480477|NCT02502149|616099334|FG002|Intermediate|Discontinued prematurely|0|||
170480478|NCT02502149|616099335|FG003|Intermediate|Discontinued prematurely|0|||
170480479|NCT02502149|616099336|FG004|Intermediate|Discontinued prematurely|0|||
170480480|NCT03359850|616099340|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
170480481|NCT03359850|616099341|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
170480482|NCT03359850|616099340|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
170480483|NCT03359850|616099341|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
170480484|NCT03359850|616099340|FG000|Extension Phase (Up to 28 Months)|Death|2|||
170480485|NCT03359850|616099341|FG001|Extension Phase (Up to 28 Months)|Death|4|||
170480486|NCT03359850|616099340|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
170480487|NCT03359850|616099341|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
170480488|NCT03359850|616099340|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
170480489|NCT03359850|616099341|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
170480490|NCT03817125|616099361|FG000|Overall Study|Adverse Event|1|||
170480491|NCT03817125|616099362|FG001|Overall Study|Adverse Event|0|||
170480492|NCT03817125|616099361|FG000|Overall Study|Physician Decision|0|||
170480493|NCT03817125|616099362|FG001|Overall Study|Physician Decision|1|||
170480494|NCT03817125|616099361|FG000|Overall Study|Lack of Efficacy|1|||
170480495|NCT03817125|616099362|FG001|Overall Study|Lack of Efficacy|5|||
170480496|NCT02002221|616099363|FG000|Overall Study|Adverse Event|2|||
170480497|NCT02002221|616099364|FG001|Overall Study|Adverse Event|1|||
170480498|NCT02002221|616099363|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170480499|NCT02002221|616099364|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170480500|NCT02002221|616099363|FG000|Overall Study|Patient withdrew consent|0|||
170480501|NCT02002221|616099364|FG001|Overall Study|Patient withdrew consent|1|||
170480502|NCT01062425|616099365|FG000|Overall Study|Protocol Violation|3|||
170480503|NCT01062425|616099366|FG001|Overall Study|Protocol Violation|6|||
170480504|NCT02088177|616099367|FG000|Overall Study|Lost to Follow-up|3|||
170480505|NCT01234350|616099368|FG000|Overall Study|Adverse Event|277|||
170480506|NCT01234350|616099369|FG001|Overall Study|Adverse Event|92|||
170480507|NCT01234350|616099368|FG000|Overall Study|Withdrawal by Subject|61|||
170480508|NCT01234350|616099369|FG001|Overall Study|Withdrawal by Subject|36|||
170480509|NCT01234350|616099368|FG000|Overall Study|Lost to Follow-up|115|||
170480510|NCT01234350|616099369|FG001|Overall Study|Lost to Follow-up|47|||
170480511|NCT01234350|616099368|FG000|Overall Study|Covers a diverse set of reasons|234|||
170480512|NCT01234350|616099369|FG001|Overall Study|Covers a diverse set of reasons|92|||
170480513|NCT00289848|616099370|FG000|Overall Study|Adverse Event|6|||
170480514|NCT00289848|616099371|FG001|Overall Study|Adverse Event|4|||
170480515|NCT00289848|616099370|FG000|Overall Study|Death|1|||
170480516|NCT00289848|616099371|FG001|Overall Study|Death|0|||
170480517|NCT00289848|616099370|FG000|Overall Study|Lack of Efficacy|20|||
170480518|NCT00289848|616099371|FG001|Overall Study|Lack of Efficacy|24|||
170480519|NCT00289848|616099370|FG000|Overall Study|Lost to Follow-up|3|||
170480520|NCT00289848|616099371|FG001|Overall Study|Lost to Follow-up|1|||
170480521|NCT00289848|616099370|FG000|Overall Study|Protocol Violation|5|||
170480522|NCT00289848|616099371|FG001|Overall Study|Protocol Violation|2|||
170480523|NCT00289848|616099370|FG000|Overall Study|Withdrawal by Subject|5|||
170480524|NCT00289848|616099371|FG001|Overall Study|Withdrawal by Subject|11|||
170480525|NCT00289848|616099370|FG000|Overall Study|Patient Moved|6|||
170480526|NCT00289848|616099371|FG001|Overall Study|Patient Moved|2|||
170480527|NCT00289848|616099370|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
170480528|NCT00289848|616099371|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
170480529|NCT00063934|616099376|FG000|Overall Study|Ineligible|1|||
170480530|NCT04341363|616099377|FG000|Overall Study|Adverse Event|1|||
170480531|NCT04341363|616099377|FG000|Overall Study|Withdrawal by Subject|1|||
170480532|NCT03428152|616099378|FG000|Overall Study|Physician Decision|4|||
170480533|NCT03428152|616099379|FG001|Overall Study|Physician Decision|2|||
170480534|NCT03428152|616099378|FG000|Overall Study|Protocol Violation|3|||
170480535|NCT03428152|616099379|FG001|Overall Study|Protocol Violation|5|||
170480536|NCT03428152|616099378|FG000|Overall Study|Lack of Efficacy|0|||
170480537|NCT03428152|616099379|FG001|Overall Study|Lack of Efficacy|4|||
170480538|NCT00395629|616099380|FG000|Core Study|Adverse Event|0|||
170480539|NCT00395629|616099381|FG001|Core Study|Adverse Event|3|||
170480540|NCT00395629|616099382|FG002|Core Study|Adverse Event|4|||
170480541|NCT00395629|616099380|FG000|Core Study|Abnormal laboratory value(s)|0|||
170480542|NCT00395629|616099381|FG001|Core Study|Abnormal laboratory value(s)|0|||
170480543|NCT00395629|616099382|FG002|Core Study|Abnormal laboratory value(s)|1|||
170480544|NCT00395629|616099380|FG000|Core Study|Protocol Violation|1|||
170480545|NCT00395629|616099381|FG001|Core Study|Protocol Violation|0|||
170480546|NCT00395629|616099382|FG002|Core Study|Protocol Violation|0|||
170480547|NCT00395629|616099380|FG000|Core Study|Withdrawal by Subject|0|||
170480548|NCT00395629|616099381|FG001|Core Study|Withdrawal by Subject|1|||
170480549|NCT00395629|616099382|FG002|Core Study|Withdrawal by Subject|1|||
170480550|NCT00395629|616099380|FG000|Core Study|Lost to Follow-up|0|||
170480551|NCT00395629|616099381|FG001|Core Study|Lost to Follow-up|0|||
170480552|NCT00395629|616099382|FG002|Core Study|Lost to Follow-up|1|||
170480553|NCT00395629|616099380|FG000|Extension Study|Adverse Event|0|||
170480554|NCT00395629|616099381|FG001|Extension Study|Adverse Event|0|||
170480555|NCT00395629|616099382|FG002|Extension Study|Adverse Event|2|||
170480556|NCT00395629|616099380|FG000|Extension Study|Administrative problems|0|||
170480557|NCT00395629|616099381|FG001|Extension Study|Administrative problems|0|||
170480558|NCT00395629|616099382|FG002|Extension Study|Administrative problems|1|||
170480559|NCT01686373|616099383|FG000|Overall Study|Lost to Follow-up|3|||
170480560|NCT01686373|616099384|FG001|Overall Study|Lost to Follow-up|0|||
170639882|NCT00622440|616693773|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
170480561|NCT01686373|616099383|FG000|Overall Study|Withdrawal by Subject|0|||
170480562|NCT01686373|616099384|FG001|Overall Study|Withdrawal by Subject|1|||
170480563|NCT01686373|616099383|FG000|Overall Study|Adverse Event|0|||
170480564|NCT01686373|616099384|FG001|Overall Study|Adverse Event|1|||
170480565|NCT01836471|616099391|FG000|Overall Study|Pregnancy|1|||
170480566|NCT01836471|616099392|FG001|Overall Study|Pregnancy|0|||
170480567|NCT01836471|616099393|FG002|Overall Study|Pregnancy|0|||
170480568|NCT01836471|616099394|FG003|Overall Study|Pregnancy|0|||
170480569|NCT01836471|616099395|FG004|Overall Study|Pregnancy|0|||
170480570|NCT01836471|616099391|FG000|Overall Study|Withdrawal by Subject|3|||
170480571|NCT01836471|616099392|FG001|Overall Study|Withdrawal by Subject|4|||
170480572|NCT01836471|616099393|FG002|Overall Study|Withdrawal by Subject|1|||
170480573|NCT01836471|616099394|FG003|Overall Study|Withdrawal by Subject|0|||
170480574|NCT01836471|616099395|FG004|Overall Study|Withdrawal by Subject|2|||
170480575|NCT01836471|616099391|FG000|Overall Study|Physician Decision|0|||
170480576|NCT01836471|616099392|FG001|Overall Study|Physician Decision|1|||
170480577|NCT01836471|616099393|FG002|Overall Study|Physician Decision|0|||
170480578|NCT01836471|616099394|FG003|Overall Study|Physician Decision|0|||
170480579|NCT01836471|616099395|FG004|Overall Study|Physician Decision|0|||
170480580|NCT01836471|616099391|FG000|Overall Study|Lost to Follow-up|0|||
170480581|NCT01836471|616099392|FG001|Overall Study|Lost to Follow-up|0|||
170480582|NCT01836471|616099393|FG002|Overall Study|Lost to Follow-up|0|||
170480583|NCT01836471|616099394|FG003|Overall Study|Lost to Follow-up|1|||
170480584|NCT01836471|616099395|FG004|Overall Study|Lost to Follow-up|1|||
170480585|NCT01836471|616099391|FG000|Overall Study|Adverse Event|6|||
170480586|NCT01836471|616099392|FG001|Overall Study|Adverse Event|3|||
170480587|NCT01836471|616099393|FG002|Overall Study|Adverse Event|1|||
170480588|NCT01836471|616099394|FG003|Overall Study|Adverse Event|1|||
170547821|NCT04518410|616350243|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
170547822|NCT04518410|616350244|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
170547823|NCT04518410|616350245|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
170565507|NCT02286895|616418551|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
170480589|NCT01836471|616099395|FG004|Overall Study|Adverse Event|2|||
170480590|NCT01836471|616099391|FG000|Overall Study|Non compliance with tx|1|||
170480591|NCT01836471|616099392|FG001|Overall Study|Non compliance with tx|1|||
170480592|NCT01836471|616099393|FG002|Overall Study|Non compliance with tx|0|||
170480593|NCT01836471|616099394|FG003|Overall Study|Non compliance with tx|0|||
170480594|NCT01836471|616099395|FG004|Overall Study|Non compliance with tx|0|||
170480595|NCT02570308|616099401|FG000|Overall Study|Death|1|||
170480596|NCT02570308|616099402|FG001|Overall Study|Death|5|||
170480597|NCT02570308|616099403|FG002|Overall Study|Death|4|||
170480598|NCT02570308|616099404|FG003|Overall Study|Death|4|||
170480599|NCT02570308|616099405|FG004|Overall Study|Death|69|||
170480600|NCT02570308|616099401|FG000|Overall Study|Lost to Follow-up|0|||
170480601|NCT02570308|616099402|FG001|Overall Study|Lost to Follow-up|0|||
170480602|NCT02570308|616099403|FG002|Overall Study|Lost to Follow-up|0|||
170480603|NCT02570308|616099404|FG003|Overall Study|Lost to Follow-up|0|||
170480604|NCT02570308|616099405|FG004|Overall Study|Lost to Follow-up|2|||
170480605|NCT02570308|616099401|FG000|Overall Study|Withdrawal by Subject|0|||
170480606|NCT02570308|616099402|FG001|Overall Study|Withdrawal by Subject|0|||
170480607|NCT02570308|616099403|FG002|Overall Study|Withdrawal by Subject|0|||
170480608|NCT02570308|616099404|FG003|Overall Study|Withdrawal by Subject|0|||
170480609|NCT02570308|616099405|FG004|Overall Study|Withdrawal by Subject|1|||
170480610|NCT02570308|616099401|FG000|Overall Study|Other|0|||
170480611|NCT02570308|616099402|FG001|Overall Study|Other|0|||
170480612|NCT02570308|616099403|FG002|Overall Study|Other|0|||
170480613|NCT02570308|616099404|FG003|Overall Study|Other|0|||
170480614|NCT02570308|616099405|FG004|Overall Study|Other|2|||
170480615|NCT01960413|616099406|FG000|Overall Study|Withdrawal by Subject|1|||
170480616|NCT01960413|616099407|FG001|Overall Study|Withdrawal by Subject|1|||
170480617|NCT01960413|616099406|FG000|Overall Study|Physician Decision|1|||
170480618|NCT01960413|616099407|FG001|Overall Study|Physician Decision|0|||
170480619|NCT01960413|616099406|FG000|Overall Study|Lost to Follow-up|2|||
170480620|NCT01960413|616099407|FG001|Overall Study|Lost to Follow-up|0|||
170480621|NCT02285361|616099408|FG000|Overall Study|Protocol Violation|43|||
170480622|NCT02285361|616099408|FG000|Overall Study|Lost to Follow-up|5|||
170480623|NCT02285361|616099408|FG000|Overall Study|Not taken GIOTRIF|2|||
170480624|NCT02285361|616099408|FG000|Overall Study|Consented prior to the contract date|1|||
170480625|NCT01283464|616099409|FG000|Overall Study|Lost to Follow-up|0|||
170480626|NCT01283464|616099410|FG001|Overall Study|Lost to Follow-up|1|||
170480627|NCT01283464|616099409|FG000|Overall Study|Withdrawal by Subject|1|||
170480628|NCT01283464|616099410|FG001|Overall Study|Withdrawal by Subject|0|||
170480629|NCT01283464|616099409|FG000|Overall Study|Physician Decision|1|||
170480630|NCT01283464|616099410|FG001|Overall Study|Physician Decision|0|||
170480631|NCT02059135|616099411|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
170480632|NCT02059135|616099412|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
170480633|NCT02059135|616099411|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
170480634|NCT02059135|616099412|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
170480635|NCT02059135|616099411|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
170480636|NCT02059135|616099412|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
170547824|NCT04518410|616350246|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
170547825|NCT04518410|616350247|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
170547826|NCT04518410|616350248|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
170547827|NCT04518410|616350249|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
170547828|NCT04518410|616350250|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
170547829|NCT04518410|616350251|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
170547830|NCT04518410|616350227|FG000|Overall Study|Dual Enrolled Subject|0|||
170547831|NCT04518410|616350228|FG001|Overall Study|Dual Enrolled Subject|0|||
170547832|NCT04518410|616350229|FG002|Overall Study|Dual Enrolled Subject|0|||
170547833|NCT04518410|616350230|FG003|Overall Study|Dual Enrolled Subject|0|||
170547834|NCT04518410|616350231|FG004|Overall Study|Dual Enrolled Subject|0|||
170547835|NCT04518410|616350232|FG005|Overall Study|Dual Enrolled Subject|0|||
170547836|NCT04518410|616350233|FG006|Overall Study|Dual Enrolled Subject|0|||
170547837|NCT04518410|616350234|FG007|Overall Study|Dual Enrolled Subject|0|||
170547838|NCT04518410|616350235|FG008|Overall Study|Dual Enrolled Subject|0|||
170547839|NCT04518410|616350236|FG009|Overall Study|Dual Enrolled Subject|0|||
170547840|NCT04518410|616350237|FG010|Overall Study|Dual Enrolled Subject|0|||
170547841|NCT04518410|616350238|FG011|Overall Study|Dual Enrolled Subject|0|||
170547842|NCT04518410|616350239|FG012|Overall Study|Dual Enrolled Subject|0|||
170639883|NCT00622440|616693774|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
170639884|NCT02867384|616693777|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
170639885|NCT02867384|616693778|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
170639886|NCT02867384|616693779|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
170795027|NCT02361216|617260075|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
170480637|NCT02059135|616099411|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
170480638|NCT02059135|616099412|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
170480639|NCT02059135|616099411|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
170480640|NCT02059135|616099412|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
170795028|NCT02361216|617260076|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
170480641|NCT02059135|616099411|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
170547843|NCT04518410|616350240|FG013|Overall Study|Dual Enrolled Subject|0|||
170547844|NCT04518410|616350241|FG014|Overall Study|Dual Enrolled Subject|0|||
170547845|NCT04518410|616350242|FG015|Overall Study|Dual Enrolled Subject|0|||
170547846|NCT04518410|616350243|FG016|Overall Study|Dual Enrolled Subject|0|||
170547847|NCT04518410|616350244|FG017|Overall Study|Dual Enrolled Subject|1|||
170547848|NCT04518410|616350245|FG018|Overall Study|Dual Enrolled Subject|0|||
170547849|NCT04518410|616350246|FG019|Overall Study|Dual Enrolled Subject|0|||
170547850|NCT04518410|616350247|FG020|Overall Study|Dual Enrolled Subject|0|||
170547851|NCT04518410|616350248|FG021|Overall Study|Dual Enrolled Subject|0|||
170547852|NCT04518410|616350249|FG022|Overall Study|Dual Enrolled Subject|0|||
170547853|NCT04518410|616350250|FG023|Overall Study|Dual Enrolled Subject|0|||
170547854|NCT04518410|616350251|FG024|Overall Study|Dual Enrolled Subject|0|||
170547855|NCT05737745|616350252|FG000|Overall Study|Withdrawal by Subject|0|||
170547856|NCT05737745|616350253|FG001|Overall Study|Withdrawal by Subject|6|||
170547857|NCT05737745|616350254|FG002|Overall Study|Withdrawal by Subject|1|||
170547858|NCT02218268|616350255|FG000|24 Hour Washout|Physician Decision|11|||
170547859|NCT02218268|616350256|FG001|24 Hour Washout|Physician Decision|9|||
170547860|NCT04648241|616350257|FG000|Overall Study|Lost to Follow-up|1|||
170547861|NCT04648241|616350258|FG001|Overall Study|Lost to Follow-up|0|||
170547862|NCT03651336|616350259|FG000|Overall Study|Withdrawal by Subject|4|||
170547863|NCT01341990|616350260|FG000|Overall Study|Adverse Event|0|||
170547864|NCT01341990|616350261|FG001|Overall Study|Adverse Event|1|||
170547865|NCT01341990|616350260|FG000|Overall Study|Torn Study Lens|1|||
170547866|NCT01341990|616350261|FG001|Overall Study|Torn Study Lens|0|||
170547867|NCT01341990|616350260|FG000|Overall Study|Withdrawal by Subject|2|||
170547868|NCT01341990|616350261|FG001|Overall Study|Withdrawal by Subject|0|||
170547869|NCT02489045|616350262|FG000|Overall Study|unable to collect usable data|53|||
170547870|NCT02489045|616350262|FG000|Follow-up|Lost to Follow-up|10|||
170547871|NCT04796207|616350265|FG000|Overall Study|Lost to Follow-up|7|||
170547872|NCT04796207|616350266|FG001|Overall Study|Lost to Follow-up|2|||
170547873|NCT01860989|616350267|FG000|Overall Study|Unsatisfactory therapeutic|5|||
170547874|NCT01125748|616350270|FG000|Overall Study|Adverse Event|0|||
170547875|NCT01125748|616350271|FG001|Overall Study|Adverse Event|2|||
170547876|NCT01125748|616350270|FG000|Overall Study|Lost to Follow-up|0|||
170547877|NCT01125748|616350271|FG001|Overall Study|Lost to Follow-up|1|||
170547878|NCT01125748|616350270|FG000|Overall Study|Physician Decision|8|||
170547879|NCT01125748|616350271|FG001|Overall Study|Physician Decision|7|||
170547880|NCT01125748|616350270|FG000|Overall Study|Patient Decision to Withdraw|2|||
170639887|NCT02867384|616693777|FG000|Overall Study|Progression/ Relapse|15|||
170795029|NCT02361216|617260075|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
170795030|NCT02361216|617260076|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
170795031|NCT02361216|617260075|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
170795032|NCT02361216|617260076|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
170795033|NCT02361216|617260075|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
170795034|NCT02361216|617260076|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
170795035|NCT02361216|617260075|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
170795036|NCT02361216|617260076|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
170795037|NCT02437136|617260077|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
170795038|NCT02437136|617260078|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
170795039|NCT02437136|617260079|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
170795040|NCT02437136|617260080|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
170795041|NCT02437136|617260081|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
170795042|NCT02437136|617260082|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
170795043|NCT02437136|617260083|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
170795044|NCT02437136|617260077|FG000|Expansion (Phase 2)|Death|0|||
170795045|NCT02437136|617260078|FG001|Expansion (Phase 2)|Death|0|||
170795046|NCT02437136|617260079|FG002|Expansion (Phase 2)|Death|0|||
170795047|NCT02437136|617260080|FG003|Expansion (Phase 2)|Death|6|||
170795048|NCT02437136|617260081|FG004|Expansion (Phase 2)|Death|37|||
170795049|NCT02437136|617260082|FG005|Expansion (Phase 2)|Death|29|||
170795050|NCT02437136|617260083|FG006|Expansion (Phase 2)|Death|24|||
170795051|NCT02437136|617260077|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
170795052|NCT02437136|617260078|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
170795053|NCT02437136|617260079|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
170795054|NCT02437136|617260080|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
170795055|NCT02437136|617260081|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
170895195|NCT00289913|617624222|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
170547881|NCT01125748|616350271|FG001|Overall Study|Patient Decision to Withdraw|4|||
170547882|NCT01107457|616350272|FG000|Part A|Adverse Event|1|||
170795056|NCT02437136|617260082|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
170795057|NCT02437136|617260083|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
170795058|NCT02437136|617260077|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
170795059|NCT02437136|617260078|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
170795060|NCT02437136|617260079|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
170795061|NCT02437136|617260080|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
170480642|NCT02059135|616099412|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
170480643|NCT02059135|616099411|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
170480644|NCT02059135|616099412|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
170480645|NCT02059135|616099411|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
170480646|NCT02059135|616099412|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
170480647|NCT06481709|616099415|FG000|Overall Study|Withdrawal by Subject|0|||
170480648|NCT06481709|616099416|FG001|Overall Study|Withdrawal by Subject|0|||
170480649|NCT06481709|616099417|FG002|Overall Study|Withdrawal by Subject|2|||
170480650|NCT06481709|616099418|FG003|Overall Study|Withdrawal by Subject|0|||
170480651|NCT00729937|616099419|FG000|Overall Study|Lost to Follow-up|49|||
170480652|NCT00729937|616099420|FG001|Overall Study|Lost to Follow-up|58|||
170480653|NCT00729937|616099421|FG002|Overall Study|Lost to Follow-up|18|||
170480654|NCT00729937|616099422|FG003|Overall Study|Lost to Follow-up|33|||
170480655|NCT00729937|616099423|FG004|Overall Study|Lost to Follow-up|18|||
170480656|NCT00729937|616099424|FG005|Overall Study|Lost to Follow-up|23|||
170480657|NCT00729937|616099419|FG000|Overall Study|Physician Decision|7|||
170480658|NCT00729937|616099420|FG001|Overall Study|Physician Decision|16|||
170480659|NCT00729937|616099421|FG002|Overall Study|Physician Decision|2|||
170480660|NCT00729937|616099422|FG003|Overall Study|Physician Decision|0|||
170480661|NCT00729937|616099423|FG004|Overall Study|Physician Decision|5|||
170480662|NCT00729937|616099424|FG005|Overall Study|Physician Decision|8|||
170480663|NCT00729937|616099419|FG000|Overall Study|Death|1|||
170480664|NCT00729937|616099420|FG001|Overall Study|Death|0|||
170480665|NCT00729937|616099421|FG002|Overall Study|Death|1|||
170480666|NCT00729937|616099422|FG003|Overall Study|Death|0|||
170480667|NCT00729937|616099423|FG004|Overall Study|Death|0|||
170480668|NCT00729937|616099424|FG005|Overall Study|Death|1|||
170480669|NCT00729937|616099419|FG000|Overall Study|Withdrawal by Subject|3|||
170480670|NCT00729937|616099420|FG001|Overall Study|Withdrawal by Subject|5|||
170480671|NCT00729937|616099421|FG002|Overall Study|Withdrawal by Subject|6|||
170480672|NCT00729937|616099422|FG003|Overall Study|Withdrawal by Subject|0|||
170480673|NCT00729937|616099423|FG004|Overall Study|Withdrawal by Subject|4|||
170480674|NCT00729937|616099424|FG005|Overall Study|Withdrawal by Subject|2|||
170480675|NCT00729937|616099419|FG000|Overall Study|Randomized but not treated|12|||
170480676|NCT00729937|616099420|FG001|Overall Study|Randomized but not treated|6|||
170480677|NCT00729937|616099421|FG002|Overall Study|Randomized but not treated|1|||
170480678|NCT00729937|616099422|FG003|Overall Study|Randomized but not treated|0|||
170480679|NCT00729937|616099423|FG004|Overall Study|Randomized but not treated|1|||
170480680|NCT00729937|616099424|FG005|Overall Study|Randomized but not treated|3|||
170480681|NCT00729937|616099419|FG000|Overall Study|Did not meet eligibility criteria|2|||
170480682|NCT00729937|616099420|FG001|Overall Study|Did not meet eligibility criteria|1|||
170480683|NCT00729937|616099421|FG002|Overall Study|Did not meet eligibility criteria|0|||
170480684|NCT00729937|616099422|FG003|Overall Study|Did not meet eligibility criteria|0|||
170480685|NCT00729937|616099423|FG004|Overall Study|Did not meet eligibility criteria|0|||
170480686|NCT00729937|616099424|FG005|Overall Study|Did not meet eligibility criteria|0|||
170480687|NCT00729937|616099419|FG000|Overall Study|Incarcerated|0|||
170480688|NCT00729937|616099420|FG001|Overall Study|Incarcerated|2|||
170480689|NCT00729937|616099421|FG002|Overall Study|Incarcerated|1|||
170480690|NCT00729937|616099422|FG003|Overall Study|Incarcerated|1|||
170480691|NCT00729937|616099423|FG004|Overall Study|Incarcerated|0|||
170480692|NCT00729937|616099424|FG005|Overall Study|Incarcerated|0|||
170480693|NCT00281957|616099425|FG000|Overall Study|Adverse Event|7|||
170480694|NCT00281957|616099426|FG001|Overall Study|Adverse Event|2|||
170480695|NCT00281957|616099425|FG000|Overall Study|Death|1|||
170480696|NCT00281957|616099426|FG001|Overall Study|Death|0|||
170480697|NCT00281957|616099425|FG000|Overall Study|Progression/relapse|47|||
170480698|NCT00281957|616099426|FG001|Overall Study|Progression/relapse|35|||
170480699|NCT00281957|616099425|FG000|Overall Study|Not protocol specified|8|||
170480700|NCT00281957|616099426|FG001|Overall Study|Not protocol specified|1|||
170480701|NCT00281957|616099425|FG000|Overall Study|Not eligible|1|||
170480702|NCT00281957|616099426|FG001|Overall Study|Not eligible|2|||
170639888|NCT02867384|616693778|FG001|Overall Study|Progression/ Relapse|19|||
170480703|NCT00281957|616099425|FG000|Overall Study|Did not start treatment|3|||
170639889|NCT02867384|616693779|FG002|Overall Study|Progression/ Relapse|0|||
170639890|NCT02867384|616693777|FG000|Overall Study|Adverse Event|13|||
170639891|NCT02867384|616693778|FG001|Overall Study|Adverse Event|1|||
170480704|NCT00281957|616099426|FG001|Overall Study|Did not start treatment|1|||
170480705|NCT00281957|616099425|FG000|Overall Study|Refusal unrelated to adverse events|0|||
170480706|NCT00281957|616099426|FG001|Overall Study|Refusal unrelated to adverse events|1|||
170480707|NCT03281876|616099427|FG000|Overall Study|Adverse Event|4|||
170480708|NCT03281876|616099428|FG001|Overall Study|Adverse Event|15|||
170480709|NCT03281876|616099427|FG000|Overall Study|Lost to Follow-up|1|||
170480710|NCT03281876|616099428|FG001|Overall Study|Lost to Follow-up|4|||
170795062|NCT02437136|617260081|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
170480711|NCT03281876|616099427|FG000|Overall Study|Withdrawal by Subject|11|||
170480712|NCT03281876|616099428|FG001|Overall Study|Withdrawal by Subject|15|||
170639892|NCT02867384|616693779|FG002|Overall Study|Adverse Event|0|||
170480713|NCT03281876|616099427|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
170480714|NCT03281876|616099428|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170480715|NCT03281876|616099427|FG000|Overall Study|OTHER|5|||
170480716|NCT03281876|616099428|FG001|Overall Study|OTHER|5|||
170480717|NCT01478373|616099429|FG000|Treatment Phase|Protocol Violation|1|||
170480718|NCT01478373|616099429|FG000|Survival Phase|Adverse Event|8|||
170480719|NCT01478373|616099429|FG000|Survival Phase|Protocol Violation|1|||
170480720|NCT01478373|616099429|FG000|Survival Phase|crossover to another study|2|||
170480721|NCT01478373|616099429|FG000|Survival Phase|Progressive Disease|27|||
170480722|NCT00683657|616099430|FG000|Overall Study|Adverse Event|0|||
170480723|NCT00683657|616099431|FG001|Overall Study|Adverse Event|1|||
170480724|NCT00683657|616099430|FG000|Overall Study|Subject Withdrew Consent|1|||
170480725|NCT00683657|616099431|FG001|Overall Study|Subject Withdrew Consent|0|||
170480726|NCT03200717|616099436|FG000|Overall Study|Progressive disease|24|||
170480727|NCT03200717|616099437|FG001|Overall Study|Progressive disease|5|||
170480728|NCT03200717|616099436|FG000|Overall Study|Adverse Event|11|||
170480729|NCT03200717|616099437|FG001|Overall Study|Adverse Event|8|||
170480730|NCT03200717|616099436|FG000|Overall Study|Physician Decision|3|||
170480731|NCT03200717|616099437|FG001|Overall Study|Physician Decision|2|||
170480732|NCT03200717|616099436|FG000|Overall Study|Death|2|||
170480733|NCT03200717|616099437|FG001|Overall Study|Death|0|||
170480734|NCT03200717|616099436|FG000|Overall Study|Subject/Guardian Decision|1|||
170480735|NCT03200717|616099437|FG001|Overall Study|Subject/Guardian Decision|0|||
170480736|NCT01522456|616099438|FG000|Overall Study|Adverse Event|2|||
170480737|NCT01522456|616099438|FG000|Overall Study|Lost to Follow-up|2|||
170480738|NCT01522456|616099438|FG000|Overall Study|Withdrawal by Subject|2|||
170480739|NCT01522456|616099438|FG000|Overall Study|Pregnancy|1|||
170480740|NCT01522456|616099438|FG000|Overall Study|Tolerability Assessment|1|||
170480741|NCT02431364|616099439|FG000|Overall Study|Adverse Event|0|||
170480742|NCT02431364|616099440|FG001|Overall Study|Adverse Event|1|||
170480743|NCT02431364|616099441|FG002|Overall Study|Adverse Event|0|||
170480744|NCT02431364|616099442|FG003|Overall Study|Adverse Event|0|||
170480745|NCT02431364|616099443|FG004|Overall Study|Adverse Event|0|||
170480746|NCT02431364|616099439|FG000|Overall Study|Randomized but never treated|0|||
170480747|NCT02431364|616099440|FG001|Overall Study|Randomized but never treated|0|||
170480748|NCT02431364|616099441|FG002|Overall Study|Randomized but never treated|0|||
170480749|NCT02431364|616099442|FG003|Overall Study|Randomized but never treated|1|||
170480750|NCT02431364|616099443|FG004|Overall Study|Randomized but never treated|0|||
170480751|NCT00061932|616099444|FG000|Overall Study|Withdrawal by Subject|13|||
170480752|NCT00061932|616099445|FG001|Overall Study|Withdrawal by Subject|4|||
170480753|NCT00916383|616099446|FG000|Overall Study|Adverse Event|1|||
170480754|NCT00916383|616099446|FG000|Overall Study|Death|1|||
170639893|NCT02867384|616693777|FG000|Overall Study|Withdrawal by Subject|6|||
170639894|NCT02867384|616693778|FG001|Overall Study|Withdrawal by Subject|5|||
170639895|NCT02867384|616693779|FG002|Overall Study|Withdrawal by Subject|0|||
170639896|NCT02867384|616693777|FG000|Overall Study|Physician Decision|1|||
170639897|NCT02867384|616693778|FG001|Overall Study|Physician Decision|2|||
170639898|NCT02867384|616693779|FG002|Overall Study|Physician Decision|0|||
170639899|NCT02867384|616693777|FG000|Overall Study|Patient compliance|1|||
170639900|NCT02867384|616693778|FG001|Overall Study|Patient compliance|0|||
170639901|NCT02867384|616693779|FG002|Overall Study|Patient compliance|0|||
170639902|NCT02867384|616693777|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
170639903|NCT02867384|616693778|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
170639904|NCT02867384|616693779|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
170639905|NCT02867384|616693777|FG000|Overall Study|Never start treatment|3|||
170639906|NCT02867384|616693778|FG001|Overall Study|Never start treatment|0|||
170795063|NCT02437136|617260082|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
170480755|NCT00916383|616099446|FG000|Overall Study|Protocol Violation|1|||
170480756|NCT02899962|616099447|FG000|Open-label Phase|Adverse Event|2|||
170795064|NCT02437136|617260083|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
170795065|NCT02056834|617260084|FG000|Overall Study|Lost to Follow-up|7|||
170795066|NCT02780700|617260085|FG000|Overall Study|Progressive disease|1|||
170795067|NCT04068831|617260090|FG000|Overall Study|Disease Progression|10|||
170795068|NCT04068831|617260091|FG001|Overall Study|Disease Progression|8|||
170480757|NCT02899962|616099448|FG001|Open-label Phase|Adverse Event|0|||
170480758|NCT02899962|616099449|FG002|Open-label Phase|Adverse Event|0|||
170480759|NCT02899962|616099447|FG000|Open-label Phase|Lost to Follow-up|9|||
170480760|NCT02899962|616099448|FG001|Open-label Phase|Lost to Follow-up|0|||
170639907|NCT02867384|616693779|FG002|Overall Study|Never start treatment|0|||
170639908|NCT02675634|616693780|FG000|Test Period 1|Adverse Event|0|||
170480761|NCT02899962|616099449|FG002|Open-label Phase|Lost to Follow-up|0|||
170480762|NCT02899962|616099447|FG000|Open-label Phase|Other reasons|9|||
170795069|NCT04086121|617260093|FG000|Overall Study|Other than listed|8|||
170480763|NCT02899962|616099448|FG001|Open-label Phase|Other reasons|0|||
170480764|NCT02899962|616099449|FG002|Open-label Phase|Other reasons|0|||
170480765|NCT02899962|616099447|FG000|Open-label Phase|Withdrawal by Subject|7|||
170480766|NCT02899962|616099448|FG001|Open-label Phase|Withdrawal by Subject|0|||
170480767|NCT02899962|616099449|FG002|Open-label Phase|Withdrawal by Subject|0|||
170480768|NCT02899962|616099447|FG000|Maintenance Phase|Adverse Event|0|||
170480769|NCT02899962|616099448|FG001|Maintenance Phase|Adverse Event|2|||
170480770|NCT02899962|616099449|FG002|Maintenance Phase|Adverse Event|1|||
170480771|NCT02899962|616099447|FG000|Maintenance Phase|Death|0|||
170480772|NCT02899962|616099448|FG001|Maintenance Phase|Death|0|||
170480773|NCT02899962|616099449|FG002|Maintenance Phase|Death|1|||
170480774|NCT02899962|616099447|FG000|Maintenance Phase|Lack of Efficacy|0|||
170480775|NCT02899962|616099448|FG001|Maintenance Phase|Lack of Efficacy|20|||
170480776|NCT02899962|616099449|FG002|Maintenance Phase|Lack of Efficacy|16|||
170480777|NCT02899962|616099447|FG000|Maintenance Phase|Lost to Follow-up|0|||
170480778|NCT02899962|616099448|FG001|Maintenance Phase|Lost to Follow-up|12|||
170480779|NCT02899962|616099449|FG002|Maintenance Phase|Lost to Follow-up|14|||
170480780|NCT02899962|616099447|FG000|Maintenance Phase|Other reasons|0|||
170480781|NCT02899962|616099448|FG001|Maintenance Phase|Other reasons|9|||
170480782|NCT02899962|616099449|FG002|Maintenance Phase|Other reasons|13|||
170480783|NCT02899962|616099447|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
170480784|NCT02899962|616099448|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
170480785|NCT02899962|616099449|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
170480786|NCT02899962|616099447|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
170480787|NCT02899962|616099448|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
170480788|NCT02899962|616099449|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
170480789|NCT02899962|616099447|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170480790|NCT02899962|616099448|FG001|Maintenance Phase|Withdrawal by Subject|30|||
170480791|NCT02899962|616099449|FG002|Maintenance Phase|Withdrawal by Subject|36|||
170480792|NCT00258960|616099450|FG000|Overall Study|Death|2|||
170480793|NCT00258960|616099450|FG000|Overall Study|Disease Progression|7|||
170480794|NCT00258960|616099450|FG000|Overall Study|Adverse Event|4|||
170480795|NCT00258960|616099450|FG000|Overall Study|Physician Decision|1|||
170480796|NCT00258960|616099450|FG000|Overall Study|Withdrawal by Subject|1|||
170480797|NCT00258960|616099450|FG000|Overall Study|Mistake|2|||
170480798|NCT03367819|616099451|FG000|Overall Study|Adverse Event|4|||
170480799|NCT03367819|616099452|FG001|Overall Study|Adverse Event|4|||
170480800|NCT03367819|616099451|FG000|Overall Study|Progressive Disease|15|||
170480801|NCT03367819|616099452|FG001|Overall Study|Progressive Disease|13|||
170480802|NCT03367819|616099451|FG000|Overall Study|Withdrawal by Subject|1|||
170480803|NCT03367819|616099452|FG001|Overall Study|Withdrawal by Subject|0|||
170480804|NCT03367819|616099451|FG000|Overall Study|Other|4|||
170480805|NCT03367819|616099452|FG001|Overall Study|Other|2|||
170480806|NCT02601014|616099453|FG000|Overall Study|Adverse Event|3|||
170480807|NCT02601014|616099454|FG001|Overall Study|Adverse Event|3|||
170480808|NCT02601014|616099453|FG000|Overall Study|Death|3|||
170480809|NCT02601014|616099454|FG001|Overall Study|Death|1|||
170480810|NCT02601014|616099453|FG000|Overall Study|Disease progression|4|||
170480811|NCT02601014|616099454|FG001|Overall Study|Disease progression|8|||
170480812|NCT00445146|616099458|FG000|Overall Study|Withdrew Consent|29|||
170480813|NCT00445146|616099458|FG000|Overall Study|Lack of Efficacy|28|||
170480814|NCT00445146|616099458|FG000|Overall Study|Investigator's Discretion|22|||
170480815|NCT00445146|616099458|FG000|Overall Study|Adverse Event|13|||
170480816|NCT00445146|616099458|FG000|Overall Study|Lost to Follow-up|13|||
170480817|NCT00445146|616099458|FG000|Overall Study|Death|9|||
170480818|NCT00445146|616099458|FG000|Overall Study|Protocol Violation|4|||
170480819|NCT00445146|616099458|FG000|Overall Study|Pregnancy|1|||
170480820|NCT03918629|616099459|FG000|Overall Study|Adverse Event|19|||
170480821|NCT03918629|616099460|FG001|Overall Study|Adverse Event|20|||
170480822|NCT03918629|616099459|FG000|Overall Study|Death|14|||
170547883|NCT01107457|616350273|FG001|Part A|Adverse Event|2|||
170547884|NCT01107457|616350274|FG002|Part A|Adverse Event|1|||
170547885|NCT01107457|616350275|FG003|Part A|Adverse Event|0|||
170547886|NCT01107457|616350276|FG004|Part A|Adverse Event|0|||
170547887|NCT01107457|616350277|FG005|Part A|Adverse Event|0|||
170547888|NCT01107457|616350272|FG000|Part A|Withdrawal by Subject|3|||
170547889|NCT01107457|616350273|FG001|Part A|Withdrawal by Subject|3|||
170547890|NCT01107457|616350274|FG002|Part A|Withdrawal by Subject|0|||
170547891|NCT01107457|616350275|FG003|Part A|Withdrawal by Subject|3|||
170480823|NCT03918629|616099460|FG001|Overall Study|Death|7|||
170547892|NCT01107457|616350276|FG004|Part A|Withdrawal by Subject|1|||
170480824|NCT03918629|616099459|FG000|Overall Study|Lost to Follow-up|36|||
170547893|NCT01107457|616350277|FG005|Part A|Withdrawal by Subject|0|||
170547894|NCT01107457|616350272|FG000|Part A|Lost to Follow-up|0|||
170547895|NCT01107457|616350273|FG001|Part A|Lost to Follow-up|1|||
170547896|NCT01107457|616350274|FG002|Part A|Lost to Follow-up|0|||
170547897|NCT01107457|616350275|FG003|Part A|Lost to Follow-up|0|||
170480825|NCT03918629|616099460|FG001|Overall Study|Lost to Follow-up|28|||
170480826|NCT03918629|616099459|FG000|Overall Study|Physician Decision|1|||
170480827|NCT03918629|616099460|FG001|Overall Study|Physician Decision|0|||
170480828|NCT03918629|616099459|FG000|Overall Study|Protocol Violation|7|||
170480829|NCT03918629|616099460|FG001|Overall Study|Protocol Violation|4|||
170480830|NCT03918629|616099459|FG000|Overall Study|Withdrawal by Subject|47|||
170547898|NCT01107457|616350276|FG004|Part A|Lost to Follow-up|0|||
170480831|NCT03918629|616099460|FG001|Overall Study|Withdrawal by Subject|47|||
170480832|NCT03918629|616099459|FG000|Overall Study|Other|7|||
170480833|NCT03918629|616099460|FG001|Overall Study|Other|11|||
170480834|NCT03918629|616099459|FG000|Overall Study|Randomized but not vaccinated|2|||
170480835|NCT03918629|616099460|FG001|Overall Study|Randomized but not vaccinated|1|||
170480836|NCT02623725|616099461|FG000|Overall Study|Non compliance with protocol|9|||
170480837|NCT02623725|616099462|FG001|Overall Study|Non compliance with protocol|3|||
170480838|NCT02623725|616099461|FG000|Overall Study|Serious adverse event|0|||
170480839|NCT02623725|616099462|FG001|Overall Study|Serious adverse event|2|||
170480840|NCT02623725|616099461|FG000|Overall Study|Withdrawal by Subject|7|||
170480841|NCT02623725|616099462|FG001|Overall Study|Withdrawal by Subject|1|||
170480842|NCT01891864|616099465|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
170480843|NCT01891864|616099466|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
170480844|NCT01891864|616099467|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
170480845|NCT01891864|616099468|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
170480846|NCT01891864|616099469|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
170480847|NCT01891864|616099470|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
170480848|NCT01891864|616099465|FG000|Treatment Period 1|Physician Decision|0|||
170480849|NCT01891864|616099466|FG001|Treatment Period 1|Physician Decision|1|||
170480850|NCT01891864|616099467|FG002|Treatment Period 1|Physician Decision|0|||
170480851|NCT01891864|616099468|FG003|Treatment Period 1|Physician Decision|0|||
170480852|NCT01891864|616099469|FG004|Treatment Period 1|Physician Decision|0|||
170480853|NCT01891864|616099470|FG005|Treatment Period 1|Physician Decision|0|||
170480854|NCT01891864|616099465|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
170480855|NCT01891864|616099466|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
170480856|NCT01891864|616099467|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
170480857|NCT01891864|616099468|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
170480858|NCT01891864|616099469|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
170480859|NCT01891864|616099470|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
170480860|NCT01891864|616099465|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
170480861|NCT01891864|616099466|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
170480862|NCT01891864|616099467|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
170480863|NCT01891864|616099468|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
170480864|NCT01891864|616099469|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
170480865|NCT01891864|616099470|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
170480866|NCT01891864|616099465|FG000|Treatment Period 1|Withdrawal by Subject|2|||
170480867|NCT01891864|616099466|FG001|Treatment Period 1|Withdrawal by Subject|5|||
170480868|NCT01891864|616099467|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170480869|NCT01891864|616099468|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170480870|NCT01891864|616099469|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170480871|NCT01891864|616099470|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170480872|NCT01891864|616099465|FG000|Treatment Period 1|Lost to Follow-up|1|||
170480873|NCT01891864|616099466|FG001|Treatment Period 1|Lost to Follow-up|0|||
170480874|NCT01891864|616099467|FG002|Treatment Period 1|Lost to Follow-up|0|||
170480875|NCT01891864|616099468|FG003|Treatment Period 1|Lost to Follow-up|0|||
170480876|NCT01891864|616099469|FG004|Treatment Period 1|Lost to Follow-up|0|||
170480877|NCT01891864|616099470|FG005|Treatment Period 1|Lost to Follow-up|0|||
170480878|NCT01891864|616099465|FG000|Treatment Period 2|Protocol Violation|0|||
170480879|NCT01891864|616099466|FG001|Treatment Period 2|Protocol Violation|0|||
170480880|NCT01891864|616099467|FG002|Treatment Period 2|Protocol Violation|0|||
170480881|NCT01891864|616099468|FG003|Treatment Period 2|Protocol Violation|1|||
170480882|NCT01891864|616099469|FG004|Treatment Period 2|Protocol Violation|0|||
170480883|NCT01891864|616099470|FG005|Treatment Period 2|Protocol Violation|0|||
170480884|NCT01891864|616099465|FG000|Treatment Period 2|Physician Decision|0|||
170547899|NCT01107457|616350277|FG005|Part A|Lost to Follow-up|0|||
170795070|NCT04086121|617260093|FG000|Overall Study|Withdrawal by Subject|3|||
170795071|NCT04086121|617260093|FG000|Overall Study|Lost to Follow-up|2|||
170795072|NCT04086121|617260093|FG000|Overall Study|Adverse Event|1|||
170795073|NCT05533190|617260098|FG000|Overall Study|Lost to Follow-up|19|||
170795074|NCT05533190|617260099|FG001|Overall Study|Lost to Follow-up|7|||
170795075|NCT05533190|617260098|FG000|Overall Study|Failed to download app|1|||
170795076|NCT05533190|617260099|FG001|Overall Study|Failed to download app|0|||
170795077|NCT05533190|617260098|FG000|Overall Study|Thought app was a scam|1|||
170795078|NCT05533190|617260099|FG001|Overall Study|Thought app was a scam|0|||
170795079|NCT05533190|617260098|FG000|Overall Study|Withdrawal by Subject|2|||
170795080|NCT05533190|617260099|FG001|Overall Study|Withdrawal by Subject|0|||
170795081|NCT05552508|617260100|FG000|Overall Study|Adverse Event|3|||
170480885|NCT01891864|616099466|FG001|Treatment Period 2|Physician Decision|0|||
170480886|NCT01891864|616099467|FG002|Treatment Period 2|Physician Decision|1|||
170547900|NCT01107457|616350272|FG000|Part A|Lack of Efficacy|1|||
170795082|NCT04311632|617260114|FG000|Overall Study|Withdrawal by Subject|0|||
170795083|NCT04311632|617260115|FG001|Overall Study|Withdrawal by Subject|0|||
170480887|NCT01891864|616099468|FG003|Treatment Period 2|Physician Decision|0|||
170480888|NCT01891864|616099469|FG004|Treatment Period 2|Physician Decision|0|||
170480889|NCT01891864|616099470|FG005|Treatment Period 2|Physician Decision|0|||
170480890|NCT01891864|616099465|FG000|Treatment Period 2|Site Termination|0|||
170480891|NCT01891864|616099466|FG001|Treatment Period 2|Site Termination|0|||
170480892|NCT01891864|616099467|FG002|Treatment Period 2|Site Termination|1|||
170480893|NCT01891864|616099468|FG003|Treatment Period 2|Site Termination|2|||
170480894|NCT01891864|616099469|FG004|Treatment Period 2|Site Termination|0|||
170480895|NCT01891864|616099470|FG005|Treatment Period 2|Site Termination|0|||
170480896|NCT01891864|616099465|FG000|Treatment Period 2|Lack of Efficacy|0|||
170480897|NCT01891864|616099466|FG001|Treatment Period 2|Lack of Efficacy|0|||
170480898|NCT01891864|616099467|FG002|Treatment Period 2|Lack of Efficacy|1|||
170480899|NCT01891864|616099468|FG003|Treatment Period 2|Lack of Efficacy|0|||
170480900|NCT01891864|616099469|FG004|Treatment Period 2|Lack of Efficacy|1|||
170480901|NCT01891864|616099470|FG005|Treatment Period 2|Lack of Efficacy|0|||
170480902|NCT01891864|616099465|FG000|Treatment Period 2|Adverse Event|0|||
170480903|NCT01891864|616099466|FG001|Treatment Period 2|Adverse Event|0|||
170480904|NCT01891864|616099467|FG002|Treatment Period 2|Adverse Event|1|||
170480905|NCT01891864|616099468|FG003|Treatment Period 2|Adverse Event|2|||
170480906|NCT01891864|616099469|FG004|Treatment Period 2|Adverse Event|0|||
170480907|NCT01891864|616099470|FG005|Treatment Period 2|Adverse Event|4|||
170480908|NCT01891864|616099465|FG000|Treatment Period 2|Termination of Site|0|||
170480909|NCT01891864|616099466|FG001|Treatment Period 2|Termination of Site|0|||
170480910|NCT01891864|616099467|FG002|Treatment Period 2|Termination of Site|0|||
170480911|NCT01891864|616099468|FG003|Treatment Period 2|Termination of Site|0|||
170480912|NCT01891864|616099469|FG004|Treatment Period 2|Termination of Site|2|||
170480913|NCT01891864|616099470|FG005|Treatment Period 2|Termination of Site|0|||
170480914|NCT01891864|616099465|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170480915|NCT01891864|616099466|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170480916|NCT01891864|616099467|FG002|Treatment Period 2|Withdrawal by Subject|3|||
170480917|NCT01891864|616099468|FG003|Treatment Period 2|Withdrawal by Subject|4|||
170480918|NCT01891864|616099469|FG004|Treatment Period 2|Withdrawal by Subject|1|||
170480919|NCT01891864|616099470|FG005|Treatment Period 2|Withdrawal by Subject|1|||
170480920|NCT01891864|616099465|FG000|Extension Period|Lack of Efficacy|0|||
170480921|NCT01891864|616099466|FG001|Extension Period|Lack of Efficacy|0|||
170480922|NCT01891864|616099467|FG002|Extension Period|Lack of Efficacy|0|||
170480923|NCT01891864|616099468|FG003|Extension Period|Lack of Efficacy|1|||
170480924|NCT01891864|616099469|FG004|Extension Period|Lack of Efficacy|1|||
170480925|NCT01891864|616099470|FG005|Extension Period|Lack of Efficacy|0|||
170480926|NCT01891864|616099465|FG000|Extension Period|Pregnancy|0|||
170480927|NCT01891864|616099466|FG001|Extension Period|Pregnancy|0|||
170480928|NCT01891864|616099467|FG002|Extension Period|Pregnancy|1|||
170480929|NCT01891864|616099468|FG003|Extension Period|Pregnancy|0|||
170480930|NCT01891864|616099469|FG004|Extension Period|Pregnancy|0|||
170480931|NCT01891864|616099470|FG005|Extension Period|Pregnancy|0|||
170480932|NCT01891864|616099465|FG000|Extension Period|Adverse Event|0|||
170480933|NCT01891864|616099466|FG001|Extension Period|Adverse Event|0|||
170480934|NCT01891864|616099467|FG002|Extension Period|Adverse Event|4|||
170480935|NCT01891864|616099468|FG003|Extension Period|Adverse Event|2|||
170480936|NCT01891864|616099469|FG004|Extension Period|Adverse Event|2|||
170480937|NCT01891864|616099470|FG005|Extension Period|Adverse Event|0|||
170895196|NCT00289913|617624223|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
170895197|NCT00289913|617624224|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
170895198|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895199|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895200|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
170895201|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895202|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895203|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
170895204|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
170895205|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
170895206|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
170895207|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
170480938|NCT01891864|616099465|FG000|Extension Period|Withdrawal by Subject|0|||
170480939|NCT01891864|616099466|FG001|Extension Period|Withdrawal by Subject|0|||
170480940|NCT01891864|616099467|FG002|Extension Period|Withdrawal by Subject|1|||
170480941|NCT01891864|616099468|FG003|Extension Period|Withdrawal by Subject|2|||
170480942|NCT01891864|616099469|FG004|Extension Period|Withdrawal by Subject|4|||
170480943|NCT01891864|616099470|FG005|Extension Period|Withdrawal by Subject|0|||
170480944|NCT01891864|616099465|FG000|Extension Period|Lost to Follow-up|0|||
170480945|NCT01891864|616099466|FG001|Extension Period|Lost to Follow-up|0|||
170547901|NCT01107457|616350273|FG001|Part A|Lack of Efficacy|0|||
170480946|NCT01891864|616099467|FG002|Extension Period|Lost to Follow-up|2|||
170547902|NCT01107457|616350274|FG002|Part A|Lack of Efficacy|0|||
170547903|NCT01107457|616350275|FG003|Part A|Lack of Efficacy|0|||
170480947|NCT01891864|616099468|FG003|Extension Period|Lost to Follow-up|0|||
170480948|NCT01891864|616099469|FG004|Extension Period|Lost to Follow-up|0|||
170480949|NCT01891864|616099470|FG005|Extension Period|Lost to Follow-up|0|||
170480950|NCT04720105|616099471|FG000|Overall Study|Lack of Efficacy|1|||
170480951|NCT04720105|616099471|FG000|Overall Study|Lost to Follow-up|1|||
170480952|NCT04720105|616099471|FG000|Overall Study|Withdrawal by Subject|3|||
170480953|NCT02698163|616099474|FG000|Overall Study|Lost to Follow-up|0|||
170480954|NCT02698163|616099475|FG001|Overall Study|Lost to Follow-up|1|||
170480955|NCT05373108|616099476|FG000|Overall Study|Withdrawal by Subject|2|||
170480956|NCT01133067|616099478|FG000|Overall Study|Death|136|||
170480957|NCT01133067|616099478|FG000|Overall Study|Lost to Follow-up|3|||
170480958|NCT00752128|616099479|FG000|Overall Study|Withdrawal by Subject|4|||
170480959|NCT04135937|616099482|FG000|Overall Study|Lost to Follow-up|2|||
170480960|NCT04135937|616099482|FG000|Overall Study|Withdrawal by Subject|1|||
170480961|NCT00349973|616099483|FG000|Overall Study|Adverse Event|3|||
170480962|NCT00349973|616099484|FG001|Overall Study|Adverse Event|3|||
170480963|NCT00349973|616099483|FG000|Overall Study|Withdrawal by Subject|1|||
170480964|NCT00349973|616099484|FG001|Overall Study|Withdrawal by Subject|0|||
170480965|NCT02654054|616099486|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
170480966|NCT02654054|616099487|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
170480967|NCT02654054|616099488|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
170480968|NCT02654054|616099486|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
170480969|NCT02654054|616099487|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170480970|NCT02654054|616099488|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
170480971|NCT02654054|616099486|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
170480972|NCT02654054|616099487|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
170480973|NCT02654054|616099488|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
170480974|NCT02654054|616099486|FG000|Post-Treatment Follow-Up Period|Other|1|||
170480975|NCT02654054|616099487|FG001|Post-Treatment Follow-Up Period|Other|0|||
170480976|NCT02654054|616099488|FG002|Post-Treatment Follow-Up Period|Other|4|||
170480977|NCT02654054|616099486|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
170480978|NCT02654054|616099487|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
170480979|NCT02654054|616099488|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
170480980|NCT05620082|616099489|FG000|Overall Study|Discharged before study end|1|||
170480981|NCT05620082|616099490|FG001|Overall Study|Discharged before study end|4|||
170480982|NCT05620082|616099491|FG002|Overall Study|Discharged before study end|0|||
170480983|NCT05620082|616099489|FG000|Overall Study|Moved to a different ward|1|||
170480984|NCT05620082|616099490|FG001|Overall Study|Moved to a different ward|0|||
170480985|NCT05620082|616099491|FG002|Overall Study|Moved to a different ward|0|||
170480986|NCT05620082|616099489|FG000|Overall Study|Feeling too unwell|1|||
170480987|NCT05620082|616099490|FG001|Overall Study|Feeling too unwell|0|||
170480988|NCT05620082|616099491|FG002|Overall Study|Feeling too unwell|0|||
170480989|NCT02141438|616101646|FG000|Overall Study|Death|1308|||
170480990|NCT02141438|616101646|FG000|Overall Study|Lost to Follow-up|84|||
170480991|NCT02141438|616101646|FG000|Overall Study|Withdrawal by Subject|52|||
170480992|NCT02141438|616101646|FG000|Overall Study|Physician Decision|1|||
170480993|NCT02141438|616101646|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
170480994|NCT02861586|616101649|FG000|Overall Study|Withdrawal by Subject|1|||
170480995|NCT02861586|616101650|FG001|Overall Study|Withdrawal by Subject|2|||
170480996|NCT02861586|616101651|FG002|Overall Study|Withdrawal by Subject|0|||
170480997|NCT02861586|616101652|FG003|Overall Study|Withdrawal by Subject|0|||
170480998|NCT02861586|616101653|FG004|Overall Study|Withdrawal by Subject|0|||
170480999|NCT02861586|616101654|FG005|Overall Study|Withdrawal by Subject|1|||
170481000|NCT02861586|616101655|FG006|Overall Study|Withdrawal by Subject|1|||
170481001|NCT02861586|616101656|FG007|Overall Study|Withdrawal by Subject|0|||
170547904|NCT01107457|616350276|FG004|Part A|Lack of Efficacy|0|||
170547905|NCT01107457|616350277|FG005|Part A|Lack of Efficacy|0|||
170547906|NCT01107457|616350272|FG000|Part A|Protocol Violation|0|||
170547907|NCT01107457|616350273|FG001|Part A|Protocol Violation|1|||
170547908|NCT01107457|616350274|FG002|Part A|Protocol Violation|0|||
170547909|NCT01107457|616350275|FG003|Part A|Protocol Violation|0|||
170547910|NCT01107457|616350276|FG004|Part A|Protocol Violation|0|||
170547911|NCT01107457|616350277|FG005|Part A|Protocol Violation|0|||
170547912|NCT01107457|616350272|FG000|Part B and C|Adverse Event|0|||
170547913|NCT01107457|616350273|FG001|Part B and C|Adverse Event|0|||
170547914|NCT01107457|616350274|FG002|Part B and C|Adverse Event|0|||
170547915|NCT01107457|616350275|FG003|Part B and C|Adverse Event|0|||
170481002|NCT02861586|616101649|FG000|Overall Study|Lost to Follow-up|3|||
170481003|NCT02861586|616101650|FG001|Overall Study|Lost to Follow-up|1|||
170481004|NCT02861586|616101651|FG002|Overall Study|Lost to Follow-up|1|||
170481005|NCT02861586|616101652|FG003|Overall Study|Lost to Follow-up|0|||
170481006|NCT02861586|616101653|FG004|Overall Study|Lost to Follow-up|0|||
170481007|NCT02861586|616101654|FG005|Overall Study|Lost to Follow-up|3|||
170481008|NCT02861586|616101655|FG006|Overall Study|Lost to Follow-up|0|||
170481009|NCT02861586|616101656|FG007|Overall Study|Lost to Follow-up|0|||
170481010|NCT02861586|616101649|FG000|Overall Study|Adverse Event|0|||
170481011|NCT02861586|616101650|FG001|Overall Study|Adverse Event|0|||
170481012|NCT02861586|616101651|FG002|Overall Study|Adverse Event|0|||
170481013|NCT02861586|616101652|FG003|Overall Study|Adverse Event|0|||
170481014|NCT02861586|616101653|FG004|Overall Study|Adverse Event|0|||
170481015|NCT02861586|616101654|FG005|Overall Study|Adverse Event|1|||
170481016|NCT02861586|616101655|FG006|Overall Study|Adverse Event|0|||
170481017|NCT02861586|616101656|FG007|Overall Study|Adverse Event|0|||
170481018|NCT04796909|616101657|FG000|Overall Study|Withdrawal by Subject|1|||
170481019|NCT04796909|616101658|FG001|Overall Study|Withdrawal by Subject|1|||
170481020|NCT00437021|616101659|FG000|Overall Study|Adverse Event|0|||
170481021|NCT00437021|616101660|FG001|Overall Study|Adverse Event|0|||
170481022|NCT00437021|616101661|FG002|Overall Study|Adverse Event|0|||
170481023|NCT00437021|616101662|FG003|Overall Study|Adverse Event|0|||
170481024|NCT00437021|616101663|FG004|Overall Study|Adverse Event|0|||
170481025|NCT00437021|616101664|FG005|Overall Study|Adverse Event|0|||
170481026|NCT00437021|616101665|FG006|Overall Study|Adverse Event|1|||
170547916|NCT01107457|616350276|FG004|Part B and C|Adverse Event|0|||
170547917|NCT01107457|616350277|FG005|Part B and C|Adverse Event|12|||
170547918|NCT01107457|616350272|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
170547919|NCT01107457|616350273|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
170547920|NCT01107457|616350274|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
170481027|NCT00437021|616101666|FG007|Overall Study|Adverse Event|0|||
170481028|NCT00437021|616101667|FG008|Overall Study|Adverse Event|0|||
170481029|NCT00437021|616101668|FG009|Overall Study|Adverse Event|0|||
170547921|NCT01107457|616350275|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
170547922|NCT01107457|616350276|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
170547923|NCT01107457|616350277|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
170481030|NCT00437021|616101669|FG010|Overall Study|Adverse Event|0|||
170481031|NCT00437021|616101670|FG011|Overall Study|Adverse Event|0|||
170481032|NCT00437021|616101659|FG000|Overall Study|Lost to Follow-up|0|||
170481033|NCT00437021|616101660|FG001|Overall Study|Lost to Follow-up|3|||
170481034|NCT00437021|616101661|FG002|Overall Study|Lost to Follow-up|0|||
170481035|NCT00437021|616101662|FG003|Overall Study|Lost to Follow-up|0|||
170481036|NCT00437021|616101663|FG004|Overall Study|Lost to Follow-up|0|||
170481037|NCT00437021|616101664|FG005|Overall Study|Lost to Follow-up|2|||
170481038|NCT00437021|616101665|FG006|Overall Study|Lost to Follow-up|0|||
170481039|NCT00437021|616101666|FG007|Overall Study|Lost to Follow-up|1|||
170481040|NCT00437021|616101667|FG008|Overall Study|Lost to Follow-up|0|||
170481041|NCT00437021|616101668|FG009|Overall Study|Lost to Follow-up|0|||
170481042|NCT00437021|616101669|FG010|Overall Study|Lost to Follow-up|0|||
170481043|NCT00437021|616101670|FG011|Overall Study|Lost to Follow-up|0|||
170481044|NCT00437021|616101659|FG000|Overall Study|Withdrawal by Subject|2|||
170481045|NCT00437021|616101660|FG001|Overall Study|Withdrawal by Subject|1|||
170481046|NCT00437021|616101661|FG002|Overall Study|Withdrawal by Subject|0|||
170481047|NCT00437021|616101662|FG003|Overall Study|Withdrawal by Subject|0|||
170481048|NCT00437021|616101663|FG004|Overall Study|Withdrawal by Subject|0|||
170481049|NCT00437021|616101664|FG005|Overall Study|Withdrawal by Subject|0|||
170481050|NCT00437021|616101665|FG006|Overall Study|Withdrawal by Subject|0|||
170481051|NCT00437021|616101666|FG007|Overall Study|Withdrawal by Subject|0|||
170481052|NCT00437021|616101667|FG008|Overall Study|Withdrawal by Subject|0|||
170481053|NCT00437021|616101668|FG009|Overall Study|Withdrawal by Subject|0|||
170481054|NCT00437021|616101669|FG010|Overall Study|Withdrawal by Subject|0|||
170481055|NCT00437021|616101670|FG011|Overall Study|Withdrawal by Subject|0|||
170481056|NCT04162847|616101671|FG000|Overall Study|Withdrawal by Subject|7|||
170481057|NCT04162847|616101672|FG001|Overall Study|Withdrawal by Subject|1|||
170481058|NCT03657797|616101692|FG000|Overall Study|Lost to Follow-up|0|||
170481059|NCT03657797|616101693|FG001|Overall Study|Lost to Follow-up|1|||
170481060|NCT03657797|616101694|FG002|Overall Study|Lost to Follow-up|1|||
170481061|NCT03657797|616101695|FG003|Overall Study|Lost to Follow-up|0|||
170481062|NCT03657797|616101692|FG000|Overall Study|Physician Decision|0|||
170481063|NCT03657797|616101693|FG001|Overall Study|Physician Decision|1|||
170481064|NCT03657797|616101694|FG002|Overall Study|Physician Decision|0|||
170481065|NCT03657797|616101695|FG003|Overall Study|Physician Decision|0|||
170481066|NCT03657797|616101692|FG000|Overall Study|Withdrawal by Subject|0|||
170895208|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
170895209|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
170895210|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
170895211|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
170895212|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
170895213|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
170895214|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
170895215|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
170895216|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
170895217|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
170895218|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
170895219|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895220|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
170895221|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895222|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895223|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
170895224|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
170895225|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
170895226|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
170481067|NCT03657797|616101693|FG001|Overall Study|Withdrawal by Subject|1|||
170481068|NCT03657797|616101694|FG002|Overall Study|Withdrawal by Subject|2|||
170481069|NCT03657797|616101695|FG003|Overall Study|Withdrawal by Subject|0|||
170481070|NCT03657797|616101692|FG000|Overall Study|Adverse Event|0|||
170481071|NCT03657797|616101693|FG001|Overall Study|Adverse Event|0|||
170481072|NCT03657797|616101694|FG002|Overall Study|Adverse Event|2|||
170481073|NCT03657797|616101695|FG003|Overall Study|Adverse Event|0|||
170481074|NCT03642262|616101696|FG000|Period 1|Withdrawal by Subject|1|||
170481075|NCT03642262|616101697|FG001|Period 1|Withdrawal by Subject|1|||
170481076|NCT03642262|616101696|FG000|Period 1|Adverse Event|0|||
170481077|NCT03642262|616101697|FG001|Period 1|Adverse Event|1|||
170481078|NCT04231825|616101698|FG000|Overall Study|Protocol Violation|3|||
170481079|NCT04231825|616101699|FG001|Overall Study|Protocol Violation|3|||
170481080|NCT04231825|616101698|FG000|Overall Study|Lost to Follow-up|0|||
170481081|NCT04231825|616101699|FG001|Overall Study|Lost to Follow-up|1|||
170481082|NCT02596971|616101702|FG000|Overall Study|Death|5|||
170481083|NCT02596971|616101703|FG001|Overall Study|Death|1|||
170481084|NCT02596971|616101704|FG002|Overall Study|Death|5|||
170481085|NCT02596971|616101702|FG000|Overall Study|Withdrawal by Subject|5|||
170481086|NCT02596971|616101703|FG001|Overall Study|Withdrawal by Subject|1|||
170481087|NCT02596971|616101704|FG002|Overall Study|Withdrawal by Subject|4|||
170481088|NCT00824772|616101705|FG000|Overall Study|Withdrawal by Subject|8|||
170481089|NCT00683618|616101706|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
170481090|NCT00683618|616101707|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
170481091|NCT00683618|616101708|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
170481092|NCT00683618|616101706|FG000|Randomised Treatment Period|Protocol Violation|0|||
170481093|NCT00683618|616101707|FG001|Randomised Treatment Period|Protocol Violation|1|||
170481094|NCT00683618|616101708|FG002|Randomised Treatment Period|Protocol Violation|0|||
170481095|NCT00683618|616101706|FG000|Randomised Treatment Period|Adverse Event|2|||
170481096|NCT00683618|616101707|FG001|Randomised Treatment Period|Adverse Event|0|||
170481097|NCT00683618|616101708|FG002|Randomised Treatment Period|Adverse Event|2|||
170481098|NCT00683618|616101706|FG000|Randomised Treatment Period|Reason not provided|0|||
170481099|NCT00683618|616101707|FG001|Randomised Treatment Period|Reason not provided|0|||
170481100|NCT00683618|616101708|FG002|Randomised Treatment Period|Reason not provided|2|||
170481101|NCT00683618|616101706|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
170481102|NCT00683618|616101707|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
170481103|NCT00683618|616101708|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
170481104|NCT00683618|616101706|FG000|Extension Treatment Period|Adverse Event|1|||
170481105|NCT00683618|616101707|FG001|Extension Treatment Period|Adverse Event|0|||
170481106|NCT00683618|616101708|FG002|Extension Treatment Period|Adverse Event|0|||
170481107|NCT00683618|616101706|FG000|Extension Treatment Period|Protocol Violation|1|||
170481108|NCT00683618|616101707|FG001|Extension Treatment Period|Protocol Violation|0|||
170481109|NCT00683618|616101708|FG002|Extension Treatment Period|Protocol Violation|0|||
170481110|NCT04570670|616101709|FG000|Overall Study|Withdrawal by Subject|1|||
170481111|NCT04570670|616101710|FG001|Overall Study|Withdrawal by Subject|0|||
170481112|NCT02392481|616101712|FG000|Overall Study|Adverse Event|0|||
170481113|NCT02392481|616101713|FG001|Overall Study|Adverse Event|0|||
170481114|NCT02392481|616101714|FG002|Overall Study|Adverse Event|1|||
170481115|NCT02392481|616101715|FG003|Overall Study|Adverse Event|2|||
170481116|NCT02392481|616101712|FG000|Overall Study|Withdrawal by Subject|0|||
170481117|NCT02392481|616101713|FG001|Overall Study|Withdrawal by Subject|0|||
170481118|NCT02392481|616101714|FG002|Overall Study|Withdrawal by Subject|1|||
170481119|NCT02392481|616101715|FG003|Overall Study|Withdrawal by Subject|0|||
170481120|NCT04067050|616101716|FG000|One Month|Lost to Follow-up|4|||
170481121|NCT04067050|616101717|FG001|One Month|Lost to Follow-up|0|||
170481122|NCT04067050|616101716|FG000|Two Month|Lost to Follow-up|1|||
170481123|NCT04067050|616101717|FG001|Two Month|Lost to Follow-up|0|||
170481124|NCT04067050|616101716|FG000|Two Month|Adverse Event|1|||
170481125|NCT04067050|616101717|FG001|Two Month|Adverse Event|0|||
170481126|NCT02383017|616101723|FG000|Overall Study|Injury Sustained Outside Study|1|||
170481127|NCT02383017|616101724|FG001|Overall Study|Injury Sustained Outside Study|0|||
170481128|NCT02383017|616101723|FG000|Overall Study|Compliance|3|||
170481129|NCT02383017|616101724|FG001|Overall Study|Compliance|2|||
170481130|NCT02383017|616101723|FG000|Overall Study|Found to be Hypogonadal|1|||
170481131|NCT02383017|616101724|FG001|Overall Study|Found to be Hypogonadal|0|||
170481132|NCT03534687|616101730|FG000|Overall Study|Lost to Follow-up|7|||
170481133|NCT03534687|616101731|FG001|Overall Study|Lost to Follow-up|2|||
170481134|NCT03051100|616101732|FG000|Overall Study|Withdrawal by Subject|1|||
170481135|NCT03051100|616101733|FG001|Overall Study|Withdrawal by Subject|0|||
170481136|NCT01286467|616101734|FG000|Overall Study|Death|1|||
170481137|NCT01286467|616101735|FG001|Overall Study|Death|1|||
170481138|NCT01286467|616101736|FG002|Overall Study|Death|1|||
170481139|NCT01286467|616101737|FG003|Overall Study|Death|0|||
170481140|NCT01286467|616101734|FG000|Overall Study|Lost to Follow-up|0|||
170481141|NCT01286467|616101735|FG001|Overall Study|Lost to Follow-up|0|||
170481142|NCT01286467|616101736|FG002|Overall Study|Lost to Follow-up|0|||
170547924|NCT01107457|616350272|FG000|Part B and C|Physician Decision|0|||
170547925|NCT01107457|616350273|FG001|Part B and C|Physician Decision|0|||
170547926|NCT01107457|616350274|FG002|Part B and C|Physician Decision|0|||
170547927|NCT01107457|616350275|FG003|Part B and C|Physician Decision|0|||
170547928|NCT01107457|616350276|FG004|Part B and C|Physician Decision|0|||
170547929|NCT01107457|616350277|FG005|Part B and C|Physician Decision|3|||
170547930|NCT01107457|616350272|FG000|Part B and C|Lack of Efficacy|0|||
170547931|NCT01107457|616350273|FG001|Part B and C|Lack of Efficacy|0|||
170547932|NCT01107457|616350274|FG002|Part B and C|Lack of Efficacy|0|||
170547933|NCT01107457|616350275|FG003|Part B and C|Lack of Efficacy|0|||
170547934|NCT01107457|616350276|FG004|Part B and C|Lack of Efficacy|0|||
170481143|NCT01286467|616101737|FG003|Overall Study|Lost to Follow-up|1|||
170481144|NCT01286467|616101734|FG000|Overall Study|Withdrawal by Subject|0|||
170481145|NCT01286467|616101735|FG001|Overall Study|Withdrawal by Subject|0|||
170547935|NCT01107457|616350277|FG005|Part B and C|Lack of Efficacy|7|||
170547936|NCT01107457|616350272|FG000|Part B and C|Lost to Follow-up|0|||
170639909|NCT02675634|616693781|FG001|Test Period 1|Adverse Event|1|||
170639910|NCT02675634|616693782|FG002|Test Period 1|Adverse Event|0|||
170639911|NCT02675634|616693783|FG003|Test Period 1|Adverse Event|1|||
170639912|NCT02675634|616693784|FG004|Test Period 1|Adverse Event|0|||
170639913|NCT02675634|616693785|FG005|Test Period 1|Adverse Event|0|||
170639914|NCT02675634|616693780|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
170639915|NCT02675634|616693781|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
170639916|NCT02675634|616693782|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
170639917|NCT02675634|616693783|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
170639918|NCT02675634|616693784|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
170639919|NCT02675634|616693785|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
170639920|NCT02675634|616693780|FG000|Test Period 2|Lack of Efficacy|1|||
170639921|NCT02675634|616693781|FG001|Test Period 2|Lack of Efficacy|0|||
170639922|NCT02675634|616693782|FG002|Test Period 2|Lack of Efficacy|0|||
170639923|NCT02675634|616693783|FG003|Test Period 2|Lack of Efficacy|0|||
170639924|NCT02675634|616693784|FG004|Test Period 2|Lack of Efficacy|0|||
170639925|NCT02675634|616693785|FG005|Test Period 2|Lack of Efficacy|0|||
170639926|NCT02675634|616693780|FG000|Test Period 2|Adverse Event|0|||
170639927|NCT02675634|616693781|FG001|Test Period 2|Adverse Event|0|||
170639928|NCT02675634|616693782|FG002|Test Period 2|Adverse Event|0|||
170639929|NCT02675634|616693783|FG003|Test Period 2|Adverse Event|0|||
170639930|NCT02675634|616693784|FG004|Test Period 2|Adverse Event|0|||
170639931|NCT02675634|616693785|FG005|Test Period 2|Adverse Event|1|||
170639932|NCT01941186|616693786|FG000|Follow-up|Lost to Follow-up|1|||
170639933|NCT01941186|616693787|FG001|Follow-up|Lost to Follow-up|0|||
170639934|NCT01623050|616693793|FG000|Overall Study|Lost to Follow-up|9|||
170639935|NCT00526071|616693794|FG000|Overall Study|Adverse Event|1|||
170639936|NCT00526071|616693794|FG000|Overall Study|Withdrawal by Subject|1|||
170639937|NCT00526071|616693794|FG000|Overall Study|Lack of Response to Study Drug|4|||
170481146|NCT01286467|616101736|FG002|Overall Study|Withdrawal by Subject|1|||
170481147|NCT01286467|616101737|FG003|Overall Study|Withdrawal by Subject|0|||
170481148|NCT01286467|616101734|FG000|Overall Study|Physician Decision|0|||
170481149|NCT01286467|616101735|FG001|Overall Study|Physician Decision|0|||
170481150|NCT01286467|616101736|FG002|Overall Study|Physician Decision|0|||
170481151|NCT01286467|616101737|FG003|Overall Study|Physician Decision|1|||
170481152|NCT01286467|616101734|FG000|Overall Study|Disease progression|3|||
170481153|NCT01286467|616101735|FG001|Overall Study|Disease progression|2|||
170481154|NCT01286467|616101736|FG002|Overall Study|Disease progression|2|||
170481155|NCT01286467|616101737|FG003|Overall Study|Disease progression|3|||
170481156|NCT01286467|616101734|FG000|Overall Study|Adverse Event|0|||
170481157|NCT01286467|616101735|FG001|Overall Study|Adverse Event|1|||
170481158|NCT01286467|616101736|FG002|Overall Study|Adverse Event|2|||
170481159|NCT01286467|616101737|FG003|Overall Study|Adverse Event|3|||
170481160|NCT01286467|616101734|FG000|Overall Study|Study drug stop longer than 14 days|0|||
170481161|NCT01286467|616101735|FG001|Overall Study|Study drug stop longer than 14 days|0|||
170481162|NCT01286467|616101736|FG002|Overall Study|Study drug stop longer than 14 days|1|||
170481163|NCT01286467|616101737|FG003|Overall Study|Study drug stop longer than 14 days|0|||
170481164|NCT03335475|616101738|FG000|Overall Study|Did not wear accelerometer|4|||
170481165|NCT03335475|616101739|FG001|Overall Study|Did not wear accelerometer|0|||
170481166|NCT03335475|616101738|FG000|Overall Study|Withdrawal by Subject|0|||
170481167|NCT03335475|616101739|FG001|Overall Study|Withdrawal by Subject|1|||
170481168|NCT03305848|616101740|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
170481169|NCT03305848|616101740|FG000|Overall Study|Physician Decision|2|||
170481170|NCT05906628|616101744|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
170481171|NCT05906628|616101745|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
170639938|NCT05300763|616693795|FG000|Overall Study|Adverse Event|0|||
170481172|NCT05906628|616101744|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
170639939|NCT05300763|616693796|FG001|Overall Study|Adverse Event|1|||
170639940|NCT05300763|616693795|FG000|Overall Study|Major Protocol Deviation|1|||
170639941|NCT05300763|616693796|FG001|Overall Study|Major Protocol Deviation|0|||
170639942|NCT05300763|616693795|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
170639943|NCT05300763|616693796|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
170895227|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
170895228|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
170895229|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
170895230|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
170895231|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
170895232|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
170895233|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
170481173|NCT05906628|616101745|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
170481174|NCT05906628|616101744|FG000|16-Week DBVC Period|Protocol Violation|4|||
170481175|NCT05906628|616101745|FG001|16-Week DBVC Period|Protocol Violation|2|||
170639944|NCT01485172|616693797|FG000|Overall Study|Adverse Event|2|||
170639945|NCT01485172|616693798|FG001|Overall Study|Adverse Event|1|||
170895234|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
170481176|NCT05906628|616101744|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
170481177|NCT05906628|616101745|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
170481178|NCT05906628|616101744|FG000|16-Week OLE Period|Death|1|||
170481179|NCT05906628|616101745|FG001|16-Week OLE Period|Death|0|||
170481180|NCT05906628|616101744|FG000|16-Week OLE Period|Lost to Follow-up|1|||
170481181|NCT05906628|616101745|FG001|16-Week OLE Period|Lost to Follow-up|1|||
170481182|NCT05906628|616101744|FG000|16-Week OLE Period|Protocol Violation|0|||
170481183|NCT05906628|616101745|FG001|16-Week OLE Period|Protocol Violation|1|||
170481184|NCT05906628|616101744|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
170481185|NCT05906628|616101745|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
170481186|NCT01108718|616101746|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
170481187|NCT01108718|616101747|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
170481188|NCT02301169|616101748|FG000|Overall Study|Adverse Event|1|||
170481189|NCT02301169|616101749|FG001|Overall Study|Adverse Event|0|||
170481190|NCT03762265|616101750|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
170481191|NCT03762265|616101751|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
170481192|NCT03762265|616101750|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
170481193|NCT03762265|616101751|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
170481194|NCT03762265|616101750|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
170481195|NCT03762265|616101751|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
170481196|NCT03762265|616101750|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
170481197|NCT03762265|616101751|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
170481198|NCT03762265|616101750|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
170481199|NCT03762265|616101751|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
170481200|NCT03762265|616101750|FG000|BT Period: Weeks 1 to 37|Other|0|||
170481201|NCT03762265|616101751|FG001|BT Period: Weeks 1 to 37|Other|1|||
170481202|NCT03762265|616101750|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
170481203|NCT03762265|616101751|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
170481204|NCT03762265|616101750|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
170895235|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
170895236|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
170895237|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
170895238|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
170895239|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
170481205|NCT03762265|616101751|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
170481206|NCT03762265|616101750|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
170481207|NCT03762265|616101751|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
170481208|NCT03762265|616101750|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
170481209|NCT03762265|616101751|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
170481210|NCT03762265|616101750|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
170481211|NCT03762265|616101751|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
170481212|NCT03762265|616101750|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
170481213|NCT03762265|616101751|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
170481214|NCT03762265|616101750|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
170481215|NCT03762265|616101751|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
170481216|NCT03762265|616101750|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
170481217|NCT03762265|616101751|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
170481218|NCT03762265|616101750|FG000|LTE Period: Weeks 61 to 109|Other|1|||
170481219|NCT03762265|616101751|FG001|LTE Period: Weeks 61 to 109|Other|0|||
170481220|NCT02289729|616101755|FG000|Overall Study|Lack of Efficacy|3|||
170481221|NCT02289729|616101755|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
170547937|NCT01107457|616350273|FG001|Part B and C|Lost to Follow-up|0|||
170547938|NCT01107457|616350274|FG002|Part B and C|Lost to Follow-up|0|||
170547939|NCT01107457|616350275|FG003|Part B and C|Lost to Follow-up|0|||
170547940|NCT01107457|616350276|FG004|Part B and C|Lost to Follow-up|0|||
170547941|NCT01107457|616350277|FG005|Part B and C|Lost to Follow-up|10|||
170547942|NCT01107457|616350272|FG000|Part B and C|Protocol Violation|0|||
170547943|NCT01107457|616350273|FG001|Part B and C|Protocol Violation|0|||
170547944|NCT01107457|616350274|FG002|Part B and C|Protocol Violation|0|||
170547945|NCT01107457|616350275|FG003|Part B and C|Protocol Violation|0|||
170547946|NCT01107457|616350276|FG004|Part B and C|Protocol Violation|0|||
170547947|NCT01107457|616350277|FG005|Part B and C|Protocol Violation|1|||
170547948|NCT01107457|616350272|FG000|Part B and C|Sponsor Decision|0|||
170547949|NCT01107457|616350273|FG001|Part B and C|Sponsor Decision|0|||
170547950|NCT01107457|616350274|FG002|Part B and C|Sponsor Decision|0|||
170481222|NCT02289729|616101755|FG000|Overall Study|Withdrawal by Subject|1|||
170481223|NCT02289729|616101755|FG000|Overall Study|Death|1|||
170481224|NCT02198963|616101761|FG000|Overall Study|Adverse Event|1|||
170481225|NCT02198963|616101761|FG000|Overall Study|Withdrawal by Subject|6|||
170481226|NCT02208089|616101769|FG000|Overall Study|Withdrawal by Subject|1|||
170547951|NCT01107457|616350275|FG003|Part B and C|Sponsor Decision|0|||
170547952|NCT01107457|616350276|FG004|Part B and C|Sponsor Decision|0|||
170481227|NCT02208089|616101770|FG001|Overall Study|Withdrawal by Subject|0|||
170481228|NCT02208089|616101769|FG000|Overall Study|Lost to Follow-up|6|||
170481229|NCT02208089|616101770|FG001|Overall Study|Lost to Follow-up|0|||
170481230|NCT02443740|616101771|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
170795084|NCT04311632|617260116|FG002|Overall Study|Withdrawal by Subject|1|||
170795085|NCT05856435|617260117|FG000|Overall Study|Lost to Follow-up|6|||
170795086|NCT04605159|617260118|FG000|Overall Study|Adverse Event|6|||
170795087|NCT04605159|617260119|FG001|Overall Study|Adverse Event|3|||
170795088|NCT04605159|617260120|FG002|Overall Study|Adverse Event|21|||
170795089|NCT04605159|617260121|FG003|Overall Study|Adverse Event|4|||
170795090|NCT04605159|617260118|FG000|Overall Study|Lost to Follow-up|74|||
170795091|NCT04605159|617260119|FG001|Overall Study|Lost to Follow-up|45|||
170795092|NCT04605159|617260120|FG002|Overall Study|Lost to Follow-up|119|||
170795093|NCT04605159|617260121|FG003|Overall Study|Lost to Follow-up|80|||
170795094|NCT04605159|617260118|FG000|Overall Study|Protocol Violation|4|||
170795095|NCT04605159|617260119|FG001|Overall Study|Protocol Violation|5|||
170481231|NCT02443740|616101772|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
170481232|NCT02443740|616101773|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
170481233|NCT02443740|616101774|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
170481234|NCT02443740|616101775|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
170481235|NCT02443740|616101776|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
170481236|NCT02443740|616101777|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
170795096|NCT04605159|617260120|FG002|Overall Study|Protocol Violation|2|||
170795097|NCT04605159|617260121|FG003|Overall Study|Protocol Violation|0|||
170795098|NCT04605159|617260118|FG000|Overall Study|Withdrawal by Subject|66|||
170795099|NCT04605159|617260119|FG001|Overall Study|Withdrawal by Subject|37|||
170795100|NCT04605159|617260120|FG002|Overall Study|Withdrawal by Subject|68|||
170795101|NCT04605159|617260121|FG003|Overall Study|Withdrawal by Subject|50|||
170795102|NCT04605159|617260118|FG000|Overall Study|Migrated / moved from the study area|32|||
170795103|NCT04605159|617260119|FG001|Overall Study|Migrated / moved from the study area|22|||
170795104|NCT04605159|617260120|FG002|Overall Study|Migrated / moved from the study area|41|||
170795105|NCT04605159|617260121|FG003|Overall Study|Migrated / moved from the study area|21|||
170795106|NCT04605159|617260118|FG000|Overall Study|Other|1|||
170795107|NCT04605159|617260119|FG001|Overall Study|Other|2|||
170795108|NCT04605159|617260120|FG002|Overall Study|Other|7|||
170795109|NCT04605159|617260121|FG003|Overall Study|Other|3|||
170795110|NCT03221426|617260125|FG000|Overall Study|Ongoing in study|212|||
170795111|NCT03221426|617260126|FG001|Overall Study|Ongoing in study|193|||
170795112|NCT03221426|617260127|FG002|Overall Study|Ongoing in study|61|||
170795113|NCT03221426|617260128|FG003|Overall Study|Ongoing in study|55|||
170795114|NCT03221426|617260125|FG000|Overall Study|Withdrawal by Subject|12|||
170795115|NCT03221426|617260126|FG001|Overall Study|Withdrawal by Subject|4|||
170795116|NCT03221426|617260127|FG002|Overall Study|Withdrawal by Subject|2|||
170795117|NCT03221426|617260128|FG003|Overall Study|Withdrawal by Subject|3|||
170795118|NCT03221426|617260125|FG000|Overall Study|Lost to Follow-up|4|||
170795119|NCT03221426|617260126|FG001|Overall Study|Lost to Follow-up|1|||
170795120|NCT03221426|617260127|FG002|Overall Study|Lost to Follow-up|1|||
170795121|NCT03221426|617260128|FG003|Overall Study|Lost to Follow-up|0|||
170795122|NCT03221426|617260125|FG000|Overall Study|Death|174|||
170795123|NCT03221426|617260126|FG001|Overall Study|Death|204|||
170795124|NCT03221426|617260127|FG002|Overall Study|Death|36|||
170481237|NCT02443740|616101778|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
170481238|NCT02443740|616101779|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
170481239|NCT02443740|616101780|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
170481240|NCT02443740|616101781|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
170481241|NCT02443740|616101771|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
170481242|NCT02443740|616101772|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481243|NCT02443740|616101773|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481244|NCT02443740|616101774|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481245|NCT02443740|616101775|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481246|NCT02443740|616101776|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481247|NCT02443740|616101777|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
170481248|NCT02443740|616101778|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481249|NCT02443740|616101779|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481250|NCT02443740|616101780|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481251|NCT02443740|616101781|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
170481252|NCT02443740|616101771|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170481253|NCT02443740|616101772|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170547953|NCT01107457|616350277|FG005|Part B and C|Sponsor Decision|66|||
170547954|NCT01107457|616350272|FG000|Part B and C|Withdrawal by Subject|0|||
170795125|NCT03221426|617260128|FG003|Overall Study|Death|45|||
170795126|NCT03505710|617261683|FG000|Overall Study|Progressive Disease|24|||
170795127|NCT03505710|617261684|FG001|Overall Study|Progressive Disease|17|||
170795128|NCT03505710|617261685|FG002|Overall Study|Progressive Disease|43|||
170481254|NCT02443740|616101773|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170481255|NCT02443740|616101774|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170481256|NCT02443740|616101775|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170547955|NCT01107457|616350273|FG001|Part B and C|Withdrawal by Subject|0|||
170481257|NCT02443740|616101776|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
170481258|NCT02443740|616101777|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170481259|NCT02443740|616101778|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170481260|NCT02443740|616101779|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170481261|NCT02443740|616101780|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170481262|NCT02443740|616101781|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
170481263|NCT01074944|616101783|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
170481264|NCT01074944|616101784|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
170481265|NCT01074944|616101785|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
170481266|NCT01074944|616101786|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
170481267|NCT01074944|616101787|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
170481268|NCT01074944|616101783|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
170481269|NCT01074944|616101784|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
170481270|NCT01074944|616101785|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
170481271|NCT01074944|616101786|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
170547956|NCT01107457|616350274|FG002|Part B and C|Withdrawal by Subject|0|||
170547957|NCT01107457|616350275|FG003|Part B and C|Withdrawal by Subject|0|||
170547958|NCT01107457|616350276|FG004|Part B and C|Withdrawal by Subject|0|||
170547959|NCT01107457|616350277|FG005|Part B and C|Withdrawal by Subject|16|||
170547960|NCT01107457|616350272|FG000|Part B and C|Clinical Relapse|0|||
170547961|NCT01107457|616350273|FG001|Part B and C|Clinical Relapse|0|||
170547962|NCT01107457|616350274|FG002|Part B and C|Clinical Relapse|0|||
170547963|NCT01107457|616350275|FG003|Part B and C|Clinical Relapse|0|||
170547964|NCT01107457|616350276|FG004|Part B and C|Clinical Relapse|0|||
170547965|NCT01107457|616350277|FG005|Part B and C|Clinical Relapse|4|||
170547966|NCT01483651|616350278|FG000|Overall Study|Withdrawal by Subject|0|||
170547967|NCT01483651|616350279|FG001|Overall Study|Withdrawal by Subject|1|||
170547968|NCT01483651|616350280|FG002|Overall Study|Withdrawal by Subject|1|||
170547969|NCT01483651|616350281|FG003|Overall Study|Withdrawal by Subject|0|||
170547970|NCT01483651|616350282|FG004|Overall Study|Withdrawal by Subject|0|||
170547971|NCT01483651|616350283|FG005|Overall Study|Withdrawal by Subject|1|||
170547972|NCT02547935|616350290|FG000|Overall Study|Other|0|||
170547973|NCT02547935|616350291|FG001|Overall Study|Other|1|||
170547974|NCT02547935|616350292|FG002|Overall Study|Other|0|||
170547975|NCT02547935|616350290|FG000|Overall Study|Withdrawal by Subject|2|||
170547976|NCT02547935|616350291|FG001|Overall Study|Withdrawal by Subject|3|||
170547977|NCT02547935|616350292|FG002|Overall Study|Withdrawal by Subject|4|||
170547978|NCT02547935|616350290|FG000|Overall Study|Screen Failure|2|||
170547979|NCT02547935|616350291|FG001|Overall Study|Screen Failure|0|||
170547980|NCT02547935|616350292|FG002|Overall Study|Screen Failure|0|||
170895240|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
170895241|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
170895242|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
170895243|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
170895244|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
170895245|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
170895246|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
170895247|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
170895248|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
170547981|NCT02547935|616350290|FG000|Overall Study|Physician Decision|0|||
170547982|NCT02547935|616350291|FG001|Overall Study|Physician Decision|1|||
170547983|NCT02547935|616350292|FG002|Overall Study|Physician Decision|0|||
170547984|NCT02547935|616350290|FG000|Overall Study|Lost to Follow-up|0|||
170547985|NCT02547935|616350291|FG001|Overall Study|Lost to Follow-up|2|||
170547986|NCT02547935|616350292|FG002|Overall Study|Lost to Follow-up|1|||
170547987|NCT02547935|616350290|FG000|Overall Study|Death|1|||
170547988|NCT02547935|616350291|FG001|Overall Study|Death|1|||
170481272|NCT01074944|616101787|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
170481273|NCT01074944|616101783|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
170481274|NCT01074944|616101784|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
170481275|NCT01074944|616101785|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
170481276|NCT01074944|616101786|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
170481277|NCT01074944|616101787|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
170481278|NCT01074944|616101783|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
170481279|NCT01074944|616101784|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
170481280|NCT01074944|616101785|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
170481281|NCT01074944|616101786|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
170481282|NCT01074944|616101787|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
170481283|NCT01074944|616101783|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
170481284|NCT01074944|616101784|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
170481285|NCT01074944|616101785|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
170481286|NCT01074944|616101786|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
170481287|NCT01074944|616101787|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
170481288|NCT01074944|616101783|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
170481289|NCT01074944|616101784|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
170481290|NCT01074944|616101785|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
170481291|NCT01074944|616101786|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
170481292|NCT01074944|616101787|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
170481293|NCT01074944|616101783|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
170481294|NCT01074944|616101784|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
170481295|NCT01074944|616101785|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
170481296|NCT01074944|616101786|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
170481297|NCT01074944|616101787|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
170481298|NCT01074944|616101783|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
170481299|NCT01074944|616101784|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
170481300|NCT01074944|616101785|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
170547989|NCT02547935|616350292|FG002|Overall Study|Death|0|||
170547990|NCT03020888|616350295|FG000|Overall Study|Physician Decision|4|||
170547991|NCT03020888|616350295|FG000|Overall Study|Withdrawal by Subject|6|||
170547992|NCT03020888|616350295|FG000|Overall Study|Insurance coverage|2|||
170795129|NCT03505710|617261683|FG000|Overall Study|Clinical Progression|6|||
170795130|NCT03505710|617261684|FG001|Overall Study|Clinical Progression|8|||
170795131|NCT03505710|617261685|FG002|Overall Study|Clinical Progression|3|||
170795132|NCT03505710|617261683|FG000|Overall Study|Adverse Event|12|||
170795133|NCT03505710|617261684|FG001|Overall Study|Adverse Event|6|||
170795134|NCT03505710|617261685|FG002|Overall Study|Adverse Event|28|||
170795135|NCT03505710|617261683|FG000|Overall Study|Withdrawal by Subject|1|||
170795136|NCT03505710|617261684|FG001|Overall Study|Withdrawal by Subject|3|||
170795137|NCT03505710|617261685|FG002|Overall Study|Withdrawal by Subject|7|||
170795138|NCT03505710|617261683|FG000|Overall Study|Physician Decision|1|||
170795139|NCT03505710|617261684|FG001|Overall Study|Physician Decision|1|||
170795140|NCT03505710|617261685|FG002|Overall Study|Physician Decision|2|||
170795141|NCT03505710|617261683|FG000|Overall Study|Death|4|||
170795142|NCT03505710|617261684|FG001|Overall Study|Death|5|||
170795143|NCT03505710|617261685|FG002|Overall Study|Death|6|||
170795144|NCT03505710|617261683|FG000|Overall Study|Other Reasons|1|||
170795145|NCT03505710|617261684|FG001|Overall Study|Other Reasons|1|||
170795146|NCT03505710|617261685|FG002|Overall Study|Other Reasons|1|||
170795147|NCT03505710|617261683|FG000|Overall Study|Study Terminated by Sponsor|0|||
170795148|NCT03505710|617261684|FG001|Overall Study|Study Terminated by Sponsor|0|||
170795149|NCT03505710|617261685|FG002|Overall Study|Study Terminated by Sponsor|1|||
170795150|NCT04024020|617261686|FG000|Overall Study|Withdrawal by Subject|2|||
170795151|NCT04024020|617261687|FG001|Overall Study|Withdrawal by Subject|2|||
170795152|NCT05269966|617261688|FG000|Overall Study|Adverse Event|4|||
170795153|NCT05269966|617261688|FG000|Overall Study|Withdrawal by Subject|1|||
170795154|NCT05269966|617261688|FG000|Overall Study|Lost to Follow-up|4|||
170795155|NCT05269966|617261688|FG000|Overall Study|Physician Decision|1|||
170795156|NCT06262347|617261689|FG000|Overall Study|Lost to Follow-up|4|||
170795157|NCT06262347|617261690|FG001|Overall Study|Lost to Follow-up|3|||
170795158|NCT06262347|617261689|FG000|Overall Study|Withdrawal by Subject|0|||
170795159|NCT06262347|617261690|FG001|Overall Study|Withdrawal by Subject|1|||
170795160|NCT03711474|617261691|FG000|Overall Study|Physician Decision|2|||
170795161|NCT03711474|617261692|FG001|Overall Study|Physician Decision|0|||
170547993|NCT03020888|616350295|FG000|Overall Study|Lost to Follow-up|1|||
170795162|NCT04304144|617261693|FG000|DLT Observation Period|Physician Decision|0|||
170795163|NCT04304144|617261694|FG001|DLT Observation Period|Physician Decision|1|||
170795164|NCT04304144|617261695|FG002|DLT Observation Period|Physician Decision|0|||
170795165|NCT04304144|617261696|FG003|DLT Observation Period|Physician Decision|0|||
170795166|NCT04304144|617261693|FG000|Continued Treatment Period|Adverse Event|0|||
170795167|NCT04304144|617261694|FG001|Continued Treatment Period|Adverse Event|1|||
170481301|NCT01074944|616101786|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
170481302|NCT01074944|616101787|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
170481303|NCT01074944|616101783|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
170481304|NCT01074944|616101784|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
170795168|NCT04304144|617261695|FG002|Continued Treatment Period|Adverse Event|0|||
170795169|NCT04304144|617261696|FG003|Continued Treatment Period|Adverse Event|0|||
170795170|NCT04304144|617261693|FG000|Continued Treatment Period|Death|0|||
170795171|NCT04304144|617261694|FG001|Continued Treatment Period|Death|0|||
170795172|NCT04304144|617261695|FG002|Continued Treatment Period|Death|1|||
170795173|NCT04304144|617261696|FG003|Continued Treatment Period|Death|2|||
170795174|NCT04304144|617261693|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
170795175|NCT04304144|617261694|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
170795176|NCT04304144|617261695|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
170795177|NCT04304144|617261696|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
170795178|NCT04304144|617261693|FG000|Continued Treatment Period|Other than specified|2|||
170795179|NCT04304144|617261694|FG001|Continued Treatment Period|Other than specified|0|||
170795180|NCT04304144|617261695|FG002|Continued Treatment Period|Other than specified|1|||
170795181|NCT04304144|617261696|FG003|Continued Treatment Period|Other than specified|1|||
170795182|NCT04660539|617261697|FG000|Overall Study|Adverse Event|10|||
170795183|NCT04660539|617261697|FG000|Overall Study|Lack of Efficacy|4|||
170795184|NCT04660539|617261697|FG000|Overall Study|Lost to Follow-up|5|||
170795185|NCT04660539|617261697|FG000|Overall Study|Non-Compliance With Study Drug|3|||
170795186|NCT04660539|617261697|FG000|Overall Study|Reason not Specified|12|||
170795187|NCT04660539|617261697|FG000|Overall Study|Pregnancy|2|||
170795188|NCT04660539|617261697|FG000|Overall Study|Protocol Violation|2|||
170795189|NCT04660539|617261697|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
170795190|NCT04660539|617261697|FG000|Overall Study|Withdrawal by Subject|21|||
170795191|NCT05618587|617261698|FG000|Overall Study|Lost to Follow-up|2|||
170795192|NCT05618587|617261699|FG001|Overall Study|Lost to Follow-up|0|||
170795193|NCT05167864|617261700|FG000|Overall Study|Lost to Follow-up|7|||
170795194|NCT05167864|617261701|FG001|Overall Study|Lost to Follow-up|6|||
170795195|NCT05167864|617261702|FG002|Overall Study|Lost to Follow-up|7|||
170795196|NCT05167864|617261703|FG003|Overall Study|Lost to Follow-up|9|||
170795197|NCT03852550|617261704|FG000|Overall Study|Lost to Follow-up|4|||
170795198|NCT03852550|617261705|FG001|Overall Study|Lost to Follow-up|3|||
170795199|NCT03852550|617261704|FG000|Overall Study|Only parent outcomes completed|0|||
170795200|NCT03852550|617261705|FG001|Overall Study|Only parent outcomes completed|1|||
170795201|NCT03852550|617261704|FG000|Overall Study|Withdrawal by Subject|1|||
170795202|NCT03852550|617261705|FG001|Overall Study|Withdrawal by Subject|0|||
170795203|NCT05204654|617261706|FG000|Overall Study|Study terminated due to time restraint|2|||
170795204|NCT05204654|617261707|FG001|Overall Study|Study terminated due to time restraint|2|||
170795205|NCT01828112|617261711|FG000|Treatment Phase|Adverse Event|7|||
170795206|NCT01828112|617261712|FG001|Treatment Phase|Adverse Event|8|||
170795207|NCT01828112|617261713|FG002|Treatment Phase|Adverse Event|0|||
170795208|NCT01828112|617261711|FG000|Treatment Phase|Death|9|||
170795209|NCT01828112|617261712|FG001|Treatment Phase|Death|5|||
170795210|NCT01828112|617261713|FG002|Treatment Phase|Death|0|||
170795211|NCT01828112|617261711|FG000|Treatment Phase|No longer required treatment|0|||
170795212|NCT01828112|617261712|FG001|Treatment Phase|No longer required treatment|1|||
170795213|NCT01828112|617261713|FG002|Treatment Phase|No longer required treatment|0|||
170795214|NCT01828112|617261711|FG000|Treatment Phase|Physician Decision|6|||
170795215|NCT01828112|617261712|FG001|Treatment Phase|Physician Decision|7|||
170795216|NCT01828112|617261713|FG002|Treatment Phase|Physician Decision|0|||
170795217|NCT01828112|617261711|FG000|Treatment Phase|Pregnancy|1|||
170795218|NCT01828112|617261712|FG001|Treatment Phase|Pregnancy|0|||
170795219|NCT01828112|617261713|FG002|Treatment Phase|Pregnancy|0|||
170795220|NCT01828112|617261711|FG000|Treatment Phase|Progressive disease|79|||
170795221|NCT01828112|617261712|FG001|Treatment Phase|Progressive disease|87|||
170795222|NCT01828112|617261713|FG002|Treatment Phase|Progressive disease|0|||
170795223|NCT01828112|617261711|FG000|Treatment Phase|Study terminated by sponsor|1|||
170795224|NCT01828112|617261712|FG001|Treatment Phase|Study terminated by sponsor|0|||
170795225|NCT01828112|617261713|FG002|Treatment Phase|Study terminated by sponsor|0|||
170795226|NCT01828112|617261711|FG000|Treatment Phase|Subject/guardian decision|12|||
170795227|NCT01828112|617261712|FG001|Treatment Phase|Subject/guardian decision|8|||
170795228|NCT01828112|617261713|FG002|Treatment Phase|Subject/guardian decision|0|||
170795229|NCT01828112|617261711|FG000|Extension Treatment Phase|Adverse Event|0|||
170795230|NCT01828112|617261712|FG001|Extension Treatment Phase|Adverse Event|0|||
170795231|NCT01828112|617261713|FG002|Extension Treatment Phase|Adverse Event|6|||
170795232|NCT01828112|617261711|FG000|Extension Treatment Phase|Death|0|||
170795233|NCT01828112|617261712|FG001|Extension Treatment Phase|Death|0|||
170795234|NCT01828112|617261713|FG002|Extension Treatment Phase|Death|17|||
170795235|NCT01828112|617261711|FG000|Extension Treatment Phase|Physician Decision|0|||
170795236|NCT01828112|617261712|FG001|Extension Treatment Phase|Physician Decision|0|||
170795237|NCT01828112|617261713|FG002|Extension Treatment Phase|Physician Decision|5|||
170795238|NCT01828112|617261711|FG000|Extension Treatment Phase|Progressive disease|0|||
170795239|NCT01828112|617261712|FG001|Extension Treatment Phase|Progressive disease|0|||
170795240|NCT01828112|617261713|FG002|Extension Treatment Phase|Progressive disease|46|||
170795241|NCT01828112|617261711|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
170795242|NCT01828112|617261712|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
170795243|NCT01828112|617261713|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
170795244|NCT01828112|617261711|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
170795245|NCT01828112|617261712|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
170795246|NCT01828112|617261713|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
170481305|NCT01074944|616101785|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
170481306|NCT01074944|616101786|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
170481307|NCT01074944|616101787|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
170481308|NCT01074944|616101783|FG000|Long Term Treatment|Adverse Event|0|||
170481309|NCT01074944|616101784|FG001|Long Term Treatment|Adverse Event|0|||
170481310|NCT01074944|616101785|FG002|Long Term Treatment|Adverse Event|0|||
170481311|NCT01074944|616101786|FG003|Long Term Treatment|Adverse Event|3|||
170481312|NCT01074944|616101787|FG004|Long Term Treatment|Adverse Event|0|||
170481313|NCT01074944|616101783|FG000|Long Term Treatment|Lost to Follow-up|0|||
170481314|NCT01074944|616101784|FG001|Long Term Treatment|Lost to Follow-up|0|||
170547994|NCT01937117|616350299|FG000|Overall Study|Disease Progression|7|||
170547995|NCT01937117|616350299|FG000|Overall Study|Physician Decision|4|||
170547996|NCT01937117|616350299|FG000|Overall Study|Adverse Event|2|||
170547997|NCT01407367|616350300|FG000|Overall Study|Death|24|||
170795247|NCT05565820|617261724|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
170795248|NCT05565820|617261725|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
170795249|NCT05565820|617261724|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
170547998|NCT01407367|616350301|FG001|Overall Study|Death|32|||
170795250|NCT05565820|617261725|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
170795251|NCT04871529|617261731|FG000|Overall Study|Withdrawal by Subject|0|||
170795252|NCT04871529|617261732|FG001|Overall Study|Withdrawal by Subject|1|||
170795253|NCT04871529|617261731|FG000|Overall Study|Death|0|||
170795254|NCT04871529|617261732|FG001|Overall Study|Death|1|||
170795255|NCT04871529|617261731|FG000|Overall Study|Not protocol specified|0|||
170795256|NCT04871529|617261732|FG001|Overall Study|Not protocol specified|1|||
170481315|NCT01074944|616101785|FG002|Long Term Treatment|Lost to Follow-up|0|||
170481316|NCT01074944|616101786|FG003|Long Term Treatment|Lost to Follow-up|2|||
170481317|NCT01074944|616101787|FG004|Long Term Treatment|Lost to Follow-up|0|||
170795257|NCT03606408|617261733|FG000|Overall Study|Adverse Event|13|||
170795258|NCT03606408|617261733|FG000|Overall Study|Withdrawal by Subject|7|||
170795259|NCT03606408|617261733|FG000|Overall Study|Physician Decision|4|||
170795260|NCT03606408|617261733|FG000|Overall Study|Lack of Efficacy|2|||
170795261|NCT03606408|617261733|FG000|Overall Study|Death|1|||
170795262|NCT03606408|617261733|FG000|Overall Study|new therapy for study indication|1|||
170795263|NCT04003246|617261737|FG000|Overall Study|Death|9|||
170795264|NCT04132518|617261740|FG000|Overall Study|Prematurely withdrawn from the study|0|||
170795265|NCT04132518|617261741|FG001|Overall Study|Prematurely withdrawn from the study|9|||
170795266|NCT04132518|617261742|FG002|Overall Study|Prematurely withdrawn from the study|1|||
170795267|NCT03824366|617261758|FG000|Overall Study|Death|1|||
170795268|NCT03824366|617261758|FG000|Overall Study|Previously unidentified metal artifact|1|||
170795269|NCT03824366|617261758|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
170795270|NCT03824366|617261758|FG000|Overall Study|Withdrawal by Subject|1|||
170795271|NCT04580914|617261763|FG000|Overall Study|Withdrawal by Subject|6|||
170795272|NCT04580914|617261763|FG000|Overall Study|Lost to Follow-up|2|||
170795273|NCT03485729|617261771|FG000|Overall Study|Withdrawal by Subject|0|||
170795274|NCT03485729|617261772|FG001|Overall Study|Withdrawal by Subject|0|||
170795275|NCT03485729|617261773|FG002|Overall Study|Withdrawal by Subject|1|||
170795276|NCT03485729|617261771|FG000|Overall Study|Disease progression|8|||
170795277|NCT03485729|617261772|FG001|Overall Study|Disease progression|13|||
170795278|NCT03485729|617261773|FG002|Overall Study|Disease progression|1|||
170795279|NCT03485729|617261771|FG000|Overall Study|Hospice care|1|||
170795280|NCT03485729|617261772|FG001|Overall Study|Hospice care|0|||
170795281|NCT03485729|617261773|FG002|Overall Study|Hospice care|0|||
170795282|NCT03485729|617261771|FG000|Overall Study|Poor performance status|1|||
170795283|NCT03485729|617261772|FG001|Overall Study|Poor performance status|0|||
170795284|NCT03485729|617261773|FG002|Overall Study|Poor performance status|0|||
170795285|NCT03485729|617261771|FG000|Overall Study|Illness|0|||
170795286|NCT03485729|617261772|FG001|Overall Study|Illness|1|||
170547999|NCT01407367|616350300|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
170548000|NCT01407367|616350301|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
170481318|NCT01074944|616101783|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
170481319|NCT01074944|616101784|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
170481320|NCT01074944|616101785|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
170481321|NCT01074944|616101786|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
170481322|NCT01074944|616101787|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
170481323|NCT01074944|616101783|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
170481324|NCT01074944|616101784|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
170481325|NCT01074944|616101785|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
170481326|NCT01074944|616101786|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
170481327|NCT01074944|616101787|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
170481328|NCT01074944|616101783|FG000|Long Term Treatment|Withdrawal by Subject|0|||
170481329|NCT01074944|616101784|FG001|Long Term Treatment|Withdrawal by Subject|0|||
170481330|NCT01074944|616101785|FG002|Long Term Treatment|Withdrawal by Subject|0|||
170481331|NCT01074944|616101786|FG003|Long Term Treatment|Withdrawal by Subject|2|||
170481332|NCT01074944|616101787|FG004|Long Term Treatment|Withdrawal by Subject|0|||
170481333|NCT01074944|616101783|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
170481334|NCT01074944|616101784|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
170481335|NCT01074944|616101785|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
170481336|NCT01074944|616101786|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
170481337|NCT01074944|616101787|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
170481338|NCT01074944|616101783|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
170481339|NCT01074944|616101784|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
170481340|NCT01074944|616101785|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
170481341|NCT01074944|616101786|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
170481342|NCT01074944|616101787|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
170481343|NCT02046603|616101789|FG000|Overall Study|Other|11|||
170481344|NCT02046603|616101790|FG001|Overall Study|Other|66|||
170481345|NCT02046603|616101789|FG000|Overall Study|Protocol Violation|0|||
170481346|NCT02046603|616101790|FG001|Overall Study|Protocol Violation|1|||
170481347|NCT02046603|616101789|FG000|Overall Study|Participant/legal guardian decision|1|||
170481348|NCT02046603|616101790|FG001|Overall Study|Participant/legal guardian decision|3|||
170639946|NCT01485172|616693799|FG002|Overall Study|Adverse Event|2|||
170639947|NCT01485172|616693800|FG003|Overall Study|Adverse Event|2|||
170639948|NCT01485172|616693801|FG004|Overall Study|Adverse Event|1|||
170639949|NCT01485172|616693802|FG005|Overall Study|Adverse Event|2|||
170639950|NCT01485172|616693797|FG000|Overall Study|Lack of Efficacy|2|||
170795287|NCT03485729|617261773|FG002|Overall Study|Illness|0|||
170795288|NCT05035654|617261775|FG000|Overall Study|Physician Decision|0|||
170795289|NCT05035654|617261776|FG001|Overall Study|Physician Decision|1|||
170795290|NCT05035654|617261777|FG002|Overall Study|Physician Decision|0|||
170795291|NCT05035654|617261775|FG000|Overall Study|Adverse Event|0|||
170795292|NCT05035654|617261776|FG001|Overall Study|Adverse Event|1|||
170795293|NCT05035654|617261777|FG002|Overall Study|Adverse Event|0|||
170795294|NCT05035654|617261775|FG000|Overall Study|Withdrawal by Subject|0|||
170795295|NCT05035654|617261776|FG001|Overall Study|Withdrawal by Subject|0|||
170795296|NCT05035654|617261777|FG002|Overall Study|Withdrawal by Subject|4|||
170795297|NCT05035654|617261775|FG000|Overall Study|Bilateral Dislodgement|1|||
170795298|NCT05035654|617261776|FG001|Overall Study|Bilateral Dislodgement|0|||
170795299|NCT05035654|617261777|FG002|Overall Study|Bilateral Dislodgement|0|||
170795300|NCT04632225|617261782|FG000|Overall Study|Withdrawal by Subject|2|||
170795301|NCT04632225|617261783|FG001|Overall Study|Withdrawal by Subject|2|||
170795302|NCT04934072|617261785|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
170795303|NCT04934072|617261786|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
170795304|NCT04934072|617261787|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
170795305|NCT04934072|617261788|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
170795306|NCT04934072|617261789|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
170795307|NCT04934072|617261785|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
170795308|NCT04934072|617261786|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
170795309|NCT04934072|617261787|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
170795310|NCT04934072|617261788|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
170795311|NCT04934072|617261789|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
170795312|NCT04934072|617261785|FG000|Day 0 to Week 52|Other|3|||
170795313|NCT04934072|617261786|FG001|Day 0 to Week 52|Other|1|||
170795314|NCT04934072|617261787|FG002|Day 0 to Week 52|Other|0|||
170795315|NCT04934072|617261788|FG003|Day 0 to Week 52|Other|0|||
170795316|NCT04934072|617261789|FG004|Day 0 to Week 52|Other|0|||
170795317|NCT04934072|617261785|FG000|Day 0 to Week 52|Adverse Event|1|||
170795318|NCT04934072|617261786|FG001|Day 0 to Week 52|Adverse Event|3|||
170795319|NCT04934072|617261787|FG002|Day 0 to Week 52|Adverse Event|0|||
170795320|NCT04934072|617261788|FG003|Day 0 to Week 52|Adverse Event|0|||
170795321|NCT04934072|617261789|FG004|Day 0 to Week 52|Adverse Event|0|||
170795322|NCT04934072|617261785|FG000|Week 52 to Week 78|Adverse Event|0|||
170795323|NCT04934072|617261786|FG001|Week 52 to Week 78|Adverse Event|0|||
170548001|NCT01407367|616350300|FG000|Overall Study|Withdrawal by Subject|4|||
170548002|NCT01407367|616350301|FG001|Overall Study|Withdrawal by Subject|15|||
170548003|NCT01407367|616350300|FG000|Overall Study|Lost to Follow-up|0|||
170548004|NCT01407367|616350301|FG001|Overall Study|Lost to Follow-up|2|||
170548005|NCT02186171|616350304|FG000|Overall Study|Withdrawal by Subject|1|||
170548006|NCT02186171|616350305|FG001|Overall Study|Withdrawal by Subject|9|||
170548007|NCT02186171|616350304|FG000|Overall Study|Lost to Follow-up|2|||
170895249|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
170548008|NCT02186171|616350305|FG001|Overall Study|Lost to Follow-up|2|||
170548009|NCT02186171|616350304|FG000|Overall Study|Death|1|||
170548010|NCT02186171|616350305|FG001|Overall Study|Death|2|||
170548011|NCT02186171|616350304|FG000|Overall Study|Protocol-specified Criteria|0|||
170548012|NCT02186171|616350305|FG001|Overall Study|Protocol-specified Criteria|2|||
170548013|NCT01452347|616350306|FG000|Overall Study|Adverse Event|2|||
170548014|NCT01452347|616350307|FG001|Overall Study|Adverse Event|1|||
170548015|NCT01452347|616350306|FG000|Overall Study|Non compliance protocol|2|||
170548016|NCT01452347|616350307|FG001|Overall Study|Non compliance protocol|0|||
170548017|NCT01452347|616350306|FG000|Overall Study|Lost to Follow-up|2|||
170548018|NCT01452347|616350307|FG001|Overall Study|Lost to Follow-up|0|||
170548019|NCT01452347|616350306|FG000|Overall Study|Withdrawal by Subject|3|||
170548020|NCT01452347|616350307|FG001|Overall Study|Withdrawal by Subject|3|||
170895250|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
170895251|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
170895252|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
170895253|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
170895254|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
170895255|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
170895256|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
170895257|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
170895258|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
170895259|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
170895260|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
170895261|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
170895262|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
170895263|NCT00289913|617624220|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
170895264|NCT00289913|617624221|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
170895265|NCT00289913|617624222|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
170895266|NCT00289913|617624223|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
170895267|NCT00289913|617624224|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
170895268|NCT00289913|617624220|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895269|NCT00289913|617624221|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
170895270|NCT00289913|617624222|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895271|NCT00289913|617624223|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895272|NCT00289913|617624224|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
170895273|NCT00289913|617624220|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
170895274|NCT00289913|617624221|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
170895275|NCT00289913|617624222|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
170895276|NCT00289913|617624223|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
170895277|NCT00289913|617624224|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
170895278|NCT00289913|617624220|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
170895279|NCT00289913|617624221|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
170895280|NCT00289913|617624222|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
170895281|NCT00289913|617624223|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
170895282|NCT00289913|617624224|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
170895283|NCT00289913|617624220|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895284|NCT00289913|617624221|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895285|NCT00289913|617624222|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895286|NCT00289913|617624223|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
170895287|NCT00289913|617624224|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
170895288|NCT00289913|617624220|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
170895289|NCT00289913|617624221|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
170895290|NCT00289913|617624222|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
170895291|NCT00289913|617624223|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
170895292|NCT00289913|617624224|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
170548021|NCT01452347|616350306|FG000|Overall Study|Not treated|6|||
170548022|NCT01452347|616350307|FG001|Overall Study|Not treated|3|||
170548023|NCT01452347|616350306|FG000|Overall Study|Other reason not defined above|2|||
170548024|NCT01452347|616350307|FG001|Overall Study|Other reason not defined above|0|||
170481349|NCT02046603|616101789|FG000|Overall Study|Physician Decision|2|||
170481350|NCT02046603|616101790|FG001|Overall Study|Physician Decision|1|||
170481351|NCT02046603|616101789|FG000|Overall Study|Lost to Follow-up|1|||
170481352|NCT02046603|616101790|FG001|Overall Study|Lost to Follow-up|2|||
170481353|NCT02046603|616101789|FG000|Overall Study|Death|0|||
170481354|NCT02046603|616101790|FG001|Overall Study|Death|1|||
170481355|NCT02046603|616101789|FG000|Overall Study|Adverse Event|0|||
170481356|NCT02046603|616101790|FG001|Overall Study|Adverse Event|1|||
170481357|NCT02461160|616101791|FG000|Overall Study|Lost to Follow-up|0|||
170481358|NCT02461160|616101792|FG001|Overall Study|Lost to Follow-up|0|||
170481359|NCT02461160|616101793|FG002|Overall Study|Lost to Follow-up|0|||
170481360|NCT02461160|616101794|FG003|Overall Study|Lost to Follow-up|0|||
170481361|NCT02461160|616101795|FG004|Overall Study|Lost to Follow-up|0|||
170481362|NCT02461160|616101796|FG005|Overall Study|Lost to Follow-up|0|||
170481363|NCT02461160|616101797|FG006|Overall Study|Lost to Follow-up|0|||
170481364|NCT02461160|616101798|FG007|Overall Study|Lost to Follow-up|1|||
170481365|NCT02461160|616101799|FG008|Overall Study|Lost to Follow-up|0|||
170481366|NCT02461160|616101800|FG009|Overall Study|Lost to Follow-up|0|||
170481367|NCT02461160|616101801|FG010|Overall Study|Lost to Follow-up|0|||
170481368|NCT02461160|616101802|FG011|Overall Study|Lost to Follow-up|0|||
170481369|NCT02461160|616101803|FG012|Overall Study|Lost to Follow-up|0|||
170481370|NCT02072980|616101804|FG000|Period 2, Second Wear|Adverse Event|0|||
170481371|NCT02072980|616101805|FG001|Period 2, Second Wear|Adverse Event|1|||
170481372|NCT00193050|616101806|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
170481373|NCT00193050|616101806|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
170481374|NCT00193050|616101806|FG000|Neoadjuvant Treatment|Physician Decision|2|||
170481375|NCT00193050|616101806|FG000|Neoadjuvant Treatment|Adverse Event|2|||
170481376|NCT00193050|616101806|FG000|Adjuvant|Physician Decision|5|||
170481377|NCT00193050|616101806|FG000|Adjuvant|Intercurrent Hospitalization|3|||
170481378|NCT00193050|616101806|FG000|Adjuvant|Lack of Efficacy|2|||
170481379|NCT04314037|616101807|FG000|Treatment Period 2|Adverse Event|1|||
170481380|NCT04314037|616101808|FG001|Treatment Period 2|Adverse Event|0|||
170481381|NCT04314037|616101807|FG000|Treatment Period 3|Protocol Violation|1|||
170481382|NCT04314037|616101808|FG001|Treatment Period 3|Protocol Violation|0|||
170481383|NCT04314037|616101807|FG000|Treatment Period 3|Adverse Event|0|||
170481384|NCT04314037|616101808|FG001|Treatment Period 3|Adverse Event|1|||
170481385|NCT00856492|616101809|FG000|Overall Study|Ineligible or withdrew consent|1|||
170481386|NCT00856492|616101810|FG001|Overall Study|Ineligible or withdrew consent|1|||
170481387|NCT00856492|616101811|FG002|Overall Study|Ineligible or withdrew consent|2|||
170481388|NCT06389487|616101812|FG000|Overall Study|Lost to Follow-up|9|||
170639951|NCT01485172|616693798|FG001|Overall Study|Lack of Efficacy|0|||
170639952|NCT01485172|616693799|FG002|Overall Study|Lack of Efficacy|0|||
170639953|NCT01485172|616693800|FG003|Overall Study|Lack of Efficacy|0|||
170481389|NCT06389487|616101813|FG001|Overall Study|Lost to Follow-up|5|||
170481390|NCT06389487|616101814|FG002|Overall Study|Lost to Follow-up|13|||
170481391|NCT06389487|616101812|FG000|Overall Study|Protocol Violation|0|||
170481392|NCT06389487|616101813|FG001|Overall Study|Protocol Violation|0|||
170481393|NCT06389487|616101814|FG002|Overall Study|Protocol Violation|2|||
170481394|NCT06389487|616101812|FG000|Overall Study|Withdrawal by Subject|2|||
170481395|NCT06389487|616101813|FG001|Overall Study|Withdrawal by Subject|2|||
170481396|NCT06389487|616101814|FG002|Overall Study|Withdrawal by Subject|1|||
170481397|NCT06389487|616101812|FG000|Overall Study|Other|1|||
170481398|NCT06389487|616101813|FG001|Overall Study|Other|0|||
170481399|NCT06389487|616101814|FG002|Overall Study|Other|1|||
170481400|NCT00625820|616101815|FG000|Overall Study|Withdrawal by Subject|1|||
170481401|NCT05258773|616103410|FG000|Overall Study|Screen Failure|1|||
170481402|NCT05258773|616103411|FG001|Overall Study|Screen Failure|1|||
170481403|NCT05258773|616103410|FG000|Overall Study|Adverse Event|1|||
170481404|NCT05258773|616103411|FG001|Overall Study|Adverse Event|0|||
170481405|NCT05258773|616103410|FG000|Overall Study|Withdrawal by Subject|0|||
170481406|NCT05258773|616103411|FG001|Overall Study|Withdrawal by Subject|1|||
170481407|NCT03018288|616103412|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
170481408|NCT03018288|616103413|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
170481409|NCT03018288|616103414|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
170481410|NCT03018288|616103415|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
170481411|NCT03018288|616103412|FG000|Overall Study|Participant withdrew consent.|0|||
170481412|NCT03018288|616103413|FG001|Overall Study|Participant withdrew consent.|0|||
170481413|NCT03018288|616103414|FG002|Overall Study|Participant withdrew consent.|1|||
170481414|NCT03018288|616103415|FG003|Overall Study|Participant withdrew consent.|0|||
170481415|NCT03018288|616103412|FG000|Overall Study|Switched to alternative treatment.|0|||
170481416|NCT03018288|616103413|FG001|Overall Study|Switched to alternative treatment.|0|||
170481417|NCT03018288|616103414|FG002|Overall Study|Switched to alternative treatment.|1|||
170481418|NCT03018288|616103415|FG003|Overall Study|Switched to alternative treatment.|0|||
170639954|NCT01485172|616693801|FG004|Overall Study|Lack of Efficacy|0|||
170481419|NCT03018288|616103412|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
170481420|NCT03018288|616103413|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
170639955|NCT01485172|616693802|FG005|Overall Study|Lack of Efficacy|0|||
170481421|NCT03018288|616103414|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
170481422|NCT03018288|616103415|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
170481423|NCT03018288|616103412|FG000|Overall Study|Screen failures|0|||
170481424|NCT03018288|616103413|FG001|Overall Study|Screen failures|0|||
170481425|NCT03018288|616103414|FG002|Overall Study|Screen failures|0|||
170481426|NCT03018288|616103415|FG003|Overall Study|Screen failures|51|||
170481427|NCT03018288|616103412|FG000|Overall Study|Chose treatment outside of UNC|0|||
170481428|NCT03018288|616103413|FG001|Overall Study|Chose treatment outside of UNC|0|||
170481429|NCT03018288|616103414|FG002|Overall Study|Chose treatment outside of UNC|0|||
170481430|NCT03018288|616103415|FG003|Overall Study|Chose treatment outside of UNC|1|||
170481431|NCT03018288|616103412|FG000|Overall Study|Unable to comply with protocol requirements|1|||
170481432|NCT03018288|616103413|FG001|Overall Study|Unable to comply with protocol requirements|1|||
170481433|NCT03018288|616103414|FG002|Overall Study|Unable to comply with protocol requirements|0|||
170481434|NCT03018288|616103415|FG003|Overall Study|Unable to comply with protocol requirements|1|||
170481435|NCT03018288|616103412|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
170481436|NCT03018288|616103413|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
170481437|NCT03018288|616103414|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
170481438|NCT03018288|616103415|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
170481439|NCT03018288|616103412|FG000|Overall Study|Physician Decision|0|||
170481440|NCT03018288|616103413|FG001|Overall Study|Physician Decision|0|||
170481441|NCT03018288|616103414|FG002|Overall Study|Physician Decision|0|||
170895293|NCT00289913|617624220|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
170895294|NCT00289913|617624221|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
170895295|NCT00289913|617624222|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
170895296|NCT00289913|617624223|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
170895297|NCT00289913|617624224|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
170895298|NCT00289913|617624220|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
170895299|NCT00289913|617624221|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
170895300|NCT00289913|617624222|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
170895301|NCT00289913|617624223|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
170895302|NCT00289913|617624224|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
170895303|NCT00289913|617624220|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
170895304|NCT00289913|617624221|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
170895305|NCT00289913|617624222|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
170895306|NCT00289913|617624223|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
170895307|NCT00289913|617624224|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
170895308|NCT03822884|617624225|FG000|Overall Study|Withdrawal by Subject|0|||
170895309|NCT03822884|617624226|FG001|Overall Study|Withdrawal by Subject|0|||
170895310|NCT03822884|617624227|FG002|Overall Study|Withdrawal by Subject|0|||
170895311|NCT03822884|617624228|FG003|Overall Study|Withdrawal by Subject|0|||
170895312|NCT03822884|617624229|FG004|Overall Study|Withdrawal by Subject|1|||
170895313|NCT03822884|617624230|FG005|Overall Study|Withdrawal by Subject|0|||
170895314|NCT00548548|617624234|FG000|Overall Study|Death|345|||
170895315|NCT00548548|617624235|FG001|Overall Study|Death|348|||
170895316|NCT00548548|617624234|FG000|Overall Study|Lost to Follow-up|17|||
170895317|NCT00548548|617624235|FG001|Overall Study|Lost to Follow-up|18|||
170895318|NCT03617705|617624236|FG000|Overall Study|Withdrawal by Subject|2|||
170895319|NCT03617705|617624236|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
170895320|NCT03617705|617624236|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
170895321|NCT06118385|617624237|FG000|Overall Study|Protocol Violation|0|||
170895322|NCT06118385|617624238|FG001|Overall Study|Protocol Violation|0|||
170895323|NCT06118385|617624239|FG002|Overall Study|Protocol Violation|0|||
170895324|NCT06118385|617624240|FG003|Overall Study|Protocol Violation|0|||
170481442|NCT03018288|616103415|FG003|Overall Study|Physician Decision|1|||
170481443|NCT00075816|616103420|FG000|Overall Study|Did not undergo transplantation|14|||
170481444|NCT00075816|616103421|FG001|Overall Study|Did not undergo transplantation|11|||
170481445|NCT01120184|616103426|FG000|Overall Study|Adverse Event|0|||
170481446|NCT01120184|616103427|FG001|Overall Study|Adverse Event|1|||
170481447|NCT01120184|616103428|FG002|Overall Study|Adverse Event|0|||
170481448|NCT01120184|616103426|FG000|Overall Study|Lost to Follow-up|13|||
170481449|NCT01120184|616103427|FG001|Overall Study|Lost to Follow-up|13|||
170481450|NCT01120184|616103428|FG002|Overall Study|Lost to Follow-up|11|||
170481451|NCT01120184|616103426|FG000|Overall Study|Physician Decision|9|||
170481452|NCT01120184|616103427|FG001|Overall Study|Physician Decision|1|||
170639956|NCT01485172|616693797|FG000|Overall Study|Protocol Violation|0|||
170895325|NCT06118385|617624241|FG004|Overall Study|Protocol Violation|0|||
170895326|NCT06118385|617624242|FG005|Overall Study|Protocol Violation|0|||
170895327|NCT06118385|617624243|FG006|Overall Study|Protocol Violation|0|||
170895328|NCT06118385|617624244|FG007|Overall Study|Protocol Violation|0|||
170481453|NCT01120184|616103428|FG002|Overall Study|Physician Decision|3|||
170639957|NCT01485172|616693798|FG001|Overall Study|Protocol Violation|0|||
170895329|NCT06118385|617624245|FG008|Overall Study|Protocol Violation|1|||
170895330|NCT06118385|617624246|FG009|Overall Study|Protocol Violation|0|||
170895331|NCT06118385|617624247|FG010|Overall Study|Protocol Violation|0|||
170895332|NCT06118385|617624248|FG011|Overall Study|Protocol Violation|0|||
170895333|NCT06118385|617624237|FG000|Overall Study|Out-of-range blood tests|0|||
170895334|NCT06118385|617624238|FG001|Overall Study|Out-of-range blood tests|0|||
170895335|NCT06118385|617624239|FG002|Overall Study|Out-of-range blood tests|0|||
170895336|NCT06118385|617624240|FG003|Overall Study|Out-of-range blood tests|0|||
170895337|NCT06118385|617624241|FG004|Overall Study|Out-of-range blood tests|0|||
170895338|NCT06118385|617624242|FG005|Overall Study|Out-of-range blood tests|0|||
170895339|NCT06118385|617624243|FG006|Overall Study|Out-of-range blood tests|0|||
170895340|NCT06118385|617624244|FG007|Overall Study|Out-of-range blood tests|0|||
170895341|NCT06118385|617624245|FG008|Overall Study|Out-of-range blood tests|1|||
170895342|NCT06118385|617624246|FG009|Overall Study|Out-of-range blood tests|0|||
170895343|NCT06118385|617624247|FG010|Overall Study|Out-of-range blood tests|0|||
170895344|NCT06118385|617624248|FG011|Overall Study|Out-of-range blood tests|0|||
170895345|NCT03213366|617624249|FG000|Overall Study|Lost to Follow-up|9|||
170895346|NCT03213366|617624250|FG001|Overall Study|Lost to Follow-up|4|||
170895347|NCT02058147|617624251|FG000|Overall Study|Randomized but not treated|0|||
170895348|NCT02058147|617624252|FG001|Overall Study|Randomized but not treated|0|||
170895349|NCT02058147|617624253|FG002|Overall Study|Randomized but not treated|1|||
170895350|NCT02058147|617624251|FG000|Overall Study|Adverse Event|12|||
170895351|NCT02058147|617624252|FG001|Overall Study|Adverse Event|9|||
170895352|NCT02058147|617624253|FG002|Overall Study|Adverse Event|21|||
170895353|NCT02058147|617624251|FG000|Overall Study|Lack of Efficacy|1|||
170895354|NCT02058147|617624252|FG001|Overall Study|Lack of Efficacy|0|||
170895355|NCT02058147|617624253|FG002|Overall Study|Lack of Efficacy|3|||
170895356|NCT02058147|617624251|FG000|Overall Study|Poor compliance to protocol|8|||
170895357|NCT02058147|617624252|FG001|Overall Study|Poor compliance to protocol|9|||
170895358|NCT02058147|617624253|FG002|Overall Study|Poor compliance to protocol|4|||
170895359|NCT02058147|617624251|FG000|Overall Study|Other than specified|8|||
170895360|NCT02058147|617624252|FG001|Overall Study|Other than specified|9|||
170895361|NCT02058147|617624253|FG002|Overall Study|Other than specified|0|||
170895362|NCT00364182|617624258|FG000|First Intervention|Secondary prophylaxis|1|||
170895363|NCT00364182|617624259|FG001|First Intervention|Secondary prophylaxis|0|||
170895364|NCT00364182|617624260|FG002|First Intervention|Secondary prophylaxis|0|||
170895365|NCT00364182|617624258|FG000|First Intervention|Withdrawal by Subject|2|||
170895366|NCT00364182|617624259|FG001|First Intervention|Withdrawal by Subject|0|||
170895367|NCT00364182|617624260|FG002|First Intervention|Withdrawal by Subject|0|||
170895368|NCT00364182|617624258|FG000|Second Intervention|non-compliance|0|||
170895369|NCT00364182|617624259|FG001|Second Intervention|non-compliance|1|||
170895370|NCT00364182|617624260|FG002|Second Intervention|non-compliance|1|||
170895371|NCT00364182|617624258|FG000|Second Intervention|Protocol Violation|0|||
170895372|NCT00364182|617624259|FG001|Second Intervention|Protocol Violation|1|||
170895373|NCT00364182|617624260|FG002|Second Intervention|Protocol Violation|0|||
170895374|NCT00364182|617624258|FG000|Second Intervention|Adverse Event|0|||
170895375|NCT00364182|617624259|FG001|Second Intervention|Adverse Event|0|||
170895376|NCT00364182|617624260|FG002|Second Intervention|Adverse Event|1|||
170895377|NCT00364182|617624258|FG000|Third Intervention|non-compliance|0|||
170895378|NCT00364182|617624259|FG001|Third Intervention|non-compliance|1|||
170895379|NCT00364182|617624260|FG002|Third Intervention|non-compliance|0|||
170481454|NCT01120184|616103426|FG000|Overall Study|Reason not Specified|8|||
170481455|NCT01120184|616103427|FG001|Overall Study|Reason not Specified|3|||
170481456|NCT01120184|616103428|FG002|Overall Study|Reason not Specified|12|||
170481457|NCT01120184|616103426|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
170481458|NCT01120184|616103427|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
170481459|NCT01120184|616103428|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
170481460|NCT01120184|616103426|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
170481461|NCT01120184|616103427|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
170481462|NCT01120184|616103428|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
170481463|NCT01120184|616103426|FG000|Overall Study|Death|170|||
170639958|NCT01485172|616693799|FG002|Overall Study|Protocol Violation|4|||
170895380|NCT00364182|617624258|FG000|Third Intervention|Lost to Follow-up|0|||
170895381|NCT00364182|617624259|FG001|Third Intervention|Lost to Follow-up|0|||
170895382|NCT00364182|617624260|FG002|Third Intervention|Lost to Follow-up|1|||
170895383|NCT03336502|617624261|FG000|Overall Study|Physician Decision|0|||
170481464|NCT01120184|616103427|FG001|Overall Study|Death|176|||
170481465|NCT01120184|616103428|FG002|Overall Study|Death|169|||
170481466|NCT01002989|616103431|FG000|Overall Study|exclusion criteria, no consent|5|||
170895384|NCT03336502|617624262|FG001|Overall Study|Physician Decision|1|||
170895385|NCT03336502|617624261|FG000|Overall Study|Prohibited Drugs|1|||
170895386|NCT03336502|617624262|FG001|Overall Study|Prohibited Drugs|1|||
170895387|NCT03336502|617624261|FG000|Overall Study|Death|1|||
170895388|NCT03336502|617624262|FG001|Overall Study|Death|2|||
170895389|NCT03336502|617624261|FG000|Overall Study|Adverse Event|2|||
170895390|NCT03336502|617624262|FG001|Overall Study|Adverse Event|5|||
170895391|NCT02928952|617624264|FG000|Overall Study|Lost to Follow-up|5|||
170895392|NCT02928952|617624265|FG001|Overall Study|Lost to Follow-up|5|||
170895393|NCT02928952|617624264|FG000|Overall Study|Withdrawal by Subject|5|||
170895394|NCT02928952|617624265|FG001|Overall Study|Withdrawal by Subject|1|||
170895395|NCT02928952|617624264|FG000|Overall Study|Physician Decision|0|||
170895396|NCT02928952|617624265|FG001|Overall Study|Physician Decision|1|||
170895397|NCT02601573|617624266|FG000|Overall Study|Lost to Follow-up|0|||
170895398|NCT02601573|617624267|FG001|Overall Study|Lost to Follow-up|3|||
170895399|NCT02601573|617624268|FG002|Overall Study|Lost to Follow-up|1|||
170895400|NCT02601573|617624269|FG003|Overall Study|Lost to Follow-up|0|||
170895401|NCT02601573|617624270|FG004|Overall Study|Lost to Follow-up|2|||
170895402|NCT02601573|617624266|FG000|Overall Study|Withdrawal by Subject|0|||
170895403|NCT02601573|617624267|FG001|Overall Study|Withdrawal by Subject|1|||
170895404|NCT02601573|617624268|FG002|Overall Study|Withdrawal by Subject|0|||
170895405|NCT02601573|617624269|FG003|Overall Study|Withdrawal by Subject|1|||
170895406|NCT02601573|617624270|FG004|Overall Study|Withdrawal by Subject|0|||
170895407|NCT00974220|617624271|FG000|Treatment Period 1|Adverse Event|2|||
170895408|NCT00974220|617624272|FG001|Treatment Period 1|Adverse Event|1|||
170895409|NCT00974220|617624271|FG000|Treatment Period 1|noncompliant subjects|0|||
170895410|NCT00974220|617624272|FG001|Treatment Period 1|noncompliant subjects|1|||
170895411|NCT01145560|617624274|FG000|Overall Study|Withdrawal by Subject|2|||
170895412|NCT01145560|617624275|FG001|Overall Study|Withdrawal by Subject|1|||
170895413|NCT01145560|617624276|FG002|Overall Study|Withdrawal by Subject|0|||
170895414|NCT01145560|617624274|FG000|Overall Study|Lost to Follow-up|1|||
170895415|NCT01145560|617624275|FG001|Overall Study|Lost to Follow-up|1|||
170895416|NCT01145560|617624276|FG002|Overall Study|Lost to Follow-up|1|||
170895417|NCT01145560|617624274|FG000|Overall Study|No study drug by 24h after organ failure|1|||
170895418|NCT01145560|617624275|FG001|Overall Study|No study drug by 24h after organ failure|0|||
170895419|NCT01145560|617624276|FG002|Overall Study|No study drug by 24h after organ failure|0|||
170895420|NCT01145560|617624274|FG000|Overall Study|Accidental unblinding of study treatment|0|||
170895421|NCT01145560|617624275|FG001|Overall Study|Accidental unblinding of study treatment|1|||
170895422|NCT01145560|617624276|FG002|Overall Study|Accidental unblinding of study treatment|0|||
170895423|NCT01145560|617624274|FG000|Overall Study|False insurance information|0|||
170895424|NCT01145560|617624275|FG001|Overall Study|False insurance information|1|||
170895425|NCT01145560|617624276|FG002|Overall Study|False insurance information|0|||
170895426|NCT01145560|617624274|FG000|Overall Study|Withdrawal of therapy|0|||
170895427|NCT01145560|617624275|FG001|Overall Study|Withdrawal of therapy|0|||
170895428|NCT01145560|617624276|FG002|Overall Study|Withdrawal of therapy|1|||
170895429|NCT03310970|617624277|FG000|Overall Study|Withdrawal by Subject|0|||
170895430|NCT03310970|617624278|FG001|Overall Study|Withdrawal by Subject|1|||
170895431|NCT01557166|617624279|FG000|Overall Study|Adverse Event|20|||
170895432|NCT01557166|617624280|FG001|Overall Study|Adverse Event|6|||
170895433|NCT01557166|617624279|FG000|Overall Study|Lack of Efficacy|2|||
170895434|NCT01557166|617624280|FG001|Overall Study|Lack of Efficacy|1|||
170895435|NCT01557166|617624279|FG000|Overall Study|Protocol Violation|8|||
170895436|NCT01557166|617624280|FG001|Overall Study|Protocol Violation|5|||
170895437|NCT01557166|617624279|FG000|Overall Study|Withdrawn consent|12|||
170895438|NCT01557166|617624280|FG001|Overall Study|Withdrawn consent|20|||
170895439|NCT01557166|617624279|FG000|Overall Study|Target dose not tolerated|1|||
170895440|NCT01557166|617624280|FG001|Overall Study|Target dose not tolerated|0|||
170895441|NCT01557166|617624279|FG000|Overall Study|Psychiatric disorder|1|||
170895442|NCT01557166|617624280|FG001|Overall Study|Psychiatric disorder|0|||
170895443|NCT01557166|617624279|FG000|Overall Study|Unclassified|2|||
170895444|NCT01557166|617624280|FG001|Overall Study|Unclassified|5|||
170895445|NCT01465659|617624281|FG000|Completed 1 Cycle of Treatment|Death|0|||
170895446|NCT01465659|617624282|FG001|Completed 1 Cycle of Treatment|Death|1|||
170895447|NCT01465659|617624283|FG002|Completed 1 Cycle of Treatment|Death|0|||
170895448|NCT01465659|617624284|FG003|Completed 1 Cycle of Treatment|Death|0|||
170895449|NCT01465659|617624281|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
170895450|NCT01465659|617624282|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
170481467|NCT00471081|616103432|FG000|Active Phase|Protocol Violation|1|||
170481468|NCT00471081|616103433|FG001|Active Phase|Protocol Violation|1|||
170639959|NCT01485172|616693800|FG003|Overall Study|Protocol Violation|5|||
170895451|NCT01465659|617624283|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
170895452|NCT01465659|617624284|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
170895453|NCT01465659|617624281|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
170895454|NCT01465659|617624282|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
170895455|NCT01465659|617624283|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
170895456|NCT01465659|617624284|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
170895457|NCT01465659|617624281|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
170895458|NCT01465659|617624282|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
170895459|NCT01465659|617624283|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
170895460|NCT01465659|617624284|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
170639960|NCT01485172|616693801|FG004|Overall Study|Protocol Violation|1|||
170481469|NCT00471081|616103432|FG000|Active Phase|Withdrawal by Subject|0|||
170481470|NCT00471081|616103433|FG001|Active Phase|Withdrawal by Subject|3|||
170481471|NCT00471081|616103432|FG000|Active Phase|Lost to Follow-up|0|||
170481472|NCT00471081|616103433|FG001|Active Phase|Lost to Follow-up|1|||
170481473|NCT00471081|616103432|FG000|Active Phase|Lost health plan/insurance|1|||
170481474|NCT00471081|616103433|FG001|Active Phase|Lost health plan/insurance|8|||
170481475|NCT00471081|616103432|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
170481476|NCT00471081|616103433|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
170481477|NCT00471081|616103432|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
170481478|NCT00471081|616103433|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
170481479|NCT00471081|616103432|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
170481480|NCT00471081|616103433|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
170481481|NCT01439802|616103436|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
170481482|NCT01439802|616103436|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
170481483|NCT04886596|616103453|FG000|Overall Study|Adverse Event|442|||
170481484|NCT04886596|616103454|FG001|Overall Study|Adverse Event|441|||
170481485|NCT04886596|616103453|FG000|Overall Study|Lost to Follow-up|448|||
170481486|NCT04886596|616103454|FG001|Overall Study|Lost to Follow-up|465|||
170481487|NCT04886596|616103453|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
170481488|NCT04886596|616103454|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
170481489|NCT04886596|616103453|FG000|Overall Study|Migrated/moved from the study area|201|||
170481490|NCT04886596|616103454|FG001|Overall Study|Migrated/moved from the study area|184|||
170481491|NCT04886596|616103453|FG000|Overall Study|Other|298|||
170481492|NCT04886596|616103454|FG001|Overall Study|Other|326|||
170481493|NCT02211209|616103455|FG000|Overall Study|Investigator judgment|0|||
170481494|NCT02211209|616103456|FG001|Overall Study|Investigator judgment|1|||
170481495|NCT02211209|616103455|FG000|Overall Study|Voluntary withdrawal|1|||
170481496|NCT02211209|616103456|FG001|Overall Study|Voluntary withdrawal|4|||
170481497|NCT02211209|616103455|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
170481498|NCT02211209|616103456|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
170481499|NCT02211209|616103455|FG000|Overall Study|Reason Not Specified|1|||
170481500|NCT02211209|616103456|FG001|Overall Study|Reason Not Specified|0|||
170481501|NCT03751098|616103458|FG000|Overall Study|Withdrawal by Subject|0|||
170481502|NCT03751098|616103459|FG001|Overall Study|Withdrawal by Subject|1|||
170481503|NCT05366010|616103461|FG000|Overall Study|Withdrawal by Subject|1|||
170481504|NCT05366010|616103461|FG000|Overall Study|Protocol Violation|1|||
170481505|NCT05366010|616103461|FG000|Overall Study|Lost to Follow-up|2|||
170481506|NCT05366010|616103461|FG000|Overall Study|Screen Failure|2|||
170481507|NCT01060072|616103462|FG000|Overall Study|Adverse Event|1|||
170481508|NCT01060072|616103463|FG001|Overall Study|Adverse Event|1|||
170481509|NCT01060072|616103462|FG000|Overall Study|Physician Decision|0|||
170481510|NCT01060072|616103463|FG001|Overall Study|Physician Decision|2|||
170481511|NCT01060072|616103462|FG000|Overall Study|Protocol Violation|0|||
170481512|NCT01060072|616103463|FG001|Overall Study|Protocol Violation|1|||
170481513|NCT01060072|616103462|FG000|Overall Study|Acute cholecystitis|1|||
170481514|NCT01060072|616103463|FG001|Overall Study|Acute cholecystitis|0|||
170481515|NCT01060072|616103462|FG000|Overall Study|Excluded Medications|0|||
170481516|NCT01060072|616103463|FG001|Overall Study|Excluded Medications|1|||
170481517|NCT01149863|616103469|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
170481518|NCT01306305|616103470|FG000|Overall Study|Lost to Follow-up|1|||
170548025|NCT05762744|616350308|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
170548026|NCT05762744|616350309|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
170548027|NCT05762744|616350308|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
170548028|NCT05762744|616350309|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
170548029|NCT00520572|616351985|FG000|Overall Study|Adverse Event|9|||
170895461|NCT01465659|617624281|FG000|Completed Follow for 1 Year|Death|6|||
170895462|NCT01465659|617624282|FG001|Completed Follow for 1 Year|Death|3|||
170895463|NCT01465659|617624283|FG002|Completed Follow for 1 Year|Death|2|||
170895464|NCT01465659|617624284|FG003|Completed Follow for 1 Year|Death|4|||
170895465|NCT02411747|617624289|FG000|Overall Study|Withdrawal by Subject|1|||
170548030|NCT00520572|616351986|FG001|Overall Study|Adverse Event|3|||
170895466|NCT02411747|617624290|FG001|Overall Study|Withdrawal by Subject|0|||
170895467|NCT02411747|617624289|FG000|Overall Study|Protocol Violation|2|||
170481519|NCT01306305|616103471|FG001|Overall Study|Lost to Follow-up|0|||
170481520|NCT01306305|616103470|FG000|Overall Study|Withdrew consent|1|||
170481521|NCT01306305|616103471|FG001|Overall Study|Withdrew consent|0|||
170481522|NCT03326193|616103473|FG000|Overall Study|Sponsor decision|35|||
170481523|NCT00822692|616103474|FG000|Overall Study|Lost to Follow-up|17|||
170481524|NCT00822692|616103475|FG001|Overall Study|Lost to Follow-up|25|||
170481525|NCT02452476|616103478|FG000|Overall Study|Death|4|||
170481526|NCT02452476|616103479|FG001|Overall Study|Death|7|||
170481527|NCT02452476|616103478|FG000|Overall Study|Lost to Follow-up|1|||
170481528|NCT02452476|616103479|FG001|Overall Study|Lost to Follow-up|1|||
170481529|NCT02452476|616103478|FG000|Overall Study|Physician Decision|1|||
170481530|NCT02452476|616103479|FG001|Overall Study|Physician Decision|1|||
170481531|NCT02452476|616103478|FG000|Overall Study|Not treated|5|||
170548031|NCT00520572|616351987|FG002|Overall Study|Adverse Event|6|||
170548032|NCT00520572|616351988|FG003|Overall Study|Adverse Event|9|||
170548033|NCT00520572|616351989|FG004|Overall Study|Adverse Event|7|||
170548034|NCT00520572|616351990|FG005|Overall Study|Adverse Event|2|||
170548035|NCT00520572|616351985|FG000|Overall Study|Withdrawal by Subject|0|||
170548036|NCT00520572|616351986|FG001|Overall Study|Withdrawal by Subject|9|||
170548037|NCT00520572|616351987|FG002|Overall Study|Withdrawal by Subject|5|||
170548038|NCT00520572|616351988|FG003|Overall Study|Withdrawal by Subject|2|||
170548039|NCT00520572|616351989|FG004|Overall Study|Withdrawal by Subject|2|||
170548040|NCT00520572|616351990|FG005|Overall Study|Withdrawal by Subject|0|||
170548041|NCT00520572|616351985|FG000|Overall Study|Protocol Violation|0|||
170548042|NCT00520572|616351986|FG001|Overall Study|Protocol Violation|0|||
170548043|NCT00520572|616351987|FG002|Overall Study|Protocol Violation|1|||
170548044|NCT00520572|616351988|FG003|Overall Study|Protocol Violation|0|||
170548045|NCT00520572|616351989|FG004|Overall Study|Protocol Violation|0|||
170548046|NCT00520572|616351990|FG005|Overall Study|Protocol Violation|0|||
170548047|NCT00520572|616351985|FG000|Overall Study|Lack of Efficacy|1|||
170548048|NCT00520572|616351986|FG001|Overall Study|Lack of Efficacy|1|||
170548049|NCT00520572|616351987|FG002|Overall Study|Lack of Efficacy|1|||
170548050|NCT00520572|616351988|FG003|Overall Study|Lack of Efficacy|2|||
170548051|NCT00520572|616351989|FG004|Overall Study|Lack of Efficacy|1|||
170548052|NCT00520572|616351990|FG005|Overall Study|Lack of Efficacy|0|||
170548053|NCT00520572|616351985|FG000|Overall Study|Lost to Follow-up|0|||
170548054|NCT00520572|616351986|FG001|Overall Study|Lost to Follow-up|0|||
170548055|NCT00520572|616351987|FG002|Overall Study|Lost to Follow-up|0|||
170548056|NCT00520572|616351988|FG003|Overall Study|Lost to Follow-up|0|||
170548057|NCT00520572|616351989|FG004|Overall Study|Lost to Follow-up|1|||
170548058|NCT00520572|616351990|FG005|Overall Study|Lost to Follow-up|0|||
170548059|NCT00520572|616351985|FG000|Overall Study|Incorrect enrollment|1|||
170548060|NCT00520572|616351986|FG001|Overall Study|Incorrect enrollment|0|||
170795324|NCT04934072|617261787|FG002|Week 52 to Week 78|Adverse Event|0|||
170795325|NCT04934072|617261788|FG003|Week 52 to Week 78|Adverse Event|1|||
170795326|NCT04934072|617261789|FG004|Week 52 to Week 78|Adverse Event|1|||
170795327|NCT04934072|617261785|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
170795328|NCT04934072|617261786|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
170795329|NCT04934072|617261787|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
170795330|NCT04934072|617261788|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
170795331|NCT04934072|617261789|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
170795332|NCT04934072|617261785|FG000|Week 52 to Week 78|Other|0|||
170795333|NCT04934072|617261786|FG001|Week 52 to Week 78|Other|0|||
170795334|NCT04934072|617261787|FG002|Week 52 to Week 78|Other|1|||
170795335|NCT04934072|617261788|FG003|Week 52 to Week 78|Other|0|||
170795336|NCT04934072|617261789|FG004|Week 52 to Week 78|Other|0|||
170795337|NCT05660434|617261791|FG000|Overall Study|Never obtained study materials|2|||
170795338|NCT05660434|617261792|FG001|Overall Study|Never obtained study materials|1|||
170795339|NCT04218851|617261795|FG000|Overall Study|Death|1|||
170795340|NCT04218851|617261796|FG001|Overall Study|Death|3|||
170795341|NCT05285137|617261797|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
170795342|NCT05285137|617261798|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
170795343|NCT05285137|617261799|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
170795344|NCT05285137|617261800|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
170795345|NCT05285137|617261801|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
170795346|NCT05285137|617261802|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
170795347|NCT05285137|617261803|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
170795348|NCT05285137|617261804|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
170795349|NCT05285137|617261805|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
170795350|NCT05285137|617261797|FG000|Overall Study|Lost to Follow-up|0|||
170795351|NCT05285137|617261798|FG001|Overall Study|Lost to Follow-up|0|||
170795352|NCT05285137|617261799|FG002|Overall Study|Lost to Follow-up|1|||
170795353|NCT05285137|617261800|FG003|Overall Study|Lost to Follow-up|3|||
170795354|NCT05285137|617261801|FG004|Overall Study|Lost to Follow-up|0|||
170795355|NCT05285137|617261802|FG005|Overall Study|Lost to Follow-up|0|||
170795356|NCT05285137|617261803|FG006|Overall Study|Lost to Follow-up|1|||
170795357|NCT05285137|617261804|FG007|Overall Study|Lost to Follow-up|0|||
170795358|NCT05285137|617261805|FG008|Overall Study|Lost to Follow-up|0|||
170795359|NCT05285137|617261797|FG000|Overall Study|Physician Decision|0|||
170795360|NCT05285137|617261798|FG001|Overall Study|Physician Decision|1|||
170795361|NCT05285137|617261799|FG002|Overall Study|Physician Decision|0|||
170548061|NCT00520572|616351987|FG002|Overall Study|Incorrect enrollment|1|||
170548062|NCT00520572|616351988|FG003|Overall Study|Incorrect enrollment|0|||
170548063|NCT00520572|616351989|FG004|Overall Study|Incorrect enrollment|1|||
170548064|NCT00520572|616351990|FG005|Overall Study|Incorrect enrollment|0|||
170548065|NCT00520572|616351985|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
170548066|NCT00520572|616351986|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
170548067|NCT00520572|616351987|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
170548068|NCT00520572|616351988|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
170795362|NCT05285137|617261800|FG003|Overall Study|Physician Decision|0|||
170481532|NCT02452476|616103479|FG001|Overall Study|Not treated|1|||
170481533|NCT02348112|616103480|FG000|Overall Study|Withdrawal by Subject|32|||
170481534|NCT02348112|616103481|FG001|Overall Study|Withdrawal by Subject|29|||
170481535|NCT02348112|616103480|FG000|Overall Study|Lost to Follow-up|24|||
170481536|NCT02348112|616103481|FG001|Overall Study|Lost to Follow-up|20|||
170481537|NCT02348112|616103480|FG000|Overall Study|Physician Decision|17|||
170481538|NCT02348112|616103481|FG001|Overall Study|Physician Decision|15|||
170481539|NCT02348112|616103480|FG000|Overall Study|Site closed due to PI leaving|0|||
170481540|NCT02348112|616103481|FG001|Overall Study|Site closed due to PI leaving|30|||
170481541|NCT02348112|616103480|FG000|Overall Study|Sponsor withdrawal|0|||
170481542|NCT02348112|616103481|FG001|Overall Study|Sponsor withdrawal|7|||
170481543|NCT02348112|616103480|FG000|Overall Study|Death|0|||
170481544|NCT02348112|616103481|FG001|Overall Study|Death|1|||
170481545|NCT01408043|616103482|FG000|Overall Study|unable to collect cells|1|||
170481546|NCT00699998|616103484|FG000|Overall Study|Withdrawal by Subject|194|||
170895468|NCT02411747|617624290|FG001|Overall Study|Protocol Violation|4|||
170895469|NCT02149810|617624291|FG000|Overall Study|Physician Decision|1|||
170895470|NCT02149810|617624292|FG001|Overall Study|Physician Decision|2|||
170895471|NCT02149810|617624291|FG000|Overall Study|Lost to Follow-up|2|||
170895472|NCT02149810|617624292|FG001|Overall Study|Lost to Follow-up|1|||
170895473|NCT02149810|617624291|FG000|Overall Study|Withdrawal by Subject|5|||
170895474|NCT02149810|617624292|FG001|Overall Study|Withdrawal by Subject|1|||
170895475|NCT00428597|617624293|FG000|Overall Study|Randomized but not treated|3|||
170895476|NCT00428597|617624294|FG001|Overall Study|Randomized but not treated|3|||
170895477|NCT00428597|617624293|FG000|Overall Study|Objective Progression or Relapse|19|||
170895478|NCT00428597|617624294|FG001|Overall Study|Objective Progression or Relapse|47|||
170895479|NCT00428597|617624293|FG000|Overall Study|Study Terminated by Sponsor|41|||
170895480|NCT00428597|617624294|FG001|Overall Study|Study Terminated by Sponsor|16|||
170895481|NCT00428597|617624293|FG000|Overall Study|Adverse Event|15|||
170895482|NCT00428597|617624294|FG001|Overall Study|Adverse Event|7|||
170895483|NCT00428597|617624293|FG000|Overall Study|Global Deterioration of Health Status|1|||
170895484|NCT00428597|617624294|FG001|Overall Study|Global Deterioration of Health Status|5|||
170895485|NCT00428597|617624293|FG000|Overall Study|Protocol Violation|2|||
170895486|NCT00428597|617624294|FG001|Overall Study|Protocol Violation|1|||
170895487|NCT00428597|617624293|FG000|Overall Study|Withdrawal by Subject|2|||
170895488|NCT00428597|617624294|FG001|Overall Study|Withdrawal by Subject|1|||
170895489|NCT00428597|617624293|FG000|Overall Study|Other|1|||
170895490|NCT00428597|617624294|FG001|Overall Study|Other|1|||
170895491|NCT00428597|617624293|FG000|Overall Study|Lost to Follow-up|0|||
170639961|NCT01485172|616693802|FG005|Overall Study|Protocol Violation|0|||
170639962|NCT01485172|616693797|FG000|Overall Study|Protocol defined stopping criteria|1|||
170639963|NCT01485172|616693798|FG001|Overall Study|Protocol defined stopping criteria|0|||
170795363|NCT05285137|617261801|FG004|Overall Study|Physician Decision|0|||
170795364|NCT05285137|617261802|FG005|Overall Study|Physician Decision|0|||
170795365|NCT05285137|617261803|FG006|Overall Study|Physician Decision|0|||
170795366|NCT05285137|617261804|FG007|Overall Study|Physician Decision|0|||
170795367|NCT05285137|617261805|FG008|Overall Study|Physician Decision|0|||
170795368|NCT05285137|617261797|FG000|Overall Study|Pregnancy|0|||
170795369|NCT05285137|617261798|FG001|Overall Study|Pregnancy|0|||
170795370|NCT05285137|617261799|FG002|Overall Study|Pregnancy|0|||
170795371|NCT05285137|617261800|FG003|Overall Study|Pregnancy|0|||
170795372|NCT05285137|617261801|FG004|Overall Study|Pregnancy|0|||
170795373|NCT05285137|617261802|FG005|Overall Study|Pregnancy|0|||
170795374|NCT05285137|617261803|FG006|Overall Study|Pregnancy|1|||
170795375|NCT05285137|617261804|FG007|Overall Study|Pregnancy|0|||
170795376|NCT05285137|617261805|FG008|Overall Study|Pregnancy|0|||
170795377|NCT05285137|617261797|FG000|Overall Study|Withdrawal by Subject|0|||
170795378|NCT05285137|617261798|FG001|Overall Study|Withdrawal by Subject|1|||
170795379|NCT05285137|617261799|FG002|Overall Study|Withdrawal by Subject|2|||
170795380|NCT05285137|617261800|FG003|Overall Study|Withdrawal by Subject|1|||
170795381|NCT05285137|617261801|FG004|Overall Study|Withdrawal by Subject|0|||
170795382|NCT05285137|617261802|FG005|Overall Study|Withdrawal by Subject|0|||
170795383|NCT05285137|617261803|FG006|Overall Study|Withdrawal by Subject|0|||
170795384|NCT05285137|617261804|FG007|Overall Study|Withdrawal by Subject|0|||
170795385|NCT05285137|617261805|FG008|Overall Study|Withdrawal by Subject|1|||
170795386|NCT03717935|617261806|FG000|Overall Study|Withdrawal by Subject|0|||
170795387|NCT03717935|617261807|FG001|Overall Study|Withdrawal by Subject|2|||
170795388|NCT04456296|617261808|FG000|Overall Study|Withdrawal by Subject|14|||
170795389|NCT04456296|617261809|FG001|Overall Study|Withdrawal by Subject|21|||
170795390|NCT04456296|617261810|FG002|Overall Study|Withdrawal by Subject|21|||
170795391|NCT04456296|617261808|FG000|Overall Study|Adverse Event|2|||
170795392|NCT04456296|617261809|FG001|Overall Study|Adverse Event|2|||
170795393|NCT04456296|617261810|FG002|Overall Study|Adverse Event|2|||
170795394|NCT04456296|617261808|FG000|Overall Study|Death|1|||
170795395|NCT04456296|617261809|FG001|Overall Study|Death|0|||
170895492|NCT00428597|617624294|FG001|Overall Study|Lost to Follow-up|1|||
170895493|NCT00428597|617624293|FG000|Overall Study|Pregnancy|1|||
170795396|NCT04456296|617261810|FG002|Overall Study|Death|0|||
170795397|NCT04456296|617261808|FG000|Overall Study|Lost to Follow-up|3|||
170795398|NCT04456296|617261809|FG001|Overall Study|Lost to Follow-up|5|||
170795399|NCT04456296|617261810|FG002|Overall Study|Lost to Follow-up|6|||
170795400|NCT04456296|617261808|FG000|Overall Study|Other than specified|0|||
170795401|NCT04456296|617261809|FG001|Overall Study|Other than specified|1|||
170795402|NCT04456296|617261810|FG002|Overall Study|Other than specified|4|||
170795403|NCT04456296|617261808|FG000|Overall Study|Randomized, not treated|2|||
170795404|NCT04456296|617261809|FG001|Overall Study|Randomized, not treated|1|||
170895494|NCT00428597|617624294|FG001|Overall Study|Pregnancy|0|||
170895495|NCT00428597|617624293|FG000|Overall Study|Death|1|||
170895496|NCT00428597|617624294|FG001|Overall Study|Death|3|||
170795405|NCT04456296|617261810|FG002|Overall Study|Randomized, not treated|0|||
170795406|NCT01199133|617261811|FG000|Year 1|Adverse Event|16|||
170795407|NCT01199133|617261812|FG001|Year 1|Adverse Event|4|||
170795408|NCT01199133|617261811|FG000|Year 1|Withdrawal by Subject|8|||
170795409|NCT01199133|617261812|FG001|Year 1|Withdrawal by Subject|4|||
170795410|NCT01199133|617261811|FG000|Year 1|Any other reason not above-mentioned|6|||
170795411|NCT01199133|617261812|FG001|Year 1|Any other reason not above-mentioned|7|||
170795412|NCT01199133|617261811|FG000|Year 2|Adverse Event|1|||
170795413|NCT01199133|617261812|FG001|Year 2|Adverse Event|0|||
170795414|NCT01199133|617261811|FG000|Year 2|Withdrawal by Subject|1|||
170795415|NCT01199133|617261812|FG001|Year 2|Withdrawal by Subject|1|||
170795416|NCT01199133|617261811|FG000|Year 2|Any other reason not above-mentioned|1|||
170795417|NCT01199133|617261812|FG001|Year 2|Any other reason not above-mentioned|2|||
170795418|NCT05309291|617261813|FG000|Overall Study|Adverse Event|0|||
170795419|NCT05309291|617261814|FG001|Overall Study|Adverse Event|1|||
170795420|NCT02575950|617261815|FG000|Overall Study|Withdrawal by Subject|0|||
170795421|NCT02575950|617261816|FG001|Overall Study|Withdrawal by Subject|0|||
170795422|NCT02575950|617261817|FG002|Overall Study|Withdrawal by Subject|0|||
170795423|NCT02575950|617261818|FG003|Overall Study|Withdrawal by Subject|2|||
170795424|NCT02575950|617261815|FG000|Overall Study|Lost to Follow-up|0|||
170795425|NCT02575950|617261816|FG001|Overall Study|Lost to Follow-up|1|||
170795426|NCT02575950|617261817|FG002|Overall Study|Lost to Follow-up|0|||
170795427|NCT02575950|617261818|FG003|Overall Study|Lost to Follow-up|3|||
170795428|NCT03334695|617261819|FG000|Overall Study|Lost to Follow-up|3|||
170795429|NCT03334695|617261820|FG001|Overall Study|Lost to Follow-up|3|||
170795430|NCT03334695|617261819|FG000|Overall Study|Physician Decision|1|||
170795431|NCT03334695|617261820|FG001|Overall Study|Physician Decision|2|||
170795432|NCT03334695|617261819|FG000|Overall Study|Protocol Violation|0|||
170795433|NCT03334695|617261820|FG001|Overall Study|Protocol Violation|1|||
170795434|NCT05292391|617261822|FG000|Overall Study|Lost to Follow-up|0|||
170795435|NCT05292391|617261823|FG001|Overall Study|Lost to Follow-up|0|||
170795436|NCT05292391|617261824|FG002|Overall Study|Lost to Follow-up|0|||
170795437|NCT05292391|617261825|FG003|Overall Study|Lost to Follow-up|1|||
170795438|NCT05292391|617261826|FG004|Overall Study|Lost to Follow-up|0|||
170795439|NCT05654662|617261827|FG000|Overall Study|Withdrawal by Subject|1|||
170795440|NCT05654662|617261828|FG001|Overall Study|Withdrawal by Subject|0|||
170795441|NCT05654662|617261827|FG000|Overall Study|A death in the family|1|||
170795442|NCT05654662|617261828|FG001|Overall Study|A death in the family|0|||
170795443|NCT04330040|617261829|FG000|Overall Study|Other: Adverse event|5|||
170795444|NCT04330040|617261830|FG001|Overall Study|Other: Adverse event|0|||
170795445|NCT04330040|617261831|FG002|Overall Study|Other: Adverse event|0|||
170795446|NCT04330040|617261829|FG000|Overall Study|Disease progression|38|||
170795447|NCT04330040|617261830|FG001|Overall Study|Disease progression|10|||
170795448|NCT04330040|617261831|FG002|Overall Study|Disease progression|0|||
170795449|NCT04330040|617261829|FG000|Overall Study|Physician Decision|5|||
170795450|NCT04330040|617261830|FG001|Overall Study|Physician Decision|3|||
170795451|NCT04330040|617261831|FG002|Overall Study|Physician Decision|0|||
170795452|NCT04330040|617261829|FG000|Overall Study|Lost to Follow-up|1|||
170795453|NCT04330040|617261830|FG001|Overall Study|Lost to Follow-up|1|||
170481547|NCT00699998|616103485|FG001|Overall Study|Withdrawal by Subject|83|||
170481548|NCT00699998|616103486|FG002|Overall Study|Withdrawal by Subject|202|||
170481549|NCT00699998|616103487|FG003|Overall Study|Withdrawal by Subject|80|||
170481550|NCT00699998|616103484|FG000|Overall Study|Physician Decision|3|||
170481551|NCT00699998|616103485|FG001|Overall Study|Physician Decision|2|||
170481552|NCT00699998|616103486|FG002|Overall Study|Physician Decision|1|||
170481553|NCT00699998|616103487|FG003|Overall Study|Physician Decision|1|||
170481554|NCT00699998|616103484|FG000|Overall Study|Lost to Follow-up|2|||
170481555|NCT00699998|616103485|FG001|Overall Study|Lost to Follow-up|1|||
170481556|NCT00699998|616103486|FG002|Overall Study|Lost to Follow-up|3|||
170481557|NCT00699998|616103487|FG003|Overall Study|Lost to Follow-up|1|||
170481558|NCT04616612|616103488|FG000|Overall Study|Lost to Follow-up|6|||
170481559|NCT04616612|616103489|FG001|Overall Study|Lost to Follow-up|3|||
170548069|NCT00520572|616351989|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
170548070|NCT00520572|616351990|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
170548071|NCT00520572|616351985|FG000|Overall Study|Long break in taking Medication|0|||
170548072|NCT00520572|616351986|FG001|Overall Study|Long break in taking Medication|0|||
170548073|NCT00520572|616351987|FG002|Overall Study|Long break in taking Medication|0|||
170548074|NCT00520572|616351988|FG003|Overall Study|Long break in taking Medication|1|||
170795454|NCT04330040|617261831|FG002|Overall Study|Lost to Follow-up|0|||
170795455|NCT04330040|617261829|FG000|Overall Study|Death|2|||
170795456|NCT04330040|617261830|FG001|Overall Study|Death|1|||
170795457|NCT04330040|617261831|FG002|Overall Study|Death|0|||
170795458|NCT04330040|617261829|FG000|Overall Study|Withdrawal by Subject|3|||
170795459|NCT04330040|617261830|FG001|Overall Study|Withdrawal by Subject|3|||
170795460|NCT04330040|617261831|FG002|Overall Study|Withdrawal by Subject|0|||
170795461|NCT04330040|617261829|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
170795462|NCT04330040|617261830|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
170548075|NCT00520572|616351989|FG004|Overall Study|Long break in taking Medication|0|||
170795463|NCT04330040|617261831|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
170639964|NCT01485172|616693799|FG002|Overall Study|Protocol defined stopping criteria|0|||
170639965|NCT01485172|616693800|FG003|Overall Study|Protocol defined stopping criteria|0|||
170639966|NCT01485172|616693801|FG004|Overall Study|Protocol defined stopping criteria|1|||
170639967|NCT01485172|616693802|FG005|Overall Study|Protocol defined stopping criteria|0|||
170639968|NCT01485172|616693797|FG000|Overall Study|Lost to Follow-up|0|||
170639969|NCT01485172|616693798|FG001|Overall Study|Lost to Follow-up|0|||
170639970|NCT01485172|616693799|FG002|Overall Study|Lost to Follow-up|1|||
170639971|NCT01485172|616693800|FG003|Overall Study|Lost to Follow-up|0|||
170639972|NCT01485172|616693801|FG004|Overall Study|Lost to Follow-up|0|||
170639973|NCT01485172|616693802|FG005|Overall Study|Lost to Follow-up|1|||
170639974|NCT01485172|616693797|FG000|Overall Study|Physician Decision|0|||
170639975|NCT01485172|616693798|FG001|Overall Study|Physician Decision|0|||
170639976|NCT01485172|616693799|FG002|Overall Study|Physician Decision|0|||
170639977|NCT01485172|616693800|FG003|Overall Study|Physician Decision|0|||
170639978|NCT01485172|616693801|FG004|Overall Study|Physician Decision|1|||
170639979|NCT01485172|616693802|FG005|Overall Study|Physician Decision|0|||
170639980|NCT01485172|616693797|FG000|Overall Study|Withdrawal by Subject|2|||
170639981|NCT01485172|616693798|FG001|Overall Study|Withdrawal by Subject|0|||
170639982|NCT01485172|616693799|FG002|Overall Study|Withdrawal by Subject|0|||
170639983|NCT01485172|616693800|FG003|Overall Study|Withdrawal by Subject|1|||
170639984|NCT01485172|616693801|FG004|Overall Study|Withdrawal by Subject|1|||
170795464|NCT04330040|617261829|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
170795465|NCT04330040|617261830|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
170795466|NCT04330040|617261831|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
170795467|NCT04330040|617261829|FG000|Overall Study|Other: Disease progression|1|||
170795468|NCT04330040|617261830|FG001|Overall Study|Other: Disease progression|0|||
170795469|NCT04330040|617261831|FG002|Overall Study|Other: Disease progression|0|||
170795470|NCT04330040|617261829|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
170795471|NCT04330040|617261830|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
170795472|NCT04330040|617261831|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
170795473|NCT04330040|617261829|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
170795474|NCT04330040|617261830|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
170795475|NCT04330040|617261831|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
170795476|NCT04330040|617261829|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
170795477|NCT04330040|617261830|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
170795478|NCT04330040|617261831|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
170795479|NCT04857723|617261835|FG000|Overall Study|Withdrawal by Subject|2|||
170795480|NCT06262477|617263217|FG000|Overall Study|Withdrawal by Subject|1|||
170795481|NCT06262477|617263218|FG001|Overall Study|Withdrawal by Subject|0|||
170795482|NCT06262477|617263217|FG000|Overall Study|Adverse Event|0|||
170795483|NCT06262477|617263218|FG001|Overall Study|Adverse Event|1|||
170795484|NCT06262477|617263217|FG000|Overall Study|Lost to Follow-up|0|||
170795485|NCT06262477|617263218|FG001|Overall Study|Lost to Follow-up|1|||
170795486|NCT01064440|617263219|FG000|Overall Study|Lost to Follow-up|1|||
170795487|NCT01064440|617263220|FG001|Overall Study|Lost to Follow-up|1|||
170795488|NCT01064440|617263221|FG002|Overall Study|Lost to Follow-up|1|||
170795489|NCT01064440|617263219|FG000|Overall Study|Non-compliance|0|||
170795490|NCT01064440|617263220|FG001|Overall Study|Non-compliance|1|||
170795491|NCT01064440|617263221|FG002|Overall Study|Non-compliance|0|||
170795492|NCT01064440|617263219|FG000|Overall Study|Death|1|||
170795493|NCT01064440|617263220|FG001|Overall Study|Death|0|||
170795494|NCT01064440|617263221|FG002|Overall Study|Death|1|||
170795495|NCT01064440|617263219|FG000|Overall Study|Withdrawal by Subject|0|||
170795496|NCT01064440|617263220|FG001|Overall Study|Withdrawal by Subject|1|||
170795497|NCT01064440|617263221|FG002|Overall Study|Withdrawal by Subject|1|||
170795498|NCT01064440|617263219|FG000|Overall Study|Other: amputation|1|||
170795499|NCT01064440|617263220|FG001|Overall Study|Other: amputation|0|||
170795500|NCT01064440|617263221|FG002|Overall Study|Other: amputation|0|||
170795501|NCT04565990|617263222|FG000|Overall Study|Death|5|||
170795502|NCT04565990|617263222|FG000|Overall Study|Lost to Follow-up|1|||
170795503|NCT04565990|617263222|FG000|Overall Study|Withdrawal by Subject|1|||
170795504|NCT05507333|617263223|FG000|Overall Study|Protocol Violation|1|||
170795505|NCT04797858|617263224|FG000|Overall Study|Withdrawal by Subject|0|||
170795506|NCT04797858|617263225|FG001|Overall Study|Withdrawal by Subject|1|||
170795507|NCT04797858|617263224|FG000|Overall Study|Excluded due to administrative error|7|||
170795508|NCT04797858|617263225|FG001|Overall Study|Excluded due to administrative error|8|||
170795509|NCT03417284|617263226|FG000|Overall Study|Inadequate supply on study drug|1|||
170795510|NCT03417284|617263227|FG001|Overall Study|Inadequate supply on study drug|0|||
170795511|NCT03417284|617263228|FG002|Overall Study|Inadequate supply on study drug|0|||
170795512|NCT03417284|617263229|FG003|Overall Study|Inadequate supply on study drug|0|||
170795513|NCT03417284|617263226|FG000|Overall Study|Disease Progression|0|||
170895497|NCT00675597|617624295|FG000|Overall Study|Withdrawal by Subject|3|||
170895498|NCT00686647|617624299|FG000|Overall Study|Lost to Follow-up|1|||
170895499|NCT00686647|617624299|FG000|Overall Study|Death|1|||
170895500|NCT00705263|617624302|FG000|Overall Study|Withdrawal by Subject|2|||
170895501|NCT01609842|617624311|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
170895502|NCT01609842|617624312|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
170895503|NCT02474329|617624313|FG000|Overall Study|Withdraw or did not contribute data.|13|||
170895504|NCT03186989|617624314|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
170895505|NCT03186989|617624315|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
170895506|NCT03186989|617624316|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
170895507|NCT03186989|617624317|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
170895508|NCT03186989|617624318|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
170895509|NCT03186989|617624319|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
170895510|NCT03186989|617624320|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
170895511|NCT03186989|617624321|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
170895512|NCT03186989|617624322|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
170895513|NCT03186989|617624323|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
170895514|NCT03186989|617624324|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
170895515|NCT03186989|617624314|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895516|NCT03186989|617624315|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895517|NCT03186989|617624316|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895518|NCT03186989|617624317|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895519|NCT03186989|617624318|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895520|NCT03186989|617624319|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
170895521|NCT03186989|617624320|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895522|NCT03186989|617624321|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895523|NCT03186989|617624322|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895524|NCT03186989|617624323|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895525|NCT03186989|617624324|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
170895526|NCT03186989|617624314|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170895527|NCT03186989|617624315|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170895528|NCT03186989|617624316|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170895529|NCT03186989|617624317|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170895530|NCT03186989|617624318|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170548076|NCT00520572|616351990|FG005|Overall Study|Long break in taking Medication|0|||
170548077|NCT00520572|616351985|FG000|Overall Study|Did not receive Treatment|1|||
170548078|NCT00520572|616351986|FG001|Overall Study|Did not receive Treatment|0|||
170548079|NCT00520572|616351987|FG002|Overall Study|Did not receive Treatment|1|||
170548080|NCT00520572|616351988|FG003|Overall Study|Did not receive Treatment|0|||
170548081|NCT00520572|616351989|FG004|Overall Study|Did not receive Treatment|0|||
170548082|NCT00520572|616351990|FG005|Overall Study|Did not receive Treatment|0|||
170548083|NCT04821245|616352001|FG000|Overall Study|Withdrawal by Subject|3|||
170548084|NCT04821245|616352001|FG000|Overall Study|Physician Decision|1|||
170548085|NCT04821245|616352001|FG000|Overall Study|Protocol Violation|5|||
170548086|NCT01133977|616352006|FG000|Overall Study|Adverse Event|0|||
170548087|NCT01133977|616352007|FG001|Overall Study|Adverse Event|0|||
170548088|NCT01133977|616352008|FG002|Overall Study|Adverse Event|1|||
170548089|NCT01133977|616352009|FG003|Overall Study|Adverse Event|0|||
170548090|NCT01133977|616352010|FG004|Overall Study|Adverse Event|0|||
170548091|NCT01133977|616352006|FG000|Overall Study|Death|1|||
170548092|NCT01133977|616352007|FG001|Overall Study|Death|1|||
170548093|NCT01133977|616352008|FG002|Overall Study|Death|1|||
170548094|NCT01133977|616352009|FG003|Overall Study|Death|7|||
170548095|NCT01133977|616352010|FG004|Overall Study|Death|3|||
170548096|NCT01133977|616352006|FG000|Overall Study|Started a New Line of Therapy|2|||
170548097|NCT01133977|616352007|FG001|Overall Study|Started a New Line of Therapy|6|||
170548098|NCT01133977|616352008|FG002|Overall Study|Started a New Line of Therapy|4|||
170548099|NCT01133977|616352009|FG003|Overall Study|Started a New Line of Therapy|25|||
170548100|NCT01133977|616352010|FG004|Overall Study|Started a New Line of Therapy|33|||
170895531|NCT03186989|617624319|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170895532|NCT03186989|617624320|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
170895533|NCT03186989|617624321|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170548101|NCT01133977|616352006|FG000|Overall Study|Lost to Follow-up|0|||
170895534|NCT03186989|617624322|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170895535|NCT03186989|617624323|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170548102|NCT01133977|616352007|FG001|Overall Study|Lost to Follow-up|0|||
170548103|NCT01133977|616352008|FG002|Overall Study|Lost to Follow-up|0|||
170548104|NCT01133977|616352009|FG003|Overall Study|Lost to Follow-up|2|||
170548105|NCT01133977|616352010|FG004|Overall Study|Lost to Follow-up|1|||
170548106|NCT01133977|616352006|FG000|Overall Study|Withdrawal by Subject|0|||
170548107|NCT01133977|616352007|FG001|Overall Study|Withdrawal by Subject|0|||
170895536|NCT03186989|617624324|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
170895537|NCT03186989|617624314|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
170895538|NCT03186989|617624315|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
170895539|NCT03186989|617624316|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
170895540|NCT03186989|617624317|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
170895541|NCT03186989|617624318|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
170895542|NCT03186989|617624319|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
170895543|NCT03186989|617624320|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
170895544|NCT03186989|617624321|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
170895545|NCT03186989|617624322|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
170895546|NCT03186989|617624323|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
170895547|NCT03186989|617624324|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
170895548|NCT04343651|617624325|FG000|Overall Study|Physician Decision|2|||
170895549|NCT04343651|617624326|FG001|Overall Study|Physician Decision|1|||
170895550|NCT04343651|617624325|FG000|Overall Study|Lost to Follow-up|2|||
170895551|NCT04343651|617624326|FG001|Overall Study|Lost to Follow-up|1|||
170895552|NCT04343651|617624325|FG000|Overall Study|Protocol Violation|4|||
170895553|NCT04343651|617624326|FG001|Overall Study|Protocol Violation|6|||
170895554|NCT04343651|617624325|FG000|Overall Study|Missing|3|||
170895555|NCT04343651|617624326|FG001|Overall Study|Missing|9|||
170895556|NCT04343651|617624325|FG000|Overall Study|Withdrawal by Subject|0|||
170895557|NCT04343651|617624326|FG001|Overall Study|Withdrawal by Subject|4|||
170895558|NCT04343651|617624325|FG000|Overall Study|Death|0|||
170895559|NCT04343651|617624326|FG001|Overall Study|Death|1|||
170895560|NCT04343651|617624325|FG000|Overall Study|Did not start treatment|1|||
170895561|NCT04343651|617624326|FG001|Overall Study|Did not start treatment|1|||
170895562|NCT04343651|617624325|FG000|Overall Study|Patient did not complete visits 3-6|0|||
170895563|NCT04343651|617624326|FG001|Overall Study|Patient did not complete visits 3-6|1|||
170895564|NCT01583374|617624327|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
170895565|NCT01583374|617624328|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
170895566|NCT01583374|617624329|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
170895567|NCT01583374|617624330|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170895568|NCT01583374|617624331|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170895569|NCT01583374|617624332|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170895570|NCT01583374|617624333|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170895571|NCT01583374|617624334|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170481560|NCT01168427|616103491|FG000|Overall Study|Patient exited prior to implant|1|||
170481561|NCT00640315|616103492|FG000|Overall Study|Withdrawal by Subject|0|||
170481562|NCT00640315|616103493|FG001|Overall Study|Withdrawal by Subject|1|||
170481563|NCT00397514|616103494|FG000|Overall Study|Withdrawal by Subject|1|||
170481564|NCT00397514|616103494|FG000|Overall Study|Pacing wire malfunction|1|||
170481565|NCT00397514|616103494|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
170481566|NCT00397514|616103494|FG000|Overall Study|early extubation|2|||
170481567|NCT00397514|616103494|FG000|Overall Study|poor echocardiographic windows|1|||
170481568|NCT02964247|616103496|FG000|Overall Study|Lost to Follow-up|2|||
170481569|NCT02964247|616103497|FG001|Overall Study|Lost to Follow-up|0|||
170481570|NCT02964247|616103496|FG000|Overall Study|Withdrawal by Subject|1|||
170481571|NCT02964247|616103497|FG001|Overall Study|Withdrawal by Subject|2|||
170481572|NCT02456740|616103498|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
170481573|NCT02456740|616103499|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
170481574|NCT02456740|616103500|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
170481575|NCT02456740|616103501|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
170481576|NCT02456740|616103502|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
170481577|NCT02456740|616103503|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
170481578|NCT02456740|616103504|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
170481579|NCT02456740|616103505|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
170481580|NCT02456740|616103506|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
170481581|NCT02456740|616103498|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
170481582|NCT02456740|616103499|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
170895572|NCT01583374|617624335|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170481583|NCT02456740|616103500|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
170481584|NCT02456740|616103501|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
170481585|NCT02456740|616103502|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
170481586|NCT02456740|616103503|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
170481587|NCT02456740|616103504|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
170481588|NCT02456740|616103505|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
170481589|NCT02456740|616103506|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
170795514|NCT03417284|617263227|FG001|Overall Study|Disease Progression|0|||
170795515|NCT03417284|617263228|FG002|Overall Study|Disease Progression|1|||
170795516|NCT03417284|617263229|FG003|Overall Study|Disease Progression|0|||
170795517|NCT04427007|617263230|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
170481590|NCT02456740|616103498|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
170481591|NCT02456740|616103499|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
170481592|NCT02456740|616103500|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
170481593|NCT02456740|616103501|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
170481594|NCT02456740|616103502|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
170481595|NCT02456740|616103503|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
170481596|NCT02456740|616103504|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
170481597|NCT02456740|616103505|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
170481598|NCT02456740|616103506|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
170795518|NCT04427007|617263231|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
170795519|NCT05311176|617263237|FG000|Overall Study|Death|6|||
170795520|NCT05311176|617263237|FG000|Overall Study|Sponsor discontinued the study|1|||
170795521|NCT01880515|617263238|FG000|Overall Study|Lost to Follow-up|3|||
170795522|NCT01880515|617263239|FG001|Overall Study|Lost to Follow-up|2|||
170795523|NCT01880515|617263238|FG000|Overall Study|Disease Progression|5|||
170795524|NCT01880515|617263239|FG001|Overall Study|Disease Progression|7|||
170795525|NCT05247034|617263240|FG000|Overall Study|Lost to Follow-up|3|||
170795526|NCT05247034|617263241|FG001|Overall Study|Lost to Follow-up|2|||
170795527|NCT05247034|617263240|FG000|Overall Study|Organizational problems when attending appointments|1|||
170795528|NCT05247034|617263241|FG001|Overall Study|Organizational problems when attending appointments|0|||
170795529|NCT03972150|617263244|FG000|Overall Study|Adverse Event|0|||
170795530|NCT03972150|617263245|FG001|Overall Study|Adverse Event|1|||
170795531|NCT03972150|617263246|FG002|Overall Study|Adverse Event|1|||
170795532|NCT03972150|617263247|FG003|Overall Study|Adverse Event|0|||
170795533|NCT03972150|617263248|FG004|Overall Study|Adverse Event|0|||
170795534|NCT03972150|617263244|FG000|Overall Study|Progressive disease|3|||
170795535|NCT03972150|617263245|FG001|Overall Study|Progressive disease|5|||
170795536|NCT03972150|617263246|FG002|Overall Study|Progressive disease|2|||
170795537|NCT03972150|617263247|FG003|Overall Study|Progressive disease|2|||
170795538|NCT03972150|617263248|FG004|Overall Study|Progressive disease|3|||
170795539|NCT03220035|617263249|FG000|Overall Study|Adverse Event|1|||
170795540|NCT03220035|617263249|FG000|Overall Study|Protocol Violation|1|||
170795541|NCT03220035|617263249|FG000|Overall Study|Progressive Disease|2|||
170795542|NCT04414722|617263250|FG000|Overall Study|Lost to Follow-up|3|||
170795543|NCT04414722|617263251|FG001|Overall Study|Lost to Follow-up|4|||
170795544|NCT04414722|617263252|FG002|Overall Study|Lost to Follow-up|3|||
170795545|NCT04414722|617263253|FG003|Overall Study|Lost to Follow-up|2|||
170795546|NCT04414722|617263254|FG004|Overall Study|Lost to Follow-up|3|||
170795547|NCT04414722|617263250|FG000|Overall Study|Withdrawal by Subject|6|||
170795548|NCT04414722|617263251|FG001|Overall Study|Withdrawal by Subject|3|||
170795549|NCT04414722|617263252|FG002|Overall Study|Withdrawal by Subject|1|||
170795550|NCT04414722|617263253|FG003|Overall Study|Withdrawal by Subject|5|||
170795551|NCT04414722|617263254|FG004|Overall Study|Withdrawal by Subject|1|||
170795552|NCT04414722|617263250|FG000|Overall Study|Physician Decision|0|||
170795553|NCT04414722|617263251|FG001|Overall Study|Physician Decision|1|||
170795554|NCT04414722|617263252|FG002|Overall Study|Physician Decision|2|||
170795555|NCT04414722|617263253|FG003|Overall Study|Physician Decision|0|||
170795556|NCT04414722|617263254|FG004|Overall Study|Physician Decision|0|||
170795557|NCT04414722|617263250|FG000|Overall Study|Non-participatory|0|||
170795558|NCT04414722|617263251|FG001|Overall Study|Non-participatory|1|||
170795559|NCT04414722|617263252|FG002|Overall Study|Non-participatory|1|||
170795560|NCT04414722|617263253|FG003|Overall Study|Non-participatory|0|||
170795561|NCT04414722|617263254|FG004|Overall Study|Non-participatory|0|||
170795562|NCT04615273|617263260|FG000|Overall Study|Withdrawal by Subject|3|||
170481599|NCT02456740|616103498|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
170548108|NCT01133977|616352008|FG002|Overall Study|Withdrawal by Subject|0|||
170548109|NCT01133977|616352009|FG003|Overall Study|Withdrawal by Subject|5|||
170548110|NCT01133977|616352010|FG004|Overall Study|Withdrawal by Subject|1|||
170548111|NCT01058005|616352017|FG000|Overall Study|Adverse Event|0|||
170548112|NCT01058005|616352018|FG001|Overall Study|Adverse Event|2|||
170795563|NCT04615273|617263261|FG001|Overall Study|Withdrawal by Subject|1|||
170795564|NCT04615273|617263262|FG002|Overall Study|Withdrawal by Subject|2|||
170795565|NCT04615273|617263260|FG000|Overall Study|Adverse Event|1|||
170795566|NCT04615273|617263261|FG001|Overall Study|Adverse Event|0|||
170795567|NCT04615273|617263262|FG002|Overall Study|Adverse Event|1|||
170548113|NCT01058005|616352019|FG002|Overall Study|Adverse Event|1|||
170548114|NCT01058005|616352017|FG000|Overall Study|Physician Decision|2|||
170795568|NCT04615273|617263260|FG000|Overall Study|Lost to Follow-up|0|||
170795569|NCT04615273|617263261|FG001|Overall Study|Lost to Follow-up|1|||
170795570|NCT04615273|617263262|FG002|Overall Study|Lost to Follow-up|0|||
170895573|NCT01583374|617624327|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
170895574|NCT01583374|617624328|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
170895575|NCT01583374|617624329|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
170895576|NCT01583374|617624330|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170895577|NCT01583374|617624331|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170895578|NCT01583374|617624332|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170895579|NCT01583374|617624333|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170895580|NCT01583374|617624334|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170895581|NCT01583374|617624335|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170895582|NCT01583374|617624327|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
170895583|NCT01583374|617624328|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
170895584|NCT01583374|617624329|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170895585|NCT01583374|617624330|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170895586|NCT01583374|617624331|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170895587|NCT01583374|617624332|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170895588|NCT01583374|617624333|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170895589|NCT01583374|617624334|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170895590|NCT01583374|617624335|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170895591|NCT01583374|617624327|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
170895592|NCT01583374|617624328|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
170895593|NCT01583374|617624329|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
170895594|NCT01583374|617624330|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170895595|NCT01583374|617624331|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170481600|NCT02456740|616103499|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
170481601|NCT02456740|616103500|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
170895596|NCT01583374|617624332|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170895597|NCT01583374|617624333|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170895598|NCT01583374|617624334|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170895599|NCT01583374|617624335|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170895600|NCT01583374|617624327|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
170895601|NCT01583374|617624328|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
170895602|NCT01583374|617624329|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
170895603|NCT01583374|617624330|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
170895604|NCT01583374|617624331|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
170895605|NCT01583374|617624332|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
170895606|NCT01583374|617624333|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
170895607|NCT01583374|617624334|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
170895608|NCT01583374|617624335|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
170895609|NCT01583374|617624327|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170895610|NCT01583374|617624328|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170895611|NCT01583374|617624329|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
170895612|NCT01583374|617624330|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170895613|NCT01583374|617624331|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170895614|NCT01583374|617624332|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170895615|NCT01583374|617624333|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170895616|NCT01583374|617624334|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170895617|NCT01583374|617624335|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170895618|NCT01583374|617624327|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
170895619|NCT01583374|617624328|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
170895620|NCT01583374|617624329|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
170481602|NCT02456740|616103501|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
170481603|NCT02456740|616103502|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
170481604|NCT02456740|616103503|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
170481605|NCT02456740|616103504|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
170481606|NCT02456740|616103505|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
170481607|NCT02456740|616103506|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
170481608|NCT02456740|616103498|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
170481609|NCT02456740|616103499|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
170548115|NCT01058005|616352018|FG001|Overall Study|Physician Decision|2|||
170548116|NCT01058005|616352019|FG002|Overall Study|Physician Decision|0|||
170548117|NCT01058005|616352017|FG000|Overall Study|Withdrawal by Subject|4|||
170548118|NCT01058005|616352018|FG001|Overall Study|Withdrawal by Subject|5|||
170548119|NCT01058005|616352019|FG002|Overall Study|Withdrawal by Subject|11|||
170481610|NCT02456740|616103500|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
170481611|NCT02456740|616103501|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
170481612|NCT02456740|616103502|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
170481613|NCT02456740|616103503|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
170481614|NCT02456740|616103504|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
170481615|NCT02456740|616103505|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
170481616|NCT02456740|616103506|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
170481617|NCT02456740|616103498|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
170481618|NCT02456740|616103499|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
170481619|NCT02456740|616103500|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
170548120|NCT01058005|616352017|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
170795571|NCT04615273|617263260|FG000|Overall Study|Physician Decision|0|||
170795572|NCT04615273|617263261|FG001|Overall Study|Physician Decision|0|||
170795573|NCT04615273|617263262|FG002|Overall Study|Physician Decision|1|||
170795574|NCT04615273|617263260|FG000|Overall Study|Other|0|||
170795575|NCT04615273|617263261|FG001|Overall Study|Other|1|||
170795576|NCT04615273|617263262|FG002|Overall Study|Other|0|||
170795577|NCT04615273|617263260|FG000|Overall Study|Randomized but not treated|1|||
170795578|NCT04615273|617263261|FG001|Overall Study|Randomized but not treated|3|||
170795579|NCT04615273|617263262|FG002|Overall Study|Randomized but not treated|1|||
170795580|NCT03677141|617263263|FG000|Overall Study|Death|2|||
170795581|NCT03677141|617263264|FG001|Overall Study|Death|1|||
170795582|NCT03677141|617263265|FG002|Overall Study|Death|6|||
170795583|NCT03677141|617263266|FG003|Overall Study|Death|9|||
170795584|NCT03677141|617263267|FG004|Overall Study|Death|5|||
170795585|NCT03677141|617263268|FG005|Overall Study|Death|3|||
170795586|NCT03677141|617263263|FG000|Overall Study|Lost to Follow-up|0|||
170795587|NCT03677141|617263264|FG001|Overall Study|Lost to Follow-up|0|||
170795588|NCT03677141|617263265|FG002|Overall Study|Lost to Follow-up|0|||
170795589|NCT03677141|617263266|FG003|Overall Study|Lost to Follow-up|2|||
170795590|NCT03677141|617263267|FG004|Overall Study|Lost to Follow-up|0|||
170795591|NCT03677141|617263268|FG005|Overall Study|Lost to Follow-up|0|||
170795592|NCT03677141|617263263|FG000|Overall Study|Screen failure or enrolled in error|0|||
170795593|NCT03677141|617263264|FG001|Overall Study|Screen failure or enrolled in error|0|||
170795594|NCT03677141|617263265|FG002|Overall Study|Screen failure or enrolled in error|0|||
170795595|NCT03677141|617263266|FG003|Overall Study|Screen failure or enrolled in error|0|||
170795596|NCT03677141|617263267|FG004|Overall Study|Screen failure or enrolled in error|2|||
170795597|NCT03677141|617263268|FG005|Overall Study|Screen failure or enrolled in error|0|||
170795598|NCT03677141|617263263|FG000|Overall Study|Physician Decision|0|||
170795599|NCT03677141|617263264|FG001|Overall Study|Physician Decision|0|||
170795600|NCT03677141|617263265|FG002|Overall Study|Physician Decision|0|||
170795601|NCT03677141|617263266|FG003|Overall Study|Physician Decision|0|||
170795602|NCT03677141|617263267|FG004|Overall Study|Physician Decision|1|||
170795603|NCT03677141|617263268|FG005|Overall Study|Physician Decision|0|||
170795604|NCT03677141|617263263|FG000|Overall Study|Withdrawal by Subject|0|||
170795605|NCT03677141|617263264|FG001|Overall Study|Withdrawal by Subject|0|||
170795606|NCT03677141|617263265|FG002|Overall Study|Withdrawal by Subject|1|||
170795607|NCT03677141|617263266|FG003|Overall Study|Withdrawal by Subject|1|||
170795608|NCT03677141|617263267|FG004|Overall Study|Withdrawal by Subject|1|||
170795609|NCT03677141|617263268|FG005|Overall Study|Withdrawal by Subject|0|||
170795610|NCT05976334|617263278|FG000|Part B|Death|0|||
170795611|NCT05976334|617263279|FG001|Part B|Death|1|||
170795612|NCT05976334|617263278|FG000|Part B|Study Terminated by Sponsor|0|||
170795613|NCT05976334|617263279|FG001|Part B|Study Terminated by Sponsor|1|||
170795614|NCT05976334|617263278|FG000|Part B|Reason Not Specified|0|||
170795615|NCT05976334|617263279|FG001|Part B|Reason Not Specified|1|||
170795616|NCT05280574|617263281|FG000|Overall Study|Withdrawal by Subject|0|||
170795617|NCT05280574|617263282|FG001|Overall Study|Withdrawal by Subject|2|||
170795618|NCT05280574|617263283|FG002|Overall Study|Withdrawal by Subject|0|||
170795619|NCT05363163|617263284|FG000|Overall Study|Withdrawal by Subject|13|||
170795620|NCT05237284|617263286|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
170795621|NCT05237284|617263287|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
170795622|NCT05237284|617263288|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
170548121|NCT01058005|616352018|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
170795623|NCT05237284|617263289|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
170795624|NCT05237284|617263286|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
170795625|NCT05237284|617263287|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
170795626|NCT05237284|617263288|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
170795627|NCT05237284|617263289|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
170895621|NCT01583374|617624330|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
170895622|NCT01583374|617624331|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
170895623|NCT01583374|617624332|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
170895624|NCT01583374|617624333|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
170895625|NCT01583374|617624334|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
170895626|NCT01583374|617624335|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
170895627|NCT01583374|617624327|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170895628|NCT01583374|617624328|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170895629|NCT01583374|617624329|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170895630|NCT01583374|617624330|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170895631|NCT01583374|617624331|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170481620|NCT02456740|616103501|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
170481621|NCT02456740|616103502|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
170481622|NCT02456740|616103503|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
170481623|NCT02456740|616103504|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
170481624|NCT02456740|616103505|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
170481625|NCT02456740|616103506|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
170481626|NCT02456740|616103498|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170481627|NCT02456740|616103499|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170481628|NCT02456740|616103500|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
170481629|NCT02456740|616103501|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
170481630|NCT02456740|616103502|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
170481631|NCT02456740|616103503|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
170481632|NCT02456740|616103504|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
170481633|NCT02456740|616103505|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
170481634|NCT02456740|616103506|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
170481635|NCT01530464|616103509|FG000|Washout (24h)|Withdrawal by Subject|1|||
170481636|NCT01530464|616103510|FG001|Washout (24h)|Withdrawal by Subject|0|||
170481637|NCT01530464|616103509|FG000|Washout (24h)|Withdrawal by Subject|0|||
170481638|NCT01530464|616103510|FG001|Washout (24h)|Withdrawal by Subject|1|||
170481639|NCT01709500|616103511|FG000|Overall Study|Randomized but not treated|0|||
170481640|NCT01709500|616103512|FG001|Overall Study|Randomized but not treated|1|||
170481641|NCT01709500|616103511|FG000|Overall Study|Adverse Event|5|||
170481642|NCT01709500|616103512|FG001|Overall Study|Adverse Event|1|||
170481643|NCT01709500|616103511|FG000|Overall Study|Poor compliance to protocol|2|||
170481644|NCT01709500|616103512|FG001|Overall Study|Poor compliance to protocol|1|||
170895632|NCT01583374|617624332|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170895633|NCT01583374|617624333|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170895634|NCT01583374|617624334|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
170895635|NCT01583374|617624335|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170895636|NCT01583374|617624327|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
170895637|NCT01583374|617624328|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
170895638|NCT01583374|617624329|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
170895639|NCT01583374|617624330|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
170895640|NCT01583374|617624331|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
170895641|NCT01583374|617624332|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
170895642|NCT01583374|617624333|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
170481645|NCT01709500|616103511|FG000|Overall Study|Other|3|||
170481646|NCT01709500|616103512|FG001|Overall Study|Other|1|||
170481647|NCT01709500|616103511|FG000|Overall Study|Related to IMP administration|1|||
170481648|NCT01709500|616103512|FG001|Overall Study|Related to IMP administration|0|||
170481649|NCT01709500|616103511|FG000|Overall Study|Treatment ongoing|156|||
170481650|NCT01709500|616103512|FG001|Overall Study|Treatment ongoing|78|||
170481651|NCT02892331|616103513|FG000|Overall Study|Withdrawal by Subject|0|||
170481652|NCT02892331|616103514|FG001|Overall Study|Withdrawal by Subject|1|||
170481653|NCT02892331|616103515|FG002|Overall Study|Withdrawal by Subject|1|||
170481654|NCT02892331|616103513|FG000|Overall Study|Sick family member|0|||
170481655|NCT02892331|616103514|FG001|Overall Study|Sick family member|0|||
170481656|NCT02892331|616103515|FG002|Overall Study|Sick family member|1|||
170481657|NCT02892331|616103513|FG000|Overall Study|Corona virus pandemic|1|||
170481658|NCT02892331|616103514|FG001|Overall Study|Corona virus pandemic|0|||
170481659|NCT02892331|616103515|FG002|Overall Study|Corona virus pandemic|1|||
170481660|NCT02892331|616103513|FG000|Overall Study|Lost to Follow-up|1|||
170481661|NCT02892331|616103514|FG001|Overall Study|Lost to Follow-up|0|||
170481662|NCT02892331|616103515|FG002|Overall Study|Lost to Follow-up|1|||
170481663|NCT02892331|616103513|FG000|Overall Study|Blood pressure was too elevated|0|||
170548122|NCT01058005|616352019|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
170895643|NCT01583374|617624334|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
170481664|NCT02892331|616103514|FG001|Overall Study|Blood pressure was too elevated|1|||
170481665|NCT02892331|616103515|FG002|Overall Study|Blood pressure was too elevated|0|||
170548123|NCT01058005|616352017|FG000|Overall Study|Reason Missing|5|||
170548124|NCT01058005|616352018|FG001|Overall Study|Reason Missing|3|||
170639985|NCT01485172|616693802|FG005|Overall Study|Withdrawal by Subject|1|||
170639986|NCT00035932|616693803|FG000|Overall Study|Adverse Event|10|||
170639987|NCT00035932|616693804|FG001|Overall Study|Adverse Event|9|||
170639988|NCT00035932|616693805|FG002|Overall Study|Adverse Event|9|||
170639989|NCT00035932|616693803|FG000|Overall Study|Death|0|||
170639990|NCT00035932|616693804|FG001|Overall Study|Death|0|||
170639991|NCT00035932|616693805|FG002|Overall Study|Death|1|||
170639992|NCT00035932|616693803|FG000|Overall Study|Disease Progression / Relapse|1|||
170639993|NCT00035932|616693804|FG001|Overall Study|Disease Progression / Relapse|1|||
170639994|NCT00035932|616693805|FG002|Overall Study|Disease Progression / Relapse|0|||
170639995|NCT00035932|616693803|FG000|Overall Study|Lost to Follow-up|4|||
170639996|NCT00035932|616693804|FG001|Overall Study|Lost to Follow-up|4|||
170639997|NCT00035932|616693805|FG002|Overall Study|Lost to Follow-up|3|||
170639998|NCT00035932|616693803|FG000|Overall Study|Noncompliance|6|||
170639999|NCT00035932|616693804|FG001|Overall Study|Noncompliance|7|||
170640000|NCT00035932|616693805|FG002|Overall Study|Noncompliance|6|||
170640001|NCT00035932|616693803|FG000|Overall Study|Protocol Violation While on Study|0|||
170640002|NCT00035932|616693804|FG001|Overall Study|Protocol Violation While on Study|1|||
170640003|NCT00035932|616693805|FG002|Overall Study|Protocol Violation While on Study|2|||
170640004|NCT00035932|616693803|FG000|Overall Study|Withdrawal by Subject|1|||
170895644|NCT01583374|617624335|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
170640005|NCT00035932|616693804|FG001|Overall Study|Withdrawal by Subject|5|||
170795628|NCT05237284|617263286|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
170795629|NCT05237284|617263287|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
170795630|NCT05237284|617263288|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
170795631|NCT05237284|617263289|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
170795632|NCT05237284|617263286|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
170795633|NCT05237284|617263287|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
170795634|NCT05237284|617263288|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
170795635|NCT05237284|617263289|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
170795636|NCT05237284|617263286|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
170795637|NCT05237284|617263287|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
170795638|NCT05237284|617263288|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
170795639|NCT05237284|617263289|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
170795640|NCT05237284|617263286|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
170795641|NCT05237284|617263287|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
170795642|NCT05237284|617263288|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
170795643|NCT05237284|617263289|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
170795644|NCT05237284|617263286|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
170795645|NCT05237284|617263287|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
170795646|NCT05237284|617263288|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
170795647|NCT05237284|617263289|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
170795648|NCT05237284|617263286|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
170795649|NCT05237284|617263287|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
170795650|NCT05237284|617263288|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
170795651|NCT05237284|617263289|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
170795652|NCT05237284|617263286|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
170795653|NCT05237284|617263287|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
170795654|NCT05237284|617263288|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
170795655|NCT05237284|617263289|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
170795656|NCT04599634|617263290|FG000|Overall Study|Dose limiting toxicity|0|||
170795657|NCT04599634|617263291|FG001|Overall Study|Dose limiting toxicity|0|||
170795658|NCT04599634|617263292|FG002|Overall Study|Dose limiting toxicity|2|||
170795659|NCT04599634|617263293|FG003|Overall Study|Dose limiting toxicity|0|||
170795660|NCT03213873|617263294|FG000|Overall Study|Withdrawal by Subject|8|||
170795661|NCT03213873|617263295|FG001|Overall Study|Withdrawal by Subject|9|||
170795662|NCT03213873|617263294|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
170795663|NCT03213873|617263295|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
170795664|NCT03213873|617263294|FG000|Overall Study|Lost to Follow-up|0|||
170795665|NCT03213873|617263295|FG001|Overall Study|Lost to Follow-up|2|||
170795666|NCT03583333|617263297|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
170795667|NCT03583333|617263298|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
170795668|NCT03583333|617263297|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
170795669|NCT03583333|617263298|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
170795670|NCT03583333|617263297|FG000|Overall Study|Withdrawal by Subject|9|||
170795671|NCT03583333|617263298|FG001|Overall Study|Withdrawal by Subject|5|||
170795672|NCT03583333|617263297|FG000|Overall Study|Physician Decision|3|||
170795673|NCT03583333|617263298|FG001|Overall Study|Physician Decision|2|||
170640006|NCT00035932|616693805|FG002|Overall Study|Withdrawal by Subject|0|||
170895645|NCT01583374|617624327|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
170895646|NCT01583374|617624328|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
170895647|NCT01583374|617624329|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
170895648|NCT01583374|617624330|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
170895649|NCT01583374|617624331|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
170895650|NCT01583374|617624332|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
170895651|NCT01583374|617624333|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
170895652|NCT01583374|617624334|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
170895653|NCT01583374|617624335|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
170895654|NCT01583374|617624327|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
170895655|NCT01583374|617624328|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
170895656|NCT01583374|617624329|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
170895657|NCT01583374|617624330|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
170895658|NCT01583374|617624331|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
170895659|NCT01583374|617624332|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
170895660|NCT01583374|617624333|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
170895661|NCT01583374|617624334|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
170895662|NCT01583374|617624335|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
170895663|NCT01583374|617624327|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
170895664|NCT01583374|617624328|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
170895665|NCT01583374|617624329|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
170895666|NCT01583374|617624330|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
170895667|NCT01583374|617624331|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
170895668|NCT01583374|617624332|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
170895669|NCT01583374|617624333|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
170895670|NCT01583374|617624334|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
170895671|NCT01583374|617624335|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
170895672|NCT01583374|617624327|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
170895673|NCT01583374|617624328|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
170895674|NCT01583374|617624329|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
170895675|NCT01583374|617624330|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
170895676|NCT01583374|617624331|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
170895677|NCT01583374|617624332|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
170895678|NCT01583374|617624333|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
170895679|NCT01583374|617624334|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
170895680|NCT01583374|617624335|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
170895681|NCT01583374|617624327|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
170895682|NCT01583374|617624328|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
170895683|NCT01583374|617624329|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
170895684|NCT01583374|617624330|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
170895685|NCT01583374|617624331|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
170895686|NCT01583374|617624332|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
170895687|NCT01583374|617624333|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
170895688|NCT01583374|617624334|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
170481666|NCT02892331|616103513|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
170895689|NCT01583374|617624335|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
170895690|NCT01583374|617624327|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
170895691|NCT01583374|617624328|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
170895692|NCT01583374|617624329|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
170895693|NCT01583374|617624330|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
170895694|NCT01583374|617624331|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
170895695|NCT01583374|617624332|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
170895696|NCT01583374|617624333|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
170895697|NCT01583374|617624334|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
170895698|NCT01583374|617624335|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
170895699|NCT01583374|617624327|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
170895700|NCT01583374|617624328|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
170895701|NCT01583374|617624329|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
170895702|NCT01583374|617624330|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
170481667|NCT02892331|616103514|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
170548125|NCT01058005|616352019|FG002|Overall Study|Reason Missing|1|||
170895703|NCT01583374|617624331|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
170895704|NCT01583374|617624332|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
170481668|NCT02892331|616103515|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
170481669|NCT02107131|616103517|FG000|Overall Study|Lost to Follow-up|4|||
170795674|NCT03583333|617263297|FG000|Overall Study|Death|12|||
170795675|NCT03583333|617263298|FG001|Overall Study|Death|7|||
170795676|NCT02839265|617263299|FG000|Overall Study|Screen Failure|2|||
170795677|NCT02839265|617263299|FG000|Overall Study|Death|1|||
170481670|NCT02107131|616103518|FG001|Overall Study|Lost to Follow-up|4|||
170481671|NCT02107131|616103517|FG000|Overall Study|Physician Decision|1|||
170481672|NCT02107131|616103518|FG001|Overall Study|Physician Decision|0|||
170481673|NCT02107131|616103517|FG000|Overall Study|Withdrawal by Subject|2|||
170481674|NCT02107131|616103518|FG001|Overall Study|Withdrawal by Subject|0|||
170481675|NCT02107131|616103517|FG000|Overall Study|mental instability|1|||
170481676|NCT02107131|616103518|FG001|Overall Study|mental instability|0|||
170481677|NCT02107131|616103517|FG000|Overall Study|Death|0|||
170481678|NCT02107131|616103518|FG001|Overall Study|Death|1|||
170481679|NCT02107131|616103517|FG000|Overall Study|Protocol Violation|0|||
170481680|NCT02107131|616103518|FG001|Overall Study|Protocol Violation|4|||
170481681|NCT02286713|616103519|FG000|One Week Follow-Up|Death|1|||
170481682|NCT02286713|616103520|FG001|One Week Follow-Up|Death|0|||
170481683|NCT02286713|616103519|FG000|One Week Follow-Up|Lost to Follow-up|17|||
170481684|NCT02286713|616103520|FG001|One Week Follow-Up|Lost to Follow-up|21|||
170481685|NCT02286713|616103519|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
170481686|NCT02286713|616103520|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
170481687|NCT02286713|616103519|FG000|Three Month Follow-Up|Death|1|||
170481688|NCT02286713|616103520|FG001|Three Month Follow-Up|Death|1|||
170481689|NCT02286713|616103519|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
170481690|NCT02286713|616103520|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
170481691|NCT02286713|616103519|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
170481692|NCT02286713|616103520|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
170481693|NCT02286713|616103519|FG000|Six Month Follow-Up|Death|2|||
170481694|NCT02286713|616103520|FG001|Six Month Follow-Up|Death|0|||
170481695|NCT02286713|616103519|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
170481696|NCT02286713|616103520|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
170481697|NCT04871776|616103523|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
170481698|NCT04871776|616103524|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
170481699|NCT04871776|616103525|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
170481700|NCT04871776|616103523|FG000|Overall Study|Did not meet eligibility criteria|1|||
170481701|NCT04871776|616103524|FG001|Overall Study|Did not meet eligibility criteria|1|||
170481702|NCT04871776|616103525|FG002|Overall Study|Did not meet eligibility criteria|1|||
170481703|NCT02235454|616103528|FG000|Overall Study|Withdrawal by Subject|2|||
170481704|NCT03323398|616103529|FG000|Overall Study|Other than Specified|0|||
170795678|NCT02839265|617263299|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
170795679|NCT05424380|617263303|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
170795680|NCT05424380|617263304|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
170795681|NCT05424380|617263305|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
170795682|NCT05424380|617263306|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
170795683|NCT05424380|617263307|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
170795684|NCT05424380|617263308|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
170795685|NCT05424380|617263303|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
170795686|NCT05424380|617263304|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
170795687|NCT05424380|617263305|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
170795688|NCT05424380|617263306|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
170795689|NCT05424380|617263307|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
170795690|NCT05424380|617263308|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
170795691|NCT05424380|617263303|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
170795692|NCT05424380|617263304|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
170795693|NCT05424380|617263305|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
170795694|NCT05424380|617263306|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
170795695|NCT05424380|617263307|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
170795696|NCT05424380|617263308|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
170795697|NCT05424380|617263303|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
170795698|NCT05424380|617263304|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
170795699|NCT05424380|617263305|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
170795700|NCT05424380|617263306|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
170481705|NCT03323398|616103530|FG001|Overall Study|Other than Specified|1|||
170481706|NCT03323398|616103531|FG002|Overall Study|Other than Specified|2|||
170481707|NCT03323398|616103532|FG003|Overall Study|Other than Specified|0|||
170481708|NCT03323398|616103533|FG004|Overall Study|Other than Specified|0|||
170481709|NCT03323398|616103534|FG005|Overall Study|Other than Specified|0|||
170481710|NCT03323398|616103535|FG006|Overall Study|Other than Specified|1|||
170481711|NCT03323398|616103536|FG007|Overall Study|Other than Specified|0|||
170481712|NCT03323398|616103537|FG008|Overall Study|Other than Specified|2|||
170481713|NCT03323398|616103529|FG000|Overall Study|Lost to Follow-up|1|||
170895705|NCT01583374|617624333|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
170895706|NCT01583374|617624334|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
170895707|NCT01583374|617624335|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
170895708|NCT01583374|617624327|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
170895709|NCT01583374|617624328|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
170895710|NCT01583374|617624329|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
170895711|NCT01583374|617624330|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
170895712|NCT01583374|617624331|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
170895713|NCT01583374|617624332|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
170895714|NCT01583374|617624333|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
170895715|NCT01583374|617624334|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
170895716|NCT01583374|617624335|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
170895717|NCT01583374|617624327|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
170895718|NCT01583374|617624328|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
170895719|NCT01583374|617624329|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
170895720|NCT01583374|617624330|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
170895721|NCT01583374|617624331|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
170895722|NCT01583374|617624332|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
170895723|NCT01583374|617624333|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
170895724|NCT01583374|617624334|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
170895725|NCT01583374|617624335|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
170481714|NCT03323398|616103530|FG001|Overall Study|Lost to Follow-up|2|||
170481715|NCT03323398|616103531|FG002|Overall Study|Lost to Follow-up|1|||
170481716|NCT03323398|616103532|FG003|Overall Study|Lost to Follow-up|0|||
170481717|NCT03323398|616103533|FG004|Overall Study|Lost to Follow-up|0|||
170481718|NCT03323398|616103534|FG005|Overall Study|Lost to Follow-up|0|||
170481719|NCT03323398|616103535|FG006|Overall Study|Lost to Follow-up|0|||
170481720|NCT03323398|616103536|FG007|Overall Study|Lost to Follow-up|0|||
170481721|NCT03323398|616103537|FG008|Overall Study|Lost to Follow-up|0|||
170481722|NCT03323398|616103529|FG000|Overall Study|Death|4|||
170481723|NCT03323398|616103530|FG001|Overall Study|Death|6|||
170481724|NCT03323398|616103531|FG002|Overall Study|Death|2|||
170481725|NCT03323398|616103532|FG003|Overall Study|Death|2|||
170481726|NCT03323398|616103533|FG004|Overall Study|Death|1|||
170481727|NCT03323398|616103534|FG005|Overall Study|Death|2|||
170481728|NCT03323398|616103535|FG006|Overall Study|Death|0|||
170481729|NCT03323398|616103536|FG007|Overall Study|Death|0|||
170481730|NCT03323398|616103537|FG008|Overall Study|Death|6|||
170481731|NCT03323398|616103529|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
170895726|NCT01583374|617624327|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
170895727|NCT01583374|617624328|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
170895728|NCT01583374|617624329|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
170895729|NCT01583374|617624330|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
170895730|NCT01583374|617624331|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
170895731|NCT01583374|617624332|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
170895732|NCT01583374|617624333|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
170895733|NCT01583374|617624334|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
170895734|NCT01583374|617624335|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
170895735|NCT01292057|617624336|FG000|Overall Study|Protocol Violation|1|||
170895736|NCT01292057|617624337|FG001|Overall Study|Protocol Violation|1|||
170895737|NCT01292057|617624336|FG000|Overall Study|Lost to Follow-up|1|||
170481732|NCT03323398|616103530|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
170481733|NCT03323398|616103531|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
170481734|NCT03323398|616103532|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
170481735|NCT03323398|616103533|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
170481736|NCT03323398|616103534|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
170895738|NCT01292057|617624337|FG001|Overall Study|Lost to Follow-up|1|||
170895739|NCT03219164|617626043|FG000|Overall Study|Study Terminated by Sponsor|16|||
170895740|NCT03219164|617626044|FG001|Overall Study|Study Terminated by Sponsor|12|||
170895741|NCT03219164|617626043|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
170895742|NCT03219164|617626044|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
170895743|NCT03219164|617626043|FG000|Overall Study|Lost to Follow-up|1|||
170895744|NCT03219164|617626044|FG001|Overall Study|Lost to Follow-up|1|||
170895745|NCT03219164|617626043|FG000|Overall Study|Adverse Event|1|||
170895746|NCT03219164|617626044|FG001|Overall Study|Adverse Event|0|||
170481737|NCT03323398|616103535|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
170481738|NCT03323398|616103536|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
170481739|NCT03323398|616103537|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
170895747|NCT03219164|617626043|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170895748|NCT03219164|617626044|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170895749|NCT03219164|617626043|FG000|Overall Study|Protocol Violation|0|||
170481740|NCT03323398|616103529|FG000|Overall Study|Withdrawal by Subject|2|||
170481741|NCT03323398|616103530|FG001|Overall Study|Withdrawal by Subject|1|||
170481742|NCT03323398|616103531|FG002|Overall Study|Withdrawal by Subject|3|||
170481743|NCT03323398|616103532|FG003|Overall Study|Withdrawal by Subject|0|||
170481744|NCT03323398|616103533|FG004|Overall Study|Withdrawal by Subject|0|||
170481745|NCT03323398|616103534|FG005|Overall Study|Withdrawal by Subject|1|||
170481746|NCT03323398|616103535|FG006|Overall Study|Withdrawal by Subject|0|||
170481747|NCT03323398|616103536|FG007|Overall Study|Withdrawal by Subject|0|||
170481748|NCT03323398|616103537|FG008|Overall Study|Withdrawal by Subject|0|||
170481749|NCT03323398|616103529|FG000|Overall Study|Participant was Put on Hospice|0|||
170481750|NCT03323398|616103530|FG001|Overall Study|Participant was Put on Hospice|0|||
170481751|NCT03323398|616103531|FG002|Overall Study|Participant was Put on Hospice|0|||
170481752|NCT03323398|616103532|FG003|Overall Study|Participant was Put on Hospice|0|||
170481753|NCT03323398|616103533|FG004|Overall Study|Participant was Put on Hospice|0|||
170481754|NCT03323398|616103534|FG005|Overall Study|Participant was Put on Hospice|0|||
170481755|NCT03323398|616103535|FG006|Overall Study|Participant was Put on Hospice|1|||
170481756|NCT03323398|616103536|FG007|Overall Study|Participant was Put on Hospice|0|||
170481757|NCT03323398|616103537|FG008|Overall Study|Participant was Put on Hospice|0|||
170481758|NCT03323398|616103529|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
170795701|NCT05424380|617263307|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
170795702|NCT05424380|617263308|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
170795703|NCT05424380|617263303|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
170795704|NCT05424380|617263304|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
170795705|NCT05424380|617263305|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
170795706|NCT05424380|617263306|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
170795707|NCT05424380|617263307|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
170795708|NCT05424380|617263308|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
170795709|NCT05424380|617263303|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
170795710|NCT05424380|617263304|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
170795711|NCT05424380|617263305|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
170795712|NCT05424380|617263306|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
170795713|NCT05424380|617263307|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
170795714|NCT05424380|617263308|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
170795715|NCT05424380|617263303|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
170795716|NCT05424380|617263304|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
170795717|NCT05424380|617263305|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
170795718|NCT05424380|617263306|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
170795719|NCT05424380|617263307|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
170795720|NCT05424380|617263308|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
170795721|NCT05424380|617263303|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
170795722|NCT05424380|617263304|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
170795723|NCT05424380|617263305|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
170795724|NCT05424380|617263306|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
170795725|NCT05424380|617263307|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
170795726|NCT05424380|617263308|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
170795727|NCT05424380|617263303|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795728|NCT05424380|617263304|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795729|NCT05424380|617263305|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795730|NCT05424380|617263306|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
170795731|NCT05424380|617263307|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795732|NCT05424380|617263308|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795733|NCT05424380|617263303|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
170795734|NCT05424380|617263304|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
170795735|NCT05424380|617263305|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
170795736|NCT05424380|617263306|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
170795737|NCT05424380|617263307|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
170795738|NCT05424380|617263308|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
170795739|NCT05424380|617263303|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
170795740|NCT05424380|617263304|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
170795741|NCT05424380|617263305|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
170481759|NCT03323398|616103530|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
170795742|NCT05424380|617263306|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
170548126|NCT01145222|616352020|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
170795743|NCT05424380|617263307|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
170795744|NCT05424380|617263308|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
170895750|NCT03219164|617626044|FG001|Overall Study|Protocol Violation|1|||
170548127|NCT01145222|616352021|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
170548128|NCT01145222|616352022|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
170895751|NCT03219164|617626043|FG000|Overall Study|Withdrew Assent|1|||
170895752|NCT03219164|617626044|FG001|Overall Study|Withdrew Assent|0|||
170895753|NCT01974817|617626047|FG000|Overall Study|Death|4|||
170895754|NCT01974817|617626047|FG000|Overall Study|Lost to Follow-up|2|||
170895755|NCT01974817|617626047|FG000|Overall Study|Protocol Violation|2|||
170895756|NCT00956943|617626052|FG000|Overall Study|Lost to Follow-up|9|||
170895757|NCT00956943|617626053|FG001|Overall Study|Lost to Follow-up|10|||
170895758|NCT02613208|617626054|FG000|Overall Study|Withdrawal by Subject|1|||
170895759|NCT02613208|617626054|FG000|Overall Study|Change of address|2|||
170895760|NCT02613208|617626054|FG000|Overall Study|Physician Decision|2|||
170895761|NCT02613208|617626054|FG000|Overall Study|Lost to Follow-up|5|||
170895762|NCT02613208|617626054|FG000|Overall Study|Death|37|||
170895763|NCT01524991|617626055|FG000|Overall Study|Adverse Event|12|||
170895764|NCT01524991|617626055|FG000|Overall Study|Death|1|||
170895765|NCT01524991|617626055|FG000|Overall Study|Disease ProgressionDu|17|||
170895766|NCT01524991|617626055|FG000|Overall Study|Other complicating disease|1|||
170895767|NCT01524991|617626055|FG000|Overall Study|Withdrawal by Subject|2|||
170895768|NCT01524991|617626055|FG000|Overall Study|Symptomatic Deterioration|1|||
170895769|NCT01805180|617626056|FG000|Lead-in Donor Phase|screen failure|1|||
170895770|NCT01805180|617626057|FG001|Lead-in Donor Phase|screen failure|0|||
170895771|NCT01805180|617626058|FG002|Lead-in Donor Phase|screen failure|0|||
170895772|NCT00206726|617626059|FG000|Overall Study|Delayed recovery of blood counts|1|||
170895773|NCT00206726|617626059|FG000|Overall Study|Progressive disease or relapsed disease|18|||
170895774|NCT00206726|617626059|FG000|Overall Study|Placed on new protocol|1|||
170895775|NCT00206726|617626059|FG000|Overall Study|Bone marrow transplant|1|||
170895776|NCT00206726|617626059|FG000|Overall Study|Adverse Event|17|||
170895777|NCT00206726|617626059|FG000|Overall Study|Death|4|||
170895778|NCT00206726|617626059|FG000|Overall Study|Protocol Violation|1|||
170895779|NCT00206726|617626059|FG000|Overall Study|Withdrawal by Subject|8|||
170895780|NCT00008385|617626060|FG000|Overall Study|Off treatment reasons not reported|79|||
170895781|NCT00008385|617626061|FG001|Overall Study|Off treatment reasons not reported|70|||
170895782|NCT00008385|617626060|FG000|Overall Study|Progressive disease|52|||
170895783|NCT00008385|617626061|FG001|Overall Study|Progressive disease|117|||
170895784|NCT00008385|617626060|FG000|Overall Study|Adverse Event|8|||
170895785|NCT00008385|617626061|FG001|Overall Study|Adverse Event|20|||
170895786|NCT00008385|617626060|FG000|Overall Study|Death|12|||
170895787|NCT00008385|617626061|FG001|Overall Study|Death|18|||
170895788|NCT00008385|617626060|FG000|Overall Study|Withdrawal by Subject|67|||
170895789|NCT00008385|617626061|FG001|Overall Study|Withdrawal by Subject|157|||
170895790|NCT00008385|617626060|FG000|Overall Study|Start non-protocol therapy|3|||
170895791|NCT00008385|617626061|FG001|Overall Study|Start non-protocol therapy|1|||
170895792|NCT00008385|617626060|FG000|Overall Study|Other complicating disease|17|||
170895793|NCT00008385|617626061|FG001|Overall Study|Other complicating disease|30|||
170548129|NCT01145222|616352023|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
170548130|NCT01145222|616352020|FG000|Overall Study|Poor bowel preparation|0|||
170548131|NCT01145222|616352021|FG001|Overall Study|Poor bowel preparation|0|||
170895794|NCT00008385|617626060|FG000|Overall Study|Maximum dose reached|0|||
170895795|NCT00008385|617626061|FG001|Overall Study|Maximum dose reached|2|||
170895796|NCT00008385|617626060|FG000|Overall Study|Other|105|||
170895797|NCT00008385|617626061|FG001|Overall Study|Other|212|||
170895798|NCT00008385|617626060|FG000|Overall Study|Not start protocol therapy|44|||
170895799|NCT00008385|617626061|FG001|Overall Study|Not start protocol therapy|175|||
170895800|NCT05148884|617626062|FG000|Overall Study|Withdrawal by Subject|3|||
170895801|NCT05148884|617626063|FG001|Overall Study|Withdrawal by Subject|0|||
170895802|NCT05148884|617626062|FG000|Overall Study|Deep brain stimulation operation|0|||
170895803|NCT05148884|617626063|FG001|Overall Study|Deep brain stimulation operation|1|||
170548132|NCT01145222|616352022|FG002|Overall Study|Poor bowel preparation|0|||
170548133|NCT01145222|616352023|FG003|Overall Study|Poor bowel preparation|1|||
170895804|NCT01341457|617626066|FG000|Overall Study|Adverse Event|2|||
170895805|NCT01341457|617626067|FG001|Overall Study|Adverse Event|0|||
170895806|NCT00282243|617626070|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
170895807|NCT00282243|617626070|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
170895808|NCT00282243|617626070|FG000|Extension Treatment Period|Adverse Event|15|||
170895809|NCT00282243|617626070|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
170895810|NCT00282243|617626070|FG000|Extension Treatment Period|Non-compliance|2|||
170895811|NCT00282243|617626070|FG000|Extension Treatment Period|Physician Decision|1|||
170895812|NCT04317690|617626071|FG000|Overall Study|did not have complete information for primary outcome|0|||
170895813|NCT04317690|617626072|FG001|Overall Study|did not have complete information for primary outcome|4|||
170895814|NCT04317690|617626073|FG002|Overall Study|did not have complete information for primary outcome|0|||
170895815|NCT04317690|617626074|FG003|Overall Study|did not have complete information for primary outcome|2|||
170548134|NCT00927186|616352024|FG000|12 Months Primary Study|Adverse Event|5|||
170895816|NCT04317690|617626075|FG004|Overall Study|did not have complete information for primary outcome|0|||
170895817|NCT02863848|617626076|FG000|Overall Study|Lost to Follow-up|1|||
170895818|NCT02863848|617626077|FG001|Overall Study|Lost to Follow-up|1|||
170895819|NCT02863848|617626076|FG000|Overall Study|Protocol Violation|1|||
170895820|NCT02863848|617626077|FG001|Overall Study|Protocol Violation|2|||
170895821|NCT02318095|617626080|FG000|Overall Study|Adverse Event|1|||
170895822|NCT01717638|617626081|FG000|Overall Study|Lost to Follow-up|0|||
170895823|NCT01717638|617626082|FG001|Overall Study|Lost to Follow-up|0|||
170895824|NCT01717638|617626083|FG002|Overall Study|Lost to Follow-up|0|||
170895825|NCT01717638|617626084|FG003|Overall Study|Lost to Follow-up|0|||
170895826|NCT01717638|617626085|FG004|Overall Study|Lost to Follow-up|0|||
170895827|NCT01717638|617626086|FG005|Overall Study|Lost to Follow-up|1|||
170895828|NCT01717638|617626087|FG006|Overall Study|Lost to Follow-up|0|||
170548135|NCT00927186|616352025|FG001|12 Months Primary Study|Adverse Event|2|||
170548136|NCT00927186|616352024|FG000|12 Months Primary Study|Lost to Follow-up|1|||
170548137|NCT00927186|616352025|FG001|12 Months Primary Study|Lost to Follow-up|0|||
170895829|NCT01717638|617626088|FG007|Overall Study|Lost to Follow-up|0|||
170895830|NCT01717638|617626089|FG008|Overall Study|Lost to Follow-up|0|||
170895831|NCT01717638|617626090|FG009|Overall Study|Lost to Follow-up|0|||
170895832|NCT01717638|617626091|FG010|Overall Study|Lost to Follow-up|0|||
170895833|NCT01717638|617626092|FG011|Overall Study|Lost to Follow-up|0|||
170548138|NCT00927186|616352024|FG000|12 Months Primary Study|Protocol Violation|0|||
170548139|NCT00927186|616352025|FG001|12 Months Primary Study|Protocol Violation|1|||
170548140|NCT00927186|616352024|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
170548141|NCT00927186|616352025|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
170548142|NCT01717859|616352029|FG000|Overall Study|Adverse Event|5|||
170548143|NCT01717859|616352029|FG000|Overall Study|Moved out of state|1|||
170548144|NCT01717859|616352029|FG000|Overall Study|Patient concerned about mental health|1|||
170548145|NCT01717859|616352029|FG000|Overall Study|Lost to Follow-up|1|||
170548146|NCT01717859|616352029|FG000|Overall Study|Withdrawal by Subject|2|||
170548147|NCT01623752|616352030|FG000|Phase 1 (78 Weeks)|No Data|249|||
170548148|NCT01623752|616352031|FG001|Phase 1 (78 Weeks)|No Data|66|||
170548149|NCT01623752|616352032|FG002|Phase 1 (78 Weeks)|No Data|2|||
170548150|NCT01623752|616352030|FG000|Phase 1 (78 Weeks)|Other|33|||
170548151|NCT01623752|616352031|FG001|Phase 1 (78 Weeks)|Other|20|||
170548152|NCT01623752|616352032|FG002|Phase 1 (78 Weeks)|Other|0|||
170795745|NCT05424380|617263303|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
170795746|NCT05424380|617263304|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
170795747|NCT05424380|617263305|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
170795748|NCT05424380|617263306|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
170795749|NCT05424380|617263307|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
170795750|NCT05424380|617263308|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
170795751|NCT05424380|617263303|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795752|NCT05424380|617263304|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795753|NCT05424380|617263305|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795754|NCT05424380|617263306|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795755|NCT05424380|617263307|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
170795756|NCT05424380|617263308|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
170795757|NCT05424380|617263303|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
170795758|NCT05424380|617263304|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
170795759|NCT05424380|617263305|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
170795760|NCT05424380|617263306|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
170795761|NCT05424380|617263307|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
170795762|NCT05424380|617263308|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
170795763|NCT05736458|617263318|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
170795764|NCT05736458|617263319|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
170795765|NCT05736458|617263320|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
170795766|NCT05736458|617263318|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
170795767|NCT05736458|617263319|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
170795768|NCT05736458|617263320|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
170795769|NCT05736458|617263318|FG000|TMS/fMRI #1|Physician Decision|0|||
170795770|NCT05736458|617263319|FG001|TMS/fMRI #1|Physician Decision|0|||
170795771|NCT05736458|617263320|FG002|TMS/fMRI #1|Physician Decision|2|||
170795772|NCT05736458|617263318|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
170795773|NCT05736458|617263319|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
170795774|NCT05736458|617263320|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
170795775|NCT02990338|617263321|FG000|Overall Study|Randomized and not treated|4|||
170795776|NCT02990338|617263322|FG001|Overall Study|Randomized and not treated|2|||
170795777|NCT02990338|617263321|FG000|Overall Study|Adverse Event|23|||
170795778|NCT02990338|617263322|FG001|Overall Study|Adverse Event|22|||
170795779|NCT02990338|617263321|FG000|Overall Study|Progressive disease|118|||
170795780|NCT02990338|617263322|FG001|Overall Study|Progressive disease|107|||
170795781|NCT02990338|617263321|FG000|Overall Study|Poor compliance to protocol|0|||
170795782|NCT02990338|617263322|FG001|Overall Study|Poor compliance to protocol|1|||
170795783|NCT02990338|617263321|FG000|Overall Study|Withdrawal by Subject|6|||
170795784|NCT02990338|617263322|FG001|Overall Study|Withdrawal by Subject|8|||
170795785|NCT02990338|617263321|FG000|Overall Study|Physician's decision|2|||
170795786|NCT02990338|617263322|FG001|Overall Study|Physician's decision|6|||
170795787|NCT02990338|617263321|FG000|Overall Study|Treatment extension study|0|||
170795788|NCT02990338|617263322|FG001|Overall Study|Treatment extension study|6|||
170795789|NCT02990338|617263321|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
170795790|NCT02990338|617263322|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
170795791|NCT02990338|617263321|FG000|Overall Study|Continue with therapy available commercially|0|||
170795792|NCT02990338|617263322|FG001|Overall Study|Continue with therapy available commercially|1|||
170795793|NCT02938923|617263323|FG000|Overall Study|Death|1|||
170795794|NCT02938923|617263324|FG001|Overall Study|Death|0|||
170795795|NCT02938923|617263325|FG002|Overall Study|Death|0|||
170795796|NCT02938923|617263323|FG000|Overall Study|Physician Decision|0|||
170795797|NCT02938923|617263324|FG001|Overall Study|Physician Decision|2|||
170795798|NCT02938923|617263325|FG002|Overall Study|Physician Decision|0|||
170548153|NCT01623752|616352030|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
170548154|NCT01623752|616352031|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
170548155|NCT01623752|616352032|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
170548156|NCT01623752|616352030|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
170548157|NCT01623752|616352031|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
170548158|NCT01623752|616352032|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
170548159|NCT01623752|616352030|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
170548160|NCT01623752|616352031|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
170548161|NCT01623752|616352032|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
170548162|NCT01623752|616352030|FG000|Phase 2 (78 Weeks)|Other|5|||
170548163|NCT01623752|616352031|FG001|Phase 2 (78 Weeks)|Other|1|||
170548164|NCT01623752|616352032|FG002|Phase 2 (78 Weeks)|Other|0|||
170548165|NCT01623752|616352030|FG000|Phase 2 (78 Weeks)|No Data|43|||
170548166|NCT01623752|616352031|FG001|Phase 2 (78 Weeks)|No Data|11|||
170548167|NCT01623752|616352032|FG002|Phase 2 (78 Weeks)|No Data|0|||
170548168|NCT01623752|616352030|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
170548169|NCT01623752|616352031|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
170548170|NCT01623752|616352032|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
170548171|NCT01421134|616352037|FG000|Overall Study|Adverse Event|3|||
170548172|NCT01421134|616352038|FG001|Overall Study|Adverse Event|5|||
170548173|NCT01421134|616352037|FG000|Overall Study|Lack of Efficacy|2|||
170548174|NCT01421134|616352038|FG001|Overall Study|Lack of Efficacy|4|||
170548175|NCT01421134|616352037|FG000|Overall Study|Protocol Violation|0|||
170548176|NCT01421134|616352038|FG001|Overall Study|Protocol Violation|3|||
170548177|NCT01421134|616352037|FG000|Overall Study|Withdrawal by Subject|1|||
170548178|NCT01421134|616352038|FG001|Overall Study|Withdrawal by Subject|1|||
170548179|NCT01421134|616352037|FG000|Overall Study|Administrative|0|||
170548180|NCT01421134|616352038|FG001|Overall Study|Administrative|1|||
170548181|NCT01421134|616352037|FG000|Overall Study|Lost to Follow-up|1|||
170548182|NCT01421134|616352038|FG001|Overall Study|Lost to Follow-up|1|||
170795799|NCT02938923|617263323|FG000|Overall Study|Withdrawal by Subject|0|||
170795800|NCT02938923|617263324|FG001|Overall Study|Withdrawal by Subject|1|||
170795801|NCT02938923|617263325|FG002|Overall Study|Withdrawal by Subject|1|||
170795802|NCT00721149|617263326|FG000|Overall Study|Physician Decision|1|||
170795803|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
170795804|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
170795805|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
170795806|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
170795807|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
170795808|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
170795809|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
170795810|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
170795811|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
170795812|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
170795813|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
170795814|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
170795815|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
170795816|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
170795817|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
170795818|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
170795819|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
170795820|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
170795821|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
170795822|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
170795823|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
170795824|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
170795825|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
170795826|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
170795827|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
170795828|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
170795829|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
170795830|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
170795831|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
170795832|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
170795833|NCT04614948|617263328|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
170795834|NCT04614948|617263329|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
170795835|NCT04614948|617263330|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
170548183|NCT02959892|616352039|FG000|Overall Study|PET tracer synthesis failure|1|||
170548184|NCT02959892|616352040|FG001|Overall Study|PET tracer synthesis failure|0|||
170548185|NCT02959892|616352039|FG000|Overall Study|Study termination|0|||
170548186|NCT02959892|616352040|FG001|Overall Study|Study termination|1|||
170548187|NCT04985682|616352049|FG000|Overall Study|Withdrawal by Subject|1|||
170548188|NCT00799864|616352052|FG000|Overall Study|Participant reached a virologic endpoint|9|||
170548189|NCT00799864|616352053|FG001|Overall Study|Participant reached a virologic endpoint|2|||
170640007|NCT00035932|616693803|FG000|Overall Study|Study Termination by Sponsor|1|||
170640008|NCT00035932|616693804|FG001|Overall Study|Study Termination by Sponsor|0|||
170640009|NCT00035932|616693805|FG002|Overall Study|Study Termination by Sponsor|0|||
170640010|NCT00035932|616693803|FG000|Overall Study|Lack of Efficacy|33|||
170640011|NCT00035932|616693804|FG001|Overall Study|Lack of Efficacy|33|||
170640012|NCT00035932|616693805|FG002|Overall Study|Lack of Efficacy|28|||
170640013|NCT02100696|616693808|FG000|Induction Phase|Adverse Event|0|||
170640014|NCT02100696|616693809|FG001|Induction Phase|Adverse Event|0|||
170640015|NCT02100696|616693810|FG002|Induction Phase|Adverse Event|1|||
170640016|NCT02100696|616693811|FG003|Induction Phase|Adverse Event|0|||
170640017|NCT02100696|616693812|FG004|Induction Phase|Adverse Event|0|||
170640018|NCT02100696|616693813|FG005|Induction Phase|Adverse Event|0|||
170795836|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
170795837|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
170795838|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
170795839|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
170795840|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
170795841|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
170795842|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
170795843|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
170795844|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
170795845|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
170795846|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
170795847|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
170795848|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
170795849|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
170795850|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
170795851|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
170795852|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
170795853|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
170795854|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
170795855|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
170795856|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
170795857|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
170795858|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
170795859|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
170795860|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
170795861|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
170795862|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
170795863|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
170795864|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
170795865|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
170795866|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
170795867|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
170795868|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
170795869|NCT04614948|617263328|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
170795870|NCT04614948|617263329|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
170795871|NCT04614948|617263330|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
170795872|NCT04271046|617263331|FG000|Overall Study|Death|0|||
170795873|NCT04271046|617263332|FG001|Overall Study|Death|2|||
170795874|NCT04271046|617263333|FG002|Overall Study|Death|0|||
170795875|NCT04271046|617263334|FG003|Overall Study|Death|2|||
170795876|NCT04271046|617263331|FG000|Overall Study|Lost to Follow-up|12|||
170795877|NCT04271046|617263332|FG001|Overall Study|Lost to Follow-up|12|||
170795878|NCT04271046|617263333|FG002|Overall Study|Lost to Follow-up|11|||
170795879|NCT04271046|617263334|FG003|Overall Study|Lost to Follow-up|11|||
170795880|NCT04271046|617263331|FG000|Overall Study|Patient with Dementia Died|2|||
170795881|NCT04271046|617263332|FG001|Overall Study|Patient with Dementia Died|0|||
170795882|NCT04271046|617263333|FG002|Overall Study|Patient with Dementia Died|2|||
170795883|NCT04271046|617263334|FG003|Overall Study|Patient with Dementia Died|0|||
170795884|NCT04271046|617263331|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
170795885|NCT04271046|617263332|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
170795886|NCT04271046|617263333|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
170795887|NCT04271046|617263334|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
170795888|NCT01570361|617263335|FG000|Overall Study|Subject discontinued|1|||
170795889|NCT01570361|617263336|FG001|Overall Study|Subject discontinued|2|||
170795890|NCT01570361|617263335|FG000|Overall Study|Sponsor closing the study|51|||
170640019|NCT02100696|616693808|FG000|Induction Phase|Lost to Follow-up|1|||
170895834|NCT01717638|617626093|FG012|Overall Study|Lost to Follow-up|0|||
170895835|NCT01717638|617626081|FG000|Overall Study|Father in hospital|0|||
170895836|NCT01717638|617626082|FG001|Overall Study|Father in hospital|0|||
170895837|NCT01717638|617626083|FG002|Overall Study|Father in hospital|0|||
170895838|NCT01717638|617626084|FG003|Overall Study|Father in hospital|0|||
170895839|NCT01717638|617626085|FG004|Overall Study|Father in hospital|0|||
170895840|NCT01717638|617626086|FG005|Overall Study|Father in hospital|0|||
170895841|NCT01717638|617626087|FG006|Overall Study|Father in hospital|0|||
170895842|NCT01717638|617626088|FG007|Overall Study|Father in hospital|0|||
170895843|NCT01717638|617626089|FG008|Overall Study|Father in hospital|0|||
170895844|NCT01717638|617626090|FG009|Overall Study|Father in hospital|0|||
170895845|NCT01717638|617626091|FG010|Overall Study|Father in hospital|0|||
170895846|NCT01717638|617626092|FG011|Overall Study|Father in hospital|0|||
170895847|NCT01717638|617626093|FG012|Overall Study|Father in hospital|1|||
170895848|NCT01717638|617626081|FG000|Overall Study|Withdrawal by Subject|0|||
170895849|NCT01717638|617626082|FG001|Overall Study|Withdrawal by Subject|1|||
170895850|NCT01717638|617626083|FG002|Overall Study|Withdrawal by Subject|1|||
170895851|NCT01717638|617626084|FG003|Overall Study|Withdrawal by Subject|0|||
170895852|NCT01717638|617626085|FG004|Overall Study|Withdrawal by Subject|1|||
170895853|NCT01717638|617626086|FG005|Overall Study|Withdrawal by Subject|0|||
170895854|NCT01717638|617626087|FG006|Overall Study|Withdrawal by Subject|2|||
170895855|NCT01717638|617626088|FG007|Overall Study|Withdrawal by Subject|1|||
170895856|NCT01717638|617626089|FG008|Overall Study|Withdrawal by Subject|2|||
170895857|NCT01717638|617626090|FG009|Overall Study|Withdrawal by Subject|1|||
170895858|NCT01717638|617626091|FG010|Overall Study|Withdrawal by Subject|0|||
170895859|NCT01717638|617626092|FG011|Overall Study|Withdrawal by Subject|0|||
170895860|NCT01717638|617626093|FG012|Overall Study|Withdrawal by Subject|18|||
170895861|NCT01719757|617626094|FG000|Overall Study|Adverse Event|38|||
170895862|NCT01719757|617626094|FG000|Overall Study|Withdrawal by Subject|15|||
170895863|NCT01719757|617626094|FG000|Overall Study|Lost to Follow-up|20|||
170895864|NCT01719757|617626094|FG000|Overall Study|Protocol Violation|1|||
170895865|NCT01719757|617626094|FG000|Overall Study|well controlled pain|27|||
170895866|NCT01901224|617626100|FG000|Overall Study|study was not funded and terminated|2|||
170895867|NCT02162862|617626101|FG000|Overall Study|Lost to Follow-up|0|||
170895868|NCT02162862|617626102|FG001|Overall Study|Lost to Follow-up|11|||
170895869|NCT02162862|617626103|FG002|Overall Study|Lost to Follow-up|0|||
170895870|NCT02162862|617626101|FG000|Overall Study|Subject did not feel the med was needed|0|||
170895871|NCT02162862|617626102|FG001|Overall Study|Subject did not feel the med was needed|0|||
170895872|NCT02162862|617626103|FG002|Overall Study|Subject did not feel the med was needed|4|||
170895873|NCT01254669|617626106|FG000|Overall Study|Withdrawal by Subject|0|||
170895874|NCT01254669|617626107|FG001|Overall Study|Withdrawal by Subject|1|||
170895875|NCT01254669|617626106|FG000|Overall Study|time constraint|2|||
170895876|NCT01254669|617626107|FG001|Overall Study|time constraint|2|||
170895877|NCT01254669|617626106|FG000|Overall Study|called to clinic during intervention|1|||
170895878|NCT01254669|617626107|FG001|Overall Study|called to clinic during intervention|1|||
170895879|NCT00542191|617626108|FG000|Overall Study|Death|3|||
170895880|NCT01703000|617626111|FG000|Overall Study|Death|1|||
170895881|NCT02631538|617626113|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
170895882|NCT02631538|617626114|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
170895883|NCT02631538|617626115|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
170895884|NCT02631538|617626116|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
170895885|NCT02631538|617626113|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
170895886|NCT02631538|617626114|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
170895887|NCT02631538|617626115|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
170895888|NCT02631538|617626116|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
170895889|NCT02631538|617626113|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
170895890|NCT02631538|617626114|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
170895891|NCT02631538|617626115|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
170895892|NCT02631538|617626116|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
170895893|NCT02631538|617626113|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
170895894|NCT02631538|617626114|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
170895895|NCT02631538|617626115|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
170481760|NCT03323398|616103531|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
170895896|NCT02631538|617626116|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
170895897|NCT02631538|617626113|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
170895898|NCT02631538|617626114|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
170895899|NCT02631538|617626115|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
170895900|NCT02631538|617626116|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
170895901|NCT02631538|617626113|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
170895902|NCT02631538|617626114|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
170481761|NCT03323398|616103532|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
170481762|NCT03323398|616103533|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
170895903|NCT02631538|617626115|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
170895904|NCT02631538|617626116|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
170895905|NCT00440726|617626117|FG000|Phase 1|Dose-Limiting Toxicity|0|||
170895906|NCT00440726|617626118|FG001|Phase 1|Dose-Limiting Toxicity|1|||
170895907|NCT00440726|617626119|FG002|Phase 1|Dose-Limiting Toxicity|0|||
170895908|NCT00440726|617626117|FG000|Phase 1|Physician Decision|1|||
170895909|NCT00440726|617626118|FG001|Phase 1|Physician Decision|0|||
170895910|NCT00440726|617626119|FG002|Phase 1|Physician Decision|0|||
170895911|NCT00440726|617626117|FG000|Phase 2|Death|0|||
170895912|NCT00440726|617626118|FG001|Phase 2|Death|0|||
170895913|NCT00440726|617626119|FG002|Phase 2|Death|1|||
170895914|NCT00440726|617626117|FG000|Phase 2|Adverse Event|0|||
170895915|NCT00440726|617626118|FG001|Phase 2|Adverse Event|0|||
170895916|NCT00440726|617626119|FG002|Phase 2|Adverse Event|1|||
170895917|NCT00849667|617626122|FG000|Overall Study|Withdrawal by Subject|16|||
170895918|NCT00849667|617626123|FG001|Overall Study|Withdrawal by Subject|33|||
170895919|NCT00849667|617626124|FG002|Overall Study|Withdrawal by Subject|35|||
170895920|NCT00849667|617626122|FG000|Overall Study|Lost to Follow-up|8|||
170895921|NCT00849667|617626123|FG001|Overall Study|Lost to Follow-up|8|||
170895922|NCT00849667|617626124|FG002|Overall Study|Lost to Follow-up|8|||
170895923|NCT00849667|617626122|FG000|Overall Study|Adverse Event|1|||
170895924|NCT00849667|617626123|FG001|Overall Study|Adverse Event|2|||
170895925|NCT00849667|617626124|FG002|Overall Study|Adverse Event|0|||
170895926|NCT00849667|617626122|FG000|Overall Study|Other|18|||
170895927|NCT00849667|617626123|FG001|Overall Study|Other|19|||
170895928|NCT00849667|617626124|FG002|Overall Study|Other|18|||
170895929|NCT00849667|617626122|FG000|Overall Study|Progressive disease|119|||
170895930|NCT00849667|617626123|FG001|Overall Study|Progressive disease|100|||
170895931|NCT00849667|617626124|FG002|Overall Study|Progressive disease|112|||
170895932|NCT00849667|617626122|FG000|Overall Study|Sponsor decision|208|||
170895933|NCT00849667|617626123|FG001|Overall Study|Sponsor decision|204|||
170895934|NCT00849667|617626124|FG002|Overall Study|Sponsor decision|190|||
170895935|NCT00849667|617626122|FG000|Overall Study|Investigator discretion|0|||
170895936|NCT00849667|617626123|FG001|Overall Study|Investigator discretion|0|||
170895937|NCT00849667|617626124|FG002|Overall Study|Investigator discretion|1|||
170895938|NCT00189462|617626125|FG000|Overall Study|Lack of Efficacy|5|||
170895939|NCT00189462|617626126|FG001|Overall Study|Lack of Efficacy|1|||
170895940|NCT00189462|617626125|FG000|Overall Study|Lost to Follow-up|18|||
170895941|NCT00189462|617626126|FG001|Overall Study|Lost to Follow-up|20|||
170895942|NCT00110994|617626127|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
170895943|NCT00110994|617626128|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
170895944|NCT00110994|617626127|FG000|Double-blind (DB) Treatment|Death|1|||
170895945|NCT00110994|617626128|FG001|Double-blind (DB) Treatment|Death|0|||
170895946|NCT00110994|617626127|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
170895947|NCT00110994|617626128|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
170895948|NCT00110994|617626127|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
170895949|NCT00110994|617626128|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
170895950|NCT00110994|617626127|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
170895951|NCT00110994|617626128|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
170895952|NCT00110994|617626127|FG000|Double-blind (DB) Treatment|other reasons|2|||
170895953|NCT00110994|617626128|FG001|Double-blind (DB) Treatment|other reasons|3|||
170895954|NCT00110994|617626127|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
170895955|NCT00110994|617626128|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
170895956|NCT00110994|617626127|FG000|Active Follow-up|Other reasons|0|||
170895957|NCT00110994|617626128|FG001|Active Follow-up|Other reasons|2|||
170895958|NCT00110994|617626127|FG000|Long Term Follow-up|Death|19|||
170895959|NCT00110994|617626128|FG001|Long Term Follow-up|Death|17|||
170895960|NCT01879410|617626134|FG000|Overall Study|Adverse Event|9|||
170895961|NCT01879410|617626135|FG001|Overall Study|Adverse Event|14|||
170481763|NCT03323398|616103534|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
170481764|NCT03323398|616103535|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
170481765|NCT03323398|616103536|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
170895962|NCT01879410|617626134|FG000|Overall Study|Lack of Efficacy|4|||
170895963|NCT01879410|617626135|FG001|Overall Study|Lack of Efficacy|6|||
170895964|NCT01879410|617626134|FG000|Overall Study|Protocol Violation|1|||
170895965|NCT01879410|617626135|FG001|Overall Study|Protocol Violation|7|||
170895966|NCT01879410|617626134|FG000|Overall Study|Lost to Follow-up|2|||
170895967|NCT01879410|617626135|FG001|Overall Study|Lost to Follow-up|1|||
170895968|NCT01879410|617626134|FG000|Overall Study|Withdrawal by Subject|7|||
170895969|NCT01879410|617626135|FG001|Overall Study|Withdrawal by Subject|8|||
170895970|NCT01879410|617626134|FG000|Overall Study|Randomised in Error|1|||
170895971|NCT01879410|617626135|FG001|Overall Study|Randomised in Error|2|||
170895972|NCT00773279|617626136|FG000|Period 1|Adverse Event|2|||
170895973|NCT00773279|617626137|FG001|Period 1|Adverse Event|1|||
170895974|NCT00773279|617626136|FG000|Period 1|Lack of Efficacy|0|||
170895975|NCT00773279|617626137|FG001|Period 1|Lack of Efficacy|2|||
170895976|NCT00773279|617626136|FG000|Period 1|Unclassified|5|||
170895977|NCT00773279|617626137|FG001|Period 1|Unclassified|1|||
170895978|NCT00773279|617626136|FG000|Period 2|Adverse Event|0|||
170895979|NCT00773279|617626137|FG001|Period 2|Adverse Event|1|||
170895980|NCT00773279|617626136|FG000|Period 2|Lack of Efficacy|1|||
170895981|NCT00773279|617626137|FG001|Period 2|Lack of Efficacy|0|||
170895982|NCT00773279|617626136|FG000|Period 2|Protocol Violation|0|||
170895983|NCT00773279|617626137|FG001|Period 2|Protocol Violation|3|||
170895984|NCT00773279|617626136|FG000|Period 2|Unclassified|2|||
170895985|NCT00773279|617626137|FG001|Period 2|Unclassified|2|||
170895986|NCT01481896|617626141|FG000|Overall Study|Lost to Follow-up|12|||
170895987|NCT01227967|617626142|FG000|Overall Study|Protocol Violation|3|||
170895988|NCT01227967|617626143|FG001|Overall Study|Protocol Violation|1|||
170895989|NCT01227967|617626142|FG000|Overall Study|Death|0|||
170895990|NCT01227967|617626143|FG001|Overall Study|Death|1|||
170895991|NCT01227967|617626142|FG000|Overall Study|Lost to Follow-up|8|||
170895992|NCT01227967|617626143|FG001|Overall Study|Lost to Follow-up|3|||
170895993|NCT01227967|617626142|FG000|Overall Study|Withdrawal by Subject|4|||
170895994|NCT01227967|617626143|FG001|Overall Study|Withdrawal by Subject|3|||
170895995|NCT01227967|617626142|FG000|Overall Study|Physician Decision|0|||
170895996|NCT01227967|617626143|FG001|Overall Study|Physician Decision|1|||
170895997|NCT01227967|617626142|FG000|Overall Study|Never Started Treatment|0|||
170895998|NCT01227967|617626143|FG001|Overall Study|Never Started Treatment|4|||
170895999|NCT01227967|617626142|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
170896000|NCT01227967|617626143|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
170896001|NCT03403400|617626144|FG000|Overall Study|Lost to Follow-up|1|||
170896002|NCT03403400|617626145|FG001|Overall Study|Lost to Follow-up|0|||
170896003|NCT03403400|617626146|FG002|Overall Study|Lost to Follow-up|1|||
170481766|NCT03323398|616103537|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
170481767|NCT03641469|616103540|FG000|Overall Study|Ineligible|2|||
170481768|NCT03641469|616103540|FG000|Overall Study|Withdrawal by Subject|5|||
170481769|NCT03641469|616103540|FG000|Overall Study|Physician Decision|1|||
170481770|NCT03641469|616103540|FG000|Overall Study|Protocol Violation|1|||
170481771|NCT03641469|616103540|FG000|Overall Study|Lost to Follow-up|2|||
170481772|NCT00858273|616103541|FG000|Overall Study|Protocol Violation|3|||
170481773|NCT00858273|616103542|FG001|Overall Study|Protocol Violation|5|||
170481774|NCT00739882|616105539|FG000|Double-blind Period|Adverse Event|1|||
170481775|NCT00739882|616105540|FG001|Double-blind Period|Adverse Event|2|||
170481776|NCT00739882|616105539|FG000|Double-blind Period|Protocol Violation|1|||
170481777|NCT00739882|616105540|FG001|Double-blind Period|Protocol Violation|0|||
170481778|NCT00739882|616105539|FG000|Double-blind Period|Lack of Efficacy|1|||
170481779|NCT00739882|616105540|FG001|Double-blind Period|Lack of Efficacy|1|||
170481780|NCT00739882|616105539|FG000|Double-blind Period|Other|16|||
170481781|NCT00739882|616105540|FG001|Double-blind Period|Other|8|||
170481782|NCT00739882|616105539|FG000|Open-label Period|Adverse Event|1|||
170481783|NCT00739882|616105540|FG001|Open-label Period|Adverse Event|0|||
170481784|NCT00739882|616105539|FG000|Open-label Period|Other|9|||
170481785|NCT00739882|616105540|FG001|Open-label Period|Other|5|||
170481786|NCT02844543|616105541|FG000|Overall Study|Withdrawal by Subject|4|||
170481787|NCT02844543|616105541|FG000|Overall Study|Did not meet eligibility criteria|1|||
170481788|NCT00955409|616105542|FG000|Overall Study|Lack of Efficacy|1|||
170481789|NCT00955409|616105543|FG001|Overall Study|Lack of Efficacy|0|||
170481790|NCT00955409|616105544|FG002|Overall Study|Lack of Efficacy|0|||
170481791|NCT00955409|616105545|FG003|Overall Study|Lack of Efficacy|0|||
170481792|NCT00955409|616105546|FG004|Overall Study|Lack of Efficacy|0|||
170481793|NCT00955409|616105547|FG005|Overall Study|Lack of Efficacy|0|||
170481794|NCT00955409|616105548|FG006|Overall Study|Lack of Efficacy|0|||
170481795|NCT00955409|616105549|FG007|Overall Study|Lack of Efficacy|0|||
170481796|NCT00955409|616105550|FG008|Overall Study|Lack of Efficacy|0|||
170481797|NCT00955409|616105551|FG009|Overall Study|Lack of Efficacy|0|||
170481798|NCT00955409|616105542|FG000|Overall Study|Withdrawal by Subject|1|||
170481799|NCT00955409|616105543|FG001|Overall Study|Withdrawal by Subject|0|||
170481800|NCT00955409|616105544|FG002|Overall Study|Withdrawal by Subject|5|||
170481801|NCT00955409|616105545|FG003|Overall Study|Withdrawal by Subject|2|||
170481802|NCT00955409|616105546|FG004|Overall Study|Withdrawal by Subject|0|||
170481803|NCT00955409|616105547|FG005|Overall Study|Withdrawal by Subject|0|||
170481804|NCT00955409|616105548|FG006|Overall Study|Withdrawal by Subject|2|||
170481805|NCT00955409|616105549|FG007|Overall Study|Withdrawal by Subject|0|||
170896004|NCT03403400|617626144|FG000|Overall Study|Hospitalization|1|||
170896005|NCT03403400|617626145|FG001|Overall Study|Hospitalization|0|||
170896006|NCT03403400|617626146|FG002|Overall Study|Hospitalization|0|||
170896007|NCT03403400|617626144|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
170896008|NCT03403400|617626145|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
170896009|NCT03403400|617626146|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
170896010|NCT01107444|617626147|FG000|Overall Study|Withdrawal by Subject|8|||
170896011|NCT01107444|617626148|FG001|Overall Study|Withdrawal by Subject|12|||
170481806|NCT00955409|616105550|FG008|Overall Study|Withdrawal by Subject|1|||
170481807|NCT00955409|616105551|FG009|Overall Study|Withdrawal by Subject|0|||
170481808|NCT00955409|616105542|FG000|Overall Study|Caregiver Request|2|||
170481809|NCT00955409|616105543|FG001|Overall Study|Caregiver Request|0|||
170481810|NCT00955409|616105544|FG002|Overall Study|Caregiver Request|6|||
170896012|NCT01107444|617626147|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
170896013|NCT01107444|617626148|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
170896014|NCT02266433|617626152|FG000|Overall Study|Lost to Follow-up|54|||
170896015|NCT02266433|617626153|FG001|Overall Study|Lost to Follow-up|46|||
170896016|NCT02266433|617626152|FG000|Overall Study|Withdrawal by Subject|5|||
170896017|NCT02266433|617626153|FG001|Overall Study|Withdrawal by Subject|7|||
170896018|NCT00737529|617626157|FG000|Overall Study|Disease Progression|95|||
170896019|NCT00737529|617626157|FG000|Overall Study|Adverse Event|24|||
170896020|NCT00737529|617626157|FG000|Overall Study|Withdrawal by Subject|5|||
170896021|NCT00737529|617626157|FG000|Overall Study|Death|4|||
170896022|NCT00737529|617626157|FG000|Overall Study|Protocol Violation|1|||
170896023|NCT00737529|617626157|FG000|Overall Study|Other|4|||
170896024|NCT00712348|617626158|FG000|Overall Study|Withdrawal by Subject|1|||
170896025|NCT01133171|617626160|FG000|Overall Study|Withdrawal by Subject|1|||
170896026|NCT01133171|617626161|FG001|Overall Study|Withdrawal by Subject|2|||
170896027|NCT01133171|617626162|FG002|Overall Study|Withdrawal by Subject|0|||
170896028|NCT01273064|617626163|FG000|Overall Study|Adverse Event|5|||
170896029|NCT01273064|617626164|FG001|Overall Study|Adverse Event|1|||
170896030|NCT01273064|617626165|FG002|Overall Study|Adverse Event|3|||
170896031|NCT01273064|617626166|FG003|Overall Study|Adverse Event|2|||
170896032|NCT01273064|617626167|FG004|Overall Study|Adverse Event|1|||
170896033|NCT01273064|617626163|FG000|Overall Study|Withdrawal by Subject|4|||
170896034|NCT01273064|617626164|FG001|Overall Study|Withdrawal by Subject|2|||
170896035|NCT01273064|617626165|FG002|Overall Study|Withdrawal by Subject|2|||
170896036|NCT01273064|617626166|FG003|Overall Study|Withdrawal by Subject|2|||
170896037|NCT01273064|617626167|FG004|Overall Study|Withdrawal by Subject|0|||
170896038|NCT01273064|617626163|FG000|Overall Study|Study Termination|13|||
170896039|NCT01273064|617626164|FG001|Overall Study|Study Termination|27|||
170896040|NCT01273064|617626165|FG002|Overall Study|Study Termination|26|||
170896041|NCT01273064|617626166|FG003|Overall Study|Study Termination|16|||
170896042|NCT01273064|617626167|FG004|Overall Study|Study Termination|8|||
170896043|NCT01273064|617626163|FG000|Overall Study|Lost to Follow-up|1|||
170896044|NCT01273064|617626164|FG001|Overall Study|Lost to Follow-up|0|||
170896045|NCT01273064|617626165|FG002|Overall Study|Lost to Follow-up|0|||
170896046|NCT01273064|617626166|FG003|Overall Study|Lost to Follow-up|0|||
170896047|NCT01273064|617626167|FG004|Overall Study|Lost to Follow-up|0|||
170896048|NCT01273064|617626163|FG000|Overall Study|Physician Decision|0|||
170896049|NCT01273064|617626164|FG001|Overall Study|Physician Decision|0|||
170896050|NCT01273064|617626165|FG002|Overall Study|Physician Decision|0|||
170896051|NCT01273064|617626166|FG003|Overall Study|Physician Decision|0|||
170896052|NCT01273064|617626167|FG004|Overall Study|Physician Decision|1|||
170896053|NCT01446419|617626171|FG000|Overall Study|Death|1|||
170896054|NCT01446419|617626172|FG001|Overall Study|Death|0|||
170896055|NCT01446419|617626171|FG000|Overall Study|Withdrawal by Subject|1|||
170896056|NCT01446419|617626172|FG001|Overall Study|Withdrawal by Subject|1|||
170896057|NCT01446419|617626171|FG000|Overall Study|Terminated per protocol|3|||
170896058|NCT01446419|617626172|FG001|Overall Study|Terminated per protocol|0|||
170896059|NCT03595280|617626176|FG000|Overall Study|Lost to Follow-up|6|||
170896060|NCT03595280|617626177|FG001|Overall Study|Lost to Follow-up|9|||
170896061|NCT03595280|617626178|FG002|Overall Study|Lost to Follow-up|15|||
170896062|NCT03434379|617626180|FG000|Global Period|Lost to Follow-up|3|||
170896063|NCT03434379|617626181|FG001|Global Period|Lost to Follow-up|6|||
170896064|NCT03434379|617626182|FG002|Global Period|Lost to Follow-up|0|||
170896065|NCT03434379|617626183|FG003|Global Period|Lost to Follow-up|0|||
170896066|NCT03434379|617626180|FG000|Global Period|Death|115|||
170896067|NCT03434379|617626181|FG001|Global Period|Death|228|||
170896068|NCT03434379|617626182|FG002|Global Period|Death|0|||
170896069|NCT03434379|617626183|FG003|Global Period|Death|0|||
170896070|NCT03434379|617626180|FG000|Global Period|Withdrawal by Subject|20|||
170896071|NCT03434379|617626181|FG001|Global Period|Withdrawal by Subject|21|||
170896072|NCT03434379|617626182|FG002|Global Period|Withdrawal by Subject|0|||
170896073|NCT03434379|617626183|FG003|Global Period|Withdrawal by Subject|0|||
170896074|NCT03434379|617626180|FG000|Global Period|Reason Unspecified|0|||
170896075|NCT03434379|617626181|FG001|Global Period|Reason Unspecified|1|||
170896076|NCT03434379|617626182|FG002|Global Period|Reason Unspecified|0|||
170896077|NCT03434379|617626183|FG003|Global Period|Reason Unspecified|0|||
170896078|NCT03434379|617626180|FG000|Global Period|Study Ended by Sponsor|26|||
170896079|NCT03434379|617626181|FG001|Global Period|Study Ended by Sponsor|80|||
170896080|NCT03434379|617626182|FG002|Global Period|Study Ended by Sponsor|0|||
170896081|NCT03434379|617626183|FG003|Global Period|Study Ended by Sponsor|0|||
170896082|NCT03434379|617626180|FG000|Global Period|Physician Decision|1|||
170896083|NCT03434379|617626181|FG001|Global Period|Physician Decision|0|||
170896084|NCT03434379|617626182|FG002|Global Period|Physician Decision|0|||
170896085|NCT03434379|617626183|FG003|Global Period|Physician Decision|0|||
170896086|NCT03434379|617626180|FG000|China Extension Period|Lost to Follow-up|0|||
170896087|NCT03434379|617626181|FG001|China Extension Period|Lost to Follow-up|0|||
170896088|NCT03434379|617626182|FG002|China Extension Period|Lost to Follow-up|2|||
170896089|NCT03434379|617626183|FG003|China Extension Period|Lost to Follow-up|3|||
170896090|NCT03434379|617626180|FG000|China Extension Period|Death|0|||
170896091|NCT03434379|617626181|FG001|China Extension Period|Death|0|||
170896092|NCT03434379|617626182|FG002|China Extension Period|Death|46|||
170896093|NCT03434379|617626183|FG003|China Extension Period|Death|88|||
170896094|NCT03434379|617626180|FG000|China Extension Period|Withdrawal by Subject|0|||
170896095|NCT03434379|617626181|FG001|China Extension Period|Withdrawal by Subject|0|||
170795891|NCT01570361|617263336|FG001|Overall Study|Sponsor closing the study|50|||
170795892|NCT01570361|617263335|FG000|Overall Study|Subject excluded|5|||
170896096|NCT03434379|617626182|FG002|China Extension Period|Withdrawal by Subject|8|||
170896097|NCT03434379|617626183|FG003|China Extension Period|Withdrawal by Subject|6|||
170896098|NCT03434379|617626180|FG000|China Extension Period|Study Ended by Sponsor|0|||
170896099|NCT03434379|617626181|FG001|China Extension Period|Study Ended by Sponsor|0|||
170896100|NCT03434379|617626182|FG002|China Extension Period|Study Ended by Sponsor|5|||
170896101|NCT03434379|617626183|FG003|China Extension Period|Study Ended by Sponsor|36|||
170896102|NCT01194440|617626184|FG000|Baseline (First Dose)|Reason not specified|4|||
170896103|NCT01194440|617626184|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
170896104|NCT01194440|617626184|FG000|Baseline (First Dose)|Change in therapy|1|||
170896105|NCT01194440|617626184|FG000|Baseline (First Dose)|Adverse Event|1|||
170896106|NCT01194440|617626184|FG000|6-months (2nd Dose)|Change in therapy|4|||
170896107|NCT02675075|617626186|FG000|Overall Study|Lost to Follow-up|3|||
170896108|NCT02675075|617626187|FG001|Overall Study|Lost to Follow-up|0|||
170896109|NCT00560755|617626188|FG000|Overall Study|Protocol Violation|15|||
170896110|NCT00560755|617626188|FG000|Overall Study|Withdrawal by Subject|26|||
170795893|NCT01570361|617263336|FG001|Overall Study|Subject excluded|3|||
170795894|NCT01570361|617263335|FG000|Overall Study|Subject withdrew consent|14|||
170795895|NCT01570361|617263336|FG001|Overall Study|Subject withdrew consent|9|||
170795896|NCT01570361|617263335|FG000|Overall Study|Adverse Event|2|||
170795897|NCT01570361|617263336|FG001|Overall Study|Adverse Event|1|||
170795898|NCT01570361|617263335|FG000|Overall Study|Lost to Follow-up|4|||
170795899|NCT01570361|617263336|FG001|Overall Study|Lost to Follow-up|4|||
170795900|NCT01570361|617263335|FG000|Overall Study|Death|5|||
170795901|NCT01570361|617263336|FG001|Overall Study|Death|4|||
170795902|NCT01570361|617263335|FG000|Overall Study|Other|0|||
170795903|NCT01570361|617263336|FG001|Overall Study|Other|2|||
170795904|NCT05513937|617263337|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
170795905|NCT05513937|617263338|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
170795906|NCT05513937|617263339|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
170795907|NCT05513937|617263340|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
170795908|NCT05513937|617263337|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
170795909|NCT05513937|617263338|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
170795910|NCT05513937|617263339|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
170795911|NCT05513937|617263340|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
170795912|NCT05513937|617263337|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
170795913|NCT05513937|617263338|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
170795914|NCT05513937|617263339|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
170795915|NCT05513937|617263340|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
170795916|NCT05513937|617263337|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
170795917|NCT05513937|617263338|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
170795918|NCT05513937|617263339|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
170795919|NCT05513937|617263340|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
170795920|NCT05513937|617263337|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
170795921|NCT05513937|617263338|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
170795922|NCT05513937|617263339|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
170795923|NCT05513937|617263340|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
170795924|NCT05513937|617263337|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
170795925|NCT05513937|617263338|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
170795926|NCT05513937|617263339|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
170795927|NCT05513937|617263340|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
170896111|NCT00560755|617626188|FG000|Overall Study|Lost to Follow-up|9|||
170896112|NCT00560755|617626188|FG000|Overall Study|Adverse Event|8|||
170896113|NCT00560755|617626188|FG000|Overall Study|Physician Decision|2|||
170896114|NCT01988090|617626196|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
170896115|NCT01988090|617626197|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
170896116|NCT01988090|617626196|FG000|Start Treament After Randomization|Protocol Violation|0|||
170896117|NCT01988090|617626197|FG001|Start Treament After Randomization|Protocol Violation|1|||
170896118|NCT01988090|617626196|FG000|Complete Study After Start|Withdrawal by Subject|2|||
170896119|NCT01988090|617626197|FG001|Complete Study After Start|Withdrawal by Subject|0|||
170896120|NCT01988090|617626196|FG000|Complete Study After Start|Protocol Violation|1|||
170481811|NCT00955409|616105545|FG003|Overall Study|Caregiver Request|5|||
170896121|NCT01988090|617626197|FG001|Complete Study After Start|Protocol Violation|1|||
170896122|NCT01961115|617626203|FG000|Overall Study|Disease Progression|1|||
170640020|NCT02100696|616693809|FG001|Induction Phase|Lost to Follow-up|0|||
170640021|NCT02100696|616693810|FG002|Induction Phase|Lost to Follow-up|1|||
170640022|NCT02100696|616693811|FG003|Induction Phase|Lost to Follow-up|0|||
170640023|NCT02100696|616693812|FG004|Induction Phase|Lost to Follow-up|0|||
170640024|NCT02100696|616693813|FG005|Induction Phase|Lost to Follow-up|0|||
170640025|NCT02100696|616693808|FG000|Induction Phase|Protocol Violation|0|||
170640026|NCT02100696|616693809|FG001|Induction Phase|Protocol Violation|1|||
170640027|NCT02100696|616693810|FG002|Induction Phase|Protocol Violation|1|||
170640028|NCT02100696|616693811|FG003|Induction Phase|Protocol Violation|0|||
170640029|NCT02100696|616693812|FG004|Induction Phase|Protocol Violation|0|||
170640030|NCT02100696|616693813|FG005|Induction Phase|Protocol Violation|0|||
170640031|NCT02100696|616693808|FG000|Induction Phase|Withdrawal by Subject|8|||
170896123|NCT01961115|617626204|FG001|Overall Study|Disease Progression|0|||
170896124|NCT01961115|617626205|FG002|Overall Study|Disease Progression|3|||
170896125|NCT01961115|617626203|FG000|Overall Study|Adverse Event|1|||
170896126|NCT01961115|617626204|FG001|Overall Study|Adverse Event|0|||
170896127|NCT01961115|617626205|FG002|Overall Study|Adverse Event|1|||
170896128|NCT03887130|617626206|FG000|Overall Study|Progressive disease|23|||
170896129|NCT03887130|617626207|FG001|Overall Study|Progressive disease|14|||
170896130|NCT03887130|617626208|FG002|Overall Study|Progressive disease|7|||
170896131|NCT03887130|617626206|FG000|Overall Study|Protocol Violation|3|||
170896132|NCT03887130|617626207|FG001|Overall Study|Protocol Violation|1|||
170896133|NCT03887130|617626208|FG002|Overall Study|Protocol Violation|2|||
170896134|NCT03887130|617626206|FG000|Overall Study|Drug related toxicity|7|||
170896135|NCT03887130|617626207|FG001|Overall Study|Drug related toxicity|7|||
170896136|NCT03887130|617626208|FG002|Overall Study|Drug related toxicity|13|||
170896137|NCT03887130|617626206|FG000|Overall Study|Non drug related toxicity|3|||
170896138|NCT03887130|617626207|FG001|Overall Study|Non drug related toxicity|0|||
170896139|NCT03887130|617626208|FG002|Overall Study|Non drug related toxicity|0|||
170896140|NCT03887130|617626206|FG000|Overall Study|Death|2|||
170896141|NCT03887130|617626207|FG001|Overall Study|Death|2|||
170896142|NCT03887130|617626208|FG002|Overall Study|Death|1|||
170896143|NCT03887130|617626206|FG000|Overall Study|Withdrawal by Subject|7|||
170896144|NCT03887130|617626207|FG001|Overall Study|Withdrawal by Subject|6|||
170896145|NCT03887130|617626208|FG002|Overall Study|Withdrawal by Subject|11|||
170896146|NCT03887130|617626206|FG000|Overall Study|other reason|6|||
170896147|NCT03887130|617626207|FG001|Overall Study|other reason|20|||
170896148|NCT03887130|617626208|FG002|Overall Study|other reason|17|||
170896149|NCT02497001|617626212|FG000|Overall Study|Lost to Follow-up|10|||
170896150|NCT02497001|617626213|FG001|Overall Study|Lost to Follow-up|2|||
170896151|NCT02497001|617626214|FG002|Overall Study|Lost to Follow-up|0|||
170896152|NCT02497001|617626215|FG003|Overall Study|Lost to Follow-up|2|||
170896153|NCT02497001|617626212|FG000|Overall Study|Adverse Event|28|||
170896154|NCT02497001|617626213|FG001|Overall Study|Adverse Event|30|||
170896155|NCT02497001|617626214|FG002|Overall Study|Adverse Event|11|||
170896156|NCT02497001|617626215|FG003|Overall Study|Adverse Event|11|||
170896157|NCT02497001|617626212|FG000|Overall Study|Withdrawal by Subject|14|||
170640032|NCT02100696|616693809|FG001|Induction Phase|Withdrawal by Subject|2|||
170640033|NCT02100696|616693810|FG002|Induction Phase|Withdrawal by Subject|13|||
170640034|NCT02100696|616693811|FG003|Induction Phase|Withdrawal by Subject|0|||
170640035|NCT02100696|616693812|FG004|Induction Phase|Withdrawal by Subject|0|||
170640036|NCT02100696|616693813|FG005|Induction Phase|Withdrawal by Subject|0|||
170640037|NCT02100696|616693808|FG000|Induction Phase|Physician Decision|1|||
170640038|NCT02100696|616693809|FG001|Induction Phase|Physician Decision|0|||
170640039|NCT02100696|616693810|FG002|Induction Phase|Physician Decision|2|||
170640040|NCT02100696|616693811|FG003|Induction Phase|Physician Decision|0|||
170640041|NCT02100696|616693812|FG004|Induction Phase|Physician Decision|0|||
170640042|NCT02100696|616693813|FG005|Induction Phase|Physician Decision|0|||
170640043|NCT02100696|616693808|FG000|Induction Phase|Multiple Reasons|5|||
170640044|NCT02100696|616693809|FG001|Induction Phase|Multiple Reasons|2|||
170640045|NCT02100696|616693810|FG002|Induction Phase|Multiple Reasons|8|||
170640046|NCT02100696|616693811|FG003|Induction Phase|Multiple Reasons|0|||
170640047|NCT02100696|616693812|FG004|Induction Phase|Multiple Reasons|0|||
170640048|NCT02100696|616693813|FG005|Induction Phase|Multiple Reasons|0|||
170640049|NCT02100696|616693808|FG000|Maintenance Phase|Adverse Event|0|||
170640050|NCT02100696|616693809|FG001|Maintenance Phase|Adverse Event|0|||
170640051|NCT02100696|616693810|FG002|Maintenance Phase|Adverse Event|0|||
170640052|NCT02100696|616693811|FG003|Maintenance Phase|Adverse Event|0|||
170640053|NCT02100696|616693812|FG004|Maintenance Phase|Adverse Event|0|||
170896158|NCT02497001|617626213|FG001|Overall Study|Withdrawal by Subject|37|||
170896159|NCT02497001|617626214|FG002|Overall Study|Withdrawal by Subject|19|||
170896160|NCT02497001|617626215|FG003|Overall Study|Withdrawal by Subject|15|||
170896161|NCT02497001|617626212|FG000|Overall Study|Physician Decision|5|||
170896162|NCT02497001|617626213|FG001|Overall Study|Physician Decision|11|||
170896163|NCT02497001|617626214|FG002|Overall Study|Physician Decision|5|||
170896164|NCT02497001|617626215|FG003|Overall Study|Physician Decision|1|||
170640054|NCT02100696|616693813|FG005|Maintenance Phase|Adverse Event|2|||
170896165|NCT02497001|617626212|FG000|Overall Study|subjects that were not treated|1|||
170795928|NCT04505410|617263344|FG000|Overall Study|Adverse Event|2|||
170795929|NCT04505410|617263345|FG001|Overall Study|Adverse Event|0|||
170795930|NCT04505410|617263344|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
170795931|NCT04505410|617263345|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
170795932|NCT04505410|617263344|FG000|Overall Study|did not want to follow diet|1|||
170795933|NCT04505410|617263345|FG001|Overall Study|did not want to follow diet|0|||
170795934|NCT04505410|617263344|FG000|Overall Study|flare up of ulcerative colitis|0|||
170795935|NCT04505410|617263345|FG001|Overall Study|flare up of ulcerative colitis|1|||
170795936|NCT04505410|617263344|FG000|Overall Study|Lost to Follow-up|0|||
170795937|NCT04505410|617263345|FG001|Overall Study|Lost to Follow-up|2|||
170795938|NCT04505410|617263344|FG000|Overall Study|Lost to Follow-up|1|||
170795939|NCT04505410|617263345|FG001|Overall Study|Lost to Follow-up|0|||
170795940|NCT04505410|617263344|FG000|Overall Study|initiated another diet on their own|0|||
170795941|NCT04505410|617263345|FG001|Overall Study|initiated another diet on their own|2|||
170795942|NCT05123027|617263350|FG000|Overall Study|Lost to Follow-up|17|||
170795943|NCT05123027|617263351|FG001|Overall Study|Lost to Follow-up|22|||
170795944|NCT05123027|617263350|FG000|Overall Study|Incarceration|3|||
170795945|NCT05123027|617263351|FG001|Overall Study|Incarceration|4|||
170795946|NCT05123027|617263350|FG000|Overall Study|Death|2|||
170795947|NCT05123027|617263351|FG001|Overall Study|Death|2|||
170795948|NCT05123027|617263350|FG000|Overall Study|Other|2|||
170795949|NCT05123027|617263351|FG001|Overall Study|Other|0|||
170795950|NCT02593773|617264736|FG000|Overall Study|Voluntary Withdrawal|3|||
170795951|NCT02593773|617264736|FG000|Overall Study|Study Terminated by Sponsor|31|||
170795952|NCT02593773|617264736|FG000|Overall Study|Death|1|||
170795953|NCT01960452|617264739|FG000|Overall Study|Withdrawal by Subject|2|||
170795954|NCT01960452|617264740|FG001|Overall Study|Withdrawal by Subject|1|||
170795955|NCT01960452|617264739|FG000|Overall Study|Sleep apnea in Night 1|1|||
170795956|NCT01960452|617264740|FG001|Overall Study|Sleep apnea in Night 1|0|||
170795957|NCT01960452|617264739|FG000|Overall Study|Poor Sleep in Night 1|0|||
170795958|NCT01960452|617264740|FG001|Overall Study|Poor Sleep in Night 1|2|||
170795959|NCT01960452|617264739|FG000|Overall Study|No Sex/Age Match Night 1|1|||
170795960|NCT01960452|617264740|FG001|Overall Study|No Sex/Age Match Night 1|0|||
170795961|NCT01960452|617264739|FG000|Overall Study|No Sex/Age Match Night 2|0|||
170795962|NCT01960452|617264740|FG001|Overall Study|No Sex/Age Match Night 2|2|||
170795963|NCT01960452|617264739|FG000|Overall Study|Technical Difficulties Night 2|2|||
170795964|NCT01960452|617264740|FG001|Overall Study|Technical Difficulties Night 2|0|||
170795965|NCT02668692|617264741|FG000|Overall Study|Adverse Event|1|||
170795966|NCT02668692|617264742|FG001|Overall Study|Adverse Event|0|||
170795967|NCT03981926|617264743|FG000|Overall Study|Lost to Follow-up|5|||
170795968|NCT03981926|617264744|FG001|Overall Study|Lost to Follow-up|9|||
170795969|NCT05464069|617264746|FG000|Overall Study|Protocol Violation|3|||
170795970|NCT05464069|617264747|FG001|Overall Study|Protocol Violation|2|||
170795971|NCT04709419|617264752|FG000|Overall Study|Physician Decision|1|||
170795972|NCT04709419|617264753|FG001|Overall Study|Physician Decision|0|||
170795973|NCT04526886|617264758|FG000|Overall Study|Physician Decision|4|||
170795974|NCT03276676|617264761|FG000|Overall Study|Withdrawal by Subject|2|||
170795975|NCT03276676|617264762|FG001|Overall Study|Withdrawal by Subject|1|||
170795976|NCT02962076|617264763|FG000|Overall Study|MHED tracer not available|5|||
170795977|NCT02962076|617264763|FG000|Overall Study|Protocol Violation|1|||
170795978|NCT02962076|617264763|FG000|Overall Study|Physician Decision|1|||
170795979|NCT03926130|617264764|FG000|Overall Study|Adverse Event|9|||
170795980|NCT03926130|617264765|FG001|Overall Study|Adverse Event|11|||
170795981|NCT03926130|617264766|FG002|Overall Study|Adverse Event|2|||
170795982|NCT03926130|617264767|FG003|Overall Study|Adverse Event|0|||
170795983|NCT03926130|617264764|FG000|Overall Study|Death|2|||
170795984|NCT03926130|617264765|FG001|Overall Study|Death|0|||
170795985|NCT03926130|617264766|FG002|Overall Study|Death|1|||
170795986|NCT03926130|617264767|FG003|Overall Study|Death|0|||
170795987|NCT03926130|617264764|FG000|Overall Study|Lack of Efficacy|14|||
170795988|NCT03926130|617264765|FG001|Overall Study|Lack of Efficacy|11|||
170795989|NCT03926130|617264766|FG002|Overall Study|Lack of Efficacy|7|||
170795990|NCT03926130|617264767|FG003|Overall Study|Lack of Efficacy|1|||
170795991|NCT03926130|617264764|FG000|Overall Study|Lost to Follow-up|0|||
170795992|NCT03926130|617264765|FG001|Overall Study|Lost to Follow-up|7|||
170795993|NCT03926130|617264766|FG002|Overall Study|Lost to Follow-up|1|||
170795994|NCT03926130|617264767|FG003|Overall Study|Lost to Follow-up|0|||
170896166|NCT02497001|617626213|FG001|Overall Study|subjects that were not treated|2|||
170896167|NCT02497001|617626214|FG002|Overall Study|subjects that were not treated|2|||
170795995|NCT03926130|617264764|FG000|Overall Study|As Reported by Investigator|2|||
170795996|NCT03926130|617264765|FG001|Overall Study|As Reported by Investigator|6|||
170795997|NCT03926130|617264766|FG002|Overall Study|As Reported by Investigator|6|||
170795998|NCT03926130|617264767|FG003|Overall Study|As Reported by Investigator|0|||
170795999|NCT03926130|617264764|FG000|Overall Study|Physician Decision|3|||
170796000|NCT03926130|617264765|FG001|Overall Study|Physician Decision|2|||
170796001|NCT03926130|617264766|FG002|Overall Study|Physician Decision|1|||
170796002|NCT03926130|617264767|FG003|Overall Study|Physician Decision|0|||
170796003|NCT03926130|617264764|FG000|Overall Study|Pregnancy|2|||
170796004|NCT03926130|617264765|FG001|Overall Study|Pregnancy|2|||
170796005|NCT03926130|617264766|FG002|Overall Study|Pregnancy|1|||
170896168|NCT02497001|617626215|FG003|Overall Study|subjects that were not treated|1|||
170796006|NCT03926130|617264767|FG003|Overall Study|Pregnancy|0|||
170896169|NCT02497001|617626212|FG000|Overall Study|Major Protocol Deviation|3|||
170896170|NCT02497001|617626213|FG001|Overall Study|Major Protocol Deviation|4|||
170896171|NCT02497001|617626214|FG002|Overall Study|Major Protocol Deviation|4|||
170896172|NCT02497001|617626215|FG003|Overall Study|Major Protocol Deviation|4|||
170896173|NCT02497001|617626212|FG000|Overall Study|Lack of Efficacy|10|||
170896174|NCT02497001|617626213|FG001|Overall Study|Lack of Efficacy|16|||
170896175|NCT02497001|617626214|FG002|Overall Study|Lack of Efficacy|6|||
170896176|NCT02497001|617626215|FG003|Overall Study|Lack of Efficacy|6|||
170896177|NCT02497001|617626212|FG000|Overall Study|Protocol Violation|3|||
170896178|NCT02497001|617626213|FG001|Overall Study|Protocol Violation|1|||
170896179|NCT02497001|617626214|FG002|Overall Study|Protocol Violation|3|||
170896180|NCT02497001|617626215|FG003|Overall Study|Protocol Violation|1|||
170896181|NCT02542072|617626216|FG000|First Intervention (1 Month)|Adverse Event|1|||
170896182|NCT02542072|617626217|FG001|First Intervention (1 Month)|Adverse Event|1|||
170896183|NCT02542072|617626216|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
170896184|NCT02542072|617626217|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
170896185|NCT02542072|617626216|FG000|First Intervention (1 Month)|Lens discomfort|1|||
170896186|NCT02542072|617626217|FG001|First Intervention (1 Month)|Lens discomfort|2|||
170896187|NCT02542072|617626216|FG000|First Intervention (1 Month)|Protocol Violation|1|||
170896188|NCT02542072|617626217|FG001|First Intervention (1 Month)|Protocol Violation|0|||
170896189|NCT02542072|617626216|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
170896190|NCT02542072|617626217|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
170896191|NCT02542072|617626216|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
170896192|NCT02542072|617626217|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
170896193|NCT04574999|617628453|FG000|Overall Study|Adverse Event|1|||
170896194|NCT04574999|617628454|FG001|Overall Study|Adverse Event|0|||
170896195|NCT04574999|617628453|FG000|Overall Study|Lack of Efficacy|2|||
170896196|NCT04574999|617628454|FG001|Overall Study|Lack of Efficacy|3|||
170896197|NCT04574999|617628453|FG000|Overall Study|Protocol Violation|1|||
170896198|NCT04574999|617628454|FG001|Overall Study|Protocol Violation|0|||
170896199|NCT04574999|617628453|FG000|Overall Study|Withdrawal by Subject|2|||
170896200|NCT04574999|617628454|FG001|Overall Study|Withdrawal by Subject|2|||
170896201|NCT04574999|617628453|FG000|Overall Study|Lost to Follow-up|1|||
170896202|NCT04574999|617628454|FG001|Overall Study|Lost to Follow-up|0|||
170896203|NCT04574999|617628453|FG000|Overall Study|Personal problems|1|||
170896204|NCT04574999|617628454|FG001|Overall Study|Personal problems|0|||
170896205|NCT04574999|617628453|FG000|Overall Study|Previous planned surgery|1|||
170896206|NCT04574999|617628454|FG001|Overall Study|Previous planned surgery|0|||
170896207|NCT00832819|617628456|FG000|Overall Study|Adverse Event|0|||
170896208|NCT00832819|617628457|FG001|Overall Study|Adverse Event|1|||
170896209|NCT00832819|617628458|FG002|Overall Study|Adverse Event|0|||
170896210|NCT00832819|617628456|FG000|Overall Study|Protocol Violation|0|||
170896211|NCT00832819|617628457|FG001|Overall Study|Protocol Violation|0|||
170896212|NCT00832819|617628458|FG002|Overall Study|Protocol Violation|1|||
170896213|NCT02626338|617628459|FG000|Overall Study|Lack of Efficacy|3|||
170896214|NCT02626338|617628460|FG001|Overall Study|Lack of Efficacy|2|||
170896215|NCT02626338|617628461|FG002|Overall Study|Lack of Efficacy|0|||
170896216|NCT00950170|617628462|FG000|Overall Study|Parent/Legal Guardian Request|1|||
170896217|NCT00950170|617628462|FG000|Overall Study|Adverse Event|2|||
170896218|NCT00950170|617628462|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
170796007|NCT03926130|617264764|FG000|Overall Study|Withdrawal by Subject|20|||
170796008|NCT03926130|617264765|FG001|Overall Study|Withdrawal by Subject|28|||
170796009|NCT03926130|617264766|FG002|Overall Study|Withdrawal by Subject|18|||
170796010|NCT03926130|617264767|FG003|Overall Study|Withdrawal by Subject|1|||
170796011|NCT03926130|617264764|FG000|Overall Study|Non-Compliance|1|||
170796012|NCT03926130|617264765|FG001|Overall Study|Non-Compliance|1|||
170796013|NCT03926130|617264766|FG002|Overall Study|Non-Compliance|0|||
170896219|NCT00463476|617628463|FG000|Overall Study|Withdrawal by Subject|1|||
170896220|NCT00463476|617628464|FG001|Overall Study|Withdrawal by Subject|2|||
170796014|NCT03926130|617264767|FG003|Overall Study|Non-Compliance|0|||
170796015|NCT03926130|617264764|FG000|Overall Study|Disposition Not Captured|0|||
170896221|NCT00463476|617628463|FG000|Overall Study|Lost to Follow-up|1|||
170896222|NCT00463476|617628464|FG001|Overall Study|Lost to Follow-up|1|||
170896223|NCT01279057|617628465|FG000|Overall Study|Adverse Event|1|||
170896224|NCT01279057|617628466|FG001|Overall Study|Adverse Event|0|||
170896225|NCT01279057|617628467|FG002|Overall Study|Adverse Event|1|||
170896226|NCT01279057|617628465|FG000|Overall Study|Insufficient therapeutic response|0|||
170796016|NCT03926130|617264765|FG001|Overall Study|Disposition Not Captured|2|||
170796017|NCT03926130|617264766|FG002|Overall Study|Disposition Not Captured|1|||
170896227|NCT01279057|617628466|FG001|Overall Study|Insufficient therapeutic response|0|||
170896228|NCT01279057|617628467|FG002|Overall Study|Insufficient therapeutic response|1|||
170896229|NCT01279057|617628465|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
170796018|NCT03926130|617264767|FG003|Overall Study|Disposition Not Captured|0|||
170796019|NCT05069896|617264776|FG000|Overall Study|Adverse Event|0|||
170796020|NCT05069896|617264777|FG001|Overall Study|Adverse Event|1|||
170796021|NCT05069896|617264778|FG002|Overall Study|Adverse Event|1|||
170796022|NCT05069896|617264779|FG003|Overall Study|Adverse Event|0|||
170796023|NCT05069896|617264780|FG004|Overall Study|Adverse Event|0|||
170796024|NCT05069896|617264781|FG005|Overall Study|Adverse Event|0|||
170796025|NCT05069896|617264776|FG000|Overall Study|Lost to Follow-up|0|||
170796026|NCT05069896|617264777|FG001|Overall Study|Lost to Follow-up|0|||
170796027|NCT05069896|617264778|FG002|Overall Study|Lost to Follow-up|1|||
170796028|NCT05069896|617264779|FG003|Overall Study|Lost to Follow-up|0|||
170796029|NCT05069896|617264780|FG004|Overall Study|Lost to Follow-up|1|||
170796030|NCT05069896|617264781|FG005|Overall Study|Lost to Follow-up|2|||
170796031|NCT03156465|617264785|FG000|Overall Study|Withdrawal by Subject|2|||
170796032|NCT03640286|617264786|FG000|Overall Study|Adverse Event|6|||
170796033|NCT03640286|617264787|FG001|Overall Study|Adverse Event|6|||
170796034|NCT03640286|617264786|FG000|Overall Study|Lost to Follow-up|3|||
170796035|NCT03640286|617264787|FG001|Overall Study|Lost to Follow-up|6|||
170796036|NCT03640286|617264786|FG000|Overall Study|Pregnancy|1|||
170796037|NCT03640286|617264787|FG001|Overall Study|Pregnancy|0|||
170796038|NCT03640286|617264786|FG000|Overall Study|Withdrawal by Subject|10|||
170796039|NCT03640286|617264787|FG001|Overall Study|Withdrawal by Subject|10|||
170796040|NCT03640286|617264786|FG000|Overall Study|Non-compliance|4|||
170796041|NCT03640286|617264787|FG001|Overall Study|Non-compliance|10|||
170796042|NCT03640286|617264786|FG000|Overall Study|Medication change|1|||
170796043|NCT03640286|617264787|FG001|Overall Study|Medication change|0|||
170796044|NCT03640286|617264786|FG000|Overall Study|Other|1|||
170796045|NCT03640286|617264787|FG001|Overall Study|Other|2|||
170796046|NCT03640286|617264786|FG000|Overall Study|Joined another lifestyle program|0|||
170796047|NCT03640286|617264787|FG001|Overall Study|Joined another lifestyle program|1|||
170796048|NCT05524116|617264795|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
170796049|NCT05524116|617264796|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
170796050|NCT05524116|617264795|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
170796051|NCT05524116|617264796|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
170796052|NCT05524116|617264795|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
170796053|NCT05524116|617264796|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
170796054|NCT05524116|617264795|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
170796055|NCT05524116|617264796|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
170796056|NCT05524116|617264795|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
170796057|NCT05524116|617264796|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
170796058|NCT04389957|617264798|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
170796059|NCT04389957|617264799|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
170796060|NCT04389957|617264800|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
170796061|NCT04389957|617264801|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
170796062|NCT04389957|617264802|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
170796063|NCT03181516|617264803|FG000|Overall Study|Withdrawal by Subject|14|||
170796064|NCT03181516|617264804|FG001|Overall Study|Withdrawal by Subject|7|||
170796065|NCT03181516|617264803|FG000|Overall Study|Lost to Follow-up|2|||
170796066|NCT03181516|617264804|FG001|Overall Study|Lost to Follow-up|2|||
170796067|NCT03580356|617264807|FG000|Treatment Period|Withdrawal by Subject|13|||
170796068|NCT03580356|617264808|FG001|Treatment Period|Withdrawal by Subject|0|||
170796069|NCT03580356|617264809|FG002|Treatment Period|Withdrawal by Subject|13|||
170796070|NCT03580356|617264810|FG003|Treatment Period|Withdrawal by Subject|1|||
170796071|NCT03580356|617264811|FG004|Treatment Period|Withdrawal by Subject|17|||
170796072|NCT03580356|617264812|FG005|Treatment Period|Withdrawal by Subject|0|||
170796073|NCT03580356|617264813|FG006|Treatment Period|Withdrawal by Subject|5|||
170796074|NCT03580356|617264814|FG007|Treatment Period|Withdrawal by Subject|0|||
170796075|NCT03580356|617264807|FG000|Treatment Period|Adverse Event|10|||
170796076|NCT03580356|617264808|FG001|Treatment Period|Adverse Event|0|||
170796077|NCT03580356|617264809|FG002|Treatment Period|Adverse Event|13|||
170796078|NCT03580356|617264810|FG003|Treatment Period|Adverse Event|0|||
170796079|NCT03580356|617264811|FG004|Treatment Period|Adverse Event|5|||
170796080|NCT03580356|617264812|FG005|Treatment Period|Adverse Event|0|||
170796081|NCT03580356|617264813|FG006|Treatment Period|Adverse Event|8|||
170796082|NCT03580356|617264814|FG007|Treatment Period|Adverse Event|0|||
170796083|NCT03580356|617264807|FG000|Treatment Period|Protocol Violation|5|||
170796084|NCT03580356|617264808|FG001|Treatment Period|Protocol Violation|0|||
170796085|NCT03580356|617264809|FG002|Treatment Period|Protocol Violation|6|||
170796086|NCT03580356|617264810|FG003|Treatment Period|Protocol Violation|1|||
170796087|NCT03580356|617264811|FG004|Treatment Period|Protocol Violation|9|||
170796088|NCT03580356|617264812|FG005|Treatment Period|Protocol Violation|1|||
170796089|NCT03580356|617264813|FG006|Treatment Period|Protocol Violation|1|||
170796090|NCT03580356|617264814|FG007|Treatment Period|Protocol Violation|0|||
170796091|NCT03580356|617264807|FG000|Treatment Period|Lack of Efficacy|6|||
170796092|NCT03580356|617264808|FG001|Treatment Period|Lack of Efficacy|0|||
170896230|NCT01279057|617628466|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
170796093|NCT03580356|617264809|FG002|Treatment Period|Lack of Efficacy|2|||
170896231|NCT01279057|617628467|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
170896232|NCT01279057|617628465|FG000|Overall Study|Withdrew consent|2|||
170896233|NCT01279057|617628466|FG001|Overall Study|Withdrew consent|0|||
170896234|NCT01279057|617628467|FG002|Overall Study|Withdrew consent|1|||
170896235|NCT01279057|617628465|FG000|Overall Study|Pregnancy|0|||
170896236|NCT01279057|617628466|FG001|Overall Study|Pregnancy|1|||
170896237|NCT01279057|617628467|FG002|Overall Study|Pregnancy|0|||
170896238|NCT01279057|617628465|FG000|Overall Study|Other|3|||
170896239|NCT01279057|617628466|FG001|Overall Study|Other|3|||
170896240|NCT01279057|617628467|FG002|Overall Study|Other|0|||
170896241|NCT01427309|617628469|FG000|Overall Study|Lost to Follow-up|130|||
170896242|NCT01427309|617628470|FG001|Overall Study|Lost to Follow-up|145|||
170896243|NCT01427309|617628471|FG002|Overall Study|Lost to Follow-up|122|||
170896244|NCT01427309|617628472|FG003|Overall Study|Lost to Follow-up|135|||
170896245|NCT01427309|617628469|FG000|Overall Study|Protocol Violation|42|||
170796094|NCT03580356|617264810|FG003|Treatment Period|Lack of Efficacy|0|||
170796095|NCT03580356|617264811|FG004|Treatment Period|Lack of Efficacy|3|||
170796096|NCT03580356|617264812|FG005|Treatment Period|Lack of Efficacy|0|||
170796097|NCT03580356|617264813|FG006|Treatment Period|Lack of Efficacy|3|||
170796098|NCT03580356|617264814|FG007|Treatment Period|Lack of Efficacy|0|||
170796099|NCT03580356|617264807|FG000|Treatment Period|Pregnancy|1|||
170796100|NCT03580356|617264808|FG001|Treatment Period|Pregnancy|0|||
170796101|NCT03580356|617264809|FG002|Treatment Period|Pregnancy|7|||
170796102|NCT03580356|617264810|FG003|Treatment Period|Pregnancy|0|||
170796103|NCT03580356|617264811|FG004|Treatment Period|Pregnancy|2|||
170796104|NCT03580356|617264812|FG005|Treatment Period|Pregnancy|0|||
170796105|NCT03580356|617264813|FG006|Treatment Period|Pregnancy|1|||
170796106|NCT03580356|617264814|FG007|Treatment Period|Pregnancy|0|||
170796107|NCT03580356|617264807|FG000|Treatment Period|Physician Decision|2|||
170796108|NCT03580356|617264808|FG001|Treatment Period|Physician Decision|0|||
170796109|NCT03580356|617264809|FG002|Treatment Period|Physician Decision|1|||
170796110|NCT03580356|617264810|FG003|Treatment Period|Physician Decision|0|||
170796111|NCT03580356|617264811|FG004|Treatment Period|Physician Decision|4|||
170796112|NCT03580356|617264812|FG005|Treatment Period|Physician Decision|0|||
170796113|NCT03580356|617264813|FG006|Treatment Period|Physician Decision|2|||
170796114|NCT03580356|617264814|FG007|Treatment Period|Physician Decision|0|||
170796115|NCT03580356|617264807|FG000|Treatment Period|Lost to Follow-up|1|||
170796116|NCT03580356|617264808|FG001|Treatment Period|Lost to Follow-up|1|||
170796117|NCT03580356|617264809|FG002|Treatment Period|Lost to Follow-up|1|||
170796118|NCT03580356|617264810|FG003|Treatment Period|Lost to Follow-up|0|||
170796119|NCT03580356|617264811|FG004|Treatment Period|Lost to Follow-up|3|||
170796120|NCT03580356|617264812|FG005|Treatment Period|Lost to Follow-up|0|||
170796121|NCT03580356|617264813|FG006|Treatment Period|Lost to Follow-up|1|||
170796122|NCT03580356|617264814|FG007|Treatment Period|Lost to Follow-up|0|||
170796123|NCT03580356|617264807|FG000|Treatment Period|Death|0|||
170796124|NCT03580356|617264808|FG001|Treatment Period|Death|0|||
170796125|NCT03580356|617264809|FG002|Treatment Period|Death|1|||
170796126|NCT03580356|617264810|FG003|Treatment Period|Death|0|||
170796127|NCT03580356|617264811|FG004|Treatment Period|Death|0|||
170796128|NCT03580356|617264812|FG005|Treatment Period|Death|0|||
170796129|NCT03580356|617264813|FG006|Treatment Period|Death|0|||
170796130|NCT03580356|617264814|FG007|Treatment Period|Death|0|||
170796131|NCT03580356|617264807|FG000|Treatment Period|Technical problems|0|||
170796132|NCT03580356|617264808|FG001|Treatment Period|Technical problems|0|||
170796133|NCT03580356|617264809|FG002|Treatment Period|Technical problems|0|||
170796134|NCT03580356|617264810|FG003|Treatment Period|Technical problems|0|||
170896246|NCT01427309|617628470|FG001|Overall Study|Protocol Violation|69|||
170896247|NCT01427309|617628471|FG002|Overall Study|Protocol Violation|125|||
170896248|NCT01427309|617628472|FG003|Overall Study|Protocol Violation|124|||
170896249|NCT01427309|617628469|FG000|Overall Study|Adverse Event|0|||
170896250|NCT01427309|617628470|FG001|Overall Study|Adverse Event|0|||
170796135|NCT03580356|617264811|FG004|Treatment Period|Technical problems|1|||
170896251|NCT01427309|617628471|FG002|Overall Study|Adverse Event|3|||
170896252|NCT01427309|617628472|FG003|Overall Study|Adverse Event|1|||
170896253|NCT01427309|617628469|FG000|Overall Study|Serious adverse event|52|||
170796136|NCT03580356|617264812|FG005|Treatment Period|Technical problems|0|||
170796137|NCT03580356|617264813|FG006|Treatment Period|Technical problems|0|||
170796138|NCT03580356|617264814|FG007|Treatment Period|Technical problems|0|||
170796139|NCT03580356|617264807|FG000|Treatment Period|Misrandomized, no treatment|0|||
170796140|NCT03580356|617264808|FG001|Treatment Period|Misrandomized, no treatment|0|||
170796141|NCT03580356|617264809|FG002|Treatment Period|Misrandomized, no treatment|1|||
170796142|NCT03580356|617264810|FG003|Treatment Period|Misrandomized, no treatment|0|||
170796143|NCT03580356|617264811|FG004|Treatment Period|Misrandomized, no treatment|2|||
170796144|NCT03580356|617264812|FG005|Treatment Period|Misrandomized, no treatment|0|||
170796145|NCT03580356|617264813|FG006|Treatment Period|Misrandomized, no treatment|0|||
170896254|NCT01427309|617628470|FG001|Overall Study|Serious adverse event|45|||
170896255|NCT01427309|617628471|FG002|Overall Study|Serious adverse event|50|||
170896256|NCT01427309|617628472|FG003|Overall Study|Serious adverse event|61|||
170896257|NCT01427309|617628469|FG000|Overall Study|Withdrawal by Subject|148|||
170896258|NCT01427309|617628470|FG001|Overall Study|Withdrawal by Subject|148|||
170896259|NCT01427309|617628471|FG002|Overall Study|Withdrawal by Subject|61|||
170896260|NCT01427309|617628472|FG003|Overall Study|Withdrawal by Subject|55|||
170896261|NCT00928070|617628475|FG000|Overall Study|Lost to Follow-up|1|||
170896262|NCT00928070|617628476|FG001|Overall Study|Lost to Follow-up|2|||
170896263|NCT00928070|617628475|FG000|Overall Study|Withdrawal by Subject|10|||
170896264|NCT00928070|617628476|FG001|Overall Study|Withdrawal by Subject|3|||
170896265|NCT00928070|617628475|FG000|Overall Study|Adverse Event|14|||
170896266|NCT00928070|617628476|FG001|Overall Study|Adverse Event|26|||
170896267|NCT00928070|617628475|FG000|Overall Study|Lack of Efficacy|9|||
170896268|NCT00928070|617628476|FG001|Overall Study|Lack of Efficacy|5|||
170896269|NCT00928070|617628475|FG000|Overall Study|Did not meet entrance criteria|16|||
170896270|NCT00928070|617628476|FG001|Overall Study|Did not meet entrance criteria|9|||
170896271|NCT00928070|617628475|FG000|Overall Study|Protocol Violation|6|||
170896272|NCT00928070|617628476|FG001|Overall Study|Protocol Violation|5|||
170896273|NCT00928070|617628475|FG000|Overall Study|Randomized but not treated|2|||
170896274|NCT00928070|617628476|FG001|Overall Study|Randomized but not treated|2|||
170896275|NCT00928070|617628475|FG000|Overall Study|Other|5|||
170896276|NCT00928070|617628476|FG001|Overall Study|Other|5|||
170896277|NCT02913313|617628477|FG000|Overall Study|DISEASE PROGRESSION|1|||
170896278|NCT02913313|617628478|FG001|Overall Study|DISEASE PROGRESSION|2|||
170896279|NCT02913313|617628479|FG002|Overall Study|DISEASE PROGRESSION|2|||
170896280|NCT02913313|617628480|FG003|Overall Study|DISEASE PROGRESSION|4|||
170896281|NCT02913313|617628481|FG004|Overall Study|DISEASE PROGRESSION|6|||
170896282|NCT02913313|617628482|FG005|Overall Study|DISEASE PROGRESSION|4|||
170896283|NCT02913313|617628483|FG006|Overall Study|DISEASE PROGRESSION|19|||
170896284|NCT02913313|617628484|FG007|Overall Study|DISEASE PROGRESSION|3|||
170896285|NCT02913313|617628485|FG008|Overall Study|DISEASE PROGRESSION|4|||
170896286|NCT02913313|617628486|FG009|Overall Study|DISEASE PROGRESSION|4|||
170896287|NCT02913313|617628487|FG010|Overall Study|DISEASE PROGRESSION|11|||
170896288|NCT02913313|617628488|FG011|Overall Study|DISEASE PROGRESSION|5|||
170896289|NCT02913313|617628489|FG012|Overall Study|DISEASE PROGRESSION|14|||
170896290|NCT02913313|617628490|FG013|Overall Study|DISEASE PROGRESSION|3|||
170896291|NCT02913313|617628477|FG000|Overall Study|Not Reported|0|||
170896292|NCT02913313|617628478|FG001|Overall Study|Not Reported|0|||
170896293|NCT02913313|617628479|FG002|Overall Study|Not Reported|0|||
170896294|NCT02913313|617628480|FG003|Overall Study|Not Reported|0|||
170896295|NCT02913313|617628481|FG004|Overall Study|Not Reported|1|||
170896296|NCT02913313|617628482|FG005|Overall Study|Not Reported|0|||
170896297|NCT02913313|617628483|FG006|Overall Study|Not Reported|0|||
170896298|NCT02913313|617628484|FG007|Overall Study|Not Reported|0|||
170896299|NCT02913313|617628485|FG008|Overall Study|Not Reported|0|||
170896300|NCT02913313|617628486|FG009|Overall Study|Not Reported|0|||
170896301|NCT02913313|617628487|FG010|Overall Study|Not Reported|4|||
170896302|NCT02913313|617628488|FG011|Overall Study|Not Reported|0|||
170896303|NCT02913313|617628489|FG012|Overall Study|Not Reported|0|||
170896304|NCT02913313|617628490|FG013|Overall Study|Not Reported|0|||
170896305|NCT02913313|617628477|FG000|Overall Study|Other reasons|0|||
170896306|NCT02913313|617628478|FG001|Overall Study|Other reasons|0|||
170896307|NCT02913313|617628479|FG002|Overall Study|Other reasons|0|||
170896308|NCT02913313|617628480|FG003|Overall Study|Other reasons|0|||
170896309|NCT02913313|617628481|FG004|Overall Study|Other reasons|1|||
170896310|NCT02913313|617628482|FG005|Overall Study|Other reasons|0|||
170896311|NCT02913313|617628483|FG006|Overall Study|Other reasons|0|||
170896312|NCT02913313|617628484|FG007|Overall Study|Other reasons|0|||
170896313|NCT02913313|617628485|FG008|Overall Study|Other reasons|0|||
170896314|NCT02913313|617628486|FG009|Overall Study|Other reasons|0|||
170896315|NCT02913313|617628487|FG010|Overall Study|Other reasons|1|||
170896316|NCT02913313|617628488|FG011|Overall Study|Other reasons|0|||
170481812|NCT00955409|616105546|FG004|Overall Study|Caregiver Request|0|||
170481813|NCT00955409|616105547|FG005|Overall Study|Caregiver Request|2|||
170896317|NCT02913313|617628489|FG012|Overall Study|Other reasons|0|||
170896318|NCT02913313|617628490|FG013|Overall Study|Other reasons|0|||
170896319|NCT02913313|617628477|FG000|Overall Study|Withdrawal by Subject|0|||
170896320|NCT02913313|617628478|FG001|Overall Study|Withdrawal by Subject|0|||
170896321|NCT02913313|617628479|FG002|Overall Study|Withdrawal by Subject|1|||
170896322|NCT02913313|617628480|FG003|Overall Study|Withdrawal by Subject|0|||
170896323|NCT02913313|617628481|FG004|Overall Study|Withdrawal by Subject|0|||
170896324|NCT02913313|617628482|FG005|Overall Study|Withdrawal by Subject|0|||
170896325|NCT02913313|617628483|FG006|Overall Study|Withdrawal by Subject|1|||
170896326|NCT02913313|617628484|FG007|Overall Study|Withdrawal by Subject|1|||
170896327|NCT02913313|617628485|FG008|Overall Study|Withdrawal by Subject|0|||
170896328|NCT02913313|617628486|FG009|Overall Study|Withdrawal by Subject|0|||
170896329|NCT02913313|617628487|FG010|Overall Study|Withdrawal by Subject|1|||
170896330|NCT02913313|617628488|FG011|Overall Study|Withdrawal by Subject|0|||
170896331|NCT02913313|617628489|FG012|Overall Study|Withdrawal by Subject|0|||
170896332|NCT02913313|617628490|FG013|Overall Study|Withdrawal by Subject|0|||
170896333|NCT02913313|617628477|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896334|NCT02913313|617628478|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896335|NCT02913313|617628479|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896336|NCT02913313|617628480|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896337|NCT02913313|617628481|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896338|NCT02913313|617628482|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896339|NCT02913313|617628483|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896340|NCT02913313|617628484|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896341|NCT02913313|617628485|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896342|NCT02913313|617628486|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896343|NCT02913313|617628487|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
170896344|NCT02913313|617628488|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
170896345|NCT02913313|617628489|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
170896346|NCT02913313|617628490|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
170896347|NCT02913313|617628477|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
170896348|NCT02913313|617628478|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
170896349|NCT02913313|617628479|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
170896350|NCT02913313|617628480|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
170896351|NCT02913313|617628481|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
170896352|NCT02913313|617628482|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
170896353|NCT02913313|617628483|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
170896354|NCT02913313|617628484|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
170896355|NCT02913313|617628485|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
170896356|NCT02913313|617628486|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
170896357|NCT02913313|617628487|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
170896358|NCT02913313|617628488|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
170896359|NCT02913313|617628489|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
170896360|NCT02913313|617628490|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
170896361|NCT01061008|617628491|FG000|Overall Study|Badiocephalic fistula failed|3|||
170896362|NCT01061008|617628492|FG001|Overall Study|Badiocephalic fistula failed|2|||
170896363|NCT01061008|617628491|FG000|Overall Study|Death|1|||
170896364|NCT01061008|617628492|FG001|Overall Study|Death|0|||
170896365|NCT01061008|617628491|FG000|Overall Study|Withdrawal by Subject|1|||
170896366|NCT01061008|617628492|FG001|Overall Study|Withdrawal by Subject|3|||
170896367|NCT01061008|617628491|FG000|Overall Study|Unable to exercise following surgery|1|||
170896368|NCT01061008|617628492|FG001|Overall Study|Unable to exercise following surgery|0|||
170896369|NCT01061008|617628491|FG000|Overall Study|Adverse Event|0|||
170896370|NCT01061008|617628492|FG001|Overall Study|Adverse Event|1|||
170896371|NCT02024971|617628494|FG000|Overall Study|Data Not Available|30|||
170896372|NCT02024971|617628494|FG000|Overall Study|Lost to Follow-up|6|||
170896373|NCT02908100|617628495|FG000|Overall Study|Adverse Event|7|||
170481814|NCT00955409|616105548|FG006|Overall Study|Caregiver Request|3|||
170481815|NCT00955409|616105549|FG007|Overall Study|Caregiver Request|1|||
170481816|NCT00955409|616105550|FG008|Overall Study|Caregiver Request|3|||
170481817|NCT00955409|616105551|FG009|Overall Study|Caregiver Request|0|||
170640055|NCT02100696|616693808|FG000|Maintenance Phase|Lost to Follow-up|0|||
170481818|NCT00955409|616105542|FG000|Overall Study|Investigator Request|0|||
170481819|NCT00955409|616105543|FG001|Overall Study|Investigator Request|0|||
170481820|NCT00955409|616105544|FG002|Overall Study|Investigator Request|1|||
170481821|NCT00955409|616105545|FG003|Overall Study|Investigator Request|0|||
170481822|NCT00955409|616105546|FG004|Overall Study|Investigator Request|0|||
170640056|NCT02100696|616693809|FG001|Maintenance Phase|Lost to Follow-up|0|||
170896374|NCT02908100|617628496|FG001|Overall Study|Adverse Event|6|||
170896375|NCT02908100|617628497|FG002|Overall Study|Adverse Event|9|||
170896376|NCT02908100|617628495|FG000|Overall Study|Death|2|||
170896377|NCT02908100|617628496|FG001|Overall Study|Death|0|||
170896378|NCT02908100|617628497|FG002|Overall Study|Death|0|||
170896379|NCT02908100|617628495|FG000|Overall Study|Lack of Efficacy|2|||
170896380|NCT02908100|617628496|FG001|Overall Study|Lack of Efficacy|3|||
170896381|NCT02908100|617628497|FG002|Overall Study|Lack of Efficacy|3|||
170896382|NCT02908100|617628495|FG000|Overall Study|Lost to Follow-up|0|||
170896383|NCT02908100|617628496|FG001|Overall Study|Lost to Follow-up|1|||
170896384|NCT02908100|617628497|FG002|Overall Study|Lost to Follow-up|2|||
170896385|NCT02908100|617628495|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170896386|NCT02908100|617628496|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170896387|NCT02908100|617628497|FG002|Overall Study|Non-Compliance With Study Drug|2|||
170896388|NCT02908100|617628495|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
170896389|NCT02908100|617628496|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
170896390|NCT02908100|617628497|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
170896391|NCT02908100|617628495|FG000|Overall Study|Physician Decision|0|||
170896392|NCT02908100|617628496|FG001|Overall Study|Physician Decision|1|||
170896393|NCT02908100|617628497|FG002|Overall Study|Physician Decision|0|||
170896394|NCT02908100|617628495|FG000|Overall Study|Pregnancy|1|||
170896395|NCT02908100|617628496|FG001|Overall Study|Pregnancy|2|||
170896396|NCT02908100|617628497|FG002|Overall Study|Pregnancy|0|||
170796146|NCT03580356|617264814|FG007|Treatment Period|Misrandomized, no treatment|0|||
170796147|NCT03580356|617264807|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
170796148|NCT03580356|617264808|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
170481823|NCT00955409|616105547|FG005|Overall Study|Investigator Request|0|||
170481824|NCT00955409|616105548|FG006|Overall Study|Investigator Request|0|||
170796149|NCT03580356|617264809|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
170796150|NCT03580356|617264810|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
170796151|NCT03580356|617264811|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
170796152|NCT03580356|617264812|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
170796153|NCT03580356|617264813|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
170796154|NCT03580356|617264814|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
170796155|NCT03580356|617264807|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
170796156|NCT03580356|617264808|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
170796157|NCT03580356|617264809|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
170796158|NCT03580356|617264810|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
170796159|NCT03580356|617264811|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
170796160|NCT03580356|617264812|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
170796161|NCT03580356|617264813|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
170796162|NCT03580356|617264814|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
170796163|NCT03580356|617264807|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
170796164|NCT03580356|617264808|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
170796165|NCT03580356|617264809|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
170796166|NCT03580356|617264810|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
170796167|NCT03580356|617264811|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
170796168|NCT03580356|617264812|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
170796169|NCT03580356|617264813|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
170796170|NCT03580356|617264814|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
170796171|NCT03580356|617264807|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
170796172|NCT03580356|617264808|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
170796173|NCT03580356|617264809|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
170796174|NCT03580356|617264810|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
170796175|NCT03580356|617264811|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
170796176|NCT03580356|617264812|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
170796177|NCT03580356|617264813|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
170796178|NCT03580356|617264814|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
170796179|NCT03580356|617264807|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
170481825|NCT00955409|616105549|FG007|Overall Study|Investigator Request|0|||
170481826|NCT00955409|616105550|FG008|Overall Study|Investigator Request|0|||
170796180|NCT03580356|617264808|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
170796181|NCT03580356|617264809|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
170796182|NCT03580356|617264810|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
170796183|NCT03580356|617264811|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
170796184|NCT03580356|617264812|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
170796185|NCT03580356|617264813|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
170796186|NCT03580356|617264814|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
170796187|NCT03580356|617264807|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
170796188|NCT03580356|617264808|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
170796189|NCT03580356|617264809|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
170796190|NCT03580356|617264810|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
170796191|NCT03580356|617264811|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
170796192|NCT03580356|617264812|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
170796193|NCT03580356|617264813|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
170796194|NCT03580356|617264814|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
170796195|NCT03580356|617264807|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
170796196|NCT03580356|617264808|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
170796197|NCT03580356|617264809|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
170796198|NCT03580356|617264810|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
170796199|NCT03580356|617264811|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
170796200|NCT03580356|617264812|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
170796201|NCT03580356|617264813|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
170796202|NCT03580356|617264814|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
170796203|NCT05715528|617264816|FG000|Overall Study|Randomized but never treated|11|||
170796204|NCT05715528|617264817|FG001|Overall Study|Randomized but never treated|13|||
170796205|NCT05715528|617264816|FG000|Overall Study|Withdrew consent|7|||
170796206|NCT05715528|617264817|FG001|Overall Study|Withdrew consent|15|||
170796207|NCT05715528|617264816|FG000|Overall Study|Lost to Follow-up|5|||
170796208|NCT05715528|617264817|FG001|Overall Study|Lost to Follow-up|13|||
170796209|NCT05715528|617264816|FG000|Overall Study|Investigator's discretion|3|||
170796210|NCT05715528|617264817|FG001|Overall Study|Investigator's discretion|1|||
170796211|NCT05715528|617264816|FG000|Overall Study|Protocol Violation|2|||
170796212|NCT05715528|617264817|FG001|Overall Study|Protocol Violation|0|||
170796213|NCT05715528|617264816|FG000|Overall Study|Non-compliance with study drug|0|||
170796214|NCT05715528|617264817|FG001|Overall Study|Non-compliance with study drug|1|||
170796215|NCT03118518|617264818|FG000|Overall Study|Early Exit after treatment|2|||
170796216|NCT03118518|617264819|FG001|Overall Study|Early Exit after treatment|8|||
170796217|NCT03118518|617264818|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
170796218|NCT03118518|617264819|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
170796219|NCT02834390|617264820|FG000|Induction Phase|Progressive disease|0|||
170796220|NCT02834390|617264821|FG001|Induction Phase|Progressive disease|1|||
170796221|NCT02834390|617264820|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
170796222|NCT02834390|617264821|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
170796223|NCT02834390|617264820|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
170796224|NCT02834390|617264821|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
170796225|NCT02834390|617264820|FG000|Consolidation Phase|Physician Decision|1|||
170796226|NCT02834390|617264821|FG001|Consolidation Phase|Physician Decision|1|||
170796227|NCT05405985|617264828|FG000|Overall Study|Withdrawal by Subject|1|||
170796228|NCT05405985|617264829|FG001|Overall Study|Withdrawal by Subject|0|||
170796229|NCT02323880|617264834|FG000|Overall Study|Adverse Event|2|||
170796230|NCT02323880|617264835|FG001|Overall Study|Adverse Event|0|||
170796231|NCT02323880|617264836|FG002|Overall Study|Adverse Event|1|||
170796232|NCT02323880|617264837|FG003|Overall Study|Adverse Event|1|||
170796233|NCT02323880|617264838|FG004|Overall Study|Adverse Event|1|||
170796234|NCT02323880|617264839|FG005|Overall Study|Adverse Event|0|||
170796235|NCT02323880|617264840|FG006|Overall Study|Adverse Event|1|||
170796236|NCT02323880|617264841|FG007|Overall Study|Adverse Event|0|||
170796237|NCT02323880|617264834|FG000|Overall Study|Death|0|||
170796238|NCT02323880|617264835|FG001|Overall Study|Death|0|||
170796239|NCT02323880|617264836|FG002|Overall Study|Death|0|||
170796240|NCT02323880|617264837|FG003|Overall Study|Death|0|||
170796241|NCT02323880|617264838|FG004|Overall Study|Death|0|||
170796242|NCT02323880|617264839|FG005|Overall Study|Death|1|||
170796243|NCT02323880|617264840|FG006|Overall Study|Death|0|||
170796244|NCT02323880|617264841|FG007|Overall Study|Death|0|||
170796245|NCT02323880|617264834|FG000|Overall Study|Lack of Efficacy|4|||
170796246|NCT02323880|617264835|FG001|Overall Study|Lack of Efficacy|11|||
170796247|NCT02323880|617264836|FG002|Overall Study|Lack of Efficacy|5|||
170796248|NCT02323880|617264837|FG003|Overall Study|Lack of Efficacy|5|||
170796249|NCT02323880|617264838|FG004|Overall Study|Lack of Efficacy|4|||
170796250|NCT02323880|617264839|FG005|Overall Study|Lack of Efficacy|8|||
170796251|NCT02323880|617264840|FG006|Overall Study|Lack of Efficacy|4|||
170896397|NCT02908100|617628495|FG000|Overall Study|Withdrawal by Subject|8|||
170896398|NCT02908100|617628496|FG001|Overall Study|Withdrawal by Subject|7|||
170896399|NCT02908100|617628497|FG002|Overall Study|Withdrawal by Subject|5|||
170896400|NCT02908100|617628495|FG000|Overall Study|Randomised in Error|1|||
170896401|NCT02908100|617628496|FG001|Overall Study|Randomised in Error|0|||
170896402|NCT02908100|617628497|FG002|Overall Study|Randomised in Error|0|||
170896403|NCT05254418|617628499|FG000|Overall Study|Adverse Event|2|||
170896404|NCT00553462|617628503|FG000|Overall Study|Adverse Event|4|||
170896405|NCT00553462|617628503|FG000|Overall Study|Progression|4|||
170896406|NCT00553462|617628503|FG000|Overall Study|Withdrawal by Subject|5|||
170896407|NCT00553462|617628503|FG000|Overall Study|Physician Decision|1|||
170896408|NCT04398732|617628504|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
170896409|NCT00944034|617628506|FG000|Overall Study|Inappropriate enrollment|0|||
170896410|NCT00944034|617628507|FG001|Overall Study|Inappropriate enrollment|1|||
170896411|NCT00944034|617628508|FG002|Overall Study|Inappropriate enrollment|0|||
170896412|NCT00944034|617628509|FG003|Overall Study|Inappropriate enrollment|1|||
170896413|NCT00944034|617628510|FG004|Overall Study|Inappropriate enrollment|2|||
170896414|NCT00944034|617628511|FG005|Overall Study|Inappropriate enrollment|1|||
170896415|NCT00944034|617628512|FG006|Overall Study|Inappropriate enrollment|0|||
170896416|NCT00944034|617628513|FG007|Overall Study|Inappropriate enrollment|0|||
170896417|NCT00944034|617628514|FG008|Overall Study|Inappropriate enrollment|1|||
170896418|NCT00944034|617628515|FG009|Overall Study|Inappropriate enrollment|1|||
170896419|NCT00944034|617628516|FG010|Overall Study|Inappropriate enrollment|0|||
170896420|NCT00944034|617628517|FG011|Overall Study|Inappropriate enrollment|0|||
170896421|NCT00944034|617628506|FG000|Overall Study|Withdrawal by Subject|3|||
170896422|NCT00944034|617628507|FG001|Overall Study|Withdrawal by Subject|2|||
170548190|NCT00799864|616352054|FG002|Overall Study|Participant reached a virologic endpoint|2|||
170548191|NCT00799864|616352055|FG003|Overall Study|Participant reached a virologic endpoint|0|||
170548192|NCT00799864|616352056|FG004|Overall Study|Participant reached a virologic endpoint|0|||
170548193|NCT00799864|616352052|FG000|Overall Study|Other|2|||
170548194|NCT00799864|616352053|FG001|Overall Study|Other|1|||
170548195|NCT00799864|616352054|FG002|Overall Study|Other|0|||
170548196|NCT00799864|616352055|FG003|Overall Study|Other|0|||
170548197|NCT00799864|616352056|FG004|Overall Study|Other|0|||
170548198|NCT00576407|616352057|FG000|Overall Study|Death|7|||
170548199|NCT00576407|616352057|FG000|Overall Study|Physician Decision|1|||
170796252|NCT02323880|617264841|FG007|Overall Study|Lack of Efficacy|6|||
170796253|NCT02323880|617264834|FG000|Overall Study|Physician Decision|0|||
170796254|NCT02323880|617264835|FG001|Overall Study|Physician Decision|0|||
170796255|NCT02323880|617264836|FG002|Overall Study|Physician Decision|0|||
170796256|NCT02323880|617264837|FG003|Overall Study|Physician Decision|0|||
170796257|NCT02323880|617264838|FG004|Overall Study|Physician Decision|1|||
170796258|NCT02323880|617264839|FG005|Overall Study|Physician Decision|1|||
170796259|NCT02323880|617264840|FG006|Overall Study|Physician Decision|1|||
170796260|NCT02323880|617264841|FG007|Overall Study|Physician Decision|0|||
170796261|NCT02323880|617264834|FG000|Overall Study|Withdrawal by Subject|0|||
170896423|NCT00944034|617628508|FG002|Overall Study|Withdrawal by Subject|6|||
170896424|NCT00944034|617628509|FG003|Overall Study|Withdrawal by Subject|2|||
170896425|NCT00944034|617628510|FG004|Overall Study|Withdrawal by Subject|5|||
170896426|NCT00944034|617628511|FG005|Overall Study|Withdrawal by Subject|8|||
170896427|NCT00944034|617628512|FG006|Overall Study|Withdrawal by Subject|2|||
170896428|NCT00944034|617628513|FG007|Overall Study|Withdrawal by Subject|2|||
170896429|NCT00944034|617628514|FG008|Overall Study|Withdrawal by Subject|3|||
170896430|NCT00944034|617628515|FG009|Overall Study|Withdrawal by Subject|4|||
170896431|NCT00944034|617628516|FG010|Overall Study|Withdrawal by Subject|0|||
170896432|NCT00944034|617628517|FG011|Overall Study|Withdrawal by Subject|4|||
170896433|NCT00944034|617628506|FG000|Overall Study|Lost to Follow-up|0|||
170896434|NCT00944034|617628507|FG001|Overall Study|Lost to Follow-up|4|||
170896435|NCT00944034|617628508|FG002|Overall Study|Lost to Follow-up|2|||
170896436|NCT00944034|617628509|FG003|Overall Study|Lost to Follow-up|0|||
170896437|NCT00944034|617628510|FG004|Overall Study|Lost to Follow-up|5|||
170896438|NCT00944034|617628511|FG005|Overall Study|Lost to Follow-up|7|||
170896439|NCT00944034|617628512|FG006|Overall Study|Lost to Follow-up|0|||
170896440|NCT00944034|617628513|FG007|Overall Study|Lost to Follow-up|1|||
170548200|NCT00621322|616352058|FG000|Overall Study|Lost to Follow-up|0|||
170896441|NCT00944034|617628514|FG008|Overall Study|Lost to Follow-up|5|||
170548201|NCT00621322|616352059|FG001|Overall Study|Lost to Follow-up|0|||
170548202|NCT00621322|616352060|FG002|Overall Study|Lost to Follow-up|0|||
170896442|NCT00944034|617628515|FG009|Overall Study|Lost to Follow-up|1|||
170896443|NCT00944034|617628516|FG010|Overall Study|Lost to Follow-up|1|||
170896444|NCT00944034|617628517|FG011|Overall Study|Lost to Follow-up|0|||
170896445|NCT00944034|617628506|FG000|Overall Study|Death|0|||
170896446|NCT00944034|617628507|FG001|Overall Study|Death|0|||
170896447|NCT00944034|617628508|FG002|Overall Study|Death|1|||
170896448|NCT00944034|617628509|FG003|Overall Study|Death|0|||
170481827|NCT00955409|616105551|FG009|Overall Study|Investigator Request|0|||
170481828|NCT00955409|616105542|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
170481829|NCT00955409|616105543|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
170481830|NCT00955409|616105544|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
170481831|NCT00955409|616105545|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
170481832|NCT00955409|616105546|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
170481833|NCT00955409|616105547|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
170481834|NCT00955409|616105548|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
170481835|NCT00955409|616105549|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
170481836|NCT00955409|616105550|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
170796262|NCT02323880|617264835|FG001|Overall Study|Withdrawal by Subject|2|||
170796263|NCT02323880|617264836|FG002|Overall Study|Withdrawal by Subject|0|||
170796264|NCT02323880|617264837|FG003|Overall Study|Withdrawal by Subject|0|||
170796265|NCT02323880|617264838|FG004|Overall Study|Withdrawal by Subject|0|||
170796266|NCT02323880|617264839|FG005|Overall Study|Withdrawal by Subject|0|||
170796267|NCT02323880|617264840|FG006|Overall Study|Withdrawal by Subject|0|||
170796268|NCT02323880|617264841|FG007|Overall Study|Withdrawal by Subject|0|||
170796269|NCT05100628|617264845|FG000|Overall Study|Progressive Disease|1|||
170796270|NCT05100628|617264846|FG001|Overall Study|Progressive Disease|0|||
170796271|NCT05100628|617264847|FG002|Overall Study|Progressive Disease|0|||
170796272|NCT05100628|617264848|FG003|Overall Study|Progressive Disease|0|||
170796273|NCT05100628|617264845|FG000|Overall Study|Study Terminated by Sponsor|0|||
170796274|NCT05100628|617264846|FG001|Overall Study|Study Terminated by Sponsor|0|||
170796275|NCT05100628|617264847|FG002|Overall Study|Study Terminated by Sponsor|3|||
170796276|NCT05100628|617264848|FG003|Overall Study|Study Terminated by Sponsor|0|||
170796277|NCT05100628|617264845|FG000|Overall Study|unkown|0|||
170796278|NCT05100628|617264846|FG001|Overall Study|unkown|1|||
170796279|NCT05100628|617264847|FG002|Overall Study|unkown|0|||
170796280|NCT05100628|617264848|FG003|Overall Study|unkown|0|||
170796281|NCT03914469|617264851|FG000|Overall Study|Lost to Follow-up|1|||
170796282|NCT03914469|617264852|FG001|Overall Study|Lost to Follow-up|4|||
170796283|NCT05900154|617264854|FG000|Follow-Up Period|Lost to Follow-up|1|||
170796284|NCT05900154|617264855|FG001|Follow-Up Period|Lost to Follow-up|2|||
170796285|NCT05900154|617264856|FG002|Follow-Up Period|Lost to Follow-up|1|||
170796286|NCT05900154|617264857|FG003|Follow-Up Period|Lost to Follow-up|0|||
170796287|NCT05900154|617264858|FG004|Follow-Up Period|Lost to Follow-up|1|||
170796288|NCT05900154|617264859|FG005|Follow-Up Period|Lost to Follow-up|1|||
170796289|NCT05158504|617264861|FG000|Overall Study|Lost to Follow-up|2|||
170796290|NCT05158504|617264862|FG001|Overall Study|Lost to Follow-up|3|||
170796291|NCT03606512|617264865|FG000|Overall Study|Lost to Follow-up|0|||
170796292|NCT03606512|617264866|FG001|Overall Study|Lost to Follow-up|1|||
170796293|NCT03606512|617264865|FG000|Overall Study|'moved from study area|0|||
170481837|NCT00955409|616105551|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
170796294|NCT03606512|617264866|FG001|Overall Study|'moved from study area|1|||
170896449|NCT00944034|617628510|FG004|Overall Study|Death|0|||
170896450|NCT00944034|617628511|FG005|Overall Study|Death|0|||
170896451|NCT00944034|617628512|FG006|Overall Study|Death|0|||
170896452|NCT00944034|617628513|FG007|Overall Study|Death|0|||
170896453|NCT00944034|617628514|FG008|Overall Study|Death|0|||
170896454|NCT00944034|617628515|FG009|Overall Study|Death|0|||
170896455|NCT00944034|617628516|FG010|Overall Study|Death|0|||
170896456|NCT00944034|617628517|FG011|Overall Study|Death|0|||
170896457|NCT00944034|617628506|FG000|Overall Study|Protocol Violation|2|||
170896458|NCT00944034|617628507|FG001|Overall Study|Protocol Violation|0|||
170896459|NCT00944034|617628508|FG002|Overall Study|Protocol Violation|0|||
170896460|NCT00944034|617628509|FG003|Overall Study|Protocol Violation|1|||
170896461|NCT00944034|617628510|FG004|Overall Study|Protocol Violation|2|||
170896462|NCT00944034|617628511|FG005|Overall Study|Protocol Violation|3|||
170896463|NCT00944034|617628512|FG006|Overall Study|Protocol Violation|0|||
170896464|NCT00944034|617628513|FG007|Overall Study|Protocol Violation|1|||
170896465|NCT00944034|617628514|FG008|Overall Study|Protocol Violation|1|||
170896466|NCT00944034|617628515|FG009|Overall Study|Protocol Violation|4|||
170896467|NCT00944034|617628516|FG010|Overall Study|Protocol Violation|0|||
170896468|NCT00944034|617628517|FG011|Overall Study|Protocol Violation|0|||
170896469|NCT00944034|617628506|FG000|Overall Study|Unable to classify|0|||
170896470|NCT00944034|617628507|FG001|Overall Study|Unable to classify|0|||
170896471|NCT00944034|617628508|FG002|Overall Study|Unable to classify|0|||
170896472|NCT00944034|617628509|FG003|Overall Study|Unable to classify|0|||
170896473|NCT00944034|617628510|FG004|Overall Study|Unable to classify|0|||
170896474|NCT00944034|617628511|FG005|Overall Study|Unable to classify|1|||
170896475|NCT00944034|617628512|FG006|Overall Study|Unable to classify|1|||
170896476|NCT00944034|617628513|FG007|Overall Study|Unable to classify|1|||
170896477|NCT00944034|617628514|FG008|Overall Study|Unable to classify|0|||
170896478|NCT00944034|617628515|FG009|Overall Study|Unable to classify|0|||
170896479|NCT00944034|617628516|FG010|Overall Study|Unable to classify|0|||
170896480|NCT00944034|617628517|FG011|Overall Study|Unable to classify|0|||
170896481|NCT00944034|617628506|FG000|Overall Study|Administrative reason|0|||
170896482|NCT00944034|617628507|FG001|Overall Study|Administrative reason|0|||
170796295|NCT02846545|617264867|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
170796296|NCT02846545|617264868|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
170796297|NCT02846545|617264867|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
170796298|NCT02846545|617264868|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
170796299|NCT02846545|617264867|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
170796300|NCT02846545|617264868|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
170796301|NCT02846545|617264867|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
170796302|NCT02846545|617264868|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
170796303|NCT02846545|617264867|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
170796304|NCT02846545|617264868|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
170796305|NCT02326974|617264871|FG000|Overall Study|Withdrawal by Subject|2|||
170796306|NCT02326974|617264871|FG000|Overall Study|failed heterogenity evaluation|5|||
170796307|NCT04924400|617264872|FG000|Overall Study|Lost to Follow-up|3|||
170796308|NCT04924400|617264873|FG001|Overall Study|Lost to Follow-up|0|||
170796309|NCT02518048|617264878|FG000|Overall Study|Withdrawal by Subject|1|||
170796310|NCT03011034|617264883|FG000|Overall Study|Adverse Event|1|||
170796311|NCT03011034|617264884|FG001|Overall Study|Adverse Event|0|||
170796312|NCT04230681|617264885|FG000|Overall Study|Physician Decision|2|||
170796313|NCT04230681|617264886|FG001|Overall Study|Physician Decision|3|||
170796314|NCT04230681|617264885|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
170796315|NCT04230681|617264886|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
170796316|NCT04230681|617264885|FG000|Overall Study|IV inadvertently removed|0|||
170796317|NCT04230681|617264886|FG001|Overall Study|IV inadvertently removed|1|||
170796318|NCT03057054|617264889|FG000|Overall Study|Death|4|||
170796319|NCT03057054|617264890|FG001|Overall Study|Death|4|||
170796320|NCT03057054|617264889|FG000|Overall Study|Withdrawal by Subject|6|||
170796321|NCT03057054|617264890|FG001|Overall Study|Withdrawal by Subject|3|||
170796322|NCT03057054|617264889|FG000|Overall Study|Ineligible|1|||
170796323|NCT03057054|617264890|FG001|Overall Study|Ineligible|1|||
170796324|NCT06037668|617266197|FG000|Overall Study|Lost to Follow-up|1|||
170796325|NCT06037668|617266198|FG001|Overall Study|Lost to Follow-up|1|||
170796326|NCT06037668|617266197|FG000|Overall Study|Protocol Violation|1|||
170796327|NCT06037668|617266198|FG001|Overall Study|Protocol Violation|0|||
170796328|NCT06037668|617266197|FG000|Overall Study|Withdrawal by Subject|1|||
170796329|NCT06037668|617266198|FG001|Overall Study|Withdrawal by Subject|0|||
170796330|NCT06037668|617266197|FG000|Overall Study|Other Study Discontinuation Reason|1|||
170796331|NCT06037668|617266198|FG001|Overall Study|Other Study Discontinuation Reason|0|||
170796332|NCT03213678|617266200|FG000|Overall Study|Death|1|||
170796333|NCT03213678|617266200|FG000|Overall Study|Physician Decision|1|||
170796334|NCT03213678|617266200|FG000|Overall Study|Progressive disease|16|||
170796335|NCT00844415|617266201|FG000|Overall Study|Withdrawal by Subject|1|||
170796336|NCT03174275|617266204|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
170796337|NCT03174275|617266204|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
170796338|NCT03174275|617266204|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
170796339|NCT03174275|617266204|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
170796340|NCT03174275|617266204|FG000|Adjuvant Chemotherapy|Progression|1|||
170796341|NCT03174275|617266204|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
170796342|NCT03174275|617266204|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
170796343|NCT03174275|617266204|FG000|Adjuvant Durvalumab|Progression|1|||
170796344|NCT03174275|617266204|FG000|Adjuvant Durvalumab|Adverse Event|3|||
170796345|NCT03174275|617266204|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
170796346|NCT03174275|617266204|FG000|Adjuvant Radiotherapy|Progression|1|||
170796347|NCT03174275|617266204|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
170796348|NCT02413489|617266205|FG000|Overall Study|Death|11|||
170796349|NCT02413489|617266206|FG001|Overall Study|Death|3|||
170796350|NCT02413489|617266207|FG002|Overall Study|Death|4|||
170796351|NCT02413489|617266205|FG000|Overall Study|Withdrawal by Subject|2|||
170796352|NCT02413489|617266206|FG001|Overall Study|Withdrawal by Subject|0|||
170796353|NCT02413489|617266207|FG002|Overall Study|Withdrawal by Subject|0|||
170796354|NCT02413489|617266205|FG000|Overall Study|Study Terminated By Sponsor|2|||
170796355|NCT02413489|617266206|FG001|Overall Study|Study Terminated By Sponsor|13|||
170796356|NCT02413489|617266207|FG002|Overall Study|Study Terminated By Sponsor|1|||
170796357|NCT01820611|617266212|FG000|Overall Study|Death|8|||
170796358|NCT01820611|617266212|FG000|Overall Study|Adverse Event|1|||
170796359|NCT01820611|617266212|FG000|Overall Study|Withdrawal by Subject|9|||
170796360|NCT03015532|617266213|FG000|Overall Study|Adverse Event|0|||
170796361|NCT03015532|617266214|FG001|Overall Study|Adverse Event|0|||
170796362|NCT03015532|617266215|FG002|Overall Study|Adverse Event|0|||
170796363|NCT03015532|617266216|FG003|Overall Study|Adverse Event|0|||
170796364|NCT03015532|617266217|FG004|Overall Study|Adverse Event|0|||
170796365|NCT03015532|617266218|FG005|Overall Study|Adverse Event|2|||
170796366|NCT03015532|617266219|FG006|Overall Study|Adverse Event|1|||
170796367|NCT03015532|617266220|FG007|Overall Study|Adverse Event|0|||
170796368|NCT03015532|617266213|FG000|Overall Study|Withdrawal by Subject|0|||
170796369|NCT03015532|617266214|FG001|Overall Study|Withdrawal by Subject|0|||
170796370|NCT03015532|617266215|FG002|Overall Study|Withdrawal by Subject|0|||
170796371|NCT03015532|617266216|FG003|Overall Study|Withdrawal by Subject|0|||
170796372|NCT03015532|617266217|FG004|Overall Study|Withdrawal by Subject|0|||
170796373|NCT03015532|617266218|FG005|Overall Study|Withdrawal by Subject|0|||
170481838|NCT00955409|616105542|FG000|Overall Study|Lost to Follow-up|0|||
170640057|NCT02100696|616693810|FG002|Maintenance Phase|Lost to Follow-up|0|||
170640058|NCT02100696|616693811|FG003|Maintenance Phase|Lost to Follow-up|0|||
170796374|NCT03015532|617266219|FG006|Overall Study|Withdrawal by Subject|1|||
170796375|NCT03015532|617266220|FG007|Overall Study|Withdrawal by Subject|0|||
170796376|NCT03484819|617266221|FG000|Overall Study|Death|2|||
170796377|NCT03484819|617266221|FG000|Overall Study|Adverse Event|2|||
170796378|NCT03484819|617266221|FG000|Overall Study|Physician Decision|1|||
170796379|NCT03484819|617266221|FG000|Overall Study|Withdrawal by Subject|2|||
170796380|NCT03484819|617266221|FG000|Overall Study|Disease Progression|4|||
170796381|NCT03484819|617266221|FG000|Overall Study|Complicating Condition|1|||
170796382|NCT05970861|617266222|FG000|Overall Study|Physician Decision|4|||
170796383|NCT05970861|617266223|FG001|Overall Study|Physician Decision|4|||
170796384|NCT05970861|617266222|FG000|Overall Study|Lost to Follow-up|4|||
170796385|NCT05970861|617266223|FG001|Overall Study|Lost to Follow-up|3|||
170796386|NCT04186819|617266224|FG000|Overall Study|Adverse Event|1|||
170796387|NCT04186819|617266224|FG000|Overall Study|Lost to Follow-up|1|||
170796388|NCT04186819|617266224|FG000|Overall Study|Opted for EBRT|1|||
170796389|NCT04186819|617266224|FG000|Overall Study|Opted SBRT|1|||
170796390|NCT04186819|617266224|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
170796391|NCT04186819|617266224|FG000|Overall Study|Physician Decision|1|||
170796392|NCT04186819|617266224|FG000|Overall Study|RP Delayed|1|||
170796393|NCT04186819|617266224|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
170796394|NCT04186819|617266224|FG000|Overall Study|Subject declined for financial reasons|1|||
170796395|NCT04186819|617266224|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
170796396|NCT04186819|617266224|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
170796397|NCT04186819|617266224|FG000|Overall Study|The subject opted for other treatment option|2|||
170796398|NCT04186819|617266224|FG000|Overall Study|The subject opted for other treatment options|1|||
170796399|NCT04186819|617266224|FG000|Overall Study|Withdrawal by Subject|3|||
170796400|NCT04186819|617266224|FG000|Overall Study|Reason not specified|1|||
170796401|NCT05013385|617266229|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
170796402|NCT01447719|617266230|FG000|Overall Study|Image acquisition failure|2|||
170796403|NCT01447719|617266230|FG000|Overall Study|Invalid image or not imaged|3|||
170796404|NCT01447719|617266230|FG000|Overall Study|Subject still living at end of study|79|||
170796405|NCT01447719|617266230|FG000|Overall Study|Withdrawal by Subject|2|||
170796406|NCT01447719|617266230|FG000|Overall Study|Family withdrew autopsy consent|7|||
170796407|NCT05460871|617266238|FG000|Overall Study|Withdrawal by Subject|1|||
170796408|NCT05460871|617266239|FG001|Overall Study|Withdrawal by Subject|2|||
170796409|NCT02874742|617266240|FG000|Overall Study|Death|0|||
170796410|NCT02874742|617266241|FG001|Overall Study|Death|1|||
170796411|NCT02874742|617266242|FG002|Overall Study|Death|0|||
170796412|NCT02874742|617266240|FG000|Overall Study|Lost to Follow-up|5|||
170796413|NCT02874742|617266241|FG001|Overall Study|Lost to Follow-up|4|||
170796414|NCT02874742|617266242|FG002|Overall Study|Lost to Follow-up|1|||
170796415|NCT02874742|617266240|FG000|Overall Study|Withdrawal by Subject|17|||
170796416|NCT02874742|617266241|FG001|Overall Study|Withdrawal by Subject|8|||
170796417|NCT02874742|617266242|FG002|Overall Study|Withdrawal by Subject|0|||
170796418|NCT02874742|617266240|FG000|Overall Study|Other|4|||
170796419|NCT02874742|617266241|FG001|Overall Study|Other|1|||
170796420|NCT02874742|617266242|FG002|Overall Study|Other|0|||
170796421|NCT02874742|617266240|FG000|Overall Study|Progressive Disease|1|||
170796422|NCT02874742|617266241|FG001|Overall Study|Progressive Disease|0|||
170796423|NCT02874742|617266242|FG002|Overall Study|Progressive Disease|0|||
170796424|NCT02874742|617266240|FG000|Overall Study|Screen Failure|0|||
170796425|NCT02874742|617266241|FG001|Overall Study|Screen Failure|2|||
170796426|NCT02874742|617266242|FG002|Overall Study|Screen Failure|0|||
170796427|NCT04129554|617266244|FG000|Overall Study|Withdrawal by Subject|4|||
170796428|NCT04129554|617266245|FG001|Overall Study|Withdrawal by Subject|3|||
170796429|NCT04129554|617266244|FG000|Overall Study|Other|0|||
170796430|NCT04129554|617266245|FG001|Overall Study|Other|2|||
170796431|NCT03663205|617266248|FG000|Overall Study|Death|144|||
170796432|NCT03663205|617266249|FG001|Overall Study|Death|69|||
170796433|NCT03663205|617266248|FG000|Overall Study|Sponsor decision|53|||
170481839|NCT00955409|616105543|FG001|Overall Study|Lost to Follow-up|0|||
170796434|NCT03663205|617266249|FG001|Overall Study|Sponsor decision|19|||
170796435|NCT03663205|617266248|FG000|Overall Study|Withdrawal by Subject|8|||
170796436|NCT03663205|617266249|FG001|Overall Study|Withdrawal by Subject|11|||
170796437|NCT03663205|617266248|FG000|Overall Study|Lost to Follow-up|7|||
170796438|NCT03663205|617266249|FG001|Overall Study|Lost to Follow-up|9|||
170796439|NCT03663205|617266248|FG000|Overall Study|Transferred to long term extension study|11|||
170481840|NCT00955409|616105544|FG002|Overall Study|Lost to Follow-up|1|||
170481841|NCT00955409|616105545|FG003|Overall Study|Lost to Follow-up|0|||
170481842|NCT00955409|616105546|FG004|Overall Study|Lost to Follow-up|0|||
170481843|NCT00955409|616105547|FG005|Overall Study|Lost to Follow-up|0|||
170481844|NCT00955409|616105548|FG006|Overall Study|Lost to Follow-up|1|||
170796440|NCT03663205|617266249|FG001|Overall Study|Transferred to long term extension study|3|||
170796441|NCT04424316|617266259|FG000|Overall Study|Adverse Event|0|||
170796442|NCT04424316|617266260|FG001|Overall Study|Adverse Event|1|||
170796443|NCT04424316|617266261|FG002|Overall Study|Adverse Event|0|||
170796444|NCT04424316|617266262|FG003|Overall Study|Adverse Event|0|||
170796445|NCT04424316|617266259|FG000|Overall Study|Death|1|||
170796446|NCT04424316|617266260|FG001|Overall Study|Death|0|||
170796447|NCT04424316|617266261|FG002|Overall Study|Death|8|||
170796448|NCT04424316|617266262|FG003|Overall Study|Death|14|||
170796449|NCT04424316|617266259|FG000|Overall Study|Lost to Follow-up|93|||
170796450|NCT04424316|617266260|FG001|Overall Study|Lost to Follow-up|88|||
170796451|NCT04424316|617266261|FG002|Overall Study|Lost to Follow-up|224|||
170796452|NCT04424316|617266262|FG003|Overall Study|Lost to Follow-up|211|||
170796453|NCT04424316|617266259|FG000|Overall Study|No longer met eligibility criteria|1|||
170796454|NCT04424316|617266260|FG001|Overall Study|No longer met eligibility criteria|0|||
170796455|NCT04424316|617266261|FG002|Overall Study|No longer met eligibility criteria|0|||
170796456|NCT04424316|617266262|FG003|Overall Study|No longer met eligibility criteria|0|||
170796457|NCT04424316|617266259|FG000|Overall Study|Other|15|||
170796458|NCT04424316|617266260|FG001|Overall Study|Other|11|||
170796459|NCT04424316|617266261|FG002|Overall Study|Other|34|||
170796460|NCT04424316|617266262|FG003|Overall Study|Other|45|||
170796461|NCT04424316|617266259|FG000|Overall Study|Physician Decision|1|||
170796462|NCT04424316|617266260|FG001|Overall Study|Physician Decision|0|||
170796463|NCT04424316|617266261|FG002|Overall Study|Physician Decision|1|||
170796464|NCT04424316|617266262|FG003|Overall Study|Physician Decision|1|||
170796465|NCT04424316|617266259|FG000|Overall Study|Protocol Violation|0|||
170796466|NCT04424316|617266260|FG001|Overall Study|Protocol Violation|1|||
170796467|NCT04424316|617266261|FG002|Overall Study|Protocol Violation|0|||
170796468|NCT04424316|617266262|FG003|Overall Study|Protocol Violation|0|||
170796469|NCT04424316|617266259|FG000|Overall Study|Withdrawal by Subject|71|||
170796470|NCT04424316|617266260|FG001|Overall Study|Withdrawal by Subject|77|||
170796471|NCT04424316|617266261|FG002|Overall Study|Withdrawal by Subject|0|||
170796472|NCT04424316|617266262|FG003|Overall Study|Withdrawal by Subject|0|||
170796473|NCT04424316|617266259|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170796474|NCT04424316|617266260|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170796475|NCT04424316|617266261|FG002|Overall Study|Withdrawal by parent/guardian|74|||
170796476|NCT04424316|617266262|FG003|Overall Study|Withdrawal by parent/guardian|81|||
170796477|NCT04424316|617266259|FG000|Overall Study|Randomized but not vaccinated|13|||
170796478|NCT04424316|617266260|FG001|Overall Study|Randomized but not vaccinated|21|||
170796479|NCT04424316|617266261|FG002|Overall Study|Randomized but not vaccinated|0|||
170796480|NCT04424316|617266262|FG003|Overall Study|Randomized but not vaccinated|0|||
170796481|NCT04424316|617266259|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
170796482|NCT04424316|617266260|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
170796483|NCT04424316|617266261|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
170796484|NCT04424316|617266262|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
170796485|NCT04633538|617266263|FG000|Overall Study|Death|1|||
170796486|NCT04633538|617266263|FG000|Overall Study|Lost to Follow-up|3|||
170796487|NCT04633538|617266263|FG000|Overall Study|Withdrawal by Subject|1|||
170796488|NCT03993392|617266264|FG000|Overall Study|Withdrawal by Subject|3|||
170796489|NCT03993392|617266264|FG000|Overall Study|Lost to Follow-up|2|||
170796490|NCT03993392|617266264|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
170796491|NCT03245840|617266269|FG000|Overall Study|Adverse Event|6|||
170796492|NCT03245840|617266270|FG001|Overall Study|Adverse Event|0|||
170796493|NCT03245840|617266269|FG000|Overall Study|Death|2|||
170796494|NCT03245840|617266270|FG001|Overall Study|Death|0|||
170796495|NCT03245840|617266269|FG000|Overall Study|Withdrawal by Subject|31|||
170796496|NCT03245840|617266270|FG001|Overall Study|Withdrawal by Subject|1|||
170796497|NCT03245840|617266269|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
170796498|NCT03245840|617266270|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170796499|NCT03245840|617266269|FG000|Overall Study|Physician Decision|4|||
170796500|NCT03245840|617266270|FG001|Overall Study|Physician Decision|1|||
170796501|NCT03245840|617266269|FG000|Overall Study|Study Terminated by Sponsor|56|||
170796502|NCT03245840|617266270|FG001|Overall Study|Study Terminated by Sponsor|6|||
170796503|NCT03245840|617266269|FG000|Overall Study|Site Terminated by Sponsor|4|||
170796504|NCT03245840|617266270|FG001|Overall Study|Site Terminated by Sponsor|0|||
170796505|NCT03245840|617266269|FG000|Overall Study|Lost to Follow-up|12|||
170796506|NCT03245840|617266270|FG001|Overall Study|Lost to Follow-up|2|||
170796507|NCT03245840|617266269|FG000|Overall Study|Pregnancy|2|||
170796508|NCT03245840|617266270|FG001|Overall Study|Pregnancy|0|||
170796509|NCT03245840|617266269|FG000|Overall Study|Non-Compliance with Study Drug|2|||
170796510|NCT03245840|617266270|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170796511|NCT03245840|617266269|FG000|Overall Study|Not treated|1|||
170796512|NCT03245840|617266270|FG001|Overall Study|Not treated|1|||
170796513|NCT05451693|617266274|FG000|Overall Study|Withdrawal by Subject|1|||
170796514|NCT05451693|617266275|FG001|Overall Study|Withdrawal by Subject|1|||
170796515|NCT03372057|617266280|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
170796516|NCT03372057|617266281|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
170796517|NCT03372057|617266282|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
170796518|NCT03372057|617266280|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
170796519|NCT03372057|617266281|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
170796520|NCT03372057|617266282|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
170796521|NCT03372057|617266280|FG000|Dose Optimization Phase|Death|16|||
170796522|NCT03372057|617266281|FG001|Dose Optimization Phase|Death|11|||
170796523|NCT03372057|617266282|FG002|Dose Optimization Phase|Death|0|||
170796524|NCT03372057|617266280|FG000|Expansion Phase|Withdrawal by Subject|0|||
170796525|NCT03372057|617266281|FG001|Expansion Phase|Withdrawal by Subject|0|||
170796526|NCT03372057|617266282|FG002|Expansion Phase|Withdrawal by Subject|4|||
170796527|NCT03372057|617266280|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
170796528|NCT03372057|617266281|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
170796529|NCT03372057|617266282|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
170796530|NCT03372057|617266280|FG000|Expansion Phase|Death|0|||
170796531|NCT03372057|617266281|FG001|Expansion Phase|Death|0|||
170796532|NCT03372057|617266282|FG002|Expansion Phase|Death|78|||
170796533|NCT03372057|617266280|FG000|Expansion Phase|Progressive Disease|0|||
170796534|NCT03372057|617266281|FG001|Expansion Phase|Progressive Disease|0|||
170796535|NCT03372057|617266282|FG002|Expansion Phase|Progressive Disease|1|||
170796536|NCT03372057|617266280|FG000|Expansion Phase|Adverse Event|0|||
170796537|NCT03372057|617266281|FG001|Expansion Phase|Adverse Event|0|||
170796538|NCT03372057|617266282|FG002|Expansion Phase|Adverse Event|1|||
170796539|NCT05890105|617266284|FG000|Overall Study|Adverse Event|1|||
170796540|NCT05890105|617266285|FG001|Overall Study|Adverse Event|0|||
170796541|NCT05890105|617266286|FG002|Overall Study|Adverse Event|0|||
170796542|NCT05890105|617266284|FG000|Overall Study|Other|1|||
170796543|NCT05890105|617266285|FG001|Overall Study|Other|2|||
170796544|NCT05890105|617266286|FG002|Overall Study|Other|0|||
170796545|NCT04206787|617266287|FG000|Overall Study|Other than listed|2|||
170796546|NCT04206787|617266287|FG000|Overall Study|Investigator decision|1|||
170796547|NCT04206787|617266287|FG000|Overall Study|Death|25|||
170796548|NCT04206787|617266287|FG000|Overall Study|Lost to Follow-up|9|||
170796549|NCT04206787|617266287|FG000|Overall Study|Withdrawal of consent|9|||
170796550|NCT05008055|617266288|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
170796551|NCT05008055|617266289|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
170796552|NCT05008055|617266290|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
170796553|NCT03735979|617266291|FG000|Overall Study|Lost to Follow-up|1|||
170796554|NCT03735979|617266292|FG001|Overall Study|Lost to Follow-up|12|||
170796555|NCT03735979|617266293|FG002|Overall Study|Lost to Follow-up|14|||
170796556|NCT03735979|617266291|FG000|Overall Study|Withdrawal by Subject|1|||
170796557|NCT03735979|617266292|FG001|Overall Study|Withdrawal by Subject|5|||
170796558|NCT03735979|617266293|FG002|Overall Study|Withdrawal by Subject|2|||
170796559|NCT03735979|617266291|FG000|Overall Study|Not due to the above reasons|1|||
170796560|NCT03735979|617266292|FG001|Overall Study|Not due to the above reasons|0|||
170796561|NCT03735979|617266293|FG002|Overall Study|Not due to the above reasons|0|||
170796562|NCT04761198|617266296|FG000|Overall Study|Progressive Disease|1|||
170796563|NCT04761198|617266297|FG001|Overall Study|Progressive Disease|0|||
170796564|NCT04761198|617266298|FG002|Overall Study|Progressive Disease|0|||
170796565|NCT04761198|617266299|FG003|Overall Study|Progressive Disease|1|||
170796566|NCT04761198|617266300|FG004|Overall Study|Progressive Disease|4|||
170796567|NCT04761198|617266301|FG005|Overall Study|Progressive Disease|1|||
170796568|NCT04761198|617266302|FG006|Overall Study|Progressive Disease|2|||
170796569|NCT04761198|617266296|FG000|Overall Study|Protocol Violation|0|||
170796570|NCT04761198|617266297|FG001|Overall Study|Protocol Violation|0|||
170481845|NCT00955409|616105549|FG007|Overall Study|Lost to Follow-up|0|||
170481846|NCT00955409|616105550|FG008|Overall Study|Lost to Follow-up|0|||
170481847|NCT00955409|616105551|FG009|Overall Study|Lost to Follow-up|0|||
170481848|NCT00955409|616105542|FG000|Overall Study|Failed to Return|2|||
170481849|NCT00955409|616105543|FG001|Overall Study|Failed to Return|0|||
170481850|NCT00955409|616105544|FG002|Overall Study|Failed to Return|0|||
170481851|NCT00955409|616105545|FG003|Overall Study|Failed to Return|0|||
170481852|NCT00955409|616105546|FG004|Overall Study|Failed to Return|0|||
170481853|NCT00955409|616105547|FG005|Overall Study|Failed to Return|0|||
170481854|NCT00955409|616105548|FG006|Overall Study|Failed to Return|0|||
170481855|NCT00955409|616105549|FG007|Overall Study|Failed to Return|2|||
170481856|NCT00955409|616105550|FG008|Overall Study|Failed to Return|0|||
170796571|NCT04761198|617266298|FG002|Overall Study|Protocol Violation|0|||
170796572|NCT04761198|617266299|FG003|Overall Study|Protocol Violation|0|||
170796573|NCT04761198|617266300|FG004|Overall Study|Protocol Violation|1|||
170796574|NCT04761198|617266301|FG005|Overall Study|Protocol Violation|0|||
170796575|NCT04761198|617266302|FG006|Overall Study|Protocol Violation|0|||
170796576|NCT04761198|617266296|FG000|Overall Study|Death|2|||
170896483|NCT00944034|617628508|FG002|Overall Study|Administrative reason|0|||
170896484|NCT00944034|617628509|FG003|Overall Study|Administrative reason|0|||
170896485|NCT00944034|617628510|FG004|Overall Study|Administrative reason|0|||
170796577|NCT04761198|617266297|FG001|Overall Study|Death|1|||
170796578|NCT04761198|617266298|FG002|Overall Study|Death|2|||
170796579|NCT04761198|617266299|FG003|Overall Study|Death|5|||
170796580|NCT04761198|617266300|FG004|Overall Study|Death|14|||
170896486|NCT00944034|617628511|FG005|Overall Study|Administrative reason|0|||
170896487|NCT00944034|617628512|FG006|Overall Study|Administrative reason|1|||
170896488|NCT00944034|617628513|FG007|Overall Study|Administrative reason|0|||
170896489|NCT00944034|617628514|FG008|Overall Study|Administrative reason|0|||
170896490|NCT00944034|617628515|FG009|Overall Study|Administrative reason|0|||
170896491|NCT00944034|617628516|FG010|Overall Study|Administrative reason|0|||
170896492|NCT00944034|617628517|FG011|Overall Study|Administrative reason|0|||
170896493|NCT01596257|617628518|FG000|Overall Study|Inadequate Collection|23|||
170896494|NCT01596257|617628519|FG001|Overall Study|Inadequate Collection|19|||
170896495|NCT01570244|617628523|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
170896496|NCT00531960|617628528|FG000|Overall Study|Adverse Event|5|||
170896497|NCT00531960|617628529|FG001|Overall Study|Adverse Event|4|||
170896498|NCT00531960|617628528|FG000|Overall Study|Death|3|||
170896499|NCT00531960|617628529|FG001|Overall Study|Death|2|||
170896500|NCT00531960|617628528|FG000|Overall Study|Lack of Efficacy|42|||
170896501|NCT00531960|617628529|FG001|Overall Study|Lack of Efficacy|41|||
170896502|NCT00531960|617628528|FG000|Overall Study|Violation of Selection Criteria|2|||
170896503|NCT00531960|617628529|FG001|Overall Study|Violation of Selection Criteria|0|||
170896504|NCT00531960|617628528|FG000|Overall Study|Refused Treatment|5|||
170896505|NCT00531960|617628529|FG001|Overall Study|Refused Treatment|6|||
170896506|NCT00531960|617628528|FG000|Overall Study|Other|4|||
170896507|NCT00531960|617628529|FG001|Overall Study|Other|10|||
170896508|NCT02347631|617628532|FG000|First Intervention (2 Months)|Adverse Event|1|||
170896509|NCT02347631|617628533|FG001|First Intervention (2 Months)|Adverse Event|1|||
170896510|NCT02347631|617628532|FG000|First Intervention (2 Months)|Pregnancy|1|||
170896511|NCT02347631|617628533|FG001|First Intervention (2 Months)|Pregnancy|0|||
170896512|NCT02347631|617628532|FG000|First Intervention (2 Months)|Moved out of area|0|||
170896513|NCT02347631|617628533|FG001|First Intervention (2 Months)|Moved out of area|2|||
170896514|NCT02347631|617628532|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
170896515|NCT02347631|617628533|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
170896516|NCT02347631|617628532|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
170896517|NCT02347631|617628533|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
170896518|NCT02347631|617628532|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
170896519|NCT02347631|617628533|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
170896520|NCT02347631|617628532|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
170896521|NCT02347631|617628533|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
170896522|NCT02347631|617628532|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
170896523|NCT02347631|617628533|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
170896524|NCT01262898|617628534|FG000|Overall Study|Protocol Violation|1|||
170896525|NCT01262898|617628535|FG001|Overall Study|Protocol Violation|1|||
170796581|NCT04761198|617266301|FG005|Overall Study|Death|2|||
170796582|NCT04761198|617266302|FG006|Overall Study|Death|5|||
170796583|NCT04761198|617266296|FG000|Overall Study|Lost to Follow-up|0|||
170796584|NCT04761198|617266297|FG001|Overall Study|Lost to Follow-up|0|||
170796585|NCT04761198|617266298|FG002|Overall Study|Lost to Follow-up|0|||
170796586|NCT04761198|617266299|FG003|Overall Study|Lost to Follow-up|0|||
170796587|NCT04761198|617266300|FG004|Overall Study|Lost to Follow-up|1|||
170796588|NCT04761198|617266301|FG005|Overall Study|Lost to Follow-up|0|||
170796589|NCT04761198|617266302|FG006|Overall Study|Lost to Follow-up|0|||
170796590|NCT04761198|617266296|FG000|Overall Study|Withdrawal by Subject|2|||
170796591|NCT04761198|617266297|FG001|Overall Study|Withdrawal by Subject|0|||
170796592|NCT04761198|617266298|FG002|Overall Study|Withdrawal by Subject|1|||
170796593|NCT04761198|617266299|FG003|Overall Study|Withdrawal by Subject|0|||
170796594|NCT04761198|617266300|FG004|Overall Study|Withdrawal by Subject|2|||
170896526|NCT01262898|617628536|FG002|Overall Study|Protocol Violation|0|||
170896527|NCT01262898|617628537|FG003|Overall Study|Protocol Violation|0|||
170896528|NCT01262898|617628534|FG000|Overall Study|Lost to Follow-up|1|||
170896529|NCT01262898|617628535|FG001|Overall Study|Lost to Follow-up|0|||
170896530|NCT01262898|617628536|FG002|Overall Study|Lost to Follow-up|0|||
170796595|NCT04761198|617266301|FG005|Overall Study|Withdrawal by Subject|0|||
170796596|NCT04761198|617266302|FG006|Overall Study|Withdrawal by Subject|1|||
170796597|NCT04761198|617266296|FG000|Overall Study|Study Terminated by Sponsor|6|||
170796598|NCT04761198|617266297|FG001|Overall Study|Study Terminated by Sponsor|0|||
170796599|NCT04761198|617266298|FG002|Overall Study|Study Terminated by Sponsor|5|||
170796600|NCT04761198|617266299|FG003|Overall Study|Study Terminated by Sponsor|3|||
170896531|NCT01262898|617628537|FG003|Overall Study|Lost to Follow-up|0|||
170896532|NCT01262898|617628534|FG000|Overall Study|Withdrawal by Subject|1|||
170896533|NCT01262898|617628535|FG001|Overall Study|Withdrawal by Subject|1|||
170548203|NCT00621322|616352061|FG003|Overall Study|Lost to Follow-up|0|||
170548204|NCT00621322|616352062|FG004|Overall Study|Lost to Follow-up|1|||
170796601|NCT04761198|617266300|FG004|Overall Study|Study Terminated by Sponsor|10|||
170796602|NCT04761198|617266301|FG005|Overall Study|Study Terminated by Sponsor|1|||
170796603|NCT04761198|617266302|FG006|Overall Study|Study Terminated by Sponsor|2|||
170796604|NCT03533257|617266303|FG000|Overall Study|Adverse Event|4|||
170796605|NCT03533257|617266304|FG001|Overall Study|Adverse Event|2|||
170796606|NCT03533257|617266303|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
170796607|NCT03533257|617266304|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
170796608|NCT01130883|617267651|FG000|Overall Study|Patient Noncompliance|6|||
170796609|NCT01130883|617267651|FG000|Overall Study|Reason Unknown|1|||
170796610|NCT01130883|617267651|FG000|Overall Study|Adverse Event|3|||
170796611|NCT03442309|617267652|FG000|Overall Study|Lost to Follow-up|1676|||
170796612|NCT03442309|617267653|FG001|Overall Study|Lost to Follow-up|1642|||
170796613|NCT04544007|617267661|FG000|Overall Study|Withdrawal by Subject|1|||
170796614|NCT04544007|617267661|FG000|Overall Study|Confirmed Progressive Disease|1|||
170796615|NCT04282980|617267664|FG000|Overall Study|Remained on treatment|6|||
170796616|NCT04282980|617267664|FG000|Overall Study|Survival follow-up|11|||
170796617|NCT04282980|617267664|FG000|Overall Study|Withdrawal of informed consent|1|||
170796618|NCT04282980|617267664|FG000|Overall Study|Lost to Follow-up|1|||
170796619|NCT01917084|617267666|FG000|Overall Study|Withdrawal by Subject|1|||
170796620|NCT03571386|617267667|FG000|Overall Study|scheduling conflict|4|||
170796621|NCT03571386|617267668|FG001|Overall Study|scheduling conflict|0|||
170796622|NCT03571386|617267667|FG000|Overall Study|Withdrawal by Subject|15|||
170796623|NCT03571386|617267668|FG001|Overall Study|Withdrawal by Subject|5|||
170796624|NCT03252288|617267679|FG000|Overall Study|Death|1|||
170796625|NCT03252288|617267680|FG001|Overall Study|Death|0|||
170796626|NCT03252288|617267681|FG002|Overall Study|Death|0|||
170796627|NCT03252288|617267679|FG000|Overall Study|Death|11|||
170796628|NCT03252288|617267680|FG001|Overall Study|Death|0|||
170796629|NCT03252288|617267681|FG002|Overall Study|Death|0|||
170796630|NCT03252288|617267679|FG000|Overall Study|Withdrawal by Subject|2|||
170796631|NCT03252288|617267680|FG001|Overall Study|Withdrawal by Subject|0|||
170796632|NCT03252288|617267681|FG002|Overall Study|Withdrawal by Subject|0|||
170796633|NCT03252288|617267679|FG000|Overall Study|Lost to Follow-up|79|||
170796634|NCT03252288|617267680|FG001|Overall Study|Lost to Follow-up|0|||
170796635|NCT03252288|617267681|FG002|Overall Study|Lost to Follow-up|0|||
170796636|NCT03252288|617267679|FG000|Overall Study|Loss of baseline data on tablets|6|||
170796637|NCT03252288|617267680|FG001|Overall Study|Loss of baseline data on tablets|0|||
170796638|NCT03252288|617267681|FG002|Overall Study|Loss of baseline data on tablets|0|||
170796639|NCT00677365|617267682|FG000|Overall Study|Adverse Event|2|||
170796640|NCT00677365|617267683|FG001|Overall Study|Adverse Event|1|||
170796641|NCT00677365|617267684|FG002|Overall Study|Adverse Event|1|||
170796642|NCT00677365|617267685|FG003|Overall Study|Adverse Event|2|||
170796643|NCT00677365|617267682|FG000|Overall Study|Withdrawal by Subject|0|||
170796644|NCT00677365|617267683|FG001|Overall Study|Withdrawal by Subject|0|||
170796645|NCT00677365|617267684|FG002|Overall Study|Withdrawal by Subject|1|||
170796646|NCT00677365|617267685|FG003|Overall Study|Withdrawal by Subject|0|||
170796647|NCT00677365|617267682|FG000|Overall Study|Other reason|0|||
170796648|NCT00677365|617267683|FG001|Overall Study|Other reason|0|||
170796649|NCT00677365|617267684|FG002|Overall Study|Other reason|0|||
170796650|NCT00677365|617267685|FG003|Overall Study|Other reason|1|||
170796651|NCT00631475|617267686|FG000|Overall Study|Death|18|||
170796652|NCT00631475|617267686|FG000|Overall Study|Adverse Event|14|||
170796653|NCT00631475|617267686|FG000|Overall Study|Withdrew consent|5|||
170796654|NCT00631475|617267686|FG000|Overall Study|Preparation for lung transplant|8|||
170796655|NCT03691298|617267687|FG000|Overall Study|Lost to Follow-up|8|||
170796656|NCT03691298|617267687|FG000|Overall Study|Sponsor terminated study|2|||
170796657|NCT02577354|617267688|FG000|Overall Study|Lack of Efficacy|4|||
170796658|NCT02577354|617267689|FG001|Overall Study|Lack of Efficacy|4|||
170796659|NCT02577354|617267688|FG000|Overall Study|Lost to Follow-up|3|||
170796660|NCT02577354|617267689|FG001|Overall Study|Lost to Follow-up|1|||
170796661|NCT02577354|617267688|FG000|Overall Study|Missed Visit|4|||
170796662|NCT02577354|617267689|FG001|Overall Study|Missed Visit|3|||
170548205|NCT00621322|616352063|FG005|Overall Study|Lost to Follow-up|0|||
170796663|NCT02577354|617267688|FG000|Overall Study|Adverse Event|4|||
170796664|NCT02577354|617267689|FG001|Overall Study|Adverse Event|5|||
170796665|NCT04173247|617267690|FG000|Overall Study|Withdrawal by Subject|0|||
170796666|NCT04173247|617267691|FG001|Overall Study|Withdrawal by Subject|2|||
170796667|NCT04173247|617267690|FG000|Overall Study|Death|1|||
170796668|NCT04173247|617267691|FG001|Overall Study|Death|0|||
170796669|NCT04173247|617267690|FG000|Overall Study|Physician Decision|1|||
170796670|NCT04173247|617267691|FG001|Overall Study|Physician Decision|0|||
170796671|NCT04214834|617267694|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
170796672|NCT04214834|617267695|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
170796673|NCT05070741|617267699|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
170796674|NCT03582033|617267704|FG000|Part A|Other|0|||
170896534|NCT01262898|617628536|FG002|Overall Study|Withdrawal by Subject|0|||
170896535|NCT01262898|617628537|FG003|Overall Study|Withdrawal by Subject|0|||
170896536|NCT02304926|617628538|FG000|Overall Study|Lost to Follow-up|2|||
170896537|NCT02304926|617628539|FG001|Overall Study|Lost to Follow-up|1|||
170896538|NCT01551693|617628546|FG000|Overall Study|Disease Progression|1|||
170896539|NCT01551693|617628547|FG001|Overall Study|Disease Progression|0|||
170796675|NCT03582033|617267705|FG001|Part A|Other|0|||
170796676|NCT03582033|617267706|FG002|Part A|Other|0|||
170796677|NCT03582033|617267707|FG003|Part A|Other|0|||
170796678|NCT03582033|617267708|FG004|Part A|Other|2|||
170796679|NCT03582033|617267709|FG005|Part A|Other|0|||
170796680|NCT03582033|617267710|FG006|Part A|Other|0|||
170796681|NCT03582033|617267711|FG007|Part A|Other|0|||
170796682|NCT03582033|617267712|FG008|Part A|Other|0|||
170796683|NCT03582033|617267713|FG009|Part A|Other|0|||
170796684|NCT03582033|617267704|FG000|Part A|Death|1|||
170796685|NCT03582033|617267705|FG001|Part A|Death|1|||
170796686|NCT03582033|617267706|FG002|Part A|Death|2|||
170796687|NCT03582033|617267707|FG003|Part A|Death|4|||
170796688|NCT03582033|617267708|FG004|Part A|Death|11|||
170796689|NCT03582033|617267709|FG005|Part A|Death|0|||
170896540|NCT01551693|617628546|FG000|Overall Study|Adverse Event|0|||
170896541|NCT01551693|617628547|FG001|Overall Study|Adverse Event|1|||
170896542|NCT01551693|617628546|FG000|Overall Study|Withdrawal by Subject|0|||
170796690|NCT03582033|617267710|FG006|Part A|Death|0|||
170796691|NCT03582033|617267711|FG007|Part A|Death|0|||
170796692|NCT03582033|617267712|FG008|Part A|Death|0|||
170796693|NCT03582033|617267713|FG009|Part A|Death|0|||
170796694|NCT03582033|617267704|FG000|Part A|Lost to Follow-up|0|||
170796695|NCT03582033|617267705|FG001|Part A|Lost to Follow-up|0|||
170796696|NCT03582033|617267706|FG002|Part A|Lost to Follow-up|0|||
170796697|NCT03582033|617267707|FG003|Part A|Lost to Follow-up|0|||
170796698|NCT03582033|617267708|FG004|Part A|Lost to Follow-up|1|||
170796699|NCT03582033|617267709|FG005|Part A|Lost to Follow-up|0|||
170796700|NCT03582033|617267710|FG006|Part A|Lost to Follow-up|0|||
170796701|NCT03582033|617267711|FG007|Part A|Lost to Follow-up|0|||
170796702|NCT03582033|617267712|FG008|Part A|Lost to Follow-up|0|||
170796703|NCT03582033|617267713|FG009|Part A|Lost to Follow-up|0|||
170796704|NCT03582033|617267704|FG000|Part A|Study terminated by sponsor|0|||
170796705|NCT03582033|617267705|FG001|Part A|Study terminated by sponsor|0|||
170796706|NCT03582033|617267706|FG002|Part A|Study terminated by sponsor|0|||
170796707|NCT03582033|617267707|FG003|Part A|Study terminated by sponsor|2|||
170796708|NCT03582033|617267708|FG004|Part A|Study terminated by sponsor|1|||
170796709|NCT03582033|617267709|FG005|Part A|Study terminated by sponsor|0|||
170796710|NCT03582033|617267710|FG006|Part A|Study terminated by sponsor|0|||
170796711|NCT03582033|617267711|FG007|Part A|Study terminated by sponsor|0|||
170796712|NCT03582033|617267712|FG008|Part A|Study terminated by sponsor|0|||
170796713|NCT03582033|617267713|FG009|Part A|Study terminated by sponsor|0|||
170796714|NCT03582033|617267704|FG000|Part A|Withdrawal by Subject|1|||
170796715|NCT03582033|617267705|FG001|Part A|Withdrawal by Subject|1|||
170796716|NCT03582033|617267706|FG002|Part A|Withdrawal by Subject|0|||
170796717|NCT03582033|617267707|FG003|Part A|Withdrawal by Subject|1|||
170796718|NCT03582033|617267708|FG004|Part A|Withdrawal by Subject|7|||
170796719|NCT03582033|617267709|FG005|Part A|Withdrawal by Subject|0|||
170796720|NCT03582033|617267710|FG006|Part A|Withdrawal by Subject|0|||
170796721|NCT03582033|617267711|FG007|Part A|Withdrawal by Subject|0|||
170796722|NCT03582033|617267712|FG008|Part A|Withdrawal by Subject|0|||
170796723|NCT03582033|617267713|FG009|Part A|Withdrawal by Subject|0|||
170796724|NCT03582033|617267704|FG000|Part B|Death|0|||
170896543|NCT01551693|617628547|FG001|Overall Study|Withdrawal by Subject|1|||
170896544|NCT01960855|617628548|FG000|Overall Study|Subject noncompliant|1|||
170896545|NCT01960855|617628549|FG001|Overall Study|Subject noncompliant|0|||
170896546|NCT01960855|617628550|FG002|Overall Study|Subject noncompliant|0|||
170548206|NCT00621322|616352058|FG000|Overall Study|Physician Decision|0|||
170796725|NCT03582033|617267705|FG001|Part B|Death|0|||
170796726|NCT03582033|617267706|FG002|Part B|Death|0|||
170796727|NCT03582033|617267707|FG003|Part B|Death|0|||
170796728|NCT03582033|617267708|FG004|Part B|Death|0|||
170796729|NCT03582033|617267709|FG005|Part B|Death|2|||
170796730|NCT03582033|617267710|FG006|Part B|Death|0|||
170796731|NCT03582033|617267711|FG007|Part B|Death|0|||
170796732|NCT03582033|617267712|FG008|Part B|Death|0|||
170796733|NCT03582033|617267713|FG009|Part B|Death|0|||
170796734|NCT03582033|617267704|FG000|Part B|Study terminated by sponsor|0|||
170796735|NCT03582033|617267705|FG001|Part B|Study terminated by sponsor|0|||
170896547|NCT01960855|617628551|FG003|Overall Study|Subject noncompliant|0|||
170796736|NCT03582033|617267706|FG002|Part B|Study terminated by sponsor|0|||
170796737|NCT03582033|617267707|FG003|Part B|Study terminated by sponsor|0|||
170796738|NCT03582033|617267708|FG004|Part B|Study terminated by sponsor|0|||
170796739|NCT03582033|617267709|FG005|Part B|Study terminated by sponsor|12|||
170796740|NCT03582033|617267710|FG006|Part B|Study terminated by sponsor|0|||
170796741|NCT03582033|617267711|FG007|Part B|Study terminated by sponsor|0|||
170796742|NCT03582033|617267712|FG008|Part B|Study terminated by sponsor|0|||
170896548|NCT01960855|617628552|FG004|Overall Study|Subject noncompliant|0|||
170481857|NCT00955409|616105551|FG009|Overall Study|Failed to Return|0|||
170481858|NCT00955409|616105542|FG000|Overall Study|Adverse Event (AE)|2|||
170896549|NCT01960855|617628548|FG000|Overall Study|Adverse Event|2|||
170896550|NCT01960855|617628549|FG001|Overall Study|Adverse Event|0|||
170896551|NCT01960855|617628550|FG002|Overall Study|Adverse Event|6|||
170896552|NCT01960855|617628551|FG003|Overall Study|Adverse Event|2|||
170896553|NCT01960855|617628552|FG004|Overall Study|Adverse Event|2|||
170896554|NCT01960855|617628548|FG000|Overall Study|Lack of Efficacy|1|||
170896555|NCT01960855|617628549|FG001|Overall Study|Lack of Efficacy|1|||
170896556|NCT01960855|617628550|FG002|Overall Study|Lack of Efficacy|0|||
170896557|NCT01960855|617628551|FG003|Overall Study|Lack of Efficacy|0|||
170896558|NCT01960855|617628552|FG004|Overall Study|Lack of Efficacy|0|||
170896559|NCT01960855|617628548|FG000|Overall Study|Other|2|||
170896560|NCT01960855|617628549|FG001|Overall Study|Other|1|||
170896561|NCT01960855|617628550|FG002|Overall Study|Other|1|||
170896562|NCT01960855|617628551|FG003|Overall Study|Other|1|||
170896563|NCT01960855|617628552|FG004|Overall Study|Other|0|||
170896564|NCT01960855|617628548|FG000|Overall Study|Consent withdrawn by subject|3|||
170896565|NCT01960855|617628549|FG001|Overall Study|Consent withdrawn by subject|1|||
170896566|NCT01960855|617628550|FG002|Overall Study|Consent withdrawn by subject|2|||
170896567|NCT01960855|617628551|FG003|Overall Study|Consent withdrawn by subject|1|||
170896568|NCT01960855|617628552|FG004|Overall Study|Consent withdrawn by subject|1|||
170896569|NCT01960855|617628548|FG000|Overall Study|Lost to Follow-up|2|||
170896570|NCT01960855|617628549|FG001|Overall Study|Lost to Follow-up|1|||
170896571|NCT01960855|617628550|FG002|Overall Study|Lost to Follow-up|0|||
170896572|NCT01960855|617628551|FG003|Overall Study|Lost to Follow-up|0|||
170896573|NCT01960855|617628552|FG004|Overall Study|Lost to Follow-up|2|||
170896574|NCT01014585|617628556|FG000|Overall Study|Adverse Event|0|||
170896575|NCT01014585|617628557|FG001|Overall Study|Adverse Event|2|||
170896576|NCT01014585|617628558|FG002|Overall Study|Adverse Event|0|||
170896577|NCT01014585|617628559|FG003|Overall Study|Adverse Event|3|||
170896578|NCT01014585|617628556|FG000|Overall Study|Withdrawal by Subject|2|||
170896579|NCT01014585|617628557|FG001|Overall Study|Withdrawal by Subject|0|||
170896580|NCT01014585|617628558|FG002|Overall Study|Withdrawal by Subject|1|||
170896581|NCT01014585|617628559|FG003|Overall Study|Withdrawal by Subject|3|||
170896582|NCT01014585|617628556|FG000|Overall Study|Lost to Follow-up|0|||
170896583|NCT01014585|617628557|FG001|Overall Study|Lost to Follow-up|0|||
170896584|NCT01014585|617628558|FG002|Overall Study|Lost to Follow-up|0|||
170896585|NCT01014585|617628559|FG003|Overall Study|Lost to Follow-up|2|||
170896586|NCT01014585|617628556|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
170896587|NCT01014585|617628557|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
170896588|NCT01014585|617628558|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
170896589|NCT01014585|617628559|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
170896590|NCT04178772|617628560|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
170896591|NCT04178772|617628560|FG000|Overall Study|study terminated early due to COVID-19|7|||
170896592|NCT01737931|617628561|FG000|Overall Study|Withdrawal by Subject|0|||
170896593|NCT01737931|617628562|FG001|Overall Study|Withdrawal by Subject|1|||
170896594|NCT01737931|617628563|FG002|Overall Study|Withdrawal by Subject|1|||
170896595|NCT01737931|617628561|FG000|Overall Study|Physician Decision|0|||
170896596|NCT01737931|617628562|FG001|Overall Study|Physician Decision|1|||
170896597|NCT01737931|617628563|FG002|Overall Study|Physician Decision|0|||
170896598|NCT04897867|617628564|FG000|Overall Study|Withdrawal of Consent|1|||
170896599|NCT04897867|617628564|FG000|Overall Study|Pregnancy|1|||
170896600|NCT04897867|617628564|FG000|Overall Study|Lost to Follow-up|7|||
170896601|NCT04897867|617628564|FG000|Overall Study|Reason not Specified|2|||
170896602|NCT00508391|617628565|FG000|First Treatment|Withdrawal by Subject|6|||
170896603|NCT00508391|617628566|FG001|First Treatment|Withdrawal by Subject|3|||
170896604|NCT00508391|617628565|FG000|Second Treatment|Withdrawal by Subject|2|||
170896605|NCT00508391|617628566|FG001|Second Treatment|Withdrawal by Subject|0|||
170896606|NCT00880256|617628567|FG000|Overall Study|Lost to Follow-up|28|||
170896607|NCT03183128|617628571|FG000|Overall Study|Adverse Event|1|||
170896608|NCT03183128|617628572|FG001|Overall Study|Adverse Event|2|||
170896609|NCT03183128|617628571|FG000|Overall Study|Withdrawal by Subject|1|||
170896610|NCT03183128|617628572|FG001|Overall Study|Withdrawal by Subject|8|||
170896611|NCT03183128|617628571|FG000|Overall Study|Protocol Violation|2|||
170481859|NCT00955409|616105543|FG001|Overall Study|Adverse Event (AE)|0|||
170896612|NCT03183128|617628572|FG001|Overall Study|Protocol Violation|0|||
170896613|NCT03183128|617628571|FG000|Overall Study|Lack of Efficacy|4|||
170896614|NCT03183128|617628572|FG001|Overall Study|Lack of Efficacy|27|||
170896615|NCT03183128|617628571|FG000|Overall Study|Lost to Follow-up|1|||
170481860|NCT00955409|616105544|FG002|Overall Study|Adverse Event (AE)|0|||
170896616|NCT03183128|617628572|FG001|Overall Study|Lost to Follow-up|0|||
170896617|NCT03183128|617628571|FG000|Overall Study|Death|2|||
170896618|NCT03183128|617628572|FG001|Overall Study|Death|0|||
170896619|NCT03183128|617628571|FG000|Overall Study|Physician Decision|1|||
170896620|NCT03183128|617628572|FG001|Overall Study|Physician Decision|0|||
170896621|NCT02041962|617628573|FG000|Overall Study|Lost Aetna Coverage|43|||
170896622|NCT02041962|617628574|FG001|Overall Study|Lost Aetna Coverage|40|||
170896623|NCT02041962|617628573|FG000|Overall Study|Death|1|||
170896624|NCT02041962|617628574|FG001|Overall Study|Death|1|||
170896625|NCT02041962|617628573|FG000|Overall Study|Lost to Follow-up|37|||
170896626|NCT02041962|617628574|FG001|Overall Study|Lost to Follow-up|32|||
170896627|NCT02041962|617628573|FG000|Overall Study|Withdrawal by Subject|0|||
170896628|NCT02041962|617628574|FG001|Overall Study|Withdrawal by Subject|11|||
170481861|NCT00955409|616105545|FG003|Overall Study|Adverse Event (AE)|0|||
170481862|NCT00955409|616105546|FG004|Overall Study|Adverse Event (AE)|0|||
170481863|NCT00955409|616105547|FG005|Overall Study|Adverse Event (AE)|1|||
170896629|NCT01686568|617628575|FG000|Main Study|Withdrawal by Subject|1|||
170896630|NCT01686568|617628576|FG001|Main Study|Withdrawal by Subject|3|||
170481864|NCT00955409|616105548|FG006|Overall Study|Adverse Event (AE)|2|||
170481865|NCT00955409|616105549|FG007|Overall Study|Adverse Event (AE)|0|||
170481866|NCT00955409|616105550|FG008|Overall Study|Adverse Event (AE)|2|||
170481867|NCT00955409|616105551|FG009|Overall Study|Adverse Event (AE)|0|||
170481868|NCT00955409|616105542|FG000|Overall Study|Reason not Specified|2|||
170481869|NCT00955409|616105543|FG001|Overall Study|Reason not Specified|1|||
170481870|NCT00955409|616105544|FG002|Overall Study|Reason not Specified|13|||
170481871|NCT00955409|616105545|FG003|Overall Study|Reason not Specified|1|||
170481872|NCT00955409|616105546|FG004|Overall Study|Reason not Specified|2|||
170481873|NCT00955409|616105547|FG005|Overall Study|Reason not Specified|0|||
170481874|NCT00955409|616105548|FG006|Overall Study|Reason not Specified|16|||
170481875|NCT00955409|616105549|FG007|Overall Study|Reason not Specified|0|||
170481876|NCT00955409|616105550|FG008|Overall Study|Reason not Specified|8|||
170481877|NCT00955409|616105551|FG009|Overall Study|Reason not Specified|1|||
170481878|NCT00485732|616105552|FG000|Overall Study|Protocol Violation|1|||
170481879|NCT00485732|616105553|FG001|Overall Study|Protocol Violation|3|||
170481880|NCT00485732|616105552|FG000|Overall Study|Withdrawal by Subject|5|||
170481881|NCT00485732|616105553|FG001|Overall Study|Withdrawal by Subject|4|||
170481882|NCT00485732|616105552|FG000|Overall Study|Lost to Follow-up|2|||
170481883|NCT00485732|616105553|FG001|Overall Study|Lost to Follow-up|2|||
170481884|NCT00975611|616105554|FG000|Overall Study|Screen Fail|16|||
170481885|NCT00975611|616105554|FG000|Overall Study|Physician Decision|1|||
170481886|NCT04710576|616105555|FG000|Overall Study|Participants still in the study|73|||
170481887|NCT04710576|616105556|FG001|Overall Study|Participants still in the study|70|||
170481888|NCT04710576|616105557|FG002|Overall Study|Participants still in the study|60|||
170481889|NCT04710576|616105555|FG000|Overall Study|Death|2|||
170481890|NCT04710576|616105556|FG001|Overall Study|Death|7|||
170481891|NCT04710576|616105557|FG002|Overall Study|Death|12|||
170481892|NCT04710576|616105555|FG000|Overall Study|Withdrawal by Subject|4|||
170481893|NCT04710576|616105556|FG001|Overall Study|Withdrawal by Subject|3|||
170481894|NCT04710576|616105557|FG002|Overall Study|Withdrawal by Subject|7|||
170481895|NCT04710576|616105555|FG000|Overall Study|Sponsor decision|1|||
170481896|NCT04710576|616105556|FG001|Overall Study|Sponsor decision|0|||
170481897|NCT04710576|616105557|FG002|Overall Study|Sponsor decision|0|||
170481898|NCT05423093|616105559|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
170481899|NCT05423093|616105559|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
170481900|NCT05423093|616105559|FG000|Attended Intervention Session|Lost to Follow-up|3|||
170481901|NCT05423093|616105559|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
170481902|NCT05423093|616105559|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
170481903|NCT03593525|616105560|FG000|Overall Study|Withdrawal by Subject|1|||
170481904|NCT03593525|616105561|FG001|Overall Study|Withdrawal by Subject|0|||
170481905|NCT03593525|616105560|FG000|Overall Study|Lost to Follow-up|7|||
170481906|NCT03593525|616105561|FG001|Overall Study|Lost to Follow-up|5|||
170481907|NCT04846569|616105562|FG000|Overall Study|Withdrawal by Subject|3|||
170481908|NCT04846569|616105563|FG001|Overall Study|Withdrawal by Subject|1|||
170481909|NCT00210210|616105564|FG000|Overall Study|Withdrawal by Subject|3|||
170481910|NCT00210210|616105565|FG001|Overall Study|Withdrawal by Subject|2|||
170481911|NCT00210210|616105564|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
170481912|NCT00210210|616105565|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
170481913|NCT02445248|616105566|FG000|Overall Study|Death|45|||
170481914|NCT02445248|616105567|FG001|Overall Study|Death|12|||
170481915|NCT02445248|616105566|FG000|Overall Study|Progressive disease|13|||
170481916|NCT02445248|616105567|FG001|Overall Study|Progressive disease|1|||
170481917|NCT02445248|616105566|FG000|Overall Study|Subject decision|8|||
170548207|NCT00621322|616352059|FG001|Overall Study|Physician Decision|0|||
170896631|NCT01686568|617628575|FG000|Main Study|Noncompliance with protocol|0|||
170896632|NCT01686568|617628576|FG001|Main Study|Noncompliance with protocol|1|||
170896633|NCT01686568|617628575|FG000|Main Study|Liver enzymes above range of exclusion|1|||
170896634|NCT01686568|617628576|FG001|Main Study|Liver enzymes above range of exclusion|0|||
170896635|NCT01686568|617628575|FG000|Sub-Study|Not consented for sub-study|2|||
170896636|NCT01686568|617628576|FG001|Sub-Study|Not consented for sub-study|2|||
170896637|NCT02978222|617628577|FG000|Overall Study|Withdrawal by Subject|2|||
170896638|NCT02978222|617628578|FG001|Overall Study|Withdrawal by Subject|2|||
170896639|NCT02978222|617628577|FG000|Overall Study|Physician Decision|2|||
170896640|NCT02978222|617628578|FG001|Overall Study|Physician Decision|0|||
170896641|NCT02978222|617628577|FG000|Overall Study|Adverse Event|0|||
170896642|NCT02978222|617628578|FG001|Overall Study|Adverse Event|1|||
170896643|NCT02978222|617628577|FG000|Overall Study|Death|1|||
170896644|NCT02978222|617628578|FG001|Overall Study|Death|0|||
170896645|NCT02978222|617628577|FG000|Overall Study|Disease Progression|32|||
170896646|NCT02978222|617628578|FG001|Overall Study|Disease Progression|32|||
170896647|NCT02978222|617628577|FG000|Overall Study|Early Study Termination|24|||
170896648|NCT02978222|617628578|FG001|Overall Study|Early Study Termination|21|||
170896649|NCT02908516|617628579|FG000|Overall Study|Study Terminated|3|||
170896650|NCT02908516|617628580|FG001|Overall Study|Study Terminated|3|||
170896651|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896652|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896653|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896654|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
170896655|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896656|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
170896657|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896658|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896659|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896660|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896661|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896662|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896663|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896664|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896665|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170796743|NCT03582033|617267713|FG009|Part B|Study terminated by sponsor|0|||
170796744|NCT03582033|617267704|FG000|Part B|Withdrawal by Subject|0|||
170796745|NCT03582033|617267705|FG001|Part B|Withdrawal by Subject|0|||
170796746|NCT03582033|617267706|FG002|Part B|Withdrawal by Subject|0|||
170796747|NCT03582033|617267707|FG003|Part B|Withdrawal by Subject|0|||
170796748|NCT03582033|617267708|FG004|Part B|Withdrawal by Subject|0|||
170796749|NCT03582033|617267709|FG005|Part B|Withdrawal by Subject|6|||
170796750|NCT03582033|617267710|FG006|Part B|Withdrawal by Subject|0|||
170796751|NCT03582033|617267711|FG007|Part B|Withdrawal by Subject|0|||
170796752|NCT03582033|617267712|FG008|Part B|Withdrawal by Subject|0|||
170796753|NCT03582033|617267713|FG009|Part B|Withdrawal by Subject|0|||
170896666|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896667|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896668|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896669|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896670|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896671|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170896672|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170796754|NCT03582033|617267704|FG000|Part C|Other|0|||
170796755|NCT03582033|617267705|FG001|Part C|Other|0|||
170796756|NCT03582033|617267706|FG002|Part C|Other|0|||
170796757|NCT03582033|617267707|FG003|Part C|Other|0|||
170796758|NCT03582033|617267708|FG004|Part C|Other|0|||
170796759|NCT03582033|617267709|FG005|Part C|Other|0|||
170796760|NCT03582033|617267710|FG006|Part C|Other|2|||
170896673|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
170548208|NCT00621322|616352060|FG002|Overall Study|Physician Decision|1|||
170548209|NCT00621322|616352061|FG003|Overall Study|Physician Decision|1|||
170796761|NCT03582033|617267711|FG007|Part C|Other|0|||
170796762|NCT03582033|617267712|FG008|Part C|Other|0|||
170796763|NCT03582033|617267713|FG009|Part C|Other|0|||
170796764|NCT03582033|617267704|FG000|Part C|Death|0|||
170896674|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
170896675|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
170796765|NCT03582033|617267705|FG001|Part C|Death|0|||
170796766|NCT03582033|617267706|FG002|Part C|Death|0|||
170796767|NCT03582033|617267707|FG003|Part C|Death|0|||
170796768|NCT03582033|617267708|FG004|Part C|Death|0|||
170796769|NCT03582033|617267709|FG005|Part C|Death|0|||
170796770|NCT03582033|617267710|FG006|Part C|Death|6|||
170796771|NCT03582033|617267711|FG007|Part C|Death|1|||
170548210|NCT00621322|616352062|FG004|Overall Study|Physician Decision|0|||
170796772|NCT03582033|617267712|FG008|Part C|Death|2|||
170796773|NCT03582033|617267713|FG009|Part C|Death|0|||
170796774|NCT03582033|617267704|FG000|Part C|Study terminated by sponsor|0|||
170796775|NCT03582033|617267705|FG001|Part C|Study terminated by sponsor|0|||
170796776|NCT03582033|617267706|FG002|Part C|Study terminated by sponsor|0|||
170796777|NCT03582033|617267707|FG003|Part C|Study terminated by sponsor|0|||
170796778|NCT03582033|617267708|FG004|Part C|Study terminated by sponsor|0|||
170796779|NCT03582033|617267709|FG005|Part C|Study terminated by sponsor|0|||
170796780|NCT03582033|617267710|FG006|Part C|Study terminated by sponsor|3|||
170796781|NCT03582033|617267711|FG007|Part C|Study terminated by sponsor|3|||
170796782|NCT03582033|617267712|FG008|Part C|Study terminated by sponsor|2|||
170796783|NCT03582033|617267713|FG009|Part C|Study terminated by sponsor|0|||
170796784|NCT03582033|617267704|FG000|Part C|Withdrawal by Subject|0|||
170796785|NCT03582033|617267705|FG001|Part C|Withdrawal by Subject|0|||
170796786|NCT03582033|617267706|FG002|Part C|Withdrawal by Subject|0|||
170796787|NCT03582033|617267707|FG003|Part C|Withdrawal by Subject|0|||
170796788|NCT03582033|617267708|FG004|Part C|Withdrawal by Subject|0|||
170796789|NCT03582033|617267709|FG005|Part C|Withdrawal by Subject|0|||
170796790|NCT03582033|617267710|FG006|Part C|Withdrawal by Subject|1|||
170796791|NCT03582033|617267711|FG007|Part C|Withdrawal by Subject|2|||
170796792|NCT03582033|617267712|FG008|Part C|Withdrawal by Subject|1|||
170796793|NCT03582033|617267713|FG009|Part C|Withdrawal by Subject|0|||
170796794|NCT03582033|617267704|FG000|Part D|Death|0|||
170796795|NCT03582033|617267705|FG001|Part D|Death|0|||
170796796|NCT03582033|617267706|FG002|Part D|Death|0|||
170796797|NCT03582033|617267707|FG003|Part D|Death|0|||
170796798|NCT03582033|617267708|FG004|Part D|Death|0|||
170796799|NCT03582033|617267709|FG005|Part D|Death|0|||
170796800|NCT03582033|617267710|FG006|Part D|Death|0|||
170796801|NCT03582033|617267711|FG007|Part D|Death|0|||
170796802|NCT03582033|617267712|FG008|Part D|Death|0|||
170796803|NCT03582033|617267713|FG009|Part D|Death|1|||
170796804|NCT03582033|617267704|FG000|Part D|Study terminated by sponsor|0|||
170796805|NCT03582033|617267705|FG001|Part D|Study terminated by sponsor|0|||
170796806|NCT03582033|617267706|FG002|Part D|Study terminated by sponsor|0|||
170796807|NCT03582033|617267707|FG003|Part D|Study terminated by sponsor|0|||
170796808|NCT03582033|617267708|FG004|Part D|Study terminated by sponsor|0|||
170796809|NCT03582033|617267709|FG005|Part D|Study terminated by sponsor|0|||
170796810|NCT03582033|617267710|FG006|Part D|Study terminated by sponsor|0|||
170796811|NCT03582033|617267711|FG007|Part D|Study terminated by sponsor|0|||
170796812|NCT03582033|617267712|FG008|Part D|Study terminated by sponsor|0|||
170796813|NCT03582033|617267713|FG009|Part D|Study terminated by sponsor|4|||
170796814|NCT06010836|617267714|FG000|Overall Study|Lost to Follow-up|2|||
170796815|NCT06010836|617267715|FG001|Overall Study|Lost to Follow-up|2|||
170796816|NCT06010836|617267714|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
170796817|NCT06010836|617267715|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
170796818|NCT06010836|617267714|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
170796819|NCT06010836|617267715|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
170796820|NCT06010836|617267714|FG000|Overall Study|Did not receive intervention discussion|0|||
170796821|NCT06010836|617267715|FG001|Overall Study|Did not receive intervention discussion|4|||
170796822|NCT03812614|617267716|FG000|Intervention|Withdrawal by Subject|7|||
170796823|NCT03812614|617267717|FG001|Intervention|Withdrawal by Subject|2|||
170796824|NCT03812614|617267718|FG002|Intervention|Withdrawal by Subject|7|||
170796825|NCT03812614|617267719|FG003|Intervention|Withdrawal by Subject|2|||
170796826|NCT03812614|617267716|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
170796827|NCT03812614|617267717|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
170796828|NCT03812614|617267718|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
170796829|NCT03812614|617267719|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
170796830|NCT03812614|617267716|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
170796831|NCT03812614|617267717|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
170796832|NCT03812614|617267718|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
170796833|NCT03812614|617267719|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
170796834|NCT03812614|617267716|FG000|6-month Follow-up|Lost to Follow-up|0|||
170796835|NCT03812614|617267717|FG001|6-month Follow-up|Lost to Follow-up|0|||
170796836|NCT03812614|617267718|FG002|6-month Follow-up|Lost to Follow-up|12|||
170796837|NCT03812614|617267719|FG003|6-month Follow-up|Lost to Follow-up|8|||
170796838|NCT03812614|617267716|FG000|12-month Follow-up|Lost to Follow-up|18|||
170796839|NCT03812614|617267717|FG001|12-month Follow-up|Lost to Follow-up|17|||
170796840|NCT03812614|617267718|FG002|12-month Follow-up|Lost to Follow-up|5|||
170796841|NCT03812614|617267719|FG003|12-month Follow-up|Lost to Follow-up|2|||
170796842|NCT05652010|617267720|FG000|First Intervention|Withdrawal by Subject|0|||
170896676|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
170896677|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
170896678|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
170896679|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
170896680|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
170896681|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896682|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896683|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896684|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896685|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896686|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896687|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896688|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896689|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896690|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896691|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896692|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896693|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896694|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896695|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896696|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
170896697|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
170896698|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
170896699|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
170896700|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
170896701|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
170896702|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
170896703|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
170896704|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
170896705|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896706|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896707|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896708|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896709|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896710|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896711|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896712|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896713|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896714|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896715|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170481918|NCT02445248|616105567|FG001|Overall Study|Subject decision|0|||
170481919|NCT02445248|616105566|FG000|Overall Study|Physician Decision|5|||
170481920|NCT02445248|616105567|FG001|Overall Study|Physician Decision|0|||
170481921|NCT02445248|616105566|FG000|Overall Study|Adverse Event|1|||
170481922|NCT02445248|616105567|FG001|Overall Study|Adverse Event|0|||
170481923|NCT02445248|616105566|FG000|Overall Study|Lost to Follow-up|1|||
170481924|NCT02445248|616105567|FG001|Overall Study|Lost to Follow-up|0|||
170481925|NCT02525783|616105568|FG000|Overall Study|Lost to Follow-up|10|||
170896716|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896717|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896718|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896719|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
170896720|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896721|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896722|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
170896723|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896724|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
170896725|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896726|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896727|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896728|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170481926|NCT02512302|616105569|FG000|Period 1|Adverse Event|0|||
170481927|NCT02512302|616105570|FG001|Period 1|Adverse Event|1|||
170481928|NCT02512302|616105571|FG002|Period 1|Adverse Event|0|||
170481929|NCT02512302|616105572|FG003|Period 1|Adverse Event|0|||
170481930|NCT02512302|616105573|FG004|Period 1|Adverse Event|0|||
170481931|NCT02512302|616105574|FG005|Period 1|Adverse Event|0|||
170481932|NCT02512302|616105575|FG006|Period 1|Adverse Event|0|||
170481933|NCT02512302|616105576|FG007|Period 1|Adverse Event|0|||
170481934|NCT02512302|616105577|FG008|Period 1|Adverse Event|0|||
170481935|NCT02512302|616105578|FG009|Period 1|Adverse Event|0|||
170481936|NCT02512302|616105569|FG000|Period 2|Adverse Event|0|||
170796843|NCT05652010|617267721|FG001|First Intervention|Withdrawal by Subject|1|||
170796844|NCT05652010|617267720|FG000|Second Intervention|Withdrawal by Subject|1|||
170796845|NCT05652010|617267721|FG001|Second Intervention|Withdrawal by Subject|0|||
170796846|NCT04490109|617267732|FG000|Overall Study|Lost to Follow-up|3|||
170796847|NCT04490109|617267733|FG001|Overall Study|Lost to Follow-up|10|||
170796848|NCT04490109|617267734|FG002|Overall Study|Lost to Follow-up|4|||
170796849|NCT04490109|617267732|FG000|Overall Study|Withdrawal by Subject|8|||
170796850|NCT04490109|617267733|FG001|Overall Study|Withdrawal by Subject|6|||
170796851|NCT04490109|617267734|FG002|Overall Study|Withdrawal by Subject|9|||
170796852|NCT04490109|617267732|FG000|Overall Study|Physician Decision|0|||
170796853|NCT04490109|617267733|FG001|Overall Study|Physician Decision|2|||
170796854|NCT04490109|617267734|FG002|Overall Study|Physician Decision|3|||
170796855|NCT04490109|617267732|FG000|Overall Study|Adverse Event|2|||
170796856|NCT04490109|617267733|FG001|Overall Study|Adverse Event|1|||
170796857|NCT04490109|617267734|FG002|Overall Study|Adverse Event|0|||
170796858|NCT04490109|617267732|FG000|Overall Study|Significant Non-Compliance|2|||
170796859|NCT04490109|617267733|FG001|Overall Study|Significant Non-Compliance|4|||
170796860|NCT04490109|617267734|FG002|Overall Study|Significant Non-Compliance|4|||
170796861|NCT04490109|617267732|FG000|Overall Study|Significant Clinical Event|0|||
170481937|NCT02512302|616105570|FG001|Period 2|Adverse Event|0|||
170481938|NCT02512302|616105571|FG002|Period 2|Adverse Event|0|||
170481939|NCT02512302|616105572|FG003|Period 2|Adverse Event|0|||
170481940|NCT02512302|616105573|FG004|Period 2|Adverse Event|0|||
170481941|NCT02512302|616105574|FG005|Period 2|Adverse Event|0|||
170481942|NCT02512302|616105575|FG006|Period 2|Adverse Event|0|||
170481943|NCT02512302|616105576|FG007|Period 2|Adverse Event|0|||
170481944|NCT02512302|616105577|FG008|Period 2|Adverse Event|0|||
170481945|NCT02512302|616105578|FG009|Period 2|Adverse Event|1|||
170481946|NCT02512302|616105569|FG000|Period 3|Lost to Follow-up|0|||
170481947|NCT02512302|616105570|FG001|Period 3|Lost to Follow-up|0|||
170481948|NCT02512302|616105571|FG002|Period 3|Lost to Follow-up|1|||
170481949|NCT02512302|616105572|FG003|Period 3|Lost to Follow-up|0|||
170481950|NCT02512302|616105573|FG004|Period 3|Lost to Follow-up|0|||
170481951|NCT02512302|616105574|FG005|Period 3|Lost to Follow-up|0|||
170481952|NCT02512302|616105575|FG006|Period 3|Lost to Follow-up|0|||
170481953|NCT02512302|616105576|FG007|Period 3|Lost to Follow-up|0|||
170481954|NCT02512302|616105577|FG008|Period 3|Lost to Follow-up|0|||
170481955|NCT02512302|616105578|FG009|Period 3|Lost to Follow-up|0|||
170481956|NCT02512302|616105569|FG000|Period 4|Adverse Event|0|||
170481957|NCT02512302|616105570|FG001|Period 4|Adverse Event|0|||
170481958|NCT02512302|616105571|FG002|Period 4|Adverse Event|0|||
170481959|NCT02512302|616105572|FG003|Period 4|Adverse Event|0|||
170481960|NCT02512302|616105573|FG004|Period 4|Adverse Event|0|||
170481961|NCT02512302|616105574|FG005|Period 4|Adverse Event|0|||
170481962|NCT02512302|616105575|FG006|Period 4|Adverse Event|1|||
170481963|NCT02512302|616105576|FG007|Period 4|Adverse Event|0|||
170481964|NCT02512302|616105577|FG008|Period 4|Adverse Event|0|||
170481965|NCT02512302|616105578|FG009|Period 4|Adverse Event|0|||
170481966|NCT02764762|616105579|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
170481967|NCT02764762|616105579|FG000|Overall Study|Lost to Follow-up|4|||
170481968|NCT02764762|616105579|FG000|Overall Study|Voluntary Withdrawal|8|||
170481969|NCT02764762|616105579|FG000|Overall Study|Site Termination|1|||
170481970|NCT02764762|616105579|FG000|Overall Study|Lack of Efficacy|16|||
170481971|NCT02764762|616105579|FG000|Overall Study|Reason not Specified|1|||
170481972|NCT02954601|616105580|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
170481973|NCT02954601|616105581|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
170796862|NCT04490109|617267733|FG001|Overall Study|Significant Clinical Event|1|||
170481974|NCT02954601|616105582|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
170481975|NCT02954601|616105583|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
170481976|NCT00917852|616105595|FG000|Overall Study|Death|6|||
170481977|NCT01735916|616105596|FG000|Overall Study|Subject not eligible to be randomized|11|||
170481978|NCT01735916|616105597|FG001|Overall Study|Subject not eligible to be randomized|0|||
170796863|NCT04490109|617267734|FG002|Overall Study|Significant Clinical Event|0|||
170796864|NCT04490109|617267732|FG000|Overall Study|Other Reason|4|||
170796865|NCT04490109|617267733|FG001|Overall Study|Other Reason|1|||
170481979|NCT01735916|616105598|FG002|Overall Study|Subject not eligible to be randomized|0|||
170481980|NCT01735916|616105596|FG000|Overall Study|Early termination of study by sponsor|4|||
170481981|NCT01735916|616105597|FG001|Overall Study|Early termination of study by sponsor|19|||
170481982|NCT01735916|616105598|FG002|Overall Study|Early termination of study by sponsor|7|||
170481983|NCT01735916|616105596|FG000|Overall Study|Withdrawal by Subject|3|||
170481984|NCT01735916|616105597|FG001|Overall Study|Withdrawal by Subject|0|||
170481985|NCT01735916|616105598|FG002|Overall Study|Withdrawal by Subject|0|||
170796866|NCT04490109|617267734|FG002|Overall Study|Other Reason|1|||
170796867|NCT00319111|617267737|FG000|Overall Study|Adverse Event|20|||
170796868|NCT00319111|617267737|FG000|Overall Study|Withdrawal of consent|11|||
170796869|NCT00319111|617267737|FG000|Overall Study|Death|9|||
170796870|NCT00319111|617267737|FG000|Overall Study|Lack of clinical improvement|4|||
170796871|NCT00319111|617267737|FG000|Overall Study|Administrative|2|||
170796872|NCT00319111|617267737|FG000|Overall Study|Treatment failure|1|||
170796873|NCT03418740|617267738|FG000|Overall Study|Lost to Follow-up|13|||
170796874|NCT03418740|617267738|FG000|Overall Study|Scheduling Issues|7|||
170796875|NCT03418740|617267738|FG000|Overall Study|Withdrawal by Subject|2|||
170796876|NCT03418740|617267738|FG000|Overall Study|Unable to Continue Consent|1|||
170796877|NCT01475786|617267739|FG000|Overall Study|Adverse Event|0|||
170796878|NCT01475786|617267740|FG001|Overall Study|Adverse Event|1|||
170796879|NCT01475786|617267741|FG002|Overall Study|Adverse Event|0|||
170796880|NCT01475786|617267739|FG000|Overall Study|Lost to Follow-up|1|||
170796881|NCT01475786|617267740|FG001|Overall Study|Lost to Follow-up|2|||
170796882|NCT01475786|617267741|FG002|Overall Study|Lost to Follow-up|1|||
170796883|NCT01475786|617267739|FG000|Overall Study|Withdrawal by Subject|0|||
170796884|NCT01475786|617267740|FG001|Overall Study|Withdrawal by Subject|1|||
170796885|NCT01475786|617267741|FG002|Overall Study|Withdrawal by Subject|1|||
170796886|NCT01475786|617267739|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
170796887|NCT01475786|617267740|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
170796888|NCT01475786|617267741|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
170796889|NCT03165955|617267743|FG000|Treatment|Withdrawal by Subject|3|||
170796890|NCT03165955|617267743|FG000|Treatment|Death|1|||
170796891|NCT03165955|617267743|FG000|Treatment|Adverse Event|1|||
170796892|NCT03165955|617267743|FG000|Treatment|Progressive disease|3|||
170796893|NCT02994927|617267744|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170796894|NCT02994927|617267745|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170796895|NCT02994927|617267744|FG000|Overall Study|Did not meet eligibility criteria|0|||
170796896|NCT02994927|617267745|FG001|Overall Study|Did not meet eligibility criteria|1|||
170796897|NCT02994927|617267744|FG000|Overall Study|Physician Decision|4|||
170796898|NCT02994927|617267745|FG001|Overall Study|Physician Decision|3|||
170796899|NCT02994927|617267744|FG000|Overall Study|Death|4|||
170796900|NCT02994927|617267745|FG001|Overall Study|Death|2|||
170796901|NCT02994927|617267744|FG000|Overall Study|Adverse Event|2|||
170796902|NCT02994927|617267745|FG001|Overall Study|Adverse Event|1|||
170796903|NCT02994927|617267744|FG000|Overall Study|Withdrawal by Subject|3|||
170796904|NCT02994927|617267745|FG001|Overall Study|Withdrawal by Subject|6|||
170796905|NCT02994927|617267744|FG000|Overall Study|Lost to Follow-up|2|||
170796906|NCT02994927|617267745|FG001|Overall Study|Lost to Follow-up|1|||
170796907|NCT05962814|617267753|FG000|Overall Study|failed eligibility|1|||
170796908|NCT05525104|617267755|FG000|Overall Study|Failed caudal analgesia|1|||
170796909|NCT05525104|617267756|FG001|Overall Study|Failed caudal analgesia|3|||
170796910|NCT05525104|617267755|FG000|Overall Study|Premedication needed|0|||
170796911|NCT05525104|617267756|FG001|Overall Study|Premedication needed|1|||
170796912|NCT05525104|617267755|FG000|Overall Study|Protocol Violation|10|||
170796913|NCT05525104|617267756|FG001|Overall Study|Protocol Violation|0|||
170796914|NCT05525104|617267755|FG000|Overall Study|Cancelled operation|1|||
170796915|NCT05525104|617267756|FG001|Overall Study|Cancelled operation|0|||
170796916|NCT02039401|617267757|FG000|Overall Study|Adverse Event|0|||
170796917|NCT02039401|617267758|FG001|Overall Study|Adverse Event|1|||
170796918|NCT02865538|617267759|FG000|Overall Study|Withdrawal by Subject|0|||
170796919|NCT02865538|617267760|FG001|Overall Study|Withdrawal by Subject|0|||
170796920|NCT02865538|617267761|FG002|Overall Study|Withdrawal by Subject|1|||
170796921|NCT02865538|617267762|FG003|Overall Study|Withdrawal by Subject|0|||
170796922|NCT02865538|617267763|FG004|Overall Study|Withdrawal by Subject|0|||
170796923|NCT02865538|617267759|FG000|Overall Study|Lost to Follow-up|1|||
170796924|NCT02865538|617267760|FG001|Overall Study|Lost to Follow-up|0|||
170796925|NCT02865538|617267761|FG002|Overall Study|Lost to Follow-up|0|||
170796926|NCT02865538|617267762|FG003|Overall Study|Lost to Follow-up|0|||
170796927|NCT02865538|617267763|FG004|Overall Study|Lost to Follow-up|0|||
170796928|NCT04244175|617268964|FG000|Overall Study|Adverse Event|3|||
170796929|NCT04244175|617268965|FG001|Overall Study|Adverse Event|2|||
170796930|NCT04244175|617268966|FG002|Overall Study|Adverse Event|5|||
170796931|NCT04244175|617268964|FG000|Overall Study|Lack of Efficacy|1|||
170796932|NCT04244175|617268965|FG001|Overall Study|Lack of Efficacy|0|||
170796933|NCT04244175|617268966|FG002|Overall Study|Lack of Efficacy|1|||
170796934|NCT04244175|617268964|FG000|Overall Study|Lost to Follow-up|1|||
170796935|NCT04244175|617268965|FG001|Overall Study|Lost to Follow-up|0|||
170796936|NCT04244175|617268966|FG002|Overall Study|Lost to Follow-up|0|||
170796937|NCT04244175|617268964|FG000|Overall Study|Non-compliance with study drug|1|||
170796938|NCT04244175|617268965|FG001|Overall Study|Non-compliance with study drug|0|||
170796939|NCT04244175|617268966|FG002|Overall Study|Non-compliance with study drug|1|||
170796940|NCT04244175|617268964|FG000|Overall Study|Protocol deviation|0|||
170796941|NCT04244175|617268965|FG001|Overall Study|Protocol deviation|1|||
170796942|NCT04244175|617268966|FG002|Overall Study|Protocol deviation|0|||
170796943|NCT04244175|617268964|FG000|Overall Study|Withdrawal by Subject|1|||
170896729|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896730|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896731|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170796944|NCT04244175|617268965|FG001|Overall Study|Withdrawal by Subject|3|||
170796945|NCT04244175|617268966|FG002|Overall Study|Withdrawal by Subject|1|||
170796946|NCT04244175|617268964|FG000|Overall Study|Other, not specified|0|||
170796947|NCT04244175|617268965|FG001|Overall Study|Other, not specified|1|||
170796948|NCT04244175|617268966|FG002|Overall Study|Other, not specified|2|||
170796949|NCT02585323|617268967|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
170796950|NCT02585323|617268968|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
170796951|NCT02585323|617268967|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
170796952|NCT02585323|617268968|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
170796953|NCT02585323|617268967|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
170796954|NCT02585323|617268968|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
170796955|NCT02585323|617268967|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
170896732|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896733|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896734|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896735|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896736|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170796956|NCT02585323|617268968|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
170796957|NCT00739908|617268969|FG000|Overall Study|Adverse Event|5|||
170796958|NCT00739908|617268970|FG001|Overall Study|Adverse Event|6|||
170796959|NCT00739908|617268969|FG000|Overall Study|Withdrawal by Subject|4|||
170796960|NCT00739908|617268970|FG001|Overall Study|Withdrawal by Subject|2|||
170796961|NCT00739908|617268969|FG000|Overall Study|Lost to Follow-up|14|||
170796962|NCT00739908|617268970|FG001|Overall Study|Lost to Follow-up|9|||
170796963|NCT00739908|617268969|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
170796964|NCT00739908|617268970|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
170796965|NCT00739908|617268969|FG000|Overall Study|Non-Compliance With Study Medication|0|||
170796966|NCT00739908|617268970|FG001|Overall Study|Non-Compliance With Study Medication|3|||
170796967|NCT00739908|617268969|FG000|Overall Study|Lack of Efficacy|0|||
170796968|NCT00739908|617268970|FG001|Overall Study|Lack of Efficacy|1|||
170796969|NCT00739908|617268969|FG000|Overall Study|Relocation|0|||
170796970|NCT00739908|617268970|FG001|Overall Study|Relocation|1|||
170796971|NCT01314105|617268982|FG000|Overall Study|Progressive Disease|6|||
170796972|NCT01314105|617268983|FG001|Overall Study|Progressive Disease|10|||
170796973|NCT01314105|617268982|FG000|Overall Study|Refused to continue taking medication|0|||
170796974|NCT01314105|617268983|FG001|Overall Study|Refused to continue taking medication|1|||
170796975|NCT01314105|617268982|FG000|Overall Study|Other Adverse Event|1|||
170796976|NCT01314105|617268983|FG001|Overall Study|Other Adverse Event|1|||
170796977|NCT04820322|617268984|FG000|Overall Study|Adverse Event|1|||
170796978|NCT04820322|617268985|FG001|Overall Study|Adverse Event|0|||
170796979|NCT03858517|617268992|FG000|Overall Study|Adverse Event|1|||
170796980|NCT03858517|617268992|FG000|Overall Study|Lost to Follow-up|1|||
170796981|NCT03858517|617268992|FG000|Overall Study|removed for being incarcerated|1|||
170796982|NCT03858517|617268992|FG000|Overall Study|Sponsor Closure|48|||
170796983|NCT03988621|617268995|FG000|Overall Study|Lost to Follow-up|16|||
170896737|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896738|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896739|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896740|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896741|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896742|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
170896743|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
170896744|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896745|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896746|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
170896747|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896748|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896749|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170796984|NCT03988621|617268996|FG001|Overall Study|Lost to Follow-up|17|||
170796985|NCT03988621|617268995|FG000|Overall Study|Withdrawal by Subject|14|||
170896750|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170796986|NCT03988621|617268996|FG001|Overall Study|Withdrawal by Subject|7|||
170796987|NCT03988621|617268995|FG000|Overall Study|Patient Lost to Follow Up|15|||
170796988|NCT03988621|617268996|FG001|Overall Study|Patient Lost to Follow Up|15|||
170796989|NCT03988621|617268995|FG000|Overall Study|Patient death|1|||
170796990|NCT03988621|617268996|FG001|Overall Study|Patient death|5|||
170796991|NCT04247802|617268997|FG000|Overall Study|Withdrawal by Subject|1|||
170896751|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896752|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896753|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896754|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896755|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896756|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896757|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896758|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896759|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896760|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896761|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896762|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896763|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896764|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896765|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
170896766|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896767|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896768|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
170896769|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896770|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896771|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896772|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896773|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896774|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896775|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896776|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896777|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896778|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896779|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896780|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896781|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896782|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896783|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896784|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896785|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896786|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896787|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896788|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
170896789|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896790|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896791|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
170896792|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896793|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896794|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896795|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896796|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896797|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896798|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896799|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896800|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896801|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896802|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896803|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896804|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896805|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896806|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896807|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896808|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896809|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896810|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896811|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
170896812|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896813|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896814|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170548211|NCT00621322|616352063|FG005|Overall Study|Physician Decision|0|||
170548212|NCT00621322|616352058|FG000|Overall Study|Withdrawal by Subject|0|||
170548213|NCT00621322|616352059|FG001|Overall Study|Withdrawal by Subject|0|||
170548214|NCT00621322|616352060|FG002|Overall Study|Withdrawal by Subject|0|||
170548215|NCT00621322|616352061|FG003|Overall Study|Withdrawal by Subject|1|||
170548216|NCT00621322|616352062|FG004|Overall Study|Withdrawal by Subject|0|||
170548217|NCT00621322|616352063|FG005|Overall Study|Withdrawal by Subject|2|||
170548218|NCT00621322|616352058|FG000|Overall Study|Migrated/moved from study area|1|||
170548219|NCT00621322|616352059|FG001|Overall Study|Migrated/moved from study area|0|||
170548220|NCT00621322|616352060|FG002|Overall Study|Migrated/moved from study area|1|||
170548221|NCT00621322|616352061|FG003|Overall Study|Migrated/moved from study area|1|||
170548222|NCT00621322|616352062|FG004|Overall Study|Migrated/moved from study area|0|||
170548223|NCT00621322|616352063|FG005|Overall Study|Migrated/moved from study area|2|||
170548224|NCT04641975|616352064|FG000|Overall Study|Protocol Violation|1|||
170548225|NCT04641975|616352065|FG001|Overall Study|Protocol Violation|2|||
170548226|NCT04641975|616352066|FG002|Overall Study|Protocol Violation|0|||
170548227|NCT04641975|616352067|FG003|Overall Study|Protocol Violation|0|||
170548228|NCT04641975|616352064|FG000|Overall Study|Adverse Event|0|||
170548229|NCT04641975|616352065|FG001|Overall Study|Adverse Event|0|||
170548230|NCT04641975|616352066|FG002|Overall Study|Adverse Event|1|||
170548231|NCT04641975|616352067|FG003|Overall Study|Adverse Event|1|||
170548232|NCT04641975|616352064|FG000|Overall Study|Withdrawal by Subject|1|||
170548233|NCT04641975|616352065|FG001|Overall Study|Withdrawal by Subject|0|||
170548234|NCT04641975|616352066|FG002|Overall Study|Withdrawal by Subject|0|||
170548235|NCT04641975|616352067|FG003|Overall Study|Withdrawal by Subject|0|||
170548236|NCT04865978|616352073|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
170548237|NCT04865978|616352074|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
170548238|NCT06083493|616352075|FG000|Overall Study|Technical issues with the interventional device|2|||
170548239|NCT06083493|616352076|FG001|Overall Study|Technical issues with the interventional device|2|||
170548240|NCT06083493|616352075|FG000|Overall Study|Performed incorrect visual task|1|||
170548241|NCT06083493|616352076|FG001|Overall Study|Performed incorrect visual task|0|||
170548242|NCT06083493|616352075|FG000|Overall Study|Insufficient baseline performance|0|||
170548243|NCT06083493|616352076|FG001|Overall Study|Insufficient baseline performance|1|||
170548244|NCT04392635|616352081|FG000|Overall Study|Lost to Follow-up|0|||
170548245|NCT04392635|616352082|FG001|Overall Study|Lost to Follow-up|1|||
170548246|NCT04098302|616352083|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
170548247|NCT04098302|616352084|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
170548248|NCT04098302|616352085|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
170548249|NCT04098302|616352086|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
170548250|NCT04098302|616352083|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
170548251|NCT04098302|616352084|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
170548252|NCT04098302|616352085|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
170548253|NCT04098302|616352086|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
170548254|NCT04098302|616352083|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
170548255|NCT04098302|616352084|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
170548256|NCT04098302|616352085|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
170548257|NCT04098302|616352086|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
170548258|NCT04098302|616352083|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
170796992|NCT04247802|617268998|FG001|Overall Study|Withdrawal by Subject|3|||
170796993|NCT04247802|617268997|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
170796994|NCT04247802|617268998|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
170796995|NCT04629339|617268999|FG000|Overall Study|Death|1|||
170796996|NCT04629339|617269000|FG001|Overall Study|Death|0|||
170796997|NCT04629339|617269001|FG002|Overall Study|Death|2|||
170796998|NCT04629339|617269002|FG003|Overall Study|Death|2|||
170796999|NCT04629339|617269003|FG004|Overall Study|Death|0|||
170797000|NCT04629339|617268999|FG000|Overall Study|Disease Progression|0|||
170797001|NCT04629339|617269000|FG001|Overall Study|Disease Progression|0|||
170797002|NCT04629339|617269001|FG002|Overall Study|Disease Progression|1|||
170797003|NCT04629339|617269002|FG003|Overall Study|Disease Progression|1|||
170797004|NCT04629339|617269003|FG004|Overall Study|Disease Progression|0|||
170797005|NCT04629339|617268999|FG000|Overall Study|Lost to Follow-up|0|||
170797006|NCT04629339|617269000|FG001|Overall Study|Lost to Follow-up|0|||
170797007|NCT04629339|617269001|FG002|Overall Study|Lost to Follow-up|0|||
170548259|NCT04098302|616352084|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
170548260|NCT04098302|616352085|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
170548261|NCT04098302|616352086|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
170548262|NCT04098302|616352083|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
170548263|NCT04098302|616352084|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
170797008|NCT04629339|617269002|FG003|Overall Study|Lost to Follow-up|1|||
170797009|NCT04629339|617269003|FG004|Overall Study|Lost to Follow-up|0|||
170797010|NCT04629339|617268999|FG000|Overall Study|Physician Decision|0|||
170548264|NCT04098302|616352085|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
170548265|NCT04098302|616352086|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
170896815|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
170896816|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896817|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896818|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896819|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896820|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896821|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896822|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896823|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896824|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896825|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896826|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896827|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896828|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896829|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896830|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896831|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896832|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896833|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170797011|NCT04629339|617269000|FG001|Overall Study|Physician Decision|1|||
170797012|NCT04629339|617269001|FG002|Overall Study|Physician Decision|0|||
170797013|NCT04629339|617269002|FG003|Overall Study|Physician Decision|0|||
170797014|NCT04629339|617269003|FG004|Overall Study|Physician Decision|0|||
170896834|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
170896835|NCT00896532|617628583|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896836|NCT00896532|617628584|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
170896837|NCT00896532|617628585|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896838|NCT00896532|617628586|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
170896839|NCT00896532|617628587|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
170896840|NCT00896532|617628588|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896841|NCT00896532|617628589|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896842|NCT00896532|617628590|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896843|NCT00896532|617628591|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896844|NCT00896532|617628592|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896845|NCT00896532|617628593|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896846|NCT00896532|617628594|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896847|NCT00896532|617628595|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170548266|NCT04098302|616352083|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
170548267|NCT04098302|616352084|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
170548268|NCT04098302|616352085|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
170548269|NCT04098302|616352086|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
170548270|NCT04098302|616352083|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
170548271|NCT04098302|616352084|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
170548272|NCT04098302|616352085|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
170548273|NCT04098302|616352086|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
170548274|NCT04098302|616352083|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
170548275|NCT04098302|616352084|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
170548276|NCT04098302|616352085|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
170548277|NCT04098302|616352086|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
170548278|NCT05061706|616352089|FG000|Overall Study|Adverse Event|29|||
170548279|NCT05061706|616352090|FG001|Overall Study|Adverse Event|1|||
170548280|NCT05061706|616352089|FG000|Overall Study|Lack of Efficacy|0|||
170797015|NCT04629339|617268999|FG000|Overall Study|Study Terminated by Sponsor|0|||
170797016|NCT04629339|617269000|FG001|Overall Study|Study Terminated by Sponsor|0|||
170797017|NCT04629339|617269001|FG002|Overall Study|Study Terminated by Sponsor|0|||
170896848|NCT00896532|617628596|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896849|NCT00896532|617628597|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896850|NCT00896532|617628598|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896851|NCT00896532|617628599|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896852|NCT00896532|617628600|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896853|NCT00896532|617628601|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170797018|NCT04629339|617269002|FG003|Overall Study|Study Terminated by Sponsor|1|||
170797019|NCT04629339|617269003|FG004|Overall Study|Study Terminated by Sponsor|0|||
170797020|NCT04629339|617268999|FG000|Overall Study|Withdrawal by Subject|0|||
170640059|NCT02100696|616693812|FG004|Maintenance Phase|Lost to Follow-up|1|||
170640060|NCT02100696|616693813|FG005|Maintenance Phase|Lost to Follow-up|0|||
170640061|NCT02100696|616693808|FG000|Maintenance Phase|Protocol Violation|0|||
170640062|NCT02100696|616693809|FG001|Maintenance Phase|Protocol Violation|0|||
170640063|NCT02100696|616693810|FG002|Maintenance Phase|Protocol Violation|0|||
170640064|NCT02100696|616693811|FG003|Maintenance Phase|Protocol Violation|0|||
170640065|NCT02100696|616693812|FG004|Maintenance Phase|Protocol Violation|1|||
170640066|NCT02100696|616693813|FG005|Maintenance Phase|Protocol Violation|0|||
170640067|NCT02100696|616693808|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170640068|NCT02100696|616693809|FG001|Maintenance Phase|Withdrawal by Subject|0|||
170640069|NCT02100696|616693810|FG002|Maintenance Phase|Withdrawal by Subject|0|||
170640070|NCT02100696|616693811|FG003|Maintenance Phase|Withdrawal by Subject|1|||
170640071|NCT02100696|616693812|FG004|Maintenance Phase|Withdrawal by Subject|4|||
170640072|NCT02100696|616693813|FG005|Maintenance Phase|Withdrawal by Subject|2|||
170640073|NCT02100696|616693808|FG000|Maintenance Phase|Physician Decision|0|||
170640074|NCT02100696|616693809|FG001|Maintenance Phase|Physician Decision|0|||
170640075|NCT02100696|616693810|FG002|Maintenance Phase|Physician Decision|0|||
170896854|NCT00896532|617628602|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896855|NCT00896532|617628603|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896856|NCT00896532|617628604|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896857|NCT00896532|617628605|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
170896858|NCT00896532|617628583|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896859|NCT00896532|617628584|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170640076|NCT02100696|616693811|FG003|Maintenance Phase|Physician Decision|0|||
170640077|NCT02100696|616693812|FG004|Maintenance Phase|Physician Decision|1|||
170640078|NCT02100696|616693813|FG005|Maintenance Phase|Physician Decision|0|||
170640079|NCT02100696|616693808|FG000|Maintenance Phase|Multiple Reasons|0|||
170640080|NCT02100696|616693809|FG001|Maintenance Phase|Multiple Reasons|0|||
170640081|NCT02100696|616693810|FG002|Maintenance Phase|Multiple Reasons|0|||
170640082|NCT02100696|616693811|FG003|Maintenance Phase|Multiple Reasons|0|||
170640083|NCT02100696|616693812|FG004|Maintenance Phase|Multiple Reasons|2|||
170640084|NCT02100696|616693813|FG005|Maintenance Phase|Multiple Reasons|1|||
170640085|NCT04476797|616693814|FG000|Overall Study|Withdrawal by Subject|1|||
170896860|NCT00896532|617628585|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896861|NCT00896532|617628586|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896862|NCT00896532|617628587|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896863|NCT00896532|617628588|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896864|NCT00896532|617628589|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896865|NCT00896532|617628590|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896866|NCT00896532|617628591|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
170896867|NCT00896532|617628592|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170640086|NCT04476797|616693815|FG001|Overall Study|Withdrawal by Subject|0|||
170640087|NCT04476797|616693816|FG002|Overall Study|Withdrawal by Subject|0|||
170896868|NCT00896532|617628593|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896869|NCT00896532|617628594|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896870|NCT00896532|617628595|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896871|NCT00896532|617628596|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896872|NCT00896532|617628597|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896873|NCT00896532|617628598|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896874|NCT00896532|617628599|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170481986|NCT01379768|616105601|FG000|Overall Study|Adverse Event|1|||
170481987|NCT01379768|616105602|FG001|Overall Study|Adverse Event|1|||
170481988|NCT01379768|616105603|FG002|Overall Study|Adverse Event|0|||
170481989|NCT01379768|616105601|FG000|Overall Study|Lost to Follow-up|2|||
170481990|NCT01379768|616105602|FG001|Overall Study|Lost to Follow-up|0|||
170481991|NCT01379768|616105603|FG002|Overall Study|Lost to Follow-up|0|||
170481992|NCT02393950|616105604|FG000|Overall Study|Adverse Event|1|||
170481993|NCT02393950|616105605|FG001|Overall Study|Adverse Event|0|||
170640088|NCT04476797|616693814|FG000|Overall Study|Death|0|||
170640089|NCT04476797|616693815|FG001|Overall Study|Death|1|||
170797021|NCT04629339|617269000|FG001|Overall Study|Withdrawal by Subject|0|||
170797022|NCT04629339|617269001|FG002|Overall Study|Withdrawal by Subject|2|||
170797023|NCT04629339|617269002|FG003|Overall Study|Withdrawal by Subject|2|||
170797024|NCT04629339|617269003|FG004|Overall Study|Withdrawal by Subject|0|||
170797025|NCT01121588|617269008|FG000|Overall Study|Death|5|||
170797026|NCT01121588|617269009|FG001|Overall Study|Death|3|||
170797027|NCT01121588|617269010|FG002|Overall Study|Death|13|||
170797028|NCT01121588|617269008|FG000|Overall Study|Study Terminated by Sponsor|1|||
170481994|NCT02393950|616105604|FG000|Overall Study|Withdrawal by Subject|0|||
170481995|NCT02393950|616105605|FG001|Overall Study|Withdrawal by Subject|1|||
170481996|NCT05486091|616105606|FG000|Overall Study|Withdrawal by Subject|1|||
170481997|NCT05486091|616105606|FG000|Overall Study|Lost to Follow-up|2|||
170896875|NCT00896532|617628600|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896876|NCT00896532|617628601|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896877|NCT00896532|617628602|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896878|NCT00896532|617628603|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896879|NCT00896532|617628604|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896880|NCT00896532|617628605|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
170896881|NCT00896532|617628583|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896882|NCT00896532|617628584|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896883|NCT00896532|617628585|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896884|NCT00896532|617628586|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896885|NCT00896532|617628587|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896886|NCT00896532|617628588|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896887|NCT00896532|617628589|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896888|NCT00896532|617628590|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896889|NCT00896532|617628591|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896890|NCT00896532|617628592|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896891|NCT00896532|617628593|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896892|NCT00896532|617628594|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896893|NCT00896532|617628595|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
170896894|NCT00896532|617628596|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896895|NCT00896532|617628597|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896896|NCT00896532|617628598|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896897|NCT00896532|617628599|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896898|NCT00896532|617628600|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896899|NCT00896532|617628601|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896900|NCT00896532|617628602|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896901|NCT00896532|617628603|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896902|NCT00896532|617628604|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896903|NCT00896532|617628605|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
170896904|NCT00896532|617628583|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896905|NCT00896532|617628584|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896906|NCT00896532|617628585|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896907|NCT00896532|617628586|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896908|NCT00896532|617628587|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896909|NCT00896532|617628588|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896910|NCT00896532|617628589|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896911|NCT00896532|617628590|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896912|NCT00896532|617628591|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896913|NCT00896532|617628592|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896914|NCT00896532|617628593|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
170896915|NCT00896532|617628594|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896916|NCT00896532|617628595|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
170896917|NCT00896532|617628596|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896918|NCT00896532|617628597|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896919|NCT00896532|617628598|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896920|NCT00896532|617628599|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896921|NCT00896532|617628600|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896922|NCT00896532|617628601|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896923|NCT00896532|617628602|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896924|NCT00896532|617628603|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896925|NCT00896532|617628604|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896926|NCT00896532|617628605|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
170896927|NCT00896532|617628583|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896928|NCT00896532|617628584|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896929|NCT00896532|617628585|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896930|NCT00896532|617628586|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896931|NCT00896532|617628587|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896932|NCT00896532|617628588|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896933|NCT00896532|617628589|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896934|NCT00896532|617628590|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896935|NCT00896532|617628591|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896936|NCT00896532|617628592|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896937|NCT00896532|617628593|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170548281|NCT05061706|616352090|FG001|Overall Study|Lack of Efficacy|1|||
170548282|NCT05061706|616352089|FG000|Overall Study|Lost to Follow-up|2|||
170548283|NCT05061706|616352090|FG001|Overall Study|Lost to Follow-up|2|||
170548284|NCT05061706|616352089|FG000|Overall Study|Protocol Violation|3|||
170548285|NCT05061706|616352090|FG001|Overall Study|Protocol Violation|1|||
170548286|NCT05061706|616352089|FG000|Overall Study|Withdrawal by Subject|3|||
170548287|NCT05061706|616352090|FG001|Overall Study|Withdrawal by Subject|9|||
170548288|NCT00601107|616352100|FG000|Overall Study|Adverse Event|0|||
170548289|NCT00601107|616352101|FG001|Overall Study|Adverse Event|1|||
170548290|NCT00601107|616352102|FG002|Overall Study|Adverse Event|3|||
170548291|NCT00601107|616352103|FG003|Overall Study|Adverse Event|0|||
170548292|NCT00601107|616352100|FG000|Overall Study|Withdrawal by Subject|5|||
170548293|NCT00601107|616352101|FG001|Overall Study|Withdrawal by Subject|4|||
170548294|NCT00601107|616352102|FG002|Overall Study|Withdrawal by Subject|7|||
170548295|NCT00601107|616352103|FG003|Overall Study|Withdrawal by Subject|4|||
170548296|NCT00601107|616352100|FG000|Overall Study|Lost to Follow-up|3|||
170548297|NCT00601107|616352101|FG001|Overall Study|Lost to Follow-up|3|||
170548298|NCT00601107|616352102|FG002|Overall Study|Lost to Follow-up|0|||
170548299|NCT00601107|616352103|FG003|Overall Study|Lost to Follow-up|3|||
170548300|NCT00601107|616352100|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
170548301|NCT00601107|616352101|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
170548302|NCT00601107|616352102|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
170548303|NCT00601107|616352103|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
170548304|NCT00601107|616352100|FG000|Overall Study|Worsening of Psoriasis|4|||
170548305|NCT00601107|616352101|FG001|Overall Study|Worsening of Psoriasis|1|||
170548306|NCT00601107|616352102|FG002|Overall Study|Worsening of Psoriasis|1|||
170548307|NCT00601107|616352103|FG003|Overall Study|Worsening of Psoriasis|4|||
170548308|NCT00601107|616352100|FG000|Overall Study|Undefined|1|||
170548309|NCT00601107|616352101|FG001|Overall Study|Undefined|0|||
170548310|NCT00601107|616352102|FG002|Overall Study|Undefined|1|||
170548311|NCT00601107|616352103|FG003|Overall Study|Undefined|0|||
170548312|NCT03892915|616352104|FG000|Overall Study|Lost to Follow-up|6|||
170548313|NCT03892915|616352105|FG001|Overall Study|Lost to Follow-up|12|||
170548314|NCT03892915|616352104|FG000|Overall Study|Death|0|||
170548315|NCT03892915|616352105|FG001|Overall Study|Death|2|||
170548316|NCT03892915|616352104|FG000|Overall Study|Withdrawal by Subject|1|||
170548317|NCT03892915|616352105|FG001|Overall Study|Withdrawal by Subject|1|||
170548318|NCT03892915|616352104|FG000|Overall Study|unsuccessful delivery|13|||
170548319|NCT03892915|616352105|FG001|Overall Study|unsuccessful delivery|18|||
170548320|NCT00191152|616352107|FG000|Initial Treatment|Adverse Event|43|||
170548321|NCT00191152|616352108|FG001|Initial Treatment|Adverse Event|67|||
170548322|NCT00191152|616352107|FG000|Initial Treatment|Physician Decision|40|||
170548323|NCT00191152|616352108|FG001|Initial Treatment|Physician Decision|31|||
170548324|NCT00191152|616352107|FG000|Initial Treatment|Withdrawal by Subject|40|||
170548325|NCT00191152|616352108|FG001|Initial Treatment|Withdrawal by Subject|28|||
170548326|NCT00191152|616352107|FG000|Initial Treatment|Lost to Follow-up|0|||
170548327|NCT00191152|616352108|FG001|Initial Treatment|Lost to Follow-up|6|||
170548328|NCT00191152|616352107|FG000|Initial Treatment|Other|18|||
170797029|NCT01121588|617269009|FG001|Overall Study|Study Terminated by Sponsor|1|||
170797030|NCT01121588|617269010|FG002|Overall Study|Study Terminated by Sponsor|0|||
170797031|NCT01121588|617269008|FG000|Overall Study|Participant Refused Further Followup|2|||
170797032|NCT01121588|617269009|FG001|Overall Study|Participant Refused Further Followup|0|||
170797033|NCT01121588|617269010|FG002|Overall Study|Participant Refused Further Followup|2|||
170797034|NCT01121588|617269008|FG000|Overall Study|Lost to Follow-up|0|||
170797035|NCT01121588|617269009|FG001|Overall Study|Lost to Follow-up|1|||
170797036|NCT01121588|617269010|FG002|Overall Study|Lost to Follow-up|1|||
170797037|NCT01121588|617269008|FG000|Overall Study|Non-Specified Reasons|9|||
170797038|NCT01121588|617269009|FG001|Overall Study|Non-Specified Reasons|4|||
170548329|NCT00191152|616352108|FG001|Initial Treatment|Other|21|||
170548330|NCT00191152|616352107|FG000|Crossover Treatment|Adverse Event|8|||
170548331|NCT00191152|616352108|FG001|Crossover Treatment|Adverse Event|8|||
170548332|NCT00191152|616352107|FG000|Crossover Treatment|Physician Decision|7|||
170548333|NCT00191152|616352108|FG001|Crossover Treatment|Physician Decision|7|||
170548334|NCT00191152|616352107|FG000|Crossover Treatment|Withdrawal by Subject|6|||
170548335|NCT00191152|616352108|FG001|Crossover Treatment|Withdrawal by Subject|9|||
170548336|NCT00191152|616352107|FG000|Crossover Treatment|Lost to Follow-up|2|||
170548337|NCT00191152|616352108|FG001|Crossover Treatment|Lost to Follow-up|1|||
170548338|NCT00191152|616352107|FG000|Crossover Treatment|Other|4|||
170548339|NCT00191152|616352108|FG001|Crossover Treatment|Other|3|||
170548340|NCT01181128|616352110|FG000|Overall Study|Withdrawal by Subject|2|||
170548341|NCT01181128|616352111|FG001|Overall Study|Withdrawal by Subject|2|||
170797039|NCT01121588|617269010|FG002|Overall Study|Non-Specified Reasons|2|||
170797040|NCT00942877|617269011|FG000|Overall Study|Refused further treatment|1|||
170797041|NCT00942877|617269012|FG001|Overall Study|Refused further treatment|1|||
170548342|NCT01181128|616352112|FG002|Overall Study|Withdrawal by Subject|0|||
170548343|NCT01181128|616352110|FG000|Overall Study|Death|1|||
170548344|NCT01181128|616352111|FG001|Overall Study|Death|0|||
170548345|NCT01181128|616352112|FG002|Overall Study|Death|0|||
170797042|NCT00942877|617269011|FG000|Overall Study|Patient was not treated|1|||
170797043|NCT00942877|617269012|FG001|Overall Study|Patient was not treated|0|||
170797044|NCT00942877|617269011|FG000|Overall Study|Adverse Event|1|||
170797045|NCT00942877|617269012|FG001|Overall Study|Adverse Event|0|||
170797046|NCT00942877|617269011|FG000|Overall Study|Progressive disease|42|||
170797047|NCT00942877|617269012|FG001|Overall Study|Progressive disease|3|||
170797048|NCT02944968|617269013|FG000|Overall Study|Subject excluded before study procedure|1|||
170797049|NCT02944968|617269013|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
170797050|NCT02905331|617269014|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
170797051|NCT02905331|617269015|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
170797052|NCT02905331|617269016|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
170797053|NCT02905331|617269014|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
170797054|NCT02905331|617269015|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
170797055|NCT02905331|617269016|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
170797056|NCT02905331|617269014|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
170797057|NCT02905331|617269015|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
170797058|NCT02905331|617269016|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
170797059|NCT02905331|617269014|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
170797060|NCT02905331|617269015|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
170797061|NCT02905331|617269016|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
170797062|NCT02905331|617269014|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
170797063|NCT02905331|617269015|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
170797064|NCT02905331|617269016|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
170797065|NCT04102111|617269018|FG000|Overall Study|Withdrawal by Subject|2|||
170797066|NCT04102111|617269019|FG001|Overall Study|Withdrawal by Subject|3|||
170797067|NCT04102111|617269018|FG000|Overall Study|Adverse Event|1|||
170797068|NCT04102111|617269019|FG001|Overall Study|Adverse Event|1|||
170797069|NCT04102111|617269018|FG000|Overall Study|Study terminated by sponsor|1|||
170797070|NCT04102111|617269019|FG001|Overall Study|Study terminated by sponsor|3|||
170797071|NCT02542631|617269020|FG000|Overall Study|Adverse Event|1|||
170797072|NCT02542631|617269021|FG001|Overall Study|Adverse Event|1|||
170797073|NCT02542631|617269020|FG000|Overall Study|Sponsor Termination|1|||
170797074|NCT02542631|617269021|FG001|Overall Study|Sponsor Termination|0|||
170797075|NCT02542631|617269020|FG000|Overall Study|Withdrawal by Subject|11|||
170797076|NCT02542631|617269021|FG001|Overall Study|Withdrawal by Subject|16|||
170797077|NCT02542631|617269020|FG000|Overall Study|Protocol Violation|1|||
170797078|NCT02542631|617269021|FG001|Overall Study|Protocol Violation|1|||
170797079|NCT02542631|617269020|FG000|Overall Study|Physician Decision|6|||
170797080|NCT02542631|617269021|FG001|Overall Study|Physician Decision|4|||
170797081|NCT02542631|617269020|FG000|Overall Study|Lost to Follow-up|6|||
170797082|NCT02542631|617269021|FG001|Overall Study|Lost to Follow-up|5|||
170797083|NCT02542631|617269020|FG000|Overall Study|Death|1|||
170797084|NCT02542631|617269021|FG001|Overall Study|Death|2|||
170797085|NCT02542631|617269020|FG000|Overall Study|Other|2|||
170797086|NCT02542631|617269021|FG001|Overall Study|Other|1|||
170797087|NCT02542631|617269020|FG000|Overall Study|Used Prohibited Medication|2|||
170797088|NCT02542631|617269021|FG001|Overall Study|Used Prohibited Medication|1|||
170797089|NCT02641730|617269022|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
170797090|NCT02641730|617269023|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
170797091|NCT02641730|617269024|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
170797092|NCT02641730|617269025|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
170797093|NCT02641730|617269026|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
170797094|NCT02641730|617269022|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
170797095|NCT02641730|617269023|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
170797096|NCT02641730|617269024|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
170797097|NCT02641730|617269025|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
170797098|NCT02641730|617269026|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
170797099|NCT02641730|617269022|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
170797100|NCT02641730|617269023|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
170797101|NCT02641730|617269024|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
170797102|NCT02641730|617269025|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
170797103|NCT02641730|617269026|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
170797104|NCT02641730|617269022|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
170797105|NCT02641730|617269023|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
170797106|NCT02641730|617269024|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
170797107|NCT02641730|617269025|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
170797108|NCT02641730|617269026|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
170797109|NCT02641730|617269022|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
170797110|NCT02641730|617269023|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
170797111|NCT02641730|617269024|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
170797112|NCT02641730|617269025|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
170797113|NCT02641730|617269026|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
170797114|NCT02641730|617269022|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
170797115|NCT02641730|617269023|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
170797116|NCT02641730|617269024|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
170797117|NCT02641730|617269025|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
170797118|NCT02641730|617269026|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
170797119|NCT05007080|617269027|FG000|Overall Study|Lost to Follow-up|0|||
170797120|NCT05007080|617269028|FG001|Overall Study|Lost to Follow-up|1|||
170797121|NCT05007080|617269029|FG002|Overall Study|Lost to Follow-up|0|||
170797122|NCT05007080|617269030|FG003|Overall Study|Lost to Follow-up|1|||
170797123|NCT05007080|617269031|FG004|Overall Study|Lost to Follow-up|1|||
170797124|NCT05007080|617269032|FG005|Overall Study|Lost to Follow-up|1|||
170797125|NCT05007080|617269027|FG000|Overall Study|Death|0|||
170797126|NCT05007080|617269028|FG001|Overall Study|Death|1|||
170797127|NCT05007080|617269029|FG002|Overall Study|Death|0|||
170797128|NCT05007080|617269030|FG003|Overall Study|Death|0|||
170797129|NCT05007080|617269031|FG004|Overall Study|Death|0|||
170797130|NCT05007080|617269032|FG005|Overall Study|Death|0|||
170797131|NCT05007080|617269027|FG000|Overall Study|Withdrawal by Subject|1|||
170797132|NCT05007080|617269028|FG001|Overall Study|Withdrawal by Subject|2|||
170797133|NCT05007080|617269029|FG002|Overall Study|Withdrawal by Subject|0|||
170797134|NCT05007080|617269030|FG003|Overall Study|Withdrawal by Subject|2|||
170797135|NCT05007080|617269031|FG004|Overall Study|Withdrawal by Subject|1|||
170797136|NCT05007080|617269032|FG005|Overall Study|Withdrawal by Subject|1|||
170797137|NCT05007080|617269027|FG000|Overall Study|Other|1|||
170797138|NCT05007080|617269028|FG001|Overall Study|Other|0|||
170797139|NCT05007080|617269029|FG002|Overall Study|Other|1|||
170797140|NCT05007080|617269030|FG003|Overall Study|Other|1|||
170797141|NCT05007080|617269031|FG004|Overall Study|Other|0|||
170797142|NCT05007080|617269032|FG005|Overall Study|Other|2|||
170797143|NCT05007080|617269027|FG000|Overall Study|Randomized not vaccinated|0|||
170797144|NCT05007080|617269028|FG001|Overall Study|Randomized not vaccinated|0|||
170797145|NCT05007080|617269029|FG002|Overall Study|Randomized not vaccinated|0|||
170797146|NCT05007080|617269030|FG003|Overall Study|Randomized not vaccinated|0|||
170797147|NCT05007080|617269031|FG004|Overall Study|Randomized not vaccinated|0|||
170797148|NCT05007080|617269032|FG005|Overall Study|Randomized not vaccinated|1|||
170797149|NCT04583280|617269034|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
170797150|NCT04583280|617269035|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
170797151|NCT04967599|617269043|FG000|Overall Study|Lost to Follow-up|35|||
170797152|NCT04967599|617269044|FG001|Overall Study|Lost to Follow-up|19|||
170797153|NCT04967599|617269045|FG002|Overall Study|Lost to Follow-up|23|||
170797154|NCT05741294|617269046|FG000|Overall Study|Lost to Follow-up|3|||
170797155|NCT05741294|617269046|FG000|Overall Study|Protocol deviation|3|||
170797156|NCT05741294|617269046|FG000|Overall Study|Withdrawal by Subject|1|||
170797157|NCT03817983|617269051|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
170797158|NCT03817983|617269052|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
170797159|NCT03817983|617269053|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
170797160|NCT04108130|617269956|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
170797161|NCT04108130|617269957|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
170797162|NCT04108130|617269956|FG000|Overall Study|Consent Withdrawn|9|||
170797163|NCT04108130|617269957|FG001|Overall Study|Consent Withdrawn|6|||
170797164|NCT04108130|617269956|FG000|Overall Study|Surgery Cancelled|4|||
170797165|NCT04108130|617269957|FG001|Overall Study|Surgery Cancelled|4|||
170797166|NCT04108130|617269956|FG000|Overall Study|Found Ineligible for Study|4|||
170797167|NCT04108130|617269957|FG001|Overall Study|Found Ineligible for Study|3|||
170797168|NCT04108130|617269956|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
170797169|NCT04108130|617269957|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
170797170|NCT04108130|617269956|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
170797171|NCT04108130|617269957|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
170797172|NCT05132400|617269958|FG000|Overall Study|Withdrawal by Subject|14|||
170797173|NCT05132400|617269959|FG001|Overall Study|Withdrawal by Subject|8|||
170797174|NCT05132400|617269958|FG000|Overall Study|Lost to Follow-up|132|||
170797175|NCT05132400|617269959|FG001|Overall Study|Lost to Follow-up|121|||
170797176|NCT03636490|617269964|FG000|Overall Study|Dropped out or incomplete data|141|||
170797177|NCT04165213|617269972|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
170797178|NCT04165213|617269973|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
170797179|NCT04165213|617269972|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
170797180|NCT04165213|617269973|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
170797181|NCT04165213|617269972|FG000|Clinician Enrollment|Termination from site|0|||
170797182|NCT04165213|617269973|FG001|Clinician Enrollment|Termination from site|1|||
170797183|NCT04165213|617269972|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
170797184|NCT04165213|617269973|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
170797185|NCT04165213|617269972|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
170797186|NCT04165213|617269973|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
170797187|NCT04165213|617269972|FG000|Caregiver Enrollment|Physician Decision|1|||
170797188|NCT04165213|617269973|FG001|Caregiver Enrollment|Physician Decision|0|||
170896938|NCT00896532|617628594|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896939|NCT00896532|617628595|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
170896940|NCT00896532|617628596|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
170896941|NCT00896532|617628597|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896942|NCT00896532|617628598|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896943|NCT00896532|617628599|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896944|NCT00896532|617628600|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896945|NCT00896532|617628601|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896946|NCT00896532|617628602|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896947|NCT00896532|617628603|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896948|NCT00896532|617628604|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896949|NCT00896532|617628605|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
170896950|NCT00896532|617628583|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
170896951|NCT00896532|617628584|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
170896952|NCT00896532|617628585|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
170896953|NCT00896532|617628586|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
170896954|NCT00896532|617628587|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
170896955|NCT00896532|617628588|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
170896956|NCT00896532|617628589|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
170896957|NCT00896532|617628590|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
170896958|NCT00896532|617628591|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
170896959|NCT00896532|617628592|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
170896960|NCT00896532|617628593|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
170896961|NCT00896532|617628594|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
170896962|NCT00896532|617628595|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
170896963|NCT00896532|617628596|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
170896964|NCT00896532|617628597|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
170896965|NCT00896532|617628598|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
170896966|NCT00896532|617628599|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
170896967|NCT00896532|617628600|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
170896968|NCT00896532|617628601|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
170896969|NCT00896532|617628602|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
170896970|NCT00896532|617628603|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
170896971|NCT00896532|617628604|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
170896972|NCT00896532|617628605|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
170896973|NCT00896532|617628583|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896974|NCT00896532|617628584|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896975|NCT00896532|617628585|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896976|NCT00896532|617628586|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896977|NCT00896532|617628587|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896978|NCT00896532|617628588|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896979|NCT00896532|617628589|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896980|NCT00896532|617628590|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896981|NCT00896532|617628591|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896982|NCT00896532|617628592|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896983|NCT00896532|617628593|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896984|NCT00896532|617628594|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896985|NCT00896532|617628595|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896986|NCT00896532|617628596|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896987|NCT00896532|617628597|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896988|NCT00896532|617628598|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
170896989|NCT00896532|617628599|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
170896990|NCT00896532|617628600|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896991|NCT00896532|617628601|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896992|NCT00896532|617628602|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170481998|NCT03334435|616105607|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
170481999|NCT03334435|616105608|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
170896993|NCT00896532|617628603|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896994|NCT00896532|617628604|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170482000|NCT03334435|616105609|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
170548346|NCT01181128|616352110|FG000|Overall Study|Physician Decision|2|||
170797189|NCT04165213|617269972|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
170797190|NCT04165213|617269973|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
170797191|NCT04165213|617269972|FG000|Caregiver Enrollment|PLWD death|2|||
170797192|NCT04165213|617269973|FG001|Caregiver Enrollment|PLWD death|0|||
170797193|NCT04165213|617269972|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
170797194|NCT04165213|617269973|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
170797195|NCT04165213|617269972|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
170797196|NCT04165213|617269973|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
170797197|NCT04165213|617269972|FG000|PLWD Enrollment|Lost to Follow-up|1|||
170797198|NCT04165213|617269973|FG001|PLWD Enrollment|Lost to Follow-up|1|||
170797199|NCT04165213|617269972|FG000|PLWD Enrollment|Physician Decision|1|||
170797200|NCT04165213|617269973|FG001|PLWD Enrollment|Physician Decision|0|||
170797201|NCT04165213|617269972|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
170797202|NCT04165213|617269973|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
170797203|NCT04165213|617269972|FG000|PLWD Enrollment|Death|2|||
170797204|NCT04165213|617269973|FG001|PLWD Enrollment|Death|0|||
170797205|NCT04165213|617269972|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
170797206|NCT04165213|617269973|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
170797207|NCT04804540|617269978|FG000|Overall Study|Adverse Event|26|||
170797208|NCT04804540|617269979|FG001|Overall Study|Adverse Event|13|||
170797209|NCT05172232|617269980|FG000|Overall Study|Lost to Follow-up|3|||
170797210|NCT01828021|617269981|FG000|Overall Study|Adverse Event|5|||
170797211|NCT01828021|617269981|FG000|Overall Study|Lack of Efficacy|17|||
170797212|NCT01828021|617269981|FG000|Overall Study|Withdrawal by Subject|2|||
170797213|NCT01828021|617269981|FG000|Overall Study|Ileal obstruction, unrelated|1|||
170797214|NCT02473445|617269983|FG000|Overall Study|Withdrawal by Subject|2|||
170797215|NCT02473445|617269983|FG000|Overall Study|Sponsor Decision|20|||
170797216|NCT04881461|617269984|FG000|Overall Study|Adverse Event|2|||
170797217|NCT04881461|617269985|FG001|Overall Study|Adverse Event|4|||
170797218|NCT04881461|617269984|FG000|Overall Study|Withdrawal by Subject|19|||
170797219|NCT04881461|617269985|FG001|Overall Study|Withdrawal by Subject|19|||
170797220|NCT04881461|617269984|FG000|Overall Study|Lost to Follow-up|4|||
170797221|NCT04881461|617269985|FG001|Overall Study|Lost to Follow-up|4|||
170797222|NCT04881461|617269984|FG000|Overall Study|Lack of Efficacy|1|||
170797223|NCT04881461|617269985|FG001|Overall Study|Lack of Efficacy|0|||
170797224|NCT04881461|617269984|FG000|Overall Study|"Reason stated as other in CRF"|1|||
170797225|NCT04881461|617269985|FG001|Overall Study|"Reason stated as other in CRF"|2|||
170797226|NCT04778410|617269992|FG000|Safety Run-in Period|Death|5|||
170797227|NCT04778410|617269993|FG001|Safety Run-in Period|Death|6|||
170797228|NCT04778410|617269994|FG002|Safety Run-in Period|Death|0|||
170797229|NCT04778410|617269995|FG003|Safety Run-in Period|Death|0|||
170797230|NCT04778410|617269996|FG004|Safety Run-in Period|Death|0|||
170797231|NCT04778410|617269997|FG005|Safety Run-in Period|Death|0|||
170797232|NCT04778410|617269992|FG000|Phase 2 Period|Death|0|||
170797233|NCT04778410|617269993|FG001|Phase 2 Period|Death|0|||
170797234|NCT04778410|617269994|FG002|Phase 2 Period|Death|0|||
170797235|NCT04778410|617269995|FG003|Phase 2 Period|Death|5|||
170797236|NCT04778410|617269996|FG004|Phase 2 Period|Death|18|||
170797237|NCT04778410|617269997|FG005|Phase 2 Period|Death|0|||
170797238|NCT04778410|617269992|FG000|Phase 2 Period|Lost to Follow-up|0|||
170797239|NCT04778410|617269993|FG001|Phase 2 Period|Lost to Follow-up|0|||
170797240|NCT04778410|617269994|FG002|Phase 2 Period|Lost to Follow-up|0|||
170797241|NCT04778410|617269995|FG003|Phase 2 Period|Lost to Follow-up|1|||
170797242|NCT04778410|617269996|FG004|Phase 2 Period|Lost to Follow-up|1|||
170797243|NCT04778410|617269997|FG005|Phase 2 Period|Lost to Follow-up|0|||
170797244|NCT04778410|617269992|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
170797245|NCT04778410|617269993|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
170797246|NCT04778410|617269994|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
170797247|NCT04778410|617269995|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
170797248|NCT04778410|617269996|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
170797249|NCT04778410|617269997|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
170797250|NCT04778410|617269992|FG000|Phase 2 Period|Withdrew Consent|0|||
170797251|NCT04778410|617269993|FG001|Phase 2 Period|Withdrew Consent|0|||
170797252|NCT04778410|617269994|FG002|Phase 2 Period|Withdrew Consent|0|||
170548347|NCT01181128|616352111|FG001|Overall Study|Physician Decision|0|||
170548348|NCT01181128|616352112|FG002|Overall Study|Physician Decision|0|||
170548349|NCT01181128|616352110|FG000|Overall Study|Adverse Event|0|||
170548350|NCT01181128|616352111|FG001|Overall Study|Adverse Event|2|||
170548351|NCT01181128|616352112|FG002|Overall Study|Adverse Event|0|||
170548352|NCT01181128|616352110|FG000|Overall Study|Other|1|||
170548353|NCT01181128|616352111|FG001|Overall Study|Other|1|||
170797253|NCT04778410|617269995|FG003|Phase 2 Period|Withdrew Consent|0|||
170797254|NCT04778410|617269996|FG004|Phase 2 Period|Withdrew Consent|2|||
170548354|NCT01181128|616352112|FG002|Overall Study|Other|1|||
170797255|NCT04778410|617269997|FG005|Phase 2 Period|Withdrew Consent|0|||
170797256|NCT05422885|617270000|FG000|Overall Study|Lost to Follow-up|1|||
170797257|NCT05422885|617270000|FG000|Overall Study|Withdrawal by Subject|2|||
170797258|NCT04084574|617270001|FG000|Overall Study|Lost to Follow-up|1|||
170797259|NCT04084574|617270002|FG001|Overall Study|Lost to Follow-up|0|||
170797260|NCT04084574|617270001|FG000|Overall Study|Physician Decision|1|||
170797261|NCT04084574|617270002|FG001|Overall Study|Physician Decision|0|||
170797262|NCT04084574|617270001|FG000|Overall Study|Relocated out of state|1|||
170797263|NCT04084574|617270002|FG001|Overall Study|Relocated out of state|0|||
170797264|NCT01385202|617270005|FG000|Overall Study|Lost to Follow-up|6|||
170797265|NCT01385202|617270005|FG000|Overall Study|Not Eligible|11|||
170797266|NCT01385202|617270005|FG000|Overall Study|Withdrawn|1|||
170797267|NCT02095691|617270006|FG000|Overall Study|Physician Decision|1|||
170797268|NCT03681262|617270007|FG000|Overall Study|Continuing on study|3|||
170797269|NCT03681262|617270008|FG001|Overall Study|Continuing on study|3|||
170797270|NCT03681262|617270007|FG000|Overall Study|Lost to Follow-up|1|||
170797271|NCT03681262|617270008|FG001|Overall Study|Lost to Follow-up|0|||
170797272|NCT00887198|617270009|FG000|Randomized Period|Ongoing|42|||
170797273|NCT00887198|617270010|FG001|Randomized Period|Ongoing|0|||
170797274|NCT00887198|617270011|FG002|Randomized Period|Ongoing|0|||
170797275|NCT00887198|617270009|FG000|Randomized Period|Adverse Event|50|||
170797276|NCT00887198|617270010|FG001|Randomized Period|Adverse Event|33|||
170797277|NCT00887198|617270011|FG002|Randomized Period|Adverse Event|0|||
170797278|NCT00887198|617270009|FG000|Randomized Period|Lost to Follow-up|1|||
170797279|NCT00887198|617270010|FG001|Randomized Period|Lost to Follow-up|0|||
170797280|NCT00887198|617270011|FG002|Randomized Period|Lost to Follow-up|0|||
170797281|NCT00887198|617270009|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
170797282|NCT00887198|617270010|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
170797283|NCT00887198|617270011|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
170797284|NCT00887198|617270009|FG000|Randomized Period|Withdrawal by Subject|41|||
170797285|NCT00887198|617270010|FG001|Randomized Period|Withdrawal by Subject|56|||
170797286|NCT00887198|617270011|FG002|Randomized Period|Withdrawal by Subject|0|||
170797287|NCT00887198|617270009|FG000|Randomized Period|Progressive disease|366|||
170797288|NCT00887198|617270010|FG001|Randomized Period|Progressive disease|370|||
170797289|NCT00887198|617270011|FG002|Randomized Period|Progressive disease|0|||
170797290|NCT00887198|617270009|FG000|Randomized Period|Other|42|||
170797291|NCT00887198|617270010|FG001|Randomized Period|Other|30|||
170797292|NCT00887198|617270011|FG002|Randomized Period|Other|0|||
170797293|NCT00887198|617270009|FG000|Randomized Period|Randomized, Not treated|4|||
170797294|NCT00887198|617270010|FG001|Randomized Period|Randomized, Not treated|2|||
170797295|NCT00887198|617270011|FG002|Randomized Period|Randomized, Not treated|0|||
170797296|NCT00887198|617270009|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
170797297|NCT00887198|617270010|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
170797298|NCT00887198|617270011|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
170797299|NCT00887198|617270009|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
170797300|NCT00887198|617270010|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
170797301|NCT00887198|617270011|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
170797302|NCT00887198|617270009|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
170797303|NCT00887198|617270010|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
170797304|NCT00887198|617270011|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
170797305|NCT00887198|617270009|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
170797306|NCT00887198|617270010|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
170797307|NCT00887198|617270011|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
170797308|NCT00887198|617270009|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
170797309|NCT00887198|617270010|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
170797310|NCT00887198|617270011|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
170797311|NCT00887198|617270009|FG000|Cross Over (Placebo to AA)|Other|0|||
170797312|NCT00887198|617270010|FG001|Cross Over (Placebo to AA)|Other|0|||
170797313|NCT00887198|617270011|FG002|Cross Over (Placebo to AA)|Other|19|||
170797314|NCT00303459|617270017|FG000|Overall Study|Death|33|||
170797315|NCT00303459|617270018|FG001|Overall Study|Death|44|||
170797316|NCT00303459|617270017|FG000|Overall Study|Withdrawal of consent|32|||
170797317|NCT00303459|617270018|FG001|Overall Study|Withdrawal of consent|26|||
170797318|NCT00303459|617270017|FG000|Overall Study|Lost to Follow-up|5|||
170797319|NCT00303459|617270018|FG001|Overall Study|Lost to Follow-up|4|||
170797320|NCT00303459|617270017|FG000|Overall Study|Administrative reason|7|||
170797321|NCT00303459|617270018|FG001|Overall Study|Administrative reason|7|||
170797322|NCT00303459|617270017|FG000|Overall Study|Decision by the investigator|5|||
170797323|NCT00303459|617270018|FG001|Overall Study|Decision by the investigator|7|||
170797324|NCT00303459|617270017|FG000|Overall Study|Lung transplantation|1|||
170797325|NCT00303459|617270018|FG001|Overall Study|Lung transplantation|1|||
170797326|NCT05830799|617270021|FG000|Overall Study|Withdrawal by Subject|1|||
170797327|NCT04631016|617270027|FG000|Overall Study|Adverse Event|3|||
170797328|NCT04631016|617270028|FG001|Overall Study|Adverse Event|0|||
170797329|NCT04631016|617270027|FG000|Overall Study|Withdrawal by Subject|5|||
170797330|NCT04631016|617270028|FG001|Overall Study|Withdrawal by Subject|4|||
170797331|NCT04631016|617270027|FG000|Overall Study|Reason unspecified|1|||
170797332|NCT04631016|617270028|FG001|Overall Study|Reason unspecified|0|||
170797333|NCT04631016|617270027|FG000|Overall Study|Failure to meet randomization criteria|2|||
170896995|NCT00896532|617628605|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
170896996|NCT00896532|617628583|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170896997|NCT00896532|617628584|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170896998|NCT00896532|617628585|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170896999|NCT00896532|617628586|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897000|NCT00896532|617628587|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897001|NCT00896532|617628588|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897002|NCT00896532|617628589|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897003|NCT00896532|617628590|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897004|NCT00896532|617628591|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897005|NCT00896532|617628592|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897006|NCT00896532|617628593|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897007|NCT00896532|617628594|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897008|NCT00896532|617628595|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897009|NCT00896532|617628596|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897010|NCT00896532|617628597|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897011|NCT00896532|617628598|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
170897012|NCT00896532|617628599|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
170897013|NCT00896532|617628600|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
170897014|NCT00896532|617628601|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897015|NCT00896532|617628602|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897016|NCT00896532|617628603|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897017|NCT00896532|617628604|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897018|NCT00896532|617628605|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
170897019|NCT00896532|617628583|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897020|NCT00896532|617628584|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897021|NCT00896532|617628585|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897022|NCT00896532|617628586|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897023|NCT00896532|617628587|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897024|NCT00896532|617628588|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897025|NCT00896532|617628589|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897026|NCT00896532|617628590|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897027|NCT00896532|617628591|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897028|NCT00896532|617628592|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897029|NCT00896532|617628593|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897030|NCT00896532|617628594|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897031|NCT00896532|617628595|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897032|NCT00896532|617628596|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897033|NCT00896532|617628597|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897034|NCT00896532|617628598|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897035|NCT00896532|617628599|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
170897036|NCT00896532|617628600|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897037|NCT00896532|617628601|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897038|NCT00896532|617628602|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897039|NCT00896532|617628603|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897040|NCT00896532|617628604|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897041|NCT00896532|617628605|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
170897042|NCT00896532|617628583|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
170897043|NCT00896532|617628584|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
170897044|NCT00896532|617628585|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
170897045|NCT00896532|617628586|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
170897046|NCT00896532|617628587|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
170897047|NCT00896532|617628588|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
170897048|NCT00896532|617628589|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
170897049|NCT00896532|617628590|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
170897050|NCT00896532|617628591|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
170897051|NCT00896532|617628592|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
170897052|NCT00896532|617628593|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
170897053|NCT00896532|617628594|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
170897054|NCT00896532|617628595|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
170897055|NCT00896532|617628596|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
170897056|NCT00896532|617628597|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
170897057|NCT00896532|617628598|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
170897058|NCT00896532|617628599|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
170897059|NCT00896532|617628600|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
170482001|NCT03334435|616105610|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
170482002|NCT03334435|616105611|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
170482003|NCT03334435|616105612|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170482004|NCT03334435|616105613|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170482005|NCT03334435|616105614|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170482006|NCT03334435|616105615|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170797334|NCT04631016|617270028|FG001|Overall Study|Failure to meet randomization criteria|1|||
170797335|NCT04109066|617270029|FG000|Pre-treatment|Participant withdrew consent|2|||
170797336|NCT04109066|617270030|FG001|Pre-treatment|Participant withdrew consent|0|||
170482007|NCT03334435|616105616|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170548355|NCT00421993|616352116|FG000|Overall Study|Withdrawal by Subject|22|||
170548356|NCT00421993|616352117|FG001|Overall Study|Withdrawal by Subject|23|||
170548357|NCT00421993|616352118|FG002|Overall Study|Withdrawal by Subject|23|||
170548358|NCT00421993|616352119|FG003|Overall Study|Withdrawal by Subject|24|||
170548359|NCT00421993|616352116|FG000|Overall Study|Lost to Follow-up|18|||
170548360|NCT00421993|616352117|FG001|Overall Study|Lost to Follow-up|19|||
170548361|NCT00421993|616352118|FG002|Overall Study|Lost to Follow-up|22|||
170548362|NCT00421993|616352119|FG003|Overall Study|Lost to Follow-up|20|||
170548363|NCT00421993|616352116|FG000|Overall Study|Adverse Event|11|||
170548364|NCT00421993|616352117|FG001|Overall Study|Adverse Event|1|||
170548365|NCT00421993|616352118|FG002|Overall Study|Adverse Event|6|||
170548366|NCT00421993|616352119|FG003|Overall Study|Adverse Event|4|||
170548367|NCT00421993|616352116|FG000|Overall Study|Protocol Violation|2|||
170548368|NCT00421993|616352117|FG001|Overall Study|Protocol Violation|2|||
170548369|NCT00421993|616352118|FG002|Overall Study|Protocol Violation|0|||
170548370|NCT00421993|616352119|FG003|Overall Study|Protocol Violation|1|||
170548371|NCT00421993|616352116|FG000|Overall Study|Lack of Efficacy|0|||
170548372|NCT00421993|616352117|FG001|Overall Study|Lack of Efficacy|3|||
170548373|NCT00421993|616352118|FG002|Overall Study|Lack of Efficacy|0|||
170548374|NCT00421993|616352119|FG003|Overall Study|Lack of Efficacy|5|||
170548375|NCT00421993|616352116|FG000|Overall Study|Pregnancy|0|||
170548376|NCT00421993|616352117|FG001|Overall Study|Pregnancy|1|||
170548377|NCT00421993|616352118|FG002|Overall Study|Pregnancy|1|||
170548378|NCT00421993|616352119|FG003|Overall Study|Pregnancy|2|||
170548379|NCT00421993|616352116|FG000|Overall Study|Subject transportation issues|0|||
170548380|NCT00421993|616352117|FG001|Overall Study|Subject transportation issues|0|||
170548381|NCT00421993|616352118|FG002|Overall Study|Subject transportation issues|0|||
170548382|NCT00421993|616352119|FG003|Overall Study|Subject transportation issues|1|||
170548383|NCT01751685|616352120|FG000|6-mo Followup|Missed study visit|1|||
170548384|NCT01751685|616352121|FG001|6-mo Followup|Missed study visit|0|||
170548385|NCT01751685|616352120|FG000|6-mo Followup|Withdrawal by Subject|2|||
170548386|NCT01751685|616352121|FG001|6-mo Followup|Withdrawal by Subject|2|||
170548387|NCT01751685|616352120|FG000|6-mo Followup|Lost to Follow-up|0|||
170548388|NCT01751685|616352121|FG001|6-mo Followup|Lost to Follow-up|1|||
170548389|NCT01751685|616352120|FG000|12-mo Followup|Lost to Follow-up|5|||
170548390|NCT01751685|616352121|FG001|12-mo Followup|Lost to Follow-up|0|||
170548391|NCT03601052|616352123|FG000|Overall Study|Lost to Follow-up|2|||
170548392|NCT02774278|616352124|FG000|Overall Study|Lack of Efficacy|199|||
170548393|NCT02774278|616352124|FG000|Overall Study|Death|29|||
170548394|NCT02774278|616352124|FG000|Overall Study|Adverse event/intercurrent illness|16|||
170797337|NCT04109066|617270029|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
170797338|NCT04109066|617270030|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
170797339|NCT04109066|617270029|FG000|Treatment|Lack of Efficacy|2|||
170797340|NCT04109066|617270030|FG001|Treatment|Lack of Efficacy|4|||
170797341|NCT04109066|617270029|FG000|Treatment|Adverse Event|23|||
170797342|NCT04109066|617270030|FG001|Treatment|Adverse Event|7|||
170797343|NCT04109066|617270029|FG000|Treatment|Participant request to discontinue Study treatment|15|||
170797344|NCT04109066|617270030|FG001|Treatment|Participant request to discontinue Study treatment|14|||
170548395|NCT02774278|616352124|FG000|Overall Study|Refused treatment/did not cooperate|9|||
170548396|NCT02774278|616352124|FG000|Overall Study|Administrative reasons|6|||
170548397|NCT02774278|616352124|FG000|Overall Study|Withdrawal by Subject|3|||
170548398|NCT02774278|616352124|FG000|Overall Study|Protocol Violation|2|||
170548399|NCT00694122|616352127|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
170548400|NCT00694122|616352128|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
170548401|NCT00694122|616352127|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
170548402|NCT00694122|616352128|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
170548403|NCT00694122|616352127|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
170548404|NCT00694122|616352128|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
170797345|NCT04109066|617270029|FG000|Treatment|Withdrawal by Subject|8|||
170797346|NCT04109066|617270030|FG001|Treatment|Withdrawal by Subject|8|||
170797347|NCT04109066|617270029|FG000|Treatment|Death|3|||
170797348|NCT04109066|617270030|FG001|Treatment|Death|0|||
170797349|NCT04109066|617270029|FG000|Treatment|Participant no longer meets study criteria|2|||
170797350|NCT04109066|617270030|FG001|Treatment|Participant no longer meets study criteria|2|||
170797351|NCT04109066|617270029|FG000|Treatment|Administrative reasons by sponsor|2|||
170797352|NCT04109066|617270030|FG001|Treatment|Administrative reasons by sponsor|3|||
170797353|NCT04109066|617270029|FG000|Treatment|Other reasons|17|||
170797354|NCT04109066|617270030|FG001|Treatment|Other reasons|23|||
170797355|NCT04109066|617270029|FG000|Treatment|Disease Progression|4|||
170797356|NCT04109066|617270030|FG001|Treatment|Disease Progression|7|||
170797357|NCT04109066|617270029|FG000|Treatment|Study drug toxicity|12|||
170797358|NCT04109066|617270030|FG001|Treatment|Study drug toxicity|5|||
170797359|NCT04109066|617270029|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
170797360|NCT04109066|617270030|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
170797361|NCT04109066|617270029|FG000|Treatment|Disease Recurrence|0|||
170797362|NCT04109066|617270030|FG001|Treatment|Disease Recurrence|2|||
170797363|NCT04109066|617270029|FG000|Treatment|Not reported|4|||
170797364|NCT04109066|617270030|FG001|Treatment|Not reported|8|||
170797365|NCT04707768|617270031|FG000|Overall Study|Adverse Event|9|||
170797366|NCT04707768|617270032|FG001|Overall Study|Adverse Event|18|||
170797367|NCT04707768|617270033|FG002|Overall Study|Adverse Event|3|||
170797368|NCT04707768|617270031|FG000|Overall Study|Investigator's Discretion|8|||
170797369|NCT04707768|617270032|FG001|Overall Study|Investigator's Discretion|4|||
170797370|NCT04707768|617270033|FG002|Overall Study|Investigator's Discretion|3|||
170797371|NCT04707768|617270031|FG000|Overall Study|Withdrawal by Subject|6|||
170797372|NCT04707768|617270032|FG001|Overall Study|Withdrawal by Subject|8|||
170797373|NCT04707768|617270033|FG002|Overall Study|Withdrawal by Subject|2|||
170797374|NCT04707768|617270031|FG000|Overall Study|Lack of Efficacy|1|||
170797375|NCT04707768|617270032|FG001|Overall Study|Lack of Efficacy|3|||
170797376|NCT04707768|617270033|FG002|Overall Study|Lack of Efficacy|0|||
170797377|NCT04707768|617270031|FG000|Overall Study|Lost to Follow-up|0|||
170797378|NCT04707768|617270032|FG001|Overall Study|Lost to Follow-up|0|||
170797379|NCT04707768|617270033|FG002|Overall Study|Lost to Follow-up|3|||
170797380|NCT04707768|617270031|FG000|Overall Study|Death|13|||
170797381|NCT04707768|617270032|FG001|Overall Study|Death|11|||
170797382|NCT04707768|617270033|FG002|Overall Study|Death|13|||
170797383|NCT04707768|617270031|FG000|Overall Study|Protocol Violation|2|||
170797384|NCT04707768|617270032|FG001|Overall Study|Protocol Violation|1|||
170797385|NCT04707768|617270033|FG002|Overall Study|Protocol Violation|0|||
170797386|NCT04707768|617270031|FG000|Overall Study|Non Compliance with Study Drug|1|||
170797387|NCT04707768|617270032|FG001|Overall Study|Non Compliance with Study Drug|0|||
170797388|NCT04707768|617270033|FG002|Overall Study|Non Compliance with Study Drug|0|||
170797389|NCT04707768|617270031|FG000|Overall Study|Transplant|4|||
170797390|NCT04707768|617270032|FG001|Overall Study|Transplant|4|||
170797391|NCT04707768|617270033|FG002|Overall Study|Transplant|8|||
170797392|NCT04707768|617270031|FG000|Overall Study|Other|9|||
170797393|NCT04707768|617270032|FG001|Overall Study|Other|5|||
170797394|NCT04707768|617270033|FG002|Overall Study|Other|2|||
170797395|NCT02510235|617270034|FG000|Overall Study|Withdrawal by Subject|1|||
170797396|NCT02510235|617270035|FG001|Overall Study|Withdrawal by Subject|0|||
170797397|NCT00450216|617270037|FG000|Overall Study|Adverse Event|38|||
170797398|NCT00450216|617270038|FG001|Overall Study|Adverse Event|23|||
170797399|NCT00450216|617270037|FG000|Overall Study|Withdrawal by Subject|48|||
170797400|NCT00450216|617270038|FG001|Overall Study|Withdrawal by Subject|26|||
170797401|NCT00450216|617270037|FG000|Overall Study|Lost to Follow-up|16|||
170797402|NCT00450216|617270038|FG001|Overall Study|Lost to Follow-up|9|||
170548405|NCT00683384|616352129|FG000|Overall Study|Death|1|||
170797403|NCT00450216|617270037|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
170797404|NCT00450216|617270038|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
170797405|NCT00450216|617270037|FG000|Overall Study|misc|21|||
170797406|NCT00450216|617270038|FG001|Overall Study|misc|20|||
170797407|NCT05541484|617270043|FG000|Overall Study|Withdrawal by Subject|1|||
170797408|NCT05541484|617270044|FG001|Overall Study|Withdrawal by Subject|0|||
170797409|NCT01756300|617270046|FG000|Overall Study|Death|1|||
170548406|NCT00683384|616352129|FG000|Overall Study|Adverse Event|1|||
170797410|NCT01756300|617270046|FG000|Overall Study|Withdrawal by Subject|1|||
170797411|NCT05157841|617271217|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
170797412|NCT05157841|617271218|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
170797413|NCT05157841|617271219|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
170797414|NCT05157841|617271217|FG000|Part A (14 Days)|Adverse Event|1|||
170548407|NCT01727154|616352131|FG000|Overall Study|Death|17|||
170797415|NCT05157841|617271218|FG001|Part A (14 Days)|Adverse Event|0|||
170797416|NCT05157841|617271219|FG002|Part A (14 Days)|Adverse Event|0|||
170797417|NCT05157841|617271217|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
170797418|NCT05157841|617271218|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
170797419|NCT05157841|617271219|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
170797420|NCT05988398|617271226|FG000|Overall Study|Lack of time|21|||
170897060|NCT00896532|617628601|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
170897061|NCT00896532|617628602|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
170897062|NCT00896532|617628603|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
170897063|NCT00896532|617628604|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
170897064|NCT00896532|617628605|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
170897065|NCT00896532|617628583|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897066|NCT00896532|617628584|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897067|NCT00896532|617628585|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897068|NCT00896532|617628586|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897069|NCT00896532|617628587|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897070|NCT00896532|617628588|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897071|NCT00896532|617628589|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897072|NCT00896532|617628590|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897073|NCT00896532|617628591|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897074|NCT00896532|617628592|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170482008|NCT03334435|616105617|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170482009|NCT03334435|616105618|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170482010|NCT03334435|616105619|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170482011|NCT03334435|616105620|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170482012|NCT03334435|616105621|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
170482013|NCT03334435|616105607|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
170482014|NCT03334435|616105608|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
170640090|NCT04476797|616693816|FG002|Overall Study|Death|2|||
170797421|NCT05988398|617271227|FG001|Overall Study|Lack of time|0|||
170797422|NCT05988398|617271226|FG000|Overall Study|Absent from school|0|||
170797423|NCT05988398|617271227|FG001|Overall Study|Absent from school|38|||
170797424|NCT05988398|617271226|FG000|Overall Study|Chose not to participate|0|||
170797425|NCT05988398|617271227|FG001|Overall Study|Chose not to participate|42|||
170797426|NCT05988398|617271226|FG000|Overall Study|Other commitments (e.g., sports)|0|||
170797427|NCT05988398|617271227|FG001|Overall Study|Other commitments (e.g., sports)|25|||
170797428|NCT06106022|617271230|FG000|Overall Study|Lost to Follow-up|1|||
170797429|NCT06106022|617271231|FG001|Overall Study|Lost to Follow-up|0|||
170797430|NCT06106022|617271230|FG000|Overall Study|Voluntary Withdrawal|0|||
170797431|NCT06106022|617271231|FG001|Overall Study|Voluntary Withdrawal|2|||
170797432|NCT04089865|617271232|FG000|Overall Study|Withdrawal by Subject|2|||
170797433|NCT04089865|617271233|FG001|Overall Study|Withdrawal by Subject|2|||
170797434|NCT04089865|617271234|FG002|Overall Study|Withdrawal by Subject|7|||
170797435|NCT04089865|617271235|FG003|Overall Study|Withdrawal by Subject|2|||
170797436|NCT02278211|617271237|FG000|Overall Study|Unable to analyse PET scan|2|||
170797437|NCT02909686|617271238|FG000|Overall Study|Physician Decision|3|||
170797438|NCT02909686|617271238|FG000|Overall Study|Withdrawal by Subject|2|||
170797439|NCT03733626|617271239|FG000|Overall Study|Physician Decision|4|||
170797440|NCT03733626|617271240|FG001|Overall Study|Physician Decision|4|||
170797441|NCT02997202|617271241|FG000|Overall Study|Miscellaneous|2|||
170797442|NCT02997202|617271242|FG001|Overall Study|Miscellaneous|2|||
170797443|NCT02997202|617271241|FG000|Overall Study|Withdrawal by Subject|8|||
170797444|NCT02997202|617271242|FG001|Overall Study|Withdrawal by Subject|12|||
170797445|NCT02997202|617271241|FG000|Overall Study|Lost to Follow-up|5|||
170797446|NCT02997202|617271242|FG001|Overall Study|Lost to Follow-up|3|||
170797447|NCT02997202|617271241|FG000|Overall Study|Death|41|||
170797448|NCT02997202|617271242|FG001|Overall Study|Death|45|||
170797449|NCT02782676|617271251|FG000|Overall Study|Lost to Follow-up|0|||
170797450|NCT02782676|617271252|FG001|Overall Study|Lost to Follow-up|1|||
170797451|NCT00964392|617271260|FG000|Overall Study|Withdrawal by Subject|4|||
170797452|NCT00964392|617271261|FG001|Overall Study|Withdrawal by Subject|6|||
170797453|NCT00964392|617271260|FG000|Overall Study|Lost to Follow-up|4|||
170797454|NCT00964392|617271261|FG001|Overall Study|Lost to Follow-up|10|||
170797455|NCT00964392|617271260|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
170797456|NCT00964392|617271261|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
170797457|NCT00964392|617271260|FG000|Overall Study|Not completed|44|||
170797458|NCT00964392|617271261|FG001|Overall Study|Not completed|168|||
170797459|NCT03370913|617271262|FG000|Overall Study|Death|1|||
170797460|NCT03370913|617271262|FG000|Overall Study|Lost to Follow-up|1|||
170797461|NCT04560179|617271265|FG000|Overall Study|Physician Decision|1|||
170797462|NCT04560179|617271266|FG001|Overall Study|Physician Decision|0|||
170797463|NCT04560179|617271267|FG002|Overall Study|Physician Decision|0|||
170797464|NCT04560179|617271268|FG003|Overall Study|Physician Decision|0|||
170797465|NCT04560179|617271269|FG004|Overall Study|Physician Decision|0|||
170797466|NCT04560179|617271265|FG000|Overall Study|Adverse Event|0|||
170897075|NCT00896532|617628593|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897076|NCT00896532|617628594|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897077|NCT00896532|617628595|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897078|NCT00896532|617628596|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897079|NCT00896532|617628597|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897080|NCT00896532|617628598|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897081|NCT00896532|617628599|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
170897082|NCT00896532|617628600|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897083|NCT00896532|617628601|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897084|NCT00896532|617628602|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897085|NCT00896532|617628603|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897086|NCT00896532|617628604|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897087|NCT00896532|617628605|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
170897088|NCT00896532|617628583|FG000|Months 48-72: Follow-on Phase|Death|0|||
170897089|NCT00896532|617628584|FG001|Months 48-72: Follow-on Phase|Death|0|||
170897090|NCT00896532|617628585|FG002|Months 48-72: Follow-on Phase|Death|0|||
170897091|NCT00896532|617628586|FG003|Months 48-72: Follow-on Phase|Death|0|||
170897092|NCT00896532|617628587|FG004|Months 48-72: Follow-on Phase|Death|0|||
170897093|NCT00896532|617628588|FG005|Months 48-72: Follow-on Phase|Death|0|||
170897094|NCT00896532|617628589|FG006|Months 48-72: Follow-on Phase|Death|0|||
170897095|NCT00896532|617628590|FG007|Months 48-72: Follow-on Phase|Death|0|||
170897096|NCT00896532|617628591|FG008|Months 48-72: Follow-on Phase|Death|0|||
170897097|NCT00896532|617628592|FG009|Months 48-72: Follow-on Phase|Death|0|||
170897098|NCT00896532|617628593|FG010|Months 48-72: Follow-on Phase|Death|0|||
170897099|NCT00896532|617628594|FG011|Months 48-72: Follow-on Phase|Death|0|||
170897100|NCT00896532|617628595|FG012|Months 48-72: Follow-on Phase|Death|0|||
170897101|NCT00896532|617628596|FG013|Months 48-72: Follow-on Phase|Death|0|||
170897102|NCT00896532|617628597|FG014|Months 48-72: Follow-on Phase|Death|0|||
170897103|NCT00896532|617628598|FG015|Months 48-72: Follow-on Phase|Death|0|||
170897104|NCT00896532|617628599|FG016|Months 48-72: Follow-on Phase|Death|0|||
170897105|NCT00896532|617628600|FG017|Months 48-72: Follow-on Phase|Death|0|||
170897106|NCT00896532|617628601|FG018|Months 48-72: Follow-on Phase|Death|1|||
170897107|NCT00896532|617628602|FG019|Months 48-72: Follow-on Phase|Death|0|||
170897108|NCT00896532|617628603|FG020|Months 48-72: Follow-on Phase|Death|0|||
170897109|NCT00896532|617628604|FG021|Months 48-72: Follow-on Phase|Death|0|||
170897110|NCT00896532|617628605|FG022|Months 48-72: Follow-on Phase|Death|0|||
170897111|NCT00896532|617628583|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897112|NCT00896532|617628584|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897113|NCT00896532|617628585|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897114|NCT00896532|617628586|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897115|NCT00896532|617628587|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170482015|NCT03334435|616105609|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
170482016|NCT03334435|616105610|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
170482017|NCT03334435|616105611|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
170482018|NCT03334435|616105612|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482019|NCT03334435|616105613|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482020|NCT03334435|616105614|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482021|NCT03334435|616105615|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482022|NCT03334435|616105616|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170548408|NCT01727154|616352131|FG000|Overall Study|Withdrawal by Subject|14|||
170797467|NCT04560179|617271266|FG001|Overall Study|Adverse Event|0|||
170797468|NCT04560179|617271267|FG002|Overall Study|Adverse Event|0|||
170797469|NCT04560179|617271268|FG003|Overall Study|Adverse Event|1|||
170797470|NCT04560179|617271269|FG004|Overall Study|Adverse Event|0|||
170797471|NCT04369911|617271271|FG000|Overall Study|Lost to Follow-up|3|||
170797472|NCT04369911|617271272|FG001|Overall Study|Lost to Follow-up|3|||
170797473|NCT04369911|617271271|FG000|Overall Study|Withdrawal by Subject|1|||
170797474|NCT04369911|617271272|FG001|Overall Study|Withdrawal by Subject|2|||
170797475|NCT04163991|617271273|FG000|Overall Study|Adverse Event|0|||
170797476|NCT04163991|617271274|FG001|Overall Study|Adverse Event|0|||
170797477|NCT04163991|617271275|FG002|Overall Study|Adverse Event|0|||
170897116|NCT00896532|617628588|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170548409|NCT01727154|616352131|FG000|Overall Study|Subject Withdrew Consent|18|||
170797478|NCT04163991|617271276|FG003|Overall Study|Adverse Event|1|||
170797479|NCT04163991|617271277|FG004|Overall Study|Adverse Event|0|||
170797480|NCT04163991|617271273|FG000|Overall Study|Death|0|||
170797481|NCT04163991|617271274|FG001|Overall Study|Death|0|||
170797482|NCT04163991|617271275|FG002|Overall Study|Death|1|||
170797483|NCT04163991|617271276|FG003|Overall Study|Death|0|||
170797484|NCT04163991|617271277|FG004|Overall Study|Death|0|||
170897117|NCT00896532|617628589|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897118|NCT00896532|617628590|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897119|NCT00896532|617628591|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897120|NCT00896532|617628592|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897121|NCT00896532|617628593|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897122|NCT00896532|617628594|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897123|NCT00896532|617628595|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897124|NCT00896532|617628596|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897125|NCT00896532|617628597|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897126|NCT00896532|617628598|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897127|NCT00896532|617628599|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897128|NCT00896532|617628600|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897129|NCT00896532|617628601|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897130|NCT00896532|617628602|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897131|NCT00896532|617628603|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897132|NCT00896532|617628604|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
170897133|NCT00896532|617628605|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
170897134|NCT00896532|617628583|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897135|NCT00896532|617628584|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897136|NCT00896532|617628585|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897137|NCT00896532|617628586|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897138|NCT00896532|617628587|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897139|NCT00896532|617628588|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897140|NCT00896532|617628589|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897141|NCT00896532|617628590|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897142|NCT00896532|617628591|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897143|NCT00896532|617628592|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897144|NCT00896532|617628593|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897145|NCT00896532|617628594|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897146|NCT00896532|617628595|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897147|NCT00896532|617628596|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897148|NCT00896532|617628597|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897149|NCT00896532|617628598|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897150|NCT00896532|617628599|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897151|NCT00896532|617628600|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897152|NCT00896532|617628601|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897153|NCT00896532|617628602|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897154|NCT00896532|617628603|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170482023|NCT03334435|616105617|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482024|NCT03334435|616105618|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482025|NCT03334435|616105619|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482026|NCT03334435|616105620|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482027|NCT03334435|616105621|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
170482028|NCT03334435|616105607|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
170482029|NCT03334435|616105608|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
170482030|NCT03334435|616105609|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
170482031|NCT03334435|616105610|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
170482032|NCT03334435|616105611|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
170482033|NCT03334435|616105612|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170482034|NCT03334435|616105613|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170482035|NCT03334435|616105614|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170897155|NCT00896532|617628604|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
170897156|NCT00896532|617628605|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
170897157|NCT01671280|617628606|FG000|Overall Study|Withdrawal by Subject|2|||
170897158|NCT00848120|617628607|FG000|Overall Study|Adverse Event|1|||
170897159|NCT00927563|617628627|FG000|Overall Study|Lost to Follow-up|1|||
170897160|NCT00927563|617628627|FG000|Overall Study|Withdrawal by Subject|1|||
170897161|NCT03529409|617628628|FG000|Randomized|Lost to Follow-up|0|||
170897162|NCT03529409|617628629|FG001|Randomized|Lost to Follow-up|0|||
170897163|NCT03529409|617628630|FG002|Randomized|Lost to Follow-up|4|||
170482036|NCT03334435|616105615|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170482037|NCT03334435|616105616|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170482038|NCT03334435|616105617|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170897164|NCT03529409|617628628|FG000|Randomized|Excluded|0|||
170897165|NCT03529409|617628629|FG001|Randomized|Excluded|0|||
170897166|NCT03529409|617628630|FG002|Randomized|Excluded|1|||
170897167|NCT03529409|617628628|FG000|Post-treatment Assessment|Death|1|||
170897168|NCT03529409|617628629|FG001|Post-treatment Assessment|Death|0|||
170897169|NCT03529409|617628630|FG002|Post-treatment Assessment|Death|0|||
170897170|NCT03529409|617628628|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
170897171|NCT03529409|617628629|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
170897172|NCT03529409|617628630|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
170897173|NCT03529409|617628628|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
170897174|NCT03529409|617628629|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
170897175|NCT03529409|617628630|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
170897176|NCT03529409|617628628|FG000|Follow-up Assessment|Death|1|||
170897177|NCT03529409|617628629|FG001|Follow-up Assessment|Death|0|||
170897178|NCT03529409|617628630|FG002|Follow-up Assessment|Death|0|||
170897179|NCT03529409|617628628|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
170897180|NCT03529409|617628629|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
170897181|NCT03529409|617628630|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
170897182|NCT01497262|617628631|FG000|Overall Study|Abnormal Lab Values|4|||
170897183|NCT01497262|617628631|FG000|Overall Study|Abnormal Test Procedure Result|1|||
170897184|NCT01497262|617628631|FG000|Overall Study|Physician Decision|1|||
170897185|NCT01497262|617628631|FG000|Overall Study|Withdrawal by Subject|2|||
170897186|NCT01497262|617628631|FG000|Overall Study|Adverse Event|2|||
170897187|NCT01497262|617628631|FG000|Overall Study|Protocol Violation|1|||
170897188|NCT05501119|617628632|FG000|Overall Study|Withdrawal by Subject|2|||
170897189|NCT05501119|617628632|FG000|Overall Study|Lost to Follow-up|5|||
170897190|NCT02899156|617628636|FG000|Overall Study|Death|1|||
170897191|NCT02899156|617628637|FG001|Overall Study|Death|0|||
170897192|NCT02899156|617628636|FG000|Overall Study|Physician Decision|0|||
170897193|NCT02899156|617628637|FG001|Overall Study|Physician Decision|1|||
170897194|NCT00787787|617628642|FG000|Overall Study|Lack of Efficacy|4|||
170897195|NCT00787787|617628642|FG000|Overall Study|Adverse Event|3|||
170897196|NCT03828487|617628643|FG000|Overall Study|Physician Decision|1|||
170897197|NCT05032950|617628644|FG000|Overall Study|Adverse Event|0|||
170897198|NCT05032950|617628645|FG001|Overall Study|Adverse Event|0|||
170897199|NCT05032950|617628646|FG002|Overall Study|Adverse Event|1|||
170897200|NCT05032950|617628647|FG003|Overall Study|Adverse Event|1|||
170897201|NCT05032950|617628648|FG004|Overall Study|Adverse Event|0|||
170897202|NCT05032950|617628649|FG005|Overall Study|Adverse Event|0|||
170897203|NCT02959814|617628650|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
170897204|NCT02959814|617628650|FG000|Overall Study|Excluded based on anatomical criteria|2|||
170897205|NCT02959814|617628650|FG000|Overall Study|Protocol Violation|7|||
170897206|NCT02959814|617628650|FG000|Overall Study|FFR not measured|2|||
170897207|NCT02959814|617628650|FG000|Overall Study|In-procedure QFR not computed|6|||
170897208|NCT02959814|617628650|FG000|Overall Study|Excluded by FFR core-lab|24|||
170897209|NCT00484315|617628651|FG000|12-Month Clinical Follow-up|Death|6|||
170897210|NCT00484315|617628652|FG001|12-Month Clinical Follow-up|Death|2|||
170897211|NCT00484315|617628651|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
170897212|NCT00484315|617628652|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
170897213|NCT00484315|617628651|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
170897214|NCT00484315|617628652|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
170897215|NCT00484315|617628651|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
170897216|NCT00484315|617628652|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
170897217|NCT00484315|617628651|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
170897218|NCT00484315|617628652|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
170897219|NCT00484315|617628651|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
170897220|NCT00484315|617628652|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
170897221|NCT00484315|617628651|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
170897222|NCT00484315|617628652|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
170897223|NCT01990261|617628653|FG000|Overall Study|Death Before Treatment Start|2|||
170897224|NCT01990261|617628653|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
170897225|NCT01990261|617628653|FG000|Overall Study|Death From other Causes|1|||
170897226|NCT01990261|617628653|FG000|Overall Study|Disease Progression (PD)|8|||
170897227|NCT01990261|617628653|FG000|Overall Study|PD Before Treatment Start|1|||
170897228|NCT01990261|617628653|FG000|Overall Study|Dossier not Approved|1|||
170897229|NCT01990261|617628653|FG000|Overall Study|Lost to Follow-up|2|||
170897230|NCT03179436|617628656|FG000|Overall Study|Withdrawal by Subject|1|||
170897231|NCT03179436|617628657|FG001|Overall Study|Withdrawal by Subject|0|||
170897232|NCT03179436|617628658|FG002|Overall Study|Withdrawal by Subject|0|||
170897233|NCT03179436|617628659|FG003|Overall Study|Withdrawal by Subject|4|||
170897234|NCT03179436|617628660|FG004|Overall Study|Withdrawal by Subject|2|||
170897235|NCT03179436|617628661|FG005|Overall Study|Withdrawal by Subject|2|||
170897236|NCT03179436|617628662|FG006|Overall Study|Withdrawal by Subject|5|||
170897237|NCT03179436|617628663|FG007|Overall Study|Withdrawal by Subject|0|||
170897238|NCT03179436|617628664|FG008|Overall Study|Withdrawal by Subject|3|||
170897239|NCT03179436|617628665|FG009|Overall Study|Withdrawal by Subject|0|||
170897240|NCT03179436|617628666|FG010|Overall Study|Withdrawal by Subject|0|||
170548410|NCT01727154|616352131|FG000|Overall Study|Study Terminated|6|||
170548411|NCT01727154|616352131|FG000|Overall Study|No Discontinuation Documentation|4|||
170548412|NCT00003474|616352132|FG000|Overall Study|Not Evaluable|14|||
170548413|NCT03632720|616352142|FG000|Overall Study|Adverse Event|2|||
170548414|NCT03632720|616352143|FG001|Overall Study|Adverse Event|0|||
170797485|NCT04163991|617271273|FG000|Overall Study|Lost to Follow-up|0|||
170797486|NCT04163991|617271274|FG001|Overall Study|Lost to Follow-up|1|||
170797487|NCT04163991|617271275|FG002|Overall Study|Lost to Follow-up|0|||
170797488|NCT04163991|617271276|FG003|Overall Study|Lost to Follow-up|0|||
170797489|NCT04163991|617271277|FG004|Overall Study|Lost to Follow-up|0|||
170797490|NCT04163991|617271273|FG000|Overall Study|Withdrawal by Subject|1|||
170797491|NCT04163991|617271274|FG001|Overall Study|Withdrawal by Subject|1|||
170797492|NCT04163991|617271275|FG002|Overall Study|Withdrawal by Subject|3|||
170797493|NCT04163991|617271276|FG003|Overall Study|Withdrawal by Subject|1|||
170797494|NCT04163991|617271277|FG004|Overall Study|Withdrawal by Subject|1|||
170797495|NCT04163991|617271273|FG000|Overall Study|Other, Not Specified|0|||
170797496|NCT04163991|617271274|FG001|Overall Study|Other, Not Specified|1|||
170797497|NCT04163991|617271275|FG002|Overall Study|Other, Not Specified|1|||
170797498|NCT04163991|617271276|FG003|Overall Study|Other, Not Specified|1|||
170797499|NCT04163991|617271277|FG004|Overall Study|Other, Not Specified|0|||
170797500|NCT05953740|617271278|FG000|Period 1|Physician Decision|0|||
170797501|NCT05953740|617271279|FG001|Period 1|Physician Decision|1|||
170797502|NCT05953740|617271280|FG002|Period 1|Physician Decision|0|||
170797503|NCT05953740|617271281|FG003|Period 1|Physician Decision|0|||
170797504|NCT05953740|617271282|FG004|Period 1|Physician Decision|0|||
170797505|NCT05953740|617271283|FG005|Period 1|Physician Decision|0|||
170797506|NCT05953740|617271284|FG006|Period 1|Physician Decision|0|||
170797507|NCT05953740|617271285|FG007|Period 1|Physician Decision|0|||
170797508|NCT05953740|617271278|FG000|Period 2|Withdrawal by Subject|0|||
170797509|NCT05953740|617271279|FG001|Period 2|Withdrawal by Subject|1|||
170797510|NCT05953740|617271280|FG002|Period 2|Withdrawal by Subject|1|||
170797511|NCT05953740|617271281|FG003|Period 2|Withdrawal by Subject|0|||
170797512|NCT05953740|617271282|FG004|Period 2|Withdrawal by Subject|0|||
170797513|NCT05953740|617271283|FG005|Period 2|Withdrawal by Subject|0|||
170797514|NCT05953740|617271284|FG006|Period 2|Withdrawal by Subject|0|||
170797515|NCT05953740|617271285|FG007|Period 2|Withdrawal by Subject|0|||
170797516|NCT03880955|617271286|FG000|Overall Study|Adverse Event|1|||
170797517|NCT03880955|617271286|FG000|Overall Study|Death|1|||
170797518|NCT03880955|617271286|FG000|Overall Study|Lost to Follow-up|12|||
170797519|NCT03880955|617271286|FG000|Overall Study|Withdrawal by Subject|4|||
170797520|NCT03880955|617271286|FG000|Overall Study|Missing- Study Site Closed|27|||
170797521|NCT03744676|617271287|FG000|Pre-Treatment Phase|Disease related complications|2|||
170797522|NCT03744676|617271287|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
170797523|NCT03744676|617271287|FG000|Pre-Treatment Phase|Death|7|||
170797524|NCT03744676|617271287|FG000|Pre-Treatment Phase|Other Reasons|7|||
170797525|NCT03744676|617271287|FG000|Treatment Phase|Participant withdrew consent|8|||
170797526|NCT03744676|617271287|FG000|Treatment Phase|Death|33|||
170797527|NCT03744676|617271287|FG000|Treatment Phase|other reasons|6|||
170797528|NCT04078152|617271288|FG000|Overall Study|Other|83|||
170797529|NCT04078152|617271289|FG001|Overall Study|Other|22|||
170797530|NCT04078152|617271290|FG002|Overall Study|Other|25|||
170797531|NCT04078152|617271288|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
170797532|NCT04078152|617271289|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
170797533|NCT04078152|617271290|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
170797534|NCT04078152|617271288|FG000|Overall Study|Withdrawal by Subject|5|||
170797535|NCT04078152|617271289|FG001|Overall Study|Withdrawal by Subject|0|||
170797536|NCT04078152|617271290|FG002|Overall Study|Withdrawal by Subject|1|||
170797537|NCT04078152|617271288|FG000|Overall Study|Death|10|||
170797538|NCT04078152|617271289|FG001|Overall Study|Death|2|||
170797539|NCT04078152|617271290|FG002|Overall Study|Death|12|||
170797540|NCT04078152|617271288|FG000|Overall Study|Adverse Event|1|||
170797541|NCT04078152|617271289|FG001|Overall Study|Adverse Event|0|||
170797542|NCT04078152|617271290|FG002|Overall Study|Adverse Event|0|||
170797543|NCT04795245|617271297|FG000|Overall Study|Unkown reason|7|||
170797544|NCT04795245|617271297|FG000|Overall Study|Death|17|||
170797545|NCT04795245|617271297|FG000|Overall Study|Other than listed|19|||
170797546|NCT04795245|617271297|FG000|Overall Study|Adverse Event|143|||
170797547|NCT04795245|617271297|FG000|Overall Study|Progressive disease|512|||
170797548|NCT04795245|617271297|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
170797549|NCT04743973|617271298|FG000|Overall Study|Withdrawal by Subject|5|||
170797550|NCT01897441|617271299|FG000|Overall Study|Lost to Follow-up|0|||
170797551|NCT01897441|617271300|FG001|Overall Study|Lost to Follow-up|0|||
170797552|NCT01897441|617271301|FG002|Overall Study|Lost to Follow-up|1|||
170797553|NCT01897441|617271302|FG003|Overall Study|Lost to Follow-up|0|||
170548415|NCT03632720|616352144|FG002|Overall Study|Adverse Event|0|||
170797554|NCT01897441|617271303|FG004|Overall Study|Lost to Follow-up|0|||
170797555|NCT01897441|617271304|FG005|Overall Study|Lost to Follow-up|0|||
170797556|NCT01897441|617271299|FG000|Overall Study|Withdrawal by Subject|0|||
170482039|NCT03334435|616105618|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170482040|NCT03334435|616105619|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170482041|NCT03334435|616105620|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170482042|NCT03334435|616105621|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
170482043|NCT03334435|616105607|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
170482044|NCT03334435|616105608|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
170482045|NCT03334435|616105609|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
170482046|NCT03334435|616105610|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
170482047|NCT03334435|616105611|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
170640091|NCT04476797|616693814|FG000|Overall Study|Sponsor Terminated Study|0|||
170640092|NCT04476797|616693815|FG001|Overall Study|Sponsor Terminated Study|18|||
170797557|NCT01897441|617271300|FG001|Overall Study|Withdrawal by Subject|0|||
170797558|NCT01897441|617271301|FG002|Overall Study|Withdrawal by Subject|0|||
170797559|NCT01897441|617271302|FG003|Overall Study|Withdrawal by Subject|0|||
170797560|NCT01897441|617271303|FG004|Overall Study|Withdrawal by Subject|1|||
170797561|NCT01897441|617271304|FG005|Overall Study|Withdrawal by Subject|0|||
170797562|NCT01897441|617271299|FG000|Overall Study|Withdrawn by Provider|0|||
170797563|NCT01897441|617271300|FG001|Overall Study|Withdrawn by Provider|2|||
170797564|NCT01897441|617271301|FG002|Overall Study|Withdrawn by Provider|0|||
170797565|NCT01897441|617271302|FG003|Overall Study|Withdrawn by Provider|0|||
170797566|NCT01897441|617271303|FG004|Overall Study|Withdrawn by Provider|0|||
170797567|NCT01897441|617271304|FG005|Overall Study|Withdrawn by Provider|0|||
170797568|NCT02933489|617271305|FG000|Overall Study|Ineligible|3|||
170797569|NCT02933489|617271306|FG001|Overall Study|Ineligible|3|||
170797570|NCT02933489|617271305|FG000|Overall Study|Withdrawal by Subject|27|||
170797571|NCT02933489|617271306|FG001|Overall Study|Withdrawal by Subject|18|||
170482048|NCT03334435|616105612|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482049|NCT03334435|616105613|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482050|NCT03334435|616105614|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482051|NCT03334435|616105615|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482052|NCT03334435|616105616|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482053|NCT03334435|616105617|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482054|NCT03334435|616105618|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170548416|NCT03632720|616352142|FG000|Overall Study|Lost to Follow-up|0|||
170548417|NCT03632720|616352143|FG001|Overall Study|Lost to Follow-up|1|||
170548418|NCT03632720|616352144|FG002|Overall Study|Lost to Follow-up|0|||
170548419|NCT03632720|616352142|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
170548420|NCT03632720|616352143|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
170548421|NCT03632720|616352144|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
170548422|NCT03632720|616352142|FG000|Overall Study|Screen failure|0|||
170548423|NCT03632720|616352143|FG001|Overall Study|Screen failure|1|||
170548424|NCT03632720|616352144|FG002|Overall Study|Screen failure|0|||
170548425|NCT01049828|616352146|FG000|Overall Study|Claustrophibia and Frustration|2|||
170548426|NCT01245062|616352147|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
170548427|NCT01245062|616352148|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
170548428|NCT01245062|616352149|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
170548429|NCT01245062|616352147|FG000|Randomization and Crossover Phase|Physician Decision|2|||
170548430|NCT01245062|616352148|FG001|Randomization and Crossover Phase|Physician Decision|4|||
170548431|NCT01245062|616352149|FG002|Randomization and Crossover Phase|Physician Decision|0|||
170548432|NCT01245062|616352147|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
170548433|NCT01245062|616352148|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
170548434|NCT01245062|616352149|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
170548435|NCT01245062|616352147|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
170548436|NCT01245062|616352148|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
170548437|NCT01245062|616352149|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
170548438|NCT01245062|616352147|FG000|Cross-over Phase|Lost to Follow-up|0|||
170548439|NCT01245062|616352148|FG001|Cross-over Phase|Lost to Follow-up|0|||
170548440|NCT01245062|616352149|FG002|Cross-over Phase|Lost to Follow-up|1|||
170548441|NCT01245062|616352147|FG000|Cross-over Phase|Physician Decision|0|||
170548442|NCT01245062|616352148|FG001|Cross-over Phase|Physician Decision|0|||
170548443|NCT01245062|616352149|FG002|Cross-over Phase|Physician Decision|1|||
170548444|NCT01245062|616352147|FG000|Cross-over Phase|Withdrew Consent|0|||
170548445|NCT01245062|616352148|FG001|Cross-over Phase|Withdrew Consent|0|||
170548446|NCT01245062|616352149|FG002|Cross-over Phase|Withdrew Consent|4|||
170548447|NCT01245062|616352147|FG000|Cross-over Phase|Study closed/ terminated|0|||
170548448|NCT01245062|616352148|FG001|Cross-over Phase|Study closed/ terminated|0|||
170548449|NCT01245062|616352149|FG002|Cross-over Phase|Study closed/ terminated|11|||
170548450|NCT01301092|616352150|FG000|Overall Study|Lost to Follow-up|0|||
170897241|NCT03179436|617628667|FG011|Overall Study|Withdrawal by Subject|0|||
170897242|NCT03179436|617628656|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170897243|NCT03179436|617628657|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170897244|NCT03179436|617628658|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170897245|NCT03179436|617628659|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170897246|NCT03179436|617628660|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
170897247|NCT03179436|617628661|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
170897248|NCT03179436|617628662|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
170897249|NCT03179436|617628663|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
170897250|NCT03179436|617628664|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
170897251|NCT03179436|617628665|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
170897252|NCT03179436|617628666|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
170897253|NCT03179436|617628667|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
170897254|NCT03179436|617628656|FG000|Overall Study|Sponsor Decision|0|||
170897255|NCT03179436|617628657|FG001|Overall Study|Sponsor Decision|0|||
170897256|NCT03179436|617628658|FG002|Overall Study|Sponsor Decision|1|||
170897257|NCT03179436|617628659|FG003|Overall Study|Sponsor Decision|3|||
170897258|NCT03179436|617628660|FG004|Overall Study|Sponsor Decision|9|||
170897259|NCT03179436|617628661|FG005|Overall Study|Sponsor Decision|7|||
170897260|NCT03179436|617628662|FG006|Overall Study|Sponsor Decision|2|||
170897261|NCT03179436|617628663|FG007|Overall Study|Sponsor Decision|4|||
170897262|NCT03179436|617628664|FG008|Overall Study|Sponsor Decision|23|||
170897263|NCT03179436|617628665|FG009|Overall Study|Sponsor Decision|6|||
170897264|NCT03179436|617628666|FG010|Overall Study|Sponsor Decision|7|||
170897265|NCT03179436|617628667|FG011|Overall Study|Sponsor Decision|5|||
170897266|NCT03179436|617628656|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897267|NCT03179436|617628657|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
170897268|NCT03179436|617628658|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897269|NCT03179436|617628659|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897270|NCT03179436|617628660|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897271|NCT03179436|617628661|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
170897272|NCT03179436|617628662|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897273|NCT03179436|617628663|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897274|NCT03179436|617628664|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897275|NCT03179436|617628665|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897276|NCT03179436|617628666|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897277|NCT03179436|617628667|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
170897278|NCT03179436|617628656|FG000|Overall Study|Lost to Follow-up|1|||
170897279|NCT03179436|617628657|FG001|Overall Study|Lost to Follow-up|0|||
170897280|NCT03179436|617628658|FG002|Overall Study|Lost to Follow-up|0|||
170897281|NCT03179436|617628659|FG003|Overall Study|Lost to Follow-up|1|||
170897282|NCT03179436|617628660|FG004|Overall Study|Lost to Follow-up|0|||
170897283|NCT03179436|617628661|FG005|Overall Study|Lost to Follow-up|1|||
170482055|NCT03334435|616105619|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482056|NCT03334435|616105620|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482057|NCT03334435|616105621|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
170482058|NCT03334435|616105607|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
170482059|NCT03334435|616105608|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482060|NCT03334435|616105609|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
170482061|NCT03334435|616105610|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
170482062|NCT03334435|616105611|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
170548451|NCT01301092|616352151|FG001|Overall Study|Lost to Follow-up|0|||
170548452|NCT01301092|616352152|FG002|Overall Study|Lost to Follow-up|1|||
170548453|NCT03334175|616352153|FG000|Overall Study|Lost to Follow-up|0|||
170548454|NCT03334175|616352154|FG001|Overall Study|Lost to Follow-up|1|||
170548455|NCT01926509|616354595|FG000|Overall Study|vital sign met discontinuation criteria|1|||
170548456|NCT01926509|616354596|FG001|Overall Study|vital sign met discontinuation criteria|0|||
170548457|NCT01926509|616354597|FG002|Overall Study|vital sign met discontinuation criteria|0|||
170548458|NCT01926509|616354598|FG003|Overall Study|vital sign met discontinuation criteria|0|||
170548459|NCT02730169|616354599|FG000|Overall Study|Protocol Violation|1|||
170548460|NCT02730169|616354600|FG001|Overall Study|Protocol Violation|0|||
170548461|NCT02730169|616354601|FG002|Overall Study|Protocol Violation|0|||
170548462|NCT02730169|616354602|FG003|Overall Study|Protocol Violation|1|||
170548463|NCT02730169|616354599|FG000|Overall Study|Adverse Event|2|||
170548464|NCT02730169|616354600|FG001|Overall Study|Adverse Event|3|||
170548465|NCT02730169|616354601|FG002|Overall Study|Adverse Event|3|||
170548466|NCT02730169|616354602|FG003|Overall Study|Adverse Event|0|||
170548467|NCT02730169|616354599|FG000|Overall Study|Adverse Event of Special Interest|0|||
170548468|NCT02730169|616354600|FG001|Overall Study|Adverse Event of Special Interest|1|||
170548469|NCT02730169|616354601|FG002|Overall Study|Adverse Event of Special Interest|2|||
170482063|NCT03334435|616105612|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482064|NCT03334435|616105613|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482065|NCT03334435|616105614|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482066|NCT03334435|616105615|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482067|NCT03334435|616105616|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482068|NCT03334435|616105617|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482069|NCT03334435|616105618|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482070|NCT03334435|616105619|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482071|NCT03334435|616105620|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482072|NCT03334435|616105621|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
170482073|NCT03334435|616105607|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482074|NCT03334435|616105608|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482075|NCT03334435|616105609|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482076|NCT03334435|616105610|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
170482077|NCT03334435|616105611|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482078|NCT03334435|616105612|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482079|NCT03334435|616105613|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482080|NCT03334435|616105614|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482081|NCT03334435|616105615|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482082|NCT03334435|616105616|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482083|NCT03334435|616105617|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
170482084|NCT03334435|616105618|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
170797572|NCT02933489|617271305|FG000|Overall Study|Unable to complete exams (other)|14|||
170797573|NCT02933489|617271306|FG001|Overall Study|Unable to complete exams (other)|7|||
170797574|NCT00626795|617271310|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
170797575|NCT00626795|617271311|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
170797576|NCT00626795|617271312|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
170797577|NCT00626795|617271310|FG000|Blinded Treatment|Lack of Efficacy|2|||
170797578|NCT00626795|617271311|FG001|Blinded Treatment|Lack of Efficacy|0|||
170797579|NCT00626795|617271312|FG002|Blinded Treatment|Lack of Efficacy|0|||
170797580|NCT00626795|617271310|FG000|Blinded Treatment|Unacceptable adverse event|0|||
170797581|NCT00626795|617271311|FG001|Blinded Treatment|Unacceptable adverse event|0|||
170797582|NCT00626795|617271312|FG002|Blinded Treatment|Unacceptable adverse event|1|||
170797583|NCT00626795|617271310|FG000|Blinded Treatment|Protocol Violation|0|||
170797584|NCT00626795|617271311|FG001|Blinded Treatment|Protocol Violation|1|||
170797585|NCT00626795|617271312|FG002|Blinded Treatment|Protocol Violation|1|||
170797586|NCT00626795|617271310|FG000|Blinded Treatment|Withdrawal by Subject|1|||
170797587|NCT00626795|617271311|FG001|Blinded Treatment|Withdrawal by Subject|1|||
170797588|NCT00626795|617271312|FG002|Blinded Treatment|Withdrawal by Subject|0|||
170797589|NCT00626795|617271310|FG000|Blinded Treatment|Other reasons|2|||
170797590|NCT00626795|617271311|FG001|Blinded Treatment|Other reasons|0|||
170797591|NCT00626795|617271312|FG002|Blinded Treatment|Other reasons|2|||
170797592|NCT00626795|617271310|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
170797593|NCT00626795|617271311|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
170797594|NCT00626795|617271312|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
170797595|NCT04499521|617271316|FG000|Overall Study|Disease Progression|1|||
170797596|NCT04499521|617271317|FG001|Overall Study|Disease Progression|0|||
170797597|NCT04780581|617271318|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
170797598|NCT04780581|617271319|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
170797599|NCT04780581|617271318|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
170797600|NCT04780581|617271319|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
170797601|NCT01651000|617271320|FG000|Overall Study|Adverse Event|2|||
170797602|NCT01651000|617271321|FG001|Overall Study|Adverse Event|8|||
170797603|NCT01651000|617271320|FG000|Overall Study|Lost to Follow-up|3|||
170797604|NCT01651000|617271321|FG001|Overall Study|Lost to Follow-up|2|||
170797605|NCT01651000|617271320|FG000|Overall Study|Protocol Violation|0|||
170797606|NCT01651000|617271321|FG001|Overall Study|Protocol Violation|3|||
170797607|NCT01651000|617271320|FG000|Overall Study|Withdrawal by Subject|2|||
170797608|NCT01651000|617271321|FG001|Overall Study|Withdrawal by Subject|10|||
170797609|NCT01651000|617271320|FG000|Overall Study|Subject noncompliance|0|||
170797610|NCT01651000|617271321|FG001|Overall Study|Subject noncompliance|3|||
170797611|NCT01651000|617271320|FG000|Overall Study|Lack of Efficacy|1|||
170797612|NCT01651000|617271321|FG001|Overall Study|Lack of Efficacy|1|||
170797613|NCT01651000|617271320|FG000|Overall Study|Physician Decision|1|||
170797614|NCT01651000|617271321|FG001|Overall Study|Physician Decision|0|||
170797615|NCT01651000|617271320|FG000|Overall Study|Administrative reason|1|||
170797616|NCT01651000|617271321|FG001|Overall Study|Administrative reason|0|||
170797617|NCT01651000|617271320|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
170797618|NCT01651000|617271321|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
170797619|NCT04595331|617272418|FG000|Overall Study|Withdrawal by Subject|0|||
170482085|NCT03334435|616105619|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
170797620|NCT04595331|617272419|FG001|Overall Study|Withdrawal by Subject|1|||
170897284|NCT03179436|617628662|FG006|Overall Study|Lost to Follow-up|0|||
170897285|NCT03179436|617628663|FG007|Overall Study|Lost to Follow-up|0|||
170897286|NCT03179436|617628664|FG008|Overall Study|Lost to Follow-up|1|||
170897287|NCT03179436|617628665|FG009|Overall Study|Lost to Follow-up|1|||
170897288|NCT03179436|617628666|FG010|Overall Study|Lost to Follow-up|0|||
170897289|NCT03179436|617628667|FG011|Overall Study|Lost to Follow-up|0|||
170897290|NCT03179436|617628656|FG000|Overall Study|Death|12|||
170897291|NCT03179436|617628657|FG001|Overall Study|Death|17|||
170897292|NCT03179436|617628658|FG002|Overall Study|Death|7|||
170897293|NCT03179436|617628659|FG003|Overall Study|Death|32|||
170897294|NCT03179436|617628660|FG004|Overall Study|Death|29|||
170897295|NCT03179436|617628661|FG005|Overall Study|Death|30|||
170897296|NCT03179436|617628662|FG006|Overall Study|Death|33|||
170897297|NCT03179436|617628663|FG007|Overall Study|Death|9|||
170897298|NCT03179436|617628664|FG008|Overall Study|Death|84|||
170897299|NCT03179436|617628665|FG009|Overall Study|Death|33|||
170897300|NCT03179436|617628666|FG010|Overall Study|Death|22|||
170897301|NCT03179436|617628667|FG011|Overall Study|Death|15|||
170897302|NCT01078805|617628668|FG000|Overall Study|Clinically significant abnormal lab|5|||
170897303|NCT01078805|617628668|FG000|Overall Study|Death|134|||
170897304|NCT01078805|617628668|FG000|Overall Study|Lost to Follow-up|676|||
170897305|NCT01078805|617628668|FG000|Overall Study|Physician Decision|169|||
170897306|NCT01078805|617628668|FG000|Overall Study|Serious adverse event|26|||
170897307|NCT01078805|617628668|FG000|Overall Study|Sponsor decision|46|||
170897308|NCT01078805|617628668|FG000|Overall Study|Withdrawal by Subject|739|||
170897309|NCT01078805|617628668|FG000|Overall Study|Other|173|||
170897310|NCT01078805|617628668|FG000|Overall Study|Didn't take study drug|82|||
170897311|NCT04722991|617628669|FG000|Overall Study|Adverse Event|12|||
170897312|NCT04722991|617628670|FG001|Overall Study|Adverse Event|4|||
170897313|NCT04722991|617628669|FG000|Overall Study|Death|2|||
170897314|NCT04722991|617628670|FG001|Overall Study|Death|0|||
170897315|NCT04722991|617628669|FG000|Overall Study|Lost to Follow-up|1|||
170897316|NCT04722991|617628670|FG001|Overall Study|Lost to Follow-up|1|||
170897317|NCT04722991|617628669|FG000|Overall Study|Withdrawal cirterion met|2|||
170897318|NCT04722991|617628670|FG001|Overall Study|Withdrawal cirterion met|2|||
170897319|NCT04722991|617628669|FG000|Overall Study|Other|1|||
170897320|NCT04722991|617628670|FG001|Overall Study|Other|0|||
170897321|NCT04722991|617628669|FG000|Overall Study|Non-compliance|0|||
170897322|NCT04722991|617628670|FG001|Overall Study|Non-compliance|1|||
170897323|NCT04722991|617628669|FG000|Overall Study|Withdrawal by Subject|0|||
170897324|NCT04722991|617628670|FG001|Overall Study|Withdrawal by Subject|1|||
170897325|NCT01445678|617628674|FG000|Overall Study|Adverse Event|12|||
170897326|NCT01445678|617628675|FG001|Overall Study|Adverse Event|8|||
170897327|NCT01445678|617628674|FG000|Overall Study|Lack of Efficacy|0|||
170897328|NCT01445678|617628675|FG001|Overall Study|Lack of Efficacy|2|||
170897329|NCT01445678|617628674|FG000|Overall Study|Lost to Follow-up|8|||
170897330|NCT01445678|617628675|FG001|Overall Study|Lost to Follow-up|5|||
170897331|NCT01445678|617628674|FG000|Overall Study|Protocol Violation|1|||
170897332|NCT01445678|617628675|FG001|Overall Study|Protocol Violation|1|||
170897333|NCT01445678|617628674|FG000|Overall Study|Withdrawal by Subject|9|||
170897334|NCT01445678|617628675|FG001|Overall Study|Withdrawal by Subject|5|||
170897335|NCT02307370|617628676|FG000|Overall Study|Death|5|||
170897336|NCT02307370|617628676|FG000|Overall Study|Lost to Follow-up|1|||
170897337|NCT02307370|617628676|FG000|Overall Study|Withdrawal by Subject|1|||
170897338|NCT02307370|617628676|FG000|Overall Study|Declined Addendum ICF|6|||
170897339|NCT02307370|617628676|FG000|Overall Study|No response during telephone contact|5|||
170897340|NCT02307370|617628676|FG000|Overall Study|Protocol Violation|1|||
170897341|NCT01565980|617628677|FG000|Overall Study|Death|1|||
170482086|NCT03334435|616105620|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
170897342|NCT01565980|617628678|FG001|Overall Study|Death|0|||
170897343|NCT01565980|617628677|FG000|Overall Study|Lost to Follow-up|1|||
170482087|NCT03334435|616105621|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
170897344|NCT01565980|617628678|FG001|Overall Study|Lost to Follow-up|0|||
170897345|NCT01565980|617628677|FG000|Overall Study|health complications|1|||
170897346|NCT01565980|617628678|FG001|Overall Study|health complications|1|||
170897347|NCT01565980|617628677|FG000|Overall Study|stopped medical treatment|1|||
170897348|NCT01565980|617628678|FG001|Overall Study|stopped medical treatment|0|||
170897349|NCT01565980|617628677|FG000|Overall Study|Withdrawal by Subject|0|||
170897350|NCT01565980|617628678|FG001|Overall Study|Withdrawal by Subject|3|||
170897351|NCT00821678|617628679|FG000|Overall Study|Withdrawal by Subject|8|||
170897352|NCT00821678|617628680|FG001|Overall Study|Withdrawal by Subject|0|||
170897353|NCT00821678|617628679|FG000|Overall Study|Lost to Follow-up|13|||
170897354|NCT00821678|617628680|FG001|Overall Study|Lost to Follow-up|12|||
170897355|NCT00821678|617628679|FG000|Overall Study|Death|0|||
170897356|NCT00821678|617628680|FG001|Overall Study|Death|2|||
170897357|NCT02078219|617628681|FG000|Overall Study|Other|2|||
170897358|NCT02078219|617628682|FG001|Overall Study|Other|2|||
170897359|NCT02078219|617628683|FG002|Overall Study|Other|3|||
170897360|NCT02078219|617628684|FG003|Overall Study|Other|0|||
170897361|NCT02078219|617628685|FG004|Overall Study|Other|1|||
170897362|NCT02078219|617628681|FG000|Overall Study|Withdrawal by Subject|0|||
170797621|NCT04595331|617272418|FG000|Overall Study|Lost to Follow-up|0|||
170548470|NCT02730169|616354602|FG003|Overall Study|Adverse Event of Special Interest|0|||
170548471|NCT02730169|616354599|FG000|Overall Study|Withdrawal by Subject|6|||
170548472|NCT02730169|616354600|FG001|Overall Study|Withdrawal by Subject|11|||
170548473|NCT02730169|616354601|FG002|Overall Study|Withdrawal by Subject|6|||
170548474|NCT02730169|616354602|FG003|Overall Study|Withdrawal by Subject|8|||
170797622|NCT04595331|617272419|FG001|Overall Study|Lost to Follow-up|5|||
170797623|NCT04595331|617272418|FG000|Overall Study|Medical reason|0|||
170797624|NCT04595331|617272419|FG001|Overall Study|Medical reason|1|||
170797625|NCT05412004|617272423|FG000|Overall Study|Adverse Event|0|||
170797626|NCT05412004|617272424|FG001|Overall Study|Adverse Event|2|||
170797627|NCT05412004|617272425|FG002|Overall Study|Adverse Event|1|||
170797628|NCT05412004|617272426|FG003|Overall Study|Adverse Event|5|||
170797629|NCT05412004|617272423|FG000|Overall Study|Assigned Treatment by Mistake|5|||
170797630|NCT05412004|617272424|FG001|Overall Study|Assigned Treatment by Mistake|10|||
170797631|NCT05412004|617272425|FG002|Overall Study|Assigned Treatment by Mistake|2|||
170797632|NCT05412004|617272426|FG003|Overall Study|Assigned Treatment by Mistake|5|||
170797633|NCT05412004|617272423|FG000|Overall Study|Lost to Follow-up|3|||
170797634|NCT05412004|617272424|FG001|Overall Study|Lost to Follow-up|0|||
170797635|NCT05412004|617272425|FG002|Overall Study|Lost to Follow-up|0|||
170797636|NCT05412004|617272426|FG003|Overall Study|Lost to Follow-up|0|||
170797637|NCT05412004|617272423|FG000|Overall Study|Patient could not travel to site|0|||
170797638|NCT05412004|617272424|FG001|Overall Study|Patient could not travel to site|1|||
170797639|NCT05412004|617272425|FG002|Overall Study|Patient could not travel to site|0|||
170797640|NCT05412004|617272426|FG003|Overall Study|Patient could not travel to site|0|||
170797641|NCT05412004|617272423|FG000|Overall Study|Physician Decision|0|||
170797642|NCT05412004|617272424|FG001|Overall Study|Physician Decision|1|||
170797643|NCT05412004|617272425|FG002|Overall Study|Physician Decision|0|||
170797644|NCT05412004|617272426|FG003|Overall Study|Physician Decision|0|||
170797645|NCT05412004|617272423|FG000|Overall Study|Pregnancy|0|||
170797646|NCT05412004|617272424|FG001|Overall Study|Pregnancy|1|||
170797647|NCT05412004|617272425|FG002|Overall Study|Pregnancy|0|||
170797648|NCT05412004|617272426|FG003|Overall Study|Pregnancy|0|||
170797649|NCT05412004|617272423|FG000|Overall Study|Protocol Violation|1|||
170797650|NCT05412004|617272424|FG001|Overall Study|Protocol Violation|0|||
170797651|NCT05412004|617272425|FG002|Overall Study|Protocol Violation|0|||
170797652|NCT05412004|617272426|FG003|Overall Study|Protocol Violation|0|||
170797653|NCT05412004|617272423|FG000|Overall Study|Withdrawal by Subject|4|||
170797654|NCT05412004|617272424|FG001|Overall Study|Withdrawal by Subject|19|||
170797655|NCT05412004|617272425|FG002|Overall Study|Withdrawal by Subject|4|||
170797656|NCT05412004|617272426|FG003|Overall Study|Withdrawal by Subject|14|||
170797657|NCT05412004|617272423|FG000|Overall Study|Screen Failure|0|||
170797658|NCT05412004|617272424|FG001|Overall Study|Screen Failure|0|||
170797659|NCT05412004|617272425|FG002|Overall Study|Screen Failure|0|||
170797660|NCT05412004|617272426|FG003|Overall Study|Screen Failure|1|||
170797661|NCT05412004|617272423|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
170797662|NCT05412004|617272424|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
170797663|NCT05412004|617272425|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
170797664|NCT05412004|617272426|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
170797665|NCT03781089|617272427|FG000|Overall Study|Constipation|1|||
170797666|NCT03781089|617272428|FG001|Overall Study|Constipation|0|||
170797667|NCT03781089|617272427|FG000|Overall Study|Positive pregnancy test|0|||
170797668|NCT03781089|617272428|FG001|Overall Study|Positive pregnancy test|1|||
170797669|NCT05020353|617272429|FG000|Overall Study|Protocol Violation|7|||
170797670|NCT05020353|617272429|FG000|Overall Study|Withdrawal by Subject|33|||
170797671|NCT04633278|617272431|FG000|Overall Study|Adverse Event|1|||
170797672|NCT04633278|617272432|FG001|Overall Study|Adverse Event|0|||
170797673|NCT04633278|617272431|FG000|Overall Study|Withdrawal by Subject|1|||
170797674|NCT04633278|617272432|FG001|Overall Study|Withdrawal by Subject|0|||
170797675|NCT04633278|617272431|FG000|Overall Study|Death|11|||
170797676|NCT04633278|617272432|FG001|Overall Study|Death|7|||
170797677|NCT04633278|617272431|FG000|Overall Study|Sponsor Decision|3|||
170797678|NCT04633278|617272432|FG001|Overall Study|Sponsor Decision|0|||
170797679|NCT04633278|617272431|FG000|Overall Study|Not Listed|1|||
170797680|NCT04633278|617272432|FG001|Overall Study|Not Listed|0|||
170797681|NCT03934931|617272433|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
170797682|NCT03934931|617272434|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
170797683|NCT03934931|617272435|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
170797684|NCT02246127|617272438|FG000|First Course Treatment|Adverse Event|9|||
170797685|NCT02246127|617272439|FG001|First Course Treatment|Adverse Event|7|||
170797686|NCT02246127|617272438|FG000|First Course Treatment|Withdrawal by Subject|6|||
170548475|NCT02730169|616354599|FG000|Overall Study|Lost to Follow-up|5|||
170797687|NCT02246127|617272439|FG001|First Course Treatment|Withdrawal by Subject|7|||
170797688|NCT02246127|617272438|FG000|First Course Treatment|Physician Decision|9|||
170797689|NCT02246127|617272439|FG001|First Course Treatment|Physician Decision|9|||
170897363|NCT02078219|617628682|FG001|Overall Study|Withdrawal by Subject|1|||
170897364|NCT02078219|617628683|FG002|Overall Study|Withdrawal by Subject|0|||
170897365|NCT02078219|617628684|FG003|Overall Study|Withdrawal by Subject|1|||
170897366|NCT02078219|617628685|FG004|Overall Study|Withdrawal by Subject|1|||
170897367|NCT02078219|617628681|FG000|Overall Study|Protocol Violation|0|||
170897368|NCT02078219|617628682|FG001|Overall Study|Protocol Violation|0|||
170897369|NCT02078219|617628683|FG002|Overall Study|Protocol Violation|0|||
170897370|NCT02078219|617628684|FG003|Overall Study|Protocol Violation|1|||
170897371|NCT02078219|617628685|FG004|Overall Study|Protocol Violation|0|||
170897372|NCT02078219|617628681|FG000|Overall Study|Death|0|||
170897373|NCT02078219|617628682|FG001|Overall Study|Death|0|||
170897374|NCT02078219|617628683|FG002|Overall Study|Death|0|||
170897375|NCT02078219|617628684|FG003|Overall Study|Death|1|||
170897376|NCT02078219|617628685|FG004|Overall Study|Death|0|||
170897377|NCT02078219|617628681|FG000|Overall Study|Adverse Event|1|||
170897378|NCT02078219|617628682|FG001|Overall Study|Adverse Event|1|||
170897379|NCT02078219|617628683|FG002|Overall Study|Adverse Event|3|||
170897380|NCT02078219|617628684|FG003|Overall Study|Adverse Event|1|||
170897381|NCT02078219|617628685|FG004|Overall Study|Adverse Event|0|||
170897382|NCT03283085|617628691|FG000|Overall Study|Adverse Event|18|||
170897383|NCT03283085|617628692|FG001|Overall Study|Adverse Event|3|||
170897384|NCT03283085|617628693|FG002|Overall Study|Adverse Event|13|||
170897385|NCT03283085|617628694|FG003|Overall Study|Adverse Event|0|||
170897386|NCT03283085|617628695|FG004|Overall Study|Adverse Event|0|||
170897387|NCT03283085|617628696|FG005|Overall Study|Adverse Event|5|||
170897388|NCT03283085|617628691|FG000|Overall Study|Death|0|||
170897389|NCT03283085|617628692|FG001|Overall Study|Death|0|||
170897390|NCT03283085|617628693|FG002|Overall Study|Death|3|||
170897391|NCT03283085|617628694|FG003|Overall Study|Death|1|||
170897392|NCT03283085|617628695|FG004|Overall Study|Death|0|||
170897393|NCT03283085|617628696|FG005|Overall Study|Death|0|||
170897394|NCT03283085|617628691|FG000|Overall Study|Withdrawal by Subject|42|||
170897395|NCT03283085|617628692|FG001|Overall Study|Withdrawal by Subject|21|||
170897396|NCT03283085|617628693|FG002|Overall Study|Withdrawal by Subject|66|||
170897397|NCT03283085|617628694|FG003|Overall Study|Withdrawal by Subject|3|||
170897398|NCT03283085|617628695|FG004|Overall Study|Withdrawal by Subject|3|||
170897399|NCT03283085|617628696|FG005|Overall Study|Withdrawal by Subject|5|||
170897400|NCT03283085|617628691|FG000|Overall Study|Physician Decision|14|||
170897401|NCT03283085|617628692|FG001|Overall Study|Physician Decision|8|||
170897402|NCT03283085|617628693|FG002|Overall Study|Physician Decision|19|||
170897403|NCT03283085|617628694|FG003|Overall Study|Physician Decision|0|||
170897404|NCT03283085|617628695|FG004|Overall Study|Physician Decision|0|||
170897405|NCT03283085|617628696|FG005|Overall Study|Physician Decision|2|||
170897406|NCT03283085|617628691|FG000|Overall Study|Site Terminated by Sponsor|1|||
170897407|NCT03283085|617628692|FG001|Overall Study|Site Terminated by Sponsor|0|||
170897408|NCT03283085|617628693|FG002|Overall Study|Site Terminated by Sponsor|3|||
170897409|NCT03283085|617628694|FG003|Overall Study|Site Terminated by Sponsor|0|||
170897410|NCT03283085|617628695|FG004|Overall Study|Site Terminated by Sponsor|0|||
170897411|NCT03283085|617628696|FG005|Overall Study|Site Terminated by Sponsor|0|||
170897412|NCT03283085|617628691|FG000|Overall Study|Lost to Follow-up|2|||
170897413|NCT03283085|617628692|FG001|Overall Study|Lost to Follow-up|0|||
170897414|NCT03283085|617628693|FG002|Overall Study|Lost to Follow-up|2|||
170897415|NCT03283085|617628694|FG003|Overall Study|Lost to Follow-up|0|||
170897416|NCT03283085|617628695|FG004|Overall Study|Lost to Follow-up|0|||
170897417|NCT03283085|617628696|FG005|Overall Study|Lost to Follow-up|1|||
170897418|NCT03283085|617628691|FG000|Overall Study|Pregnancy|0|||
170897419|NCT03283085|617628692|FG001|Overall Study|Pregnancy|0|||
170897420|NCT03283085|617628693|FG002|Overall Study|Pregnancy|1|||
170897421|NCT03283085|617628694|FG003|Overall Study|Pregnancy|0|||
170897422|NCT03283085|617628695|FG004|Overall Study|Pregnancy|0|||
170548476|NCT02730169|616354600|FG001|Overall Study|Lost to Follow-up|6|||
170897423|NCT03283085|617628696|FG005|Overall Study|Pregnancy|0|||
170897424|NCT03283085|617628691|FG000|Overall Study|Lack of Efficacy|12|||
170897425|NCT03283085|617628692|FG001|Overall Study|Lack of Efficacy|6|||
170548477|NCT02730169|616354601|FG002|Overall Study|Lost to Follow-up|5|||
170897426|NCT03283085|617628693|FG002|Overall Study|Lack of Efficacy|24|||
170897427|NCT03283085|617628694|FG003|Overall Study|Lack of Efficacy|1|||
170897428|NCT03283085|617628695|FG004|Overall Study|Lack of Efficacy|1|||
170897429|NCT03283085|617628696|FG005|Overall Study|Lack of Efficacy|0|||
170897430|NCT03283085|617628691|FG000|Overall Study|Reason not Specified|0|||
170897431|NCT03283085|617628692|FG001|Overall Study|Reason not Specified|4|||
170897432|NCT03283085|617628693|FG002|Overall Study|Reason not Specified|8|||
170897433|NCT03283085|617628694|FG003|Overall Study|Reason not Specified|0|||
170897434|NCT03283085|617628695|FG004|Overall Study|Reason not Specified|0|||
170897435|NCT03283085|617628696|FG005|Overall Study|Reason not Specified|1|||
170897436|NCT00891202|617628697|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
170897437|NCT00891202|617628698|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
170897438|NCT00891202|617628699|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
170897439|NCT00891202|617628700|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
170897440|NCT00891202|617628697|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
170897441|NCT00891202|617628698|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
170897442|NCT00891202|617628699|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
170897443|NCT00891202|617628700|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
170897444|NCT00891202|617628697|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
170897445|NCT00891202|617628698|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
170897446|NCT00891202|617628699|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
170897447|NCT00891202|617628700|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
170897448|NCT00891202|617628697|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
170897449|NCT00891202|617628698|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
170897450|NCT00891202|617628699|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
170897451|NCT00891202|617628700|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
170797690|NCT02246127|617272438|FG000|First Course Treatment|Death|3|||
170797691|NCT02246127|617272439|FG001|First Course Treatment|Death|3|||
170797692|NCT02246127|617272438|FG000|First Course Treatment|Not reported reasons|6|||
170897452|NCT03532100|617630174|FG000|Overall Study|Intervention malfunction|1|||
170897453|NCT02732951|617630177|FG000|Overall Study|Other than listed|1|||
170897454|NCT02732951|617630178|FG001|Overall Study|Other than listed|0|||
170897455|NCT02732951|617630177|FG000|Overall Study|Lost to Follow-up|0|||
170897456|NCT02732951|617630178|FG001|Overall Study|Lost to Follow-up|1|||
170897457|NCT02732951|617630177|FG000|Overall Study|Adverse Event|4|||
170897458|NCT02732951|617630178|FG001|Overall Study|Adverse Event|4|||
170897459|NCT02732951|617630177|FG000|Overall Study|Protocol Violation|0|||
170897460|NCT02732951|617630178|FG001|Overall Study|Protocol Violation|1|||
170897461|NCT01750918|617630179|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
170897462|NCT01750918|617630180|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
170897463|NCT01750918|617630181|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
170897464|NCT01750918|617630182|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
170897465|NCT01750918|617630183|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
170897466|NCT01750918|617630184|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
170897467|NCT01750918|617630185|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
170640093|NCT04476797|616693816|FG002|Overall Study|Sponsor Terminated Study|17|||
170640094|NCT03237286|616693817|FG000|Overall Study|Withdrawal by Subject|1|||
170640095|NCT03237286|616693818|FG001|Overall Study|Withdrawal by Subject|0|||
170640096|NCT03237286|616693819|FG002|Overall Study|Withdrawal by Subject|2|||
170640097|NCT03237286|616693817|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
170640098|NCT03237286|616693818|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
170640099|NCT03237286|616693819|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
170640100|NCT00104520|616693821|FG000|Overall Study|Unrelated adverse event|34|||
170640101|NCT00104520|616693822|FG001|Overall Study|Unrelated adverse event|47|||
170640102|NCT00104520|616693821|FG000|Overall Study|Study drug intolerance|0|||
170640103|NCT00104520|616693822|FG001|Overall Study|Study drug intolerance|1|||
170640104|NCT00104520|616693821|FG000|Overall Study|Related adverse event|13|||
170640105|NCT00104520|616693822|FG001|Overall Study|Related adverse event|15|||
170640106|NCT00104520|616693821|FG000|Overall Study|Lost to Follow-up|1|||
170640107|NCT00104520|616693822|FG001|Overall Study|Lost to Follow-up|0|||
170640108|NCT00104520|616693821|FG000|Overall Study|Noncompliance|0|||
170797693|NCT02246127|617272439|FG001|First Course Treatment|Not reported reasons|7|||
170797694|NCT02246127|617272438|FG000|First Course Treatment|Not treated|3|||
170797695|NCT02246127|617272439|FG001|First Course Treatment|Not treated|3|||
170897468|NCT01750918|617630186|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
170897469|NCT01750918|617630179|FG000|Overall Study|Lost to Follow-up|0|||
170897470|NCT01750918|617630180|FG001|Overall Study|Lost to Follow-up|0|||
170797696|NCT02720068|617272441|FG000|Overall Study|Adverse Event|0|||
170797697|NCT02720068|617272442|FG001|Overall Study|Adverse Event|0|||
170897471|NCT01750918|617630181|FG002|Overall Study|Lost to Follow-up|2|||
170897472|NCT01750918|617630182|FG003|Overall Study|Lost to Follow-up|2|||
170897473|NCT01750918|617630183|FG004|Overall Study|Lost to Follow-up|0|||
170897474|NCT01750918|617630184|FG005|Overall Study|Lost to Follow-up|0|||
170897475|NCT01750918|617630185|FG006|Overall Study|Lost to Follow-up|0|||
170897476|NCT01750918|617630186|FG007|Overall Study|Lost to Follow-up|1|||
170897477|NCT01750918|617630179|FG000|Overall Study|Withdrawal by Subject|0|||
170797698|NCT02720068|617272443|FG002|Overall Study|Adverse Event|0|||
170797699|NCT02720068|617272444|FG003|Overall Study|Adverse Event|0|||
170797700|NCT02720068|617272445|FG004|Overall Study|Adverse Event|0|||
170797701|NCT02720068|617272446|FG005|Overall Study|Adverse Event|0|||
170640109|NCT00104520|616693822|FG001|Overall Study|Noncompliance|2|||
170640110|NCT00104520|616693821|FG000|Overall Study|Personal/administrative|1|||
170897478|NCT01750918|617630180|FG001|Overall Study|Withdrawal by Subject|0|||
170897479|NCT01750918|617630181|FG002|Overall Study|Withdrawal by Subject|1|||
170897480|NCT01750918|617630182|FG003|Overall Study|Withdrawal by Subject|2|||
170897481|NCT01750918|617630183|FG004|Overall Study|Withdrawal by Subject|1|||
170897482|NCT01750918|617630184|FG005|Overall Study|Withdrawal by Subject|1|||
170482088|NCT03334435|616105607|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482089|NCT03334435|616105608|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
170482090|NCT03334435|616105609|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
170482091|NCT03334435|616105610|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
170482092|NCT03334435|616105611|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
170797702|NCT02720068|617272447|FG006|Overall Study|Adverse Event|0|||
170797703|NCT02720068|617272448|FG007|Overall Study|Adverse Event|0|||
170797704|NCT02720068|617272449|FG008|Overall Study|Adverse Event|0|||
170797705|NCT02720068|617272450|FG009|Overall Study|Adverse Event|0|||
170797706|NCT02720068|617272451|FG010|Overall Study|Adverse Event|0|||
170797707|NCT02720068|617272452|FG011|Overall Study|Adverse Event|1|||
170797708|NCT02720068|617272453|FG012|Overall Study|Adverse Event|0|||
170797709|NCT02720068|617272454|FG013|Overall Study|Adverse Event|0|||
170797710|NCT02720068|617272455|FG014|Overall Study|Adverse Event|0|||
170797711|NCT02720068|617272456|FG015|Overall Study|Adverse Event|0|||
170797712|NCT02720068|617272457|FG016|Overall Study|Adverse Event|0|||
170797713|NCT02720068|617272458|FG017|Overall Study|Adverse Event|0|||
170797714|NCT02720068|617272441|FG000|Overall Study|Death|1|||
170797715|NCT02720068|617272442|FG001|Overall Study|Death|3|||
170797716|NCT02720068|617272443|FG002|Overall Study|Death|2|||
170797717|NCT02720068|617272444|FG003|Overall Study|Death|1|||
170797718|NCT02720068|617272445|FG004|Overall Study|Death|2|||
170797719|NCT02720068|617272446|FG005|Overall Study|Death|1|||
170797720|NCT02720068|617272447|FG006|Overall Study|Death|2|||
170797721|NCT02720068|617272448|FG007|Overall Study|Death|2|||
170797722|NCT02720068|617272449|FG008|Overall Study|Death|3|||
170797723|NCT02720068|617272450|FG009|Overall Study|Death|1|||
170797724|NCT02720068|617272451|FG010|Overall Study|Death|20|||
170797725|NCT02720068|617272452|FG011|Overall Study|Death|166|||
170797726|NCT02720068|617272453|FG012|Overall Study|Death|34|||
170797727|NCT02720068|617272454|FG013|Overall Study|Death|30|||
170797728|NCT02720068|617272455|FG014|Overall Study|Death|45|||
170797729|NCT02720068|617272456|FG015|Overall Study|Death|16|||
170797730|NCT02720068|617272457|FG016|Overall Study|Death|20|||
170797731|NCT02720068|617272458|FG017|Overall Study|Death|28|||
170797732|NCT02720068|617272441|FG000|Overall Study|Lost to Follow-up|0|||
170797733|NCT02720068|617272442|FG001|Overall Study|Lost to Follow-up|0|||
170797734|NCT02720068|617272443|FG002|Overall Study|Lost to Follow-up|0|||
170797735|NCT02720068|617272444|FG003|Overall Study|Lost to Follow-up|0|||
170797736|NCT02720068|617272445|FG004|Overall Study|Lost to Follow-up|0|||
170797737|NCT02720068|617272446|FG005|Overall Study|Lost to Follow-up|0|||
170797738|NCT02720068|617272447|FG006|Overall Study|Lost to Follow-up|0|||
170797739|NCT02720068|617272448|FG007|Overall Study|Lost to Follow-up|0|||
170797740|NCT02720068|617272449|FG008|Overall Study|Lost to Follow-up|0|||
170797741|NCT02720068|617272450|FG009|Overall Study|Lost to Follow-up|0|||
170797742|NCT02720068|617272451|FG010|Overall Study|Lost to Follow-up|0|||
170797743|NCT02720068|617272452|FG011|Overall Study|Lost to Follow-up|1|||
170797744|NCT02720068|617272453|FG012|Overall Study|Lost to Follow-up|0|||
170797745|NCT02720068|617272454|FG013|Overall Study|Lost to Follow-up|1|||
170797746|NCT02720068|617272455|FG014|Overall Study|Lost to Follow-up|2|||
170797747|NCT02720068|617272456|FG015|Overall Study|Lost to Follow-up|0|||
170797748|NCT02720068|617272457|FG016|Overall Study|Lost to Follow-up|0|||
170797749|NCT02720068|617272458|FG017|Overall Study|Lost to Follow-up|1|||
170797750|NCT02720068|617272441|FG000|Overall Study|Physician Decision|0|||
170797751|NCT02720068|617272442|FG001|Overall Study|Physician Decision|0|||
170797752|NCT02720068|617272443|FG002|Overall Study|Physician Decision|0|||
170797753|NCT02720068|617272444|FG003|Overall Study|Physician Decision|1|||
170797754|NCT02720068|617272445|FG004|Overall Study|Physician Decision|0|||
170797755|NCT02720068|617272446|FG005|Overall Study|Physician Decision|0|||
170797756|NCT02720068|617272447|FG006|Overall Study|Physician Decision|0|||
170797757|NCT02720068|617272448|FG007|Overall Study|Physician Decision|0|||
170797758|NCT02720068|617272449|FG008|Overall Study|Physician Decision|0|||
170797759|NCT02720068|617272450|FG009|Overall Study|Physician Decision|0|||
170797760|NCT02720068|617272451|FG010|Overall Study|Physician Decision|0|||
170797761|NCT02720068|617272452|FG011|Overall Study|Physician Decision|1|||
170797762|NCT02720068|617272453|FG012|Overall Study|Physician Decision|0|||
170797763|NCT02720068|617272454|FG013|Overall Study|Physician Decision|0|||
170797764|NCT02720068|617272455|FG014|Overall Study|Physician Decision|0|||
170797765|NCT02720068|617272456|FG015|Overall Study|Physician Decision|0|||
170797766|NCT02720068|617272457|FG016|Overall Study|Physician Decision|0|||
170797767|NCT02720068|617272458|FG017|Overall Study|Physician Decision|1|||
170797768|NCT02720068|617272441|FG000|Overall Study|Progressive Disease|2|||
170797769|NCT02720068|617272442|FG001|Overall Study|Progressive Disease|3|||
170797770|NCT02720068|617272443|FG002|Overall Study|Progressive Disease|1|||
170797771|NCT02720068|617272444|FG003|Overall Study|Progressive Disease|1|||
170797772|NCT02720068|617272445|FG004|Overall Study|Progressive Disease|1|||
170797773|NCT02720068|617272446|FG005|Overall Study|Progressive Disease|2|||
170797774|NCT02720068|617272447|FG006|Overall Study|Progressive Disease|1|||
170797775|NCT02720068|617272448|FG007|Overall Study|Progressive Disease|1|||
170797776|NCT02720068|617272449|FG008|Overall Study|Progressive Disease|0|||
170797777|NCT02720068|617272450|FG009|Overall Study|Progressive Disease|1|||
170797778|NCT02720068|617272451|FG010|Overall Study|Progressive Disease|0|||
170548478|NCT02730169|616354602|FG003|Overall Study|Lost to Follow-up|6|||
170548479|NCT02730169|616354599|FG000|Overall Study|Other|0|||
170548480|NCT02730169|616354600|FG001|Overall Study|Other|0|||
170548481|NCT02730169|616354601|FG002|Overall Study|Other|1|||
170548482|NCT02730169|616354602|FG003|Overall Study|Other|1|||
170548483|NCT04605588|616354611|FG000|Overall Study|Withdrawal by Subject|1|||
170548484|NCT04605588|616354612|FG001|Overall Study|Withdrawal by Subject|0|||
170548485|NCT01803737|616354613|FG000|Overall Study|Lack of Time|1|||
170548486|NCT01803737|616354614|FG001|Overall Study|Lack of Time|0|||
170548487|NCT01803737|616354613|FG000|Overall Study|Medical Reason|0|||
170548488|NCT01803737|616354614|FG001|Overall Study|Medical Reason|1|||
170548489|NCT01803737|616354613|FG000|Overall Study|Lost to Follow-up|0|||
170548490|NCT01803737|616354614|FG001|Overall Study|Lost to Follow-up|2|||
170548491|NCT01748552|616354615|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
170548492|NCT01748552|616354616|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
170548493|NCT01748552|616354617|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
170548494|NCT01748552|616354618|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
170897483|NCT01750918|617630185|FG006|Overall Study|Withdrawal by Subject|2|||
170897484|NCT01750918|617630186|FG007|Overall Study|Withdrawal by Subject|2|||
170897485|NCT02031679|617630189|FG000|Overall Study|Protocol Violation|0|||
170897486|NCT02031679|617630190|FG001|Overall Study|Protocol Violation|1|||
170897487|NCT02031679|617630189|FG000|Overall Study|Lack of Efficacy|0|||
170897488|NCT02031679|617630190|FG001|Overall Study|Lack of Efficacy|1|||
170897489|NCT00162773|617630199|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
170897490|NCT02338843|617630201|FG000|Overall Study|Adverse Event|2|||
170897491|NCT02338843|617630202|FG001|Overall Study|Adverse Event|1|||
170897492|NCT02338843|617630201|FG000|Overall Study|Death|40|||
170897493|NCT02338843|617630202|FG001|Overall Study|Death|53|||
170897494|NCT02338843|617630201|FG000|Overall Study|Physician Decision|1|||
170897495|NCT02338843|617630202|FG001|Overall Study|Physician Decision|0|||
170897496|NCT02338843|617630201|FG000|Overall Study|Withdrawal by Subject|0|||
170548495|NCT01748552|616354619|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
170548496|NCT01748552|616354620|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
170548497|NCT01748552|616354621|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
170797779|NCT02720068|617272452|FG011|Overall Study|Progressive Disease|4|||
170797780|NCT02720068|617272453|FG012|Overall Study|Progressive Disease|1|||
170797781|NCT02720068|617272454|FG013|Overall Study|Progressive Disease|0|||
170797782|NCT02720068|617272455|FG014|Overall Study|Progressive Disease|0|||
170797783|NCT02720068|617272456|FG015|Overall Study|Progressive Disease|0|||
170797784|NCT02720068|617272457|FG016|Overall Study|Progressive Disease|0|||
170797785|NCT02720068|617272458|FG017|Overall Study|Progressive Disease|0|||
170797786|NCT02720068|617272441|FG000|Overall Study|Sponsor Decision|0|||
170797787|NCT02720068|617272442|FG001|Overall Study|Sponsor Decision|0|||
170797788|NCT02720068|617272443|FG002|Overall Study|Sponsor Decision|0|||
170797789|NCT02720068|617272444|FG003|Overall Study|Sponsor Decision|0|||
170797790|NCT02720068|617272445|FG004|Overall Study|Sponsor Decision|0|||
170797791|NCT02720068|617272446|FG005|Overall Study|Sponsor Decision|0|||
170797792|NCT02720068|617272447|FG006|Overall Study|Sponsor Decision|0|||
170797793|NCT02720068|617272448|FG007|Overall Study|Sponsor Decision|0|||
170797794|NCT02720068|617272449|FG008|Overall Study|Sponsor Decision|0|||
170797795|NCT02720068|617272450|FG009|Overall Study|Sponsor Decision|0|||
170797796|NCT02720068|617272451|FG010|Overall Study|Sponsor Decision|0|||
170797797|NCT02720068|617272452|FG011|Overall Study|Sponsor Decision|6|||
170797798|NCT02720068|617272453|FG012|Overall Study|Sponsor Decision|3|||
170797799|NCT02720068|617272454|FG013|Overall Study|Sponsor Decision|2|||
170797800|NCT02720068|617272455|FG014|Overall Study|Sponsor Decision|4|||
170797801|NCT02720068|617272456|FG015|Overall Study|Sponsor Decision|4|||
170797802|NCT02720068|617272457|FG016|Overall Study|Sponsor Decision|0|||
170797803|NCT02720068|617272458|FG017|Overall Study|Sponsor Decision|8|||
170797804|NCT02720068|617272441|FG000|Overall Study|Withdrawal by Subject|0|||
170797805|NCT02720068|617272442|FG001|Overall Study|Withdrawal by Subject|0|||
170797806|NCT02720068|617272443|FG002|Overall Study|Withdrawal by Subject|0|||
170797807|NCT02720068|617272444|FG003|Overall Study|Withdrawal by Subject|0|||
170897497|NCT02338843|617630202|FG001|Overall Study|Withdrawal by Subject|2|||
170897498|NCT02338843|617630201|FG000|Overall Study|Subject Recovered|0|||
170548498|NCT01748552|616354622|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
170548499|NCT01748552|616354623|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
170548500|NCT01748552|616354624|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
170797808|NCT02720068|617272445|FG004|Overall Study|Withdrawal by Subject|0|||
170797809|NCT02720068|617272446|FG005|Overall Study|Withdrawal by Subject|0|||
170797810|NCT02720068|617272447|FG006|Overall Study|Withdrawal by Subject|0|||
170797811|NCT02720068|617272448|FG007|Overall Study|Withdrawal by Subject|0|||
170797812|NCT02720068|617272449|FG008|Overall Study|Withdrawal by Subject|0|||
170797813|NCT02720068|617272450|FG009|Overall Study|Withdrawal by Subject|1|||
170897499|NCT02338843|617630202|FG001|Overall Study|Subject Recovered|2|||
170897500|NCT02338843|617630201|FG000|Overall Study|Discontinued prior to randomizat|1|||
170897501|NCT02338843|617630202|FG001|Overall Study|Discontinued prior to randomizat|0|||
170797814|NCT02720068|617272451|FG010|Overall Study|Withdrawal by Subject|0|||
170797815|NCT02720068|617272452|FG011|Overall Study|Withdrawal by Subject|27|||
170797816|NCT02720068|617272453|FG012|Overall Study|Withdrawal by Subject|2|||
170797817|NCT02720068|617272454|FG013|Overall Study|Withdrawal by Subject|8|||
170797818|NCT02720068|617272455|FG014|Overall Study|Withdrawal by Subject|7|||
170797819|NCT02720068|617272456|FG015|Overall Study|Withdrawal by Subject|0|||
170797820|NCT02720068|617272457|FG016|Overall Study|Withdrawal by Subject|0|||
170797821|NCT02720068|617272458|FG017|Overall Study|Withdrawal by Subject|2|||
170797822|NCT02720068|617272441|FG000|Overall Study|Protocol Violation|0|||
170797823|NCT02720068|617272442|FG001|Overall Study|Protocol Violation|0|||
170797824|NCT02720068|617272443|FG002|Overall Study|Protocol Violation|0|||
170797825|NCT02720068|617272444|FG003|Overall Study|Protocol Violation|0|||
170797826|NCT02720068|617272445|FG004|Overall Study|Protocol Violation|0|||
170797827|NCT02720068|617272446|FG005|Overall Study|Protocol Violation|0|||
170797828|NCT02720068|617272447|FG006|Overall Study|Protocol Violation|0|||
170797829|NCT02720068|617272448|FG007|Overall Study|Protocol Violation|0|||
170797830|NCT02720068|617272449|FG008|Overall Study|Protocol Violation|0|||
170797831|NCT02720068|617272450|FG009|Overall Study|Protocol Violation|0|||
170797832|NCT02720068|617272451|FG010|Overall Study|Protocol Violation|1|||
170797833|NCT02720068|617272452|FG011|Overall Study|Protocol Violation|0|||
170797834|NCT02720068|617272453|FG012|Overall Study|Protocol Violation|0|||
170797835|NCT02720068|617272454|FG013|Overall Study|Protocol Violation|0|||
170797836|NCT02720068|617272455|FG014|Overall Study|Protocol Violation|1|||
170797837|NCT02720068|617272456|FG015|Overall Study|Protocol Violation|0|||
170797838|NCT02720068|617272457|FG016|Overall Study|Protocol Violation|1|||
170797839|NCT02720068|617272458|FG017|Overall Study|Protocol Violation|0|||
170797840|NCT02076009|617272465|FG000|Overall Study|Death|172|||
170797841|NCT02076009|617272466|FG001|Overall Study|Death|153|||
170797842|NCT02076009|617272465|FG000|Overall Study|Withdrawal by Subject|16|||
170797843|NCT02076009|617272466|FG001|Overall Study|Withdrawal by Subject|12|||
170797844|NCT02076009|617272465|FG000|Overall Study|Lost to Follow-up|4|||
170797845|NCT02076009|617272466|FG001|Overall Study|Lost to Follow-up|2|||
170797846|NCT02076009|617272465|FG000|Overall Study|Progressive Disease|1|||
170797847|NCT02076009|617272466|FG001|Overall Study|Progressive Disease|0|||
170797848|NCT02076009|617272465|FG000|Overall Study|Physician Decision|0|||
170797849|NCT02076009|617272466|FG001|Overall Study|Physician Decision|1|||
170797850|NCT02076009|617272465|FG000|Overall Study|End of data collection|90|||
170797851|NCT02076009|617272466|FG001|Overall Study|End of data collection|118|||
170797852|NCT04464564|617272467|FG000|Period A (Placebo lead-in)|Other|5|||
170797853|NCT04464564|617272468|FG001|Period A (Placebo lead-in)|Other|0|||
170797854|NCT04464564|617272469|FG002|Period A (Placebo lead-in)|Other|0|||
170797855|NCT04464564|617272470|FG003|Period A (Placebo lead-in)|Other|0|||
170797856|NCT04464564|617272467|FG000|Period B (Randomization Period)|Adverse Event|0|||
170797857|NCT04464564|617272468|FG001|Period B (Randomization Period)|Adverse Event|1|||
170797858|NCT04464564|617272469|FG002|Period B (Randomization Period)|Adverse Event|2|||
170797859|NCT04464564|617272470|FG003|Period B (Randomization Period)|Adverse Event|8|||
170797860|NCT04464564|617272467|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
170797861|NCT04464564|617272468|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
170797862|NCT04464564|617272469|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
170797863|NCT04464564|617272470|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
170797864|NCT04464564|617272467|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
170797865|NCT04464564|617272468|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
170797866|NCT04464564|617272469|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
170797867|NCT04464564|617272470|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
170797868|NCT04464564|617272467|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
170797869|NCT04464564|617272468|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
170797870|NCT04464564|617272469|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
170797871|NCT04464564|617272470|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
170797872|NCT04464564|617272467|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
170797873|NCT04464564|617272468|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
170797874|NCT04464564|617272469|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
170797875|NCT04464564|617272470|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
170797876|NCT04464564|617272467|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
170797877|NCT04464564|617272468|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
170797878|NCT04464564|617272469|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
170897502|NCT00023322|617630203|FG000|Overall Study|Lost to Follow-up|1|||
170897503|NCT01609933|617630204|FG000|Overall Study|Adverse Event|1|||
170897504|NCT01609933|617630204|FG000|Overall Study|Withdrawal by Subject|3|||
170797879|NCT04464564|617272470|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
170797880|NCT04464564|617272467|FG000|Period B (Randomization Period)|Reason not Specified|0|||
170797881|NCT04464564|617272468|FG001|Period B (Randomization Period)|Reason not Specified|3|||
170797882|NCT04464564|617272469|FG002|Period B (Randomization Period)|Reason not Specified|3|||
170797883|NCT04464564|617272470|FG003|Period B (Randomization Period)|Reason not Specified|3|||
170897505|NCT05019131|617630205|FG000|Overall Study|Lost to Follow-up|0|||
170897506|NCT05019131|617630206|FG001|Overall Study|Lost to Follow-up|3|||
170897507|NCT03575104|617630207|FG000|Overall Study|Adverse Event|4|||
170897508|NCT03575104|617630208|FG001|Overall Study|Adverse Event|3|||
170897509|NCT03575104|617630209|FG002|Overall Study|Adverse Event|4|||
170897510|NCT03575104|617630207|FG000|Overall Study|Withdrawal by Subject|13|||
170897511|NCT03575104|617630208|FG001|Overall Study|Withdrawal by Subject|16|||
170897512|NCT03575104|617630209|FG002|Overall Study|Withdrawal by Subject|11|||
170897513|NCT03575104|617630207|FG000|Overall Study|Other reasons|6|||
170897514|NCT03575104|617630208|FG001|Overall Study|Other reasons|8|||
170897515|NCT03575104|617630209|FG002|Overall Study|Other reasons|6|||
170897516|NCT03575104|617630207|FG000|Overall Study|Lost to Follow-up|1|||
170897517|NCT03575104|617630208|FG001|Overall Study|Lost to Follow-up|2|||
170897518|NCT03575104|617630209|FG002|Overall Study|Lost to Follow-up|1|||
170897519|NCT00332709|617630210|FG000|Overall Study|Adverse Event|11|||
170897520|NCT00332709|617630211|FG001|Overall Study|Adverse Event|14|||
170897521|NCT00332709|617630210|FG000|Overall Study|Withdrawal by Subject|2|||
170897522|NCT00332709|617630211|FG001|Overall Study|Withdrawal by Subject|3|||
170897523|NCT00332709|617630210|FG000|Overall Study|Lost to Follow-up|2|||
170897524|NCT00332709|617630211|FG001|Overall Study|Lost to Follow-up|0|||
170897525|NCT00332709|617630210|FG000|Overall Study|Administrative Problems|0|||
170897526|NCT00332709|617630211|FG001|Overall Study|Administrative Problems|3|||
170897527|NCT00332709|617630210|FG000|Overall Study|Abnormal test procedure result|1|||
170897528|NCT00332709|617630211|FG001|Overall Study|Abnormal test procedure result|0|||
170897529|NCT04684420|617630212|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170897530|NCT04684420|617630213|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170897531|NCT04684420|617630214|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
170897532|NCT04684420|617630215|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
170897533|NCT04684420|617630212|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
170897534|NCT04684420|617630213|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
170897535|NCT04684420|617630214|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
170897536|NCT04684420|617630215|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
170897537|NCT04067518|617630218|FG000|Overall Study|Adverse Event|1|||
170897538|NCT04067518|617630219|FG001|Overall Study|Adverse Event|3|||
170897539|NCT04067518|617630218|FG000|Overall Study|Screen failures|0|||
170897540|NCT04067518|617630219|FG001|Overall Study|Screen failures|1|||
170897541|NCT04067518|617630218|FG000|Overall Study|Enrolled but not treated|0|||
170897542|NCT04067518|617630219|FG001|Overall Study|Enrolled but not treated|1|||
170897543|NCT00110019|617630220|FG000|Overall Study|Lack of Efficacy|253|||
170897544|NCT00110019|617630221|FG001|Overall Study|Lack of Efficacy|285|||
170897545|NCT00110019|617630220|FG000|Overall Study|Adverse Event|61|||
170897546|NCT00110019|617630221|FG001|Overall Study|Adverse Event|40|||
170897547|NCT00110019|617630220|FG000|Overall Study|Death|13|||
170897548|NCT00110019|617630221|FG001|Overall Study|Death|15|||
170897549|NCT00110019|617630220|FG000|Overall Study|Withdrawal by Subject|21|||
170897550|NCT00110019|617630221|FG001|Overall Study|Withdrawal by Subject|9|||
170897551|NCT00110019|617630220|FG000|Overall Study|alternative therapy|5|||
170897552|NCT00110019|617630221|FG001|Overall Study|alternative therapy|1|||
170897553|NCT00110019|617630220|FG000|Overall Study|complicating disease|1|||
170897554|NCT00110019|617630221|FG001|Overall Study|complicating disease|1|||
170897555|NCT00110019|617630220|FG000|Overall Study|symptom deterioration|13|||
170897556|NCT00110019|617630221|FG001|Overall Study|symptom deterioration|16|||
170897557|NCT00110019|617630220|FG000|Overall Study|Not start protocol therapy|17|||
170897558|NCT00110019|617630221|FG001|Overall Study|Not start protocol therapy|16|||
170897559|NCT00110019|617630220|FG000|Overall Study|other reasons|22|||
170897560|NCT00110019|617630221|FG001|Overall Study|other reasons|30|||
170897561|NCT04276207|617630223|FG000|Period 1|Withdrawal by Subject|0|||
170897562|NCT04276207|617630224|FG001|Period 1|Withdrawal by Subject|1|||
170897563|NCT01256177|617630225|FG000|Overall Study|Withdrawal by Subject|23|||
170897564|NCT01256177|617630226|FG001|Overall Study|Withdrawal by Subject|22|||
170897565|NCT01256177|617630225|FG000|Overall Study|Lost to Follow-up|2|||
170897566|NCT01256177|617630226|FG001|Overall Study|Lost to Follow-up|2|||
170897567|NCT01256177|617630225|FG000|Overall Study|Adverse Event|8|||
170897568|NCT01256177|617630226|FG001|Overall Study|Adverse Event|9|||
170897569|NCT01256177|617630225|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
170897570|NCT01256177|617630226|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
170897571|NCT01256177|617630225|FG000|Overall Study|Condition under Investigation Worsened|1|||
170897572|NCT01256177|617630226|FG001|Overall Study|Condition under Investigation Worsened|0|||
170897573|NCT01256177|617630225|FG000|Overall Study|Lack of Efficacy|11|||
170897574|NCT01256177|617630226|FG001|Overall Study|Lack of Efficacy|2|||
170897575|NCT01256177|617630225|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
170897576|NCT01256177|617630226|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
170897577|NCT02690194|617630227|FG000|Overall Study|Withdrawal by Subject|1|||
170897578|NCT02690194|617630228|FG001|Overall Study|Withdrawal by Subject|4|||
170897579|NCT02690194|617630229|FG002|Overall Study|Withdrawal by Subject|0|||
170897580|NCT03624946|617630230|FG000|Overall Study|Lost to Follow-up|0|||
170897581|NCT03624946|617630231|FG001|Overall Study|Lost to Follow-up|1|||
170797884|NCT04757753|617272475|FG000|Overall Study|Lost to Follow-up|7|||
170797885|NCT04757753|617272476|FG001|Overall Study|Lost to Follow-up|7|||
170797886|NCT04757753|617272475|FG000|Overall Study|Withdrawal by Subject|0|||
170482093|NCT03334435|616105612|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482094|NCT03334435|616105613|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482095|NCT03334435|616105614|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482096|NCT03334435|616105615|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482097|NCT03334435|616105616|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482098|NCT03334435|616105617|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482099|NCT03334435|616105618|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482100|NCT03334435|616105619|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482101|NCT03334435|616105620|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482102|NCT03334435|616105621|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
170482103|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
170482104|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
170482105|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
170482106|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
170482107|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
170482108|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
170482109|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
170482110|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
170482111|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
170482112|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
170482113|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
170482114|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
170482115|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
170482116|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
170482117|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
170482118|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
170482119|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
170482120|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
170482121|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
170482122|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
170482123|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
170482124|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
170482125|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
170482126|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
170482127|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
170482128|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
170482129|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
170482130|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
170482131|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
170482132|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
170482133|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
170482134|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
170482135|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
170482136|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
170482137|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
170482138|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
170482139|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
170482140|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
170482141|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
170482142|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
170482143|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
170482144|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
170482145|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
170482146|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
170482147|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
170482148|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
170482149|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
170797887|NCT04757753|617272476|FG001|Overall Study|Withdrawal by Subject|3|||
170797888|NCT04757753|617272475|FG000|Overall Study|Endodontic treatment failure|1|||
170797889|NCT04757753|617272476|FG001|Overall Study|Endodontic treatment failure|2|||
170797890|NCT04757753|617272475|FG000|Overall Study|Tooth fracture/extraction|3|||
170482150|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
170482151|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
170482152|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
170482153|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
170482154|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
170482155|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
170482156|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
170482157|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
170482158|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
170482159|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
170482160|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
170482161|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
170482162|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
170482163|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
170482164|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
170482165|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
170482166|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
170482167|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
170482168|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
170482169|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
170482170|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
170482171|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
170482172|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
170482173|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
170482174|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
170482175|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
170482176|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
170482177|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
170482178|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482179|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482180|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482181|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482182|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482183|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482184|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482185|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482186|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482187|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482188|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482189|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
170482190|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482191|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
170482192|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
170482193|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482194|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482195|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482196|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482197|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482198|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
170548501|NCT01748552|616354625|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
170548502|NCT01748552|616354626|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
170548503|NCT01748552|616354615|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170548504|NCT01748552|616354616|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170548505|NCT01748552|616354617|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170548506|NCT01748552|616354618|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170548507|NCT01748552|616354619|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170897582|NCT00862251|617630237|FG000|Overall Study|Adverse Event|8|||
170897583|NCT00862251|617630238|FG001|Overall Study|Adverse Event|3|||
170897584|NCT00862251|617630239|FG002|Overall Study|Adverse Event|1|||
170897585|NCT00862251|617630237|FG000|Overall Study|Lost to Follow-up|0|||
170548508|NCT01748552|616354620|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170548509|NCT01748552|616354621|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
170897586|NCT00862251|617630238|FG001|Overall Study|Lost to Follow-up|0|||
170897587|NCT00862251|617630239|FG002|Overall Study|Lost to Follow-up|1|||
170482199|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482200|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482201|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482202|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482203|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482204|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482205|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482206|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
170482207|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
170482208|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
170482209|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
170482210|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
170482211|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
170482212|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
170482213|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
170482214|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
170482215|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
170482216|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
170482217|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
170482218|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
170482219|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
170482220|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
170482221|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
170482222|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
170482223|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482224|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482225|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482226|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482227|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482228|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
170482229|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
170482230|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482231|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482232|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482233|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
170482234|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
170482235|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
170482236|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
170482237|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
170482238|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482239|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482240|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482241|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482242|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482243|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
170482244|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482245|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482246|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482247|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482248|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
170482249|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482250|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482251|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
170482252|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
170482253|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482254|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482255|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482256|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482257|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482258|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170797891|NCT04757753|617272476|FG001|Overall Study|Tooth fracture/extraction|0|||
170797892|NCT05147584|617272479|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
170482259|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482260|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
170482261|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
170482262|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482263|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
170482264|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
170482265|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
170482266|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482267|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
170482268|NCT03334435|616105607|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482269|NCT03334435|616105608|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482270|NCT03334435|616105609|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482271|NCT03334435|616105610|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482272|NCT03334435|616105611|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482273|NCT03334435|616105612|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482274|NCT03334435|616105613|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482275|NCT03334435|616105614|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482276|NCT03334435|616105615|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482277|NCT03334435|616105616|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482278|NCT03334435|616105617|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482279|NCT03334435|616105618|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
170482280|NCT03334435|616105619|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
170482281|NCT03334435|616105620|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
170482282|NCT03334435|616105621|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
170482283|NCT03871543|616105628|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
170482284|NCT03871543|616105628|FG000|Period 1|Investigator Error|1|||
170482285|NCT03871543|616105628|FG000|Period 1|Protocol Violation|2|||
170482286|NCT03871543|616105628|FG000|Period 1|COVID-19 Related|1|||
170482287|NCT03871543|616105628|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
170482288|NCT03871543|616105628|FG000|Period 1|Withdrawal by Subject|10|||
170482289|NCT03871543|616105628|FG000|Period 2|Adverse Event|1|||
170482290|NCT03871543|616105628|FG000|Period 2|Withdrawal by Subject|1|||
170482291|NCT01894919|616105629|FG000|Overall Study|Withdrawal by Subject|1|||
170482292|NCT01894919|616105630|FG001|Overall Study|Withdrawal by Subject|0|||
170482293|NCT01894919|616105631|FG002|Overall Study|Withdrawal by Subject|0|||
170482294|NCT01894919|616105632|FG003|Overall Study|Withdrawal by Subject|0|||
170482295|NCT01894919|616105633|FG004|Overall Study|Withdrawal by Subject|1|||
170482296|NCT01894919|616105634|FG005|Overall Study|Withdrawal by Subject|0|||
170482297|NCT01894919|616105635|FG006|Overall Study|Withdrawal by Subject|0|||
170482298|NCT01894919|616105636|FG007|Overall Study|Withdrawal by Subject|0|||
170482299|NCT01894919|616105637|FG008|Overall Study|Withdrawal by Subject|0|||
170482300|NCT01894919|616105638|FG009|Overall Study|Withdrawal by Subject|1|||
170797893|NCT04055012|617272480|FG000|Overall Study|Withdrawal by Subject|1|||
170797894|NCT04055012|617272481|FG001|Overall Study|Withdrawal by Subject|3|||
170482301|NCT01894919|616105639|FG010|Overall Study|Withdrawal by Subject|1|||
170797895|NCT04055012|617272482|FG002|Overall Study|Withdrawal by Subject|1|||
170797896|NCT04055012|617272483|FG003|Overall Study|Withdrawal by Subject|0|||
170797897|NCT04055012|617272480|FG000|Overall Study|Metformin Recall|1|||
170797898|NCT04055012|617272481|FG001|Overall Study|Metformin Recall|1|||
170797899|NCT04055012|617272482|FG002|Overall Study|Metformin Recall|1|||
170797900|NCT04055012|617272483|FG003|Overall Study|Metformin Recall|0|||
170797901|NCT02492711|617272487|FG000|Overall Study|Adverse Event|9|||
170797902|NCT02492711|617272488|FG001|Overall Study|Adverse Event|9|||
170797903|NCT02492711|617272489|FG002|Overall Study|Adverse Event|2|||
170797904|NCT02492711|617272487|FG000|Overall Study|Death|3|||
170797905|NCT02492711|617272488|FG001|Overall Study|Death|3|||
170797906|NCT02492711|617272489|FG002|Overall Study|Death|0|||
170797907|NCT02492711|617272487|FG000|Overall Study|Withdrawal by Subject|10|||
170797908|NCT02492711|617272488|FG001|Overall Study|Withdrawal by Subject|16|||
170797909|NCT02492711|617272489|FG002|Overall Study|Withdrawal by Subject|5|||
170797910|NCT02492711|617272487|FG000|Overall Study|Physician Decision|10|||
170797911|NCT02492711|617272488|FG001|Overall Study|Physician Decision|6|||
170797912|NCT02492711|617272489|FG002|Overall Study|Physician Decision|4|||
170797913|NCT02492711|617272487|FG000|Overall Study|Lost to Follow-up|0|||
170797914|NCT02492711|617272488|FG001|Overall Study|Lost to Follow-up|0|||
170797915|NCT02492711|617272489|FG002|Overall Study|Lost to Follow-up|1|||
170797916|NCT02492711|617272487|FG000|Overall Study|study treatment delay|2|||
170797917|NCT02492711|617272488|FG001|Overall Study|study treatment delay|1|||
170897588|NCT00862251|617630237|FG000|Overall Study|Protocol Violation|2|||
170482302|NCT01894919|616105640|FG011|Overall Study|Withdrawal by Subject|0|||
170482303|NCT01894919|616105641|FG012|Overall Study|Withdrawal by Subject|0|||
170897589|NCT00862251|617630238|FG001|Overall Study|Protocol Violation|0|||
170482304|NCT01894919|616105629|FG000|Overall Study|Adverse Event|0|||
170797918|NCT02492711|617272489|FG002|Overall Study|study treatment delay|0|||
170797919|NCT02492711|617272487|FG000|Overall Study|change in chemotherapy|0|||
170797920|NCT02492711|617272488|FG001|Overall Study|change in chemotherapy|1|||
170482305|NCT01894919|616105630|FG001|Overall Study|Adverse Event|0|||
170482306|NCT01894919|616105631|FG002|Overall Study|Adverse Event|0|||
170482307|NCT01894919|616105632|FG003|Overall Study|Adverse Event|0|||
170482308|NCT01894919|616105633|FG004|Overall Study|Adverse Event|0|||
170482309|NCT01894919|616105634|FG005|Overall Study|Adverse Event|0|||
170482310|NCT01894919|616105635|FG006|Overall Study|Adverse Event|0|||
170482311|NCT01894919|616105636|FG007|Overall Study|Adverse Event|0|||
170482312|NCT01894919|616105637|FG008|Overall Study|Adverse Event|0|||
170482313|NCT01894919|616105638|FG009|Overall Study|Adverse Event|0|||
170482314|NCT01894919|616105639|FG010|Overall Study|Adverse Event|1|||
170482315|NCT01894919|616105640|FG011|Overall Study|Adverse Event|0|||
170482316|NCT01894919|616105641|FG012|Overall Study|Adverse Event|0|||
170482317|NCT01894919|616105629|FG000|Overall Study|Other-Unspecified|1|||
170482318|NCT01894919|616105630|FG001|Overall Study|Other-Unspecified|0|||
170482319|NCT01894919|616105631|FG002|Overall Study|Other-Unspecified|0|||
170482320|NCT01894919|616105632|FG003|Overall Study|Other-Unspecified|0|||
170482321|NCT01894919|616105633|FG004|Overall Study|Other-Unspecified|0|||
170482322|NCT01894919|616105634|FG005|Overall Study|Other-Unspecified|0|||
170482323|NCT01894919|616105635|FG006|Overall Study|Other-Unspecified|0|||
170482324|NCT01894919|616105636|FG007|Overall Study|Other-Unspecified|0|||
170482325|NCT01894919|616105637|FG008|Overall Study|Other-Unspecified|0|||
170482326|NCT01894919|616105638|FG009|Overall Study|Other-Unspecified|0|||
170482327|NCT01894919|616105639|FG010|Overall Study|Other-Unspecified|0|||
170482328|NCT01894919|616105640|FG011|Overall Study|Other-Unspecified|0|||
170482329|NCT01894919|616105641|FG012|Overall Study|Other-Unspecified|0|||
170482330|NCT01894919|616105629|FG000|Overall Study|Lost to Follow-up|0|||
170482331|NCT01894919|616105630|FG001|Overall Study|Lost to Follow-up|0|||
170482332|NCT01894919|616105631|FG002|Overall Study|Lost to Follow-up|0|||
170482333|NCT01894919|616105632|FG003|Overall Study|Lost to Follow-up|0|||
170482334|NCT01894919|616105633|FG004|Overall Study|Lost to Follow-up|2|||
170482335|NCT01894919|616105634|FG005|Overall Study|Lost to Follow-up|0|||
170482336|NCT01894919|616105635|FG006|Overall Study|Lost to Follow-up|0|||
170482337|NCT01894919|616105636|FG007|Overall Study|Lost to Follow-up|0|||
170482338|NCT01894919|616105637|FG008|Overall Study|Lost to Follow-up|0|||
170482339|NCT01894919|616105638|FG009|Overall Study|Lost to Follow-up|0|||
170482340|NCT01894919|616105639|FG010|Overall Study|Lost to Follow-up|0|||
170482341|NCT01894919|616105640|FG011|Overall Study|Lost to Follow-up|0|||
170482342|NCT01894919|616105641|FG012|Overall Study|Lost to Follow-up|0|||
170482343|NCT02075203|616105642|FG000|Overall Study|Withdrawal by Subject|1|||
170482344|NCT02075203|616105643|FG001|Overall Study|Withdrawal by Subject|0|||
170482345|NCT02075203|616105644|FG002|Overall Study|Withdrawal by Subject|1|||
170482346|NCT02075203|616105642|FG000|Overall Study|Adverse Event|1|||
170482347|NCT02075203|616105643|FG001|Overall Study|Adverse Event|0|||
170482348|NCT02075203|616105644|FG002|Overall Study|Adverse Event|0|||
170482349|NCT02075203|616105642|FG000|Overall Study|participant refused to use contraception|1|||
170482350|NCT02075203|616105643|FG001|Overall Study|participant refused to use contraception|0|||
170482351|NCT02075203|616105644|FG002|Overall Study|participant refused to use contraception|0|||
170482352|NCT03711188|616105645|FG000|Overall Study|Disease progression|11|||
170482353|NCT03711188|616105645|FG000|Overall Study|Adverse Event|1|||
170482354|NCT03802825|616105654|FG000|Overall Study|Lost to follow-up for intervention|12|||
170482355|NCT03802825|616105655|FG001|Overall Study|Lost to follow-up for intervention|3|||
170482356|NCT03802825|616105654|FG000|Overall Study|Received only 1 component of intervention|0|||
170482357|NCT03802825|616105655|FG001|Overall Study|Received only 1 component of intervention|13|||
170482358|NCT00568451|616105656|FG000|Overall Study|Disease Progression|0|||
170482359|NCT00568451|616105657|FG001|Overall Study|Disease Progression|0|||
170482360|NCT00568451|616105658|FG002|Overall Study|Disease Progression|2|||
170482361|NCT00568451|616105659|FG003|Overall Study|Disease Progression|7|||
170482362|NCT02069015|616105663|FG000|Overall Study|Lost to Follow-up|39|||
170482363|NCT02069015|616105664|FG001|Overall Study|Lost to Follow-up|32|||
170482364|NCT02069015|616105663|FG000|Overall Study|Withdrawal by Subject|1|||
170482365|NCT02069015|616105664|FG001|Overall Study|Withdrawal by Subject|1|||
170482366|NCT03776357|616105666|FG000|Overall Study|Lost to Follow-up|3|||
170482367|NCT01704495|616105668|FG000|Subjects Randomized|Other Reason|3|||
170482368|NCT01704495|616105669|FG001|Subjects Randomized|Other Reason|2|||
170482369|NCT01704495|616105670|FG002|Subjects Randomized|Other Reason|3|||
170482370|NCT01704495|616105671|FG003|Subjects Randomized|Other Reason|2|||
170482371|NCT01704495|616105668|FG000|Subjects Randomized|Discontinuation criteria met|4|||
170482372|NCT01704495|616105669|FG001|Subjects Randomized|Discontinuation criteria met|2|||
170482373|NCT01704495|616105670|FG002|Subjects Randomized|Discontinuation criteria met|2|||
170482374|NCT01704495|616105671|FG003|Subjects Randomized|Discontinuation criteria met|0|||
170482375|NCT01704495|616105668|FG000|Subjects Randomized|Adverse Event|8|||
170482376|NCT01704495|616105669|FG001|Subjects Randomized|Adverse Event|2|||
170482377|NCT01704495|616105670|FG002|Subjects Randomized|Adverse Event|0|||
170548510|NCT01748552|616354622|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
170482378|NCT01704495|616105671|FG003|Subjects Randomized|Adverse Event|7|||
170482379|NCT01704495|616105668|FG000|Subjects Randomized|Withdrawal by Subject|5|||
170482380|NCT01704495|616105669|FG001|Subjects Randomized|Withdrawal by Subject|5|||
170482381|NCT01704495|616105670|FG002|Subjects Randomized|Withdrawal by Subject|5|||
170482382|NCT01704495|616105671|FG003|Subjects Randomized|Withdrawal by Subject|5|||
170482383|NCT01704495|616105668|FG000|Subjects Randomized|Protocol Violation|1|||
170482384|NCT01704495|616105669|FG001|Subjects Randomized|Protocol Violation|1|||
170482385|NCT01704495|616105670|FG002|Subjects Randomized|Protocol Violation|2|||
170482386|NCT01704495|616105671|FG003|Subjects Randomized|Protocol Violation|0|||
170482387|NCT01704495|616105668|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
170482388|NCT01704495|616105669|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
170482389|NCT01704495|616105670|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
170482390|NCT01704495|616105671|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
170482391|NCT01704495|616105668|FG000|Optional Safety Extension|Adverse Event|0|||
170482392|NCT01704495|616105669|FG001|Optional Safety Extension|Adverse Event|4|||
170482393|NCT01704495|616105670|FG002|Optional Safety Extension|Adverse Event|0|||
170482394|NCT01704495|616105671|FG003|Optional Safety Extension|Adverse Event|1|||
170482395|NCT01704495|616105668|FG000|Optional Safety Extension|Other reason|27|||
170482396|NCT01704495|616105669|FG001|Optional Safety Extension|Other reason|29|||
170482397|NCT01704495|616105670|FG002|Optional Safety Extension|Other reason|30|||
170482398|NCT01704495|616105671|FG003|Optional Safety Extension|Other reason|28|||
170482399|NCT01704495|616105668|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
170897590|NCT00862251|617630239|FG002|Overall Study|Protocol Violation|1|||
170482400|NCT01704495|616105669|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
170482401|NCT01704495|616105670|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
170482402|NCT01704495|616105671|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
170482403|NCT03876743|616105675|FG000|Overall Study|Lost to Follow-up|6|||
170482404|NCT03876743|616105676|FG001|Overall Study|Lost to Follow-up|4|||
170482405|NCT03876743|616105677|FG002|Overall Study|Lost to Follow-up|4|||
170482406|NCT03876743|616105678|FG003|Overall Study|Lost to Follow-up|7|||
170482407|NCT01139125|616105680|FG000|Overall Study|Withdrawal by Subject|1|||
170482408|NCT01592786|616105681|FG000|Overall Study|Adverse Event|60|||
170482409|NCT01592786|616105681|FG000|Overall Study|Lack of Efficacy|19|||
170482410|NCT01592786|616105681|FG000|Overall Study|Protocol Violation|14|||
170482411|NCT01592786|616105681|FG000|Overall Study|Withdrawal by Subject|23|||
170482412|NCT01592786|616105681|FG000|Overall Study|Lost to Follow-up|19|||
170482413|NCT01592786|616105681|FG000|Overall Study|Other|3|||
170482414|NCT02025725|616105682|FG000|Overall Study|Adverse Event|5|||
170482415|NCT02025725|616105683|FG001|Overall Study|Adverse Event|0|||
170482416|NCT02025725|616105682|FG000|Overall Study|Lost to Follow-up|2|||
170482417|NCT02025725|616105683|FG001|Overall Study|Lost to Follow-up|0|||
170482418|NCT02025725|616105682|FG000|Overall Study|Protocol Violation|1|||
170482419|NCT02025725|616105683|FG001|Overall Study|Protocol Violation|1|||
170482420|NCT02025725|616105682|FG000|Overall Study|Withdrawal by Subject|3|||
170482421|NCT02025725|616105683|FG001|Overall Study|Withdrawal by Subject|2|||
170482422|NCT02025725|616105682|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
170482423|NCT02025725|616105683|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
170482424|NCT00923013|616105684|FG000|Overall Study|Refused further treatment|0|||
170482425|NCT00923013|616105685|FG001|Overall Study|Refused further treatment|1|||
170482426|NCT00923013|616105686|FG002|Overall Study|Refused further treatment|2|||
170482427|NCT00923013|616105687|FG003|Overall Study|Refused further treatment|0|||
170482428|NCT00923013|616105688|FG004|Overall Study|Refused further treatment|0|||
170482429|NCT00923013|616105689|FG005|Overall Study|Refused further treatment|0|||
170482430|NCT00923013|616105684|FG000|Overall Study|Switched to alternative treatment|0|||
170482431|NCT00923013|616105685|FG001|Overall Study|Switched to alternative treatment|1|||
170482432|NCT00923013|616105686|FG002|Overall Study|Switched to alternative treatment|0|||
170482433|NCT00923013|616105687|FG003|Overall Study|Switched to alternative treatment|0|||
170482434|NCT00923013|616105688|FG004|Overall Study|Switched to alternative treatment|0|||
170482435|NCT00923013|616105689|FG005|Overall Study|Switched to alternative treatment|0|||
170482436|NCT00923013|616105684|FG000|Overall Study|Death on study|2|||
170482437|NCT00923013|616105685|FG001|Overall Study|Death on study|2|||
170482438|NCT00923013|616105686|FG002|Overall Study|Death on study|0|||
170482439|NCT00923013|616105687|FG003|Overall Study|Death on study|1|||
170482440|NCT00923013|616105688|FG004|Overall Study|Death on study|0|||
170482441|NCT00923013|616105689|FG005|Overall Study|Death on study|0|||
170482442|NCT00837148|616105691|FG000|Overall Study|Adverse Event|1|||
170482443|NCT00837148|616105691|FG000|Overall Study|Death|1|||
170482444|NCT00235755|616105692|FG000|4-Week Titration Phase|Adverse Event|6|||
170482445|NCT00235755|616105693|FG001|4-Week Titration Phase|Adverse Event|14|||
170482446|NCT00235755|616105694|FG002|4-Week Titration Phase|Adverse Event|20|||
170482447|NCT00235755|616105692|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
170482448|NCT00235755|616105693|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
170482449|NCT00235755|616105694|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
170482450|NCT00235755|616105692|FG000|4-Week Titration Phase|Protocol Violation|2|||
170482451|NCT00235755|616105693|FG001|4-Week Titration Phase|Protocol Violation|2|||
170482452|NCT00235755|616105694|FG002|4-Week Titration Phase|Protocol Violation|1|||
170482453|NCT00235755|616105692|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
170482454|NCT00235755|616105693|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
170482455|NCT00235755|616105694|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
170797921|NCT02492711|617272489|FG002|Overall Study|change in chemotherapy|0|||
170797922|NCT02492711|617272487|FG000|Overall Study|never treated|2|||
170797923|NCT02492711|617272488|FG001|Overall Study|never treated|4|||
170482456|NCT00235755|616105692|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
170482457|NCT00235755|616105693|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
170482458|NCT00235755|616105694|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
170482459|NCT00235755|616105692|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
170482460|NCT00235755|616105693|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
170482461|NCT00235755|616105694|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
170482462|NCT00235755|616105692|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
170482463|NCT00235755|616105693|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
170482464|NCT00235755|616105694|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
170482465|NCT00235755|616105692|FG000|12-Week Maintenance Phase|Adverse Event|8|||
170482466|NCT00235755|616105693|FG001|12-Week Maintenance Phase|Adverse Event|12|||
170482467|NCT00235755|616105694|FG002|12-Week Maintenance Phase|Adverse Event|26|||
170482468|NCT00235755|616105692|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
170482469|NCT00235755|616105693|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
170482470|NCT00235755|616105694|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
170482471|NCT00235755|616105692|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
170482472|NCT00235755|616105693|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
170482473|NCT00235755|616105694|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
170482474|NCT00235755|616105692|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
170482475|NCT00235755|616105693|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
170482476|NCT00235755|616105694|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
170482477|NCT00235755|616105692|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
170482478|NCT00235755|616105693|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
170482479|NCT00235755|616105694|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
170482480|NCT00235755|616105692|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
170482481|NCT00235755|616105693|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
170482482|NCT00235755|616105694|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
170482483|NCT00931411|616105699|FG000|First Intervention - 42 Days|Adverse Event|2|||
170482484|NCT00931411|616105700|FG001|First Intervention - 42 Days|Adverse Event|3|||
170482485|NCT00931411|616105699|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
170482486|NCT00931411|616105700|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
170482487|NCT00931411|616105699|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
170482488|NCT00931411|616105700|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
170482489|NCT01532934|616105701|FG000|Overall Study|Lost to Follow-up|11|||
170482490|NCT01532934|616105702|FG001|Overall Study|Lost to Follow-up|11|||
170482491|NCT01532934|616105701|FG000|Overall Study|In controlled environment|3|||
170482492|NCT01532934|616105702|FG001|Overall Study|In controlled environment|2|||
170482493|NCT01827111|616105703|FG000|Overall Study|Disease Progression|1|||
170482494|NCT03181633|616105706|FG000|Overall Study|Withdrawal by Subject|1|||
170482495|NCT03181633|616105706|FG000|Overall Study|Missing follow-up visit|1|||
170482496|NCT04383327|616105713|FG000|Overall Study|Lost to Follow-up|112|||
170482497|NCT04383327|616105714|FG001|Overall Study|Lost to Follow-up|14|||
170482498|NCT04383327|616105715|FG002|Overall Study|Lost to Follow-up|78|||
170482499|NCT04383327|616105716|FG003|Overall Study|Lost to Follow-up|13|||
170482500|NCT04383327|616105717|FG004|Overall Study|Lost to Follow-up|110|||
170482501|NCT04383327|616105718|FG005|Overall Study|Lost to Follow-up|13|||
170482502|NCT04383327|616105719|FG006|Overall Study|Lost to Follow-up|74|||
170482503|NCT04383327|616105720|FG007|Overall Study|Lost to Follow-up|13|||
170482504|NCT04383327|616105721|FG008|Overall Study|Lost to Follow-up|78|||
170482505|NCT04383327|616105722|FG009|Overall Study|Lost to Follow-up|10|||
170482506|NCT04383327|616105723|FG010|Overall Study|Lost to Follow-up|160|||
170482507|NCT04383327|616105724|FG011|Overall Study|Lost to Follow-up|13|||
170482508|NCT04837196|616105725|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
170482509|NCT04837196|616105726|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
170482510|NCT04837196|616105727|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
170482511|NCT04837196|616105728|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
170482512|NCT04837196|616105729|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
170482513|NCT04837196|616105725|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
170482514|NCT04837196|616105726|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
170482515|NCT04837196|616105727|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
170482516|NCT04837196|616105728|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
170482517|NCT04837196|616105729|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
170482518|NCT04837196|616105725|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
170482519|NCT04837196|616105726|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
170482520|NCT04837196|616105727|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
170482521|NCT04837196|616105728|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
170797924|NCT02492711|617272489|FG002|Overall Study|never treated|0|||
170482522|NCT04837196|616105729|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
170482523|NCT04837196|616105725|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
170482524|NCT04837196|616105726|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
170482525|NCT04837196|616105727|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
170482526|NCT04837196|616105728|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
170482527|NCT04837196|616105729|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
170482528|NCT04837196|616105725|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
170482529|NCT04837196|616105726|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
170482530|NCT04837196|616105727|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
170482531|NCT04837196|616105728|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
170482532|NCT04837196|616105729|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
170482533|NCT04740918|616105732|FG000|Overall Study|Study Terminated by Sponsor|41|||
170482534|NCT04740918|616105733|FG001|Overall Study|Study Terminated by Sponsor|32|||
170482535|NCT04740918|616105732|FG000|Overall Study|Death|3|||
170482536|NCT04740918|616105733|FG001|Overall Study|Death|6|||
170482537|NCT04740918|616105732|FG000|Overall Study|Withdrawal by Subject|5|||
170482538|NCT04740918|616105733|FG001|Overall Study|Withdrawal by Subject|4|||
170482539|NCT04740918|616105732|FG000|Overall Study|Lost to Follow-up|1|||
170797925|NCT02492711|617272487|FG000|Overall Study|Other|0|||
170797926|NCT02492711|617272488|FG001|Overall Study|Other|0|||
170482540|NCT04740918|616105733|FG001|Overall Study|Lost to Follow-up|3|||
170482541|NCT04740918|616105732|FG000|Overall Study|Progressive disease|0|||
170482542|NCT04740918|616105733|FG001|Overall Study|Progressive disease|1|||
170482543|NCT01880554|616107272|FG000|Overall Study|Protocol Violation|14|||
170482544|NCT01880554|616107272|FG000|Overall Study|Simon's design requirements|2|||
170482545|NCT01415518|616107273|FG000|Overall Study|Withdrawal by Subject|2|||
170482546|NCT01415518|616107274|FG001|Overall Study|Withdrawal by Subject|12|||
170482547|NCT01415518|616107273|FG000|Overall Study|Protocol Violation|6|||
170482548|NCT01415518|616107274|FG001|Overall Study|Protocol Violation|8|||
170482549|NCT01415518|616107273|FG000|Overall Study|Lost to Follow-up|3|||
170482550|NCT01415518|616107274|FG001|Overall Study|Lost to Follow-up|5|||
170482551|NCT01415518|616107273|FG000|Overall Study|Adverse Event|3|||
170482552|NCT01415518|616107274|FG001|Overall Study|Adverse Event|4|||
170482553|NCT01415518|616107273|FG000|Overall Study|Death|1|||
170482554|NCT01415518|616107274|FG001|Overall Study|Death|1|||
170482555|NCT01415518|616107273|FG000|Overall Study|Condition under Investigation Worsened|1|||
170482556|NCT01415518|616107274|FG001|Overall Study|Condition under Investigation Worsened|1|||
170482557|NCT03752970|616107282|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
170482558|NCT03752970|616107283|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
170482559|NCT03752970|616107284|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
170482560|NCT03752970|616107282|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
170482561|NCT03752970|616107283|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
170482562|NCT03752970|616107284|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
170482563|NCT03752970|616107282|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
170482564|NCT03752970|616107283|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
170482565|NCT03752970|616107284|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
170482566|NCT03752970|616107282|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
170482567|NCT03752970|616107283|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
170482568|NCT03752970|616107284|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
170797927|NCT02492711|617272489|FG002|Overall Study|Other|1|||
170797928|NCT03652272|617272490|FG000|3 Month|Withdrawal by Subject|1|||
170797929|NCT03652272|617272491|FG001|3 Month|Withdrawal by Subject|1|||
170797930|NCT03652272|617272490|FG000|3 Month|Lost to Follow-up|16|||
170797931|NCT03652272|617272491|FG001|3 Month|Lost to Follow-up|14|||
170797932|NCT05205161|617272497|FG000|Overall Study|Study terminated by sponsor|3|||
170797933|NCT05205161|617272498|FG001|Overall Study|Study terminated by sponsor|3|||
170797934|NCT05205161|617272499|FG002|Overall Study|Study terminated by sponsor|1|||
170797935|NCT05112900|617272502|FG000|Overall Study|Withdrawal by Subject|960|||
170797936|NCT05112900|617272503|FG001|Overall Study|Withdrawal by Subject|921|||
170797937|NCT05112900|617272504|FG002|Overall Study|Withdrawal by Subject|968|||
170797938|NCT05454514|617272505|FG000|Overall Study|Withdrawal by Subject|4|||
170797939|NCT01438853|617272510|FG000|Overall Study|Death|0|||
170797940|NCT01438853|617272511|FG001|Overall Study|Death|0|||
170797941|NCT01438853|617272512|FG002|Overall Study|Death|0|||
170797942|NCT01438853|617272513|FG003|Overall Study|Death|1|||
170797943|NCT01438853|617272510|FG000|Overall Study|Withdrawal by Subject|0|||
170797944|NCT01438853|617272511|FG001|Overall Study|Withdrawal by Subject|0|||
170797945|NCT01438853|617272512|FG002|Overall Study|Withdrawal by Subject|1|||
170482569|NCT03752970|616107282|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
170797946|NCT01438853|617272513|FG003|Overall Study|Withdrawal by Subject|0|||
170797947|NCT03734029|617272514|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
170797948|NCT03734029|617272515|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
170797949|NCT03734029|617272514|FG000|Overall Study|Adverse Event|60|||
170640111|NCT00104520|616693822|FG001|Overall Study|Personal/administrative|1|||
170640112|NCT00104520|616693821|FG000|Overall Study|Other|1|||
170640113|NCT00104520|616693822|FG001|Overall Study|Other|5|||
170640114|NCT04393454|616693823|FG000|Overall Study|Death|1|||
170640115|NCT04393454|616693823|FG000|Overall Study|Lost to Follow-up|1|||
170640116|NCT01120964|616693824|FG000|Overall Study|Did not receive full treatment|1|||
170640117|NCT01120964|616693825|FG001|Overall Study|Did not receive full treatment|0|||
170640118|NCT01704599|616693829|FG000|Overall Study|Adverse Event|1|||
170640119|NCT01395524|616695585|FG000|Overall Study|Non-compliance with study schedule|1|||
170482570|NCT03752970|616107283|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
170482571|NCT03752970|616107284|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
170482572|NCT03976362|616107285|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
170482573|NCT03976362|616107286|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
170482574|NCT03976362|616107287|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
170482575|NCT03976362|616107285|FG000|Induction Phase|Death|62|||
170482576|NCT03976362|616107286|FG001|Induction Phase|Death|0|||
170482577|NCT03976362|616107287|FG002|Induction Phase|Death|0|||
170482578|NCT03976362|616107285|FG000|Maintenance Phase|Participants Ongoing|0|||
170482579|NCT03976362|616107286|FG001|Maintenance Phase|Participants Ongoing|106|||
170482580|NCT03976362|616107287|FG002|Maintenance Phase|Participants Ongoing|103|||
170482581|NCT03976362|616107285|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170482582|NCT03976362|616107286|FG001|Maintenance Phase|Withdrawal by Subject|4|||
170482583|NCT03976362|616107287|FG002|Maintenance Phase|Withdrawal by Subject|4|||
170482584|NCT03976362|616107285|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
170482585|NCT03976362|616107286|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
170482586|NCT03976362|616107287|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
170482587|NCT03976362|616107285|FG000|Maintenance Phase|Death|0|||
170482588|NCT03976362|616107286|FG001|Maintenance Phase|Death|186|||
170482589|NCT03976362|616107287|FG002|Maintenance Phase|Death|187|||
170482590|NCT04767282|616107288|FG000|Overall Study|Refused or did not begin surveys|6|||
170482591|NCT04767282|616107289|FG001|Overall Study|Refused or did not begin surveys|2|||
170548511|NCT01748552|616354623|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
170548512|NCT01748552|616354624|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170548513|NCT01748552|616354625|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170548514|NCT01748552|616354626|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
170548515|NCT00504556|616354632|FG000|Overall Study|Adverse Event|11|||
170548516|NCT00504556|616354633|FG001|Overall Study|Adverse Event|11|||
170548517|NCT00504556|616354634|FG002|Overall Study|Adverse Event|14|||
170548518|NCT00504556|616354635|FG003|Overall Study|Adverse Event|13|||
170548519|NCT00504556|616354636|FG004|Overall Study|Adverse Event|5|||
170548520|NCT00504556|616354632|FG000|Overall Study|Death|3|||
170640120|NCT01395524|616695586|FG001|Overall Study|Non-compliance with study schedule|0|||
170640121|NCT01395524|616695587|FG002|Overall Study|Non-compliance with study schedule|1|||
170640122|NCT01395524|616695585|FG000|Overall Study|Lost to Follow-up|3|||
170640123|NCT01395524|616695586|FG001|Overall Study|Lost to Follow-up|1|||
170640124|NCT01395524|616695587|FG002|Overall Study|Lost to Follow-up|1|||
170640125|NCT01395524|616695585|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
170640126|NCT01395524|616695586|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
170640127|NCT01395524|616695587|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
170640128|NCT01395524|616695585|FG000|Overall Study|Severe noncompliance with protocol|1|||
170640129|NCT01395524|616695586|FG001|Overall Study|Severe noncompliance with protocol|0|||
170640130|NCT01395524|616695587|FG002|Overall Study|Severe noncompliance with protocol|0|||
170897591|NCT00862251|617630237|FG000|Overall Study|Withdrawal by Subject|9|||
170897592|NCT00862251|617630238|FG001|Overall Study|Withdrawal by Subject|2|||
170897593|NCT00862251|617630239|FG002|Overall Study|Withdrawal by Subject|6|||
170897594|NCT00624520|617630240|FG000|Overall Study|Withdrawal by Subject|12|||
170897595|NCT00624520|617630241|FG001|Overall Study|Withdrawal by Subject|7|||
170897596|NCT00624520|617630240|FG000|Overall Study|Death|0|||
170897597|NCT00624520|617630241|FG001|Overall Study|Death|1|||
170482592|NCT04767282|616107290|FG002|Overall Study|Refused or did not begin surveys|2|||
170482593|NCT04767282|616107288|FG000|Overall Study|Duplicate household previously enrolled|2|||
170548521|NCT00504556|616354633|FG001|Overall Study|Death|3|||
170548522|NCT00504556|616354634|FG002|Overall Study|Death|1|||
170548523|NCT00504556|616354635|FG003|Overall Study|Death|0|||
170548524|NCT00504556|616354636|FG004|Overall Study|Death|2|||
170548525|NCT00504556|616354632|FG000|Overall Study|Protocol Violation|1|||
170548526|NCT00504556|616354633|FG001|Overall Study|Protocol Violation|3|||
170640131|NCT01395524|616695585|FG000|Overall Study|Adverse Event|4|||
170640132|NCT01395524|616695586|FG001|Overall Study|Adverse Event|4|||
170897598|NCT02796755|617630242|FG000|Overall Study|Adverse Event|2|||
170897599|NCT02796755|617630243|FG001|Overall Study|Adverse Event|0|||
170482594|NCT04767282|616107289|FG001|Overall Study|Duplicate household previously enrolled|0|||
170482595|NCT04767282|616107290|FG002|Overall Study|Duplicate household previously enrolled|8|||
170482596|NCT04767282|616107288|FG000|Overall Study|Unable to confirm legal guardian|0|||
170640133|NCT01395524|616695587|FG002|Overall Study|Adverse Event|3|||
170640134|NCT01395524|616695585|FG000|Overall Study|Death|1|||
170640135|NCT01395524|616695586|FG001|Overall Study|Death|0|||
170640136|NCT01395524|616695587|FG002|Overall Study|Death|0|||
170640137|NCT01395524|616695585|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
170640138|NCT01395524|616695586|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
170640139|NCT01395524|616695587|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
170482597|NCT04767282|616107289|FG001|Overall Study|Unable to confirm legal guardian|2|||
170482598|NCT04767282|616107290|FG002|Overall Study|Unable to confirm legal guardian|8|||
170482599|NCT04767282|616107288|FG000|Overall Study|Withdrawal by Subject|0|||
170482600|NCT04767282|616107289|FG001|Overall Study|Withdrawal by Subject|0|||
170482601|NCT04767282|616107290|FG002|Overall Study|Withdrawal by Subject|6|||
170482602|NCT04767282|616107288|FG000|Overall Study|Survey comprehension challenges|4|||
170482603|NCT04767282|616107289|FG001|Overall Study|Survey comprehension challenges|0|||
170482604|NCT04767282|616107290|FG002|Overall Study|Survey comprehension challenges|0|||
170482605|NCT01467713|616107293|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
170482606|NCT01467713|616107294|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
170482607|NCT01467713|616107295|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
170482608|NCT01467713|616107296|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
170482609|NCT01467713|616107293|FG000|Overall Study|Major Protocol Deviation|2|||
170482610|NCT01467713|616107294|FG001|Overall Study|Major Protocol Deviation|4|||
170482611|NCT01467713|616107295|FG002|Overall Study|Major Protocol Deviation|4|||
170482612|NCT01467713|616107296|FG003|Overall Study|Major Protocol Deviation|1|||
170482613|NCT01467713|616107293|FG000|Overall Study|Lost to Follow-up|9|||
170482614|NCT01467713|616107294|FG001|Overall Study|Lost to Follow-up|12|||
170482615|NCT01467713|616107295|FG002|Overall Study|Lost to Follow-up|6|||
170482616|NCT01467713|616107296|FG003|Overall Study|Lost to Follow-up|9|||
170482617|NCT01467713|616107293|FG000|Overall Study|Voluntary Withdrawal|18|||
170482618|NCT01467713|616107294|FG001|Overall Study|Voluntary Withdrawal|14|||
170482619|NCT01467713|616107295|FG002|Overall Study|Voluntary Withdrawal|21|||
170482620|NCT01467713|616107296|FG003|Overall Study|Voluntary Withdrawal|20|||
170482621|NCT01467713|616107293|FG000|Overall Study|Study Termination|23|||
170482622|NCT01467713|616107294|FG001|Overall Study|Study Termination|33|||
170482623|NCT01467713|616107295|FG002|Overall Study|Study Termination|28|||
170482624|NCT01467713|616107296|FG003|Overall Study|Study Termination|29|||
170482625|NCT01467713|616107293|FG000|Overall Study|Pregnancy|0|||
170482626|NCT01467713|616107294|FG001|Overall Study|Pregnancy|1|||
170482627|NCT01467713|616107295|FG002|Overall Study|Pregnancy|1|||
170482628|NCT01467713|616107296|FG003|Overall Study|Pregnancy|3|||
170482629|NCT01467713|616107293|FG000|Overall Study|Relapse|35|||
170482630|NCT01467713|616107294|FG001|Overall Study|Relapse|25|||
170482631|NCT01467713|616107295|FG002|Overall Study|Relapse|28|||
170482632|NCT01467713|616107296|FG003|Overall Study|Relapse|35|||
170482633|NCT01467713|616107293|FG000|Overall Study|Reason not Specified|6|||
170482634|NCT01467713|616107294|FG001|Overall Study|Reason not Specified|11|||
170482635|NCT01467713|616107295|FG002|Overall Study|Reason not Specified|8|||
170482636|NCT01467713|616107296|FG003|Overall Study|Reason not Specified|7|||
170482637|NCT01100086|616107301|FG000|Period 1|Withdrawal by Subject|1|||
170482638|NCT01100086|616107302|FG001|Period 1|Withdrawal by Subject|0|||
170482639|NCT04168112|616107305|FG000|Overall Study|Lost to Follow-up|1|||
170482640|NCT04168112|616107306|FG001|Overall Study|Lost to Follow-up|0|||
170482641|NCT04168112|616107305|FG000|Overall Study|Withdrawal by Subject|1|||
170482642|NCT04168112|616107306|FG001|Overall Study|Withdrawal by Subject|0|||
170482643|NCT02275546|616107314|FG000|Treatment Period 2|Withdrawal by Subject|2|||
170640140|NCT01395524|616695585|FG000|Overall Study|Withdrawal by Subject|4|||
170640141|NCT01395524|616695586|FG001|Overall Study|Withdrawal by Subject|8|||
170640142|NCT01395524|616695587|FG002|Overall Study|Withdrawal by Subject|8|||
170797950|NCT03734029|617272515|FG001|Overall Study|Adverse Event|14|||
170797951|NCT03734029|617272514|FG000|Overall Study|Withdrawal by Subject|12|||
170797952|NCT03734029|617272515|FG001|Overall Study|Withdrawal by Subject|11|||
170797953|NCT03734029|617272514|FG000|Overall Study|Clinical progression by investigator|10|||
170797954|NCT03734029|617272515|FG001|Overall Study|Clinical progression by investigator|8|||
170797955|NCT03734029|617272514|FG000|Overall Study|Death|5|||
170797956|NCT03734029|617272515|FG001|Overall Study|Death|2|||
170797957|NCT03734029|617272514|FG000|Overall Study|Physician Decision|4|||
170482644|NCT02275546|616107315|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170482645|NCT02275546|616107314|FG000|Treatment Period 2|Protocol Violation|0|||
170482646|NCT02275546|616107315|FG001|Treatment Period 2|Protocol Violation|1|||
170482647|NCT04227197|616107316|FG000|Randomization|Protocol Violation|1|||
170482648|NCT04227197|616107317|FG001|Randomization|Protocol Violation|0|||
170482649|NCT04227197|616107316|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
170482650|NCT04227197|616107317|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
170640143|NCT01395524|616695585|FG000|Overall Study|Did not receive treatment|1|||
170797958|NCT03734029|617272515|FG001|Overall Study|Physician Decision|3|||
170482651|NCT04227197|616107316|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
170797959|NCT03734029|617272514|FG000|Overall Study|Other|2|||
170482652|NCT04227197|616107317|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
170482653|NCT04227197|616107316|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
170482654|NCT04227197|616107317|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
170482655|NCT04227197|616107316|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
170482656|NCT04227197|616107317|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
170482657|NCT04227197|616107316|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
170482658|NCT04227197|616107317|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
170482659|NCT04227197|616107316|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
170482660|NCT04227197|616107317|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
170482661|NCT00570141|616107318|FG000|Overall Study|Adverse Event|1|||
170482662|NCT00570141|616107318|FG000|Overall Study|Missed visits|1|||
170482663|NCT00570141|616107318|FG000|Overall Study|Lost to Follow-up|1|||
170482664|NCT00729612|616107327|FG000|Overall Study|Non evaluable for response|10|||
170482665|NCT02309411|616107328|FG000|Overall Study|Physician Decision|1|||
170482666|NCT02309411|616107329|FG001|Overall Study|Physician Decision|0|||
170482667|NCT02309411|616107330|FG002|Overall Study|Physician Decision|0|||
170482668|NCT02309411|616107328|FG000|Overall Study|Withdrawal by Subject|1|||
170482669|NCT02309411|616107329|FG001|Overall Study|Withdrawal by Subject|1|||
170482670|NCT02309411|616107330|FG002|Overall Study|Withdrawal by Subject|0|||
170482671|NCT00370552|616107332|FG000|Overall Study|Adverse Event|2|||
170482672|NCT00370552|616107333|FG001|Overall Study|Adverse Event|2|||
170482673|NCT00370552|616107334|FG002|Overall Study|Adverse Event|2|||
170482674|NCT00370552|616107332|FG000|Overall Study|Disease progression|23|||
170482675|NCT00370552|616107333|FG001|Overall Study|Disease progression|23|||
170482676|NCT00370552|616107334|FG002|Overall Study|Disease progression|15|||
170482677|NCT00370552|616107332|FG000|Overall Study|Maximum clinical benefit|3|||
170482678|NCT00370552|616107333|FG001|Overall Study|Maximum clinical benefit|5|||
170482679|NCT00370552|616107334|FG002|Overall Study|Maximum clinical benefit|5|||
170482680|NCT00370552|616107332|FG000|Overall Study|Poor or noncompliance|0|||
170482681|NCT00370552|616107333|FG001|Overall Study|Poor or noncompliance|0|||
170482682|NCT00370552|616107334|FG002|Overall Study|Poor or noncompliance|1|||
170482683|NCT00370552|616107332|FG000|Overall Study|Study drug toxicity|11|||
170482684|NCT00370552|616107333|FG001|Overall Study|Study drug toxicity|8|||
170482685|NCT00370552|616107334|FG002|Overall Study|Study drug toxicity|6|||
170482686|NCT00370552|616107332|FG000|Overall Study|Withdrawal by Subject|2|||
170482687|NCT00370552|616107333|FG001|Overall Study|Withdrawal by Subject|0|||
170482688|NCT00370552|616107334|FG002|Overall Study|Withdrawal by Subject|1|||
170482689|NCT00370552|616107332|FG000|Overall Study|Still on treatment|1|||
170482690|NCT00370552|616107333|FG001|Overall Study|Still on treatment|3|||
170482691|NCT00370552|616107334|FG002|Overall Study|Still on treatment|2|||
170482692|NCT00370552|616107332|FG000|Overall Study|Never treated|1|||
170482693|NCT00370552|616107333|FG001|Overall Study|Never treated|0|||
170482694|NCT00370552|616107334|FG002|Overall Study|Never treated|0|||
170482695|NCT00370552|616107332|FG000|Overall Study|Physician Decision|1|||
170482696|NCT00370552|616107333|FG001|Overall Study|Physician Decision|1|||
170482697|NCT00370552|616107334|FG002|Overall Study|Physician Decision|0|||
170482698|NCT00370552|616107332|FG000|Overall Study|Investigator decision|2|||
170482699|NCT00370552|616107333|FG001|Overall Study|Investigator decision|1|||
170482700|NCT00370552|616107334|FG002|Overall Study|Investigator decision|0|||
170482701|NCT00370552|616107332|FG000|Overall Study|High risk of allergic reaction|0|||
170482702|NCT00370552|616107333|FG001|Overall Study|High risk of allergic reaction|1|||
170482703|NCT00370552|616107334|FG002|Overall Study|High risk of allergic reaction|0|||
170482704|NCT00370552|616107332|FG000|Overall Study|Planned radiation for palliation|0|||
170482705|NCT00370552|616107333|FG001|Overall Study|Planned radiation for palliation|1|||
170482706|NCT00370552|616107334|FG002|Overall Study|Planned radiation for palliation|0|||
170797960|NCT03734029|617272515|FG001|Overall Study|Other|0|||
170797961|NCT03734029|617272514|FG000|Overall Study|Lost to Follow-up|0|||
170797962|NCT03734029|617272515|FG001|Overall Study|Lost to Follow-up|1|||
170797963|NCT03734029|617272514|FG000|Overall Study|Randomized, but not treated|2|||
170797964|NCT03734029|617272515|FG001|Overall Study|Randomized, but not treated|12|||
170797965|NCT01773993|617273573|FG000|Overall Study|No Visit After Treatment|35|||
170797966|NCT04993677|617273574|FG000|Overall Study|Lost to Follow-up|1|||
170797967|NCT04993677|617273575|FG001|Overall Study|Lost to Follow-up|0|||
170482707|NCT03499067|616107335|FG000|First Intervention|Physician Decision|2|||
170482708|NCT03499067|616107336|FG001|First Intervention|Physician Decision|1|||
170482709|NCT03499067|616107335|FG000|First Intervention|Withdrawal by Subject|3|||
170482710|NCT03499067|616107336|FG001|First Intervention|Withdrawal by Subject|6|||
170482711|NCT03922321|616107337|FG000|Overall Study|Participant Moved|1|||
170482712|NCT03922321|616107337|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
170482713|NCT02342678|616107338|FG000|Overall Study|Lost to Follow-up|0|||
170482714|NCT02342678|616107339|FG001|Overall Study|Lost to Follow-up|1|||
170482715|NCT02342678|616107338|FG000|Overall Study|Too busy to complete study|0|||
170482716|NCT02342678|616107339|FG001|Overall Study|Too busy to complete study|2|||
170548527|NCT00504556|616354634|FG002|Overall Study|Protocol Violation|2|||
170797968|NCT04993677|617273576|FG002|Overall Study|Lost to Follow-up|0|||
170797969|NCT04993677|617273577|FG003|Overall Study|Lost to Follow-up|0|||
170897600|NCT00675025|617630244|FG000|Overall Study|Study Terminated by Sponsor|38|||
170897601|NCT00675025|617630245|FG001|Overall Study|Study Terminated by Sponsor|42|||
170482717|NCT02342678|616107338|FG000|Overall Study|Family illness/emergency|0|||
170482718|NCT02342678|616107339|FG001|Overall Study|Family illness/emergency|1|||
170482719|NCT02342678|616107338|FG000|Overall Study|Illness/medical reason|1|||
170482720|NCT02342678|616107339|FG001|Overall Study|Illness/medical reason|1|||
170482721|NCT01651117|616107343|FG000|Overall Study|Death|2|||
170482722|NCT01651117|616107344|FG001|Overall Study|Death|3|||
170482723|NCT01651117|616107345|FG002|Overall Study|Death|2|||
170482724|NCT01651117|616107346|FG003|Overall Study|Death|2|||
170482725|NCT00350207|616107347|FG000|Overall Study|Adverse Event|5|||
170482726|NCT00350207|616107348|FG001|Overall Study|Adverse Event|2|||
170482727|NCT00350207|616107349|FG002|Overall Study|Adverse Event|2|||
170482728|NCT00350207|616107347|FG000|Overall Study|Lack of Efficacy|1|||
170482729|NCT00350207|616107348|FG001|Overall Study|Lack of Efficacy|0|||
170482730|NCT00350207|616107349|FG002|Overall Study|Lack of Efficacy|2|||
170482731|NCT00350207|616107347|FG000|Overall Study|Lost to Follow-up|1|||
170482732|NCT00350207|616107348|FG001|Overall Study|Lost to Follow-up|0|||
170482733|NCT00350207|616107349|FG002|Overall Study|Lost to Follow-up|1|||
170482734|NCT00350207|616107347|FG000|Overall Study|Withdrawal by Subject|0|||
170482735|NCT00350207|616107348|FG001|Overall Study|Withdrawal by Subject|1|||
170482736|NCT00350207|616107349|FG002|Overall Study|Withdrawal by Subject|1|||
170482737|NCT00350207|616107347|FG000|Overall Study|Other|1|||
170482738|NCT00350207|616107348|FG001|Overall Study|Other|3|||
170482739|NCT00350207|616107349|FG002|Overall Study|Other|1|||
170482740|NCT03214224|616107352|FG000|Overall Study|Protocol Violation|1|||
170482741|NCT03214224|616107352|FG000|Overall Study|Withdrawal by Subject|2|||
170482742|NCT03214224|616107352|FG000|Overall Study|Practice controls or therapists|6|||
170482743|NCT05344560|616107353|FG000|Period 1|Subject out of visit window|1|||
170482744|NCT05344560|616107354|FG001|Period 1|Subject out of visit window|1|||
170897602|NCT00675025|617630244|FG000|Overall Study|Adverse Event|6|||
170897603|NCT00675025|617630245|FG001|Overall Study|Adverse Event|11|||
170482745|NCT05344560|616107353|FG000|Period 2|Covid-19 Related|1|||
170482746|NCT05344560|616107354|FG001|Period 2|Covid-19 Related|0|||
170482747|NCT05344560|616107353|FG000|Period 2|Adverse Event|1|||
170482748|NCT05344560|616107354|FG001|Period 2|Adverse Event|0|||
170482749|NCT05344560|616107353|FG000|Period 2|Subject out of visit window|1|||
170482750|NCT05344560|616107354|FG001|Period 2|Subject out of visit window|1|||
170482751|NCT05344560|616107353|FG000|Period 3|Subject out of visit window|1|||
170482752|NCT05344560|616107354|FG001|Period 3|Subject out of visit window|0|||
170482753|NCT00314340|616107356|FG000|Overall Study|lost interest|1|||
170482754|NCT00991887|616107361|FG000|Overall Study|Lost to Follow-up|2|||
170482755|NCT00991887|616107362|FG001|Overall Study|Lost to Follow-up|1|||
170482756|NCT00946920|616107363|FG000|Overall Study|Withdrawal by Subject|28|||
170482757|NCT00946920|616107364|FG001|Overall Study|Withdrawal by Subject|15|||
170482758|NCT00946920|616107363|FG000|Overall Study|Lost to Follow-up|2|||
170482759|NCT00946920|616107364|FG001|Overall Study|Lost to Follow-up|2|||
170482760|NCT00946920|616107363|FG000|Overall Study|Physician Decision|5|||
170482761|NCT00946920|616107364|FG001|Overall Study|Physician Decision|2|||
170482762|NCT00946920|616107363|FG000|Overall Study|Adverse Event|41|||
170897604|NCT00675025|617630244|FG000|Overall Study|Lost to Follow-up|6|||
170482763|NCT00946920|616107364|FG001|Overall Study|Adverse Event|14|||
170482764|NCT00946920|616107363|FG000|Overall Study|Protocol Violation|16|||
170482765|NCT00946920|616107364|FG001|Overall Study|Protocol Violation|8|||
170482766|NCT00946920|616107363|FG000|Overall Study|Miscellaneous reasons|18|||
170548528|NCT00504556|616354635|FG003|Overall Study|Protocol Violation|1|||
170548529|NCT00504556|616354636|FG004|Overall Study|Protocol Violation|2|||
170548530|NCT00504556|616354632|FG000|Overall Study|Lost to Follow-up|0|||
170548531|NCT00504556|616354633|FG001|Overall Study|Lost to Follow-up|0|||
170548532|NCT00504556|616354634|FG002|Overall Study|Lost to Follow-up|1|||
170897605|NCT00675025|617630245|FG001|Overall Study|Lost to Follow-up|4|||
170548533|NCT00504556|616354635|FG003|Overall Study|Lost to Follow-up|1|||
170548534|NCT00504556|616354636|FG004|Overall Study|Lost to Follow-up|1|||
170548535|NCT00504556|616354632|FG000|Overall Study|Withdrawal by Subject|16|||
170482767|NCT00946920|616107364|FG001|Overall Study|Miscellaneous reasons|3|||
170482768|NCT02723344|616107367|FG000|Overall Study|Lost to Follow-up|0|||
170482769|NCT02723344|616107368|FG001|Overall Study|Lost to Follow-up|4|||
170482770|NCT01288079|616107369|FG000|Overall Study|Withdrawal by Subject|2|||
170482771|NCT01288079|616107370|FG001|Overall Study|Withdrawal by Subject|4|||
170482772|NCT01288079|616107371|FG002|Overall Study|Withdrawal by Subject|1|||
170482773|NCT01288079|616107372|FG003|Overall Study|Withdrawal by Subject|0|||
170482774|NCT01288079|616107369|FG000|Overall Study|Adverse Event|2|||
170482775|NCT01288079|616107370|FG001|Overall Study|Adverse Event|1|||
170482776|NCT01288079|616107371|FG002|Overall Study|Adverse Event|2|||
170482777|NCT01288079|616107372|FG003|Overall Study|Adverse Event|3|||
170482778|NCT01288079|616107369|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
170897606|NCT00675025|617630244|FG000|Overall Study|Withdrawal by Subject|4|||
170897607|NCT00675025|617630245|FG001|Overall Study|Withdrawal by Subject|6|||
170897608|NCT00556426|617630249|FG000|Overall Study|Withdrawal by Subject|3|||
170897609|NCT00556426|617630249|FG000|Overall Study|Death|6|||
170482779|NCT01288079|616107370|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
170482780|NCT01288079|616107371|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
170482781|NCT01288079|616107372|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
170482782|NCT01288079|616107369|FG000|Overall Study|Condition under Investigation Worsened|0|||
170482783|NCT01288079|616107370|FG001|Overall Study|Condition under Investigation Worsened|0|||
170482784|NCT01288079|616107371|FG002|Overall Study|Condition under Investigation Worsened|0|||
170482785|NCT01288079|616107372|FG003|Overall Study|Condition under Investigation Worsened|1|||
170482786|NCT01288079|616107369|FG000|Overall Study|Lack of Efficacy|2|||
170482787|NCT01288079|616107370|FG001|Overall Study|Lack of Efficacy|2|||
170482788|NCT01288079|616107371|FG002|Overall Study|Lack of Efficacy|0|||
170482789|NCT01288079|616107372|FG003|Overall Study|Lack of Efficacy|2|||
170482790|NCT01288079|616107369|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
170482791|NCT01288079|616107370|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
170482792|NCT01288079|616107371|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
170482793|NCT01288079|616107372|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
170482794|NCT01288079|616107369|FG000|Overall Study|Lost to Follow-up|1|||
170482795|NCT01288079|616107370|FG001|Overall Study|Lost to Follow-up|1|||
170482796|NCT01288079|616107371|FG002|Overall Study|Lost to Follow-up|1|||
170482797|NCT01288079|616107372|FG003|Overall Study|Lost to Follow-up|0|||
170482798|NCT01288079|616107369|FG000|Overall Study|Other or Study Termination|11|||
170482799|NCT01288079|616107370|FG001|Overall Study|Other or Study Termination|15|||
170482800|NCT01288079|616107371|FG002|Overall Study|Other or Study Termination|14|||
170482801|NCT01288079|616107372|FG003|Overall Study|Other or Study Termination|8|||
170482802|NCT00420420|616107377|FG000|Overall Study|Adverse Event|5|||
170482803|NCT00420420|616107378|FG001|Overall Study|Adverse Event|3|||
170482804|NCT00420420|616107377|FG000|Overall Study|Protocol Violation|1|||
170482805|NCT00420420|616107378|FG001|Overall Study|Protocol Violation|1|||
170482806|NCT00420420|616107377|FG000|Overall Study|Withdrawal by Subject|1|||
170482807|NCT00420420|616107378|FG001|Overall Study|Withdrawal by Subject|0|||
170482808|NCT00420420|616107377|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
170482809|NCT00420420|616107378|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
170482810|NCT06018129|616107381|FG000|Overall Study|Death|1|||
170482811|NCT06018129|616107382|FG001|Overall Study|Death|1|||
170482812|NCT06018129|616107383|FG002|Overall Study|Death|2|||
170482813|NCT06018129|616107381|FG000|Overall Study|Sponsor Decision|2|||
170482814|NCT06018129|616107382|FG001|Overall Study|Sponsor Decision|2|||
170482815|NCT06018129|616107383|FG002|Overall Study|Sponsor Decision|1|||
170482816|NCT03832686|616107384|FG000|Overall Study|Lost to Follow-up|6|||
170482817|NCT03832686|616107385|FG001|Overall Study|Lost to Follow-up|9|||
170482818|NCT03832686|616107384|FG000|Overall Study|Discontinued Intervention|5|||
170482819|NCT03832686|616107385|FG001|Overall Study|Discontinued Intervention|4|||
170482820|NCT02208362|616107386|FG000|Overall Study|Participant did not complete treatment|0|||
170482821|NCT02208362|616107387|FG001|Overall Study|Participant did not complete treatment|1|||
170482822|NCT02208362|616107388|FG002|Overall Study|Participant did not complete treatment|0|||
170482823|NCT02208362|616107389|FG003|Overall Study|Participant did not complete treatment|0|||
170482824|NCT02208362|616107390|FG004|Overall Study|Participant did not complete treatment|0|||
170482825|NCT02208362|616107391|FG005|Overall Study|Participant did not complete treatment|0|||
170482826|NCT02208362|616107392|FG006|Overall Study|Participant did not complete treatment|1|||
170482827|NCT02208362|616107393|FG007|Overall Study|Participant did not complete treatment|1|||
170482828|NCT02208362|616107394|FG008|Overall Study|Participant did not complete treatment|2|||
170482829|NCT02208362|616107395|FG009|Overall Study|Participant did not complete treatment|0|||
170482830|NCT02208362|616107396|FG010|Overall Study|Participant did not complete treatment|1|||
170482831|NCT02208362|616107397|FG011|Overall Study|Participant did not complete treatment|0|||
170482832|NCT02208362|616107386|FG000|Overall Study|Participant received disallowed treatment|0|||
170482833|NCT02208362|616107387|FG001|Overall Study|Participant received disallowed treatment|0|||
170482834|NCT02208362|616107388|FG002|Overall Study|Participant received disallowed treatment|0|||
170482835|NCT02208362|616107389|FG003|Overall Study|Participant received disallowed treatment|0|||
170482836|NCT02208362|616107390|FG004|Overall Study|Participant received disallowed treatment|0|||
170482837|NCT02208362|616107391|FG005|Overall Study|Participant received disallowed treatment|0|||
170897610|NCT00331006|617630251|FG000|Screening Phase|Withdrawal by Subject|1|||
170897611|NCT00331006|617630251|FG000|Screening Phase|enrollment halted|1|||
170897612|NCT00331006|617630251|FG000|Screening Phase|Lost to Follow-up|1|||
170897613|NCT00331006|617630251|FG000|Screening Phase|Ineligible for treatment phase|4|||
170897614|NCT00331006|617630251|FG000|Treatment Phase|Withdrawal by Subject|1|||
170482838|NCT02208362|616107392|FG006|Overall Study|Participant received disallowed treatment|0|||
170482839|NCT02208362|616107393|FG007|Overall Study|Participant received disallowed treatment|0|||
170482840|NCT02208362|616107394|FG008|Overall Study|Participant received disallowed treatment|1|||
170482841|NCT02208362|616107395|FG009|Overall Study|Participant received disallowed treatment|0|||
170897615|NCT00331006|617630251|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
170897616|NCT00331006|617630251|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
170897617|NCT01950819|617630255|FG000|Overall Study|Graft Loss|35|||
170897618|NCT01950819|617630256|FG001|Overall Study|Graft Loss|30|||
170897619|NCT01950819|617630255|FG000|Overall Study|Death|29|||
170482842|NCT02208362|616107396|FG010|Overall Study|Participant received disallowed treatment|0|||
170482843|NCT02208362|616107397|FG011|Overall Study|Participant received disallowed treatment|0|||
170482844|NCT05479435|616107398|FG000|Overall Study|Withdrawal by Subject|1|||
170482845|NCT05479435|616107399|FG001|Overall Study|Withdrawal by Subject|0|||
170482846|NCT05479435|616107400|FG002|Overall Study|Withdrawal by Subject|0|||
170482847|NCT05479435|616107398|FG000|Overall Study|Covid 19|0|||
170482848|NCT05479435|616107399|FG001|Overall Study|Covid 19|0|||
170482849|NCT05479435|616107400|FG002|Overall Study|Covid 19|2|||
170482850|NCT00955617|616107405|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
170482851|NCT00955617|616107406|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
170482852|NCT00955617|616107405|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
170482853|NCT00955617|616107406|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
170482854|NCT00955617|616107405|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
170482855|NCT00955617|616107406|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
170482856|NCT00955617|616107405|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
170482857|NCT00955617|616107406|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
170482858|NCT00982657|616107407|FG000|Overall Study|Death|1|||
170482859|NCT00982657|616107408|FG001|Overall Study|Death|0|||
170482860|NCT00982657|616107409|FG002|Overall Study|Death|1|||
170482861|NCT00982657|616107410|FG003|Overall Study|Death|1|||
170482862|NCT00982657|616107407|FG000|Overall Study|Withdrawal by Subject|0|||
170482863|NCT00982657|616107408|FG001|Overall Study|Withdrawal by Subject|0|||
170482864|NCT00982657|616107409|FG002|Overall Study|Withdrawal by Subject|1|||
170482865|NCT00982657|616107410|FG003|Overall Study|Withdrawal by Subject|3|||
170482866|NCT00982657|616107407|FG000|Overall Study|Other|0|||
170482867|NCT00982657|616107408|FG001|Overall Study|Other|0|||
170482868|NCT00982657|616107409|FG002|Overall Study|Other|0|||
170482869|NCT00982657|616107410|FG003|Overall Study|Other|4|||
170482870|NCT00982657|616107407|FG000|Overall Study|On going at date of cut-off|0|||
170482871|NCT00982657|616107408|FG001|Overall Study|On going at date of cut-off|0|||
170482872|NCT00982657|616107409|FG002|Overall Study|On going at date of cut-off|0|||
170482873|NCT00982657|616107410|FG003|Overall Study|On going at date of cut-off|1|||
170482874|NCT03760744|616108873|FG000|Overall Study|Lost to Follow-up|3|||
170482875|NCT03760744|616108874|FG001|Overall Study|Lost to Follow-up|0|||
170482876|NCT03668119|616108875|FG000|Pre-treatment|Disease Progression|1|||
170482877|NCT03668119|616108876|FG001|Pre-treatment|Disease Progression|0|||
170482878|NCT03668119|616108875|FG000|Treatment|Disease Progression|76|||
170482879|NCT03668119|616108876|FG001|Treatment|Disease Progression|57|||
170482880|NCT03668119|616108875|FG000|Treatment|Study drug toxicity|19|||
170482881|NCT03668119|616108876|FG001|Treatment|Study drug toxicity|1|||
170482882|NCT03668119|616108875|FG000|Treatment|Death|3|||
170482883|NCT03668119|616108876|FG001|Treatment|Death|0|||
170482884|NCT03668119|616108875|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
170482885|NCT03668119|616108876|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
170482886|NCT03668119|616108875|FG000|Treatment|Withdrawal by Subject|1|||
170482887|NCT03668119|616108876|FG001|Treatment|Withdrawal by Subject|1|||
170482888|NCT03668119|616108875|FG000|Treatment|Participant request to discontinue study treatment|3|||
170482889|NCT03668119|616108876|FG001|Treatment|Participant request to discontinue study treatment|1|||
170482890|NCT03668119|616108875|FG000|Treatment|Maximum Clinical Benefit|0|||
170482891|NCT03668119|616108876|FG001|Treatment|Maximum Clinical Benefit|1|||
170482892|NCT03668119|616108875|FG000|Treatment|Participants completed treatment|27|||
170482893|NCT03668119|616108876|FG001|Treatment|Participants completed treatment|11|||
170482894|NCT03668119|616108875|FG000|Treatment|Other reasons|2|||
170482895|NCT03668119|616108876|FG001|Treatment|Other reasons|1|||
170640144|NCT01395524|616695586|FG001|Overall Study|Did not receive treatment|1|||
170640145|NCT01395524|616695587|FG002|Overall Study|Did not receive treatment|3|||
170482896|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Adverse Event|7|||
170482897|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
170482898|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Non-compliance|3|||
170482899|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Other|17|||
170482900|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Physician Decision|2|||
170482901|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Pregnancy|1|||
170482902|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
170482903|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
170482904|NCT05207865|616108877|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
170482905|NCT05207865|616108877|FG000|Follow-up Phase|Lost to Follow-up|1|||
170482906|NCT05207865|616108877|FG000|Follow-up Phase|Non-compliance|1|||
170482907|NCT05207865|616108877|FG000|Follow-up Phase|Not reported|2|||
170482908|NCT05207865|616108877|FG000|Follow-up Phase|Not collected|11|||
170482909|NCT00925704|616108878|FG000|First Intervention|Withdrew consent|0|||
170482910|NCT00925704|616108879|FG001|First Intervention|Withdrew consent|0|||
170482911|NCT00925704|616108880|FG002|First Intervention|Withdrew consent|0|||
170482912|NCT00925704|616108881|FG003|First Intervention|Withdrew consent|1|||
170482913|NCT00925704|616108882|FG004|First Intervention|Withdrew consent|1|||
170482914|NCT00925704|616108883|FG005|First Intervention|Withdrew consent|0|||
170640146|NCT01395524|616695585|FG000|Overall Study|Subject had spinal surgery|0|||
170482915|NCT00925704|616108878|FG000|Second Intervention|Withdrawal by Subject|1|||
170482916|NCT00925704|616108879|FG001|Second Intervention|Withdrawal by Subject|0|||
170482917|NCT00925704|616108880|FG002|Second Intervention|Withdrawal by Subject|0|||
170482918|NCT00925704|616108881|FG003|Second Intervention|Withdrawal by Subject|0|||
170482919|NCT00925704|616108882|FG004|Second Intervention|Withdrawal by Subject|1|||
170482920|NCT00925704|616108883|FG005|Second Intervention|Withdrawal by Subject|0|||
170482921|NCT00925704|616108878|FG000|Third Intervention|Withdrew consent|0|||
170482922|NCT00925704|616108879|FG001|Third Intervention|Withdrew consent|0|||
170482923|NCT00925704|616108880|FG002|Third Intervention|Withdrew consent|0|||
170482924|NCT00925704|616108881|FG003|Third Intervention|Withdrew consent|0|||
170482925|NCT00925704|616108882|FG004|Third Intervention|Withdrew consent|0|||
170482926|NCT00925704|616108883|FG005|Third Intervention|Withdrew consent|1|||
170482927|NCT04537078|616108886|FG000|Overall Study|Protocol Violation|3|||
170482928|NCT04537078|616108887|FG001|Overall Study|Protocol Violation|2|||
170482929|NCT04537078|616108886|FG000|Overall Study|Lost to Follow-up|1|||
170482930|NCT04537078|616108887|FG001|Overall Study|Lost to Follow-up|0|||
170482931|NCT04537078|616108886|FG000|Overall Study|Withdrawal by Subject|0|||
170482932|NCT04537078|616108887|FG001|Overall Study|Withdrawal by Subject|1|||
170482933|NCT01293695|616108888|FG000|Overall Study|Withdrawal by Subject|7|||
170482934|NCT01293695|616108889|FG001|Overall Study|Withdrawal by Subject|1|||
170482935|NCT01293695|616108888|FG000|Overall Study|Lost to Follow-up|8|||
170482936|NCT01293695|616108889|FG001|Overall Study|Lost to Follow-up|6|||
170482937|NCT00957801|616108890|FG000|Overall Study|Withdrawal by Subject|0|||
170482938|NCT00957801|616108891|FG001|Overall Study|Withdrawal by Subject|0|||
170482939|NCT00957801|616108892|FG002|Overall Study|Withdrawal by Subject|0|||
170482940|NCT00957801|616108893|FG003|Overall Study|Withdrawal by Subject|1|||
170482941|NCT04177095|616108904|FG000|Overall Study|Withdrawal by Subject|3|||
170482942|NCT04177095|616108904|FG000|Overall Study|Screen Failure|3|||
170482943|NCT04177095|616108904|FG000|Overall Study|Problems with the Trugraf assay|1|||
170482944|NCT02275819|616108905|FG000|Overall Study|Adverse Event|0|||
170482945|NCT02275819|616108906|FG001|Overall Study|Adverse Event|1|||
170482946|NCT01346059|616108907|FG000|Overall Study|Withdrawal by Subject|1|||
170482947|NCT01346059|616108908|FG001|Overall Study|Withdrawal by Subject|0|||
170482948|NCT02556775|616108909|FG000|Overall Study|Withdrawal by Subject|1|||
170482949|NCT02556775|616108910|FG001|Overall Study|Withdrawal by Subject|0|||
170482950|NCT02556775|616108911|FG002|Overall Study|Withdrawal by Subject|1|||
170482951|NCT02556775|616108912|FG003|Overall Study|Withdrawal by Subject|0|||
170482952|NCT02556775|616108909|FG000|Overall Study|Lost to Follow-up|1|||
170482953|NCT02556775|616108910|FG001|Overall Study|Lost to Follow-up|0|||
170482954|NCT02556775|616108911|FG002|Overall Study|Lost to Follow-up|0|||
170482955|NCT02556775|616108912|FG003|Overall Study|Lost to Follow-up|0|||
170482956|NCT00777296|616108913|FG000|Overall Study|Adverse Event|0|||
170482957|NCT00777296|616108914|FG001|Overall Study|Adverse Event|1|||
170482958|NCT00777296|616108915|FG002|Overall Study|Adverse Event|0|||
170482959|NCT00777296|616108916|FG003|Overall Study|Adverse Event|1|||
170482960|NCT00777296|616108913|FG000|Overall Study|Withdrawal by Subject|1|||
170482961|NCT00777296|616108914|FG001|Overall Study|Withdrawal by Subject|0|||
170482962|NCT00777296|616108915|FG002|Overall Study|Withdrawal by Subject|0|||
170482963|NCT00777296|616108916|FG003|Overall Study|Withdrawal by Subject|0|||
170482964|NCT00777296|616108913|FG000|Overall Study|CRF form not completed|0|||
170482965|NCT00777296|616108914|FG001|Overall Study|CRF form not completed|0|||
170482966|NCT00777296|616108915|FG002|Overall Study|CRF form not completed|2|||
170482967|NCT00777296|616108916|FG003|Overall Study|CRF form not completed|0|||
170482968|NCT00658723|616108921|FG000|Overall Study|Lost to Follow-up|0|||
170482969|NCT00658723|616108922|FG001|Overall Study|Lost to Follow-up|2|||
170482970|NCT00658723|616108923|FG002|Overall Study|Lost to Follow-up|2|||
170482971|NCT00658723|616108921|FG000|Overall Study|Death|2|||
170482972|NCT00658723|616108922|FG001|Overall Study|Death|1|||
170482973|NCT00658723|616108923|FG002|Overall Study|Death|4|||
170482974|NCT00658723|616108921|FG000|Overall Study|Scheduling Issue|1|||
170482975|NCT00658723|616108922|FG001|Overall Study|Scheduling Issue|1|||
170482976|NCT00658723|616108923|FG002|Overall Study|Scheduling Issue|0|||
170482977|NCT00658723|616108921|FG000|Overall Study|Withdrawal by Subject|1|||
170482978|NCT00658723|616108922|FG001|Overall Study|Withdrawal by Subject|0|||
170482979|NCT00658723|616108923|FG002|Overall Study|Withdrawal by Subject|1|||
170482980|NCT03889418|616108924|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
170482981|NCT03889418|616108925|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482982|NCT03889418|616108926|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482983|NCT03889418|616108927|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482984|NCT03889418|616108928|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482985|NCT03889418|616108929|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482986|NCT03889418|616108930|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482987|NCT03889418|616108931|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482988|NCT03889418|616108932|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482989|NCT03889418|616108933|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
170482990|NCT03889418|616108924|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
170482991|NCT03889418|616108925|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
170482992|NCT03889418|616108926|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
170482993|NCT03889418|616108927|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
170482994|NCT03889418|616108928|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
170482995|NCT03889418|616108929|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
170482996|NCT03889418|616108930|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
170797970|NCT04993677|617273574|FG000|Overall Study|Death|11|||
170797971|NCT04993677|617273575|FG001|Overall Study|Death|8|||
170797972|NCT04993677|617273576|FG002|Overall Study|Death|3|||
170797973|NCT04993677|617273577|FG003|Overall Study|Death|1|||
170797974|NCT04993677|617273574|FG000|Overall Study|Subject withdrawal of consent|4|||
170797975|NCT04993677|617273575|FG001|Overall Study|Subject withdrawal of consent|3|||
170797976|NCT04993677|617273576|FG002|Overall Study|Subject withdrawal of consent|0|||
170797977|NCT04993677|617273577|FG003|Overall Study|Subject withdrawal of consent|2|||
170797978|NCT04993677|617273574|FG000|Overall Study|Study termination by sponsor|3|||
170797979|NCT04993677|617273575|FG001|Overall Study|Study termination by sponsor|25|||
170797980|NCT04993677|617273576|FG002|Overall Study|Study termination by sponsor|3|||
170797981|NCT04993677|617273577|FG003|Overall Study|Study termination by sponsor|3|||
170797982|NCT04993677|617273574|FG000|Overall Study|Other|2|||
170797983|NCT04993677|617273575|FG001|Overall Study|Other|3|||
170797984|NCT04993677|617273576|FG002|Overall Study|Other|3|||
170797985|NCT04993677|617273577|FG003|Overall Study|Other|2|||
170797986|NCT04174170|617273578|FG000|Placebo Run-in Period|Not Randomized|38|||
170797987|NCT04174170|617273579|FG001|Placebo Run-in Period|Not Randomized|0|||
170797988|NCT04174170|617273580|FG002|Placebo Run-in Period|Not Randomized|0|||
170797989|NCT04174170|617273581|FG003|Placebo Run-in Period|Not Randomized|0|||
170482997|NCT03889418|616108931|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
170482998|NCT03889418|616108932|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
170482999|NCT03889418|616108933|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
170483000|NCT03889418|616108924|FG000|October-December 2019 (Month 7-9)|Death|0|||
170483001|NCT03889418|616108925|FG001|October-December 2019 (Month 7-9)|Death|0|||
170483002|NCT03889418|616108926|FG002|October-December 2019 (Month 7-9)|Death|0|||
170483003|NCT03889418|616108927|FG003|October-December 2019 (Month 7-9)|Death|0|||
170483004|NCT03889418|616108928|FG004|October-December 2019 (Month 7-9)|Death|0|||
170483005|NCT03889418|616108929|FG005|October-December 2019 (Month 7-9)|Death|0|||
170483006|NCT03889418|616108930|FG006|October-December 2019 (Month 7-9)|Death|0|||
170483007|NCT03889418|616108931|FG007|October-December 2019 (Month 7-9)|Death|0|||
170483008|NCT03889418|616108932|FG008|October-December 2019 (Month 7-9)|Death|1|||
170483009|NCT03889418|616108933|FG009|October-December 2019 (Month 7-9)|Death|0|||
170483010|NCT03889418|616108924|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
170483011|NCT03889418|616108925|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
170483012|NCT03889418|616108926|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
170483013|NCT03889418|616108927|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
170483014|NCT03889418|616108928|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
170483015|NCT03889418|616108929|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
170483016|NCT03889418|616108930|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
170483017|NCT03889418|616108931|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
170483018|NCT03889418|616108932|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
170483019|NCT03889418|616108933|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
170483020|NCT03889418|616108924|FG000|April - June 2020 (Month 13-15)|Death|0|||
170483021|NCT03889418|616108925|FG001|April - June 2020 (Month 13-15)|Death|1|||
170483022|NCT03889418|616108926|FG002|April - June 2020 (Month 13-15)|Death|0|||
170483023|NCT03889418|616108927|FG003|April - June 2020 (Month 13-15)|Death|0|||
170483024|NCT03889418|616108928|FG004|April - June 2020 (Month 13-15)|Death|0|||
170483025|NCT03889418|616108929|FG005|April - June 2020 (Month 13-15)|Death|0|||
170483026|NCT03889418|616108930|FG006|April - June 2020 (Month 13-15)|Death|0|||
170483027|NCT03889418|616108931|FG007|April - June 2020 (Month 13-15)|Death|0|||
170483028|NCT03889418|616108932|FG008|April - June 2020 (Month 13-15)|Death|0|||
170483029|NCT03889418|616108933|FG009|April - June 2020 (Month 13-15)|Death|0|||
170483030|NCT03889418|616108924|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170483031|NCT03889418|616108925|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170483032|NCT03889418|616108926|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170483033|NCT03889418|616108927|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
170483034|NCT03889418|616108928|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170797990|NCT04174170|617273578|FG000|Double Blind Treatment Period|Adverse Event|0|||
170797991|NCT04174170|617273579|FG001|Double Blind Treatment Period|Adverse Event|9|||
170483035|NCT03889418|616108929|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170483036|NCT03889418|616108930|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170483037|NCT03889418|616108931|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170483038|NCT03889418|616108932|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170797992|NCT04174170|617273580|FG002|Double Blind Treatment Period|Adverse Event|9|||
170897620|NCT01950819|617630256|FG001|Overall Study|Death|34|||
170897621|NCT01950819|617630255|FG000|Overall Study|Subject / Gardian decision|54|||
170897622|NCT01950819|617630256|FG001|Overall Study|Subject / Gardian decision|51|||
170897623|NCT01950819|617630255|FG000|Overall Study|technical problems|2|||
170897624|NCT01950819|617630256|FG001|Overall Study|technical problems|0|||
170897625|NCT01950819|617630255|FG000|Overall Study|Pregnancy|0|||
170897626|NCT01950819|617630256|FG001|Overall Study|Pregnancy|2|||
170897627|NCT01950819|617630255|FG000|Overall Study|Lost to Follow-up|9|||
170897628|NCT01950819|617630256|FG001|Overall Study|Lost to Follow-up|17|||
170483039|NCT03889418|616108933|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
170483040|NCT03889418|616108924|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
170483041|NCT03889418|616108925|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
170483042|NCT03889418|616108926|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
170483043|NCT03889418|616108927|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
170483044|NCT03889418|616108928|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
170897629|NCT04134494|617630257|FG000|Overall Study|Lost to Follow-up|2|||
170483045|NCT03889418|616108929|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
170483046|NCT03889418|616108930|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
170483047|NCT03889418|616108931|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
170483048|NCT03889418|616108932|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
170483049|NCT03889418|616108933|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
170483050|NCT03889418|616108924|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
170483051|NCT03889418|616108925|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
170483052|NCT03889418|616108926|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
170483053|NCT03889418|616108927|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
170483054|NCT03889418|616108928|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
170483055|NCT03889418|616108929|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
170483056|NCT03889418|616108930|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
170483057|NCT03889418|616108931|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
170483058|NCT03889418|616108932|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
170548536|NCT00504556|616354633|FG001|Overall Study|Withdrawal by Subject|16|||
170897630|NCT00781365|617630258|FG000|Overall Study|Withdrawal by Subject|13|||
170897631|NCT00781365|617630259|FG001|Overall Study|Withdrawal by Subject|8|||
170897632|NCT00781365|617630258|FG000|Overall Study|Did Not Attend Visit|20|||
170897633|NCT00781365|617630259|FG001|Overall Study|Did Not Attend Visit|28|||
170897634|NCT00781365|617630258|FG000|Overall Study|Language barrier|1|||
170897635|NCT00781365|617630259|FG001|Overall Study|Language barrier|0|||
170897636|NCT00238264|617630264|FG000|Overall Study|Death|7|||
170897637|NCT00238264|617630264|FG000|Overall Study|Lost to Follow-up|18|||
170897638|NCT00238264|617630264|FG000|Overall Study|Withdrawal by Subject|4|||
170897639|NCT00238264|617630264|FG000|Overall Study|Ineligible|7|||
170897640|NCT01295125|617630265|FG000|Overall Study|Study stopped prematurely|9|||
170897641|NCT01360645|617630266|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
170897642|NCT01360645|617630267|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
170897643|NCT01360645|617630268|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
170897644|NCT01360645|617630269|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
170897645|NCT01360645|617630266|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
170897646|NCT01360645|617630267|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
170897647|NCT01360645|617630268|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
170897648|NCT01360645|617630269|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
170897649|NCT01360645|617630266|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
170897650|NCT01360645|617630267|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
170897651|NCT01360645|617630268|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
170897652|NCT01360645|617630269|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
170897653|NCT01360645|617630266|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
170897654|NCT01360645|617630267|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
170897655|NCT01360645|617630268|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
170897656|NCT01360645|617630269|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
170897657|NCT01360645|617630266|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
170483059|NCT03889418|616108933|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
170483060|NCT00092118|616108935|FG000|Overall Study|Adverse Event|35|||
170548537|NCT00504556|616354634|FG002|Overall Study|Withdrawal by Subject|7|||
170548538|NCT00504556|616354635|FG003|Overall Study|Withdrawal by Subject|8|||
170897658|NCT01360645|617630267|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
170897659|NCT01360645|617630268|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
170897660|NCT01360645|617630269|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
170548539|NCT00504556|616354636|FG004|Overall Study|Withdrawal by Subject|12|||
170548540|NCT00504556|616354632|FG000|Overall Study|administrative reasons|0|||
170548541|NCT00504556|616354633|FG001|Overall Study|administrative reasons|2|||
170897661|NCT01360645|617630266|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
170483061|NCT00092118|616108936|FG001|Overall Study|Adverse Event|32|||
170483062|NCT00092118|616108935|FG000|Overall Study|Lack of Efficacy|12|||
170483063|NCT00092118|616108936|FG001|Overall Study|Lack of Efficacy|14|||
170483064|NCT00092118|616108935|FG000|Overall Study|Lost to Follow-up|4|||
170483065|NCT00092118|616108936|FG001|Overall Study|Lost to Follow-up|3|||
170483066|NCT00092118|616108935|FG000|Overall Study|Protocol Violation|23|||
170483067|NCT00092118|616108936|FG001|Overall Study|Protocol Violation|25|||
170483068|NCT00092118|616108935|FG000|Overall Study|Withdrawal by Subject|4|||
170483069|NCT00092118|616108936|FG001|Overall Study|Withdrawal by Subject|10|||
170483070|NCT00092118|616108935|FG000|Overall Study|Other|6|||
170483071|NCT00092118|616108936|FG001|Overall Study|Other|5|||
170483072|NCT02172664|616108944|FG000|Overall Study|Lost to Follow-up|4|||
170483073|NCT02172664|616108945|FG001|Overall Study|Lost to Follow-up|4|||
170483074|NCT02172664|616108944|FG000|Overall Study|Death|1|||
170483075|NCT02172664|616108945|FG001|Overall Study|Death|1|||
170483076|NCT02172664|616108944|FG000|Overall Study|Moved out of area|1|||
170483077|NCT02172664|616108945|FG001|Overall Study|Moved out of area|1|||
170483078|NCT03810092|616108946|FG000|Overall Study|no ground support|17|||
170483079|NCT03810092|616108946|FG000|Overall Study|ADL not done at J0|16|||
170483080|NCT03810092|616108946|FG000|Overall Study|No hemoglobin measure at J5|27|||
170483081|NCT00806403|616108949|FG000|Overall Study|Death|4|||
170483082|NCT00806403|616108950|FG001|Overall Study|Death|3|||
170483083|NCT01320293|616108951|FG000|Overall Study|Lack of Efficacy|1|||
170483084|NCT01320293|616108951|FG000|Overall Study|Adverse Event|1|||
170483085|NCT01787292|616108952|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
170897662|NCT01360645|617630267|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
170897663|NCT01360645|617630268|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
170897664|NCT01360645|617630269|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
170897665|NCT01360645|617630266|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
170897666|NCT01360645|617630267|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
170897667|NCT01360645|617630268|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
170897668|NCT01360645|617630269|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
170897669|NCT01360645|617630266|FG000|Phase B (6 Weeks)|Adverse Event|0|||
170897670|NCT01360645|617630267|FG001|Phase B (6 Weeks)|Adverse Event|6|||
170897671|NCT01360645|617630268|FG002|Phase B (6 Weeks)|Adverse Event|0|||
170897672|NCT01360645|617630269|FG003|Phase B (6 Weeks)|Adverse Event|0|||
170897673|NCT01360645|617630266|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
170897674|NCT01360645|617630267|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
170897675|NCT01360645|617630268|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
170897676|NCT01360645|617630269|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
170897677|NCT01360645|617630266|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
170897678|NCT01360645|617630267|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
170897679|NCT01360645|617630268|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
170897680|NCT01360645|617630269|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
170897681|NCT01360645|617630266|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
170897682|NCT01360645|617630267|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
170897683|NCT01360645|617630268|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
170897684|NCT01360645|617630269|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
170897685|NCT01360645|617630266|FG000|Phase A+|Lost to Follow-up|0|||
170897686|NCT01360645|617630267|FG001|Phase A+|Lost to Follow-up|0|||
170897687|NCT01360645|617630268|FG002|Phase A+|Lost to Follow-up|0|||
170897688|NCT01360645|617630269|FG003|Phase A+|Lost to Follow-up|7|||
170897689|NCT01360645|617630266|FG000|Phase A+|Adverse Event|0|||
170897690|NCT01360645|617630267|FG001|Phase A+|Adverse Event|0|||
170897691|NCT01360645|617630268|FG002|Phase A+|Adverse Event|0|||
170897692|NCT01360645|617630269|FG003|Phase A+|Adverse Event|2|||
170897693|NCT01360645|617630266|FG000|Phase A+|Met Withdrawal Criteria|0|||
170483086|NCT01787292|616108953|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
170483087|NCT01787292|616108952|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
170483088|NCT01787292|616108953|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
170548542|NCT00504556|616354634|FG002|Overall Study|administrative reasons|2|||
170897694|NCT01360645|617630267|FG001|Phase A+|Met Withdrawal Criteria|0|||
170897695|NCT01360645|617630268|FG002|Phase A+|Met Withdrawal Criteria|0|||
170897696|NCT01360645|617630269|FG003|Phase A+|Met Withdrawal Criteria|4|||
170897697|NCT01360645|617630266|FG000|Phase A+|Physician Decision|0|||
170897698|NCT01360645|617630267|FG001|Phase A+|Physician Decision|0|||
170897699|NCT01360645|617630268|FG002|Phase A+|Physician Decision|0|||
170897700|NCT01360645|617630269|FG003|Phase A+|Physician Decision|2|||
170483089|NCT01147068|616108954|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
170483090|NCT01147068|616108955|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
170548543|NCT00504556|616354635|FG003|Overall Study|administrative reasons|1|||
170483091|NCT01147068|616108956|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
170483092|NCT01147068|616108957|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
170483093|NCT01147068|616108958|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
170483094|NCT01147068|616108959|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
170483095|NCT01147068|616108960|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
170897701|NCT01360645|617630266|FG000|Phase A+|Withdrawal by Subject|0|||
170483096|NCT01147068|616108954|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
170483097|NCT01147068|616108955|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
170483098|NCT01147068|616108956|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
170483099|NCT01147068|616108957|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
170483100|NCT01147068|616108958|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
170897702|NCT01360645|617630267|FG001|Phase A+|Withdrawal by Subject|0|||
170897703|NCT01360645|617630268|FG002|Phase A+|Withdrawal by Subject|0|||
170897704|NCT01360645|617630269|FG003|Phase A+|Withdrawal by Subject|5|||
170897705|NCT01360645|617630266|FG000|Phase A+|Protocol Deviation|0|||
170897706|NCT01360645|617630267|FG001|Phase A+|Protocol Deviation|0|||
170897707|NCT01360645|617630268|FG002|Phase A+|Protocol Deviation|0|||
170897708|NCT01360645|617630269|FG003|Phase A+|Protocol Deviation|4|||
170897709|NCT01355289|617630270|FG000|Core Study|Adverse Event, Non-Fatal|1|||
170897710|NCT01355289|617630271|FG001|Core Study|Adverse Event, Non-Fatal|0|||
170897711|NCT01355289|617630272|FG002|Core Study|Adverse Event, Non-Fatal|0|||
170897712|NCT01355289|617630273|FG003|Core Study|Adverse Event, Non-Fatal|0|||
170897713|NCT01355289|617630274|FG004|Core Study|Adverse Event, Non-Fatal|0|||
170897714|NCT01355289|617630270|FG000|Core Study|Inadequate Therapeutic Effect|0|||
170897715|NCT01355289|617630271|FG001|Core Study|Inadequate Therapeutic Effect|0|||
170897716|NCT01355289|617630272|FG002|Core Study|Inadequate Therapeutic Effect|0|||
170897717|NCT01355289|617630273|FG003|Core Study|Inadequate Therapeutic Effect|1|||
170897718|NCT01355289|617630274|FG004|Core Study|Inadequate Therapeutic Effect|0|||
170897719|NCT01355289|617630270|FG000|Core Study|Other|0|||
170897720|NCT01355289|617630271|FG001|Core Study|Other|0|||
170897721|NCT01355289|617630272|FG002|Core Study|Other|0|||
170897722|NCT01355289|617630273|FG003|Core Study|Other|1|||
170897723|NCT01355289|617630274|FG004|Core Study|Other|0|||
170897724|NCT01355289|617630270|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
170897725|NCT01355289|617630271|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
170897726|NCT01355289|617630272|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
170897727|NCT01355289|617630273|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
170897728|NCT01355289|617630274|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
170897729|NCT01355289|617630270|FG000|Open Label Extension|Lost to Follow-up|0|||
170897730|NCT01355289|617630271|FG001|Open Label Extension|Lost to Follow-up|0|||
170897731|NCT01355289|617630272|FG002|Open Label Extension|Lost to Follow-up|0|||
170897732|NCT01355289|617630273|FG003|Open Label Extension|Lost to Follow-up|0|||
170897733|NCT01355289|617630274|FG004|Open Label Extension|Lost to Follow-up|1|||
170897734|NCT01355289|617630270|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
170897735|NCT01355289|617630271|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
170897736|NCT01355289|617630272|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
170897737|NCT01355289|617630273|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
170897738|NCT01355289|617630274|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
170897739|NCT01355289|617630270|FG000|Open Label Extension|Other|0|||
170897740|NCT01355289|617630271|FG001|Open Label Extension|Other|0|||
170897741|NCT01355289|617630272|FG002|Open Label Extension|Other|0|||
170897742|NCT01355289|617630273|FG003|Open Label Extension|Other|0|||
170897743|NCT01355289|617630274|FG004|Open Label Extension|Other|3|||
170897744|NCT00713219|617630275|FG000|Overall Study|Death|1|||
170897745|NCT00713219|617630275|FG000|Overall Study|Protocol Violation|1|||
170897746|NCT00802360|617630278|FG000|Overall Study|Stimulation failure|4|||
170897747|NCT00802360|617630279|FG001|Overall Study|Stimulation failure|0|||
170897748|NCT00802360|617630280|FG002|Overall Study|Stimulation failure|3|||
170897749|NCT00802360|617630281|FG003|Overall Study|Stimulation failure|3|||
170897750|NCT00802360|617630278|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
170897751|NCT00802360|617630279|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
170897752|NCT00802360|617630280|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
170897753|NCT00802360|617630281|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
170897754|NCT00802360|617630278|FG000|Overall Study|Cycle cancelled|0|||
170897755|NCT00802360|617630279|FG001|Overall Study|Cycle cancelled|1|||
170897756|NCT00802360|617630280|FG002|Overall Study|Cycle cancelled|1|||
170897757|NCT00802360|617630281|FG003|Overall Study|Cycle cancelled|1|||
170897758|NCT00802360|617630278|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
170483101|NCT01147068|616108959|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
170483102|NCT01147068|616108960|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
170640147|NCT01395524|616695586|FG001|Overall Study|Subject had spinal surgery|0|||
170897759|NCT00802360|617630279|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
170897760|NCT00802360|617630280|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
170897761|NCT00802360|617630281|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
170897762|NCT00802360|617630278|FG000|Overall Study|No positive serum pregnancy|17|||
170897763|NCT00802360|617630279|FG001|Overall Study|No positive serum pregnancy|20|||
170897764|NCT00802360|617630280|FG002|Overall Study|No positive serum pregnancy|14|||
170897765|NCT00802360|617630281|FG003|Overall Study|No positive serum pregnancy|10|||
170897766|NCT00802360|617630278|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
170897767|NCT00802360|617630279|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
170483103|NCT01147068|616108954|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
170483104|NCT01147068|616108955|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
170483105|NCT01147068|616108956|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
170483106|NCT01147068|616108957|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
170483107|NCT01147068|616108958|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
170483108|NCT01147068|616108959|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
170483109|NCT01147068|616108960|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
170483110|NCT01147068|616108954|FG000|Subjects That Received 2nd Dose|Other|0|||
170483111|NCT01147068|616108955|FG001|Subjects That Received 2nd Dose|Other|3|||
170483112|NCT01147068|616108956|FG002|Subjects That Received 2nd Dose|Other|3|||
170483113|NCT01147068|616108957|FG003|Subjects That Received 2nd Dose|Other|0|||
170483114|NCT01147068|616108958|FG004|Subjects That Received 2nd Dose|Other|1|||
170483115|NCT01147068|616108959|FG005|Subjects That Received 2nd Dose|Other|0|||
170483116|NCT01147068|616108960|FG006|Subjects That Received 2nd Dose|Other|0|||
170483117|NCT01147068|616108954|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
170483118|NCT01147068|616108955|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
170483119|NCT01147068|616108956|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
170483120|NCT01147068|616108957|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
170483121|NCT01147068|616108958|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
170483122|NCT01147068|616108959|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
170483123|NCT01147068|616108960|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
170483124|NCT01147068|616108954|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
170483125|NCT01147068|616108955|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
170483126|NCT01147068|616108956|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
170483127|NCT01147068|616108957|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
170483128|NCT01147068|616108958|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
170483129|NCT01147068|616108959|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
170483130|NCT01147068|616108960|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
170483131|NCT01147068|616108954|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
170483132|NCT01147068|616108955|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
170548544|NCT00504556|616354636|FG004|Overall Study|administrative reasons|2|||
170548545|NCT00504556|616354632|FG000|Overall Study|did not meet entry criteria|2|||
170548546|NCT00504556|616354633|FG001|Overall Study|did not meet entry criteria|0|||
170548547|NCT00504556|616354634|FG002|Overall Study|did not meet entry criteria|1|||
170548548|NCT00504556|616354635|FG003|Overall Study|did not meet entry criteria|1|||
170548549|NCT00504556|616354636|FG004|Overall Study|did not meet entry criteria|0|||
170548550|NCT00504556|616354632|FG000|Overall Study|data monitor committee decision|0|||
170548551|NCT00504556|616354633|FG001|Overall Study|data monitor committee decision|0|||
170548552|NCT00504556|616354634|FG002|Overall Study|data monitor committee decision|0|||
170797993|NCT04174170|617273581|FG003|Double Blind Treatment Period|Adverse Event|8|||
170797994|NCT04174170|617273578|FG000|Double Blind Treatment Period|Death|0|||
170797995|NCT04174170|617273579|FG001|Double Blind Treatment Period|Death|1|||
170797996|NCT04174170|617273580|FG002|Double Blind Treatment Period|Death|0|||
170797997|NCT04174170|617273581|FG003|Double Blind Treatment Period|Death|0|||
170797998|NCT04174170|617273578|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
170797999|NCT04174170|617273579|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
170798000|NCT04174170|617273580|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
170798001|NCT04174170|617273581|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
170798002|NCT04174170|617273578|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
170798003|NCT04174170|617273579|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
170798004|NCT04174170|617273580|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
170798005|NCT04174170|617273581|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
170798006|NCT04174170|617273578|FG000|Double Blind Treatment Period|Physician Decision|0|||
170798007|NCT04174170|617273579|FG001|Double Blind Treatment Period|Physician Decision|1|||
170798008|NCT04174170|617273580|FG002|Double Blind Treatment Period|Physician Decision|0|||
170798009|NCT04174170|617273581|FG003|Double Blind Treatment Period|Physician Decision|1|||
170798010|NCT04174170|617273578|FG000|Double Blind Treatment Period|Pregnancy|0|||
170798011|NCT04174170|617273579|FG001|Double Blind Treatment Period|Pregnancy|1|||
170798012|NCT04174170|617273580|FG002|Double Blind Treatment Period|Pregnancy|0|||
170798013|NCT04174170|617273581|FG003|Double Blind Treatment Period|Pregnancy|1|||
170798014|NCT04174170|617273578|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
170798015|NCT04174170|617273579|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
170798016|NCT04174170|617273580|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
170798017|NCT04174170|617273581|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
170798018|NCT04174170|617273578|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
170548553|NCT00504556|616354635|FG003|Overall Study|data monitor committee decision|100|||
170548554|NCT00504556|616354636|FG004|Overall Study|data monitor committee decision|0|||
170483133|NCT01147068|616108956|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
170798019|NCT04174170|617273579|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
170798020|NCT04174170|617273580|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
170798021|NCT04174170|617273581|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
170798022|NCT04174170|617273578|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
170798023|NCT04174170|617273579|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
170798024|NCT04174170|617273580|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
170798025|NCT04174170|617273581|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
170798026|NCT04664881|617273582|FG000|Overall Study|Withdrawal by Subject|1|||
170798027|NCT04664881|617273583|FG001|Overall Study|Withdrawal by Subject|8|||
170798028|NCT04664881|617273582|FG000|Overall Study|Physician Decision|0|||
170798029|NCT04664881|617273583|FG001|Overall Study|Physician Decision|5|||
170798030|NCT04664881|617273582|FG000|Overall Study|Lost to Follow-up|1|||
170483134|NCT01147068|616108957|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
170483135|NCT01147068|616108958|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
170483136|NCT01147068|616108959|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
170483137|NCT01147068|616108960|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
170483138|NCT02962648|616108961|FG000|Overall Study|Withdrawal by Subject|3|||
170483139|NCT02962648|616108961|FG000|Overall Study|Lost to Follow-up|3|||
170483140|NCT02962648|616108961|FG000|Overall Study|Physician Decision|1|||
170483141|NCT02962648|616108961|FG000|Overall Study|Subject had problems with transportation|2|||
170483142|NCT01597778|616108963|FG000|Overall Study|Death|7|||
170483143|NCT01597778|616108964|FG001|Overall Study|Death|10|||
170483144|NCT01597778|616108963|FG000|Overall Study|Withdrawal by Subject|3|||
170483145|NCT01597778|616108964|FG001|Overall Study|Withdrawal by Subject|4|||
170548555|NCT00504556|616354632|FG000|Overall Study|Other|2|||
170548556|NCT00504556|616354633|FG001|Overall Study|Other|2|||
170548557|NCT00504556|616354634|FG002|Overall Study|Other|2|||
170548558|NCT00504556|616354635|FG003|Overall Study|Other|3|||
170548559|NCT00504556|616354636|FG004|Overall Study|Other|0|||
170548560|NCT00504556|616354632|FG000|Overall Study|not in safety analysis set|0|||
170548561|NCT00504556|616354633|FG001|Overall Study|not in safety analysis set|1|||
170548562|NCT00504556|616354634|FG002|Overall Study|not in safety analysis set|1|||
170548563|NCT00504556|616354635|FG003|Overall Study|not in safety analysis set|0|||
170548564|NCT00504556|616354636|FG004|Overall Study|not in safety analysis set|1|||
170548565|NCT01386645|616354637|FG000|Overall Study|Physician Decision|0|||
170548566|NCT01386645|616354638|FG001|Overall Study|Physician Decision|0|||
170548567|NCT01386645|616354639|FG002|Overall Study|Physician Decision|1|||
170548568|NCT01386645|616354637|FG000|Overall Study|Withdrawal by Subject|0|||
170483146|NCT01597778|616108963|FG000|Overall Study|Adverse Event|1|||
170483147|NCT01597778|616108964|FG001|Overall Study|Adverse Event|1|||
170483148|NCT01597778|616108963|FG000|Overall Study|Protocol Violation|1|||
170483149|NCT01597778|616108964|FG001|Overall Study|Protocol Violation|11|||
170483150|NCT01597778|616108963|FG000|Overall Study|Transplanted off protocol|2|||
170483151|NCT01597778|616108964|FG001|Overall Study|Transplanted off protocol|3|||
170483152|NCT03267212|616108965|FG000|First Intervention|Lost to Follow-up|0|||
170483153|NCT03267212|616108966|FG001|First Intervention|Lost to Follow-up|2|||
170483154|NCT03267212|616108965|FG000|First Intervention|Withdrawal by Subject|1|||
170483155|NCT03267212|616108966|FG001|First Intervention|Withdrawal by Subject|1|||
170483156|NCT03267212|616108965|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
170483157|NCT03267212|616108966|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
170483158|NCT05691712|616108967|FG000|Overall Study|Adverse Event|0|||
170483159|NCT05691712|616108968|FG001|Overall Study|Adverse Event|1|||
170483160|NCT05691712|616108969|FG002|Overall Study|Adverse Event|2|||
170483161|NCT05691712|616108970|FG003|Overall Study|Adverse Event|1|||
170483162|NCT05691712|616108967|FG000|Overall Study|Withdrawal by Subject|2|||
170483163|NCT05691712|616108968|FG001|Overall Study|Withdrawal by Subject|3|||
170483164|NCT05691712|616108969|FG002|Overall Study|Withdrawal by Subject|3|||
170483165|NCT05691712|616108970|FG003|Overall Study|Withdrawal by Subject|1|||
170483166|NCT05691712|616108967|FG000|Overall Study|Death|1|||
170483167|NCT05691712|616108968|FG001|Overall Study|Death|0|||
170483168|NCT05691712|616108969|FG002|Overall Study|Death|0|||
170548569|NCT01386645|616354638|FG001|Overall Study|Withdrawal by Subject|1|||
170548570|NCT01386645|616354639|FG002|Overall Study|Withdrawal by Subject|1|||
170548571|NCT02930941|616354640|FG000|Overall Study|Lost to Follow-up|1|||
170548572|NCT02930941|616354641|FG001|Overall Study|Lost to Follow-up|2|||
170548573|NCT00289978|616354642|FG000|Overall Study|Withdrawal by Subject|31|||
170548574|NCT00289978|616354643|FG001|Overall Study|Withdrawal by Subject|17|||
170548575|NCT00289978|616354644|FG002|Overall Study|Withdrawal by Subject|28|||
170798031|NCT04664881|617273583|FG001|Overall Study|Lost to Follow-up|0|||
170798032|NCT03786926|617273584|FG000|Overall Study|Adverse Event|0|||
170483169|NCT05691712|616108970|FG003|Overall Study|Death|0|||
170483170|NCT05691712|616108967|FG000|Overall Study|Pregnancy|0|||
170483171|NCT05691712|616108968|FG001|Overall Study|Pregnancy|1|||
170483172|NCT05691712|616108969|FG002|Overall Study|Pregnancy|0|||
170483173|NCT05691712|616108970|FG003|Overall Study|Pregnancy|0|||
170483174|NCT05691712|616108967|FG000|Overall Study|Assigned Treatment by Mistake|1|||
170897768|NCT00802360|617630280|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
170897769|NCT00802360|617630281|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
170897770|NCT00802360|617630278|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
170897771|NCT00802360|617630279|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
170483175|NCT05691712|616108968|FG001|Overall Study|Assigned Treatment by Mistake|0|||
170483176|NCT05691712|616108969|FG002|Overall Study|Assigned Treatment by Mistake|0|||
170483177|NCT05691712|616108970|FG003|Overall Study|Assigned Treatment by Mistake|1|||
170483178|NCT05303194|616108971|FG000|Overall Study|Lost to Follow-up|1|||
170483179|NCT05303194|616108972|FG001|Overall Study|Lost to Follow-up|1|||
170483180|NCT05303194|616108971|FG000|Overall Study|Withdrawal by Subject|0|||
170483181|NCT05303194|616108972|FG001|Overall Study|Withdrawal by Subject|1|||
170483182|NCT00468819|616108973|FG000|Overall Study|Withdrawal by Subject|4|||
170483183|NCT00468819|616108974|FG001|Overall Study|Withdrawal by Subject|0|||
170483184|NCT00468819|616108975|FG002|Overall Study|Withdrawal by Subject|1|||
170483185|NCT00468819|616108973|FG000|Overall Study|Lost to Follow-up|0|||
170483186|NCT00468819|616108974|FG001|Overall Study|Lost to Follow-up|0|||
170483187|NCT00468819|616108975|FG002|Overall Study|Lost to Follow-up|1|||
170483188|NCT00468819|616108973|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
170483189|NCT00468819|616108974|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
170483190|NCT00468819|616108975|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
170483191|NCT04030299|616108976|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
170483192|NCT04030299|616108976|FG000|Overall Study|Withdrawal by Subject|3|||
170483193|NCT01964976|616108977|FG000|Overall Study|Protocol Violation|31|||
170548576|NCT00289978|616354642|FG000|Overall Study|Adverse Event|22|||
170548577|NCT00289978|616354643|FG001|Overall Study|Adverse Event|13|||
170548578|NCT00289978|616354644|FG002|Overall Study|Adverse Event|18|||
170548579|NCT00289978|616354642|FG000|Overall Study|Lack of Efficacy|13|||
170548580|NCT00289978|616354643|FG001|Overall Study|Lack of Efficacy|6|||
170548581|NCT00289978|616354644|FG002|Overall Study|Lack of Efficacy|25|||
170548582|NCT00289978|616354642|FG000|Overall Study|Abnormal laboratory value(s)|20|||
170548583|NCT00289978|616354643|FG001|Overall Study|Abnormal laboratory value(s)|9|||
170548584|NCT00289978|616354644|FG002|Overall Study|Abnormal laboratory value(s)|1|||
170548585|NCT00289978|616354642|FG000|Overall Study|Lost to Follow-up|3|||
170548586|NCT00289978|616354643|FG001|Overall Study|Lost to Follow-up|5|||
170548587|NCT00289978|616354644|FG002|Overall Study|Lost to Follow-up|7|||
170548588|NCT00289978|616354642|FG000|Overall Study|Protocol Violation|5|||
170548589|NCT00289978|616354643|FG001|Overall Study|Protocol Violation|5|||
170548590|NCT00289978|616354644|FG002|Overall Study|Protocol Violation|4|||
170548591|NCT00289978|616354642|FG000|Overall Study|Abnormal test procedure result(s)|2|||
170548592|NCT00289978|616354643|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170548593|NCT00289978|616354644|FG002|Overall Study|Abnormal test procedure result(s)|1|||
170548594|NCT00289978|616354642|FG000|Overall Study|Death|1|||
170548595|NCT00289978|616354643|FG001|Overall Study|Death|0|||
170548596|NCT00289978|616354644|FG002|Overall Study|Death|2|||
170548597|NCT02391584|616354645|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
170548598|NCT02391584|616354646|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
170548599|NCT02391584|616354645|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
170548600|NCT02391584|616354646|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
170548601|NCT02391584|616354645|FG000|3 Month|Lost to Follow-up|1|||
170548602|NCT02391584|616354646|FG001|3 Month|Lost to Follow-up|0|||
170548603|NCT02391584|616354645|FG000|6 Month|Withdrawal by Subject|1|||
170548604|NCT02391584|616354646|FG001|6 Month|Withdrawal by Subject|0|||
170548605|NCT02391584|616354645|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
170548606|NCT02391584|616354646|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
170548607|NCT02533674|616354647|FG000|Dose Level I|Progressive disease|1|||
170548608|NCT02533674|616354648|FG001|Dose Level I|Progressive disease|0|||
170548609|NCT02533674|616354649|FG002|Dose Level I|Progressive disease|0|||
170548610|NCT02533674|616354650|FG003|Dose Level I|Progressive disease|0|||
170548611|NCT02533674|616354651|FG004|Dose Level I|Progressive disease|0|||
170548612|NCT02533674|616354652|FG005|Dose Level I|Progressive disease|0|||
170548613|NCT02533674|616354653|FG006|Dose Level I|Progressive disease|0|||
170897772|NCT00802360|617630280|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
170897773|NCT00802360|617630281|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
170897774|NCT00802360|617630278|FG000|Overall Study|Other|2|||
170483194|NCT04352101|616108986|FG000|Overall Study|Physician Decision|2|||
170548614|NCT02533674|616354654|FG007|Dose Level I|Progressive disease|0|||
170548615|NCT02533674|616354647|FG000|Dose Level I|Withdrawal by Subject|1|||
170548616|NCT02533674|616354648|FG001|Dose Level I|Withdrawal by Subject|0|||
170640148|NCT01395524|616695587|FG002|Overall Study|Subject had spinal surgery|1|||
170897775|NCT00802360|617630279|FG001|Overall Study|Other|3|||
170483195|NCT04352101|616108987|FG001|Overall Study|Physician Decision|1|||
170483196|NCT01256879|616108988|FG000|Overall Study|Withdrawal by Subject|1|||
170483197|NCT00725920|616108989|FG000|Overall Study|Lack of Efficacy|3|||
170548617|NCT02533674|616354649|FG002|Dose Level I|Withdrawal by Subject|0|||
170548618|NCT02533674|616354650|FG003|Dose Level I|Withdrawal by Subject|0|||
170548619|NCT02533674|616354651|FG004|Dose Level I|Withdrawal by Subject|0|||
170640149|NCT01657461|616695588|FG000|Overall Study|Death|9|||
170483198|NCT00725920|616108990|FG001|Overall Study|Lack of Efficacy|6|||
170483199|NCT03759392|616108994|FG000|Overall Study|Adverse Event|12|||
170483200|NCT03759392|616108995|FG001|Overall Study|Adverse Event|4|||
170483201|NCT03759392|616108994|FG000|Overall Study|Death|2|||
170483202|NCT03759392|616108995|FG001|Overall Study|Death|1|||
170483203|NCT03759392|616108994|FG000|Overall Study|Withdrawal by Subject|2|||
170483204|NCT03759392|616108995|FG001|Overall Study|Withdrawal by Subject|0|||
170483205|NCT03759392|616108994|FG000|Overall Study|Protocol Violation|2|||
170483206|NCT03759392|616108995|FG001|Overall Study|Protocol Violation|0|||
170483207|NCT03759392|616108994|FG000|Overall Study|Physician Decision|0|||
170483208|NCT03759392|616108995|FG001|Overall Study|Physician Decision|1|||
170483209|NCT03759392|616108994|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
170483210|NCT03759392|616108995|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
170483211|NCT03759392|616108994|FG000|Overall Study|No longer able to take medicines|1|||
170483212|NCT03759392|616108995|FG001|Overall Study|No longer able to take medicines|0|||
170483213|NCT03759392|616108994|FG000|Overall Study|Stopped taking study drug|1|||
170483214|NCT03759392|616108995|FG001|Overall Study|Stopped taking study drug|0|||
170483215|NCT02387840|616108997|FG000|Overall Study|Death|0|||
170483216|NCT02387840|616108998|FG001|Overall Study|Death|0|||
170483217|NCT02387840|616108999|FG002|Overall Study|Death|0|||
170483218|NCT02387840|616109000|FG003|Overall Study|Death|0|||
170483219|NCT02387840|616109001|FG004|Overall Study|Death|0|||
170483220|NCT02387840|616109002|FG005|Overall Study|Death|1|||
170483221|NCT03170544|616109003|FG000|Part 1|Lost to Follow-up|1|||
170483222|NCT03170544|616109004|FG001|Part 1|Lost to Follow-up|0|||
170483223|NCT03170544|616109005|FG002|Part 1|Lost to Follow-up|0|||
170483224|NCT03170544|616109006|FG003|Part 1|Lost to Follow-up|0|||
170483225|NCT03170544|616109007|FG004|Part 1|Lost to Follow-up|0|||
170483226|NCT03170544|616109008|FG005|Part 1|Lost to Follow-up|0|||
170483227|NCT03170544|616109009|FG006|Part 1|Lost to Follow-up|0|||
170483228|NCT03170544|616109010|FG007|Part 1|Lost to Follow-up|0|||
170483229|NCT03170544|616109011|FG008|Part 1|Lost to Follow-up|0|||
170483230|NCT03170544|616109012|FG009|Part 1|Lost to Follow-up|0|||
170483231|NCT03170544|616109013|FG010|Part 1|Lost to Follow-up|0|||
170483232|NCT03170544|616109014|FG011|Part 1|Lost to Follow-up|0|||
170483233|NCT03170544|616109003|FG000|Part 1|Not treated|0|||
170483234|NCT03170544|616109004|FG001|Part 1|Not treated|0|||
170483235|NCT03170544|616109005|FG002|Part 1|Not treated|0|||
170483236|NCT03170544|616109006|FG003|Part 1|Not treated|1|||
170483237|NCT03170544|616109007|FG004|Part 1|Not treated|0|||
170483238|NCT03170544|616109008|FG005|Part 1|Not treated|0|||
170483239|NCT03170544|616109009|FG006|Part 1|Not treated|0|||
170483240|NCT03170544|616109010|FG007|Part 1|Not treated|0|||
170483241|NCT03170544|616109011|FG008|Part 1|Not treated|0|||
170483242|NCT03170544|616109012|FG009|Part 1|Not treated|0|||
170798033|NCT03786926|617273585|FG001|Overall Study|Adverse Event|0|||
170798034|NCT03786926|617273586|FG002|Overall Study|Adverse Event|0|||
170798035|NCT03786926|617273587|FG003|Overall Study|Adverse Event|0|||
170798036|NCT03786926|617273588|FG004|Overall Study|Adverse Event|0|||
170798037|NCT03786926|617273589|FG005|Overall Study|Adverse Event|0|||
170483243|NCT03170544|616109013|FG010|Part 1|Not treated|0|||
170483244|NCT03170544|616109014|FG011|Part 1|Not treated|0|||
170483245|NCT01213966|616109015|FG000|Overall Study|Protocol Violation|1|||
170483246|NCT01213966|616109016|FG001|Overall Study|Protocol Violation|0|||
170483247|NCT01213966|616109017|FG002|Overall Study|Protocol Violation|3|||
170548620|NCT02533674|616354652|FG005|Dose Level I|Withdrawal by Subject|0|||
170548621|NCT02533674|616354653|FG006|Dose Level I|Withdrawal by Subject|0|||
170548622|NCT02533674|616354654|FG007|Dose Level I|Withdrawal by Subject|0|||
170548623|NCT02533674|616354647|FG000|Dose Level I|Physician Decision|1|||
170548624|NCT02533674|616354648|FG001|Dose Level I|Physician Decision|0|||
170548625|NCT02533674|616354649|FG002|Dose Level I|Physician Decision|0|||
170798038|NCT03786926|617273590|FG006|Overall Study|Adverse Event|0|||
170798039|NCT03786926|617273591|FG007|Overall Study|Adverse Event|1|||
170798040|NCT03786926|617273592|FG008|Overall Study|Adverse Event|1|||
170798041|NCT03786926|617273593|FG009|Overall Study|Adverse Event|0|||
170798042|NCT03786926|617273594|FG010|Overall Study|Adverse Event|1|||
170798043|NCT03786926|617273584|FG000|Overall Study|Progressive disease|3|||
170798044|NCT03786926|617273585|FG001|Overall Study|Progressive disease|0|||
170798045|NCT03786926|617273586|FG002|Overall Study|Progressive disease|3|||
170798046|NCT03786926|617273587|FG003|Overall Study|Progressive disease|1|||
170798047|NCT03786926|617273588|FG004|Overall Study|Progressive disease|2|||
170483248|NCT01213966|616109018|FG003|Overall Study|Protocol Violation|1|||
170483249|NCT00273182|616109027|FG000|Overall Study|Death|450|||
170483250|NCT00273182|616109027|FG000|Overall Study|Lost to Follow-up|88|||
170483251|NCT00273182|616109027|FG000|Overall Study|Withdrawal by Subject|257|||
170483252|NCT00273182|616109027|FG000|Overall Study|Device/System Explant|154|||
170483253|NCT00273182|616109027|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
170483254|NCT00359424|616109029|FG000|Overall Study|Death|99|||
170483255|NCT00359424|616109030|FG001|Overall Study|Death|58|||
170483256|NCT00359424|616109029|FG000|Overall Study|Lost to Follow-up|19|||
170548626|NCT02533674|616354650|FG003|Dose Level I|Physician Decision|0|||
170483257|NCT00359424|616109030|FG001|Overall Study|Lost to Follow-up|7|||
170483258|NCT00359424|616109029|FG000|Overall Study|Withdrawal by Subject|10|||
170483259|NCT00359424|616109030|FG001|Overall Study|Withdrawal by Subject|2|||
170483260|NCT00359424|616109029|FG000|Overall Study|follow up not conducted|2|||
170483261|NCT00359424|616109030|FG001|Overall Study|follow up not conducted|0|||
170483262|NCT04762160|616109031|FG000|Overall Study|Study terminated early due to business reasons|5|||
170483263|NCT04146012|616109035|FG000|Overall Study|Study Terminated|30|||
170483264|NCT04146012|616109036|FG001|Overall Study|Study Terminated|15|||
170483265|NCT00868530|616109039|FG000|Overall Study|Adverse Event|3|||
170483266|NCT00868530|616109039|FG000|Overall Study|Lost to Follow-up|1|||
170483267|NCT01609790|616109040|FG000|Overall Study|Protocol Violation|1|||
170483268|NCT01609790|616109041|FG001|Overall Study|Protocol Violation|7|||
170483269|NCT01609790|616109042|FG002|Overall Study|Protocol Violation|8|||
170483270|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
170483271|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
170483272|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
170483273|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
170483274|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
170483275|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
170483276|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
170483277|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
170483278|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
170483279|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
170483280|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
170483281|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
170483282|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
170483283|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
170798048|NCT03786926|617273589|FG005|Overall Study|Progressive disease|2|||
170798049|NCT03786926|617273590|FG006|Overall Study|Progressive disease|1|||
170798050|NCT03786926|617273591|FG007|Overall Study|Progressive disease|6|||
170798051|NCT03786926|617273592|FG008|Overall Study|Progressive disease|1|||
170798052|NCT03786926|617273593|FG009|Overall Study|Progressive disease|1|||
170798053|NCT03786926|617273594|FG010|Overall Study|Progressive disease|1|||
170798054|NCT03786926|617273584|FG000|Overall Study|Death|0|||
170798055|NCT03786926|617273585|FG001|Overall Study|Death|1|||
170798056|NCT03786926|617273586|FG002|Overall Study|Death|1|||
170798057|NCT03786926|617273587|FG003|Overall Study|Death|0|||
170483284|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
170483285|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
170483286|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
170483287|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
170483288|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
170483289|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
170483290|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
170483291|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
170483292|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
170483293|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
170483294|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
170483295|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
170483296|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
170483297|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
170483298|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
170483299|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
170483300|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
170483301|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
170483302|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483303|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483304|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
170483305|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483306|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483307|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170548627|NCT02533674|616354651|FG004|Dose Level I|Physician Decision|0|||
170798058|NCT03786926|617273588|FG004|Overall Study|Death|0|||
170798059|NCT03786926|617273589|FG005|Overall Study|Death|0|||
170798060|NCT03786926|617273590|FG006|Overall Study|Death|0|||
170798061|NCT03786926|617273591|FG007|Overall Study|Death|0|||
170798062|NCT03786926|617273592|FG008|Overall Study|Death|0|||
170483308|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
170483309|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483310|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
170483311|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
170483312|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
170483313|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
170483314|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
170483315|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
170483316|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
170483317|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
170483318|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
170483319|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
170483320|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
170483321|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
170483322|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
170483323|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
170483324|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
170483325|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
170483326|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
170483327|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
170483328|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
170483329|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
170483330|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
170897776|NCT00802360|617630280|FG002|Overall Study|Other|6|||
170897777|NCT00802360|617630281|FG003|Overall Study|Other|3|||
170897778|NCT03258814|617630285|FG000|Overall Study|Early Termination|4|||
170897779|NCT03258814|617630286|FG001|Overall Study|Early Termination|3|||
170897780|NCT03258814|617630287|FG002|Overall Study|Early Termination|10|||
170897781|NCT01413958|617630288|FG000|Overall Study|Lost to Follow-up|0|||
170897782|NCT01413958|617630289|FG001|Overall Study|Lost to Follow-up|1|||
170897783|NCT01384292|617630295|FG000|Part B|Severe non-compliance to protocol|1|||
170483331|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
170483332|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
170483333|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
170483334|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
170483335|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
170483336|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
170483337|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
170483338|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
170483339|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
170483340|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
170483341|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
170483342|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483343|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483344|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483345|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483346|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483347|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
170483348|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483349|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
170483350|NCT03896503|616111056|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
170483351|NCT03896503|616111057|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
170483352|NCT03896503|616111058|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
170483353|NCT03896503|616111059|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
170483354|NCT03896503|616111060|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
170548628|NCT02533674|616354652|FG005|Dose Level I|Physician Decision|0|||
170897784|NCT01384292|617630296|FG001|Part B|Severe non-compliance to protocol|0|||
170897785|NCT01384292|617630297|FG002|Part B|Severe non-compliance to protocol|0|||
170897786|NCT01171612|617630298|FG000|Overall Study|Lost to Follow-up|51|||
170897787|NCT01285349|617630299|FG000|Overall Study|Lost to Follow-up|27|||
170897788|NCT01285349|617630300|FG001|Overall Study|Lost to Follow-up|20|||
170897789|NCT01285349|617630301|FG002|Overall Study|Lost to Follow-up|27|||
170483355|NCT03896503|616111061|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
170483356|NCT03896503|616111062|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
170483357|NCT03896503|616111063|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
170483358|NCT01068678|616111072|FG000|Overall Study|Lack of Efficacy|3|||
170483359|NCT01068678|616111073|FG001|Overall Study|Lack of Efficacy|2|||
170483360|NCT01068678|616111072|FG000|Overall Study|Protocol Violation|5|||
170483361|NCT01068678|616111073|FG001|Overall Study|Protocol Violation|1|||
170483362|NCT01068678|616111072|FG000|Overall Study|Withdrawal criteria|12|||
170483363|NCT01068678|616111073|FG001|Overall Study|Withdrawal criteria|6|||
170483364|NCT01068678|616111072|FG000|Overall Study|Unclassified|18|||
170483365|NCT01068678|616111073|FG001|Overall Study|Unclassified|15|||
170483366|NCT03055338|616111076|FG000|Overall Study|Lost to Follow-up|9|||
170483367|NCT03055338|616111077|FG001|Overall Study|Lost to Follow-up|2|||
170483368|NCT03055338|616111078|FG002|Overall Study|Lost to Follow-up|3|||
170483369|NCT03055338|616111076|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
170483370|NCT03055338|616111077|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
170483371|NCT03055338|616111078|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
170483372|NCT03055338|616111076|FG000|Overall Study|Physician Decision|0|||
170483373|NCT03055338|616111077|FG001|Overall Study|Physician Decision|0|||
170483374|NCT03055338|616111078|FG002|Overall Study|Physician Decision|2|||
170483375|NCT03055338|616111076|FG000|Overall Study|Withdrawal by Subject|9|||
170483376|NCT03055338|616111077|FG001|Overall Study|Withdrawal by Subject|8|||
170483377|NCT03055338|616111078|FG002|Overall Study|Withdrawal by Subject|7|||
170483378|NCT03058705|616111079|FG000|Overall Study|Withdrawal by Subject|2|||
170483379|NCT03058705|616111079|FG000|Overall Study|Physician Decision|2|||
170483380|NCT05161481|616111080|FG000|Overall Study|Withdrawal of consent|0|||
170483381|NCT05161481|616111081|FG001|Overall Study|Withdrawal of consent|1|||
170483382|NCT05161481|616111082|FG002|Overall Study|Withdrawal of consent|1|||
170483383|NCT05161481|616111080|FG000|Overall Study|Study terminated by sponsor|3|||
170483384|NCT05161481|616111081|FG001|Overall Study|Study terminated by sponsor|3|||
170483385|NCT05161481|616111082|FG002|Overall Study|Study terminated by sponsor|2|||
170483386|NCT05161481|616111080|FG000|Overall Study|Adverse Event|3|||
170483387|NCT05161481|616111081|FG001|Overall Study|Adverse Event|0|||
170483388|NCT05161481|616111082|FG002|Overall Study|Adverse Event|6|||
170483389|NCT05161481|616111080|FG000|Overall Study|Randomised in error and was not treated|1|||
170483390|NCT05161481|616111081|FG001|Overall Study|Randomised in error and was not treated|0|||
170483391|NCT05161481|616111082|FG002|Overall Study|Randomised in error and was not treated|0|||
170483392|NCT05161481|616111080|FG000|Overall Study|Subject decision|0|||
170483393|NCT05161481|616111081|FG001|Overall Study|Subject decision|0|||
170483394|NCT05161481|616111082|FG002|Overall Study|Subject decision|1|||
170483395|NCT01611935|616111085|FG000|Overall Study|Family Declined Participation|1|||
170483396|NCT01611935|616111086|FG001|Overall Study|Family Declined Participation|0|||
170483397|NCT02549859|616111093|FG000|Long-term 60 Hz DBS|Study Closed|1|||
170483398|NCT01209949|616111101|FG000|Overall Study|Lost to Follow-up|3|||
170483399|NCT00708552|616111102|FG000|Overall Study|Adverse Event|10|||
170483400|NCT00708552|616111103|FG001|Overall Study|Adverse Event|3|||
170483401|NCT00708552|616111104|FG002|Overall Study|Adverse Event|4|||
170483402|NCT00708552|616111105|FG003|Overall Study|Adverse Event|6|||
170483403|NCT00708552|616111102|FG000|Overall Study|Lack of Efficacy|0|||
170483404|NCT00708552|616111103|FG001|Overall Study|Lack of Efficacy|4|||
170483405|NCT00708552|616111104|FG002|Overall Study|Lack of Efficacy|1|||
170483406|NCT00708552|616111105|FG003|Overall Study|Lack of Efficacy|0|||
170483407|NCT00708552|616111102|FG000|Overall Study|Protocol Violation|0|||
170483408|NCT00708552|616111103|FG001|Overall Study|Protocol Violation|0|||
170483409|NCT00708552|616111104|FG002|Overall Study|Protocol Violation|2|||
170483410|NCT00708552|616111105|FG003|Overall Study|Protocol Violation|4|||
170483411|NCT00708552|616111102|FG000|Overall Study|Lost to Follow-up|4|||
170483412|NCT00708552|616111103|FG001|Overall Study|Lost to Follow-up|2|||
170483413|NCT00708552|616111104|FG002|Overall Study|Lost to Follow-up|0|||
170483414|NCT00708552|616111105|FG003|Overall Study|Lost to Follow-up|1|||
170483415|NCT00708552|616111102|FG000|Overall Study|Physician Decision|1|||
170483416|NCT00708552|616111103|FG001|Overall Study|Physician Decision|2|||
170483417|NCT00708552|616111104|FG002|Overall Study|Physician Decision|0|||
170483418|NCT00708552|616111105|FG003|Overall Study|Physician Decision|0|||
170483419|NCT00708552|616111102|FG000|Overall Study|Withdrawal by Subject|12|||
170483420|NCT00708552|616111103|FG001|Overall Study|Withdrawal by Subject|7|||
170483421|NCT00708552|616111104|FG002|Overall Study|Withdrawal by Subject|8|||
170483422|NCT00708552|616111105|FG003|Overall Study|Withdrawal by Subject|10|||
170483423|NCT03971071|616111107|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
170483424|NCT03971071|616111108|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
170483425|NCT03971071|616111109|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
170483426|NCT03971071|616111110|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
170483427|NCT03971071|616111111|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
170483428|NCT03971071|616111107|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
170483429|NCT03971071|616111108|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
170548629|NCT02533674|616354653|FG006|Dose Level I|Physician Decision|0|||
170483430|NCT03971071|616111109|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
170483431|NCT03971071|616111110|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
170483432|NCT03971071|616111111|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
170483433|NCT03971071|616111107|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
170483434|NCT03971071|616111108|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
170483435|NCT03971071|616111109|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
170483436|NCT03971071|616111110|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
170483437|NCT03971071|616111111|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
170483438|NCT03971071|616111107|FG000|Open-label Treatment Period|Sponsor decision|0|||
170483439|NCT03971071|616111108|FG001|Open-label Treatment Period|Sponsor decision|0|||
170483440|NCT03971071|616111109|FG002|Open-label Treatment Period|Sponsor decision|0|||
170483441|NCT03971071|616111110|FG003|Open-label Treatment Period|Sponsor decision|0|||
170483442|NCT03971071|616111111|FG004|Open-label Treatment Period|Sponsor decision|1|||
170483443|NCT03971071|616111107|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
170483444|NCT03971071|616111108|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
170483445|NCT03971071|616111109|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
170483446|NCT03971071|616111110|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
170483447|NCT03971071|616111111|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
170483448|NCT03971071|616111107|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
170483449|NCT03971071|616111108|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
170483450|NCT03971071|616111109|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
170483451|NCT03971071|616111110|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
170483452|NCT03971071|616111111|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
170483453|NCT00460603|616111112|FG000|Phase 1|Death|1|||
170483454|NCT00460603|616111113|FG001|Phase 1|Death|0|||
170483455|NCT00460603|616111114|FG002|Phase 1|Death|0|||
170483456|NCT00460603|616111115|FG003|Phase 1|Death|2|||
170483457|NCT00460603|616111116|FG004|Phase 1|Death|0|||
170897790|NCT02909153|617630302|FG000|Overall Study|Withdrawal by Subject|0|||
170897791|NCT02909153|617630303|FG001|Overall Study|Withdrawal by Subject|1|||
170897792|NCT02909153|617630304|FG002|Overall Study|Withdrawal by Subject|0|||
170897793|NCT02909153|617630305|FG003|Overall Study|Withdrawal by Subject|0|||
170897794|NCT02909153|617630306|FG004|Overall Study|Withdrawal by Subject|0|||
170897795|NCT00565617|617630307|FG000|Overall Study|Withdrawal by Subject|1|||
170897796|NCT03040024|617630308|FG000|Overall Study|Adverse Event|0|||
170897797|NCT03040024|617630309|FG001|Overall Study|Adverse Event|1|||
170897798|NCT03040024|617630310|FG002|Overall Study|Adverse Event|0|||
170897799|NCT03040024|617630308|FG000|Overall Study|Death|0|||
170897800|NCT03040024|617630309|FG001|Overall Study|Death|1|||
170897801|NCT03040024|617630310|FG002|Overall Study|Death|0|||
170897802|NCT03040024|617630308|FG000|Overall Study|Physician Decision|0|||
170897803|NCT03040024|617630309|FG001|Overall Study|Physician Decision|0|||
170897804|NCT03040024|617630310|FG002|Overall Study|Physician Decision|1|||
170897805|NCT04666038|617630312|FG000|Overall Study|Progressive Disease|2|||
170897806|NCT04666038|617630313|FG001|Overall Study|Progressive Disease|0|||
170897807|NCT04666038|617630312|FG000|Overall Study|Death|38|||
170897808|NCT04666038|617630313|FG001|Overall Study|Death|32|||
170897809|NCT04666038|617630312|FG000|Overall Study|Withdrawal by Subject|10|||
170897810|NCT04666038|617630313|FG001|Overall Study|Withdrawal by Subject|19|||
170897811|NCT04666038|617630312|FG000|Overall Study|Lost to Follow-up|0|||
170897812|NCT04666038|617630313|FG001|Overall Study|Lost to Follow-up|2|||
170897813|NCT04666038|617630312|FG000|Overall Study|On Study Treatment|46|||
170897814|NCT04666038|617630313|FG001|Overall Study|On Study Treatment|5|||
170897815|NCT04666038|617630312|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
170897816|NCT04666038|617630313|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
170897817|NCT03641560|617630317|FG000|Overall Study|Withdrawal by Subject|6|||
170897818|NCT03641560|617630317|FG000|Overall Study|Progressive disease|40|||
170897819|NCT03641560|617630317|FG000|Overall Study|Death|6|||
170897820|NCT00110305|617632264|FG000|Overall Study|Adverse Event|46|||
170897821|NCT00110305|617632265|FG001|Overall Study|Adverse Event|13|||
170483458|NCT00460603|616111117|FG005|Phase 1|Death|0|||
170483459|NCT00460603|616111118|FG006|Phase 1|Death|0|||
170483460|NCT00460603|616111119|FG007|Phase 1|Death|0|||
170483461|NCT00460603|616111120|FG008|Phase 1|Death|1|||
170483462|NCT00460603|616111121|FG009|Phase 1|Death|0|||
170483463|NCT00460603|616111122|FG010|Phase 1|Death|0|||
170548630|NCT02533674|616354654|FG007|Dose Level I|Physician Decision|0|||
170897822|NCT00110305|617632264|FG000|Overall Study|Sponsors Decision|1|||
170897823|NCT00110305|617632265|FG001|Overall Study|Sponsors Decision|0|||
170897824|NCT00110305|617632264|FG000|Overall Study|Subject Non-Compliant|9|||
170897825|NCT00110305|617632265|FG001|Overall Study|Subject Non-Compliant|2|||
170897826|NCT00110305|617632264|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
170897827|NCT00110305|617632265|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
170483464|NCT00460603|616111123|FG011|Phase 1|Death|0|||
170483465|NCT00460603|616111112|FG000|Phase 1|Adverse Event|3|||
170897828|NCT00110305|617632264|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
170897829|NCT00110305|617632265|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
170897830|NCT00110305|617632264|FG000|Overall Study|Protocol Violation|0|||
170897831|NCT00110305|617632265|FG001|Overall Study|Protocol Violation|1|||
170897832|NCT00110305|617632264|FG000|Overall Study|Withdrawal by Subject|7|||
170897833|NCT00110305|617632265|FG001|Overall Study|Withdrawal by Subject|7|||
170897834|NCT00110305|617632264|FG000|Overall Study|Lost to Follow-up|20|||
170897835|NCT00110305|617632265|FG001|Overall Study|Lost to Follow-up|3|||
170897836|NCT00110305|617632264|FG000|Overall Study|Other|8|||
170897837|NCT00110305|617632265|FG001|Overall Study|Other|2|||
170897838|NCT05047523|617632266|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
170897839|NCT05047523|617632267|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
170897840|NCT05047523|617632268|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
170897841|NCT05047523|617632269|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
170483466|NCT00460603|616111113|FG001|Phase 1|Adverse Event|1|||
170483467|NCT00460603|616111114|FG002|Phase 1|Adverse Event|1|||
170483468|NCT00460603|616111115|FG003|Phase 1|Adverse Event|2|||
170483469|NCT00460603|616111116|FG004|Phase 1|Adverse Event|0|||
170483470|NCT00460603|616111117|FG005|Phase 1|Adverse Event|0|||
170483471|NCT00460603|616111118|FG006|Phase 1|Adverse Event|3|||
170483472|NCT00460603|616111119|FG007|Phase 1|Adverse Event|0|||
170483473|NCT00460603|616111120|FG008|Phase 1|Adverse Event|4|||
170483474|NCT00460603|616111121|FG009|Phase 1|Adverse Event|0|||
170483475|NCT00460603|616111122|FG010|Phase 1|Adverse Event|0|||
170483476|NCT00460603|616111123|FG011|Phase 1|Adverse Event|0|||
170483477|NCT00460603|616111112|FG000|Phase 1|Lack of Efficacy|1|||
170483478|NCT00460603|616111113|FG001|Phase 1|Lack of Efficacy|0|||
170483479|NCT00460603|616111114|FG002|Phase 1|Lack of Efficacy|1|||
170483480|NCT00460603|616111115|FG003|Phase 1|Lack of Efficacy|2|||
170483481|NCT00460603|616111116|FG004|Phase 1|Lack of Efficacy|2|||
170483482|NCT00460603|616111117|FG005|Phase 1|Lack of Efficacy|2|||
170483483|NCT00460603|616111118|FG006|Phase 1|Lack of Efficacy|2|||
170483484|NCT00460603|616111119|FG007|Phase 1|Lack of Efficacy|2|||
170483485|NCT00460603|616111120|FG008|Phase 1|Lack of Efficacy|11|||
170483486|NCT00460603|616111121|FG009|Phase 1|Lack of Efficacy|0|||
170483487|NCT00460603|616111122|FG010|Phase 1|Lack of Efficacy|0|||
170483488|NCT00460603|616111123|FG011|Phase 1|Lack of Efficacy|0|||
170483489|NCT00460603|616111112|FG000|Phase 1|Withdrawal by Subject|1|||
170483490|NCT00460603|616111113|FG001|Phase 1|Withdrawal by Subject|2|||
170483491|NCT00460603|616111114|FG002|Phase 1|Withdrawal by Subject|1|||
170483492|NCT00460603|616111115|FG003|Phase 1|Withdrawal by Subject|1|||
170483493|NCT00460603|616111116|FG004|Phase 1|Withdrawal by Subject|3|||
170483494|NCT00460603|616111117|FG005|Phase 1|Withdrawal by Subject|0|||
170483495|NCT00460603|616111118|FG006|Phase 1|Withdrawal by Subject|1|||
170483496|NCT00460603|616111119|FG007|Phase 1|Withdrawal by Subject|0|||
170483497|NCT00460603|616111120|FG008|Phase 1|Withdrawal by Subject|2|||
170483498|NCT00460603|616111121|FG009|Phase 1|Withdrawal by Subject|0|||
170483499|NCT00460603|616111122|FG010|Phase 1|Withdrawal by Subject|0|||
170483500|NCT00460603|616111123|FG011|Phase 1|Withdrawal by Subject|0|||
170483501|NCT00460603|616111112|FG000|Phase 1|Other|0|||
170483502|NCT00460603|616111113|FG001|Phase 1|Other|3|||
170483503|NCT00460603|616111114|FG002|Phase 1|Other|1|||
170483504|NCT00460603|616111115|FG003|Phase 1|Other|1|||
170483505|NCT00460603|616111116|FG004|Phase 1|Other|1|||
170483506|NCT00460603|616111117|FG005|Phase 1|Other|2|||
170483507|NCT00460603|616111118|FG006|Phase 1|Other|0|||
170483508|NCT00460603|616111119|FG007|Phase 1|Other|1|||
170483509|NCT00460603|616111120|FG008|Phase 1|Other|0|||
170483510|NCT00460603|616111121|FG009|Phase 1|Other|0|||
170483511|NCT00460603|616111122|FG010|Phase 1|Other|0|||
170483512|NCT00460603|616111123|FG011|Phase 1|Other|0|||
170483513|NCT00460603|616111112|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483514|NCT00460603|616111113|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483515|NCT00460603|616111114|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483516|NCT00460603|616111115|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170897842|NCT05047523|617632270|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
170897843|NCT05047523|617632271|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
170897844|NCT05047523|617632266|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
170897845|NCT05047523|617632267|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
170897846|NCT05047523|617632268|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
170897847|NCT05047523|617632269|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
170483517|NCT00460603|616111116|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483518|NCT00460603|616111117|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483519|NCT00460603|616111118|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483520|NCT00460603|616111119|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483521|NCT00460603|616111120|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483522|NCT00460603|616111121|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
170483523|NCT00460603|616111122|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483524|NCT00460603|616111123|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
170483525|NCT00460603|616111112|FG000|Phase 2|Adverse Event|0|||
170483526|NCT00460603|616111113|FG001|Phase 2|Adverse Event|0|||
170483527|NCT00460603|616111114|FG002|Phase 2|Adverse Event|0|||
170483528|NCT00460603|616111115|FG003|Phase 2|Adverse Event|0|||
170798063|NCT03786926|617273593|FG009|Overall Study|Death|1|||
170798064|NCT03786926|617273594|FG010|Overall Study|Death|2|||
170798065|NCT03786926|617273584|FG000|Overall Study|Physician Decision|0|||
170798066|NCT03786926|617273585|FG001|Overall Study|Physician Decision|1|||
170798067|NCT03786926|617273586|FG002|Overall Study|Physician Decision|0|||
170798068|NCT03786926|617273587|FG003|Overall Study|Physician Decision|1|||
170798069|NCT03786926|617273588|FG004|Overall Study|Physician Decision|2|||
170798070|NCT03786926|617273589|FG005|Overall Study|Physician Decision|0|||
170798071|NCT03786926|617273590|FG006|Overall Study|Physician Decision|0|||
170798072|NCT03786926|617273591|FG007|Overall Study|Physician Decision|2|||
170798073|NCT03786926|617273592|FG008|Overall Study|Physician Decision|1|||
170798074|NCT03786926|617273593|FG009|Overall Study|Physician Decision|1|||
170798075|NCT03786926|617273594|FG010|Overall Study|Physician Decision|0|||
170798076|NCT03786926|617273584|FG000|Overall Study|Withdrawal by Subject|0|||
170798077|NCT03786926|617273585|FG001|Overall Study|Withdrawal by Subject|1|||
170798078|NCT03786926|617273586|FG002|Overall Study|Withdrawal by Subject|1|||
170798079|NCT03786926|617273587|FG003|Overall Study|Withdrawal by Subject|0|||
170798080|NCT03786926|617273588|FG004|Overall Study|Withdrawal by Subject|0|||
170798081|NCT03786926|617273589|FG005|Overall Study|Withdrawal by Subject|0|||
170798082|NCT03786926|617273590|FG006|Overall Study|Withdrawal by Subject|1|||
170798083|NCT03786926|617273591|FG007|Overall Study|Withdrawal by Subject|0|||
170798084|NCT03786926|617273592|FG008|Overall Study|Withdrawal by Subject|1|||
170798085|NCT03786926|617273593|FG009|Overall Study|Withdrawal by Subject|0|||
170798086|NCT03786926|617273594|FG010|Overall Study|Withdrawal by Subject|1|||
170798087|NCT03786926|617273584|FG000|Overall Study|Study terminated by Sponsor|0|||
170798088|NCT03786926|617273585|FG001|Overall Study|Study terminated by Sponsor|0|||
170798089|NCT03786926|617273586|FG002|Overall Study|Study terminated by Sponsor|0|||
170798090|NCT03786926|617273587|FG003|Overall Study|Study terminated by Sponsor|0|||
170798091|NCT03786926|617273588|FG004|Overall Study|Study terminated by Sponsor|1|||
170798092|NCT03786926|617273589|FG005|Overall Study|Study terminated by Sponsor|0|||
170798093|NCT03786926|617273590|FG006|Overall Study|Study terminated by Sponsor|0|||
170798094|NCT03786926|617273591|FG007|Overall Study|Study terminated by Sponsor|4|||
170798095|NCT03786926|617273592|FG008|Overall Study|Study terminated by Sponsor|0|||
170798096|NCT03786926|617273593|FG009|Overall Study|Study terminated by Sponsor|0|||
170798097|NCT03786926|617273594|FG010|Overall Study|Study terminated by Sponsor|0|||
170798098|NCT03786926|617273584|FG000|Overall Study|Anti-neoplasm treatment|0|||
170798099|NCT03786926|617273585|FG001|Overall Study|Anti-neoplasm treatment|0|||
170798100|NCT03786926|617273586|FG002|Overall Study|Anti-neoplasm treatment|0|||
170798101|NCT03786926|617273587|FG003|Overall Study|Anti-neoplasm treatment|0|||
170798102|NCT03786926|617273588|FG004|Overall Study|Anti-neoplasm treatment|1|||
170798103|NCT03786926|617273589|FG005|Overall Study|Anti-neoplasm treatment|0|||
170798104|NCT03786926|617273590|FG006|Overall Study|Anti-neoplasm treatment|1|||
170798105|NCT03786926|617273591|FG007|Overall Study|Anti-neoplasm treatment|0|||
170798106|NCT03786926|617273592|FG008|Overall Study|Anti-neoplasm treatment|0|||
170798107|NCT03786926|617273593|FG009|Overall Study|Anti-neoplasm treatment|0|||
170798108|NCT03786926|617273594|FG010|Overall Study|Anti-neoplasm treatment|0|||
170798109|NCT03786926|617273584|FG000|Overall Study|Other|0|||
170798110|NCT03786926|617273585|FG001|Overall Study|Other|0|||
170798111|NCT03786926|617273586|FG002|Overall Study|Other|0|||
170798112|NCT03786926|617273587|FG003|Overall Study|Other|1|||
170798113|NCT03786926|617273588|FG004|Overall Study|Other|0|||
170798114|NCT03786926|617273589|FG005|Overall Study|Other|1|||
170798115|NCT03786926|617273590|FG006|Overall Study|Other|0|||
170798116|NCT03786926|617273591|FG007|Overall Study|Other|0|||
170798117|NCT03786926|617273592|FG008|Overall Study|Other|2|||
170798118|NCT03786926|617273593|FG009|Overall Study|Other|0|||
170798119|NCT03786926|617273594|FG010|Overall Study|Other|0|||
170798120|NCT02163694|617273613|FG000|Overall Study|Adverse event- related to progression|4|||
170798121|NCT02163694|617273614|FG001|Overall Study|Adverse event- related to progression|10|||
170798122|NCT02163694|617273613|FG000|Overall Study|Adverse event- not related to progression|7|||
170798123|NCT02163694|617273614|FG001|Overall Study|Adverse event- not related to progression|22|||
170798124|NCT02163694|617273613|FG000|Overall Study|Withdrew consent|13|||
170798125|NCT02163694|617273614|FG001|Overall Study|Withdrew consent|28|||
170798126|NCT02163694|617273613|FG000|Overall Study|Lost to Follow-up|2|||
170798127|NCT02163694|617273614|FG001|Overall Study|Lost to Follow-up|2|||
170798128|NCT02163694|617273613|FG000|Overall Study|Sponsor discontinued study|3|||
170798129|NCT02163694|617273614|FG001|Overall Study|Sponsor discontinued study|29|||
170798130|NCT02163694|617273613|FG000|Overall Study|Progressive disease per protocol|125|||
170798131|NCT02163694|617273614|FG001|Overall Study|Progressive disease per protocol|224|||
170798132|NCT02163694|617273613|FG000|Overall Study|Other, not specified|17|||
170798133|NCT02163694|617273614|FG001|Overall Study|Other, not specified|22|||
170798134|NCT02163694|617273613|FG000|Overall Study|Randomized but Not Treated|1|||
170798135|NCT02163694|617273614|FG001|Overall Study|Randomized but Not Treated|0|||
170798136|NCT02163694|617273613|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
170798137|NCT02163694|617273614|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
170798138|NCT03816397|617273615|FG000|Overall Study|Censored at interim analysis date.|13|||
170798139|NCT03816397|617273616|FG001|Overall Study|Censored at interim analysis date.|6|||
170798140|NCT03816397|617273615|FG000|Overall Study|Withdrawal by Subject|1|||
170798141|NCT03816397|617273616|FG001|Overall Study|Withdrawal by Subject|1|||
170798142|NCT04496752|617273619|FG000|Second Assessment|Lost to Follow-up|3|||
170798143|NCT04496752|617273620|FG001|Second Assessment|Lost to Follow-up|3|||
170798144|NCT04496752|617273619|FG000|Second Assessment|Adverse Event|2|||
170483529|NCT00460603|616111116|FG004|Phase 2|Adverse Event|0|||
170483530|NCT00460603|616111117|FG005|Phase 2|Adverse Event|0|||
170483531|NCT00460603|616111118|FG006|Phase 2|Adverse Event|0|||
170483532|NCT00460603|616111119|FG007|Phase 2|Adverse Event|0|||
170483533|NCT00460603|616111120|FG008|Phase 2|Adverse Event|0|||
170483534|NCT00460603|616111121|FG009|Phase 2|Adverse Event|12|||
170483535|NCT00460603|616111122|FG010|Phase 2|Adverse Event|9|||
170483536|NCT00460603|616111123|FG011|Phase 2|Adverse Event|10|||
170483537|NCT00460603|616111112|FG000|Phase 2|Death|0|||
170483538|NCT00460603|616111113|FG001|Phase 2|Death|0|||
170483539|NCT00460603|616111114|FG002|Phase 2|Death|0|||
170483540|NCT00460603|616111115|FG003|Phase 2|Death|0|||
170483541|NCT00460603|616111116|FG004|Phase 2|Death|0|||
170483542|NCT00460603|616111117|FG005|Phase 2|Death|0|||
170483543|NCT00460603|616111118|FG006|Phase 2|Death|0|||
170483544|NCT00460603|616111119|FG007|Phase 2|Death|0|||
170483545|NCT00460603|616111120|FG008|Phase 2|Death|0|||
170483546|NCT00460603|616111121|FG009|Phase 2|Death|4|||
170483547|NCT00460603|616111122|FG010|Phase 2|Death|2|||
170483548|NCT00460603|616111123|FG011|Phase 2|Death|2|||
170483549|NCT00460603|616111112|FG000|Phase 2|Protocol Violation|0|||
170798145|NCT04496752|617273620|FG001|Second Assessment|Adverse Event|0|||
170798146|NCT03662022|617273621|FG000|Year 1 2019|prevalent case|83|||
170798147|NCT03662022|617273622|FG001|Year 1 2019|prevalent case|116|||
170483550|NCT00460603|616111113|FG001|Phase 2|Protocol Violation|0|||
170483551|NCT00460603|616111114|FG002|Phase 2|Protocol Violation|0|||
170483552|NCT00460603|616111115|FG003|Phase 2|Protocol Violation|0|||
170483553|NCT00460603|616111116|FG004|Phase 2|Protocol Violation|0|||
170483554|NCT00460603|616111117|FG005|Phase 2|Protocol Violation|0|||
170483555|NCT00460603|616111118|FG006|Phase 2|Protocol Violation|0|||
170483556|NCT00460603|616111119|FG007|Phase 2|Protocol Violation|0|||
170483557|NCT00460603|616111120|FG008|Phase 2|Protocol Violation|0|||
170483558|NCT00460603|616111121|FG009|Phase 2|Protocol Violation|1|||
170483559|NCT00460603|616111122|FG010|Phase 2|Protocol Violation|1|||
170483560|NCT00460603|616111123|FG011|Phase 2|Protocol Violation|0|||
170483561|NCT00460603|616111112|FG000|Phase 2|Lost to Follow-up|0|||
170483562|NCT00460603|616111113|FG001|Phase 2|Lost to Follow-up|0|||
170798148|NCT03662022|617273623|FG002|Year 1 2019|prevalent case|158|||
170798149|NCT03662022|617273624|FG003|Year 1 2019|prevalent case|99|||
170798150|NCT03662022|617273621|FG000|Year 2 2020|incident case|18|||
170483563|NCT00460603|616111114|FG002|Phase 2|Lost to Follow-up|0|||
170798151|NCT03662022|617273622|FG001|Year 2 2020|incident case|18|||
170483564|NCT00460603|616111115|FG003|Phase 2|Lost to Follow-up|0|||
170483565|NCT00460603|616111116|FG004|Phase 2|Lost to Follow-up|0|||
170483566|NCT00460603|616111117|FG005|Phase 2|Lost to Follow-up|0|||
170483567|NCT00460603|616111118|FG006|Phase 2|Lost to Follow-up|0|||
170483568|NCT00460603|616111119|FG007|Phase 2|Lost to Follow-up|0|||
170483569|NCT00460603|616111120|FG008|Phase 2|Lost to Follow-up|0|||
170483570|NCT00460603|616111121|FG009|Phase 2|Lost to Follow-up|1|||
170483571|NCT00460603|616111122|FG010|Phase 2|Lost to Follow-up|0|||
170483572|NCT00460603|616111123|FG011|Phase 2|Lost to Follow-up|0|||
170483573|NCT00460603|616111112|FG000|Phase 2|Other|0|||
170483574|NCT00460603|616111113|FG001|Phase 2|Other|0|||
170483575|NCT00460603|616111114|FG002|Phase 2|Other|0|||
170483576|NCT00460603|616111115|FG003|Phase 2|Other|0|||
170483577|NCT00460603|616111116|FG004|Phase 2|Other|0|||
170483578|NCT00460603|616111117|FG005|Phase 2|Other|0|||
170483579|NCT00460603|616111118|FG006|Phase 2|Other|0|||
170483580|NCT00460603|616111119|FG007|Phase 2|Other|0|||
170483581|NCT00460603|616111120|FG008|Phase 2|Other|0|||
170483582|NCT00460603|616111121|FG009|Phase 2|Other|6|||
170483583|NCT00460603|616111122|FG010|Phase 2|Other|16|||
170483584|NCT00460603|616111123|FG011|Phase 2|Other|7|||
170483585|NCT00460603|616111112|FG000|Phase 2|Objective Progression or Relapse|0|||
170483586|NCT00460603|616111113|FG001|Phase 2|Objective Progression or Relapse|0|||
170483587|NCT00460603|616111114|FG002|Phase 2|Objective Progression or Relapse|0|||
170483588|NCT00460603|616111115|FG003|Phase 2|Objective Progression or Relapse|0|||
170483589|NCT00460603|616111116|FG004|Phase 2|Objective Progression or Relapse|0|||
170483590|NCT00460603|616111117|FG005|Phase 2|Objective Progression or Relapse|0|||
170483591|NCT00460603|616111118|FG006|Phase 2|Objective Progression or Relapse|0|||
170483592|NCT00460603|616111119|FG007|Phase 2|Objective Progression or Relapse|0|||
170483593|NCT00460603|616111120|FG008|Phase 2|Objective Progression or Relapse|0|||
170483594|NCT00460603|616111121|FG009|Phase 2|Objective Progression or Relapse|9|||
170483595|NCT00460603|616111122|FG010|Phase 2|Objective Progression or Relapse|10|||
170483596|NCT00460603|616111123|FG011|Phase 2|Objective Progression or Relapse|17|||
170483597|NCT00460603|616111112|FG000|Phase 2|Global Deterioration of Health Status|0|||
170483598|NCT00460603|616111113|FG001|Phase 2|Global Deterioration of Health Status|0|||
170483599|NCT00460603|616111114|FG002|Phase 2|Global Deterioration of Health Status|0|||
170483600|NCT00460603|616111115|FG003|Phase 2|Global Deterioration of Health Status|0|||
170483601|NCT00460603|616111116|FG004|Phase 2|Global Deterioration of Health Status|0|||
170483602|NCT00460603|616111117|FG005|Phase 2|Global Deterioration of Health Status|0|||
170483603|NCT00460603|616111118|FG006|Phase 2|Global Deterioration of Health Status|0|||
170483604|NCT00460603|616111119|FG007|Phase 2|Global Deterioration of Health Status|0|||
170483605|NCT00460603|616111120|FG008|Phase 2|Global Deterioration of Health Status|0|||
170483606|NCT00460603|616111121|FG009|Phase 2|Global Deterioration of Health Status|0|||
170483607|NCT00460603|616111122|FG010|Phase 2|Global Deterioration of Health Status|1|||
170483608|NCT00460603|616111123|FG011|Phase 2|Global Deterioration of Health Status|0|||
170483609|NCT00460603|616111112|FG000|Phase 2|Withdrawal by Subject|0|||
170483610|NCT00460603|616111113|FG001|Phase 2|Withdrawal by Subject|0|||
170483611|NCT00460603|616111114|FG002|Phase 2|Withdrawal by Subject|0|||
170483612|NCT00460603|616111115|FG003|Phase 2|Withdrawal by Subject|0|||
170483613|NCT00460603|616111116|FG004|Phase 2|Withdrawal by Subject|0|||
170483614|NCT00460603|616111117|FG005|Phase 2|Withdrawal by Subject|0|||
170483615|NCT00460603|616111118|FG006|Phase 2|Withdrawal by Subject|0|||
170483616|NCT00460603|616111119|FG007|Phase 2|Withdrawal by Subject|0|||
170483617|NCT00460603|616111120|FG008|Phase 2|Withdrawal by Subject|0|||
170483618|NCT00460603|616111121|FG009|Phase 2|Withdrawal by Subject|5|||
170483619|NCT00460603|616111122|FG010|Phase 2|Withdrawal by Subject|4|||
170483620|NCT00460603|616111123|FG011|Phase 2|Withdrawal by Subject|5|||
170483621|NCT00460603|616111112|FG000|Phase 2|Randomized, but not treated|0|||
170483622|NCT00460603|616111113|FG001|Phase 2|Randomized, but not treated|0|||
170483623|NCT00460603|616111114|FG002|Phase 2|Randomized, but not treated|0|||
170483624|NCT00460603|616111115|FG003|Phase 2|Randomized, but not treated|0|||
170483625|NCT00460603|616111116|FG004|Phase 2|Randomized, but not treated|0|||
170483626|NCT00460603|616111117|FG005|Phase 2|Randomized, but not treated|0|||
170483627|NCT00460603|616111118|FG006|Phase 2|Randomized, but not treated|0|||
170483628|NCT00460603|616111119|FG007|Phase 2|Randomized, but not treated|0|||
170483629|NCT00460603|616111120|FG008|Phase 2|Randomized, but not treated|0|||
170483630|NCT00460603|616111121|FG009|Phase 2|Randomized, but not treated|3|||
170483631|NCT00460603|616111122|FG010|Phase 2|Randomized, but not treated|0|||
170483632|NCT00460603|616111123|FG011|Phase 2|Randomized, but not treated|0|||
170483633|NCT00495391|616111124|FG000|Overall Study|Lack of Efficacy|34|||
170483634|NCT00495391|616111125|FG001|Overall Study|Lack of Efficacy|18|||
170483635|NCT00495391|616111124|FG000|Overall Study|Withdrawal by Subject|2|||
170483636|NCT00495391|616111125|FG001|Overall Study|Withdrawal by Subject|3|||
170483637|NCT02712320|616111126|FG000|Overall Study|Lost to Follow-up|1|||
170483638|NCT02712320|616111126|FG000|Overall Study|Withdrawal by Subject|1|||
170483639|NCT02712320|616111126|FG000|Overall Study|Transferred to another facility|1|||
170483640|NCT02712320|616111126|FG000|Overall Study|Treating with the prohibited medications|2|||
170483641|NCT05266053|616111127|FG000|Overall Study|Withdrawal by Subject|8|||
170483642|NCT05266053|616111128|FG001|Overall Study|Withdrawal by Subject|4|||
170483643|NCT01051960|616111134|FG000|Overall Study|Adverse Event|1|||
170483644|NCT00360282|616111135|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
170548631|NCT02533674|616354647|FG000|Dose Level I|Death|1|||
170548632|NCT02533674|616354648|FG001|Dose Level I|Death|0|||
170548633|NCT02533674|616354649|FG002|Dose Level I|Death|0|||
170548634|NCT02533674|616354650|FG003|Dose Level I|Death|0|||
170897848|NCT05047523|617632270|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
170483645|NCT00360282|616111136|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
170483646|NCT00360282|616111137|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
170483647|NCT00360282|616111138|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
170483648|NCT00360282|616111135|FG000|Second Intervention|Adverse Event|0|||
170897849|NCT05047523|617632271|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
170897850|NCT05047523|617632266|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
170897851|NCT05047523|617632267|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
170897852|NCT05047523|617632268|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
170897853|NCT05047523|617632269|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
170897854|NCT05047523|617632270|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
170897855|NCT05047523|617632271|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
170897856|NCT05047523|617632266|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
170897857|NCT05047523|617632267|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170897858|NCT05047523|617632268|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170897859|NCT05047523|617632269|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170897860|NCT05047523|617632270|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170897861|NCT05047523|617632271|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
170897862|NCT05047523|617632266|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
170897863|NCT05047523|617632267|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
170897864|NCT05047523|617632268|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
170897865|NCT05047523|617632269|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
170897866|NCT05047523|617632270|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
170897867|NCT05047523|617632271|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
170897868|NCT05047523|617632266|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
170897869|NCT05047523|617632267|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
170897870|NCT05047523|617632268|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
170483649|NCT00360282|616111136|FG001|Second Intervention|Adverse Event|1|||
170483650|NCT00360282|616111137|FG002|Second Intervention|Adverse Event|0|||
170897871|NCT05047523|617632269|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
170897872|NCT05047523|617632270|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
170897873|NCT05047523|617632271|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
170897874|NCT03658889|617632272|FG000|Overall Study|Protocol Violation|2|||
170897875|NCT03658889|617632273|FG001|Overall Study|Protocol Violation|0|||
170897876|NCT04188197|617632277|FG000|Overall Study|Lost to Follow-up|4|||
170897877|NCT04188197|617632278|FG001|Overall Study|Lost to Follow-up|1|||
170897878|NCT04188197|617632277|FG000|Overall Study|Withdrawal by Subject|1|||
170897879|NCT04188197|617632278|FG001|Overall Study|Withdrawal by Subject|1|||
170897880|NCT04188197|617632277|FG000|Overall Study|Pregnancy|0|||
170897881|NCT04188197|617632278|FG001|Overall Study|Pregnancy|1|||
170897882|NCT00365989|617632284|FG000|Overall Study|Withdrawal by Subject|1|||
170897883|NCT00365989|617632284|FG000|Overall Study|Non-compliance|1|||
170897884|NCT00317044|617632285|FG000|Overall Study|Protocol Violation|28|||
170897885|NCT00317044|617632286|FG001|Overall Study|Protocol Violation|22|||
170897886|NCT00317044|617632287|FG002|Overall Study|Protocol Violation|20|||
170897887|NCT00317044|617632285|FG000|Overall Study|Adverse Event|4|||
170897888|NCT00317044|617632286|FG001|Overall Study|Adverse Event|7|||
170897889|NCT00317044|617632287|FG002|Overall Study|Adverse Event|4|||
170897890|NCT00317044|617632285|FG000|Overall Study|Withdrawal by Subject|10|||
170897891|NCT00317044|617632286|FG001|Overall Study|Withdrawal by Subject|7|||
170897892|NCT00317044|617632287|FG002|Overall Study|Withdrawal by Subject|12|||
170897893|NCT00317044|617632285|FG000|Overall Study|Lost to Follow-up|0|||
170897894|NCT00317044|617632286|FG001|Overall Study|Lost to Follow-up|2|||
170897895|NCT00317044|617632287|FG002|Overall Study|Lost to Follow-up|3|||
170897896|NCT00317044|617632285|FG000|Overall Study|Multiple Reasons|6|||
170897897|NCT00317044|617632286|FG001|Overall Study|Multiple Reasons|2|||
170897898|NCT00317044|617632287|FG002|Overall Study|Multiple Reasons|6|||
170483651|NCT00360282|616111138|FG003|Second Intervention|Adverse Event|0|||
170483652|NCT02996968|616111139|FG000|Overall Study|Withdrawal by Subject|1|||
170897899|NCT06441877|617632288|FG000|Overall Study|Withdrawal by Subject|0|||
170483653|NCT02996968|616111140|FG001|Overall Study|Withdrawal by Subject|0|||
170897900|NCT06441877|617632289|FG001|Overall Study|Withdrawal by Subject|2|||
170897901|NCT06441877|617632290|FG002|Overall Study|Withdrawal by Subject|0|||
170897902|NCT06441877|617632291|FG003|Overall Study|Withdrawal by Subject|0|||
170897903|NCT01154101|617632301|FG000|Overall Study|Adverse Event|0|||
170897904|NCT01154101|617632302|FG001|Overall Study|Adverse Event|2|||
170897905|NCT01154101|617632303|FG002|Overall Study|Adverse Event|1|||
170897906|NCT01154101|617632304|FG003|Overall Study|Adverse Event|1|||
170897907|NCT01154101|617632305|FG004|Overall Study|Adverse Event|0|||
170897908|NCT01154101|617632301|FG000|Overall Study|Lost to Follow-up|0|||
170897909|NCT01154101|617632302|FG001|Overall Study|Lost to Follow-up|1|||
170897910|NCT01154101|617632303|FG002|Overall Study|Lost to Follow-up|0|||
170897911|NCT01154101|617632304|FG003|Overall Study|Lost to Follow-up|1|||
170897912|NCT01154101|617632305|FG004|Overall Study|Lost to Follow-up|0|||
170897913|NCT01154101|617632301|FG000|Overall Study|Withdrawal by Subject|0|||
170897914|NCT01154101|617632302|FG001|Overall Study|Withdrawal by Subject|1|||
170897915|NCT01154101|617632303|FG002|Overall Study|Withdrawal by Subject|2|||
170897916|NCT01154101|617632304|FG003|Overall Study|Withdrawal by Subject|0|||
170897917|NCT01154101|617632305|FG004|Overall Study|Withdrawal by Subject|1|||
170897918|NCT04258579|617632308|FG000|Overall Study|Withdrawal by Subject|7|||
170897919|NCT04258579|617632308|FG000|Overall Study|Lost to Follow-up|3|||
170897920|NCT04258579|617632308|FG000|Overall Study|Protocol Violation|2|||
170897921|NCT04258579|617632308|FG000|Overall Study|Adverse Event|1|||
170897922|NCT04007159|617632310|FG000|Induction Phase|(missed study visits)|16|||
170897923|NCT04007159|617632310|FG000|Induction Phase|Withdrawal by Subject|4|||
170897924|NCT04007159|617632310|FG000|Induction Phase|Adverse Event|2|||
170483654|NCT03207815|616111141|FG000|Overall Study|Protocol Violation|3|||
170483655|NCT03207815|616111142|FG001|Overall Study|Protocol Violation|1|||
170483656|NCT03207815|616111141|FG000|Overall Study|Adverse Event|1|||
170483657|NCT03207815|616111142|FG001|Overall Study|Adverse Event|2|||
170483658|NCT03207815|616111141|FG000|Overall Study|Lost to Follow-up|1|||
170483659|NCT03207815|616111142|FG001|Overall Study|Lost to Follow-up|2|||
170483660|NCT03207815|616111141|FG000|Overall Study|Investigator's Discretion|1|||
170483661|NCT03207815|616111142|FG001|Overall Study|Investigator's Discretion|1|||
170483662|NCT03207815|616111141|FG000|Overall Study|Lack of Efficacy|0|||
170483663|NCT03207815|616111142|FG001|Overall Study|Lack of Efficacy|1|||
170483664|NCT03207815|616111141|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
170483665|NCT03207815|616111142|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
170483666|NCT03207815|616111141|FG000|Overall Study|Withdrew Consent|1|||
170483667|NCT03207815|616111142|FG001|Overall Study|Withdrew Consent|0|||
170483668|NCT03817853|616111143|FG000|Induction Phase|Adverse Event|5|||
170483669|NCT03817853|616111144|FG001|Induction Phase|Adverse Event|0|||
170483670|NCT03817853|616111145|FG002|Induction Phase|Adverse Event|0|||
170483671|NCT03817853|616111143|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
170483672|NCT03817853|616111144|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
170483673|NCT03817853|616111145|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
170483674|NCT03817853|616111143|FG000|Induction Phase|Physician Decision|2|||
170483675|NCT03817853|616111144|FG001|Induction Phase|Physician Decision|0|||
170483676|NCT03817853|616111145|FG002|Induction Phase|Physician Decision|0|||
170483677|NCT03817853|616111143|FG000|Induction Phase|Progressive Disease|6|||
170483678|NCT03817853|616111144|FG001|Induction Phase|Progressive Disease|0|||
170483679|NCT03817853|616111145|FG002|Induction Phase|Progressive Disease|0|||
170483680|NCT03817853|616111143|FG000|Induction Phase|Withdrawal by Subject|4|||
170483681|NCT03817853|616111144|FG001|Induction Phase|Withdrawal by Subject|0|||
170483682|NCT03817853|616111145|FG002|Induction Phase|Withdrawal by Subject|0|||
170483683|NCT03817853|616111143|FG000|Maintenance Phase|Adverse Event|0|||
170483684|NCT03817853|616111144|FG001|Maintenance Phase|Adverse Event|8|||
170483685|NCT03817853|616111145|FG002|Maintenance Phase|Adverse Event|0|||
170483686|NCT03817853|616111143|FG000|Maintenance Phase|Death|0|||
170483687|NCT03817853|616111144|FG001|Maintenance Phase|Death|5|||
170483688|NCT03817853|616111145|FG002|Maintenance Phase|Death|0|||
170483689|NCT03817853|616111143|FG000|Maintenance Phase|Progressive Disease|0|||
170483690|NCT03817853|616111144|FG001|Maintenance Phase|Progressive Disease|7|||
170483691|NCT03817853|616111145|FG002|Maintenance Phase|Progressive Disease|0|||
170483692|NCT03817853|616111143|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170483693|NCT03817853|616111144|FG001|Maintenance Phase|Withdrawal by Subject|2|||
170483694|NCT03817853|616111145|FG002|Maintenance Phase|Withdrawal by Subject|0|||
170483695|NCT03817853|616111143|FG000|Maintenance Phase|Physician Decision|0|||
170483696|NCT03817853|616111144|FG001|Maintenance Phase|Physician Decision|1|||
170483697|NCT03817853|616111145|FG002|Maintenance Phase|Physician Decision|0|||
170483698|NCT03817853|616111143|FG000|Maintenance Phase|Various reasons|0|||
170483699|NCT03817853|616111144|FG001|Maintenance Phase|Various reasons|4|||
170483700|NCT03817853|616111145|FG002|Maintenance Phase|Various reasons|0|||
170483701|NCT03817853|616111143|FG000|Maintenance Phase|Protocol Deviation|0|||
170483702|NCT03817853|616111144|FG001|Maintenance Phase|Protocol Deviation|1|||
170483703|NCT03817853|616111145|FG002|Maintenance Phase|Protocol Deviation|0|||
170483704|NCT03817853|616111143|FG000|Follow-up Phase|Adverse Event|0|||
170483705|NCT03817853|616111144|FG001|Follow-up Phase|Adverse Event|0|||
170483706|NCT03817853|616111145|FG002|Follow-up Phase|Adverse Event|2|||
170483707|NCT03817853|616111143|FG000|Follow-up Phase|Death|0|||
170483708|NCT03817853|616111144|FG001|Follow-up Phase|Death|0|||
170483709|NCT03817853|616111145|FG002|Follow-up Phase|Death|1|||
170483710|NCT03817853|616111143|FG000|Follow-up Phase|Progressive Disease|0|||
170483711|NCT03817853|616111144|FG001|Follow-up Phase|Progressive Disease|0|||
170483712|NCT03817853|616111145|FG002|Follow-up Phase|Progressive Disease|3|||
170483713|NCT03817853|616111143|FG000|Follow-up Phase|Withdrawal by Subject|0|||
170548635|NCT02533674|616354651|FG004|Dose Level I|Death|0|||
170548636|NCT02533674|616354652|FG005|Dose Level I|Death|0|||
170483714|NCT03817853|616111144|FG001|Follow-up Phase|Withdrawal by Subject|0|||
170483715|NCT03817853|616111145|FG002|Follow-up Phase|Withdrawal by Subject|1|||
170483716|NCT00791778|616111149|FG000|Double-blind Treatment|Adverse Event|49|||
170483717|NCT00791778|616111150|FG001|Double-blind Treatment|Adverse Event|9|||
170483718|NCT00791778|616111149|FG000|Double-blind Treatment|Physician Decision|6|||
170483719|NCT00791778|616111150|FG001|Double-blind Treatment|Physician Decision|26|||
170483720|NCT00791778|616111149|FG000|Double-blind Treatment|Protocol Violation|0|||
170483721|NCT00791778|616111150|FG001|Double-blind Treatment|Protocol Violation|4|||
170483722|NCT00791778|616111149|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
170483723|NCT00791778|616111150|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
170483724|NCT00791778|616111149|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
170483725|NCT00791778|616111150|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
170483726|NCT00791778|616111149|FG000|Follow-up|Withdrawal by Subject|3|||
170548637|NCT02533674|616354653|FG006|Dose Level I|Death|0|||
170483727|NCT00791778|616111150|FG001|Follow-up|Withdrawal by Subject|0|||
170483728|NCT00791778|616111149|FG000|Follow-up|Lost to Follow-up|2|||
170483729|NCT00791778|616111150|FG001|Follow-up|Lost to Follow-up|1|||
170483730|NCT00031590|616111153|FG000|Overall Study|Adverse Event|1|||
170483731|NCT00031590|616111153|FG000|Overall Study|Withdrawal by parents|2|||
170483732|NCT05506046|616111154|FG000|Overall Study|Lost to Follow-up|89|||
170483733|NCT05506046|616111155|FG001|Overall Study|Lost to Follow-up|101|||
170483734|NCT05506046|616111156|FG002|Overall Study|Lost to Follow-up|102|||
170483735|NCT05506046|616111157|FG003|Overall Study|Lost to Follow-up|99|||
170483736|NCT00444535|616111158|FG000|Overall Study|Withdrawal by Subject|5|||
170483737|NCT00444535|616111158|FG000|Overall Study|Physician Decision|5|||
170483738|NCT00444535|616111158|FG000|Overall Study|progressive disease|1|||
170483739|NCT00444535|616111158|FG000|Overall Study|Adverse Event|2|||
170548638|NCT02533674|616354654|FG007|Dose Level I|Death|0|||
170798152|NCT03662022|617273623|FG002|Year 2 2020|incident case|16|||
170897925|NCT04007159|617632310|FG000|Challenge Phase|missed study visits|3|||
170897926|NCT02388295|617632311|FG000|Dose Escalation Week 1|Adverse Event|1|||
170897927|NCT02388295|617632312|FG001|Dose Escalation Week 1|Adverse Event|2|||
170897928|NCT02388295|617632313|FG002|Dose Escalation Week 1|Adverse Event|1|||
170798153|NCT03662022|617273624|FG003|Year 2 2020|incident case|26|||
170798154|NCT03662022|617273621|FG000|Year 2 2020|other case|18|||
170798155|NCT03662022|617273622|FG001|Year 2 2020|other case|16|||
170798156|NCT03662022|617273623|FG002|Year 2 2020|other case|16|||
170798157|NCT03662022|617273624|FG003|Year 2 2020|other case|24|||
170798158|NCT03662022|617273621|FG000|Year 2 2020|Lost to Follow-up|1633|||
170798159|NCT03662022|617273622|FG001|Year 2 2020|Lost to Follow-up|1183|||
170798160|NCT03662022|617273623|FG002|Year 2 2020|Lost to Follow-up|1381|||
170798161|NCT03662022|617273624|FG003|Year 2 2020|Lost to Follow-up|2858|||
170798162|NCT03662022|617273621|FG000|Year 3 2021|incident case|24|||
170798163|NCT03662022|617273622|FG001|Year 3 2021|incident case|27|||
170798164|NCT03662022|617273623|FG002|Year 3 2021|incident case|24|||
170798165|NCT03662022|617273624|FG003|Year 3 2021|incident case|11|||
170798166|NCT03662022|617273621|FG000|Year 3 2021|other case|4|||
170798167|NCT03662022|617273622|FG001|Year 3 2021|other case|15|||
170798168|NCT03662022|617273623|FG002|Year 3 2021|other case|10|||
170798169|NCT03662022|617273624|FG003|Year 3 2021|other case|14|||
170798170|NCT03662022|617273621|FG000|Year 3 2021|Lost to Follow-up|179|||
170798171|NCT03662022|617273622|FG001|Year 3 2021|Lost to Follow-up|244|||
170798172|NCT03662022|617273623|FG002|Year 3 2021|Lost to Follow-up|480|||
170798173|NCT03662022|617273624|FG003|Year 3 2021|Lost to Follow-up|477|||
170798174|NCT03662022|617273621|FG000|Year 4 2022|incident case|25|||
170798175|NCT03662022|617273622|FG001|Year 4 2022|incident case|41|||
170897929|NCT02388295|617632311|FG000|Dose Escalation Week 1|Determined not eligible|1|||
170897930|NCT02388295|617632312|FG001|Dose Escalation Week 1|Determined not eligible|1|||
170897931|NCT02388295|617632313|FG002|Dose Escalation Week 1|Determined not eligible|1|||
170897932|NCT02388295|617632311|FG000|Dose Escalation Week 2|Protocol Violation|0|||
170897933|NCT02388295|617632312|FG001|Dose Escalation Week 2|Protocol Violation|1|||
170483740|NCT01568892|616111159|FG000|Open-label Phase|Adverse Event|2|||
170483741|NCT01568892|616111160|FG001|Open-label Phase|Adverse Event|0|||
170798176|NCT03662022|617273623|FG002|Year 4 2022|incident case|28|||
170798177|NCT03662022|617273624|FG003|Year 4 2022|incident case|7|||
170798178|NCT03662022|617273621|FG000|Year 4 2022|other case|8|||
170798179|NCT03662022|617273622|FG001|Year 4 2022|other case|19|||
170798180|NCT03662022|617273623|FG002|Year 4 2022|other case|13|||
170798181|NCT03662022|617273624|FG003|Year 4 2022|other case|7|||
170897934|NCT02388295|617632313|FG002|Dose Escalation Week 2|Protocol Violation|0|||
170897935|NCT02388295|617632311|FG000|Dose Escalation Week 2|Determined not eligible|1|||
170897936|NCT02388295|617632312|FG001|Dose Escalation Week 2|Determined not eligible|1|||
170897937|NCT02388295|617632313|FG002|Dose Escalation Week 2|Determined not eligible|1|||
170897938|NCT02388295|617632311|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
170897939|NCT02388295|617632312|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
170897940|NCT02388295|617632313|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
170897941|NCT02076165|617632314|FG000|Overall Study|Lost to Follow-up|7|||
170897942|NCT02076165|617632315|FG001|Overall Study|Lost to Follow-up|5|||
170897943|NCT02076165|617632314|FG000|Overall Study|Refused follow-up assessment|1|||
170897944|NCT02076165|617632315|FG001|Overall Study|Refused follow-up assessment|1|||
170640150|NCT01657461|616695589|FG001|Overall Study|Death|12|||
170640151|NCT01657461|616695588|FG000|Overall Study|Lost to Follow-up|0|||
170640152|NCT01657461|616695589|FG001|Overall Study|Lost to Follow-up|3|||
170640153|NCT01657461|616695588|FG000|Overall Study|Physician Decision|0|||
170640154|NCT01657461|616695589|FG001|Overall Study|Physician Decision|2|||
170640155|NCT01657461|616695588|FG000|Overall Study|Withdrawal by Subject|1|||
170897945|NCT03804684|617632316|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
170897946|NCT03804684|617632317|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
170897947|NCT02429856|617632318|FG000|Overall Study|Death|12|||
170897948|NCT02429856|617632319|FG001|Overall Study|Death|13|||
170897949|NCT02429856|617632318|FG000|Overall Study|Lost to Follow-up|6|||
170897950|NCT02429856|617632319|FG001|Overall Study|Lost to Follow-up|5|||
170897951|NCT02429856|617632318|FG000|Overall Study|Withdrawal by Subject|1|||
170897952|NCT02429856|617632319|FG001|Overall Study|Withdrawal by Subject|1|||
170897953|NCT03603652|617632320|FG000|Overall Study|Death|2|||
170897954|NCT03838484|617632325|FG000|Overall Study|Lost to Follow-up|0|||
170897955|NCT03838484|617632326|FG001|Overall Study|Lost to Follow-up|1|||
170897956|NCT03838484|617632327|FG002|Overall Study|Lost to Follow-up|0|||
170897957|NCT03838484|617632328|FG003|Overall Study|Lost to Follow-up|0|||
170897958|NCT01900002|617632329|FG000|Overall Study|Withdrawal by Subject|2|||
170897959|NCT01900002|617632329|FG000|Overall Study|ineligible for Y-90|4|||
170897960|NCT01614964|617632330|FG000|Overall Study|Withdrawal by Subject|2|||
170897961|NCT01614964|617632331|FG001|Overall Study|Withdrawal by Subject|0|||
170897962|NCT01614964|617632330|FG000|Overall Study|Lost to Follow-up|3|||
170897963|NCT01614964|617632331|FG001|Overall Study|Lost to Follow-up|0|||
170897964|NCT00860470|617632342|FG000|Overall Study|Death|6|||
170897965|NCT00860470|617632343|FG001|Overall Study|Death|10|||
170897966|NCT00860470|617632342|FG000|Overall Study|Moved away|8|||
170897967|NCT00860470|617632343|FG001|Overall Study|Moved away|10|||
170897968|NCT00860470|617632342|FG000|Overall Study|Lost to Follow-up|34|||
170897969|NCT00860470|617632343|FG001|Overall Study|Lost to Follow-up|39|||
170897970|NCT01225562|617632346|FG000|Overall Study|Withdrawal by Subject|52|||
170897971|NCT01225562|617632347|FG001|Overall Study|Withdrawal by Subject|50|||
170897972|NCT01225562|617632348|FG002|Overall Study|Withdrawal by Subject|52|||
170897973|NCT01225562|617632346|FG000|Overall Study|Lost to Follow-up|3|||
170897974|NCT01225562|617632347|FG001|Overall Study|Lost to Follow-up|6|||
170897975|NCT01225562|617632348|FG002|Overall Study|Lost to Follow-up|1|||
170897976|NCT00888238|617632349|FG000|Washout Period After Period 2|Adverse Event|0|||
170897977|NCT00888238|617632350|FG001|Washout Period After Period 2|Adverse Event|0|||
170897978|NCT00888238|617632351|FG002|Washout Period After Period 2|Adverse Event|1|||
170897979|NCT00348140|617632354|FG000|Overall Study|Adverse Event|46|||
170897980|NCT00348140|617632355|FG001|Overall Study|Adverse Event|49|||
170897981|NCT00348140|617632356|FG002|Overall Study|Adverse Event|78|||
170640156|NCT01657461|616695589|FG001|Overall Study|Withdrawal by Subject|3|||
170640157|NCT01124864|616695590|FG000|Overall Study|Follow up phase competed as per protocol|18|||
170640158|NCT01124864|616695591|FG001|Overall Study|Follow up phase competed as per protocol|22|||
170640159|NCT01124864|616695592|FG002|Overall Study|Follow up phase competed as per protocol|24|||
170640160|NCT01124864|616695593|FG003|Overall Study|Follow up phase competed as per protocol|18|||
170640161|NCT01124864|616695594|FG004|Overall Study|Follow up phase competed as per protocol|26|||
170640162|NCT01124864|616695595|FG005|Overall Study|Follow up phase competed as per protocol|2|||
170640163|NCT01124864|616695590|FG000|Overall Study|Death|6|||
170640164|NCT01124864|616695591|FG001|Overall Study|Death|9|||
170897982|NCT00348140|617632354|FG000|Overall Study|Lost to Follow-up|4|||
170897983|NCT00348140|617632355|FG001|Overall Study|Lost to Follow-up|4|||
170897984|NCT00348140|617632356|FG002|Overall Study|Lost to Follow-up|4|||
170640165|NCT01124864|616695592|FG002|Overall Study|Death|6|||
170640166|NCT01124864|616695593|FG003|Overall Study|Death|2|||
170897985|NCT00348140|617632354|FG000|Overall Study|Protocol Violation|12|||
170897986|NCT00348140|617632355|FG001|Overall Study|Protocol Violation|13|||
170897987|NCT00348140|617632356|FG002|Overall Study|Protocol Violation|14|||
170897988|NCT00348140|617632354|FG000|Overall Study|Withdrawal by Subject|32|||
170897989|NCT00348140|617632355|FG001|Overall Study|Withdrawal by Subject|40|||
170897990|NCT00348140|617632356|FG002|Overall Study|Withdrawal by Subject|40|||
170897991|NCT00348140|617632354|FG000|Overall Study|Non-compliance|8|||
170640167|NCT01124864|616695594|FG004|Overall Study|Death|1|||
170640168|NCT01124864|616695595|FG005|Overall Study|Death|0|||
170640169|NCT01124864|616695590|FG000|Overall Study|Withdrawal by Subject|2|||
170640170|NCT01124864|616695591|FG001|Overall Study|Withdrawal by Subject|3|||
170640171|NCT01124864|616695592|FG002|Overall Study|Withdrawal by Subject|4|||
170640172|NCT01124864|616695593|FG003|Overall Study|Withdrawal by Subject|0|||
170640173|NCT01124864|616695594|FG004|Overall Study|Withdrawal by Subject|2|||
170640174|NCT01124864|616695595|FG005|Overall Study|Withdrawal by Subject|1|||
170640175|NCT01124864|616695590|FG000|Overall Study|Lost to Follow-up|1|||
170640176|NCT01124864|616695591|FG001|Overall Study|Lost to Follow-up|1|||
170640177|NCT01124864|616695592|FG002|Overall Study|Lost to Follow-up|0|||
170640178|NCT01124864|616695593|FG003|Overall Study|Lost to Follow-up|1|||
170640179|NCT01124864|616695594|FG004|Overall Study|Lost to Follow-up|0|||
170640180|NCT01124864|616695595|FG005|Overall Study|Lost to Follow-up|0|||
170640181|NCT01124864|616695590|FG000|Overall Study|Protocol Violation|1|||
170640182|NCT01124864|616695591|FG001|Overall Study|Protocol Violation|0|||
170640183|NCT01124864|616695592|FG002|Overall Study|Protocol Violation|0|||
170640184|NCT01124864|616695593|FG003|Overall Study|Protocol Violation|0|||
170640185|NCT01124864|616695594|FG004|Overall Study|Protocol Violation|1|||
170640186|NCT01124864|616695595|FG005|Overall Study|Protocol Violation|0|||
170640187|NCT01239992|616695601|FG000|Overall Study|Withdrawal by Subject|2|||
170640188|NCT00535288|616695602|FG000|Overall Study|Adverse Event|20|||
170640189|NCT00535288|616695603|FG001|Overall Study|Adverse Event|19|||
170640190|NCT00535288|616695604|FG002|Overall Study|Adverse Event|25|||
170640191|NCT00535288|616695605|FG003|Overall Study|Adverse Event|20|||
170640192|NCT00535288|616695606|FG004|Overall Study|Adverse Event|30|||
170640193|NCT00535288|616695602|FG000|Overall Study|Lost to Follow-up|0|||
170640194|NCT00535288|616695603|FG001|Overall Study|Lost to Follow-up|3|||
170640195|NCT00535288|616695604|FG002|Overall Study|Lost to Follow-up|0|||
170640196|NCT00535288|616695605|FG003|Overall Study|Lost to Follow-up|0|||
170640197|NCT00535288|616695606|FG004|Overall Study|Lost to Follow-up|0|||
170640198|NCT00535288|616695602|FG000|Overall Study|Lack of Efficacy|26|||
170640199|NCT00535288|616695603|FG001|Overall Study|Lack of Efficacy|3|||
170640200|NCT00535288|616695604|FG002|Overall Study|Lack of Efficacy|4|||
170640201|NCT00535288|616695605|FG003|Overall Study|Lack of Efficacy|4|||
170640202|NCT00535288|616695606|FG004|Overall Study|Lack of Efficacy|7|||
170640203|NCT00535288|616695602|FG000|Overall Study|Unwilling to cooperate|6|||
170640204|NCT00535288|616695603|FG001|Overall Study|Unwilling to cooperate|6|||
170640205|NCT00535288|616695604|FG002|Overall Study|Unwilling to cooperate|3|||
170640206|NCT00535288|616695605|FG003|Overall Study|Unwilling to cooperate|3|||
170640207|NCT00535288|616695606|FG004|Overall Study|Unwilling to cooperate|4|||
170640208|NCT00535288|616695602|FG000|Overall Study|Other|2|||
170640209|NCT00535288|616695603|FG001|Overall Study|Other|1|||
170640210|NCT00535288|616695604|FG002|Overall Study|Other|1|||
170640211|NCT00535288|616695605|FG003|Overall Study|Other|2|||
170640212|NCT00535288|616695606|FG004|Overall Study|Other|1|||
170640213|NCT00220779|616695607|FG000|Overall Study|Adverse Event|1|||
170640214|NCT00220779|616695608|FG001|Overall Study|Adverse Event|0|||
170640215|NCT00220779|616695609|FG002|Overall Study|Adverse Event|0|||
170640216|NCT00220779|616695607|FG000|Overall Study|Withdrawal by Subject|1|||
170640217|NCT00220779|616695608|FG001|Overall Study|Withdrawal by Subject|4|||
170640218|NCT00220779|616695609|FG002|Overall Study|Withdrawal by Subject|1|||
170640219|NCT00220779|616695607|FG000|Overall Study|Non-compliance|1|||
170640220|NCT00220779|616695608|FG001|Overall Study|Non-compliance|0|||
170897992|NCT00348140|617632355|FG001|Overall Study|Non-compliance|13|||
170897993|NCT00348140|617632356|FG002|Overall Study|Non-compliance|5|||
170897994|NCT00348140|617632354|FG000|Overall Study|Participant at risk due to study drug|2|||
170897995|NCT00348140|617632355|FG001|Overall Study|Participant at risk due to study drug|0|||
170897996|NCT00348140|617632356|FG002|Overall Study|Participant at risk due to study drug|0|||
170640221|NCT00220779|616695609|FG002|Overall Study|Non-compliance|0|||
170640222|NCT00220779|616695607|FG000|Overall Study|Too time consuming|1|||
170897997|NCT00348140|617632354|FG000|Overall Study|Conditional medication increased dose|1|||
170640223|NCT00220779|616695608|FG001|Overall Study|Too time consuming|0|||
170640224|NCT00220779|616695609|FG002|Overall Study|Too time consuming|0|||
170640225|NCT00220779|616695607|FG000|Overall Study|Pregnancy|0|||
170640226|NCT00220779|616695608|FG001|Overall Study|Pregnancy|0|||
170640227|NCT00220779|616695609|FG002|Overall Study|Pregnancy|2|||
170897998|NCT00348140|617632355|FG001|Overall Study|Conditional medication increased dose|0|||
170640228|NCT00220779|616695607|FG000|Overall Study|Lack of Efficacy|3|||
170640229|NCT00220779|616695608|FG001|Overall Study|Lack of Efficacy|0|||
170640230|NCT00220779|616695609|FG002|Overall Study|Lack of Efficacy|1|||
170640231|NCT04518995|616695610|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
170640232|NCT04518995|616695611|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
170640233|NCT04518995|616695612|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
170640234|NCT04518995|616695610|FG000|Overall Study|Lack of Efficacy|2|||
170640235|NCT04518995|616695611|FG001|Overall Study|Lack of Efficacy|1|||
170897999|NCT00348140|617632356|FG002|Overall Study|Conditional medication increased dose|0|||
170640236|NCT04518995|616695612|FG002|Overall Study|Lack of Efficacy|0|||
170640237|NCT04518995|616695610|FG000|Overall Study|Non-compliance With Study Drug|0|||
170640238|NCT04518995|616695611|FG001|Overall Study|Non-compliance With Study Drug|3|||
170640239|NCT04518995|616695612|FG002|Overall Study|Non-compliance With Study Drug|2|||
170640240|NCT04518995|616695610|FG000|Overall Study|Pregnancy|0|||
170640241|NCT04518995|616695611|FG001|Overall Study|Pregnancy|0|||
170640242|NCT04518995|616695612|FG002|Overall Study|Pregnancy|1|||
170640243|NCT04518995|616695610|FG000|Overall Study|Protocol Violation|2|||
170640244|NCT04518995|616695611|FG001|Overall Study|Protocol Violation|0|||
170640245|NCT04518995|616695612|FG002|Overall Study|Protocol Violation|1|||
170640246|NCT04518995|616695610|FG000|Overall Study|Reason not Specified|4|||
170640247|NCT04518995|616695611|FG001|Overall Study|Reason not Specified|11|||
170640248|NCT04518995|616695612|FG002|Overall Study|Reason not Specified|2|||
170640249|NCT04518995|616695610|FG000|Overall Study|Lost to Follow-up|1|||
170640250|NCT04518995|616695611|FG001|Overall Study|Lost to Follow-up|10|||
170640251|NCT04518995|616695612|FG002|Overall Study|Lost to Follow-up|6|||
170640252|NCT02350478|616695614|FG000|Overall Study|Lost to Follow-up|5|||
170640253|NCT02350478|616695615|FG001|Overall Study|Lost to Follow-up|1|||
170640254|NCT00856518|616695619|FG000|Overall Study|Lost to Follow-up|4|||
170640255|NCT00856518|616695620|FG001|Overall Study|Lost to Follow-up|2|||
170640256|NCT03330002|616695622|FG000|Overall Study|Lost to Follow-up|15|||
170640257|NCT03330002|616695622|FG000|Overall Study|Death|7|||
170640258|NCT03869216|616695623|FG000|Overall Study|prostate removed during the study|1|||
170640259|NCT03869216|616695624|FG001|Overall Study|prostate removed during the study|1|||
170640260|NCT03869216|616695623|FG000|Overall Study|Withdrawal by Subject|0|||
170640261|NCT03869216|616695624|FG001|Overall Study|Withdrawal by Subject|1|||
170640262|NCT03869216|616695623|FG000|Overall Study|Lost to Follow-up|3|||
170640263|NCT03869216|616695624|FG001|Overall Study|Lost to Follow-up|12|||
170640264|NCT03869216|616695623|FG000|Overall Study|Changed clinical site or moved out of city|5|||
170640265|NCT03869216|616695624|FG001|Overall Study|Changed clinical site or moved out of city|9|||
170640266|NCT03869216|616695623|FG000|Overall Study|No primary care appointment scheduled|10|||
170640267|NCT03869216|616695624|FG001|Overall Study|No primary care appointment scheduled|4|||
170640268|NCT03869216|616695623|FG000|Overall Study|Death|1|||
170640269|NCT03869216|616695624|FG001|Overall Study|Death|1|||
170640270|NCT01652534|616695627|FG000|Overall Study|Lack of Efficacy|1|||
170640271|NCT01652534|616695628|FG001|Overall Study|Lack of Efficacy|0|||
170640272|NCT03737981|616695629|FG000|Initial Treatment|Withdrawal by Subject|6|||
170640273|NCT03737981|616695630|FG001|Initial Treatment|Withdrawal by Subject|9|||
170640274|NCT03737981|616695629|FG000|Initial Treatment|Adverse Event|32|||
170640275|NCT03737981|616695630|FG001|Initial Treatment|Adverse Event|22|||
170640276|NCT03737981|616695629|FG000|Initial Treatment|Disease progression|1|||
170640277|NCT03737981|616695630|FG001|Initial Treatment|Disease progression|4|||
170640278|NCT03737981|616695629|FG000|Initial Treatment|Alternative therapy|1|||
170640279|NCT03737981|616695630|FG001|Initial Treatment|Alternative therapy|1|||
170640280|NCT03737981|616695629|FG000|Initial Treatment|Complicating disease|8|||
170640281|NCT03737981|616695630|FG001|Initial Treatment|Complicating disease|6|||
170640282|NCT03737981|616695629|FG000|Initial Treatment|Death|11|||
170640283|NCT03737981|616695630|FG001|Initial Treatment|Death|15|||
170640284|NCT03737981|616695629|FG000|Initial Treatment|Patient withdrawal prior to treatment|1|||
170640285|NCT03737981|616695630|FG001|Initial Treatment|Patient withdrawal prior to treatment|2|||
170640286|NCT03737981|616695629|FG000|Initial Treatment|Patient not on Ibrutinib|0|||
170640287|NCT03737981|616695630|FG001|Initial Treatment|Patient not on Ibrutinib|1|||
170640288|NCT03737981|616695629|FG000|Initial Treatment|Patient moved|0|||
170640289|NCT03737981|616695630|FG001|Initial Treatment|Patient moved|1|||
170640290|NCT03737981|616695629|FG000|Initial Treatment|Patient ineligible|0|||
170640291|NCT03737981|616695630|FG001|Initial Treatment|Patient ineligible|1|||
170640292|NCT03737981|616695629|FG000|Initial Treatment|Physician Decision|2|||
170640293|NCT03737981|616695630|FG001|Initial Treatment|Physician Decision|2|||
170640294|NCT03737981|616695629|FG000|Initial Treatment|Death prior to treatment|0|||
170640295|NCT03737981|616695630|FG001|Initial Treatment|Death prior to treatment|1|||
170640296|NCT03737981|616695629|FG000|Initial Treatment|Patient inability to follow protocol|0|||
170798182|NCT03662022|617273621|FG000|Year 4 2022|Lost to Follow-up|986|||
170640297|NCT03737981|616695630|FG001|Initial Treatment|Patient inability to follow protocol|1|||
170640298|NCT03737981|616695629|FG000|Initial Treatment|Other|4|||
170640299|NCT03737981|616695630|FG001|Initial Treatment|Other|9|||
170640300|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Withdrawal by Subject|11|||
170640301|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Withdrawal by Subject|7|||
170640302|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Adverse Event|38|||
170640303|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Adverse Event|12|||
170640304|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Disease progression|3|||
170640305|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Disease progression|3|||
170640306|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Alternative therapy|1|||
170640307|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Alternative therapy|2|||
170798183|NCT03662022|617273622|FG001|Year 4 2022|Lost to Follow-up|1079|||
170798184|NCT03662022|617273623|FG002|Year 4 2022|Lost to Follow-up|1236|||
170798185|NCT03662022|617273624|FG003|Year 4 2022|Lost to Follow-up|1826|||
170898000|NCT00348140|617632354|FG000|Overall Study|Caregiver related|4|||
170898001|NCT00348140|617632355|FG001|Overall Study|Caregiver related|7|||
170898002|NCT00348140|617632356|FG002|Overall Study|Caregiver related|3|||
170898003|NCT00348140|617632354|FG000|Overall Study|Participant hospitalised|3|||
170898004|NCT00348140|617632355|FG001|Overall Study|Participant hospitalised|0|||
170898005|NCT00348140|617632356|FG002|Overall Study|Participant hospitalised|0|||
170898006|NCT00348140|617632354|FG000|Overall Study|Efficacy related|1|||
170640308|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Complicating disease|4|||
170640309|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Complicating disease|5|||
170640310|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Death|13|||
170640311|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Death|16|||
170640312|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Other|2|||
170640313|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Other|7|||
170640314|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|On treatment|90|||
170640315|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|On treatment|101|||
170640316|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Physician Decision|3|||
170640317|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Physician Decision|1|||
170640318|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|Clinical response|1|||
170640319|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|Clinical response|1|||
170640320|NCT03737981|616695629|FG000|Subsequent Ibrutinib/Observation|VA denial of authorization|0|||
170640321|NCT03737981|616695630|FG001|Subsequent Ibrutinib/Observation|VA denial of authorization|1|||
170640322|NCT03860259|616695631|FG000|Overall Study|Lost to Follow-up|5|||
170640323|NCT03860259|616695632|FG001|Overall Study|Lost to Follow-up|5|||
170640324|NCT03860259|616695631|FG000|Overall Study|Protocol Violation|1|||
170640325|NCT03860259|616695632|FG001|Overall Study|Protocol Violation|0|||
170640326|NCT02722304|616695633|FG000|Overall Study|Study Terminated by Sponsor|1|||
170640327|NCT02722304|616695634|FG001|Overall Study|Study Terminated by Sponsor|0|||
170640328|NCT02722304|616695635|FG002|Overall Study|Study Terminated by Sponsor|2|||
170640329|NCT02722304|616695636|FG003|Overall Study|Study Terminated by Sponsor|1|||
170640330|NCT02722304|616695637|FG004|Overall Study|Study Terminated by Sponsor|1|||
170640331|NCT02722304|616695633|FG000|Overall Study|Other|0|||
170640332|NCT02722304|616695634|FG001|Overall Study|Other|0|||
170640333|NCT02722304|616695635|FG002|Overall Study|Other|0|||
170640334|NCT02722304|616695636|FG003|Overall Study|Other|1|||
170640335|NCT02722304|616695637|FG004|Overall Study|Other|1|||
170640336|NCT01068600|616695638|FG000|Overall Study|Withdrawal by Subject|5|||
170640337|NCT01068600|616695639|FG001|Overall Study|Withdrawal by Subject|6|||
170640338|NCT01068600|616695638|FG000|Overall Study|Adverse Event|3|||
170640339|NCT01068600|616695639|FG001|Overall Study|Adverse Event|3|||
170640340|NCT01068600|616695638|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170640341|NCT01068600|616695639|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170640342|NCT01068600|616695638|FG000|Overall Study|Lost to Follow-up|1|||
170640343|NCT01068600|616695639|FG001|Overall Study|Lost to Follow-up|2|||
170640344|NCT01068600|616695638|FG000|Overall Study|Protocol deviation|1|||
170640345|NCT01068600|616695639|FG001|Overall Study|Protocol deviation|1|||
170898007|NCT00348140|617632355|FG001|Overall Study|Efficacy related|1|||
170898008|NCT00348140|617632356|FG002|Overall Study|Efficacy related|0|||
170898009|NCT00348140|617632354|FG000|Overall Study|Administration related|3|||
170640346|NCT01068600|616695638|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170640347|NCT01068600|616695639|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
170640348|NCT01068600|616695638|FG000|Overall Study|Administrative problems|0|||
170640349|NCT01068600|616695639|FG001|Overall Study|Administrative problems|1|||
170640350|NCT03710083|616695646|FG000|Overall Study|Withdrawal by Subject|2|||
170640351|NCT03710083|616695646|FG000|Overall Study|Unsuccessful Procedure|1|||
170640352|NCT02283762|616695647|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
170640353|NCT02283762|616695648|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
170640354|NCT02283762|616695647|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
170898010|NCT00348140|617632355|FG001|Overall Study|Administration related|1|||
170898011|NCT00348140|617632356|FG002|Overall Study|Administration related|1|||
170898012|NCT00348140|617632354|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
170898013|NCT00348140|617632355|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
170898014|NCT00348140|617632356|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
170898015|NCT00348140|617632354|FG000|Overall Study|Participant unwell|1|||
170898016|NCT00348140|617632355|FG001|Overall Study|Participant unwell|0|||
170898017|NCT00348140|617632356|FG002|Overall Study|Participant unwell|0|||
170898018|NCT00348140|617632354|FG000|Overall Study|Screen failure|1|||
170898019|NCT00348140|617632355|FG001|Overall Study|Screen failure|0|||
170898020|NCT00348140|617632356|FG002|Overall Study|Screen failure|0|||
170640355|NCT02283762|616695648|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
170640356|NCT02283762|616695647|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
170640357|NCT02283762|616695648|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
170640358|NCT02283762|616695647|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
170898021|NCT00348140|617632354|FG000|Overall Study|Investigator decided to discontinue|4|||
170898022|NCT00348140|617632355|FG001|Overall Study|Investigator decided to discontinue|1|||
170640359|NCT02283762|616695648|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
170640360|NCT02283762|616695647|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
170640361|NCT02283762|616695648|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
170640362|NCT02283762|616695647|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
170640363|NCT02283762|616695648|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
170640364|NCT02283762|616695647|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
170640365|NCT02283762|616695648|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
170640366|NCT02283762|616695647|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
170640367|NCT02283762|616695648|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
170640368|NCT02283762|616695647|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
170640369|NCT02283762|616695648|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
170640370|NCT02283762|616695647|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
170640371|NCT02283762|616695648|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
170640372|NCT02283762|616695647|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
170640373|NCT02283762|616695648|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
170640374|NCT02283762|616695647|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
170640375|NCT02283762|616695648|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
170640376|NCT00202878|616695649|FG000|Overall Study|Death|964|||
170640377|NCT00202878|616695650|FG001|Overall Study|Death|968|||
170640378|NCT00202878|616695649|FG000|Overall Study|Only Vital Status Known|357|||
170640379|NCT00202878|616695650|FG001|Overall Study|Only Vital Status Known|356|||
170640380|NCT00202878|616695649|FG000|Overall Study|Lost to Follow-up|44|||
170640381|NCT00202878|616695650|FG001|Overall Study|Lost to Follow-up|49|||
170640382|NCT00202878|616695649|FG000|Overall Study|Site Closure|39|||
170640383|NCT00202878|616695650|FG001|Overall Study|Site Closure|36|||
170640384|NCT00202878|616695649|FG000|Overall Study|Withdrawal by Subject|795|||
170640385|NCT00202878|616695650|FG001|Overall Study|Withdrawal by Subject|808|||
170640386|NCT02123472|616695651|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
170640387|NCT02123472|616695652|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
170640388|NCT00918736|616695653|FG000|Overall Study|Withdrawal by Subject|4|||
170640389|NCT01474018|616695654|FG000|Overall Study|Lost to Follow-up|0|||
170640390|NCT01474018|616695655|FG001|Overall Study|Lost to Follow-up|1|||
170640391|NCT01474018|616695654|FG000|Overall Study|Withdrawal by Subject|0|||
170640392|NCT01474018|616695655|FG001|Overall Study|Withdrawal by Subject|2|||
170640393|NCT02433080|616695656|FG000|Overall Study|Lost to Follow-up|1|||
170640394|NCT02433080|616695657|FG001|Overall Study|Lost to Follow-up|2|||
170640395|NCT02433080|616695656|FG000|Overall Study|Withdrawal by Subject|0|||
170640396|NCT02433080|616695657|FG001|Overall Study|Withdrawal by Subject|2|||
170640397|NCT01942733|616695659|FG000|Overall Study|Lost to Follow-up|1|||
170640398|NCT01942733|616695659|FG000|Overall Study|Non-compliance with IMP|1|||
170640399|NCT01942733|616695659|FG000|Overall Study|Administrative|1|||
170640400|NCT00838513|616695660|FG000|Screening Period|Screen Failure|3|||
170640401|NCT00838513|616695660|FG000|Extension Treatment Period|Death|1|||
170640402|NCT00838513|616695660|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
170640403|NCT00126490|616695664|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
170640404|NCT03962504|616695665|FG000|Overall Study|Other|11|||
170640405|NCT03962504|616695666|FG001|Overall Study|Other|32|||
170640406|NCT01976741|616695668|FG000|Overall Study|Withdrawal by Subject|1|||
170640407|NCT01976741|616695669|FG001|Overall Study|Withdrawal by Subject|0|||
170640408|NCT01976741|616695670|FG002|Overall Study|Withdrawal by Subject|1|||
170640409|NCT01976741|616695671|FG003|Overall Study|Withdrawal by Subject|1|||
170640410|NCT01976741|616695672|FG004|Overall Study|Withdrawal by Subject|0|||
170640411|NCT01976741|616695673|FG005|Overall Study|Withdrawal by Subject|0|||
170640412|NCT01976741|616695674|FG006|Overall Study|Withdrawal by Subject|1|||
170640413|NCT01976741|616695675|FG007|Overall Study|Withdrawal by Subject|4|||
170640414|NCT01976741|616695676|FG008|Overall Study|Withdrawal by Subject|0|||
170640415|NCT01976741|616695677|FG009|Overall Study|Withdrawal by Subject|0|||
170640416|NCT01976741|616695668|FG000|Overall Study|Adverse Event|0|||
170898023|NCT00348140|617632356|FG002|Overall Study|Investigator decided to discontinue|4|||
170898024|NCT00348140|617632354|FG000|Overall Study|Decided to discontinue on their own|1|||
170898025|NCT00348140|617632355|FG001|Overall Study|Decided to discontinue on their own|4|||
170898026|NCT00348140|617632356|FG002|Overall Study|Decided to discontinue on their own|1|||
170640417|NCT01976741|616695669|FG001|Overall Study|Adverse Event|0|||
170640418|NCT01976741|616695670|FG002|Overall Study|Adverse Event|2|||
170640419|NCT01976741|616695671|FG003|Overall Study|Adverse Event|0|||
170640420|NCT01976741|616695672|FG004|Overall Study|Adverse Event|0|||
170640421|NCT01976741|616695673|FG005|Overall Study|Adverse Event|0|||
170640422|NCT01976741|616695674|FG006|Overall Study|Adverse Event|3|||
170640423|NCT01976741|616695675|FG007|Overall Study|Adverse Event|8|||
170640424|NCT01976741|616695676|FG008|Overall Study|Adverse Event|1|||
170640425|NCT01976741|616695677|FG009|Overall Study|Adverse Event|4|||
170640426|NCT04080167|616695678|FG000|Overall Study|Lost to Follow-up-Patients|7|||
170640427|NCT04080167|616695679|FG001|Overall Study|Lost to Follow-up-Patients|14|||
170640428|NCT04080167|616695680|FG002|Overall Study|Lost to Follow-up-Patients|0|||
170640429|NCT04080167|616695678|FG000|Overall Study|Lost to Follow-up-Providers|2|||
170483742|NCT01568892|616111159|FG000|Open-label Phase|Lack of Efficacy|4|||
170483743|NCT01568892|616111160|FG001|Open-label Phase|Lack of Efficacy|2|||
170483744|NCT01568892|616111159|FG000|Open-label Phase|Lost to Follow-up|0|||
170483745|NCT01568892|616111160|FG001|Open-label Phase|Lost to Follow-up|1|||
170640430|NCT04080167|616695679|FG001|Overall Study|Lost to Follow-up-Providers|2|||
170640431|NCT04080167|616695680|FG002|Overall Study|Lost to Follow-up-Providers|0|||
170640432|NCT04080167|616695678|FG000|Overall Study|Withdrawal by Subject|1|||
170640433|NCT04080167|616695679|FG001|Overall Study|Withdrawal by Subject|2|||
170640434|NCT04080167|616695680|FG002|Overall Study|Withdrawal by Subject|0|||
170640435|NCT04080167|616695678|FG000|Overall Study|Withdrawal by Provider|0|||
170640436|NCT04080167|616695679|FG001|Overall Study|Withdrawal by Provider|0|||
170640437|NCT04080167|616695680|FG002|Overall Study|Withdrawal by Provider|4|||
170483746|NCT03922308|616111165|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
170483747|NCT03922308|616111166|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
170483748|NCT03922308|616111167|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
170483749|NCT03922308|616111165|FG000|Overall Study|Lost to Follow-up|1|||
170483750|NCT03922308|616111166|FG001|Overall Study|Lost to Follow-up|0|||
170483751|NCT03922308|616111167|FG002|Overall Study|Lost to Follow-up|0|||
170483752|NCT03922308|616111165|FG000|Overall Study|Reason not Specified|0|||
170483753|NCT03922308|616111166|FG001|Overall Study|Reason not Specified|2|||
170483754|NCT03922308|616111167|FG002|Overall Study|Reason not Specified|1|||
170483755|NCT05005507|616111170|FG000|Overall Study|Premature termination of study|1|||
170483756|NCT03313180|616111175|FG000|Overall Study|Adverse Event|120|||
170483757|NCT03313180|616111175|FG000|Overall Study|Lost to Follow-up|3|||
170483758|NCT03313180|616111175|FG000|Overall Study|Withdrawal by Subject|39|||
170483759|NCT03313180|616111175|FG000|Overall Study|Other than listed above|15|||
170483760|NCT03313180|616111175|FG000|Overall Study|Covid-19 related|2|||
170483761|NCT01697748|616111176|FG000|Overall Study|ineligible skin incision|1|||
170483762|NCT01697748|616111177|FG001|Overall Study|ineligible skin incision|2|||
170483763|NCT01697748|616111176|FG000|Overall Study|ineligible uterine incision|4|||
170483764|NCT01697748|616111177|FG001|Overall Study|ineligible uterine incision|1|||
170483765|NCT01697748|616111176|FG000|Overall Study|Lost to Follow-up|53|||
170483766|NCT01697748|616111177|FG001|Overall Study|Lost to Follow-up|65|||
170483767|NCT01058642|616111180|FG000|Treatment Period 1|Adverse Event|0|||
170483768|NCT01058642|616111181|FG001|Treatment Period 1|Adverse Event|1|||
170483769|NCT01058642|616111182|FG002|Treatment Period 1|Adverse Event|1|||
170483770|NCT01058642|616111183|FG003|Treatment Period 1|Adverse Event|0|||
170483771|NCT01058642|616111180|FG000|Treatment Period 1|Physician Decision|0|||
170483772|NCT01058642|616111181|FG001|Treatment Period 1|Physician Decision|0|||
170483773|NCT01058642|616111182|FG002|Treatment Period 1|Physician Decision|1|||
170483774|NCT01058642|616111183|FG003|Treatment Period 1|Physician Decision|0|||
170483775|NCT01058642|616111180|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170483776|NCT01058642|616111181|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170483777|NCT01058642|616111182|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170483778|NCT01058642|616111183|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170483779|NCT01058642|616111180|FG000|Treatment Period 1|Lack of Efficacy|0|||
170483780|NCT01058642|616111181|FG001|Treatment Period 1|Lack of Efficacy|0|||
170483781|NCT01058642|616111182|FG002|Treatment Period 1|Lack of Efficacy|0|||
170483782|NCT01058642|616111183|FG003|Treatment Period 1|Lack of Efficacy|1|||
170483783|NCT01058642|616111180|FG000|Treatment Period 1|Protocol Violation|0|||
170483784|NCT01058642|616111181|FG001|Treatment Period 1|Protocol Violation|0|||
170483785|NCT01058642|616111182|FG002|Treatment Period 1|Protocol Violation|0|||
170483786|NCT01058642|616111183|FG003|Treatment Period 1|Protocol Violation|1|||
170483787|NCT01058642|616111180|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
170483788|NCT01058642|616111181|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
170483789|NCT01058642|616111182|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
170483790|NCT01058642|616111183|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
170483791|NCT01256450|616111184|FG000|Open-label Titration|Adverse Event|39|||
170798186|NCT04679389|617273629|FG000|Overall Study|Adverse Event|1|||
170798187|NCT04679389|617273630|FG001|Overall Study|Adverse Event|0|||
170798188|NCT04679389|617273629|FG000|Overall Study|Protocol Violation|2|||
170798189|NCT04679389|617273630|FG001|Overall Study|Protocol Violation|0|||
170798190|NCT04679389|617273629|FG000|Overall Study|Physician Decision|3|||
170798191|NCT04679389|617273630|FG001|Overall Study|Physician Decision|5|||
170640438|NCT04080167|616695678|FG000|Overall Study|Death-Patient|2|||
170798192|NCT04679389|617273629|FG000|Overall Study|Withdrawal by Subject|5|||
170798193|NCT04679389|617273630|FG001|Overall Study|Withdrawal by Subject|7|||
170798194|NCT02777593|617273633|FG000|Overall Study|Still in study|1|||
170798195|NCT02777593|617273634|FG001|Overall Study|Still in study|32|||
170798196|NCT02777593|617273635|FG002|Overall Study|Still in study|3|||
170798197|NCT02777593|617273636|FG003|Overall Study|Still in study|6|||
170798198|NCT02777593|617273637|FG004|Overall Study|Still in study|5|||
170798199|NCT02777593|617273633|FG000|Overall Study|Death|21|||
170483792|NCT01256450|616111185|FG001|Open-label Titration|Adverse Event|0|||
170798200|NCT02777593|617273634|FG001|Overall Study|Death|28|||
170483793|NCT01256450|616111186|FG002|Open-label Titration|Adverse Event|0|||
170483794|NCT01256450|616111184|FG000|Open-label Titration|Lost to Follow-up|7|||
170483795|NCT01256450|616111185|FG001|Open-label Titration|Lost to Follow-up|0|||
170483796|NCT01256450|616111186|FG002|Open-label Titration|Lost to Follow-up|0|||
170483797|NCT01256450|616111184|FG000|Open-label Titration|Lack of analgesic effect|30|||
170483798|NCT01256450|616111185|FG001|Open-label Titration|Lack of analgesic effect|0|||
170483799|NCT01256450|616111186|FG002|Open-label Titration|Lack of analgesic effect|0|||
170483800|NCT01256450|616111184|FG000|Open-label Titration|Non-compliance|9|||
170483801|NCT01256450|616111185|FG001|Open-label Titration|Non-compliance|0|||
170483802|NCT01256450|616111186|FG002|Open-label Titration|Non-compliance|0|||
170483803|NCT01256450|616111184|FG000|Open-label Titration|Screen failure|1|||
170483804|NCT01256450|616111185|FG001|Open-label Titration|Screen failure|0|||
170483805|NCT01256450|616111186|FG002|Open-label Titration|Screen failure|0|||
170483806|NCT01256450|616111184|FG000|Open-label Titration|Other|13|||
170483807|NCT01256450|616111185|FG001|Open-label Titration|Other|0|||
170483808|NCT01256450|616111186|FG002|Open-label Titration|Other|0|||
170483809|NCT01256450|616111184|FG000|Double-blind Treatment|Adverse Event|0|||
170483810|NCT01256450|616111185|FG001|Double-blind Treatment|Adverse Event|8|||
170483811|NCT01256450|616111186|FG002|Double-blind Treatment|Adverse Event|6|||
170483812|NCT01256450|616111184|FG000|Double-blind Treatment|Lost to Follow-up|0|||
170483813|NCT01256450|616111185|FG001|Double-blind Treatment|Lost to Follow-up|1|||
170483814|NCT01256450|616111186|FG002|Double-blind Treatment|Lost to Follow-up|7|||
170483815|NCT01256450|616111184|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
170483816|NCT01256450|616111185|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
170483817|NCT01256450|616111186|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
170483818|NCT01256450|616111184|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
170483819|NCT01256450|616111185|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
170483820|NCT01256450|616111186|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
170483821|NCT01256450|616111184|FG000|Double-blind Treatment|Non-compliance|0|||
170483822|NCT01256450|616111185|FG001|Double-blind Treatment|Non-compliance|5|||
170483823|NCT01256450|616111186|FG002|Double-blind Treatment|Non-compliance|4|||
170483824|NCT01256450|616111184|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
170483825|NCT01256450|616111185|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
170483826|NCT01256450|616111186|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
170483827|NCT01256450|616111184|FG000|Double-blind Treatment|Other|0|||
170483828|NCT01256450|616111185|FG001|Double-blind Treatment|Other|9|||
170483829|NCT01256450|616111186|FG002|Double-blind Treatment|Other|12|||
170483830|NCT00891020|616111188|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
170483831|NCT00891020|616111189|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
170483832|NCT00891020|616111190|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
170483833|NCT00891020|616111188|FG000|24 Week Treatment Period|Death|0|||
170483834|NCT00891020|616111189|FG001|24 Week Treatment Period|Death|2|||
170483835|NCT00891020|616111190|FG002|24 Week Treatment Period|Death|0|||
170483836|NCT00891020|616111188|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
170483837|NCT00891020|616111189|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
170483838|NCT00891020|616111190|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
170483839|NCT00891020|616111188|FG000|24 Week Treatment Period|Failure to return|4|||
170483840|NCT00891020|616111189|FG001|24 Week Treatment Period|Failure to return|5|||
170483841|NCT00891020|616111190|FG002|24 Week Treatment Period|Failure to return|5|||
170483842|NCT00891020|616111188|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
170483843|NCT00891020|616111189|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
170483844|NCT00891020|616111190|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
170483845|NCT00891020|616111188|FG000|24 Week Treatment Period|Other protocol violation|1|||
170483846|NCT00891020|616111189|FG001|24 Week Treatment Period|Other protocol violation|1|||
170483847|NCT00891020|616111190|FG002|24 Week Treatment Period|Other protocol violation|2|||
170483848|NCT00891020|616111188|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
170898027|NCT00348140|617632354|FG000|Overall Study|Use of prohibited drug|1|||
170898028|NCT00348140|617632355|FG001|Overall Study|Use of prohibited drug|0|||
170898029|NCT00348140|617632356|FG002|Overall Study|Use of prohibited drug|2|||
170898030|NCT00348140|617632354|FG000|Overall Study|Disease progression|1|||
170898031|NCT00348140|617632355|FG001|Overall Study|Disease progression|2|||
170898032|NCT00348140|617632356|FG002|Overall Study|Disease progression|5|||
170898033|NCT00348140|617632354|FG000|Overall Study|Increased risk of cardiac infarction|0|||
170898034|NCT00348140|617632355|FG001|Overall Study|Increased risk of cardiac infarction|1|||
170898035|NCT00348140|617632356|FG002|Overall Study|Increased risk of cardiac infarction|0|||
170898036|NCT00348140|617632354|FG000|Overall Study|Serious adverse event|0|||
170483849|NCT00891020|616111189|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
170483850|NCT00891020|616111190|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
170483851|NCT00891020|616111188|FG000|24 Week Treatment Period|Withdrew consent|6|||
170548639|NCT02533674|616354647|FG000|Dose Level I|Never Treated|1|||
170898037|NCT00348140|617632355|FG001|Overall Study|Serious adverse event|1|||
170898038|NCT00348140|617632356|FG002|Overall Study|Serious adverse event|0|||
170898039|NCT00348140|617632354|FG000|Overall Study|Abnormal ECG|0|||
170483852|NCT00891020|616111189|FG001|24 Week Treatment Period|Withdrew consent|3|||
170483853|NCT00891020|616111190|FG002|24 Week Treatment Period|Withdrew consent|15|||
170483854|NCT00891020|616111188|FG000|24 Week Treatment Period|Administrative/Other|5|||
170483855|NCT00891020|616111189|FG001|24 Week Treatment Period|Administrative/Other|6|||
170483856|NCT00891020|616111190|FG002|24 Week Treatment Period|Administrative/Other|1|||
170483857|NCT00891020|616111188|FG000|Long-term Extension Period|Adverse Event|1|||
170483858|NCT00891020|616111189|FG001|Long-term Extension Period|Adverse Event|11|||
170483859|NCT00891020|616111190|FG002|Long-term Extension Period|Adverse Event|10|||
170483860|NCT00891020|616111188|FG000|Long-term Extension Period|Death|0|||
170483861|NCT00891020|616111189|FG001|Long-term Extension Period|Death|0|||
170483862|NCT00891020|616111190|FG002|Long-term Extension Period|Death|1|||
170483863|NCT00891020|616111188|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
170483864|NCT00891020|616111189|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
170483865|NCT00891020|616111190|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
170483866|NCT00891020|616111188|FG000|Long-term Extension Period|Protocol Violation|0|||
170483867|NCT00891020|616111189|FG001|Long-term Extension Period|Protocol Violation|1|||
170483868|NCT00891020|616111190|FG002|Long-term Extension Period|Protocol Violation|1|||
170483869|NCT00891020|616111188|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
170483870|NCT00891020|616111189|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
170483871|NCT00891020|616111190|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
170483872|NCT00891020|616111188|FG000|Long-term Extension Period|Failure to return|0|||
170483873|NCT00891020|616111189|FG001|Long-term Extension Period|Failure to return|2|||
170483874|NCT00891020|616111190|FG002|Long-term Extension Period|Failure to return|3|||
170483875|NCT00891020|616111188|FG000|Long-term Extension Period|Administrative|1|||
170483876|NCT00891020|616111189|FG001|Long-term Extension Period|Administrative|2|||
170483877|NCT00891020|616111190|FG002|Long-term Extension Period|Administrative|2|||
170483878|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
170483879|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
170483880|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
170483881|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
170483882|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
170483883|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
170483884|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
170483885|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
170483886|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
170483887|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
170483888|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
170483889|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
170483890|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
170483891|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
170483892|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
170483893|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
170483894|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
170483895|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
170483896|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
170483897|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
170483898|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
170483899|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
170483900|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
170483901|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
170483902|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
170483903|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
170483904|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
170483905|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
170483906|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
170548640|NCT02533674|616354648|FG001|Dose Level I|Never Treated|0|||
170548641|NCT02533674|616354649|FG002|Dose Level I|Never Treated|0|||
170898040|NCT00348140|617632355|FG001|Overall Study|Abnormal ECG|1|||
170898041|NCT00348140|617632356|FG002|Overall Study|Abnormal ECG|3|||
170898042|NCT00348140|617632354|FG000|Overall Study|Participant died|0|||
170898043|NCT00348140|617632355|FG001|Overall Study|Participant died|1|||
170898044|NCT00348140|617632356|FG002|Overall Study|Participant died|0|||
170898045|NCT00348140|617632354|FG000|Overall Study|Exclusion criteria met|0|||
170483907|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
170898046|NCT00348140|617632355|FG001|Overall Study|Exclusion criteria met|0|||
170898047|NCT00348140|617632356|FG002|Overall Study|Exclusion criteria met|1|||
170898048|NCT00348140|617632354|FG000|Overall Study|Memory declined|0|||
170483908|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
170483909|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
170483910|NCT00506415|616111192|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
170483911|NCT00506415|616111193|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
170483912|NCT00506415|616111194|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
170483913|NCT00506415|616111195|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
170483914|NCT00506415|616111192|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
170483915|NCT00506415|616111193|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
170483916|NCT00506415|616111194|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
170483917|NCT00506415|616111195|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
170483918|NCT00506415|616111192|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
170483919|NCT00506415|616111193|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
170483920|NCT00506415|616111194|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
170483921|NCT00506415|616111195|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
170483922|NCT00506415|616111192|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
170483923|NCT00506415|616111193|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
170483924|NCT00506415|616111194|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
170483925|NCT00506415|616111195|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
170483926|NCT00506415|616111192|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
170483927|NCT00506415|616111193|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
170483928|NCT00506415|616111194|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
170483929|NCT00506415|616111195|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
170483930|NCT00506415|616111192|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
170483931|NCT00506415|616111193|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
170483932|NCT00506415|616111194|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
170483933|NCT00506415|616111195|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
170483934|NCT00506415|616111192|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
170483935|NCT00506415|616111193|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
170483936|NCT00506415|616111194|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
170483937|NCT00506415|616111195|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
170483938|NCT00506415|616111192|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
170483939|NCT00506415|616111193|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
170483940|NCT00506415|616111194|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
170483941|NCT00506415|616111195|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
170483942|NCT00506415|616111192|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
170483943|NCT00506415|616111193|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
170483944|NCT00506415|616111194|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
170483945|NCT00506415|616111195|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
170483946|NCT00506415|616111192|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
170483947|NCT00506415|616111193|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
170483948|NCT00506415|616111194|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
170483949|NCT00506415|616111195|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
170483950|NCT00506415|616111192|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
170483951|NCT00506415|616111193|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
170483952|NCT00506415|616111194|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
170483953|NCT00506415|616111195|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
170483954|NCT00506415|616111192|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
170483955|NCT00506415|616111193|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
170483956|NCT00506415|616111194|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
170483957|NCT00506415|616111195|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
170483958|NCT00506415|616111192|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
170483959|NCT00506415|616111193|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
170483960|NCT00506415|616111194|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
170483961|NCT00506415|616111195|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
170483962|NCT00506415|616111192|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
170483963|NCT00506415|616111193|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
170483964|NCT00506415|616111194|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
170483965|NCT00506415|616111195|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
170483966|NCT00506415|616111192|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
170483967|NCT00506415|616111193|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
170483968|NCT00506415|616111194|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
170483969|NCT00506415|616111195|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
170798201|NCT02777593|617273635|FG002|Overall Study|Death|0|||
170483970|NCT00506415|616111192|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
170798202|NCT02777593|617273636|FG003|Overall Study|Death|5|||
170898049|NCT00348140|617632355|FG001|Overall Study|Memory declined|0|||
170898050|NCT00348140|617632356|FG002|Overall Study|Memory declined|1|||
170898051|NCT03371355|617632359|FG000|Overall Study|Investigator judgment|0|||
170483971|NCT00506415|616111193|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
170483972|NCT00506415|616111194|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
170483973|NCT00506415|616111195|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
170483974|NCT00832455|616111200|FG000|Overall Study|Adverse Event|13|||
170483975|NCT00832455|616111200|FG000|Overall Study|Lost to Follow-up|26|||
170483976|NCT00832455|616111200|FG000|Overall Study|Protocol Violation|4|||
170483977|NCT00832455|616111200|FG000|Overall Study|Withdrawal by Subject|17|||
170483978|NCT00832455|616111200|FG000|Overall Study|Screening Failure|2|||
170483979|NCT00832455|616111200|FG000|Overall Study|Stopped Medication|4|||
170483980|NCT00832455|616111200|FG000|Overall Study|Parent misunderstood study|1|||
170483981|NCT00832455|616111200|FG000|Overall Study|Parent dissatisfied|1|||
170483982|NCT00832455|616111200|FG000|Overall Study|No improvement|3|||
170483983|NCT00832455|616111200|FG000|Overall Study|Patient moved|1|||
170483984|NCT03123393|616111204|FG000|Overall Study|Study Terminated by Sponsor|6|||
170483985|NCT03123393|616111205|FG001|Overall Study|Study Terminated by Sponsor|9|||
170483986|NCT03123393|616111204|FG000|Overall Study|Withdrawal by Subject|2|||
170483987|NCT03123393|616111205|FG001|Overall Study|Withdrawal by Subject|1|||
170483988|NCT03123393|616111204|FG000|Overall Study|Reason not Specified|13|||
170483989|NCT03123393|616111205|FG001|Overall Study|Reason not Specified|13|||
170483990|NCT01609296|616111207|FG000|Overall Study|Death|253|||
170483991|NCT01609296|616111207|FG000|Overall Study|Withdrawal by Subject|151|||
170483992|NCT01609296|616111207|FG000|Overall Study|Lost to Follow-up|21|||
170483993|NCT01609296|616111207|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
170483994|NCT01609296|616111207|FG000|Overall Study|missed visit but known to be alive|28|||
170483995|NCT00740636|616111212|FG000|Overall Study|Adverse Event|0|||
170483996|NCT00740636|616111213|FG001|Overall Study|Adverse Event|2|||
170483997|NCT00740636|616111212|FG000|Overall Study|Patient Ineligible|0|||
170483998|NCT00740636|616111213|FG001|Overall Study|Patient Ineligible|1|||
170483999|NCT00740636|616111212|FG000|Overall Study|Patient Not Treated|0|||
170484000|NCT00740636|616111213|FG001|Overall Study|Patient Not Treated|1|||
170484001|NCT00740636|616111212|FG000|Overall Study|Progressive Disease|1|||
170484002|NCT00740636|616111213|FG001|Overall Study|Progressive Disease|0|||
170484003|NCT00740636|616111212|FG000|Overall Study|Death|1|||
170484004|NCT00740636|616111213|FG001|Overall Study|Death|0|||
170484005|NCT03539302|616111214|FG000|Overall Study|Spontaneous cardio version|0|||
170484006|NCT03539302|616111215|FG001|Overall Study|Spontaneous cardio version|0|||
170484007|NCT03539302|616111216|FG002|Overall Study|Spontaneous cardio version|0|||
170484008|NCT03539302|616111217|FG003|Overall Study|Spontaneous cardio version|0|||
170484009|NCT03539302|616111218|FG004|Overall Study|Spontaneous cardio version|0|||
170484010|NCT03539302|616111219|FG005|Overall Study|Spontaneous cardio version|1|||
170484011|NCT03539302|616111220|FG006|Overall Study|Spontaneous cardio version|1|||
170484012|NCT02174627|616111224|FG000|Overall Study|Missing|0|||
170484013|NCT02174627|616111225|FG001|Overall Study|Missing|1|||
170484014|NCT02174627|616111224|FG000|Overall Study|Incorrect enrolment before randomization|0|||
170484015|NCT02174627|616111225|FG001|Overall Study|Incorrect enrolment before randomization|1|||
170484016|NCT02174627|616111224|FG000|Overall Study|Participant decision|84|||
170484017|NCT02174627|616111225|FG001|Overall Study|Participant decision|128|||
170484018|NCT02166333|616111226|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
170484019|NCT02166333|616111227|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
170484020|NCT02166333|616111228|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
170484021|NCT02166333|616111229|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
170484022|NCT02166333|616111230|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
170484023|NCT02166333|616111231|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
170484024|NCT02166333|616111226|FG000|Stage 1|Death|4|||
170484025|NCT02166333|616111227|FG001|Stage 1|Death|0|||
170484026|NCT02166333|616111228|FG002|Stage 1|Death|2|||
170484027|NCT02166333|616111229|FG003|Stage 1|Death|0|||
170484028|NCT02166333|616111230|FG004|Stage 1|Death|3|||
170484029|NCT02166333|616111231|FG005|Stage 1|Death|2|||
170484030|NCT02166333|616111226|FG000|Stage 1|Lost to Follow-up|12|||
170484031|NCT02166333|616111227|FG001|Stage 1|Lost to Follow-up|0|||
170484032|NCT02166333|616111228|FG002|Stage 1|Lost to Follow-up|6|||
170484033|NCT02166333|616111229|FG003|Stage 1|Lost to Follow-up|0|||
170484034|NCT02166333|616111230|FG004|Stage 1|Lost to Follow-up|3|||
170484035|NCT02166333|616111231|FG005|Stage 1|Lost to Follow-up|3|||
170484036|NCT02166333|616111226|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
170548642|NCT02533674|616354650|FG003|Dose Level I|Never Treated|0|||
170898052|NCT03371355|617632360|FG001|Overall Study|Investigator judgment|0|||
170484037|NCT02166333|616111227|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
170484038|NCT02166333|616111228|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
170548643|NCT02533674|616354651|FG004|Dose Level I|Never Treated|0|||
170484039|NCT02166333|616111229|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
170484040|NCT02166333|616111230|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
170484041|NCT02166333|616111231|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
170484042|NCT02166333|616111226|FG000|Stage 2|Death|4|||
170484043|NCT02166333|616111227|FG001|Stage 2|Death|2|||
170484044|NCT02166333|616111228|FG002|Stage 2|Death|1|||
170484045|NCT02166333|616111229|FG003|Stage 2|Death|0|||
170484046|NCT02166333|616111230|FG004|Stage 2|Death|0|||
170484047|NCT02166333|616111231|FG005|Stage 2|Death|1|||
170484048|NCT02166333|616111226|FG000|Stage 2|Lost to Follow-up|23|||
170484049|NCT02166333|616111227|FG001|Stage 2|Lost to Follow-up|4|||
170484050|NCT02166333|616111228|FG002|Stage 2|Lost to Follow-up|11|||
170484051|NCT02166333|616111229|FG003|Stage 2|Lost to Follow-up|9|||
170484052|NCT02166333|616111230|FG004|Stage 2|Lost to Follow-up|3|||
170484053|NCT02166333|616111231|FG005|Stage 2|Lost to Follow-up|6|||
170484054|NCT05795153|616113065|FG000|Overall Study|Adverse Event|2|||
170484055|NCT05795153|616113065|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170484056|NCT05795153|616113065|FG000|Overall Study|Lost to Follow-up|1|||
170484057|NCT05795153|616113065|FG000|Overall Study|Subject decision|2|||
170484058|NCT03769168|616113066|FG000|Overall Study|Adverse Event|0|||
170484059|NCT03769168|616113067|FG001|Overall Study|Adverse Event|1|||
170484060|NCT03769168|616113066|FG000|Overall Study|Lack of Efficacy|2|||
170484061|NCT03769168|616113067|FG001|Overall Study|Lack of Efficacy|4|||
170484062|NCT03769168|616113066|FG000|Overall Study|Post study access to treatment|3|||
170484063|NCT03769168|616113067|FG001|Overall Study|Post study access to treatment|11|||
170484064|NCT03769168|616113066|FG000|Overall Study|Physician Decision|1|||
170484065|NCT03769168|616113067|FG001|Overall Study|Physician Decision|4|||
170484066|NCT03769168|616113066|FG000|Overall Study|Subject Decision|2|||
170484067|NCT03769168|616113067|FG001|Overall Study|Subject Decision|4|||
170484068|NCT03769168|616113066|FG000|Overall Study|Guardian decision|1|||
170484069|NCT03769168|616113067|FG001|Overall Study|Guardian decision|0|||
170484070|NCT05142722|616113072|FG000|Overall Study|Lost to Follow-up|16|||
170484071|NCT05142722|616113073|FG001|Overall Study|Lost to Follow-up|38|||
170484072|NCT05142722|616113072|FG000|Overall Study|Withdrawal by Subject|20|||
170484073|NCT05142722|616113073|FG001|Overall Study|Withdrawal by Subject|27|||
170484074|NCT05142722|616113072|FG000|Overall Study|Death|11|||
170484075|NCT05142722|616113073|FG001|Overall Study|Death|17|||
170484076|NCT05142722|616113072|FG000|Overall Study|Physician Decision|0|||
170484077|NCT05142722|616113073|FG001|Overall Study|Physician Decision|1|||
170484078|NCT05142722|616113072|FG000|Overall Study|Participant Moved Away|0|||
170484079|NCT05142722|616113073|FG001|Overall Study|Participant Moved Away|2|||
170484080|NCT05142722|616113072|FG000|Overall Study|Adverse Event|2|||
170898053|NCT03371355|617632361|FG002|Overall Study|Investigator judgment|1|||
170484081|NCT05142722|616113073|FG001|Overall Study|Adverse Event|1|||
170484082|NCT05468164|616113074|FG000|Treatment Period 4|Adverse Event|0|||
170484083|NCT05468164|616113075|FG001|Treatment Period 4|Adverse Event|0|||
170484084|NCT05468164|616113076|FG002|Treatment Period 4|Adverse Event|0|||
170484085|NCT05468164|616113077|FG003|Treatment Period 4|Adverse Event|1|||
170484086|NCT04795466|616113078|FG000|Overall Study|Adverse Event|3|||
170484087|NCT04795466|616113079|FG001|Overall Study|Adverse Event|1|||
170484088|NCT04795466|616113078|FG000|Overall Study|Physician Decision|1|||
170484089|NCT04795466|616113079|FG001|Overall Study|Physician Decision|0|||
170484090|NCT04795466|616113078|FG000|Overall Study|Withdrawal by Subject|2|||
170484091|NCT04795466|616113079|FG001|Overall Study|Withdrawal by Subject|1|||
170484092|NCT01102257|616113084|FG000|Overall Study|Adverse Event|1|||
170484093|NCT01102257|616113085|FG001|Overall Study|Adverse Event|0|||
170484094|NCT01102257|616113084|FG000|Overall Study|Adverse Event|1|||
170484095|NCT01102257|616113085|FG001|Overall Study|Adverse Event|0|||
170484096|NCT05364931|616113086|FG000|Overall Study|Adverse Event|0|||
170484097|NCT05364931|616113087|FG001|Overall Study|Adverse Event|2|||
170484098|NCT05364931|616113088|FG002|Overall Study|Adverse Event|1|||
170484099|NCT05364931|616113089|FG003|Overall Study|Adverse Event|0|||
170484100|NCT05364931|616113086|FG000|Overall Study|Lost to Follow-up|1|||
170484101|NCT05364931|616113087|FG001|Overall Study|Lost to Follow-up|0|||
170484102|NCT05364931|616113088|FG002|Overall Study|Lost to Follow-up|0|||
170484103|NCT05364931|616113089|FG003|Overall Study|Lost to Follow-up|0|||
170484104|NCT05364931|616113086|FG000|Overall Study|Withdrawal by Subject|1|||
170484105|NCT05364931|616113087|FG001|Overall Study|Withdrawal by Subject|1|||
170484106|NCT05364931|616113088|FG002|Overall Study|Withdrawal by Subject|3|||
170484107|NCT05364931|616113089|FG003|Overall Study|Withdrawal by Subject|2|||
170484108|NCT05364931|616113086|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
170484109|NCT05364931|616113087|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
170484110|NCT05364931|616113088|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
170484111|NCT05364931|616113089|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
170484112|NCT05364931|616113086|FG000|Overall Study|Discontinued|1|||
170484113|NCT05364931|616113087|FG001|Overall Study|Discontinued|0|||
170484114|NCT05364931|616113088|FG002|Overall Study|Discontinued|0|||
170484115|NCT05364931|616113089|FG003|Overall Study|Discontinued|0|||
170484116|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
170484117|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
170484118|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
170484119|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
170484120|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
170484121|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
170484122|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
170484123|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
170484124|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
170484125|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
170484126|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
170484127|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
170484128|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
170484129|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
170484130|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
170484131|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
170484132|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
170484133|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
170484134|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
170484135|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
170484136|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
170484137|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
170484138|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
170484139|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
170484140|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
170484141|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
170484142|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
170484143|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
170484144|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
170484145|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
170484146|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
170484147|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
170484148|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
170484149|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
170484150|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
170484151|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
170484152|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
170484153|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
170484154|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
170484155|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
170484156|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
170484157|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
170484158|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
170484159|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
170484160|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
170484161|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
170484162|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
170484163|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
170484164|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
170484165|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
170484166|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
170484167|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
170484168|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Site closed|0|||
170484169|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Site closed|0|||
170484170|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Site closed|1|||
170484171|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Site closed|0|||
170484172|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
170484173|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
170484174|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
170484175|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
170798203|NCT02777593|617273637|FG004|Overall Study|Death|0|||
170798204|NCT02777593|617273633|FG000|Overall Study|Withdrawal by Subject|8|||
170798205|NCT02777593|617273634|FG001|Overall Study|Withdrawal by Subject|4|||
170548644|NCT02533674|616354652|FG005|Dose Level I|Never Treated|0|||
170798206|NCT02777593|617273635|FG002|Overall Study|Withdrawal by Subject|1|||
170798207|NCT02777593|617273636|FG003|Overall Study|Withdrawal by Subject|1|||
170484176|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
170484177|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
170484178|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
170484179|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
170484180|NCT00838903|616113090|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
170484181|NCT00838903|616113091|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
170484182|NCT00838903|616113092|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
170484183|NCT00838903|616113093|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
170484184|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
170484185|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
170484186|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
170484187|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
170484188|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
170484189|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
170484190|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
170484191|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
170484192|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
170484193|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
170484194|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
170484195|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
170484196|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
170484197|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
170484198|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
170484199|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
170484200|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
170484201|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
170484202|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
170484203|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
170484204|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
170484205|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
170484206|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
170484207|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
170484208|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
170484209|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
170484210|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
170484211|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
170484212|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
170484213|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
170484214|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
170484215|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
170484216|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
170484217|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
170898054|NCT03371355|617632362|FG003|Overall Study|Investigator judgment|1|||
170484218|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
170484219|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
170484220|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
170484221|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
170484222|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
170484223|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
170484224|NCT00838903|616113090|FG000|Follow-up Period (8 Weeks)|Missing|1|||
170484225|NCT00838903|616113091|FG001|Follow-up Period (8 Weeks)|Missing|2|||
170484226|NCT00838903|616113092|FG002|Follow-up Period (8 Weeks)|Missing|1|||
170484227|NCT00838903|616113093|FG003|Follow-up Period (8 Weeks)|Missing|1|||
170484228|NCT00536939|616113094|FG000|Overall Study|Withdrawal by Subject|1|||
170484229|NCT00536939|616113095|FG001|Overall Study|Withdrawal by Subject|0|||
170484230|NCT00536939|616113094|FG000|Overall Study|Other Complicating Disease|1|||
170484231|NCT00536939|616113095|FG001|Overall Study|Other Complicating Disease|0|||
170484232|NCT04225715|616113096|FG000|Overall Study|Reason not Specified|1|||
170484233|NCT04225715|616113097|FG001|Overall Study|Reason not Specified|0|||
170484234|NCT04225715|616113098|FG002|Overall Study|Reason not Specified|0|||
170484235|NCT04225715|616113099|FG003|Overall Study|Reason not Specified|0|||
170484236|NCT04225715|616113100|FG004|Overall Study|Reason not Specified|0|||
170484237|NCT04225715|616113101|FG005|Overall Study|Reason not Specified|0|||
170484238|NCT04225715|616113102|FG006|Overall Study|Reason not Specified|0|||
170484239|NCT04225715|616113103|FG007|Overall Study|Reason not Specified|0|||
170484240|NCT04225715|616113104|FG008|Overall Study|Reason not Specified|0|||
170484241|NCT04225715|616113096|FG000|Overall Study|Protocol Violation|1|||
170548645|NCT02533674|616354653|FG006|Dose Level I|Never Treated|0|||
170548646|NCT02533674|616354654|FG007|Dose Level I|Never Treated|0|||
170484242|NCT04225715|616113097|FG001|Overall Study|Protocol Violation|0|||
170484243|NCT04225715|616113098|FG002|Overall Study|Protocol Violation|0|||
170484244|NCT04225715|616113099|FG003|Overall Study|Protocol Violation|0|||
170484245|NCT04225715|616113100|FG004|Overall Study|Protocol Violation|0|||
170484246|NCT04225715|616113101|FG005|Overall Study|Protocol Violation|9|||
170484247|NCT04225715|616113102|FG006|Overall Study|Protocol Violation|0|||
170484248|NCT04225715|616113103|FG007|Overall Study|Protocol Violation|0|||
170484249|NCT04225715|616113104|FG008|Overall Study|Protocol Violation|0|||
170484250|NCT04225715|616113096|FG000|Overall Study|Withdrawal by Subject|4|||
170484251|NCT04225715|616113097|FG001|Overall Study|Withdrawal by Subject|1|||
170484252|NCT04225715|616113098|FG002|Overall Study|Withdrawal by Subject|1|||
170484253|NCT04225715|616113099|FG003|Overall Study|Withdrawal by Subject|0|||
170484254|NCT04225715|616113100|FG004|Overall Study|Withdrawal by Subject|3|||
170484255|NCT04225715|616113101|FG005|Overall Study|Withdrawal by Subject|1|||
170484256|NCT04225715|616113102|FG006|Overall Study|Withdrawal by Subject|1|||
170484257|NCT04225715|616113103|FG007|Overall Study|Withdrawal by Subject|1|||
170484258|NCT04225715|616113104|FG008|Overall Study|Withdrawal by Subject|0|||
170484259|NCT04225715|616113096|FG000|Overall Study|Adverse Event|0|||
170484260|NCT04225715|616113097|FG001|Overall Study|Adverse Event|0|||
170484261|NCT04225715|616113098|FG002|Overall Study|Adverse Event|0|||
170484262|NCT04225715|616113099|FG003|Overall Study|Adverse Event|0|||
170484263|NCT04225715|616113100|FG004|Overall Study|Adverse Event|0|||
170484264|NCT04225715|616113101|FG005|Overall Study|Adverse Event|0|||
170484265|NCT04225715|616113102|FG006|Overall Study|Adverse Event|0|||
170484266|NCT04225715|616113103|FG007|Overall Study|Adverse Event|0|||
170484267|NCT04225715|616113104|FG008|Overall Study|Adverse Event|1|||
170484268|NCT04225715|616113096|FG000|Overall Study|Arm Terminated By Sponsor|0|||
170484269|NCT04225715|616113097|FG001|Overall Study|Arm Terminated By Sponsor|0|||
170484270|NCT04225715|616113098|FG002|Overall Study|Arm Terminated By Sponsor|0|||
170484271|NCT04225715|616113099|FG003|Overall Study|Arm Terminated By Sponsor|0|||
170484272|NCT04225715|616113100|FG004|Overall Study|Arm Terminated By Sponsor|0|||
170484273|NCT04225715|616113101|FG005|Overall Study|Arm Terminated By Sponsor|0|||
170484274|NCT04225715|616113102|FG006|Overall Study|Arm Terminated By Sponsor|0|||
170484275|NCT04225715|616113103|FG007|Overall Study|Arm Terminated By Sponsor|17|||
170484276|NCT04225715|616113104|FG008|Overall Study|Arm Terminated By Sponsor|18|||
170484277|NCT01894841|616113105|FG000|Overall Study|Withdrawal by Subject|9|||
170484278|NCT01894841|616113106|FG001|Overall Study|Withdrawal by Subject|4|||
170484279|NCT01894841|616113105|FG000|Overall Study|Withdrawn by investigator|2|||
170484280|NCT01894841|616113106|FG001|Overall Study|Withdrawn by investigator|2|||
170484281|NCT01894841|616113105|FG000|Overall Study|Lost to Follow-up|7|||
170484282|NCT01894841|616113106|FG001|Overall Study|Lost to Follow-up|3|||
170484283|NCT02955355|616113115|FG000|Overall Study|Adverse Event|4|||
170484284|NCT02955355|616113115|FG000|Overall Study|Death|1|||
170484285|NCT02955355|616113115|FG000|Overall Study|Physician Decision|21|||
170484286|NCT02955355|616113115|FG000|Overall Study|Site Terminated by Sponsor|35|||
170484287|NCT02955355|616113115|FG000|Overall Study|Withdrawal by Subject|19|||
170484288|NCT02955355|616113115|FG000|Overall Study|Reason Not Specified|5|||
170484289|NCT02612623|616113116|FG000|Overall Study|Withdrawal by Subject|0|||
170484290|NCT02612623|616113117|FG001|Overall Study|Withdrawal by Subject|1|||
170484291|NCT02612623|616113118|FG002|Overall Study|Withdrawal by Subject|0|||
170484292|NCT02612623|616113119|FG003|Overall Study|Withdrawal by Subject|0|||
170484293|NCT02612623|616113116|FG000|Overall Study|Adverse Event|1|||
170484294|NCT02612623|616113117|FG001|Overall Study|Adverse Event|0|||
170484295|NCT02612623|616113118|FG002|Overall Study|Adverse Event|1|||
170484296|NCT02612623|616113119|FG003|Overall Study|Adverse Event|0|||
170484297|NCT04878432|616113122|FG000|Overall Study|Adverse Event|1|||
170484298|NCT04878432|616113122|FG000|Overall Study|Death|2|||
170484299|NCT04878432|616113122|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170484300|NCT04878432|616113122|FG000|Overall Study|Withdrawal by Subject|6|||
170484301|NCT04878432|616113122|FG000|Overall Study|Progressive Disease|7|||
170484302|NCT04878432|616113122|FG000|Overall Study|New Therapy for Study Indication|7|||
170484303|NCT04878432|616113122|FG000|Overall Study|Physician Decision|11|||
170484304|NCT02375971|616113123|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
170484305|NCT02375971|616113124|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
170484306|NCT02375971|616113125|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
170484307|NCT02375971|616113123|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
170484308|NCT02375971|616113124|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
170484309|NCT02375971|616113125|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
170484310|NCT02375971|616113123|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
170484311|NCT02375971|616113124|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
170484312|NCT02375971|616113125|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
170484313|NCT02375971|616113123|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
170484314|NCT02375971|616113124|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
170484315|NCT02375971|616113125|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
170484316|NCT02375971|616113123|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
170484317|NCT02375971|616113124|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
170484318|NCT02375971|616113125|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
170484319|NCT02375971|616113123|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
170484320|NCT02375971|616113124|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
170484321|NCT02375971|616113125|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
170484322|NCT02375971|616113123|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
170484323|NCT02375971|616113124|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
170484324|NCT02375971|616113125|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
170484325|NCT02375971|616113123|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
170484326|NCT02375971|616113124|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
170484327|NCT02375971|616113125|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
170484328|NCT00320710|616113127|FG000|Overall Study|Disease progression|24|||
170484329|NCT00320710|616113128|FG001|Overall Study|Disease progression|19|||
170484330|NCT00320710|616113129|FG002|Overall Study|Disease progression|2|||
170484331|NCT00320710|616113127|FG000|Overall Study|Death|10|||
170484332|NCT00320710|616113128|FG001|Overall Study|Death|7|||
170484333|NCT00320710|616113129|FG002|Overall Study|Death|1|||
170484334|NCT00320710|616113127|FG000|Overall Study|Administrative problems|1|||
170484335|NCT00320710|616113128|FG001|Overall Study|Administrative problems|2|||
170484336|NCT00320710|616113129|FG002|Overall Study|Administrative problems|0|||
170484337|NCT00320710|616113127|FG000|Overall Study|Withdrawal by Subject|20|||
170484338|NCT00320710|616113128|FG001|Overall Study|Withdrawal by Subject|26|||
170484339|NCT00320710|616113129|FG002|Overall Study|Withdrawal by Subject|1|||
170484340|NCT00320710|616113127|FG000|Overall Study|Protocol Violation|6|||
170484341|NCT00320710|616113128|FG001|Overall Study|Protocol Violation|5|||
170484342|NCT00320710|616113129|FG002|Overall Study|Protocol Violation|0|||
170484343|NCT00320710|616113127|FG000|Overall Study|Abnormal test procedure result(s)|2|||
170484344|NCT00320710|616113128|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170484345|NCT00320710|616113129|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170484346|NCT00320710|616113127|FG000|Overall Study|Abnormal laboratory value(s)|12|||
170484347|NCT00320710|616113128|FG001|Overall Study|Abnormal laboratory value(s)|3|||
170484348|NCT00320710|616113129|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170484349|NCT00320710|616113127|FG000|Overall Study|Adverse Event|18|||
170484350|NCT00320710|616113128|FG001|Overall Study|Adverse Event|14|||
170484351|NCT00320710|616113129|FG002|Overall Study|Adverse Event|1|||
170484352|NCT00320710|616113127|FG000|Overall Study|Lost to Follow-up|1|||
170484353|NCT00320710|616113128|FG001|Overall Study|Lost to Follow-up|0|||
170484354|NCT00320710|616113129|FG002|Overall Study|Lost to Follow-up|0|||
170484355|NCT04578457|616113130|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
170484356|NCT04578457|616113130|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
170484357|NCT04578457|616113130|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
170484358|NCT04578457|616113130|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
170484359|NCT00997373|616113131|FG000|Overall Study|Withdrawal by Subject|5|||
170484360|NCT00997373|616113132|FG001|Overall Study|Withdrawal by Subject|0|||
170484361|NCT00997373|616113131|FG000|Overall Study|wrong tumor type|4|||
170484362|NCT00997373|616113132|FG001|Overall Study|wrong tumor type|0|||
170484363|NCT00997373|616113131|FG000|Overall Study|could not have hysterectomy|6|||
170484364|NCT00997373|616113132|FG001|Overall Study|could not have hysterectomy|0|||
170484365|NCT02841995|616113140|FG000|Overall Study|Disease progression|5|||
170484366|NCT02841995|616113141|FG001|Overall Study|Disease progression|11|||
170484367|NCT02841995|616113142|FG002|Overall Study|Disease progression|8|||
170484368|NCT02841995|616113140|FG000|Overall Study|Withdrawal by Subject|2|||
170484369|NCT02841995|616113141|FG001|Overall Study|Withdrawal by Subject|4|||
170484370|NCT02841995|616113142|FG002|Overall Study|Withdrawal by Subject|4|||
170484371|NCT02841995|616113140|FG000|Overall Study|Adverse Event|2|||
170484372|NCT02841995|616113141|FG001|Overall Study|Adverse Event|0|||
170484373|NCT02841995|616113142|FG002|Overall Study|Adverse Event|1|||
170484374|NCT02841995|616113140|FG000|Overall Study|Investigator decision|2|||
170484375|NCT02841995|616113141|FG001|Overall Study|Investigator decision|0|||
170484376|NCT02841995|616113142|FG002|Overall Study|Investigator decision|1|||
170484377|NCT02841995|616113140|FG000|Overall Study|Death|0|||
170484378|NCT02841995|616113141|FG001|Overall Study|Death|0|||
170484379|NCT02841995|616113142|FG002|Overall Study|Death|2|||
170484380|NCT02841995|616113140|FG000|Overall Study|Noncompliance to protocol|1|||
170484381|NCT02841995|616113141|FG001|Overall Study|Noncompliance to protocol|0|||
170484382|NCT02841995|616113142|FG002|Overall Study|Noncompliance to protocol|0|||
170484383|NCT02841995|616113140|FG000|Overall Study|Sponsor decision|1|||
170484384|NCT02841995|616113141|FG001|Overall Study|Sponsor decision|0|||
170484385|NCT02841995|616113142|FG002|Overall Study|Sponsor decision|0|||
170484386|NCT02841995|616113140|FG000|Overall Study|Other|4|||
170484387|NCT02841995|616113141|FG001|Overall Study|Other|1|||
170484388|NCT02841995|616113142|FG002|Overall Study|Other|5|||
170484389|NCT02230904|616113149|FG000|Overall Study|Safety follow up could not take place|0|||
170484390|NCT02230904|616113150|FG001|Overall Study|Safety follow up could not take place|1|||
170484391|NCT01464333|616113153|FG000|Overall Study|Adverse Event|34|||
170484392|NCT01464333|616113153|FG000|Overall Study|Lack of Efficacy|72|||
170484393|NCT01464333|616113153|FG000|Overall Study|Withdrawal by Subject|11|||
170484394|NCT01464333|616113153|FG000|Overall Study|Other|4|||
170484395|NCT01464333|616113153|FG000|Overall Study|No Hospital Visit|42|||
170484396|NCT05047211|616113155|FG000|Overall Study|Lost to Follow-up|8|||
170484397|NCT05047211|616113156|FG001|Overall Study|Lost to Follow-up|5|||
170484398|NCT00739661|616113159|FG000|Overall Study|Adverse Event|2|||
170484399|NCT00739661|616113160|FG001|Overall Study|Adverse Event|0|||
170484400|NCT00739661|616113159|FG000|Overall Study|Physician decision to withdraw patient|1|||
170484401|NCT00739661|616113160|FG001|Overall Study|Physician decision to withdraw patient|0|||
170484402|NCT00739661|616113159|FG000|Overall Study|Patient decision to withdraw|9|||
170484403|NCT00739661|616113160|FG001|Overall Study|Patient decision to withdraw|4|||
170484404|NCT00739661|616113159|FG000|Overall Study|Disease progression, radiographic|33|||
170484405|NCT00739661|616113160|FG001|Overall Study|Disease progression, radiographic|37|||
170484406|NCT00739661|616113159|FG000|Overall Study|Reason for discontinuation not available|1|||
170484407|NCT00739661|616113160|FG001|Overall Study|Reason for discontinuation not available|1|||
170484408|NCT02632409|616113161|FG000|Randomized|AE unrelated to study Drug|0|||
170484409|NCT02632409|616113162|FG001|Randomized|AE unrelated to study Drug|1|||
170484410|NCT02632409|616113161|FG000|Randomized|Participant withdrew consent|2|||
170484411|NCT02632409|616113162|FG001|Randomized|Participant withdrew consent|1|||
170484412|NCT02632409|616113161|FG000|Randomized|No Longer meets study criteria|5|||
170484413|NCT02632409|616113162|FG001|Randomized|No Longer meets study criteria|0|||
170484414|NCT02632409|616113161|FG000|Randomized|other reasons|1|||
170484415|NCT02632409|616113162|FG001|Randomized|other reasons|0|||
170484416|NCT02632409|616113161|FG000|Treatment Period|Ongoing Treatment|20|||
170484417|NCT02632409|616113162|FG001|Treatment Period|Ongoing Treatment|21|||
170484418|NCT02632409|616113161|FG000|Treatment Period|Disease Recurrence|147|||
170484419|NCT02632409|616113162|FG001|Treatment Period|Disease Recurrence|90|||
170484420|NCT02632409|616113161|FG000|Treatment Period|Study Drug Toxicity|8|||
170484421|NCT02632409|616113162|FG001|Treatment Period|Study Drug Toxicity|49|||
170484422|NCT02632409|616113161|FG000|Treatment Period|Death|1|||
170484423|NCT02632409|616113162|FG001|Treatment Period|Death|0|||
170484424|NCT02632409|616113161|FG000|Treatment Period|AE unrelated to study drug|15|||
170484425|NCT02632409|616113162|FG001|Treatment Period|AE unrelated to study drug|16|||
170484426|NCT02632409|616113161|FG000|Treatment Period|Request to discontinue treatment|4|||
170484427|NCT02632409|616113162|FG001|Treatment Period|Request to discontinue treatment|19|||
170484428|NCT02632409|616113161|FG000|Treatment Period|Participant withdrew consent|7|||
170484429|NCT02632409|616113162|FG001|Treatment Period|Participant withdrew consent|5|||
170484430|NCT02632409|616113161|FG000|Treatment Period|Lost to Follow-up|0|||
170484431|NCT02632409|616113162|FG001|Treatment Period|Lost to Follow-up|1|||
170484432|NCT02632409|616113161|FG000|Treatment Period|Maximum clinical benefit|1|||
170484433|NCT02632409|616113162|FG001|Treatment Period|Maximum clinical benefit|0|||
170484434|NCT02632409|616113161|FG000|Treatment Period|No longer meets study criteria|3|||
170484435|NCT02632409|616113162|FG001|Treatment Period|No longer meets study criteria|0|||
170484436|NCT02632409|616113161|FG000|Treatment Period|Administrative Reason by sponsor|0|||
170484437|NCT02632409|616113162|FG001|Treatment Period|Administrative Reason by sponsor|1|||
170484438|NCT02632409|616113161|FG000|Treatment Period|Other Reasons|10|||
170484439|NCT02632409|616113162|FG001|Treatment Period|Other Reasons|6|||
170484440|NCT01909934|616113163|FG000|Overall Study|Withdrawal by Subject|3|||
170484441|NCT01909934|616113163|FG000|Overall Study|Lost to Follow-up|1|||
170484442|NCT01909934|616113163|FG000|Overall Study|Death|25|||
170484443|NCT01909934|616113163|FG000|Overall Study|Withdrawal of Informed Consent|1|||
170484444|NCT01909934|616113163|FG000|Overall Study|Reason Not Specified|1|||
170484445|NCT04578535|616113164|FG000|Overall Study|Lost to Follow-up|1|||
170484446|NCT04578535|616113165|FG001|Overall Study|Lost to Follow-up|0|||
170484447|NCT04578535|616113166|FG002|Overall Study|Lost to Follow-up|0|||
170484448|NCT04578535|616113167|FG003|Overall Study|Lost to Follow-up|1|||
170548647|NCT02533674|616354647|FG000|Dose Level II|Progressive disease|0|||
170548648|NCT02533674|616354648|FG001|Dose Level II|Progressive disease|3|||
170548649|NCT02533674|616354649|FG002|Dose Level II|Progressive disease|0|||
170548650|NCT02533674|616354650|FG003|Dose Level II|Progressive disease|0|||
170484449|NCT04578535|616113168|FG004|Overall Study|Lost to Follow-up|0|||
170484450|NCT04578535|616113169|FG005|Overall Study|Lost to Follow-up|2|||
170484451|NCT04578535|616113164|FG000|Overall Study|Pregnancy|1|||
170484452|NCT04578535|616113165|FG001|Overall Study|Pregnancy|0|||
170484453|NCT04578535|616113166|FG002|Overall Study|Pregnancy|0|||
170548651|NCT02533674|616354651|FG004|Dose Level II|Progressive disease|0|||
170548652|NCT02533674|616354652|FG005|Dose Level II|Progressive disease|0|||
170484454|NCT04578535|616113167|FG003|Overall Study|Pregnancy|0|||
170484455|NCT04578535|616113168|FG004|Overall Study|Pregnancy|0|||
170548653|NCT02533674|616354653|FG006|Dose Level II|Progressive disease|0|||
170484456|NCT04578535|616113169|FG005|Overall Study|Pregnancy|0|||
170484457|NCT04578535|616113164|FG000|Overall Study|Withdrawal by Subject|0|||
170548654|NCT02533674|616354654|FG007|Dose Level II|Progressive disease|0|||
170548655|NCT02533674|616354647|FG000|Dose Level II|Withdrawal by Subject|0|||
170484458|NCT04578535|616113165|FG001|Overall Study|Withdrawal by Subject|0|||
170484459|NCT04578535|616113166|FG002|Overall Study|Withdrawal by Subject|0|||
170484460|NCT04578535|616113167|FG003|Overall Study|Withdrawal by Subject|1|||
170484461|NCT04578535|616113168|FG004|Overall Study|Withdrawal by Subject|1|||
170898055|NCT03371355|617632359|FG000|Overall Study|Voluntary withdrawal|1|||
170898056|NCT03371355|617632360|FG001|Overall Study|Voluntary withdrawal|0|||
170898057|NCT03371355|617632361|FG002|Overall Study|Voluntary withdrawal|1|||
170898058|NCT03371355|617632362|FG003|Overall Study|Voluntary withdrawal|2|||
170898059|NCT03371355|617632359|FG000|Overall Study|Adverse Event|0|||
170484462|NCT04578535|616113169|FG005|Overall Study|Withdrawal by Subject|5|||
170484463|NCT04578535|616113164|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
170484464|NCT04578535|616113165|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
170484465|NCT04578535|616113166|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
170484466|NCT04578535|616113167|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
170484467|NCT04578535|616113168|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
170484468|NCT04578535|616113169|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
170484469|NCT03839628|616113170|FG000|Overall Study|Withdrawal by Subject|1|||
170484470|NCT00380874|616113171|FG000|Overall Study|Adverse Event|7|||
170484471|NCT00380874|616113172|FG001|Overall Study|Adverse Event|7|||
170484472|NCT00380874|616113171|FG000|Overall Study|Death|1|||
170484473|NCT00380874|616113172|FG001|Overall Study|Death|0|||
170484474|NCT00380874|616113171|FG000|Overall Study|Withdrawal by Subject|2|||
170484475|NCT00380874|616113172|FG001|Overall Study|Withdrawal by Subject|1|||
170484476|NCT00380874|616113171|FG000|Overall Study|Not related to study drug|3|||
170484477|NCT00380874|616113172|FG001|Overall Study|Not related to study drug|2|||
170484478|NCT03380429|616113173|FG000|Overall Study|Physician Decision|0|||
170484479|NCT03380429|616113174|FG001|Overall Study|Physician Decision|1|||
170484480|NCT03380429|616113175|FG002|Overall Study|Physician Decision|0|||
170484481|NCT03380429|616113176|FG003|Overall Study|Physician Decision|1|||
170484482|NCT03380429|616113177|FG004|Overall Study|Physician Decision|1|||
170484483|NCT03380429|616113173|FG000|Overall Study|Withdrawal by Subject|3|||
170484484|NCT03380429|616113174|FG001|Overall Study|Withdrawal by Subject|3|||
170484485|NCT03380429|616113175|FG002|Overall Study|Withdrawal by Subject|5|||
170484486|NCT03380429|616113176|FG003|Overall Study|Withdrawal by Subject|2|||
170484487|NCT03380429|616113177|FG004|Overall Study|Withdrawal by Subject|1|||
170484488|NCT03380429|616113173|FG000|Overall Study|Lost to Follow-up|0|||
170484489|NCT03380429|616113174|FG001|Overall Study|Lost to Follow-up|2|||
170484490|NCT03380429|616113175|FG002|Overall Study|Lost to Follow-up|4|||
170484491|NCT03380429|616113176|FG003|Overall Study|Lost to Follow-up|3|||
170484492|NCT03380429|616113177|FG004|Overall Study|Lost to Follow-up|1|||
170484493|NCT03380429|616113173|FG000|Overall Study|Protocol Violation|1|||
170484494|NCT03380429|616113174|FG001|Overall Study|Protocol Violation|0|||
170484495|NCT03380429|616113175|FG002|Overall Study|Protocol Violation|1|||
170484496|NCT03380429|616113176|FG003|Overall Study|Protocol Violation|0|||
170484497|NCT03380429|616113177|FG004|Overall Study|Protocol Violation|1|||
170484498|NCT03380429|616113173|FG000|Overall Study|Lack of Efficacy|0|||
170484499|NCT03380429|616113174|FG001|Overall Study|Lack of Efficacy|0|||
170484500|NCT03380429|616113175|FG002|Overall Study|Lack of Efficacy|0|||
170484501|NCT03380429|616113176|FG003|Overall Study|Lack of Efficacy|2|||
170484502|NCT03380429|616113177|FG004|Overall Study|Lack of Efficacy|1|||
170484503|NCT03380429|616113173|FG000|Overall Study|Adverse Event|1|||
170484504|NCT03380429|616113174|FG001|Overall Study|Adverse Event|1|||
170484505|NCT03380429|616113175|FG002|Overall Study|Adverse Event|1|||
170484506|NCT03380429|616113176|FG003|Overall Study|Adverse Event|2|||
170484507|NCT03380429|616113177|FG004|Overall Study|Adverse Event|0|||
170484508|NCT01707290|616113186|FG000|Overall Study|Adverse event (AE)|1|||
170484509|NCT01707290|616113187|FG001|Overall Study|Adverse event (AE)|0|||
170484510|NCT01707290|616113186|FG000|Overall Study|Physician Decision|1|||
170484511|NCT01707290|616113187|FG001|Overall Study|Physician Decision|0|||
170484512|NCT01707290|616113186|FG000|Overall Study|Lost to Follow-up|3|||
170484513|NCT01707290|616113187|FG001|Overall Study|Lost to Follow-up|0|||
170484514|NCT01707290|616113186|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
170484515|NCT01707290|616113187|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
170484516|NCT01707290|616113186|FG000|Overall Study|Commercial drug available|60|||
170484517|NCT01707290|616113187|FG001|Overall Study|Commercial drug available|1|||
170898060|NCT03371355|617632360|FG001|Overall Study|Adverse Event|1|||
170898061|NCT03371355|617632361|FG002|Overall Study|Adverse Event|2|||
170898062|NCT03371355|617632362|FG003|Overall Study|Adverse Event|3|||
170484518|NCT01707290|616113186|FG000|Overall Study|Other unspecified|17|||
170484519|NCT01707290|616113187|FG001|Overall Study|Other unspecified|0|||
170484520|NCT01198470|616113188|FG000|Overall Study|Adverse Event|2|||
170484521|NCT02314026|616113190|FG000|Overall Study|Protocol Violation|28|||
170484522|NCT01139775|616113191|FG000|Overall Study|Adverse Event|0|||
170484523|NCT01139775|616113192|FG001|Overall Study|Adverse Event|6|||
170898063|NCT03371355|617632359|FG000|Overall Study|Reason not Specified|0|||
170898064|NCT03371355|617632360|FG001|Overall Study|Reason not Specified|1|||
170484524|NCT01139775|616113193|FG002|Overall Study|Adverse Event|2|||
170484525|NCT01139775|616113191|FG000|Overall Study|Protocol Violation|0|||
170484526|NCT01139775|616113192|FG001|Overall Study|Protocol Violation|5|||
170484527|NCT01139775|616113193|FG002|Overall Study|Protocol Violation|0|||
170484528|NCT01139775|616113191|FG000|Overall Study|Withdrawal by Subject|1|||
170484529|NCT01139775|616113192|FG001|Overall Study|Withdrawal by Subject|0|||
170484530|NCT01139775|616113193|FG002|Overall Study|Withdrawal by Subject|2|||
170484531|NCT01139775|616113191|FG000|Overall Study|Physician Decision|0|||
170484532|NCT01139775|616113192|FG001|Overall Study|Physician Decision|2|||
170484533|NCT01139775|616113193|FG002|Overall Study|Physician Decision|2|||
170484534|NCT01882985|616113196|FG000|Overall Study|Lost to Follow-up|1|||
170484535|NCT01882985|616113196|FG000|Overall Study|Withdrawal by Subject|1|||
170484536|NCT03193853|616113203|FG000|Overall Study|Death|6|||
170484537|NCT04129125|616113204|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
170484538|NCT04129125|616113204|FG000|Overall Study|Study device was not used|3|||
170484539|NCT01289678|616113222|FG000|Overall Study|Physician Decision|6|||
170484540|NCT02524847|616113223|FG000|Overall Study|Adverse Event|4|||
170484541|NCT02524847|616113223|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
170484542|NCT02524847|616113223|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
170484543|NCT02524847|616113223|FG000|Overall Study|Death|1|||
170484544|NCT02524847|616113223|FG000|Overall Study|Reason not Specified|1|||
170484545|NCT04564092|616113226|FG000|Overall Study|Withdrawal by Subject|1|||
170484546|NCT02269098|616113227|FG000|Overall Study|Lost to Follow-up|14|||
170484547|NCT02269098|616113228|FG001|Overall Study|Lost to Follow-up|9|||
170484548|NCT01662492|616113231|FG000|Overall Study|Other miscellaneous reasons.|1|||
170484549|NCT01662492|616113232|FG001|Overall Study|Other miscellaneous reasons.|0|||
170484550|NCT01662492|616113233|FG002|Overall Study|Other miscellaneous reasons.|1|||
170484551|NCT01662492|616113231|FG000|Overall Study|Withdrawal by Subject|0|||
170484552|NCT01662492|616113232|FG001|Overall Study|Withdrawal by Subject|0|||
170484553|NCT01662492|616113233|FG002|Overall Study|Withdrawal by Subject|1|||
170484554|NCT01662492|616113231|FG000|Overall Study|Protocol Violation|1|||
170484555|NCT01662492|616113232|FG001|Overall Study|Protocol Violation|0|||
170484556|NCT01662492|616113233|FG002|Overall Study|Protocol Violation|0|||
170484557|NCT01662492|616113231|FG000|Overall Study|Lost to Follow-up|0|||
170484558|NCT01662492|616113232|FG001|Overall Study|Lost to Follow-up|0|||
170484559|NCT01662492|616113233|FG002|Overall Study|Lost to Follow-up|2|||
170484560|NCT01662492|616113231|FG000|Overall Study|Lack of Efficacy|1|||
170484561|NCT01662492|616113232|FG001|Overall Study|Lack of Efficacy|1|||
170484562|NCT01662492|616113233|FG002|Overall Study|Lack of Efficacy|2|||
170484563|NCT01591096|616113234|FG000|Overall Study|Adverse Event|1|||
170484564|NCT01831635|616113235|FG000|Overall Study|Withdrawal by Subject|0|||
170484565|NCT01831635|616113236|FG001|Overall Study|Withdrawal by Subject|2|||
170484566|NCT01831635|616113237|FG002|Overall Study|Withdrawal by Subject|0|||
170484567|NCT01991743|616113238|FG000|Overall Study|external cephalic version not performed|0|||
170484568|NCT01991743|616113239|FG001|Overall Study|external cephalic version not performed|0|||
170484569|NCT01991743|616113240|FG002|Overall Study|external cephalic version not performed|1|||
170484570|NCT01991743|616113241|FG003|Overall Study|external cephalic version not performed|0|||
170484571|NCT02362360|616113252|FG000|Period 1|Lack of Efficacy|1|||
170484572|NCT02362360|616113253|FG001|Period 1|Lack of Efficacy|0|||
170484573|NCT02362360|616113252|FG000|Period 1|Withdrawal by Subject|2|||
170484574|NCT02362360|616113253|FG001|Period 1|Withdrawal by Subject|1|||
170484575|NCT03817190|616113254|FG000|Overall Study|Early Termination|13|||
170484576|NCT03817190|616113255|FG001|Overall Study|Early Termination|20|||
170484577|NCT03817190|616113254|FG000|Overall Study|Adverse Event|10|||
170484578|NCT03817190|616113255|FG001|Overall Study|Adverse Event|17|||
170484579|NCT03817190|616113254|FG000|Overall Study|Withdrawal by Subject|12|||
170484580|NCT03817190|616113255|FG001|Overall Study|Withdrawal by Subject|8|||
170484581|NCT03817190|616113254|FG000|Overall Study|Lost to Follow-up|11|||
170484582|NCT03817190|616113255|FG001|Overall Study|Lost to Follow-up|7|||
170548656|NCT02533674|616354648|FG001|Dose Level II|Withdrawal by Subject|1|||
170484583|NCT03817190|616113254|FG000|Overall Study|Lack of Efficacy|7|||
170484584|NCT03817190|616113255|FG001|Overall Study|Lack of Efficacy|5|||
170484585|NCT03817190|616113254|FG000|Overall Study|Investigator Decision|5|||
170484586|NCT03817190|616113255|FG001|Overall Study|Investigator Decision|1|||
170484587|NCT03817190|616113254|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
170484588|NCT03817190|616113255|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
170484589|NCT03817190|616113254|FG000|Overall Study|Lack of Contact|1|||
170484590|NCT03817190|616113255|FG001|Overall Study|Lack of Contact|0|||
170484591|NCT03817190|616113254|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
170484592|NCT03817190|616113255|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
170484593|NCT01546025|616113256|FG000|Overall Study|Lost to Follow-up|0|||
170484594|NCT01546025|616113257|FG001|Overall Study|Lost to Follow-up|1|||
170484595|NCT04955691|616115195|FG000|Period 2|Discontinued intervention|1|||
170484596|NCT04955691|616115196|FG001|Period 2|Discontinued intervention|2|||
170484597|NCT05336227|616115197|FG000|Overall Study|Adverse Event|1|||
170484598|NCT05336227|616115198|FG001|Overall Study|Adverse Event|0|||
170484599|NCT05336227|616115197|FG000|Overall Study|Lost to Follow-up|2|||
170484600|NCT05336227|616115198|FG001|Overall Study|Lost to Follow-up|0|||
170484601|NCT05336227|616115197|FG000|Overall Study|Withdrawal by Subject|1|||
170484602|NCT05336227|616115198|FG001|Overall Study|Withdrawal by Subject|0|||
170484603|NCT04050462|616115199|FG000|Overall Study|Withdrawal by Subject|1|||
170484604|NCT04050462|616115200|FG001|Overall Study|Withdrawal by Subject|0|||
170484605|NCT04050462|616115201|FG002|Overall Study|Withdrawal by Subject|0|||
170484606|NCT05151744|616115204|FG000|Overall Study|Adverse Event|6|||
170484607|NCT05151744|616115205|FG001|Overall Study|Adverse Event|2|||
170484608|NCT05151744|616115204|FG000|Overall Study|Death|1|||
170484609|NCT05151744|616115205|FG001|Overall Study|Death|2|||
170484610|NCT05151744|616115204|FG000|Overall Study|Lack of Efficacy|1|||
170484611|NCT05151744|616115205|FG001|Overall Study|Lack of Efficacy|1|||
170484612|NCT05151744|616115204|FG000|Overall Study|Lost to Follow-up|2|||
170484613|NCT05151744|616115205|FG001|Overall Study|Lost to Follow-up|2|||
170484614|NCT05151744|616115204|FG000|Overall Study|Need for Rescue Treatment|0|||
170484615|NCT05151744|616115205|FG001|Overall Study|Need for Rescue Treatment|1|||
170484616|NCT05151744|616115204|FG000|Overall Study|Non-compliance with Study Drug|0|||
170484617|NCT05151744|616115205|FG001|Overall Study|Non-compliance with Study Drug|1|||
170484618|NCT05151744|616115204|FG000|Overall Study|Reason not Specified|10|||
170484619|NCT05151744|616115205|FG001|Overall Study|Reason not Specified|0|||
170484620|NCT05151744|616115204|FG000|Overall Study|Physician Decision|2|||
170484621|NCT05151744|616115205|FG001|Overall Study|Physician Decision|1|||
170484622|NCT05151744|616115204|FG000|Overall Study|Protocol Violation|1|||
170484623|NCT05151744|616115205|FG001|Overall Study|Protocol Violation|0|||
170484624|NCT05151744|616115204|FG000|Overall Study|Withdrawal by Subject|6|||
170484625|NCT05151744|616115205|FG001|Overall Study|Withdrawal by Subject|3|||
170484626|NCT04053868|616115206|FG000|Overall Study|Withdrawal by Subject|1|||
170484627|NCT04053868|616115207|FG001|Overall Study|Withdrawal by Subject|0|||
170484628|NCT05731700|616115208|FG000|Overall Study|Death|1|||
170484629|NCT05400655|616115209|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
170484630|NCT05400655|616115210|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
170484631|NCT05400655|616115211|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
170484632|NCT05400655|616115212|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
170484633|NCT05400655|616115213|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
170484634|NCT05400655|616115214|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
170484635|NCT05400655|616115215|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
170484636|NCT05400655|616115216|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
170484637|NCT05400655|616115217|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
170484638|NCT05400655|616115218|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
170484639|NCT05400655|616115219|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
170484640|NCT05400655|616115220|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
170484641|NCT05400655|616115221|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
170484642|NCT05400655|616115222|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
170484643|NCT05400655|616115223|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
170484644|NCT05400655|616115224|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
170484645|NCT05400655|616115225|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
170484646|NCT05400655|616115226|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
170484647|NCT05400655|616115227|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
170484648|NCT05400655|616115228|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
170484649|NCT05400655|616115229|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
170484650|NCT05400655|616115230|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
170484651|NCT05400655|616115209|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484652|NCT05400655|616115210|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484653|NCT05400655|616115211|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484654|NCT05400655|616115212|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484655|NCT05400655|616115213|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484656|NCT05400655|616115214|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484657|NCT05400655|616115215|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484658|NCT05400655|616115216|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484659|NCT05400655|616115217|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484660|NCT05400655|616115218|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484661|NCT05400655|616115219|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484662|NCT05400655|616115220|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484663|NCT05400655|616115221|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
170484664|NCT05400655|616115222|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484665|NCT05400655|616115223|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484666|NCT05400655|616115224|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484667|NCT05400655|616115225|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
170484668|NCT05400655|616115226|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484669|NCT05400655|616115227|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
170484670|NCT05400655|616115228|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
170484671|NCT05400655|616115229|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484672|NCT05400655|616115230|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
170484673|NCT05400655|616115209|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484674|NCT05400655|616115210|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484675|NCT05400655|616115211|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484676|NCT05400655|616115212|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484677|NCT05400655|616115213|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484678|NCT05400655|616115214|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484679|NCT05400655|616115215|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484680|NCT05400655|616115216|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484681|NCT05400655|616115217|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484682|NCT05400655|616115218|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484683|NCT05400655|616115219|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484684|NCT05400655|616115220|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484685|NCT05400655|616115221|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484686|NCT05400655|616115222|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
170484687|NCT05400655|616115223|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484688|NCT05400655|616115224|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484689|NCT05400655|616115225|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
170484690|NCT05400655|616115226|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484691|NCT05400655|616115227|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
170484692|NCT05400655|616115228|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484693|NCT05400655|616115229|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484694|NCT05400655|616115230|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
170484695|NCT05400655|616115209|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484696|NCT05400655|616115210|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484697|NCT05400655|616115211|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484698|NCT05400655|616115212|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484699|NCT05400655|616115213|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484700|NCT05400655|616115214|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484701|NCT05400655|616115215|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484702|NCT05400655|616115216|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484703|NCT05400655|616115217|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484704|NCT05400655|616115218|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484705|NCT05400655|616115219|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484706|NCT05400655|616115220|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484707|NCT05400655|616115221|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484708|NCT05400655|616115222|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484709|NCT05400655|616115223|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484710|NCT05400655|616115224|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484711|NCT05400655|616115225|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
170484712|NCT05400655|616115226|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
170484713|NCT05400655|616115227|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
170484714|NCT05400655|616115228|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
170484715|NCT05400655|616115229|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
170484716|NCT05400655|616115230|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
170484717|NCT05400655|616115209|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484718|NCT05400655|616115210|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484719|NCT05400655|616115211|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484720|NCT05400655|616115212|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484721|NCT05400655|616115213|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484722|NCT05400655|616115214|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484723|NCT05400655|616115215|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484724|NCT05400655|616115216|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484725|NCT05400655|616115217|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484726|NCT05400655|616115218|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484727|NCT05400655|616115219|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484728|NCT05400655|616115220|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484729|NCT05400655|616115221|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484730|NCT05400655|616115222|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484731|NCT05400655|616115223|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484732|NCT05400655|616115224|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484733|NCT05400655|616115225|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484734|NCT05400655|616115226|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
170484735|NCT05400655|616115227|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
170484736|NCT05400655|616115228|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484737|NCT05400655|616115229|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170640439|NCT04080167|616695679|FG001|Overall Study|Death-Patient|1|||
170484738|NCT05400655|616115230|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
170484739|NCT05400655|616115209|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484740|NCT05400655|616115210|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484741|NCT05400655|616115211|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484742|NCT05400655|616115212|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484743|NCT05400655|616115213|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484744|NCT05400655|616115214|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484745|NCT05400655|616115215|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484746|NCT05400655|616115216|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484747|NCT05400655|616115217|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484748|NCT05400655|616115218|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484749|NCT05400655|616115219|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484750|NCT05400655|616115220|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484751|NCT05400655|616115221|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484752|NCT05400655|616115222|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484753|NCT05400655|616115223|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484754|NCT05400655|616115224|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484755|NCT05400655|616115225|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
170484756|NCT05400655|616115226|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
170484757|NCT05400655|616115227|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
170484758|NCT05400655|616115228|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
170484759|NCT05400655|616115229|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
170484760|NCT05400655|616115230|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
170484761|NCT01682226|616115233|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
170484762|NCT01682226|616115233|FG000|Overall Study|Participants did not receive treatment|2|||
170484763|NCT01682226|616115233|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
170484764|NCT03135548|616115245|FG000|Overall Study|Lost to Follow-up|3|||
170484765|NCT03135548|616115246|FG001|Overall Study|Lost to Follow-up|0|||
170484766|NCT03135548|616115247|FG002|Overall Study|Lost to Follow-up|0|||
170484767|NCT03135548|616115245|FG000|Overall Study|Withdrawal by Subject|2|||
170484768|NCT03135548|616115246|FG001|Overall Study|Withdrawal by Subject|2|||
170484769|NCT03135548|616115247|FG002|Overall Study|Withdrawal by Subject|1|||
170484770|NCT03135548|616115245|FG000|Overall Study|Other than listed|0|||
170484771|NCT03135548|616115246|FG001|Overall Study|Other than listed|2|||
170484772|NCT03135548|616115247|FG002|Overall Study|Other than listed|2|||
170484773|NCT02632175|616115248|FG000|Overall Study|Withdrawal by Subject|6|||
170484774|NCT02632175|616115248|FG000|Overall Study|Lost to Follow-up|1|||
170484775|NCT02632175|616115248|FG000|Overall Study|Lack of Efficacy|18|||
170484776|NCT02632175|616115248|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
170484777|NCT02632175|616115248|FG000|Overall Study|Subject noncompliance|3|||
170484778|NCT02632175|616115248|FG000|Overall Study|other|2|||
170484779|NCT02088554|616115249|FG000|Overall Study|Exited before procedure|130|||
170484780|NCT02088554|616115249|FG000|Overall Study|Attempted but not implanted|31|||
170484781|NCT02088554|616115249|FG000|Overall Study|Implant not attempted|19|||
170484782|NCT02088554|616115249|FG000|Overall Study|Pending next visit|532|||
170484783|NCT02088554|616115249|FG000|Overall Study|Death|170|||
170484784|NCT02088554|616115249|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
170484785|NCT02088554|616115249|FG000|Overall Study|Lost to Follow-up|23|||
170484786|NCT02088554|616115249|FG000|Overall Study|Explanted|32|||
170484787|NCT02088554|616115249|FG000|Overall Study|Any other reason not covered by previous categories|11|||
170484788|NCT04623216|616115250|FG000|Overall Study|Death|5|||
170484789|NCT04623216|616115251|FG001|Overall Study|Death|2|||
170484790|NCT04623216|616115252|FG002|Overall Study|Death|0|||
170484791|NCT04623216|616115253|FG003|Overall Study|Death|0|||
170484792|NCT04623216|616115250|FG000|Overall Study|Terminated by Sponsor|3|||
170484793|NCT04623216|616115251|FG001|Overall Study|Terminated by Sponsor|2|||
170484794|NCT04623216|616115252|FG002|Overall Study|Terminated by Sponsor|2|||
170484795|NCT04623216|616115253|FG003|Overall Study|Terminated by Sponsor|0|||
170484796|NCT04623216|616115250|FG000|Overall Study|Physician Decision|1|||
170484797|NCT04623216|616115251|FG001|Overall Study|Physician Decision|0|||
170484798|NCT04623216|616115252|FG002|Overall Study|Physician Decision|0|||
170484799|NCT04623216|616115253|FG003|Overall Study|Physician Decision|0|||
170484800|NCT03521154|616115256|FG000|Overall Study|Ongoing study at data cut-off|111|||
170484801|NCT03521154|616115257|FG001|Overall Study|Ongoing study at data cut-off|52|||
170484802|NCT04632927|616115258|FG000|Overall Study|Adverse Event|0|||
170484803|NCT04632927|616115259|FG001|Overall Study|Adverse Event|1|||
170484804|NCT04632927|616115258|FG000|Overall Study|Lack of Efficacy|0|||
170484805|NCT04632927|616115259|FG001|Overall Study|Lack of Efficacy|4|||
170484806|NCT04632927|616115258|FG000|Overall Study|Loss of efficacy|0|||
170640440|NCT04080167|616695680|FG002|Overall Study|Death-Patient|0|||
170640441|NCT04080167|616695678|FG000|Overall Study|Hydroxyurea New Starts|0|||
170484807|NCT04632927|616115259|FG001|Overall Study|Loss of efficacy|1|||
170484808|NCT04632927|616115258|FG000|Overall Study|Non-compliance with study drug|0|||
170484809|NCT04632927|616115259|FG001|Overall Study|Non-compliance with study drug|1|||
170484810|NCT04632927|616115258|FG000|Overall Study|Physician Decision|0|||
170484811|NCT04632927|616115259|FG001|Overall Study|Physician Decision|1|||
170484812|NCT04632927|616115258|FG000|Overall Study|Subject decision|0|||
170484813|NCT04632927|616115259|FG001|Overall Study|Subject decision|1|||
170484814|NCT04632927|616115258|FG000|Overall Study|Withdrawal by Subject|0|||
170484815|NCT04632927|616115259|FG001|Overall Study|Withdrawal by Subject|1|||
170484816|NCT03827291|616115260|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
170484817|NCT03827291|616115261|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
170484818|NCT05271370|616115264|FG000|Overall Study|Study early termination|8|||
170484819|NCT05271370|616115265|FG001|Overall Study|Study early termination|16|||
170484820|NCT05271370|616115266|FG002|Overall Study|Study early termination|29|||
170484821|NCT04066244|616115280|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
170484822|NCT04066244|616115281|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
170484823|NCT04066244|616115282|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
170484824|NCT04066244|616115283|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
170484825|NCT04066244|616115284|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
170484826|NCT04066244|616115285|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
170484827|NCT04066244|616115280|FG000|Part 2 (Cohort 5)|Death|0|||
170484828|NCT04066244|616115281|FG001|Part 2 (Cohort 5)|Death|0|||
170484829|NCT04066244|616115282|FG002|Part 2 (Cohort 5)|Death|0|||
170484830|NCT04066244|616115283|FG003|Part 2 (Cohort 5)|Death|0|||
170484831|NCT04066244|616115284|FG004|Part 2 (Cohort 5)|Death|0|||
170484832|NCT04066244|616115285|FG005|Part 2 (Cohort 5)|Death|2|||
170484833|NCT04066244|616115280|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
170484834|NCT04066244|616115281|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
170484835|NCT04066244|616115282|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
170484836|NCT04066244|616115283|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
170484837|NCT04066244|616115284|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
170484838|NCT04066244|616115285|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
170484839|NCT04066244|616115280|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
170484840|NCT04066244|616115281|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
170484841|NCT04066244|616115282|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
170484842|NCT04066244|616115283|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
170484843|NCT04066244|616115284|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
170484844|NCT04066244|616115285|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
170484845|NCT02283268|616115288|FG000|Overall Study|Withdrawal by Subject|1|||
170484846|NCT02770170|616115289|FG000|Overall Study|Withdrawal by Subject|0|||
170484847|NCT02770170|616115290|FG001|Overall Study|Withdrawal by Subject|0|||
170484848|NCT02770170|616115291|FG002|Overall Study|Withdrawal by Subject|0|||
170484849|NCT02770170|616115292|FG003|Overall Study|Withdrawal by Subject|2|||
170484850|NCT02770170|616115289|FG000|Overall Study|due to pregnancy|1|||
170484851|NCT02770170|616115290|FG001|Overall Study|due to pregnancy|0|||
170484852|NCT02770170|616115291|FG002|Overall Study|due to pregnancy|0|||
170484853|NCT02770170|616115292|FG003|Overall Study|due to pregnancy|0|||
170484854|NCT02770170|616115289|FG000|Overall Study|Lack of Efficacy|2|||
170484855|NCT02770170|616115290|FG001|Overall Study|Lack of Efficacy|0|||
170484856|NCT02770170|616115291|FG002|Overall Study|Lack of Efficacy|0|||
170484857|NCT02770170|616115292|FG003|Overall Study|Lack of Efficacy|1|||
170484858|NCT02770170|616115289|FG000|Overall Study|Adverse Event|4|||
170484859|NCT02770170|616115290|FG001|Overall Study|Adverse Event|3|||
170484860|NCT02770170|616115291|FG002|Overall Study|Adverse Event|5|||
170484861|NCT02770170|616115292|FG003|Overall Study|Adverse Event|3|||
170484862|NCT02770170|616115289|FG000|Overall Study|due to disease worsening|0|||
170898065|NCT03371355|617632361|FG002|Overall Study|Reason not Specified|0|||
170898066|NCT03371355|617632362|FG003|Overall Study|Reason not Specified|1|||
170898067|NCT01662648|617632363|FG000|Overall Study|Death|1|||
170898068|NCT01662648|617632364|FG001|Overall Study|Death|3|||
170898069|NCT01662648|617632363|FG000|Overall Study|Adverse Event|40|||
170898070|NCT01662648|617632364|FG001|Overall Study|Adverse Event|37|||
170484863|NCT02770170|616115290|FG001|Overall Study|due to disease worsening|0|||
170484864|NCT02770170|616115291|FG002|Overall Study|due to disease worsening|0|||
170484865|NCT02770170|616115292|FG003|Overall Study|due to disease worsening|1|||
170484866|NCT03270657|616115293|FG000|Overall Study|Withdrawal by Subject|1|||
170484867|NCT00162981|616115294|FG000|Overall Study|Adverse Event|2|||
170484868|NCT00162981|616115295|FG001|Overall Study|Adverse Event|5|||
170484869|NCT00162981|616115294|FG000|Overall Study|Withdrawal by Subject|1|||
170484870|NCT00162981|616115295|FG001|Overall Study|Withdrawal by Subject|1|||
170548657|NCT02533674|616354649|FG002|Dose Level II|Withdrawal by Subject|0|||
170548658|NCT02533674|616354650|FG003|Dose Level II|Withdrawal by Subject|0|||
170548659|NCT02533674|616354651|FG004|Dose Level II|Withdrawal by Subject|0|||
170898071|NCT01662648|617632363|FG000|Overall Study|Lack of Efficacy|17|||
170484871|NCT00162981|616115294|FG000|Overall Study|Physician Decision|1|||
170484872|NCT00162981|616115295|FG001|Overall Study|Physician Decision|0|||
170484873|NCT00391768|616115296|FG000|Overall Study|Withdrawal by Subject|0|||
170484874|NCT00391768|616115297|FG001|Overall Study|Withdrawal by Subject|0|||
170484875|NCT00391768|616115298|FG002|Overall Study|Withdrawal by Subject|1|||
170484876|NCT00391768|616115299|FG003|Overall Study|Withdrawal by Subject|0|||
170484877|NCT00391768|616115300|FG004|Overall Study|Withdrawal by Subject|0|||
170484878|NCT00391768|616115301|FG005|Overall Study|Withdrawal by Subject|1|||
170484879|NCT00391768|616115302|FG006|Overall Study|Withdrawal by Subject|1|||
170484880|NCT00391768|616115296|FG000|Overall Study|Lost to Follow-up|0|||
170484881|NCT00391768|616115297|FG001|Overall Study|Lost to Follow-up|0|||
170484882|NCT00391768|616115298|FG002|Overall Study|Lost to Follow-up|0|||
170484883|NCT00391768|616115299|FG003|Overall Study|Lost to Follow-up|1|||
170484884|NCT00391768|616115300|FG004|Overall Study|Lost to Follow-up|2|||
170484885|NCT00391768|616115301|FG005|Overall Study|Lost to Follow-up|2|||
170484886|NCT00391768|616115302|FG006|Overall Study|Lost to Follow-up|3|||
170484887|NCT03877068|616115303|FG000|Overall Study|Physician Decision|9|||
170484888|NCT03877068|616115304|FG001|Overall Study|Physician Decision|3|||
170484889|NCT01620138|616115308|FG000|Overall Study|Withdrawal by Subject|3|||
170484890|NCT01620138|616115309|FG001|Overall Study|Withdrawal by Subject|0|||
170484891|NCT01620138|616115308|FG000|Overall Study|Lack of Efficacy|1|||
170484892|NCT01620138|616115309|FG001|Overall Study|Lack of Efficacy|0|||
170484893|NCT01620138|616115308|FG000|Overall Study|Adverse Event|2|||
170484894|NCT01620138|616115309|FG001|Overall Study|Adverse Event|0|||
170484895|NCT01082328|616115310|FG000|Overall Study|Adverse Event|1|||
170484896|NCT00449865|616115313|FG000|Overall Study|Withdrawal by Subject|110|||
170484897|NCT00449865|616115314|FG001|Overall Study|Withdrawal by Subject|110|||
170484898|NCT00449865|616115313|FG000|Overall Study|Lost to Follow-up|36|||
170484899|NCT00449865|616115314|FG001|Overall Study|Lost to Follow-up|37|||
170484900|NCT00449865|616115313|FG000|Overall Study|Physician Decision|13|||
170484901|NCT00449865|616115314|FG001|Overall Study|Physician Decision|12|||
170484902|NCT00449865|616115313|FG000|Overall Study|Death|31|||
170484903|NCT00449865|616115314|FG001|Overall Study|Death|40|||
170484904|NCT00449865|616115313|FG000|Overall Study|Protocol Violation|8|||
170484905|NCT00449865|616115314|FG001|Overall Study|Protocol Violation|7|||
170484906|NCT00449865|616115313|FG000|Overall Study|Study was stopped|324|||
170484907|NCT00449865|616115314|FG001|Overall Study|Study was stopped|328|||
170484908|NCT00406367|616115315|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
170484909|NCT00406367|616115316|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
170484910|NCT00406367|616115315|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
170484911|NCT00406367|616115316|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
170484912|NCT00406367|616115315|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
170484913|NCT00406367|616115316|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
170484914|NCT00406367|616115315|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
170484915|NCT00406367|616115316|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
170484916|NCT00406367|616115315|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
170484917|NCT00406367|616115316|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
170484918|NCT00406367|616115315|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
170484919|NCT00406367|616115316|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
170484920|NCT00406367|616115315|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
170484921|NCT00406367|616115316|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
170484922|NCT00406367|616115315|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
170484923|NCT00406367|616115316|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
170484924|NCT00406367|616115315|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
170484925|NCT00406367|616115316|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
170484926|NCT00406367|616115315|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
170484927|NCT00406367|616115316|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
170484928|NCT00406367|616115315|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
170484929|NCT00406367|616115316|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
170484930|NCT00406367|616115315|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
170484931|NCT00406367|616115316|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
170484932|NCT03187301|616115319|FG000|Titration Period|Adverse Event|0|||
170484933|NCT03187301|616115320|FG001|Titration Period|Adverse Event|0|||
170484934|NCT03187301|616115321|FG002|Titration Period|Adverse Event|0|||
170484935|NCT03187301|616115322|FG003|Titration Period|Adverse Event|0|||
170484936|NCT03187301|616115323|FG004|Titration Period|Adverse Event|0|||
170484937|NCT03187301|616115324|FG005|Titration Period|Adverse Event|0|||
170548660|NCT02533674|616354652|FG005|Dose Level II|Withdrawal by Subject|0|||
170548661|NCT02533674|616354653|FG006|Dose Level II|Withdrawal by Subject|0|||
170548662|NCT02533674|616354654|FG007|Dose Level II|Withdrawal by Subject|0|||
170548663|NCT02533674|616354647|FG000|Dose Level II|Treatment-related AE|0|||
170548664|NCT02533674|616354648|FG001|Dose Level II|Treatment-related AE|1|||
170484938|NCT03187301|616115325|FG006|Titration Period|Adverse Event|5|||
170484939|NCT03187301|616115319|FG000|Titration Period|Withdrawal by Subject|0|||
170484940|NCT03187301|616115320|FG001|Titration Period|Withdrawal by Subject|0|||
170484941|NCT03187301|616115321|FG002|Titration Period|Withdrawal by Subject|0|||
170484942|NCT03187301|616115322|FG003|Titration Period|Withdrawal by Subject|0|||
170898072|NCT01662648|617632364|FG001|Overall Study|Lack of Efficacy|16|||
170898073|NCT01662648|617632363|FG000|Overall Study|Participant ineligible to continue trial|1|||
170898074|NCT01662648|617632364|FG001|Overall Study|Participant ineligible to continue trial|1|||
170898075|NCT01662648|617632363|FG000|Overall Study|Lost to Follow-up|24|||
170898076|NCT01662648|617632364|FG001|Overall Study|Lost to Follow-up|36|||
170484943|NCT03187301|616115323|FG004|Titration Period|Withdrawal by Subject|0|||
170484944|NCT03187301|616115324|FG005|Titration Period|Withdrawal by Subject|0|||
170484945|NCT03187301|616115325|FG006|Titration Period|Withdrawal by Subject|1|||
170484946|NCT03187301|616115319|FG000|Titration Period|Exclusion Criteria Met|0|||
170484947|NCT03187301|616115320|FG001|Titration Period|Exclusion Criteria Met|0|||
170484948|NCT03187301|616115321|FG002|Titration Period|Exclusion Criteria Met|0|||
170484949|NCT03187301|616115322|FG003|Titration Period|Exclusion Criteria Met|0|||
170484950|NCT03187301|616115323|FG004|Titration Period|Exclusion Criteria Met|0|||
170484951|NCT03187301|616115324|FG005|Titration Period|Exclusion Criteria Met|0|||
170484952|NCT03187301|616115325|FG006|Titration Period|Exclusion Criteria Met|1|||
170484953|NCT03187301|616115319|FG000|Pre-Intervention|Withdrawal by Subject|1|||
170484954|NCT03187301|616115320|FG001|Pre-Intervention|Withdrawal by Subject|0|||
170484955|NCT03187301|616115321|FG002|Pre-Intervention|Withdrawal by Subject|0|||
170484956|NCT03187301|616115322|FG003|Pre-Intervention|Withdrawal by Subject|0|||
170484957|NCT03187301|616115323|FG004|Pre-Intervention|Withdrawal by Subject|0|||
170484958|NCT03187301|616115324|FG005|Pre-Intervention|Withdrawal by Subject|0|||
170484959|NCT03187301|616115325|FG006|Pre-Intervention|Withdrawal by Subject|0|||
170484960|NCT01966120|616115328|FG000|Overall Study|Withdrawal by Subject|0|||
170484961|NCT01966120|616115329|FG001|Overall Study|Withdrawal by Subject|5|||
170484962|NCT01966120|616115328|FG000|Overall Study|Lost to Follow-up|1|||
170484963|NCT01966120|616115329|FG001|Overall Study|Lost to Follow-up|1|||
170484964|NCT03866512|616115330|FG000|Overall Study|Lost to Follow-up|1|||
170484965|NCT03866512|616115331|FG001|Overall Study|Lost to Follow-up|2|||
170484966|NCT03866512|616115332|FG002|Overall Study|Lost to Follow-up|1|||
170484967|NCT03866512|616115330|FG000|Overall Study|Cannulation issues|0|||
170484968|NCT03866512|616115331|FG001|Overall Study|Cannulation issues|1|||
170484969|NCT03866512|616115332|FG002|Overall Study|Cannulation issues|2|||
170484970|NCT03376789|616115333|FG000|Overall Study|Withdrawal by Subject|3|||
170484971|NCT03376789|616115334|FG001|Overall Study|Withdrawal by Subject|5|||
170484972|NCT03376789|616115333|FG000|Overall Study|Protocol Violation|0|||
170484973|NCT03376789|616115334|FG001|Overall Study|Protocol Violation|1|||
170484974|NCT03376789|616115333|FG000|Overall Study|Adverse Event|0|||
170484975|NCT03376789|616115334|FG001|Overall Study|Adverse Event|1|||
170484976|NCT03376789|616115333|FG000|Overall Study|Lost to Follow-up|1|||
170484977|NCT03376789|616115334|FG001|Overall Study|Lost to Follow-up|1|||
170484978|NCT03376789|616115333|FG000|Overall Study|Per sponsor due to noncompliance|1|||
170484979|NCT03376789|616115334|FG001|Overall Study|Per sponsor due to noncompliance|0|||
170484980|NCT03376789|616115333|FG000|Overall Study|Subject off study medication|0|||
170484981|NCT03376789|616115334|FG001|Overall Study|Subject off study medication|1|||
170484982|NCT02042014|616115337|FG000|Overall Study|Adverse Event|1|||
170484983|NCT02042014|616115337|FG000|Overall Study|Physician Decision|7|||
170484984|NCT00561392|616115344|FG000|Overall Study|Adverse Event|38|||
170484985|NCT00561392|616115344|FG000|Overall Study|Lack of Efficacy|2|||
170484986|NCT00561392|616115344|FG000|Overall Study|Protocol Violation|1|||
170484987|NCT00561392|616115344|FG000|Overall Study|Withdrawal by Subject|8|||
170484988|NCT00561392|616115344|FG000|Overall Study|Administrative problems|4|||
170484989|NCT03321968|616115345|FG000|Overall Study|Withdrawal by Subject|1|||
170484990|NCT03321968|616115346|FG001|Overall Study|Withdrawal by Subject|2|||
170484991|NCT03321968|616115347|FG002|Overall Study|Withdrawal by Subject|1|||
170484992|NCT03321968|616115345|FG000|Overall Study|Lost to Follow-up|2|||
170484993|NCT03321968|616115346|FG001|Overall Study|Lost to Follow-up|0|||
170484994|NCT03321968|616115347|FG002|Overall Study|Lost to Follow-up|1|||
170484995|NCT03321968|616115345|FG000|Overall Study|Other than specified|0|||
170484996|NCT03321968|616115346|FG001|Overall Study|Other than specified|0|||
170484997|NCT03321968|616115347|FG002|Overall Study|Other than specified|1|||
170548665|NCT02533674|616354649|FG002|Dose Level II|Treatment-related AE|0|||
170548666|NCT02533674|616354650|FG003|Dose Level II|Treatment-related AE|0|||
170548667|NCT02533674|616354651|FG004|Dose Level II|Treatment-related AE|0|||
170548668|NCT02533674|616354652|FG005|Dose Level II|Treatment-related AE|0|||
170548669|NCT02533674|616354653|FG006|Dose Level II|Treatment-related AE|0|||
170548670|NCT02533674|616354654|FG007|Dose Level II|Treatment-related AE|0|||
170898077|NCT01662648|617632363|FG000|Overall Study|Withdrawal by Subject|36|||
170484998|NCT03822468|616115348|FG000|Treatment Period|Progressive disease|98|||
170484999|NCT03822468|616115349|FG001|Treatment Period|Progressive disease|94|||
170485000|NCT03822468|616115348|FG000|Treatment Period|Adverse Event|21|||
170548671|NCT02533674|616354647|FG000|Dose Level II|Physician Decision|0|||
170485001|NCT03822468|616115349|FG001|Treatment Period|Adverse Event|24|||
170485002|NCT03822468|616115348|FG000|Treatment Period|Withdrawal by Subject|9|||
170485003|NCT03822468|616115349|FG001|Treatment Period|Withdrawal by Subject|5|||
170548672|NCT02533674|616354648|FG001|Dose Level II|Physician Decision|1|||
170548673|NCT02533674|616354649|FG002|Dose Level II|Physician Decision|0|||
170485004|NCT03822468|616115348|FG000|Treatment Period|Physician Decision|9|||
170485005|NCT03822468|616115349|FG001|Treatment Period|Physician Decision|7|||
170485006|NCT03822468|616115348|FG000|Treatment Period|Protocol Violation|2|||
170485007|NCT03822468|616115349|FG001|Treatment Period|Protocol Violation|1|||
170485008|NCT03822468|616115348|FG000|Treatment Period|Death|2|||
170485009|NCT03822468|616115349|FG001|Treatment Period|Death|3|||
170485010|NCT03822468|616115348|FG000|Treatment Period|Lost to Follow-up|1|||
170485011|NCT03822468|616115349|FG001|Treatment Period|Lost to Follow-up|1|||
170485012|NCT03822468|616115348|FG000|Treatment Period|Sponsor decision|46|||
170485013|NCT03822468|616115349|FG001|Treatment Period|Sponsor decision|53|||
170485014|NCT03822468|616115348|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
170485015|NCT03822468|616115349|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
170485016|NCT03822468|616115348|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
170485017|NCT03822468|616115349|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
170485018|NCT03822468|616115348|FG000|Post-treatment Efficacy Follow-up|Death|1|||
170485019|NCT03822468|616115349|FG001|Post-treatment Efficacy Follow-up|Death|0|||
170485020|NCT03822468|616115348|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
170485021|NCT03822468|616115349|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
170485022|NCT03822468|616115348|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
170485023|NCT03822468|616115349|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170485024|NCT03822468|616115348|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
170485025|NCT03822468|616115349|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170485026|NCT03822468|616115348|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
170485027|NCT03822468|616115349|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
170485028|NCT02282813|616115352|FG000|Overall Study|Withdrawal by Subject|4|||
170485029|NCT02282813|616115353|FG001|Overall Study|Withdrawal by Subject|5|||
170485030|NCT02282813|616115354|FG002|Overall Study|Withdrawal by Subject|0|||
170485031|NCT02282813|616115352|FG000|Overall Study|Adverse Event|3|||
170485032|NCT02282813|616115353|FG001|Overall Study|Adverse Event|10|||
170485033|NCT02282813|616115354|FG002|Overall Study|Adverse Event|1|||
170485034|NCT02282813|616115352|FG000|Overall Study|Subject non-compliance|1|||
170485035|NCT02282813|616115353|FG001|Overall Study|Subject non-compliance|4|||
170485036|NCT02282813|616115354|FG002|Overall Study|Subject non-compliance|0|||
170485037|NCT02282813|616115352|FG000|Overall Study|Physician Decision|0|||
170485038|NCT02282813|616115353|FG001|Overall Study|Physician Decision|3|||
170485039|NCT02282813|616115354|FG002|Overall Study|Physician Decision|1|||
170485040|NCT02282813|616115352|FG000|Overall Study|Lost to Follow-up|2|||
170485041|NCT02282813|616115353|FG001|Overall Study|Lost to Follow-up|0|||
170485042|NCT02282813|616115354|FG002|Overall Study|Lost to Follow-up|1|||
170485043|NCT02282813|616115352|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
170485044|NCT02282813|616115353|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
170485045|NCT02282813|616115354|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
170485046|NCT02282813|616115352|FG000|Overall Study|Lack of Efficacy|1|||
170485047|NCT02282813|616115353|FG001|Overall Study|Lack of Efficacy|0|||
170485048|NCT02282813|616115354|FG002|Overall Study|Lack of Efficacy|0|||
170485049|NCT02282813|616115352|FG000|Overall Study|Administrative reasons|0|||
170485050|NCT02282813|616115353|FG001|Overall Study|Administrative reasons|1|||
170485051|NCT02282813|616115354|FG002|Overall Study|Administrative reasons|0|||
170485052|NCT02198664|616115355|FG000|Overall Study|Adverse Event|2|||
170485053|NCT02198664|616115356|FG001|Overall Study|Adverse Event|0|||
170485054|NCT02198664|616115355|FG000|Overall Study|Withdrawal by Subject|11|||
170485055|NCT02198664|616115356|FG001|Overall Study|Withdrawal by Subject|8|||
170485056|NCT02198664|616115355|FG000|Overall Study|Failure to tolerate|2|||
170485057|NCT02198664|616115356|FG001|Overall Study|Failure to tolerate|0|||
170485058|NCT02198664|616115355|FG000|Overall Study|Not stated|1|||
170485059|NCT02198664|616115356|FG001|Overall Study|Not stated|0|||
170485060|NCT00529308|616115357|FG000|Overall Study|Withdrawal by Subject|1|||
170485061|NCT00529308|616115358|FG001|Overall Study|Withdrawal by Subject|1|||
170485062|NCT02883062|616115361|FG000|Overall Study|Withdrawal by Subject|6|||
170485063|NCT02883062|616115362|FG001|Overall Study|Withdrawal by Subject|0|||
170485064|NCT04426006|616115363|FG000|Inclusion|Protocol Violation|1|||
170485065|NCT04426006|616115363|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
170485066|NCT04426006|616115363|FG000|Inclusion|Blood sample at inclusion not done|1|||
170485067|NCT04426006|616115363|FG000|3 Months|Lost to Follow-up|17|||
170485068|NCT04426006|616115363|FG000|12 Months|Lost to Follow-up|38|||
170485069|NCT01420068|616115366|FG000|Overall Study|Administrative problems|1|||
170548674|NCT02533674|616354650|FG003|Dose Level II|Physician Decision|0|||
170548675|NCT02533674|616354651|FG004|Dose Level II|Physician Decision|0|||
170548676|NCT02533674|616354652|FG005|Dose Level II|Physician Decision|0|||
170548677|NCT02533674|616354653|FG006|Dose Level II|Physician Decision|0|||
170548678|NCT02533674|616354654|FG007|Dose Level II|Physician Decision|0|||
170485070|NCT01420068|616115367|FG001|Overall Study|Administrative problems|3|||
170485071|NCT01420068|616115366|FG000|Overall Study|Withdrawal by Subject|1|||
170485072|NCT01420068|616115367|FG001|Overall Study|Withdrawal by Subject|2|||
170485073|NCT00365794|616115368|FG000|Overall Study|Withdrawal by Subject|2|||
170485074|NCT00745901|616115369|FG000|Overall Study|Adverse Event|3|||
170485075|NCT00745901|616115370|FG001|Overall Study|Adverse Event|4|||
170485076|NCT00745901|616115369|FG000|Overall Study|Protocol Violation|0|||
170485077|NCT00745901|616115370|FG001|Overall Study|Protocol Violation|1|||
170485078|NCT00745901|616115369|FG000|Overall Study|Withdrawal by Subject|1|||
170485079|NCT00745901|616115370|FG001|Overall Study|Withdrawal by Subject|0|||
170485080|NCT00745901|616115369|FG000|Overall Study|Lost to Follow-up|7|||
170485081|NCT00745901|616115370|FG001|Overall Study|Lost to Follow-up|4|||
170485082|NCT00745901|616115369|FG000|Overall Study|Pregnancy|2|||
170485083|NCT00745901|616115370|FG001|Overall Study|Pregnancy|4|||
170485084|NCT00745901|616115369|FG000|Overall Study|Lack of compliance|2|||
170485085|NCT00745901|616115370|FG001|Overall Study|Lack of compliance|2|||
170485086|NCT00745901|616115369|FG000|Overall Study|Patient's next menses did not start with|1|||
170485087|NCT00745901|616115370|FG001|Overall Study|Patient's next menses did not start with|0|||
170485088|NCT00745901|616115369|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
170485089|NCT00745901|616115370|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
170485090|NCT00745901|616115369|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
170485091|NCT00745901|616115370|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
170485092|NCT00745901|616115369|FG000|Overall Study|Patient didn't take any study medication|7|||
170485093|NCT00745901|616115370|FG001|Overall Study|Patient didn't take any study medication|3|||
170485094|NCT02554682|616115371|FG000|Overall Study|Lost to Follow-up|11|||
170485095|NCT02554682|616115372|FG001|Overall Study|Lost to Follow-up|9|||
170485096|NCT02554682|616115373|FG002|Overall Study|Lost to Follow-up|4|||
170485097|NCT02554682|616115374|FG003|Overall Study|Lost to Follow-up|3|||
170485098|NCT02554682|616115375|FG004|Overall Study|Lost to Follow-up|2|||
170485099|NCT02554682|616115376|FG005|Overall Study|Lost to Follow-up|1|||
170485100|NCT02554682|616115377|FG006|Overall Study|Lost to Follow-up|6|||
170485101|NCT02554682|616115378|FG007|Overall Study|Lost to Follow-up|6|||
170485102|NCT02554682|616115379|FG008|Overall Study|Lost to Follow-up|2|||
170485103|NCT02554682|616115380|FG009|Overall Study|Lost to Follow-up|2|||
170485104|NCT02554682|616115371|FG000|Overall Study|Withdrawal by Subject|2|||
170485105|NCT02554682|616115372|FG001|Overall Study|Withdrawal by Subject|1|||
170485106|NCT02554682|616115373|FG002|Overall Study|Withdrawal by Subject|0|||
170485107|NCT02554682|616115374|FG003|Overall Study|Withdrawal by Subject|0|||
170485108|NCT02554682|616115375|FG004|Overall Study|Withdrawal by Subject|0|||
170485109|NCT02554682|616115376|FG005|Overall Study|Withdrawal by Subject|0|||
170485110|NCT02554682|616115377|FG006|Overall Study|Withdrawal by Subject|0|||
170485111|NCT02554682|616115378|FG007|Overall Study|Withdrawal by Subject|0|||
170485112|NCT02554682|616115379|FG008|Overall Study|Withdrawal by Subject|0|||
170485113|NCT02554682|616115380|FG009|Overall Study|Withdrawal by Subject|0|||
170485114|NCT02554682|616115371|FG000|Overall Study|Physician Decision|2|||
170485115|NCT02554682|616115372|FG001|Overall Study|Physician Decision|2|||
170485116|NCT02554682|616115373|FG002|Overall Study|Physician Decision|0|||
170485117|NCT02554682|616115374|FG003|Overall Study|Physician Decision|0|||
170485118|NCT02554682|616115375|FG004|Overall Study|Physician Decision|0|||
170485119|NCT02554682|616115376|FG005|Overall Study|Physician Decision|0|||
170485120|NCT02554682|616115377|FG006|Overall Study|Physician Decision|0|||
170485121|NCT02554682|616115378|FG007|Overall Study|Physician Decision|0|||
170485122|NCT02554682|616115379|FG008|Overall Study|Physician Decision|0|||
170485123|NCT02554682|616115380|FG009|Overall Study|Physician Decision|0|||
170485124|NCT00884117|616115381|FG000|Overall Study|Adverse Event|2|||
170485125|NCT00884117|616115381|FG000|Overall Study|Withdrawal by Subject|89|||
170485126|NCT00884117|616115381|FG000|Overall Study|Death|3|||
170485127|NCT00884117|616115381|FG000|Overall Study|Lost to Follow-up|143|||
170485128|NCT00884117|616115381|FG000|Overall Study|Other|12|||
170485129|NCT02946463|616115382|FG000|Primary Evaluation Period|Physician Decision|0|||
170485130|NCT02946463|616115383|FG001|Primary Evaluation Period|Physician Decision|1|||
170485131|NCT02946463|616115384|FG002|Primary Evaluation Period|Physician Decision|0|||
170485132|NCT02946463|616115385|FG003|Primary Evaluation Period|Physician Decision|0|||
170485133|NCT02946463|616115382|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
170485134|NCT02946463|616115383|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
170548679|NCT02533674|616354647|FG000|Dose Level II|Non-treatment-related AE|0|||
170548680|NCT02533674|616354648|FG001|Dose Level II|Non-treatment-related AE|1|||
170548681|NCT02533674|616354649|FG002|Dose Level II|Non-treatment-related AE|0|||
170548682|NCT02533674|616354650|FG003|Dose Level II|Non-treatment-related AE|0|||
170485135|NCT02946463|616115384|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
170485136|NCT02946463|616115385|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
170485137|NCT02946463|616115382|FG000|Extension Period|Death|4|||
170485138|NCT02946463|616115383|FG001|Extension Period|Death|4|||
170485139|NCT02946463|616115384|FG002|Extension Period|Death|0|||
170485140|NCT02946463|616115385|FG003|Extension Period|Death|0|||
170485141|NCT02946463|616115382|FG000|Extension Period|Withdrawal by Subject|4|||
170485142|NCT02946463|616115383|FG001|Extension Period|Withdrawal by Subject|3|||
170485143|NCT02946463|616115384|FG002|Extension Period|Withdrawal by Subject|0|||
170485144|NCT02946463|616115385|FG003|Extension Period|Withdrawal by Subject|0|||
170485145|NCT02946463|616115382|FG000|Extension Period|Other than specified|2|||
170485146|NCT02946463|616115383|FG001|Extension Period|Other than specified|3|||
170485147|NCT02946463|616115384|FG002|Extension Period|Other than specified|2|||
170548683|NCT02533674|616354651|FG004|Dose Level II|Non-treatment-related AE|0|||
170485148|NCT02946463|616115385|FG003|Extension Period|Other than specified|0|||
170485149|NCT02946463|616115382|FG000|Extension Period|Physician Decision|1|||
170485150|NCT02946463|616115383|FG001|Extension Period|Physician Decision|4|||
170485151|NCT02946463|616115384|FG002|Extension Period|Physician Decision|0|||
170485152|NCT02946463|616115385|FG003|Extension Period|Physician Decision|0|||
170485153|NCT02946463|616115382|FG000|Extension Period|Pregnancy|3|||
170485154|NCT02946463|616115383|FG001|Extension Period|Pregnancy|1|||
170485155|NCT02946463|616115384|FG002|Extension Period|Pregnancy|0|||
170485156|NCT02946463|616115385|FG003|Extension Period|Pregnancy|0|||
170485157|NCT02946463|616115382|FG000|Extension Period|Adverse Event|1|||
170485158|NCT02946463|616115383|FG001|Extension Period|Adverse Event|2|||
170485159|NCT02946463|616115384|FG002|Extension Period|Adverse Event|0|||
170485160|NCT02946463|616115385|FG003|Extension Period|Adverse Event|0|||
170485161|NCT02946463|616115382|FG000|Extension Period|Lost to Follow-up|1|||
170485162|NCT02946463|616115383|FG001|Extension Period|Lost to Follow-up|0|||
170485163|NCT02946463|616115384|FG002|Extension Period|Lost to Follow-up|0|||
170485164|NCT02946463|616115385|FG003|Extension Period|Lost to Follow-up|0|||
170485165|NCT00226499|616115389|FG000|Overall Study|Adverse Event|10|||
170485166|NCT00226499|616115390|FG001|Overall Study|Adverse Event|6|||
170485167|NCT00226499|616115391|FG002|Overall Study|Adverse Event|3|||
170485168|NCT00226499|616115389|FG000|Overall Study|Others|1064|||
170485169|NCT00226499|616115390|FG001|Overall Study|Others|1066|||
170485170|NCT00226499|616115391|FG002|Overall Study|Others|356|||
170485171|NCT02859337|616115392|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
170485172|NCT02859337|616115393|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
170485173|NCT02859337|616115394|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
170485174|NCT02859337|616115392|FG000|Overall Study|Withdrawal by Subject|3|||
170485175|NCT02859337|616115393|FG001|Overall Study|Withdrawal by Subject|1|||
170485176|NCT02859337|616115394|FG002|Overall Study|Withdrawal by Subject|0|||
170485177|NCT02859337|616115392|FG000|Overall Study|Lost to Follow-up|1|||
170485178|NCT02859337|616115393|FG001|Overall Study|Lost to Follow-up|0|||
170485179|NCT02859337|616115394|FG002|Overall Study|Lost to Follow-up|0|||
170485180|NCT03123120|616117378|FG000|Overall Study|Lost to Follow-up|0|||
170485181|NCT03123120|616117379|FG001|Overall Study|Lost to Follow-up|1|||
170485182|NCT03123120|616117378|FG000|Overall Study|Withdrawal by Subject|0|||
170485183|NCT03123120|616117379|FG001|Overall Study|Withdrawal by Subject|1|||
170485184|NCT02395848|616117382|FG000|Overall Study|Lost to Follow-up|2|||
170485185|NCT01609010|616117384|FG000|Overall Study|Stable disease (SD)|22|||
170485186|NCT01609010|616117385|FG001|Overall Study|Stable disease (SD)|16|||
170485187|NCT01609010|616117384|FG000|Overall Study|Progressive disease (PD)|8|||
170485188|NCT01609010|616117385|FG001|Overall Study|Progressive disease (PD)|10|||
170485189|NCT01609010|616117384|FG000|Overall Study|Adverse Event|3|||
170485190|NCT01609010|616117385|FG001|Overall Study|Adverse Event|6|||
170485191|NCT01609010|616117384|FG000|Overall Study|Withdrawal by Subject|2|||
170485192|NCT01609010|616117385|FG001|Overall Study|Withdrawal by Subject|2|||
170485193|NCT01609010|616117384|FG000|Overall Study|Other|2|||
170485194|NCT01609010|616117385|FG001|Overall Study|Other|0|||
170485195|NCT01609010|616117384|FG000|Overall Study|Other malignancy|1|||
170485196|NCT01609010|616117385|FG001|Overall Study|Other malignancy|0|||
170798208|NCT02777593|617273637|FG004|Overall Study|Withdrawal by Subject|0|||
170798209|NCT02777593|617273633|FG000|Overall Study|Lost to Follow-up|8|||
170798210|NCT02777593|617273634|FG001|Overall Study|Lost to Follow-up|16|||
170798211|NCT02777593|617273635|FG002|Overall Study|Lost to Follow-up|5|||
170798212|NCT02777593|617273636|FG003|Overall Study|Lost to Follow-up|0|||
170485197|NCT01609010|616117384|FG000|Overall Study|Pathology review|2|||
170485198|NCT01609010|616117385|FG001|Overall Study|Pathology review|1|||
170485199|NCT01609010|616117384|FG000|Overall Study|Protocol Violation|1|||
170485200|NCT01609010|616117385|FG001|Overall Study|Protocol Violation|1|||
170485201|NCT01609010|616117384|FG000|Overall Study|New cancer|1|||
170485202|NCT01609010|616117385|FG001|Overall Study|New cancer|0|||
170485203|NCT01609010|616117384|FG000|Overall Study|Lost to Follow-up|1|||
170485204|NCT01609010|616117385|FG001|Overall Study|Lost to Follow-up|1|||
170485205|NCT01134107|616117386|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
170485206|NCT01134107|616117387|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
170485207|NCT01134107|616117386|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
170485208|NCT01134107|616117387|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
170485209|NCT01134107|616117386|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
170485210|NCT01134107|616117387|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
170798213|NCT02777593|617273637|FG004|Overall Study|Lost to Follow-up|1|||
170485211|NCT01134107|616117386|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
170485212|NCT01134107|616117387|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
170485213|NCT01134107|616117386|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
170798214|NCT02777593|617273633|FG000|Overall Study|Physician Decision|2|||
170485214|NCT01134107|616117387|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
170485215|NCT01134107|616117386|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
170485216|NCT01134107|616117387|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
170485217|NCT01134107|616117386|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
170485218|NCT01134107|616117387|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
170485219|NCT04541589|616117398|FG000|Treatment Period|Adverse Event|8|||
170485220|NCT04541589|616117399|FG001|Treatment Period|Adverse Event|2|||
170485221|NCT04541589|616117398|FG000|Treatment Period|Physician Decision|3|||
170485222|NCT04541589|616117399|FG001|Treatment Period|Physician Decision|1|||
170485223|NCT04541589|616117398|FG000|Treatment Period|Subject decision|7|||
170485224|NCT04541589|616117399|FG001|Treatment Period|Subject decision|4|||
170485225|NCT04541589|616117398|FG000|Treatment Period|Withdrawal by Subject|1|||
170485226|NCT04541589|616117399|FG001|Treatment Period|Withdrawal by Subject|0|||
170485227|NCT04541589|616117398|FG000|Safety Follow-up Period|Adverse Event|2|||
170485228|NCT04541589|616117399|FG001|Safety Follow-up Period|Adverse Event|1|||
170485229|NCT04541589|616117398|FG000|Safety Follow-up Period|Physician Decision|1|||
170485230|NCT04541589|616117399|FG001|Safety Follow-up Period|Physician Decision|0|||
170485231|NCT04541589|616117398|FG000|Safety Follow-up Period|Subject decision|5|||
170485232|NCT04541589|616117399|FG001|Safety Follow-up Period|Subject decision|3|||
170485233|NCT04541589|616117398|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
170485234|NCT04541589|616117399|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
170485235|NCT03581123|616117402|FG000|2-month Follow-up|Withdrawal by Subject|5|||
170485236|NCT03581123|616117403|FG001|2-month Follow-up|Withdrawal by Subject|4|||
170485237|NCT03581123|616117404|FG002|2-month Follow-up|Withdrawal by Subject|6|||
170485238|NCT03581123|616117405|FG003|2-month Follow-up|Withdrawal by Subject|4|||
170485239|NCT03581123|616117402|FG000|2-month Follow-up|Lost to Follow-up|8|||
170485240|NCT03581123|616117403|FG001|2-month Follow-up|Lost to Follow-up|1|||
170485241|NCT03581123|616117404|FG002|2-month Follow-up|Lost to Follow-up|2|||
170485242|NCT03581123|616117405|FG003|2-month Follow-up|Lost to Follow-up|2|||
170485243|NCT03581123|616117402|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
170485244|NCT03581123|616117403|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
170485245|NCT03581123|616117404|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
170485246|NCT03581123|616117405|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
170485247|NCT03581123|616117402|FG000|6-Month Follow-up|Lost to Follow-up|3|||
170485248|NCT03581123|616117403|FG001|6-Month Follow-up|Lost to Follow-up|3|||
170485249|NCT03581123|616117404|FG002|6-Month Follow-up|Lost to Follow-up|1|||
170485250|NCT03581123|616117405|FG003|6-Month Follow-up|Lost to Follow-up|1|||
170485251|NCT03581123|616117402|FG000|12-Month Follow-up|Lost to Follow-up|4|||
170485252|NCT03581123|616117403|FG001|12-Month Follow-up|Lost to Follow-up|3|||
170485253|NCT03581123|616117404|FG002|12-Month Follow-up|Lost to Follow-up|4|||
170485254|NCT03581123|616117405|FG003|12-Month Follow-up|Lost to Follow-up|5|||
170485255|NCT04195685|616117406|FG000|Overall Study|Withdrawal by Subject|6|||
170485256|NCT04195685|616117407|FG001|Overall Study|Withdrawal by Subject|2|||
170485257|NCT04195685|616117406|FG000|Overall Study|Lost to Follow-up|1|||
170485258|NCT04195685|616117407|FG001|Overall Study|Lost to Follow-up|4|||
170485259|NCT00455403|616117409|FG000|Overall Study|Lost to Follow-up|2|||
170485260|NCT00455403|616117410|FG001|Overall Study|Lost to Follow-up|1|||
170485261|NCT00455403|616117409|FG000|Overall Study|Withdrawal by Subject|1|||
170485262|NCT00455403|616117410|FG001|Overall Study|Withdrawal by Subject|3|||
170485263|NCT00455403|616117409|FG000|Overall Study|Protocol Violation|0|||
170485264|NCT00455403|616117410|FG001|Overall Study|Protocol Violation|2|||
170485265|NCT04509076|616117411|FG000|Overall Study|Withdrawal by Subject|1|||
170485266|NCT04509076|616117412|FG001|Overall Study|Withdrawal by Subject|2|||
170485267|NCT04509076|616117411|FG000|Overall Study|Lost to Follow-up|1|||
170485268|NCT04509076|616117412|FG001|Overall Study|Lost to Follow-up|2|||
170485269|NCT00502242|616117422|FG000|Overall Study|Lack of Efficacy|1|||
170485270|NCT00502242|616117423|FG001|Overall Study|Lack of Efficacy|11|||
170485271|NCT00502242|616117422|FG000|Overall Study|Adverse Event|31|||
170485272|NCT00502242|616117423|FG001|Overall Study|Adverse Event|20|||
170485273|NCT00502242|616117422|FG000|Overall Study|Physician Decision|2|||
170485274|NCT00502242|616117423|FG001|Overall Study|Physician Decision|3|||
170485275|NCT00502242|616117422|FG000|Overall Study|Other - Unspecified|8|||
170485276|NCT00502242|616117423|FG001|Overall Study|Other - Unspecified|14|||
170485277|NCT00502242|616117422|FG000|Overall Study|Protocol Violation|3|||
170485278|NCT00502242|616117423|FG001|Overall Study|Protocol Violation|1|||
170485279|NCT00502242|616117422|FG000|Overall Study|Withdrawal by Subject|6|||
170485280|NCT00502242|616117423|FG001|Overall Study|Withdrawal by Subject|7|||
170485281|NCT01671007|616117424|FG000|Overall Study|Other reasons than listed|166|||
170485282|NCT01671007|616117425|FG001|Overall Study|Other reasons than listed|373|||
170485283|NCT01671007|616117426|FG002|Overall Study|Other reasons than listed|197|||
170485284|NCT01671007|616117427|FG003|Overall Study|Other reasons than listed|228|||
170485285|NCT01671007|616117428|FG004|Overall Study|Other reasons than listed|14|||
170485286|NCT01671007|616117429|FG005|Overall Study|Other reasons than listed|71|||
170485287|NCT01671007|616117430|FG006|Overall Study|Other reasons than listed|17|||
170485288|NCT01671007|616117431|FG007|Overall Study|Other reasons than listed|66|||
170485289|NCT01671007|616117432|FG008|Overall Study|Other reasons than listed|0|||
170485290|NCT01671007|616117424|FG000|Overall Study|Withdrawal by Subject|36|||
170485291|NCT01671007|616117425|FG001|Overall Study|Withdrawal by Subject|59|||
170485292|NCT01671007|616117426|FG002|Overall Study|Withdrawal by Subject|53|||
170485293|NCT01671007|616117427|FG003|Overall Study|Withdrawal by Subject|58|||
170485294|NCT01671007|616117428|FG004|Overall Study|Withdrawal by Subject|4|||
170485295|NCT01671007|616117429|FG005|Overall Study|Withdrawal by Subject|15|||
170485296|NCT01671007|616117430|FG006|Overall Study|Withdrawal by Subject|1|||
170485297|NCT01671007|616117431|FG007|Overall Study|Withdrawal by Subject|19|||
170485298|NCT01671007|616117432|FG008|Overall Study|Withdrawal by Subject|0|||
170485299|NCT01671007|616117424|FG000|Overall Study|Lost to Follow-up|93|||
170485300|NCT01671007|616117425|FG001|Overall Study|Lost to Follow-up|142|||
170485301|NCT01671007|616117426|FG002|Overall Study|Lost to Follow-up|91|||
170485302|NCT01671007|616117427|FG003|Overall Study|Lost to Follow-up|63|||
170485303|NCT01671007|616117428|FG004|Overall Study|Lost to Follow-up|7|||
170485304|NCT01671007|616117429|FG005|Overall Study|Lost to Follow-up|20|||
170485305|NCT01671007|616117430|FG006|Overall Study|Lost to Follow-up|2|||
170485306|NCT01671007|616117431|FG007|Overall Study|Lost to Follow-up|28|||
170485307|NCT01671007|616117432|FG008|Overall Study|Lost to Follow-up|0|||
170485308|NCT01671007|616117424|FG000|Overall Study|No end of study case report form|3|||
170485309|NCT01671007|616117425|FG001|Overall Study|No end of study case report form|1|||
170485310|NCT01671007|616117426|FG002|Overall Study|No end of study case report form|0|||
170485311|NCT01671007|616117427|FG003|Overall Study|No end of study case report form|2|||
170485312|NCT01671007|616117428|FG004|Overall Study|No end of study case report form|0|||
170485313|NCT01671007|616117429|FG005|Overall Study|No end of study case report form|0|||
170485314|NCT01671007|616117430|FG006|Overall Study|No end of study case report form|0|||
170485315|NCT01671007|616117431|FG007|Overall Study|No end of study case report form|0|||
170485316|NCT01671007|616117432|FG008|Overall Study|No end of study case report form|0|||
170485317|NCT01671007|616117424|FG000|Overall Study|Not eligible|23|||
170485318|NCT01671007|616117425|FG001|Overall Study|Not eligible|76|||
170485319|NCT01671007|616117426|FG002|Overall Study|Not eligible|25|||
170485320|NCT01671007|616117427|FG003|Overall Study|Not eligible|17|||
170485321|NCT01671007|616117428|FG004|Overall Study|Not eligible|0|||
170485322|NCT01671007|616117429|FG005|Overall Study|Not eligible|6|||
170485323|NCT01671007|616117430|FG006|Overall Study|Not eligible|1|||
170485324|NCT01671007|616117431|FG007|Overall Study|Not eligible|19|||
170485325|NCT01671007|616117432|FG008|Overall Study|Not eligible|0|||
170485326|NCT02509507|616117433|FG000|Overall Study|Death|21|||
170485327|NCT02509507|616117434|FG001|Overall Study|Death|3|||
170485328|NCT02509507|616117435|FG002|Overall Study|Death|22|||
170485329|NCT02509507|616117436|FG003|Overall Study|Death|14|||
170485330|NCT02509507|616117437|FG004|Overall Study|Death|8|||
170485331|NCT02509507|616117438|FG005|Overall Study|Death|12|||
170485332|NCT02509507|616117439|FG006|Overall Study|Death|5|||
170485333|NCT02509507|616117440|FG007|Overall Study|Death|4|||
170485334|NCT02509507|616117441|FG008|Overall Study|Death|8|||
170485335|NCT02509507|616117433|FG000|Overall Study|Lost to Follow-up|0|||
170485336|NCT02509507|616117434|FG001|Overall Study|Lost to Follow-up|1|||
170485337|NCT02509507|616117435|FG002|Overall Study|Lost to Follow-up|0|||
170485338|NCT02509507|616117436|FG003|Overall Study|Lost to Follow-up|0|||
170485339|NCT02509507|616117437|FG004|Overall Study|Lost to Follow-up|0|||
170485340|NCT02509507|616117438|FG005|Overall Study|Lost to Follow-up|2|||
170485341|NCT02509507|616117439|FG006|Overall Study|Lost to Follow-up|0|||
170485342|NCT02509507|616117440|FG007|Overall Study|Lost to Follow-up|0|||
170485343|NCT02509507|616117441|FG008|Overall Study|Lost to Follow-up|0|||
170485344|NCT02509507|616117433|FG000|Overall Study|Withdrawal by Subject|2|||
170485345|NCT02509507|616117434|FG001|Overall Study|Withdrawal by Subject|0|||
170485346|NCT02509507|616117435|FG002|Overall Study|Withdrawal by Subject|1|||
170548684|NCT02533674|616354652|FG005|Dose Level II|Non-treatment-related AE|0|||
170548685|NCT02533674|616354653|FG006|Dose Level II|Non-treatment-related AE|0|||
170548686|NCT02533674|616354654|FG007|Dose Level II|Non-treatment-related AE|0|||
170485347|NCT02509507|616117436|FG003|Overall Study|Withdrawal by Subject|4|||
170485348|NCT02509507|616117437|FG004|Overall Study|Withdrawal by Subject|1|||
170485349|NCT02509507|616117438|FG005|Overall Study|Withdrawal by Subject|3|||
170485350|NCT02509507|616117439|FG006|Overall Study|Withdrawal by Subject|4|||
170485351|NCT02509507|616117440|FG007|Overall Study|Withdrawal by Subject|0|||
170485352|NCT02509507|616117441|FG008|Overall Study|Withdrawal by Subject|1|||
170485353|NCT00171210|616117442|FG000|Overall Study|Adverse Event|16|||
170485354|NCT00171210|616117443|FG001|Overall Study|Adverse Event|27|||
170485355|NCT00171210|616117442|FG000|Overall Study|Abnormal laboratory value(s)|6|||
170485356|NCT00171210|616117443|FG001|Overall Study|Abnormal laboratory value(s)|3|||
170485357|NCT00171210|616117442|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170485358|NCT00171210|616117443|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170485359|NCT00171210|616117442|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
170485360|NCT00171210|616117443|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
170485361|NCT00171210|616117442|FG000|Overall Study|Protocol Violation|0|||
170485362|NCT00171210|616117443|FG001|Overall Study|Protocol Violation|2|||
170485363|NCT00171210|616117442|FG000|Overall Study|Withdrawal by Subject|32|||
170548687|NCT02533674|616354647|FG000|Dose Level III|Progressive disease|0|||
170485364|NCT00171210|616117443|FG001|Overall Study|Withdrawal by Subject|30|||
170485365|NCT00171210|616117442|FG000|Overall Study|Lost to Follow-up|1|||
170485366|NCT00171210|616117443|FG001|Overall Study|Lost to Follow-up|0|||
170485367|NCT00171210|616117442|FG000|Overall Study|Administrative problems|1|||
170485368|NCT00171210|616117443|FG001|Overall Study|Administrative problems|1|||
170485369|NCT00171210|616117442|FG000|Overall Study|Death|2|||
170485370|NCT00171210|616117443|FG001|Overall Study|Death|3|||
170485371|NCT00171210|616117442|FG000|Overall Study|Stopped at end of core|0|||
170485372|NCT00171210|616117443|FG001|Overall Study|Stopped at end of core|32|||
170485373|NCT00171210|616117442|FG000|Overall Study|Stopped at end of extension 1|0|||
170485374|NCT00171210|616117443|FG001|Overall Study|Stopped at end of extension 1|1|||
170485375|NCT03252535|616117445|FG000|Overall Study|Withdrawal by Subject|1|||
170485376|NCT03252535|616117446|FG001|Overall Study|Withdrawal by Subject|0|||
170485377|NCT03252535|616117447|FG002|Overall Study|Withdrawal by Subject|0|||
170485378|NCT03252535|616117445|FG000|Overall Study|Physician Decision|0|||
170485379|NCT03252535|616117446|FG001|Overall Study|Physician Decision|1|||
170485380|NCT03252535|616117447|FG002|Overall Study|Physician Decision|0|||
170485381|NCT03252535|616117445|FG000|Overall Study|Met discontinuation criteria|0|||
170485382|NCT03252535|616117446|FG001|Overall Study|Met discontinuation criteria|1|||
170485383|NCT03252535|616117447|FG002|Overall Study|Met discontinuation criteria|0|||
170485384|NCT00461630|616117452|FG000|Overall Study|Death|798|||
170485385|NCT00461630|616117453|FG001|Overall Study|Death|732|||
170485386|NCT00461630|616117452|FG000|Overall Study|Lost to Follow-up|108|||
170485387|NCT00461630|616117453|FG001|Overall Study|Lost to Follow-up|95|||
170485388|NCT02588612|616117457|FG000|Overall Study|Physician Decision|1|||
170485389|NCT02588612|616117457|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
170485390|NCT02588612|616117457|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
170485391|NCT02588612|616117457|FG000|Overall Study|Death prior to T-cell infusion|1|||
170485392|NCT03809663|616117458|FG000|Overall Study|Decision by sponsor|24|||
170485393|NCT03809663|616117459|FG001|Overall Study|Decision by sponsor|18|||
170485394|NCT03809663|616117460|FG002|Overall Study|Decision by sponsor|20|||
170485395|NCT03809663|616117461|FG003|Overall Study|Decision by sponsor|20|||
170485396|NCT03809663|616117462|FG004|Overall Study|Decision by sponsor|0|||
170485397|NCT03809663|616117463|FG005|Overall Study|Decision by sponsor|0|||
170485398|NCT03809663|616117458|FG000|Overall Study|Withdrawal by Subject|26|||
170485399|NCT03809663|616117459|FG001|Overall Study|Withdrawal by Subject|22|||
170485400|NCT03809663|616117460|FG002|Overall Study|Withdrawal by Subject|27|||
170485401|NCT03809663|616117461|FG003|Overall Study|Withdrawal by Subject|26|||
170485402|NCT03809663|616117462|FG004|Overall Study|Withdrawal by Subject|0|||
170485403|NCT03809663|616117463|FG005|Overall Study|Withdrawal by Subject|0|||
170485404|NCT03809663|616117458|FG000|Overall Study|Lost to Follow-up|1|||
170485405|NCT03809663|616117459|FG001|Overall Study|Lost to Follow-up|4|||
170485406|NCT03809663|616117460|FG002|Overall Study|Lost to Follow-up|1|||
170485407|NCT03809663|616117461|FG003|Overall Study|Lost to Follow-up|1|||
170485408|NCT03809663|616117462|FG004|Overall Study|Lost to Follow-up|0|||
170485409|NCT03809663|616117463|FG005|Overall Study|Lost to Follow-up|0|||
170485410|NCT02755103|616117464|FG000|Overall Study|Lost to Follow-up|17|||
170485411|NCT02755103|616117465|FG001|Overall Study|Lost to Follow-up|15|||
170485412|NCT02755103|616117464|FG000|Overall Study|Death|0|||
170485413|NCT02755103|616117465|FG001|Overall Study|Death|1|||
170485414|NCT02755103|616117464|FG000|Overall Study|Physician Decision|0|||
170485415|NCT02755103|616117465|FG001|Overall Study|Physician Decision|1|||
170485416|NCT02755103|616117464|FG000|Overall Study|Pregnancy|0|||
170485417|NCT02755103|616117465|FG001|Overall Study|Pregnancy|1|||
170548688|NCT02533674|616354648|FG001|Dose Level III|Progressive disease|0|||
170548689|NCT02533674|616354649|FG002|Dose Level III|Progressive disease|2|||
170548690|NCT02533674|616354650|FG003|Dose Level III|Progressive disease|0|||
170548691|NCT02533674|616354651|FG004|Dose Level III|Progressive disease|0|||
170548692|NCT02533674|616354652|FG005|Dose Level III|Progressive disease|0|||
170548693|NCT02533674|616354653|FG006|Dose Level III|Progressive disease|0|||
170898078|NCT01662648|617632364|FG001|Overall Study|Withdrawal by Subject|53|||
170898079|NCT01662648|617632363|FG000|Overall Study|Participant non-compliant|16|||
170485418|NCT02755103|616117464|FG000|Overall Study|Withdrawal by Subject|3|||
170485419|NCT02755103|616117465|FG001|Overall Study|Withdrawal by Subject|0|||
170485420|NCT01703260|616117466|FG000|Overall Study|Adverse Event|1|||
170485421|NCT01703260|616117467|FG001|Overall Study|Adverse Event|2|||
170485422|NCT01703260|616117468|FG002|Overall Study|Adverse Event|2|||
170485423|NCT01703260|616117466|FG000|Overall Study|Lost to Follow-up|1|||
170485424|NCT01703260|616117467|FG001|Overall Study|Lost to Follow-up|0|||
170485425|NCT01703260|616117468|FG002|Overall Study|Lost to Follow-up|0|||
170485426|NCT01703260|616117466|FG000|Overall Study|Withdrawal by Subject|0|||
170485427|NCT01703260|616117467|FG001|Overall Study|Withdrawal by Subject|0|||
170485428|NCT01703260|616117468|FG002|Overall Study|Withdrawal by Subject|1|||
170485429|NCT01703260|616117466|FG000|Overall Study|Study Termination|1|||
170485430|NCT01703260|616117467|FG001|Overall Study|Study Termination|2|||
170548694|NCT02533674|616354654|FG007|Dose Level III|Progressive disease|0|||
170485431|NCT01703260|616117468|FG002|Overall Study|Study Termination|0|||
170898080|NCT01662648|617632364|FG001|Overall Study|Participant non-compliant|20|||
170485432|NCT02792062|616117471|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
170485433|NCT02792062|616117472|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
170485434|NCT02792062|616117473|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
170485435|NCT02792062|616117474|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
170485436|NCT02792062|616117475|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
170485437|NCT02792062|616117476|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
170485438|NCT00720213|616117477|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
170485439|NCT00720213|616117478|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
170485440|NCT00720213|616117479|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
170485441|NCT00586703|616117480|FG000|Overall Study|Death|12|||
170485442|NCT05271175|616117482|FG000|One Week Follow up|Lost to Follow-up|10|||
170485443|NCT05271175|616117483|FG001|One Week Follow up|Lost to Follow-up|7|||
170485444|NCT05271175|616117484|FG002|One Week Follow up|Lost to Follow-up|5|||
170485445|NCT05271175|616117482|FG000|One Month Follow up|Lost to Follow-up|12|||
170485446|NCT05271175|616117483|FG001|One Month Follow up|Lost to Follow-up|7|||
170485447|NCT05271175|616117484|FG002|One Month Follow up|Lost to Follow-up|9|||
170485448|NCT05271175|616117482|FG000|Six Months Follow up|Lost to Follow-up|8|||
170485449|NCT05271175|616117483|FG001|Six Months Follow up|Lost to Follow-up|2|||
170485450|NCT05271175|616117484|FG002|Six Months Follow up|Lost to Follow-up|2|||
170485451|NCT02492867|616117485|FG000|Overall Study|Alternate therapy|1|||
170485452|NCT02492867|616117485|FG000|Overall Study|Withdrawal by Subject|2|||
170485453|NCT02492867|616117485|FG000|Overall Study|Disease progression after treatment started|1|||
170485454|NCT02492867|616117485|FG000|Overall Study|Death|1|||
170485455|NCT03296527|616117486|FG000|Overall Study|Adverse Event|15|||
170485456|NCT03296527|616117487|FG001|Overall Study|Adverse Event|33|||
170485457|NCT03296527|616117486|FG000|Overall Study|Protocol Deviation|4|||
170485458|NCT03296527|616117487|FG001|Overall Study|Protocol Deviation|0|||
170485459|NCT03296527|616117486|FG000|Overall Study|Participant withdrew consent|3|||
170485460|NCT03296527|616117487|FG001|Overall Study|Participant withdrew consent|1|||
170485461|NCT03296527|616117486|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
170485462|NCT03296527|616117487|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
170485463|NCT03296527|616117486|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
170485464|NCT03296527|616117487|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
170485465|NCT03296527|616117486|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
170485466|NCT03296527|616117487|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
170485467|NCT03296527|616117486|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
170485468|NCT03296527|616117487|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
170485469|NCT03296527|616117486|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
170485470|NCT03296527|616117487|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
170485471|NCT01597973|616117488|FG000|Overall Study|Found ineligible before study medication started|4|||
170485472|NCT01597973|616117489|FG001|Overall Study|Found ineligible before study medication started|2|||
170485473|NCT01597973|616117488|FG000|Overall Study|Eligible pathogen not confirmed|14|||
170485474|NCT01597973|616117489|FG001|Overall Study|Eligible pathogen not confirmed|15|||
170485475|NCT01597973|616117488|FG000|Overall Study|LAR not authorized to consent|0|||
170485476|NCT01597973|616117489|FG001|Overall Study|LAR not authorized to consent|1|||
170485477|NCT01597973|616117488|FG000|Overall Study|Ineligible due to early seizures|1|||
170485478|NCT01597973|616117489|FG001|Overall Study|Ineligible due to early seizures|0|||
170485479|NCT01597973|616117488|FG000|Overall Study|Ineligible due to non-target infection|1|||
170485480|NCT01597973|616117489|FG001|Overall Study|Ineligible due to non-target infection|1|||
170485481|NCT01565889|616117490|FG000|Part A|Withdrawal by Subject|1|||
170485482|NCT01565889|616117491|FG001|Part A|Withdrawal by Subject|0|||
170485483|NCT01565889|616117492|FG002|Part A|Withdrawal by Subject|0|||
170485484|NCT01565889|616117493|FG003|Part A|Withdrawal by Subject|0|||
170485485|NCT01565889|616117494|FG004|Part A|Withdrawal by Subject|0|||
170485486|NCT01565889|616117495|FG005|Part A|Withdrawal by Subject|0|||
170485487|NCT01565889|616117490|FG000|Part B|Withdrawal by Subject|0|||
170485488|NCT01565889|616117491|FG001|Part B|Withdrawal by Subject|0|||
170485489|NCT01565889|616117492|FG002|Part B|Withdrawal by Subject|0|||
170485490|NCT01565889|616117493|FG003|Part B|Withdrawal by Subject|0|||
170485491|NCT01565889|616117494|FG004|Part B|Withdrawal by Subject|0|||
170485492|NCT01565889|616117495|FG005|Part B|Withdrawal by Subject|1|||
170485493|NCT01565889|616117490|FG000|Part B|Lack of Efficacy|0|||
170485494|NCT01565889|616117491|FG001|Part B|Lack of Efficacy|0|||
170485495|NCT01565889|616117492|FG002|Part B|Lack of Efficacy|0|||
170485496|NCT01565889|616117493|FG003|Part B|Lack of Efficacy|0|||
170485497|NCT01565889|616117494|FG004|Part B|Lack of Efficacy|0|||
170548695|NCT02533674|616354647|FG000|Dose Level III|Withdrawal by Subject|0|||
170798215|NCT02777593|617273634|FG001|Overall Study|Physician Decision|2|||
170485498|NCT01565889|616117495|FG005|Part B|Lack of Efficacy|2|||
170485499|NCT01565889|616117490|FG000|Part B|Lost to Follow-up|0|||
170485500|NCT01565889|616117491|FG001|Part B|Lost to Follow-up|0|||
170485501|NCT01565889|616117492|FG002|Part B|Lost to Follow-up|0|||
170485502|NCT01565889|616117493|FG003|Part B|Lost to Follow-up|0|||
170485503|NCT01565889|616117494|FG004|Part B|Lost to Follow-up|0|||
170485504|NCT01565889|616117495|FG005|Part B|Lost to Follow-up|1|||
170485505|NCT01326845|616117496|FG000|Overall Study|Administrative Problems|5|||
170485506|NCT01326845|616117497|FG001|Overall Study|Administrative Problems|2|||
170485507|NCT01326845|616117496|FG000|Overall Study|Adverse Event|1|||
170485508|NCT01326845|616117497|FG001|Overall Study|Adverse Event|0|||
170485509|NCT01326845|616117496|FG000|Overall Study|Misisng|1|||
170485510|NCT01326845|616117497|FG001|Overall Study|Misisng|3|||
170485511|NCT00122382|616117500|FG000|Double-Blind Study|Adverse Event|9|||
170485512|NCT00122382|616117501|FG001|Double-Blind Study|Adverse Event|11|||
170485513|NCT00122382|616117502|FG002|Double-Blind Study|Adverse Event|0|||
170485514|NCT00122382|616117500|FG000|Double-Blind Study|Death|2|||
170485515|NCT00122382|616117501|FG001|Double-Blind Study|Death|2|||
170485516|NCT00122382|616117502|FG002|Double-Blind Study|Death|0|||
170485517|NCT00122382|616117500|FG000|Double-Blind Study|Lack of Efficacy|0|||
170485518|NCT00122382|616117501|FG001|Double-Blind Study|Lack of Efficacy|8|||
170485519|NCT00122382|616117502|FG002|Double-Blind Study|Lack of Efficacy|0|||
170485520|NCT00122382|616117500|FG000|Double-Blind Study|Lost to Follow-up|2|||
170485521|NCT00122382|616117501|FG001|Double-Blind Study|Lost to Follow-up|1|||
170485522|NCT00122382|616117502|FG002|Double-Blind Study|Lost to Follow-up|0|||
170485523|NCT00122382|616117500|FG000|Double-Blind Study|Pregnancy|2|||
170485524|NCT00122382|616117501|FG001|Double-Blind Study|Pregnancy|0|||
170485525|NCT00122382|616117502|FG002|Double-Blind Study|Pregnancy|0|||
170485526|NCT00122382|616117500|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
170485527|NCT00122382|616117501|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
170485528|NCT00122382|616117502|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
170485529|NCT00122382|616117500|FG000|Double-Blind Study|Withdrawal of Consent|7|||
170485530|NCT00122382|616117501|FG001|Double-Blind Study|Withdrawal of Consent|3|||
170485531|NCT00122382|616117502|FG002|Double-Blind Study|Withdrawal of Consent|0|||
170485532|NCT00122382|616117500|FG000|Double-Blind Study|Protocol Violation|1|||
170485533|NCT00122382|616117501|FG001|Double-Blind Study|Protocol Violation|0|||
170485534|NCT00122382|616117502|FG002|Double-Blind Study|Protocol Violation|0|||
170485535|NCT00122382|616117500|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
170485536|NCT00122382|616117501|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
170485537|NCT00122382|616117502|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
170485538|NCT00122382|616117500|FG000|Double-Blind Study|Randomized but not treated|0|||
170485539|NCT00122382|616117501|FG001|Double-Blind Study|Randomized but not treated|2|||
170485540|NCT00122382|616117502|FG002|Double-Blind Study|Randomized but not treated|0|||
170485541|NCT00122382|616117500|FG000|Open-Label Study|Adverse Event|0|||
170485542|NCT00122382|616117501|FG001|Open-Label Study|Adverse Event|0|||
170485543|NCT00122382|616117502|FG002|Open-Label Study|Adverse Event|11|||
170485544|NCT00122382|616117500|FG000|Open-Label Study|Death|0|||
170485545|NCT00122382|616117501|FG001|Open-Label Study|Death|0|||
170485546|NCT00122382|616117502|FG002|Open-Label Study|Death|2|||
170485547|NCT00122382|616117500|FG000|Open-Label Study|Lack of Efficacy|0|||
170485548|NCT00122382|616117501|FG001|Open-Label Study|Lack of Efficacy|0|||
170485549|NCT00122382|616117502|FG002|Open-Label Study|Lack of Efficacy|3|||
170485550|NCT00122382|616117500|FG000|Open-Label Study|Lost to Follow-up|0|||
170485551|NCT00122382|616117501|FG001|Open-Label Study|Lost to Follow-up|0|||
170485552|NCT00122382|616117502|FG002|Open-Label Study|Lost to Follow-up|3|||
170485553|NCT00122382|616117500|FG000|Open-Label Study|Pregnancy|0|||
170485554|NCT00122382|616117501|FG001|Open-Label Study|Pregnancy|0|||
170485555|NCT00122382|616117502|FG002|Open-Label Study|Pregnancy|2|||
170485556|NCT00122382|616117500|FG000|Open-Label Study|Poor/Non-Compliance|0|||
170548696|NCT02533674|616354648|FG001|Dose Level III|Withdrawal by Subject|0|||
170548697|NCT02533674|616354649|FG002|Dose Level III|Withdrawal by Subject|1|||
170548698|NCT02533674|616354650|FG003|Dose Level III|Withdrawal by Subject|0|||
170548699|NCT02533674|616354651|FG004|Dose Level III|Withdrawal by Subject|0|||
170548700|NCT02533674|616354652|FG005|Dose Level III|Withdrawal by Subject|0|||
170548701|NCT02533674|616354653|FG006|Dose Level III|Withdrawal by Subject|0|||
170548702|NCT02533674|616354654|FG007|Dose Level III|Withdrawal by Subject|0|||
170548703|NCT02533674|616354647|FG000|Dose Level III|Treatment-related AE|0|||
170548704|NCT02533674|616354648|FG001|Dose Level III|Treatment-related AE|0|||
170798216|NCT02777593|617273635|FG002|Overall Study|Physician Decision|0|||
170548705|NCT02533674|616354649|FG002|Dose Level III|Treatment-related AE|1|||
170485557|NCT00122382|616117501|FG001|Open-Label Study|Poor/Non-Compliance|0|||
170485558|NCT00122382|616117502|FG002|Open-Label Study|Poor/Non-Compliance|1|||
170485559|NCT00122382|616117500|FG000|Open-Label Study|Withdrawal of Consent|0|||
170485560|NCT00122382|616117501|FG001|Open-Label Study|Withdrawal of Consent|0|||
170485561|NCT00122382|616117502|FG002|Open-Label Study|Withdrawal of Consent|4|||
170485562|NCT02040805|616117504|FG000|Overall Study|Lost to Follow-up|14|||
170485563|NCT02040805|616117505|FG001|Overall Study|Lost to Follow-up|9|||
170485564|NCT02040805|616117504|FG000|Overall Study|Withdrawal by Subject|28|||
170485565|NCT02040805|616117505|FG001|Overall Study|Withdrawal by Subject|41|||
170485566|NCT00908544|616117506|FG000|Overall Study|Withdrawal by Subject|2|||
170548706|NCT02533674|616354650|FG003|Dose Level III|Treatment-related AE|0|||
170485567|NCT00908544|616117507|FG001|Overall Study|Withdrawal by Subject|4|||
170485568|NCT00908544|616117506|FG000|Overall Study|Lack of Efficacy|0|||
170485569|NCT00908544|616117507|FG001|Overall Study|Lack of Efficacy|1|||
170485570|NCT00908544|616117506|FG000|Overall Study|Pregnancy|1|||
170485571|NCT00908544|616117507|FG001|Overall Study|Pregnancy|0|||
170485572|NCT00908544|616117506|FG000|Overall Study|Relocation abroad|1|||
170485573|NCT00908544|616117507|FG001|Overall Study|Relocation abroad|1|||
170485574|NCT00908544|616117506|FG000|Overall Study|Unable to visit sutdy center|1|||
170485575|NCT00908544|616117507|FG001|Overall Study|Unable to visit sutdy center|0|||
170485576|NCT00071110|616117510|FG000|Overall Study|Protocol Violation|0|||
170485577|NCT00071110|616117511|FG001|Overall Study|Protocol Violation|4|||
170485578|NCT00503698|616117513|FG000|Overall Study|Protocol Violation|5|||
170485579|NCT00503698|616117514|FG001|Overall Study|Protocol Violation|6|||
170485580|NCT00503698|616117513|FG000|Overall Study|Adverse Event|52|||
170485581|NCT00503698|616117514|FG001|Overall Study|Adverse Event|41|||
170485582|NCT00503698|616117513|FG000|Overall Study|Death|1|||
170485583|NCT00503698|616117514|FG001|Overall Study|Death|0|||
170485584|NCT00503698|616117513|FG000|Overall Study|Lack of Efficacy|3|||
170485585|NCT00503698|616117514|FG001|Overall Study|Lack of Efficacy|4|||
170485586|NCT00503698|616117513|FG000|Overall Study|Trial terminated|216|||
170485587|NCT00503698|616117514|FG001|Overall Study|Trial terminated|253|||
170485588|NCT00503698|616117513|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
170485589|NCT00503698|616117514|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
170485590|NCT00503698|616117513|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
170485591|NCT00503698|616117514|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
170485592|NCT00503698|616117513|FG000|Overall Study|Any condition in exclusion criteria|4|||
170485593|NCT00503698|616117514|FG001|Overall Study|Any condition in exclusion criteria|6|||
170485594|NCT00503698|616117513|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
170485595|NCT00503698|616117514|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
170485596|NCT00503698|616117513|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
170485597|NCT00503698|616117514|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
170485598|NCT00503698|616117513|FG000|Overall Study|Critically ill|2|||
170485599|NCT00503698|616117514|FG001|Overall Study|Critically ill|0|||
170485600|NCT00503698|616117513|FG000|Overall Study|Unclassified|48|||
170485601|NCT00503698|616117514|FG001|Overall Study|Unclassified|32|||
170485602|NCT00503698|616117513|FG000|Overall Study|Not exposed to trial drug|11|||
170485603|NCT00503698|616117514|FG001|Overall Study|Not exposed to trial drug|6|||
170485604|NCT00682786|616117519|FG000|Overall Study|Withdrawal by Subject|2|||
170485605|NCT00682786|616117520|FG001|Overall Study|Withdrawal by Subject|2|||
170485606|NCT00682786|616117519|FG000|Overall Study|Did not receive irinotecan|0|||
170485607|NCT00682786|616117520|FG001|Overall Study|Did not receive irinotecan|1|||
170485608|NCT02462603|616117525|FG000|Overall Study|Investigator Decision|1|||
170485609|NCT02462603|616117525|FG000|Overall Study|Non-Compliance|1|||
170485610|NCT02462603|616117525|FG000|Overall Study|Withdrawal by Subject|2|||
170485611|NCT03859427|616117527|FG000|Overall Study|Withdrawal by Subject|4|||
170485612|NCT03859427|616117528|FG001|Overall Study|Withdrawal by Subject|7|||
170485613|NCT03859427|616117527|FG000|Overall Study|Decision by sponsor|0|||
170485614|NCT03859427|616117528|FG001|Overall Study|Decision by sponsor|3|||
170485615|NCT03859427|616117527|FG000|Overall Study|Lost to Follow-up|3|||
170485616|NCT03859427|616117528|FG001|Overall Study|Lost to Follow-up|2|||
170485617|NCT03859427|616117527|FG000|Overall Study|Death|22|||
170548707|NCT02533674|616354651|FG004|Dose Level III|Treatment-related AE|0|||
170548708|NCT02533674|616354652|FG005|Dose Level III|Treatment-related AE|0|||
170548709|NCT02533674|616354653|FG006|Dose Level III|Treatment-related AE|0|||
170548710|NCT02533674|616354654|FG007|Dose Level III|Treatment-related AE|0|||
170548711|NCT02533674|616354647|FG000|Dose Level IV|Progressive disease|0|||
170548712|NCT02533674|616354648|FG001|Dose Level IV|Progressive disease|0|||
170485618|NCT03859427|616117528|FG001|Overall Study|Death|25|||
170485619|NCT03655405|616117531|FG000|Overall Study|Death after initial data collection|4|||
170485620|NCT03655405|616117532|FG001|Overall Study|Death after initial data collection|2|||
170485621|NCT03655405|616117531|FG000|Overall Study|Died before initial data collection|1|||
170485622|NCT03655405|616117532|FG001|Overall Study|Died before initial data collection|2|||
170485623|NCT03655405|616117531|FG000|Overall Study|Protocol Violation|0|||
170485624|NCT03655405|616117532|FG001|Overall Study|Protocol Violation|1|||
170485625|NCT02389829|616117533|FG000|Overall Study|Lost to Follow-up|0|||
170485626|NCT02389829|616117534|FG001|Overall Study|Lost to Follow-up|1|||
170485627|NCT00571727|616117535|FG000|Overall Study|Did not enter in this study|1|||
170548713|NCT02533674|616354649|FG002|Dose Level IV|Progressive disease|0|||
170485628|NCT00571727|616117535|FG000|Overall Study|Non-compliance|4|||
170798217|NCT02777593|617273636|FG003|Overall Study|Physician Decision|0|||
170485629|NCT00571727|616117535|FG000|Overall Study|Lost to Follow-up|30|||
170485630|NCT00571727|616117535|FG000|Overall Study|Poor growth|1|||
170485631|NCT00571727|616117535|FG000|Overall Study|Parent/patient decision|2|||
170548714|NCT02533674|616354650|FG003|Dose Level IV|Progressive disease|3|||
170798218|NCT02777593|617273637|FG004|Overall Study|Physician Decision|0|||
170798219|NCT02777593|617273633|FG000|Overall Study|Discontinued due to Other|1|||
170798220|NCT02777593|617273634|FG001|Overall Study|Discontinued due to Other|0|||
170485632|NCT00571727|616117535|FG000|Overall Study|Participant transferred to commercial drug|14|||
170485633|NCT00571727|616117535|FG000|Overall Study|Unable to provide study drug|6|||
170485634|NCT00571727|616117535|FG000|Overall Study|On-treatment at end of study|8|||
170485635|NCT01622673|616117536|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170485636|NCT01622673|616117537|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170485637|NCT01622673|616117538|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170485638|NCT01622673|616117539|FG003|Treatment Period 1|Withdrawal by Subject|1|||
170485639|NCT01622673|616117540|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170485640|NCT01622673|616117541|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170485641|NCT01622673|616117536|FG000|Treatment Period 1|Protocol Violation|0|||
170485642|NCT01622673|616117537|FG001|Treatment Period 1|Protocol Violation|1|||
170485643|NCT01622673|616117538|FG002|Treatment Period 1|Protocol Violation|0|||
170485644|NCT01622673|616117539|FG003|Treatment Period 1|Protocol Violation|0|||
170485645|NCT01622673|616117540|FG004|Treatment Period 1|Protocol Violation|0|||
170485646|NCT01622673|616117541|FG005|Treatment Period 1|Protocol Violation|0|||
170485647|NCT01622673|616117536|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170485648|NCT01622673|616117537|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170485649|NCT01622673|616117538|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170485650|NCT01622673|616117539|FG003|Treatment Period 2|Withdrawal by Subject|1|||
170485651|NCT01622673|616117540|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170485652|NCT01622673|616117541|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170485653|NCT01622673|616117536|FG000|Treatment Period 3|Protocol Violation|0|||
170485654|NCT01622673|616117537|FG001|Treatment Period 3|Protocol Violation|1|||
170485655|NCT01622673|616117538|FG002|Treatment Period 3|Protocol Violation|0|||
170485656|NCT01622673|616117539|FG003|Treatment Period 3|Protocol Violation|0|||
170485657|NCT01622673|616117540|FG004|Treatment Period 3|Protocol Violation|0|||
170485658|NCT01622673|616117541|FG005|Treatment Period 3|Protocol Violation|0|||
170485659|NCT05086744|616119169|FG000|Part A|Adverse Event|0|||
170485660|NCT05086744|616119170|FG001|Part A|Adverse Event|1|||
170485661|NCT05086744|616119169|FG000|Part A|Lack of Efficacy|3|||
170485662|NCT05086744|616119170|FG001|Part A|Lack of Efficacy|0|||
170485663|NCT05086744|616119169|FG000|Part A|Protocol deviation|1|||
170485664|NCT05086744|616119170|FG001|Part A|Protocol deviation|0|||
170485665|NCT05086744|616119169|FG000|Part A|Subject decision|1|||
170485666|NCT05086744|616119170|FG001|Part A|Subject decision|0|||
170548715|NCT02533674|616354651|FG004|Dose Level IV|Progressive disease|0|||
170548716|NCT02533674|616354652|FG005|Dose Level IV|Progressive disease|0|||
170548717|NCT02533674|616354653|FG006|Dose Level IV|Progressive disease|0|||
170548718|NCT02533674|616354654|FG007|Dose Level IV|Progressive disease|0|||
170548719|NCT02533674|616354647|FG000|Dose Level IV|Withdrawal by Subject|0|||
170548720|NCT02533674|616354648|FG001|Dose Level IV|Withdrawal by Subject|0|||
170548721|NCT02533674|616354649|FG002|Dose Level IV|Withdrawal by Subject|0|||
170548722|NCT02533674|616354650|FG003|Dose Level IV|Withdrawal by Subject|1|||
170548723|NCT02533674|616354651|FG004|Dose Level IV|Withdrawal by Subject|0|||
170548724|NCT02533674|616354652|FG005|Dose Level IV|Withdrawal by Subject|0|||
170548725|NCT02533674|616354653|FG006|Dose Level IV|Withdrawal by Subject|0|||
170548726|NCT02533674|616354654|FG007|Dose Level IV|Withdrawal by Subject|0|||
170548727|NCT02533674|616354647|FG000|Dose Level IV|Physician Decision|0|||
170548728|NCT02533674|616354648|FG001|Dose Level IV|Physician Decision|0|||
170548729|NCT02533674|616354649|FG002|Dose Level IV|Physician Decision|0|||
170548730|NCT02533674|616354650|FG003|Dose Level IV|Physician Decision|1|||
170548731|NCT02533674|616354651|FG004|Dose Level IV|Physician Decision|0|||
170798221|NCT02777593|617273635|FG002|Overall Study|Discontinued due to Other|0|||
170798222|NCT02777593|617273636|FG003|Overall Study|Discontinued due to Other|0|||
170798223|NCT02777593|617273637|FG004|Overall Study|Discontinued due to Other|0|||
170798224|NCT05785130|617273646|FG000|Overall Study|Withdrawal by Subject|1|||
170798225|NCT05785130|617273647|FG001|Overall Study|Withdrawal by Subject|0|||
170798226|NCT05785130|617273646|FG000|Overall Study|Lack of Efficacy|0|||
170798227|NCT05785130|617273647|FG001|Overall Study|Lack of Efficacy|1|||
170798228|NCT06065735|617273651|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
170798229|NCT06065735|617273652|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
170798230|NCT06065735|617273653|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
170798231|NCT06065735|617273651|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
170798232|NCT06065735|617273652|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
170798233|NCT06065735|617273653|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
170485667|NCT05086744|616119169|FG000|Part B|Adverse Event|0|||
170485668|NCT05086744|616119170|FG001|Part B|Adverse Event|1|||
170485669|NCT05086744|616119169|FG000|Part B|Lack of Efficacy|0|||
170485670|NCT05086744|616119170|FG001|Part B|Lack of Efficacy|1|||
170485671|NCT05086744|616119169|FG000|Part B|Study terminated by sponsor|1|||
170548732|NCT02533674|616354652|FG005|Dose Level IV|Physician Decision|0|||
170548733|NCT02533674|616354653|FG006|Dose Level IV|Physician Decision|0|||
170548734|NCT02533674|616354654|FG007|Dose Level IV|Physician Decision|0|||
170548735|NCT02533674|616354647|FG000|Dose Level V|Progressive disease|0|||
170548736|NCT02533674|616354648|FG001|Dose Level V|Progressive disease|0|||
170548737|NCT02533674|616354649|FG002|Dose Level V|Progressive disease|0|||
170898081|NCT01662648|617632363|FG000|Overall Study|Other|8|||
170898082|NCT01662648|617632364|FG001|Overall Study|Other|11|||
170485672|NCT05086744|616119170|FG001|Part B|Study terminated by sponsor|6|||
170485673|NCT05343000|616119171|FG000|Overall Study|Physician Decision|2|||
170485674|NCT03782792|616119172|FG000|Overall Study|Patient left the country|0|||
170485675|NCT03782792|616119173|FG001|Overall Study|Patient left the country|1|||
170485676|NCT03782792|616119172|FG000|Overall Study|Withdrawal by Subject|1|||
170485677|NCT03782792|616119173|FG001|Overall Study|Withdrawal by Subject|2|||
170485678|NCT00617890|616119174|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
170485679|NCT00617890|616119175|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
170485680|NCT00617890|616119176|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
170485681|NCT00617890|616119177|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
170485682|NCT00617890|616119174|FG000|Overall Study|Lack of Efficacy|23|||
170485683|NCT00617890|616119175|FG001|Overall Study|Lack of Efficacy|26|||
170485684|NCT00617890|616119176|FG002|Overall Study|Lack of Efficacy|30|||
170485685|NCT00617890|616119177|FG003|Overall Study|Lack of Efficacy|97|||
170485686|NCT00617890|616119174|FG000|Overall Study|Lost to Follow-up|0|||
170485687|NCT00617890|616119175|FG001|Overall Study|Lost to Follow-up|0|||
170485688|NCT00617890|616119176|FG002|Overall Study|Lost to Follow-up|1|||
170485689|NCT00617890|616119177|FG003|Overall Study|Lost to Follow-up|2|||
170485690|NCT00617890|616119174|FG000|Overall Study|Withdrawal by Subject|4|||
170485691|NCT00617890|616119175|FG001|Overall Study|Withdrawal by Subject|1|||
170485692|NCT00617890|616119176|FG002|Overall Study|Withdrawal by Subject|0|||
170485693|NCT00617890|616119177|FG003|Overall Study|Withdrawal by Subject|2|||
170485694|NCT00617890|616119174|FG000|Overall Study|Protocol Violation|2|||
170485695|NCT00617890|616119175|FG001|Overall Study|Protocol Violation|1|||
170485696|NCT00617890|616119176|FG002|Overall Study|Protocol Violation|0|||
170485697|NCT00617890|616119177|FG003|Overall Study|Protocol Violation|0|||
170485698|NCT00617890|616119174|FG000|Overall Study|Adverse Event|1|||
170485699|NCT00617890|616119175|FG001|Overall Study|Adverse Event|0|||
170485700|NCT00617890|616119176|FG002|Overall Study|Adverse Event|3|||
170485701|NCT00617890|616119177|FG003|Overall Study|Adverse Event|8|||
170485702|NCT00617890|616119174|FG000|Overall Study|Not treated|1|||
170485703|NCT00617890|616119175|FG001|Overall Study|Not treated|0|||
170485704|NCT00617890|616119176|FG002|Overall Study|Not treated|1|||
170485705|NCT00617890|616119177|FG003|Overall Study|Not treated|1|||
170485706|NCT00866281|616119178|FG000|Overall Study|Adverse Event|1|||
170485707|NCT00866281|616119179|FG001|Overall Study|Adverse Event|0|||
170485708|NCT00866281|616119178|FG000|Overall Study|Withdrawal by participants|3|||
170485709|NCT00866281|616119179|FG001|Overall Study|Withdrawal by participants|0|||
170485710|NCT00866281|616119178|FG000|Overall Study|Disease progression|3|||
170485711|NCT00866281|616119179|FG001|Overall Study|Disease progression|11|||
170485712|NCT00866281|616119178|FG000|Overall Study|New cancer therapy|0|||
170485713|NCT00866281|616119179|FG001|Overall Study|New cancer therapy|4|||
170485714|NCT00529087|616119180|FG000|Overall Study|Adverse Event|10|||
170485715|NCT00529087|616119181|FG001|Overall Study|Adverse Event|13|||
170485716|NCT00529087|616119182|FG002|Overall Study|Adverse Event|4|||
170485717|NCT00529087|616119180|FG000|Overall Study|Lost to Follow-up|6|||
170485718|NCT00529087|616119181|FG001|Overall Study|Lost to Follow-up|4|||
170898083|NCT01662648|617632363|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
170898084|NCT01662648|617632364|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
170898085|NCT01662648|617632363|FG000|Overall Study|LOE and other reason unspecified|1|||
170898086|NCT01662648|617632364|FG001|Overall Study|LOE and other reason unspecified|0|||
170898087|NCT01662648|617632363|FG000|Overall Study|LOE and Participant non-compliant|0|||
170898088|NCT01662648|617632364|FG001|Overall Study|LOE and Participant non-compliant|1|||
170898089|NCT00619957|617632366|FG000|Month 24 Double-Blind|Adverse Event|9|||
170898090|NCT00619957|617632367|FG001|Month 24 Double-Blind|Adverse Event|7|||
170898091|NCT00619957|617632366|FG000|Month 24 Double-Blind|Protocol Violation|1|||
170898092|NCT00619957|617632367|FG001|Month 24 Double-Blind|Protocol Violation|0|||
170898093|NCT00619957|617632366|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
170898094|NCT00619957|617632367|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
170898095|NCT00619957|617632366|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
170898096|NCT00619957|617632367|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
170898097|NCT00619957|617632366|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
170898098|NCT00619957|617632367|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
170485719|NCT00529087|616119182|FG002|Overall Study|Lost to Follow-up|1|||
170485720|NCT00529087|616119180|FG000|Overall Study|Protocol Violation|8|||
170548738|NCT02533674|616354650|FG003|Dose Level V|Progressive disease|0|||
170898099|NCT00619957|617632366|FG000|Month 48 Open-Label|Adverse Event|4|||
170485721|NCT00529087|616119181|FG001|Overall Study|Protocol Violation|7|||
170485722|NCT00529087|616119182|FG002|Overall Study|Protocol Violation|6|||
170485723|NCT00529087|616119180|FG000|Overall Study|Withdrawal by Subject|3|||
170485724|NCT00529087|616119181|FG001|Overall Study|Withdrawal by Subject|3|||
170485725|NCT00529087|616119182|FG002|Overall Study|Withdrawal by Subject|3|||
170485726|NCT00529087|616119180|FG000|Overall Study|Protocol deviation|1|||
170485727|NCT00529087|616119181|FG001|Overall Study|Protocol deviation|1|||
170485728|NCT00529087|616119182|FG002|Overall Study|Protocol deviation|2|||
170485729|NCT00333983|616119188|FG000|Overall Study|Lost to Follow-up|2|||
170548739|NCT02533674|616354651|FG004|Dose Level V|Progressive disease|3|||
170898100|NCT00619957|617632367|FG001|Month 48 Open-Label|Adverse Event|4|||
170898101|NCT00619957|617632366|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
170898102|NCT00619957|617632367|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
170485730|NCT00333983|616119189|FG001|Overall Study|Lost to Follow-up|1|||
170485731|NCT00333983|616119190|FG002|Overall Study|Lost to Follow-up|0|||
170485732|NCT00333983|616119188|FG000|Overall Study|Adverse Event|1|||
170485733|NCT00333983|616119189|FG001|Overall Study|Adverse Event|1|||
170485734|NCT00333983|616119190|FG002|Overall Study|Adverse Event|1|||
170485735|NCT00333983|616119188|FG000|Overall Study|Withdrawal by Subject|0|||
170485736|NCT00333983|616119189|FG001|Overall Study|Withdrawal by Subject|3|||
170485737|NCT00333983|616119190|FG002|Overall Study|Withdrawal by Subject|1|||
170485738|NCT00833105|616119191|FG000|Overall Study|Withdrawal by Subject|1|||
170485739|NCT00833105|616119191|FG000|Overall Study|Adverse Event|2|||
170485740|NCT02898597|616119192|FG000|Overall Study|Protocol Violation|4|||
170485741|NCT02898597|616119193|FG001|Overall Study|Protocol Violation|2|||
170485742|NCT02898597|616119192|FG000|Overall Study|Lost to Follow-up|0|||
170485743|NCT02898597|616119193|FG001|Overall Study|Lost to Follow-up|9|||
170485744|NCT02898597|616119192|FG000|Overall Study|Death|0|||
170485745|NCT02898597|616119193|FG001|Overall Study|Death|1|||
170485746|NCT03656068|616119194|FG000|Overall Study|Withdrawal by Subject|4|||
170485747|NCT03656068|616119194|FG000|Overall Study|Adverse Event|1|||
170485748|NCT00154284|616119195|FG000|Overall Study|Adverse Event|6|||
170485749|NCT00154284|616119196|FG001|Overall Study|Adverse Event|9|||
170485750|NCT00154284|616119195|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170485751|NCT00154284|616119196|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170485752|NCT00154284|616119195|FG000|Overall Study|Lack of Efficacy|1|||
170485753|NCT00154284|616119196|FG001|Overall Study|Lack of Efficacy|2|||
170485754|NCT00154284|616119195|FG000|Overall Study|Protocol Violation|0|||
170485755|NCT00154284|616119196|FG001|Overall Study|Protocol Violation|1|||
170485756|NCT01436370|616119206|FG000|Overall Study|Lost to Follow-up|0|||
170485757|NCT01436370|616119207|FG001|Overall Study|Lost to Follow-up|0|||
170485758|NCT01436370|616119208|FG002|Overall Study|Lost to Follow-up|0|||
170485759|NCT01436370|616119209|FG003|Overall Study|Lost to Follow-up|0|||
170485760|NCT01436370|616119210|FG004|Overall Study|Lost to Follow-up|1|||
170485761|NCT01436370|616119211|FG005|Overall Study|Lost to Follow-up|0|||
170485762|NCT01436370|616119212|FG006|Overall Study|Lost to Follow-up|0|||
170485763|NCT01436370|616119213|FG007|Overall Study|Lost to Follow-up|0|||
170485764|NCT02276560|616119214|FG000|Overall Study|Adverse Event|1|||
170485765|NCT02276560|616119215|FG001|Overall Study|Adverse Event|0|||
170485766|NCT02276560|616119216|FG002|Overall Study|Adverse Event|0|||
170485767|NCT02058537|616119217|FG000|Overall Study|Withdrawal by Subject|1|||
170485768|NCT01780038|616119220|FG000|Overall Study|Lost to Follow-up|4|||
170485769|NCT01780038|616119221|FG001|Overall Study|Lost to Follow-up|1|||
170485770|NCT01085630|616119222|FG000|Overall Study|Insufficient data|1|||
170485771|NCT01085630|616119223|FG001|Overall Study|Insufficient data|0|||
170485772|NCT01085630|616119222|FG000|Overall Study|Ineligible|3|||
170485773|NCT01085630|616119223|FG001|Overall Study|Ineligible|0|||
170485774|NCT01081769|616119224|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
170485775|NCT01081769|616119225|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
170485776|NCT01081769|616119224|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
170485777|NCT01081769|616119225|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
170898103|NCT00619957|617632366|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
170898104|NCT00619957|617632367|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
170898105|NCT00723957|617632368|FG000|Overall Study|Adverse event unrelated to study drug|1|||
170898106|NCT00723957|617632369|FG001|Overall Study|Adverse event unrelated to study drug|4|||
170898107|NCT00723957|617632368|FG000|Overall Study|Death|3|||
170898108|NCT00723957|617632369|FG001|Overall Study|Death|4|||
170898109|NCT00723957|617632368|FG000|Overall Study|Disease progression|27|||
170898110|NCT00723957|617632369|FG001|Overall Study|Disease progression|25|||
170485778|NCT01081769|616119224|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
170485779|NCT01081769|616119225|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
170485780|NCT01081769|616119224|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
170485781|NCT01081769|616119225|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
170485782|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Adverse Event|14|||
170485783|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Adverse Event|11|||
170485784|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Death|1|||
170485785|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Death|1|||
170485786|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
170485787|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
170485788|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
170485789|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
170898111|NCT00723957|617632368|FG000|Overall Study|Maximum clinical benefit|4|||
170485790|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Pregnancy|1|||
170485791|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Pregnancy|0|||
170485792|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
170485793|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
170485794|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
170485795|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
170485796|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Other|0|||
170485797|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Other|1|||
170485798|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Ineligibility|3|||
170485799|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Ineligibility|4|||
170485800|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
170485801|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
170485802|NCT01081769|616119224|FG000|CORE Intent-To-Treat|Patient Moved|2|||
170485803|NCT01081769|616119225|FG001|CORE Intent-To-Treat|Patient Moved|2|||
170485804|NCT03309943|616119226|FG000|Overall Study|Withdrawal by Subject|0|||
170485805|NCT03309943|616119227|FG001|Overall Study|Withdrawal by Subject|1|||
170485806|NCT03309943|616119226|FG000|Overall Study|Inappropriate behavior towards staff|0|||
170485807|NCT03309943|616119227|FG001|Overall Study|Inappropriate behavior towards staff|1|||
170485808|NCT00427648|616119230|FG000|Overall Study|Protocol Violation|1|||
170485809|NCT00427648|616119231|FG001|Overall Study|Protocol Violation|2|||
170485810|NCT00427648|616119230|FG000|Overall Study|Adverse Event|0|||
170485811|NCT00427648|616119231|FG001|Overall Study|Adverse Event|1|||
170485812|NCT06509438|616119232|FG000|Overall Study|Adverse Event|1|||
170485813|NCT06509438|616119232|FG000|Overall Study|Lost to Follow-up|3|||
170485814|NCT03331796|616119233|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
170485815|NCT03331796|616119234|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
170485816|NCT03331796|616119235|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
170485817|NCT03331796|616119233|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
170485818|NCT03331796|616119234|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
170485819|NCT03331796|616119235|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
170485820|NCT03331796|616119233|FG000|Extended Follow-up|Adverse Event|1|||
170485821|NCT03331796|616119234|FG001|Extended Follow-up|Adverse Event|0|||
170485822|NCT03331796|616119235|FG002|Extended Follow-up|Adverse Event|1|||
170485823|NCT03331796|616119233|FG000|Extended Follow-up|Lost to Follow-up|0|||
170485824|NCT03331796|616119234|FG001|Extended Follow-up|Lost to Follow-up|0|||
170485825|NCT03331796|616119235|FG002|Extended Follow-up|Lost to Follow-up|1|||
170485826|NCT03331796|616119233|FG000|Extended Follow-up|Withdrawal by Subject|1|||
170485827|NCT03331796|616119234|FG001|Extended Follow-up|Withdrawal by Subject|0|||
170485828|NCT03331796|616119235|FG002|Extended Follow-up|Withdrawal by Subject|0|||
170485829|NCT03331796|616119233|FG000|Extended Follow-up|Termination of Funding|0|||
170485830|NCT03331796|616119234|FG001|Extended Follow-up|Termination of Funding|1|||
170485831|NCT03331796|616119235|FG002|Extended Follow-up|Termination of Funding|0|||
170485832|NCT01262872|616119236|FG000|Step 2|Death|0|||
170485833|NCT01262872|616119237|FG001|Step 2|Death|0|||
170485834|NCT01262872|616119238|FG002|Step 2|Death|0|||
170485835|NCT01262872|616119239|FG003|Step 2|Death|1|||
170485836|NCT01262872|616119240|FG004|Step 2|Death|0|||
170485837|NCT01262872|616119241|FG005|Step 2|Death|2|||
170485838|NCT01262872|616119242|FG006|Step 2|Death|2|||
170485839|NCT01262872|616119243|FG007|Step 2|Death|1|||
170485840|NCT01262872|616119236|FG000|Step 2|Protocol Violation|0|||
170485841|NCT01262872|616119237|FG001|Step 2|Protocol Violation|0|||
170485842|NCT01262872|616119238|FG002|Step 2|Protocol Violation|1|||
170485843|NCT01262872|616119239|FG003|Step 2|Protocol Violation|0|||
170485844|NCT01262872|616119240|FG004|Step 2|Protocol Violation|0|||
170485845|NCT01262872|616119241|FG005|Step 2|Protocol Violation|0|||
170485846|NCT01262872|616119242|FG006|Step 2|Protocol Violation|3|||
170485847|NCT01262872|616119243|FG007|Step 2|Protocol Violation|1|||
170485848|NCT01262872|616119236|FG000|Step 2|Withdrawal by Subject|0|||
170485849|NCT01262872|616119237|FG001|Step 2|Withdrawal by Subject|0|||
170485850|NCT01262872|616119238|FG002|Step 2|Withdrawal by Subject|4|||
170485851|NCT01262872|616119239|FG003|Step 2|Withdrawal by Subject|6|||
170485852|NCT01262872|616119240|FG004|Step 2|Withdrawal by Subject|3|||
170548740|NCT02533674|616354652|FG005|Dose Level V|Progressive disease|0|||
170485853|NCT01262872|616119241|FG005|Step 2|Withdrawal by Subject|1|||
170485854|NCT01262872|616119242|FG006|Step 2|Withdrawal by Subject|2|||
170485855|NCT01262872|616119243|FG007|Step 2|Withdrawal by Subject|1|||
170485856|NCT01262872|616119236|FG000|Step 2|Migrated/moved from study area|0|||
170485857|NCT01262872|616119237|FG001|Step 2|Migrated/moved from study area|0|||
170485858|NCT01262872|616119238|FG002|Step 2|Migrated/moved from study area|4|||
170485859|NCT01262872|616119239|FG003|Step 2|Migrated/moved from study area|3|||
170485860|NCT01262872|616119240|FG004|Step 2|Migrated/moved from study area|2|||
170485861|NCT01262872|616119241|FG005|Step 2|Migrated/moved from study area|6|||
170485862|NCT01262872|616119242|FG006|Step 2|Migrated/moved from study area|2|||
170485863|NCT01262872|616119243|FG007|Step 2|Migrated/moved from study area|3|||
170485864|NCT01808066|616119244|FG000|Overall Study|Withdrawal by Subject|15|||
170485865|NCT01753310|616119250|FG000|Overall Study|Entered into open label extension study|25|||
170485866|NCT01753310|616119251|FG001|Overall Study|Entered into open label extension study|22|||
170485867|NCT01753310|616119250|FG000|Overall Study|Adverse Event|1|||
170485868|NCT01753310|616119251|FG001|Overall Study|Adverse Event|0|||
170485869|NCT01753310|616119250|FG000|Overall Study|Lost to Follow-up|2|||
170485870|NCT01753310|616119251|FG001|Overall Study|Lost to Follow-up|0|||
170485871|NCT01753310|616119250|FG000|Overall Study|Subject decision|2|||
170485872|NCT01753310|616119251|FG001|Overall Study|Subject decision|2|||
170485873|NCT01753310|616119250|FG000|Overall Study|Sponsor decision|1|||
170485874|NCT01753310|616119251|FG001|Overall Study|Sponsor decision|0|||
170485875|NCT01753310|616119250|FG000|Overall Study|Withdrawal by Subject|1|||
170485876|NCT01753310|616119251|FG001|Overall Study|Withdrawal by Subject|0|||
170485877|NCT02022202|616119252|FG000|Overall Study|Withdrawal by Subject|2|||
170485878|NCT02022202|616119252|FG000|Overall Study|Disease Progression|3|||
170485879|NCT02022202|616119252|FG000|Overall Study|Desire go to immediately to surgery|3|||
170485880|NCT05581641|616119253|FG000|Overall Study|Withdrawal by Subject|0|||
170485881|NCT05581641|616119254|FG001|Overall Study|Withdrawal by Subject|1|||
170485882|NCT05581641|616119255|FG002|Overall Study|Withdrawal by Subject|3|||
170485883|NCT05581641|616119256|FG003|Overall Study|Withdrawal by Subject|1|||
170485884|NCT05581641|616119253|FG000|Overall Study|Lost to Follow-up|0|||
170485885|NCT05581641|616119254|FG001|Overall Study|Lost to Follow-up|1|||
170485886|NCT05581641|616119255|FG002|Overall Study|Lost to Follow-up|0|||
170485887|NCT05581641|616119256|FG003|Overall Study|Lost to Follow-up|1|||
170485888|NCT05581641|616119253|FG000|Overall Study|Protocol Violation|1|||
170485889|NCT05581641|616119254|FG001|Overall Study|Protocol Violation|0|||
170485890|NCT05581641|616119255|FG002|Overall Study|Protocol Violation|0|||
170485891|NCT05581641|616119256|FG003|Overall Study|Protocol Violation|0|||
170485892|NCT05581641|616119253|FG000|Overall Study|Other|1|||
170485893|NCT05581641|616119254|FG001|Overall Study|Other|0|||
170485894|NCT05581641|616119255|FG002|Overall Study|Other|2|||
170485895|NCT05581641|616119256|FG003|Overall Study|Other|1|||
170485896|NCT04390763|616119257|FG000|Safety run-in Part|Adverse Event|4|||
170485897|NCT04390763|616119258|FG001|Safety run-in Part|Adverse Event|0|||
170485898|NCT04390763|616119259|FG002|Safety run-in Part|Adverse Event|0|||
170485899|NCT04390763|616119260|FG003|Safety run-in Part|Adverse Event|0|||
170485900|NCT04390763|616119257|FG000|Safety run-in Part|Physician Decision|1|||
170485901|NCT04390763|616119258|FG001|Safety run-in Part|Physician Decision|0|||
170485902|NCT04390763|616119259|FG002|Safety run-in Part|Physician Decision|0|||
170485903|NCT04390763|616119260|FG003|Safety run-in Part|Physician Decision|0|||
170485904|NCT04390763|616119257|FG000|Safety run-in Part|Progressive Disease|6|||
170485905|NCT04390763|616119258|FG001|Safety run-in Part|Progressive Disease|0|||
170485906|NCT04390763|616119259|FG002|Safety run-in Part|Progressive Disease|0|||
170485907|NCT04390763|616119260|FG003|Safety run-in Part|Progressive Disease|0|||
170485908|NCT04390763|616119257|FG000|Randomized Part|Adverse Event|0|||
170485909|NCT04390763|616119258|FG001|Randomized Part|Adverse Event|11|||
170485910|NCT04390763|616119259|FG002|Randomized Part|Adverse Event|5|||
170485911|NCT04390763|616119260|FG003|Randomized Part|Adverse Event|5|||
170485912|NCT04390763|616119257|FG000|Randomized Part|Death|0|||
170485913|NCT04390763|616119258|FG001|Randomized Part|Death|3|||
170485914|NCT04390763|616119259|FG002|Randomized Part|Death|4|||
170485915|NCT04390763|616119260|FG003|Randomized Part|Death|2|||
170485916|NCT04390763|616119257|FG000|Randomized Part|Physician Decision|0|||
170485917|NCT04390763|616119258|FG001|Randomized Part|Physician Decision|2|||
170485918|NCT04390763|616119259|FG002|Randomized Part|Physician Decision|2|||
170485919|NCT04390763|616119260|FG003|Randomized Part|Physician Decision|9|||
170485920|NCT04390763|616119257|FG000|Randomized Part|Progressive Disease|0|||
170485921|NCT04390763|616119258|FG001|Randomized Part|Progressive Disease|24|||
170485922|NCT04390763|616119259|FG002|Randomized Part|Progressive Disease|31|||
170485923|NCT04390763|616119260|FG003|Randomized Part|Progressive Disease|23|||
170640442|NCT04080167|616695679|FG001|Overall Study|Hydroxyurea New Starts|0|||
170640443|NCT04080167|616695680|FG002|Overall Study|Hydroxyurea New Starts|1|||
170640444|NCT04080167|616695678|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
170485924|NCT04390763|616119257|FG000|Randomized Part|Study terminated by sponsor|0|||
170485925|NCT04390763|616119258|FG001|Randomized Part|Study terminated by sponsor|1|||
170485926|NCT04390763|616119259|FG002|Randomized Part|Study terminated by sponsor|0|||
170485927|NCT04390763|616119260|FG003|Randomized Part|Study terminated by sponsor|0|||
170485928|NCT04390763|616119257|FG000|Randomized Part|Participant Decision|0|||
170485929|NCT04390763|616119258|FG001|Randomized Part|Participant Decision|5|||
170485930|NCT04390763|616119259|FG002|Randomized Part|Participant Decision|7|||
170485931|NCT04390763|616119260|FG003|Randomized Part|Participant Decision|6|||
170485932|NCT04390763|616119257|FG000|Randomized Part|Not treated|0|||
170485933|NCT04390763|616119258|FG001|Randomized Part|Not treated|4|||
170485934|NCT04390763|616119259|FG002|Randomized Part|Not treated|2|||
170485935|NCT04390763|616119260|FG003|Randomized Part|Not treated|7|||
170485936|NCT01786993|616119261|FG000|Overall Study|Death|6|||
170485937|NCT01786993|616119262|FG001|Overall Study|Death|7|||
170485938|NCT01786993|616119261|FG000|Overall Study|Withdrawal by Subject|3|||
170485939|NCT01786993|616119262|FG001|Overall Study|Withdrawal by Subject|2|||
170485940|NCT01786993|616119261|FG000|Overall Study|Lost to Follow-up|0|||
170485941|NCT01786993|616119262|FG001|Overall Study|Lost to Follow-up|1|||
170485942|NCT01786993|616119261|FG000|Overall Study|Subject Non-Compliance|1|||
170485943|NCT01786993|616119262|FG001|Overall Study|Subject Non-Compliance|0|||
170485944|NCT01786993|616119261|FG000|Overall Study|System Explant|1|||
170485945|NCT01786993|616119262|FG001|Overall Study|System Explant|0|||
170485946|NCT01786993|616119261|FG000|Overall Study|Hospice Admission|1|||
170485947|NCT01786993|616119262|FG001|Overall Study|Hospice Admission|0|||
170485948|NCT00450437|616119263|FG000|Overall Study|Withdrawal by Subject|10|||
170485949|NCT00450437|616119264|FG001|Overall Study|Withdrawal by Subject|2|||
170485950|NCT00450437|616119265|FG002|Overall Study|Withdrawal by Subject|0|||
170485951|NCT00450437|616119266|FG003|Overall Study|Withdrawal by Subject|1|||
170485952|NCT00450437|616119263|FG000|Overall Study|Lost to Follow-up|31|||
170485953|NCT00450437|616119264|FG001|Overall Study|Lost to Follow-up|12|||
170485954|NCT00450437|616119265|FG002|Overall Study|Lost to Follow-up|19|||
170485955|NCT00450437|616119266|FG003|Overall Study|Lost to Follow-up|9|||
170485956|NCT00450437|616119263|FG000|Overall Study|Protocol Violation|0|||
170485957|NCT00450437|616119264|FG001|Overall Study|Protocol Violation|1|||
170485958|NCT00450437|616119265|FG002|Overall Study|Protocol Violation|0|||
170485959|NCT00450437|616119266|FG003|Overall Study|Protocol Violation|1|||
170485960|NCT00450437|616119263|FG000|Overall Study|Inappropriate enrollment|4|||
170485961|NCT00450437|616119264|FG001|Overall Study|Inappropriate enrollment|1|||
170485962|NCT00450437|616119265|FG002|Overall Study|Inappropriate enrollment|3|||
170485963|NCT00450437|616119266|FG003|Overall Study|Inappropriate enrollment|0|||
170485964|NCT00450437|616119263|FG000|Overall Study|Administrative reason|0|||
170485965|NCT00450437|616119264|FG001|Overall Study|Administrative reason|0|||
170485966|NCT00450437|616119265|FG002|Overall Study|Administrative reason|1|||
170485967|NCT00450437|616119266|FG003|Overall Study|Administrative reason|0|||
170485968|NCT00450437|616119263|FG000|Overall Study|Unable to Classify|1|||
170485969|NCT00450437|616119264|FG001|Overall Study|Unable to Classify|0|||
170485970|NCT00450437|616119265|FG002|Overall Study|Unable to Classify|1|||
170485971|NCT00450437|616119266|FG003|Overall Study|Unable to Classify|0|||
170485972|NCT04025879|616119267|FG000|Randomization|Participant withdrew consent|0|||
170485973|NCT04025879|616119268|FG001|Randomization|Participant withdrew consent|1|||
170485974|NCT04025879|616119267|FG000|Randomization|Participant no longer met study criteria|1|||
170485975|NCT04025879|616119268|FG001|Randomization|Participant no longer met study criteria|1|||
170485976|NCT04025879|616119267|FG000|Treatment|Ongoing treatment|10|||
170485977|NCT04025879|616119268|FG001|Treatment|Ongoing treatment|8|||
170485978|NCT04025879|616119267|FG000|Treatment|Disease progression/recurrence|36|||
170485979|NCT04025879|616119268|FG001|Treatment|Disease progression/recurrence|72|||
170485980|NCT04025879|616119267|FG000|Treatment|Study drug toxicity|36|||
170485981|NCT04025879|616119268|FG001|Treatment|Study drug toxicity|13|||
170485982|NCT04025879|616119267|FG000|Treatment|Death|2|||
170485983|NCT04025879|616119268|FG001|Treatment|Death|0|||
170485984|NCT04025879|616119267|FG000|Treatment|Adverse event unrelated to study drug|21|||
170485985|NCT04025879|616119268|FG001|Treatment|Adverse event unrelated to study drug|14|||
170485986|NCT04025879|616119267|FG000|Treatment|Participant request to discontinue study treatment|16|||
170485987|NCT04025879|616119268|FG001|Treatment|Participant request to discontinue study treatment|8|||
170485988|NCT04025879|616119267|FG000|Treatment|Participant withdrew consent|1|||
170485989|NCT04025879|616119268|FG001|Treatment|Participant withdrew consent|3|||
170485990|NCT04025879|616119267|FG000|Treatment|Participant no longer meets study criteria|3|||
170485991|NCT04025879|616119268|FG001|Treatment|Participant no longer meets study criteria|2|||
170485992|NCT04025879|616119267|FG000|Treatment|Lost to Follow-up|1|||
170485993|NCT04025879|616119268|FG001|Treatment|Lost to Follow-up|0|||
170485994|NCT04025879|616119267|FG000|Treatment|Other reasons|15|||
170485995|NCT04025879|616119268|FG001|Treatment|Other reasons|17|||
170485996|NCT04025879|616119267|FG000|Treatment|Administrative reason by sponsor|0|||
170485997|NCT04025879|616119268|FG001|Treatment|Administrative reason by sponsor|1|||
170485998|NCT04025879|616119267|FG000|Treatment|Not reported|2|||
170485999|NCT04025879|616119268|FG001|Treatment|Not reported|0|||
170486000|NCT03591874|616119273|FG000|Overall Study|Adverse Event|4|||
170486001|NCT03591874|616119274|FG001|Overall Study|Adverse Event|0|||
170486002|NCT03591874|616119273|FG000|Overall Study|Withdrawal by Subject|2|||
170548741|NCT02533674|616354653|FG006|Dose Level V|Progressive disease|0|||
170548742|NCT02533674|616354654|FG007|Dose Level V|Progressive disease|0|||
170486003|NCT03591874|616119274|FG001|Overall Study|Withdrawal by Subject|1|||
170486004|NCT03591874|616119273|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
170548743|NCT02533674|616354647|FG000|Dose Level V|Withdrawal by Subject|0|||
170548744|NCT02533674|616354648|FG001|Dose Level V|Withdrawal by Subject|0|||
170486005|NCT03591874|616119274|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
170486006|NCT03591874|616119273|FG000|Overall Study|On Study at Time of Study Termination|12|||
170486007|NCT03591874|616119274|FG001|Overall Study|On Study at Time of Study Termination|6|||
170486008|NCT03644342|616119277|FG000|Overall Study|Adverse Event|2|||
170486009|NCT03644342|616119278|FG001|Overall Study|Adverse Event|0|||
170486010|NCT03644342|616119277|FG000|Overall Study|Protocol Violation|0|||
170486011|NCT03644342|616119278|FG001|Overall Study|Protocol Violation|1|||
170486012|NCT00848718|616119282|FG000|Overall Study|Adverse Event|2|||
170486013|NCT00848718|616119283|FG001|Overall Study|Adverse Event|2|||
170486014|NCT00848718|616119284|FG002|Overall Study|Adverse Event|1|||
170486015|NCT00848718|616119285|FG003|Overall Study|Adverse Event|1|||
170486016|NCT00848718|616119286|FG004|Overall Study|Adverse Event|1|||
170486017|NCT00848718|616119287|FG005|Overall Study|Adverse Event|0|||
170486018|NCT00848718|616119288|FG006|Overall Study|Adverse Event|0|||
170486019|NCT00848718|616119289|FG007|Overall Study|Adverse Event|1|||
170486020|NCT00848718|616119290|FG008|Overall Study|Adverse Event|1|||
170486021|NCT00848718|616119291|FG009|Overall Study|Adverse Event|0|||
170486022|NCT00848718|616119292|FG010|Overall Study|Adverse Event|0|||
170486023|NCT00848718|616119293|FG011|Overall Study|Adverse Event|0|||
170486024|NCT00848718|616119294|FG012|Overall Study|Adverse Event|2|||
170486025|NCT00848718|616119282|FG000|Overall Study|Lack of Efficacy|0|||
170486026|NCT00848718|616119283|FG001|Overall Study|Lack of Efficacy|0|||
170486027|NCT00848718|616119284|FG002|Overall Study|Lack of Efficacy|1|||
170486028|NCT00848718|616119285|FG003|Overall Study|Lack of Efficacy|0|||
170486029|NCT00848718|616119286|FG004|Overall Study|Lack of Efficacy|0|||
170486030|NCT00848718|616119287|FG005|Overall Study|Lack of Efficacy|0|||
170486031|NCT00848718|616119288|FG006|Overall Study|Lack of Efficacy|1|||
170486032|NCT00848718|616119289|FG007|Overall Study|Lack of Efficacy|0|||
170486033|NCT00848718|616119290|FG008|Overall Study|Lack of Efficacy|0|||
170486034|NCT00848718|616119291|FG009|Overall Study|Lack of Efficacy|0|||
170486035|NCT00848718|616119292|FG010|Overall Study|Lack of Efficacy|0|||
170486036|NCT00848718|616119293|FG011|Overall Study|Lack of Efficacy|0|||
170486037|NCT00848718|616119294|FG012|Overall Study|Lack of Efficacy|0|||
170486038|NCT00848718|616119282|FG000|Overall Study|Physician Decision|0|||
170486039|NCT00848718|616119283|FG001|Overall Study|Physician Decision|1|||
170486040|NCT00848718|616119284|FG002|Overall Study|Physician Decision|0|||
170486041|NCT00848718|616119285|FG003|Overall Study|Physician Decision|0|||
170486042|NCT00848718|616119286|FG004|Overall Study|Physician Decision|1|||
170486043|NCT00848718|616119287|FG005|Overall Study|Physician Decision|1|||
170486044|NCT00848718|616119288|FG006|Overall Study|Physician Decision|0|||
170486045|NCT00848718|616119289|FG007|Overall Study|Physician Decision|0|||
170486046|NCT00848718|616119290|FG008|Overall Study|Physician Decision|1|||
170486047|NCT00848718|616119291|FG009|Overall Study|Physician Decision|2|||
170486048|NCT00848718|616119292|FG010|Overall Study|Physician Decision|0|||
170486049|NCT00848718|616119293|FG011|Overall Study|Physician Decision|0|||
170486050|NCT00848718|616119294|FG012|Overall Study|Physician Decision|1|||
170486051|NCT00848718|616119282|FG000|Overall Study|Progressive disease before treatment|1|||
170486052|NCT00848718|616119283|FG001|Overall Study|Progressive disease before treatment|5|||
170486053|NCT00848718|616119284|FG002|Overall Study|Progressive disease before treatment|1|||
170486054|NCT00848718|616119285|FG003|Overall Study|Progressive disease before treatment|3|||
170486055|NCT00848718|616119286|FG004|Overall Study|Progressive disease before treatment|4|||
170486056|NCT00848718|616119287|FG005|Overall Study|Progressive disease before treatment|4|||
170486057|NCT00848718|616119288|FG006|Overall Study|Progressive disease before treatment|2|||
170486058|NCT00848718|616119289|FG007|Overall Study|Progressive disease before treatment|1|||
170486059|NCT00848718|616119290|FG008|Overall Study|Progressive disease before treatment|2|||
170486060|NCT00848718|616119291|FG009|Overall Study|Progressive disease before treatment|7|||
170486061|NCT00848718|616119292|FG010|Overall Study|Progressive disease before treatment|3|||
170486062|NCT00848718|616119293|FG011|Overall Study|Progressive disease before treatment|6|||
170486063|NCT00848718|616119294|FG012|Overall Study|Progressive disease before treatment|2|||
170486064|NCT00848718|616119282|FG000|Overall Study|Protocol Violation|0|||
170486065|NCT00848718|616119283|FG001|Overall Study|Protocol Violation|1|||
170486066|NCT00848718|616119284|FG002|Overall Study|Protocol Violation|0|||
170486067|NCT00848718|616119285|FG003|Overall Study|Protocol Violation|0|||
170486068|NCT00848718|616119286|FG004|Overall Study|Protocol Violation|0|||
170486069|NCT00848718|616119287|FG005|Overall Study|Protocol Violation|0|||
170486070|NCT00848718|616119288|FG006|Overall Study|Protocol Violation|0|||
170486071|NCT00848718|616119289|FG007|Overall Study|Protocol Violation|1|||
170486072|NCT00848718|616119290|FG008|Overall Study|Protocol Violation|0|||
170798234|NCT06065735|617273651|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
170798235|NCT06065735|617273652|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
170486073|NCT00848718|616119291|FG009|Overall Study|Protocol Violation|0|||
170486074|NCT00848718|616119292|FG010|Overall Study|Protocol Violation|0|||
170486075|NCT00848718|616119293|FG011|Overall Study|Protocol Violation|0|||
170486076|NCT00848718|616119294|FG012|Overall Study|Protocol Violation|1|||
170486077|NCT00848718|616119282|FG000|Overall Study|Withdrawal by Subject|1|||
170486078|NCT00848718|616119283|FG001|Overall Study|Withdrawal by Subject|0|||
170486079|NCT00848718|616119284|FG002|Overall Study|Withdrawal by Subject|0|||
170486080|NCT00848718|616119285|FG003|Overall Study|Withdrawal by Subject|1|||
170798236|NCT06065735|617273653|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
170798237|NCT06065735|617273651|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
170798238|NCT06065735|617273652|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
170486081|NCT00848718|616119286|FG004|Overall Study|Withdrawal by Subject|0|||
170486082|NCT00848718|616119287|FG005|Overall Study|Withdrawal by Subject|0|||
170486083|NCT00848718|616119288|FG006|Overall Study|Withdrawal by Subject|0|||
170486084|NCT00848718|616119289|FG007|Overall Study|Withdrawal by Subject|0|||
170486085|NCT00848718|616119290|FG008|Overall Study|Withdrawal by Subject|0|||
170486086|NCT00848718|616119291|FG009|Overall Study|Withdrawal by Subject|0|||
170486087|NCT00848718|616119292|FG010|Overall Study|Withdrawal by Subject|1|||
170486088|NCT00848718|616119293|FG011|Overall Study|Withdrawal by Subject|0|||
170486089|NCT00848718|616119294|FG012|Overall Study|Withdrawal by Subject|0|||
170486090|NCT00848718|616119282|FG000|Overall Study|Progressive disease during treatment|3|||
170898112|NCT00723957|617632369|FG001|Overall Study|Maximum clinical benefit|5|||
170898113|NCT00723957|617632368|FG000|Overall Study|Investigator decision|1|||
170898114|NCT00723957|617632369|FG001|Overall Study|Investigator decision|1|||
170898115|NCT00723957|617632368|FG000|Overall Study|Study drug toxicity|4|||
170898116|NCT00723957|617632369|FG001|Overall Study|Study drug toxicity|6|||
170898117|NCT00723957|617632368|FG000|Overall Study|Withdrawal by Subject|7|||
170898118|NCT00723957|617632369|FG001|Overall Study|Withdrawal by Subject|5|||
170898119|NCT00723957|617632368|FG000|Overall Study|Reason not analyzed|1|||
170898120|NCT00723957|617632369|FG001|Overall Study|Reason not analyzed|0|||
170898121|NCT00723957|617632368|FG000|Overall Study|Never received treatment|3|||
170898122|NCT00723957|617632369|FG001|Overall Study|Never received treatment|3|||
170898123|NCT00868790|617632370|FG000|Period 1|Adverse Event|1|||
170898124|NCT00868790|617632371|FG001|Period 1|Adverse Event|0|||
170898125|NCT00868790|617632372|FG002|Period 1|Adverse Event|0|||
170898126|NCT00868790|617632373|FG003|Period 1|Adverse Event|0|||
170898127|NCT00868790|617632374|FG004|Period 1|Adverse Event|0|||
170898128|NCT00868790|617632375|FG005|Period 1|Adverse Event|0|||
170898129|NCT00868790|617632376|FG006|Period 1|Adverse Event|0|||
170898130|NCT00868790|617632377|FG007|Period 1|Adverse Event|3|||
170898131|NCT00868790|617632378|FG008|Period 1|Adverse Event|1|||
170898132|NCT00868790|617632379|FG009|Period 1|Adverse Event|0|||
170898133|NCT00868790|617632380|FG010|Period 1|Adverse Event|0|||
170898134|NCT00868790|617632381|FG011|Period 1|Adverse Event|0|||
170898135|NCT00868790|617632382|FG012|Period 1|Adverse Event|0|||
170486091|NCT00848718|616119283|FG001|Overall Study|Progressive disease during treatment|0|||
170486092|NCT00848718|616119284|FG002|Overall Study|Progressive disease during treatment|3|||
170486093|NCT00848718|616119285|FG003|Overall Study|Progressive disease during treatment|0|||
170486094|NCT00848718|616119286|FG004|Overall Study|Progressive disease during treatment|0|||
170486095|NCT00848718|616119287|FG005|Overall Study|Progressive disease during treatment|0|||
170486096|NCT00848718|616119288|FG006|Overall Study|Progressive disease during treatment|0|||
170486097|NCT00848718|616119289|FG007|Overall Study|Progressive disease during treatment|2|||
170486098|NCT00848718|616119290|FG008|Overall Study|Progressive disease during treatment|0|||
170486099|NCT00848718|616119291|FG009|Overall Study|Progressive disease during treatment|0|||
170486100|NCT00848718|616119292|FG010|Overall Study|Progressive disease during treatment|0|||
170486101|NCT00848718|616119293|FG011|Overall Study|Progressive disease during treatment|0|||
170486102|NCT00848718|616119294|FG012|Overall Study|Progressive disease during treatment|2|||
170486103|NCT04031846|616119295|FG000|Overall Study|Lost to Follow-up|4|||
170486104|NCT04031846|616119296|FG001|Overall Study|Lost to Follow-up|4|||
170486105|NCT04031846|616119295|FG000|Overall Study|Physician Decision|0|||
170486106|NCT04031846|616119296|FG001|Overall Study|Physician Decision|1|||
170486107|NCT04031846|616119295|FG000|Overall Study|Protocol Violation|1|||
170486108|NCT04031846|616119296|FG001|Overall Study|Protocol Violation|1|||
170486109|NCT04031846|616119295|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
170486110|NCT04031846|616119296|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
170486111|NCT05514873|616119299|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
170486112|NCT05514873|616119299|FG000|Main Treatment Period|Adverse Event|2|||
170486113|NCT05514873|616119299|FG000|Extension Treatment Period|Lost to Follow-up|3|||
170486114|NCT02366637|616120636|FG000|First Intervention Period|Adverse Event|0|||
170486115|NCT02366637|616120637|FG001|First Intervention Period|Adverse Event|1|||
170486116|NCT02366637|616120636|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
170486117|NCT02366637|616120637|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
170486118|NCT02366637|616120636|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
170486119|NCT02366637|616120637|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
170486120|NCT02609607|616120638|FG000|Overall Study|Lost to Follow-up|0|||
170898136|NCT00868790|617632383|FG013|Period 1|Adverse Event|1|||
170898137|NCT00868790|617632370|FG000|Period 1|Protocol Violation|1|||
170898138|NCT00868790|617632371|FG001|Period 1|Protocol Violation|0|||
170898139|NCT00868790|617632372|FG002|Period 1|Protocol Violation|0|||
170898140|NCT00868790|617632373|FG003|Period 1|Protocol Violation|0|||
170898141|NCT00868790|617632374|FG004|Period 1|Protocol Violation|0|||
170486121|NCT02609607|616120639|FG001|Overall Study|Lost to Follow-up|1|||
170486122|NCT03168711|616120642|FG000|Overall Study|Adverse Event|2|||
170486123|NCT03168711|616120643|FG001|Overall Study|Adverse Event|0|||
170486124|NCT03168711|616120642|FG000|Overall Study|Withdrawal by Subject|0|||
170486125|NCT03168711|616120643|FG001|Overall Study|Withdrawal by Subject|1|||
170898142|NCT00868790|617632375|FG005|Period 1|Protocol Violation|0|||
170898143|NCT00868790|617632376|FG006|Period 1|Protocol Violation|0|||
170898144|NCT00868790|617632377|FG007|Period 1|Protocol Violation|0|||
170898145|NCT00868790|617632378|FG008|Period 1|Protocol Violation|0|||
170898146|NCT00868790|617632379|FG009|Period 1|Protocol Violation|0|||
170486126|NCT03168711|616120642|FG000|Overall Study|Death|0|||
170548745|NCT02533674|616354649|FG002|Dose Level V|Withdrawal by Subject|0|||
170898147|NCT00868790|617632380|FG010|Period 1|Protocol Violation|0|||
170898148|NCT00868790|617632381|FG011|Period 1|Protocol Violation|0|||
170486127|NCT03168711|616120643|FG001|Overall Study|Death|1|||
170486128|NCT02877004|616120644|FG000|Overall Study|Pregnancy|0|||
170898149|NCT00868790|617632382|FG012|Period 1|Protocol Violation|0|||
170486129|NCT02877004|616120645|FG001|Overall Study|Pregnancy|0|||
170486130|NCT02877004|616120646|FG002|Overall Study|Pregnancy|1|||
170486131|NCT02727478|616120647|FG000|Overall Study|Withdrawal by Subject|8|||
170486132|NCT02727478|616120648|FG001|Overall Study|Withdrawal by Subject|10|||
170486133|NCT02633293|616120650|FG000|Overall Study|Death|56|||
170486134|NCT02633293|616120650|FG000|Overall Study|Progressive Disease|12|||
170486135|NCT02633293|616120650|FG000|Overall Study|Adverse Event|29|||
170486136|NCT02633293|616120650|FG000|Overall Study|Withdrawal by Subject|41|||
170486137|NCT02633293|616120650|FG000|Overall Study|Protocol Violation|1|||
170486138|NCT02633293|616120650|FG000|Overall Study|Lost to Follow-up|1|||
170486139|NCT02633293|616120650|FG000|Overall Study|Study Terminated by Sponsor|24|||
170486140|NCT02633293|616120650|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
170486141|NCT02633293|616120650|FG000|Overall Study|Lung Transplant|5|||
170486142|NCT02633293|616120650|FG000|Overall Study|Lack of Efficacy|2|||
170486143|NCT02633293|616120650|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
170486144|NCT01343043|616120651|FG000|Overall Study|Disease progression before treatment|1|||
170486145|NCT01343043|616120652|FG001|Overall Study|Disease progression before treatment|0|||
170486146|NCT01343043|616120653|FG002|Overall Study|Disease progression before treatment|0|||
170486147|NCT01343043|616120654|FG003|Overall Study|Disease progression before treatment|0|||
170486148|NCT01343043|616120651|FG000|Overall Study|Withdrawal by Subject|1|||
170486149|NCT01343043|616120652|FG001|Overall Study|Withdrawal by Subject|0|||
170486150|NCT01343043|616120653|FG002|Overall Study|Withdrawal by Subject|0|||
170486151|NCT01343043|616120654|FG003|Overall Study|Withdrawal by Subject|0|||
170486152|NCT01343043|616120651|FG000|Overall Study|Death|1|||
170486153|NCT01343043|616120652|FG001|Overall Study|Death|1|||
170486154|NCT01343043|616120653|FG002|Overall Study|Death|0|||
170486155|NCT01343043|616120654|FG003|Overall Study|Death|1|||
170486156|NCT01017874|616120655|FG000|Overall Study|Withdrawal by Subject|23|||
170486157|NCT01017874|616120656|FG001|Overall Study|Withdrawal by Subject|20|||
170486158|NCT01017874|616120655|FG000|Overall Study|Sponsor decision|3|||
170486159|NCT01017874|616120656|FG001|Overall Study|Sponsor decision|1|||
170486160|NCT01017874|616120655|FG000|Overall Study|Lost to Follow-up|3|||
170486161|NCT01017874|616120656|FG001|Overall Study|Lost to Follow-up|2|||
170486162|NCT01017874|616120655|FG000|Overall Study|Physician Decision|1|||
170486163|NCT01017874|616120656|FG001|Overall Study|Physician Decision|3|||
170486164|NCT00808210|616120657|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
170486165|NCT00808210|616120658|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
170486166|NCT00808210|616120657|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
170486167|NCT00808210|616120658|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
170548746|NCT02533674|616354650|FG003|Dose Level V|Withdrawal by Subject|0|||
170798239|NCT06065735|617273653|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
170798240|NCT06065735|617273651|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
170798241|NCT06065735|617273652|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
170798242|NCT06065735|617273653|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
170798243|NCT03904576|617273654|FG000|Washout Period|Protocol Violation|1|||
170798244|NCT03904576|617273655|FG001|Washout Period|Protocol Violation|1|||
170798245|NCT02919917|617273656|FG000|Overall Study|Withdrawal by Subject|4|||
170798246|NCT02919917|617273657|FG001|Overall Study|Withdrawal by Subject|8|||
170798247|NCT05718687|617273660|FG000|Overall Study|Withdrawal by Subject|3|||
170798248|NCT03279978|617273665|FG000|Overall Study|Withdrawal by Subject|0|||
170798249|NCT03279978|617273666|FG001|Overall Study|Withdrawal by Subject|1|||
170798250|NCT03279978|617273667|FG002|Overall Study|Withdrawal by Subject|0|||
170798251|NCT03279978|617273668|FG003|Overall Study|Withdrawal by Subject|0|||
170798252|NCT03279978|617273669|FG004|Overall Study|Withdrawal by Subject|0|||
170798253|NCT03279978|617273670|FG005|Overall Study|Withdrawal by Subject|0|||
170798254|NCT03279978|617273671|FG006|Overall Study|Withdrawal by Subject|0|||
170798255|NCT03279978|617273672|FG007|Overall Study|Withdrawal by Subject|0|||
170798256|NCT03279978|617273673|FG008|Overall Study|Withdrawal by Subject|0|||
170798257|NCT03279978|617273674|FG009|Overall Study|Withdrawal by Subject|1|||
170798258|NCT03279978|617273665|FG000|Overall Study|Lost to Follow-up|1|||
170798259|NCT03279978|617273666|FG001|Overall Study|Lost to Follow-up|0|||
170798260|NCT03279978|617273667|FG002|Overall Study|Lost to Follow-up|1|||
170548747|NCT02533674|616354651|FG004|Dose Level V|Withdrawal by Subject|1|||
170798261|NCT03279978|617273668|FG003|Overall Study|Lost to Follow-up|0|||
170798262|NCT03279978|617273669|FG004|Overall Study|Lost to Follow-up|0|||
170798263|NCT03279978|617273670|FG005|Overall Study|Lost to Follow-up|0|||
170486168|NCT00808210|616120657|FG000|Double-Blind TX Period|Adverse Event|0|||
170486169|NCT00808210|616120658|FG001|Double-Blind TX Period|Adverse Event|1|||
170486170|NCT00808210|616120657|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
170486171|NCT00808210|616120658|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
170486172|NCT00808210|616120657|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
170486173|NCT00808210|616120658|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
170798264|NCT03279978|617273671|FG006|Overall Study|Lost to Follow-up|0|||
170798265|NCT03279978|617273672|FG007|Overall Study|Lost to Follow-up|0|||
170898150|NCT00868790|617632383|FG013|Period 1|Protocol Violation|0|||
170898151|NCT00868790|617632370|FG000|Period 1|Withdrawal by Subject|0|||
170898152|NCT00868790|617632371|FG001|Period 1|Withdrawal by Subject|1|||
170898153|NCT00868790|617632372|FG002|Period 1|Withdrawal by Subject|0|||
170898154|NCT00868790|617632373|FG003|Period 1|Withdrawal by Subject|0|||
170898155|NCT00868790|617632374|FG004|Period 1|Withdrawal by Subject|0|||
170898156|NCT00868790|617632375|FG005|Period 1|Withdrawal by Subject|0|||
170898157|NCT00868790|617632376|FG006|Period 1|Withdrawal by Subject|0|||
170898158|NCT00868790|617632377|FG007|Period 1|Withdrawal by Subject|0|||
170898159|NCT00868790|617632378|FG008|Period 1|Withdrawal by Subject|0|||
170898160|NCT00868790|617632379|FG009|Period 1|Withdrawal by Subject|0|||
170898161|NCT00868790|617632380|FG010|Period 1|Withdrawal by Subject|0|||
170898162|NCT00868790|617632381|FG011|Period 1|Withdrawal by Subject|0|||
170898163|NCT00868790|617632382|FG012|Period 1|Withdrawal by Subject|0|||
170898164|NCT00868790|617632383|FG013|Period 1|Withdrawal by Subject|1|||
170486174|NCT00808210|616120657|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
170486175|NCT00808210|616120658|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
170486176|NCT02356588|616120661|FG000|Overall Study|Lack of Efficacy|4|||
170486177|NCT02356588|616120662|FG001|Overall Study|Lack of Efficacy|10|||
170486178|NCT02356588|616120661|FG000|Overall Study|Adverse Event|0|||
170486179|NCT02356588|616120662|FG001|Overall Study|Adverse Event|2|||
170486180|NCT02356588|616120661|FG000|Overall Study|Withdrawal by Subject|1|||
170486181|NCT02356588|616120662|FG001|Overall Study|Withdrawal by Subject|0|||
170486182|NCT02356588|616120661|FG000|Overall Study|Protocol Violation|0|||
170486183|NCT02356588|616120662|FG001|Overall Study|Protocol Violation|1|||
170486184|NCT00442897|616120664|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
170486185|NCT00442897|616120665|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
170486186|NCT00442897|616120664|FG000|Base Study (12 Week Follow-up)|Death|0|||
170486187|NCT00442897|616120665|FG001|Base Study (12 Week Follow-up)|Death|1|||
170486188|NCT00442897|616120664|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
170486189|NCT00442897|616120665|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
170486190|NCT00442897|616120664|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
170486191|NCT00442897|616120665|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
170486192|NCT00442897|616120664|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
170486193|NCT00442897|616120665|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
170486194|NCT00442897|616120664|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
170486195|NCT00442897|616120665|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
170486196|NCT00442897|616120664|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
170486197|NCT00442897|616120665|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
170486198|NCT00442897|616120664|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
170486199|NCT00442897|616120665|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
170486200|NCT01372618|616120666|FG000|Overall Study|PI Died. Study Terminated|9|||
170486201|NCT04548193|616120667|FG000|Overall Study|Lost to Follow-up|0|||
170486202|NCT04548193|616120668|FG001|Overall Study|Lost to Follow-up|1|||
170486203|NCT04548193|616120667|FG000|Overall Study|Death|0|||
170486204|NCT04548193|616120668|FG001|Overall Study|Death|1|||
170486205|NCT04548193|616120667|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
170486206|NCT04548193|616120668|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
170486207|NCT04548193|616120667|FG000|Overall Study|Withdrawal by Subject|2|||
170486208|NCT04548193|616120668|FG001|Overall Study|Withdrawal by Subject|2|||
170486209|NCT00558467|616120669|FG000|Overall Study|Adverse Event|1|||
170486210|NCT00558467|616120670|FG001|Overall Study|Adverse Event|2|||
170486211|NCT00558467|616120669|FG000|Overall Study|Lack of Efficacy|0|||
170486212|NCT00558467|616120670|FG001|Overall Study|Lack of Efficacy|1|||
170486213|NCT00558467|616120669|FG000|Overall Study|Patient moving out of state|0|||
170486214|NCT00558467|616120670|FG001|Overall Study|Patient moving out of state|1|||
170486215|NCT00931255|616120671|FG000|Overall Study|Follow up biopsy not done|2|||
170486216|NCT00931255|616120672|FG001|Overall Study|Follow up biopsy not done|3|||
170898165|NCT00868790|617632370|FG000|Period 1|Abnormal Triglycerides|0|||
170898166|NCT00868790|617632371|FG001|Period 1|Abnormal Triglycerides|0|||
170898167|NCT00868790|617632372|FG002|Period 1|Abnormal Triglycerides|0|||
170486217|NCT02019264|616120673|FG000|Overall Study|Not treated|6|||
170486218|NCT02019264|616120674|FG001|Overall Study|Not treated|4|||
170486219|NCT02019264|616120673|FG000|Overall Study|Lost to Follow-up|50|||
170486220|NCT02019264|616120674|FG001|Overall Study|Lost to Follow-up|47|||
170486221|NCT02019264|616120673|FG000|Overall Study|Withdrawal by Subject|142|||
170486222|NCT02019264|616120674|FG001|Overall Study|Withdrawal by Subject|117|||
170898168|NCT00868790|617632373|FG003|Period 1|Abnormal Triglycerides|0|||
170486223|NCT02019264|616120673|FG000|Overall Study|Administrative reason|36|||
170486224|NCT02019264|616120674|FG001|Overall Study|Administrative reason|28|||
170486225|NCT02019264|616120673|FG000|Overall Study|Missing|14|||
170486226|NCT02019264|616120674|FG001|Overall Study|Missing|11|||
170486227|NCT00558701|616120677|FG000|Overall Study|Protocol Deviations|1|||
170486228|NCT00558701|616120678|FG001|Overall Study|Protocol Deviations|4|||
170486229|NCT01681212|616120679|FG000|Overall Study|No longer met study criteria|5|||
170486230|NCT01681212|616120679|FG000|Overall Study|Administrative reason by sponsor|1|||
170486231|NCT01464424|616120680|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
170486232|NCT01464424|616120681|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
170486233|NCT01532518|616120682|FG000|Overall Study|Withdrawal by Subject|0|||
170486234|NCT01532518|616120683|FG001|Overall Study|Withdrawal by Subject|0|||
170486235|NCT01532518|616120684|FG002|Overall Study|Withdrawal by Subject|1|||
170486236|NCT01000155|616120685|FG000|Overall Study|Withdrawal by Subject|1|||
170486237|NCT01000155|616120685|FG000|Overall Study|Adverse Event|1|||
170486238|NCT02949973|616120688|FG000|Overall Study|Physician Decision|1|||
170486239|NCT01252095|616120689|FG000|Overall Study|Disease progression|1|||
170548748|NCT02533674|616354652|FG005|Dose Level V|Withdrawal by Subject|0|||
170548749|NCT02533674|616354653|FG006|Dose Level V|Withdrawal by Subject|0|||
170548750|NCT02533674|616354654|FG007|Dose Level V|Withdrawal by Subject|0|||
170798266|NCT03279978|617273673|FG008|Overall Study|Lost to Follow-up|0|||
170798267|NCT03279978|617273674|FG009|Overall Study|Lost to Follow-up|0|||
170798268|NCT03279978|617273665|FG000|Overall Study|Other than stated above|0|||
170798269|NCT03279978|617273666|FG001|Overall Study|Other than stated above|0|||
170798270|NCT03279978|617273667|FG002|Overall Study|Other than stated above|0|||
170798271|NCT03279978|617273668|FG003|Overall Study|Other than stated above|0|||
170798272|NCT03279978|617273669|FG004|Overall Study|Other than stated above|0|||
170798273|NCT03279978|617273670|FG005|Overall Study|Other than stated above|0|||
170798274|NCT03279978|617273671|FG006|Overall Study|Other than stated above|1|||
170798275|NCT03279978|617273672|FG007|Overall Study|Other than stated above|0|||
170798276|NCT03279978|617273673|FG008|Overall Study|Other than stated above|0|||
170798277|NCT03279978|617273674|FG009|Overall Study|Other than stated above|0|||
170798278|NCT02461134|617273675|FG000|Overall Study|Adverse Event|1|||
170798279|NCT04159519|617273676|FG000|Overall Study|Adverse Event|1|||
170798280|NCT04159519|617273677|FG001|Overall Study|Adverse Event|1|||
170798281|NCT04159519|617273676|FG000|Overall Study|Lack of Efficacy|1|||
170798282|NCT04159519|617273677|FG001|Overall Study|Lack of Efficacy|0|||
170798283|NCT04159519|617273676|FG000|Overall Study|Discontinued from study|1|||
170798284|NCT04159519|617273677|FG001|Overall Study|Discontinued from study|0|||
170798285|NCT04159519|617273676|FG000|Overall Study|Protocol Violation|1|||
170798286|NCT04159519|617273677|FG001|Overall Study|Protocol Violation|1|||
170798287|NCT04159519|617273676|FG000|Overall Study|Withdrawal by Subject|4|||
170798288|NCT04159519|617273677|FG001|Overall Study|Withdrawal by Subject|4|||
170798289|NCT03493542|617273678|FG000|Base Study|Withdrawal by Subject|0|||
170798290|NCT03493542|617273679|FG001|Base Study|Withdrawal by Subject|4|||
170798291|NCT03493542|617273680|FG002|Base Study|Withdrawal by Subject|0|||
170798292|NCT03493542|617273678|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
170798293|NCT03493542|617273679|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
170798294|NCT03493542|617273680|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
170798295|NCT03493542|617273678|FG000|Extension Study|Withdrawal by Subject|0|||
170798296|NCT03493542|617273679|FG001|Extension Study|Withdrawal by Subject|0|||
170798297|NCT03493542|617273680|FG002|Extension Study|Withdrawal by Subject|25|||
170798298|NCT05129501|617273681|FG000|Overall Study|Lost to Follow-up|54|||
170798299|NCT05129501|617273682|FG001|Overall Study|Lost to Follow-up|41|||
170798300|NCT02611687|617274399|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
170798301|NCT02611687|617274400|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
170798302|NCT00308997|617274401|FG000|Overall Study|Subject feigned clinical data|0|||
170798303|NCT00308997|617274402|FG001|Overall Study|Subject feigned clinical data|1|||
170798304|NCT00308997|617274401|FG000|Overall Study|Unable to tolerate intervention|1|||
170798305|NCT00308997|617274402|FG001|Overall Study|Unable to tolerate intervention|0|||
170798306|NCT04675034|617274407|FG000|Overall Study|Lost to Follow-up|1|||
170798307|NCT04675034|617274408|FG001|Overall Study|Lost to Follow-up|1|||
170798308|NCT04675034|617274409|FG002|Overall Study|Lost to Follow-up|0|||
170798309|NCT04675034|617274410|FG003|Overall Study|Lost to Follow-up|2|||
170798310|NCT04675034|617274411|FG004|Overall Study|Lost to Follow-up|0|||
170798311|NCT04675034|617274407|FG000|Overall Study|Protocol Violation|1|||
170798312|NCT04675034|617274408|FG001|Overall Study|Protocol Violation|0|||
170798313|NCT04675034|617274409|FG002|Overall Study|Protocol Violation|0|||
170798314|NCT04675034|617274410|FG003|Overall Study|Protocol Violation|1|||
170798315|NCT04675034|617274411|FG004|Overall Study|Protocol Violation|3|||
170798316|NCT04675034|617274407|FG000|Overall Study|Withdrawal by Subject|9|||
170798317|NCT04675034|617274408|FG001|Overall Study|Withdrawal by Subject|3|||
170798318|NCT04675034|617274409|FG002|Overall Study|Withdrawal by Subject|4|||
170798319|NCT04675034|617274410|FG003|Overall Study|Withdrawal by Subject|8|||
170798320|NCT04675034|617274411|FG004|Overall Study|Withdrawal by Subject|6|||
170548751|NCT02533674|616354647|FG000|Dose Level V|Physician Decision|0|||
170486240|NCT01252095|616120690|FG001|Overall Study|Disease progression|0|||
170486241|NCT04760626|616120691|FG000|Overall Study|Withdrawal by Subject|24|||
170486242|NCT04760626|616120692|FG001|Overall Study|Withdrawal by Subject|20|||
170486243|NCT04760626|616120691|FG000|Overall Study|Lost to Follow-up|14|||
170486244|NCT04760626|616120692|FG001|Overall Study|Lost to Follow-up|19|||
170486245|NCT04760626|616120691|FG000|Overall Study|Physician Decision|3|||
170486246|NCT04760626|616120692|FG001|Overall Study|Physician Decision|5|||
170486247|NCT04760626|616120691|FG000|Overall Study|Death|3|||
170486248|NCT04760626|616120692|FG001|Overall Study|Death|6|||
170486249|NCT04760626|616120691|FG000|Overall Study|Site closure|1|||
170486250|NCT04760626|616120692|FG001|Overall Study|Site closure|0|||
170486251|NCT01956773|616120698|FG000|Overall Study|Lost to Follow-up|628|||
170486252|NCT01956773|616120699|FG001|Overall Study|Lost to Follow-up|1|||
170798321|NCT04214418|617274412|FG000|Overall Study|Withdrawal by Subject|1|||
170798322|NCT04214418|617274413|FG001|Overall Study|Withdrawal by Subject|0|||
170798323|NCT04214418|617274414|FG002|Overall Study|Withdrawal by Subject|0|||
170798324|NCT04214418|617274415|FG003|Overall Study|Withdrawal by Subject|0|||
170798325|NCT04214418|617274416|FG004|Overall Study|Withdrawal by Subject|0|||
170798326|NCT04214418|617274417|FG005|Overall Study|Withdrawal by Subject|0|||
170798327|NCT04214418|617274412|FG000|Overall Study|Adverse Event|0|||
170798328|NCT04214418|617274413|FG001|Overall Study|Adverse Event|2|||
170798329|NCT04214418|617274414|FG002|Overall Study|Adverse Event|0|||
170798330|NCT04214418|617274415|FG003|Overall Study|Adverse Event|0|||
170798331|NCT04214418|617274416|FG004|Overall Study|Adverse Event|0|||
170798332|NCT04214418|617274417|FG005|Overall Study|Adverse Event|0|||
170798333|NCT04214418|617274412|FG000|Overall Study|Death|1|||
170798334|NCT04214418|617274413|FG001|Overall Study|Death|0|||
170798335|NCT04214418|617274414|FG002|Overall Study|Death|0|||
170798336|NCT04214418|617274415|FG003|Overall Study|Death|0|||
170798337|NCT04214418|617274416|FG004|Overall Study|Death|0|||
170798338|NCT04214418|617274417|FG005|Overall Study|Death|0|||
170798339|NCT05836012|617274420|FG000|Overall Study|Lost to Follow-up|1|||
170798340|NCT05836012|617274421|FG001|Overall Study|Lost to Follow-up|0|||
170798341|NCT05836012|617274420|FG000|Overall Study|Withdrawal by Subject|1|||
170798342|NCT05836012|617274421|FG001|Overall Study|Withdrawal by Subject|3|||
170798343|NCT05836012|617274420|FG000|Overall Study|Reason not included in pre-specified categories|2|||
170798344|NCT05836012|617274421|FG001|Overall Study|Reason not included in pre-specified categories|1|||
170798345|NCT04908930|617274422|FG000|Overall Study|Lost to Follow-up|1|||
170798346|NCT04908930|617274423|FG001|Overall Study|Lost to Follow-up|1|||
170798347|NCT04908930|617274424|FG002|Overall Study|Lost to Follow-up|0|||
170798348|NCT04908930|617274425|FG003|Overall Study|Lost to Follow-up|0|||
170798349|NCT04908930|617274426|FG004|Overall Study|Lost to Follow-up|0|||
170798350|NCT04908930|617274422|FG000|Overall Study|hardware in mouth|1|||
170798351|NCT04908930|617274423|FG001|Overall Study|hardware in mouth|1|||
170798352|NCT04908930|617274424|FG002|Overall Study|hardware in mouth|0|||
170798353|NCT04908930|617274425|FG003|Overall Study|hardware in mouth|0|||
170798354|NCT04908930|617274426|FG004|Overall Study|hardware in mouth|0|||
170798355|NCT04908930|617274422|FG000|Overall Study|wrong team|1|||
170798356|NCT04908930|617274423|FG001|Overall Study|wrong team|0|||
170798357|NCT04908930|617274424|FG002|Overall Study|wrong team|0|||
170798358|NCT04908930|617274425|FG003|Overall Study|wrong team|0|||
170798359|NCT04908930|617274426|FG004|Overall Study|wrong team|0|||
170798360|NCT04908930|617274422|FG000|Overall Study|quit team|2|||
170798361|NCT04908930|617274423|FG001|Overall Study|quit team|4|||
170798362|NCT04908930|617274424|FG002|Overall Study|quit team|0|||
170798363|NCT04908930|617274425|FG003|Overall Study|quit team|0|||
170798364|NCT04908930|617274426|FG004|Overall Study|quit team|0|||
170798365|NCT04908930|617274422|FG000|Overall Study|Withdrawal by Subject|1|||
170486253|NCT01890122|616120700|FG000|Overall Study|Adverse Event|1|||
170486254|NCT01890122|616120701|FG001|Overall Study|Adverse Event|1|||
170486255|NCT01890122|616120702|FG002|Overall Study|Adverse Event|1|||
170486256|NCT01890122|616120703|FG003|Overall Study|Adverse Event|2|||
170486257|NCT01890122|616120700|FG000|Overall Study|Major Protocol Deviation|3|||
170486258|NCT01890122|616120701|FG001|Overall Study|Major Protocol Deviation|1|||
170798366|NCT04908930|617274423|FG001|Overall Study|Withdrawal by Subject|2|||
170798367|NCT04908930|617274424|FG002|Overall Study|Withdrawal by Subject|0|||
170798368|NCT04908930|617274425|FG003|Overall Study|Withdrawal by Subject|0|||
170798369|NCT04908930|617274426|FG004|Overall Study|Withdrawal by Subject|0|||
170798370|NCT04908930|617274422|FG000|Overall Study|parent not liking program|0|||
170798371|NCT04908930|617274423|FG001|Overall Study|parent not liking program|1|||
170798372|NCT04908930|617274424|FG002|Overall Study|parent not liking program|0|||
170798373|NCT04908930|617274425|FG003|Overall Study|parent not liking program|0|||
170798374|NCT04908930|617274426|FG004|Overall Study|parent not liking program|0|||
170798375|NCT03884439|617274427|FG000|Overall Study|No informed consent for publication of study results|38|||
170798376|NCT03884439|617274427|FG000|Overall Study|Contract violation/deficiency|7|||
170798377|NCT02624050|617274429|FG000|Overall Study|Physician Decision|4|||
170798378|NCT02624050|617274430|FG001|Overall Study|Physician Decision|0|||
170486259|NCT01890122|616120702|FG002|Overall Study|Major Protocol Deviation|0|||
170798379|NCT02624050|617274429|FG000|Overall Study|Protocol Violation|2|||
170798380|NCT02624050|617274430|FG001|Overall Study|Protocol Violation|0|||
170898169|NCT00868790|617632374|FG004|Period 1|Abnormal Triglycerides|1|||
170898170|NCT00868790|617632375|FG005|Period 1|Abnormal Triglycerides|0|||
170898171|NCT00868790|617632376|FG006|Period 1|Abnormal Triglycerides|0|||
170898172|NCT00868790|617632377|FG007|Period 1|Abnormal Triglycerides|0|||
170898173|NCT00868790|617632378|FG008|Period 1|Abnormal Triglycerides|0|||
170898174|NCT00868790|617632379|FG009|Period 1|Abnormal Triglycerides|0|||
170486260|NCT01890122|616120703|FG003|Overall Study|Major Protocol Deviation|1|||
170486261|NCT01890122|616120700|FG000|Overall Study|Lost to Follow-up|0|||
170486262|NCT01890122|616120701|FG001|Overall Study|Lost to Follow-up|1|||
170486263|NCT01890122|616120702|FG002|Overall Study|Lost to Follow-up|2|||
170486264|NCT01890122|616120703|FG003|Overall Study|Lost to Follow-up|2|||
170486265|NCT01890122|616120700|FG000|Overall Study|Voluntary Withdrawal|8|||
170486266|NCT01890122|616120701|FG001|Overall Study|Voluntary Withdrawal|8|||
170486267|NCT01890122|616120702|FG002|Overall Study|Voluntary Withdrawal|2|||
170486268|NCT01890122|616120703|FG003|Overall Study|Voluntary Withdrawal|11|||
170486269|NCT01890122|616120700|FG000|Overall Study|Lack of Efficacy|14|||
170486270|NCT01890122|616120701|FG001|Overall Study|Lack of Efficacy|24|||
170486271|NCT01890122|616120702|FG002|Overall Study|Lack of Efficacy|7|||
170486272|NCT01890122|616120703|FG003|Overall Study|Lack of Efficacy|41|||
170486273|NCT01890122|616120700|FG000|Overall Study|Reason not Specified|0|||
170486274|NCT01890122|616120701|FG001|Overall Study|Reason not Specified|1|||
170486275|NCT01890122|616120702|FG002|Overall Study|Reason not Specified|1|||
170486276|NCT01890122|616120703|FG003|Overall Study|Reason not Specified|2|||
170486277|NCT01890122|616120700|FG000|Overall Study|Randomized but not Treated|1|||
170486278|NCT01890122|616120701|FG001|Overall Study|Randomized but not Treated|1|||
170486279|NCT01890122|616120702|FG002|Overall Study|Randomized but not Treated|0|||
170486280|NCT01890122|616120703|FG003|Overall Study|Randomized but not Treated|0|||
170486281|NCT01924689|616120704|FG000|Overall Study|Death|0|||
170486282|NCT01924689|616120705|FG001|Overall Study|Death|1|||
170486283|NCT01924689|616120706|FG002|Overall Study|Death|0|||
170486284|NCT01924689|616120707|FG003|Overall Study|Death|1|||
170486285|NCT01924689|616120708|FG004|Overall Study|Death|0|||
170486286|NCT01924689|616120709|FG005|Overall Study|Death|0|||
170486287|NCT01924689|616120704|FG000|Overall Study|Disease progression|0|||
170486288|NCT01924689|616120705|FG001|Overall Study|Disease progression|0|||
170486289|NCT01924689|616120706|FG002|Overall Study|Disease progression|2|||
170486290|NCT01924689|616120707|FG003|Overall Study|Disease progression|0|||
170486291|NCT01924689|616120708|FG004|Overall Study|Disease progression|3|||
170486292|NCT01924689|616120709|FG005|Overall Study|Disease progression|2|||
170486293|NCT01924689|616120704|FG000|Overall Study|New therapy or study|3|||
170486294|NCT01924689|616120705|FG001|Overall Study|New therapy or study|2|||
170486295|NCT01924689|616120706|FG002|Overall Study|New therapy or study|1|||
170486296|NCT01924689|616120707|FG003|Overall Study|New therapy or study|4|||
170486297|NCT01924689|616120708|FG004|Overall Study|New therapy or study|2|||
170486298|NCT01924689|616120709|FG005|Overall Study|New therapy or study|0|||
170486299|NCT01924689|616120704|FG000|Overall Study|Withdrawal of consent|0|||
170486300|NCT01924689|616120705|FG001|Overall Study|Withdrawal of consent|0|||
170486301|NCT01924689|616120706|FG002|Overall Study|Withdrawal of consent|1|||
170486302|NCT01924689|616120707|FG003|Overall Study|Withdrawal of consent|1|||
170486303|NCT01924689|616120708|FG004|Overall Study|Withdrawal of consent|0|||
170486304|NCT01924689|616120709|FG005|Overall Study|Withdrawal of consent|0|||
170486305|NCT01924689|616120704|FG000|Overall Study|Other|0|||
170486306|NCT01924689|616120705|FG001|Overall Study|Other|0|||
170486307|NCT01924689|616120706|FG002|Overall Study|Other|0|||
170486308|NCT01924689|616120707|FG003|Overall Study|Other|0|||
170486309|NCT01924689|616120708|FG004|Overall Study|Other|1|||
170486310|NCT01924689|616120709|FG005|Overall Study|Other|0|||
170486311|NCT00722137|616120716|FG000|Overall Study|Overt Disease Progression|5|||
170486312|NCT00722137|616120717|FG001|Overall Study|Overt Disease Progression|4|||
170486313|NCT00722137|616120716|FG000|Overall Study|Adverse Event|17|||
170486314|NCT00722137|616120717|FG001|Overall Study|Adverse Event|21|||
170486315|NCT00722137|616120716|FG000|Overall Study|Death|12|||
170486316|NCT00722137|616120717|FG001|Overall Study|Death|7|||
170486317|NCT00722137|616120716|FG000|Overall Study|Withdrawal by Subject|6|||
170898175|NCT00868790|617632380|FG010|Period 1|Abnormal Triglycerides|0|||
170898176|NCT00868790|617632381|FG011|Period 1|Abnormal Triglycerides|0|||
170898177|NCT00868790|617632382|FG012|Period 1|Abnormal Triglycerides|0|||
170486318|NCT00722137|616120717|FG001|Overall Study|Withdrawal by Subject|9|||
170486319|NCT00722137|616120716|FG000|Overall Study|Other Reason Unknown|3|||
170486320|NCT00722137|616120717|FG001|Overall Study|Other Reason Unknown|4|||
170486321|NCT00722137|616120716|FG000|Overall Study|Randomized But Not Treated|2|||
170486322|NCT00722137|616120717|FG001|Overall Study|Randomized But Not Treated|3|||
170486323|NCT03711786|616120722|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
170486324|NCT03711786|616120723|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
170486325|NCT03711786|616120722|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
170486326|NCT03711786|616120723|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
170486327|NCT03711786|616120722|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
170898178|NCT00868790|617632383|FG013|Period 1|Abnormal Triglycerides|0|||
170898179|NCT00868790|617632370|FG000|Period 1|Lost to Follow-up|0|||
170898180|NCT00868790|617632371|FG001|Period 1|Lost to Follow-up|0|||
170898181|NCT00868790|617632372|FG002|Period 1|Lost to Follow-up|0|||
170898182|NCT00868790|617632373|FG003|Period 1|Lost to Follow-up|0|||
170898183|NCT00868790|617632374|FG004|Period 1|Lost to Follow-up|0|||
170898184|NCT00868790|617632375|FG005|Period 1|Lost to Follow-up|1|||
170898185|NCT00868790|617632376|FG006|Period 1|Lost to Follow-up|0|||
170486328|NCT03711786|616120723|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
170486329|NCT03711786|616120722|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
170486330|NCT03711786|616120723|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
170486331|NCT03711786|616120722|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
170898186|NCT00868790|617632377|FG007|Period 1|Lost to Follow-up|0|||
170898187|NCT00868790|617632378|FG008|Period 1|Lost to Follow-up|0|||
170898188|NCT00868790|617632379|FG009|Period 1|Lost to Follow-up|0|||
170898189|NCT00868790|617632380|FG010|Period 1|Lost to Follow-up|0|||
170898190|NCT00868790|617632381|FG011|Period 1|Lost to Follow-up|0|||
170898191|NCT00868790|617632382|FG012|Period 1|Lost to Follow-up|0|||
170898192|NCT00868790|617632383|FG013|Period 1|Lost to Follow-up|0|||
170898193|NCT00868790|617632370|FG000|Period 2|Adverse Event|0|||
170898194|NCT00868790|617632371|FG001|Period 2|Adverse Event|0|||
170898195|NCT00868790|617632372|FG002|Period 2|Adverse Event|0|||
170898196|NCT00868790|617632373|FG003|Period 2|Adverse Event|0|||
170898197|NCT00868790|617632374|FG004|Period 2|Adverse Event|0|||
170898198|NCT00868790|617632375|FG005|Period 2|Adverse Event|0|||
170898199|NCT00868790|617632376|FG006|Period 2|Adverse Event|0|||
170898200|NCT00868790|617632377|FG007|Period 2|Adverse Event|0|||
170898201|NCT00868790|617632378|FG008|Period 2|Adverse Event|1|||
170898202|NCT00868790|617632379|FG009|Period 2|Adverse Event|0|||
170898203|NCT00868790|617632380|FG010|Period 2|Adverse Event|0|||
170898204|NCT00868790|617632381|FG011|Period 2|Adverse Event|0|||
170898205|NCT00868790|617632382|FG012|Period 2|Adverse Event|0|||
170898206|NCT00868790|617632383|FG013|Period 2|Adverse Event|0|||
170898207|NCT00868790|617632370|FG000|Period 2|Lost to Follow-up|0|||
170898208|NCT00868790|617632371|FG001|Period 2|Lost to Follow-up|1|||
170898209|NCT00868790|617632372|FG002|Period 2|Lost to Follow-up|0|||
170898210|NCT00868790|617632373|FG003|Period 2|Lost to Follow-up|0|||
170898211|NCT00868790|617632374|FG004|Period 2|Lost to Follow-up|0|||
170898212|NCT00868790|617632375|FG005|Period 2|Lost to Follow-up|1|||
170898213|NCT00868790|617632376|FG006|Period 2|Lost to Follow-up|0|||
170898214|NCT00868790|617632377|FG007|Period 2|Lost to Follow-up|0|||
170898215|NCT00868790|617632378|FG008|Period 2|Lost to Follow-up|0|||
170898216|NCT00868790|617632379|FG009|Period 2|Lost to Follow-up|0|||
170898217|NCT00868790|617632380|FG010|Period 2|Lost to Follow-up|0|||
170898218|NCT00868790|617632381|FG011|Period 2|Lost to Follow-up|0|||
170898219|NCT00868790|617632382|FG012|Period 2|Lost to Follow-up|0|||
170898220|NCT00868790|617632383|FG013|Period 2|Lost to Follow-up|0|||
170898221|NCT00868790|617632370|FG000|Period 2|Withdrawal by Subject|0|||
170898222|NCT00868790|617632371|FG001|Period 2|Withdrawal by Subject|0|||
170898223|NCT00868790|617632372|FG002|Period 2|Withdrawal by Subject|0|||
170898224|NCT00868790|617632373|FG003|Period 2|Withdrawal by Subject|0|||
170898225|NCT00868790|617632374|FG004|Period 2|Withdrawal by Subject|0|||
170898226|NCT00868790|617632375|FG005|Period 2|Withdrawal by Subject|0|||
170898227|NCT00868790|617632376|FG006|Period 2|Withdrawal by Subject|0|||
170898228|NCT00868790|617632377|FG007|Period 2|Withdrawal by Subject|0|||
170898229|NCT00868790|617632378|FG008|Period 2|Withdrawal by Subject|1|||
170898230|NCT00868790|617632379|FG009|Period 2|Withdrawal by Subject|0|||
170898231|NCT00868790|617632380|FG010|Period 2|Withdrawal by Subject|0|||
170486332|NCT03711786|616120723|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
170486333|NCT03711786|616120722|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
170486334|NCT03711786|616120723|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
170486335|NCT00030901|616120724|FG000|Initial Registration|Ineligible|167|||
170486336|NCT00030901|616120725|FG001|Initial Registration|Ineligible|0|||
170486337|NCT00030901|616120726|FG002|Initial Registration|Ineligible|0|||
170548752|NCT02533674|616354648|FG001|Dose Level V|Physician Decision|0|||
170898232|NCT00868790|617632381|FG011|Period 2|Withdrawal by Subject|0|||
170898233|NCT00868790|617632382|FG012|Period 2|Withdrawal by Subject|0|||
170898234|NCT00868790|617632383|FG013|Period 2|Withdrawal by Subject|1|||
170898235|NCT00868790|617632370|FG000|Period 3|Adverse Event|0|||
170898236|NCT00868790|617632371|FG001|Period 3|Adverse Event|0|||
170898237|NCT00868790|617632372|FG002|Period 3|Adverse Event|0|||
170898238|NCT00868790|617632373|FG003|Period 3|Adverse Event|0|||
170898239|NCT00868790|617632374|FG004|Period 3|Adverse Event|0|||
170898240|NCT00868790|617632375|FG005|Period 3|Adverse Event|0|||
170486338|NCT00030901|616120724|FG000|Randomization|Adverse Event|0|||
170486339|NCT00030901|616120725|FG001|Randomization|Adverse Event|11|||
170486340|NCT00030901|616120726|FG002|Randomization|Adverse Event|7|||
170898241|NCT00868790|617632376|FG006|Period 3|Adverse Event|0|||
170898242|NCT00868790|617632377|FG007|Period 3|Adverse Event|0|||
170898243|NCT00868790|617632378|FG008|Period 3|Adverse Event|0|||
170898244|NCT00868790|617632379|FG009|Period 3|Adverse Event|1|||
170898245|NCT00868790|617632380|FG010|Period 3|Adverse Event|0|||
170898246|NCT00868790|617632381|FG011|Period 3|Adverse Event|0|||
170898247|NCT00868790|617632382|FG012|Period 3|Adverse Event|0|||
170486341|NCT00030901|616120724|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
170486342|NCT00030901|616120725|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
170486343|NCT00030901|616120726|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
170486344|NCT00030901|616120724|FG000|Randomization|Progression/Relapse|0|||
170486345|NCT00030901|616120725|FG001|Randomization|Progression/Relapse|22|||
170898248|NCT00868790|617632383|FG013|Period 3|Adverse Event|0|||
170898249|NCT00868790|617632370|FG000|Period 3|Protocol Violation|0|||
170898250|NCT00868790|617632371|FG001|Period 3|Protocol Violation|0|||
170898251|NCT00868790|617632372|FG002|Period 3|Protocol Violation|0|||
170898252|NCT00868790|617632373|FG003|Period 3|Protocol Violation|0|||
170898253|NCT00868790|617632374|FG004|Period 3|Protocol Violation|0|||
170898254|NCT00868790|617632375|FG005|Period 3|Protocol Violation|0|||
170898255|NCT00868790|617632376|FG006|Period 3|Protocol Violation|0|||
170898256|NCT00868790|617632377|FG007|Period 3|Protocol Violation|0|||
170898257|NCT00868790|617632378|FG008|Period 3|Protocol Violation|0|||
170898258|NCT00868790|617632379|FG009|Period 3|Protocol Violation|0|||
170898259|NCT00868790|617632380|FG010|Period 3|Protocol Violation|1|||
170898260|NCT00868790|617632381|FG011|Period 3|Protocol Violation|0|||
170898261|NCT00868790|617632382|FG012|Period 3|Protocol Violation|0|||
170898262|NCT00868790|617632383|FG013|Period 3|Protocol Violation|0|||
170898263|NCT00868790|617632370|FG000|Period 3|Study Terminated by Sponsor|0|||
170898264|NCT00868790|617632371|FG001|Period 3|Study Terminated by Sponsor|0|||
170898265|NCT00868790|617632372|FG002|Period 3|Study Terminated by Sponsor|0|||
170898266|NCT00868790|617632373|FG003|Period 3|Study Terminated by Sponsor|1|||
170898267|NCT00868790|617632374|FG004|Period 3|Study Terminated by Sponsor|0|||
170898268|NCT00868790|617632375|FG005|Period 3|Study Terminated by Sponsor|0|||
170898269|NCT00868790|617632376|FG006|Period 3|Study Terminated by Sponsor|0|||
170898270|NCT00868790|617632377|FG007|Period 3|Study Terminated by Sponsor|0|||
170898271|NCT00868790|617632378|FG008|Period 3|Study Terminated by Sponsor|0|||
170898272|NCT00868790|617632379|FG009|Period 3|Study Terminated by Sponsor|0|||
170898273|NCT00868790|617632380|FG010|Period 3|Study Terminated by Sponsor|0|||
170898274|NCT00868790|617632381|FG011|Period 3|Study Terminated by Sponsor|0|||
170898275|NCT00868790|617632382|FG012|Period 3|Study Terminated by Sponsor|0|||
170898276|NCT00868790|617632383|FG013|Period 3|Study Terminated by Sponsor|0|||
170898277|NCT00868790|617632370|FG000|Period 4|Adverse Event|0|||
170898278|NCT00868790|617632371|FG001|Period 4|Adverse Event|0|||
170898279|NCT00868790|617632372|FG002|Period 4|Adverse Event|0|||
170898280|NCT00868790|617632373|FG003|Period 4|Adverse Event|0|||
170898281|NCT00868790|617632374|FG004|Period 4|Adverse Event|0|||
170898282|NCT00868790|617632375|FG005|Period 4|Adverse Event|0|||
170898283|NCT00868790|617632376|FG006|Period 4|Adverse Event|0|||
170898284|NCT00868790|617632377|FG007|Period 4|Adverse Event|1|||
170898285|NCT00868790|617632378|FG008|Period 4|Adverse Event|0|||
170898286|NCT00868790|617632379|FG009|Period 4|Adverse Event|0|||
170898287|NCT00868790|617632380|FG010|Period 4|Adverse Event|1|||
170898288|NCT00868790|617632381|FG011|Period 4|Adverse Event|0|||
170898289|NCT00868790|617632382|FG012|Period 4|Adverse Event|1|||
170898290|NCT00868790|617632383|FG013|Period 4|Adverse Event|0|||
170898291|NCT00868790|617632370|FG000|Period 4|Lost to Follow-up|0|||
170898292|NCT00868790|617632371|FG001|Period 4|Lost to Follow-up|0|||
170898293|NCT00868790|617632372|FG002|Period 4|Lost to Follow-up|0|||
170898294|NCT00868790|617632373|FG003|Period 4|Lost to Follow-up|0|||
170898295|NCT00868790|617632374|FG004|Period 4|Lost to Follow-up|0|||
170898296|NCT00868790|617632375|FG005|Period 4|Lost to Follow-up|0|||
170898297|NCT00868790|617632376|FG006|Period 4|Lost to Follow-up|0|||
170898298|NCT00868790|617632377|FG007|Period 4|Lost to Follow-up|1|||
170898299|NCT00868790|617632378|FG008|Period 4|Lost to Follow-up|0|||
170898300|NCT00868790|617632379|FG009|Period 4|Lost to Follow-up|0|||
170898301|NCT00868790|617632380|FG010|Period 4|Lost to Follow-up|0|||
170898302|NCT00868790|617632381|FG011|Period 4|Lost to Follow-up|0|||
170898303|NCT00868790|617632382|FG012|Period 4|Lost to Follow-up|0|||
170898304|NCT00868790|617632383|FG013|Period 4|Lost to Follow-up|0|||
170898305|NCT00868790|617632370|FG000|Period 4|Study Terminated by Sponsor|2|||
170898306|NCT00868790|617632371|FG001|Period 4|Study Terminated by Sponsor|0|||
170898307|NCT00868790|617632372|FG002|Period 4|Study Terminated by Sponsor|0|||
170898308|NCT00868790|617632373|FG003|Period 4|Study Terminated by Sponsor|0|||
170898309|NCT00868790|617632374|FG004|Period 4|Study Terminated by Sponsor|0|||
170898310|NCT00868790|617632375|FG005|Period 4|Study Terminated by Sponsor|0|||
170898311|NCT00868790|617632376|FG006|Period 4|Study Terminated by Sponsor|0|||
170898312|NCT00868790|617632377|FG007|Period 4|Study Terminated by Sponsor|1|||
170486346|NCT00030901|616120726|FG002|Randomization|Progression/Relapse|21|||
170486347|NCT00030901|616120724|FG000|Randomization|Death|0|||
170898313|NCT00868790|617632378|FG008|Period 4|Study Terminated by Sponsor|2|||
170898314|NCT00868790|617632379|FG009|Period 4|Study Terminated by Sponsor|0|||
170898315|NCT00868790|617632380|FG010|Period 4|Study Terminated by Sponsor|2|||
170898316|NCT00868790|617632381|FG011|Period 4|Study Terminated by Sponsor|1|||
170898317|NCT00868790|617632382|FG012|Period 4|Study Terminated by Sponsor|0|||
170898318|NCT00868790|617632383|FG013|Period 4|Study Terminated by Sponsor|1|||
170898319|NCT00868790|617632370|FG000|Period 4|Abnormal ALT/AST|0|||
170898320|NCT00868790|617632371|FG001|Period 4|Abnormal ALT/AST|0|||
170898321|NCT00868790|617632372|FG002|Period 4|Abnormal ALT/AST|1|||
170898322|NCT00868790|617632373|FG003|Period 4|Abnormal ALT/AST|0|||
170898323|NCT00868790|617632374|FG004|Period 4|Abnormal ALT/AST|0|||
170898324|NCT00868790|617632375|FG005|Period 4|Abnormal ALT/AST|0|||
170898325|NCT00868790|617632376|FG006|Period 4|Abnormal ALT/AST|0|||
170898326|NCT00868790|617632377|FG007|Period 4|Abnormal ALT/AST|0|||
170898327|NCT00868790|617632378|FG008|Period 4|Abnormal ALT/AST|0|||
170898328|NCT00868790|617632379|FG009|Period 4|Abnormal ALT/AST|0|||
170898329|NCT00868790|617632380|FG010|Period 4|Abnormal ALT/AST|0|||
170898330|NCT00868790|617632381|FG011|Period 4|Abnormal ALT/AST|0|||
170898331|NCT00868790|617632382|FG012|Period 4|Abnormal ALT/AST|0|||
170898332|NCT00868790|617632383|FG013|Period 4|Abnormal ALT/AST|0|||
170898333|NCT00868790|617632370|FG000|Post-study|Withdrawal by Subject|0|||
170898334|NCT00868790|617632371|FG001|Post-study|Withdrawal by Subject|0|||
170898335|NCT00868790|617632372|FG002|Post-study|Withdrawal by Subject|0|||
170898336|NCT00868790|617632373|FG003|Post-study|Withdrawal by Subject|0|||
170898337|NCT00868790|617632374|FG004|Post-study|Withdrawal by Subject|1|||
170898338|NCT00868790|617632375|FG005|Post-study|Withdrawal by Subject|0|||
170898339|NCT00868790|617632376|FG006|Post-study|Withdrawal by Subject|0|||
170898340|NCT00868790|617632377|FG007|Post-study|Withdrawal by Subject|0|||
170898341|NCT00868790|617632378|FG008|Post-study|Withdrawal by Subject|0|||
170898342|NCT00868790|617632379|FG009|Post-study|Withdrawal by Subject|0|||
170898343|NCT00868790|617632380|FG010|Post-study|Withdrawal by Subject|0|||
170898344|NCT00868790|617632381|FG011|Post-study|Withdrawal by Subject|0|||
170898345|NCT00868790|617632382|FG012|Post-study|Withdrawal by Subject|0|||
170898346|NCT00868790|617632383|FG013|Post-study|Withdrawal by Subject|0|||
170898347|NCT00868790|617632370|FG000|Post-study|Excluded Medication|0|||
170898348|NCT00868790|617632371|FG001|Post-study|Excluded Medication|0|||
170898349|NCT00868790|617632372|FG002|Post-study|Excluded Medication|0|||
170898350|NCT00868790|617632373|FG003|Post-study|Excluded Medication|0|||
170898351|NCT00868790|617632374|FG004|Post-study|Excluded Medication|0|||
170898352|NCT00868790|617632375|FG005|Post-study|Excluded Medication|0|||
170898353|NCT00868790|617632376|FG006|Post-study|Excluded Medication|0|||
170898354|NCT00868790|617632377|FG007|Post-study|Excluded Medication|2|||
170898355|NCT00868790|617632378|FG008|Post-study|Excluded Medication|0|||
170898356|NCT00868790|617632379|FG009|Post-study|Excluded Medication|1|||
170898357|NCT00868790|617632380|FG010|Post-study|Excluded Medication|0|||
170898358|NCT00868790|617632381|FG011|Post-study|Excluded Medication|0|||
170898359|NCT00868790|617632382|FG012|Post-study|Excluded Medication|0|||
170898360|NCT00868790|617632383|FG013|Post-study|Excluded Medication|0|||
170898361|NCT01763164|617632384|FG000|Treatment Phase|Participant/Guardian decision|26|||
170898362|NCT01763164|617632385|FG001|Treatment Phase|Participant/Guardian decision|14|||
170898363|NCT01763164|617632384|FG000|Treatment Phase|Protocol Violation|1|||
170898364|NCT01763164|617632385|FG001|Treatment Phase|Protocol Violation|1|||
170898365|NCT01763164|617632384|FG000|Treatment Phase|Progressive Disease|142|||
170898366|NCT01763164|617632385|FG001|Treatment Phase|Progressive Disease|76|||
170898367|NCT01763164|617632384|FG000|Treatment Phase|Physician Decision|24|||
170898368|NCT01763164|617632385|FG001|Treatment Phase|Physician Decision|13|||
170898369|NCT01763164|617632384|FG000|Treatment Phase|Death|10|||
170898370|NCT01763164|617632385|FG001|Treatment Phase|Death|1|||
170898371|NCT01763164|617632384|FG000|Treatment Phase|Adverse Event|66|||
170898372|NCT01763164|617632385|FG001|Treatment Phase|Adverse Event|8|||
170898373|NCT01763164|617632384|FG000|Treatment Phase|Randomized but not Treated|0|||
170898374|NCT01763164|617632385|FG001|Treatment Phase|Randomized but not Treated|19|||
170898375|NCT01763164|617632384|FG000|Treatment Phase|Other|0|||
170898376|NCT01763164|617632385|FG001|Treatment Phase|Other|1|||
170898377|NCT01763164|617632384|FG000|Follow up Phase|New therapy for study indication|12|||
170898378|NCT01763164|617632385|FG001|Follow up Phase|New therapy for study indication|3|||
170898379|NCT01763164|617632384|FG000|Follow up Phase|Death|21|||
170898380|NCT01763164|617632385|FG001|Follow up Phase|Death|4|||
170898381|NCT01763164|617632384|FG000|Follow up Phase|Subject/guardian decision|9|||
170898382|NCT01763164|617632385|FG001|Follow up Phase|Subject/guardian decision|2|||
170898383|NCT01763164|617632384|FG000|Follow up Phase|Progressive disease|127|||
170898384|NCT01763164|617632385|FG001|Follow up Phase|Progressive disease|62|||
170898385|NCT01763164|617632384|FG000|Follow up Phase|Physician Decision|10|||
170898386|NCT01763164|617632385|FG001|Follow up Phase|Physician Decision|3|||
170548753|NCT02533674|616354649|FG002|Dose Level V|Physician Decision|0|||
170898387|NCT01763164|617632384|FG000|Follow up Phase|Lost to Follow-up|1|||
170898388|NCT01763164|617632385|FG001|Follow up Phase|Lost to Follow-up|0|||
170898389|NCT01763164|617632384|FG000|Follow up Phase|Adverse Event|17|||
170898390|NCT01763164|617632385|FG001|Follow up Phase|Adverse Event|1|||
170898391|NCT01264939|617632386|FG000|Overall Study|Adverse Event|1|||
170898392|NCT01264939|617632387|FG001|Overall Study|Adverse Event|3|||
170898393|NCT01264939|617632386|FG000|Overall Study|Lost to Follow-up|0|||
170898394|NCT01264939|617632387|FG001|Overall Study|Lost to Follow-up|3|||
170898395|NCT01264939|617632386|FG000|Overall Study|Physician Decision|1|||
170898396|NCT01264939|617632387|FG001|Overall Study|Physician Decision|1|||
170898397|NCT01264939|617632386|FG000|Overall Study|Patient/Guardian Decision|8|||
170898398|NCT01264939|617632387|FG001|Overall Study|Patient/Guardian Decision|10|||
170898399|NCT01264939|617632386|FG000|Overall Study|Disease Progression|8|||
170898400|NCT01264939|617632387|FG001|Overall Study|Disease Progression|11|||
170898401|NCT01454076|617632388|FG000|Overall Study|Other|2|||
170898402|NCT01454076|617632389|FG001|Overall Study|Other|0|||
170898403|NCT01454076|617632390|FG002|Overall Study|Other|0|||
170898404|NCT01454076|617632391|FG003|Overall Study|Other|1|||
170898405|NCT01454076|617632392|FG004|Overall Study|Other|2|||
170898406|NCT01454076|617632388|FG000|Overall Study|Withdrawal by Subject|3|||
170898407|NCT01454076|617632389|FG001|Overall Study|Withdrawal by Subject|4|||
170898408|NCT01454076|617632390|FG002|Overall Study|Withdrawal by Subject|2|||
170898409|NCT01454076|617632391|FG003|Overall Study|Withdrawal by Subject|1|||
170898410|NCT01454076|617632392|FG004|Overall Study|Withdrawal by Subject|2|||
170898411|NCT01454076|617632388|FG000|Overall Study|Adverse Event|8|||
170898412|NCT01454076|617632389|FG001|Overall Study|Adverse Event|2|||
170898413|NCT01454076|617632390|FG002|Overall Study|Adverse Event|7|||
170898414|NCT01454076|617632391|FG003|Overall Study|Adverse Event|0|||
170898415|NCT01454076|617632392|FG004|Overall Study|Adverse Event|2|||
170898416|NCT04964258|617632393|FG000|Overall Study|Lost to Follow-up|1|||
170898417|NCT04964258|617632394|FG001|Overall Study|Lost to Follow-up|0|||
170898418|NCT04964258|617632395|FG002|Overall Study|Lost to Follow-up|0|||
170898419|NCT04964258|617632396|FG003|Overall Study|Lost to Follow-up|0|||
170898420|NCT04964258|617632397|FG004|Overall Study|Lost to Follow-up|0|||
170898421|NCT04964258|617632398|FG005|Overall Study|Lost to Follow-up|1|||
170898422|NCT04964258|617632399|FG006|Overall Study|Lost to Follow-up|0|||
170898423|NCT04964258|617632400|FG007|Overall Study|Lost to Follow-up|0|||
170898424|NCT04964258|617632401|FG008|Overall Study|Lost to Follow-up|0|||
170898425|NCT04964258|617632402|FG009|Overall Study|Lost to Follow-up|0|||
170898426|NCT04964258|617632403|FG010|Overall Study|Lost to Follow-up|0|||
170898427|NCT02965378|617632404|FG000|Overall Study|Progression|16|||
170898428|NCT02965378|617632405|FG001|Overall Study|Progression|4|||
170898429|NCT02965378|617632404|FG000|Overall Study|Adverse Event|5|||
170898430|NCT02965378|617632405|FG001|Overall Study|Adverse Event|2|||
170898431|NCT02965378|617632404|FG000|Overall Study|Death|2|||
170898432|NCT02965378|617632405|FG001|Overall Study|Death|0|||
170898433|NCT02965378|617632404|FG000|Overall Study|Refusal|2|||
170898434|NCT02965378|617632405|FG001|Overall Study|Refusal|1|||
170898435|NCT02965378|617632404|FG000|Overall Study|Not protocol specified|0|||
170898436|NCT02965378|617632405|FG001|Overall Study|Not protocol specified|2|||
170898437|NCT01526148|617632413|FG000|Overall Study|Adverse Event|6|||
170898438|NCT01526148|617632414|FG001|Overall Study|Adverse Event|5|||
170898439|NCT01526148|617632413|FG000|Overall Study|Lost to Follow-up|3|||
170898440|NCT01526148|617632414|FG001|Overall Study|Lost to Follow-up|6|||
170898441|NCT01526148|617632413|FG000|Overall Study|Withdrawal by Subject|2|||
170898442|NCT01526148|617632414|FG001|Overall Study|Withdrawal by Subject|0|||
170898443|NCT01526148|617632413|FG000|Overall Study|Unstable Medical Condition|1|||
170898444|NCT01526148|617632414|FG001|Overall Study|Unstable Medical Condition|0|||
170898445|NCT01526148|617632413|FG000|Overall Study|Unable to discontinue concomitant med|1|||
170898446|NCT01526148|617632414|FG001|Overall Study|Unable to discontinue concomitant med|0|||
170898447|NCT01526148|617632413|FG000|Overall Study|Moved out of state|1|||
170898448|NCT01526148|617632414|FG001|Overall Study|Moved out of state|0|||
170898449|NCT01526148|617632413|FG000|Overall Study|Incarcerated|0|||
170898450|NCT01526148|617632414|FG001|Overall Study|Incarcerated|2|||
170898451|NCT01173653|617632415|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
170898452|NCT01173653|617632416|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
170898453|NCT00291551|617632419|FG000|Overall Study|Death|7|||
170898454|NCT00291551|617632419|FG000|Overall Study|Withdrawal by Subject|6|||
170898455|NCT01375764|617632420|FG000|Overall Study|Lost to Follow-up|0|||
170898456|NCT01375764|617632421|FG001|Overall Study|Lost to Follow-up|1|||
170898457|NCT01375764|617632422|FG002|Overall Study|Lost to Follow-up|0|||
170898458|NCT01375764|617632423|FG003|Overall Study|Lost to Follow-up|0|||
170898459|NCT01375764|617632424|FG004|Overall Study|Lost to Follow-up|0|||
170898460|NCT01375764|617632420|FG000|Overall Study|Withdrawal by Subject|2|||
170898461|NCT01375764|617632421|FG001|Overall Study|Withdrawal by Subject|0|||
170898462|NCT01375764|617632422|FG002|Overall Study|Withdrawal by Subject|0|||
170898463|NCT01375764|617632423|FG003|Overall Study|Withdrawal by Subject|0|||
170898464|NCT01375764|617632424|FG004|Overall Study|Withdrawal by Subject|1|||
170898465|NCT01375764|617632420|FG000|Overall Study|Other|0|||
170898466|NCT01375764|617632421|FG001|Overall Study|Other|0|||
170898467|NCT01375764|617632422|FG002|Overall Study|Other|0|||
170898468|NCT01375764|617632423|FG003|Overall Study|Other|1|||
170898469|NCT01375764|617632424|FG004|Overall Study|Other|0|||
170898470|NCT02452762|617632425|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
170898471|NCT02452762|617632426|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
170898472|NCT02452762|617632425|FG000|Overall Study|Withdrawal by Subject|1|||
170898473|NCT02452762|617632426|FG001|Overall Study|Withdrawal by Subject|0|||
170898474|NCT02867761|617632427|FG000|Overall Study|Participant withdrawn by investigator|0|||
170898475|NCT02867761|617632428|FG001|Overall Study|Participant withdrawn by investigator|1|||
170898476|NCT02867761|617632427|FG000|Overall Study|Lost to Follow-up|25|||
170898477|NCT02867761|617632428|FG001|Overall Study|Lost to Follow-up|18|||
170898478|NCT02867761|617632427|FG000|Overall Study|Unable to complete protocol|3|||
170898479|NCT02867761|617632428|FG001|Overall Study|Unable to complete protocol|7|||
170898480|NCT02658812|617632429|FG000|Overall Study|Disease Progression|7|||
170898481|NCT02658812|617632429|FG000|Overall Study|Unrelated to study treatment|1|||
170898482|NCT02658812|617632429|FG000|Overall Study|Adverse Event|1|||
170898483|NCT02445586|617632430|FG000|Overall Study|Death|14|||
170898484|NCT02445586|617632430|FG000|Overall Study|Withdrawal by Subject|13|||
170898485|NCT02445586|617632430|FG000|Overall Study|Disease Progression|10|||
170898486|NCT02445586|617632430|FG000|Overall Study|Protocol Violation|1|||
170898487|NCT02445586|617632430|FG000|Overall Study|Medical Condition|1|||
170898488|NCT01512264|617632431|FG000|Overall Study|Lost to Follow-up|0|||
170898489|NCT01512264|617632432|FG001|Overall Study|Lost to Follow-up|0|||
170898490|NCT01512264|617632433|FG002|Overall Study|Lost to Follow-up|0|||
170898491|NCT01512264|617632434|FG003|Overall Study|Lost to Follow-up|1|||
170898492|NCT00854828|617632435|FG000|Overall Study|Death|1|||
170898493|NCT00854828|617632436|FG001|Overall Study|Death|0|||
170898494|NCT00854828|617632437|FG002|Overall Study|Death|0|||
170898495|NCT00854828|617632438|FG003|Overall Study|Death|0|||
170898496|NCT00854828|617632435|FG000|Overall Study|Withdrawal by Subject|1|||
170898497|NCT00854828|617632436|FG001|Overall Study|Withdrawal by Subject|1|||
170898498|NCT00854828|617632437|FG002|Overall Study|Withdrawal by Subject|0|||
170898499|NCT00854828|617632438|FG003|Overall Study|Withdrawal by Subject|9|||
170898500|NCT00854828|617632435|FG000|Overall Study|Missed 24mo visit|1|||
170898501|NCT00854828|617632436|FG001|Overall Study|Missed 24mo visit|1|||
170898502|NCT00854828|617632437|FG002|Overall Study|Missed 24mo visit|8|||
170898503|NCT00854828|617632438|FG003|Overall Study|Missed 24mo visit|8|||
170898504|NCT01931059|617632439|FG000|Day 1|Pregnancy|0|||
170898505|NCT01931059|617632440|FG001|Day 1|Pregnancy|1|||
170898506|NCT01931059|617632439|FG000|Day3|Lost to Follow-up|1|||
170898507|NCT01931059|617632440|FG001|Day3|Lost to Follow-up|0|||
170898508|NCT02292212|617632449|FG000|ViE Phase|Withdrawal by Subject|1|||
170898509|NCT02292212|617632449|FG000|ViE Phase|Protocol Violation|2|||
170898510|NCT04957290|617632450|FG000|Overall Study|Progressive disease|3|||
170898511|NCT04957290|617632451|FG001|Overall Study|Progressive disease|3|||
170898512|NCT04957290|617632452|FG002|Overall Study|Progressive disease|2|||
170898513|NCT04957290|617632453|FG003|Overall Study|Progressive disease|0|||
170898514|NCT04957290|617632454|FG004|Overall Study|Progressive disease|0|||
170898515|NCT04957290|617632455|FG005|Overall Study|Progressive disease|0|||
170898516|NCT04957290|617632450|FG000|Overall Study|Withdrawal by Subject|1|||
170898517|NCT04957290|617632451|FG001|Overall Study|Withdrawal by Subject|0|||
170898518|NCT04957290|617632452|FG002|Overall Study|Withdrawal by Subject|1|||
170898519|NCT04957290|617632453|FG003|Overall Study|Withdrawal by Subject|0|||
170898520|NCT04957290|617632454|FG004|Overall Study|Withdrawal by Subject|0|||
170898521|NCT04957290|617632455|FG005|Overall Study|Withdrawal by Subject|0|||
170898522|NCT04957290|617632450|FG000|Overall Study|Death|0|||
170898523|NCT04957290|617632451|FG001|Overall Study|Death|2|||
170898524|NCT04957290|617632452|FG002|Overall Study|Death|1|||
170898525|NCT04957290|617632453|FG003|Overall Study|Death|0|||
170898526|NCT04957290|617632454|FG004|Overall Study|Death|0|||
170898527|NCT04957290|617632455|FG005|Overall Study|Death|0|||
170898528|NCT04957290|617632450|FG000|Overall Study|non compliance with study drug|0|||
170898529|NCT04957290|617632451|FG001|Overall Study|non compliance with study drug|1|||
170898530|NCT04957290|617632452|FG002|Overall Study|non compliance with study drug|0|||
170898531|NCT04957290|617632453|FG003|Overall Study|non compliance with study drug|0|||
170898532|NCT04957290|617632454|FG004|Overall Study|non compliance with study drug|0|||
170898533|NCT04957290|617632455|FG005|Overall Study|non compliance with study drug|0|||
170898534|NCT04957290|617632450|FG000|Overall Study|none specified.|0|||
170898535|NCT04957290|617632451|FG001|Overall Study|none specified.|1|||
170898536|NCT04957290|617632452|FG002|Overall Study|none specified.|2|||
170898537|NCT04957290|617632453|FG003|Overall Study|none specified.|0|||
170898538|NCT04957290|617632454|FG004|Overall Study|none specified.|0|||
170898539|NCT04957290|617632455|FG005|Overall Study|none specified.|0|||
170898540|NCT04957290|617632450|FG000|Overall Study|unacceptable toxicity|0|||
170898541|NCT04957290|617632451|FG001|Overall Study|unacceptable toxicity|0|||
170898542|NCT04957290|617632452|FG002|Overall Study|unacceptable toxicity|1|||
170898543|NCT04957290|617632453|FG003|Overall Study|unacceptable toxicity|0|||
170898544|NCT04957290|617632454|FG004|Overall Study|unacceptable toxicity|0|||
170898545|NCT04957290|617632455|FG005|Overall Study|unacceptable toxicity|0|||
170898546|NCT04957290|617632450|FG000|Overall Study|Adverse Event|0|||
170898547|NCT04957290|617632451|FG001|Overall Study|Adverse Event|0|||
170898548|NCT04957290|617632452|FG002|Overall Study|Adverse Event|1|||
170898549|NCT04957290|617632453|FG003|Overall Study|Adverse Event|0|||
170898550|NCT04957290|617632454|FG004|Overall Study|Adverse Event|0|||
170898551|NCT04957290|617632455|FG005|Overall Study|Adverse Event|0|||
170898552|NCT04957290|617632450|FG000|Overall Study|study terminated by sponsor|0|||
170898553|NCT04957290|617632451|FG001|Overall Study|study terminated by sponsor|0|||
170898554|NCT04957290|617632452|FG002|Overall Study|study terminated by sponsor|2|||
170898555|NCT04957290|617632453|FG003|Overall Study|study terminated by sponsor|0|||
170898556|NCT04957290|617632454|FG004|Overall Study|study terminated by sponsor|0|||
170898557|NCT04957290|617632455|FG005|Overall Study|study terminated by sponsor|0|||
170898558|NCT01282229|617632456|FG000|Overall Study|Protocol Violation|2|||
170486348|NCT00030901|616120725|FG001|Randomization|Death|1|||
170486349|NCT00030901|616120726|FG002|Randomization|Death|3|||
170486350|NCT00030901|616120724|FG000|Randomization|Other|0|||
170486351|NCT00030901|616120725|FG001|Randomization|Other|36|||
170486352|NCT00030901|616120726|FG002|Randomization|Other|33|||
170486353|NCT00030901|616120724|FG000|Randomization|Ineligible|0|||
170486354|NCT00030901|616120725|FG001|Randomization|Ineligible|15|||
170486355|NCT00030901|616120726|FG002|Randomization|Ineligible|14|||
170486356|NCT01806051|616120727|FG000|Overall Study|Withdrawal by Subject|6|||
170486357|NCT00734994|616120728|FG000|Overall Study|Withdrawal by Subject|1|||
170548754|NCT02533674|616354650|FG003|Dose Level V|Physician Decision|0|||
170548755|NCT02533674|616354651|FG004|Dose Level V|Physician Decision|1|||
170548756|NCT02533674|616354652|FG005|Dose Level V|Physician Decision|0|||
170548757|NCT02533674|616354653|FG006|Dose Level V|Physician Decision|0|||
170548758|NCT02533674|616354654|FG007|Dose Level V|Physician Decision|0|||
170548759|NCT02533674|616354647|FG000|Dose Level VI|Progressive disease|0|||
170548760|NCT02533674|616354648|FG001|Dose Level VI|Progressive disease|0|||
170548761|NCT02533674|616354649|FG002|Dose Level VI|Progressive disease|0|||
170548762|NCT02533674|616354650|FG003|Dose Level VI|Progressive disease|0|||
170548763|NCT02533674|616354651|FG004|Dose Level VI|Progressive disease|0|||
170548764|NCT02533674|616354652|FG005|Dose Level VI|Progressive disease|7|||
170548765|NCT02533674|616354653|FG006|Dose Level VI|Progressive disease|0|||
170798381|NCT03522298|617274435|FG000|Overall Study|Adverse Event|1|||
170798382|NCT03522298|617274436|FG001|Overall Study|Adverse Event|0|||
170798383|NCT03522298|617274437|FG002|Overall Study|Adverse Event|0|||
170798384|NCT03522298|617274438|FG003|Overall Study|Adverse Event|1|||
170798385|NCT03522298|617274435|FG000|Overall Study|Death|2|||
170798386|NCT03522298|617274436|FG001|Overall Study|Death|4|||
170798387|NCT03522298|617274437|FG002|Overall Study|Death|8|||
170798388|NCT03522298|617274438|FG003|Overall Study|Death|8|||
170798389|NCT03522298|617274435|FG000|Overall Study|Patient decision|0|||
170798390|NCT03522298|617274436|FG001|Overall Study|Patient decision|2|||
170798391|NCT03522298|617274437|FG002|Overall Study|Patient decision|2|||
170798392|NCT03522298|617274438|FG003|Overall Study|Patient decision|2|||
170798393|NCT05215054|617274442|FG000|Overall Study|Lost to Follow-up|1|||
170798394|NCT05215054|617274443|FG001|Overall Study|Lost to Follow-up|1|||
170798395|NCT05215054|617274442|FG000|Overall Study|Protocol Violation|1|||
170798396|NCT05215054|617274443|FG001|Overall Study|Protocol Violation|1|||
170798397|NCT05215054|617274442|FG000|Overall Study|Withdrawal by Subject|4|||
170798398|NCT05215054|617274443|FG001|Overall Study|Withdrawal by Subject|4|||
170798399|NCT05485935|617274445|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
170798400|NCT05485935|617274446|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
170798401|NCT05485935|617274445|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
170798402|NCT05485935|617274446|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
170798403|NCT05485935|617274445|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
170798404|NCT05485935|617274446|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
170798405|NCT05485935|617274445|FG000|Period 2 (T2 and V3)|loss of contact|0|||
170798406|NCT05485935|617274446|FG001|Period 2 (T2 and V3)|loss of contact|1|||
170798407|NCT03587805|617274449|FG000|Overall Study|Adverse Event|72|||
170798408|NCT03587805|617274449|FG000|Overall Study|Death|1|||
170798409|NCT03587805|617274449|FG000|Overall Study|Lost to Follow-up|78|||
170798410|NCT03587805|617274449|FG000|Overall Study|Withdrawal by Subject|105|||
170798411|NCT03587805|617274449|FG000|Overall Study|Lack of Efficacy|119|||
170798412|NCT03587805|617274449|FG000|Overall Study|Reason unknown|26|||
170798413|NCT03587805|617274449|FG000|Overall Study|COVID_19 pandemic|4|||
170798414|NCT03587805|617274449|FG000|Overall Study|Various reasons|121|||
170798415|NCT03587805|617274449|FG000|Overall Study|Withdrawal by parent/guardian|3|||
170798416|NCT04626427|617274450|FG000|Overall Study|Death|1|||
170798417|NCT04626427|617274450|FG000|Overall Study|Withdrawal by Subject|1|||
170486358|NCT02729025|616120732|FG000|Overall Study|Sponsor Decision|0|||
170486359|NCT02729025|616120733|FG001|Overall Study|Sponsor Decision|1|||
170486360|NCT03525678|616120738|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
170486361|NCT03525678|616120739|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
170548766|NCT02533674|616354654|FG007|Dose Level VI|Progressive disease|0|||
170798418|NCT04626427|617274450|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
170798419|NCT04626427|617274450|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
170798420|NCT02765412|617274451|FG000|Overall Study|Death|482|||
170798421|NCT02765412|617274452|FG001|Overall Study|Death|855|||
170798422|NCT03705793|617274983|FG000|Overall Study|Lost to Follow-up|3|||
170798423|NCT03705793|617274984|FG001|Overall Study|Lost to Follow-up|4|||
170798424|NCT03705793|617274983|FG000|Overall Study|Withdrawal by Subject|2|||
170798425|NCT03705793|617274984|FG001|Overall Study|Withdrawal by Subject|1|||
170798426|NCT00447980|617274985|FG000|Overall Study|Withdrawal by Subject|1|||
170798427|NCT00447980|617274986|FG001|Overall Study|Withdrawal by Subject|1|||
170798428|NCT00447980|617274987|FG002|Overall Study|Withdrawal by Subject|4|||
170798429|NCT00447980|617274988|FG003|Overall Study|Withdrawal by Subject|4|||
170798430|NCT00447980|617274985|FG000|Overall Study|Lost to Follow-up|1|||
170798431|NCT00447980|617274986|FG001|Overall Study|Lost to Follow-up|1|||
170798432|NCT00447980|617274987|FG002|Overall Study|Lost to Follow-up|0|||
170640445|NCT04080167|616695679|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
170640446|NCT04080167|616695680|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
170640447|NCT02167139|616695681|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
170640448|NCT02167139|616695682|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
170640449|NCT02167139|616695683|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
170640450|NCT02167139|616695684|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
170640451|NCT02167139|616695681|FG000|Randomised, Double-blind|Adverse Event|2|||
170640452|NCT02167139|616695682|FG001|Randomised, Double-blind|Adverse Event|9|||
170640453|NCT02167139|616695683|FG002|Randomised, Double-blind|Adverse Event|0|||
170640454|NCT02167139|616695684|FG003|Randomised, Double-blind|Adverse Event|0|||
170898559|NCT01176916|617632457|FG000|Overall Study|Adverse Event|61|||
170898560|NCT01176916|617632457|FG000|Overall Study|Death|1|||
170898561|NCT01176916|617632457|FG000|Overall Study|Lost to Follow-up|15|||
170898562|NCT01176916|617632457|FG000|Overall Study|Objective progression or relapse|17|||
170898563|NCT01176916|617632457|FG000|Overall Study|Protocol Violation|24|||
170898564|NCT01176916|617632457|FG000|Overall Study|Withdrawal by Subject|37|||
170898565|NCT01176916|617632457|FG000|Overall Study|Other|6|||
170898566|NCT01176916|617632457|FG000|Overall Study|Withdrawal prior to Treatment|6|||
170898567|NCT03158220|617632460|FG000|Overall Study|Screen Failure|0|||
170898568|NCT03158220|617632461|FG001|Overall Study|Screen Failure|1|||
170486362|NCT03525678|616120740|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
170486363|NCT03525678|616120741|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
170486364|NCT03525678|616120742|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
170486365|NCT03525678|616120738|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
170486366|NCT03525678|616120739|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
170486367|NCT03525678|616120740|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
170486368|NCT03525678|616120741|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
170486369|NCT03525678|616120742|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
170486370|NCT03525678|616120738|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
170486371|NCT03525678|616120739|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
170486372|NCT03525678|616120740|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
170486373|NCT03525678|616120741|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
170486374|NCT03525678|616120742|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
170486375|NCT03525678|616120738|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
170486376|NCT03525678|616120739|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
170486377|NCT03525678|616120740|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
170486378|NCT03525678|616120741|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
170486379|NCT03525678|616120742|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
170486380|NCT03525678|616120738|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
170486381|NCT03525678|616120739|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
170486382|NCT03525678|616120740|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
170486383|NCT03525678|616120741|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
170486384|NCT03525678|616120742|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
170486385|NCT03525678|616120738|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
170486386|NCT03525678|616120739|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
170486387|NCT03525678|616120740|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
170486388|NCT03525678|616120741|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
170486389|NCT03525678|616120742|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
170486390|NCT00734162|616122630|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
170486391|NCT00734162|616122631|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
170486392|NCT00734162|616122632|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
170486393|NCT00734162|616122633|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
170486394|NCT00734162|616122630|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
170486395|NCT00734162|616122631|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
170486396|NCT00734162|616122632|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
170486397|NCT00734162|616122633|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
170486398|NCT00734162|616122630|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
170486399|NCT00734162|616122631|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
170486400|NCT00734162|616122632|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
170486401|NCT00734162|616122633|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
170640455|NCT02167139|616695681|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
170640456|NCT02167139|616695682|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
170640457|NCT02167139|616695683|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
170640458|NCT02167139|616695684|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
170640459|NCT02167139|616695681|FG000|Randomised, Double-blind|Other|3|||
170640460|NCT02167139|616695682|FG001|Randomised, Double-blind|Other|0|||
170640461|NCT02167139|616695683|FG002|Randomised, Double-blind|Other|0|||
170640462|NCT02167139|616695684|FG003|Randomised, Double-blind|Other|0|||
170898569|NCT03158220|617632460|FG000|Overall Study|Withdrawal by Subject|8|||
170898570|NCT03158220|617632461|FG001|Overall Study|Withdrawal by Subject|9|||
170898571|NCT03158220|617632460|FG000|Overall Study|Status unknown|0|||
170898572|NCT03158220|617632461|FG001|Overall Study|Status unknown|1|||
170898573|NCT03158220|617632460|FG000|Overall Study|Lost to Follow-up|8|||
170898574|NCT03158220|617632461|FG001|Overall Study|Lost to Follow-up|5|||
170898575|NCT03158220|617632460|FG000|Overall Study|Physician Decision|1|||
170898576|NCT03158220|617632461|FG001|Overall Study|Physician Decision|0|||
170898577|NCT03682120|617632462|FG000|Overall Study|Lost to Follow-up|11|||
170898578|NCT03682120|617632463|FG001|Overall Study|Lost to Follow-up|4|||
170898579|NCT03682120|617632464|FG002|Overall Study|Lost to Follow-up|5|||
170898580|NCT03682120|617632465|FG003|Overall Study|Lost to Follow-up|2|||
170898581|NCT03682120|617632462|FG000|Overall Study|Physician Decision|1|||
170898582|NCT03682120|617632463|FG001|Overall Study|Physician Decision|0|||
170898583|NCT03682120|617632464|FG002|Overall Study|Physician Decision|0|||
170898584|NCT03682120|617632465|FG003|Overall Study|Physician Decision|0|||
170898585|NCT03682120|617632462|FG000|Overall Study|Withdrawal by Subject|1|||
170898586|NCT03682120|617632463|FG001|Overall Study|Withdrawal by Subject|2|||
170898587|NCT03682120|617632464|FG002|Overall Study|Withdrawal by Subject|3|||
170898588|NCT03682120|617632465|FG003|Overall Study|Withdrawal by Subject|0|||
170898589|NCT03682120|617632462|FG000|Overall Study|Death|0|||
170898590|NCT03682120|617632463|FG001|Overall Study|Death|1|||
170898591|NCT03682120|617632464|FG002|Overall Study|Death|0|||
170898592|NCT03682120|617632465|FG003|Overall Study|Death|0|||
170898593|NCT03682120|617632462|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
170898594|NCT03682120|617632463|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
170798433|NCT00447980|617274988|FG003|Overall Study|Lost to Follow-up|0|||
170798434|NCT00447980|617274985|FG000|Overall Study|Did not proceed with surgery|3|||
170798435|NCT00447980|617274986|FG001|Overall Study|Did not proceed with surgery|3|||
170798436|NCT00447980|617274987|FG002|Overall Study|Did not proceed with surgery|2|||
170798437|NCT00447980|617274988|FG003|Overall Study|Did not proceed with surgery|2|||
170798438|NCT02075554|617274989|FG000|Overall Study|Lost to Follow-up|7|||
170798439|NCT02075554|617274989|FG000|Overall Study|Withdrawal by Subject|5|||
170798440|NCT02075554|617274989|FG000|Overall Study|Physician Decision|3|||
170798441|NCT04408755|617274994|FG000|Period A (Placebo lead-in)|Other|11|||
170798442|NCT04408755|617274995|FG001|Period A (Placebo lead-in)|Other|0|||
170798443|NCT04408755|617274996|FG002|Period A (Placebo lead-in)|Other|0|||
170798444|NCT04408755|617274997|FG003|Period A (Placebo lead-in)|Other|0|||
170798445|NCT04408755|617274994|FG000|Period B (Randomization Period)|Adverse Event|0|||
170798446|NCT04408755|617274995|FG001|Period B (Randomization Period)|Adverse Event|3|||
170798447|NCT04408755|617274996|FG002|Period B (Randomization Period)|Adverse Event|0|||
170798448|NCT04408755|617274997|FG003|Period B (Randomization Period)|Adverse Event|1|||
170798449|NCT04408755|617274994|FG000|Period B (Randomization Period)|Death|0|||
170798450|NCT04408755|617274995|FG001|Period B (Randomization Period)|Death|0|||
170798451|NCT04408755|617274996|FG002|Period B (Randomization Period)|Death|1|||
170798452|NCT04408755|617274997|FG003|Period B (Randomization Period)|Death|0|||
170798453|NCT04408755|617274994|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
170798454|NCT04408755|617274995|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
170798455|NCT04408755|617274996|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
170798456|NCT04408755|617274997|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
170798457|NCT04408755|617274994|FG000|Period B (Randomization Period)|Physician Decision|0|||
170798458|NCT04408755|617274995|FG001|Period B (Randomization Period)|Physician Decision|0|||
170798459|NCT04408755|617274996|FG002|Period B (Randomization Period)|Physician Decision|1|||
170798460|NCT04408755|617274997|FG003|Period B (Randomization Period)|Physician Decision|0|||
170798461|NCT04408755|617274994|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
170798462|NCT04408755|617274995|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
170798463|NCT04408755|617274996|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
170798464|NCT04408755|617274997|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
170798465|NCT04408755|617274994|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
170798466|NCT04408755|617274995|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
170798467|NCT04408755|617274996|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
170798468|NCT04408755|617274997|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
170798469|NCT04408755|617274994|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
170798470|NCT04408755|617274995|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
170798471|NCT04408755|617274996|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
170798472|NCT04408755|617274997|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
170798473|NCT04408755|617274994|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
170798474|NCT04408755|617274995|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
170798475|NCT04408755|617274996|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
170798476|NCT04408755|617274997|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
170898595|NCT03682120|617632464|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
170898596|NCT03682120|617632465|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
170898597|NCT01015833|617632466|FG000|Overall Study|Death|1|||
170898598|NCT01015833|617632467|FG001|Overall Study|Death|0|||
170486402|NCT00734162|616122630|FG000|Open-Label Phase|Withdrew Consent|1|||
170486403|NCT00734162|616122631|FG001|Open-Label Phase|Withdrew Consent|0|||
170486404|NCT00734162|616122632|FG002|Open-Label Phase|Withdrew Consent|1|||
170486405|NCT00734162|616122633|FG003|Open-Label Phase|Withdrew Consent|1|||
170486406|NCT00734162|616122630|FG000|Open-Label Phase|Lost to Follow-up|1|||
170486407|NCT00734162|616122631|FG001|Open-Label Phase|Lost to Follow-up|2|||
170486408|NCT00734162|616122632|FG002|Open-Label Phase|Lost to Follow-up|0|||
170486409|NCT00734162|616122633|FG003|Open-Label Phase|Lost to Follow-up|1|||
170486410|NCT00734162|616122630|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
170486411|NCT00734162|616122631|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
170486412|NCT00734162|616122632|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
170486413|NCT00734162|616122633|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
170798477|NCT04408755|617274994|FG000|Period B (Randomization Period)|Reason not Specified|0|||
170798478|NCT04408755|617274995|FG001|Period B (Randomization Period)|Reason not Specified|1|||
170798479|NCT04408755|617274996|FG002|Period B (Randomization Period)|Reason not Specified|0|||
170798480|NCT04408755|617274997|FG003|Period B (Randomization Period)|Reason not Specified|2|||
170798481|NCT00942734|617274998|FG000|Overall Study|Adverse Event|2|||
170798482|NCT00942734|617274998|FG000|Overall Study|Protocol Violation|3|||
170798483|NCT00942734|617274998|FG000|Overall Study|Disease Progression|2|||
170798484|NCT00942734|617274998|FG000|Overall Study|Physician Decision|1|||
170798485|NCT06655818|617275004|FG000|Overall Study|Withdrawal by Subject|1|||
170798486|NCT00319046|617275005|FG000|Overall Study|withdrawal of subject's consent|7|||
170798487|NCT00319046|617275005|FG000|Overall Study|administrative reason|1|||
170798488|NCT03201939|617275010|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
170798489|NCT03201939|617275011|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
170798490|NCT04093869|617275013|FG000|Overall Study|Death|0|||
170798491|NCT04093869|617275014|FG001|Overall Study|Death|1|||
170798492|NCT04093869|617275013|FG000|Overall Study|Withdrawal by Subject|1|||
170798493|NCT04093869|617275014|FG001|Overall Study|Withdrawal by Subject|0|||
170798494|NCT02806726|617275019|FG000|Overall Study|Lost to Follow-up|1|||
170798495|NCT03142009|617275022|FG000|Overall Study|Lost to Follow-up|45|||
170798496|NCT03142009|617275023|FG001|Overall Study|Lost to Follow-up|30|||
170798497|NCT06059443|617275024|FG000|Overall Study|Withdrawal by Subject|2|||
170798498|NCT06059443|617275025|FG001|Overall Study|Withdrawal by Subject|0|||
170798499|NCT06059443|617275024|FG000|Overall Study|Lost to Follow-up|2|||
170798500|NCT06059443|617275025|FG001|Overall Study|Lost to Follow-up|2|||
170798501|NCT01527188|617275026|FG000|Overall Study|Adverse Event|5|||
170798502|NCT01527188|617275027|FG001|Overall Study|Adverse Event|5|||
170798503|NCT01527188|617275028|FG002|Overall Study|Adverse Event|11|||
170798504|NCT01527188|617275029|FG003|Overall Study|Adverse Event|0|||
170798505|NCT01527188|617275026|FG000|Overall Study|Withdrawal by Subject|3|||
170798506|NCT01527188|617275027|FG001|Overall Study|Withdrawal by Subject|6|||
170798507|NCT01527188|617275028|FG002|Overall Study|Withdrawal by Subject|4|||
170798508|NCT01527188|617275029|FG003|Overall Study|Withdrawal by Subject|4|||
170798509|NCT01527188|617275026|FG000|Overall Study|Any other reason not above-mentioned|6|||
170798510|NCT01527188|617275027|FG001|Overall Study|Any other reason not above-mentioned|7|||
170798511|NCT01527188|617275028|FG002|Overall Study|Any other reason not above-mentioned|8|||
170798512|NCT01527188|617275029|FG003|Overall Study|Any other reason not above-mentioned|8|||
170798513|NCT01553149|617275030|FG000|Overall Study|Adverse Event|0|||
170798514|NCT01553149|617275031|FG001|Overall Study|Adverse Event|9|||
170798515|NCT01553149|617275030|FG000|Overall Study|Physician Decision|5|||
170798516|NCT01553149|617275031|FG001|Overall Study|Physician Decision|10|||
170798517|NCT01553149|617275030|FG000|Overall Study|Ineligible|0|||
170798518|NCT01553149|617275031|FG001|Overall Study|Ineligible|1|||
170798519|NCT00709956|617275033|FG000|Overall Study|Withdrawal by Subject|1|||
170798520|NCT00709956|617275034|FG001|Overall Study|Withdrawal by Subject|1|||
170798521|NCT00709956|617275033|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
170798522|NCT00709956|617275034|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
170798523|NCT04039113|617275038|FG000|Overall Study|Withdrawal by Subject|8|||
170798524|NCT04039113|617275039|FG001|Overall Study|Withdrawal by Subject|11|||
170798525|NCT04039113|617275038|FG000|Overall Study|Lost to Follow-up|1|||
170486414|NCT05253573|616122634|FG000|Overall Study|Death|1|||
170486415|NCT05253573|616122635|FG001|Overall Study|Death|0|||
170486416|NCT01344824|616122636|FG000|Overall Study|Adverse Event|15|||
170486417|NCT01344824|616122636|FG000|Overall Study|Withdrawal by Subject|6|||
170486418|NCT01344824|616122636|FG000|Overall Study|Other complicating disease|1|||
170798526|NCT04039113|617275039|FG001|Overall Study|Lost to Follow-up|1|||
170798527|NCT04039113|617275038|FG000|Overall Study|Adverse Event|2|||
170798528|NCT04039113|617275039|FG001|Overall Study|Adverse Event|2|||
170798529|NCT04039113|617275038|FG000|Overall Study|Death|2|||
170798530|NCT04039113|617275039|FG001|Overall Study|Death|4|||
170798531|NCT04039113|617275038|FG000|Overall Study|Site Closure|6|||
170798532|NCT04039113|617275039|FG001|Overall Study|Site Closure|0|||
170798533|NCT04039113|617275038|FG000|Overall Study|Failure to meet randomisation criteria|4|||
170486419|NCT01344824|616122636|FG000|Overall Study|Progression|15|||
170486420|NCT01295671|616122637|FG000|Overall Study|Lost to Follow-up|4|||
170486421|NCT01295671|616122638|FG001|Overall Study|Lost to Follow-up|6|||
170486422|NCT01295671|616122639|FG002|Overall Study|Lost to Follow-up|3|||
170486423|NCT01295671|616122637|FG000|Overall Study|Withdrawal by Subject|3|||
170486424|NCT01295671|616122638|FG001|Overall Study|Withdrawal by Subject|1|||
170486425|NCT01295671|616122639|FG002|Overall Study|Withdrawal by Subject|0|||
170486426|NCT03351608|616122650|FG000|Overall Study|Lost to Follow-up|0|||
170486427|NCT03351608|616122651|FG001|Overall Study|Lost to Follow-up|1|||
170486428|NCT03351608|616122652|FG002|Overall Study|Lost to Follow-up|1|||
170486429|NCT03351608|616122653|FG003|Overall Study|Lost to Follow-up|1|||
170486430|NCT03351608|616122654|FG004|Overall Study|Lost to Follow-up|1|||
170486431|NCT03351608|616122650|FG000|Overall Study|Physician Decision|1|||
170486432|NCT03351608|616122651|FG001|Overall Study|Physician Decision|0|||
170486433|NCT03351608|616122652|FG002|Overall Study|Physician Decision|0|||
170486434|NCT03351608|616122653|FG003|Overall Study|Physician Decision|2|||
170486435|NCT03351608|616122654|FG004|Overall Study|Physician Decision|1|||
170486436|NCT03351608|616122650|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
170486437|NCT03351608|616122651|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
170486438|NCT03351608|616122652|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
170486439|NCT03351608|616122653|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
170486440|NCT03351608|616122654|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
170486441|NCT03351608|616122650|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170486442|NCT03351608|616122651|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170486443|NCT03351608|616122652|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170486444|NCT03351608|616122653|FG003|Overall Study|Withdrawal by parent/guardian|1|||
170486445|NCT03351608|616122654|FG004|Overall Study|Withdrawal by parent/guardian|0|||
170798534|NCT04039113|617275039|FG001|Overall Study|Failure to meet randomisation criteria|0|||
170798535|NCT04678856|617275040|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
170798536|NCT04678856|617275041|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
170798537|NCT04678856|617275040|FG000|Overall Study|Withdrawal by Subject|5|||
170798538|NCT04678856|617275041|FG001|Overall Study|Withdrawal by Subject|1|||
170798539|NCT04518943|617275678|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
170798540|NCT04518943|617275679|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
170798541|NCT04518943|617275680|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
170798542|NCT04518943|617275681|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
170798543|NCT04518943|617275682|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
170798544|NCT04518943|617275683|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
170798545|NCT04518943|617275684|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
170798546|NCT04518943|617275685|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
170798547|NCT04518943|617275686|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
170798548|NCT04518943|617275687|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
170798549|NCT04518943|617275688|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
170798550|NCT04518943|617275689|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
170798551|NCT04518943|617275690|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
170798552|NCT04518943|617275691|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
170798553|NCT04518943|617275692|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
170798554|NCT04518943|617275693|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
170798555|NCT02502266|617275695|FG000|Overall Study|Adverse Event|0|||
170798556|NCT02502266|617275696|FG001|Overall Study|Adverse Event|0|||
170798557|NCT02502266|617275697|FG002|Overall Study|Adverse Event|0|||
170798558|NCT02502266|617275698|FG003|Overall Study|Adverse Event|0|||
170798559|NCT02502266|617275699|FG004|Overall Study|Adverse Event|1|||
170798560|NCT02502266|617275700|FG005|Overall Study|Adverse Event|1|||
170798561|NCT02502266|617275701|FG006|Overall Study|Adverse Event|1|||
170798562|NCT02502266|617275695|FG000|Overall Study|Withdrawal by Subject|30|||
170798563|NCT02502266|617275696|FG001|Overall Study|Withdrawal by Subject|15|||
170798564|NCT02502266|617275697|FG002|Overall Study|Withdrawal by Subject|16|||
170798565|NCT02502266|617275698|FG003|Overall Study|Withdrawal by Subject|0|||
170798566|NCT02502266|617275699|FG004|Overall Study|Withdrawal by Subject|0|||
170798567|NCT02502266|617275700|FG005|Overall Study|Withdrawal by Subject|0|||
170798568|NCT02502266|617275701|FG006|Overall Study|Withdrawal by Subject|0|||
170798569|NCT02502266|617275695|FG000|Overall Study|Still on Treatment|0|||
170798570|NCT02502266|617275696|FG001|Overall Study|Still on Treatment|0|||
170798571|NCT02502266|617275697|FG002|Overall Study|Still on Treatment|1|||
170798572|NCT02502266|617275698|FG003|Overall Study|Still on Treatment|0|||
170798573|NCT02502266|617275699|FG004|Overall Study|Still on Treatment|0|||
170486446|NCT03351608|616122650|FG000|Overall Study|Other|0|||
170486447|NCT03351608|616122651|FG001|Overall Study|Other|1|||
170486448|NCT03351608|616122652|FG002|Overall Study|Other|1|||
170486449|NCT03351608|616122653|FG003|Overall Study|Other|3|||
170486450|NCT03351608|616122654|FG004|Overall Study|Other|0|||
170486451|NCT00778817|616122656|FG000|Overall Study|Adverse Event|2|||
170486452|NCT00778817|616122656|FG000|Overall Study|Withdrawal by Subject|2|||
170486453|NCT01418378|616122657|FG000|Overall Study|Death|1|||
170486454|NCT01418378|616122658|FG001|Overall Study|Death|2|||
170486455|NCT01418378|616122657|FG000|Overall Study|Physician Decision|0|||
170486456|NCT01418378|616122658|FG001|Overall Study|Physician Decision|1|||
170486457|NCT01418378|616122657|FG000|Overall Study|ligament imbalance|0|||
170486458|NCT01418378|616122658|FG001|Overall Study|ligament imbalance|1|||
170486459|NCT01418378|616122657|FG000|Overall Study|developed chronic myopathy|0|||
170798574|NCT02502266|617275700|FG005|Overall Study|Still on Treatment|0|||
170798575|NCT02502266|617275701|FG006|Overall Study|Still on Treatment|0|||
170798576|NCT02502266|617275695|FG000|Overall Study|Other Reasons|19|||
170798577|NCT02502266|617275696|FG001|Overall Study|Other Reasons|6|||
170798578|NCT02502266|617275697|FG002|Overall Study|Other Reasons|14|||
170798579|NCT02502266|617275698|FG003|Overall Study|Other Reasons|0|||
170798580|NCT02502266|617275699|FG004|Overall Study|Other Reasons|1|||
170798581|NCT02502266|617275700|FG005|Overall Study|Other Reasons|1|||
170798582|NCT02502266|617275701|FG006|Overall Study|Other Reasons|0|||
170798583|NCT02502266|617275695|FG000|Overall Study|Arm 4 Discontinued|0|||
170798584|NCT02502266|617275696|FG001|Overall Study|Arm 4 Discontinued|0|||
170798585|NCT02502266|617275697|FG002|Overall Study|Arm 4 Discontinued|0|||
170798586|NCT02502266|617275698|FG003|Overall Study|Arm 4 Discontinued|52|||
170798587|NCT02502266|617275699|FG004|Overall Study|Arm 4 Discontinued|0|||
170798588|NCT02502266|617275700|FG005|Overall Study|Arm 4 Discontinued|0|||
170798589|NCT02502266|617275701|FG006|Overall Study|Arm 4 Discontinued|0|||
170798590|NCT02502266|617275695|FG000|Overall Study|Never treated|0|||
170798591|NCT02502266|617275696|FG001|Overall Study|Never treated|0|||
170798592|NCT02502266|617275697|FG002|Overall Study|Never treated|0|||
170798593|NCT02502266|617275698|FG003|Overall Study|Never treated|0|||
170798594|NCT02502266|617275699|FG004|Overall Study|Never treated|0|||
170798595|NCT02502266|617275700|FG005|Overall Study|Never treated|1|||
170798596|NCT02502266|617275701|FG006|Overall Study|Never treated|0|||
170798597|NCT02166463|617275702|FG000|Overall Study|Lost to Follow-up|0|||
170798598|NCT02166463|617275703|FG001|Overall Study|Lost to Follow-up|1|||
170798599|NCT02166463|617275702|FG000|Overall Study|Physician Decision|10|||
170798600|NCT02166463|617275703|FG001|Overall Study|Physician Decision|10|||
170798601|NCT02166463|617275702|FG000|Overall Study|Ineligible|11|||
170798602|NCT02166463|617275703|FG001|Overall Study|Ineligible|2|||
170798603|NCT02166463|617275702|FG000|Overall Study|Progressive Disease|9|||
170798604|NCT02166463|617275703|FG001|Overall Study|Progressive Disease|6|||
170798605|NCT02166463|617275702|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
170798606|NCT02166463|617275703|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
170798607|NCT02166463|617275702|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
170798608|NCT02166463|617275703|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
170798609|NCT02166463|617275702|FG000|Overall Study|Refusal of further protocol therapy|5|||
170798610|NCT02166463|617275703|FG001|Overall Study|Refusal of further protocol therapy|6|||
170798611|NCT02231749|617275704|FG000|Overall Study|Disease progression|229|||
170798612|NCT02231749|617275705|FG001|Overall Study|Disease progression|297|||
170798613|NCT02231749|617275704|FG000|Overall Study|Study Drug Toxicity|134|||
170798614|NCT02231749|617275705|FG001|Overall Study|Study Drug Toxicity|63|||
170798615|NCT02231749|617275704|FG000|Overall Study|Death|1|||
170798616|NCT02231749|617275705|FG001|Overall Study|Death|1|||
170798617|NCT02231749|617275704|FG000|Overall Study|AE unrelated to Study drug|32|||
170798618|NCT02231749|617275705|FG001|Overall Study|AE unrelated to Study drug|31|||
170798619|NCT02231749|617275704|FG000|Overall Study|Participant's request to discontinue|10|||
170798620|NCT02231749|617275705|FG001|Overall Study|Participant's request to discontinue|21|||
170798621|NCT02231749|617275704|FG000|Overall Study|Participant withdrew Consent|8|||
170798622|NCT02231749|617275705|FG001|Overall Study|Participant withdrew Consent|15|||
170798623|NCT02231749|617275704|FG000|Overall Study|Lost to Follow-up|1|||
170798624|NCT02231749|617275705|FG001|Overall Study|Lost to Follow-up|2|||
170798625|NCT02231749|617275704|FG000|Overall Study|Maximum Clinical Benefit|5|||
170798626|NCT02231749|617275705|FG001|Overall Study|Maximum Clinical Benefit|8|||
170798627|NCT02231749|617275704|FG000|Overall Study|Poor/Non-Compliance|0|||
170798628|NCT02231749|617275705|FG001|Overall Study|Poor/Non-Compliance|3|||
170798629|NCT02231749|617275704|FG000|Overall Study|Pregnancy|1|||
170798630|NCT02231749|617275705|FG001|Overall Study|Pregnancy|0|||
170798631|NCT02231749|617275704|FG000|Overall Study|other|0|||
170798632|NCT02231749|617275705|FG001|Overall Study|other|8|||
170798633|NCT02231749|617275704|FG000|Overall Study|No longer meets Study Criteria|1|||
170798634|NCT02231749|617275705|FG001|Overall Study|No longer meets Study Criteria|0|||
170798635|NCT04194450|617275708|FG000|Overall Study|not eligible|1|||
170486460|NCT01418378|616122658|FG001|Overall Study|developed chronic myopathy|1|||
170798636|NCT04194450|617275709|FG001|Overall Study|not eligible|0|||
170798637|NCT00412607|617275716|FG000|Overall Study|Withdrawal by Subject|9|||
170798638|NCT00412607|617275716|FG000|Overall Study|Lost to Follow-up|19|||
170798639|NCT00412607|617275716|FG000|Overall Study|Death|61|||
170486461|NCT01812109|616122661|FG000|Overall Study|research personnel delay|16|||
170486462|NCT01812109|616122661|FG000|Overall Study|NIRS Unattainable|17|||
170486463|NCT04630002|616122662|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
170486464|NCT04630002|616122663|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
170486465|NCT04630002|616122664|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
170486466|NCT04630002|616122662|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
170486467|NCT04630002|616122663|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
170486468|NCT04630002|616122664|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
170798640|NCT00412607|617275716|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
170486469|NCT04630002|616122662|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
170486470|NCT04630002|616122663|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
170486471|NCT04630002|616122664|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
170486472|NCT04630002|616122662|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
170486473|NCT04630002|616122663|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
170486474|NCT04630002|616122664|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
170486475|NCT04630002|616122662|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
170486476|NCT04630002|616122663|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
170486477|NCT04630002|616122664|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
170486478|NCT04630002|616122662|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
170486479|NCT04630002|616122663|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
170486480|NCT04630002|616122664|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
170548767|NCT02533674|616354647|FG000|Dose Level VI|Withdrawal by Subject|0|||
170548768|NCT02533674|616354648|FG001|Dose Level VI|Withdrawal by Subject|0|||
170548769|NCT02533674|616354649|FG002|Dose Level VI|Withdrawal by Subject|0|||
170548770|NCT02533674|616354650|FG003|Dose Level VI|Withdrawal by Subject|0|||
170486481|NCT04630002|616122662|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
170486482|NCT04630002|616122663|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
170486483|NCT04630002|616122664|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
170486484|NCT04630002|616122662|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
170798641|NCT03248479|617275719|FG000|Overall Study|Death|12|||
170798642|NCT03248479|617275720|FG001|Overall Study|Death|44|||
170798643|NCT03248479|617275721|FG002|Overall Study|Death|1|||
170798644|NCT03248479|617275722|FG003|Overall Study|Death|72|||
170798645|NCT03248479|617275723|FG004|Overall Study|Death|17|||
170798646|NCT03248479|617275724|FG005|Overall Study|Death|6|||
170798647|NCT03248479|617275725|FG006|Overall Study|Death|1|||
170798648|NCT03248479|617275726|FG007|Overall Study|Death|14|||
170798649|NCT03248479|617275727|FG008|Overall Study|Death|3|||
170798650|NCT03248479|617275728|FG009|Overall Study|Death|7|||
170798651|NCT03248479|617275729|FG010|Overall Study|Death|3|||
170798652|NCT03248479|617275730|FG011|Overall Study|Death|1|||
170798653|NCT03248479|617275731|FG012|Overall Study|Death|1|||
170798654|NCT03248479|617275719|FG000|Overall Study|Study terminated by sponsor|12|||
170798655|NCT03248479|617275720|FG001|Overall Study|Study terminated by sponsor|15|||
170798656|NCT03248479|617275721|FG002|Overall Study|Study terminated by sponsor|0|||
170798657|NCT03248479|617275722|FG003|Overall Study|Study terminated by sponsor|5|||
170798658|NCT03248479|617275723|FG004|Overall Study|Study terminated by sponsor|0|||
170798659|NCT03248479|617275724|FG005|Overall Study|Study terminated by sponsor|0|||
170798660|NCT03248479|617275725|FG006|Overall Study|Study terminated by sponsor|0|||
170548771|NCT02533674|616354651|FG004|Dose Level VI|Withdrawal by Subject|0|||
170548772|NCT02533674|616354652|FG005|Dose Level VI|Withdrawal by Subject|1|||
170548773|NCT02533674|616354653|FG006|Dose Level VI|Withdrawal by Subject|0|||
170548774|NCT02533674|616354654|FG007|Dose Level VI|Withdrawal by Subject|0|||
170548775|NCT02533674|616354647|FG000|Dose Level VI|Treatment-related AE|0|||
170548776|NCT02533674|616354648|FG001|Dose Level VI|Treatment-related AE|0|||
170548777|NCT02533674|616354649|FG002|Dose Level VI|Treatment-related AE|0|||
170548778|NCT02533674|616354650|FG003|Dose Level VI|Treatment-related AE|0|||
170548779|NCT02533674|616354651|FG004|Dose Level VI|Treatment-related AE|0|||
170548780|NCT02533674|616354652|FG005|Dose Level VI|Treatment-related AE|1|||
170548781|NCT02533674|616354653|FG006|Dose Level VI|Treatment-related AE|0|||
170548782|NCT02533674|616354654|FG007|Dose Level VI|Treatment-related AE|0|||
170548783|NCT02533674|616354647|FG000|Dose Level VII|Progressive disease|0|||
170548784|NCT02533674|616354648|FG001|Dose Level VII|Progressive disease|0|||
170548785|NCT02533674|616354649|FG002|Dose Level VII|Progressive disease|0|||
170548786|NCT02533674|616354650|FG003|Dose Level VII|Progressive disease|0|||
170548787|NCT02533674|616354651|FG004|Dose Level VII|Progressive disease|0|||
170548788|NCT02533674|616354652|FG005|Dose Level VII|Progressive disease|0|||
170798661|NCT03248479|617275726|FG007|Overall Study|Study terminated by sponsor|1|||
170798662|NCT03248479|617275727|FG008|Overall Study|Study terminated by sponsor|1|||
170798663|NCT03248479|617275728|FG009|Overall Study|Study terminated by sponsor|0|||
170548789|NCT02533674|616354653|FG006|Dose Level VII|Progressive disease|10|||
170798664|NCT03248479|617275729|FG010|Overall Study|Study terminated by sponsor|5|||
170798665|NCT03248479|617275730|FG011|Overall Study|Study terminated by sponsor|4|||
170898599|NCT01015833|617632466|FG000|Overall Study|Withdrawal by Subject|3|||
170898600|NCT01015833|617632467|FG001|Overall Study|Withdrawal by Subject|2|||
170486485|NCT04630002|616122663|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
170486486|NCT04630002|616122664|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
170486487|NCT04498182|616122665|FG000|Overall Study|Adverse Event|2|||
170486488|NCT04498182|616122666|FG001|Overall Study|Adverse Event|3|||
170486489|NCT04498182|616122667|FG002|Overall Study|Adverse Event|2|||
170486490|NCT04498182|616122665|FG000|Overall Study|Withdrawal of Consent|3|||
170486491|NCT04498182|616122666|FG001|Overall Study|Withdrawal of Consent|4|||
170486492|NCT04498182|616122667|FG002|Overall Study|Withdrawal of Consent|3|||
170486493|NCT04498182|616122665|FG000|Overall Study|Non-Compliant|1|||
170486494|NCT04498182|616122666|FG001|Overall Study|Non-Compliant|0|||
170486495|NCT04498182|616122667|FG002|Overall Study|Non-Compliant|1|||
170486496|NCT04498182|616122665|FG000|Overall Study|Lost to Follow-up|0|||
170486497|NCT04498182|616122666|FG001|Overall Study|Lost to Follow-up|0|||
170486498|NCT04498182|616122667|FG002|Overall Study|Lost to Follow-up|1|||
170486499|NCT04498182|616122665|FG000|Overall Study|Investigator Decision|0|||
170486500|NCT04498182|616122666|FG001|Overall Study|Investigator Decision|0|||
170486501|NCT04498182|616122667|FG002|Overall Study|Investigator Decision|1|||
170486502|NCT04498182|616122665|FG000|Overall Study|Protocol Violation|1|||
170486503|NCT04498182|616122666|FG001|Overall Study|Protocol Violation|0|||
170486504|NCT04498182|616122667|FG002|Overall Study|Protocol Violation|2|||
170486505|NCT02182843|616122668|FG000|Overall Study|Withdrawal by Subject|7|||
170486506|NCT02182843|616122668|FG000|Overall Study|Lost to Follow-up|2|||
170486507|NCT02182843|616122668|FG000|Overall Study|Adverse Event|1|||
170486508|NCT00288626|616122679|FG000|Overall Study|Death|3|||
170486509|NCT00288626|616122679|FG000|Overall Study|Withdrawal by Subject|4|||
170486510|NCT03448419|616122689|FG000|Overall Study|Adverse Event|10|||
170486511|NCT03448419|616122690|FG001|Overall Study|Adverse Event|9|||
170486512|NCT03448419|616122689|FG000|Overall Study|Lost to Follow-up|0|||
170486513|NCT03448419|616122690|FG001|Overall Study|Lost to Follow-up|2|||
170486514|NCT03448419|616122689|FG000|Overall Study|Withdrawal by Subject|3|||
170486515|NCT03448419|616122690|FG001|Overall Study|Withdrawal by Subject|1|||
170486516|NCT03448419|616122689|FG000|Overall Study|Not treated|0|||
170486517|NCT03448419|616122690|FG001|Overall Study|Not treated|1|||
170486518|NCT03448419|616122689|FG000|Overall Study|Patient did not attend all visits|0|||
170486519|NCT03448419|616122690|FG001|Overall Study|Patient did not attend all visits|2|||
170486520|NCT03448419|616122689|FG000|Overall Study|Withdrawn by Sponsor|0|||
170486521|NCT03448419|616122690|FG001|Overall Study|Withdrawn by Sponsor|1|||
170486522|NCT02187198|616122692|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
170486523|NCT02187198|616122693|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
170486524|NCT02187198|616122692|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
170486525|NCT02187198|616122693|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
170486526|NCT00546377|616122694|FG000|Overall Study|Deemed ineligible|1|||
170486527|NCT00546377|616122694|FG000|Overall Study|Adverse Event|6|||
170486528|NCT01684423|616122695|FG000|Overall Study|Withdrawal by Subject|0|||
170486529|NCT01684423|616122696|FG001|Overall Study|Withdrawal by Subject|0|||
170486530|NCT01684423|616122697|FG002|Overall Study|Withdrawal by Subject|1|||
170486531|NCT01684423|616122698|FG003|Overall Study|Withdrawal by Subject|0|||
170898601|NCT01015833|617632466|FG000|Overall Study|Adverse Event|0|||
170898602|NCT01015833|617632467|FG001|Overall Study|Adverse Event|1|||
170898603|NCT01015833|617632466|FG000|Overall Study|Physician Decision|2|||
170898604|NCT01015833|617632467|FG001|Overall Study|Physician Decision|0|||
170898605|NCT01015833|617632466|FG000|Overall Study|Symptomatic deterioration|0|||
170898606|NCT01015833|617632467|FG001|Overall Study|Symptomatic deterioration|1|||
170898607|NCT01015833|617632466|FG000|Overall Study|Other|5|||
170898608|NCT01015833|617632467|FG001|Overall Study|Other|1|||
170898609|NCT01015833|617632466|FG000|Overall Study|Motor Vehicle Accidents|1|||
170898610|NCT01015833|617632467|FG001|Overall Study|Motor Vehicle Accidents|0|||
170898611|NCT01015833|617632466|FG000|Overall Study|Did not start treatment|1|||
170898612|NCT01015833|617632467|FG001|Overall Study|Did not start treatment|0|||
170898613|NCT00996203|617632468|FG000|Overall Study|Adverse Event|3|||
170486532|NCT01684423|616122699|FG004|Overall Study|Withdrawal by Subject|0|||
170486533|NCT01575834|616122700|FG000|Overall Study|Withdrawal by Subject|352|||
170486534|NCT01575834|616122701|FG001|Overall Study|Withdrawal by Subject|390|||
170486535|NCT01575834|616122700|FG000|Overall Study|Death|81|||
170486536|NCT01575834|616122701|FG001|Overall Study|Death|74|||
170486537|NCT01575834|616122700|FG000|Overall Study|Other|70|||
170486538|NCT01575834|616122701|FG001|Overall Study|Other|70|||
170486539|NCT01575834|616122700|FG000|Overall Study|Adverse Event|63|||
170486540|NCT01575834|616122701|FG001|Overall Study|Adverse Event|61|||
170898614|NCT00996203|617632468|FG000|Overall Study|Lost to Follow-up|1|||
170898615|NCT00996203|617632468|FG000|Overall Study|Lack of Efficacy|1|||
170486541|NCT01575834|616122700|FG000|Overall Study|Lost to Follow-up|55|||
170486542|NCT01575834|616122701|FG001|Overall Study|Lost to Follow-up|68|||
170898616|NCT00996203|617632468|FG000|Overall Study|Protocol Violation|2|||
170548790|NCT02533674|616354654|FG007|Dose Level VII|Progressive disease|0|||
170548791|NCT02533674|616354647|FG000|Dose Level VII|Withdrawal by Subject|0|||
170548792|NCT02533674|616354648|FG001|Dose Level VII|Withdrawal by Subject|0|||
170548793|NCT02533674|616354649|FG002|Dose Level VII|Withdrawal by Subject|0|||
170548794|NCT02533674|616354650|FG003|Dose Level VII|Withdrawal by Subject|0|||
170548795|NCT02533674|616354651|FG004|Dose Level VII|Withdrawal by Subject|0|||
170548796|NCT02533674|616354652|FG005|Dose Level VII|Withdrawal by Subject|0|||
170548797|NCT02533674|616354653|FG006|Dose Level VII|Withdrawal by Subject|3|||
170548798|NCT02533674|616354654|FG007|Dose Level VII|Withdrawal by Subject|0|||
170548799|NCT02533674|616354647|FG000|Dose Level VII|Treatment-related AE|0|||
170548800|NCT02533674|616354648|FG001|Dose Level VII|Treatment-related AE|0|||
170548801|NCT02533674|616354649|FG002|Dose Level VII|Treatment-related AE|0|||
170548802|NCT02533674|616354650|FG003|Dose Level VII|Treatment-related AE|0|||
170548803|NCT02533674|616354651|FG004|Dose Level VII|Treatment-related AE|0|||
170548804|NCT02533674|616354652|FG005|Dose Level VII|Treatment-related AE|0|||
170548805|NCT02533674|616354653|FG006|Dose Level VII|Treatment-related AE|1|||
170548806|NCT02533674|616354654|FG007|Dose Level VII|Treatment-related AE|0|||
170548807|NCT02533674|616354647|FG000|Dose Level VII|Death|0|||
170548808|NCT02533674|616354648|FG001|Dose Level VII|Death|0|||
170548809|NCT02533674|616354649|FG002|Dose Level VII|Death|0|||
170548810|NCT02533674|616354650|FG003|Dose Level VII|Death|0|||
170548811|NCT02533674|616354651|FG004|Dose Level VII|Death|0|||
170548812|NCT02533674|616354652|FG005|Dose Level VII|Death|0|||
170548813|NCT02533674|616354653|FG006|Dose Level VII|Death|2|||
170548814|NCT02533674|616354654|FG007|Dose Level VII|Death|0|||
170548815|NCT02533674|616354647|FG000|Dose Level VIII|Progressive disease|0|||
170548816|NCT02533674|616354648|FG001|Dose Level VIII|Progressive disease|0|||
170548817|NCT02533674|616354649|FG002|Dose Level VIII|Progressive disease|0|||
170548818|NCT02533674|616354650|FG003|Dose Level VIII|Progressive disease|0|||
170548819|NCT02533674|616354651|FG004|Dose Level VIII|Progressive disease|0|||
170548820|NCT02533674|616354652|FG005|Dose Level VIII|Progressive disease|0|||
170548821|NCT02533674|616354653|FG006|Dose Level VIII|Progressive disease|0|||
170548822|NCT02533674|616354654|FG007|Dose Level VIII|Progressive disease|3|||
170548823|NCT02533674|616354647|FG000|Dose Level VIII|Withdrawal by Subject|0|||
170548824|NCT02533674|616354648|FG001|Dose Level VIII|Withdrawal by Subject|0|||
170548825|NCT02533674|616354649|FG002|Dose Level VIII|Withdrawal by Subject|0|||
170548826|NCT02533674|616354650|FG003|Dose Level VIII|Withdrawal by Subject|0|||
170548827|NCT02533674|616354651|FG004|Dose Level VIII|Withdrawal by Subject|0|||
170548828|NCT02533674|616354652|FG005|Dose Level VIII|Withdrawal by Subject|0|||
170548829|NCT02533674|616354653|FG006|Dose Level VIII|Withdrawal by Subject|0|||
170548830|NCT02533674|616354654|FG007|Dose Level VIII|Withdrawal by Subject|1|||
170548831|NCT02533674|616354647|FG000|Dose Level VIII|Treatment-related AE|0|||
170548832|NCT02533674|616354648|FG001|Dose Level VIII|Treatment-related AE|0|||
170548833|NCT02533674|616354649|FG002|Dose Level VIII|Treatment-related AE|0|||
170548834|NCT02533674|616354650|FG003|Dose Level VIII|Treatment-related AE|0|||
170548835|NCT02533674|616354651|FG004|Dose Level VIII|Treatment-related AE|0|||
170548836|NCT02533674|616354652|FG005|Dose Level VIII|Treatment-related AE|0|||
170548837|NCT02533674|616354653|FG006|Dose Level VIII|Treatment-related AE|0|||
170548838|NCT02533674|616354654|FG007|Dose Level VIII|Treatment-related AE|1|||
170548839|NCT02533674|616354647|FG000|Dose Level VIII|Never treated|0|||
170548840|NCT02533674|616354648|FG001|Dose Level VIII|Never treated|0|||
170548841|NCT02533674|616354649|FG002|Dose Level VIII|Never treated|0|||
170548842|NCT02533674|616354650|FG003|Dose Level VIII|Never treated|0|||
170798666|NCT03248479|617275731|FG012|Overall Study|Study terminated by sponsor|0|||
170798667|NCT03248479|617275719|FG000|Overall Study|Consent withdrawn|6|||
170798668|NCT03248479|617275720|FG001|Overall Study|Consent withdrawn|3|||
170798669|NCT03248479|617275721|FG002|Overall Study|Consent withdrawn|0|||
170798670|NCT03248479|617275722|FG003|Overall Study|Consent withdrawn|9|||
170548843|NCT02533674|616354651|FG004|Dose Level VIII|Never treated|0|||
170548844|NCT02533674|616354652|FG005|Dose Level VIII|Never treated|0|||
170548845|NCT02533674|616354653|FG006|Dose Level VIII|Never treated|0|||
170548846|NCT02533674|616354654|FG007|Dose Level VIII|Never treated|1|||
170548847|NCT01346709|616354655|FG000|Overall Study|Protocol Violation|35|||
170548848|NCT01346709|616354655|FG000|Overall Study|Lost to Follow-up|31|||
170548849|NCT01346709|616354655|FG000|Overall Study|Missing data in candidate risk factor|285|||
170548850|NCT02773537|616354661|FG000|Overall Study|Lost to Follow-up|0|||
170548851|NCT02773537|616354662|FG001|Overall Study|Lost to Follow-up|1|||
170548852|NCT02773537|616354663|FG002|Overall Study|Lost to Follow-up|4|||
170548853|NCT01840163|616354664|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
170548854|NCT01840163|616354665|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
170548855|NCT01840163|616354664|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
170548856|NCT01840163|616354665|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
170798671|NCT03248479|617275723|FG004|Overall Study|Consent withdrawn|1|||
170798672|NCT03248479|617275724|FG005|Overall Study|Consent withdrawn|0|||
170548857|NCT01840163|616354664|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
170548858|NCT01840163|616354665|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
170798673|NCT03248479|617275725|FG006|Overall Study|Consent withdrawn|0|||
170898617|NCT01959165|617632469|FG000|Overall Study|Adverse Event|0|||
170898618|NCT01959165|617632470|FG001|Overall Study|Adverse Event|0|||
170898619|NCT01959165|617632471|FG002|Overall Study|Adverse Event|0|||
170898620|NCT01959165|617632472|FG003|Overall Study|Adverse Event|1|||
170898621|NCT01959165|617632469|FG000|Overall Study|Lack of Efficacy|1|||
170898622|NCT01959165|617632470|FG001|Overall Study|Lack of Efficacy|0|||
170898623|NCT01959165|617632471|FG002|Overall Study|Lack of Efficacy|0|||
170898624|NCT01959165|617632472|FG003|Overall Study|Lack of Efficacy|0|||
170898625|NCT01959165|617632469|FG000|Overall Study|overdose|0|||
170898626|NCT01959165|617632470|FG001|Overall Study|overdose|0|||
170898627|NCT01959165|617632471|FG002|Overall Study|overdose|0|||
170898628|NCT01959165|617632472|FG003|Overall Study|overdose|1|||
170898629|NCT01959165|617632469|FG000|Overall Study|Welfare recipient|0|||
170898630|NCT01959165|617632470|FG001|Overall Study|Welfare recipient|1|||
170898631|NCT01959165|617632471|FG002|Overall Study|Welfare recipient|0|||
170898632|NCT01959165|617632472|FG003|Overall Study|Welfare recipient|0|||
170898633|NCT06001307|617634205|FG000|Overall Study|Lost to Follow-up|1|||
170898634|NCT06001307|617634206|FG001|Overall Study|Lost to Follow-up|2|||
170898635|NCT04439279|617634211|FG000|Overall Study|Adverse Event|7|||
170898636|NCT04439279|617634211|FG000|Overall Study|Death|4|||
170898637|NCT04439279|617634211|FG000|Overall Study|Disease progression|17|||
170898638|NCT04439279|617634211|FG000|Overall Study|Complicating disease|3|||
170898639|NCT04439279|617634211|FG000|Overall Study|Withdrawal by Subject|2|||
170898640|NCT04439279|617634211|FG000|Overall Study|Ineligible|1|||
170898641|NCT04439279|617634211|FG000|Overall Study|Treatment still ongoing|1|||
170898642|NCT02689492|617634212|FG000|Overall Study|Lost to Follow-up|61|||
170898643|NCT02689492|617634212|FG000|Overall Study|Withdrawal by Subject|11|||
170898644|NCT02689492|617634212|FG000|Overall Study|Death|9|||
170486543|NCT01575834|616122700|FG000|Overall Study|Noncompliance|52|||
170486544|NCT01575834|616122701|FG001|Overall Study|Noncompliance|27|||
170486545|NCT01575834|616122700|FG000|Overall Study|Administrative decision|15|||
170486546|NCT01575834|616122701|FG001|Overall Study|Administrative decision|33|||
170486547|NCT01575834|616122700|FG000|Overall Study|Ineligibility Determined|5|||
170486548|NCT01575834|616122701|FG001|Overall Study|Ineligibility Determined|8|||
170486549|NCT01575834|616122700|FG000|Overall Study|Protocol Deviation|4|||
170486550|NCT01575834|616122701|FG001|Overall Study|Protocol Deviation|3|||
170486551|NCT01575834|616122700|FG000|Overall Study|Requirement for Alternative Therapy|2|||
170486552|NCT01575834|616122701|FG001|Overall Study|Requirement for Alternative Therapy|4|||
170486553|NCT02155283|616122703|FG000|Overall Study|Lost to Follow-up|3|||
170486554|NCT02155283|616122703|FG000|Overall Study|Withdrawal by Subject|1|||
170486555|NCT02155283|616122703|FG000|Overall Study|Protocol Violation|3|||
170486556|NCT00869999|616122709|FG000|Overall Study|Withdrawal by Subject|1|||
170486557|NCT00869999|616122709|FG000|Overall Study|removed prior to starting therapy|1|||
170486558|NCT03674112|616122711|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
170486559|NCT03674112|616122712|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
170486560|NCT03674112|616122711|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
170486561|NCT03674112|616122712|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
170486562|NCT03674112|616122711|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
170486563|NCT03674112|616122712|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
170486564|NCT03674112|616122711|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
170486565|NCT03674112|616122712|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
170486566|NCT03674112|616122711|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
170486567|NCT03674112|616122712|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
170798674|NCT03248479|617275726|FG007|Overall Study|Consent withdrawn|1|||
170798675|NCT03248479|617275727|FG008|Overall Study|Consent withdrawn|0|||
170798676|NCT03248479|617275728|FG009|Overall Study|Consent withdrawn|3|||
170798677|NCT03248479|617275729|FG010|Overall Study|Consent withdrawn|1|||
170798678|NCT03248479|617275730|FG011|Overall Study|Consent withdrawn|0|||
170798679|NCT03248479|617275731|FG012|Overall Study|Consent withdrawn|1|||
170798680|NCT03248479|617275719|FG000|Overall Study|Lost to Follow-up|2|||
170798681|NCT03248479|617275720|FG001|Overall Study|Lost to Follow-up|1|||
170798682|NCT03248479|617275721|FG002|Overall Study|Lost to Follow-up|0|||
170798683|NCT03248479|617275722|FG003|Overall Study|Lost to Follow-up|0|||
170798684|NCT03248479|617275723|FG004|Overall Study|Lost to Follow-up|0|||
170798685|NCT03248479|617275724|FG005|Overall Study|Lost to Follow-up|0|||
170898645|NCT02689492|617634212|FG000|Overall Study|Physician Decision|2|||
170898646|NCT02689492|617634212|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
170898647|NCT02689492|617634212|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
170798686|NCT03248479|617275725|FG006|Overall Study|Lost to Follow-up|0|||
170798687|NCT03248479|617275726|FG007|Overall Study|Lost to Follow-up|0|||
170898648|NCT02689492|617634212|FG000|Overall Study|Other than listed|1|||
170898649|NCT00224016|617634224|FG000|Titration Period|Withdrawal by Subject|0|||
170898650|NCT00224016|617634225|FG001|Titration Period|Withdrawal by Subject|1|||
170898651|NCT00224016|617634224|FG000|Titration Period|Lost to Follow-up|1|||
170898652|NCT00224016|617634225|FG001|Titration Period|Lost to Follow-up|0|||
170486568|NCT03674112|616122711|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
170486569|NCT03674112|616122712|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
170486570|NCT03674112|616122711|FG000|Follow-Up Period (≥3 Years)|Death|2|||
170486571|NCT03674112|616122712|FG001|Follow-Up Period (≥3 Years)|Death|0|||
170486572|NCT03674112|616122711|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
170486573|NCT03674112|616122712|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
170486574|NCT02220764|616122715|FG000|Overall Study|Lost to Follow-up|3|||
170486575|NCT02220764|616122716|FG001|Overall Study|Lost to Follow-up|1|||
170486576|NCT02220764|616122715|FG000|Overall Study|Death|1|||
170486577|NCT02220764|616122716|FG001|Overall Study|Death|0|||
170486578|NCT03020992|616122717|FG000|Overall Study|Adverse Event|5|||
170486579|NCT03020992|616122717|FG000|Overall Study|Withdrawal by Subject|1|||
170486580|NCT01006122|616122718|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
170486581|NCT01006122|616122719|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
170486582|NCT01006122|616122718|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
170486583|NCT01006122|616122719|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
170486584|NCT01006122|616122718|FG000|First Double-blind Intervention Period|Pregnancy|0|||
170486585|NCT01006122|616122719|FG001|First Double-blind Intervention Period|Pregnancy|1|||
170486586|NCT01006122|616122718|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
170486587|NCT01006122|616122719|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
170486588|NCT01006122|616122718|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
170486589|NCT01006122|616122719|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
170486590|NCT01006122|616122718|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
170486591|NCT01006122|616122719|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
170486592|NCT01006122|616122718|FG000|First Double-blind Intervention Period|Other|3|||
170798688|NCT03248479|617275727|FG008|Overall Study|Lost to Follow-up|0|||
170798689|NCT03248479|617275728|FG009|Overall Study|Lost to Follow-up|0|||
170798690|NCT03248479|617275729|FG010|Overall Study|Lost to Follow-up|0|||
170798691|NCT03248479|617275730|FG011|Overall Study|Lost to Follow-up|0|||
170798692|NCT03248479|617275731|FG012|Overall Study|Lost to Follow-up|1|||
170798693|NCT03248479|617275719|FG000|Overall Study|Not reported|0|||
170798694|NCT03248479|617275720|FG001|Overall Study|Not reported|0|||
170798695|NCT03248479|617275721|FG002|Overall Study|Not reported|0|||
170798696|NCT03248479|617275722|FG003|Overall Study|Not reported|1|||
170798697|NCT03248479|617275723|FG004|Overall Study|Not reported|1|||
170798698|NCT03248479|617275724|FG005|Overall Study|Not reported|0|||
170798699|NCT03248479|617275725|FG006|Overall Study|Not reported|0|||
170798700|NCT03248479|617275726|FG007|Overall Study|Not reported|1|||
170798701|NCT03248479|617275727|FG008|Overall Study|Not reported|1|||
170798702|NCT03248479|617275728|FG009|Overall Study|Not reported|0|||
170798703|NCT03248479|617275729|FG010|Overall Study|Not reported|0|||
170798704|NCT03248479|617275730|FG011|Overall Study|Not reported|0|||
170798705|NCT03248479|617275731|FG012|Overall Study|Not reported|0|||
170798706|NCT03547271|617275734|FG000|Overall Study|Adverse Event|1|||
170798707|NCT03547271|617275735|FG001|Overall Study|Adverse Event|1|||
170798708|NCT03547271|617275736|FG002|Overall Study|Adverse Event|0|||
170798709|NCT03547271|617275737|FG003|Overall Study|Adverse Event|0|||
170798710|NCT03547271|617275734|FG000|Overall Study|Protocol deviation|5|||
170798711|NCT03547271|617275735|FG001|Overall Study|Protocol deviation|7|||
170798712|NCT03547271|617275736|FG002|Overall Study|Protocol deviation|3|||
170798713|NCT03547271|617275737|FG003|Overall Study|Protocol deviation|0|||
170798714|NCT03547271|617275734|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
170798715|NCT03547271|617275735|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
170798716|NCT03547271|617275736|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
170798717|NCT03547271|617275737|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
170798718|NCT03547271|617275734|FG000|Overall Study|Lost to Follow-up|3|||
170798719|NCT03547271|617275735|FG001|Overall Study|Lost to Follow-up|3|||
170798720|NCT03547271|617275736|FG002|Overall Study|Lost to Follow-up|1|||
170798721|NCT03547271|617275737|FG003|Overall Study|Lost to Follow-up|0|||
170798722|NCT04281498|617275740|FG000|Overall Study|Progression of disease|1|||
170798723|NCT04281498|617275740|FG000|Overall Study|Planned SCT|1|||
170898653|NCT00224016|617634224|FG000|Maintenance Period|Withdrawal by Subject|2|||
170486593|NCT01006122|616122719|FG001|First Double-blind Intervention Period|Other|0|||
170486594|NCT01006122|616122718|FG000|First Double-blind Intervention Period|Adverse Event|0|||
170486595|NCT01006122|616122719|FG001|First Double-blind Intervention Period|Adverse Event|4|||
170486596|NCT01006122|616122718|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
170486597|NCT01006122|616122719|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
170486598|NCT01006122|616122718|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
170486599|NCT01006122|616122719|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
170798724|NCT04281498|617275740|FG000|Overall Study|Alternative Treatment|1|||
170798725|NCT01499368|617275741|FG000|Overall Study|Did not meet I/E criteria|8|||
170798726|NCT01499368|617275742|FG001|Overall Study|Did not meet I/E criteria|4|||
170798727|NCT01499368|617275743|FG002|Overall Study|Did not meet I/E criteria|4|||
170798728|NCT01499368|617275741|FG000|Overall Study|Prohibited Concomitant medication|1|||
170898654|NCT00224016|617634225|FG001|Maintenance Period|Withdrawal by Subject|0|||
170898655|NCT00224016|617634224|FG000|Maintenance Period|Lost to Follow-up|0|||
170486600|NCT01006122|616122718|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
170486601|NCT01006122|616122719|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
170486602|NCT01006122|616122718|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
170486603|NCT01006122|616122719|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
170486604|NCT01006122|616122718|FG000|Second Double-blind Intervention Period|Death|0|||
170486605|NCT01006122|616122719|FG001|Second Double-blind Intervention Period|Death|1|||
170486606|NCT00410813|616122720|FG000|Overall Study|Adverse Event|6|||
170486607|NCT00410813|616122721|FG001|Overall Study|Adverse Event|11|||
170486608|NCT00410813|616122720|FG000|Overall Study|Progression|32|||
170486609|NCT00410813|616122721|FG001|Overall Study|Progression|21|||
170486610|NCT00410813|616122720|FG000|Overall Study|Not protocol specified|3|||
170486611|NCT00410813|616122721|FG001|Overall Study|Not protocol specified|4|||
170486612|NCT00410813|616122720|FG000|Overall Study|Ineligible|2|||
170486613|NCT00410813|616122721|FG001|Overall Study|Ineligible|4|||
170486614|NCT00410813|616122720|FG000|Overall Study|Death|0|||
170486615|NCT00410813|616122721|FG001|Overall Study|Death|2|||
170486616|NCT04526288|616122728|FG000|Overall Study|Disease Progression|1|||
170486617|NCT04526288|616122729|FG001|Overall Study|Disease Progression|0|||
170486618|NCT00594165|616122730|FG000|Overall Study|Major protocol violation|1|||
170486619|NCT00594165|616122730|FG000|Overall Study|Lack of Efficacy|12|||
170486620|NCT00594165|616122730|FG000|Overall Study|Adverse Event|52|||
170486621|NCT00594165|616122730|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
170486622|NCT00594165|616122730|FG000|Overall Study|Subject withdrew consent|27|||
170486623|NCT00594165|616122730|FG000|Overall Study|Study ended per sponsor|102|||
170486624|NCT00594165|616122730|FG000|Overall Study|Lost to Follow-up|4|||
170486625|NCT00594165|616122730|FG000|Overall Study|Other: PI discretion|5|||
170486626|NCT00594165|616122730|FG000|Overall Study|Other: Subject moving|3|||
170486627|NCT00594165|616122730|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
170486628|NCT00594165|616122730|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
170486629|NCT00594165|616122730|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
170486630|NCT00594165|616122730|FG000|Overall Study|Other: Site terminated participation|2|||
170486631|NCT02748356|616122731|FG000|Overall Study|Withdrawal by Subject|1|||
170486632|NCT00952068|616122732|FG000|Overall Study|Adverse Event|3|||
170486633|NCT00952068|616122732|FG000|Overall Study|Withdrawal by Subject|4|||
170486634|NCT05236764|616122733|FG000|Overall Study|In follow up (ongoing)|1|||
170486635|NCT05236764|616122733|FG000|Overall Study|Taken off study - secondary graft failure|1|||
170486636|NCT05236764|616122733|FG000|Overall Study|Death|1|||
170486637|NCT01153815|616122736|FG000|Overall Study|Adverse Event|3|||
170486638|NCT01153815|616122737|FG001|Overall Study|Adverse Event|1|||
170486639|NCT01153815|616122736|FG000|Overall Study|Withdrawal by Subject|6|||
170486640|NCT01153815|616122737|FG001|Overall Study|Withdrawal by Subject|4|||
170486641|NCT04926831|616122740|FG000|Overall Study|Withdrawal by Subject|2|||
170486642|NCT04926831|616122740|FG000|Overall Study|Adverse Event|2|||
170486643|NCT02259010|616122741|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
170486644|NCT02640664|616122744|FG000|Epoch 1|Withdrawal of informed consent|1|||
170486645|NCT02640664|616122745|FG001|Epoch 1|Withdrawal of informed consent|0|||
170486646|NCT02640664|616122746|FG002|Epoch 1|Withdrawal of informed consent|0|||
170486647|NCT02640664|616122744|FG000|Epoch 1|Death|0|||
170486648|NCT02640664|616122745|FG001|Epoch 1|Death|0|||
170486649|NCT02640664|616122746|FG002|Epoch 1|Death|1|||
170486650|NCT02640664|616122744|FG000|Epoch 2|Withdrawal of informed consent|3|||
170486651|NCT02640664|616122745|FG001|Epoch 2|Withdrawal of informed consent|4|||
170486652|NCT02640664|616122746|FG002|Epoch 2|Withdrawal of informed consent|2|||
170486653|NCT02640664|616122744|FG000|Epoch 2|Subject/guardian decision|0|||
170486654|NCT02640664|616122745|FG001|Epoch 2|Subject/guardian decision|2|||
170486655|NCT02640664|616122746|FG002|Epoch 2|Subject/guardian decision|2|||
170486656|NCT02640664|616122744|FG000|Epoch 2|Lost to Follow-up|3|||
170486657|NCT02640664|616122745|FG001|Epoch 2|Lost to Follow-up|4|||
170486658|NCT02640664|616122746|FG002|Epoch 2|Lost to Follow-up|1|||
170486659|NCT02640664|616122744|FG000|Epoch 2|Death|0|||
170486660|NCT02640664|616122745|FG001|Epoch 2|Death|0|||
170486661|NCT02640664|616122746|FG002|Epoch 2|Death|1|||
170486662|NCT00987337|616122748|FG000|Overall Study|Adverse Event|10|||
170486663|NCT00987337|616122749|FG001|Overall Study|Adverse Event|9|||
170486664|NCT00987337|616122750|FG002|Overall Study|Adverse Event|8|||
170486665|NCT00987337|616122748|FG000|Overall Study|Insufficient Virologic Response|10|||
170486666|NCT00987337|616122749|FG001|Overall Study|Insufficient Virologic Response|7|||
170486667|NCT00987337|616122750|FG002|Overall Study|Insufficient Virologic Response|12|||
170486668|NCT00987337|616122748|FG000|Overall Study|Virologic Breakthrough|2|||
170548859|NCT03636269|616354673|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
170486669|NCT00987337|616122749|FG001|Overall Study|Virologic Breakthrough|2|||
170486670|NCT00987337|616122750|FG002|Overall Study|Virologic Breakthrough|8|||
170486671|NCT00987337|616122748|FG000|Overall Study|Lost to Follow-up|10|||
170486672|NCT00987337|616122749|FG001|Overall Study|Lost to Follow-up|6|||
170486673|NCT00987337|616122750|FG002|Overall Study|Lost to Follow-up|2|||
170486674|NCT00987337|616122748|FG000|Overall Study|Withdrawal by Subject|6|||
170486675|NCT00987337|616122749|FG001|Overall Study|Withdrawal by Subject|9|||
170486676|NCT00987337|616122750|FG002|Overall Study|Withdrawal by Subject|9|||
170486677|NCT00987337|616122748|FG000|Overall Study|Other|0|||
170486678|NCT00987337|616122749|FG001|Overall Study|Other|2|||
170486679|NCT00987337|616122750|FG002|Overall Study|Other|5|||
170486680|NCT00987337|616122748|FG000|Overall Study|Protocol Violation|1|||
170486681|NCT00987337|616122749|FG001|Overall Study|Protocol Violation|0|||
170486682|NCT00987337|616122750|FG002|Overall Study|Protocol Violation|2|||
170486683|NCT00987337|616122748|FG000|Overall Study|Participant Relapsed|18|||
170548860|NCT03636269|616354674|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
170548861|NCT03636269|616354675|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
170486684|NCT00987337|616122749|FG001|Overall Study|Participant Relapsed|20|||
170486685|NCT00987337|616122750|FG002|Overall Study|Participant Relapsed|5|||
170486686|NCT01129557|616122752|FG000|Overall Study|Adverse Event|1|||
170486687|NCT01129557|616122753|FG001|Overall Study|Adverse Event|2|||
170548862|NCT03636269|616354673|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
170548863|NCT03636269|616354674|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
170798729|NCT01499368|617275742|FG001|Overall Study|Prohibited Concomitant medication|1|||
170798730|NCT01499368|617275743|FG002|Overall Study|Prohibited Concomitant medication|0|||
170798731|NCT01499368|617275741|FG000|Overall Study|Withdrawal by Subject|11|||
170798732|NCT01499368|617275742|FG001|Overall Study|Withdrawal by Subject|10|||
170798733|NCT01499368|617275743|FG002|Overall Study|Withdrawal by Subject|8|||
170798734|NCT01499368|617275741|FG000|Overall Study|Lost to Follow-up|3|||
170798735|NCT01499368|617275742|FG001|Overall Study|Lost to Follow-up|2|||
170798736|NCT01499368|617275743|FG002|Overall Study|Lost to Follow-up|5|||
170798737|NCT01499368|617275741|FG000|Overall Study|Adverse Event|4|||
170798738|NCT01499368|617275742|FG001|Overall Study|Adverse Event|0|||
170798739|NCT01499368|617275743|FG002|Overall Study|Adverse Event|2|||
170798740|NCT01499368|617275741|FG000|Overall Study|Physician Decision|0|||
170798741|NCT01499368|617275742|FG001|Overall Study|Physician Decision|1|||
170798742|NCT01499368|617275743|FG002|Overall Study|Physician Decision|0|||
170798743|NCT01499368|617275741|FG000|Overall Study|Deviation from visit window|0|||
170798744|NCT01499368|617275742|FG001|Overall Study|Deviation from visit window|0|||
170798745|NCT01499368|617275743|FG002|Overall Study|Deviation from visit window|1|||
170798746|NCT01499368|617275741|FG000|Overall Study|Error of Prescriptions|0|||
170798747|NCT01499368|617275742|FG001|Overall Study|Error of Prescriptions|0|||
170798748|NCT01499368|617275743|FG002|Overall Study|Error of Prescriptions|1|||
170798749|NCT03092674|617275744|FG000|Overall Study|Adverse Event or Side Effects|1|||
170798750|NCT03092674|617275745|FG001|Overall Study|Adverse Event or Side Effects|4|||
170798751|NCT03092674|617275746|FG002|Overall Study|Adverse Event or Side Effects|4|||
170798752|NCT03092674|617275744|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
170798753|NCT03092674|617275745|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
170798754|NCT03092674|617275746|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
170798755|NCT03092674|617275744|FG000|Overall Study|Progression/Relapse|5|||
170798756|NCT03092674|617275745|FG001|Overall Study|Progression/Relapse|4|||
170798757|NCT03092674|617275746|FG002|Overall Study|Progression/Relapse|8|||
170798758|NCT03092674|617275744|FG000|Overall Study|Death|4|||
170798759|NCT03092674|617275745|FG001|Overall Study|Death|8|||
170798760|NCT03092674|617275746|FG002|Overall Study|Death|2|||
170798761|NCT03092674|617275744|FG000|Overall Study|Other - Not Protocol Specified|11|||
170798762|NCT03092674|617275745|FG001|Overall Study|Other - Not Protocol Specified|8|||
170798763|NCT03092674|617275746|FG002|Overall Study|Other - Not Protocol Specified|8|||
170798764|NCT02325154|617275752|FG000|Overall Study|Physician Decision|1|||
170798765|NCT03990883|617275753|FG000|Blinded Treatment Phase|Adverse Event|1|||
170798766|NCT03990883|617275754|FG001|Blinded Treatment Phase|Adverse Event|1|||
170798767|NCT03990883|617275755|FG002|Blinded Treatment Phase|Adverse Event|0|||
170798768|NCT03990883|617275753|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
170798769|NCT03990883|617275754|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
170798770|NCT03990883|617275755|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
170798771|NCT03990883|617275753|FG000|Blinded Treatment Phase|Physician Decision|1|||
170798772|NCT03990883|617275754|FG001|Blinded Treatment Phase|Physician Decision|0|||
170798773|NCT03990883|617275755|FG002|Blinded Treatment Phase|Physician Decision|0|||
170798774|NCT03990883|617275753|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
170798775|NCT03990883|617275754|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
170798776|NCT03990883|617275755|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
170798777|NCT03990883|617275753|FG000|Blinded Treatment Phase|COVID-19|3|||
170798778|NCT03990883|617275754|FG001|Blinded Treatment Phase|COVID-19|2|||
170798779|NCT03990883|617275755|FG002|Blinded Treatment Phase|COVID-19|0|||
170798780|NCT03990883|617275753|FG000|Blinded Treatment Phase|Personal Reasons|6|||
170798781|NCT03990883|617275754|FG001|Blinded Treatment Phase|Personal Reasons|3|||
170798782|NCT03990883|617275755|FG002|Blinded Treatment Phase|Personal Reasons|0|||
170798783|NCT03990883|617275753|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
170798784|NCT03990883|617275754|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
170798785|NCT03990883|617275755|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
170898656|NCT00224016|617634225|FG001|Maintenance Period|Lost to Follow-up|1|||
170898657|NCT01252966|617634226|FG000|Overall Study|Lost to Follow-up|16|||
170898658|NCT01252966|617634227|FG001|Overall Study|Lost to Follow-up|10|||
170898659|NCT01252966|617634226|FG000|Overall Study|Withdrawal by Subject|7|||
170898660|NCT01252966|617634227|FG001|Overall Study|Withdrawal by Subject|3|||
170898661|NCT02660580|617634228|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
170898662|NCT02660580|617634229|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
170898663|NCT02660580|617634230|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
170898664|NCT02660580|617634231|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
170898665|NCT02660580|617634232|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
170898666|NCT02660580|617634228|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
170898667|NCT02660580|617634229|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
170898668|NCT02660580|617634230|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
170486688|NCT01129557|616122754|FG002|Overall Study|Adverse Event|2|||
170486689|NCT01129557|616122752|FG000|Overall Study|Novartis terminated study early|3|||
170898669|NCT02660580|617634231|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
170898670|NCT02660580|617634232|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
170898671|NCT02660580|617634228|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
170898672|NCT02660580|617634229|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
170898673|NCT02660580|617634230|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
170898674|NCT02660580|617634231|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
170898675|NCT02660580|617634232|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
170898676|NCT02660580|617634228|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
170898677|NCT02660580|617634229|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
170898678|NCT02660580|617634230|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
170898679|NCT02660580|617634231|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
170898680|NCT02660580|617634232|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
170898681|NCT02660580|617634228|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
170898682|NCT02660580|617634229|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
170898683|NCT02660580|617634230|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
170898684|NCT02660580|617634231|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
170486690|NCT01129557|616122753|FG001|Overall Study|Novartis terminated study early|3|||
170486691|NCT01129557|616122754|FG002|Overall Study|Novartis terminated study early|2|||
170486692|NCT01486446|616122755|FG000|Overall Study|Adverse Event|1|||
170486693|NCT01486446|616122756|FG001|Overall Study|Adverse Event|0|||
170486694|NCT01367886|616122757|FG000|Overall Study|Lost to Follow-up|4|||
170486695|NCT01367886|616122757|FG000|Overall Study|Lack of Efficacy|2|||
170486696|NCT01367886|616122757|FG000|Overall Study|Death|1|||
170486697|NCT00985504|616122762|FG000|Acute Treatment Period|Adverse Event|3|||
170486698|NCT00985504|616122763|FG001|Acute Treatment Period|Adverse Event|4|||
170486699|NCT00985504|616122762|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
170486700|NCT00985504|616122763|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
170486701|NCT00985504|616122762|FG000|Acute Treatment Period|Protocol Violation|2|||
170486702|NCT00985504|616122763|FG001|Acute Treatment Period|Protocol Violation|0|||
170486703|NCT00985504|616122762|FG000|Acute Treatment Period|Sponsor Decision|0|||
170486704|NCT00985504|616122763|FG001|Acute Treatment Period|Sponsor Decision|1|||
170486705|NCT00985504|616122762|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
170486706|NCT00985504|616122763|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
170486707|NCT00985504|616122762|FG000|Optimization Period|Adverse Event|7|||
170898685|NCT02660580|617634232|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
170898686|NCT02660580|617634228|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
170486708|NCT00985504|616122763|FG001|Optimization Period|Adverse Event|9|||
170486709|NCT00985504|616122762|FG000|Optimization Period|Death|0|||
170548864|NCT03636269|616354675|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
170548865|NCT03636269|616354673|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
170548866|NCT03636269|616354674|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
170548867|NCT03636269|616354675|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
170548868|NCT03636269|616354673|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
170548869|NCT03636269|616354674|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
170898687|NCT02660580|617634229|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
170898688|NCT02660580|617634230|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
170486710|NCT00985504|616122763|FG001|Optimization Period|Death|1|||
170486711|NCT00985504|616122762|FG000|Optimization Period|Lack of Efficacy|5|||
170486712|NCT00985504|616122763|FG001|Optimization Period|Lack of Efficacy|3|||
170486713|NCT00985504|616122762|FG000|Optimization Period|Lost to Follow-up|0|||
170486714|NCT00985504|616122763|FG001|Optimization Period|Lost to Follow-up|1|||
170486715|NCT00985504|616122762|FG000|Optimization Period|Physician Decision|1|||
170486716|NCT00985504|616122763|FG001|Optimization Period|Physician Decision|0|||
170486717|NCT00985504|616122762|FG000|Optimization Period|Protocol Violation|3|||
170486718|NCT00985504|616122763|FG001|Optimization Period|Protocol Violation|1|||
170486719|NCT00985504|616122762|FG000|Optimization Period|Withdrawal by Subject|10|||
170486720|NCT00985504|616122763|FG001|Optimization Period|Withdrawal by Subject|8|||
170486721|NCT03805412|616122764|FG000|Overall Study|Lost to Follow-up|0|||
170486722|NCT03805412|616122765|FG001|Overall Study|Lost to Follow-up|1|||
170486723|NCT00669669|616122768|FG000|Overall Study|To late to start treatment|1|||
170486724|NCT01611883|616122770|FG000|Overall Study|Adverse Event|1|||
170486725|NCT01611883|616122771|FG001|Overall Study|Adverse Event|1|||
170486726|NCT02576847|616122777|FG000|Overall Study|Adverse Event|27|||
170486727|NCT02576847|616122777|FG000|Overall Study|Lost to Follow-up|22|||
170486728|NCT02576847|616122777|FG000|Overall Study|Physician Decision|1|||
170486729|NCT02576847|616122777|FG000|Overall Study|Pregnancy|1|||
170486730|NCT02576847|616122777|FG000|Overall Study|Protocol Violation|3|||
170486731|NCT02576847|616122777|FG000|Overall Study|Withdrawal by Subject|78|||
170486732|NCT02576847|616122777|FG000|Overall Study|Other|5|||
170486733|NCT02431676|616122778|FG000|Overall Study|no lab obtained|0|||
170486734|NCT02431676|616122779|FG001|Overall Study|no lab obtained|1|||
170486735|NCT02431676|616122780|FG002|Overall Study|no lab obtained|2|||
170486736|NCT03100903|616124784|FG000|Overall Study|Withdrawal by Subject|0|||
170486737|NCT03100903|616124785|FG001|Overall Study|Withdrawal by Subject|0|||
170486738|NCT03100903|616124786|FG002|Overall Study|Withdrawal by Subject|1|||
170486739|NCT04659993|616124787|FG000|Overall Study|Withdrawal by Subject|2|||
170486740|NCT04659993|616124787|FG000|Overall Study|Lost to Follow-up|2|||
170486741|NCT04010240|616124788|FG000|Overall Study|IHC not performed|2299|||
170486742|NCT00347958|616124789|FG000|Overall Study|Adverse Event|1|||
170486743|NCT00347958|616124789|FG000|Overall Study|Protocol Violation|2|||
170486744|NCT00347958|616124789|FG000|Overall Study|Withdrawal by Subject|1|||
170486745|NCT00754234|616124790|FG000|Overall Study|Withdrawal by Subject|3|||
170486746|NCT03263936|616124791|FG000|Overall Study|Adverse Event|0|||
170548870|NCT03636269|616354675|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
170548871|NCT03636269|616354673|FG000|Period 1: Double-blind Phase|Other|6|||
170548872|NCT03636269|616354674|FG001|Period 1: Double-blind Phase|Other|3|||
170548873|NCT03636269|616354675|FG002|Period 1: Double-blind Phase|Other|0|||
170798786|NCT03990883|617275753|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
170798787|NCT03990883|617275754|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
170798788|NCT03990883|617275755|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
170798789|NCT03990883|617275753|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
170798790|NCT03990883|617275754|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
170798791|NCT03990883|617275755|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
170798792|NCT05267639|617276640|FG000|Overall Study|Withdrawal by Subject|1|||
170798793|NCT05267639|617276641|FG001|Overall Study|Withdrawal by Subject|0|||
170798794|NCT05180539|617276642|FG000|Overall Study|Lost to Follow-up|27|||
170798795|NCT05180539|617276643|FG001|Overall Study|Lost to Follow-up|30|||
170798796|NCT02719574|617276649|FG000|Phase 1 (Dose Escalation)|Other|0|||
170798797|NCT02719574|617276650|FG001|Phase 1 (Dose Escalation)|Other|2|||
170798798|NCT02719574|617276651|FG002|Phase 1 (Dose Escalation)|Other|1|||
170798799|NCT02719574|617276652|FG003|Phase 1 (Dose Escalation)|Other|2|||
170798800|NCT02719574|617276653|FG004|Phase 1 (Dose Escalation)|Other|2|||
170798801|NCT02719574|617276654|FG005|Phase 1 (Dose Escalation)|Other|0|||
170798802|NCT02719574|617276655|FG006|Phase 1 (Dose Escalation)|Other|0|||
170798803|NCT02719574|617276656|FG007|Phase 1 (Dose Escalation)|Other|0|||
170798804|NCT02719574|617276657|FG008|Phase 1 (Dose Escalation)|Other|0|||
170798805|NCT02719574|617276658|FG009|Phase 1 (Dose Escalation)|Other|0|||
170798806|NCT02719574|617276659|FG010|Phase 1 (Dose Escalation)|Other|0|||
170798807|NCT02719574|617276660|FG011|Phase 1 (Dose Escalation)|Other|0|||
170798808|NCT02719574|617276661|FG012|Phase 1 (Dose Escalation)|Other|0|||
170798809|NCT02719574|617276662|FG013|Phase 1 (Dose Escalation)|Other|0|||
170486747|NCT03263936|616124792|FG001|Overall Study|Adverse Event|1|||
170486748|NCT03263936|616124793|FG002|Overall Study|Adverse Event|0|||
170486749|NCT03263936|616124791|FG000|Overall Study|Death|0|||
170486750|NCT03263936|616124792|FG001|Overall Study|Death|1|||
170486751|NCT03263936|616124793|FG002|Overall Study|Death|0|||
170486752|NCT01540487|616124794|FG000|Overall Study|Protocol Violation|1|||
170486753|NCT01540487|616124795|FG001|Overall Study|Protocol Violation|0|||
170486754|NCT04003636|616124797|FG000|Overall Study|Death|409|||
170548874|NCT03636269|616354673|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
170798810|NCT02719574|617276663|FG014|Phase 1 (Dose Escalation)|Other|0|||
170798811|NCT02719574|617276664|FG015|Phase 1 (Dose Escalation)|Other|0|||
170798812|NCT02719574|617276665|FG016|Phase 1 (Dose Escalation)|Other|0|||
170486755|NCT04003636|616124798|FG001|Overall Study|Death|443|||
170486756|NCT04003636|616124797|FG000|Overall Study|Lost to Follow-up|0|||
170486757|NCT04003636|616124798|FG001|Overall Study|Lost to Follow-up|1|||
170798813|NCT02719574|617276649|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
170798814|NCT02719574|617276650|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
170798815|NCT02719574|617276651|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
170486758|NCT04003636|616124797|FG000|Overall Study|Withdrawal by Subject|5|||
170486759|NCT04003636|616124798|FG001|Overall Study|Withdrawal by Subject|2|||
170798816|NCT02719574|617276652|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
170798817|NCT02719574|617276653|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
170798818|NCT02719574|617276654|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
170798819|NCT02719574|617276655|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798820|NCT02719574|617276656|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798821|NCT02719574|617276657|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798822|NCT02719574|617276658|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798823|NCT02719574|617276659|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798824|NCT02719574|617276660|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798825|NCT02719574|617276661|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798826|NCT02719574|617276662|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798827|NCT02719574|617276663|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798828|NCT02719574|617276664|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798829|NCT02719574|617276665|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
170798830|NCT02719574|617276649|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798831|NCT02719574|617276650|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
170798832|NCT02719574|617276651|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
170798833|NCT02719574|617276652|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798834|NCT02719574|617276653|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
170798835|NCT02719574|617276654|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
170798836|NCT02719574|617276655|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798837|NCT02719574|617276656|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798838|NCT02719574|617276657|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798839|NCT02719574|617276658|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798840|NCT02719574|617276659|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798841|NCT02719574|617276660|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798842|NCT02719574|617276661|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798843|NCT02719574|617276662|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798844|NCT02719574|617276663|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798845|NCT02719574|617276664|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798846|NCT02719574|617276665|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
170798847|NCT02719574|617276649|FG000|Phase 1 (Dose Escalation)|Death|2|||
170798848|NCT02719574|617276650|FG001|Phase 1 (Dose Escalation)|Death|1|||
170798849|NCT02719574|617276651|FG002|Phase 1 (Dose Escalation)|Death|1|||
170798850|NCT02719574|617276652|FG003|Phase 1 (Dose Escalation)|Death|0|||
170798851|NCT02719574|617276653|FG004|Phase 1 (Dose Escalation)|Death|0|||
170798852|NCT02719574|617276654|FG005|Phase 1 (Dose Escalation)|Death|0|||
170798853|NCT02719574|617276655|FG006|Phase 1 (Dose Escalation)|Death|0|||
170798854|NCT02719574|617276656|FG007|Phase 1 (Dose Escalation)|Death|0|||
170798855|NCT02719574|617276657|FG008|Phase 1 (Dose Escalation)|Death|0|||
170798856|NCT02719574|617276658|FG009|Phase 1 (Dose Escalation)|Death|0|||
170798857|NCT02719574|617276659|FG010|Phase 1 (Dose Escalation)|Death|0|||
170798858|NCT02719574|617276660|FG011|Phase 1 (Dose Escalation)|Death|0|||
170798859|NCT02719574|617276661|FG012|Phase 1 (Dose Escalation)|Death|0|||
170798860|NCT02719574|617276662|FG013|Phase 1 (Dose Escalation)|Death|0|||
170798861|NCT02719574|617276663|FG014|Phase 1 (Dose Escalation)|Death|0|||
170798862|NCT02719574|617276664|FG015|Phase 1 (Dose Escalation)|Death|0|||
170798863|NCT02719574|617276665|FG016|Phase 1 (Dose Escalation)|Death|0|||
170798864|NCT02719574|617276649|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798865|NCT02719574|617276650|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
170798866|NCT02719574|617276651|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798867|NCT02719574|617276652|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798868|NCT02719574|617276653|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
170798869|NCT02719574|617276654|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
170798870|NCT02719574|617276655|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798871|NCT02719574|617276656|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
170548875|NCT03636269|616354674|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
170548876|NCT03636269|616354675|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
170548877|NCT03636269|616354673|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
170548878|NCT03636269|616354674|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
170548879|NCT03636269|616354675|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
170548880|NCT03636269|616354673|FG000|Period 2: Open-label Phase|Adverse Event|0|||
170548881|NCT03636269|616354674|FG001|Period 2: Open-label Phase|Adverse Event|0|||
170798872|NCT02719574|617276657|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
170548882|NCT03636269|616354675|FG002|Period 2: Open-label Phase|Adverse Event|21|||
170798873|NCT02719574|617276658|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798874|NCT02719574|617276659|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798875|NCT02719574|617276660|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798876|NCT02719574|617276661|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
170548883|NCT03636269|616354673|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
170548884|NCT03636269|616354674|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
170548885|NCT03636269|616354675|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
170798877|NCT02719574|617276662|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798878|NCT02719574|617276663|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798879|NCT02719574|617276664|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798880|NCT02719574|617276665|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
170798881|NCT02719574|617276649|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798882|NCT02719574|617276650|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798883|NCT02719574|617276651|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798884|NCT02719574|617276652|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798885|NCT02719574|617276653|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
170798886|NCT02719574|617276654|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
170798887|NCT02719574|617276655|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798888|NCT02719574|617276656|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798889|NCT02719574|617276657|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798890|NCT02719574|617276658|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798891|NCT02719574|617276659|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798892|NCT02719574|617276660|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798893|NCT02719574|617276661|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798894|NCT02719574|617276662|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798895|NCT02719574|617276663|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798896|NCT02719574|617276664|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798897|NCT02719574|617276665|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
170798898|NCT02719574|617276649|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798899|NCT02719574|617276650|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798900|NCT02719574|617276651|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
170798901|NCT02719574|617276652|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798902|NCT02719574|617276653|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798903|NCT02719574|617276654|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798904|NCT02719574|617276655|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798905|NCT02719574|617276656|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798906|NCT02719574|617276657|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798907|NCT02719574|617276658|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798908|NCT02719574|617276659|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798909|NCT02719574|617276660|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798910|NCT02719574|617276661|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798911|NCT02719574|617276662|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798912|NCT02719574|617276663|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798913|NCT02719574|617276664|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798914|NCT02719574|617276665|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
170798915|NCT02719574|617276649|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798916|NCT02719574|617276650|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798917|NCT02719574|617276651|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798918|NCT02719574|617276652|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798919|NCT02719574|617276653|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798920|NCT02719574|617276654|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798921|NCT02719574|617276655|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
170798922|NCT02719574|617276656|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
170798923|NCT02719574|617276657|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
170798924|NCT02719574|617276658|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798925|NCT02719574|617276659|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798926|NCT02719574|617276660|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798927|NCT02719574|617276661|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798928|NCT02719574|617276662|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798929|NCT02719574|617276663|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798930|NCT02719574|617276664|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798931|NCT02719574|617276665|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
170798932|NCT02719574|617276649|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798933|NCT02719574|617276650|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798934|NCT02719574|617276651|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170548886|NCT03636269|616354673|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
170548887|NCT03636269|616354674|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
170548888|NCT03636269|616354675|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
170548889|NCT03636269|616354673|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
170548890|NCT03636269|616354674|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
170798935|NCT02719574|617276652|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798936|NCT02719574|617276653|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798937|NCT02719574|617276654|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798938|NCT02719574|617276655|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
170548891|NCT03636269|616354675|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
170548892|NCT03636269|616354673|FG000|Period 2: Open-label Phase|Administrative|0|||
170486760|NCT04003636|616124797|FG000|Overall Study|Participant On-going|119|||
170486761|NCT04003636|616124798|FG001|Overall Study|Participant On-going|90|||
170486762|NCT00298272|616124799|FG000|Double-blind Phase|Adverse Event|2|||
170486763|NCT00298272|616124800|FG001|Double-blind Phase|Adverse Event|0|||
170486764|NCT00298272|616124799|FG000|Double-blind Phase|Failure to Return|2|||
170486765|NCT00298272|616124800|FG001|Double-blind Phase|Failure to Return|0|||
170486766|NCT00298272|616124799|FG000|Double-blind Phase|Protocol Violation|2|||
170486767|NCT00298272|616124800|FG001|Double-blind Phase|Protocol Violation|0|||
170486768|NCT00298272|616124799|FG000|Double-blind Phase|Withdrawal by Subject|2|||
170486769|NCT00298272|616124800|FG001|Double-blind Phase|Withdrawal by Subject|0|||
170486770|NCT00298272|616124799|FG000|Open Label Retreatment Phase|Adverse Event|1|||
170486771|NCT00298272|616124800|FG001|Open Label Retreatment Phase|Adverse Event|2|||
170486772|NCT00298272|616124799|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
170486773|NCT00298272|616124800|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
170486774|NCT00298272|616124799|FG000|Open Label Retreatment Phase|Failure to Return|1|||
170486775|NCT00298272|616124800|FG001|Open Label Retreatment Phase|Failure to Return|0|||
170486776|NCT00298272|616124799|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
170486777|NCT00298272|616124800|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
170486778|NCT00298272|616124799|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
170486779|NCT00298272|616124800|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
170486780|NCT00298272|616124799|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
170486781|NCT00298272|616124800|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
170486782|NCT00298272|616124799|FG000|Safety Follow-up Phase|Failure to Return|1|||
170486783|NCT00298272|616124800|FG001|Safety Follow-up Phase|Failure to Return|1|||
170486784|NCT00298272|616124799|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
170486785|NCT00298272|616124800|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
170486786|NCT00298272|616124799|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
170486787|NCT00298272|616124800|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
170486788|NCT01623310|616124801|FG000|Overall Study|Adverse Event|21|||
170486789|NCT01623310|616124801|FG000|Overall Study|Lost to Follow-up|18|||
170486790|NCT01623310|616124801|FG000|Overall Study|Lack of Efficacy|6|||
170486791|NCT01623310|616124801|FG000|Overall Study|Protocol Violation|6|||
170486792|NCT01623310|616124801|FG000|Overall Study|Withdrawal by Subject|25|||
170486793|NCT01623310|616124801|FG000|Overall Study|Became potentially child-bearing|1|||
170486794|NCT01623310|616124801|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
170486795|NCT01623310|616124801|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
170486796|NCT00326716|616124802|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
170548893|NCT03636269|616354674|FG001|Period 2: Open-label Phase|Administrative|0|||
170548894|NCT03636269|616354675|FG002|Period 2: Open-label Phase|Administrative|36|||
170548895|NCT03636269|616354673|FG000|Period 2: Open-label Phase|Other|0|||
170548896|NCT03636269|616354674|FG001|Period 2: Open-label Phase|Other|0|||
170548897|NCT03636269|616354675|FG002|Period 2: Open-label Phase|Other|9|||
170548898|NCT03636269|616354673|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
170486797|NCT00326716|616124803|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
170486798|NCT00326716|616124804|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
170486799|NCT00326716|616124805|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
170486800|NCT00684411|616124806|FG000|Overall Study|New Primary Cancer|1|||
170486801|NCT00684411|616124806|FG000|Overall Study|Disease Progression|10|||
170486802|NCT00684411|616124806|FG000|Overall Study|Adverse Event|1|||
170486803|NCT01754129|616124807|FG000|Overall Study|Death|13|||
170486804|NCT01754129|616124807|FG000|Overall Study|Duodopa discontinuation|9|||
170486805|NCT01754129|616124807|FG000|Overall Study|Lost to Follow-up|7|||
170486806|NCT01754129|616124807|FG000|Overall Study|Withdrew consent|1|||
170486807|NCT01754129|616124807|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
170486808|NCT04134767|616124808|FG000|Overall Study|Death|0|||
170486809|NCT04134767|616124809|FG001|Overall Study|Death|1|||
170548899|NCT03636269|616354674|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
170548900|NCT03636269|616354675|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
170548901|NCT01908699|616354689|FG000|Overall Study|Adverse Event|8|||
170548902|NCT01908699|616354690|FG001|Overall Study|Adverse Event|12|||
170548903|NCT01908699|616354689|FG000|Overall Study|Lack of Efficacy|2|||
170548904|NCT01908699|616354690|FG001|Overall Study|Lack of Efficacy|2|||
170548905|NCT01908699|616354689|FG000|Overall Study|Lost to Follow-up|2|||
170548906|NCT01908699|616354690|FG001|Overall Study|Lost to Follow-up|4|||
170548907|NCT01908699|616354689|FG000|Overall Study|Physician Decision|8|||
170548908|NCT01908699|616354690|FG001|Overall Study|Physician Decision|8|||
170548909|NCT01908699|616354689|FG000|Overall Study|Withdrawal by Subject|15|||
170548910|NCT01908699|616354690|FG001|Overall Study|Withdrawal by Subject|10|||
170548911|NCT01908699|616354689|FG000|Overall Study|Pregnancy|0|||
170548912|NCT01908699|616354690|FG001|Overall Study|Pregnancy|1|||
170548913|NCT01908699|616354689|FG000|Overall Study|Randomized in Error|1|||
170486810|NCT04134767|616124808|FG000|Overall Study|Removed for harassing staff|0|||
170486811|NCT04134767|616124809|FG001|Overall Study|Removed for harassing staff|1|||
170486812|NCT04134767|616124808|FG000|Overall Study|Lost to Follow-up|44|||
170548914|NCT01908699|616354690|FG001|Overall Study|Randomized in Error|0|||
170486813|NCT04134767|616124809|FG001|Overall Study|Lost to Follow-up|40|||
170486814|NCT02126579|616124813|FG000|Overall Study|disease progression|0|||
170486815|NCT02126579|616124814|FG001|Overall Study|disease progression|0|||
170486816|NCT02126579|616124815|FG002|Overall Study|disease progression|0|||
170486817|NCT02126579|616124816|FG003|Overall Study|disease progression|1|||
170486818|NCT02126579|616124817|FG004|Overall Study|disease progression|0|||
170486819|NCT02126579|616124818|FG005|Overall Study|disease progression|0|||
170486820|NCT02126579|616124819|FG006|Overall Study|disease progression|1|||
170486821|NCT03691207|616124820|FG000|Overall Study|Death|41|||
170486822|NCT03691207|616124821|FG001|Overall Study|Death|26|||
170486823|NCT03691207|616124820|FG000|Overall Study|Lost to Follow-up|1|||
170486824|NCT03691207|616124821|FG001|Overall Study|Lost to Follow-up|1|||
170486825|NCT03691207|616124820|FG000|Overall Study|Withdrawal by Subject|2|||
170486826|NCT03691207|616124821|FG001|Overall Study|Withdrawal by Subject|8|||
170486827|NCT03691207|616124820|FG000|Overall Study|Sponsor decision|1|||
170486828|NCT03691207|616124821|FG001|Overall Study|Sponsor decision|7|||
170486829|NCT00651261|616124822|FG000|Overall Study|Adverse Event|32|||
170486830|NCT00651261|616124823|FG001|Overall Study|Adverse Event|22|||
170486831|NCT00651261|616124822|FG000|Overall Study|Death|18|||
170486832|NCT00651261|616124823|FG001|Overall Study|Death|18|||
170486833|NCT00651261|616124822|FG000|Overall Study|Withdrawal by Subject|22|||
170486834|NCT00651261|616124823|FG001|Overall Study|Withdrawal by Subject|40|||
170486835|NCT00651261|616124822|FG000|Overall Study|Induction failure|24|||
170486836|NCT00651261|616124823|FG001|Overall Study|Induction failure|35|||
170486837|NCT00651261|616124822|FG000|Overall Study|Disease progression|58|||
170486838|NCT00651261|616124823|FG001|Overall Study|Disease progression|58|||
170486839|NCT00651261|616124822|FG000|Overall Study|Alternative therapy|109|||
170486840|NCT00651261|616124823|FG001|Overall Study|Alternative therapy|107|||
170548915|NCT01908699|616354689|FG000|Overall Study|Death|9|||
170548916|NCT01908699|616354690|FG001|Overall Study|Death|12|||
170548917|NCT01908699|616354689|FG000|Overall Study|Progressive Disease|30|||
170798939|NCT02719574|617276656|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
170798940|NCT02719574|617276657|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798941|NCT02719574|617276658|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798942|NCT02719574|617276659|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798943|NCT02719574|617276660|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798944|NCT02719574|617276661|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798945|NCT02719574|617276662|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798946|NCT02719574|617276663|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798947|NCT02719574|617276664|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798948|NCT02719574|617276665|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
170798949|NCT02719574|617276649|FG000|Phase 1 (Dose Expansion)|Death|0|||
170798950|NCT02719574|617276650|FG001|Phase 1 (Dose Expansion)|Death|0|||
170798951|NCT02719574|617276651|FG002|Phase 1 (Dose Expansion)|Death|0|||
170798952|NCT02719574|617276652|FG003|Phase 1 (Dose Expansion)|Death|0|||
170798953|NCT02719574|617276653|FG004|Phase 1 (Dose Expansion)|Death|0|||
170798954|NCT02719574|617276654|FG005|Phase 1 (Dose Expansion)|Death|0|||
170798955|NCT02719574|617276655|FG006|Phase 1 (Dose Expansion)|Death|1|||
170798956|NCT02719574|617276656|FG007|Phase 1 (Dose Expansion)|Death|6|||
170798957|NCT02719574|617276657|FG008|Phase 1 (Dose Expansion)|Death|0|||
170798958|NCT02719574|617276658|FG009|Phase 1 (Dose Expansion)|Death|0|||
170798959|NCT02719574|617276659|FG010|Phase 1 (Dose Expansion)|Death|0|||
170798960|NCT02719574|617276660|FG011|Phase 1 (Dose Expansion)|Death|0|||
170798961|NCT02719574|617276661|FG012|Phase 1 (Dose Expansion)|Death|0|||
170798962|NCT02719574|617276662|FG013|Phase 1 (Dose Expansion)|Death|0|||
170798963|NCT02719574|617276663|FG014|Phase 1 (Dose Expansion)|Death|0|||
170798964|NCT02719574|617276664|FG015|Phase 1 (Dose Expansion)|Death|0|||
170798965|NCT02719574|617276665|FG016|Phase 1 (Dose Expansion)|Death|0|||
170798966|NCT02719574|617276649|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
170486841|NCT00651261|616124822|FG000|Overall Study|Other disease or participant decisions|23|||
170486842|NCT00651261|616124823|FG001|Overall Study|Other disease or participant decisions|23|||
170486843|NCT00651261|616124822|FG000|Overall Study|Never treated|5|||
170548918|NCT01908699|616354690|FG001|Overall Study|Progressive Disease|29|||
170486844|NCT00651261|616124823|FG001|Overall Study|Never treated|3|||
170548919|NCT00493285|616354693|FG000|Overall Study|Lost to Follow-up|0|||
170798967|NCT02719574|617276650|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798968|NCT02719574|617276651|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798969|NCT02719574|617276652|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798970|NCT02719574|617276653|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798971|NCT02719574|617276654|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
170486845|NCT02027545|616124824|FG000|Overall Study|Failed to sign HIPAA|0|||
170486846|NCT02027545|616124825|FG001|Overall Study|Failed to sign HIPAA|2|||
170486847|NCT02027545|616124824|FG000|Overall Study|Failed to attend study visit|2|||
170486848|NCT02027545|616124825|FG001|Overall Study|Failed to attend study visit|0|||
170486849|NCT02027545|616124824|FG000|Overall Study|Protocol Violation|1|||
170486850|NCT02027545|616124825|FG001|Overall Study|Protocol Violation|0|||
170486851|NCT05483686|616124826|FG000|Overall Study|Lost to Follow-up|5|||
170548920|NCT00493285|616354694|FG001|Overall Study|Lost to Follow-up|0|||
170798972|NCT02719574|617276655|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
170898689|NCT02660580|617634231|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
170898690|NCT02660580|617634232|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
170898691|NCT02660580|617634228|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
170898692|NCT02660580|617634229|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
170898693|NCT02660580|617634230|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
170898694|NCT02660580|617634231|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
170898695|NCT02660580|617634232|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
170898696|NCT02660580|617634228|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
170898697|NCT02660580|617634229|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
170898698|NCT02660580|617634230|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
170898699|NCT02660580|617634231|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
170898700|NCT02660580|617634232|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
170898701|NCT02660580|617634228|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
170898702|NCT02660580|617634229|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
170898703|NCT02660580|617634230|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
170898704|NCT02660580|617634231|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
170898705|NCT02660580|617634232|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
170898706|NCT02660580|617634228|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
170898707|NCT02660580|617634229|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
170898708|NCT02660580|617634230|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
170898709|NCT02660580|617634231|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
170898710|NCT02660580|617634232|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
170898711|NCT02660580|617634228|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
170898712|NCT02660580|617634229|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
170898713|NCT02660580|617634230|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
170898714|NCT02660580|617634231|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
170486852|NCT05483686|616124827|FG001|Overall Study|Lost to Follow-up|7|||
170486853|NCT05780983|616124828|FG000|Overall Study|Withdrawal by Subject|1|||
170486854|NCT06028438|616124832|FG000|Overall Study|Adverse Event|3|||
170486855|NCT06028438|616124833|FG001|Overall Study|Adverse Event|9|||
170486856|NCT06028438|616124832|FG000|Overall Study|Lack of Efficacy|1|||
170486857|NCT06028438|616124833|FG001|Overall Study|Lack of Efficacy|1|||
170486858|NCT06028438|616124832|FG000|Overall Study|Lost to Follow-up|1|||
170486859|NCT06028438|616124833|FG001|Overall Study|Lost to Follow-up|0|||
170486860|NCT06028438|616124832|FG000|Overall Study|Withdrawal by Subject|1|||
170486861|NCT06028438|616124833|FG001|Overall Study|Withdrawal by Subject|0|||
170486862|NCT06028438|616124832|FG000|Overall Study|Other|3|||
170486863|NCT06028438|616124833|FG001|Overall Study|Other|3|||
170486864|NCT02044302|616124834|FG000|Overall Study|study terminated|2|||
170486865|NCT02044302|616124835|FG001|Overall Study|study terminated|0|||
170486866|NCT01954056|616124838|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
170486867|NCT01954056|616124839|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
170486868|NCT00630825|616124840|FG000|Overall Study|Adverse Event|4|||
170486869|NCT00630825|616124841|FG001|Overall Study|Adverse Event|4|||
170486870|NCT00630825|616124842|FG002|Overall Study|Adverse Event|3|||
170486871|NCT00630825|616124843|FG003|Overall Study|Adverse Event|1|||
170486872|NCT00630825|616124840|FG000|Overall Study|Entry Criteria Not Met|1|||
170486873|NCT00630825|616124841|FG001|Overall Study|Entry Criteria Not Met|0|||
170486874|NCT00630825|616124842|FG002|Overall Study|Entry Criteria Not Met|2|||
170486875|NCT00630825|616124843|FG003|Overall Study|Entry Criteria Not Met|1|||
170486876|NCT00630825|616124840|FG000|Overall Study|Lost to Follow-up|1|||
170486877|NCT00630825|616124841|FG001|Overall Study|Lost to Follow-up|1|||
170486878|NCT00630825|616124842|FG002|Overall Study|Lost to Follow-up|1|||
170486879|NCT00630825|616124843|FG003|Overall Study|Lost to Follow-up|1|||
170548921|NCT00493285|616354695|FG002|Overall Study|Lost to Follow-up|0|||
170548922|NCT00493285|616354696|FG003|Overall Study|Lost to Follow-up|0|||
170548923|NCT00493285|616354697|FG004|Overall Study|Lost to Follow-up|1|||
170548924|NCT00493285|616354698|FG005|Overall Study|Lost to Follow-up|0|||
170548925|NCT03021005|616354699|FG000|Overall Study|Lost to Follow-up|39|||
170548926|NCT03021005|616354700|FG001|Overall Study|Lost to Follow-up|26|||
170548927|NCT02421510|616354701|FG000|Overall Study|Other|4|||
170548928|NCT02421510|616354702|FG001|Overall Study|Other|2|||
170548929|NCT02421510|616354703|FG002|Overall Study|Other|3|||
170898715|NCT02660580|617634232|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
170548930|NCT02421510|616354701|FG000|Overall Study|Protocol Violation|1|||
170898716|NCT02660580|617634228|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
170486880|NCT00630825|616124840|FG000|Overall Study|Physician Decision|1|||
170486881|NCT00630825|616124841|FG001|Overall Study|Physician Decision|0|||
170486882|NCT00630825|616124842|FG002|Overall Study|Physician Decision|0|||
170548931|NCT02421510|616354702|FG001|Overall Study|Protocol Violation|2|||
170548932|NCT02421510|616354703|FG002|Overall Study|Protocol Violation|0|||
170548933|NCT02421510|616354701|FG000|Overall Study|Death|1|||
170798973|NCT02719574|617276656|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
170798974|NCT02719574|617276657|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798975|NCT02719574|617276658|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798976|NCT02719574|617276659|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798977|NCT02719574|617276660|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798978|NCT02719574|617276661|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798979|NCT02719574|617276662|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798980|NCT02719574|617276663|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798981|NCT02719574|617276664|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798982|NCT02719574|617276665|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
170798983|NCT02719574|617276649|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798984|NCT02719574|617276650|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798985|NCT02719574|617276651|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798986|NCT02719574|617276652|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798987|NCT02719574|617276653|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798988|NCT02719574|617276654|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798989|NCT02719574|617276655|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
170798990|NCT02719574|617276656|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
170798991|NCT02719574|617276657|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798992|NCT02719574|617276658|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798993|NCT02719574|617276659|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798994|NCT02719574|617276660|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798995|NCT02719574|617276661|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798996|NCT02719574|617276662|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798997|NCT02719574|617276663|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798998|NCT02719574|617276664|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
170798999|NCT02719574|617276665|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
170799000|NCT02719574|617276649|FG000|Phase 1 (Dose Expansion)|Other|0|||
170799001|NCT02719574|617276650|FG001|Phase 1 (Dose Expansion)|Other|0|||
170799002|NCT02719574|617276651|FG002|Phase 1 (Dose Expansion)|Other|0|||
170799003|NCT02719574|617276652|FG003|Phase 1 (Dose Expansion)|Other|0|||
170799004|NCT02719574|617276653|FG004|Phase 1 (Dose Expansion)|Other|0|||
170799005|NCT02719574|617276654|FG005|Phase 1 (Dose Expansion)|Other|0|||
170799006|NCT02719574|617276655|FG006|Phase 1 (Dose Expansion)|Other|1|||
170799007|NCT02719574|617276656|FG007|Phase 1 (Dose Expansion)|Other|7|||
170799008|NCT02719574|617276657|FG008|Phase 1 (Dose Expansion)|Other|0|||
170799009|NCT02719574|617276658|FG009|Phase 1 (Dose Expansion)|Other|0|||
170799010|NCT02719574|617276659|FG010|Phase 1 (Dose Expansion)|Other|0|||
170799011|NCT02719574|617276660|FG011|Phase 1 (Dose Expansion)|Other|0|||
170799012|NCT02719574|617276661|FG012|Phase 1 (Dose Expansion)|Other|0|||
170799013|NCT02719574|617276662|FG013|Phase 1 (Dose Expansion)|Other|0|||
170799014|NCT02719574|617276663|FG014|Phase 1 (Dose Expansion)|Other|0|||
170799015|NCT02719574|617276664|FG015|Phase 1 (Dose Expansion)|Other|0|||
170799016|NCT02719574|617276665|FG016|Phase 1 (Dose Expansion)|Other|0|||
170799017|NCT02719574|617276649|FG000|Phase 2|Protocol Defined Disease Progression|0|||
170799018|NCT02719574|617276650|FG001|Phase 2|Protocol Defined Disease Progression|0|||
170799019|NCT02719574|617276651|FG002|Phase 2|Protocol Defined Disease Progression|0|||
170799020|NCT02719574|617276652|FG003|Phase 2|Protocol Defined Disease Progression|0|||
170799021|NCT02719574|617276653|FG004|Phase 2|Protocol Defined Disease Progression|0|||
170799022|NCT02719574|617276654|FG005|Phase 2|Protocol Defined Disease Progression|0|||
170799023|NCT02719574|617276655|FG006|Phase 2|Protocol Defined Disease Progression|0|||
170799024|NCT02719574|617276656|FG007|Phase 2|Protocol Defined Disease Progression|0|||
170799025|NCT02719574|617276657|FG008|Phase 2|Protocol Defined Disease Progression|0|||
170799026|NCT02719574|617276658|FG009|Phase 2|Protocol Defined Disease Progression|65|||
170799027|NCT02719574|617276659|FG010|Phase 2|Protocol Defined Disease Progression|8|||
170799028|NCT02719574|617276660|FG011|Phase 2|Protocol Defined Disease Progression|2|||
170799029|NCT02719574|617276661|FG012|Phase 2|Protocol Defined Disease Progression|4|||
170799030|NCT02719574|617276662|FG013|Phase 2|Protocol Defined Disease Progression|9|||
170799031|NCT02719574|617276663|FG014|Phase 2|Protocol Defined Disease Progression|11|||
170799032|NCT02719574|617276664|FG015|Phase 2|Protocol Defined Disease Progression|3|||
170799033|NCT02719574|617276665|FG016|Phase 2|Protocol Defined Disease Progression|4|||
170799034|NCT02719574|617276649|FG000|Phase 2|Adverse Event|0|||
170799035|NCT02719574|617276650|FG001|Phase 2|Adverse Event|0|||
170799036|NCT02719574|617276651|FG002|Phase 2|Adverse Event|0|||
170799037|NCT02719574|617276652|FG003|Phase 2|Adverse Event|0|||
170799038|NCT02719574|617276653|FG004|Phase 2|Adverse Event|0|||
170799039|NCT02719574|617276654|FG005|Phase 2|Adverse Event|0|||
170898717|NCT02660580|617634229|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
170898718|NCT02660580|617634230|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
170898719|NCT02660580|617634231|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
170799040|NCT02719574|617276655|FG006|Phase 2|Adverse Event|0|||
170799041|NCT02719574|617276656|FG007|Phase 2|Adverse Event|0|||
170799042|NCT02719574|617276657|FG008|Phase 2|Adverse Event|0|||
170799043|NCT02719574|617276658|FG009|Phase 2|Adverse Event|27|||
170898720|NCT02660580|617634232|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
170898721|NCT02660580|617634228|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
170898722|NCT02660580|617634229|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
170898723|NCT02660580|617634230|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
170898724|NCT02660580|617634231|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
170898725|NCT02660580|617634232|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
170799044|NCT02719574|617276659|FG010|Phase 2|Adverse Event|0|||
170799045|NCT02719574|617276660|FG011|Phase 2|Adverse Event|1|||
170799046|NCT02719574|617276661|FG012|Phase 2|Adverse Event|1|||
170799047|NCT02719574|617276662|FG013|Phase 2|Adverse Event|1|||
170799048|NCT02719574|617276663|FG014|Phase 2|Adverse Event|2|||
170799049|NCT02719574|617276664|FG015|Phase 2|Adverse Event|2|||
170799050|NCT02719574|617276665|FG016|Phase 2|Adverse Event|3|||
170799051|NCT02719574|617276649|FG000|Phase 2|Other|0|||
170799052|NCT02719574|617276650|FG001|Phase 2|Other|0|||
170799053|NCT02719574|617276651|FG002|Phase 2|Other|0|||
170799054|NCT02719574|617276652|FG003|Phase 2|Other|0|||
170799055|NCT02719574|617276653|FG004|Phase 2|Other|0|||
170799056|NCT02719574|617276654|FG005|Phase 2|Other|0|||
170799057|NCT02719574|617276655|FG006|Phase 2|Other|0|||
170799058|NCT02719574|617276656|FG007|Phase 2|Other|0|||
170799059|NCT02719574|617276657|FG008|Phase 2|Other|0|||
170799060|NCT02719574|617276658|FG009|Phase 2|Other|20|||
170799061|NCT02719574|617276659|FG010|Phase 2|Other|7|||
170799062|NCT02719574|617276660|FG011|Phase 2|Other|0|||
170799063|NCT02719574|617276661|FG012|Phase 2|Other|5|||
170799064|NCT02719574|617276662|FG013|Phase 2|Other|7|||
170799065|NCT02719574|617276663|FG014|Phase 2|Other|0|||
170799066|NCT02719574|617276664|FG015|Phase 2|Other|1|||
170799067|NCT02719574|617276665|FG016|Phase 2|Other|4|||
170799068|NCT02719574|617276649|FG000|Phase 2|Transplant|0|||
170799069|NCT02719574|617276650|FG001|Phase 2|Transplant|0|||
170799070|NCT02719574|617276651|FG002|Phase 2|Transplant|0|||
170799071|NCT02719574|617276652|FG003|Phase 2|Transplant|0|||
170799072|NCT02719574|617276653|FG004|Phase 2|Transplant|0|||
170799073|NCT02719574|617276654|FG005|Phase 2|Transplant|0|||
170799074|NCT02719574|617276655|FG006|Phase 2|Transplant|0|||
170799075|NCT02719574|617276656|FG007|Phase 2|Transplant|0|||
170799076|NCT02719574|617276657|FG008|Phase 2|Transplant|0|||
170799077|NCT02719574|617276658|FG009|Phase 2|Transplant|15|||
170799078|NCT02719574|617276659|FG010|Phase 2|Transplant|2|||
170799079|NCT02719574|617276660|FG011|Phase 2|Transplant|0|||
170799080|NCT02719574|617276661|FG012|Phase 2|Transplant|6|||
170799081|NCT02719574|617276662|FG013|Phase 2|Transplant|1|||
170799082|NCT02719574|617276663|FG014|Phase 2|Transplant|1|||
170799083|NCT02719574|617276664|FG015|Phase 2|Transplant|0|||
170799084|NCT02719574|617276665|FG016|Phase 2|Transplant|0|||
170799085|NCT02719574|617276649|FG000|Phase 2|Death|0|||
170799086|NCT02719574|617276650|FG001|Phase 2|Death|0|||
170799087|NCT02719574|617276651|FG002|Phase 2|Death|0|||
170799088|NCT02719574|617276652|FG003|Phase 2|Death|0|||
170799089|NCT02719574|617276653|FG004|Phase 2|Death|0|||
170799090|NCT02719574|617276654|FG005|Phase 2|Death|0|||
170799091|NCT02719574|617276655|FG006|Phase 2|Death|0|||
170799092|NCT02719574|617276656|FG007|Phase 2|Death|0|||
170799093|NCT02719574|617276657|FG008|Phase 2|Death|0|||
170799094|NCT02719574|617276658|FG009|Phase 2|Death|14|||
170799095|NCT02719574|617276659|FG010|Phase 2|Death|0|||
170799096|NCT02719574|617276660|FG011|Phase 2|Death|0|||
170799097|NCT02719574|617276661|FG012|Phase 2|Death|1|||
170799098|NCT02719574|617276662|FG013|Phase 2|Death|1|||
170486883|NCT00630825|616124843|FG003|Overall Study|Physician Decision|0|||
170799099|NCT02719574|617276663|FG014|Phase 2|Death|2|||
170799100|NCT02719574|617276664|FG015|Phase 2|Death|0|||
170799101|NCT02719574|617276665|FG016|Phase 2|Death|0|||
170799102|NCT02719574|617276649|FG000|Phase 2|Investigator Decision|0|||
170799103|NCT02719574|617276650|FG001|Phase 2|Investigator Decision|0|||
170799104|NCT02719574|617276651|FG002|Phase 2|Investigator Decision|0|||
170799105|NCT02719574|617276652|FG003|Phase 2|Investigator Decision|0|||
170799106|NCT02719574|617276653|FG004|Phase 2|Investigator Decision|0|||
170799107|NCT02719574|617276654|FG005|Phase 2|Investigator Decision|0|||
170799108|NCT02719574|617276655|FG006|Phase 2|Investigator Decision|0|||
170799109|NCT02719574|617276656|FG007|Phase 2|Investigator Decision|0|||
170799110|NCT02719574|617276657|FG008|Phase 2|Investigator Decision|0|||
170799111|NCT02719574|617276658|FG009|Phase 2|Investigator Decision|6|||
170799112|NCT02719574|617276659|FG010|Phase 2|Investigator Decision|1|||
170799113|NCT02719574|617276660|FG011|Phase 2|Investigator Decision|2|||
170799114|NCT02719574|617276661|FG012|Phase 2|Investigator Decision|3|||
170799115|NCT02719574|617276662|FG013|Phase 2|Investigator Decision|1|||
170799116|NCT02719574|617276663|FG014|Phase 2|Investigator Decision|3|||
170799117|NCT02719574|617276664|FG015|Phase 2|Investigator Decision|2|||
170486884|NCT00630825|616124840|FG000|Overall Study|Withdrawal by Subject|2|||
170486885|NCT00630825|616124841|FG001|Overall Study|Withdrawal by Subject|2|||
170486886|NCT00630825|616124842|FG002|Overall Study|Withdrawal by Subject|2|||
170486887|NCT00630825|616124843|FG003|Overall Study|Withdrawal by Subject|3|||
170486888|NCT04610346|616124845|FG000|Overall Study|Withdrawal by Subject|1|||
170486889|NCT04610346|616124846|FG001|Overall Study|Withdrawal by Subject|1|||
170486890|NCT04610346|616124845|FG000|Overall Study|did not complete shelter onboarding|2|||
170486891|NCT04610346|616124846|FG001|Overall Study|did not complete shelter onboarding|1|||
170486892|NCT01019694|616124859|FG000|Overall Study|Adverse Event|12|||
170486893|NCT01019694|616124860|FG001|Overall Study|Adverse Event|16|||
170486894|NCT01019694|616124861|FG002|Overall Study|Adverse Event|19|||
170486895|NCT01019694|616124859|FG000|Overall Study|Protocol Violation|2|||
170799118|NCT02719574|617276665|FG016|Phase 2|Investigator Decision|0|||
170799119|NCT02719574|617276649|FG000|Phase 2|Withdrawal by Subject|0|||
170799120|NCT02719574|617276650|FG001|Phase 2|Withdrawal by Subject|0|||
170799121|NCT02719574|617276651|FG002|Phase 2|Withdrawal by Subject|0|||
170799122|NCT02719574|617276652|FG003|Phase 2|Withdrawal by Subject|0|||
170799123|NCT02719574|617276653|FG004|Phase 2|Withdrawal by Subject|0|||
170799124|NCT02719574|617276654|FG005|Phase 2|Withdrawal by Subject|0|||
170799125|NCT02719574|617276655|FG006|Phase 2|Withdrawal by Subject|0|||
170799126|NCT02719574|617276656|FG007|Phase 2|Withdrawal by Subject|0|||
170799127|NCT02719574|617276657|FG008|Phase 2|Withdrawal by Subject|0|||
170799128|NCT02719574|617276658|FG009|Phase 2|Withdrawal by Subject|5|||
170799129|NCT02719574|617276659|FG010|Phase 2|Withdrawal by Subject|0|||
170799130|NCT02719574|617276660|FG011|Phase 2|Withdrawal by Subject|0|||
170799131|NCT02719574|617276661|FG012|Phase 2|Withdrawal by Subject|0|||
170799132|NCT02719574|617276662|FG013|Phase 2|Withdrawal by Subject|1|||
170799133|NCT02719574|617276663|FG014|Phase 2|Withdrawal by Subject|1|||
170799134|NCT02719574|617276664|FG015|Phase 2|Withdrawal by Subject|2|||
170799135|NCT02719574|617276665|FG016|Phase 2|Withdrawal by Subject|0|||
170799136|NCT02719574|617276649|FG000|Phase 2|Protocol Violation|0|||
170799137|NCT02719574|617276650|FG001|Phase 2|Protocol Violation|0|||
170799138|NCT02719574|617276651|FG002|Phase 2|Protocol Violation|0|||
170799139|NCT02719574|617276652|FG003|Phase 2|Protocol Violation|0|||
170799140|NCT02719574|617276653|FG004|Phase 2|Protocol Violation|0|||
170799141|NCT02719574|617276654|FG005|Phase 2|Protocol Violation|0|||
170799142|NCT02719574|617276655|FG006|Phase 2|Protocol Violation|0|||
170799143|NCT02719574|617276656|FG007|Phase 2|Protocol Violation|0|||
170799144|NCT02719574|617276657|FG008|Phase 2|Protocol Violation|0|||
170799145|NCT02719574|617276658|FG009|Phase 2|Protocol Violation|1|||
170799146|NCT02719574|617276659|FG010|Phase 2|Protocol Violation|0|||
170799147|NCT02719574|617276660|FG011|Phase 2|Protocol Violation|0|||
170799148|NCT02719574|617276661|FG012|Phase 2|Protocol Violation|0|||
170799149|NCT02719574|617276662|FG013|Phase 2|Protocol Violation|0|||
170799150|NCT02719574|617276663|FG014|Phase 2|Protocol Violation|0|||
170799151|NCT02719574|617276664|FG015|Phase 2|Protocol Violation|0|||
170799152|NCT02719574|617276665|FG016|Phase 2|Protocol Violation|0|||
170799153|NCT00113360|617276666|FG000|Overall Study|Adverse Event|3|||
170799154|NCT00113360|617276666|FG000|Overall Study|Subject required surgery|1|||
170799155|NCT00113360|617276666|FG000|Overall Study|Did not meet eligibility criteria|3|||
170799156|NCT01976936|617276679|FG000|Overall Study|Did not receive at least 9 doses|9|||
170799157|NCT01976936|617276680|FG001|Overall Study|Did not receive at least 9 doses|4|||
170799158|NCT02467270|617276681|FG000|Overall Study|Participants Never Treated|0|||
170799159|NCT02467270|617276682|FG001|Overall Study|Participants Never Treated|1|||
170799160|NCT02467270|617276683|FG002|Overall Study|Participants Never Treated|0|||
170799161|NCT02467270|617276681|FG000|Overall Study|Ongoing|50|||
170799162|NCT02467270|617276682|FG001|Overall Study|Ongoing|41|||
170799163|NCT02467270|617276683|FG002|Overall Study|Ongoing|43|||
170799164|NCT02467270|617276681|FG000|Overall Study|Adverse Event|16|||
170799165|NCT02467270|617276682|FG001|Overall Study|Adverse Event|15|||
170799166|NCT02467270|617276683|FG002|Overall Study|Adverse Event|14|||
170799167|NCT02467270|617276681|FG000|Overall Study|Progressive Disease|7|||
170799168|NCT02467270|617276682|FG001|Overall Study|Progressive Disease|7|||
170799169|NCT02467270|617276683|FG002|Overall Study|Progressive Disease|4|||
170799170|NCT02467270|617276681|FG000|Overall Study|Death|2|||
170486896|NCT01019694|616124860|FG001|Overall Study|Protocol Violation|6|||
170486897|NCT01019694|616124861|FG002|Overall Study|Protocol Violation|4|||
170486898|NCT01019694|616124859|FG000|Overall Study|Lost to Follow-up|5|||
170799171|NCT02467270|617276682|FG001|Overall Study|Death|0|||
170799172|NCT02467270|617276683|FG002|Overall Study|Death|2|||
170799173|NCT02467270|617276681|FG000|Overall Study|Lack of Efficacy|12|||
170799174|NCT02467270|617276682|FG001|Overall Study|Lack of Efficacy|18|||
170799175|NCT02467270|617276683|FG002|Overall Study|Lack of Efficacy|23|||
170799176|NCT02467270|617276681|FG000|Overall Study|Non-compliance With Study Drug|0|||
170799177|NCT02467270|617276682|FG001|Overall Study|Non-compliance With Study Drug|2|||
170799178|NCT02467270|617276683|FG002|Overall Study|Non-compliance With Study Drug|1|||
170799179|NCT02467270|617276681|FG000|Overall Study|Lost to Follow-up|2|||
170799180|NCT02467270|617276682|FG001|Overall Study|Lost to Follow-up|1|||
170799181|NCT02467270|617276683|FG002|Overall Study|Lost to Follow-up|0|||
170799182|NCT02467270|617276681|FG000|Overall Study|Pregnancy|0|||
170898726|NCT05194345|617634233|FG000|Overall Study|Withdrawal by Subject|6|||
170898727|NCT05194345|617634234|FG001|Overall Study|Withdrawal by Subject|4|||
170898728|NCT05194345|617634235|FG002|Overall Study|Withdrawal by Subject|0|||
170898729|NCT05194345|617634233|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
170898730|NCT05194345|617634234|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
170898731|NCT05194345|617634235|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
170898732|NCT05415449|617634236|FG000|Overall Study|Lost to Follow-up|2|||
170898733|NCT05415449|617634236|FG000|Overall Study|Withdrawal by Subject|4|||
170898734|NCT02185521|617634239|FG000|Overall Study|Withdrawal by Subject|1|||
170898735|NCT02185521|617634239|FG000|Overall Study|Protocol Violation|1|||
170898736|NCT00398112|617634256|FG000|Overall Study|Adverse Event|4|||
170898737|NCT00398112|617634256|FG000|Overall Study|Disease progression|9|||
170898738|NCT00398112|617634256|FG000|Overall Study|Alternative treatment|1|||
170898739|NCT00398112|617634256|FG000|Overall Study|Withdrawal by Subject|3|||
170898740|NCT00398112|617634256|FG000|Overall Study|Death|1|||
170898741|NCT00582556|617634257|FG000|Overall Study|Withdrawal by Subject|0|||
170898742|NCT00582556|617634258|FG001|Overall Study|Withdrawal by Subject|1|||
170898743|NCT00582556|617634259|FG002|Overall Study|Withdrawal by Subject|1|||
170898744|NCT00582556|617634257|FG000|Overall Study|Physician Decision|0|||
170898745|NCT00582556|617634258|FG001|Overall Study|Physician Decision|0|||
170898746|NCT00582556|617634259|FG002|Overall Study|Physician Decision|1|||
170898747|NCT01993888|617634260|FG000|Overall Study|Death|1|||
170898748|NCT01993888|617634261|FG001|Overall Study|Death|1|||
170898749|NCT01993888|617634260|FG000|Overall Study|Lost to Follow-up|1|||
170898750|NCT01993888|617634261|FG001|Overall Study|Lost to Follow-up|1|||
170898751|NCT01993888|617634260|FG000|Overall Study|Withdrawal by Subject|0|||
170898752|NCT01993888|617634261|FG001|Overall Study|Withdrawal by Subject|1|||
170898753|NCT01028352|617634265|FG000|Overall Study|Ineligible due to baseline average pain|5|||
170898754|NCT01028352|617634265|FG000|Overall Study|Withdrawal by Subject|1|||
170898755|NCT01903876|617634266|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
170898756|NCT01903876|617634267|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
170898757|NCT01903876|617634266|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
170898758|NCT01903876|617634267|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
170898759|NCT00826748|617634277|FG000|Overall Study|Withdrawal by Subject|0|||
170898760|NCT00826748|617634278|FG001|Overall Study|Withdrawal by Subject|0|||
170898761|NCT00826748|617634279|FG002|Overall Study|Withdrawal by Subject|2|||
170898762|NCT00826748|617634277|FG000|Overall Study|Physician Decision|0|||
170898763|NCT00826748|617634278|FG001|Overall Study|Physician Decision|0|||
170898764|NCT00826748|617634279|FG002|Overall Study|Physician Decision|1|||
170898765|NCT00826748|617634277|FG000|Overall Study|Samples Did Not pass QC|0|||
170898766|NCT00826748|617634278|FG001|Overall Study|Samples Did Not pass QC|0|||
170898767|NCT00826748|617634279|FG002|Overall Study|Samples Did Not pass QC|1|||
170898768|NCT02747927|617634280|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
170898769|NCT02747927|617634281|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
170898770|NCT02747927|617634280|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
170898771|NCT02747927|617634281|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
170898772|NCT02747927|617634280|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
170898773|NCT02747927|617634281|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
170898774|NCT02747927|617634280|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
170898775|NCT02747927|617634281|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
170898776|NCT02747927|617634280|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
170898777|NCT02747927|617634281|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
170898778|NCT02747927|617634280|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
170898779|NCT02747927|617634281|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
170898780|NCT02747927|617634280|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
170898781|NCT02747927|617634281|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
170898782|NCT02747927|617634280|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
170640463|NCT02167139|616695681|FG000|Transition-extension|Adverse Event|2|||
170640464|NCT02167139|616695682|FG001|Transition-extension|Adverse Event|0|||
170640465|NCT02167139|616695683|FG002|Transition-extension|Adverse Event|2|||
170640466|NCT02167139|616695684|FG003|Transition-extension|Adverse Event|3|||
170640467|NCT02167139|616695681|FG000|Transition-extension|Withdrawal by Subject|2|||
170640468|NCT02167139|616695682|FG001|Transition-extension|Withdrawal by Subject|0|||
170640469|NCT02167139|616695683|FG002|Transition-extension|Withdrawal by Subject|4|||
170898783|NCT02747927|617634281|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
170898784|NCT02747927|617634280|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
170898785|NCT02747927|617634281|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
170898786|NCT02747927|617634280|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
170898787|NCT02747927|617634281|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
170898788|NCT02747927|617634280|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
170799183|NCT02467270|617276682|FG001|Overall Study|Pregnancy|1|||
170799184|NCT02467270|617276683|FG002|Overall Study|Pregnancy|0|||
170799185|NCT02467270|617276681|FG000|Overall Study|Physician Decision|0|||
170898789|NCT02747927|617634281|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
170898790|NCT02747927|617634280|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
170486899|NCT01019694|616124860|FG001|Overall Study|Lost to Follow-up|3|||
170486900|NCT01019694|616124861|FG002|Overall Study|Lost to Follow-up|3|||
170486901|NCT01019694|616124859|FG000|Overall Study|Withdrawal by Subject|4|||
170486902|NCT01019694|616124860|FG001|Overall Study|Withdrawal by Subject|6|||
170486903|NCT01019694|616124861|FG002|Overall Study|Withdrawal by Subject|12|||
170486904|NCT01019694|616124859|FG000|Overall Study|Not treated|0|||
170486905|NCT01019694|616124860|FG001|Overall Study|Not treated|2|||
170486906|NCT01019694|616124861|FG002|Overall Study|Not treated|3|||
170486907|NCT01019694|616124859|FG000|Overall Study|Other reason (not specified)|1|||
170486908|NCT01019694|616124860|FG001|Overall Study|Other reason (not specified)|5|||
170486909|NCT01019694|616124861|FG002|Overall Study|Other reason (not specified)|6|||
170486910|NCT00441129|616124868|FG000|Overall Study|Withdrawal by Subject|6|||
170486911|NCT00441129|616124869|FG001|Overall Study|Withdrawal by Subject|14|||
170486912|NCT01741688|616124870|FG000|Overall Study|Lack of insurance coverage|2|||
170486913|NCT01741688|616124870|FG000|Overall Study|Withdrawal by Subject|1|||
170486914|NCT03850496|616124875|FG000|Overall Study|Withdrawal by Subject|1|||
170486915|NCT03850496|616124876|FG001|Overall Study|Withdrawal by Subject|0|||
170486916|NCT03850496|616124877|FG002|Overall Study|Withdrawal by Subject|0|||
170486917|NCT03850496|616124875|FG000|Overall Study|Lost to Follow-up|0|||
170486918|NCT03850496|616124876|FG001|Overall Study|Lost to Follow-up|1|||
170486919|NCT03850496|616124877|FG002|Overall Study|Lost to Follow-up|4|||
170486920|NCT05000164|616124886|FG000|Overall Study|Adverse Event|1|||
170486921|NCT05000164|616124886|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
170486922|NCT05000164|616124886|FG000|Overall Study|Lens Discomfort|3|||
170486923|NCT05000164|616124886|FG000|Overall Study|Withdrew Consent during Study|2|||
170486924|NCT05000164|616124886|FG000|Overall Study|Subject Withdrawn by PI|2|||
170486925|NCT05000164|616124886|FG000|Overall Study|Other Fractured Test Article|1|||
170486926|NCT03493854|616124887|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
170486927|NCT03493854|616124888|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
170486928|NCT03493854|616124887|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
170486929|NCT03493854|616124888|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
170486930|NCT03493854|616124887|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
170799186|NCT02467270|617276682|FG001|Overall Study|Physician Decision|4|||
170799187|NCT02467270|617276683|FG002|Overall Study|Physician Decision|1|||
170799188|NCT02467270|617276681|FG000|Overall Study|Withdrawal by Subject|4|||
170799189|NCT02467270|617276682|FG001|Overall Study|Withdrawal by Subject|3|||
170799190|NCT02467270|617276683|FG002|Overall Study|Withdrawal by Subject|5|||
170799191|NCT02467270|617276681|FG000|Overall Study|Reason not Specified|1|||
170799192|NCT02467270|617276682|FG001|Overall Study|Reason not Specified|2|||
170799193|NCT02467270|617276683|FG002|Overall Study|Reason not Specified|1|||
170799194|NCT06408870|617276684|FG000|Washout period|Withdrawal by Subject|1|||
170799195|NCT06408870|617276685|FG001|Washout period|Withdrawal by Subject|0|||
170799196|NCT06408870|617276684|FG000|Washout period|Adverse Event|2|||
170799197|NCT06408870|617276685|FG001|Washout period|Adverse Event|0|||
170799198|NCT00495677|617276686|FG000|Stage 1 (25 Days)|Adverse Event|0|||
170799199|NCT00495677|617276687|FG001|Stage 1 (25 Days)|Adverse Event|0|||
170799200|NCT00495677|617276688|FG002|Stage 1 (25 Days)|Adverse Event|1|||
170799201|NCT00495677|617276689|FG003|Stage 1 (25 Days)|Adverse Event|0|||
170799202|NCT00495677|617276690|FG004|Stage 1 (25 Days)|Adverse Event|0|||
170799203|NCT00495677|617276691|FG005|Stage 1 (25 Days)|Adverse Event|0|||
170799204|NCT00495677|617276692|FG006|Stage 1 (25 Days)|Adverse Event|0|||
170799205|NCT05030584|617276700|FG000|Overall Study|Adverse Event|17|||
170799206|NCT05030584|617276701|FG001|Overall Study|Adverse Event|2|||
170799207|NCT05030584|617276700|FG000|Overall Study|Lack of Efficacy|0|||
170799208|NCT05030584|617276701|FG001|Overall Study|Lack of Efficacy|6|||
170799209|NCT05030584|617276700|FG000|Overall Study|Lost to Follow-up|5|||
170799210|NCT05030584|617276701|FG001|Overall Study|Lost to Follow-up|2|||
170898791|NCT02747927|617634281|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
170486931|NCT03493854|616124888|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
170486932|NCT03493854|616124887|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
170486933|NCT03493854|616124888|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
170486934|NCT03493854|616124887|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
170486935|NCT03493854|616124888|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
170486936|NCT03493854|616124887|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
170799211|NCT05030584|617276700|FG000|Overall Study|Non-Compliance with Study Drug|2|||
170799212|NCT05030584|617276701|FG001|Overall Study|Non-Compliance with Study Drug|3|||
170799213|NCT05030584|617276700|FG000|Overall Study|Other reason|4|||
170799214|NCT05030584|617276701|FG001|Overall Study|Other reason|3|||
170799215|NCT05030584|617276700|FG000|Overall Study|Physician Decision|1|||
170486937|NCT03493854|616124888|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
170486938|NCT03493854|616124887|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
170486939|NCT03493854|616124888|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
170486940|NCT03493854|616124887|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
170486941|NCT03493854|616124888|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
170486942|NCT03493854|616124887|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
170486943|NCT03493854|616124888|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
170486944|NCT03493854|616124887|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
170548934|NCT02421510|616354702|FG001|Overall Study|Death|0|||
170548935|NCT02421510|616354703|FG002|Overall Study|Death|0|||
170548936|NCT02421510|616354701|FG000|Overall Study|Noncompliance with study drug|1|||
170548937|NCT02421510|616354702|FG001|Overall Study|Noncompliance with study drug|0|||
170799216|NCT05030584|617276701|FG001|Overall Study|Physician Decision|4|||
170799217|NCT05030584|617276700|FG000|Overall Study|Protocol Violation|0|||
170799218|NCT05030584|617276701|FG001|Overall Study|Protocol Violation|2|||
170799219|NCT05030584|617276700|FG000|Overall Study|Randomized by Mistake|0|||
170799220|NCT05030584|617276701|FG001|Overall Study|Randomized by Mistake|2|||
170799221|NCT05030584|617276700|FG000|Overall Study|Withdrawal by Subject|21|||
170799222|NCT05030584|617276701|FG001|Overall Study|Withdrawal by Subject|28|||
170799223|NCT05030584|617276700|FG000|Overall Study|Technical Problems|0|||
170799224|NCT05030584|617276701|FG001|Overall Study|Technical Problems|1|||
170799225|NCT05030584|617276700|FG000|Overall Study|Completed post-treatment/FU visits|41|||
170799226|NCT05030584|617276701|FG001|Overall Study|Completed post-treatment/FU visits|31|||
170799227|NCT03767335|617276702|FG000|Overall Study|Physician Decision|1|||
170799228|NCT03767335|617276703|FG001|Overall Study|Physician Decision|1|||
170799229|NCT03767335|617276704|FG002|Overall Study|Physician Decision|0|||
170799230|NCT03767335|617276702|FG000|Overall Study|Withdrawal by Subject|0|||
170799231|NCT03767335|617276703|FG001|Overall Study|Withdrawal by Subject|0|||
170799232|NCT03767335|617276704|FG002|Overall Study|Withdrawal by Subject|6|||
170799233|NCT03767335|617276702|FG000|Overall Study|Participant excluded from efficacy population|0|||
170799234|NCT03767335|617276703|FG001|Overall Study|Participant excluded from efficacy population|0|||
170799235|NCT03767335|617276704|FG002|Overall Study|Participant excluded from efficacy population|1|||
170799236|NCT03767335|617276702|FG000|Overall Study|Death|0|||
170799237|NCT03767335|617276703|FG001|Overall Study|Death|0|||
170799238|NCT03767335|617276704|FG002|Overall Study|Death|2|||
170799239|NCT03767335|617276702|FG000|Overall Study|Progressive Disease|2|||
170799240|NCT03767335|617276703|FG001|Overall Study|Progressive Disease|2|||
170799241|NCT03767335|617276704|FG002|Overall Study|Progressive Disease|2|||
170799242|NCT03767335|617276702|FG000|Overall Study|Disease progression needing additional medication|0|||
170799243|NCT03767335|617276703|FG001|Overall Study|Disease progression needing additional medication|0|||
170799244|NCT03767335|617276704|FG002|Overall Study|Disease progression needing additional medication|17|||
170799245|NCT03767335|617276702|FG000|Overall Study|Sponsor decision|0|||
170799246|NCT03767335|617276703|FG001|Overall Study|Sponsor decision|0|||
170799247|NCT03767335|617276704|FG002|Overall Study|Sponsor decision|2|||
170799248|NCT03767335|617276702|FG000|Overall Study|Other Medical Reasons|0|||
170799249|NCT03767335|617276703|FG001|Overall Study|Other Medical Reasons|0|||
170799250|NCT03767335|617276704|FG002|Overall Study|Other Medical Reasons|3|||
170799251|NCT02446600|617276705|FG000|Overall Study|Never treated|20|||
170799252|NCT02446600|617276706|FG001|Overall Study|Never treated|2|||
170799253|NCT02446600|617276707|FG002|Overall Study|Never treated|6|||
170799254|NCT02446600|617276708|FG003|Overall Study|Never treated|0|||
170799255|NCT02446600|617276705|FG000|Overall Study|Withdrawal by Subject|19|||
170799256|NCT02446600|617276706|FG001|Overall Study|Withdrawal by Subject|5|||
170799257|NCT02446600|617276707|FG002|Overall Study|Withdrawal by Subject|17|||
170799258|NCT02446600|617276708|FG003|Overall Study|Withdrawal by Subject|0|||
170799259|NCT02446600|617276705|FG000|Overall Study|Ineligible|1|||
170799260|NCT02446600|617276706|FG001|Overall Study|Ineligible|4|||
170799261|NCT02446600|617276707|FG002|Overall Study|Ineligible|4|||
170799262|NCT02446600|617276708|FG003|Overall Study|Ineligible|1|||
170799263|NCT02446600|617276705|FG000|Overall Study|Duplicate Enrollment|0|||
170799264|NCT02446600|617276706|FG001|Overall Study|Duplicate Enrollment|1|||
170799265|NCT02446600|617276707|FG002|Overall Study|Duplicate Enrollment|0|||
170799266|NCT02446600|617276708|FG003|Overall Study|Duplicate Enrollment|0|||
170799267|NCT00328783|617276709|FG000|Overall Study|Could not tolerate ABC|21|||
170799268|NCT00328783|617276709|FG000|Overall Study|No heart in RT field|4|||
170799269|NCT00328783|617276709|FG000|Overall Study|Withdrawal by Subject|1|||
170799270|NCT03242915|617276713|FG000|Overall Study|Adverse Event|5|||
170799271|NCT03242915|617276714|FG001|Overall Study|Adverse Event|1|||
170799272|NCT03242915|617276713|FG000|Overall Study|Withdrawal by Subject|0|||
170799273|NCT03242915|617276714|FG001|Overall Study|Withdrawal by Subject|2|||
170799274|NCT03242915|617276713|FG000|Overall Study|Physician Decision|4|||
170799275|NCT03242915|617276714|FG001|Overall Study|Physician Decision|1|||
170799276|NCT03250676|617276723|FG000|Overall Study|Adverse Event|0|||
170799277|NCT03250676|617276724|FG001|Overall Study|Adverse Event|0|||
170799278|NCT03250676|617276725|FG002|Overall Study|Adverse Event|0|||
170799279|NCT03250676|617276726|FG003|Overall Study|Adverse Event|1|||
170799280|NCT03250676|617276727|FG004|Overall Study|Adverse Event|2|||
170486945|NCT03493854|616124888|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
170486946|NCT03493854|616124887|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
170486947|NCT03493854|616124888|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
170486948|NCT03493854|616124887|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
170486949|NCT03493854|616124888|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
170486950|NCT03493854|616124887|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
170486951|NCT03493854|616124888|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
170486952|NCT03493854|616124887|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
170486953|NCT03493854|616124888|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
170486954|NCT03493854|616124887|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
170486955|NCT03493854|616124888|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
170486956|NCT03493854|616124887|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
170486957|NCT03493854|616124888|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
170486958|NCT03493854|616124887|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
170486959|NCT03493854|616124888|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
170486960|NCT03493854|616124887|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
170486961|NCT03493854|616124888|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
170486962|NCT04278417|616124902|FG000|Overall Study|Withdrawal by Subject|20|||
170486963|NCT04278417|616124903|FG001|Overall Study|Withdrawal by Subject|20|||
170486964|NCT04278417|616124902|FG000|Overall Study|Progressive disease|0|||
170486965|NCT04278417|616124903|FG001|Overall Study|Progressive disease|2|||
170486966|NCT04278417|616124902|FG000|Overall Study|Physician Decision|4|||
170486967|NCT04278417|616124903|FG001|Overall Study|Physician Decision|6|||
170486968|NCT04278417|616124902|FG000|Overall Study|Lost to Follow-up|11|||
170486969|NCT04278417|616124903|FG001|Overall Study|Lost to Follow-up|13|||
170486970|NCT04278417|616124902|FG000|Overall Study|Death|8|||
170486971|NCT04278417|616124903|FG001|Overall Study|Death|9|||
170486972|NCT04278417|616124902|FG000|Overall Study|Adverse Event|3|||
170486973|NCT04278417|616124903|FG001|Overall Study|Adverse Event|5|||
170486974|NCT02268916|616124906|FG000|Overall Study|Lost to Follow-up|1|||
170486975|NCT02268916|616124907|FG001|Overall Study|Lost to Follow-up|1|||
170486976|NCT02268916|616124906|FG000|Overall Study|Withdrawal by Subject|6|||
170486977|NCT02268916|616124907|FG001|Overall Study|Withdrawal by Subject|5|||
170486978|NCT02268916|616124906|FG000|Overall Study|Participant did not have diabetes|1|||
170486979|NCT02268916|616124907|FG001|Overall Study|Participant did not have diabetes|0|||
170486980|NCT02268916|616124906|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
170486981|NCT02268916|616124907|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
170486982|NCT04830969|616124911|FG000|Overall Study|Withdrawal by Subject|6|||
170486983|NCT04830969|616124912|FG001|Overall Study|Withdrawal by Subject|2|||
170486984|NCT04830969|616124911|FG000|Overall Study|Protocol Violation|3|||
170486985|NCT04830969|616124912|FG001|Overall Study|Protocol Violation|9|||
170486986|NCT04830969|616124911|FG000|Overall Study|Lost to Follow-up|4|||
170486987|NCT04830969|616124912|FG001|Overall Study|Lost to Follow-up|4|||
170486988|NCT02097745|616124915|FG000|Overall Study|Adverse Event|25|||
170486989|NCT02097745|616124915|FG000|Overall Study|Death|16|||
170486990|NCT02097745|616124915|FG000|Overall Study|Failure to Return|14|||
170486991|NCT02097745|616124915|FG000|Overall Study|Administrative/Other|27|||
170486992|NCT02097745|616124915|FG000|Overall Study|Reason Not Specified|96|||
170486993|NCT00425750|616124916|FG000|Overall Study|Death|1|||
170486994|NCT00425750|616124916|FG000|Overall Study|Withdrawal by Subject|3|||
170486995|NCT00425750|616124916|FG000|Overall Study|Adverse Event|3|||
170486996|NCT00425750|616124916|FG000|Overall Study|Progression of disease|18|||
170486997|NCT00996125|616124917|FG000|Overall Study|Adverse Event|0|||
170486998|NCT00996125|616124918|FG001|Overall Study|Adverse Event|2|||
170486999|NCT00996125|616124917|FG000|Overall Study|Lost to Follow-up|1|||
170487000|NCT00996125|616124918|FG001|Overall Study|Lost to Follow-up|6|||
170487001|NCT00996125|616124917|FG000|Overall Study|Withdrawal by Subject|4|||
170487002|NCT00996125|616124918|FG001|Overall Study|Withdrawal by Subject|3|||
170487003|NCT01732458|616124919|FG000|Overall Study|Lost to Follow-up|0|||
170799281|NCT03250676|617276728|FG005|Overall Study|Adverse Event|9|||
170799282|NCT03250676|617276723|FG000|Overall Study|Withdrawal by Subject|1|||
170799283|NCT03250676|617276724|FG001|Overall Study|Withdrawal by Subject|0|||
170799284|NCT03250676|617276725|FG002|Overall Study|Withdrawal by Subject|0|||
170799285|NCT03250676|617276726|FG003|Overall Study|Withdrawal by Subject|1|||
170487004|NCT01732458|616124920|FG001|Overall Study|Lost to Follow-up|2|||
170487005|NCT01732458|616124921|FG002|Overall Study|Lost to Follow-up|0|||
170487006|NCT01732458|616124922|FG003|Overall Study|Lost to Follow-up|0|||
170487007|NCT01732458|616124919|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170799286|NCT03250676|617276727|FG004|Overall Study|Withdrawal by Subject|1|||
170487008|NCT01732458|616124920|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170487009|NCT01732458|616124921|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170487010|NCT01732458|616124922|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170487011|NCT01732458|616124919|FG000|Overall Study|Physician Decision|1|||
170487012|NCT01732458|616124920|FG001|Overall Study|Physician Decision|2|||
170487013|NCT01732458|616124921|FG002|Overall Study|Physician Decision|2|||
170487014|NCT01732458|616124922|FG003|Overall Study|Physician Decision|0|||
170487015|NCT01732458|616124919|FG000|Overall Study|Protocol Violation|2|||
170487016|NCT01732458|616124920|FG001|Overall Study|Protocol Violation|0|||
170487017|NCT01732458|616124921|FG002|Overall Study|Protocol Violation|0|||
170487018|NCT01732458|616124922|FG003|Overall Study|Protocol Violation|2|||
170487019|NCT01732458|616124919|FG000|Overall Study|Screen Failure|0|||
170487020|NCT01732458|616124920|FG001|Overall Study|Screen Failure|1|||
170487021|NCT01732458|616124921|FG002|Overall Study|Screen Failure|0|||
170487022|NCT01732458|616124922|FG003|Overall Study|Screen Failure|0|||
170487023|NCT00488644|616124924|FG000|Overall Study|Not Eligible|1|||
170487024|NCT00488644|616124924|FG000|Overall Study|Not Evaluable|1|||
170487025|NCT04331067|616124925|FG000|Overall Study|Adverse Event|1|||
170487026|NCT04331067|616124926|FG001|Overall Study|Adverse Event|3|||
170487027|NCT04331067|616124927|FG002|Overall Study|Adverse Event|1|||
170487028|NCT04331067|616124925|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
170487029|NCT04331067|616124926|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
170487030|NCT04331067|616124927|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
170487031|NCT01383174|616124935|FG000|3 Month Assessment|Death|0|||
170487032|NCT01383174|616124936|FG001|3 Month Assessment|Death|1|||
170487033|NCT01383174|616124935|FG000|3 Month Assessment|Lost to Follow-up|2|||
170487034|NCT01383174|616124936|FG001|3 Month Assessment|Lost to Follow-up|0|||
170487035|NCT01383174|616124935|FG000|3 Month Assessment|Refused to complete|4|||
170487036|NCT01383174|616124936|FG001|3 Month Assessment|Refused to complete|0|||
170548938|NCT02421510|616354703|FG002|Overall Study|Noncompliance with study drug|0|||
170548939|NCT02421510|616354701|FG000|Overall Study|Physician Decision|1|||
170548940|NCT02421510|616354702|FG001|Overall Study|Physician Decision|1|||
170548941|NCT02421510|616354703|FG002|Overall Study|Physician Decision|3|||
170548942|NCT02421510|616354701|FG000|Overall Study|Adverse Event|9|||
170548943|NCT02421510|616354702|FG001|Overall Study|Adverse Event|10|||
170548944|NCT02421510|616354703|FG002|Overall Study|Adverse Event|18|||
170548945|NCT02421510|616354701|FG000|Overall Study|Pregnancy|1|||
170548946|NCT02421510|616354702|FG001|Overall Study|Pregnancy|1|||
170548947|NCT02421510|616354703|FG002|Overall Study|Pregnancy|0|||
170548948|NCT02421510|616354701|FG000|Overall Study|Withdrawal by Subject|14|||
170548949|NCT02421510|616354702|FG001|Overall Study|Withdrawal by Subject|18|||
170548950|NCT02421510|616354703|FG002|Overall Study|Withdrawal by Subject|12|||
170548951|NCT02421510|616354701|FG000|Overall Study|Lost to Follow-up|1|||
170548952|NCT02421510|616354702|FG001|Overall Study|Lost to Follow-up|1|||
170548953|NCT02421510|616354703|FG002|Overall Study|Lost to Follow-up|0|||
170548954|NCT02852434|616354704|FG000|Overall Study|Withdrawal by Subject|0|||
170548955|NCT02852434|616354705|FG001|Overall Study|Withdrawal by Subject|1|||
170548956|NCT02852434|616354704|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
170548957|NCT02852434|616354705|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
170548958|NCT03188705|616354708|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
170548959|NCT03188705|616354708|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
170799287|NCT03250676|617276728|FG005|Overall Study|Withdrawal by Subject|2|||
170799288|NCT03250676|617276723|FG000|Overall Study|Physician Decision|0|||
170799289|NCT03250676|617276724|FG001|Overall Study|Physician Decision|0|||
170799290|NCT03250676|617276725|FG002|Overall Study|Physician Decision|0|||
170799291|NCT03250676|617276726|FG003|Overall Study|Physician Decision|2|||
170799292|NCT03250676|617276727|FG004|Overall Study|Physician Decision|0|||
170799293|NCT03250676|617276728|FG005|Overall Study|Physician Decision|3|||
170799294|NCT03250676|617276723|FG000|Overall Study|Withdrawal of consent|0|||
170799295|NCT03250676|617276724|FG001|Overall Study|Withdrawal of consent|0|||
170799296|NCT03250676|617276725|FG002|Overall Study|Withdrawal of consent|2|||
170799297|NCT03250676|617276726|FG003|Overall Study|Withdrawal of consent|0|||
170799298|NCT03250676|617276727|FG004|Overall Study|Withdrawal of consent|0|||
170799299|NCT03250676|617276728|FG005|Overall Study|Withdrawal of consent|2|||
170799300|NCT03250676|617276723|FG000|Overall Study|Other|1|||
170799301|NCT03250676|617276724|FG001|Overall Study|Other|0|||
170799302|NCT03250676|617276725|FG002|Overall Study|Other|0|||
170799303|NCT03250676|617276726|FG003|Overall Study|Other|0|||
170548960|NCT01174459|616354712|FG000|Overall Study|case report form (CRF) not collected|5|||
170548961|NCT00290758|616354713|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
170548962|NCT00290758|616354714|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
170799304|NCT03250676|617276727|FG004|Overall Study|Other|0|||
170799305|NCT03250676|617276728|FG005|Overall Study|Other|0|||
170487037|NCT01383174|616124935|FG000|6 Month Assessment|Lost to Follow-up|1|||
170487038|NCT01383174|616124936|FG001|6 Month Assessment|Lost to Follow-up|1|||
170548963|NCT00290758|616354713|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
170548964|NCT00290758|616354714|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
170799306|NCT03250676|617276723|FG000|Overall Study|Disease progression|4|||
170799307|NCT03250676|617276724|FG001|Overall Study|Disease progression|12|||
170487039|NCT01383174|616124935|FG000|6 Month Assessment|Refused to complete|4|||
170487040|NCT01383174|616124936|FG001|6 Month Assessment|Refused to complete|0|||
170898792|NCT02747927|617634280|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
170898793|NCT02747927|617634281|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
170898794|NCT02747927|617634280|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
170898795|NCT02747927|617634281|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
170898796|NCT02747927|617634280|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
170898797|NCT02747927|617634281|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
170898798|NCT02747927|617634280|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
170898799|NCT02747927|617634281|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
170898800|NCT02747927|617634280|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
170898801|NCT02747927|617634281|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
170898802|NCT02747927|617634280|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
170898803|NCT02747927|617634281|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
170898804|NCT02747927|617634280|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
170898805|NCT02747927|617634281|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
170898806|NCT02747927|617634280|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
170898807|NCT02747927|617634281|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
170898808|NCT02747927|617634280|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
170898809|NCT02747927|617634281|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
170898810|NCT02747927|617634280|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
170898811|NCT02747927|617634281|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
170898812|NCT02747927|617634280|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
170898813|NCT02747927|617634281|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
170898814|NCT02747927|617634280|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
170898815|NCT02747927|617634281|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
170898816|NCT02747927|617634280|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
170898817|NCT02747927|617634281|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
170898818|NCT02747927|617634280|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
170898819|NCT02747927|617634281|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
170898820|NCT02747927|617634280|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
170898821|NCT02747927|617634281|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
170898822|NCT02747927|617634280|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
170898823|NCT02747927|617634281|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
170898824|NCT02747927|617634280|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
170898825|NCT02747927|617634281|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
170898826|NCT02747927|617634280|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
170898827|NCT02747927|617634281|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
170898828|NCT02747927|617634280|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
170898829|NCT02747927|617634281|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
170898830|NCT02747927|617634280|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
170898831|NCT02747927|617634281|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
170898832|NCT00450580|617634282|FG000|Overall Study|Adverse Event|5|||
170898833|NCT00450580|617634283|FG001|Overall Study|Adverse Event|7|||
170898834|NCT00450580|617634282|FG000|Overall Study|Lost to Follow-up|4|||
170898835|NCT00450580|617634283|FG001|Overall Study|Lost to Follow-up|5|||
170898836|NCT00450580|617634282|FG000|Overall Study|Withdrawal by Subject|2|||
170898837|NCT00450580|617634283|FG001|Overall Study|Withdrawal by Subject|2|||
170898838|NCT00450580|617634282|FG000|Overall Study|Protocol Violation|1|||
170898839|NCT00450580|617634283|FG001|Overall Study|Protocol Violation|1|||
170898840|NCT00450580|617634282|FG000|Overall Study|Protocol-defined virologic failure|1|||
170898841|NCT00450580|617634283|FG001|Overall Study|Protocol-defined virologic failure|0|||
170898842|NCT00450580|617634282|FG000|Overall Study|Could not comply with scheduled visits|1|||
170898843|NCT00450580|617634283|FG001|Overall Study|Could not comply with scheduled visits|0|||
170898844|NCT00450580|617634282|FG000|Overall Study|Patient went to Brazil|1|||
170898845|NCT00450580|617634283|FG001|Overall Study|Patient went to Brazil|0|||
170898846|NCT00450580|617634282|FG000|Overall Study|Patient could not swallow Norvir|1|||
170898847|NCT00450580|617634283|FG001|Overall Study|Patient could not swallow Norvir|0|||
170898848|NCT00450580|617634282|FG000|Overall Study|Withdrawal due to pregnancy|0|||
170487041|NCT02203721|616124939|FG000|Overall Study|Lost to Follow-up|1|||
170487042|NCT02203721|616124940|FG001|Overall Study|Lost to Follow-up|0|||
170487043|NCT02203721|616124939|FG000|Overall Study|Death|0|||
170487044|NCT02203721|616124940|FG001|Overall Study|Death|2|||
170487045|NCT02203721|616124939|FG000|Overall Study|Illness|0|||
170487046|NCT02203721|616124940|FG001|Overall Study|Illness|1|||
170487047|NCT00979654|616124941|FG000|Overall Study|Lost to Follow-up|1|||
170487048|NCT00979654|616124941|FG000|Overall Study|Withdrawal by Subject|22|||
170487049|NCT00979654|616124941|FG000|Overall Study|Death|1|||
170487050|NCT00979654|616124941|FG000|Overall Study|Lack of Efficacy|6|||
170487051|NCT00979654|616124941|FG000|Overall Study|Adverse Event|1|||
170487052|NCT00979654|616124941|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
170487053|NCT00979654|616124941|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
170487054|NCT00979654|616124941|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
170487055|NCT00979654|616124941|FG000|Overall Study|Serious Adverse Event|1|||
170487056|NCT00979654|616124941|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
170799308|NCT03250676|617276725|FG002|Overall Study|Disease progression|9|||
170799309|NCT03250676|617276726|FG003|Overall Study|Disease progression|7|||
170799310|NCT03250676|617276727|FG004|Overall Study|Disease progression|4|||
170799311|NCT03250676|617276728|FG005|Overall Study|Disease progression|88|||
170799312|NCT01265537|617276729|FG000|Overall Study|Adverse Event|2|||
170799313|NCT01265537|617276730|FG001|Overall Study|Adverse Event|1|||
170799314|NCT01265537|617276729|FG000|Overall Study|Physician Decision|0|||
170799315|NCT01265537|617276730|FG001|Overall Study|Physician Decision|1|||
170799316|NCT05866926|617276731|FG000|Overall Study|Death|16|||
170799317|NCT05866926|617276732|FG001|Overall Study|Death|9|||
170799318|NCT05866926|617276731|FG000|Overall Study|Lost to Follow-up|0|||
170799319|NCT05866926|617276732|FG001|Overall Study|Lost to Follow-up|1|||
170799320|NCT05866926|617276731|FG000|Overall Study|Adverse Event|1|||
170799321|NCT05866926|617276732|FG001|Overall Study|Adverse Event|0|||
170799322|NCT05866926|617276731|FG000|Overall Study|Withdrawal by Subject|5|||
170799323|NCT05866926|617276732|FG001|Overall Study|Withdrawal by Subject|1|||
170799324|NCT05866926|617276731|FG000|Overall Study|Disease progression|1|||
170799325|NCT05866926|617276732|FG001|Overall Study|Disease progression|0|||
170799326|NCT05866926|617276731|FG000|Overall Study|other causes|2|||
170799327|NCT05866926|617276732|FG001|Overall Study|other causes|1|||
170799328|NCT01105091|617276733|FG000|Overall Study|Death|2|||
170799329|NCT01105091|617276734|FG001|Overall Study|Death|0|||
170799330|NCT04940624|617276735|FG000|Overall Study|Adverse Event|4|||
170799331|NCT04940624|617276736|FG001|Overall Study|Adverse Event|11|||
170799332|NCT04940624|617276735|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170799333|NCT04940624|617276736|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
170799334|NCT04940624|617276735|FG000|Overall Study|Physician Decision|1|||
170799335|NCT04940624|617276736|FG001|Overall Study|Physician Decision|0|||
170799336|NCT04940624|617276735|FG000|Overall Study|Lost to Follow-up|1|||
170799337|NCT04940624|617276736|FG001|Overall Study|Lost to Follow-up|0|||
170799338|NCT04940624|617276735|FG000|Overall Study|Reason Not Specified|1|||
170799339|NCT04940624|617276736|FG001|Overall Study|Reason Not Specified|0|||
170799340|NCT03008382|617276737|FG000|Overall Study|Withdrawal by Subject|2|||
170799341|NCT03008382|617276738|FG001|Overall Study|Withdrawal by Subject|5|||
170799342|NCT03008382|617276739|FG002|Overall Study|Withdrawal by Subject|2|||
170799343|NCT03008382|617276740|FG003|Overall Study|Withdrawal by Subject|0|||
170799344|NCT03008382|617276737|FG000|Overall Study|Protocol Violation|1|||
170799345|NCT03008382|617276738|FG001|Overall Study|Protocol Violation|0|||
170799346|NCT03008382|617276739|FG002|Overall Study|Protocol Violation|0|||
170799347|NCT03008382|617276740|FG003|Overall Study|Protocol Violation|0|||
170799348|NCT03008382|617276737|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
170799349|NCT03008382|617276738|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
170799350|NCT03008382|617276739|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
170799351|NCT03008382|617276740|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
170799352|NCT03008382|617276737|FG000|Overall Study|Lost to Follow-up|0|||
170799353|NCT03008382|617276738|FG001|Overall Study|Lost to Follow-up|0|||
170799354|NCT03008382|617276739|FG002|Overall Study|Lost to Follow-up|1|||
170799355|NCT03008382|617276740|FG003|Overall Study|Lost to Follow-up|0|||
170799356|NCT03008382|617276737|FG000|Overall Study|Screenfail|0|||
170799357|NCT03008382|617276738|FG001|Overall Study|Screenfail|0|||
170799358|NCT03008382|617276739|FG002|Overall Study|Screenfail|2|||
170799359|NCT03008382|617276740|FG003|Overall Study|Screenfail|0|||
170799360|NCT05162586|617277951|FG000|Overall Study|Other|0|||
170799361|NCT05162586|617277952|FG001|Overall Study|Other|0|||
170799362|NCT05162586|617277953|FG002|Overall Study|Other|0|||
170799363|NCT05162586|617277954|FG003|Overall Study|Other|0|||
170799364|NCT05162586|617277955|FG004|Overall Study|Other|1|||
170799365|NCT05162586|617277956|FG005|Overall Study|Other|0|||
170487057|NCT01205269|616124942|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
170487058|NCT01205269|616124943|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
170487059|NCT01205269|616124944|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
170487060|NCT01205269|616124945|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
170799366|NCT05162586|617277957|FG006|Overall Study|Other|2|||
170799367|NCT05162586|617277958|FG007|Overall Study|Other|2|||
170799368|NCT05162586|617277951|FG000|Overall Study|Lack of Efficacy|0|||
170799369|NCT05162586|617277952|FG001|Overall Study|Lack of Efficacy|0|||
170799370|NCT05162586|617277953|FG002|Overall Study|Lack of Efficacy|0|||
170799371|NCT05162586|617277954|FG003|Overall Study|Lack of Efficacy|0|||
170799372|NCT05162586|617277955|FG004|Overall Study|Lack of Efficacy|1|||
170799373|NCT05162586|617277956|FG005|Overall Study|Lack of Efficacy|0|||
170799374|NCT05162586|617277957|FG006|Overall Study|Lack of Efficacy|0|||
170799375|NCT05162586|617277958|FG007|Overall Study|Lack of Efficacy|1|||
170487061|NCT01205269|616124946|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
170487062|NCT01205269|616124947|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
170487063|NCT01804946|616124948|FG000|Overall Study|Protocol Violation|1|||
170487064|NCT01804946|616124949|FG001|Overall Study|Protocol Violation|0|||
170487065|NCT01804946|616124948|FG000|Overall Study|Adverse Event|0|||
170487066|NCT01804946|616124949|FG001|Overall Study|Adverse Event|1|||
170487067|NCT01804946|616124948|FG000|Overall Study|Insufficient data available|0|||
170487068|NCT01804946|616124949|FG001|Overall Study|Insufficient data available|1|||
170487069|NCT01804946|616124948|FG000|Overall Study|Do not meet inclusion criteria|1|||
170487070|NCT01804946|616124949|FG001|Overall Study|Do not meet inclusion criteria|2|||
170487071|NCT03830333|616124950|FG000|Overall Study|Death|0|||
170487072|NCT03830333|616124951|FG001|Overall Study|Death|1|||
170487073|NCT03830333|616124950|FG000|Overall Study|Withdrawal by Subject|5|||
170487074|NCT03830333|616124951|FG001|Overall Study|Withdrawal by Subject|1|||
170487075|NCT03830333|616124950|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
170487076|NCT03830333|616124951|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
170487077|NCT01445730|616124952|FG000|Overall Study|Adverse Event|1|||
170487078|NCT01445730|616124952|FG000|Overall Study|For the advice of a dentist|1|||
170487079|NCT01445730|616124952|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
170487080|NCT01167140|616124955|FG000|Overall Study|Withdrawal by Subject|1|||
170487081|NCT04390113|616124956|FG000|Overall Study|Not Treated|0|||
170487082|NCT04390113|616124957|FG001|Overall Study|Not Treated|1|||
170487083|NCT04390113|616124956|FG000|Overall Study|Adverse Event|1|||
170487084|NCT04390113|616124957|FG001|Overall Study|Adverse Event|0|||
170487085|NCT04390113|616124956|FG000|Overall Study|Death|2|||
170487086|NCT04390113|616124957|FG001|Overall Study|Death|1|||
170487087|NCT04390113|616124956|FG000|Overall Study|Physician Decision|1|||
170487088|NCT04390113|616124957|FG001|Overall Study|Physician Decision|3|||
170487089|NCT04390113|616124956|FG000|Overall Study|Study Terminated by Sponsor|5|||
170487090|NCT04390113|616124957|FG001|Overall Study|Study Terminated by Sponsor|3|||
170487091|NCT04390113|616124956|FG000|Overall Study|Withdrawal by Subject|10|||
170487092|NCT04390113|616124957|FG001|Overall Study|Withdrawal by Subject|5|||
170487093|NCT04390113|616124956|FG000|Overall Study|Other|1|||
170487094|NCT04390113|616124957|FG001|Overall Study|Other|0|||
170487095|NCT04390113|616124956|FG000|Overall Study|Missing|0|||
170487096|NCT04390113|616124957|FG001|Overall Study|Missing|1|||
170487097|NCT00638404|616126611|FG000|Overall Study|Physician Decision|8|||
170487098|NCT00638404|616126612|FG001|Overall Study|Physician Decision|0|||
170487099|NCT01068730|616126613|FG000|Period 3|Personal reason|1|||
170487100|NCT01068730|616126614|FG001|Period 3|Personal reason|0|||
170487101|NCT01068730|616126615|FG002|Period 3|Personal reason|0|||
170487102|NCT01068730|616126616|FG003|Period 3|Personal reason|0|||
170487103|NCT01068730|616126613|FG000|Period 4|Family emergency|0|||
170548965|NCT00290758|616354713|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
170898849|NCT00450580|617634283|FG001|Overall Study|Withdrawal due to pregnancy|1|||
170898850|NCT01409928|617634286|FG000|Overall Study|Physician Decision|12|||
170898851|NCT00988247|617634287|FG000|Overall Study|Adverse Event|17|||
170898852|NCT00988247|617634288|FG001|Overall Study|Adverse Event|3|||
170898853|NCT00988247|617634287|FG000|Overall Study|Withdrawal by Subject|44|||
170898854|NCT00988247|617634288|FG001|Overall Study|Withdrawal by Subject|13|||
170898855|NCT00988247|617634287|FG000|Overall Study|Pregnancy|1|||
170898856|NCT00988247|617634288|FG001|Overall Study|Pregnancy|2|||
170487104|NCT01068730|616126614|FG001|Period 4|Family emergency|1|||
170487105|NCT01068730|616126615|FG002|Period 4|Family emergency|0|||
170487106|NCT01068730|616126616|FG003|Period 4|Family emergency|0|||
170640470|NCT02167139|616695684|FG003|Transition-extension|Withdrawal by Subject|1|||
170640471|NCT02167139|616695681|FG000|Transition-extension|Lack of Efficacy|0|||
170640472|NCT02167139|616695682|FG001|Transition-extension|Lack of Efficacy|0|||
170640473|NCT02167139|616695683|FG002|Transition-extension|Lack of Efficacy|1|||
170640474|NCT02167139|616695684|FG003|Transition-extension|Lack of Efficacy|1|||
170640475|NCT02167139|616695681|FG000|Transition-extension|Other|1|||
170640476|NCT02167139|616695682|FG001|Transition-extension|Other|0|||
170640477|NCT02167139|616695683|FG002|Transition-extension|Other|1|||
170487115|NCT03150719|616126624|FG000|Overall Study|Adverse Event|0|||
170898857|NCT00988247|617634287|FG000|Overall Study|Lost to Follow-up|11|||
170487116|NCT03150719|616126625|FG001|Overall Study|Adverse Event|1|||
170487117|NCT03150719|616126624|FG000|Overall Study|Death|0|||
170487118|NCT03150719|616126625|FG001|Overall Study|Death|1|||
170548966|NCT00290758|616354714|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
170898858|NCT00988247|617634288|FG001|Overall Study|Lost to Follow-up|2|||
170487119|NCT03150719|616126624|FG000|Overall Study|Other|1|||
170487120|NCT03150719|616126625|FG001|Overall Study|Other|0|||
170487121|NCT01964222|616126629|FG000|Overall Study|Lost to Follow-up|7|||
170487122|NCT01964222|616126630|FG001|Overall Study|Lost to Follow-up|5|||
170487123|NCT01964222|616126629|FG000|Overall Study|Withdrawal by Subject|6|||
170898859|NCT00988247|617634287|FG000|Overall Study|Protocol Violation|4|||
170487124|NCT01964222|616126630|FG001|Overall Study|Withdrawal by Subject|6|||
170487125|NCT01964222|616126629|FG000|Overall Study|Screening Failure|2|||
170487126|NCT01964222|616126630|FG001|Overall Study|Screening Failure|0|||
170487127|NCT00812981|616126633|FG000|Overall Study|Other|0|||
170487128|NCT00812981|616126634|FG001|Overall Study|Other|1|||
170487129|NCT01757184|616126648|FG000|Double-blind Period|Adverse Event|1|||
170487130|NCT01757184|616126649|FG001|Double-blind Period|Adverse Event|0|||
170487131|NCT01757184|616126650|FG002|Double-blind Period|Adverse Event|0|||
170487132|NCT01757184|616126651|FG003|Double-blind Period|Adverse Event|0|||
170487133|NCT01757184|616126648|FG000|Open-label Period|Lost to Follow-up|0|||
170487134|NCT01757184|616126649|FG001|Open-label Period|Lost to Follow-up|0|||
170487135|NCT01757184|616126650|FG002|Open-label Period|Lost to Follow-up|2|||
170487136|NCT01757184|616126651|FG003|Open-label Period|Lost to Follow-up|0|||
170487137|NCT01757184|616126648|FG000|Open-label Period|Withdrawal by Subject|0|||
170487138|NCT01757184|616126649|FG001|Open-label Period|Withdrawal by Subject|0|||
170487139|NCT01757184|616126650|FG002|Open-label Period|Withdrawal by Subject|1|||
170487140|NCT01757184|616126651|FG003|Open-label Period|Withdrawal by Subject|1|||
170487141|NCT01757184|616126648|FG000|Open-label Period|Discontinued by Sponsor|0|||
170487142|NCT01757184|616126649|FG001|Open-label Period|Discontinued by Sponsor|0|||
170487143|NCT01757184|616126650|FG002|Open-label Period|Discontinued by Sponsor|1|||
170487144|NCT01757184|616126651|FG003|Open-label Period|Discontinued by Sponsor|2|||
170487145|NCT04468347|616126652|FG000|Overall Study|Withdrawal by Subject|0|||
170487146|NCT04468347|616126653|FG001|Overall Study|Withdrawal by Subject|1|||
170487147|NCT04468347|616126654|FG002|Overall Study|Withdrawal by Subject|3|||
170487148|NCT04468347|616126655|FG003|Overall Study|Withdrawal by Subject|3|||
170487149|NCT04468347|616126652|FG000|Overall Study|Lost to Follow-up|0|||
170487150|NCT04468347|616126653|FG001|Overall Study|Lost to Follow-up|0|||
170487151|NCT04468347|616126654|FG002|Overall Study|Lost to Follow-up|1|||
170487152|NCT04468347|616126655|FG003|Overall Study|Lost to Follow-up|1|||
170487153|NCT04468347|616126652|FG000|Overall Study|Physician Decision|1|||
170487154|NCT04468347|616126653|FG001|Overall Study|Physician Decision|0|||
170487155|NCT04468347|616126654|FG002|Overall Study|Physician Decision|2|||
170487156|NCT04468347|616126655|FG003|Overall Study|Physician Decision|0|||
170487157|NCT04468347|616126652|FG000|Overall Study|Protocol Violation|1|||
170487158|NCT04468347|616126653|FG001|Overall Study|Protocol Violation|0|||
170487159|NCT04468347|616126654|FG002|Overall Study|Protocol Violation|0|||
170487160|NCT04468347|616126655|FG003|Overall Study|Protocol Violation|0|||
170487161|NCT05870371|616126657|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
170487162|NCT05870371|616126658|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
170487163|NCT02062450|616126664|FG000|Overall Study|No follow-up visit|124|||
170487164|NCT02169271|616126665|FG000|Overall Study|Protocol Violation|1|||
170487165|NCT02169271|616126666|FG001|Overall Study|Protocol Violation|2|||
170487166|NCT02589639|616126667|FG000|Overall Study|Lost to Follow-up|1|||
170487167|NCT02589639|616126668|FG001|Overall Study|Lost to Follow-up|0|||
170487168|NCT02589639|616126669|FG002|Overall Study|Lost to Follow-up|0|||
170487169|NCT02589639|616126667|FG000|Overall Study|Protocol Violation|1|||
170487170|NCT02589639|616126668|FG001|Overall Study|Protocol Violation|0|||
170487171|NCT02589639|616126669|FG002|Overall Study|Protocol Violation|0|||
170487172|NCT02589639|616126667|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
170487173|NCT02589639|616126668|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
170487174|NCT02589639|616126669|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
170487175|NCT02589639|616126667|FG000|Overall Study|Adverse Event|4|||
170487176|NCT02589639|616126668|FG001|Overall Study|Adverse Event|5|||
170487177|NCT02589639|616126669|FG002|Overall Study|Adverse Event|3|||
170487178|NCT02589639|616126667|FG000|Overall Study|Other reason than specified above|1|||
170799376|NCT05162586|617277951|FG000|Overall Study|Lost to Follow-up|0|||
170799377|NCT05162586|617277952|FG001|Overall Study|Lost to Follow-up|0|||
170799378|NCT05162586|617277953|FG002|Overall Study|Lost to Follow-up|0|||
170799379|NCT05162586|617277954|FG003|Overall Study|Lost to Follow-up|0|||
170799380|NCT05162586|617277955|FG004|Overall Study|Lost to Follow-up|2|||
170799381|NCT05162586|617277956|FG005|Overall Study|Lost to Follow-up|0|||
170799382|NCT05162586|617277957|FG006|Overall Study|Lost to Follow-up|0|||
170799383|NCT05162586|617277958|FG007|Overall Study|Lost to Follow-up|2|||
170799384|NCT05162586|617277951|FG000|Overall Study|Non-Compliance|0|||
170799385|NCT05162586|617277952|FG001|Overall Study|Non-Compliance|1|||
170799386|NCT05162586|617277953|FG002|Overall Study|Non-Compliance|0|||
170487179|NCT02589639|616126668|FG001|Overall Study|Other reason than specified above|2|||
170487180|NCT02589639|616126669|FG002|Overall Study|Other reason than specified above|1|||
170487181|NCT02589639|616126667|FG000|Overall Study|Not Treated|0|||
170487182|NCT02589639|616126668|FG001|Overall Study|Not Treated|3|||
170487183|NCT02589639|616126669|FG002|Overall Study|Not Treated|0|||
170487184|NCT00703157|616126672|FG000|Overall Study|Lost to Follow-up|0|||
170487185|NCT00703157|616126673|FG001|Overall Study|Lost to Follow-up|1|||
170487186|NCT00703157|616126672|FG000|Overall Study|source data permanently lost/ other|4|||
170487187|NCT00703157|616126673|FG001|Overall Study|source data permanently lost/ other|1|||
170487188|NCT00347009|616126674|FG000|Overall Study|Death|1|||
170487189|NCT00347009|616126674|FG000|Overall Study|Adverse Event|6|||
170799387|NCT05162586|617277954|FG003|Overall Study|Non-Compliance|0|||
170487190|NCT00347009|616126674|FG000|Overall Study|Withdrawal by Subject|3|||
170799388|NCT05162586|617277955|FG004|Overall Study|Non-Compliance|1|||
170898860|NCT00988247|617634288|FG001|Overall Study|Protocol Violation|5|||
170898861|NCT00988247|617634287|FG000|Overall Study|Sponsor requested withdrawal|3|||
170898862|NCT00988247|617634288|FG001|Overall Study|Sponsor requested withdrawal|1|||
170898863|NCT00988247|617634287|FG000|Overall Study|Other|3|||
170898864|NCT00988247|617634288|FG001|Overall Study|Other|0|||
170898865|NCT01169779|617634291|FG000|Overall Study|Adverse Event|3|||
170898866|NCT01169779|617634292|FG001|Overall Study|Adverse Event|11|||
170898867|NCT01169779|617634291|FG000|Overall Study|Lack of Efficacy|1|||
170898868|NCT01169779|617634292|FG001|Overall Study|Lack of Efficacy|0|||
170898869|NCT01169779|617634291|FG000|Overall Study|Protocol Violation|1|||
170898870|NCT01169779|617634292|FG001|Overall Study|Protocol Violation|1|||
170898871|NCT01169779|617634291|FG000|Overall Study|Withdrawal by Subject|3|||
170898872|NCT01169779|617634292|FG001|Overall Study|Withdrawal by Subject|2|||
170898873|NCT01169779|617634291|FG000|Overall Study|Familial and personal reasons|3|||
170898874|NCT01169779|617634292|FG001|Overall Study|Familial and personal reasons|3|||
170898875|NCT00432237|617634293|FG000|Overall Study|Adverse Event|0|||
170898876|NCT00432237|617634294|FG001|Overall Study|Adverse Event|0|||
170487191|NCT00347009|616126674|FG000|Overall Study|Physician Decision|5|||
170487192|NCT00347009|616126674|FG000|Overall Study|Lost to Follow-up|4|||
170487193|NCT00347009|616126674|FG000|Overall Study|Protocol Violation|2|||
170487194|NCT00347009|616126674|FG000|Overall Study|Adverse Laboratory Experience|1|||
170487195|NCT00347009|616126674|FG000|Overall Study|Insufficient Viral Suppression|3|||
170487196|NCT00347009|616126674|FG000|Overall Study|Increased ALT/HBV DNA|1|||
170487197|NCT00347009|616126674|FG000|Overall Study|Serious Adverse Event|1|||
170487198|NCT05868577|616126675|FG000|Overall Study|Lost to Follow-up|5|||
170487199|NCT05868577|616126676|FG001|Overall Study|Lost to Follow-up|5|||
170487200|NCT02522884|616126679|FG000|Overall Study|Withdrawal by Subject|6|||
170487201|NCT02522884|616126679|FG000|Overall Study|Death|3|||
170898877|NCT00432237|617634295|FG002|Overall Study|Adverse Event|0|||
170898878|NCT00432237|617634296|FG003|Overall Study|Adverse Event|1|||
170898879|NCT00432237|617634293|FG000|Overall Study|Lack of Efficacy|0|||
170898880|NCT00432237|617634294|FG001|Overall Study|Lack of Efficacy|0|||
170898881|NCT00432237|617634295|FG002|Overall Study|Lack of Efficacy|0|||
170898882|NCT00432237|617634296|FG003|Overall Study|Lack of Efficacy|1|||
170898883|NCT00432237|617634293|FG000|Overall Study|Lost to Follow-up|10|||
170898884|NCT00432237|617634294|FG001|Overall Study|Lost to Follow-up|10|||
170898885|NCT00432237|617634295|FG002|Overall Study|Lost to Follow-up|18|||
170898886|NCT00432237|617634296|FG003|Overall Study|Lost to Follow-up|18|||
170898887|NCT00432237|617634293|FG000|Overall Study|Physician Decision|1|||
170898888|NCT00432237|617634294|FG001|Overall Study|Physician Decision|3|||
170898889|NCT00432237|617634295|FG002|Overall Study|Physician Decision|2|||
170898890|NCT00432237|617634296|FG003|Overall Study|Physician Decision|1|||
170898891|NCT00432237|617634293|FG000|Overall Study|Pregnancy|0|||
170898892|NCT00432237|617634294|FG001|Overall Study|Pregnancy|1|||
170898893|NCT00432237|617634295|FG002|Overall Study|Pregnancy|0|||
170898894|NCT00432237|617634296|FG003|Overall Study|Pregnancy|0|||
170898895|NCT00432237|617634293|FG000|Overall Study|Protocol Violation|13|||
170898896|NCT00432237|617634294|FG001|Overall Study|Protocol Violation|10|||
170898897|NCT00432237|617634295|FG002|Overall Study|Protocol Violation|11|||
170898898|NCT00432237|617634296|FG003|Overall Study|Protocol Violation|8|||
170898899|NCT00432237|617634293|FG000|Overall Study|Withdrawal by Subject|5|||
170898900|NCT00432237|617634294|FG001|Overall Study|Withdrawal by Subject|6|||
170898901|NCT00432237|617634295|FG002|Overall Study|Withdrawal by Subject|9|||
170898902|NCT00432237|617634296|FG003|Overall Study|Withdrawal by Subject|11|||
170898903|NCT00432237|617634293|FG000|Overall Study|Lack of Qualifying Event|38|||
170898904|NCT00432237|617634294|FG001|Overall Study|Lack of Qualifying Event|71|||
170487202|NCT02522884|616126679|FG000|Overall Study|Missed 12-month Follow-up|9|||
170487203|NCT04495751|616126680|FG000|Overall Study|Withdrawal by Subject|1|||
170487204|NCT04495751|616126681|FG001|Overall Study|Withdrawal by Subject|0|||
170487205|NCT04495751|616126680|FG000|Overall Study|Lost to Follow-up|1|||
170487206|NCT04495751|616126681|FG001|Overall Study|Lost to Follow-up|0|||
170487207|NCT04873934|616126682|FG000|Overall Study|Adverse Event|0|||
170487208|NCT04873934|616126683|FG001|Overall Study|Adverse Event|1|||
170487209|NCT04873934|616126682|FG000|Overall Study|Death|0|||
170898905|NCT00432237|617634295|FG002|Overall Study|Lack of Qualifying Event|69|||
170898906|NCT00432237|617634296|FG003|Overall Study|Lack of Qualifying Event|84|||
170898907|NCT01354132|617634297|FG000|Randomization|Physician Decision|1|||
170898908|NCT01354132|617634298|FG001|Randomization|Physician Decision|0|||
170898909|NCT01354132|617634297|FG000|Randomization|Withdrawal by Subject|0|||
170898910|NCT01354132|617634298|FG001|Randomization|Withdrawal by Subject|1|||
170898911|NCT01354132|617634297|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
170898912|NCT01354132|617634298|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
170898913|NCT01354132|617634297|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
170898914|NCT01354132|617634298|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
170898915|NCT01354132|617634297|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
170898916|NCT01354132|617634298|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
170898917|NCT03293654|617634299|FG000|Overall Study|Lost to Follow-up|0|||
170898918|NCT03293654|617634300|FG001|Overall Study|Lost to Follow-up|1|||
170799389|NCT05162586|617277956|FG005|Overall Study|Non-Compliance|0|||
170799390|NCT05162586|617277957|FG006|Overall Study|Non-Compliance|0|||
170799391|NCT05162586|617277958|FG007|Overall Study|Non-Compliance|1|||
170799392|NCT05162586|617277951|FG000|Overall Study|Withdrawal by Subject|2|||
170799393|NCT05162586|617277952|FG001|Overall Study|Withdrawal by Subject|0|||
170799394|NCT05162586|617277953|FG002|Overall Study|Withdrawal by Subject|0|||
170799395|NCT05162586|617277954|FG003|Overall Study|Withdrawal by Subject|0|||
170799396|NCT05162586|617277955|FG004|Overall Study|Withdrawal by Subject|7|||
170799397|NCT05162586|617277956|FG005|Overall Study|Withdrawal by Subject|6|||
170799398|NCT05162586|617277957|FG006|Overall Study|Withdrawal by Subject|2|||
170799399|NCT05162586|617277958|FG007|Overall Study|Withdrawal by Subject|2|||
170799400|NCT05162586|617277951|FG000|Overall Study|Adverse Event|2|||
170799401|NCT05162586|617277952|FG001|Overall Study|Adverse Event|0|||
170799402|NCT05162586|617277953|FG002|Overall Study|Adverse Event|1|||
170799403|NCT05162586|617277954|FG003|Overall Study|Adverse Event|2|||
170799404|NCT05162586|617277955|FG004|Overall Study|Adverse Event|4|||
170799405|NCT05162586|617277956|FG005|Overall Study|Adverse Event|1|||
170799406|NCT05162586|617277957|FG006|Overall Study|Adverse Event|5|||
170799407|NCT05162586|617277958|FG007|Overall Study|Adverse Event|2|||
170799408|NCT02567435|617277968|FG000|Overall Study|Death|1|||
170799409|NCT02567435|617277969|FG001|Overall Study|Death|1|||
170799410|NCT02567435|617277970|FG002|Overall Study|Death|0|||
170799411|NCT02567435|617277971|FG003|Overall Study|Death|0|||
170799412|NCT02567435|617277968|FG000|Overall Study|Ineligible|1|||
170799413|NCT02567435|617277969|FG001|Overall Study|Ineligible|3|||
170799414|NCT02567435|617277970|FG002|Overall Study|Ineligible|0|||
170799415|NCT02567435|617277971|FG003|Overall Study|Ineligible|0|||
170799416|NCT02567435|617277968|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
170799417|NCT02567435|617277969|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
170799418|NCT02567435|617277970|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
170799419|NCT02567435|617277971|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
170799420|NCT00982644|617277972|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
170799421|NCT00982644|617277973|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
170799422|NCT00982644|617277972|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
170799423|NCT00982644|617277973|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
170799424|NCT00982644|617277972|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
170799425|NCT00982644|617277973|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
170799426|NCT00982644|617277972|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
170799427|NCT00982644|617277973|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
170799428|NCT00982644|617277972|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
170799429|NCT00982644|617277973|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
170799430|NCT00982644|617277972|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
170799431|NCT00982644|617277973|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
170799432|NCT00982644|617277972|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
170799433|NCT00982644|617277973|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
170799434|NCT00982644|617277972|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
170799435|NCT00982644|617277973|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
170799436|NCT00982644|617277972|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
170799437|NCT00982644|617277973|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
170799438|NCT00982644|617277972|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
170799439|NCT00982644|617277973|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
170799440|NCT04772534|617277978|FG000|Overall Study|Physician Decision|1|||
170799441|NCT04772534|617277979|FG001|Overall Study|Physician Decision|0|||
170799442|NCT04772534|617277980|FG002|Overall Study|Physician Decision|0|||
170799443|NCT04772534|617277978|FG000|Overall Study|Withdrawal by Subject|3|||
170799444|NCT04772534|617277979|FG001|Overall Study|Withdrawal by Subject|0|||
170799445|NCT04772534|617277980|FG002|Overall Study|Withdrawal by Subject|1|||
170799446|NCT03705390|617277985|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
170799447|NCT03705390|617277985|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
170799448|NCT03047213|617277986|FG000|Overall Study|Withdrawal by Subject|2|||
170799449|NCT03047213|617277987|FG001|Overall Study|Withdrawal by Subject|0|||
170799450|NCT03047213|617277986|FG000|Overall Study|Adverse Event|2|||
170799451|NCT03047213|617277987|FG001|Overall Study|Adverse Event|0|||
170799452|NCT05875701|617277991|FG000|Overall Study|Lost to Follow-up|2|||
170799453|NCT05875701|617277992|FG001|Overall Study|Lost to Follow-up|0|||
170799454|NCT05875701|617277991|FG000|Overall Study|Withdrawal by Subject|1|||
170799455|NCT05875701|617277992|FG001|Overall Study|Withdrawal by Subject|1|||
170799456|NCT06393127|617277993|FG000|Washout period|Withdrawal by Subject|1|||
170799457|NCT06393127|617277994|FG001|Washout period|Withdrawal by Subject|0|||
170799458|NCT06393127|617277993|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
170799459|NCT06393127|617277994|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
170799460|NCT00357682|617277995|FG000|Overall Study|Did not receive allocated Treatment|10|||
170898919|NCT03293654|617634301|FG002|Overall Study|Lost to Follow-up|0|||
170898920|NCT05052723|617634305|FG000|Overall Study|Death|19|||
170898921|NCT02601950|617634306|FG000|Overall Study|Participant enrolled in rollover study|0|||
170898922|NCT02601950|617634307|FG001|Overall Study|Participant enrolled in rollover study|0|||
170898923|NCT02601950|617634308|FG002|Overall Study|Participant enrolled in rollover study|1|||
170898924|NCT02601950|617634309|FG003|Overall Study|Participant enrolled in rollover study|0|||
170898925|NCT02601950|617634310|FG004|Overall Study|Participant enrolled in rollover study|1|||
170898926|NCT02601950|617634311|FG005|Overall Study|Participant enrolled in rollover study|1|||
170898927|NCT02601950|617634312|FG006|Overall Study|Participant enrolled in rollover study|1|||
170898928|NCT02601950|617634313|FG007|Overall Study|Participant enrolled in rollover study|0|||
170898929|NCT02601950|617634306|FG000|Overall Study|Disease progression - radiological|21|||
170898930|NCT02601950|617634307|FG001|Overall Study|Disease progression - radiological|26|||
170898931|NCT02601950|617634308|FG002|Overall Study|Disease progression - radiological|22|||
170487210|NCT04873934|616126683|FG001|Overall Study|Death|2|||
170487211|NCT04873934|616126682|FG000|Overall Study|Lost to Follow-up|13|||
170487212|NCT04873934|616126683|FG001|Overall Study|Lost to Follow-up|9|||
170487213|NCT04873934|616126682|FG000|Overall Study|Physician Decision|1|||
170487214|NCT04873934|616126683|FG001|Overall Study|Physician Decision|1|||
170487215|NCT04873934|616126682|FG000|Overall Study|Protocol deviation|2|||
170487216|NCT04873934|616126683|FG001|Overall Study|Protocol deviation|1|||
170487217|NCT04873934|616126682|FG000|Overall Study|Subject decision|1|||
170898932|NCT02601950|617634309|FG003|Overall Study|Disease progression - radiological|11|||
170898933|NCT02601950|617634310|FG004|Overall Study|Disease progression - radiological|46|||
170898934|NCT02601950|617634311|FG005|Overall Study|Disease progression - radiological|52|||
170898935|NCT02601950|617634312|FG006|Overall Study|Disease progression - radiological|7|||
170898936|NCT02601950|617634313|FG007|Overall Study|Disease progression - radiological|5|||
170898937|NCT02601950|617634306|FG000|Overall Study|Disease progression - clinical|3|||
170898938|NCT02601950|617634307|FG001|Overall Study|Disease progression - clinical|5|||
170898939|NCT02601950|617634308|FG002|Overall Study|Disease progression - clinical|4|||
170898940|NCT02601950|617634309|FG003|Overall Study|Disease progression - clinical|2|||
170898941|NCT02601950|617634310|FG004|Overall Study|Disease progression - clinical|6|||
170898942|NCT02601950|617634311|FG005|Overall Study|Disease progression - clinical|6|||
170898943|NCT02601950|617634312|FG006|Overall Study|Disease progression - clinical|5|||
170898944|NCT02601950|617634313|FG007|Overall Study|Disease progression - clinical|1|||
170898945|NCT02601950|617634306|FG000|Overall Study|Death|6|||
170898946|NCT02601950|617634307|FG001|Overall Study|Death|0|||
170487218|NCT04873934|616126683|FG001|Overall Study|Subject decision|8|||
170487219|NCT04873934|616126682|FG000|Overall Study|Withdrew consent|0|||
170898947|NCT02601950|617634308|FG002|Overall Study|Death|3|||
170898948|NCT02601950|617634309|FG003|Overall Study|Death|1|||
170898949|NCT02601950|617634310|FG004|Overall Study|Death|4|||
170898950|NCT02601950|617634311|FG005|Overall Study|Death|1|||
170898951|NCT02601950|617634312|FG006|Overall Study|Death|0|||
170898952|NCT02601950|617634313|FG007|Overall Study|Death|0|||
170898953|NCT02601950|617634306|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
170898954|NCT02601950|617634307|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
170898955|NCT02601950|617634308|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
170898956|NCT02601950|617634309|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
170898957|NCT02601950|617634310|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
170898958|NCT02601950|617634311|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
170898959|NCT02601950|617634312|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
170898960|NCT02601950|617634313|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
170487220|NCT04873934|616126683|FG001|Overall Study|Withdrew consent|4|||
170487221|NCT04873934|616126682|FG000|Overall Study|Missing|1|||
170487222|NCT04873934|616126683|FG001|Overall Study|Missing|0|||
170898961|NCT02601950|617634306|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
170898962|NCT02601950|617634307|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
170898963|NCT02601950|617634308|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
170898964|NCT02601950|617634309|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
170898965|NCT02601950|617634310|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
170898966|NCT02601950|617634311|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
170898967|NCT02601950|617634312|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
170487223|NCT00708461|616126685|FG000|Overall Study|Lost to Follow-up|18|||
170487224|NCT00708461|616126686|FG001|Overall Study|Lost to Follow-up|11|||
170487225|NCT00708461|616126685|FG000|Overall Study|Withdrawal by Subject|8|||
170487226|NCT00708461|616126686|FG001|Overall Study|Withdrawal by Subject|9|||
170487227|NCT00708461|616126685|FG000|Overall Study|left workforce|115|||
170487228|NCT00708461|616126686|FG001|Overall Study|left workforce|180|||
170487229|NCT01796392|616126687|FG000|Overall Study|Withdrawal by Subject|2|||
170487230|NCT01796392|616126688|FG001|Overall Study|Withdrawal by Subject|0|||
170898968|NCT02601950|617634313|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
170898969|NCT02601950|617634306|FG000|Overall Study|Non-compliance|0|||
170487231|NCT01796392|616126687|FG000|Overall Study|Death|5|||
170487232|NCT01796392|616126688|FG001|Overall Study|Death|1|||
170487233|NCT01796392|616126687|FG000|Overall Study|Excluded for medical reasons|1|||
170487234|NCT01796392|616126688|FG001|Overall Study|Excluded for medical reasons|2|||
170487235|NCT01796392|616126687|FG000|Overall Study|Lost to Follow-up|1|||
170487236|NCT01796392|616126688|FG001|Overall Study|Lost to Follow-up|0|||
170487237|NCT03482635|616126689|FG000|Overall Study|Lack of Efficacy|0|||
170487238|NCT03482635|616126690|FG001|Overall Study|Lack of Efficacy|0|||
170487239|NCT03482635|616126691|FG002|Overall Study|Lack of Efficacy|1|||
170799461|NCT00357682|617277996|FG001|Overall Study|Did not receive allocated Treatment|9|||
170799462|NCT00357682|617277997|FG002|Overall Study|Did not receive allocated Treatment|9|||
170799463|NCT00357682|617277998|FG003|Overall Study|Did not receive allocated Treatment|10|||
170799464|NCT00357682|617277995|FG000|Overall Study|Withdrew consent|6|||
170799465|NCT00357682|617277996|FG001|Overall Study|Withdrew consent|6|||
170799466|NCT00357682|617277997|FG002|Overall Study|Withdrew consent|5|||
170799467|NCT00357682|617277998|FG003|Overall Study|Withdrew consent|5|||
170799468|NCT00357682|617277995|FG000|Overall Study|Lost to Follow-up|39|||
170799469|NCT00357682|617277996|FG001|Overall Study|Lost to Follow-up|33|||
170799470|NCT00357682|617277997|FG002|Overall Study|Lost to Follow-up|26|||
170799471|NCT00357682|617277998|FG003|Overall Study|Lost to Follow-up|35|||
170799472|NCT00357682|617277995|FG000|Overall Study|Adverse Event|24|||
170799473|NCT00357682|617277996|FG001|Overall Study|Adverse Event|32|||
170799474|NCT00357682|617277997|FG002|Overall Study|Adverse Event|22|||
170799475|NCT00357682|617277998|FG003|Overall Study|Adverse Event|27|||
170799476|NCT00357682|617277995|FG000|Overall Study|Physician Decision|32|||
170799477|NCT00357682|617277996|FG001|Overall Study|Physician Decision|20|||
170799478|NCT00357682|617277997|FG002|Overall Study|Physician Decision|24|||
170799479|NCT00357682|617277998|FG003|Overall Study|Physician Decision|30|||
170799480|NCT00357682|617277995|FG000|Overall Study|Patient decision|73|||
170799481|NCT00357682|617277996|FG001|Overall Study|Patient decision|80|||
170799482|NCT00357682|617277997|FG002|Overall Study|Patient decision|51|||
170799483|NCT00357682|617277998|FG003|Overall Study|Patient decision|59|||
170799484|NCT00357682|617277995|FG000|Overall Study|Other reason|157|||
170799485|NCT00357682|617277996|FG001|Overall Study|Other reason|130|||
170799486|NCT00357682|617277997|FG002|Overall Study|Other reason|114|||
170799487|NCT00357682|617277998|FG003|Overall Study|Other reason|99|||
170799488|NCT03660930|617277999|FG000|Overall Study|Adverse Event|0|||
170799489|NCT03660930|617278000|FG001|Overall Study|Adverse Event|0|||
170799490|NCT03660930|617278001|FG002|Overall Study|Adverse Event|0|||
170799491|NCT03660930|617278002|FG003|Overall Study|Adverse Event|2|||
170799492|NCT03660930|617278003|FG004|Overall Study|Adverse Event|0|||
170799493|NCT03660930|617278004|FG005|Overall Study|Adverse Event|1|||
170799494|NCT03660930|617278005|FG006|Overall Study|Adverse Event|0|||
170799495|NCT03660930|617278006|FG007|Overall Study|Adverse Event|0|||
170799496|NCT03660930|617277999|FG000|Overall Study|Withdrawal by Subject|0|||
170799497|NCT03660930|617278000|FG001|Overall Study|Withdrawal by Subject|0|||
170799498|NCT03660930|617278001|FG002|Overall Study|Withdrawal by Subject|0|||
170799499|NCT03660930|617278002|FG003|Overall Study|Withdrawal by Subject|0|||
170799500|NCT03660930|617278003|FG004|Overall Study|Withdrawal by Subject|0|||
170799501|NCT03660930|617278004|FG005|Overall Study|Withdrawal by Subject|1|||
170799502|NCT03660930|617278005|FG006|Overall Study|Withdrawal by Subject|0|||
170799503|NCT03660930|617278006|FG007|Overall Study|Withdrawal by Subject|0|||
170799504|NCT04490356|617278007|FG000|Overall Study|Lost to Follow-up|1|||
170799505|NCT03333915|617278012|FG000|Overall Study|Lost to Follow-up|0|||
170799506|NCT03333915|617278013|FG001|Overall Study|Lost to Follow-up|0|||
170799507|NCT03333915|617278014|FG002|Overall Study|Lost to Follow-up|1|||
170799508|NCT03333915|617278015|FG003|Overall Study|Lost to Follow-up|0|||
170799509|NCT03333915|617278016|FG004|Overall Study|Lost to Follow-up|0|||
170799510|NCT03333915|617278012|FG000|Overall Study|Disease Progression|0|||
170799511|NCT03333915|617278013|FG001|Overall Study|Disease Progression|1|||
170799512|NCT03333915|617278014|FG002|Overall Study|Disease Progression|0|||
170799513|NCT03333915|617278015|FG003|Overall Study|Disease Progression|0|||
170799514|NCT03333915|617278016|FG004|Overall Study|Disease Progression|0|||
170799515|NCT03333915|617278012|FG000|Overall Study|Death|0|||
170799516|NCT03333915|617278013|FG001|Overall Study|Death|0|||
170799517|NCT03333915|617278014|FG002|Overall Study|Death|0|||
170799518|NCT03333915|617278015|FG003|Overall Study|Death|37|||
170799519|NCT03333915|617278016|FG004|Overall Study|Death|18|||
170799520|NCT03333915|617278012|FG000|Overall Study|Sponsor's Decision|0|||
170799521|NCT03333915|617278013|FG001|Overall Study|Sponsor's Decision|0|||
170799522|NCT03333915|617278014|FG002|Overall Study|Sponsor's Decision|0|||
170799523|NCT03333915|617278015|FG003|Overall Study|Sponsor's Decision|48|||
170799524|NCT03333915|617278016|FG004|Overall Study|Sponsor's Decision|4|||
170487240|NCT03482635|616126692|FG003|Overall Study|Lack of Efficacy|3|||
170487241|NCT03482635|616126689|FG000|Overall Study|Adverse Event|2|||
170487242|NCT03482635|616126690|FG001|Overall Study|Adverse Event|2|||
170487243|NCT03482635|616126691|FG002|Overall Study|Adverse Event|0|||
170487244|NCT03482635|616126692|FG003|Overall Study|Adverse Event|3|||
170799525|NCT03333915|617278012|FG000|Overall Study|Withdrawal by Subject|0|||
170487245|NCT03482635|616126689|FG000|Overall Study|Withdrawal by Subject|2|||
170487246|NCT03482635|616126690|FG001|Overall Study|Withdrawal by Subject|1|||
170487247|NCT03482635|616126691|FG002|Overall Study|Withdrawal by Subject|0|||
170487248|NCT03482635|616126692|FG003|Overall Study|Withdrawal by Subject|1|||
170487249|NCT03482635|616126689|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
170487250|NCT03482635|616126690|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
170487251|NCT03482635|616126691|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
170487252|NCT03482635|616126692|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
170487253|NCT03482635|616126689|FG000|Overall Study|Not treated|0|||
170487254|NCT03482635|616126690|FG001|Overall Study|Not treated|0|||
170487255|NCT03482635|616126691|FG002|Overall Study|Not treated|0|||
170487256|NCT03482635|616126692|FG003|Overall Study|Not treated|1|||
170487257|NCT04681066|616126693|FG000|Overall Study|Lost to Follow-up|3|||
170487258|NCT04681066|616126694|FG001|Overall Study|Lost to Follow-up|1|||
170487259|NCT04681066|616126695|FG002|Overall Study|Lost to Follow-up|2|||
170487260|NCT04681066|616126696|FG003|Overall Study|Lost to Follow-up|1|||
170487261|NCT04681066|616126693|FG000|Overall Study|Withdrawal by Subject|2|||
170487262|NCT04681066|616126694|FG001|Overall Study|Withdrawal by Subject|1|||
170487263|NCT04681066|616126695|FG002|Overall Study|Withdrawal by Subject|0|||
170487264|NCT04681066|616126696|FG003|Overall Study|Withdrawal by Subject|3|||
170487265|NCT04681066|616126693|FG000|Overall Study|Death|0|||
170548967|NCT00290758|616354713|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
170548968|NCT00290758|616354714|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
170548969|NCT00290758|616354713|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
170548970|NCT00290758|616354714|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
170548971|NCT00290758|616354713|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
170548972|NCT00290758|616354714|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
170548973|NCT00290758|616354713|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
170548974|NCT00290758|616354714|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
170548975|NCT00290758|616354713|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
170548976|NCT00290758|616354714|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
170548977|NCT03994120|616354716|FG000|Overall Study|Lost to Follow-up|3|||
170548978|NCT03994120|616354717|FG001|Overall Study|Lost to Follow-up|1|||
170548979|NCT00474968|616354718|FG000|Overall Study|Withdrawal by Subject|8|||
170799526|NCT03333915|617278013|FG001|Overall Study|Withdrawal by Subject|0|||
170799527|NCT03333915|617278014|FG002|Overall Study|Withdrawal by Subject|0|||
170799528|NCT03333915|617278015|FG003|Overall Study|Withdrawal by Subject|5|||
170799529|NCT03333915|617278016|FG004|Overall Study|Withdrawal by Subject|1|||
170799530|NCT02532621|617278028|FG000|Overall Study|Death|3|||
170799531|NCT02532621|617278028|FG000|Overall Study|Lost to Follow-up|3|||
170799532|NCT02532621|617278028|FG000|Overall Study|Withdrawal by Subject|6|||
170799533|NCT02532621|617278028|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
170799534|NCT02532621|617278028|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
170799535|NCT03982186|617278031|FG000|Overall Study|Lost to Follow-up|0|||
170799536|NCT03982186|617278032|FG001|Overall Study|Lost to Follow-up|1|||
170799537|NCT03982186|617278033|FG002|Overall Study|Lost to Follow-up|2|||
170799538|NCT03982186|617278034|FG003|Overall Study|Lost to Follow-up|1|||
170799539|NCT03982186|617278035|FG004|Overall Study|Lost to Follow-up|1|||
170799540|NCT03982186|617278036|FG005|Overall Study|Lost to Follow-up|0|||
170799541|NCT03982186|617278031|FG000|Overall Study|Physician Decision|0|||
170799542|NCT03982186|617278032|FG001|Overall Study|Physician Decision|1|||
170799543|NCT03982186|617278033|FG002|Overall Study|Physician Decision|0|||
170799544|NCT03982186|617278034|FG003|Overall Study|Physician Decision|0|||
170799545|NCT03982186|617278035|FG004|Overall Study|Physician Decision|0|||
170799546|NCT03982186|617278036|FG005|Overall Study|Physician Decision|0|||
170799547|NCT03982186|617278031|FG000|Overall Study|Withdrawal by Subject|3|||
170799548|NCT03982186|617278032|FG001|Overall Study|Withdrawal by Subject|4|||
170799549|NCT03982186|617278033|FG002|Overall Study|Withdrawal by Subject|1|||
170799550|NCT03982186|617278034|FG003|Overall Study|Withdrawal by Subject|7|||
170799551|NCT03982186|617278035|FG004|Overall Study|Withdrawal by Subject|2|||
170799552|NCT03982186|617278036|FG005|Overall Study|Withdrawal by Subject|0|||
170799553|NCT03982186|617278031|FG000|Overall Study|Randomized and not treated|0|||
170799554|NCT03982186|617278032|FG001|Overall Study|Randomized and not treated|0|||
170799555|NCT03982186|617278033|FG002|Overall Study|Randomized and not treated|0|||
170799556|NCT03982186|617278034|FG003|Overall Study|Randomized and not treated|1|||
170799557|NCT03982186|617278035|FG004|Overall Study|Randomized and not treated|0|||
170799558|NCT03982186|617278036|FG005|Overall Study|Randomized and not treated|0|||
170799559|NCT04479787|617278037|FG000|Through 6 Months|Withdrawal by Subject|16|||
170487266|NCT04681066|616126694|FG001|Overall Study|Death|1|||
170640478|NCT02167139|616695684|FG003|Transition-extension|Other|0|||
170487267|NCT04681066|616126695|FG002|Overall Study|Death|0|||
170487268|NCT04681066|616126696|FG003|Overall Study|Death|0|||
170487269|NCT04495829|616126700|FG000|Overall Study|Lost to Follow-up|2|||
170487270|NCT04495829|616126700|FG000|Overall Study|Inclusion criterion not met|3|||
170487271|NCT03194542|616126703|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
170548980|NCT00474968|616354719|FG001|Overall Study|Withdrawal by Subject|7|||
170548981|NCT00474968|616354718|FG000|Overall Study|Protocol Violation|9|||
170548982|NCT00474968|616354719|FG001|Overall Study|Protocol Violation|8|||
170548983|NCT00474968|616354718|FG000|Overall Study|Sample not collected|1|||
170548984|NCT00474968|616354719|FG001|Overall Study|Sample not collected|1|||
170548985|NCT01429623|616354720|FG000|Overall Study|Death|1|||
170548986|NCT01429623|616354721|FG001|Overall Study|Death|0|||
170548987|NCT01429623|616354720|FG000|Overall Study|Adverse Event|7|||
170548988|NCT01429623|616354721|FG001|Overall Study|Adverse Event|14|||
170548989|NCT01429623|616354720|FG000|Overall Study|Withdrawal by Subject|19|||
170548990|NCT01429623|616354721|FG001|Overall Study|Withdrawal by Subject|13|||
170548991|NCT01429623|616354720|FG000|Overall Study|Physician Decision|2|||
170548992|NCT01429623|616354721|FG001|Overall Study|Physician Decision|3|||
170548993|NCT01429623|616354720|FG000|Overall Study|Protocol Violation|3|||
170548994|NCT01429623|616354721|FG001|Overall Study|Protocol Violation|2|||
170548995|NCT01429623|616354720|FG000|Overall Study|Assorted|1|||
170548996|NCT01429623|616354721|FG001|Overall Study|Assorted|2|||
170548997|NCT01429623|616354720|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
170548998|NCT01429623|616354721|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
170548999|NCT01429623|616354720|FG000|Overall Study|No post baseline data|4|||
170549000|NCT01429623|616354721|FG001|Overall Study|No post baseline data|4|||
170549001|NCT05345405|616354722|FG000|Overall Study|Withdrawal by Subject|2|||
170549002|NCT05345405|616354723|FG001|Overall Study|Withdrawal by Subject|0|||
170549003|NCT05345405|616354724|FG002|Overall Study|Withdrawal by Subject|0|||
170549004|NCT05345405|616354722|FG000|Overall Study|Did not meet eligibility criteria|0|||
170549005|NCT05345405|616354723|FG001|Overall Study|Did not meet eligibility criteria|2|||
170549006|NCT05345405|616354724|FG002|Overall Study|Did not meet eligibility criteria|0|||
170549007|NCT05345405|616354722|FG000|Overall Study|Lost to Follow-up|0|||
170549008|NCT05345405|616354723|FG001|Overall Study|Lost to Follow-up|0|||
170549009|NCT05345405|616354724|FG002|Overall Study|Lost to Follow-up|1|||
170549010|NCT04053452|616354726|FG000|Overall Study|Withdrawal by Subject|1|||
170549011|NCT04053452|616354727|FG001|Overall Study|Withdrawal by Subject|0|||
170549012|NCT04053452|616354726|FG000|Overall Study|Time restraint due to inpatient needs|1|||
170549013|NCT04053452|616354727|FG001|Overall Study|Time restraint due to inpatient needs|2|||
170549014|NCT03156621|616354733|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
170549015|NCT03156621|616354734|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
170549016|NCT03156621|616354733|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170549017|NCT03156621|616354734|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
170549018|NCT03016403|616354735|FG000|Baseline|Death|5|||
170549019|NCT03016403|616354736|FG001|Baseline|Death|8|||
170549020|NCT03016403|616354737|FG002|Baseline|Death|1|||
170549021|NCT03016403|616354738|FG003|Baseline|Death|0|||
170549022|NCT03016403|616354735|FG000|Baseline|Withdrawal by Subject|2|||
170549023|NCT03016403|616354736|FG001|Baseline|Withdrawal by Subject|8|||
170549024|NCT03016403|616354737|FG002|Baseline|Withdrawal by Subject|4|||
170549025|NCT03016403|616354738|FG003|Baseline|Withdrawal by Subject|10|||
170549026|NCT03016403|616354735|FG000|Baseline|Lost to Follow-up|9|||
170549027|NCT03016403|616354736|FG001|Baseline|Lost to Follow-up|11|||
170549028|NCT03016403|616354737|FG002|Baseline|Lost to Follow-up|6|||
170549029|NCT03016403|616354738|FG003|Baseline|Lost to Follow-up|24|||
170898970|NCT02601950|617634307|FG001|Overall Study|Non-compliance|1|||
170898971|NCT02601950|617634308|FG002|Overall Study|Non-compliance|0|||
170898972|NCT02601950|617634309|FG003|Overall Study|Non-compliance|0|||
170898973|NCT02601950|617634310|FG004|Overall Study|Non-compliance|0|||
170898974|NCT02601950|617634311|FG005|Overall Study|Non-compliance|1|||
170898975|NCT02601950|617634312|FG006|Overall Study|Non-compliance|1|||
170898976|NCT02601950|617634313|FG007|Overall Study|Non-compliance|0|||
170898977|NCT02601950|617634306|FG000|Overall Study|Participant refused further study treatment|0|||
170549030|NCT03016403|616354735|FG000|6-week Follow-up|Death|1|||
170549031|NCT03016403|616354736|FG001|6-week Follow-up|Death|4|||
170549032|NCT03016403|616354737|FG002|6-week Follow-up|Death|0|||
170549033|NCT03016403|616354738|FG003|6-week Follow-up|Death|0|||
170549034|NCT03016403|616354735|FG000|6-week Follow-up|Lost to Follow-up|2|||
170549035|NCT03016403|616354736|FG001|6-week Follow-up|Lost to Follow-up|7|||
170549036|NCT03016403|616354737|FG002|6-week Follow-up|Lost to Follow-up|4|||
170549037|NCT03016403|616354738|FG003|6-week Follow-up|Lost to Follow-up|8|||
170549038|NCT03016403|616354735|FG000|6-week Follow-up|Withdrawal by Subject|0|||
170549039|NCT03016403|616354736|FG001|6-week Follow-up|Withdrawal by Subject|2|||
170549040|NCT03016403|616354737|FG002|6-week Follow-up|Withdrawal by Subject|0|||
170898978|NCT02601950|617634307|FG001|Overall Study|Participant refused further study treatment|1|||
170549041|NCT03016403|616354738|FG003|6-week Follow-up|Withdrawal by Subject|1|||
170549042|NCT03016403|616354735|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
170549043|NCT03016403|616354736|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
170549044|NCT03016403|616354737|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
170549045|NCT03016403|616354738|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
170898979|NCT02601950|617634308|FG002|Overall Study|Participant refused further study treatment|1|||
170549046|NCT03016403|616354735|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
170549047|NCT03016403|616354736|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
170549048|NCT03016403|616354737|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
170549049|NCT03016403|616354738|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
170549050|NCT03016403|616354735|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
170549051|NCT03016403|616354736|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
170549052|NCT03016403|616354737|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
170549053|NCT03016403|616354738|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
170549054|NCT00225758|616354739|FG000|Overall Study|Adverse Event|4|||
170549055|NCT00079781|616354740|FG000|Pre-implant Period|Withdrawal by Subject|2|||
170549056|NCT00079781|616354741|FG001|Pre-implant Period|Withdrawal by Subject|0|||
170549057|NCT00079781|616354742|FG002|Pre-implant Period|Withdrawal by Subject|0|||
170549058|NCT00079781|616354740|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
170549059|NCT00079781|616354741|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
170549060|NCT00079781|616354742|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
170549061|NCT00079781|616354740|FG000|Follow-up Period|Withdrawal by Subject|3|||
170549062|NCT00079781|616354741|FG001|Follow-up Period|Withdrawal by Subject|0|||
170549063|NCT00079781|616354742|FG002|Follow-up Period|Withdrawal by Subject|1|||
170549064|NCT00079781|616354740|FG000|Follow-up Period|Lost to Follow-up|1|||
170549065|NCT00079781|616354741|FG001|Follow-up Period|Lost to Follow-up|0|||
170549066|NCT00079781|616354742|FG002|Follow-up Period|Lost to Follow-up|0|||
170549067|NCT00079781|616354740|FG000|Follow-up Period|Death|0|||
170549068|NCT00079781|616354741|FG001|Follow-up Period|Death|0|||
170549069|NCT00079781|616354742|FG002|Follow-up Period|Death|1|||
170549070|NCT01657500|616354746|FG000|Overall Study|set impropperly matched|3|||
170549071|NCT01657500|616354747|FG001|Overall Study|set impropperly matched|3|||
170549072|NCT01657500|616354746|FG000|Overall Study|Lost to Follow-up|2|||
170549073|NCT01657500|616354747|FG001|Overall Study|Lost to Follow-up|2|||
170549074|NCT00756444|616354748|FG000|Overall Study|Adverse Event|1|||
170549075|NCT00756444|616354749|FG001|Overall Study|Adverse Event|1|||
170549076|NCT00756444|616354748|FG000|Overall Study|Withdrawal by Subject|6|||
170549077|NCT00756444|616354749|FG001|Overall Study|Withdrawal by Subject|8|||
170549078|NCT00756444|616354748|FG000|Overall Study|Lost to Follow-up|0|||
170549079|NCT00756444|616354749|FG001|Overall Study|Lost to Follow-up|1|||
170487272|NCT03194542|616126704|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
170487273|NCT03194542|616126705|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
170487274|NCT03194542|616126706|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
170487275|NCT03194542|616126703|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
170487276|NCT03194542|616126704|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
170487277|NCT03194542|616126705|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
170487278|NCT03194542|616126706|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
170487279|NCT03194542|616126703|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
170487280|NCT03194542|616126704|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
170487281|NCT03194542|616126705|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
170487282|NCT03194542|616126706|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
170487283|NCT03194542|616126703|FG000|Overall Study|Loss of Response|4|||
170487284|NCT03194542|616126704|FG001|Overall Study|Loss of Response|2|||
170487285|NCT03194542|616126705|FG002|Overall Study|Loss of Response|3|||
170487286|NCT03194542|616126706|FG003|Overall Study|Loss of Response|4|||
170487287|NCT03194542|616126703|FG000|Overall Study|Physician Decision|0|||
170487288|NCT03194542|616126704|FG001|Overall Study|Physician Decision|1|||
170487289|NCT03194542|616126705|FG002|Overall Study|Physician Decision|0|||
170487290|NCT03194542|616126706|FG003|Overall Study|Physician Decision|0|||
170487291|NCT03194542|616126703|FG000|Overall Study|Lack of Efficacy|2|||
170487292|NCT03194542|616126704|FG001|Overall Study|Lack of Efficacy|2|||
170487293|NCT03194542|616126705|FG002|Overall Study|Lack of Efficacy|2|||
170487294|NCT03194542|616126706|FG003|Overall Study|Lack of Efficacy|6|||
170487295|NCT03194542|616126703|FG000|Overall Study|Withdrawal by Subject|2|||
170487296|NCT03194542|616126704|FG001|Overall Study|Withdrawal by Subject|1|||
170549080|NCT00756444|616354748|FG000|Overall Study|Death|5|||
170549081|NCT00756444|616354749|FG001|Overall Study|Death|4|||
170549082|NCT00756444|616354748|FG000|Overall Study|Disease Progression|2|||
170549083|NCT00756444|616354749|FG001|Overall Study|Disease Progression|7|||
170549084|NCT00756444|616354748|FG000|Overall Study|Ineligibility Determined|1|||
170487297|NCT03194542|616126705|FG002|Overall Study|Withdrawal by Subject|5|||
170487298|NCT03194542|616126706|FG003|Overall Study|Withdrawal by Subject|4|||
170487299|NCT03194542|616126703|FG000|Overall Study|Progressive Disease|1|||
170549085|NCT00756444|616354749|FG001|Overall Study|Ineligibility Determined|0|||
170549086|NCT00564070|616354750|FG000|Overall Study|Lost to Follow-up|9|||
170549087|NCT00564070|616354751|FG001|Overall Study|Lost to Follow-up|7|||
170487300|NCT03194542|616126704|FG001|Overall Study|Progressive Disease|0|||
170487301|NCT03194542|616126705|FG002|Overall Study|Progressive Disease|1|||
170549088|NCT00564070|616354750|FG000|Overall Study|Worsening depression, referred to care|3|||
170549089|NCT00564070|616354751|FG001|Overall Study|Worsening depression, referred to care|0|||
170487302|NCT03194542|616126706|FG003|Overall Study|Progressive Disease|1|||
170487303|NCT03194542|616126703|FG000|Overall Study|Adverse Event|1|||
170487304|NCT03194542|616126704|FG001|Overall Study|Adverse Event|2|||
170487305|NCT03194542|616126705|FG002|Overall Study|Adverse Event|0|||
170487306|NCT03194542|616126706|FG003|Overall Study|Adverse Event|5|||
170487307|NCT03194542|616126703|FG000|Overall Study|Death|1|||
170487308|NCT03194542|616126704|FG001|Overall Study|Death|2|||
170487309|NCT03194542|616126705|FG002|Overall Study|Death|0|||
170487310|NCT03194542|616126706|FG003|Overall Study|Death|5|||
170487311|NCT03194542|616126703|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
170487312|NCT03194542|616126704|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
170487313|NCT03194542|616126705|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
170487314|NCT03194542|616126706|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
170487315|NCT02712554|616126712|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
170487316|NCT02712554|616126713|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
170487317|NCT02712554|616126712|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
170487318|NCT02712554|616126713|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
170487319|NCT02712554|616126712|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
170487320|NCT02712554|616126713|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
170487321|NCT02712554|616126712|FG000|Part B: Qualification Phase|Adverse Event|0|||
170487322|NCT02712554|616126713|FG001|Part B: Qualification Phase|Adverse Event|1|||
170487323|NCT02712554|616126712|FG000|Part B: Treatment Phase|Adverse Event|0|||
170487324|NCT02712554|616126713|FG001|Part B: Treatment Phase|Adverse Event|1|||
170487325|NCT02712554|616126712|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
170487326|NCT02712554|616126713|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
170487327|NCT02712554|616126712|FG000|Part B: Treatment Phase|Other|0|||
170487328|NCT02712554|616126713|FG001|Part B: Treatment Phase|Other|1|||
170487329|NCT02503540|616126714|FG000|Overall Study|Death|2|||
170487330|NCT02503540|616126714|FG000|Overall Study|Withdrawal by Subject|1|||
170487331|NCT00564850|616126716|FG000|Overall Study|Protocol Violation|2|||
170487332|NCT00314327|616126719|FG000|Overall Study|Withdrawal by Subject|1|||
170487333|NCT03379727|616126723|FG000|Overall Study|Lack of Efficacy|73|||
170487334|NCT03379727|616126723|FG000|Overall Study|Adverse Event|32|||
170487335|NCT03379727|616126723|FG000|Overall Study|Death|18|||
170487336|NCT03379727|616126723|FG000|Overall Study|Patient/guardian decision|17|||
170898980|NCT02601950|617634309|FG003|Overall Study|Participant refused further study treatment|0|||
170898981|NCT02601950|617634310|FG004|Overall Study|Participant refused further study treatment|2|||
170898982|NCT02601950|617634311|FG005|Overall Study|Participant refused further study treatment|2|||
170898983|NCT02601950|617634312|FG006|Overall Study|Participant refused further study treatment|2|||
170898984|NCT02601950|617634313|FG007|Overall Study|Participant refused further study treatment|1|||
170898985|NCT02601950|617634306|FG000|Overall Study|Investigator discretion|1|||
170898986|NCT02601950|617634307|FG001|Overall Study|Investigator discretion|0|||
170898987|NCT02601950|617634308|FG002|Overall Study|Investigator discretion|1|||
170898988|NCT02601950|617634309|FG003|Overall Study|Investigator discretion|0|||
170898989|NCT02601950|617634310|FG004|Overall Study|Investigator discretion|1|||
170898990|NCT02601950|617634311|FG005|Overall Study|Investigator discretion|1|||
170898991|NCT02601950|617634312|FG006|Overall Study|Investigator discretion|1|||
170898992|NCT02601950|617634313|FG007|Overall Study|Investigator discretion|0|||
170898993|NCT02601950|617634306|FG000|Overall Study|Other|0|||
170898994|NCT02601950|617634307|FG001|Overall Study|Other|0|||
170898995|NCT02601950|617634308|FG002|Overall Study|Other|0|||
170898996|NCT02601950|617634309|FG003|Overall Study|Other|0|||
170898997|NCT02601950|617634310|FG004|Overall Study|Other|2|||
170487337|NCT03379727|616126723|FG000|Overall Study|Physician Decision|104|||
170487338|NCT03379727|616126723|FG000|Overall Study|Protocol Violation|4|||
170487339|NCT03379727|616126723|FG000|Overall Study|Lost to Follow-up|1|||
170487340|NCT02418182|616126726|FG000|Overall Study|Unable to re-consent|18|||
170487341|NCT02418182|616126727|FG001|Overall Study|Unable to re-consent|15|||
170487342|NCT02418182|616126726|FG000|Overall Study|Lost to Follow-up|0|||
170487343|NCT02418182|616126727|FG001|Overall Study|Lost to Follow-up|2|||
170487344|NCT01205776|616126728|FG000|Overall Study|Lost to Follow-up|53|||
170487345|NCT01205776|616126729|FG001|Overall Study|Lost to Follow-up|61|||
170487346|NCT01205776|616126728|FG000|Overall Study|Withdrawal by Subject|11|||
170487347|NCT01205776|616126729|FG001|Overall Study|Withdrawal by Subject|34|||
170487348|NCT02134015|616126734|FG000|Overall Study|Protocol Violation|0|||
170487349|NCT02134015|616126735|FG001|Overall Study|Protocol Violation|1|||
170487350|NCT02134015|616126734|FG000|Overall Study|Death|2|||
170487351|NCT02134015|616126735|FG001|Overall Study|Death|1|||
170487352|NCT02134015|616126734|FG000|Overall Study|Reason not provided|1|||
170487353|NCT02134015|616126735|FG001|Overall Study|Reason not provided|2|||
170898998|NCT02601950|617634311|FG005|Overall Study|Other|2|||
170898999|NCT02601950|617634312|FG006|Overall Study|Other|1|||
170487354|NCT02134015|616126734|FG000|Overall Study|Clinical progression|14|||
170487355|NCT02134015|616126735|FG001|Overall Study|Clinical progression|7|||
170487356|NCT02134015|616126734|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
170487357|NCT02134015|616126735|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
170487358|NCT02134015|616126734|FG000|Overall Study|Study terminated by sponsor|2|||
170487359|NCT02134015|616126735|FG001|Overall Study|Study terminated by sponsor|3|||
170487360|NCT02134015|616126734|FG000|Overall Study|Adverse Event|9|||
170487361|NCT02134015|616126735|FG001|Overall Study|Adverse Event|10|||
170487362|NCT02134015|616126734|FG000|Overall Study|Withdrawal by Subject|3|||
170487363|NCT02134015|616126735|FG001|Overall Study|Withdrawal by Subject|7|||
170487364|NCT02747108|616126740|FG000|Overall Study|Death|2|||
170487365|NCT02747108|616126741|FG001|Overall Study|Death|2|||
170799560|NCT04479787|617278038|FG001|Through 6 Months|Withdrawal by Subject|14|||
170487366|NCT02747108|616126740|FG000|Overall Study|Withdrawal by Subject|1|||
170487367|NCT02747108|616126741|FG001|Overall Study|Withdrawal by Subject|0|||
170487368|NCT02747108|616126740|FG000|Overall Study|Protocol Violation|2|||
170487369|NCT02747108|616126741|FG001|Overall Study|Protocol Violation|0|||
170487370|NCT03103152|616126742|FG000|Overall Study|Physician Decision|5|||
170487371|NCT03103152|616126743|FG001|Overall Study|Physician Decision|2|||
170487372|NCT03103152|616126744|FG002|Overall Study|Physician Decision|6|||
170487373|NCT03103152|616126745|FG003|Overall Study|Physician Decision|3|||
170487374|NCT03103152|616126746|FG004|Overall Study|Physician Decision|3|||
170487375|NCT03103152|616126747|FG005|Overall Study|Physician Decision|1|||
170487376|NCT03103152|616126742|FG000|Overall Study|Protocol Violation|2|||
170487377|NCT03103152|616126743|FG001|Overall Study|Protocol Violation|2|||
170487378|NCT03103152|616126744|FG002|Overall Study|Protocol Violation|1|||
170799561|NCT04479787|617278037|FG000|Through 6 Months|Unsuccessful Trial|17|||
170487379|NCT03103152|616126745|FG003|Overall Study|Protocol Violation|2|||
170487380|NCT03103152|616126746|FG004|Overall Study|Protocol Violation|1|||
170487381|NCT03103152|616126747|FG005|Overall Study|Protocol Violation|1|||
170487382|NCT03103152|616126742|FG000|Overall Study|Inter-current illness|0|||
170549090|NCT02264821|616354755|FG000|Overall Study|Protocol Violation|1|||
170549091|NCT02264821|616354756|FG001|Overall Study|Protocol Violation|3|||
170799562|NCT04479787|617278038|FG001|Through 6 Months|Unsuccessful Trial|0|||
170799563|NCT04479787|617278037|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
170799564|NCT04479787|617278038|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
170799565|NCT04479787|617278037|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
170799566|NCT04479787|617278038|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
170799567|NCT04479787|617278037|FG000|Through 6 Months|Lost to Follow-up|3|||
170799568|NCT04479787|617278038|FG001|Through 6 Months|Lost to Follow-up|2|||
170799569|NCT04479787|617278037|FG000|Through 6 Months|Death|3|||
170799570|NCT04479787|617278038|FG001|Through 6 Months|Death|0|||
170799571|NCT04479787|617278037|FG000|Through 6 Months|Inclusion/Exclusion|2|||
170799572|NCT04479787|617278038|FG001|Through 6 Months|Inclusion/Exclusion|1|||
170799573|NCT04479787|617278037|FG000|Through 6 Months|Subject Became Pregnant|1|||
170799574|NCT04479787|617278038|FG001|Through 6 Months|Subject Became Pregnant|1|||
170799575|NCT04479787|617278037|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
170799576|NCT04479787|617278038|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
170799577|NCT04479787|617278037|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
170799578|NCT04479787|617278038|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
170799579|NCT04479787|617278037|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
170799580|NCT04479787|617278038|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
170799581|NCT04479787|617278037|FG000|After 6 Months|Withdrawal by Subject|3|||
170799582|NCT04479787|617278038|FG001|After 6 Months|Withdrawal by Subject|13|||
170799583|NCT04479787|617278037|FG000|After 6 Months|Unsuccessful Trial|0|||
170799584|NCT04479787|617278038|FG001|After 6 Months|Unsuccessful Trial|7|||
170799585|NCT04479787|617278037|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
170799586|NCT04479787|617278038|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
170799587|NCT04479787|617278037|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
170799588|NCT04479787|617278038|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
170799589|NCT04479787|617278037|FG000|After 6 Months|Death|2|||
170799590|NCT04479787|617278038|FG001|After 6 Months|Death|0|||
170799591|NCT04479787|617278037|FG000|After 6 Months|Lost to Follow-up|1|||
170799592|NCT04479787|617278038|FG001|After 6 Months|Lost to Follow-up|1|||
170799593|NCT04479787|617278037|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
170799594|NCT04479787|617278038|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
170799595|NCT04479787|617278037|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
170799596|NCT04479787|617278038|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
170487383|NCT03103152|616126743|FG001|Overall Study|Inter-current illness|0|||
170487384|NCT03103152|616126744|FG002|Overall Study|Inter-current illness|1|||
170487385|NCT03103152|616126745|FG003|Overall Study|Inter-current illness|0|||
170487386|NCT03103152|616126746|FG004|Overall Study|Inter-current illness|0|||
170487387|NCT03103152|616126747|FG005|Overall Study|Inter-current illness|0|||
170487388|NCT03103152|616126742|FG000|Overall Study|Death|0|||
170487389|NCT03103152|616126743|FG001|Overall Study|Death|1|||
170487390|NCT03103152|616126744|FG002|Overall Study|Death|0|||
170487391|NCT03103152|616126745|FG003|Overall Study|Death|0|||
170487392|NCT03103152|616126746|FG004|Overall Study|Death|0|||
170487393|NCT03103152|616126747|FG005|Overall Study|Death|0|||
170487394|NCT03103152|616126742|FG000|Overall Study|Adverse Event|0|||
170487395|NCT03103152|616126743|FG001|Overall Study|Adverse Event|0|||
170487396|NCT03103152|616126744|FG002|Overall Study|Adverse Event|1|||
170487397|NCT03103152|616126745|FG003|Overall Study|Adverse Event|0|||
170487398|NCT03103152|616126746|FG004|Overall Study|Adverse Event|0|||
170487399|NCT03103152|616126747|FG005|Overall Study|Adverse Event|1|||
170487400|NCT03103152|616126742|FG000|Overall Study|Withdrawal by Subject|1|||
170487401|NCT03103152|616126743|FG001|Overall Study|Withdrawal by Subject|0|||
170487402|NCT03103152|616126744|FG002|Overall Study|Withdrawal by Subject|1|||
170487403|NCT03103152|616126745|FG003|Overall Study|Withdrawal by Subject|1|||
170487404|NCT03103152|616126746|FG004|Overall Study|Withdrawal by Subject|1|||
170487405|NCT03103152|616126747|FG005|Overall Study|Withdrawal by Subject|1|||
170487406|NCT03103152|616126742|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
170487407|NCT03103152|616126743|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
170487408|NCT03103152|616126744|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
170487409|NCT03103152|616126745|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
170487410|NCT03103152|616126746|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
170487411|NCT03103152|616126747|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
170487412|NCT03103152|616126742|FG000|Overall Study|Unacceptable side effects|0|||
170487413|NCT03103152|616126743|FG001|Overall Study|Unacceptable side effects|0|||
170487414|NCT03103152|616126744|FG002|Overall Study|Unacceptable side effects|0|||
170487415|NCT03103152|616126745|FG003|Overall Study|Unacceptable side effects|0|||
170487416|NCT03103152|616126746|FG004|Overall Study|Unacceptable side effects|0|||
170487417|NCT03103152|616126747|FG005|Overall Study|Unacceptable side effects|1|||
170487418|NCT03103152|616126742|FG000|Overall Study|Lost to Follow-up|0|||
170487419|NCT03103152|616126743|FG001|Overall Study|Lost to Follow-up|1|||
170487420|NCT03103152|616126744|FG002|Overall Study|Lost to Follow-up|0|||
170487421|NCT03103152|616126745|FG003|Overall Study|Lost to Follow-up|1|||
170487422|NCT03103152|616126746|FG004|Overall Study|Lost to Follow-up|0|||
170487423|NCT03103152|616126747|FG005|Overall Study|Lost to Follow-up|1|||
170487424|NCT03103152|616126742|FG000|Overall Study|Testicular pain|0|||
170487425|NCT03103152|616126743|FG001|Overall Study|Testicular pain|0|||
170487426|NCT03103152|616126744|FG002|Overall Study|Testicular pain|0|||
170487427|NCT03103152|616126745|FG003|Overall Study|Testicular pain|1|||
170487428|NCT03103152|616126746|FG004|Overall Study|Testicular pain|0|||
170487429|NCT03103152|616126747|FG005|Overall Study|Testicular pain|0|||
170899000|NCT02601950|617634313|FG007|Overall Study|Other|0|||
170899001|NCT01756456|617634321|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
170899002|NCT01756456|617634322|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
170899003|NCT01756456|617634323|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
170899004|NCT01756456|617634324|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
170899005|NCT01756456|617634325|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
170899006|NCT01756456|617634326|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
170899007|NCT01756456|617634321|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
170899008|NCT01756456|617634322|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
170899009|NCT01756456|617634323|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
170899010|NCT01756456|617634324|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
170899011|NCT01756456|617634325|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
170899012|NCT01756456|617634326|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
170899013|NCT01756456|617634321|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
170899014|NCT01756456|617634322|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
170899015|NCT01756456|617634323|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
170899016|NCT01756456|617634324|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
170899017|NCT01756456|617634325|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
170487430|NCT05966584|616126748|FG000|Overall Study|Lost to Follow-up|1|||
170549092|NCT02264821|616354757|FG002|Overall Study|Protocol Violation|6|||
170549093|NCT02067156|616354760|FG000|Overall Study|Lost to Follow-up|4|||
170549094|NCT03142334|616354761|FG000|Overall Study|Death|18|||
170549095|NCT03142334|616354762|FG001|Overall Study|Death|33|||
170549096|NCT03142334|616354761|FG000|Overall Study|Withdrawal by Subject|15|||
170549097|NCT03142334|616354762|FG001|Overall Study|Withdrawal by Subject|11|||
170549098|NCT03142334|616354761|FG000|Overall Study|Ongoing on trial follow up|463|||
170549099|NCT03142334|616354762|FG001|Overall Study|Ongoing on trial follow up|454|||
170549100|NCT05587998|616354763|FG000|Overall Study|Withdrawal by Subject|1|||
170549101|NCT05587998|616354764|FG001|Overall Study|Withdrawal by Subject|1|||
170640479|NCT02167139|616695681|FG000|Transition-extension|Lost to Follow-up|1|||
170899018|NCT01756456|617634326|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
170899019|NCT01756456|617634321|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
170899020|NCT01756456|617634322|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
170899021|NCT01756456|617634323|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
170899022|NCT01756456|617634324|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
170899023|NCT01756456|617634325|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
170899024|NCT01756456|617634326|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
170899025|NCT01756456|617634321|FG000|Treatment Period: Phase I/II|Other causes|0|||
170899026|NCT01756456|617634322|FG001|Treatment Period: Phase I/II|Other causes|0|||
170899027|NCT01756456|617634323|FG002|Treatment Period: Phase I/II|Other causes|0|||
170899028|NCT01756456|617634324|FG003|Treatment Period: Phase I/II|Other causes|1|||
170899029|NCT01756456|617634325|FG004|Treatment Period: Phase I/II|Other causes|2|||
170899030|NCT01756456|617634326|FG005|Treatment Period: Phase I/II|Other causes|2|||
170899031|NCT01756456|617634321|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
170899032|NCT01756456|617634322|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
170899033|NCT01756456|617634323|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
170899034|NCT01756456|617634324|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
170899035|NCT01756456|617634325|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
170899036|NCT01756456|617634326|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
170899037|NCT01756456|617634321|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
170899038|NCT01756456|617634322|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
170899039|NCT01756456|617634323|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
170899040|NCT01756456|617634324|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
170899041|NCT01756456|617634325|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
170899042|NCT01756456|617634326|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
170899043|NCT01756456|617634321|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
170899044|NCT01756456|617634322|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
170899045|NCT01756456|617634323|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
170899046|NCT01756456|617634324|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
170899047|NCT01756456|617634325|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
170899048|NCT01756456|617634326|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
170799597|NCT04479787|617278037|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
170799598|NCT04479787|617278038|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
170799599|NCT04479787|617278037|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
170799600|NCT04479787|617278038|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
170799601|NCT00353496|617278044|FG000|Overall Study|Adverse Event|1|||
170799602|NCT00353496|617278045|FG001|Overall Study|Adverse Event|0|||
170799603|NCT00353496|617278044|FG000|Overall Study|Protocol Violation|2|||
170799604|NCT00353496|617278045|FG001|Overall Study|Protocol Violation|2|||
170799605|NCT00353496|617278044|FG000|Overall Study|Withdrawal by Subject|3|||
170799606|NCT00353496|617278045|FG001|Overall Study|Withdrawal by Subject|4|||
170799607|NCT00353496|617278044|FG000|Overall Study|Physician Decision|6|||
170799608|NCT00353496|617278045|FG001|Overall Study|Physician Decision|9|||
170799609|NCT00353496|617278044|FG000|Overall Study|Not otherwise specified|4|||
170799610|NCT00353496|617278045|FG001|Overall Study|Not otherwise specified|2|||
170799611|NCT02180867|617278046|FG000|Overall Study|Adverse Event|3|||
170799612|NCT02180867|617278047|FG001|Overall Study|Adverse Event|4|||
170799613|NCT02180867|617278048|FG002|Overall Study|Adverse Event|1|||
170799614|NCT02180867|617278049|FG003|Overall Study|Adverse Event|5|||
170799615|NCT02180867|617278050|FG004|Overall Study|Adverse Event|0|||
170799616|NCT02180867|617278051|FG005|Overall Study|Adverse Event|0|||
170799617|NCT02180867|617278052|FG006|Overall Study|Adverse Event|0|||
170799618|NCT02180867|617278046|FG000|Overall Study|Death|0|||
170799619|NCT02180867|617278047|FG001|Overall Study|Death|0|||
170799620|NCT02180867|617278048|FG002|Overall Study|Death|0|||
170799621|NCT02180867|617278049|FG003|Overall Study|Death|0|||
170799622|NCT02180867|617278050|FG004|Overall Study|Death|1|||
170799623|NCT02180867|617278051|FG005|Overall Study|Death|0|||
170799624|NCT02180867|617278052|FG006|Overall Study|Death|0|||
170799625|NCT02180867|617278046|FG000|Overall Study|Lack of Efficacy|0|||
170799626|NCT02180867|617278047|FG001|Overall Study|Lack of Efficacy|2|||
170799627|NCT02180867|617278048|FG002|Overall Study|Lack of Efficacy|0|||
170799628|NCT02180867|617278049|FG003|Overall Study|Lack of Efficacy|1|||
170799629|NCT02180867|617278050|FG004|Overall Study|Lack of Efficacy|6|||
170799630|NCT02180867|617278051|FG005|Overall Study|Lack of Efficacy|0|||
170799631|NCT02180867|617278052|FG006|Overall Study|Lack of Efficacy|1|||
170899049|NCT01756456|617634321|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
170899050|NCT01756456|617634322|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
170799632|NCT02180867|617278046|FG000|Overall Study|Physician Decision|1|||
170799633|NCT02180867|617278047|FG001|Overall Study|Physician Decision|3|||
170799634|NCT02180867|617278048|FG002|Overall Study|Physician Decision|1|||
170799635|NCT02180867|617278049|FG003|Overall Study|Physician Decision|10|||
170799636|NCT02180867|617278050|FG004|Overall Study|Physician Decision|9|||
170899051|NCT01756456|617634323|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
170899052|NCT01756456|617634324|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
170899053|NCT01756456|617634325|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
170899054|NCT01756456|617634326|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
170899055|NCT01756456|617634321|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
170899056|NCT01756456|617634322|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
170899057|NCT01756456|617634323|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
170899058|NCT01756456|617634324|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
170899059|NCT01756456|617634325|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
170899060|NCT01756456|617634326|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
170899061|NCT01756456|617634321|FG000|Follow Up Period Phase I/II|Other causes|0|||
170899062|NCT01756456|617634322|FG001|Follow Up Period Phase I/II|Other causes|0|||
170899063|NCT01756456|617634323|FG002|Follow Up Period Phase I/II|Other causes|0|||
170899064|NCT01756456|617634324|FG003|Follow Up Period Phase I/II|Other causes|1|||
170899065|NCT01756456|617634325|FG004|Follow Up Period Phase I/II|Other causes|3|||
170899066|NCT01756456|617634326|FG005|Follow Up Period Phase I/II|Other causes|5|||
170899067|NCT00813995|617634327|FG000|Overall Study|Clinical adverse event|9|||
170899068|NCT00813995|617634328|FG001|Overall Study|Clinical adverse event|3|||
170899069|NCT00813995|617634327|FG000|Overall Study|Laboratory adverse event|0|||
170899070|NCT00813995|617634328|FG001|Overall Study|Laboratory adverse event|2|||
170899071|NCT00813995|617634327|FG000|Overall Study|Lack of Efficacy|1|||
170899072|NCT00813995|617634328|FG001|Overall Study|Lack of Efficacy|0|||
170899073|NCT00813995|617634327|FG000|Overall Study|Lost to Follow-up|4|||
170899074|NCT00813995|617634328|FG001|Overall Study|Lost to Follow-up|2|||
170899075|NCT00813995|617634327|FG000|Overall Study|Other reason|2|||
170899076|NCT00813995|617634328|FG001|Overall Study|Other reason|2|||
170899077|NCT00813995|617634327|FG000|Overall Study|Protocol Violation|3|||
170899078|NCT00813995|617634328|FG001|Overall Study|Protocol Violation|2|||
170899079|NCT00813995|617634327|FG000|Overall Study|Subject moved|4|||
170899080|NCT00813995|617634328|FG001|Overall Study|Subject moved|0|||
170899081|NCT00813995|617634327|FG000|Overall Study|Withdrawal by Subject|0|||
170899082|NCT00813995|617634328|FG001|Overall Study|Withdrawal by Subject|5|||
170899083|NCT03686969|617634331|FG000|Overall Study|Study terminated|1|||
170899084|NCT03686969|617634332|FG001|Overall Study|Study terminated|0|||
170899085|NCT01439945|617634334|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
170899086|NCT01439945|617634335|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
170487431|NCT03694002|616128578|FG000|Overall Study|Progression|4|||
170487432|NCT03694002|616128579|FG001|Overall Study|Progression|2|||
170487433|NCT03694002|616128578|FG000|Overall Study|Adverse Event|2|||
170487434|NCT03694002|616128579|FG001|Overall Study|Adverse Event|0|||
170487435|NCT03694002|616128578|FG000|Overall Study|Other not protocol specified|1|||
170487436|NCT03694002|616128579|FG001|Overall Study|Other not protocol specified|0|||
170487437|NCT03694002|616128578|FG000|Overall Study|Ineligible|0|||
170487438|NCT03694002|616128579|FG001|Overall Study|Ineligible|1|||
170487439|NCT03694002|616128578|FG000|Overall Study|Withdrew consent before starting treatment|0|||
170487440|NCT03694002|616128579|FG001|Overall Study|Withdrew consent before starting treatment|3|||
170487441|NCT06360588|616128580|FG000|Overall Study|Adverse Event|3|||
170487442|NCT06360588|616128580|FG000|Overall Study|Death|2|||
170487443|NCT06360588|616128580|FG000|Overall Study|Disease Progression|14|||
170487444|NCT06360588|616128580|FG000|Overall Study|Withdrawal by Subject|1|||
170487445|NCT06360588|616128580|FG000|Overall Study|Lack of Efficacy|1|||
170487446|NCT06360588|616128580|FG000|Overall Study|Ineligible|1|||
170487447|NCT01481766|616128582|FG000|4 months|Lost to Follow-up|3|||
170487448|NCT01481766|616128583|FG001|4 months|Lost to Follow-up|2|||
170487449|NCT01481766|616128584|FG002|4 months|Lost to Follow-up|1|||
170487450|NCT01481766|616128585|FG003|4 months|Lost to Follow-up|5|||
170487451|NCT01481766|616128582|FG000|12 months|Lost to Follow-up|7|||
170487452|NCT01481766|616128583|FG001|12 months|Lost to Follow-up|8|||
170487453|NCT01481766|616128584|FG002|12 months|Lost to Follow-up|5|||
170487454|NCT01481766|616128585|FG003|12 months|Lost to Follow-up|3|||
170487455|NCT00570687|616128586|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487456|NCT00570687|616128587|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487457|NCT00570687|616128588|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170899087|NCT01439945|617634336|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
170487458|NCT00570687|616128589|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487459|NCT00570687|616128590|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
170487460|NCT00570687|616128591|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
170899088|NCT01439945|617634337|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
170899089|NCT01439945|617634334|FG000|Double-Blind Treatment Phase|Ineligible|1|||
170899090|NCT01439945|617634335|FG001|Double-Blind Treatment Phase|Ineligible|2|||
170899091|NCT01439945|617634336|FG002|Double-Blind Treatment Phase|Ineligible|0|||
170899092|NCT01439945|617634337|FG003|Double-Blind Treatment Phase|Ineligible|1|||
170899093|NCT04082663|617634338|FG000|Overall Study|Adverse Event|6|||
170899094|NCT04082663|617634338|FG000|Overall Study|Lost to Follow-up|1|||
170899095|NCT03898063|617634343|FG000|Overall Study|Withdrawal by Subject|10|||
170899096|NCT03898063|617634344|FG001|Overall Study|Withdrawal by Subject|8|||
170899097|NCT01752023|617634345|FG000|Overall Study|Physician Decision|2|||
170899098|NCT01752023|617634346|FG001|Overall Study|Physician Decision|1|||
170899099|NCT02440581|617634349|FG000|Overall Study|Death|0|||
170899100|NCT02440581|617634350|FG001|Overall Study|Death|0|||
170899101|NCT02440581|617634351|FG002|Overall Study|Death|7|||
170899102|NCT02440581|617634352|FG003|Overall Study|Death|5|||
170899103|NCT02440581|617634349|FG000|Overall Study|Transplanted|1|||
170899104|NCT02440581|617634350|FG001|Overall Study|Transplanted|0|||
170899105|NCT02440581|617634351|FG002|Overall Study|Transplanted|3|||
170899106|NCT02440581|617634352|FG003|Overall Study|Transplanted|2|||
170899107|NCT02440581|617634349|FG000|Overall Study|Withdrawal by Subject|4|||
170899108|NCT02440581|617634350|FG001|Overall Study|Withdrawal by Subject|11|||
170899109|NCT02440581|617634351|FG002|Overall Study|Withdrawal by Subject|3|||
170899110|NCT02440581|617634352|FG003|Overall Study|Withdrawal by Subject|7|||
170899111|NCT00654498|617634353|FG000|Overall Study|Not Treated|1|||
170899112|NCT00654498|617634354|FG001|Overall Study|Not Treated|0|||
170899113|NCT00654498|617634353|FG000|Overall Study|Adverse Event|6|||
170899114|NCT00654498|617634354|FG001|Overall Study|Adverse Event|1|||
170899115|NCT00654498|617634353|FG000|Overall Study|Protocol Violation|1|||
170899116|NCT00654498|617634354|FG001|Overall Study|Protocol Violation|1|||
170899117|NCT00654498|617634353|FG000|Overall Study|Lost to Follow-up|1|||
170899118|NCT00654498|617634354|FG001|Overall Study|Lost to Follow-up|5|||
170899119|NCT00654498|617634353|FG000|Overall Study|Withdrawal by Subject|1|||
170899120|NCT00654498|617634354|FG001|Overall Study|Withdrawal by Subject|0|||
170899121|NCT00654498|617634353|FG000|Overall Study|Other reason not defined above|4|||
170899122|NCT00654498|617634354|FG001|Overall Study|Other reason not defined above|5|||
170899123|NCT01468987|617634355|FG000|Overall Study|Adverse Event|12|||
170899124|NCT01468987|617634356|FG001|Overall Study|Adverse Event|9|||
170899125|NCT01468987|617634355|FG000|Overall Study|Death|4|||
170899126|NCT01468987|617634356|FG001|Overall Study|Death|1|||
170899127|NCT01468987|617634355|FG000|Overall Study|Lost to Follow-up|10|||
170899128|NCT01468987|617634356|FG001|Overall Study|Lost to Follow-up|5|||
170899129|NCT01468987|617634355|FG000|Overall Study|Protocol Violation|8|||
170899130|NCT01468987|617634356|FG001|Overall Study|Protocol Violation|2|||
170899131|NCT01468987|617634355|FG000|Overall Study|Withdrawal by Subject|28|||
170899132|NCT01468987|617634356|FG001|Overall Study|Withdrawal by Subject|28|||
170899133|NCT01468987|617634355|FG000|Overall Study|Physician Decision|8|||
170899134|NCT01468987|617634356|FG001|Overall Study|Physician Decision|15|||
170899135|NCT01468987|617634355|FG000|Overall Study|Sponsor Decision|1|||
170899136|NCT01468987|617634356|FG001|Overall Study|Sponsor Decision|0|||
170487461|NCT00570687|616128592|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
170487462|NCT00570687|616128593|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
170487463|NCT00570687|616128594|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
170487464|NCT00570687|616128595|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
170487465|NCT00570687|616128586|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487466|NCT00570687|616128587|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487467|NCT00570687|616128588|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487468|NCT00570687|616128589|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487469|NCT00570687|616128590|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487470|NCT00570687|616128591|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487471|NCT00570687|616128592|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487472|NCT00570687|616128593|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487473|NCT00570687|616128594|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
170487474|NCT00570687|616128595|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170899137|NCT03430986|617634357|FG000|24-week Control Period|Adverse Event|1|||
170549102|NCT05587998|616354763|FG000|Overall Study|Not treated|3|||
170549103|NCT05587998|616354764|FG001|Overall Study|Not treated|1|||
170899138|NCT03430986|617634358|FG001|24-week Control Period|Adverse Event|0|||
170899139|NCT03430986|617634357|FG000|24-week Control Period|Lost to Follow-up|2|||
170899140|NCT03430986|617634358|FG001|24-week Control Period|Lost to Follow-up|2|||
170899141|NCT03430986|617634357|FG000|24-week Control Period|Withdrawal by Participant|5|||
170899142|NCT03430986|617634358|FG001|24-week Control Period|Withdrawal by Participant|0|||
170899143|NCT03430986|617634357|FG000|24-week Control Period|Protocol Deviation|0|||
170899144|NCT03430986|617634358|FG001|24-week Control Period|Protocol Deviation|2|||
170899145|NCT03430986|617634357|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
170899146|NCT03430986|617634358|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
170899147|NCT03430986|617634357|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
170899148|NCT03430986|617634358|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
170899149|NCT01889602|617634362|FG000|First Intervention|Adverse Event|1|||
170899150|NCT01889602|617634363|FG001|First Intervention|Adverse Event|1|||
170899151|NCT01889602|617634364|FG002|First Intervention|Adverse Event|1|||
170899152|NCT01889602|617634362|FG000|First Intervention|Protocol Violation|0|||
170899153|NCT01889602|617634363|FG001|First Intervention|Protocol Violation|1|||
170899154|NCT01889602|617634364|FG002|First Intervention|Protocol Violation|1|||
170899155|NCT01889602|617634362|FG000|First Intervention|Study ending|0|||
170899156|NCT01889602|617634363|FG001|First Intervention|Study ending|1|||
170899157|NCT01889602|617634364|FG002|First Intervention|Study ending|0|||
170899158|NCT01889602|617634362|FG000|Second Intervention|Adverse Event|0|||
170899159|NCT01889602|617634363|FG001|Second Intervention|Adverse Event|0|||
170899160|NCT01889602|617634364|FG002|Second Intervention|Adverse Event|1|||
170899161|NCT01889602|617634362|FG000|Second Intervention|Study ending|1|||
170899162|NCT01889602|617634363|FG001|Second Intervention|Study ending|0|||
170899163|NCT01889602|617634364|FG002|Second Intervention|Study ending|0|||
170899164|NCT01889602|617634362|FG000|Second Intervention|Withdrawal by Subject|0|||
170899165|NCT01889602|617634363|FG001|Second Intervention|Withdrawal by Subject|0|||
170899166|NCT01889602|617634364|FG002|Second Intervention|Withdrawal by Subject|1|||
170899167|NCT01889602|617634362|FG000|Third Intervention|Protocol Violation|1|||
170899168|NCT01889602|617634363|FG001|Third Intervention|Protocol Violation|0|||
170899169|NCT01889602|617634364|FG002|Third Intervention|Protocol Violation|0|||
170899170|NCT01889602|617634362|FG000|Third Intervention|Withdrawal by Subject|2|||
170899171|NCT01889602|617634363|FG001|Third Intervention|Withdrawal by Subject|2|||
170899172|NCT01889602|617634364|FG002|Third Intervention|Withdrawal by Subject|0|||
170899173|NCT01412957|617634365|FG000|Overall Study|Withdrawal by Subject|6|||
170899174|NCT01412957|617634366|FG001|Overall Study|Withdrawal by Subject|22|||
170899175|NCT01412957|617634365|FG000|Overall Study|Lost to Follow-up|7|||
170899176|NCT01412957|617634366|FG001|Overall Study|Lost to Follow-up|2|||
170899177|NCT01412957|617634365|FG000|Overall Study|Death|136|||
170899178|NCT01412957|617634366|FG001|Overall Study|Death|133|||
170899179|NCT00943683|617634367|FG000|Overall Study|Adverse Event|3|||
170899180|NCT00943683|617634368|FG001|Overall Study|Adverse Event|3|||
170899181|NCT00943683|617634367|FG000|Overall Study|Lost to Follow-up|1|||
170899182|NCT00943683|617634368|FG001|Overall Study|Lost to Follow-up|1|||
170899183|NCT00943683|617634367|FG000|Overall Study|Protocol Violation|1|||
170899184|NCT00943683|617634368|FG001|Overall Study|Protocol Violation|2|||
170899185|NCT00943683|617634367|FG000|Overall Study|Withdrawal by Subject|1|||
170899186|NCT00943683|617634368|FG001|Overall Study|Withdrawal by Subject|0|||
170899187|NCT00943683|617634367|FG000|Overall Study|Patient Moved|1|||
170899188|NCT00943683|617634368|FG001|Overall Study|Patient Moved|0|||
170899189|NCT01245673|617634369|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
170899190|NCT02040142|617634375|FG000|Overall Study|Lost to Follow-up|5|||
170899191|NCT02040142|617634375|FG000|Overall Study|Death|17|||
170899192|NCT02040142|617634375|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
170899193|NCT03797001|617635955|FG000|Overall Study|Withdrawn due to COVID19|4|||
170899194|NCT03797001|617635956|FG001|Overall Study|Withdrawn due to COVID19|0|||
170899195|NCT03797001|617635955|FG000|Overall Study|Withdrawal by Subject|7|||
170899196|NCT03797001|617635956|FG001|Overall Study|Withdrawal by Subject|6|||
170899197|NCT03797001|617635955|FG000|Overall Study|Adverse Event|0|||
170899198|NCT03797001|617635956|FG001|Overall Study|Adverse Event|1|||
170899199|NCT00500266|617635957|FG000|Overall Study|Death|3|||
170899200|NCT00500266|617635957|FG000|Overall Study|Lost to Follow-up|3|||
170899201|NCT00500266|617635957|FG000|Overall Study|Withdrawal by Subject|3|||
170899202|NCT00500266|617635957|FG000|Overall Study|Assigned, not treated|4|||
170899203|NCT02029976|617635958|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
170899204|NCT02029976|617635959|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
170899205|NCT02029976|617635958|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
170549104|NCT05587998|616354763|FG000|Overall Study|Non-compliance with study procedures|0|||
170549105|NCT05587998|616354764|FG001|Overall Study|Non-compliance with study procedures|1|||
170549106|NCT01520714|616354765|FG000|Overall Study|Protocol Violation|0|||
170549107|NCT01520714|616354766|FG001|Overall Study|Protocol Violation|3|||
170549108|NCT01520714|616354765|FG000|Overall Study|Adverse Event|0|||
170549109|NCT01520714|616354766|FG001|Overall Study|Adverse Event|2|||
170549110|NCT01520714|616354765|FG000|Overall Study|Lack of Efficacy|0|||
170549111|NCT01520714|616354766|FG001|Overall Study|Lack of Efficacy|1|||
170549112|NCT03566550|616354774|FG000|Overall Study|Withdrawal by Subject|0|||
170899206|NCT02029976|617635959|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
170899207|NCT02029976|617635958|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
170899208|NCT02029976|617635959|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
170899209|NCT02029976|617635958|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
170899210|NCT02029976|617635959|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
170899211|NCT03263806|617635960|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
170899212|NCT03263806|617635961|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
170899213|NCT03263806|617635960|FG000|Overall Study|Withdrawal by Subject|0|||
170899214|NCT03263806|617635961|FG001|Overall Study|Withdrawal by Subject|1|||
170899215|NCT03263806|617635960|FG000|Overall Study|Study Termination|5|||
170899216|NCT03263806|617635961|FG001|Overall Study|Study Termination|6|||
170487475|NCT00570687|616128586|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487476|NCT00570687|616128587|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487477|NCT00570687|616128588|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487478|NCT00570687|616128589|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487479|NCT00570687|616128590|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487480|NCT00570687|616128591|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487481|NCT00570687|616128592|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
170487482|NCT00570687|616128593|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487483|NCT00570687|616128594|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170549113|NCT03566550|616354775|FG001|Overall Study|Withdrawal by Subject|1|||
170549114|NCT00052715|616354781|FG000|Overall Study|wrong histology|1|||
170799637|NCT02180867|617278051|FG005|Overall Study|Physician Decision|3|||
170799638|NCT02180867|617278052|FG006|Overall Study|Physician Decision|4|||
170799639|NCT02180867|617278046|FG000|Overall Study|Withdrawal by Subject|0|||
170799640|NCT02180867|617278047|FG001|Overall Study|Withdrawal by Subject|0|||
170799641|NCT02180867|617278048|FG002|Overall Study|Withdrawal by Subject|0|||
170799642|NCT02180867|617278049|FG003|Overall Study|Withdrawal by Subject|1|||
170799643|NCT02180867|617278050|FG004|Overall Study|Withdrawal by Subject|1|||
170799644|NCT02180867|617278051|FG005|Overall Study|Withdrawal by Subject|0|||
170799645|NCT02180867|617278052|FG006|Overall Study|Withdrawal by Subject|0|||
170799646|NCT02180867|617278046|FG000|Overall Study|Ineligible|1|||
170799647|NCT02180867|617278047|FG001|Overall Study|Ineligible|2|||
170799648|NCT02180867|617278048|FG002|Overall Study|Ineligible|0|||
170799649|NCT02180867|617278049|FG003|Overall Study|Ineligible|3|||
170799650|NCT02180867|617278050|FG004|Overall Study|Ineligible|5|||
170799651|NCT02180867|617278051|FG005|Overall Study|Ineligible|0|||
170799652|NCT02180867|617278052|FG006|Overall Study|Ineligible|0|||
170799653|NCT02180867|617278046|FG000|Overall Study|Repeat Eligibility Studies|0|||
170799654|NCT02180867|617278047|FG001|Overall Study|Repeat Eligibility Studies|0|||
170799655|NCT02180867|617278048|FG002|Overall Study|Repeat Eligibility Studies|0|||
170799656|NCT02180867|617278049|FG003|Overall Study|Repeat Eligibility Studies|0|||
170799657|NCT02180867|617278050|FG004|Overall Study|Repeat Eligibility Studies|1|||
170799658|NCT02180867|617278051|FG005|Overall Study|Repeat Eligibility Studies|0|||
170799659|NCT02180867|617278052|FG006|Overall Study|Repeat Eligibility Studies|0|||
170799660|NCT02180867|617278046|FG000|Overall Study|Refusal of further protocol therapy|1|||
170799661|NCT02180867|617278047|FG001|Overall Study|Refusal of further protocol therapy|0|||
170799662|NCT02180867|617278048|FG002|Overall Study|Refusal of further protocol therapy|2|||
170799663|NCT02180867|617278049|FG003|Overall Study|Refusal of further protocol therapy|6|||
170799664|NCT02180867|617278050|FG004|Overall Study|Refusal of further protocol therapy|4|||
170799665|NCT02180867|617278051|FG005|Overall Study|Refusal of further protocol therapy|0|||
170799666|NCT02180867|617278052|FG006|Overall Study|Refusal of further protocol therapy|0|||
170799667|NCT04732871|617278813|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
170799668|NCT04732871|617278814|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
170799669|NCT04732871|617278815|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
170799670|NCT04732871|617278813|FG000|Overall Study|Lost to Follow-up|7|||
170799671|NCT04732871|617278814|FG001|Overall Study|Lost to Follow-up|4|||
170799672|NCT04732871|617278815|FG002|Overall Study|Lost to Follow-up|3|||
170799673|NCT04732871|617278813|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
170799674|NCT04732871|617278814|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
170799675|NCT04732871|617278815|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
170799676|NCT04732871|617278813|FG000|Overall Study|Migrated / moved from the study area|5|||
170799677|NCT04732871|617278814|FG001|Overall Study|Migrated / moved from the study area|0|||
170799678|NCT04732871|617278815|FG002|Overall Study|Migrated / moved from the study area|0|||
170799679|NCT04732871|617278813|FG000|Overall Study|Other|1|||
170799680|NCT04732871|617278814|FG001|Overall Study|Other|0|||
170799681|NCT04732871|617278815|FG002|Overall Study|Other|1|||
170799682|NCT04732871|617278813|FG000|Overall Study|Ongoing|6|||
170799683|NCT04732871|617278814|FG001|Overall Study|Ongoing|0|||
170799684|NCT04732871|617278815|FG002|Overall Study|Ongoing|1|||
170799685|NCT04732871|617278813|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
170799686|NCT04732871|617278814|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
170799687|NCT04732871|617278815|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
170799688|NCT03512301|617278828|FG000|Overall Study|Protocol Violation|2|||
170799689|NCT03512301|617278828|FG000|Overall Study|Did Not Qualify|3|||
170799690|NCT03512301|617278828|FG000|Overall Study|Age-ineligible|1|||
170799691|NCT03512301|617278828|FG000|Overall Study|Inadequate fluency with the English language|3|||
170799692|NCT00968149|617278829|FG000|Overall Study|Adverse Event|5|||
170799693|NCT00968149|617278830|FG001|Overall Study|Adverse Event|1|||
170799694|NCT00968149|617278829|FG000|Overall Study|Lack of Efficacy|0|||
170799695|NCT00968149|617278830|FG001|Overall Study|Lack of Efficacy|4|||
170799696|NCT00968149|617278829|FG000|Overall Study|Lost to Follow-up|0|||
170799697|NCT00968149|617278830|FG001|Overall Study|Lost to Follow-up|1|||
170899217|NCT04840667|617635962|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
170899218|NCT01445171|617635963|FG000|Overall Study|Lost to Follow-up|11|||
170899219|NCT01445171|617635963|FG000|Overall Study|Withdrawal by Subject|16|||
170899220|NCT01445171|617635963|FG000|Overall Study|Death|51|||
170899221|NCT01445171|617635963|FG000|Overall Study|Subjects declined to return for followup|9|||
170899222|NCT01445171|617635963|FG000|Overall Study|Consented but did not receive device|8|||
170899223|NCT04854499|617635969|FG000|Overall Study|Study Terminated by Sponsor|5|||
170899224|NCT04854499|617635970|FG001|Overall Study|Study Terminated by Sponsor|27|||
170899225|NCT04854499|617635971|FG002|Overall Study|Study Terminated by Sponsor|28|||
170899226|NCT04854499|617635972|FG003|Overall Study|Study Terminated by Sponsor|19|||
170899227|NCT04854499|617635973|FG004|Overall Study|Study Terminated by Sponsor|1|||
170899228|NCT04854499|617635974|FG005|Overall Study|Study Terminated by Sponsor|10|||
170899229|NCT04854499|617635969|FG000|Overall Study|Death|1|||
170899230|NCT04854499|617635970|FG001|Overall Study|Death|23|||
170899231|NCT04854499|617635971|FG002|Overall Study|Death|21|||
170899232|NCT04854499|617635972|FG003|Overall Study|Death|7|||
170899233|NCT04854499|617635973|FG004|Overall Study|Death|6|||
170899234|NCT04854499|617635974|FG005|Overall Study|Death|24|||
170899235|NCT04854499|617635969|FG000|Overall Study|Investigator's Discretion|0|||
170899236|NCT04854499|617635970|FG001|Overall Study|Investigator's Discretion|1|||
170899237|NCT04854499|617635971|FG002|Overall Study|Investigator's Discretion|3|||
170899238|NCT04854499|617635972|FG003|Overall Study|Investigator's Discretion|4|||
170899239|NCT04854499|617635973|FG004|Overall Study|Investigator's Discretion|1|||
170899240|NCT04854499|617635974|FG005|Overall Study|Investigator's Discretion|5|||
170899241|NCT04854499|617635969|FG000|Overall Study|Withdrew Consent|0|||
170899242|NCT04854499|617635970|FG001|Overall Study|Withdrew Consent|1|||
170899243|NCT04854499|617635971|FG002|Overall Study|Withdrew Consent|2|||
170899244|NCT04854499|617635972|FG003|Overall Study|Withdrew Consent|2|||
170899245|NCT04854499|617635973|FG004|Overall Study|Withdrew Consent|0|||
170899246|NCT04854499|617635974|FG005|Overall Study|Withdrew Consent|1|||
170899247|NCT04854499|617635969|FG000|Overall Study|Lost to Follow-up|0|||
170899248|NCT04854499|617635970|FG001|Overall Study|Lost to Follow-up|0|||
170899249|NCT04854499|617635971|FG002|Overall Study|Lost to Follow-up|0|||
170899250|NCT04854499|617635972|FG003|Overall Study|Lost to Follow-up|0|||
170899251|NCT04854499|617635973|FG004|Overall Study|Lost to Follow-up|0|||
170899252|NCT04854499|617635974|FG005|Overall Study|Lost to Follow-up|1|||
170899253|NCT03124459|617635975|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
170899254|NCT03124459|617635976|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
170899255|NCT03124459|617635977|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
170899256|NCT03124459|617635978|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
170899257|NCT03124459|617635979|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
170899258|NCT03124459|617635980|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
170899259|NCT03124459|617635975|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
170899260|NCT03124459|617635976|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
170899261|NCT03124459|617635977|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
170899262|NCT03124459|617635978|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
170899263|NCT03124459|617635979|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
170899264|NCT03124459|617635980|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
170899265|NCT03124459|617635975|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
170899266|NCT03124459|617635976|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
170899267|NCT03124459|617635977|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
170899268|NCT03124459|617635978|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
170899269|NCT03124459|617635979|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
170549115|NCT04193527|616354786|FG000|Overall Study|Other|1|||
170899270|NCT03124459|617635980|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
170899271|NCT03124459|617635975|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
170899272|NCT03124459|617635976|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
170899273|NCT03124459|617635977|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
170899274|NCT03124459|617635978|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
170899275|NCT03124459|617635979|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
170899276|NCT03124459|617635980|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
170899277|NCT03124459|617635975|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
170899278|NCT03124459|617635976|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
170899279|NCT03124459|617635977|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
170899280|NCT03124459|617635978|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
170899281|NCT03124459|617635979|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
170899282|NCT03124459|617635980|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
170899283|NCT03124459|617635975|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
170899284|NCT03124459|617635976|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
170899285|NCT03124459|617635977|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
170899286|NCT03124459|617635978|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
170899287|NCT03124459|617635979|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
170899288|NCT03124459|617635980|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
170487484|NCT00570687|616128595|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
170487485|NCT03868930|616128596|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
170487486|NCT03868930|616128597|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
170487487|NCT03868930|616128596|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
170487488|NCT03868930|616128597|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
170487489|NCT03868930|616128596|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
170487490|NCT03868930|616128597|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
170549116|NCT04193527|616354787|FG001|Overall Study|Other|1|||
170899289|NCT02612909|617635981|FG000|Phase 2|Withdrawal by Subject|2|||
170899290|NCT02612909|617635982|FG001|Phase 2|Withdrawal by Subject|5|||
170899291|NCT02612909|617635983|FG002|Phase 2|Withdrawal by Subject|0|||
170899292|NCT02612909|617635984|FG003|Phase 2|Withdrawal by Subject|0|||
170899293|NCT02612909|617635985|FG004|Phase 2|Withdrawal by Subject|0|||
170899294|NCT02612909|617635981|FG000|Phase 2|Pregnancy|0|||
170899295|NCT02612909|617635982|FG001|Phase 2|Pregnancy|0|||
170899296|NCT02612909|617635983|FG002|Phase 2|Pregnancy|1|||
170899297|NCT02612909|617635984|FG003|Phase 2|Pregnancy|0|||
170899298|NCT02612909|617635985|FG004|Phase 2|Pregnancy|0|||
170899299|NCT02612909|617635981|FG000|Phase 3|Withdrawal by Subject|0|||
170899300|NCT02612909|617635982|FG001|Phase 3|Withdrawal by Subject|0|||
170899301|NCT02612909|617635983|FG002|Phase 3|Withdrawal by Subject|0|||
170899302|NCT02612909|617635984|FG003|Phase 3|Withdrawal by Subject|1|||
170899303|NCT02612909|617635985|FG004|Phase 3|Withdrawal by Subject|0|||
170899304|NCT02300129|617635992|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
170899305|NCT02300129|617635993|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
170899306|NCT02300129|617635994|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
170899307|NCT02300129|617635995|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
170899308|NCT02300129|617635992|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
170899309|NCT02300129|617635993|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
170899310|NCT02300129|617635994|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
170899311|NCT02300129|617635995|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
170899312|NCT02300129|617635992|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
170899313|NCT02300129|617635993|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
170899314|NCT02300129|617635994|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
170899315|NCT02300129|617635995|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
170899316|NCT01887912|617635996|FG000|Overall Study|Serious adverse event|400|||
170899317|NCT01887912|617635997|FG001|Overall Study|Serious adverse event|198|||
170899318|NCT01887912|617635996|FG000|Overall Study|Other Adverse Event|34|||
170899319|NCT01887912|617635997|FG001|Overall Study|Other Adverse Event|15|||
170899320|NCT01887912|617635996|FG000|Overall Study|Protocol Violation|67|||
170899321|NCT01887912|617635997|FG001|Overall Study|Protocol Violation|37|||
170899322|NCT01887912|617635996|FG000|Overall Study|Lost to Follow-up|163|||
170899323|NCT01887912|617635997|FG001|Overall Study|Lost to Follow-up|74|||
170899324|NCT01887912|617635996|FG000|Overall Study|Withdrawal by Subject|606|||
170899325|NCT01887912|617635997|FG001|Overall Study|Withdrawal by Subject|349|||
170899326|NCT01887912|617635996|FG000|Overall Study|Other|122|||
170899327|NCT01887912|617635997|FG001|Overall Study|Other|58|||
170549117|NCT04193527|616354788|FG002|Overall Study|Other|0|||
170549118|NCT03808909|616354789|FG000|Overall Study|Lost to Follow-up|3|||
170549119|NCT03808909|616354790|FG001|Overall Study|Lost to Follow-up|0|||
170899328|NCT04462536|617635998|FG000|Overall Study|Withdrawal by Subject|3|||
170899329|NCT04462536|617635999|FG001|Overall Study|Withdrawal by Subject|9|||
170899330|NCT04462536|617635998|FG000|Overall Study|Lost to Follow-up|2|||
170899331|NCT04462536|617635999|FG001|Overall Study|Lost to Follow-up|4|||
170899332|NCT03932812|617636010|FG000|Overall Study|Lost to Follow-up|12|||
170899333|NCT03932812|617636011|FG001|Overall Study|Lost to Follow-up|14|||
170899334|NCT03932812|617636010|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
170899335|NCT03932812|617636011|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
170899336|NCT03615222|617636016|FG000|Overall Study|Ineligible|26|||
170549120|NCT01487161|616354791|FG000|Overall Study|Adverse Event|1|||
170899337|NCT03615222|617636016|FG000|Overall Study|Withdrawal by Subject|7|||
170899338|NCT03615222|617636016|FG000|Overall Study|Death|1|||
170899339|NCT00430755|617636017|FG000|Overall Study|Withdrawal by Subject|53|||
170899340|NCT03480802|617636018|FG000|Overall Study|Lost to Follow-up|5|||
170899341|NCT03480802|617636019|FG001|Overall Study|Lost to Follow-up|1|||
170899342|NCT03480802|617636018|FG000|Overall Study|Withdrawal by Subject|2|||
170899343|NCT03480802|617636019|FG001|Overall Study|Withdrawal by Subject|1|||
170899344|NCT03480802|617636018|FG000|Overall Study|Relocated|0|||
170899345|NCT03480802|617636019|FG001|Overall Study|Relocated|1|||
170899346|NCT02661594|617636020|FG000|Overall Study|Protocol Violation|1|||
170899347|NCT02661594|617636021|FG001|Overall Study|Protocol Violation|0|||
170899348|NCT02661594|617636022|FG002|Overall Study|Protocol Violation|1|||
170899349|NCT02661594|617636023|FG003|Overall Study|Protocol Violation|0|||
170899350|NCT00191854|617636030|FG000|Overall Study|Death|26|||
170899351|NCT00191854|617636031|FG001|Overall Study|Death|23|||
170899352|NCT00191854|617636032|FG002|Overall Study|Death|29|||
170899353|NCT00191854|617636030|FG000|Overall Study|Lost to Follow-up|7|||
170899354|NCT00191854|617636031|FG001|Overall Study|Lost to Follow-up|5|||
170899355|NCT00191854|617636032|FG002|Overall Study|Lost to Follow-up|5|||
170899356|NCT00191854|617636030|FG000|Overall Study|Withdrawal by Subject|4|||
170899357|NCT00191854|617636031|FG001|Overall Study|Withdrawal by Subject|2|||
170899358|NCT00191854|617636032|FG002|Overall Study|Withdrawal by Subject|3|||
170899359|NCT00191854|617636030|FG000|Overall Study|Sponsor Decision|0|||
170899360|NCT00191854|617636031|FG001|Overall Study|Sponsor Decision|0|||
170899361|NCT00191854|617636032|FG002|Overall Study|Sponsor Decision|1|||
170899362|NCT00191854|617636030|FG000|Overall Study|Screen Failure|0|||
170899363|NCT00191854|617636031|FG001|Overall Study|Screen Failure|0|||
170899364|NCT00191854|617636032|FG002|Overall Study|Screen Failure|1|||
170899365|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
170899366|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
170899367|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
170899368|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
170899369|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
170899370|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
170899371|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
170899372|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
170899373|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
170899374|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
170899375|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
170899376|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
170899377|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
170899378|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
170487491|NCT03868930|616128596|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
170487492|NCT03868930|616128597|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
170487493|NCT03868930|616128596|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
170487494|NCT03868930|616128597|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
170487495|NCT02151851|616128602|FG000|Overall Study|Lack of Efficacy|67|||
170487496|NCT02151851|616128603|FG001|Overall Study|Lack of Efficacy|94|||
170487497|NCT02151851|616128602|FG000|Overall Study|Protocol Violation|0|||
170487498|NCT02151851|616128603|FG001|Overall Study|Protocol Violation|1|||
170487499|NCT02151851|616128602|FG000|Overall Study|Withdrawal by Subject|2|||
170487500|NCT02151851|616128603|FG001|Overall Study|Withdrawal by Subject|5|||
170487501|NCT02151851|616128602|FG000|Overall Study|Medical impairment|1|||
170487502|NCT02151851|616128603|FG001|Overall Study|Medical impairment|0|||
170487503|NCT02151851|616128602|FG000|Overall Study|Low compliance to study visits|0|||
170487504|NCT02151851|616128603|FG001|Overall Study|Low compliance to study visits|1|||
170487505|NCT02151851|616128602|FG000|Overall Study|Subject entered into study in error|0|||
170487506|NCT02151851|616128603|FG001|Overall Study|Subject entered into study in error|1|||
170487507|NCT02151851|616128602|FG000|Overall Study|Adverse Event|6|||
170487508|NCT02151851|616128603|FG001|Overall Study|Adverse Event|28|||
170487509|NCT02159053|616128604|FG000|Overall Study|Death|2|||
170549121|NCT01487161|616354792|FG001|Overall Study|Adverse Event|0|||
170487510|NCT02159053|616128605|FG001|Overall Study|Death|0|||
170487511|NCT02159053|616128606|FG002|Overall Study|Death|1|||
170899379|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
170487512|NCT02159053|616128604|FG000|Overall Study|Physician Decision|0|||
170487513|NCT02159053|616128605|FG001|Overall Study|Physician Decision|1|||
170899380|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
170899381|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
170899382|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
170899383|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
170899384|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
170899385|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
170487514|NCT02159053|616128606|FG002|Overall Study|Physician Decision|1|||
170487515|NCT02159053|616128604|FG000|Overall Study|Lack of Efficacy|3|||
170899386|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
170899387|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
170899388|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
170899389|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
170899390|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
170899391|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
170899392|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
170899393|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
170899394|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
170899395|NCT00849017|617636033|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
170899396|NCT00849017|617636034|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
170899397|NCT00849017|617636035|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
170899398|NCT00849017|617636033|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
170899399|NCT00849017|617636034|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
170899400|NCT00849017|617636035|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
170899401|NCT00849017|617636033|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
170899402|NCT00849017|617636034|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
170899403|NCT00849017|617636035|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
170899404|NCT00849017|617636033|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
170899405|NCT00849017|617636034|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
170899406|NCT00849017|617636035|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
170899407|NCT00849017|617636033|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
170899408|NCT00849017|617636034|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
170899409|NCT00849017|617636035|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
170899410|NCT00849017|617636033|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
170899411|NCT00849017|617636034|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
170899412|NCT00849017|617636035|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
170899413|NCT00849017|617636033|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
170899414|NCT00849017|617636034|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
170899415|NCT00849017|617636035|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
170899416|NCT00849017|617636033|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
170899417|NCT00849017|617636034|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
170899418|NCT00849017|617636035|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
170899419|NCT00849017|617636033|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
170899420|NCT00849017|617636034|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
170899421|NCT00849017|617636035|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
170899422|NCT02360098|617636036|FG000|Overall Study|Physician Decision|7|||
170899423|NCT01933932|617636043|FG000|Overall Study|Death|173|||
170899424|NCT01933932|617636044|FG001|Overall Study|Death|163|||
170899425|NCT01933932|617636043|FG000|Overall Study|Withdrawal by Subject|11|||
170899426|NCT01933932|617636044|FG001|Overall Study|Withdrawal by Subject|14|||
170899427|NCT01933932|617636043|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170899428|NCT01933932|617636044|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170899429|NCT02771522|617636048|FG000|Overall Study|Lost to Follow-up|3|||
170899430|NCT02771522|617636048|FG000|Overall Study|Withdrawal by Subject|2|||
170899431|NCT02771522|617636048|FG000|Overall Study|No white spot lesions|3|||
170899432|NCT02054702|617636056|FG000|Overall Study|Lost to Follow-up|3|||
170899433|NCT02054702|617636057|FG001|Overall Study|Lost to Follow-up|5|||
170899434|NCT02054702|617636056|FG000|Overall Study|Adverse Event|3|||
170899435|NCT02054702|617636057|FG001|Overall Study|Adverse Event|1|||
170899436|NCT02054702|617636056|FG000|Overall Study|Met Withdrawal Criteria|4|||
170899437|NCT02054702|617636057|FG001|Overall Study|Met Withdrawal Criteria|1|||
170899438|NCT02054702|617636056|FG000|Overall Study|Physician Decision|0|||
170899439|NCT02054702|617636057|FG001|Overall Study|Physician Decision|1|||
170899440|NCT02054702|617636056|FG000|Overall Study|Withdrawal by Subject|14|||
170899441|NCT02054702|617636057|FG001|Overall Study|Withdrawal by Subject|4|||
170899442|NCT03486392|617636058|FG000|Overall Study|Lost to Follow-up|0|||
170899443|NCT03486392|617636059|FG001|Overall Study|Lost to Follow-up|0|||
170899444|NCT03486392|617636060|FG002|Overall Study|Lost to Follow-up|8|||
170899445|NCT03486392|617636061|FG003|Overall Study|Lost to Follow-up|5|||
170899446|NCT03486392|617636062|FG004|Overall Study|Lost to Follow-up|2|||
170899447|NCT03486392|617636058|FG000|Overall Study|Withdrawal by Subject|3|||
170899448|NCT03486392|617636059|FG001|Overall Study|Withdrawal by Subject|0|||
170899449|NCT03486392|617636060|FG002|Overall Study|Withdrawal by Subject|6|||
170899450|NCT03486392|617636061|FG003|Overall Study|Withdrawal by Subject|4|||
170899451|NCT03486392|617636062|FG004|Overall Study|Withdrawal by Subject|1|||
170899452|NCT03486392|617636058|FG000|Overall Study|Death|0|||
170899453|NCT03486392|617636059|FG001|Overall Study|Death|0|||
170899454|NCT03486392|617636060|FG002|Overall Study|Death|0|||
170899455|NCT03486392|617636061|FG003|Overall Study|Death|0|||
170899456|NCT03486392|617636062|FG004|Overall Study|Death|1|||
170899457|NCT00763009|617636066|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
170899458|NCT00891735|617636068|FG000|Overall Study|Adverse Event|2|||
170899459|NCT00891735|617636069|FG001|Overall Study|Adverse Event|0|||
170899460|NCT00891735|617636070|FG002|Overall Study|Adverse Event|2|||
170899461|NCT00891735|617636071|FG003|Overall Study|Adverse Event|0|||
170899462|NCT00891735|617636068|FG000|Overall Study|Death|8|||
170899463|NCT00891735|617636069|FG001|Overall Study|Death|5|||
170899464|NCT00891735|617636070|FG002|Overall Study|Death|4|||
170899465|NCT00891735|617636071|FG003|Overall Study|Death|5|||
170899466|NCT00891735|617636068|FG000|Overall Study|Lost to Follow-up|2|||
170899467|NCT00891735|617636069|FG001|Overall Study|Lost to Follow-up|2|||
170899468|NCT00891735|617636070|FG002|Overall Study|Lost to Follow-up|2|||
170899469|NCT00891735|617636071|FG003|Overall Study|Lost to Follow-up|2|||
170899470|NCT00891735|617636068|FG000|Overall Study|Physician's decision to withdraw patient|1|||
170899471|NCT00891735|617636069|FG001|Overall Study|Physician's decision to withdraw patient|0|||
170899472|NCT00891735|617636070|FG002|Overall Study|Physician's decision to withdraw patient|0|||
170899473|NCT00891735|617636071|FG003|Overall Study|Physician's decision to withdraw patient|0|||
170899474|NCT00891735|617636068|FG000|Overall Study|Patient's decision to withdraw|4|||
170899475|NCT00891735|617636069|FG001|Overall Study|Patient's decision to withdraw|9|||
170899476|NCT00891735|617636070|FG002|Overall Study|Patient's decision to withdraw|4|||
170899477|NCT00891735|617636071|FG003|Overall Study|Patient's decision to withdraw|8|||
170899478|NCT02706938|617636076|FG000|First Period, 6 Weeks|Adverse Event|8|||
170899479|NCT02706938|617636077|FG001|First Period, 6 Weeks|Adverse Event|0|||
170899480|NCT02706938|617636076|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
170899481|NCT02706938|617636077|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
170899482|NCT02706938|617636076|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
170899483|NCT02706938|617636077|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
170899484|NCT02706938|617636076|FG000|Second Period, 6 Weeks|Adverse Event|0|||
170899485|NCT02706938|617636077|FG001|Second Period, 6 Weeks|Adverse Event|7|||
170899486|NCT02706938|617636076|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
170899487|NCT02706938|617636077|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
170899488|NCT00473876|617636081|FG000|Overall Study|Lost to Follow-up|3|||
170899489|NCT00473876|617636082|FG001|Overall Study|Lost to Follow-up|1|||
170899490|NCT01032629|617636083|FG000|Overall Study|Closed Site|21|||
170899491|NCT01032629|617636084|FG001|Overall Study|Closed Site|18|||
170899492|NCT01032629|617636085|FG002|Overall Study|Closed Site|16|||
170899493|NCT01032629|617636083|FG000|Overall Study|Withdrawal by Subject|50|||
170899494|NCT01032629|617636084|FG001|Overall Study|Withdrawal by Subject|36|||
170899495|NCT01032629|617636085|FG002|Overall Study|Withdrawal by Subject|35|||
170899496|NCT01032629|617636083|FG000|Overall Study|Lost to Follow-up|74|||
170899497|NCT01032629|617636084|FG001|Overall Study|Lost to Follow-up|47|||
170899498|NCT01032629|617636085|FG002|Overall Study|Lost to Follow-up|37|||
170899499|NCT02868892|617636086|FG000|Overall Study|Investigator left site and no follow-up|6|||
170899500|NCT01360996|617636094|FG000|Overall Study|Withdrawal by Subject|4|||
170899501|NCT01360996|617636095|FG001|Overall Study|Withdrawal by Subject|3|||
170899502|NCT01360996|617636096|FG002|Overall Study|Withdrawal by Subject|2|||
170899503|NCT01360996|617636094|FG000|Overall Study|Noncompliant|2|||
170899504|NCT01360996|617636095|FG001|Overall Study|Noncompliant|0|||
170899505|NCT01360996|617636096|FG002|Overall Study|Noncompliant|0|||
170899506|NCT03377634|617636097|FG000|Study Period|Adverse Event|1|||
170899507|NCT03377634|617636098|FG001|Study Period|Adverse Event|0|||
170899508|NCT03377634|617636097|FG000|Study Period|Withdrawal by Subject|1|||
170899509|NCT03377634|617636098|FG001|Study Period|Withdrawal by Subject|0|||
170899510|NCT04525703|617636099|FG000|Overall Study|Lost to Follow-up|6|||
170899511|NCT04525703|617636100|FG001|Overall Study|Lost to Follow-up|15|||
170899512|NCT04525703|617636101|FG002|Overall Study|Lost to Follow-up|8|||
170899513|NCT00584870|617636104|FG000|Overall Study|Adverse Event|4|||
170899514|NCT00584870|617636105|FG001|Overall Study|Adverse Event|3|||
170899515|NCT00584870|617636106|FG002|Overall Study|Adverse Event|2|||
170899516|NCT00584870|617636104|FG000|Overall Study|Lost to Follow-up|4|||
170899517|NCT00584870|617636105|FG001|Overall Study|Lost to Follow-up|1|||
170899518|NCT00584870|617636106|FG002|Overall Study|Lost to Follow-up|1|||
170899519|NCT00584870|617636104|FG000|Overall Study|Lack of Efficacy|7|||
170899520|NCT00584870|617636105|FG001|Overall Study|Lack of Efficacy|14|||
170899521|NCT00584870|617636106|FG002|Overall Study|Lack of Efficacy|8|||
170899522|NCT00584870|617636104|FG000|Overall Study|Withdrawal by Subject|10|||
170899523|NCT00584870|617636105|FG001|Overall Study|Withdrawal by Subject|5|||
170899524|NCT00584870|617636106|FG002|Overall Study|Withdrawal by Subject|3|||
170899525|NCT00584870|617636104|FG000|Overall Study|Protocol Violation|1|||
170899526|NCT00584870|617636105|FG001|Overall Study|Protocol Violation|1|||
170899527|NCT00584870|617636106|FG002|Overall Study|Protocol Violation|2|||
170899528|NCT00584870|617636104|FG000|Overall Study|Did not met entrance criteria|1|||
170487516|NCT02159053|616128605|FG001|Overall Study|Lack of Efficacy|4|||
170899529|NCT00584870|617636105|FG001|Overall Study|Did not met entrance criteria|0|||
170899530|NCT00584870|617636106|FG002|Overall Study|Did not met entrance criteria|0|||
170899531|NCT00584870|617636104|FG000|Overall Study|Other|2|||
170899532|NCT00584870|617636105|FG001|Overall Study|Other|0|||
170899533|NCT00584870|617636106|FG002|Overall Study|Other|0|||
170487517|NCT02159053|616128606|FG002|Overall Study|Lack of Efficacy|7|||
170487518|NCT02159053|616128604|FG000|Overall Study|Adverse Event|7|||
170487519|NCT02159053|616128605|FG001|Overall Study|Adverse Event|6|||
170487520|NCT02159053|616128606|FG002|Overall Study|Adverse Event|5|||
170487521|NCT02159053|616128604|FG000|Overall Study|Participants/guardian decision|8|||
170487522|NCT02159053|616128605|FG001|Overall Study|Participants/guardian decision|10|||
170487523|NCT02159053|616128606|FG002|Overall Study|Participants/guardian decision|6|||
170487524|NCT03503370|616128607|FG000|Overall Study|Death|3|||
170487525|NCT03503370|616128608|FG001|Overall Study|Death|1|||
170487526|NCT03483961|616128609|FG000|Overall Study|Lost to Follow-up|7|||
170487527|NCT03483961|616128610|FG001|Overall Study|Lost to Follow-up|6|||
170487528|NCT03483961|616128611|FG002|Overall Study|Lost to Follow-up|6|||
170487529|NCT03483961|616128612|FG003|Overall Study|Lost to Follow-up|6|||
170487530|NCT03483961|616128613|FG004|Overall Study|Lost to Follow-up|6|||
170487531|NCT03483961|616128614|FG005|Overall Study|Lost to Follow-up|4|||
170487532|NCT03483961|616128615|FG006|Overall Study|Lost to Follow-up|4|||
170487533|NCT03483961|616128616|FG007|Overall Study|Lost to Follow-up|11|||
170487534|NCT03483961|616128617|FG008|Overall Study|Lost to Follow-up|1|||
170487535|NCT03483961|616128618|FG009|Overall Study|Lost to Follow-up|0|||
170487536|NCT03483961|616128609|FG000|Overall Study|Withdrawal by Subject|3|||
170487537|NCT03483961|616128610|FG001|Overall Study|Withdrawal by Subject|4|||
170487538|NCT03483961|616128611|FG002|Overall Study|Withdrawal by Subject|5|||
170487539|NCT03483961|616128612|FG003|Overall Study|Withdrawal by Subject|3|||
170487540|NCT03483961|616128613|FG004|Overall Study|Withdrawal by Subject|4|||
170487541|NCT03483961|616128614|FG005|Overall Study|Withdrawal by Subject|2|||
170487542|NCT03483961|616128615|FG006|Overall Study|Withdrawal by Subject|1|||
170640480|NCT02167139|616695682|FG001|Transition-extension|Lost to Follow-up|0|||
170640481|NCT02167139|616695683|FG002|Transition-extension|Lost to Follow-up|0|||
170640482|NCT02167139|616695684|FG003|Transition-extension|Lost to Follow-up|0|||
170640483|NCT03865381|616695696|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
170640484|NCT03865381|616695696|FG000|Overall Study|Withdrawal by Subject|2|||
170799698|NCT00968149|617278829|FG000|Overall Study|Protocol Violation|4|||
170799699|NCT00968149|617278830|FG001|Overall Study|Protocol Violation|0|||
170799700|NCT00968149|617278829|FG000|Overall Study|Withdrawal by Subject|2|||
170799701|NCT00968149|617278830|FG001|Overall Study|Withdrawal by Subject|0|||
170799702|NCT03699163|617278831|FG000|Overall Study|Physician Decision|12|||
170799703|NCT03699163|617278832|FG001|Overall Study|Physician Decision|0|||
170799704|NCT03699163|617278831|FG000|Overall Study|failed QC measures|205|||
170799705|NCT03699163|617278832|FG001|Overall Study|failed QC measures|206|||
170799706|NCT01964300|617278833|FG000|Overall Study|Ineligible after enrollment|0|||
170799707|NCT01964300|617278834|FG001|Overall Study|Ineligible after enrollment|1|||
170799708|NCT01964300|617278833|FG000|Overall Study|Adverse Event|1|||
170799709|NCT01964300|617278834|FG001|Overall Study|Adverse Event|1|||
170799710|NCT01964300|617278833|FG000|Overall Study|Lack of Efficacy|3|||
170799711|NCT01964300|617278834|FG001|Overall Study|Lack of Efficacy|5|||
170799712|NCT01964300|617278833|FG000|Overall Study|Withdrawal by Subject|0|||
170799713|NCT01964300|617278834|FG001|Overall Study|Withdrawal by Subject|1|||
170799714|NCT01964300|617278833|FG000|Overall Study|To receive alternative therapy|1|||
170799715|NCT01964300|617278834|FG001|Overall Study|To receive alternative therapy|2|||
170799716|NCT01964300|617278833|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
170799717|NCT01964300|617278834|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
170799718|NCT01964300|617278833|FG000|Overall Study|Weight criteria not met|0|||
170799719|NCT01964300|617278834|FG001|Overall Study|Weight criteria not met|1|||
170799720|NCT00557492|617278835|FG000|Overall Study|Change in health insurance|1|||
170799721|NCT02438137|617278837|FG000|Overall Study|Lost to Follow-up|3|||
170799722|NCT02438137|617278838|FG001|Overall Study|Lost to Follow-up|2|||
170799723|NCT02438137|617278837|FG000|Overall Study|Adverse Event|1|||
170799724|NCT02438137|617278838|FG001|Overall Study|Adverse Event|0|||
170799725|NCT02438137|617278837|FG000|Overall Study|Withdrawal by Subject|4|||
170799726|NCT02438137|617278838|FG001|Overall Study|Withdrawal by Subject|3|||
170799727|NCT02438137|617278837|FG000|Overall Study|Physician Decision|0|||
170799728|NCT02438137|617278838|FG001|Overall Study|Physician Decision|1|||
170899534|NCT00584870|617636104|FG000|Overall Study|Randomized but not treated|0|||
170899535|NCT00584870|617636105|FG001|Overall Study|Randomized but not treated|1|||
170640485|NCT04927364|616695697|FG000|Overall Study|Withdrawal by Subject|3|||
170799729|NCT00692913|617278839|FG000|Overall Study|Adverse Event|8|||
170799730|NCT00692913|617278840|FG001|Overall Study|Adverse Event|4|||
170799731|NCT00692913|617278839|FG000|Overall Study|Lost to Follow-up|3|||
170799732|NCT00692913|617278840|FG001|Overall Study|Lost to Follow-up|5|||
170487543|NCT03483961|616128616|FG007|Overall Study|Withdrawal by Subject|2|||
170487544|NCT03483961|616128617|FG008|Overall Study|Withdrawal by Subject|1|||
170487545|NCT03483961|616128618|FG009|Overall Study|Withdrawal by Subject|0|||
170487546|NCT03483961|616128609|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
170487547|NCT03483961|616128610|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170799733|NCT00692913|617278839|FG000|Overall Study|Physician Decision|2|||
170799734|NCT00692913|617278840|FG001|Overall Study|Physician Decision|0|||
170487548|NCT03483961|616128611|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170487549|NCT03483961|616128612|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170487550|NCT03483961|616128613|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170487551|NCT03483961|616128614|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170487552|NCT03483961|616128615|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170487553|NCT03483961|616128616|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170487554|NCT03483961|616128617|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170487555|NCT03483961|616128618|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
170487556|NCT03483961|616128609|FG000|Overall Study|Adverse Event|0|||
170487557|NCT03483961|616128610|FG001|Overall Study|Adverse Event|0|||
170487558|NCT03483961|616128611|FG002|Overall Study|Adverse Event|1|||
170487559|NCT03483961|616128612|FG003|Overall Study|Adverse Event|0|||
170487560|NCT03483961|616128613|FG004|Overall Study|Adverse Event|0|||
170487561|NCT03483961|616128614|FG005|Overall Study|Adverse Event|0|||
170487562|NCT03483961|616128615|FG006|Overall Study|Adverse Event|0|||
170487563|NCT03483961|616128616|FG007|Overall Study|Adverse Event|0|||
170487564|NCT03483961|616128617|FG008|Overall Study|Adverse Event|0|||
170487565|NCT03483961|616128618|FG009|Overall Study|Adverse Event|0|||
170487566|NCT02640950|616128619|FG000|Overall Study|Adverse Event|1|||
170487567|NCT02640950|616128619|FG000|Overall Study|Withdrawal by Subject|1|||
170487568|NCT04545489|616128620|FG000|Overall Study|Withdrawal by Subject|12|||
170899536|NCT00584870|617636106|FG002|Overall Study|Randomized but not treated|2|||
170899537|NCT00631137|617636107|FG000|Overall Study|Withdrawal by Subject|1|||
170899538|NCT00631137|617636108|FG001|Overall Study|Withdrawal by Subject|0|||
170899539|NCT02116621|617636109|FG000|Baseline|Withdrawal by Subject|0|||
170487569|NCT04545489|616128621|FG001|Overall Study|Withdrawal by Subject|4|||
170487570|NCT04545489|616128620|FG000|Overall Study|Lost to Follow-up|17|||
170487571|NCT04545489|616128621|FG001|Overall Study|Lost to Follow-up|18|||
170487572|NCT04545489|616128620|FG000|Overall Study|12month BP not collected|4|||
170487573|NCT04545489|616128621|FG001|Overall Study|12month BP not collected|4|||
170487574|NCT00652626|616128622|FG000|Initial Treatment Phase|Adverse Event|0|||
170487575|NCT00652626|616128623|FG001|Initial Treatment Phase|Adverse Event|0|||
170487576|NCT00652626|616128624|FG002|Initial Treatment Phase|Adverse Event|0|||
170487577|NCT00652626|616128625|FG003|Initial Treatment Phase|Adverse Event|0|||
170487578|NCT00652626|616128626|FG004|Initial Treatment Phase|Adverse Event|1|||
170487579|NCT00652626|616128627|FG005|Initial Treatment Phase|Adverse Event|0|||
170487580|NCT00652626|616128628|FG006|Initial Treatment Phase|Adverse Event|0|||
170487581|NCT00652626|616128622|FG000|Initial Treatment Phase|Protocol Violation|0|||
170487582|NCT00652626|616128623|FG001|Initial Treatment Phase|Protocol Violation|0|||
170487583|NCT00652626|616128624|FG002|Initial Treatment Phase|Protocol Violation|0|||
170487584|NCT00652626|616128625|FG003|Initial Treatment Phase|Protocol Violation|1|||
170487585|NCT00652626|616128626|FG004|Initial Treatment Phase|Protocol Violation|0|||
170487586|NCT00652626|616128627|FG005|Initial Treatment Phase|Protocol Violation|0|||
170487587|NCT00652626|616128628|FG006|Initial Treatment Phase|Protocol Violation|0|||
170487588|NCT00652626|616128622|FG000|Initial Treatment Phase|Physician Decision|0|||
170487589|NCT00652626|616128623|FG001|Initial Treatment Phase|Physician Decision|0|||
170487590|NCT00652626|616128624|FG002|Initial Treatment Phase|Physician Decision|0|||
170899540|NCT02116621|617636110|FG001|Baseline|Withdrawal by Subject|4|||
170487591|NCT00652626|616128625|FG003|Initial Treatment Phase|Physician Decision|0|||
170487592|NCT00652626|616128626|FG004|Initial Treatment Phase|Physician Decision|1|||
170899541|NCT02116621|617636109|FG000|Three Month Follow-up|Death|1|||
170899542|NCT02116621|617636110|FG001|Three Month Follow-up|Death|1|||
170899543|NCT02116621|617636109|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
170899544|NCT02116621|617636110|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
170899545|NCT02116621|617636109|FG000|Three Month Follow-up|Lost to Follow-up|0|||
170899546|NCT02116621|617636110|FG001|Three Month Follow-up|Lost to Follow-up|1|||
170487593|NCT00652626|616128627|FG005|Initial Treatment Phase|Physician Decision|0|||
170487594|NCT00652626|616128628|FG006|Initial Treatment Phase|Physician Decision|0|||
170899547|NCT02116621|617636109|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
170899548|NCT02116621|617636110|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
170899549|NCT02116621|617636109|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
170899550|NCT02116621|617636110|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
170487595|NCT00652626|616128622|FG000|Initial Treatment Phase|Sponsor Request|0|||
170487596|NCT00652626|616128623|FG001|Initial Treatment Phase|Sponsor Request|0|||
170487597|NCT00652626|616128624|FG002|Initial Treatment Phase|Sponsor Request|1|||
170549122|NCT01487161|616354793|FG002|Overall Study|Adverse Event|0|||
170899551|NCT02116621|617636109|FG000|Six Month Follow-up|Lost to Follow-up|2|||
170899552|NCT02116621|617636110|FG001|Six Month Follow-up|Lost to Follow-up|1|||
170487598|NCT00652626|616128625|FG003|Initial Treatment Phase|Sponsor Request|0|||
170487599|NCT00652626|616128626|FG004|Initial Treatment Phase|Sponsor Request|0|||
170487600|NCT00652626|616128627|FG005|Initial Treatment Phase|Sponsor Request|0|||
170487601|NCT00652626|616128628|FG006|Initial Treatment Phase|Sponsor Request|0|||
170487602|NCT00652626|616128622|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
170487603|NCT00652626|616128623|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
170487604|NCT00652626|616128624|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
170487605|NCT00652626|616128625|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
170640486|NCT04927364|616695697|FG000|Overall Study|Unable to complete preassessment MRI|1|||
170640487|NCT01354314|616695702|FG000|Overall Study|Lost to Follow-up|1|||
170640488|NCT01354314|616695703|FG001|Overall Study|Lost to Follow-up|0|||
170640489|NCT01354314|616695704|FG002|Overall Study|Lost to Follow-up|1|||
170640490|NCT01354314|616695705|FG003|Overall Study|Lost to Follow-up|1|||
170640491|NCT01354314|616695702|FG000|Overall Study|Withdrawal by Subject|0|||
170640492|NCT01354314|616695703|FG001|Overall Study|Withdrawal by Subject|0|||
170640493|NCT01354314|616695704|FG002|Overall Study|Withdrawal by Subject|1|||
170640494|NCT01354314|616695705|FG003|Overall Study|Withdrawal by Subject|0|||
170640495|NCT01354314|616695702|FG000|Overall Study|Adverse Event|0|||
170799735|NCT00692913|617278839|FG000|Overall Study|Protocol Violation|1|||
170799736|NCT00692913|617278840|FG001|Overall Study|Protocol Violation|1|||
170799737|NCT00692913|617278839|FG000|Overall Study|Withdrawal by Subject|15|||
170799738|NCT00692913|617278840|FG001|Overall Study|Withdrawal by Subject|20|||
170799739|NCT00439270|617278845|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
170799740|NCT00439270|617278846|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
170487606|NCT00652626|616128626|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
170487607|NCT00652626|616128627|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
170487608|NCT00652626|616128628|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
170487609|NCT00652626|616128622|FG000|Extension Phase|Withdrawal by Subject|0|||
170799741|NCT00439270|617278847|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
170799742|NCT00439270|617278848|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
170799743|NCT00439270|617278849|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
170799744|NCT00439270|617278845|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
170799745|NCT00439270|617278846|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
170799746|NCT00439270|617278847|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
170799747|NCT00439270|617278848|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
170799748|NCT00439270|617278849|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
170799749|NCT00439270|617278845|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
170799750|NCT00439270|617278846|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
170799751|NCT00439270|617278847|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
170799752|NCT00439270|617278848|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
170799753|NCT00439270|617278849|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
170799754|NCT00439270|617278845|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
170799755|NCT00439270|617278846|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
170799756|NCT00439270|617278847|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
170799757|NCT00439270|617278848|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
170799758|NCT00439270|617278849|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
170799759|NCT00439270|617278845|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
170799760|NCT00439270|617278846|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
170799761|NCT00439270|617278847|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
170799762|NCT00439270|617278848|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
170799763|NCT00439270|617278849|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
170799764|NCT00439270|617278845|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
170799765|NCT00439270|617278846|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
170799766|NCT00439270|617278847|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
170799767|NCT00439270|617278848|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
170799768|NCT00439270|617278849|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
170799769|NCT00439270|617278845|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
170799770|NCT00439270|617278846|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
170799771|NCT00439270|617278847|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
170799772|NCT00439270|617278848|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
170640496|NCT01354314|616695703|FG001|Overall Study|Adverse Event|0|||
170640497|NCT01354314|616695704|FG002|Overall Study|Adverse Event|0|||
170640498|NCT01354314|616695705|FG003|Overall Study|Adverse Event|1|||
170640499|NCT01354314|616695702|FG000|Overall Study|Protocol Violation|1|||
170640500|NCT01354314|616695703|FG001|Overall Study|Protocol Violation|1|||
170799773|NCT00439270|617278849|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
170799774|NCT00439270|617278845|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
170799775|NCT00439270|617278846|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
170799776|NCT00439270|617278847|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
170487610|NCT00652626|616128623|FG001|Extension Phase|Withdrawal by Subject|0|||
170487611|NCT00652626|616128624|FG002|Extension Phase|Withdrawal by Subject|0|||
170640501|NCT01354314|616695704|FG002|Overall Study|Protocol Violation|0|||
170487612|NCT00652626|616128625|FG003|Extension Phase|Withdrawal by Subject|0|||
170487613|NCT00652626|616128626|FG004|Extension Phase|Withdrawal by Subject|0|||
170487614|NCT00652626|616128627|FG005|Extension Phase|Withdrawal by Subject|2|||
170487615|NCT00652626|616128628|FG006|Extension Phase|Withdrawal by Subject|0|||
170487616|NCT00652626|616128622|FG000|Extension Phase|Adverse Event|0|||
170487617|NCT00652626|616128623|FG001|Extension Phase|Adverse Event|0|||
170487618|NCT00652626|616128624|FG002|Extension Phase|Adverse Event|0|||
170487619|NCT00652626|616128625|FG003|Extension Phase|Adverse Event|0|||
170487620|NCT00652626|616128626|FG004|Extension Phase|Adverse Event|0|||
170487621|NCT00652626|616128627|FG005|Extension Phase|Adverse Event|2|||
170487622|NCT00652626|616128628|FG006|Extension Phase|Adverse Event|1|||
170487623|NCT00652626|616128622|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
170487624|NCT00652626|616128623|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
170487625|NCT00652626|616128624|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
170487626|NCT00652626|616128625|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
170899553|NCT02116621|617636109|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
170899554|NCT02116621|617636110|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
170899555|NCT02116621|617636109|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
170899556|NCT02116621|617636110|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
170899557|NCT02116621|617636109|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
170899558|NCT02116621|617636110|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
170899559|NCT02116621|617636109|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
170899560|NCT02116621|617636110|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
170899561|NCT02116621|617636109|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
170487627|NCT00652626|616128626|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
170487628|NCT00652626|616128627|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
170487629|NCT00652626|616128628|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
170487630|NCT00652626|616128622|FG000|Extension Phase|Physician Decision|0|||
170487631|NCT00652626|616128623|FG001|Extension Phase|Physician Decision|0|||
170487632|NCT00652626|616128624|FG002|Extension Phase|Physician Decision|0|||
170487633|NCT00652626|616128625|FG003|Extension Phase|Physician Decision|0|||
170487634|NCT00652626|616128626|FG004|Extension Phase|Physician Decision|0|||
170487635|NCT00652626|616128627|FG005|Extension Phase|Physician Decision|1|||
170487636|NCT00652626|616128628|FG006|Extension Phase|Physician Decision|1|||
170487637|NCT00652626|616128622|FG000|Extension Phase|Death|0|||
170487638|NCT00652626|616128623|FG001|Extension Phase|Death|0|||
170487639|NCT00652626|616128624|FG002|Extension Phase|Death|0|||
170487640|NCT00652626|616128625|FG003|Extension Phase|Death|0|||
170487641|NCT00652626|616128626|FG004|Extension Phase|Death|0|||
170487642|NCT00652626|616128627|FG005|Extension Phase|Death|1|||
170487643|NCT00652626|616128628|FG006|Extension Phase|Death|1|||
170487644|NCT03048747|616128629|FG000|Overall Study|Adverse Event|2|||
170487645|NCT03048747|616128629|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
170487646|NCT03048747|616128629|FG000|Overall Study|Physician Decision|1|||
170487647|NCT00915018|616128632|FG000|Overall Study|Death|75|||
170899562|NCT02116621|617636110|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
170899563|NCT00961961|617636111|FG000|Phase I|Withdrawal by Subject|7|||
170899564|NCT00961961|617636112|FG001|Phase I|Withdrawal by Subject|0|||
170899565|NCT00961961|617636113|FG002|Phase I|Withdrawal by Subject|0|||
170899566|NCT00961961|617636114|FG003|Phase I|Withdrawal by Subject|0|||
170899567|NCT00961961|617636111|FG000|Phase I|Lost to Follow-up|10|||
170899568|NCT00961961|617636112|FG001|Phase I|Lost to Follow-up|0|||
170899569|NCT00961961|617636113|FG002|Phase I|Lost to Follow-up|0|||
170899570|NCT00961961|617636114|FG003|Phase I|Lost to Follow-up|0|||
170899571|NCT00961961|617636111|FG000|Phase I|Lack of Efficacy|94|||
170899572|NCT00961961|617636112|FG001|Phase I|Lack of Efficacy|0|||
170899573|NCT00961961|617636113|FG002|Phase I|Lack of Efficacy|0|||
170899574|NCT00961961|617636114|FG003|Phase I|Lack of Efficacy|0|||
170899575|NCT00961961|617636111|FG000|Phase I|Adverse Event|7|||
170899576|NCT00961961|617636112|FG001|Phase I|Adverse Event|0|||
170899577|NCT00961961|617636113|FG002|Phase I|Adverse Event|0|||
170899578|NCT00961961|617636114|FG003|Phase I|Adverse Event|0|||
170899579|NCT00961961|617636111|FG000|Phase I|Physician Decision|8|||
170899580|NCT00961961|617636112|FG001|Phase I|Physician Decision|0|||
170899581|NCT00961961|617636113|FG002|Phase I|Physician Decision|0|||
170899582|NCT00961961|617636114|FG003|Phase I|Physician Decision|0|||
170487648|NCT00915018|616128633|FG001|Overall Study|Death|70|||
170487649|NCT00915018|616128632|FG000|Overall Study|Lost to Follow-up|10|||
170487650|NCT00915018|616128633|FG001|Overall Study|Lost to Follow-up|5|||
170487651|NCT00915018|616128632|FG000|Overall Study|Withdrawal by Subject|38|||
170487652|NCT00915018|616128633|FG001|Overall Study|Withdrawal by Subject|27|||
170487653|NCT00915018|616128632|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
170487654|NCT00915018|616128633|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
170487655|NCT00457002|616128634|FG000|Overall Study|Death|40|||
170487656|NCT00457002|616128635|FG001|Overall Study|Death|47|||
170487657|NCT00457002|616128634|FG000|Overall Study|Adverse Event|284|||
170487658|NCT00457002|616128635|FG001|Overall Study|Adverse Event|260|||
170487659|NCT00457002|616128634|FG000|Overall Study|Withdrawal by Subject|299|||
170487660|NCT00457002|616128635|FG001|Overall Study|Withdrawal by Subject|271|||
170487661|NCT00457002|616128634|FG000|Overall Study|Lost to Follow-up|72|||
170487662|NCT00457002|616128635|FG001|Overall Study|Lost to Follow-up|71|||
170487663|NCT00457002|616128634|FG000|Overall Study|Poor/Non-compliance|46|||
170487664|NCT00457002|616128635|FG001|Overall Study|Poor/Non-compliance|33|||
170487665|NCT00457002|616128634|FG000|Overall Study|No longer met criteria|41|||
170487666|NCT00457002|616128635|FG001|Overall Study|No longer met criteria|37|||
170487667|NCT00457002|616128634|FG000|Overall Study|Administrative reason by Sponsor|1|||
170487668|NCT00457002|616128635|FG001|Overall Study|Administrative reason by Sponsor|0|||
170487669|NCT00457002|616128634|FG000|Overall Study|non-specified|29|||
170487670|NCT00457002|616128635|FG001|Overall Study|non-specified|38|||
170899583|NCT00961961|617636111|FG000|Phase II|Lost to Follow-up|0|||
170899584|NCT00961961|617636112|FG001|Phase II|Lost to Follow-up|0|||
170899585|NCT00961961|617636113|FG002|Phase II|Lost to Follow-up|10|||
170487671|NCT00457002|616128634|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
170487672|NCT00457002|616128635|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
170487673|NCT00784238|616128636|FG000|Overall Study|Adverse Event|14|||
170487674|NCT00784238|616128636|FG000|Overall Study|Death|2|||
170487675|NCT00784238|616128636|FG000|Overall Study|Lack of Efficacy|33|||
170487676|NCT00784238|616128636|FG000|Overall Study|Lost to Follow-up|29|||
170487677|NCT00784238|616128636|FG000|Overall Study|Pregnancy|1|||
170799777|NCT00439270|617278848|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
170799778|NCT00439270|617278849|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
170799779|NCT00439270|617278845|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
170799780|NCT00439270|617278846|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
170799781|NCT00439270|617278847|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
170799782|NCT00439270|617278848|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
170799783|NCT00439270|617278849|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
170799784|NCT00439270|617278845|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
170799785|NCT00439270|617278846|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
170799786|NCT00439270|617278847|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
170799787|NCT00439270|617278848|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
170799788|NCT00439270|617278849|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
170799789|NCT01268306|617278850|FG000|Overall Study|Lost to Follow-up|1|||
170799790|NCT03286114|617278856|FG000|Overall Study|Adverse Event|6|||
170799791|NCT03286114|617278856|FG000|Overall Study|Death|3|||
170799792|NCT03983382|617278857|FG000|Overall Study|Death|1|||
170799793|NCT03983382|617278857|FG000|Overall Study|Lost to Follow-up|3|||
170799794|NCT03983382|617278857|FG000|Overall Study|Physician Decision|2|||
170799795|NCT03983382|617278857|FG000|Overall Study|Withdrawal by Subject|10|||
170799796|NCT03983382|617278857|FG000|Overall Study|Change in cancer treatment|2|||
170799797|NCT01313559|617278863|FG000|Overall Study|Withdrawal by Subject|1|||
170799798|NCT01313559|617278864|FG001|Overall Study|Withdrawal by Subject|2|||
170799799|NCT01313559|617278863|FG000|Overall Study|Disease progression|1|||
170799800|NCT01313559|617278864|FG001|Overall Study|Disease progression|0|||
170799801|NCT01313559|617278863|FG000|Overall Study|Rising PSA|2|||
170799802|NCT01313559|617278864|FG001|Overall Study|Rising PSA|0|||
170799803|NCT02989662|617278865|FG000|Overall Study|Lost to Follow-up|0|||
170799804|NCT02989662|617278866|FG001|Overall Study|Lost to Follow-up|0|||
170799805|NCT02989662|617278867|FG002|Overall Study|Lost to Follow-up|0|||
170799806|NCT02989662|617278868|FG003|Overall Study|Lost to Follow-up|2|||
170799807|NCT02989662|617278865|FG000|Overall Study|Physician Decision|3|||
170799808|NCT02989662|617278866|FG001|Overall Study|Physician Decision|0|||
170799809|NCT02989662|617278867|FG002|Overall Study|Physician Decision|0|||
170799810|NCT02989662|617278868|FG003|Overall Study|Physician Decision|0|||
170799811|NCT02989662|617278865|FG000|Overall Study|Withdrawal by Subject|1|||
170799812|NCT02989662|617278866|FG001|Overall Study|Withdrawal by Subject|0|||
170799813|NCT02989662|617278867|FG002|Overall Study|Withdrawal by Subject|0|||
170799814|NCT02989662|617278868|FG003|Overall Study|Withdrawal by Subject|0|||
170799815|NCT02466971|617278869|FG000|Overall Study|eligible and never treated|14|||
170799816|NCT02466971|617278870|FG001|Overall Study|eligible and never treated|20|||
170799817|NCT02466971|617278869|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
170799818|NCT02466971|617278870|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
170799819|NCT02466971|617278869|FG000|Overall Study|ineligible and treated|1|||
170799820|NCT02466971|617278870|FG001|Overall Study|ineligible and treated|0|||
170899586|NCT00961961|617636114|FG003|Phase II|Lost to Follow-up|7|||
170899587|NCT00961961|617636111|FG000|Phase II|Adverse Event|0|||
170899588|NCT00961961|617636112|FG001|Phase II|Adverse Event|0|||
170899589|NCT00961961|617636113|FG002|Phase II|Adverse Event|0|||
170487678|NCT00784238|616128636|FG000|Overall Study|Withdrawal by Subject|26|||
170487679|NCT00784238|616128636|FG000|Overall Study|Other|14|||
170487680|NCT00454246|616128637|FG000|Overall Study|Adverse Event|2|||
170487681|NCT00454246|616128638|FG001|Overall Study|Adverse Event|2|||
170487682|NCT00454246|616128639|FG002|Overall Study|Adverse Event|0|||
170487683|NCT00454246|616128637|FG000|Overall Study|Violation of selection criteria at entry|6|||
170487684|NCT00454246|616128638|FG001|Overall Study|Violation of selection criteria at entry|0|||
170487685|NCT00454246|616128639|FG002|Overall Study|Violation of selection criteria at entry|0|||
170487686|NCT00454246|616128637|FG000|Overall Study|Protocol Violation|1|||
170487687|NCT00454246|616128638|FG001|Overall Study|Protocol Violation|0|||
170487688|NCT00454246|616128639|FG002|Overall Study|Protocol Violation|0|||
170487689|NCT00454246|616128637|FG000|Overall Study|Refused Treatment|1|||
170487690|NCT00454246|616128638|FG001|Overall Study|Refused Treatment|1|||
170487691|NCT00454246|616128639|FG002|Overall Study|Refused Treatment|0|||
170487692|NCT00454246|616128637|FG000|Overall Study|Failure to return|1|||
170487693|NCT00454246|616128638|FG001|Overall Study|Failure to return|0|||
170487694|NCT00454246|616128639|FG002|Overall Study|Failure to return|0|||
170487695|NCT00454246|616128637|FG000|Overall Study|Early termination of study|62|||
170487696|NCT00454246|616128638|FG001|Overall Study|Early termination of study|26|||
170487697|NCT00454246|616128639|FG002|Overall Study|Early termination of study|9|||
170487698|NCT00356603|616128640|FG000|Overall Study|Other|6|||
170487699|NCT00356603|616128641|FG001|Overall Study|Other|3|||
170487700|NCT05326529|616128642|FG000|Overall Study|Lack of Efficacy|0|||
170487701|NCT05326529|616128643|FG001|Overall Study|Lack of Efficacy|1|||
170487702|NCT05326529|616128644|FG002|Overall Study|Lack of Efficacy|0|||
170487703|NCT05326529|616128642|FG000|Overall Study|Physician Decision|0|||
170487704|NCT05326529|616128643|FG001|Overall Study|Physician Decision|0|||
170487705|NCT05326529|616128644|FG002|Overall Study|Physician Decision|2|||
170487706|NCT00566020|616128647|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
170487707|NCT00566020|616128648|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
170487708|NCT00566020|616128647|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
170487709|NCT00566020|616128648|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
170487710|NCT00566020|616128647|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
170487711|NCT00566020|616128648|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
170487712|NCT00566020|616128647|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
170487713|NCT00566020|616128648|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
170487714|NCT00566020|616128647|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
170487715|NCT00566020|616128648|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
170487716|NCT00566020|616128647|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
170487717|NCT00566020|616128648|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
170487718|NCT01568034|616128649|FG000|Overall Study|Withdrawal by Subject|1|||
170487719|NCT01568034|616128650|FG001|Overall Study|Withdrawal by Subject|0|||
170487720|NCT01568034|616128651|FG002|Overall Study|Withdrawal by Subject|0|||
170487721|NCT01568034|616128652|FG003|Overall Study|Withdrawal by Subject|0|||
170487722|NCT01262287|616128653|FG000|Overall Study|Lost to Follow-up|2|||
170487723|NCT01262287|616128654|FG001|Overall Study|Lost to Follow-up|1|||
170487724|NCT00932373|616128655|FG000|Overall Study|Progressive disease|3|||
170487725|NCT00932373|616128656|FG001|Overall Study|Progressive disease|1|||
170487726|NCT00932373|616128657|FG002|Overall Study|Progressive disease|0|||
170487727|NCT00932373|616128658|FG003|Overall Study|Progressive disease|0|||
170487728|NCT00932373|616128659|FG004|Overall Study|Progressive disease|10|||
170487729|NCT00932373|616128660|FG005|Overall Study|Progressive disease|1|||
170487730|NCT00932373|616128661|FG006|Overall Study|Progressive disease|0|||
170487731|NCT00932373|616128662|FG007|Overall Study|Progressive disease|2|||
170487732|NCT00932373|616128663|FG008|Overall Study|Progressive disease|1|||
170487733|NCT00932373|616128664|FG009|Overall Study|Progressive disease|9|||
170487734|NCT00932373|616128665|FG010|Overall Study|Progressive disease|2|||
170799821|NCT02466971|617278869|FG000|Overall Study|ineligible and never treated|0|||
170487735|NCT00932373|616128655|FG000|Overall Study|Adverse Event|0|||
170487736|NCT00932373|616128656|FG001|Overall Study|Adverse Event|0|||
170487737|NCT00932373|616128657|FG002|Overall Study|Adverse Event|0|||
170487738|NCT00932373|616128658|FG003|Overall Study|Adverse Event|0|||
170487739|NCT00932373|616128659|FG004|Overall Study|Adverse Event|2|||
170549123|NCT01487161|616354794|FG003|Overall Study|Adverse Event|0|||
170799822|NCT02466971|617278870|FG001|Overall Study|ineligible and never treated|1|||
170799823|NCT02726386|617278875|FG000|Overall Study|Adverse Event|17|||
170799824|NCT02726386|617278876|FG001|Overall Study|Adverse Event|20|||
170799825|NCT02726386|617278875|FG000|Overall Study|Withdrawal by Subject|14|||
170799826|NCT02726386|617278876|FG001|Overall Study|Withdrawal by Subject|28|||
170799827|NCT02726386|617278875|FG000|Overall Study|Other reasons|7|||
170799828|NCT02726386|617278876|FG001|Overall Study|Other reasons|8|||
170799829|NCT02101853|617278877|FG000|Block 1 Induction|Adverse Event|11|||
170799830|NCT02101853|617278878|FG001|Block 1 Induction|Adverse Event|0|||
170799831|NCT02101853|617278879|FG002|Block 1 Induction|Adverse Event|0|||
170487740|NCT00932373|616128660|FG005|Overall Study|Adverse Event|1|||
170487741|NCT00932373|616128661|FG006|Overall Study|Adverse Event|0|||
170487742|NCT00932373|616128662|FG007|Overall Study|Adverse Event|1|||
170799832|NCT02101853|617278880|FG003|Block 1 Induction|Adverse Event|0|||
170799833|NCT02101853|617278881|FG004|Block 1 Induction|Adverse Event|0|||
170799834|NCT02101853|617278882|FG005|Block 1 Induction|Adverse Event|0|||
170799835|NCT02101853|617278877|FG000|Block 1 Induction|Death|20|||
170487743|NCT00932373|616128663|FG008|Overall Study|Adverse Event|0|||
170487744|NCT00932373|616128664|FG009|Overall Study|Adverse Event|2|||
170487745|NCT00932373|616128665|FG010|Overall Study|Adverse Event|1|||
170487746|NCT00932373|616128655|FG000|Overall Study|Physician Decision|0|||
170487747|NCT00932373|616128656|FG001|Overall Study|Physician Decision|0|||
170487748|NCT00932373|616128657|FG002|Overall Study|Physician Decision|1|||
170487749|NCT00932373|616128658|FG003|Overall Study|Physician Decision|0|||
170487750|NCT00932373|616128659|FG004|Overall Study|Physician Decision|2|||
170487751|NCT00932373|616128660|FG005|Overall Study|Physician Decision|0|||
170487752|NCT00932373|616128661|FG006|Overall Study|Physician Decision|0|||
170487753|NCT00932373|616128662|FG007|Overall Study|Physician Decision|0|||
170487754|NCT00932373|616128663|FG008|Overall Study|Physician Decision|0|||
170487755|NCT00932373|616128664|FG009|Overall Study|Physician Decision|1|||
170487756|NCT00932373|616128665|FG010|Overall Study|Physician Decision|0|||
170487757|NCT00932373|616128655|FG000|Overall Study|Dose limiting toxicity|0|||
170487758|NCT00932373|616128656|FG001|Overall Study|Dose limiting toxicity|0|||
170487759|NCT00932373|616128657|FG002|Overall Study|Dose limiting toxicity|0|||
170487760|NCT00932373|616128658|FG003|Overall Study|Dose limiting toxicity|0|||
170487761|NCT00932373|616128659|FG004|Overall Study|Dose limiting toxicity|0|||
170487762|NCT00932373|616128660|FG005|Overall Study|Dose limiting toxicity|1|||
170487763|NCT00932373|616128661|FG006|Overall Study|Dose limiting toxicity|0|||
170487764|NCT00932373|616128662|FG007|Overall Study|Dose limiting toxicity|0|||
170487765|NCT00932373|616128663|FG008|Overall Study|Dose limiting toxicity|0|||
170487766|NCT00932373|616128664|FG009|Overall Study|Dose limiting toxicity|0|||
170487767|NCT00932373|616128665|FG010|Overall Study|Dose limiting toxicity|0|||
170487768|NCT00932373|616128655|FG000|Overall Study|Withdrawal by Subject|0|||
170487769|NCT00932373|616128656|FG001|Overall Study|Withdrawal by Subject|0|||
170487770|NCT00932373|616128657|FG002|Overall Study|Withdrawal by Subject|0|||
170487771|NCT00932373|616128658|FG003|Overall Study|Withdrawal by Subject|0|||
170487772|NCT00932373|616128659|FG004|Overall Study|Withdrawal by Subject|0|||
170487773|NCT00932373|616128660|FG005|Overall Study|Withdrawal by Subject|0|||
170487774|NCT00932373|616128661|FG006|Overall Study|Withdrawal by Subject|0|||
170487775|NCT00932373|616128662|FG007|Overall Study|Withdrawal by Subject|0|||
170487776|NCT00932373|616128663|FG008|Overall Study|Withdrawal by Subject|1|||
170487777|NCT00932373|616128664|FG009|Overall Study|Withdrawal by Subject|0|||
170487778|NCT00932373|616128665|FG010|Overall Study|Withdrawal by Subject|0|||
170487779|NCT00932373|616128655|FG000|Overall Study|Clinical progression|0|||
170487780|NCT00932373|616128656|FG001|Overall Study|Clinical progression|0|||
170487781|NCT00932373|616128657|FG002|Overall Study|Clinical progression|0|||
170487782|NCT00932373|616128658|FG003|Overall Study|Clinical progression|0|||
170487783|NCT00932373|616128659|FG004|Overall Study|Clinical progression|0|||
170487784|NCT00932373|616128660|FG005|Overall Study|Clinical progression|0|||
170487785|NCT00932373|616128661|FG006|Overall Study|Clinical progression|1|||
170487786|NCT00932373|616128662|FG007|Overall Study|Clinical progression|0|||
170487787|NCT00932373|616128663|FG008|Overall Study|Clinical progression|0|||
170487788|NCT00932373|616128664|FG009|Overall Study|Clinical progression|0|||
170487789|NCT00932373|616128665|FG010|Overall Study|Clinical progression|0|||
170487790|NCT00932373|616128655|FG000|Overall Study|Lack of Efficacy|0|||
170487791|NCT00932373|616128656|FG001|Overall Study|Lack of Efficacy|0|||
170487792|NCT00932373|616128657|FG002|Overall Study|Lack of Efficacy|0|||
170487793|NCT00932373|616128658|FG003|Overall Study|Lack of Efficacy|0|||
170487794|NCT00932373|616128659|FG004|Overall Study|Lack of Efficacy|0|||
170487795|NCT00932373|616128660|FG005|Overall Study|Lack of Efficacy|0|||
170487796|NCT00932373|616128661|FG006|Overall Study|Lack of Efficacy|0|||
170487797|NCT00932373|616128662|FG007|Overall Study|Lack of Efficacy|0|||
170487798|NCT00932373|616128663|FG008|Overall Study|Lack of Efficacy|0|||
170487799|NCT00932373|616128664|FG009|Overall Study|Lack of Efficacy|1|||
170487800|NCT00932373|616128665|FG010|Overall Study|Lack of Efficacy|0|||
170487801|NCT00300885|616128668|FG000|Treatment|Adverse Event|134|||
170487802|NCT00300885|616128669|FG001|Treatment|Adverse Event|82|||
170487803|NCT00300885|616128668|FG000|Treatment|Death|20|||
170487804|NCT00300885|616128669|FG001|Treatment|Death|7|||
170487805|NCT00300885|616128668|FG000|Treatment|Lack of Efficacy|1|||
170487806|NCT00300885|616128669|FG001|Treatment|Lack of Efficacy|1|||
170549124|NCT01487161|616354791|FG000|Overall Study|Withdrawal by Subject|1|||
170549125|NCT01487161|616354792|FG001|Overall Study|Withdrawal by Subject|1|||
170487807|NCT00300885|616128668|FG000|Treatment|Lost to Follow-up|3|||
170487808|NCT00300885|616128669|FG001|Treatment|Lost to Follow-up|2|||
170487809|NCT00300885|616128668|FG000|Treatment|Physician Decision|4|||
170487810|NCT00300885|616128669|FG001|Treatment|Physician Decision|5|||
170487811|NCT00300885|616128668|FG000|Treatment|Protocol Violation|11|||
170487812|NCT00300885|616128669|FG001|Treatment|Protocol Violation|11|||
170487813|NCT00300885|616128668|FG000|Treatment|Withdrawal by Subject|26|||
170487814|NCT00300885|616128669|FG001|Treatment|Withdrawal by Subject|23|||
170487815|NCT00300885|616128668|FG000|Treatment|Disease progression|171|||
170487816|NCT00300885|616128669|FG001|Treatment|Disease progression|238|||
170487817|NCT00300885|616128668|FG000|Treatment|Random code broken (subject died)|0|||
170487818|NCT00300885|616128669|FG001|Treatment|Random code broken (subject died)|1|||
170640502|NCT01354314|616695705|FG003|Overall Study|Protocol Violation|0|||
170487819|NCT00300885|616128668|FG000|Treatment|Non-compliant with study medication|3|||
170487820|NCT00300885|616128669|FG001|Treatment|Non-compliant with study medication|4|||
170487821|NCT00300885|616128668|FG000|Follow-up|Death|141|||
170487822|NCT00300885|616128669|FG001|Follow-up|Death|163|||
170487823|NCT00300885|616128668|FG000|Follow-up|Lost to Follow-up|11|||
170487824|NCT00300885|616128669|FG001|Follow-up|Lost to Follow-up|7|||
170487825|NCT00300885|616128668|FG000|Follow-up|Withdrawal by Subject|26|||
170487826|NCT00300885|616128669|FG001|Follow-up|Withdrawal by Subject|25|||
170487827|NCT02582242|616128670|FG000|Overall Study|Adverse Event|4|||
170487828|NCT02582242|616128671|FG001|Overall Study|Adverse Event|3|||
170487829|NCT02582242|616128670|FG000|Overall Study|Protocol Violation|3|||
170487830|NCT02582242|616128671|FG001|Overall Study|Protocol Violation|1|||
170487831|NCT02582242|616128670|FG000|Overall Study|Lost to Follow-up|0|||
170487832|NCT02582242|616128671|FG001|Overall Study|Lost to Follow-up|1|||
170487833|NCT02582242|616128670|FG000|Overall Study|Withdrawal by Subject|11|||
170487834|NCT02582242|616128671|FG001|Overall Study|Withdrawal by Subject|11|||
170487835|NCT02582242|616128670|FG000|Overall Study|Unclassified|2|||
170487836|NCT02582242|616128671|FG001|Overall Study|Unclassified|1|||
170487837|NCT01637922|616128672|FG000|Overall Study|Adverse Event|0|||
170487838|NCT01637922|616128673|FG001|Overall Study|Adverse Event|1|||
170487839|NCT01637922|616128672|FG000|Overall Study|Protocol Violation|0|||
170799836|NCT02101853|617278878|FG001|Block 1 Induction|Death|0|||
170799837|NCT02101853|617278879|FG002|Block 1 Induction|Death|0|||
170487840|NCT01637922|616128673|FG001|Overall Study|Protocol Violation|1|||
170487841|NCT01637922|616128672|FG000|Overall Study|Withdrawal by Subject|0|||
170487842|NCT01637922|616128673|FG001|Overall Study|Withdrawal by Subject|3|||
170487843|NCT01637922|616128672|FG000|Overall Study|Lost to Follow-up|2|||
170487844|NCT01637922|616128673|FG001|Overall Study|Lost to Follow-up|0|||
170487845|NCT02492984|616128676|FG000|Overall Study|Adverse Event|1|||
170487846|NCT02492984|616128677|FG001|Overall Study|Adverse Event|0|||
170487847|NCT02492984|616128676|FG000|Overall Study|Protocol Violation|1|||
170487848|NCT02492984|616128677|FG001|Overall Study|Protocol Violation|0|||
170487849|NCT02492984|616128676|FG000|Overall Study|Withdrawal by Subject|1|||
170487850|NCT02492984|616128677|FG001|Overall Study|Withdrawal by Subject|0|||
170487851|NCT02101736|616128678|FG000|Overall Study|Protocol Violation|3|||
170487852|NCT02101736|616128679|FG001|Overall Study|Protocol Violation|0|||
170487853|NCT02101736|616128678|FG000|Overall Study|Withdrawal by Subject|1|||
170487854|NCT02101736|616128679|FG001|Overall Study|Withdrawal by Subject|1|||
170487855|NCT02282631|616128680|FG000|Overall Study|Lost to Follow-up|2|||
170487856|NCT02282631|616128681|FG001|Overall Study|Lost to Follow-up|0|||
170487857|NCT01515865|616128682|FG000|Part A (Open-label)|Other|3|||
170487858|NCT01515865|616128683|FG001|Part A (Open-label)|Other|0|||
170487859|NCT01515865|616128684|FG002|Part A (Open-label)|Other|0|||
170487860|NCT01515865|616128682|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
170487861|NCT01515865|616128683|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
170487862|NCT01515865|616128684|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
170487863|NCT01515865|616128682|FG000|Part B (Open-label)|Other|1|||
170487864|NCT01515865|616128683|FG001|Part B (Open-label)|Other|0|||
170487865|NCT01515865|616128684|FG002|Part B (Open-label)|Other|0|||
170487866|NCT00459290|616128685|FG000|Overall Study|Adverse Event|3|||
170799838|NCT02101853|617278880|FG003|Block 1 Induction|Death|0|||
170799839|NCT02101853|617278881|FG004|Block 1 Induction|Death|0|||
170799840|NCT02101853|617278882|FG005|Block 1 Induction|Death|0|||
170799841|NCT02101853|617278877|FG000|Block 1 Induction|Lack of Efficacy|6|||
170799842|NCT02101853|617278878|FG001|Block 1 Induction|Lack of Efficacy|0|||
170799843|NCT02101853|617278879|FG002|Block 1 Induction|Lack of Efficacy|0|||
170799844|NCT02101853|617278880|FG003|Block 1 Induction|Lack of Efficacy|0|||
170799845|NCT02101853|617278881|FG004|Block 1 Induction|Lack of Efficacy|0|||
170799846|NCT02101853|617278882|FG005|Block 1 Induction|Lack of Efficacy|0|||
170799847|NCT02101853|617278877|FG000|Block 1 Induction|Physician Decision|61|||
170799848|NCT02101853|617278878|FG001|Block 1 Induction|Physician Decision|0|||
170799849|NCT02101853|617278879|FG002|Block 1 Induction|Physician Decision|0|||
170799850|NCT02101853|617278880|FG003|Block 1 Induction|Physician Decision|0|||
170487867|NCT00459290|616128685|FG000|Overall Study|Ineligible|2|||
170487868|NCT00687271|616128686|FG000|Overall Study|Adverse Event|1|||
170487869|NCT00687271|616128687|FG001|Overall Study|Adverse Event|3|||
170799851|NCT02101853|617278881|FG004|Block 1 Induction|Physician Decision|0|||
170799852|NCT02101853|617278882|FG005|Block 1 Induction|Physician Decision|0|||
170799853|NCT02101853|617278877|FG000|Block 1 Induction|Protocol Violation|2|||
170487870|NCT00687271|616128688|FG002|Overall Study|Adverse Event|1|||
170487871|NCT00687271|616128689|FG003|Overall Study|Adverse Event|0|||
170487872|NCT00687271|616128686|FG000|Overall Study|Lost to Follow-up|0|||
170487873|NCT00687271|616128687|FG001|Overall Study|Lost to Follow-up|1|||
170487874|NCT00687271|616128688|FG002|Overall Study|Lost to Follow-up|0|||
170487875|NCT00687271|616128689|FG003|Overall Study|Lost to Follow-up|0|||
170487876|NCT00687271|616128686|FG000|Overall Study|Protocol Violation|2|||
170487877|NCT00687271|616128687|FG001|Overall Study|Protocol Violation|1|||
170799854|NCT02101853|617278878|FG001|Block 1 Induction|Protocol Violation|0|||
170799855|NCT02101853|617278879|FG002|Block 1 Induction|Protocol Violation|0|||
170799856|NCT02101853|617278880|FG003|Block 1 Induction|Protocol Violation|0|||
170487878|NCT00687271|616128688|FG002|Overall Study|Protocol Violation|1|||
170487879|NCT00687271|616128689|FG003|Overall Study|Protocol Violation|0|||
170487880|NCT00687271|616128686|FG000|Overall Study|Withdrawal by Subject|0|||
170487881|NCT00687271|616128687|FG001|Overall Study|Withdrawal by Subject|1|||
170487882|NCT00687271|616128688|FG002|Overall Study|Withdrawal by Subject|3|||
170899590|NCT00961961|617636114|FG003|Phase II|Adverse Event|1|||
170899591|NCT00961961|617636111|FG000|Phase II|Physician Decision|0|||
170899592|NCT00961961|617636112|FG001|Phase II|Physician Decision|0|||
170899593|NCT00961961|617636113|FG002|Phase II|Physician Decision|1|||
170487883|NCT00687271|616128689|FG003|Overall Study|Withdrawal by Subject|0|||
170487884|NCT02453334|616128690|FG000|Overall Study|Death|15|||
170487885|NCT02453334|616128691|FG001|Overall Study|Death|13|||
170487886|NCT02453334|616128690|FG000|Overall Study|Adverse Event|2|||
170487887|NCT02453334|616128691|FG001|Overall Study|Adverse Event|1|||
170487888|NCT02453334|616128690|FG000|Overall Study|Lost to Follow-up|5|||
170487889|NCT02453334|616128691|FG001|Overall Study|Lost to Follow-up|9|||
170487890|NCT02453334|616128690|FG000|Overall Study|Physician Decision|1|||
170487891|NCT02453334|616128691|FG001|Overall Study|Physician Decision|0|||
170487892|NCT02453334|616128690|FG000|Overall Study|Withdrawal by Subject|17|||
170487893|NCT02453334|616128691|FG001|Overall Study|Withdrawal by Subject|13|||
170487894|NCT02453334|616128690|FG000|Overall Study|Other reason|1|||
170487895|NCT02453334|616128691|FG001|Overall Study|Other reason|4|||
170487896|NCT01841762|616128692|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
170487897|NCT01841762|616128692|FG000|Treatment Period|Adverse Event|16|||
170487898|NCT01841762|616128692|FG000|Treatment Period|Death|1|||
170487899|NCT01841762|616128692|FG000|Treatment Period|Withdrawal by Subject|7|||
170487900|NCT01841762|616128692|FG000|Treatment Period|Lost to Follow-up|1|||
170487901|NCT01841762|616128692|FG000|Treatment Period|Physician Decision|2|||
170899594|NCT00961961|617636114|FG003|Phase II|Physician Decision|0|||
170899595|NCT00961961|617636111|FG000|Phase II|Withdrawal by Subject|0|||
170899596|NCT00961961|617636112|FG001|Phase II|Withdrawal by Subject|0|||
170899597|NCT00961961|617636113|FG002|Phase II|Withdrawal by Subject|1|||
170899598|NCT00961961|617636114|FG003|Phase II|Withdrawal by Subject|0|||
170899599|NCT01551745|617636115|FG000|Overall Study|Withdrawal by Subject|1|||
170899600|NCT01551745|617636115|FG000|Overall Study|Disease Progression|2|||
170899601|NCT01813890|617636116|FG000|Overall Study|Adverse Event|0|||
170899602|NCT01813890|617636117|FG001|Overall Study|Adverse Event|3|||
170487902|NCT01841762|616128692|FG000|Treatment Period|Other, including non-compliance|5|||
170487903|NCT01841762|616128692|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
170487904|NCT01841762|616128692|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
170487905|NCT01841762|616128692|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
170487906|NCT01841762|616128692|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
170487907|NCT02693106|616128694|FG000|Overall Study|No time|3|||
170487908|NCT03981900|616128695|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
170487909|NCT03981900|616128695|FG000|Overall Study|Adverse Event|5|||
170487910|NCT03981900|616128695|FG000|Overall Study|Protocol Violation|1|||
170487911|NCT03981900|616128695|FG000|Overall Study|Withdrawal by Subject|7|||
170487912|NCT03981900|616128695|FG000|Overall Study|Lost to Follow-up|46|||
170487913|NCT03981900|616128695|FG000|Overall Study|Decision of the researcher|3|||
170487914|NCT03981900|616128695|FG000|Overall Study|Death|3|||
170487915|NCT03981900|616128695|FG000|Overall Study|Other|5|||
170487916|NCT06152224|616128704|FG000|Overall Study|Withdrawal by Subject|1|||
170487917|NCT06152224|616128705|FG001|Overall Study|Withdrawal by Subject|0|||
170487918|NCT06152224|616128704|FG000|Overall Study|Lost to Follow-up|0|||
170487919|NCT06152224|616128705|FG001|Overall Study|Lost to Follow-up|1|||
170487920|NCT06152224|616128704|FG000|Overall Study|On Follow Up|18|||
170487921|NCT06152224|616128705|FG001|Overall Study|On Follow Up|18|||
170487922|NCT01790984|616128706|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
170487923|NCT01790984|616128707|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
170487924|NCT01790984|616128708|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
170487925|NCT01790984|616128709|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
170487926|NCT01346696|616128711|FG000|Overall Study|Death|1|||
170487927|NCT01051791|616128717|FG000|Overall Study|Failed screening|3|||
170487928|NCT01051791|616128717|FG000|Overall Study|Withdrawal by Subject|1|||
170487929|NCT03337113|616128726|FG000|Overall Study|Adverse Event|1|||
170549126|NCT01487161|616354793|FG002|Overall Study|Withdrawal by Subject|1|||
170549127|NCT01487161|616354794|FG003|Overall Study|Withdrawal by Subject|2|||
170899603|NCT01813890|617636118|FG002|Overall Study|Adverse Event|4|||
170899604|NCT01813890|617636116|FG000|Overall Study|Lack of Efficacy|9|||
170487930|NCT03337113|616128727|FG001|Overall Study|Adverse Event|1|||
170487931|NCT03337113|616128728|FG002|Overall Study|Adverse Event|0|||
170487932|NCT03337113|616128729|FG003|Overall Study|Adverse Event|1|||
170487933|NCT03337113|616128726|FG000|Overall Study|Physician Decision|0|||
170487934|NCT03337113|616128727|FG001|Overall Study|Physician Decision|2|||
170487935|NCT03337113|616128728|FG002|Overall Study|Physician Decision|0|||
170487936|NCT03337113|616128729|FG003|Overall Study|Physician Decision|1|||
170487937|NCT03337113|616128726|FG000|Overall Study|Withdrawal by Subject|0|||
170487938|NCT03337113|616128727|FG001|Overall Study|Withdrawal by Subject|0|||
170487939|NCT03337113|616128728|FG002|Overall Study|Withdrawal by Subject|1|||
170487940|NCT03337113|616128729|FG003|Overall Study|Withdrawal by Subject|0|||
170487941|NCT00507455|616128740|FG000|Overall Study|Adverse Event|3|||
170487942|NCT00507455|616128741|FG001|Overall Study|Adverse Event|3|||
170487943|NCT00507455|616128742|FG002|Overall Study|Adverse Event|6|||
170487944|NCT00507455|616128740|FG000|Overall Study|Withdrawal by Subject|2|||
170487945|NCT00507455|616128741|FG001|Overall Study|Withdrawal by Subject|1|||
170487946|NCT00507455|616128742|FG002|Overall Study|Withdrawal by Subject|2|||
170487947|NCT00507455|616128740|FG000|Overall Study|Protocol Violation|4|||
170487948|NCT00507455|616128741|FG001|Overall Study|Protocol Violation|1|||
170487949|NCT00507455|616128742|FG002|Overall Study|Protocol Violation|1|||
170487950|NCT00507455|616128740|FG000|Overall Study|Lost to Follow-up|2|||
170487951|NCT00507455|616128741|FG001|Overall Study|Lost to Follow-up|0|||
170487952|NCT00507455|616128742|FG002|Overall Study|Lost to Follow-up|2|||
170487953|NCT00507455|616128740|FG000|Overall Study|Lack of Efficacy|0|||
170487954|NCT00507455|616128741|FG001|Overall Study|Lack of Efficacy|1|||
170487955|NCT00507455|616128742|FG002|Overall Study|Lack of Efficacy|0|||
170487956|NCT00507455|616128740|FG000|Overall Study|Other - miscellaneous reason|1|||
170487957|NCT00507455|616128741|FG001|Overall Study|Other - miscellaneous reason|0|||
170487958|NCT00507455|616128742|FG002|Overall Study|Other - miscellaneous reason|1|||
170487959|NCT02176655|616128743|FG000|Overall Study|Subjects did not treat|6|||
170487960|NCT01372995|616128744|FG000|Overall Study|Spouse withdrew participant from study|0|||
170487961|NCT01372995|616128745|FG001|Overall Study|Spouse withdrew participant from study|1|||
170487962|NCT01372995|616128746|FG002|Overall Study|Spouse withdrew participant from study|0|||
170487963|NCT01372995|616128744|FG000|Overall Study|Physician Decision|0|||
170487964|NCT01372995|616128745|FG001|Overall Study|Physician Decision|0|||
170487965|NCT01372995|616128746|FG002|Overall Study|Physician Decision|1|||
170487966|NCT06110494|616128754|FG000|Overall Study|Protocol Violation|2|||
170487967|NCT06110494|616128755|FG001|Overall Study|Protocol Violation|0|||
170487968|NCT06110494|616128756|FG002|Overall Study|Protocol Violation|1|||
170487969|NCT06110494|616128754|FG000|Overall Study|Dixon's test for outlier analysis|1|||
170487970|NCT06110494|616128755|FG001|Overall Study|Dixon's test for outlier analysis|1|||
170487971|NCT06110494|616128756|FG002|Overall Study|Dixon's test for outlier analysis|0|||
170487972|NCT00105079|616128757|FG000|Overall Study|Adverse Event|5|||
170487973|NCT00105079|616128758|FG001|Overall Study|Adverse Event|12|||
170487974|NCT00105079|616128757|FG000|Overall Study|Death|3|||
170487975|NCT00105079|616128758|FG001|Overall Study|Death|1|||
170487976|NCT00105079|616128757|FG000|Overall Study|Lost to Follow-up|12|||
170487977|NCT00105079|616128758|FG001|Overall Study|Lost to Follow-up|12|||
170487978|NCT00105079|616128757|FG000|Overall Study|Lack of Efficacy|9|||
170487979|NCT00105079|616128758|FG001|Overall Study|Lack of Efficacy|3|||
170487980|NCT00105079|616128757|FG000|Overall Study|Refused treatment|6|||
170487981|NCT00105079|616128758|FG001|Overall Study|Refused treatment|4|||
170487982|NCT00105079|616128757|FG000|Overall Study|Violation of selection criteria at entry|0|||
170487983|NCT00105079|616128758|FG001|Overall Study|Violation of selection criteria at entry|2|||
170487984|NCT00105079|616128757|FG000|Overall Study|Protocol Violation|1|||
170487985|NCT00105079|616128758|FG001|Overall Study|Protocol Violation|0|||
170487986|NCT00105079|616128757|FG000|Overall Study|Other|3|||
170487987|NCT00105079|616128758|FG001|Overall Study|Other|1|||
170487988|NCT01464593|616128761|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
170487989|NCT01297517|616128764|FG000|Overall Study|Adverse Event|21|||
170487990|NCT01297517|616128765|FG001|Overall Study|Adverse Event|7|||
170487991|NCT01297517|616128766|FG002|Overall Study|Adverse Event|16|||
170487992|NCT01297517|616128764|FG000|Overall Study|Lost to Follow-up|1|||
170487993|NCT01297517|616128765|FG001|Overall Study|Lost to Follow-up|0|||
170487994|NCT01297517|616128766|FG002|Overall Study|Lost to Follow-up|1|||
170487995|NCT01297517|616128764|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
170899605|NCT01813890|617636117|FG001|Overall Study|Lack of Efficacy|1|||
170899606|NCT01813890|617636118|FG002|Overall Study|Lack of Efficacy|2|||
170899607|NCT03049449|617637698|FG000|Overall Study|Did not receive treatment.|0|||
170899608|NCT03049449|617637699|FG001|Overall Study|Did not receive treatment.|0|||
170899609|NCT03049449|617637700|FG002|Overall Study|Did not receive treatment.|0|||
170899610|NCT03049449|617637701|FG003|Overall Study|Did not receive treatment.|0|||
170487996|NCT01297517|616128765|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
170487997|NCT01297517|616128766|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
170487998|NCT01297517|616128764|FG000|Overall Study|Noncompliance|1|||
170487999|NCT01297517|616128765|FG001|Overall Study|Noncompliance|0|||
170488000|NCT01297517|616128766|FG002|Overall Study|Noncompliance|0|||
170488001|NCT01297517|616128764|FG000|Overall Study|Protocol Violation|1|||
170488002|NCT01297517|616128765|FG001|Overall Study|Protocol Violation|1|||
170488003|NCT01297517|616128766|FG002|Overall Study|Protocol Violation|1|||
170899611|NCT03049449|617637702|FG004|Overall Study|Did not receive treatment.|0|||
170488004|NCT01297517|616128764|FG000|Overall Study|Inadequate Control of IOP|1|||
170488005|NCT01297517|616128765|FG001|Overall Study|Inadequate Control of IOP|1|||
170899612|NCT03049449|617637703|FG005|Overall Study|Did not receive treatment.|0|||
170899613|NCT03049449|617637704|FG006|Overall Study|Did not receive treatment.|0|||
170799857|NCT02101853|617278881|FG004|Block 1 Induction|Protocol Violation|0|||
170799858|NCT02101853|617278882|FG005|Block 1 Induction|Protocol Violation|0|||
170488006|NCT01297517|616128766|FG002|Overall Study|Inadequate Control of IOP|2|||
170488007|NCT02490371|616128767|FG000|Overall Study|Lost to Follow-up|1|||
170488008|NCT02490371|616128768|FG001|Overall Study|Lost to Follow-up|1|||
170488009|NCT02914613|616128769|FG000|Overall Study|Withdrawal by Subject|1|||
170488010|NCT02914613|616128770|FG001|Overall Study|Withdrawal by Subject|2|||
170488011|NCT02914613|616128769|FG000|Overall Study|Adverse Event|1|||
170488012|NCT02914613|616128770|FG001|Overall Study|Adverse Event|0|||
170488013|NCT04938180|616128771|FG000|Overall Study|Adverse Event|1|||
170488014|NCT02527434|616128772|FG000|Overall Study|Lost to Follow-up|2|||
170488015|NCT02527434|616128773|FG001|Overall Study|Lost to Follow-up|2|||
170488016|NCT02527434|616128774|FG002|Overall Study|Lost to Follow-up|0|||
170488017|NCT02527434|616128772|FG000|Overall Study|Death|19|||
170488018|NCT02527434|616128773|FG001|Overall Study|Death|6|||
170488019|NCT02527434|616128774|FG002|Overall Study|Death|17|||
170488020|NCT02527434|616128772|FG000|Overall Study|Withdrawal by Subject|5|||
170488021|NCT02527434|616128773|FG001|Overall Study|Withdrawal by Subject|3|||
170488022|NCT02527434|616128774|FG002|Overall Study|Withdrawal by Subject|3|||
170488023|NCT02527434|616128772|FG000|Overall Study|Reason Not Specified|1|||
170488024|NCT02527434|616128773|FG001|Overall Study|Reason Not Specified|0|||
170488025|NCT02527434|616128774|FG002|Overall Study|Reason Not Specified|0|||
170488026|NCT02527434|616128772|FG000|Overall Study|Site closure|1|||
170488027|NCT02527434|616128773|FG001|Overall Study|Site closure|0|||
170488028|NCT02527434|616128774|FG002|Overall Study|Site closure|0|||
170488029|NCT01760655|616130774|FG000|Overall Study|Death|18|||
170488030|NCT01760655|616130774|FG000|Overall Study|Physician Decision|1|||
170488031|NCT03056638|616130784|FG000|Overall Study|Death|1|||
170488032|NCT03056638|616130785|FG001|Overall Study|Death|0|||
170488033|NCT02530125|616130786|FG000|Completed Treatment|Early termination of study|1|||
170488034|NCT02530125|616130786|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
170488035|NCT00468481|616130787|FG000|Overall Study|Adverse Event|13|||
170488036|NCT00468481|616130788|FG001|Overall Study|Adverse Event|3|||
170488037|NCT00468481|616130787|FG000|Overall Study|Lost to Follow-up|25|||
170488038|NCT00468481|616130788|FG001|Overall Study|Lost to Follow-up|8|||
170488039|NCT00468481|616130787|FG000|Overall Study|Pregnancy|2|||
170488040|NCT00468481|616130788|FG001|Overall Study|Pregnancy|0|||
170488041|NCT00468481|616130787|FG000|Overall Study|Protocol Violation|18|||
170488042|NCT00468481|616130788|FG001|Overall Study|Protocol Violation|8|||
170488043|NCT00468481|616130787|FG000|Overall Study|Withdrawal by Subject|12|||
170488044|NCT00468481|616130788|FG001|Overall Study|Withdrawal by Subject|3|||
170488045|NCT00468481|616130787|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
170488046|NCT00468481|616130788|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
170488047|NCT00468481|616130787|FG000|Overall Study|Prohibited Medication|1|||
170488048|NCT00468481|616130788|FG001|Overall Study|Prohibited Medication|1|||
170488049|NCT00468481|616130787|FG000|Overall Study|Egg Donor|1|||
170488050|NCT00468481|616130788|FG001|Overall Study|Egg Donor|0|||
170488051|NCT00468481|616130787|FG000|Overall Study|Moved out of area|4|||
170488052|NCT00468481|616130788|FG001|Overall Study|Moved out of area|1|||
170488053|NCT00468481|616130787|FG000|Overall Study|Non-Compliance|5|||
170488054|NCT00468481|616130788|FG001|Overall Study|Non-Compliance|0|||
170488055|NCT00468481|616130787|FG000|Overall Study|Other|6|||
170488056|NCT00468481|616130788|FG001|Overall Study|Other|0|||
170799859|NCT02101853|617278877|FG000|Block 1 Induction|Withdrawal by Subject|65|||
170799860|NCT02101853|617278878|FG001|Block 1 Induction|Withdrawal by Subject|0|||
170799861|NCT02101853|617278879|FG002|Block 1 Induction|Withdrawal by Subject|0|||
170799862|NCT02101853|617278880|FG003|Block 1 Induction|Withdrawal by Subject|0|||
170799863|NCT02101853|617278881|FG004|Block 1 Induction|Withdrawal by Subject|0|||
170799864|NCT02101853|617278882|FG005|Block 1 Induction|Withdrawal by Subject|0|||
170799865|NCT02101853|617278877|FG000|Block 1 Induction|Ineligible|8|||
170799866|NCT02101853|617278878|FG001|Block 1 Induction|Ineligible|0|||
170799867|NCT02101853|617278879|FG002|Block 1 Induction|Ineligible|0|||
170799868|NCT02101853|617278880|FG003|Block 1 Induction|Ineligible|0|||
170488057|NCT00078767|616130789|FG000|Overall Study|Withdrawal by Subject|1|||
170488058|NCT00078767|616130790|FG001|Overall Study|Withdrawal by Subject|1|||
170488059|NCT00728468|616130791|FG000|Overall Study|Enrolled but not treated|1|||
170488060|NCT00728468|616130791|FG000|Overall Study|Death|1|||
170488061|NCT00728468|616130791|FG000|Overall Study|Protocol Violation|4|||
170488062|NCT00728468|616130791|FG000|Overall Study|Objective progression or relapse|9|||
170488063|NCT00728468|616130791|FG000|Overall Study|Study terminated by sponsor|1|||
170488064|NCT00596687|616130792|FG000|Overall Study|< 24 hours of insulin treatment|8|||
170488065|NCT00596687|616130793|FG001|Overall Study|< 24 hours of insulin treatment|6|||
170488066|NCT00596687|616130792|FG000|Overall Study|continuous insulin infusion during TPN|2|||
170488067|NCT00596687|616130793|FG001|Overall Study|continuous insulin infusion during TPN|1|||
170488068|NCT00596687|616130792|FG000|Overall Study|Withdrawal by Subject|3|||
170488069|NCT00596687|616130793|FG001|Overall Study|Withdrawal by Subject|1|||
170799869|NCT02101853|617278881|FG004|Block 1 Induction|Ineligible|0|||
170799870|NCT02101853|617278882|FG005|Block 1 Induction|Ineligible|0|||
170488070|NCT00596687|616130792|FG000|Overall Study|cancelled surgery|1|||
170488071|NCT00596687|616130793|FG001|Overall Study|cancelled surgery|1|||
170488072|NCT06098339|616130794|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
170488073|NCT06098339|616130795|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
170488074|NCT06098339|616130794|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
170488075|NCT06098339|616130795|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
170488076|NCT03831113|616130796|FG000|Overall Study|Withdrawal by Subject|0|||
170488077|NCT03831113|616130797|FG001|Overall Study|Withdrawal by Subject|2|||
170488078|NCT03831113|616130796|FG000|Overall Study|Protocol Violation|0|||
170488079|NCT03831113|616130797|FG001|Overall Study|Protocol Violation|9|||
170488080|NCT03508726|616130798|FG000|Overall Study|Withdrawal by Subject|0|||
170488081|NCT03508726|616130799|FG001|Overall Study|Withdrawal by Subject|1|||
170488082|NCT05656534|616130800|FG000|Overall Study|Withdrawal by Subject|1|||
170488083|NCT05656534|616130801|FG001|Overall Study|Withdrawal by Subject|1|||
170488084|NCT05656534|616130802|FG002|Overall Study|Withdrawal by Subject|0|||
170488085|NCT05656534|616130803|FG003|Overall Study|Withdrawal by Subject|0|||
170488086|NCT05656534|616130800|FG000|Overall Study|Physician Decision|1|||
170488087|NCT05656534|616130801|FG001|Overall Study|Physician Decision|1|||
170488088|NCT05656534|616130802|FG002|Overall Study|Physician Decision|0|||
170488089|NCT05656534|616130803|FG003|Overall Study|Physician Decision|0|||
170488090|NCT05625802|616130804|FG000|Overall Study|Lost to Follow-up|1|||
170488091|NCT05625802|616130805|FG001|Overall Study|Lost to Follow-up|0|||
170488092|NCT04090060|616130815|FG000|Overall Study|Lost to Follow-up|76|||
170488093|NCT04090060|616130816|FG001|Overall Study|Lost to Follow-up|77|||
170488094|NCT01164579|616130817|FG000|Overall Study|Lack of Efficacy|0|||
170488095|NCT01164579|616130818|FG001|Overall Study|Lack of Efficacy|0|||
170488096|NCT01164579|616130819|FG002|Overall Study|Lack of Efficacy|6|||
170488097|NCT01164579|616130817|FG000|Overall Study|Lost to Follow-up|1|||
170488098|NCT01164579|616130818|FG001|Overall Study|Lost to Follow-up|1|||
170488099|NCT01164579|616130819|FG002|Overall Study|Lost to Follow-up|0|||
170488100|NCT01164579|616130817|FG000|Overall Study|Withdrawal by Subject|2|||
170488101|NCT01164579|616130818|FG001|Overall Study|Withdrawal by Subject|5|||
170488102|NCT01164579|616130819|FG002|Overall Study|Withdrawal by Subject|3|||
170488103|NCT01164579|616130817|FG000|Overall Study|Protocol Violation|0|||
170488104|NCT01164579|616130818|FG001|Overall Study|Protocol Violation|1|||
170488105|NCT01164579|616130819|FG002|Overall Study|Protocol Violation|2|||
170488106|NCT01164579|616130817|FG000|Overall Study|Adverse Event|4|||
170488107|NCT01164579|616130818|FG001|Overall Study|Adverse Event|2|||
170488108|NCT01164579|616130819|FG002|Overall Study|Adverse Event|5|||
170488109|NCT01164579|616130817|FG000|Overall Study|Reason not specified|1|||
170488110|NCT01164579|616130818|FG001|Overall Study|Reason not specified|0|||
170488111|NCT01164579|616130819|FG002|Overall Study|Reason not specified|0|||
170640503|NCT01354314|616695702|FG000|Overall Study|Less than 90% Adherence|4|||
170640504|NCT01354314|616695703|FG001|Overall Study|Less than 90% Adherence|2|||
170640505|NCT01354314|616695704|FG002|Overall Study|Less than 90% Adherence|6|||
170640506|NCT01354314|616695705|FG003|Overall Study|Less than 90% Adherence|4|||
170640507|NCT00369265|616695706|FG000|Overall Study|Study terminated|4|||
170640508|NCT00369265|616695707|FG001|Overall Study|Study terminated|7|||
170799871|NCT02101853|617278877|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
170799872|NCT02101853|617278878|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
170799873|NCT02101853|617278879|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
170488112|NCT00386360|616130826|FG000|Overall Study|Adverse Event|4|||
170488113|NCT00386360|616130827|FG001|Overall Study|Adverse Event|2|||
170488114|NCT00386360|616130826|FG000|Overall Study|Physician Decision|2|||
170488115|NCT00386360|616130827|FG001|Overall Study|Physician Decision|2|||
170488116|NCT00386360|616130826|FG000|Overall Study|Lost to Follow-up|0|||
170488117|NCT00386360|616130827|FG001|Overall Study|Lost to Follow-up|2|||
170799874|NCT02101853|617278880|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
170799875|NCT02101853|617278881|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
170488118|NCT00386360|616130826|FG000|Overall Study|Protocol Violation|0|||
170488119|NCT00386360|616130827|FG001|Overall Study|Protocol Violation|3|||
170488120|NCT00386360|616130826|FG000|Overall Study|Withdrawal by Subject|3|||
170488121|NCT00386360|616130827|FG001|Overall Study|Withdrawal by Subject|6|||
170488122|NCT00386360|616130826|FG000|Overall Study|Did not take any study medication|0|||
170488123|NCT00386360|616130827|FG001|Overall Study|Did not take any study medication|2|||
170488124|NCT01718535|616130828|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
170488125|NCT01718535|616130829|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
170488126|NCT01718535|616130830|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
170640509|NCT02598583|616695713|FG000|Extension Period|Withdrawal by Subject|1|||
170640510|NCT02598583|616695714|FG001|Extension Period|Withdrawal by Subject|0|||
170640511|NCT00452361|616695715|FG000|Overall Study|Adverse Event|8|||
170488127|NCT01718535|616130831|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
170488128|NCT01718535|616130832|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
170488129|NCT01718535|616130833|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
170488130|NCT01718535|616130834|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
170488131|NCT01718535|616130835|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
170488132|NCT01718535|616130836|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
170488133|NCT01718535|616130837|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
170488134|NCT01163851|616130840|FG000|Overall Study|Site Closure|0|||
170488135|NCT01163851|616130841|FG001|Overall Study|Site Closure|1|||
170488136|NCT01163851|616130840|FG000|Overall Study|Enrolled but not treated|1|||
170488137|NCT01163851|616130841|FG001|Overall Study|Enrolled but not treated|0|||
170488138|NCT00789373|616130842|FG000|Induction|Adverse Event|64|||
170488139|NCT00789373|616130843|FG001|Induction|Adverse Event|0|||
170488140|NCT00789373|616130844|FG002|Induction|Adverse Event|0|||
170488141|NCT00789373|616130842|FG000|Induction|Death Due to study disease|24|||
170488142|NCT00789373|616130843|FG001|Induction|Death Due to study disease|0|||
170488143|NCT00789373|616130844|FG002|Induction|Death Due to study disease|0|||
170488144|NCT00789373|616130842|FG000|Induction|Death due to adverse event|19|||
170488145|NCT00789373|616130843|FG001|Induction|Death due to adverse event|0|||
170488146|NCT00789373|616130844|FG002|Induction|Death due to adverse event|0|||
170488147|NCT00789373|616130842|FG000|Induction|Death due to toxicity|11|||
170488148|NCT00789373|616130843|FG001|Induction|Death due to toxicity|0|||
170488149|NCT00789373|616130844|FG002|Induction|Death due to toxicity|0|||
170488150|NCT00789373|616130842|FG000|Induction|Death due to procedure|1|||
170488151|NCT00789373|616130843|FG001|Induction|Death due to procedure|0|||
170488152|NCT00789373|616130844|FG002|Induction|Death due to procedure|0|||
170488153|NCT00789373|616130842|FG000|Induction|Investigator decision|7|||
170488154|NCT00789373|616130843|FG001|Induction|Investigator decision|0|||
170488155|NCT00789373|616130844|FG002|Induction|Investigator decision|0|||
170488156|NCT00789373|616130842|FG000|Induction|Protocol entry criteria not met|9|||
170488157|NCT00789373|616130843|FG001|Induction|Protocol entry criteria not met|0|||
170488158|NCT00789373|616130844|FG002|Induction|Protocol entry criteria not met|0|||
170488159|NCT00789373|616130842|FG000|Induction|Lost to Follow-up|6|||
170488160|NCT00789373|616130843|FG001|Induction|Lost to Follow-up|0|||
170488161|NCT00789373|616130844|FG002|Induction|Lost to Follow-up|0|||
170488162|NCT00789373|616130842|FG000|Induction|Protocol Violation|1|||
170488163|NCT00789373|616130843|FG001|Induction|Protocol Violation|0|||
170488164|NCT00789373|616130844|FG002|Induction|Protocol Violation|0|||
170488165|NCT00789373|616130842|FG000|Induction|Progressive Disease|220|||
170488166|NCT00789373|616130843|FG001|Induction|Progressive Disease|0|||
170488167|NCT00789373|616130844|FG002|Induction|Progressive Disease|0|||
170488168|NCT00789373|616130842|FG000|Induction|Withdrawal by Subject|37|||
170488169|NCT00789373|616130843|FG001|Induction|Withdrawal by Subject|0|||
170488170|NCT00789373|616130844|FG002|Induction|Withdrawal by Subject|0|||
170488171|NCT00789373|616130842|FG000|Maintenance|Adverse Event|0|||
170488172|NCT00789373|616130843|FG001|Maintenance|Adverse Event|65|||
170488173|NCT00789373|616130844|FG002|Maintenance|Adverse Event|12|||
170488174|NCT00789373|616130842|FG000|Maintenance|Death due to study disease|0|||
170488175|NCT00789373|616130843|FG001|Maintenance|Death due to study disease|3|||
170488176|NCT00789373|616130844|FG002|Maintenance|Death due to study disease|1|||
170488177|NCT00789373|616130842|FG000|Maintenance|Death due to adverse event|0|||
170488178|NCT00789373|616130843|FG001|Maintenance|Death due to adverse event|4|||
170488179|NCT00789373|616130844|FG002|Maintenance|Death due to adverse event|1|||
170488180|NCT00789373|616130842|FG000|Maintenance|Death due to toxicity|0|||
170488181|NCT00789373|616130843|FG001|Maintenance|Death due to toxicity|1|||
170488182|NCT00789373|616130844|FG002|Maintenance|Death due to toxicity|2|||
170488183|NCT00789373|616130842|FG000|Maintenance|Investigator Decision|0|||
170488184|NCT00789373|616130843|FG001|Maintenance|Investigator Decision|4|||
170488185|NCT00789373|616130844|FG002|Maintenance|Investigator Decision|2|||
170488186|NCT00789373|616130842|FG000|Maintenance|Protocol entry criteria not met|0|||
170799876|NCT02101853|617278882|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
170799877|NCT02101853|617278877|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
170799878|NCT02101853|617278878|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170799879|NCT02101853|617278879|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170488187|NCT00789373|616130843|FG001|Maintenance|Protocol entry criteria not met|2|||
170488188|NCT00789373|616130844|FG002|Maintenance|Protocol entry criteria not met|0|||
170488189|NCT00789373|616130842|FG000|Maintenance|Lost to Follow-up|0|||
170488190|NCT00789373|616130843|FG001|Maintenance|Lost to Follow-up|2|||
170488191|NCT00789373|616130844|FG002|Maintenance|Lost to Follow-up|0|||
170799880|NCT02101853|617278880|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170488192|NCT00789373|616130842|FG000|Maintenance|Progressive Disease|0|||
170488193|NCT00789373|616130843|FG001|Maintenance|Progressive Disease|253|||
170488194|NCT00789373|616130844|FG002|Maintenance|Progressive Disease|152|||
170488195|NCT00789373|616130842|FG000|Maintenance|Withdrawal by Subject|0|||
170488196|NCT00789373|616130843|FG001|Maintenance|Withdrawal by Subject|21|||
170488197|NCT00789373|616130844|FG002|Maintenance|Withdrawal by Subject|8|||
170488198|NCT00789373|616130842|FG000|Maintenance|Sponsor Decision|0|||
170488199|NCT00789373|616130843|FG001|Maintenance|Sponsor Decision|0|||
170488200|NCT00789373|616130844|FG002|Maintenance|Sponsor Decision|2|||
170488201|NCT00789373|616130842|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
170488202|NCT00789373|616130843|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
170488203|NCT00789373|616130844|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
170488204|NCT01737710|616130849|FG000|Overall Study|Lost to Follow-up|0|||
170488205|NCT01737710|616130850|FG001|Overall Study|Lost to Follow-up|2|||
170488206|NCT01737710|616130851|FG002|Overall Study|Lost to Follow-up|2|||
170488207|NCT01737710|616130852|FG003|Overall Study|Lost to Follow-up|0|||
170488208|NCT01737710|616130853|FG004|Overall Study|Lost to Follow-up|0|||
170488209|NCT01737710|616130849|FG000|Overall Study|Withdrawal by Subject|1|||
170488210|NCT01737710|616130850|FG001|Overall Study|Withdrawal by Subject|1|||
170488211|NCT01737710|616130851|FG002|Overall Study|Withdrawal by Subject|1|||
170488212|NCT01737710|616130852|FG003|Overall Study|Withdrawal by Subject|0|||
170488213|NCT01737710|616130853|FG004|Overall Study|Withdrawal by Subject|0|||
170488214|NCT01737710|616130849|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
170488215|NCT01737710|616130850|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
170488216|NCT01737710|616130851|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
170488217|NCT01737710|616130852|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
170488218|NCT01737710|616130853|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
170488219|NCT00402688|616130859|FG000|Overall Study|Adverse Event|12|||
170488220|NCT00402688|616130860|FG001|Overall Study|Adverse Event|9|||
170488221|NCT00402688|616130861|FG002|Overall Study|Adverse Event|3|||
170488222|NCT00402688|616130859|FG000|Overall Study|Withdrawal by Subject|3|||
170488223|NCT00402688|616130860|FG001|Overall Study|Withdrawal by Subject|1|||
170488224|NCT00402688|616130861|FG002|Overall Study|Withdrawal by Subject|1|||
170549128|NCT01487161|616354791|FG000|Overall Study|missing data|0|||
170549129|NCT01487161|616354792|FG001|Overall Study|missing data|1|||
170549130|NCT01487161|616354793|FG002|Overall Study|missing data|0|||
170549131|NCT01487161|616354794|FG003|Overall Study|missing data|0|||
170549132|NCT01084135|616354795|FG000|20 Week|Physician Decision|0|||
170549133|NCT01084135|616354796|FG001|20 Week|Physician Decision|1|||
170549134|NCT02366130|616354797|FG000|Overall Study|Withdrawal by Subject|3|||
170549135|NCT02366130|616354797|FG000|Overall Study|Ineligible|6|||
170549136|NCT01065766|616354798|FG000|Overall Study|Assessed before the contracted date|1|||
170549137|NCT01065766|616354798|FG000|Overall Study|Contraindication to administration|6|||
170549138|NCT01065766|616354798|FG000|Overall Study|Violated dosage/administration|25|||
170549139|NCT01608308|616354800|FG000|Overall Study|pretreatment medical and billing reasons|0|||
170549140|NCT01608308|616354801|FG001|Overall Study|pretreatment medical and billing reasons|2|||
170549141|NCT03113136|616354802|FG000|Overall Study|Lost to Follow-up|22|||
170549142|NCT03113136|616354803|FG001|Overall Study|Lost to Follow-up|47|||
170549143|NCT03113136|616354804|FG002|Overall Study|Lost to Follow-up|54|||
170549144|NCT03113136|616354802|FG000|Overall Study|Withdrawal by Subject|4|||
170549145|NCT03113136|616354803|FG001|Overall Study|Withdrawal by Subject|13|||
170549146|NCT03113136|616354804|FG002|Overall Study|Withdrawal by Subject|14|||
170549147|NCT03113136|616354802|FG000|Overall Study|Ineligible|0|||
170549148|NCT03113136|616354803|FG001|Overall Study|Ineligible|2|||
170549149|NCT03113136|616354804|FG002|Overall Study|Ineligible|1|||
170549150|NCT03113136|616354802|FG000|Overall Study|Study Team Decision|1|||
170549151|NCT03113136|616354803|FG001|Overall Study|Study Team Decision|4|||
170549152|NCT03113136|616354804|FG002|Overall Study|Study Team Decision|0|||
170549153|NCT02675452|616354805|FG000|Overall Study|Sponsor decision|0|||
170549154|NCT02675452|616354806|FG001|Overall Study|Sponsor decision|0|||
170549155|NCT02675452|616354807|FG002|Overall Study|Sponsor decision|0|||
170549156|NCT02675452|616354808|FG003|Overall Study|Sponsor decision|0|||
170549157|NCT02675452|616354809|FG004|Overall Study|Sponsor decision|0|||
170549158|NCT02675452|616354810|FG005|Overall Study|Sponsor decision|0|||
170549159|NCT02675452|616354811|FG006|Overall Study|Sponsor decision|0|||
170799881|NCT02101853|617278881|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170799882|NCT02101853|617278882|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170799883|NCT02101853|617278877|FG000|Post Induction Randomization|Adverse Event|0|||
170799884|NCT02101853|617278878|FG001|Post Induction Randomization|Adverse Event|3|||
170799885|NCT02101853|617278879|FG002|Post Induction Randomization|Adverse Event|8|||
170799886|NCT02101853|617278880|FG003|Post Induction Randomization|Adverse Event|4|||
170488225|NCT00402688|616130859|FG000|Overall Study|Physician Decision|0|||
170488226|NCT00402688|616130860|FG001|Overall Study|Physician Decision|0|||
170488227|NCT00402688|616130861|FG002|Overall Study|Physician Decision|1|||
170549160|NCT02675452|616354812|FG007|Overall Study|Sponsor decision|0|||
170488228|NCT00402688|616130859|FG000|Overall Study|Lack of Efficacy|4|||
170488229|NCT00402688|616130860|FG001|Overall Study|Lack of Efficacy|4|||
170488230|NCT00402688|616130861|FG002|Overall Study|Lack of Efficacy|5|||
170549161|NCT02675452|616354813|FG008|Overall Study|Sponsor decision|0|||
170549162|NCT02675452|616354814|FG009|Overall Study|Sponsor decision|1|||
170549163|NCT02675452|616354815|FG010|Overall Study|Sponsor decision|0|||
170549164|NCT02675452|616354816|FG011|Overall Study|Sponsor decision|0|||
170488231|NCT00402688|616130859|FG000|Overall Study|Protocol Violation|1|||
170488232|NCT00402688|616130860|FG001|Overall Study|Protocol Violation|1|||
170488233|NCT00402688|616130861|FG002|Overall Study|Protocol Violation|1|||
170488234|NCT00402688|616130859|FG000|Overall Study|Lost to Follow-up|1|||
170488235|NCT00402688|616130860|FG001|Overall Study|Lost to Follow-up|0|||
170488236|NCT00402688|616130861|FG002|Overall Study|Lost to Follow-up|2|||
170488237|NCT00402688|616130859|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
170488238|NCT00402688|616130860|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
170488239|NCT00402688|616130861|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
170488240|NCT00402688|616130859|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
170640512|NCT00452361|616695716|FG001|Overall Study|Adverse Event|0|||
170640513|NCT00452361|616695715|FG000|Overall Study|Withdrawal by Subject|0|||
170640514|NCT00452361|616695716|FG001|Overall Study|Withdrawal by Subject|1|||
170640515|NCT00452361|616695715|FG000|Overall Study|Premature termination|13|||
170640516|NCT00452361|616695716|FG001|Overall Study|Premature termination|9|||
170640517|NCT05188053|616695717|FG000|Overall Study|Lost to Follow-up|23|||
170640518|NCT05188053|616695718|FG001|Overall Study|Lost to Follow-up|30|||
170640519|NCT05188053|616695717|FG000|Overall Study|Protocol Violation|16|||
170640520|NCT05188053|616695718|FG001|Overall Study|Protocol Violation|16|||
170640521|NCT05188053|616695717|FG000|Overall Study|Physician Decision|3|||
170640522|NCT05188053|616695718|FG001|Overall Study|Physician Decision|0|||
170640523|NCT05188053|616695717|FG000|Overall Study|Withdrawal by Subject|0|||
170640524|NCT05188053|616695718|FG001|Overall Study|Withdrawal by Subject|1|||
170640525|NCT01761240|616695723|FG000|Overall Study|Progressive disease:radiology assessment|3|||
170640526|NCT01761240|616695724|FG001|Overall Study|Progressive disease:radiology assessment|3|||
170640527|NCT01761240|616695725|FG002|Overall Study|Progressive disease:radiology assessment|0|||
170640528|NCT01761240|616695726|FG003|Overall Study|Progressive disease:radiology assessment|0|||
170640529|NCT01761240|616695727|FG004|Overall Study|Progressive disease:radiology assessment|0|||
170640530|NCT01761240|616695723|FG000|Overall Study|Progressive disease:clinical assessment|0|||
170640531|NCT01761240|616695724|FG001|Overall Study|Progressive disease:clinical assessment|0|||
170640532|NCT01761240|616695725|FG002|Overall Study|Progressive disease:clinical assessment|3|||
170640533|NCT01761240|616695726|FG003|Overall Study|Progressive disease:clinical assessment|1|||
170640534|NCT01761240|616695727|FG004|Overall Study|Progressive disease:clinical assessment|0|||
170640535|NCT01761240|616695723|FG000|Overall Study|Withdrawal by Subject|0|||
170640536|NCT01761240|616695724|FG001|Overall Study|Withdrawal by Subject|0|||
170640537|NCT01761240|616695725|FG002|Overall Study|Withdrawal by Subject|0|||
170640538|NCT01761240|616695726|FG003|Overall Study|Withdrawal by Subject|3|||
170640539|NCT01761240|616695727|FG004|Overall Study|Withdrawal by Subject|1|||
170488241|NCT00402688|616130860|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
170488242|NCT00402688|616130861|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
170488243|NCT00402688|616130859|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
170488244|NCT00402688|616130860|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
170488245|NCT00402688|616130861|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
170640540|NCT01761240|616695723|FG000|Overall Study|Adverse Event|0|||
170640541|NCT01761240|616695724|FG001|Overall Study|Adverse Event|0|||
170640542|NCT01761240|616695725|FG002|Overall Study|Adverse Event|0|||
170799887|NCT02101853|617278881|FG004|Post Induction Randomization|Adverse Event|4|||
170799888|NCT02101853|617278882|FG005|Post Induction Randomization|Adverse Event|0|||
170799889|NCT02101853|617278877|FG000|Post Induction Randomization|Death|0|||
170799890|NCT02101853|617278878|FG001|Post Induction Randomization|Death|9|||
170799891|NCT02101853|617278879|FG002|Post Induction Randomization|Death|2|||
170799892|NCT02101853|617278880|FG003|Post Induction Randomization|Death|2|||
170799893|NCT02101853|617278881|FG004|Post Induction Randomization|Death|0|||
170799894|NCT02101853|617278882|FG005|Post Induction Randomization|Death|0|||
170799895|NCT02101853|617278877|FG000|Post Induction Randomization|Lack of Efficacy|0|||
170799896|NCT02101853|617278878|FG001|Post Induction Randomization|Lack of Efficacy|14|||
170799897|NCT02101853|617278879|FG002|Post Induction Randomization|Lack of Efficacy|23|||
170799898|NCT02101853|617278880|FG003|Post Induction Randomization|Lack of Efficacy|18|||
170799899|NCT02101853|617278881|FG004|Post Induction Randomization|Lack of Efficacy|21|||
170799900|NCT02101853|617278882|FG005|Post Induction Randomization|Lack of Efficacy|0|||
170799901|NCT02101853|617278877|FG000|Post Induction Randomization|Physician Decision|0|||
170799902|NCT02101853|617278878|FG001|Post Induction Randomization|Physician Decision|43|||
170799903|NCT02101853|617278879|FG002|Post Induction Randomization|Physician Decision|23|||
170640543|NCT01761240|616695726|FG003|Overall Study|Adverse Event|1|||
170640544|NCT01761240|616695727|FG004|Overall Study|Adverse Event|6|||
170640545|NCT01761240|616695723|FG000|Overall Study|Death|0|||
170799904|NCT02101853|617278880|FG003|Post Induction Randomization|Physician Decision|14|||
170799905|NCT02101853|617278881|FG004|Post Induction Randomization|Physician Decision|14|||
170799906|NCT02101853|617278882|FG005|Post Induction Randomization|Physician Decision|0|||
170488246|NCT00758485|616130862|FG000|Overall Study|Lost to Follow-up|0|||
170488247|NCT00758485|616130863|FG001|Overall Study|Lost to Follow-up|1|||
170488248|NCT00758485|616130862|FG000|Overall Study|Not Treated|1|||
170488249|NCT00758485|616130863|FG001|Overall Study|Not Treated|2|||
170488250|NCT01136356|616130864|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
170488251|NCT01136356|616130865|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
170488252|NCT01136356|616130864|FG000|First 18-day Withdrawal|Physician Decision|1|||
170488253|NCT01136356|616130865|FG001|First 18-day Withdrawal|Physician Decision|0|||
170488254|NCT01136356|616130864|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
170488255|NCT01136356|616130865|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
170488256|NCT00656292|616130866|FG000|Overall Study|Withdrawal by Subject|2|||
170488257|NCT00656292|616130867|FG001|Overall Study|Withdrawal by Subject|3|||
170488258|NCT00656292|616130866|FG000|Overall Study|Screen failure|1|||
170488259|NCT00656292|616130867|FG001|Overall Study|Screen failure|2|||
170488260|NCT00921557|616130868|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
170488261|NCT00921557|616130869|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
170488262|NCT00921557|616130870|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
170488263|NCT00921557|616130868|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
170488264|NCT00921557|616130869|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
170488265|NCT00921557|616130870|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
170488266|NCT00921557|616130868|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
170488267|NCT00921557|616130869|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
170488268|NCT00921557|616130870|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
170488269|NCT00921557|616130868|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
170488270|NCT00921557|616130869|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
170488271|NCT00921557|616130870|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
170488272|NCT00921557|616130868|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
170488273|NCT00921557|616130869|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
170488274|NCT00921557|616130870|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
170488275|NCT03259425|616130871|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
170488276|NCT04157296|616130872|FG000|Overall Study|Withdrawal by Subject|0|||
170488277|NCT04157296|616130873|FG001|Overall Study|Withdrawal by Subject|1|||
170488278|NCT04157296|616130872|FG000|Overall Study|Did not obtain second fMRI.|0|||
170488279|NCT04157296|616130873|FG001|Overall Study|Did not obtain second fMRI.|1|||
170488280|NCT04157296|616130872|FG000|Overall Study|MRI failed/no second fMRI|0|||
170488281|NCT04157296|616130873|FG001|Overall Study|MRI failed/no second fMRI|1|||
170488282|NCT00463047|616130876|FG000|Titration Period 1|Adverse Event|10|||
170488283|NCT00463047|616130877|FG001|Titration Period 1|Adverse Event|8|||
170488284|NCT00463047|616130876|FG000|Titration Period 1|Lack of Efficacy|10|||
170488285|NCT00463047|616130877|FG001|Titration Period 1|Lack of Efficacy|4|||
170488286|NCT00463047|616130876|FG000|Titration Period 1|Lost to Follow-up|2|||
170488287|NCT00463047|616130877|FG001|Titration Period 1|Lost to Follow-up|0|||
170549165|NCT02675452|616354817|FG012|Overall Study|Sponsor decision|0|||
170549166|NCT02675452|616354818|FG013|Overall Study|Sponsor decision|2|||
170549167|NCT02675452|616354819|FG014|Overall Study|Sponsor decision|1|||
170549168|NCT02675452|616354820|FG015|Overall Study|Sponsor decision|0|||
170549169|NCT02675452|616354821|FG016|Overall Study|Sponsor decision|1|||
170488288|NCT00463047|616130876|FG000|Titration Period 1|Non-compliance with study medication|3|||
170488289|NCT00463047|616130877|FG001|Titration Period 1|Non-compliance with study medication|5|||
170549170|NCT02675452|616354822|FG017|Overall Study|Sponsor decision|0|||
170549171|NCT02675452|616354823|FG018|Overall Study|Sponsor decision|0|||
170549172|NCT02675452|616354824|FG019|Overall Study|Sponsor decision|0|||
170549173|NCT02675452|616354825|FG020|Overall Study|Sponsor decision|0|||
170549174|NCT02675452|616354826|FG021|Overall Study|Sponsor decision|0|||
170549175|NCT02675452|616354827|FG022|Overall Study|Sponsor decision|0|||
170549176|NCT02675452|616354828|FG023|Overall Study|Sponsor decision|0|||
170549177|NCT02675452|616354829|FG024|Overall Study|Sponsor decision|0|||
170549178|NCT02675452|616354830|FG025|Overall Study|Sponsor decision|0|||
170549179|NCT02675452|616354831|FG026|Overall Study|Sponsor decision|2|||
170549180|NCT02675452|616354832|FG027|Overall Study|Sponsor decision|0|||
170488290|NCT00463047|616130876|FG000|Titration Period 1|Protocol Violation|5|||
170488291|NCT00463047|616130877|FG001|Titration Period 1|Protocol Violation|5|||
170488292|NCT00463047|616130876|FG000|Titration Period 1|Withdrawal by Subject|3|||
170488293|NCT00463047|616130877|FG001|Titration Period 1|Withdrawal by Subject|5|||
170549181|NCT02675452|616354833|FG028|Overall Study|Sponsor decision|0|||
170549182|NCT02675452|616354805|FG000|Overall Study|Withdrawal by Subject|0|||
170549183|NCT02675452|616354806|FG001|Overall Study|Withdrawal by Subject|0|||
170549184|NCT02675452|616354807|FG002|Overall Study|Withdrawal by Subject|0|||
170549185|NCT02675452|616354808|FG003|Overall Study|Withdrawal by Subject|0|||
170640546|NCT01761240|616695724|FG001|Overall Study|Death|1|||
170488294|NCT00463047|616130876|FG000|Titration Period 1|Non-compliance procedures|4|||
170488295|NCT00463047|616130877|FG001|Titration Period 1|Non-compliance procedures|10|||
170488296|NCT00463047|616130876|FG000|Titration Period 1|Other|0|||
170549186|NCT02675452|616354809|FG004|Overall Study|Withdrawal by Subject|0|||
170549187|NCT02675452|616354810|FG005|Overall Study|Withdrawal by Subject|0|||
170549188|NCT02675452|616354811|FG006|Overall Study|Withdrawal by Subject|0|||
170640547|NCT01761240|616695725|FG002|Overall Study|Death|1|||
170640548|NCT01761240|616695726|FG003|Overall Study|Death|2|||
170640549|NCT01761240|616695727|FG004|Overall Study|Death|1|||
170640550|NCT01761240|616695723|FG000|Overall Study|Non-compliance|0|||
170640551|NCT01761240|616695724|FG001|Overall Study|Non-compliance|0|||
170640552|NCT01761240|616695725|FG002|Overall Study|Non-compliance|1|||
170640553|NCT01761240|616695726|FG003|Overall Study|Non-compliance|0|||
170640554|NCT01761240|616695727|FG004|Overall Study|Non-compliance|0|||
170488297|NCT00463047|616130877|FG001|Titration Period 1|Other|2|||
170488298|NCT00463047|616130876|FG000|Titration Period 2|Adverse Event|9|||
170488299|NCT00463047|616130877|FG001|Titration Period 2|Adverse Event|9|||
170488300|NCT00463047|616130876|FG000|Titration Period 2|Lack of Efficacy|6|||
170488301|NCT00463047|616130877|FG001|Titration Period 2|Lack of Efficacy|4|||
170488302|NCT00463047|616130876|FG000|Titration Period 2|Withdrawal by Subject|1|||
170488303|NCT00463047|616130877|FG001|Titration Period 2|Withdrawal by Subject|0|||
170488304|NCT00463047|616130876|FG000|Titration Period 2|Protocol Violation|2|||
170640555|NCT05422638|616695728|FG000|Overall Study|Withdrawal by Subject|8|||
170640556|NCT05422638|616695729|FG001|Overall Study|Withdrawal by Subject|2|||
170640557|NCT02752165|616695730|FG000|Overall Study|Withdrawal by Subject|6|||
170640558|NCT02752165|616695731|FG001|Overall Study|Withdrawal by Subject|6|||
170640559|NCT02752165|616695730|FG000|Overall Study|Protocol Violation|6|||
170640560|NCT02752165|616695731|FG001|Overall Study|Protocol Violation|5|||
170640561|NCT02752165|616695730|FG000|Overall Study|Lost to Follow-up|33|||
170640562|NCT02752165|616695731|FG001|Overall Study|Lost to Follow-up|38|||
170640563|NCT04129151|616696903|FG000|Overall Study|Adverse Event|1|||
170640564|NCT04129151|616696903|FG000|Overall Study|Disease Progression|7|||
170640565|NCT04129151|616696903|FG000|Overall Study|Study closure|1|||
170640566|NCT04473235|616696904|FG000|Overall Study|Lost to Follow-up|6|||
170799907|NCT02101853|617278877|FG000|Post Induction Randomization|Protocol Violation|0|||
170799908|NCT02101853|617278878|FG001|Post Induction Randomization|Protocol Violation|3|||
170799909|NCT02101853|617278879|FG002|Post Induction Randomization|Protocol Violation|0|||
170799910|NCT02101853|617278880|FG003|Post Induction Randomization|Protocol Violation|0|||
170799911|NCT02101853|617278881|FG004|Post Induction Randomization|Protocol Violation|0|||
170799912|NCT02101853|617278882|FG005|Post Induction Randomization|Protocol Violation|0|||
170799913|NCT02101853|617278877|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
170799914|NCT02101853|617278878|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
170799915|NCT02101853|617278879|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
170799916|NCT02101853|617278880|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
170799917|NCT02101853|617278881|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
170799918|NCT02101853|617278882|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
170799919|NCT02101853|617278877|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170799920|NCT02101853|617278878|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170799921|NCT02101853|617278879|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170799922|NCT02101853|617278880|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
170799923|NCT02101853|617278881|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170799924|NCT02101853|617278882|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
170799925|NCT02101853|617278877|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
170799926|NCT02101853|617278878|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
170799927|NCT02101853|617278879|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
170799928|NCT02101853|617278880|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
170799929|NCT02101853|617278881|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
170799930|NCT02101853|617278882|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
170799931|NCT02101853|617278877|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
170799932|NCT02101853|617278878|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
170799933|NCT02101853|617278879|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
170799934|NCT02101853|617278880|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
170799935|NCT02101853|617278881|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
170799936|NCT02101853|617278882|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
170799937|NCT02101853|617278877|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
170799938|NCT02101853|617278878|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
170799939|NCT02101853|617278879|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
170799940|NCT02101853|617278880|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
170806979|NCT02063659|617301673|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
170488305|NCT00463047|616130877|FG001|Titration Period 2|Protocol Violation|3|||
170640567|NCT04473235|616696905|FG001|Overall Study|Lost to Follow-up|5|||
170488306|NCT00463047|616130876|FG000|Titration Period 2|Lost to Follow-up|1|||
170488307|NCT00463047|616130877|FG001|Titration Period 2|Lost to Follow-up|2|||
170640568|NCT04473235|616696904|FG000|Overall Study|Declined continuation|2|||
170488308|NCT00463047|616130876|FG000|Titration Period 2|Non-compliance study medication|4|||
170488309|NCT00463047|616130877|FG001|Titration Period 2|Non-compliance study medication|2|||
170488310|NCT00463047|616130876|FG000|Titration Period 2|Non-compliance procedures|4|||
170488311|NCT00463047|616130877|FG001|Titration Period 2|Non-compliance procedures|1|||
170488312|NCT00463047|616130876|FG000|Titration Period 2|Other|3|||
170488313|NCT00463047|616130877|FG001|Titration Period 2|Other|2|||
170488314|NCT00463047|616130876|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
170488315|NCT00463047|616130877|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
170488316|NCT00463047|616130876|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
170488317|NCT00463047|616130877|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
170488318|NCT00463047|616130876|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
170488319|NCT00463047|616130877|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
170488320|NCT00463047|616130876|FG000|Double-Blind Treatment Period 1|Other|1|||
170488321|NCT00463047|616130877|FG001|Double-Blind Treatment Period 1|Other|0|||
170488322|NCT00463047|616130876|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
170488323|NCT00463047|616130877|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
170488324|NCT00463047|616130876|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
170488325|NCT00463047|616130877|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
170488326|NCT00463047|616130876|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
170488327|NCT00463047|616130877|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
170488328|NCT02649439|616130880|FG000|Overall Study|Switched to alternative treatment|6|||
170488329|NCT02649439|616130881|FG001|Overall Study|Switched to alternative treatment|4|||
170488330|NCT02649439|616130880|FG000|Overall Study|Patient decision|1|||
170488331|NCT02649439|616130881|FG001|Overall Study|Patient decision|0|||
170488332|NCT02649439|616130880|FG000|Overall Study|Patient going out of country|1|||
170488333|NCT02649439|616130881|FG001|Overall Study|Patient going out of country|0|||
170488334|NCT02649439|616130880|FG000|Overall Study|To start finasteride|1|||
170488335|NCT02649439|616130881|FG001|Overall Study|To start finasteride|0|||
170488336|NCT02649439|616130880|FG000|Overall Study|Physician Decision|1|||
170488337|NCT02649439|616130881|FG001|Overall Study|Physician Decision|0|||
170488338|NCT02649439|616130880|FG000|Overall Study|Disease progression on study|12|||
170488339|NCT02649439|616130881|FG001|Overall Study|Disease progression on study|13|||
170488340|NCT02649439|616130880|FG000|Overall Study|Refused further treatment|1|||
170488341|NCT02649439|616130881|FG001|Overall Study|Refused further treatment|0|||
170488342|NCT02649439|616130880|FG000|Overall Study|Refused further follow up|2|||
170488343|NCT02649439|616130881|FG001|Overall Study|Refused further follow up|7|||
170488344|NCT02649439|616130880|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
170488345|NCT02649439|616130881|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
170488346|NCT02649439|616130880|FG000|Overall Study|No treatment, per protocol|1|||
170488347|NCT02649439|616130881|FG001|Overall Study|No treatment, per protocol|0|||
170488348|NCT02649439|616130880|FG000|Overall Study|PSA DT makes ineligible|0|||
170488349|NCT02649439|616130881|FG001|Overall Study|PSA DT makes ineligible|1|||
170488350|NCT02649439|616130880|FG000|Overall Study|Rising PSA No Mets|0|||
170488351|NCT02649439|616130881|FG001|Overall Study|Rising PSA No Mets|1|||
170488352|NCT02649439|616130880|FG000|Overall Study|Rising PSA|0|||
170488353|NCT02649439|616130881|FG001|Overall Study|Rising PSA|1|||
170488354|NCT02649439|616130880|FG000|Overall Study|Signed follow up protocol|0|||
170488355|NCT02649439|616130881|FG001|Overall Study|Signed follow up protocol|1|||
170488356|NCT02097238|616130883|FG000|Overall Study|Death|1|||
170488357|NCT02097238|616130883|FG000|Overall Study|Physician Decision|1|||
170488358|NCT02097238|616130883|FG000|Overall Study|Progressive Disease|17|||
170488359|NCT05027451|616130893|FG000|Overall Study|Lost to Follow-up|1|||
170488360|NCT05027451|616130894|FG001|Overall Study|Lost to Follow-up|1|||
170488361|NCT02693002|616130895|FG000|Overall Study|Withdrawal by Subject|1|||
170488362|NCT02693002|616130896|FG001|Overall Study|Withdrawal by Subject|0|||
170488363|NCT04666259|616130897|FG000|Treatment Phase|Physician Decision|9|||
170488364|NCT04666259|616130898|FG001|Treatment Phase|Physician Decision|3|||
170488365|NCT04666259|616130899|FG002|Treatment Phase|Physician Decision|3|||
170488366|NCT04666259|616130897|FG000|Treatment Phase|Adverse Event|3|||
170488367|NCT04666259|616130898|FG001|Treatment Phase|Adverse Event|1|||
170488368|NCT04666259|616130899|FG002|Treatment Phase|Adverse Event|0|||
170488369|NCT04666259|616130897|FG000|Treatment Phase|Subject decision|1|||
170488370|NCT04666259|616130898|FG001|Treatment Phase|Subject decision|2|||
170488371|NCT04666259|616130899|FG002|Treatment Phase|Subject decision|0|||
170488372|NCT04666259|616130897|FG000|Treatment Phase|Progressive disease|0|||
170488373|NCT04666259|616130898|FG001|Treatment Phase|Progressive disease|1|||
170488374|NCT04666259|616130899|FG002|Treatment Phase|Progressive disease|0|||
170488375|NCT04666259|616130897|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
170488376|NCT04666259|616130898|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
170488377|NCT04666259|616130899|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
170488378|NCT04666259|616130897|FG000|Safety Follow-up Phase|Physician Decision|2|||
170488379|NCT04666259|616130898|FG001|Safety Follow-up Phase|Physician Decision|0|||
170488380|NCT04666259|616130899|FG002|Safety Follow-up Phase|Physician Decision|0|||
170488381|NCT04666259|616130897|FG000|Safety Follow-up Phase|Subject decision|1|||
170488382|NCT04666259|616130898|FG001|Safety Follow-up Phase|Subject decision|0|||
170488383|NCT04666259|616130899|FG002|Safety Follow-up Phase|Subject decision|0|||
170488384|NCT04666259|616130897|FG000|Safety Follow-up Phase|Death|0|||
170488385|NCT04666259|616130898|FG001|Safety Follow-up Phase|Death|1|||
170488386|NCT04666259|616130899|FG002|Safety Follow-up Phase|Death|0|||
170488387|NCT02737930|616130900|FG000|Overall Study|Withdrawal by Subject|0|||
170488388|NCT02737930|616130901|FG001|Overall Study|Withdrawal by Subject|1|||
170488389|NCT04178122|616130902|FG000|Overall Study|Withdrawal by Subject|1|||
170488390|NCT04178122|616130903|FG001|Overall Study|Withdrawal by Subject|1|||
170488391|NCT04178122|616130902|FG000|Overall Study|Death|2|||
170488392|NCT04178122|616130903|FG001|Overall Study|Death|0|||
170488393|NCT04178122|616130902|FG000|Overall Study|Did not complete testing|3|||
170488394|NCT04178122|616130903|FG001|Overall Study|Did not complete testing|13|||
170488395|NCT03124407|616130904|FG000|Overall Study|Lost to Follow-up|1|||
170488396|NCT03124407|616130905|FG001|Overall Study|Lost to Follow-up|0|||
170488397|NCT03124407|616130906|FG002|Overall Study|Lost to Follow-up|0|||
170488398|NCT03124407|616130907|FG003|Overall Study|Lost to Follow-up|0|||
170488399|NCT03124407|616130904|FG000|Overall Study|Adverse Event|0|||
170488400|NCT03124407|616130905|FG001|Overall Study|Adverse Event|0|||
170488401|NCT03124407|616130906|FG002|Overall Study|Adverse Event|1|||
170799941|NCT02101853|617278881|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
170799942|NCT02101853|617278882|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
170799943|NCT02101853|617278877|FG000|Blinatumomab Salvage Therapy|Death|0|||
170799944|NCT02101853|617278878|FG001|Blinatumomab Salvage Therapy|Death|0|||
170799945|NCT02101853|617278879|FG002|Blinatumomab Salvage Therapy|Death|0|||
170799946|NCT02101853|617278880|FG003|Blinatumomab Salvage Therapy|Death|0|||
170799947|NCT02101853|617278881|FG004|Blinatumomab Salvage Therapy|Death|0|||
170799948|NCT02101853|617278882|FG005|Blinatumomab Salvage Therapy|Death|2|||
170799949|NCT02101853|617278877|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
170799950|NCT02101853|617278878|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
170799951|NCT02101853|617278879|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
170799952|NCT02101853|617278880|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
170799953|NCT02101853|617278881|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
170799954|NCT02101853|617278882|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
170799955|NCT02101853|617278877|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
170799956|NCT02101853|617278878|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
170799957|NCT02101853|617278879|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
170799958|NCT02101853|617278880|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
170799959|NCT02101853|617278881|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
170799960|NCT02101853|617278882|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
170799961|NCT02101853|617278877|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
170799962|NCT02101853|617278878|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
170799963|NCT02101853|617278879|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
170799964|NCT02101853|617278880|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
170799965|NCT02101853|617278881|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
170799966|NCT02101853|617278882|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
170799967|NCT03872466|617278889|FG000|Overall Study|Withdrawal by Subject|1|||
170799968|NCT03872466|617278890|FG001|Overall Study|Withdrawal by Subject|0|||
170799969|NCT03872466|617278889|FG000|Overall Study|Physician Decision|2|||
170799970|NCT03872466|617278890|FG001|Overall Study|Physician Decision|0|||
170799971|NCT05771467|617278891|FG000|Overall Study|Lost to Follow-up|6|||
170799972|NCT05771467|617278892|FG001|Overall Study|Lost to Follow-up|3|||
170799973|NCT04018495|617278895|FG000|Overall Study|Physician Decision|1|||
170799974|NCT03782116|617278896|FG000|Completed Intervetion|Lost to Follow-up|11|||
170799975|NCT03782116|617278897|FG001|Completed Intervetion|Lost to Follow-up|7|||
170799976|NCT03782116|617278896|FG000|Completed Intervetion|Withdrawal by Subject|6|||
170799977|NCT03782116|617278897|FG001|Completed Intervetion|Withdrawal by Subject|5|||
170799978|NCT03782116|617278896|FG000|Included in Analysis|Protocol Violation|5|||
170799979|NCT03782116|617278897|FG001|Included in Analysis|Protocol Violation|5|||
170799980|NCT00945724|617278900|FG000|Overall Study|Withdrawal by Subject|2|||
170799981|NCT00945724|617278900|FG000|Overall Study|Physician Decision|1|||
170799982|NCT00945724|617278900|FG000|Overall Study|Adverse Event|5|||
170799983|NCT00945724|617278900|FG000|Overall Study|Second malignancy|1|||
170799984|NCT00003222|617279398|FG000|Overall Study|Physician Decision|0|||
170799985|NCT00003222|617279399|FG001|Overall Study|Physician Decision|1|||
170799986|NCT03725332|617279400|FG000|Overall Study|Adverse Event|5|||
170799987|NCT03725332|617279401|FG001|Overall Study|Adverse Event|10|||
170799988|NCT03725332|617279400|FG000|Overall Study|Death|1|||
170799989|NCT03725332|617279401|FG001|Overall Study|Death|3|||
170799990|NCT03725332|617279400|FG000|Overall Study|Lost to Follow-up|43|||
170799991|NCT03725332|617279401|FG001|Overall Study|Lost to Follow-up|122|||
170799992|NCT03725332|617279400|FG000|Overall Study|Withdrawal by Subject|0|||
170488402|NCT03124407|616130907|FG003|Overall Study|Adverse Event|0|||
170488403|NCT05343364|616130908|FG000|Overall Study|Miscellaneous|0|||
170799993|NCT03725332|617279401|FG001|Overall Study|Withdrawal by Subject|1|||
170799994|NCT03725332|617279400|FG000|Overall Study|Duplicate enrollment|0|||
170799995|NCT03725332|617279401|FG001|Overall Study|Duplicate enrollment|1|||
170488404|NCT05343364|616130909|FG001|Overall Study|Miscellaneous|1|||
170488405|NCT01791894|616130910|FG000|Overall Study|Adverse Event|1|||
170488406|NCT00984542|616130919|FG000|Overall Study|disease progression|19|||
170488407|NCT00984542|616130919|FG000|Overall Study|toxicity|7|||
170488408|NCT00984542|616130919|FG000|Overall Study|Death|7|||
170488409|NCT00984542|616130919|FG000|Overall Study|complicating disease|3|||
170488410|NCT00984542|616130919|FG000|Overall Study|Withdrawal by Subject|3|||
170488411|NCT00984542|616130919|FG000|Overall Study|clinical deterioration|2|||
170488412|NCT01422889|616130920|FG000|Overall Study|No Data Entered for Study Stent|9|||
170488413|NCT00994461|616130923|FG000|Overall Study|Adverse Event|2|||
170488414|NCT00994461|616130924|FG001|Overall Study|Adverse Event|1|||
170488415|NCT00994461|616130925|FG002|Overall Study|Adverse Event|0|||
170488416|NCT04339062|616130926|FG000|Overall Study|Death|0|||
170488417|NCT04339062|616130927|FG001|Overall Study|Death|1|||
170488418|NCT01276756|616130928|FG000|Overall Study|Lost to Follow-up|2|||
170488419|NCT01276756|616130929|FG001|Overall Study|Lost to Follow-up|0|||
170488420|NCT01276756|616130928|FG000|Overall Study|Adverse Event|3|||
170488421|NCT01276756|616130929|FG001|Overall Study|Adverse Event|2|||
170488422|NCT03289754|616130930|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
170488423|NCT03584854|616130931|FG000|Overall Study|Primary outcome not measured|1|||
170488424|NCT03584854|616130932|FG001|Overall Study|Primary outcome not measured|2|||
170488425|NCT02907177|616130933|FG000|Overall Study|Death|0|||
170488426|NCT02907177|616130934|FG001|Overall Study|Death|1|||
170488427|NCT02907177|616130933|FG000|Overall Study|Physician Decision|3|||
170488428|NCT02907177|616130934|FG001|Overall Study|Physician Decision|3|||
170488429|NCT02907177|616130933|FG000|Overall Study|Withdrawal by Subject|15|||
170488430|NCT02907177|616130934|FG001|Overall Study|Withdrawal by Subject|7|||
170488431|NCT02907177|616130933|FG000|Overall Study|Sponsor's Decision|50|||
170488432|NCT02907177|616130934|FG001|Overall Study|Sponsor's Decision|57|||
170488433|NCT02630251|616130935|FG000|Overall Study|Physician Decision|0|||
170488434|NCT02630251|616130936|FG001|Overall Study|Physician Decision|0|||
170488435|NCT02630251|616130937|FG002|Overall Study|Physician Decision|1|||
170488436|NCT02630251|616130938|FG003|Overall Study|Physician Decision|0|||
170488437|NCT02968173|616130939|FG000|Overall Study|Withdrawal by Subject|1|||
170488438|NCT04586244|616130940|FG000|Overall Study|Lost to Follow-up|1|||
170488439|NCT04586244|616130941|FG001|Overall Study|Lost to Follow-up|0|||
170488440|NCT04586244|616130942|FG002|Overall Study|Lost to Follow-up|0|||
170488441|NCT04586244|616130943|FG003|Overall Study|Lost to Follow-up|1|||
170488442|NCT04586244|616130944|FG004|Overall Study|Lost to Follow-up|0|||
170488443|NCT04586244|616130940|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
170488444|NCT04586244|616130941|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
170488445|NCT04586244|616130942|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
170488446|NCT04586244|616130943|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
170488447|NCT04586244|616130944|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
170488448|NCT04639219|616130945|FG000|Overall Study|Withdrawal by Subject|8|||
170488449|NCT04639219|616130945|FG000|Overall Study|Lost to Follow-up|6|||
170488450|NCT04639219|616130945|FG000|Overall Study|Death|55|||
170488451|NCT00153179|616130946|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
170488452|NCT00153179|616130947|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
170488453|NCT00153179|616130948|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
170488454|NCT00153179|616130949|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
170488455|NCT02741076|616130950|FG000|Overall Study|Adverse Event|0|||
170488456|NCT02741076|616130951|FG001|Overall Study|Adverse Event|1|||
170488457|NCT02741076|616130952|FG002|Overall Study|Adverse Event|1|||
170799996|NCT03725332|617279400|FG000|Overall Study|Did not consent|0|||
170799997|NCT03725332|617279401|FG001|Overall Study|Did not consent|1|||
170799998|NCT02754596|617279402|FG000|Overall Study|Withdrawal by Subject|3|||
170799999|NCT02754596|617279403|FG001|Overall Study|Withdrawal by Subject|4|||
170800000|NCT02754596|617279404|FG002|Overall Study|Withdrawal by Subject|0|||
170488458|NCT02741076|616130953|FG003|Overall Study|Adverse Event|0|||
170488459|NCT02741076|616130950|FG000|Overall Study|Lack of Efficacy|1|||
170488460|NCT02741076|616130951|FG001|Overall Study|Lack of Efficacy|0|||
170488461|NCT02741076|616130952|FG002|Overall Study|Lack of Efficacy|0|||
170488462|NCT02741076|616130953|FG003|Overall Study|Lack of Efficacy|0|||
170488463|NCT02741076|616130950|FG000|Overall Study|Withdrawal by Subject|0|||
170488464|NCT02741076|616130951|FG001|Overall Study|Withdrawal by Subject|1|||
170488465|NCT02741076|616130952|FG002|Overall Study|Withdrawal by Subject|0|||
170800001|NCT02754596|617279402|FG000|Overall Study|Physician Decision|1|||
170488466|NCT02741076|616130953|FG003|Overall Study|Withdrawal by Subject|0|||
170488467|NCT02741076|616130950|FG000|Overall Study|Sponsor Request|2|||
170488468|NCT02741076|616130951|FG001|Overall Study|Sponsor Request|3|||
170488469|NCT02741076|616130952|FG002|Overall Study|Sponsor Request|0|||
170488470|NCT02741076|616130953|FG003|Overall Study|Sponsor Request|1|||
170800002|NCT02754596|617279403|FG001|Overall Study|Physician Decision|1|||
170800003|NCT02754596|617279404|FG002|Overall Study|Physician Decision|1|||
170800004|NCT02754596|617279402|FG000|Overall Study|Lost to Follow-up|1|||
170800005|NCT02754596|617279403|FG001|Overall Study|Lost to Follow-up|1|||
170800006|NCT02754596|617279404|FG002|Overall Study|Lost to Follow-up|2|||
170800007|NCT02754596|617279402|FG000|Overall Study|Death|0|||
170800008|NCT02754596|617279403|FG001|Overall Study|Death|2|||
170800009|NCT02754596|617279404|FG002|Overall Study|Death|0|||
170800010|NCT02754596|617279402|FG000|Overall Study|Adverse Event|1|||
170800011|NCT02754596|617279403|FG001|Overall Study|Adverse Event|0|||
170800012|NCT02754596|617279404|FG002|Overall Study|Adverse Event|1|||
170800013|NCT02754596|617279402|FG000|Overall Study|Other|1|||
170800014|NCT02754596|617279403|FG001|Overall Study|Other|0|||
170800015|NCT02754596|617279404|FG002|Overall Study|Other|0|||
170800016|NCT02112916|617279405|FG000|Overall Study|Adverse Event|6|||
170800017|NCT02112916|617279406|FG001|Overall Study|Adverse Event|9|||
170800018|NCT02112916|617279407|FG002|Overall Study|Adverse Event|3|||
170800019|NCT02112916|617279408|FG003|Overall Study|Adverse Event|2|||
170800020|NCT02112916|617279405|FG000|Overall Study|Death|9|||
170800021|NCT02112916|617279406|FG001|Overall Study|Death|9|||
170800022|NCT02112916|617279407|FG002|Overall Study|Death|3|||
170800023|NCT02112916|617279408|FG003|Overall Study|Death|4|||
170800024|NCT02112916|617279405|FG000|Overall Study|Lost to Follow-up|1|||
170800025|NCT02112916|617279406|FG001|Overall Study|Lost to Follow-up|0|||
170800026|NCT02112916|617279407|FG002|Overall Study|Lost to Follow-up|0|||
170488471|NCT02741076|616130950|FG000|Overall Study|No additional information available|0|||
170488472|NCT02741076|616130951|FG001|Overall Study|No additional information available|0|||
170488473|NCT02741076|616130952|FG002|Overall Study|No additional information available|1|||
170488474|NCT02741076|616130953|FG003|Overall Study|No additional information available|1|||
170488475|NCT01207687|616130954|FG000|Overall Study|Adverse Event|1|||
170488476|NCT01207687|616130954|FG000|Overall Study|Withdrawal by Subject|1|||
170488477|NCT04015518|616130957|FG000|Overall Study|Adverse Event|6|||
170488478|NCT04015518|616130958|FG001|Overall Study|Adverse Event|1|||
170488479|NCT04015518|616130959|FG002|Overall Study|Adverse Event|1|||
170488480|NCT04015518|616130960|FG003|Overall Study|Adverse Event|3|||
170488481|NCT04015518|616130961|FG004|Overall Study|Adverse Event|3|||
170488482|NCT04015518|616130957|FG000|Overall Study|Lack of Efficacy|1|||
170488483|NCT04015518|616130958|FG001|Overall Study|Lack of Efficacy|0|||
170488484|NCT04015518|616130959|FG002|Overall Study|Lack of Efficacy|1|||
170488485|NCT04015518|616130960|FG003|Overall Study|Lack of Efficacy|0|||
170488486|NCT04015518|616130961|FG004|Overall Study|Lack of Efficacy|4|||
170488487|NCT04015518|616130957|FG000|Overall Study|Lost to Follow-up|0|||
170488488|NCT04015518|616130958|FG001|Overall Study|Lost to Follow-up|0|||
170488489|NCT04015518|616130959|FG002|Overall Study|Lost to Follow-up|0|||
170488490|NCT04015518|616130960|FG003|Overall Study|Lost to Follow-up|0|||
170488491|NCT04015518|616130961|FG004|Overall Study|Lost to Follow-up|1|||
170488492|NCT04015518|616130957|FG000|Overall Study|Withdrawal by Subject|0|||
170488493|NCT04015518|616130958|FG001|Overall Study|Withdrawal by Subject|1|||
170488494|NCT04015518|616130959|FG002|Overall Study|Withdrawal by Subject|0|||
170488495|NCT04015518|616130960|FG003|Overall Study|Withdrawal by Subject|1|||
170488496|NCT04015518|616130961|FG004|Overall Study|Withdrawal by Subject|1|||
170488497|NCT04015518|616130957|FG000|Overall Study|Patient did not come for consecutive visits|0|||
170488498|NCT04015518|616130958|FG001|Overall Study|Patient did not come for consecutive visits|1|||
170488499|NCT04015518|616130959|FG002|Overall Study|Patient did not come for consecutive visits|0|||
170488500|NCT04015518|616130960|FG003|Overall Study|Patient did not come for consecutive visits|0|||
170488501|NCT04015518|616130961|FG004|Overall Study|Patient did not come for consecutive visits|0|||
170488502|NCT04015518|616130957|FG000|Overall Study|not willing to travel due to Covid-19|0|||
170488503|NCT04015518|616130958|FG001|Overall Study|not willing to travel due to Covid-19|0|||
170488504|NCT04015518|616130959|FG002|Overall Study|not willing to travel due to Covid-19|1|||
170488505|NCT04015518|616130960|FG003|Overall Study|not willing to travel due to Covid-19|0|||
170488506|NCT04015518|616130961|FG004|Overall Study|not willing to travel due to Covid-19|0|||
170488507|NCT04015518|616130957|FG000|Overall Study|Patient wants to discontinue treatment|0|||
170488508|NCT04015518|616130958|FG001|Overall Study|Patient wants to discontinue treatment|0|||
170800027|NCT02112916|617279408|FG003|Overall Study|Lost to Follow-up|0|||
170800028|NCT02112916|617279405|FG000|Overall Study|Physician Decision|94|||
170800029|NCT02112916|617279406|FG001|Overall Study|Physician Decision|72|||
170800030|NCT02112916|617279407|FG002|Overall Study|Physician Decision|24|||
170800031|NCT02112916|617279408|FG003|Overall Study|Physician Decision|15|||
170800032|NCT02112916|617279405|FG000|Overall Study|Withdrawal by Subject|5|||
170488509|NCT04015518|616130959|FG002|Overall Study|Patient wants to discontinue treatment|0|||
170800033|NCT02112916|617279406|FG001|Overall Study|Withdrawal by Subject|3|||
170800034|NCT02112916|617279407|FG002|Overall Study|Withdrawal by Subject|1|||
170800035|NCT02112916|617279408|FG003|Overall Study|Withdrawal by Subject|1|||
170800036|NCT02112916|617279405|FG000|Overall Study|Ineligible|4|||
170800037|NCT02112916|617279406|FG001|Overall Study|Ineligible|8|||
170800038|NCT02112916|617279407|FG002|Overall Study|Ineligible|3|||
170800039|NCT02112916|617279408|FG003|Overall Study|Ineligible|8|||
170800040|NCT02112916|617279405|FG000|Overall Study|Inevaluable|6|||
170899614|NCT03049449|617637705|FG007|Overall Study|Did not receive treatment.|0|||
170899615|NCT03049449|617637706|FG008|Overall Study|Did not receive treatment.|1|||
170899616|NCT03049449|617637707|FG009|Overall Study|Did not receive treatment.|0|||
170899617|NCT03049449|617637698|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
170899618|NCT03049449|617637699|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
170899619|NCT03049449|617637700|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
170488510|NCT04015518|616130960|FG003|Overall Study|Patient wants to discontinue treatment|1|||
170488511|NCT04015518|616130961|FG004|Overall Study|Patient wants to discontinue treatment|0|||
170488512|NCT04015518|616130957|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
170488513|NCT04015518|616130958|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
170488514|NCT04015518|616130959|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
170488515|NCT04015518|616130960|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
170488516|NCT04015518|616130961|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
170488517|NCT04015518|616130957|FG000|Overall Study|Pregnancy|0|||
170488518|NCT04015518|616130958|FG001|Overall Study|Pregnancy|0|||
170488519|NCT04015518|616130959|FG002|Overall Study|Pregnancy|0|||
170488520|NCT04015518|616130960|FG003|Overall Study|Pregnancy|0|||
170488521|NCT04015518|616130961|FG004|Overall Study|Pregnancy|1|||
170488522|NCT04015518|616130957|FG000|Overall Study|Personal reasons|1|||
170488523|NCT04015518|616130958|FG001|Overall Study|Personal reasons|0|||
170488524|NCT04015518|616130959|FG002|Overall Study|Personal reasons|0|||
170488525|NCT04015518|616130960|FG003|Overall Study|Personal reasons|0|||
170488526|NCT04015518|616130961|FG004|Overall Study|Personal reasons|1|||
170488527|NCT04015518|616130957|FG000|Overall Study|Withdrew consent|1|||
170488528|NCT04015518|616130958|FG001|Overall Study|Withdrew consent|0|||
170488529|NCT04015518|616130959|FG002|Overall Study|Withdrew consent|0|||
170488530|NCT04015518|616130960|FG003|Overall Study|Withdrew consent|0|||
170488531|NCT04015518|616130961|FG004|Overall Study|Withdrew consent|0|||
170488532|NCT04015518|616130957|FG000|Overall Study|Prostate carcinoma|1|||
170488533|NCT04015518|616130958|FG001|Overall Study|Prostate carcinoma|0|||
170488534|NCT04015518|616130959|FG002|Overall Study|Prostate carcinoma|0|||
170488535|NCT04015518|616130960|FG003|Overall Study|Prostate carcinoma|0|||
170488536|NCT04015518|616130961|FG004|Overall Study|Prostate carcinoma|0|||
170488537|NCT04015518|616130957|FG000|Overall Study|Could not keep appointments due to work|1|||
170488538|NCT04015518|616130958|FG001|Overall Study|Could not keep appointments due to work|0|||
170899620|NCT03049449|617637701|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
170488539|NCT04015518|616130959|FG002|Overall Study|Could not keep appointments due to work|0|||
170488540|NCT04015518|616130960|FG003|Overall Study|Could not keep appointments due to work|0|||
170488541|NCT04015518|616130961|FG004|Overall Study|Could not keep appointments due to work|0|||
170488542|NCT03474965|616130963|FG000|Overall Study|Pregnancy|1|||
170488543|NCT03474965|616130964|FG001|Overall Study|Pregnancy|0|||
170488544|NCT03474965|616130965|FG002|Overall Study|Pregnancy|0|||
170488545|NCT03474965|616130966|FG003|Overall Study|Pregnancy|0|||
170488546|NCT03474965|616130963|FG000|Overall Study|Lost to Follow-up|0|||
170488547|NCT03474965|616130964|FG001|Overall Study|Lost to Follow-up|0|||
170488548|NCT03474965|616130965|FG002|Overall Study|Lost to Follow-up|1|||
170488549|NCT03474965|616130966|FG003|Overall Study|Lost to Follow-up|0|||
170488550|NCT03474965|616130963|FG000|Overall Study|Death|1|||
170488551|NCT03474965|616130964|FG001|Overall Study|Death|0|||
170488552|NCT03474965|616130965|FG002|Overall Study|Death|0|||
170488553|NCT03474965|616130966|FG003|Overall Study|Death|0|||
170488554|NCT03474965|616130963|FG000|Overall Study|Adverse Event|1|||
170488555|NCT03474965|616130964|FG001|Overall Study|Adverse Event|0|||
170488556|NCT03474965|616130965|FG002|Overall Study|Adverse Event|0|||
170488557|NCT03474965|616130966|FG003|Overall Study|Adverse Event|1|||
170488558|NCT03474965|616130963|FG000|Overall Study|Physician Decision|3|||
170488559|NCT03474965|616130964|FG001|Overall Study|Physician Decision|1|||
170488560|NCT03474965|616130965|FG002|Overall Study|Physician Decision|2|||
170488561|NCT03474965|616130966|FG003|Overall Study|Physician Decision|0|||
170488562|NCT03474965|616130963|FG000|Overall Study|Participant Decision|7|||
170488563|NCT03474965|616130964|FG001|Overall Study|Participant Decision|0|||
170488564|NCT03474965|616130965|FG002|Overall Study|Participant Decision|1|||
170488565|NCT03474965|616130966|FG003|Overall Study|Participant Decision|0|||
170488566|NCT03474965|616130963|FG000|Overall Study|Guardian Decision|4|||
170488567|NCT03474965|616130964|FG001|Overall Study|Guardian Decision|2|||
170488568|NCT03474965|616130965|FG002|Overall Study|Guardian Decision|7|||
170899621|NCT03049449|617637702|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
170488569|NCT03474965|616130966|FG003|Overall Study|Guardian Decision|2|||
170488570|NCT02186873|616132174|FG000|Overall Study|Adverse Event|1|||
170488571|NCT02186873|616132175|FG001|Overall Study|Adverse Event|3|||
170488572|NCT02186873|616132174|FG000|Overall Study|Lack of Efficacy|0|||
170488573|NCT02186873|616132175|FG001|Overall Study|Lack of Efficacy|1|||
170488574|NCT02186873|616132174|FG000|Overall Study|Lost to Follow-up|1|||
170488575|NCT02186873|616132175|FG001|Overall Study|Lost to Follow-up|2|||
170488576|NCT02186873|616132174|FG000|Overall Study|Withdrawal by Subject|7|||
170488577|NCT02186873|616132175|FG001|Overall Study|Withdrawal by Subject|2|||
170488578|NCT01806961|616132176|FG000|Overall Study|sponsor decision|16|||
170488579|NCT01108341|616132179|FG000|Overall Study|Death|2|||
170488580|NCT01108341|616132179|FG000|Overall Study|Withdrawal by Subject|1|||
170488581|NCT01108341|616132179|FG000|Overall Study|Lost to Follow-up|1|||
170488582|NCT01108341|616132179|FG000|Overall Study|Other|1|||
170488583|NCT00302328|616132181|FG000|Overall Study|Physician Decision|0|||
170899622|NCT03049449|617637703|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
170899623|NCT03049449|617637704|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
170899624|NCT03049449|617637705|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
170899625|NCT03049449|617637706|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
170899626|NCT03049449|617637707|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
170899627|NCT03049449|617637698|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
170899628|NCT03049449|617637699|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
170899629|NCT03049449|617637700|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
170899630|NCT03049449|617637701|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
170899631|NCT03049449|617637702|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
170899632|NCT03049449|617637703|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
170899633|NCT03049449|617637704|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
170899634|NCT03049449|617637705|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
170899635|NCT03049449|617637706|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
170899636|NCT03049449|617637707|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
170899637|NCT02507349|617637714|FG000|Overall Study|Death|12|||
170899638|NCT02507349|617637715|FG001|Overall Study|Death|16|||
170899639|NCT02507349|617637714|FG000|Overall Study|Withdrawal by Subject|1|||
170899640|NCT02507349|617637715|FG001|Overall Study|Withdrawal by Subject|1|||
170899641|NCT02507349|617637714|FG000|Overall Study|Lost to Follow-up|174|||
170488584|NCT00302328|616132182|FG001|Overall Study|Physician Decision|1|||
170488585|NCT00302328|616132183|FG002|Overall Study|Physician Decision|0|||
170488586|NCT02476578|616132189|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
170488587|NCT02476578|616132190|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
170488588|NCT02476578|616132189|FG000|Overall Study|Lost to Follow-up|6|||
170488589|NCT02476578|616132190|FG001|Overall Study|Lost to Follow-up|13|||
170488590|NCT00026494|616132191|FG000|Overall Study|Withdrawal by Subject|1|||
170488591|NCT00026494|616132192|FG001|Overall Study|Withdrawal by Subject|0|||
170488592|NCT00026494|616132193|FG002|Overall Study|Withdrawal by Subject|1|||
170488593|NCT00026494|616132194|FG003|Overall Study|Withdrawal by Subject|0|||
170488594|NCT00026494|616132191|FG000|Overall Study|Patient non-compliance|1|||
170488595|NCT00026494|616132192|FG001|Overall Study|Patient non-compliance|0|||
170488596|NCT00026494|616132193|FG002|Overall Study|Patient non-compliance|0|||
170488597|NCT00026494|616132194|FG003|Overall Study|Patient non-compliance|0|||
170488598|NCT00026494|616132191|FG000|Overall Study|Patient not treated|0|||
170488599|NCT00026494|616132192|FG001|Overall Study|Patient not treated|0|||
170488600|NCT00026494|616132193|FG002|Overall Study|Patient not treated|2|||
170488601|NCT00026494|616132194|FG003|Overall Study|Patient not treated|0|||
170488602|NCT00026494|616132191|FG000|Overall Study|Clinical progression|0|||
170488603|NCT00026494|616132192|FG001|Overall Study|Clinical progression|0|||
170488604|NCT00026494|616132193|FG002|Overall Study|Clinical progression|3|||
170488605|NCT00026494|616132194|FG003|Overall Study|Clinical progression|0|||
170488606|NCT00423332|616132196|FG000|Overall Study|Adverse Event|6|||
170488607|NCT00423332|616132197|FG001|Overall Study|Adverse Event|2|||
170488608|NCT00423332|616132196|FG000|Overall Study|Withdrawal by Subject|1|||
170488609|NCT00423332|616132197|FG001|Overall Study|Withdrawal by Subject|0|||
170488610|NCT00423332|616132196|FG000|Overall Study|Condition under investigation worsened|1|||
170488611|NCT00423332|616132197|FG001|Overall Study|Condition under investigation worsened|1|||
170488612|NCT00423332|616132196|FG000|Overall Study|Progressive at Week 6|0|||
170488613|NCT00423332|616132197|FG001|Overall Study|Progressive at Week 6|1|||
170488614|NCT00423332|616132196|FG000|Overall Study|Unblinded before 12 weeks|1|||
170488615|NCT00423332|616132197|FG001|Overall Study|Unblinded before 12 weeks|3|||
170488616|NCT00685399|616132200|FG000|Treatment Period 1|Withdrawal by Subject|2|||
170488617|NCT00685399|616132201|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170488618|NCT00685399|616132202|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170488619|NCT00685399|616132203|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170488620|NCT00685399|616132204|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170899642|NCT02507349|617637715|FG001|Overall Study|Lost to Follow-up|144|||
170488621|NCT00685399|616132205|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170488622|NCT00685399|616132206|FG006|Treatment Period 1|Withdrawal by Subject|0|||
170488623|NCT00685399|616132207|FG007|Treatment Period 1|Withdrawal by Subject|0|||
170488624|NCT00685399|616132200|FG000|Treatment Period 1|Protocol Violation|1|||
170800041|NCT02112916|617279406|FG001|Overall Study|Inevaluable|4|||
170800042|NCT02112916|617279407|FG002|Overall Study|Inevaluable|5|||
170800043|NCT02112916|617279408|FG003|Overall Study|Inevaluable|5|||
170800044|NCT02112916|617279405|FG000|Overall Study|Refusal of further protocol therapy|19|||
170800045|NCT02112916|617279406|FG001|Overall Study|Refusal of further protocol therapy|16|||
170800046|NCT02112916|617279407|FG002|Overall Study|Refusal of further protocol therapy|1|||
170800047|NCT02112916|617279408|FG003|Overall Study|Refusal of further protocol therapy|7|||
170800048|NCT02112916|617279405|FG000|Overall Study|Development of SMN|1|||
170800049|NCT02112916|617279406|FG001|Overall Study|Development of SMN|0|||
170800050|NCT02112916|617279407|FG002|Overall Study|Development of SMN|0|||
170800051|NCT02112916|617279408|FG003|Overall Study|Development of SMN|1|||
170800052|NCT02112916|617279405|FG000|Overall Study|Relapse/Progression|10|||
170800053|NCT02112916|617279406|FG001|Overall Study|Relapse/Progression|18|||
170800054|NCT02112916|617279407|FG002|Overall Study|Relapse/Progression|15|||
170800055|NCT02112916|617279408|FG003|Overall Study|Relapse/Progression|2|||
170800056|NCT02112916|617279405|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
170800057|NCT02112916|617279406|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
170800058|NCT02112916|617279407|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
170800059|NCT02112916|617279408|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
170800060|NCT02112916|617279405|FG000|Overall Study|Still on Therapy|44|||
170800061|NCT02112916|617279406|FG001|Overall Study|Still on Therapy|47|||
170800062|NCT02112916|617279407|FG002|Overall Study|Still on Therapy|3|||
170800063|NCT02112916|617279408|FG003|Overall Study|Still on Therapy|2|||
170800064|NCT02112916|617279405|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
170800065|NCT02112916|617279406|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
170800066|NCT02112916|617279407|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
170800067|NCT02112916|617279408|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
170488625|NCT00685399|616132201|FG001|Treatment Period 1|Protocol Violation|0|||
170488626|NCT00685399|616132202|FG002|Treatment Period 1|Protocol Violation|0|||
170488627|NCT00685399|616132203|FG003|Treatment Period 1|Protocol Violation|0|||
170488628|NCT00685399|616132204|FG004|Treatment Period 1|Protocol Violation|0|||
170488629|NCT00685399|616132205|FG005|Treatment Period 1|Protocol Violation|0|||
170488630|NCT00685399|616132206|FG006|Treatment Period 1|Protocol Violation|0|||
170488631|NCT00685399|616132207|FG007|Treatment Period 1|Protocol Violation|0|||
170488632|NCT00685399|616132200|FG000|Treatment Period 1|Administrative|2|||
170488633|NCT00685399|616132201|FG001|Treatment Period 1|Administrative|0|||
170488634|NCT00685399|616132202|FG002|Treatment Period 1|Administrative|0|||
170488635|NCT00685399|616132203|FG003|Treatment Period 1|Administrative|0|||
170488636|NCT00685399|616132204|FG004|Treatment Period 1|Administrative|0|||
170488637|NCT00685399|616132205|FG005|Treatment Period 1|Administrative|0|||
170488638|NCT00685399|616132206|FG006|Treatment Period 1|Administrative|0|||
170488639|NCT00685399|616132207|FG007|Treatment Period 1|Administrative|0|||
170488640|NCT00685399|616132200|FG000|Treatment Period 1|Lack of Efficacy|1|||
170488641|NCT00685399|616132201|FG001|Treatment Period 1|Lack of Efficacy|0|||
170488642|NCT00685399|616132202|FG002|Treatment Period 1|Lack of Efficacy|0|||
170488643|NCT00685399|616132203|FG003|Treatment Period 1|Lack of Efficacy|0|||
170488644|NCT00685399|616132204|FG004|Treatment Period 1|Lack of Efficacy|0|||
170488645|NCT00685399|616132205|FG005|Treatment Period 1|Lack of Efficacy|0|||
170488646|NCT00685399|616132206|FG006|Treatment Period 1|Lack of Efficacy|0|||
170488647|NCT00685399|616132207|FG007|Treatment Period 1|Lack of Efficacy|0|||
170488648|NCT00685399|616132200|FG000|Treatment Period 2|Administrative Problems|0|||
170488649|NCT00685399|616132201|FG001|Treatment Period 2|Administrative Problems|2|||
170488650|NCT00685399|616132202|FG002|Treatment Period 2|Administrative Problems|1|||
170800068|NCT02112916|617279405|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
170800069|NCT02112916|617279406|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
170800070|NCT02112916|617279407|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
170800071|NCT02112916|617279408|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
170800072|NCT04174560|617279416|FG000|Overall Study|Lost to Follow-up|1|||
170899643|NCT01071070|617637716|FG000|Overall Study|Adverse Event|0|||
170899644|NCT01071070|617637717|FG001|Overall Study|Adverse Event|3|||
170899645|NCT01071070|617637716|FG000|Overall Study|Withdrawal by Subject|1|||
170488651|NCT00685399|616132203|FG003|Treatment Period 2|Administrative Problems|0|||
170488652|NCT00685399|616132204|FG004|Treatment Period 2|Administrative Problems|0|||
170488653|NCT00685399|616132205|FG005|Treatment Period 2|Administrative Problems|0|||
170488654|NCT00685399|616132206|FG006|Treatment Period 2|Administrative Problems|0|||
170800073|NCT04174560|617279417|FG001|Overall Study|Lost to Follow-up|0|||
170800074|NCT04174560|617279418|FG002|Overall Study|Lost to Follow-up|0|||
170488655|NCT00685399|616132207|FG007|Treatment Period 2|Administrative Problems|0|||
170488656|NCT00685399|616132200|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170549189|NCT02675452|616354812|FG007|Overall Study|Withdrawal by Subject|0|||
170549190|NCT02675452|616354813|FG008|Overall Study|Withdrawal by Subject|0|||
170800075|NCT04174560|617279419|FG003|Overall Study|Lost to Follow-up|0|||
170800076|NCT04174560|617279416|FG000|Overall Study|Withdrawal by Subject|0|||
170899646|NCT01071070|617637717|FG001|Overall Study|Withdrawal by Subject|0|||
170899647|NCT01071070|617637716|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
170899648|NCT01071070|617637717|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
170899649|NCT01071070|617637716|FG000|Overall Study|Hypercalcemia|1|||
170899650|NCT01071070|617637717|FG001|Overall Study|Hypercalcemia|0|||
170899651|NCT00195650|617637720|FG000|Overall Study|Adverse Event|194|||
170899652|NCT00195650|617637720|FG000|Overall Study|Lack of Efficacy|99|||
170899653|NCT00195650|617637720|FG000|Overall Study|Withdrawal by Subject|67|||
170488657|NCT00685399|616132201|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170488658|NCT00685399|616132202|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170488659|NCT00685399|616132203|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170488660|NCT00685399|616132204|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170488661|NCT00685399|616132205|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170488662|NCT00685399|616132206|FG006|Treatment Period 2|Withdrawal by Subject|0|||
170488663|NCT00685399|616132207|FG007|Treatment Period 2|Withdrawal by Subject|2|||
170488664|NCT00685399|616132200|FG000|Treatment Period 2|Adverse Event|0|||
170488665|NCT00685399|616132201|FG001|Treatment Period 2|Adverse Event|0|||
170488666|NCT00685399|616132202|FG002|Treatment Period 2|Adverse Event|0|||
170899654|NCT00195650|617637720|FG000|Overall Study|Lost to Follow-up|44|||
170899655|NCT00195650|617637720|FG000|Overall Study|Death|23|||
170488667|NCT00685399|616132203|FG003|Treatment Period 2|Adverse Event|0|||
170488668|NCT00685399|616132204|FG004|Treatment Period 2|Adverse Event|0|||
170488669|NCT00685399|616132205|FG005|Treatment Period 2|Adverse Event|1|||
170488670|NCT00685399|616132206|FG006|Treatment Period 2|Adverse Event|0|||
170488671|NCT00685399|616132207|FG007|Treatment Period 2|Adverse Event|0|||
170488672|NCT00685399|616132200|FG000|Treatment Period 2|Lack of Efficacy|0|||
170488673|NCT00685399|616132201|FG001|Treatment Period 2|Lack of Efficacy|10|||
170488674|NCT00685399|616132202|FG002|Treatment Period 2|Lack of Efficacy|2|||
170488675|NCT00685399|616132203|FG003|Treatment Period 2|Lack of Efficacy|0|||
170488676|NCT00685399|616132204|FG004|Treatment Period 2|Lack of Efficacy|0|||
170488677|NCT00685399|616132205|FG005|Treatment Period 2|Lack of Efficacy|1|||
170488678|NCT00685399|616132206|FG006|Treatment Period 2|Lack of Efficacy|0|||
170488679|NCT00685399|616132207|FG007|Treatment Period 2|Lack of Efficacy|0|||
170488680|NCT00685399|616132200|FG000|Extension|Administrative Issues|0|||
170488681|NCT00685399|616132201|FG001|Extension|Administrative Issues|0|||
170488682|NCT00685399|616132202|FG002|Extension|Administrative Issues|0|||
170488683|NCT00685399|616132203|FG003|Extension|Administrative Issues|1|||
170488684|NCT00685399|616132204|FG004|Extension|Administrative Issues|0|||
170488685|NCT00685399|616132205|FG005|Extension|Administrative Issues|0|||
170488686|NCT00685399|616132206|FG006|Extension|Administrative Issues|0|||
170488687|NCT00685399|616132207|FG007|Extension|Administrative Issues|0|||
170488688|NCT00685399|616132200|FG000|Extension|Withdrawal by Subject|0|||
170488689|NCT00685399|616132201|FG001|Extension|Withdrawal by Subject|0|||
170488690|NCT00685399|616132202|FG002|Extension|Withdrawal by Subject|0|||
170488691|NCT00685399|616132203|FG003|Extension|Withdrawal by Subject|1|||
170488692|NCT00685399|616132204|FG004|Extension|Withdrawal by Subject|0|||
170899656|NCT00195650|617637720|FG000|Overall Study|Protocol Violation|15|||
170488693|NCT00685399|616132205|FG005|Extension|Withdrawal by Subject|0|||
170488694|NCT00685399|616132206|FG006|Extension|Withdrawal by Subject|0|||
170488695|NCT00685399|616132207|FG007|Extension|Withdrawal by Subject|0|||
170488696|NCT00685399|616132200|FG000|Extension|Protocol Violation|0|||
170488697|NCT00685399|616132201|FG001|Extension|Protocol Violation|0|||
170488698|NCT00685399|616132202|FG002|Extension|Protocol Violation|0|||
170488699|NCT00685399|616132203|FG003|Extension|Protocol Violation|1|||
170488700|NCT00685399|616132204|FG004|Extension|Protocol Violation|0|||
170488701|NCT00685399|616132205|FG005|Extension|Protocol Violation|0|||
170488702|NCT00685399|616132206|FG006|Extension|Protocol Violation|0|||
170488703|NCT00685399|616132207|FG007|Extension|Protocol Violation|0|||
170488704|NCT00685399|616132200|FG000|Extension|Lack of Efficacy|0|||
170488705|NCT00685399|616132201|FG001|Extension|Lack of Efficacy|0|||
170488706|NCT00685399|616132202|FG002|Extension|Lack of Efficacy|0|||
170488707|NCT00685399|616132203|FG003|Extension|Lack of Efficacy|2|||
170488708|NCT00685399|616132204|FG004|Extension|Lack of Efficacy|0|||
170488709|NCT00685399|616132205|FG005|Extension|Lack of Efficacy|0|||
170488710|NCT00685399|616132206|FG006|Extension|Lack of Efficacy|0|||
170488711|NCT00685399|616132207|FG007|Extension|Lack of Efficacy|0|||
170899657|NCT00195650|617637720|FG000|Overall Study|Administrative reasons|83|||
170899658|NCT00629083|617637726|FG000|Overall Study|Adverse Event|0|||
170899659|NCT00629083|617637727|FG001|Overall Study|Adverse Event|2|||
170488712|NCT00685399|616132200|FG000|Extension|Adverse Event|0|||
170488713|NCT00685399|616132201|FG001|Extension|Adverse Event|0|||
170488714|NCT00685399|616132202|FG002|Extension|Adverse Event|0|||
170899660|NCT00629083|617637726|FG000|Overall Study|Lack of Efficacy|3|||
170899661|NCT00629083|617637727|FG001|Overall Study|Lack of Efficacy|1|||
170899662|NCT00629083|617637726|FG000|Overall Study|Withdrawal by Subject|10|||
170899663|NCT00629083|617637727|FG001|Overall Study|Withdrawal by Subject|2|||
170488715|NCT00685399|616132203|FG003|Extension|Adverse Event|2|||
170488716|NCT00685399|616132204|FG004|Extension|Adverse Event|0|||
170488717|NCT00685399|616132205|FG005|Extension|Adverse Event|0|||
170488718|NCT00685399|616132206|FG006|Extension|Adverse Event|0|||
170488719|NCT00685399|616132207|FG007|Extension|Adverse Event|0|||
170488720|NCT02088905|616132208|FG000|Overall Study|Withdrawal by Subject|5|||
170488721|NCT02088905|616132209|FG001|Overall Study|Withdrawal by Subject|1|||
170488722|NCT01421225|616132217|FG000|Overall Study|Withdrawal by Subject|0|||
170488723|NCT01421225|616132218|FG001|Overall Study|Withdrawal by Subject|1|||
170488724|NCT01106911|616132221|FG000|Overall Study|Physician Decision|2|||
170488725|NCT01106911|616132221|FG000|Overall Study|deemed ineligible after screening|3|||
170488726|NCT01282372|616132223|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
170488727|NCT01282372|616132223|FG000|Overall Study|Lost to Follow-up|23|||
170488728|NCT01282372|616132223|FG000|Overall Study|Withdrawal by Subject|11|||
170488729|NCT01282372|616132223|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
170488730|NCT01282372|616132223|FG000|Overall Study|Death|1|||
170488731|NCT01282372|616132223|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
170488732|NCT01282372|616132223|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
170488733|NCT01282372|616132223|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
170488734|NCT01282372|616132223|FG000|Overall Study|Adverse Event|12|||
170488735|NCT02993250|616132225|FG000|Overall Study|Lost to Follow-up|0|||
170488736|NCT02993250|616132226|FG001|Overall Study|Lost to Follow-up|1|||
170488737|NCT02861807|616132228|FG000|Overall Study|Lost to Follow-up|7|||
170488738|NCT02861807|616132229|FG001|Overall Study|Lost to Follow-up|6|||
170488739|NCT02861807|616132228|FG000|Overall Study|Withdrawal by Subject|5|||
170488740|NCT02861807|616132229|FG001|Overall Study|Withdrawal by Subject|8|||
170488741|NCT00568061|616132232|FG000|Overall Study|Inclusion / exclusion criteria|5|||
170488742|NCT00568061|616132233|FG001|Overall Study|Inclusion / exclusion criteria|1|||
170488743|NCT00568061|616132232|FG000|Overall Study|Adverse Event|0|||
170488744|NCT00568061|616132233|FG001|Overall Study|Adverse Event|1|||
170488745|NCT00356148|616132234|FG000|Overall Study|Reoperation within 30 days|2|||
170488746|NCT00356148|616132235|FG001|Overall Study|Reoperation within 30 days|1|||
170488747|NCT02343939|616132244|FG000|Overall Study|Death|0|||
170488748|NCT02343939|616132245|FG001|Overall Study|Death|15|||
170488749|NCT02343939|616132246|FG002|Overall Study|Death|4|||
170488750|NCT02343939|616132247|FG003|Overall Study|Death|2|||
170488751|NCT02343939|616132248|FG004|Overall Study|Death|5|||
170488752|NCT02343939|616132249|FG005|Overall Study|Death|11|||
170488753|NCT02343939|616132250|FG006|Overall Study|Death|8|||
170488754|NCT02343939|616132251|FG007|Overall Study|Death|22|||
170488755|NCT02343939|616132252|FG008|Overall Study|Death|1|||
170488756|NCT02343939|616132244|FG000|Overall Study|Study terminated by sponsor|0|||
170488757|NCT02343939|616132245|FG001|Overall Study|Study terminated by sponsor|27|||
170488758|NCT02343939|616132246|FG002|Overall Study|Study terminated by sponsor|0|||
170488759|NCT02343939|616132247|FG003|Overall Study|Study terminated by sponsor|1|||
170488760|NCT02343939|616132248|FG004|Overall Study|Study terminated by sponsor|1|||
170488761|NCT02343939|616132249|FG005|Overall Study|Study terminated by sponsor|5|||
170488762|NCT02343939|616132250|FG006|Overall Study|Study terminated by sponsor|3|||
170488763|NCT02343939|616132251|FG007|Overall Study|Study terminated by sponsor|4|||
170488764|NCT02343939|616132252|FG008|Overall Study|Study terminated by sponsor|0|||
170488765|NCT02343939|616132244|FG000|Overall Study|Withdrew consent|3|||
170488766|NCT02343939|616132245|FG001|Overall Study|Withdrew consent|6|||
170488767|NCT02343939|616132246|FG002|Overall Study|Withdrew consent|1|||
170488768|NCT02343939|616132247|FG003|Overall Study|Withdrew consent|2|||
170488769|NCT02343939|616132248|FG004|Overall Study|Withdrew consent|2|||
170488770|NCT02343939|616132249|FG005|Overall Study|Withdrew consent|0|||
170488771|NCT02343939|616132250|FG006|Overall Study|Withdrew consent|0|||
170488772|NCT02343939|616132251|FG007|Overall Study|Withdrew consent|8|||
170488773|NCT02343939|616132252|FG008|Overall Study|Withdrew consent|6|||
170488774|NCT02343939|616132244|FG000|Overall Study|Treatment failure|0|||
170488775|NCT02343939|616132245|FG001|Overall Study|Treatment failure|0|||
170488776|NCT02343939|616132246|FG002|Overall Study|Treatment failure|0|||
170488777|NCT02343939|616132247|FG003|Overall Study|Treatment failure|0|||
170488778|NCT02343939|616132248|FG004|Overall Study|Treatment failure|0|||
170488779|NCT02343939|616132249|FG005|Overall Study|Treatment failure|0|||
170488780|NCT02343939|616132250|FG006|Overall Study|Treatment failure|2|||
170488781|NCT02343939|616132251|FG007|Overall Study|Treatment failure|1|||
170488782|NCT02343939|616132252|FG008|Overall Study|Treatment failure|0|||
170488783|NCT02343939|616132244|FG000|Overall Study|Investigator's discretion|0|||
170488784|NCT02343939|616132245|FG001|Overall Study|Investigator's discretion|0|||
170488785|NCT02343939|616132246|FG002|Overall Study|Investigator's discretion|0|||
170488786|NCT02343939|616132247|FG003|Overall Study|Investigator's discretion|1|||
170488787|NCT02343939|616132248|FG004|Overall Study|Investigator's discretion|0|||
170488788|NCT02343939|616132249|FG005|Overall Study|Investigator's discretion|0|||
170488789|NCT02343939|616132250|FG006|Overall Study|Investigator's discretion|1|||
170488790|NCT02343939|616132251|FG007|Overall Study|Investigator's discretion|0|||
170488791|NCT02343939|616132252|FG008|Overall Study|Investigator's discretion|0|||
170488792|NCT02343939|616132244|FG000|Overall Study|Adverse Event|0|||
170488793|NCT02343939|616132245|FG001|Overall Study|Adverse Event|0|||
170488794|NCT02343939|616132246|FG002|Overall Study|Adverse Event|0|||
170488795|NCT02343939|616132247|FG003|Overall Study|Adverse Event|0|||
170488796|NCT02343939|616132248|FG004|Overall Study|Adverse Event|0|||
170488797|NCT02343939|616132249|FG005|Overall Study|Adverse Event|1|||
170488798|NCT02343939|616132250|FG006|Overall Study|Adverse Event|0|||
170488799|NCT02343939|616132251|FG007|Overall Study|Adverse Event|0|||
170488800|NCT02343939|616132252|FG008|Overall Study|Adverse Event|0|||
170488801|NCT02343939|616132244|FG000|Overall Study|Never Treated With ENTO|0|||
170488802|NCT02343939|616132245|FG001|Overall Study|Never Treated With ENTO|0|||
170488803|NCT02343939|616132246|FG002|Overall Study|Never Treated With ENTO|0|||
170488804|NCT02343939|616132247|FG003|Overall Study|Never Treated With ENTO|0|||
170488805|NCT02343939|616132248|FG004|Overall Study|Never Treated With ENTO|0|||
170488806|NCT02343939|616132249|FG005|Overall Study|Never Treated With ENTO|0|||
170488807|NCT02343939|616132250|FG006|Overall Study|Never Treated With ENTO|1|||
170488808|NCT02343939|616132251|FG007|Overall Study|Never Treated With ENTO|2|||
170488809|NCT02343939|616132252|FG008|Overall Study|Never Treated With ENTO|0|||
170488810|NCT02064816|616132253|FG000|Overall Study|Adverse Event|3|||
170488811|NCT02064816|616132254|FG001|Overall Study|Adverse Event|2|||
170488812|NCT02064816|616132253|FG000|Overall Study|Withdrawal by Subject|2|||
170488813|NCT02064816|616132254|FG001|Overall Study|Withdrawal by Subject|1|||
170488814|NCT02064816|616132253|FG000|Overall Study|Lost to Follow-up|2|||
170488815|NCT02064816|616132254|FG001|Overall Study|Lost to Follow-up|1|||
170488816|NCT02064816|616132253|FG000|Overall Study|Therapeutic failure|0|||
170488817|NCT02064816|616132254|FG001|Overall Study|Therapeutic failure|1|||
170488818|NCT02064816|616132253|FG000|Overall Study|Other|1|||
170488819|NCT02064816|616132254|FG001|Overall Study|Other|3|||
170488820|NCT02505217|616132255|FG000|Overall Study|Withdrawal by Subject|1|||
170488821|NCT02505217|616132256|FG001|Overall Study|Withdrawal by Subject|2|||
170640569|NCT04473235|616696905|FG001|Overall Study|Declined continuation|0|||
170640570|NCT04473235|616696904|FG000|Overall Study|Physician Decision|1|||
170640571|NCT04473235|616696905|FG001|Overall Study|Physician Decision|1|||
170640572|NCT04473235|616696904|FG000|Overall Study|Protocol Violation|10|||
170640573|NCT04473235|616696905|FG001|Overall Study|Protocol Violation|6|||
170640574|NCT00727441|616696906|FG000|Overall Study|Disease Progression|11|||
170640575|NCT00727441|616696907|FG001|Overall Study|Disease Progression|14|||
170640576|NCT00727441|616696908|FG002|Overall Study|Disease Progression|17|||
170640577|NCT00727441|616696906|FG000|Overall Study|Eligibility|7|||
170640578|NCT00727441|616696907|FG001|Overall Study|Eligibility|5|||
170640579|NCT00727441|616696908|FG002|Overall Study|Eligibility|7|||
170640580|NCT00727441|616696906|FG000|Overall Study|Death|0|||
170640581|NCT00727441|616696907|FG001|Overall Study|Death|1|||
170640582|NCT00727441|616696908|FG002|Overall Study|Death|1|||
170640583|NCT00727441|616696906|FG000|Overall Study|Physician Decision|0|||
170640584|NCT00727441|616696907|FG001|Overall Study|Physician Decision|1|||
170640585|NCT00727441|616696908|FG002|Overall Study|Physician Decision|0|||
170640586|NCT00727441|616696906|FG000|Overall Study|Withdrawal by Subject|0|||
170640587|NCT00727441|616696907|FG001|Overall Study|Withdrawal by Subject|1|||
170640588|NCT00727441|616696908|FG002|Overall Study|Withdrawal by Subject|0|||
170640589|NCT02810444|616696909|FG000|Overall Study|Screen Failures|14|||
170640590|NCT02810444|616696909|FG000|Overall Study|Withdrawal by Subject|4|||
170640591|NCT02810444|616696909|FG000|Overall Study|Adverse Event|3|||
170640592|NCT01754727|616696910|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
170640593|NCT02785770|616696911|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
170640594|NCT02785770|616696912|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
170640595|NCT02785770|616696913|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
170640596|NCT02785770|616696914|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
170640597|NCT02785770|616696911|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
170640598|NCT02785770|616696912|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
170640599|NCT02785770|616696913|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
170640600|NCT02785770|616696914|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
170640601|NCT02785770|616696911|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
170640602|NCT02785770|616696912|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
170640603|NCT02785770|616696913|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
170640604|NCT02785770|616696914|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
170640605|NCT02848729|616696917|FG000|Overall Study|Withdrawal by Subject|1|||
170488822|NCT03564119|616132262|FG000|Overall Study|Adverse Event|4|||
170488823|NCT03564119|616132263|FG001|Overall Study|Adverse Event|0|||
170488824|NCT03564119|616132262|FG000|Overall Study|Lost to Follow-up|1|||
170488825|NCT03564119|616132263|FG001|Overall Study|Lost to Follow-up|4|||
170488826|NCT03564119|616132262|FG000|Overall Study|Protocol Violation|1|||
170640606|NCT02848729|616696918|FG001|Overall Study|Withdrawal by Subject|0|||
170488827|NCT03564119|616132263|FG001|Overall Study|Protocol Violation|0|||
170488828|NCT03564119|616132262|FG000|Overall Study|Withdrawal by Subject|9|||
170488829|NCT03564119|616132263|FG001|Overall Study|Withdrawal by Subject|4|||
170640607|NCT02848729|616696917|FG000|Overall Study|Emesis|15|||
170640608|NCT02848729|616696918|FG001|Overall Study|Emesis|11|||
170640609|NCT01343693|616696920|FG000|Overall Study|Lost to Follow-up|9|||
170640610|NCT01235598|616696921|FG000|Overall Study|Adverse Event|0|||
170640611|NCT01235598|616696922|FG001|Overall Study|Adverse Event|3|||
170800077|NCT04174560|617279417|FG001|Overall Study|Withdrawal by Subject|0|||
170800078|NCT04174560|617279418|FG002|Overall Study|Withdrawal by Subject|2|||
170800079|NCT04174560|617279419|FG003|Overall Study|Withdrawal by Subject|0|||
170800080|NCT05424718|617279423|FG000|Overall Study|Lost to Follow-up|5|||
170800081|NCT05424718|617279424|FG001|Overall Study|Lost to Follow-up|4|||
170488830|NCT03564119|616132262|FG000|Overall Study|Other Than Specified|0|||
170488831|NCT03564119|616132263|FG001|Overall Study|Other Than Specified|1|||
170488832|NCT03517540|616132264|FG000|Overall Study|Protocol Violation|2|||
170488833|NCT03517540|616132265|FG001|Overall Study|Protocol Violation|0|||
170488834|NCT03517540|616132266|FG002|Overall Study|Protocol Violation|0|||
170488835|NCT03517540|616132267|FG003|Overall Study|Protocol Violation|1|||
170488836|NCT03517540|616132264|FG000|Overall Study|Adverse Event|9|||
170488837|NCT03517540|616132265|FG001|Overall Study|Adverse Event|3|||
170488838|NCT03517540|616132266|FG002|Overall Study|Adverse Event|8|||
170488839|NCT03517540|616132267|FG003|Overall Study|Adverse Event|1|||
170488840|NCT03517540|616132264|FG000|Overall Study|Withdrawal by Subject|3|||
170488841|NCT03517540|616132265|FG001|Overall Study|Withdrawal by Subject|4|||
170488842|NCT03517540|616132266|FG002|Overall Study|Withdrawal by Subject|1|||
170488843|NCT03517540|616132267|FG003|Overall Study|Withdrawal by Subject|3|||
170488844|NCT03896022|616132268|FG000|Overall Study|Withdrawal by Subject|1|||
170488845|NCT03896022|616132269|FG001|Overall Study|Withdrawal by Subject|0|||
170488846|NCT03896022|616132270|FG002|Overall Study|Withdrawal by Subject|0|||
170488847|NCT03896022|616132268|FG000|Overall Study|Did not have procedure|3|||
170488848|NCT03896022|616132269|FG001|Overall Study|Did not have procedure|0|||
170488849|NCT03896022|616132270|FG002|Overall Study|Did not have procedure|0|||
170488850|NCT00615550|616132275|FG000|Overall Study|Lost to Follow-up|6|||
170488851|NCT00615550|616132276|FG001|Overall Study|Lost to Follow-up|1|||
170488852|NCT01408303|616132277|FG000|Overall Study|Adverse Event|3|||
170488853|NCT01408303|616132278|FG001|Overall Study|Adverse Event|7|||
170488854|NCT01408303|616132279|FG002|Overall Study|Adverse Event|2|||
170488855|NCT01408303|616132277|FG000|Overall Study|Lost to Follow-up|0|||
170488856|NCT01408303|616132278|FG001|Overall Study|Lost to Follow-up|1|||
170488857|NCT01408303|616132279|FG002|Overall Study|Lost to Follow-up|2|||
170488858|NCT01408303|616132277|FG000|Overall Study|Withdrawal by Subject|2|||
170488859|NCT01408303|616132278|FG001|Overall Study|Withdrawal by Subject|3|||
170488860|NCT01408303|616132279|FG002|Overall Study|Withdrawal by Subject|1|||
170488861|NCT01408303|616132277|FG000|Overall Study|Protocol Violation|0|||
170488862|NCT01408303|616132278|FG001|Overall Study|Protocol Violation|1|||
170488863|NCT01408303|616132279|FG002|Overall Study|Protocol Violation|0|||
170488864|NCT01408303|616132277|FG000|Overall Study|Noncompliance|1|||
170488865|NCT01408303|616132278|FG001|Overall Study|Noncompliance|0|||
170488866|NCT01408303|616132279|FG002|Overall Study|Noncompliance|1|||
170488867|NCT01801865|616132280|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
170488868|NCT01801865|616132280|FG000|Overall Study|Physician Decision|7|||
170488869|NCT02644668|616132281|FG000|Overall Study|Adverse Event|2|||
170488870|NCT02644668|616132282|FG001|Overall Study|Adverse Event|0|||
170488871|NCT02644668|616132283|FG002|Overall Study|Adverse Event|1|||
170488872|NCT02644668|616132281|FG000|Overall Study|Protocol Violation|0|||
170488873|NCT02644668|616132282|FG001|Overall Study|Protocol Violation|0|||
170488874|NCT02644668|616132283|FG002|Overall Study|Protocol Violation|1|||
170488875|NCT02644668|616132281|FG000|Overall Study|Withdrawal by Subject|0|||
170488876|NCT02644668|616132282|FG001|Overall Study|Withdrawal by Subject|0|||
170488877|NCT02644668|616132283|FG002|Overall Study|Withdrawal by Subject|1|||
170488878|NCT01500382|616132286|FG000|Washout Period|Study site went out of business|0|||
170549191|NCT02675452|616354814|FG009|Overall Study|Withdrawal by Subject|1|||
170549192|NCT02675452|616354815|FG010|Overall Study|Withdrawal by Subject|0|||
170549193|NCT02675452|616354816|FG011|Overall Study|Withdrawal by Subject|1|||
170549194|NCT02675452|616354817|FG012|Overall Study|Withdrawal by Subject|0|||
170800082|NCT04046549|617279425|FG000|Overall Study|Adverse Event|1|||
170800083|NCT04046549|617279425|FG000|Overall Study|Physician Decision|1|||
170800084|NCT04046549|617279425|FG000|Overall Study|Withdrawal by Subject|3|||
170800085|NCT04046549|617279425|FG000|Overall Study|Other, Not Specified|5|||
170800086|NCT01220531|617279427|FG000|Overall Study|Death|7|||
170800087|NCT01220531|617279427|FG000|Overall Study|Lost to Follow-up|1|||
170800088|NCT04908514|617279428|FG000|Overall Study|Lost to Follow-up|2|||
170800089|NCT04908514|617279428|FG000|Overall Study|Withdrawal by Subject|1|||
170488879|NCT01500382|616132287|FG001|Washout Period|Study site went out of business|0|||
170488880|NCT01500382|616132288|FG002|Washout Period|Study site went out of business|1|||
170488881|NCT01500382|616132289|FG003|Washout Period|Study site went out of business|0|||
170488882|NCT05763875|616132294|FG000|Overall Study|Subject decision|5|||
170488883|NCT05763875|616132295|FG001|Overall Study|Subject decision|2|||
170488884|NCT05763875|616132296|FG002|Overall Study|Subject decision|1|||
170488885|NCT05763875|616132294|FG000|Overall Study|Lost to Follow-up|4|||
170488886|NCT05763875|616132295|FG001|Overall Study|Lost to Follow-up|1|||
170549195|NCT02675452|616354818|FG013|Overall Study|Withdrawal by Subject|1|||
170549196|NCT02675452|616354819|FG014|Overall Study|Withdrawal by Subject|1|||
170800090|NCT04755595|617279436|FG000|Overall Study|Lost to Follow-up|1|||
170640612|NCT01235598|616696921|FG000|Overall Study|Lack of Efficacy|0|||
170640613|NCT01235598|616696922|FG001|Overall Study|Lack of Efficacy|1|||
170488887|NCT05763875|616132296|FG002|Overall Study|Lost to Follow-up|2|||
170640614|NCT01235598|616696921|FG000|Overall Study|Withdrawal by Subject|1|||
170800091|NCT04305327|617279437|FG000|Overall Study|Study early termination|2|||
170488888|NCT05763875|616132294|FG000|Overall Study|Adverse Event|1|||
170488889|NCT05763875|616132295|FG001|Overall Study|Adverse Event|0|||
170488890|NCT05763875|616132296|FG002|Overall Study|Adverse Event|0|||
170488891|NCT01777282|616132297|FG000|Overall Study|Persistent Hyperglycemia|0|||
170488892|NCT01777282|616132298|FG001|Overall Study|Persistent Hyperglycemia|0|||
170488893|NCT01777282|616132299|FG002|Overall Study|Persistent Hyperglycemia|1|||
170488894|NCT01777282|616132300|FG003|Overall Study|Persistent Hyperglycemia|0|||
170488895|NCT01777282|616132301|FG004|Overall Study|Persistent Hyperglycemia|0|||
170488896|NCT01777282|616132297|FG000|Overall Study|New Antidiabetic Medication|0|||
170488897|NCT01777282|616132298|FG001|Overall Study|New Antidiabetic Medication|0|||
170488898|NCT01777282|616132299|FG002|Overall Study|New Antidiabetic Medication|1|||
170488899|NCT01777282|616132300|FG003|Overall Study|New Antidiabetic Medication|0|||
170488900|NCT01777282|616132301|FG004|Overall Study|New Antidiabetic Medication|0|||
170488901|NCT01777282|616132297|FG000|Overall Study|Adverse Event|4|||
170488902|NCT01777282|616132298|FG001|Overall Study|Adverse Event|4|||
170488903|NCT01777282|616132299|FG002|Overall Study|Adverse Event|2|||
170488904|NCT01777282|616132300|FG003|Overall Study|Adverse Event|1|||
170488905|NCT01777282|616132301|FG004|Overall Study|Adverse Event|3|||
170488906|NCT01777282|616132297|FG000|Overall Study|Withdrawal by Subject|4|||
170488907|NCT01777282|616132298|FG001|Overall Study|Withdrawal by Subject|0|||
170488908|NCT01777282|616132299|FG002|Overall Study|Withdrawal by Subject|0|||
170488909|NCT01777282|616132300|FG003|Overall Study|Withdrawal by Subject|1|||
170488910|NCT01777282|616132301|FG004|Overall Study|Withdrawal by Subject|2|||
170488911|NCT01777282|616132297|FG000|Overall Study|Protocol Violation|2|||
170488912|NCT01777282|616132298|FG001|Overall Study|Protocol Violation|0|||
170488913|NCT01777282|616132299|FG002|Overall Study|Protocol Violation|1|||
170488914|NCT01777282|616132300|FG003|Overall Study|Protocol Violation|0|||
170488915|NCT01777282|616132301|FG004|Overall Study|Protocol Violation|2|||
170488916|NCT01777282|616132297|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
170488917|NCT01777282|616132298|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
170488918|NCT01777282|616132299|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
170488919|NCT01777282|616132300|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
170488920|NCT01777282|616132301|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
170488921|NCT00550745|616132302|FG000|Overall Study|Death|20|||
170488922|NCT00550745|616132303|FG001|Overall Study|Death|16|||
170488923|NCT00550745|616132302|FG000|Overall Study|Lost to Follow-up|45|||
170488924|NCT00550745|616132303|FG001|Overall Study|Lost to Follow-up|30|||
170488925|NCT00550745|616132302|FG000|Overall Study|Physician Decision|0|||
170488926|NCT00550745|616132303|FG001|Overall Study|Physician Decision|2|||
170488927|NCT00550745|616132302|FG000|Overall Study|Protocol Violation|4|||
170488928|NCT00550745|616132303|FG001|Overall Study|Protocol Violation|2|||
170488929|NCT00550745|616132302|FG000|Overall Study|Withdrawal by Subject|17|||
170488930|NCT00550745|616132303|FG001|Overall Study|Withdrawal by Subject|10|||
170488931|NCT00550745|616132302|FG000|Overall Study|Screen failure|1|||
170488932|NCT00550745|616132303|FG001|Overall Study|Screen failure|0|||
170488933|NCT00764660|616132304|FG000|Overall Study|Adverse Event|6|||
170488934|NCT00764660|616132305|FG001|Overall Study|Adverse Event|3|||
170488935|NCT00764660|616132304|FG000|Overall Study|Lost to Follow-up|3|||
170488936|NCT00764660|616132305|FG001|Overall Study|Lost to Follow-up|4|||
170488937|NCT00764660|616132304|FG000|Overall Study|Withdrawal by Subject|7|||
170488938|NCT00764660|616132305|FG001|Overall Study|Withdrawal by Subject|3|||
170488939|NCT00764660|616132304|FG000|Overall Study|Noncompliance With Protocol|5|||
170488940|NCT00764660|616132305|FG001|Overall Study|Noncompliance With Protocol|1|||
170800092|NCT04305327|617279438|FG001|Overall Study|Study early termination|5|||
170800093|NCT04305327|617279439|FG002|Overall Study|Study early termination|2|||
170800094|NCT04305327|617279440|FG003|Overall Study|Study early termination|2|||
170800095|NCT04305327|617279437|FG000|Overall Study|Withdrawal by Subject|0|||
170800096|NCT04305327|617279438|FG001|Overall Study|Withdrawal by Subject|1|||
170800097|NCT04305327|617279439|FG002|Overall Study|Withdrawal by Subject|0|||
170800098|NCT04305327|617279440|FG003|Overall Study|Withdrawal by Subject|0|||
170800099|NCT05864209|617280178|FG000|Overall Study|Lost to Follow-up|2|||
170800100|NCT05864209|617280179|FG001|Overall Study|Lost to Follow-up|3|||
170640615|NCT01235598|616696922|FG001|Overall Study|Withdrawal by Subject|0|||
170488941|NCT00764660|616132304|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
170488942|NCT00764660|616132305|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
170488943|NCT00068393|616133756|FG000|Overall Study|Adverse Event|2|||
170488944|NCT00068393|616133756|FG000|Overall Study|Death|3|||
170488945|NCT00068393|616133756|FG000|Overall Study|Withdrawal by Subject|3|||
170800101|NCT05039021|617280180|FG000|Overall Study|Death|1|||
170488946|NCT00068393|616133756|FG000|Overall Study|Alternative treatment|1|||
170800102|NCT05039021|617280180|FG000|Overall Study|Lost to Follow-up|3|||
170800103|NCT04530487|617280181|FG000|Overall Study|Death|1|||
170488947|NCT00068393|616133756|FG000|Overall Study|Quality of life worsening|1|||
170488948|NCT01399047|616133757|FG000|Overall Study|Withdrawal by Subject|0|||
170488949|NCT01399047|616133758|FG001|Overall Study|Withdrawal by Subject|1|||
170488950|NCT03300505|616133775|FG000|Overall Study|Death|0|||
170488951|NCT03300505|616133776|FG001|Overall Study|Death|1|||
170488952|NCT03300505|616133777|FG002|Overall Study|Death|0|||
170488953|NCT03300505|616133775|FG000|Overall Study|Withdrawal by Subject|0|||
170488954|NCT03300505|616133776|FG001|Overall Study|Withdrawal by Subject|1|||
170488955|NCT03300505|616133777|FG002|Overall Study|Withdrawal by Subject|1|||
170488956|NCT03300505|616133775|FG000|Overall Study|Sponsor Termination|0|||
170488957|NCT03300505|616133776|FG001|Overall Study|Sponsor Termination|1|||
170488958|NCT03300505|616133777|FG002|Overall Study|Sponsor Termination|0|||
170488959|NCT03300505|616133775|FG000|Overall Study|Adverse Event|0|||
170488960|NCT03300505|616133776|FG001|Overall Study|Adverse Event|0|||
170549197|NCT02675452|616354820|FG015|Overall Study|Withdrawal by Subject|0|||
170549198|NCT02675452|616354821|FG016|Overall Study|Withdrawal by Subject|2|||
170549199|NCT02675452|616354822|FG017|Overall Study|Withdrawal by Subject|0|||
170549200|NCT02675452|616354823|FG018|Overall Study|Withdrawal by Subject|0|||
170549201|NCT02675452|616354824|FG019|Overall Study|Withdrawal by Subject|0|||
170549202|NCT02675452|616354825|FG020|Overall Study|Withdrawal by Subject|0|||
170549203|NCT02675452|616354826|FG021|Overall Study|Withdrawal by Subject|0|||
170549204|NCT02675452|616354827|FG022|Overall Study|Withdrawal by Subject|3|||
170549205|NCT02675452|616354828|FG023|Overall Study|Withdrawal by Subject|0|||
170549206|NCT02675452|616354829|FG024|Overall Study|Withdrawal by Subject|1|||
170549207|NCT02675452|616354830|FG025|Overall Study|Withdrawal by Subject|0|||
170549208|NCT02675452|616354831|FG026|Overall Study|Withdrawal by Subject|1|||
170549209|NCT02675452|616354832|FG027|Overall Study|Withdrawal by Subject|3|||
170549210|NCT02675452|616354833|FG028|Overall Study|Withdrawal by Subject|4|||
170549211|NCT02675452|616354805|FG000|Overall Study|Death|0|||
170549212|NCT02675452|616354806|FG001|Overall Study|Death|0|||
170549213|NCT02675452|616354807|FG002|Overall Study|Death|1|||
170549214|NCT02675452|616354808|FG003|Overall Study|Death|0|||
170549215|NCT02675452|616354809|FG004|Overall Study|Death|0|||
170549216|NCT02675452|616354810|FG005|Overall Study|Death|1|||
170549217|NCT02675452|616354811|FG006|Overall Study|Death|0|||
170549218|NCT02675452|616354812|FG007|Overall Study|Death|0|||
170549219|NCT02675452|616354813|FG008|Overall Study|Death|1|||
170549220|NCT02675452|616354814|FG009|Overall Study|Death|0|||
170549221|NCT02675452|616354815|FG010|Overall Study|Death|0|||
170549222|NCT02675452|616354816|FG011|Overall Study|Death|0|||
170549223|NCT02675452|616354817|FG012|Overall Study|Death|1|||
170549224|NCT02675452|616354818|FG013|Overall Study|Death|0|||
170549225|NCT02675452|616354819|FG014|Overall Study|Death|0|||
170549226|NCT02675452|616354820|FG015|Overall Study|Death|2|||
170549227|NCT02675452|616354821|FG016|Overall Study|Death|0|||
170549228|NCT02675452|616354822|FG017|Overall Study|Death|0|||
170549229|NCT02675452|616354823|FG018|Overall Study|Death|4|||
170549230|NCT02675452|616354824|FG019|Overall Study|Death|3|||
170549231|NCT02675452|616354825|FG020|Overall Study|Death|3|||
170549232|NCT02675452|616354826|FG021|Overall Study|Death|3|||
170549233|NCT02675452|616354827|FG022|Overall Study|Death|7|||
170549234|NCT02675452|616354828|FG023|Overall Study|Death|5|||
170549235|NCT02675452|616354829|FG024|Overall Study|Death|3|||
170549236|NCT02675452|616354830|FG025|Overall Study|Death|4|||
170549237|NCT02675452|616354831|FG026|Overall Study|Death|7|||
170549238|NCT02675452|616354832|FG027|Overall Study|Death|6|||
170488961|NCT03300505|616133777|FG002|Overall Study|Adverse Event|2|||
170488962|NCT05119595|616133778|FG000|Overall Study|Death|1|||
170488963|NCT05119595|616133778|FG000|Overall Study|Lost to Follow-up|7|||
170488964|NCT00769067|616133784|FG000|Overall Study|Death|89|||
170488965|NCT00769067|616133785|FG001|Overall Study|Death|86|||
170488966|NCT00769067|616133784|FG000|Overall Study|Lost to Follow-up|3|||
170488967|NCT00769067|616133785|FG001|Overall Study|Lost to Follow-up|1|||
170488968|NCT00769067|616133784|FG000|Overall Study|Study terminated by sponsor|1|||
170488969|NCT00769067|616133785|FG001|Overall Study|Study terminated by sponsor|3|||
170488970|NCT00769067|616133784|FG000|Overall Study|Other|1|||
170549239|NCT02675452|616354833|FG028|Overall Study|Death|9|||
170549240|NCT02675452|616354805|FG000|Overall Study|Lost to Follow-up|0|||
170549241|NCT02675452|616354806|FG001|Overall Study|Lost to Follow-up|1|||
170549242|NCT02675452|616354807|FG002|Overall Study|Lost to Follow-up|0|||
170488971|NCT00769067|616133785|FG001|Overall Study|Other|3|||
170488972|NCT00769067|616133784|FG000|Overall Study|Withdrawal by Subject|0|||
170549243|NCT02675452|616354808|FG003|Overall Study|Lost to Follow-up|0|||
170549244|NCT02675452|616354809|FG004|Overall Study|Lost to Follow-up|0|||
170549245|NCT02675452|616354810|FG005|Overall Study|Lost to Follow-up|0|||
170549246|NCT02675452|616354811|FG006|Overall Study|Lost to Follow-up|0|||
170549247|NCT02675452|616354812|FG007|Overall Study|Lost to Follow-up|0|||
170549248|NCT02675452|616354813|FG008|Overall Study|Lost to Follow-up|0|||
170549249|NCT02675452|616354814|FG009|Overall Study|Lost to Follow-up|0|||
170549250|NCT02675452|616354815|FG010|Overall Study|Lost to Follow-up|0|||
170549251|NCT02675452|616354816|FG011|Overall Study|Lost to Follow-up|0|||
170488973|NCT00769067|616133785|FG001|Overall Study|Withdrawal by Subject|1|||
170488974|NCT04981470|616133788|FG000|Overall Study|Device failure in all 4 patients|4|||
170488975|NCT04402138|616133789|FG000|Overall Study|Progressive Disease|2|||
170488976|NCT04402138|616133789|FG000|Overall Study|Adverse Event|1|||
170488977|NCT01073605|616133798|FG000|Overall Study|Ongoing at Cutoff Date|1|||
170488978|NCT01073605|616133799|FG001|Overall Study|Ongoing at Cutoff Date|1|||
170488979|NCT01073605|616133800|FG002|Overall Study|Ongoing at Cutoff Date|0|||
170488980|NCT01073605|616133798|FG000|Overall Study|Adverse Event|2|||
170488981|NCT01073605|616133799|FG001|Overall Study|Adverse Event|1|||
170488982|NCT01073605|616133800|FG002|Overall Study|Adverse Event|0|||
170488983|NCT01073605|616133798|FG000|Overall Study|Lost to Follow-up|3|||
170488984|NCT01073605|616133799|FG001|Overall Study|Lost to Follow-up|4|||
170488985|NCT01073605|616133800|FG002|Overall Study|Lost to Follow-up|9|||
170488986|NCT01073605|616133798|FG000|Overall Study|Other|25|||
170488987|NCT01073605|616133799|FG001|Overall Study|Other|21|||
170488988|NCT01073605|616133800|FG002|Overall Study|Other|29|||
170488989|NCT01073605|616133798|FG000|Overall Study|Withdrawal by Subject|31|||
170488990|NCT01073605|616133799|FG001|Overall Study|Withdrawal by Subject|39|||
170488991|NCT01073605|616133800|FG002|Overall Study|Withdrawal by Subject|22|||
170488992|NCT01073605|616133798|FG000|Overall Study|Randomized But Not Treated|0|||
170488993|NCT01073605|616133799|FG001|Overall Study|Randomized But Not Treated|1|||
170488994|NCT01073605|616133800|FG002|Overall Study|Randomized But Not Treated|1|||
170488995|NCT03491462|616133801|FG000|Overall Study|Lost to Follow-up|2|||
170488996|NCT03491462|616133802|FG001|Overall Study|Lost to Follow-up|0|||
170488997|NCT03491462|616133801|FG000|Overall Study|Adverse Event|11|||
170488998|NCT03491462|616133802|FG001|Overall Study|Adverse Event|1|||
170488999|NCT03491462|616133801|FG000|Overall Study|Physician Decision|3|||
170489000|NCT03491462|616133802|FG001|Overall Study|Physician Decision|0|||
170489001|NCT03491462|616133801|FG000|Overall Study|Withdrawal by Subject|22|||
170489002|NCT03491462|616133802|FG001|Overall Study|Withdrawal by Subject|15|||
170489003|NCT03018080|616133803|FG000|Overall Study|Death|12|||
170489004|NCT03018080|616133804|FG001|Overall Study|Death|19|||
170489005|NCT00740792|616133805|FG000|Overall Study|Adverse Event|3|||
170489006|NCT00740792|616133806|FG001|Overall Study|Adverse Event|1|||
170489007|NCT00740792|616133807|FG002|Overall Study|Adverse Event|1|||
170489008|NCT00740792|616133808|FG003|Overall Study|Adverse Event|3|||
170489009|NCT00740792|616133805|FG000|Overall Study|Lack of Efficacy|1|||
170489010|NCT00740792|616133806|FG001|Overall Study|Lack of Efficacy|1|||
170489011|NCT00740792|616133807|FG002|Overall Study|Lack of Efficacy|0|||
170489012|NCT00740792|616133808|FG003|Overall Study|Lack of Efficacy|3|||
170489013|NCT00740792|616133805|FG000|Overall Study|Lost to Follow-up|2|||
170489014|NCT00740792|616133806|FG001|Overall Study|Lost to Follow-up|1|||
170489015|NCT00740792|616133807|FG002|Overall Study|Lost to Follow-up|0|||
170800104|NCT00994643|617280182|FG000|Overall Study|Withdrawal by Subject|1|||
170489016|NCT00740792|616133808|FG003|Overall Study|Lost to Follow-up|0|||
170489017|NCT00740792|616133805|FG000|Overall Study|Protocol Violation|0|||
170489018|NCT00740792|616133806|FG001|Overall Study|Protocol Violation|1|||
170489019|NCT00740792|616133807|FG002|Overall Study|Protocol Violation|0|||
170489020|NCT00740792|616133808|FG003|Overall Study|Protocol Violation|2|||
170489021|NCT00740792|616133805|FG000|Overall Study|Withdrawal by Subject|1|||
170489022|NCT00740792|616133806|FG001|Overall Study|Withdrawal by Subject|1|||
170489023|NCT00740792|616133807|FG002|Overall Study|Withdrawal by Subject|0|||
170489024|NCT00740792|616133808|FG003|Overall Study|Withdrawal by Subject|0|||
170489025|NCT00740792|616133805|FG000|Overall Study|administrative|3|||
170489026|NCT00740792|616133806|FG001|Overall Study|administrative|3|||
170489027|NCT00740792|616133807|FG002|Overall Study|administrative|8|||
170489028|NCT00740792|616133808|FG003|Overall Study|administrative|2|||
170489029|NCT01455597|616133811|FG000|Overall Study|Adverse Event|7|||
170489030|NCT01455597|616133812|FG001|Overall Study|Adverse Event|0|||
170489031|NCT01455597|616133813|FG002|Overall Study|Adverse Event|5|||
170489032|NCT01455597|616133814|FG003|Overall Study|Adverse Event|1|||
170800105|NCT04977583|617280183|FG000|Overall Study|Lost to Follow-up|8|||
170800106|NCT04977583|617280184|FG001|Overall Study|Lost to Follow-up|4|||
170800107|NCT04977583|617280185|FG002|Overall Study|Lost to Follow-up|13|||
170800108|NCT04977583|617280183|FG000|Overall Study|Withdrawal by Subject|3|||
170800109|NCT04977583|617280184|FG001|Overall Study|Withdrawal by Subject|2|||
170800110|NCT04977583|617280185|FG002|Overall Study|Withdrawal by Subject|1|||
170800111|NCT02566889|617280188|FG000|Overall Study|Withdrawal by Subject|3|||
170800112|NCT02566889|617280189|FG001|Overall Study|Withdrawal by Subject|1|||
170489033|NCT01455597|616133811|FG000|Overall Study|Lack of Efficacy|0|||
170800113|NCT02566889|617280188|FG000|Overall Study|Adverse Event|4|||
170800114|NCT02566889|617280189|FG001|Overall Study|Adverse Event|2|||
170489034|NCT01455597|616133812|FG001|Overall Study|Lack of Efficacy|1|||
170489035|NCT01455597|616133813|FG002|Overall Study|Lack of Efficacy|2|||
170489036|NCT01455597|616133814|FG003|Overall Study|Lack of Efficacy|0|||
170489037|NCT01455597|616133811|FG000|Overall Study|Lost to Follow-up|3|||
170489038|NCT01455597|616133812|FG001|Overall Study|Lost to Follow-up|0|||
170489039|NCT01455597|616133813|FG002|Overall Study|Lost to Follow-up|2|||
170489040|NCT01455597|616133814|FG003|Overall Study|Lost to Follow-up|1|||
170489041|NCT01455597|616133811|FG000|Overall Study|Withdrew Consent|6|||
170899664|NCT00629083|617637726|FG000|Overall Study|Lost to Follow-up|12|||
170899665|NCT00629083|617637727|FG001|Overall Study|Lost to Follow-up|8|||
170899666|NCT00629083|617637726|FG000|Overall Study|Moved out of country/state|2|||
170899667|NCT00629083|617637727|FG001|Overall Study|Moved out of country/state|1|||
170899668|NCT00629083|617637726|FG000|Overall Study|Refused to return for 12 month visit|1|||
170899669|NCT00629083|617637727|FG001|Overall Study|Refused to return for 12 month visit|0|||
170899670|NCT01193686|617637728|FG000|Overall Study|Withdrawal by Subject|4|||
170899671|NCT01193686|617637729|FG001|Overall Study|Withdrawal by Subject|1|||
170899672|NCT01193686|617637728|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
170899673|NCT01193686|617637729|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
170899674|NCT03401749|617637730|FG000|Overall Study|Lost to Follow-up|20|||
170899675|NCT03401749|617637731|FG001|Overall Study|Lost to Follow-up|16|||
170899676|NCT03401749|617637732|FG002|Overall Study|Lost to Follow-up|26|||
170899677|NCT01147809|617637733|FG000|Phase I (168 Days)|Adverse Event|0|||
170899678|NCT01147809|617637734|FG001|Phase I (168 Days)|Adverse Event|0|||
170899679|NCT01147809|617637735|FG002|Phase I (168 Days)|Adverse Event|0|||
170489042|NCT01455597|616133812|FG001|Overall Study|Withdrew Consent|5|||
170489043|NCT01455597|616133813|FG002|Overall Study|Withdrew Consent|8|||
170489044|NCT01455597|616133814|FG003|Overall Study|Withdrew Consent|5|||
170489045|NCT01455597|616133811|FG000|Overall Study|Reason not Specified|1|||
170489046|NCT01455597|616133812|FG001|Overall Study|Reason not Specified|2|||
170489047|NCT01455597|616133813|FG002|Overall Study|Reason not Specified|3|||
170489048|NCT01455597|616133814|FG003|Overall Study|Reason not Specified|3|||
170489049|NCT03412734|616133817|FG000|Overall Study|Incorrect labeling of samples|2|||
170489050|NCT03412734|616133818|FG001|Overall Study|Incorrect labeling of samples|0|||
170489051|NCT03412734|616133817|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
170489052|NCT03412734|616133818|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
170489053|NCT04747886|616133819|FG000|Overall Study|Withdrawal by Subject|1|||
170489054|NCT04747886|616133820|FG001|Overall Study|Withdrawal by Subject|4|||
170489055|NCT00644917|616133821|FG000|Overall Study|Withdrawal by Subject|2|||
170489056|NCT03363776|616133828|FG000|Overall Study|Progressive disease|2|||
170489057|NCT03363776|616133829|FG001|Overall Study|Progressive disease|3|||
170489058|NCT03363776|616133830|FG002|Overall Study|Progressive disease|1|||
170489059|NCT03363776|616133828|FG000|Overall Study|Study drug toxicity|0|||
170489060|NCT03363776|616133829|FG001|Overall Study|Study drug toxicity|0|||
170489061|NCT03363776|616133830|FG002|Overall Study|Study drug toxicity|1|||
170489062|NCT03363776|616133828|FG000|Overall Study|Death|1|||
170489063|NCT03363776|616133829|FG001|Overall Study|Death|0|||
170489064|NCT03363776|616133830|FG002|Overall Study|Death|0|||
170489065|NCT01562782|616133831|FG000|Overall Study|Withdrawal by Subject|3|||
170489066|NCT01562782|616133832|FG001|Overall Study|Withdrawal by Subject|3|||
170489067|NCT01562782|616133831|FG000|Overall Study|screen failure|1|||
170489068|NCT01562782|616133832|FG001|Overall Study|screen failure|2|||
170489069|NCT00857896|616133835|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
170489070|NCT02308540|616133836|FG000|Overall Study|Lost to Follow-up|0|||
170489071|NCT02308540|616133837|FG001|Overall Study|Lost to Follow-up|0|||
170489072|NCT02308540|616133838|FG002|Overall Study|Lost to Follow-up|0|||
170489073|NCT02308540|616133839|FG003|Overall Study|Lost to Follow-up|0|||
170489074|NCT02308540|616133840|FG004|Overall Study|Lost to Follow-up|0|||
170489075|NCT02308540|616133841|FG005|Overall Study|Lost to Follow-up|1|||
170489076|NCT01091662|616133842|FG000|Overall Study|Adverse Event|1|||
170489077|NCT01091662|616133843|FG001|Overall Study|Adverse Event|9|||
170489078|NCT01091662|616133842|FG000|Overall Study|Physician Decision|1|||
170489079|NCT01091662|616133843|FG001|Overall Study|Physician Decision|1|||
170489080|NCT01091662|616133842|FG000|Overall Study|Withdrawal by Subject|7|||
170489081|NCT01091662|616133843|FG001|Overall Study|Withdrawal by Subject|6|||
170489082|NCT01091662|616133842|FG000|Overall Study|met exit criteria|7|||
170489083|NCT01091662|616133843|FG001|Overall Study|met exit criteria|13|||
170489084|NCT01091662|616133842|FG000|Overall Study|met exclusion criteria|1|||
170489085|NCT01091662|616133843|FG001|Overall Study|met exclusion criteria|0|||
170489086|NCT01091662|616133842|FG000|Overall Study|Lost to Follow-up|0|||
170489087|NCT01091662|616133843|FG001|Overall Study|Lost to Follow-up|1|||
170489088|NCT01091662|616133842|FG000|Overall Study|Pregnancy|0|||
170489089|NCT01091662|616133843|FG001|Overall Study|Pregnancy|1|||
170899680|NCT01147809|617637736|FG003|Phase I (168 Days)|Adverse Event|1|||
170899681|NCT01147809|617637737|FG004|Phase I (168 Days)|Adverse Event|0|||
170489090|NCT01091662|616133842|FG000|Overall Study|Protocol Violation|0|||
170489091|NCT01091662|616133843|FG001|Overall Study|Protocol Violation|2|||
170489092|NCT01091662|616133842|FG000|Overall Study|unable to swallow capsule|0|||
170489093|NCT01091662|616133843|FG001|Overall Study|unable to swallow capsule|1|||
170489094|NCT04109391|616133844|FG000|Overall Study|Adverse Event|2|||
170489095|NCT04109391|616133845|FG001|Overall Study|Adverse Event|2|||
170489096|NCT04109391|616133846|FG002|Overall Study|Adverse Event|0|||
170489097|NCT04109391|616133844|FG000|Overall Study|Withdrawal by Subject|2|||
170899682|NCT01147809|617637738|FG005|Phase I (168 Days)|Adverse Event|0|||
170899683|NCT01147809|617637733|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
170549252|NCT02675452|616354817|FG012|Overall Study|Lost to Follow-up|1|||
170549253|NCT02675452|616354818|FG013|Overall Study|Lost to Follow-up|0|||
170549254|NCT02675452|616354819|FG014|Overall Study|Lost to Follow-up|0|||
170549255|NCT02675452|616354820|FG015|Overall Study|Lost to Follow-up|0|||
170800115|NCT02566889|617280188|FG000|Overall Study|Other|6|||
170800116|NCT02566889|617280189|FG001|Overall Study|Other|2|||
170800117|NCT03391466|617280191|FG000|Overall Study|Death|84|||
170800118|NCT03391466|617280192|FG001|Overall Study|Death|91|||
170800119|NCT03391466|617280191|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
170800120|NCT03391466|617280192|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
170800121|NCT03391466|617280191|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
170800122|NCT03391466|617280192|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
170800123|NCT03391466|617280191|FG000|Overall Study|Lost to Follow-up|9|||
170800124|NCT03391466|617280192|FG001|Overall Study|Lost to Follow-up|5|||
170800125|NCT03391466|617280191|FG000|Overall Study|Reason Not Specified|2|||
170800126|NCT03391466|617280192|FG001|Overall Study|Reason Not Specified|2|||
170800127|NCT03391466|617280191|FG000|Overall Study|Investigator Decision|0|||
170800128|NCT03391466|617280192|FG001|Overall Study|Investigator Decision|1|||
170800129|NCT03140670|617280193|FG000|Overall Study|Withdrawal by Subject|2|||
170800130|NCT03140670|617280193|FG000|Overall Study|Lost to Follow-up|1|||
170800131|NCT03140670|617280193|FG000|Overall Study|Physician Decision|1|||
170800132|NCT00210106|617280195|FG000|Overall Study|Death|1|||
170800133|NCT00210106|617280195|FG000|Overall Study|Protocol Violation|13|||
170800134|NCT01639131|617280199|FG000|Overall Study|Disease Progression|6|||
170800135|NCT01637402|617280203|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
170800136|NCT01637402|617280204|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
170800137|NCT01637402|617280203|FG000|Standard Dose Regimen|Adverse Event|1|||
170800138|NCT01637402|617280204|FG001|Standard Dose Regimen|Adverse Event|0|||
170800139|NCT01637402|617280203|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
170800140|NCT01637402|617280204|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
170800141|NCT01637402|617280203|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
170800142|NCT01637402|617280204|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
170800143|NCT01637402|617280203|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
170800144|NCT01637402|617280204|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
170800145|NCT01637402|617280203|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
170800146|NCT01637402|617280204|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
170800147|NCT04876417|617280205|FG000|Overall Study|Lost to Follow-up|5|||
170800148|NCT04876417|617280206|FG001|Overall Study|Lost to Follow-up|8|||
170800149|NCT04876417|617280207|FG002|Overall Study|Lost to Follow-up|0|||
170800150|NCT04876417|617280208|FG003|Overall Study|Lost to Follow-up|0|||
170800151|NCT02285270|617280209|FG000|Overall Study|Lost to Follow-up|1|||
170800152|NCT02285270|617280209|FG000|Overall Study|Physician Decision|3|||
170800153|NCT02285270|617280209|FG000|Overall Study|Determined to be ineligible|1|||
170800154|NCT04121546|617280211|FG000|Overall Study|Lost to Follow-up|1|||
170800155|NCT04121546|617280212|FG001|Overall Study|Lost to Follow-up|3|||
170800156|NCT04129164|617280213|FG000|Overall Study|Non-compliance with procedures|0|||
170800157|NCT04129164|617280214|FG001|Overall Study|Non-compliance with procedures|0|||
170800158|NCT04129164|617280215|FG002|Overall Study|Non-compliance with procedures|2|||
170800159|NCT04129164|617280216|FG003|Overall Study|Non-compliance with procedures|0|||
170800160|NCT04129164|617280213|FG000|Overall Study|Adverse Event|0|||
170800161|NCT04129164|617280214|FG001|Overall Study|Adverse Event|0|||
170800162|NCT04129164|617280215|FG002|Overall Study|Adverse Event|2|||
170800163|NCT04129164|617280216|FG003|Overall Study|Adverse Event|0|||
170800164|NCT04129164|617280213|FG000|Overall Study|Pregnancy|0|||
170800165|NCT04129164|617280214|FG001|Overall Study|Pregnancy|0|||
170800166|NCT04129164|617280215|FG002|Overall Study|Pregnancy|0|||
170800167|NCT04129164|617280216|FG003|Overall Study|Pregnancy|1|||
170800168|NCT04129164|617280213|FG000|Overall Study|Withdrawal by Subject|3|||
170800169|NCT04129164|617280214|FG001|Overall Study|Withdrawal by Subject|2|||
170800170|NCT04129164|617280215|FG002|Overall Study|Withdrawal by Subject|4|||
170800171|NCT04129164|617280216|FG003|Overall Study|Withdrawal by Subject|6|||
170800172|NCT04129164|617280213|FG000|Overall Study|Death|0|||
170800173|NCT04129164|617280214|FG001|Overall Study|Death|1|||
170800174|NCT04129164|617280215|FG002|Overall Study|Death|0|||
170800175|NCT04129164|617280216|FG003|Overall Study|Death|0|||
170800176|NCT04129164|617280213|FG000|Overall Study|Lost to Follow-up|0|||
170800177|NCT04129164|617280214|FG001|Overall Study|Lost to Follow-up|1|||
170800178|NCT04129164|617280215|FG002|Overall Study|Lost to Follow-up|0|||
170899684|NCT01147809|617637734|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
170899685|NCT01147809|617637735|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
170800179|NCT04129164|617280216|FG003|Overall Study|Lost to Follow-up|0|||
170800180|NCT03709706|617280217|FG000|Overall Study|Adverse Event|0|||
170800181|NCT03709706|617280218|FG001|Overall Study|Adverse Event|1|||
170800182|NCT03709706|617280217|FG000|Overall Study|Physician Decision|14|||
170549256|NCT02675452|616354821|FG016|Overall Study|Lost to Follow-up|0|||
170549257|NCT02675452|616354822|FG017|Overall Study|Lost to Follow-up|0|||
170899686|NCT01147809|617637736|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
170899687|NCT01147809|617637737|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
170899688|NCT01147809|617637738|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
170899689|NCT01147809|617637733|FG000|Phase I (168 Days)|Physician Decision|0|||
170899690|NCT01147809|617637734|FG001|Phase I (168 Days)|Physician Decision|1|||
170899691|NCT01147809|617637735|FG002|Phase I (168 Days)|Physician Decision|2|||
170899692|NCT01147809|617637736|FG003|Phase I (168 Days)|Physician Decision|0|||
170899693|NCT01147809|617637737|FG004|Phase I (168 Days)|Physician Decision|0|||
170899694|NCT01147809|617637738|FG005|Phase I (168 Days)|Physician Decision|0|||
170899695|NCT01147809|617637733|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
170899696|NCT01147809|617637734|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
170899697|NCT01147809|617637735|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
170899698|NCT01147809|617637736|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
170899699|NCT01147809|617637737|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
170899700|NCT01147809|617637738|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
170899701|NCT01147809|617637733|FG000|Phase II (168 Days)|Adverse Event|0|||
170899702|NCT01147809|617637734|FG001|Phase II (168 Days)|Adverse Event|0|||
170899703|NCT01147809|617637735|FG002|Phase II (168 Days)|Adverse Event|0|||
170899704|NCT01147809|617637736|FG003|Phase II (168 Days)|Adverse Event|0|||
170899705|NCT01147809|617637737|FG004|Phase II (168 Days)|Adverse Event|3|||
170899706|NCT01147809|617637738|FG005|Phase II (168 Days)|Adverse Event|6|||
170899707|NCT01147809|617637733|FG000|Phase II (168 Days)|Protocol Violation|0|||
170899708|NCT01147809|617637734|FG001|Phase II (168 Days)|Protocol Violation|0|||
170899709|NCT01147809|617637735|FG002|Phase II (168 Days)|Protocol Violation|0|||
170899710|NCT01147809|617637736|FG003|Phase II (168 Days)|Protocol Violation|0|||
170899711|NCT01147809|617637737|FG004|Phase II (168 Days)|Protocol Violation|0|||
170899712|NCT01147809|617637738|FG005|Phase II (168 Days)|Protocol Violation|1|||
170899713|NCT01147809|617637733|FG000|Phase II (168 Days)|Physician Decision|0|||
170899714|NCT01147809|617637734|FG001|Phase II (168 Days)|Physician Decision|0|||
170899715|NCT01147809|617637735|FG002|Phase II (168 Days)|Physician Decision|0|||
170899716|NCT01147809|617637736|FG003|Phase II (168 Days)|Physician Decision|0|||
170899717|NCT01147809|617637737|FG004|Phase II (168 Days)|Physician Decision|5|||
170489098|NCT04109391|616133845|FG001|Overall Study|Withdrawal by Subject|0|||
170489099|NCT04109391|616133846|FG002|Overall Study|Withdrawal by Subject|0|||
170489100|NCT04109391|616133844|FG000|Overall Study|Pregnancy|1|||
170489101|NCT04109391|616133845|FG001|Overall Study|Pregnancy|0|||
170489102|NCT04109391|616133846|FG002|Overall Study|Pregnancy|0|||
170489103|NCT04109391|616133844|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
170489104|NCT04109391|616133845|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
170489105|NCT04109391|616133846|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
170489106|NCT04109391|616133844|FG000|Overall Study|Lost to Follow-up|0|||
170489107|NCT04109391|616133845|FG001|Overall Study|Lost to Follow-up|0|||
170489108|NCT04109391|616133846|FG002|Overall Study|Lost to Follow-up|1|||
170489109|NCT04109391|616133844|FG000|Overall Study|Lack of Efficacy|2|||
170489110|NCT04109391|616133845|FG001|Overall Study|Lack of Efficacy|2|||
170489111|NCT04109391|616133846|FG002|Overall Study|Lack of Efficacy|3|||
170489112|NCT02285166|616133847|FG000|Overall Study|Case Report Forms Uncollected|564|||
170489113|NCT02285166|616133847|FG000|Overall Study|Protocol Deviation|402|||
170489114|NCT00443079|616133848|FG000|Overall Study|Lost to Follow-up|0|||
170489115|NCT00443079|616133849|FG001|Overall Study|Lost to Follow-up|1|||
170489116|NCT00713258|616133854|FG000|Overall Study|Adverse Event|2|||
170489117|NCT00713258|616133855|FG001|Overall Study|Adverse Event|4|||
170489118|NCT00713258|616133854|FG000|Overall Study|Non-Compliance|2|||
170489119|NCT00713258|616133855|FG001|Overall Study|Non-Compliance|1|||
170489120|NCT00713258|616133854|FG000|Overall Study|Other|1|||
170489121|NCT00713258|616133855|FG001|Overall Study|Other|1|||
170489122|NCT01322490|616133856|FG000|Treatment Period|Adverse Event|12|||
170489123|NCT01322490|616133857|FG001|Treatment Period|Adverse Event|18|||
170489124|NCT01322490|616133858|FG002|Treatment Period|Adverse Event|15|||
170489125|NCT01322490|616133856|FG000|Treatment Period|Death|5|||
170489126|NCT01322490|616133857|FG001|Treatment Period|Death|7|||
170489127|NCT01322490|616133858|FG002|Treatment Period|Death|3|||
170489128|NCT01322490|616133856|FG000|Treatment Period|Lack of Efficacy|89|||
170489129|NCT01322490|616133857|FG001|Treatment Period|Lack of Efficacy|100|||
170489130|NCT01322490|616133858|FG002|Treatment Period|Lack of Efficacy|112|||
170899718|NCT01147809|617637738|FG005|Phase II (168 Days)|Physician Decision|11|||
170899719|NCT01147809|617637733|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
170899720|NCT01147809|617637734|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
170899721|NCT01147809|617637735|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
170899722|NCT01147809|617637736|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
170489131|NCT01322490|616133856|FG000|Treatment Period|Physician Decision|0|||
170899723|NCT01147809|617637737|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
170899724|NCT01147809|617637738|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
170899725|NCT01147809|617637733|FG000|Phase II (168 Days)|Ongoing|0|||
170489132|NCT01322490|616133857|FG001|Treatment Period|Physician Decision|2|||
170489133|NCT01322490|616133858|FG002|Treatment Period|Physician Decision|1|||
170899726|NCT01147809|617637734|FG001|Phase II (168 Days)|Ongoing|0|||
170899727|NCT01147809|617637735|FG002|Phase II (168 Days)|Ongoing|0|||
170899728|NCT01147809|617637736|FG003|Phase II (168 Days)|Ongoing|0|||
170899729|NCT01147809|617637737|FG004|Phase II (168 Days)|Ongoing|1|||
170899730|NCT01147809|617637738|FG005|Phase II (168 Days)|Ongoing|0|||
170899731|NCT02209766|617637739|FG000|Overall Study|Withdrawal by Subject|0|||
170899732|NCT02209766|617637740|FG001|Overall Study|Withdrawal by Subject|0|||
170899733|NCT02209766|617637741|FG002|Overall Study|Withdrawal by Subject|0|||
170899734|NCT02209766|617637742|FG003|Overall Study|Withdrawal by Subject|1|||
170899735|NCT02209766|617637743|FG004|Overall Study|Withdrawal by Subject|0|||
170899736|NCT00805207|617637744|FG000|Overall Study|Protocol Violation|0|||
170899737|NCT00805207|617637745|FG001|Overall Study|Protocol Violation|0|||
170899738|NCT00805207|617637746|FG002|Overall Study|Protocol Violation|1|||
170899739|NCT00805207|617637747|FG003|Overall Study|Protocol Violation|0|||
170899740|NCT00805207|617637748|FG004|Overall Study|Protocol Violation|0|||
170899741|NCT00805207|617637749|FG005|Overall Study|Protocol Violation|0|||
170899742|NCT00805207|617637750|FG006|Overall Study|Protocol Violation|0|||
170899743|NCT00805207|617637751|FG007|Overall Study|Protocol Violation|0|||
170899744|NCT00805207|617637752|FG008|Overall Study|Protocol Violation|0|||
170899745|NCT00805207|617637744|FG000|Overall Study|Physician Decision|0|||
170899746|NCT00805207|617637745|FG001|Overall Study|Physician Decision|1|||
170899747|NCT00805207|617637746|FG002|Overall Study|Physician Decision|0|||
170899748|NCT00805207|617637747|FG003|Overall Study|Physician Decision|0|||
170899749|NCT00805207|617637748|FG004|Overall Study|Physician Decision|0|||
170489134|NCT01322490|616133856|FG000|Treatment Period|Protocol Violation|7|||
170489135|NCT01322490|616133857|FG001|Treatment Period|Protocol Violation|5|||
170489136|NCT01322490|616133858|FG002|Treatment Period|Protocol Violation|4|||
170489137|NCT01322490|616133856|FG000|Treatment Period|Withdrawal by Subject|14|||
170489138|NCT01322490|616133857|FG001|Treatment Period|Withdrawal by Subject|16|||
170489139|NCT01322490|616133858|FG002|Treatment Period|Withdrawal by Subject|11|||
170489140|NCT01322490|616133856|FG000|Treatment Period|Non-compliance with study drug|0|||
170489141|NCT01322490|616133857|FG001|Treatment Period|Non-compliance with study drug|0|||
170489142|NCT01322490|616133858|FG002|Treatment Period|Non-compliance with study drug|1|||
170489143|NCT01322490|616133856|FG000|Treatment Period|Other per report|2|||
170489144|NCT01322490|616133857|FG001|Treatment Period|Other per report|2|||
170489145|NCT01322490|616133858|FG002|Treatment Period|Other per report|1|||
170489146|NCT01322490|616133856|FG000|Treatment Period|Randomized but Not Treated|3|||
170489147|NCT01322490|616133857|FG001|Treatment Period|Randomized but Not Treated|3|||
170640616|NCT00395343|616696923|FG000|Overall Study|Adverse Event|13|||
170640617|NCT00395343|616696924|FG001|Overall Study|Adverse Event|5|||
170640618|NCT00395343|616696923|FG000|Overall Study|Lack of Efficacy|0|||
170640619|NCT00395343|616696924|FG001|Overall Study|Lack of Efficacy|1|||
170640620|NCT00395343|616696923|FG000|Overall Study|Lost to Follow-up|4|||
170640621|NCT00395343|616696924|FG001|Overall Study|Lost to Follow-up|4|||
170640622|NCT00395343|616696923|FG000|Overall Study|Physician Decision|2|||
170640623|NCT00395343|616696924|FG001|Overall Study|Physician Decision|4|||
170640624|NCT00395343|616696923|FG000|Overall Study|Protocol Violation|6|||
170640625|NCT00395343|616696924|FG001|Overall Study|Protocol Violation|8|||
170640626|NCT00395343|616696923|FG000|Overall Study|Withdrawal by Subject|11|||
170640627|NCT00395343|616696924|FG001|Overall Study|Withdrawal by Subject|12|||
170640628|NCT00395343|616696923|FG000|Overall Study|Other|5|||
170640629|NCT00395343|616696924|FG001|Overall Study|Other|2|||
170640630|NCT04027608|616696925|FG000|Overall Study|Withdrawal by Subject|13|||
170640631|NCT04027608|616696926|FG001|Overall Study|Withdrawal by Subject|2|||
170640632|NCT04027608|616696925|FG000|Overall Study|Protocol Violation|2|||
170640633|NCT04027608|616696926|FG001|Overall Study|Protocol Violation|1|||
170640634|NCT04027608|616696925|FG000|Overall Study|Physician Decision|1|||
170640635|NCT04027608|616696926|FG001|Overall Study|Physician Decision|0|||
170640636|NCT04027608|616696925|FG000|Overall Study|Lost to Follow-up|20|||
170640637|NCT04027608|616696926|FG001|Overall Study|Lost to Follow-up|4|||
170489148|NCT01322490|616133858|FG002|Treatment Period|Randomized but Not Treated|5|||
170640638|NCT02864862|616696933|FG000|Overall Study|Lost to Follow-up|1|||
170640639|NCT02864862|616696934|FG001|Overall Study|Lost to Follow-up|0|||
170640640|NCT02864862|616696935|FG002|Overall Study|Lost to Follow-up|1|||
170640641|NCT02864862|616696933|FG000|Overall Study|Protocol Violation|0|||
170640642|NCT02864862|616696934|FG001|Overall Study|Protocol Violation|0|||
170640643|NCT02864862|616696935|FG002|Overall Study|Protocol Violation|1|||
170899750|NCT00805207|617637749|FG005|Overall Study|Physician Decision|1|||
170899751|NCT00805207|617637750|FG006|Overall Study|Physician Decision|0|||
170899752|NCT00805207|617637751|FG007|Overall Study|Physician Decision|0|||
170489149|NCT01322490|616133856|FG000|Long Term Follow-up Period|Death|235|||
170489150|NCT01322490|616133857|FG001|Long Term Follow-up Period|Death|239|||
170899753|NCT00805207|617637752|FG008|Overall Study|Physician Decision|0|||
170640644|NCT04657666|616696942|FG000|Period 1|Withdrawal of participant consent|2|||
170640645|NCT04657666|616696943|FG001|Period 1|Withdrawal of participant consent|1|||
170640646|NCT04657666|616696942|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
170899754|NCT00805207|617637744|FG000|Overall Study|Withdrawal by Subject|0|||
170899755|NCT00805207|617637745|FG001|Overall Study|Withdrawal by Subject|1|||
170899756|NCT00805207|617637746|FG002|Overall Study|Withdrawal by Subject|0|||
170899757|NCT00805207|617637747|FG003|Overall Study|Withdrawal by Subject|0|||
170899758|NCT00805207|617637748|FG004|Overall Study|Withdrawal by Subject|1|||
170899759|NCT00805207|617637749|FG005|Overall Study|Withdrawal by Subject|2|||
170899760|NCT00805207|617637750|FG006|Overall Study|Withdrawal by Subject|0|||
170899761|NCT00805207|617637751|FG007|Overall Study|Withdrawal by Subject|0|||
170899762|NCT00805207|617637752|FG008|Overall Study|Withdrawal by Subject|0|||
170899763|NCT00064701|617637753|FG000|One Year Post-transplant|Did not receive study drug|7|||
170899764|NCT00064701|617637754|FG001|One Year Post-transplant|Did not receive study drug|12|||
170899765|NCT00064701|617637755|FG002|One Year Post-transplant|Did not receive study drug|11|||
170899766|NCT00064701|617637753|FG000|One Year Post-transplant|Adverse Event|23|||
170899767|NCT00064701|617637754|FG001|One Year Post-transplant|Adverse Event|19|||
170899768|NCT00064701|617637755|FG002|One Year Post-transplant|Adverse Event|37|||
170899769|NCT00064701|617637753|FG000|One Year Post-transplant|Rejection|0|||
170899770|NCT00064701|617637754|FG001|One Year Post-transplant|Rejection|1|||
170899771|NCT00064701|617637755|FG002|One Year Post-transplant|Rejection|16|||
170899772|NCT00064701|617637753|FG000|One Year Post-transplant|Non-compliance|4|||
170899773|NCT00064701|617637754|FG001|One Year Post-transplant|Non-compliance|2|||
170899774|NCT00064701|617637755|FG002|One Year Post-transplant|Non-compliance|5|||
170899775|NCT00064701|617637753|FG000|One Year Post-transplant|Graft Failure|3|||
170899776|NCT00064701|617637754|FG001|One Year Post-transplant|Graft Failure|2|||
170899777|NCT00064701|617637755|FG002|One Year Post-transplant|Graft Failure|1|||
170899778|NCT00064701|617637753|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
170899779|NCT00064701|617637754|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
170899780|NCT00064701|617637755|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
170899781|NCT00064701|617637753|FG000|One Year Post-transplant|Lost to Follow-up|1|||
170899782|NCT00064701|617637754|FG001|One Year Post-transplant|Lost to Follow-up|0|||
170899783|NCT00064701|617637755|FG002|One Year Post-transplant|Lost to Follow-up|0|||
170899784|NCT00064701|617637753|FG000|One Year Post-transplant|Converted to rapamycin|1|||
170899785|NCT00064701|617637754|FG001|One Year Post-transplant|Converted to rapamycin|0|||
170899786|NCT00064701|617637755|FG002|One Year Post-transplant|Converted to rapamycin|0|||
170489151|NCT01322490|616133858|FG002|Long Term Follow-up Period|Death|236|||
170489152|NCT01322490|616133856|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
170489153|NCT01322490|616133857|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
170489154|NCT01322490|616133858|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
170489155|NCT01322490|616133856|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
170489156|NCT01322490|616133857|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
170489157|NCT01322490|616133858|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
170489158|NCT01322490|616133856|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
170489159|NCT01322490|616133857|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
170489160|NCT01322490|616133858|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
170489161|NCT01322490|616133856|FG000|Long Term Follow-up Period|Other per report|3|||
170489162|NCT01322490|616133857|FG001|Long Term Follow-up Period|Other per report|2|||
170489163|NCT01322490|616133858|FG002|Long Term Follow-up Period|Other per report|2|||
170489164|NCT01322490|616133856|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
170489165|NCT01322490|616133857|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
170489166|NCT01322490|616133858|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
170489167|NCT02257489|616133861|FG000|Overall Study|Withdrawal by Subject|0|||
170489168|NCT02257489|616133862|FG001|Overall Study|Withdrawal by Subject|0|||
170489169|NCT02257489|616133863|FG002|Overall Study|Withdrawal by Subject|0|||
170489170|NCT02257489|616133864|FG003|Overall Study|Withdrawal by Subject|1|||
170489171|NCT02257489|616133865|FG004|Overall Study|Withdrawal by Subject|0|||
170489172|NCT02257489|616133866|FG005|Overall Study|Withdrawal by Subject|0|||
170489173|NCT02257489|616133867|FG006|Overall Study|Withdrawal by Subject|0|||
170899787|NCT00064701|617637753|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
170899788|NCT00064701|617637754|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
170899789|NCT00064701|617637755|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
170899790|NCT00064701|617637753|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
170899791|NCT00064701|617637754|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
170899792|NCT00064701|617637755|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
170899793|NCT00064701|617637753|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
170899794|NCT00064701|617637754|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
170489174|NCT02257489|616133868|FG007|Overall Study|Withdrawal by Subject|0|||
170489175|NCT02257489|616133869|FG008|Overall Study|Withdrawal by Subject|0|||
170489176|NCT04606394|616133870|FG000|Overall Study|Withdrawal by Subject|3|||
170489177|NCT04606394|616133870|FG000|Overall Study|Exclusion criteria screen failure|12|||
170899795|NCT00064701|617637755|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
170899796|NCT00064701|617637753|FG000|One Year Post-transplant|Poor absorption|0|||
170899797|NCT00064701|617637754|FG001|One Year Post-transplant|Poor absorption|1|||
170899798|NCT00064701|617637755|FG002|One Year Post-transplant|Poor absorption|0|||
170899799|NCT00064701|617637753|FG000|One Year Post-transplant|Pancreas transplant|0|||
170489178|NCT05708976|616133881|FG000|Overall Study|Withdrawal by Subject|0|||
170640647|NCT04657666|616696943|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
170640648|NCT04657666|616696942|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
170640649|NCT04657666|616696943|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
170640650|NCT04657666|616696942|FG000|Period 2|Other|2|||
170640651|NCT04657666|616696943|FG001|Period 2|Other|0|||
170640652|NCT04657666|616696942|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
170640653|NCT04657666|616696943|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
170640654|NCT03120351|616696945|FG000|Overall Study|Physician Decision|1|||
170800183|NCT03709706|617280218|FG001|Overall Study|Physician Decision|8|||
170800184|NCT03709706|617280217|FG000|Overall Study|Withdrawal by Subject|2|||
170489179|NCT05708976|616133882|FG001|Overall Study|Withdrawal by Subject|1|||
170489180|NCT02105987|616133883|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
170489181|NCT02105987|616133884|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
170489182|NCT02105987|616133885|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
170489183|NCT02105987|616133886|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
170489184|NCT02105987|616133887|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
170489185|NCT02105987|616133888|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
170489186|NCT02105987|616133883|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
170489187|NCT02105987|616133884|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
170489188|NCT02105987|616133885|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
170489189|NCT02105987|616133886|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
170489190|NCT02105987|616133887|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
170489191|NCT02105987|616133888|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
170489192|NCT02105987|616133883|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
170489193|NCT02105987|616133884|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
170489194|NCT02105987|616133885|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
170489195|NCT02105987|616133886|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
170489196|NCT02105987|616133887|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
170489197|NCT02105987|616133888|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
170489198|NCT02105987|616133883|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
170489199|NCT02105987|616133884|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
170489200|NCT02105987|616133885|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
170489201|NCT02105987|616133886|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
170489202|NCT02105987|616133887|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
170489203|NCT02105987|616133888|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
170489204|NCT02105987|616133883|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
170489205|NCT02105987|616133884|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
170489206|NCT02105987|616133885|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
170489207|NCT02105987|616133886|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
170489208|NCT02105987|616133887|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
170489209|NCT02105987|616133888|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
170489210|NCT02105987|616133883|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
170489211|NCT02105987|616133884|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
170489212|NCT02105987|616133885|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
170489213|NCT02105987|616133886|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
170489214|NCT02105987|616133887|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
170489215|NCT02105987|616133888|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
170489216|NCT02105987|616133883|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
170489217|NCT02105987|616133884|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
170489218|NCT02105987|616133885|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
170489219|NCT02105987|616133886|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
170489220|NCT02105987|616133887|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
170489221|NCT02105987|616133888|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
170489222|NCT02105987|616133883|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
170489223|NCT02105987|616133884|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
170489224|NCT02105987|616133885|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
170489225|NCT02105987|616133886|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
170489226|NCT02105987|616133887|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
170489227|NCT02105987|616133888|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
170489228|NCT02105987|616133883|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
170489229|NCT02105987|616133884|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
170489230|NCT02105987|616133885|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
170489231|NCT02105987|616133886|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
170489232|NCT02105987|616133887|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
170489233|NCT02105987|616133888|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
170489234|NCT02105987|616133883|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
170489235|NCT02105987|616133884|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
170489236|NCT02105987|616133885|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
170489237|NCT02105987|616133886|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
170489238|NCT02105987|616133887|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
170489239|NCT02105987|616133888|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
170489240|NCT02105987|616133883|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
170489241|NCT02105987|616133884|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
170489242|NCT02105987|616133885|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
170489243|NCT02105987|616133886|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
170489244|NCT02105987|616133887|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
170489245|NCT02105987|616133888|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
170489246|NCT02105987|616133883|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
170489247|NCT02105987|616133884|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
170489248|NCT02105987|616133885|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
170489249|NCT02105987|616133886|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
170489250|NCT02105987|616133887|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
170489251|NCT02105987|616133888|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
170489252|NCT02105987|616133883|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
170489253|NCT02105987|616133884|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
170489254|NCT02105987|616133885|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
170489255|NCT02105987|616133886|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
170489256|NCT02105987|616133887|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
170489257|NCT02105987|616133888|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
170489258|NCT02105987|616133883|FG000|Continuation Phase|Protocol Violation|0|||
170489259|NCT02105987|616133884|FG001|Continuation Phase|Protocol Violation|0|||
170489260|NCT02105987|616133885|FG002|Continuation Phase|Protocol Violation|0|||
170489261|NCT02105987|616133886|FG003|Continuation Phase|Protocol Violation|0|||
170489262|NCT02105987|616133887|FG004|Continuation Phase|Protocol Violation|1|||
170489263|NCT02105987|616133888|FG005|Continuation Phase|Protocol Violation|0|||
170489264|NCT02418949|616133889|FG000|Overall Study|Withdrawal by Subject|1|||
170489265|NCT02418949|616133890|FG001|Overall Study|Withdrawal by Subject|0|||
170489266|NCT02418949|616133891|FG002|Overall Study|Withdrawal by Subject|1|||
170489267|NCT02418949|616133892|FG003|Overall Study|Withdrawal by Subject|1|||
170489268|NCT02418949|616133889|FG000|Overall Study|Lost to Follow-up|1|||
170489269|NCT02418949|616133890|FG001|Overall Study|Lost to Follow-up|0|||
170489270|NCT02418949|616133891|FG002|Overall Study|Lost to Follow-up|1|||
170489271|NCT02418949|616133892|FG003|Overall Study|Lost to Follow-up|0|||
170489272|NCT02418949|616133889|FG000|Overall Study|Physician Decision|1|||
170489273|NCT02418949|616133890|FG001|Overall Study|Physician Decision|1|||
170489274|NCT02418949|616133891|FG002|Overall Study|Physician Decision|1|||
170489275|NCT02418949|616133892|FG003|Overall Study|Physician Decision|0|||
170489276|NCT02684097|616133893|FG000|Overall Study|Lack of Efficacy|13|||
170489277|NCT02684097|616133894|FG001|Overall Study|Lack of Efficacy|6|||
170489278|NCT01075256|616133895|FG000|Overall Study|Withdrawal by Subject|1|||
170549258|NCT02675452|616354823|FG018|Overall Study|Lost to Follow-up|0|||
170549259|NCT02675452|616354824|FG019|Overall Study|Lost to Follow-up|0|||
170549260|NCT02675452|616354825|FG020|Overall Study|Lost to Follow-up|0|||
170549261|NCT02675452|616354826|FG021|Overall Study|Lost to Follow-up|0|||
170549262|NCT02675452|616354827|FG022|Overall Study|Lost to Follow-up|0|||
170549263|NCT02675452|616354828|FG023|Overall Study|Lost to Follow-up|0|||
170549264|NCT02675452|616354829|FG024|Overall Study|Lost to Follow-up|0|||
170549265|NCT02675452|616354830|FG025|Overall Study|Lost to Follow-up|0|||
170549266|NCT02675452|616354831|FG026|Overall Study|Lost to Follow-up|1|||
170549267|NCT02675452|616354832|FG027|Overall Study|Lost to Follow-up|0|||
170549268|NCT02675452|616354833|FG028|Overall Study|Lost to Follow-up|0|||
170549269|NCT02675452|616354805|FG000|Overall Study|Other|0|||
170549270|NCT02675452|616354806|FG001|Overall Study|Other|0|||
170549271|NCT02675452|616354807|FG002|Overall Study|Other|0|||
170549272|NCT02675452|616354808|FG003|Overall Study|Other|0|||
170549273|NCT02675452|616354809|FG004|Overall Study|Other|0|||
170549274|NCT02675452|616354810|FG005|Overall Study|Other|0|||
170549275|NCT02675452|616354811|FG006|Overall Study|Other|0|||
170549276|NCT02675452|616354812|FG007|Overall Study|Other|0|||
170549277|NCT02675452|616354813|FG008|Overall Study|Other|0|||
170640655|NCT03120351|616696946|FG001|Overall Study|Physician Decision|1|||
170489279|NCT01075256|616133896|FG001|Overall Study|Withdrawal by Subject|0|||
170489280|NCT01075256|616133897|FG002|Overall Study|Withdrawal by Subject|0|||
170489281|NCT03502070|616133898|FG000|Overall Study|Withdrawal by Subject|1|||
170489282|NCT03502070|616133898|FG000|Overall Study|Screen Failure|1|||
170489283|NCT01197534|616133899|FG000|Overall Study|Not reported|16|||
170489284|NCT01197534|616133900|FG001|Overall Study|Not reported|10|||
170549278|NCT02675452|616354814|FG009|Overall Study|Other|0|||
170549279|NCT02675452|616354815|FG010|Overall Study|Other|0|||
170549280|NCT02675452|616354816|FG011|Overall Study|Other|0|||
170549281|NCT02675452|616354817|FG012|Overall Study|Other|0|||
170549282|NCT02675452|616354818|FG013|Overall Study|Other|0|||
170549283|NCT02675452|616354819|FG014|Overall Study|Other|0|||
170549284|NCT02675452|616354820|FG015|Overall Study|Other|0|||
170549285|NCT02675452|616354821|FG016|Overall Study|Other|0|||
170549286|NCT02675452|616354822|FG017|Overall Study|Other|0|||
170489285|NCT01197534|616133901|FG002|Overall Study|Not reported|16|||
170489286|NCT01197534|616133899|FG000|Overall Study|Enrolment in long term extension|57|||
170489287|NCT01197534|616133900|FG001|Overall Study|Enrolment in long term extension|66|||
170489288|NCT01197534|616133901|FG002|Overall Study|Enrolment in long term extension|119|||
170489289|NCT01197534|616133899|FG000|Overall Study|Severe non-compliance to protocol|3|||
170489290|NCT01197534|616133900|FG001|Overall Study|Severe non-compliance to protocol|4|||
170489291|NCT01197534|616133901|FG002|Overall Study|Severe non-compliance to protocol|1|||
170489292|NCT01197534|616133899|FG000|Overall Study|Lack of therapeutic response|9|||
170489293|NCT01197534|616133900|FG001|Overall Study|Lack of therapeutic response|4|||
170489294|NCT01197534|616133901|FG002|Overall Study|Lack of therapeutic response|9|||
170489295|NCT01197534|616133899|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
170489296|NCT01197534|616133900|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
170489297|NCT01197534|616133901|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
170489298|NCT01197534|616133899|FG000|Overall Study|Lost to Follow-up|1|||
170489299|NCT01197534|616133900|FG001|Overall Study|Lost to Follow-up|4|||
170489300|NCT01197534|616133901|FG002|Overall Study|Lost to Follow-up|2|||
170489301|NCT01197534|616133899|FG000|Overall Study|Adverse Event|35|||
170489302|NCT01197534|616133900|FG001|Overall Study|Adverse Event|36|||
170489303|NCT01197534|616133901|FG002|Overall Study|Adverse Event|24|||
170489304|NCT02593097|616133904|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
170489305|NCT02593097|616133905|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
170489306|NCT02593097|616133904|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
170489307|NCT02593097|616133905|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
170489308|NCT02593097|616133904|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
170489309|NCT02593097|616133905|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
170489310|NCT02593097|616133904|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
170489311|NCT02593097|616133905|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
170489312|NCT02593097|616133904|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
170489313|NCT02593097|616133905|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
170489314|NCT00634036|616133908|FG000|Overall Study|Lost to Follow-up|1|||
170489315|NCT00634036|616133909|FG001|Overall Study|Lost to Follow-up|1|||
170489316|NCT00634036|616133908|FG000|Overall Study|Withdrawal by Subject|1|||
170489317|NCT00634036|616133909|FG001|Overall Study|Withdrawal by Subject|1|||
170489318|NCT03627546|616133911|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
170489319|NCT03627546|616133912|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
170489320|NCT03627546|616133913|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
170489321|NCT03627546|616133911|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
170489322|NCT03627546|616133912|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
170899800|NCT00064701|617637754|FG001|One Year Post-transplant|Pancreas transplant|0|||
170899801|NCT00064701|617637755|FG002|One Year Post-transplant|Pancreas transplant|1|||
170489323|NCT03627546|616133913|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
170489324|NCT01779440|616133914|FG000|Overall Study|Withdrawal by Subject|3|||
170489325|NCT01779440|616133915|FG001|Overall Study|Withdrawal by Subject|5|||
170489326|NCT00315458|616133916|FG000|Overall Study|Administrative|0|||
170489327|NCT00315458|616133917|FG001|Overall Study|Administrative|3|||
170489328|NCT00315458|616133918|FG002|Overall Study|Administrative|8|||
170489329|NCT00315458|616133919|FG003|Overall Study|Administrative|21|||
170489330|NCT00315458|616133916|FG000|Overall Study|Adverse Event|2|||
170489331|NCT00315458|616133917|FG001|Overall Study|Adverse Event|4|||
170489332|NCT00315458|616133918|FG002|Overall Study|Adverse Event|23|||
170489333|NCT00315458|616133919|FG003|Overall Study|Adverse Event|3|||
170489334|NCT00315458|616133916|FG000|Overall Study|Lost to Follow-up|1|||
170489335|NCT00315458|616133917|FG001|Overall Study|Lost to Follow-up|2|||
170489336|NCT00315458|616133918|FG002|Overall Study|Lost to Follow-up|0|||
170489337|NCT00315458|616133919|FG003|Overall Study|Lost to Follow-up|2|||
170489338|NCT00315458|616133916|FG000|Overall Study|Withdrawal by Subject|0|||
170489339|NCT00315458|616133917|FG001|Overall Study|Withdrawal by Subject|3|||
170899802|NCT00064701|617637753|FG000|Clinical Continuation Phase|Adverse Event|12|||
170899803|NCT00064701|617637754|FG001|Clinical Continuation Phase|Adverse Event|21|||
170899804|NCT00064701|617637755|FG002|Clinical Continuation Phase|Adverse Event|14|||
170899805|NCT00064701|617637753|FG000|Clinical Continuation Phase|Non-compliance|8|||
170899806|NCT00064701|617637754|FG001|Clinical Continuation Phase|Non-compliance|6|||
170489340|NCT00315458|616133918|FG002|Overall Study|Withdrawal by Subject|0|||
170489341|NCT00315458|616133919|FG003|Overall Study|Withdrawal by Subject|2|||
170489342|NCT00315458|616133916|FG000|Overall Study|Lack of Efficacy|0|||
170899807|NCT00064701|617637755|FG002|Clinical Continuation Phase|Non-compliance|7|||
170899808|NCT00064701|617637753|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
170489343|NCT00315458|616133917|FG001|Overall Study|Lack of Efficacy|0|||
170489344|NCT00315458|616133918|FG002|Overall Study|Lack of Efficacy|20|||
170489345|NCT00315458|616133919|FG003|Overall Study|Lack of Efficacy|1|||
170489346|NCT00315458|616133916|FG000|Overall Study|Did not qualify|0|||
170489347|NCT00315458|616133917|FG001|Overall Study|Did not qualify|0|||
170489348|NCT00315458|616133918|FG002|Overall Study|Did not qualify|1|||
170489349|NCT00315458|616133919|FG003|Overall Study|Did not qualify|0|||
170489350|NCT00961350|616133920|FG000|Overall Study|Adverse Event|18|||
170489351|NCT00961350|616133921|FG001|Overall Study|Adverse Event|33|||
170489352|NCT00961350|616133920|FG000|Overall Study|Withdrawal by Subject|10|||
170489353|NCT00961350|616133921|FG001|Overall Study|Withdrawal by Subject|10|||
170489354|NCT00961350|616133920|FG000|Overall Study|Lost to Follow-up|3|||
170489355|NCT00961350|616133921|FG001|Overall Study|Lost to Follow-up|3|||
170489356|NCT00961350|616133920|FG000|Overall Study|Misc|16|||
170489357|NCT00961350|616133921|FG001|Overall Study|Misc|21|||
170489358|NCT01190410|616134833|FG000|Overall Study|Adverse Event|0|||
170489359|NCT01190410|616134834|FG001|Overall Study|Adverse Event|3|||
170489360|NCT01190410|616134833|FG000|Overall Study|Lack of Efficacy|0|||
170489361|NCT01190410|616134834|FG001|Overall Study|Lack of Efficacy|2|||
170489362|NCT01190410|616134833|FG000|Overall Study|Withdrawal by Subject|0|||
170489363|NCT01190410|616134834|FG001|Overall Study|Withdrawal by Subject|2|||
170489364|NCT01190410|616134833|FG000|Overall Study|Administrative decision|1|||
170489365|NCT01190410|616134834|FG001|Overall Study|Administrative decision|0|||
170489366|NCT01190410|616134833|FG000|Overall Study|PI discretion|0|||
170489367|NCT01190410|616134834|FG001|Overall Study|PI discretion|2|||
170489368|NCT04390503|616134838|FG000|Overall Study|Physician Decision|2|||
170489369|NCT04390503|616134839|FG001|Overall Study|Physician Decision|1|||
170489370|NCT04390503|616134838|FG000|Overall Study|Adverse Event|1|||
170489371|NCT04390503|616134839|FG001|Overall Study|Adverse Event|0|||
170489372|NCT02498444|616134840|FG000|Overall Study|Withdrawal by Subject|3|||
170489373|NCT02498444|616134841|FG001|Overall Study|Withdrawal by Subject|0|||
170489374|NCT02498444|616134840|FG000|Overall Study|Physician Decision|1|||
170489375|NCT02498444|616134841|FG001|Overall Study|Physician Decision|0|||
170489376|NCT03656692|616134842|FG000|Overall Study|Worsening of disease activity|2|||
170489377|NCT03656692|616134842|FG000|Overall Study|Physician Decision|1|||
170489378|NCT03233529|616134843|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
170489379|NCT03233529|616134843|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
170489380|NCT02448537|616134844|FG000|Overall Study|Withdrawal by Subject|1|||
170489381|NCT02448537|616134845|FG001|Overall Study|Withdrawal by Subject|1|||
170489382|NCT02448537|616134846|FG002|Overall Study|Withdrawal by Subject|1|||
170489383|NCT03528369|616134847|FG000|Overall Study|Withdrawal by Subject|2|||
170489384|NCT03528369|616134848|FG001|Overall Study|Withdrawal by Subject|0|||
170489385|NCT03528369|616134849|FG002|Overall Study|Withdrawal by Subject|0|||
170489386|NCT03528369|616134847|FG000|Overall Study|Lost to Follow-up|1|||
170489387|NCT03528369|616134848|FG001|Overall Study|Lost to Follow-up|0|||
170489388|NCT03528369|616134849|FG002|Overall Study|Lost to Follow-up|0|||
170489389|NCT03528369|616134847|FG000|Overall Study|Adverse Event|0|||
170489390|NCT03528369|616134848|FG001|Overall Study|Adverse Event|1|||
170489391|NCT03528369|616134849|FG002|Overall Study|Adverse Event|0|||
170489392|NCT04725812|616134850|FG000|Overall Study|Withdrawal by Subject|1|||
170489393|NCT00839800|616134852|FG000|Overall Study|Adverse Event|8|||
170489394|NCT00839800|616134853|FG001|Overall Study|Adverse Event|12|||
170489395|NCT00839800|616134852|FG000|Overall Study|Lost to Follow-up|31|||
170489396|NCT00839800|616134853|FG001|Overall Study|Lost to Follow-up|26|||
170489397|NCT00839800|616134852|FG000|Overall Study|Withdrawal by Subject|28|||
170489398|NCT00839800|616134853|FG001|Overall Study|Withdrawal by Subject|34|||
170489399|NCT00839800|616134852|FG000|Overall Study|Incorrect Enrolment|3|||
170489400|NCT00839800|616134853|FG001|Overall Study|Incorrect Enrolment|3|||
170489401|NCT00839800|616134852|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
170489402|NCT00839800|616134853|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
170899809|NCT00064701|617637754|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
170899810|NCT00064701|617637755|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
170899811|NCT00064701|617637753|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
170899812|NCT00064701|617637754|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
170899813|NCT00064701|617637755|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
170899814|NCT00064701|617637753|FG000|Clinical Continuation Phase|Graft Failure|5|||
170899815|NCT00064701|617637754|FG001|Clinical Continuation Phase|Graft Failure|5|||
170899816|NCT00064701|617637755|FG002|Clinical Continuation Phase|Graft Failure|2|||
170899817|NCT00064701|617637753|FG000|Clinical Continuation Phase|Rejection|1|||
170899818|NCT00064701|617637754|FG001|Clinical Continuation Phase|Rejection|2|||
170489403|NCT00839800|616134852|FG000|Overall Study|Safety Reasons|2|||
170489404|NCT00839800|616134853|FG001|Overall Study|Safety Reasons|1|||
170489405|NCT00839800|616134852|FG000|Overall Study|Other|8|||
170489406|NCT00839800|616134853|FG001|Overall Study|Other|14|||
170899819|NCT00064701|617637755|FG002|Clinical Continuation Phase|Rejection|2|||
170489407|NCT00839800|616134852|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
170489408|NCT00839800|616134853|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
170489409|NCT02510664|616134854|FG000|Overall Study|Transferred Care|9|||
170489410|NCT02510664|616134855|FG001|Overall Study|Transferred Care|9|||
170489411|NCT02510664|616134856|FG002|Overall Study|Transferred Care|0|||
170489412|NCT02510664|616134854|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
170899820|NCT00064701|617637753|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
170489413|NCT02510664|616134855|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
170489414|NCT02510664|616134856|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
170489415|NCT02510664|616134854|FG000|Overall Study|Time Constraints|1|||
170489416|NCT02510664|616134855|FG001|Overall Study|Time Constraints|1|||
170489417|NCT02510664|616134856|FG002|Overall Study|Time Constraints|0|||
170489418|NCT02801617|616134858|FG000|Overall Study|Protocol Violation|2|||
170489419|NCT02801617|616134859|FG001|Overall Study|Protocol Violation|6|||
170489420|NCT00912743|616134866|FG000|Overall Study|Adverse Event|3|||
170489421|NCT00912743|616134867|FG001|Overall Study|Adverse Event|1|||
170489422|NCT00912743|616134866|FG000|Overall Study|Lack of Efficacy|9|||
170899821|NCT00064701|617637754|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
170489423|NCT00912743|616134867|FG001|Overall Study|Lack of Efficacy|18|||
170489424|NCT00912743|616134866|FG000|Overall Study|Toxicity|0|||
170489425|NCT00912743|616134867|FG001|Overall Study|Toxicity|1|||
170489426|NCT00912743|616134866|FG000|Overall Study|End of treatment form was not collected|1|||
170489427|NCT00912743|616134867|FG001|Overall Study|End of treatment form was not collected|0|||
170489428|NCT00179660|616134877|FG000|Overall Study|Adverse Event|7|||
170489429|NCT00179660|616134877|FG000|Overall Study|Lack of therapeutic effect|28|||
170489430|NCT00179660|616134877|FG000|Overall Study|Withdrawal by Subject|2|||
170489431|NCT00179660|616134877|FG000|Overall Study|Lost to Follow-up|1|||
170489432|NCT00179660|616134877|FG000|Overall Study|Death|3|||
170489433|NCT00179660|616134877|FG000|Overall Study|Other - Unspecified|9|||
170549287|NCT02675452|616354823|FG018|Overall Study|Other|0|||
170549288|NCT02675452|616354824|FG019|Overall Study|Other|0|||
170549289|NCT02675452|616354825|FG020|Overall Study|Other|0|||
170549290|NCT02675452|616354826|FG021|Overall Study|Other|0|||
170549291|NCT02675452|616354827|FG022|Overall Study|Other|0|||
170549292|NCT02675452|616354828|FG023|Overall Study|Other|0|||
170549293|NCT02675452|616354829|FG024|Overall Study|Other|0|||
170549294|NCT02675452|616354830|FG025|Overall Study|Other|0|||
170549295|NCT02675452|616354831|FG026|Overall Study|Other|1|||
170549296|NCT02675452|616354832|FG027|Overall Study|Other|0|||
170549297|NCT02675452|616354833|FG028|Overall Study|Other|0|||
170549298|NCT03520387|616354834|FG000|Pre-Randomization|Withdrawal by Subject|1|||
170549299|NCT03520387|616354835|FG001|Pre-Randomization|Withdrawal by Subject|0|||
170549300|NCT03520387|616354836|FG002|Pre-Randomization|Withdrawal by Subject|0|||
170549301|NCT03520387|616354837|FG003|Pre-Randomization|Withdrawal by Subject|0|||
170549302|NCT03520387|616354838|FG004|Pre-Randomization|Withdrawal by Subject|0|||
170549303|NCT03520387|616354834|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
170549304|NCT03520387|616354835|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
170549305|NCT03520387|616354836|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
170549306|NCT03520387|616354837|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
170549307|NCT03520387|616354838|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
170549308|NCT00541775|616354839|FG000|Overall Study|Adverse Event|3|||
170549309|NCT00541775|616354840|FG001|Overall Study|Adverse Event|2|||
170549310|NCT00541775|616354841|FG002|Overall Study|Adverse Event|1|||
170549311|NCT00541775|616354839|FG000|Overall Study|Lack of Efficacy|0|||
170549312|NCT00541775|616354840|FG001|Overall Study|Lack of Efficacy|0|||
170549313|NCT00541775|616354841|FG002|Overall Study|Lack of Efficacy|3|||
170549314|NCT00541775|616354839|FG000|Overall Study|Lost to Follow-up|0|||
170549315|NCT00541775|616354840|FG001|Overall Study|Lost to Follow-up|0|||
170549316|NCT00541775|616354841|FG002|Overall Study|Lost to Follow-up|2|||
170549317|NCT00541775|616354839|FG000|Overall Study|Protocol Violation|1|||
170549318|NCT00541775|616354840|FG001|Overall Study|Protocol Violation|0|||
170549319|NCT00541775|616354841|FG002|Overall Study|Protocol Violation|0|||
170549320|NCT00541775|616354839|FG000|Overall Study|Withdrawal by Subject and Other|5|||
170549321|NCT00541775|616354840|FG001|Overall Study|Withdrawal by Subject and Other|0|||
170549322|NCT00541775|616354841|FG002|Overall Study|Withdrawal by Subject and Other|2|||
170549323|NCT01945242|616354842|FG000|Overall Study|Physician Decision|3|||
170549324|NCT01945242|616354843|FG001|Overall Study|Physician Decision|3|||
170549325|NCT00032487|616354844|FG000|Overall Study|Withdrawal by Subject|67|||
170549326|NCT00032487|616354845|FG001|Overall Study|Withdrawal by Subject|43|||
170899822|NCT00064701|617637755|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
170899823|NCT00064701|617637753|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
170489434|NCT02035202|616134878|FG000|Overall Study|Lost to Follow-up|8|||
170899824|NCT00064701|617637754|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
170899825|NCT00064701|617637755|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
170899826|NCT00064701|617637753|FG000|Clinical Continuation Phase|Physician Decision|1|||
170899827|NCT00064701|617637754|FG001|Clinical Continuation Phase|Physician Decision|3|||
170489435|NCT02035202|616134879|FG001|Overall Study|Lost to Follow-up|16|||
170489436|NCT02035202|616134880|FG002|Overall Study|Lost to Follow-up|2|||
170549327|NCT00032487|616354844|FG000|Overall Study|Adverse Event|3|||
170549328|NCT00032487|616354845|FG001|Overall Study|Adverse Event|7|||
170549329|NCT00032487|616354844|FG000|Overall Study|Lost to Follow-up|57|||
170549330|NCT00032487|616354845|FG001|Overall Study|Lost to Follow-up|58|||
170549331|NCT00032487|616354844|FG000|Overall Study|Had other reason|12|||
170549332|NCT00032487|616354845|FG001|Overall Study|Had other reason|12|||
170489437|NCT03777436|616134881|FG000|Placebo-controlled Phase|Adverse Event|8|||
170489438|NCT03777436|616134882|FG001|Placebo-controlled Phase|Adverse Event|10|||
170489439|NCT03777436|616134883|FG002|Placebo-controlled Phase|Adverse Event|0|||
170489440|NCT03777436|616134881|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
170489441|NCT03777436|616134882|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
170489442|NCT03777436|616134883|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
170489443|NCT03777436|616134881|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
170489444|NCT03777436|616134882|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
170489445|NCT03777436|616134883|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
170489446|NCT03777436|616134881|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
170489447|NCT03777436|616134882|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
170489448|NCT03777436|616134883|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
170489449|NCT03777436|616134881|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
170489450|NCT03777436|616134882|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
170489451|NCT03777436|616134883|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
170489452|NCT03777436|616134881|FG000|Placebo-controlled Phase|Physician Decision|0|||
170489453|NCT03777436|616134882|FG001|Placebo-controlled Phase|Physician Decision|1|||
170489454|NCT03777436|616134883|FG002|Placebo-controlled Phase|Physician Decision|0|||
170489455|NCT03777436|616134881|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
170489456|NCT03777436|616134882|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
170489457|NCT03777436|616134883|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
170489458|NCT03777436|616134881|FG000|Apremilast Extension Phase|Adverse Event|0|||
170489459|NCT03777436|616134882|FG001|Apremilast Extension Phase|Adverse Event|0|||
170489460|NCT03777436|616134883|FG002|Apremilast Extension Phase|Adverse Event|6|||
170489461|NCT03777436|616134881|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
170489462|NCT03777436|616134882|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
170489463|NCT03777436|616134883|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
170489464|NCT03777436|616134881|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
170489465|NCT03777436|616134882|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
170489466|NCT03777436|616134883|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
170489467|NCT03777436|616134881|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
170489468|NCT03777436|616134882|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
170489469|NCT03777436|616134883|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
170489470|NCT03777436|616134881|FG000|Apremilast Extension Phase|Miscellaneous|0|||
170489471|NCT03777436|616134882|FG001|Apremilast Extension Phase|Miscellaneous|0|||
170489472|NCT03777436|616134883|FG002|Apremilast Extension Phase|Miscellaneous|1|||
170489473|NCT04478695|616134884|FG000|Overall Study|Death|1|||
170489474|NCT04478695|616134885|FG001|Overall Study|Death|0|||
170489475|NCT00178685|616134886|FG000|Overall Study|Death|3|||
170489476|NCT00178685|616134887|FG001|Overall Study|Death|3|||
170489477|NCT00178685|616134888|FG002|Overall Study|Death|6|||
170489478|NCT00178685|616134886|FG000|Overall Study|Lost to Follow-up|100|||
170489479|NCT00178685|616134887|FG001|Overall Study|Lost to Follow-up|187|||
170489480|NCT00178685|616134888|FG002|Overall Study|Lost to Follow-up|183|||
170489481|NCT00178685|616134886|FG000|Overall Study|Withdrawal by Subject|8|||
170489482|NCT00178685|616134887|FG001|Overall Study|Withdrawal by Subject|14|||
170549333|NCT04739709|616354846|FG000|Overall Study|Physician Decision|1|||
170549334|NCT04739709|616354847|FG001|Overall Study|Physician Decision|0|||
170549335|NCT01028391|616354850|FG000|Overall Study|Adverse Event|4|||
170549336|NCT01028391|616354851|FG001|Overall Study|Adverse Event|0|||
170549337|NCT01028391|616354850|FG000|Overall Study|Lack of Efficacy|0|||
170549338|NCT01028391|616354851|FG001|Overall Study|Lack of Efficacy|2|||
170549339|NCT01028391|616354850|FG000|Overall Study|Lost to Follow-up|3|||
170549340|NCT01028391|616354851|FG001|Overall Study|Lost to Follow-up|4|||
170800185|NCT03709706|617280218|FG001|Overall Study|Withdrawal by Subject|1|||
170800186|NCT03709706|617280217|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
170800187|NCT03709706|617280218|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
170800188|NCT04868617|617280219|FG000|Overall Study|Death|1|||
170800189|NCT04868617|617280220|FG001|Overall Study|Death|0|||
170800190|NCT04868617|617280219|FG000|Overall Study|Adverse Event|1|||
170800191|NCT04868617|617280220|FG001|Overall Study|Adverse Event|0|||
170800192|NCT04868617|617280219|FG000|Overall Study|Withdrawal by Subject|1|||
170489483|NCT00178685|616134888|FG002|Overall Study|Withdrawal by Subject|7|||
170489484|NCT00927862|616134889|FG000|Overall Study|Missing data needed for endpt analyses|27|||
170489485|NCT00927862|616134890|FG001|Overall Study|Missing data needed for endpt analyses|45|||
170489486|NCT00820248|616134891|FG000|Overall Study|No treated|4|||
170489487|NCT00820248|616134892|FG001|Overall Study|No treated|1|||
170489488|NCT02237196|616134902|FG000|Overall Study|Adverse Event|0|||
170489489|NCT02237196|616134903|FG001|Overall Study|Adverse Event|1|||
170549341|NCT01028391|616354850|FG000|Overall Study|Physician Decision|0|||
170549342|NCT01028391|616354851|FG001|Overall Study|Physician Decision|1|||
170549343|NCT01028391|616354850|FG000|Overall Study|Withdrawal by Subject|6|||
170800193|NCT04868617|617280220|FG001|Overall Study|Withdrawal by Subject|0|||
170800194|NCT04868617|617280219|FG000|Overall Study|Device deficiency|1|||
170800195|NCT04868617|617280220|FG001|Overall Study|Device deficiency|0|||
170899828|NCT00064701|617637755|FG002|Clinical Continuation Phase|Physician Decision|0|||
170899829|NCT00064701|617637753|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
170899830|NCT00064701|617637754|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
170489490|NCT02237196|616134904|FG002|Overall Study|Adverse Event|1|||
170489491|NCT02237196|616134905|FG003|Overall Study|Adverse Event|0|||
170489492|NCT02237196|616134902|FG000|Overall Study|Lost to Follow-up|4|||
170489493|NCT02237196|616134903|FG001|Overall Study|Lost to Follow-up|2|||
170489494|NCT02237196|616134904|FG002|Overall Study|Lost to Follow-up|4|||
170489495|NCT02237196|616134905|FG003|Overall Study|Lost to Follow-up|6|||
170489496|NCT02237196|616134902|FG000|Overall Study|Physician Decision|2|||
170489497|NCT02237196|616134903|FG001|Overall Study|Physician Decision|0|||
170489498|NCT02237196|616134904|FG002|Overall Study|Physician Decision|0|||
170489499|NCT02237196|616134905|FG003|Overall Study|Physician Decision|1|||
170489500|NCT02237196|616134902|FG000|Overall Study|Pregnancy|0|||
170489501|NCT02237196|616134903|FG001|Overall Study|Pregnancy|0|||
170489502|NCT02237196|616134904|FG002|Overall Study|Pregnancy|1|||
170489503|NCT02237196|616134905|FG003|Overall Study|Pregnancy|1|||
170489504|NCT02237196|616134902|FG000|Overall Study|Withdrawal by Subject|1|||
170489505|NCT02237196|616134903|FG001|Overall Study|Withdrawal by Subject|1|||
170489506|NCT02237196|616134904|FG002|Overall Study|Withdrawal by Subject|4|||
170489507|NCT02237196|616134905|FG003|Overall Study|Withdrawal by Subject|1|||
170489508|NCT02237196|616134902|FG000|Overall Study|Site Error|1|||
170489509|NCT02237196|616134903|FG001|Overall Study|Site Error|2|||
170489510|NCT02237196|616134904|FG002|Overall Study|Site Error|0|||
170489511|NCT02237196|616134905|FG003|Overall Study|Site Error|2|||
170489512|NCT01057810|616134908|FG000|Overall Study|Disease progression|156|||
170489513|NCT01057810|616134909|FG001|Overall Study|Disease progression|197|||
170489514|NCT01057810|616134908|FG000|Overall Study|Study drug toxicity|5|||
170489515|NCT01057810|616134909|FG001|Overall Study|Study drug toxicity|114|||
170489516|NCT01057810|616134908|FG000|Overall Study|Adverse event unrelated to study drug|13|||
170489517|NCT01057810|616134909|FG001|Overall Study|Adverse event unrelated to study drug|29|||
170489518|NCT01057810|616134908|FG000|Overall Study|Withdrawal by Subject|10|||
170489519|NCT01057810|616134909|FG001|Overall Study|Withdrawal by Subject|25|||
170489520|NCT01057810|616134908|FG000|Overall Study|Death|2|||
170489521|NCT01057810|616134909|FG001|Overall Study|Death|12|||
170489522|NCT01057810|616134908|FG000|Overall Study|Maximum clinical benefit|5|||
170489523|NCT01057810|616134909|FG001|Overall Study|Maximum clinical benefit|5|||
170489524|NCT01057810|616134908|FG000|Overall Study|Poor/non-compliance|0|||
170489525|NCT01057810|616134909|FG001|Overall Study|Poor/non-compliance|1|||
170489526|NCT01057810|616134908|FG000|Overall Study|No longer met study criteria|0|||
170489527|NCT01057810|616134909|FG001|Overall Study|No longer met study criteria|1|||
170489528|NCT01057810|616134908|FG000|Overall Study|Other|7|||
170489529|NCT01057810|616134909|FG001|Overall Study|Other|14|||
170489530|NCT00887315|616134910|FG000|Overall Study|Study termination|7|||
170489531|NCT00887315|616134911|FG001|Overall Study|Study termination|4|||
170489532|NCT00619892|616134915|FG000|Overall Study|Adverse Event|3|||
170489533|NCT00619892|616134916|FG001|Overall Study|Adverse Event|0|||
170489534|NCT00619892|616134915|FG000|Overall Study|Lost to Follow-up|0|||
170489535|NCT00619892|616134916|FG001|Overall Study|Lost to Follow-up|1|||
170489536|NCT00619892|616134915|FG000|Overall Study|Intercurrent illness|0|||
170489537|NCT00619892|616134916|FG001|Overall Study|Intercurrent illness|1|||
170489538|NCT00384839|616134921|FG000|Overall Study|Adverse Event|4|||
170489539|NCT00384839|616134921|FG000|Overall Study|Investigator Request|1|||
170489540|NCT00384839|616134921|FG000|Overall Study|Patient Request|1|||
170489541|NCT00384839|616134921|FG000|Overall Study|Ineligible|2|||
170489542|NCT02049814|616134924|FG000|Overall Study|Reason not Specified|4|||
170489543|NCT02049814|616134925|FG001|Overall Study|Reason not Specified|3|||
170489544|NCT02049814|616134924|FG000|Overall Study|Pregnancy|1|||
170489545|NCT02049814|616134925|FG001|Overall Study|Pregnancy|0|||
170489546|NCT02049814|616134924|FG000|Overall Study|Lost to Follow-up|2|||
170489547|NCT02049814|616134925|FG001|Overall Study|Lost to Follow-up|3|||
170489548|NCT02049814|616134924|FG000|Overall Study|Serious Protocol Violation|5|||
170489549|NCT02049814|616134925|FG001|Overall Study|Serious Protocol Violation|7|||
170489550|NCT02049814|616134924|FG000|Overall Study|Study Termination|0|||
170489551|NCT02049814|616134925|FG001|Overall Study|Study Termination|1|||
170489552|NCT02049814|616134924|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
170489553|NCT02049814|616134925|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
170489554|NCT02049814|616134924|FG000|Overall Study|Voluntary withdrawal|9|||
170489555|NCT02049814|616134925|FG001|Overall Study|Voluntary withdrawal|8|||
170489556|NCT01814696|616134926|FG000|Overall Study|Withdrawal by Subject|1|||
170489557|NCT01814696|616134927|FG001|Overall Study|Withdrawal by Subject|0|||
170899831|NCT00064701|617637755|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
170899832|NCT00064701|617637753|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
170489558|NCT01814696|616134926|FG000|Overall Study|Randomized to wrong group|1|||
170489559|NCT01814696|616134927|FG001|Overall Study|Randomized to wrong group|0|||
170489560|NCT00237458|616134928|FG000|Overall Study|Lack of Efficacy|1|||
170489561|NCT00237458|616134928|FG000|Overall Study|Adverse Event|1|||
170489562|NCT00237458|616134928|FG000|Overall Study|Withdrawal by Subject|1|||
170899833|NCT00064701|617637754|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
170899834|NCT00064701|617637755|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
170899835|NCT00064701|617637753|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
170899836|NCT00064701|617637754|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
170899837|NCT00064701|617637755|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
170899838|NCT00064701|617637753|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
170899839|NCT00064701|617637754|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
170899840|NCT00064701|617637755|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
170899841|NCT00064701|617637753|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
170899842|NCT00064701|617637754|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
170899843|NCT00064701|617637755|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
170899844|NCT00064701|617637753|FG000|Clinical Continuation Phase|Patient opted out|0|||
170899845|NCT00064701|617637754|FG001|Clinical Continuation Phase|Patient opted out|0|||
170899846|NCT00064701|617637755|FG002|Clinical Continuation Phase|Patient opted out|1|||
170899847|NCT03094195|617637756|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
170899848|NCT03094195|617637757|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
170899849|NCT03094195|617637758|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
170899850|NCT03094195|617637759|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
170899851|NCT03094195|617637760|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
170899852|NCT03094195|617637761|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
170899853|NCT03094195|617637762|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
170899854|NCT03094195|617637763|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
170899855|NCT03094195|617637756|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
170489563|NCT02977572|616134929|FG000|Overall Study|Exclusion criterion|2|||
170489564|NCT02977572|616134930|FG001|Overall Study|Exclusion criterion|2|||
170489565|NCT01166438|616134931|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
170489566|NCT01166438|616134932|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
170489567|NCT01166438|616134931|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
170489568|NCT01166438|616134932|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
170489569|NCT01166438|616134931|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
170489570|NCT01166438|616134932|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
170489571|NCT01166438|616134931|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
170489572|NCT01166438|616134932|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
170640656|NCT04931888|616696948|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
170640657|NCT04931888|616696949|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
170640658|NCT04931888|616696950|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
170640659|NCT04931888|616696951|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
170640660|NCT01049009|616696952|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
170640661|NCT01049009|616696953|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
170640662|NCT01049009|616696952|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170640663|NCT01049009|616696953|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
170640664|NCT01049009|616696952|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
170640665|NCT01049009|616696953|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
170640666|NCT01049009|616696952|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
170640667|NCT01049009|616696953|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
170640668|NCT02489318|616696956|FG000|Randomized|Withdrawal by Subject|0|||
170640669|NCT02489318|616696957|FG001|Randomized|Withdrawal by Subject|1|||
170899856|NCT03094195|617637757|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
170899857|NCT03094195|617637758|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
170899858|NCT03094195|617637759|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
170899859|NCT03094195|617637760|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
170899860|NCT03094195|617637761|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
170899861|NCT03094195|617637762|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
170899862|NCT03094195|617637763|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
170489573|NCT01166438|616134931|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
170489574|NCT01166438|616134932|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
170489575|NCT01166438|616134931|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
170489576|NCT01166438|616134932|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
170489577|NCT03759587|616134933|FG000|Overall Study|Adverse Event|5|||
170489578|NCT03759587|616134933|FG000|Overall Study|Progressive Disease|10|||
170489579|NCT03759587|616134933|FG000|Overall Study|Site Terminated by Sponsor|3|||
170489580|NCT03759587|616134933|FG000|Overall Study|Withdrawal by Subject|1|||
170489581|NCT00591565|616134938|FG000|Overall Study|lost follow up, withdrawn|5|||
170489582|NCT01131455|616134939|FG000|Overall Study|Death of PI|6|||
170489583|NCT01131455|616134940|FG001|Overall Study|Death of PI|4|||
170489584|NCT01131455|616134941|FG002|Overall Study|Death of PI|0|||
170489585|NCT03232931|616136454|FG000|Overall Study|Physician Decision|1|||
170489586|NCT03232931|616136455|FG001|Overall Study|Physician Decision|1|||
170800196|NCT00686595|617280221|FG000|Overall Study|Adverse Event|3|||
170800197|NCT00686595|617280221|FG000|Overall Study|Protocol Violation|1|||
170800198|NCT00686595|617280221|FG000|Overall Study|Lost to Follow-up|1|||
170800199|NCT00686595|617280221|FG000|Overall Study|Lack of Efficacy|1|||
170800200|NCT00686595|617280221|FG000|Overall Study|Poor Compliance|1|||
170800201|NCT02306161|617280222|FG000|Overall Study|Death|1|||
170800202|NCT02306161|617280223|FG001|Overall Study|Death|3|||
170800203|NCT02306161|617280222|FG000|Overall Study|Lack of Efficacy|20|||
170800204|NCT02306161|617280223|FG001|Overall Study|Lack of Efficacy|43|||
170800205|NCT02306161|617280222|FG000|Overall Study|Physician Decision|30|||
170800206|NCT02306161|617280223|FG001|Overall Study|Physician Decision|18|||
170800207|NCT02306161|617280222|FG000|Overall Study|Withdrawal by Subject|4|||
170800208|NCT02306161|617280223|FG001|Overall Study|Withdrawal by Subject|0|||
170800209|NCT02306161|617280222|FG000|Overall Study|Ineligible|9|||
170800210|NCT02306161|617280223|FG001|Overall Study|Ineligible|5|||
170800211|NCT01171976|617280232|FG000|Overall Study|Protocol Violation|0|||
170800212|NCT01171976|617280233|FG001|Overall Study|Protocol Violation|0|||
170800213|NCT01171976|617280234|FG002|Overall Study|Protocol Violation|1|||
170800214|NCT01171976|617280232|FG000|Overall Study|Death|2|||
170800215|NCT01171976|617280233|FG001|Overall Study|Death|4|||
170800216|NCT01171976|617280234|FG002|Overall Study|Death|1|||
170800217|NCT01171976|617280232|FG000|Overall Study|Lost to Follow-up|4|||
170800218|NCT01171976|617280233|FG001|Overall Study|Lost to Follow-up|0|||
170800219|NCT01171976|617280234|FG002|Overall Study|Lost to Follow-up|2|||
170800220|NCT01171976|617280232|FG000|Overall Study|Withdrawal by Subject|1|||
170800221|NCT01171976|617280233|FG001|Overall Study|Withdrawal by Subject|5|||
170800222|NCT01171976|617280234|FG002|Overall Study|Withdrawal by Subject|6|||
170800223|NCT01171976|617280232|FG000|Overall Study|Abnormal test result|1|||
170800224|NCT01171976|617280233|FG001|Overall Study|Abnormal test result|0|||
170800225|NCT01171976|617280234|FG002|Overall Study|Abnormal test result|0|||
170800226|NCT01171976|617280232|FG000|Overall Study|Adverse Event|6|||
170800227|NCT01171976|617280233|FG001|Overall Study|Adverse Event|2|||
170800228|NCT01171976|617280234|FG002|Overall Study|Adverse Event|5|||
170800229|NCT05934292|617280253|FG000|Overall Study|Lost to Follow-up|0|||
170800230|NCT05934292|617280254|FG001|Overall Study|Lost to Follow-up|0|||
170800231|NCT05934292|617280255|FG002|Overall Study|Lost to Follow-up|1|||
170800232|NCT05934292|617280256|FG003|Overall Study|Lost to Follow-up|0|||
170800233|NCT04899674|617280257|FG000|Test|Adverse Event|1|||
170800234|NCT04059406|617280260|FG000|Overall Study|Early Treatment Termination|5|||
170800235|NCT04059406|617280261|FG001|Overall Study|Early Treatment Termination|5|||
170800236|NCT04059406|617280262|FG002|Overall Study|Early Treatment Termination|15|||
170800237|NCT05155306|617280263|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
170800238|NCT05155306|617280264|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
170800239|NCT05155306|617280265|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
170800240|NCT05155306|617280266|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
170800241|NCT05155306|617280263|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
170800242|NCT05155306|617280264|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
170800243|NCT05155306|617280265|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
170899863|NCT03094195|617637756|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170549344|NCT01028391|616354851|FG001|Overall Study|Withdrawal by Subject|3|||
170549345|NCT01028391|616354850|FG000|Overall Study|Needed excluded medication|1|||
170549346|NCT01028391|616354851|FG001|Overall Study|Needed excluded medication|1|||
170549347|NCT01198548|616354852|FG000|Overall Study|Disease Progression|9|||
170549348|NCT01198548|616354852|FG000|Overall Study|Administrative Decision|1|||
170549349|NCT00290238|616354853|FG000|Overall Study|Study terminated|27|||
170549350|NCT00290238|616354854|FG001|Overall Study|Study terminated|27|||
170549351|NCT00290238|616354853|FG000|Overall Study|Lost to Follow-up|0|||
170549352|NCT00290238|616354854|FG001|Overall Study|Lost to Follow-up|1|||
170640670|NCT02489318|616696956|FG000|Treated|Adverse Event|19|||
170640671|NCT02489318|616696957|FG001|Treated|Adverse Event|62|||
170640672|NCT02489318|616696956|FG000|Treated|Death|13|||
170800244|NCT05155306|617280266|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
170899864|NCT03094195|617637757|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170549353|NCT00290238|616354853|FG000|Overall Study|Withdrawal by Subject|15|||
170640673|NCT02489318|616696957|FG001|Treated|Death|11|||
170800245|NCT00146172|617281000|FG000|Overall Study|Adverse Event|0|||
170800246|NCT00146172|617281001|FG001|Overall Study|Adverse Event|0|||
170800247|NCT00146172|617281002|FG002|Overall Study|Adverse Event|1|||
170800248|NCT00146172|617281003|FG003|Overall Study|Adverse Event|1|||
170800249|NCT00146172|617281004|FG004|Overall Study|Adverse Event|0|||
170800250|NCT00146172|617281005|FG005|Overall Study|Adverse Event|2|||
170800251|NCT00146172|617281006|FG006|Overall Study|Adverse Event|3|||
170800252|NCT00146172|617281007|FG007|Overall Study|Adverse Event|10|||
170800253|NCT00146172|617281000|FG000|Overall Study|Lost to Follow-up|0|||
170800254|NCT00146172|617281001|FG001|Overall Study|Lost to Follow-up|0|||
170800255|NCT00146172|617281002|FG002|Overall Study|Lost to Follow-up|0|||
170800256|NCT00146172|617281003|FG003|Overall Study|Lost to Follow-up|0|||
170800257|NCT00146172|617281004|FG004|Overall Study|Lost to Follow-up|0|||
170800258|NCT00146172|617281005|FG005|Overall Study|Lost to Follow-up|0|||
170489587|NCT03232931|616136454|FG000|Overall Study|Withdrawal by Subject|6|||
170489588|NCT03232931|616136455|FG001|Overall Study|Withdrawal by Subject|0|||
170489589|NCT03232931|616136454|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
170489590|NCT03232931|616136455|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
170489591|NCT03232931|616136454|FG000|Overall Study|Parent did not record voice|1|||
170489592|NCT03232931|616136455|FG001|Overall Study|Parent did not record voice|2|||
170489593|NCT03232931|616136454|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
170489594|NCT03232931|616136455|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
170489595|NCT01283334|616136456|FG000|Overall Study|Withdrawal by Subject|1|||
170489596|NCT01283334|616136456|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
170489597|NCT01283334|616136456|FG000|Overall Study|Adverse Event|4|||
170489598|NCT01283334|616136456|FG000|Overall Study|Physician Decision|1|||
170489599|NCT03467217|616136457|FG000|Overall Study|Trial stopped early|5|||
170489600|NCT03467217|616136458|FG001|Overall Study|Trial stopped early|2|||
170489601|NCT03467217|616136457|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
170489602|NCT03467217|616136458|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
170489603|NCT03467217|616136457|FG000|Overall Study|Lost to Follow-up|0|||
170489604|NCT03467217|616136458|FG001|Overall Study|Lost to Follow-up|2|||
170489605|NCT03260244|616136460|FG000|Overall Study|Death|19|||
170489606|NCT03260244|616136460|FG000|Overall Study|Lost to Follow-up|60|||
170489607|NCT03260244|616136460|FG000|Overall Study|Withdrawal by Subject|48|||
170489608|NCT03260244|616136460|FG000|Overall Study|Procedure Not Performed|21|||
170489609|NCT03260244|616136460|FG000|Overall Study|Enrollment Criteria Not Met|31|||
170489610|NCT03260244|616136460|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
170640674|NCT02489318|616696956|FG000|Treated|Physician Decision|4|||
170640675|NCT02489318|616696957|FG001|Treated|Physician Decision|6|||
170640676|NCT02489318|616696956|FG000|Treated|Protocol Violation|1|||
170640677|NCT02489318|616696957|FG001|Treated|Protocol Violation|2|||
170640678|NCT02489318|616696956|FG000|Treated|Withdrawal by Subject|37|||
170640679|NCT02489318|616696957|FG001|Treated|Withdrawal by Subject|36|||
170640680|NCT02489318|616696956|FG000|Treated|Other: Progressive Disease|245|||
170640681|NCT02489318|616696957|FG001|Treated|Other: Progressive Disease|138|||
170640682|NCT02489318|616696956|FG000|Treated|Other|0|||
170640683|NCT02489318|616696957|FG001|Treated|Other|2|||
170640684|NCT02489318|616696956|FG000|Treated|Ongoing|0|||
170640685|NCT02489318|616696957|FG001|Treated|Ongoing|267|||
170640686|NCT04329806|616696958|FG000|Overall Study|Physician Decision|3|||
170640687|NCT04329806|616696959|FG001|Overall Study|Physician Decision|4|||
170640688|NCT04867902|616696960|FG000|Overall Study|Lost to Follow-up|1|||
170640689|NCT04867902|616696960|FG000|Overall Study|Withdrawal by Subject|2|||
170640690|NCT04867902|616696960|FG000|Overall Study|Protocol Violation|1|||
170640691|NCT03760731|616696961|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
170640692|NCT03760731|616696962|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
170640693|NCT03760731|616696961|FG000|Treatment|Attended less than 70% of sessions|10|||
170640694|NCT03760731|616696962|FG001|Treatment|Attended less than 70% of sessions|15|||
170640695|NCT01092546|616696963|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
170640696|NCT01667419|616696978|FG000|Overall Study|Reason Not Specified|1|||
170640697|NCT01667419|616696979|FG001|Overall Study|Reason Not Specified|0|||
170640698|NCT01667419|616696980|FG002|Overall Study|Reason Not Specified|0|||
170640699|NCT01667419|616696981|FG003|Overall Study|Reason Not Specified|0|||
170800259|NCT00146172|617281006|FG006|Overall Study|Lost to Follow-up|0|||
170800260|NCT00146172|617281007|FG007|Overall Study|Lost to Follow-up|1|||
170800261|NCT00146172|617281000|FG000|Overall Study|Disease Progression|2|||
170489611|NCT03260244|616136460|FG000|Overall Study|Subject Noncompliance|6|||
170489612|NCT03260244|616136460|FG000|Overall Study|No inducible Arrhythmia|2|||
170489613|NCT03260244|616136460|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
170489614|NCT03260244|616136460|FG000|Overall Study|Screen Failure|2|||
170489615|NCT03260244|616136460|FG000|Overall Study|Treated Off Label|69|||
170489616|NCT03260244|616136460|FG000|Overall Study|No Radiofrequency Ablation|14|||
170489617|NCT00594100|616136461|FG000|Procedure|Technical Failure|9|||
170489618|NCT00594100|616136461|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
170489619|NCT00594100|616136461|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
170489620|NCT00594100|616136461|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
170489621|NCT01270464|616136462|FG000|Overall Study|Protocol Violation|4|||
170489622|NCT01270464|616136463|FG001|Overall Study|Protocol Violation|3|||
170640700|NCT01667419|616696978|FG000|Overall Study|Withdrawal by Subject|16|||
170640701|NCT01667419|616696979|FG001|Overall Study|Withdrawal by Subject|8|||
170640702|NCT01667419|616696980|FG002|Overall Study|Withdrawal by Subject|9|||
170640703|NCT01667419|616696981|FG003|Overall Study|Withdrawal by Subject|8|||
170800262|NCT00146172|617281001|FG001|Overall Study|Disease Progression|4|||
170489623|NCT01270464|616136464|FG002|Overall Study|Protocol Violation|2|||
170489624|NCT01270464|616136462|FG000|Overall Study|Lack of Efficacy|2|||
170489625|NCT01270464|616136463|FG001|Overall Study|Lack of Efficacy|3|||
170899865|NCT03094195|617637758|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
170899866|NCT03094195|617637759|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170899867|NCT03094195|617637760|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170899868|NCT03094195|617637761|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170489626|NCT01270464|616136464|FG002|Overall Study|Lack of Efficacy|1|||
170489627|NCT01270464|616136462|FG000|Overall Study|Adverse Event|9|||
170489628|NCT01270464|616136463|FG001|Overall Study|Adverse Event|1|||
170489629|NCT01270464|616136464|FG002|Overall Study|Adverse Event|7|||
170489630|NCT01270464|616136462|FG000|Overall Study|Withdrawal by Subject|2|||
170899869|NCT03094195|617637762|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170899870|NCT03094195|617637763|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
170899871|NCT03094195|617637756|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170899872|NCT03094195|617637757|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
170899873|NCT03094195|617637758|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
170899874|NCT03094195|617637759|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170899875|NCT03094195|617637760|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170899876|NCT03094195|617637761|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170899877|NCT03094195|617637762|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170489631|NCT01270464|616136463|FG001|Overall Study|Withdrawal by Subject|1|||
170489632|NCT01270464|616136464|FG002|Overall Study|Withdrawal by Subject|4|||
170489633|NCT01270464|616136462|FG000|Overall Study|Lost to Follow-up|2|||
170489634|NCT01270464|616136463|FG001|Overall Study|Lost to Follow-up|3|||
170489635|NCT01270464|616136464|FG002|Overall Study|Lost to Follow-up|1|||
170489636|NCT01270464|616136462|FG000|Overall Study|Other|1|||
170489637|NCT01270464|616136463|FG001|Overall Study|Other|1|||
170489638|NCT01270464|616136464|FG002|Overall Study|Other|3|||
170489639|NCT00892151|616136465|FG000|Overall Study|Protocol Violation|1|||
170489640|NCT01431716|616136466|FG000|Overall Study|Withdrawal of consent|1|||
170489641|NCT02071706|616136467|FG000|Overall Study|Adverse Event|1|||
170489642|NCT02071706|616136467|FG000|Overall Study|Withdrawal by Subject|2|||
170489643|NCT02247440|616136473|FG000|Overall Study|Withdrawal by Subject|1|||
170489644|NCT02247440|616136473|FG000|Overall Study|Lack of Efficacy|3|||
170489645|NCT02320058|616136474|FG000|Overall Study|Death|25|||
170489646|NCT02320058|616136475|FG001|Overall Study|Death|10|||
170489647|NCT02320058|616136474|FG000|Overall Study|Lost to Follow-up|4|||
170489648|NCT02320058|616136475|FG001|Overall Study|Lost to Follow-up|0|||
170489649|NCT02320058|616136474|FG000|Overall Study|Other reasons|4|||
170489650|NCT02320058|616136475|FG001|Overall Study|Other reasons|1|||
170489651|NCT02320058|616136474|FG000|Overall Study|Withdrawal by Subject|8|||
170489652|NCT02320058|616136475|FG001|Overall Study|Withdrawal by Subject|2|||
170489653|NCT02320058|616136474|FG000|Overall Study|Not reported|1|||
170489654|NCT02320058|616136475|FG001|Overall Study|Not reported|0|||
170489655|NCT01339923|616136476|FG000|Overall Study|Adverse Event|1|||
170489656|NCT01339923|616136477|FG001|Overall Study|Adverse Event|1|||
170489657|NCT01339923|616136478|FG002|Overall Study|Adverse Event|1|||
170489658|NCT01339923|616136479|FG003|Overall Study|Adverse Event|0|||
170489659|NCT01339923|616136480|FG004|Overall Study|Adverse Event|0|||
170489660|NCT01339923|616136481|FG005|Overall Study|Adverse Event|0|||
170489661|NCT01339923|616136482|FG006|Overall Study|Adverse Event|1|||
170489662|NCT01339923|616136476|FG000|Overall Study|Inappropriate Enrollment|1|||
170489663|NCT01339923|616136477|FG001|Overall Study|Inappropriate Enrollment|0|||
170489664|NCT01339923|616136478|FG002|Overall Study|Inappropriate Enrollment|0|||
170489665|NCT01339923|616136479|FG003|Overall Study|Inappropriate Enrollment|0|||
170489666|NCT01339923|616136480|FG004|Overall Study|Inappropriate Enrollment|0|||
170549354|NCT00290238|616354854|FG001|Overall Study|Withdrawal by Subject|13|||
170549355|NCT03211858|616356700|FG000|Overall Study|Adverse Event|8|||
170549356|NCT03211858|616356701|FG001|Overall Study|Adverse Event|6|||
170549357|NCT03211858|616356700|FG000|Overall Study|Lack of Efficacy|0|||
170899878|NCT03094195|617637763|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
170899879|NCT00054132|617637764|FG000|Overall Study|Not Treated|1|||
170899880|NCT04373460|617637765|FG000|Overall Study|Did not receive tranfusion|18|||
170899881|NCT04373460|617637766|FG001|Overall Study|Did not receive tranfusion|26|||
170489667|NCT01339923|616136481|FG005|Overall Study|Inappropriate Enrollment|1|||
170489668|NCT01339923|616136482|FG006|Overall Study|Inappropriate Enrollment|0|||
170489669|NCT01339923|616136476|FG000|Overall Study|Lost to Follow-up|4|||
170489670|NCT01339923|616136477|FG001|Overall Study|Lost to Follow-up|4|||
170489671|NCT01339923|616136478|FG002|Overall Study|Lost to Follow-up|0|||
170489672|NCT01339923|616136479|FG003|Overall Study|Lost to Follow-up|3|||
170489673|NCT01339923|616136480|FG004|Overall Study|Lost to Follow-up|1|||
170489674|NCT01339923|616136481|FG005|Overall Study|Lost to Follow-up|1|||
170489675|NCT01339923|616136482|FG006|Overall Study|Lost to Follow-up|5|||
170489676|NCT01339923|616136476|FG000|Overall Study|Protocol Violation|0|||
170489677|NCT01339923|616136477|FG001|Overall Study|Protocol Violation|0|||
170489678|NCT01339923|616136478|FG002|Overall Study|Protocol Violation|0|||
170549358|NCT03211858|616356701|FG001|Overall Study|Lack of Efficacy|4|||
170489679|NCT01339923|616136479|FG003|Overall Study|Protocol Violation|0|||
170489680|NCT01339923|616136480|FG004|Overall Study|Protocol Violation|0|||
170489681|NCT01339923|616136481|FG005|Overall Study|Protocol Violation|3|||
170489682|NCT01339923|616136482|FG006|Overall Study|Protocol Violation|1|||
170489683|NCT01339923|616136476|FG000|Overall Study|Unable to Classify|1|||
170489684|NCT01339923|616136477|FG001|Overall Study|Unable to Classify|0|||
170489685|NCT01339923|616136478|FG002|Overall Study|Unable to Classify|1|||
170489686|NCT01339923|616136479|FG003|Overall Study|Unable to Classify|0|||
170489687|NCT01339923|616136480|FG004|Overall Study|Unable to Classify|0|||
170489688|NCT01339923|616136481|FG005|Overall Study|Unable to Classify|1|||
170489689|NCT01339923|616136482|FG006|Overall Study|Unable to Classify|5|||
170489690|NCT01339923|616136476|FG000|Overall Study|Withdrawal by Subject|7|||
170489691|NCT01339923|616136477|FG001|Overall Study|Withdrawal by Subject|11|||
170489692|NCT01339923|616136478|FG002|Overall Study|Withdrawal by Subject|6|||
170489693|NCT01339923|616136479|FG003|Overall Study|Withdrawal by Subject|1|||
170489694|NCT01339923|616136480|FG004|Overall Study|Withdrawal by Subject|4|||
170489695|NCT01339923|616136481|FG005|Overall Study|Withdrawal by Subject|3|||
170489696|NCT01339923|616136482|FG006|Overall Study|Withdrawal by Subject|2|||
170489697|NCT00661609|616136483|FG000|Overall Study|Adverse Event|4|||
170489698|NCT00661609|616136483|FG000|Overall Study|Death|20|||
170489699|NCT00661609|616136483|FG000|Overall Study|Withdrawal by Subject|2|||
170489700|NCT00661609|616136483|FG000|Overall Study|PI Decision|1|||
170489701|NCT00661609|616136483|FG000|Overall Study|Survival follow up stage discontinued|11|||
170489702|NCT00661609|616136483|FG000|Overall Study|Disease progression|3|||
170489703|NCT03521115|616136484|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
170489704|NCT03521115|616136485|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
170800263|NCT00146172|617281002|FG002|Overall Study|Disease Progression|2|||
170800264|NCT00146172|617281003|FG003|Overall Study|Disease Progression|5|||
170800265|NCT00146172|617281004|FG004|Overall Study|Disease Progression|2|||
170800266|NCT00146172|617281005|FG005|Overall Study|Disease Progression|2|||
170800267|NCT00146172|617281006|FG006|Overall Study|Disease Progression|1|||
170800268|NCT00146172|617281007|FG007|Overall Study|Disease Progression|22|||
170800269|NCT00146172|617281000|FG000|Overall Study|Death|0|||
170800270|NCT00146172|617281001|FG001|Overall Study|Death|0|||
170800271|NCT00146172|617281002|FG002|Overall Study|Death|0|||
170800272|NCT00146172|617281003|FG003|Overall Study|Death|0|||
170800273|NCT00146172|617281004|FG004|Overall Study|Death|0|||
170800274|NCT00146172|617281005|FG005|Overall Study|Death|0|||
170800275|NCT00146172|617281006|FG006|Overall Study|Death|1|||
170800276|NCT00146172|617281007|FG007|Overall Study|Death|0|||
170800277|NCT00146172|617281000|FG000|Overall Study|Physician Decision|0|||
170800278|NCT00146172|617281001|FG001|Overall Study|Physician Decision|0|||
170800279|NCT00146172|617281002|FG002|Overall Study|Physician Decision|0|||
170800280|NCT00146172|617281003|FG003|Overall Study|Physician Decision|0|||
170800281|NCT00146172|617281004|FG004|Overall Study|Physician Decision|0|||
170800282|NCT00146172|617281005|FG005|Overall Study|Physician Decision|0|||
170800283|NCT00146172|617281006|FG006|Overall Study|Physician Decision|0|||
170800284|NCT00146172|617281007|FG007|Overall Study|Physician Decision|1|||
170800285|NCT00146172|617281000|FG000|Overall Study|Withdrawal by Subject|0|||
170800286|NCT00146172|617281001|FG001|Overall Study|Withdrawal by Subject|0|||
170800287|NCT00146172|617281002|FG002|Overall Study|Withdrawal by Subject|0|||
170800288|NCT00146172|617281003|FG003|Overall Study|Withdrawal by Subject|0|||
170800289|NCT00146172|617281004|FG004|Overall Study|Withdrawal by Subject|0|||
170800290|NCT00146172|617281005|FG005|Overall Study|Withdrawal by Subject|1|||
170800291|NCT00146172|617281006|FG006|Overall Study|Withdrawal by Subject|1|||
170800292|NCT00146172|617281007|FG007|Overall Study|Withdrawal by Subject|4|||
170800293|NCT00146172|617281000|FG000|Overall Study|Symptomatic Deterioration|1|||
170800294|NCT00146172|617281001|FG001|Overall Study|Symptomatic Deterioration|0|||
170800295|NCT00146172|617281002|FG002|Overall Study|Symptomatic Deterioration|1|||
170800296|NCT00146172|617281003|FG003|Overall Study|Symptomatic Deterioration|0|||
170800297|NCT00146172|617281004|FG004|Overall Study|Symptomatic Deterioration|1|||
170800298|NCT00146172|617281005|FG005|Overall Study|Symptomatic Deterioration|2|||
170800299|NCT00146172|617281006|FG006|Overall Study|Symptomatic Deterioration|0|||
170800300|NCT00146172|617281007|FG007|Overall Study|Symptomatic Deterioration|2|||
170800301|NCT00786864|617281008|FG000|Overall Study|Lost to Follow-up|0|||
170800302|NCT00786864|617281009|FG001|Overall Study|Lost to Follow-up|1|||
170489705|NCT03521115|616136484|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
170800303|NCT00786864|617281008|FG000|Overall Study|Sustained serious back injury|1|||
170800304|NCT00786864|617281009|FG001|Overall Study|Sustained serious back injury|0|||
170800305|NCT02422615|617281012|FG000|Treatment Period|Progressive disease|314|||
170800306|NCT02422615|617281013|FG001|Treatment Period|Progressive disease|200|||
170800307|NCT02422615|617281012|FG000|Treatment Period|Adverse Event|51|||
170800308|NCT02422615|617281013|FG001|Treatment Period|Adverse Event|9|||
170800309|NCT02422615|617281012|FG000|Treatment Period|Physician Decision|32|||
170800310|NCT02422615|617281013|FG001|Treatment Period|Physician Decision|8|||
170800311|NCT02422615|617281012|FG000|Treatment Period|Subject/guardian decision|38|||
170800312|NCT02422615|617281013|FG001|Treatment Period|Subject/guardian decision|8|||
170800313|NCT02422615|617281012|FG000|Treatment Period|Death|2|||
170489706|NCT03521115|616136485|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
170489707|NCT01430403|616136491|FG000|Overall Study|Lost to Follow-up|5|||
170489708|NCT01430403|616136492|FG001|Overall Study|Lost to Follow-up|5|||
170489709|NCT01430403|616136493|FG002|Overall Study|Lost to Follow-up|3|||
170489710|NCT01430403|616136491|FG000|Overall Study|Physician Decision|1|||
170489711|NCT01430403|616136492|FG001|Overall Study|Physician Decision|0|||
170489712|NCT01430403|616136493|FG002|Overall Study|Physician Decision|0|||
170489713|NCT01430403|616136491|FG000|Overall Study|Protocol Violation|2|||
170489714|NCT01430403|616136492|FG001|Overall Study|Protocol Violation|3|||
170489715|NCT01430403|616136493|FG002|Overall Study|Protocol Violation|2|||
170489716|NCT01430403|616136491|FG000|Overall Study|Withdrawal by Subject|9|||
170489717|NCT01430403|616136492|FG001|Overall Study|Withdrawal by Subject|1|||
170489718|NCT01430403|616136493|FG002|Overall Study|Withdrawal by Subject|3|||
170489719|NCT02677922|616136494|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
170489720|NCT02677922|616136495|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
170489721|NCT02677922|616136496|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
170489722|NCT02677922|616136497|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
170489723|NCT02677922|616136498|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
170489724|NCT02677922|616136499|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
170489725|NCT02677922|616136494|FG000|Treatment Period|Adverse Event|0|||
170489726|NCT02677922|616136495|FG001|Treatment Period|Adverse Event|0|||
170489727|NCT02677922|616136496|FG002|Treatment Period|Adverse Event|1|||
170489728|NCT02677922|616136497|FG003|Treatment Period|Adverse Event|3|||
170489729|NCT02677922|616136498|FG004|Treatment Period|Adverse Event|5|||
170489730|NCT02677922|616136499|FG005|Treatment Period|Adverse Event|2|||
170489731|NCT02677922|616136494|FG000|Treatment Period|Progressive Disease|1|||
170489732|NCT02677922|616136495|FG001|Treatment Period|Progressive Disease|1|||
170549359|NCT03211858|616356700|FG000|Overall Study|Poor compliance to protocol|6|||
170549360|NCT03211858|616356701|FG001|Overall Study|Poor compliance to protocol|2|||
170549361|NCT03211858|616356700|FG000|Overall Study|Non-serious Hypoglycemia|1|||
170549362|NCT03211858|616356701|FG001|Overall Study|Non-serious Hypoglycemia|0|||
170549363|NCT03211858|616356700|FG000|Overall Study|Other than specified above|22|||
170549364|NCT03211858|616356701|FG001|Overall Study|Other than specified above|21|||
170549365|NCT01013870|616356704|FG000|Overall Study|Lost to Follow-up|1|||
170549366|NCT01013870|616356705|FG001|Overall Study|Lost to Follow-up|3|||
170549367|NCT01160744|616356717|FG000|Overall Study|Withdrawal by Subject|11|||
170549368|NCT01160744|616356718|FG001|Overall Study|Withdrawal by Subject|5|||
170549369|NCT01160744|616356719|FG002|Overall Study|Withdrawal by Subject|6|||
170549370|NCT01160744|616356720|FG003|Overall Study|Withdrawal by Subject|4|||
170549371|NCT01160744|616356717|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
170549372|NCT01160744|616356718|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
170549373|NCT01160744|616356719|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
170549374|NCT01160744|616356720|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
170549375|NCT04432298|616356722|FG000|Overall Study|Other than specified|1|||
170549376|NCT04432298|616356723|FG001|Overall Study|Other than specified|0|||
170549377|NCT04432298|616356722|FG000|Overall Study|Lost to Follow-up|0|||
170549378|NCT04432298|616356723|FG001|Overall Study|Lost to Follow-up|1|||
170549379|NCT04432298|616356722|FG000|Overall Study|Death|3|||
170549380|NCT04432298|616356723|FG001|Overall Study|Death|2|||
170549381|NCT04432298|616356722|FG000|Overall Study|Withdrawal by Subject|2|||
170800314|NCT02422615|617281013|FG001|Treatment Period|Death|1|||
170800315|NCT02422615|617281012|FG000|Treatment Period|Technical problems|0|||
170800316|NCT02422615|617281013|FG001|Treatment Period|Technical problems|1|||
170800317|NCT02422615|617281012|FG000|Treatment Period|Protocol deviation|1|||
170800318|NCT02422615|617281013|FG001|Treatment Period|Protocol deviation|1|||
170800319|NCT02422615|617281012|FG000|Treatment Period|Study terminated as per protocol|46|||
170800320|NCT02422615|617281013|FG001|Treatment Period|Study terminated as per protocol|14|||
170800321|NCT02422615|617281012|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
170800322|NCT02422615|617281013|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170800323|NCT02422615|617281012|FG000|Post-treatment Efficacy Follow-up|Death|2|||
170800324|NCT02422615|617281013|FG001|Post-treatment Efficacy Follow-up|Death|1|||
170800325|NCT02422615|617281012|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
170489733|NCT02677922|616136496|FG002|Treatment Period|Progressive Disease|0|||
170489734|NCT02677922|616136497|FG003|Treatment Period|Progressive Disease|0|||
170489735|NCT02677922|616136498|FG004|Treatment Period|Progressive Disease|8|||
170549382|NCT04432298|616356723|FG001|Overall Study|Withdrawal by Subject|0|||
170549383|NCT01502072|616356726|FG000|Overall Study|Withdrawal by Subject|1|||
170489736|NCT02677922|616136499|FG005|Treatment Period|Progressive Disease|7|||
170489737|NCT02677922|616136494|FG000|Treatment Period|Lack of Efficacy|0|||
170489738|NCT02677922|616136495|FG001|Treatment Period|Lack of Efficacy|0|||
170549384|NCT01502072|616356727|FG001|Overall Study|Withdrawal by Subject|0|||
170549385|NCT01502072|616356728|FG002|Overall Study|Withdrawal by Subject|0|||
170800326|NCT02422615|617281013|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
170489739|NCT02677922|616136496|FG002|Treatment Period|Lack of Efficacy|0|||
170489740|NCT02677922|616136497|FG003|Treatment Period|Lack of Efficacy|1|||
170489741|NCT02677922|616136498|FG004|Treatment Period|Lack of Efficacy|1|||
170489742|NCT02677922|616136499|FG005|Treatment Period|Lack of Efficacy|6|||
170489743|NCT02677922|616136494|FG000|Treatment Period|Withdrawal by Subject|0|||
170489744|NCT02677922|616136495|FG001|Treatment Period|Withdrawal by Subject|0|||
170489745|NCT02677922|616136496|FG002|Treatment Period|Withdrawal by Subject|1|||
170489746|NCT02677922|616136497|FG003|Treatment Period|Withdrawal by Subject|3|||
170489747|NCT02677922|616136498|FG004|Treatment Period|Withdrawal by Subject|5|||
170489748|NCT02677922|616136499|FG005|Treatment Period|Withdrawal by Subject|5|||
170489749|NCT02677922|616136494|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
170489750|NCT02677922|616136495|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
170489751|NCT02677922|616136496|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
170489752|NCT02677922|616136497|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
170489753|NCT02677922|616136498|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
170489754|NCT02677922|616136499|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
170489755|NCT02677922|616136494|FG000|Treatment Period|Disease Relapse|0|||
170489756|NCT02677922|616136495|FG001|Treatment Period|Disease Relapse|0|||
170489757|NCT02677922|616136496|FG002|Treatment Period|Disease Relapse|0|||
170489758|NCT02677922|616136497|FG003|Treatment Period|Disease Relapse|3|||
170489759|NCT02677922|616136498|FG004|Treatment Period|Disease Relapse|6|||
170489760|NCT02677922|616136499|FG005|Treatment Period|Disease Relapse|1|||
170489761|NCT02677922|616136494|FG000|Treatment Period|Allogeneic HSCT|1|||
170489762|NCT02677922|616136495|FG001|Treatment Period|Allogeneic HSCT|0|||
170489763|NCT02677922|616136496|FG002|Treatment Period|Allogeneic HSCT|0|||
170489764|NCT02677922|616136497|FG003|Treatment Period|Allogeneic HSCT|1|||
170489765|NCT02677922|616136498|FG004|Treatment Period|Allogeneic HSCT|4|||
170489766|NCT02677922|616136499|FG005|Treatment Period|Allogeneic HSCT|1|||
170489767|NCT02677922|616136494|FG000|Treatment Period|Other Reasons|0|||
170489768|NCT02677922|616136495|FG001|Treatment Period|Other Reasons|0|||
170489769|NCT02677922|616136496|FG002|Treatment Period|Other Reasons|0|||
170489770|NCT02677922|616136497|FG003|Treatment Period|Other Reasons|1|||
170489771|NCT02677922|616136498|FG004|Treatment Period|Other Reasons|3|||
170489772|NCT02677922|616136499|FG005|Treatment Period|Other Reasons|5|||
170489773|NCT02677922|616136494|FG000|Treatment Period|Death|0|||
170800327|NCT02422615|617281012|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
170800328|NCT02422615|617281013|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
170489774|NCT02677922|616136495|FG001|Treatment Period|Death|0|||
170489775|NCT02677922|616136496|FG002|Treatment Period|Death|0|||
170489776|NCT02677922|616136497|FG003|Treatment Period|Death|0|||
170489777|NCT02677922|616136498|FG004|Treatment Period|Death|12|||
170489778|NCT02677922|616136499|FG005|Treatment Period|Death|1|||
170489779|NCT02677922|616136494|FG000|Treatment Period|Non-compliance with Study Drug|0|||
170489780|NCT02677922|616136495|FG001|Treatment Period|Non-compliance with Study Drug|0|||
170489781|NCT02677922|616136496|FG002|Treatment Period|Non-compliance with Study Drug|0|||
170489782|NCT02677922|616136497|FG003|Treatment Period|Non-compliance with Study Drug|0|||
170489783|NCT02677922|616136498|FG004|Treatment Period|Non-compliance with Study Drug|1|||
170489784|NCT02677922|616136499|FG005|Treatment Period|Non-compliance with Study Drug|0|||
170800329|NCT02422615|617281012|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
170800330|NCT02422615|617281013|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
170489785|NCT02677922|616136494|FG000|Treatment Period|Physician Decision|0|||
170489786|NCT02677922|616136495|FG001|Treatment Period|Physician Decision|0|||
170489787|NCT02677922|616136496|FG002|Treatment Period|Physician Decision|0|||
170489788|NCT02677922|616136497|FG003|Treatment Period|Physician Decision|0|||
170489789|NCT02677922|616136498|FG004|Treatment Period|Physician Decision|0|||
170489790|NCT02677922|616136499|FG005|Treatment Period|Physician Decision|1|||
170489791|NCT02677922|616136494|FG000|Treatment Period|Symptomatic Deterioration|0|||
170489792|NCT02677922|616136495|FG001|Treatment Period|Symptomatic Deterioration|0|||
170489793|NCT02677922|616136496|FG002|Treatment Period|Symptomatic Deterioration|0|||
170489794|NCT02677922|616136497|FG003|Treatment Period|Symptomatic Deterioration|0|||
170489795|NCT02677922|616136498|FG004|Treatment Period|Symptomatic Deterioration|1|||
170489796|NCT02677922|616136499|FG005|Treatment Period|Symptomatic Deterioration|0|||
170489797|NCT05310071|616136511|FG000|Overall Study|Death|0|||
170489798|NCT05310071|616136512|FG001|Overall Study|Death|3|||
170899882|NCT00151892|617637768|FG000|Overall Study|Lack of Efficacy|50|||
170489799|NCT05310071|616136511|FG000|Overall Study|Adverse Event|4|||
170489800|NCT05310071|616136512|FG001|Overall Study|Adverse Event|31|||
170489801|NCT05310071|616136511|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
170489802|NCT05310071|616136512|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
170489803|NCT05310071|616136511|FG000|Overall Study|Protocol Deviation|2|||
170489804|NCT05310071|616136512|FG001|Overall Study|Protocol Deviation|0|||
170489805|NCT05310071|616136511|FG000|Overall Study|Randomized by Mistake|0|||
170489806|NCT05310071|616136512|FG001|Overall Study|Randomized by Mistake|1|||
170489807|NCT05310071|616136511|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
170549386|NCT01502072|616356726|FG000|Overall Study|Death|0|||
170489808|NCT05310071|616136512|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
170489809|NCT05310071|616136511|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
170489810|NCT05310071|616136512|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
170489811|NCT05310071|616136511|FG000|Overall Study|Site Terminated by Sponsor|0|||
170489812|NCT05310071|616136512|FG001|Overall Study|Site Terminated by Sponsor|2|||
170489813|NCT05310071|616136511|FG000|Overall Study|Study Terminated by Sponsor|282|||
170489814|NCT05310071|616136512|FG001|Overall Study|Study Terminated by Sponsor|559|||
170489815|NCT05310071|616136511|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
170489816|NCT05310071|616136512|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
170489817|NCT05310071|616136511|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
170489818|NCT05310071|616136512|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
170489819|NCT05310071|616136511|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
170489820|NCT05310071|616136512|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
170489821|NCT05310071|616136511|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
170489822|NCT05310071|616136512|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
170489823|NCT05310071|616136511|FG000|Overall Study|Withdrawal by Participant - Other|25|||
170489824|NCT05310071|616136512|FG001|Overall Study|Withdrawal by Participant - Other|30|||
170489825|NCT05310071|616136511|FG000|Overall Study|Lost to Follow-up|2|||
170489826|NCT05310071|616136512|FG001|Overall Study|Lost to Follow-up|4|||
170489827|NCT05310071|616136511|FG000|Overall Study|Reason Not Specified|1|||
170489828|NCT05310071|616136512|FG001|Overall Study|Reason Not Specified|3|||
170489829|NCT01303172|616136518|FG000|Overall Study|Physician Decision|9|||
170489830|NCT01303172|616136519|FG001|Overall Study|Physician Decision|6|||
170489831|NCT01303172|616136518|FG000|Overall Study|Adverse Event|5|||
170489832|NCT01303172|616136519|FG001|Overall Study|Adverse Event|2|||
170800331|NCT02422615|617281012|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
170800332|NCT02422615|617281013|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
170800333|NCT01288443|617281014|FG000|Overall Study|Adverse Event|0|||
170800334|NCT01288443|617281015|FG001|Overall Study|Adverse Event|0|||
170800335|NCT01288443|617281016|FG002|Overall Study|Adverse Event|1|||
170800336|NCT01288443|617281017|FG003|Overall Study|Adverse Event|1|||
170800337|NCT01288443|617281018|FG004|Overall Study|Adverse Event|3|||
170800338|NCT01288443|617281019|FG005|Overall Study|Adverse Event|1|||
170800339|NCT01288443|617281014|FG000|Overall Study|Poor compliance to protocol|0|||
170800340|NCT01288443|617281015|FG001|Overall Study|Poor compliance to protocol|0|||
170800341|NCT01288443|617281016|FG002|Overall Study|Poor compliance to protocol|0|||
170800342|NCT01288443|617281017|FG003|Overall Study|Poor compliance to protocol|0|||
170800343|NCT01288443|617281018|FG004|Overall Study|Poor compliance to protocol|0|||
170800344|NCT01288443|617281019|FG005|Overall Study|Poor compliance to protocol|1|||
170800345|NCT01288443|617281014|FG000|Overall Study|Participant Moved|0|||
170800346|NCT01288443|617281015|FG001|Overall Study|Participant Moved|0|||
170800347|NCT01288443|617281016|FG002|Overall Study|Participant Moved|0|||
170800348|NCT01288443|617281017|FG003|Overall Study|Participant Moved|1|||
170800349|NCT01288443|617281018|FG004|Overall Study|Participant Moved|2|||
170800350|NCT01288443|617281019|FG005|Overall Study|Participant Moved|1|||
170800351|NCT01288443|617281014|FG000|Overall Study|Consent withdrawn by Participant|0|||
170800352|NCT01288443|617281015|FG001|Overall Study|Consent withdrawn by Participant|0|||
170800353|NCT01288443|617281016|FG002|Overall Study|Consent withdrawn by Participant|0|||
170800354|NCT01288443|617281017|FG003|Overall Study|Consent withdrawn by Participant|0|||
170800355|NCT01288443|617281018|FG004|Overall Study|Consent withdrawn by Participant|0|||
170800356|NCT01288443|617281019|FG005|Overall Study|Consent withdrawn by Participant|1|||
170800357|NCT01288443|617281014|FG000|Overall Study|Lost to Follow-up|0|||
170800358|NCT01288443|617281015|FG001|Overall Study|Lost to Follow-up|1|||
170800359|NCT01288443|617281016|FG002|Overall Study|Lost to Follow-up|0|||
170800360|NCT01288443|617281017|FG003|Overall Study|Lost to Follow-up|0|||
170800361|NCT01288443|617281018|FG004|Overall Study|Lost to Follow-up|0|||
170800362|NCT01288443|617281019|FG005|Overall Study|Lost to Follow-up|0|||
170800363|NCT01288443|617281014|FG000|Overall Study|Study drug auto-injector administration|0|||
170489833|NCT01303172|616136518|FG000|Overall Study|Withdrawal by Subject|4|||
170489834|NCT01303172|616136519|FG001|Overall Study|Withdrawal by Subject|2|||
170489835|NCT01303172|616136518|FG000|Overall Study|Death|20|||
170800364|NCT01288443|617281015|FG001|Overall Study|Study drug auto-injector administration|0|||
170800365|NCT01288443|617281016|FG002|Overall Study|Study drug auto-injector administration|0|||
170800366|NCT01288443|617281017|FG003|Overall Study|Study drug auto-injector administration|0|||
170800367|NCT01288443|617281018|FG004|Overall Study|Study drug auto-injector administration|1|||
170800368|NCT01288443|617281019|FG005|Overall Study|Study drug auto-injector administration|1|||
170800369|NCT01288443|617281014|FG000|Overall Study|Other than above|0|||
170800370|NCT01288443|617281015|FG001|Overall Study|Other than above|0|||
170800371|NCT01288443|617281016|FG002|Overall Study|Other than above|0|||
170800372|NCT01288443|617281017|FG003|Overall Study|Other than above|2|||
170800373|NCT01288443|617281018|FG004|Overall Study|Other than above|1|||
170800374|NCT01288443|617281019|FG005|Overall Study|Other than above|0|||
170800375|NCT01596972|617281020|FG000|Overall Study|Physician Decision|1|||
170800376|NCT01596972|617281021|FG001|Overall Study|Physician Decision|9|||
170800377|NCT01596972|617281020|FG000|Overall Study|Lost to Follow-up|0|||
170800378|NCT01596972|617281021|FG001|Overall Study|Lost to Follow-up|4|||
170800379|NCT01596972|617281020|FG000|Overall Study|Withdrawal by Subject|0|||
170800380|NCT01596972|617281021|FG001|Overall Study|Withdrawal by Subject|1|||
170800381|NCT01574716|617281023|FG000|Part 1|Death|3|||
170800382|NCT01574716|617281024|FG001|Part 1|Death|1|||
170800383|NCT01574716|617281025|FG002|Part 1|Death|8|||
170800384|NCT01574716|617281026|FG003|Part 1|Death|0|||
170800385|NCT01574716|617281027|FG004|Part 1|Death|0|||
170800386|NCT01574716|617281023|FG000|Part 1|Discontinuation of study by sponsor|0|||
170800387|NCT01574716|617281024|FG001|Part 1|Discontinuation of study by sponsor|0|||
170800388|NCT01574716|617281025|FG002|Part 1|Discontinuation of study by sponsor|1|||
170800389|NCT01574716|617281026|FG003|Part 1|Discontinuation of study by sponsor|0|||
170800390|NCT01574716|617281027|FG004|Part 1|Discontinuation of study by sponsor|0|||
170489836|NCT01303172|616136519|FG001|Overall Study|Death|7|||
170489837|NCT01303172|616136518|FG000|Overall Study|Lack of Efficacy|25|||
170489838|NCT01303172|616136519|FG001|Overall Study|Lack of Efficacy|17|||
170489839|NCT00460811|616136520|FG000|Overall Study|Adverse Event|4|||
170489840|NCT00460811|616136521|FG001|Overall Study|Adverse Event|6|||
170489841|NCT00460811|616136522|FG002|Overall Study|Adverse Event|3|||
170489842|NCT00460811|616136523|FG003|Overall Study|Adverse Event|10|||
170489843|NCT00460811|616136524|FG004|Overall Study|Adverse Event|2|||
170489844|NCT00460811|616136520|FG000|Overall Study|Noncompliance|1|||
170489845|NCT00460811|616136521|FG001|Overall Study|Noncompliance|0|||
170489846|NCT00460811|616136522|FG002|Overall Study|Noncompliance|0|||
170489847|NCT00460811|616136523|FG003|Overall Study|Noncompliance|2|||
170489848|NCT00460811|616136524|FG004|Overall Study|Noncompliance|1|||
170489849|NCT00460811|616136520|FG000|Overall Study|Withdrawal by Subject|7|||
170489850|NCT00460811|616136521|FG001|Overall Study|Withdrawal by Subject|7|||
170489851|NCT00460811|616136522|FG002|Overall Study|Withdrawal by Subject|6|||
170489852|NCT00460811|616136523|FG003|Overall Study|Withdrawal by Subject|3|||
170489853|NCT00460811|616136524|FG004|Overall Study|Withdrawal by Subject|11|||
170489854|NCT00460811|616136520|FG000|Overall Study|Physician Decision|1|||
170489855|NCT00460811|616136521|FG001|Overall Study|Physician Decision|0|||
170489856|NCT00460811|616136522|FG002|Overall Study|Physician Decision|0|||
170489857|NCT00460811|616136523|FG003|Overall Study|Physician Decision|0|||
170489858|NCT00460811|616136524|FG004|Overall Study|Physician Decision|0|||
170489859|NCT00460811|616136520|FG000|Overall Study|Lost to Follow-up|3|||
170489860|NCT00460811|616136521|FG001|Overall Study|Lost to Follow-up|2|||
170489861|NCT00460811|616136522|FG002|Overall Study|Lost to Follow-up|5|||
170489862|NCT00460811|616136523|FG003|Overall Study|Lost to Follow-up|3|||
170489863|NCT00460811|616136524|FG004|Overall Study|Lost to Follow-up|6|||
170489864|NCT00462709|616136525|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
170489865|NCT00462709|616136525|FG000|Overall Study|Lost to Follow-up|10|||
170489866|NCT00462709|616136525|FG000|Overall Study|Withdrawal by Subject|8|||
170489867|NCT00462709|616136525|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
170489868|NCT00462709|616136525|FG000|Overall Study|Death|2|||
170489869|NCT00462709|616136525|FG000|Overall Study|Logistical reasons|2|||
170549387|NCT01502072|616356727|FG001|Overall Study|Death|1|||
170549388|NCT01502072|616356728|FG002|Overall Study|Death|0|||
170489870|NCT00462709|616136525|FG000|Overall Study|Physician Decision|1|||
170489871|NCT00462709|616136525|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
170800391|NCT01574716|617281023|FG000|Part 1|Withdrawal by Subject|0|||
170489872|NCT02099110|616136534|FG000|Overall Study|Protocol Violation|2|||
170549389|NCT02123511|616356731|FG000|Overall Study|Cancelled treatment|1|||
170800392|NCT01574716|617281024|FG001|Part 1|Withdrawal by Subject|2|||
170800393|NCT01574716|617281025|FG002|Part 1|Withdrawal by Subject|0|||
170800394|NCT01574716|617281026|FG003|Part 1|Withdrawal by Subject|0|||
170899883|NCT00151892|617637769|FG001|Overall Study|Lack of Efficacy|57|||
170899884|NCT00151892|617637768|FG000|Overall Study|Patient request|10|||
170489873|NCT02099110|616136535|FG001|Overall Study|Protocol Violation|1|||
170489874|NCT02099110|616136536|FG002|Overall Study|Protocol Violation|0|||
170489875|NCT02099110|616136537|FG003|Overall Study|Protocol Violation|3|||
170489876|NCT02099110|616136538|FG004|Overall Study|Protocol Violation|1|||
170489877|NCT02099110|616136534|FG000|Overall Study|Participant moved|1|||
170489878|NCT02099110|616136535|FG001|Overall Study|Participant moved|1|||
170489879|NCT02099110|616136536|FG002|Overall Study|Participant moved|1|||
170489880|NCT02099110|616136537|FG003|Overall Study|Participant moved|0|||
170489881|NCT02099110|616136538|FG004|Overall Study|Participant moved|2|||
170489882|NCT02099110|616136534|FG000|Overall Study|Withdrawal by Subject|7|||
170489883|NCT02099110|616136535|FG001|Overall Study|Withdrawal by Subject|11|||
170489884|NCT02099110|616136536|FG002|Overall Study|Withdrawal by Subject|13|||
170489885|NCT02099110|616136537|FG003|Overall Study|Withdrawal by Subject|9|||
170489886|NCT02099110|616136538|FG004|Overall Study|Withdrawal by Subject|13|||
170489887|NCT02099110|616136534|FG000|Overall Study|Adverse Event|3|||
170489888|NCT02099110|616136535|FG001|Overall Study|Adverse Event|5|||
170899885|NCT00151892|617637769|FG001|Overall Study|Patient request|7|||
170899886|NCT00151892|617637768|FG000|Overall Study|Lost to Follow-up|5|||
170899887|NCT00151892|617637769|FG001|Overall Study|Lost to Follow-up|10|||
170899888|NCT00151892|617637768|FG000|Overall Study|Adverse Event|6|||
170489889|NCT02099110|616136536|FG002|Overall Study|Adverse Event|2|||
170489890|NCT02099110|616136537|FG003|Overall Study|Adverse Event|3|||
170489891|NCT02099110|616136538|FG004|Overall Study|Adverse Event|2|||
170489892|NCT02099110|616136534|FG000|Overall Study|Lost to Follow-up|6|||
170489893|NCT02099110|616136535|FG001|Overall Study|Lost to Follow-up|12|||
170489894|NCT02099110|616136536|FG002|Overall Study|Lost to Follow-up|11|||
170489895|NCT02099110|616136537|FG003|Overall Study|Lost to Follow-up|5|||
170489896|NCT02099110|616136538|FG004|Overall Study|Lost to Follow-up|6|||
170489897|NCT02099110|616136534|FG000|Overall Study|Death|0|||
170489898|NCT02099110|616136535|FG001|Overall Study|Death|1|||
170489899|NCT02099110|616136536|FG002|Overall Study|Death|0|||
170489900|NCT02099110|616136537|FG003|Overall Study|Death|0|||
170489901|NCT02099110|616136538|FG004|Overall Study|Death|0|||
170489902|NCT02099110|616136534|FG000|Overall Study|Screen failure|0|||
170489903|NCT02099110|616136535|FG001|Overall Study|Screen failure|0|||
170489904|NCT02099110|616136536|FG002|Overall Study|Screen failure|0|||
170489905|NCT02099110|616136537|FG003|Overall Study|Screen failure|0|||
170489906|NCT02099110|616136538|FG004|Overall Study|Screen failure|1|||
170489907|NCT02099110|616136534|FG000|Overall Study|Non-compliance with study drug|2|||
170489908|NCT02099110|616136535|FG001|Overall Study|Non-compliance with study drug|0|||
170489909|NCT02099110|616136536|FG002|Overall Study|Non-compliance with study drug|0|||
170489910|NCT02099110|616136537|FG003|Overall Study|Non-compliance with study drug|0|||
170489911|NCT02099110|616136538|FG004|Overall Study|Non-compliance with study drug|1|||
170489912|NCT02099110|616136534|FG000|Overall Study|Physician Decision|3|||
170489913|NCT02099110|616136535|FG001|Overall Study|Physician Decision|0|||
170489914|NCT02099110|616136536|FG002|Overall Study|Physician Decision|1|||
170489915|NCT02099110|616136537|FG003|Overall Study|Physician Decision|2|||
170489916|NCT02099110|616136538|FG004|Overall Study|Physician Decision|1|||
170489917|NCT03515811|616136546|FG000|Overall Study|Lost to Follow-up|2|||
170489918|NCT03515811|616136547|FG001|Overall Study|Lost to Follow-up|1|||
170489919|NCT03515811|616136546|FG000|Overall Study|Protocol Violation|1|||
170489920|NCT03515811|616136547|FG001|Overall Study|Protocol Violation|1|||
170489921|NCT03515811|616136546|FG000|Overall Study|Death|1|||
170489922|NCT03515811|616136547|FG001|Overall Study|Death|1|||
170489923|NCT03515811|616136546|FG000|Overall Study|Withdrawal by Subject|0|||
170489924|NCT03515811|616136547|FG001|Overall Study|Withdrawal by Subject|2|||
170489925|NCT03515811|616136546|FG000|Overall Study|Technical Problems|1|||
170489926|NCT03515811|616136547|FG001|Overall Study|Technical Problems|0|||
170489927|NCT03515811|616136546|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
170489928|NCT03515811|616136547|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
170489929|NCT03515811|616136546|FG000|Overall Study|COVID-19|0|||
170489930|NCT03515811|616136547|FG001|Overall Study|COVID-19|1|||
170489931|NCT04657198|616136548|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
170489932|NCT04657198|616136549|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
170489933|NCT04657198|616136550|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
170489934|NCT05107492|616136553|FG000|Overall Study|Lost to Follow-up|1|||
170489935|NCT05107492|616136554|FG001|Overall Study|Lost to Follow-up|0|||
170489936|NCT03218826|616136559|FG000|Overall Study|Non-compliance with protocol|1|||
170489937|NCT03218826|616136560|FG001|Overall Study|Non-compliance with protocol|0|||
170489938|NCT03218826|616136561|FG002|Overall Study|Non-compliance with protocol|2|||
170489939|NCT03218826|616136562|FG003|Overall Study|Non-compliance with protocol|1|||
170489940|NCT03218826|616136563|FG004|Overall Study|Non-compliance with protocol|1|||
170489941|NCT00454363|616136575|FG000|Overall Study|Adverse Event|1|||
170489942|NCT00454363|616136576|FG001|Overall Study|Adverse Event|2|||
170489943|NCT00454363|616136575|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
170489944|NCT00454363|616136576|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
170489945|NCT01863667|616136577|FG000|Overall Study|Adverse Event|1|||
170489946|NCT01863667|616136578|FG001|Overall Study|Adverse Event|0|||
170489947|NCT01863667|616136577|FG000|Overall Study|Study terminated by Sponsor|30|||
170489948|NCT01863667|616136578|FG001|Overall Study|Study terminated by Sponsor|30|||
170489949|NCT01863667|616136577|FG000|Overall Study|Withdrawal by Subject|2|||
170489950|NCT01863667|616136578|FG001|Overall Study|Withdrawal by Subject|2|||
170489951|NCT01537042|616136582|FG000|Overall Study|Adverse Event|0|||
170489952|NCT01537042|616136583|FG001|Overall Study|Adverse Event|2|||
170489953|NCT01537042|616136582|FG000|Overall Study|Lack of Efficacy|0|||
170489954|NCT01537042|616136583|FG001|Overall Study|Lack of Efficacy|1|||
170489955|NCT01537042|616136582|FG000|Overall Study|Protocol Violation|0|||
170489956|NCT01537042|616136583|FG001|Overall Study|Protocol Violation|1|||
170489957|NCT01537042|616136582|FG000|Overall Study|Other|0|||
170489958|NCT01537042|616136583|FG001|Overall Study|Other|1|||
170489959|NCT02837731|616136584|FG000|Allocation|Admitted to General Floor|3|||
170489960|NCT02837731|616136585|FG001|Allocation|Admitted to General Floor|4|||
170489961|NCT02837731|616136584|FG000|Allocation|Immediate surgery/withdrew|2|||
170489962|NCT02837731|616136585|FG001|Allocation|Immediate surgery/withdrew|0|||
170489963|NCT02837731|616136584|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
170489964|NCT02837731|616136585|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
170489965|NCT02837731|616136584|FG000|Allocation|Withdrawal by Subject|2|||
170489966|NCT02837731|616136585|FG001|Allocation|Withdrawal by Subject|0|||
170489967|NCT02837731|616136584|FG000|Allocation|Device not available|1|||
170489968|NCT02837731|616136585|FG001|Allocation|Device not available|0|||
170489969|NCT02837731|616136584|FG000|Allocation|Protocol not implemented|7|||
170549390|NCT02123511|616356732|FG001|Overall Study|Cancelled treatment|0|||
170549391|NCT02123511|616356731|FG000|Overall Study|Incomplete data|1|||
170549392|NCT02123511|616356732|FG001|Overall Study|Incomplete data|3|||
170549393|NCT02123511|616356731|FG000|Overall Study|Ineligible|0|||
170549394|NCT02123511|616356732|FG001|Overall Study|Ineligible|1|||
170800395|NCT01574716|617281027|FG004|Part 1|Withdrawal by Subject|0|||
170800396|NCT01574716|617281023|FG000|Part 1|Lost to Follow-up|0|||
170549395|NCT02462057|616356739|FG000|Overall Study|Left Vitality|32|||
170549396|NCT02462057|616356740|FG001|Overall Study|Left Vitality|27|||
170549397|NCT02462057|616356741|FG002|Overall Study|Left Vitality|23|||
170549398|NCT02462057|616356742|FG003|Overall Study|Left Vitality|35|||
170549399|NCT02462057|616356743|FG004|Overall Study|Left Vitality|33|||
170549400|NCT02462057|616356739|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
170549401|NCT02462057|616356740|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
170549402|NCT02462057|616356741|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
170549403|NCT02462057|616356742|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
170549404|NCT02462057|616356743|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
170549405|NCT01791205|616356746|FG000|Phase II|Lack of Efficacy|6|||
170549406|NCT01791205|616356747|FG001|Phase II|Lack of Efficacy|0|||
170549407|NCT01791205|616356746|FG000|Phase II|Adverse Event|2|||
170549408|NCT01791205|616356747|FG001|Phase II|Adverse Event|0|||
170549409|NCT01791205|616356746|FG000|Phase II|Safety|1|||
170549410|NCT01791205|616356747|FG001|Phase II|Safety|0|||
170549411|NCT01791205|616356746|FG000|Phase II|Lost to Follow-up|1|||
170549412|NCT01791205|616356747|FG001|Phase II|Lost to Follow-up|0|||
170549413|NCT01791205|616356746|FG000|Phase II|Remission of disease|1|||
170549414|NCT01791205|616356747|FG001|Phase II|Remission of disease|0|||
170549415|NCT01791205|616356746|FG000|Phase II|Physician's decision|1|||
170549416|NCT01791205|616356747|FG001|Phase II|Physician's decision|0|||
170549417|NCT01697501|616356749|FG000|Overall Study|Protocol Violation|2|||
170549418|NCT02242903|616356750|FG000|Overall Study|Withdrawal by Subject|1|||
170549419|NCT02242903|616356751|FG001|Overall Study|Withdrawal by Subject|0|||
170549420|NCT02242903|616356752|FG002|Overall Study|Withdrawal by Subject|0|||
170549421|NCT02242903|616356753|FG003|Overall Study|Withdrawal by Subject|0|||
170800397|NCT01574716|617281024|FG001|Part 1|Lost to Follow-up|1|||
170800398|NCT01574716|617281025|FG002|Part 1|Lost to Follow-up|0|||
170800399|NCT01574716|617281026|FG003|Part 1|Lost to Follow-up|0|||
170800400|NCT01574716|617281027|FG004|Part 1|Lost to Follow-up|0|||
170800401|NCT01574716|617281023|FG000|Part 2|Progressive disease|0|||
170800402|NCT01574716|617281024|FG001|Part 2|Progressive disease|0|||
170800403|NCT01574716|617281025|FG002|Part 2|Progressive disease|0|||
170800404|NCT01574716|617281026|FG003|Part 2|Progressive disease|1|||
170800405|NCT01574716|617281027|FG004|Part 2|Progressive disease|0|||
170800406|NCT01574716|617281023|FG000|Part 2|Death|0|||
170800407|NCT01574716|617281024|FG001|Part 2|Death|0|||
170899889|NCT00151892|617637769|FG001|Overall Study|Adverse Event|3|||
170489970|NCT02837731|616136585|FG001|Allocation|Protocol not implemented|0|||
170489971|NCT02837731|616136584|FG000|Allocation|Moribund/Do not resuscitate|2|||
170489972|NCT02837731|616136585|FG001|Allocation|Moribund/Do not resuscitate|0|||
170549422|NCT02242903|616356754|FG004|Overall Study|Withdrawal by Subject|0|||
170549423|NCT02242903|616356755|FG005|Overall Study|Withdrawal by Subject|0|||
170549424|NCT02242903|616356756|FG006|Overall Study|Withdrawal by Subject|0|||
170549425|NCT00779909|616356759|FG000|Overall Study|Lost to Follow-up|1|||
170800408|NCT01574716|617281025|FG002|Part 2|Death|0|||
170800409|NCT01574716|617281026|FG003|Part 2|Death|76|||
170489973|NCT02837731|616136584|FG000|Allocation|Did not meet sepsis criteria|1|||
170489974|NCT02837731|616136585|FG001|Allocation|Did not meet sepsis criteria|2|||
170489975|NCT02837731|616136584|FG000|Allocation|Known aortic abnormalities|0|||
170489976|NCT02837731|616136585|FG001|Allocation|Known aortic abnormalities|1|||
170489977|NCT02965573|616136588|FG000|Overall Study|Lack of Efficacy|1|||
170489978|NCT02965573|616136589|FG001|Overall Study|Lack of Efficacy|0|||
170489979|NCT00086619|616136592|FG000|Overall Study|Withdrawal by Subject|6|||
170489980|NCT00086619|616136593|FG001|Overall Study|Withdrawal by Subject|6|||
170489981|NCT00086619|616136592|FG000|Overall Study|Adverse Event|8|||
170489982|NCT00086619|616136593|FG001|Overall Study|Adverse Event|10|||
170489983|NCT00086619|616136592|FG000|Overall Study|Protocol Violation|1|||
170489984|NCT00086619|616136593|FG001|Overall Study|Protocol Violation|1|||
170489985|NCT00489918|616136594|FG000|Overall Study|Withdrawal by Subject|2|||
170489986|NCT00489918|616136595|FG001|Overall Study|Withdrawal by Subject|1|||
170489987|NCT00489918|616136596|FG002|Overall Study|Withdrawal by Subject|1|||
170489988|NCT00489918|616136597|FG003|Overall Study|Withdrawal by Subject|0|||
170489989|NCT00489918|616136598|FG004|Overall Study|Withdrawal by Subject|1|||
170489990|NCT00489918|616136594|FG000|Overall Study|Adverse Event|0|||
170489991|NCT00489918|616136595|FG001|Overall Study|Adverse Event|1|||
170489992|NCT00489918|616136596|FG002|Overall Study|Adverse Event|1|||
170489993|NCT00489918|616136597|FG003|Overall Study|Adverse Event|0|||
170489994|NCT00489918|616136598|FG004|Overall Study|Adverse Event|0|||
170489995|NCT00489918|616136594|FG000|Overall Study|Lost to Follow-up|0|||
170489996|NCT00489918|616136595|FG001|Overall Study|Lost to Follow-up|0|||
170489997|NCT00489918|616136596|FG002|Overall Study|Lost to Follow-up|1|||
170489998|NCT00489918|616136597|FG003|Overall Study|Lost to Follow-up|1|||
170489999|NCT00489918|616136598|FG004|Overall Study|Lost to Follow-up|0|||
170490000|NCT00489918|616136594|FG000|Overall Study|Physician Decision|0|||
170490001|NCT00489918|616136595|FG001|Overall Study|Physician Decision|0|||
170490002|NCT00489918|616136596|FG002|Overall Study|Physician Decision|1|||
170490003|NCT00489918|616136597|FG003|Overall Study|Physician Decision|0|||
170490004|NCT00489918|616136598|FG004|Overall Study|Physician Decision|0|||
170490005|NCT02748213|616136599|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
170490006|NCT02748213|616136600|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
170490007|NCT02748213|616136599|FG000|Overall Study|Abnormal Laboratory Test|1|||
170490008|NCT02748213|616136600|FG001|Overall Study|Abnormal Laboratory Test|0|||
170490009|NCT02748213|616136599|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
170490010|NCT02748213|616136600|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
170490011|NCT02748213|616136599|FG000|Overall Study|Death|5|||
170490012|NCT02748213|616136600|FG001|Overall Study|Death|3|||
170490013|NCT02748213|616136599|FG000|Overall Study|Insufficient Therapeutic Response|56|||
170490014|NCT02748213|616136600|FG001|Overall Study|Insufficient Therapeutic Response|57|||
170490015|NCT02748213|616136599|FG000|Overall Study|Violation of Selection Criteria|2|||
170490016|NCT02748213|616136600|FG001|Overall Study|Violation of Selection Criteria|0|||
170490017|NCT02748213|616136599|FG000|Overall Study|Protocol Violation|6|||
170549426|NCT00779909|616356760|FG001|Overall Study|Lost to Follow-up|0|||
170549427|NCT00779909|616356761|FG002|Overall Study|Lost to Follow-up|0|||
170549428|NCT00779909|616356762|FG003|Overall Study|Lost to Follow-up|1|||
170549429|NCT00779909|616356759|FG000|Overall Study|Withdrawal by Subject|0|||
170549430|NCT00779909|616356760|FG001|Overall Study|Withdrawal by Subject|1|||
170549431|NCT00779909|616356761|FG002|Overall Study|Withdrawal by Subject|0|||
170549432|NCT00779909|616356762|FG003|Overall Study|Withdrawal by Subject|0|||
170549433|NCT00215553|616356767|FG000|Overall Study|Adverse Event|0|||
170549434|NCT00215553|616356768|FG001|Overall Study|Adverse Event|1|||
170549435|NCT00215553|616356769|FG002|Overall Study|Adverse Event|2|||
170549436|NCT00215553|616356770|FG003|Overall Study|Adverse Event|1|||
170549437|NCT00215553|616356771|FG004|Overall Study|Adverse Event|2|||
170549438|NCT00215553|616356772|FG005|Overall Study|Adverse Event|6|||
170549439|NCT00215553|616356773|FG006|Overall Study|Adverse Event|0|||
170549440|NCT01259024|616356774|FG000|Overall Study|Physician Decision|1|||
170549441|NCT01853280|616356775|FG000|Overall Study|Lack of Efficacy|2|||
170549442|NCT01853280|616356776|FG001|Overall Study|Lack of Efficacy|2|||
170549443|NCT01853280|616356775|FG000|Overall Study|Lost to Follow-up|0|||
170549444|NCT01853280|616356776|FG001|Overall Study|Lost to Follow-up|1|||
170549445|NCT01853280|616356775|FG000|Overall Study|Physician Decision|0|||
170549446|NCT01853280|616356776|FG001|Overall Study|Physician Decision|1|||
170549447|NCT01853280|616356775|FG000|Overall Study|Withdrawal by Subject|0|||
170549448|NCT01853280|616356776|FG001|Overall Study|Withdrawal by Subject|1|||
170549449|NCT01853280|616356775|FG000|Overall Study|Ineligible|0|||
170549450|NCT01853280|616356776|FG001|Overall Study|Ineligible|1|||
170549451|NCT03528577|616356779|FG000|Sequence 1|Failed Spirometry|1|||
170549452|NCT03528577|616356779|FG000|Sequence 1|Restricted medication|1|||
170549453|NCT03528577|616356779|FG000|Sequence 2|Adverse Event|1|||
170490018|NCT02748213|616136600|FG001|Overall Study|Protocol Violation|4|||
170549454|NCT03528577|616356779|FG000|Sequence 2|Withdrawal by Subject|1|||
170549455|NCT03528577|616356779|FG000|Sequence 2|Failed Spirometry|1|||
170549456|NCT03528577|616356779|FG000|Sequence 3|Failed Spirometry|1|||
170549457|NCT03528577|616356779|FG000|Sequence 4|Failed Spirometry|2|||
170549458|NCT03528577|616356779|FG000|Sequence 4|Adverse Event|1|||
170490019|NCT02748213|616136599|FG000|Overall Study|Refused Treatment*|6|||
170490020|NCT02748213|616136600|FG001|Overall Study|Refused Treatment*|6|||
170490021|NCT02748213|616136599|FG000|Overall Study|Failure to Return|1|||
170490022|NCT02748213|616136600|FG001|Overall Study|Failure to Return|0|||
170490023|NCT02748213|616136599|FG000|Overall Study|Other|30|||
170490024|NCT02748213|616136600|FG001|Overall Study|Other|29|||
170490025|NCT01209520|616136604|FG000|Overall Study|Withdrawal by Subject|3|||
170490026|NCT06868654|616136606|FG000|Overall Study|Death|4|||
170490027|NCT06868654|616136607|FG001|Overall Study|Death|14|||
170490028|NCT06868654|616136606|FG000|Overall Study|Lost to Follow-up|0|||
170490029|NCT06868654|616136607|FG001|Overall Study|Lost to Follow-up|1|||
170490030|NCT06868654|616136606|FG000|Overall Study|Withdrawal by Subject|5|||
170490031|NCT06868654|616136607|FG001|Overall Study|Withdrawal by Subject|3|||
170490032|NCT06868654|616136606|FG000|Overall Study|Physician Decision|0|||
170490033|NCT06868654|616136607|FG001|Overall Study|Physician Decision|1|||
170490034|NCT06868654|616136606|FG000|Overall Study|Ongoing|23|||
170490035|NCT06868654|616136607|FG001|Overall Study|Ongoing|21|||
170490036|NCT03867201|616136608|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
170490037|NCT03867201|616136609|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
170490038|NCT03867201|616136608|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
170490039|NCT03867201|616136609|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
170490040|NCT03867201|616136608|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
170490041|NCT03867201|616136609|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
170490042|NCT03867201|616136608|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
170490043|NCT03867201|616136609|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
170490044|NCT03867201|616136608|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
170490045|NCT03867201|616136609|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
170490046|NCT03867201|616136608|FG000|Open-Label Period From Week 12|Adverse Event|5|||
170490047|NCT03867201|616136609|FG001|Open-Label Period From Week 12|Adverse Event|11|||
170490048|NCT03867201|616136608|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
170490049|NCT03867201|616136609|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
170490050|NCT03867201|616136608|FG000|Open-Label Period From Week 12|Physician Decision|6|||
170490051|NCT03867201|616136609|FG001|Open-Label Period From Week 12|Physician Decision|3|||
170490052|NCT03867201|616136608|FG000|Open-Label Period From Week 12|Pregnancy|2|||
170490053|NCT03867201|616136609|FG001|Open-Label Period From Week 12|Pregnancy|2|||
170490054|NCT03867201|616136608|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
170490055|NCT03867201|616136609|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
170490056|NCT03867201|616136608|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
170490057|NCT03867201|616136609|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
170490058|NCT03867201|616136608|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
170490059|NCT03867201|616136609|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
170490060|NCT03867201|616136608|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
170490061|NCT03867201|616136609|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
170490062|NCT03850483|616136612|FG000|Treatment for Stage 1|Adverse Event|1|||
170490063|NCT03850483|616136613|FG001|Treatment for Stage 1|Adverse Event|1|||
170490064|NCT03850483|616136614|FG002|Treatment for Stage 1|Adverse Event|3|||
170490065|NCT03850483|616136615|FG003|Treatment for Stage 1|Adverse Event|0|||
170490066|NCT03850483|616136616|FG004|Treatment for Stage 1|Adverse Event|2|||
170490067|NCT03850483|616136617|FG005|Treatment for Stage 1|Adverse Event|0|||
170490068|NCT03850483|616136618|FG006|Treatment for Stage 1|Adverse Event|2|||
170490069|NCT03850483|616136619|FG007|Treatment for Stage 1|Adverse Event|2|||
170490070|NCT03850483|616136620|FG008|Treatment for Stage 1|Adverse Event|0|||
170490071|NCT03850483|616136621|FG009|Treatment for Stage 1|Adverse Event|0|||
170490072|NCT03850483|616136612|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
170490073|NCT03850483|616136613|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
170490074|NCT03850483|616136614|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
170490075|NCT03850483|616136615|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
170490076|NCT03850483|616136616|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
170549459|NCT01530997|616356780|FG000|Overall Study|Physician Decision|1|||
170549460|NCT01530997|616356780|FG000|Overall Study|Withdrawal by Subject|1|||
170549461|NCT02318277|616356781|FG000|Overall Study|Physician Decision|0|||
170800410|NCT01574716|617281027|FG004|Part 2|Death|35|||
170800411|NCT01574716|617281023|FG000|Part 2|Discontinuation of study by sponsor|0|||
170800412|NCT01574716|617281024|FG001|Part 2|Discontinuation of study by sponsor|0|||
170800413|NCT01574716|617281025|FG002|Part 2|Discontinuation of study by sponsor|0|||
170800414|NCT01574716|617281026|FG003|Part 2|Discontinuation of study by sponsor|51|||
170800415|NCT01574716|617281027|FG004|Part 2|Discontinuation of study by sponsor|31|||
170800416|NCT01574716|617281023|FG000|Part 2|Withdrawal by Subject|0|||
170800417|NCT01574716|617281024|FG001|Part 2|Withdrawal by Subject|0|||
170800418|NCT01574716|617281025|FG002|Part 2|Withdrawal by Subject|0|||
170800419|NCT01574716|617281026|FG003|Part 2|Withdrawal by Subject|5|||
170800420|NCT01574716|617281027|FG004|Part 2|Withdrawal by Subject|4|||
170800421|NCT01574716|617281023|FG000|Part 2|Brain metastases|0|||
170800422|NCT01574716|617281024|FG001|Part 2|Brain metastases|0|||
170490077|NCT03850483|616136617|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
170490078|NCT03850483|616136618|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
170490079|NCT03850483|616136619|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
170490080|NCT03850483|616136620|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
170490081|NCT03850483|616136621|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
170490082|NCT03850483|616136612|FG000|Treatment for Stage 1|Protocol Violation|1|||
170490083|NCT03850483|616136613|FG001|Treatment for Stage 1|Protocol Violation|0|||
170490084|NCT03850483|616136614|FG002|Treatment for Stage 1|Protocol Violation|0|||
170490085|NCT03850483|616136615|FG003|Treatment for Stage 1|Protocol Violation|0|||
170490086|NCT03850483|616136616|FG004|Treatment for Stage 1|Protocol Violation|0|||
170490087|NCT03850483|616136617|FG005|Treatment for Stage 1|Protocol Violation|0|||
170490088|NCT03850483|616136618|FG006|Treatment for Stage 1|Protocol Violation|1|||
170490089|NCT03850483|616136619|FG007|Treatment for Stage 1|Protocol Violation|0|||
170490090|NCT03850483|616136620|FG008|Treatment for Stage 1|Protocol Violation|0|||
170490091|NCT03850483|616136621|FG009|Treatment for Stage 1|Protocol Violation|0|||
170490092|NCT03850483|616136612|FG000|Treatment for Stage 1|Physician Decision|0|||
170490093|NCT03850483|616136613|FG001|Treatment for Stage 1|Physician Decision|0|||
170490094|NCT03850483|616136614|FG002|Treatment for Stage 1|Physician Decision|0|||
170490095|NCT03850483|616136615|FG003|Treatment for Stage 1|Physician Decision|0|||
170490096|NCT03850483|616136616|FG004|Treatment for Stage 1|Physician Decision|0|||
170490097|NCT03850483|616136617|FG005|Treatment for Stage 1|Physician Decision|1|||
170490098|NCT03850483|616136618|FG006|Treatment for Stage 1|Physician Decision|0|||
170490099|NCT03850483|616136619|FG007|Treatment for Stage 1|Physician Decision|0|||
170490100|NCT03850483|616136620|FG008|Treatment for Stage 1|Physician Decision|0|||
170490101|NCT03850483|616136621|FG009|Treatment for Stage 1|Physician Decision|0|||
170490102|NCT03850483|616136612|FG000|Treatment for Stage 1|Other|0|||
170490103|NCT03850483|616136613|FG001|Treatment for Stage 1|Other|0|||
170490104|NCT03850483|616136614|FG002|Treatment for Stage 1|Other|0|||
170490105|NCT03850483|616136615|FG003|Treatment for Stage 1|Other|0|||
170490106|NCT03850483|616136616|FG004|Treatment for Stage 1|Other|2|||
170490107|NCT03850483|616136617|FG005|Treatment for Stage 1|Other|1|||
170490108|NCT03850483|616136618|FG006|Treatment for Stage 1|Other|0|||
170490109|NCT03850483|616136619|FG007|Treatment for Stage 1|Other|0|||
170490110|NCT03850483|616136620|FG008|Treatment for Stage 1|Other|0|||
170490111|NCT03850483|616136621|FG009|Treatment for Stage 1|Other|0|||
170490112|NCT03850483|616136612|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490113|NCT03850483|616136613|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490114|NCT03850483|616136614|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
170800423|NCT01574716|617281025|FG002|Part 2|Brain metastases|0|||
170800424|NCT01574716|617281026|FG003|Part 2|Brain metastases|1|||
170800425|NCT01574716|617281027|FG004|Part 2|Brain metastases|0|||
170800426|NCT01574716|617281023|FG000|Part 2|Lost to Follow-up|0|||
170800427|NCT01574716|617281024|FG001|Part 2|Lost to Follow-up|0|||
170490115|NCT03850483|616136615|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490116|NCT03850483|616136616|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490117|NCT03850483|616136617|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490118|NCT03850483|616136618|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490119|NCT03850483|616136619|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490120|NCT03850483|616136620|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490121|NCT03850483|616136621|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
170490122|NCT03850483|616136612|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170490123|NCT03850483|616136613|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170490124|NCT03850483|616136614|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170490125|NCT03850483|616136615|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170490126|NCT03850483|616136616|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170490127|NCT03850483|616136617|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
170490128|NCT03850483|616136618|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170490129|NCT03850483|616136619|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170490130|NCT03850483|616136620|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170490131|NCT03850483|616136621|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
170800428|NCT01574716|617281025|FG002|Part 2|Lost to Follow-up|0|||
170800429|NCT01574716|617281026|FG003|Part 2|Lost to Follow-up|3|||
170800430|NCT01574716|617281027|FG004|Part 2|Lost to Follow-up|0|||
170800431|NCT04334317|617281029|FG000|Overall Study|Adverse Event|1|||
170800432|NCT04334317|617281030|FG001|Overall Study|Adverse Event|2|||
170800433|NCT04334317|617281031|FG002|Overall Study|Adverse Event|0|||
170800434|NCT04334317|617281032|FG003|Overall Study|Adverse Event|0|||
170490132|NCT03850483|616136612|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
170490133|NCT03850483|616136613|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
170490134|NCT03850483|616136614|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
170490135|NCT03850483|616136615|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
170490136|NCT03850483|616136616|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
170490137|NCT03850483|616136617|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
170800435|NCT04334317|617281029|FG000|Overall Study|Protocol Deviation|0|||
170490138|NCT03850483|616136618|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
170490139|NCT03850483|616136619|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
170490140|NCT03850483|616136620|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
170490141|NCT03850483|616136621|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
170490142|NCT03850483|616136612|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
170490143|NCT03850483|616136613|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
170490144|NCT03850483|616136614|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
170490145|NCT03850483|616136615|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
170490146|NCT03850483|616136616|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
170490147|NCT03850483|616136617|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
170490148|NCT03850483|616136618|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
170490149|NCT03850483|616136619|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
170490150|NCT03850483|616136620|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
170490151|NCT03850483|616136621|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
170490152|NCT03850483|616136612|FG000|Treatment for Stage 1|Death|0|||
170490153|NCT03850483|616136613|FG001|Treatment for Stage 1|Death|0|||
170490154|NCT03850483|616136614|FG002|Treatment for Stage 1|Death|0|||
170490155|NCT03850483|616136615|FG003|Treatment for Stage 1|Death|0|||
170490156|NCT03850483|616136616|FG004|Treatment for Stage 1|Death|0|||
170490157|NCT03850483|616136617|FG005|Treatment for Stage 1|Death|1|||
170490158|NCT03850483|616136618|FG006|Treatment for Stage 1|Death|0|||
170490159|NCT03850483|616136619|FG007|Treatment for Stage 1|Death|0|||
170490160|NCT03850483|616136620|FG008|Treatment for Stage 1|Death|0|||
170490161|NCT03850483|616136621|FG009|Treatment for Stage 1|Death|0|||
170490162|NCT03850483|616136612|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
170490163|NCT03850483|616136613|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
170490164|NCT03850483|616136614|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
170490165|NCT03850483|616136615|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
170490166|NCT03850483|616136616|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
170490167|NCT03850483|616136617|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
170490168|NCT03850483|616136618|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
170490169|NCT03850483|616136619|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
170490170|NCT03850483|616136620|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
170490171|NCT03850483|616136621|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
170490172|NCT03850483|616136612|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
170490173|NCT03850483|616136613|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
170490174|NCT03850483|616136614|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
170490175|NCT03850483|616136615|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
170490176|NCT03850483|616136616|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
170490177|NCT03850483|616136617|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
170490178|NCT03850483|616136618|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
170490179|NCT03850483|616136619|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
170490180|NCT03850483|616136620|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
170490181|NCT03850483|616136621|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
170490182|NCT03850483|616136612|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
170490183|NCT03850483|616136613|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
170490184|NCT03850483|616136614|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
170490185|NCT03850483|616136615|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
170490186|NCT03850483|616136616|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
170490187|NCT03850483|616136617|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
170490188|NCT03850483|616136618|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
170490189|NCT03850483|616136619|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
170490190|NCT03850483|616136620|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
170490191|NCT03850483|616136621|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
170490192|NCT03850483|616136612|FG000|Follow-up for Stage 1|Physician Decision|0|||
170490193|NCT03850483|616136613|FG001|Follow-up for Stage 1|Physician Decision|0|||
170490194|NCT03850483|616136614|FG002|Follow-up for Stage 1|Physician Decision|0|||
170490195|NCT03850483|616136615|FG003|Follow-up for Stage 1|Physician Decision|0|||
170490196|NCT03850483|616136616|FG004|Follow-up for Stage 1|Physician Decision|1|||
170490197|NCT03850483|616136617|FG005|Follow-up for Stage 1|Physician Decision|0|||
170490198|NCT03850483|616136618|FG006|Follow-up for Stage 1|Physician Decision|1|||
170490199|NCT03850483|616136619|FG007|Follow-up for Stage 1|Physician Decision|0|||
170490200|NCT03850483|616136620|FG008|Follow-up for Stage 1|Physician Decision|0|||
170490201|NCT03850483|616136621|FG009|Follow-up for Stage 1|Physician Decision|0|||
170549462|NCT02318277|616356782|FG001|Overall Study|Physician Decision|0|||
170490202|NCT03850483|616136612|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
170490203|NCT03850483|616136613|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
170490204|NCT03850483|616136614|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
170490205|NCT03850483|616136615|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
170490206|NCT03850483|616136616|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
170490207|NCT03850483|616136617|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
170549463|NCT02318277|616356783|FG002|Overall Study|Physician Decision|0|||
170549464|NCT02318277|616356784|FG003|Overall Study|Physician Decision|0|||
170899890|NCT00151892|617637768|FG000|Overall Study|Protocol Violation|3|||
170899891|NCT00151892|617637769|FG001|Overall Study|Protocol Violation|3|||
170899892|NCT00151892|617637768|FG000|Overall Study|Non-compliance|0|||
170899893|NCT00151892|617637769|FG001|Overall Study|Non-compliance|1|||
170899894|NCT00151892|617637768|FG000|Overall Study|Pregnancy|0|||
170899895|NCT00151892|617637769|FG001|Overall Study|Pregnancy|1|||
170899896|NCT00151892|617637768|FG000|Overall Study|Did not return for a visit|1|||
170899897|NCT00151892|617637769|FG001|Overall Study|Did not return for a visit|0|||
170899898|NCT00151892|617637768|FG000|Overall Study|Used prohibited corticosteroids|1|||
170899899|NCT00151892|617637769|FG001|Overall Study|Used prohibited corticosteroids|0|||
170490208|NCT03850483|616136618|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
170490209|NCT03850483|616136619|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
170490210|NCT03850483|616136620|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
170490211|NCT03850483|616136621|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
170490212|NCT03850483|616136612|FG000|Follow-up for Stage 1|Adverse Event|0|||
170490213|NCT03850483|616136613|FG001|Follow-up for Stage 1|Adverse Event|0|||
170490214|NCT03850483|616136614|FG002|Follow-up for Stage 1|Adverse Event|1|||
170490215|NCT03850483|616136615|FG003|Follow-up for Stage 1|Adverse Event|0|||
170490216|NCT03850483|616136616|FG004|Follow-up for Stage 1|Adverse Event|0|||
170490217|NCT03850483|616136617|FG005|Follow-up for Stage 1|Adverse Event|1|||
170490218|NCT03850483|616136618|FG006|Follow-up for Stage 1|Adverse Event|0|||
170490219|NCT03850483|616136619|FG007|Follow-up for Stage 1|Adverse Event|0|||
170490220|NCT03850483|616136620|FG008|Follow-up for Stage 1|Adverse Event|0|||
170490221|NCT03850483|616136621|FG009|Follow-up for Stage 1|Adverse Event|0|||
170490222|NCT03850483|616136612|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
170490223|NCT03850483|616136613|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
170490224|NCT03850483|616136614|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
170490225|NCT03850483|616136615|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
170490226|NCT03850483|616136616|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
170490227|NCT03850483|616136617|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
170490228|NCT03850483|616136618|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
170490229|NCT03850483|616136619|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
170490230|NCT03850483|616136620|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
170490231|NCT03850483|616136621|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
170490232|NCT03850483|616136612|FG000|Follow-up for Stage 1|Other|0|||
170490233|NCT03850483|616136613|FG001|Follow-up for Stage 1|Other|2|||
170490234|NCT03850483|616136614|FG002|Follow-up for Stage 1|Other|0|||
170899900|NCT00151892|617637768|FG000|Overall Study|Lack of study medication at center|0|||
170899901|NCT00151892|617637769|FG001|Overall Study|Lack of study medication at center|1|||
170899902|NCT00591734|617637770|FG000|Overall Study|Lack of Efficacy|35|||
170899903|NCT00591734|617637770|FG000|Overall Study|Adverse Event|5|||
170899904|NCT00591734|617637770|FG000|Overall Study|Physician Decision|5|||
170899905|NCT00591734|617637770|FG000|Overall Study|Intercurrent Illness|8|||
170899906|NCT01661790|617637771|FG000|Overall Study|Lost to Follow-up|0|||
170899907|NCT01661790|617637772|FG001|Overall Study|Lost to Follow-up|2|||
170899908|NCT02764541|617637775|FG000|Overall Study|Withdrawal by Subject|0|||
170899909|NCT02764541|617637776|FG001|Overall Study|Withdrawal by Subject|0|||
170899910|NCT02764541|617637777|FG002|Overall Study|Withdrawal by Subject|0|||
170899911|NCT02764541|617637778|FG003|Overall Study|Withdrawal by Subject|0|||
170899912|NCT02764541|617637779|FG004|Overall Study|Withdrawal by Subject|1|||
170899913|NCT02764541|617637780|FG005|Overall Study|Withdrawal by Subject|1|||
170490235|NCT03850483|616136615|FG003|Follow-up for Stage 1|Other|2|||
170490236|NCT03850483|616136616|FG004|Follow-up for Stage 1|Other|0|||
170490237|NCT03850483|616136617|FG005|Follow-up for Stage 1|Other|1|||
170490238|NCT03850483|616136618|FG006|Follow-up for Stage 1|Other|0|||
170490239|NCT03850483|616136619|FG007|Follow-up for Stage 1|Other|0|||
170640704|NCT01667419|616696978|FG000|Overall Study|Non-compliance|0|||
170899914|NCT02764541|617637781|FG006|Overall Study|Withdrawal by Subject|0|||
170899915|NCT02764541|617637782|FG007|Overall Study|Withdrawal by Subject|1|||
170640705|NCT01667419|616696979|FG001|Overall Study|Non-compliance|0|||
170899916|NCT02764541|617637775|FG000|Overall Study|Adverse Event|1|||
170899917|NCT02764541|617637776|FG001|Overall Study|Adverse Event|0|||
170899918|NCT02764541|617637777|FG002|Overall Study|Adverse Event|0|||
170490240|NCT03850483|616136620|FG008|Follow-up for Stage 1|Other|0|||
170490241|NCT03850483|616136621|FG009|Follow-up for Stage 1|Other|0|||
170490242|NCT03850483|616136612|FG000|Treatment for Stage 2|Adverse Event|0|||
170490243|NCT03850483|616136613|FG001|Treatment for Stage 2|Adverse Event|0|||
170490244|NCT03850483|616136614|FG002|Treatment for Stage 2|Adverse Event|0|||
170490245|NCT03850483|616136615|FG003|Treatment for Stage 2|Adverse Event|0|||
170490246|NCT03850483|616136616|FG004|Treatment for Stage 2|Adverse Event|0|||
170490247|NCT03850483|616136617|FG005|Treatment for Stage 2|Adverse Event|0|||
170899919|NCT02764541|617637778|FG003|Overall Study|Adverse Event|0|||
170899920|NCT02764541|617637779|FG004|Overall Study|Adverse Event|0|||
170899921|NCT02764541|617637780|FG005|Overall Study|Adverse Event|0|||
170899922|NCT02764541|617637781|FG006|Overall Study|Adverse Event|1|||
170899923|NCT02764541|617637782|FG007|Overall Study|Adverse Event|0|||
170490248|NCT03850483|616136618|FG006|Treatment for Stage 2|Adverse Event|0|||
170490249|NCT03850483|616136619|FG007|Treatment for Stage 2|Adverse Event|0|||
170490250|NCT03850483|616136620|FG008|Treatment for Stage 2|Adverse Event|0|||
170490251|NCT03850483|616136621|FG009|Treatment for Stage 2|Adverse Event|1|||
170490252|NCT03850483|616136612|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
170490253|NCT03850483|616136613|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
170490254|NCT03850483|616136614|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
170490255|NCT03850483|616136615|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
170490256|NCT03850483|616136616|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
170490257|NCT03850483|616136617|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
170490258|NCT03850483|616136618|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
170490259|NCT03850483|616136619|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
170490260|NCT03850483|616136620|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
170490261|NCT03850483|616136621|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
170490262|NCT03850483|616136612|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
170490263|NCT03850483|616136613|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
170490264|NCT03850483|616136614|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
170490265|NCT03850483|616136615|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
170490266|NCT03850483|616136616|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
170490267|NCT03850483|616136617|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
170490268|NCT03850483|616136618|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
170490269|NCT03850483|616136619|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
170490270|NCT03850483|616136620|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
170490271|NCT03850483|616136621|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
170490272|NCT03850483|616136612|FG000|Treatment for Stage 2|Physician Decision|0|||
170490273|NCT03850483|616136613|FG001|Treatment for Stage 2|Physician Decision|0|||
170490274|NCT03850483|616136614|FG002|Treatment for Stage 2|Physician Decision|0|||
170490275|NCT03850483|616136615|FG003|Treatment for Stage 2|Physician Decision|0|||
170490276|NCT03850483|616136616|FG004|Treatment for Stage 2|Physician Decision|0|||
170490277|NCT03850483|616136617|FG005|Treatment for Stage 2|Physician Decision|0|||
170490278|NCT03850483|616136618|FG006|Treatment for Stage 2|Physician Decision|0|||
170490279|NCT03850483|616136619|FG007|Treatment for Stage 2|Physician Decision|0|||
170490280|NCT03850483|616136620|FG008|Treatment for Stage 2|Physician Decision|0|||
170490281|NCT03850483|616136621|FG009|Treatment for Stage 2|Physician Decision|1|||
170490282|NCT03850483|616136612|FG000|Treatment for Stage 2|Protocol Violation|0|||
170490283|NCT03850483|616136613|FG001|Treatment for Stage 2|Protocol Violation|0|||
170490284|NCT03850483|616136614|FG002|Treatment for Stage 2|Protocol Violation|0|||
170490285|NCT03850483|616136615|FG003|Treatment for Stage 2|Protocol Violation|0|||
170490286|NCT03850483|616136616|FG004|Treatment for Stage 2|Protocol Violation|0|||
170490287|NCT03850483|616136617|FG005|Treatment for Stage 2|Protocol Violation|0|||
170490288|NCT03850483|616136618|FG006|Treatment for Stage 2|Protocol Violation|0|||
170490289|NCT03850483|616136619|FG007|Treatment for Stage 2|Protocol Violation|0|||
170490290|NCT03850483|616136620|FG008|Treatment for Stage 2|Protocol Violation|1|||
170490291|NCT03850483|616136621|FG009|Treatment for Stage 2|Protocol Violation|0|||
170490292|NCT03850483|616136612|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
170490293|NCT03850483|616136613|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
170490294|NCT03850483|616136614|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
170490295|NCT03850483|616136615|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
170490296|NCT03850483|616136616|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
170490297|NCT03850483|616136617|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
170490298|NCT03850483|616136618|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
170490299|NCT03850483|616136619|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
170490300|NCT03850483|616136620|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
170490301|NCT03850483|616136621|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
170490302|NCT03850483|616136612|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490303|NCT03850483|616136613|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490304|NCT03850483|616136614|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490305|NCT03850483|616136615|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490306|NCT03850483|616136616|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490307|NCT03850483|616136617|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490308|NCT03850483|616136618|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490309|NCT03850483|616136619|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490310|NCT03850483|616136620|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
170490311|NCT03850483|616136621|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
170490312|NCT03850483|616136612|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
170490313|NCT03850483|616136613|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
170490314|NCT03850483|616136614|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
170490315|NCT03850483|616136615|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
170490316|NCT03850483|616136616|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
170490317|NCT03850483|616136617|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
170640706|NCT01667419|616696980|FG002|Overall Study|Non-compliance|0|||
170490318|NCT03850483|616136618|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
170490319|NCT03850483|616136619|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
170490320|NCT03850483|616136620|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
170490321|NCT03850483|616136621|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
170490322|NCT03850483|616136612|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
170490323|NCT03850483|616136613|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
170549465|NCT02318277|616356785|FG004|Overall Study|Physician Decision|0|||
170549466|NCT02318277|616356786|FG005|Overall Study|Physician Decision|0|||
170549467|NCT02318277|616356787|FG006|Overall Study|Physician Decision|0|||
170549468|NCT02318277|616356788|FG007|Overall Study|Physician Decision|1|||
170549469|NCT02318277|616356781|FG000|Overall Study|Other|0|||
170549470|NCT02318277|616356782|FG001|Overall Study|Other|0|||
170549471|NCT02318277|616356783|FG002|Overall Study|Other|0|||
170549472|NCT02318277|616356784|FG003|Overall Study|Other|0|||
170549473|NCT02318277|616356785|FG004|Overall Study|Other|0|||
170549474|NCT02318277|616356786|FG005|Overall Study|Other|0|||
170549475|NCT02318277|616356787|FG006|Overall Study|Other|1|||
170549476|NCT02318277|616356788|FG007|Overall Study|Other|0|||
170549477|NCT02318277|616356781|FG000|Overall Study|Withdrawal by Subject|0|||
170549478|NCT02318277|616356782|FG001|Overall Study|Withdrawal by Subject|0|||
170549479|NCT02318277|616356783|FG002|Overall Study|Withdrawal by Subject|1|||
170549480|NCT02318277|616356784|FG003|Overall Study|Withdrawal by Subject|0|||
170549481|NCT02318277|616356785|FG004|Overall Study|Withdrawal by Subject|1|||
170549482|NCT02318277|616356786|FG005|Overall Study|Withdrawal by Subject|1|||
170549483|NCT02318277|616356787|FG006|Overall Study|Withdrawal by Subject|6|||
170549484|NCT02318277|616356788|FG007|Overall Study|Withdrawal by Subject|14|||
170549485|NCT02318277|616356781|FG000|Overall Study|Participant trial terminated by sponsor|0|||
170549486|NCT02318277|616356782|FG001|Overall Study|Participant trial terminated by sponsor|0|||
170549487|NCT02318277|616356783|FG002|Overall Study|Participant trial terminated by sponsor|1|||
170549488|NCT02318277|616356784|FG003|Overall Study|Participant trial terminated by sponsor|0|||
170549489|NCT02318277|616356785|FG004|Overall Study|Participant trial terminated by sponsor|1|||
170549490|NCT02318277|616356786|FG005|Overall Study|Participant trial terminated by sponsor|2|||
170549491|NCT02318277|616356787|FG006|Overall Study|Participant trial terminated by sponsor|5|||
170549492|NCT02318277|616356788|FG007|Overall Study|Participant trial terminated by sponsor|16|||
170549493|NCT02318277|616356781|FG000|Overall Study|Lost to Follow-up|1|||
170549494|NCT02318277|616356782|FG001|Overall Study|Lost to Follow-up|0|||
170549495|NCT02318277|616356783|FG002|Overall Study|Lost to Follow-up|1|||
170549496|NCT02318277|616356784|FG003|Overall Study|Lost to Follow-up|0|||
170549497|NCT02318277|616356785|FG004|Overall Study|Lost to Follow-up|0|||
170549498|NCT02318277|616356786|FG005|Overall Study|Lost to Follow-up|0|||
170800436|NCT04334317|617281030|FG001|Overall Study|Protocol Deviation|1|||
170800437|NCT04334317|617281031|FG002|Overall Study|Protocol Deviation|0|||
170800438|NCT04334317|617281032|FG003|Overall Study|Protocol Deviation|0|||
170800439|NCT04334317|617281029|FG000|Overall Study|Withdrawal by Subject|2|||
170800440|NCT04334317|617281030|FG001|Overall Study|Withdrawal by Subject|2|||
170800441|NCT04334317|617281031|FG002|Overall Study|Withdrawal by Subject|0|||
170490324|NCT03850483|616136614|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
170490325|NCT03850483|616136615|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
170490326|NCT03850483|616136616|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
170490327|NCT03850483|616136617|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
170490328|NCT03850483|616136618|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
170490329|NCT03850483|616136619|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
170490330|NCT03850483|616136620|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
170490331|NCT03850483|616136621|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
170490332|NCT03850483|616136612|FG000|Follow-up For Stage 2|Other|0|||
170490333|NCT03850483|616136613|FG001|Follow-up For Stage 2|Other|0|||
170490334|NCT03850483|616136614|FG002|Follow-up For Stage 2|Other|0|||
170490335|NCT03850483|616136615|FG003|Follow-up For Stage 2|Other|0|||
170490336|NCT03850483|616136616|FG004|Follow-up For Stage 2|Other|0|||
170640707|NCT01667419|616696981|FG003|Overall Study|Non-compliance|1|||
170800442|NCT04334317|617281032|FG003|Overall Study|Withdrawal by Subject|0|||
170800443|NCT03183050|617281033|FG000|Overall Study|Lost to Follow-up|23|||
170800444|NCT03653364|617281034|FG000|Overall Study|Withdrawal by Subject|1|||
170800445|NCT03653364|617281034|FG000|Overall Study|Enrolled in Error|1|||
170800446|NCT03653364|617281034|FG000|Overall Study|Death|1|||
170800447|NCT03248492|617281046|FG000|Overall Study|Progressive Disease|24|||
170490337|NCT03850483|616136617|FG005|Follow-up For Stage 2|Other|0|||
170490338|NCT03850483|616136618|FG006|Follow-up For Stage 2|Other|0|||
170490339|NCT03850483|616136619|FG007|Follow-up For Stage 2|Other|0|||
170490340|NCT03850483|616136620|FG008|Follow-up For Stage 2|Other|0|||
170549499|NCT02318277|616356787|FG006|Overall Study|Lost to Follow-up|3|||
170549500|NCT02318277|616356788|FG007|Overall Study|Lost to Follow-up|4|||
170549501|NCT02318277|616356781|FG000|Overall Study|Death|5|||
170549502|NCT02318277|616356782|FG001|Overall Study|Death|3|||
170549503|NCT02318277|616356783|FG002|Overall Study|Death|1|||
170549504|NCT02318277|616356784|FG003|Overall Study|Death|4|||
170549505|NCT02318277|616356785|FG004|Overall Study|Death|6|||
170549506|NCT02318277|616356786|FG005|Overall Study|Death|5|||
170549507|NCT02318277|616356787|FG006|Overall Study|Death|34|||
170899924|NCT02764541|617637775|FG000|Overall Study|Metastasis|1|||
170899925|NCT02764541|617637776|FG001|Overall Study|Metastasis|0|||
170899926|NCT02764541|617637777|FG002|Overall Study|Metastasis|0|||
170899927|NCT02764541|617637778|FG003|Overall Study|Metastasis|0|||
170899928|NCT02764541|617637779|FG004|Overall Study|Metastasis|0|||
170899929|NCT02764541|617637780|FG005|Overall Study|Metastasis|0|||
170899930|NCT02764541|617637781|FG006|Overall Study|Metastasis|0|||
170899931|NCT02764541|617637782|FG007|Overall Study|Metastasis|0|||
170490341|NCT03850483|616136621|FG009|Follow-up For Stage 2|Other|1|||
170490342|NCT00972816|616138569|FG000|Overall Study|Adverse Event|0|||
170490343|NCT00972816|616138570|FG001|Overall Study|Adverse Event|0|||
170490344|NCT00972816|616138571|FG002|Overall Study|Adverse Event|1|||
170490345|NCT00972816|616138572|FG003|Overall Study|Adverse Event|0|||
170490346|NCT00972816|616138573|FG004|Overall Study|Adverse Event|0|||
170490347|NCT00972816|616138574|FG005|Overall Study|Adverse Event|0|||
170490348|NCT00972816|616138575|FG006|Overall Study|Adverse Event|0|||
170490349|NCT00972816|616138576|FG007|Overall Study|Adverse Event|0|||
170490350|NCT00972816|616138569|FG000|Overall Study|Withdrawal by Subject|4|||
170490351|NCT00972816|616138570|FG001|Overall Study|Withdrawal by Subject|2|||
170490352|NCT00972816|616138571|FG002|Overall Study|Withdrawal by Subject|1|||
170490353|NCT00972816|616138572|FG003|Overall Study|Withdrawal by Subject|3|||
170490354|NCT00972816|616138573|FG004|Overall Study|Withdrawal by Subject|0|||
170490355|NCT00972816|616138574|FG005|Overall Study|Withdrawal by Subject|1|||
170490356|NCT00972816|616138575|FG006|Overall Study|Withdrawal by Subject|1|||
170490357|NCT00972816|616138576|FG007|Overall Study|Withdrawal by Subject|2|||
170490358|NCT00972816|616138569|FG000|Overall Study|Lost to Follow-up|11|||
170490359|NCT00972816|616138570|FG001|Overall Study|Lost to Follow-up|9|||
170490360|NCT00972816|616138571|FG002|Overall Study|Lost to Follow-up|7|||
170490361|NCT00972816|616138572|FG003|Overall Study|Lost to Follow-up|5|||
170490362|NCT00972816|616138573|FG004|Overall Study|Lost to Follow-up|11|||
170490363|NCT00972816|616138574|FG005|Overall Study|Lost to Follow-up|10|||
170490364|NCT00972816|616138575|FG006|Overall Study|Lost to Follow-up|7|||
170490365|NCT00972816|616138576|FG007|Overall Study|Lost to Follow-up|7|||
170490366|NCT00972816|616138569|FG000|Overall Study|Inappropriate enrolment|0|||
170490367|NCT00972816|616138570|FG001|Overall Study|Inappropriate enrolment|0|||
170490368|NCT00972816|616138571|FG002|Overall Study|Inappropriate enrolment|0|||
170490369|NCT00972816|616138572|FG003|Overall Study|Inappropriate enrolment|0|||
170490370|NCT00972816|616138573|FG004|Overall Study|Inappropriate enrolment|0|||
170899932|NCT02764541|617637775|FG000|Overall Study|Disease progression|1|||
170899933|NCT02764541|617637776|FG001|Overall Study|Disease progression|1|||
170899934|NCT02764541|617637777|FG002|Overall Study|Disease progression|0|||
170490371|NCT00972816|616138574|FG005|Overall Study|Inappropriate enrolment|0|||
170490372|NCT00972816|616138575|FG006|Overall Study|Inappropriate enrolment|2|||
170490373|NCT00972816|616138576|FG007|Overall Study|Inappropriate enrolment|0|||
170490374|NCT00972816|616138569|FG000|Overall Study|Unable to classify|2|||
170490375|NCT00972816|616138570|FG001|Overall Study|Unable to classify|0|||
170490376|NCT00972816|616138571|FG002|Overall Study|Unable to classify|0|||
170490377|NCT00972816|616138572|FG003|Overall Study|Unable to classify|0|||
170490378|NCT00972816|616138573|FG004|Overall Study|Unable to classify|1|||
170490379|NCT00972816|616138574|FG005|Overall Study|Unable to classify|0|||
170490380|NCT00972816|616138575|FG006|Overall Study|Unable to classify|0|||
170490381|NCT00972816|616138576|FG007|Overall Study|Unable to classify|0|||
170490382|NCT03806933|616138577|FG000|Main Period|Physician Decision|0|||
170490383|NCT03806933|616138578|FG001|Main Period|Physician Decision|0|||
170490384|NCT03806933|616138579|FG002|Main Period|Physician Decision|0|||
170490385|NCT03806933|616138580|FG003|Main Period|Physician Decision|1|||
170490386|NCT03806933|616138577|FG000|Main Period|Pregnancy|0|||
170490387|NCT03806933|616138578|FG001|Main Period|Pregnancy|0|||
170490388|NCT03806933|616138579|FG002|Main Period|Pregnancy|1|||
170490389|NCT03806933|616138580|FG003|Main Period|Pregnancy|0|||
170490390|NCT03806933|616138577|FG000|Main Period|Withdrawal by Subject|2|||
170490391|NCT03806933|616138578|FG001|Main Period|Withdrawal by Subject|1|||
170490392|NCT03806933|616138579|FG002|Main Period|Withdrawal by Subject|1|||
170490393|NCT03806933|616138580|FG003|Main Period|Withdrawal by Subject|2|||
170490394|NCT03806933|616138577|FG000|Main Period|Lost to Follow-up|2|||
170490395|NCT03806933|616138578|FG001|Main Period|Lost to Follow-up|2|||
170490396|NCT03806933|616138579|FG002|Main Period|Lost to Follow-up|0|||
170490397|NCT03806933|616138580|FG003|Main Period|Lost to Follow-up|0|||
170490398|NCT03806933|616138577|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
170490399|NCT03806933|616138578|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
170490400|NCT03806933|616138579|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
170490401|NCT03806933|616138580|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
170490402|NCT01736397|616138581|FG000|Overall Study|Lack of Efficacy|1|||
170490403|NCT01736397|616138582|FG001|Overall Study|Lack of Efficacy|11|||
170490404|NCT01736397|616138581|FG000|Overall Study|Withdrawal by Subject|6|||
170490405|NCT01736397|616138582|FG001|Overall Study|Withdrawal by Subject|5|||
170899935|NCT02764541|617637778|FG003|Overall Study|Disease progression|0|||
170899936|NCT02764541|617637779|FG004|Overall Study|Disease progression|0|||
170899937|NCT02764541|617637780|FG005|Overall Study|Disease progression|0|||
170899938|NCT02764541|617637781|FG006|Overall Study|Disease progression|0|||
170899939|NCT02764541|617637782|FG007|Overall Study|Disease progression|1|||
170899940|NCT02764541|617637775|FG000|Overall Study|Protocol Violation|0|||
170899941|NCT02764541|617637776|FG001|Overall Study|Protocol Violation|0|||
170899942|NCT02764541|617637777|FG002|Overall Study|Protocol Violation|0|||
170899943|NCT02764541|617637778|FG003|Overall Study|Protocol Violation|1|||
170899944|NCT02764541|617637779|FG004|Overall Study|Protocol Violation|0|||
170899945|NCT02764541|617637780|FG005|Overall Study|Protocol Violation|1|||
170899946|NCT02764541|617637781|FG006|Overall Study|Protocol Violation|0|||
170899947|NCT02764541|617637782|FG007|Overall Study|Protocol Violation|0|||
170899948|NCT02764541|617637775|FG000|Overall Study|Physician Decision|0|||
170899949|NCT02764541|617637776|FG001|Overall Study|Physician Decision|0|||
170899950|NCT02764541|617637777|FG002|Overall Study|Physician Decision|0|||
170899951|NCT02764541|617637778|FG003|Overall Study|Physician Decision|1|||
170899952|NCT02764541|617637779|FG004|Overall Study|Physician Decision|0|||
170899953|NCT02764541|617637780|FG005|Overall Study|Physician Decision|0|||
170899954|NCT02764541|617637781|FG006|Overall Study|Physician Decision|0|||
170899955|NCT02764541|617637782|FG007|Overall Study|Physician Decision|1|||
170899956|NCT02764541|617637775|FG000|Overall Study|Three Cycles completed before surgery|0|||
170899957|NCT02764541|617637776|FG001|Overall Study|Three Cycles completed before surgery|0|||
170899958|NCT02764541|617637777|FG002|Overall Study|Three Cycles completed before surgery|0|||
170899959|NCT02764541|617637778|FG003|Overall Study|Three Cycles completed before surgery|1|||
170899960|NCT02764541|617637779|FG004|Overall Study|Three Cycles completed before surgery|0|||
170899961|NCT02764541|617637780|FG005|Overall Study|Three Cycles completed before surgery|0|||
170899962|NCT02764541|617637781|FG006|Overall Study|Three Cycles completed before surgery|0|||
170899963|NCT02764541|617637782|FG007|Overall Study|Three Cycles completed before surgery|0|||
170899964|NCT02764541|617637775|FG000|Overall Study|Patient Compliance|0|||
170899965|NCT02764541|617637776|FG001|Overall Study|Patient Compliance|0|||
170899966|NCT02764541|617637777|FG002|Overall Study|Patient Compliance|1|||
170899967|NCT02764541|617637778|FG003|Overall Study|Patient Compliance|0|||
170899968|NCT02764541|617637779|FG004|Overall Study|Patient Compliance|0|||
170899969|NCT02764541|617637780|FG005|Overall Study|Patient Compliance|0|||
170899970|NCT02764541|617637781|FG006|Overall Study|Patient Compliance|0|||
170899971|NCT02764541|617637782|FG007|Overall Study|Patient Compliance|0|||
170899972|NCT02764541|617637775|FG000|Overall Study|Death|0|||
170899973|NCT02764541|617637776|FG001|Overall Study|Death|0|||
170899974|NCT02764541|617637777|FG002|Overall Study|Death|0|||
170899975|NCT02764541|617637778|FG003|Overall Study|Death|0|||
170899976|NCT02764541|617637779|FG004|Overall Study|Death|0|||
170899977|NCT02764541|617637780|FG005|Overall Study|Death|0|||
170899978|NCT02764541|617637781|FG006|Overall Study|Death|1|||
170899979|NCT02764541|617637782|FG007|Overall Study|Death|0|||
170899980|NCT02764541|617637775|FG000|Overall Study|Insurance reasons|0|||
170899981|NCT02764541|617637776|FG001|Overall Study|Insurance reasons|0|||
170899982|NCT02764541|617637777|FG002|Overall Study|Insurance reasons|0|||
170899983|NCT02764541|617637778|FG003|Overall Study|Insurance reasons|0|||
170490406|NCT01736397|616138581|FG000|Overall Study|Lost to Follow-up|0|||
170490407|NCT01736397|616138582|FG001|Overall Study|Lost to Follow-up|1|||
170490408|NCT01736397|616138581|FG000|Overall Study|Adverse Event|6|||
170490409|NCT01736397|616138582|FG001|Overall Study|Adverse Event|3|||
170490410|NCT01736397|616138581|FG000|Overall Study|Not stated|1|||
170490411|NCT01736397|616138582|FG001|Overall Study|Not stated|4|||
170490412|NCT05088603|616138585|FG000|Overall Study|Protocol Violation|6|||
170490413|NCT05088603|616138586|FG001|Overall Study|Protocol Violation|1|||
170490414|NCT01177293|616138590|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
170490415|NCT01177293|616138591|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
170490416|NCT00614523|616138592|FG000|Overall Study|Adverse Event|4|||
170490417|NCT00614523|616138593|FG001|Overall Study|Adverse Event|20|||
170899984|NCT02764541|617637779|FG004|Overall Study|Insurance reasons|0|||
170899985|NCT02764541|617637780|FG005|Overall Study|Insurance reasons|0|||
170899986|NCT02764541|617637781|FG006|Overall Study|Insurance reasons|1|||
170899987|NCT02764541|617637782|FG007|Overall Study|Insurance reasons|0|||
170899988|NCT02048904|617637783|FG000|Overall Study|Withdrawal by Subject|7|||
170899989|NCT02048904|617637783|FG000|Overall Study|Physician Decision|70|||
170899990|NCT03832387|617637784|FG000|Overall Study|Protocol Violation|2|||
170899991|NCT03832387|617637785|FG001|Overall Study|Protocol Violation|6|||
170899992|NCT03832387|617637784|FG000|Overall Study|EXCLUSION CRITERIA|3|||
170899993|NCT03832387|617637785|FG001|Overall Study|EXCLUSION CRITERIA|1|||
170490418|NCT00614523|616138592|FG000|Overall Study|Death|5|||
170490419|NCT00614523|616138593|FG001|Overall Study|Death|8|||
170490420|NCT00614523|616138592|FG000|Overall Study|Lack of Efficacy|9|||
170490421|NCT00614523|616138593|FG001|Overall Study|Lack of Efficacy|11|||
170899994|NCT00355121|617637786|FG000|Overall Study|Did not receive study vaccine|1|||
170899995|NCT00355121|617637787|FG001|Overall Study|Did not receive study vaccine|0|||
170899996|NCT00355121|617637788|FG002|Overall Study|Did not receive study vaccine|1|||
170899997|NCT00355121|617637786|FG000|Overall Study|Adverse Event|0|||
170899998|NCT00355121|617637787|FG001|Overall Study|Adverse Event|1|||
170899999|NCT00355121|617637788|FG002|Overall Study|Adverse Event|0|||
170900000|NCT00355121|617637786|FG000|Overall Study|Protocol Violation|7|||
170900001|NCT00355121|617637787|FG001|Overall Study|Protocol Violation|9|||
170900002|NCT00355121|617637788|FG002|Overall Study|Protocol Violation|1|||
170490422|NCT00614523|616138592|FG000|Overall Study|Lost to Follow-up|0|||
170900003|NCT00355121|617637786|FG000|Overall Study|Lost to Follow-up|4|||
170900004|NCT00355121|617637787|FG001|Overall Study|Lost to Follow-up|7|||
170900005|NCT00355121|617637788|FG002|Overall Study|Lost to Follow-up|1|||
170900006|NCT00355121|617637786|FG000|Overall Study|Withdrawal by Subject|9|||
170900007|NCT00355121|617637787|FG001|Overall Study|Withdrawal by Subject|10|||
170900008|NCT00355121|617637788|FG002|Overall Study|Withdrawal by Subject|2|||
170900009|NCT00355121|617637786|FG000|Overall Study|Serious adverse events|0|||
170900010|NCT00355121|617637787|FG001|Overall Study|Serious adverse events|2|||
170900011|NCT00355121|617637788|FG002|Overall Study|Serious adverse events|0|||
170900012|NCT04752384|617637790|FG000|Overall Study|Withdrawal by Subject|1|||
170900013|NCT04752384|617637790|FG000|Overall Study|Death|1|||
170900014|NCT04439331|617637791|FG000|Overall Study|Never Start Protocol Therapy|2|||
170900015|NCT04439331|617637791|FG000|Overall Study|Ineligible|2|||
170900016|NCT04439331|617637791|FG000|Overall Study|Mutation Status Not Confirmed|1|||
170900017|NCT04439331|617637791|FG000|Overall Study|Adverse Event|1|||
170900018|NCT04439331|617637791|FG000|Overall Study|Death|1|||
170900019|NCT04439331|617637791|FG000|Overall Study|Disease Progression|20|||
170900020|NCT04439331|617637791|FG000|Overall Study|Withdrawal by Subject|6|||
170900021|NCT04439331|617637791|FG000|Overall Study|Physician Decision|1|||
170900022|NCT04439331|617637791|FG000|Overall Study|Other Complicating Disease|1|||
170490423|NCT00614523|616138593|FG001|Overall Study|Lost to Follow-up|1|||
170490424|NCT00614523|616138592|FG000|Overall Study|Protocol Violation|3|||
170490425|NCT00614523|616138593|FG001|Overall Study|Protocol Violation|2|||
170490426|NCT00614523|616138592|FG000|Overall Study|Withdrawal by Subject|12|||
170490427|NCT00614523|616138593|FG001|Overall Study|Withdrawal by Subject|22|||
170490428|NCT00614523|616138592|FG000|Overall Study|Other|6|||
170490429|NCT00614523|616138593|FG001|Overall Study|Other|11|||
170490430|NCT00614523|616138592|FG000|Overall Study|Ineligibility Determined|1|||
170490431|NCT00614523|616138593|FG001|Overall Study|Ineligibility Determined|2|||
170490432|NCT00614523|616138592|FG000|Overall Study|Disease Progression|0|||
170490433|NCT00614523|616138593|FG001|Overall Study|Disease Progression|8|||
170490434|NCT00614523|616138592|FG000|Overall Study|Administrative Decision|23|||
170490435|NCT00614523|616138593|FG001|Overall Study|Administrative Decision|46|||
170490436|NCT00452673|616138594|FG000|Dose Escalation Period|Disease Progression|6|||
170549508|NCT02318277|616356788|FG007|Overall Study|Death|58|||
170549509|NCT02318277|616356781|FG000|Overall Study|Transitioned to Hospice|0|||
170549510|NCT02318277|616356782|FG001|Overall Study|Transitioned to Hospice|0|||
170549511|NCT02318277|616356783|FG002|Overall Study|Transitioned to Hospice|0|||
170549512|NCT02318277|616356784|FG003|Overall Study|Transitioned to Hospice|0|||
170549513|NCT02318277|616356785|FG004|Overall Study|Transitioned to Hospice|0|||
170549514|NCT02318277|616356786|FG005|Overall Study|Transitioned to Hospice|1|||
170549515|NCT02318277|616356787|FG006|Overall Study|Transitioned to Hospice|0|||
170549516|NCT02318277|616356788|FG007|Overall Study|Transitioned to Hospice|0|||
170549517|NCT03364686|616356789|FG000|Overall Study|Physician Decision|2|||
170549518|NCT01696214|616356790|FG000|Overall Study|Lost to Follow-up|1|||
170549519|NCT01696214|616356791|FG001|Overall Study|Lost to Follow-up|0|||
170549520|NCT01696214|616356792|FG002|Overall Study|Lost to Follow-up|0|||
170549521|NCT01696214|616356793|FG003|Overall Study|Lost to Follow-up|0|||
170549522|NCT02134028|616356794|FG000|Overall Study|Lack of Efficacy|1|||
170549523|NCT02134028|616356795|FG001|Overall Study|Lack of Efficacy|0|||
170549524|NCT02134028|616356796|FG002|Overall Study|Lack of Efficacy|3|||
170900023|NCT04370509|617637794|FG000|Overall Study|Adverse Event|1|||
170549525|NCT02134028|616356797|FG003|Overall Study|Lack of Efficacy|2|||
170549526|NCT02134028|616356798|FG004|Overall Study|Lack of Efficacy|1|||
170549527|NCT02134028|616356799|FG005|Overall Study|Lack of Efficacy|2|||
170549528|NCT02134028|616356800|FG006|Overall Study|Lack of Efficacy|1|||
170549529|NCT02134028|616356801|FG007|Overall Study|Lack of Efficacy|0|||
170549530|NCT02134028|616356794|FG000|Overall Study|Poor compliance to protocol|1|||
170549531|NCT02134028|616356795|FG001|Overall Study|Poor compliance to protocol|1|||
170549532|NCT02134028|616356796|FG002|Overall Study|Poor compliance to protocol|3|||
170549533|NCT02134028|616356797|FG003|Overall Study|Poor compliance to protocol|7|||
170549534|NCT02134028|616356798|FG004|Overall Study|Poor compliance to protocol|1|||
170549535|NCT02134028|616356799|FG005|Overall Study|Poor compliance to protocol|1|||
170549536|NCT02134028|616356800|FG006|Overall Study|Poor compliance to protocol|0|||
170900024|NCT04370509|617637795|FG001|Overall Study|Adverse Event|0|||
170900025|NCT04370509|617637794|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
170900026|NCT04370509|617637795|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
170900027|NCT04743856|617637796|FG000|Overall Study|Lost to Follow-up|6|||
170900028|NCT04743856|617637797|FG001|Overall Study|Lost to Follow-up|7|||
170490437|NCT00452673|616138595|FG001|Dose Escalation Period|Disease Progression|6|||
170900029|NCT04743856|617637796|FG000|Overall Study|Withdrawal by Subject|1|||
170490438|NCT00452673|616138596|FG002|Dose Escalation Period|Disease Progression|2|||
170549537|NCT02134028|616356801|FG007|Overall Study|Poor compliance to protocol|0|||
170549538|NCT02134028|616356794|FG000|Overall Study|Other unspecified|4|||
170549539|NCT02134028|616356795|FG001|Overall Study|Other unspecified|22|||
170490439|NCT00452673|616138597|FG003|Dose Escalation Period|Disease Progression|6|||
170490440|NCT00452673|616138598|FG004|Dose Escalation Period|Disease Progression|0|||
170490441|NCT00452673|616138594|FG000|Dose Escalation Period|study drug toxicity|1|||
170490442|NCT00452673|616138595|FG001|Dose Escalation Period|study drug toxicity|3|||
170490443|NCT00452673|616138596|FG002|Dose Escalation Period|study drug toxicity|3|||
170490444|NCT00452673|616138597|FG003|Dose Escalation Period|study drug toxicity|1|||
170490445|NCT00452673|616138598|FG004|Dose Escalation Period|study drug toxicity|0|||
170490446|NCT00452673|616138594|FG000|Dose Escalation Period|Other|0|||
170490447|NCT00452673|616138595|FG001|Dose Escalation Period|Other|0|||
170490448|NCT00452673|616138596|FG002|Dose Escalation Period|Other|1|||
170490449|NCT00452673|616138597|FG003|Dose Escalation Period|Other|0|||
170490450|NCT00452673|616138598|FG004|Dose Escalation Period|Other|0|||
170490451|NCT00452673|616138594|FG000|Dose Escalation Period|Adverse Event|0|||
170490452|NCT00452673|616138595|FG001|Dose Escalation Period|Adverse Event|0|||
170490453|NCT00452673|616138596|FG002|Dose Escalation Period|Adverse Event|0|||
170490454|NCT00452673|616138597|FG003|Dose Escalation Period|Adverse Event|1|||
170490455|NCT00452673|616138598|FG004|Dose Escalation Period|Adverse Event|0|||
170490456|NCT00452673|616138594|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
170490457|NCT00452673|616138595|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
170490458|NCT00452673|616138596|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
170490459|NCT00452673|616138597|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
170490460|NCT00452673|616138598|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
170490461|NCT00452673|616138594|FG000|Dose Expansion Period|Disease Progression|0|||
170490462|NCT00452673|616138595|FG001|Dose Expansion Period|Disease Progression|0|||
170490463|NCT00452673|616138596|FG002|Dose Expansion Period|Disease Progression|0|||
170490464|NCT00452673|616138597|FG003|Dose Expansion Period|Disease Progression|0|||
170490465|NCT00452673|616138598|FG004|Dose Expansion Period|Disease Progression|19|||
170490466|NCT00452673|616138594|FG000|Dose Expansion Period|Other|0|||
170490467|NCT00452673|616138595|FG001|Dose Expansion Period|Other|0|||
170490468|NCT00452673|616138596|FG002|Dose Expansion Period|Other|0|||
170490469|NCT00452673|616138597|FG003|Dose Expansion Period|Other|0|||
170490470|NCT00452673|616138598|FG004|Dose Expansion Period|Other|2|||
170490471|NCT02656290|616138599|FG000|Overall Study|Lost to Follow-up|1|||
170490472|NCT02656290|616138599|FG000|Overall Study|Reintervention|3|||
170490473|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
170490474|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
170900030|NCT04743856|617637797|FG001|Overall Study|Withdrawal by Subject|0|||
170900031|NCT04696861|617637798|FG000|Overall Study|Death|1|||
170900032|NCT04696861|617637799|FG001|Overall Study|Death|0|||
170900033|NCT04696861|617637798|FG000|Overall Study|Lost to Follow-up|3|||
170900034|NCT04696861|617637799|FG001|Overall Study|Lost to Follow-up|0|||
170900035|NCT04439188|617637800|FG000|Overall Study|Ineligible|3|||
170900036|NCT04439188|617637800|FG000|Overall Study|Adverse Event|4|||
170900037|NCT04439188|617637800|FG000|Overall Study|Death|1|||
170900038|NCT04439188|617637800|FG000|Overall Study|Disease Progression|25|||
170900039|NCT04439188|617637800|FG000|Overall Study|Withdrawal by Subject|2|||
170900040|NCT00413959|617637801|FG000|Overall Study|Pt had only one cycle.|1|||
170900041|NCT01459614|617637806|FG000|Overall Study|Adverse Event|1|||
170900042|NCT01459614|617637807|FG001|Overall Study|Adverse Event|0|||
170900043|NCT00630331|617637808|FG000|Overall Study|Death|2|||
170490475|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
170490476|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
170490477|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
170490478|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
170490479|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
170490480|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
170490481|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Death|0|||
170490482|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Death|1|||
170490483|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
170490484|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
170490485|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
170490486|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
170490487|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
170490488|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
170900044|NCT00630331|617637809|FG001|Overall Study|Death|1|||
170549540|NCT02134028|616356796|FG002|Overall Study|Other unspecified|33|||
170900045|NCT00630331|617637810|FG002|Overall Study|Death|1|||
170490489|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
170490490|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
170490491|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
170490492|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
170549541|NCT02134028|616356797|FG003|Overall Study|Other unspecified|64|||
170900046|NCT00630331|617637808|FG000|Overall Study|Adverse Event|1|||
170900047|NCT00630331|617637809|FG001|Overall Study|Adverse Event|0|||
170900048|NCT00630331|617637810|FG002|Overall Study|Adverse Event|0|||
170490493|NCT00394836|616138600|FG000|Teatment or Follow-up Phase|Non compliance|0|||
170490494|NCT00394836|616138601|FG001|Teatment or Follow-up Phase|Non compliance|1|||
170490495|NCT00394836|616138600|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
170490496|NCT00394836|616138601|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
170490497|NCT00394836|616138600|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
170490498|NCT00394836|616138601|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
170490499|NCT00394836|616138600|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
170490500|NCT00394836|616138601|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
170490501|NCT00394836|616138600|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
170490502|NCT00394836|616138601|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
170490503|NCT00610155|616138605|FG000|Period 1|Withdrawal by Subject|0|||
170490504|NCT00610155|616138606|FG001|Period 1|Withdrawal by Subject|0|||
170490505|NCT00610155|616138607|FG002|Period 1|Withdrawal by Subject|1|||
170490506|NCT00610155|616138608|FG003|Period 1|Withdrawal by Subject|0|||
170490507|NCT00610155|616138609|FG004|Period 1|Withdrawal by Subject|0|||
170490508|NCT00610155|616138610|FG005|Period 1|Withdrawal by Subject|0|||
170490509|NCT00610155|616138605|FG000|Period 3|Adverse Event|1|||
170490510|NCT00610155|616138606|FG001|Period 3|Adverse Event|0|||
170490511|NCT00610155|616138607|FG002|Period 3|Adverse Event|0|||
170490512|NCT00610155|616138608|FG003|Period 3|Adverse Event|0|||
170490513|NCT00610155|616138609|FG004|Period 3|Adverse Event|0|||
170490514|NCT00610155|616138610|FG005|Period 3|Adverse Event|0|||
170490515|NCT02875613|616138614|FG000|Overall Study|Withdrawal by Subject|1|||
170490516|NCT02875613|616138614|FG000|Overall Study|Screen Failure|1|||
170490517|NCT01750697|616138615|FG000|Overall Study|Transferred Back to Local Hospital|1|||
170490518|NCT01750697|616138615|FG000|Overall Study|Physician and Family Decision|1|||
170490519|NCT01750697|616138615|FG000|Overall Study|Transferred to Adult Services|5|||
170490520|NCT01750697|616138615|FG000|Overall Study|Physician Decision|1|||
170490521|NCT01750697|616138615|FG000|Overall Study|Withdrawal by Subject|1|||
170490522|NCT00267969|616138616|FG000|Controlled Period|Adverse Event|6|||
170490523|NCT00267969|616138617|FG001|Controlled Period|Adverse Event|0|||
170490524|NCT00267969|616138618|FG002|Controlled Period|Adverse Event|2|||
170900049|NCT00630331|617637808|FG000|Overall Study|Withdrawal by Subject|12|||
170900050|NCT00630331|617637809|FG001|Overall Study|Withdrawal by Subject|7|||
170900051|NCT00630331|617637810|FG002|Overall Study|Withdrawal by Subject|5|||
170900052|NCT00630331|617637808|FG000|Overall Study|Lost to Follow-up|175|||
170490525|NCT00267969|616138619|FG003|Controlled Period|Adverse Event|0|||
170490526|NCT00267969|616138620|FG004|Controlled Period|Adverse Event|0|||
170900053|NCT00630331|617637809|FG001|Overall Study|Lost to Follow-up|143|||
170900054|NCT00630331|617637810|FG002|Overall Study|Lost to Follow-up|170|||
170490527|NCT00267969|616138621|FG005|Controlled Period|Adverse Event|0|||
170490528|NCT00267969|616138622|FG006|Controlled Period|Adverse Event|0|||
170490529|NCT00267969|616138616|FG000|Controlled Period|Lack of Efficacy|3|||
170490530|NCT00267969|616138617|FG001|Controlled Period|Lack of Efficacy|0|||
170490531|NCT00267969|616138618|FG002|Controlled Period|Lack of Efficacy|1|||
170490532|NCT00267969|616138619|FG003|Controlled Period|Lack of Efficacy|0|||
170490533|NCT00267969|616138620|FG004|Controlled Period|Lack of Efficacy|0|||
170490534|NCT00267969|616138621|FG005|Controlled Period|Lack of Efficacy|0|||
170490535|NCT00267969|616138622|FG006|Controlled Period|Lack of Efficacy|0|||
170490536|NCT00267969|616138616|FG000|Controlled Period|Lost to Follow-up|1|||
170490537|NCT00267969|616138617|FG001|Controlled Period|Lost to Follow-up|0|||
170490538|NCT00267969|616138618|FG002|Controlled Period|Lost to Follow-up|1|||
170490539|NCT00267969|616138619|FG003|Controlled Period|Lost to Follow-up|0|||
170490540|NCT00267969|616138620|FG004|Controlled Period|Lost to Follow-up|0|||
170490541|NCT00267969|616138621|FG005|Controlled Period|Lost to Follow-up|0|||
170490542|NCT00267969|616138622|FG006|Controlled Period|Lost to Follow-up|0|||
170490543|NCT00267969|616138616|FG000|Controlled Period|Randomized but not treated|0|||
170900055|NCT00630331|617637808|FG000|Overall Study|Inappropriate enrollment|3|||
170490544|NCT00267969|616138617|FG001|Controlled Period|Randomized but not treated|0|||
170490545|NCT00267969|616138618|FG002|Controlled Period|Randomized but not treated|1|||
170490546|NCT00267969|616138619|FG003|Controlled Period|Randomized but not treated|0|||
170490547|NCT00267969|616138620|FG004|Controlled Period|Randomized but not treated|0|||
170490548|NCT00267969|616138621|FG005|Controlled Period|Randomized but not treated|0|||
170490549|NCT00267969|616138622|FG006|Controlled Period|Randomized but not treated|0|||
170490550|NCT00267969|616138616|FG000|Controlled Period|Other|2|||
170490551|NCT00267969|616138617|FG001|Controlled Period|Other|1|||
170490552|NCT00267969|616138618|FG002|Controlled Period|Other|6|||
170490553|NCT00267969|616138619|FG003|Controlled Period|Other|0|||
170490554|NCT00267969|616138620|FG004|Controlled Period|Other|0|||
170490555|NCT00267969|616138621|FG005|Controlled Period|Other|0|||
170490556|NCT00267969|616138622|FG006|Controlled Period|Other|0|||
170490557|NCT00267969|616138616|FG000|After Controlled Period|Adverse Event|0|||
170490558|NCT00267969|616138617|FG001|After Controlled Period|Adverse Event|0|||
170490559|NCT00267969|616138618|FG002|After Controlled Period|Adverse Event|0|||
170549542|NCT02134028|616356798|FG004|Overall Study|Other unspecified|8|||
170900056|NCT00630331|617637809|FG001|Overall Study|Inappropriate enrollment|6|||
170900057|NCT00630331|617637810|FG002|Overall Study|Inappropriate enrollment|3|||
170900058|NCT00630331|617637808|FG000|Overall Study|Unable to classify|9|||
170900059|NCT00630331|617637809|FG001|Overall Study|Unable to classify|4|||
170900060|NCT00630331|617637810|FG002|Overall Study|Unable to classify|3|||
170900061|NCT00630331|617637808|FG000|Overall Study|Protocol Violation|4|||
170900062|NCT00630331|617637809|FG001|Overall Study|Protocol Violation|5|||
170900063|NCT00630331|617637810|FG002|Overall Study|Protocol Violation|6|||
170900064|NCT01929135|617637818|FG000|Overall Study|Lost to Follow-up|1|||
170900065|NCT01929135|617637819|FG001|Overall Study|Lost to Follow-up|1|||
170900066|NCT02425098|617637820|FG000|Overall Study|Lost to Follow-up|7|||
170900067|NCT02425098|617637821|FG001|Overall Study|Lost to Follow-up|7|||
170900068|NCT02425098|617637820|FG000|Overall Study|Withdrawal by Subject|4|||
170900069|NCT02425098|617637821|FG001|Overall Study|Withdrawal by Subject|8|||
170900070|NCT02425098|617637820|FG000|Overall Study|Pregnancy|2|||
170900071|NCT02425098|617637821|FG001|Overall Study|Pregnancy|0|||
170900072|NCT02425098|617637820|FG000|Overall Study|Reason not Specified|0|||
170900073|NCT02425098|617637821|FG001|Overall Study|Reason not Specified|1|||
170900074|NCT01926626|617637822|FG000|Overall Study|Withdrawal by Subject|15|||
170900075|NCT01926626|617637822|FG000|Overall Study|Lost to Follow-up|7|||
170900076|NCT01817790|617637823|FG000|Overall Study|Adverse Event|0|||
170900077|NCT01817790|617637824|FG001|Overall Study|Adverse Event|2|||
170900078|NCT01817790|617637823|FG000|Overall Study|Lost to Follow-up|0|||
170900079|NCT01817790|617637824|FG001|Overall Study|Lost to Follow-up|1|||
170490560|NCT00267969|616138619|FG003|After Controlled Period|Adverse Event|7|||
170490561|NCT00267969|616138620|FG004|After Controlled Period|Adverse Event|8|||
170490562|NCT00267969|616138621|FG005|After Controlled Period|Adverse Event|23|||
170490563|NCT00267969|616138622|FG006|After Controlled Period|Adverse Event|21|||
170490564|NCT00267969|616138616|FG000|After Controlled Period|Death|0|||
170490565|NCT00267969|616138617|FG001|After Controlled Period|Death|0|||
170490566|NCT00267969|616138618|FG002|After Controlled Period|Death|0|||
170490567|NCT00267969|616138619|FG003|After Controlled Period|Death|1|||
170490568|NCT00267969|616138620|FG004|After Controlled Period|Death|2|||
170490569|NCT00267969|616138621|FG005|After Controlled Period|Death|0|||
170490570|NCT00267969|616138622|FG006|After Controlled Period|Death|1|||
170900080|NCT01817790|617637823|FG000|Overall Study|Protocol Violation|2|||
170900081|NCT01817790|617637824|FG001|Overall Study|Protocol Violation|1|||
170900082|NCT01817790|617637823|FG000|Overall Study|Withdrawal by Subject|1|||
170900083|NCT01817790|617637824|FG001|Overall Study|Withdrawal by Subject|3|||
170900084|NCT01817790|617637823|FG000|Overall Study|Other: Could not attend appointment|1|||
170900085|NCT01817790|617637824|FG001|Overall Study|Other: Could not attend appointment|1|||
170900086|NCT01671345|617637825|FG000|Overall Study|Lost to Follow-up|10|||
170900087|NCT01671345|617637826|FG001|Overall Study|Lost to Follow-up|6|||
170900088|NCT01671345|617637825|FG000|Overall Study|visit with non-participating physician|3|||
170900089|NCT01671345|617637826|FG001|Overall Study|visit with non-participating physician|3|||
170900090|NCT03636906|617637829|FG000|Overall Study|Adverse Event|0|||
170900091|NCT03636906|617637830|FG001|Overall Study|Adverse Event|0|||
170490571|NCT00267969|616138616|FG000|After Controlled Period|Lack of Efficacy|0|||
170490572|NCT00267969|616138617|FG001|After Controlled Period|Lack of Efficacy|0|||
170490573|NCT00267969|616138618|FG002|After Controlled Period|Lack of Efficacy|0|||
170490574|NCT00267969|616138619|FG003|After Controlled Period|Lack of Efficacy|10|||
170490575|NCT00267969|616138620|FG004|After Controlled Period|Lack of Efficacy|6|||
170490576|NCT00267969|616138621|FG005|After Controlled Period|Lack of Efficacy|28|||
170490577|NCT00267969|616138622|FG006|After Controlled Period|Lack of Efficacy|15|||
170490578|NCT00267969|616138616|FG000|After Controlled Period|Lost to Follow-up|0|||
170549543|NCT02134028|616356799|FG005|Overall Study|Other unspecified|6|||
170549544|NCT02134028|616356800|FG006|Overall Study|Other unspecified|2|||
170549545|NCT02134028|616356801|FG007|Overall Study|Other unspecified|1|||
170549546|NCT02134028|616356794|FG000|Overall Study|Adverse Event|3|||
170549547|NCT02134028|616356795|FG001|Overall Study|Adverse Event|19|||
170549548|NCT02134028|616356796|FG002|Overall Study|Adverse Event|13|||
170549549|NCT02134028|616356797|FG003|Overall Study|Adverse Event|32|||
170549550|NCT02134028|616356798|FG004|Overall Study|Adverse Event|4|||
170549551|NCT02134028|616356799|FG005|Overall Study|Adverse Event|5|||
170549552|NCT02134028|616356800|FG006|Overall Study|Adverse Event|1|||
170549553|NCT02134028|616356801|FG007|Overall Study|Adverse Event|2|||
170549554|NCT01210443|616356802|FG000|Overall Study|Study terminated by sponsor|2|||
170549555|NCT02829957|616356805|FG000|Overall Study|Lost to Follow-up|2|||
170549556|NCT02829957|616356806|FG001|Overall Study|Lost to Follow-up|1|||
170549557|NCT04913675|616356808|FG000|Main Study (Up to Week 36)|Death|0|||
170549558|NCT04913675|616356809|FG001|Main Study (Up to Week 36)|Death|2|||
170549559|NCT04913675|616356810|FG002|Main Study (Up to Week 36)|Death|2|||
170549560|NCT04913675|616356811|FG003|Main Study (Up to Week 36)|Death|0|||
170549561|NCT04913675|616356808|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
170549562|NCT04913675|616356809|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
170900092|NCT03636906|617637831|FG002|Overall Study|Adverse Event|1|||
170640708|NCT01667419|616696978|FG000|Overall Study|Protocol Violation|1|||
170900093|NCT03636906|617637829|FG000|Overall Study|Lost to Follow-up|1|||
170900094|NCT03636906|617637830|FG001|Overall Study|Lost to Follow-up|0|||
170900095|NCT03636906|617637831|FG002|Overall Study|Lost to Follow-up|0|||
170490579|NCT00267969|616138617|FG001|After Controlled Period|Lost to Follow-up|0|||
170490580|NCT00267969|616138618|FG002|After Controlled Period|Lost to Follow-up|0|||
170490581|NCT00267969|616138619|FG003|After Controlled Period|Lost to Follow-up|5|||
170490582|NCT00267969|616138620|FG004|After Controlled Period|Lost to Follow-up|8|||
170490583|NCT00267969|616138621|FG005|After Controlled Period|Lost to Follow-up|9|||
170490584|NCT00267969|616138622|FG006|After Controlled Period|Lost to Follow-up|10|||
170490585|NCT00267969|616138616|FG000|After Controlled Period|Other|0|||
170490586|NCT00267969|616138617|FG001|After Controlled Period|Other|0|||
170490587|NCT00267969|616138618|FG002|After Controlled Period|Other|0|||
170490588|NCT00267969|616138619|FG003|After Controlled Period|Other|13|||
170490589|NCT00267969|616138620|FG004|After Controlled Period|Other|11|||
170490590|NCT00267969|616138621|FG005|After Controlled Period|Other|22|||
170490591|NCT00267969|616138622|FG006|After Controlled Period|Other|25|||
170490592|NCT04075682|616138623|FG000|Overall Study|Lost to Follow-up|5|||
170490593|NCT04075682|616138624|FG001|Overall Study|Lost to Follow-up|5|||
170490594|NCT04075682|616138625|FG002|Overall Study|Lost to Follow-up|2|||
170490595|NCT04075682|616138626|FG003|Overall Study|Lost to Follow-up|2|||
170490596|NCT04075682|616138623|FG000|Overall Study|Withdrawal by Subject|1|||
170490597|NCT04075682|616138624|FG001|Overall Study|Withdrawal by Subject|0|||
170490598|NCT04075682|616138625|FG002|Overall Study|Withdrawal by Subject|1|||
170490599|NCT04075682|616138626|FG003|Overall Study|Withdrawal by Subject|0|||
170490600|NCT04075682|616138623|FG000|Overall Study|Protocol Violation|0|||
170490601|NCT04075682|616138624|FG001|Overall Study|Protocol Violation|1|||
170490602|NCT04075682|616138625|FG002|Overall Study|Protocol Violation|1|||
170490603|NCT04075682|616138626|FG003|Overall Study|Protocol Violation|0|||
170490604|NCT04075682|616138623|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
170490605|NCT04075682|616138624|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
170490606|NCT04075682|616138625|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
170490607|NCT04075682|616138626|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
170490608|NCT04075682|616138623|FG000|Overall Study|Lost study phone the first day of study participation|0|||
170490609|NCT04075682|616138624|FG001|Overall Study|Lost study phone the first day of study participation|1|||
170490610|NCT04075682|616138625|FG002|Overall Study|Lost study phone the first day of study participation|0|||
170490611|NCT04075682|616138626|FG003|Overall Study|Lost study phone the first day of study participation|0|||
170490612|NCT00862823|616138629|FG000|First Intervention|Withdrawal by Subject|1|||
170490613|NCT00862823|616138630|FG001|First Intervention|Withdrawal by Subject|1|||
170490614|NCT02714595|616138634|FG000|Overall Study|Lost to Follow-up|1|||
170490615|NCT02714595|616138635|FG001|Overall Study|Lost to Follow-up|0|||
170490616|NCT02714595|616138634|FG000|Overall Study|Withdrawal by Subject|1|||
170490617|NCT02714595|616138635|FG001|Overall Study|Withdrawal by Subject|2|||
170490618|NCT02714595|616138634|FG000|Overall Study|Lack of Efficacy|0|||
170490619|NCT02714595|616138635|FG001|Overall Study|Lack of Efficacy|1|||
170490620|NCT02714595|616138634|FG000|Overall Study|Death|30|||
170800448|NCT03248492|617281047|FG001|Overall Study|Progressive Disease|23|||
170490621|NCT02714595|616138635|FG001|Overall Study|Death|9|||
170490622|NCT02714595|616138634|FG000|Overall Study|Other-Miscellaneous|0|||
170490623|NCT02714595|616138635|FG001|Overall Study|Other-Miscellaneous|1|||
170490624|NCT00954941|616138636|FG000|Overall Study|Received treatment at home|1|||
170490625|NCT00954941|616138637|FG001|Overall Study|Received treatment at home|0|||
170490626|NCT00954941|616138636|FG000|Overall Study|Withdrawal by Subject|1|||
170490627|NCT00954941|616138637|FG001|Overall Study|Withdrawal by Subject|0|||
170490628|NCT00954941|616138636|FG000|Overall Study|Insurance Denial|2|||
170490629|NCT00954941|616138637|FG001|Overall Study|Insurance Denial|2|||
170490630|NCT00954941|616138636|FG000|Overall Study|Physician Decision|2|||
170490631|NCT00954941|616138637|FG001|Overall Study|Physician Decision|2|||
170490632|NCT00954941|616138636|FG000|Overall Study|Ineligible|2|||
170490633|NCT00954941|616138637|FG001|Overall Study|Ineligible|2|||
170490634|NCT00954941|616138636|FG000|Overall Study|Adverse Event|0|||
170640709|NCT01667419|616696979|FG001|Overall Study|Protocol Violation|0|||
170800449|NCT03248492|617281048|FG002|Overall Study|Progressive Disease|11|||
170800450|NCT03248492|617281049|FG003|Overall Study|Progressive Disease|66|||
170800451|NCT03248492|617281050|FG004|Overall Study|Progressive Disease|1|||
170800452|NCT03248492|617281046|FG000|Overall Study|Adverse Event|14|||
170800453|NCT03248492|617281047|FG001|Overall Study|Adverse Event|13|||
170800454|NCT03248492|617281048|FG002|Overall Study|Adverse Event|9|||
170490635|NCT00954941|616138637|FG001|Overall Study|Adverse Event|1|||
170490636|NCT01996254|616138638|FG000|Overall Study|Change in Eligibility|0|||
170490637|NCT01996254|616138639|FG001|Overall Study|Change in Eligibility|2|||
170490638|NCT01996254|616138640|FG002|Overall Study|Change in Eligibility|0|||
170800455|NCT03248492|617281049|FG003|Overall Study|Adverse Event|22|||
170490639|NCT01996254|616138638|FG000|Overall Study|Withdrawal by Subject|0|||
170490640|NCT01996254|616138639|FG001|Overall Study|Withdrawal by Subject|3|||
170490641|NCT01996254|616138640|FG002|Overall Study|Withdrawal by Subject|4|||
170490642|NCT01996254|616138638|FG000|Overall Study|Lost to Follow-up|1|||
170490643|NCT01996254|616138639|FG001|Overall Study|Lost to Follow-up|0|||
170490644|NCT01996254|616138640|FG002|Overall Study|Lost to Follow-up|4|||
170490645|NCT03423173|616138641|FG000|Overall Study|Randomized but not vaccinated|1|||
170900096|NCT03636906|617637829|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
170900097|NCT03636906|617637830|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
170900098|NCT03636906|617637831|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
170900099|NCT03636906|617637829|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
170900100|NCT03636906|617637830|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170490646|NCT03423173|616138642|FG001|Overall Study|Randomized but not vaccinated|0|||
170490647|NCT03423173|616138643|FG002|Overall Study|Randomized but not vaccinated|2|||
170490648|NCT03423173|616138644|FG003|Overall Study|Randomized but not vaccinated|1|||
170490649|NCT03423173|616138641|FG000|Overall Study|Adverse Event|1|||
170490650|NCT03423173|616138642|FG001|Overall Study|Adverse Event|1|||
170490651|NCT03423173|616138643|FG002|Overall Study|Adverse Event|1|||
170490652|NCT03423173|616138644|FG003|Overall Study|Adverse Event|1|||
170490653|NCT03423173|616138641|FG000|Overall Study|Lost to Follow-up|10|||
170490654|NCT03423173|616138642|FG001|Overall Study|Lost to Follow-up|19|||
170490655|NCT03423173|616138643|FG002|Overall Study|Lost to Follow-up|17|||
170490656|NCT03423173|616138644|FG003|Overall Study|Lost to Follow-up|22|||
170490657|NCT03423173|616138641|FG000|Overall Study|Withdrawal of consent|4|||
170490658|NCT03423173|616138642|FG001|Overall Study|Withdrawal of consent|10|||
170490659|NCT03423173|616138643|FG002|Overall Study|Withdrawal of consent|4|||
170490660|NCT03423173|616138644|FG003|Overall Study|Withdrawal of consent|5|||
170490661|NCT03423173|616138641|FG000|Overall Study|Death|1|||
170490662|NCT03423173|616138642|FG001|Overall Study|Death|0|||
170490663|NCT03423173|616138643|FG002|Overall Study|Death|0|||
170490664|NCT03423173|616138644|FG003|Overall Study|Death|0|||
170490665|NCT03423173|616138641|FG000|Overall Study|Reason not Specified|2|||
170490666|NCT03423173|616138642|FG001|Overall Study|Reason not Specified|5|||
170490667|NCT03423173|616138643|FG002|Overall Study|Reason not Specified|3|||
170490668|NCT03423173|616138644|FG003|Overall Study|Reason not Specified|1|||
170490669|NCT02199795|616138647|FG000|Overall Study|no longer met inclusion criteria|1|||
170490670|NCT02199795|616138648|FG001|Overall Study|no longer met inclusion criteria|0|||
170490671|NCT02199795|616138647|FG000|Overall Study|withdrew due to shoulder pain|1|||
170490672|NCT02199795|616138648|FG001|Overall Study|withdrew due to shoulder pain|0|||
170490673|NCT02411396|616138652|FG000|Overall Study|Lost to Follow-up|31|||
170490674|NCT02411396|616138652|FG000|Overall Study|Death|10|||
170490675|NCT02016105|616138659|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
170490676|NCT02016105|616138660|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
170490677|NCT02016105|616138661|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
170490678|NCT02016105|616138662|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
170490679|NCT02016105|616138663|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
170490680|NCT02016105|616138664|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
170490681|NCT02016105|616138659|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
170490682|NCT02016105|616138660|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
170490683|NCT02016105|616138661|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
170490684|NCT02016105|616138662|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
170490685|NCT02016105|616138663|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
170490686|NCT02016105|616138664|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
170490687|NCT02016105|616138659|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
170490688|NCT02016105|616138660|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
170490689|NCT02016105|616138661|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
170490690|NCT02016105|616138662|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
170490691|NCT02016105|616138663|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
170900101|NCT03636906|617637831|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
170900102|NCT03636906|617637829|FG000|Overall Study|Other|0|||
170900103|NCT03636906|617637830|FG001|Overall Study|Other|0|||
170900104|NCT03636906|617637831|FG002|Overall Study|Other|1|||
170900105|NCT02847598|617637835|FG000|Overall Study|Adverse Event|0|||
170490692|NCT02016105|616138664|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
170490693|NCT02016105|616138659|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
170490694|NCT02016105|616138660|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
170490695|NCT02016105|616138661|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
170490696|NCT02016105|616138662|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
170490697|NCT02016105|616138663|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
170490698|NCT02016105|616138664|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
170490699|NCT02016105|616138659|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
170490700|NCT02016105|616138660|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
170490701|NCT02016105|616138661|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
170490702|NCT02016105|616138662|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
170490703|NCT02016105|616138663|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
170490704|NCT02016105|616138664|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
170490705|NCT02016105|616138659|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
170490706|NCT02016105|616138660|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
170490707|NCT02016105|616138661|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
170490708|NCT02016105|616138662|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
170490709|NCT02016105|616138663|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
170490710|NCT02016105|616138664|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
170490711|NCT02016105|616138659|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
170490712|NCT02016105|616138660|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
170490713|NCT02016105|616138661|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
170490714|NCT02016105|616138662|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
170490715|NCT02016105|616138663|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
170490716|NCT02016105|616138664|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
170490717|NCT02016105|616138659|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
170490718|NCT02016105|616138660|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
170490719|NCT02016105|616138661|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
170490720|NCT02016105|616138662|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
170490721|NCT02016105|616138663|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
170490722|NCT02016105|616138664|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
170490723|NCT02016105|616138659|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
170490724|NCT02016105|616138660|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
170490725|NCT02016105|616138661|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
170490726|NCT02016105|616138662|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
170490727|NCT02016105|616138663|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
170490728|NCT02016105|616138664|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
170490729|NCT02016105|616138659|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
170490730|NCT02016105|616138660|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
170490731|NCT02016105|616138661|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
170490732|NCT02016105|616138662|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
170490733|NCT02016105|616138663|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
170490734|NCT02016105|616138664|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
170490735|NCT02016105|616138659|FG000|TREATMENT PERIOD 2|Death|0|||
170490736|NCT02016105|616138660|FG001|TREATMENT PERIOD 2|Death|0|||
170490737|NCT02016105|616138661|FG002|TREATMENT PERIOD 2|Death|0|||
170490738|NCT02016105|616138662|FG003|TREATMENT PERIOD 2|Death|0|||
170490739|NCT02016105|616138663|FG004|TREATMENT PERIOD 2|Death|0|||
170490740|NCT02016105|616138664|FG005|TREATMENT PERIOD 2|Death|1|||
170490741|NCT02016105|616138659|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
170490742|NCT02016105|616138660|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
170490743|NCT02016105|616138661|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
170490744|NCT02016105|616138662|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
170490745|NCT02016105|616138663|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
170490746|NCT02016105|616138664|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
170490747|NCT02016105|616138659|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
170490748|NCT02016105|616138660|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
170490749|NCT02016105|616138661|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
170490750|NCT02016105|616138662|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
170490751|NCT02016105|616138663|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
170490752|NCT02016105|616138664|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
170490753|NCT02016105|616138659|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
170490754|NCT02016105|616138660|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
170490755|NCT02016105|616138661|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
170490756|NCT02016105|616138662|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
170490757|NCT02016105|616138663|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
170800456|NCT03248492|617281050|FG004|Overall Study|Adverse Event|2|||
170490758|NCT02016105|616138664|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
170490759|NCT02016105|616138659|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
170490760|NCT02016105|616138660|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
170490761|NCT02016105|616138661|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
170490762|NCT02016105|616138662|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
170490763|NCT02016105|616138663|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
170490764|NCT02016105|616138664|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
170490765|NCT02016105|616138659|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
170490766|NCT02016105|616138660|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
170490767|NCT02016105|616138661|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
170490768|NCT02016105|616138662|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
170490769|NCT02016105|616138663|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
170490770|NCT02016105|616138664|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
170490771|NCT02016105|616138659|FG000|EXTENSION PERIOD|Adverse Event|0|||
170490772|NCT02016105|616138660|FG001|EXTENSION PERIOD|Adverse Event|0|||
170490773|NCT02016105|616138661|FG002|EXTENSION PERIOD|Adverse Event|2|||
170490774|NCT02016105|616138662|FG003|EXTENSION PERIOD|Adverse Event|0|||
170490775|NCT02016105|616138663|FG004|EXTENSION PERIOD|Adverse Event|1|||
170490776|NCT02016105|616138664|FG005|EXTENSION PERIOD|Adverse Event|0|||
170490777|NCT02016105|616138659|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
170490778|NCT02016105|616138660|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
170490779|NCT02016105|616138661|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
170800457|NCT03248492|617281046|FG000|Overall Study|Withdrawal by Subject|5|||
170800458|NCT03248492|617281047|FG001|Overall Study|Withdrawal by Subject|4|||
170800459|NCT03248492|617281048|FG002|Overall Study|Withdrawal by Subject|0|||
170800460|NCT03248492|617281049|FG003|Overall Study|Withdrawal by Subject|8|||
170490780|NCT02016105|616138662|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
170800461|NCT03248492|617281050|FG004|Overall Study|Withdrawal by Subject|1|||
170490781|NCT02016105|616138663|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
170490782|NCT02016105|616138664|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
170490783|NCT02016105|616138659|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
170490784|NCT02016105|616138660|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
170490785|NCT02016105|616138661|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
170490786|NCT02016105|616138662|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
170490787|NCT02016105|616138663|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
170490788|NCT02016105|616138664|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
170490789|NCT02016105|616138659|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
170490790|NCT02016105|616138660|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
170490791|NCT02016105|616138661|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
170490792|NCT02016105|616138662|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
170490793|NCT02016105|616138663|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
170490794|NCT02016105|616138664|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
170490795|NCT00090493|616138665|FG000|Overall Study|Physician Decision|2|||
170490796|NCT01908829|616138666|FG000|Overall Study|Adverse Event|13|||
170490797|NCT01908829|616138667|FG001|Overall Study|Adverse Event|11|||
170490798|NCT01908829|616138668|FG002|Overall Study|Adverse Event|13|||
170490799|NCT01908829|616138666|FG000|Overall Study|Lost to Follow-up|4|||
170490800|NCT01908829|616138667|FG001|Overall Study|Lost to Follow-up|2|||
170490801|NCT01908829|616138668|FG002|Overall Study|Lost to Follow-up|1|||
170490802|NCT01908829|616138666|FG000|Overall Study|Randomized no double-blind drug received|1|||
170490803|NCT01908829|616138667|FG001|Overall Study|Randomized no double-blind drug received|0|||
170490804|NCT01908829|616138668|FG002|Overall Study|Randomized no double-blind drug received|1|||
170490805|NCT01908829|616138666|FG000|Overall Study|Discontinued (no EoT page)|2|||
170490806|NCT01908829|616138667|FG001|Overall Study|Discontinued (no EoT page)|0|||
170490807|NCT01908829|616138668|FG002|Overall Study|Discontinued (no EoT page)|0|||
170490808|NCT01908829|616138666|FG000|Overall Study|Miscellaneous|0|||
170490809|NCT01908829|616138667|FG001|Overall Study|Miscellaneous|2|||
170490810|NCT01908829|616138668|FG002|Overall Study|Miscellaneous|0|||
170490811|NCT01908829|616138666|FG000|Overall Study|Protocol Violation|2|||
170490812|NCT01908829|616138667|FG001|Overall Study|Protocol Violation|2|||
170490813|NCT01908829|616138668|FG002|Overall Study|Protocol Violation|0|||
170490814|NCT01908829|616138666|FG000|Overall Study|Lack of Efficacy|1|||
170490815|NCT01908829|616138667|FG001|Overall Study|Lack of Efficacy|3|||
170490816|NCT01908829|616138668|FG002|Overall Study|Lack of Efficacy|2|||
170490817|NCT01908829|616138666|FG000|Overall Study|Withdrawal by Subject|26|||
170490818|NCT01908829|616138667|FG001|Overall Study|Withdrawal by Subject|29|||
170490819|NCT01908829|616138668|FG002|Overall Study|Withdrawal by Subject|22|||
170490820|NCT02865499|616138669|FG000|Baseline|Adverse Event|1|||
170490821|NCT02865499|616138669|FG000|Baseline|Withdrawal by Subject|1|||
170490822|NCT01855243|616138670|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
170490823|NCT01855243|616138671|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
170490824|NCT01855243|616138672|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
170490825|NCT03615144|616138673|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
170490826|NCT03615144|616138674|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
170490827|NCT04791319|616138677|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
170490828|NCT04791319|616138678|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
170490829|NCT04791319|616138679|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
170490830|NCT04791319|616138680|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
170490831|NCT04791319|616138681|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
170490832|NCT04791319|616138682|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
170490833|NCT04791319|616138683|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
170490834|NCT04791319|616138684|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
170490835|NCT04791319|616138685|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
170490836|NCT04791319|616138686|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
170490837|NCT04791319|616138687|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
170490838|NCT04791319|616138677|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
170490839|NCT04791319|616138678|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
170490840|NCT04791319|616138679|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
170490841|NCT04791319|616138680|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
170490842|NCT04791319|616138681|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
170800462|NCT03248492|617281046|FG000|Overall Study|Physician Decision|1|||
170490843|NCT04791319|616138682|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
170490844|NCT04791319|616138683|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
170490845|NCT04791319|616138684|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
170490846|NCT04791319|616138685|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
170490847|NCT04791319|616138686|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
170490848|NCT04791319|616138687|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
170640710|NCT01667419|616696980|FG002|Overall Study|Protocol Violation|0|||
170800463|NCT03248492|617281047|FG001|Overall Study|Physician Decision|1|||
170800464|NCT03248492|617281048|FG002|Overall Study|Physician Decision|1|||
170490849|NCT04791319|616138677|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
170490850|NCT04791319|616138678|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
170490851|NCT04791319|616138679|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
170490852|NCT04791319|616138680|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
170490853|NCT04791319|616138681|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
170490854|NCT04791319|616138682|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
170490855|NCT04791319|616138683|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
170490856|NCT04791319|616138684|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
170490857|NCT04791319|616138685|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
170490858|NCT04791319|616138686|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
170490859|NCT04791319|616138687|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
170490860|NCT04791319|616138677|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
170490861|NCT04791319|616138678|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
170490862|NCT04791319|616138679|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
170490863|NCT04791319|616138680|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
170490864|NCT04791319|616138681|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
170490865|NCT04791319|616138682|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
170490866|NCT04791319|616138683|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
170490867|NCT04791319|616138684|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
170490868|NCT04791319|616138685|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
170490869|NCT04791319|616138686|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
170490870|NCT04791319|616138687|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
170490871|NCT04791319|616138677|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490872|NCT04791319|616138678|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490873|NCT04791319|616138679|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490874|NCT04791319|616138680|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
170490875|NCT04791319|616138681|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490876|NCT04791319|616138682|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490877|NCT04791319|616138683|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490878|NCT04791319|616138684|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490879|NCT04791319|616138685|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490880|NCT04791319|616138686|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490881|NCT04791319|616138687|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
170490882|NCT04791319|616138677|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
170490883|NCT04791319|616138678|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
170490884|NCT04791319|616138679|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
170490885|NCT04791319|616138680|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
170490886|NCT04791319|616138681|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
170490887|NCT04791319|616138682|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
170490888|NCT04791319|616138683|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
170490889|NCT04791319|616138684|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
170490890|NCT04791319|616138685|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
170490891|NCT04791319|616138686|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
170490892|NCT04791319|616138687|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
170490893|NCT04791319|616138677|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490894|NCT04791319|616138678|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490895|NCT04791319|616138679|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490896|NCT04791319|616138680|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490897|NCT04791319|616138681|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490898|NCT04791319|616138682|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490899|NCT04791319|616138683|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490900|NCT04791319|616138684|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490901|NCT04791319|616138685|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490902|NCT04791319|616138686|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
170490903|NCT04791319|616138687|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
170490904|NCT04791319|616138677|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
170490905|NCT04791319|616138678|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
170490906|NCT04791319|616138679|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
170490907|NCT04791319|616138680|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
170490908|NCT04791319|616138681|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
170490909|NCT04791319|616138682|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
170549563|NCT04913675|616356810|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
170549564|NCT04913675|616356811|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
170549565|NCT04913675|616356808|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
170549566|NCT04913675|616356809|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
170549567|NCT04913675|616356810|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
170549568|NCT04913675|616356811|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
170549569|NCT04913675|616356808|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
170549570|NCT04913675|616356809|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
170549571|NCT04913675|616356810|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
170549572|NCT04913675|616356811|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
170549573|NCT04913675|616356808|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
170549574|NCT04913675|616356809|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
170549575|NCT04913675|616356810|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
170640711|NCT01667419|616696981|FG003|Overall Study|Protocol Violation|0|||
170640712|NCT01667419|616696978|FG000|Overall Study|Lost to Follow-up|7|||
170640713|NCT01667419|616696979|FG001|Overall Study|Lost to Follow-up|6|||
170640714|NCT01667419|616696980|FG002|Overall Study|Lost to Follow-up|2|||
170640715|NCT01667419|616696981|FG003|Overall Study|Lost to Follow-up|4|||
170640716|NCT01667419|616696978|FG000|Overall Study|Death|18|||
170640717|NCT01667419|616696979|FG001|Overall Study|Death|33|||
170640718|NCT01667419|616696980|FG002|Overall Study|Death|25|||
170640719|NCT01667419|616696981|FG003|Overall Study|Death|26|||
170640720|NCT05061823|616696982|FG000|Overall Study|Death|1|||
170640721|NCT05061823|616696983|FG001|Overall Study|Death|2|||
170640722|NCT05061823|616696984|FG002|Overall Study|Death|1|||
170640723|NCT05061823|616696985|FG003|Overall Study|Death|2|||
170640724|NCT05061823|616696982|FG000|Overall Study|End Of Study Due To Suspension Of Drug Supply|2|||
170640725|NCT05061823|616696983|FG001|Overall Study|End Of Study Due To Suspension Of Drug Supply|0|||
170640726|NCT05061823|616696984|FG002|Overall Study|End Of Study Due To Suspension Of Drug Supply|0|||
170640727|NCT05061823|616696985|FG003|Overall Study|End Of Study Due To Suspension Of Drug Supply|0|||
170640728|NCT05061823|616696982|FG000|Overall Study|Stop By Sponsor|2|||
170640729|NCT05061823|616696983|FG001|Overall Study|Stop By Sponsor|0|||
170640730|NCT05061823|616696984|FG002|Overall Study|Stop By Sponsor|0|||
170640731|NCT05061823|616696985|FG003|Overall Study|Stop By Sponsor|1|||
170640732|NCT05061823|616696982|FG000|Overall Study|Poor protocol compliance led to sponsor-requested study withdrawal|1|||
170640733|NCT05061823|616696983|FG001|Overall Study|Poor protocol compliance led to sponsor-requested study withdrawal|0|||
170640734|NCT05061823|616696984|FG002|Overall Study|Poor protocol compliance led to sponsor-requested study withdrawal|0|||
170640735|NCT05061823|616696985|FG003|Overall Study|Poor protocol compliance led to sponsor-requested study withdrawal|0|||
170640736|NCT01092117|616696986|FG000|Index Procedure to 1 Month|Death|1|||
170640737|NCT01092117|616696986|FG000|1 Month|Death|1|||
170640738|NCT01092117|616696986|FG000|1 Month|Withdrawal by Subject|1|||
170640739|NCT01092117|616696986|FG000|1 Month|Lost to Follow-up|1|||
170640740|NCT01092117|616696986|FG000|6 Months|Death|2|||
170640741|NCT01092117|616696986|FG000|6 Months|Withdrawal by Subject|3|||
170640742|NCT01092117|616696986|FG000|12 Month|Death|11|||
170640743|NCT01092117|616696986|FG000|12 Month|Withdrawal by Subject|2|||
170640744|NCT01092117|616696986|FG000|12 Month|Lost to Follow-up|1|||
170640745|NCT01092117|616696986|FG000|Year 2|Death|5|||
170640746|NCT01092117|616696986|FG000|Year 2|Withdrawal by Subject|4|||
170640747|NCT01092117|616696986|FG000|Year 2|Lost to Follow-up|1|||
170640748|NCT01092117|616696986|FG000|Year 3|Death|7|||
170640749|NCT01092117|616696986|FG000|Year 3|Withdrawal by Subject|9|||
170640750|NCT01092117|616696986|FG000|Year 3|Lost to Follow-up|3|||
170640751|NCT01092117|616696986|FG000|Year 4|Death|8|||
170640752|NCT01092117|616696986|FG000|Year 4|Withdrawal by Subject|4|||
170640753|NCT01092117|616696986|FG000|Year 4|Lost to Follow-up|4|||
170640754|NCT04036396|616696990|FG000|Overall Study|Withdrawal by Subject|3|||
170800465|NCT03248492|617281049|FG003|Overall Study|Physician Decision|7|||
170800466|NCT03248492|617281050|FG004|Overall Study|Physician Decision|0|||
170549576|NCT04913675|616356811|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
170549577|NCT01541254|616356815|FG000|Overall Study|Withdrawal by Subject|1|||
170640755|NCT04036396|616696991|FG001|Overall Study|Withdrawal by Subject|3|||
170640756|NCT04036396|616696990|FG000|Overall Study|Death|2|||
170640757|NCT04036396|616696991|FG001|Overall Study|Death|2|||
170640758|NCT04036396|616696990|FG000|Overall Study|Lost to Follow-up|12|||
170640759|NCT04036396|616696991|FG001|Overall Study|Lost to Follow-up|14|||
170640760|NCT04036396|616696990|FG000|Overall Study|Determined ineligible after enrollment|14|||
170640761|NCT04036396|616696991|FG001|Overall Study|Determined ineligible after enrollment|10|||
170549578|NCT01541254|616356815|FG000|Overall Study|excluded - metal allergy|1|||
170640762|NCT03742102|616696993|FG000|Overall Study|Death|14|||
170640763|NCT03742102|616696994|FG001|Overall Study|Death|17|||
170640764|NCT03742102|616696995|FG002|Overall Study|Death|25|||
170800467|NCT03248492|617281046|FG000|Overall Study|Death|1|||
170549579|NCT01541254|616356815|FG000|Overall Study|enrolled after study closed|1|||
170640765|NCT03742102|616696996|FG003|Overall Study|Death|22|||
170640766|NCT03742102|616696997|FG004|Overall Study|Death|28|||
170640767|NCT03742102|616696998|FG005|Overall Study|Death|3|||
170490910|NCT04791319|616138683|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
170490911|NCT04791319|616138684|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
170490912|NCT04791319|616138685|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
170490913|NCT04791319|616138686|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
170490914|NCT04791319|616138687|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
170490915|NCT04791319|616138677|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
170490916|NCT04791319|616138678|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
170490917|NCT04791319|616138679|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
170490918|NCT04791319|616138680|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
170490919|NCT04791319|616138681|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
170490920|NCT04791319|616138682|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
170490921|NCT04791319|616138683|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
170490922|NCT04791319|616138684|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
170490923|NCT04791319|616138685|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
170490924|NCT04791319|616138686|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
170490925|NCT04791319|616138687|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
170490926|NCT02587598|616138688|FG000|Overall Study|Death|4|||
170490927|NCT02587598|616138689|FG001|Overall Study|Death|8|||
170490928|NCT02587598|616138690|FG002|Overall Study|Death|4|||
170490929|NCT02587598|616138691|FG003|Overall Study|Death|16|||
170490930|NCT02587598|616138692|FG004|Overall Study|Death|9|||
170490931|NCT02587598|616138693|FG005|Overall Study|Death|4|||
170490932|NCT02587598|616138694|FG006|Overall Study|Death|6|||
170490933|NCT02587598|616138695|FG007|Overall Study|Death|7|||
170490934|NCT02587598|616138696|FG008|Overall Study|Death|9|||
170490935|NCT02587598|616138697|FG009|Overall Study|Death|1|||
170490936|NCT02587598|616138698|FG010|Overall Study|Death|3|||
170490937|NCT02587598|616138688|FG000|Overall Study|Study Terminated by the Sponsor|0|||
170490938|NCT02587598|616138689|FG001|Overall Study|Study Terminated by the Sponsor|1|||
170490939|NCT02587598|616138690|FG002|Overall Study|Study Terminated by the Sponsor|0|||
170490940|NCT02587598|616138691|FG003|Overall Study|Study Terminated by the Sponsor|3|||
170490941|NCT02587598|616138692|FG004|Overall Study|Study Terminated by the Sponsor|0|||
170490942|NCT02587598|616138693|FG005|Overall Study|Study Terminated by the Sponsor|1|||
170490943|NCT02587598|616138694|FG006|Overall Study|Study Terminated by the Sponsor|0|||
170490944|NCT02587598|616138695|FG007|Overall Study|Study Terminated by the Sponsor|0|||
170490945|NCT02587598|616138696|FG008|Overall Study|Study Terminated by the Sponsor|0|||
170490946|NCT02587598|616138697|FG009|Overall Study|Study Terminated by the Sponsor|1|||
170490947|NCT02587598|616138698|FG010|Overall Study|Study Terminated by the Sponsor|6|||
170490948|NCT02587598|616138688|FG000|Overall Study|Reason for study withdrawal not specified|0|||
170490949|NCT02587598|616138689|FG001|Overall Study|Reason for study withdrawal not specified|1|||
170490950|NCT02587598|616138690|FG002|Overall Study|Reason for study withdrawal not specified|0|||
170490951|NCT02587598|616138691|FG003|Overall Study|Reason for study withdrawal not specified|0|||
170490952|NCT02587598|616138692|FG004|Overall Study|Reason for study withdrawal not specified|0|||
170490953|NCT02587598|616138693|FG005|Overall Study|Reason for study withdrawal not specified|0|||
170490954|NCT02587598|616138694|FG006|Overall Study|Reason for study withdrawal not specified|0|||
170490955|NCT02587598|616138695|FG007|Overall Study|Reason for study withdrawal not specified|0|||
170490956|NCT02587598|616138696|FG008|Overall Study|Reason for study withdrawal not specified|0|||
170490957|NCT02587598|616138697|FG009|Overall Study|Reason for study withdrawal not specified|0|||
170490958|NCT02587598|616138698|FG010|Overall Study|Reason for study withdrawal not specified|0|||
170490959|NCT02587598|616138688|FG000|Overall Study|Withdrawal by Subject|0|||
170490960|NCT02587598|616138689|FG001|Overall Study|Withdrawal by Subject|1|||
170490961|NCT02587598|616138690|FG002|Overall Study|Withdrawal by Subject|0|||
170549580|NCT01541254|616356815|FG000|Overall Study|GI bleed prior to procedure|1|||
170549581|NCT01541254|616356815|FG000|Overall Study|stent not required|1|||
170549582|NCT01541254|616356815|FG000|Overall Study|alternate stent used|1|||
170549583|NCT05660538|616356816|FG000|Overall Study|Adverse Event|0|||
170549584|NCT05660538|616356817|FG001|Overall Study|Adverse Event|0|||
170549585|NCT05660538|616356818|FG002|Overall Study|Adverse Event|1|||
170549586|NCT05660538|616356819|FG003|Overall Study|Adverse Event|0|||
170549587|NCT05660538|616356816|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
170549588|NCT05660538|616356817|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
170490962|NCT02587598|616138691|FG003|Overall Study|Withdrawal by Subject|2|||
170549589|NCT05660538|616356818|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
170549590|NCT05660538|616356819|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
170549591|NCT05660538|616356816|FG000|Overall Study|Lost to Follow-up|0|||
170549592|NCT05660538|616356817|FG001|Overall Study|Lost to Follow-up|0|||
170549593|NCT05660538|616356818|FG002|Overall Study|Lost to Follow-up|1|||
170549594|NCT05660538|616356819|FG003|Overall Study|Lost to Follow-up|1|||
170549595|NCT05660538|616356816|FG000|Overall Study|Death|0|||
170900106|NCT02847598|617637836|FG001|Overall Study|Adverse Event|0|||
170900107|NCT02847598|617637837|FG002|Overall Study|Adverse Event|0|||
170900108|NCT02847598|617637838|FG003|Overall Study|Adverse Event|0|||
170900109|NCT02847598|617637839|FG004|Overall Study|Adverse Event|0|||
170900110|NCT02847598|617637840|FG005|Overall Study|Adverse Event|0|||
170900111|NCT02847598|617637841|FG006|Overall Study|Adverse Event|0|||
170900112|NCT02847598|617637842|FG007|Overall Study|Adverse Event|1|||
170900113|NCT02847598|617637835|FG000|Overall Study|Consent withdrawn|2|||
170900114|NCT02847598|617637836|FG001|Overall Study|Consent withdrawn|0|||
170900115|NCT02847598|617637837|FG002|Overall Study|Consent withdrawn|0|||
170900116|NCT02847598|617637838|FG003|Overall Study|Consent withdrawn|4|||
170900117|NCT02847598|617637839|FG004|Overall Study|Consent withdrawn|3|||
170900118|NCT02847598|617637840|FG005|Overall Study|Consent withdrawn|2|||
170900119|NCT02847598|617637841|FG006|Overall Study|Consent withdrawn|1|||
170900120|NCT02847598|617637842|FG007|Overall Study|Consent withdrawn|3|||
170900121|NCT02847598|617637835|FG000|Overall Study|Death|3|||
170900122|NCT02847598|617637836|FG001|Overall Study|Death|0|||
170900123|NCT02847598|617637837|FG002|Overall Study|Death|0|||
170900124|NCT02847598|617637838|FG003|Overall Study|Death|0|||
170900125|NCT02847598|617637839|FG004|Overall Study|Death|0|||
170900126|NCT02847598|617637840|FG005|Overall Study|Death|0|||
170900127|NCT02847598|617637841|FG006|Overall Study|Death|0|||
170900128|NCT02847598|617637842|FG007|Overall Study|Death|0|||
170900129|NCT02847598|617637835|FG000|Overall Study|Lost to Follow-up|0|||
170900130|NCT02847598|617637836|FG001|Overall Study|Lost to Follow-up|0|||
170900131|NCT02847598|617637837|FG002|Overall Study|Lost to Follow-up|0|||
170900132|NCT02847598|617637838|FG003|Overall Study|Lost to Follow-up|0|||
170900133|NCT02847598|617637839|FG004|Overall Study|Lost to Follow-up|0|||
170900134|NCT02847598|617637840|FG005|Overall Study|Lost to Follow-up|1|||
170900135|NCT02847598|617637841|FG006|Overall Study|Lost to Follow-up|1|||
170900136|NCT02847598|617637842|FG007|Overall Study|Lost to Follow-up|0|||
170490963|NCT02587598|616138692|FG004|Overall Study|Withdrawal by Subject|3|||
170490964|NCT02587598|616138693|FG005|Overall Study|Withdrawal by Subject|1|||
170490965|NCT02587598|616138694|FG006|Overall Study|Withdrawal by Subject|0|||
170490966|NCT02587598|616138695|FG007|Overall Study|Withdrawal by Subject|0|||
170490967|NCT02587598|616138696|FG008|Overall Study|Withdrawal by Subject|0|||
170490968|NCT02587598|616138697|FG009|Overall Study|Withdrawal by Subject|1|||
170490969|NCT02587598|616138698|FG010|Overall Study|Withdrawal by Subject|2|||
170490970|NCT02587598|616138688|FG000|Overall Study|Physician Decision|0|||
170490971|NCT02587598|616138689|FG001|Overall Study|Physician Decision|0|||
170490972|NCT02587598|616138690|FG002|Overall Study|Physician Decision|0|||
170490973|NCT02587598|616138691|FG003|Overall Study|Physician Decision|0|||
170490974|NCT02587598|616138692|FG004|Overall Study|Physician Decision|0|||
170490975|NCT02587598|616138693|FG005|Overall Study|Physician Decision|0|||
170490976|NCT02587598|616138694|FG006|Overall Study|Physician Decision|0|||
170490977|NCT02587598|616138695|FG007|Overall Study|Physician Decision|0|||
170490978|NCT02587598|616138696|FG008|Overall Study|Physician Decision|0|||
170490979|NCT02587598|616138697|FG009|Overall Study|Physician Decision|0|||
170490980|NCT02587598|616138698|FG010|Overall Study|Physician Decision|3|||
170490981|NCT01704651|616138703|FG000|Overall Study|Pre-op withdrawal by subject|1|||
170490982|NCT01704651|616138704|FG001|Overall Study|Pre-op withdrawal by subject|1|||
170490983|NCT01704651|616138703|FG000|Overall Study|Pre-op change in treatment plan|1|||
170490984|NCT01704651|616138704|FG001|Overall Study|Pre-op change in treatment plan|4|||
170490985|NCT01704651|616138703|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
170490986|NCT01704651|616138704|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
170490987|NCT01704651|616138703|FG000|Overall Study|Post-op did not have laparotomy|2|||
170490988|NCT01704651|616138704|FG001|Overall Study|Post-op did not have laparotomy|1|||
170490989|NCT01860040|616138709|FG000|Overall Study|Withdrawal by Subject|1|||
170490990|NCT01860040|616138710|FG001|Overall Study|Withdrawal by Subject|0|||
170490991|NCT00679289|616138729|FG000|Overall Study|Progressive disease|4|||
170490992|NCT00679289|616138730|FG001|Overall Study|Progressive disease|5|||
170490993|NCT00679289|616138731|FG002|Overall Study|Progressive disease|18|||
170900137|NCT02292771|617637845|FG000|Overall Study|Withdrawal by Subject|2|||
170900138|NCT02292771|617637846|FG001|Overall Study|Withdrawal by Subject|1|||
170900139|NCT02292771|617637845|FG000|Overall Study|Lost to Follow-up|2|||
170900140|NCT02292771|617637846|FG001|Overall Study|Lost to Follow-up|1|||
170900141|NCT04280081|617637848|FG000|Overall Study|Adverse Event|4|||
170490994|NCT00679289|616138729|FG000|Overall Study|Withdrawal by Subject|0|||
170490995|NCT00679289|616138730|FG001|Overall Study|Withdrawal by Subject|1|||
170490996|NCT00679289|616138731|FG002|Overall Study|Withdrawal by Subject|1|||
170490997|NCT00679289|616138729|FG000|Overall Study|Adverse Event|0|||
170490998|NCT00679289|616138730|FG001|Overall Study|Adverse Event|0|||
170490999|NCT00679289|616138731|FG002|Overall Study|Adverse Event|3|||
170900142|NCT04280081|617637848|FG000|Overall Study|Death|2|||
170900143|NCT04280081|617637848|FG000|Overall Study|Progressive Disease|6|||
170900144|NCT01468311|617637849|FG000|Overall Study|mobilization failure|1|||
170900145|NCT01468311|617637849|FG000|Overall Study|Withdrawal by Subject|1|||
170900146|NCT04375761|617640034|FG000|Overall Study|Death|1|||
170900147|NCT04375761|617640035|FG001|Overall Study|Death|2|||
170491000|NCT00679289|616138729|FG000|Overall Study|Physician Decision|1|||
170491001|NCT00679289|616138730|FG001|Overall Study|Physician Decision|0|||
170491002|NCT00679289|616138731|FG002|Overall Study|Physician Decision|1|||
170491003|NCT00183885|616138734|FG000|Overall Study|Adverse Event|11|||
170491004|NCT00183885|616138734|FG000|Overall Study|Death|1|||
170491005|NCT00183885|616138734|FG000|Overall Study|Lost to Follow-up|3|||
170491006|NCT00183885|616138734|FG000|Overall Study|Physician Decision|6|||
170491007|NCT00183885|616138734|FG000|Overall Study|Withdrawal by Subject|5|||
170491008|NCT00183885|616138734|FG000|Overall Study|Switched to alternative treatment|8|||
170491009|NCT00183885|616138734|FG000|Overall Study|Treatment delayed too long|4|||
170491010|NCT00183885|616138734|FG000|Overall Study|Developed second malignancy|1|||
170491011|NCT00828568|616138737|FG000|Randomized|Withdrawal by Subject|1|||
170491012|NCT00828568|616138738|FG001|Randomized|Withdrawal by Subject|0|||
170491013|NCT00828568|616138739|FG002|Randomized|Withdrawal by Subject|2|||
170491014|NCT00828568|616138737|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
170491015|NCT00828568|616138738|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
170491016|NCT00828568|616138739|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
170491017|NCT00828568|616138737|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
170491018|NCT00828568|616138738|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
170491019|NCT00828568|616138739|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
170491020|NCT00828568|616138737|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
170491021|NCT00828568|616138738|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
170491022|NCT00828568|616138739|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
170491023|NCT00828568|616138737|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
170491024|NCT00828568|616138738|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
170491025|NCT00828568|616138739|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
170491026|NCT02091089|616138742|FG000|Overall Study|Lost to Follow-up|2|||
170491027|NCT02929589|616138743|FG000|Overall Study|Withdrawal by Subject|1|||
170491028|NCT02929589|616138744|FG001|Overall Study|Withdrawal by Subject|0|||
170491029|NCT02929589|616138745|FG002|Overall Study|Withdrawal by Subject|0|||
170491030|NCT02929589|616138746|FG003|Overall Study|Withdrawal by Subject|0|||
170491031|NCT02929589|616138743|FG000|Overall Study|Physician Decision|2|||
170491032|NCT02929589|616138744|FG001|Overall Study|Physician Decision|0|||
170491033|NCT02929589|616138745|FG002|Overall Study|Physician Decision|0|||
170491034|NCT02929589|616138746|FG003|Overall Study|Physician Decision|0|||
170491035|NCT00396656|616138747|FG000|First Treatment Period|Withdrawal by Subject|0|||
170491036|NCT00396656|616138748|FG001|First Treatment Period|Withdrawal by Subject|2|||
170491037|NCT00396656|616138747|FG000|Second Treatment Period|Adverse Event|0|||
170491038|NCT00396656|616138748|FG001|Second Treatment Period|Adverse Event|1|||
170491039|NCT02821754|616138751|FG000|Overall Study|Procedure not required prior to amendment change|13|||
170491040|NCT02821754|616138752|FG001|Overall Study|Procedure not required prior to amendment change|11|||
170491041|NCT02821754|616138753|FG002|Overall Study|Procedure not required prior to amendment change|0|||
170491042|NCT02821754|616138751|FG000|Overall Study|Participant's Clinical status|2|||
170491043|NCT02821754|616138752|FG001|Overall Study|Participant's Clinical status|0|||
170491044|NCT02821754|616138753|FG002|Overall Study|Participant's Clinical status|0|||
170491045|NCT02821754|616138751|FG000|Overall Study|Participant removed for noncompliance|1|||
170491046|NCT02821754|616138752|FG001|Overall Study|Participant removed for noncompliance|0|||
170491047|NCT02821754|616138753|FG002|Overall Study|Participant removed for noncompliance|0|||
170491048|NCT02821754|616138751|FG000|Overall Study|Drug not available.|0|||
170491049|NCT02821754|616138752|FG001|Overall Study|Drug not available.|0|||
170491050|NCT02821754|616138753|FG002|Overall Study|Drug not available.|1|||
170491051|NCT02821754|616138751|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
170491052|NCT02821754|616138752|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
170491053|NCT02821754|616138753|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
170491054|NCT00364923|616138754|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
170491055|NCT00364923|616138754|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
170491056|NCT02858583|616138764|FG000|Overall Study|Declined consent|1|||
170491057|NCT02858583|616138765|FG001|Overall Study|Declined consent|1|||
170491058|NCT01554527|616138767|FG000|Overall Study|Withdrawal by Subject|1|||
170549596|NCT05660538|616356817|FG001|Overall Study|Death|0|||
170549597|NCT05660538|616356818|FG002|Overall Study|Death|1|||
170549598|NCT05660538|616356819|FG003|Overall Study|Death|0|||
170549599|NCT05660538|616356816|FG000|Overall Study|Physician Decision|0|||
170549600|NCT05660538|616356817|FG001|Overall Study|Physician Decision|0|||
170549601|NCT05660538|616356818|FG002|Overall Study|Physician Decision|0|||
170549602|NCT05660538|616356819|FG003|Overall Study|Physician Decision|1|||
170549603|NCT05660538|616356816|FG000|Overall Study|Sponsor Decision|1|||
170491059|NCT01554527|616138768|FG001|Overall Study|Withdrawal by Subject|0|||
170491060|NCT01554527|616138769|FG002|Overall Study|Withdrawal by Subject|3|||
170491061|NCT01554527|616138767|FG000|Overall Study|Lost to Follow-up|0|||
170491062|NCT01554527|616138768|FG001|Overall Study|Lost to Follow-up|0|||
170549604|NCT05660538|616356817|FG001|Overall Study|Sponsor Decision|0|||
170549605|NCT05660538|616356818|FG002|Overall Study|Sponsor Decision|0|||
170491063|NCT01554527|616138769|FG002|Overall Study|Lost to Follow-up|4|||
170491064|NCT01554527|616138767|FG000|Overall Study|Physician Decision|0|||
170491065|NCT01554527|616138768|FG001|Overall Study|Physician Decision|0|||
170491066|NCT01554527|616138769|FG002|Overall Study|Physician Decision|1|||
170491067|NCT01868438|616139956|FG000|First Intervention|Withdrawal by Subject|5|||
170491068|NCT01868438|616139957|FG001|First Intervention|Withdrawal by Subject|1|||
170491069|NCT01868438|616139956|FG000|First Intervention|Lost to Follow-up|2|||
170491070|NCT01868438|616139957|FG001|First Intervention|Lost to Follow-up|3|||
170491071|NCT01868438|616139956|FG000|First Intervention|Meeting the non-redosing criteria|0|||
170491072|NCT01868438|616139957|FG001|First Intervention|Meeting the non-redosing criteria|1|||
170491073|NCT01868438|616139956|FG000|Second Intervention|Adverse Event|3|||
170491074|NCT01868438|616139957|FG001|Second Intervention|Adverse Event|3|||
170491075|NCT00956592|616139962|FG000|Overall Study|Protocol Violation|1|||
170491076|NCT00956592|616139963|FG001|Overall Study|Protocol Violation|3|||
170491077|NCT02162719|616139964|FG000|Overall Study|Death|41|||
170491078|NCT02162719|616139965|FG001|Overall Study|Death|46|||
170491079|NCT02162719|616139964|FG000|Overall Study|Lost to Follow-up|1|||
170491080|NCT02162719|616139965|FG001|Overall Study|Lost to Follow-up|3|||
170491081|NCT02162719|616139964|FG000|Overall Study|Disease Progression|2|||
170491082|NCT02162719|616139965|FG001|Overall Study|Disease Progression|1|||
170491083|NCT02162719|616139964|FG000|Overall Study|Withdrawal by Subject|8|||
170491084|NCT02162719|616139965|FG001|Overall Study|Withdrawal by Subject|2|||
170491085|NCT02162719|616139964|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
170491086|NCT02162719|616139965|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
170491087|NCT03555565|616139967|FG000|Overall Study|Case Report Forms Uncollected|2|||
170491088|NCT03555565|616139967|FG000|Overall Study|Protocol Deviation|13|||
170491089|NCT00723255|616139968|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
170491090|NCT00723255|616139968|FG000|Overall Study|Ineligible: Second primary|1|||
170491091|NCT00723255|616139968|FG000|Overall Study|Ineligible: Wrong Primary|2|||
170491092|NCT03854370|616139975|FG000|Overall Study|samples not collected|1|||
170491093|NCT03854370|616139976|FG001|Overall Study|samples not collected|1|||
170491094|NCT03854370|616139977|FG002|Overall Study|samples not collected|1|||
170491095|NCT03854370|616139978|FG003|Overall Study|samples not collected|1|||
170491096|NCT03692325|616139983|FG000|Overall Study|Adverse Event|2|||
170491097|NCT03692325|616139983|FG000|Overall Study|Progression/Recurrence|2|||
170491098|NCT02817516|616139984|FG000|Overall Study|Other|0|||
170491099|NCT02817516|616139985|FG001|Overall Study|Other|0|||
170491100|NCT02817516|616139986|FG002|Overall Study|Other|1|||
170640768|NCT03742102|616696993|FG000|Overall Study|Ongoing study at time of data cut-off (30Jun23 for Arms 1-6 and 29Nov24 for Arms 7-8)|8|||
170640769|NCT03742102|616696994|FG001|Overall Study|Ongoing study at time of data cut-off (30Jun23 for Arms 1-6 and 29Nov24 for Arms 7-8)|9|||
170640770|NCT03742102|616696995|FG002|Overall Study|Ongoing study at time of data cut-off (30Jun23 for Arms 1-6 and 29Nov24 for Arms 7-8)|5|||
170640771|NCT03742102|616696996|FG003|Overall Study|Ongoing study at time of data cut-off (30Jun23 for Arms 1-6 and 29Nov24 for Arms 7-8)|33|||
170640772|NCT03742102|616696997|FG004|Overall Study|Ongoing study at time of data cut-off (30Jun23 for Arms 1-6 and 29Nov24 for Arms 7-8)|24|||
170640773|NCT03742102|616696998|FG005|Overall Study|Ongoing study at time of data cut-off (30Jun23 for Arms 1-6 and 29Nov24 for Arms 7-8)|25|||
170800468|NCT03248492|617281047|FG001|Overall Study|Death|1|||
170800469|NCT03248492|617281048|FG002|Overall Study|Death|0|||
170800470|NCT03248492|617281049|FG003|Overall Study|Death|6|||
170800471|NCT03248492|617281050|FG004|Overall Study|Death|0|||
170800472|NCT03248492|617281046|FG000|Overall Study|Study Terminated by Sponsor|3|||
170800473|NCT03248492|617281047|FG001|Overall Study|Study Terminated by Sponsor|1|||
170800474|NCT03248492|617281048|FG002|Overall Study|Study Terminated by Sponsor|0|||
170800475|NCT03248492|617281049|FG003|Overall Study|Study Terminated by Sponsor|7|||
170800476|NCT03248492|617281050|FG004|Overall Study|Study Terminated by Sponsor|0|||
170800477|NCT03248492|617281046|FG000|Overall Study|Other|2|||
170900148|NCT04375761|617640034|FG000|Overall Study|Lost to Follow-up|203|||
170900149|NCT04375761|617640035|FG001|Overall Study|Lost to Follow-up|380|||
170900150|NCT04375761|617640034|FG000|Overall Study|Withdrawal by Subject|47|||
170491101|NCT02817516|616139987|FG003|Overall Study|Other|0|||
170491102|NCT01288937|616139988|FG000|Overall Study|Adverse Event|1|||
170491103|NCT01288937|616139989|FG001|Overall Study|Adverse Event|0|||
170491104|NCT02347774|616139993|FG000|Study Participation|Lost to Follow-up|3|||
170491105|NCT02347774|616139994|FG001|Study Participation|Lost to Follow-up|6|||
170491106|NCT02347774|616139995|FG002|Study Participation|Lost to Follow-up|2|||
170491107|NCT02347774|616139993|FG000|Study Participation|Withdrawal by Subject|8|||
170491108|NCT02347774|616139994|FG001|Study Participation|Withdrawal by Subject|9|||
170491109|NCT02347774|616139995|FG002|Study Participation|Withdrawal by Subject|15|||
170900151|NCT04375761|617640035|FG001|Overall Study|Withdrawal by Subject|98|||
170491110|NCT02347774|616139993|FG000|Study Participation|Adverse Event|1|||
170491111|NCT02347774|616139994|FG001|Study Participation|Adverse Event|4|||
170491112|NCT02347774|616139995|FG002|Study Participation|Adverse Event|6|||
170491113|NCT02347774|616139993|FG000|Study Participation|withdrew consent|1|||
170491114|NCT02347774|616139994|FG001|Study Participation|withdrew consent|1|||
170491115|NCT02347774|616139995|FG002|Study Participation|withdrew consent|1|||
170491116|NCT02347774|616139993|FG000|Study Participation|Met Prolonged QT criteria|1|||
170491117|NCT02347774|616139994|FG001|Study Participation|Met Prolonged QT criteria|0|||
170491118|NCT02347774|616139995|FG002|Study Participation|Met Prolonged QT criteria|0|||
170491119|NCT02347774|616139993|FG000|Study Participation|non-compliance with study drug|0|||
170491120|NCT02347774|616139994|FG001|Study Participation|non-compliance with study drug|1|||
170491121|NCT02347774|616139995|FG002|Study Participation|non-compliance with study drug|0|||
170491122|NCT02347774|616139993|FG000|Study Participation|incarceration|1|||
170491123|NCT02347774|616139994|FG001|Study Participation|incarceration|0|||
170491124|NCT02347774|616139995|FG002|Study Participation|incarceration|0|||
170491125|NCT02347774|616139993|FG000|Study Participation|randomized in error|0|||
170491126|NCT02347774|616139994|FG001|Study Participation|randomized in error|0|||
170491127|NCT02347774|616139995|FG002|Study Participation|randomized in error|1|||
170491128|NCT02347774|616139993|FG000|On Study Treatment|Adverse Event|9|||
170491129|NCT02347774|616139994|FG001|On Study Treatment|Adverse Event|15|||
170491130|NCT02347774|616139995|FG002|On Study Treatment|Adverse Event|19|||
170491131|NCT02347774|616139993|FG000|On Study Treatment|Lack of Efficacy|3|||
170491132|NCT02347774|616139994|FG001|On Study Treatment|Lack of Efficacy|0|||
170491133|NCT02347774|616139995|FG002|On Study Treatment|Lack of Efficacy|2|||
170491134|NCT02347774|616139993|FG000|On Study Treatment|non-complicance with study medication|0|||
170491135|NCT02347774|616139994|FG001|On Study Treatment|non-complicance with study medication|2|||
170491136|NCT02347774|616139995|FG002|On Study Treatment|non-complicance with study medication|0|||
170491137|NCT02347774|616139993|FG000|On Study Treatment|Protocol Violation|0|||
170491138|NCT02347774|616139994|FG001|On Study Treatment|Protocol Violation|0|||
170491139|NCT02347774|616139995|FG002|On Study Treatment|Protocol Violation|1|||
170491140|NCT02347774|616139993|FG000|On Study Treatment|withdrew consent|9|||
170491141|NCT02347774|616139994|FG001|On Study Treatment|withdrew consent|8|||
170491142|NCT02347774|616139995|FG002|On Study Treatment|withdrew consent|12|||
170491143|NCT02347774|616139993|FG000|On Study Treatment|Lost to Follow-up|2|||
170491144|NCT02347774|616139994|FG001|On Study Treatment|Lost to Follow-up|6|||
170491145|NCT02347774|616139995|FG002|On Study Treatment|Lost to Follow-up|1|||
170549606|NCT05660538|616356819|FG003|Overall Study|Sponsor Decision|0|||
170549607|NCT05660538|616356816|FG000|Overall Study|Other|1|||
170549608|NCT05660538|616356817|FG001|Overall Study|Other|0|||
170549609|NCT05660538|616356818|FG002|Overall Study|Other|0|||
170549610|NCT05660538|616356819|FG003|Overall Study|Other|1|||
170549611|NCT05660538|616356816|FG000|Overall Study|Randomized but did not receive study drug|1|||
170549612|NCT05660538|616356817|FG001|Overall Study|Randomized but did not receive study drug|0|||
170549613|NCT05660538|616356818|FG002|Overall Study|Randomized but did not receive study drug|0|||
170549614|NCT05660538|616356819|FG003|Overall Study|Randomized but did not receive study drug|1|||
170549615|NCT05660538|616356816|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
170549616|NCT05660538|616356817|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
170549617|NCT05660538|616356818|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
170549618|NCT05660538|616356819|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
170549619|NCT00300495|616356823|FG000|Overall Study|Protocol Violation|4|||
170549620|NCT00300495|616356824|FG001|Overall Study|Protocol Violation|1|||
170549621|NCT02015104|616356829|FG000|Overall Study|Withdrew consent after first dose drug|1|||
170549622|NCT02015104|616356830|FG001|Overall Study|Withdrew consent after first dose drug|0|||
170549623|NCT02015104|616356829|FG000|Overall Study|Withdrew consent prior to treatment|0|||
170549624|NCT02015104|616356830|FG001|Overall Study|Withdrew consent prior to treatment|1|||
170549625|NCT06025695|616356831|FG000|Overall Study|Adverse Event|5|||
170549626|NCT06025695|616356832|FG001|Overall Study|Adverse Event|6|||
170549627|NCT06025695|616356831|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
170549628|NCT06025695|616356832|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
170549629|NCT06025695|616356831|FG000|Overall Study|Other|23|||
170491146|NCT02347774|616139993|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
170491147|NCT02347774|616139994|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
170491148|NCT02347774|616139995|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
170491149|NCT02347774|616139993|FG000|On Study Treatment|ranomized in error|0|||
170491150|NCT02347774|616139994|FG001|On Study Treatment|ranomized in error|0|||
170491151|NCT02347774|616139995|FG002|On Study Treatment|ranomized in error|1|||
170491152|NCT01222520|616140001|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
170549630|NCT06025695|616356832|FG001|Overall Study|Other|19|||
170549631|NCT06025695|616356831|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
170549632|NCT06025695|616356832|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
170491153|NCT01222520|616140002|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
170491154|NCT01222520|616140001|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
170800478|NCT03248492|617281047|FG001|Overall Study|Other|5|||
170491155|NCT01222520|616140002|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
170491156|NCT01222520|616140001|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
170491157|NCT01222520|616140002|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
170491158|NCT01222520|616140001|FG000|Double-blind Period|Adverse Event|0|||
170491159|NCT01222520|616140002|FG001|Double-blind Period|Adverse Event|1|||
170491160|NCT01222520|616140001|FG000|Double-blind Period|Lack of Efficacy|0|||
170491161|NCT01222520|616140002|FG001|Double-blind Period|Lack of Efficacy|1|||
170491162|NCT01222520|616140001|FG000|Double-blind Period|Study medication stolen|1|||
170491163|NCT01222520|616140002|FG001|Double-blind Period|Study medication stolen|0|||
170491164|NCT01896128|616140011|FG000|Overall Study|Withdrawal by Subject|3|||
170491165|NCT01896128|616140012|FG001|Overall Study|Withdrawal by Subject|3|||
170491166|NCT00708214|616140015|FG000|Overall Study|Other Adverse Event|3|||
170491167|NCT00708214|616140016|FG001|Overall Study|Other Adverse Event|6|||
170491168|NCT00708214|616140017|FG002|Overall Study|Other Adverse Event|2|||
170491169|NCT00708214|616140015|FG000|Overall Study|Other|0|||
170491170|NCT00708214|616140016|FG001|Overall Study|Other|1|||
170491171|NCT00708214|616140017|FG002|Overall Study|Other|1|||
170491172|NCT00708214|616140015|FG000|Overall Study|Progressive Disease|4|||
170491173|NCT00708214|616140016|FG001|Overall Study|Progressive Disease|6|||
170800479|NCT03248492|617281048|FG002|Overall Study|Other|0|||
170800480|NCT03248492|617281049|FG003|Overall Study|Other|14|||
170800481|NCT03248492|617281050|FG004|Overall Study|Other|0|||
170800482|NCT01315132|617281053|FG000|Overall Study|not treated due to disease progression|1|||
170800483|NCT01778686|617281058|FG000|Overall Study|Adverse Event|0|||
170800484|NCT01778686|617281059|FG001|Overall Study|Adverse Event|0|||
170800485|NCT01778686|617281060|FG002|Overall Study|Adverse Event|1|||
170800486|NCT05714059|617281065|FG000|Overall Study|Withdrawal by Subject|2|||
170800487|NCT05714059|617281066|FG001|Overall Study|Withdrawal by Subject|2|||
170800488|NCT05714059|617281065|FG000|Overall Study|Adverse Event|0|||
170800489|NCT05714059|617281066|FG001|Overall Study|Adverse Event|1|||
170800490|NCT05714059|617281065|FG000|Overall Study|Lost to Follow-up|0|||
170800491|NCT05714059|617281066|FG001|Overall Study|Lost to Follow-up|1|||
170800492|NCT05714059|617281065|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
170800493|NCT05714059|617281066|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
170800494|NCT05714059|617281065|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
170800495|NCT05714059|617281066|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
170800496|NCT02206828|617281072|FG000|Overall Study|Lost to Follow-up|7|||
170800497|NCT02549352|617281073|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
170800498|NCT02549352|617281074|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
170800499|NCT02549352|617281073|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
170800500|NCT02549352|617281074|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
170800501|NCT02549352|617281073|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
170800502|NCT02549352|617281074|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
170800503|NCT02549352|617281073|FG000|12-month Follow-up|Withdrawal by Subject|4|||
170800504|NCT02549352|617281074|FG001|12-month Follow-up|Withdrawal by Subject|5|||
170800505|NCT02549352|617281073|FG000|12-month Follow-up|Lost to Follow-up|3|||
170800506|NCT02549352|617281074|FG001|12-month Follow-up|Lost to Follow-up|2|||
170800507|NCT02549352|617281073|FG000|12-month Follow-up|Death|0|||
170800508|NCT02549352|617281074|FG001|12-month Follow-up|Death|1|||
170800509|NCT02549352|617281073|FG000|12-month Follow-up|Protocol Violation|0|||
170800510|NCT02549352|617281074|FG001|12-month Follow-up|Protocol Violation|1|||
170800511|NCT02549352|617281073|FG000|12-month Follow-up|Other|1|||
170800512|NCT02549352|617281074|FG001|12-month Follow-up|Other|3|||
170800513|NCT04974047|617281847|FG000|Overall Study|Sponsor Ended Study|20|||
170800514|NCT04974047|617281848|FG001|Overall Study|Sponsor Ended Study|22|||
170800515|NCT04974047|617281847|FG000|Overall Study|Death|8|||
170800516|NCT04974047|617281848|FG001|Overall Study|Death|17|||
170800517|NCT04974047|617281847|FG000|Overall Study|Lost to Follow-up|2|||
170800518|NCT04974047|617281848|FG001|Overall Study|Lost to Follow-up|0|||
170800519|NCT04974047|617281847|FG000|Overall Study|Withdrawal by Subject|0|||
170800520|NCT04974047|617281848|FG001|Overall Study|Withdrawal by Subject|1|||
170800521|NCT00655499|617281849|FG000|Overall Study|not eligible|4|||
170800522|NCT00220805|617281850|FG000|Overall Study|Adverse Event|1|||
170800523|NCT00220805|617281851|FG001|Overall Study|Adverse Event|3|||
170800524|NCT00220805|617281850|FG000|Overall Study|Withdrawal by Subject|3|||
170800525|NCT00220805|617281851|FG001|Overall Study|Withdrawal by Subject|0|||
170800526|NCT00220805|617281850|FG000|Overall Study|Lack of Efficacy|1|||
170800527|NCT00220805|617281851|FG001|Overall Study|Lack of Efficacy|0|||
170800528|NCT00220805|617281850|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
170800529|NCT00220805|617281851|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
170800530|NCT02325466|617281852|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
170800531|NCT02325466|617281853|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
170800532|NCT02325466|617281854|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
170549633|NCT03011372|616356833|FG000|Overall Study|Death|16|||
170549634|NCT03011372|616356833|FG000|Overall Study|Lost to Follow-up|2|||
170800533|NCT02325466|617281852|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
170800534|NCT02325466|617281853|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
170800535|NCT02325466|617281854|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
170491174|NCT00708214|616140017|FG002|Overall Study|Progressive Disease|5|||
170491175|NCT02792192|616140018|FG000|Overall Study|Death|1|||
170491176|NCT02792192|616140019|FG001|Overall Study|Death|0|||
170491177|NCT02792192|616140020|FG002|Overall Study|Death|0|||
170491178|NCT02792192|616140021|FG003|Overall Study|Death|0|||
170491179|NCT02792192|616140018|FG000|Overall Study|Informed Consent Withdrawn|4|||
170491180|NCT02792192|616140019|FG001|Overall Study|Informed Consent Withdrawn|0|||
170491181|NCT02792192|616140020|FG002|Overall Study|Informed Consent Withdrawn|0|||
170491182|NCT02792192|616140021|FG003|Overall Study|Informed Consent Withdrawn|0|||
170491183|NCT02792192|616140018|FG000|Overall Study|Physician Decision|1|||
170491184|NCT02792192|616140019|FG001|Overall Study|Physician Decision|0|||
170491185|NCT02792192|616140020|FG002|Overall Study|Physician Decision|0|||
170549635|NCT03011372|616356833|FG000|Overall Study|Sponsor Decision|17|||
170549636|NCT03011372|616356833|FG000|Overall Study|Withdrawal by Subject|7|||
170549637|NCT03011372|616356833|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
170549638|NCT03011372|616356833|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
170549639|NCT03011372|616356833|FG000|Overall Study|Sponsor's Decision|2|||
170549640|NCT03572218|616356834|FG000|Overall Study|Lost to Follow-up|3|||
170549641|NCT03572218|616356835|FG001|Overall Study|Lost to Follow-up|2|||
170549642|NCT03572218|616356834|FG000|Overall Study|No longer available for study visits|2|||
170549643|NCT03572218|616356835|FG001|Overall Study|No longer available for study visits|1|||
170549644|NCT03572218|616356834|FG000|Overall Study|No longer interested|1|||
170549645|NCT03572218|616356835|FG001|Overall Study|No longer interested|2|||
170549646|NCT01350973|616356839|FG000|Overall Study|Adverse Event|4|||
170800536|NCT02325466|617281852|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
170800537|NCT02325466|617281853|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
170549647|NCT01350973|616356840|FG001|Overall Study|Adverse Event|7|||
170549648|NCT01350973|616356841|FG002|Overall Study|Adverse Event|7|||
170549649|NCT01350973|616356839|FG000|Overall Study|Voluntary Withdrawal|2|||
170549650|NCT01350973|616356840|FG001|Overall Study|Voluntary Withdrawal|1|||
170549651|NCT01350973|616356841|FG002|Overall Study|Voluntary Withdrawal|1|||
170549652|NCT00853047|616356842|FG000|Core Phase|Participant Request|0|||
170549653|NCT00853047|616356843|FG001|Core Phase|Participant Request|0|||
170549654|NCT00853047|616356844|FG002|Core Phase|Participant Request|0|||
170549655|NCT00853047|616356845|FG003|Core Phase|Participant Request|1|||
170549656|NCT00853047|616356846|FG004|Core Phase|Participant Request|0|||
170549657|NCT00853047|616356847|FG005|Core Phase|Participant Request|0|||
170549658|NCT00853047|616356842|FG000|Open-Label Extension Phase|Participant Request|0|||
170549659|NCT00853047|616356843|FG001|Open-Label Extension Phase|Participant Request|0|||
170549660|NCT00853047|616356844|FG002|Open-Label Extension Phase|Participant Request|0|||
170549661|NCT00853047|616356845|FG003|Open-Label Extension Phase|Participant Request|0|||
170549662|NCT00853047|616356846|FG004|Open-Label Extension Phase|Participant Request|0|||
170549663|NCT00853047|616356847|FG005|Open-Label Extension Phase|Participant Request|7|||
170549664|NCT00853047|616356842|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
170549665|NCT00853047|616356843|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
170549666|NCT00853047|616356844|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
170549667|NCT00853047|616356845|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
170549668|NCT00853047|616356846|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
170549669|NCT00853047|616356847|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
170549670|NCT00853047|616356842|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
170549671|NCT00853047|616356843|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
170549672|NCT00853047|616356844|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
170549673|NCT00853047|616356845|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
170549674|NCT00853047|616356846|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
170549675|NCT00853047|616356847|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
170549676|NCT00853047|616356842|FG000|Open-Label Extension Phase|Investigator Decision|0|||
170549677|NCT00853047|616356843|FG001|Open-Label Extension Phase|Investigator Decision|0|||
170549678|NCT00853047|616356844|FG002|Open-Label Extension Phase|Investigator Decision|0|||
170549679|NCT00853047|616356845|FG003|Open-Label Extension Phase|Investigator Decision|0|||
170549680|NCT00853047|616356846|FG004|Open-Label Extension Phase|Investigator Decision|0|||
170800538|NCT02325466|617281854|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
170800539|NCT02325466|617281852|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
170800540|NCT02325466|617281853|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
170800541|NCT02325466|617281854|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
170800542|NCT02325466|617281852|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
170800543|NCT02325466|617281853|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
170549681|NCT00853047|616356847|FG005|Open-Label Extension Phase|Investigator Decision|1|||
170800544|NCT02325466|617281854|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
170800545|NCT02325466|617281852|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
170491186|NCT02792192|616140021|FG003|Overall Study|Physician Decision|0|||
170549682|NCT00853047|616356842|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
170549683|NCT00853047|616356843|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
170549684|NCT00853047|616356844|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
170549685|NCT00853047|616356845|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
170491187|NCT02792192|616140018|FG000|Overall Study|Progressive Disease|0|||
170491188|NCT02792192|616140019|FG001|Overall Study|Progressive Disease|1|||
170491189|NCT02792192|616140020|FG002|Overall Study|Progressive Disease|0|||
170491190|NCT02792192|616140021|FG003|Overall Study|Progressive Disease|0|||
170491191|NCT02792192|616140018|FG000|Overall Study|Study Terminated By Sponsor|6|||
170491192|NCT02792192|616140019|FG001|Overall Study|Study Terminated By Sponsor|10|||
170900152|NCT04375761|617640034|FG000|Overall Study|Noncompliance with study procedure|121|||
170900153|NCT04375761|617640035|FG001|Overall Study|Noncompliance with study procedure|251|||
170900154|NCT04375761|617640034|FG000|Overall Study|Reimbursement not enough|1|||
170900155|NCT04375761|617640035|FG001|Overall Study|Reimbursement not enough|2|||
170900156|NCT04375761|617640034|FG000|Overall Study|Unforeseen family circumstances|1|||
170491193|NCT02792192|616140020|FG002|Overall Study|Study Terminated By Sponsor|0|||
170491194|NCT02792192|616140021|FG003|Overall Study|Study Terminated By Sponsor|0|||
170491195|NCT01062113|616140022|FG000|Overall Study|Adverse Event|1|||
170491196|NCT01062113|616140023|FG001|Overall Study|Adverse Event|0|||
170491197|NCT01062113|616140024|FG002|Overall Study|Adverse Event|0|||
170491198|NCT01062113|616140022|FG000|Overall Study|Lack of Efficacy|38|||
170491199|NCT01062113|616140023|FG001|Overall Study|Lack of Efficacy|22|||
170491200|NCT01062113|616140024|FG002|Overall Study|Lack of Efficacy|31|||
170491201|NCT01062113|616140022|FG000|Overall Study|Withdrawal by Subject|1|||
170491202|NCT01062113|616140023|FG001|Overall Study|Withdrawal by Subject|0|||
170491203|NCT01062113|616140024|FG002|Overall Study|Withdrawal by Subject|0|||
170491204|NCT02477826|616140027|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
170491205|NCT02477826|616140028|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
170491206|NCT02477826|616140029|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
170491207|NCT02477826|616140030|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
170491208|NCT02477826|616140031|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
170491209|NCT02477826|616140032|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
170491210|NCT02477826|616140033|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
170491211|NCT02477826|616140034|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
170491212|NCT02477826|616140035|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
170491213|NCT02477826|616140036|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
170491214|NCT02477826|616140027|FG000|Pre-Treatment|Other reasons|4|||
170491215|NCT02477826|616140028|FG001|Pre-Treatment|Other reasons|1|||
170491216|NCT02477826|616140029|FG002|Pre-Treatment|Other reasons|4|||
170491217|NCT02477826|616140030|FG003|Pre-Treatment|Other reasons|1|||
170491218|NCT02477826|616140031|FG004|Pre-Treatment|Other reasons|4|||
170491219|NCT02477826|616140032|FG005|Pre-Treatment|Other reasons|2|||
170491220|NCT02477826|616140033|FG006|Pre-Treatment|Other reasons|0|||
170491221|NCT02477826|616140034|FG007|Pre-Treatment|Other reasons|0|||
170491222|NCT02477826|616140035|FG008|Pre-Treatment|Other reasons|0|||
170491223|NCT02477826|616140036|FG009|Pre-Treatment|Other reasons|0|||
170491224|NCT02477826|616140027|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
170491225|NCT02477826|616140028|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
170491226|NCT02477826|616140029|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
170491227|NCT02477826|616140030|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
170491228|NCT02477826|616140031|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
170491229|NCT02477826|616140032|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
170491230|NCT02477826|616140033|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
170491231|NCT02477826|616140034|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
170491232|NCT02477826|616140035|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
170491233|NCT02477826|616140036|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
170491234|NCT02477826|616140027|FG000|Pre-Treatment|Subject withdrew consent|0|||
170491235|NCT02477826|616140028|FG001|Pre-Treatment|Subject withdrew consent|0|||
170491236|NCT02477826|616140029|FG002|Pre-Treatment|Subject withdrew consent|3|||
170491237|NCT02477826|616140030|FG003|Pre-Treatment|Subject withdrew consent|0|||
170491238|NCT02477826|616140031|FG004|Pre-Treatment|Subject withdrew consent|0|||
170491239|NCT02477826|616140032|FG005|Pre-Treatment|Subject withdrew consent|1|||
170491240|NCT02477826|616140033|FG006|Pre-Treatment|Subject withdrew consent|0|||
170491241|NCT02477826|616140034|FG007|Pre-Treatment|Subject withdrew consent|1|||
170491242|NCT02477826|616140035|FG008|Pre-Treatment|Subject withdrew consent|0|||
170491243|NCT02477826|616140036|FG009|Pre-Treatment|Subject withdrew consent|3|||
170900157|NCT04375761|617640035|FG001|Overall Study|Unforeseen family circumstances|3|||
170491244|NCT02477826|616140027|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
170491245|NCT02477826|616140028|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
170491246|NCT02477826|616140029|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
170549686|NCT00853047|616356846|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
170491247|NCT02477826|616140030|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
170491248|NCT02477826|616140031|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
170491249|NCT02477826|616140032|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
170491250|NCT02477826|616140033|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
170900158|NCT04375761|617640034|FG000|Overall Study|Test too painful|1|||
170800546|NCT02325466|617281853|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
170800547|NCT02325466|617281854|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
170800548|NCT02325466|617281852|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
170800549|NCT02325466|617281853|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
170800550|NCT02325466|617281854|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
170800551|NCT02325466|617281852|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
170800552|NCT02325466|617281853|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
170800553|NCT02325466|617281854|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
170800554|NCT02325466|617281852|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
170800555|NCT02325466|617281853|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
170800556|NCT02325466|617281854|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
170800557|NCT01128595|617281857|FG000|Treatment Period 3|Withdrawal by Subject|0|||
170800558|NCT01128595|617281858|FG001|Treatment Period 3|Withdrawal by Subject|1|||
170800559|NCT01128595|617281859|FG002|Treatment Period 3|Withdrawal by Subject|0|||
170800560|NCT01128595|617281860|FG003|Treatment Period 3|Withdrawal by Subject|0|||
170800561|NCT00605306|617281861|FG000|Overall Study|Adverse Event|0|||
170800562|NCT00605306|617281862|FG001|Overall Study|Adverse Event|1|||
170800563|NCT03875313|617281865|FG000|Overall Study|Withdrawal by Subject|1|||
170800564|NCT03875313|617281866|FG001|Overall Study|Withdrawal by Subject|3|||
170800565|NCT03875313|617281867|FG002|Overall Study|Withdrawal by Subject|0|||
170800566|NCT03875313|617281868|FG003|Overall Study|Withdrawal by Subject|0|||
170800567|NCT03875313|617281869|FG004|Overall Study|Withdrawal by Subject|0|||
170800568|NCT03875313|617281865|FG000|Overall Study|Death|0|||
170800569|NCT03875313|617281866|FG001|Overall Study|Death|0|||
170800570|NCT03875313|617281867|FG002|Overall Study|Death|0|||
170800571|NCT03875313|617281868|FG003|Overall Study|Death|0|||
170800572|NCT03875313|617281869|FG004|Overall Study|Death|1|||
170800573|NCT03875313|617281865|FG000|Overall Study|Lost to Follow-up|0|||
170800574|NCT03875313|617281866|FG001|Overall Study|Lost to Follow-up|0|||
170800575|NCT03875313|617281867|FG002|Overall Study|Lost to Follow-up|0|||
170800576|NCT03875313|617281868|FG003|Overall Study|Lost to Follow-up|0|||
170800577|NCT03875313|617281869|FG004|Overall Study|Lost to Follow-up|1|||
170800578|NCT03875313|617281865|FG000|Overall Study|Study Termination by Sponsor|0|||
170800579|NCT03875313|617281866|FG001|Overall Study|Study Termination by Sponsor|1|||
170800580|NCT03875313|617281867|FG002|Overall Study|Study Termination by Sponsor|1|||
170800581|NCT03875313|617281868|FG003|Overall Study|Study Termination by Sponsor|0|||
170800582|NCT03875313|617281869|FG004|Overall Study|Study Termination by Sponsor|1|||
170800583|NCT03875313|617281865|FG000|Overall Study|New Anticancer Treatment|0|||
170800584|NCT03875313|617281866|FG001|Overall Study|New Anticancer Treatment|1|||
170800585|NCT03875313|617281867|FG002|Overall Study|New Anticancer Treatment|2|||
170800586|NCT03875313|617281868|FG003|Overall Study|New Anticancer Treatment|1|||
170800587|NCT03875313|617281869|FG004|Overall Study|New Anticancer Treatment|0|||
170800588|NCT03875313|617281865|FG000|Overall Study|Other, Not Specified|2|||
170800589|NCT03875313|617281866|FG001|Overall Study|Other, Not Specified|11|||
170800590|NCT03875313|617281867|FG002|Overall Study|Other, Not Specified|3|||
170800591|NCT03875313|617281868|FG003|Overall Study|Other, Not Specified|3|||
170800592|NCT03875313|617281869|FG004|Overall Study|Other, Not Specified|1|||
170800593|NCT01092416|617281870|FG000|Enrollment|Atherectomy device not inserted|3|||
170800594|NCT01092416|617281870|FG000|30-Day Follow-up|Death|2|||
170800595|NCT01092416|617281870|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
170800596|NCT01092416|617281870|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
170800597|NCT01092416|617281870|FG000|12-Month Follow-up|Death|16|||
170800598|NCT01092416|617281870|FG000|12-Month Follow-up|Lost to Follow-up|4|||
170800599|NCT01092416|617281870|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
170800600|NCT01092416|617281870|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
170800601|NCT01092416|617281870|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
170800602|NCT02797132|617281874|FG000|Part A (15 Days)|Adverse Event|1|||
170491251|NCT02477826|616140034|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
170491252|NCT02477826|616140035|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
170491253|NCT02477826|616140036|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
170491254|NCT02477826|616140027|FG000|Pre-Treatment|Death|0|||
170800603|NCT02797132|617281874|FG000|Part B (24 Weeks)|Adverse Event|3|||
170800604|NCT02502526|617281875|FG000|Overall Study|Lost to Follow-up|2|||
170491255|NCT02477826|616140028|FG001|Pre-Treatment|Death|0|||
170491256|NCT02477826|616140029|FG002|Pre-Treatment|Death|0|||
170491257|NCT02477826|616140030|FG003|Pre-Treatment|Death|0|||
170800605|NCT02502526|617281876|FG001|Overall Study|Lost to Follow-up|2|||
170800606|NCT02502526|617281877|FG002|Overall Study|Lost to Follow-up|3|||
170800607|NCT02502526|617281875|FG000|Overall Study|Withdrawal by Subject|0|||
170800608|NCT02502526|617281876|FG001|Overall Study|Withdrawal by Subject|1|||
170800609|NCT02502526|617281877|FG002|Overall Study|Withdrawal by Subject|1|||
170800610|NCT02502526|617281875|FG000|Overall Study|Disqualified due to cataract grading|0|||
170800611|NCT02502526|617281876|FG001|Overall Study|Disqualified due to cataract grading|0|||
170800612|NCT02502526|617281877|FG002|Overall Study|Disqualified due to cataract grading|1|||
170491258|NCT02477826|616140031|FG004|Pre-Treatment|Death|0|||
170491259|NCT02477826|616140032|FG005|Pre-Treatment|Death|0|||
170491260|NCT02477826|616140033|FG006|Pre-Treatment|Death|1|||
170491261|NCT02477826|616140034|FG007|Pre-Treatment|Death|0|||
170491262|NCT02477826|616140035|FG008|Pre-Treatment|Death|0|||
170491263|NCT02477826|616140036|FG009|Pre-Treatment|Death|0|||
170491264|NCT02477826|616140027|FG000|Treatment Period|Not reported|8|||
170491265|NCT02477826|616140028|FG001|Treatment Period|Not reported|6|||
170491266|NCT02477826|616140029|FG002|Treatment Period|Not reported|4|||
170491267|NCT02477826|616140030|FG003|Treatment Period|Not reported|4|||
170491268|NCT02477826|616140031|FG004|Treatment Period|Not reported|2|||
170491269|NCT02477826|616140032|FG005|Treatment Period|Not reported|1|||
170491270|NCT02477826|616140033|FG006|Treatment Period|Not reported|14|||
170491271|NCT02477826|616140034|FG007|Treatment Period|Not reported|8|||
170491272|NCT02477826|616140035|FG008|Treatment Period|Not reported|5|||
170491273|NCT02477826|616140036|FG009|Treatment Period|Not reported|2|||
170491274|NCT02477826|616140027|FG000|Treatment Period|Other reasons|5|||
170491275|NCT02477826|616140028|FG001|Treatment Period|Other reasons|6|||
170491276|NCT02477826|616140029|FG002|Treatment Period|Other reasons|12|||
170491277|NCT02477826|616140030|FG003|Treatment Period|Other reasons|7|||
170800613|NCT02502526|617281875|FG000|Overall Study|Enrollment suspension|4|||
170800614|NCT02502526|617281876|FG001|Overall Study|Enrollment suspension|1|||
170800615|NCT02502526|617281877|FG002|Overall Study|Enrollment suspension|1|||
170800616|NCT00943917|617281881|FG000|Stage I|Adverse Event|1|||
170800617|NCT00943917|617281882|FG001|Stage I|Adverse Event|2|||
170800618|NCT00943917|617281883|FG002|Stage I|Adverse Event|2|||
170800619|NCT00943917|617281884|FG003|Stage I|Adverse Event|0|||
170800620|NCT00943917|617281885|FG004|Stage I|Adverse Event|0|||
170800621|NCT00943917|617281886|FG005|Stage I|Adverse Event|0|||
170800622|NCT00943917|617281887|FG006|Stage I|Adverse Event|0|||
170800623|NCT00943917|617281888|FG007|Stage I|Adverse Event|0|||
170800624|NCT00943917|617281889|FG008|Stage I|Adverse Event|0|||
170800625|NCT00943917|617281890|FG009|Stage I|Adverse Event|0|||
170800626|NCT00943917|617281891|FG010|Stage I|Adverse Event|0|||
170800627|NCT00943917|617281892|FG011|Stage I|Adverse Event|0|||
170800628|NCT00943917|617281893|FG012|Stage I|Adverse Event|0|||
170800629|NCT00943917|617281894|FG013|Stage I|Adverse Event|0|||
170800630|NCT00943917|617281895|FG014|Stage I|Adverse Event|0|||
170800631|NCT00943917|617281881|FG000|Stage I|Lost to Follow-up|0|||
170800632|NCT00943917|617281882|FG001|Stage I|Lost to Follow-up|0|||
170800633|NCT00943917|617281883|FG002|Stage I|Lost to Follow-up|1|||
170800634|NCT00943917|617281884|FG003|Stage I|Lost to Follow-up|0|||
170800635|NCT00943917|617281885|FG004|Stage I|Lost to Follow-up|0|||
170800636|NCT00943917|617281886|FG005|Stage I|Lost to Follow-up|0|||
170800637|NCT00943917|617281887|FG006|Stage I|Lost to Follow-up|0|||
170800638|NCT00943917|617281888|FG007|Stage I|Lost to Follow-up|0|||
170800639|NCT00943917|617281889|FG008|Stage I|Lost to Follow-up|0|||
170800640|NCT00943917|617281890|FG009|Stage I|Lost to Follow-up|0|||
170800641|NCT00943917|617281891|FG010|Stage I|Lost to Follow-up|0|||
170800642|NCT00943917|617281892|FG011|Stage I|Lost to Follow-up|0|||
170800643|NCT00943917|617281893|FG012|Stage I|Lost to Follow-up|0|||
170800644|NCT00943917|617281894|FG013|Stage I|Lost to Follow-up|0|||
170800645|NCT00943917|617281895|FG014|Stage I|Lost to Follow-up|0|||
170800646|NCT00943917|617281881|FG000|Stage I|hyperglycemia|0|||
170800647|NCT00943917|617281882|FG001|Stage I|hyperglycemia|0|||
170800648|NCT00943917|617281883|FG002|Stage I|hyperglycemia|1|||
170800649|NCT00943917|617281884|FG003|Stage I|hyperglycemia|0|||
170800650|NCT00943917|617281885|FG004|Stage I|hyperglycemia|0|||
170800651|NCT00943917|617281886|FG005|Stage I|hyperglycemia|0|||
170800652|NCT00943917|617281887|FG006|Stage I|hyperglycemia|0|||
170800653|NCT00943917|617281888|FG007|Stage I|hyperglycemia|0|||
170800654|NCT00943917|617281889|FG008|Stage I|hyperglycemia|0|||
170800655|NCT00943917|617281890|FG009|Stage I|hyperglycemia|0|||
170800656|NCT00943917|617281891|FG010|Stage I|hyperglycemia|0|||
170800657|NCT00943917|617281892|FG011|Stage I|hyperglycemia|0|||
170800658|NCT00943917|617281893|FG012|Stage I|hyperglycemia|0|||
170800659|NCT00943917|617281894|FG013|Stage I|hyperglycemia|0|||
170491278|NCT02477826|616140031|FG004|Treatment Period|Other reasons|5|||
170491279|NCT02477826|616140032|FG005|Treatment Period|Other reasons|1|||
170491280|NCT02477826|616140033|FG006|Treatment Period|Other reasons|8|||
170491281|NCT02477826|616140034|FG007|Treatment Period|Other reasons|8|||
170491282|NCT02477826|616140035|FG008|Treatment Period|Other reasons|21|||
170491283|NCT02477826|616140036|FG009|Treatment Period|Other reasons|1|||
170491284|NCT02477826|616140027|FG000|Treatment Period|Administrative reason by sponsor|0|||
170800660|NCT00943917|617281895|FG014|Stage I|hyperglycemia|0|||
170800661|NCT00943917|617281881|FG000|Stage I|A1C elevation|1|||
170800662|NCT00943917|617281882|FG001|Stage I|A1C elevation|0|||
170800663|NCT00943917|617281883|FG002|Stage I|A1C elevation|0|||
170800664|NCT00943917|617281884|FG003|Stage I|A1C elevation|0|||
170800665|NCT00943917|617281885|FG004|Stage I|A1C elevation|0|||
170800666|NCT00943917|617281886|FG005|Stage I|A1C elevation|0|||
170800667|NCT00943917|617281887|FG006|Stage I|A1C elevation|0|||
170800668|NCT00943917|617281888|FG007|Stage I|A1C elevation|0|||
170800669|NCT00943917|617281889|FG008|Stage I|A1C elevation|0|||
170800670|NCT00943917|617281890|FG009|Stage I|A1C elevation|0|||
170800671|NCT00943917|617281891|FG010|Stage I|A1C elevation|0|||
170491285|NCT02477826|616140028|FG001|Treatment Period|Administrative reason by sponsor|3|||
170491286|NCT02477826|616140029|FG002|Treatment Period|Administrative reason by sponsor|0|||
170491287|NCT02477826|616140030|FG003|Treatment Period|Administrative reason by sponsor|0|||
170491288|NCT02477826|616140031|FG004|Treatment Period|Administrative reason by sponsor|0|||
170491289|NCT02477826|616140032|FG005|Treatment Period|Administrative reason by sponsor|0|||
170491290|NCT02477826|616140033|FG006|Treatment Period|Administrative reason by sponsor|0|||
170491291|NCT02477826|616140034|FG007|Treatment Period|Administrative reason by sponsor|0|||
170491292|NCT02477826|616140035|FG008|Treatment Period|Administrative reason by sponsor|0|||
170491293|NCT02477826|616140036|FG009|Treatment Period|Administrative reason by sponsor|0|||
170491294|NCT02477826|616140027|FG000|Treatment Period|Participant meet no longer study criteria|1|||
170491295|NCT02477826|616140028|FG001|Treatment Period|Participant meet no longer study criteria|1|||
170491296|NCT02477826|616140029|FG002|Treatment Period|Participant meet no longer study criteria|0|||
170491297|NCT02477826|616140030|FG003|Treatment Period|Participant meet no longer study criteria|0|||
170491298|NCT02477826|616140031|FG004|Treatment Period|Participant meet no longer study criteria|1|||
170491299|NCT02477826|616140032|FG005|Treatment Period|Participant meet no longer study criteria|1|||
170491300|NCT02477826|616140033|FG006|Treatment Period|Participant meet no longer study criteria|0|||
170491301|NCT02477826|616140034|FG007|Treatment Period|Participant meet no longer study criteria|1|||
170491302|NCT02477826|616140035|FG008|Treatment Period|Participant meet no longer study criteria|0|||
170800672|NCT00943917|617281892|FG011|Stage I|A1C elevation|0|||
170491303|NCT02477826|616140036|FG009|Treatment Period|Participant meet no longer study criteria|0|||
170491304|NCT02477826|616140027|FG000|Treatment Period|Poor/Non Compliance|1|||
170491305|NCT02477826|616140028|FG001|Treatment Period|Poor/Non Compliance|0|||
170491306|NCT02477826|616140029|FG002|Treatment Period|Poor/Non Compliance|2|||
170491307|NCT02477826|616140030|FG003|Treatment Period|Poor/Non Compliance|0|||
170491308|NCT02477826|616140031|FG004|Treatment Period|Poor/Non Compliance|0|||
170491309|NCT02477826|616140032|FG005|Treatment Period|Poor/Non Compliance|1|||
170491310|NCT02477826|616140033|FG006|Treatment Period|Poor/Non Compliance|1|||
170491311|NCT02477826|616140034|FG007|Treatment Period|Poor/Non Compliance|0|||
170491312|NCT02477826|616140035|FG008|Treatment Period|Poor/Non Compliance|0|||
170491313|NCT02477826|616140036|FG009|Treatment Period|Poor/Non Compliance|1|||
170491314|NCT02477826|616140027|FG000|Treatment Period|Maximum Clinical Benefit|3|||
170491315|NCT02477826|616140028|FG001|Treatment Period|Maximum Clinical Benefit|3|||
170491316|NCT02477826|616140029|FG002|Treatment Period|Maximum Clinical Benefit|1|||
170491317|NCT02477826|616140030|FG003|Treatment Period|Maximum Clinical Benefit|1|||
170491318|NCT02477826|616140031|FG004|Treatment Period|Maximum Clinical Benefit|3|||
170491319|NCT02477826|616140032|FG005|Treatment Period|Maximum Clinical Benefit|0|||
170491320|NCT02477826|616140033|FG006|Treatment Period|Maximum Clinical Benefit|3|||
170491321|NCT02477826|616140034|FG007|Treatment Period|Maximum Clinical Benefit|2|||
170491322|NCT02477826|616140035|FG008|Treatment Period|Maximum Clinical Benefit|2|||
170491323|NCT02477826|616140036|FG009|Treatment Period|Maximum Clinical Benefit|2|||
170491324|NCT02477826|616140027|FG000|Treatment Period|Lost to Follow-up|0|||
170491325|NCT02477826|616140028|FG001|Treatment Period|Lost to Follow-up|0|||
170491326|NCT02477826|616140029|FG002|Treatment Period|Lost to Follow-up|1|||
170491327|NCT02477826|616140030|FG003|Treatment Period|Lost to Follow-up|1|||
170491328|NCT02477826|616140031|FG004|Treatment Period|Lost to Follow-up|0|||
170491329|NCT02477826|616140032|FG005|Treatment Period|Lost to Follow-up|0|||
170491330|NCT02477826|616140033|FG006|Treatment Period|Lost to Follow-up|2|||
170491331|NCT02477826|616140034|FG007|Treatment Period|Lost to Follow-up|2|||
170491332|NCT02477826|616140035|FG008|Treatment Period|Lost to Follow-up|0|||
170491333|NCT02477826|616140036|FG009|Treatment Period|Lost to Follow-up|0|||
170491334|NCT02477826|616140027|FG000|Treatment Period|Participant withdrew Consent|5|||
170491335|NCT02477826|616140028|FG001|Treatment Period|Participant withdrew Consent|5|||
170491336|NCT02477826|616140029|FG002|Treatment Period|Participant withdrew Consent|3|||
170491337|NCT02477826|616140030|FG003|Treatment Period|Participant withdrew Consent|3|||
170491338|NCT02477826|616140031|FG004|Treatment Period|Participant withdrew Consent|1|||
170491339|NCT02477826|616140032|FG005|Treatment Period|Participant withdrew Consent|3|||
170491340|NCT02477826|616140033|FG006|Treatment Period|Participant withdrew Consent|3|||
170491341|NCT02477826|616140034|FG007|Treatment Period|Participant withdrew Consent|3|||
170491342|NCT02477826|616140035|FG008|Treatment Period|Participant withdrew Consent|2|||
170491343|NCT02477826|616140036|FG009|Treatment Period|Participant withdrew Consent|3|||
170491344|NCT02477826|616140027|FG000|Treatment Period|Participant request to discontinue treatment|5|||
170491345|NCT02477826|616140028|FG001|Treatment Period|Participant request to discontinue treatment|3|||
170800673|NCT00943917|617281893|FG012|Stage I|A1C elevation|0|||
170491346|NCT02477826|616140029|FG002|Treatment Period|Participant request to discontinue treatment|15|||
170491347|NCT02477826|616140030|FG003|Treatment Period|Participant request to discontinue treatment|5|||
170491348|NCT02477826|616140031|FG004|Treatment Period|Participant request to discontinue treatment|3|||
170491349|NCT02477826|616140032|FG005|Treatment Period|Participant request to discontinue treatment|6|||
170491350|NCT02477826|616140033|FG006|Treatment Period|Participant request to discontinue treatment|13|||
170491351|NCT02477826|616140034|FG007|Treatment Period|Participant request to discontinue treatment|15|||
170640774|NCT03742102|616696993|FG000|Overall Study|Lost to Follow-up|0|||
170491352|NCT02477826|616140035|FG008|Treatment Period|Participant request to discontinue treatment|4|||
170491353|NCT02477826|616140036|FG009|Treatment Period|Participant request to discontinue treatment|18|||
170491354|NCT02477826|616140027|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
170491355|NCT02477826|616140028|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
170491356|NCT02477826|616140029|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
170491357|NCT02477826|616140030|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
170491358|NCT02477826|616140031|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
170491359|NCT02477826|616140032|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
170491360|NCT02477826|616140033|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
170491361|NCT02477826|616140034|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
170491362|NCT02477826|616140035|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
170491363|NCT02477826|616140036|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
170491364|NCT02477826|616140027|FG000|Treatment Period|Death|4|||
170491365|NCT02477826|616140028|FG001|Treatment Period|Death|7|||
170491366|NCT02477826|616140029|FG002|Treatment Period|Death|0|||
170491367|NCT02477826|616140030|FG003|Treatment Period|Death|0|||
170491368|NCT02477826|616140031|FG004|Treatment Period|Death|1|||
170491369|NCT02477826|616140032|FG005|Treatment Period|Death|2|||
170491370|NCT02477826|616140033|FG006|Treatment Period|Death|6|||
170491371|NCT02477826|616140034|FG007|Treatment Period|Death|5|||
170491372|NCT02477826|616140035|FG008|Treatment Period|Death|9|||
170491373|NCT02477826|616140036|FG009|Treatment Period|Death|0|||
170491374|NCT02477826|616140027|FG000|Treatment Period|Study Drug Toxicity|79|||
170491375|NCT02477826|616140028|FG001|Treatment Period|Study Drug Toxicity|51|||
170491376|NCT02477826|616140029|FG002|Treatment Period|Study Drug Toxicity|31|||
170491377|NCT02477826|616140030|FG003|Treatment Period|Study Drug Toxicity|39|||
170491378|NCT02477826|616140031|FG004|Treatment Period|Study Drug Toxicity|12|||
170491379|NCT02477826|616140032|FG005|Treatment Period|Study Drug Toxicity|25|||
170491380|NCT02477826|616140033|FG006|Treatment Period|Study Drug Toxicity|52|||
170491381|NCT02477826|616140034|FG007|Treatment Period|Study Drug Toxicity|30|||
170491382|NCT02477826|616140035|FG008|Treatment Period|Study Drug Toxicity|20|||
170491383|NCT02477826|616140036|FG009|Treatment Period|Study Drug Toxicity|9|||
170491384|NCT02477826|616140027|FG000|Treatment Period|Disease progression|212|||
170491385|NCT02477826|616140028|FG001|Treatment Period|Disease progression|240|||
170491386|NCT02477826|616140029|FG002|Treatment Period|Disease progression|202|||
170491387|NCT02477826|616140030|FG003|Treatment Period|Disease progression|93|||
170491388|NCT02477826|616140031|FG004|Treatment Period|Disease progression|113|||
170491389|NCT02477826|616140032|FG005|Treatment Period|Disease progression|96|||
170491390|NCT02477826|616140033|FG006|Treatment Period|Disease progression|208|||
170491391|NCT02477826|616140034|FG007|Treatment Period|Disease progression|195|||
170491392|NCT02477826|616140035|FG008|Treatment Period|Disease progression|59|||
170491393|NCT02477826|616140036|FG009|Treatment Period|Disease progression|46|||
170491394|NCT02477826|616140027|FG000|Treatment Period|Pregnancy|0|||
170491395|NCT02477826|616140028|FG001|Treatment Period|Pregnancy|0|||
170491396|NCT02477826|616140029|FG002|Treatment Period|Pregnancy|0|||
170491397|NCT02477826|616140030|FG003|Treatment Period|Pregnancy|0|||
170491398|NCT02477826|616140031|FG004|Treatment Period|Pregnancy|0|||
170491399|NCT02477826|616140032|FG005|Treatment Period|Pregnancy|0|||
170491400|NCT02477826|616140033|FG006|Treatment Period|Pregnancy|0|||
170491401|NCT02477826|616140034|FG007|Treatment Period|Pregnancy|0|||
170491402|NCT02477826|616140035|FG008|Treatment Period|Pregnancy|0|||
170491403|NCT02477826|616140036|FG009|Treatment Period|Pregnancy|1|||
170491404|NCT02477826|616140027|FG000|Treatment Period|Other|0|||
170491405|NCT02477826|616140028|FG001|Treatment Period|Other|0|||
170491406|NCT02477826|616140029|FG002|Treatment Period|Other|0|||
170491407|NCT02477826|616140030|FG003|Treatment Period|Other|0|||
170491408|NCT02477826|616140031|FG004|Treatment Period|Other|0|||
170491409|NCT02477826|616140032|FG005|Treatment Period|Other|0|||
170491410|NCT02477826|616140033|FG006|Treatment Period|Other|0|||
170491411|NCT02477826|616140034|FG007|Treatment Period|Other|0|||
170491412|NCT02477826|616140035|FG008|Treatment Period|Other|0|||
170491413|NCT02477826|616140036|FG009|Treatment Period|Other|1|||
170491414|NCT00014495|616140037|FG000|Overall Study|Death|0|||
170491415|NCT00014495|616140038|FG001|Overall Study|Death|0|||
170491416|NCT00014495|616140039|FG002|Overall Study|Death|1|||
170491417|NCT00014495|616140040|FG003|Overall Study|Death|0|||
170491418|NCT00014495|616140037|FG000|Overall Study|Clinical deterioration|0|||
170491419|NCT00014495|616140038|FG001|Overall Study|Clinical deterioration|0|||
170491420|NCT00014495|616140039|FG002|Overall Study|Clinical deterioration|0|||
170491421|NCT00014495|616140040|FG003|Overall Study|Clinical deterioration|1|||
170491422|NCT00403481|616140074|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
170491423|NCT00403481|616140074|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
170491424|NCT00403481|616140074|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
170491425|NCT00403481|616140074|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
170491426|NCT00403481|616140074|FG000|Olm 40 mg|Adverse Event|2|||
170491427|NCT00403481|616140074|FG000|Olm 40 mg|Protocol Violation|1|||
170491428|NCT00403481|616140074|FG000|Olm 40 mg|Withdrawal by Subject|1|||
170491429|NCT00403481|616140074|FG000|Olm 40 mg|Other|1|||
170800674|NCT00943917|617281894|FG013|Stage I|A1C elevation|0|||
170800675|NCT00943917|617281895|FG014|Stage I|A1C elevation|0|||
170800676|NCT00943917|617281881|FG000|Stage I|Withdrawal by Subject|2|||
170800677|NCT00943917|617281882|FG001|Stage I|Withdrawal by Subject|1|||
170800678|NCT00943917|617281883|FG002|Stage I|Withdrawal by Subject|2|||
170800679|NCT00943917|617281884|FG003|Stage I|Withdrawal by Subject|0|||
170800680|NCT00943917|617281885|FG004|Stage I|Withdrawal by Subject|0|||
170800681|NCT00943917|617281886|FG005|Stage I|Withdrawal by Subject|0|||
170800682|NCT00943917|617281887|FG006|Stage I|Withdrawal by Subject|0|||
170800683|NCT00943917|617281888|FG007|Stage I|Withdrawal by Subject|0|||
170800684|NCT00943917|617281889|FG008|Stage I|Withdrawal by Subject|0|||
170800685|NCT00943917|617281890|FG009|Stage I|Withdrawal by Subject|0|||
170800686|NCT00943917|617281891|FG010|Stage I|Withdrawal by Subject|0|||
170800687|NCT00943917|617281892|FG011|Stage I|Withdrawal by Subject|0|||
170800688|NCT00943917|617281893|FG012|Stage I|Withdrawal by Subject|0|||
170800689|NCT00943917|617281894|FG013|Stage I|Withdrawal by Subject|0|||
170800690|NCT00943917|617281895|FG014|Stage I|Withdrawal by Subject|0|||
170800691|NCT00943917|617281881|FG000|Stage II|Adverse Event|0|||
170800692|NCT00943917|617281882|FG001|Stage II|Adverse Event|0|||
170800693|NCT00943917|617281883|FG002|Stage II|Adverse Event|0|||
170800694|NCT00943917|617281884|FG003|Stage II|Adverse Event|0|||
170800695|NCT00943917|617281885|FG004|Stage II|Adverse Event|0|||
170800696|NCT00943917|617281886|FG005|Stage II|Adverse Event|1|||
170800697|NCT00943917|617281887|FG006|Stage II|Adverse Event|3|||
170800698|NCT00943917|617281888|FG007|Stage II|Adverse Event|0|||
170800699|NCT00943917|617281889|FG008|Stage II|Adverse Event|1|||
170800700|NCT00943917|617281890|FG009|Stage II|Adverse Event|0|||
170800701|NCT00943917|617281891|FG010|Stage II|Adverse Event|0|||
170800702|NCT00943917|617281892|FG011|Stage II|Adverse Event|0|||
170800703|NCT00943917|617281893|FG012|Stage II|Adverse Event|0|||
170800704|NCT00943917|617281894|FG013|Stage II|Adverse Event|0|||
170800705|NCT00943917|617281895|FG014|Stage II|Adverse Event|0|||
170800706|NCT00943917|617281881|FG000|Stage II|Withdrawal by Subject|0|||
170800707|NCT00943917|617281882|FG001|Stage II|Withdrawal by Subject|0|||
170800708|NCT00943917|617281883|FG002|Stage II|Withdrawal by Subject|0|||
170800709|NCT00943917|617281884|FG003|Stage II|Withdrawal by Subject|0|||
170800710|NCT00943917|617281885|FG004|Stage II|Withdrawal by Subject|0|||
170800711|NCT00943917|617281886|FG005|Stage II|Withdrawal by Subject|1|||
170640775|NCT03742102|616696994|FG001|Overall Study|Lost to Follow-up|1|||
170640776|NCT03742102|616696995|FG002|Overall Study|Lost to Follow-up|0|||
170640777|NCT03742102|616696996|FG003|Overall Study|Lost to Follow-up|0|||
170640778|NCT03742102|616696997|FG004|Overall Study|Lost to Follow-up|1|||
170640779|NCT03742102|616696998|FG005|Overall Study|Lost to Follow-up|0|||
170640780|NCT03742102|616696993|FG000|Overall Study|Withdrawal by Subject|1|||
170640781|NCT03742102|616696994|FG001|Overall Study|Withdrawal by Subject|4|||
170640782|NCT03742102|616696995|FG002|Overall Study|Withdrawal by Subject|3|||
170640783|NCT03742102|616696996|FG003|Overall Study|Withdrawal by Subject|2|||
170800712|NCT00943917|617281887|FG006|Stage II|Withdrawal by Subject|0|||
170800713|NCT00943917|617281888|FG007|Stage II|Withdrawal by Subject|0|||
170491430|NCT00403481|616140074|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
170491431|NCT00403481|616140074|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
170491432|NCT00403481|616140074|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
170491433|NCT00403481|616140074|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
170491434|NCT00403481|616140074|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
170491435|NCT00403481|616140074|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
170491436|NCT00766636|616140077|FG000|Overall Study|Withdrawal by Subject|1|||
170491437|NCT00766636|616140078|FG001|Overall Study|Withdrawal by Subject|1|||
170491438|NCT00766636|616140077|FG000|Overall Study|Incomplete Treatment|0|||
170491439|NCT00766636|616140078|FG001|Overall Study|Incomplete Treatment|1|||
170491440|NCT00766636|616140077|FG000|Overall Study|Adverse Event|1|||
170491441|NCT00766636|616140078|FG001|Overall Study|Adverse Event|0|||
170491442|NCT00766636|616140077|FG000|Overall Study|Disease Progression|1|||
170491443|NCT00766636|616140078|FG001|Overall Study|Disease Progression|0|||
170491444|NCT01355575|616140081|FG000|Overall Study|Withdrawal by Subject|2|||
170491445|NCT02477332|616140082|FG000|Overall Study|Adverse Event|0|||
170800714|NCT00943917|617281889|FG008|Stage II|Withdrawal by Subject|0|||
170800715|NCT00943917|617281890|FG009|Stage II|Withdrawal by Subject|0|||
170800716|NCT00943917|617281891|FG010|Stage II|Withdrawal by Subject|0|||
170800717|NCT00943917|617281892|FG011|Stage II|Withdrawal by Subject|0|||
170640784|NCT03742102|616696997|FG004|Overall Study|Withdrawal by Subject|3|||
170640785|NCT03742102|616696998|FG005|Overall Study|Withdrawal by Subject|2|||
170640786|NCT03742102|616696993|FG000|Overall Study|Reason unknown|0|||
170800718|NCT00943917|617281893|FG012|Stage II|Withdrawal by Subject|0|||
170800719|NCT00943917|617281894|FG013|Stage II|Withdrawal by Subject|0|||
170800720|NCT00943917|617281895|FG014|Stage II|Withdrawal by Subject|0|||
170800721|NCT00943917|617281881|FG000|Stage II|Pregnancy|0|||
170800722|NCT00943917|617281882|FG001|Stage II|Pregnancy|0|||
170800723|NCT00943917|617281883|FG002|Stage II|Pregnancy|0|||
170800724|NCT00943917|617281884|FG003|Stage II|Pregnancy|0|||
170800725|NCT00943917|617281885|FG004|Stage II|Pregnancy|0|||
170800726|NCT00943917|617281886|FG005|Stage II|Pregnancy|1|||
170640787|NCT03742102|616696994|FG001|Overall Study|Reason unknown|0|||
170640788|NCT03742102|616696995|FG002|Overall Study|Reason unknown|0|||
170640789|NCT03742102|616696996|FG003|Overall Study|Reason unknown|1|||
170640790|NCT03742102|616696997|FG004|Overall Study|Reason unknown|0|||
170640791|NCT03742102|616696998|FG005|Overall Study|Reason unknown|0|||
170640792|NCT03652740|616697002|FG000|Caffeine Choice Sessions (Weeks 2-8)|Lost to Follow-up|0|||
170640793|NCT03652740|616697003|FG001|Caffeine Choice Sessions (Weeks 2-8)|Lost to Follow-up|3|||
170640794|NCT03652740|616697004|FG002|Caffeine Choice Sessions (Weeks 2-8)|Lost to Follow-up|0|||
170640795|NCT03652740|616697005|FG003|Caffeine Choice Sessions (Weeks 2-8)|Lost to Follow-up|0|||
170640796|NCT03652740|616697002|FG000|Caffeine Choice Sessions (Weeks 2-8)|Protocol Violation|0|||
170640797|NCT03652740|616697003|FG001|Caffeine Choice Sessions (Weeks 2-8)|Protocol Violation|1|||
170640798|NCT03652740|616697004|FG002|Caffeine Choice Sessions (Weeks 2-8)|Protocol Violation|0|||
170640799|NCT03652740|616697005|FG003|Caffeine Choice Sessions (Weeks 2-8)|Protocol Violation|0|||
170640800|NCT00494676|616697008|FG000|Allocation|Withdrawal by Subject|2|||
170640801|NCT00494676|616697009|FG001|Allocation|Withdrawal by Subject|4|||
170640802|NCT00494676|616697008|FG000|First Intervention|Withdrawal by Subject|1|||
170640803|NCT00494676|616697009|FG001|First Intervention|Withdrawal by Subject|3|||
170640804|NCT00494676|616697008|FG000|Second Intervention|Withdrawal by Subject|1|||
170640805|NCT00494676|616697009|FG001|Second Intervention|Withdrawal by Subject|1|||
170640806|NCT02853331|616697012|FG000|Overall Study|Death|59|||
170640807|NCT02853331|616697013|FG001|Overall Study|Death|95|||
170640808|NCT02853331|616697012|FG000|Overall Study|Withdrawal by Subject|5|||
170640809|NCT02853331|616697013|FG001|Overall Study|Withdrawal by Subject|9|||
170640810|NCT02853331|616697012|FG000|Overall Study|Ongoing in study|368|||
170640811|NCT02853331|616697013|FG001|Overall Study|Ongoing in study|325|||
170640812|NCT05569954|616697014|FG000|Base Study|Lost to Follow-up|3|||
170640813|NCT05569954|616697015|FG001|Base Study|Lost to Follow-up|4|||
170640814|NCT05569954|616697014|FG000|Base Study|Protocol Violation|1|||
170640815|NCT05569954|616697015|FG001|Base Study|Protocol Violation|2|||
170640816|NCT05569954|616697014|FG000|Base Study|Withdrawal by Subject|4|||
170640817|NCT05569954|616697015|FG001|Base Study|Withdrawal by Subject|2|||
170640818|NCT05569954|616697014|FG000|Immunogenicity Substudy Extension|Lost to Follow-up|3|||
170640819|NCT05569954|616697015|FG001|Immunogenicity Substudy Extension|Lost to Follow-up|4|||
170640820|NCT05569954|616697014|FG000|Immunogenicity Substudy Extension|Randomized by mistake without study treatment|0|||
170491446|NCT02477332|616140083|FG001|Overall Study|Adverse Event|1|||
170491447|NCT02477332|616140084|FG002|Overall Study|Adverse Event|1|||
170491448|NCT02477332|616140085|FG003|Overall Study|Adverse Event|2|||
170491449|NCT02477332|616140086|FG004|Overall Study|Adverse Event|1|||
170491450|NCT02477332|616140087|FG005|Overall Study|Adverse Event|2|||
170491451|NCT02477332|616140082|FG000|Overall Study|Lack of Efficacy|1|||
170491452|NCT02477332|616140083|FG001|Overall Study|Lack of Efficacy|2|||
170491453|NCT02477332|616140084|FG002|Overall Study|Lack of Efficacy|1|||
170640821|NCT05569954|616697015|FG001|Immunogenicity Substudy Extension|Randomized by mistake without study treatment|2|||
170800727|NCT00943917|617281887|FG006|Stage II|Pregnancy|0|||
170800728|NCT00943917|617281888|FG007|Stage II|Pregnancy|0|||
170800729|NCT00943917|617281889|FG008|Stage II|Pregnancy|0|||
170800730|NCT00943917|617281890|FG009|Stage II|Pregnancy|0|||
170800731|NCT00943917|617281891|FG010|Stage II|Pregnancy|0|||
170800732|NCT00943917|617281892|FG011|Stage II|Pregnancy|0|||
170800733|NCT00943917|617281893|FG012|Stage II|Pregnancy|0|||
170800734|NCT00943917|617281894|FG013|Stage II|Pregnancy|0|||
170800735|NCT00943917|617281895|FG014|Stage II|Pregnancy|0|||
170800736|NCT00943917|617281881|FG000|Stage II Continuation|Adverse Event|0|||
170800737|NCT00943917|617281882|FG001|Stage II Continuation|Adverse Event|0|||
170800738|NCT00943917|617281883|FG002|Stage II Continuation|Adverse Event|0|||
170800739|NCT00943917|617281884|FG003|Stage II Continuation|Adverse Event|0|||
170800740|NCT00943917|617281885|FG004|Stage II Continuation|Adverse Event|0|||
170800741|NCT00943917|617281886|FG005|Stage II Continuation|Adverse Event|0|||
170800742|NCT00943917|617281887|FG006|Stage II Continuation|Adverse Event|0|||
170800743|NCT00943917|617281888|FG007|Stage II Continuation|Adverse Event|0|||
170800744|NCT00943917|617281889|FG008|Stage II Continuation|Adverse Event|0|||
170800745|NCT00943917|617281890|FG009|Stage II Continuation|Adverse Event|0|||
170800746|NCT00943917|617281891|FG010|Stage II Continuation|Adverse Event|0|||
170800747|NCT00943917|617281892|FG011|Stage II Continuation|Adverse Event|1|||
170800748|NCT00943917|617281893|FG012|Stage II Continuation|Adverse Event|2|||
170800749|NCT00943917|617281894|FG013|Stage II Continuation|Adverse Event|1|||
170800750|NCT00943917|617281895|FG014|Stage II Continuation|Adverse Event|1|||
170800751|NCT00943917|617281881|FG000|Stage II Continuation|Withdrawal by Subject|0|||
170491454|NCT02477332|616140085|FG003|Overall Study|Lack of Efficacy|2|||
170491455|NCT02477332|616140086|FG004|Overall Study|Lack of Efficacy|1|||
170640822|NCT05569954|616697014|FG000|Immunogenicity Substudy Extension|Withdrawal by Subject|12|||
170640823|NCT05569954|616697015|FG001|Immunogenicity Substudy Extension|Withdrawal by Subject|5|||
170640824|NCT05569954|616697014|FG000|Immunogenicity Substudy Extension|Non-Study pneumococcal vaccine administered|0|||
170800752|NCT00943917|617281882|FG001|Stage II Continuation|Withdrawal by Subject|0|||
170800753|NCT00943917|617281883|FG002|Stage II Continuation|Withdrawal by Subject|0|||
170491456|NCT02477332|616140087|FG005|Overall Study|Lack of Efficacy|1|||
170491457|NCT02477332|616140082|FG000|Overall Study|Non-compliance with study treatment|0|||
170491458|NCT02477332|616140083|FG001|Overall Study|Non-compliance with study treatment|1|||
170491459|NCT02477332|616140084|FG002|Overall Study|Non-compliance with study treatment|2|||
170491460|NCT02477332|616140085|FG003|Overall Study|Non-compliance with study treatment|0|||
170491461|NCT02477332|616140086|FG004|Overall Study|Non-compliance with study treatment|0|||
170491462|NCT02477332|616140087|FG005|Overall Study|Non-compliance with study treatment|0|||
170491463|NCT02477332|616140082|FG000|Overall Study|Pregnancy|0|||
170491464|NCT02477332|616140083|FG001|Overall Study|Pregnancy|0|||
170491465|NCT02477332|616140084|FG002|Overall Study|Pregnancy|0|||
170491466|NCT02477332|616140085|FG003|Overall Study|Pregnancy|1|||
170491467|NCT02477332|616140086|FG004|Overall Study|Pregnancy|0|||
170491468|NCT02477332|616140087|FG005|Overall Study|Pregnancy|0|||
170491469|NCT02477332|616140082|FG000|Overall Study|Protocol Violation|2|||
170800754|NCT00943917|617281884|FG003|Stage II Continuation|Withdrawal by Subject|0|||
170491470|NCT02477332|616140083|FG001|Overall Study|Protocol Violation|0|||
170800755|NCT00943917|617281885|FG004|Stage II Continuation|Withdrawal by Subject|0|||
170491471|NCT02477332|616140084|FG002|Overall Study|Protocol Violation|3|||
170491472|NCT02477332|616140085|FG003|Overall Study|Protocol Violation|3|||
170491473|NCT02477332|616140086|FG004|Overall Study|Protocol Violation|1|||
170491474|NCT02477332|616140087|FG005|Overall Study|Protocol Violation|1|||
170491475|NCT02477332|616140082|FG000|Overall Study|Technical problems|0|||
170491476|NCT02477332|616140083|FG001|Overall Study|Technical problems|0|||
170491477|NCT02477332|616140084|FG002|Overall Study|Technical problems|1|||
170491478|NCT02477332|616140085|FG003|Overall Study|Technical problems|0|||
170491479|NCT02477332|616140086|FG004|Overall Study|Technical problems|0|||
170491480|NCT02477332|616140087|FG005|Overall Study|Technical problems|0|||
170491481|NCT02477332|616140082|FG000|Overall Study|Lost to Follow-up|0|||
170491482|NCT02477332|616140083|FG001|Overall Study|Lost to Follow-up|0|||
170491483|NCT02477332|616140084|FG002|Overall Study|Lost to Follow-up|2|||
170491484|NCT02477332|616140085|FG003|Overall Study|Lost to Follow-up|0|||
170491485|NCT02477332|616140086|FG004|Overall Study|Lost to Follow-up|0|||
170491486|NCT02477332|616140087|FG005|Overall Study|Lost to Follow-up|0|||
170491487|NCT02477332|616140082|FG000|Overall Study|Physician Decision|0|||
170491488|NCT02477332|616140083|FG001|Overall Study|Physician Decision|0|||
170491489|NCT02477332|616140084|FG002|Overall Study|Physician Decision|1|||
170491490|NCT02477332|616140085|FG003|Overall Study|Physician Decision|3|||
170491491|NCT02477332|616140086|FG004|Overall Study|Physician Decision|0|||
170491492|NCT02477332|616140087|FG005|Overall Study|Physician Decision|1|||
170491493|NCT02477332|616140082|FG000|Overall Study|Withdrawal by Subject|0|||
170491494|NCT02477332|616140083|FG001|Overall Study|Withdrawal by Subject|3|||
170491495|NCT02477332|616140084|FG002|Overall Study|Withdrawal by Subject|1|||
170491496|NCT02477332|616140085|FG003|Overall Study|Withdrawal by Subject|2|||
170491497|NCT02477332|616140086|FG004|Overall Study|Withdrawal by Subject|1|||
170491498|NCT02477332|616140087|FG005|Overall Study|Withdrawal by Subject|0|||
170491499|NCT03340454|616140088|FG000|Overall Study|Lost to Follow-up|0|||
170491500|NCT03340454|616140089|FG001|Overall Study|Lost to Follow-up|4|||
170491501|NCT02568189|616140095|FG000|Overall Study|Protocol Violation|0|||
170491502|NCT02568189|616140096|FG001|Overall Study|Protocol Violation|0|||
170491503|NCT02568189|616140097|FG002|Overall Study|Protocol Violation|19|||
170491504|NCT02568189|616140098|FG003|Overall Study|Protocol Violation|18|||
170491505|NCT01119859|616140101|FG000|Overall Study|Adverse Event|9|||
170491506|NCT01119859|616140102|FG001|Overall Study|Adverse Event|10|||
170491507|NCT01119859|616140101|FG000|Overall Study|Death|2|||
170491508|NCT01119859|616140102|FG001|Overall Study|Death|0|||
170491509|NCT01119859|616140101|FG000|Overall Study|Insufficient therapeutic response|7|||
170491510|NCT01119859|616140102|FG001|Overall Study|Insufficient therapeutic response|14|||
170491511|NCT01119859|616140101|FG000|Overall Study|Refused treatment|3|||
170491512|NCT01119859|616140102|FG001|Overall Study|Refused treatment|6|||
170491513|NCT01119859|616140101|FG000|Overall Study|Failure to return|3|||
170491514|NCT01119859|616140102|FG001|Overall Study|Failure to return|0|||
170491515|NCT00523848|616140103|FG000|Overall Study|Adverse Event|11|||
170491516|NCT00523848|616140103|FG000|Overall Study|Withdrawal by Subject|2|||
170800756|NCT00943917|617281886|FG005|Stage II Continuation|Withdrawal by Subject|0|||
170800757|NCT00943917|617281887|FG006|Stage II Continuation|Withdrawal by Subject|0|||
170800758|NCT00943917|617281888|FG007|Stage II Continuation|Withdrawal by Subject|0|||
170491517|NCT00523848|616140103|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
170491518|NCT00523848|616140103|FG000|Overall Study|Disease Progression|5|||
170491519|NCT00523848|616140103|FG000|Overall Study|Other, unspecified|4|||
170491520|NCT03291431|616140107|FG000|Overall Study|Protocol Violation|2|||
170491521|NCT03291431|616140108|FG001|Overall Study|Protocol Violation|1|||
170491522|NCT03291431|616140107|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
170491523|NCT03291431|616140108|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
170491524|NCT03291431|616140107|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
170491525|NCT03291431|616140108|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
170491526|NCT02981082|616140111|FG000|Overall Study|Withdrawal by Subject|2|||
170491527|NCT02981082|616140112|FG001|Overall Study|Withdrawal by Subject|0|||
170491528|NCT02981082|616140111|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
170491529|NCT02981082|616140112|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
170491530|NCT02981082|616140111|FG000|Overall Study|Adverse Event|0|||
170491531|NCT02981082|616140112|FG001|Overall Study|Adverse Event|1|||
170491532|NCT03225105|616140113|FG000|Overall Study|Withdrawal by Subject|1|||
170491533|NCT03225105|616140114|FG001|Overall Study|Withdrawal by Subject|0|||
170491534|NCT03225105|616140115|FG002|Overall Study|Withdrawal by Subject|0|||
170491535|NCT03225105|616140116|FG003|Overall Study|Withdrawal by Subject|0|||
170491536|NCT03225105|616140113|FG000|Overall Study|Death|0|||
170491537|NCT03225105|616140114|FG001|Overall Study|Death|4|||
170491538|NCT03225105|616140115|FG002|Overall Study|Death|2|||
170491539|NCT03225105|616140116|FG003|Overall Study|Death|0|||
170491540|NCT03225105|616140113|FG000|Overall Study|Study termination per Sponsor Decision|2|||
170491541|NCT03225105|616140114|FG001|Overall Study|Study termination per Sponsor Decision|0|||
170491542|NCT03225105|616140115|FG002|Overall Study|Study termination per Sponsor Decision|3|||
170491543|NCT03225105|616140116|FG003|Overall Study|Study termination per Sponsor Decision|3|||
170491544|NCT03634033|616141847|FG000|Overall Study|Did not have a post-assessment|384|||
170491545|NCT03634033|616141848|FG001|Overall Study|Did not have a post-assessment|291|||
170491546|NCT03634033|616141849|FG002|Overall Study|Did not have a post-assessment|114|||
170491547|NCT03634033|616141850|FG003|Overall Study|Did not have a post-assessment|161|||
170491548|NCT03634033|616141851|FG004|Overall Study|Did not have a post-assessment|5|||
170491549|NCT03634033|616141852|FG005|Overall Study|Did not have a post-assessment|0|||
170491550|NCT03634033|616141853|FG006|Overall Study|Did not have a post-assessment|0|||
170491551|NCT03634033|616141847|FG000|Overall Study|Death|0|||
170491552|NCT03634033|616141848|FG001|Overall Study|Death|0|||
170491553|NCT03634033|616141849|FG002|Overall Study|Death|0|||
170491554|NCT03634033|616141850|FG003|Overall Study|Death|0|||
170491555|NCT03634033|616141851|FG004|Overall Study|Death|0|||
170491556|NCT03634033|616141852|FG005|Overall Study|Death|7|||
170491557|NCT03634033|616141853|FG006|Overall Study|Death|7|||
170491558|NCT03634033|616141847|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
170491559|NCT03634033|616141848|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
170491560|NCT03634033|616141849|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
170491561|NCT03634033|616141850|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
170491562|NCT03634033|616141851|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
170491563|NCT03634033|616141852|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
170491564|NCT03634033|616141853|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
170491565|NCT03634033|616141847|FG000|Overall Study|Lost to Follow-up|0|||
170491566|NCT03634033|616141848|FG001|Overall Study|Lost to Follow-up|0|||
170491567|NCT03634033|616141849|FG002|Overall Study|Lost to Follow-up|0|||
170491568|NCT03634033|616141850|FG003|Overall Study|Lost to Follow-up|0|||
170491569|NCT03634033|616141851|FG004|Overall Study|Lost to Follow-up|0|||
170491570|NCT03634033|616141852|FG005|Overall Study|Lost to Follow-up|1|||
170491571|NCT03634033|616141853|FG006|Overall Study|Lost to Follow-up|2|||
170491572|NCT03634033|616141847|FG000|Overall Study|Withdrawal by Subject|0|||
170491573|NCT03634033|616141848|FG001|Overall Study|Withdrawal by Subject|0|||
170491574|NCT03634033|616141849|FG002|Overall Study|Withdrawal by Subject|0|||
170491575|NCT03634033|616141850|FG003|Overall Study|Withdrawal by Subject|0|||
170491576|NCT03634033|616141851|FG004|Overall Study|Withdrawal by Subject|0|||
170491577|NCT03634033|616141852|FG005|Overall Study|Withdrawal by Subject|0|||
170491578|NCT03634033|616141853|FG006|Overall Study|Withdrawal by Subject|1|||
170491579|NCT04925557|616141854|FG000|Overall Study|Study closed|5|||
170491580|NCT04925557|616141855|FG001|Overall Study|Study closed|3|||
170491581|NCT05488470|616141856|FG000|Overall Study|Physician Decision|2|||
170491582|NCT05488470|616141856|FG000|Overall Study|Withdrawal by Subject|1|||
170491583|NCT05488470|616141856|FG000|Overall Study|Death|1|||
170491584|NCT00199797|616141857|FG000|Overall Study|Progressive Disease|1|||
170491585|NCT00199797|616141857|FG000|Overall Study|Adverse Event|1|||
170491586|NCT00199797|616141857|FG000|Overall Study|Physician Decision|1|||
170491587|NCT03652636|616141860|FG000|Overall Study|Withdrawal by Subject|7|||
170491588|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
170491589|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
170491590|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
170900159|NCT04375761|617640035|FG001|Overall Study|Test too painful|1|||
170491591|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
170491592|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Death|0|||
170491593|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Death|0|||
170491594|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Death|1|||
170491595|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Death|0|||
170491596|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
170900160|NCT04375761|617640034|FG000|Overall Study|Moved|0|||
170900161|NCT04375761|617640035|FG001|Overall Study|Moved|2|||
170491597|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
170491598|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
170800759|NCT00943917|617281889|FG008|Stage II Continuation|Withdrawal by Subject|0|||
170491599|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
170491600|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
170491601|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
170491602|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
170491603|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
170491604|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
170491605|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
170491606|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
170491607|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
170491608|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
170491609|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
170491610|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
170491611|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
170491612|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
170491613|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
170491614|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
170491615|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
170491616|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
170491617|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
170491618|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
170491619|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
170491620|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
170491621|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
170491622|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
170491623|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
170491624|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
170491625|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
170491626|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
170491627|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
170491628|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
170491629|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
170800760|NCT00943917|617281890|FG009|Stage II Continuation|Withdrawal by Subject|0|||
170800761|NCT00943917|617281891|FG010|Stage II Continuation|Withdrawal by Subject|0|||
170800762|NCT00943917|617281892|FG011|Stage II Continuation|Withdrawal by Subject|0|||
170800763|NCT00943917|617281893|FG012|Stage II Continuation|Withdrawal by Subject|0|||
170800764|NCT00943917|617281894|FG013|Stage II Continuation|Withdrawal by Subject|1|||
170800765|NCT00943917|617281895|FG014|Stage II Continuation|Withdrawal by Subject|3|||
170491630|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
170491631|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
170491632|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Other|8|||
170491633|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Other|14|||
170491634|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Other|8|||
170800766|NCT00943917|617281881|FG000|Stage II Continuation|Protocol Violation|0|||
170800767|NCT00943917|617281882|FG001|Stage II Continuation|Protocol Violation|0|||
170800768|NCT00943917|617281883|FG002|Stage II Continuation|Protocol Violation|0|||
170800769|NCT00943917|617281884|FG003|Stage II Continuation|Protocol Violation|0|||
170800770|NCT00943917|617281885|FG004|Stage II Continuation|Protocol Violation|0|||
170900162|NCT04375761|617640034|FG000|Overall Study|Nonresponsive|0|||
170900163|NCT04375761|617640035|FG001|Overall Study|Nonresponsive|5|||
170900164|NCT00960076|617640036|FG000|Overall Study|Adverse Event|1|||
170491635|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Other|23|||
170491636|NCT01106677|616141863|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
170491637|NCT01106677|616141864|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
170549687|NCT00853047|616356847|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
170549688|NCT02638493|616356848|FG000|Overall Study|Inability to provide semen samples|2|||
170900165|NCT00960076|617640037|FG001|Overall Study|Adverse Event|7|||
170900166|NCT00960076|617640036|FG000|Overall Study|No longer met study criteria|1|||
170800771|NCT00943917|617281886|FG005|Stage II Continuation|Protocol Violation|0|||
170800772|NCT00943917|617281887|FG006|Stage II Continuation|Protocol Violation|0|||
170800773|NCT00943917|617281888|FG007|Stage II Continuation|Protocol Violation|0|||
170800774|NCT00943917|617281889|FG008|Stage II Continuation|Protocol Violation|0|||
170800775|NCT00943917|617281890|FG009|Stage II Continuation|Protocol Violation|1|||
170491638|NCT01106677|616141865|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
170491639|NCT01106677|616141866|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
170549689|NCT02638493|616356849|FG001|Overall Study|Inability to provide semen samples|0|||
170800776|NCT00943917|617281891|FG010|Stage II Continuation|Protocol Violation|0|||
170800777|NCT00943917|617281892|FG011|Stage II Continuation|Protocol Violation|1|||
170800778|NCT00943917|617281893|FG012|Stage II Continuation|Protocol Violation|0|||
170800779|NCT00943917|617281894|FG013|Stage II Continuation|Protocol Violation|0|||
170800780|NCT00943917|617281895|FG014|Stage II Continuation|Protocol Violation|0|||
170800781|NCT00943917|617281881|FG000|Stage II Continuation|hypoglycemia|0|||
170800782|NCT00943917|617281882|FG001|Stage II Continuation|hypoglycemia|0|||
170800783|NCT00943917|617281883|FG002|Stage II Continuation|hypoglycemia|0|||
170800784|NCT00943917|617281884|FG003|Stage II Continuation|hypoglycemia|0|||
170800785|NCT00943917|617281885|FG004|Stage II Continuation|hypoglycemia|0|||
170800786|NCT00943917|617281886|FG005|Stage II Continuation|hypoglycemia|0|||
170800787|NCT00943917|617281887|FG006|Stage II Continuation|hypoglycemia|0|||
170800788|NCT00943917|617281888|FG007|Stage II Continuation|hypoglycemia|0|||
170800789|NCT00943917|617281889|FG008|Stage II Continuation|hypoglycemia|0|||
170800790|NCT00943917|617281890|FG009|Stage II Continuation|hypoglycemia|0|||
170800791|NCT00943917|617281891|FG010|Stage II Continuation|hypoglycemia|0|||
170800792|NCT00943917|617281892|FG011|Stage II Continuation|hypoglycemia|0|||
170800793|NCT00943917|617281893|FG012|Stage II Continuation|hypoglycemia|1|||
170800794|NCT00943917|617281894|FG013|Stage II Continuation|hypoglycemia|0|||
170800795|NCT00943917|617281895|FG014|Stage II Continuation|hypoglycemia|0|||
170800796|NCT00943917|617281881|FG000|Stage II Continuation|A1C elevation|0|||
170800797|NCT00943917|617281882|FG001|Stage II Continuation|A1C elevation|0|||
170800798|NCT00943917|617281883|FG002|Stage II Continuation|A1C elevation|0|||
170800799|NCT00943917|617281884|FG003|Stage II Continuation|A1C elevation|0|||
170800800|NCT00943917|617281885|FG004|Stage II Continuation|A1C elevation|0|||
170800801|NCT00943917|617281886|FG005|Stage II Continuation|A1C elevation|0|||
170800802|NCT00943917|617281887|FG006|Stage II Continuation|A1C elevation|0|||
170800803|NCT00943917|617281888|FG007|Stage II Continuation|A1C elevation|0|||
170800804|NCT00943917|617281889|FG008|Stage II Continuation|A1C elevation|0|||
170800805|NCT00943917|617281890|FG009|Stage II Continuation|A1C elevation|0|||
170800806|NCT00943917|617281891|FG010|Stage II Continuation|A1C elevation|0|||
170800807|NCT00943917|617281892|FG011|Stage II Continuation|A1C elevation|0|||
170800808|NCT00943917|617281893|FG012|Stage II Continuation|A1C elevation|0|||
170800809|NCT00943917|617281894|FG013|Stage II Continuation|A1C elevation|1|||
170800810|NCT00943917|617281895|FG014|Stage II Continuation|A1C elevation|0|||
170800811|NCT05707351|617281899|FG000|Overall Study|Withdrawal by Subject|2|||
170800812|NCT05707351|617281899|FG000|Overall Study|Reason Not Specified|1|||
170800813|NCT04012567|617281900|FG000|Overall Study|Lost to Follow-up|0|||
170800814|NCT04012567|617281901|FG001|Overall Study|Lost to Follow-up|1|||
170800815|NCT04012567|617281900|FG000|Overall Study|Withdrawal by Subject|1|||
170800816|NCT04012567|617281901|FG001|Overall Study|Withdrawal by Subject|0|||
170800817|NCT03774472|617281902|FG000|Overall Study|Physician Decision|1|||
170800818|NCT03774472|617281903|FG001|Overall Study|Physician Decision|0|||
170800819|NCT03774472|617281904|FG002|Overall Study|Physician Decision|0|||
170800820|NCT03774472|617281902|FG000|Overall Study|Progression prior to 4 weeks|0|||
170800821|NCT03774472|617281903|FG001|Overall Study|Progression prior to 4 weeks|1|||
170800822|NCT03774472|617281904|FG002|Overall Study|Progression prior to 4 weeks|0|||
170800823|NCT03774472|617281902|FG000|Overall Study|Withdrawal by Subject|0|||
170800824|NCT03774472|617281903|FG001|Overall Study|Withdrawal by Subject|1|||
170800825|NCT03774472|617281904|FG002|Overall Study|Withdrawal by Subject|0|||
170800826|NCT04158141|617281909|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
170800827|NCT04158141|617281910|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
170800828|NCT04158141|617281911|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
170800829|NCT04158141|617281909|FG000|Step 1: Registration|Adverse Event|1|||
170800830|NCT04158141|617281910|FG001|Step 1: Registration|Adverse Event|0|||
170800831|NCT04158141|617281911|FG002|Step 1: Registration|Adverse Event|0|||
170800832|NCT04158141|617281909|FG000|Step 1: Registration|Withdrawal by Subject|1|||
170800833|NCT04158141|617281910|FG001|Step 1: Registration|Withdrawal by Subject|0|||
170800834|NCT04158141|617281911|FG002|Step 1: Registration|Withdrawal by Subject|0|||
170800835|NCT04158141|617281909|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
170800836|NCT04158141|617281910|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
170800837|NCT04158141|617281911|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
170800838|NCT04121741|617281912|FG000|Overall Study|Protocol Violation|1|||
170800839|NCT04121741|617281913|FG001|Overall Study|Protocol Violation|0|||
170646062|NCT01628029|616717881|FG002|Overall Study|Incomplete primary outcome assessment|0|||
170800840|NCT04121741|617281914|FG002|Overall Study|Protocol Violation|0|||
170800841|NCT04121741|617281915|FG003|Overall Study|Protocol Violation|0|||
170800842|NCT04121741|617281916|FG004|Overall Study|Protocol Violation|0|||
170800843|NCT04121741|617281917|FG005|Overall Study|Protocol Violation|0|||
170800844|NCT01084863|617281919|FG000|Main Study Treatment Period|Disease progression|11|||
170800845|NCT01084863|617281920|FG001|Main Study Treatment Period|Disease progression|7|||
170800846|NCT01084863|617281919|FG000|Main Study Treatment Period|Adverse Event|5|||
170800847|NCT01084863|617281920|FG001|Main Study Treatment Period|Adverse Event|3|||
170800848|NCT01084863|617281919|FG000|Main Study Treatment Period|Other Reason|0|||
170800849|NCT01084863|617281920|FG001|Main Study Treatment Period|Other Reason|1|||
170800850|NCT01084863|617281919|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
170491640|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
170491641|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
170491642|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
170491643|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
170491644|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Death|0|||
170491645|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Death|0|||
170491646|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Death|0|||
170491647|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Death|1|||
170491648|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
170491649|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
170549690|NCT02638493|616356850|FG002|Overall Study|Inability to provide semen samples|0|||
170549691|NCT01213251|616358325|FG000|Overall Study|Death|2|||
170549692|NCT01213251|616358326|FG001|Overall Study|Death|1|||
170549693|NCT01213251|616358327|FG002|Overall Study|Death|2|||
170549694|NCT01213251|616358325|FG000|Overall Study|Exit|3|||
170549695|NCT01213251|616358326|FG001|Overall Study|Exit|2|||
170549696|NCT01213251|616358327|FG002|Overall Study|Exit|8|||
170549697|NCT01213251|616358325|FG000|Overall Study|Protocol Violation|1|||
170549698|NCT01213251|616358326|FG001|Overall Study|Protocol Violation|1|||
170549699|NCT01213251|616358327|FG002|Overall Study|Protocol Violation|0|||
170549700|NCT01213251|616358325|FG000|Overall Study|Missed 18-Month Follow-up|0|||
170549701|NCT01213251|616358326|FG001|Overall Study|Missed 18-Month Follow-up|0|||
170549702|NCT01213251|616358327|FG002|Overall Study|Missed 18-Month Follow-up|1|||
170549703|NCT01882829|616358332|FG000|Overall Study|Adverse Event|4|||
170549704|NCT01882829|616358332|FG000|Overall Study|Protocol Violation|1|||
170549705|NCT01882829|616358332|FG000|Overall Study|Withdrawal by Subject|1|||
170549706|NCT01557244|616358335|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
170549707|NCT01557244|616358336|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
170549708|NCT01557244|616358337|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
170549709|NCT01557244|616358338|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
170549710|NCT01557244|616358339|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
170549711|NCT01557244|616358340|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
170549712|NCT01557244|616358341|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
170549713|NCT01557244|616358335|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
170549714|NCT01557244|616358336|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
170549715|NCT01557244|616358337|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
170549716|NCT01557244|616358338|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
170549717|NCT01557244|616358339|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
170549718|NCT01557244|616358340|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
170549719|NCT01557244|616358341|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
170549720|NCT01557244|616358335|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
170549721|NCT01557244|616358336|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
170549722|NCT01557244|616358337|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
170549723|NCT01557244|616358338|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
170549724|NCT01557244|616358339|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
170549725|NCT01557244|616358340|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
170549726|NCT01557244|616358341|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
170549727|NCT01557244|616358335|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
170549728|NCT01557244|616358336|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
170549729|NCT01557244|616358337|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
170549730|NCT01557244|616358338|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
170549731|NCT01557244|616358339|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
170549732|NCT01557244|616358340|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
170549733|NCT01557244|616358341|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
170549734|NCT01557244|616358335|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
170549735|NCT01557244|616358336|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
170549736|NCT01557244|616358337|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
170800851|NCT01084863|617281920|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
170800852|NCT01084863|617281919|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
170491650|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
170491651|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
170491652|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
170491653|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
170549737|NCT01557244|616358338|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
170491654|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
170491655|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
170491656|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
170491657|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
170491658|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
170491659|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
170491660|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
170491661|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170491662|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170491663|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170491664|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
170491665|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
170491666|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
170491667|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
170491668|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
170491669|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
170549738|NCT01557244|616358339|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
170549739|NCT01557244|616358340|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
170549740|NCT01557244|616358341|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
170549741|NCT01557244|616358335|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
170549742|NCT01557244|616358336|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
170549743|NCT01557244|616358337|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
170549744|NCT01557244|616358338|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
170549745|NCT01557244|616358339|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
170549746|NCT01557244|616358340|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
170549747|NCT01557244|616358341|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
170549748|NCT01557244|616358335|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
170549749|NCT01557244|616358336|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
170549750|NCT01557244|616358337|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
170549751|NCT01557244|616358338|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
170549752|NCT01557244|616358339|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
170549753|NCT01557244|616358340|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
170549754|NCT01557244|616358341|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
170549755|NCT01557244|616358335|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
170549756|NCT01557244|616358336|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
170549757|NCT01557244|616358337|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
170549758|NCT01557244|616358338|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
170549759|NCT01557244|616358339|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
170549760|NCT01557244|616358340|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
170549761|NCT01557244|616358341|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
170549762|NCT01557244|616358335|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
170549763|NCT01557244|616358336|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
170549764|NCT01557244|616358337|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
170549765|NCT01557244|616358338|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
170549766|NCT01557244|616358339|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
170549767|NCT01557244|616358340|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
170549768|NCT01557244|616358341|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
170549769|NCT01557244|616358335|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
170549770|NCT01557244|616358336|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
170549771|NCT01557244|616358337|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
170549772|NCT01557244|616358338|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
170549773|NCT01557244|616358339|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
170800853|NCT01084863|617281920|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
170491670|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
170491671|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
170549774|NCT01557244|616358340|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
170549775|NCT01557244|616358341|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
170549776|NCT01557244|616358335|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
170800854|NCT01084863|617281919|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
170800855|NCT01084863|617281920|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
170800856|NCT01084863|617281919|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
170800857|NCT01084863|617281920|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
170800858|NCT01084863|617281919|FG000|Treatment Period Beyond Cycle 8|Other|0|||
170800859|NCT01084863|617281920|FG001|Treatment Period Beyond Cycle 8|Other|1|||
170491672|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
170491673|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
170491674|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
170491675|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
170491676|NCT01106677|616141863|FG000|Extension Period: Week 26 to Week 52|Other|6|||
170491677|NCT01106677|616141864|FG001|Extension Period: Week 26 to Week 52|Other|5|||
170491678|NCT01106677|616141865|FG002|Extension Period: Week 26 to Week 52|Other|8|||
170491679|NCT01106677|616141866|FG003|Extension Period: Week 26 to Week 52|Other|5|||
170491680|NCT03937908|616141867|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
170491681|NCT03937908|616141868|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
170491682|NCT00160706|616141870|FG000|Overall Study|Adverse Event|53|||
170491683|NCT00160706|616141870|FG000|Overall Study|Adverse Event and Other Reason|105|||
170491684|NCT00160706|616141870|FG000|Overall Study|Protocol Violation|3|||
170491685|NCT00160706|616141870|FG000|Overall Study|Withdrawal by Subject|41|||
170491686|NCT00160706|616141870|FG000|Overall Study|Withdrawal by Subject and Other|12|||
170491687|NCT00160706|616141870|FG000|Overall Study|Physician Decision|10|||
170491688|NCT00160706|616141870|FG000|Overall Study|Physician Decision and Other|3|||
170491689|NCT00160706|616141870|FG000|Overall Study|Lost to Follow-up|4|||
170491690|NCT00160706|616141870|FG000|Overall Study|Lost to Follow-up and Other|1|||
170491691|NCT00160706|616141870|FG000|Overall Study|Lack of Efficacy|42|||
170491692|NCT00160706|616141870|FG000|Overall Study|Lack of Efficacy and Other|1|||
170491693|NCT00160706|616141870|FG000|Overall Study|Other Reason|11|||
170491694|NCT00076752|616141871|FG000|Overall Study|Death|2|||
170491695|NCT00076752|616141871|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
170491696|NCT04481191|616141872|FG000|Overall Study|Withdrawn by parent/guardian|15|||
170491697|NCT04481191|616141873|FG001|Overall Study|Withdrawn by parent/guardian|10|||
170491698|NCT01284348|616141876|FG000|Overall Study|Death|1|||
170491699|NCT01284348|616141877|FG001|Overall Study|Death|1|||
170491700|NCT01284348|616141876|FG000|Overall Study|Withdrew consent|0|||
170491701|NCT01284348|616141877|FG001|Overall Study|Withdrew consent|1|||
170491702|NCT01284348|616141876|FG000|Overall Study|Status not recorded|9|||
170640825|NCT05569954|616697015|FG001|Immunogenicity Substudy Extension|Non-Study pneumococcal vaccine administered|1|||
170640826|NCT05569954|616697014|FG000|PBMC Substudy Extension|Withdrawal by Subject|2|||
170640827|NCT05569954|616697015|FG001|PBMC Substudy Extension|Withdrawal by Subject|0|||
170640828|NCT05767749|616697019|FG000|Overall Study|Withdrawal by Subject|0|||
170640829|NCT05767749|616697020|FG001|Overall Study|Withdrawal by Subject|0|||
170640830|NCT05767749|616697021|FG002|Overall Study|Withdrawal by Subject|2|||
170640831|NCT05767749|616697022|FG003|Overall Study|Withdrawal by Subject|2|||
170900167|NCT00960076|617640037|FG001|Overall Study|No longer met study criteria|5|||
170491703|NCT01284348|616141877|FG001|Overall Study|Status not recorded|10|||
170491704|NCT04112043|616141878|FG000|Overall Study|Withdrawal by Subject|1|||
170491705|NCT04112043|616141879|FG001|Overall Study|Withdrawal by Subject|1|||
170491706|NCT04112043|616141880|FG002|Overall Study|Withdrawal by Subject|1|||
170491707|NCT04112043|616141878|FG000|Overall Study|Taking NR supplement|1|||
170491708|NCT04112043|616141879|FG001|Overall Study|Taking NR supplement|0|||
170491709|NCT04112043|616141880|FG002|Overall Study|Taking NR supplement|0|||
170491710|NCT04112043|616141878|FG000|Overall Study|Adverse Event|0|||
170491711|NCT04112043|616141879|FG001|Overall Study|Adverse Event|1|||
170491712|NCT04112043|616141880|FG002|Overall Study|Adverse Event|0|||
170491713|NCT00955955|616141881|FG000|Overall Study|Lost to Follow-up|2|||
170491714|NCT00955955|616141882|FG001|Overall Study|Lost to Follow-up|0|||
170491715|NCT00955955|616141883|FG002|Overall Study|Lost to Follow-up|0|||
170491716|NCT02484456|616141885|FG000|Washout Period|Withdrawal by Subject|0|||
170491717|NCT02484456|616141886|FG001|Washout Period|Withdrawal by Subject|1|||
170491718|NCT02484456|616141885|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
170491719|NCT02484456|616141886|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
170491720|NCT02484456|616141885|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
170491721|NCT02484456|616141886|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
170491722|NCT02484456|616141885|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
170491723|NCT02484456|616141886|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
170491724|NCT01053663|616141889|FG000|Overall Study|Death|2|||
170491725|NCT01053663|616141889|FG000|Overall Study|Lost to Follow-up|1|||
170491726|NCT01053663|616141889|FG000|Overall Study|Poor IV Access|1|||
170900168|NCT00960076|617640036|FG000|Overall Study|Withdrawal by Subject|1|||
170900169|NCT00960076|617640037|FG001|Overall Study|Withdrawal by Subject|2|||
170491727|NCT01053663|616141889|FG000|Overall Study|Transferred to Another Hospital|1|||
170491728|NCT01053663|616141889|FG000|Overall Study|Negative Influenza Diagnosis|1|||
170900170|NCT00960076|617640036|FG000|Overall Study|Lost to Follow-up|3|||
170491729|NCT02920008|616141890|FG000|Overall Study|Death|117|||
170491730|NCT02920008|616141891|FG001|Overall Study|Death|127|||
170491731|NCT02920008|616141890|FG000|Overall Study|Withdrawal by Subject|3|||
170491732|NCT02920008|616141891|FG001|Overall Study|Withdrawal by Subject|6|||
170491733|NCT02920008|616141890|FG000|Overall Study|Lost to Follow-up|0|||
170491734|NCT02920008|616141891|FG001|Overall Study|Lost to Follow-up|1|||
170900171|NCT00960076|617640037|FG001|Overall Study|Lost to Follow-up|3|||
170900172|NCT00960076|617640036|FG000|Overall Study|Severe non-compliance to protocol|1|||
170491735|NCT03533114|616141892|FG000|Overall|Adverse Event|16|||
170491736|NCT03533114|616141893|FG001|Overall|Adverse Event|11|||
170491737|NCT03533114|616141892|FG000|Overall|Consent Withdrawal by Participant|7|||
170491738|NCT03533114|616141893|FG001|Overall|Consent Withdrawal by Participant|6|||
170491739|NCT03533114|616141892|FG000|Overall|Lack of Efficacy|5|||
170491740|NCT03533114|616141893|FG001|Overall|Lack of Efficacy|3|||
170491741|NCT03533114|616141892|FG000|Overall|Lost to Follow-up|1|||
170491742|NCT03533114|616141893|FG001|Overall|Lost to Follow-up|1|||
170491743|NCT03533114|616141892|FG000|Overall|Physician Decision|0|||
170491744|NCT03533114|616141893|FG001|Overall|Physician Decision|2|||
170491745|NCT03533114|616141892|FG000|Overall|Protocol deviation|1|||
170491746|NCT03533114|616141893|FG001|Overall|Protocol deviation|1|||
170491747|NCT03533114|616141892|FG000|Overall|Failure to meet randomization criteria|1|||
170491748|NCT03533114|616141893|FG001|Overall|Failure to meet randomization criteria|2|||
170491749|NCT03533114|616141892|FG000|Overall|Non-Compliance with study drug|0|||
170491750|NCT03533114|616141893|FG001|Overall|Non-Compliance with study drug|1|||
170491751|NCT03533114|616141892|FG000|Overall|Other|0|||
170491752|NCT03533114|616141893|FG001|Overall|Other|1|||
170491753|NCT03533114|616141892|FG000|Open Label Titration and Optimization|Adverse Event|11|||
170491754|NCT03533114|616141893|FG001|Open Label Titration and Optimization|Adverse Event|8|||
170491755|NCT03533114|616141892|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
170491756|NCT03533114|616141893|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
170491757|NCT03533114|616141892|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
170491758|NCT03533114|616141893|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
170491759|NCT03533114|616141892|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
170491760|NCT03533114|616141893|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
170491761|NCT03533114|616141892|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
170491762|NCT03533114|616141893|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
170491763|NCT03533114|616141892|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
170491764|NCT03533114|616141893|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
170491765|NCT03533114|616141892|FG000|Stable Dose|Adverse Event|0|||
170491766|NCT03533114|616141893|FG001|Stable Dose|Adverse Event|2|||
170491767|NCT03533114|616141892|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
170491768|NCT03533114|616141893|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
170491769|NCT03533114|616141892|FG000|Stable Dose|Lack of Efficacy|1|||
170491770|NCT03533114|616141893|FG001|Stable Dose|Lack of Efficacy|0|||
170491771|NCT03533114|616141892|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
170491772|NCT03533114|616141893|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
170491773|NCT03533114|616141892|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
170491774|NCT03533114|616141893|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
170491775|NCT03533114|616141892|FG000|Open-Label Safety Extension|Adverse Event|3|||
170491776|NCT03533114|616141893|FG001|Open-Label Safety Extension|Adverse Event|0|||
170491777|NCT03533114|616141892|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
170491778|NCT03533114|616141893|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
170491779|NCT03533114|616141892|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
170800860|NCT01084863|617281919|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
170800861|NCT01084863|617281920|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
170800862|NCT03473223|617281921|FG000|Overall Study|Lost to Follow-up|1|||
170800863|NCT03473223|617281922|FG001|Overall Study|Lost to Follow-up|1|||
170800864|NCT03473223|617281921|FG000|Overall Study|Withdrawal by Subject|47|||
170800865|NCT03473223|617281922|FG001|Overall Study|Withdrawal by Subject|42|||
170800866|NCT03473223|617281921|FG000|Overall Study|Indirect contact|32|||
170800867|NCT03473223|617281922|FG001|Overall Study|Indirect contact|29|||
170800868|NCT03473223|617281921|FG000|Overall Study|Other (Not specified)|32|||
170800869|NCT03473223|617281922|FG001|Overall Study|Other (Not specified)|20|||
170800870|NCT04505722|617281923|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
170800871|NCT04505722|617281924|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
170800872|NCT04505722|617281925|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
170800873|NCT04505722|617281923|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
170800874|NCT04505722|617281924|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
170800875|NCT04505722|617281925|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
170800876|NCT04505722|617281923|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
170800877|NCT04505722|617281924|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
170800878|NCT04505722|617281925|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
170800879|NCT04505722|617281923|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
170800880|NCT04505722|617281924|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
170491780|NCT03533114|616141893|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
170491781|NCT03533114|616141892|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
170800881|NCT04505722|617281925|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
170800882|NCT04505722|617281923|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
170491782|NCT03533114|616141893|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
170491783|NCT03533114|616141892|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
170491784|NCT03533114|616141893|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
170491785|NCT03852264|616141894|FG000|Third Research Visit|Lost to Follow-up|1|||
170491786|NCT03852264|616141895|FG001|Third Research Visit|Lost to Follow-up|0|||
170491787|NCT01862250|616141896|FG000|Overall Study|Adverse Event|4|||
170491788|NCT05338502|616141897|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
170800883|NCT04505722|617281924|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
170800884|NCT04505722|617281925|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
170800885|NCT04505722|617281923|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
170491789|NCT05338502|616141898|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
170491790|NCT05338502|616141899|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
170491791|NCT05338502|616141897|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
170491792|NCT05338502|616141898|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
170491793|NCT05338502|616141899|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
170491794|NCT00729157|616141902|FG000|Overall Study|Withdrawal by Subject|1|||
170491795|NCT03063086|616141910|FG000|Overall Study|technical problems|1|||
170491796|NCT03063086|616141911|FG001|Overall Study|technical problems|0|||
170491797|NCT03063086|616141912|FG002|Overall Study|technical problems|0|||
170491798|NCT03063086|616141913|FG003|Overall Study|technical problems|0|||
170491799|NCT03063086|616141914|FG004|Overall Study|technical problems|0|||
170491800|NCT03063086|616141915|FG005|Overall Study|technical problems|0|||
170491801|NCT03063086|616141910|FG000|Overall Study|Adverse Event|1|||
170491802|NCT03063086|616141911|FG001|Overall Study|Adverse Event|1|||
170491803|NCT03063086|616141912|FG002|Overall Study|Adverse Event|1|||
170491804|NCT03063086|616141913|FG003|Overall Study|Adverse Event|1|||
170491805|NCT03063086|616141914|FG004|Overall Study|Adverse Event|0|||
170491806|NCT03063086|616141915|FG005|Overall Study|Adverse Event|0|||
170491807|NCT03063086|616141910|FG000|Overall Study|subject/guardian decision|1|||
170491808|NCT03063086|616141911|FG001|Overall Study|subject/guardian decision|0|||
170491809|NCT03063086|616141912|FG002|Overall Study|subject/guardian decision|0|||
170491810|NCT03063086|616141913|FG003|Overall Study|subject/guardian decision|0|||
170491811|NCT03063086|616141914|FG004|Overall Study|subject/guardian decision|0|||
170491812|NCT03063086|616141915|FG005|Overall Study|subject/guardian decision|0|||
170491813|NCT03063086|616141910|FG000|Overall Study|Non-compliance with study treatment|0|||
170491814|NCT03063086|616141911|FG001|Overall Study|Non-compliance with study treatment|0|||
170491815|NCT03063086|616141912|FG002|Overall Study|Non-compliance with study treatment|0|||
170491816|NCT03063086|616141913|FG003|Overall Study|Non-compliance with study treatment|1|||
170491817|NCT03063086|616141914|FG004|Overall Study|Non-compliance with study treatment|0|||
170491818|NCT03063086|616141915|FG005|Overall Study|Non-compliance with study treatment|1|||
170491819|NCT03063086|616141910|FG000|Overall Study|Physician Decision|0|||
170491820|NCT03063086|616141911|FG001|Overall Study|Physician Decision|0|||
170491821|NCT03063086|616141912|FG002|Overall Study|Physician Decision|0|||
170491822|NCT03063086|616141913|FG003|Overall Study|Physician Decision|1|||
170549777|NCT01557244|616358336|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
170549778|NCT01557244|616358337|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
170549779|NCT01557244|616358338|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
170549780|NCT01557244|616358339|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
170549781|NCT01557244|616358340|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
170800886|NCT04505722|617281924|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
170800887|NCT04505722|617281925|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
170800888|NCT04505722|617281923|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
170800889|NCT04505722|617281924|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
170800890|NCT04505722|617281925|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
170800891|NCT04505722|617281923|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
170800892|NCT04505722|617281924|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
170800893|NCT04505722|617281925|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
170800894|NCT04505722|617281923|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
170800895|NCT04505722|617281924|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
170800896|NCT04505722|617281925|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
170800897|NCT04505722|617281923|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
170800898|NCT04505722|617281924|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
170800899|NCT04505722|617281925|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
170800900|NCT04505722|617281923|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
170800901|NCT04505722|617281924|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
170800902|NCT04505722|617281925|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
170800903|NCT04505722|617281923|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
170800904|NCT04505722|617281924|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
170800905|NCT04505722|617281925|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
170491823|NCT03063086|616141914|FG004|Overall Study|Physician Decision|0|||
170491824|NCT03063086|616141915|FG005|Overall Study|Physician Decision|0|||
170491825|NCT02244463|616141918|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
170800906|NCT04505722|617281923|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
170800907|NCT04505722|617281924|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
170800908|NCT04505722|617281925|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
170800909|NCT04505722|617281923|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
170800910|NCT04505722|617281924|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
170800911|NCT04505722|617281925|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
170800912|NCT04505722|617281923|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
170800913|NCT04505722|617281924|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
170800914|NCT04505722|617281925|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
170800915|NCT02890355|617281926|FG000|Overall Study|Adverse Event|5|||
170800916|NCT02890355|617281927|FG001|Overall Study|Adverse Event|5|||
170800917|NCT02890355|617281926|FG000|Overall Study|Refusal unrelated to adverse event|5|||
170800918|NCT02890355|617281927|FG001|Overall Study|Refusal unrelated to adverse event|10|||
170800919|NCT02890355|617281926|FG000|Overall Study|Progression/relapse|46|||
170800920|NCT02890355|617281927|FG001|Overall Study|Progression/relapse|39|||
170800921|NCT02890355|617281926|FG000|Overall Study|Not protocol specified|3|||
170800922|NCT02890355|617281927|FG001|Overall Study|Not protocol specified|4|||
170800923|NCT00319696|617281928|FG000|Overall Study|Adverse Event|36|||
170800924|NCT00319696|617281928|FG000|Overall Study|withdrawal of consent|14|||
170800925|NCT00319696|617281928|FG000|Overall Study|administrative|7|||
170800926|NCT00319696|617281928|FG000|Overall Study|Lost to Follow-up|3|||
170800927|NCT04129450|617281929|FG000|Overall Study|Lost to Follow-up|20|||
170800928|NCT04129450|617281930|FG001|Overall Study|Lost to Follow-up|10|||
170800929|NCT04129450|617281929|FG000|Overall Study|Withdrawal by Subject|9|||
170800930|NCT04129450|617281930|FG001|Overall Study|Withdrawal by Subject|5|||
170800931|NCT04129450|617281929|FG000|Overall Study|Work Family Obligations|2|||
170800932|NCT04129450|617281930|FG001|Overall Study|Work Family Obligations|0|||
170800933|NCT04129450|617281929|FG000|Overall Study|Other|3|||
170800934|NCT04129450|617281930|FG001|Overall Study|Other|0|||
170800935|NCT03352713|617283136|FG000|Overall Study|Lost to Follow-up|8|||
170800936|NCT03352713|617283136|FG000|Overall Study|Withdrawn by investigator|5|||
170800937|NCT03352713|617283136|FG000|Overall Study|Completed 0 EMAs|8|||
170800938|NCT03352713|617283136|FG000|Overall Study|Device incompatible/stolen|5|||
170800939|NCT01812759|617283137|FG000|Overall Study|Physician Decision|0|||
170800940|NCT01812759|617283138|FG001|Overall Study|Physician Decision|0|||
170800941|NCT01812759|617283139|FG002|Overall Study|Physician Decision|1|||
170800942|NCT00536120|617283140|FG000|Overall Study|Lost to Follow-up|1|||
170800943|NCT00536120|617283141|FG001|Overall Study|Lost to Follow-up|0|||
170800944|NCT00536120|617283140|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
170800945|NCT00536120|617283141|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
170800946|NCT00536120|617283140|FG000|Overall Study|Non-compliance|1|||
170800947|NCT00536120|617283141|FG001|Overall Study|Non-compliance|0|||
170800948|NCT00536120|617283140|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
170800949|NCT00536120|617283141|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
170800950|NCT00536120|617283140|FG000|Overall Study|Steroid Use|0|||
170800951|NCT00536120|617283141|FG001|Overall Study|Steroid Use|2|||
170800952|NCT00536120|617283140|FG000|Overall Study|Missed Study Visit|0|||
170800953|NCT00536120|617283141|FG001|Overall Study|Missed Study Visit|1|||
170800954|NCT02722434|617283142|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
170800955|NCT02722434|617283143|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
170800956|NCT02722434|617283142|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
170800957|NCT02722434|617283143|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
170800958|NCT04559698|617283144|FG000|Overall Study|Lost to Follow-up|14|||
170800959|NCT04559698|617283145|FG001|Overall Study|Lost to Follow-up|15|||
170800960|NCT04559698|617283144|FG000|Overall Study|Withdrawal by Subject|0|||
170800961|NCT04559698|617283145|FG001|Overall Study|Withdrawal by Subject|1|||
170800962|NCT03437733|617283146|FG000|Overall Study|Eligibility criteria not met|0|||
170800963|NCT03437733|617283147|FG001|Overall Study|Eligibility criteria not met|3|||
170800964|NCT01982682|617283148|FG000|Overall Study|Physician Decision|1|||
170800965|NCT02760654|617283149|FG000|Overall Study|Lost to Follow-up|3|||
170800966|NCT02760654|617283150|FG001|Overall Study|Lost to Follow-up|3|||
170800967|NCT02760654|617283149|FG000|Overall Study|Withdrawal by Subject|4|||
170800968|NCT02760654|617283150|FG001|Overall Study|Withdrawal by Subject|3|||
170800969|NCT01084694|617283152|FG000|Overall Study|Withdrawal by Subject|2|||
170800970|NCT01084694|617283153|FG001|Overall Study|Withdrawal by Subject|1|||
170800971|NCT01084694|617283152|FG000|Overall Study|Death|2|||
170800972|NCT01084694|617283153|FG001|Overall Study|Death|12|||
170800973|NCT01084694|617283152|FG000|Overall Study|eligibility not maintained|2|||
170800974|NCT01084694|617283153|FG001|Overall Study|eligibility not maintained|7|||
170800975|NCT00945321|617283157|FG000|Period 1|Adverse Event|0|||
170800976|NCT00945321|617283158|FG001|Period 1|Adverse Event|0|||
170800977|NCT00945321|617283159|FG002|Period 1|Adverse Event|0|||
170800978|NCT00945321|617283160|FG003|Period 1|Adverse Event|0|||
170800979|NCT00945321|617283161|FG004|Period 1|Adverse Event|1|||
170800980|NCT00945321|617283162|FG005|Period 1|Adverse Event|0|||
170640832|NCT05767749|616697023|FG004|Overall Study|Withdrawal by Subject|2|||
170640833|NCT05767749|616697024|FG005|Overall Study|Withdrawal by Subject|2|||
170640834|NCT00924027|616697026|FG000|Overall Study|Lost to Further Follow-Up|4|||
170640835|NCT00924027|616697027|FG001|Overall Study|Lost to Further Follow-Up|0|||
170640836|NCT00924027|616697028|FG002|Overall Study|Lost to Further Follow-Up|0|||
170640837|NCT00924027|616697029|FG003|Overall Study|Lost to Further Follow-Up|0|||
170640838|NCT00924027|616697026|FG000|Overall Study|Physician Decision|1|||
170640839|NCT00924027|616697027|FG001|Overall Study|Physician Decision|0|||
170640840|NCT00924027|616697028|FG002|Overall Study|Physician Decision|0|||
170640841|NCT00924027|616697029|FG003|Overall Study|Physician Decision|1|||
170640842|NCT00924027|616697026|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
170640843|NCT00924027|616697027|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
170640844|NCT00924027|616697028|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
170640845|NCT00924027|616697029|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
170640846|NCT00924027|616697026|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
170640847|NCT00924027|616697027|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
170640848|NCT00924027|616697028|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
170640849|NCT00924027|616697029|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
170640850|NCT00924027|616697026|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
170640851|NCT00924027|616697027|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
170640852|NCT00924027|616697028|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
170640853|NCT00924027|616697029|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
170640854|NCT00444678|616698319|FG000|Overall Study|Toxicity|11|||
170640855|NCT00444678|616698319|FG000|Overall Study|Disease Progression|12|||
170640856|NCT00444678|616698319|FG000|Overall Study|Death|3|||
170640857|NCT00444678|616698319|FG000|Overall Study|Physician Decision|3|||
170640858|NCT00444678|616698319|FG000|Overall Study|Withdrawal by Subject|2|||
170640859|NCT02597478|616698321|FG000|Overall Study|Withdrawal by Subject|2|||
170640860|NCT02597478|616698322|FG001|Overall Study|Withdrawal by Subject|0|||
170640861|NCT02597478|616698321|FG000|Overall Study|Change of opioid dose|1|||
170640862|NCT02597478|616698322|FG001|Overall Study|Change of opioid dose|0|||
170640863|NCT02597478|616698321|FG000|Overall Study|Insufficient exertional dyspnea|0|||
170640864|NCT02597478|616698322|FG001|Overall Study|Insufficient exertional dyspnea|1|||
170640865|NCT01536067|616698323|FG000|Overall Study|Disease Progression|1|||
170640866|NCT00606905|616698326|FG000|Overall Study|No Pregnancy|9|||
170800981|NCT00945321|617283157|FG000|Period 4|Lost to Follow-up|0|||
170800982|NCT00945321|617283158|FG001|Period 4|Lost to Follow-up|0|||
170800983|NCT00945321|617283159|FG002|Period 4|Lost to Follow-up|0|||
170800984|NCT00945321|617283160|FG003|Period 4|Lost to Follow-up|0|||
170800985|NCT00945321|617283161|FG004|Period 4|Lost to Follow-up|0|||
170800986|NCT00945321|617283162|FG005|Period 4|Lost to Follow-up|1|||
170800987|NCT04017611|617283163|FG000|Overall Study|Withdrawn prior to completion|1|||
170800988|NCT02291913|617283164|FG000|Overall Study|Progressive Disease|32|||
170800989|NCT02291913|617283164|FG000|Overall Study|Adverse Event|11|||
170800990|NCT02291913|617283164|FG000|Overall Study|Death|2|||
170800991|NCT02291913|617283164|FG000|Overall Study|Physician Decision|1|||
170800992|NCT02291913|617283164|FG000|Overall Study|Withdrawal by Subject|1|||
170800993|NCT02291913|617283164|FG000|Overall Study|Protocol Violation|1|||
170800994|NCT02111096|617283165|FG000|Overall Study|Adverse Event|4|||
170800995|NCT02111096|617283166|FG001|Overall Study|Adverse Event|1|||
170800996|NCT02111096|617283167|FG002|Overall Study|Adverse Event|2|||
170800997|NCT02111096|617283165|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170800998|NCT02111096|617283166|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170800999|NCT02111096|617283167|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170801000|NCT02111096|617283165|FG000|Overall Study|Lost to Follow Up|1|||
170801001|NCT02111096|617283166|FG001|Overall Study|Lost to Follow Up|1|||
170801002|NCT02111096|617283167|FG002|Overall Study|Lost to Follow Up|1|||
170801003|NCT02111096|617283165|FG000|Overall Study|Physician Decision|0|||
170801004|NCT02111096|617283166|FG001|Overall Study|Physician Decision|1|||
170801005|NCT02111096|617283167|FG002|Overall Study|Physician Decision|0|||
170801006|NCT02111096|617283165|FG000|Overall Study|Protocol Violation|1|||
170801007|NCT02111096|617283166|FG001|Overall Study|Protocol Violation|0|||
170801008|NCT02111096|617283167|FG002|Overall Study|Protocol Violation|1|||
170801009|NCT02111096|617283165|FG000|Overall Study|Terminated by Sponsor|53|||
170801010|NCT02111096|617283166|FG001|Overall Study|Terminated by Sponsor|35|||
170801011|NCT02111096|617283167|FG002|Overall Study|Terminated by Sponsor|54|||
170801012|NCT02111096|617283165|FG000|Overall Study|Withdrawal by Subject|4|||
170801013|NCT02111096|617283166|FG001|Overall Study|Withdrawal by Subject|2|||
170900173|NCT00960076|617640037|FG001|Overall Study|Severe non-compliance to protocol|2|||
170640867|NCT00606905|616698327|FG001|Overall Study|No Pregnancy|6|||
170640868|NCT00606905|616698326|FG000|Overall Study|Non-Index Pregnancy|1|||
170640869|NCT00606905|616698327|FG001|Overall Study|Non-Index Pregnancy|4|||
170801014|NCT02111096|617283167|FG002|Overall Study|Withdrawal by Subject|8|||
170801015|NCT03621735|617283168|FG000|Overall Study|Withdrawal by Subject|13|||
170801016|NCT03621735|617283169|FG001|Overall Study|Withdrawal by Subject|13|||
170801017|NCT02185794|617283171|FG000|Overall Study|Enrolled but Never Dosed|1|||
170491826|NCT02244463|616141919|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
170491827|NCT02244463|616141920|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
170491828|NCT02244463|616141921|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
170491829|NCT02244463|616141922|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
170491830|NCT02244463|616141923|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
170491831|NCT02244463|616141918|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
170491832|NCT02244463|616141919|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
170491833|NCT02244463|616141920|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
170491834|NCT02244463|616141921|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
170491835|NCT02244463|616141922|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
170491836|NCT02244463|616141923|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
170491837|NCT02244463|616141918|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
170491838|NCT02244463|616141919|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
170801018|NCT02185794|617283172|FG001|Overall Study|Enrolled but Never Dosed|6|||
170801019|NCT02185794|617283173|FG002|Overall Study|Enrolled but Never Dosed|3|||
170801020|NCT02185794|617283174|FG003|Overall Study|Enrolled but Never Dosed|1|||
170801021|NCT02185794|617283175|FG004|Overall Study|Enrolled but Never Dosed|1|||
170491839|NCT02244463|616141920|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
170491840|NCT02244463|616141921|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
170491841|NCT02244463|616141922|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
170491842|NCT02244463|616141923|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
170491843|NCT02244463|616141918|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
170491844|NCT02244463|616141919|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
170491845|NCT02244463|616141920|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
170491846|NCT02244463|616141921|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
170491847|NCT02244463|616141922|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
170491848|NCT02244463|616141923|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
170491849|NCT02244463|616141918|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
170491850|NCT02244463|616141919|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
170491851|NCT02244463|616141920|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
170491852|NCT02244463|616141921|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
170491853|NCT02244463|616141922|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
170491854|NCT02244463|616141923|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
170491855|NCT02244463|616141918|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
170491856|NCT02244463|616141919|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
170491857|NCT02244463|616141920|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
170491858|NCT02244463|616141921|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
170491859|NCT02244463|616141922|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
170491860|NCT02244463|616141923|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
170491861|NCT02244463|616141918|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
170491862|NCT02244463|616141919|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
170491863|NCT02244463|616141920|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
170801022|NCT02185794|617283176|FG005|Overall Study|Enrolled but Never Dosed|0|||
170801023|NCT02185794|617283171|FG000|Overall Study|Investigator's Discretion|1|||
170801024|NCT02185794|617283172|FG001|Overall Study|Investigator's Discretion|0|||
170801025|NCT02185794|617283173|FG002|Overall Study|Investigator's Discretion|1|||
170801026|NCT02185794|617283174|FG003|Overall Study|Investigator's Discretion|2|||
170801027|NCT02185794|617283175|FG004|Overall Study|Investigator's Discretion|2|||
170801028|NCT02185794|617283176|FG005|Overall Study|Investigator's Discretion|15|||
170801029|NCT02185794|617283171|FG000|Overall Study|Withdrew Consent|2|||
170801030|NCT02185794|617283172|FG001|Overall Study|Withdrew Consent|5|||
170801031|NCT02185794|617283173|FG002|Overall Study|Withdrew Consent|10|||
170801032|NCT02185794|617283174|FG003|Overall Study|Withdrew Consent|2|||
170801033|NCT02185794|617283175|FG004|Overall Study|Withdrew Consent|0|||
170801034|NCT02185794|617283176|FG005|Overall Study|Withdrew Consent|0|||
170801035|NCT02185794|617283171|FG000|Overall Study|Lost to Follow-up|1|||
170801036|NCT02185794|617283172|FG001|Overall Study|Lost to Follow-up|2|||
170801037|NCT02185794|617283173|FG002|Overall Study|Lost to Follow-up|2|||
170801038|NCT02185794|617283174|FG003|Overall Study|Lost to Follow-up|3|||
170801039|NCT02185794|617283175|FG004|Overall Study|Lost to Follow-up|0|||
170801040|NCT02185794|617283176|FG005|Overall Study|Lost to Follow-up|1|||
170801041|NCT00336505|617283177|FG000|Overall Study|Adverse Event|10|||
170801042|NCT00336505|617283178|FG001|Overall Study|Adverse Event|9|||
170801043|NCT00336505|617283177|FG000|Overall Study|Lack of Efficacy|8|||
170801044|NCT00336505|617283178|FG001|Overall Study|Lack of Efficacy|4|||
170801045|NCT00336505|617283177|FG000|Overall Study|Lost to Follow-up|7|||
170801046|NCT00336505|617283178|FG001|Overall Study|Lost to Follow-up|4|||
170801047|NCT00336505|617283177|FG000|Overall Study|Withdrawal by Subject|5|||
170801048|NCT00336505|617283178|FG001|Overall Study|Withdrawal by Subject|3|||
170801049|NCT00336505|617283177|FG000|Overall Study|Other|7|||
170801050|NCT00336505|617283178|FG001|Overall Study|Other|7|||
170801051|NCT00366249|617283179|FG000|Overall Study|Adverse Event|53|||
170900174|NCT00960076|617640036|FG000|Overall Study|Hyperglycemia|1|||
170491864|NCT02244463|616141921|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
170491865|NCT02244463|616141922|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
170491866|NCT02244463|616141923|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
170491867|NCT02244463|616141918|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
170491868|NCT02244463|616141919|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
170491869|NCT02244463|616141920|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
170491870|NCT02244463|616141921|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
170491871|NCT02244463|616141922|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
170491872|NCT02244463|616141923|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
170491873|NCT02244463|616141918|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
170491874|NCT02244463|616141919|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
170491875|NCT02244463|616141920|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
170491876|NCT02244463|616141921|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
170491877|NCT02244463|616141922|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
170491878|NCT02244463|616141923|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
170491879|NCT02244463|616141918|FG000|Period 5: Phase II|Disease Progression|0|||
170491880|NCT02244463|616141919|FG001|Period 5: Phase II|Disease Progression|0|||
170491881|NCT02244463|616141920|FG002|Period 5: Phase II|Disease Progression|0|||
170491882|NCT02244463|616141921|FG003|Period 5: Phase II|Disease Progression|0|||
170491883|NCT02244463|616141922|FG004|Period 5: Phase II|Disease Progression|10|||
170491884|NCT02244463|616141923|FG005|Period 5: Phase II|Disease Progression|11|||
170491885|NCT02244463|616141918|FG000|Period 5: Phase II|Physician Decision|0|||
170491886|NCT02244463|616141919|FG001|Period 5: Phase II|Physician Decision|0|||
170491887|NCT02244463|616141920|FG002|Period 5: Phase II|Physician Decision|0|||
170491888|NCT02244463|616141921|FG003|Period 5: Phase II|Physician Decision|0|||
170491889|NCT02244463|616141922|FG004|Period 5: Phase II|Physician Decision|3|||
170491890|NCT02244463|616141923|FG005|Period 5: Phase II|Physician Decision|2|||
170549782|NCT01557244|616358341|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
170549783|NCT01557244|616358335|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
170549784|NCT01557244|616358336|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
170549785|NCT01557244|616358337|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
170640870|NCT00606905|616698326|FG000|Overall Study|Withdrew|5|||
170801052|NCT00366249|617283180|FG001|Overall Study|Adverse Event|28|||
170801053|NCT00366249|617283179|FG000|Overall Study|Death|0|||
170801054|NCT00366249|617283180|FG001|Overall Study|Death|1|||
170801055|NCT00366249|617283179|FG000|Overall Study|Physician Decision|5|||
170801056|NCT00366249|617283180|FG001|Overall Study|Physician Decision|2|||
170801057|NCT00366249|617283179|FG000|Overall Study|Lost to Follow-up|2|||
170801058|NCT00366249|617283180|FG001|Overall Study|Lost to Follow-up|0|||
170801059|NCT00366249|617283179|FG000|Overall Study|Protocol Violation|1|||
170801060|NCT00366249|617283180|FG001|Overall Study|Protocol Violation|2|||
170801061|NCT00366249|617283179|FG000|Overall Study|Withdrawal by Subject|18|||
170801062|NCT00366249|617283180|FG001|Overall Study|Withdrawal by Subject|4|||
170801063|NCT00366249|617283179|FG000|Overall Study|Lack of Efficacy|21|||
170801064|NCT00366249|617283180|FG001|Overall Study|Lack of Efficacy|21|||
170801065|NCT00366249|617283179|FG000|Overall Study|Most due to osteomylitis status|31|||
170801066|NCT00366249|617283180|FG001|Overall Study|Most due to osteomylitis status|20|||
170801067|NCT01105975|617283181|FG000|Overall Study|Adverse Event|2|||
170801068|NCT01105975|617283182|FG001|Overall Study|Adverse Event|1|||
170801069|NCT01105975|617283183|FG002|Overall Study|Adverse Event|5|||
170801070|NCT01105975|617283184|FG003|Overall Study|Adverse Event|1|||
170801071|NCT01105975|617283185|FG004|Overall Study|Adverse Event|0|||
170801072|NCT01105975|617283186|FG005|Overall Study|Adverse Event|1|||
170801073|NCT01105975|617283187|FG006|Overall Study|Adverse Event|2|||
170801074|NCT01105975|617283188|FG007|Overall Study|Adverse Event|4|||
170801075|NCT01105975|617283189|FG008|Overall Study|Adverse Event|1|||
170801076|NCT01105975|617283190|FG009|Overall Study|Adverse Event|4|||
170801077|NCT01105975|617283181|FG000|Overall Study|Withdrawal by Subject|2|||
170801078|NCT01105975|617283182|FG001|Overall Study|Withdrawal by Subject|2|||
170801079|NCT01105975|617283183|FG002|Overall Study|Withdrawal by Subject|2|||
170801080|NCT01105975|617283184|FG003|Overall Study|Withdrawal by Subject|0|||
170801081|NCT01105975|617283185|FG004|Overall Study|Withdrawal by Subject|4|||
170801082|NCT01105975|617283186|FG005|Overall Study|Withdrawal by Subject|1|||
170801083|NCT01105975|617283187|FG006|Overall Study|Withdrawal by Subject|2|||
170801084|NCT01105975|617283188|FG007|Overall Study|Withdrawal by Subject|1|||
170801085|NCT01105975|617283189|FG008|Overall Study|Withdrawal by Subject|0|||
170801086|NCT01105975|617283190|FG009|Overall Study|Withdrawal by Subject|3|||
170801087|NCT01105975|617283181|FG000|Overall Study|Lost to Follow-up|1|||
170801088|NCT01105975|617283182|FG001|Overall Study|Lost to Follow-up|0|||
170801089|NCT01105975|617283183|FG002|Overall Study|Lost to Follow-up|0|||
170801090|NCT01105975|617283184|FG003|Overall Study|Lost to Follow-up|1|||
170801091|NCT01105975|617283185|FG004|Overall Study|Lost to Follow-up|1|||
170801092|NCT01105975|617283186|FG005|Overall Study|Lost to Follow-up|0|||
170801093|NCT01105975|617283187|FG006|Overall Study|Lost to Follow-up|0|||
170491891|NCT02244463|616141918|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
170491892|NCT02244463|616141919|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
170491893|NCT02244463|616141920|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
170491894|NCT02244463|616141921|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
170491895|NCT02244463|616141922|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
170491896|NCT02244463|616141923|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
170491897|NCT02244463|616141918|FG000|Period 5: Phase II|Intercurrent Illness|0|||
170491898|NCT02244463|616141919|FG001|Period 5: Phase II|Intercurrent Illness|0|||
170491899|NCT02244463|616141920|FG002|Period 5: Phase II|Intercurrent Illness|0|||
170491900|NCT02244463|616141921|FG003|Period 5: Phase II|Intercurrent Illness|0|||
170491901|NCT02244463|616141922|FG004|Period 5: Phase II|Intercurrent Illness|2|||
170491902|NCT02244463|616141923|FG005|Period 5: Phase II|Intercurrent Illness|0|||
170491903|NCT02244463|616141918|FG000|Period 5: Phase II|Adverse Event|0|||
170491904|NCT02244463|616141919|FG001|Period 5: Phase II|Adverse Event|0|||
170491905|NCT02244463|616141920|FG002|Period 5: Phase II|Adverse Event|0|||
170491906|NCT02244463|616141921|FG003|Period 5: Phase II|Adverse Event|0|||
170491907|NCT02244463|616141922|FG004|Period 5: Phase II|Adverse Event|0|||
170491908|NCT02244463|616141923|FG005|Period 5: Phase II|Adverse Event|2|||
170491909|NCT02244463|616141918|FG000|Period 5: Phase II|Still On treatment|0|||
170491910|NCT02244463|616141919|FG001|Period 5: Phase II|Still On treatment|0|||
170491911|NCT02244463|616141920|FG002|Period 5: Phase II|Still On treatment|0|||
170491912|NCT02244463|616141921|FG003|Period 5: Phase II|Still On treatment|0|||
170491913|NCT02244463|616141922|FG004|Period 5: Phase II|Still On treatment|0|||
170491914|NCT02244463|616141923|FG005|Period 5: Phase II|Still On treatment|3|||
170491915|NCT05481125|616141924|FG000|Overall Study|Adverse Event|1|||
170491916|NCT05481125|616141925|FG001|Overall Study|Adverse Event|0|||
170491917|NCT05481125|616141924|FG000|Overall Study|Lost to Follow-up|0|||
170491918|NCT05481125|616141925|FG001|Overall Study|Lost to Follow-up|1|||
170491919|NCT05481125|616141924|FG000|Overall Study|Withdrawal by Subject|0|||
170491920|NCT05481125|616141925|FG001|Overall Study|Withdrawal by Subject|1|||
170491921|NCT03702010|616141926|FG000|Follow-up (30days)|Lack of Efficacy|2|||
170491922|NCT03702010|616141927|FG001|Follow-up (30days)|Lack of Efficacy|2|||
170491923|NCT01769508|616141928|FG000|Overall Study|Death|3|||
170491924|NCT01769508|616141928|FG000|Overall Study|Withdrawal by Subject|1|||
170491925|NCT01769508|616141928|FG000|Overall Study|Adverse Event|1|||
170491926|NCT01769508|616141928|FG000|Overall Study|Lost to Follow-up|1|||
170491927|NCT00637000|616141929|FG000|Overall Study|Withdrawal by Subject|4|||
170491928|NCT00637000|616141930|FG001|Overall Study|Withdrawal by Subject|3|||
170491929|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
170491930|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
170491931|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
170491932|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
170491933|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
170491934|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
170491935|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
170491936|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
170491937|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
170491938|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
170491939|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
170491940|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
170491941|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
170491942|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
170491943|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
170491944|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
170491945|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
170491946|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
170491947|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
170491948|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
170491949|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
170491950|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
170491951|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
170491952|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
170491953|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
170491954|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
170491955|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
170491956|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
170491957|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
170491958|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
170491959|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
170491960|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
170549786|NCT01557244|616358338|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
170491961|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
170900175|NCT00960076|617640037|FG001|Overall Study|Hyperglycemia|5|||
170900176|NCT00960076|617640036|FG000|Overall Study|Did not attend the termination visit|0|||
170900177|NCT00960076|617640037|FG001|Overall Study|Did not attend the termination visit|1|||
170900178|NCT00522392|617640040|FG000|Overall Study|Disease progression|0|||
170900179|NCT00522392|617640041|FG001|Overall Study|Disease progression|3|||
170900180|NCT00522392|617640040|FG000|Overall Study|Adverse Event|7|||
170900181|NCT00522392|617640041|FG001|Overall Study|Adverse Event|7|||
170900182|NCT00522392|617640040|FG000|Overall Study|Withdrawal by Subject|1|||
170900183|NCT00522392|617640041|FG001|Overall Study|Withdrawal by Subject|1|||
170900184|NCT00522392|617640040|FG000|Overall Study|Physician Decision|0|||
170900185|NCT00522392|617640041|FG001|Overall Study|Physician Decision|1|||
170900186|NCT00522392|617640040|FG000|Overall Study|Non-compliance|0|||
170900187|NCT00522392|617640041|FG001|Overall Study|Non-compliance|1|||
170900188|NCT04572633|617640042|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
170900189|NCT02292849|617640043|FG000|Overall Study|Lost to Follow-up|0|||
170900190|NCT02292849|617640044|FG001|Overall Study|Lost to Follow-up|2|||
170900191|NCT02292849|617640045|FG002|Overall Study|Lost to Follow-up|2|||
170900192|NCT02292849|617640043|FG000|Overall Study|Physician Decision|4|||
170900193|NCT02292849|617640044|FG001|Overall Study|Physician Decision|0|||
170900194|NCT02292849|617640045|FG002|Overall Study|Physician Decision|0|||
170900195|NCT01919307|617640046|FG000|Overall Study|Withdrawal by Subject|9|||
170900196|NCT01287754|617640049|FG000|Overall Study|Death|2|||
170900197|NCT01287754|617640050|FG001|Overall Study|Death|12|||
170900198|NCT01287754|617640049|FG000|Overall Study|Lost to Follow-up|1|||
170900199|NCT01287754|617640050|FG001|Overall Study|Lost to Follow-up|6|||
170900200|NCT01287754|617640049|FG000|Overall Study|Protocol Violation|0|||
170900201|NCT01287754|617640050|FG001|Overall Study|Protocol Violation|3|||
170900202|NCT05540652|617640051|FG000|Overall Study|Withdrawal by Subject|1|||
170900203|NCT01725165|617640052|FG000|Overall Study|Death|11|||
170900204|NCT01725165|617640053|FG001|Overall Study|Death|18|||
170900205|NCT02157883|617640058|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
170900206|NCT02157883|617640058|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
170900207|NCT02157883|617640058|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
170900208|NCT02157883|617640058|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
170900209|NCT02157883|617640058|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
170900210|NCT01701258|617640059|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
170900211|NCT01701258|617640060|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
170900212|NCT01701258|617640061|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
170900213|NCT01701258|617640062|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
170900214|NCT01701258|617640063|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
170491962|NCT00839527|616141935|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
170491963|NCT00839527|616141936|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
170491964|NCT00839527|616141937|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
170491965|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
170491966|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
170491967|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
170491968|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
170491969|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
170491970|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
170491971|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
170491972|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
170491973|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
170491974|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
170491975|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
170491976|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
170491977|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
170491978|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
170491979|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
170491980|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
170491981|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
170491982|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
170491983|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
170900215|NCT01701258|617640064|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
170900216|NCT01701258|617640065|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
170900217|NCT01701258|617640066|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
170900218|NCT01701258|617640067|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
170900219|NCT01701258|617640068|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
170900220|NCT01701258|617640069|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
170900221|NCT01701258|617640070|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
170900222|NCT01701258|617640071|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
170900223|NCT01701258|617640059|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
170900224|NCT01701258|617640060|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
170900225|NCT01701258|617640061|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
170900226|NCT01701258|617640062|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
170900227|NCT01701258|617640063|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
170900228|NCT01701258|617640064|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
170900229|NCT01701258|617640065|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
170900230|NCT01701258|617640066|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
170900231|NCT01701258|617640067|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
170900232|NCT01701258|617640068|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
170900233|NCT01701258|617640069|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
170900234|NCT01701258|617640070|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
170900235|NCT01701258|617640071|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
170900236|NCT01701258|617640059|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
170900237|NCT01701258|617640060|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
170900238|NCT01701258|617640061|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
170900239|NCT01701258|617640062|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
170900240|NCT01701258|617640063|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
170900241|NCT01701258|617640064|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
170900242|NCT01701258|617640065|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
170900243|NCT01701258|617640066|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
170900244|NCT01701258|617640067|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
170900245|NCT01701258|617640068|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
170900246|NCT01701258|617640069|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
170900247|NCT01701258|617640070|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
170900248|NCT01701258|617640071|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
170900249|NCT01701258|617640059|FG000|Assessment and Scheduling|Investigator Terminated|2|||
170900250|NCT01701258|617640060|FG001|Assessment and Scheduling|Investigator Terminated|0|||
170900251|NCT01701258|617640061|FG002|Assessment and Scheduling|Investigator Terminated|0|||
170900252|NCT01701258|617640062|FG003|Assessment and Scheduling|Investigator Terminated|0|||
170900253|NCT01701258|617640063|FG004|Assessment and Scheduling|Investigator Terminated|0|||
170900254|NCT01701258|617640064|FG005|Assessment and Scheduling|Investigator Terminated|0|||
170900255|NCT01701258|617640065|FG006|Assessment and Scheduling|Investigator Terminated|0|||
170900256|NCT01701258|617640066|FG007|Assessment and Scheduling|Investigator Terminated|0|||
170900257|NCT01701258|617640067|FG008|Assessment and Scheduling|Investigator Terminated|0|||
170900258|NCT01701258|617640068|FG009|Assessment and Scheduling|Investigator Terminated|0|||
170900259|NCT01701258|617640069|FG010|Assessment and Scheduling|Investigator Terminated|0|||
170900260|NCT01701258|617640070|FG011|Assessment and Scheduling|Investigator Terminated|0|||
170900261|NCT01701258|617640071|FG012|Assessment and Scheduling|Investigator Terminated|0|||
170900262|NCT04454489|617640072|FG000|Overall Study|Disease progression|12|||
170900263|NCT04454489|617640072|FG000|Overall Study|Death|4|||
170900264|NCT04454489|617640072|FG000|Overall Study|Adverse Event|1|||
170900265|NCT04454489|617640072|FG000|Overall Study|Physician Decision|1|||
170900266|NCT01323478|617640073|FG000|Overall Study|Adverse Event|7|||
170900267|NCT01323478|617640073|FG000|Overall Study|Lack of Efficacy|4|||
170900268|NCT01323478|617640073|FG000|Overall Study|Non-compliance With Study Product|3|||
170900269|NCT01323478|617640073|FG000|Overall Study|Protocol Violation|1|||
170900270|NCT01323478|617640073|FG000|Overall Study|Withdrawal of Consent|1|||
170900271|NCT01323478|617640073|FG000|Overall Study|Administrative or Other Reasons|8|||
170491984|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
170491985|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
170491986|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
170491987|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
170640871|NCT00606905|616698327|FG001|Overall Study|Withdrew|5|||
170640872|NCT02386189|616698328|FG000|Overall Study|Lost to Follow-up|2|||
170640873|NCT02386189|616698329|FG001|Overall Study|Lost to Follow-up|3|||
170640874|NCT02386189|616698328|FG000|Overall Study|Withdrawal by Subject|1|||
170640875|NCT02386189|616698329|FG001|Overall Study|Withdrawal by Subject|0|||
170640876|NCT02386189|616698328|FG000|Overall Study|Death|1|||
170640877|NCT02386189|616698329|FG001|Overall Study|Death|0|||
170640878|NCT01305577|616698330|FG000|Overall Study|Adverse Event|2|||
170640879|NCT01305577|616698331|FG001|Overall Study|Adverse Event|2|||
170640880|NCT01305577|616698332|FG002|Overall Study|Adverse Event|1|||
170640881|NCT01305577|616698330|FG000|Overall Study|Withdrawal by Subject|7|||
170640882|NCT01305577|616698331|FG001|Overall Study|Withdrawal by Subject|5|||
170640883|NCT01305577|616698332|FG002|Overall Study|Withdrawal by Subject|6|||
170640884|NCT01305577|616698330|FG000|Overall Study|Lost to Follow-up|4|||
170640885|NCT01305577|616698331|FG001|Overall Study|Lost to Follow-up|3|||
170640886|NCT01305577|616698332|FG002|Overall Study|Lost to Follow-up|2|||
170640887|NCT01305577|616698330|FG000|Overall Study|Protocol Deviation|0|||
170900272|NCT03155997|617640074|FG000|Overall Study|Withdrawal by Subject|119|||
170900273|NCT03155997|617640075|FG001|Overall Study|Withdrawal by Subject|134|||
170900274|NCT03155997|617640074|FG000|Overall Study|Lost to Follow-up|12|||
170640888|NCT01305577|616698331|FG001|Overall Study|Protocol Deviation|1|||
170640889|NCT01305577|616698332|FG002|Overall Study|Protocol Deviation|1|||
170640890|NCT00796978|616698333|FG000|Overall Study|Cardiac adverse event|5|||
170640891|NCT00796978|616698333|FG000|Overall Study|Adverse Event|4|||
170640892|NCT00796978|616698333|FG000|Overall Study|Withdrawal by Subject|3|||
170640893|NCT02364336|616698334|FG000|Overall Study|Adverse Event|0|||
170640894|NCT02364336|616698335|FG001|Overall Study|Adverse Event|1|||
170640895|NCT00486291|616698336|FG000|Overall Study|Adverse Event|3|||
170640896|NCT00486291|616698337|FG001|Overall Study|Adverse Event|4|||
170640897|NCT00486291|616698336|FG000|Overall Study|Lost to Follow-up|3|||
170640898|NCT00486291|616698337|FG001|Overall Study|Lost to Follow-up|7|||
170640899|NCT00486291|616698336|FG000|Overall Study|protocol non-compliance|10|||
170640900|NCT00486291|616698337|FG001|Overall Study|protocol non-compliance|15|||
170900275|NCT03155997|617640075|FG001|Overall Study|Lost to Follow-up|13|||
170900276|NCT03155997|617640074|FG000|Overall Study|Missing disposition data|0|||
170900277|NCT03155997|617640075|FG001|Overall Study|Missing disposition data|1|||
170900278|NCT03155997|617640074|FG000|Overall Study|On study treatment|2027|||
170640901|NCT00486291|616698336|FG000|Overall Study|requirement for restricted medication|0|||
170640902|NCT00486291|616698337|FG001|Overall Study|requirement for restricted medication|3|||
170640903|NCT03462511|616698339|FG000|Overall Study|Withdrawal by Subject|2|||
170640904|NCT03462511|616698340|FG001|Overall Study|Withdrawal by Subject|3|||
170640905|NCT00975780|616698341|FG000|Follow Up|Death|88|||
170640906|NCT00975780|616698342|FG001|Follow Up|Death|122|||
170640907|NCT00975780|616698341|FG000|Follow Up|Facility Withdrawal|7|||
170640908|NCT00975780|616698342|FG001|Follow Up|Facility Withdrawal|23|||
170640909|NCT00975780|616698341|FG000|Follow Up|Discharged from Facility|7|||
170640910|NCT00975780|616698342|FG001|Follow Up|Discharged from Facility|12|||
170640911|NCT00889720|616698346|FG000|Overall Study|Withdrawal by Subject|4|||
170640912|NCT00889720|616698346|FG000|Overall Study|Other|4|||
170640913|NCT02067676|616698347|FG000|Overall Study|Withdrawal by Subject|1|||
170640914|NCT02067676|616698348|FG001|Overall Study|Withdrawal by Subject|0|||
170640915|NCT02067676|616698349|FG002|Overall Study|Withdrawal by Subject|0|||
170640916|NCT02067676|616698350|FG003|Overall Study|Withdrawal by Subject|0|||
170640917|NCT02067676|616698351|FG004|Overall Study|Withdrawal by Subject|0|||
170640918|NCT02067676|616698352|FG005|Overall Study|Withdrawal by Subject|0|||
170640919|NCT00996333|616698353|FG000|Overall Study|Screen failure|1|||
170640920|NCT00996333|616698353|FG000|Overall Study|Withdrawal by Subject|1|||
170640921|NCT00996333|616698353|FG000|Overall Study|Death|4|||
170640922|NCT00996333|616698353|FG000|Overall Study|Adverse Event|1|||
170900279|NCT03155997|617640075|FG001|Overall Study|On study treatment|2074|||
170900280|NCT00934102|617640083|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
170900281|NCT00934102|617640084|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
170900282|NCT00934102|617640085|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
170900283|NCT00792298|617640087|FG000|Treatment Period 1|Adverse Event|0|||
170900284|NCT00792298|617640088|FG001|Treatment Period 1|Adverse Event|1|||
170900285|NCT00792298|617640089|FG002|Treatment Period 1|Adverse Event|0|||
170900286|NCT00792298|617640090|FG003|Treatment Period 1|Adverse Event|1|||
170491988|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
170491989|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
170491990|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
170491991|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
170491992|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
170900287|NCT00792298|617640091|FG004|Treatment Period 1|Adverse Event|0|||
170900288|NCT00792298|617640092|FG005|Treatment Period 1|Adverse Event|1|||
170491993|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
170640923|NCT00996333|616698353|FG000|Overall Study|Physician Decision|1|||
170491994|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
170491995|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
170491996|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
170640924|NCT00996333|616698353|FG000|Overall Study|Other|5|||
170640925|NCT00984620|616698354|FG000|Overall Study|Adverse Event|5|||
170640926|NCT00984620|616698355|FG001|Overall Study|Adverse Event|5|||
170640927|NCT00984620|616698354|FG000|Overall Study|Lost to Follow-up|1|||
170640928|NCT00984620|616698355|FG001|Overall Study|Lost to Follow-up|1|||
170900289|NCT00792298|617640093|FG006|Treatment Period 1|Adverse Event|1|||
170900290|NCT00792298|617640094|FG007|Treatment Period 1|Adverse Event|0|||
170640929|NCT00984620|616698354|FG000|Overall Study|Withdrawal by Subject|0|||
170640930|NCT00984620|616698355|FG001|Overall Study|Withdrawal by Subject|2|||
170640931|NCT00984620|616698354|FG000|Overall Study|reason other than listed above|0|||
170640932|NCT00984620|616698355|FG001|Overall Study|reason other than listed above|4|||
170640933|NCT00476229|616698356|FG000|Overall Study|Progressive shortness of breath|1|||
170640934|NCT03566485|616698357|FG000|Overall Study|Disease progression|5|||
170640935|NCT03566485|616698358|FG001|Overall Study|Disease progression|4|||
170640936|NCT03566485|616698357|FG000|Overall Study|Clinical progression|0|||
170900291|NCT00792298|617640087|FG000|Treatment Period 1|Lack of Efficacy|0|||
170640937|NCT03566485|616698358|FG001|Overall Study|Clinical progression|1|||
170640938|NCT03566485|616698357|FG000|Overall Study|Toxicity|0|||
170640939|NCT03566485|616698358|FG001|Overall Study|Toxicity|2|||
170640940|NCT00324961|616698359|FG000|Overall Study|Adverse Event|5|||
170640941|NCT00324961|616698359|FG000|Overall Study|Consent Withdrawn|11|||
170640942|NCT00324961|616698359|FG000|Overall Study|Lost to Follow-up|22|||
170640943|NCT00324961|616698359|FG000|Overall Study|Protocol Violation|3|||
170640944|NCT00324961|616698359|FG000|Overall Study|Other|2|||
170640945|NCT05916170|616698360|FG000|No Warning Control|Lost to Follow-up|12|||
170491997|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
170491998|NCT00839527|616141935|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
170491999|NCT00839527|616141936|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
170492000|NCT00839527|616141937|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
170492001|NCT02295020|616141938|FG000|Overall Study|Adverse Event|0|||
170492002|NCT02295020|616141939|FG001|Overall Study|Adverse Event|1|||
170492003|NCT02295020|616141938|FG000|Overall Study|Withdrawal by Subject|3|||
170492004|NCT02295020|616141939|FG001|Overall Study|Withdrawal by Subject|2|||
170492005|NCT02751450|616141940|FG000|Overall Study|Adverse Event|1|||
170492006|NCT02751450|616141941|FG001|Overall Study|Adverse Event|0|||
170492007|NCT01290679|616141942|FG000|Overall Study|Adverse Event|2|||
170492008|NCT01290679|616141943|FG001|Overall Study|Adverse Event|0|||
170492009|NCT01290679|616141942|FG000|Overall Study|Lost to Follow-up|8|||
170492010|NCT01290679|616141943|FG001|Overall Study|Lost to Follow-up|10|||
170640946|NCT05916170|616698360|FG000|No Warning Control|Withdrawal by Subject|15|||
170640947|NCT05916170|616698360|FG000|No Warning Control|Noncompliance with protocol|1|||
170640948|NCT05916170|616698360|FG000|Health Warning Intervention|Lost to Follow-up|15|||
170640949|NCT05916170|616698360|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
170640950|NCT05916170|616698360|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
170492011|NCT01290679|616141942|FG000|Overall Study|Protocol Violation|0|||
170492012|NCT01290679|616141943|FG001|Overall Study|Protocol Violation|1|||
170492013|NCT01290679|616141942|FG000|Overall Study|Withdrawal by Subject|6|||
170492014|NCT01290679|616141943|FG001|Overall Study|Withdrawal by Subject|5|||
170492015|NCT01290679|616141942|FG000|Overall Study|Subject Entered Another Trial|0|||
170492016|NCT01290679|616141943|FG001|Overall Study|Subject Entered Another Trial|5|||
170492017|NCT00562302|616141944|FG000|Overall Study|Lost to Follow-up|3|||
170492018|NCT00562302|616141945|FG001|Overall Study|Lost to Follow-up|3|||
170492019|NCT00562302|616141944|FG000|Overall Study|Adverse Event|0|||
170492020|NCT00562302|616141945|FG001|Overall Study|Adverse Event|6|||
170492021|NCT00562302|616141944|FG000|Overall Study|Non-compliance|1|||
170492022|NCT00562302|616141945|FG001|Overall Study|Non-compliance|2|||
170492023|NCT00562302|616141944|FG000|Overall Study|Withdrawal by Subject|7|||
170492024|NCT00562302|616141945|FG001|Overall Study|Withdrawal by Subject|8|||
170492025|NCT00562302|616141944|FG000|Overall Study|Death|1|||
170492026|NCT00562302|616141945|FG001|Overall Study|Death|2|||
170492027|NCT00562302|616141944|FG000|Overall Study|Lung resection prior to study completion|7|||
170492028|NCT00562302|616141945|FG001|Overall Study|Lung resection prior to study completion|7|||
170492029|NCT00562302|616141944|FG000|Overall Study|Not stated|1|||
170492030|NCT00562302|616141945|FG001|Overall Study|Not stated|4|||
170492031|NCT01931995|616141948|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
170492032|NCT01931995|616141949|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
170492033|NCT01931995|616141948|FG000|First Intervention (1 Day)|Physician Decision|1|||
170492034|NCT01931995|616141949|FG001|First Intervention (1 Day)|Physician Decision|1|||
170492035|NCT01931995|616141948|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
170492036|NCT01931995|616141949|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
170492037|NCT00791661|616141950|FG000|7 Day Wash-out|Adverse Event|0|||
170492038|NCT00791661|616141951|FG001|7 Day Wash-out|Adverse Event|0|||
170492039|NCT00791661|616141952|FG002|7 Day Wash-out|Adverse Event|1|||
170492040|NCT00791661|616141950|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
170492041|NCT00791661|616141951|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
170492042|NCT00791661|616141952|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
170492043|NCT00937040|616141953|FG000|Overall Study|Adverse Event|5|||
170492044|NCT00937040|616141954|FG001|Overall Study|Adverse Event|8|||
170492045|NCT00937040|616141953|FG000|Overall Study|Lost to Follow-up|12|||
170492046|NCT00937040|616141954|FG001|Overall Study|Lost to Follow-up|12|||
170492047|NCT00937040|616141953|FG000|Overall Study|Protocol Violation|3|||
170492048|NCT00937040|616141954|FG001|Overall Study|Protocol Violation|0|||
170492049|NCT00937040|616141953|FG000|Overall Study|Withdrawal by Subject|13|||
170492050|NCT00937040|616141954|FG001|Overall Study|Withdrawal by Subject|7|||
170492051|NCT00937040|616141953|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
170640951|NCT05519982|616698361|FG000|Required Follow-up|Lost to Follow-up|0|||
170492052|NCT00937040|616141954|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
170492053|NCT00937040|616141953|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
170492054|NCT00937040|616141954|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
170492055|NCT02549287|616141957|FG000|Overall Study|Lost to Follow-up|65|||
170492056|NCT02549287|616141958|FG001|Overall Study|Lost to Follow-up|26|||
170492057|NCT02549287|616141957|FG000|Overall Study|Withdrawal by Subject|15|||
170492058|NCT02549287|616141958|FG001|Overall Study|Withdrawal by Subject|6|||
170492059|NCT00520533|616141961|FG000|Overall Study|Death|1|||
170492060|NCT00520533|616141961|FG000|Overall Study|Suspension of the study for safety reasons|1|||
170492061|NCT00520533|616141961|FG000|Overall Study|Withdrawal by Subject|1|||
170492062|NCT00520533|616141961|FG000|Overall Study|Physician Decision|1|||
170492063|NCT01218087|616141962|FG000|Overall Study|Death|2|||
170492064|NCT01218087|616141963|FG001|Overall Study|Death|1|||
170492065|NCT01218087|616141962|FG000|Overall Study|Withdrawal by Subject|5|||
170492066|NCT01218087|616141963|FG001|Overall Study|Withdrawal by Subject|0|||
170492067|NCT01218087|616141962|FG000|Overall Study|Transferred|8|||
170492068|NCT01218087|616141963|FG001|Overall Study|Transferred|5|||
170492069|NCT00552396|616141964|FG000|Overall Study|protocol withdrawal criteria|3|||
170492070|NCT00552396|616141965|FG001|Overall Study|protocol withdrawal criteria|3|||
170549787|NCT01557244|616358339|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
170549788|NCT01557244|616358340|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
170549789|NCT01557244|616358341|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
170549790|NCT01699685|616358346|FG000|Period 1|Adverse Event|1|||
170549791|NCT01699685|616358347|FG001|Period 1|Adverse Event|1|||
170549792|NCT01699685|616358346|FG000|Period 1|Medical or ethical, noncompliance|2|||
170549793|NCT01699685|616358347|FG001|Period 1|Medical or ethical, noncompliance|0|||
170549794|NCT01699685|616358346|FG000|Period 1|Other|0|||
170549795|NCT01699685|616358347|FG001|Period 1|Other|1|||
170549796|NCT01699685|616358346|FG000|Period 1|Patient request|0|||
170549797|NCT01699685|616358347|FG001|Period 1|Patient request|1|||
170549798|NCT01699685|616358346|FG000|Period 2|Lost to Follow-up|1|||
170549799|NCT01699685|616358347|FG001|Period 2|Lost to Follow-up|0|||
170549800|NCT00326495|616358348|FG000|Overall Study|Switched to alternative treatment|1|||
170549801|NCT00326495|616358348|FG000|Overall Study|Disease progression before treatment|1|||
170549802|NCT00326495|616358348|FG000|Overall Study|Refused further treatment|2|||
170549803|NCT00326495|616358348|FG000|Overall Study|Subject off study before assessment|1|||
170549804|NCT02933151|616358349|FG000|Overall Study|Lost to Follow-up|19|||
170549805|NCT02933151|616358350|FG001|Overall Study|Lost to Follow-up|18|||
170549806|NCT02933151|616358349|FG000|Overall Study|Death|1732|||
170549807|NCT02933151|616358350|FG001|Overall Study|Death|1827|||
170549808|NCT02933151|616358349|FG000|Overall Study|Transplant|210|||
170549809|NCT02933151|616358350|FG001|Overall Study|Transplant|278|||
170549810|NCT02933151|616358349|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
170549811|NCT02933151|616358350|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
170549812|NCT02933151|616358349|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
170549813|NCT02933151|616358350|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
170549814|NCT02933151|616358349|FG000|Overall Study|Recovered Kidney Function|47|||
170549815|NCT02933151|616358350|FG001|Overall Study|Recovered Kidney Function|29|||
170549816|NCT00394472|616358352|FG000|Overall Study|Protocol Violation|1|||
170549817|NCT00394472|616358353|FG001|Overall Study|Protocol Violation|3|||
170549818|NCT00394472|616358352|FG000|Overall Study|incorrect enrolment|4|||
170549819|NCT00394472|616358353|FG001|Overall Study|incorrect enrolment|2|||
170549820|NCT00394472|616358352|FG000|Overall Study|Adverse Event|4|||
170549821|NCT00394472|616358353|FG001|Overall Study|Adverse Event|2|||
170549822|NCT00394472|616358352|FG000|Overall Study|Withdrawal by Subject|0|||
170549823|NCT00394472|616358353|FG001|Overall Study|Withdrawal by Subject|2|||
170549824|NCT00394472|616358352|FG000|Overall Study|Physician Decision|0|||
170549825|NCT00394472|616358353|FG001|Overall Study|Physician Decision|1|||
170549826|NCT00394472|616358352|FG000|Overall Study|Lost to Follow-up|0|||
170549827|NCT00394472|616358353|FG001|Overall Study|Lost to Follow-up|1|||
170640952|NCT05519982|616698362|FG001|Required Follow-up|Lost to Follow-up|2|||
170640953|NCT05519982|616698361|FG000|Required Follow-up|Withdrawal by Subject|1|||
170640954|NCT05519982|616698362|FG001|Required Follow-up|Withdrawal by Subject|0|||
170640955|NCT05519982|616698361|FG000|Optional Extended Follow-up|Lost to Follow-up|9|||
170801094|NCT01105975|617283188|FG007|Overall Study|Lost to Follow-up|0|||
170801095|NCT01105975|617283189|FG008|Overall Study|Lost to Follow-up|1|||
170801096|NCT01105975|617283190|FG009|Overall Study|Lost to Follow-up|0|||
170801097|NCT01105975|617283181|FG000|Overall Study|Physician Decision|0|||
170801098|NCT01105975|617283182|FG001|Overall Study|Physician Decision|0|||
170801099|NCT01105975|617283183|FG002|Overall Study|Physician Decision|0|||
170801100|NCT01105975|617283184|FG003|Overall Study|Physician Decision|0|||
170801101|NCT01105975|617283185|FG004|Overall Study|Physician Decision|0|||
170801102|NCT01105975|617283186|FG005|Overall Study|Physician Decision|0|||
170801103|NCT01105975|617283187|FG006|Overall Study|Physician Decision|2|||
170492071|NCT00552396|616141966|FG002|Overall Study|protocol withdrawal criteria|3|||
170492072|NCT00552396|616141967|FG003|Overall Study|protocol withdrawal criteria|6|||
170492073|NCT00552396|616141968|FG004|Overall Study|protocol withdrawal criteria|3|||
170549828|NCT01245751|616358354|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
170549829|NCT01245751|616358355|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
170549830|NCT01245751|616358356|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
170549831|NCT01245751|616358357|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
170549832|NCT01245751|616358354|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
170801104|NCT01105975|617283188|FG007|Overall Study|Physician Decision|0|||
170801105|NCT01105975|617283189|FG008|Overall Study|Physician Decision|0|||
170801106|NCT01105975|617283190|FG009|Overall Study|Physician Decision|0|||
170492074|NCT00552396|616141969|FG005|Overall Study|protocol withdrawal criteria|3|||
170492075|NCT00552396|616141970|FG006|Overall Study|protocol withdrawal criteria|9|||
170492076|NCT03307252|616141974|FG000|Part 2, Period 1|Treatment not received|0|||
170492077|NCT03307252|616141975|FG001|Part 2, Period 1|Treatment not received|0|||
170492078|NCT03307252|616141976|FG002|Part 2, Period 1|Treatment not received|0|||
170492079|NCT03307252|616141977|FG003|Part 2, Period 1|Treatment not received|0|||
170492080|NCT03307252|616141978|FG004|Part 2, Period 1|Treatment not received|0|||
170492081|NCT03307252|616141979|FG005|Part 2, Period 1|Treatment not received|1|||
170492082|NCT03307252|616141980|FG006|Part 2, Period 1|Treatment not received|0|||
170492083|NCT03307252|616141981|FG007|Part 2, Period 1|Treatment not received|0|||
170492084|NCT03307252|616141982|FG008|Part 2, Period 1|Treatment not received|0|||
170492085|NCT03307252|616141983|FG009|Part 2, Period 1|Treatment not received|0|||
170492086|NCT03307252|616141984|FG010|Part 2, Period 1|Treatment not received|0|||
170492087|NCT03307252|616141974|FG000|Part 2, Period 3|Other than listed|0|||
170492088|NCT03307252|616141975|FG001|Part 2, Period 3|Other than listed|0|||
170492089|NCT03307252|616141976|FG002|Part 2, Period 3|Other than listed|0|||
170492090|NCT03307252|616141977|FG003|Part 2, Period 3|Other than listed|0|||
170492091|NCT03307252|616141978|FG004|Part 2, Period 3|Other than listed|1|||
170492092|NCT03307252|616141979|FG005|Part 2, Period 3|Other than listed|0|||
170492093|NCT03307252|616141980|FG006|Part 2, Period 3|Other than listed|0|||
170492094|NCT03307252|616141981|FG007|Part 2, Period 3|Other than listed|0|||
170492095|NCT03307252|616141982|FG008|Part 2, Period 3|Other than listed|0|||
170492096|NCT03307252|616141983|FG009|Part 2, Period 3|Other than listed|0|||
170492097|NCT03307252|616141984|FG010|Part 2, Period 3|Other than listed|0|||
170492098|NCT03307252|616141974|FG000|Part 2, Period 4|Other than listed|0|||
170492099|NCT03307252|616141975|FG001|Part 2, Period 4|Other than listed|0|||
170492100|NCT03307252|616141976|FG002|Part 2, Period 4|Other than listed|0|||
170492101|NCT03307252|616141977|FG003|Part 2, Period 4|Other than listed|0|||
170492102|NCT03307252|616141978|FG004|Part 2, Period 4|Other than listed|0|||
170492103|NCT03307252|616141979|FG005|Part 2, Period 4|Other than listed|0|||
170492104|NCT03307252|616141980|FG006|Part 2, Period 4|Other than listed|1|||
170492105|NCT03307252|616141981|FG007|Part 2, Period 4|Other than listed|0|||
170492106|NCT03307252|616141982|FG008|Part 2, Period 4|Other than listed|0|||
170492107|NCT03307252|616141983|FG009|Part 2, Period 4|Other than listed|0|||
170492108|NCT03307252|616141984|FG010|Part 2, Period 4|Other than listed|0|||
170492109|NCT03307252|616141974|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492110|NCT03307252|616141975|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492111|NCT03307252|616141976|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492112|NCT03307252|616141977|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492113|NCT03307252|616141978|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492114|NCT03307252|616141979|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492115|NCT03307252|616141980|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492116|NCT03307252|616141981|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492117|NCT03307252|616141982|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170640956|NCT05519982|616698362|FG001|Optional Extended Follow-up|Lost to Follow-up|12|||
170640957|NCT01946204|616698363|FG000|Overall Study|Death|38|||
170640958|NCT01946204|616698364|FG001|Overall Study|Death|59|||
170801107|NCT01105975|617283181|FG000|Overall Study|Protocol Violation|0|||
170801108|NCT01105975|617283182|FG001|Overall Study|Protocol Violation|2|||
170801109|NCT01105975|617283183|FG002|Overall Study|Protocol Violation|2|||
170801110|NCT01105975|617283184|FG003|Overall Study|Protocol Violation|0|||
170801111|NCT01105975|617283185|FG004|Overall Study|Protocol Violation|1|||
170801112|NCT01105975|617283186|FG005|Overall Study|Protocol Violation|1|||
170801113|NCT01105975|617283187|FG006|Overall Study|Protocol Violation|1|||
170801114|NCT01105975|617283188|FG007|Overall Study|Protocol Violation|1|||
170801115|NCT01105975|617283189|FG008|Overall Study|Protocol Violation|2|||
170801116|NCT01105975|617283190|FG009|Overall Study|Protocol Violation|2|||
170801117|NCT01105975|617283181|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
170801118|NCT01105975|617283182|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
170801119|NCT01105975|617283183|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
170801120|NCT01105975|617283184|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
170801121|NCT01105975|617283185|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
170640959|NCT01946204|616698363|FG000|Overall Study|Withdrawal by Subject|37|||
170640960|NCT01946204|616698364|FG001|Overall Study|Withdrawal by Subject|50|||
170640961|NCT01946204|616698363|FG000|Overall Study|Lost to Follow-up|3|||
170640962|NCT01946204|616698364|FG001|Overall Study|Lost to Follow-up|7|||
170801122|NCT01105975|617283186|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
170801123|NCT01105975|617283187|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
170492118|NCT03307252|616141983|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
170492119|NCT03307252|616141984|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
170492120|NCT01052480|616141985|FG000|Overall Study|Lost to Follow-up|3|||
170492121|NCT01052480|616141986|FG001|Overall Study|Lost to Follow-up|3|||
170492122|NCT01052480|616141985|FG000|Overall Study|Protocol Violation|1|||
170492123|NCT01052480|616141986|FG001|Overall Study|Protocol Violation|0|||
170492124|NCT01052480|616141985|FG000|Overall Study|Withdrawal by Subject|3|||
170492125|NCT01052480|616141986|FG001|Overall Study|Withdrawal by Subject|7|||
170492126|NCT01052480|616141985|FG000|Overall Study|Physician Decision|0|||
170492127|NCT01052480|616141986|FG001|Overall Study|Physician Decision|2|||
170640963|NCT01946204|616698363|FG000|Overall Study|Ongoing|316|||
170801124|NCT01105975|617283188|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
170801125|NCT01105975|617283189|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
170801126|NCT01105975|617283190|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
170801127|NCT00609869|617283191|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
170801128|NCT00609869|617283191|FG000|Overall Study|Severe hematologic toxicity|1|||
170801129|NCT00609869|617283191|FG000|Overall Study|Withdrawal by Subject|1|||
170801130|NCT00609869|617283191|FG000|Overall Study|Seizures|1|||
170801131|NCT00609869|617283191|FG000|Overall Study|Severe tumor flare reaction|1|||
170801132|NCT00609869|617283191|FG000|Overall Study|Hepatitis B infection|1|||
170801133|NCT00609869|617283191|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
170801134|NCT00609869|617283191|FG000|Overall Study|Mantle cell: not evaluable|4|||
170801135|NCT03478969|617283192|FG000|Overall Study|Withdrawal by Subject|4|||
170801136|NCT03478969|617283193|FG001|Overall Study|Withdrawal by Subject|7|||
170801137|NCT03478969|617283194|FG002|Overall Study|Withdrawal by Subject|6|||
170801138|NCT03478969|617283192|FG000|Overall Study|Adverse Event|2|||
170801139|NCT03478969|617283193|FG001|Overall Study|Adverse Event|0|||
170801140|NCT03478969|617283194|FG002|Overall Study|Adverse Event|1|||
170801141|NCT03478969|617283192|FG000|Overall Study|Pregnancy|1|||
170801142|NCT03478969|617283193|FG001|Overall Study|Pregnancy|0|||
170801143|NCT03478969|617283194|FG002|Overall Study|Pregnancy|0|||
170801144|NCT03478969|617283192|FG000|Overall Study|Personal Reasons|1|||
170801145|NCT03478969|617283193|FG001|Overall Study|Personal Reasons|0|||
170801146|NCT03478969|617283194|FG002|Overall Study|Personal Reasons|1|||
170801147|NCT03478969|617283192|FG000|Overall Study|Covid-19|1|||
170801148|NCT03478969|617283193|FG001|Overall Study|Covid-19|4|||
170801149|NCT03478969|617283194|FG002|Overall Study|Covid-19|3|||
170801150|NCT03478969|617283192|FG000|Overall Study|Multiple Reasons|0|||
170801151|NCT03478969|617283193|FG001|Overall Study|Multiple Reasons|1|||
170801152|NCT03478969|617283194|FG002|Overall Study|Multiple Reasons|1|||
170801153|NCT03478969|617283192|FG000|Overall Study|Eligibility Criteria|0|||
170801154|NCT03478969|617283193|FG001|Overall Study|Eligibility Criteria|0|||
170801155|NCT03478969|617283194|FG002|Overall Study|Eligibility Criteria|5|||
170801156|NCT03478969|617283192|FG000|Overall Study|Lost to Follow-up|0|||
170801157|NCT03478969|617283193|FG001|Overall Study|Lost to Follow-up|0|||
170801158|NCT03478969|617283194|FG002|Overall Study|Lost to Follow-up|1|||
170801159|NCT01185600|617283195|FG000|Overall Study|Adverse Event|1|||
170801160|NCT01185600|617283196|FG001|Overall Study|Adverse Event|1|||
170801161|NCT01185600|617283195|FG000|Overall Study|Death|0|||
170801162|NCT01185600|617283196|FG001|Overall Study|Death|1|||
170801163|NCT01185600|617283195|FG000|Overall Study|Lost to Follow-up|0|||
170801164|NCT01185600|617283196|FG001|Overall Study|Lost to Follow-up|5|||
170801165|NCT01185600|617283195|FG000|Overall Study|Physician Decision|29|||
170801166|NCT01185600|617283196|FG001|Overall Study|Physician Decision|35|||
170801167|NCT01185600|617283195|FG000|Overall Study|Withdrawal by Subject|1|||
170801168|NCT01185600|617283196|FG001|Overall Study|Withdrawal by Subject|1|||
170801169|NCT01185600|617283195|FG000|Overall Study|Hold by DSMB|1|||
170801170|NCT01185600|617283196|FG001|Overall Study|Hold by DSMB|2|||
170801171|NCT00739934|617283197|FG000|Voriconazole IV|Adverse Event|6|||
170801172|NCT00739934|617283197|FG000|Voriconazole Oral|Other|3|||
170801173|NCT04353492|617283198|FG000|Overall Study|Subject decision|24|||
170801174|NCT04353492|617283198|FG000|Overall Study|Physician Decision|5|||
170801175|NCT04353492|617283198|FG000|Overall Study|Adverse Event|3|||
170801176|NCT04353492|617283198|FG000|Overall Study|Pregnancy|3|||
170801177|NCT04353492|617283198|FG000|Overall Study|Lost to Follow-up|2|||
170801178|NCT04353492|617283198|FG000|Overall Study|Protocol deviation|1|||
170801179|NCT04353492|617283198|FG000|Overall Study|Technical problems|1|||
170801180|NCT01500200|617283199|FG000|Stage 1|Adverse Event|1|||
170801181|NCT01500200|617283200|FG001|Stage 1|Adverse Event|4|||
170801182|NCT01500200|617283201|FG002|Stage 1|Adverse Event|5|||
170492128|NCT01052480|616141985|FG000|Overall Study|Death|1|||
170801183|NCT01500200|617283202|FG003|Stage 1|Adverse Event|0|||
170801184|NCT01500200|617283203|FG004|Stage 1|Adverse Event|0|||
170801185|NCT01500200|617283204|FG005|Stage 1|Adverse Event|0|||
170801186|NCT01500200|617283199|FG000|Stage 1|Lost to Follow-up|2|||
170801187|NCT01500200|617283200|FG001|Stage 1|Lost to Follow-up|2|||
170801188|NCT01500200|617283201|FG002|Stage 1|Lost to Follow-up|1|||
170801189|NCT01500200|617283202|FG003|Stage 1|Lost to Follow-up|0|||
170801190|NCT01500200|617283203|FG004|Stage 1|Lost to Follow-up|0|||
170801191|NCT01500200|617283204|FG005|Stage 1|Lost to Follow-up|0|||
170801192|NCT01500200|617283199|FG000|Stage 1|Withdrawal by Subject|3|||
170801193|NCT01500200|617283200|FG001|Stage 1|Withdrawal by Subject|0|||
170801194|NCT01500200|617283201|FG002|Stage 1|Withdrawal by Subject|0|||
170801195|NCT01500200|617283202|FG003|Stage 1|Withdrawal by Subject|0|||
170801196|NCT01500200|617283203|FG004|Stage 1|Withdrawal by Subject|0|||
170801197|NCT01500200|617283204|FG005|Stage 1|Withdrawal by Subject|0|||
170801198|NCT01500200|617283199|FG000|Stage 1|Noncompliance with Study Drug|1|||
170801199|NCT01500200|617283200|FG001|Stage 1|Noncompliance with Study Drug|0|||
170801200|NCT01500200|617283201|FG002|Stage 1|Noncompliance with Study Drug|0|||
170801201|NCT01500200|617283202|FG003|Stage 1|Noncompliance with Study Drug|0|||
170801202|NCT01500200|617283203|FG004|Stage 1|Noncompliance with Study Drug|0|||
170801203|NCT01500200|617283204|FG005|Stage 1|Noncompliance with Study Drug|0|||
170801204|NCT01500200|617283199|FG000|Stage 1|Physician Decision|1|||
170801205|NCT01500200|617283200|FG001|Stage 1|Physician Decision|0|||
170801206|NCT01500200|617283201|FG002|Stage 1|Physician Decision|0|||
170801207|NCT01500200|617283202|FG003|Stage 1|Physician Decision|0|||
170801208|NCT01500200|617283203|FG004|Stage 1|Physician Decision|0|||
170801209|NCT01500200|617283204|FG005|Stage 1|Physician Decision|0|||
170801210|NCT01500200|617283199|FG000|Stage 2|Adverse Event|0|||
170801211|NCT01500200|617283200|FG001|Stage 2|Adverse Event|0|||
170801212|NCT01500200|617283201|FG002|Stage 2|Adverse Event|0|||
170801213|NCT01500200|617283202|FG003|Stage 2|Adverse Event|0|||
170801214|NCT01500200|617283203|FG004|Stage 2|Adverse Event|5|||
170801215|NCT01500200|617283204|FG005|Stage 2|Adverse Event|4|||
170801216|NCT00112359|617283205|FG000|Overall Study|Unrelated adverse event|16|||
170801217|NCT00112359|617283206|FG001|Overall Study|Unrelated adverse event|8|||
170801218|NCT00112359|617283205|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
170801219|NCT00112359|617283206|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
170801220|NCT00112359|617283205|FG000|Overall Study|Related adverse event|5|||
170801221|NCT00112359|617283206|FG001|Overall Study|Related adverse event|3|||
170801222|NCT00112359|617283205|FG000|Overall Study|Lost to Follow-up|0|||
170801223|NCT00112359|617283206|FG001|Overall Study|Lost to Follow-up|1|||
170801224|NCT00112359|617283205|FG000|Overall Study|Personal/administrative|1|||
170801225|NCT00112359|617283206|FG001|Overall Study|Personal/administrative|1|||
170801226|NCT00112359|617283205|FG000|Overall Study|Other|3|||
170801227|NCT00112359|617283206|FG001|Overall Study|Other|0|||
170801228|NCT01260896|617283207|FG000|First Intervention|Withdrawn Due to Emesis|2|||
170801229|NCT01260896|617283208|FG001|First Intervention|Withdrawn Due to Emesis|0|||
170549833|NCT01245751|616358355|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
170801230|NCT00312208|617283209|FG000|Overall Study|Adverse Event|97|||
170549834|NCT01245751|616358356|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
170549835|NCT01245751|616358357|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
170549836|NCT01245751|616358354|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
170549837|NCT01245751|616358355|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
170549838|NCT01245751|616358356|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
170549839|NCT01245751|616358357|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
170549840|NCT01654250|616358358|FG000|Overall Study|Lost to Follow-up|1|||
170549841|NCT01654250|616358359|FG001|Overall Study|Lost to Follow-up|0|||
170549842|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
170640964|NCT01946204|616698364|FG001|Overall Study|Ongoing|687|||
170801231|NCT00312208|617283210|FG001|Overall Study|Adverse Event|61|||
170801232|NCT00312208|617283209|FG000|Overall Study|Protocol Violation|5|||
170801233|NCT00312208|617283210|FG001|Overall Study|Protocol Violation|3|||
170801234|NCT00312208|617283209|FG000|Overall Study|Death|2|||
170801235|NCT00312208|617283210|FG001|Overall Study|Death|1|||
170801236|NCT00312208|617283209|FG000|Overall Study|Lack of Efficacy|7|||
170801237|NCT00312208|617283210|FG001|Overall Study|Lack of Efficacy|4|||
170801238|NCT00312208|617283209|FG000|Overall Study|Lost to Follow-up|3|||
170801239|NCT00312208|617283210|FG001|Overall Study|Lost to Follow-up|5|||
170801240|NCT00312208|617283209|FG000|Overall Study|Withdrawal by Subject|53|||
170801241|NCT00312208|617283210|FG001|Overall Study|Withdrawal by Subject|42|||
170801242|NCT00312208|617283209|FG000|Overall Study|Other|5|||
170801243|NCT00312208|617283210|FG001|Overall Study|Other|7|||
170801244|NCT01218659|617283212|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
170549843|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
170549844|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
170549845|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
170549846|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
170801245|NCT01218659|617283213|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
170801246|NCT01218659|617283214|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
170801247|NCT01218659|617283212|FG000|18-Month Randomized Period|Did not receive study drug|0|||
170801248|NCT01218659|617283213|FG001|18-Month Randomized Period|Did not receive study drug|3|||
170801249|NCT01218659|617283214|FG002|18-Month Randomized Period|Did not receive study drug|0|||
170492129|NCT01052480|616141986|FG001|Overall Study|Death|5|||
170492130|NCT01074268|616141987|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
170492131|NCT01074268|616141988|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
170492132|NCT01074268|616141987|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
170492133|NCT01074268|616141988|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
170492134|NCT01074268|616141987|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
170492135|NCT01074268|616141988|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
170492136|NCT01074268|616141987|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
170492137|NCT01074268|616141988|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
170492138|NCT01074268|616141987|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
170492139|NCT01074268|616141988|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
170492140|NCT01074268|616141987|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
170492141|NCT01074268|616141988|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
170492142|NCT01074268|616141987|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
170492143|NCT01074268|616141988|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
170492144|NCT01074268|616141987|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
170492145|NCT01074268|616141988|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
170492146|NCT01074268|616141987|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
170492147|NCT01074268|616141988|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
170492148|NCT01578239|616141989|FG000|Treatment Period|Progressive Disease|19|||
170492149|NCT01578239|616141990|FG001|Treatment Period|Progressive Disease|64|||
170801250|NCT01218659|617283212|FG000|12-Month OLE|Withdrawal by Subject|0|||
170801251|NCT01218659|617283213|FG001|12-Month OLE|Withdrawal by Subject|0|||
170801252|NCT01218659|617283214|FG002|12-Month OLE|Withdrawal by Subject|2|||
170801253|NCT01218659|617283212|FG000|12-Month OLE|Physician Decision|0|||
170801254|NCT01218659|617283213|FG001|12-Month OLE|Physician Decision|0|||
170801255|NCT01218659|617283214|FG002|12-Month OLE|Physician Decision|1|||
170801256|NCT01218659|617283212|FG000|12-Month OLE|Lost to Follow-up|0|||
170801257|NCT01218659|617283213|FG001|12-Month OLE|Lost to Follow-up|0|||
170801258|NCT01218659|617283214|FG002|12-Month OLE|Lost to Follow-up|1|||
170801259|NCT01218659|617283212|FG000|12-Month OLE|Pregnancy|0|||
170801260|NCT01218659|617283213|FG001|12-Month OLE|Pregnancy|0|||
170801261|NCT01218659|617283214|FG002|12-Month OLE|Pregnancy|1|||
170801262|NCT01218659|617283212|FG000|12-Month OLE|Lack of Efficacy|0|||
170801263|NCT01218659|617283213|FG001|12-Month OLE|Lack of Efficacy|0|||
170801264|NCT01218659|617283214|FG002|12-Month OLE|Lack of Efficacy|1|||
170801265|NCT01218659|617283212|FG000|12-Month OLE|Declined to participate in the OLE|0|||
170801266|NCT01218659|617283213|FG001|12-Month OLE|Declined to participate in the OLE|0|||
170801267|NCT01218659|617283214|FG002|12-Month OLE|Declined to participate in the OLE|4|||
170801268|NCT03066609|617283217|FG000|INDUCTION|Pregnancy|0|||
170801269|NCT03066609|617283218|FG001|INDUCTION|Pregnancy|0|||
170801270|NCT03066609|617283219|FG002|INDUCTION|Pregnancy|1|||
170801271|NCT03066609|617283220|FG003|INDUCTION|Pregnancy|0|||
170801272|NCT03066609|617283217|FG000|INDUCTION|Lack of Efficacy|0|||
170801273|NCT03066609|617283218|FG001|INDUCTION|Lack of Efficacy|0|||
170801274|NCT03066609|617283219|FG002|INDUCTION|Lack of Efficacy|1|||
170801275|NCT03066609|617283220|FG003|INDUCTION|Lack of Efficacy|0|||
170801276|NCT03066609|617283217|FG000|INDUCTION|Adverse Event|2|||
170801277|NCT03066609|617283218|FG001|INDUCTION|Adverse Event|2|||
170801278|NCT03066609|617283219|FG002|INDUCTION|Adverse Event|0|||
170801279|NCT03066609|617283220|FG003|INDUCTION|Adverse Event|0|||
170801280|NCT03066609|617283217|FG000|MAINTENANCE|Adverse Event|0|||
170801281|NCT03066609|617283218|FG001|MAINTENANCE|Adverse Event|0|||
170801282|NCT03066609|617283219|FG002|MAINTENANCE|Adverse Event|0|||
170801283|NCT03066609|617283220|FG003|MAINTENANCE|Adverse Event|1|||
170801284|NCT03066609|617283217|FG000|MAINTENANCE|Withdrawal by Subject|4|||
170801285|NCT03066609|617283218|FG001|MAINTENANCE|Withdrawal by Subject|2|||
170801286|NCT03066609|617283219|FG002|MAINTENANCE|Withdrawal by Subject|1|||
170801287|NCT03066609|617283220|FG003|MAINTENANCE|Withdrawal by Subject|1|||
170801288|NCT03066609|617283217|FG000|MAINTENANCE|Lost to Follow-up|0|||
170801289|NCT03066609|617283218|FG001|MAINTENANCE|Lost to Follow-up|1|||
170801290|NCT03066609|617283219|FG002|MAINTENANCE|Lost to Follow-up|1|||
170801291|NCT03066609|617283220|FG003|MAINTENANCE|Lost to Follow-up|0|||
170801292|NCT03066609|617283217|FG000|MAINTENANCE|Pregnancy|1|||
170801293|NCT03066609|617283218|FG001|MAINTENANCE|Pregnancy|0|||
170801294|NCT03066609|617283219|FG002|MAINTENANCE|Pregnancy|0|||
170801295|NCT03066609|617283220|FG003|MAINTENANCE|Pregnancy|0|||
170801296|NCT03066609|617283217|FG000|MAINTENANCE|Lack of Efficacy|2|||
170801297|NCT03066609|617283218|FG001|MAINTENANCE|Lack of Efficacy|1|||
170801298|NCT03066609|617283219|FG002|MAINTENANCE|Lack of Efficacy|0|||
170801299|NCT03066609|617283220|FG003|MAINTENANCE|Lack of Efficacy|1|||
170801300|NCT03066609|617283217|FG000|OVERALL STUDY|Adverse Event|2|||
170801301|NCT03066609|617283218|FG001|OVERALL STUDY|Adverse Event|2|||
170801302|NCT03066609|617283219|FG002|OVERALL STUDY|Adverse Event|0|||
170801303|NCT03066609|617283220|FG003|OVERALL STUDY|Adverse Event|1|||
170801304|NCT03066609|617283217|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
170801305|NCT03066609|617283218|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
170801306|NCT03066609|617283219|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
170640965|NCT01946204|616698363|FG000|Overall Study|Other|7|||
170640966|NCT01946204|616698364|FG001|Overall Study|Other|3|||
170640967|NCT01827956|616698365|FG000|Overall Study|Protocol Violation|3|||
170640968|NCT06364072|616698367|FG000|Overall Study|Physician Decision|1|||
170640969|NCT05064358|616698368|FG000|Overall Study|Death|23|||
170640970|NCT05064358|616698369|FG001|Overall Study|Death|23|||
170900292|NCT00792298|617640088|FG001|Treatment Period 1|Lack of Efficacy|0|||
170900293|NCT00792298|617640089|FG002|Treatment Period 1|Lack of Efficacy|1|||
170900294|NCT00792298|617640090|FG003|Treatment Period 1|Lack of Efficacy|0|||
170900295|NCT00792298|617640091|FG004|Treatment Period 1|Lack of Efficacy|0|||
170900296|NCT00792298|617640092|FG005|Treatment Period 1|Lack of Efficacy|0|||
170900297|NCT00792298|617640093|FG006|Treatment Period 1|Lack of Efficacy|0|||
170900298|NCT00792298|617640094|FG007|Treatment Period 1|Lack of Efficacy|0|||
170900299|NCT00792298|617640087|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170492150|NCT01578239|616141989|FG000|Treatment Period|Physician Decision|17|||
170640971|NCT05064358|616698370|FG002|Overall Study|Death|25|||
170640972|NCT05064358|616698371|FG003|Overall Study|Death|21|||
170640973|NCT05064358|616698372|FG004|Overall Study|Death|5|||
170640974|NCT05064358|616698368|FG000|Overall Study|Lost to Follow-up|1|||
170640975|NCT05064358|616698369|FG001|Overall Study|Lost to Follow-up|2|||
170640976|NCT05064358|616698370|FG002|Overall Study|Lost to Follow-up|0|||
170492151|NCT01578239|616141990|FG001|Treatment Period|Physician Decision|17|||
170492152|NCT01578239|616141989|FG000|Treatment Period|Adverse Event|13|||
170492153|NCT01578239|616141990|FG001|Treatment Period|Adverse Event|10|||
170640977|NCT05064358|616698371|FG003|Overall Study|Lost to Follow-up|2|||
170640978|NCT05064358|616698372|FG004|Overall Study|Lost to Follow-up|0|||
170640979|NCT05064358|616698368|FG000|Overall Study|Physician Decision|1|||
170640980|NCT05064358|616698369|FG001|Overall Study|Physician Decision|1|||
170640981|NCT05064358|616698370|FG002|Overall Study|Physician Decision|2|||
170640982|NCT05064358|616698371|FG003|Overall Study|Physician Decision|0|||
170640983|NCT05064358|616698372|FG004|Overall Study|Physician Decision|0|||
170492154|NCT01578239|616141989|FG000|Treatment Period|Non-compliance|2|||
170492155|NCT01578239|616141990|FG001|Treatment Period|Non-compliance|0|||
170492156|NCT01578239|616141989|FG000|Treatment Period|Withdrawal by Subject|10|||
170492157|NCT01578239|616141990|FG001|Treatment Period|Withdrawal by Subject|9|||
170492158|NCT01578239|616141989|FG000|Treatment Period|Other|6|||
170492159|NCT01578239|616141990|FG001|Treatment Period|Other|1|||
170492160|NCT01578239|616141989|FG000|Long-term Follow-Up Period|Death|69|||
170492161|NCT01578239|616141990|FG001|Long-term Follow-Up Period|Death|64|||
170492162|NCT01578239|616141989|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
170492163|NCT01578239|616141990|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
170492164|NCT01578239|616141989|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
170492165|NCT01578239|616141990|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
170492166|NCT01578239|616141989|FG000|Long-term Follow-Up Period|Other|2|||
170492167|NCT01578239|616141990|FG001|Long-term Follow-Up Period|Other|2|||
170492168|NCT00603473|616141993|FG000|Overall Study|Adverse Event|4|||
170492169|NCT00603473|616141993|FG000|Overall Study|Lack of Efficacy|4|||
170492170|NCT00603473|616141993|FG000|Overall Study|Protocol Violation|1|||
170492171|NCT01397786|616143915|FG000|Phase A|Lost to Follow-up|0|||
170492172|NCT01397786|616143916|FG001|Phase A|Lost to Follow-up|0|||
170492173|NCT01397786|616143917|FG002|Phase A|Lost to Follow-up|6|||
170492174|NCT01397786|616143915|FG000|Phase A|Adverse Event|0|||
170492175|NCT01397786|616143916|FG001|Phase A|Adverse Event|0|||
170492176|NCT01397786|616143917|FG002|Phase A|Adverse Event|8|||
170492177|NCT01397786|616143915|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
170492178|NCT01397786|616143916|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
170492179|NCT01397786|616143917|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
170492180|NCT01397786|616143915|FG000|Phase A|Physician Decision|0|||
170492181|NCT01397786|616143916|FG001|Phase A|Physician Decision|0|||
170492182|NCT01397786|616143917|FG002|Phase A|Physician Decision|1|||
170640984|NCT05064358|616698368|FG000|Overall Study|Withdrawal by Subject|4|||
170640985|NCT05064358|616698369|FG001|Overall Study|Withdrawal by Subject|5|||
170900300|NCT00792298|617640088|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170900301|NCT00792298|617640089|FG002|Treatment Period 1|Withdrawal by Subject|1|||
170900302|NCT00792298|617640090|FG003|Treatment Period 1|Withdrawal by Subject|2|||
170492183|NCT01397786|616143915|FG000|Phase A|Withdrawal by Subject|0|||
170492184|NCT01397786|616143916|FG001|Phase A|Withdrawal by Subject|0|||
170492185|NCT01397786|616143917|FG002|Phase A|Withdrawal by Subject|5|||
170492186|NCT01397786|616143915|FG000|Phase A|Lack of Efficacy|0|||
170492187|NCT01397786|616143916|FG001|Phase A|Lack of Efficacy|0|||
170492188|NCT01397786|616143917|FG002|Phase A|Lack of Efficacy|1|||
170492189|NCT01397786|616143915|FG000|Phase B|Lost to Follow-up|22|||
170640986|NCT05064358|616698370|FG002|Overall Study|Withdrawal by Subject|3|||
170640987|NCT05064358|616698371|FG003|Overall Study|Withdrawal by Subject|6|||
170640988|NCT05064358|616698372|FG004|Overall Study|Withdrawal by Subject|3|||
170640989|NCT05064358|616698368|FG000|Overall Study|Ongoing at the time of analysis|1|||
170640990|NCT05064358|616698369|FG001|Overall Study|Ongoing at the time of analysis|2|||
170900303|NCT00792298|617640091|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170900304|NCT00792298|617640092|FG005|Treatment Period 1|Withdrawal by Subject|2|||
170492190|NCT01397786|616143916|FG001|Phase B|Lost to Follow-up|12|||
170492191|NCT01397786|616143917|FG002|Phase B|Lost to Follow-up|22|||
170492192|NCT01397786|616143915|FG000|Phase B|Adverse Event|109|||
170492193|NCT01397786|616143916|FG001|Phase B|Adverse Event|23|||
170492194|NCT01397786|616143917|FG002|Phase B|Adverse Event|27|||
170492195|NCT01397786|616143915|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
170492196|NCT01397786|616143916|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
170492197|NCT01397786|616143917|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
170492198|NCT01397786|616143915|FG000|Phase B|Physician Decision|9|||
170492199|NCT01397786|616143916|FG001|Phase B|Physician Decision|1|||
170492200|NCT01397786|616143917|FG002|Phase B|Physician Decision|3|||
170492201|NCT01397786|616143915|FG000|Phase B|Withdrawal by Subject|102|||
170492202|NCT01397786|616143916|FG001|Phase B|Withdrawal by Subject|45|||
170492203|NCT01397786|616143917|FG002|Phase B|Withdrawal by Subject|30|||
170492204|NCT01397786|616143915|FG000|Phase B|Protocol Deviation|1|||
170492205|NCT01397786|616143916|FG001|Phase B|Protocol Deviation|2|||
170492206|NCT01397786|616143917|FG002|Phase B|Protocol Deviation|4|||
170492207|NCT01397786|616143915|FG000|Phase B|Lack of Efficacy|22|||
170640991|NCT05064358|616698370|FG002|Overall Study|Ongoing at the time of analysis|2|||
170640992|NCT05064358|616698371|FG003|Overall Study|Ongoing at the time of analysis|2|||
170640993|NCT05064358|616698372|FG004|Overall Study|Ongoing at the time of analysis|2|||
170492208|NCT01397786|616143916|FG001|Phase B|Lack of Efficacy|7|||
170492209|NCT01397786|616143917|FG002|Phase B|Lack of Efficacy|14|||
170492210|NCT04250350|616143921|FG000|Overall Study|Withdrawal by Subject|13|||
170492211|NCT04250350|616143921|FG000|Overall Study|Lost to Follow-up|8|||
170492212|NCT04250350|616143921|FG000|Overall Study|Adverse Event|5|||
170492213|NCT04250350|616143921|FG000|Overall Study|Lack of Efficacy|4|||
170492214|NCT04250350|616143921|FG000|Overall Study|Physician Decision|1|||
170492215|NCT04250350|616143921|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
170492216|NCT03875092|616143922|FG000|Overall Study|Adverse Event|2|||
170492217|NCT03875092|616143923|FG001|Overall Study|Adverse Event|5|||
170492218|NCT03875092|616143922|FG000|Overall Study|Death|44|||
170492219|NCT03875092|616143923|FG001|Overall Study|Death|51|||
170492220|NCT03875092|616143922|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
170492221|NCT03875092|616143923|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
170492222|NCT00636194|616143924|FG000|Overall Study|Study related symptoms and complaints|1|||
170492223|NCT00636194|616143925|FG001|Overall Study|Study related symptoms and complaints|0|||
170492224|NCT00636194|616143924|FG000|Overall Study|Protocol Violation|2|||
170492225|NCT00636194|616143925|FG001|Overall Study|Protocol Violation|0|||
170492226|NCT04114357|616143926|FG000|Baseline-Randomization|Adverse Event|2|||
170492227|NCT04114357|616143927|FG001|Baseline-Randomization|Adverse Event|1|||
170492228|NCT04114357|616143926|FG000|Baseline-Randomization|Lost to Follow-up|1|||
170492229|NCT04114357|616143927|FG001|Baseline-Randomization|Lost to Follow-up|1|||
170492230|NCT04114357|616143926|FG000|Cross-over|Adverse Event|0|||
170492231|NCT04114357|616143927|FG001|Cross-over|Adverse Event|1|||
170492232|NCT02163226|616143928|FG000|Overall Study|Death|2|||
170492233|NCT02163226|616143929|FG001|Overall Study|Death|1|||
170492234|NCT02163226|616143928|FG000|Overall Study|Withdrawal by Subject|5|||
170492235|NCT02163226|616143929|FG001|Overall Study|Withdrawal by Subject|2|||
170492236|NCT02163226|616143928|FG000|Overall Study|Returned home, local radiotherapy|3|||
170492237|NCT02163226|616143929|FG001|Overall Study|Returned home, local radiotherapy|0|||
170492238|NCT02163226|616143928|FG000|Overall Study|Repeat imaging showed no disease|2|||
170492239|NCT02163226|616143929|FG001|Overall Study|Repeat imaging showed no disease|0|||
170492240|NCT02163226|616143928|FG000|Overall Study|Incomplete radiotherapy|3|||
170492241|NCT02163226|616143929|FG001|Overall Study|Incomplete radiotherapy|0|||
170492242|NCT02163226|616143928|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
170492243|NCT02163226|616143929|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
170492244|NCT02163226|616143928|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
170492245|NCT02163226|616143929|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
170492246|NCT02163226|616143928|FG000|Overall Study|ineligible|0|||
170492247|NCT02163226|616143929|FG001|Overall Study|ineligible|3|||
170492248|NCT00593684|616143933|FG000|Overall Study|Death|2|||
170492249|NCT00593684|616143934|FG001|Overall Study|Death|1|||
170492250|NCT05318092|616143936|FG000|Overall Study|Lost to Follow-up|3|||
170492251|NCT05318092|616143936|FG000|Overall Study|Withdrawal by Subject|1|||
170640994|NCT05388669|616698373|FG000|Overall Study|Withdrawal by Subject|7|||
170640995|NCT05388669|616698374|FG001|Overall Study|Withdrawal by Subject|8|||
170640996|NCT05388669|616698373|FG000|Overall Study|Lost to Follow-up|0|||
170640997|NCT05388669|616698374|FG001|Overall Study|Lost to Follow-up|1|||
170492252|NCT00748189|616143942|FG000|Overall Study|Death|99|||
170492253|NCT00748189|616143943|FG001|Overall Study|Death|84|||
170492254|NCT00748189|616143942|FG000|Overall Study|Withdrawal by Subject|23|||
170492255|NCT00748189|616143943|FG001|Overall Study|Withdrawal by Subject|29|||
170492256|NCT00748189|616143942|FG000|Overall Study|Physician Decision|16|||
170492257|NCT00748189|616143943|FG001|Overall Study|Physician Decision|5|||
170492258|NCT00748189|616143942|FG000|Overall Study|Lost to Follow-up|8|||
170640998|NCT05388669|616698373|FG000|Overall Study|Other-Ongoing|156|||
170640999|NCT05388669|616698374|FG001|Overall Study|Other-Ongoing|141|||
170641000|NCT02621151|616698376|FG000|Overall Study|Not eligible for trial|6|||
170641001|NCT03390504|616698382|FG000|Overall Study|Lost to Follow-up|2|||
170641002|NCT03390504|616698383|FG001|Overall Study|Lost to Follow-up|4|||
170641003|NCT03390504|616698384|FG002|Overall Study|Lost to Follow-up|0|||
170641004|NCT03390504|616698385|FG003|Overall Study|Lost to Follow-up|1|||
170641005|NCT03390504|616698382|FG000|Overall Study|Withdrawal by Subject|3|||
170641006|NCT03390504|616698383|FG001|Overall Study|Withdrawal by Subject|15|||
170641007|NCT03390504|616698384|FG002|Overall Study|Withdrawal by Subject|5|||
170641008|NCT03390504|616698385|FG003|Overall Study|Withdrawal by Subject|2|||
170641009|NCT03390504|616698382|FG000|Overall Study|Other|1|||
170641010|NCT03390504|616698383|FG001|Overall Study|Other|2|||
170492259|NCT00748189|616143943|FG001|Overall Study|Lost to Follow-up|15|||
170492260|NCT00748189|616143942|FG000|Overall Study|Study terminated by Sponsor|70|||
170492261|NCT00748189|616143943|FG001|Overall Study|Study terminated by Sponsor|79|||
170492262|NCT01598090|616143968|FG000|Treatment Period|Poor/non-compliance|0|||
170492263|NCT01598090|616143969|FG001|Treatment Period|Poor/non-compliance|2|||
170492264|NCT01598090|616143970|FG002|Treatment Period|Poor/non-compliance|0|||
170492265|NCT01598090|616143968|FG000|Treatment Period|No longer meet study criteria|0|||
170492266|NCT01598090|616143969|FG001|Treatment Period|No longer meet study criteria|1|||
170492267|NCT01598090|616143970|FG002|Treatment Period|No longer meet study criteria|0|||
170492268|NCT01598090|616143968|FG000|Treatment Period|Lack of Efficacy|5|||
170492269|NCT01598090|616143969|FG001|Treatment Period|Lack of Efficacy|14|||
170492270|NCT01598090|616143970|FG002|Treatment Period|Lack of Efficacy|6|||
170492271|NCT01598090|616143968|FG000|Treatment Period|Adverse Event|2|||
170492272|NCT01598090|616143969|FG001|Treatment Period|Adverse Event|33|||
170492273|NCT01598090|616143970|FG002|Treatment Period|Adverse Event|17|||
170492274|NCT01598090|616143968|FG000|Treatment Period|Other reasons|0|||
170492275|NCT01598090|616143969|FG001|Treatment Period|Other reasons|4|||
170492276|NCT01598090|616143970|FG002|Treatment Period|Other reasons|1|||
170492277|NCT01598090|616143968|FG000|Treatment Period|Withdrawal by Subject|3|||
170492278|NCT01598090|616143969|FG001|Treatment Period|Withdrawal by Subject|13|||
170492279|NCT01598090|616143970|FG002|Treatment Period|Withdrawal by Subject|10|||
170492280|NCT01598090|616143968|FG000|Treatment Period|Lost to Follow-up|1|||
170492281|NCT01598090|616143969|FG001|Treatment Period|Lost to Follow-up|5|||
170492282|NCT01598090|616143970|FG002|Treatment Period|Lost to Follow-up|1|||
170492283|NCT01598090|616143968|FG000|Follow-up Period|Death|0|||
170492284|NCT01598090|616143969|FG001|Follow-up Period|Death|1|||
170492285|NCT01598090|616143970|FG002|Follow-up Period|Death|0|||
170492286|NCT01598090|616143968|FG000|Follow-up Period|No longer required per protocol|1|||
170492287|NCT01598090|616143969|FG001|Follow-up Period|No longer required per protocol|3|||
170492288|NCT01598090|616143970|FG002|Follow-up Period|No longer required per protocol|2|||
170492289|NCT01598090|616143968|FG000|Follow-up Period|Not reported|0|||
170492290|NCT01598090|616143969|FG001|Follow-up Period|Not reported|10|||
170492291|NCT01598090|616143970|FG002|Follow-up Period|Not reported|4|||
170492292|NCT01598090|616143968|FG000|Follow-up Period|Withdrawal by Subject|0|||
170492293|NCT01598090|616143969|FG001|Follow-up Period|Withdrawal by Subject|3|||
170492294|NCT01598090|616143970|FG002|Follow-up Period|Withdrawal by Subject|2|||
170492295|NCT01598090|616143968|FG000|Follow-up Period|Other reasons|2|||
170492296|NCT01598090|616143969|FG001|Follow-up Period|Other reasons|8|||
170492297|NCT01598090|616143970|FG002|Follow-up Period|Other reasons|8|||
170492298|NCT01598090|616143968|FG000|Follow-up Period|Lost to Follow-up|2|||
170492299|NCT01598090|616143969|FG001|Follow-up Period|Lost to Follow-up|10|||
170492300|NCT01598090|616143970|FG002|Follow-up Period|Lost to Follow-up|12|||
170492301|NCT02394340|616143975|FG000|Overall Study|Failed drug screen test|1|||
170492302|NCT02394340|616143975|FG000|Overall Study|Adverse Event|1|||
170492303|NCT00554515|616143982|FG000|Overall Study|Withdrawal by Subject|3|||
170492304|NCT00554515|616143982|FG000|Overall Study|Disease progression|52|||
170492305|NCT00554515|616143982|FG000|Overall Study|Physician Decision|18|||
170492306|NCT00554515|616143982|FG000|Overall Study|Withdrawal by Subject|11|||
170492307|NCT00554515|616143982|FG000|Overall Study|Adverse Event|9|||
170492308|NCT00554515|616143982|FG000|Overall Study|Death|2|||
170492309|NCT00554515|616143982|FG000|Overall Study|Achieved Stable Disease|7|||
170492310|NCT00554515|616143982|FG000|Overall Study|Other|1|||
170641011|NCT03390504|616698384|FG002|Overall Study|Other|2|||
170801307|NCT03066609|617283220|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
170801308|NCT03066609|617283217|FG000|OVERALL STUDY|Lost to Follow-up|1|||
170492311|NCT00554515|616143982|FG000|Overall Study|Misc|15|||
170492312|NCT04087720|616143987|FG000|Overall Study|Withdrawal by Subject|2|||
170492313|NCT04087720|616143987|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
170492314|NCT00427921|616143993|FG000|Overall Study|Adverse Event|26|||
170492315|NCT00427921|616143993|FG000|Overall Study|Withdrawal by Subject|4|||
170492316|NCT00427921|616143993|FG000|Overall Study|Lost to Follow-up|2|||
170492317|NCT00427921|616143993|FG000|Overall Study|Other reason not specified|10|||
170641012|NCT03390504|616698385|FG003|Overall Study|Other|6|||
170641013|NCT04238819|616698386|FG000|Overall Study|Ongoing Treatment|0|||
170641014|NCT04238819|616698387|FG001|Overall Study|Ongoing Treatment|0|||
170641015|NCT04238819|616698388|FG002|Overall Study|Ongoing Treatment|0|||
170641016|NCT04238819|616698389|FG003|Overall Study|Ongoing Treatment|0|||
170641017|NCT04238819|616698390|FG004|Overall Study|Ongoing Treatment|1|||
170641018|NCT04238819|616698391|FG005|Overall Study|Ongoing Treatment|4|||
170641019|NCT04238819|616698392|FG006|Overall Study|Ongoing Treatment|0|||
170641020|NCT04238819|616698386|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
170641021|NCT04238819|616698387|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
170641022|NCT04238819|616698388|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
170641023|NCT04238819|616698389|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
170641024|NCT04238819|616698390|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
170641025|NCT04238819|616698391|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
170641026|NCT04238819|616698392|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
170641027|NCT01031836|616699799|FG000|Stage I|Adverse Event|1|||
170641028|NCT01031836|616699800|FG001|Stage I|Adverse Event|1|||
170641029|NCT01031836|616699801|FG002|Stage I|Adverse Event|0|||
170641030|NCT01031836|616699802|FG003|Stage I|Adverse Event|0|||
170641031|NCT01031836|616699803|FG004|Stage I|Adverse Event|0|||
170801309|NCT03066609|617283218|FG001|OVERALL STUDY|Lost to Follow-up|1|||
170801310|NCT03066609|617283219|FG002|OVERALL STUDY|Lost to Follow-up|1|||
170801311|NCT03066609|617283220|FG003|OVERALL STUDY|Lost to Follow-up|1|||
170492318|NCT00427921|616143993|FG000|Overall Study|Adverse Event + Hospitalization|1|||
170492319|NCT00427921|616143993|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
170492320|NCT00427921|616143993|FG000|Overall Study|Adverse Event + No Response|1|||
170492321|NCT00427921|616143993|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
170492322|NCT00427921|616143993|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
170492323|NCT00427921|616143993|FG000|Overall Study|Adverse Event + Lost Response|1|||
170492324|NCT00427921|616143993|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
170801312|NCT03066609|617283217|FG000|OVERALL STUDY|Pregnancy|1|||
170801313|NCT03066609|617283218|FG001|OVERALL STUDY|Pregnancy|0|||
170801314|NCT03066609|617283219|FG002|OVERALL STUDY|Pregnancy|1|||
170801315|NCT03066609|617283220|FG003|OVERALL STUDY|Pregnancy|0|||
170801316|NCT03066609|617283217|FG000|OVERALL STUDY|Lack of Efficacy|2|||
170801317|NCT03066609|617283218|FG001|OVERALL STUDY|Lack of Efficacy|1|||
170801318|NCT03066609|617283219|FG002|OVERALL STUDY|Lack of Efficacy|1|||
170801319|NCT03066609|617283220|FG003|OVERALL STUDY|Lack of Efficacy|1|||
170801320|NCT03066609|617283217|FG000|OVERALL STUDY|discontinued follow up|0|||
170801321|NCT03066609|617283218|FG001|OVERALL STUDY|discontinued follow up|2|||
170801322|NCT03066609|617283219|FG002|OVERALL STUDY|discontinued follow up|0|||
170801323|NCT03066609|617283220|FG003|OVERALL STUDY|discontinued follow up|0|||
170801324|NCT03355573|617283221|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
170801325|NCT03355573|617283221|FG000|Overall Study|Sponsor's decision|1|||
170801326|NCT03355573|617283221|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
170801327|NCT03355573|617283221|FG000|Overall Study|PI's decision|2|||
170801328|NCT03355573|617283221|FG000|Overall Study|Withdrawal by Subject|23|||
170801329|NCT03355573|617283221|FG000|Overall Study|Lost to Follow-up|4|||
170801330|NCT03355573|617283221|FG000|Overall Study|Lack of Efficacy|2|||
170801331|NCT03355573|617283221|FG000|Overall Study|Adverse Event, non-fatal|17|||
170801332|NCT03355573|617283221|FG000|Overall Study|Adverse Event, serious fatal|2|||
170801333|NCT02284113|617283222|FG000|Overall Study|Adverse Event|1|||
170801334|NCT02284113|617283223|FG001|Overall Study|Adverse Event|0|||
170801335|NCT02284113|617283222|FG000|Overall Study|non-compliance|0|||
170801336|NCT02284113|617283223|FG001|Overall Study|non-compliance|1|||
170801337|NCT02284113|617283222|FG000|Overall Study|Withdrawal by Subject|0|||
170801338|NCT02284113|617283223|FG001|Overall Study|Withdrawal by Subject|1|||
170801339|NCT02284113|617283222|FG000|Overall Study|not provided|0|||
170801340|NCT02284113|617283223|FG001|Overall Study|not provided|1|||
170801341|NCT02284113|617283222|FG000|Overall Study|surgery cancelled|2|||
170801342|NCT02284113|617283223|FG001|Overall Study|surgery cancelled|0|||
170801343|NCT01218009|617283226|FG000|Overall Study|Protocol Violation|2|||
170801344|NCT01218009|617283227|FG001|Overall Study|Protocol Violation|1|||
170801345|NCT01218009|617283226|FG000|Overall Study|Withdrawal by Subject|3|||
170801346|NCT01218009|617283227|FG001|Overall Study|Withdrawal by Subject|1|||
170801347|NCT01218009|617283226|FG000|Overall Study|Sponsor terminated study|161|||
170801348|NCT01218009|617283227|FG001|Overall Study|Sponsor terminated study|163|||
170900305|NCT00792298|617640093|FG006|Treatment Period 1|Withdrawal by Subject|1|||
170900306|NCT00792298|617640094|FG007|Treatment Period 1|Withdrawal by Subject|0|||
170900307|NCT00792298|617640087|FG000|Treatment Period 1|Lost to Follow-up|0|||
170900308|NCT00792298|617640088|FG001|Treatment Period 1|Lost to Follow-up|0|||
170900309|NCT00792298|617640089|FG002|Treatment Period 1|Lost to Follow-up|0|||
170492325|NCT00427921|616143993|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
170641032|NCT01031836|616699804|FG005|Stage I|Adverse Event|0|||
170641033|NCT01031836|616699799|FG000|Stage I|Other|0|||
170900310|NCT00792298|617640090|FG003|Treatment Period 1|Lost to Follow-up|0|||
170641034|NCT01031836|616699800|FG001|Stage I|Other|1|||
170641035|NCT01031836|616699801|FG002|Stage I|Other|0|||
170641036|NCT01031836|616699802|FG003|Stage I|Other|0|||
170641037|NCT01031836|616699803|FG004|Stage I|Other|0|||
170801349|NCT01324310|617283228|FG000|Overall Study|Adverse Event|1|||
170801350|NCT01324310|617283228|FG000|Overall Study|Disease Progression|1|||
170801351|NCT03170882|617283229|FG000|Overall Study|Death|17|||
170801352|NCT03170882|617283230|FG001|Overall Study|Death|29|||
170801353|NCT03170882|617283229|FG000|Overall Study|Lost to Follow-up|0|||
170801354|NCT03170882|617283230|FG001|Overall Study|Lost to Follow-up|1|||
170801355|NCT03170882|617283229|FG000|Overall Study|Withdrawal by Subject|4|||
170801356|NCT03170882|617283230|FG001|Overall Study|Withdrawal by Subject|7|||
170801357|NCT03170882|617283229|FG000|Overall Study|Reason not Specified|28|||
170801358|NCT03170882|617283230|FG001|Overall Study|Reason not Specified|36|||
170801359|NCT04495621|617283231|FG000|Overall Study|Withdrawal by Subject|0|||
170801360|NCT04495621|617283232|FG001|Overall Study|Withdrawal by Subject|3|||
170801361|NCT04495621|617283231|FG000|Overall Study|Death|7|||
170801362|NCT04495621|617283232|FG001|Overall Study|Death|11|||
170801363|NCT04495621|617283231|FG000|Overall Study|Investigator Decision|0|||
170801364|NCT04495621|617283232|FG001|Overall Study|Investigator Decision|7|||
170801365|NCT04495621|617283231|FG000|Overall Study|Lost to Follow-up|0|||
170801366|NCT04495621|617283232|FG001|Overall Study|Lost to Follow-up|1|||
170801367|NCT03213457|617283240|FG000|Screening Period|Withdrawal by Subject|0|||
170801368|NCT03213457|617283241|FG001|Screening Period|Withdrawal by Subject|1|||
170801369|NCT03213457|617283242|FG002|Screening Period|Withdrawal by Subject|0|||
170801370|NCT03213457|617283240|FG000|Screening Period|Other|1|||
170801371|NCT03213457|617283241|FG001|Screening Period|Other|0|||
170801372|NCT03213457|617283242|FG002|Screening Period|Other|0|||
170801373|NCT03213457|617283240|FG000|Double-Blind Period|Adverse Event|3|||
170801374|NCT03213457|617283241|FG001|Double-Blind Period|Adverse Event|2|||
170801375|NCT03213457|617283242|FG002|Double-Blind Period|Adverse Event|7|||
170801376|NCT03213457|617283240|FG000|Double-Blind Period|Withdrawal by Subject|14|||
170801377|NCT03213457|617283241|FG001|Double-Blind Period|Withdrawal by Subject|2|||
170801378|NCT03213457|617283242|FG002|Double-Blind Period|Withdrawal by Subject|14|||
170801379|NCT03213457|617283240|FG000|Double-Blind Period|Lost to Follow-up|2|||
170801380|NCT03213457|617283241|FG001|Double-Blind Period|Lost to Follow-up|3|||
170801381|NCT03213457|617283242|FG002|Double-Blind Period|Lost to Follow-up|9|||
170801382|NCT03213457|617283240|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
170801383|NCT03213457|617283241|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
170801384|NCT03213457|617283242|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
170801385|NCT03213457|617283240|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
170801386|NCT03213457|617283241|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
170801387|NCT03213457|617283242|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
170801388|NCT03213457|617283240|FG000|Double-Blind Period|Pregnancy|5|||
170801389|NCT03213457|617283241|FG001|Double-Blind Period|Pregnancy|0|||
170801390|NCT03213457|617283242|FG002|Double-Blind Period|Pregnancy|0|||
170801391|NCT03213457|617283240|FG000|Double-Blind Period|Other|10|||
170801392|NCT03213457|617283241|FG001|Double-Blind Period|Other|3|||
170801393|NCT03213457|617283242|FG002|Double-Blind Period|Other|17|||
170801394|NCT03213457|617283240|FG000|Open-Label Period|Adverse Event|1|||
170801395|NCT03213457|617283241|FG001|Open-Label Period|Adverse Event|2|||
170801396|NCT03213457|617283242|FG002|Open-Label Period|Adverse Event|2|||
170801397|NCT03213457|617283240|FG000|Open-Label Period|Withdrawal by Subject|12|||
170801398|NCT03213457|617283241|FG001|Open-Label Period|Withdrawal by Subject|5|||
170801399|NCT03213457|617283242|FG002|Open-Label Period|Withdrawal by Subject|24|||
170801400|NCT03213457|617283240|FG000|Open-Label Period|Lost to Follow-up|1|||
170801401|NCT03213457|617283241|FG001|Open-Label Period|Lost to Follow-up|2|||
170801402|NCT03213457|617283242|FG002|Open-Label Period|Lost to Follow-up|8|||
170801403|NCT03213457|617283240|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
170801404|NCT03213457|617283241|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
170806980|NCT02063659|617301674|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
170492326|NCT00900159|616143994|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
170492327|NCT00900159|616143995|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
170492328|NCT00478777|616143997|FG000|Overall Study|Adverse Event|29|||
170492329|NCT00478777|616143997|FG000|Overall Study|Lack of Efficacy|23|||
170492330|NCT00478777|616143997|FG000|Overall Study|Withdrawal by Subject|4|||
170492331|NCT00478777|616143997|FG000|Overall Study|Death|3|||
170492332|NCT00478777|616143997|FG000|Overall Study|Protocol Violation|3|||
170492333|NCT00478777|616143997|FG000|Overall Study|Lost to Follow-up|3|||
170492334|NCT00478777|616143997|FG000|Overall Study|Physician Decision|1|||
170492335|NCT00478777|616143997|FG000|Overall Study|Intolerance of therapy|1|||
170492336|NCT00478777|616143997|FG000|Overall Study|Lack of compliance|1|||
170492337|NCT00478777|616143997|FG000|Overall Study|Lymphocytes infusion|1|||
170492338|NCT00478777|616143997|FG000|Overall Study|End of therapy|2|||
170492339|NCT00478777|616143997|FG000|Overall Study|Not treated with lenalidomide|6|||
170492340|NCT01377922|616144003|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
170492341|NCT01377922|616144004|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
170492342|NCT04615403|616144007|FG000|Overall Study|Death|1|||
170492343|NCT03170362|616144008|FG000|Overall Study|Death|2|||
170492344|NCT03170362|616144009|FG001|Overall Study|Death|2|||
170492345|NCT03170362|616144008|FG000|Overall Study|Withdrawal by Subject|23|||
170549847|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
170549848|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
170549849|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
170549850|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
170549851|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
170549852|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
170549853|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
170549854|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
170549855|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
170549856|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
170549857|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
170549858|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
170549859|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
170549860|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
170549861|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
170549862|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
170549863|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
170549864|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
170549865|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
170549866|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
170549867|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
170549868|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
170549869|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
170549870|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
170549871|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
170549872|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
170549873|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
170549874|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
170549875|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
170549876|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
170549877|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
170549878|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
170549879|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
170549880|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
170549881|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
170549882|NCT02596893|616358360|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
170549883|NCT02596893|616358361|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
170549884|NCT02596893|616358362|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
170549885|NCT02596893|616358363|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
170549886|NCT03280615|616358364|FG000|Overall Study|Lost to Follow-up|1|||
170549887|NCT03280615|616358365|FG001|Overall Study|Lost to Follow-up|2|||
170549888|NCT03280615|616358364|FG000|Overall Study|Adverse Event|1|||
170549889|NCT03280615|616358365|FG001|Overall Study|Adverse Event|1|||
170549890|NCT03280615|616358364|FG000|Overall Study|Withdrawal by Subject|2|||
170549891|NCT03280615|616358365|FG001|Overall Study|Withdrawal by Subject|2|||
170549892|NCT01529112|616358366|FG000|Overall Study|Adverse Event|2|||
170549893|NCT01529112|616358367|FG001|Overall Study|Adverse Event|0|||
170549894|NCT01529112|616358366|FG000|Overall Study|Death|59|||
170549895|NCT01529112|616358367|FG001|Overall Study|Death|38|||
170549896|NCT01529112|616358366|FG000|Overall Study|Protocol Violation|1|||
170549897|NCT01529112|616358367|FG001|Overall Study|Protocol Violation|0|||
170549898|NCT01529112|616358366|FG000|Overall Study|Withdrawal by Subject|7|||
170549899|NCT01529112|616358367|FG001|Overall Study|Withdrawal by Subject|3|||
170549900|NCT00004228|616358368|FG000|Overall Study|Adverse Event|0|||
170549901|NCT00004228|616358369|FG001|Overall Study|Adverse Event|1|||
170549902|NCT00004228|616358370|FG002|Overall Study|Adverse Event|0|||
170549903|NCT00004228|616358371|FG003|Overall Study|Adverse Event|0|||
170549904|NCT00004228|616358372|FG004|Overall Study|Adverse Event|1|||
170549905|NCT00004228|616358373|FG005|Overall Study|Adverse Event|0|||
170549906|NCT00004228|616358374|FG006|Overall Study|Adverse Event|0|||
170549907|NCT00004228|616358368|FG000|Overall Study|Death|0|||
170549908|NCT00004228|616358369|FG001|Overall Study|Death|1|||
170549909|NCT00004228|616358370|FG002|Overall Study|Death|2|||
170549910|NCT00004228|616358371|FG003|Overall Study|Death|0|||
170549911|NCT00004228|616358372|FG004|Overall Study|Death|1|||
170801405|NCT03213457|617283242|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
170801406|NCT03213457|617283240|FG000|Open-Label Period|Non-compliance with study procedures|1|||
170801407|NCT03213457|617283241|FG001|Open-Label Period|Non-compliance with study procedures|1|||
170641038|NCT01031836|616699804|FG005|Stage I|Other|1|||
170801408|NCT03213457|617283242|FG002|Open-Label Period|Non-compliance with study procedures|2|||
170641039|NCT01031836|616699799|FG000|Stage II|Adverse Event|0|||
170641040|NCT01031836|616699800|FG001|Stage II|Adverse Event|0|||
170641041|NCT01031836|616699801|FG002|Stage II|Adverse Event|2|||
170641042|NCT01031836|616699802|FG003|Stage II|Adverse Event|2|||
170641043|NCT01031836|616699803|FG004|Stage II|Adverse Event|1|||
170641044|NCT01031836|616699804|FG005|Stage II|Adverse Event|1|||
170641045|NCT01031836|616699799|FG000|Stage II|Other|2|||
170641046|NCT01031836|616699800|FG001|Stage II|Other|0|||
170641047|NCT01031836|616699801|FG002|Stage II|Other|0|||
170641048|NCT01031836|616699802|FG003|Stage II|Other|1|||
170641049|NCT01031836|616699803|FG004|Stage II|Other|1|||
170641050|NCT01031836|616699804|FG005|Stage II|Other|0|||
170641051|NCT05091567|616699805|FG000|Enrollment Phase|Death|37|||
170641052|NCT05091567|616699806|FG001|Enrollment Phase|Death|0|||
170641053|NCT05091567|616699807|FG002|Enrollment Phase|Death|0|||
170641054|NCT05091567|616699805|FG000|Enrollment Phase|Adverse Event|21|||
170641055|NCT05091567|616699806|FG001|Enrollment Phase|Adverse Event|0|||
170641056|NCT05091567|616699807|FG002|Enrollment Phase|Adverse Event|0|||
170641057|NCT05091567|616699805|FG000|Enrollment Phase|Progressive Disease|10|||
170641058|NCT05091567|616699806|FG001|Enrollment Phase|Progressive Disease|0|||
170641059|NCT05091567|616699807|FG002|Enrollment Phase|Progressive Disease|0|||
170641060|NCT05091567|616699805|FG000|Enrollment Phase|Withdrawal by Subject|8|||
170641061|NCT05091567|616699806|FG001|Enrollment Phase|Withdrawal by Subject|0|||
170641062|NCT05091567|616699807|FG002|Enrollment Phase|Withdrawal by Subject|0|||
170641063|NCT05091567|616699805|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
170641064|NCT05091567|616699806|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
170641065|NCT05091567|616699807|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
170641066|NCT05091567|616699805|FG000|Enrollment Phase|Physician Decision|3|||
170641067|NCT05091567|616699806|FG001|Enrollment Phase|Physician Decision|0|||
170641068|NCT05091567|616699807|FG002|Enrollment Phase|Physician Decision|0|||
170641069|NCT05091567|616699805|FG000|Enrollment Phase|Protocol Violation|2|||
170641070|NCT05091567|616699806|FG001|Enrollment Phase|Protocol Violation|0|||
170641071|NCT05091567|616699807|FG002|Enrollment Phase|Protocol Violation|0|||
170641072|NCT05091567|616699805|FG000|Enrollment Phase|Reason not Specified|1|||
170492346|NCT03170362|616144009|FG001|Overall Study|Withdrawal by Subject|22|||
170492347|NCT03170362|616144008|FG000|Overall Study|Lost to Follow-up|187|||
170492348|NCT03170362|616144009|FG001|Overall Study|Lost to Follow-up|167|||
170492349|NCT00665431|616144010|FG000|Overall Study|Adverse Event|16|||
170492350|NCT00665431|616144011|FG001|Overall Study|Adverse Event|22|||
170492351|NCT00665431|616144012|FG002|Overall Study|Adverse Event|6|||
170492352|NCT00665431|616144010|FG000|Overall Study|Withdrawal by Subject|17|||
170492353|NCT00665431|616144011|FG001|Overall Study|Withdrawal by Subject|25|||
170492354|NCT00665431|616144012|FG002|Overall Study|Withdrawal by Subject|15|||
170492355|NCT00665431|616144010|FG000|Overall Study|Lost to Follow-up|3|||
170549912|NCT00004228|616358373|FG005|Overall Study|Death|0|||
170549913|NCT00004228|616358374|FG006|Overall Study|Death|0|||
170549914|NCT00004228|616358368|FG000|Overall Study|Lack of Efficacy|1|||
170549915|NCT00004228|616358369|FG001|Overall Study|Lack of Efficacy|6|||
170549916|NCT00004228|616358370|FG002|Overall Study|Lack of Efficacy|5|||
170549917|NCT00004228|616358371|FG003|Overall Study|Lack of Efficacy|3|||
170549918|NCT00004228|616358372|FG004|Overall Study|Lack of Efficacy|9|||
170641073|NCT05091567|616699806|FG001|Enrollment Phase|Reason not Specified|0|||
170641074|NCT05091567|616699807|FG002|Enrollment Phase|Reason not Specified|0|||
170641075|NCT05091567|616699805|FG000|Randomized Phase|Death|0|||
170641076|NCT05091567|616699806|FG001|Randomized Phase|Death|135|||
170641077|NCT05091567|616699807|FG002|Randomized Phase|Death|112|||
170641078|NCT05091567|616699805|FG000|Randomized Phase|Progressive Disease|0|||
170801409|NCT03213457|617283240|FG000|Open-Label Period|Exclusionary medications|0|||
170801410|NCT03213457|617283241|FG001|Open-Label Period|Exclusionary medications|0|||
170801411|NCT03213457|617283242|FG002|Open-Label Period|Exclusionary medications|1|||
170801412|NCT03213457|617283240|FG000|Open-Label Period|Other|1|||
170549919|NCT00004228|616358373|FG005|Overall Study|Lack of Efficacy|8|||
170549920|NCT00004228|616358374|FG006|Overall Study|Lack of Efficacy|4|||
170641079|NCT05091567|616699806|FG001|Randomized Phase|Progressive Disease|2|||
170641080|NCT05091567|616699807|FG002|Randomized Phase|Progressive Disease|0|||
170801413|NCT03213457|617283241|FG001|Open-Label Period|Other|1|||
170801414|NCT03213457|617283242|FG002|Open-Label Period|Other|6|||
170801415|NCT03213457|617283240|FG000|Follow-Up Period|Adverse Event|16|||
170801416|NCT03213457|617283241|FG001|Follow-Up Period|Adverse Event|8|||
170492356|NCT00665431|616144011|FG001|Overall Study|Lost to Follow-up|3|||
170492357|NCT00665431|616144012|FG002|Overall Study|Lost to Follow-up|1|||
170641081|NCT05091567|616699805|FG000|Randomized Phase|Withdrawal by Subject|0|||
170641082|NCT05091567|616699806|FG001|Randomized Phase|Withdrawal by Subject|1|||
170641083|NCT05091567|616699807|FG002|Randomized Phase|Withdrawal by Subject|3|||
170492358|NCT00665431|616144010|FG000|Overall Study|Other|4|||
170549921|NCT00004228|616358368|FG000|Overall Study|Lost to Follow-up|0|||
170549922|NCT00004228|616358369|FG001|Overall Study|Lost to Follow-up|0|||
170641084|NCT05091567|616699805|FG000|Randomized Phase|Lost to Follow-up|0|||
170641085|NCT05091567|616699806|FG001|Randomized Phase|Lost to Follow-up|1|||
170801417|NCT03213457|617283242|FG002|Follow-Up Period|Adverse Event|37|||
170549923|NCT00004228|616358370|FG002|Overall Study|Lost to Follow-up|1|||
170549924|NCT00004228|616358371|FG003|Overall Study|Lost to Follow-up|0|||
170549925|NCT00004228|616358372|FG004|Overall Study|Lost to Follow-up|0|||
170549926|NCT00004228|616358373|FG005|Overall Study|Lost to Follow-up|0|||
170549927|NCT00004228|616358374|FG006|Overall Study|Lost to Follow-up|0|||
170549928|NCT00004228|616358368|FG000|Overall Study|Physician Decision|1|||
170549929|NCT00004228|616358369|FG001|Overall Study|Physician Decision|0|||
170549930|NCT00004228|616358370|FG002|Overall Study|Physician Decision|3|||
170549931|NCT00004228|616358371|FG003|Overall Study|Physician Decision|2|||
170549932|NCT00004228|616358372|FG004|Overall Study|Physician Decision|1|||
170549933|NCT00004228|616358373|FG005|Overall Study|Physician Decision|1|||
170549934|NCT00004228|616358374|FG006|Overall Study|Physician Decision|1|||
170549935|NCT00004228|616358368|FG000|Overall Study|Protocol Violation|0|||
170549936|NCT00004228|616358369|FG001|Overall Study|Protocol Violation|5|||
170549937|NCT00004228|616358370|FG002|Overall Study|Protocol Violation|2|||
170549938|NCT00004228|616358371|FG003|Overall Study|Protocol Violation|1|||
170549939|NCT00004228|616358372|FG004|Overall Study|Protocol Violation|1|||
170549940|NCT00004228|616358373|FG005|Overall Study|Protocol Violation|2|||
170549941|NCT00004228|616358374|FG006|Overall Study|Protocol Violation|0|||
170549942|NCT00004228|616358368|FG000|Overall Study|Withdrawal by Subject|3|||
170549943|NCT00004228|616358369|FG001|Overall Study|Withdrawal by Subject|0|||
170549944|NCT00004228|616358370|FG002|Overall Study|Withdrawal by Subject|1|||
170549945|NCT00004228|616358371|FG003|Overall Study|Withdrawal by Subject|0|||
170549946|NCT00004228|616358372|FG004|Overall Study|Withdrawal by Subject|2|||
170549947|NCT00004228|616358373|FG005|Overall Study|Withdrawal by Subject|1|||
170549948|NCT00004228|616358374|FG006|Overall Study|Withdrawal by Subject|2|||
170549949|NCT00004228|616358368|FG000|Overall Study|Other|0|||
170549950|NCT00004228|616358369|FG001|Overall Study|Other|0|||
170549951|NCT00004228|616358370|FG002|Overall Study|Other|1|||
170549952|NCT00004228|616358371|FG003|Overall Study|Other|0|||
170549953|NCT00004228|616358372|FG004|Overall Study|Other|0|||
170549954|NCT00004228|616358373|FG005|Overall Study|Other|0|||
170549955|NCT00004228|616358374|FG006|Overall Study|Other|0|||
170549956|NCT00004228|616358368|FG000|Overall Study|ineligible|4|||
170549957|NCT00004228|616358369|FG001|Overall Study|ineligible|2|||
170549958|NCT00004228|616358370|FG002|Overall Study|ineligible|4|||
170549959|NCT00004228|616358371|FG003|Overall Study|ineligible|1|||
170549960|NCT00004228|616358372|FG004|Overall Study|ineligible|1|||
170549961|NCT00004228|616358373|FG005|Overall Study|ineligible|2|||
170549962|NCT00004228|616358374|FG006|Overall Study|ineligible|5|||
170549963|NCT00107614|616358375|FG000|Overall Study|Physician Decision|10|||
170549964|NCT00107614|616358375|FG000|Overall Study|Death|2|||
170549965|NCT02457546|616358377|FG000|Overall Study|Other reasons|4|||
170549966|NCT02457546|616358378|FG001|Overall Study|Other reasons|1|||
170549967|NCT02457546|616358377|FG000|Overall Study|Refused to complete study/procedures|1|||
170549968|NCT02457546|616358378|FG001|Overall Study|Refused to complete study/procedures|1|||
170549969|NCT02457546|616358377|FG000|Overall Study|Lost to Follow-up|4|||
170549970|NCT02457546|616358378|FG001|Overall Study|Lost to Follow-up|1|||
170549971|NCT02457546|616358377|FG000|Overall Study|Adverse Event|0|||
170549972|NCT02457546|616358378|FG001|Overall Study|Adverse Event|1|||
170549973|NCT00090402|616358379|FG000|Overall Study|Death|1|||
170549974|NCT00090402|616358380|FG001|Overall Study|Death|1|||
170549975|NCT00090402|616358381|FG002|Overall Study|Death|0|||
170549976|NCT00090402|616358379|FG000|Overall Study|subject moved|0|||
170549977|NCT00090402|616358380|FG001|Overall Study|subject moved|1|||
170549978|NCT00090402|616358381|FG002|Overall Study|subject moved|0|||
170549979|NCT00090402|616358379|FG000|Overall Study|stopped taking study medication|1|||
170549980|NCT00090402|616358380|FG001|Overall Study|stopped taking study medication|0|||
170549981|NCT00090402|616358381|FG002|Overall Study|stopped taking study medication|1|||
170549982|NCT00862277|616358384|FG000|Overall Study|Protocol Violation|1|||
170549983|NCT00862277|616358385|FG001|Overall Study|Protocol Violation|2|||
170549984|NCT00862277|616358386|FG002|Overall Study|Protocol Violation|5|||
170549985|NCT02004275|616358387|FG000|Phase 1|Ineligible|0|||
170549986|NCT02004275|616358388|FG001|Phase 1|Ineligible|0|||
170549987|NCT02004275|616358389|FG002|Phase 1|Ineligible|0|||
170549988|NCT02004275|616358390|FG003|Phase 1|Ineligible|1|||
170549989|NCT02004275|616358391|FG004|Phase 1|Ineligible|1|||
170900311|NCT00792298|617640091|FG004|Treatment Period 1|Lost to Follow-up|0|||
170900312|NCT00792298|617640092|FG005|Treatment Period 1|Lost to Follow-up|0|||
170549990|NCT02004275|616358392|FG005|Phase 1|Ineligible|0|||
170549991|NCT02004275|616358387|FG000|Phase 1|Protocol Violation|0|||
170549992|NCT02004275|616358388|FG001|Phase 1|Protocol Violation|0|||
170549993|NCT02004275|616358389|FG002|Phase 1|Protocol Violation|0|||
170549994|NCT02004275|616358390|FG003|Phase 1|Protocol Violation|1|||
170549995|NCT02004275|616358391|FG004|Phase 1|Protocol Violation|0|||
170549996|NCT02004275|616358392|FG005|Phase 1|Protocol Violation|5|||
170549997|NCT02004275|616358387|FG000|Phase 2 Part 1|Ineligible|6|||
170549998|NCT02004275|616358388|FG001|Phase 2 Part 1|Ineligible|9|||
170549999|NCT02004275|616358389|FG002|Phase 2 Part 1|Ineligible|0|||
170550000|NCT02004275|616358390|FG003|Phase 2 Part 1|Ineligible|0|||
170550001|NCT02004275|616358391|FG004|Phase 2 Part 1|Ineligible|0|||
170550002|NCT02004275|616358392|FG005|Phase 2 Part 1|Ineligible|0|||
170492359|NCT00665431|616144011|FG001|Overall Study|Other|7|||
170492360|NCT00665431|616144012|FG002|Overall Study|Other|2|||
170492361|NCT01726270|616144013|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
170492362|NCT01726270|616144013|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
170492363|NCT01726270|616144013|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
170492364|NCT01726270|616144013|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
170492365|NCT01726270|616144013|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
170492366|NCT01726270|616144013|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
170492367|NCT01464164|616144014|FG000|Overall Study|Screen failure|0|||
170492368|NCT01464164|616144015|FG001|Overall Study|Screen failure|1|||
170641086|NCT05091567|616699807|FG002|Randomized Phase|Lost to Follow-up|1|||
170641087|NCT05091567|616699805|FG000|Randomized Phase|Ongoing in Study|0|||
170641088|NCT05091567|616699806|FG001|Randomized Phase|Ongoing in Study|102|||
170641089|NCT05091567|616699807|FG002|Randomized Phase|Ongoing in Study|126|||
170641090|NCT02051933|616699811|FG000|Overall Study|Physician Decision|0|||
170641091|NCT02051933|616699812|FG001|Overall Study|Physician Decision|1|||
170641092|NCT02156271|616699813|FG000|Overall Study|Physician Decision|4|||
170641093|NCT02156271|616699814|FG001|Overall Study|Physician Decision|3|||
170641094|NCT03320824|616699815|FG000|Overall Study|Withdrawal by Subject|8|||
170641095|NCT03320824|616699816|FG001|Overall Study|Withdrawal by Subject|1|||
170641096|NCT03320824|616699815|FG000|Overall Study|Lost to Follow-up|10|||
170641097|NCT03320824|616699816|FG001|Overall Study|Lost to Follow-up|1|||
170641098|NCT03320824|616699815|FG000|Overall Study|moved out of state|0|||
170641099|NCT03320824|616699816|FG001|Overall Study|moved out of state|1|||
170641100|NCT03320824|616699815|FG000|Overall Study|could not complete final visit|0|||
170641101|NCT03320824|616699816|FG001|Overall Study|could not complete final visit|1|||
170641102|NCT00588861|616699820|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
170641103|NCT00588861|616699821|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
170641104|NCT00588861|616699820|FG000|6 Months|Patients did not return for follow-up|98|||
170641105|NCT00588861|616699821|FG001|6 Months|Patients did not return for follow-up|73|||
170641106|NCT00588861|616699820|FG000|1 Year|Patients did not return for follow-up|89|||
170641107|NCT00588861|616699821|FG001|1 Year|Patients did not return for follow-up|82|||
170641108|NCT00588861|616699820|FG000|2 Years|Patients did not return for follow-up|92|||
170641109|NCT00588861|616699821|FG001|2 Years|Patients did not return for follow-up|87|||
170641110|NCT00588861|616699820|FG000|4 Years|Patients did not return for follow-up|91|||
170641111|NCT00588861|616699821|FG001|4 Years|Patients did not return for follow-up|103|||
170641112|NCT00588861|616699820|FG000|6 Years|Patients did not return for follow-up|104|||
170641113|NCT00588861|616699821|FG001|6 Years|Patients did not return for follow-up|109|||
170641114|NCT00588861|616699820|FG000|8 Years|Patients did not return for follow-up|105|||
170641115|NCT00588861|616699821|FG001|8 Years|Patients did not return for follow-up|114|||
170641116|NCT00588861|616699820|FG000|10 Years|Incomplete due to study termination|107|||
170641117|NCT00588861|616699821|FG001|10 Years|Incomplete due to study termination|114|||
170641118|NCT00375609|616699822|FG000|Overall Study|Did not receive treatment|1|||
170641119|NCT00375609|616699823|FG001|Overall Study|Did not receive treatment|0|||
170641120|NCT00375609|616699824|FG002|Overall Study|Did not receive treatment|0|||
170641121|NCT00375609|616699822|FG000|Overall Study|Adverse Event|0|||
170641122|NCT00375609|616699823|FG001|Overall Study|Adverse Event|3|||
170641123|NCT00375609|616699824|FG002|Overall Study|Adverse Event|0|||
170641124|NCT00375609|616699822|FG000|Overall Study|Lost to Follow-up|1|||
170641125|NCT00375609|616699823|FG001|Overall Study|Lost to Follow-up|0|||
170641126|NCT00375609|616699824|FG002|Overall Study|Lost to Follow-up|0|||
170641127|NCT00375609|616699822|FG000|Overall Study|Physician Decision|0|||
170641128|NCT00375609|616699823|FG001|Overall Study|Physician Decision|0|||
170641129|NCT00375609|616699824|FG002|Overall Study|Physician Decision|1|||
170641130|NCT00375609|616699822|FG000|Overall Study|Withdrawal by Subject|1|||
170641131|NCT00375609|616699823|FG001|Overall Study|Withdrawal by Subject|4|||
170801418|NCT03213457|617283240|FG000|Follow-Up Period|Withdrawal by Subject|18|||
170801419|NCT03213457|617283241|FG001|Follow-Up Period|Withdrawal by Subject|11|||
170801420|NCT03213457|617283242|FG002|Follow-Up Period|Withdrawal by Subject|55|||
170801421|NCT03213457|617283240|FG000|Follow-Up Period|Lost to Follow-up|28|||
170801422|NCT03213457|617283241|FG001|Follow-Up Period|Lost to Follow-up|15|||
170492369|NCT01464164|616144016|FG002|Overall Study|Screen failure|2|||
170492370|NCT01464164|616144017|FG003|Overall Study|Screen failure|0|||
170492371|NCT01464164|616144018|FG004|Overall Study|Screen failure|0|||
170492372|NCT01464164|616144019|FG005|Overall Study|Screen failure|0|||
170492373|NCT01464164|616144020|FG006|Overall Study|Screen failure|0|||
170492374|NCT01464164|616144014|FG000|Overall Study|Physician Decision|0|||
170492375|NCT01464164|616144015|FG001|Overall Study|Physician Decision|1|||
170801423|NCT03213457|617283242|FG002|Follow-Up Period|Lost to Follow-up|50|||
170492376|NCT01464164|616144016|FG002|Overall Study|Physician Decision|0|||
170492377|NCT01464164|616144017|FG003|Overall Study|Physician Decision|0|||
170492378|NCT01464164|616144018|FG004|Overall Study|Physician Decision|0|||
170641132|NCT00375609|616699824|FG002|Overall Study|Withdrawal by Subject|0|||
170641133|NCT00375609|616699822|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
170641134|NCT00375609|616699823|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
170492379|NCT01464164|616144019|FG005|Overall Study|Physician Decision|0|||
170492380|NCT01464164|616144020|FG006|Overall Study|Physician Decision|2|||
170492381|NCT01972438|616144021|FG000|Baseline-Month 3 Crossover Period|Death|1|||
170492382|NCT01972438|616144022|FG001|Baseline-Month 3 Crossover Period|Death|0|||
170492383|NCT01972438|616144021|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
170492384|NCT01972438|616144022|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
170492385|NCT01972438|616144021|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
170492386|NCT01972438|616144022|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
170492387|NCT01972438|616144021|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
170492388|NCT01972438|616144022|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
170492389|NCT01972438|616144021|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
170492390|NCT01972438|616144022|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
170492391|NCT01972438|616144021|FG000|Months 6-12 Study Period|Death|1|||
170492392|NCT01972438|616144022|FG001|Months 6-12 Study Period|Death|0|||
170492393|NCT01972438|616144021|FG000|Months 6-12 Study Period|Early Study Closure|2|||
170492394|NCT01972438|616144022|FG001|Months 6-12 Study Period|Early Study Closure|2|||
170492395|NCT01972438|616144021|FG000|Post Month 12 Study Period|Early Study Closure|3|||
170492396|NCT01972438|616144022|FG001|Post Month 12 Study Period|Early Study Closure|4|||
170492397|NCT00697463|616144023|FG000|Overall Study|Withdrawal by Subject|1|||
170492398|NCT00529373|616144024|FG000|Base Study|Adverse Event|525|||
170492399|NCT00529373|616144025|FG001|Base Study|Adverse Event|470|||
170801424|NCT03213457|617283240|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
170801425|NCT03213457|617283241|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
170801426|NCT03213457|617283242|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
170801427|NCT03213457|617283240|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
170801428|NCT03213457|617283241|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
170801429|NCT03213457|617283242|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
170801430|NCT03213457|617283240|FG000|Follow-Up Period|Pregnancy|7|||
170801431|NCT03213457|617283241|FG001|Follow-Up Period|Pregnancy|0|||
170801432|NCT03213457|617283242|FG002|Follow-Up Period|Pregnancy|18|||
170801433|NCT03213457|617283240|FG000|Follow-Up Period|Exclusionary medications|1|||
170801434|NCT03213457|617283241|FG001|Follow-Up Period|Exclusionary medications|1|||
170801435|NCT03213457|617283242|FG002|Follow-Up Period|Exclusionary medications|5|||
170801436|NCT03213457|617283240|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
170801437|NCT03213457|617283241|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
170801438|NCT03213457|617283242|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
170801439|NCT03213457|617283240|FG000|Follow-Up Period|Other|14|||
170801440|NCT03213457|617283241|FG001|Follow-Up Period|Other|10|||
170801441|NCT03213457|617283242|FG002|Follow-Up Period|Other|31|||
170801442|NCT05116774|617283243|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
170801443|NCT05116774|617283244|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
170801444|NCT05116774|617283243|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
170801445|NCT05116774|617283244|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
170801446|NCT05116774|617283243|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
170801447|NCT05116774|617283244|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
170801448|NCT05116774|617283243|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
170801449|NCT05116774|617283244|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
170801450|NCT03150862|617283245|FG000|Overall Study|Death|2|||
170801451|NCT03150862|617283246|FG001|Overall Study|Death|7|||
170801452|NCT03150862|617283247|FG002|Overall Study|Death|8|||
170801453|NCT03150862|617283248|FG003|Overall Study|Death|27|||
170801454|NCT03150862|617283249|FG004|Overall Study|Death|4|||
170801455|NCT03150862|617283250|FG005|Overall Study|Death|8|||
170801456|NCT03150862|617283251|FG006|Overall Study|Death|6|||
170801457|NCT03150862|617283252|FG007|Overall Study|Death|21|||
170801458|NCT03150862|617283245|FG000|Overall Study|Withdrawal by Subject|1|||
170801459|NCT03150862|617283246|FG001|Overall Study|Withdrawal by Subject|1|||
170801460|NCT03150862|617283247|FG002|Overall Study|Withdrawal by Subject|0|||
170801461|NCT03150862|617283248|FG003|Overall Study|Withdrawal by Subject|3|||
170801462|NCT03150862|617283249|FG004|Overall Study|Withdrawal by Subject|1|||
170801463|NCT03150862|617283250|FG005|Overall Study|Withdrawal by Subject|1|||
170801464|NCT03150862|617283251|FG006|Overall Study|Withdrawal by Subject|1|||
170801465|NCT03150862|617283252|FG007|Overall Study|Withdrawal by Subject|3|||
170801466|NCT03150862|617283245|FG000|Overall Study|Lost to Follow-up|0|||
170801467|NCT03150862|617283246|FG001|Overall Study|Lost to Follow-up|0|||
170801468|NCT03150862|617283247|FG002|Overall Study|Lost to Follow-up|1|||
170801469|NCT03150862|617283248|FG003|Overall Study|Lost to Follow-up|0|||
170801470|NCT03150862|617283249|FG004|Overall Study|Lost to Follow-up|0|||
170801471|NCT03150862|617283250|FG005|Overall Study|Lost to Follow-up|0|||
170492400|NCT00529373|616144024|FG000|Base Study|Lack of Efficacy|16|||
170801472|NCT03150862|617283251|FG006|Overall Study|Lost to Follow-up|0|||
170492401|NCT00529373|616144025|FG001|Base Study|Lack of Efficacy|75|||
170492402|NCT00529373|616144024|FG000|Base Study|Lost to Follow-up|221|||
170492403|NCT00529373|616144025|FG001|Base Study|Lost to Follow-up|208|||
170492404|NCT00529373|616144024|FG000|Base Study|Other Protocol Specified Criteria|19|||
170492405|NCT00529373|616144025|FG001|Base Study|Other Protocol Specified Criteria|20|||
170492406|NCT00529373|616144024|FG000|Base Study|Physician Decision|60|||
170492407|NCT00529373|616144025|FG001|Base Study|Physician Decision|52|||
170492408|NCT00529373|616144024|FG000|Base Study|Protocol Violation|48|||
170492409|NCT00529373|616144025|FG001|Base Study|Protocol Violation|38|||
170492410|NCT00529373|616144024|FG000|Base Study|Withdrawal by Subject|1062|||
170492411|NCT00529373|616144025|FG001|Base Study|Withdrawal by Subject|967|||
170492412|NCT00529373|616144024|FG000|Base Study|Did not continue into Extension|1795|||
170492413|NCT00529373|616144025|FG001|Base Study|Did not continue into Extension|2238|||
170492414|NCT00529373|616144024|FG000|First Extension Study|Adverse Event|162|||
170492415|NCT00529373|616144025|FG001|First Extension Study|Adverse Event|142|||
170492416|NCT00529373|616144024|FG000|First Extension Study|Lack of Efficacy|65|||
170492417|NCT00529373|616144025|FG001|First Extension Study|Lack of Efficacy|427|||
170492418|NCT00529373|616144024|FG000|First Extension Study|Lost to Follow-up|41|||
170492419|NCT00529373|616144025|FG001|First Extension Study|Lost to Follow-up|37|||
170492420|NCT00529373|616144024|FG000|First Extension Study|Other|27|||
170492421|NCT00529373|616144025|FG001|First Extension Study|Other|47|||
170492422|NCT00529373|616144024|FG000|First Extension Study|Physician Decision|50|||
170492423|NCT00529373|616144025|FG001|First Extension Study|Physician Decision|45|||
170492424|NCT00529373|616144024|FG000|First Extension Study|Protocol Violation|16|||
170492425|NCT00529373|616144025|FG001|First Extension Study|Protocol Violation|13|||
170492426|NCT00529373|616144024|FG000|First Extension Study|Withdrawal by Subject|296|||
170492427|NCT00529373|616144025|FG001|First Extension Study|Withdrawal by Subject|287|||
170492428|NCT00529373|616144024|FG000|First Extension Study|Disposition record non-existing|0|||
170492429|NCT00529373|616144025|FG001|First Extension Study|Disposition record non-existing|1|||
170492430|NCT00529373|616144024|FG000|First Extension Study|Discontinued after 5 years completion|208|||
170492431|NCT00529373|616144025|FG001|First Extension Study|Discontinued after 5 years completion|346|||
170492432|NCT00529373|616144024|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
170492433|NCT00529373|616144025|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
170492434|NCT00529373|616144024|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
170492435|NCT00529373|616144025|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
170492436|NCT00529373|616144024|FG000|Second Extension Study|Adverse Event|101|||
170492437|NCT00529373|616144025|FG001|Second Extension Study|Adverse Event|51|||
170492438|NCT00529373|616144024|FG000|Second Extension Study|Lack of Efficacy|7|||
170492439|NCT00529373|616144025|FG001|Second Extension Study|Lack of Efficacy|15|||
170492440|NCT00529373|616144024|FG000|Second Extension Study|Lost to Follow-up|18|||
170492441|NCT00529373|616144025|FG001|Second Extension Study|Lost to Follow-up|12|||
170492442|NCT00529373|616144024|FG000|Second Extension Study|Other|7|||
170492443|NCT00529373|616144025|FG001|Second Extension Study|Other|12|||
170492444|NCT00529373|616144024|FG000|Second Extension Study|Physician Decision|63|||
170492445|NCT00529373|616144025|FG001|Second Extension Study|Physician Decision|26|||
170492446|NCT00529373|616144024|FG000|Second Extension Study|Protocol Violation|2|||
170492447|NCT00529373|616144025|FG001|Second Extension Study|Protocol Violation|1|||
170492448|NCT00529373|616144024|FG000|Second Extension Study|Withdrawal by Subject|97|||
170492449|NCT00529373|616144025|FG001|Second Extension Study|Withdrawal by Subject|75|||
170492450|NCT00529373|616144024|FG000|Second Extension Study|Status Missing|5|||
170492451|NCT00529373|616144025|FG001|Second Extension Study|Status Missing|5|||
170492452|NCT02347813|616144028|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
170550003|NCT02004275|616358387|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
170550004|NCT02004275|616358388|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
170550005|NCT02004275|616358389|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
170550006|NCT02004275|616358390|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
170550007|NCT02004275|616358391|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
170550008|NCT02004275|616358392|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
170550009|NCT01423084|616358395|FG000|Overall Study|Adverse Event|0|||
170550010|NCT01423084|616358396|FG001|Overall Study|Adverse Event|1|||
170550011|NCT01423084|616358395|FG000|Overall Study|Withdrawal by Subject|2|||
170550012|NCT01423084|616358396|FG001|Overall Study|Withdrawal by Subject|3|||
170550013|NCT03574389|616358397|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
170550014|NCT03574389|616358398|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
170550015|NCT03574389|616358399|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
170550016|NCT03574389|616358400|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
170550017|NCT03574389|616358401|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
170900313|NCT00792298|617640093|FG006|Treatment Period 1|Lost to Follow-up|1|||
170492453|NCT02347813|616144029|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
170492454|NCT02347813|616144028|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
170492455|NCT02347813|616144029|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
170900314|NCT00792298|617640094|FG007|Treatment Period 1|Lost to Follow-up|0|||
170492456|NCT01134939|616144032|FG000|Overall Study|Adverse Event|9|||
170492457|NCT01134939|616144033|FG001|Overall Study|Adverse Event|3|||
170492458|NCT01134939|616144034|FG002|Overall Study|Adverse Event|4|||
170492459|NCT01134939|616144035|FG003|Overall Study|Adverse Event|5|||
170492460|NCT01134939|616144036|FG004|Overall Study|Adverse Event|5|||
170492461|NCT01134939|616144037|FG005|Overall Study|Adverse Event|5|||
170492462|NCT01134939|616144038|FG006|Overall Study|Adverse Event|1|||
170492463|NCT01134939|616144039|FG007|Overall Study|Adverse Event|0|||
170492464|NCT01134939|616144032|FG000|Overall Study|Lack of Efficacy|2|||
170492465|NCT01134939|616144033|FG001|Overall Study|Lack of Efficacy|5|||
170492466|NCT01134939|616144034|FG002|Overall Study|Lack of Efficacy|1|||
170492467|NCT01134939|616144035|FG003|Overall Study|Lack of Efficacy|0|||
170492468|NCT01134939|616144036|FG004|Overall Study|Lack of Efficacy|3|||
170492469|NCT01134939|616144037|FG005|Overall Study|Lack of Efficacy|0|||
170492470|NCT01134939|616144038|FG006|Overall Study|Lack of Efficacy|1|||
170492471|NCT01134939|616144039|FG007|Overall Study|Lack of Efficacy|0|||
170492472|NCT01134939|616144032|FG000|Overall Study|Lost to Follow-up|2|||
170492473|NCT01134939|616144033|FG001|Overall Study|Lost to Follow-up|3|||
170492474|NCT01134939|616144034|FG002|Overall Study|Lost to Follow-up|0|||
170492475|NCT01134939|616144035|FG003|Overall Study|Lost to Follow-up|1|||
170492476|NCT01134939|616144036|FG004|Overall Study|Lost to Follow-up|2|||
170492477|NCT01134939|616144037|FG005|Overall Study|Lost to Follow-up|1|||
170492478|NCT01134939|616144038|FG006|Overall Study|Lost to Follow-up|0|||
170492479|NCT01134939|616144039|FG007|Overall Study|Lost to Follow-up|0|||
170492480|NCT01134939|616144032|FG000|Overall Study|Death|0|||
170492481|NCT01134939|616144033|FG001|Overall Study|Death|1|||
170492482|NCT01134939|616144034|FG002|Overall Study|Death|0|||
170492483|NCT01134939|616144035|FG003|Overall Study|Death|0|||
170492484|NCT01134939|616144036|FG004|Overall Study|Death|0|||
170492485|NCT01134939|616144037|FG005|Overall Study|Death|0|||
170492486|NCT01134939|616144038|FG006|Overall Study|Death|0|||
170492487|NCT01134939|616144039|FG007|Overall Study|Death|0|||
170492488|NCT01134939|616144032|FG000|Overall Study|Termination page not available|4|||
170492489|NCT01134939|616144033|FG001|Overall Study|Termination page not available|6|||
170492490|NCT01134939|616144034|FG002|Overall Study|Termination page not available|5|||
170492491|NCT01134939|616144035|FG003|Overall Study|Termination page not available|8|||
170492492|NCT01134939|616144036|FG004|Overall Study|Termination page not available|0|||
170492493|NCT01134939|616144037|FG005|Overall Study|Termination page not available|3|||
170492494|NCT01134939|616144038|FG006|Overall Study|Termination page not available|7|||
170492495|NCT01134939|616144039|FG007|Overall Study|Termination page not available|0|||
170492496|NCT00733421|616144040|FG000|Overall Study|Withdrawal by Subject|1|||
170492497|NCT00733421|616144041|FG001|Overall Study|Withdrawal by Subject|1|||
170492498|NCT02547220|616144045|FG000|Overall Study|Withdrawal by Subject|1|||
170492499|NCT02547220|616144046|FG001|Overall Study|Withdrawal by Subject|0|||
170492500|NCT02547220|616144045|FG000|Overall Study|Study terminated by sponsor|18|||
170492501|NCT02547220|616144046|FG001|Overall Study|Study terminated by sponsor|20|||
170492502|NCT03817229|616144047|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
170492503|NCT03817229|616144048|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
170492504|NCT03817229|616144049|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
170492505|NCT03817229|616144050|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
170492506|NCT03817229|616144047|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
170492507|NCT03817229|616144048|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
170492508|NCT03817229|616144049|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
170492509|NCT03817229|616144050|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
170492510|NCT03817229|616144047|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
170492511|NCT03817229|616144048|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
170492512|NCT03817229|616144049|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
170492513|NCT03817229|616144050|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
170492514|NCT03817229|616144047|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
170492515|NCT03817229|616144048|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
170492516|NCT03817229|616144049|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
170492517|NCT03817229|616144050|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
170801473|NCT03150862|617283252|FG007|Overall Study|Lost to Follow-up|2|||
170492518|NCT03817229|616144047|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
170492519|NCT03817229|616144048|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
170492520|NCT03817229|616144049|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
170492521|NCT03817229|616144050|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
170492522|NCT03817229|616144047|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
170492523|NCT03817229|616144048|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
170492524|NCT03817229|616144049|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
170492525|NCT03817229|616144050|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
170492526|NCT03817229|616144047|FG000|Post-Intervention|Withdrawal by Subject|6|||
170492527|NCT03817229|616144048|FG001|Post-Intervention|Withdrawal by Subject|0|||
170492528|NCT03817229|616144049|FG002|Post-Intervention|Withdrawal by Subject|2|||
170801474|NCT03150862|617283245|FG000|Overall Study|Sponsor's decision|0|||
170550018|NCT03574389|616358402|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
170550019|NCT03574389|616358403|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
170550020|NCT03574389|616358397|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
170550021|NCT03574389|616358398|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
170550022|NCT03574389|616358399|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
170550023|NCT03574389|616358400|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
170550024|NCT03574389|616358401|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
170550025|NCT03574389|616358402|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
170550026|NCT03574389|616358403|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
170550027|NCT03574389|616358397|FG000|Vaccination Period|Other|6|||
170550028|NCT03574389|616358398|FG001|Vaccination Period|Other|0|||
170550029|NCT03574389|616358399|FG002|Vaccination Period|Other|0|||
170550030|NCT03574389|616358400|FG003|Vaccination Period|Other|0|||
170550031|NCT03574389|616358401|FG004|Vaccination Period|Other|0|||
170550032|NCT03574389|616358402|FG005|Vaccination Period|Other|0|||
170550033|NCT03574389|616358403|FG006|Vaccination Period|Other|0|||
170550034|NCT03574389|616358397|FG000|Vaccination Period|Adverse Event|0|||
170550035|NCT03574389|616358398|FG001|Vaccination Period|Adverse Event|1|||
170550036|NCT03574389|616358399|FG002|Vaccination Period|Adverse Event|0|||
170550037|NCT03574389|616358400|FG003|Vaccination Period|Adverse Event|0|||
170550038|NCT03574389|616358401|FG004|Vaccination Period|Adverse Event|0|||
170550039|NCT03574389|616358402|FG005|Vaccination Period|Adverse Event|0|||
170550040|NCT03574389|616358403|FG006|Vaccination Period|Adverse Event|0|||
170550041|NCT03574389|616358397|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
170550042|NCT03574389|616358398|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
170550043|NCT03574389|616358399|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
170550044|NCT03574389|616358400|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
170550045|NCT03574389|616358401|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
170550046|NCT03574389|616358402|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
170550047|NCT03574389|616358403|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
170550048|NCT01682603|616358404|FG000|Overall Study|Lost to Follow-up|3|||
170550049|NCT01111292|616358413|FG000|Treatment|Physician Decision|1|||
170550050|NCT01111292|616358414|FG001|Treatment|Physician Decision|1|||
170550051|NCT04914000|616358415|FG000|Overall Study|Lost to Follow-up|8|||
170550052|NCT04914000|616358415|FG000|Overall Study|Withdrawal by Subject|1|||
170801475|NCT03150862|617283246|FG001|Overall Study|Sponsor's decision|0|||
170492529|NCT03817229|616144050|FG003|Post-Intervention|Withdrawal by Subject|2|||
170492530|NCT03817229|616144047|FG000|Post-Intervention|Withdrawal by Study Team|3|||
170492531|NCT03817229|616144048|FG001|Post-Intervention|Withdrawal by Study Team|1|||
170492532|NCT03817229|616144049|FG002|Post-Intervention|Withdrawal by Study Team|1|||
170492533|NCT03817229|616144050|FG003|Post-Intervention|Withdrawal by Study Team|4|||
170492534|NCT03817229|616144047|FG000|Post-Intervention|Weaned from medication|3|||
170492535|NCT03817229|616144048|FG001|Post-Intervention|Weaned from medication|0|||
170492536|NCT03817229|616144049|FG002|Post-Intervention|Weaned from medication|2|||
170492537|NCT03817229|616144050|FG003|Post-Intervention|Weaned from medication|1|||
170492538|NCT03817229|616144047|FG000|Post-Intervention|Transferred care to another institution|1|||
170492539|NCT03817229|616144048|FG001|Post-Intervention|Transferred care to another institution|0|||
170492540|NCT03817229|616144049|FG002|Post-Intervention|Transferred care to another institution|0|||
170492541|NCT03817229|616144050|FG003|Post-Intervention|Transferred care to another institution|0|||
170492542|NCT03817229|616144047|FG000|Post-Intervention|Change in parental guardianship|0|||
170492543|NCT03817229|616144048|FG001|Post-Intervention|Change in parental guardianship|0|||
170492544|NCT03817229|616144049|FG002|Post-Intervention|Change in parental guardianship|1|||
170492545|NCT03817229|616144050|FG003|Post-Intervention|Change in parental guardianship|0|||
170801476|NCT03150862|617283247|FG002|Overall Study|Sponsor's decision|0|||
170801477|NCT03150862|617283248|FG003|Overall Study|Sponsor's decision|10|||
170801478|NCT03150862|617283249|FG004|Overall Study|Sponsor's decision|3|||
170801479|NCT03150862|617283250|FG005|Overall Study|Sponsor's decision|0|||
170801480|NCT03150862|617283251|FG006|Overall Study|Sponsor's decision|1|||
170801481|NCT03150862|617283252|FG007|Overall Study|Sponsor's decision|1|||
170801482|NCT03150862|617283245|FG000|Overall Study|Change in Methylation status|0|||
170801483|NCT03150862|617283246|FG001|Overall Study|Change in Methylation status|0|||
170801484|NCT03150862|617283247|FG002|Overall Study|Change in Methylation status|0|||
170801485|NCT03150862|617283248|FG003|Overall Study|Change in Methylation status|0|||
170550053|NCT01096186|616358416|FG000|Overall Study|Adverse Event|16|||
170550054|NCT01096186|616358416|FG000|Overall Study|Death|4|||
170550055|NCT01096186|616358416|FG000|Overall Study|Lack of Efficacy|4|||
170550056|NCT01096186|616358416|FG000|Overall Study|Lost to Follow-up|2|||
170550057|NCT01096186|616358416|FG000|Overall Study|Withdrawal by Subject|22|||
170550058|NCT01096186|616358416|FG000|Overall Study|Physician Decision|1|||
170801486|NCT03150862|617283249|FG004|Overall Study|Change in Methylation status|1|||
170492546|NCT03817229|616144047|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
170492547|NCT03817229|616144048|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
170492548|NCT03817229|616144049|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
170492549|NCT03817229|616144050|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
170492550|NCT03817229|616144047|FG000|Follow-up 1|Withdrawal by Subject|1|||
170492551|NCT03817229|616144048|FG001|Follow-up 1|Withdrawal by Subject|2|||
170492552|NCT03817229|616144049|FG002|Follow-up 1|Withdrawal by Subject|0|||
170492553|NCT03817229|616144050|FG003|Follow-up 1|Withdrawal by Subject|0|||
170492554|NCT03817229|616144047|FG000|Follow-up 1|Withdrawal by Study Team|3|||
170492555|NCT03817229|616144048|FG001|Follow-up 1|Withdrawal by Study Team|1|||
170492556|NCT03817229|616144049|FG002|Follow-up 1|Withdrawal by Study Team|0|||
170492557|NCT03817229|616144050|FG003|Follow-up 1|Withdrawal by Study Team|0|||
170492558|NCT03817229|616144047|FG000|Follow-up 1|Wean from medication|3|||
170492559|NCT03817229|616144048|FG001|Follow-up 1|Wean from medication|4|||
170492560|NCT03817229|616144049|FG002|Follow-up 1|Wean from medication|0|||
170492561|NCT03817229|616144050|FG003|Follow-up 1|Wean from medication|1|||
170492562|NCT03817229|616144047|FG000|Follow-up 1|Transferred care to another hospital|1|||
170492563|NCT03817229|616144048|FG001|Follow-up 1|Transferred care to another hospital|0|||
170492564|NCT03817229|616144049|FG002|Follow-up 1|Transferred care to another hospital|0|||
170492565|NCT03817229|616144050|FG003|Follow-up 1|Transferred care to another hospital|0|||
170492566|NCT03817229|616144047|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
170492567|NCT03817229|616144048|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
170492568|NCT03817229|616144049|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
170492569|NCT03817229|616144050|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
170492570|NCT03817229|616144047|FG000|Follow-up 2|Withdrawal by Subject|2|||
170492571|NCT03817229|616144048|FG001|Follow-up 2|Withdrawal by Subject|0|||
170492572|NCT03817229|616144049|FG002|Follow-up 2|Withdrawal by Subject|1|||
170492573|NCT03817229|616144050|FG003|Follow-up 2|Withdrawal by Subject|1|||
170492574|NCT03817229|616144047|FG000|Follow-up 2|Withdrawal by Study Team|2|||
170492575|NCT03817229|616144048|FG001|Follow-up 2|Withdrawal by Study Team|0|||
170492576|NCT03817229|616144049|FG002|Follow-up 2|Withdrawal by Study Team|1|||
170492577|NCT03817229|616144050|FG003|Follow-up 2|Withdrawal by Study Team|0|||
170492578|NCT03817229|616144047|FG000|Follow-up 2|Wean from medication|1|||
170492579|NCT03817229|616144048|FG001|Follow-up 2|Wean from medication|0|||
170492580|NCT03817229|616144049|FG002|Follow-up 2|Wean from medication|0|||
170492581|NCT03817229|616144050|FG003|Follow-up 2|Wean from medication|0|||
170492582|NCT03817229|616144047|FG000|Follow-up 2|Transferred care|0|||
170492583|NCT03817229|616144048|FG001|Follow-up 2|Transferred care|0|||
170801487|NCT03150862|617283250|FG005|Overall Study|Change in Methylation status|0|||
170492584|NCT03817229|616144049|FG002|Follow-up 2|Transferred care|1|||
170492585|NCT03817229|616144050|FG003|Follow-up 2|Transferred care|0|||
170492586|NCT04185220|616144051|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
170801488|NCT03150862|617283251|FG006|Overall Study|Change in Methylation status|0|||
170801489|NCT03150862|617283252|FG007|Overall Study|Change in Methylation status|0|||
170801490|NCT03150862|617283245|FG000|Overall Study|Roll over in to Long Term Extension|0|||
170801491|NCT03150862|617283246|FG001|Overall Study|Roll over in to Long Term Extension|0|||
170801492|NCT03150862|617283247|FG002|Overall Study|Roll over in to Long Term Extension|0|||
170801493|NCT03150862|617283248|FG003|Overall Study|Roll over in to Long Term Extension|0|||
170801494|NCT03150862|617283249|FG004|Overall Study|Roll over in to Long Term Extension|0|||
170801495|NCT03150862|617283250|FG005|Overall Study|Roll over in to Long Term Extension|0|||
170801496|NCT03150862|617283251|FG006|Overall Study|Roll over in to Long Term Extension|0|||
170801497|NCT03150862|617283252|FG007|Overall Study|Roll over in to Long Term Extension|1|||
170801498|NCT03150862|617283245|FG000|Overall Study|Progressive Disease|0|||
170801499|NCT03150862|617283246|FG001|Overall Study|Progressive Disease|0|||
170801500|NCT03150862|617283247|FG002|Overall Study|Progressive Disease|0|||
170801501|NCT03150862|617283248|FG003|Overall Study|Progressive Disease|0|||
170801502|NCT03150862|617283249|FG004|Overall Study|Progressive Disease|0|||
170801503|NCT03150862|617283250|FG005|Overall Study|Progressive Disease|0|||
170801504|NCT03150862|617283251|FG006|Overall Study|Progressive Disease|0|||
170801505|NCT03150862|617283252|FG007|Overall Study|Progressive Disease|2|||
170801506|NCT00048932|617283973|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
170801507|NCT00048932|617283974|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
170801508|NCT00048932|617283975|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
170801509|NCT00048932|617283973|FG000|Double Blind Period (DB)|Adverse Event|51|||
170492587|NCT04185220|616144052|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
170492588|NCT04185220|616144051|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
170801510|NCT00048932|617283974|FG001|Double Blind Period (DB)|Adverse Event|19|||
170801511|NCT00048932|617283975|FG002|Double Blind Period (DB)|Adverse Event|0|||
170801512|NCT00048932|617283973|FG000|Double Blind Period (DB)|Death|5|||
170801513|NCT00048932|617283974|FG001|Double Blind Period (DB)|Death|3|||
170801514|NCT00048932|617283975|FG002|Double Blind Period (DB)|Death|0|||
170492589|NCT04185220|616144052|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
170492590|NCT02887183|616144053|FG000|Overall Study|Adverse Event|44|||
170492591|NCT02887183|616144053|FG000|Overall Study|Death|30|||
170492592|NCT02887183|616144053|FG000|Overall Study|Pregnancy|1|||
170492593|NCT02887183|616144053|FG000|Overall Study|Protocol Violation|6|||
170492594|NCT02887183|616144053|FG000|Overall Study|Technical Problems|2|||
170492595|NCT02887183|616144053|FG000|Overall Study|Lost to Follow-up|13|||
170492596|NCT02887183|616144053|FG000|Overall Study|Physician Decision|10|||
170492597|NCT02887183|616144053|FG000|Overall Study|Withdrawal by Subject|35|||
170492598|NCT01029782|616144057|FG000|Overall Study|Lost to Follow-up|2|||
170492599|NCT01029782|616144058|FG001|Overall Study|Lost to Follow-up|2|||
170492600|NCT01029782|616144057|FG000|Overall Study|Diagnosis changed|1|||
170492601|NCT01029782|616144058|FG001|Overall Study|Diagnosis changed|1|||
170492602|NCT01029782|616144057|FG000|Overall Study|Adverse Event|0|||
170492603|NCT01029782|616144058|FG001|Overall Study|Adverse Event|1|||
170492604|NCT01029782|616144057|FG000|Overall Study|Physician Decision|0|||
170492605|NCT01029782|616144058|FG001|Overall Study|Physician Decision|1|||
170492606|NCT01029782|616144057|FG000|Overall Study|Protocol Violation|0|||
170492607|NCT01029782|616144058|FG001|Overall Study|Protocol Violation|2|||
170492608|NCT01029782|616144057|FG000|Overall Study|Withdrawal by Subject|0|||
170492609|NCT01029782|616144058|FG001|Overall Study|Withdrawal by Subject|1|||
170492610|NCT02195869|616144064|FG000|Overall Study|cGVHD Progression|5|||
170492611|NCT02195869|616144064|FG000|Overall Study|Malignancy Progression/relapse|2|||
170492612|NCT02195869|616144064|FG000|Overall Study|Adverse Event|15|||
170492613|NCT02195869|616144064|FG000|Overall Study|Withdrawal by Subject|7|||
170492614|NCT02195869|616144064|FG000|Overall Study|Physician Decision|4|||
170492615|NCT02195869|616144064|FG000|Overall Study|Study Terminated by Sponsor|7|||
170492616|NCT02195869|616144064|FG000|Overall Study|Noncompliance with study drug|2|||
170550059|NCT01096186|616358416|FG000|Overall Study|Noncompliance with study drug|1|||
170550060|NCT01750281|616358417|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
170550061|NCT01750281|616358418|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
170550062|NCT01750281|616358419|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
170550063|NCT01750281|616358417|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
170550064|NCT01750281|616358418|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
170550065|NCT01750281|616358419|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
170550066|NCT01750281|616358417|FG000|Overall Study|Did not receive treatment|0|||
170550067|NCT01750281|616358418|FG001|Overall Study|Did not receive treatment|1|||
170550068|NCT01750281|616358419|FG002|Overall Study|Did not receive treatment|0|||
170550069|NCT01896986|616358420|FG000|Overall Study|samples lost|14|||
170550070|NCT01896986|616358421|FG001|Overall Study|samples lost|23|||
170550071|NCT04189588|616358422|FG000|Overall Study|Death|0|||
170550072|NCT04189588|616358423|FG001|Overall Study|Death|1|||
170550073|NCT04189588|616358422|FG000|Overall Study|Lost to Follow-up|0|||
170550074|NCT04189588|616358423|FG001|Overall Study|Lost to Follow-up|1|||
170550075|NCT03757715|616358427|FG000|Overall Study|Lost to Follow-up|4|||
170550076|NCT03757715|616358428|FG001|Overall Study|Lost to Follow-up|9|||
170550077|NCT03757715|616358427|FG000|Overall Study|Withdrawal by Subject|1|||
170550078|NCT03757715|616358428|FG001|Overall Study|Withdrawal by Subject|1|||
170550079|NCT03302936|616358430|FG000|Overall Study|Protocol Violation|3|||
170550080|NCT03302936|616358431|FG001|Overall Study|Protocol Violation|4|||
170550081|NCT01122680|616358432|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
170550082|NCT01122680|616358433|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
170550083|NCT01122680|616358434|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
170550084|NCT01122680|616358435|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
170550085|NCT01122680|616358432|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
170550086|NCT01122680|616358433|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
170550087|NCT01122680|616358434|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
170550088|NCT01122680|616358435|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
170550089|NCT01122680|616358432|FG000|Period 1 (4 Weeks)|Other|1|||
170550090|NCT01122680|616358433|FG001|Period 1 (4 Weeks)|Other|1|||
170550091|NCT01122680|616358434|FG002|Period 1 (4 Weeks)|Other|0|||
170550092|NCT01122680|616358435|FG003|Period 1 (4 Weeks)|Other|0|||
170550093|NCT01122680|616358432|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
170550094|NCT01122680|616358433|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
170550095|NCT01122680|616358434|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
170550096|NCT01122680|616358435|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
170550097|NCT01122680|616358432|FG000|Period 2 (4 Weeks)|Other|1|||
170550098|NCT01122680|616358433|FG001|Period 2 (4 Weeks)|Other|0|||
170550099|NCT01122680|616358434|FG002|Period 2 (4 Weeks)|Other|0|||
170550100|NCT01122680|616358435|FG003|Period 2 (4 Weeks)|Other|0|||
170550101|NCT01122680|616358432|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
170550102|NCT01122680|616358433|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
170550103|NCT01122680|616358434|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
170550104|NCT01122680|616358435|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
170550105|NCT01122680|616358432|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
170492617|NCT02702388|616144067|FG000|Overall Study|Disease Progression|18|||
170550106|NCT01122680|616358433|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
170550107|NCT01122680|616358434|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
170641135|NCT00375609|616699824|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
170641136|NCT01129583|616699826|FG000|Overall Study|Death|1|||
170641137|NCT01129583|616699827|FG001|Overall Study|Death|0|||
170641138|NCT01129583|616699826|FG000|Overall Study|Lost to Follow-up|1|||
170641139|NCT01129583|616699827|FG001|Overall Study|Lost to Follow-up|1|||
170641140|NCT01129583|616699826|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
170492618|NCT02702388|616144068|FG001|Overall Study|Disease Progression|25|||
170492619|NCT02702388|616144067|FG000|Overall Study|Withdrawal by Subject|9|||
170492620|NCT02702388|616144068|FG001|Overall Study|Withdrawal by Subject|7|||
170492621|NCT02702388|616144067|FG000|Overall Study|Adverse Event|11|||
170492622|NCT02702388|616144068|FG001|Overall Study|Adverse Event|15|||
170492623|NCT02702388|616144067|FG000|Overall Study|Other|2|||
170492624|NCT02702388|616144068|FG001|Overall Study|Other|4|||
170492625|NCT01314872|616144075|FG000|Treatment Period 1|Protocol Violation|2|||
170492626|NCT01314872|616144076|FG001|Treatment Period 1|Protocol Violation|1|||
170492627|NCT01314872|616144077|FG002|Treatment Period 1|Protocol Violation|1|||
170492628|NCT01314872|616144078|FG003|Treatment Period 1|Protocol Violation|0|||
170492629|NCT01314872|616144079|FG004|Treatment Period 1|Protocol Violation|1|||
170492630|NCT01314872|616144080|FG005|Treatment Period 1|Protocol Violation|0|||
170492631|NCT01314872|616144081|FG006|Treatment Period 1|Protocol Violation|0|||
170492632|NCT01314872|616144082|FG007|Treatment Period 1|Protocol Violation|0|||
170641141|NCT01129583|616699827|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
170641142|NCT01904773|616699837|FG000|Screen|Screen failure|3|||
170641143|NCT01904773|616699838|FG001|Screen|Screen failure|0|||
170641144|NCT01904773|616699839|FG002|Screen|Screen failure|0|||
170641145|NCT01904773|616699840|FG003|Screen|Screen failure|0|||
170641146|NCT01904773|616699841|FG004|Screen|Screen failure|0|||
170641147|NCT01904773|616699842|FG005|Screen|Screen failure|0|||
170641148|NCT01904773|616699843|FG006|Screen|Screen failure|0|||
170641149|NCT01904773|616699844|FG007|Screen|Screen failure|0|||
170641150|NCT01904773|616699845|FG008|Screen|Screen failure|0|||
170492633|NCT01314872|616144083|FG008|Treatment Period 1|Protocol Violation|0|||
170492634|NCT01314872|616144084|FG009|Treatment Period 1|Protocol Violation|1|||
170492635|NCT01314872|616144085|FG010|Treatment Period 1|Protocol Violation|1|||
170492636|NCT01314872|616144086|FG011|Treatment Period 1|Protocol Violation|0|||
170492637|NCT01314872|616144087|FG012|Treatment Period 1|Protocol Violation|0|||
170492638|NCT01314872|616144088|FG013|Treatment Period 1|Protocol Violation|0|||
170492639|NCT01314872|616144089|FG014|Treatment Period 1|Protocol Violation|0|||
170492640|NCT01314872|616144075|FG000|Treatment Period 1|Physician Decision|0|||
170492641|NCT01314872|616144076|FG001|Treatment Period 1|Physician Decision|1|||
170492642|NCT01314872|616144077|FG002|Treatment Period 1|Physician Decision|0|||
170492643|NCT01314872|616144078|FG003|Treatment Period 1|Physician Decision|1|||
170492644|NCT01314872|616144079|FG004|Treatment Period 1|Physician Decision|0|||
170492645|NCT01314872|616144080|FG005|Treatment Period 1|Physician Decision|0|||
170492646|NCT01314872|616144081|FG006|Treatment Period 1|Physician Decision|0|||
170492647|NCT01314872|616144082|FG007|Treatment Period 1|Physician Decision|0|||
170492648|NCT01314872|616144083|FG008|Treatment Period 1|Physician Decision|0|||
170492649|NCT01314872|616144084|FG009|Treatment Period 1|Physician Decision|1|||
170492650|NCT01314872|616144085|FG010|Treatment Period 1|Physician Decision|0|||
170492651|NCT01314872|616144086|FG011|Treatment Period 1|Physician Decision|0|||
170492652|NCT01314872|616144087|FG012|Treatment Period 1|Physician Decision|0|||
170492653|NCT01314872|616144088|FG013|Treatment Period 1|Physician Decision|0|||
170492654|NCT01314872|616144089|FG014|Treatment Period 1|Physician Decision|0|||
170492655|NCT01314872|616144075|FG000|Treatment Period 1|Lack of Efficacy|1|||
170492656|NCT01314872|616144076|FG001|Treatment Period 1|Lack of Efficacy|0|||
170492657|NCT01314872|616144077|FG002|Treatment Period 1|Lack of Efficacy|0|||
170492658|NCT01314872|616144078|FG003|Treatment Period 1|Lack of Efficacy|0|||
170641151|NCT01904773|616699837|FG000|Screen|Withdrawal by Subject|1|||
170641152|NCT01904773|616699838|FG001|Screen|Withdrawal by Subject|0|||
170641153|NCT01904773|616699839|FG002|Screen|Withdrawal by Subject|0|||
170641154|NCT01904773|616699840|FG003|Screen|Withdrawal by Subject|0|||
170641155|NCT01904773|616699841|FG004|Screen|Withdrawal by Subject|0|||
170492659|NCT01314872|616144079|FG004|Treatment Period 1|Lack of Efficacy|0|||
170641156|NCT01904773|616699842|FG005|Screen|Withdrawal by Subject|0|||
170492660|NCT01314872|616144080|FG005|Treatment Period 1|Lack of Efficacy|1|||
170492661|NCT01314872|616144081|FG006|Treatment Period 1|Lack of Efficacy|0|||
170492662|NCT01314872|616144082|FG007|Treatment Period 1|Lack of Efficacy|2|||
170641157|NCT01904773|616699843|FG006|Screen|Withdrawal by Subject|0|||
170641158|NCT01904773|616699844|FG007|Screen|Withdrawal by Subject|0|||
170492663|NCT01314872|616144083|FG008|Treatment Period 1|Lack of Efficacy|0|||
170492664|NCT01314872|616144084|FG009|Treatment Period 1|Lack of Efficacy|0|||
170641159|NCT01904773|616699845|FG008|Screen|Withdrawal by Subject|0|||
170641160|NCT01904773|616699837|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
170641161|NCT01904773|616699838|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
170641162|NCT01904773|616699839|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
170492665|NCT01314872|616144085|FG010|Treatment Period 1|Lack of Efficacy|0|||
170492666|NCT01314872|616144086|FG011|Treatment Period 1|Lack of Efficacy|0|||
170492667|NCT01314872|616144087|FG012|Treatment Period 1|Lack of Efficacy|0|||
170492668|NCT01314872|616144088|FG013|Treatment Period 1|Lack of Efficacy|0|||
170492669|NCT01314872|616144089|FG014|Treatment Period 1|Lack of Efficacy|0|||
170492670|NCT01314872|616144075|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
170900315|NCT00792298|617640087|FG000|Treatment Period 1|Physician Decision|0|||
170900316|NCT00792298|617640088|FG001|Treatment Period 1|Physician Decision|0|||
170900317|NCT00792298|617640089|FG002|Treatment Period 1|Physician Decision|0|||
170900318|NCT00792298|617640090|FG003|Treatment Period 1|Physician Decision|1|||
170900319|NCT00792298|617640091|FG004|Treatment Period 1|Physician Decision|0|||
170900320|NCT00792298|617640092|FG005|Treatment Period 1|Physician Decision|0|||
170900321|NCT00792298|617640093|FG006|Treatment Period 1|Physician Decision|1|||
170900322|NCT00792298|617640094|FG007|Treatment Period 1|Physician Decision|0|||
170900323|NCT00792298|617640087|FG000|Treatment Period 1|Protocol Violation|0|||
170900324|NCT00792298|617640088|FG001|Treatment Period 1|Protocol Violation|0|||
170900325|NCT00792298|617640089|FG002|Treatment Period 1|Protocol Violation|0|||
170900326|NCT00792298|617640090|FG003|Treatment Period 1|Protocol Violation|0|||
170900327|NCT00792298|617640091|FG004|Treatment Period 1|Protocol Violation|0|||
170900328|NCT00792298|617640092|FG005|Treatment Period 1|Protocol Violation|0|||
170900329|NCT00792298|617640093|FG006|Treatment Period 1|Protocol Violation|0|||
170641163|NCT01904773|616699840|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
170641164|NCT01904773|616699841|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
170641165|NCT01904773|616699842|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
170641166|NCT01904773|616699843|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
170641167|NCT01904773|616699844|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
170641168|NCT01904773|616699845|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
170900330|NCT00792298|617640094|FG007|Treatment Period 1|Protocol Violation|1|||
170900331|NCT00792298|617640087|FG000|Washout|Adverse Event|0|||
170900332|NCT00792298|617640088|FG001|Washout|Adverse Event|0|||
170900333|NCT00792298|617640089|FG002|Washout|Adverse Event|0|||
170900334|NCT00792298|617640090|FG003|Washout|Adverse Event|0|||
170900335|NCT00792298|617640091|FG004|Washout|Adverse Event|0|||
170900336|NCT00792298|617640092|FG005|Washout|Adverse Event|1|||
170900337|NCT00792298|617640093|FG006|Washout|Adverse Event|0|||
170900338|NCT00792298|617640094|FG007|Washout|Adverse Event|0|||
170900339|NCT00792298|617640087|FG000|Washout|Withdrawal by Subject|0|||
170900340|NCT00792298|617640088|FG001|Washout|Withdrawal by Subject|0|||
170900341|NCT00792298|617640089|FG002|Washout|Withdrawal by Subject|1|||
170492671|NCT01314872|616144076|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
170492672|NCT01314872|616144077|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
170492673|NCT01314872|616144078|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
170550108|NCT01122680|616358435|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
170550109|NCT01217047|616358438|FG000|Overall Study|Lost to Follow-up|0|||
170550110|NCT01217047|616358439|FG001|Overall Study|Lost to Follow-up|1|||
170550111|NCT01217047|616358440|FG002|Overall Study|Lost to Follow-up|0|||
170550112|NCT02453191|616358447|FG000|Overall Study|Withdrawal by Subject|1|||
170550113|NCT02571244|616358448|FG000|Overall Study|Lost to Follow-up|0|||
170550114|NCT02571244|616358449|FG001|Overall Study|Lost to Follow-up|1|||
170550115|NCT02571244|616358448|FG000|Overall Study|Unable to reach out post discharge|3|||
170550116|NCT02571244|616358449|FG001|Overall Study|Unable to reach out post discharge|0|||
170550117|NCT02807181|616358454|FG000|Overall Study|Death|28|||
170550118|NCT02807181|616358455|FG001|Overall Study|Death|24|||
170550119|NCT02807181|616358454|FG000|Overall Study|Withdrawal by Subject|1|||
170550120|NCT02807181|616358455|FG001|Overall Study|Withdrawal by Subject|1|||
170550121|NCT02807181|616358454|FG000|Overall Study|Lost to Follow-up|0|||
170550122|NCT02807181|616358455|FG001|Overall Study|Lost to Follow-up|2|||
170550123|NCT02807181|616358454|FG000|Overall Study|Subject decision|1|||
170550124|NCT02807181|616358455|FG001|Overall Study|Subject decision|0|||
170550125|NCT02807181|616358454|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
170550126|NCT02807181|616358455|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
170550127|NCT02807181|616358454|FG000|Overall Study|In Study|3|||
170550128|NCT02807181|616358455|FG001|Overall Study|In Study|3|||
170550129|NCT02807181|616358454|FG000|Overall Study|Post Progression|3|||
170550130|NCT02807181|616358455|FG001|Overall Study|Post Progression|2|||
170550131|NCT03518203|616358456|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
170550132|NCT03518203|616358456|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
170550133|NCT03511066|616358458|FG000|Overall Study|Withdrawal by Subject|1|||
170550134|NCT03511066|616358459|FG001|Overall Study|Withdrawal by Subject|2|||
170550135|NCT03511066|616358460|FG002|Overall Study|Withdrawal by Subject|3|||
170550136|NCT03511066|616358458|FG000|Overall Study|Lost to Follow-up|2|||
170641169|NCT01904773|616699837|FG000|First Intervention|Adverse Event|0|||
170900342|NCT00792298|617640090|FG003|Washout|Withdrawal by Subject|0|||
170900343|NCT00792298|617640091|FG004|Washout|Withdrawal by Subject|0|||
170900344|NCT00792298|617640092|FG005|Washout|Withdrawal by Subject|1|||
170900345|NCT00792298|617640093|FG006|Washout|Withdrawal by Subject|0|||
170492674|NCT01314872|616144079|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
170492675|NCT01314872|616144080|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
170492676|NCT01314872|616144081|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
170492677|NCT01314872|616144082|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
170492678|NCT01314872|616144083|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
170492679|NCT01314872|616144084|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
170492680|NCT01314872|616144085|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
170550137|NCT03511066|616358459|FG001|Overall Study|Lost to Follow-up|3|||
170550138|NCT03511066|616358460|FG002|Overall Study|Lost to Follow-up|0|||
170550139|NCT00754559|616358461|FG000|Overall Study|Adverse Event|15|||
170550140|NCT00754559|616358461|FG000|Overall Study|Protocol Violation|11|||
170550141|NCT00754559|616358461|FG000|Overall Study|Lack of Efficacy|10|||
170550142|NCT00754559|616358461|FG000|Overall Study|Lost to Follow-up|2|||
170801515|NCT00048932|617283973|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
170801516|NCT00048932|617283974|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
170801517|NCT00048932|617283975|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
170801518|NCT00048932|617283973|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
170550143|NCT00754559|616358461|FG000|Overall Study|Administrative reason|1|||
170550144|NCT00754559|616358461|FG000|Overall Study|Other|5|||
170550145|NCT00754559|616358461|FG000|Overall Study|Withdrawal by Subject|3|||
170550146|NCT02362412|616358470|FG000|Treatment Period III|Lost to Follow-up|0|||
170550147|NCT02362412|616358471|FG001|Treatment Period III|Lost to Follow-up|1|||
170550148|NCT00545948|616358472|FG000|Overall Study|Not Treated|1|||
170550149|NCT00545948|616358473|FG001|Overall Study|Not Treated|1|||
170801519|NCT00048932|617283974|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
170801520|NCT00048932|617283975|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
170550150|NCT00545948|616358474|FG002|Overall Study|Not Treated|7|||
170550151|NCT00977561|616358476|FG000|Overall Study|Death|3|||
170801521|NCT00048932|617283973|FG000|Double Blind Period (DB)|Relocation|1|||
170550152|NCT00977561|616358477|FG001|Overall Study|Death|2|||
170550153|NCT00977561|616358476|FG000|Overall Study|Study terminated|0|||
170801522|NCT00048932|617283974|FG001|Double Blind Period (DB)|Relocation|0|||
170801523|NCT00048932|617283975|FG002|Double Blind Period (DB)|Relocation|0|||
170801524|NCT00048932|617283973|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
170801525|NCT00048932|617283974|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
170801526|NCT00048932|617283975|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
170801527|NCT00048932|617283973|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
170801528|NCT00048932|617283974|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
170801529|NCT00048932|617283975|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
170801530|NCT00048932|617283973|FG000|Double Blind Period (DB)|Pregnancy|1|||
170801531|NCT00048932|617283974|FG001|Double Blind Period (DB)|Pregnancy|0|||
170801532|NCT00048932|617283975|FG002|Double Blind Period (DB)|Pregnancy|0|||
170801533|NCT00048932|617283973|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
170492681|NCT01314872|616144086|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
170550154|NCT00977561|616358477|FG001|Overall Study|Study terminated|2|||
170550155|NCT00977561|616358476|FG000|Overall Study|Other|2|||
170550156|NCT00977561|616358477|FG001|Overall Study|Other|0|||
170550157|NCT00694161|616358479|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
170550158|NCT00694161|616358479|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
170550159|NCT00694161|616358479|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
170550160|NCT01227395|616358480|FG000|Overall Study|Protocol Violation|0|||
170550161|NCT01227395|616358481|FG001|Overall Study|Protocol Violation|1|||
170550162|NCT02529488|616360473|FG000|Overall Study|Adverse Event|1|||
170550163|NCT02529488|616360473|FG000|Overall Study|Death|3|||
170550164|NCT01658735|616360474|FG000|Overall Study|Lack of Efficacy|1|||
170550165|NCT01658735|616360475|FG001|Overall Study|Lack of Efficacy|0|||
170550166|NCT01658735|616360476|FG002|Overall Study|Lack of Efficacy|1|||
170550167|NCT01658735|616360474|FG000|Overall Study|Lost to Follow-up|1|||
170550168|NCT01658735|616360475|FG001|Overall Study|Lost to Follow-up|1|||
170550169|NCT01658735|616360476|FG002|Overall Study|Lost to Follow-up|0|||
170550170|NCT01658735|616360474|FG000|Overall Study|Protocol Violation|0|||
170550171|NCT01658735|616360475|FG001|Overall Study|Protocol Violation|1|||
170550172|NCT01658735|616360476|FG002|Overall Study|Protocol Violation|0|||
170550173|NCT01658735|616360474|FG000|Overall Study|Withdrawal by Subject|3|||
170550174|NCT01658735|616360475|FG001|Overall Study|Withdrawal by Subject|5|||
170550175|NCT01658735|616360476|FG002|Overall Study|Withdrawal by Subject|3|||
170550176|NCT00281580|616360477|FG000|Overall Study|Adverse Event|2|||
170801534|NCT00048932|617283974|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
170801535|NCT00048932|617283975|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
170492682|NCT01314872|616144087|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
170550177|NCT00281580|616360478|FG001|Overall Study|Adverse Event|0|||
170550178|NCT00281580|616360479|FG002|Overall Study|Adverse Event|2|||
170550179|NCT00281580|616360480|FG003|Overall Study|Adverse Event|4|||
170550180|NCT00281580|616360481|FG004|Overall Study|Adverse Event|1|||
170550181|NCT00281580|616360482|FG005|Overall Study|Adverse Event|0|||
170550182|NCT00281580|616360483|FG006|Overall Study|Adverse Event|1|||
170492683|NCT01314872|616144088|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
170492684|NCT01314872|616144089|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
170492685|NCT01314872|616144075|FG000|Treatment Period 1|Withdrawal by Subject|3|||
170492686|NCT01314872|616144076|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170492687|NCT01314872|616144077|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170492688|NCT01314872|616144078|FG003|Treatment Period 1|Withdrawal by Subject|2|||
170492689|NCT01314872|616144079|FG004|Treatment Period 1|Withdrawal by Subject|3|||
170492690|NCT01314872|616144080|FG005|Treatment Period 1|Withdrawal by Subject|1|||
170492691|NCT01314872|616144081|FG006|Treatment Period 1|Withdrawal by Subject|3|||
170492692|NCT01314872|616144082|FG007|Treatment Period 1|Withdrawal by Subject|2|||
170492693|NCT01314872|616144083|FG008|Treatment Period 1|Withdrawal by Subject|2|||
170492694|NCT01314872|616144084|FG009|Treatment Period 1|Withdrawal by Subject|2|||
170492695|NCT01314872|616144085|FG010|Treatment Period 1|Withdrawal by Subject|1|||
170492696|NCT01314872|616144086|FG011|Treatment Period 1|Withdrawal by Subject|0|||
170492697|NCT01314872|616144087|FG012|Treatment Period 1|Withdrawal by Subject|0|||
170492698|NCT01314872|616144088|FG013|Treatment Period 1|Withdrawal by Subject|0|||
170492699|NCT01314872|616144089|FG014|Treatment Period 1|Withdrawal by Subject|0|||
170492700|NCT01314872|616144075|FG000|Treatment Period 1|Lost to Follow-up|0|||
170492701|NCT01314872|616144076|FG001|Treatment Period 1|Lost to Follow-up|1|||
170492702|NCT01314872|616144077|FG002|Treatment Period 1|Lost to Follow-up|2|||
170492703|NCT01314872|616144078|FG003|Treatment Period 1|Lost to Follow-up|2|||
170492704|NCT01314872|616144079|FG004|Treatment Period 1|Lost to Follow-up|1|||
170492705|NCT01314872|616144080|FG005|Treatment Period 1|Lost to Follow-up|1|||
170492706|NCT01314872|616144081|FG006|Treatment Period 1|Lost to Follow-up|1|||
170492707|NCT01314872|616144082|FG007|Treatment Period 1|Lost to Follow-up|1|||
170492708|NCT01314872|616144083|FG008|Treatment Period 1|Lost to Follow-up|1|||
170492709|NCT01314872|616144084|FG009|Treatment Period 1|Lost to Follow-up|0|||
170492710|NCT01314872|616144085|FG010|Treatment Period 1|Lost to Follow-up|0|||
170550183|NCT00281580|616360484|FG007|Overall Study|Adverse Event|0|||
170641170|NCT01904773|616699838|FG001|First Intervention|Adverse Event|0|||
170641171|NCT01904773|616699839|FG002|First Intervention|Adverse Event|0|||
170641172|NCT01904773|616699840|FG003|First Intervention|Adverse Event|0|||
170641173|NCT01904773|616699841|FG004|First Intervention|Adverse Event|0|||
170641174|NCT01904773|616699842|FG005|First Intervention|Adverse Event|0|||
170641175|NCT01904773|616699843|FG006|First Intervention|Adverse Event|1|||
170550184|NCT00281580|616360485|FG008|Overall Study|Adverse Event|1|||
170550185|NCT00281580|616360486|FG009|Overall Study|Adverse Event|6|||
170550186|NCT00281580|616360487|FG010|Overall Study|Adverse Event|0|||
170550187|NCT00281580|616360488|FG011|Overall Study|Adverse Event|5|||
170550188|NCT00281580|616360489|FG012|Overall Study|Adverse Event|8|||
170550189|NCT00281580|616360490|FG013|Overall Study|Adverse Event|2|||
170550190|NCT00281580|616360491|FG014|Overall Study|Adverse Event|3|||
170550191|NCT00281580|616360492|FG015|Overall Study|Adverse Event|3|||
170550192|NCT00281580|616360477|FG000|Overall Study|Protocol Violation|0|||
170550193|NCT00281580|616360478|FG001|Overall Study|Protocol Violation|0|||
170550194|NCT00281580|616360479|FG002|Overall Study|Protocol Violation|1|||
170550195|NCT00281580|616360480|FG003|Overall Study|Protocol Violation|1|||
170550196|NCT00281580|616360481|FG004|Overall Study|Protocol Violation|0|||
170550197|NCT00281580|616360482|FG005|Overall Study|Protocol Violation|0|||
170550198|NCT00281580|616360483|FG006|Overall Study|Protocol Violation|1|||
170550199|NCT00281580|616360484|FG007|Overall Study|Protocol Violation|0|||
170550200|NCT00281580|616360485|FG008|Overall Study|Protocol Violation|2|||
170550201|NCT00281580|616360486|FG009|Overall Study|Protocol Violation|0|||
170550202|NCT00281580|616360487|FG010|Overall Study|Protocol Violation|1|||
170550203|NCT00281580|616360488|FG011|Overall Study|Protocol Violation|2|||
170550204|NCT00281580|616360489|FG012|Overall Study|Protocol Violation|0|||
170801536|NCT00048932|617283973|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
170801537|NCT00048932|617283974|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
170801538|NCT00048932|617283975|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
170801539|NCT00048932|617283973|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
170801540|NCT00048932|617283974|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
170492711|NCT01314872|616144086|FG011|Treatment Period 1|Lost to Follow-up|0|||
170492712|NCT01314872|616144087|FG012|Treatment Period 1|Lost to Follow-up|0|||
170492713|NCT01314872|616144088|FG013|Treatment Period 1|Lost to Follow-up|0|||
170641176|NCT01904773|616699844|FG007|First Intervention|Adverse Event|0|||
170801541|NCT00048932|617283975|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
170492714|NCT01314872|616144089|FG014|Treatment Period 1|Lost to Follow-up|0|||
170641177|NCT01904773|616699845|FG008|First Intervention|Adverse Event|0|||
170492715|NCT01314872|616144075|FG000|Period 2|Protocol Violation|0|||
170550205|NCT00281580|616360490|FG013|Overall Study|Protocol Violation|1|||
170550206|NCT00281580|616360491|FG014|Overall Study|Protocol Violation|1|||
170641178|NCT01904773|616699837|FG000|Placebo Washout First Intervention|Condition worsened|0|||
170550207|NCT00281580|616360492|FG015|Overall Study|Protocol Violation|3|||
170550208|NCT00281580|616360477|FG000|Overall Study|Withdrawal by Subject|3|||
170550209|NCT00281580|616360478|FG001|Overall Study|Withdrawal by Subject|0|||
170801542|NCT00048932|617283973|FG000|Open Label Period (OL)|Death|0|||
170492716|NCT01314872|616144076|FG001|Period 2|Protocol Violation|0|||
170492717|NCT01314872|616144077|FG002|Period 2|Protocol Violation|0|||
170492718|NCT01314872|616144078|FG003|Period 2|Protocol Violation|0|||
170492719|NCT01314872|616144079|FG004|Period 2|Protocol Violation|0|||
170492720|NCT01314872|616144080|FG005|Period 2|Protocol Violation|0|||
170492721|NCT01314872|616144081|FG006|Period 2|Protocol Violation|0|||
170492722|NCT01314872|616144082|FG007|Period 2|Protocol Violation|0|||
170492723|NCT01314872|616144083|FG008|Period 2|Protocol Violation|0|||
170801543|NCT00048932|617283974|FG001|Open Label Period (OL)|Death|0|||
170801544|NCT00048932|617283975|FG002|Open Label Period (OL)|Death|25|||
170801545|NCT00048932|617283973|FG000|Open Label Period (OL)|Adverse Event|0|||
170801546|NCT00048932|617283974|FG001|Open Label Period (OL)|Adverse Event|0|||
170801547|NCT00048932|617283975|FG002|Open Label Period (OL)|Adverse Event|103|||
170801548|NCT00048932|617283973|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
170801549|NCT00048932|617283974|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
170801550|NCT00048932|617283975|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
170801551|NCT00048932|617283973|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
170801552|NCT00048932|617283974|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
170801553|NCT00048932|617283975|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
170801554|NCT00048932|617283973|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
170801555|NCT00048932|617283974|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
170801556|NCT00048932|617283975|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
170801557|NCT00048932|617283973|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
170801558|NCT00048932|617283974|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
170492724|NCT01314872|616144084|FG009|Period 2|Protocol Violation|0|||
170801559|NCT00048932|617283975|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
170801560|NCT00048932|617283973|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
170801561|NCT00048932|617283974|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
170492725|NCT01314872|616144085|FG010|Period 2|Protocol Violation|0|||
170801562|NCT00048932|617283975|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
170492726|NCT01314872|616144086|FG011|Period 2|Protocol Violation|3|||
170492727|NCT01314872|616144087|FG012|Period 2|Protocol Violation|3|||
170492728|NCT01314872|616144088|FG013|Period 2|Protocol Violation|2|||
170492729|NCT01314872|616144089|FG014|Period 2|Protocol Violation|0|||
170492730|NCT01314872|616144075|FG000|Period 2|Non-compliance with study drug|0|||
170492731|NCT01314872|616144076|FG001|Period 2|Non-compliance with study drug|0|||
170492732|NCT01314872|616144077|FG002|Period 2|Non-compliance with study drug|0|||
170492733|NCT01314872|616144078|FG003|Period 2|Non-compliance with study drug|0|||
170492734|NCT01314872|616144079|FG004|Period 2|Non-compliance with study drug|0|||
170492735|NCT01314872|616144080|FG005|Period 2|Non-compliance with study drug|0|||
170492736|NCT01314872|616144081|FG006|Period 2|Non-compliance with study drug|0|||
170492737|NCT01314872|616144082|FG007|Period 2|Non-compliance with study drug|0|||
170492738|NCT01314872|616144083|FG008|Period 2|Non-compliance with study drug|0|||
170492739|NCT01314872|616144084|FG009|Period 2|Non-compliance with study drug|0|||
170492740|NCT01314872|616144085|FG010|Period 2|Non-compliance with study drug|0|||
170492741|NCT01314872|616144086|FG011|Period 2|Non-compliance with study drug|3|||
170492742|NCT01314872|616144087|FG012|Period 2|Non-compliance with study drug|3|||
170801563|NCT00048932|617283973|FG000|Open Label Period (OL)|Pregnancy|0|||
170801564|NCT00048932|617283974|FG001|Open Label Period (OL)|Pregnancy|0|||
170801565|NCT00048932|617283975|FG002|Open Label Period (OL)|Pregnancy|6|||
170801566|NCT00048932|617283973|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
170801567|NCT00048932|617283974|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
170801568|NCT00048932|617283975|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
170492743|NCT01314872|616144088|FG013|Period 2|Non-compliance with study drug|1|||
170492744|NCT01314872|616144089|FG014|Period 2|Non-compliance with study drug|2|||
170492745|NCT01314872|616144075|FG000|Period 2|Lack of Efficacy|0|||
170801569|NCT00048932|617283973|FG000|Open Label Period (OL)|Investigator Retiring|0|||
170492746|NCT01314872|616144076|FG001|Period 2|Lack of Efficacy|0|||
170801570|NCT00048932|617283974|FG001|Open Label Period (OL)|Investigator Retiring|0|||
170801571|NCT00048932|617283975|FG002|Open Label Period (OL)|Investigator Retiring|2|||
170801572|NCT00048932|617283973|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
170801573|NCT00048932|617283974|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
170801574|NCT00048932|617283975|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
170801575|NCT00048932|617283973|FG000|Open Label Period (OL)|Participant Relocated|0|||
170801576|NCT00048932|617283974|FG001|Open Label Period (OL)|Participant Relocated|0|||
170801577|NCT00048932|617283975|FG002|Open Label Period (OL)|Participant Relocated|6|||
170492747|NCT01314872|616144077|FG002|Period 2|Lack of Efficacy|0|||
170492748|NCT01314872|616144078|FG003|Period 2|Lack of Efficacy|0|||
170492749|NCT01314872|616144079|FG004|Period 2|Lack of Efficacy|0|||
170492750|NCT01314872|616144080|FG005|Period 2|Lack of Efficacy|0|||
170492751|NCT01314872|616144081|FG006|Period 2|Lack of Efficacy|0|||
170492752|NCT01314872|616144082|FG007|Period 2|Lack of Efficacy|0|||
170492753|NCT01314872|616144083|FG008|Period 2|Lack of Efficacy|0|||
170641179|NCT01904773|616699838|FG001|Placebo Washout First Intervention|Condition worsened|1|||
170641180|NCT01904773|616699839|FG002|Placebo Washout First Intervention|Condition worsened|0|||
170641181|NCT01904773|616699840|FG003|Placebo Washout First Intervention|Condition worsened|0|||
170641182|NCT01904773|616699841|FG004|Placebo Washout First Intervention|Condition worsened|0|||
170641183|NCT01904773|616699842|FG005|Placebo Washout First Intervention|Condition worsened|0|||
170492754|NCT01314872|616144084|FG009|Period 2|Lack of Efficacy|0|||
170492755|NCT01314872|616144085|FG010|Period 2|Lack of Efficacy|0|||
170492756|NCT01314872|616144086|FG011|Period 2|Lack of Efficacy|7|||
170492757|NCT01314872|616144087|FG012|Period 2|Lack of Efficacy|12|||
170492758|NCT01314872|616144088|FG013|Period 2|Lack of Efficacy|9|||
170492759|NCT01314872|616144089|FG014|Period 2|Lack of Efficacy|2|||
170492760|NCT01314872|616144075|FG000|Period 2|Pregnancy|0|||
170492761|NCT01314872|616144076|FG001|Period 2|Pregnancy|0|||
170492762|NCT01314872|616144077|FG002|Period 2|Pregnancy|0|||
170492763|NCT01314872|616144078|FG003|Period 2|Pregnancy|0|||
170492764|NCT01314872|616144079|FG004|Period 2|Pregnancy|0|||
170492765|NCT01314872|616144080|FG005|Period 2|Pregnancy|0|||
170492766|NCT01314872|616144081|FG006|Period 2|Pregnancy|0|||
170492767|NCT01314872|616144082|FG007|Period 2|Pregnancy|0|||
170492768|NCT01314872|616144083|FG008|Period 2|Pregnancy|0|||
170492769|NCT01314872|616144084|FG009|Period 2|Pregnancy|0|||
170492770|NCT01314872|616144085|FG010|Period 2|Pregnancy|0|||
170492771|NCT01314872|616144086|FG011|Period 2|Pregnancy|0|||
170492772|NCT01314872|616144087|FG012|Period 2|Pregnancy|0|||
170492773|NCT01314872|616144088|FG013|Period 2|Pregnancy|0|||
170492774|NCT01314872|616144089|FG014|Period 2|Pregnancy|1|||
170492775|NCT01314872|616144075|FG000|Period 2|Study terminated by Sponsor|0|||
170492776|NCT01314872|616144076|FG001|Period 2|Study terminated by Sponsor|0|||
170492777|NCT01314872|616144077|FG002|Period 2|Study terminated by Sponsor|0|||
170492778|NCT01314872|616144078|FG003|Period 2|Study terminated by Sponsor|0|||
170492779|NCT01314872|616144079|FG004|Period 2|Study terminated by Sponsor|0|||
170492780|NCT01314872|616144080|FG005|Period 2|Study terminated by Sponsor|0|||
170641184|NCT01904773|616699843|FG006|Placebo Washout First Intervention|Condition worsened|0|||
170641185|NCT01904773|616699844|FG007|Placebo Washout First Intervention|Condition worsened|0|||
170492781|NCT01314872|616144081|FG006|Period 2|Study terminated by Sponsor|0|||
170492782|NCT01314872|616144082|FG007|Period 2|Study terminated by Sponsor|0|||
170641186|NCT01904773|616699845|FG008|Placebo Washout First Intervention|Condition worsened|0|||
170641187|NCT01904773|616699837|FG000|Fifth Intervention|Adverse Event|0|||
170641188|NCT01904773|616699838|FG001|Fifth Intervention|Adverse Event|0|||
170641189|NCT01904773|616699839|FG002|Fifth Intervention|Adverse Event|0|||
170492783|NCT01314872|616144083|FG008|Period 2|Study terminated by Sponsor|0|||
170492784|NCT01314872|616144084|FG009|Period 2|Study terminated by Sponsor|0|||
170492785|NCT01314872|616144085|FG010|Period 2|Study terminated by Sponsor|0|||
170492786|NCT01314872|616144086|FG011|Period 2|Study terminated by Sponsor|2|||
170492787|NCT01314872|616144087|FG012|Period 2|Study terminated by Sponsor|2|||
170492788|NCT01314872|616144088|FG013|Period 2|Study terminated by Sponsor|3|||
170492789|NCT01314872|616144089|FG014|Period 2|Study terminated by Sponsor|0|||
170492790|NCT01314872|616144075|FG000|Period 2|Adverse event, non-fatal|0|||
170492791|NCT01314872|616144076|FG001|Period 2|Adverse event, non-fatal|0|||
170492792|NCT01314872|616144077|FG002|Period 2|Adverse event, non-fatal|0|||
170492793|NCT01314872|616144078|FG003|Period 2|Adverse event, non-fatal|0|||
170492794|NCT01314872|616144079|FG004|Period 2|Adverse event, non-fatal|0|||
170492795|NCT01314872|616144080|FG005|Period 2|Adverse event, non-fatal|0|||
170492796|NCT01314872|616144081|FG006|Period 2|Adverse event, non-fatal|0|||
170492797|NCT01314872|616144082|FG007|Period 2|Adverse event, non-fatal|0|||
170492798|NCT01314872|616144083|FG008|Period 2|Adverse event, non-fatal|0|||
170492799|NCT01314872|616144084|FG009|Period 2|Adverse event, non-fatal|0|||
170492800|NCT01314872|616144085|FG010|Period 2|Adverse event, non-fatal|0|||
170492801|NCT01314872|616144086|FG011|Period 2|Adverse event, non-fatal|13|||
170492802|NCT01314872|616144087|FG012|Period 2|Adverse event, non-fatal|16|||
170492803|NCT01314872|616144088|FG013|Period 2|Adverse event, non-fatal|24|||
170550210|NCT00281580|616360479|FG002|Overall Study|Withdrawal by Subject|1|||
170550211|NCT00281580|616360480|FG003|Overall Study|Withdrawal by Subject|1|||
170550212|NCT00281580|616360481|FG004|Overall Study|Withdrawal by Subject|1|||
170550213|NCT00281580|616360482|FG005|Overall Study|Withdrawal by Subject|2|||
170550214|NCT00281580|616360483|FG006|Overall Study|Withdrawal by Subject|2|||
170550215|NCT00281580|616360484|FG007|Overall Study|Withdrawal by Subject|0|||
170550216|NCT00281580|616360485|FG008|Overall Study|Withdrawal by Subject|1|||
170550217|NCT00281580|616360486|FG009|Overall Study|Withdrawal by Subject|4|||
170550218|NCT00281580|616360487|FG010|Overall Study|Withdrawal by Subject|1|||
170550219|NCT00281580|616360488|FG011|Overall Study|Withdrawal by Subject|1|||
170550220|NCT00281580|616360489|FG012|Overall Study|Withdrawal by Subject|2|||
170492804|NCT01314872|616144089|FG014|Period 2|Adverse event, non-fatal|9|||
170492805|NCT01314872|616144075|FG000|Period 2|Withdrawal by Subject|0|||
170492806|NCT01314872|616144076|FG001|Period 2|Withdrawal by Subject|0|||
170492807|NCT01314872|616144077|FG002|Period 2|Withdrawal by Subject|0|||
170492808|NCT01314872|616144078|FG003|Period 2|Withdrawal by Subject|0|||
170492809|NCT01314872|616144079|FG004|Period 2|Withdrawal by Subject|0|||
170492810|NCT01314872|616144080|FG005|Period 2|Withdrawal by Subject|0|||
170801578|NCT00048932|617283973|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
170492811|NCT01314872|616144081|FG006|Period 2|Withdrawal by Subject|0|||
170492812|NCT01314872|616144082|FG007|Period 2|Withdrawal by Subject|0|||
170492813|NCT01314872|616144083|FG008|Period 2|Withdrawal by Subject|0|||
170492814|NCT01314872|616144084|FG009|Period 2|Withdrawal by Subject|0|||
170492815|NCT01314872|616144085|FG010|Period 2|Withdrawal by Subject|0|||
170492816|NCT01314872|616144086|FG011|Period 2|Withdrawal by Subject|14|||
170492817|NCT01314872|616144087|FG012|Period 2|Withdrawal by Subject|17|||
170492818|NCT01314872|616144088|FG013|Period 2|Withdrawal by Subject|12|||
170492819|NCT01314872|616144089|FG014|Period 2|Withdrawal by Subject|4|||
170492820|NCT01314872|616144075|FG000|Period 2|Lost to Follow-up|0|||
170492821|NCT01314872|616144076|FG001|Period 2|Lost to Follow-up|0|||
170492822|NCT01314872|616144077|FG002|Period 2|Lost to Follow-up|0|||
170492823|NCT01314872|616144078|FG003|Period 2|Lost to Follow-up|0|||
170492824|NCT01314872|616144079|FG004|Period 2|Lost to Follow-up|0|||
170492825|NCT01314872|616144080|FG005|Period 2|Lost to Follow-up|0|||
170492826|NCT01314872|616144081|FG006|Period 2|Lost to Follow-up|0|||
170492827|NCT01314872|616144082|FG007|Period 2|Lost to Follow-up|0|||
170492828|NCT01314872|616144083|FG008|Period 2|Lost to Follow-up|0|||
170492829|NCT01314872|616144084|FG009|Period 2|Lost to Follow-up|0|||
170492830|NCT01314872|616144085|FG010|Period 2|Lost to Follow-up|0|||
170492831|NCT01314872|616144086|FG011|Period 2|Lost to Follow-up|6|||
170492832|NCT01314872|616144087|FG012|Period 2|Lost to Follow-up|7|||
170492833|NCT01314872|616144088|FG013|Period 2|Lost to Follow-up|2|||
170492834|NCT01314872|616144089|FG014|Period 2|Lost to Follow-up|6|||
170801579|NCT00048932|617283974|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
170801580|NCT00048932|617283975|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
170801581|NCT00048932|617283973|FG000|Open Label Period (OL)|Site Closure|0|||
170801582|NCT00048932|617283974|FG001|Open Label Period (OL)|Site Closure|0|||
170801583|NCT00048932|617283975|FG002|Open Label Period (OL)|Site Closure|3|||
170801584|NCT00048932|617283973|FG000|Open Label Period (OL)|Trial Terminated|0|||
170801585|NCT00048932|617283974|FG001|Open Label Period (OL)|Trial Terminated|0|||
170801586|NCT00048932|617283975|FG002|Open Label Period (OL)|Trial Terminated|1|||
170801587|NCT00048932|617283973|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
170801588|NCT00048932|617283974|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
170801589|NCT00048932|617283975|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
170801590|NCT00048932|617283973|FG000|Open Label Period (OL)|Patient Decision|0|||
170801591|NCT00048932|617283974|FG001|Open Label Period (OL)|Patient Decision|0|||
170801592|NCT00048932|617283975|FG002|Open Label Period (OL)|Patient Decision|4|||
170801593|NCT00048932|617283973|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
170801594|NCT00048932|617283974|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
170801595|NCT00048932|617283975|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
170801596|NCT00048932|617283973|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
170801597|NCT00048932|617283974|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
170801598|NCT00048932|617283975|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
170801599|NCT00048932|617283973|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
170801600|NCT00048932|617283974|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
170801601|NCT00048932|617283975|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
170801602|NCT00048932|617283973|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
170801603|NCT00048932|617283974|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
170801604|NCT00048932|617283975|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
170801605|NCT00048932|617283973|FG000|Open Label Period (OL)|Investigator Decision|0|||
170801606|NCT00048932|617283974|FG001|Open Label Period (OL)|Investigator Decision|0|||
170801607|NCT00048932|617283975|FG002|Open Label Period (OL)|Investigator Decision|4|||
170801608|NCT00048932|617283973|FG000|Open Label Period (OL)|Site Staff Issues|0|||
170801609|NCT00048932|617283974|FG001|Open Label Period (OL)|Site Staff Issues|0|||
170801610|NCT00048932|617283975|FG002|Open Label Period (OL)|Site Staff Issues|2|||
170801611|NCT00048932|617283973|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
170801612|NCT00048932|617283974|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
170801613|NCT00048932|617283975|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
170801614|NCT00048932|617283973|FG000|Open Label Period (OL)|Participant Surgery|0|||
170801615|NCT00048932|617283974|FG001|Open Label Period (OL)|Participant Surgery|0|||
170900346|NCT00792298|617640094|FG007|Washout|Withdrawal by Subject|0|||
170492835|NCT00860249|616146153|FG000|Overall Study|trial was terminated prior to completion|21|||
170492836|NCT00860249|616146154|FG001|Overall Study|trial was terminated prior to completion|18|||
170492837|NCT00860249|616146155|FG002|Overall Study|trial was terminated prior to completion|21|||
170492838|NCT00743288|616146156|FG000|Overall Study|Adverse Event|1|||
170492839|NCT00743288|616146157|FG001|Overall Study|Adverse Event|1|||
170492840|NCT00743288|616146158|FG002|Overall Study|Adverse Event|2|||
170492841|NCT00743288|616146159|FG003|Overall Study|Adverse Event|2|||
170492842|NCT00743288|616146160|FG004|Overall Study|Adverse Event|1|||
170492843|NCT00743288|616146161|FG005|Overall Study|Adverse Event|1|||
170492844|NCT00743288|616146162|FG006|Overall Study|Adverse Event|2|||
170550221|NCT00281580|616360490|FG013|Overall Study|Withdrawal by Subject|2|||
170550222|NCT00281580|616360491|FG014|Overall Study|Withdrawal by Subject|1|||
170550223|NCT00281580|616360492|FG015|Overall Study|Withdrawal by Subject|5|||
170550224|NCT00281580|616360477|FG000|Overall Study|Lack of Efficacy|2|||
170550225|NCT00281580|616360478|FG001|Overall Study|Lack of Efficacy|1|||
170550226|NCT00281580|616360479|FG002|Overall Study|Lack of Efficacy|1|||
170550227|NCT00281580|616360480|FG003|Overall Study|Lack of Efficacy|6|||
170550228|NCT00281580|616360481|FG004|Overall Study|Lack of Efficacy|2|||
170550229|NCT00281580|616360482|FG005|Overall Study|Lack of Efficacy|0|||
170550230|NCT00281580|616360483|FG006|Overall Study|Lack of Efficacy|0|||
170550231|NCT00281580|616360484|FG007|Overall Study|Lack of Efficacy|0|||
170550232|NCT00281580|616360485|FG008|Overall Study|Lack of Efficacy|0|||
170550233|NCT00281580|616360486|FG009|Overall Study|Lack of Efficacy|0|||
170550234|NCT00281580|616360487|FG010|Overall Study|Lack of Efficacy|0|||
170550235|NCT00281580|616360488|FG011|Overall Study|Lack of Efficacy|1|||
170550236|NCT00281580|616360489|FG012|Overall Study|Lack of Efficacy|0|||
170550237|NCT00281580|616360490|FG013|Overall Study|Lack of Efficacy|2|||
170550238|NCT00281580|616360491|FG014|Overall Study|Lack of Efficacy|1|||
170550239|NCT00281580|616360492|FG015|Overall Study|Lack of Efficacy|0|||
170550240|NCT00281580|616360477|FG000|Overall Study|Lost to Follow-up|0|||
170550241|NCT00281580|616360478|FG001|Overall Study|Lost to Follow-up|0|||
170550242|NCT00281580|616360479|FG002|Overall Study|Lost to Follow-up|0|||
170550243|NCT00281580|616360480|FG003|Overall Study|Lost to Follow-up|3|||
170550244|NCT00281580|616360481|FG004|Overall Study|Lost to Follow-up|0|||
170550245|NCT00281580|616360482|FG005|Overall Study|Lost to Follow-up|1|||
170550246|NCT00281580|616360483|FG006|Overall Study|Lost to Follow-up|0|||
170550247|NCT00281580|616360484|FG007|Overall Study|Lost to Follow-up|1|||
170550248|NCT00281580|616360485|FG008|Overall Study|Lost to Follow-up|2|||
170550249|NCT00281580|616360486|FG009|Overall Study|Lost to Follow-up|1|||
170550250|NCT00281580|616360487|FG010|Overall Study|Lost to Follow-up|1|||
170550251|NCT00281580|616360488|FG011|Overall Study|Lost to Follow-up|0|||
170550252|NCT00281580|616360489|FG012|Overall Study|Lost to Follow-up|1|||
170550253|NCT00281580|616360490|FG013|Overall Study|Lost to Follow-up|0|||
170550254|NCT00281580|616360491|FG014|Overall Study|Lost to Follow-up|0|||
170550255|NCT00281580|616360492|FG015|Overall Study|Lost to Follow-up|0|||
170550256|NCT00281580|616360477|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
170550257|NCT00281580|616360478|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
170550258|NCT00281580|616360479|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
170550259|NCT00281580|616360480|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
170550260|NCT00281580|616360481|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
170550261|NCT00281580|616360482|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
170550262|NCT00281580|616360483|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
170550263|NCT00281580|616360484|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
170550264|NCT00281580|616360485|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
170550265|NCT00281580|616360486|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
170550266|NCT00281580|616360487|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
170550267|NCT00281580|616360488|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
170550268|NCT00281580|616360489|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
170550269|NCT00281580|616360490|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
170550270|NCT00281580|616360491|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
170550271|NCT00281580|616360492|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
170550272|NCT01379937|616360493|FG000|Overall Study|Protocol Violation|0|||
170550273|NCT01379937|616360494|FG001|Overall Study|Protocol Violation|0|||
170550274|NCT01379937|616360495|FG002|Overall Study|Protocol Violation|0|||
170550275|NCT01379937|616360496|FG003|Overall Study|Protocol Violation|1|||
170550276|NCT01379937|616360493|FG000|Overall Study|Consent withdrawal|0|||
170550277|NCT01379937|616360494|FG001|Overall Study|Consent withdrawal|1|||
170550278|NCT01379937|616360495|FG002|Overall Study|Consent withdrawal|0|||
170550279|NCT01379937|616360496|FG003|Overall Study|Consent withdrawal|0|||
170550280|NCT01379937|616360493|FG000|Overall Study|Lost to Follow-up|1|||
170550281|NCT01379937|616360494|FG001|Overall Study|Lost to Follow-up|2|||
170550282|NCT01379937|616360495|FG002|Overall Study|Lost to Follow-up|2|||
170550283|NCT01379937|616360496|FG003|Overall Study|Lost to Follow-up|0|||
170550284|NCT01655069|616360497|FG000|Overall Study|Physician Decision|0|||
170550285|NCT01655069|616360498|FG001|Overall Study|Physician Decision|0|||
170550286|NCT01655069|616360499|FG002|Overall Study|Physician Decision|0|||
170550287|NCT01655069|616360500|FG003|Overall Study|Physician Decision|1|||
170550288|NCT01655069|616360497|FG000|Overall Study|Adverse Event|6|||
170550289|NCT01655069|616360498|FG001|Overall Study|Adverse Event|7|||
170550290|NCT01655069|616360499|FG002|Overall Study|Adverse Event|2|||
170641190|NCT01904773|616699840|FG003|Fifth Intervention|Adverse Event|0|||
170550291|NCT01655069|616360500|FG003|Overall Study|Adverse Event|3|||
170550292|NCT01655069|616360497|FG000|Overall Study|Lack of Efficacy|0|||
170550293|NCT01655069|616360498|FG001|Overall Study|Lack of Efficacy|1|||
170641191|NCT01904773|616699841|FG004|Fifth Intervention|Adverse Event|0|||
170550294|NCT01655069|616360499|FG002|Overall Study|Lack of Efficacy|0|||
170550295|NCT01655069|616360500|FG003|Overall Study|Lack of Efficacy|0|||
170492845|NCT00743288|616146156|FG000|Overall Study|Withdrawal by Subject|0|||
170492846|NCT00743288|616146157|FG001|Overall Study|Withdrawal by Subject|0|||
170492847|NCT00743288|616146158|FG002|Overall Study|Withdrawal by Subject|1|||
170492848|NCT00743288|616146159|FG003|Overall Study|Withdrawal by Subject|0|||
170492849|NCT00743288|616146160|FG004|Overall Study|Withdrawal by Subject|0|||
170492850|NCT00743288|616146161|FG005|Overall Study|Withdrawal by Subject|1|||
170492851|NCT00743288|616146162|FG006|Overall Study|Withdrawal by Subject|1|||
170492852|NCT00743288|616146156|FG000|Overall Study|Progressive disease (PD)|2|||
170492853|NCT00743288|616146157|FG001|Overall Study|Progressive disease (PD)|0|||
170492854|NCT00743288|616146158|FG002|Overall Study|Progressive disease (PD)|1|||
170492855|NCT00743288|616146159|FG003|Overall Study|Progressive disease (PD)|4|||
170492856|NCT00743288|616146160|FG004|Overall Study|Progressive disease (PD)|5|||
170492857|NCT00743288|616146161|FG005|Overall Study|Progressive disease (PD)|3|||
170492858|NCT00743288|616146162|FG006|Overall Study|Progressive disease (PD)|6|||
170492859|NCT00743288|616146156|FG000|Overall Study|Worsening of condition (Not PD)|0|||
170492860|NCT00743288|616146157|FG001|Overall Study|Worsening of condition (Not PD)|2|||
170492861|NCT00743288|616146158|FG002|Overall Study|Worsening of condition (Not PD)|1|||
170492862|NCT00743288|616146159|FG003|Overall Study|Worsening of condition (Not PD)|1|||
170492863|NCT00743288|616146160|FG004|Overall Study|Worsening of condition (Not PD)|0|||
170492864|NCT00743288|616146161|FG005|Overall Study|Worsening of condition (Not PD)|0|||
170492865|NCT00743288|616146162|FG006|Overall Study|Worsening of condition (Not PD)|0|||
170492866|NCT00519428|616146163|FG000|Overall Study|Adverse Event|5|||
170492867|NCT00519428|616146164|FG001|Overall Study|Adverse Event|2|||
170492868|NCT00519428|616146165|FG002|Overall Study|Adverse Event|10|||
170492869|NCT00519428|616146163|FG000|Overall Study|Lost to Follow-up|7|||
170492870|NCT00519428|616146164|FG001|Overall Study|Lost to Follow-up|7|||
170492871|NCT00519428|616146165|FG002|Overall Study|Lost to Follow-up|6|||
170492872|NCT00519428|616146163|FG000|Overall Study|Withdrawal by Subject|8|||
170492873|NCT00519428|616146164|FG001|Overall Study|Withdrawal by Subject|3|||
170492874|NCT00519428|616146165|FG002|Overall Study|Withdrawal by Subject|7|||
170492875|NCT00519428|616146163|FG000|Overall Study|unstated|1|||
170492876|NCT00519428|616146164|FG001|Overall Study|unstated|3|||
170492877|NCT00519428|616146165|FG002|Overall Study|unstated|2|||
170492878|NCT00688701|616146169|FG000|Overall Study|Adverse Event|1|||
170492879|NCT00688701|616146170|FG001|Overall Study|Adverse Event|0|||
170492880|NCT00688701|616146171|FG002|Overall Study|Adverse Event|5|||
170492881|NCT00688701|616146172|FG003|Overall Study|Adverse Event|3|||
170492882|NCT00688701|616146169|FG000|Overall Study|Lack of Efficacy|0|||
170492883|NCT00688701|616146170|FG001|Overall Study|Lack of Efficacy|1|||
170492884|NCT00688701|616146171|FG002|Overall Study|Lack of Efficacy|0|||
170492885|NCT00688701|616146172|FG003|Overall Study|Lack of Efficacy|0|||
170492886|NCT00688701|616146169|FG000|Overall Study|Withdrawal by Subject|3|||
170492887|NCT00688701|616146170|FG001|Overall Study|Withdrawal by Subject|3|||
170492888|NCT00688701|616146171|FG002|Overall Study|Withdrawal by Subject|4|||
170492889|NCT00688701|616146172|FG003|Overall Study|Withdrawal by Subject|8|||
170492890|NCT00688701|616146169|FG000|Overall Study|Poor compliance to protocol|0|||
170492891|NCT00688701|616146170|FG001|Overall Study|Poor compliance to protocol|1|||
170801616|NCT00048932|617283975|FG002|Open Label Period (OL)|Participant Surgery|1|||
170801617|NCT04989816|617283978|FG000|Overall Study|Death|77|||
170801618|NCT04989816|617283978|FG000|Overall Study|Lost to Follow-up|3|||
170801619|NCT03758638|617283979|FG000|Overall Study|Pregnancy|17|||
170801620|NCT03758638|617283980|FG001|Overall Study|Pregnancy|25|||
170801621|NCT03758638|617283979|FG000|Overall Study|Lost to Follow-up|60|||
170801622|NCT03758638|617283980|FG001|Overall Study|Lost to Follow-up|54|||
170801623|NCT03758638|617283979|FG000|Overall Study|Protocol Violation|2|||
170801624|NCT03758638|617283980|FG001|Overall Study|Protocol Violation|0|||
170801625|NCT03758638|617283979|FG000|Overall Study|Withdrawal by Subject|8|||
170801626|NCT03758638|617283980|FG001|Overall Study|Withdrawal by Subject|2|||
170801627|NCT03758638|617283979|FG000|Overall Study|Providers not included in the primary outcome.|183|||
170801628|NCT03758638|617283980|FG001|Overall Study|Providers not included in the primary outcome.|128|||
170801629|NCT03442777|617283994|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
170801630|NCT03442777|617283995|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
170806981|NCT02063659|617301675|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
170492892|NCT00688701|616146171|FG002|Overall Study|Poor compliance to protocol|1|||
170492893|NCT00688701|616146172|FG003|Overall Study|Poor compliance to protocol|0|||
170492894|NCT02836236|616146175|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
170492895|NCT02836236|616146176|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
170492896|NCT02836236|616146177|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
170492897|NCT02836236|616146178|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
170492898|NCT02836236|616146175|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
170492899|NCT02836236|616146176|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
170492900|NCT02836236|616146177|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
170492901|NCT02836236|616146178|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
170492902|NCT02836236|616146175|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
170492903|NCT02836236|616146176|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
170492904|NCT02836236|616146177|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
170492905|NCT02836236|616146178|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
170492906|NCT02836236|616146175|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
170492907|NCT02836236|616146176|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
170492908|NCT02836236|616146177|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
170492909|NCT02836236|616146178|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
170492910|NCT02836236|616146175|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
170492911|NCT02836236|616146176|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
170492912|NCT02836236|616146177|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
170492913|NCT02836236|616146178|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
170492914|NCT02836236|616146175|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
170492915|NCT02836236|616146176|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
170492916|NCT02836236|616146177|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
170492917|NCT02836236|616146178|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
170492918|NCT02836236|616146175|FG000|Open-Label TAF Treatment Phase|Death|0|||
170492919|NCT02836236|616146176|FG001|Open-Label TAF Treatment Phase|Death|0|||
170492920|NCT02836236|616146177|FG002|Open-Label TAF Treatment Phase|Death|1|||
170492921|NCT02836236|616146178|FG003|Open-Label TAF Treatment Phase|Death|1|||
170492922|NCT02836236|616146175|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
170492923|NCT02836236|616146176|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
170492924|NCT02836236|616146177|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
170492925|NCT02836236|616146178|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
170492926|NCT00679029|616146186|FG000|Overall Study|Adverse Event|3|||
170492927|NCT00679029|616146186|FG000|Overall Study|Withdrawal by Subject|1|||
170492928|NCT00679029|616146186|FG000|Overall Study|Lost to Follow-up|1|||
170492929|NCT00504725|616146189|FG000|Overall Study|Protocol Violation|1|||
170492930|NCT00504725|616146190|FG001|Overall Study|Protocol Violation|0|||
170492931|NCT00378508|616146193|FG000|Overall Study|Withdrawal by Subject|1|||
170492932|NCT00378508|616146194|FG001|Overall Study|Withdrawal by Subject|3|||
170492933|NCT00378508|616146193|FG000|Overall Study|Lost to Follow-up|1|||
170492934|NCT00378508|616146194|FG001|Overall Study|Lost to Follow-up|0|||
170492935|NCT01435018|616146195|FG000|Overall Study|Death|37|||
170492936|NCT01435018|616146196|FG001|Overall Study|Death|18|||
170492937|NCT01435018|616146197|FG002|Overall Study|Death|25|||
170492938|NCT01435018|616146195|FG000|Overall Study|Site is closing|4|||
170492939|NCT01435018|616146196|FG001|Overall Study|Site is closing|9|||
170492940|NCT01435018|616146197|FG002|Overall Study|Site is closing|7|||
170492941|NCT01435018|616146195|FG000|Overall Study|Withdrew consent|0|||
170492942|NCT01435018|616146196|FG001|Overall Study|Withdrew consent|3|||
170492943|NCT01435018|616146197|FG002|Overall Study|Withdrew consent|1|||
170492944|NCT01435018|616146195|FG000|Overall Study|Not willing to adhere to requirements|0|||
170492945|NCT01435018|616146196|FG001|Overall Study|Not willing to adhere to requirements|2|||
170492946|NCT01435018|616146197|FG002|Overall Study|Not willing to adhere to requirements|3|||
170492947|NCT01435018|616146195|FG000|Overall Study|Not able to get to clinic|2|||
170492948|NCT01435018|616146196|FG001|Overall Study|Not able to get to clinic|0|||
170492949|NCT01435018|616146197|FG002|Overall Study|Not able to get to clinic|2|||
170492950|NCT01435018|616146195|FG000|Overall Study|Severe debilitation, unable to continue|0|||
170492951|NCT01435018|616146196|FG001|Overall Study|Severe debilitation, unable to continue|0|||
170492952|NCT01435018|616146197|FG002|Overall Study|Severe debilitation, unable to continue|1|||
170492953|NCT01435018|616146195|FG000|Overall Study|Unable to contact participant/parent|1|||
170492954|NCT01435018|616146196|FG001|Overall Study|Unable to contact participant/parent|1|||
170492955|NCT01435018|616146197|FG002|Overall Study|Unable to contact participant/parent|1|||
170492956|NCT01435018|616146195|FG000|Overall Study|Enrollment Violation|0|||
170492957|NCT01435018|616146196|FG001|Overall Study|Enrollment Violation|1|||
170492958|NCT01435018|616146197|FG002|Overall Study|Enrollment Violation|0|||
170492959|NCT01435018|616146195|FG000|Overall Study|Never started chemotherapy|3|||
170801631|NCT03442777|617283996|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
170801632|NCT01561300|617284000|FG000|Run in on Placebo|Adverse Event|1|||
170801633|NCT01561300|617284001|FG001|Run in on Placebo|Adverse Event|0|||
170801634|NCT00777049|617284002|FG000|Overall Study|Withdrawal by Subject|1|||
170801635|NCT00777049|617284003|FG001|Overall Study|Withdrawal by Subject|0|||
170801636|NCT00777049|617284002|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
170801637|NCT00777049|617284003|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
170492960|NCT01435018|616146196|FG001|Overall Study|Never started chemotherapy|0|||
170492961|NCT01435018|616146197|FG002|Overall Study|Never started chemotherapy|1|||
170550296|NCT01655069|616360497|FG000|Overall Study|No Treatment Needed|0|||
170550297|NCT01655069|616360498|FG001|Overall Study|No Treatment Needed|1|||
170801638|NCT00246805|617284004|FG000|Phase 1|Lost to Follow-up|1|||
170492962|NCT03205761|616146198|FG000|Overall Study|Withdrawal by Subject|1|||
170492963|NCT03205761|616146198|FG000|Overall Study|Progressive Disease|10|||
170492964|NCT04420585|616146199|FG000|Overall Study|Adverse Event|1|||
170492965|NCT04420585|616146199|FG000|Overall Study|Never initiated medication|2|||
170492966|NCT03625466|616146200|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
170492967|NCT03625466|616146201|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
170492968|NCT03625466|616146202|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
170492969|NCT03625466|616146200|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
170492970|NCT03625466|616146201|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
170492971|NCT03625466|616146202|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
170492972|NCT03625466|616146200|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
170492973|NCT03625466|616146201|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
170492974|NCT03625466|616146202|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
170492975|NCT00809471|616146204|FG000|Overall Study|Protocol non-compliance|15|||
170492976|NCT00809471|616146205|FG001|Overall Study|Protocol non-compliance|15|||
170492977|NCT00809471|616146206|FG002|Overall Study|Protocol non-compliance|6|||
170492978|NCT00809471|616146204|FG000|Overall Study|Lost to Follow-up|4|||
170492979|NCT00809471|616146205|FG001|Overall Study|Lost to Follow-up|2|||
170492980|NCT00809471|616146206|FG002|Overall Study|Lost to Follow-up|9|||
170492981|NCT00809471|616146204|FG000|Overall Study|Adverse Event|0|||
170492982|NCT00809471|616146205|FG001|Overall Study|Adverse Event|2|||
170492983|NCT00809471|616146206|FG002|Overall Study|Adverse Event|2|||
170492984|NCT00809471|616146204|FG000|Overall Study|Requirement for restricted medication|1|||
170492985|NCT00809471|616146205|FG001|Overall Study|Requirement for restricted medication|1|||
170801639|NCT00246805|617284005|FG001|Phase 1|Lost to Follow-up|0|||
170801640|NCT01627561|617284006|FG000|Overall Study|Lost to Follow-up|1|||
170801641|NCT01627561|617284007|FG001|Overall Study|Lost to Follow-up|0|||
170801642|NCT01627561|617284006|FG000|Overall Study|Withdrawal by Subject|0|||
170492986|NCT00809471|616146206|FG002|Overall Study|Requirement for restricted medication|0|||
170492987|NCT00831311|616146207|FG000|Overall Study|Definitive Contraindication|3|||
170492988|NCT00831311|616146208|FG001|Overall Study|Definitive Contraindication|3|||
170492989|NCT00831311|616146207|FG000|Overall Study|Lost to Follow-up|3|||
170492990|NCT00831311|616146208|FG001|Overall Study|Lost to Follow-up|0|||
170492991|NCT00831311|616146207|FG000|Overall Study|Physician Decision|0|||
170492992|NCT00831311|616146208|FG001|Overall Study|Physician Decision|1|||
170492993|NCT00831311|616146207|FG000|Overall Study|Withdrawal by Subject|6|||
170492994|NCT00831311|616146208|FG001|Overall Study|Withdrawal by Subject|4|||
170492995|NCT03214380|616146212|FG000|Lead-in|Adverse Event|3|||
170492996|NCT03214380|616146213|FG001|Lead-in|Adverse Event|0|||
170492997|NCT03214380|616146214|FG002|Lead-in|Adverse Event|0|||
170492998|NCT03214380|616146215|FG003|Lead-in|Adverse Event|1|||
170492999|NCT03214380|616146216|FG004|Lead-in|Adverse Event|0|||
170493000|NCT03214380|616146217|FG005|Lead-in|Adverse Event|0|||
170493001|NCT03214380|616146212|FG000|Lead-in|Lost to Follow-up|4|||
170493002|NCT03214380|616146213|FG001|Lead-in|Lost to Follow-up|0|||
170493003|NCT03214380|616146214|FG002|Lead-in|Lost to Follow-up|0|||
170493004|NCT03214380|616146215|FG003|Lead-in|Lost to Follow-up|1|||
170493005|NCT03214380|616146216|FG004|Lead-in|Lost to Follow-up|0|||
170493006|NCT03214380|616146217|FG005|Lead-in|Lost to Follow-up|0|||
170493007|NCT03214380|616146212|FG000|Lead-in|Eligibility Criteria|3|||
170493008|NCT03214380|616146213|FG001|Lead-in|Eligibility Criteria|0|||
170493009|NCT03214380|616146214|FG002|Lead-in|Eligibility Criteria|0|||
170801643|NCT01627561|617284007|FG001|Overall Study|Withdrawal by Subject|1|||
170801644|NCT01627561|617284006|FG000|Overall Study|Migrated/moved from study area|0|||
170801645|NCT01627561|617284007|FG001|Overall Study|Migrated/moved from study area|2|||
170801646|NCT00724126|617284008|FG000|Overall Study|Adverse Event|2|||
170801647|NCT00724126|617284009|FG001|Overall Study|Adverse Event|0|||
170801648|NCT00724126|617284008|FG000|Overall Study|Withdrawal by Subject|8|||
170801649|NCT00724126|617284009|FG001|Overall Study|Withdrawal by Subject|6|||
170801650|NCT00724126|617284008|FG000|Overall Study|Lost to Follow-up|6|||
170801651|NCT00724126|617284009|FG001|Overall Study|Lost to Follow-up|6|||
170801652|NCT00724126|617284008|FG000|Overall Study|Noncompliance|2|||
170801653|NCT00724126|617284009|FG001|Overall Study|Noncompliance|1|||
170801654|NCT00724126|617284008|FG000|Overall Study|Subject randomized although ineligible|1|||
170801655|NCT00724126|617284009|FG001|Overall Study|Subject randomized although ineligible|1|||
170801656|NCT00724126|617284008|FG000|Overall Study|Subject had to leave vicinity of site|0|||
170801657|NCT00724126|617284009|FG001|Overall Study|Subject had to leave vicinity of site|1|||
170801658|NCT05405244|617284010|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
170801659|NCT05405244|617284011|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
170493010|NCT03214380|616146215|FG003|Lead-in|Eligibility Criteria|0|||
170493011|NCT03214380|616146216|FG004|Lead-in|Eligibility Criteria|0|||
170493012|NCT03214380|616146217|FG005|Lead-in|Eligibility Criteria|0|||
170493013|NCT03214380|616146212|FG000|Lead-in|Physician Decision|6|||
170493014|NCT03214380|616146213|FG001|Lead-in|Physician Decision|0|||
170493015|NCT03214380|616146214|FG002|Lead-in|Physician Decision|0|||
170493016|NCT03214380|616146215|FG003|Lead-in|Physician Decision|0|||
170493017|NCT03214380|616146216|FG004|Lead-in|Physician Decision|0|||
170493018|NCT03214380|616146217|FG005|Lead-in|Physician Decision|0|||
170801660|NCT05405244|617284010|FG000|Washout (2 Weeks)|Adverse Event|2|||
170801661|NCT05405244|617284011|FG001|Washout (2 Weeks)|Adverse Event|0|||
170801662|NCT05405244|617284010|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
170801663|NCT05405244|617284011|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
170493019|NCT03214380|616146212|FG000|Lead-in|Protocol Deviation|7|||
170493020|NCT03214380|616146213|FG001|Lead-in|Protocol Deviation|0|||
170493021|NCT03214380|616146214|FG002|Lead-in|Protocol Deviation|0|||
170493022|NCT03214380|616146215|FG003|Lead-in|Protocol Deviation|3|||
170493023|NCT03214380|616146216|FG004|Lead-in|Protocol Deviation|0|||
170493024|NCT03214380|616146217|FG005|Lead-in|Protocol Deviation|0|||
170493025|NCT03214380|616146212|FG000|Lead-in|Withdrawal by Subject|41|||
170493026|NCT03214380|616146213|FG001|Lead-in|Withdrawal by Subject|0|||
170493027|NCT03214380|616146214|FG002|Lead-in|Withdrawal by Subject|0|||
170493028|NCT03214380|616146215|FG003|Lead-in|Withdrawal by Subject|14|||
170493029|NCT03214380|616146216|FG004|Lead-in|Withdrawal by Subject|0|||
170493030|NCT03214380|616146217|FG005|Lead-in|Withdrawal by Subject|0|||
170493031|NCT03214380|616146212|FG000|Lead-in|Family Emergency|1|||
170493032|NCT03214380|616146213|FG001|Lead-in|Family Emergency|0|||
170493033|NCT03214380|616146214|FG002|Lead-in|Family Emergency|0|||
170493034|NCT03214380|616146215|FG003|Lead-in|Family Emergency|0|||
170493035|NCT03214380|616146216|FG004|Lead-in|Family Emergency|0|||
170493036|NCT03214380|616146217|FG005|Lead-in|Family Emergency|0|||
170493037|NCT03214380|616146212|FG000|Lead-in|Natural Disaster|9|||
170493038|NCT03214380|616146213|FG001|Lead-in|Natural Disaster|0|||
170493039|NCT03214380|616146214|FG002|Lead-in|Natural Disaster|0|||
170801664|NCT01579318|617284014|FG000|Overall Study|Disease Progression|1|||
170801665|NCT03601715|617284015|FG000|Second Intervention|Lost to Follow-up|1|||
170801666|NCT03601715|617284016|FG001|Second Intervention|Lost to Follow-up|1|||
170801667|NCT03601715|617284017|FG002|Second Intervention|Lost to Follow-up|0|||
170801668|NCT01074294|617284019|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
170801669|NCT01074294|617284020|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
170801670|NCT01074294|617284021|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
170801671|NCT01074294|617284022|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
170801672|NCT01074294|617284019|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
170801673|NCT01074294|617284020|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
170801674|NCT01074294|617284021|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
170801675|NCT01074294|617284022|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
170801676|NCT01074294|617284019|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
170801677|NCT01074294|617284020|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
170801678|NCT01074294|617284021|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
170801679|NCT01074294|617284022|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
170801680|NCT01074294|617284019|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
170801681|NCT01074294|617284020|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
170801682|NCT01074294|617284021|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
170801683|NCT01074294|617284022|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
170801684|NCT01074294|617284019|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
170801685|NCT01074294|617284020|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
170801686|NCT01074294|617284021|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
170801687|NCT01074294|617284022|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
170801688|NCT01074294|617284019|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
170801689|NCT01074294|617284020|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
170801690|NCT01074294|617284021|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
170801691|NCT01074294|617284022|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
170801692|NCT01074294|617284019|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
170801693|NCT01074294|617284020|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
170801694|NCT01074294|617284021|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
170801695|NCT01074294|617284022|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
170801696|NCT01074294|617284019|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
170801697|NCT01074294|617284020|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
170801698|NCT01074294|617284021|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
170801699|NCT01074294|617284022|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
170801700|NCT01074294|617284019|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
170801701|NCT01074294|617284020|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
170801702|NCT01074294|617284021|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
170801703|NCT01074294|617284022|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
170801704|NCT01074294|617284019|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
170801705|NCT01074294|617284020|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
170801706|NCT01074294|617284021|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
170493040|NCT03214380|616146215|FG003|Lead-in|Natural Disaster|0|||
170493041|NCT03214380|616146216|FG004|Lead-in|Natural Disaster|0|||
170493042|NCT03214380|616146217|FG005|Lead-in|Natural Disaster|0|||
170493043|NCT03214380|616146212|FG000|Lead-in|Non Compliance|1|||
170493044|NCT03214380|616146213|FG001|Lead-in|Non Compliance|0|||
170493045|NCT03214380|616146214|FG002|Lead-in|Non Compliance|0|||
170493046|NCT03214380|616146215|FG003|Lead-in|Non Compliance|0|||
170493047|NCT03214380|616146216|FG004|Lead-in|Non Compliance|0|||
170493048|NCT03214380|616146217|FG005|Lead-in|Non Compliance|0|||
170493049|NCT03214380|616146212|FG000|Lead-in|Participant Schedule|2|||
170493050|NCT03214380|616146213|FG001|Lead-in|Participant Schedule|0|||
170493051|NCT03214380|616146214|FG002|Lead-in|Participant Schedule|0|||
170493052|NCT03214380|616146215|FG003|Lead-in|Participant Schedule|0|||
170493053|NCT03214380|616146216|FG004|Lead-in|Participant Schedule|0|||
170493054|NCT03214380|616146217|FG005|Lead-in|Participant Schedule|0|||
170493055|NCT03214380|616146212|FG000|Treatment Period|Adverse Event|0|||
170493056|NCT03214380|616146213|FG001|Treatment Period|Adverse Event|1|||
170493057|NCT03214380|616146214|FG002|Treatment Period|Adverse Event|1|||
170493058|NCT03214380|616146215|FG003|Treatment Period|Adverse Event|0|||
170493059|NCT03214380|616146216|FG004|Treatment Period|Adverse Event|1|||
170493060|NCT03214380|616146217|FG005|Treatment Period|Adverse Event|0|||
170493061|NCT03214380|616146212|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
170493062|NCT03214380|616146213|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
170493063|NCT03214380|616146214|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
170493064|NCT03214380|616146215|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
170493065|NCT03214380|616146216|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
170493066|NCT03214380|616146217|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
170493067|NCT03214380|616146212|FG000|Treatment Period|Withdrawal by Subject|0|||
170493068|NCT03214380|616146213|FG001|Treatment Period|Withdrawal by Subject|10|||
170493069|NCT03214380|616146214|FG002|Treatment Period|Withdrawal by Subject|8|||
170493070|NCT03214380|616146215|FG003|Treatment Period|Withdrawal by Subject|0|||
170493071|NCT03214380|616146216|FG004|Treatment Period|Withdrawal by Subject|7|||
170493072|NCT03214380|616146217|FG005|Treatment Period|Withdrawal by Subject|11|||
170493073|NCT03214380|616146212|FG000|Treatment Period|Death|0|||
170493074|NCT03214380|616146213|FG001|Treatment Period|Death|1|||
170493075|NCT03214380|616146214|FG002|Treatment Period|Death|2|||
170493076|NCT03214380|616146215|FG003|Treatment Period|Death|0|||
170493077|NCT03214380|616146216|FG004|Treatment Period|Death|0|||
170493078|NCT03214380|616146217|FG005|Treatment Period|Death|0|||
170493079|NCT03214380|616146212|FG000|Treatment Period|Lost to Follow-up|0|||
170493080|NCT03214380|616146213|FG001|Treatment Period|Lost to Follow-up|6|||
170493081|NCT03214380|616146214|FG002|Treatment Period|Lost to Follow-up|3|||
170493082|NCT03214380|616146215|FG003|Treatment Period|Lost to Follow-up|0|||
170493083|NCT03214380|616146216|FG004|Treatment Period|Lost to Follow-up|0|||
170493084|NCT03214380|616146217|FG005|Treatment Period|Lost to Follow-up|0|||
170493085|NCT03214380|616146212|FG000|Treatment Period|Participant schedule|0|||
170493086|NCT03214380|616146213|FG001|Treatment Period|Participant schedule|0|||
170493087|NCT03214380|616146214|FG002|Treatment Period|Participant schedule|1|||
170493088|NCT03214380|616146215|FG003|Treatment Period|Participant schedule|0|||
170493089|NCT03214380|616146216|FG004|Treatment Period|Participant schedule|0|||
170493090|NCT03214380|616146217|FG005|Treatment Period|Participant schedule|0|||
170493091|NCT03214380|616146212|FG000|Treatment Period|Treatment Interruption|0|||
170493092|NCT03214380|616146213|FG001|Treatment Period|Treatment Interruption|0|||
170493093|NCT03214380|616146214|FG002|Treatment Period|Treatment Interruption|1|||
170493094|NCT03214380|616146215|FG003|Treatment Period|Treatment Interruption|0|||
170493095|NCT03214380|616146216|FG004|Treatment Period|Treatment Interruption|0|||
170493096|NCT03214380|616146217|FG005|Treatment Period|Treatment Interruption|0|||
170493097|NCT01608087|616146228|FG000|Overall Study|Lost to Follow-up|0|||
170493098|NCT01608087|616146229|FG001|Overall Study|Lost to Follow-up|1|||
170493099|NCT01608087|616146230|FG002|Overall Study|Lost to Follow-up|0|||
170550298|NCT01655069|616360499|FG002|Overall Study|No Treatment Needed|0|||
170550299|NCT01655069|616360500|FG003|Overall Study|No Treatment Needed|0|||
170550300|NCT01655069|616360497|FG000|Overall Study|Withdrawal by Subject|2|||
170550301|NCT01655069|616360498|FG001|Overall Study|Withdrawal by Subject|3|||
170550302|NCT01655069|616360499|FG002|Overall Study|Withdrawal by Subject|0|||
170550303|NCT01655069|616360500|FG003|Overall Study|Withdrawal by Subject|0|||
170493100|NCT01608087|616146228|FG000|Overall Study|Other Reason|0|||
170493101|NCT01608087|616146229|FG001|Overall Study|Other Reason|1|||
170493102|NCT01608087|616146230|FG002|Overall Study|Other Reason|0|||
170493103|NCT00664859|616146240|FG000|Overall Study|Adverse Event|2|||
170493104|NCT00664859|616146241|FG001|Overall Study|Adverse Event|1|||
170493105|NCT00664859|616146242|FG002|Overall Study|Adverse Event|3|||
170493106|NCT00664859|616146240|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
170550304|NCT00104884|616360501|FG000|Overall Study|Disease progression|4|||
170550305|NCT03473301|616360502|FG000|Overall Study|Protocol Violation|4|||
170550306|NCT03473301|616360503|FG001|Overall Study|Protocol Violation|0|||
170550307|NCT03473301|616360504|FG002|Overall Study|Protocol Violation|0|||
170550308|NCT03473301|616360502|FG000|Overall Study|Withdrawal by Subject|0|||
170550309|NCT03473301|616360503|FG001|Overall Study|Withdrawal by Subject|1|||
170493107|NCT00664859|616146241|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
170493108|NCT00664859|616146242|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
170493109|NCT00664859|616146240|FG000|Overall Study|Noncompliance with protocol|1|||
170493110|NCT00664859|616146241|FG001|Overall Study|Noncompliance with protocol|0|||
170550310|NCT03473301|616360504|FG002|Overall Study|Withdrawal by Subject|0|||
170493111|NCT00664859|616146242|FG002|Overall Study|Noncompliance with protocol|4|||
170801707|NCT01074294|617284022|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
170801708|NCT01074294|617284019|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
170801709|NCT01074294|617284020|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
170801710|NCT01074294|617284021|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
170801711|NCT01074294|617284022|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
170801712|NCT01074294|617284019|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
170801713|NCT01074294|617284020|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
170801714|NCT01074294|617284021|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
170801715|NCT01074294|617284022|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
170801716|NCT01074294|617284019|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
170801717|NCT01074294|617284020|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
170801718|NCT01074294|617284021|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
170801719|NCT01074294|617284022|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
170801720|NCT03280030|617284024|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
170801721|NCT03280030|617284025|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
170900347|NCT00792298|617640087|FG000|Treatment Period 2|Lack of Efficacy|0|||
170493112|NCT00664859|616146240|FG000|Overall Study|Laboratory abnormality|2|||
170493113|NCT00664859|616146241|FG001|Overall Study|Laboratory abnormality|1|||
170493114|NCT00664859|616146242|FG002|Overall Study|Laboratory abnormality|4|||
170493115|NCT00664859|616146240|FG000|Overall Study|Withdrawal by Subject|4|||
170493116|NCT00664859|616146241|FG001|Overall Study|Withdrawal by Subject|1|||
170493117|NCT00664859|616146242|FG002|Overall Study|Withdrawal by Subject|3|||
170493118|NCT00664859|616146240|FG000|Overall Study|Lost to Follow-up|2|||
170493119|NCT00664859|616146241|FG001|Overall Study|Lost to Follow-up|2|||
170493120|NCT00664859|616146242|FG002|Overall Study|Lost to Follow-up|1|||
170493121|NCT00664859|616146240|FG000|Overall Study|Other|0|||
170493122|NCT00664859|616146241|FG001|Overall Study|Other|1|||
170493123|NCT00664859|616146242|FG002|Overall Study|Other|2|||
170493124|NCT01943851|616146243|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170900348|NCT00792298|617640088|FG001|Treatment Period 2|Lack of Efficacy|0|||
170900349|NCT00792298|617640089|FG002|Treatment Period 2|Lack of Efficacy|0|||
170900350|NCT00792298|617640090|FG003|Treatment Period 2|Lack of Efficacy|0|||
170900351|NCT00792298|617640091|FG004|Treatment Period 2|Lack of Efficacy|1|||
170900352|NCT00792298|617640092|FG005|Treatment Period 2|Lack of Efficacy|0|||
170900353|NCT00792298|617640093|FG006|Treatment Period 2|Lack of Efficacy|0|||
170900354|NCT00792298|617640094|FG007|Treatment Period 2|Lack of Efficacy|0|||
170900355|NCT00792298|617640087|FG000|Treatment Period 2|Physician Decision|0|||
170493125|NCT01943851|616146244|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493126|NCT01943851|616146245|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170641192|NCT01904773|616699842|FG005|Fifth Intervention|Adverse Event|0|||
170641193|NCT01904773|616699843|FG006|Fifth Intervention|Adverse Event|0|||
170641194|NCT01904773|616699844|FG007|Fifth Intervention|Adverse Event|1|||
170641195|NCT01904773|616699845|FG008|Fifth Intervention|Adverse Event|0|||
170641196|NCT01904773|616699837|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
170641197|NCT01904773|616699838|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
170641198|NCT01904773|616699839|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
170641199|NCT01904773|616699840|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
170641200|NCT01904773|616699841|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
170641201|NCT01904773|616699842|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
170641202|NCT01904773|616699843|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
170641203|NCT01904773|616699844|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
170641204|NCT01904773|616699845|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
170641205|NCT02617485|616699846|FG000|Treatment and Observation Period|Adverse Event|9|||
170641206|NCT02617485|616699847|FG001|Treatment and Observation Period|Adverse Event|1|||
170641207|NCT02617485|616699846|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
170900356|NCT00792298|617640088|FG001|Treatment Period 2|Physician Decision|0|||
170493127|NCT01943851|616146246|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
170493128|NCT01943851|616146247|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493129|NCT01943851|616146248|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170641208|NCT02617485|616699847|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
170641209|NCT02617485|616699846|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
170900357|NCT00792298|617640089|FG002|Treatment Period 2|Physician Decision|0|||
170641210|NCT02617485|616699847|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
170641211|NCT02617485|616699846|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
170641212|NCT02617485|616699847|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
170900358|NCT00792298|617640090|FG003|Treatment Period 2|Physician Decision|0|||
170493130|NCT01943851|616146249|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
170493131|NCT01943851|616146250|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
170641213|NCT02617485|616699846|FG000|Treatment and Observation Period|Physician Decision|0|||
170641214|NCT02617485|616699847|FG001|Treatment and Observation Period|Physician Decision|1|||
170641215|NCT02617485|616699846|FG000|Follow-up Period|Adverse Event|1|||
170641216|NCT02617485|616699847|FG001|Follow-up Period|Adverse Event|0|||
170641217|NCT02617485|616699846|FG000|Follow-up Period|Withdrawal by Subject|1|||
170641218|NCT02617485|616699847|FG001|Follow-up Period|Withdrawal by Subject|0|||
170641219|NCT02617485|616699846|FG000|Follow-up Period|Disease progression|2|||
170641220|NCT02617485|616699847|FG001|Follow-up Period|Disease progression|1|||
170641221|NCT02617485|616699846|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
170641222|NCT02617485|616699847|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
170641223|NCT02617485|616699846|FG000|Follow-up Period|Patient needed radiotherapy|9|||
170641224|NCT02617485|616699847|FG001|Follow-up Period|Patient needed radiotherapy|5|||
170641225|NCT02617485|616699846|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
170641226|NCT02617485|616699847|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
170641227|NCT00791076|616699848|FG000|Overall Study|Study was terminated,PI left institution|8|||
170641228|NCT02184455|616699849|FG000|Overall Study|Lost to Follow-up|1|||
170641229|NCT01511055|616699852|FG000|Overall Study|Withdrawal by Subject|6|||
170641230|NCT02704143|616699856|FG000|Overall Study|disease progression|10|||
170641231|NCT02551991|616699857|FG000|Overall Study|Death|5|||
170641232|NCT02551991|616699858|FG001|Overall Study|Death|7|||
170641233|NCT02551991|616699859|FG002|Overall Study|Death|8|||
170641234|NCT02551991|616699860|FG003|Overall Study|Death|7|||
170641235|NCT02551991|616699861|FG004|Overall Study|Death|17|||
170641236|NCT02551991|616699857|FG000|Overall Study|Withdrawal by Subject|1|||
170641237|NCT02551991|616699858|FG001|Overall Study|Withdrawal by Subject|0|||
170641238|NCT02551991|616699859|FG002|Overall Study|Withdrawal by Subject|0|||
170641239|NCT02551991|616699860|FG003|Overall Study|Withdrawal by Subject|0|||
170641240|NCT02551991|616699861|FG004|Overall Study|Withdrawal by Subject|2|||
170641241|NCT02551991|616699857|FG000|Overall Study|Lost to Follow-up|0|||
170641242|NCT02551991|616699858|FG001|Overall Study|Lost to Follow-up|0|||
170641243|NCT02551991|616699859|FG002|Overall Study|Lost to Follow-up|1|||
170641244|NCT02551991|616699860|FG003|Overall Study|Lost to Follow-up|0|||
170641245|NCT02551991|616699861|FG004|Overall Study|Lost to Follow-up|0|||
170641246|NCT02551991|616699857|FG000|Overall Study|Sponsor Decision|1|||
170641247|NCT02551991|616699858|FG001|Overall Study|Sponsor Decision|0|||
170641248|NCT02551991|616699859|FG002|Overall Study|Sponsor Decision|1|||
170641249|NCT02551991|616699860|FG003|Overall Study|Sponsor Decision|0|||
170641250|NCT02551991|616699861|FG004|Overall Study|Sponsor Decision|5|||
170641251|NCT02551991|616699857|FG000|Overall Study|Other|0|||
170641252|NCT02551991|616699858|FG001|Overall Study|Other|0|||
170641253|NCT02551991|616699859|FG002|Overall Study|Other|0|||
170641254|NCT02551991|616699860|FG003|Overall Study|Other|0|||
170801722|NCT03280030|617284026|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
170801723|NCT03280030|617284024|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
170801724|NCT03280030|617284025|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
170801725|NCT03280030|617284026|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
170801726|NCT03280030|617284024|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
170801727|NCT03280030|617284025|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
170801728|NCT03280030|617284026|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
170801729|NCT03280030|617284024|FG000|Part 2 - Efficacy|Adverse Event|0|||
170801730|NCT03280030|617284025|FG001|Part 2 - Efficacy|Adverse Event|4|||
170801731|NCT03280030|617284026|FG002|Part 2 - Efficacy|Adverse Event|6|||
170801732|NCT03280030|617284024|FG000|Part 2 - Efficacy|Death|0|||
170801733|NCT03280030|617284025|FG001|Part 2 - Efficacy|Death|3|||
170801734|NCT03280030|617284026|FG002|Part 2 - Efficacy|Death|0|||
170801735|NCT03280030|617284024|FG000|Part 2 - Efficacy|Physician Decision|0|||
170801736|NCT03280030|617284025|FG001|Part 2 - Efficacy|Physician Decision|10|||
170801737|NCT03280030|617284026|FG002|Part 2 - Efficacy|Physician Decision|16|||
170801738|NCT03280030|617284024|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
170801739|NCT03280030|617284025|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
170801740|NCT03280030|617284026|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
170801741|NCT03280030|617284024|FG000|Part 2 - Efficacy|Progressive disease|0|||
170801742|NCT03280030|617284025|FG001|Part 2 - Efficacy|Progressive disease|7|||
170801743|NCT03280030|617284026|FG002|Part 2 - Efficacy|Progressive disease|5|||
170801744|NCT05139992|617284028|FG000|Overall Study|Withdrawal by Subject|12|||
170801745|NCT05139992|617284028|FG000|Overall Study|Lost to Follow-up|6|||
170641255|NCT02551991|616699861|FG004|Overall Study|Other|1|||
170641256|NCT00942994|616699865|FG000|Overall Study|Adverse Event|7|||
170641257|NCT00942994|616699866|FG001|Overall Study|Adverse Event|4|||
170641258|NCT00942994|616699865|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170801746|NCT05521516|617284029|FG000|Overall Study|Withdrawal by Subject|1|||
170801747|NCT05521516|617284030|FG001|Overall Study|Withdrawal by Subject|1|||
170801748|NCT00747565|617284031|FG000|Overall Study|Withdrawal by Subject|10|||
170641259|NCT00942994|616699866|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170641260|NCT00942994|616699865|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170641261|NCT00942994|616699866|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170493132|NCT01943851|616146251|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
170493133|NCT01943851|616146252|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493134|NCT01943851|616146253|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493135|NCT01943851|616146254|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493136|NCT01943851|616146255|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493137|NCT01943851|616146256|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493138|NCT01943851|616146257|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493139|NCT01943851|616146258|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493140|NCT01943851|616146259|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493141|NCT01943851|616146260|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
170493142|NCT01943851|616146243|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493143|NCT01943851|616146244|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493144|NCT01943851|616146245|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493145|NCT01943851|616146246|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493146|NCT01943851|616146247|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
170493147|NCT01943851|616146248|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493148|NCT01943851|616146249|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493149|NCT01943851|616146250|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
170493150|NCT01943851|616146251|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493151|NCT01943851|616146252|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493152|NCT01943851|616146253|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493153|NCT01943851|616146254|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493154|NCT01943851|616146255|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493155|NCT01943851|616146256|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493156|NCT01943851|616146257|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493157|NCT01943851|616146258|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493158|NCT01943851|616146259|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493159|NCT01943851|616146260|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
170493160|NCT01943851|616146243|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493161|NCT01943851|616146244|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493162|NCT01943851|616146245|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493163|NCT01943851|616146246|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493164|NCT01943851|616146247|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493165|NCT01943851|616146248|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493166|NCT01943851|616146249|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493167|NCT01943851|616146250|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493168|NCT01943851|616146251|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493169|NCT01943851|616146252|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493170|NCT01943851|616146253|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493171|NCT01943851|616146254|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493172|NCT01943851|616146255|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493173|NCT01943851|616146256|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
170493174|NCT01943851|616146257|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493175|NCT01943851|616146258|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493176|NCT01943851|616146259|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493177|NCT01943851|616146260|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
170493178|NCT01943851|616146243|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493179|NCT01943851|616146244|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493180|NCT01943851|616146245|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493181|NCT01943851|616146246|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493182|NCT01943851|616146247|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493183|NCT01943851|616146248|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493184|NCT01943851|616146249|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493185|NCT01943851|616146250|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493186|NCT01943851|616146251|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493187|NCT01943851|616146252|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493188|NCT01943851|616146253|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493189|NCT01943851|616146254|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493190|NCT01943851|616146255|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493191|NCT01943851|616146256|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493192|NCT01943851|616146257|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493193|NCT01943851|616146258|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
170493194|NCT01943851|616146259|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493195|NCT01943851|616146260|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
170493196|NCT01943851|616146243|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493197|NCT01943851|616146244|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493198|NCT01943851|616146245|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493199|NCT01943851|616146246|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170641262|NCT00942994|616699865|FG000|Overall Study|Patient withdrew consent|5|||
170900359|NCT00792298|617640091|FG004|Treatment Period 2|Physician Decision|0|||
170900360|NCT00792298|617640092|FG005|Treatment Period 2|Physician Decision|0|||
170493200|NCT01943851|616146247|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493201|NCT01943851|616146248|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493202|NCT01943851|616146249|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493203|NCT01943851|616146250|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493204|NCT01943851|616146251|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493205|NCT01943851|616146252|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493206|NCT01943851|616146253|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493207|NCT01943851|616146254|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493208|NCT01943851|616146255|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493209|NCT01943851|616146256|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493210|NCT01943851|616146257|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
170493211|NCT01943851|616146258|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
170493212|NCT01943851|616146259|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
170493213|NCT01943851|616146260|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
170493214|NCT00546117|616146263|FG000|Overall Study|Withdrawal by Subject|3|||
170493215|NCT00546117|616146264|FG001|Overall Study|Withdrawal by Subject|0|||
170493216|NCT00546117|616146263|FG000|Overall Study|Inability to schedule follow-up visit|1|||
170493217|NCT00546117|616146264|FG001|Overall Study|Inability to schedule follow-up visit|0|||
170493218|NCT00401544|616146268|FG000|Overall Study|Adverse Event|5|||
170493219|NCT00401544|616146269|FG001|Overall Study|Adverse Event|1|||
170493220|NCT00401544|616146270|FG002|Overall Study|Adverse Event|1|||
170493221|NCT00401544|616146271|FG003|Overall Study|Adverse Event|1|||
170493222|NCT00401544|616146268|FG000|Overall Study|Death|3|||
170493223|NCT00401544|616146269|FG001|Overall Study|Death|6|||
170493224|NCT00401544|616146270|FG002|Overall Study|Death|2|||
170493225|NCT00401544|616146271|FG003|Overall Study|Death|5|||
170493226|NCT00401544|616146268|FG000|Overall Study|Lost to Follow-up|2|||
170493227|NCT00401544|616146269|FG001|Overall Study|Lost to Follow-up|0|||
170493228|NCT00401544|616146270|FG002|Overall Study|Lost to Follow-up|1|||
170493229|NCT00401544|616146271|FG003|Overall Study|Lost to Follow-up|1|||
170641263|NCT00942994|616699866|FG001|Overall Study|Patient withdrew consent|8|||
170641264|NCT00942994|616699865|FG000|Overall Study|Lost to Follow-up|1|||
170641265|NCT00942994|616699866|FG001|Overall Study|Lost to Follow-up|4|||
170493230|NCT00401544|616146268|FG000|Overall Study|Withdrawal by Subject|7|||
170493231|NCT00401544|616146269|FG001|Overall Study|Withdrawal by Subject|6|||
170493232|NCT00401544|616146270|FG002|Overall Study|Withdrawal by Subject|6|||
170493233|NCT00401544|616146271|FG003|Overall Study|Withdrawal by Subject|5|||
170493234|NCT00401544|616146268|FG000|Overall Study|Physician Decision|1|||
170493235|NCT00401544|616146269|FG001|Overall Study|Physician Decision|3|||
170493236|NCT00401544|616146270|FG002|Overall Study|Physician Decision|0|||
170493237|NCT00401544|616146271|FG003|Overall Study|Physician Decision|0|||
170493238|NCT00401544|616146268|FG000|Overall Study|Ineligibility determined|0|||
170493239|NCT00401544|616146269|FG001|Overall Study|Ineligibility determined|1|||
170493240|NCT00401544|616146270|FG002|Overall Study|Ineligibility determined|0|||
170493241|NCT00401544|616146271|FG003|Overall Study|Ineligibility determined|2|||
170493242|NCT00401544|616146268|FG000|Overall Study|Disease progression|0|||
170493243|NCT00401544|616146269|FG001|Overall Study|Disease progression|1|||
170493244|NCT00401544|616146270|FG002|Overall Study|Disease progression|0|||
170493245|NCT00401544|616146271|FG003|Overall Study|Disease progression|0|||
170493246|NCT00401544|616146268|FG000|Overall Study|Other|0|||
170493247|NCT00401544|616146269|FG001|Overall Study|Other|0|||
170493248|NCT00401544|616146270|FG002|Overall Study|Other|2|||
170493249|NCT00401544|616146271|FG003|Overall Study|Other|2|||
170493250|NCT04984278|616146273|FG000|Period 1|Withdrawal by Subject|1|||
170493251|NCT04984278|616146274|FG001|Period 1|Withdrawal by Subject|0|||
170493252|NCT04984278|616146273|FG000|Period 1|Other|0|||
170493253|NCT04984278|616146274|FG001|Period 1|Other|1|||
170493254|NCT04984278|616146273|FG000|Period 2|Adverse Event|1|||
170493255|NCT04984278|616146274|FG001|Period 2|Adverse Event|0|||
170493256|NCT04984278|616146273|FG000|Period 2|Other|0|||
170493257|NCT04984278|616146274|FG001|Period 2|Other|1|||
170493258|NCT04696055|616146275|FG000|Overall Study|Adverse Event|10|||
170493259|NCT04696055|616146276|FG001|Overall Study|Adverse Event|2|||
170493260|NCT04696055|616146275|FG000|Overall Study|Death|4|||
170493261|NCT04696055|616146276|FG001|Overall Study|Death|0|||
170493262|NCT04696055|616146275|FG000|Overall Study|Other|7|||
170493263|NCT04696055|616146276|FG001|Overall Study|Other|2|||
170493264|NCT04696055|616146275|FG000|Overall Study|Physician Decision|3|||
170493265|NCT04696055|616146276|FG001|Overall Study|Physician Decision|0|||
170493266|NCT04696055|616146275|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
170493267|NCT04696055|616146276|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
170493268|NCT04696055|616146275|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
170493269|NCT04696055|616146276|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
170493270|NCT04696055|616146275|FG000|Overall Study|Subject Decision|1|||
170900361|NCT00792298|617640093|FG006|Treatment Period 2|Physician Decision|1|||
170493271|NCT04696055|616146276|FG001|Overall Study|Subject Decision|2|||
170493272|NCT00348595|616146277|FG000|Overall Study|Adverse Event|5|||
170493273|NCT00348595|616146278|FG001|Overall Study|Adverse Event|8|||
170493274|NCT01920958|616146279|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
170493275|NCT01560234|616146280|FG000|Overall Study|Lost to Follow-up|3|||
170493276|NCT01560234|616146281|FG001|Overall Study|Lost to Follow-up|0|||
170493277|NCT01560234|616146282|FG002|Overall Study|Lost to Follow-up|1|||
170493278|NCT01560234|616146283|FG003|Overall Study|Lost to Follow-up|0|||
170493279|NCT01560234|616146284|FG004|Overall Study|Lost to Follow-up|0|||
170493280|NCT01560234|616146285|FG005|Overall Study|Lost to Follow-up|2|||
170493281|NCT01560234|616146286|FG006|Overall Study|Lost to Follow-up|0|||
170493282|NCT01560234|616146287|FG007|Overall Study|Lost to Follow-up|2|||
170493283|NCT02028767|616146290|FG000|Treatment Period 2|Non compliant with protocol|1|||
170493284|NCT02028767|616146291|FG001|Treatment Period 2|Non compliant with protocol|0|||
170801749|NCT00747565|617284032|FG001|Overall Study|Withdrawal by Subject|6|||
170801750|NCT00747565|617284031|FG000|Overall Study|Lost to Follow-up|4|||
170801751|NCT00747565|617284032|FG001|Overall Study|Lost to Follow-up|1|||
170801752|NCT03367156|617284893|FG000|Overall Study|Lack of interest|3|||
170801753|NCT03367156|617284894|FG001|Overall Study|Lack of interest|1|||
170801754|NCT03367156|617284893|FG000|Overall Study|Death|2|||
170801755|NCT03367156|617284894|FG001|Overall Study|Death|0|||
170801756|NCT03367156|617284893|FG000|Overall Study|Lost to Follow-up|2|||
170801757|NCT03367156|617284894|FG001|Overall Study|Lost to Follow-up|1|||
170801758|NCT03367156|617284893|FG000|Overall Study|Became ineligible|1|||
170801759|NCT03367156|617284894|FG001|Overall Study|Became ineligible|2|||
170801760|NCT03367156|617284893|FG000|Overall Study|Hospitalization|1|||
170801761|NCT03367156|617284894|FG001|Overall Study|Hospitalization|0|||
170801762|NCT03367156|617284893|FG000|Overall Study|Concerned about Treatment|11|||
170801763|NCT03367156|617284894|FG001|Overall Study|Concerned about Treatment|3|||
170801764|NCT03367156|617284893|FG000|Overall Study|Started new treatment|4|||
170801765|NCT03367156|617284894|FG001|Overall Study|Started new treatment|1|||
170801766|NCT06056310|617284899|FG000|Overall Study|Other Reasons|2|||
170801767|NCT06056310|617284899|FG000|Overall Study|Sponsor Request|16|||
170801768|NCT00360269|617284902|FG000|Overall Study|Lost to Follow-up|7|||
170801769|NCT00360269|617284903|FG001|Overall Study|Lost to Follow-up|9|||
170801770|NCT00360269|617284902|FG000|Overall Study|Physician Decision|1|||
170801771|NCT00360269|617284903|FG001|Overall Study|Physician Decision|2|||
170801772|NCT00360269|617284902|FG000|Overall Study|Adverse Event|1|||
170801773|NCT00360269|617284903|FG001|Overall Study|Adverse Event|0|||
170801774|NCT00360269|617284902|FG000|Overall Study|Withdrawal by Subject|1|||
170801775|NCT00360269|617284903|FG001|Overall Study|Withdrawal by Subject|1|||
170801776|NCT03876457|617284907|FG000|Overall Study|Lost to Follow-up|1|||
170801777|NCT03876457|617284908|FG001|Overall Study|Lost to Follow-up|3|||
170801778|NCT01184326|617284909|FG000|Overall Study|Adverse Event|1|||
170801779|NCT01184326|617284910|FG001|Overall Study|Adverse Event|2|||
170801780|NCT01184326|617284911|FG002|Overall Study|Adverse Event|0|||
170801781|NCT01184326|617284909|FG000|Overall Study|Death|0|||
170801782|NCT01184326|617284910|FG001|Overall Study|Death|0|||
170801783|NCT01184326|617284911|FG002|Overall Study|Death|1|||
170801784|NCT01184326|617284909|FG000|Overall Study|Withdrawal by Subject|0|||
170801785|NCT01184326|617284910|FG001|Overall Study|Withdrawal by Subject|0|||
170801786|NCT01184326|617284911|FG002|Overall Study|Withdrawal by Subject|1|||
170801787|NCT01184326|617284909|FG000|Overall Study|Physician Decision|1|||
170801788|NCT01184326|617284910|FG001|Overall Study|Physician Decision|1|||
170801789|NCT01184326|617284911|FG002|Overall Study|Physician Decision|0|||
170801790|NCT01184326|617284909|FG000|Overall Study|Disease Progression|1|||
170801791|NCT01184326|617284910|FG001|Overall Study|Disease Progression|3|||
170801792|NCT01184326|617284911|FG002|Overall Study|Disease Progression|12|||
170801793|NCT01036724|617284912|FG000|Overall Study|Adverse Event|1|||
170493285|NCT02028767|616146290|FG000|Treatment Period 2|Reason other than those specified above|1|||
170493286|NCT02028767|616146291|FG001|Treatment Period 2|Reason other than those specified above|0|||
170493287|NCT03192306|616146294|FG000|Overall Study|Did not treat cold sore during study|149|||
170493288|NCT03192306|616146295|FG001|Overall Study|Did not treat cold sore during study|143|||
170493289|NCT03192306|616146294|FG000|Overall Study|Withdrawal by Subject|1|||
170550311|NCT03473301|616360502|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
170550312|NCT03473301|616360503|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
170801794|NCT01036724|617284913|FG001|Overall Study|Adverse Event|2|||
170801795|NCT01036724|617284912|FG000|Overall Study|Lack of Efficacy|1|||
170801796|NCT01036724|617284913|FG001|Overall Study|Lack of Efficacy|1|||
170801797|NCT01036724|617284912|FG000|Overall Study|Protocol Violation|4|||
170801798|NCT01036724|617284913|FG001|Overall Study|Protocol Violation|5|||
170493290|NCT03192306|616146295|FG001|Overall Study|Withdrawal by Subject|1|||
170493291|NCT03192306|616146294|FG000|Overall Study|Lost to Follow-up|1|||
170493292|NCT03192306|616146295|FG001|Overall Study|Lost to Follow-up|0|||
170801799|NCT01478594|617284916|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
170801800|NCT01478594|617284917|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
170801801|NCT01478594|617284916|FG000|Overall Study|Death|45|||
170801802|NCT01478594|617284917|FG001|Overall Study|Death|18|||
170493293|NCT03192306|616146294|FG000|Overall Study|Protocol Violation|1|||
170493294|NCT03192306|616146295|FG001|Overall Study|Protocol Violation|1|||
170493295|NCT00083759|616146300|FG000|Overall Study|Adverse Event|5|||
170493296|NCT00083759|616146301|FG001|Overall Study|Adverse Event|3|||
170493297|NCT00083759|616146300|FG000|Overall Study|Lost to Follow-up|1|||
170493298|NCT00083759|616146301|FG001|Overall Study|Lost to Follow-up|0|||
170493299|NCT00083759|616146300|FG000|Overall Study|Death|1|||
170493300|NCT00083759|616146301|FG001|Overall Study|Death|1|||
170493301|NCT00083759|616146300|FG000|Overall Study|Inadequate Therapeutic Response|32|||
170493302|NCT00083759|616146301|FG001|Overall Study|Inadequate Therapeutic Response|35|||
170493303|NCT00083759|616146300|FG000|Overall Study|Subject Withdrew Consent|2|||
170493304|NCT00083759|616146301|FG001|Overall Study|Subject Withdrew Consent|2|||
170493305|NCT00083759|616146300|FG000|Overall Study|Non-Compliance|1|||
170493306|NCT00083759|616146301|FG001|Overall Study|Non-Compliance|0|||
170493307|NCT00083759|616146300|FG000|Overall Study|Sponsor's Discretion|28|||
170493308|NCT00083759|616146301|FG001|Overall Study|Sponsor's Discretion|29|||
170493309|NCT00083759|616146300|FG000|Overall Study|Other|14|||
170493310|NCT00083759|616146301|FG001|Overall Study|Other|13|||
170493311|NCT04292912|616146304|FG000|Overall Study|Physician Decision|1|||
170493312|NCT04292912|616146304|FG000|Overall Study|Protocol Violation|6|||
170493313|NCT00280397|616146305|FG000|Overall Study|Adverse Event|1|||
170493314|NCT00425061|616146306|FG000|Overall Study|Adverse Event|1|||
170493315|NCT00425061|616146307|FG001|Overall Study|Adverse Event|0|||
170493316|NCT00425061|616146308|FG002|Overall Study|Adverse Event|0|||
170493317|NCT00425061|616146309|FG003|Overall Study|Adverse Event|2|||
170493318|NCT00425061|616146310|FG004|Overall Study|Adverse Event|2|||
170493319|NCT00425061|616146311|FG005|Overall Study|Adverse Event|0|||
170493320|NCT00425061|616146312|FG006|Overall Study|Adverse Event|0|||
170493321|NCT00425061|616146306|FG000|Overall Study|Lost to Follow-up|0|||
170493322|NCT00425061|616146307|FG001|Overall Study|Lost to Follow-up|1|||
170493323|NCT00425061|616146308|FG002|Overall Study|Lost to Follow-up|0|||
170493324|NCT00425061|616146309|FG003|Overall Study|Lost to Follow-up|0|||
170493325|NCT00425061|616146310|FG004|Overall Study|Lost to Follow-up|0|||
170493326|NCT00425061|616146311|FG005|Overall Study|Lost to Follow-up|0|||
170493327|NCT00425061|616146312|FG006|Overall Study|Lost to Follow-up|0|||
170493328|NCT00425061|616146306|FG000|Overall Study|Protocol Violation|1|||
170493329|NCT00425061|616146307|FG001|Overall Study|Protocol Violation|0|||
170493330|NCT00425061|616146308|FG002|Overall Study|Protocol Violation|0|||
170493331|NCT00425061|616146309|FG003|Overall Study|Protocol Violation|0|||
170493332|NCT00425061|616146310|FG004|Overall Study|Protocol Violation|0|||
170493333|NCT00425061|616146311|FG005|Overall Study|Protocol Violation|0|||
170493334|NCT00425061|616146312|FG006|Overall Study|Protocol Violation|0|||
170493335|NCT00425061|616146306|FG000|Overall Study|Withdrawal by Subject|0|||
170493336|NCT00425061|616146307|FG001|Overall Study|Withdrawal by Subject|1|||
170493337|NCT00425061|616146308|FG002|Overall Study|Withdrawal by Subject|0|||
170550313|NCT03473301|616360504|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
170641266|NCT00942994|616699865|FG000|Overall Study|Protocol deviation|1|||
170641267|NCT00942994|616699866|FG001|Overall Study|Protocol deviation|2|||
170801803|NCT01478594|617284916|FG000|Overall Study|Lost to Follow-up|3|||
170801804|NCT01478594|617284917|FG001|Overall Study|Lost to Follow-up|1|||
170801805|NCT01478594|617284916|FG000|Overall Study|Withdrawal by Subject|9|||
170801806|NCT01478594|617284917|FG001|Overall Study|Withdrawal by Subject|3|||
170801807|NCT01478594|617284916|FG000|Overall Study|Study Closed by Sponsor|8|||
170801808|NCT01478594|617284917|FG001|Overall Study|Study Closed by Sponsor|5|||
170801809|NCT02964741|617284918|FG000|Overall Study|Protocol Violation|1|||
170801810|NCT02964741|617284919|FG001|Overall Study|Protocol Violation|0|||
170801811|NCT02964741|617284920|FG002|Overall Study|Protocol Violation|0|||
170801812|NCT02964741|617284918|FG000|Overall Study|Withdrawal by Subject|0|||
170801813|NCT02964741|617284919|FG001|Overall Study|Withdrawal by Subject|1|||
170801814|NCT02964741|617284920|FG002|Overall Study|Withdrawal by Subject|0|||
170801815|NCT02964741|617284918|FG000|Overall Study|claustrophobia|1|||
170801816|NCT02964741|617284919|FG001|Overall Study|claustrophobia|0|||
170801817|NCT02964741|617284920|FG002|Overall Study|claustrophobia|0|||
170801818|NCT00623194|617284921|FG000|Overall Study|Lack of Efficacy|1|||
170801819|NCT00623194|617284921|FG000|Overall Study|Protocol Violation|3|||
170801820|NCT00623194|617284921|FG000|Overall Study|Unclassified|1|||
170493338|NCT00425061|616146309|FG003|Overall Study|Withdrawal by Subject|0|||
170493339|NCT00425061|616146310|FG004|Overall Study|Withdrawal by Subject|1|||
170493340|NCT00425061|616146311|FG005|Overall Study|Withdrawal by Subject|0|||
170493341|NCT00425061|616146312|FG006|Overall Study|Withdrawal by Subject|3|||
170493342|NCT00425061|616146306|FG000|Overall Study|Sponsor's request|0|||
170493343|NCT00425061|616146307|FG001|Overall Study|Sponsor's request|0|||
170493344|NCT00425061|616146308|FG002|Overall Study|Sponsor's request|0|||
170801821|NCT01988402|617284922|FG000|Overall Study|Adverse Event|1|||
170801822|NCT01988402|617284923|FG001|Overall Study|Adverse Event|2|||
170801823|NCT01988402|617284922|FG000|Overall Study|Withdrawal by Subject|1|||
170641268|NCT00387790|616699869|FG000|Overall Study|Adverse Event|5|||
170641269|NCT00387790|616699869|FG000|Overall Study|Lack of Efficacy|2|||
170493345|NCT00425061|616146309|FG003|Overall Study|Sponsor's request|0|||
170493346|NCT00425061|616146310|FG004|Overall Study|Sponsor's request|19|||
170493347|NCT00425061|616146311|FG005|Overall Study|Sponsor's request|4|||
170493348|NCT00425061|616146312|FG006|Overall Study|Sponsor's request|15|||
170493349|NCT00425061|616146306|FG000|Overall Study|Physician Decision|0|||
170493350|NCT00425061|616146307|FG001|Overall Study|Physician Decision|0|||
170493351|NCT00425061|616146308|FG002|Overall Study|Physician Decision|0|||
170493352|NCT00425061|616146309|FG003|Overall Study|Physician Decision|0|||
170493353|NCT00425061|616146310|FG004|Overall Study|Physician Decision|1|||
170493354|NCT00425061|616146311|FG005|Overall Study|Physician Decision|0|||
170493355|NCT00425061|616146312|FG006|Overall Study|Physician Decision|0|||
170493356|NCT00425061|616146306|FG000|Overall Study|Other|0|||
170493357|NCT00425061|616146307|FG001|Overall Study|Other|0|||
170493358|NCT00425061|616146308|FG002|Overall Study|Other|0|||
170493359|NCT00425061|616146309|FG003|Overall Study|Other|0|||
170493360|NCT00425061|616146310|FG004|Overall Study|Other|3|||
170493361|NCT00425061|616146311|FG005|Overall Study|Other|0|||
170493362|NCT00425061|616146312|FG006|Overall Study|Other|1|||
170493363|NCT02111577|616146313|FG000|Overall Study|Protocol Violation|2|||
170493364|NCT02111577|616146314|FG001|Overall Study|Protocol Violation|0|||
170493365|NCT02111577|616146313|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
170493366|NCT02111577|616146314|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
170493367|NCT02111577|616146313|FG000|Overall Study|Failure to produce study treatment|6|||
170493368|NCT02111577|616146314|FG001|Overall Study|Failure to produce study treatment|0|||
170493369|NCT02111577|616146313|FG000|Overall Study|Death|518|||
170493370|NCT02111577|616146314|FG001|Overall Study|Death|254|||
170493371|NCT02111577|616146313|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
170493372|NCT02111577|616146314|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
170493373|NCT02111577|616146313|FG000|Overall Study|Adverse Event|1|||
170493374|NCT02111577|616146314|FG001|Overall Study|Adverse Event|1|||
170493375|NCT02111577|616146313|FG000|Overall Study|Withdrawal by Subject|51|||
170493376|NCT02111577|616146314|FG001|Overall Study|Withdrawal by Subject|23|||
170493377|NCT02111577|616146313|FG000|Overall Study|Disease progression|0|||
170493378|NCT02111577|616146314|FG001|Overall Study|Disease progression|1|||
170493379|NCT02111577|616146313|FG000|Overall Study|Lost to Follow-up|19|||
170493380|NCT02111577|616146314|FG001|Overall Study|Lost to Follow-up|10|||
170493381|NCT03474731|616146317|FG000|Overall Study|Withdrawal by Subject|36|||
170493382|NCT03474731|616146318|FG001|Overall Study|Withdrawal by Subject|29|||
170493383|NCT03474731|616146319|FG002|Overall Study|Withdrawal by Subject|11|||
170493384|NCT03474731|616146320|FG003|Overall Study|Withdrawal by Subject|27|||
170493385|NCT03474731|616146317|FG000|Overall Study|COVID|0|||
170493386|NCT03474731|616146318|FG001|Overall Study|COVID|23|||
170493387|NCT03474731|616146319|FG002|Overall Study|COVID|0|||
170493388|NCT03474731|616146320|FG003|Overall Study|COVID|0|||
170493389|NCT03474731|616146317|FG000|Overall Study|Participant moved from area|1|||
170493390|NCT03474731|616146318|FG001|Overall Study|Participant moved from area|0|||
170493391|NCT03474731|616146319|FG002|Overall Study|Participant moved from area|0|||
170493392|NCT03474731|616146320|FG003|Overall Study|Participant moved from area|0|||
170493393|NCT03474731|616146317|FG000|Overall Study|Lost to Follow-up|11|||
170493394|NCT03474731|616146318|FG001|Overall Study|Lost to Follow-up|3|||
170493395|NCT03474731|616146319|FG002|Overall Study|Lost to Follow-up|18|||
170493396|NCT03474731|616146320|FG003|Overall Study|Lost to Follow-up|17|||
170493397|NCT03474731|616146317|FG000|Overall Study|Death|0|||
170493398|NCT03474731|616146318|FG001|Overall Study|Death|1|||
170493399|NCT03474731|616146319|FG002|Overall Study|Death|0|||
170493400|NCT03474731|616146320|FG003|Overall Study|Death|0|||
170493401|NCT03474731|616146317|FG000|Overall Study|Participant Removed|0|||
170493402|NCT03474731|616146318|FG001|Overall Study|Participant Removed|0|||
170493403|NCT03474731|616146319|FG002|Overall Study|Participant Removed|0|||
170493404|NCT03474731|616146320|FG003|Overall Study|Participant Removed|1|||
170493405|NCT03793842|616146321|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
170493406|NCT03793842|616146322|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
170493407|NCT03793842|616146321|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
170493408|NCT03793842|616146322|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
170493409|NCT00886743|616146326|FG000|Overall Study|Adverse Event|3|||
170493410|NCT00886743|616146326|FG000|Overall Study|Other|1|||
170493411|NCT01323387|616146329|FG000|Overall Study|Withdrawal by Subject|41|||
170493412|NCT01323387|616146329|FG000|Overall Study|Radiographic Data Unavailable|1|||
170493413|NCT01323387|616146329|FG000|Overall Study|Revision|14|||
170493414|NCT01323387|616146329|FG000|Overall Study|Protocol Violation|12|||
170493415|NCT01323387|616146329|FG000|Overall Study|Randomized but Never Treated|16|||
170493416|NCT04200651|616146332|FG000|Overall Study|Moved to another country during follow-up|2|||
170493417|NCT04200651|616146333|FG001|Overall Study|Moved to another country during follow-up|2|||
170493418|NCT04200651|616146332|FG000|Overall Study|Lost to Follow-up|1|||
170493419|NCT04200651|616146333|FG001|Overall Study|Lost to Follow-up|3|||
170493420|NCT02589626|616147713|FG000|Overall Study|Other than the reason specified|1|||
170493421|NCT02589626|616147714|FG001|Overall Study|Other than the reason specified|0|||
170641270|NCT00387790|616699869|FG000|Overall Study|Physician Decision|2|||
170493422|NCT02589626|616147713|FG000|Overall Study|Withdrawal by Subject|1|||
170801824|NCT01988402|617284923|FG001|Overall Study|Withdrawal by Subject|0|||
170801825|NCT01212744|617284926|FG000|Overall Study|Withdrawal by Subject|1|||
170801826|NCT02167451|617284927|FG000|Overall Study|Withdrawal by Subject|1|||
170801827|NCT00571649|617284928|FG000|Treatment Period|Adverse Event|438|||
170801828|NCT00571649|617284929|FG001|Treatment Period|Adverse Event|385|||
170801829|NCT00571649|617284928|FG000|Treatment Period|Clinical endpoint reached|50|||
170493423|NCT02589626|616147714|FG001|Overall Study|Withdrawal by Subject|1|||
170493424|NCT02589626|616147713|FG000|Overall Study|Adverse Event|1|||
170493425|NCT02589626|616147714|FG001|Overall Study|Adverse Event|1|||
170493426|NCT03645395|616147715|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
170493427|NCT03645395|616147716|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
170493428|NCT03645395|616147717|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
170493429|NCT03645395|616147718|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
170493430|NCT03645395|616147715|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
170493431|NCT03645395|616147716|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
170493432|NCT03645395|616147717|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
170801830|NCT00571649|617284929|FG001|Treatment Period|Clinical endpoint reached|56|||
170493433|NCT03645395|616147718|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
170493434|NCT03645395|616147715|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
170493435|NCT03645395|616147716|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
170493436|NCT03645395|616147717|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
170493437|NCT03645395|616147718|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
170493438|NCT03645395|616147715|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
170493439|NCT03645395|616147716|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
170493440|NCT03645395|616147717|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
170493441|NCT03645395|616147718|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
170493442|NCT00379080|616147720|FG000|Overall Study|Withdrawal by Subject|0|||
170493443|NCT00379080|616147721|FG001|Overall Study|Withdrawal by Subject|4|||
170493444|NCT00379080|616147722|FG002|Overall Study|Withdrawal by Subject|0|||
170493445|NCT01289639|616147723|FG000|Overall Study|Lost to Follow-up|1|||
170493446|NCT01289639|616147724|FG001|Overall Study|Lost to Follow-up|0|||
170493447|NCT01289639|616147725|FG002|Overall Study|Lost to Follow-up|0|||
170493448|NCT02780713|616147726|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
170493449|NCT02780713|616147727|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
170493450|NCT02780713|616147728|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
170493451|NCT02780713|616147729|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
170493452|NCT02780713|616147730|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
170493453|NCT01931475|616147731|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
170493454|NCT01931475|616147732|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
170493455|NCT01931475|616147731|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
170493456|NCT01931475|616147732|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
170493457|NCT01931475|616147731|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
170493458|NCT01931475|616147732|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
170493459|NCT01931475|616147731|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
170493460|NCT01931475|616147732|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
170493461|NCT01931475|616147731|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
170493462|NCT01931475|616147732|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
170493463|NCT01931475|616147731|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
170493464|NCT01931475|616147732|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
170493465|NCT01931475|616147731|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
170493466|NCT01931475|616147732|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
170493467|NCT01931475|616147731|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
170493468|NCT01931475|616147732|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
170801831|NCT00571649|617284928|FG000|Treatment Period|Withdrawal by Subject|285|||
170900362|NCT00792298|617640094|FG007|Treatment Period 2|Physician Decision|0|||
170900363|NCT00792298|617640087|FG000|Treatment Period 2|Pregnancy|0|||
170900364|NCT00792298|617640088|FG001|Treatment Period 2|Pregnancy|0|||
170900365|NCT00792298|617640089|FG002|Treatment Period 2|Pregnancy|1|||
170900366|NCT00792298|617640090|FG003|Treatment Period 2|Pregnancy|0|||
170900367|NCT00792298|617640091|FG004|Treatment Period 2|Pregnancy|0|||
170900368|NCT00792298|617640092|FG005|Treatment Period 2|Pregnancy|0|||
170801832|NCT00571649|617284929|FG001|Treatment Period|Withdrawal by Subject|255|||
170493469|NCT01931475|616147731|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
170801833|NCT00571649|617284928|FG000|Treatment Period|Death|76|||
170801834|NCT00571649|617284929|FG001|Treatment Period|Death|59|||
170801835|NCT00571649|617284928|FG000|Treatment Period|Physician Decision|8|||
170801836|NCT00571649|617284929|FG001|Treatment Period|Physician Decision|9|||
170801837|NCT00571649|617284928|FG000|Treatment Period|Lost to Follow-up|43|||
170900369|NCT00792298|617640093|FG006|Treatment Period 2|Pregnancy|0|||
170900370|NCT00792298|617640094|FG007|Treatment Period 2|Pregnancy|0|||
170900371|NCT00792298|617640087|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170641271|NCT00387790|616699869|FG000|Overall Study|Withdrawal by Subject|3|||
170641272|NCT00387790|616699869|FG000|Overall Study|Ineligible for study|2|||
170641273|NCT01874340|616699870|FG000|Overall Study|Study terminated by Sponsor|6|||
170641274|NCT01874340|616699871|FG001|Overall Study|Study terminated by Sponsor|8|||
170641275|NCT01874340|616699872|FG002|Overall Study|Study terminated by Sponsor|8|||
170641276|NCT01874340|616699873|FG003|Overall Study|Study terminated by Sponsor|4|||
170641277|NCT01874340|616699870|FG000|Overall Study|Withdrawal by Subject|0|||
170641278|NCT01874340|616699871|FG001|Overall Study|Withdrawal by Subject|0|||
170900372|NCT00792298|617640088|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170900373|NCT00792298|617640089|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170900374|NCT00792298|617640090|FG003|Treatment Period 2|Withdrawal by Subject|2|||
170900375|NCT00792298|617640091|FG004|Treatment Period 2|Withdrawal by Subject|1|||
170900376|NCT00792298|617640092|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170900377|NCT00792298|617640093|FG006|Treatment Period 2|Withdrawal by Subject|0|||
170900378|NCT00792298|617640094|FG007|Treatment Period 2|Withdrawal by Subject|2|||
170900379|NCT01756274|617640097|FG000|Overall Study|Protocol Violation|2|||
170900380|NCT01756274|617640097|FG000|Overall Study|Laboratory error|1|||
170900381|NCT03304522|617640098|FG000|Overall Study|Adverse Event|0|||
170900382|NCT03304522|617640099|FG001|Overall Study|Adverse Event|4|||
170900383|NCT03304522|617640098|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
170900384|NCT03304522|617640099|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
170900385|NCT03304522|617640098|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
170900386|NCT03304522|617640099|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
170900387|NCT03304522|617640098|FG000|Overall Study|Other|0|||
170900388|NCT03304522|617640099|FG001|Overall Study|Other|1|||
170900389|NCT00486603|617640105|FG000|Overall Study|Withdrawal by Subject|1|||
170900390|NCT00486603|617640106|FG001|Overall Study|Withdrawal by Subject|0|||
170900391|NCT00486603|617640107|FG002|Overall Study|Withdrawal by Subject|0|||
170900392|NCT00486603|617640108|FG003|Overall Study|Withdrawal by Subject|0|||
170900393|NCT00486603|617640109|FG004|Overall Study|Withdrawal by Subject|0|||
170900394|NCT00486603|617640105|FG000|Overall Study|Physician Decision|0|||
170900395|NCT00486603|617640106|FG001|Overall Study|Physician Decision|1|||
170900396|NCT00486603|617640107|FG002|Overall Study|Physician Decision|0|||
170900397|NCT00486603|617640108|FG003|Overall Study|Physician Decision|0|||
170641279|NCT01874340|616699872|FG002|Overall Study|Withdrawal by Subject|0|||
170641280|NCT01874340|616699873|FG003|Overall Study|Withdrawal by Subject|1|||
170641281|NCT01716052|616699877|FG000|Overall Study|Withdrawal of funding|1|||
170641282|NCT01716052|616699878|FG001|Overall Study|Withdrawal of funding|1|||
170641283|NCT01523275|616699884|FG000|Overall Study|Lost to Follow-up|1|||
170641284|NCT01523275|616699885|FG001|Overall Study|Lost to Follow-up|2|||
170641285|NCT01523275|616699884|FG000|Overall Study|Withdrawal by Subject|1|||
170641286|NCT01523275|616699885|FG001|Overall Study|Withdrawal by Subject|0|||
170641287|NCT03598114|616699886|FG000|Overall Study|Staff turnover/left the program|3|||
170641288|NCT03598114|616699887|FG001|Overall Study|Staff turnover/left the program|39|||
170641289|NCT00689117|616699888|FG000|Overall Study|Adverse Event|6|||
170641290|NCT00689117|616699889|FG001|Overall Study|Adverse Event|0|||
170641291|NCT00689117|616699890|FG002|Overall Study|Adverse Event|5|||
170641292|NCT00689117|616699891|FG003|Overall Study|Adverse Event|0|||
170641293|NCT00689117|616699888|FG000|Overall Study|Lost to Follow-up|26|||
170641294|NCT00689117|616699889|FG001|Overall Study|Lost to Follow-up|19|||
170493470|NCT01931475|616147732|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
170641295|NCT00689117|616699890|FG002|Overall Study|Lost to Follow-up|17|||
170641296|NCT00689117|616699891|FG003|Overall Study|Lost to Follow-up|11|||
170641297|NCT00689117|616699888|FG000|Overall Study|Lack of Efficacy|1|||
170801838|NCT00571649|617284929|FG001|Treatment Period|Lost to Follow-up|41|||
170801839|NCT00571649|617284928|FG000|Treatment Period|Non-compliant with study medication|88|||
170801840|NCT00571649|617284929|FG001|Treatment Period|Non-compliant with study medication|89|||
170801841|NCT00571649|617284928|FG000|Treatment Period|Patient convenience|11|||
170801842|NCT00571649|617284929|FG001|Treatment Period|Patient convenience|13|||
170801843|NCT00571649|617284928|FG000|Treatment Period|Protocol Violation|90|||
170801844|NCT00571649|617284929|FG001|Treatment Period|Protocol Violation|92|||
170801845|NCT00571649|617284928|FG000|Treatment Period|Technical problems|3|||
170900398|NCT00486603|617640109|FG004|Overall Study|Physician Decision|0|||
170900399|NCT02649634|617640110|FG000|Overall Study|Withdrawal by Subject|3|||
170900400|NCT02649634|617640111|FG001|Overall Study|Withdrawal by Subject|5|||
170900401|NCT02649634|617640110|FG000|Overall Study|Lost to Follow-up|0|||
170493471|NCT01931475|616147731|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
170493472|NCT01931475|616147732|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
170493473|NCT01931475|616147731|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
170493474|NCT01931475|616147732|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
170493475|NCT01089608|616147735|FG000|Overall Study|Adverse Event|0|||
170493476|NCT01089608|616147736|FG001|Overall Study|Adverse Event|4|||
170493477|NCT01089608|616147735|FG000|Overall Study|Lost to Follow-up|0|||
170641298|NCT00689117|616699889|FG001|Overall Study|Lack of Efficacy|2|||
170900402|NCT02649634|617640111|FG001|Overall Study|Lost to Follow-up|1|||
170900403|NCT03367871|617640112|FG000|Overall Study|Lost to Follow-up|1|||
170900404|NCT02013544|617640115|FG000|Overall Study|Adverse Event|5|||
170900405|NCT02013544|617640116|FG001|Overall Study|Adverse Event|5|||
170900406|NCT02013544|617640115|FG000|Overall Study|Lost to Follow-up|2|||
170900407|NCT02013544|617640116|FG001|Overall Study|Lost to Follow-up|3|||
170900408|NCT02013544|617640115|FG000|Overall Study|Withdrawal by Subject|2|||
170900409|NCT02013544|617640116|FG001|Overall Study|Withdrawal by Subject|8|||
170900410|NCT02013544|617640115|FG000|Overall Study|Physician Decision|0|||
170900411|NCT02013544|617640116|FG001|Overall Study|Physician Decision|1|||
170900412|NCT02013544|617640115|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
170900413|NCT02013544|617640116|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
170900414|NCT00885365|617640117|FG000|4 Weeks ON Treatment|Adverse Event|2|||
170900415|NCT00885365|617640118|FG001|4 Weeks ON Treatment|Adverse Event|4|||
170493478|NCT01089608|616147736|FG001|Overall Study|Lost to Follow-up|2|||
170493479|NCT03348930|616147742|FG000|Washout (1 Week)|Lost to Follow-up|1|||
170493480|NCT03348930|616147743|FG001|Washout (1 Week)|Lost to Follow-up|1|||
170900416|NCT00885365|617640117|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
170900417|NCT00885365|617640118|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
170493481|NCT01028014|616147744|FG000|Overall Study|Lost to Follow-up|1|||
170493482|NCT01028014|616147745|FG001|Overall Study|Lost to Follow-up|2|||
170493483|NCT01028014|616147746|FG002|Overall Study|Lost to Follow-up|0|||
170493484|NCT01028014|616147747|FG003|Overall Study|Lost to Follow-up|1|||
170493485|NCT01028014|616147748|FG004|Overall Study|Lost to Follow-up|1|||
170493486|NCT01028014|616147749|FG005|Overall Study|Lost to Follow-up|2|||
170493487|NCT01250873|616147750|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
170641299|NCT00689117|616699890|FG002|Overall Study|Lack of Efficacy|2|||
170641300|NCT00689117|616699891|FG003|Overall Study|Lack of Efficacy|2|||
170641301|NCT00689117|616699888|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
170641302|NCT00689117|616699889|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
170641303|NCT00689117|616699890|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
170641304|NCT00689117|616699891|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
170641305|NCT00689117|616699888|FG000|Overall Study|Withdrawal by Subject|19|||
170641306|NCT00689117|616699889|FG001|Overall Study|Withdrawal by Subject|18|||
170641307|NCT00689117|616699890|FG002|Overall Study|Withdrawal by Subject|26|||
170641308|NCT00689117|616699891|FG003|Overall Study|Withdrawal by Subject|13|||
170641309|NCT00689117|616699888|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
170641310|NCT00689117|616699889|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
170641311|NCT00689117|616699890|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
170641312|NCT00689117|616699891|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
170641313|NCT00689117|616699888|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
170641314|NCT00689117|616699889|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
170493488|NCT01250873|616147750|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
170493489|NCT02278939|616147751|FG000|Overall Study|lack of time|1|||
170493490|NCT02278939|616147752|FG001|Overall Study|lack of time|0|||
170493491|NCT02278939|616147751|FG000|Overall Study|Lost to Follow-up|1|||
170493492|NCT02278939|616147752|FG001|Overall Study|Lost to Follow-up|1|||
170493493|NCT02278939|616147751|FG000|Overall Study|death in family|1|||
170493494|NCT02278939|616147752|FG001|Overall Study|death in family|0|||
170493495|NCT02278939|616147751|FG000|Overall Study|family emergency unable to commit|2|||
170493496|NCT02278939|616147752|FG001|Overall Study|family emergency unable to commit|0|||
170493497|NCT02423343|616147758|FG000|Overall Study|Withdrawal by Subject|0|||
170493498|NCT02423343|616147759|FG001|Overall Study|Withdrawal by Subject|1|||
170493499|NCT02423343|616147760|FG002|Overall Study|Withdrawal by Subject|0|||
170493500|NCT02423343|616147761|FG003|Overall Study|Withdrawal by Subject|0|||
170493501|NCT02423343|616147762|FG004|Overall Study|Withdrawal by Subject|0|||
170493502|NCT02423343|616147763|FG005|Overall Study|Withdrawal by Subject|0|||
170493503|NCT02423343|616147758|FG000|Overall Study|Progressive Disease|0|||
170493504|NCT02423343|616147759|FG001|Overall Study|Progressive Disease|0|||
170493505|NCT02423343|616147760|FG002|Overall Study|Progressive Disease|0|||
170641315|NCT00689117|616699890|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170641316|NCT00689117|616699891|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170641317|NCT00689117|616699888|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
170641318|NCT00689117|616699889|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
170641319|NCT00689117|616699890|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
170641320|NCT00689117|616699891|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
170641321|NCT00689117|616699888|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
170900418|NCT00885365|617640117|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
170493506|NCT02423343|616147761|FG003|Overall Study|Progressive Disease|0|||
170493507|NCT02423343|616147762|FG004|Overall Study|Progressive Disease|2|||
170493508|NCT02423343|616147763|FG005|Overall Study|Progressive Disease|0|||
170493509|NCT02423343|616147758|FG000|Overall Study|Adverse Event|0|||
170493510|NCT02423343|616147759|FG001|Overall Study|Adverse Event|0|||
170493511|NCT02423343|616147760|FG002|Overall Study|Adverse Event|0|||
170493512|NCT02423343|616147761|FG003|Overall Study|Adverse Event|0|||
170493513|NCT02423343|616147762|FG004|Overall Study|Adverse Event|2|||
170493514|NCT02423343|616147763|FG005|Overall Study|Adverse Event|0|||
170493515|NCT02423343|616147758|FG000|Overall Study|Death|0|||
170493516|NCT02423343|616147759|FG001|Overall Study|Death|0|||
170493517|NCT02423343|616147760|FG002|Overall Study|Death|0|||
170493518|NCT02423343|616147761|FG003|Overall Study|Death|0|||
170493519|NCT02423343|616147762|FG004|Overall Study|Death|1|||
170493520|NCT02423343|616147763|FG005|Overall Study|Death|0|||
170493521|NCT04429555|616147768|FG000|Overall Study|Death|0|||
170493522|NCT04429555|616147769|FG001|Overall Study|Death|2|||
170493523|NCT04429555|616147768|FG000|Overall Study|Other|2|||
170493524|NCT04429555|616147769|FG001|Overall Study|Other|0|||
170493525|NCT01127451|616147770|FG000|Overall Study|Other|2|||
170801846|NCT00571649|617284929|FG001|Treatment Period|Technical problems|5|||
170801847|NCT00571649|617284928|FG000|Follow-up Period|Adverse Event|46|||
170801848|NCT00571649|617284929|FG001|Follow-up Period|Adverse Event|40|||
170801849|NCT00571649|617284928|FG000|Follow-up Period|Clinical endpoint reached|5|||
170801850|NCT00571649|617284929|FG001|Follow-up Period|Clinical endpoint reached|2|||
170801851|NCT00571649|617284928|FG000|Follow-up Period|Withdrawal by Subject|119|||
170801852|NCT00571649|617284929|FG001|Follow-up Period|Withdrawal by Subject|115|||
170801853|NCT00571649|617284928|FG000|Follow-up Period|Death|132|||
170493526|NCT01127451|616147771|FG001|Overall Study|Other|1|||
170493527|NCT01127451|616147770|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
170493528|NCT01127451|616147771|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
170493529|NCT01127451|616147770|FG000|Overall Study|Death|22|||
170493530|NCT01127451|616147771|FG001|Overall Study|Death|17|||
170493531|NCT01127451|616147770|FG000|Overall Study|Lost to Follow-up|3|||
170493532|NCT01127451|616147771|FG001|Overall Study|Lost to Follow-up|0|||
170493533|NCT01127451|616147770|FG000|Overall Study|Administrative Reason by Sponsor|2|||
170493534|NCT01127451|616147771|FG001|Overall Study|Administrative Reason by Sponsor|2|||
170493535|NCT00930774|616147772|FG000|Overall Study|Withdrawal by Subject|1|||
170493536|NCT00930774|616147773|FG001|Overall Study|Withdrawal by Subject|9|||
170493537|NCT00930774|616147774|FG002|Overall Study|Withdrawal by Subject|2|||
170493538|NCT00930774|616147775|FG003|Overall Study|Withdrawal by Subject|0|||
170493539|NCT02703272|616147776|FG000|Overall Study|Death|4|||
170493540|NCT02703272|616147777|FG001|Overall Study|Death|9|||
170493541|NCT02703272|616147778|FG002|Overall Study|Death|19|||
170493542|NCT02703272|616147779|FG003|Overall Study|Death|10|||
170493543|NCT02703272|616147776|FG000|Overall Study|Withdrawal by Subject|0|||
170493544|NCT02703272|616147777|FG001|Overall Study|Withdrawal by Subject|0|||
170493545|NCT02703272|616147778|FG002|Overall Study|Withdrawal by Subject|4|||
170493546|NCT02703272|616147779|FG003|Overall Study|Withdrawal by Subject|2|||
170493547|NCT02703272|616147776|FG000|Overall Study|Study Terminated by Sponsor|6|||
170493548|NCT02703272|616147777|FG001|Overall Study|Study Terminated by Sponsor|1|||
170493549|NCT02703272|616147778|FG002|Overall Study|Study Terminated by Sponsor|12|||
170493550|NCT02703272|616147779|FG003|Overall Study|Study Terminated by Sponsor|4|||
170493551|NCT02703272|616147776|FG000|Overall Study|Other|1|||
170493552|NCT02703272|616147777|FG001|Overall Study|Other|0|||
170493553|NCT02703272|616147778|FG002|Overall Study|Other|0|||
170493554|NCT02703272|616147779|FG003|Overall Study|Other|0|||
170493555|NCT02429778|616147780|FG000|Overall Study|Lost to Follow-up|2|||
170493556|NCT02429778|616147781|FG001|Overall Study|Lost to Follow-up|0|||
170493557|NCT02429778|616147780|FG000|Overall Study|Withdrawal by Subject|5|||
170493558|NCT02429778|616147781|FG001|Overall Study|Withdrawal by Subject|0|||
170493559|NCT03499899|616147782|FG000|Overall Study|Adverse Event|2|||
170493560|NCT03499899|616147783|FG001|Overall Study|Adverse Event|3|||
170493561|NCT03499899|616147784|FG002|Overall Study|Adverse Event|3|||
170493562|NCT03499899|616147782|FG000|Overall Study|Death|0|||
170493563|NCT03499899|616147783|FG001|Overall Study|Death|0|||
170493564|NCT03499899|616147784|FG002|Overall Study|Death|1|||
170493565|NCT03499899|616147782|FG000|Overall Study|Physician Decision|3|||
170493566|NCT03499899|616147783|FG001|Overall Study|Physician Decision|6|||
170493567|NCT03499899|616147784|FG002|Overall Study|Physician Decision|6|||
170493568|NCT03499899|616147782|FG000|Overall Study|Progressive disease|15|||
170493569|NCT03499899|616147783|FG001|Overall Study|Progressive disease|23|||
170493570|NCT03499899|616147784|FG002|Overall Study|Progressive disease|23|||
170493571|NCT03499899|616147782|FG000|Overall Study|Patient decision|0|||
170493572|NCT03499899|616147783|FG001|Overall Study|Patient decision|1|||
170493573|NCT03499899|616147784|FG002|Overall Study|Patient decision|1|||
170493574|NCT03499899|616147782|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
170801854|NCT00571649|617284929|FG001|Follow-up Period|Death|133|||
170493575|NCT03499899|616147783|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
170493576|NCT03499899|616147784|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
170493577|NCT03655470|616147789|FG000|Overall Study|Lost to Follow-up|6|||
170493578|NCT03655470|616147790|FG001|Overall Study|Lost to Follow-up|7|||
170493579|NCT04590586|616147798|FG000|Overall Study|Death|7|||
170493580|NCT04590586|616147799|FG001|Overall Study|Death|1|||
170493581|NCT04590586|616147800|FG002|Overall Study|Death|37|||
170801855|NCT00571649|617284928|FG000|Follow-up Period|Physician Decision|7|||
170493582|NCT04590586|616147801|FG003|Overall Study|Death|34|||
170493583|NCT04590586|616147802|FG004|Overall Study|Death|19|||
170493584|NCT04590586|616147803|FG005|Overall Study|Death|3|||
170493585|NCT04590586|616147798|FG000|Overall Study|Lost to Follow-up|3|||
170493586|NCT04590586|616147799|FG001|Overall Study|Lost to Follow-up|0|||
170493587|NCT04590586|616147800|FG002|Overall Study|Lost to Follow-up|11|||
170493588|NCT04590586|616147801|FG003|Overall Study|Lost to Follow-up|11|||
170493589|NCT04590586|616147802|FG004|Overall Study|Lost to Follow-up|6|||
170493590|NCT04590586|616147803|FG005|Overall Study|Lost to Follow-up|0|||
170493591|NCT04590586|616147798|FG000|Overall Study|Withdrawal by Subject|0|||
170493592|NCT04590586|616147799|FG001|Overall Study|Withdrawal by Subject|0|||
170493593|NCT04590586|616147800|FG002|Overall Study|Withdrawal by Subject|6|||
170493594|NCT04590586|616147801|FG003|Overall Study|Withdrawal by Subject|0|||
170493595|NCT04590586|616147802|FG004|Overall Study|Withdrawal by Subject|3|||
170493596|NCT04590586|616147803|FG005|Overall Study|Withdrawal by Subject|0|||
170493597|NCT04590586|616147798|FG000|Overall Study|Other|3|||
170493598|NCT04590586|616147799|FG001|Overall Study|Other|0|||
170493599|NCT04590586|616147800|FG002|Overall Study|Other|1|||
170493600|NCT04590586|616147801|FG003|Overall Study|Other|1|||
170493601|NCT04590586|616147802|FG004|Overall Study|Other|2|||
170493602|NCT04590586|616147803|FG005|Overall Study|Other|1|||
170493603|NCT01609543|616147804|FG000|Overall Study|Disease Progression|28|||
170493604|NCT01609543|616147804|FG000|Overall Study|Adverse Event|5|||
170493605|NCT01609543|616147804|FG000|Overall Study|Withdrawal by Subject|1|||
170493606|NCT01609543|616147804|FG000|Overall Study|Protocol Violation|1|||
170493607|NCT01609543|616147804|FG000|Overall Study|Death|7|||
170493608|NCT01893281|616147806|FG000|Overall Study|Adverse Event|1|||
170493609|NCT01893281|616147806|FG000|Overall Study|Protocol Violation|1|||
170493610|NCT01893281|616147806|FG000|Overall Study|Withdrawal by Subject|1|||
170493611|NCT01254318|616147807|FG000|Overall Study|Lost to Follow-up|5|||
170493612|NCT01254318|616147807|FG000|Overall Study|Death|47|||
170493613|NCT01137110|616147808|FG000|Overall Study|Protocol Violation|1|||
170493614|NCT01137110|616147809|FG001|Overall Study|Protocol Violation|0|||
170493615|NCT00355147|616147814|FG000|Overall Study|Lost to Follow-up|10|||
170493616|NCT00355147|616147815|FG001|Overall Study|Lost to Follow-up|8|||
170493617|NCT00355147|616147814|FG000|Overall Study|Withdrawal by Subject|8|||
170493618|NCT00355147|616147815|FG001|Overall Study|Withdrawal by Subject|12|||
170493619|NCT02828124|616147818|FG000|Overall Study|Disease Progression|1|||
170493620|NCT02828124|616147819|FG001|Overall Study|Disease Progression|2|||
170493621|NCT02828124|616147820|FG002|Overall Study|Disease Progression|1|||
170493622|NCT02828124|616147821|FG003|Overall Study|Disease Progression|4|||
170493623|NCT02828124|616147818|FG000|Overall Study|AE Unrelated to Study Drug|0|||
170493624|NCT02828124|616147819|FG001|Overall Study|AE Unrelated to Study Drug|0|||
170493625|NCT02828124|616147820|FG002|Overall Study|AE Unrelated to Study Drug|0|||
170493626|NCT02828124|616147821|FG003|Overall Study|AE Unrelated to Study Drug|1|||
170493627|NCT02828124|616147818|FG000|Overall Study|Subject Withdrew Consent|0|||
170493628|NCT02828124|616147819|FG001|Overall Study|Subject Withdrew Consent|0|||
170493629|NCT02828124|616147820|FG002|Overall Study|Subject Withdrew Consent|0|||
170493630|NCT02828124|616147821|FG003|Overall Study|Subject Withdrew Consent|1|||
170493631|NCT00747474|616147823|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493632|NCT00747474|616147824|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493633|NCT00747474|616147825|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493634|NCT00747474|616147826|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493635|NCT00747474|616147827|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493636|NCT00747474|616147828|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493637|NCT00747474|616147829|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493638|NCT00747474|616147830|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
170493639|NCT00747474|616147831|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170641322|NCT00689117|616699889|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
170641323|NCT00689117|616699890|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
170641324|NCT00689117|616699891|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
170641325|NCT00689117|616699888|FG000|Overall Study|Use of Prohibitive Medication|2|||
170641326|NCT00689117|616699889|FG001|Overall Study|Use of Prohibitive Medication|1|||
170641327|NCT00689117|616699890|FG002|Overall Study|Use of Prohibitive Medication|3|||
170641328|NCT00689117|616699891|FG003|Overall Study|Use of Prohibitive Medication|0|||
170641329|NCT00689117|616699888|FG000|Overall Study|Pregnancy|0|||
170641330|NCT00689117|616699889|FG001|Overall Study|Pregnancy|2|||
170493640|NCT00747474|616147832|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493641|NCT00747474|616147833|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493642|NCT00747474|616147834|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
170493643|NCT02989649|616147835|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
170493644|NCT02989649|616147835|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
170493645|NCT02989649|616147835|FG000|Overall Study|Lost For Observation During Study|3|||
170493646|NCT02989649|616147835|FG000|Overall Study|Reason Not Specified|13|||
170493647|NCT00256854|616147836|FG000|Overall Study|Withdrawal by Subject|2|||
170641331|NCT00689117|616699890|FG002|Overall Study|Pregnancy|0|||
170900419|NCT00885365|617640118|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
170900420|NCT02700984|617640124|FG000|Overall Study|Death|2|||
170900421|NCT02700984|617640125|FG001|Overall Study|Death|1|||
170900422|NCT02700984|617640124|FG000|Overall Study|Lost to Follow-up|2|||
170900423|NCT02700984|617640125|FG001|Overall Study|Lost to Follow-up|1|||
170900424|NCT02700984|617640124|FG000|Overall Study|Physician Decision|0|||
170900425|NCT02700984|617640125|FG001|Overall Study|Physician Decision|1|||
170900426|NCT02700984|617640124|FG000|Overall Study|Withdrawal by Subject|8|||
170900427|NCT02700984|617640125|FG001|Overall Study|Withdrawal by Subject|9|||
170900428|NCT02700984|617640124|FG000|Overall Study|Reason not specified|3|||
170900429|NCT02700984|617640125|FG001|Overall Study|Reason not specified|2|||
170900430|NCT02393209|617640126|FG000|Overall Study|Study Terminated by Sponsor|1|||
170900431|NCT02393209|617640127|FG001|Overall Study|Study Terminated by Sponsor|1|||
170900432|NCT02393209|617640128|FG002|Overall Study|Study Terminated by Sponsor|0|||
170900433|NCT02393209|617640129|FG003|Overall Study|Study Terminated by Sponsor|0|||
170900434|NCT02393209|617640126|FG000|Overall Study|Withdrawal by Patient|1|||
170900435|NCT02393209|617640127|FG001|Overall Study|Withdrawal by Patient|0|||
170900436|NCT02393209|617640128|FG002|Overall Study|Withdrawal by Patient|0|||
170900437|NCT02393209|617640129|FG003|Overall Study|Withdrawal by Patient|0|||
170900438|NCT02393209|617640126|FG000|Overall Study|Death|2|||
170900439|NCT02393209|617640127|FG001|Overall Study|Death|2|||
170900440|NCT02393209|617640128|FG002|Overall Study|Death|0|||
170900441|NCT02393209|617640129|FG003|Overall Study|Death|0|||
170900442|NCT02393209|617640126|FG000|Overall Study|Death due to Disease Progression|2|||
170900443|NCT02393209|617640127|FG001|Overall Study|Death due to Disease Progression|2|||
170641332|NCT00689117|616699891|FG003|Overall Study|Pregnancy|2|||
170641333|NCT00689117|616699888|FG000|Overall Study|Incarceration|2|||
170641334|NCT00689117|616699889|FG001|Overall Study|Incarceration|0|||
170641335|NCT00689117|616699890|FG002|Overall Study|Incarceration|0|||
170641336|NCT00689117|616699891|FG003|Overall Study|Incarceration|0|||
170641337|NCT00689117|616699888|FG000|Overall Study|Fear of Birth Defects|0|||
170641338|NCT00689117|616699889|FG001|Overall Study|Fear of Birth Defects|0|||
170641339|NCT00689117|616699890|FG002|Overall Study|Fear of Birth Defects|1|||
170641340|NCT00689117|616699891|FG003|Overall Study|Fear of Birth Defects|0|||
170641341|NCT00689117|616699888|FG000|Overall Study|Transportation|1|||
170641342|NCT00689117|616699889|FG001|Overall Study|Transportation|0|||
170641343|NCT00689117|616699890|FG002|Overall Study|Transportation|0|||
170641344|NCT00689117|616699891|FG003|Overall Study|Transportation|0|||
170641345|NCT00689117|616699888|FG000|Overall Study|Patient Withdrew from Study|0|||
170641346|NCT00689117|616699889|FG001|Overall Study|Patient Withdrew from Study|0|||
170641347|NCT00689117|616699890|FG002|Overall Study|Patient Withdrew from Study|0|||
170641348|NCT00689117|616699891|FG003|Overall Study|Patient Withdrew from Study|1|||
170641349|NCT00689117|616699888|FG000|Overall Study|Personal Reason|0|||
170641350|NCT00689117|616699889|FG001|Overall Study|Personal Reason|1|||
170641351|NCT00689117|616699890|FG002|Overall Study|Personal Reason|0|||
170641352|NCT00689117|616699891|FG003|Overall Study|Personal Reason|0|||
170641353|NCT00689117|616699888|FG000|Overall Study|Dispensing Error|0|||
170641354|NCT00689117|616699889|FG001|Overall Study|Dispensing Error|1|||
170641355|NCT00689117|616699890|FG002|Overall Study|Dispensing Error|0|||
170641356|NCT00689117|616699891|FG003|Overall Study|Dispensing Error|0|||
170641357|NCT01256190|616699892|FG000|Overall Study|Lost to Follow-up|2|||
170641358|NCT01256190|616699893|FG001|Overall Study|Lost to Follow-up|0|||
170641359|NCT02834793|616699894|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
170641360|NCT02834793|616699895|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
170641361|NCT02834793|616699896|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
170641362|NCT02834793|616699897|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
170641363|NCT02834793|616699894|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
170641364|NCT02834793|616699895|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
170641365|NCT02834793|616699896|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
170641366|NCT02834793|616699897|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
170641367|NCT02834793|616699894|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
170641368|NCT02834793|616699895|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
170641369|NCT02834793|616699896|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
170641370|NCT02834793|616699897|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
170641371|NCT02834793|616699894|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
170641372|NCT02834793|616699895|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
170641373|NCT02834793|616699896|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
170641374|NCT02834793|616699897|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
170641375|NCT02834793|616699894|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
170900444|NCT02393209|617640128|FG002|Overall Study|Death due to Disease Progression|0|||
170900445|NCT02393209|617640129|FG003|Overall Study|Death due to Disease Progression|0|||
170900446|NCT02393209|617640126|FG000|Overall Study|Death from Legionella Infection|0|||
170900447|NCT02393209|617640127|FG001|Overall Study|Death from Legionella Infection|1|||
170493648|NCT00256854|616147837|FG001|Overall Study|Withdrawal by Subject|3|||
170493649|NCT00256854|616147838|FG002|Overall Study|Withdrawal by Subject|0|||
170493650|NCT00256854|616147839|FG003|Overall Study|Withdrawal by Subject|0|||
170493651|NCT00256854|616147840|FG004|Overall Study|Withdrawal by Subject|0|||
170493652|NCT00256854|616147841|FG005|Overall Study|Withdrawal by Subject|0|||
170493653|NCT00256854|616147836|FG000|Overall Study|Lack of Efficacy|1|||
170493654|NCT00256854|616147837|FG001|Overall Study|Lack of Efficacy|0|||
170493655|NCT00256854|616147838|FG002|Overall Study|Lack of Efficacy|0|||
170493656|NCT00256854|616147839|FG003|Overall Study|Lack of Efficacy|0|||
170493657|NCT00256854|616147840|FG004|Overall Study|Lack of Efficacy|0|||
170493658|NCT00256854|616147841|FG005|Overall Study|Lack of Efficacy|0|||
170493659|NCT00256854|616147836|FG000|Overall Study|Protocol Violation|0|||
170493660|NCT00256854|616147837|FG001|Overall Study|Protocol Violation|1|||
170493661|NCT00256854|616147838|FG002|Overall Study|Protocol Violation|1|||
170493662|NCT00256854|616147839|FG003|Overall Study|Protocol Violation|1|||
170493663|NCT00256854|616147840|FG004|Overall Study|Protocol Violation|0|||
170493664|NCT00256854|616147841|FG005|Overall Study|Protocol Violation|0|||
170493665|NCT00256854|616147836|FG000|Overall Study|Adverse Event|0|||
170493666|NCT00256854|616147837|FG001|Overall Study|Adverse Event|0|||
170493667|NCT00256854|616147838|FG002|Overall Study|Adverse Event|2|||
170493668|NCT00256854|616147839|FG003|Overall Study|Adverse Event|2|||
170493669|NCT00256854|616147840|FG004|Overall Study|Adverse Event|0|||
170493670|NCT00256854|616147841|FG005|Overall Study|Adverse Event|1|||
170493671|NCT00256854|616147836|FG000|Overall Study|Not compliant with the study drug|0|||
170493672|NCT00256854|616147837|FG001|Overall Study|Not compliant with the study drug|0|||
170493673|NCT00256854|616147838|FG002|Overall Study|Not compliant with the study drug|0|||
170493674|NCT00256854|616147839|FG003|Overall Study|Not compliant with the study drug|0|||
170493675|NCT00256854|616147840|FG004|Overall Study|Not compliant with the study drug|1|||
170493676|NCT00256854|616147841|FG005|Overall Study|Not compliant with the study drug|0|||
170493677|NCT00281632|616147842|FG000|Overall Study|Adverse Event|7|||
170493678|NCT00281632|616147842|FG000|Overall Study|Withdrawal by Subject|2|||
170493679|NCT00281632|616147842|FG000|Overall Study|Disease Progression|22|||
170641376|NCT02834793|616699895|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
170641377|NCT02834793|616699896|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
170550329|NCT04034056|616360510|FG000|Overall Study|Withdrawal by Subject|2|||
170550330|NCT04034056|616360510|FG000|Overall Study|Reason Not Specified|13|||
170550331|NCT04034056|616360510|FG000|Overall Study|Adverse Event|56|||
170550332|NCT04135352|616360511|FG000|Overall Study|Not treated-randomization error|0|||
170550333|NCT04135352|616360512|FG001|Overall Study|Not treated-randomization error|0|||
170550334|NCT04135352|616360513|FG002|Overall Study|Not treated-randomization error|1|||
170550335|NCT04135352|616360514|FG003|Overall Study|Not treated-randomization error|0|||
170550336|NCT04135352|616360515|FG004|Overall Study|Not treated-randomization error|0|||
170550337|NCT04135352|616360516|FG005|Overall Study|Not treated-randomization error|0|||
170550338|NCT04135352|616360517|FG006|Overall Study|Not treated-randomization error|0|||
170550339|NCT04135352|616360518|FG007|Overall Study|Not treated-randomization error|0|||
170550340|NCT04135352|616360511|FG000|Overall Study|Withdrawal by Subject|0|||
170550341|NCT04135352|616360512|FG001|Overall Study|Withdrawal by Subject|0|||
170550342|NCT04135352|616360513|FG002|Overall Study|Withdrawal by Subject|2|||
170550343|NCT04135352|616360514|FG003|Overall Study|Withdrawal by Subject|0|||
170550344|NCT04135352|616360515|FG004|Overall Study|Withdrawal by Subject|0|||
170550345|NCT04135352|616360516|FG005|Overall Study|Withdrawal by Subject|0|||
170550346|NCT04135352|616360517|FG006|Overall Study|Withdrawal by Subject|0|||
170550347|NCT04135352|616360518|FG007|Overall Study|Withdrawal by Subject|0|||
170550348|NCT04135352|616360511|FG000|Overall Study|Sponsor Decision|0|||
170550349|NCT04135352|616360512|FG001|Overall Study|Sponsor Decision|0|||
170550350|NCT04135352|616360513|FG002|Overall Study|Sponsor Decision|2|||
170550351|NCT04135352|616360514|FG003|Overall Study|Sponsor Decision|5|||
170550352|NCT04135352|616360515|FG004|Overall Study|Sponsor Decision|1|||
170550353|NCT04135352|616360516|FG005|Overall Study|Sponsor Decision|4|||
170641378|NCT02834793|616699897|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
170641379|NCT02834793|616699894|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
170550354|NCT04135352|616360517|FG006|Overall Study|Sponsor Decision|0|||
170550355|NCT04135352|616360518|FG007|Overall Study|Sponsor Decision|0|||
170493680|NCT00281632|616147842|FG000|Overall Study|Death|1|||
170493681|NCT00281632|616147842|FG000|Overall Study|Physician Decision|1|||
170493682|NCT00281632|616147842|FG000|Overall Study|Ongoing|3|||
170493683|NCT01878084|616147843|FG000|Overall Study|Physician Decision|2|||
170493684|NCT00765336|616147857|FG000|Overall Study|Protocol Violation|4|||
170493685|NCT00765336|616147858|FG001|Overall Study|Protocol Violation|2|||
170493686|NCT00765336|616147857|FG000|Overall Study|Withdrawal by Subject|6|||
170493687|NCT00765336|616147858|FG001|Overall Study|Withdrawal by Subject|4|||
170550356|NCT04135352|616360511|FG000|Overall Study|Physician Decision|0|||
170550357|NCT04135352|616360512|FG001|Overall Study|Physician Decision|0|||
170550358|NCT04135352|616360513|FG002|Overall Study|Physician Decision|1|||
170550359|NCT04135352|616360514|FG003|Overall Study|Physician Decision|0|||
170550360|NCT04135352|616360515|FG004|Overall Study|Physician Decision|1|||
170550361|NCT04135352|616360516|FG005|Overall Study|Physician Decision|0|||
170493688|NCT00765336|616147857|FG000|Overall Study|Lost to Follow-up|7|||
170493689|NCT00765336|616147858|FG001|Overall Study|Lost to Follow-up|9|||
170493690|NCT00765336|616147857|FG000|Overall Study|Adverse Event|2|||
170493691|NCT00765336|616147858|FG001|Overall Study|Adverse Event|1|||
170493692|NCT02157376|616147859|FG000|Overall Study|Death|10|||
170493693|NCT02157376|616147860|FG001|Overall Study|Death|4|||
170493694|NCT02157376|616147859|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170493695|NCT02157376|616147860|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170493696|NCT02157376|616147859|FG000|Overall Study|Withdrawal by Subject|3|||
170493697|NCT02157376|616147860|FG001|Overall Study|Withdrawal by Subject|8|||
170493698|NCT02157376|616147859|FG000|Overall Study|Not treated|8|||
170493699|NCT02157376|616147860|FG001|Overall Study|Not treated|3|||
170493700|NCT02157376|616147859|FG000|Overall Study|Investigator's misjudgement|1|||
170493701|NCT02157376|616147860|FG001|Overall Study|Investigator's misjudgement|2|||
170493702|NCT04310397|616149006|FG000|Overall Study|Lack of Efficacy|3|||
170493703|NCT04310397|616149006|FG000|Overall Study|Withdrawal by Subject|1|||
170493704|NCT00843037|616149009|FG000|Overall Study|Lost to Follow-up|1|||
170493705|NCT03991299|616149010|FG000|Overall Study|Study closed, sponsor decision|3|||
170493706|NCT03991299|616149010|FG000|Overall Study|Withdrawal by Subject|1|||
170493707|NCT04304235|616149011|FG000|Overall Study|incomplete triage data|0|||
170493708|NCT04304235|616149012|FG001|Overall Study|incomplete triage data|69|||
170493709|NCT04304235|616149013|FG002|Overall Study|incomplete triage data|0|||
170493710|NCT04304235|616149014|FG003|Overall Study|incomplete triage data|0|||
170493711|NCT04304235|616149015|FG004|Overall Study|incomplete triage data|289|||
170493712|NCT04304235|616149016|FG005|Overall Study|incomplete triage data|123|||
170493713|NCT04304235|616149017|FG006|Overall Study|incomplete triage data|65|||
170493714|NCT00712881|616149022|FG000|Overall Study|Adverse Event|3|||
170493715|NCT00712881|616149023|FG001|Overall Study|Adverse Event|3|||
170493716|NCT00712881|616149022|FG000|Overall Study|Withdrawal by Subject|1|||
170493717|NCT00712881|616149023|FG001|Overall Study|Withdrawal by Subject|1|||
170493718|NCT00712881|616149022|FG000|Overall Study|Disease Progression|2|||
170493719|NCT00712881|616149023|FG001|Overall Study|Disease Progression|1|||
170493720|NCT00712881|616149022|FG000|Overall Study|Lost to Follow-up|1|||
170493721|NCT00712881|616149023|FG001|Overall Study|Lost to Follow-up|1|||
170493722|NCT00712881|616149022|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
170493723|NCT00712881|616149023|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
170493724|NCT00712881|616149022|FG000|Overall Study|Protocol Violation|1|||
170493725|NCT00712881|616149023|FG001|Overall Study|Protocol Violation|1|||
170493726|NCT00712881|616149022|FG000|Overall Study|Randomized but not treated|1|||
170493727|NCT00712881|616149023|FG001|Overall Study|Randomized but not treated|0|||
170493728|NCT03200704|616149024|FG000|Overall Study|Withdrawal by Subject|1|||
170493729|NCT04967885|616149025|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
170493730|NCT04967885|616149026|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
170493731|NCT04967885|616149025|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
170493732|NCT04967885|616149026|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
170493733|NCT04967885|616149025|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
170493734|NCT04967885|616149026|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
170493735|NCT04967885|616149025|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
170493736|NCT04967885|616149026|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
170493737|NCT04967885|616149025|FG000|EMI-II Intervention|Lost to Follow-up|14|||
170493738|NCT04967885|616149026|FG001|EMI-II Intervention|Lost to Follow-up|10|||
170493739|NCT01279070|616149029|FG000|Overall Study|Withdrawal by Subject|2|||
170493740|NCT01279070|616149030|FG001|Overall Study|Withdrawal by Subject|3|||
170493741|NCT01279070|616149029|FG000|Overall Study|Acute exacerbation|3|||
170493742|NCT01279070|616149030|FG001|Overall Study|Acute exacerbation|1|||
170493743|NCT02217410|616149033|FG000|Overall Study|Graft Loss|0|||
170493744|NCT02217410|616149034|FG001|Overall Study|Graft Loss|0|||
170493745|NCT02217410|616149035|FG002|Overall Study|Graft Loss|2|||
170493746|NCT02217410|616149033|FG000|Overall Study|Withdrawal by Subject|0|||
170493747|NCT02217410|616149034|FG001|Overall Study|Withdrawal by Subject|0|||
170493748|NCT02217410|616149035|FG002|Overall Study|Withdrawal by Subject|2|||
170550362|NCT04135352|616360517|FG006|Overall Study|Physician Decision|0|||
170550363|NCT04135352|616360518|FG007|Overall Study|Physician Decision|0|||
170550364|NCT04135352|616360511|FG000|Overall Study|Death|3|||
170550365|NCT04135352|616360512|FG001|Overall Study|Death|4|||
170550366|NCT04135352|616360513|FG002|Overall Study|Death|7|||
170550367|NCT04135352|616360514|FG003|Overall Study|Death|0|||
170550368|NCT04135352|616360515|FG004|Overall Study|Death|3|||
170550369|NCT04135352|616360516|FG005|Overall Study|Death|1|||
170550370|NCT04135352|616360517|FG006|Overall Study|Death|0|||
170493749|NCT02217410|616149033|FG000|Overall Study|Lost to Follow-up|0|||
170493750|NCT02217410|616149034|FG001|Overall Study|Lost to Follow-up|0|||
170493751|NCT02217410|616149035|FG002|Overall Study|Lost to Follow-up|1|||
170550371|NCT04135352|616360518|FG007|Overall Study|Death|0|||
170550372|NCT03225989|616360519|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
170493752|NCT02217410|616149033|FG000|Overall Study|Lack of Efficacy|0|||
170493753|NCT02217410|616149034|FG001|Overall Study|Lack of Efficacy|1|||
170493754|NCT02217410|616149035|FG002|Overall Study|Lack of Efficacy|0|||
170493755|NCT02217410|616149033|FG000|Overall Study|Physician Decision|1|||
170900448|NCT02393209|617640128|FG002|Overall Study|Death from Legionella Infection|0|||
170900449|NCT02393209|617640129|FG003|Overall Study|Death from Legionella Infection|0|||
170900450|NCT02393209|617640126|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
170493756|NCT02217410|616149034|FG001|Overall Study|Physician Decision|3|||
170493757|NCT02217410|616149035|FG002|Overall Study|Physician Decision|0|||
170493758|NCT02475265|616149037|FG000|Overall Study|Physician Decision|1|||
170493759|NCT02475265|616149037|FG000|Overall Study|Withdrawal by Subject|2|||
170493760|NCT03557931|616149040|FG000|Overall Study|Adverse Event|4|||
170493761|NCT03557931|616149041|FG001|Overall Study|Adverse Event|6|||
170493762|NCT03557931|616149042|FG002|Overall Study|Adverse Event|1|||
170493763|NCT03557931|616149040|FG000|Overall Study|Lost to Follow-up|4|||
170493764|NCT03557931|616149041|FG001|Overall Study|Lost to Follow-up|4|||
170493765|NCT03557931|616149042|FG002|Overall Study|Lost to Follow-up|1|||
170493766|NCT03557931|616149040|FG000|Overall Study|Protocol Violation|1|||
170493767|NCT03557931|616149041|FG001|Overall Study|Protocol Violation|4|||
170493768|NCT03557931|616149042|FG002|Overall Study|Protocol Violation|1|||
170493769|NCT03557931|616149040|FG000|Overall Study|Withdrawal by Subject|14|||
170493770|NCT03557931|616149041|FG001|Overall Study|Withdrawal by Subject|0|||
170493771|NCT03557931|616149042|FG002|Overall Study|Withdrawal by Subject|7|||
170493772|NCT03557931|616149040|FG000|Overall Study|Miscellaneous|8|||
170493773|NCT03557931|616149041|FG001|Overall Study|Miscellaneous|5|||
170493774|NCT03557931|616149042|FG002|Overall Study|Miscellaneous|3|||
170493775|NCT03315286|616149043|FG000|Overall Study|Lost to Follow-up|0|||
170493776|NCT03315286|616149044|FG001|Overall Study|Lost to Follow-up|3|||
170493777|NCT03315286|616149043|FG000|Overall Study|Withdrawal by Subject|1|||
170493778|NCT03315286|616149044|FG001|Overall Study|Withdrawal by Subject|0|||
170493779|NCT03315286|616149043|FG000|Overall Study|Protocol Violation|0|||
170493780|NCT03315286|616149044|FG001|Overall Study|Protocol Violation|1|||
170493781|NCT06586788|616149045|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
170493782|NCT03990571|616149046|FG000|Overall Study|Withdrawal by Subject|1|||
170493783|NCT03990571|616149046|FG000|Overall Study|Insurance Issues|3|||
170493784|NCT03990571|616149046|FG000|Overall Study|Covid Restrictions|2|||
170493785|NCT03514485|616149047|FG000|Overall Study|Lost to Follow-up|5|||
170493786|NCT03514485|616149048|FG001|Overall Study|Lost to Follow-up|3|||
170493787|NCT03514485|616149049|FG002|Overall Study|Lost to Follow-up|2|||
170493788|NCT03514485|616149050|FG003|Overall Study|Lost to Follow-up|0|||
170550373|NCT03225989|616360520|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
170550374|NCT03225989|616360521|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
170550375|NCT03225989|616360519|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
170550376|NCT03225989|616360520|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
170550377|NCT03225989|616360521|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
170550378|NCT03225989|616360519|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
170550379|NCT03225989|616360520|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
170550380|NCT03225989|616360521|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
170550381|NCT03225989|616360519|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
170550382|NCT03225989|616360520|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
170550383|NCT03225989|616360521|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
170550384|NCT03225989|616360519|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
170550385|NCT03225989|616360520|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
170550386|NCT03225989|616360521|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
170550387|NCT03225989|616360519|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
170550388|NCT03225989|616360520|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
170550389|NCT03225989|616360521|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
170550390|NCT03225989|616360519|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
170550391|NCT03225989|616360520|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
170550392|NCT03225989|616360521|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
170550393|NCT03225989|616360519|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
170550394|NCT03225989|616360520|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
170550395|NCT03225989|616360521|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
170550396|NCT03225989|616360519|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
170550397|NCT03225989|616360520|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
170550398|NCT03225989|616360521|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
170550399|NCT03225989|616360519|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
170550400|NCT03225989|616360520|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
170550401|NCT03225989|616360521|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
170550402|NCT03225989|616360519|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
170550403|NCT03225989|616360520|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
170550404|NCT03225989|616360521|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
170550405|NCT03225989|616360519|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
170550406|NCT03225989|616360520|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
170550407|NCT03225989|616360521|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
170493789|NCT03514485|616149051|FG004|Overall Study|Lost to Follow-up|1|||
170493790|NCT03514485|616149052|FG005|Overall Study|Lost to Follow-up|4|||
170493791|NCT03514485|616149047|FG000|Overall Study|Withdrawal by Subject|0|||
170493792|NCT03514485|616149048|FG001|Overall Study|Withdrawal by Subject|1|||
170493793|NCT03514485|616149049|FG002|Overall Study|Withdrawal by Subject|3|||
170493794|NCT03514485|616149050|FG003|Overall Study|Withdrawal by Subject|1|||
170493795|NCT03514485|616149051|FG004|Overall Study|Withdrawal by Subject|2|||
170493796|NCT03514485|616149052|FG005|Overall Study|Withdrawal by Subject|1|||
170493797|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
170493798|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
170493799|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
170493800|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
170493801|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
170493802|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
170493803|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
170493804|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
170493805|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
170493806|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
170493807|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Death|1|||
170493808|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Death|0|||
170493809|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
170493810|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
170493811|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
170493812|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
170493813|NCT01876784|616149055|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
170493814|NCT01876784|616149056|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
170493815|NCT01876784|616149055|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
170493816|NCT01876784|616149056|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
170493817|NCT01876784|616149055|FG000|Open-label Period (31 Months)|Adverse Event|2|||
170493818|NCT01876784|616149056|FG001|Open-label Period (31 Months)|Adverse Event|6|||
170493819|NCT01876784|616149055|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
170493820|NCT01876784|616149056|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
170493821|NCT01876784|616149055|FG000|Open-label Period (31 Months)|Progressive disease|4|||
170493822|NCT01876784|616149056|FG001|Open-label Period (31 Months)|Progressive disease|35|||
170493823|NCT01876784|616149055|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
170493824|NCT01876784|616149056|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
170493825|NCT01876784|616149055|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
170493826|NCT01876784|616149056|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
170493827|NCT01876784|616149055|FG000|Open-label Period (31 Months)|Death|0|||
170493828|NCT01876784|616149056|FG001|Open-label Period (31 Months)|Death|1|||
170493829|NCT01876784|616149055|FG000|Open-label Period (31 Months)|Other than specified above|9|||
170493830|NCT01876784|616149056|FG001|Open-label Period (31 Months)|Other than specified above|18|||
170493831|NCT03605862|616149057|FG000|Overall Study|Withdrawal by Subject|12|||
170493832|NCT03605862|616149058|FG001|Overall Study|Withdrawal by Subject|9|||
170493833|NCT03605862|616149057|FG000|Overall Study|Adverse Event|2|||
170493834|NCT03605862|616149058|FG001|Overall Study|Adverse Event|1|||
170493835|NCT03605862|616149057|FG000|Overall Study|Physician Decision|3|||
170493836|NCT03605862|616149058|FG001|Overall Study|Physician Decision|1|||
170493837|NCT03605862|616149057|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
170493838|NCT03605862|616149058|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
170493839|NCT03047720|616149060|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
170493840|NCT03047720|616149061|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
170493841|NCT00634803|616149063|FG000|Overall Study|Lost to Follow-up|6|||
170493842|NCT00634803|616149064|FG001|Overall Study|Lost to Follow-up|7|||
170493843|NCT00634803|616149065|FG002|Overall Study|Lost to Follow-up|7|||
170493844|NCT03613649|616149066|FG000|Second Treatment|Lost to Follow-up|0|||
170493845|NCT03613649|616149067|FG001|Second Treatment|Lost to Follow-up|0|||
170493846|NCT03613649|616149068|FG002|Second Treatment|Lost to Follow-up|1|||
170493847|NCT03613649|616149069|FG003|Second Treatment|Lost to Follow-up|0|||
170493848|NCT03613649|616149070|FG004|Second Treatment|Lost to Follow-up|0|||
170493849|NCT03613649|616149071|FG005|Second Treatment|Lost to Follow-up|0|||
170493850|NCT03613649|616149072|FG006|Second Treatment|Lost to Follow-up|0|||
170493851|NCT03613649|616149073|FG007|Second Treatment|Lost to Follow-up|0|||
170493852|NCT03613649|616149074|FG008|Second Treatment|Lost to Follow-up|0|||
170493853|NCT03613649|616149075|FG009|Second Treatment|Lost to Follow-up|0|||
170493854|NCT03613649|616149076|FG010|Second Treatment|Lost to Follow-up|0|||
170493855|NCT03613649|616149077|FG011|Second Treatment|Lost to Follow-up|0|||
170550408|NCT03093870|616360525|FG000|Overall Study|Withdrawal by Subject|2|||
170493856|NCT03613649|616149066|FG000|Second Treatment|Withdrawal by Subject|0|||
170493857|NCT03613649|616149067|FG001|Second Treatment|Withdrawal by Subject|0|||
170493858|NCT03613649|616149068|FG002|Second Treatment|Withdrawal by Subject|0|||
170493859|NCT03613649|616149069|FG003|Second Treatment|Withdrawal by Subject|0|||
170493860|NCT03613649|616149070|FG004|Second Treatment|Withdrawal by Subject|1|||
170493861|NCT03613649|616149071|FG005|Second Treatment|Withdrawal by Subject|0|||
170493862|NCT03613649|616149072|FG006|Second Treatment|Withdrawal by Subject|0|||
170493863|NCT03613649|616149073|FG007|Second Treatment|Withdrawal by Subject|0|||
170493864|NCT03613649|616149074|FG008|Second Treatment|Withdrawal by Subject|0|||
170493865|NCT03613649|616149075|FG009|Second Treatment|Withdrawal by Subject|0|||
170493866|NCT03613649|616149076|FG010|Second Treatment|Withdrawal by Subject|0|||
170493867|NCT03613649|616149077|FG011|Second Treatment|Withdrawal by Subject|0|||
170493868|NCT03613649|616149066|FG000|Third Treatment|Lost to Follow-up|0|||
170493869|NCT03613649|616149067|FG001|Third Treatment|Lost to Follow-up|0|||
170493870|NCT03613649|616149068|FG002|Third Treatment|Lost to Follow-up|0|||
170493871|NCT03613649|616149069|FG003|Third Treatment|Lost to Follow-up|0|||
170493872|NCT03613649|616149070|FG004|Third Treatment|Lost to Follow-up|1|||
170493873|NCT03613649|616149071|FG005|Third Treatment|Lost to Follow-up|0|||
170493874|NCT03613649|616149072|FG006|Third Treatment|Lost to Follow-up|0|||
170493875|NCT03613649|616149073|FG007|Third Treatment|Lost to Follow-up|0|||
170493876|NCT03613649|616149074|FG008|Third Treatment|Lost to Follow-up|0|||
170493877|NCT03613649|616149075|FG009|Third Treatment|Lost to Follow-up|0|||
170493878|NCT03613649|616149076|FG010|Third Treatment|Lost to Follow-up|0|||
170493879|NCT03613649|616149077|FG011|Third Treatment|Lost to Follow-up|1|||
170493880|NCT03613649|616149066|FG000|Third Treatment|Protocol Violation|0|||
170493881|NCT03613649|616149067|FG001|Third Treatment|Protocol Violation|0|||
170493882|NCT03613649|616149068|FG002|Third Treatment|Protocol Violation|0|||
170493883|NCT03613649|616149069|FG003|Third Treatment|Protocol Violation|0|||
170493884|NCT03613649|616149070|FG004|Third Treatment|Protocol Violation|0|||
170493885|NCT03613649|616149071|FG005|Third Treatment|Protocol Violation|0|||
170493886|NCT03613649|616149072|FG006|Third Treatment|Protocol Violation|1|||
170493887|NCT03613649|616149073|FG007|Third Treatment|Protocol Violation|0|||
170493888|NCT03613649|616149074|FG008|Third Treatment|Protocol Violation|0|||
170493889|NCT03613649|616149075|FG009|Third Treatment|Protocol Violation|0|||
170493890|NCT03613649|616149076|FG010|Third Treatment|Protocol Violation|0|||
170493891|NCT03613649|616149077|FG011|Third Treatment|Protocol Violation|1|||
170493892|NCT03613649|616149066|FG000|Fourth Treatment|Protocol Violation|1|||
170493893|NCT03613649|616149067|FG001|Fourth Treatment|Protocol Violation|0|||
170493894|NCT03613649|616149068|FG002|Fourth Treatment|Protocol Violation|0|||
170493895|NCT03613649|616149069|FG003|Fourth Treatment|Protocol Violation|0|||
170493896|NCT03613649|616149070|FG004|Fourth Treatment|Protocol Violation|1|||
170493897|NCT03613649|616149071|FG005|Fourth Treatment|Protocol Violation|0|||
170493898|NCT03613649|616149072|FG006|Fourth Treatment|Protocol Violation|0|||
170493899|NCT03613649|616149073|FG007|Fourth Treatment|Protocol Violation|0|||
170493900|NCT03613649|616149074|FG008|Fourth Treatment|Protocol Violation|0|||
170493901|NCT03613649|616149075|FG009|Fourth Treatment|Protocol Violation|0|||
170493902|NCT03613649|616149076|FG010|Fourth Treatment|Protocol Violation|0|||
170493903|NCT03613649|616149077|FG011|Fourth Treatment|Protocol Violation|0|||
170493904|NCT03613649|616149066|FG000|Fourth Treatment|Physician Decision|0|||
170493905|NCT03613649|616149067|FG001|Fourth Treatment|Physician Decision|0|||
170493906|NCT03613649|616149068|FG002|Fourth Treatment|Physician Decision|0|||
170493907|NCT03613649|616149069|FG003|Fourth Treatment|Physician Decision|0|||
170493908|NCT03613649|616149070|FG004|Fourth Treatment|Physician Decision|0|||
170493909|NCT03613649|616149071|FG005|Fourth Treatment|Physician Decision|0|||
170493910|NCT03613649|616149072|FG006|Fourth Treatment|Physician Decision|1|||
170493911|NCT03613649|616149073|FG007|Fourth Treatment|Physician Decision|0|||
170493912|NCT03613649|616149074|FG008|Fourth Treatment|Physician Decision|0|||
170493913|NCT03613649|616149075|FG009|Fourth Treatment|Physician Decision|0|||
170493914|NCT03613649|616149076|FG010|Fourth Treatment|Physician Decision|0|||
170493915|NCT03613649|616149077|FG011|Fourth Treatment|Physician Decision|0|||
170493916|NCT00675428|616149078|FG000|Overall Study|Disease Progression|2|||
170493917|NCT00675428|616149079|FG001|Overall Study|Disease Progression|2|||
170493918|NCT00675428|616149078|FG000|Overall Study|No Disease Response After Cycle 6|0|||
170641380|NCT02834793|616699895|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
170641381|NCT02834793|616699896|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
170493919|NCT00675428|616149079|FG001|Overall Study|No Disease Response After Cycle 6|1|||
170641382|NCT02834793|616699897|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
170493920|NCT00675428|616149078|FG000|Overall Study|Physician Decision|1|||
170493921|NCT00675428|616149079|FG001|Overall Study|Physician Decision|0|||
170493922|NCT03482453|616149082|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493923|NCT03482453|616149083|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493924|NCT03482453|616149084|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493925|NCT03482453|616149085|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493926|NCT03482453|616149086|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493927|NCT03482453|616149087|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493928|NCT03482453|616149088|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493929|NCT03482453|616149089|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493930|NCT03482453|616149090|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493931|NCT03482453|616149091|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493932|NCT03482453|616149092|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
170493933|NCT03482453|616149093|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
170493934|NCT01186692|616149098|FG000|Overall Study|Not Catheterized|11|||
170493935|NCT01186692|616149098|FG000|Overall Study|Futher testing contraindicated implant|19|||
170493936|NCT01186692|616149098|FG000|Overall Study|Adverse Event|2|||
170493937|NCT00757042|616149102|FG000|Overall Study|Lost to Follow-up|0|||
170493938|NCT00757042|616149103|FG001|Overall Study|Lost to Follow-up|0|||
170493939|NCT00757042|616149104|FG002|Overall Study|Lost to Follow-up|0|||
170493940|NCT00757042|616149105|FG003|Overall Study|Lost to Follow-up|0|||
170493941|NCT00757042|616149106|FG004|Overall Study|Lost to Follow-up|0|||
170493942|NCT00757042|616149107|FG005|Overall Study|Lost to Follow-up|0|||
170493943|NCT00757042|616149108|FG006|Overall Study|Lost to Follow-up|0|||
170493944|NCT00757042|616149109|FG007|Overall Study|Lost to Follow-up|0|||
170493945|NCT00757042|616149110|FG008|Overall Study|Lost to Follow-up|1|||
170493946|NCT00757042|616149111|FG009|Overall Study|Lost to Follow-up|0|||
170493947|NCT00757042|616149112|FG010|Overall Study|Lost to Follow-up|0|||
170493948|NCT00757042|616149102|FG000|Overall Study|Ineligibility Determined|0|||
170493949|NCT00757042|616149103|FG001|Overall Study|Ineligibility Determined|0|||
170493950|NCT00757042|616149104|FG002|Overall Study|Ineligibility Determined|0|||
170493951|NCT00757042|616149105|FG003|Overall Study|Ineligibility Determined|0|||
170493952|NCT00757042|616149106|FG004|Overall Study|Ineligibility Determined|0|||
170493953|NCT00757042|616149107|FG005|Overall Study|Ineligibility Determined|0|||
170493954|NCT00757042|616149108|FG006|Overall Study|Ineligibility Determined|0|||
170493955|NCT00757042|616149109|FG007|Overall Study|Ineligibility Determined|0|||
170493956|NCT00757042|616149110|FG008|Overall Study|Ineligibility Determined|0|||
170493957|NCT00757042|616149111|FG009|Overall Study|Ineligibility Determined|0|||
170493958|NCT00757042|616149112|FG010|Overall Study|Ineligibility Determined|1|||
170493959|NCT00757042|616149102|FG000|Overall Study|Withdrawal by Subject|0|||
170493960|NCT00757042|616149103|FG001|Overall Study|Withdrawal by Subject|0|||
170493961|NCT00757042|616149104|FG002|Overall Study|Withdrawal by Subject|0|||
170493962|NCT00757042|616149105|FG003|Overall Study|Withdrawal by Subject|0|||
170493963|NCT00757042|616149106|FG004|Overall Study|Withdrawal by Subject|0|||
170493964|NCT00757042|616149107|FG005|Overall Study|Withdrawal by Subject|0|||
170493965|NCT00757042|616149108|FG006|Overall Study|Withdrawal by Subject|0|||
170493966|NCT00757042|616149109|FG007|Overall Study|Withdrawal by Subject|0|||
170493967|NCT00757042|616149110|FG008|Overall Study|Withdrawal by Subject|0|||
170493968|NCT00757042|616149111|FG009|Overall Study|Withdrawal by Subject|1|||
170493969|NCT00757042|616149112|FG010|Overall Study|Withdrawal by Subject|0|||
170493970|NCT03319732|616149113|FG000|Overall Study|Adverse Event|40|||
170493971|NCT03319732|616149113|FG000|Overall Study|Withdrawal by Subject|50|||
170493972|NCT03319732|616149113|FG000|Overall Study|MS relapse|10|||
170493973|NCT03319732|616149113|FG000|Overall Study|reason not specified|5|||
170493974|NCT02654977|616149114|FG000|Overall Study|Death|1|||
170493975|NCT02654977|616149114|FG000|Overall Study|Lost to Follow-up|1|||
170493976|NCT02654977|616149114|FG000|Overall Study|Adverse Event|1|||
170493977|NCT02654977|616149114|FG000|Overall Study|Withdrawal by Subject|1|||
170493978|NCT02654977|616149114|FG000|Overall Study|Lack of Efficacy|3|||
170493979|NCT00789698|616149116|FG000|Overall Study|Lack of Efficacy|10|||
170493980|NCT00789698|616149117|FG001|Overall Study|Lack of Efficacy|4|||
170493981|NCT00789698|616149118|FG002|Overall Study|Lack of Efficacy|5|||
170493982|NCT00789698|616149119|FG003|Overall Study|Lack of Efficacy|18|||
170493983|NCT00789698|616149116|FG000|Overall Study|Adverse Event|5|||
170493984|NCT00789698|616149117|FG001|Overall Study|Adverse Event|5|||
170493985|NCT00789698|616149118|FG002|Overall Study|Adverse Event|3|||
170550409|NCT03093870|616360526|FG001|Overall Study|Withdrawal by Subject|6|||
170550410|NCT03093870|616360527|FG002|Overall Study|Withdrawal by Subject|5|||
170550411|NCT03093870|616360525|FG000|Overall Study|Death|1|||
170550412|NCT03093870|616360526|FG001|Overall Study|Death|35|||
170801856|NCT00571649|617284929|FG001|Follow-up Period|Physician Decision|13|||
170801857|NCT00571649|617284928|FG000|Follow-up Period|Lost to Follow-up|95|||
170801858|NCT00571649|617284929|FG001|Follow-up Period|Lost to Follow-up|92|||
170801859|NCT00571649|617284928|FG000|Follow-up Period|Patient convenience|136|||
170801860|NCT00571649|617284929|FG001|Follow-up Period|Patient convenience|121|||
170493986|NCT00789698|616149119|FG003|Overall Study|Adverse Event|4|||
170493987|NCT00789698|616149116|FG000|Overall Study|Lost to Follow-up|5|||
170493988|NCT00789698|616149117|FG001|Overall Study|Lost to Follow-up|5|||
170493989|NCT00789698|616149118|FG002|Overall Study|Lost to Follow-up|2|||
170493990|NCT00789698|616149119|FG003|Overall Study|Lost to Follow-up|9|||
170801861|NCT00571649|617284928|FG000|Follow-up Period|Protocol Violation|5|||
170493991|NCT00789698|616149116|FG000|Overall Study|Protocol Violation|6|||
170493992|NCT00789698|616149117|FG001|Overall Study|Protocol Violation|1|||
170493993|NCT00789698|616149118|FG002|Overall Study|Protocol Violation|2|||
170801862|NCT00571649|617284929|FG001|Follow-up Period|Protocol Violation|12|||
170641383|NCT02834793|616699894|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
170641384|NCT02834793|616699895|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
170641385|NCT02834793|616699896|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
170493994|NCT00789698|616149119|FG003|Overall Study|Protocol Violation|1|||
170493995|NCT00789698|616149116|FG000|Overall Study|Withdrawal by Subject|14|||
170493996|NCT00789698|616149117|FG001|Overall Study|Withdrawal by Subject|15|||
170493997|NCT00789698|616149118|FG002|Overall Study|Withdrawal by Subject|12|||
170493998|NCT00789698|616149119|FG003|Overall Study|Withdrawal by Subject|19|||
170493999|NCT00789698|616149116|FG000|Overall Study|Administrative|0|||
170641386|NCT02834793|616699897|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
170900451|NCT02393209|617640127|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
170494000|NCT00789698|616149117|FG001|Overall Study|Administrative|3|||
170494001|NCT00789698|616149118|FG002|Overall Study|Administrative|3|||
170494002|NCT00789698|616149119|FG003|Overall Study|Administrative|1|||
170494003|NCT01921101|616149120|FG000|Overall Study|Death|16|||
170494004|NCT01921101|616149121|FG001|Overall Study|Death|6|||
170641387|NCT02834793|616699894|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
170641388|NCT02834793|616699895|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
170641389|NCT02834793|616699896|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
170641390|NCT02834793|616699897|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
170641391|NCT02834793|616699894|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
170641392|NCT02834793|616699895|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
170641393|NCT02834793|616699896|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
170641394|NCT02834793|616699897|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
170641395|NCT02834793|616699894|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
170641396|NCT02834793|616699895|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
170641397|NCT02834793|616699896|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
170641398|NCT02834793|616699897|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
170641399|NCT02834793|616699894|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
170641400|NCT02834793|616699895|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
170641401|NCT02834793|616699896|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
170641402|NCT02834793|616699897|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
170641403|NCT02834793|616699894|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
170641404|NCT02834793|616699895|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
170641405|NCT02834793|616699896|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
170641406|NCT02834793|616699897|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
170641407|NCT02834793|616699894|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
170641408|NCT02834793|616699895|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
170641409|NCT02834793|616699896|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
170641410|NCT02834793|616699897|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
170641411|NCT02834793|616699894|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
170641412|NCT02834793|616699895|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
170641413|NCT02834793|616699896|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
170641414|NCT02834793|616699897|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
170641415|NCT02834793|616699894|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
170641416|NCT02834793|616699895|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
170641417|NCT02834793|616699896|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
170641418|NCT02834793|616699897|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
170641419|NCT01022398|616699898|FG000|Overall Study|Study terminated|2|||
170641420|NCT01022398|616699899|FG001|Overall Study|Study terminated|2|||
170641421|NCT01317550|616699901|FG000|Overall Study|Withdrawal by Subject|1|||
170641422|NCT01317550|616699902|FG001|Overall Study|Withdrawal by Subject|0|||
170641423|NCT01317550|616699903|FG002|Overall Study|Withdrawal by Subject|0|||
170641424|NCT01317550|616699904|FG003|Overall Study|Withdrawal by Subject|0|||
170641425|NCT01317550|616699901|FG000|Overall Study|Lack of compliance study med|1|||
170641426|NCT01317550|616699902|FG001|Overall Study|Lack of compliance study med|0|||
170641427|NCT01317550|616699903|FG002|Overall Study|Lack of compliance study med|0|||
170641428|NCT01317550|616699904|FG003|Overall Study|Lack of compliance study med|0|||
170641429|NCT00344487|616699906|FG000|Overall Study|immunologic failure|1|||
170801863|NCT04191824|617284936|FG000|Overall Study|Death|13|||
170801864|NCT04191824|617284937|FG001|Overall Study|Death|12|||
170801865|NCT04191824|617284936|FG000|Overall Study|Lost to Follow-up|456|||
170801866|NCT04191824|617284937|FG001|Overall Study|Lost to Follow-up|435|||
170801867|NCT04191824|617284936|FG000|Overall Study|Physician Decision|2|||
170801868|NCT04191824|617284937|FG001|Overall Study|Physician Decision|1|||
170801869|NCT04191824|617284936|FG000|Overall Study|Protocol Violation|0|||
170801870|NCT04191824|617284937|FG001|Overall Study|Protocol Violation|2|||
170494005|NCT01870973|616149122|FG000|Overall Study|Lost to Follow-up|10|||
170801871|NCT04191824|617284936|FG000|Overall Study|Withdrawal by Subject|16|||
170494006|NCT01870973|616149123|FG001|Overall Study|Lost to Follow-up|3|||
170801872|NCT04191824|617284937|FG001|Overall Study|Withdrawal by Subject|18|||
170801873|NCT04191824|617284936|FG000|Overall Study|Early site closure|24|||
170494007|NCT01266291|616149125|FG000|Overall Study|Adverse Event|1|||
170494008|NCT02504827|616149126|FG000|Overall Study|Could not produce sputum|1|||
170494009|NCT00686829|616149127|FG000|Overall Study|Adverse Event|5|||
170494010|NCT00686829|616149127|FG000|Overall Study|Lack of Efficacy|6|||
170900452|NCT02393209|617640128|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
170900453|NCT02393209|617640129|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
170900454|NCT02393209|617640126|FG000|Overall Study|Lost to Follow-up|0|||
170900455|NCT02393209|617640127|FG001|Overall Study|Lost to Follow-up|1|||
170900456|NCT02393209|617640128|FG002|Overall Study|Lost to Follow-up|0|||
170900457|NCT02393209|617640129|FG003|Overall Study|Lost to Follow-up|0|||
170900458|NCT00727402|617640130|FG000|Overall Study|Physician Decision|116|||
170900459|NCT03545282|617640131|FG000|Overall Study|Lost to Follow-up|15|||
170900460|NCT03545282|617640132|FG001|Overall Study|Lost to Follow-up|10|||
170900461|NCT03545282|617640131|FG000|Overall Study|Withdrawal by Subject|2|||
170900462|NCT03545282|617640132|FG001|Overall Study|Withdrawal by Subject|2|||
170900463|NCT00929240|617640133|FG000|Initial Treatment Phase|Adverse Event|31|||
170900464|NCT00929240|617640134|FG001|Initial Treatment Phase|Adverse Event|0|||
170900465|NCT00929240|617640135|FG002|Initial Treatment Phase|Adverse Event|0|||
170900466|NCT00929240|617640133|FG000|Initial Treatment Phase|Disease progression|41|||
170494011|NCT00686829|616149127|FG000|Overall Study|Lost to Follow-up|4|||
170494012|NCT00686829|616149127|FG000|Overall Study|Withdrawal by Subject|14|||
170494013|NCT00686829|616149127|FG000|Overall Study|Protocol Violation|3|||
170494014|NCT00686829|616149127|FG000|Overall Study|Sponsor discontinued VCV|47|||
170494015|NCT00712543|616149128|FG000|Day 8-14|Lost to Follow-up|0|||
170494016|NCT00712543|616149129|FG001|Day 8-14|Lost to Follow-up|2|||
170494017|NCT02729051|616149130|FG000|Overall Study|Adverse Event|21|||
170494018|NCT02729051|616149131|FG001|Overall Study|Adverse Event|11|||
170550413|NCT03093870|616360527|FG002|Overall Study|Death|35|||
170550414|NCT03093870|616360525|FG000|Overall Study|Radiographic disease progression|10|||
170550415|NCT03093870|616360526|FG001|Overall Study|Radiographic disease progression|0|||
170550416|NCT03093870|616360527|FG002|Overall Study|Radiographic disease progression|0|||
170550417|NCT03093870|616360525|FG000|Overall Study|Clinical disease progression|1|||
170550418|NCT03093870|616360526|FG001|Overall Study|Clinical disease progression|0|||
170550419|NCT03093870|616360527|FG002|Overall Study|Clinical disease progression|0|||
170550420|NCT03093870|616360525|FG000|Overall Study|Physician Decision|2|||
170550421|NCT03093870|616360526|FG001|Overall Study|Physician Decision|0|||
170550422|NCT03093870|616360527|FG002|Overall Study|Physician Decision|0|||
170550423|NCT03093870|616360525|FG000|Overall Study|Adverse Event|7|||
170550424|NCT03093870|616360526|FG001|Overall Study|Adverse Event|0|||
170550425|NCT03093870|616360527|FG002|Overall Study|Adverse Event|0|||
170550426|NCT03093870|616360525|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
170550427|NCT03093870|616360526|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
170550428|NCT03093870|616360527|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
170550429|NCT03093870|616360525|FG000|Overall Study|Lost to Follow-up|0|||
170550430|NCT03093870|616360526|FG001|Overall Study|Lost to Follow-up|0|||
170550431|NCT03093870|616360527|FG002|Overall Study|Lost to Follow-up|1|||
170550432|NCT01392495|616360529|FG000|Overall Study|Death|3|||
170550433|NCT01392495|616360529|FG000|Overall Study|Administrative problems|8|||
170550434|NCT01392495|616360529|FG000|Overall Study|Withdrawal by Subject|2|||
170550435|NCT01392495|616360529|FG000|Overall Study|Adverse Event|3|||
170550436|NCT01309100|616360532|FG000|Overall Study|Protocol Violation|1|||
170550437|NCT01309100|616360532|FG000|Overall Study|Positive Slit lamp finding|1|||
170550438|NCT01452789|616360535|FG000|Overall Study|Withdrawal by Subject|3|||
170550439|NCT01452789|616360536|FG001|Overall Study|Withdrawal by Subject|2|||
170550440|NCT03722030|616360537|FG000|Overall Study|Withdrawal by Subject|1|||
170550441|NCT03722030|616360538|FG001|Overall Study|Withdrawal by Subject|0|||
170550442|NCT00736476|616360541|FG000|Overall Study|Adverse Event|1|||
170550443|NCT00736476|616360542|FG001|Overall Study|Adverse Event|0|||
170550444|NCT01370642|616360544|FG000|Overall Study|Adverse Event|2|||
170550445|NCT01370642|616360545|FG001|Overall Study|Adverse Event|1|||
170550446|NCT01370642|616360546|FG002|Overall Study|Adverse Event|1|||
170550447|NCT01370642|616360544|FG000|Overall Study|Detectable HCV RNA|0|||
170550448|NCT01370642|616360545|FG001|Overall Study|Detectable HCV RNA|0|||
170550449|NCT01370642|616360546|FG002|Overall Study|Detectable HCV RNA|22|||
170550450|NCT01370642|616360544|FG000|Overall Study|Lost to Follow-up|0|||
170550451|NCT01370642|616360545|FG001|Overall Study|Lost to Follow-up|0|||
170550452|NCT01370642|616360546|FG002|Overall Study|Lost to Follow-up|1|||
170550453|NCT01370642|616360544|FG000|Overall Study|Physician Decision|4|||
170550454|NCT01370642|616360545|FG001|Overall Study|Physician Decision|1|||
170550455|NCT01370642|616360546|FG002|Overall Study|Physician Decision|2|||
170550456|NCT01370642|616360544|FG000|Overall Study|Withdrawal by Subject|2|||
170550457|NCT01370642|616360545|FG001|Overall Study|Withdrawal by Subject|4|||
170550458|NCT01370642|616360546|FG002|Overall Study|Withdrawal by Subject|3|||
170550459|NCT02176525|616360548|FG000|Overall Study|Adverse Event|0|||
170494019|NCT02729051|616149130|FG000|Overall Study|Lack of Efficacy|1|||
170494020|NCT02729051|616149131|FG001|Overall Study|Lack of Efficacy|1|||
170494021|NCT02729051|616149130|FG000|Overall Study|Lost to Follow-up|1|||
170494022|NCT02729051|616149131|FG001|Overall Study|Lost to Follow-up|2|||
170494023|NCT02729051|616149130|FG000|Overall Study|Physician Decision|1|||
170494024|NCT02729051|616149131|FG001|Overall Study|Physician Decision|1|||
170494025|NCT02729051|616149130|FG000|Overall Study|Withdrawal by Subject|6|||
170494026|NCT02729051|616149131|FG001|Overall Study|Withdrawal by Subject|17|||
170494027|NCT04740827|616149132|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
170494028|NCT04740827|616149133|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
170494029|NCT04740827|616149132|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
170494030|NCT04740827|616149133|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
170494031|NCT04740827|616149132|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
170494032|NCT04740827|616149133|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
170494033|NCT04740827|616149132|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
170494034|NCT04740827|616149133|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
170494035|NCT04740827|616149132|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
170494036|NCT04740827|616149133|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
170494037|NCT04740827|616149132|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
170494038|NCT04740827|616149133|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
170494039|NCT00940823|616149135|FG000|Overall Study|Death|8|||
170494040|NCT00940823|616149136|FG001|Overall Study|Death|12|||
170494041|NCT00940823|616149135|FG000|Overall Study|Lost to Follow-up|27|||
170641430|NCT04158752|616699911|FG000|Overall Study|Adverse Event|1|||
170641431|NCT04158752|616699911|FG000|Overall Study|Withdrawal by Subject|1|||
170641432|NCT04976192|616699913|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641433|NCT04976192|616699914|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
170641434|NCT04976192|616699915|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641435|NCT04976192|616699916|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641436|NCT04976192|616699917|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641437|NCT04976192|616699918|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641438|NCT04976192|616699919|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641439|NCT04976192|616699920|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641440|NCT04976192|616699921|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641441|NCT04976192|616699922|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
170641442|NCT04976192|616699913|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
170641443|NCT04976192|616699914|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
170641444|NCT04976192|616699915|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
170641445|NCT04976192|616699916|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
170641446|NCT04976192|616699917|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641447|NCT04976192|616699918|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641448|NCT04976192|616699919|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641449|NCT04976192|616699920|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641450|NCT04976192|616699921|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641451|NCT04976192|616699922|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641452|NCT04976192|616699913|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
170494042|NCT00940823|616149136|FG001|Overall Study|Lost to Follow-up|20|||
170494043|NCT00596817|616149137|FG000|Open-label Period|Adverse Event|0|||
170494044|NCT00596817|616149138|FG001|Open-label Period|Adverse Event|49|||
170494045|NCT00596817|616149137|FG000|Open-label Period|Lack of Efficacy|0|||
170494046|NCT00596817|616149138|FG001|Open-label Period|Lack of Efficacy|33|||
170494047|NCT00596817|616149137|FG000|Open-label Period|Other Reasons|0|||
170494048|NCT00596817|616149138|FG001|Open-label Period|Other Reasons|65|||
170494049|NCT00596817|616149137|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
170494050|NCT00596817|616149138|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
170494051|NCT00596817|616149137|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
170494052|NCT00596817|616149138|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
170494053|NCT00596817|616149137|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
170494054|NCT00596817|616149138|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
170494055|NCT00596817|616149137|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
170494056|NCT00596817|616149138|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
170494057|NCT00596817|616149137|FG000|Double-blind Period|Adverse Event|5|||
170494058|NCT00596817|616149138|FG001|Double-blind Period|Adverse Event|16|||
170641453|NCT04976192|616699914|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
170641454|NCT04976192|616699915|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
170641455|NCT04976192|616699916|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
170641456|NCT04976192|616699917|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
170900467|NCT00929240|617640134|FG001|Initial Treatment Phase|Disease progression|0|||
170494059|NCT00596817|616149137|FG000|Double-blind Period|Lack of Efficacy|52|||
170494060|NCT00596817|616149138|FG001|Double-blind Period|Lack of Efficacy|28|||
170494061|NCT00596817|616149137|FG000|Double-blind Period|Non-compliance With Study Product|3|||
170641457|NCT04976192|616699918|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
170494062|NCT00596817|616149138|FG001|Double-blind Period|Non-compliance With Study Product|4|||
170494063|NCT00596817|616149137|FG000|Double-blind Period|Protocol Violation|11|||
170494064|NCT00596817|616149138|FG001|Double-blind Period|Protocol Violation|8|||
170494065|NCT00596817|616149137|FG000|Double-blind Period|Withdrawal of Consent|7|||
170641458|NCT04976192|616699919|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
170641459|NCT04976192|616699920|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
170641460|NCT04976192|616699921|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
170641461|NCT04976192|616699922|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
170641462|NCT04976192|616699913|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641463|NCT04976192|616699914|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641464|NCT04976192|616699915|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641465|NCT04976192|616699916|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170641466|NCT04976192|616699917|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
170641467|NCT04976192|616699918|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
170641468|NCT04976192|616699919|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
170641469|NCT04976192|616699920|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
170641470|NCT04976192|616699921|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
170641471|NCT04976192|616699922|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
170641472|NCT04976192|616699913|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641473|NCT04976192|616699914|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641474|NCT04976192|616699915|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641475|NCT04976192|616699916|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641476|NCT04976192|616699917|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
170641477|NCT04976192|616699918|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641478|NCT04976192|616699919|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641479|NCT04976192|616699920|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641480|NCT04976192|616699921|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641481|NCT04976192|616699922|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
170641482|NCT04976192|616699913|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641483|NCT04976192|616699914|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641484|NCT04976192|616699915|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641485|NCT04976192|616699916|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641486|NCT04976192|616699917|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641487|NCT04976192|616699918|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
170641488|NCT04976192|616699919|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641489|NCT04976192|616699920|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641490|NCT04976192|616699921|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641491|NCT04976192|616699922|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170641492|NCT03884101|616699923|FG000|Overall Study|Death|234|||
170641493|NCT03884101|616699924|FG001|Overall Study|Death|248|||
170641494|NCT03884101|616699923|FG000|Overall Study|Lost to Follow-up|1|||
170641495|NCT03884101|616699924|FG001|Overall Study|Lost to Follow-up|1|||
170641496|NCT03884101|616699923|FG000|Overall Study|Physician Decision|98|||
170641497|NCT03884101|616699924|FG001|Overall Study|Physician Decision|126|||
170641498|NCT03884101|616699923|FG000|Overall Study|Sponsor Decision|79|||
170641499|NCT03884101|616699924|FG001|Overall Study|Sponsor Decision|32|||
170641500|NCT03884101|616699923|FG000|Overall Study|Withdrawal by Subject|8|||
170641501|NCT03884101|616699924|FG001|Overall Study|Withdrawal by Subject|15|||
170641502|NCT01925131|616701265|FG000|Overall Study|Death|0|||
170641503|NCT01925131|616701266|FG001|Overall Study|Death|0|||
170641504|NCT01925131|616701267|FG002|Overall Study|Death|1|||
170641505|NCT01925131|616701268|FG003|Overall Study|Death|0|||
170641506|NCT01925131|616701269|FG004|Overall Study|Death|0|||
170641507|NCT01925131|616701270|FG005|Overall Study|Death|0|||
170641508|NCT01925131|616701265|FG000|Overall Study|Progression/Relapse|1|||
170641509|NCT01925131|616701266|FG001|Overall Study|Progression/Relapse|1|||
170641510|NCT01925131|616701267|FG002|Overall Study|Progression/Relapse|4|||
170641511|NCT01925131|616701268|FG003|Overall Study|Progression/Relapse|0|||
170641512|NCT01925131|616701269|FG004|Overall Study|Progression/Relapse|0|||
170641513|NCT01925131|616701270|FG005|Overall Study|Progression/Relapse|1|||
170641514|NCT01925131|616701265|FG000|Overall Study|Patient Refusal|1|||
170641515|NCT01925131|616701266|FG001|Overall Study|Patient Refusal|0|||
170641516|NCT01925131|616701267|FG002|Overall Study|Patient Refusal|0|||
170641517|NCT01925131|616701268|FG003|Overall Study|Patient Refusal|0|||
170641518|NCT01925131|616701269|FG004|Overall Study|Patient Refusal|0|||
170641519|NCT01925131|616701270|FG005|Overall Study|Patient Refusal|0|||
170641520|NCT01925131|616701265|FG000|Overall Study|Adverse Event|0|||
170641521|NCT01925131|616701266|FG001|Overall Study|Adverse Event|0|||
170641522|NCT01925131|616701267|FG002|Overall Study|Adverse Event|2|||
170641523|NCT01925131|616701268|FG003|Overall Study|Adverse Event|0|||
170641524|NCT01925131|616701269|FG004|Overall Study|Adverse Event|1|||
170641525|NCT01925131|616701270|FG005|Overall Study|Adverse Event|3|||
170641526|NCT01925131|616701265|FG000|Overall Study|Other - Not Protocol Specified|3|||
170641527|NCT01925131|616701266|FG001|Overall Study|Other - Not Protocol Specified|1|||
170641528|NCT01925131|616701267|FG002|Overall Study|Other - Not Protocol Specified|2|||
170641529|NCT01925131|616701268|FG003|Overall Study|Other - Not Protocol Specified|5|||
170641530|NCT01925131|616701269|FG004|Overall Study|Other - Not Protocol Specified|10|||
170641531|NCT01925131|616701270|FG005|Overall Study|Other - Not Protocol Specified|6|||
170641532|NCT01868542|616701271|FG000|Overall Study|Protocol Violation|0|||
170641533|NCT01868542|616701272|FG001|Overall Study|Protocol Violation|1|||
170641534|NCT01868542|616701271|FG000|Overall Study|Unclassified|0|||
170641535|NCT01868542|616701272|FG001|Overall Study|Unclassified|1|||
170641536|NCT00130247|616701273|FG000|Overall Study|Pregnancy|1|||
170641537|NCT00130247|616701274|FG001|Overall Study|Pregnancy|0|||
170641538|NCT00130247|616701273|FG000|Overall Study|Post-randomization exclusion|1|||
170641539|NCT00130247|616701274|FG001|Overall Study|Post-randomization exclusion|2|||
170641540|NCT00130247|616701273|FG000|Overall Study|Not compliant with DOT|0|||
170641541|NCT00130247|616701274|FG001|Overall Study|Not compliant with DOT|2|||
170641542|NCT01954927|616701275|FG000|Overall Study|Withdrawal by Subject|3|||
170641543|NCT01954927|616701276|FG001|Overall Study|Withdrawal by Subject|1|||
170641544|NCT00955305|616701277|FG000|Overall Study|Disease progression|39|||
170641545|NCT00955305|616701278|FG001|Overall Study|Disease progression|41|||
170641546|NCT00955305|616701277|FG000|Overall Study|Adverse Event|22|||
170641547|NCT00955305|616701278|FG001|Overall Study|Adverse Event|22|||
170641548|NCT00955305|616701277|FG000|Overall Study|Death|2|||
170641549|NCT00955305|616701278|FG001|Overall Study|Death|1|||
170641550|NCT00955305|616701277|FG000|Overall Study|Withdrawal by Subject|5|||
170641551|NCT00955305|616701278|FG001|Overall Study|Withdrawal by Subject|4|||
170641552|NCT00955305|616701277|FG000|Overall Study|Alternative therapy|4|||
170641553|NCT00955305|616701278|FG001|Overall Study|Alternative therapy|0|||
170641554|NCT00955305|616701277|FG000|Overall Study|Other complicating disease|2|||
170641555|NCT00955305|616701278|FG001|Overall Study|Other complicating disease|4|||
170494066|NCT00596817|616149138|FG001|Double-blind Period|Withdrawal of Consent|3|||
170494067|NCT00596817|616149137|FG000|Double-blind Period|Lost to Follow-up|0|||
170494068|NCT00596817|616149138|FG001|Double-blind Period|Lost to Follow-up|2|||
170494069|NCT00596817|616149137|FG000|Double-blind Period|Other Reasons|10|||
170494070|NCT00596817|616149138|FG001|Double-blind Period|Other Reasons|18|||
170494071|NCT01346189|616151932|FG000|Overall Study|Withdrawal by Subject|7|||
170494072|NCT01346189|616151933|FG001|Overall Study|Withdrawal by Subject|5|||
170494073|NCT01346189|616151934|FG002|Overall Study|Withdrawal by Subject|3|||
170494074|NCT01346189|616151935|FG003|Overall Study|Withdrawal by Subject|5|||
170494075|NCT01346189|616151932|FG000|Overall Study|Physician Decision|4|||
170494076|NCT01346189|616151933|FG001|Overall Study|Physician Decision|0|||
170494077|NCT01346189|616151934|FG002|Overall Study|Physician Decision|0|||
170494078|NCT01346189|616151935|FG003|Overall Study|Physician Decision|0|||
170494079|NCT01346189|616151932|FG000|Overall Study|Moved|3|||
170494080|NCT01346189|616151933|FG001|Overall Study|Moved|0|||
170494081|NCT01346189|616151934|FG002|Overall Study|Moved|4|||
170494082|NCT01346189|616151935|FG003|Overall Study|Moved|0|||
170494083|NCT01346189|616151932|FG000|Overall Study|Other|2|||
170494084|NCT01346189|616151933|FG001|Overall Study|Other|4|||
170494085|NCT01346189|616151934|FG002|Overall Study|Other|7|||
170494086|NCT01346189|616151935|FG003|Overall Study|Other|3|||
170494087|NCT01346189|616151932|FG000|Overall Study|Death|0|||
170494088|NCT01346189|616151933|FG001|Overall Study|Death|3|||
170494089|NCT01346189|616151934|FG002|Overall Study|Death|0|||
170641556|NCT00955305|616701277|FG000|Overall Study|Physician Decision|1|||
170641557|NCT00955305|616701278|FG001|Overall Study|Physician Decision|0|||
170641558|NCT00955305|616701277|FG000|Overall Study|Continued presence of residual disease|0|||
170494090|NCT01346189|616151935|FG003|Overall Study|Death|0|||
170494091|NCT01346189|616151932|FG000|Overall Study|Non-health system primary care physician|0|||
170494092|NCT01346189|616151933|FG001|Overall Study|Non-health system primary care physician|5|||
170494093|NCT01346189|616151934|FG002|Overall Study|Non-health system primary care physician|0|||
170494094|NCT01346189|616151935|FG003|Overall Study|Non-health system primary care physician|0|||
170494095|NCT01346189|616151932|FG000|Overall Study|Travel|0|||
170494096|NCT01346189|616151933|FG001|Overall Study|Travel|0|||
170494097|NCT01346189|616151934|FG002|Overall Study|Travel|0|||
170494098|NCT01346189|616151935|FG003|Overall Study|Travel|3|||
170494099|NCT02564900|616151936|FG000|Dose Escalation|Progressive disease per RECIST|2|||
170641559|NCT00955305|616701278|FG001|Overall Study|Continued presence of residual disease|1|||
170641560|NCT00955305|616701277|FG000|Overall Study|Functional decline|2|||
170641561|NCT00955305|616701278|FG001|Overall Study|Functional decline|0|||
170641562|NCT00955305|616701277|FG000|Overall Study|Maximum response achieved|0|||
170641563|NCT00955305|616701278|FG001|Overall Study|Maximum response achieved|1|||
170641564|NCT00955305|616701277|FG000|Overall Study|Lost to Follow-up|0|||
170641565|NCT00955305|616701278|FG001|Overall Study|Lost to Follow-up|1|||
170641566|NCT00955305|616701277|FG000|Overall Study|No off-treatment reason submitted|1|||
170641567|NCT00955305|616701278|FG001|Overall Study|No off-treatment reason submitted|0|||
170641568|NCT00955305|616701277|FG000|Overall Study|Never started protocol treatment|5|||
170494100|NCT02564900|616151937|FG001|Dose Escalation|Progressive disease per RECIST|3|||
170494101|NCT02564900|616151938|FG002|Dose Escalation|Progressive disease per RECIST|3|||
170494102|NCT02564900|616151939|FG003|Dose Escalation|Progressive disease per RECIST|3|||
170494103|NCT02564900|616151940|FG004|Dose Escalation|Progressive disease per RECIST|3|||
170494104|NCT02564900|616151941|FG005|Dose Escalation|Progressive disease per RECIST|1|||
170494105|NCT02564900|616151942|FG006|Dose Escalation|Progressive disease per RECIST|0|||
170494106|NCT02564900|616151943|FG007|Dose Escalation|Progressive disease per RECIST|0|||
170494107|NCT02564900|616151944|FG008|Dose Escalation|Progressive disease per RECIST|0|||
170494108|NCT02564900|616151945|FG009|Dose Escalation|Progressive disease per RECIST|0|||
170494109|NCT02564900|616151946|FG010|Dose Escalation|Progressive disease per RECIST|0|||
170494110|NCT02564900|616151947|FG011|Dose Escalation|Progressive disease per RECIST|0|||
170494111|NCT02564900|616151948|FG012|Dose Escalation|Progressive disease per RECIST|0|||
170494112|NCT02564900|616151949|FG013|Dose Escalation|Progressive disease per RECIST|0|||
170494113|NCT02564900|616151950|FG014|Dose Escalation|Progressive disease per RECIST|0|||
170494114|NCT02564900|616151936|FG000|Dose Escalation|Ongoing|1|||
170494115|NCT02564900|616151937|FG001|Dose Escalation|Ongoing|0|||
170494116|NCT02564900|616151938|FG002|Dose Escalation|Ongoing|0|||
170494117|NCT02564900|616151939|FG003|Dose Escalation|Ongoing|2|||
170494118|NCT02564900|616151940|FG004|Dose Escalation|Ongoing|2|||
170494119|NCT02564900|616151941|FG005|Dose Escalation|Ongoing|2|||
170494120|NCT02564900|616151942|FG006|Dose Escalation|Ongoing|0|||
170494121|NCT02564900|616151943|FG007|Dose Escalation|Ongoing|0|||
170494122|NCT02564900|616151944|FG008|Dose Escalation|Ongoing|0|||
170494123|NCT02564900|616151945|FG009|Dose Escalation|Ongoing|0|||
170494124|NCT02564900|616151946|FG010|Dose Escalation|Ongoing|0|||
170494125|NCT02564900|616151947|FG011|Dose Escalation|Ongoing|0|||
170494126|NCT02564900|616151948|FG012|Dose Escalation|Ongoing|0|||
170494127|NCT02564900|616151949|FG013|Dose Escalation|Ongoing|0|||
170494128|NCT02564900|616151950|FG014|Dose Escalation|Ongoing|0|||
170494129|NCT02564900|616151936|FG000|Dose Escalation|Adverse Event|0|||
170494130|NCT02564900|616151937|FG001|Dose Escalation|Adverse Event|0|||
170494131|NCT02564900|616151938|FG002|Dose Escalation|Adverse Event|0|||
170494132|NCT02564900|616151939|FG003|Dose Escalation|Adverse Event|1|||
170494133|NCT02564900|616151940|FG004|Dose Escalation|Adverse Event|1|||
170494134|NCT02564900|616151941|FG005|Dose Escalation|Adverse Event|3|||
170494135|NCT02564900|616151942|FG006|Dose Escalation|Adverse Event|0|||
170494136|NCT02564900|616151943|FG007|Dose Escalation|Adverse Event|0|||
170494137|NCT02564900|616151944|FG008|Dose Escalation|Adverse Event|0|||
170494138|NCT02564900|616151945|FG009|Dose Escalation|Adverse Event|0|||
170494139|NCT02564900|616151946|FG010|Dose Escalation|Adverse Event|0|||
170494140|NCT02564900|616151947|FG011|Dose Escalation|Adverse Event|0|||
170494141|NCT02564900|616151948|FG012|Dose Escalation|Adverse Event|0|||
170494142|NCT02564900|616151949|FG013|Dose Escalation|Adverse Event|0|||
170494143|NCT02564900|616151950|FG014|Dose Escalation|Adverse Event|0|||
170494144|NCT02564900|616151936|FG000|Dose Expansion|Progressive disease per RECIST|0|||
170494145|NCT02564900|616151937|FG001|Dose Expansion|Progressive disease per RECIST|0|||
170494146|NCT02564900|616151938|FG002|Dose Expansion|Progressive disease per RECIST|0|||
170494147|NCT02564900|616151939|FG003|Dose Expansion|Progressive disease per RECIST|0|||
170494148|NCT02564900|616151940|FG004|Dose Expansion|Progressive disease per RECIST|0|||
170494149|NCT02564900|616151941|FG005|Dose Expansion|Progressive disease per RECIST|0|||
170494150|NCT02564900|616151942|FG006|Dose Expansion|Progressive disease per RECIST|19|||
170494151|NCT02564900|616151943|FG007|Dose Expansion|Progressive disease per RECIST|17|||
170494152|NCT02564900|616151944|FG008|Dose Expansion|Progressive disease per RECIST|8|||
170494153|NCT02564900|616151945|FG009|Dose Expansion|Progressive disease per RECIST|16|||
170494154|NCT02564900|616151946|FG010|Dose Expansion|Progressive disease per RECIST|13|||
170494155|NCT02564900|616151947|FG011|Dose Expansion|Progressive disease per RECIST|19|||
170494156|NCT02564900|616151948|FG012|Dose Expansion|Progressive disease per RECIST|10|||
170494157|NCT02564900|616151949|FG013|Dose Expansion|Progressive disease per RECIST|13|||
170494158|NCT02564900|616151950|FG014|Dose Expansion|Progressive disease per RECIST|11|||
170494159|NCT02564900|616151936|FG000|Dose Expansion|Clinical progression|0|||
170494160|NCT02564900|616151937|FG001|Dose Expansion|Clinical progression|0|||
170494161|NCT02564900|616151938|FG002|Dose Expansion|Clinical progression|0|||
170494162|NCT02564900|616151939|FG003|Dose Expansion|Clinical progression|0|||
170494163|NCT02564900|616151940|FG004|Dose Expansion|Clinical progression|0|||
170494164|NCT02564900|616151941|FG005|Dose Expansion|Clinical progression|0|||
170550460|NCT02176525|616360549|FG001|Overall Study|Adverse Event|0|||
170550461|NCT02176525|616360550|FG002|Overall Study|Adverse Event|0|||
170550462|NCT02176525|616360551|FG003|Overall Study|Adverse Event|1|||
170550463|NCT02176525|616360552|FG004|Overall Study|Adverse Event|1|||
170494165|NCT02564900|616151942|FG006|Dose Expansion|Clinical progression|5|||
170494166|NCT02564900|616151943|FG007|Dose Expansion|Clinical progression|12|||
170494167|NCT02564900|616151944|FG008|Dose Expansion|Clinical progression|0|||
170494168|NCT02564900|616151945|FG009|Dose Expansion|Clinical progression|3|||
170494169|NCT02564900|616151946|FG010|Dose Expansion|Clinical progression|2|||
170494170|NCT02564900|616151947|FG011|Dose Expansion|Clinical progression|0|||
170494171|NCT02564900|616151948|FG012|Dose Expansion|Clinical progression|1|||
170550464|NCT02176525|616360553|FG005|Overall Study|Adverse Event|0|||
170494172|NCT02564900|616151949|FG013|Dose Expansion|Clinical progression|3|||
170494173|NCT02564900|616151950|FG014|Dose Expansion|Clinical progression|1|||
170494174|NCT02564900|616151936|FG000|Dose Expansion|Adverse Event|0|||
170494175|NCT02564900|616151937|FG001|Dose Expansion|Adverse Event|0|||
170494176|NCT02564900|616151938|FG002|Dose Expansion|Adverse Event|0|||
170494177|NCT02564900|616151939|FG003|Dose Expansion|Adverse Event|0|||
170494178|NCT02564900|616151940|FG004|Dose Expansion|Adverse Event|0|||
170494179|NCT02564900|616151941|FG005|Dose Expansion|Adverse Event|0|||
170494180|NCT02564900|616151942|FG006|Dose Expansion|Adverse Event|9|||
170494181|NCT02564900|616151943|FG007|Dose Expansion|Adverse Event|22|||
170494182|NCT02564900|616151944|FG008|Dose Expansion|Adverse Event|0|||
170494183|NCT02564900|616151945|FG009|Dose Expansion|Adverse Event|11|||
170494184|NCT02564900|616151946|FG010|Dose Expansion|Adverse Event|0|||
170494185|NCT02564900|616151947|FG011|Dose Expansion|Adverse Event|5|||
170494186|NCT02564900|616151948|FG012|Dose Expansion|Adverse Event|2|||
170494187|NCT02564900|616151949|FG013|Dose Expansion|Adverse Event|2|||
170494188|NCT02564900|616151950|FG014|Dose Expansion|Adverse Event|1|||
170494189|NCT02564900|616151936|FG000|Dose Expansion|Ongoing|0|||
170494190|NCT02564900|616151937|FG001|Dose Expansion|Ongoing|0|||
170494191|NCT02564900|616151938|FG002|Dose Expansion|Ongoing|0|||
170494192|NCT02564900|616151939|FG003|Dose Expansion|Ongoing|0|||
170494193|NCT02564900|616151940|FG004|Dose Expansion|Ongoing|0|||
170494194|NCT02564900|616151941|FG005|Dose Expansion|Ongoing|0|||
170494195|NCT02564900|616151942|FG006|Dose Expansion|Ongoing|9|||
170494196|NCT02564900|616151943|FG007|Dose Expansion|Ongoing|10|||
170494197|NCT02564900|616151944|FG008|Dose Expansion|Ongoing|11|||
170494198|NCT02564900|616151945|FG009|Dose Expansion|Ongoing|3|||
170494199|NCT02564900|616151946|FG010|Dose Expansion|Ongoing|0|||
170494200|NCT02564900|616151947|FG011|Dose Expansion|Ongoing|0|||
170494201|NCT02564900|616151948|FG012|Dose Expansion|Ongoing|4|||
170494202|NCT02564900|616151949|FG013|Dose Expansion|Ongoing|0|||
170494203|NCT02564900|616151950|FG014|Dose Expansion|Ongoing|6|||
170494204|NCT02564900|616151936|FG000|Dose Expansion|Death|0|||
170494205|NCT02564900|616151937|FG001|Dose Expansion|Death|0|||
170494206|NCT02564900|616151938|FG002|Dose Expansion|Death|0|||
170494207|NCT02564900|616151939|FG003|Dose Expansion|Death|0|||
170494208|NCT02564900|616151940|FG004|Dose Expansion|Death|0|||
170494209|NCT02564900|616151941|FG005|Dose Expansion|Death|0|||
170494210|NCT02564900|616151942|FG006|Dose Expansion|Death|1|||
170494211|NCT02564900|616151943|FG007|Dose Expansion|Death|0|||
170494212|NCT02564900|616151944|FG008|Dose Expansion|Death|0|||
170494213|NCT02564900|616151945|FG009|Dose Expansion|Death|0|||
170494214|NCT02564900|616151946|FG010|Dose Expansion|Death|1|||
170494215|NCT02564900|616151947|FG011|Dose Expansion|Death|0|||
170494216|NCT02564900|616151948|FG012|Dose Expansion|Death|1|||
170494217|NCT02564900|616151949|FG013|Dose Expansion|Death|1|||
170494218|NCT02564900|616151950|FG014|Dose Expansion|Death|0|||
170494219|NCT02564900|616151936|FG000|Dose Expansion|Withdrawal by Subject|0|||
170494220|NCT02564900|616151937|FG001|Dose Expansion|Withdrawal by Subject|0|||
170494221|NCT02564900|616151938|FG002|Dose Expansion|Withdrawal by Subject|0|||
170494222|NCT02564900|616151939|FG003|Dose Expansion|Withdrawal by Subject|0|||
170494223|NCT02564900|616151940|FG004|Dose Expansion|Withdrawal by Subject|0|||
170801874|NCT04191824|617284937|FG001|Overall Study|Early site closure|22|||
170801875|NCT00822120|617284938|FG000|Initial Registration|Adverse Event|1|||
170801876|NCT00822120|617284939|FG001|Initial Registration|Adverse Event|0|||
170801877|NCT00822120|617284940|FG002|Initial Registration|Adverse Event|0|||
170801878|NCT00822120|617284941|FG003|Initial Registration|Adverse Event|0|||
170801879|NCT00822120|617284942|FG004|Initial Registration|Adverse Event|0|||
170801880|NCT00822120|617284943|FG005|Initial Registration|Adverse Event|0|||
170801881|NCT00822120|617284938|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
170801882|NCT00822120|617284939|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
170801883|NCT00822120|617284940|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
170494224|NCT02564900|616151941|FG005|Dose Expansion|Withdrawal by Subject|0|||
170494225|NCT02564900|616151942|FG006|Dose Expansion|Withdrawal by Subject|4|||
170494226|NCT02564900|616151943|FG007|Dose Expansion|Withdrawal by Subject|0|||
170494227|NCT02564900|616151944|FG008|Dose Expansion|Withdrawal by Subject|0|||
170550465|NCT02176525|616360554|FG006|Overall Study|Adverse Event|1|||
170494228|NCT02564900|616151945|FG009|Dose Expansion|Withdrawal by Subject|0|||
170494229|NCT02564900|616151946|FG010|Dose Expansion|Withdrawal by Subject|1|||
170494230|NCT02564900|616151947|FG011|Dose Expansion|Withdrawal by Subject|0|||
170494231|NCT02564900|616151948|FG012|Dose Expansion|Withdrawal by Subject|0|||
170494232|NCT02564900|616151949|FG013|Dose Expansion|Withdrawal by Subject|1|||
170494233|NCT02564900|616151950|FG014|Dose Expansion|Withdrawal by Subject|1|||
170494234|NCT02564900|616151936|FG000|Dose Expansion|Other|0|||
170494235|NCT02564900|616151937|FG001|Dose Expansion|Other|0|||
170494236|NCT02564900|616151938|FG002|Dose Expansion|Other|0|||
170494237|NCT02564900|616151939|FG003|Dose Expansion|Other|0|||
170494238|NCT02564900|616151940|FG004|Dose Expansion|Other|0|||
170494239|NCT02564900|616151941|FG005|Dose Expansion|Other|0|||
170494240|NCT02564900|616151942|FG006|Dose Expansion|Other|1|||
170801884|NCT00822120|617284941|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
170550466|NCT02176525|616360555|FG007|Overall Study|Adverse Event|0|||
170550467|NCT02176525|616360548|FG000|Overall Study|not treated|1|||
170550468|NCT02176525|616360549|FG001|Overall Study|not treated|0|||
170550469|NCT02176525|616360550|FG002|Overall Study|not treated|0|||
170550470|NCT02176525|616360551|FG003|Overall Study|not treated|0|||
170550471|NCT02176525|616360552|FG004|Overall Study|not treated|0|||
170550472|NCT02176525|616360553|FG005|Overall Study|not treated|1|||
170550473|NCT02176525|616360554|FG006|Overall Study|not treated|0|||
170550474|NCT02176525|616360555|FG007|Overall Study|not treated|0|||
170550475|NCT02100644|616360558|FG000|LTG Escalation Phase|Adverse Event|9|||
170550476|NCT02100644|616360559|FG001|LTG Escalation Phase|Adverse Event|0|||
170550477|NCT02100644|616360560|FG002|LTG Escalation Phase|Adverse Event|0|||
170550478|NCT02100644|616360558|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
170550479|NCT02100644|616360559|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
170550480|NCT02100644|616360560|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
170550481|NCT02100644|616360558|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
170550482|NCT02100644|616360559|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
170550483|NCT02100644|616360560|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
170550484|NCT00468546|616360561|FG000|Week 24 Analysis|Lack of Efficacy|83|||
170550485|NCT00468546|616360562|FG001|Week 24 Analysis|Lack of Efficacy|37|||
170550486|NCT00468546|616360561|FG000|Week 24 Analysis|Refused treatment|5|||
170550487|NCT00468546|616360562|FG001|Week 24 Analysis|Refused treatment|5|||
170550488|NCT00468546|616360561|FG000|Week 24 Analysis|Adverse Event|1|||
170550489|NCT00468546|616360562|FG001|Week 24 Analysis|Adverse Event|8|||
170550490|NCT00468546|616360561|FG000|Week 24 Analysis|Failure to return|3|||
170550491|NCT00468546|616360562|FG001|Week 24 Analysis|Failure to return|4|||
170550492|NCT00468546|616360561|FG000|Week 24 Analysis|Rescue therapy|2|||
170550493|NCT00468546|616360562|FG001|Week 24 Analysis|Rescue therapy|0|||
170550494|NCT00468546|616360561|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
170550495|NCT00468546|616360562|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
170550496|NCT00468546|616360561|FG000|Week 24 Analysis|Due to clinical hold|1|||
170550497|NCT00468546|616360562|FG001|Week 24 Analysis|Due to clinical hold|0|||
170550498|NCT00468546|616360561|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
170550499|NCT00468546|616360562|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
170550500|NCT00468546|616360561|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
170550501|NCT00468546|616360562|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
170550502|NCT00468546|616360561|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
170550503|NCT00468546|616360562|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
170550504|NCT00468546|616360561|FG000|Week 24 to Week 104 Analysis|Death|1|||
170550505|NCT00468546|616360562|FG001|Week 24 to Week 104 Analysis|Death|0|||
170550506|NCT00468546|616360561|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
170550507|NCT00468546|616360562|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
170550508|NCT00468546|616360561|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
170550509|NCT00468546|616360562|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
170550510|NCT00468546|616360561|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
170550511|NCT00468546|616360562|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
170550512|NCT00468546|616360561|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
170550513|NCT00468546|616360562|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
170550514|NCT00468546|616360561|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
170550515|NCT00468546|616360562|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
170550516|NCT00468546|616360561|FG000|Week 24 to Week 104 Analysis|Other|17|||
170550517|NCT00468546|616360562|FG001|Week 24 to Week 104 Analysis|Other|14|||
170550518|NCT04000724|616360565|FG000|Overall Study|Withdrawal by Subject|5|||
170550519|NCT04000724|616360566|FG001|Overall Study|Withdrawal by Subject|3|||
170550520|NCT04000724|616360567|FG002|Overall Study|Withdrawal by Subject|4|||
170550521|NCT04000724|616360565|FG000|Overall Study|Lost to Follow-up|11|||
170550522|NCT04000724|616360566|FG001|Overall Study|Lost to Follow-up|7|||
170550523|NCT04000724|616360567|FG002|Overall Study|Lost to Follow-up|13|||
170550524|NCT00472641|616360568|FG000|Overall Study|Lack of Efficacy|3|||
170550525|NCT00472641|616360568|FG000|Overall Study|Adverse Event|3|||
170550526|NCT00472641|616360568|FG000|Overall Study|Lost to Follow-up|1|||
170550527|NCT02006654|616360569|FG000|Overall Study|Withdrawal before treatment|4|||
170550528|NCT02006654|616360570|FG001|Overall Study|Withdrawal before treatment|2|||
170550529|NCT02006654|616360569|FG000|Overall Study|Adverse Event|16|||
170550530|NCT02006654|616360570|FG001|Overall Study|Adverse Event|17|||
170550531|NCT02006654|616360569|FG000|Overall Study|Death|1|||
170550532|NCT02006654|616360570|FG001|Overall Study|Death|0|||
170550533|NCT02006654|616360569|FG000|Overall Study|Withdrawal by Subject|14|||
170550534|NCT02006654|616360570|FG001|Overall Study|Withdrawal by Subject|12|||
170550535|NCT02006654|616360569|FG000|Overall Study|Protocol Violation|5|||
170550536|NCT02006654|616360570|FG001|Overall Study|Protocol Violation|8|||
170550537|NCT02006654|616360569|FG000|Overall Study|Lost to Follow-up|1|||
170550538|NCT02006654|616360570|FG001|Overall Study|Lost to Follow-up|0|||
170550539|NCT02006654|616360569|FG000|Overall Study|patient's will|2|||
170550540|NCT02006654|616360570|FG001|Overall Study|patient's will|1|||
170494241|NCT02564900|616151943|FG007|Dose Expansion|Other|0|||
170641569|NCT00955305|616701278|FG001|Overall Study|Never started protocol treatment|5|||
170641570|NCT00955305|616701277|FG000|Overall Study|Ineligible|5|||
170641571|NCT00955305|616701278|FG001|Overall Study|Ineligible|7|||
170641572|NCT00109590|616701279|FG000|Overall Study|Lost to Follow-up|1|||
170494242|NCT02564900|616151944|FG008|Dose Expansion|Other|1|||
170494243|NCT02564900|616151945|FG009|Dose Expansion|Other|0|||
170494244|NCT02564900|616151946|FG010|Dose Expansion|Other|0|||
170494245|NCT02564900|616151947|FG011|Dose Expansion|Other|0|||
170641573|NCT00109590|616701280|FG001|Overall Study|Lost to Follow-up|0|||
170641574|NCT00109590|616701281|FG002|Overall Study|Lost to Follow-up|1|||
170641575|NCT00109590|616701279|FG000|Overall Study|Never Started Treatment|1|||
170641576|NCT00109590|616701280|FG001|Overall Study|Never Started Treatment|2|||
170641577|NCT00109590|616701281|FG002|Overall Study|Never Started Treatment|3|||
170641578|NCT01221285|616701282|FG000|Overall Study|Withdrawal by Subject|1|||
170641579|NCT00095940|616701298|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
170641580|NCT00095940|616701299|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
170641581|NCT00095940|616701300|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
170641582|NCT00095940|616701301|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
170641583|NCT00095940|616701302|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
170641584|NCT00095940|616701303|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
170641585|NCT00095940|616701304|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
170641586|NCT00095940|616701305|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
170641587|NCT00095940|616701306|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
170641588|NCT00095940|616701298|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
170641589|NCT00095940|616701299|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
170641590|NCT00095940|616701300|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
170641591|NCT00095940|616701301|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
170641592|NCT00095940|616701302|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
170641593|NCT00095940|616701303|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
170641594|NCT00095940|616701304|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
170641595|NCT00095940|616701305|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
170641596|NCT00095940|616701306|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
170641597|NCT00095940|616701298|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
170641598|NCT00095940|616701299|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
170641599|NCT00095940|616701300|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
170641600|NCT00095940|616701301|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
170494246|NCT02564900|616151948|FG012|Dose Expansion|Other|0|||
170494247|NCT02564900|616151949|FG013|Dose Expansion|Other|0|||
170494248|NCT02564900|616151950|FG014|Dose Expansion|Other|1|||
170494249|NCT02564900|616151936|FG000|Dose Expansion|Did not receive treatment|0|||
170494250|NCT02564900|616151937|FG001|Dose Expansion|Did not receive treatment|0|||
170494251|NCT02564900|616151938|FG002|Dose Expansion|Did not receive treatment|0|||
170494252|NCT02564900|616151939|FG003|Dose Expansion|Did not receive treatment|0|||
170494253|NCT02564900|616151940|FG004|Dose Expansion|Did not receive treatment|0|||
170494254|NCT02564900|616151941|FG005|Dose Expansion|Did not receive treatment|0|||
170494255|NCT02564900|616151942|FG006|Dose Expansion|Did not receive treatment|1|||
170494256|NCT02564900|616151943|FG007|Dose Expansion|Did not receive treatment|1|||
170494257|NCT02564900|616151944|FG008|Dose Expansion|Did not receive treatment|0|||
170550541|NCT02006654|616360569|FG000|Overall Study|insufficient compliance|1|||
170550542|NCT02006654|616360570|FG001|Overall Study|insufficient compliance|0|||
170550543|NCT02006654|616360569|FG000|Overall Study|worsening cognitive condition|0|||
170550544|NCT02006654|616360570|FG001|Overall Study|worsening cognitive condition|1|||
170550545|NCT02006654|616360569|FG000|Overall Study|faecal incontinence|0|||
170641601|NCT00095940|616701302|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
170641602|NCT00095940|616701303|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
170641603|NCT00095940|616701304|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
170641604|NCT00095940|616701305|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
170641605|NCT00095940|616701306|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
170641606|NCT03263702|616701308|FG000|Overall Study|Lost to Follow-up|2|||
170641607|NCT03263702|616701309|FG001|Overall Study|Lost to Follow-up|2|||
170641608|NCT03263702|616701308|FG000|Overall Study|Withdrawal by Subject|1|||
170641609|NCT03263702|616701309|FG001|Overall Study|Withdrawal by Subject|2|||
170641610|NCT00966875|616701310|FG000|Part A|Adverse Event|2|||
170494258|NCT02564900|616151945|FG009|Dose Expansion|Did not receive treatment|0|||
170550546|NCT02006654|616360570|FG001|Overall Study|faecal incontinence|1|||
170550547|NCT02006654|616360569|FG000|Overall Study|mood disorder|0|||
170494259|NCT02564900|616151946|FG010|Dose Expansion|Did not receive treatment|0|||
170494260|NCT02564900|616151947|FG011|Dose Expansion|Did not receive treatment|0|||
170494261|NCT02564900|616151948|FG012|Dose Expansion|Did not receive treatment|0|||
170494262|NCT02564900|616151949|FG013|Dose Expansion|Did not receive treatment|0|||
170494263|NCT02564900|616151950|FG014|Dose Expansion|Did not receive treatment|1|||
170494264|NCT04470544|616151951|FG000|Overall Study|Withdrawal by Subject|4|||
170550548|NCT02006654|616360570|FG001|Overall Study|mood disorder|1|||
170494265|NCT04470544|616151952|FG001|Overall Study|Withdrawal by Subject|6|||
170494266|NCT01680861|616151953|FG000|Early Post-transplant Period|Protocol Violation|1|||
170494267|NCT01680861|616151954|FG001|Early Post-transplant Period|Protocol Violation|1|||
170494268|NCT02005692|616151955|FG000|Overall Study|Protocol Violation|1|||
170494269|NCT02005692|616151955|FG000|Overall Study|Withdrawal by Subject|1|||
170494270|NCT02005692|616151955|FG000|Overall Study|Discharged earlier than anticipated|5|||
170494271|NCT01011465|616151956|FG000|Overall Study|Withdrawal by Subject|2|||
170494272|NCT01011465|616151957|FG001|Overall Study|Withdrawal by Subject|1|||
170494273|NCT01011465|616151958|FG002|Overall Study|Withdrawal by Subject|0|||
170494274|NCT01011465|616151959|FG003|Overall Study|Withdrawal by Subject|0|||
170494275|NCT01011465|616151960|FG004|Overall Study|Withdrawal by Subject|1|||
170494276|NCT01011465|616151961|FG005|Overall Study|Withdrawal by Subject|0|||
170494277|NCT01011465|616151962|FG006|Overall Study|Withdrawal by Subject|1|||
170494278|NCT01011465|616151963|FG007|Overall Study|Withdrawal by Subject|0|||
170494279|NCT02042950|616151964|FG000|Overall Study|Progressive Disease|4|||
170494280|NCT00723008|616151965|FG000|Enrollment|Lost to Follow-up|1|||
170550549|NCT02006654|616360569|FG000|Overall Study|disallowed medication|1|||
170550550|NCT02006654|616360570|FG001|Overall Study|disallowed medication|0|||
170550551|NCT02006654|616360569|FG000|Overall Study|moving out of state|0|||
170550552|NCT02006654|616360570|FG001|Overall Study|moving out of state|1|||
170550553|NCT00676689|616360573|FG000|Overall Study|Screen Failure|2|||
170550554|NCT00676689|616360573|FG000|Overall Study|Death|2|||
170550555|NCT00676689|616360573|FG000|Overall Study|Lost to Follow-up|4|||
170550556|NCT00676689|616360573|FG000|Overall Study|Physician Decision|1|||
170550557|NCT00676689|616360573|FG000|Overall Study|Withdrawal by Subject|3|||
170550558|NCT00676689|616360573|FG000|Overall Study|Continuing FU|49|||
170550559|NCT04128228|616360574|FG000|Overall Study|Withdrawal by Subject|3|||
170550560|NCT04128228|616360575|FG001|Overall Study|Withdrawal by Subject|3|||
170550561|NCT04128228|616360576|FG002|Overall Study|Withdrawal by Subject|0|||
170550562|NCT04128228|616360577|FG003|Overall Study|Withdrawal by Subject|0|||
170550563|NCT04128228|616360574|FG000|Overall Study|noncompliance|2|||
170550564|NCT04128228|616360575|FG001|Overall Study|noncompliance|2|||
170550565|NCT04128228|616360576|FG002|Overall Study|noncompliance|0|||
170550566|NCT04128228|616360577|FG003|Overall Study|noncompliance|0|||
170550567|NCT01016015|616360578|FG000|Overall Study|Not Treated|3|||
170550568|NCT01016015|616360578|FG000|Overall Study|Withdrawal by Subject|1|||
170550569|NCT01016015|616360578|FG000|Overall Study|Adverse Event|15|||
170550570|NCT02569242|616360579|FG000|Overall Study|Death|1|||
170550571|NCT02569242|616360580|FG001|Overall Study|Death|0|||
170550572|NCT02569242|616360579|FG000|Overall Study|Withdrawal by Subject|0|||
170550573|NCT02569242|616360580|FG001|Overall Study|Withdrawal by Subject|1|||
170550574|NCT00837330|616360581|FG000|Overall Study|Lost to Follow-up|1|||
170550575|NCT00837330|616360582|FG001|Overall Study|Lost to Follow-up|3|||
170550576|NCT03259308|616360583|FG000|Overall Study|Adverse Event|5|||
170550577|NCT03259308|616360584|FG001|Overall Study|Adverse Event|4|||
170550578|NCT03259308|616360585|FG002|Overall Study|Adverse Event|1|||
170550579|NCT03259308|616360583|FG000|Overall Study|Withdrawal by Subject|2|||
170550580|NCT03259308|616360584|FG001|Overall Study|Withdrawal by Subject|1|||
170550581|NCT03259308|616360585|FG002|Overall Study|Withdrawal by Subject|3|||
170550582|NCT03259308|616360583|FG000|Overall Study|Lost to Follow-up|0|||
170550583|NCT03259308|616360584|FG001|Overall Study|Lost to Follow-up|0|||
170550584|NCT03259308|616360585|FG002|Overall Study|Lost to Follow-up|1|||
170550585|NCT03259308|616360583|FG000|Overall Study|Pregnancy|0|||
170550586|NCT03259308|616360584|FG001|Overall Study|Pregnancy|0|||
170550587|NCT03259308|616360585|FG002|Overall Study|Pregnancy|1|||
170550588|NCT03259308|616360583|FG000|Overall Study|Protocol Deviation|0|||
170550589|NCT03259308|616360584|FG001|Overall Study|Protocol Deviation|3|||
170550590|NCT03259308|616360585|FG002|Overall Study|Protocol Deviation|0|||
170550591|NCT03259308|616360583|FG000|Overall Study|Lack of Efficacy|0|||
170550592|NCT03259308|616360584|FG001|Overall Study|Lack of Efficacy|0|||
170550593|NCT03259308|616360585|FG002|Overall Study|Lack of Efficacy|1|||
170550594|NCT00105508|616360586|FG000|Overall Study|Prephase Dropout|1|||
170550595|NCT00105508|616360587|FG001|Overall Study|Prephase Dropout|0|||
170550596|NCT00105508|616360586|FG000|Overall Study|Adverse Event|16|||
170550597|NCT00105508|616360587|FG001|Overall Study|Adverse Event|19|||
170550598|NCT00105508|616360586|FG000|Overall Study|Insufficient Efficacy|1|||
170641611|NCT00966875|616701311|FG001|Part A|Adverse Event|1|||
170494281|NCT00723008|616151966|FG001|Enrollment|Lost to Follow-up|0|||
170550599|NCT00105508|616360587|FG001|Overall Study|Insufficient Efficacy|0|||
170550600|NCT00105508|616360586|FG000|Overall Study|Withdrawal by Subject|10|||
170550601|NCT00105508|616360587|FG001|Overall Study|Withdrawal by Subject|6|||
170550602|NCT00105508|616360586|FG000|Overall Study|Lost to Follow-up|3|||
170550603|NCT00105508|616360587|FG001|Overall Study|Lost to Follow-up|0|||
170550604|NCT00105508|616360586|FG000|Overall Study|Protocol Violation|1|||
170550605|NCT00105508|616360587|FG001|Overall Study|Protocol Violation|2|||
170550606|NCT00105508|616360586|FG000|Overall Study|Other|8|||
170550607|NCT00105508|616360587|FG001|Overall Study|Other|9|||
170550608|NCT00120874|616360592|FG000|Overall Study|Death|0|||
170550609|NCT00120874|616360593|FG001|Overall Study|Death|1|||
170641612|NCT00966875|616701312|FG002|Part A|Adverse Event|0|||
170494282|NCT00723008|616151965|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
170494283|NCT00723008|616151966|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
170494284|NCT00723008|616151965|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
170494285|NCT00723008|616151966|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
170494286|NCT00723008|616151965|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
170494287|NCT00723008|616151966|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
170494288|NCT00723008|616151965|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
170494289|NCT00723008|616151966|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
170494290|NCT00723008|616151965|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
170494291|NCT00723008|616151966|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
170494292|NCT05896527|616151967|FG000|Overall Study|Withdrawal by Subject|11|||
170494293|NCT05896527|616151968|FG001|Overall Study|Withdrawal by Subject|10|||
170494294|NCT05896527|616151969|FG002|Overall Study|Withdrawal by Subject|4|||
170494295|NCT05896527|616151970|FG003|Overall Study|Withdrawal by Subject|3|||
170494296|NCT05896527|616151971|FG004|Overall Study|Withdrawal by Subject|2|||
170494297|NCT05896527|616151967|FG000|Overall Study|Lost to Follow-up|0|||
170494298|NCT05896527|616151968|FG001|Overall Study|Lost to Follow-up|2|||
170494299|NCT05896527|616151969|FG002|Overall Study|Lost to Follow-up|2|||
170494300|NCT05896527|616151970|FG003|Overall Study|Lost to Follow-up|2|||
170494301|NCT05896527|616151971|FG004|Overall Study|Lost to Follow-up|1|||
170494302|NCT05896527|616151967|FG000|Overall Study|Significant protocol noncompliance|0|||
170494303|NCT05896527|616151968|FG001|Overall Study|Significant protocol noncompliance|1|||
170494304|NCT05896527|616151969|FG002|Overall Study|Significant protocol noncompliance|0|||
170494305|NCT05896527|616151970|FG003|Overall Study|Significant protocol noncompliance|0|||
170494306|NCT05896527|616151971|FG004|Overall Study|Significant protocol noncompliance|0|||
170494307|NCT05896527|616151967|FG000|Overall Study|Eligibility criteria not met|1|||
170494308|NCT05896527|616151968|FG001|Overall Study|Eligibility criteria not met|0|||
170494309|NCT05896527|616151969|FG002|Overall Study|Eligibility criteria not met|0|||
170494310|NCT05896527|616151970|FG003|Overall Study|Eligibility criteria not met|0|||
170494311|NCT05896527|616151971|FG004|Overall Study|Eligibility criteria not met|0|||
170494312|NCT05896527|616151967|FG000|Overall Study|Sponsor's decision|0|||
170494313|NCT05896527|616151968|FG001|Overall Study|Sponsor's decision|0|||
170494314|NCT05896527|616151969|FG002|Overall Study|Sponsor's decision|0|||
170494315|NCT05896527|616151970|FG003|Overall Study|Sponsor's decision|1|||
170494316|NCT05896527|616151971|FG004|Overall Study|Sponsor's decision|0|||
170494317|NCT05896527|616151967|FG000|Overall Study|Investigator's decision|0|||
170494318|NCT05896527|616151968|FG001|Overall Study|Investigator's decision|1|||
170494319|NCT05896527|616151969|FG002|Overall Study|Investigator's decision|0|||
170494320|NCT05896527|616151970|FG003|Overall Study|Investigator's decision|0|||
170494321|NCT05896527|616151971|FG004|Overall Study|Investigator's decision|0|||
170494322|NCT05896527|616151967|FG000|Overall Study|Pregnancy of his partner|0|||
170494323|NCT05896527|616151968|FG001|Overall Study|Pregnancy of his partner|0|||
170494324|NCT05896527|616151969|FG002|Overall Study|Pregnancy of his partner|0|||
170494325|NCT05896527|616151970|FG003|Overall Study|Pregnancy of his partner|1|||
170494326|NCT05896527|616151971|FG004|Overall Study|Pregnancy of his partner|0|||
170494327|NCT00626821|616151977|FG000|Overall Study|Adverse Event|44|||
170494328|NCT00626821|616151977|FG000|Overall Study|Protocol Violation|33|||
170494329|NCT00626821|616151977|FG000|Overall Study|Withdrawal by Subject|10|||
170494330|NCT00626821|616151977|FG000|Overall Study|Physician Decision|9|||
170494331|NCT00626821|616151977|FG000|Overall Study|Product dysfunction|21|||
170494332|NCT00626821|616151977|FG000|Overall Study|other/unknown reason|104|||
170494333|NCT01940887|616151978|FG000|Year 1|Protocol Violation|0|||
170494334|NCT01940887|616151979|FG001|Year 1|Protocol Violation|1|||
170494335|NCT01940887|616151978|FG000|Year 1|Physician Decision|7|||
170494336|NCT01940887|616151979|FG001|Year 1|Physician Decision|3|||
170494337|NCT01940887|616151978|FG000|Year 1|Death|5|||
170494338|NCT01940887|616151979|FG001|Year 1|Death|3|||
170494339|NCT01940887|616151978|FG000|Year 1|Adverse Event|7|||
170494340|NCT01940887|616151979|FG001|Year 1|Adverse Event|6|||
170641613|NCT00966875|616701313|FG003|Part A|Adverse Event|1|||
170494341|NCT01940887|616151978|FG000|Year 1|Withdrawal by Subject|18|||
170494342|NCT01940887|616151979|FG001|Year 1|Withdrawal by Subject|9|||
170494343|NCT01940887|616151978|FG000|Year 1|Lost to Follow-up|2|||
170494344|NCT01940887|616151979|FG001|Year 1|Lost to Follow-up|1|||
170494345|NCT01940887|616151978|FG000|Year 2|Physician Decision|8|||
170494346|NCT01940887|616151979|FG001|Year 2|Physician Decision|1|||
170494347|NCT01940887|616151978|FG000|Year 2|Death|0|||
170641614|NCT00966875|616701314|FG004|Part A|Adverse Event|0|||
170641615|NCT00966875|616701315|FG005|Part A|Adverse Event|1|||
170494348|NCT01940887|616151979|FG001|Year 2|Death|2|||
170494349|NCT01940887|616151978|FG000|Year 2|Sponsor Decision, early termination|192|||
170494350|NCT01940887|616151979|FG001|Year 2|Sponsor Decision, early termination|203|||
170494351|NCT01940887|616151978|FG000|Year 2|Adverse Event|8|||
170494352|NCT01940887|616151979|FG001|Year 2|Adverse Event|2|||
170494353|NCT01940887|616151978|FG000|Year 2|Withdrawal by Subject|8|||
170494354|NCT01940887|616151979|FG001|Year 2|Withdrawal by Subject|8|||
170494355|NCT01940887|616151978|FG000|Year 2|Lost to Follow-up|1|||
170494356|NCT01940887|616151979|FG001|Year 2|Lost to Follow-up|6|||
170641616|NCT00966875|616701316|FG006|Part A|Adverse Event|0|||
170494357|NCT00090220|616151980|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
170494358|NCT00090220|616151981|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
170494359|NCT00090220|616151982|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
170494360|NCT00090220|616151983|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
170494361|NCT00090220|616151984|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
170494362|NCT00090220|616151985|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
170494363|NCT00090220|616151980|FG000|Base Study Vaccination Period|Adverse Event|6|||
170494364|NCT00090220|616151981|FG001|Base Study Vaccination Period|Adverse Event|1|||
170494365|NCT00090220|616151982|FG002|Base Study Vaccination Period|Adverse Event|0|||
170494366|NCT00090220|616151983|FG003|Base Study Vaccination Period|Adverse Event|0|||
170494367|NCT00090220|616151984|FG004|Base Study Vaccination Period|Adverse Event|0|||
170494368|NCT00090220|616151985|FG005|Base Study Vaccination Period|Adverse Event|0|||
170494369|NCT00090220|616151980|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
170494370|NCT00090220|616151981|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
170494371|NCT00090220|616151982|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
170494372|NCT00090220|616151983|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
170494373|NCT00090220|616151984|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
170494374|NCT00090220|616151985|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
170494375|NCT00090220|616151980|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
170494376|NCT00090220|616151981|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
170494377|NCT00090220|616151982|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
170494378|NCT00090220|616151983|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
170494379|NCT00090220|616151984|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
170494380|NCT00090220|616151985|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
170494381|NCT00090220|616151980|FG000|Base Study Vaccination Period|Patient Moved|6|||
170494382|NCT00090220|616151981|FG001|Base Study Vaccination Period|Patient Moved|2|||
170494383|NCT00090220|616151982|FG002|Base Study Vaccination Period|Patient Moved|0|||
170494384|NCT00090220|616151983|FG003|Base Study Vaccination Period|Patient Moved|0|||
170494385|NCT00090220|616151984|FG004|Base Study Vaccination Period|Patient Moved|0|||
170494386|NCT00090220|616151985|FG005|Base Study Vaccination Period|Patient Moved|0|||
170494387|NCT00090220|616151980|FG000|Base Study Vaccination Period|Other|4|||
170494388|NCT00090220|616151981|FG001|Base Study Vaccination Period|Other|4|||
170494389|NCT00090220|616151982|FG002|Base Study Vaccination Period|Other|0|||
170494390|NCT00090220|616151983|FG003|Base Study Vaccination Period|Other|0|||
170494391|NCT00090220|616151984|FG004|Base Study Vaccination Period|Other|0|||
170550610|NCT01108055|616360594|FG000|Overall Study|Ineligible|11|||
170550611|NCT01108055|616360594|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
170550612|NCT03339453|616360603|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
170550613|NCT03339453|616360604|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
170550614|NCT00362609|616360605|FG000|Overall Study|Withdrawal by Subject|0|||
170550615|NCT00362609|616360606|FG001|Overall Study|Withdrawal by Subject|1|||
170550616|NCT00362609|616360605|FG000|Overall Study|Protocol Violation|0|||
170801885|NCT00822120|617284942|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
170494392|NCT00090220|616151985|FG005|Base Study Vaccination Period|Other|0|||
170494393|NCT00090220|616151980|FG000|Base Study Follow-up Period|Adverse Event|6|||
170494394|NCT00090220|616151981|FG001|Base Study Follow-up Period|Adverse Event|1|||
170494395|NCT00090220|616151982|FG002|Base Study Follow-up Period|Adverse Event|0|||
170550617|NCT00362609|616360606|FG001|Overall Study|Protocol Violation|1|||
170550618|NCT01348490|616360609|FG000|Overall Study|Death|1|||
170550619|NCT01348490|616360609|FG000|Overall Study|Adverse Event|3|||
170550620|NCT01348490|616360609|FG000|Overall Study|Consent withdrawn|7|||
170494396|NCT00090220|616151983|FG003|Base Study Follow-up Period|Adverse Event|0|||
170494397|NCT00090220|616151984|FG004|Base Study Follow-up Period|Adverse Event|0|||
170494398|NCT00090220|616151985|FG005|Base Study Follow-up Period|Adverse Event|0|||
170550621|NCT01348490|616360609|FG000|Overall Study|Disease progression|3|||
170550622|NCT01348490|616360609|FG000|Overall Study|Lost to Follow-up|1|||
170550623|NCT01348490|616360609|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
170550624|NCT01348490|616360609|FG000|Overall Study|Other Unspecified|8|||
170550625|NCT03834883|616360611|FG000|Second Treatment|Withdrawal by Subject|1|||
170550626|NCT03834883|616360612|FG001|Second Treatment|Withdrawal by Subject|0|||
170550627|NCT03834883|616360613|FG002|Second Treatment|Withdrawal by Subject|0|||
170550628|NCT03834883|616360614|FG003|Second Treatment|Withdrawal by Subject|0|||
170550629|NCT03834883|616360611|FG000|Second Treatment|COVID-19 pandemic|1|||
170550630|NCT03834883|616360612|FG001|Second Treatment|COVID-19 pandemic|0|||
170550631|NCT03834883|616360613|FG002|Second Treatment|COVID-19 pandemic|1|||
170641617|NCT00966875|616701317|FG007|Part A|Adverse Event|3|||
170494399|NCT00090220|616151980|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
170494400|NCT00090220|616151981|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
170550632|NCT03834883|616360614|FG003|Second Treatment|COVID-19 pandemic|1|||
170550633|NCT01179399|616360615|FG000|Overall Study|Adverse Event|1|||
170550634|NCT01179399|616360615|FG000|Overall Study|Lack of Efficacy|30|||
170550635|NCT01179399|616360615|FG000|Overall Study|Withdrawal by Subject|1|||
170641618|NCT00966875|616701318|FG008|Part A|Adverse Event|3|||
170641619|NCT00966875|616701310|FG000|Part A|Entry Criteria|0|||
170641620|NCT00966875|616701311|FG001|Part A|Entry Criteria|0|||
170641621|NCT00966875|616701312|FG002|Part A|Entry Criteria|0|||
170641622|NCT00966875|616701313|FG003|Part A|Entry Criteria|0|||
170641623|NCT00966875|616701314|FG004|Part A|Entry Criteria|0|||
170641624|NCT00966875|616701315|FG005|Part A|Entry Criteria|2|||
170641625|NCT00966875|616701316|FG006|Part A|Entry Criteria|0|||
170641626|NCT00966875|616701317|FG007|Part A|Entry Criteria|0|||
170641627|NCT00966875|616701318|FG008|Part A|Entry Criteria|0|||
170641628|NCT00966875|616701310|FG000|Part A|Lack of Efficacy|0|||
170641629|NCT00966875|616701311|FG001|Part A|Lack of Efficacy|1|||
170641630|NCT00966875|616701312|FG002|Part A|Lack of Efficacy|0|||
170494401|NCT00090220|616151982|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
170494402|NCT00090220|616151983|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
170641631|NCT00966875|616701313|FG003|Part A|Lack of Efficacy|0|||
170641632|NCT00966875|616701314|FG004|Part A|Lack of Efficacy|0|||
170641633|NCT00966875|616701315|FG005|Part A|Lack of Efficacy|0|||
170641634|NCT00966875|616701316|FG006|Part A|Lack of Efficacy|4|||
170641635|NCT00966875|616701317|FG007|Part A|Lack of Efficacy|0|||
170641636|NCT00966875|616701318|FG008|Part A|Lack of Efficacy|0|||
170641637|NCT00966875|616701310|FG000|Part A|Lost to Follow-up|2|||
170641638|NCT00966875|616701311|FG001|Part A|Lost to Follow-up|0|||
170641639|NCT00966875|616701312|FG002|Part A|Lost to Follow-up|0|||
170641640|NCT00966875|616701313|FG003|Part A|Lost to Follow-up|0|||
170641641|NCT00966875|616701314|FG004|Part A|Lost to Follow-up|0|||
170641642|NCT00966875|616701315|FG005|Part A|Lost to Follow-up|1|||
170641643|NCT00966875|616701316|FG006|Part A|Lost to Follow-up|0|||
170641644|NCT00966875|616701317|FG007|Part A|Lost to Follow-up|0|||
170494403|NCT00090220|616151984|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
170494404|NCT00090220|616151985|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
170494405|NCT00090220|616151980|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
170494406|NCT00090220|616151981|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
170494407|NCT00090220|616151982|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
170494408|NCT00090220|616151983|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
170494409|NCT00090220|616151984|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
170494410|NCT00090220|616151985|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
170494411|NCT00090220|616151980|FG000|Base Study Follow-up Period|Patient Moved|20|||
170494412|NCT00090220|616151981|FG001|Base Study Follow-up Period|Patient Moved|28|||
170494413|NCT00090220|616151982|FG002|Base Study Follow-up Period|Patient Moved|0|||
170494414|NCT00090220|616151983|FG003|Base Study Follow-up Period|Patient Moved|0|||
170494415|NCT00090220|616151984|FG004|Base Study Follow-up Period|Patient Moved|0|||
170641645|NCT00966875|616701318|FG008|Part A|Lost to Follow-up|0|||
170641646|NCT00966875|616701310|FG000|Part A|Parent/Caregiver Decision|0|||
170641647|NCT00966875|616701311|FG001|Part A|Parent/Caregiver Decision|0|||
170641648|NCT00966875|616701312|FG002|Part A|Parent/Caregiver Decision|0|||
170641649|NCT00966875|616701313|FG003|Part A|Parent/Caregiver Decision|1|||
170641650|NCT00966875|616701314|FG004|Part A|Parent/Caregiver Decision|0|||
170641651|NCT00966875|616701315|FG005|Part A|Parent/Caregiver Decision|0|||
170494416|NCT00090220|616151985|FG005|Base Study Follow-up Period|Patient Moved|0|||
170494417|NCT00090220|616151980|FG000|Base Study Follow-up Period|Other|19|||
170494418|NCT00090220|616151981|FG001|Base Study Follow-up Period|Other|21|||
170494419|NCT00090220|616151982|FG002|Base Study Follow-up Period|Other|0|||
170494420|NCT00090220|616151983|FG003|Base Study Follow-up Period|Other|0|||
170494421|NCT00090220|616151984|FG004|Base Study Follow-up Period|Other|0|||
170494422|NCT00090220|616151985|FG005|Base Study Follow-up Period|Other|0|||
170494423|NCT00090220|616151980|FG000|Extension 1 (EXT1)|Adverse Event|0|||
170641652|NCT00966875|616701316|FG006|Part A|Parent/Caregiver Decision|0|||
170641653|NCT00966875|616701317|FG007|Part A|Parent/Caregiver Decision|0|||
170641654|NCT00966875|616701318|FG008|Part A|Parent/Caregiver Decision|0|||
170641655|NCT00966875|616701310|FG000|Part A|Physician Decision|0|||
170641656|NCT00966875|616701311|FG001|Part A|Physician Decision|0|||
170801886|NCT00822120|617284943|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
170494424|NCT00090220|616151981|FG001|Extension 1 (EXT1)|Adverse Event|0|||
170494425|NCT00090220|616151982|FG002|Extension 1 (EXT1)|Adverse Event|4|||
170494426|NCT00090220|616151983|FG003|Extension 1 (EXT1)|Adverse Event|0|||
170641657|NCT00966875|616701312|FG002|Part A|Physician Decision|0|||
170641658|NCT00966875|616701313|FG003|Part A|Physician Decision|0|||
170641659|NCT00966875|616701314|FG004|Part A|Physician Decision|1|||
170641660|NCT00966875|616701315|FG005|Part A|Physician Decision|0|||
170641661|NCT00966875|616701316|FG006|Part A|Physician Decision|1|||
170494427|NCT00090220|616151984|FG004|Extension 1 (EXT1)|Adverse Event|0|||
170641662|NCT00966875|616701317|FG007|Part A|Physician Decision|0|||
170641663|NCT00966875|616701318|FG008|Part A|Physician Decision|2|||
170641664|NCT00966875|616701310|FG000|Part A|Sponsor Decision|0|||
170641665|NCT00966875|616701311|FG001|Part A|Sponsor Decision|0|||
170641666|NCT00966875|616701312|FG002|Part A|Sponsor Decision|1|||
170641667|NCT00966875|616701313|FG003|Part A|Sponsor Decision|0|||
170641668|NCT00966875|616701314|FG004|Part A|Sponsor Decision|1|||
170641669|NCT00966875|616701315|FG005|Part A|Sponsor Decision|0|||
170641670|NCT00966875|616701316|FG006|Part A|Sponsor Decision|0|||
170641671|NCT00966875|616701317|FG007|Part A|Sponsor Decision|2|||
170494428|NCT00090220|616151985|FG005|Extension 1 (EXT1)|Adverse Event|0|||
170494429|NCT00090220|616151980|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
170494430|NCT00090220|616151981|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
170494431|NCT00090220|616151982|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
170494432|NCT00090220|616151983|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
170494433|NCT00090220|616151984|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
170494434|NCT00090220|616151985|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
170494435|NCT00090220|616151980|FG000|Extension 1 (EXT1)|Moved|0|||
170550636|NCT00286455|616360616|FG000|Overall Study|Hyperglycemia rescue|19|||
170550637|NCT00286455|616360617|FG001|Overall Study|Hyperglycemia rescue|13|||
170550638|NCT00286455|616360618|FG002|Overall Study|Hyperglycemia rescue|10|||
170550639|NCT00286455|616360616|FG000|Overall Study|Adverse Event|1|||
170550640|NCT00286455|616360617|FG001|Overall Study|Adverse Event|3|||
170494436|NCT00090220|616151981|FG001|Extension 1 (EXT1)|Moved|0|||
170494437|NCT00090220|616151982|FG002|Extension 1 (EXT1)|Moved|2|||
170494438|NCT00090220|616151983|FG003|Extension 1 (EXT1)|Moved|1|||
170494439|NCT00090220|616151984|FG004|Extension 1 (EXT1)|Moved|0|||
170494440|NCT00090220|616151985|FG005|Extension 1 (EXT1)|Moved|0|||
170494441|NCT00090220|616151980|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
170494442|NCT00090220|616151981|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
170494443|NCT00090220|616151982|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
170494444|NCT00090220|616151983|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
170494445|NCT00090220|616151984|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
170494446|NCT00090220|616151985|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
170494447|NCT00090220|616151980|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
170494448|NCT00090220|616151981|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
170494449|NCT00090220|616151982|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
170494450|NCT00090220|616151983|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
170494451|NCT00090220|616151984|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
170494452|NCT00090220|616151985|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
170494453|NCT00090220|616151980|FG000|Extension 1 (EXT1)|Other reason|0|||
170494454|NCT00090220|616151981|FG001|Extension 1 (EXT1)|Other reason|0|||
170494455|NCT00090220|616151982|FG002|Extension 1 (EXT1)|Other reason|2|||
170494456|NCT00090220|616151983|FG003|Extension 1 (EXT1)|Other reason|0|||
170494457|NCT00090220|616151984|FG004|Extension 1 (EXT1)|Other reason|0|||
170494458|NCT00090220|616151985|FG005|Extension 1 (EXT1)|Other reason|0|||
170494459|NCT00090220|616151980|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
170494460|NCT00090220|616151981|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
170494461|NCT00090220|616151982|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
170494462|NCT00090220|616151983|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
170494463|NCT00090220|616151984|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
170494464|NCT00090220|616151985|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
170494465|NCT00090220|616151980|FG000|Long-term Follow-up (EXT2)|Death|0|||
170494466|NCT00090220|616151981|FG001|Long-term Follow-up (EXT2)|Death|0|||
170494467|NCT00090220|616151982|FG002|Long-term Follow-up (EXT2)|Death|0|||
170494468|NCT00090220|616151983|FG003|Long-term Follow-up (EXT2)|Death|0|||
170494469|NCT00090220|616151984|FG004|Long-term Follow-up (EXT2)|Death|1|||
170494470|NCT00090220|616151985|FG005|Long-term Follow-up (EXT2)|Death|1|||
170494471|NCT00090220|616151980|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
170494472|NCT00090220|616151981|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
170494473|NCT00090220|616151982|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
170494474|NCT00090220|616151983|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
170494475|NCT00090220|616151984|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
170494476|NCT00090220|616151985|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
170494477|NCT00090220|616151980|FG000|Long-term Follow-up (EXT2)|Other|0|||
170494478|NCT00090220|616151981|FG001|Long-term Follow-up (EXT2)|Other|0|||
170494479|NCT00090220|616151982|FG002|Long-term Follow-up (EXT2)|Other|0|||
170494480|NCT00090220|616151983|FG003|Long-term Follow-up (EXT2)|Other|0|||
170550641|NCT00286455|616360618|FG002|Overall Study|Adverse Event|2|||
170550642|NCT00286455|616360616|FG000|Overall Study|Lost to Follow-up|0|||
170550643|NCT00286455|616360617|FG001|Overall Study|Lost to Follow-up|3|||
170550644|NCT00286455|616360618|FG002|Overall Study|Lost to Follow-up|3|||
170550645|NCT00286455|616360616|FG000|Overall Study|Physician Decision|3|||
170550646|NCT00286455|616360617|FG001|Overall Study|Physician Decision|0|||
170550647|NCT00286455|616360618|FG002|Overall Study|Physician Decision|2|||
170494481|NCT00090220|616151984|FG004|Long-term Follow-up (EXT2)|Other|1|||
170494482|NCT00090220|616151985|FG005|Long-term Follow-up (EXT2)|Other|0|||
170494483|NCT00941863|616151986|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
170494484|NCT00941863|616151987|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
170494485|NCT00941863|616151988|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
170494486|NCT00941863|616151989|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
170494487|NCT00941863|616151990|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
170494488|NCT00941863|616151986|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
170550648|NCT00286455|616360616|FG000|Overall Study|Protocol Violation|1|||
170550649|NCT00286455|616360617|FG001|Overall Study|Protocol Violation|1|||
170550650|NCT00286455|616360618|FG002|Overall Study|Protocol Violation|0|||
170550651|NCT00286455|616360616|FG000|Overall Study|Participant Non-compliance|1|||
170494489|NCT00941863|616151987|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
170494490|NCT00941863|616151988|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
170494491|NCT00941863|616151989|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
170494492|NCT00941863|616151990|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
170494493|NCT00941863|616151986|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
170494494|NCT00941863|616151987|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
170494495|NCT00941863|616151988|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
170494496|NCT00941863|616151989|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
170494497|NCT00941863|616151990|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
170494498|NCT00941863|616151986|FG000|Until Primary Completion Date (PCD)|Death|0|||
170641672|NCT00966875|616701318|FG008|Part A|Sponsor Decision|1|||
170494499|NCT00941863|616151987|FG001|Until Primary Completion Date (PCD)|Death|0|||
170494500|NCT00941863|616151988|FG002|Until Primary Completion Date (PCD)|Death|1|||
170494501|NCT00941863|616151989|FG003|Until Primary Completion Date (PCD)|Death|2|||
170494502|NCT00941863|616151990|FG004|Until Primary Completion Date (PCD)|Death|7|||
170494503|NCT00941863|616151986|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
170494504|NCT00941863|616151987|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
170494505|NCT00941863|616151988|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
170494506|NCT00941863|616151989|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
170494507|NCT00941863|616151990|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
170494508|NCT00941863|616151986|FG000|Continued After PCD|Withdrawal by Subject|0|||
170494509|NCT00941863|616151987|FG001|Continued After PCD|Withdrawal by Subject|0|||
170494510|NCT00941863|616151988|FG002|Continued After PCD|Withdrawal by Subject|0|||
170494511|NCT00941863|616151989|FG003|Continued After PCD|Withdrawal by Subject|0|||
170494512|NCT00941863|616151990|FG004|Continued After PCD|Withdrawal by Subject|1|||
170494513|NCT00941863|616151986|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
170494514|NCT00941863|616151987|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
170494515|NCT00941863|616151988|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
170494516|NCT00941863|616151989|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
170494517|NCT00941863|616151990|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
170494518|NCT01471340|616151994|FG000|Overall Study|Death|5|||
170494519|NCT01471340|616151995|FG001|Overall Study|Death|4|||
170494520|NCT01471340|616151994|FG000|Overall Study|Lost to Follow-up|0|||
170494521|NCT01471340|616151995|FG001|Overall Study|Lost to Follow-up|1|||
170494522|NCT01471340|616151994|FG000|Overall Study|Investigational site closure|0|||
170494523|NCT01471340|616151995|FG001|Overall Study|Investigational site closure|1|||
170494524|NCT01471340|616151994|FG000|Overall Study|Invalid informed consent|1|||
170494525|NCT01471340|616151995|FG001|Overall Study|Invalid informed consent|0|||
170494526|NCT02218736|616151997|FG000|Overall Study|Withdrawal by Subject|10|||
170494527|NCT02218736|616151998|FG001|Overall Study|Withdrawal by Subject|9|||
170494528|NCT02218736|616151997|FG000|Overall Study|Protocol Violation|2|||
170494529|NCT02218736|616151998|FG001|Overall Study|Protocol Violation|0|||
170494530|NCT04016779|616152005|FG000|Overall Study|Adverse Event|9|||
170494531|NCT04016779|616152006|FG001|Overall Study|Adverse Event|17|||
170494532|NCT04016779|616152005|FG000|Overall Study|Lack of Efficacy|4|||
170494533|NCT04016779|616152006|FG001|Overall Study|Lack of Efficacy|1|||
170494534|NCT04016779|616152005|FG000|Overall Study|Lost to Follow-up|5|||
170494535|NCT04016779|616152006|FG001|Overall Study|Lost to Follow-up|14|||
170494536|NCT04016779|616152005|FG000|Overall Study|Physician Decision|1|||
170494537|NCT04016779|616152006|FG001|Overall Study|Physician Decision|3|||
170494538|NCT04016779|616152005|FG000|Overall Study|Withdrawal by Subject|6|||
170494539|NCT04016779|616152006|FG001|Overall Study|Withdrawal by Subject|8|||
170494540|NCT04016779|616152005|FG000|Overall Study|Non-compliance with Study Drug|2|||
170494541|NCT04016779|616152006|FG001|Overall Study|Non-compliance with Study Drug|3|||
170494542|NCT04016779|616152005|FG000|Overall Study|Other, Multiple categories|17|||
170494543|NCT04016779|616152006|FG001|Overall Study|Other, Multiple categories|17|||
170494544|NCT00623935|616152010|FG000|Overall Study|Death|1|||
170494545|NCT00623935|616152010|FG000|Overall Study|Patient Declined Transplant|1|||
170641673|NCT00966875|616701310|FG000|Part A|Withdrawal by Subject|2|||
170641674|NCT00966875|616701311|FG001|Part A|Withdrawal by Subject|2|||
170494546|NCT02829723|616152011|FG000|Overall Study|Adverse Event|0|||
170641675|NCT00966875|616701312|FG002|Part A|Withdrawal by Subject|1|||
170641676|NCT00966875|616701313|FG003|Part A|Withdrawal by Subject|1|||
170641677|NCT00966875|616701314|FG004|Part A|Withdrawal by Subject|3|||
170494547|NCT02829723|616152012|FG001|Overall Study|Adverse Event|0|||
170494548|NCT02829723|616152013|FG002|Overall Study|Adverse Event|1|||
170494549|NCT02829723|616152014|FG003|Overall Study|Adverse Event|1|||
170494550|NCT02829723|616152015|FG004|Overall Study|Adverse Event|0|||
170494551|NCT02829723|616152016|FG005|Overall Study|Adverse Event|0|||
170494552|NCT02829723|616152017|FG006|Overall Study|Adverse Event|0|||
170641678|NCT00966875|616701315|FG005|Part A|Withdrawal by Subject|0|||
170641679|NCT00966875|616701316|FG006|Part A|Withdrawal by Subject|5|||
170494553|NCT02829723|616152018|FG007|Overall Study|Adverse Event|1|||
170494554|NCT02829723|616152019|FG008|Overall Study|Adverse Event|0|||
170494555|NCT02829723|616152020|FG009|Overall Study|Adverse Event|0|||
170494556|NCT02829723|616152021|FG010|Overall Study|Adverse Event|0|||
170494557|NCT02829723|616152022|FG011|Overall Study|Adverse Event|0|||
170494558|NCT02829723|616152023|FG012|Overall Study|Adverse Event|0|||
170494559|NCT02829723|616152024|FG013|Overall Study|Adverse Event|0|||
170494560|NCT02829723|616152025|FG014|Overall Study|Adverse Event|1|||
170494561|NCT02829723|616152026|FG015|Overall Study|Adverse Event|1|||
170494562|NCT02829723|616152027|FG016|Overall Study|Adverse Event|1|||
170494563|NCT02829723|616152028|FG017|Overall Study|Adverse Event|2|||
170494564|NCT02829723|616152029|FG018|Overall Study|Adverse Event|1|||
170494565|NCT02829723|616152030|FG019|Overall Study|Adverse Event|1|||
170494566|NCT02829723|616152031|FG020|Overall Study|Adverse Event|3|||
170494567|NCT02829723|616152032|FG021|Overall Study|Adverse Event|0|||
170494568|NCT02829723|616152033|FG022|Overall Study|Adverse Event|0|||
170494569|NCT02829723|616152034|FG023|Overall Study|Adverse Event|1|||
170494570|NCT02829723|616152035|FG024|Overall Study|Adverse Event|1|||
170494571|NCT02829723|616152036|FG025|Overall Study|Adverse Event|3|||
170494572|NCT02829723|616152037|FG026|Overall Study|Adverse Event|5|||
170494573|NCT02829723|616152011|FG000|Overall Study|Death|1|||
170494574|NCT02829723|616152012|FG001|Overall Study|Death|0|||
170494575|NCT02829723|616152013|FG002|Overall Study|Death|1|||
170494576|NCT02829723|616152014|FG003|Overall Study|Death|1|||
170494577|NCT02829723|616152015|FG004|Overall Study|Death|0|||
170494578|NCT02829723|616152016|FG005|Overall Study|Death|0|||
170494579|NCT02829723|616152017|FG006|Overall Study|Death|2|||
170494580|NCT02829723|616152018|FG007|Overall Study|Death|0|||
170494581|NCT02829723|616152019|FG008|Overall Study|Death|1|||
170641680|NCT00966875|616701317|FG007|Part A|Withdrawal by Subject|1|||
170641681|NCT00966875|616701318|FG008|Part A|Withdrawal by Subject|1|||
170494582|NCT02829723|616152020|FG009|Overall Study|Death|0|||
170494583|NCT02829723|616152021|FG010|Overall Study|Death|0|||
170494584|NCT02829723|616152022|FG011|Overall Study|Death|0|||
170494585|NCT02829723|616152023|FG012|Overall Study|Death|2|||
170494586|NCT02829723|616152024|FG013|Overall Study|Death|1|||
170641682|NCT00966875|616701310|FG000|Part A|Protocol Violation|0|||
170641683|NCT00966875|616701311|FG001|Part A|Protocol Violation|0|||
170641684|NCT00966875|616701312|FG002|Part A|Protocol Violation|0|||
170641685|NCT00966875|616701313|FG003|Part A|Protocol Violation|0|||
170641686|NCT00966875|616701314|FG004|Part A|Protocol Violation|0|||
170641687|NCT00966875|616701315|FG005|Part A|Protocol Violation|0|||
170641688|NCT00966875|616701316|FG006|Part A|Protocol Violation|2|||
170641689|NCT00966875|616701317|FG007|Part A|Protocol Violation|1|||
170641690|NCT00966875|616701318|FG008|Part A|Protocol Violation|1|||
170641691|NCT00966875|616701310|FG000|Part B|Adverse Event|0|||
170641692|NCT00966875|616701311|FG001|Part B|Adverse Event|1|||
170641693|NCT00966875|616701312|FG002|Part B|Adverse Event|1|||
170641694|NCT00966875|616701313|FG003|Part B|Adverse Event|0|||
170641695|NCT00966875|616701314|FG004|Part B|Adverse Event|1|||
170641696|NCT00966875|616701315|FG005|Part B|Adverse Event|0|||
170641697|NCT00966875|616701316|FG006|Part B|Adverse Event|5|||
170641698|NCT00966875|616701317|FG007|Part B|Adverse Event|2|||
170641699|NCT00966875|616701318|FG008|Part B|Adverse Event|2|||
170494587|NCT02829723|616152025|FG014|Overall Study|Death|0|||
170550652|NCT00286455|616360617|FG001|Overall Study|Participant Non-compliance|0|||
170550653|NCT00286455|616360618|FG002|Overall Study|Participant Non-compliance|0|||
170550654|NCT00286455|616360616|FG000|Overall Study|Withdrawal by Subject|0|||
170550655|NCT00286455|616360617|FG001|Overall Study|Withdrawal by Subject|8|||
170550656|NCT00286455|616360618|FG002|Overall Study|Withdrawal by Subject|7|||
170550657|NCT02487199|616360619|FG000|Overall Study|Withdrew Consent|0|||
170550658|NCT02487199|616360620|FG001|Overall Study|Withdrew Consent|1|||
170550659|NCT03738215|616360621|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
170550660|NCT03738215|616360622|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
170550661|NCT03738215|616360623|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
170550662|NCT03738215|616360621|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
170550663|NCT03738215|616360622|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
170641700|NCT00966875|616701310|FG000|Part B|Death|0|||
170641701|NCT00966875|616701311|FG001|Part B|Death|0|||
170494588|NCT02829723|616152026|FG015|Overall Study|Death|0|||
170494589|NCT02829723|616152027|FG016|Overall Study|Death|0|||
170494590|NCT02829723|616152028|FG017|Overall Study|Death|0|||
170494591|NCT02829723|616152029|FG018|Overall Study|Death|0|||
170494592|NCT02829723|616152030|FG019|Overall Study|Death|0|||
170641702|NCT00966875|616701312|FG002|Part B|Death|1|||
170641703|NCT00966875|616701313|FG003|Part B|Death|0|||
170641704|NCT00966875|616701314|FG004|Part B|Death|0|||
170494593|NCT02829723|616152031|FG020|Overall Study|Death|0|||
170494594|NCT02829723|616152032|FG021|Overall Study|Death|2|||
170494595|NCT02829723|616152033|FG022|Overall Study|Death|0|||
170494596|NCT02829723|616152034|FG023|Overall Study|Death|0|||
170641705|NCT00966875|616701315|FG005|Part B|Death|0|||
170641706|NCT00966875|616701316|FG006|Part B|Death|0|||
170641707|NCT00966875|616701317|FG007|Part B|Death|1|||
170641708|NCT00966875|616701318|FG008|Part B|Death|0|||
170641709|NCT00966875|616701310|FG000|Part B|Lack of Efficacy|2|||
170641710|NCT00966875|616701311|FG001|Part B|Lack of Efficacy|1|||
170641711|NCT00966875|616701312|FG002|Part B|Lack of Efficacy|1|||
170641712|NCT00966875|616701313|FG003|Part B|Lack of Efficacy|1|||
170641713|NCT00966875|616701314|FG004|Part B|Lack of Efficacy|2|||
170641714|NCT00966875|616701315|FG005|Part B|Lack of Efficacy|3|||
170641715|NCT00966875|616701316|FG006|Part B|Lack of Efficacy|12|||
170641716|NCT00966875|616701317|FG007|Part B|Lack of Efficacy|9|||
170641717|NCT00966875|616701318|FG008|Part B|Lack of Efficacy|6|||
170641718|NCT00966875|616701310|FG000|Part B|Lost to Follow-up|0|||
170641719|NCT00966875|616701311|FG001|Part B|Lost to Follow-up|0|||
170641720|NCT00966875|616701312|FG002|Part B|Lost to Follow-up|0|||
170641721|NCT00966875|616701313|FG003|Part B|Lost to Follow-up|1|||
170641722|NCT00966875|616701314|FG004|Part B|Lost to Follow-up|0|||
170641723|NCT00966875|616701315|FG005|Part B|Lost to Follow-up|0|||
170641724|NCT00966875|616701316|FG006|Part B|Lost to Follow-up|0|||
170641725|NCT00966875|616701317|FG007|Part B|Lost to Follow-up|0|||
170641726|NCT00966875|616701318|FG008|Part B|Lost to Follow-up|1|||
170641727|NCT00966875|616701310|FG000|Part B|Physician Decision|0|||
170641728|NCT00966875|616701311|FG001|Part B|Physician Decision|0|||
170641729|NCT00966875|616701312|FG002|Part B|Physician Decision|1|||
170641730|NCT00966875|616701313|FG003|Part B|Physician Decision|0|||
170641731|NCT00966875|616701314|FG004|Part B|Physician Decision|2|||
170641732|NCT00966875|616701315|FG005|Part B|Physician Decision|1|||
170641733|NCT00966875|616701316|FG006|Part B|Physician Decision|0|||
170641734|NCT00966875|616701317|FG007|Part B|Physician Decision|0|||
170641735|NCT00966875|616701318|FG008|Part B|Physician Decision|2|||
170641736|NCT00966875|616701310|FG000|Part B|Sponsor Decision|1|||
170641737|NCT00966875|616701311|FG001|Part B|Sponsor Decision|0|||
170641738|NCT00966875|616701312|FG002|Part B|Sponsor Decision|0|||
170641739|NCT00966875|616701313|FG003|Part B|Sponsor Decision|0|||
170641740|NCT00966875|616701314|FG004|Part B|Sponsor Decision|0|||
170641741|NCT00966875|616701315|FG005|Part B|Sponsor Decision|1|||
170641742|NCT00966875|616701316|FG006|Part B|Sponsor Decision|0|||
170641743|NCT00966875|616701317|FG007|Part B|Sponsor Decision|2|||
170641744|NCT00966875|616701318|FG008|Part B|Sponsor Decision|1|||
170641745|NCT00966875|616701310|FG000|Part B|Withdrawal by Subject|2|||
170641746|NCT00966875|616701311|FG001|Part B|Withdrawal by Subject|1|||
170641747|NCT00966875|616701312|FG002|Part B|Withdrawal by Subject|2|||
170641748|NCT00966875|616701313|FG003|Part B|Withdrawal by Subject|1|||
170641749|NCT00966875|616701314|FG004|Part B|Withdrawal by Subject|2|||
170641750|NCT00966875|616701315|FG005|Part B|Withdrawal by Subject|1|||
170641751|NCT00966875|616701316|FG006|Part B|Withdrawal by Subject|4|||
170641752|NCT00966875|616701317|FG007|Part B|Withdrawal by Subject|5|||
170641753|NCT00966875|616701318|FG008|Part B|Withdrawal by Subject|5|||
170641754|NCT00966875|616701310|FG000|Part B|Entry Criteria|0|||
170641755|NCT00966875|616701311|FG001|Part B|Entry Criteria|0|||
170641756|NCT00966875|616701312|FG002|Part B|Entry Criteria|0|||
170641757|NCT00966875|616701313|FG003|Part B|Entry Criteria|0|||
170641758|NCT00966875|616701314|FG004|Part B|Entry Criteria|0|||
170641759|NCT00966875|616701315|FG005|Part B|Entry Criteria|0|||
170641760|NCT00966875|616701316|FG006|Part B|Entry Criteria|1|||
170641761|NCT00966875|616701317|FG007|Part B|Entry Criteria|0|||
170641762|NCT00966875|616701318|FG008|Part B|Entry Criteria|1|||
170641763|NCT01731938|616701319|FG000|Preliminary Part I|Withdrawal by Subject|2|||
170641764|NCT01731938|616701320|FG001|Preliminary Part I|Withdrawal by Subject|2|||
170641765|NCT01731938|616701319|FG000|Preliminary Part I|Physician Decision|1|||
170641766|NCT01731938|616701320|FG001|Preliminary Part I|Physician Decision|0|||
170641767|NCT01731938|616701319|FG000|Preliminary Part I|Lost to Follow-up|0|||
170641768|NCT01731938|616701320|FG001|Preliminary Part I|Lost to Follow-up|3|||
170641769|NCT01731938|616701319|FG000|Preliminary Part I|Missed Week 6 visit|0|||
170641770|NCT01731938|616701320|FG001|Preliminary Part I|Missed Week 6 visit|3|||
170641771|NCT01731938|616701319|FG000|Primary Part II|Withdrawal by Subject|5|||
170641772|NCT01731938|616701320|FG001|Primary Part II|Withdrawal by Subject|4|||
170641773|NCT01731938|616701319|FG000|Primary Part II|Lost to Follow-up|4|||
170494597|NCT02829723|616152035|FG024|Overall Study|Death|0|||
170641774|NCT01731938|616701320|FG001|Primary Part II|Lost to Follow-up|5|||
170641775|NCT01731938|616701319|FG000|Primary Part II|Death|2|||
170641776|NCT01731938|616701320|FG001|Primary Part II|Death|1|||
170641777|NCT01731938|616701319|FG000|Primary Part II|Missed Week 6 visit|2|||
170641778|NCT01731938|616701320|FG001|Primary Part II|Missed Week 6 visit|3|||
170641779|NCT02969408|616701321|FG000|Overall Study|Adverse Event|2|||
170641780|NCT02969408|616701321|FG000|Overall Study|Withdrawal by Subject|8|||
170641781|NCT02969408|616701321|FG000|Overall Study|Lost to Follow-up|4|||
170641782|NCT02969408|616701321|FG000|Overall Study|Protocol Violation|1|||
170641783|NCT02969408|616701321|FG000|Overall Study|Other than specified|1|||
170641784|NCT02888119|616701323|FG000|Overall Study|Lost to Follow-up|5|||
170641785|NCT02888119|616701324|FG001|Overall Study|Lost to Follow-up|4|||
170641786|NCT02888119|616701325|FG002|Overall Study|Lost to Follow-up|0|||
170641787|NCT03206788|616701326|FG000|Overall Study|Withdrawal by Subject|0|||
170641788|NCT03206788|616701327|FG001|Overall Study|Withdrawal by Subject|1|||
170641789|NCT03206788|616701326|FG000|Overall Study|Adverse Event|0|||
170641790|NCT03206788|616701327|FG001|Overall Study|Adverse Event|1|||
170641791|NCT03206788|616701326|FG000|Overall Study|Physician Decision|0|||
170641792|NCT03206788|616701327|FG001|Overall Study|Physician Decision|1|||
170494598|NCT02829723|616152036|FG025|Overall Study|Death|1|||
170494599|NCT02829723|616152037|FG026|Overall Study|Death|2|||
170494600|NCT02829723|616152011|FG000|Overall Study|Physician Decision|0|||
170494601|NCT02829723|616152012|FG001|Overall Study|Physician Decision|0|||
170494602|NCT02829723|616152013|FG002|Overall Study|Physician Decision|0|||
170494603|NCT02829723|616152014|FG003|Overall Study|Physician Decision|0|||
170494604|NCT02829723|616152015|FG004|Overall Study|Physician Decision|0|||
170494605|NCT02829723|616152016|FG005|Overall Study|Physician Decision|0|||
170494606|NCT02829723|616152017|FG006|Overall Study|Physician Decision|0|||
170494607|NCT02829723|616152018|FG007|Overall Study|Physician Decision|0|||
170494608|NCT02829723|616152019|FG008|Overall Study|Physician Decision|0|||
170494609|NCT02829723|616152020|FG009|Overall Study|Physician Decision|1|||
170494610|NCT02829723|616152021|FG010|Overall Study|Physician Decision|1|||
170494611|NCT02829723|616152022|FG011|Overall Study|Physician Decision|0|||
170494612|NCT02829723|616152023|FG012|Overall Study|Physician Decision|0|||
170494613|NCT02829723|616152024|FG013|Overall Study|Physician Decision|1|||
170494614|NCT02829723|616152025|FG014|Overall Study|Physician Decision|0|||
170801887|NCT00822120|617284938|FG000|Initial Registration|Reasons not Protocol Specified|2|||
170801888|NCT00822120|617284939|FG001|Initial Registration|Reasons not Protocol Specified|0|||
170801889|NCT00822120|617284940|FG002|Initial Registration|Reasons not Protocol Specified|0|||
170801890|NCT00822120|617284941|FG003|Initial Registration|Reasons not Protocol Specified|0|||
170801891|NCT00822120|617284942|FG004|Initial Registration|Reasons not Protocol Specified|0|||
170494615|NCT02829723|616152026|FG015|Overall Study|Physician Decision|0|||
170494616|NCT02829723|616152027|FG016|Overall Study|Physician Decision|2|||
170494617|NCT02829723|616152028|FG017|Overall Study|Physician Decision|0|||
170494618|NCT02829723|616152029|FG018|Overall Study|Physician Decision|0|||
170494619|NCT02829723|616152030|FG019|Overall Study|Physician Decision|0|||
170494620|NCT02829723|616152031|FG020|Overall Study|Physician Decision|0|||
170494621|NCT02829723|616152032|FG021|Overall Study|Physician Decision|0|||
170494622|NCT02829723|616152033|FG022|Overall Study|Physician Decision|1|||
170494623|NCT02829723|616152034|FG023|Overall Study|Physician Decision|1|||
170494624|NCT02829723|616152035|FG024|Overall Study|Physician Decision|1|||
170494625|NCT02829723|616152036|FG025|Overall Study|Physician Decision|1|||
170494626|NCT02829723|616152037|FG026|Overall Study|Physician Decision|3|||
170494627|NCT02829723|616152011|FG000|Overall Study|Progressive disease|4|||
170494628|NCT02829723|616152012|FG001|Overall Study|Progressive disease|6|||
170494629|NCT02829723|616152013|FG002|Overall Study|Progressive disease|3|||
170494630|NCT02829723|616152014|FG003|Overall Study|Progressive disease|3|||
170494631|NCT02829723|616152015|FG004|Overall Study|Progressive disease|3|||
170494632|NCT02829723|616152016|FG005|Overall Study|Progressive disease|5|||
170494633|NCT02829723|616152017|FG006|Overall Study|Progressive disease|4|||
170494634|NCT02829723|616152018|FG007|Overall Study|Progressive disease|6|||
170494635|NCT02829723|616152019|FG008|Overall Study|Progressive disease|8|||
170494636|NCT02829723|616152020|FG009|Overall Study|Progressive disease|4|||
170494637|NCT02829723|616152021|FG010|Overall Study|Progressive disease|9|||
170494638|NCT02829723|616152022|FG011|Overall Study|Progressive disease|0|||
170494639|NCT02829723|616152023|FG012|Overall Study|Progressive disease|3|||
170494640|NCT02829723|616152024|FG013|Overall Study|Progressive disease|4|||
170494641|NCT02829723|616152025|FG014|Overall Study|Progressive disease|2|||
170494642|NCT02829723|616152026|FG015|Overall Study|Progressive disease|4|||
170494643|NCT02829723|616152027|FG016|Overall Study|Progressive disease|5|||
170494644|NCT02829723|616152028|FG017|Overall Study|Progressive disease|3|||
170494645|NCT02829723|616152029|FG018|Overall Study|Progressive disease|4|||
170494646|NCT02829723|616152030|FG019|Overall Study|Progressive disease|4|||
170494647|NCT02829723|616152031|FG020|Overall Study|Progressive disease|7|||
170494648|NCT02829723|616152032|FG021|Overall Study|Progressive disease|6|||
170494649|NCT02829723|616152033|FG022|Overall Study|Progressive disease|3|||
170494650|NCT02829723|616152034|FG023|Overall Study|Progressive disease|3|||
170494651|NCT02829723|616152035|FG024|Overall Study|Progressive disease|3|||
170494652|NCT02829723|616152036|FG025|Overall Study|Progressive disease|16|||
170641793|NCT01625260|616701328|FG000|Overall Study|Adverse Event|3|||
170801892|NCT00822120|617284943|FG005|Initial Registration|Reasons not Protocol Specified|0|||
170801893|NCT00822120|617284938|FG000|Initial Registration|Ineligible|22|||
170801894|NCT00822120|617284939|FG001|Initial Registration|Ineligible|1|||
170494653|NCT02829723|616152037|FG026|Overall Study|Progressive disease|10|||
170494654|NCT02829723|616152011|FG000|Overall Study|Subject/guardian decision|0|||
170494655|NCT02829723|616152012|FG001|Overall Study|Subject/guardian decision|1|||
170494656|NCT02829723|616152013|FG002|Overall Study|Subject/guardian decision|0|||
170494657|NCT02829723|616152014|FG003|Overall Study|Subject/guardian decision|1|||
170494658|NCT02829723|616152015|FG004|Overall Study|Subject/guardian decision|0|||
170494659|NCT02829723|616152016|FG005|Overall Study|Subject/guardian decision|0|||
170494660|NCT02829723|616152017|FG006|Overall Study|Subject/guardian decision|0|||
170494661|NCT02829723|616152018|FG007|Overall Study|Subject/guardian decision|1|||
170494662|NCT02829723|616152019|FG008|Overall Study|Subject/guardian decision|0|||
170494663|NCT02829723|616152020|FG009|Overall Study|Subject/guardian decision|0|||
170494664|NCT02829723|616152021|FG010|Overall Study|Subject/guardian decision|0|||
170494665|NCT02829723|616152022|FG011|Overall Study|Subject/guardian decision|0|||
170801895|NCT00822120|617284940|FG002|Initial Registration|Ineligible|0|||
170801896|NCT00822120|617284941|FG003|Initial Registration|Ineligible|0|||
170494666|NCT02829723|616152023|FG012|Overall Study|Subject/guardian decision|0|||
170494667|NCT02829723|616152024|FG013|Overall Study|Subject/guardian decision|0|||
170494668|NCT02829723|616152025|FG014|Overall Study|Subject/guardian decision|1|||
170494669|NCT02829723|616152026|FG015|Overall Study|Subject/guardian decision|0|||
170494670|NCT02829723|616152027|FG016|Overall Study|Subject/guardian decision|1|||
170494671|NCT02829723|616152028|FG017|Overall Study|Subject/guardian decision|0|||
170494672|NCT02829723|616152029|FG018|Overall Study|Subject/guardian decision|1|||
170494673|NCT02829723|616152030|FG019|Overall Study|Subject/guardian decision|0|||
170494674|NCT02829723|616152031|FG020|Overall Study|Subject/guardian decision|1|||
170494675|NCT02829723|616152032|FG021|Overall Study|Subject/guardian decision|0|||
170494676|NCT02829723|616152033|FG022|Overall Study|Subject/guardian decision|0|||
170494677|NCT02829723|616152034|FG023|Overall Study|Subject/guardian decision|1|||
170494678|NCT02829723|616152035|FG024|Overall Study|Subject/guardian decision|0|||
170494679|NCT02829723|616152036|FG025|Overall Study|Subject/guardian decision|1|||
170494680|NCT02829723|616152037|FG026|Overall Study|Subject/guardian decision|1|||
170494681|NCT02829723|616152011|FG000|Overall Study|Study terminated by sponsor|0|||
170494682|NCT02829723|616152012|FG001|Overall Study|Study terminated by sponsor|0|||
170494683|NCT02829723|616152013|FG002|Overall Study|Study terminated by sponsor|0|||
170494684|NCT02829723|616152014|FG003|Overall Study|Study terminated by sponsor|0|||
170494685|NCT02829723|616152015|FG004|Overall Study|Study terminated by sponsor|0|||
170494686|NCT02829723|616152016|FG005|Overall Study|Study terminated by sponsor|0|||
170494687|NCT02829723|616152017|FG006|Overall Study|Study terminated by sponsor|0|||
170494688|NCT02829723|616152018|FG007|Overall Study|Study terminated by sponsor|0|||
170494689|NCT02829723|616152019|FG008|Overall Study|Study terminated by sponsor|0|||
170494690|NCT02829723|616152020|FG009|Overall Study|Study terminated by sponsor|0|||
170494691|NCT02829723|616152021|FG010|Overall Study|Study terminated by sponsor|0|||
170494692|NCT02829723|616152022|FG011|Overall Study|Study terminated by sponsor|0|||
170494693|NCT02829723|616152023|FG012|Overall Study|Study terminated by sponsor|0|||
170494694|NCT02829723|616152024|FG013|Overall Study|Study terminated by sponsor|0|||
170494695|NCT02829723|616152025|FG014|Overall Study|Study terminated by sponsor|0|||
170494696|NCT02829723|616152026|FG015|Overall Study|Study terminated by sponsor|0|||
170494697|NCT02829723|616152027|FG016|Overall Study|Study terminated by sponsor|0|||
170494698|NCT02829723|616152028|FG017|Overall Study|Study terminated by sponsor|0|||
170550664|NCT03738215|616360623|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
170550665|NCT03738215|616360621|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
170550666|NCT03738215|616360622|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
170550667|NCT03738215|616360623|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
170550668|NCT03738215|616360621|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
170550669|NCT03738215|616360622|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
170550670|NCT03738215|616360623|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
170550671|NCT03738215|616360621|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
170550672|NCT03738215|616360622|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
170550673|NCT03738215|616360623|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
170550674|NCT03738215|616360621|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
170550675|NCT03738215|616360622|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
170550676|NCT03738215|616360623|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
170550677|NCT03738215|616360621|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
170801897|NCT00822120|617284942|FG004|Initial Registration|Ineligible|0|||
170801898|NCT00822120|617284943|FG005|Initial Registration|Ineligible|0|||
170801899|NCT00822120|617284938|FG000|PET-directed Therapy|Adverse Event|0|||
170801900|NCT00822120|617284939|FG001|PET-directed Therapy|Adverse Event|0|||
170801901|NCT00822120|617284940|FG002|PET-directed Therapy|Adverse Event|0|||
170801902|NCT00822120|617284941|FG003|PET-directed Therapy|Adverse Event|1|||
170801903|NCT00822120|617284942|FG004|PET-directed Therapy|Adverse Event|0|||
170801904|NCT00822120|617284943|FG005|PET-directed Therapy|Adverse Event|0|||
170801905|NCT00822120|617284938|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
170801906|NCT00822120|617284939|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
170801907|NCT00822120|617284940|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
170801908|NCT00822120|617284941|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
170801909|NCT00822120|617284942|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
170801910|NCT00822120|617284943|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
170801911|NCT00822120|617284938|FG000|PET-directed Therapy|Death|0|||
170801912|NCT00822120|617284939|FG001|PET-directed Therapy|Death|0|||
170494699|NCT02829723|616152029|FG018|Overall Study|Study terminated by sponsor|0|||
170494700|NCT02829723|616152030|FG019|Overall Study|Study terminated by sponsor|0|||
170494701|NCT02829723|616152031|FG020|Overall Study|Study terminated by sponsor|0|||
170494702|NCT02829723|616152032|FG021|Overall Study|Study terminated by sponsor|1|||
170550678|NCT03738215|616360622|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
170801913|NCT00822120|617284940|FG002|PET-directed Therapy|Death|0|||
170801914|NCT00822120|617284941|FG003|PET-directed Therapy|Death|2|||
170801915|NCT00822120|617284942|FG004|PET-directed Therapy|Death|0|||
170801916|NCT00822120|617284943|FG005|PET-directed Therapy|Death|0|||
170494703|NCT02829723|616152033|FG022|Overall Study|Study terminated by sponsor|0|||
170494704|NCT02829723|616152034|FG023|Overall Study|Study terminated by sponsor|0|||
170494705|NCT02829723|616152035|FG024|Overall Study|Study terminated by sponsor|0|||
170494706|NCT02829723|616152036|FG025|Overall Study|Study terminated by sponsor|0|||
170494707|NCT02829723|616152037|FG026|Overall Study|Study terminated by sponsor|0|||
170494708|NCT00330343|616152038|FG000|Overall Study|Lost to Follow-up|5|||
170494709|NCT02738879|616152052|FG000|Overall Study|Adverse Event|1|||
170494710|NCT02738879|616152053|FG001|Overall Study|Adverse Event|1|||
170494711|NCT02738879|616152052|FG000|Overall Study|Death|0|||
170494712|NCT02738879|616152053|FG001|Overall Study|Death|2|||
170494713|NCT02738879|616152052|FG000|Overall Study|Lost to Follow-up|1|||
170494714|NCT02738879|616152053|FG001|Overall Study|Lost to Follow-up|5|||
170494715|NCT02738879|616152052|FG000|Overall Study|Protocol Violation|1|||
170494716|NCT02738879|616152053|FG001|Overall Study|Protocol Violation|3|||
170494717|NCT02738879|616152052|FG000|Overall Study|Physician Decision|3|||
170494718|NCT02738879|616152053|FG001|Overall Study|Physician Decision|4|||
170494719|NCT02738879|616152052|FG000|Overall Study|Pregnancy|0|||
170494720|NCT02738879|616152053|FG001|Overall Study|Pregnancy|1|||
170494721|NCT02738879|616152052|FG000|Overall Study|Screen Failure|1|||
170494722|NCT02738879|616152053|FG001|Overall Study|Screen Failure|2|||
170494723|NCT02738879|616152052|FG000|Overall Study|Site Discontinued Study Participation|1|||
170494724|NCT02738879|616152053|FG001|Overall Study|Site Discontinued Study Participation|0|||
170494725|NCT02738879|616152052|FG000|Overall Study|Withdrawal by Subject|5|||
170494726|NCT02738879|616152053|FG001|Overall Study|Withdrawal by Subject|7|||
170494727|NCT00890084|616152054|FG000|Overall Study|Adverse Event|16|||
170494728|NCT00890084|616152054|FG000|Overall Study|Lost to Follow-up|126|||
170494729|NCT03075891|616152055|FG000|Overall Study|Withdrawal by Subject|3|||
170494730|NCT03075891|616152056|FG001|Overall Study|Withdrawal by Subject|6|||
170494731|NCT03075891|616152055|FG000|Overall Study|Lost to Follow-up|1|||
170494732|NCT03075891|616152056|FG001|Overall Study|Lost to Follow-up|0|||
170494733|NCT03075891|616152055|FG000|Overall Study|Pregnancy|3|||
170494734|NCT03075891|616152056|FG001|Overall Study|Pregnancy|1|||
170494735|NCT03075891|616152055|FG000|Overall Study|visits not performed (no time)|1|||
170494736|NCT03075891|616152056|FG001|Overall Study|visits not performed (no time)|0|||
170494737|NCT03075891|616152055|FG000|Overall Study|Drug abuse relapse issue|0|||
170494738|NCT03075891|616152056|FG001|Overall Study|Drug abuse relapse issue|1|||
170494739|NCT03075891|616152055|FG000|Overall Study|Participant requiring study withdrawal|0|||
170494740|NCT03075891|616152056|FG001|Overall Study|Participant requiring study withdrawal|1|||
170494741|NCT03075891|616152055|FG000|Overall Study|Adverse event, non-fatal|1|||
170494742|NCT03075891|616152056|FG001|Overall Study|Adverse event, non-fatal|4|||
170494743|NCT02691936|616152059|FG000|Overall Study|Withdrawal by Subject|2|||
170494744|NCT02691936|616152060|FG001|Overall Study|Withdrawal by Subject|5|||
170494745|NCT01023256|616152061|FG000|Overall Study|Protocol Violation|2|||
170494746|NCT01023256|616152062|FG001|Overall Study|Protocol Violation|3|||
170494747|NCT01023256|616152063|FG002|Overall Study|Protocol Violation|0|||
170494748|NCT01023256|616152064|FG003|Overall Study|Protocol Violation|0|||
170494749|NCT01023256|616152061|FG000|Overall Study|Randomized but not treated|1|||
170494750|NCT01023256|616152062|FG001|Overall Study|Randomized but not treated|0|||
170494751|NCT01023256|616152063|FG002|Overall Study|Randomized but not treated|1|||
170494752|NCT01023256|616152064|FG003|Overall Study|Randomized but not treated|0|||
170494753|NCT01023256|616152061|FG000|Overall Study|Other|1|||
170494754|NCT01023256|616152062|FG001|Overall Study|Other|0|||
170494755|NCT01023256|616152063|FG002|Overall Study|Other|0|||
170494756|NCT01023256|616152064|FG003|Overall Study|Other|2|||
170494757|NCT01023256|616152061|FG000|Overall Study|Adverse Event|0|||
170494758|NCT01023256|616152062|FG001|Overall Study|Adverse Event|0|||
170494759|NCT01023256|616152063|FG002|Overall Study|Adverse Event|0|||
170494760|NCT01023256|616152064|FG003|Overall Study|Adverse Event|1|||
170494761|NCT01023256|616152061|FG000|Overall Study|Withdrawal by Subject|0|||
170494762|NCT01023256|616152062|FG001|Overall Study|Withdrawal by Subject|0|||
170494763|NCT01023256|616152063|FG002|Overall Study|Withdrawal by Subject|0|||
170494764|NCT01023256|616152064|FG003|Overall Study|Withdrawal by Subject|2|||
170494765|NCT00732758|616152067|FG000|Overall Study|Lost to Follow-up|8|||
170494766|NCT00732758|616152068|FG001|Overall Study|Lost to Follow-up|16|||
170550679|NCT03738215|616360623|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
170550680|NCT03738215|616360621|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
170550681|NCT03738215|616360622|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
170494767|NCT00373958|616152069|FG000|Infant Series|Withdrawal by Subject|13|||
170494768|NCT00373958|616152070|FG001|Infant Series|Withdrawal by Subject|15|||
170494769|NCT00373958|616152069|FG000|Infant Series|Failed to return|8|||
170494770|NCT00373958|616152070|FG001|Infant Series|Failed to return|13|||
170494771|NCT00373958|616152069|FG000|Infant Series|Lost to Follow-up|6|||
170494772|NCT00373958|616152070|FG001|Infant Series|Lost to Follow-up|5|||
170550682|NCT03738215|616360623|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
170494773|NCT00373958|616152069|FG000|Infant Series|Protocol Violation|3|||
170494774|NCT00373958|616152070|FG001|Infant Series|Protocol Violation|7|||
170494775|NCT00373958|616152069|FG000|Infant Series|Lost Kaiser coverage|4|||
170494776|NCT00373958|616152070|FG001|Infant Series|Lost Kaiser coverage|0|||
170900468|NCT00929240|617640135|FG002|Initial Treatment Phase|Disease progression|0|||
170900469|NCT00929240|617640133|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
170900470|NCT00929240|617640134|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
170900471|NCT00929240|617640135|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
170900472|NCT00929240|617640133|FG000|Initial Treatment Phase|Protocol Violation|5|||
170900473|NCT00929240|617640134|FG001|Initial Treatment Phase|Protocol Violation|0|||
170900474|NCT00929240|617640135|FG002|Initial Treatment Phase|Protocol Violation|0|||
170900475|NCT00929240|617640133|FG000|Initial Treatment Phase|Death|2|||
170494777|NCT00373958|616152069|FG000|Infant Series|Child relocated|1|||
170494778|NCT00373958|616152070|FG001|Infant Series|Child relocated|0|||
170494779|NCT00373958|616152069|FG000|Infant Series|Consent was not received|1|||
170494780|NCT00373958|616152070|FG001|Infant Series|Consent was not received|0|||
170494781|NCT00373958|616152069|FG000|Infant Series|Adverse Event|3|||
170494782|NCT00373958|616152070|FG001|Infant Series|Adverse Event|1|||
170494783|NCT00373958|616152069|FG000|Infant Series|Physician Decision|1|||
170494784|NCT00373958|616152070|FG001|Infant Series|Physician Decision|1|||
170494785|NCT00373958|616152069|FG000|Toddler Dose|Lost to Follow-up|5|||
170494786|NCT00373958|616152070|FG001|Toddler Dose|Lost to Follow-up|8|||
170494787|NCT00373958|616152069|FG000|Toddler Dose|Withdrawal by Subject|2|||
170494788|NCT00373958|616152070|FG001|Toddler Dose|Withdrawal by Subject|2|||
170494789|NCT00373958|616152069|FG000|Toddler Dose|Failed to return|1|||
170494790|NCT00373958|616152070|FG001|Toddler Dose|Failed to return|2|||
170494791|NCT00373958|616152069|FG000|Toddler Dose|Protocol Violation|0|||
170494792|NCT00373958|616152070|FG001|Toddler Dose|Protocol Violation|1|||
170494793|NCT00373958|616152069|FG000|Toddler Dose|Withdrawn after infant series|22|||
170494794|NCT00373958|616152070|FG001|Toddler Dose|Withdrawn after infant series|25|||
170494795|NCT00179673|616152076|FG000|Overall Study|Adverse Event|7|||
170494796|NCT00179673|616152076|FG000|Overall Study|Lack of Efficacy|15|||
170494797|NCT00179673|616152076|FG000|Overall Study|Withdrawal by Subject|3|||
170494798|NCT00179673|616152076|FG000|Overall Study|Death|4|||
170550683|NCT03738215|616360621|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
170550684|NCT03738215|616360622|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
170550685|NCT03738215|616360623|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
170550686|NCT03738215|616360621|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
170550687|NCT03738215|616360622|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
170550688|NCT03738215|616360623|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
170550689|NCT01027754|616362428|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
170550690|NCT01027754|616362429|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
170550691|NCT01027754|616362428|FG000|Overall Study|Withdrawal by Subject|0|||
170550692|NCT01027754|616362429|FG001|Overall Study|Withdrawal by Subject|5|||
170550693|NCT02802865|616362430|FG000|Overall Study|Pregnancy|1|||
170550694|NCT02802865|616362431|FG001|Overall Study|Pregnancy|1|||
170550695|NCT02802865|616362430|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
170550696|NCT02802865|616362431|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
170550697|NCT01862029|616362432|FG000|Overall Study|Physician Decision|1|||
170550698|NCT03931785|616362433|FG000|Overall Study|Lost to Follow-up|4|||
170550699|NCT03931785|616362434|FG001|Overall Study|Lost to Follow-up|1|||
170550700|NCT03931785|616362435|FG002|Overall Study|Lost to Follow-up|4|||
170550701|NCT03931785|616362436|FG003|Overall Study|Lost to Follow-up|3|||
170550702|NCT03931785|616362433|FG000|Overall Study|Adverse Event|1|||
170550703|NCT03931785|616362434|FG001|Overall Study|Adverse Event|0|||
170550704|NCT03931785|616362435|FG002|Overall Study|Adverse Event|3|||
170550705|NCT03931785|616362436|FG003|Overall Study|Adverse Event|4|||
170550706|NCT03931785|616362433|FG000|Overall Study|Protocol Violation|0|||
170550707|NCT03931785|616362434|FG001|Overall Study|Protocol Violation|1|||
170550708|NCT03931785|616362435|FG002|Overall Study|Protocol Violation|0|||
170550709|NCT03931785|616362436|FG003|Overall Study|Protocol Violation|0|||
170550710|NCT03931785|616362433|FG000|Overall Study|Noncompliance With Study drug|0|||
170550711|NCT03931785|616362434|FG001|Overall Study|Noncompliance With Study drug|1|||
170550712|NCT03931785|616362435|FG002|Overall Study|Noncompliance With Study drug|0|||
170550713|NCT03931785|616362436|FG003|Overall Study|Noncompliance With Study drug|0|||
170550714|NCT03931785|616362433|FG000|Overall Study|Other Not specified|0|||
170550715|NCT03931785|616362434|FG001|Overall Study|Other Not specified|2|||
170550716|NCT03931785|616362435|FG002|Overall Study|Other Not specified|2|||
170550717|NCT03931785|616362436|FG003|Overall Study|Other Not specified|2|||
170550718|NCT03931785|616362433|FG000|Overall Study|Withdrawal by Subject|0|||
170550719|NCT03931785|616362434|FG001|Overall Study|Withdrawal by Subject|2|||
170550720|NCT03931785|616362435|FG002|Overall Study|Withdrawal by Subject|4|||
170550721|NCT03931785|616362436|FG003|Overall Study|Withdrawal by Subject|1|||
170494799|NCT00179673|616152076|FG000|Overall Study|Other Observations and options|14|||
170550722|NCT03931785|616362433|FG000|Overall Study|Pregnancy|0|||
170550723|NCT03931785|616362434|FG001|Overall Study|Pregnancy|0|||
170494800|NCT00492648|616152077|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
170550724|NCT03931785|616362435|FG002|Overall Study|Pregnancy|0|||
170641794|NCT01625260|616701329|FG001|Overall Study|Adverse Event|0|||
170494801|NCT00492648|616152078|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
170900476|NCT00929240|617640134|FG001|Initial Treatment Phase|Death|0|||
170900477|NCT00929240|617640135|FG002|Initial Treatment Phase|Death|0|||
170900478|NCT00929240|617640133|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
170900479|NCT00929240|617640134|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
170900480|NCT00929240|617640135|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
170900481|NCT00929240|617640133|FG000|Initial Treatment Phase|Physician Decision|4|||
170900482|NCT00929240|617640134|FG001|Initial Treatment Phase|Physician Decision|0|||
170494802|NCT02387957|616152079|FG000|Overall Study|The study was discontinued|21|||
170494803|NCT02387957|616152080|FG001|Overall Study|The study was discontinued|21|||
170494804|NCT02387957|616152081|FG002|Overall Study|The study was discontinued|20|||
170494805|NCT02887248|616152082|FG000|Overall Study|Withdrawal by Subject|1|||
170494806|NCT02887248|616152082|FG000|Overall Study|Adverse Event|1|||
170494807|NCT02887248|616152082|FG000|Overall Study|Progressive Disease|1|||
170494808|NCT02294396|616152083|FG000|Overall Study|Adverse Event|26|||
170494809|NCT02294396|616152084|FG001|Overall Study|Adverse Event|25|||
170494810|NCT02294396|616152085|FG002|Overall Study|Adverse Event|21|||
170494811|NCT02294396|616152086|FG003|Overall Study|Adverse Event|24|||
170494812|NCT02294396|616152083|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
170494813|NCT02294396|616152084|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
170494814|NCT02294396|616152085|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
170494815|NCT02294396|616152086|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
170494816|NCT02294396|616152083|FG000|Overall Study|Withdrawal by Subject|8|||
170494817|NCT02294396|616152084|FG001|Overall Study|Withdrawal by Subject|6|||
170550725|NCT03931785|616362436|FG003|Overall Study|Pregnancy|1|||
170550726|NCT01832038|616362437|FG000|Overall Study|Death|5|||
170550727|NCT01832038|616362437|FG000|Overall Study|Adverse Event|50|||
170550728|NCT01832038|616362437|FG000|Overall Study|Lack of Efficacy|81|||
170550729|NCT01832038|616362437|FG000|Overall Study|Protocol Violation|7|||
170550730|NCT01832038|616362437|FG000|Overall Study|Lost to Follow-up|10|||
170550731|NCT01832038|616362437|FG000|Overall Study|Withdrawal by Subject|49|||
170550732|NCT01832038|616362437|FG000|Overall Study|Visit non-compliance|2|||
170550733|NCT01832038|616362437|FG000|Overall Study|Subject refused to return visit|2|||
170641795|NCT01625260|616701328|FG000|Overall Study|Study Terminated by Investigator|2|||
170641796|NCT01625260|616701329|FG001|Overall Study|Study Terminated by Investigator|0|||
170641797|NCT01625260|616701328|FG000|Overall Study|Disease Progression|2|||
170641798|NCT01625260|616701329|FG001|Overall Study|Disease Progression|0|||
170641799|NCT01625260|616701328|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
170641800|NCT01625260|616701329|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
170641801|NCT03646123|616701330|FG000|Overall Study|Withdrawal by Subject|2|||
170641802|NCT03646123|616701331|FG001|Overall Study|Withdrawal by Subject|2|||
170641803|NCT03646123|616701332|FG002|Overall Study|Withdrawal by Subject|3|||
170641804|NCT03646123|616701330|FG000|Overall Study|Study termination by sponsor|0|||
170641805|NCT03646123|616701331|FG001|Overall Study|Study termination by sponsor|45|||
170641806|NCT03646123|616701332|FG002|Overall Study|Study termination by sponsor|139|||
170641807|NCT03646123|616701330|FG000|Overall Study|Lost to Follow-up|4|||
170641808|NCT03646123|616701331|FG001|Overall Study|Lost to Follow-up|10|||
170641809|NCT03646123|616701332|FG002|Overall Study|Lost to Follow-up|10|||
170641810|NCT03646123|616701330|FG000|Overall Study|Death|2|||
170641811|NCT03646123|616701331|FG001|Overall Study|Death|1|||
170641812|NCT03646123|616701332|FG002|Overall Study|Death|1|||
170641813|NCT03646123|616701330|FG000|Overall Study|Other|2|||
170641814|NCT03646123|616701331|FG001|Overall Study|Other|0|||
170550734|NCT01832038|616362437|FG000|Overall Study|Not convenient to come back to site|2|||
170550735|NCT01832038|616362437|FG000|Overall Study|Participant was asked to quit|5|||
170550736|NCT01832038|616362437|FG000|Overall Study|Back home|1|||
170550737|NCT01832038|616362437|FG000|Overall Study|Pregnancy|1|||
170550738|NCT01832038|616362437|FG000|Overall Study|Low compliance|3|||
170550739|NCT01832038|616362437|FG000|Overall Study|Prohibit procedure|2|||
170550740|NCT01832038|616362437|FG000|Overall Study|Not possible to visit the hospital|1|||
170550741|NCT01832038|616362437|FG000|Overall Study|Changes of implementation system|3|||
170550742|NCT01832038|616362437|FG000|Overall Study|Plan to pregnancy|7|||
170641815|NCT03646123|616701332|FG002|Overall Study|Other|2|||
170641816|NCT02280408|616701339|FG000|Overall Study|Lost to Follow-up|0|||
170641817|NCT02280408|616701340|FG001|Overall Study|Lost to Follow-up|2|||
170641818|NCT02280408|616701341|FG002|Overall Study|Lost to Follow-up|0|||
170550743|NCT01832038|616362437|FG000|Overall Study|Bad mood and has suicidal thought|1|||
170550744|NCT01832038|616362437|FG000|Overall Study|Prohibited concomitant medication|1|||
170641819|NCT02280408|616701342|FG003|Overall Study|Lost to Follow-up|0|||
170900483|NCT00929240|617640135|FG002|Initial Treatment Phase|Physician Decision|0|||
170900484|NCT00929240|617640133|FG000|Maintenance Phase|Disease progression|0|||
170494818|NCT02294396|616152085|FG002|Overall Study|Withdrawal by Subject|6|||
170494819|NCT02294396|616152086|FG003|Overall Study|Withdrawal by Subject|8|||
170494820|NCT02294396|616152083|FG000|Overall Study|Lost to Follow-up|0|||
170550745|NCT01832038|616362437|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
170641820|NCT01519869|616701343|FG000|Overall Study|Lost to Follow-up|1|||
170494821|NCT02294396|616152084|FG001|Overall Study|Lost to Follow-up|0|||
170494822|NCT02294396|616152085|FG002|Overall Study|Lost to Follow-up|1|||
170494823|NCT02294396|616152086|FG003|Overall Study|Lost to Follow-up|1|||
170494824|NCT02294396|616152083|FG000|Overall Study|Protocol Deviation|3|||
170494825|NCT02294396|616152084|FG001|Overall Study|Protocol Deviation|2|||
170494826|NCT02294396|616152085|FG002|Overall Study|Protocol Deviation|2|||
170494827|NCT02294396|616152086|FG003|Overall Study|Protocol Deviation|1|||
170494828|NCT02294396|616152083|FG000|Overall Study|Miscellaneous|2|||
170494829|NCT02294396|616152084|FG001|Overall Study|Miscellaneous|0|||
170550746|NCT01832038|616362437|FG000|Overall Study|Subject considered the efficacy was poor|1|||
170550747|NCT03810365|616362438|FG000|Overall Study|Lost to Follow-up|2|||
170550748|NCT03810365|616362439|FG001|Overall Study|Lost to Follow-up|2|||
170550749|NCT03810365|616362438|FG000|Overall Study|Withdrawal by Subject|4|||
170550750|NCT03810365|616362439|FG001|Overall Study|Withdrawal by Subject|5|||
170550751|NCT01052428|616362446|FG000|Overall Study|Death|1|||
170550752|NCT01052428|616362447|FG001|Overall Study|Death|0|||
170550753|NCT01052428|616362446|FG000|Overall Study|Withdrawal by Subject|0|||
170550754|NCT01052428|616362447|FG001|Overall Study|Withdrawal by Subject|1|||
170550755|NCT00382863|616362448|FG000|Overall Study|Death|9|||
170550756|NCT00382863|616362449|FG001|Overall Study|Death|9|||
170550757|NCT00382863|616362448|FG000|Overall Study|Lost to Follow-up|1|||
170550758|NCT00382863|616362449|FG001|Overall Study|Lost to Follow-up|2|||
170550759|NCT00382863|616362448|FG000|Overall Study|Withdrawal by Subject|5|||
170550760|NCT00382863|616362449|FG001|Overall Study|Withdrawal by Subject|25|||
170550761|NCT03400787|616362450|FG000|Overall Study|Lost to Follow-up|1|||
170550762|NCT03400787|616362451|FG001|Overall Study|Lost to Follow-up|0|||
170550763|NCT03400787|616362450|FG000|Overall Study|Death|1|||
170550764|NCT03400787|616362451|FG001|Overall Study|Death|0|||
170550765|NCT03400787|616362450|FG000|Overall Study|Protocol Violation|0|||
170550766|NCT03400787|616362451|FG001|Overall Study|Protocol Violation|2|||
170550767|NCT03400787|616362450|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
170550768|NCT03400787|616362451|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
170550769|NCT02168439|616362452|FG000|Overall Study|Protocol Violation|0|||
170550770|NCT02168439|616362453|FG001|Overall Study|Protocol Violation|2|||
170550771|NCT00378560|616362461|FG000|Overall Study|Adverse Event|1|||
170550772|NCT00378560|616362462|FG001|Overall Study|Adverse Event|0|||
170550773|NCT00378560|616362461|FG000|Overall Study|Lost to Follow-up|24|||
170550774|NCT00378560|616362462|FG001|Overall Study|Lost to Follow-up|29|||
170550775|NCT00378560|616362461|FG000|Overall Study|Protocol Violation|2|||
170550776|NCT00378560|616362462|FG001|Overall Study|Protocol Violation|0|||
170550777|NCT00378560|616362461|FG000|Overall Study|Withdrawal by Subject|17|||
170550778|NCT00378560|616362462|FG001|Overall Study|Withdrawal by Subject|21|||
170550779|NCT00378560|616362461|FG000|Overall Study|Moved|4|||
170550780|NCT00378560|616362462|FG001|Overall Study|Moved|3|||
170550781|NCT00378560|616362461|FG000|Overall Study|Pregnancy|7|||
170550782|NCT00378560|616362462|FG001|Overall Study|Pregnancy|5|||
170550783|NCT00378560|616362461|FG000|Overall Study|Laboratory test values abnormal|1|||
170550784|NCT00378560|616362462|FG001|Overall Study|Laboratory test values abnormal|0|||
170550785|NCT01061710|616362477|FG000|Overall Study|Protocol Violation|14|||
170550786|NCT00159874|616362479|FG000|Overall Study|Adverse Event|2|||
170550787|NCT00159874|616362480|FG001|Overall Study|Adverse Event|2|||
170550788|NCT00159874|616362481|FG002|Overall Study|Adverse Event|5|||
170550789|NCT00159874|616362482|FG003|Overall Study|Adverse Event|1|||
170550790|NCT00159874|616362483|FG004|Overall Study|Adverse Event|1|||
170550791|NCT00159874|616362484|FG005|Overall Study|Adverse Event|2|||
170550792|NCT00159874|616362485|FG006|Overall Study|Adverse Event|0|||
170550793|NCT00159874|616362479|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
170550794|NCT00159874|616362480|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
170550795|NCT00159874|616362481|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
170550796|NCT00159874|616362482|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
170641821|NCT04075734|616701346|FG000|Overall Study|Lost to Follow-up|1|||
170641822|NCT04075734|616701347|FG001|Overall Study|Lost to Follow-up|1|||
170641823|NCT04075734|616701348|FG002|Overall Study|Lost to Follow-up|0|||
170494830|NCT02294396|616152085|FG002|Overall Study|Miscellaneous|5|||
170550797|NCT00159874|616362483|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
170550798|NCT00159874|616362484|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
170550799|NCT00159874|616362485|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
170550800|NCT00159874|616362479|FG000|Overall Study|Lack of Efficacy|2|||
170550801|NCT00159874|616362480|FG001|Overall Study|Lack of Efficacy|0|||
170550802|NCT00159874|616362481|FG002|Overall Study|Lack of Efficacy|1|||
170550803|NCT00159874|616362482|FG003|Overall Study|Lack of Efficacy|1|||
170550804|NCT00159874|616362483|FG004|Overall Study|Lack of Efficacy|0|||
170550805|NCT00159874|616362484|FG005|Overall Study|Lack of Efficacy|3|||
170641824|NCT04075734|616701346|FG000|Overall Study|Withdrawal by Subject|3|||
170641825|NCT04075734|616701347|FG001|Overall Study|Withdrawal by Subject|0|||
170494831|NCT02294396|616152086|FG003|Overall Study|Miscellaneous|2|||
170550806|NCT00159874|616362485|FG006|Overall Study|Lack of Efficacy|0|||
170641826|NCT04075734|616701348|FG002|Overall Study|Withdrawal by Subject|0|||
170550807|NCT00159874|616362479|FG000|Overall Study|Lost to Follow-up|1|||
170494832|NCT04105218|616152095|FG000|Overall Study|Withdrawal by Subject|3|||
170900485|NCT00929240|617640134|FG001|Maintenance Phase|Disease progression|73|||
170900486|NCT00929240|617640135|FG002|Maintenance Phase|Disease progression|60|||
170900487|NCT00929240|617640133|FG000|Maintenance Phase|Adverse Event|0|||
170900488|NCT00929240|617640134|FG001|Maintenance Phase|Adverse Event|9|||
170494833|NCT04105218|616152096|FG001|Overall Study|Withdrawal by Subject|2|||
170494834|NCT04105218|616152095|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
170494835|NCT04105218|616152096|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
170494836|NCT04105218|616152095|FG000|Overall Study|Failed screening tests|2|||
170900489|NCT00929240|617640135|FG002|Maintenance Phase|Adverse Event|12|||
170900490|NCT00929240|617640133|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170900491|NCT00929240|617640134|FG001|Maintenance Phase|Withdrawal by Subject|2|||
170900492|NCT00929240|617640135|FG002|Maintenance Phase|Withdrawal by Subject|6|||
170900493|NCT00929240|617640133|FG000|Maintenance Phase|Protocol Violation|0|||
170900494|NCT00929240|617640134|FG001|Maintenance Phase|Protocol Violation|1|||
170900495|NCT00929240|617640135|FG002|Maintenance Phase|Protocol Violation|0|||
170900496|NCT00929240|617640133|FG000|Maintenance Phase|Health authority/Study termination|0|||
170900497|NCT00929240|617640134|FG001|Maintenance Phase|Health authority/Study termination|1|||
170900498|NCT00929240|617640135|FG002|Maintenance Phase|Health authority/Study termination|2|||
170900499|NCT00929240|617640133|FG000|Maintenance Phase|Physician Decision|0|||
170900500|NCT00929240|617640134|FG001|Maintenance Phase|Physician Decision|2|||
170900501|NCT00929240|617640135|FG002|Maintenance Phase|Physician Decision|1|||
170900502|NCT00929240|617640133|FG000|Maintenance Phase|Change of treatment|0|||
170900503|NCT00929240|617640134|FG001|Maintenance Phase|Change of treatment|4|||
170900504|NCT00929240|617640135|FG002|Maintenance Phase|Change of treatment|0|||
170900505|NCT00929240|617640133|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
170641827|NCT03601806|616701351|FG000|Overall Study|Adverse Event|2|||
170641828|NCT03601806|616701351|FG000|Overall Study|Death|1|||
170641829|NCT03601806|616701351|FG000|Overall Study|Withdrawal by Subject|2|||
170641830|NCT03601806|616701351|FG000|Overall Study|Lack of Efficacy|7|||
170641831|NCT03601806|616701351|FG000|Overall Study|Other|6|||
170641832|NCT00530816|616701363|FG000|Overall Study|Progressive Disease|16|||
170641833|NCT00530816|616701364|FG001|Overall Study|Progressive Disease|24|||
170641834|NCT00530816|616701365|FG002|Overall Study|Progressive Disease|24|||
170641835|NCT00530816|616701363|FG000|Overall Study|Adverse Event|6|||
170641836|NCT00530816|616701364|FG001|Overall Study|Adverse Event|13|||
170641837|NCT00530816|616701365|FG002|Overall Study|Adverse Event|7|||
170641838|NCT00530816|616701363|FG000|Overall Study|Other|3|||
170641839|NCT00530816|616701364|FG001|Overall Study|Other|3|||
170641840|NCT00530816|616701365|FG002|Overall Study|Other|4|||
170641841|NCT00530816|616701363|FG000|Overall Study|Withdrawal by Subject|1|||
170641842|NCT00530816|616701364|FG001|Overall Study|Withdrawal by Subject|2|||
170641843|NCT00530816|616701365|FG002|Overall Study|Withdrawal by Subject|6|||
170641844|NCT04198714|616701366|FG000|Overall Study|Physician Decision|0|||
170641845|NCT04198714|616701367|FG001|Overall Study|Physician Decision|1|||
170641846|NCT02529553|616701369|FG000|Overall Study|Progressive Disease|1|||
170641847|NCT02529553|616701370|FG001|Overall Study|Progressive Disease|0|||
170641848|NCT02529553|616701371|FG002|Overall Study|Progressive Disease|1|||
170641849|NCT02529553|616701372|FG003|Overall Study|Progressive Disease|3|||
170641850|NCT02529553|616701373|FG004|Overall Study|Progressive Disease|2|||
170900506|NCT00929240|617640134|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
170900507|NCT00929240|617640135|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
170900508|NCT00929240|617640133|FG000|Maintenance Phase|Participant not treated|0|||
170900509|NCT00929240|617640134|FG001|Maintenance Phase|Participant not treated|2|||
170900510|NCT00929240|617640135|FG002|Maintenance Phase|Participant not treated|0|||
170900511|NCT02582671|617640136|FG000|Overall Study|Failure to return|1|||
170900512|NCT02582671|617640136|FG000|Overall Study|Other, not specified|1|||
170641851|NCT02529553|616701374|FG005|Overall Study|Progressive Disease|3|||
170494837|NCT04105218|616152096|FG001|Overall Study|Failed screening tests|1|||
170641852|NCT02529553|616701375|FG006|Overall Study|Progressive Disease|3|||
170641853|NCT02529553|616701376|FG007|Overall Study|Progressive Disease|5|||
170641854|NCT02529553|616701377|FG008|Overall Study|Progressive Disease|3|||
170641855|NCT02529553|616701369|FG000|Overall Study|Physician Decision|0|||
170641856|NCT02529553|616701370|FG001|Overall Study|Physician Decision|1|||
170641857|NCT02529553|616701371|FG002|Overall Study|Physician Decision|0|||
170900513|NCT01287104|617640137|FG000|Overall Study|Patient developed progressive disease|1|||
170900514|NCT01287104|617640138|FG001|Overall Study|Patient developed progressive disease|1|||
170641858|NCT02529553|616701372|FG003|Overall Study|Physician Decision|0|||
170900515|NCT01287104|617640139|FG002|Overall Study|Patient developed progressive disease|3|||
170900516|NCT01287104|617640140|FG003|Overall Study|Patient developed progressive disease|2|||
170900517|NCT01287104|617640137|FG000|Overall Study|Donor anaphylaxis|0|||
170641859|NCT02529553|616701373|FG004|Overall Study|Physician Decision|1|||
170641860|NCT02529553|616701374|FG005|Overall Study|Physician Decision|0|||
170641861|NCT02529553|616701375|FG006|Overall Study|Physician Decision|0|||
170641862|NCT02529553|616701376|FG007|Overall Study|Physician Decision|0|||
170641863|NCT02529553|616701377|FG008|Overall Study|Physician Decision|0|||
170641864|NCT02529553|616701369|FG000|Overall Study|Withdrawal by Subject|0|||
170641865|NCT02529553|616701370|FG001|Overall Study|Withdrawal by Subject|0|||
170641866|NCT02529553|616701371|FG002|Overall Study|Withdrawal by Subject|0|||
170641867|NCT02529553|616701372|FG003|Overall Study|Withdrawal by Subject|0|||
170641868|NCT02529553|616701373|FG004|Overall Study|Withdrawal by Subject|0|||
170641869|NCT02529553|616701374|FG005|Overall Study|Withdrawal by Subject|1|||
170641870|NCT02529553|616701375|FG006|Overall Study|Withdrawal by Subject|0|||
170641871|NCT02529553|616701376|FG007|Overall Study|Withdrawal by Subject|1|||
170641872|NCT02529553|616701377|FG008|Overall Study|Withdrawal by Subject|0|||
170641873|NCT00114517|616701378|FG000|Overall Study|Adverse Event|6|||
170641874|NCT00114517|616701379|FG001|Overall Study|Adverse Event|1|||
170641875|NCT00114517|616701380|FG002|Overall Study|Adverse Event|6|||
170641876|NCT00114517|616701381|FG003|Overall Study|Adverse Event|3|||
170641877|NCT00114517|616701378|FG000|Overall Study|Lost to Follow-up|2|||
170641878|NCT00114517|616701379|FG001|Overall Study|Lost to Follow-up|2|||
170900518|NCT01287104|617640138|FG001|Overall Study|Donor anaphylaxis|1|||
170900519|NCT01287104|617640139|FG002|Overall Study|Donor anaphylaxis|0|||
170900520|NCT01287104|617640140|FG003|Overall Study|Donor anaphylaxis|1|||
170900521|NCT01287104|617640137|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
170900522|NCT01287104|617640138|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
170900523|NCT01287104|617640139|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
170900524|NCT01287104|617640140|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
170900525|NCT01287104|617640137|FG000|Overall Study|Low donor chimerism|0|||
170900526|NCT01287104|617640138|FG001|Overall Study|Low donor chimerism|1|||
170900527|NCT01287104|617640139|FG002|Overall Study|Low donor chimerism|0|||
170900528|NCT01287104|617640140|FG003|Overall Study|Low donor chimerism|0|||
170900529|NCT01287104|617640137|FG000|Overall Study|NK cells did not meet release criteria|0|||
170494838|NCT02553499|616152108|FG000|Overall Study|Adverse Event|0|||
170494839|NCT02553499|616152109|FG001|Overall Study|Adverse Event|0|||
170494840|NCT02553499|616152110|FG002|Overall Study|Adverse Event|0|||
170494841|NCT02553499|616152111|FG003|Overall Study|Adverse Event|0|||
170494842|NCT02553499|616152112|FG004|Overall Study|Adverse Event|0|||
170494843|NCT02553499|616152113|FG005|Overall Study|Adverse Event|0|||
170494844|NCT02553499|616152114|FG006|Overall Study|Adverse Event|1|||
170494845|NCT02553499|616152115|FG007|Overall Study|Adverse Event|1|||
170494846|NCT02553499|616152116|FG008|Overall Study|Adverse Event|0|||
170494847|NCT02553499|616152117|FG009|Overall Study|Adverse Event|0|||
170494848|NCT02553499|616152118|FG010|Overall Study|Adverse Event|0|||
170494849|NCT02553499|616152119|FG011|Overall Study|Adverse Event|0|||
170494850|NCT02553499|616152120|FG012|Overall Study|Adverse Event|0|||
170494851|NCT02553499|616152121|FG013|Overall Study|Adverse Event|1|||
170494852|NCT02553499|616152108|FG000|Overall Study|Death|0|||
170494853|NCT02553499|616152109|FG001|Overall Study|Death|1|||
170494854|NCT02553499|616152110|FG002|Overall Study|Death|1|||
170494855|NCT02553499|616152111|FG003|Overall Study|Death|0|||
170494856|NCT02553499|616152112|FG004|Overall Study|Death|1|||
170494857|NCT02553499|616152113|FG005|Overall Study|Death|2|||
170494858|NCT02553499|616152114|FG006|Overall Study|Death|0|||
170494859|NCT02553499|616152115|FG007|Overall Study|Death|0|||
170494860|NCT02553499|616152116|FG008|Overall Study|Death|0|||
170494861|NCT02553499|616152117|FG009|Overall Study|Death|0|||
170494862|NCT02553499|616152118|FG010|Overall Study|Death|1|||
170494863|NCT02553499|616152119|FG011|Overall Study|Death|0|||
170494864|NCT02553499|616152120|FG012|Overall Study|Death|0|||
170494865|NCT02553499|616152121|FG013|Overall Study|Death|0|||
170494866|NCT02553499|616152108|FG000|Overall Study|Lost to Follow-up|0|||
170494867|NCT02553499|616152109|FG001|Overall Study|Lost to Follow-up|0|||
170494868|NCT02553499|616152110|FG002|Overall Study|Lost to Follow-up|0|||
170494869|NCT02553499|616152111|FG003|Overall Study|Lost to Follow-up|0|||
170494870|NCT02553499|616152112|FG004|Overall Study|Lost to Follow-up|0|||
170641879|NCT00114517|616701380|FG002|Overall Study|Lost to Follow-up|2|||
170641880|NCT00114517|616701381|FG003|Overall Study|Lost to Follow-up|1|||
170641881|NCT00114517|616701378|FG000|Overall Study|Too busy|3|||
170641882|NCT00114517|616701379|FG001|Overall Study|Too busy|1|||
170641883|NCT00114517|616701380|FG002|Overall Study|Too busy|1|||
170900530|NCT01287104|617640138|FG001|Overall Study|NK cells did not meet release criteria|1|||
170900531|NCT01287104|617640139|FG002|Overall Study|NK cells did not meet release criteria|0|||
170494871|NCT02553499|616152113|FG005|Overall Study|Lost to Follow-up|0|||
170494872|NCT02553499|616152114|FG006|Overall Study|Lost to Follow-up|1|||
170494873|NCT02553499|616152115|FG007|Overall Study|Lost to Follow-up|0|||
170641884|NCT00114517|616701381|FG003|Overall Study|Too busy|2|||
170641885|NCT00114517|616701378|FG000|Overall Study|Moved from area|0|||
170641886|NCT00114517|616701379|FG001|Overall Study|Moved from area|3|||
170494874|NCT02553499|616152116|FG008|Overall Study|Lost to Follow-up|0|||
170494875|NCT02553499|616152117|FG009|Overall Study|Lost to Follow-up|0|||
170494876|NCT02553499|616152118|FG010|Overall Study|Lost to Follow-up|0|||
170494877|NCT02553499|616152119|FG011|Overall Study|Lost to Follow-up|0|||
170494878|NCT02553499|616152120|FG012|Overall Study|Lost to Follow-up|0|||
170494879|NCT02553499|616152121|FG013|Overall Study|Lost to Follow-up|0|||
170641887|NCT00114517|616701380|FG002|Overall Study|Moved from area|2|||
170494880|NCT02553499|616152108|FG000|Overall Study|Physician Decision|0|||
170494881|NCT02553499|616152109|FG001|Overall Study|Physician Decision|1|||
170494882|NCT02553499|616152110|FG002|Overall Study|Physician Decision|1|||
170494883|NCT02553499|616152111|FG003|Overall Study|Physician Decision|0|||
170494884|NCT02553499|616152112|FG004|Overall Study|Physician Decision|1|||
170494885|NCT02553499|616152113|FG005|Overall Study|Physician Decision|0|||
170494886|NCT02553499|616152114|FG006|Overall Study|Physician Decision|0|||
170494887|NCT02553499|616152115|FG007|Overall Study|Physician Decision|1|||
170494888|NCT02553499|616152116|FG008|Overall Study|Physician Decision|1|||
170494889|NCT02553499|616152117|FG009|Overall Study|Physician Decision|2|||
170494890|NCT02553499|616152118|FG010|Overall Study|Physician Decision|1|||
170494891|NCT02553499|616152119|FG011|Overall Study|Physician Decision|3|||
170494892|NCT02553499|616152120|FG012|Overall Study|Physician Decision|1|||
170494893|NCT02553499|616152121|FG013|Overall Study|Physician Decision|0|||
170494894|NCT02553499|616152108|FG000|Overall Study|Progressive Disease|0|||
170494895|NCT02553499|616152109|FG001|Overall Study|Progressive Disease|0|||
170494896|NCT02553499|616152110|FG002|Overall Study|Progressive Disease|0|||
170494897|NCT02553499|616152111|FG003|Overall Study|Progressive Disease|2|||
170494898|NCT02553499|616152112|FG004|Overall Study|Progressive Disease|1|||
170494899|NCT02553499|616152113|FG005|Overall Study|Progressive Disease|1|||
170494900|NCT02553499|616152114|FG006|Overall Study|Progressive Disease|1|||
170494901|NCT02553499|616152115|FG007|Overall Study|Progressive Disease|0|||
170494902|NCT02553499|616152116|FG008|Overall Study|Progressive Disease|0|||
170494903|NCT02553499|616152117|FG009|Overall Study|Progressive Disease|1|||
170494904|NCT02553499|616152118|FG010|Overall Study|Progressive Disease|0|||
170494905|NCT02553499|616152119|FG011|Overall Study|Progressive Disease|0|||
170494906|NCT02553499|616152120|FG012|Overall Study|Progressive Disease|2|||
170494907|NCT02553499|616152121|FG013|Overall Study|Progressive Disease|1|||
170494908|NCT02553499|616152108|FG000|Overall Study|Study Terminated by Sponsor|0|||
170494909|NCT02553499|616152109|FG001|Overall Study|Study Terminated by Sponsor|0|||
170494910|NCT02553499|616152110|FG002|Overall Study|Study Terminated by Sponsor|0|||
170494911|NCT02553499|616152111|FG003|Overall Study|Study Terminated by Sponsor|0|||
170494912|NCT02553499|616152112|FG004|Overall Study|Study Terminated by Sponsor|0|||
170494913|NCT02553499|616152113|FG005|Overall Study|Study Terminated by Sponsor|0|||
170494914|NCT02553499|616152114|FG006|Overall Study|Study Terminated by Sponsor|0|||
170494915|NCT02553499|616152115|FG007|Overall Study|Study Terminated by Sponsor|0|||
170494916|NCT02553499|616152116|FG008|Overall Study|Study Terminated by Sponsor|1|||
170494917|NCT02553499|616152117|FG009|Overall Study|Study Terminated by Sponsor|0|||
170550808|NCT00159874|616362480|FG001|Overall Study|Lost to Follow-up|0|||
170550809|NCT00159874|616362481|FG002|Overall Study|Lost to Follow-up|3|||
170550810|NCT00159874|616362482|FG003|Overall Study|Lost to Follow-up|0|||
170550811|NCT00159874|616362483|FG004|Overall Study|Lost to Follow-up|1|||
170550812|NCT00159874|616362484|FG005|Overall Study|Lost to Follow-up|2|||
170550813|NCT00159874|616362485|FG006|Overall Study|Lost to Follow-up|1|||
170550814|NCT00159874|616362479|FG000|Overall Study|Other|8|||
170550815|NCT00159874|616362480|FG001|Overall Study|Other|8|||
170550816|NCT00159874|616362481|FG002|Overall Study|Other|8|||
170550817|NCT00159874|616362482|FG003|Overall Study|Other|0|||
170550818|NCT00159874|616362483|FG004|Overall Study|Other|2|||
170550819|NCT00159874|616362484|FG005|Overall Study|Other|1|||
170550820|NCT00159874|616362485|FG006|Overall Study|Other|3|||
170550821|NCT00159874|616362479|FG000|Overall Study|Protocol Violation|0|||
170550822|NCT00159874|616362480|FG001|Overall Study|Protocol Violation|5|||
170550823|NCT00159874|616362481|FG002|Overall Study|Protocol Violation|2|||
170550824|NCT00159874|616362482|FG003|Overall Study|Protocol Violation|0|||
170550825|NCT00159874|616362483|FG004|Overall Study|Protocol Violation|0|||
170550826|NCT00159874|616362484|FG005|Overall Study|Protocol Violation|0|||
170550827|NCT00159874|616362485|FG006|Overall Study|Protocol Violation|0|||
170550828|NCT00159874|616362479|FG000|Overall Study|Death|3|||
170550829|NCT00159874|616362480|FG001|Overall Study|Death|8|||
170550830|NCT00159874|616362481|FG002|Overall Study|Death|15|||
170550831|NCT00159874|616362482|FG003|Overall Study|Death|0|||
170550832|NCT00159874|616362483|FG004|Overall Study|Death|1|||
170550833|NCT00159874|616362484|FG005|Overall Study|Death|2|||
170550834|NCT00159874|616362485|FG006|Overall Study|Death|0|||
170550835|NCT00159874|616362479|FG000|Overall Study|Withdrawal by Subject|2|||
170550836|NCT00159874|616362480|FG001|Overall Study|Withdrawal by Subject|6|||
170550837|NCT00159874|616362481|FG002|Overall Study|Withdrawal by Subject|8|||
170550838|NCT00159874|616362482|FG003|Overall Study|Withdrawal by Subject|4|||
170494918|NCT02553499|616152118|FG010|Overall Study|Study Terminated by Sponsor|0|||
170494919|NCT02553499|616152119|FG011|Overall Study|Study Terminated by Sponsor|0|||
170494920|NCT02553499|616152120|FG012|Overall Study|Study Terminated by Sponsor|0|||
170494921|NCT02553499|616152121|FG013|Overall Study|Study Terminated by Sponsor|0|||
170494922|NCT02553499|616152108|FG000|Overall Study|Withdrawal by Subject|2|||
170550839|NCT00159874|616362483|FG004|Overall Study|Withdrawal by Subject|3|||
170494923|NCT02553499|616152109|FG001|Overall Study|Withdrawal by Subject|0|||
170494924|NCT02553499|616152110|FG002|Overall Study|Withdrawal by Subject|0|||
170550840|NCT00159874|616362484|FG005|Overall Study|Withdrawal by Subject|2|||
170550841|NCT00159874|616362485|FG006|Overall Study|Withdrawal by Subject|1|||
170494925|NCT02553499|616152111|FG003|Overall Study|Withdrawal by Subject|0|||
170494926|NCT02553499|616152112|FG004|Overall Study|Withdrawal by Subject|0|||
170494927|NCT02553499|616152113|FG005|Overall Study|Withdrawal by Subject|0|||
170494928|NCT02553499|616152114|FG006|Overall Study|Withdrawal by Subject|0|||
170494929|NCT02553499|616152115|FG007|Overall Study|Withdrawal by Subject|1|||
170494930|NCT02553499|616152116|FG008|Overall Study|Withdrawal by Subject|1|||
170494931|NCT02553499|616152117|FG009|Overall Study|Withdrawal by Subject|0|||
170494932|NCT02553499|616152118|FG010|Overall Study|Withdrawal by Subject|1|||
170494933|NCT02553499|616152119|FG011|Overall Study|Withdrawal by Subject|0|||
170494934|NCT02553499|616152120|FG012|Overall Study|Withdrawal by Subject|0|||
170494935|NCT02553499|616152121|FG013|Overall Study|Withdrawal by Subject|0|||
170494936|NCT01582178|616152122|FG000|Overall Study|Physician Decision|6|||
170494937|NCT01582178|616152123|FG001|Overall Study|Physician Decision|5|||
170494938|NCT00582608|616152124|FG000|Overall Study|Not Treated|7|||
170494939|NCT00582608|616152124|FG000|Overall Study|Patient Ineligible|1|||
170494940|NCT00582608|616152124|FG000|Overall Study|Lack of accrual|4|||
170494941|NCT00570063|616152125|FG000|Overall Study|Adverse Event|4|||
170494942|NCT00570063|616152126|FG001|Overall Study|Adverse Event|1|||
170494943|NCT00570063|616152125|FG000|Overall Study|Lack of Efficacy|0|||
170494944|NCT00570063|616152126|FG001|Overall Study|Lack of Efficacy|1|||
170494945|NCT00570063|616152125|FG000|Overall Study|Withdrawal by Subject|4|||
170494946|NCT00570063|616152126|FG001|Overall Study|Withdrawal by Subject|3|||
170494947|NCT00570063|616152125|FG000|Overall Study|Sponsor's Decision|7|||
170494948|NCT00570063|616152126|FG001|Overall Study|Sponsor's Decision|3|||
170494949|NCT00550043|616152130|FG000|Overall Study|Adverse Event|0|||
170494950|NCT00550043|616152131|FG001|Overall Study|Adverse Event|0|||
170494951|NCT00550043|616152132|FG002|Overall Study|Adverse Event|0|||
170494952|NCT00550043|616152133|FG003|Overall Study|Adverse Event|1|||
170494953|NCT00550043|616152134|FG004|Overall Study|Adverse Event|1|||
170494954|NCT00550043|616152130|FG000|Overall Study|Subject Withdrew Consent|0|||
170494955|NCT00550043|616152131|FG001|Overall Study|Subject Withdrew Consent|2|||
170494956|NCT00550043|616152132|FG002|Overall Study|Subject Withdrew Consent|1|||
170494957|NCT00550043|616152133|FG003|Overall Study|Subject Withdrew Consent|0|||
170494958|NCT00550043|616152134|FG004|Overall Study|Subject Withdrew Consent|0|||
170494959|NCT00550043|616152130|FG000|Overall Study|Other Reasons- Unspecified|0|||
170494960|NCT00550043|616152131|FG001|Overall Study|Other Reasons- Unspecified|1|||
170494961|NCT00550043|616152132|FG002|Overall Study|Other Reasons- Unspecified|0|||
170494962|NCT00550043|616152133|FG003|Overall Study|Other Reasons- Unspecified|1|||
170494963|NCT00550043|616152134|FG004|Overall Study|Other Reasons- Unspecified|0|||
170494964|NCT01031680|616152135|FG000|Overall Study|Adverse Event|8|||
170494965|NCT01031680|616152136|FG001|Overall Study|Adverse Event|3|||
170494966|NCT01031680|616152135|FG000|Overall Study|Lost to Follow-up|2|||
170494967|NCT01031680|616152136|FG001|Overall Study|Lost to Follow-up|10|||
170494968|NCT01031680|616152135|FG000|Overall Study|Withdrawal by Subject|12|||
170494969|NCT01031680|616152136|FG001|Overall Study|Withdrawal by Subject|16|||
170494970|NCT01031680|616152135|FG000|Overall Study|Death|2|||
170494971|NCT01031680|616152136|FG001|Overall Study|Death|1|||
170494972|NCT01031680|616152135|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
170494973|NCT01031680|616152136|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
170494974|NCT01031680|616152135|FG000|Overall Study|Poor/Non-compliance|5|||
170494975|NCT01031680|616152136|FG001|Overall Study|Poor/Non-compliance|6|||
170494976|NCT01031680|616152135|FG000|Overall Study|Safety|1|||
170494977|NCT01031680|616152136|FG001|Overall Study|Safety|0|||
170494978|NCT01031680|616152135|FG000|Overall Study|Incorrect Enrolment|1|||
170494979|NCT01031680|616152136|FG001|Overall Study|Incorrect Enrolment|2|||
170494980|NCT01031680|616152135|FG000|Overall Study|Administrative Reason by Sponsor|0|||
170494981|NCT01031680|616152136|FG001|Overall Study|Administrative Reason by Sponsor|1|||
170494982|NCT01031680|616152135|FG000|Overall Study|Various|0|||
170550842|NCT00159874|616362479|FG000|Overall Study|Pregnancy|1|||
170550843|NCT00159874|616362480|FG001|Overall Study|Pregnancy|1|||
170550844|NCT00159874|616362481|FG002|Overall Study|Pregnancy|0|||
170550845|NCT00159874|616362482|FG003|Overall Study|Pregnancy|0|||
170550846|NCT00159874|616362483|FG004|Overall Study|Pregnancy|0|||
170550847|NCT00159874|616362484|FG005|Overall Study|Pregnancy|0|||
170550848|NCT00159874|616362485|FG006|Overall Study|Pregnancy|0|||
170550849|NCT01104870|616362486|FG000|Overall Study|Adverse Event|1|||
170550850|NCT01104870|616362487|FG001|Overall Study|Adverse Event|1|||
170550851|NCT01104870|616362488|FG002|Overall Study|Adverse Event|0|||
170550852|NCT01104870|616362486|FG000|Overall Study|Death|0|||
170550853|NCT01104870|616362487|FG001|Overall Study|Death|0|||
170550854|NCT01104870|616362488|FG002|Overall Study|Death|1|||
170550855|NCT01104870|616362486|FG000|Overall Study|Withdrawal by Subject|0|||
170494983|NCT01031680|616152136|FG001|Overall Study|Various|2|||
170494984|NCT03478644|616152137|FG000|Phase 2|Withdrawal by Subject|2|||
170550856|NCT01104870|616362487|FG001|Overall Study|Withdrawal by Subject|0|||
170550857|NCT01104870|616362488|FG002|Overall Study|Withdrawal by Subject|1|||
170494985|NCT03478644|616152138|FG001|Phase 2|Withdrawal by Subject|1|||
170494986|NCT03478644|616152137|FG000|Phase 2|Lost to Follow-up|1|||
170550858|NCT05463705|616362491|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
170494987|NCT03478644|616152138|FG001|Phase 2|Lost to Follow-up|0|||
170494988|NCT00430573|616152139|FG000|Overall Study|Withdrawal by Subject|5|||
170494989|NCT01483027|616152140|FG000|Overall Study|Administrative Reasons|2|||
170494990|NCT01483027|616152141|FG001|Overall Study|Administrative Reasons|1|||
170494991|NCT01483027|616152140|FG000|Overall Study|Withdrawal by Subject|21|||
170494992|NCT01483027|616152141|FG001|Overall Study|Withdrawal by Subject|32|||
170494993|NCT01483027|616152140|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
170494994|NCT01483027|616152141|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
170494995|NCT01483027|616152140|FG000|Overall Study|Lost to Follow-up|1|||
170494996|NCT01483027|616152141|FG001|Overall Study|Lost to Follow-up|1|||
170494997|NCT01483027|616152140|FG000|Overall Study|Adverse Event|0|||
170494998|NCT01483027|616152141|FG001|Overall Study|Adverse Event|1|||
170494999|NCT01483027|616152140|FG000|Overall Study|Withdrawal by Subject|0|||
170495000|NCT01483027|616152141|FG001|Overall Study|Withdrawal by Subject|1|||
170495001|NCT05020665|616152144|FG000|Overall Study|Study terminated by Sponsor|5|||
170495002|NCT05020665|616152145|FG001|Overall Study|Study terminated by Sponsor|4|||
170495003|NCT05020665|616152144|FG000|Overall Study|Death|2|||
170495004|NCT05020665|616152145|FG001|Overall Study|Death|1|||
170495005|NCT05020665|616152144|FG000|Overall Study|Physician Decision|0|||
170495006|NCT05020665|616152145|FG001|Overall Study|Physician Decision|1|||
170495007|NCT05020665|616152144|FG000|Overall Study|Withdrawal by Subject|0|||
170495008|NCT05020665|616152145|FG001|Overall Study|Withdrawal by Subject|1|||
170495009|NCT05020665|616152144|FG000|Overall Study|Reason not specified|1|||
170495010|NCT05020665|616152145|FG001|Overall Study|Reason not specified|0|||
170495011|NCT01743560|616152150|FG000|Overall Study|Disease progression|26|||
170495012|NCT01743560|616152150|FG000|Overall Study|Adverse Event|8|||
170495013|NCT01743560|616152150|FG000|Overall Study|Death|3|||
170495014|NCT01743560|616152150|FG000|Overall Study|Withdrawal by Subject|2|||
170495015|NCT01743560|616152150|FG000|Overall Study|Protocol Violation|1|||
170495016|NCT01743560|616152150|FG000|Overall Study|>1 dose of study drug|3|||
170495017|NCT03070002|616152151|FG000|Follow up for 2 Years|Death|1|||
170495018|NCT00784550|616154504|FG000|Overall Study|Adverse Event|12|||
170495019|NCT00784550|616154505|FG001|Overall Study|Adverse Event|10|||
170495020|NCT00784550|616154504|FG000|Overall Study|Lack of Efficacy|0|||
170495021|NCT00784550|616154505|FG001|Overall Study|Lack of Efficacy|1|||
170495022|NCT00784550|616154504|FG000|Overall Study|Protocol Violation|10|||
170495023|NCT00784550|616154505|FG001|Overall Study|Protocol Violation|10|||
170495024|NCT00784550|616154504|FG000|Overall Study|Lost to Follow-up|8|||
170495025|NCT00784550|616154505|FG001|Overall Study|Lost to Follow-up|5|||
170495026|NCT00784550|616154504|FG000|Overall Study|Physician Decision|2|||
170495027|NCT00784550|616154505|FG001|Overall Study|Physician Decision|3|||
170495028|NCT00784550|616154504|FG000|Overall Study|Withdrawal by Subject|4|||
170495029|NCT00784550|616154505|FG001|Overall Study|Withdrawal by Subject|13|||
170495030|NCT05903924|616154506|FG000|Overall Study|Lost to Follow-up|1|||
170495031|NCT05903924|616154507|FG001|Overall Study|Lost to Follow-up|0|||
170495032|NCT05903924|616154508|FG002|Overall Study|Lost to Follow-up|0|||
170495033|NCT04338269|616154509|FG000|Overall Study|Death|86|||
170495034|NCT04338269|616154510|FG001|Overall Study|Death|89|||
170495035|NCT04338269|616154509|FG000|Overall Study|Lost to Follow-up|1|||
170495036|NCT04338269|616154510|FG001|Overall Study|Lost to Follow-up|2|||
170495037|NCT04338269|616154509|FG000|Overall Study|Physician Decision|1|||
170495038|NCT04338269|616154510|FG001|Overall Study|Physician Decision|0|||
170495039|NCT04338269|616154509|FG000|Overall Study|Withdrawal by Subject|14|||
170495040|NCT04338269|616154510|FG001|Overall Study|Withdrawal by Subject|11|||
170495041|NCT00477750|616154514|FG000|Overall Study|Currently Receiving Treatment|11|||
170495042|NCT04166591|616154515|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
170641888|NCT00114517|616701381|FG003|Overall Study|Moved from area|1|||
170641889|NCT00114517|616701378|FG000|Overall Study|Did not want estradiol|1|||
170641890|NCT00114517|616701379|FG001|Overall Study|Did not want estradiol|1|||
170641891|NCT00114517|616701380|FG002|Overall Study|Did not want estradiol|0|||
170641892|NCT00114517|616701381|FG003|Overall Study|Did not want estradiol|0|||
170641893|NCT00114517|616701378|FG000|Overall Study|Armed-services duty|0|||
170641894|NCT00114517|616701379|FG001|Overall Study|Armed-services duty|1|||
170641895|NCT00114517|616701380|FG002|Overall Study|Armed-services duty|0|||
170495043|NCT04166591|616154516|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
170495044|NCT04166591|616154517|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
170495045|NCT04166591|616154518|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
170495046|NCT04166591|616154515|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
170641896|NCT00114517|616701381|FG003|Overall Study|Armed-services duty|1|||
170641897|NCT00114517|616701378|FG000|Overall Study|Competing family issue|0|||
170641898|NCT00114517|616701379|FG001|Overall Study|Competing family issue|1|||
170495047|NCT04166591|616154516|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
170495048|NCT04166591|616154517|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
170495049|NCT04166591|616154518|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
170495050|NCT03960021|616154519|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
170495051|NCT03693612|616154520|FG000|Overall Study|Lost to Follow-up|0|||
170495052|NCT03693612|616154521|FG001|Overall Study|Lost to Follow-up|0|||
170495053|NCT03693612|616154522|FG002|Overall Study|Lost to Follow-up|0|||
170495054|NCT03693612|616154523|FG003|Overall Study|Lost to Follow-up|0|||
170495055|NCT03693612|616154524|FG004|Overall Study|Lost to Follow-up|1|||
170495056|NCT03693612|616154525|FG005|Overall Study|Lost to Follow-up|0|||
170495057|NCT03693612|616154526|FG006|Overall Study|Lost to Follow-up|0|||
170495058|NCT03693612|616154520|FG000|Overall Study|Withdrawal by Subject|0|||
170495059|NCT03693612|616154521|FG001|Overall Study|Withdrawal by Subject|0|||
170495060|NCT03693612|616154522|FG002|Overall Study|Withdrawal by Subject|1|||
170495061|NCT03693612|616154523|FG003|Overall Study|Withdrawal by Subject|0|||
170495062|NCT03693612|616154524|FG004|Overall Study|Withdrawal by Subject|2|||
170495063|NCT03693612|616154525|FG005|Overall Study|Withdrawal by Subject|0|||
170495064|NCT03693612|616154526|FG006|Overall Study|Withdrawal by Subject|0|||
170495065|NCT03693612|616154520|FG000|Overall Study|Study Terminated by Sponsor|0|||
170495066|NCT03693612|616154521|FG001|Overall Study|Study Terminated by Sponsor|1|||
170495067|NCT03693612|616154522|FG002|Overall Study|Study Terminated by Sponsor|0|||
170495068|NCT03693612|616154523|FG003|Overall Study|Study Terminated by Sponsor|0|||
170495069|NCT03693612|616154524|FG004|Overall Study|Study Terminated by Sponsor|3|||
170495070|NCT03693612|616154525|FG005|Overall Study|Study Terminated by Sponsor|0|||
170495071|NCT03693612|616154526|FG006|Overall Study|Study Terminated by Sponsor|0|||
170495072|NCT00601172|616154527|FG000|Overall Study|Adverse Event|43|||
170495073|NCT00601172|616154528|FG001|Overall Study|Adverse Event|32|||
170495074|NCT00601172|616154527|FG000|Overall Study|Lack of Efficacy|11|||
170495075|NCT00601172|616154528|FG001|Overall Study|Lack of Efficacy|12|||
170495076|NCT00601172|616154527|FG000|Overall Study|Protocol Violation|2|||
170495077|NCT00601172|616154528|FG001|Overall Study|Protocol Violation|5|||
170495078|NCT00601172|616154527|FG000|Overall Study|Lost to Follow-up|4|||
170495079|NCT00601172|616154528|FG001|Overall Study|Lost to Follow-up|3|||
170495080|NCT00601172|616154527|FG000|Overall Study|Physician Decision|27|||
170495081|NCT00601172|616154528|FG001|Overall Study|Physician Decision|28|||
170495082|NCT00601172|616154527|FG000|Overall Study|Withdrawal by Subject|35|||
170495083|NCT00601172|616154528|FG001|Overall Study|Withdrawal by Subject|27|||
170495084|NCT00601172|616154527|FG000|Overall Study|Did not meet continuation criteria|19|||
170495085|NCT00601172|616154528|FG001|Overall Study|Did not meet continuation criteria|20|||
170495086|NCT01953601|616154532|FG000|Part 1 (Base Study)|Adverse Event|24|||
170495087|NCT01953601|616154533|FG001|Part 1 (Base Study)|Adverse Event|37|||
170495088|NCT01953601|616154534|FG002|Part 1 (Base Study)|Adverse Event|15|||
170495089|NCT01953601|616154532|FG000|Part 1 (Base Study)|Death|2|||
170495090|NCT01953601|616154533|FG001|Part 1 (Base Study)|Death|0|||
170495091|NCT01953601|616154534|FG002|Part 1 (Base Study)|Death|3|||
170495092|NCT01953601|616154532|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
170495093|NCT01953601|616154533|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
170495094|NCT01953601|616154534|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
170495095|NCT01953601|616154532|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
170495096|NCT01953601|616154533|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
170495097|NCT01953601|616154534|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
170495098|NCT01953601|616154532|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
170495099|NCT01953601|616154533|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
170495100|NCT01953601|616154534|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
170495101|NCT01953601|616154532|FG000|Part 1 (Base Study)|Physician Decision|3|||
170495102|NCT01953601|616154533|FG001|Part 1 (Base Study)|Physician Decision|7|||
170550859|NCT05463705|616362492|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
170550860|NCT05463705|616362493|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
170550861|NCT05463705|616362494|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
170550862|NCT05463705|616362495|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
170550863|NCT05463705|616362496|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
170550864|NCT02244957|616362499|FG000|Overall Study|Lack of Efficacy|1|||
170550865|NCT02244957|616362500|FG001|Overall Study|Lack of Efficacy|0|||
170550866|NCT02624687|616362502|FG000|Overall Study|Withdrawal by Subject|1|||
170550867|NCT02624687|616362503|FG001|Overall Study|Withdrawal by Subject|1|||
170550868|NCT02624687|616362502|FG000|Overall Study|medical leave from work|0|||
170550869|NCT02624687|616362503|FG001|Overall Study|medical leave from work|1|||
170550870|NCT02771145|616362506|FG000|Overall Study|Adverse Event|3|||
170495103|NCT01953601|616154534|FG002|Part 1 (Base Study)|Physician Decision|4|||
170495104|NCT01953601|616154532|FG000|Part 1 (Base Study)|Screen failure|1|||
170495105|NCT01953601|616154533|FG001|Part 1 (Base Study)|Screen failure|0|||
170495106|NCT01953601|616154534|FG002|Part 1 (Base Study)|Screen failure|1|||
170495107|NCT01953601|616154532|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
170495108|NCT01953601|616154533|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
170495109|NCT01953601|616154534|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
170495110|NCT01953601|616154532|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
170550871|NCT02771145|616362506|FG000|Overall Study|Lost to Follow-up|1|||
170495111|NCT01953601|616154533|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
170550872|NCT00276380|616362507|FG000|Overall Study|Adverse Event|5|||
170550873|NCT00276380|616362508|FG001|Overall Study|Adverse Event|3|||
170495112|NCT01953601|616154534|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
170495113|NCT01953601|616154532|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
170495114|NCT01953601|616154533|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
170495115|NCT01953601|616154534|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
170495116|NCT01953601|616154532|FG000|Part 1 (Base Study)|Subject moved|2|||
170495117|NCT01953601|616154533|FG001|Part 1 (Base Study)|Subject moved|2|||
170495118|NCT01953601|616154534|FG002|Part 1 (Base Study)|Subject moved|1|||
170495119|NCT01953601|616154532|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
170495120|NCT01953601|616154533|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
170495121|NCT01953601|616154534|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
170495122|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Adverse Event|1|||
170495123|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Adverse Event|1|||
170495124|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Adverse Event|10|||
170495125|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Death|0|||
170495126|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Death|3|||
170495127|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Death|0|||
170495128|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
170495129|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
170495130|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
170495131|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
170495132|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
170495133|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
170495134|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Physician Decision|2|||
170495135|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Physician Decision|0|||
170495136|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Physician Decision|2|||
170495137|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
170495138|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
170495139|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
170495140|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
170495141|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
170495142|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
170495143|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
170495144|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
170495145|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
170495146|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Subject moved|0|||
170495147|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Subject moved|0|||
170495148|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Subject moved|1|||
170495149|NCT01953601|616154532|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
170495150|NCT01953601|616154533|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
170495151|NCT01953601|616154534|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
170495152|NCT01905553|616154536|FG000|Period 2|Adverse Event|1|||
170495153|NCT01905553|616154537|FG001|Period 2|Adverse Event|0|||
170495154|NCT03962790|616154538|FG000|Period 1|Adverse Event|0|||
170495155|NCT03962790|616154539|FG001|Period 1|Adverse Event|1|||
170495156|NCT03962790|616154538|FG000|Period 1|Failed to meet all eligibility criteria|1|||
170495157|NCT03962790|616154539|FG001|Period 1|Failed to meet all eligibility criteria|1|||
170495158|NCT03962790|616154538|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
170495159|NCT03962790|616154539|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
170495160|NCT03962790|616154538|FG000|Period 1|Withdrawal by Subject|1|||
170495161|NCT03962790|616154539|FG001|Period 1|Withdrawal by Subject|0|||
170495162|NCT01300338|616154541|FG000|Overall Study|Lost to Follow-up|5|||
170495163|NCT01300338|616154542|FG001|Overall Study|Lost to Follow-up|0|||
170495164|NCT02461524|616154543|FG000|Overall Study|Death|16|||
170495165|NCT02461524|616154543|FG000|Overall Study|Withdrawal by Subject|4|||
170495166|NCT02461524|616154543|FG000|Overall Study|Device Explanted|5|||
170495167|NCT02461524|616154543|FG000|Overall Study|Missed Visit|6|||
170495168|NCT01936181|616154544|FG000|Randomised, Double-blind|Adverse Event|27|||
170495169|NCT01936181|616154545|FG001|Randomised, Double-blind|Adverse Event|21|||
170495170|NCT01936181|616154546|FG002|Randomised, Double-blind|Adverse Event|0|||
170495171|NCT01936181|616154547|FG003|Randomised, Double-blind|Adverse Event|0|||
170495172|NCT01936181|616154544|FG000|Randomised, Double-blind|Protocol Violation|1|||
170495173|NCT01936181|616154545|FG001|Randomised, Double-blind|Protocol Violation|5|||
170495174|NCT01936181|616154546|FG002|Randomised, Double-blind|Protocol Violation|0|||
170495175|NCT01936181|616154547|FG003|Randomised, Double-blind|Protocol Violation|0|||
170495176|NCT01936181|616154544|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
170495177|NCT01936181|616154545|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
170495178|NCT01936181|616154546|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
170495179|NCT01936181|616154547|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
170495180|NCT01936181|616154544|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
170495181|NCT01936181|616154545|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
170495182|NCT01936181|616154546|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
170495183|NCT01936181|616154547|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
170495184|NCT01936181|616154544|FG000|Randomised, Double-blind|Pregnancy|0|||
170495185|NCT01936181|616154545|FG001|Randomised, Double-blind|Pregnancy|1|||
170495186|NCT01936181|616154546|FG002|Randomised, Double-blind|Pregnancy|0|||
170495187|NCT01936181|616154547|FG003|Randomised, Double-blind|Pregnancy|0|||
170495188|NCT01936181|616154544|FG000|Randomised, Double-blind|Physician Decision|4|||
170495189|NCT01936181|616154545|FG001|Randomised, Double-blind|Physician Decision|4|||
170495190|NCT01936181|616154546|FG002|Randomised, Double-blind|Physician Decision|0|||
170495191|NCT01936181|616154547|FG003|Randomised, Double-blind|Physician Decision|0|||
170550874|NCT00276380|616362507|FG000|Overall Study|Lost to Follow-up|1|||
170550875|NCT00276380|616362508|FG001|Overall Study|Lost to Follow-up|1|||
170550876|NCT00276380|616362507|FG000|Overall Study|Withdrawal by Subject|3|||
170550877|NCT00276380|616362508|FG001|Overall Study|Withdrawal by Subject|6|||
170550878|NCT00276380|616362507|FG000|Overall Study|Death|5|||
170550879|NCT00276380|616362508|FG001|Overall Study|Death|3|||
170550880|NCT00276380|616362507|FG000|Overall Study|Abnormal aPPT Levels|0|||
170550881|NCT00276380|616362508|FG001|Overall Study|Abnormal aPPT Levels|1|||
170550882|NCT00552279|616362512|FG000|Overall Study|Adverse Event|0|||
170550883|NCT00552279|616362513|FG001|Overall Study|Adverse Event|1|||
170550884|NCT00552279|616362512|FG000|Overall Study|Withdrawal by Subject|12|||
170550885|NCT00552279|616362513|FG001|Overall Study|Withdrawal by Subject|1|||
170550886|NCT00552279|616362512|FG000|Overall Study|Lost to Follow-up|1|||
170550887|NCT00552279|616362513|FG001|Overall Study|Lost to Follow-up|0|||
170550888|NCT00552279|616362512|FG000|Overall Study|Other|1|||
170550889|NCT00552279|616362513|FG001|Overall Study|Other|1|||
170550890|NCT02150863|616362514|FG000|Overall Study|Lost to Follow-up|0|||
170550891|NCT02150863|616362515|FG001|Overall Study|Lost to Follow-up|1|||
170550892|NCT02150863|616362516|FG002|Overall Study|Lost to Follow-up|0|||
170550893|NCT01651208|616362517|FG000|Overall Study|Lost to Follow-up|14|||
170550894|NCT01651208|616362518|FG001|Overall Study|Lost to Follow-up|16|||
170550895|NCT05287685|616362519|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
170550896|NCT05287685|616362520|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
170550897|NCT05287685|616362519|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
170550898|NCT05287685|616362520|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
170550899|NCT05529173|616362521|FG000|Overall Study|Physician Decision|3|||
170550900|NCT05529173|616362522|FG001|Overall Study|Physician Decision|6|||
170550901|NCT05529173|616362521|FG000|Overall Study|Sample shipment delay more than one day|4|||
170550902|NCT05529173|616362522|FG001|Overall Study|Sample shipment delay more than one day|0|||
170550903|NCT00835042|616362523|FG000|First Intervention|Withdrawal by Subject|3|||
170550904|NCT00835042|616362524|FG001|First Intervention|Withdrawal by Subject|0|||
170550905|NCT00835042|616362523|FG000|First Intervention|Adverse Event|1|||
170550906|NCT00835042|616362524|FG001|First Intervention|Adverse Event|2|||
170550907|NCT00835042|616362523|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
170550908|NCT00835042|616362524|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
170550909|NCT03760081|616362525|FG000|Overall Study|Miscellaneous|0|||
170550910|NCT03760081|616362526|FG001|Overall Study|Miscellaneous|1|||
170550911|NCT03760081|616362525|FG000|Overall Study|Progressive Disease|5|||
170550912|NCT03760081|616362526|FG001|Overall Study|Progressive Disease|10|||
170550913|NCT03760081|616362525|FG000|Overall Study|Death|1|||
170550914|NCT03760081|616362526|FG001|Overall Study|Death|1|||
170550915|NCT03835117|616362527|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
170550916|NCT03835117|616362528|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
170550917|NCT02662582|616362529|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
170550918|NCT02662582|616362530|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
170550919|NCT02662582|616362529|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
170550920|NCT02662582|616362530|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
170550921|NCT02662582|616362529|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
170550922|NCT02662582|616362530|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
170550923|NCT02662582|616362529|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170550924|NCT02662582|616362530|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170550925|NCT01063881|616362535|FG000|Overall Study|Adverse Event|12|||
170550926|NCT01063881|616362536|FG001|Overall Study|Adverse Event|2|||
170550927|NCT01063881|616362537|FG002|Overall Study|Adverse Event|0|||
170495192|NCT01936181|616154544|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
170550928|NCT01063881|616362535|FG000|Overall Study|Lost to Follow-up|13|||
170550929|NCT01063881|616362536|FG001|Overall Study|Lost to Follow-up|7|||
170550930|NCT01063881|616362537|FG002|Overall Study|Lost to Follow-up|1|||
170550931|NCT01063881|616362535|FG000|Overall Study|Withdrawal by Subject|25|||
170550932|NCT01063881|616362536|FG001|Overall Study|Withdrawal by Subject|1|||
170550933|NCT01063881|616362537|FG002|Overall Study|Withdrawal by Subject|0|||
170550934|NCT01063881|616362535|FG000|Overall Study|Reason for not completed not specified|5|||
170550935|NCT01063881|616362536|FG001|Overall Study|Reason for not completed not specified|1|||
170550936|NCT01063881|616362537|FG002|Overall Study|Reason for not completed not specified|0|||
170550937|NCT00407030|616362538|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
170550938|NCT00407030|616362539|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
170495193|NCT01936181|616154545|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
170641899|NCT00114517|616701380|FG002|Overall Study|Competing family issue|0|||
170641900|NCT00114517|616701381|FG003|Overall Study|Competing family issue|1|||
170641901|NCT00114517|616701378|FG000|Overall Study|Physician Decision|0|||
170495194|NCT01936181|616154546|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
170495195|NCT01936181|616154547|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
170495196|NCT01936181|616154544|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
170495197|NCT01936181|616154545|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
170495198|NCT01936181|616154546|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
170495199|NCT01936181|616154547|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
170495200|NCT01936181|616154544|FG000|Transition-extension|Adverse Event|3|||
170495201|NCT01936181|616154545|FG001|Transition-extension|Adverse Event|0|||
170495202|NCT01936181|616154546|FG002|Transition-extension|Adverse Event|3|||
170495203|NCT01936181|616154547|FG003|Transition-extension|Adverse Event|1|||
170495204|NCT01936181|616154544|FG000|Transition-extension|Lost to Follow-up|3|||
170495205|NCT01936181|616154545|FG001|Transition-extension|Lost to Follow-up|0|||
170495206|NCT01936181|616154546|FG002|Transition-extension|Lost to Follow-up|1|||
170495207|NCT01936181|616154547|FG003|Transition-extension|Lost to Follow-up|2|||
170495208|NCT01936181|616154544|FG000|Transition-extension|Physician Decision|2|||
170495209|NCT01936181|616154545|FG001|Transition-extension|Physician Decision|0|||
170495210|NCT01936181|616154546|FG002|Transition-extension|Physician Decision|0|||
170495211|NCT01936181|616154547|FG003|Transition-extension|Physician Decision|1|||
170495212|NCT01936181|616154544|FG000|Transition-extension|Withdrawal by Subject|7|||
170495213|NCT01936181|616154545|FG001|Transition-extension|Withdrawal by Subject|0|||
170495214|NCT01936181|616154546|FG002|Transition-extension|Withdrawal by Subject|2|||
170495215|NCT01936181|616154547|FG003|Transition-extension|Withdrawal by Subject|1|||
170495216|NCT03535194|616154555|FG000|Induction Period|Adverse Event|2|||
170495217|NCT03535194|616154556|FG001|Induction Period|Adverse Event|2|||
170495218|NCT03535194|616154557|FG002|Induction Period|Adverse Event|1|||
170495219|NCT03535194|616154558|FG003|Induction Period|Adverse Event|3|||
170495220|NCT03535194|616154559|FG004|Induction Period|Adverse Event|0|||
170495221|NCT03535194|616154555|FG000|Induction Period|Death|0|||
170495222|NCT03535194|616154556|FG001|Induction Period|Death|1|||
170495223|NCT03535194|616154557|FG002|Induction Period|Death|0|||
170495224|NCT03535194|616154558|FG003|Induction Period|Death|0|||
170495225|NCT03535194|616154559|FG004|Induction Period|Death|0|||
170495226|NCT03535194|616154555|FG000|Induction Period|Lack of Efficacy|1|||
170495227|NCT03535194|616154556|FG001|Induction Period|Lack of Efficacy|3|||
170495228|NCT03535194|616154557|FG002|Induction Period|Lack of Efficacy|2|||
170495229|NCT03535194|616154558|FG003|Induction Period|Lack of Efficacy|2|||
170495230|NCT03535194|616154559|FG004|Induction Period|Lack of Efficacy|0|||
170495231|NCT03535194|616154555|FG000|Induction Period|Lost to Follow-up|3|||
170495232|NCT03535194|616154556|FG001|Induction Period|Lost to Follow-up|5|||
170495233|NCT03535194|616154557|FG002|Induction Period|Lost to Follow-up|2|||
170495234|NCT03535194|616154558|FG003|Induction Period|Lost to Follow-up|3|||
170495235|NCT03535194|616154559|FG004|Induction Period|Lost to Follow-up|0|||
170495236|NCT03535194|616154555|FG000|Induction Period|Physician Decision|1|||
170495237|NCT03535194|616154556|FG001|Induction Period|Physician Decision|1|||
170495238|NCT03535194|616154557|FG002|Induction Period|Physician Decision|0|||
170495239|NCT03535194|616154558|FG003|Induction Period|Physician Decision|0|||
170495240|NCT03535194|616154559|FG004|Induction Period|Physician Decision|0|||
170495241|NCT03535194|616154555|FG000|Induction Period|Protocol Violation|1|||
170495242|NCT03535194|616154556|FG001|Induction Period|Protocol Violation|0|||
170495243|NCT03535194|616154557|FG002|Induction Period|Protocol Violation|0|||
170495244|NCT03535194|616154558|FG003|Induction Period|Protocol Violation|1|||
170495245|NCT03535194|616154559|FG004|Induction Period|Protocol Violation|0|||
170495246|NCT03535194|616154555|FG000|Induction Period|Screen Failure|0|||
170495247|NCT03535194|616154556|FG001|Induction Period|Screen Failure|1|||
170495248|NCT03535194|616154557|FG002|Induction Period|Screen Failure|0|||
170495249|NCT03535194|616154558|FG003|Induction Period|Screen Failure|0|||
170495250|NCT03535194|616154559|FG004|Induction Period|Screen Failure|0|||
170495251|NCT03535194|616154555|FG000|Induction Period|Withdrawal by Subject|3|||
170495252|NCT03535194|616154556|FG001|Induction Period|Withdrawal by Subject|4|||
170495253|NCT03535194|616154557|FG002|Induction Period|Withdrawal by Subject|3|||
170495254|NCT03535194|616154558|FG003|Induction Period|Withdrawal by Subject|2|||
170495255|NCT03535194|616154559|FG004|Induction Period|Withdrawal by Subject|0|||
170495256|NCT03535194|616154555|FG000|Maintenance Period|Adverse Event|6|||
170495257|NCT03535194|616154556|FG001|Maintenance Period|Adverse Event|5|||
170495258|NCT03535194|616154557|FG002|Maintenance Period|Adverse Event|1|||
170495259|NCT03535194|616154558|FG003|Maintenance Period|Adverse Event|11|||
170495260|NCT03535194|616154559|FG004|Maintenance Period|Adverse Event|4|||
170495261|NCT03535194|616154555|FG000|Maintenance Period|Lack of Efficacy|3|||
170495262|NCT03535194|616154556|FG001|Maintenance Period|Lack of Efficacy|2|||
170495263|NCT03535194|616154557|FG002|Maintenance Period|Lack of Efficacy|5|||
170495264|NCT03535194|616154558|FG003|Maintenance Period|Lack of Efficacy|9|||
170495265|NCT03535194|616154559|FG004|Maintenance Period|Lack of Efficacy|0|||
170495266|NCT03535194|616154555|FG000|Maintenance Period|Lost to Follow-up|4|||
170495267|NCT03535194|616154556|FG001|Maintenance Period|Lost to Follow-up|2|||
170495268|NCT03535194|616154557|FG002|Maintenance Period|Lost to Follow-up|1|||
170495269|NCT03535194|616154558|FG003|Maintenance Period|Lost to Follow-up|5|||
170495270|NCT03535194|616154559|FG004|Maintenance Period|Lost to Follow-up|2|||
170495271|NCT03535194|616154555|FG000|Maintenance Period|Other|1|||
170495272|NCT03535194|616154556|FG001|Maintenance Period|Other|2|||
170495273|NCT03535194|616154557|FG002|Maintenance Period|Other|0|||
170495274|NCT03535194|616154558|FG003|Maintenance Period|Other|0|||
170495275|NCT03535194|616154559|FG004|Maintenance Period|Other|0|||
170495276|NCT03535194|616154555|FG000|Maintenance Period|Physician Decision|1|||
170495277|NCT03535194|616154556|FG001|Maintenance Period|Physician Decision|2|||
170495278|NCT03535194|616154557|FG002|Maintenance Period|Physician Decision|0|||
170495279|NCT03535194|616154558|FG003|Maintenance Period|Physician Decision|2|||
170495280|NCT03535194|616154559|FG004|Maintenance Period|Physician Decision|0|||
170495281|NCT03535194|616154555|FG000|Maintenance Period|Pregnancy|0|||
170495282|NCT03535194|616154556|FG001|Maintenance Period|Pregnancy|0|||
170495283|NCT03535194|616154557|FG002|Maintenance Period|Pregnancy|0|||
170495284|NCT03535194|616154558|FG003|Maintenance Period|Pregnancy|2|||
170495285|NCT03535194|616154559|FG004|Maintenance Period|Pregnancy|0|||
170495286|NCT03535194|616154555|FG000|Maintenance Period|Protocol Violation|0|||
170495287|NCT03535194|616154556|FG001|Maintenance Period|Protocol Violation|1|||
170495288|NCT03535194|616154557|FG002|Maintenance Period|Protocol Violation|0|||
170495289|NCT03535194|616154558|FG003|Maintenance Period|Protocol Violation|0|||
170495290|NCT03535194|616154559|FG004|Maintenance Period|Protocol Violation|0|||
170495291|NCT03535194|616154555|FG000|Maintenance Period|Withdrawal by Subject|7|||
170495292|NCT03535194|616154556|FG001|Maintenance Period|Withdrawal by Subject|2|||
170495293|NCT03535194|616154557|FG002|Maintenance Period|Withdrawal by Subject|1|||
170495294|NCT03535194|616154558|FG003|Maintenance Period|Withdrawal by Subject|8|||
170495295|NCT03535194|616154559|FG004|Maintenance Period|Withdrawal by Subject|0|||
170495296|NCT03535194|616154555|FG000|Post-Treatment Followup Period|Adverse Event|4|||
170495297|NCT03535194|616154556|FG001|Post-Treatment Followup Period|Adverse Event|5|||
170495298|NCT03535194|616154557|FG002|Post-Treatment Followup Period|Adverse Event|1|||
170495299|NCT03535194|616154558|FG003|Post-Treatment Followup Period|Adverse Event|8|||
170495300|NCT03535194|616154559|FG004|Post-Treatment Followup Period|Adverse Event|0|||
170495301|NCT03535194|616154555|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
170495302|NCT03535194|616154556|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
170550939|NCT00407030|616362540|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
170550940|NCT00407030|616362538|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
170550941|NCT00407030|616362539|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
170550942|NCT00407030|616362540|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
170550943|NCT00407030|616362538|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
170550944|NCT00407030|616362539|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
170550945|NCT00407030|616362540|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
170550946|NCT00407030|616362538|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
170801917|NCT00822120|617284938|FG000|PET-directed Therapy|Protocol Violation|0|||
170801918|NCT00822120|617284939|FG001|PET-directed Therapy|Protocol Violation|0|||
170801919|NCT00822120|617284940|FG002|PET-directed Therapy|Protocol Violation|0|||
170801920|NCT00822120|617284941|FG003|PET-directed Therapy|Protocol Violation|6|||
170801921|NCT00822120|617284942|FG004|PET-directed Therapy|Protocol Violation|0|||
170801922|NCT00822120|617284943|FG005|PET-directed Therapy|Protocol Violation|0|||
170801923|NCT02397096|617284944|FG000|Day 1 to Week 24|Adverse Event|7|||
170801924|NCT02397096|617284945|FG001|Day 1 to Week 24|Adverse Event|1|||
170801925|NCT02397096|617284944|FG000|Day 1 to Week 24|Death|1|||
170801926|NCT02397096|617284945|FG001|Day 1 to Week 24|Death|0|||
170801927|NCT02397096|617284944|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
170801928|NCT02397096|617284945|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
170801929|NCT02397096|617284944|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
170801930|NCT02397096|617284945|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
170801931|NCT02397096|617284944|FG000|Day 1 to Week 24|Physician Decision|2|||
170801932|NCT02397096|617284945|FG001|Day 1 to Week 24|Physician Decision|3|||
170801933|NCT02397096|617284944|FG000|Day 1 to Week 24|Protocol Violation|1|||
170801934|NCT02397096|617284945|FG001|Day 1 to Week 24|Protocol Violation|4|||
170801935|NCT02397096|617284944|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
170801936|NCT02397096|617284945|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
170801937|NCT02397096|617284944|FG000|Day 1 to Week 24|Randomized, not treated|3|||
170495303|NCT03535194|616154557|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
170801938|NCT02397096|617284945|FG001|Day 1 to Week 24|Randomized, not treated|0|||
170495304|NCT03535194|616154558|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
170495305|NCT03535194|616154559|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
170495306|NCT03535194|616154555|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
170495307|NCT03535194|616154556|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
170801939|NCT02397096|617284944|FG000|Week 24 to Week 48|Adverse Event|6|||
170801940|NCT02397096|617284945|FG001|Week 24 to Week 48|Adverse Event|2|||
170801941|NCT02397096|617284944|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
170801942|NCT02397096|617284945|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
170801943|NCT02397096|617284944|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
170495308|NCT03535194|616154557|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
170495309|NCT03535194|616154558|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
170495310|NCT03535194|616154559|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
170495311|NCT03535194|616154555|FG000|Post-Treatment Followup Period|Other|1|||
170495312|NCT03535194|616154556|FG001|Post-Treatment Followup Period|Other|0|||
170495313|NCT03535194|616154557|FG002|Post-Treatment Followup Period|Other|0|||
170495314|NCT03535194|616154558|FG003|Post-Treatment Followup Period|Other|5|||
170495315|NCT03535194|616154559|FG004|Post-Treatment Followup Period|Other|0|||
170495316|NCT03535194|616154555|FG000|Post-Treatment Followup Period|Physician Decision|0|||
170495317|NCT03535194|616154556|FG001|Post-Treatment Followup Period|Physician Decision|2|||
170495318|NCT03535194|616154557|FG002|Post-Treatment Followup Period|Physician Decision|1|||
170495319|NCT03535194|616154558|FG003|Post-Treatment Followup Period|Physician Decision|1|||
170495320|NCT03535194|616154559|FG004|Post-Treatment Followup Period|Physician Decision|0|||
170495321|NCT03535194|616154555|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
170801944|NCT02397096|617284945|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
170801945|NCT02397096|617284944|FG000|Week 24 to Week 48|Physician Decision|2|||
170801946|NCT02397096|617284945|FG001|Week 24 to Week 48|Physician Decision|1|||
170801947|NCT02397096|617284944|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
170801948|NCT02397096|617284945|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
170801949|NCT02397096|617284944|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
170801950|NCT02397096|617284945|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
170801951|NCT02397096|617284944|FG000|Study Extension 1|Adverse Event|7|||
170801952|NCT02397096|617284945|FG001|Study Extension 1|Adverse Event|5|||
170801953|NCT02397096|617284944|FG000|Study Extension 1|Death|1|||
170900532|NCT01287104|617640140|FG003|Overall Study|NK cells did not meet release criteria|0|||
170495322|NCT03535194|616154556|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
170495323|NCT03535194|616154557|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
170495324|NCT03535194|616154558|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
170495325|NCT03535194|616154559|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170495326|NCT04411810|616154560|FG000|Overall Study|Screen failure|1|||
170495327|NCT04411810|616154560|FG000|Overall Study|Withdrawal by Subject|1|||
170495328|NCT05835011|616154565|FG000|Overall Study|Study Terminated by the Sponsor|1|||
170495329|NCT05835011|616154565|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
170495330|NCT02222545|616154566|FG000|Overall Study|Adverse Event|1|||
170495331|NCT02222545|616154567|FG001|Overall Study|Adverse Event|0|||
170495332|NCT02222545|616154568|FG002|Overall Study|Adverse Event|2|||
170495333|NCT02222545|616154566|FG000|Overall Study|Death|0|||
170495334|NCT02222545|616154567|FG001|Overall Study|Death|0|||
170495335|NCT02222545|616154568|FG002|Overall Study|Death|9|||
170495336|NCT02222545|616154566|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
170495337|NCT02222545|616154567|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
170495338|NCT02222545|616154568|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
170495339|NCT02222545|616154566|FG000|Overall Study|Withdrawal by Subject|0|||
170495340|NCT02222545|616154567|FG001|Overall Study|Withdrawal by Subject|0|||
170495341|NCT02222545|616154568|FG002|Overall Study|Withdrawal by Subject|3|||
170495342|NCT02222545|616154566|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
170495343|NCT02222545|616154567|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
170495344|NCT02222545|616154568|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
170495345|NCT02651155|616154569|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
170495346|NCT02651155|616154570|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
170495347|NCT02651155|616154569|FG000|Overall Study|Voluntary Withdrawal|5|||
170495348|NCT02651155|616154570|FG001|Overall Study|Voluntary Withdrawal|0|||
170495349|NCT00976820|616154571|FG000|Overall Study|Lost to Follow-up|5|||
170495350|NCT00976820|616154572|FG001|Overall Study|Lost to Follow-up|16|||
170495351|NCT00976820|616154573|FG002|Overall Study|Lost to Follow-up|2|||
170495352|NCT00976820|616154574|FG003|Overall Study|Lost to Follow-up|3|||
170495353|NCT00976820|616154571|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
170495354|NCT00976820|616154572|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
170495355|NCT00976820|616154573|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
170495356|NCT00976820|616154574|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
170495357|NCT00976820|616154571|FG000|Overall Study|Withdrawal by Subject|2|||
170495358|NCT00976820|616154572|FG001|Overall Study|Withdrawal by Subject|4|||
170495359|NCT00976820|616154573|FG002|Overall Study|Withdrawal by Subject|1|||
170495360|NCT00976820|616154574|FG003|Overall Study|Withdrawal by Subject|4|||
170495361|NCT02048826|616154575|FG000|Overall Study|Withdrawal by Subject|1|||
170495362|NCT02048826|616154576|FG001|Overall Study|Withdrawal by Subject|0|||
170641902|NCT00114517|616701379|FG001|Overall Study|Physician Decision|1|||
170900533|NCT01478958|617640148|FG000|Overall Study|Withdrawal by Subject|1|||
170900534|NCT01478958|617640149|FG001|Overall Study|Withdrawal by Subject|1|||
170495363|NCT01489254|616154579|FG000|Double-blind Part|Adverse Event|7|||
170495364|NCT01489254|616154580|FG001|Double-blind Part|Adverse Event|2|||
170801954|NCT02397096|617284945|FG001|Study Extension 1|Death|0|||
170801955|NCT02397096|617284944|FG000|Study Extension 1|Lack of Efficacy|2|||
170801956|NCT02397096|617284945|FG001|Study Extension 1|Lack of Efficacy|5|||
170495365|NCT01489254|616154581|FG002|Double-blind Part|Adverse Event|2|||
170495366|NCT01489254|616154582|FG003|Double-blind Part|Adverse Event|0|||
170495367|NCT01489254|616154579|FG000|Double-blind Part|Pregnancy|1|||
170495368|NCT01489254|616154580|FG001|Double-blind Part|Pregnancy|3|||
170495369|NCT01489254|616154581|FG002|Double-blind Part|Pregnancy|0|||
170495370|NCT01489254|616154582|FG003|Double-blind Part|Pregnancy|0|||
170495371|NCT01489254|616154579|FG000|Double-blind Part|Withdrawal by Subject|12|||
170495372|NCT01489254|616154580|FG001|Double-blind Part|Withdrawal by Subject|20|||
170495373|NCT01489254|616154581|FG002|Double-blind Part|Withdrawal by Subject|1|||
170495374|NCT01489254|616154582|FG003|Double-blind Part|Withdrawal by Subject|0|||
170495375|NCT01489254|616154579|FG000|Double-blind Part|Lost to Follow-up|1|||
170495376|NCT01489254|616154580|FG001|Double-blind Part|Lost to Follow-up|2|||
170495377|NCT01489254|616154581|FG002|Double-blind Part|Lost to Follow-up|0|||
170495378|NCT01489254|616154582|FG003|Double-blind Part|Lost to Follow-up|0|||
170495379|NCT01489254|616154579|FG000|Double-blind Part|Other reasons for not completing study|4|||
170495380|NCT01489254|616154580|FG001|Double-blind Part|Other reasons for not completing study|6|||
170495381|NCT01489254|616154581|FG002|Double-blind Part|Other reasons for not completing study|0|||
170495382|NCT01489254|616154582|FG003|Double-blind Part|Other reasons for not completing study|0|||
170495383|NCT01489254|616154579|FG000|Open-label Extension Part|Adverse Event|0|||
170495384|NCT01489254|616154580|FG001|Open-label Extension Part|Adverse Event|0|||
170495385|NCT01489254|616154581|FG002|Open-label Extension Part|Adverse Event|0|||
170495386|NCT01489254|616154582|FG003|Open-label Extension Part|Adverse Event|10|||
170495387|NCT01489254|616154579|FG000|Open-label Extension Part|Pregnancy|0|||
170495388|NCT01489254|616154580|FG001|Open-label Extension Part|Pregnancy|0|||
170495389|NCT01489254|616154581|FG002|Open-label Extension Part|Pregnancy|0|||
170495390|NCT01489254|616154582|FG003|Open-label Extension Part|Pregnancy|3|||
170495391|NCT01489254|616154579|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
170495392|NCT01489254|616154580|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
170495393|NCT01489254|616154581|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
170495394|NCT01489254|616154582|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
170495395|NCT01489254|616154579|FG000|Open-label Extension Part|Protocol Violation|0|||
170495396|NCT01489254|616154580|FG001|Open-label Extension Part|Protocol Violation|0|||
170550947|NCT00407030|616362539|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
170550948|NCT00407030|616362540|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
170550949|NCT00407030|616362538|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
170550950|NCT00407030|616362539|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
170550951|NCT00407030|616362540|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
170550952|NCT00407030|616362538|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
170550953|NCT00407030|616362539|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
170550954|NCT00407030|616362540|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
170550955|NCT00407030|616362538|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
170550956|NCT00407030|616362539|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
170550957|NCT00407030|616362540|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
170550958|NCT00407030|616362538|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
170550959|NCT00407030|616362539|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
170550960|NCT00407030|616362540|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
170550961|NCT00407030|616362538|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
170550962|NCT00407030|616362539|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
170550963|NCT00407030|616362540|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
170550964|NCT00407030|616362538|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
170550965|NCT00407030|616362539|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
170550966|NCT00407030|616362540|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
170550967|NCT00407030|616362538|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
170550968|NCT00407030|616362539|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
170550969|NCT00407030|616362540|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
170495397|NCT01489254|616154581|FG002|Open-label Extension Part|Protocol Violation|0|||
170495398|NCT01489254|616154582|FG003|Open-label Extension Part|Protocol Violation|1|||
170495399|NCT01489254|616154579|FG000|Open-label Extension Part|Lost to Follow-up|0|||
170550970|NCT00407030|616362538|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
170641903|NCT00114517|616701380|FG002|Overall Study|Physician Decision|0|||
170801957|NCT02397096|617284944|FG000|Study Extension 1|Lost to Follow-up|2|||
170801958|NCT02397096|617284945|FG001|Study Extension 1|Lost to Follow-up|3|||
170801959|NCT02397096|617284944|FG000|Study Extension 1|Non-compliance with study drug|3|||
170801960|NCT02397096|617284945|FG001|Study Extension 1|Non-compliance with study drug|0|||
170495400|NCT01489254|616154580|FG001|Open-label Extension Part|Lost to Follow-up|0|||
170495401|NCT01489254|616154581|FG002|Open-label Extension Part|Lost to Follow-up|0|||
170495402|NCT01489254|616154582|FG003|Open-label Extension Part|Lost to Follow-up|9|||
170495403|NCT01489254|616154579|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
170495404|NCT01489254|616154580|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
170550971|NCT00407030|616362539|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
170550972|NCT00407030|616362540|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
170550973|NCT00407030|616362538|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
170550974|NCT00407030|616362539|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
170550975|NCT00407030|616362540|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
170550976|NCT03878602|616362541|FG000|Overall Study|cord blood donation|7|||
170550977|NCT03878602|616362542|FG001|Overall Study|cord blood donation|1|||
170550978|NCT03878602|616362541|FG000|Overall Study|incomplete data collection|2|||
170550979|NCT03878602|616362542|FG001|Overall Study|incomplete data collection|0|||
170550980|NCT00066170|616362543|FG000|Overall Study|Adverse Event|2|||
170550981|NCT00066170|616362544|FG001|Overall Study|Adverse Event|4|||
170550982|NCT00066170|616362545|FG002|Overall Study|Adverse Event|1|||
170550983|NCT00066170|616362546|FG003|Overall Study|Adverse Event|7|||
170550984|NCT00066170|616362543|FG000|Overall Study|Serious Adverse Event|0|||
170550985|NCT00066170|616362544|FG001|Overall Study|Serious Adverse Event|0|||
170550986|NCT00066170|616362545|FG002|Overall Study|Serious Adverse Event|1|||
170550987|NCT00066170|616362546|FG003|Overall Study|Serious Adverse Event|1|||
170550988|NCT00066170|616362543|FG000|Overall Study|Lost to Follow-up|0|||
170550989|NCT00066170|616362544|FG001|Overall Study|Lost to Follow-up|1|||
170550990|NCT00066170|616362545|FG002|Overall Study|Lost to Follow-up|0|||
170550991|NCT00066170|616362546|FG003|Overall Study|Lost to Follow-up|0|||
170550992|NCT00066170|616362543|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
170550993|NCT00066170|616362544|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
170550994|NCT00066170|616362545|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
170550995|NCT00066170|616362546|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
170550996|NCT00066170|616362543|FG000|Overall Study|Protocol Violation|3|||
170550997|NCT00066170|616362544|FG001|Overall Study|Protocol Violation|0|||
170550998|NCT00066170|616362545|FG002|Overall Study|Protocol Violation|0|||
170550999|NCT00066170|616362546|FG003|Overall Study|Protocol Violation|0|||
170551000|NCT00066170|616362543|FG000|Overall Study|Other|1|||
170551001|NCT00066170|616362544|FG001|Overall Study|Other|5|||
170551002|NCT00066170|616362545|FG002|Overall Study|Other|2|||
170641904|NCT00114517|616701381|FG003|Overall Study|Physician Decision|0|||
170641905|NCT00114517|616701378|FG000|Overall Study|Lost interest|0|||
170641906|NCT00114517|616701379|FG001|Overall Study|Lost interest|0|||
170551003|NCT00066170|616362546|FG003|Overall Study|Other|0|||
170551004|NCT01796470|616362553|FG000|Overall Study|Adverse Event|4|||
170551005|NCT01796470|616362554|FG001|Overall Study|Adverse Event|2|||
170551006|NCT01796470|616362555|FG002|Overall Study|Adverse Event|2|||
170551007|NCT01796470|616362556|FG003|Overall Study|Adverse Event|1|||
170551008|NCT01796470|616362557|FG004|Overall Study|Adverse Event|3|||
170551009|NCT01796470|616362553|FG000|Overall Study|Death|2|||
170495405|NCT01489254|616154581|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
170495406|NCT01489254|616154582|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
170495407|NCT03452488|616154584|FG000|Overall Study|Adverse Event|4|||
170495408|NCT03452488|616154585|FG001|Overall Study|Adverse Event|6|||
170495409|NCT03452488|616154586|FG002|Overall Study|Adverse Event|1|||
170495410|NCT03452488|616154584|FG000|Overall Study|Death|0|||
170495411|NCT03452488|616154585|FG001|Overall Study|Death|0|||
170495412|NCT03452488|616154586|FG002|Overall Study|Death|1|||
170495413|NCT03452488|616154584|FG000|Overall Study|Lost to Follow-up|1|||
170495414|NCT03452488|616154585|FG001|Overall Study|Lost to Follow-up|2|||
170495415|NCT03452488|616154586|FG002|Overall Study|Lost to Follow-up|0|||
170495416|NCT03452488|616154584|FG000|Overall Study|PI Decision|1|||
170495417|NCT03452488|616154585|FG001|Overall Study|PI Decision|0|||
170495418|NCT03452488|616154586|FG002|Overall Study|PI Decision|0|||
170495419|NCT03452488|616154584|FG000|Overall Study|Withdrew consent|4|||
170495420|NCT03452488|616154585|FG001|Overall Study|Withdrew consent|2|||
170495421|NCT03452488|616154586|FG002|Overall Study|Withdrew consent|2|||
170495422|NCT03452488|616154584|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
170495423|NCT03452488|616154585|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
170495424|NCT03452488|616154586|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
170495425|NCT03452488|616154584|FG000|Overall Study|Other|0|||
170495426|NCT03452488|616154585|FG001|Overall Study|Other|2|||
170551010|NCT01796470|616362554|FG001|Overall Study|Death|0|||
170551011|NCT01796470|616362555|FG002|Overall Study|Death|0|||
170551012|NCT01796470|616362556|FG003|Overall Study|Death|0|||
170495427|NCT03452488|616154586|FG002|Overall Study|Other|2|||
170495428|NCT04143594|616154596|FG000|Overall Study|Withdrew consent|3|||
170495429|NCT04143594|616154597|FG001|Overall Study|Withdrew consent|10|||
170495430|NCT04143594|616154598|FG002|Overall Study|Withdrew consent|3|||
170551013|NCT01796470|616362557|FG004|Overall Study|Death|1|||
170641907|NCT00114517|616701380|FG002|Overall Study|Lost interest|1|||
170495431|NCT04143594|616154599|FG003|Overall Study|Withdrew consent|1|||
170551014|NCT01796470|616362553|FG000|Overall Study|Initiated New Therapy|9|||
170551015|NCT01796470|616362554|FG001|Overall Study|Initiated New Therapy|0|||
170551016|NCT01796470|616362555|FG002|Overall Study|Initiated New Therapy|0|||
170551017|NCT01796470|616362556|FG003|Overall Study|Initiated New Therapy|0|||
170641908|NCT00114517|616701381|FG003|Overall Study|Lost interest|0|||
170495432|NCT04143594|616154596|FG000|Overall Study|Lost to Follow-up|3|||
170495433|NCT04143594|616154597|FG001|Overall Study|Lost to Follow-up|5|||
170495434|NCT04143594|616154598|FG002|Overall Study|Lost to Follow-up|11|||
170495435|NCT04143594|616154599|FG003|Overall Study|Lost to Follow-up|0|||
170495436|NCT04143594|616154596|FG000|Overall Study|Investigator's discretion|2|||
170495437|NCT04143594|616154597|FG001|Overall Study|Investigator's discretion|2|||
170495438|NCT04143594|616154598|FG002|Overall Study|Investigator's discretion|0|||
170495439|NCT04143594|616154599|FG003|Overall Study|Investigator's discretion|0|||
170495440|NCT04143594|616154596|FG000|Overall Study|Randomized but never treated|0|||
170495441|NCT04143594|616154597|FG001|Overall Study|Randomized but never treated|0|||
170495442|NCT04143594|616154598|FG002|Overall Study|Randomized but never treated|0|||
170495443|NCT04143594|616154599|FG003|Overall Study|Randomized but never treated|1|||
170495444|NCT04143594|616154596|FG000|Overall Study|Death|1|||
170495445|NCT04143594|616154597|FG001|Overall Study|Death|0|||
170495446|NCT04143594|616154598|FG002|Overall Study|Death|1|||
170495447|NCT04143594|616154599|FG003|Overall Study|Death|0|||
170495448|NCT04143594|616154596|FG000|Overall Study|Adverse Event|1|||
170495449|NCT04143594|616154597|FG001|Overall Study|Adverse Event|0|||
170495450|NCT04143594|616154598|FG002|Overall Study|Adverse Event|0|||
170495451|NCT04143594|616154599|FG003|Overall Study|Adverse Event|0|||
170495452|NCT04143594|616154596|FG000|Overall Study|Pregnancy|0|||
170495453|NCT04143594|616154597|FG001|Overall Study|Pregnancy|0|||
170495454|NCT04143594|616154598|FG002|Overall Study|Pregnancy|1|||
170495455|NCT04143594|616154599|FG003|Overall Study|Pregnancy|0|||
170495456|NCT04143594|616154596|FG000|Overall Study|Lack of Efficacy|1|||
170495457|NCT04143594|616154597|FG001|Overall Study|Lack of Efficacy|1|||
170495458|NCT04143594|616154598|FG002|Overall Study|Lack of Efficacy|0|||
170495459|NCT04143594|616154599|FG003|Overall Study|Lack of Efficacy|0|||
170495460|NCT03089697|616154602|FG000|Overall Study|Adverse Event|1|||
170495461|NCT03089697|616154603|FG001|Overall Study|Adverse Event|2|||
170495462|NCT03089697|616154602|FG000|Overall Study|Withdrawal by Subject|1|||
170495463|NCT03089697|616154603|FG001|Overall Study|Withdrawal by Subject|0|||
170495464|NCT00638443|616154604|FG000|First Intervention|Adverse Event|2|||
170495465|NCT00638443|616154605|FG001|First Intervention|Adverse Event|1|||
170495466|NCT01044290|616154606|FG000|Follow-up 1|Death|3|||
170495467|NCT01044290|616154607|FG001|Follow-up 1|Death|3|||
170495468|NCT01044290|616154608|FG002|Follow-up 1|Death|1|||
170495469|NCT01044290|616154606|FG000|Follow-up 1|Withdrawal by Subject|2|||
170495470|NCT01044290|616154607|FG001|Follow-up 1|Withdrawal by Subject|2|||
170495471|NCT01044290|616154608|FG002|Follow-up 1|Withdrawal by Subject|0|||
170495472|NCT01044290|616154606|FG000|Follow-Up 2|Death|0|||
170495473|NCT01044290|616154607|FG001|Follow-Up 2|Death|1|||
170495474|NCT01044290|616154608|FG002|Follow-Up 2|Death|1|||
170495475|NCT01044290|616154606|FG000|Follow-Up 2|Withdrawal by Subject|0|||
170495476|NCT01044290|616154607|FG001|Follow-Up 2|Withdrawal by Subject|1|||
170801961|NCT02397096|617284944|FG000|Study Extension 1|Physician Decision|4|||
170495477|NCT01044290|616154608|FG002|Follow-Up 2|Withdrawal by Subject|1|||
170495478|NCT01967706|616154611|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
170495479|NCT01967706|616154612|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
170495480|NCT01967706|616154613|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
170495481|NCT01967706|616154614|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
170495482|NCT01154088|616154615|FG000|Overall Study|Lost to Follow-up|4|||
170495483|NCT01154088|616154616|FG001|Overall Study|Lost to Follow-up|6|||
170495484|NCT01154088|616154617|FG002|Overall Study|Lost to Follow-up|7|||
170495485|NCT04603482|616154618|FG000|Overall Study|Lost to Follow-up|15|||
170495486|NCT04603482|616154619|FG001|Overall Study|Lost to Follow-up|15|||
170495487|NCT04603482|616154620|FG002|Overall Study|Lost to Follow-up|15|||
170495488|NCT01552915|616154621|FG000|Overall Study|Adverse Event|3|||
170495489|NCT01552915|616154622|FG001|Overall Study|Adverse Event|14|||
170495490|NCT01552915|616154623|FG002|Overall Study|Adverse Event|3|||
170495491|NCT01552915|616154621|FG000|Overall Study|Lost to Follow-up|4|||
170495492|NCT01552915|616154622|FG001|Overall Study|Lost to Follow-up|6|||
170495493|NCT01552915|616154623|FG002|Overall Study|Lost to Follow-up|5|||
170495494|NCT01552915|616154621|FG000|Overall Study|Withdrawal by Subject|6|||
170495495|NCT01552915|616154622|FG001|Overall Study|Withdrawal by Subject|4|||
170495496|NCT01552915|616154623|FG002|Overall Study|Withdrawal by Subject|5|||
170495497|NCT01552915|616154621|FG000|Overall Study|Protocol Violation|0|||
170495498|NCT01552915|616154622|FG001|Overall Study|Protocol Violation|4|||
170495499|NCT01552915|616154623|FG002|Overall Study|Protocol Violation|4|||
170495500|NCT01552915|616154621|FG000|Overall Study|Lack of Efficacy|8|||
170495501|NCT01552915|616154622|FG001|Overall Study|Lack of Efficacy|1|||
170495502|NCT01552915|616154623|FG002|Overall Study|Lack of Efficacy|4|||
170495503|NCT01552915|616154621|FG000|Overall Study|Other|2|||
170495504|NCT01552915|616154622|FG001|Overall Study|Other|0|||
170495505|NCT01552915|616154623|FG002|Overall Study|Other|6|||
170495506|NCT00282113|616154624|FG000|Overall Study|Removed at parents request|1|||
170495507|NCT00282113|616154625|FG001|Overall Study|Removed at parents request|0|||
170495508|NCT00282113|616154626|FG002|Overall Study|Removed at parents request|0|||
170495509|NCT03382834|616154627|FG000|Step 1|Lost to Follow-up|0|||
170495510|NCT03382834|616154628|FG001|Step 1|Lost to Follow-up|1|||
170495511|NCT03382834|616154627|FG000|Step 2|Death|1|||
170495512|NCT03382834|616154628|FG001|Step 2|Death|0|||
170495513|NCT03382834|616154627|FG000|Step 2|Lost to Follow-up|2|||
170495514|NCT03382834|616154628|FG001|Step 2|Lost to Follow-up|2|||
170495515|NCT03382834|616154627|FG000|Step 2|Site Terminated by Sponsor|1|||
170495516|NCT03382834|616154628|FG001|Step 2|Site Terminated by Sponsor|0|||
170495517|NCT02120833|616154629|FG000|Overall Study|Adverse Event|1|||
170495518|NCT02120833|616154630|FG001|Overall Study|Adverse Event|0|||
170495519|NCT02120833|616154629|FG000|Overall Study|Withdrawal by Subject|2|||
170495520|NCT02120833|616154630|FG001|Overall Study|Withdrawal by Subject|0|||
170495521|NCT02120833|616154629|FG000|Overall Study|Lost to Follow-up|1|||
170495522|NCT02120833|616154630|FG001|Overall Study|Lost to Follow-up|1|||
170495523|NCT02438826|616154634|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
170495524|NCT02438826|616154635|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
170495525|NCT02438826|616154636|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
170495526|NCT02438826|616154637|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
170495527|NCT02438826|616154634|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
170495528|NCT02438826|616154635|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
170495529|NCT02438826|616154636|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
170495530|NCT02438826|616154637|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
170495531|NCT02438826|616154634|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
170495532|NCT02438826|616154635|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
170495533|NCT02438826|616154636|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
170495534|NCT02438826|616154637|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
170495535|NCT02438826|616154634|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
170495536|NCT02438826|616154635|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
170495537|NCT02438826|616154636|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
170495538|NCT02438826|616154637|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
170495539|NCT02438826|616154634|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
170495540|NCT02438826|616154635|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
170495541|NCT02438826|616154636|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
170495542|NCT02438826|616154637|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
170495543|NCT02438826|616154634|FG000|Open-Label Treatment Phase|Adverse Event|11|||
170495544|NCT02438826|616154635|FG001|Open-Label Treatment Phase|Adverse Event|6|||
170495545|NCT02438826|616154636|FG002|Open-Label Treatment Phase|Adverse Event|0|||
170495546|NCT02438826|616154637|FG003|Open-Label Treatment Phase|Adverse Event|0|||
170495547|NCT02438826|616154634|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
170495548|NCT02438826|616154635|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
170495549|NCT02438826|616154636|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
170495550|NCT02438826|616154637|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
170495551|NCT02438826|616154634|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
170495552|NCT02438826|616154635|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
170495553|NCT02438826|616154636|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
170495554|NCT02438826|616154637|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
170495555|NCT02438826|616154634|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
170495556|NCT02438826|616154635|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
170495557|NCT02438826|616154636|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
170495558|NCT02438826|616154637|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
170495559|NCT02438826|616154634|FG000|Post-Treatment Phase|Adverse Event|3|||
170495560|NCT02438826|616154635|FG001|Post-Treatment Phase|Adverse Event|0|||
170495561|NCT02438826|616154636|FG002|Post-Treatment Phase|Adverse Event|0|||
170495562|NCT02438826|616154637|FG003|Post-Treatment Phase|Adverse Event|0|||
170495563|NCT02438826|616154634|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
170495564|NCT02438826|616154635|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
170495565|NCT02438826|616154636|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
170495566|NCT02438826|616154637|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
170495567|NCT02438826|616154634|FG000|Post-Treatment Phase|Physician Decision|1|||
170495568|NCT02438826|616154635|FG001|Post-Treatment Phase|Physician Decision|0|||
170495569|NCT02438826|616154636|FG002|Post-Treatment Phase|Physician Decision|0|||
170495570|NCT02438826|616154637|FG003|Post-Treatment Phase|Physician Decision|0|||
170495571|NCT02438826|616154634|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
170495572|NCT02438826|616154635|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
170495573|NCT02438826|616154636|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
170495574|NCT02438826|616154637|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
170495575|NCT02693171|616154638|FG000|Overall Study|Adverse Event|1|||
170495576|NCT02693171|616154638|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
170495577|NCT00319592|616154640|FG000|Overall Study|Protocol Violation|1|||
170495578|NCT00319592|616154641|FG001|Overall Study|Protocol Violation|0|||
170495579|NCT00319592|616154640|FG000|Overall Study|Physician Decision|0|||
170495580|NCT00319592|616154641|FG001|Overall Study|Physician Decision|1|||
170495581|NCT03429244|616154644|FG000|Overall Study|Withdrawal by Subject|2|||
170495582|NCT03429244|616154645|FG001|Overall Study|Withdrawal by Subject|1|||
170495583|NCT03429244|616154646|FG002|Overall Study|Withdrawal by Subject|1|||
170495584|NCT00750139|616154649|FG000|Overall Study|Adverse Event|1|||
170495585|NCT00750139|616154650|FG001|Overall Study|Adverse Event|2|||
170495586|NCT00750139|616154651|FG002|Overall Study|Adverse Event|0|||
170495587|NCT00750139|616154652|FG003|Overall Study|Adverse Event|1|||
170495588|NCT00750139|616154649|FG000|Overall Study|Lost to Follow-up|17|||
170495589|NCT00750139|616154650|FG001|Overall Study|Lost to Follow-up|12|||
170495590|NCT00750139|616154651|FG002|Overall Study|Lost to Follow-up|15|||
170495591|NCT00750139|616154652|FG003|Overall Study|Lost to Follow-up|6|||
170495592|NCT00750139|616154649|FG000|Overall Study|Withdrawal by Subject|3|||
170495593|NCT00750139|616154650|FG001|Overall Study|Withdrawal by Subject|2|||
170495594|NCT00750139|616154651|FG002|Overall Study|Withdrawal by Subject|6|||
170495595|NCT00750139|616154652|FG003|Overall Study|Withdrawal by Subject|2|||
170495596|NCT00750139|616154649|FG000|Overall Study|Physician Decision|1|||
170495597|NCT00750139|616154650|FG001|Overall Study|Physician Decision|1|||
170495598|NCT00750139|616154651|FG002|Overall Study|Physician Decision|0|||
170495599|NCT00750139|616154652|FG003|Overall Study|Physician Decision|0|||
170495600|NCT00750139|616154649|FG000|Overall Study|Non-compliance|1|||
170495601|NCT00750139|616154650|FG001|Overall Study|Non-compliance|0|||
170495602|NCT00750139|616154651|FG002|Overall Study|Non-compliance|1|||
170495603|NCT00750139|616154652|FG003|Overall Study|Non-compliance|3|||
170495604|NCT00750139|616154649|FG000|Overall Study|Termination by sponsor|4|||
170495605|NCT00750139|616154650|FG001|Overall Study|Termination by sponsor|0|||
170495606|NCT00750139|616154651|FG002|Overall Study|Termination by sponsor|0|||
170495607|NCT00750139|616154652|FG003|Overall Study|Termination by sponsor|1|||
170495608|NCT00750139|616154649|FG000|Overall Study|Non-specific|62|||
170495609|NCT00750139|616154650|FG001|Overall Study|Non-specific|42|||
170495610|NCT00750139|616154651|FG002|Overall Study|Non-specific|79|||
170495611|NCT00750139|616154652|FG003|Overall Study|Non-specific|33|||
170495612|NCT03085238|616154653|FG000|Overall Study|Adverse Event|2|||
170495613|NCT03085238|616154653|FG000|Overall Study|Death|2|||
170495614|NCT01992653|616154657|FG000|Overall Study|Death|0|||
170495615|NCT01992653|616154658|FG001|Overall Study|Death|0|||
170495616|NCT01992653|616154659|FG002|Overall Study|Death|1|||
170495617|NCT01992653|616154660|FG003|Overall Study|Death|0|||
170495618|NCT01992653|616154661|FG004|Overall Study|Death|1|||
170495619|NCT01992653|616154662|FG005|Overall Study|Death|0|||
170495620|NCT01992653|616154663|FG006|Overall Study|Death|4|||
170495621|NCT01992653|616154664|FG007|Overall Study|Death|2|||
170495622|NCT01992653|616154657|FG000|Overall Study|Lost to Follow-up|0|||
170495623|NCT01992653|616154658|FG001|Overall Study|Lost to Follow-up|0|||
170495624|NCT01992653|616154659|FG002|Overall Study|Lost to Follow-up|0|||
170495625|NCT01992653|616154660|FG003|Overall Study|Lost to Follow-up|0|||
170495626|NCT01992653|616154661|FG004|Overall Study|Lost to Follow-up|0|||
170495627|NCT01992653|616154662|FG005|Overall Study|Lost to Follow-up|0|||
170495628|NCT01992653|616154663|FG006|Overall Study|Lost to Follow-up|0|||
170495629|NCT01992653|616154664|FG007|Overall Study|Lost to Follow-up|1|||
170495630|NCT01992653|616154657|FG000|Overall Study|Study Completed|0|||
170495631|NCT01992653|616154658|FG001|Overall Study|Study Completed|0|||
170495632|NCT01992653|616154659|FG002|Overall Study|Study Completed|0|||
170495633|NCT01992653|616154660|FG003|Overall Study|Study Completed|0|||
170495634|NCT01992653|616154661|FG004|Overall Study|Study Completed|0|||
170495635|NCT01992653|616154662|FG005|Overall Study|Study Completed|0|||
170495636|NCT01992653|616154663|FG006|Overall Study|Study Completed|0|||
170495637|NCT01992653|616154664|FG007|Overall Study|Study Completed|1|||
170495638|NCT01992653|616154657|FG000|Overall Study|Disease Progression|0|||
170495639|NCT01992653|616154658|FG001|Overall Study|Disease Progression|0|||
170495640|NCT01992653|616154659|FG002|Overall Study|Disease Progression|0|||
170495641|NCT01992653|616154660|FG003|Overall Study|Disease Progression|0|||
170495642|NCT01992653|616154661|FG004|Overall Study|Disease Progression|0|||
170495643|NCT01992653|616154662|FG005|Overall Study|Disease Progression|0|||
170551018|NCT01796470|616362557|FG004|Overall Study|Initiated New Therapy|2|||
170551019|NCT01796470|616362553|FG000|Overall Study|Lost to Follow-up|0|||
170495644|NCT01992653|616154663|FG006|Overall Study|Disease Progression|4|||
170495645|NCT01992653|616154664|FG007|Overall Study|Disease Progression|0|||
170495646|NCT01435460|616154665|FG000|Overall Study|Adverse Event|2|||
170551020|NCT01796470|616362554|FG001|Overall Study|Lost to Follow-up|1|||
170551021|NCT01796470|616362555|FG002|Overall Study|Lost to Follow-up|0|||
170495647|NCT01435460|616154666|FG001|Overall Study|Adverse Event|1|||
170495648|NCT01435460|616154665|FG000|Overall Study|Lost to Follow-up|6|||
170495649|NCT01435460|616154666|FG001|Overall Study|Lost to Follow-up|1|||
170495650|NCT01435460|616154665|FG000|Overall Study|Withdrawal by Subject|1|||
170495651|NCT01435460|616154666|FG001|Overall Study|Withdrawal by Subject|3|||
170551022|NCT01796470|616362556|FG003|Overall Study|Lost to Follow-up|0|||
170495652|NCT01435460|616154665|FG000|Overall Study|Protocol Violation|0|||
170495653|NCT01435460|616154666|FG001|Overall Study|Protocol Violation|1|||
170495654|NCT01435460|616154665|FG000|Overall Study|Did not meet eligibility criteria|2|||
170495655|NCT01435460|616154666|FG001|Overall Study|Did not meet eligibility criteria|0|||
170495656|NCT01706939|616154667|FG000|Pre Randomization|Screen Failure|1|||
170495657|NCT01706939|616154668|FG001|Pre Randomization|Screen Failure|0|||
170495658|NCT01706939|616154669|FG002|Pre Randomization|Screen Failure|0|||
170495659|NCT01706939|616154667|FG000|Pre Randomization|Ineligible for Randomization|1|||
170495660|NCT01706939|616154668|FG001|Pre Randomization|Ineligible for Randomization|0|||
170495661|NCT01706939|616154669|FG002|Pre Randomization|Ineligible for Randomization|0|||
170495662|NCT01706939|616154667|FG000|Pre Randomization|Withdrawal by Subject|1|||
170495663|NCT01706939|616154668|FG001|Pre Randomization|Withdrawal by Subject|0|||
170495664|NCT01706939|616154669|FG002|Pre Randomization|Withdrawal by Subject|0|||
170495665|NCT01706939|616154667|FG000|Randomization|Insufficient QoL survey compliance|0|||
170495666|NCT01706939|616154668|FG001|Randomization|Insufficient QoL survey compliance|1|||
170495667|NCT01706939|616154669|FG002|Randomization|Insufficient QoL survey compliance|1|||
170495668|NCT01706939|616154667|FG000|Randomization|Progression of disease|0|||
170495669|NCT01706939|616154668|FG001|Randomization|Progression of disease|2|||
170495670|NCT01706939|616154669|FG002|Randomization|Progression of disease|1|||
170495671|NCT01275755|616156782|FG000|Double-blind Treatment Period|Adverse Event|0|||
170495672|NCT01275755|616156783|FG001|Double-blind Treatment Period|Adverse Event|2|||
170495673|NCT01275755|616156782|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
170495674|NCT01275755|616156783|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
170495675|NCT01275755|616156782|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
170495676|NCT01275755|616156783|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
170495677|NCT01275755|616156782|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
170495678|NCT01275755|616156783|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
170495679|NCT00174967|616156784|FG000|Overall Study|Adverse Event|1|||
170495680|NCT00174967|616156785|FG001|Overall Study|Adverse Event|2|||
170495681|NCT00174967|616156786|FG002|Overall Study|Adverse Event|2|||
170495682|NCT00174967|616156787|FG003|Overall Study|Adverse Event|1|||
170495683|NCT00174967|616156784|FG000|Overall Study|Gout Flare|0|||
170495684|NCT00174967|616156785|FG001|Overall Study|Gout Flare|0|||
170495685|NCT00174967|616156786|FG002|Overall Study|Gout Flare|0|||
170495686|NCT00174967|616156787|FG003|Overall Study|Gout Flare|1|||
170495687|NCT00174967|616156784|FG000|Overall Study|Other|0|||
170495688|NCT00174967|616156785|FG001|Overall Study|Other|1|||
170495689|NCT00174967|616156786|FG002|Overall Study|Other|0|||
170495690|NCT00174967|616156787|FG003|Overall Study|Other|0|||
170495691|NCT03558152|616156788|FG000|Overall Study|Adverse Event|0|||
170495692|NCT03558152|616156789|FG001|Overall Study|Adverse Event|0|||
170495693|NCT03558152|616156790|FG002|Overall Study|Adverse Event|1|||
170495694|NCT03558152|616156791|FG003|Overall Study|Adverse Event|1|||
170495695|NCT03558152|616156792|FG004|Overall Study|Adverse Event|2|||
170495696|NCT03558152|616156793|FG005|Overall Study|Adverse Event|1|||
170495697|NCT03558152|616156794|FG006|Overall Study|Adverse Event|1|||
170495698|NCT03558152|616156795|FG007|Overall Study|Adverse Event|0|||
170495699|NCT03558152|616156788|FG000|Overall Study|Death|0|||
170495700|NCT03558152|616156789|FG001|Overall Study|Death|0|||
170495701|NCT03558152|616156790|FG002|Overall Study|Death|0|||
170495702|NCT03558152|616156791|FG003|Overall Study|Death|0|||
170495703|NCT03558152|616156792|FG004|Overall Study|Death|1|||
170495704|NCT03558152|616156793|FG005|Overall Study|Death|0|||
170495705|NCT03558152|616156794|FG006|Overall Study|Death|0|||
170495706|NCT03558152|616156795|FG007|Overall Study|Death|0|||
170495707|NCT03558152|616156788|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
170495708|NCT03558152|616156789|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
170495709|NCT03558152|616156790|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
170495710|NCT03558152|616156791|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
170495711|NCT03558152|616156792|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
170495712|NCT03558152|616156793|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
170495713|NCT03558152|616156794|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
170495714|NCT03558152|616156795|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
170495715|NCT03558152|616156788|FG000|Overall Study|Miscalculation in mmcs|0|||
170495716|NCT03558152|616156789|FG001|Overall Study|Miscalculation in mmcs|0|||
170495717|NCT03558152|616156790|FG002|Overall Study|Miscalculation in mmcs|0|||
170495718|NCT03558152|616156791|FG003|Overall Study|Miscalculation in mmcs|0|||
170495719|NCT03558152|616156792|FG004|Overall Study|Miscalculation in mmcs|0|||
170495720|NCT03558152|616156793|FG005|Overall Study|Miscalculation in mmcs|0|||
170495721|NCT03558152|616156794|FG006|Overall Study|Miscalculation in mmcs|1|||
170495722|NCT03558152|616156795|FG007|Overall Study|Miscalculation in mmcs|0|||
170495723|NCT03558152|616156788|FG000|Overall Study|Mistake in calculation|0|||
170495724|NCT03558152|616156789|FG001|Overall Study|Mistake in calculation|0|||
170495725|NCT03558152|616156790|FG002|Overall Study|Mistake in calculation|0|||
170495726|NCT03558152|616156791|FG003|Overall Study|Mistake in calculation|1|||
170495727|NCT03558152|616156792|FG004|Overall Study|Mistake in calculation|0|||
170495728|NCT03558152|616156793|FG005|Overall Study|Mistake in calculation|0|||
170495729|NCT03558152|616156794|FG006|Overall Study|Mistake in calculation|0|||
170495730|NCT03558152|616156795|FG007|Overall Study|Mistake in calculation|0|||
170495731|NCT03558152|616156788|FG000|Overall Study|Mistake in evaluation of disease status|0|||
170495732|NCT03558152|616156789|FG001|Overall Study|Mistake in evaluation of disease status|0|||
170495733|NCT03558152|616156790|FG002|Overall Study|Mistake in evaluation of disease status|0|||
170495734|NCT03558152|616156791|FG003|Overall Study|Mistake in evaluation of disease status|0|||
170495735|NCT03558152|616156792|FG004|Overall Study|Mistake in evaluation of disease status|0|||
170495736|NCT03558152|616156793|FG005|Overall Study|Mistake in evaluation of disease status|0|||
170495737|NCT03558152|616156794|FG006|Overall Study|Mistake in evaluation of disease status|0|||
170495738|NCT03558152|616156795|FG007|Overall Study|Mistake in evaluation of disease status|1|||
170495739|NCT03558152|616156788|FG000|Overall Study|Physician Decision|0|||
170495740|NCT03558152|616156789|FG001|Overall Study|Physician Decision|0|||
170495741|NCT03558152|616156790|FG002|Overall Study|Physician Decision|0|||
170495742|NCT03558152|616156791|FG003|Overall Study|Physician Decision|0|||
170495743|NCT03558152|616156792|FG004|Overall Study|Physician Decision|0|||
170495744|NCT03558152|616156793|FG005|Overall Study|Physician Decision|0|||
170495745|NCT03558152|616156794|FG006|Overall Study|Physician Decision|1|||
170495746|NCT03558152|616156795|FG007|Overall Study|Physician Decision|0|||
170495747|NCT03558152|616156788|FG000|Overall Study|Withdrawal by Subject|2|||
170495748|NCT03558152|616156789|FG001|Overall Study|Withdrawal by Subject|3|||
170495749|NCT03558152|616156790|FG002|Overall Study|Withdrawal by Subject|2|||
170495750|NCT03558152|616156791|FG003|Overall Study|Withdrawal by Subject|1|||
170495751|NCT03558152|616156792|FG004|Overall Study|Withdrawal by Subject|1|||
170495752|NCT03558152|616156793|FG005|Overall Study|Withdrawal by Subject|1|||
170495753|NCT03558152|616156794|FG006|Overall Study|Withdrawal by Subject|3|||
170495754|NCT03558152|616156795|FG007|Overall Study|Withdrawal by Subject|2|||
170495755|NCT03558152|616156788|FG000|Overall Study|Lack of Efficacy|11|||
170495756|NCT03558152|616156789|FG001|Overall Study|Lack of Efficacy|11|||
170495757|NCT03558152|616156790|FG002|Overall Study|Lack of Efficacy|10|||
170495758|NCT03558152|616156791|FG003|Overall Study|Lack of Efficacy|11|||
170495759|NCT03558152|616156792|FG004|Overall Study|Lack of Efficacy|14|||
170495760|NCT03558152|616156793|FG005|Overall Study|Lack of Efficacy|12|||
170495761|NCT03558152|616156794|FG006|Overall Study|Lack of Efficacy|14|||
170495762|NCT03558152|616156795|FG007|Overall Study|Lack of Efficacy|13|||
170495763|NCT03558152|616156788|FG000|Overall Study|Protocol Violation|1|||
170495764|NCT03558152|616156789|FG001|Overall Study|Protocol Violation|1|||
170495765|NCT03558152|616156790|FG002|Overall Study|Protocol Violation|0|||
170495766|NCT03558152|616156791|FG003|Overall Study|Protocol Violation|1|||
170495767|NCT03558152|616156792|FG004|Overall Study|Protocol Violation|1|||
170495768|NCT03558152|616156793|FG005|Overall Study|Protocol Violation|0|||
170495769|NCT03558152|616156794|FG006|Overall Study|Protocol Violation|2|||
170495770|NCT03558152|616156795|FG007|Overall Study|Protocol Violation|0|||
170495771|NCT02730377|616156801|FG000|Overall Study|Other|5|||
170495772|NCT02730377|616156802|FG001|Overall Study|Other|4|||
170495773|NCT02730377|616156801|FG000|Overall Study|Death|1|||
170495774|NCT02730377|616156802|FG001|Overall Study|Death|8|||
170495775|NCT02730377|616156801|FG000|Overall Study|Inadequate glycaemic control|368|||
170495776|NCT02730377|616156802|FG001|Overall Study|Inadequate glycaemic control|473|||
170495777|NCT02730377|616156801|FG000|Overall Study|Adverse Event|79|||
170495778|NCT02730377|616156802|FG001|Overall Study|Adverse Event|41|||
170495779|NCT02730377|616156801|FG000|Overall Study|Protocol Violation|23|||
170495780|NCT02730377|616156802|FG001|Overall Study|Protocol Violation|30|||
170495781|NCT02730377|616156801|FG000|Overall Study|Lack of Efficacy|4|||
170495782|NCT02730377|616156802|FG001|Overall Study|Lack of Efficacy|13|||
170495783|NCT02730377|616156801|FG000|Overall Study|Pregnancy|0|||
170495784|NCT02730377|616156802|FG001|Overall Study|Pregnancy|1|||
170495785|NCT02730377|616156801|FG000|Overall Study|Withdrawal by Subject|45|||
170495786|NCT02730377|616156802|FG001|Overall Study|Withdrawal by Subject|42|||
170495787|NCT02730377|616156801|FG000|Overall Study|Lost to Follow-up|25|||
170495788|NCT02730377|616156802|FG001|Overall Study|Lost to Follow-up|21|||
170495789|NCT02706886|616156803|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
170495790|NCT02706886|616156804|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
170495791|NCT02706886|616156805|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
170495792|NCT02706886|616156806|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
170495793|NCT02706886|616156807|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
170495794|NCT02706886|616156808|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
170495795|NCT02706886|616156809|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
170495796|NCT02706886|616156810|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
170495797|NCT02706886|616156811|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
170495798|NCT04434469|616156818|FG000|Overall Study|Death|2|||
170495799|NCT04434469|616156819|FG001|Overall Study|Death|3|||
170495800|NCT04434469|616156820|FG002|Overall Study|Death|2|||
170495801|NCT04434469|616156821|FG003|Overall Study|Death|2|||
170495802|NCT04434469|616156822|FG004|Overall Study|Death|2|||
170495803|NCT04434469|616156823|FG005|Overall Study|Death|0|||
170495804|NCT04434469|616156818|FG000|Overall Study|Lost to Follow-up|0|||
170495805|NCT04434469|616156819|FG001|Overall Study|Lost to Follow-up|0|||
170495806|NCT04434469|616156820|FG002|Overall Study|Lost to Follow-up|0|||
170495807|NCT04434469|616156821|FG003|Overall Study|Lost to Follow-up|1|||
170495808|NCT04434469|616156822|FG004|Overall Study|Lost to Follow-up|1|||
170495809|NCT04434469|616156823|FG005|Overall Study|Lost to Follow-up|0|||
170495810|NCT04434469|616156818|FG000|Overall Study|Study terminated by sponsor|1|||
170495811|NCT04434469|616156819|FG001|Overall Study|Study terminated by sponsor|1|||
170495812|NCT04434469|616156820|FG002|Overall Study|Study terminated by sponsor|1|||
170495813|NCT04434469|616156821|FG003|Overall Study|Study terminated by sponsor|2|||
170495814|NCT04434469|616156822|FG004|Overall Study|Study terminated by sponsor|3|||
170495815|NCT04434469|616156823|FG005|Overall Study|Study terminated by sponsor|3|||
170495816|NCT04434469|616156818|FG000|Overall Study|Withdrawal by Subject|0|||
170495817|NCT04434469|616156819|FG001|Overall Study|Withdrawal by Subject|0|||
170495818|NCT04434469|616156820|FG002|Overall Study|Withdrawal by Subject|1|||
170495819|NCT04434469|616156821|FG003|Overall Study|Withdrawal by Subject|0|||
170495820|NCT04434469|616156822|FG004|Overall Study|Withdrawal by Subject|0|||
170495821|NCT04434469|616156823|FG005|Overall Study|Withdrawal by Subject|0|||
170495822|NCT01669174|616156824|FG000|Overall Study|Subject withdrew consent|2|||
170495823|NCT01669174|616156825|FG001|Overall Study|Subject withdrew consent|2|||
170495824|NCT01669174|616156824|FG000|Overall Study|Lost to Follow-up|1|||
170495825|NCT01669174|616156825|FG001|Overall Study|Lost to Follow-up|0|||
170495826|NCT01669174|616156824|FG000|Overall Study|Adverse Event|2|||
170495827|NCT01669174|616156825|FG001|Overall Study|Adverse Event|2|||
170495828|NCT01669174|616156824|FG000|Overall Study|Administrative problems|1|||
170495829|NCT01669174|616156825|FG001|Overall Study|Administrative problems|2|||
170495830|NCT01938430|616156831|FG000|Overall Study|Randomized but Not Treated|0|||
170495831|NCT01938430|616156832|FG001|Overall Study|Randomized but Not Treated|0|||
170495832|NCT01938430|616156833|FG002|Overall Study|Randomized but Not Treated|0|||
170495833|NCT01938430|616156834|FG003|Overall Study|Randomized but Not Treated|0|||
170495834|NCT01938430|616156835|FG004|Overall Study|Randomized but Not Treated|0|||
170495835|NCT01938430|616156836|FG005|Overall Study|Randomized but Not Treated|0|||
170495836|NCT01938430|616156837|FG006|Overall Study|Randomized but Not Treated|0|||
170495837|NCT01938430|616156838|FG007|Overall Study|Randomized but Not Treated|0|||
170495838|NCT01938430|616156839|FG008|Overall Study|Randomized but Not Treated|0|||
170495839|NCT01938430|616156840|FG009|Overall Study|Randomized but Not Treated|0|||
170495840|NCT01938430|616156841|FG010|Overall Study|Randomized but Not Treated|1|||
170495841|NCT01938430|616156842|FG011|Overall Study|Randomized but Not Treated|0|||
170495842|NCT01938430|616156843|FG012|Overall Study|Randomized but Not Treated|0|||
170495843|NCT01938430|616156844|FG013|Overall Study|Randomized but Not Treated|1|||
170495844|NCT01938430|616156831|FG000|Overall Study|Adverse Event|0|||
170495845|NCT01938430|616156832|FG001|Overall Study|Adverse Event|0|||
170495846|NCT01938430|616156833|FG002|Overall Study|Adverse Event|0|||
170495847|NCT01938430|616156834|FG003|Overall Study|Adverse Event|0|||
170495848|NCT01938430|616156835|FG004|Overall Study|Adverse Event|0|||
170495849|NCT01938430|616156836|FG005|Overall Study|Adverse Event|0|||
170495850|NCT01938430|616156837|FG006|Overall Study|Adverse Event|1|||
170495851|NCT01938430|616156838|FG007|Overall Study|Adverse Event|0|||
170495852|NCT01938430|616156839|FG008|Overall Study|Adverse Event|0|||
170495853|NCT01938430|616156840|FG009|Overall Study|Adverse Event|0|||
170495854|NCT01938430|616156841|FG010|Overall Study|Adverse Event|0|||
170495855|NCT01938430|616156842|FG011|Overall Study|Adverse Event|0|||
170495856|NCT01938430|616156843|FG012|Overall Study|Adverse Event|0|||
170495857|NCT01938430|616156844|FG013|Overall Study|Adverse Event|0|||
170495858|NCT01938430|616156831|FG000|Overall Study|Death|1|||
170495859|NCT01938430|616156832|FG001|Overall Study|Death|2|||
170495860|NCT01938430|616156833|FG002|Overall Study|Death|2|||
170495861|NCT01938430|616156834|FG003|Overall Study|Death|1|||
170495862|NCT01938430|616156835|FG004|Overall Study|Death|0|||
170495863|NCT01938430|616156836|FG005|Overall Study|Death|0|||
170495864|NCT01938430|616156837|FG006|Overall Study|Death|1|||
170495865|NCT01938430|616156838|FG007|Overall Study|Death|1|||
170495866|NCT01938430|616156839|FG008|Overall Study|Death|2|||
170495867|NCT01938430|616156840|FG009|Overall Study|Death|3|||
170495868|NCT01938430|616156841|FG010|Overall Study|Death|0|||
170495869|NCT01938430|616156842|FG011|Overall Study|Death|0|||
170495870|NCT01938430|616156843|FG012|Overall Study|Death|0|||
170801962|NCT02397096|617284945|FG001|Study Extension 1|Physician Decision|2|||
170801963|NCT02397096|617284944|FG000|Study Extension 1|Pregnancy|1|||
170801964|NCT02397096|617284945|FG001|Study Extension 1|Pregnancy|0|||
170801965|NCT02397096|617284944|FG000|Study Extension 1|Protocol Violation|0|||
170801966|NCT02397096|617284945|FG001|Study Extension 1|Protocol Violation|1|||
170495871|NCT01938430|616156844|FG013|Overall Study|Death|0|||
170495872|NCT01938430|616156831|FG000|Overall Study|Investigator's Discretion|0|||
170495873|NCT01938430|616156832|FG001|Overall Study|Investigator's Discretion|0|||
170495874|NCT01938430|616156833|FG002|Overall Study|Investigator's Discretion|1|||
170495875|NCT01938430|616156834|FG003|Overall Study|Investigator's Discretion|0|||
170495876|NCT01938430|616156835|FG004|Overall Study|Investigator's Discretion|0|||
170495877|NCT01938430|616156836|FG005|Overall Study|Investigator's Discretion|0|||
170495878|NCT01938430|616156837|FG006|Overall Study|Investigator's Discretion|0|||
170801967|NCT02397096|617284944|FG000|Study Extension 1|Withdrawal by Subject|21|||
170801968|NCT02397096|617284945|FG001|Study Extension 1|Withdrawal by Subject|7|||
170801969|NCT02397096|617284944|FG000|Study Extension 2|Adverse Event|3|||
170551023|NCT01796470|616362557|FG004|Overall Study|Lost to Follow-up|0|||
170551024|NCT01796470|616362553|FG000|Overall Study|Physician Decision|5|||
170551025|NCT01796470|616362554|FG001|Overall Study|Physician Decision|4|||
170551026|NCT01796470|616362555|FG002|Overall Study|Physician Decision|1|||
170551027|NCT01796470|616362556|FG003|Overall Study|Physician Decision|0|||
170551028|NCT01796470|616362557|FG004|Overall Study|Physician Decision|1|||
170551029|NCT01796470|616362553|FG000|Overall Study|Progressive Disease|7|||
170551030|NCT01796470|616362554|FG001|Overall Study|Progressive Disease|7|||
170551031|NCT01796470|616362555|FG002|Overall Study|Progressive Disease|3|||
170801970|NCT02397096|617284945|FG001|Study Extension 2|Adverse Event|3|||
170801971|NCT02397096|617284944|FG000|Study Extension 2|Availability of study medication locally|152|||
170801972|NCT02397096|617284945|FG001|Study Extension 2|Availability of study medication locally|64|||
170801973|NCT02397096|617284944|FG000|Study Extension 2|Death|2|||
170641909|NCT00114517|616701378|FG000|Overall Study|Weight increase|0|||
170641910|NCT00114517|616701379|FG001|Overall Study|Weight increase|0|||
170641911|NCT00114517|616701380|FG002|Overall Study|Weight increase|1|||
170641912|NCT00114517|616701381|FG003|Overall Study|Weight increase|0|||
170641913|NCT00114517|616701378|FG000|Overall Study|Concern about blood clots|0|||
170641914|NCT00114517|616701379|FG001|Overall Study|Concern about blood clots|0|||
170641915|NCT00114517|616701380|FG002|Overall Study|Concern about blood clots|1|||
170641916|NCT00114517|616701381|FG003|Overall Study|Concern about blood clots|0|||
170641917|NCT00114517|616701378|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
170641918|NCT00114517|616701379|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
170641919|NCT00114517|616701380|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
170641920|NCT00114517|616701381|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
170641921|NCT05500417|616701382|FG000|Overall Study|Lost to Follow-up|0|||
170641922|NCT05500417|616701383|FG001|Overall Study|Lost to Follow-up|0|||
170641923|NCT05500417|616701384|FG002|Overall Study|Lost to Follow-up|0|||
170641924|NCT05500417|616701385|FG003|Overall Study|Lost to Follow-up|1|||
170551032|NCT01796470|616362556|FG003|Overall Study|Progressive Disease|2|||
170551033|NCT01796470|616362557|FG004|Overall Study|Progressive Disease|0|||
170801974|NCT02397096|617284945|FG001|Study Extension 2|Death|0|||
170801975|NCT02397096|617284944|FG000|Study Extension 2|Lack of Efficacy|1|||
170801976|NCT02397096|617284945|FG001|Study Extension 2|Lack of Efficacy|0|||
170801977|NCT02397096|617284944|FG000|Study Extension 2|Lost to Follow-up|2|||
170801978|NCT02397096|617284945|FG001|Study Extension 2|Lost to Follow-up|1|||
170801979|NCT02397096|617284944|FG000|Study Extension 2|Non-compliance with study drug|1|||
170801980|NCT02397096|617284945|FG001|Study Extension 2|Non-compliance with study drug|0|||
170801981|NCT02397096|617284944|FG000|Study Extension 2|Physician Decision|2|||
170801982|NCT02397096|617284945|FG001|Study Extension 2|Physician Decision|5|||
170801983|NCT02397096|617284944|FG000|Study Extension 2|Pregnancy|1|||
170801984|NCT02397096|617284945|FG001|Study Extension 2|Pregnancy|0|||
170801985|NCT02397096|617284944|FG000|Study Extension 2|Withdrawal by Subject|10|||
170801986|NCT02397096|617284945|FG001|Study Extension 2|Withdrawal by Subject|3|||
170801987|NCT02397096|617284944|FG000|Study Extension 3|Adverse Event|1|||
170801988|NCT02397096|617284945|FG001|Study Extension 3|Adverse Event|0|||
170801989|NCT02397096|617284944|FG000|Study Extension 3|Availability of study medication locally|11|||
170801990|NCT02397096|617284945|FG001|Study Extension 3|Availability of study medication locally|3|||
170801991|NCT02397096|617284944|FG000|Study Extension 3|Lost to Follow-up|1|||
170801992|NCT02397096|617284945|FG001|Study Extension 3|Lost to Follow-up|0|||
170801993|NCT02397096|617284944|FG000|Study Extension 3|Withdrawal by Subject|2|||
170801994|NCT02397096|617284945|FG001|Study Extension 3|Withdrawal by Subject|1|||
170801995|NCT03500549|617284946|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
170801996|NCT03500549|617284947|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
170801997|NCT03500549|617284946|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
170801998|NCT03500549|617284947|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
170801999|NCT01371994|617284951|FG000|Overall Study|Adverse Event|3|||
170802000|NCT01371994|617284952|FG001|Overall Study|Adverse Event|6|||
170802001|NCT01371994|617284951|FG000|Overall Study|Lack of Efficacy|3|||
170802002|NCT01371994|617284952|FG001|Overall Study|Lack of Efficacy|0|||
170802003|NCT01371994|617284951|FG000|Overall Study|Withdrawal by Subject|13|||
170802004|NCT01371994|617284952|FG001|Overall Study|Withdrawal by Subject|7|||
170802005|NCT01371994|617284951|FG000|Overall Study|Lost to Follow-up|1|||
170802006|NCT01371994|617284952|FG001|Overall Study|Lost to Follow-up|1|||
170802007|NCT01371994|617284951|FG000|Overall Study|Protocol Violation|24|||
170802008|NCT01371994|617284952|FG001|Overall Study|Protocol Violation|17|||
170802009|NCT01371994|617284951|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
170802010|NCT01371994|617284952|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
170802011|NCT01371994|617284951|FG000|Overall Study|Physician Decision|1|||
170900535|NCT01478958|617640150|FG002|Overall Study|Withdrawal by Subject|1|||
170551034|NCT01796470|616362553|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
170641925|NCT05500417|616701386|FG004|Overall Study|Lost to Follow-up|0|||
170641926|NCT05500417|616701387|FG005|Overall Study|Lost to Follow-up|0|||
170641927|NCT06394323|616701388|FG000|Overall Study|Death|0|||
170641928|NCT06394323|616701389|FG001|Overall Study|Death|1|||
170802012|NCT01371994|617284952|FG001|Overall Study|Physician Decision|1|||
170900536|NCT01478958|617640148|FG000|Overall Study|Weight loss|1|||
170900537|NCT01478958|617640149|FG001|Overall Study|Weight loss|0|||
170900538|NCT01478958|617640150|FG002|Overall Study|Weight loss|0|||
170900539|NCT01478958|617640148|FG000|Overall Study|Re-located|0|||
170900540|NCT01478958|617640149|FG001|Overall Study|Re-located|1|||
170900541|NCT01478958|617640150|FG002|Overall Study|Re-located|0|||
170900542|NCT01478958|617640148|FG000|Overall Study|Unable to comply|0|||
170900543|NCT01478958|617640149|FG001|Overall Study|Unable to comply|0|||
170551035|NCT01796470|616362554|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
170551036|NCT01796470|616362555|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
170551037|NCT01796470|616362556|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
170551038|NCT01796470|616362557|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
170551039|NCT01796470|616362553|FG000|Overall Study|Withdrawal by Subject|7|||
170551040|NCT01796470|616362554|FG001|Overall Study|Withdrawal by Subject|0|||
170900544|NCT01478958|617640150|FG002|Overall Study|Unable to comply|2|||
170900545|NCT00432809|617640153|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
170900546|NCT00432809|617640154|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
170900547|NCT00432809|617640155|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
170900548|NCT00432809|617640153|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
170900549|NCT00432809|617640154|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
170900550|NCT00432809|617640155|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
170551041|NCT01796470|616362555|FG002|Overall Study|Withdrawal by Subject|0|||
170551042|NCT01796470|616362556|FG003|Overall Study|Withdrawal by Subject|0|||
170551043|NCT01796470|616362557|FG004|Overall Study|Withdrawal by Subject|1|||
170551044|NCT01927861|616362558|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
170551045|NCT01927861|616362559|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
170551046|NCT01927861|616362558|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
170551047|NCT01927861|616362559|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
170551048|NCT01663987|616362562|FG000|Overall Study|Adverse Event|7|||
170551049|NCT01663987|616362563|FG001|Overall Study|Adverse Event|2|||
170551050|NCT01663987|616362562|FG000|Overall Study|Lost to Follow-up|1|||
170551051|NCT01663987|616362563|FG001|Overall Study|Lost to Follow-up|1|||
170641929|NCT06394323|616701390|FG002|Overall Study|Death|0|||
170641930|NCT06394323|616701391|FG003|Overall Study|Death|0|||
170641931|NCT06394323|616701388|FG000|Overall Study|Physician Decision|0|||
170641932|NCT06394323|616701389|FG001|Overall Study|Physician Decision|2|||
170641933|NCT06394323|616701390|FG002|Overall Study|Physician Decision|0|||
170641934|NCT06394323|616701391|FG003|Overall Study|Physician Decision|0|||
170641935|NCT06394323|616701388|FG000|Overall Study|Withdrawal by Subject|4|||
170641936|NCT06394323|616701389|FG001|Overall Study|Withdrawal by Subject|4|||
170641937|NCT06394323|616701390|FG002|Overall Study|Withdrawal by Subject|0|||
170641938|NCT06394323|616701391|FG003|Overall Study|Withdrawal by Subject|0|||
170641939|NCT02355184|616701392|FG000|Overall Study|Lost to Follow-up|2|||
170641940|NCT02355184|616701392|FG000|Overall Study|Study Terminated|10|||
170641941|NCT06173063|616701393|FG000|Overall Study|Withdrawal by Subject|2|||
170641942|NCT02655016|616701394|FG000|Overall Study|Disease progression|6|||
170641943|NCT02655016|616701395|FG001|Overall Study|Disease progression|4|||
170641944|NCT02655016|616701394|FG000|Overall Study|Site closed|0|||
170641945|NCT02655016|616701395|FG001|Overall Study|Site closed|1|||
170641946|NCT02655016|616701394|FG000|Overall Study|Death|30|||
170641947|NCT02655016|616701395|FG001|Overall Study|Death|48|||
170641948|NCT02655016|616701394|FG000|Overall Study|Lost to Follow-up|1|||
170641949|NCT02655016|616701395|FG001|Overall Study|Lost to Follow-up|1|||
170641950|NCT02655016|616701394|FG000|Overall Study|Withdrawal by Subject|18|||
170641951|NCT02655016|616701395|FG001|Overall Study|Withdrawal by Subject|36|||
170900551|NCT03853694|617640159|FG000|Overall Study|Protocol Violation|3|||
170900552|NCT03853694|617640160|FG001|Overall Study|Protocol Violation|5|||
170551052|NCT01663987|616362562|FG000|Overall Study|Withdrawal by Subject|2|||
170551053|NCT01663987|616362563|FG001|Overall Study|Withdrawal by Subject|3|||
170551054|NCT01663987|616362562|FG000|Overall Study|Other reason not defined above|3|||
170551055|NCT01663987|616362563|FG001|Overall Study|Other reason not defined above|0|||
170551056|NCT00728182|616362565|FG000|Overall Study|Adverse Event|1|||
170551057|NCT00728182|616362566|FG001|Overall Study|Adverse Event|0|||
170551058|NCT00728182|616362565|FG000|Overall Study|Lost to Follow-up|2|||
170551059|NCT00728182|616362566|FG001|Overall Study|Lost to Follow-up|0|||
170900553|NCT03853694|617640161|FG002|Overall Study|Protocol Violation|3|||
170551060|NCT00728182|616362565|FG000|Overall Study|Death|0|||
170641952|NCT04695977|616701398|FG000|Overall Study|Sponsor Decision|9|||
170641953|NCT04695977|616701399|FG001|Overall Study|Sponsor Decision|4|||
170641954|NCT04695977|616701398|FG000|Overall Study|Death|2|||
170641955|NCT04695977|616701399|FG001|Overall Study|Death|5|||
170551061|NCT00728182|616362566|FG001|Overall Study|Death|2|||
170551062|NCT00728182|616362565|FG000|Overall Study|Protocol Noncompliance|0|||
170551063|NCT00728182|616362566|FG001|Overall Study|Protocol Noncompliance|1|||
170641956|NCT06503991|616701404|FG000|Overall Study|Lost to Follow-up|2|||
170641957|NCT06503991|616701404|FG000|Overall Study|Withdrawal by Subject|2|||
170900554|NCT03853694|617640159|FG000|Overall Study|Delivered early|0|||
170900555|NCT03853694|617640160|FG001|Overall Study|Delivered early|1|||
170900556|NCT03853694|617640161|FG002|Overall Study|Delivered early|0|||
170495879|NCT01938430|616156838|FG007|Overall Study|Investigator's Discretion|0|||
170495880|NCT01938430|616156839|FG008|Overall Study|Investigator's Discretion|0|||
170495881|NCT01938430|616156840|FG009|Overall Study|Investigator's Discretion|0|||
170495882|NCT01938430|616156841|FG010|Overall Study|Investigator's Discretion|0|||
170495883|NCT01938430|616156842|FG011|Overall Study|Investigator's Discretion|0|||
170495884|NCT01938430|616156843|FG012|Overall Study|Investigator's Discretion|0|||
170495885|NCT01938430|616156844|FG013|Overall Study|Investigator's Discretion|0|||
170495886|NCT01938430|616156831|FG000|Overall Study|Lack of Efficacy|3|||
170495887|NCT01938430|616156832|FG001|Overall Study|Lack of Efficacy|1|||
170495888|NCT01938430|616156833|FG002|Overall Study|Lack of Efficacy|1|||
170495889|NCT01938430|616156834|FG003|Overall Study|Lack of Efficacy|1|||
170495890|NCT01938430|616156835|FG004|Overall Study|Lack of Efficacy|0|||
170495891|NCT01938430|616156836|FG005|Overall Study|Lack of Efficacy|0|||
170495892|NCT01938430|616156837|FG006|Overall Study|Lack of Efficacy|0|||
170495893|NCT01938430|616156838|FG007|Overall Study|Lack of Efficacy|0|||
170495894|NCT01938430|616156839|FG008|Overall Study|Lack of Efficacy|1|||
170495895|NCT01938430|616156840|FG009|Overall Study|Lack of Efficacy|0|||
170495896|NCT01938430|616156841|FG010|Overall Study|Lack of Efficacy|2|||
170495897|NCT01938430|616156842|FG011|Overall Study|Lack of Efficacy|1|||
170495898|NCT01938430|616156843|FG012|Overall Study|Lack of Efficacy|0|||
170495899|NCT01938430|616156844|FG013|Overall Study|Lack of Efficacy|0|||
170495900|NCT01938430|616156831|FG000|Overall Study|Lost to Follow-up|0|||
170495901|NCT01938430|616156832|FG001|Overall Study|Lost to Follow-up|0|||
170495902|NCT01938430|616156833|FG002|Overall Study|Lost to Follow-up|1|||
170495903|NCT01938430|616156834|FG003|Overall Study|Lost to Follow-up|0|||
170495904|NCT01938430|616156835|FG004|Overall Study|Lost to Follow-up|0|||
170495905|NCT01938430|616156836|FG005|Overall Study|Lost to Follow-up|1|||
170495906|NCT01938430|616156837|FG006|Overall Study|Lost to Follow-up|0|||
170495907|NCT01938430|616156838|FG007|Overall Study|Lost to Follow-up|0|||
170495908|NCT01938430|616156839|FG008|Overall Study|Lost to Follow-up|0|||
170495909|NCT01938430|616156840|FG009|Overall Study|Lost to Follow-up|0|||
170495910|NCT01938430|616156841|FG010|Overall Study|Lost to Follow-up|0|||
170495911|NCT01938430|616156842|FG011|Overall Study|Lost to Follow-up|0|||
170495912|NCT01938430|616156843|FG012|Overall Study|Lost to Follow-up|0|||
170495913|NCT01938430|616156844|FG013|Overall Study|Lost to Follow-up|0|||
170495914|NCT01938430|616156831|FG000|Overall Study|Withdrew Consent|0|||
170495915|NCT01938430|616156832|FG001|Overall Study|Withdrew Consent|0|||
170495916|NCT01938430|616156833|FG002|Overall Study|Withdrew Consent|0|||
170495917|NCT01938430|616156834|FG003|Overall Study|Withdrew Consent|0|||
170495918|NCT01938430|616156835|FG004|Overall Study|Withdrew Consent|0|||
170495919|NCT01938430|616156836|FG005|Overall Study|Withdrew Consent|0|||
170495920|NCT01938430|616156837|FG006|Overall Study|Withdrew Consent|0|||
170495921|NCT01938430|616156838|FG007|Overall Study|Withdrew Consent|0|||
170495922|NCT01938430|616156839|FG008|Overall Study|Withdrew Consent|1|||
170495923|NCT01938430|616156840|FG009|Overall Study|Withdrew Consent|0|||
170495924|NCT01938430|616156841|FG010|Overall Study|Withdrew Consent|0|||
170495925|NCT01938430|616156842|FG011|Overall Study|Withdrew Consent|0|||
170495926|NCT01938430|616156843|FG012|Overall Study|Withdrew Consent|0|||
170495927|NCT01938430|616156844|FG013|Overall Study|Withdrew Consent|0|||
170495928|NCT00537316|616156845|FG000|Part 1|Adverse Event|7|||
170495929|NCT00537316|616156846|FG001|Part 1|Adverse Event|11|||
170495930|NCT00537316|616156847|FG002|Part 1|Adverse Event|8|||
170802013|NCT01371994|617284951|FG000|Overall Study|Miscellaneous Reasons|6|||
170802014|NCT01371994|617284952|FG001|Overall Study|Miscellaneous Reasons|4|||
170802015|NCT00087685|617284953|FG000|Overall Study|Adverse Event|5|||
170802016|NCT00087685|617284953|FG000|Overall Study|Non-Compliance|1|||
170802017|NCT00087685|617284953|FG000|Overall Study|Progressive Disease|5|||
170802018|NCT00087685|617284953|FG000|Overall Study|Withdrawal by Subject|3|||
170802019|NCT01983683|617284954|FG000|Overall Study|Withdrawal by Subject|14|||
170802020|NCT01983683|617284955|FG001|Overall Study|Withdrawal by Subject|18|||
170802021|NCT01983683|617284954|FG000|Overall Study|Death|11|||
170802022|NCT01983683|617284955|FG001|Overall Study|Death|15|||
170802023|NCT01983683|617284954|FG000|Overall Study|Physician Decision|8|||
170802024|NCT01983683|617284955|FG001|Overall Study|Physician Decision|9|||
170802025|NCT01983683|617284954|FG000|Overall Study|Lost to Follow-up|4|||
170802026|NCT01983683|617284955|FG001|Overall Study|Lost to Follow-up|8|||
170495931|NCT00537316|616156848|FG003|Part 1|Adverse Event|0|||
170495932|NCT00537316|616156849|FG004|Part 1|Adverse Event|0|||
170495933|NCT00537316|616156850|FG005|Part 1|Adverse Event|0|||
170495934|NCT00537316|616156851|FG006|Part 1|Adverse Event|0|||
170495935|NCT00537316|616156845|FG000|Part 1|Protocol defined clinical event|1|||
170495936|NCT00537316|616156846|FG001|Part 1|Protocol defined clinical event|0|||
170495937|NCT00537316|616156847|FG002|Part 1|Protocol defined clinical event|0|||
170495938|NCT00537316|616156848|FG003|Part 1|Protocol defined clinical event|0|||
170495939|NCT00537316|616156849|FG004|Part 1|Protocol defined clinical event|0|||
170495940|NCT00537316|616156850|FG005|Part 1|Protocol defined clinical event|0|||
170641958|NCT01217307|616703348|FG000|Overall Study|Withdrawal by Subject|0|||
170802027|NCT01983683|617284954|FG000|Overall Study|Sponsor Decision|1|||
170495941|NCT00537316|616156851|FG006|Part 1|Protocol defined clinical event|0|||
170495942|NCT00537316|616156845|FG000|Part 1|Lost to Follow-up|1|||
170495943|NCT00537316|616156846|FG001|Part 1|Lost to Follow-up|0|||
170495944|NCT00537316|616156847|FG002|Part 1|Lost to Follow-up|0|||
170495945|NCT00537316|616156848|FG003|Part 1|Lost to Follow-up|0|||
170495946|NCT00537316|616156849|FG004|Part 1|Lost to Follow-up|0|||
170495947|NCT00537316|616156850|FG005|Part 1|Lost to Follow-up|0|||
170495948|NCT00537316|616156851|FG006|Part 1|Lost to Follow-up|0|||
170495949|NCT00537316|616156845|FG000|Part 1|Withdrawal by Subject|3|||
170495950|NCT00537316|616156846|FG001|Part 1|Withdrawal by Subject|8|||
170495951|NCT00537316|616156847|FG002|Part 1|Withdrawal by Subject|4|||
170495952|NCT00537316|616156848|FG003|Part 1|Withdrawal by Subject|0|||
170495953|NCT00537316|616156849|FG004|Part 1|Withdrawal by Subject|0|||
170495954|NCT00537316|616156850|FG005|Part 1|Withdrawal by Subject|0|||
170495955|NCT00537316|616156851|FG006|Part 1|Withdrawal by Subject|0|||
170495956|NCT00537316|616156845|FG000|Part 1|Protocol Violation|1|||
170495957|NCT00537316|616156846|FG001|Part 1|Protocol Violation|5|||
170495958|NCT00537316|616156847|FG002|Part 1|Protocol Violation|1|||
170495959|NCT00537316|616156848|FG003|Part 1|Protocol Violation|0|||
170495960|NCT00537316|616156849|FG004|Part 1|Protocol Violation|0|||
170495961|NCT00537316|616156850|FG005|Part 1|Protocol Violation|0|||
170495962|NCT00537316|616156851|FG006|Part 1|Protocol Violation|0|||
170495963|NCT00537316|616156845|FG000|Part 1|Did not meet protocol eligibility|1|||
170495964|NCT00537316|616156846|FG001|Part 1|Did not meet protocol eligibility|3|||
170495965|NCT00537316|616156847|FG002|Part 1|Did not meet protocol eligibility|2|||
170495966|NCT00537316|616156848|FG003|Part 1|Did not meet protocol eligibility|0|||
170495967|NCT00537316|616156849|FG004|Part 1|Did not meet protocol eligibility|0|||
170495968|NCT00537316|616156850|FG005|Part 1|Did not meet protocol eligibility|0|||
170495969|NCT00537316|616156851|FG006|Part 1|Did not meet protocol eligibility|0|||
170495970|NCT00537316|616156845|FG000|Part 1|Administrative|0|||
170495971|NCT00537316|616156846|FG001|Part 1|Administrative|0|||
170495972|NCT00537316|616156847|FG002|Part 1|Administrative|2|||
170495973|NCT00537316|616156848|FG003|Part 1|Administrative|0|||
170495974|NCT00537316|616156849|FG004|Part 1|Administrative|0|||
170495975|NCT00537316|616156850|FG005|Part 1|Administrative|0|||
170495976|NCT00537316|616156851|FG006|Part 1|Administrative|0|||
170495977|NCT00537316|616156845|FG000|Part 2|Never entered follow-up|0|||
170495978|NCT00537316|616156846|FG001|Part 2|Never entered follow-up|0|||
170495979|NCT00537316|616156847|FG002|Part 2|Never entered follow-up|0|||
170495980|NCT00537316|616156848|FG003|Part 2|Never entered follow-up|0|||
170495981|NCT00537316|616156849|FG004|Part 2|Never entered follow-up|0|||
170495982|NCT00537316|616156850|FG005|Part 2|Never entered follow-up|0|||
170495983|NCT00537316|616156851|FG006|Part 2|Never entered follow-up|1|||
170495984|NCT00537316|616156845|FG000|Part 2|Adverse Event|4|||
170495985|NCT00537316|616156846|FG001|Part 2|Adverse Event|0|||
170495986|NCT00537316|616156847|FG002|Part 2|Adverse Event|2|||
170495987|NCT00537316|616156848|FG003|Part 2|Adverse Event|0|||
170495988|NCT00537316|616156849|FG004|Part 2|Adverse Event|0|||
170495989|NCT00537316|616156850|FG005|Part 2|Adverse Event|0|||
170495990|NCT00537316|616156851|FG006|Part 2|Adverse Event|0|||
170495991|NCT00537316|616156845|FG000|Part 2|Lost to Follow-up|1|||
170495992|NCT00537316|616156846|FG001|Part 2|Lost to Follow-up|0|||
170495993|NCT00537316|616156847|FG002|Part 2|Lost to Follow-up|2|||
170495994|NCT00537316|616156848|FG003|Part 2|Lost to Follow-up|0|||
170495995|NCT00537316|616156849|FG004|Part 2|Lost to Follow-up|0|||
170495996|NCT00537316|616156850|FG005|Part 2|Lost to Follow-up|0|||
170495997|NCT00537316|616156851|FG006|Part 2|Lost to Follow-up|0|||
170495998|NCT00537316|616156845|FG000|Part 2|Withdrawal by Subject|5|||
170495999|NCT00537316|616156846|FG001|Part 2|Withdrawal by Subject|1|||
170496000|NCT00537316|616156847|FG002|Part 2|Withdrawal by Subject|4|||
170496001|NCT00537316|616156848|FG003|Part 2|Withdrawal by Subject|0|||
170496002|NCT00537316|616156849|FG004|Part 2|Withdrawal by Subject|0|||
170496003|NCT00537316|616156850|FG005|Part 2|Withdrawal by Subject|0|||
170496004|NCT00537316|616156851|FG006|Part 2|Withdrawal by Subject|0|||
170496005|NCT00537316|616156845|FG000|Part 2|Administrative|16|||
170496006|NCT00537316|616156846|FG001|Part 2|Administrative|8|||
170496007|NCT00537316|616156847|FG002|Part 2|Administrative|24|||
170496008|NCT00537316|616156848|FG003|Part 2|Administrative|3|||
170496009|NCT00537316|616156849|FG004|Part 2|Administrative|1|||
170496010|NCT00537316|616156850|FG005|Part 2|Administrative|4|||
170496011|NCT00537316|616156851|FG006|Part 2|Administrative|1|||
170496012|NCT00526669|616156852|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
170496013|NCT00526669|616156853|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
170496014|NCT00526669|616156852|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
170496015|NCT00526669|616156853|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
170496016|NCT00526669|616156852|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
170496017|NCT00526669|616156853|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
170496018|NCT00526669|616156852|FG000|Combined Treatment Phase|Death|0|||
170496019|NCT00526669|616156853|FG001|Combined Treatment Phase|Death|2|||
170496020|NCT00968981|616156854|FG000|Overall Study|Adverse Event|2|||
170496021|NCT00968981|616156855|FG001|Overall Study|Adverse Event|0|||
170496022|NCT00968981|616156856|FG002|Overall Study|Adverse Event|0|||
170496023|NCT00968981|616156854|FG000|Overall Study|Disease Progression|14|||
170496024|NCT00968981|616156855|FG001|Overall Study|Disease Progression|16|||
170900557|NCT03853694|617640159|FG000|Overall Study|not suitable to proceed|0|||
170900558|NCT03853694|617640160|FG001|Overall Study|not suitable to proceed|1|||
170900559|NCT03853694|617640161|FG002|Overall Study|not suitable to proceed|0|||
170900560|NCT03853694|617640159|FG000|Overall Study|difficult surgery|0|||
170900561|NCT03853694|617640160|FG001|Overall Study|difficult surgery|0|||
170900562|NCT03853694|617640161|FG002|Overall Study|difficult surgery|1|||
170900563|NCT03853694|617640159|FG000|Overall Study|Lost to Follow-up|0|||
170900564|NCT03853694|617640160|FG001|Overall Study|Lost to Follow-up|1|||
170900565|NCT03853694|617640161|FG002|Overall Study|Lost to Follow-up|0|||
170900566|NCT03853694|617640159|FG000|Overall Study|Withdrawal by Subject|0|||
170900567|NCT03853694|617640160|FG001|Overall Study|Withdrawal by Subject|1|||
170900568|NCT03853694|617640161|FG002|Overall Study|Withdrawal by Subject|0|||
170900569|NCT00481065|617640162|FG000|Overall Study|Adverse event or death|1|||
170496025|NCT00968981|616156856|FG002|Overall Study|Disease Progression|13|||
170496026|NCT00968981|616156854|FG000|Overall Study|Lost to Follow-up|0|||
170496027|NCT00968981|616156855|FG001|Overall Study|Lost to Follow-up|0|||
170496028|NCT00968981|616156856|FG002|Overall Study|Lost to Follow-up|1|||
170496029|NCT00968981|616156854|FG000|Overall Study|Physician Decision|5|||
170496030|NCT00968981|616156855|FG001|Overall Study|Physician Decision|3|||
170496031|NCT00968981|616156856|FG002|Overall Study|Physician Decision|5|||
170496032|NCT00968981|616156854|FG000|Overall Study|Withdrawal by Subject|1|||
170496033|NCT00968981|616156855|FG001|Overall Study|Withdrawal by Subject|3|||
170496034|NCT00968981|616156856|FG002|Overall Study|Withdrawal by Subject|3|||
170496035|NCT01676896|616156858|FG000|Overall Study|Withdrawal by Subject|12|||
170496036|NCT01676896|616156859|FG001|Overall Study|Withdrawal by Subject|7|||
170496037|NCT01676896|616156860|FG002|Overall Study|Withdrawal by Subject|19|||
170496038|NCT01647516|616156861|FG000|Induction Period (IP)|Physician Decision|2|||
170496039|NCT01647516|616156862|FG001|Induction Period (IP)|Physician Decision|0|||
170496040|NCT01647516|616156863|FG002|Induction Period (IP)|Physician Decision|0|||
170496041|NCT01647516|616156864|FG003|Induction Period (IP)|Physician Decision|0|||
170496042|NCT01647516|616156865|FG004|Induction Period (IP)|Physician Decision|0|||
170496043|NCT01647516|616156866|FG005|Induction Period (IP)|Physician Decision|0|||
170496044|NCT01647516|616156861|FG000|Induction Period (IP)|Adverse Event|1|||
170496045|NCT01647516|616156862|FG001|Induction Period (IP)|Adverse Event|2|||
170496046|NCT01647516|616156863|FG002|Induction Period (IP)|Adverse Event|0|||
170496047|NCT01647516|616156864|FG003|Induction Period (IP)|Adverse Event|0|||
170496048|NCT01647516|616156865|FG004|Induction Period (IP)|Adverse Event|0|||
170496049|NCT01647516|616156866|FG005|Induction Period (IP)|Adverse Event|0|||
170496050|NCT01647516|616156861|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
170496051|NCT01647516|616156862|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
170496052|NCT01647516|616156863|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
170496053|NCT01647516|616156864|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
170496054|NCT01647516|616156865|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
170496055|NCT01647516|616156866|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
170551064|NCT01898091|616362569|FG000|Overall Study|Lost to Follow-up|1|||
170551065|NCT01898091|616362570|FG001|Overall Study|Lost to Follow-up|1|||
170551066|NCT01898091|616362569|FG000|Overall Study|Withdrawal by Subject|1|||
170551067|NCT01898091|616362570|FG001|Overall Study|Withdrawal by Subject|5|||
170551068|NCT01827943|616362573|FG000|Overall Study|Protocol Violation|8|||
170551069|NCT01827943|616362573|FG000|Overall Study|Never treated because of an rapid progression|1|||
170551070|NCT00309244|616362574|FG000|Overall Study|Adverse Event|29|||
170551071|NCT00309244|616362575|FG001|Overall Study|Adverse Event|12|||
170551072|NCT00309244|616362574|FG000|Overall Study|Lost to Follow-up|6|||
170551073|NCT00309244|616362575|FG001|Overall Study|Lost to Follow-up|22|||
170551074|NCT00309244|616362574|FG000|Overall Study|Physician Decision|5|||
170551075|NCT00309244|616362575|FG001|Overall Study|Physician Decision|8|||
170551076|NCT00309244|616362574|FG000|Overall Study|Protocol Violation|6|||
170551077|NCT00309244|616362575|FG001|Overall Study|Protocol Violation|3|||
170551078|NCT00309244|616362574|FG000|Overall Study|Withdrawal by Subject|50|||
170551079|NCT00309244|616362575|FG001|Overall Study|Withdrawal by Subject|32|||
170551080|NCT00309244|616362574|FG000|Overall Study|Various|7|||
170900570|NCT00481065|617640163|FG001|Overall Study|Adverse event or death|1|||
170900571|NCT00481065|617640164|FG002|Overall Study|Adverse event or death|3|||
170900572|NCT00481065|617640165|FG003|Overall Study|Adverse event or death|0|||
170496056|NCT01647516|616156861|FG000|Induction Period (IP)|Participant Choice|0|||
170496057|NCT01647516|616156862|FG001|Induction Period (IP)|Participant Choice|0|||
170496058|NCT01647516|616156863|FG002|Induction Period (IP)|Participant Choice|1|||
170496059|NCT01647516|616156864|FG003|Induction Period (IP)|Participant Choice|0|||
170496060|NCT01647516|616156865|FG004|Induction Period (IP)|Participant Choice|0|||
170496061|NCT01647516|616156866|FG005|Induction Period (IP)|Participant Choice|0|||
170496062|NCT01647516|616156861|FG000|Induction Period (IP)|Lack of Efficacy|1|||
170551081|NCT00309244|616362575|FG001|Overall Study|Various|7|||
170551082|NCT00309244|616362574|FG000|Overall Study|Randomized but not dosed|11|||
170551083|NCT00309244|616362575|FG001|Overall Study|Randomized but not dosed|12|||
170900573|NCT00481065|617640166|FG004|Overall Study|Adverse event or death|2|||
170900574|NCT00481065|617640167|FG005|Overall Study|Adverse event or death|0|||
170496063|NCT01647516|616156862|FG001|Induction Period (IP)|Lack of Efficacy|0|||
170496064|NCT01647516|616156863|FG002|Induction Period (IP)|Lack of Efficacy|0|||
170496065|NCT01647516|616156864|FG003|Induction Period (IP)|Lack of Efficacy|0|||
170496066|NCT01647516|616156865|FG004|Induction Period (IP)|Lack of Efficacy|0|||
170496067|NCT01647516|616156866|FG005|Induction Period (IP)|Lack of Efficacy|0|||
170496068|NCT01647516|616156861|FG000|Induction Period (IP)|No study drug received|1|||
170496069|NCT01647516|616156862|FG001|Induction Period (IP)|No study drug received|1|||
170496070|NCT01647516|616156863|FG002|Induction Period (IP)|No study drug received|0|||
170496071|NCT01647516|616156864|FG003|Induction Period (IP)|No study drug received|0|||
170496072|NCT01647516|616156865|FG004|Induction Period (IP)|No study drug received|0|||
170496073|NCT01647516|616156866|FG005|Induction Period (IP)|No study drug received|0|||
170496074|NCT01647516|616156861|FG000|Maintenance Period (MP)|Adverse Event|2|||
170496075|NCT01647516|616156862|FG001|Maintenance Period (MP)|Adverse Event|1|||
170496076|NCT01647516|616156863|FG002|Maintenance Period (MP)|Adverse Event|0|||
170496077|NCT01647516|616156864|FG003|Maintenance Period (MP)|Adverse Event|0|||
170496078|NCT01647516|616156865|FG004|Maintenance Period (MP)|Adverse Event|0|||
170496079|NCT01647516|616156866|FG005|Maintenance Period (MP)|Adverse Event|0|||
170496080|NCT01647516|616156861|FG000|Maintenance Period (MP)|Non-compliance|1|||
170496081|NCT01647516|616156862|FG001|Maintenance Period (MP)|Non-compliance|0|||
170496082|NCT01647516|616156863|FG002|Maintenance Period (MP)|Non-compliance|0|||
170496083|NCT01647516|616156864|FG003|Maintenance Period (MP)|Non-compliance|0|||
170496084|NCT01647516|616156865|FG004|Maintenance Period (MP)|Non-compliance|0|||
170496085|NCT01647516|616156866|FG005|Maintenance Period (MP)|Non-compliance|0|||
170496086|NCT01647516|616156861|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
170496087|NCT01647516|616156862|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
170496088|NCT01647516|616156863|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
170496089|NCT01647516|616156864|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
170496090|NCT01647516|616156865|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
170496091|NCT01647516|616156866|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
170496092|NCT01647516|616156861|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
170496093|NCT01647516|616156862|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
170496094|NCT01647516|616156863|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
170496095|NCT01647516|616156864|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
170496096|NCT01647516|616156865|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
170496097|NCT01647516|616156866|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
170496098|NCT01647516|616156861|FG000|Open-Label Period|Adverse Event|0|||
170496099|NCT01647516|616156862|FG001|Open-Label Period|Adverse Event|0|||
170496100|NCT01647516|616156863|FG002|Open-Label Period|Adverse Event|0|||
170496101|NCT01647516|616156864|FG003|Open-Label Period|Adverse Event|5|||
170496102|NCT01647516|616156865|FG004|Open-Label Period|Adverse Event|6|||
170496103|NCT01647516|616156866|FG005|Open-Label Period|Adverse Event|3|||
170496104|NCT01647516|616156861|FG000|Open-Label Period|Pregnancy|0|||
170496105|NCT01647516|616156862|FG001|Open-Label Period|Pregnancy|0|||
170496106|NCT01647516|616156863|FG002|Open-Label Period|Pregnancy|0|||
170496107|NCT01647516|616156864|FG003|Open-Label Period|Pregnancy|0|||
170496108|NCT01647516|616156865|FG004|Open-Label Period|Pregnancy|0|||
170496109|NCT01647516|616156866|FG005|Open-Label Period|Pregnancy|1|||
170496110|NCT01647516|616156861|FG000|Open-Label Period|Non-compliance|0|||
170496111|NCT01647516|616156862|FG001|Open-Label Period|Non-compliance|0|||
170496112|NCT01647516|616156863|FG002|Open-Label Period|Non-compliance|0|||
170496113|NCT01647516|616156864|FG003|Open-Label Period|Non-compliance|1|||
170496114|NCT01647516|616156865|FG004|Open-Label Period|Non-compliance|0|||
170496115|NCT01647516|616156866|FG005|Open-Label Period|Non-compliance|1|||
170496116|NCT01647516|616156861|FG000|Open-Label Period|Physician Decision|0|||
170496117|NCT01647516|616156862|FG001|Open-Label Period|Physician Decision|0|||
170496118|NCT01647516|616156863|FG002|Open-Label Period|Physician Decision|0|||
170496119|NCT01647516|616156864|FG003|Open-Label Period|Physician Decision|1|||
170496120|NCT01647516|616156865|FG004|Open-Label Period|Physician Decision|1|||
170496121|NCT01647516|616156866|FG005|Open-Label Period|Physician Decision|0|||
170496122|NCT01647516|616156861|FG000|Open-Label Period|Withdrawal by Subject|0|||
170496123|NCT01647516|616156862|FG001|Open-Label Period|Withdrawal by Subject|0|||
170496124|NCT01647516|616156863|FG002|Open-Label Period|Withdrawal by Subject|0|||
170496125|NCT01647516|616156864|FG003|Open-Label Period|Withdrawal by Subject|9|||
170802028|NCT01983683|617284955|FG001|Overall Study|Sponsor Decision|1|||
170802029|NCT04882917|617284961|FG000|Overall Study|Adverse Event|0|||
170496126|NCT01647516|616156865|FG004|Open-Label Period|Withdrawal by Subject|11|||
170496127|NCT01647516|616156866|FG005|Open-Label Period|Withdrawal by Subject|6|||
170496128|NCT01647516|616156861|FG000|Open-Label Period|Lost to Follow-up|0|||
170496129|NCT01647516|616156862|FG001|Open-Label Period|Lost to Follow-up|0|||
170496130|NCT01647516|616156863|FG002|Open-Label Period|Lost to Follow-up|0|||
170496131|NCT01647516|616156864|FG003|Open-Label Period|Lost to Follow-up|1|||
170496132|NCT01647516|616156865|FG004|Open-Label Period|Lost to Follow-up|0|||
170496133|NCT01647516|616156866|FG005|Open-Label Period|Lost to Follow-up|1|||
170551084|NCT00309244|616362574|FG000|Overall Study|Death|4|||
170551085|NCT00309244|616362575|FG001|Overall Study|Death|1|||
170551086|NCT01905267|616362576|FG000|Overall Study|Physician Decision|2|||
170496134|NCT01647516|616156861|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
170496135|NCT01647516|616156862|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
170496136|NCT01647516|616156863|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
170496137|NCT01647516|616156864|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
170496138|NCT01647516|616156865|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
170496139|NCT01647516|616156866|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
170496140|NCT01647516|616156861|FG000|Open-Label Period|Lack of Efficacy|0|||
170496141|NCT01647516|616156862|FG001|Open-Label Period|Lack of Efficacy|0|||
170496142|NCT01647516|616156863|FG002|Open-Label Period|Lack of Efficacy|0|||
170496143|NCT01647516|616156864|FG003|Open-Label Period|Lack of Efficacy|7|||
170496144|NCT01647516|616156865|FG004|Open-Label Period|Lack of Efficacy|9|||
170496145|NCT01647516|616156866|FG005|Open-Label Period|Lack of Efficacy|10|||
170496146|NCT01647516|616156861|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
170496147|NCT01647516|616156862|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
170496148|NCT01647516|616156863|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
170496149|NCT01647516|616156864|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
170496150|NCT01647516|616156865|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
170496151|NCT01647516|616156866|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
170496152|NCT01647516|616156861|FG000|Open-Label Period|No completion / discontinuation visit|0|||
170496153|NCT01647516|616156862|FG001|Open-Label Period|No completion / discontinuation visit|0|||
170496154|NCT01647516|616156863|FG002|Open-Label Period|No completion / discontinuation visit|0|||
170496155|NCT01647516|616156864|FG003|Open-Label Period|No completion / discontinuation visit|0|||
170496156|NCT01647516|616156865|FG004|Open-Label Period|No completion / discontinuation visit|2|||
170496157|NCT01647516|616156866|FG005|Open-Label Period|No completion / discontinuation visit|1|||
170496158|NCT01053962|616156867|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
170496159|NCT01053962|616156868|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
170496160|NCT01053962|616156869|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
170496161|NCT01053962|616156870|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
170496162|NCT01053962|616156871|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
170496163|NCT01053962|616156867|FG000|Pretreatment Period|Venipuncture Failure|0|||
170496164|NCT01053962|616156868|FG001|Pretreatment Period|Venipuncture Failure|0|||
170496165|NCT01053962|616156869|FG002|Pretreatment Period|Venipuncture Failure|1|||
170496166|NCT01053962|616156870|FG003|Pretreatment Period|Venipuncture Failure|0|||
170496167|NCT01053962|616156871|FG004|Pretreatment Period|Venipuncture Failure|0|||
170496168|NCT01053962|616156867|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
170496169|NCT01053962|616156868|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
170496170|NCT01053962|616156869|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
170496171|NCT01053962|616156870|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
170496172|NCT01053962|616156871|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
170496173|NCT01053962|616156867|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
170496174|NCT01053962|616156868|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
170496175|NCT01053962|616156869|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
170496176|NCT01053962|616156870|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
170496177|NCT01053962|616156871|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
170496178|NCT01053962|616156867|FG000|Treatment Period|Lack of Efficacy|0|||
170496179|NCT01053962|616156868|FG001|Treatment Period|Lack of Efficacy|0|||
170496180|NCT01053962|616156869|FG002|Treatment Period|Lack of Efficacy|0|||
170496181|NCT01053962|616156870|FG003|Treatment Period|Lack of Efficacy|0|||
170496182|NCT01053962|616156871|FG004|Treatment Period|Lack of Efficacy|1|||
170496183|NCT01053962|616156867|FG000|Treatment Period|Adverse Event|0|||
170496184|NCT01053962|616156868|FG001|Treatment Period|Adverse Event|0|||
170496185|NCT01053962|616156869|FG002|Treatment Period|Adverse Event|0|||
170496186|NCT01053962|616156870|FG003|Treatment Period|Adverse Event|0|||
170496187|NCT01053962|616156871|FG004|Treatment Period|Adverse Event|1|||
170496188|NCT01053962|616156867|FG000|Treatment Period|Withdrawal by Subject|0|||
170496189|NCT01053962|616156868|FG001|Treatment Period|Withdrawal by Subject|0|||
170496190|NCT01053962|616156869|FG002|Treatment Period|Withdrawal by Subject|0|||
170496191|NCT01053962|616156870|FG003|Treatment Period|Withdrawal by Subject|0|||
170496192|NCT01053962|616156871|FG004|Treatment Period|Withdrawal by Subject|1|||
170496193|NCT01053962|616156867|FG000|Treatment Period|Noncompliance with protocol|1|||
170496194|NCT01053962|616156868|FG001|Treatment Period|Noncompliance with protocol|0|||
170496195|NCT01053962|616156869|FG002|Treatment Period|Noncompliance with protocol|0|||
170496196|NCT01053962|616156870|FG003|Treatment Period|Noncompliance with protocol|0|||
170496197|NCT01053962|616156871|FG004|Treatment Period|Noncompliance with protocol|0|||
170496198|NCT00308087|616156872|FG000|Overall Study|Progressive Disease|19|||
170551087|NCT01905267|616362577|FG001|Overall Study|Physician Decision|2|||
170551088|NCT03888482|616362578|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
170551089|NCT03888482|616362579|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
170551090|NCT03888482|616362578|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
170551091|NCT03888482|616362579|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
170802030|NCT04882917|617284962|FG001|Overall Study|Adverse Event|1|||
170551092|NCT02294019|616362580|FG000|Overall Study|Adverse Event|2|||
170551093|NCT02294019|616362580|FG000|Overall Study|Protocol Violation|68|||
170496199|NCT00308087|616156873|FG001|Overall Study|Progressive Disease|21|||
170496200|NCT00308087|616156872|FG000|Overall Study|Study Closure|11|||
170496201|NCT00308087|616156873|FG001|Overall Study|Study Closure|12|||
170496202|NCT00308087|616156872|FG000|Overall Study|Withdrawal by Subject|2|||
170551094|NCT02294019|616362580|FG000|Overall Study|Lost to Follow-up|31|||
170551095|NCT02294019|616362580|FG000|Overall Study|Other|1|||
170551096|NCT02294019|616362580|FG000|Overall Study|Withdrawal by Subject|1|||
170551097|NCT00501085|616362581|FG000|Overall Study|Lost to Follow-up|195|||
170551098|NCT00501085|616362581|FG000|Overall Study|Withdrawal by Subject|34|||
170551099|NCT00501085|616362581|FG000|Overall Study|Subject Decision|1|||
170551100|NCT00501085|616362581|FG000|Overall Study|Revision Surgery|7|||
170551101|NCT00501085|616362581|FG000|Overall Study|Explantation Surgery|26|||
170551102|NCT00501085|616362581|FG000|Overall Study|Adverse Event|4|||
170551103|NCT00501085|616362581|FG000|Overall Study|Non-Compliance|24|||
170551104|NCT00501085|616362581|FG000|Overall Study|Study closed by sponsor|109|||
170551105|NCT00501085|616362581|FG000|Overall Study|Other loss to follow-up|32|||
170551106|NCT03438656|616362583|FG000|Overall Study|Lost to Follow-up|2|||
170551107|NCT01189227|616362584|FG000|Overall Study|Study terminated due to low accrual|6|||
170551108|NCT01189227|616362585|FG001|Overall Study|Study terminated due to low accrual|3|||
170551109|NCT03335566|616362586|FG000|Overall Study|Adverse Event|0|||
170551110|NCT03335566|616362587|FG001|Overall Study|Adverse Event|1|||
170551111|NCT03335566|616362586|FG000|Overall Study|Lost to Follow-up|1|||
170551112|NCT03335566|616362587|FG001|Overall Study|Lost to Follow-up|0|||
170551113|NCT03335566|616362586|FG000|Overall Study|Technical Problems|1|||
170496203|NCT00308087|616156873|FG001|Overall Study|Withdrawal by Subject|1|||
170496204|NCT00308087|616156872|FG000|Overall Study|Other|4|||
170496205|NCT00308087|616156873|FG001|Overall Study|Other|3|||
170496206|NCT01475851|616156874|FG000|Overall Study|Protocol defined stopping criteria|1|||
170496207|NCT01475851|616156875|FG001|Overall Study|Protocol defined stopping criteria|0|||
170496208|NCT03729570|616156876|FG000|Overall Study|Lost to Follow-up|16|||
170496209|NCT03729570|616156877|FG001|Overall Study|Lost to Follow-up|20|||
170496210|NCT03729570|616156876|FG000|Overall Study|Seroconversion|5|||
170496211|NCT03729570|616156877|FG001|Overall Study|Seroconversion|0|||
170496212|NCT03729570|616156876|FG000|Overall Study|Moved out of the city|1|||
170496213|NCT03729570|616156877|FG001|Overall Study|Moved out of the city|0|||
170496214|NCT03729570|616156876|FG000|Overall Study|Time Conflict|1|||
170496215|NCT03729570|616156877|FG001|Overall Study|Time Conflict|0|||
170496216|NCT03729570|616156876|FG000|Overall Study|Time Commitment|2|||
170496217|NCT03729570|616156877|FG001|Overall Study|Time Commitment|0|||
170551114|NCT03335566|616362587|FG001|Overall Study|Technical Problems|0|||
170551115|NCT03335566|616362586|FG000|Overall Study|Protocol Violation|1|||
170551116|NCT03335566|616362587|FG001|Overall Study|Protocol Violation|0|||
170551117|NCT03335566|616362586|FG000|Overall Study|Other than specified above|1|||
170551118|NCT03335566|616362587|FG001|Overall Study|Other than specified above|2|||
170551119|NCT00663351|616362588|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
170551120|NCT00663351|616362589|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
170551121|NCT00663351|616362588|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
170551122|NCT00663351|616362589|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
170551123|NCT00663351|616362588|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
170641959|NCT01217307|616703349|FG001|Overall Study|Withdrawal by Subject|1|||
170641960|NCT01888432|616703354|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
170641961|NCT01888432|616703355|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
170641962|NCT01888432|616703354|FG000|12-month Analysis (FAS)|Physician Decision|1|||
170641963|NCT01888432|616703355|FG001|12-month Analysis (FAS)|Physician Decision|1|||
170641964|NCT01888432|616703354|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
170641965|NCT01888432|616703355|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
170641966|NCT01888432|616703354|FG000|12-month Analysis (FAS)|Death|4|||
170802031|NCT04882917|617284963|FG002|Overall Study|Adverse Event|2|||
170496218|NCT03729570|616156876|FG000|Overall Study|Bad Experience|0|||
170496219|NCT03729570|616156877|FG001|Overall Study|Bad Experience|1|||
170496220|NCT03729570|616156876|FG000|Overall Study|No reason provided|2|||
170496221|NCT03729570|616156877|FG001|Overall Study|No reason provided|1|||
170496222|NCT03729570|616156876|FG000|Overall Study|Family Conflict|0|||
170496223|NCT03729570|616156877|FG001|Overall Study|Family Conflict|1|||
170496224|NCT03729570|616156876|FG000|Overall Study|Did not want to continue taking medications|0|||
170551124|NCT00663351|616362589|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
170641967|NCT01888432|616703355|FG001|12-month Analysis (FAS)|Death|3|||
170641968|NCT01888432|616703354|FG000|24-month Analysis (FAS)|Graft loss|0|||
170641969|NCT01888432|616703355|FG001|24-month Analysis (FAS)|Graft loss|1|||
170551125|NCT00663351|616362588|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
170551126|NCT00663351|616362589|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
170551127|NCT00663351|616362588|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
170551128|NCT00663351|616362589|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
170551129|NCT00663351|616362588|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
170496225|NCT03729570|616156877|FG001|Overall Study|Did not want to continue taking medications|1|||
170496226|NCT03729570|616156876|FG000|Overall Study|Found another PrEP provider|1|||
170496227|NCT03729570|616156877|FG001|Overall Study|Found another PrEP provider|0|||
170496228|NCT03729570|616156876|FG000|Overall Study|Did not enjoy being in the control group|0|||
170496229|NCT03729570|616156877|FG001|Overall Study|Did not enjoy being in the control group|1|||
170496230|NCT02017912|616156878|FG000|Overall Study|Withdrawal by Subject|2|||
170496231|NCT02017912|616156879|FG001|Overall Study|Withdrawal by Subject|1|||
170496232|NCT02017912|616156878|FG000|Overall Study|miscellaneous|1|||
170496233|NCT02017912|616156879|FG001|Overall Study|miscellaneous|1|||
170496234|NCT00727844|616156880|FG000|Initial Randomization|Physician Decision|2|||
170496235|NCT00727844|616156881|FG001|Initial Randomization|Physician Decision|0|||
170496236|NCT00727844|616156882|FG002|Initial Randomization|Physician Decision|0|||
170496237|NCT00727844|616156883|FG003|Initial Randomization|Physician Decision|0|||
170496238|NCT02949843|616156885|FG000|Overall Study|Withdrawal by Subject|0|||
170496239|NCT02949843|616156886|FG001|Overall Study|Withdrawal by Subject|1|||
170496240|NCT02949843|616156887|FG002|Overall Study|Withdrawal by Subject|1|||
170496241|NCT02783729|616156888|FG000|Overall Study|Lack of Efficacy|1|||
170496242|NCT02783729|616156889|FG001|Overall Study|Lack of Efficacy|0|||
170496243|NCT02783729|616156890|FG002|Overall Study|Lack of Efficacy|0|||
170496244|NCT02783729|616156891|FG003|Overall Study|Lack of Efficacy|0|||
170496245|NCT02783729|616156888|FG000|Overall Study|Adverse Event|2|||
170496246|NCT02783729|616156889|FG001|Overall Study|Adverse Event|6|||
170496247|NCT02783729|616156890|FG002|Overall Study|Adverse Event|2|||
170496248|NCT02783729|616156891|FG003|Overall Study|Adverse Event|3|||
170496249|NCT02783729|616156888|FG000|Overall Study|Other|1|||
170496250|NCT02783729|616156889|FG001|Overall Study|Other|6|||
170496251|NCT02783729|616156890|FG002|Overall Study|Other|2|||
170496252|NCT02783729|616156891|FG003|Overall Study|Other|3|||
170496253|NCT02783729|616156888|FG000|Overall Study|Withdrawal by Subject|2|||
170496254|NCT02783729|616156889|FG001|Overall Study|Withdrawal by Subject|3|||
170496255|NCT02783729|616156890|FG002|Overall Study|Withdrawal by Subject|1|||
170496256|NCT02783729|616156891|FG003|Overall Study|Withdrawal by Subject|2|||
170496257|NCT02783729|616156888|FG000|Overall Study|Participant's choice|2|||
170496258|NCT02783729|616156889|FG001|Overall Study|Participant's choice|1|||
170496259|NCT02783729|616156890|FG002|Overall Study|Participant's choice|2|||
170496260|NCT02783729|616156891|FG003|Overall Study|Participant's choice|1|||
170496261|NCT02783729|616156888|FG000|Overall Study|Lost to Follow-up|2|||
170496262|NCT02783729|616156889|FG001|Overall Study|Lost to Follow-up|1|||
170496263|NCT02783729|616156890|FG002|Overall Study|Lost to Follow-up|1|||
170496264|NCT02783729|616156891|FG003|Overall Study|Lost to Follow-up|0|||
170496265|NCT01500187|616156894|FG000|Overall Study|Lost to Follow-up|6|||
170496266|NCT01500187|616156895|FG001|Overall Study|Lost to Follow-up|0|||
170496267|NCT00658775|616156896|FG000|Overall Study|Adverse Event|4|||
170496268|NCT00658775|616156897|FG001|Overall Study|Adverse Event|6|||
170496269|NCT00658775|616156896|FG000|Overall Study|Lost to Follow-up|17|||
170496270|NCT00658775|616156897|FG001|Overall Study|Lost to Follow-up|18|||
170496271|NCT00658775|616156896|FG000|Overall Study|Withdrawal by Subject|6|||
170496272|NCT00658775|616156897|FG001|Overall Study|Withdrawal by Subject|4|||
170496273|NCT00658775|616156896|FG000|Overall Study|Withdrawal of consent|8|||
170496274|NCT00658775|616156897|FG001|Overall Study|Withdrawal of consent|7|||
170496275|NCT00658775|616156896|FG000|Overall Study|Other|7|||
170496276|NCT00658775|616156897|FG001|Overall Study|Other|8|||
170496277|NCT01046903|616156898|FG000|Overall Study|Lost to Follow-up|16|||
170496278|NCT01046903|616156898|FG000|Overall Study|Adverse Event|4|||
170496279|NCT01046903|616156898|FG000|Overall Study|Withdrawal by Subject|3|||
170496280|NCT01046903|616156898|FG000|Overall Study|Other|5|||
170496281|NCT00977314|616156901|FG000|Overall Study|Withdrawal by Subject|1|||
170496282|NCT00977314|616156902|FG001|Overall Study|Withdrawal by Subject|0|||
170641970|NCT01888432|616703354|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
170641971|NCT01888432|616703355|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
170496283|NCT00977314|616156901|FG000|Overall Study|Physician Decision|1|||
170496284|NCT00977314|616156902|FG001|Overall Study|Physician Decision|0|||
170496285|NCT01343277|616156906|FG000|Overall Study|Other|3|||
170496286|NCT01343277|616156907|FG001|Overall Study|Other|3|||
170496287|NCT01343277|616156906|FG000|Overall Study|Withdrawal by Subject|18|||
170496288|NCT01343277|616156907|FG001|Overall Study|Withdrawal by Subject|13|||
170496289|NCT01343277|616156906|FG000|Overall Study|Physician Decision|1|||
170496290|NCT01343277|616156907|FG001|Overall Study|Physician Decision|2|||
170496291|NCT01343277|616156906|FG000|Overall Study|Death|10|||
170496292|NCT01343277|616156907|FG001|Overall Study|Death|1|||
170496293|NCT01343277|616156906|FG000|Overall Study|Adverse Event|67|||
170496294|NCT01343277|616156907|FG001|Overall Study|Adverse Event|13|||
170496295|NCT01343277|616156906|FG000|Overall Study|Disease progression|270|||
170496296|NCT01343277|616156907|FG001|Overall Study|Disease progression|138|||
170496297|NCT01343277|616156906|FG000|Overall Study|Randomized not treated|6|||
170496298|NCT01343277|616156907|FG001|Overall Study|Randomized not treated|21|||
170496299|NCT01343277|616156906|FG000|Overall Study|Treatment ongoing|8|||
170641972|NCT01888432|616703354|FG000|24-month Analysis (FAS)|Physician Decision|2|||
170802032|NCT04882917|617284964|FG003|Overall Study|Adverse Event|2|||
170496300|NCT01343277|616156907|FG001|Overall Study|Treatment ongoing|2|||
170496301|NCT01343277|616156906|FG000|Overall Study|Subsequent anticancer therapy|1|||
170496302|NCT01343277|616156907|FG001|Overall Study|Subsequent anticancer therapy|0|||
170496303|NCT01894100|616156910|FG000|Overall Study|Lost to Follow-up|0|||
170496304|NCT01894100|616156911|FG001|Overall Study|Lost to Follow-up|1|||
170496305|NCT01894100|616156910|FG000|Overall Study|Withdrawal by Subject|3|||
170496306|NCT01894100|616156911|FG001|Overall Study|Withdrawal by Subject|0|||
170496307|NCT01094301|616156918|FG000|Trial Stage|Withdrawal by Subject|1|||
170496308|NCT01094301|616156918|FG000|Implant Stage|Adverse Event|1|||
170496309|NCT01094301|616156918|FG000|Implant Stage|Protocol Violation|1|||
170496310|NCT01094301|616156918|FG000|Implant Stage|Withdrawal by Subject|2|||
170496311|NCT01094301|616156918|FG000|Implant Stage|No return of pain|4|||
170496312|NCT00135512|616156919|FG000|Overall Study|Adverse Event|56|||
170496313|NCT00135512|616156919|FG000|Overall Study|Lack of Efficacy|25|||
170496314|NCT00135512|616156919|FG000|Overall Study|Other|42|||
170496315|NCT04152837|616156937|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
170496316|NCT04152837|616156937|FG000|Maintenance Period|Adverse Event|1|||
170496317|NCT04152837|616156937|FG000|Maintenance Period|Withdrawal by Subject|1|||
170496318|NCT04152837|616156937|FG000|Maintenance Period|Sponsor Termination of Study|2|||
170496319|NCT00586820|616156938|FG000|Overall Study|Unsuccessful PCI|1|||
170496320|NCT00586820|616156939|FG001|Overall Study|Unsuccessful PCI|0|||
170496321|NCT02073929|616156940|FG000|Overall Study|Lost to Follow-up|2|||
170496322|NCT02073929|616156941|FG001|Overall Study|Lost to Follow-up|1|||
170496323|NCT02073929|616156940|FG000|Overall Study|Adverse Event|2|||
170496324|NCT02073929|616156941|FG001|Overall Study|Adverse Event|1|||
170496325|NCT02073929|616156940|FG000|Overall Study|Withdrawal by Subject|0|||
170496326|NCT02073929|616156941|FG001|Overall Study|Withdrawal by Subject|1|||
170496327|NCT04463251|616156946|FG000|Overall Study|Death|1|||
170496328|NCT04463251|616156947|FG001|Overall Study|Death|0|||
170496329|NCT04463251|616156948|FG002|Overall Study|Death|1|||
170496330|NCT04463251|616156946|FG000|Overall Study|Adverse Event|0|||
170496331|NCT04463251|616156947|FG001|Overall Study|Adverse Event|1|||
170496332|NCT04463251|616156948|FG002|Overall Study|Adverse Event|0|||
170496333|NCT04463251|616156946|FG000|Overall Study|Lost to Follow-up|0|||
170496334|NCT04463251|616156947|FG001|Overall Study|Lost to Follow-up|1|||
170496335|NCT04463251|616156948|FG002|Overall Study|Lost to Follow-up|0|||
170496336|NCT04463251|616156946|FG000|Overall Study|Withdrawal by Subject|0|||
170496337|NCT04463251|616156947|FG001|Overall Study|Withdrawal by Subject|2|||
170496338|NCT04463251|616156948|FG002|Overall Study|Withdrawal by Subject|2|||
170496339|NCT04553471|616156951|FG000|Overall Study|Did not start treatment on protocol|3|||
170496340|NCT04553471|616156951|FG000|Overall Study|Death|1|||
170496341|NCT03425396|616156963|FG000|Overall Study|Lost to Follow-up|2|||
170496342|NCT03425396|616156964|FG001|Overall Study|Lost to Follow-up|5|||
170496343|NCT03425396|616156965|FG002|Overall Study|Lost to Follow-up|2|||
170496344|NCT03425396|616156966|FG003|Overall Study|Lost to Follow-up|0|||
170496345|NCT03425396|616156967|FG004|Overall Study|Lost to Follow-up|0|||
170496346|NCT03425396|616156963|FG000|Overall Study|Withdrawal by Subject|0|||
170496347|NCT03425396|616156964|FG001|Overall Study|Withdrawal by Subject|1|||
170496348|NCT03425396|616156965|FG002|Overall Study|Withdrawal by Subject|0|||
170496349|NCT03425396|616156966|FG003|Overall Study|Withdrawal by Subject|1|||
170496350|NCT03425396|616156967|FG004|Overall Study|Withdrawal by Subject|0|||
170496351|NCT03425396|616156963|FG000|Overall Study|Other|0|||
170496352|NCT03425396|616156964|FG001|Overall Study|Other|1|||
170496353|NCT03425396|616156965|FG002|Overall Study|Other|1|||
170496354|NCT03425396|616156966|FG003|Overall Study|Other|0|||
170496355|NCT03425396|616156967|FG004|Overall Study|Other|1|||
170496356|NCT01441765|616156968|FG000|Overall Study|Death|1|||
170496357|NCT01441765|616156969|FG001|Overall Study|Death|0|||
170496358|NCT03689374|616156972|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
170496359|NCT03689374|616156973|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
170641973|NCT01888432|616703355|FG001|24-month Analysis (FAS)|Physician Decision|4|||
170802033|NCT04882917|617284961|FG000|Overall Study|Withdrawal by Subject|1|||
170802034|NCT04882917|617284962|FG001|Overall Study|Withdrawal by Subject|0|||
170802035|NCT04882917|617284963|FG002|Overall Study|Withdrawal by Subject|2|||
170802036|NCT04882917|617284964|FG003|Overall Study|Withdrawal by Subject|1|||
170802037|NCT04882917|617284961|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
170496360|NCT03689374|616156974|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
170496361|NCT03689374|616156972|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
170496362|NCT03689374|616156973|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
170496363|NCT03689374|616156974|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
170496364|NCT03689374|616156972|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
170496365|NCT03689374|616156973|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
170496366|NCT03689374|616156974|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
170496367|NCT03689374|616156972|FG000|Treatment Period (Week 0 to 52)|Death|0|||
170496368|NCT03689374|616156973|FG001|Treatment Period (Week 0 to 52)|Death|11|||
170496369|NCT03689374|616156974|FG002|Treatment Period (Week 0 to 52)|Death|1|||
170496370|NCT05367973|616156975|FG000|Overall Study|Adverse Event|0|||
170496371|NCT05367973|616156976|FG001|Overall Study|Adverse Event|2|||
170496372|NCT00986921|616156977|FG000|Overall Study|Physician Decision|1|||
170496373|NCT00986921|616156978|FG001|Overall Study|Physician Decision|0|||
170496374|NCT00813813|616156979|FG000|Overall Study|Withdrawal by Subject|1|||
170496375|NCT00813813|616156980|FG001|Overall Study|Withdrawal by Subject|1|||
170496376|NCT00813813|616156979|FG000|Overall Study|Lost to Follow-up|2|||
170496377|NCT00813813|616156980|FG001|Overall Study|Lost to Follow-up|7|||
170496378|NCT00813813|616156979|FG000|Overall Study|Other|0|||
170496379|NCT00813813|616156980|FG001|Overall Study|Other|1|||
170496380|NCT01082211|616156981|FG000|Overall Study|Protocol Violation|4|||
170496381|NCT01082211|616156981|FG000|Overall Study|No protocol treatment received|3|||
170496382|NCT04999163|616156982|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
170496383|NCT04999163|616156983|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
170496384|NCT04999163|616156982|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
170496385|NCT04999163|616156983|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
170496386|NCT04999163|616156982|FG000|Overall Study|Withdrawal by Subject|1|||
170496387|NCT04999163|616156983|FG001|Overall Study|Withdrawal by Subject|0|||
170496388|NCT03030989|616158938|FG000|Overall Study|Fever|2|||
170496389|NCT03030989|616158939|FG001|Overall Study|Fever|2|||
170496390|NCT03030989|616158938|FG000|Overall Study|Rash|2|||
170496391|NCT03030989|616158939|FG001|Overall Study|Rash|1|||
170496392|NCT03030989|616158938|FG000|Overall Study|Fatigue/Overwhelmed|1|||
170496393|NCT03030989|616158939|FG001|Overall Study|Fatigue/Overwhelmed|5|||
170496394|NCT03030989|616158938|FG000|Overall Study|Positive Blood Cultures|2|||
170496395|NCT03030989|616158939|FG001|Overall Study|Positive Blood Cultures|1|||
170496396|NCT03030989|616158938|FG000|Overall Study|Line Removed|0|||
170496397|NCT03030989|616158939|FG001|Overall Study|Line Removed|2|||
170496398|NCT03030989|616158938|FG000|Overall Study|No longer interested|5|||
170496399|NCT03030989|616158939|FG001|Overall Study|No longer interested|3|||
170496400|NCT03917472|616158940|FG000|Overall Study|Physician Decision|4|||
170496401|NCT03917472|616158941|FG001|Overall Study|Physician Decision|0|||
170496402|NCT03917472|616158940|FG000|Overall Study|Adverse Event|3|||
170496403|NCT03917472|616158941|FG001|Overall Study|Adverse Event|1|||
170496404|NCT03917472|616158940|FG000|Overall Study|Death|7|||
170496405|NCT03917472|616158941|FG001|Overall Study|Death|5|||
170496406|NCT03917472|616158940|FG000|Overall Study|Withdrawal by Subject|11|||
170496407|NCT03917472|616158941|FG001|Overall Study|Withdrawal by Subject|4|||
170496408|NCT03917472|616158940|FG000|Overall Study|Lost to Follow-up|10|||
170496409|NCT03917472|616158941|FG001|Overall Study|Lost to Follow-up|5|||
170496410|NCT01154296|616158942|FG000|Randomization and Intervention|Decided to decline|1|||
170496411|NCT01154296|616158943|FG001|Randomization and Intervention|Decided to decline|1|||
170496412|NCT01154296|616158942|FG000|Randomization and Intervention|Declined by staff|1|||
170496413|NCT01154296|616158943|FG001|Randomization and Intervention|Declined by staff|0|||
170496414|NCT01154296|616158942|FG000|Randomization and Intervention|Did not return|1|||
170496415|NCT01154296|616158943|FG001|Randomization and Intervention|Did not return|0|||
170496416|NCT01154296|616158942|FG000|Randomization and Intervention|Left before test|0|||
170496417|NCT01154296|616158943|FG001|Randomization and Intervention|Left before test|1|||
170496418|NCT01154296|616158942|FG000|Randomization and Intervention|Left clinic early|2|||
170496419|NCT01154296|616158943|FG001|Randomization and Intervention|Left clinic early|0|||
170496420|NCT01154296|616158942|FG000|6-month Follow-up|Lost contact|269|||
170496421|NCT01154296|616158943|FG001|6-month Follow-up|Lost contact|275|||
170496422|NCT01154296|616158942|FG000|6-month Follow-up|Incarcerated|37|||
170496423|NCT01154296|616158943|FG001|6-month Follow-up|Incarcerated|32|||
170802038|NCT04882917|617284962|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
170802039|NCT04882917|617284963|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
170802040|NCT04882917|617284964|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
170802041|NCT00319020|617284965|FG000|Overall Study|Death|2|||
170802042|NCT00319020|617284966|FG001|Overall Study|Death|2|||
170802043|NCT00319020|617284965|FG000|Overall Study|Withdrawal by Subject|4|||
170802044|NCT00319020|617284966|FG001|Overall Study|Withdrawal by Subject|1|||
170802045|NCT00319020|617284965|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
170802046|NCT00319020|617284966|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
170496424|NCT01154296|616158942|FG000|6-month Follow-up|Withdrew consent|14|||
170496425|NCT01154296|616158943|FG001|6-month Follow-up|Withdrew consent|15|||
170496426|NCT01154296|616158942|FG000|6-month Follow-up|Death|3|||
170496427|NCT01154296|616158943|FG001|6-month Follow-up|Death|2|||
170496428|NCT01154296|616158942|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
170496429|NCT01154296|616158943|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
170496430|NCT02203851|616158944|FG000|Overall Study|Lost to Follow-up|4|||
170496431|NCT02203851|616158944|FG000|Overall Study|Withdrawal by Subject|6|||
170496432|NCT02203851|616158944|FG000|Overall Study|Other|1|||
170496433|NCT04934189|616158945|FG000|Overall Study|Lost to Follow-up|4|||
170496434|NCT04934189|616158945|FG000|Overall Study|Withdrawal by Subject|17|||
170496435|NCT00900757|616158948|FG000|Overall Study|screen failure|19|||
170496436|NCT03320850|616158949|FG000|Overall Study|Lost to Follow-up|0|||
170496437|NCT03320850|616158950|FG001|Overall Study|Lost to Follow-up|0|||
170496438|NCT03320850|616158951|FG002|Overall Study|Lost to Follow-up|0|||
170496439|NCT03320850|616158952|FG003|Overall Study|Lost to Follow-up|0|||
170496440|NCT03320850|616158953|FG004|Overall Study|Lost to Follow-up|1|||
170496441|NCT03320850|616158954|FG005|Overall Study|Lost to Follow-up|2|||
170496442|NCT03320850|616158955|FG006|Overall Study|Lost to Follow-up|2|||
170496443|NCT03320850|616158956|FG007|Overall Study|Lost to Follow-up|0|||
170496444|NCT03320850|616158957|FG008|Overall Study|Lost to Follow-up|6|||
170496445|NCT03320850|616158958|FG009|Overall Study|Lost to Follow-up|4|||
170496446|NCT03320850|616158949|FG000|Overall Study|Withdrawal by Subject|0|||
170496447|NCT03320850|616158950|FG001|Overall Study|Withdrawal by Subject|0|||
170496448|NCT03320850|616158951|FG002|Overall Study|Withdrawal by Subject|0|||
170496449|NCT03320850|616158952|FG003|Overall Study|Withdrawal by Subject|0|||
170496450|NCT03320850|616158953|FG004|Overall Study|Withdrawal by Subject|1|||
170496451|NCT03320850|616158954|FG005|Overall Study|Withdrawal by Subject|2|||
170496452|NCT03320850|616158955|FG006|Overall Study|Withdrawal by Subject|4|||
170496453|NCT03320850|616158956|FG007|Overall Study|Withdrawal by Subject|5|||
170496454|NCT03320850|616158957|FG008|Overall Study|Withdrawal by Subject|2|||
170496455|NCT03320850|616158958|FG009|Overall Study|Withdrawal by Subject|1|||
170496456|NCT03320850|616158949|FG000|Overall Study|Lack of Efficacy|0|||
170496457|NCT03320850|616158950|FG001|Overall Study|Lack of Efficacy|0|||
170496458|NCT03320850|616158951|FG002|Overall Study|Lack of Efficacy|0|||
170496459|NCT03320850|616158952|FG003|Overall Study|Lack of Efficacy|1|||
170496460|NCT03320850|616158953|FG004|Overall Study|Lack of Efficacy|0|||
170496461|NCT03320850|616158954|FG005|Overall Study|Lack of Efficacy|1|||
170496462|NCT03320850|616158955|FG006|Overall Study|Lack of Efficacy|0|||
170496463|NCT03320850|616158956|FG007|Overall Study|Lack of Efficacy|2|||
170496464|NCT03320850|616158957|FG008|Overall Study|Lack of Efficacy|0|||
170496465|NCT03320850|616158958|FG009|Overall Study|Lack of Efficacy|3|||
170496466|NCT03320850|616158949|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
170496467|NCT03320850|616158950|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
170496468|NCT03320850|616158951|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
170496469|NCT03320850|616158952|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
170496470|NCT03320850|616158953|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
170496471|NCT03320850|616158954|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
170496472|NCT03320850|616158955|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
170496473|NCT03320850|616158956|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
170496474|NCT03320850|616158957|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
170496475|NCT03320850|616158958|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
170496476|NCT03320850|616158949|FG000|Overall Study|Adverse Event|0|||
170802047|NCT00319020|617284965|FG000|Overall Study|Administrative reason|0|||
170496477|NCT03320850|616158950|FG001|Overall Study|Adverse Event|0|||
170496478|NCT03320850|616158951|FG002|Overall Study|Adverse Event|0|||
170496479|NCT03320850|616158952|FG003|Overall Study|Adverse Event|0|||
170496480|NCT03320850|616158953|FG004|Overall Study|Adverse Event|0|||
170496481|NCT03320850|616158954|FG005|Overall Study|Adverse Event|2|||
170496482|NCT03320850|616158955|FG006|Overall Study|Adverse Event|1|||
170496483|NCT03320850|616158956|FG007|Overall Study|Adverse Event|0|||
170496484|NCT03320850|616158957|FG008|Overall Study|Adverse Event|2|||
170496485|NCT03320850|616158958|FG009|Overall Study|Adverse Event|0|||
170496486|NCT03320850|616158949|FG000|Overall Study|Reason Not Specified|0|||
170496487|NCT03320850|616158950|FG001|Overall Study|Reason Not Specified|0|||
170496488|NCT03320850|616158951|FG002|Overall Study|Reason Not Specified|0|||
170496489|NCT03320850|616158952|FG003|Overall Study|Reason Not Specified|0|||
170496490|NCT03320850|616158953|FG004|Overall Study|Reason Not Specified|0|||
170496491|NCT03320850|616158954|FG005|Overall Study|Reason Not Specified|1|||
170496492|NCT03320850|616158955|FG006|Overall Study|Reason Not Specified|0|||
170496493|NCT03320850|616158956|FG007|Overall Study|Reason Not Specified|0|||
170496494|NCT03320850|616158957|FG008|Overall Study|Reason Not Specified|0|||
170496495|NCT03320850|616158958|FG009|Overall Study|Reason Not Specified|1|||
170496496|NCT02002533|616158962|FG000|Overall Study|Withdrawal by Subject|6|||
170496497|NCT02002533|616158963|FG001|Overall Study|Withdrawal by Subject|13|||
170496498|NCT02002533|616158962|FG000|Overall Study|Protocol Violation|0|||
170496499|NCT02002533|616158963|FG001|Overall Study|Protocol Violation|1|||
170496500|NCT02002533|616158962|FG000|Overall Study|Adverse Event|0|||
170496501|NCT02002533|616158963|FG001|Overall Study|Adverse Event|3|||
170496502|NCT02002533|616158962|FG000|Overall Study|Lost to Follow-up|0|||
170496503|NCT02002533|616158963|FG001|Overall Study|Lost to Follow-up|1|||
170496504|NCT00381238|616158965|FG000|Overall Study|Adverse Event|3|||
170496505|NCT00381238|616158965|FG000|Overall Study|Protocol Violation|1|||
170496506|NCT00381238|616158965|FG000|Overall Study|Withdrawal by Subject|4|||
170496507|NCT00381238|616158965|FG000|Overall Study|Lack of Efficacy|2|||
170496508|NCT00381238|616158965|FG000|Overall Study|Withdrew by physician|1|||
170496509|NCT00381238|616158965|FG000|Overall Study|Disease progression|1|||
170496510|NCT02086448|616158966|FG000|Overall Study|Withdrawal by Subject|1|||
170496511|NCT02086448|616158967|FG001|Overall Study|Withdrawal by Subject|0|||
170496512|NCT02086448|616158968|FG002|Overall Study|Withdrawal by Subject|0|||
170496513|NCT02086448|616158969|FG003|Overall Study|Withdrawal by Subject|2|||
170496514|NCT03408444|616158982|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
170496515|NCT03408444|616158983|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
170496516|NCT03408444|616158984|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
170496517|NCT03408444|616158985|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
170496518|NCT03408444|616158982|FG000|Overall Study|Lens Discomfort|0|||
170496519|NCT03408444|616158983|FG001|Overall Study|Lens Discomfort|1|||
170496520|NCT03408444|616158984|FG002|Overall Study|Lens Discomfort|0|||
170496521|NCT03408444|616158985|FG003|Overall Study|Lens Discomfort|0|||
170496522|NCT03408444|616158982|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
170496523|NCT03408444|616158983|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
170496524|NCT03408444|616158984|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
170496525|NCT03408444|616158985|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
170496526|NCT03408444|616158982|FG000|Overall Study|Withdrawal by Subject|0|||
170496527|NCT03408444|616158983|FG001|Overall Study|Withdrawal by Subject|2|||
170496528|NCT03408444|616158984|FG002|Overall Study|Withdrawal by Subject|3|||
170496529|NCT03408444|616158985|FG003|Overall Study|Withdrawal by Subject|0|||
170496530|NCT03408444|616158982|FG000|Overall Study|Lost to Follow-up|0|||
170496531|NCT03408444|616158983|FG001|Overall Study|Lost to Follow-up|0|||
170496532|NCT03408444|616158984|FG002|Overall Study|Lost to Follow-up|1|||
170496533|NCT03408444|616158985|FG003|Overall Study|Lost to Follow-up|0|||
170496534|NCT03408444|616158982|FG000|Overall Study|Adverse Event|0|||
170496535|NCT03408444|616158983|FG001|Overall Study|Adverse Event|0|||
170496536|NCT03408444|616158984|FG002|Overall Study|Adverse Event|0|||
170496537|NCT03408444|616158985|FG003|Overall Study|Adverse Event|1|||
170496538|NCT03408444|616158982|FG000|Overall Study|Lens Handling Difficulties|0|||
170496539|NCT03408444|616158983|FG001|Overall Study|Lens Handling Difficulties|0|||
170496540|NCT03408444|616158984|FG002|Overall Study|Lens Handling Difficulties|1|||
170496541|NCT03408444|616158985|FG003|Overall Study|Lens Handling Difficulties|0|||
170496542|NCT03408444|616158982|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
170496543|NCT03408444|616158983|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
170496544|NCT03408444|616158984|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
170496545|NCT03408444|616158985|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
170496546|NCT02031640|616158990|FG000|Screening Period|Adverse Event|1|||
170496547|NCT02031640|616158991|FG001|Screening Period|Adverse Event|0|||
170496548|NCT02031640|616158992|FG002|Screening Period|Adverse Event|0|||
170496549|NCT02031640|616158993|FG003|Screening Period|Adverse Event|0|||
170496550|NCT02031640|616158994|FG004|Screening Period|Adverse Event|0|||
170496551|NCT02031640|616158995|FG005|Screening Period|Adverse Event|0|||
170496552|NCT02031640|616158990|FG000|Screening Period|Withdrawal by Subject|29|||
170496553|NCT02031640|616158991|FG001|Screening Period|Withdrawal by Subject|0|||
170496554|NCT02031640|616158992|FG002|Screening Period|Withdrawal by Subject|0|||
170496555|NCT02031640|616158993|FG003|Screening Period|Withdrawal by Subject|0|||
170496556|NCT02031640|616158994|FG004|Screening Period|Withdrawal by Subject|0|||
170496557|NCT02031640|616158995|FG005|Screening Period|Withdrawal by Subject|0|||
170496558|NCT02031640|616158990|FG000|Screening Period|Inclusion criteria not met|312|||
170496559|NCT02031640|616158991|FG001|Screening Period|Inclusion criteria not met|0|||
170496560|NCT02031640|616158992|FG002|Screening Period|Inclusion criteria not met|0|||
170496561|NCT02031640|616158993|FG003|Screening Period|Inclusion criteria not met|0|||
170496562|NCT02031640|616158994|FG004|Screening Period|Inclusion criteria not met|0|||
170496563|NCT02031640|616158995|FG005|Screening Period|Inclusion criteria not met|0|||
170496564|NCT02031640|616158990|FG000|Screening Period|Exclusion criteria met|30|||
170496565|NCT02031640|616158991|FG001|Screening Period|Exclusion criteria met|0|||
170496566|NCT02031640|616158992|FG002|Screening Period|Exclusion criteria met|0|||
170496567|NCT02031640|616158993|FG003|Screening Period|Exclusion criteria met|0|||
170496568|NCT02031640|616158994|FG004|Screening Period|Exclusion criteria met|0|||
170551130|NCT00663351|616362589|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
170551131|NCT04818086|616362594|FG000|Overall Study|Physician Decision|1|||
170551132|NCT04818086|616362595|FG001|Overall Study|Physician Decision|0|||
170551133|NCT04818086|616362594|FG000|Overall Study|Withdrawal by Subject|0|||
170551134|NCT04818086|616362595|FG001|Overall Study|Withdrawal by Subject|1|||
170551135|NCT02057666|616362598|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
170551136|NCT02057666|616362599|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
170551137|NCT02057666|616362598|FG000|Double Blind Treatment Period|Poor tolerability|7|||
170496569|NCT02031640|616158995|FG005|Screening Period|Exclusion criteria met|0|||
170496570|NCT02031640|616158990|FG000|Screening Period|Lost to Follow-up|14|||
170496571|NCT02031640|616158991|FG001|Screening Period|Lost to Follow-up|0|||
170496572|NCT02031640|616158992|FG002|Screening Period|Lost to Follow-up|0|||
170496573|NCT02031640|616158993|FG003|Screening Period|Lost to Follow-up|0|||
170496574|NCT02031640|616158994|FG004|Screening Period|Lost to Follow-up|0|||
170496575|NCT02031640|616158995|FG005|Screening Period|Lost to Follow-up|0|||
170496576|NCT02031640|616158990|FG000|Screening Period|Enrollment closed|26|||
170496577|NCT02031640|616158991|FG001|Screening Period|Enrollment closed|0|||
170496578|NCT02031640|616158992|FG002|Screening Period|Enrollment closed|0|||
170496579|NCT02031640|616158993|FG003|Screening Period|Enrollment closed|0|||
170641974|NCT01888432|616703354|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
170641975|NCT01888432|616703355|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
170641976|NCT01888432|616703354|FG000|24-month Analysis (FAS)|Death|8|||
170641977|NCT01888432|616703355|FG001|24-month Analysis (FAS)|Death|4|||
170641978|NCT01888432|616703354|FG000|36-month Analysis (Extension)|Death|1|||
170641979|NCT01888432|616703355|FG001|36-month Analysis (Extension)|Death|0|||
170641980|NCT00843284|616703358|FG000|Overall Study|Adverse Event|39|||
170641981|NCT00843284|616703358|FG000|Overall Study|Lack of Efficacy|5|||
170641982|NCT00843284|616703358|FG000|Overall Study|Lost to Follow-up|11|||
170641983|NCT00843284|616703358|FG000|Overall Study|Other|10|||
170641984|NCT00843284|616703358|FG000|Overall Study|Withdrawal by Subject|4|||
170641985|NCT00843284|616703358|FG000|Overall Study|Death|3|||
170641986|NCT01696929|616703359|FG000|Overall Study|Physician Decision|1|||
170496580|NCT02031640|616158994|FG004|Screening Period|Enrollment closed|0|||
170496581|NCT02031640|616158995|FG005|Screening Period|Enrollment closed|0|||
170496582|NCT02031640|616158990|FG000|Run-In Period|Adverse Event|4|||
170496583|NCT02031640|616158991|FG001|Run-In Period|Adverse Event|0|||
170496584|NCT02031640|616158992|FG002|Run-In Period|Adverse Event|0|||
170496585|NCT02031640|616158993|FG003|Run-In Period|Adverse Event|0|||
170496586|NCT02031640|616158994|FG004|Run-In Period|Adverse Event|0|||
170496587|NCT02031640|616158995|FG005|Run-In Period|Adverse Event|0|||
170496588|NCT02031640|616158990|FG000|Run-In Period|Withdrawal by Subject|17|||
170496589|NCT02031640|616158991|FG001|Run-In Period|Withdrawal by Subject|0|||
170496590|NCT02031640|616158992|FG002|Run-In Period|Withdrawal by Subject|0|||
170496591|NCT02031640|616158993|FG003|Run-In Period|Withdrawal by Subject|0|||
170496592|NCT02031640|616158994|FG004|Run-In Period|Withdrawal by Subject|0|||
170802048|NCT00319020|617284966|FG001|Overall Study|Administrative reason|5|||
170496593|NCT02031640|616158995|FG005|Run-In Period|Withdrawal by Subject|0|||
170496594|NCT02031640|616158990|FG000|Run-In Period|Inclusion criteria not met|38|||
170496595|NCT02031640|616158991|FG001|Run-In Period|Inclusion criteria not met|0|||
170496596|NCT02031640|616158992|FG002|Run-In Period|Inclusion criteria not met|0|||
170496597|NCT02031640|616158993|FG003|Run-In Period|Inclusion criteria not met|0|||
170496598|NCT02031640|616158994|FG004|Run-In Period|Inclusion criteria not met|0|||
170496599|NCT02031640|616158995|FG005|Run-In Period|Inclusion criteria not met|0|||
170496600|NCT02031640|616158990|FG000|Run-In Period|Exclusion criteria met|8|||
170496601|NCT02031640|616158991|FG001|Run-In Period|Exclusion criteria met|0|||
170496602|NCT02031640|616158992|FG002|Run-In Period|Exclusion criteria met|0|||
170496603|NCT02031640|616158993|FG003|Run-In Period|Exclusion criteria met|0|||
170496604|NCT02031640|616158994|FG004|Run-In Period|Exclusion criteria met|0|||
170496605|NCT02031640|616158995|FG005|Run-In Period|Exclusion criteria met|0|||
170496606|NCT02031640|616158990|FG000|Run-In Period|Randomization criteria not met|85|||
170496607|NCT02031640|616158991|FG001|Run-In Period|Randomization criteria not met|0|||
170496608|NCT02031640|616158992|FG002|Run-In Period|Randomization criteria not met|0|||
170496609|NCT02031640|616158993|FG003|Run-In Period|Randomization criteria not met|0|||
170496610|NCT02031640|616158994|FG004|Run-In Period|Randomization criteria not met|0|||
170496611|NCT02031640|616158995|FG005|Run-In Period|Randomization criteria not met|0|||
170496612|NCT02031640|616158990|FG000|Run-In Period|Various administrative reasons|17|||
170496613|NCT02031640|616158991|FG001|Run-In Period|Various administrative reasons|0|||
170496614|NCT02031640|616158992|FG002|Run-In Period|Various administrative reasons|0|||
170496615|NCT02031640|616158993|FG003|Run-In Period|Various administrative reasons|0|||
170496616|NCT02031640|616158994|FG004|Run-In Period|Various administrative reasons|0|||
170496617|NCT02031640|616158995|FG005|Run-In Period|Various administrative reasons|0|||
170496618|NCT02031640|616158990|FG000|Double-blind Treatment Period|Protocol deviation|0|||
170496619|NCT02031640|616158991|FG001|Double-blind Treatment Period|Protocol deviation|2|||
170496620|NCT02031640|616158992|FG002|Double-blind Treatment Period|Protocol deviation|0|||
170802049|NCT00319020|617284965|FG000|Overall Study|Disease progression|0|||
170802050|NCT00319020|617284966|FG001|Overall Study|Disease progression|2|||
170496621|NCT02031640|616158993|FG003|Double-blind Treatment Period|Protocol deviation|1|||
170496622|NCT02031640|616158994|FG004|Double-blind Treatment Period|Protocol deviation|3|||
170496623|NCT02031640|616158995|FG005|Double-blind Treatment Period|Protocol deviation|1|||
170496624|NCT02031640|616158990|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
170496625|NCT02031640|616158991|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
170496626|NCT02031640|616158992|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
170641987|NCT01794338|616703366|FG000|Overall Study|Death|2|||
170641988|NCT01794338|616703367|FG001|Overall Study|Death|0|||
170641989|NCT01794338|616703366|FG000|Overall Study|Lost to Follow-up|6|||
170641990|NCT01794338|616703367|FG001|Overall Study|Lost to Follow-up|9|||
170641991|NCT01754402|616703368|FG000|Overall Study|Death|0|||
170641992|NCT01754402|616703369|FG001|Overall Study|Death|0|||
170802051|NCT00319020|617284965|FG000|Overall Study|Transplant|0|||
170496627|NCT02031640|616158993|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
170496628|NCT02031640|616158994|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
170496629|NCT02031640|616158995|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
170496630|NCT02031640|616158990|FG000|Double-blind Treatment Period|Non-compliance|0|||
170496631|NCT02031640|616158991|FG001|Double-blind Treatment Period|Non-compliance|1|||
170496632|NCT02031640|616158992|FG002|Double-blind Treatment Period|Non-compliance|0|||
170496633|NCT02031640|616158993|FG003|Double-blind Treatment Period|Non-compliance|1|||
170496634|NCT02031640|616158994|FG004|Double-blind Treatment Period|Non-compliance|1|||
170496635|NCT02031640|616158995|FG005|Double-blind Treatment Period|Non-compliance|0|||
170496636|NCT02031640|616158990|FG000|Double-blind Treatment Period|Adverse Event|0|||
170496637|NCT02031640|616158991|FG001|Double-blind Treatment Period|Adverse Event|0|||
170496638|NCT02031640|616158992|FG002|Double-blind Treatment Period|Adverse Event|0|||
170496639|NCT02031640|616158993|FG003|Double-blind Treatment Period|Adverse Event|2|||
170496640|NCT02031640|616158994|FG004|Double-blind Treatment Period|Adverse Event|0|||
170496641|NCT02031640|616158995|FG005|Double-blind Treatment Period|Adverse Event|0|||
170496642|NCT02031640|616158990|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
170496643|NCT02031640|616158991|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
170496644|NCT02031640|616158992|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
170496645|NCT02031640|616158993|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
170496646|NCT02031640|616158994|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
170496647|NCT02031640|616158995|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
170496648|NCT02031640|616158990|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
170496649|NCT02031640|616158991|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
170496650|NCT02031640|616158992|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
170496651|NCT02031640|616158993|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
170496652|NCT02031640|616158994|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
170496653|NCT02031640|616158995|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
170496654|NCT02091375|616158996|FG000|Overall Study|Adverse Event|8|||
170496655|NCT02091375|616158997|FG001|Overall Study|Adverse Event|1|||
170496656|NCT02091375|616158996|FG000|Overall Study|Lost to Follow-up|0|||
170551138|NCT02057666|616362599|FG001|Double Blind Treatment Period|Poor tolerability|2|||
170551139|NCT02057666|616362598|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
170551140|NCT02057666|616362599|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
170551141|NCT02057666|616362598|FG000|Double Blind Treatment Period|Physician Decision|1|||
170551142|NCT02057666|616362599|FG001|Double Blind Treatment Period|Physician Decision|0|||
170551143|NCT02057666|616362598|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
170551144|NCT02057666|616362599|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
170641993|NCT01754402|616703370|FG002|Overall Study|Death|1|||
170551145|NCT02057666|616362598|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
170551146|NCT02057666|616362599|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
170551147|NCT02057666|616362598|FG000|Double Blind Treatment Period|Sponsor's request|70|||
170551148|NCT02057666|616362599|FG001|Double Blind Treatment Period|Sponsor's request|34|||
170551149|NCT02057666|616362598|FG000|Open-Label Treatment Period|Poor tolerability|0|||
170551150|NCT02057666|616362599|FG001|Open-Label Treatment Period|Poor tolerability|1|||
170551151|NCT02057666|616362598|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
170551152|NCT02057666|616362599|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
170551153|NCT02057666|616362598|FG000|Open-Label Treatment Period|Sponsor's request|0|||
170551154|NCT02057666|616362599|FG001|Open-Label Treatment Period|Sponsor's request|4|||
170551155|NCT02205359|616362600|FG000|Overall Study|Death|293|||
170551156|NCT02205359|616362601|FG001|Overall Study|Death|327|||
170551157|NCT02205359|616362600|FG000|Overall Study|Lost to Follow-up|182|||
170551158|NCT02205359|616362601|FG001|Overall Study|Lost to Follow-up|162|||
170551159|NCT02205359|616362600|FG000|Overall Study|Physician Decision|51|||
170551160|NCT02205359|616362601|FG001|Overall Study|Physician Decision|53|||
170551161|NCT02205359|616362600|FG000|Overall Study|Withdrawal by Subject|167|||
170641994|NCT01754402|616703368|FG000|Overall Study|Adverse Event|2|||
170496657|NCT02091375|616158997|FG001|Overall Study|Lost to Follow-up|1|||
170496658|NCT02091375|616158996|FG000|Overall Study|Withdrawal by Subject|0|||
170496659|NCT02091375|616158997|FG001|Overall Study|Withdrawal by Subject|1|||
170496660|NCT02091375|616158996|FG000|Overall Study|Withdrawn by the investigator|1|||
170496661|NCT02091375|616158997|FG001|Overall Study|Withdrawn by the investigator|0|||
170496662|NCT02682823|616158999|FG000|Overall Study|Withdrawal by Subject|0|||
170496663|NCT02682823|616159000|FG001|Overall Study|Withdrawal by Subject|0|||
170496664|NCT02682823|616159001|FG002|Overall Study|Withdrawal by Subject|1|||
170496665|NCT02682823|616159002|FG003|Overall Study|Withdrawal by Subject|0|||
170551162|NCT02205359|616362601|FG001|Overall Study|Withdrawal by Subject|169|||
170551163|NCT00236197|616362603|FG000|Overall Study|Withdrawal by Subject|3|||
170551164|NCT00236197|616362604|FG001|Overall Study|Withdrawal by Subject|2|||
170551165|NCT00236197|616362603|FG000|Overall Study|Lost to Follow-up|1|||
170551166|NCT00236197|616362604|FG001|Overall Study|Lost to Follow-up|5|||
170551167|NCT00236197|616362603|FG000|Overall Study|Protocol Violation|0|||
170641995|NCT01754402|616703369|FG001|Overall Study|Adverse Event|2|||
170496666|NCT02682823|616159003|FG004|Overall Study|Withdrawal by Subject|1|||
170496667|NCT02682823|616158999|FG000|Overall Study|Protocol Deviation|0|||
170496668|NCT02682823|616159000|FG001|Overall Study|Protocol Deviation|1|||
170496669|NCT02682823|616159001|FG002|Overall Study|Protocol Deviation|0|||
170496670|NCT02682823|616159002|FG003|Overall Study|Protocol Deviation|0|||
170496671|NCT02682823|616159003|FG004|Overall Study|Protocol Deviation|0|||
170496672|NCT02682823|616158999|FG000|Overall Study|Adverse Event|0|||
170496673|NCT02682823|616159000|FG001|Overall Study|Adverse Event|0|||
170496674|NCT02682823|616159001|FG002|Overall Study|Adverse Event|0|||
170496675|NCT02682823|616159002|FG003|Overall Study|Adverse Event|1|||
170496676|NCT02682823|616159003|FG004|Overall Study|Adverse Event|0|||
170496677|NCT01014988|616159005|FG000|Overall Study|Adverse Event|20|||
170496678|NCT01014988|616159006|FG001|Overall Study|Adverse Event|0|||
170496679|NCT01014988|616159007|FG002|Overall Study|Adverse Event|1|||
170496680|NCT01014988|616159008|FG003|Overall Study|Adverse Event|0|||
170496681|NCT01014988|616159009|FG004|Overall Study|Adverse Event|1|||
170496682|NCT01014988|616159010|FG005|Overall Study|Adverse Event|3|||
170496683|NCT01014988|616159005|FG000|Overall Study|Lost to Follow-up|1|||
170496684|NCT01014988|616159006|FG001|Overall Study|Lost to Follow-up|0|||
170496685|NCT01014988|616159007|FG002|Overall Study|Lost to Follow-up|1|||
170496686|NCT01014988|616159008|FG003|Overall Study|Lost to Follow-up|0|||
170496687|NCT01014988|616159009|FG004|Overall Study|Lost to Follow-up|0|||
170496688|NCT01014988|616159010|FG005|Overall Study|Lost to Follow-up|0|||
170496689|NCT01014988|616159005|FG000|Overall Study|Physician Decision|1|||
170496690|NCT01014988|616159006|FG001|Overall Study|Physician Decision|0|||
170496691|NCT01014988|616159007|FG002|Overall Study|Physician Decision|0|||
170496692|NCT01014988|616159008|FG003|Overall Study|Physician Decision|0|||
170496693|NCT01014988|616159009|FG004|Overall Study|Physician Decision|0|||
170496694|NCT01014988|616159010|FG005|Overall Study|Physician Decision|0|||
170496695|NCT01014988|616159005|FG000|Overall Study|Withdrawal by Subject|1|||
170496696|NCT01014988|616159006|FG001|Overall Study|Withdrawal by Subject|0|||
170496697|NCT01014988|616159007|FG002|Overall Study|Withdrawal by Subject|0|||
170496698|NCT01014988|616159008|FG003|Overall Study|Withdrawal by Subject|0|||
170496699|NCT01014988|616159009|FG004|Overall Study|Withdrawal by Subject|0|||
170496700|NCT01014988|616159010|FG005|Overall Study|Withdrawal by Subject|0|||
170496701|NCT01683266|616159013|FG000|Overall Study|Adverse Event|5|||
170496702|NCT01683266|616159014|FG001|Overall Study|Adverse Event|4|||
170496703|NCT01683266|616159013|FG000|Overall Study|Lack of Efficacy|5|||
170496704|NCT01683266|616159014|FG001|Overall Study|Lack of Efficacy|2|||
170496705|NCT01683266|616159013|FG000|Overall Study|Protocol Violation|13|||
170496706|NCT01683266|616159014|FG001|Overall Study|Protocol Violation|6|||
170496707|NCT01683266|616159013|FG000|Overall Study|Personal Reason|17|||
170496708|NCT01683266|616159014|FG001|Overall Study|Personal Reason|25|||
170496709|NCT01683266|616159013|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
170496710|NCT01683266|616159014|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
170496711|NCT01683266|616159013|FG000|Overall Study|Lost to Follow-up|5|||
170496712|NCT01683266|616159014|FG001|Overall Study|Lost to Follow-up|0|||
170496713|NCT01683266|616159013|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
170496714|NCT01683266|616159014|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
170496715|NCT01683266|616159013|FG000|Overall Study|Nonserious Hypoglycemia|0|||
170496716|NCT01683266|616159014|FG001|Overall Study|Nonserious Hypoglycemia|3|||
170496717|NCT01683266|616159013|FG000|Overall Study|Perceived Lack of Efficacy|1|||
170496718|NCT01683266|616159014|FG001|Overall Study|Perceived Lack of Efficacy|1|||
170496719|NCT01683266|616159013|FG000|Overall Study|Possibly Hypoglycemia|1|||
170496720|NCT01683266|616159014|FG001|Overall Study|Possibly Hypoglycemia|0|||
170496721|NCT01683266|616159013|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
170496722|NCT01683266|616159014|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
170496723|NCT03781583|616159015|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
170496724|NCT03781583|616159016|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
170496725|NCT03781583|616159017|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
170496726|NCT03781583|616159018|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
170496727|NCT03781583|616159015|FG000|Overall Study|Technology did not work for that person in that environment|1|||
170496728|NCT03781583|616159016|FG001|Overall Study|Technology did not work for that person in that environment|0|||
170641996|NCT01754402|616703370|FG002|Overall Study|Adverse Event|1|||
170496729|NCT03781583|616159017|FG002|Overall Study|Technology did not work for that person in that environment|0|||
170496730|NCT03781583|616159018|FG003|Overall Study|Technology did not work for that person in that environment|0|||
170496731|NCT03781583|616159015|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
170496732|NCT03781583|616159016|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
170496733|NCT03781583|616159017|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
170496734|NCT03781583|616159018|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
170496735|NCT03781583|616159015|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
170496736|NCT03781583|616159016|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
170496737|NCT03781583|616159017|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
170496738|NCT03781583|616159018|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
170496739|NCT01867710|616159022|FG000|Overall Study|Death|25|||
170496740|NCT01867710|616159023|FG001|Overall Study|Death|15|||
170496741|NCT01867710|616159024|FG002|Overall Study|Death|27|||
170496742|NCT01867710|616159025|FG003|Overall Study|Death|20|||
170496743|NCT01867710|616159022|FG000|Overall Study|Lost to Follow-up|3|||
170496744|NCT01867710|616159023|FG001|Overall Study|Lost to Follow-up|4|||
170496745|NCT01867710|616159024|FG002|Overall Study|Lost to Follow-up|3|||
170496746|NCT01867710|616159025|FG003|Overall Study|Lost to Follow-up|2|||
170496747|NCT01867710|616159022|FG000|Overall Study|Withdrawal of consent|2|||
170496748|NCT01867710|616159023|FG001|Overall Study|Withdrawal of consent|5|||
170496749|NCT01867710|616159024|FG002|Overall Study|Withdrawal of consent|1|||
170496750|NCT01867710|616159025|FG003|Overall Study|Withdrawal of consent|2|||
170496751|NCT01867710|616159022|FG000|Overall Study|Study Terminated by Sponsor|9|||
170496752|NCT01867710|616159023|FG001|Overall Study|Study Terminated by Sponsor|13|||
170496753|NCT01867710|616159024|FG002|Overall Study|Study Terminated by Sponsor|8|||
170496754|NCT01867710|616159025|FG003|Overall Study|Study Terminated by Sponsor|16|||
170496755|NCT01867710|616159022|FG000|Overall Study|Biochemical progression|0|||
170496756|NCT01867710|616159023|FG001|Overall Study|Biochemical progression|1|||
170496757|NCT01867710|616159024|FG002|Overall Study|Biochemical progression|0|||
170496758|NCT01867710|616159025|FG003|Overall Study|Biochemical progression|0|||
170496759|NCT01867710|616159022|FG000|Overall Study|Clinical progression|0|||
170496760|NCT01867710|616159023|FG001|Overall Study|Clinical progression|0|||
170496761|NCT01867710|616159024|FG002|Overall Study|Clinical progression|1|||
170496762|NCT01867710|616159025|FG003|Overall Study|Clinical progression|0|||
170496763|NCT01867710|616159022|FG000|Overall Study|Disease progression|1|||
170496764|NCT01867710|616159023|FG001|Overall Study|Disease progression|0|||
170496765|NCT01867710|616159024|FG002|Overall Study|Disease progression|0|||
170496766|NCT01867710|616159025|FG003|Overall Study|Disease progression|0|||
170496767|NCT01867710|616159022|FG000|Overall Study|Patient decision|0|||
170496768|NCT01867710|616159023|FG001|Overall Study|Patient decision|0|||
170496769|NCT01867710|616159024|FG002|Overall Study|Patient decision|0|||
170496770|NCT01867710|616159025|FG003|Overall Study|Patient decision|1|||
170496771|NCT01867710|616159022|FG000|Overall Study|Patient to follow subsequent treatment|0|||
170496772|NCT01867710|616159023|FG001|Overall Study|Patient to follow subsequent treatment|1|||
170496773|NCT01867710|616159024|FG002|Overall Study|Patient to follow subsequent treatment|0|||
170496774|NCT01867710|616159025|FG003|Overall Study|Patient to follow subsequent treatment|0|||
170496775|NCT01867710|616159022|FG000|Overall Study|Progressive disease|1|||
170496776|NCT01867710|616159023|FG001|Overall Study|Progressive disease|0|||
170496777|NCT01867710|616159024|FG002|Overall Study|Progressive disease|0|||
170496778|NCT01867710|616159025|FG003|Overall Study|Progressive disease|0|||
170496779|NCT01867710|616159022|FG000|Overall Study|Protocol Violation|0|||
170496780|NCT01867710|616159023|FG001|Overall Study|Protocol Violation|0|||
170496781|NCT01867710|616159024|FG002|Overall Study|Protocol Violation|0|||
170496782|NCT01867710|616159025|FG003|Overall Study|Protocol Violation|1|||
170496783|NCT01867710|616159022|FG000|Overall Study|PSA-progression|0|||
170496784|NCT01867710|616159023|FG001|Overall Study|PSA-progression|1|||
170496785|NCT01867710|616159024|FG002|Overall Study|PSA-progression|0|||
170496786|NCT01867710|616159025|FG003|Overall Study|PSA-progression|0|||
170496787|NCT01867710|616159022|FG000|Overall Study|Study medication no longer effective|0|||
170496788|NCT01867710|616159023|FG001|Overall Study|Study medication no longer effective|1|||
170496789|NCT01867710|616159024|FG002|Overall Study|Study medication no longer effective|0|||
170496790|NCT01867710|616159025|FG003|Overall Study|Study medication no longer effective|0|||
170496791|NCT05113979|616159026|FG000|Overall Study|Death|2|||
170496792|NCT05113979|616159026|FG000|Overall Study|Lost to Follow-up|1|||
170496793|NCT01981954|616159027|FG000|Titration Period|Protocol Deviation|1|||
170496794|NCT01981954|616159027|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
170496795|NCT01438294|616159028|FG000|Overall Study|Lost to Follow-up|3|||
170496796|NCT01438294|616159029|FG001|Overall Study|Lost to Follow-up|7|||
170551168|NCT00236197|616362604|FG001|Overall Study|Protocol Violation|3|||
170900575|NCT00481065|617640168|FG006|Overall Study|Adverse event or death|1|||
170496797|NCT01730534|616159034|FG000|Overall Study|Withdrawal by Subject|97|||
170551169|NCT00236197|616362603|FG000|Overall Study|Medication non-compliance|1|||
170496798|NCT01730534|616159035|FG001|Overall Study|Withdrawal by Subject|127|||
170496799|NCT01730534|616159034|FG000|Overall Study|Lost to Follow-up|12|||
170496800|NCT01730534|616159035|FG001|Overall Study|Lost to Follow-up|18|||
170496801|NCT02980341|616159036|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
170496802|NCT02980341|616159037|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
170496803|NCT02980341|616159038|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
170900576|NCT00481065|617640169|FG007|Overall Study|Adverse event or death|1|||
170496804|NCT02980341|616159039|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
170496805|NCT02980341|616159040|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
170496806|NCT02980341|616159041|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
170900577|NCT00481065|617640162|FG000|Overall Study|Withdrawal by Subject|11|||
170900578|NCT00481065|617640163|FG001|Overall Study|Withdrawal by Subject|12|||
170900579|NCT00481065|617640164|FG002|Overall Study|Withdrawal by Subject|7|||
170900580|NCT00481065|617640165|FG003|Overall Study|Withdrawal by Subject|11|||
170900581|NCT00481065|617640166|FG004|Overall Study|Withdrawal by Subject|13|||
170900582|NCT00481065|617640167|FG005|Overall Study|Withdrawal by Subject|12|||
170900583|NCT00481065|617640168|FG006|Overall Study|Withdrawal by Subject|9|||
170900584|NCT00481065|617640169|FG007|Overall Study|Withdrawal by Subject|10|||
170900585|NCT00481065|617640162|FG000|Overall Study|Lost to Follow-up|4|||
170900586|NCT00481065|617640163|FG001|Overall Study|Lost to Follow-up|2|||
170496807|NCT02980341|616159042|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
170900587|NCT00481065|617640164|FG002|Overall Study|Lost to Follow-up|4|||
170900588|NCT00481065|617640165|FG003|Overall Study|Lost to Follow-up|3|||
170900589|NCT00481065|617640166|FG004|Overall Study|Lost to Follow-up|3|||
170900590|NCT00481065|617640167|FG005|Overall Study|Lost to Follow-up|3|||
170900591|NCT00481065|617640168|FG006|Overall Study|Lost to Follow-up|2|||
170900592|NCT00481065|617640169|FG007|Overall Study|Lost to Follow-up|5|||
170900593|NCT00481065|617640162|FG000|Overall Study|Inappropriate enrollment|4|||
170900594|NCT00481065|617640163|FG001|Overall Study|Inappropriate enrollment|0|||
170900595|NCT00481065|617640164|FG002|Overall Study|Inappropriate enrollment|2|||
170900596|NCT00481065|617640165|FG003|Overall Study|Inappropriate enrollment|0|||
170900597|NCT00481065|617640166|FG004|Overall Study|Inappropriate enrollment|2|||
170900598|NCT00481065|617640167|FG005|Overall Study|Inappropriate enrollment|1|||
170900599|NCT00481065|617640168|FG006|Overall Study|Inappropriate enrollment|0|||
170900600|NCT00481065|617640169|FG007|Overall Study|Inappropriate enrollment|1|||
170900601|NCT00481065|617640162|FG000|Overall Study|Administrative reason|0|||
170496808|NCT02980341|616159043|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
170496809|NCT02980341|616159044|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
170496810|NCT02980341|616159045|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
170496811|NCT02980341|616159046|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
170496812|NCT02980341|616159036|FG000|Dose Escalation|Clinical progression|0|||
170496813|NCT02980341|616159037|FG001|Dose Escalation|Clinical progression|0|||
170496814|NCT02980341|616159038|FG002|Dose Escalation|Clinical progression|2|||
170496815|NCT02980341|616159039|FG003|Dose Escalation|Clinical progression|1|||
170496816|NCT02980341|616159040|FG004|Dose Escalation|Clinical progression|0|||
170900602|NCT00481065|617640163|FG001|Overall Study|Administrative reason|0|||
170900603|NCT00481065|617640164|FG002|Overall Study|Administrative reason|0|||
170551170|NCT00236197|616362604|FG001|Overall Study|Medication non-compliance|2|||
170551171|NCT00236197|616362603|FG000|Overall Study|Other|0|||
170551172|NCT00236197|616362604|FG001|Overall Study|Other|2|||
170551173|NCT00480025|616362605|FG000|Overall Study|Protocol Violation|12|||
170551174|NCT00480025|616362606|FG001|Overall Study|Protocol Violation|7|||
170551175|NCT00480025|616362605|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
170551176|NCT00480025|616362606|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
170551177|NCT00480025|616362605|FG000|Overall Study|Disease Progression / Recurrence|449|||
170551178|NCT00480025|616362606|FG001|Overall Study|Disease Progression / Recurrence|224|||
170551179|NCT00480025|616362605|FG000|Overall Study|Adverse Event|44|||
170551180|NCT00480025|616362606|FG001|Overall Study|Adverse Event|12|||
170551181|NCT00480025|616362605|FG000|Overall Study|Other|70|||
170551182|NCT00480025|616362606|FG001|Overall Study|Other|29|||
170551183|NCT00480025|616362605|FG000|Overall Study|SAE including intercurrent illness|76|||
170551184|NCT00480025|616362606|FG001|Overall Study|SAE including intercurrent illness|42|||
170551185|NCT06868667|616362608|FG000|Overall Study|Death|0|||
170551186|NCT06868667|616362609|FG001|Overall Study|Death|4|||
170551187|NCT06868667|616362608|FG000|Overall Study|Lost to Follow-up|0|||
170551188|NCT06868667|616362609|FG001|Overall Study|Lost to Follow-up|1|||
170551189|NCT06868667|616362608|FG000|Overall Study|Withdrawal by Subject|1|||
170551190|NCT06868667|616362609|FG001|Overall Study|Withdrawal by Subject|0|||
170551191|NCT06868667|616362608|FG000|Overall Study|Ongoing|9|||
170551192|NCT06868667|616362609|FG001|Overall Study|Ongoing|9|||
170551193|NCT02113878|616364673|FG000|Overall Study|Adverse Event|1|||
170551194|NCT02113878|616364674|FG001|Overall Study|Adverse Event|0|||
170496817|NCT02980341|616159041|FG005|Dose Escalation|Clinical progression|0|||
170551195|NCT02113878|616364673|FG000|Overall Study|Withdrawal by Subject|1|||
170551196|NCT02113878|616364674|FG001|Overall Study|Withdrawal by Subject|0|||
170900604|NCT00481065|617640165|FG003|Overall Study|Administrative reason|0|||
170900605|NCT00481065|617640166|FG004|Overall Study|Administrative reason|0|||
170900606|NCT00481065|617640167|FG005|Overall Study|Administrative reason|2|||
170551197|NCT02113878|616364673|FG000|Overall Study|patient non-compliance|1|||
170551198|NCT02113878|616364674|FG001|Overall Study|patient non-compliance|0|||
170900607|NCT00481065|617640168|FG006|Overall Study|Administrative reason|1|||
170900608|NCT00481065|617640169|FG007|Overall Study|Administrative reason|0|||
170496818|NCT02980341|616159042|FG006|Dose Escalation|Clinical progression|0|||
170496819|NCT02980341|616159043|FG007|Dose Escalation|Clinical progression|0|||
170551199|NCT01251965|616364675|FG000|Overall Study|Participant/physician decision|1|||
170900609|NCT00481065|617640162|FG000|Overall Study|Protocol Violation|2|||
170496820|NCT02980341|616159044|FG008|Dose Escalation|Clinical progression|0|||
170496821|NCT02980341|616159045|FG009|Dose Escalation|Clinical progression|0|||
170496822|NCT02980341|616159046|FG010|Dose Escalation|Clinical progression|0|||
170496823|NCT02980341|616159036|FG000|Dose Escalation|Adverse Event|0|||
170496824|NCT02980341|616159037|FG001|Dose Escalation|Adverse Event|0|||
170496825|NCT02980341|616159038|FG002|Dose Escalation|Adverse Event|1|||
170496826|NCT02980341|616159039|FG003|Dose Escalation|Adverse Event|2|||
170496827|NCT02980341|616159040|FG004|Dose Escalation|Adverse Event|2|||
170496828|NCT02980341|616159041|FG005|Dose Escalation|Adverse Event|0|||
170496829|NCT02980341|616159042|FG006|Dose Escalation|Adverse Event|0|||
170496830|NCT02980341|616159043|FG007|Dose Escalation|Adverse Event|0|||
170496831|NCT02980341|616159044|FG008|Dose Escalation|Adverse Event|0|||
170496832|NCT02980341|616159045|FG009|Dose Escalation|Adverse Event|0|||
170496833|NCT02980341|616159046|FG010|Dose Escalation|Adverse Event|0|||
170496834|NCT02980341|616159036|FG000|Dose Escalation|Withdrawal by Subject|0|||
170496835|NCT02980341|616159037|FG001|Dose Escalation|Withdrawal by Subject|0|||
170496836|NCT02980341|616159038|FG002|Dose Escalation|Withdrawal by Subject|1|||
170496837|NCT02980341|616159039|FG003|Dose Escalation|Withdrawal by Subject|0|||
170496838|NCT02980341|616159040|FG004|Dose Escalation|Withdrawal by Subject|0|||
170496839|NCT02980341|616159041|FG005|Dose Escalation|Withdrawal by Subject|0|||
170496840|NCT02980341|616159042|FG006|Dose Escalation|Withdrawal by Subject|0|||
170496841|NCT02980341|616159043|FG007|Dose Escalation|Withdrawal by Subject|0|||
170496842|NCT02980341|616159044|FG008|Dose Escalation|Withdrawal by Subject|0|||
170496843|NCT02980341|616159045|FG009|Dose Escalation|Withdrawal by Subject|0|||
170496844|NCT02980341|616159046|FG010|Dose Escalation|Withdrawal by Subject|0|||
170496845|NCT02980341|616159036|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496846|NCT02980341|616159037|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496847|NCT02980341|616159038|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496848|NCT02980341|616159039|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
170496849|NCT02980341|616159040|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496850|NCT02980341|616159041|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496851|NCT02980341|616159042|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496852|NCT02980341|616159043|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496853|NCT02980341|616159044|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496854|NCT02980341|616159045|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496855|NCT02980341|616159046|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
170496856|NCT02980341|616159036|FG000|Dose Escalation|Due to investigator's decision|0|||
170496857|NCT02980341|616159037|FG001|Dose Escalation|Due to investigator's decision|0|||
170496858|NCT02980341|616159038|FG002|Dose Escalation|Due to investigator's decision|0|||
170496859|NCT02980341|616159039|FG003|Dose Escalation|Due to investigator's decision|0|||
170496860|NCT02980341|616159040|FG004|Dose Escalation|Due to investigator's decision|1|||
170496861|NCT02980341|616159041|FG005|Dose Escalation|Due to investigator's decision|0|||
170496862|NCT02980341|616159042|FG006|Dose Escalation|Due to investigator's decision|0|||
170496863|NCT02980341|616159043|FG007|Dose Escalation|Due to investigator's decision|0|||
170496864|NCT02980341|616159044|FG008|Dose Escalation|Due to investigator's decision|0|||
170496865|NCT02980341|616159045|FG009|Dose Escalation|Due to investigator's decision|0|||
170496866|NCT02980341|616159046|FG010|Dose Escalation|Due to investigator's decision|0|||
170496867|NCT02980341|616159036|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496868|NCT02980341|616159037|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496869|NCT02980341|616159038|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496870|NCT02980341|616159039|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496871|NCT02980341|616159040|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496872|NCT02980341|616159041|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
170496873|NCT02980341|616159042|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
170496874|NCT02980341|616159043|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496875|NCT02980341|616159044|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496876|NCT02980341|616159045|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496877|NCT02980341|616159046|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
170496878|NCT02980341|616159036|FG000|Dose Finding|Adverse Event|0|||
170496879|NCT02980341|616159037|FG001|Dose Finding|Adverse Event|0|||
170496880|NCT02980341|616159038|FG002|Dose Finding|Adverse Event|0|||
170496881|NCT02980341|616159039|FG003|Dose Finding|Adverse Event|0|||
170496882|NCT02980341|616159040|FG004|Dose Finding|Adverse Event|0|||
170496883|NCT02980341|616159041|FG005|Dose Finding|Adverse Event|3|||
170641997|NCT01754402|616703368|FG000|Overall Study|Withdrawal by Subject|0|||
170641998|NCT01754402|616703369|FG001|Overall Study|Withdrawal by Subject|0|||
170496884|NCT02980341|616159042|FG006|Dose Finding|Adverse Event|0|||
170496885|NCT02980341|616159043|FG007|Dose Finding|Adverse Event|0|||
170496886|NCT02980341|616159044|FG008|Dose Finding|Adverse Event|0|||
170496887|NCT02980341|616159045|FG009|Dose Finding|Adverse Event|0|||
170496888|NCT02980341|616159046|FG010|Dose Finding|Adverse Event|0|||
170496889|NCT02980341|616159036|FG000|Dose Finding|Withdrawal by Subject|0|||
170641999|NCT01754402|616703370|FG002|Overall Study|Withdrawal by Subject|1|||
170496890|NCT02980341|616159037|FG001|Dose Finding|Withdrawal by Subject|0|||
170496891|NCT02980341|616159038|FG002|Dose Finding|Withdrawal by Subject|0|||
170496892|NCT02980341|616159039|FG003|Dose Finding|Withdrawal by Subject|0|||
170496893|NCT02980341|616159040|FG004|Dose Finding|Withdrawal by Subject|0|||
170496894|NCT02980341|616159041|FG005|Dose Finding|Withdrawal by Subject|1|||
170496895|NCT02980341|616159042|FG006|Dose Finding|Withdrawal by Subject|1|||
170496896|NCT02980341|616159043|FG007|Dose Finding|Withdrawal by Subject|0|||
170496897|NCT02980341|616159044|FG008|Dose Finding|Withdrawal by Subject|0|||
170496898|NCT02980341|616159045|FG009|Dose Finding|Withdrawal by Subject|0|||
170496899|NCT02980341|616159046|FG010|Dose Finding|Withdrawal by Subject|0|||
170496900|NCT02980341|616159036|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
170496901|NCT02980341|616159037|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
170496902|NCT02980341|616159038|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
170496903|NCT02980341|616159039|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
170496904|NCT02980341|616159040|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
170496905|NCT02980341|616159041|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
170496906|NCT02980341|616159042|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
170496907|NCT02980341|616159043|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
170496908|NCT02980341|616159044|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
170496909|NCT02980341|616159045|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
170496910|NCT02980341|616159046|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
170496911|NCT02980341|616159036|FG000|Dose Expansion|Clinical progression|0|||
170496912|NCT02980341|616159037|FG001|Dose Expansion|Clinical progression|0|||
170496913|NCT02980341|616159038|FG002|Dose Expansion|Clinical progression|0|||
170496914|NCT02980341|616159039|FG003|Dose Expansion|Clinical progression|0|||
170496915|NCT02980341|616159040|FG004|Dose Expansion|Clinical progression|0|||
170496916|NCT02980341|616159041|FG005|Dose Expansion|Clinical progression|0|||
170496917|NCT02980341|616159042|FG006|Dose Expansion|Clinical progression|0|||
170496918|NCT02980341|616159043|FG007|Dose Expansion|Clinical progression|4|||
170496919|NCT02980341|616159044|FG008|Dose Expansion|Clinical progression|3|||
170496920|NCT02980341|616159045|FG009|Dose Expansion|Clinical progression|1|||
170496921|NCT02980341|616159046|FG010|Dose Expansion|Clinical progression|4|||
170496922|NCT02980341|616159036|FG000|Dose Expansion|Adverse Event|0|||
170496923|NCT02980341|616159037|FG001|Dose Expansion|Adverse Event|0|||
170496924|NCT02980341|616159038|FG002|Dose Expansion|Adverse Event|0|||
170496925|NCT02980341|616159039|FG003|Dose Expansion|Adverse Event|0|||
170496926|NCT02980341|616159040|FG004|Dose Expansion|Adverse Event|0|||
170496927|NCT02980341|616159041|FG005|Dose Expansion|Adverse Event|0|||
170496928|NCT02980341|616159042|FG006|Dose Expansion|Adverse Event|0|||
170496929|NCT02980341|616159043|FG007|Dose Expansion|Adverse Event|3|||
170496930|NCT02980341|616159044|FG008|Dose Expansion|Adverse Event|0|||
170496931|NCT02980341|616159045|FG009|Dose Expansion|Adverse Event|1|||
170496932|NCT02980341|616159046|FG010|Dose Expansion|Adverse Event|3|||
170496933|NCT02980341|616159036|FG000|Dose Expansion|Death|0|||
170496934|NCT02980341|616159037|FG001|Dose Expansion|Death|0|||
170496935|NCT02980341|616159038|FG002|Dose Expansion|Death|0|||
170496936|NCT02980341|616159039|FG003|Dose Expansion|Death|0|||
170496937|NCT02980341|616159040|FG004|Dose Expansion|Death|0|||
170496938|NCT02980341|616159041|FG005|Dose Expansion|Death|0|||
170496939|NCT02980341|616159042|FG006|Dose Expansion|Death|0|||
170496940|NCT02980341|616159043|FG007|Dose Expansion|Death|0|||
170496941|NCT02980341|616159044|FG008|Dose Expansion|Death|2|||
170496942|NCT02980341|616159045|FG009|Dose Expansion|Death|1|||
170496943|NCT02980341|616159046|FG010|Dose Expansion|Death|0|||
170496944|NCT02980341|616159036|FG000|Dose Expansion|Withdrawal by Subject|0|||
170496945|NCT02980341|616159037|FG001|Dose Expansion|Withdrawal by Subject|0|||
170496946|NCT02980341|616159038|FG002|Dose Expansion|Withdrawal by Subject|0|||
170496947|NCT02980341|616159039|FG003|Dose Expansion|Withdrawal by Subject|0|||
170496948|NCT02980341|616159040|FG004|Dose Expansion|Withdrawal by Subject|0|||
170496949|NCT02980341|616159041|FG005|Dose Expansion|Withdrawal by Subject|0|||
170496950|NCT02980341|616159042|FG006|Dose Expansion|Withdrawal by Subject|0|||
170496951|NCT02980341|616159043|FG007|Dose Expansion|Withdrawal by Subject|2|||
170496952|NCT02980341|616159044|FG008|Dose Expansion|Withdrawal by Subject|0|||
170496953|NCT02980341|616159045|FG009|Dose Expansion|Withdrawal by Subject|1|||
170496954|NCT02980341|616159046|FG010|Dose Expansion|Withdrawal by Subject|0|||
170496955|NCT02980341|616159036|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496956|NCT02980341|616159037|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496957|NCT02980341|616159038|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496958|NCT02980341|616159039|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496959|NCT02980341|616159040|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496960|NCT02980341|616159041|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496961|NCT02980341|616159042|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170551200|NCT01251965|616364676|FG001|Overall Study|Participant/physician decision|2|||
170496962|NCT02980341|616159043|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
170496963|NCT02980341|616159044|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496964|NCT02980341|616159045|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496965|NCT02980341|616159046|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
170496966|NCT02980341|616159036|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496967|NCT02980341|616159037|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496968|NCT02980341|616159038|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496969|NCT02980341|616159039|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496970|NCT02980341|616159040|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496971|NCT02980341|616159041|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496972|NCT02980341|616159042|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496973|NCT02980341|616159043|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496974|NCT02980341|616159044|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
170496975|NCT02980341|616159045|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496976|NCT02980341|616159046|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
170496977|NCT02980341|616159036|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496978|NCT02980341|616159037|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496979|NCT02980341|616159038|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496980|NCT02980341|616159039|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496981|NCT02980341|616159040|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496982|NCT02980341|616159041|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496983|NCT02980341|616159042|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496984|NCT02980341|616159043|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496985|NCT02980341|616159044|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
170496986|NCT02980341|616159045|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496987|NCT02980341|616159046|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
170496988|NCT02980341|616159036|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496989|NCT02980341|616159037|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496990|NCT02980341|616159038|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496991|NCT02980341|616159039|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496992|NCT02980341|616159040|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496993|NCT02980341|616159041|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496994|NCT02980341|616159042|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496995|NCT02980341|616159043|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496996|NCT02980341|616159044|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496997|NCT02980341|616159045|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
170496998|NCT02980341|616159046|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
170496999|NCT00459706|616159049|FG000|Overall Study|Adverse Event|19|||
170497000|NCT00459706|616159050|FG001|Overall Study|Adverse Event|13|||
170497001|NCT00459706|616159049|FG000|Overall Study|Withdrawal by Subject|1|||
170497002|NCT00459706|616159050|FG001|Overall Study|Withdrawal by Subject|6|||
170497003|NCT00459706|616159049|FG000|Overall Study|Physician Decision|2|||
170497004|NCT00459706|616159050|FG001|Overall Study|Physician Decision|0|||
170497005|NCT00459706|616159049|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
170497006|NCT00459706|616159050|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
170497007|NCT00459706|616159049|FG000|Overall Study|Protocol Violation|2|||
170497008|NCT00459706|616159050|FG001|Overall Study|Protocol Violation|1|||
170497009|NCT00459706|616159049|FG000|Overall Study|Failed to Return|1|||
170497010|NCT00459706|616159050|FG001|Overall Study|Failed to Return|0|||
170497011|NCT00459706|616159049|FG000|Overall Study|Other|0|||
170497012|NCT00459706|616159050|FG001|Overall Study|Other|1|||
170497013|NCT00535847|616159051|FG000|Overall Study|Adverse Event|5|||
170497014|NCT00535847|616159052|FG001|Overall Study|Adverse Event|3|||
170497015|NCT00535847|616159053|FG002|Overall Study|Adverse Event|2|||
170497016|NCT00535847|616159051|FG000|Overall Study|Non compliance|1|||
170497017|NCT00535847|616159052|FG001|Overall Study|Non compliance|1|||
170497018|NCT00535847|616159053|FG002|Overall Study|Non compliance|0|||
170802052|NCT00319020|617284966|FG001|Overall Study|Transplant|1|||
170802053|NCT00319020|617284965|FG000|Overall Study|Treatment failure|0|||
170802054|NCT00319020|617284966|FG001|Overall Study|Treatment failure|1|||
170802055|NCT00319020|617284965|FG000|Overall Study|Adverse Event|0|||
170802056|NCT00319020|617284966|FG001|Overall Study|Adverse Event|1|||
170802057|NCT04980300|617284967|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
170497019|NCT00535847|616159051|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
170497020|NCT00535847|616159052|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
170497021|NCT00535847|616159053|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
170497022|NCT04439214|616159057|FG000|Overall Study|Adverse Event|13|||
170497023|NCT04439214|616159057|FG000|Overall Study|Disease progression|16|||
170497024|NCT04439214|616159057|FG000|Overall Study|Death|1|||
170497025|NCT04439214|616159057|FG000|Overall Study|Withdrawal by Subject|2|||
170497026|NCT04439214|616159057|FG000|Overall Study|Declining health|1|||
170900610|NCT00481065|617640163|FG001|Overall Study|Protocol Violation|1|||
170900611|NCT00481065|617640164|FG002|Overall Study|Protocol Violation|1|||
170900612|NCT00481065|617640165|FG003|Overall Study|Protocol Violation|1|||
170900613|NCT00481065|617640166|FG004|Overall Study|Protocol Violation|2|||
170497027|NCT04439214|616159057|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
170497028|NCT04439214|616159057|FG000|Overall Study|Ineligible|5|||
170497029|NCT02964208|616159058|FG000|Overall Study|Death|103|||
170497030|NCT02964208|616159058|FG000|Overall Study|Withdrawal by Subject|6|||
170497031|NCT02964208|616159058|FG000|Overall Study|Lost to Follow-up|6|||
170497032|NCT02964208|616159058|FG000|Overall Study|Unsuccessful Procedure|5|||
170497033|NCT02964208|616159058|FG000|Overall Study|Device Explant|1|||
170497034|NCT02964208|616159058|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
170497035|NCT00556933|616159059|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
170497036|NCT00556933|616159060|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
170497037|NCT00556933|616159061|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
170497038|NCT00556933|616159062|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
170497039|NCT00556933|616159059|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
170497040|NCT00556933|616159060|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
170497041|NCT00556933|616159061|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
170497042|NCT00556933|616159062|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
170497043|NCT00556933|616159059|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
170497044|NCT00556933|616159060|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
170497045|NCT00556933|616159061|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
170497046|NCT00556933|616159062|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
170497047|NCT00556933|616159059|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
170497048|NCT00556933|616159060|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
170497049|NCT00556933|616159061|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
170497050|NCT00556933|616159062|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
170497051|NCT00556933|616159059|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
170497052|NCT00556933|616159060|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
170497053|NCT00556933|616159061|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
170497054|NCT00556933|616159062|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
170642000|NCT01754402|616703368|FG000|Overall Study|Lack of Efficacy|0|||
170900614|NCT00481065|617640167|FG005|Overall Study|Protocol Violation|6|||
170900615|NCT00481065|617640168|FG006|Overall Study|Protocol Violation|3|||
170900616|NCT00481065|617640169|FG007|Overall Study|Protocol Violation|2|||
170900617|NCT00481065|617640162|FG000|Overall Study|Unable to classify|0|||
170900618|NCT00481065|617640163|FG001|Overall Study|Unable to classify|1|||
170900619|NCT00481065|617640164|FG002|Overall Study|Unable to classify|2|||
170900620|NCT00481065|617640165|FG003|Overall Study|Unable to classify|0|||
170900621|NCT00481065|617640166|FG004|Overall Study|Unable to classify|1|||
170900622|NCT00481065|617640167|FG005|Overall Study|Unable to classify|0|||
170900623|NCT00481065|617640168|FG006|Overall Study|Unable to classify|0|||
170900624|NCT00481065|617640169|FG007|Overall Study|Unable to classify|0|||
170900625|NCT01709331|617640170|FG000|Overall Study|Adverse Event|1|||
170900626|NCT04439344|617640171|FG000|Overall Study|Never started threapy|3|||
170900627|NCT04439344|617640171|FG000|Overall Study|Ineligible|3|||
170900628|NCT04439344|617640171|FG000|Overall Study|Adverse Event|13|||
170900629|NCT04439344|617640171|FG000|Overall Study|Death|2|||
170900630|NCT04439344|617640171|FG000|Overall Study|Disease progression|29|||
170900631|NCT04439344|617640171|FG000|Overall Study|Withdrawal by Subject|2|||
170900632|NCT04439344|617640171|FG000|Overall Study|Alternative therapy|1|||
170900633|NCT03896295|617640174|FG000|Overall Study|Adverse Event|0|||
170900634|NCT03896295|617640175|FG001|Overall Study|Adverse Event|1|||
170900635|NCT03896295|617640174|FG000|Overall Study|COVID-19|7|||
170900636|NCT03896295|617640175|FG001|Overall Study|COVID-19|29|||
170900637|NCT03440944|617640178|FG000|Overall Study|Physician Decision|1|||
170900638|NCT03440944|617640179|FG001|Overall Study|Physician Decision|0|||
170900639|NCT03440944|617640178|FG000|Overall Study|No Acceptable Vasculature|0|||
170900640|NCT03440944|617640179|FG001|Overall Study|No Acceptable Vasculature|1|||
170900641|NCT00749190|617640180|FG000|Overall Study|Adverse Event|0|||
170900642|NCT00749190|617640181|FG001|Overall Study|Adverse Event|2|||
170900643|NCT00749190|617640182|FG002|Overall Study|Adverse Event|0|||
170900644|NCT00749190|617640183|FG003|Overall Study|Adverse Event|4|||
170900645|NCT00749190|617640184|FG004|Overall Study|Adverse Event|0|||
170900646|NCT00749190|617640185|FG005|Overall Study|Adverse Event|3|||
170802058|NCT04980300|617284968|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
170802059|NCT04980300|617284967|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
170802060|NCT04980300|617284968|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
170802061|NCT04980300|617284967|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
170802062|NCT04980300|617284968|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
170802063|NCT04980300|617284967|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
170802064|NCT04980300|617284968|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
170802065|NCT04213807|617286380|FG000|Overall Study|Physician Decision|0|||
170802066|NCT04213807|617286381|FG001|Overall Study|Physician Decision|0|||
170802067|NCT04213807|617286382|FG002|Overall Study|Physician Decision|1|||
170802068|NCT02866942|617286383|FG000|Overall Study|Invalid consent|1|||
170802069|NCT00372775|617286384|FG000|Overall Study|Adverse Event|8|||
170802070|NCT00372775|617286384|FG000|Overall Study|Death|15|||
170802071|NCT00372775|617286384|FG000|Overall Study|Objective progression or relapse|30|||
170802072|NCT00372775|617286384|FG000|Overall Study|Global deterioration of health status|6|||
170802073|NCT00372775|617286384|FG000|Overall Study|Withdrawal by Subject|1|||
170802074|NCT00372775|617286384|FG000|Overall Study|Other|1|||
170802075|NCT00372775|617286384|FG000|Overall Study|Not Treated|2|||
170802076|NCT01750684|617286385|FG000|Overall Study|Death|1|||
170802077|NCT01750684|617286386|FG001|Overall Study|Death|0|||
170802078|NCT01750684|617286385|FG000|Overall Study|Non-compliance with Study Drug|0|||
170802079|NCT01750684|617286386|FG001|Overall Study|Non-compliance with Study Drug|1|||
170802080|NCT01750684|617286385|FG000|Overall Study|Withdrawn by Sponsor|0|||
170802081|NCT01750684|617286386|FG001|Overall Study|Withdrawn by Sponsor|1|||
170802082|NCT01750684|617286385|FG000|Overall Study|Protocol Violation|1|||
170802083|NCT01750684|617286386|FG001|Overall Study|Protocol Violation|0|||
170802084|NCT00790569|617286387|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
170802085|NCT00790569|617286388|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
170802086|NCT00790569|617286389|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
170802087|NCT00790569|617286387|FG000|End of Treatment (6 Month Interview)|Death|0|||
170802088|NCT00790569|617286388|FG001|End of Treatment (6 Month Interview)|Death|2|||
170802089|NCT00790569|617286389|FG002|End of Treatment (6 Month Interview)|Death|1|||
170802090|NCT00790569|617286387|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
170802091|NCT00790569|617286388|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
170802092|NCT00790569|617286389|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
170802093|NCT00790569|617286387|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
170802094|NCT00790569|617286388|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
170802095|NCT00790569|617286389|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
170802096|NCT00790569|617286387|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
170802097|NCT00790569|617286388|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
170802098|NCT00790569|617286389|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
170802099|NCT00790569|617286387|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
170802100|NCT00790569|617286388|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
170802101|NCT00790569|617286389|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
170802102|NCT01436175|617286390|FG000|Overall Study|Adverse Event|111|||
170802103|NCT01436175|617286390|FG000|Overall Study|Protocol Violation|49|||
170802104|NCT01436175|617286390|FG000|Overall Study|Withdrawal by Subject|108|||
170802105|NCT01436175|617286390|FG000|Overall Study|Lost to Follow-up|89|||
170802106|NCT01436175|617286390|FG000|Overall Study|Lack of Efficacy|24|||
170802107|NCT01436175|617286390|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
170802108|NCT01436175|617286390|FG000|Overall Study|Other|826|||
170802109|NCT03418922|617286395|FG000|Overall Study|Withdrawal by Subject|0|||
170802110|NCT03418922|617286396|FG001|Overall Study|Withdrawal by Subject|2|||
170802111|NCT03418922|617286395|FG000|Overall Study|Adverse Event|2|||
170802112|NCT03418922|617286396|FG001|Overall Study|Adverse Event|2|||
170802113|NCT03418922|617286395|FG000|Overall Study|Death|0|||
170802114|NCT03418922|617286396|FG001|Overall Study|Death|1|||
170802115|NCT03418922|617286395|FG000|Overall Study|Physician Decision|0|||
170802116|NCT03418922|617286396|FG001|Overall Study|Physician Decision|1|||
170802117|NCT03577106|617286397|FG000|Overall Study|Withdrawal by Subject|3|||
170802118|NCT03451422|617286398|FG000|Overall Study|Lost to Follow-up|0|||
170802119|NCT03451422|617286399|FG001|Overall Study|Lost to Follow-up|0|||
170802120|NCT03451422|617286400|FG002|Overall Study|Lost to Follow-up|0|||
170802121|NCT03451422|617286401|FG003|Overall Study|Lost to Follow-up|0|||
170802122|NCT03451422|617286402|FG004|Overall Study|Lost to Follow-up|0|||
170802123|NCT03451422|617286403|FG005|Overall Study|Lost to Follow-up|1|||
170802124|NCT03451422|617286398|FG000|Overall Study|Decision by sponsor|1|||
170802125|NCT03451422|617286399|FG001|Overall Study|Decision by sponsor|0|||
170802126|NCT03451422|617286400|FG002|Overall Study|Decision by sponsor|1|||
170802127|NCT03451422|617286401|FG003|Overall Study|Decision by sponsor|0|||
170802128|NCT03451422|617286402|FG004|Overall Study|Decision by sponsor|0|||
170802129|NCT03451422|617286403|FG005|Overall Study|Decision by sponsor|0|||
170802130|NCT03451422|617286398|FG000|Overall Study|Withdrawal by Subject|0|||
170802131|NCT03451422|617286399|FG001|Overall Study|Withdrawal by Subject|0|||
170802132|NCT03451422|617286400|FG002|Overall Study|Withdrawal by Subject|2|||
170900647|NCT00749190|617640186|FG006|Overall Study|Adverse Event|0|||
170900648|NCT00749190|617640180|FG000|Overall Study|Lack of Efficacy|3|||
170900649|NCT00749190|617640181|FG001|Overall Study|Lack of Efficacy|1|||
170900650|NCT00749190|617640182|FG002|Overall Study|Lack of Efficacy|1|||
170900651|NCT00749190|617640183|FG003|Overall Study|Lack of Efficacy|0|||
170900652|NCT00749190|617640184|FG004|Overall Study|Lack of Efficacy|0|||
170900653|NCT00749190|617640185|FG005|Overall Study|Lack of Efficacy|1|||
170900654|NCT00749190|617640186|FG006|Overall Study|Lack of Efficacy|0|||
170900655|NCT00749190|617640180|FG000|Overall Study|Withdrawal by Subject|2|||
170900656|NCT00749190|617640181|FG001|Overall Study|Withdrawal by Subject|1|||
170900657|NCT00749190|617640182|FG002|Overall Study|Withdrawal by Subject|0|||
170900658|NCT00749190|617640183|FG003|Overall Study|Withdrawal by Subject|0|||
170900659|NCT00749190|617640184|FG004|Overall Study|Withdrawal by Subject|0|||
170900660|NCT00749190|617640185|FG005|Overall Study|Withdrawal by Subject|1|||
170642001|NCT01754402|616703369|FG001|Overall Study|Lack of Efficacy|0|||
170900661|NCT00749190|617640186|FG006|Overall Study|Withdrawal by Subject|0|||
170900662|NCT00749190|617640180|FG000|Overall Study|Protocol Violation|0|||
170900663|NCT00749190|617640181|FG001|Overall Study|Protocol Violation|1|||
170900664|NCT00749190|617640182|FG002|Overall Study|Protocol Violation|0|||
170900665|NCT00749190|617640183|FG003|Overall Study|Protocol Violation|0|||
170900666|NCT00749190|617640184|FG004|Overall Study|Protocol Violation|0|||
170900667|NCT00749190|617640185|FG005|Overall Study|Protocol Violation|0|||
170900668|NCT00749190|617640186|FG006|Overall Study|Protocol Violation|1|||
170900669|NCT00749190|617640180|FG000|Overall Study|Other reason not defined above|0|||
170900670|NCT00749190|617640181|FG001|Overall Study|Other reason not defined above|0|||
170900671|NCT00749190|617640182|FG002|Overall Study|Other reason not defined above|0|||
170900672|NCT00749190|617640183|FG003|Overall Study|Other reason not defined above|1|||
170900673|NCT00749190|617640184|FG004|Overall Study|Other reason not defined above|0|||
170900674|NCT00749190|617640185|FG005|Overall Study|Other reason not defined above|0|||
170900675|NCT00749190|617640186|FG006|Overall Study|Other reason not defined above|0|||
170900676|NCT04482647|617640189|FG000|Overall Study|Time constraints|2|||
170900677|NCT04482647|617640189|FG000|Overall Study|Health issues|1|||
170900678|NCT04482647|617640189|FG000|Overall Study|Death in the family|1|||
170900679|NCT04482647|617640189|FG000|Overall Study|Disliked the intervention|1|||
170900680|NCT04482647|617640189|FG000|Overall Study|No reasons specified|7|||
170900681|NCT03952559|617640190|FG000|Double Blind Treatment Period|Adverse Event|0|||
170900682|NCT03952559|617640191|FG001|Double Blind Treatment Period|Adverse Event|2|||
170900683|NCT03952559|617640192|FG002|Double Blind Treatment Period|Adverse Event|1|||
170900684|NCT03952559|617640193|FG003|Double Blind Treatment Period|Adverse Event|0|||
170900685|NCT03952559|617640194|FG004|Double Blind Treatment Period|Adverse Event|1|||
170900686|NCT03952559|617640190|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
170900687|NCT03952559|617640191|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
170642002|NCT01754402|616703370|FG002|Overall Study|Lack of Efficacy|1|||
170642003|NCT01282463|616703371|FG000|Overall Study|Lost to Follow-up|1|||
170642004|NCT01282463|616703372|FG001|Overall Study|Lost to Follow-up|0|||
170642005|NCT01282463|616703373|FG002|Overall Study|Lost to Follow-up|0|||
170642006|NCT01282463|616703371|FG000|Overall Study|Withdrawal by Subject|6|||
170642007|NCT01282463|616703372|FG001|Overall Study|Withdrawal by Subject|2|||
170642008|NCT01282463|616703373|FG002|Overall Study|Withdrawal by Subject|3|||
170642009|NCT01282463|616703371|FG000|Overall Study|"Never Treated Death"|0|||
170642010|NCT01282463|616703372|FG001|Overall Study|"Never Treated Death"|1|||
170642011|NCT01282463|616703373|FG002|Overall Study|"Never Treated Death"|0|||
170642012|NCT01282463|616703371|FG000|Overall Study|"Never Treated PD"|0|||
170642013|NCT01282463|616703372|FG001|Overall Study|"Never Treated PD"|1|||
170642014|NCT01282463|616703373|FG002|Overall Study|"Never Treated PD"|0|||
170642015|NCT01282463|616703371|FG000|Overall Study|Protocol Violation|0|||
170642016|NCT01282463|616703372|FG001|Overall Study|Protocol Violation|0|||
170900688|NCT03952559|617640192|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
170900689|NCT03952559|617640193|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
170642017|NCT01282463|616703373|FG002|Overall Study|Protocol Violation|1|||
170642018|NCT01282463|616703371|FG000|Overall Study|Physician Decision|1|||
170642019|NCT01282463|616703372|FG001|Overall Study|Physician Decision|0|||
170900690|NCT03952559|617640194|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
170900691|NCT03952559|617640190|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
170900692|NCT03952559|617640191|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
170497055|NCT00556933|616159059|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
170642020|NCT01282463|616703373|FG002|Overall Study|Physician Decision|0|||
170642021|NCT02123251|616703374|FG000|Overall Study|Death|1|||
170642022|NCT02123251|616703375|FG001|Overall Study|Death|1|||
170900693|NCT03952559|617640192|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
170900694|NCT03952559|617640193|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
170900695|NCT03952559|617640194|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
170900696|NCT03952559|617640190|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
170900697|NCT03952559|617640191|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
170642023|NCT02123251|616703374|FG000|Overall Study|Withdrawal by Subject|0|||
170802133|NCT03451422|617286401|FG003|Overall Study|Withdrawal by Subject|3|||
170802134|NCT03451422|617286402|FG004|Overall Study|Withdrawal by Subject|2|||
170802135|NCT03451422|617286403|FG005|Overall Study|Withdrawal by Subject|1|||
170802136|NCT02347332|617286406|FG000|Overall Study|Not treated|5|||
170802137|NCT02347332|617286407|FG001|Overall Study|Not treated|2|||
170802138|NCT02347332|617286406|FG000|Overall Study|Progressive disease|141|||
170802139|NCT02347332|617286407|FG001|Overall Study|Progressive disease|159|||
170802140|NCT02347332|617286406|FG000|Overall Study|Adverse Event|50|||
170802141|NCT02347332|617286407|FG001|Overall Study|Adverse Event|41|||
170802142|NCT02347332|617286406|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
170802143|NCT02347332|617286407|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
170802144|NCT02347332|617286406|FG000|Overall Study|Protocol Violation|1|||
170802145|NCT02347332|617286407|FG001|Overall Study|Protocol Violation|1|||
170802146|NCT02347332|617286406|FG000|Overall Study|Lost to Follow-up|2|||
170802147|NCT02347332|617286407|FG001|Overall Study|Lost to Follow-up|1|||
170802148|NCT02347332|617286406|FG000|Overall Study|Physician Decision|4|||
170802149|NCT02347332|617286407|FG001|Overall Study|Physician Decision|3|||
170802150|NCT02347332|617286406|FG000|Overall Study|Withdrawal by Subject|20|||
170802151|NCT02347332|617286407|FG001|Overall Study|Withdrawal by Subject|14|||
170802152|NCT02347332|617286406|FG000|Overall Study|Protocol requirement|1|||
170802153|NCT02347332|617286407|FG001|Overall Study|Protocol requirement|1|||
170802154|NCT02347332|617286406|FG000|Overall Study|Switch Post-Trial program|0|||
170802155|NCT02347332|617286407|FG001|Overall Study|Switch Post-Trial program|1|||
170802156|NCT01313884|617286409|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
170802157|NCT01970007|617286410|FG000|Overall Study|Death|5|||
170802158|NCT01970007|617286410|FG000|Overall Study|Withdrawal by Subject|23|||
170802159|NCT01970007|617286410|FG000|Overall Study|Lost to Follow-up|24|||
170802160|NCT01970007|617286410|FG000|Overall Study|"Other endpoint"|3|||
170802161|NCT04384172|617286416|FG000|Overall Study|Lost to Follow-up|0|||
170802162|NCT04384172|617286417|FG001|Overall Study|Lost to Follow-up|2|||
170802163|NCT04384172|617286416|FG000|Overall Study|Pregnancy|1|||
170802164|NCT04384172|617286417|FG001|Overall Study|Pregnancy|0|||
170802165|NCT04384172|617286416|FG000|Overall Study|Withdrawal by Subject|0|||
170802166|NCT04384172|617286417|FG001|Overall Study|Withdrawal by Subject|1|||
170802167|NCT00754065|617286418|FG000|Overall Study|Never received treatment|12|||
170802168|NCT00754065|617286419|FG001|Overall Study|Never received treatment|2|||
170802169|NCT00754065|617286418|FG000|Overall Study|Adverse Event|19|||
170802170|NCT00754065|617286419|FG001|Overall Study|Adverse Event|25|||
170802171|NCT00754065|617286418|FG000|Overall Study|Lost to Follow-up|7|||
170802172|NCT00754065|617286419|FG001|Overall Study|Lost to Follow-up|11|||
170802173|NCT00754065|617286418|FG000|Overall Study|Protocol Violation|12|||
170802174|NCT00754065|617286419|FG001|Overall Study|Protocol Violation|10|||
170802175|NCT00754065|617286418|FG000|Overall Study|Withdrawal by Subject|4|||
170802176|NCT00754065|617286419|FG001|Overall Study|Withdrawal by Subject|5|||
170802177|NCT00754065|617286418|FG000|Overall Study|Pregnancy|6|||
170802178|NCT00754065|617286419|FG001|Overall Study|Pregnancy|0|||
170802179|NCT00754065|617286418|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
170802180|NCT00754065|617286419|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
170802181|NCT04250194|617286422|FG000|Overall Study|Declined to schedule biopsy|6|||
170802182|NCT04250194|617286423|FG001|Overall Study|Declined to schedule biopsy|10|||
170802183|NCT04250194|617286422|FG000|Overall Study|Medically Unfit for Biopsy|2|||
170802184|NCT04250194|617286423|FG001|Overall Study|Medically Unfit for Biopsy|1|||
170802185|NCT04250194|617286422|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
170802186|NCT04250194|617286423|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
170802187|NCT04250194|617286422|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
170802188|NCT04250194|617286423|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
170802189|NCT04250194|617286422|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
170802190|NCT04250194|617286423|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
170802191|NCT01342367|617286426|FG000|Overall Study|Death|1|||
170802192|NCT01342367|617286427|FG001|Overall Study|Death|0|||
170802193|NCT01342367|617286426|FG000|Overall Study|Withdrawal by Subject|1|||
170802194|NCT01342367|617286427|FG001|Overall Study|Withdrawal by Subject|2|||
170802195|NCT00640159|617286431|FG000|Overall Study|Lost to Follow-up|2|||
170802196|NCT01952366|617286432|FG000|Overall Study|Death|22|||
170802197|NCT01952366|617286432|FG000|Overall Study|Withdrawal by Subject|9|||
170802198|NCT04860505|617286433|FG000|Overall Study|Lost to Follow-up|2|||
170802199|NCT00857766|617286434|FG000|Overall Study|Adverse Event|13|||
170802200|NCT00857766|617286435|FG001|Overall Study|Adverse Event|12|||
170802201|NCT00857766|617286434|FG000|Overall Study|Protocol Violation|11|||
170802202|NCT00857766|617286435|FG001|Overall Study|Protocol Violation|11|||
170802203|NCT00857766|617286434|FG000|Overall Study|Lost to Follow-up|1|||
170802204|NCT00857766|617286435|FG001|Overall Study|Lost to Follow-up|0|||
170802205|NCT00857766|617286434|FG000|Overall Study|Investigator Discretion|2|||
170802206|NCT00857766|617286435|FG001|Overall Study|Investigator Discretion|3|||
170802207|NCT00857766|617286434|FG000|Overall Study|Participant Withdrew Consent|4|||
170642024|NCT02123251|616703375|FG001|Overall Study|Withdrawal by Subject|3|||
170642025|NCT02123251|616703374|FG000|Overall Study|Lost Medicaid eligibility|29|||
170642026|NCT02123251|616703375|FG001|Overall Study|Lost Medicaid eligibility|22|||
170642027|NCT02123251|616703374|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
170642028|NCT02123251|616703375|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
170642029|NCT00490529|616703380|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
170642030|NCT00490529|616703380|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
170642031|NCT00490529|616703380|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
170642032|NCT00490529|616703380|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
170642033|NCT00490529|616703380|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
170642034|NCT00490529|616703380|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
170642035|NCT03254459|616703381|FG000|Overall Study|Adverse Event|7|||
170642036|NCT03254459|616703382|FG001|Overall Study|Adverse Event|20|||
170642037|NCT03254459|616703381|FG000|Overall Study|Withdrawal by Subject Consent|3|||
170642038|NCT03254459|616703382|FG001|Overall Study|Withdrawal by Subject Consent|1|||
170642039|NCT03254459|616703381|FG000|Overall Study|Lost to Follow-up|0|||
170642040|NCT03254459|616703382|FG001|Overall Study|Lost to Follow-up|1|||
170642041|NCT03254459|616703381|FG000|Overall Study|Miscellaneous|0|||
170642042|NCT03254459|616703382|FG001|Overall Study|Miscellaneous|1|||
170642043|NCT00669409|616703389|FG000|Part 2|Withdrawal by Subject|0|||
170642044|NCT00669409|616703390|FG001|Part 2|Withdrawal by Subject|0|||
170642045|NCT00669409|616703391|FG002|Part 2|Withdrawal by Subject|0|||
170642046|NCT00669409|616703392|FG003|Part 2|Withdrawal by Subject|0|||
170642047|NCT00669409|616703393|FG004|Part 2|Withdrawal by Subject|0|||
170642048|NCT00669409|616703394|FG005|Part 2|Withdrawal by Subject|0|||
170642049|NCT00669409|616703395|FG006|Part 2|Withdrawal by Subject|0|||
170642050|NCT00669409|616703396|FG007|Part 2|Withdrawal by Subject|0|||
170642051|NCT00669409|616703397|FG008|Part 2|Withdrawal by Subject|0|||
170642052|NCT00669409|616703398|FG009|Part 2|Withdrawal by Subject|1|||
170642053|NCT00669409|616703399|FG010|Part 2|Withdrawal by Subject|0|||
170642054|NCT02891070|616703402|FG000|Overall Study|Adverse Event|1|||
170642055|NCT02891070|616703403|FG001|Overall Study|Adverse Event|0|||
170642056|NCT02891070|616703402|FG000|Overall Study|Physician Decision|0|||
170642057|NCT02891070|616703403|FG001|Overall Study|Physician Decision|1|||
170642058|NCT02891070|616703402|FG000|Overall Study|Lost to Follow-up|4|||
170642059|NCT02891070|616703403|FG001|Overall Study|Lost to Follow-up|4|||
170642060|NCT02891070|616703402|FG000|Overall Study|Other|1|||
170642061|NCT02891070|616703403|FG001|Overall Study|Other|0|||
170642062|NCT02891070|616703402|FG000|Overall Study|Protocol Violation|0|||
170642063|NCT02891070|616703403|FG001|Overall Study|Protocol Violation|1|||
170642064|NCT02891070|616703402|FG000|Overall Study|Withdrawal by Subject|1|||
170642065|NCT02891070|616703403|FG001|Overall Study|Withdrawal by Subject|2|||
170642066|NCT02891070|616703402|FG000|Overall Study|Death|3|||
170642067|NCT02891070|616703403|FG001|Overall Study|Death|0|||
170642068|NCT00870103|616703407|FG000|Overall Study|Physician Decision|2|||
170642069|NCT00870103|616703407|FG000|Overall Study|Lost to Follow-up|2|||
170642070|NCT03255629|616703408|FG000|Overall Study|Adverse Event|1|||
170642071|NCT03255629|616703409|FG001|Overall Study|Adverse Event|0|||
170642072|NCT03255629|616703408|FG000|Overall Study|did not experience hypoglycemia|2|||
170642073|NCT03255629|616703409|FG001|Overall Study|did not experience hypoglycemia|1|||
170642074|NCT04540198|616703410|FG000|Overall Study|Lost to Follow-up|25|||
170900698|NCT03952559|617640192|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
170900699|NCT03952559|617640193|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
170900700|NCT03952559|617640194|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
170900701|NCT01291017|617640201|FG000|Overall Study|Lost to Follow-up|2|||
170900702|NCT01291017|617640201|FG000|Overall Study|Withdrawal by Subject|3|||
170900703|NCT02848833|617640208|FG000|Overall Study|subject who are duplicated|1|||
170900704|NCT02848833|617640208|FG000|Overall Study|have not taken the study drug|11|||
170900705|NCT02848833|617640208|FG000|Overall Study|follow-up failure|6|||
170900706|NCT02848833|617640208|FG000|Overall Study|Protocol Violation|119|||
170900707|NCT04980391|617640209|FG000|Overall Study|Death|0|||
170642075|NCT04540198|616703411|FG001|Overall Study|Lost to Follow-up|23|||
170900708|NCT04980391|617640210|FG001|Overall Study|Death|0|||
170900709|NCT04980391|617640211|FG002|Overall Study|Death|1|||
170642076|NCT04540198|616703410|FG000|Overall Study|Withdrawal by Subject|15|||
170642077|NCT04540198|616703411|FG001|Overall Study|Withdrawal by Subject|9|||
170642078|NCT04540198|616703410|FG000|Overall Study|Discontinued|1|||
170642079|NCT04540198|616703411|FG001|Overall Study|Discontinued|0|||
170642080|NCT02779556|616703412|FG000|Baseline|Partial baseline interview completed|1|||
170642081|NCT02779556|616703413|FG001|Baseline|Partial baseline interview completed|0|||
170642082|NCT02779556|616703412|FG000|3 Months|Lost to Follow-up|40|||
170642083|NCT02779556|616703413|FG001|3 Months|Lost to Follow-up|29|||
170642084|NCT02779556|616703412|FG000|3 Months|Missed 3 month clinic visit|27|||
170900710|NCT04980391|617640212|FG003|Overall Study|Death|1|||
170900711|NCT04980391|617640209|FG000|Overall Study|Lost to Follow-up|3|||
170900712|NCT04980391|617640210|FG001|Overall Study|Lost to Follow-up|3|||
170900713|NCT04980391|617640211|FG002|Overall Study|Lost to Follow-up|2|||
170900714|NCT04980391|617640212|FG003|Overall Study|Lost to Follow-up|3|||
170900715|NCT04980391|617640209|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
170900716|NCT04980391|617640210|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
170900717|NCT04980391|617640211|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
170900718|NCT04980391|617640212|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
170900719|NCT04980391|617640209|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170900720|NCT04980391|617640210|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170900721|NCT04980391|617640211|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
170900722|NCT04980391|617640212|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170900723|NCT04980391|617640209|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
170900724|NCT04980391|617640210|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
170900725|NCT04980391|617640211|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
170900726|NCT04980391|617640212|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
170900727|NCT03690869|617640213|FG000|Overall Study|Adverse Event|0|||
170900728|NCT03690869|617640214|FG001|Overall Study|Adverse Event|0|||
170900729|NCT03690869|617640215|FG002|Overall Study|Adverse Event|0|||
170900730|NCT03690869|617640216|FG003|Overall Study|Adverse Event|1|||
170900731|NCT03690869|617640217|FG004|Overall Study|Adverse Event|0|||
170900732|NCT03690869|617640218|FG005|Overall Study|Adverse Event|0|||
170900733|NCT03690869|617640219|FG006|Overall Study|Adverse Event|0|||
170900734|NCT03690869|617640220|FG007|Overall Study|Adverse Event|1|||
170900735|NCT03690869|617640221|FG008|Overall Study|Adverse Event|0|||
170900736|NCT03690869|617640222|FG009|Overall Study|Adverse Event|1|||
170900737|NCT03690869|617640213|FG000|Overall Study|Death|1|||
170900738|NCT03690869|617640214|FG001|Overall Study|Death|1|||
170900739|NCT03690869|617640215|FG002|Overall Study|Death|1|||
170900740|NCT03690869|617640216|FG003|Overall Study|Death|4|||
170900741|NCT03690869|617640217|FG004|Overall Study|Death|2|||
170900742|NCT03690869|617640218|FG005|Overall Study|Death|5|||
170900743|NCT03690869|617640219|FG006|Overall Study|Death|3|||
170900744|NCT03690869|617640220|FG007|Overall Study|Death|2|||
170900745|NCT03690869|617640221|FG008|Overall Study|Death|0|||
170900746|NCT03690869|617640222|FG009|Overall Study|Death|3|||
170900747|NCT03690869|617640213|FG000|Overall Study|Lost to Follow-up|0|||
170900748|NCT03690869|617640214|FG001|Overall Study|Lost to Follow-up|0|||
170900749|NCT03690869|617640215|FG002|Overall Study|Lost to Follow-up|1|||
170900750|NCT03690869|617640216|FG003|Overall Study|Lost to Follow-up|0|||
170900751|NCT03690869|617640217|FG004|Overall Study|Lost to Follow-up|0|||
170900752|NCT03690869|617640218|FG005|Overall Study|Lost to Follow-up|0|||
170900753|NCT03690869|617640219|FG006|Overall Study|Lost to Follow-up|0|||
170497056|NCT00556933|616159060|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
170497057|NCT00556933|616159061|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
170497058|NCT00556933|616159062|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
170497059|NCT00556933|616159059|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
170497060|NCT00556933|616159060|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
170497061|NCT00556933|616159061|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
170497062|NCT00556933|616159062|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
170497063|NCT00556933|616159059|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
170497064|NCT00556933|616159060|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
170497065|NCT00556933|616159061|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
170497066|NCT00556933|616159062|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
170497067|NCT00556933|616159059|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
170497068|NCT00556933|616159060|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
170497069|NCT00556933|616159061|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
170497070|NCT00556933|616159062|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
170497071|NCT00556933|616159059|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
170497072|NCT00556933|616159060|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
170497073|NCT00556933|616159061|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
170497074|NCT00556933|616159062|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
170497075|NCT00556933|616159059|FG000|CNI Withdrawal vs. Minimization|Death|0|||
170497076|NCT00556933|616159060|FG001|CNI Withdrawal vs. Minimization|Death|0|||
170497077|NCT00556933|616159061|FG002|CNI Withdrawal vs. Minimization|Death|0|||
170497078|NCT00556933|616159062|FG003|CNI Withdrawal vs. Minimization|Death|1|||
170497079|NCT03887442|616159063|FG000|Overall Study|Adverse Event|1|||
170497080|NCT03887442|616159064|FG001|Overall Study|Adverse Event|0|||
170497081|NCT01827267|616159068|FG000|Overall Study|Did not receive study drug|1|||
170497082|NCT01827267|616159069|FG001|Overall Study|Did not receive study drug|1|||
170497083|NCT01827267|616159068|FG000|Overall Study|Physician Decision|1|||
170642085|NCT02779556|616703413|FG001|3 Months|Missed 3 month clinic visit|19|||
170900754|NCT03690869|617640220|FG007|Overall Study|Lost to Follow-up|0|||
170900755|NCT03690869|617640221|FG008|Overall Study|Lost to Follow-up|0|||
170900756|NCT03690869|617640222|FG009|Overall Study|Lost to Follow-up|0|||
170900757|NCT03690869|617640213|FG000|Overall Study|Other Treatment|1|||
170900758|NCT03690869|617640214|FG001|Overall Study|Other Treatment|1|||
170900759|NCT03690869|617640215|FG002|Overall Study|Other Treatment|1|||
170900760|NCT03690869|617640216|FG003|Overall Study|Other Treatment|2|||
170900761|NCT03690869|617640217|FG004|Overall Study|Other Treatment|3|||
170900762|NCT03690869|617640218|FG005|Overall Study|Other Treatment|1|||
170900763|NCT03690869|617640219|FG006|Overall Study|Other Treatment|2|||
170900764|NCT03690869|617640220|FG007|Overall Study|Other Treatment|7|||
170900765|NCT03690869|617640221|FG008|Overall Study|Other Treatment|0|||
170900766|NCT03690869|617640222|FG009|Overall Study|Other Treatment|3|||
170900767|NCT03690869|617640213|FG000|Overall Study|Physician Decision|0|||
170900768|NCT03690869|617640214|FG001|Overall Study|Physician Decision|1|||
170900769|NCT03690869|617640215|FG002|Overall Study|Physician Decision|0|||
170900770|NCT03690869|617640216|FG003|Overall Study|Physician Decision|0|||
170900771|NCT03690869|617640217|FG004|Overall Study|Physician Decision|0|||
170900772|NCT03690869|617640218|FG005|Overall Study|Physician Decision|0|||
170900773|NCT03690869|617640219|FG006|Overall Study|Physician Decision|0|||
170900774|NCT03690869|617640220|FG007|Overall Study|Physician Decision|0|||
170900775|NCT03690869|617640221|FG008|Overall Study|Physician Decision|0|||
170900776|NCT03690869|617640222|FG009|Overall Study|Physician Decision|0|||
170900777|NCT03690869|617640213|FG000|Overall Study|Progressive Disease|1|||
170900778|NCT03690869|617640214|FG001|Overall Study|Progressive Disease|2|||
170900779|NCT03690869|617640215|FG002|Overall Study|Progressive Disease|0|||
170900780|NCT03690869|617640216|FG003|Overall Study|Progressive Disease|1|||
170900781|NCT03690869|617640217|FG004|Overall Study|Progressive Disease|0|||
170900782|NCT03690869|617640218|FG005|Overall Study|Progressive Disease|0|||
170900783|NCT03690869|617640219|FG006|Overall Study|Progressive Disease|0|||
170900784|NCT03690869|617640220|FG007|Overall Study|Progressive Disease|0|||
170900785|NCT03690869|617640221|FG008|Overall Study|Progressive Disease|1|||
170900786|NCT03690869|617640222|FG009|Overall Study|Progressive Disease|1|||
170900787|NCT03690869|617640213|FG000|Overall Study|Subject Decision|0|||
170900788|NCT03690869|617640214|FG001|Overall Study|Subject Decision|0|||
170900789|NCT03690869|617640215|FG002|Overall Study|Subject Decision|0|||
170900790|NCT03690869|617640216|FG003|Overall Study|Subject Decision|1|||
170900791|NCT03690869|617640217|FG004|Overall Study|Subject Decision|0|||
170900792|NCT03690869|617640218|FG005|Overall Study|Subject Decision|0|||
170900793|NCT03690869|617640219|FG006|Overall Study|Subject Decision|0|||
170900794|NCT03690869|617640220|FG007|Overall Study|Subject Decision|1|||
170900795|NCT03690869|617640221|FG008|Overall Study|Subject Decision|0|||
170900796|NCT03690869|617640222|FG009|Overall Study|Subject Decision|0|||
170900797|NCT00506389|617642091|FG000|In-treatment Period|Other|3|||
170900798|NCT00506389|617642092|FG001|In-treatment Period|Other|3|||
170900799|NCT00506389|617642093|FG002|In-treatment Period|Other|4|||
170900800|NCT00506389|617642091|FG000|In-treatment Period|Lost to Follow-up|0|||
170900801|NCT00506389|617642092|FG001|In-treatment Period|Lost to Follow-up|0|||
170900802|NCT00506389|617642093|FG002|In-treatment Period|Lost to Follow-up|1|||
170900803|NCT00506389|617642091|FG000|In-treatment Period|Lack of compliance|1|||
170900804|NCT00506389|617642092|FG001|In-treatment Period|Lack of compliance|0|||
170900805|NCT00506389|617642093|FG002|In-treatment Period|Lack of compliance|0|||
170900806|NCT00506389|617642091|FG000|In-treatment Period|Reasons not related to trial|4|||
170900807|NCT00506389|617642092|FG001|In-treatment Period|Reasons not related to trial|1|||
170900808|NCT00506389|617642093|FG002|In-treatment Period|Reasons not related to trial|0|||
170900809|NCT00506389|617642091|FG000|In-treatment Period|Withdrawal by Subject|3|||
170900810|NCT00506389|617642092|FG001|In-treatment Period|Withdrawal by Subject|3|||
170900811|NCT00506389|617642093|FG002|In-treatment Period|Withdrawal by Subject|4|||
170900812|NCT00506389|617642091|FG000|In-treatment Period|Lack of Efficacy|0|||
170900813|NCT00506389|617642092|FG001|In-treatment Period|Lack of Efficacy|2|||
170900814|NCT00506389|617642093|FG002|In-treatment Period|Lack of Efficacy|0|||
170900815|NCT00506389|617642091|FG000|In-treatment Period|Adverse Event|11|||
170900816|NCT00506389|617642092|FG001|In-treatment Period|Adverse Event|5|||
170900817|NCT00506389|617642093|FG002|In-treatment Period|Adverse Event|2|||
170900818|NCT00506389|617642091|FG000|In-treatment Period|Randomized but not treated|4|||
170900819|NCT00506389|617642092|FG001|In-treatment Period|Randomized but not treated|1|||
170900820|NCT00506389|617642093|FG002|In-treatment Period|Randomized but not treated|1|||
170551201|NCT01251965|616364677|FG002|Overall Study|Participant/physician decision|0|||
170551202|NCT01251965|616364675|FG000|Overall Study|Death|0|||
170551203|NCT01251965|616364676|FG001|Overall Study|Death|0|||
170551204|NCT01251965|616364677|FG002|Overall Study|Death|11|||
170551205|NCT03681093|616364678|FG000|Overall Study|Subject decision|0|||
170551206|NCT03681093|616364679|FG001|Overall Study|Subject decision|2|||
170551207|NCT03681093|616364680|FG002|Overall Study|Subject decision|1|||
170551208|NCT01897896|616364681|FG000|Overall Study|Death|1|||
170900821|NCT00775021|617642103|FG000|First Intervention|Lost to Follow-up|1|||
170900822|NCT00775021|617642104|FG001|First Intervention|Lost to Follow-up|0|||
170900823|NCT00775021|617642103|FG000|Second Intervention|Adverse Event|0|||
170900824|NCT00775021|617642104|FG001|Second Intervention|Adverse Event|1|||
170900825|NCT00363415|617642105|FG000|Overall Study|Progressive Disease|196|||
170900826|NCT00363415|617642106|FG001|Overall Study|Progressive Disease|107|||
170900827|NCT00363415|617642105|FG000|Overall Study|Sponsor Decision|67|||
170900828|NCT00363415|617642106|FG001|Overall Study|Sponsor Decision|31|||
170900829|NCT00363415|617642105|FG000|Overall Study|Death|32|||
170900830|NCT00363415|617642106|FG001|Overall Study|Death|29|||
170900831|NCT00363415|617642105|FG000|Overall Study|Adverse Event|24|||
170900832|NCT00363415|617642106|FG001|Overall Study|Adverse Event|15|||
170900833|NCT00363415|617642105|FG000|Overall Study|Physician Decision|18|||
170900834|NCT00363415|617642106|FG001|Overall Study|Physician Decision|35|||
170900835|NCT00363415|617642105|FG000|Overall Study|Entry Criteria Not Met|11|||
170900836|NCT00363415|617642106|FG001|Overall Study|Entry Criteria Not Met|10|||
170900837|NCT00363415|617642105|FG000|Overall Study|Withdrawal by Subject|9|||
170900838|NCT00363415|617642106|FG001|Overall Study|Withdrawal by Subject|15|||
170900839|NCT00363415|617642105|FG000|Overall Study|Lost to Follow-up|3|||
170900840|NCT00363415|617642106|FG001|Overall Study|Lost to Follow-up|3|||
170900841|NCT00363415|617642105|FG000|Overall Study|Protocol Violation|1|||
170900842|NCT00363415|617642106|FG001|Overall Study|Protocol Violation|4|||
170900843|NCT04439266|617642117|FG000|Overall Study|Ineligible|1|||
170900844|NCT04439266|617642117|FG000|Overall Study|Adverse Event|1|||
170900845|NCT04439266|617642117|FG000|Overall Study|Death|1|||
170900846|NCT04439266|617642117|FG000|Overall Study|Disease progression|1|||
170900847|NCT04439266|617642117|FG000|Overall Study|Still on treatment|1|||
170900848|NCT00001337|617642118|FG000|Overall Study|Switched to alternate treatment|2|||
170900849|NCT00001337|617642119|FG001|Overall Study|Switched to alternate treatment|2|||
170900850|NCT00001337|617642120|FG002|Overall Study|Switched to alternate treatment|0|||
170900851|NCT00001337|617642118|FG000|Overall Study|Refused further treatment|2|||
170900852|NCT00001337|617642119|FG001|Overall Study|Refused further treatment|1|||
170900853|NCT00001337|617642120|FG002|Overall Study|Refused further treatment|0|||
170900854|NCT00001337|617642118|FG000|Overall Study|Began other Tx|1|||
170900855|NCT00001337|617642119|FG001|Overall Study|Began other Tx|0|||
170900856|NCT00001337|617642120|FG002|Overall Study|Began other Tx|0|||
170900857|NCT00001337|617642118|FG000|Overall Study|Physician Decision|3|||
170900858|NCT00001337|617642119|FG001|Overall Study|Physician Decision|1|||
170900859|NCT00001337|617642120|FG002|Overall Study|Physician Decision|0|||
170900860|NCT00001337|617642118|FG000|Overall Study|Doesn't have NHL|0|||
170900861|NCT00001337|617642119|FG001|Overall Study|Doesn't have NHL|1|||
170900862|NCT00001337|617642120|FG002|Overall Study|Doesn't have NHL|0|||
170900863|NCT00001337|617642118|FG000|Overall Study|Non protocol tx needed|3|||
170900864|NCT00001337|617642119|FG001|Overall Study|Non protocol tx needed|1|||
170900865|NCT00001337|617642120|FG002|Overall Study|Non protocol tx needed|0|||
170900866|NCT00001337|617642118|FG000|Overall Study|Protocol change|1|||
170900867|NCT00001337|617642119|FG001|Overall Study|Protocol change|0|||
170900868|NCT00001337|617642120|FG002|Overall Study|Protocol change|0|||
170900869|NCT00001337|617642118|FG000|Overall Study|2nd primary disease|0|||
170900870|NCT00001337|617642119|FG001|Overall Study|2nd primary disease|0|||
170900871|NCT00001337|617642120|FG002|Overall Study|2nd primary disease|1|||
170900872|NCT00001337|617642118|FG000|Overall Study|Death during follow up period|9|||
170900873|NCT00001337|617642119|FG001|Overall Study|Death during follow up period|4|||
170900874|NCT00001337|617642120|FG002|Overall Study|Death during follow up period|0|||
170900875|NCT00001337|617642118|FG000|Overall Study|Death on study|19|||
170900876|NCT00001337|617642119|FG001|Overall Study|Death on study|9|||
170900877|NCT00001337|617642120|FG002|Overall Study|Death on study|0|||
170900878|NCT00001337|617642118|FG000|Overall Study|Disease progression during follow-up period|3|||
170900879|NCT00001337|617642119|FG001|Overall Study|Disease progression during follow-up period|1|||
170900880|NCT00001337|617642120|FG002|Overall Study|Disease progression during follow-up period|0|||
170900881|NCT00001337|617642118|FG000|Overall Study|Disease progression on study|33|||
170900882|NCT00001337|617642119|FG001|Overall Study|Disease progression on study|41|||
170900883|NCT00001337|617642120|FG002|Overall Study|Disease progression on study|0|||
170900884|NCT00001337|617642118|FG000|Overall Study|Lost to further follow-up|10|||
170900885|NCT00001337|617642119|FG001|Overall Study|Lost to further follow-up|6|||
170900886|NCT00001337|617642120|FG002|Overall Study|Lost to further follow-up|0|||
170900887|NCT00001337|617642118|FG000|Overall Study|2nd malignancy|1|||
170900888|NCT00001337|617642119|FG001|Overall Study|2nd malignancy|0|||
170900889|NCT00001337|617642120|FG002|Overall Study|2nd malignancy|0|||
170900890|NCT00001337|617642118|FG000|Overall Study|Treatment for second lymphoma|0|||
170900891|NCT00001337|617642119|FG001|Overall Study|Treatment for second lymphoma|1|||
170900892|NCT00001337|617642120|FG002|Overall Study|Treatment for second lymphoma|0|||
170900893|NCT00001337|617642118|FG000|Overall Study|Transfer to transplant|0|||
170900894|NCT00001337|617642119|FG001|Overall Study|Transfer to transplant|1|||
170900895|NCT00001337|617642120|FG002|Overall Study|Transfer to transplant|0|||
170900896|NCT06161012|617642121|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
170900897|NCT06161012|617642122|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
170900898|NCT00408005|617642127|FG000|Induction|Adverse Event|19|||
170900899|NCT00408005|617642128|FG001|Induction|Adverse Event|3|||
170900900|NCT00408005|617642129|FG002|Induction|Adverse Event|0|||
170900901|NCT00408005|617642130|FG003|Induction|Adverse Event|0|||
170900902|NCT00408005|617642131|FG004|Induction|Adverse Event|0|||
170900903|NCT00408005|617642132|FG005|Induction|Adverse Event|0|||
170900904|NCT00408005|617642133|FG006|Induction|Adverse Event|0|||
170900905|NCT00408005|617642134|FG007|Induction|Adverse Event|0|||
170900906|NCT00408005|617642127|FG000|Induction|Death|6|||
170900907|NCT00408005|617642128|FG001|Induction|Death|0|||
170900908|NCT00408005|617642129|FG002|Induction|Death|0|||
170900909|NCT00408005|617642130|FG003|Induction|Death|0|||
170900910|NCT00408005|617642131|FG004|Induction|Death|0|||
170900911|NCT00408005|617642132|FG005|Induction|Death|0|||
170900912|NCT00408005|617642133|FG006|Induction|Death|0|||
170900913|NCT00408005|617642134|FG007|Induction|Death|0|||
170900914|NCT00408005|617642127|FG000|Induction|Physician Decision|83|||
170900915|NCT00408005|617642128|FG001|Induction|Physician Decision|9|||
170900916|NCT00408005|617642129|FG002|Induction|Physician Decision|0|||
170900917|NCT00408005|617642130|FG003|Induction|Physician Decision|0|||
170900918|NCT00408005|617642131|FG004|Induction|Physician Decision|0|||
170900919|NCT00408005|617642132|FG005|Induction|Physician Decision|0|||
170900920|NCT00408005|617642133|FG006|Induction|Physician Decision|0|||
170900921|NCT00408005|617642134|FG007|Induction|Physician Decision|0|||
170900922|NCT00408005|617642127|FG000|Induction|Withdrawal by Subject|2|||
170900923|NCT00408005|617642128|FG001|Induction|Withdrawal by Subject|4|||
170900924|NCT00408005|617642129|FG002|Induction|Withdrawal by Subject|0|||
170900925|NCT00408005|617642130|FG003|Induction|Withdrawal by Subject|0|||
170900926|NCT00408005|617642131|FG004|Induction|Withdrawal by Subject|0|||
170900927|NCT00408005|617642132|FG005|Induction|Withdrawal by Subject|0|||
170900928|NCT00408005|617642133|FG006|Induction|Withdrawal by Subject|0|||
170900929|NCT00408005|617642134|FG007|Induction|Withdrawal by Subject|0|||
170900930|NCT00408005|617642127|FG000|Induction|Ineligible|33|||
170900931|NCT00408005|617642128|FG001|Induction|Ineligible|14|||
170900932|NCT00408005|617642129|FG002|Induction|Ineligible|0|||
170900933|NCT00408005|617642130|FG003|Induction|Ineligible|0|||
170900934|NCT00408005|617642131|FG004|Induction|Ineligible|0|||
170900935|NCT00408005|617642132|FG005|Induction|Ineligible|0|||
170900936|NCT00408005|617642133|FG006|Induction|Ineligible|0|||
170900937|NCT00408005|617642134|FG007|Induction|Ineligible|0|||
170900938|NCT00408005|617642127|FG000|Induction|Refusal of Further Protocol Therapy|225|||
170900939|NCT00408005|617642128|FG001|Induction|Refusal of Further Protocol Therapy|44|||
170900940|NCT00408005|617642129|FG002|Induction|Refusal of Further Protocol Therapy|0|||
170900941|NCT00408005|617642130|FG003|Induction|Refusal of Further Protocol Therapy|0|||
170900942|NCT00408005|617642131|FG004|Induction|Refusal of Further Protocol Therapy|0|||
170900943|NCT00408005|617642132|FG005|Induction|Refusal of Further Protocol Therapy|0|||
170900944|NCT00408005|617642133|FG006|Induction|Refusal of Further Protocol Therapy|0|||
170900945|NCT00408005|617642134|FG007|Induction|Refusal of Further Protocol Therapy|0|||
170900946|NCT00408005|617642127|FG000|Induction|Entered another COG therapeutic protocol|4|||
170900947|NCT00408005|617642128|FG001|Induction|Entered another COG therapeutic protocol|0|||
170900948|NCT00408005|617642129|FG002|Induction|Entered another COG therapeutic protocol|0|||
170900949|NCT00408005|617642130|FG003|Induction|Entered another COG therapeutic protocol|0|||
170900950|NCT00408005|617642131|FG004|Induction|Entered another COG therapeutic protocol|0|||
170900951|NCT00408005|617642132|FG005|Induction|Entered another COG therapeutic protocol|0|||
170900952|NCT00408005|617642133|FG006|Induction|Entered another COG therapeutic protocol|0|||
170900953|NCT00408005|617642134|FG007|Induction|Entered another COG therapeutic protocol|0|||
170900954|NCT00408005|617642127|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
170900955|NCT00408005|617642128|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
170900956|NCT00408005|617642129|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
170900957|NCT00408005|617642130|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
170900958|NCT00408005|617642131|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
170900959|NCT00408005|617642132|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
170900960|NCT00408005|617642133|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
170551209|NCT01897896|616364682|FG001|Overall Study|Death|0|||
170551210|NCT01897896|616364681|FG000|Overall Study|Adverse Event|11|||
170551211|NCT01897896|616364682|FG001|Overall Study|Adverse Event|1|||
170802208|NCT00857766|617286435|FG001|Overall Study|Participant Withdrew Consent|4|||
170802209|NCT01961609|617286436|FG000|Initiation|Missing|3|||
170802210|NCT01961609|617286437|FG001|Initiation|Missing|2|||
170802211|NCT01961609|617286438|FG002|Initiation|Missing|0|||
170802212|NCT01961609|617286439|FG003|Initiation|Missing|0|||
170802213|NCT01961609|617286436|FG000|Initiation|Protocol deviation|1|||
170802214|NCT01961609|617286437|FG001|Initiation|Protocol deviation|0|||
170802215|NCT01961609|617286438|FG002|Initiation|Protocol deviation|0|||
170802216|NCT01961609|617286439|FG003|Initiation|Protocol deviation|0|||
170900961|NCT00408005|617642134|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
170900962|NCT00408005|617642127|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
170900963|NCT00408005|617642128|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
170900964|NCT00408005|617642129|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
170900965|NCT00408005|617642130|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
170900966|NCT00408005|617642131|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
170900967|NCT00408005|617642132|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
170900968|NCT00408005|617642133|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
170802217|NCT01961609|617286436|FG000|Initiation|Death|0|||
170551212|NCT01897896|616364681|FG000|Overall Study|Lost to Follow-up|1|||
170802218|NCT01961609|617286437|FG001|Initiation|Death|1|||
170802219|NCT01961609|617286438|FG002|Initiation|Death|0|||
170802220|NCT01961609|617286439|FG003|Initiation|Death|0|||
170802221|NCT01961609|617286436|FG000|Initiation|Administrative problems|1|||
170802222|NCT01961609|617286437|FG001|Initiation|Administrative problems|0|||
170802223|NCT01961609|617286438|FG002|Initiation|Administrative problems|0|||
170802224|NCT01961609|617286439|FG003|Initiation|Administrative problems|0|||
170802225|NCT01961609|617286436|FG000|Initiation|Withdrawal by Subject|1|||
170802226|NCT01961609|617286437|FG001|Initiation|Withdrawal by Subject|2|||
170802227|NCT01961609|617286438|FG002|Initiation|Withdrawal by Subject|0|||
170802228|NCT01961609|617286439|FG003|Initiation|Withdrawal by Subject|0|||
170802229|NCT01961609|617286436|FG000|Initiation|Lack of Efficacy|2|||
170802230|NCT01961609|617286437|FG001|Initiation|Lack of Efficacy|1|||
170802231|NCT01961609|617286438|FG002|Initiation|Lack of Efficacy|0|||
170802232|NCT01961609|617286439|FG003|Initiation|Lack of Efficacy|0|||
170802233|NCT01961609|617286436|FG000|Initiation|Abnormal lab values|0|||
170802234|NCT01961609|617286437|FG001|Initiation|Abnormal lab values|1|||
170802235|NCT01961609|617286438|FG002|Initiation|Abnormal lab values|0|||
170802236|NCT01961609|617286439|FG003|Initiation|Abnormal lab values|0|||
170802237|NCT01961609|617286436|FG000|Initiation|Adverse Event|3|||
170802238|NCT01961609|617286437|FG001|Initiation|Adverse Event|5|||
170802239|NCT01961609|617286438|FG002|Initiation|Adverse Event|0|||
170802240|NCT01961609|617286439|FG003|Initiation|Adverse Event|0|||
170802241|NCT01961609|617286436|FG000|Initiation|Randomized but not treated|1|||
170802242|NCT01961609|617286437|FG001|Initiation|Randomized but not treated|1|||
170802243|NCT01961609|617286438|FG002|Initiation|Randomized but not treated|0|||
170802244|NCT01961609|617286439|FG003|Initiation|Randomized but not treated|0|||
170802245|NCT01961609|617286436|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
170802246|NCT01961609|617286437|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
170802247|NCT01961609|617286438|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
170802248|NCT01961609|617286439|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
170802249|NCT01961609|617286436|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
170802250|NCT01961609|617286437|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
170802251|NCT01961609|617286438|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
170802252|NCT01961609|617286439|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
170802253|NCT01961609|617286436|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
170802254|NCT01961609|617286437|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
170802255|NCT01961609|617286438|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
170802256|NCT01961609|617286439|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
170802257|NCT01961609|617286436|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
170802258|NCT01961609|617286437|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
170802259|NCT01961609|617286438|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
170802260|NCT01961609|617286439|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
170802261|NCT01961609|617286436|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
170802262|NCT01961609|617286437|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
170802263|NCT01961609|617286438|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
170802264|NCT01961609|617286439|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
170802265|NCT01961609|617286436|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
170802266|NCT01961609|617286437|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
170802267|NCT01961609|617286438|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
170802268|NCT01961609|617286439|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
170802269|NCT01961609|617286436|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
170802270|NCT01961609|617286437|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
170802271|NCT01961609|617286438|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
170802272|NCT01961609|617286439|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
170802273|NCT01961609|617286436|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
170802274|NCT01961609|617286437|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
170802275|NCT01961609|617286438|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
170802276|NCT01961609|617286439|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
170802277|NCT01961609|617286436|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
170802278|NCT01961609|617286437|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
170802279|NCT01961609|617286438|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
170802280|NCT01961609|617286439|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
170551213|NCT01897896|616364682|FG001|Overall Study|Lost to Follow-up|0|||
170551214|NCT01897896|616364681|FG000|Overall Study|Non-compliance with study drug dosing|1|||
170551215|NCT01897896|616364682|FG001|Overall Study|Non-compliance with study drug dosing|1|||
170551216|NCT01897896|616364681|FG000|Overall Study|Withdrawal by Subject|7|||
170551217|NCT01897896|616364682|FG001|Overall Study|Withdrawal by Subject|1|||
170551218|NCT01897896|616364681|FG000|Overall Study|Require drug that interfere with study|1|||
170551219|NCT01897896|616364682|FG001|Overall Study|Require drug that interfere with study|4|||
170551220|NCT01897896|616364681|FG000|Overall Study|Protocol Violation|1|||
170551221|NCT01897896|616364682|FG001|Overall Study|Protocol Violation|1|||
170642086|NCT02779556|616703412|FG000|6 Month|Lost to Follow-up|33|||
170900969|NCT00408005|617642134|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
170900970|NCT00408005|617642127|FG000|Induction|Progressive Disease|0|||
170900971|NCT00408005|617642128|FG001|Induction|Progressive Disease|1|||
170900972|NCT00408005|617642129|FG002|Induction|Progressive Disease|0|||
170900973|NCT00408005|617642130|FG003|Induction|Progressive Disease|0|||
170900974|NCT00408005|617642131|FG004|Induction|Progressive Disease|0|||
170900975|NCT00408005|617642132|FG005|Induction|Progressive Disease|0|||
170900976|NCT00408005|617642133|FG006|Induction|Progressive Disease|0|||
170900977|NCT00408005|617642134|FG007|Induction|Progressive Disease|0|||
170900978|NCT00408005|617642127|FG000|Induction|Inevaluable|18|||
170900979|NCT00408005|617642128|FG001|Induction|Inevaluable|14|||
170900980|NCT00408005|617642129|FG002|Induction|Inevaluable|0|||
170900981|NCT00408005|617642130|FG003|Induction|Inevaluable|0|||
170900982|NCT00408005|617642131|FG004|Induction|Inevaluable|0|||
170900983|NCT00408005|617642132|FG005|Induction|Inevaluable|0|||
170900984|NCT00408005|617642133|FG006|Induction|Inevaluable|0|||
170900985|NCT00408005|617642134|FG007|Induction|Inevaluable|0|||
170900986|NCT00408005|617642127|FG000|Induction|Failed to Complete Randomization|3|||
170900987|NCT00408005|617642128|FG001|Induction|Failed to Complete Randomization|2|||
170900988|NCT00408005|617642129|FG002|Induction|Failed to Complete Randomization|0|||
170900989|NCT00408005|617642130|FG003|Induction|Failed to Complete Randomization|0|||
170900990|NCT00408005|617642131|FG004|Induction|Failed to Complete Randomization|0|||
170900991|NCT00408005|617642132|FG005|Induction|Failed to Complete Randomization|0|||
170900992|NCT00408005|617642133|FG006|Induction|Failed to Complete Randomization|0|||
170900993|NCT00408005|617642134|FG007|Induction|Failed to Complete Randomization|0|||
170900994|NCT00408005|617642127|FG000|Induction|Protocol Deviation|3|||
170900995|NCT00408005|617642128|FG001|Induction|Protocol Deviation|1|||
170900996|NCT00408005|617642129|FG002|Induction|Protocol Deviation|0|||
170900997|NCT00408005|617642130|FG003|Induction|Protocol Deviation|0|||
170900998|NCT00408005|617642131|FG004|Induction|Protocol Deviation|0|||
170900999|NCT00408005|617642132|FG005|Induction|Protocol Deviation|0|||
170901000|NCT00408005|617642133|FG006|Induction|Protocol Deviation|0|||
170901001|NCT00408005|617642134|FG007|Induction|Protocol Deviation|0|||
170901002|NCT00408005|617642127|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
170901003|NCT00408005|617642128|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
170901004|NCT00408005|617642129|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
170901005|NCT00408005|617642130|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
170901006|NCT00408005|617642131|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
170901007|NCT00408005|617642132|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
170901008|NCT00408005|617642133|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
170901009|NCT00408005|617642134|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
170901010|NCT00408005|617642127|FG000|Induction|Recurrent leukemia|1|||
170901011|NCT00408005|617642128|FG001|Induction|Recurrent leukemia|0|||
170901012|NCT00408005|617642129|FG002|Induction|Recurrent leukemia|0|||
170901013|NCT00408005|617642130|FG003|Induction|Recurrent leukemia|0|||
170901014|NCT00408005|617642131|FG004|Induction|Recurrent leukemia|0|||
170901015|NCT00408005|617642132|FG005|Induction|Recurrent leukemia|0|||
170901016|NCT00408005|617642133|FG006|Induction|Recurrent leukemia|0|||
170901017|NCT00408005|617642134|FG007|Induction|Recurrent leukemia|0|||
170901018|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
170901019|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
170901020|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
170901021|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
170901022|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
170901023|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
170901024|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
170901025|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
170901026|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
170901027|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
170901028|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
170901029|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
170901030|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
170901031|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
170901032|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
170901033|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
170901034|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
170901035|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
170901036|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
170901037|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
170901038|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
170497084|NCT01827267|616159069|FG001|Overall Study|Physician Decision|0|||
170802281|NCT01961609|617286436|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
170802282|NCT01961609|617286437|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
170802283|NCT01961609|617286438|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
170802284|NCT01961609|617286439|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
170802285|NCT01961609|617286436|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
170802286|NCT01961609|617286437|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
170802287|NCT01961609|617286438|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
170802288|NCT01961609|617286439|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
170802289|NCT01961609|617286436|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
170802290|NCT01961609|617286437|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
170802291|NCT01961609|617286438|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
170802292|NCT01961609|617286439|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
170802293|NCT01640951|617286440|FG000|Overall Study|Adverse Event|8|||
170802294|NCT01640951|617286441|FG001|Overall Study|Adverse Event|3|||
170802295|NCT01640951|617286442|FG002|Overall Study|Adverse Event|10|||
170802296|NCT01640951|617286443|FG003|Overall Study|Adverse Event|6|||
170802297|NCT01640951|617286444|FG004|Overall Study|Adverse Event|1|||
170802298|NCT01640951|617286445|FG005|Overall Study|Adverse Event|11|||
170802299|NCT01640951|617286446|FG006|Overall Study|Adverse Event|1|||
170802300|NCT01640951|617286447|FG007|Overall Study|Adverse Event|3|||
170802301|NCT01640951|617286440|FG000|Overall Study|Lack of Efficacy|20|||
170802302|NCT01640951|617286441|FG001|Overall Study|Lack of Efficacy|1|||
170802303|NCT01640951|617286442|FG002|Overall Study|Lack of Efficacy|7|||
170802304|NCT01640951|617286443|FG003|Overall Study|Lack of Efficacy|14|||
170802305|NCT01640951|617286444|FG004|Overall Study|Lack of Efficacy|0|||
170802306|NCT01640951|617286445|FG005|Overall Study|Lack of Efficacy|6|||
170802307|NCT01640951|617286446|FG006|Overall Study|Lack of Efficacy|5|||
170802308|NCT01640951|617286447|FG007|Overall Study|Lack of Efficacy|6|||
170802309|NCT01640951|617286440|FG000|Overall Study|Lost to Follow-up|1|||
170802310|NCT01640951|617286441|FG001|Overall Study|Lost to Follow-up|0|||
170802311|NCT01640951|617286442|FG002|Overall Study|Lost to Follow-up|6|||
170802312|NCT01640951|617286443|FG003|Overall Study|Lost to Follow-up|2|||
170802313|NCT01640951|617286444|FG004|Overall Study|Lost to Follow-up|2|||
170802314|NCT01640951|617286445|FG005|Overall Study|Lost to Follow-up|3|||
170802315|NCT01640951|617286446|FG006|Overall Study|Lost to Follow-up|1|||
170802316|NCT01640951|617286447|FG007|Overall Study|Lost to Follow-up|1|||
170802317|NCT01640951|617286440|FG000|Overall Study|Non-compliance with study treatment|0|||
170802318|NCT01640951|617286441|FG001|Overall Study|Non-compliance with study treatment|0|||
170802319|NCT01640951|617286442|FG002|Overall Study|Non-compliance with study treatment|1|||
170802320|NCT01640951|617286443|FG003|Overall Study|Non-compliance with study treatment|1|||
170802321|NCT01640951|617286444|FG004|Overall Study|Non-compliance with study treatment|1|||
170802322|NCT01640951|617286445|FG005|Overall Study|Non-compliance with study treatment|4|||
170802323|NCT01640951|617286446|FG006|Overall Study|Non-compliance with study treatment|1|||
170802324|NCT01640951|617286447|FG007|Overall Study|Non-compliance with study treatment|0|||
170802325|NCT01640951|617286440|FG000|Overall Study|Physician Decision|2|||
170802326|NCT01640951|617286441|FG001|Overall Study|Physician Decision|5|||
170802327|NCT01640951|617286442|FG002|Overall Study|Physician Decision|2|||
170802328|NCT01640951|617286443|FG003|Overall Study|Physician Decision|2|||
170802329|NCT01640951|617286444|FG004|Overall Study|Physician Decision|2|||
170802330|NCT01640951|617286445|FG005|Overall Study|Physician Decision|3|||
170802331|NCT01640951|617286446|FG006|Overall Study|Physician Decision|3|||
170802332|NCT01640951|617286447|FG007|Overall Study|Physician Decision|0|||
170802333|NCT01640951|617286440|FG000|Overall Study|Pregnancy|3|||
170802334|NCT01640951|617286441|FG001|Overall Study|Pregnancy|0|||
170802335|NCT01640951|617286442|FG002|Overall Study|Pregnancy|0|||
170802336|NCT01640951|617286443|FG003|Overall Study|Pregnancy|4|||
170802337|NCT01640951|617286444|FG004|Overall Study|Pregnancy|0|||
170802338|NCT01640951|617286445|FG005|Overall Study|Pregnancy|0|||
170802339|NCT01640951|617286446|FG006|Overall Study|Pregnancy|2|||
170802340|NCT01640951|617286447|FG007|Overall Study|Pregnancy|0|||
170802341|NCT01640951|617286440|FG000|Overall Study|Protocol Deviation|0|||
170802342|NCT01640951|617286441|FG001|Overall Study|Protocol Deviation|1|||
170802343|NCT01640951|617286442|FG002|Overall Study|Protocol Deviation|2|||
170802344|NCT01640951|617286443|FG003|Overall Study|Protocol Deviation|1|||
170802345|NCT01640951|617286444|FG004|Overall Study|Protocol Deviation|0|||
170802346|NCT01640951|617286445|FG005|Overall Study|Protocol Deviation|1|||
170802347|NCT01640951|617286446|FG006|Overall Study|Protocol Deviation|0|||
170802348|NCT01640951|617286447|FG007|Overall Study|Protocol Deviation|0|||
170802349|NCT01640951|617286440|FG000|Overall Study|Subject/Guardian decision|12|||
170802350|NCT01640951|617286441|FG001|Overall Study|Subject/Guardian decision|4|||
170802351|NCT01640951|617286442|FG002|Overall Study|Subject/Guardian decision|13|||
170802352|NCT01640951|617286443|FG003|Overall Study|Subject/Guardian decision|15|||
170802353|NCT01640951|617286444|FG004|Overall Study|Subject/Guardian decision|7|||
170497085|NCT01827267|616159068|FG000|Overall Study|Disease Progression|1|||
170497086|NCT01827267|616159069|FG001|Overall Study|Disease Progression|1|||
170802354|NCT01640951|617286445|FG005|Overall Study|Subject/Guardian decision|19|||
170802355|NCT01640951|617286446|FG006|Overall Study|Subject/Guardian decision|5|||
170901039|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
170901040|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
170901041|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
170901042|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
170901043|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
170901044|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
170901045|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
170901046|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
170901047|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
170901048|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
170901049|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
170901050|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
170901051|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
170901052|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
170901053|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
170901054|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
170901055|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
170901056|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
170901057|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
170901058|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
170901059|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
170901060|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
170901061|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
170901062|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
170901063|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
170901064|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
170901065|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
170901066|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
170901067|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
170901068|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
170901069|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
170901070|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
170901071|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
170901072|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
170901073|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
170901074|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
170901075|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
170901076|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
170901077|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
170901078|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
170901079|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
170901080|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
170901081|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
170901082|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
170901083|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
170901084|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
170901085|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
170551222|NCT01897896|616364681|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
170551223|NCT01897896|616364682|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
170551224|NCT01897896|616364681|FG000|Overall Study|Caregiver can no longer participate|0|||
170802356|NCT01640951|617286447|FG007|Overall Study|Subject/Guardian decision|4|||
170802357|NCT01640951|617286440|FG000|Overall Study|Death|0|||
170802358|NCT01640951|617286441|FG001|Overall Study|Death|1|||
170802359|NCT01640951|617286442|FG002|Overall Study|Death|1|||
170802360|NCT01640951|617286443|FG003|Overall Study|Death|0|||
170802361|NCT01640951|617286444|FG004|Overall Study|Death|0|||
170802362|NCT01640951|617286445|FG005|Overall Study|Death|0|||
170802363|NCT01640951|617286446|FG006|Overall Study|Death|0|||
170802364|NCT01640951|617286447|FG007|Overall Study|Death|2|||
170802365|NCT01566890|617286448|FG000|Overall Study|Adverse Event|1|||
170802366|NCT01566890|617286449|FG001|Overall Study|Adverse Event|0|||
170802367|NCT01566890|617286450|FG002|Overall Study|Adverse Event|0|||
170642087|NCT02779556|616703413|FG001|6 Month|Lost to Follow-up|39|||
170642088|NCT02779556|616703412|FG000|6 Month HbA1c|No value collected during window|69|||
170802368|NCT01566890|617286451|FG003|Overall Study|Adverse Event|0|||
170802369|NCT01566890|617286452|FG004|Overall Study|Adverse Event|0|||
170802370|NCT01566890|617286448|FG000|Overall Study|Withdrawal by Subject|3|||
170802371|NCT01566890|617286449|FG001|Overall Study|Withdrawal by Subject|1|||
170802372|NCT01566890|617286450|FG002|Overall Study|Withdrawal by Subject|1|||
170802373|NCT01566890|617286451|FG003|Overall Study|Withdrawal by Subject|1|||
170802374|NCT01566890|617286452|FG004|Overall Study|Withdrawal by Subject|0|||
170802375|NCT01566890|617286448|FG000|Overall Study|Screen failure|6|||
170802376|NCT01566890|617286449|FG001|Overall Study|Screen failure|0|||
170802377|NCT01566890|617286450|FG002|Overall Study|Screen failure|1|||
170802378|NCT01566890|617286451|FG003|Overall Study|Screen failure|1|||
170802379|NCT01566890|617286452|FG004|Overall Study|Screen failure|0|||
170802380|NCT01566890|617286448|FG000|Overall Study|Incomplete CEU data|1|||
170802381|NCT01566890|617286449|FG001|Overall Study|Incomplete CEU data|3|||
170802382|NCT01566890|617286450|FG002|Overall Study|Incomplete CEU data|5|||
170802383|NCT01566890|617286451|FG003|Overall Study|Incomplete CEU data|8|||
170802384|NCT01566890|617286452|FG004|Overall Study|Incomplete CEU data|0|||
170802385|NCT01566890|617286448|FG000|Overall Study|Lost to Follow-up|0|||
170802386|NCT01566890|617286449|FG001|Overall Study|Lost to Follow-up|0|||
170802387|NCT01566890|617286450|FG002|Overall Study|Lost to Follow-up|4|||
170802388|NCT01566890|617286451|FG003|Overall Study|Lost to Follow-up|4|||
170802389|NCT01566890|617286452|FG004|Overall Study|Lost to Follow-up|0|||
170802390|NCT01566890|617286448|FG000|Overall Study|Other|0|||
170802391|NCT01566890|617286449|FG001|Overall Study|Other|0|||
170802392|NCT01566890|617286450|FG002|Overall Study|Other|0|||
170802393|NCT01566890|617286451|FG003|Overall Study|Other|0|||
170802394|NCT01566890|617286452|FG004|Overall Study|Other|7|||
170802395|NCT00293397|617286455|FG000|Overall Study|Death|2|||
170802396|NCT00523419|617286457|FG000|Overall Study|Adverse Event|1|||
170802397|NCT00523419|617286457|FG000|Overall Study|Withdrawal by Subject|1|||
170802398|NCT00523419|617286457|FG000|Overall Study|Physician Decision|2|||
170802399|NCT00523419|617286457|FG000|Overall Study|Progressive Disease|22|||
170802400|NCT00523419|617286457|FG000|Overall Study|Death due to Study Disease|4|||
170802401|NCT00523419|617286457|FG000|Overall Study|Death due to Adverse Event|2|||
170802402|NCT01759862|617286458|FG000|Overall Study|Physician Decision|3|||
170802403|NCT01759862|617286459|FG001|Overall Study|Physician Decision|1|||
170802404|NCT01759862|617286458|FG000|Overall Study|Adverse Event|0|||
170802405|NCT01759862|617286459|FG001|Overall Study|Adverse Event|1|||
170802406|NCT04060212|617286461|FG000|Overall Study|Withdrawal by Subject|7|||
170802407|NCT02844439|617286480|FG000|Overall Study|Withdrawal by Subject|1|||
170802408|NCT02844439|617286480|FG000|Overall Study|Lost to Follow-up|2|||
170802409|NCT02844439|617286480|FG000|Overall Study|Termination by Sponsor|4|||
170802410|NCT02844439|617286480|FG000|Overall Study|Death|28|||
170802411|NCT02844439|617286480|FG000|Overall Study|Other|5|||
170802412|NCT02646618|617286481|FG000|Overall Study|Lost to Follow-up|10|||
170802413|NCT02646618|617286482|FG001|Overall Study|Lost to Follow-up|14|||
170802414|NCT00390884|617286483|FG000|Overall Study|Withdrawal by Subject|2|||
170802415|NCT00390884|617286484|FG001|Overall Study|Withdrawal by Subject|2|||
170802416|NCT03304587|617286488|FG000|Overall Study|Headache after intervention|0|||
170802417|NCT03304587|617286489|FG001|Overall Study|Headache after intervention|1|||
170802418|NCT03304587|617286488|FG000|Overall Study|Withdrawal by Subject|1|||
170802419|NCT03304587|617286489|FG001|Overall Study|Withdrawal by Subject|0|||
170802420|NCT03885232|617286490|FG000|Overall Study|Lost to Follow-up|74|||
170802421|NCT03885232|617286491|FG001|Overall Study|Lost to Follow-up|32|||
170802422|NCT03885232|617286490|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
170802423|NCT03885232|617286491|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
170802424|NCT00309166|617286496|FG000|Overall Study|Adverse event, non-fatal|1|||
170802425|NCT00309166|617286497|FG001|Overall Study|Adverse event, non-fatal|0|||
170802426|NCT00309166|617286496|FG000|Overall Study|Withdrawal by Subject|4|||
170802427|NCT00309166|617286497|FG001|Overall Study|Withdrawal by Subject|3|||
170802428|NCT02016872|617286500|FG000|Overall Study|Withdrawal by Subject|10|||
170802429|NCT02016872|617286500|FG000|Overall Study|Death Progression|2|||
170802430|NCT02016872|617286500|FG000|Overall Study|No FMISO scan|1|||
170802431|NCT02016872|617286500|FG000|Overall Study|Ineligible|2|||
170802432|NCT00115934|617286505|FG000|Overall Study|Lost to Follow-up|1|||
170802433|NCT00115934|617286506|FG001|Overall Study|Lost to Follow-up|0|||
170802434|NCT00115934|617286505|FG000|Overall Study|Did not receive intervention|3|||
170802435|NCT00115934|617286506|FG001|Overall Study|Did not receive intervention|2|||
170802436|NCT03777657|617286507|FG000|Overall Study|Death|397|||
170802437|NCT03777657|617286508|FG001|Overall Study|Death|431|||
170802438|NCT03777657|617286507|FG000|Overall Study|Study Closed by Sponsor|77|||
170802439|NCT03777657|617286508|FG001|Overall Study|Study Closed by Sponsor|38|||
170802440|NCT03777657|617286507|FG000|Overall Study|Withdrawal by Subject|20|||
170802441|NCT03777657|617286508|FG001|Overall Study|Withdrawal by Subject|17|||
170802442|NCT03777657|617286507|FG000|Overall Study|Lost to Follow-up|6|||
170802443|NCT03777657|617286508|FG001|Overall Study|Lost to Follow-up|10|||
170802444|NCT05802173|617287733|FG000|Overall Study|Withdrawal by Subject|2|||
170802445|NCT05802173|617287734|FG001|Overall Study|Withdrawal by Subject|0|||
170802446|NCT05802173|617287735|FG002|Overall Study|Withdrawal by Subject|0|||
170802447|NCT05802173|617287733|FG000|Overall Study|Protocol Violation|1|||
170802448|NCT05802173|617287734|FG001|Overall Study|Protocol Violation|0|||
170802449|NCT05802173|617287735|FG002|Overall Study|Protocol Violation|0|||
170802450|NCT05802173|617287733|FG000|Overall Study|Lost to Follow-up|0|||
170802451|NCT05802173|617287734|FG001|Overall Study|Lost to Follow-up|6|||
170802452|NCT05802173|617287735|FG002|Overall Study|Lost to Follow-up|4|||
170802453|NCT05802173|617287733|FG000|Overall Study|non-compliance|0|||
170802454|NCT05802173|617287734|FG001|Overall Study|non-compliance|1|||
170802455|NCT05802173|617287735|FG002|Overall Study|non-compliance|0|||
170802456|NCT04503681|617287736|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
170802457|NCT04503681|617287737|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
170802458|NCT05250115|617287738|FG000|Overall Study|Premature study end|40|||
170802459|NCT05250115|617287738|FG000|Overall Study|Adverse Event|8|||
170802460|NCT05250115|617287738|FG000|Overall Study|Lost to Follow-up|7|||
170802461|NCT05250115|617287738|FG000|Overall Study|Withdrawal by Subject|6|||
170802462|NCT05250115|617287738|FG000|Overall Study|Withdrawal of informed consent|1|||
170802463|NCT05250115|617287738|FG000|Overall Study|Other|7|||
170802464|NCT00065182|617287743|FG000|Overall Study|Adverse Event|24|||
170802465|NCT00065182|617287744|FG001|Overall Study|Adverse Event|17|||
170802466|NCT00065182|617287743|FG000|Overall Study|Lost to Follow-up|0|||
170802467|NCT00065182|617287744|FG001|Overall Study|Lost to Follow-up|4|||
170802468|NCT00065182|617287743|FG000|Overall Study|Protocol Violation|3|||
170802469|NCT00065182|617287744|FG001|Overall Study|Protocol Violation|4|||
170802470|NCT00065182|617287743|FG000|Overall Study|Serious adverse events (SAE)|1|||
170802471|NCT00065182|617287744|FG001|Overall Study|Serious adverse events (SAE)|0|||
170802472|NCT00065182|617287743|FG000|Overall Study|Sponsor Decision|11|||
170802473|NCT00065182|617287744|FG001|Overall Study|Sponsor Decision|7|||
170802474|NCT00065182|617287743|FG000|Overall Study|Withdrawal by Subject|8|||
170802475|NCT00065182|617287744|FG001|Overall Study|Withdrawal by Subject|3|||
170802476|NCT00065182|617287743|FG000|Overall Study|No clinical benefit|1|||
170802477|NCT00065182|617287744|FG001|Overall Study|No clinical benefit|0|||
170802478|NCT00065182|617287743|FG000|Overall Study|Death|0|||
170802479|NCT00065182|617287744|FG001|Overall Study|Death|1|||
170802480|NCT00065182|617287743|FG000|Overall Study|Decline in Status|0|||
170802481|NCT00065182|617287744|FG001|Overall Study|Decline in Status|1|||
170802482|NCT00582972|617287751|FG000|Overall Study|Protocol Violation|2|||
170802483|NCT01536093|617287757|FG000|Overall Study|Death|1|||
170802484|NCT01536093|617287758|FG001|Overall Study|Death|2|||
170802485|NCT01536093|617287757|FG000|Overall Study|absence of maternal colostrum|2|||
170802486|NCT01536093|617287758|FG001|Overall Study|absence of maternal colostrum|0|||
170802487|NCT01536093|617287757|FG000|Overall Study|Withdrawal by Subject|0|||
170802488|NCT01536093|617287758|FG001|Overall Study|Withdrawal by Subject|1|||
170802489|NCT03631407|617287759|FG000|Overall Study|Withdrawal by Subject|3|||
170802490|NCT03631407|617287760|FG001|Overall Study|Withdrawal by Subject|2|||
170802491|NCT03631407|617287759|FG000|Overall Study|Sponsor Decision|0|||
170802492|NCT03631407|617287760|FG001|Overall Study|Sponsor Decision|2|||
170802493|NCT03631407|617287759|FG000|Overall Study|Death|16|||
170802494|NCT03631407|617287760|FG001|Overall Study|Death|16|||
170802495|NCT03631407|617287759|FG000|Overall Study|Randomized by mistake without study treatment|1|||
170802496|NCT03631407|617287760|FG001|Overall Study|Randomized by mistake without study treatment|0|||
170802497|NCT01499849|617287761|FG000|Overall Study|Adverse Event|28|||
170802498|NCT01499849|617287762|FG001|Overall Study|Adverse Event|32|||
170802499|NCT01499849|617287761|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
170802500|NCT01499849|617287762|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
170802501|NCT01499849|617287761|FG000|Overall Study|Withdrawal by Subject|43|||
170802502|NCT01499849|617287762|FG001|Overall Study|Withdrawal by Subject|43|||
170802503|NCT01499849|617287761|FG000|Overall Study|Death|5|||
170802504|NCT01499849|617287762|FG001|Overall Study|Death|7|||
170802505|NCT01499849|617287761|FG000|Overall Study|Disease Progression|11|||
170802506|NCT01499849|617287762|FG001|Overall Study|Disease Progression|10|||
170802507|NCT01499849|617287761|FG000|Overall Study|Protocol Violation|11|||
170802508|NCT01499849|617287762|FG001|Overall Study|Protocol Violation|11|||
170802509|NCT01499849|617287761|FG000|Overall Study|Physician Decision|20|||
170802510|NCT01499849|617287762|FG001|Overall Study|Physician Decision|19|||
170802511|NCT01499849|617287761|FG000|Overall Study|Lack of Efficacy|3|||
170802512|NCT01499849|617287762|FG001|Overall Study|Lack of Efficacy|4|||
170802513|NCT01499849|617287761|FG000|Overall Study|Lost to Follow-up|6|||
170802514|NCT01499849|617287762|FG001|Overall Study|Lost to Follow-up|3|||
170802515|NCT01499849|617287761|FG000|Overall Study|Other Reasons|27|||
170802516|NCT01499849|617287762|FG001|Overall Study|Other Reasons|30|||
170802517|NCT01437319|617287763|FG000|Phase I|Lost to Follow-up|2|||
170802518|NCT01437319|617287764|FG001|Phase I|Lost to Follow-up|0|||
170802519|NCT01437319|617287765|FG002|Phase I|Lost to Follow-up|0|||
170802520|NCT01437319|617287763|FG000|Phase I|Protocol Violation|1|||
170802521|NCT01437319|617287764|FG001|Phase I|Protocol Violation|0|||
170802522|NCT01437319|617287765|FG002|Phase I|Protocol Violation|0|||
170802523|NCT01437319|617287763|FG000|Phase I|Study related symptoms/complaints|27|||
170802524|NCT01437319|617287764|FG001|Phase I|Study related symptoms/complaints|0|||
170802525|NCT01437319|617287765|FG002|Phase I|Study related symptoms/complaints|0|||
170802526|NCT01437319|617287763|FG000|Phase I|Withdrawal by Subject|25|||
170802527|NCT01437319|617287764|FG001|Phase I|Withdrawal by Subject|0|||
170802528|NCT01437319|617287765|FG002|Phase I|Withdrawal by Subject|0|||
170802529|NCT01437319|617287763|FG000|Phase II|Withdrawal by Subject|0|||
170802530|NCT01437319|617287764|FG001|Phase II|Withdrawal by Subject|8|||
170802531|NCT01437319|617287765|FG002|Phase II|Withdrawal by Subject|16|||
170802532|NCT01437319|617287763|FG000|Phase II|Lost to Follow-up|0|||
170802533|NCT01437319|617287764|FG001|Phase II|Lost to Follow-up|7|||
170802534|NCT01437319|617287765|FG002|Phase II|Lost to Follow-up|2|||
170802535|NCT01437319|617287763|FG000|Phase II|Study related symptoms/complaints|0|||
170802536|NCT01437319|617287764|FG001|Phase II|Study related symptoms/complaints|28|||
170802537|NCT01437319|617287765|FG002|Phase II|Study related symptoms/complaints|19|||
170802538|NCT01437319|617287763|FG000|Phase II|Protocol Violation|0|||
170802539|NCT01437319|617287764|FG001|Phase II|Protocol Violation|1|||
170802540|NCT01437319|617287765|FG002|Phase II|Protocol Violation|0|||
170802541|NCT03802994|617287768|FG000|Overall Study|Lost to Follow-up|0|||
170802542|NCT03802994|617287769|FG001|Overall Study|Lost to Follow-up|2|||
170802543|NCT03802994|617287770|FG002|Overall Study|Lost to Follow-up|3|||
170802544|NCT03802994|617287771|FG003|Overall Study|Lost to Follow-up|2|||
170642089|NCT02779556|616703413|FG001|6 Month HbA1c|No value collected during window|50|||
170642090|NCT02779556|616703412|FG000|12 Month HbA1c|No value collected during window|138|||
170642091|NCT02779556|616703413|FG001|12 Month HbA1c|No value collected during window|102|||
170642092|NCT03110770|616703414|FG000|Overall Study|Death|1|||
170901086|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
170901087|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
170901088|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
170901089|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
170901090|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
170901091|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
170901092|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
170901093|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
170901094|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
170901095|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
170901096|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
170901097|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
170901098|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
170901099|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
170901100|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
170901101|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
170901102|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
170901103|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
170901104|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
170901105|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
170901106|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
170901107|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
170901108|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
170901109|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
170901110|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
170901111|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
170901112|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
170901113|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
170901114|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
170901115|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
170901116|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
170642093|NCT03110770|616703415|FG001|Overall Study|Death|0|||
170642094|NCT03110770|616703416|FG002|Overall Study|Death|0|||
170642095|NCT03110770|616703417|FG003|Overall Study|Death|1|||
170642096|NCT03110770|616703418|FG004|Overall Study|Death|0|||
170642097|NCT03110770|616703414|FG000|Overall Study|Enrolled but did not receive product|0|||
170642098|NCT03110770|616703415|FG001|Overall Study|Enrolled but did not receive product|0|||
170642099|NCT03110770|616703416|FG002|Overall Study|Enrolled but did not receive product|0|||
170802545|NCT03802994|617287772|FG004|Overall Study|Lost to Follow-up|2|||
170802546|NCT00622700|617287776|FG000|Core Treatment Period|Randomized but Not Treated|0|||
170802547|NCT00622700|617287777|FG001|Core Treatment Period|Randomized but Not Treated|2|||
170802548|NCT00622700|617287778|FG002|Core Treatment Period|Randomized but Not Treated|2|||
170802549|NCT00622700|617287779|FG003|Core Treatment Period|Randomized but Not Treated|0|||
170642100|NCT03110770|616703417|FG003|Overall Study|Enrolled but did not receive product|8|||
170642101|NCT03110770|616703418|FG004|Overall Study|Enrolled but did not receive product|7|||
170642102|NCT03110770|616703414|FG000|Overall Study|Lost to Follow-up|0|||
170642103|NCT03110770|616703415|FG001|Overall Study|Lost to Follow-up|0|||
170802550|NCT00622700|617287780|FG004|Core Treatment Period|Randomized but Not Treated|0|||
170802551|NCT00622700|617287781|FG005|Core Treatment Period|Randomized but Not Treated|0|||
170802552|NCT00622700|617287782|FG006|Core Treatment Period|Randomized but Not Treated|0|||
170802553|NCT00622700|617287776|FG000|Core Treatment Period|Adverse Event|18|||
170802554|NCT00622700|617287777|FG001|Core Treatment Period|Adverse Event|25|||
170802555|NCT00622700|617287778|FG002|Core Treatment Period|Adverse Event|18|||
170802556|NCT00622700|617287779|FG003|Core Treatment Period|Adverse Event|0|||
170802557|NCT00622700|617287780|FG004|Core Treatment Period|Adverse Event|0|||
170802558|NCT00622700|617287781|FG005|Core Treatment Period|Adverse Event|0|||
170802559|NCT00622700|617287782|FG006|Core Treatment Period|Adverse Event|0|||
170802560|NCT00622700|617287776|FG000|Core Treatment Period|Lack of Efficacy|19|||
170802561|NCT00622700|617287777|FG001|Core Treatment Period|Lack of Efficacy|6|||
170802562|NCT00622700|617287778|FG002|Core Treatment Period|Lack of Efficacy|12|||
170802563|NCT00622700|617287779|FG003|Core Treatment Period|Lack of Efficacy|0|||
170802564|NCT00622700|617287780|FG004|Core Treatment Period|Lack of Efficacy|0|||
170802565|NCT00622700|617287781|FG005|Core Treatment Period|Lack of Efficacy|0|||
170802566|NCT00622700|617287782|FG006|Core Treatment Period|Lack of Efficacy|0|||
170802567|NCT00622700|617287776|FG000|Core Treatment Period|Lost to Follow-up|1|||
170802568|NCT00622700|617287777|FG001|Core Treatment Period|Lost to Follow-up|1|||
170802569|NCT00622700|617287778|FG002|Core Treatment Period|Lost to Follow-up|1|||
170901117|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
170901118|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
170901119|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
170901120|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
170901121|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
170901122|NCT00408005|617642127|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
170901123|NCT00408005|617642128|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
170901124|NCT00408005|617642129|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
170901125|NCT00408005|617642130|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
170901126|NCT00408005|617642131|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
170901127|NCT00408005|617642132|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
170901128|NCT00408005|617642133|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
170901129|NCT00408005|617642134|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
170901130|NCT05817045|617642135|FG000|Overall Study|Protocol Violation|0|||
170901131|NCT05817045|617642136|FG001|Overall Study|Protocol Violation|3|||
170551225|NCT01897896|616364682|FG001|Overall Study|Caregiver can no longer participate|2|||
170551226|NCT01897896|616364681|FG000|Overall Study|Other than specified|2|||
170551227|NCT01897896|616364682|FG001|Overall Study|Other than specified|1|||
170551228|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
170551229|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
170551230|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
170551231|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
170551232|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
170551233|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
170551234|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
170551235|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
170551236|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
170551237|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
170551238|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
170551239|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
170551240|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
170551241|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
170551242|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
170551243|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
170551244|NCT01755156|616364692|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
170551245|NCT01755156|616364693|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
170551246|NCT01755156|616364692|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
170551247|NCT01755156|616364693|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
170551248|NCT01755156|616364692|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
170551249|NCT01755156|616364693|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
170551250|NCT03142451|616364694|FG000|Overall Study|Adverse Event|5|||
170551251|NCT03142451|616364695|FG001|Overall Study|Adverse Event|2|||
170551252|NCT03142451|616364694|FG000|Overall Study|Lost to Follow-up|25|||
170642104|NCT03110770|616703416|FG002|Overall Study|Lost to Follow-up|0|||
170551253|NCT03142451|616364695|FG001|Overall Study|Lost to Follow-up|8|||
170642105|NCT03110770|616703417|FG003|Overall Study|Lost to Follow-up|53|||
170642106|NCT03110770|616703418|FG004|Overall Study|Lost to Follow-up|45|||
170642107|NCT03110770|616703414|FG000|Overall Study|Investigator Decision|0|||
170642108|NCT03110770|616703415|FG001|Overall Study|Investigator Decision|0|||
170642109|NCT03110770|616703416|FG002|Overall Study|Investigator Decision|0|||
170642110|NCT03110770|616703417|FG003|Overall Study|Investigator Decision|5|||
170642111|NCT03110770|616703418|FG004|Overall Study|Investigator Decision|3|||
170642112|NCT03110770|616703414|FG000|Overall Study|Withdrawal by Subject|0|||
170642113|NCT03110770|616703415|FG001|Overall Study|Withdrawal by Subject|0|||
170642114|NCT03110770|616703416|FG002|Overall Study|Withdrawal by Subject|0|||
170642115|NCT03110770|616703417|FG003|Overall Study|Withdrawal by Subject|24|||
170642116|NCT03110770|616703418|FG004|Overall Study|Withdrawal by Subject|24|||
170642117|NCT03110770|616703414|FG000|Overall Study|Moved from area|5|||
170642118|NCT03110770|616703415|FG001|Overall Study|Moved from area|0|||
170642119|NCT03110770|616703416|FG002|Overall Study|Moved from area|2|||
170642120|NCT03110770|616703417|FG003|Overall Study|Moved from area|42|||
170642121|NCT03110770|616703418|FG004|Overall Study|Moved from area|43|||
170642122|NCT03110770|616703414|FG000|Overall Study|Illness/Injury unrelated to product|0|||
170642123|NCT03110770|616703415|FG001|Overall Study|Illness/Injury unrelated to product|0|||
170642124|NCT03110770|616703416|FG002|Overall Study|Illness/Injury unrelated to product|0|||
170642125|NCT03110770|616703417|FG003|Overall Study|Illness/Injury unrelated to product|0|||
170642126|NCT03110770|616703418|FG004|Overall Study|Illness/Injury unrelated to product|1|||
170642127|NCT01086358|616703421|FG000|First Intervention|Lost to Follow-up|9|||
170642128|NCT01086358|616703422|FG001|First Intervention|Lost to Follow-up|4|||
170642129|NCT01086358|616703421|FG000|First Intervention|Withdrawal by Subject|0|||
170802570|NCT00622700|617287779|FG003|Core Treatment Period|Lost to Follow-up|0|||
170802571|NCT00622700|617287780|FG004|Core Treatment Period|Lost to Follow-up|0|||
170802572|NCT00622700|617287781|FG005|Core Treatment Period|Lost to Follow-up|0|||
170802573|NCT00622700|617287782|FG006|Core Treatment Period|Lost to Follow-up|0|||
170802574|NCT00622700|617287776|FG000|Core Treatment Period|Death|1|||
170802575|NCT00622700|617287777|FG001|Core Treatment Period|Death|0|||
170802576|NCT00622700|617287778|FG002|Core Treatment Period|Death|0|||
170802577|NCT00622700|617287779|FG003|Core Treatment Period|Death|0|||
170802578|NCT00622700|617287780|FG004|Core Treatment Period|Death|0|||
170802579|NCT00622700|617287781|FG005|Core Treatment Period|Death|0|||
170802580|NCT00622700|617287782|FG006|Core Treatment Period|Death|0|||
170802581|NCT00622700|617287776|FG000|Core Treatment Period|Progressive Disease|3|||
170802582|NCT00622700|617287777|FG001|Core Treatment Period|Progressive Disease|1|||
170802583|NCT00622700|617287778|FG002|Core Treatment Period|Progressive Disease|0|||
170802584|NCT00622700|617287779|FG003|Core Treatment Period|Progressive Disease|0|||
170802585|NCT00622700|617287780|FG004|Core Treatment Period|Progressive Disease|0|||
170802586|NCT00622700|617287781|FG005|Core Treatment Period|Progressive Disease|0|||
170802587|NCT00622700|617287782|FG006|Core Treatment Period|Progressive Disease|0|||
170802588|NCT00622700|617287776|FG000|Core Treatment Period|Withdrawal by Subject|12|||
170802589|NCT00622700|617287777|FG001|Core Treatment Period|Withdrawal by Subject|18|||
170802590|NCT00622700|617287778|FG002|Core Treatment Period|Withdrawal by Subject|15|||
170802591|NCT00622700|617287779|FG003|Core Treatment Period|Withdrawal by Subject|0|||
170802592|NCT00622700|617287780|FG004|Core Treatment Period|Withdrawal by Subject|0|||
170802593|NCT00622700|617287781|FG005|Core Treatment Period|Withdrawal by Subject|0|||
170802594|NCT00622700|617287782|FG006|Core Treatment Period|Withdrawal by Subject|0|||
170802595|NCT00622700|617287776|FG000|Core Treatment Period|Other than specified above|2|||
170802596|NCT00622700|617287777|FG001|Core Treatment Period|Other than specified above|2|||
170802597|NCT00622700|617287778|FG002|Core Treatment Period|Other than specified above|5|||
170802598|NCT00622700|617287779|FG003|Core Treatment Period|Other than specified above|0|||
170802599|NCT00622700|617287780|FG004|Core Treatment Period|Other than specified above|0|||
170802600|NCT00622700|617287781|FG005|Core Treatment Period|Other than specified above|0|||
170802601|NCT00622700|617287782|FG006|Core Treatment Period|Other than specified above|0|||
170802602|NCT00622700|617287776|FG000|Extension Treatment Period|Adverse Event|0|||
170802603|NCT00622700|617287777|FG001|Extension Treatment Period|Adverse Event|0|||
170802604|NCT00622700|617287778|FG002|Extension Treatment Period|Adverse Event|0|||
170802605|NCT00622700|617287779|FG003|Extension Treatment Period|Adverse Event|5|||
170802606|NCT00622700|617287780|FG004|Extension Treatment Period|Adverse Event|9|||
170802607|NCT00622700|617287781|FG005|Extension Treatment Period|Adverse Event|6|||
170802608|NCT00622700|617287782|FG006|Extension Treatment Period|Adverse Event|8|||
170802609|NCT00622700|617287776|FG000|Extension Treatment Period|Lack of Efficacy|0|||
170802610|NCT00622700|617287777|FG001|Extension Treatment Period|Lack of Efficacy|0|||
170802611|NCT00622700|617287778|FG002|Extension Treatment Period|Lack of Efficacy|0|||
170802612|NCT00622700|617287779|FG003|Extension Treatment Period|Lack of Efficacy|2|||
170802613|NCT00622700|617287780|FG004|Extension Treatment Period|Lack of Efficacy|8|||
170802614|NCT00622700|617287781|FG005|Extension Treatment Period|Lack of Efficacy|1|||
170802615|NCT00622700|617287782|FG006|Extension Treatment Period|Lack of Efficacy|9|||
170802616|NCT00622700|617287776|FG000|Extension Treatment Period|Protocol Violation|0|||
170802617|NCT00622700|617287777|FG001|Extension Treatment Period|Protocol Violation|0|||
170802618|NCT00622700|617287778|FG002|Extension Treatment Period|Protocol Violation|0|||
170802619|NCT00622700|617287779|FG003|Extension Treatment Period|Protocol Violation|0|||
170901132|NCT05817045|617642135|FG000|Overall Study|Withdrawal by Subject|10|||
170901133|NCT05817045|617642136|FG001|Overall Study|Withdrawal by Subject|7|||
170901134|NCT05817045|617642135|FG000|Overall Study|Physician Decision|3|||
170901135|NCT05817045|617642136|FG001|Overall Study|Physician Decision|0|||
170901136|NCT05817045|617642135|FG000|Overall Study|Lost to Follow-up|0|||
170901137|NCT05817045|617642136|FG001|Overall Study|Lost to Follow-up|1|||
170901138|NCT05817045|617642135|FG000|Overall Study|Device Deficiency|1|||
170901139|NCT05817045|617642136|FG001|Overall Study|Device Deficiency|0|||
170901140|NCT05817045|617642135|FG000|Overall Study|System Error|1|||
170901141|NCT05817045|617642136|FG001|Overall Study|System Error|0|||
170901142|NCT01670994|617642137|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
170901143|NCT01670994|617642138|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
170901144|NCT01670994|617642137|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
170901145|NCT01670994|617642138|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
170901146|NCT01670994|617642137|FG000|Overall Study|Patient experienced DLT|0|||
170901147|NCT01670994|617642138|FG001|Overall Study|Patient experienced DLT|1|||
170901148|NCT01111604|617642139|FG000|Overall Study|Lost to Follow-up|0|||
170901149|NCT01111604|617642140|FG001|Overall Study|Lost to Follow-up|0|||
170901150|NCT01111604|617642141|FG002|Overall Study|Lost to Follow-up|1|||
170901151|NCT01111604|617642139|FG000|Overall Study|Withdrew Consent|3|||
170901152|NCT01111604|617642140|FG001|Overall Study|Withdrew Consent|0|||
170901153|NCT01111604|617642141|FG002|Overall Study|Withdrew Consent|2|||
170901154|NCT01111604|617642139|FG000|Overall Study|Withdrawal by Subject|2|||
170901155|NCT01111604|617642140|FG001|Overall Study|Withdrawal by Subject|0|||
170901156|NCT01111604|617642141|FG002|Overall Study|Withdrawal by Subject|0|||
170901157|NCT01111604|617642139|FG000|Overall Study|Death|1|||
170642130|NCT01086358|616703422|FG001|First Intervention|Withdrawal by Subject|1|||
170642131|NCT01086358|616703421|FG000|Second Intervention|Lost to Follow-up|4|||
170642132|NCT01086358|616703422|FG001|Second Intervention|Lost to Follow-up|4|||
170642133|NCT02644109|616703426|FG000|Overall Study|Adverse Event|0|||
170642134|NCT02644109|616703427|FG001|Overall Study|Adverse Event|4|||
170642135|NCT01137604|616703434|FG000|Overall Study|Adverse Event|3|||
170642136|NCT01137604|616703435|FG001|Overall Study|Adverse Event|6|||
170802620|NCT00622700|617287780|FG004|Extension Treatment Period|Protocol Violation|0|||
170901158|NCT01111604|617642140|FG001|Overall Study|Death|0|||
170901159|NCT01111604|617642141|FG002|Overall Study|Death|0|||
170901160|NCT01111604|617642139|FG000|Overall Study|Met Exclusion Criteria|2|||
170551254|NCT03142451|616364694|FG000|Overall Study|Participant request|24|||
170551255|NCT03142451|616364695|FG001|Overall Study|Participant request|12|||
170551256|NCT03142451|616364694|FG000|Overall Study|Protocol Violation|3|||
170551257|NCT03142451|616364695|FG001|Overall Study|Protocol Violation|1|||
170551258|NCT03142451|616364694|FG000|Overall Study|Other|1|||
170551259|NCT03142451|616364695|FG001|Overall Study|Other|1|||
170551260|NCT01530256|616364696|FG000|Overall Study|Death|2|||
170551261|NCT03048019|616364697|FG000|Overall Study|Adverse Event|1|||
170551262|NCT03048019|616364698|FG001|Overall Study|Adverse Event|0|||
170551263|NCT01730729|616364699|FG000|Overall Study|Adverse Event|1|||
170551264|NCT01730729|616364699|FG000|Overall Study|Death|1|||
170551265|NCT01730729|616364699|FG000|Overall Study|Progressive Disease|12|||
170551266|NCT00871000|616364700|FG000|Overall Study|Withdrawal by Subject|1|||
170551267|NCT00871000|616364701|FG001|Overall Study|Withdrawal by Subject|0|||
170551268|NCT01292473|616364702|FG000|Overall Study|Adverse Event|1|||
170551269|NCT01292473|616364703|FG001|Overall Study|Adverse Event|0|||
170551270|NCT01292473|616364704|FG002|Overall Study|Adverse Event|1|||
170802621|NCT00622700|617287781|FG005|Extension Treatment Period|Protocol Violation|2|||
170642137|NCT01137604|616703436|FG002|Overall Study|Adverse Event|9|||
170642138|NCT01137604|616703437|FG003|Overall Study|Adverse Event|9|||
170802622|NCT00622700|617287782|FG006|Extension Treatment Period|Protocol Violation|0|||
170802623|NCT00622700|617287776|FG000|Extension Treatment Period|Lost to Follow-up|0|||
170802624|NCT00622700|617287777|FG001|Extension Treatment Period|Lost to Follow-up|0|||
170802625|NCT00622700|617287778|FG002|Extension Treatment Period|Lost to Follow-up|0|||
170802626|NCT00622700|617287779|FG003|Extension Treatment Period|Lost to Follow-up|0|||
170802627|NCT00622700|617287780|FG004|Extension Treatment Period|Lost to Follow-up|1|||
170802628|NCT00622700|617287781|FG005|Extension Treatment Period|Lost to Follow-up|0|||
170802629|NCT00622700|617287782|FG006|Extension Treatment Period|Lost to Follow-up|0|||
170802630|NCT00622700|617287776|FG000|Extension Treatment Period|Progressive Disease|0|||
170901161|NCT01111604|617642140|FG001|Overall Study|Met Exclusion Criteria|0|||
170901162|NCT01111604|617642141|FG002|Overall Study|Met Exclusion Criteria|0|||
170901163|NCT03514914|617642142|FG000|Overall Study|Death|3|||
170901164|NCT03514914|617642143|FG001|Overall Study|Death|3|||
170551271|NCT01292473|616364705|FG003|Overall Study|Adverse Event|1|||
170802631|NCT00622700|617287777|FG001|Extension Treatment Period|Progressive Disease|0|||
170551272|NCT01292473|616364702|FG000|Overall Study|Lost to Follow-up|1|||
170551273|NCT01292473|616364703|FG001|Overall Study|Lost to Follow-up|1|||
170642139|NCT01137604|616703434|FG000|Overall Study|Participant Choice|0|||
170901165|NCT03514914|617642142|FG000|Overall Study|Lost to Follow-up|117|||
170901166|NCT03514914|617642143|FG001|Overall Study|Lost to Follow-up|89|||
170642140|NCT01137604|616703435|FG001|Overall Study|Participant Choice|2|||
170642141|NCT01137604|616703436|FG002|Overall Study|Participant Choice|2|||
170642142|NCT01137604|616703437|FG003|Overall Study|Participant Choice|0|||
170901167|NCT01824979|617642144|FG000|Overall Study|Withdrawal by Subject|5|||
170901168|NCT01824979|617642145|FG001|Overall Study|Withdrawal by Subject|0|||
170901169|NCT01824979|617642144|FG000|Overall Study|Physician Decision|2|||
170901170|NCT01824979|617642145|FG001|Overall Study|Physician Decision|0|||
170901171|NCT01824979|617642144|FG000|Overall Study|Protocol Violation|6|||
170901172|NCT01824979|617642145|FG001|Overall Study|Protocol Violation|13|||
170642143|NCT01137604|616703434|FG000|Overall Study|Withdrawal of consent|0|||
170642144|NCT01137604|616703435|FG001|Overall Study|Withdrawal of consent|0|||
170642145|NCT01137604|616703436|FG002|Overall Study|Withdrawal of consent|0|||
170901173|NCT01085682|617642146|FG000|Overall Study|Withdrawal by Subject|25|||
170901174|NCT01085682|617642147|FG001|Overall Study|Withdrawal by Subject|25|||
170901175|NCT03926143|617642151|FG000|Overall Study|Physician Decision|3|||
170901176|NCT03926143|617642151|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
170901177|NCT03926143|617642151|FG000|Overall Study|Adverse Event|2|||
170901178|NCT03926143|617642151|FG000|Overall Study|Progressive disease|3|||
170901179|NCT02561156|617642154|FG000|Part 2|Adverse Event|0|||
170901180|NCT02561156|617642155|FG001|Part 2|Adverse Event|0|||
170901181|NCT02561156|617642156|FG002|Part 2|Adverse Event|0|||
170901182|NCT02561156|617642157|FG003|Part 2|Adverse Event|0|||
170901183|NCT02561156|617642158|FG004|Part 2|Adverse Event|0|||
170901184|NCT02561156|617642159|FG005|Part 2|Adverse Event|0|||
170901185|NCT02561156|617642160|FG006|Part 2|Adverse Event|0|||
170901186|NCT02561156|617642161|FG007|Part 2|Adverse Event|0|||
170901187|NCT02561156|617642162|FG008|Part 2|Adverse Event|0|||
170901188|NCT02561156|617642163|FG009|Part 2|Adverse Event|0|||
170901189|NCT02561156|617642164|FG010|Part 2|Adverse Event|0|||
170901190|NCT02561156|617642165|FG011|Part 2|Adverse Event|1|||
170901191|NCT02561156|617642166|FG012|Part 2|Adverse Event|0|||
170901192|NCT02207907|617642170|FG000|Overall Study|Lost to Follow-up|3|||
170901193|NCT02207907|617642171|FG001|Overall Study|Lost to Follow-up|1|||
170901194|NCT02207907|617642170|FG000|Overall Study|Withdrawal by Subject|5|||
170901195|NCT02207907|617642171|FG001|Overall Study|Withdrawal by Subject|6|||
170901196|NCT02207907|617642170|FG000|Overall Study|Did not meet study criteria|3|||
170901197|NCT02207907|617642171|FG001|Overall Study|Did not meet study criteria|0|||
170901198|NCT02207907|617642170|FG000|Overall Study|Pregnancy|0|||
170901199|NCT02207907|617642171|FG001|Overall Study|Pregnancy|1|||
170901200|NCT00158184|617642172|FG000|Overall Study|personal issues|3|||
170901201|NCT00158184|617642173|FG001|Overall Study|personal issues|1|||
170901202|NCT00158184|617642172|FG000|Overall Study|failed for follow unit/study rules|2|||
170901203|NCT00158184|617642173|FG001|Overall Study|failed for follow unit/study rules|0|||
170901204|NCT00158184|617642172|FG000|Overall Study|Adverse Event|1|||
170901205|NCT00158184|617642173|FG001|Overall Study|Adverse Event|1|||
170901206|NCT01025635|617642179|FG000|Overall Study|Withdrawal by Subject|6|||
170901207|NCT01025635|617642180|FG001|Overall Study|Withdrawal by Subject|7|||
170901208|NCT01025635|617642179|FG000|Overall Study|Protocol Violation|4|||
170901209|NCT01025635|617642180|FG001|Overall Study|Protocol Violation|2|||
170901210|NCT01025635|617642179|FG000|Overall Study|Lack of Efficacy|0|||
170901211|NCT01025635|617642180|FG001|Overall Study|Lack of Efficacy|1|||
170901212|NCT01025635|617642179|FG000|Overall Study|Lost to Follow-up|9|||
170901213|NCT01025635|617642180|FG001|Overall Study|Lost to Follow-up|13|||
170901214|NCT01025635|617642179|FG000|Overall Study|Reason not known|4|||
170901215|NCT01025635|617642180|FG001|Overall Study|Reason not known|2|||
170901216|NCT01307423|617642181|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
170901217|NCT01307423|617642182|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
170901218|NCT01307423|617642183|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
170901219|NCT01307423|617642184|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170901220|NCT01307423|617642185|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170901221|NCT01307423|617642186|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170901222|NCT01307423|617642187|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170642146|NCT01137604|616703437|FG003|Overall Study|Withdrawal of consent|2|||
170642147|NCT01137604|616703434|FG000|Overall Study|Clinical progression/deterioration|1|||
170642148|NCT01137604|616703435|FG001|Overall Study|Clinical progression/deterioration|2|||
170901223|NCT01307423|617642188|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170901224|NCT01307423|617642189|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170901225|NCT01307423|617642181|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
170901226|NCT01307423|617642182|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
170901227|NCT01307423|617642183|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
170901228|NCT01307423|617642184|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170901229|NCT01307423|617642185|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170901230|NCT01307423|617642186|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170642149|NCT01137604|616703436|FG002|Overall Study|Clinical progression/deterioration|2|||
170901231|NCT01307423|617642187|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170901232|NCT01307423|617642188|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170901233|NCT01307423|617642189|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170901234|NCT01307423|617642181|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
170901235|NCT01307423|617642182|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
170901236|NCT01307423|617642183|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
170901237|NCT01307423|617642184|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170901238|NCT01307423|617642185|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170901239|NCT01307423|617642186|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170901240|NCT01307423|617642187|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170901241|NCT01307423|617642188|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170901242|NCT01307423|617642189|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170901243|NCT01307423|617642181|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170802632|NCT00622700|617287778|FG002|Extension Treatment Period|Progressive Disease|0|||
170802633|NCT00622700|617287779|FG003|Extension Treatment Period|Progressive Disease|1|||
170802634|NCT00622700|617287780|FG004|Extension Treatment Period|Progressive Disease|2|||
170802635|NCT00622700|617287781|FG005|Extension Treatment Period|Progressive Disease|0|||
170802636|NCT00622700|617287782|FG006|Extension Treatment Period|Progressive Disease|2|||
170802637|NCT00622700|617287776|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
170802638|NCT00622700|617287777|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
170802639|NCT00622700|617287778|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
170802640|NCT00622700|617287779|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
170802641|NCT00622700|617287780|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
170802642|NCT00622700|617287781|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
170802643|NCT00622700|617287782|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
170802644|NCT00622700|617287776|FG000|Extension Treatment Period|Missing|0|||
170802645|NCT00622700|617287777|FG001|Extension Treatment Period|Missing|0|||
170802646|NCT00622700|617287778|FG002|Extension Treatment Period|Missing|0|||
170802647|NCT00622700|617287779|FG003|Extension Treatment Period|Missing|2|||
170802648|NCT00622700|617287780|FG004|Extension Treatment Period|Missing|3|||
170802649|NCT00622700|617287781|FG005|Extension Treatment Period|Missing|1|||
170802650|NCT00622700|617287782|FG006|Extension Treatment Period|Missing|0|||
170802651|NCT00622700|617287776|FG000|Extension Treatment Period|Other than specified above|0|||
170901244|NCT01307423|617642182|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170901245|NCT01307423|617642183|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
170901246|NCT01307423|617642184|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170901247|NCT01307423|617642185|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170901248|NCT01307423|617642186|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170901249|NCT01307423|617642187|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170901250|NCT01307423|617642188|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170901251|NCT01307423|617642189|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
170901252|NCT01307423|617642181|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
170901253|NCT01307423|617642182|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
170901254|NCT01307423|617642183|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
170901255|NCT01307423|617642184|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170901256|NCT01307423|617642185|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170901257|NCT01307423|617642186|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170901258|NCT01307423|617642187|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170802652|NCT00622700|617287777|FG001|Extension Treatment Period|Other than specified above|0|||
170802653|NCT00622700|617287778|FG002|Extension Treatment Period|Other than specified above|0|||
170802654|NCT00622700|617287779|FG003|Extension Treatment Period|Other than specified above|0|||
170802655|NCT00622700|617287780|FG004|Extension Treatment Period|Other than specified above|0|||
170802656|NCT00622700|617287781|FG005|Extension Treatment Period|Other than specified above|1|||
170802657|NCT00622700|617287782|FG006|Extension Treatment Period|Other than specified above|1|||
170802658|NCT00756574|617287785|FG000|Overall Study|Withdrawal by Subject|9|||
170802659|NCT00756574|617287786|FG001|Overall Study|Withdrawal by Subject|7|||
170802660|NCT00756574|617287785|FG000|Overall Study|Lost to Follow-up|4|||
170802661|NCT00756574|617287786|FG001|Overall Study|Lost to Follow-up|4|||
170802662|NCT04035447|617287787|FG000|Treatment Period|Lost to Follow-up|6|||
170802663|NCT04035447|617287788|FG001|Treatment Period|Lost to Follow-up|5|||
170802664|NCT04035447|617287787|FG000|Treatment Period|Physician Decision|0|||
170802665|NCT04035447|617287788|FG001|Treatment Period|Physician Decision|2|||
170802666|NCT04622332|617287789|FG000|Overall Study|Withdrawal by Subject|4|||
170802667|NCT04622332|617287790|FG001|Overall Study|Withdrawal by Subject|2|||
170802668|NCT04622332|617287789|FG000|Overall Study|Physician Decision|1|||
170551274|NCT01292473|616364704|FG002|Overall Study|Lost to Follow-up|2|||
170802669|NCT04622332|617287790|FG001|Overall Study|Physician Decision|1|||
170802670|NCT04622332|617287789|FG000|Overall Study|Adverse Event|0|||
170802671|NCT04622332|617287790|FG001|Overall Study|Adverse Event|2|||
170551275|NCT01292473|616364705|FG003|Overall Study|Lost to Follow-up|2|||
170901259|NCT01307423|617642188|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170901260|NCT01307423|617642189|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170901261|NCT01307423|617642181|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
170901262|NCT01307423|617642182|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170901263|NCT01307423|617642183|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170901264|NCT01307423|617642184|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170901265|NCT01307423|617642185|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170901266|NCT01307423|617642186|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170901267|NCT01307423|617642187|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170901268|NCT01307423|617642188|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170901269|NCT01307423|617642189|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170901270|NCT01307423|617642181|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
170901271|NCT01307423|617642182|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
170901272|NCT01307423|617642183|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170901273|NCT01307423|617642184|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170901274|NCT01307423|617642185|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170901275|NCT01307423|617642186|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170901276|NCT01307423|617642187|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170901277|NCT01307423|617642188|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170901278|NCT01307423|617642189|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
170901279|NCT01307423|617642181|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
170901280|NCT01307423|617642182|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
170901281|NCT01307423|617642183|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
170901282|NCT01307423|617642184|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
170901283|NCT01307423|617642185|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
170901284|NCT01307423|617642186|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
170901285|NCT01307423|617642187|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
170901286|NCT01307423|617642188|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
170901287|NCT01307423|617642189|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
170901288|NCT01307423|617642181|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
170901289|NCT01307423|617642182|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
170901290|NCT01307423|617642183|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
170901291|NCT01307423|617642184|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
170901292|NCT01307423|617642185|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
170901293|NCT01307423|617642186|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
170901294|NCT01307423|617642187|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
170901295|NCT01307423|617642188|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
170901296|NCT01307423|617642189|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
170642150|NCT01137604|616703437|FG003|Overall Study|Clinical progression/deterioration|0|||
170802672|NCT04622332|617287789|FG000|Overall Study|Protocol Violation|0|||
170802673|NCT04622332|617287790|FG001|Overall Study|Protocol Violation|1|||
170802674|NCT05966155|617287791|FG000|Overall Study|Death|1|||
170802675|NCT05966155|617287792|FG001|Overall Study|Death|2|||
170802676|NCT05966155|617287791|FG000|Overall Study|Lost to Follow-up|63|||
170802677|NCT05966155|617287792|FG001|Overall Study|Lost to Follow-up|67|||
170802678|NCT05966155|617287791|FG000|Overall Study|Protocol Violation|1|||
170802679|NCT05966155|617287792|FG001|Overall Study|Protocol Violation|0|||
170802680|NCT05966155|617287791|FG000|Overall Study|Withdrawal by Subject|8|||
170802681|NCT05966155|617287792|FG001|Overall Study|Withdrawal by Subject|9|||
170802682|NCT05966155|617287791|FG000|Overall Study|Enrolled Erroneously|0|||
170802683|NCT05966155|617287792|FG001|Overall Study|Enrolled Erroneously|1|||
170802684|NCT05966155|617287791|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
170802685|NCT05966155|617287792|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
170802686|NCT03890289|617287796|FG000|Overall Study|Adverse Event|1|||
170802687|NCT03890289|617287796|FG000|Overall Study|Physician Decision|1|||
170802688|NCT03890289|617287796|FG000|Overall Study|Lack of Efficacy|2|||
170802689|NCT00274261|617287797|FG000|Overall Study|Adverse Event|19|||
170802690|NCT00274261|617287798|FG001|Overall Study|Adverse Event|11|||
170802691|NCT00274261|617287797|FG000|Overall Study|Pregnancy|114|||
170802692|NCT00274261|617287798|FG001|Overall Study|Pregnancy|83|||
170802693|NCT00274261|617287797|FG000|Overall Study|Withdrawal by Subject|179|||
170802694|NCT00274261|617287798|FG001|Overall Study|Withdrawal by Subject|126|||
170802695|NCT00274261|617287797|FG000|Overall Study|Protocol Violation|71|||
170802696|NCT00274261|617287798|FG001|Overall Study|Protocol Violation|42|||
170802697|NCT00274261|617287797|FG000|Overall Study|Lost to Follow-up|106|||
170802698|NCT00274261|617287798|FG001|Overall Study|Lost to Follow-up|75|||
170802699|NCT02029235|617287800|FG000|Overall Study|Non-compliance with study meds or diary|4|||
170802700|NCT02029235|617287801|FG001|Overall Study|Non-compliance with study meds or diary|1|||
170901297|NCT01307423|617642181|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
170642151|NCT01776307|616703438|FG000|Overall Study|Not dosed|0|||
170642152|NCT01776307|616703439|FG001|Overall Study|Not dosed|0|||
170642153|NCT01776307|616703440|FG002|Overall Study|Not dosed|1|||
170642154|NCT02745145|616703441|FG000|Overall Study|Adverse Event|1|||
170642155|NCT02745145|616703442|FG001|Overall Study|Adverse Event|0|||
170642156|NCT02745145|616703443|FG002|Overall Study|Adverse Event|0|||
170642157|NCT02745145|616703441|FG000|Overall Study|Death|0|||
170642158|NCT02745145|616703442|FG001|Overall Study|Death|1|||
170642159|NCT02745145|616703443|FG002|Overall Study|Death|0|||
170642160|NCT02745145|616703441|FG000|Overall Study|Progressive disease|0|||
170642161|NCT02745145|616703442|FG001|Overall Study|Progressive disease|0|||
170642162|NCT02745145|616703443|FG002|Overall Study|Progressive disease|1|||
170642163|NCT02745145|616703441|FG000|Overall Study|Withdrew consent|1|||
170642164|NCT02745145|616703442|FG001|Overall Study|Withdrew consent|1|||
170642165|NCT02745145|616703443|FG002|Overall Study|Withdrew consent|1|||
170642166|NCT02745145|616703441|FG000|Overall Study|Study Termination|8|||
170642167|NCT02745145|616703442|FG001|Overall Study|Study Termination|3|||
170642168|NCT02745145|616703443|FG002|Overall Study|Study Termination|7|||
170642169|NCT02925416|616703447|FG000|Overall Study|Adverse Event|2|||
170642170|NCT02925416|616703448|FG001|Overall Study|Adverse Event|0|||
170642171|NCT01598506|616703449|FG000|Overall Study|Withdrawal by Subject|2|||
170642172|NCT02367833|616703455|FG000|Overall Study|Withdrawal by Subject|1|||
170642173|NCT02367833|616703456|FG001|Overall Study|Withdrawal by Subject|1|||
170642174|NCT02367833|616703457|FG002|Overall Study|Withdrawal by Subject|0|||
170642175|NCT01015638|616703460|FG000|Overall Study|Withdrawal by Subject|1|||
170642176|NCT01015638|616703461|FG001|Overall Study|Withdrawal by Subject|0|||
170642177|NCT02164461|616703462|FG000|Overall Study|Adverse Event|0|||
170642178|NCT02164461|616703463|FG001|Overall Study|Adverse Event|0|||
170802701|NCT02107261|617287806|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
170802702|NCT02107261|617287807|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
170551276|NCT01292473|616364702|FG000|Overall Study|Withdrawal by Subject|3|||
170551277|NCT01292473|616364703|FG001|Overall Study|Withdrawal by Subject|4|||
170551278|NCT01292473|616364704|FG002|Overall Study|Withdrawal by Subject|3|||
170551279|NCT01292473|616364705|FG003|Overall Study|Withdrawal by Subject|3|||
170551280|NCT01292473|616364702|FG000|Overall Study|Physician Decision|0|||
170551281|NCT01292473|616364703|FG001|Overall Study|Physician Decision|1|||
170551282|NCT01292473|616364704|FG002|Overall Study|Physician Decision|0|||
170551283|NCT01292473|616364705|FG003|Overall Study|Physician Decision|0|||
170802703|NCT02107261|617287806|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
170802704|NCT02107261|617287807|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
170802705|NCT01738438|617287809|FG000|Overall Study|Disease Progression|32|||
170551284|NCT01292473|616364702|FG000|Overall Study|Disease Progression|0|||
170802706|NCT01738438|617287809|FG000|Overall Study|Adverse Event|3|||
170802707|NCT02130557|617287810|FG000|Overall Study|Withdrawal by Subject|12|||
170802708|NCT02130557|617287811|FG001|Overall Study|Withdrawal by Subject|12|||
170802709|NCT02130557|617287810|FG000|Overall Study|Investigator Request|0|||
170802710|NCT02130557|617287811|FG001|Overall Study|Investigator Request|2|||
170802711|NCT02130557|617287810|FG000|Overall Study|Deceased|14|||
170802712|NCT02130557|617287811|FG001|Overall Study|Deceased|14|||
170802713|NCT02130557|617287810|FG000|Overall Study|Lost to Follow-up|6|||
170802714|NCT02130557|617287811|FG001|Overall Study|Lost to Follow-up|7|||
170802715|NCT02130557|617287810|FG000|Overall Study|Other|2|||
170802716|NCT02130557|617287811|FG001|Overall Study|Other|1|||
170551285|NCT01292473|616364703|FG001|Overall Study|Disease Progression|1|||
170551286|NCT01292473|616364704|FG002|Overall Study|Disease Progression|3|||
170642179|NCT02164461|616703464|FG002|Overall Study|Adverse Event|1|||
170642180|NCT02164461|616703462|FG000|Overall Study|Disease Progression|1|||
170802717|NCT02130557|617287810|FG000|Overall Study|Missing|2|||
170802718|NCT02130557|617287811|FG001|Overall Study|Missing|1|||
170802719|NCT01532999|617287812|FG000|Overall Study|Lost to Follow-up|14|||
170802720|NCT01532999|617287813|FG001|Overall Study|Lost to Follow-up|8|||
170802721|NCT01532999|617287812|FG000|Overall Study|Physician Decision|1|||
170802722|NCT01532999|617287813|FG001|Overall Study|Physician Decision|2|||
170802723|NCT01532999|617287812|FG000|Overall Study|Withdrawal by Subject|5|||
170802724|NCT01532999|617287813|FG001|Overall Study|Withdrawal by Subject|0|||
170802725|NCT01532999|617287812|FG000|Overall Study|Relocated|2|||
170802726|NCT01532999|617287813|FG001|Overall Study|Relocated|0|||
170802727|NCT01532999|617287812|FG000|Overall Study|should not have been randomized|1|||
170802728|NCT01532999|617287813|FG001|Overall Study|should not have been randomized|0|||
170901298|NCT01307423|617642182|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
170802729|NCT01532999|617287812|FG000|Overall Study|substantial noncompliance|2|||
170802730|NCT01532999|617287813|FG001|Overall Study|substantial noncompliance|0|||
170802731|NCT01532999|617287812|FG000|Overall Study|no show for week 9 assessments|6|||
170551287|NCT01292473|616364705|FG003|Overall Study|Disease Progression|6|||
170551288|NCT02451007|616364706|FG000|Overall Study|Withdrawal by Subject|4|||
170642181|NCT02164461|616703463|FG001|Overall Study|Disease Progression|3|||
170642182|NCT02164461|616703464|FG002|Overall Study|Disease Progression|4|||
170642183|NCT02164461|616703462|FG000|Overall Study|Withdrawal by Subject|0|||
170642184|NCT02164461|616703463|FG001|Overall Study|Withdrawal by Subject|3|||
170802732|NCT01532999|617287813|FG001|Overall Study|no show for week 9 assessments|4|||
170802733|NCT01532999|617287812|FG000|Overall Study|Adverse Event|0|||
170802734|NCT01532999|617287813|FG001|Overall Study|Adverse Event|1|||
170802735|NCT01532999|617287812|FG000|Overall Study|incarcerated|0|||
170802736|NCT01532999|617287813|FG001|Overall Study|incarcerated|1|||
170802737|NCT01532999|617287812|FG000|Overall Study|New job|0|||
170802738|NCT01532999|617287813|FG001|Overall Study|New job|2|||
170802739|NCT03333109|617287814|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
170802740|NCT03333109|617287815|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
170802741|NCT03333109|617287816|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
170802742|NCT03333109|617287814|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170802743|NCT03333109|617287815|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170802744|NCT03333109|617287816|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
170802745|NCT03333109|617287814|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
170802746|NCT03333109|617287815|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
170802747|NCT03333109|617287816|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
170802748|NCT03333109|617287814|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
170802749|NCT03333109|617287815|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
170901299|NCT01307423|617642183|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
170901300|NCT01307423|617642184|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
170901301|NCT01307423|617642185|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
170901302|NCT01307423|617642186|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
170901303|NCT01307423|617642187|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
170901304|NCT01307423|617642188|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
170901305|NCT01307423|617642189|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
170901306|NCT01307423|617642181|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
170901307|NCT01307423|617642182|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
170901308|NCT01307423|617642183|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
170901309|NCT01307423|617642184|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
170901310|NCT01307423|617642185|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
170901311|NCT01307423|617642186|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
170901312|NCT01307423|617642187|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
170901313|NCT01307423|617642188|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
170901314|NCT01307423|617642189|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
170901315|NCT01307423|617642181|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
170901316|NCT01307423|617642182|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
170901317|NCT01307423|617642183|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
170901318|NCT01307423|617642184|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
170901319|NCT01307423|617642185|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
170901320|NCT01307423|617642186|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
170901321|NCT01307423|617642187|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
170901322|NCT01307423|617642188|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
170901323|NCT01307423|617642189|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
170901324|NCT01307423|617642181|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
170901325|NCT01307423|617642182|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
170901326|NCT01307423|617642183|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
170901327|NCT01307423|617642184|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
170901328|NCT01307423|617642185|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
170901329|NCT01307423|617642186|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
170901330|NCT01307423|617642187|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
170901331|NCT01307423|617642188|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
170901332|NCT01307423|617642189|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
170901333|NCT01307423|617642181|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
170642185|NCT02164461|616703464|FG002|Overall Study|Withdrawal by Subject|0|||
170642186|NCT03530124|616703466|FG000|Overall Study|Withdrawal by Subject|0|||
170642187|NCT03530124|616703467|FG001|Overall Study|Withdrawal by Subject|1|||
170642188|NCT03530124|616703466|FG000|Overall Study|Protocol Violation|1|||
170642189|NCT03530124|616703467|FG001|Overall Study|Protocol Violation|0|||
170642190|NCT03530124|616703466|FG000|Overall Study|Discharged prior to study completion|1|||
170642191|NCT03530124|616703467|FG001|Overall Study|Discharged prior to study completion|0|||
170642192|NCT01120717|616703468|FG000|Overall Study|Withdrawal by Subject|11|||
170642193|NCT01120717|616703469|FG001|Overall Study|Withdrawal by Subject|6|||
170642194|NCT01120717|616703468|FG000|Overall Study|Adverse Event|10|||
170642195|NCT01120717|616703469|FG001|Overall Study|Adverse Event|6|||
170642196|NCT01120717|616703468|FG000|Overall Study|Protocol Deviation|2|||
170642197|NCT01120717|616703469|FG001|Overall Study|Protocol Deviation|5|||
170642198|NCT01120717|616703468|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170642199|NCT01120717|616703469|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170642200|NCT01120717|616703468|FG000|Overall Study|Lost to Follow-up|2|||
170642201|NCT01120717|616703469|FG001|Overall Study|Lost to Follow-up|3|||
170642202|NCT01120717|616703468|FG000|Overall Study|Death|3|||
170642203|NCT01120717|616703469|FG001|Overall Study|Death|1|||
170642204|NCT01120717|616703468|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
170642205|NCT01120717|616703469|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
170642206|NCT02447302|616703470|FG000|Overall Study|Physician Decision|1|||
170642207|NCT02447302|616703471|FG001|Overall Study|Physician Decision|0|||
170642208|NCT02447302|616703472|FG002|Overall Study|Physician Decision|0|||
170642209|NCT02447302|616703470|FG000|Overall Study|Adverse Event|4|||
170642210|NCT02447302|616703471|FG001|Overall Study|Adverse Event|3|||
170642211|NCT02447302|616703472|FG002|Overall Study|Adverse Event|0|||
170642212|NCT02447302|616703470|FG000|Overall Study|Withdrawal by Subject|0|||
170642213|NCT02447302|616703471|FG001|Overall Study|Withdrawal by Subject|1|||
170642214|NCT02447302|616703472|FG002|Overall Study|Withdrawal by Subject|5|||
170642215|NCT02447302|616703470|FG000|Overall Study|Sponsor Decision|0|||
170642216|NCT02447302|616703471|FG001|Overall Study|Sponsor Decision|0|||
170642217|NCT02447302|616703472|FG002|Overall Study|Sponsor Decision|1|||
170642218|NCT00910299|616703475|FG000|Overall Study|Withdrawal by Subject|16|||
170642219|NCT00910299|616703476|FG001|Overall Study|Withdrawal by Subject|13|||
170642220|NCT00910299|616703475|FG000|Overall Study|Sponsor Decision|58|||
170642221|NCT00910299|616703476|FG001|Overall Study|Sponsor Decision|60|||
170642222|NCT00910299|616703475|FG000|Overall Study|Didn't receive any study drug|2|||
170642223|NCT00910299|616703476|FG001|Overall Study|Didn't receive any study drug|1|||
170642224|NCT00635999|616703477|FG000|Overall Study|Withdrawal by Subject|4|||
170642225|NCT00635999|616703478|FG001|Overall Study|Withdrawal by Subject|2|||
170642226|NCT00635999|616703479|FG002|Overall Study|Withdrawal by Subject|1|||
170642227|NCT01456897|616703480|FG000|Overall Study|Adverse Event|19|||
170642228|NCT01456897|616703481|FG001|Overall Study|Adverse Event|22|||
170642229|NCT01456897|616703480|FG000|Overall Study|Protocol Violation|3|||
170642230|NCT01456897|616703481|FG001|Overall Study|Protocol Violation|4|||
170642231|NCT01456897|616703480|FG000|Overall Study|Physician Decision|5|||
170642232|NCT01456897|616703481|FG001|Overall Study|Physician Decision|3|||
170642233|NCT01456897|616703480|FG000|Overall Study|Withdrawal by Subject|44|||
170642234|NCT01456897|616703481|FG001|Overall Study|Withdrawal by Subject|17|||
170642235|NCT01456897|616703480|FG000|Overall Study|Lack of Efficacy|4|||
170642236|NCT01456897|616703481|FG001|Overall Study|Lack of Efficacy|11|||
170802750|NCT03333109|617287816|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
170802751|NCT03333109|617287814|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
170802752|NCT03333109|617287815|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
170802753|NCT03333109|617287816|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
170802754|NCT03333109|617287814|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
170802755|NCT03333109|617287815|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
170802756|NCT03333109|617287816|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
170802757|NCT03333109|617287814|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
170802758|NCT03333109|617287815|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
170802759|NCT03333109|617287816|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
170802760|NCT03333109|617287814|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
170642237|NCT01396070|616703488|FG000|Overall Study|Withdrawal by Subject|2|||
170642238|NCT01396070|616703488|FG000|Overall Study|Death|2|||
170802761|NCT03333109|617287815|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
170642239|NCT01396070|616703488|FG000|Overall Study|Adverse Event|8|||
170901334|NCT01307423|617642182|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
170901335|NCT01307423|617642183|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
170901336|NCT01307423|617642184|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
170901337|NCT01307423|617642185|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
170901338|NCT01307423|617642186|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
170901339|NCT01307423|617642187|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
170901340|NCT01307423|617642188|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
170802762|NCT03333109|617287816|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
170802763|NCT00918203|617287818|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
170901341|NCT01307423|617642189|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
170551289|NCT02451007|616364706|FG000|Overall Study|Adverse Event|1|||
170551290|NCT02451007|616364706|FG000|Overall Study|Disease Progression|2|||
170551291|NCT00449787|616364707|FG000|Overall Study|Lost to Follow-up|10|||
170802764|NCT00918203|617287819|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
170802765|NCT00918203|617287820|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
170802766|NCT00918203|617287818|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
170802767|NCT00918203|617287819|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
170802768|NCT00918203|617287820|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
170802769|NCT00918203|617287818|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
170802770|NCT00918203|617287819|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
170802771|NCT00918203|617287820|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
170901342|NCT01307423|617642181|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
170901343|NCT01307423|617642182|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
170901344|NCT01307423|617642183|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
170901345|NCT01307423|617642184|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
170901346|NCT01307423|617642185|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
170901347|NCT01307423|617642186|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
170901348|NCT01307423|617642187|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
170901349|NCT01307423|617642188|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
170901350|NCT01307423|617642189|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
170901351|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170901352|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
170901353|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
170901354|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170901355|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170901356|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170901357|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170901358|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
170901359|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
170901360|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170901361|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
170901362|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
170901363|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170901364|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170901365|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170901366|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170901367|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
170901368|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
170901369|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
170901370|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
170901371|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
170901372|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
170901373|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
170901374|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
170901375|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
170901376|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
170901377|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
170901378|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170901379|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
170901380|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
170901381|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170901382|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170901383|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170901384|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170901385|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
170551292|NCT00449787|616364708|FG001|Overall Study|Lost to Follow-up|8|||
170551293|NCT00449787|616364707|FG000|Overall Study|Did not require medication|95|||
170802772|NCT00918203|617287818|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
170802773|NCT00918203|617287819|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
170802774|NCT00918203|617287820|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
170802775|NCT04066075|617287821|FG000|Overall Study|Lost to Follow-up|3|||
170802776|NCT04066075|617287822|FG001|Overall Study|Lost to Follow-up|3|||
170802777|NCT04066075|617287821|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
170802778|NCT04066075|617287822|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
170802779|NCT04066075|617287821|FG000|Overall Study|Withdrawal by Subject|2|||
170802780|NCT04066075|617287822|FG001|Overall Study|Withdrawal by Subject|2|||
170802781|NCT00701701|617287825|FG000|Overall Study|Withdrawal by Subject|0|||
170802782|NCT00701701|617287826|FG001|Overall Study|Withdrawal by Subject|1|||
170802783|NCT00701701|617287825|FG000|Overall Study|Adverse Event|0|||
170802784|NCT00701701|617287826|FG001|Overall Study|Adverse Event|1|||
170802785|NCT01830595|617287827|FG000|First Period|Withdrawal by Subject|1|||
170802786|NCT01830595|617287828|FG001|First Period|Withdrawal by Subject|3|||
170802787|NCT01830595|617287827|FG000|Washout|Withdrawal by Subject|2|||
170802788|NCT01830595|617287828|FG001|Washout|Withdrawal by Subject|2|||
170802789|NCT03834740|617287833|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
170802790|NCT03834740|617287834|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
170802791|NCT03834740|617287835|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
170802792|NCT01208974|617287836|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
170802793|NCT01208974|617287837|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
170802794|NCT01208974|617287838|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
170802795|NCT01208974|617287839|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
170802796|NCT01208974|617287836|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
170802797|NCT01208974|617287837|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
170802798|NCT01208974|617287838|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
170802799|NCT01208974|617287839|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
170802800|NCT01208974|617287836|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
170802801|NCT01208974|617287837|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
170802802|NCT01208974|617287838|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
170802803|NCT01208974|617287839|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
170802804|NCT05827068|617287840|FG000|Overall Study|Lost to Follow-up|1|||
170802805|NCT05827068|617287841|FG001|Overall Study|Lost to Follow-up|4|||
170802806|NCT05827068|617287842|FG002|Overall Study|Lost to Follow-up|1|||
170802807|NCT05827068|617287843|FG003|Overall Study|Lost to Follow-up|1|||
170802808|NCT05827068|617287844|FG004|Overall Study|Lost to Follow-up|2|||
170802809|NCT05827068|617287845|FG005|Overall Study|Lost to Follow-up|4|||
170802810|NCT05827068|617287846|FG006|Overall Study|Lost to Follow-up|1|||
170802811|NCT05827068|617287840|FG000|Overall Study|Withdrawal by Subject|4|||
170802812|NCT05827068|617287841|FG001|Overall Study|Withdrawal by Subject|0|||
170802813|NCT05827068|617287842|FG002|Overall Study|Withdrawal by Subject|1|||
170802814|NCT05827068|617287843|FG003|Overall Study|Withdrawal by Subject|2|||
170802815|NCT05827068|617287844|FG004|Overall Study|Withdrawal by Subject|3|||
170802816|NCT05827068|617287845|FG005|Overall Study|Withdrawal by Subject|0|||
170802817|NCT05827068|617287846|FG006|Overall Study|Withdrawal by Subject|1|||
170802818|NCT05827068|617287840|FG000|Overall Study|Physician Decision|0|||
170802819|NCT05827068|617287841|FG001|Overall Study|Physician Decision|0|||
170802820|NCT05827068|617287842|FG002|Overall Study|Physician Decision|0|||
170802821|NCT05827068|617287843|FG003|Overall Study|Physician Decision|0|||
170802822|NCT05827068|617287844|FG004|Overall Study|Physician Decision|1|||
170802823|NCT05827068|617287845|FG005|Overall Study|Physician Decision|0|||
170802824|NCT05827068|617287846|FG006|Overall Study|Physician Decision|1|||
170802825|NCT05827068|617287840|FG000|Overall Study|Other Than Specified|0|||
170802826|NCT05827068|617287841|FG001|Overall Study|Other Than Specified|1|||
170802827|NCT05827068|617287842|FG002|Overall Study|Other Than Specified|0|||
170802828|NCT05827068|617287843|FG003|Overall Study|Other Than Specified|0|||
170802829|NCT05827068|617287844|FG004|Overall Study|Other Than Specified|0|||
170802830|NCT05827068|617287845|FG005|Overall Study|Other Than Specified|0|||
170802831|NCT05827068|617287846|FG006|Overall Study|Other Than Specified|0|||
170802832|NCT00227266|617287847|FG000|Overall Study|Withdrawal by Subject|0|||
170802833|NCT00227266|617287848|FG001|Overall Study|Withdrawal by Subject|0|||
170802834|NCT00227266|617287849|FG002|Overall Study|Withdrawal by Subject|1|||
170802835|NCT00227266|617287847|FG000|Overall Study|Protocol Violation|1|||
170802836|NCT00227266|617287848|FG001|Overall Study|Protocol Violation|0|||
170802837|NCT00227266|617287849|FG002|Overall Study|Protocol Violation|1|||
170802838|NCT00227266|617287847|FG000|Overall Study|Excessive weight gain|0|||
170802839|NCT00227266|617287848|FG001|Overall Study|Excessive weight gain|0|||
170802840|NCT00227266|617287849|FG002|Overall Study|Excessive weight gain|2|||
170802841|NCT02678689|617287850|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
170802842|NCT02678689|617287851|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
170802843|NCT02761187|617287855|FG000|Overall Study|Too ill to Participate|13|||
170642240|NCT01396070|616703488|FG000|Overall Study|Physician Decision|3|||
170802844|NCT02761187|617287856|FG001|Overall Study|Too ill to Participate|8|||
170802845|NCT02761187|617287855|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
170802846|NCT02761187|617287856|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
170802847|NCT02761187|617287855|FG000|Overall Study|Patient withdrew consent|64|||
170802848|NCT02761187|617287856|FG001|Overall Study|Patient withdrew consent|58|||
170802849|NCT02761187|617287855|FG000|Overall Study|Physician discretion|4|||
170802850|NCT02761187|617287856|FG001|Overall Study|Physician discretion|8|||
170802851|NCT02761187|617287855|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
170802852|NCT02761187|617287856|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
170802853|NCT02761187|617287855|FG000|Overall Study|On Hospice|20|||
170802854|NCT02761187|617287856|FG001|Overall Study|On Hospice|26|||
170802855|NCT02761187|617287855|FG000|Overall Study|Deceased|474|||
170802856|NCT02761187|617287856|FG001|Overall Study|Deceased|642|||
170802857|NCT02761187|617287855|FG000|Overall Study|Lost to Follow-up|73|||
170802858|NCT02761187|617287856|FG001|Overall Study|Lost to Follow-up|63|||
170802859|NCT02761187|617287855|FG000|Overall Study|Due to study discontinued at site|100|||
170802860|NCT02761187|617287856|FG001|Overall Study|Due to study discontinued at site|85|||
170802861|NCT02761187|617287855|FG000|Overall Study|Reason not Specified|1484|||
170802862|NCT02761187|617287856|FG001|Overall Study|Reason not Specified|937|||
170802863|NCT03959423|617287857|FG000|Overall Study|Withdrawal by Subject|2|||
170802864|NCT03959423|617287858|FG001|Overall Study|Withdrawal by Subject|3|||
170802865|NCT03959423|617287857|FG000|Overall Study|Physician Decision|0|||
170802866|NCT03959423|617287858|FG001|Overall Study|Physician Decision|1|||
170802867|NCT03959423|617287857|FG000|Overall Study|Lost to Follow-up|1|||
170802868|NCT03959423|617287858|FG001|Overall Study|Lost to Follow-up|0|||
170802869|NCT03959423|617287857|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
170802870|NCT03959423|617287858|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170802871|NCT04926740|617287860|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
170802872|NCT04926740|617287861|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
170802873|NCT04926740|617287860|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
170802874|NCT04926740|617287861|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
170802875|NCT00593840|617287862|FG000|Overall Study|Withdrawal by Subject|1|||
170802876|NCT02941549|617289013|FG000|Overall Study|Adverse Event|1|||
170802877|NCT02941549|617289014|FG001|Overall Study|Adverse Event|0|||
170802878|NCT02941549|617289015|FG002|Overall Study|Adverse Event|0|||
170802879|NCT02941549|617289013|FG000|Overall Study|Withdrawal by Subject|2|||
170802880|NCT02941549|617289014|FG001|Overall Study|Withdrawal by Subject|1|||
170802881|NCT02941549|617289015|FG002|Overall Study|Withdrawal by Subject|2|||
170802882|NCT00705406|617289016|FG000|Overall Study|Lost to Follow-up|3|||
170802883|NCT00705406|617289017|FG001|Overall Study|Lost to Follow-up|3|||
170802884|NCT00705406|617289016|FG000|Overall Study|Did not receive study drug|1|||
170802885|NCT00705406|617289017|FG001|Overall Study|Did not receive study drug|2|||
170802886|NCT03611556|617289018|FG000|Overall Study|Death|7|||
170802887|NCT03611556|617289019|FG001|Overall Study|Death|7|||
170802888|NCT03611556|617289020|FG002|Overall Study|Death|3|||
170802889|NCT03611556|617289021|FG003|Overall Study|Death|8|||
170802890|NCT03611556|617289022|FG004|Overall Study|Death|47|||
170802891|NCT03611556|617289023|FG005|Overall Study|Death|32|||
170802892|NCT03611556|617289024|FG006|Overall Study|Death|53|||
170802893|NCT03611556|617289018|FG000|Overall Study|Withdrawal by Subject|0|||
170802894|NCT03611556|617289019|FG001|Overall Study|Withdrawal by Subject|0|||
170802895|NCT03611556|617289020|FG002|Overall Study|Withdrawal by Subject|0|||
170802896|NCT03611556|617289021|FG003|Overall Study|Withdrawal by Subject|0|||
170802897|NCT03611556|617289022|FG004|Overall Study|Withdrawal by Subject|4|||
170802898|NCT03611556|617289023|FG005|Overall Study|Withdrawal by Subject|2|||
170802899|NCT03611556|617289024|FG006|Overall Study|Withdrawal by Subject|4|||
170802900|NCT03611556|617289018|FG000|Overall Study|Sponsor decision|0|||
170802901|NCT03611556|617289019|FG001|Overall Study|Sponsor decision|0|||
170802902|NCT03611556|617289020|FG002|Overall Study|Sponsor decision|0|||
170802903|NCT03611556|617289021|FG003|Overall Study|Sponsor decision|0|||
170802904|NCT03611556|617289022|FG004|Overall Study|Sponsor decision|9|||
170802905|NCT03611556|617289023|FG005|Overall Study|Sponsor decision|4|||
170802906|NCT03611556|617289024|FG006|Overall Study|Sponsor decision|12|||
170802907|NCT03611556|617289018|FG000|Overall Study|Reasons|0|||
170551294|NCT00449787|616364708|FG001|Overall Study|Did not require medication|92|||
170802908|NCT03611556|617289019|FG001|Overall Study|Reasons|0|||
170802909|NCT03611556|617289020|FG002|Overall Study|Reasons|0|||
170802910|NCT03611556|617289021|FG003|Overall Study|Reasons|0|||
170802911|NCT03611556|617289022|FG004|Overall Study|Reasons|2|||
170802912|NCT03611556|617289023|FG005|Overall Study|Reasons|0|||
170802913|NCT03611556|617289024|FG006|Overall Study|Reasons|1|||
170802914|NCT05036278|617289033|FG000|Overall Study|Withdrawal by Subject|1|||
170802915|NCT05036278|617289033|FG000|Overall Study|Adverse Event|1|||
170802916|NCT01458366|617289034|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
170802917|NCT01458366|617289035|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
170802918|NCT01458366|617289036|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
170802919|NCT01458366|617289037|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
170802920|NCT01458366|617289038|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
170802921|NCT01458366|617289034|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
170802922|NCT01458366|617289035|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
170802923|NCT01458366|617289036|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
170802924|NCT01458366|617289037|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
170802925|NCT01458366|617289038|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
170802926|NCT04647487|617289041|FG000|Overall Study|Protocol Deviation|0|||
170802927|NCT04647487|617289042|FG001|Overall Study|Protocol Deviation|0|||
170802928|NCT04647487|617289043|FG002|Overall Study|Protocol Deviation|1|||
170802929|NCT04647487|617289041|FG000|Overall Study|Withdrawal by Subject|1|||
170802930|NCT04647487|617289042|FG001|Overall Study|Withdrawal by Subject|0|||
170802931|NCT04647487|617289043|FG002|Overall Study|Withdrawal by Subject|2|||
170802932|NCT02787005|617289044|FG000|Overall Study|Adverse Event|24|||
170802933|NCT02787005|617289045|FG001|Overall Study|Adverse Event|9|||
170802934|NCT02787005|617289046|FG002|Overall Study|Adverse Event|9|||
170802935|NCT02787005|617289047|FG003|Overall Study|Adverse Event|7|||
170802936|NCT02787005|617289048|FG004|Overall Study|Adverse Event|2|||
170802937|NCT02787005|617289044|FG000|Overall Study|Death|100|||
170802938|NCT02787005|617289045|FG001|Overall Study|Death|53|||
170802939|NCT02787005|617289046|FG002|Overall Study|Death|48|||
170551295|NCT01716559|616364709|FG000|Overall Study|Adverse Event|11|||
170551296|NCT01716559|616364709|FG000|Overall Study|Death|21|||
170551297|NCT01716559|616364709|FG000|Overall Study|Withdrawal by Subject|4|||
170551298|NCT01716559|616364709|FG000|Overall Study|Other withdrawal reason|75|||
170551299|NCT03701074|616364710|FG000|Overall Study|Physician Decision|1|||
170551300|NCT03701074|616364711|FG001|Overall Study|Physician Decision|0|||
170551301|NCT00348374|616364712|FG000|Overall Study|Adverse Event|1|||
170551302|NCT00348374|616364713|FG001|Overall Study|Adverse Event|4|||
170551303|NCT00348374|616364712|FG000|Overall Study|Lost to Follow-up|1|||
170551304|NCT00348374|616364713|FG001|Overall Study|Lost to Follow-up|3|||
170551305|NCT00348374|616364712|FG000|Overall Study|Withdrawal by Subject|5|||
170551306|NCT00348374|616364713|FG001|Overall Study|Withdrawal by Subject|5|||
170551307|NCT00348374|616364712|FG000|Overall Study|Other|11|||
170551308|NCT00348374|616364713|FG001|Overall Study|Other|12|||
170551309|NCT00348374|616364712|FG000|Overall Study|ongoing at date of cutoff|1|||
170551310|NCT00348374|616364713|FG001|Overall Study|ongoing at date of cutoff|1|||
170551311|NCT00348374|616364712|FG000|Overall Study|randomized but did not receive treatment|0|||
170802940|NCT02787005|617289047|FG003|Overall Study|Death|69|||
170802941|NCT02787005|617289048|FG004|Overall Study|Death|38|||
170802942|NCT02787005|617289044|FG000|Overall Study|Sponsor Decision|7|||
170802943|NCT02787005|617289045|FG001|Overall Study|Sponsor Decision|4|||
170802944|NCT02787005|617289046|FG002|Overall Study|Sponsor Decision|0|||
170802945|NCT02787005|617289047|FG003|Overall Study|Sponsor Decision|4|||
170802946|NCT02787005|617289048|FG004|Overall Study|Sponsor Decision|5|||
170802947|NCT02787005|617289044|FG000|Overall Study|Withdrawal by Subject|2|||
170802948|NCT02787005|617289045|FG001|Overall Study|Withdrawal by Subject|1|||
170802949|NCT02787005|617289046|FG002|Overall Study|Withdrawal by Subject|1|||
170802950|NCT02787005|617289047|FG003|Overall Study|Withdrawal by Subject|0|||
170802951|NCT02787005|617289048|FG004|Overall Study|Withdrawal by Subject|1|||
170802952|NCT02787005|617289044|FG000|Overall Study|Screen Failure|0|||
170802953|NCT02787005|617289045|FG001|Overall Study|Screen Failure|2|||
170802954|NCT02787005|617289046|FG002|Overall Study|Screen Failure|0|||
170802955|NCT02787005|617289047|FG003|Overall Study|Screen Failure|0|||
170802956|NCT02787005|617289048|FG004|Overall Study|Screen Failure|1|||
170802957|NCT02787005|617289044|FG000|Overall Study|Lost to Follow-up|0|||
170802958|NCT02787005|617289045|FG001|Overall Study|Lost to Follow-up|0|||
170802959|NCT02787005|617289046|FG002|Overall Study|Lost to Follow-up|0|||
170802960|NCT02787005|617289047|FG003|Overall Study|Lost to Follow-up|1|||
170802961|NCT02787005|617289048|FG004|Overall Study|Lost to Follow-up|0|||
170802962|NCT04795167|617289054|FG000|Overall Study|Death|1|||
170802963|NCT04795167|617289055|FG001|Overall Study|Death|18|||
170802964|NCT04795167|617289056|FG002|Overall Study|Death|1|||
170642241|NCT01396070|616703488|FG000|Overall Study|Lack of Efficacy|4|||
170802965|NCT04795167|617289054|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
170802966|NCT04795167|617289055|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
170802967|NCT04795167|617289056|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
170802968|NCT01753999|617289057|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
170802969|NCT01753999|617289058|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
170802970|NCT01753999|617289057|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
170802971|NCT01753999|617289058|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
170802972|NCT01753999|617289057|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
170642242|NCT01561313|616703489|FG000|Overall Study|Withdrawal by Subject|1|||
170642243|NCT01561313|616703490|FG001|Overall Study|Withdrawal by Subject|0|||
170642244|NCT01561313|616703489|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
170642245|NCT01561313|616703490|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
170642246|NCT02695420|616703491|FG000|Overall Study|Death|0|||
170642247|NCT02695420|616703492|FG001|Overall Study|Death|1|||
170642248|NCT02695420|616703493|FG002|Overall Study|Death|0|||
170642249|NCT02695420|616703494|FG003|Overall Study|Death|0|||
170642250|NCT01742286|616703498|FG000|Escalation Phase|Administrative problems|1|||
170642251|NCT01742286|616703499|FG001|Escalation Phase|Administrative problems|1|||
170642252|NCT01742286|616703500|FG002|Escalation Phase|Administrative problems|0|||
170642253|NCT01742286|616703501|FG003|Escalation Phase|Administrative problems|0|||
170802973|NCT01753999|617289058|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
170642254|NCT01742286|616703502|FG004|Escalation Phase|Administrative problems|0|||
170642255|NCT01742286|616703503|FG005|Escalation Phase|Administrative problems|0|||
170802974|NCT01753999|617289057|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
170802975|NCT01753999|617289058|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
170802976|NCT01753999|617289057|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
170802977|NCT01753999|617289058|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
170802978|NCT01753999|617289057|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
170802979|NCT01753999|617289058|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
170802980|NCT02392234|617289061|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
170802981|NCT02392234|617289062|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
170802982|NCT02392234|617289063|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
170802983|NCT02392234|617289064|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
170802984|NCT02392234|617289065|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
170802985|NCT02392234|617289066|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
170802986|NCT02392234|617289061|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
170802987|NCT02392234|617289062|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
170802988|NCT02392234|617289063|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
170802989|NCT02392234|617289064|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
170551312|NCT00348374|616364713|FG001|Overall Study|randomized but did not receive treatment|7|||
170551313|NCT00458705|616364721|FG000|Overall Study|Adverse Event|4|||
170802990|NCT02392234|617289065|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
170551314|NCT00458705|616364721|FG000|Overall Study|Not Treated|1|||
170551315|NCT02180672|616364722|FG000|Overall Study|Lost to Follow-up|5|||
170551316|NCT02180672|616364723|FG001|Overall Study|Lost to Follow-up|7|||
170551317|NCT02837952|616364724|FG000|Overall Study|Adverse Event|0|||
170551318|NCT02837952|616364725|FG001|Overall Study|Adverse Event|1|||
170551319|NCT02837952|616364724|FG000|Overall Study|Withdrawal by Subject|4|||
170551320|NCT02837952|616364725|FG001|Overall Study|Withdrawal by Subject|5|||
170551321|NCT02837952|616364724|FG000|Overall Study|Medication Error|1|||
170551322|NCT02837952|616364725|FG001|Overall Study|Medication Error|0|||
170551323|NCT02070380|616364726|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
170551324|NCT02070380|616364727|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
170551325|NCT02070380|616364728|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
170551326|NCT02070380|616364729|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
170551327|NCT02070380|616364726|FG000|Second Injection|Image sets missing or technically inadeq|0|||
170551328|NCT02070380|616364727|FG001|Second Injection|Image sets missing or technically inadeq|1|||
170551329|NCT02070380|616364728|FG002|Second Injection|Image sets missing or technically inadeq|0|||
170551330|NCT02070380|616364729|FG003|Second Injection|Image sets missing or technically inadeq|0|||
170551331|NCT02070380|616364726|FG000|Second Injection|Protocol Violation|0|||
170551332|NCT02070380|616364727|FG001|Second Injection|Protocol Violation|1|||
170551333|NCT02070380|616364728|FG002|Second Injection|Protocol Violation|1|||
170551334|NCT02070380|616364729|FG003|Second Injection|Protocol Violation|5|||
170551335|NCT03596983|616364741|FG000|Overall Study|Withdrawal by Subject|3|||
170551336|NCT03071965|616364742|FG000|Overall Study|Adverse Event|0|||
170802991|NCT02392234|617289066|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
170551337|NCT03071965|616364743|FG001|Overall Study|Adverse Event|0|||
170802992|NCT02392234|617289061|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
170802993|NCT02392234|617289062|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
170551338|NCT03071965|616364744|FG002|Overall Study|Adverse Event|1|||
170551339|NCT03071965|616364745|FG003|Overall Study|Adverse Event|0|||
170642256|NCT01742286|616703504|FG006|Escalation Phase|Administrative problems|2|||
170642257|NCT01742286|616703498|FG000|Escalation Phase|Adverse Event|0|||
170642258|NCT01742286|616703499|FG001|Escalation Phase|Adverse Event|1|||
170642259|NCT01742286|616703500|FG002|Escalation Phase|Adverse Event|2|||
170642260|NCT01742286|616703501|FG003|Escalation Phase|Adverse Event|0|||
170642261|NCT01742286|616703502|FG004|Escalation Phase|Adverse Event|0|||
170642262|NCT01742286|616703503|FG005|Escalation Phase|Adverse Event|1|||
170642263|NCT01742286|616703504|FG006|Escalation Phase|Adverse Event|0|||
170642264|NCT01742286|616703498|FG000|Escalation Phase|Disease progression|3|||
170642265|NCT01742286|616703499|FG001|Escalation Phase|Disease progression|7|||
170642266|NCT01742286|616703500|FG002|Escalation Phase|Disease progression|4|||
170642267|NCT01742286|616703501|FG003|Escalation Phase|Disease progression|1|||
170642268|NCT01742286|616703502|FG004|Escalation Phase|Disease progression|4|||
170642269|NCT01742286|616703503|FG005|Escalation Phase|Disease progression|3|||
170642270|NCT01742286|616703504|FG006|Escalation Phase|Disease progression|2|||
170642271|NCT01742286|616703498|FG000|Escalation Phase|Death|0|||
170642272|NCT01742286|616703499|FG001|Escalation Phase|Death|0|||
170642273|NCT01742286|616703500|FG002|Escalation Phase|Death|0|||
170642274|NCT01742286|616703501|FG003|Escalation Phase|Death|0|||
170642275|NCT01742286|616703502|FG004|Escalation Phase|Death|0|||
170642276|NCT01742286|616703503|FG005|Escalation Phase|Death|1|||
170642277|NCT01742286|616703504|FG006|Escalation Phase|Death|0|||
170642278|NCT01742286|616703498|FG000|Escalation Phase|Physician Decision|0|||
170642279|NCT01742286|616703499|FG001|Escalation Phase|Physician Decision|3|||
170642280|NCT01742286|616703500|FG002|Escalation Phase|Physician Decision|0|||
170901386|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
170901387|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170901388|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
170901389|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170901390|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170901391|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170901392|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170901393|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170901394|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
170901395|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
170901396|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170642281|NCT01742286|616703501|FG003|Escalation Phase|Physician Decision|1|||
170642282|NCT01742286|616703502|FG004|Escalation Phase|Physician Decision|0|||
170642283|NCT01742286|616703503|FG005|Escalation Phase|Physician Decision|0|||
170642284|NCT01742286|616703504|FG006|Escalation Phase|Physician Decision|2|||
170642285|NCT01742286|616703498|FG000|Escalation Phase|Subject/guardian decision|1|||
170642286|NCT01742286|616703499|FG001|Escalation Phase|Subject/guardian decision|0|||
170802994|NCT02392234|617289063|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
170802995|NCT02392234|617289064|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
170802996|NCT02392234|617289065|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
170802997|NCT02392234|617289066|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
170802998|NCT02392234|617289061|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
170802999|NCT02392234|617289062|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
170803000|NCT02392234|617289063|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
170803001|NCT02392234|617289064|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
170803002|NCT02392234|617289065|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
170803003|NCT02392234|617289066|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
170803004|NCT02392234|617289061|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
170803005|NCT02392234|617289062|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
170803006|NCT02392234|617289063|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
170803007|NCT02392234|617289064|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
170803008|NCT02392234|617289065|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
170803009|NCT02392234|617289066|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
170803010|NCT02392234|617289061|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
170803011|NCT02392234|617289062|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
170803012|NCT02392234|617289063|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
170803013|NCT02392234|617289064|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
170803014|NCT02392234|617289065|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
170803015|NCT02392234|617289066|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
170803016|NCT02392234|617289061|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
170803017|NCT02392234|617289062|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
170803018|NCT02392234|617289063|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
170803019|NCT02392234|617289064|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
170803020|NCT02392234|617289065|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
170803021|NCT02392234|617289066|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
170803022|NCT02392234|617289061|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
170803023|NCT02392234|617289062|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
170803024|NCT02392234|617289063|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
170901397|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
170901398|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
170803025|NCT02392234|617289064|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
170803026|NCT02392234|617289065|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
170803027|NCT02392234|617289066|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
170803028|NCT02816398|617289067|FG000|Overall Study|Death|5|||
170803029|NCT02816398|617289067|FG000|Overall Study|Lack of Efficacy|8|||
170803030|NCT02816398|617289067|FG000|Overall Study|Lost to Follow-up|1|||
170803031|NCT01387516|617289068|FG000|Overall Study|Lost to Follow-up|4|||
170803032|NCT01387516|617289069|FG001|Overall Study|Lost to Follow-up|4|||
170803033|NCT01387516|617289070|FG002|Overall Study|Lost to Follow-up|2|||
170803034|NCT01387516|617289071|FG003|Overall Study|Lost to Follow-up|3|||
170803035|NCT01387516|617289068|FG000|Overall Study|Withdrawal by Subject|1|||
170803036|NCT01387516|617289069|FG001|Overall Study|Withdrawal by Subject|1|||
170803037|NCT01387516|617289070|FG002|Overall Study|Withdrawal by Subject|2|||
170803038|NCT01387516|617289071|FG003|Overall Study|Withdrawal by Subject|0|||
170803039|NCT01387516|617289068|FG000|Overall Study|Death|0|||
170803040|NCT01387516|617289069|FG001|Overall Study|Death|0|||
170803041|NCT01387516|617289070|FG002|Overall Study|Death|0|||
170803042|NCT01387516|617289071|FG003|Overall Study|Death|1|||
170803043|NCT03582475|617289072|FG000|Treatment Period|Withdrawal by Subject|0|||
170803044|NCT03582475|617289073|FG001|Treatment Period|Withdrawal by Subject|1|||
170803045|NCT03582475|617289072|FG000|Follow-up Period|Withdrawal by Subject|0|||
170803046|NCT03582475|617289073|FG001|Follow-up Period|Withdrawal by Subject|1|||
170803047|NCT00174252|617289077|FG000|Overall Study|Protocol Violation|2|||
170803048|NCT01588951|617289078|FG000|Overall Study|Ineligible in retrospect|0|||
170803049|NCT01588951|617289079|FG001|Overall Study|Ineligible in retrospect|0|||
170803050|NCT01588951|617289080|FG002|Overall Study|Ineligible in retrospect|1|||
170803051|NCT03683576|617289081|FG000|Overall Study|Withdrawal by Subject|2|||
170803052|NCT03683576|617289082|FG001|Overall Study|Withdrawal by Subject|0|||
170803053|NCT03683576|617289083|FG002|Overall Study|Withdrawal by Subject|8|||
170803054|NCT03683576|617289084|FG003|Overall Study|Withdrawal by Subject|3|||
170803055|NCT03683576|617289081|FG000|Overall Study|Adverse Event|3|||
170803056|NCT03683576|617289082|FG001|Overall Study|Adverse Event|0|||
170803057|NCT03683576|617289083|FG002|Overall Study|Adverse Event|0|||
170803058|NCT03683576|617289084|FG003|Overall Study|Adverse Event|4|||
170803059|NCT03683576|617289081|FG000|Overall Study|Lack of Efficacy|1|||
170803060|NCT03683576|617289082|FG001|Overall Study|Lack of Efficacy|0|||
170803061|NCT03683576|617289083|FG002|Overall Study|Lack of Efficacy|1|||
170901399|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170901400|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170901401|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170901402|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170803062|NCT03683576|617289084|FG003|Overall Study|Lack of Efficacy|1|||
170901403|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
170901404|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
170901405|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170901406|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
170901407|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
170901408|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170901409|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170901410|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170901411|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170901412|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
170901413|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
170901414|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
170901415|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
170901416|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
170901417|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
170901418|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
170901419|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
170901420|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
170901421|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
170901422|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
170901423|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170901424|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
170901425|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
170901426|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170901427|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170901428|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170803063|NCT03683576|617289081|FG000|Overall Study|Lost to Follow-up|0|||
170803064|NCT03683576|617289082|FG001|Overall Study|Lost to Follow-up|1|||
170803065|NCT03683576|617289083|FG002|Overall Study|Lost to Follow-up|2|||
170803066|NCT03683576|617289084|FG003|Overall Study|Lost to Follow-up|0|||
170803067|NCT03683576|617289081|FG000|Overall Study|Other, Not Specified|0|||
170803068|NCT03683576|617289082|FG001|Overall Study|Other, Not Specified|2|||
170803069|NCT03683576|617289083|FG002|Overall Study|Other, Not Specified|0|||
170803070|NCT03683576|617289084|FG003|Overall Study|Other, Not Specified|0|||
170803071|NCT03683576|617289081|FG000|Overall Study|Protocol Violation|0|||
170803072|NCT03683576|617289082|FG001|Overall Study|Protocol Violation|1|||
170803073|NCT03683576|617289083|FG002|Overall Study|Protocol Violation|1|||
170803074|NCT03683576|617289084|FG003|Overall Study|Protocol Violation|0|||
170803075|NCT02744066|617289085|FG000|Overall Study|Withdrawal by parent|0|||
170803076|NCT02744066|617289086|FG001|Overall Study|Withdrawal by parent|1|||
170803077|NCT02744066|617289085|FG000|Overall Study|Discharged from NICU prior to completion|0|||
170803078|NCT02744066|617289086|FG001|Overall Study|Discharged from NICU prior to completion|4|||
170803079|NCT05509816|617289087|FG000|Overall Study|Lost to Follow-up|1|||
170803080|NCT01400958|617289090|FG000|Overall Study|Physician Decision|0|||
170803081|NCT01400958|617289091|FG001|Overall Study|Physician Decision|1|||
170803082|NCT01400958|617289090|FG000|Overall Study|Withdrawal by Subject|0|||
170803083|NCT01400958|617289091|FG001|Overall Study|Withdrawal by Subject|1|||
170803084|NCT01400958|617289090|FG000|Overall Study|Adverse Event|1|||
170803085|NCT01400958|617289091|FG001|Overall Study|Adverse Event|0|||
170642287|NCT01742286|616703500|FG002|Escalation Phase|Subject/guardian decision|0|||
170803086|NCT04337931|617289092|FG000|Overall Study|Death|4|||
170803087|NCT04337931|617289093|FG001|Overall Study|Death|1|||
170803088|NCT04337931|617289094|FG002|Overall Study|Death|7|||
170803089|NCT04337931|617289092|FG000|Overall Study|Withdrawal by Subject|0|||
170901429|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170901430|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
170901431|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
170901432|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170901433|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
170901434|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
170901435|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170901436|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170901437|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170901438|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170901439|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
170901440|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
170901441|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170901442|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
170901443|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170901444|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170901445|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170901446|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170901447|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170901448|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
170642288|NCT01742286|616703501|FG003|Escalation Phase|Subject/guardian decision|0|||
170642289|NCT01742286|616703502|FG004|Escalation Phase|Subject/guardian decision|0|||
170642290|NCT01742286|616703503|FG005|Escalation Phase|Subject/guardian decision|0|||
170642291|NCT01742286|616703504|FG006|Escalation Phase|Subject/guardian decision|0|||
170642292|NCT01742286|616703498|FG000|Expansion Phase|Administrative problems|0|||
170642293|NCT01742286|616703499|FG001|Expansion Phase|Administrative problems|0|||
170642294|NCT01742286|616703500|FG002|Expansion Phase|Administrative problems|0|||
170642295|NCT01742286|616703501|FG003|Expansion Phase|Administrative problems|0|||
170642296|NCT01742286|616703502|FG004|Expansion Phase|Administrative problems|0|||
170642297|NCT01742286|616703503|FG005|Expansion Phase|Administrative problems|0|||
170642298|NCT01742286|616703504|FG006|Expansion Phase|Administrative problems|5|||
170642299|NCT01742286|616703498|FG000|Expansion Phase|Physician Decision|0|||
170642300|NCT01742286|616703499|FG001|Expansion Phase|Physician Decision|0|||
170642301|NCT01742286|616703500|FG002|Expansion Phase|Physician Decision|4|||
170642302|NCT01742286|616703501|FG003|Expansion Phase|Physician Decision|0|||
170642303|NCT01742286|616703502|FG004|Expansion Phase|Physician Decision|0|||
170642304|NCT01742286|616703503|FG005|Expansion Phase|Physician Decision|0|||
170642305|NCT01742286|616703504|FG006|Expansion Phase|Physician Decision|9|||
170642306|NCT01742286|616703498|FG000|Expansion Phase|Adverse Event|0|||
170642307|NCT01742286|616703499|FG001|Expansion Phase|Adverse Event|0|||
170642308|NCT01742286|616703500|FG002|Expansion Phase|Adverse Event|0|||
170642309|NCT01742286|616703501|FG003|Expansion Phase|Adverse Event|0|||
170642310|NCT01742286|616703502|FG004|Expansion Phase|Adverse Event|0|||
170642311|NCT01742286|616703503|FG005|Expansion Phase|Adverse Event|0|||
170803090|NCT04337931|617289093|FG001|Overall Study|Withdrawal by Subject|1|||
170803091|NCT04337931|617289094|FG002|Overall Study|Withdrawal by Subject|0|||
170803092|NCT04337931|617289092|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
170803093|NCT04337931|617289093|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
170803094|NCT04337931|617289094|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
170803095|NCT04337931|617289092|FG000|Overall Study|Study terminated by sponsor|3|||
170803096|NCT04337931|617289093|FG001|Overall Study|Study terminated by sponsor|6|||
170803097|NCT04337931|617289094|FG002|Overall Study|Study terminated by sponsor|2|||
170803098|NCT04337931|617289092|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
170803099|NCT04337931|617289093|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
170803100|NCT04337931|617289094|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
170803101|NCT04337931|617289092|FG000|Overall Study|Colorectal cancer treatment|1|||
170803102|NCT04337931|617289093|FG001|Overall Study|Colorectal cancer treatment|0|||
170803103|NCT04337931|617289094|FG002|Overall Study|Colorectal cancer treatment|0|||
170803104|NCT04337931|617289092|FG000|Overall Study|Participant decision|0|||
170803105|NCT04337931|617289093|FG001|Overall Study|Participant decision|1|||
170803106|NCT04337931|617289094|FG002|Overall Study|Participant decision|0|||
170803107|NCT04436289|617289095|FG000|Overall Study|Death prior to hospital discharge|8|||
170803108|NCT04436289|617289096|FG001|Overall Study|Death prior to hospital discharge|5|||
170803109|NCT04436289|617289097|FG002|Overall Study|Death prior to hospital discharge|0|||
170803110|NCT04436289|617289098|FG003|Overall Study|Death prior to hospital discharge|1|||
170642312|NCT01742286|616703504|FG006|Expansion Phase|Adverse Event|6|||
170642313|NCT01742286|616703498|FG000|Expansion Phase|Disease progression|0|||
170642314|NCT01742286|616703499|FG001|Expansion Phase|Disease progression|0|||
170642315|NCT01742286|616703500|FG002|Expansion Phase|Disease progression|3|||
170642316|NCT01742286|616703501|FG003|Expansion Phase|Disease progression|0|||
170803111|NCT04436289|617289095|FG000|Overall Study|Withdrawal by Subject|0|||
170901449|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170803112|NCT04436289|617289096|FG001|Overall Study|Withdrawal by Subject|1|||
170803113|NCT04436289|617289097|FG002|Overall Study|Withdrawal by Subject|4|||
170803114|NCT04436289|617289098|FG003|Overall Study|Withdrawal by Subject|0|||
170803115|NCT04436289|617289095|FG000|Overall Study|Extended hospital stay|0|||
170803116|NCT04436289|617289096|FG001|Overall Study|Extended hospital stay|1|||
170803117|NCT04436289|617289097|FG002|Overall Study|Extended hospital stay|0|||
170803118|NCT04436289|617289098|FG003|Overall Study|Extended hospital stay|0|||
170803119|NCT04436289|617289095|FG000|Overall Study|Lost to Follow-up|0|||
170803120|NCT04436289|617289096|FG001|Overall Study|Lost to Follow-up|4|||
170803121|NCT04436289|617289097|FG002|Overall Study|Lost to Follow-up|1|||
170803122|NCT04436289|617289098|FG003|Overall Study|Lost to Follow-up|3|||
170803123|NCT00589875|617289100|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
170803124|NCT00589875|617289100|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
170803125|NCT05018143|617289101|FG000|Overall Study|Lost to Follow-up|5|||
170803126|NCT05018143|617289102|FG001|Overall Study|Lost to Follow-up|4|||
170803127|NCT05018143|617289101|FG000|Overall Study|Withdrawal by Subject|0|||
170803128|NCT05018143|617289102|FG001|Overall Study|Withdrawal by Subject|1|||
170803129|NCT06688357|617289103|FG000|Overall Study|Adverse Event|0|||
170803130|NCT06688357|617289104|FG001|Overall Study|Adverse Event|1|||
170803131|NCT03691493|617289109|FG000|Overall Study|Withdrawal by Subject|1|||
170803132|NCT05786612|617289124|FG000|Overall Study|Adverse Event|1|||
170803133|NCT05786612|617289125|FG001|Overall Study|Adverse Event|2|||
170803134|NCT05786612|617289124|FG000|Overall Study|one screening failure|0|||
170803135|NCT05786612|617289125|FG001|Overall Study|one screening failure|2|||
170803136|NCT03277989|617289131|FG000|Overall Study|Lost to Follow-up|6|||
170803137|NCT03277989|617289131|FG000|Overall Study|Adverse Event|6|||
170803138|NCT03277989|617289131|FG000|Overall Study|Withdrawal by Subject|3|||
170803139|NCT03277989|617289131|FG000|Overall Study|Didn't Receive Study Device|7|||
170803140|NCT03277989|617289131|FG000|Overall Study|Site Closure|26|||
170803141|NCT03277989|617289131|FG000|Overall Study|Sponsor Closure|107|||
170806982|NCT02063659|617301676|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
170806983|NCT02063659|617301673|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
170806984|NCT02063659|617301674|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
170806985|NCT02063659|617301675|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
170806986|NCT02063659|617301676|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
170806987|NCT02063659|617301673|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
170806988|NCT02063659|617301674|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
170806989|NCT02063659|617301675|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
170806990|NCT02063659|617301676|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
170806991|NCT02063659|617301673|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
170806992|NCT02063659|617301674|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
170806993|NCT02063659|617301675|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
170806994|NCT02063659|617301676|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
170806995|NCT02063659|617301673|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
170806996|NCT02063659|617301674|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
170806997|NCT02063659|617301675|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
170806998|NCT02063659|617301676|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
170806999|NCT00949117|617303640|FG000|Overall Study|Lack of Efficacy|2|||
170807000|NCT00949117|617303641|FG001|Overall Study|Lack of Efficacy|3|||
170807001|NCT00949117|617303640|FG000|Overall Study|Protocol Violation|1|||
170807002|NCT00949117|617303641|FG001|Overall Study|Protocol Violation|1|||
170807003|NCT00949117|617303640|FG000|Overall Study|Adverse Event|0|||
170807004|NCT00949117|617303641|FG001|Overall Study|Adverse Event|1|||
170807005|NCT03839459|617303642|FG000|Overall Study|Withdrawal by Subject|2|||
170807006|NCT03839459|617303642|FG000|Overall Study|progression of disease|3|||
170803142|NCT03459196|617290529|FG000|Overall Study|Subject didn't receive study catheter|2|||
170803143|NCT00092534|617290530|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
170803144|NCT00092534|617290531|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
170803145|NCT00092534|617290532|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
170803146|NCT00092534|617290533|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
170803147|NCT00092534|617290534|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
170803148|NCT00092534|617290530|FG000|Base Study Vaccination Period|Adverse Event|3|||
170803149|NCT00092534|617290531|FG001|Base Study Vaccination Period|Adverse Event|1|||
170803150|NCT00092534|617290532|FG002|Base Study Vaccination Period|Adverse Event|0|||
170803151|NCT00092534|617290533|FG003|Base Study Vaccination Period|Adverse Event|0|||
170803152|NCT00092534|617290534|FG004|Base Study Vaccination Period|Adverse Event|0|||
170803153|NCT00092534|617290530|FG000|Base Study Vaccination Period|Death|5|||
170803154|NCT00092534|617290531|FG001|Base Study Vaccination Period|Death|4|||
170803155|NCT00092534|617290532|FG002|Base Study Vaccination Period|Death|0|||
170803156|NCT00092534|617290533|FG003|Base Study Vaccination Period|Death|0|||
170803157|NCT00092534|617290534|FG004|Base Study Vaccination Period|Death|0|||
170803158|NCT00092534|617290530|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
170803159|NCT00092534|617290531|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
170803160|NCT00092534|617290532|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
170803161|NCT00092534|617290533|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
170803162|NCT00092534|617290534|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
170803163|NCT00092534|617290530|FG000|Base Study Vaccination Period|Physician Decision|1|||
170803164|NCT00092534|617290531|FG001|Base Study Vaccination Period|Physician Decision|0|||
170803165|NCT00092534|617290532|FG002|Base Study Vaccination Period|Physician Decision|0|||
170803166|NCT00092534|617290533|FG003|Base Study Vaccination Period|Physician Decision|0|||
170803167|NCT00092534|617290534|FG004|Base Study Vaccination Period|Physician Decision|0|||
170803168|NCT00092534|617290530|FG000|Base Study Vaccination Period|Pregnancy|9|||
170803169|NCT00092534|617290531|FG001|Base Study Vaccination Period|Pregnancy|7|||
170803170|NCT00092534|617290532|FG002|Base Study Vaccination Period|Pregnancy|0|||
170803171|NCT00092534|617290533|FG003|Base Study Vaccination Period|Pregnancy|0|||
170901450|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170901451|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
170901452|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170901453|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170901454|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170901455|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170901456|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170551340|NCT03071965|616364742|FG000|Overall Study|Death|0|||
170551341|NCT03071965|616364743|FG001|Overall Study|Death|0|||
170551342|NCT03071965|616364744|FG002|Overall Study|Death|1|||
170551343|NCT03071965|616364745|FG003|Overall Study|Death|1|||
170551344|NCT03071965|616364742|FG000|Overall Study|COVID-19|0|||
170551345|NCT03071965|616364743|FG001|Overall Study|COVID-19|1|||
170551346|NCT03071965|616364744|FG002|Overall Study|COVID-19|0|||
170551347|NCT03071965|616364745|FG003|Overall Study|COVID-19|1|||
170551348|NCT03071965|616364742|FG000|Overall Study|Other Health Reason|0|||
170551349|NCT03071965|616364743|FG001|Overall Study|Other Health Reason|0|||
170551350|NCT03071965|616364744|FG002|Overall Study|Other Health Reason|0|||
170551351|NCT03071965|616364745|FG003|Overall Study|Other Health Reason|1|||
170551352|NCT02346370|616364746|FG000|Overall Study|Not treated|1|||
170551353|NCT02346370|616364747|FG001|Overall Study|Not treated|0|||
170551354|NCT02346370|616364748|FG002|Overall Study|Not treated|0|||
170551355|NCT02346370|616364746|FG000|Overall Study|Withdrawal of consent|1|||
170551356|NCT02346370|616364747|FG001|Overall Study|Withdrawal of consent|0|||
170551357|NCT02346370|616364748|FG002|Overall Study|Withdrawal of consent|0|||
170551358|NCT02346370|616364746|FG000|Overall Study|Death|1|||
170551359|NCT02346370|616364747|FG001|Overall Study|Death|3|||
170551360|NCT02346370|616364748|FG002|Overall Study|Death|1|||
170551361|NCT02346370|616364746|FG000|Overall Study|Sponsor discontinued study|5|||
170551362|NCT02346370|616364747|FG001|Overall Study|Sponsor discontinued study|0|||
170551363|NCT02346370|616364748|FG002|Overall Study|Sponsor discontinued study|2|||
170551364|NCT02346370|616364746|FG000|Overall Study|Radiologic progression|0|||
170551365|NCT02346370|616364747|FG001|Overall Study|Radiologic progression|0|||
170551366|NCT02346370|616364748|FG002|Overall Study|Radiologic progression|1|||
170551367|NCT02346370|616364746|FG000|Overall Study|Physician Decision|0|||
170551368|NCT02346370|616364747|FG001|Overall Study|Physician Decision|1|||
170551369|NCT02346370|616364748|FG002|Overall Study|Physician Decision|0|||
170551370|NCT03654326|616364749|FG000|Overall Study|Withdrawal by Subject|5|||
170551371|NCT03654326|616364750|FG001|Overall Study|Withdrawal by Subject|3|||
170551372|NCT03654326|616364749|FG000|Overall Study|Physician Decision|0|||
170551373|NCT03654326|616364750|FG001|Overall Study|Physician Decision|1|||
170551374|NCT03654326|616364749|FG000|Overall Study|Unable to adhere to study schedule|0|||
170551375|NCT03654326|616364750|FG001|Overall Study|Unable to adhere to study schedule|1|||
170551376|NCT03654326|616364749|FG000|Overall Study|Lost to Follow-up|1|||
170551377|NCT03654326|616364750|FG001|Overall Study|Lost to Follow-up|1|||
170551378|NCT06399471|616364751|FG000|Overall Study|Withdrawal by Subject|1|||
170551379|NCT00511199|616364765|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
170551380|NCT00511199|616364766|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
170551381|NCT00511199|616364765|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
170551382|NCT00511199|616364766|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
170551383|NCT00511199|616364765|FG000|Overall Study|Withdrawal of Informed Consent|19|||
170551384|NCT00511199|616364766|FG001|Overall Study|Withdrawal of Informed Consent|4|||
170551385|NCT00511199|616364765|FG000|Overall Study|Pregnancy|6|||
170551386|NCT00511199|616364766|FG001|Overall Study|Pregnancy|3|||
170551387|NCT00511199|616364765|FG000|Overall Study|Pregnancy Wish|16|||
170551388|NCT00511199|616364766|FG001|Overall Study|Pregnancy Wish|8|||
170551389|NCT00511199|616364765|FG000|Overall Study|Lost to Follow-up|40|||
170551390|NCT00511199|616364766|FG001|Overall Study|Lost to Follow-up|17|||
170551391|NCT00511199|616364765|FG000|Overall Study|Other Reason|78|||
170551392|NCT00511199|616364766|FG001|Overall Study|Other Reason|37|||
170551393|NCT01362270|616364768|FG000|Overall Study|Withdrawal by Subject|1|||
170551394|NCT01362270|616364769|FG001|Overall Study|Withdrawal by Subject|0|||
170551395|NCT01362270|616364768|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
170551396|NCT01362270|616364769|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
170551397|NCT01362270|616364768|FG000|Overall Study|Met excl. criteria before 1st session|1|||
170551398|NCT01362270|616364769|FG001|Overall Study|Met excl. criteria before 1st session|1|||
170551399|NCT02314247|616364772|FG000|Overall Study|Adverse Event|2|||
170551400|NCT02314247|616364773|FG001|Overall Study|Adverse Event|1|||
170551401|NCT02314247|616364774|FG002|Overall Study|Adverse Event|0|||
170551402|NCT02314247|616364772|FG000|Overall Study|Withdrawal by Subject|1|||
170551403|NCT02314247|616364773|FG001|Overall Study|Withdrawal by Subject|3|||
170551404|NCT02314247|616364774|FG002|Overall Study|Withdrawal by Subject|1|||
170551405|NCT02314247|616364772|FG000|Overall Study|Progression of Disease|6|||
170551406|NCT02314247|616364773|FG001|Overall Study|Progression of Disease|2|||
170551407|NCT02314247|616364774|FG002|Overall Study|Progression of Disease|0|||
170551408|NCT01691482|616364775|FG000|Treatment Period 2|Adverse Event|0|||
170551409|NCT01691482|616364776|FG001|Treatment Period 2|Adverse Event|1|||
170901457|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170901458|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170901459|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170901460|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
170901461|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170901462|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170901463|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170901464|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170901465|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170901466|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170901467|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
170901468|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170901469|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
170901470|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
170901471|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170901472|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170901473|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170901474|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170901475|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
170901476|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
170901477|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170901478|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170901479|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
170901480|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170901481|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170901482|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170803172|NCT00092534|617290534|FG004|Base Study Vaccination Period|Pregnancy|0|||
170803173|NCT00092534|617290530|FG000|Base Study Vaccination Period|Protocol Violation|2|||
170803174|NCT00092534|617290531|FG001|Base Study Vaccination Period|Protocol Violation|1|||
170803175|NCT00092534|617290532|FG002|Base Study Vaccination Period|Protocol Violation|0|||
170803176|NCT00092534|617290533|FG003|Base Study Vaccination Period|Protocol Violation|0|||
170803177|NCT00092534|617290534|FG004|Base Study Vaccination Period|Protocol Violation|0|||
170803178|NCT00092534|617290530|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
170803179|NCT00092534|617290531|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
170803180|NCT00092534|617290532|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
170803181|NCT00092534|617290533|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
170803182|NCT00092534|617290534|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
170901483|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170901484|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170901485|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170901486|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170901487|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170901488|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170803183|NCT00092534|617290530|FG000|Base Study Vaccination Period|Moved|14|||
170803184|NCT00092534|617290531|FG001|Base Study Vaccination Period|Moved|12|||
170803185|NCT00092534|617290532|FG002|Base Study Vaccination Period|Moved|0|||
170803186|NCT00092534|617290533|FG003|Base Study Vaccination Period|Moved|0|||
170803187|NCT00092534|617290534|FG004|Base Study Vaccination Period|Moved|0|||
170803188|NCT00092534|617290530|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
170803189|NCT00092534|617290531|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
170901489|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170901490|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170901491|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170901492|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170901493|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
170901494|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170901495|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170901496|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
170901497|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
170901498|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170901499|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170901500|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170901501|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170901502|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170901503|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
170901504|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170901505|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
170901506|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
170901507|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170803190|NCT00092534|617290532|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
170803191|NCT00092534|617290533|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
170803192|NCT00092534|617290534|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
170803193|NCT00092534|617290530|FG000|Base Study Vaccination Period|Travel|1|||
170803194|NCT00092534|617290531|FG001|Base Study Vaccination Period|Travel|0|||
170803195|NCT00092534|617290532|FG002|Base Study Vaccination Period|Travel|0|||
170803196|NCT00092534|617290533|FG003|Base Study Vaccination Period|Travel|0|||
170803197|NCT00092534|617290534|FG004|Base Study Vaccination Period|Travel|0|||
170803198|NCT00092534|617290530|FG000|Base Study Vaccination Period|Site Closed|0|||
170803199|NCT00092534|617290531|FG001|Base Study Vaccination Period|Site Closed|1|||
170803200|NCT00092534|617290532|FG002|Base Study Vaccination Period|Site Closed|0|||
170803201|NCT00092534|617290533|FG003|Base Study Vaccination Period|Site Closed|0|||
170803202|NCT00092534|617290534|FG004|Base Study Vaccination Period|Site Closed|0|||
170803203|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Adverse Event|2|||
170803204|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Adverse Event|4|||
170803205|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Adverse Event|0|||
170803206|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Adverse Event|0|||
170803207|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Adverse Event|0|||
170803208|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Death|2|||
170803209|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Death|1|||
170803210|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Death|0|||
170803211|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Death|0|||
170803212|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Death|0|||
170803213|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
170803214|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
170803215|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
170803216|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
170803217|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
170803218|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Pregnancy|6|||
170803219|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Pregnancy|10|||
170803220|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Pregnancy|0|||
170803221|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Pregnancy|0|||
170803222|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Pregnancy|0|||
170803223|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
170803224|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
170803225|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
170803226|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
170803227|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
170803228|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
170803229|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
170803230|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
170803231|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
170803232|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
170803233|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Moved|62|||
170803234|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Moved|58|||
170803235|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Moved|0|||
170803236|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Moved|0|||
170803237|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Moved|0|||
170803238|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Travel|10|||
170803239|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Travel|7|||
170803240|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Travel|0|||
170803241|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Travel|0|||
170803242|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Travel|0|||
170803243|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Site Closed|0|||
170803244|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Site Closed|2|||
170803245|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Site Closed|0|||
170803246|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Site Closed|0|||
170803247|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Site Closed|0|||
170803248|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
170803249|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
170803250|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
170803251|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
170803252|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
170803253|NCT00092534|617290530|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
170803254|NCT00092534|617290531|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
170803255|NCT00092534|617290532|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
170803256|NCT00092534|617290533|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
170803257|NCT00092534|617290534|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
170803258|NCT00092534|617290530|FG000|Base Study EXT|Lost to Follow-up|0|||
170803259|NCT00092534|617290531|FG001|Base Study EXT|Lost to Follow-up|0|||
170803260|NCT00092534|617290532|FG002|Base Study EXT|Lost to Follow-up|41|||
170803261|NCT00092534|617290533|FG003|Base Study EXT|Lost to Follow-up|0|||
170803262|NCT00092534|617290534|FG004|Base Study EXT|Lost to Follow-up|0|||
170803263|NCT00092534|617290530|FG000|Base Study EXT|Physician Decision|0|||
170803264|NCT00092534|617290531|FG001|Base Study EXT|Physician Decision|0|||
170803265|NCT00092534|617290532|FG002|Base Study EXT|Physician Decision|1|||
170803266|NCT00092534|617290533|FG003|Base Study EXT|Physician Decision|0|||
170803267|NCT00092534|617290534|FG004|Base Study EXT|Physician Decision|0|||
170803268|NCT00092534|617290530|FG000|Base Study EXT|Pregnancy|0|||
170803269|NCT00092534|617290531|FG001|Base Study EXT|Pregnancy|0|||
170803270|NCT00092534|617290532|FG002|Base Study EXT|Pregnancy|12|||
170803271|NCT00092534|617290533|FG003|Base Study EXT|Pregnancy|0|||
170803272|NCT00092534|617290534|FG004|Base Study EXT|Pregnancy|0|||
170803273|NCT00092534|617290530|FG000|Base Study EXT|Withdrawal by Subject|0|||
170803274|NCT00092534|617290531|FG001|Base Study EXT|Withdrawal by Subject|0|||
170803275|NCT00092534|617290532|FG002|Base Study EXT|Withdrawal by Subject|18|||
170803276|NCT00092534|617290533|FG003|Base Study EXT|Withdrawal by Subject|0|||
170803277|NCT00092534|617290534|FG004|Base Study EXT|Withdrawal by Subject|0|||
170803278|NCT00092534|617290530|FG000|Base Study EXT|Participant moved|0|||
170803279|NCT00092534|617290531|FG001|Base Study EXT|Participant moved|0|||
170803280|NCT00092534|617290532|FG002|Base Study EXT|Participant moved|6|||
170803281|NCT00092534|617290533|FG003|Base Study EXT|Participant moved|0|||
170803282|NCT00092534|617290534|FG004|Base Study EXT|Participant moved|0|||
170803283|NCT00092534|617290530|FG000|Base Study EXT|Travel|0|||
170803284|NCT00092534|617290531|FG001|Base Study EXT|Travel|0|||
170803285|NCT00092534|617290532|FG002|Base Study EXT|Travel|2|||
170803286|NCT00092534|617290533|FG003|Base Study EXT|Travel|0|||
170803287|NCT00092534|617290534|FG004|Base Study EXT|Travel|0|||
170803288|NCT00092534|617290530|FG000|Base Study EXT|Site closed|0|||
170803289|NCT00092534|617290531|FG001|Base Study EXT|Site closed|0|||
170803290|NCT00092534|617290532|FG002|Base Study EXT|Site closed|21|||
170803291|NCT00092534|617290533|FG003|Base Study EXT|Site closed|0|||
170803292|NCT00092534|617290534|FG004|Base Study EXT|Site closed|0|||
170901508|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170803293|NCT00092534|617290530|FG000|Base Study EXT|Study ended|0|||
170803294|NCT00092534|617290531|FG001|Base Study EXT|Study ended|0|||
170803295|NCT00092534|617290532|FG002|Base Study EXT|Study ended|29|||
170803296|NCT00092534|617290533|FG003|Base Study EXT|Study ended|0|||
170803297|NCT00092534|617290534|FG004|Base Study EXT|Study ended|0|||
170803298|NCT00092534|617290530|FG000|Base Study EXT|Protocol Violation|0|||
170803299|NCT00092534|617290531|FG001|Base Study EXT|Protocol Violation|0|||
170803300|NCT00092534|617290532|FG002|Base Study EXT|Protocol Violation|15|||
170803301|NCT00092534|617290533|FG003|Base Study EXT|Protocol Violation|0|||
170901509|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170901510|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170901511|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170901512|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170901513|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170901514|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
170901515|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
170901516|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170901517|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170901518|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170901519|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170901520|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170901521|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
170901522|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
170901523|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
170901524|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
170901525|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
170901526|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
170901527|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
170901528|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
170901529|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
170901530|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
170901531|NCT01307423|617642181|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170901532|NCT01307423|617642182|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170901533|NCT01307423|617642183|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
170901534|NCT01307423|617642184|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170901535|NCT01307423|617642185|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170901536|NCT01307423|617642186|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170803302|NCT00092534|617290534|FG004|Base Study EXT|Protocol Violation|0|||
170803303|NCT00092534|617290530|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
170803304|NCT00092534|617290531|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
170803305|NCT00092534|617290532|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
170803306|NCT00092534|617290533|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
170803307|NCT00092534|617290534|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
170901537|NCT01307423|617642187|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170901538|NCT01307423|617642188|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
170901539|NCT01307423|617642189|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
170901540|NCT03406962|617642190|FG000|Overall Study|Death|2|||
170901541|NCT03406962|617642190|FG000|Overall Study|Adverse Event|1|||
170901542|NCT01651780|617642193|FG000|Overall Study|Physician decision: No 30-day visit|2|||
170901543|NCT01651780|617642194|FG001|Overall Study|Physician decision: No 30-day visit|1|||
170901544|NCT01651780|617642193|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
170901545|NCT01651780|617642194|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
170901546|NCT01651780|617642193|FG000|Overall Study|Withdrawal by Subject|2|||
170901547|NCT01651780|617642194|FG001|Overall Study|Withdrawal by Subject|0|||
170901548|NCT01651780|617642193|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
170901549|NCT01651780|617642194|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170901550|NCT01651780|617642193|FG000|Overall Study|Lost to Follow-up|1|||
170901551|NCT01651780|617642194|FG001|Overall Study|Lost to Follow-up|2|||
170901552|NCT01651780|617642193|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
170901553|NCT01651780|617642194|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
170901554|NCT01290887|617642195|FG000|Overall Study|Adverse Event|6|||
170901555|NCT01290887|617642196|FG001|Overall Study|Adverse Event|11|||
170901556|NCT01290887|617642195|FG000|Overall Study|Lack of Efficacy|4|||
170901557|NCT01290887|617642196|FG001|Overall Study|Lack of Efficacy|5|||
170901558|NCT01290887|617642195|FG000|Overall Study|Withdrawal by Subject|26|||
170901559|NCT01290887|617642196|FG001|Overall Study|Withdrawal by Subject|32|||
170901560|NCT01290887|617642195|FG000|Overall Study|Protocol Violation|2|||
170901561|NCT01290887|617642196|FG001|Overall Study|Protocol Violation|1|||
170901562|NCT01290887|617642195|FG000|Overall Study|Lost to Follow-up|4|||
170901563|NCT01290887|617642196|FG001|Overall Study|Lost to Follow-up|4|||
170901564|NCT01290887|617642195|FG000|Overall Study|Non-compliance to study procedures|0|||
170901565|NCT01290887|617642196|FG001|Overall Study|Non-compliance to study procedures|1|||
170901566|NCT01290887|617642195|FG000|Overall Study|Non-compliance to study medications|1|||
170901567|NCT01290887|617642196|FG001|Overall Study|Non-compliance to study medications|0|||
170901568|NCT01290887|617642195|FG000|Overall Study|Sponsor closure of study|420|||
170901569|NCT01290887|617642196|FG001|Overall Study|Sponsor closure of study|476|||
170901570|NCT01290887|617642195|FG000|Overall Study|Other|3|||
170901571|NCT01290887|617642196|FG001|Overall Study|Other|6|||
170901572|NCT01412229|617642197|FG000|Overall Study|Physician Decision|1|||
170901573|NCT00454207|617642198|FG000|Overall Study|Adverse Event|3|||
170901574|NCT00454207|617642199|FG001|Overall Study|Adverse Event|1|||
170901575|NCT00454207|617642198|FG000|Overall Study|Lack of Efficacy|1|||
170901576|NCT00454207|617642199|FG001|Overall Study|Lack of Efficacy|0|||
170901577|NCT00454207|617642198|FG000|Overall Study|Protocol Violation|0|||
170901578|NCT00454207|617642199|FG001|Overall Study|Protocol Violation|1|||
170901579|NCT01672957|617642200|FG000|Overall Study|Protocol Violation|48|||
170901580|NCT01672957|617642200|FG000|Overall Study|Death|2|||
170901581|NCT01672957|617642200|FG000|Overall Study|ICF Signed After Transplantation|5|||
170901582|NCT01795547|617642203|FG000|Overall Study|Adverse Event|16|||
170901583|NCT01795547|617642204|FG001|Overall Study|Adverse Event|27|||
170901584|NCT01795547|617642203|FG000|Overall Study|Lack of Efficacy|8|||
170901585|NCT01795547|617642204|FG001|Overall Study|Lack of Efficacy|3|||
170901586|NCT01795547|617642203|FG000|Overall Study|Protocol Violation|6|||
170901587|NCT01795547|617642204|FG001|Overall Study|Protocol Violation|4|||
170901588|NCT01795547|617642203|FG000|Overall Study|Lost to Follow-up|2|||
170901589|NCT01795547|617642204|FG001|Overall Study|Lost to Follow-up|5|||
170901590|NCT01795547|617642203|FG000|Overall Study|Withdrawal of consent|7|||
170901591|NCT01795547|617642204|FG001|Overall Study|Withdrawal of consent|12|||
170901592|NCT01795547|617642203|FG000|Overall Study|Not Treated|4|||
170901593|NCT01795547|617642204|FG001|Overall Study|Not Treated|10|||
170901594|NCT01795547|617642203|FG000|Overall Study|Non-compliance with IMP|1|||
170901595|NCT01795547|617642204|FG001|Overall Study|Non-compliance with IMP|1|||
170901596|NCT01795547|617642203|FG000|Overall Study|Others|4|||
170901597|NCT01795547|617642204|FG001|Overall Study|Others|1|||
170901598|NCT01795547|617642203|FG000|Overall Study|Not stated|0|||
170901599|NCT01795547|617642204|FG001|Overall Study|Not stated|1|||
170901600|NCT00642642|617642205|FG000|Treatment & Follow Up|Adverse Event|2|||
170901601|NCT00642642|617642205|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
170901602|NCT00642642|617642205|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
170901603|NCT03437447|617642206|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170901604|NCT03437447|617642207|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170901605|NCT03437447|617642208|FG002|Treatment Period 1|Withdrawal by Subject|1|||
170901606|NCT00784758|617642209|FG000|Overall Study|Withdrawal by Subject|3|||
170901607|NCT00784758|617642210|FG001|Overall Study|Withdrawal by Subject|0|||
170901608|NCT00784758|617642209|FG000|Overall Study|Adverse Event|1|||
170901609|NCT00784758|617642210|FG001|Overall Study|Adverse Event|0|||
170901610|NCT03726268|617642211|FG000|Overall Study|Physician Decision|2|||
170901611|NCT03726268|617642212|FG001|Overall Study|Physician Decision|8|||
170901612|NCT03726268|617642213|FG002|Overall Study|Physician Decision|6|||
170901613|NCT03726268|617642214|FG003|Overall Study|Physician Decision|3|||
170803308|NCT03083366|617290535|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
170803309|NCT03083366|617290536|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
170803310|NCT03083366|617290535|FG000|Enrollment Period|Lack of Efficacy|1|||
170803311|NCT03083366|617290536|FG001|Enrollment Period|Lack of Efficacy|0|||
170803312|NCT02633215|617290552|FG000|Overall Study|Lost to Follow-up|2|||
170803313|NCT02633215|617290553|FG001|Overall Study|Lost to Follow-up|3|||
170803314|NCT00754325|617290554|FG000|Initial Treatment|Continuing Active Treatment|4|||
170803315|NCT00754325|617290555|FG001|Initial Treatment|Continuing Active Treatment|5|||
170901614|NCT03726268|617642211|FG000|Overall Study|Withdrawal by Subject|11|||
170901615|NCT03726268|617642212|FG001|Overall Study|Withdrawal by Subject|5|||
170803316|NCT00754325|617290554|FG000|Initial Treatment|Adverse Event|7|||
170803317|NCT00754325|617290555|FG001|Initial Treatment|Adverse Event|6|||
170901616|NCT03726268|617642213|FG002|Overall Study|Withdrawal by Subject|9|||
170901617|NCT03726268|617642214|FG003|Overall Study|Withdrawal by Subject|8|||
170901618|NCT01955707|617642215|FG000|Overall Study|Adverse Event|1|||
170901619|NCT01955707|617642216|FG001|Overall Study|Adverse Event|2|||
170901620|NCT01955707|617642215|FG000|Overall Study|Lost to Follow-up|2|||
170901621|NCT01955707|617642216|FG001|Overall Study|Lost to Follow-up|1|||
170901622|NCT01955707|617642215|FG000|Overall Study|Withdrawal by Subject|0|||
170901623|NCT01955707|617642216|FG001|Overall Study|Withdrawal by Subject|3|||
170901624|NCT01955707|617642215|FG000|Overall Study|Death|13|||
170901625|NCT01955707|617642216|FG001|Overall Study|Death|14|||
170901626|NCT01955707|617642215|FG000|Overall Study|Other|4|||
170901627|NCT01955707|617642216|FG001|Overall Study|Other|2|||
170901628|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
170901629|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
170901630|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
170803318|NCT00754325|617290554|FG000|Initial Treatment|Withdrawal by Subject|2|||
170803319|NCT00754325|617290555|FG001|Initial Treatment|Withdrawal by Subject|2|||
170803320|NCT00754325|617290554|FG000|Initial Treatment|Physician Decision|2|||
170803321|NCT00754325|617290555|FG001|Initial Treatment|Physician Decision|0|||
170803322|NCT00754325|617290554|FG000|Initial Treatment|Sponsor Request|0|||
170803323|NCT00754325|617290555|FG001|Initial Treatment|Sponsor Request|1|||
170803324|NCT00754325|617290554|FG000|Initial Treatment|Disease Progression|35|||
170803325|NCT00754325|617290555|FG001|Initial Treatment|Disease Progression|35|||
170803326|NCT03738228|617290556|FG000|Overall Study|Never received study treatment|2|||
170803327|NCT03738228|617290557|FG001|Overall Study|Never received study treatment|2|||
170803328|NCT06212752|617290558|FG000|Overall Study|Death|5|||
170803329|NCT06212752|617290559|FG001|Overall Study|Death|3|||
170803330|NCT06212752|617290558|FG000|Overall Study|Participants ongoing|23|||
170803331|NCT06212752|617290559|FG001|Overall Study|Participants ongoing|8|||
170803332|NCT00890591|617290560|FG000|Overall Study|Lack of Efficacy|20|||
170803333|NCT03712371|617290563|FG000|Overall Study|Lack of Efficacy|0|||
170803334|NCT03712371|617290564|FG001|Overall Study|Lack of Efficacy|0|||
170803335|NCT03712371|617290565|FG002|Overall Study|Lack of Efficacy|0|||
170803336|NCT03712371|617290566|FG003|Overall Study|Lack of Efficacy|1|||
170803337|NCT00776009|617290567|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
170803338|NCT00776009|617290568|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
170803339|NCT00776009|617290569|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
170803340|NCT00776009|617290570|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
170803341|NCT00776009|617290571|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
170803342|NCT00776009|617290572|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
170901631|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
170901632|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
170901633|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
170901634|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
170901635|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
170901636|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
170901637|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
170901638|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
170901639|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
170901640|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
170901641|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
170901642|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
170901643|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
170803343|NCT00776009|617290567|FG000|Period 1: First Intervention|Protocol Violation|0|||
170803344|NCT00776009|617290568|FG001|Period 1: First Intervention|Protocol Violation|1|||
170803345|NCT00776009|617290569|FG002|Period 1: First Intervention|Protocol Violation|0|||
170803346|NCT00776009|617290570|FG003|Period 1: First Intervention|Protocol Violation|0|||
170803347|NCT00776009|617290571|FG004|Period 1: First Intervention|Protocol Violation|1|||
170803348|NCT00776009|617290572|FG005|Period 1: First Intervention|Protocol Violation|0|||
170901644|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
170901645|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
170901646|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
170901647|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
170901648|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
170803349|NCT00776009|617290567|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
170803350|NCT00776009|617290568|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
170803351|NCT00776009|617290569|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
170803352|NCT00776009|617290570|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
170803353|NCT00776009|617290571|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
170803354|NCT00776009|617290572|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
170803355|NCT00776009|617290567|FG000|Period 2: Second Intervention|Protocol Violation|1|||
170803356|NCT00776009|617290568|FG001|Period 2: Second Intervention|Protocol Violation|0|||
170803357|NCT00776009|617290569|FG002|Period 2: Second Intervention|Protocol Violation|1|||
170803358|NCT00776009|617290570|FG003|Period 2: Second Intervention|Protocol Violation|0|||
170803359|NCT00776009|617290571|FG004|Period 2: Second Intervention|Protocol Violation|0|||
170803360|NCT00776009|617290572|FG005|Period 2: Second Intervention|Protocol Violation|0|||
170803361|NCT00776009|617290567|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
170803362|NCT00776009|617290568|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
170803363|NCT00776009|617290569|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
170803364|NCT00776009|617290570|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
170803365|NCT00776009|617290571|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
170803366|NCT00776009|617290572|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
170803367|NCT02275611|617290575|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
170803368|NCT02275611|617290576|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
170803369|NCT02275611|617290577|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
170803370|NCT02275611|617290578|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
170803371|NCT00811941|617290584|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
170803372|NCT00811941|617290585|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
170803373|NCT00811941|617290584|FG000|All Treated Patients|Adverse Event|2|||
170803374|NCT00811941|617290585|FG001|All Treated Patients|Adverse Event|43|||
170803375|NCT00811941|617290584|FG000|All Treated Patients|Lack of Efficacy|2|||
170803376|NCT00811941|617290585|FG001|All Treated Patients|Lack of Efficacy|3|||
170803377|NCT00811941|617290584|FG000|All Treated Patients|Non-compliance|1|||
170803378|NCT00811941|617290585|FG001|All Treated Patients|Non-compliance|8|||
170803379|NCT00811941|617290584|FG000|All Treated Patients|Protocol Violation|5|||
170803380|NCT00811941|617290585|FG001|All Treated Patients|Protocol Violation|17|||
170803381|NCT00811941|617290584|FG000|All Treated Patients|Withdrawal by Subject|35|||
170803382|NCT00811941|617290585|FG001|All Treated Patients|Withdrawal by Subject|94|||
170803383|NCT00811941|617290584|FG000|All Treated Patients|Lost to Follow-up|3|||
170803384|NCT00811941|617290585|FG001|All Treated Patients|Lost to Follow-up|12|||
170803385|NCT00811941|617290584|FG000|All Treated Patients|Other Reason|4|||
170803386|NCT00811941|617290585|FG001|All Treated Patients|Other Reason|14|||
170803387|NCT00983294|617290586|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
170803388|NCT00983294|617290586|FG000|Colchicine With Azithromycin|Adverse Event|1|||
170803389|NCT00942266|617290587|FG000|Overall Study|Withdrawal by Subject|1|||
170803390|NCT00942266|617290588|FG001|Overall Study|Withdrawal by Subject|0|||
170803391|NCT00942266|617290587|FG000|Overall Study|Adverse Event|2|||
170803392|NCT00942266|617290588|FG001|Overall Study|Adverse Event|1|||
170803393|NCT00942266|617290587|FG000|Overall Study|Disease Progression|38|||
170803394|NCT00942266|617290588|FG001|Overall Study|Disease Progression|11|||
170803395|NCT00942266|617290587|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
170803396|NCT00942266|617290588|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
170803397|NCT00942266|617290587|FG000|Overall Study|Intercurrent illness|0|||
170803398|NCT00942266|617290588|FG001|Overall Study|Intercurrent illness|1|||
170803399|NCT00942266|617290587|FG000|Overall Study|Physician Decision|2|||
170803400|NCT00942266|617290588|FG001|Overall Study|Physician Decision|0|||
170803401|NCT00942266|617290587|FG000|Overall Study|medical deterioration (pneumonia)|0|||
170803402|NCT00942266|617290588|FG001|Overall Study|medical deterioration (pneumonia)|1|||
170803403|NCT00641537|617290589|FG000|96-week Period|Adverse Event|0|||
170803404|NCT00641537|617290590|FG001|96-week Period|Adverse Event|1|||
170803405|NCT00641537|617290591|FG002|96-week Period|Adverse Event|3|||
170901649|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
170901650|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
170901651|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
170901652|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
170803406|NCT00641537|617290592|FG003|96-week Period|Adverse Event|0|||
170803407|NCT00641537|617290593|FG004|96-week Period|Adverse Event|2|||
170803408|NCT00641537|617290594|FG005|96-week Period|Adverse Event|0|||
170803409|NCT00641537|617290595|FG006|96-week Period|Adverse Event|0|||
170803410|NCT00641537|617290596|FG007|96-week Period|Adverse Event|0|||
170803411|NCT00641537|617290589|FG000|96-week Period|Lost to Follow-up|3|||
170803412|NCT00641537|617290590|FG001|96-week Period|Lost to Follow-up|1|||
170803413|NCT00641537|617290591|FG002|96-week Period|Lost to Follow-up|2|||
170803414|NCT00641537|617290592|FG003|96-week Period|Lost to Follow-up|2|||
170803415|NCT00641537|617290593|FG004|96-week Period|Lost to Follow-up|4|||
170901653|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
170901654|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
170803416|NCT00641537|617290594|FG005|96-week Period|Lost to Follow-up|0|||
170803417|NCT00641537|617290595|FG006|96-week Period|Lost to Follow-up|1|||
170803418|NCT00641537|617290596|FG007|96-week Period|Lost to Follow-up|0|||
170803419|NCT00641537|617290589|FG000|96-week Period|Protocol Violation|0|||
170803420|NCT00641537|617290590|FG001|96-week Period|Protocol Violation|1|||
170803421|NCT00641537|617290591|FG002|96-week Period|Protocol Violation|0|||
170803422|NCT00641537|617290592|FG003|96-week Period|Protocol Violation|1|||
170803423|NCT00641537|617290593|FG004|96-week Period|Protocol Violation|0|||
170803424|NCT00641537|617290594|FG005|96-week Period|Protocol Violation|1|||
170803425|NCT00641537|617290595|FG006|96-week Period|Protocol Violation|0|||
170803426|NCT00641537|617290596|FG007|96-week Period|Protocol Violation|0|||
170803427|NCT00641537|617290589|FG000|96-week Period|Death|2|||
170803428|NCT00641537|617290590|FG001|96-week Period|Death|0|||
170803429|NCT00641537|617290591|FG002|96-week Period|Death|1|||
170803430|NCT00641537|617290592|FG003|96-week Period|Death|0|||
170803431|NCT00641537|617290593|FG004|96-week Period|Death|0|||
170803432|NCT00641537|617290594|FG005|96-week Period|Death|0|||
170803433|NCT00641537|617290595|FG006|96-week Period|Death|0|||
170803434|NCT00641537|617290596|FG007|96-week Period|Death|0|||
170803435|NCT00641537|617290589|FG000|96-week Period|Other|4|||
170803436|NCT00641537|617290590|FG001|96-week Period|Other|7|||
170803437|NCT00641537|617290591|FG002|96-week Period|Other|14|||
170803438|NCT00641537|617290592|FG003|96-week Period|Other|9|||
170803439|NCT00641537|617290593|FG004|96-week Period|Other|11|||
170803440|NCT00641537|617290594|FG005|96-week Period|Other|6|||
170803441|NCT00641537|617290595|FG006|96-week Period|Other|4|||
170803442|NCT00641537|617290596|FG007|96-week Period|Other|6|||
170803443|NCT00641537|617290589|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
170803444|NCT00641537|617290590|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
170803445|NCT00641537|617290591|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
170803446|NCT00641537|617290592|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
170803447|NCT00641537|617290593|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
170803448|NCT00641537|617290594|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
170803449|NCT00641537|617290595|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
170642317|NCT01742286|616703502|FG004|Expansion Phase|Disease progression|0|||
170642318|NCT01742286|616703503|FG005|Expansion Phase|Disease progression|0|||
170642319|NCT01742286|616703504|FG006|Expansion Phase|Disease progression|15|||
170642320|NCT01742286|616703498|FG000|Expansion Phase|Withdrawal by Subject|0|||
170642321|NCT01742286|616703499|FG001|Expansion Phase|Withdrawal by Subject|0|||
170642322|NCT01742286|616703500|FG002|Expansion Phase|Withdrawal by Subject|0|||
170642323|NCT01742286|616703501|FG003|Expansion Phase|Withdrawal by Subject|0|||
170642324|NCT01742286|616703502|FG004|Expansion Phase|Withdrawal by Subject|0|||
170642325|NCT01742286|616703503|FG005|Expansion Phase|Withdrawal by Subject|0|||
170642326|NCT01742286|616703504|FG006|Expansion Phase|Withdrawal by Subject|1|||
170642327|NCT02445794|616703508|FG000|Overall Study|Adverse Event|0|||
170642328|NCT02445794|616703509|FG001|Overall Study|Adverse Event|0|||
170642329|NCT02445794|616703510|FG002|Overall Study|Adverse Event|2|||
170642330|NCT02445794|616703511|FG003|Overall Study|Adverse Event|0|||
170642331|NCT03596645|616703516|FG000|Overall Study|Adverse Event|17|||
170901655|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
170901656|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
170901657|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
170901658|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
170803450|NCT00641537|617290596|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
170803451|NCT00641537|617290589|FG000|24-Week Supplemental Follow-up Period|Other|0|||
170803452|NCT00641537|617290590|FG001|24-Week Supplemental Follow-up Period|Other|2|||
170803453|NCT00641537|617290591|FG002|24-Week Supplemental Follow-up Period|Other|2|||
170803454|NCT00641537|617290592|FG003|24-Week Supplemental Follow-up Period|Other|1|||
170901659|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
170642332|NCT03596645|616703517|FG001|Overall Study|Adverse Event|0|||
170642333|NCT03596645|616703516|FG000|Overall Study|Lack of Efficacy|8|||
170803455|NCT00641537|617290593|FG004|24-Week Supplemental Follow-up Period|Other|3|||
170803456|NCT00641537|617290594|FG005|24-Week Supplemental Follow-up Period|Other|0|||
170803457|NCT00641537|617290595|FG006|24-Week Supplemental Follow-up Period|Other|1|||
170803458|NCT00641537|617290596|FG007|24-Week Supplemental Follow-up Period|Other|1|||
170803459|NCT05580003|617290597|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803460|NCT05580003|617290598|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803461|NCT05580003|617290599|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803462|NCT05580003|617290600|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803463|NCT05580003|617290601|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803464|NCT05580003|617290602|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803465|NCT05580003|617290603|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
170803466|NCT05580003|617290604|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803467|NCT05580003|617290605|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803468|NCT05580003|617290606|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803469|NCT05580003|617290607|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803470|NCT05580003|617290608|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803471|NCT05580003|617290609|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803472|NCT05580003|617290610|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803473|NCT05580003|617290611|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803474|NCT05580003|617290612|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803475|NCT05580003|617290613|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803476|NCT05580003|617290614|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803477|NCT05580003|617290615|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803478|NCT05580003|617290616|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803479|NCT05580003|617290617|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803480|NCT05580003|617290618|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803481|NCT05580003|617290619|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803482|NCT05580003|617290620|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803483|NCT05580003|617290621|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803484|NCT05580003|617290622|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803485|NCT05580003|617290623|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803486|NCT05580003|617290624|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
170803487|NCT05580003|617290597|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803488|NCT05580003|617290598|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803489|NCT05580003|617290599|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803490|NCT05580003|617290600|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803491|NCT05580003|617290601|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803492|NCT05580003|617290602|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
170803493|NCT05580003|617290603|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803494|NCT05580003|617290604|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803495|NCT05580003|617290605|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803496|NCT05580003|617290606|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803497|NCT05580003|617290607|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803498|NCT05580003|617290608|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803499|NCT05580003|617290609|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803500|NCT05580003|617290610|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803501|NCT05580003|617290611|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803502|NCT05580003|617290612|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803503|NCT05580003|617290613|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803504|NCT05580003|617290614|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803505|NCT05580003|617290615|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803506|NCT05580003|617290616|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170642334|NCT03596645|616703517|FG001|Overall Study|Lack of Efficacy|0|||
170551410|NCT01691482|616364775|FG000|Treatment Period 2|Protocol Violation|1|||
170551411|NCT01691482|616364776|FG001|Treatment Period 2|Protocol Violation|1|||
170551412|NCT01570192|616364782|FG000|Overall Study|no qualifying organism|6|||
170803507|NCT05580003|617290617|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803508|NCT05580003|617290618|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803509|NCT05580003|617290619|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803510|NCT05580003|617290620|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803511|NCT05580003|617290621|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803512|NCT05580003|617290622|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803513|NCT05580003|617290623|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803514|NCT05580003|617290624|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
170803515|NCT05580003|617290597|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803516|NCT05580003|617290598|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803517|NCT05580003|617290599|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803518|NCT05580003|617290600|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
170803519|NCT05580003|617290601|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803520|NCT05580003|617290602|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803521|NCT05580003|617290603|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803522|NCT05580003|617290604|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803523|NCT05580003|617290605|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803524|NCT05580003|617290606|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803525|NCT05580003|617290607|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803526|NCT05580003|617290608|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803527|NCT05580003|617290609|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803528|NCT05580003|617290610|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170901660|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
170901661|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
170901662|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
170901663|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
170901664|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
170901665|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
170901666|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
170901667|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
170901668|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
170901669|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
170901670|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
170901671|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
170901672|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
170901673|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
170901674|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
170901675|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
170901676|NCT01707992|617642220|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
170901677|NCT01707992|617642221|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
170901678|NCT01707992|617642222|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
170901679|NCT01707992|617642223|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
170901680|NCT01707992|617642224|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
170901681|NCT01707992|617642225|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
170901682|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
170901683|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
170901684|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
170901685|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
170901686|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
170901687|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
170901688|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
170901689|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
170901690|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
170901691|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
170901692|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
170901693|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
170901694|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
170901695|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
170901696|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
170901697|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
170901698|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
170551413|NCT01570192|616364783|FG001|Overall Study|no qualifying organism|12|||
170642335|NCT03596645|616703516|FG000|Overall Study|Lost to Follow-up|1|||
170803529|NCT05580003|617290611|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803530|NCT05580003|617290612|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170901699|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
170901700|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
170901701|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
170901702|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
170901703|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
170901704|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
170901705|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
170901706|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
170901707|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
170901708|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
170901709|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
170901710|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
170901711|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
170901712|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Death|0|||
170901713|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Death|0|||
170901714|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Death|0|||
170803531|NCT05580003|617290613|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803532|NCT05580003|617290614|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803533|NCT05580003|617290615|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170901715|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Death|2|||
170901716|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Death|0|||
170901717|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Death|0|||
170901718|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
170901719|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
170901720|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
170901721|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
170901722|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
170901723|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
170901724|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
170901725|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
170901726|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
170901727|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
170901728|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
170901729|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
170901730|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
170901731|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
170901732|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
170901733|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
170901734|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
170901735|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
170901736|NCT01707992|617642220|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
170901737|NCT01707992|617642221|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
170901738|NCT01707992|617642222|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
170901739|NCT01707992|617642223|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
170901740|NCT01707992|617642224|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
170901741|NCT01707992|617642225|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
170901742|NCT00998738|617642226|FG000|Overall Study|Uknown|1|||
170901743|NCT03498521|617642227|FG000|Overall Study|Death|227|||
170901744|NCT03498521|617642228|FG001|Overall Study|Death|79|||
170901745|NCT03498521|617642229|FG002|Overall Study|Death|84|||
170803534|NCT05580003|617290616|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170901746|NCT03498521|617642227|FG000|Overall Study|Exclusion criteria|1|||
170901747|NCT03498521|617642228|FG001|Overall Study|Exclusion criteria|0|||
170803535|NCT05580003|617290617|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803536|NCT05580003|617290618|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803537|NCT05580003|617290619|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803538|NCT05580003|617290620|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803539|NCT05580003|617290621|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170901748|NCT03498521|617642229|FG002|Overall Study|Exclusion criteria|0|||
170901749|NCT03498521|617642227|FG000|Overall Study|Lost to Follow-up|4|||
170901750|NCT03498521|617642228|FG001|Overall Study|Lost to Follow-up|3|||
170901751|NCT03498521|617642229|FG002|Overall Study|Lost to Follow-up|3|||
170803540|NCT05580003|617290622|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803541|NCT05580003|617290623|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803542|NCT05580003|617290624|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
170803543|NCT05580003|617290597|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803544|NCT05580003|617290598|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
170803545|NCT05580003|617290599|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803546|NCT05580003|617290600|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803547|NCT05580003|617290601|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803548|NCT05580003|617290602|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803549|NCT05580003|617290603|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170901752|NCT03498521|617642227|FG000|Overall Study|No profile due to technical failure|1|||
170901753|NCT03498521|617642228|FG001|Overall Study|No profile due to technical failure|0|||
170901754|NCT03498521|617642229|FG002|Overall Study|No profile due to technical failure|0|||
170901755|NCT03498521|617642227|FG000|Overall Study|Physician Decision|3|||
170901756|NCT03498521|617642228|FG001|Overall Study|Physician Decision|1|||
170901757|NCT03498521|617642229|FG002|Overall Study|Physician Decision|0|||
170901758|NCT03498521|617642227|FG000|Overall Study|Withdrawal by Subject|11|||
170803550|NCT05580003|617290604|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803551|NCT05580003|617290605|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803552|NCT05580003|617290606|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803553|NCT05580003|617290607|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803554|NCT05580003|617290608|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170901759|NCT03498521|617642228|FG001|Overall Study|Withdrawal by Subject|6|||
170803555|NCT05580003|617290609|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803556|NCT05580003|617290610|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803557|NCT05580003|617290611|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803558|NCT05580003|617290612|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803559|NCT05580003|617290613|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803560|NCT05580003|617290614|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803561|NCT05580003|617290615|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803562|NCT05580003|617290616|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803563|NCT05580003|617290617|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803564|NCT05580003|617290618|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803565|NCT05580003|617290619|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803566|NCT05580003|617290620|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803567|NCT05580003|617290621|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803568|NCT05580003|617290622|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170551414|NCT01570192|616364782|FG000|Overall Study|changed to palliative care|1|||
170803569|NCT05580003|617290623|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803570|NCT05580003|617290624|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
170803571|NCT05580003|617290597|FG000|Part 2 (up to 10 Days)|Other|0|||
170803572|NCT05580003|617290598|FG001|Part 2 (up to 10 Days)|Other|0|||
170803573|NCT05580003|617290599|FG002|Part 2 (up to 10 Days)|Other|0|||
170803574|NCT05580003|617290600|FG003|Part 2 (up to 10 Days)|Other|0|||
170803575|NCT05580003|617290601|FG004|Part 2 (up to 10 Days)|Other|0|||
170803576|NCT05580003|617290602|FG005|Part 2 (up to 10 Days)|Other|0|||
170803577|NCT05580003|617290603|FG006|Part 2 (up to 10 Days)|Other|0|||
170803578|NCT05580003|617290604|FG007|Part 2 (up to 10 Days)|Other|0|||
170803579|NCT05580003|617290605|FG008|Part 2 (up to 10 Days)|Other|0|||
170803580|NCT05580003|617290606|FG009|Part 2 (up to 10 Days)|Other|1|||
170803581|NCT05580003|617290607|FG010|Part 2 (up to 10 Days)|Other|0|||
170803582|NCT05580003|617290608|FG011|Part 2 (up to 10 Days)|Other|0|||
170803583|NCT05580003|617290609|FG012|Part 2 (up to 10 Days)|Other|0|||
170803584|NCT05580003|617290610|FG013|Part 2 (up to 10 Days)|Other|0|||
170803585|NCT05580003|617290611|FG014|Part 2 (up to 10 Days)|Other|0|||
170803586|NCT05580003|617290612|FG015|Part 2 (up to 10 Days)|Other|0|||
170803587|NCT05580003|617290613|FG016|Part 2 (up to 10 Days)|Other|0|||
170803588|NCT05580003|617290614|FG017|Part 2 (up to 10 Days)|Other|0|||
170803589|NCT05580003|617290615|FG018|Part 2 (up to 10 Days)|Other|0|||
170803590|NCT05580003|617290616|FG019|Part 2 (up to 10 Days)|Other|0|||
170803591|NCT05580003|617290617|FG020|Part 2 (up to 10 Days)|Other|0|||
170803592|NCT05580003|617290618|FG021|Part 2 (up to 10 Days)|Other|0|||
170803593|NCT05580003|617290619|FG022|Part 2 (up to 10 Days)|Other|0|||
170803594|NCT05580003|617290620|FG023|Part 2 (up to 10 Days)|Other|0|||
170803595|NCT05580003|617290621|FG024|Part 2 (up to 10 Days)|Other|0|||
170803596|NCT05580003|617290622|FG025|Part 2 (up to 10 Days)|Other|0|||
170803597|NCT05580003|617290623|FG026|Part 2 (up to 10 Days)|Other|0|||
170803598|NCT05580003|617290624|FG027|Part 2 (up to 10 Days)|Other|0|||
170803599|NCT05580003|617290597|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803600|NCT05580003|617290598|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803601|NCT05580003|617290599|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803602|NCT05580003|617290600|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803603|NCT05580003|617290601|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803604|NCT05580003|617290602|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803605|NCT05580003|617290603|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803606|NCT05580003|617290604|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803607|NCT05580003|617290605|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803608|NCT05580003|617290606|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803609|NCT05580003|617290607|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803610|NCT05580003|617290608|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803611|NCT05580003|617290609|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803612|NCT05580003|617290610|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803613|NCT05580003|617290611|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803614|NCT05580003|617290612|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170642336|NCT03596645|616703517|FG001|Overall Study|Lost to Follow-up|1|||
170642337|NCT03596645|616703516|FG000|Overall Study|Physician Decision|1|||
170642338|NCT03596645|616703517|FG001|Overall Study|Physician Decision|1|||
170642339|NCT03596645|616703516|FG000|Overall Study|Protocol Violation|1|||
170642340|NCT03596645|616703517|FG001|Overall Study|Protocol Violation|0|||
170642341|NCT03596645|616703516|FG000|Overall Study|Initiated Prohibited Medication|1|||
170642342|NCT03596645|616703517|FG001|Overall Study|Initiated Prohibited Medication|0|||
170642343|NCT03596645|616703516|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170642344|NCT03596645|616703517|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170803615|NCT05580003|617290613|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803616|NCT05580003|617290614|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803617|NCT05580003|617290615|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803618|NCT05580003|617290616|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
170803619|NCT05580003|617290617|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803620|NCT05580003|617290618|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803621|NCT05580003|617290619|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803622|NCT05580003|617290620|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803623|NCT05580003|617290621|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803624|NCT05580003|617290622|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803625|NCT05580003|617290623|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803626|NCT05580003|617290624|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
170803627|NCT05580003|617290597|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803628|NCT05580003|617290598|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803629|NCT05580003|617290599|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803630|NCT05580003|617290600|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803631|NCT05580003|617290601|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803632|NCT05580003|617290602|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803633|NCT05580003|617290603|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803634|NCT05580003|617290604|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803635|NCT05580003|617290605|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803636|NCT05580003|617290606|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803637|NCT05580003|617290607|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803638|NCT05580003|617290608|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803639|NCT05580003|617290609|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803640|NCT05580003|617290610|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803641|NCT05580003|617290611|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803642|NCT05580003|617290612|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803643|NCT05580003|617290613|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803644|NCT05580003|617290614|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803645|NCT05580003|617290615|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803646|NCT05580003|617290616|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803647|NCT05580003|617290617|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
170901760|NCT03498521|617642229|FG002|Overall Study|Withdrawal by Subject|2|||
170901761|NCT03498521|617642227|FG000|Overall Study|Study terminated by sponsor|79|||
170901762|NCT03498521|617642228|FG001|Overall Study|Study terminated by sponsor|21|||
170901763|NCT03498521|617642229|FG002|Overall Study|Study terminated by sponsor|4|||
170901764|NCT04167345|617642231|FG000|Overall Study|Other|1|||
170901765|NCT04167345|617642232|FG001|Overall Study|Other|1|||
170901766|NCT04167345|617642233|FG002|Overall Study|Other|0|||
170901767|NCT04167345|617642234|FG003|Overall Study|Other|0|||
170901768|NCT04167345|617642235|FG004|Overall Study|Other|0|||
170901769|NCT02251743|617644393|FG000|Overall Study|Withdrawal by Subject|1|||
170901770|NCT02251743|617644394|FG001|Overall Study|Withdrawal by Subject|1|||
170901771|NCT05224258|617644396|FG000|Overall Study|Withdrawal by Subject|1|||
170901772|NCT05224258|617644397|FG001|Overall Study|Withdrawal by Subject|1|||
170901773|NCT05224258|617644396|FG000|Overall Study|Physician Decision|1|||
170901774|NCT05224258|617644397|FG001|Overall Study|Physician Decision|1|||
170901775|NCT05224258|617644396|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170901776|NCT05224258|617644397|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170901777|NCT05224258|617644396|FG000|Overall Study|Study Product No Longer in Use|1|||
170901778|NCT05224258|617644397|FG001|Overall Study|Study Product No Longer in Use|0|||
170901779|NCT05224258|617644396|FG000|Overall Study|Adverse Event|0|||
170901780|NCT05224258|617644397|FG001|Overall Study|Adverse Event|1|||
170901781|NCT05224258|617644396|FG000|Overall Study|Protocol Deviation|0|||
170901782|NCT05224258|617644397|FG001|Overall Study|Protocol Deviation|1|||
170901783|NCT03095703|617644399|FG000|Overall Study|Withdrawal by Subject|1|||
170901784|NCT02443402|617644400|FG000|Overall Study|Withdrawal by Subject|3|||
170901785|NCT02443402|617644401|FG001|Overall Study|Withdrawal by Subject|1|||
170901786|NCT02443402|617644400|FG000|Overall Study|Screen Failure|1|||
170901787|NCT02443402|617644401|FG001|Overall Study|Screen Failure|2|||
170901788|NCT00824564|617644402|FG000|Overall Study|Lost to Follow-up|5|||
170901789|NCT00824564|617644403|FG001|Overall Study|Lost to Follow-up|7|||
170901790|NCT00824564|617644402|FG000|Overall Study|Withdrawal by Subject|1|||
170901791|NCT00824564|617644403|FG001|Overall Study|Withdrawal by Subject|1|||
170901792|NCT00824564|617644402|FG000|Overall Study|Other|1|||
170901793|NCT00824564|617644403|FG001|Overall Study|Other|2|||
170901794|NCT00824564|617644402|FG000|Overall Study|Randomized, but not treated|1|||
170901795|NCT00824564|617644403|FG001|Overall Study|Randomized, but not treated|0|||
170901796|NCT01552057|617644416|FG000|Overall Study|Adverse Event|14|||
170901797|NCT01552057|617644417|FG001|Overall Study|Adverse Event|15|||
170901798|NCT01552057|617644416|FG000|Overall Study|Lack of Efficacy|8|||
170901799|NCT01552057|617644417|FG001|Overall Study|Lack of Efficacy|23|||
170901800|NCT01552057|617644416|FG000|Overall Study|Withdrawal by Subject|5|||
170901801|NCT01552057|617644417|FG001|Overall Study|Withdrawal by Subject|8|||
170901802|NCT01552057|617644416|FG000|Overall Study|Entry Criteria Not Met|2|||
170901803|NCT01552057|617644417|FG001|Overall Study|Entry Criteria Not Met|2|||
170901804|NCT01552057|617644416|FG000|Overall Study|Physician Decision|1|||
170901805|NCT01552057|617644417|FG001|Overall Study|Physician Decision|0|||
170901806|NCT00476086|617644418|FG000|Overall Study|Alternative therapy|1|||
170901807|NCT00476086|617644418|FG000|Overall Study|Progressive Disease|4|||
170901808|NCT02900092|617644419|FG000|Overall Study|Adverse Event|1|||
170901809|NCT00996840|617644420|FG000|Overall Study|Adverse Event|0|||
170901810|NCT00996840|617644421|FG001|Overall Study|Adverse Event|1|||
170901811|NCT00996840|617644422|FG002|Overall Study|Adverse Event|0|||
170901812|NCT00996840|617644423|FG003|Overall Study|Adverse Event|0|||
170901813|NCT00996840|617644424|FG004|Overall Study|Adverse Event|0|||
170901814|NCT00996840|617644420|FG000|Overall Study|Physician Decision|0|||
170901815|NCT00996840|617644421|FG001|Overall Study|Physician Decision|0|||
170901816|NCT00996840|617644422|FG002|Overall Study|Physician Decision|1|||
170901817|NCT00996840|617644423|FG003|Overall Study|Physician Decision|1|||
170901818|NCT00996840|617644424|FG004|Overall Study|Physician Decision|2|||
170901819|NCT00996840|617644420|FG000|Overall Study|Withdrawal by Subject|1|||
170901820|NCT00996840|617644421|FG001|Overall Study|Withdrawal by Subject|1|||
170901821|NCT00996840|617644422|FG002|Overall Study|Withdrawal by Subject|0|||
170901822|NCT00996840|617644423|FG003|Overall Study|Withdrawal by Subject|0|||
170901823|NCT00996840|617644424|FG004|Overall Study|Withdrawal by Subject|0|||
170901824|NCT01562028|617644426|FG000|Overall Study|Withdrawal by Subject|1|||
170901825|NCT01562028|617644427|FG001|Overall Study|Withdrawal by Subject|1|||
170901826|NCT01562028|617644426|FG000|Overall Study|Lost to Follow-up|2|||
170901827|NCT01562028|617644427|FG001|Overall Study|Lost to Follow-up|1|||
170901828|NCT05027802|617644429|FG000|Overall Study|Adverse Event|2|||
170901829|NCT05027802|617644429|FG000|Overall Study|Withdrawal by Subject|18|||
170901830|NCT05027802|617644429|FG000|Overall Study|Death|2|||
170901831|NCT05027802|617644429|FG000|Overall Study|Other|1|||
170901832|NCT01506141|617644436|FG000|Overall Study|Adverse Event|0|||
170901833|NCT01506141|617644437|FG001|Overall Study|Adverse Event|2|||
170901834|NCT01506141|617644436|FG000|Overall Study|Participation Terminated by Investigator|1|||
170901835|NCT01506141|617644437|FG001|Overall Study|Participation Terminated by Investigator|1|||
170901836|NCT01506141|617644436|FG000|Overall Study|Site Terminated by Sponsor|2|||
170901837|NCT01506141|617644437|FG001|Overall Study|Site Terminated by Sponsor|0|||
170551415|NCT01570192|616364783|FG001|Overall Study|changed to palliative care|0|||
170551416|NCT01570192|616364782|FG000|Overall Study|Physician Decision|0|||
170551417|NCT01570192|616364783|FG001|Overall Study|Physician Decision|1|||
170642345|NCT03596645|616703516|FG000|Overall Study|No mucosal healing achieved|1|||
170642346|NCT03596645|616703517|FG001|Overall Study|No mucosal healing achieved|0|||
170642347|NCT03596645|616703516|FG000|Overall Study|Disease progression|1|||
170642348|NCT03596645|616703517|FG001|Overall Study|Disease progression|0|||
170642349|NCT03596645|616703516|FG000|Overall Study|Ongoing|37|||
170642350|NCT03596645|616703517|FG001|Overall Study|Ongoing|12|||
170642351|NCT03596645|616703516|FG000|Overall Study|Randomized but not treated|0|||
170642352|NCT03596645|616703517|FG001|Overall Study|Randomized but not treated|1|||
170642353|NCT02338882|616705203|FG000|Overall Study|Death|1|||
170642354|NCT02338882|616705204|FG001|Overall Study|Death|0|||
170642355|NCT02338882|616705203|FG000|Overall Study|Lost to Follow-up|6|||
170901838|NCT01506141|617644436|FG000|Overall Study|Reason Not Specified|4|||
170901839|NCT01506141|617644437|FG001|Overall Study|Reason Not Specified|2|||
170901840|NCT04889209|617644438|FG000|All Cohorts Except 15E|Adverse Event|0|||
170901841|NCT04889209|617644439|FG001|All Cohorts Except 15E|Adverse Event|0|||
170901842|NCT04889209|617644440|FG002|All Cohorts Except 15E|Adverse Event|0|||
170901843|NCT04889209|617644441|FG003|All Cohorts Except 15E|Adverse Event|0|||
170901844|NCT04889209|617644442|FG004|All Cohorts Except 15E|Adverse Event|0|||
170901845|NCT04889209|617644443|FG005|All Cohorts Except 15E|Adverse Event|0|||
170901846|NCT04889209|617644444|FG006|All Cohorts Except 15E|Adverse Event|1|||
170901847|NCT04889209|617644445|FG007|All Cohorts Except 15E|Adverse Event|0|||
170901848|NCT04889209|617644446|FG008|All Cohorts Except 15E|Adverse Event|0|||
170901849|NCT04889209|617644447|FG009|All Cohorts Except 15E|Adverse Event|0|||
170901850|NCT04889209|617644448|FG010|All Cohorts Except 15E|Adverse Event|0|||
170901851|NCT04889209|617644449|FG011|All Cohorts Except 15E|Adverse Event|0|||
170901852|NCT04889209|617644450|FG012|All Cohorts Except 15E|Adverse Event|0|||
170901853|NCT04889209|617644451|FG013|All Cohorts Except 15E|Adverse Event|0|||
170901854|NCT04889209|617644452|FG014|All Cohorts Except 15E|Adverse Event|0|||
170901855|NCT04889209|617644453|FG015|All Cohorts Except 15E|Adverse Event|0|||
170901856|NCT04889209|617644454|FG016|All Cohorts Except 15E|Adverse Event|0|||
170901857|NCT04889209|617644455|FG017|All Cohorts Except 15E|Adverse Event|0|||
170901858|NCT04889209|617644438|FG000|All Cohorts Except 15E|Death|0|||
170901859|NCT04889209|617644439|FG001|All Cohorts Except 15E|Death|1|||
170901860|NCT04889209|617644440|FG002|All Cohorts Except 15E|Death|0|||
170901861|NCT04889209|617644441|FG003|All Cohorts Except 15E|Death|0|||
170901862|NCT04889209|617644442|FG004|All Cohorts Except 15E|Death|0|||
170901863|NCT04889209|617644443|FG005|All Cohorts Except 15E|Death|0|||
170901864|NCT04889209|617644444|FG006|All Cohorts Except 15E|Death|0|||
170901865|NCT04889209|617644445|FG007|All Cohorts Except 15E|Death|0|||
170901866|NCT04889209|617644446|FG008|All Cohorts Except 15E|Death|0|||
170901867|NCT04889209|617644447|FG009|All Cohorts Except 15E|Death|0|||
170901868|NCT04889209|617644448|FG010|All Cohorts Except 15E|Death|0|||
170901869|NCT04889209|617644449|FG011|All Cohorts Except 15E|Death|0|||
170901870|NCT04889209|617644450|FG012|All Cohorts Except 15E|Death|0|||
170901871|NCT04889209|617644451|FG013|All Cohorts Except 15E|Death|0|||
170901872|NCT04889209|617644452|FG014|All Cohorts Except 15E|Death|0|||
170901873|NCT04889209|617644453|FG015|All Cohorts Except 15E|Death|0|||
170901874|NCT04889209|617644454|FG016|All Cohorts Except 15E|Death|0|||
170901875|NCT04889209|617644455|FG017|All Cohorts Except 15E|Death|0|||
170901876|NCT04889209|617644438|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
170901877|NCT04889209|617644439|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
170901878|NCT04889209|617644440|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
170901879|NCT04889209|617644441|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
170901880|NCT04889209|617644442|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
170901881|NCT04889209|617644443|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
170901882|NCT04889209|617644444|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
170901883|NCT04889209|617644445|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
170901884|NCT04889209|617644446|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
170901885|NCT04889209|617644447|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
170901886|NCT04889209|617644448|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
170901887|NCT04889209|617644449|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
170901888|NCT04889209|617644450|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
170901889|NCT04889209|617644451|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
170901890|NCT04889209|617644452|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
170901891|NCT04889209|617644453|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
170901892|NCT04889209|617644454|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
170901893|NCT04889209|617644455|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
170901894|NCT04889209|617644438|FG000|All Cohorts Except 15E|Physician Decision|0|||
170901895|NCT04889209|617644439|FG001|All Cohorts Except 15E|Physician Decision|0|||
170642356|NCT02338882|616705204|FG001|Overall Study|Lost to Follow-up|3|||
170901896|NCT04889209|617644440|FG002|All Cohorts Except 15E|Physician Decision|0|||
170901897|NCT04889209|617644441|FG003|All Cohorts Except 15E|Physician Decision|0|||
170901898|NCT04889209|617644442|FG004|All Cohorts Except 15E|Physician Decision|1|||
170901899|NCT04889209|617644443|FG005|All Cohorts Except 15E|Physician Decision|0|||
170901900|NCT04889209|617644444|FG006|All Cohorts Except 15E|Physician Decision|0|||
170901901|NCT04889209|617644445|FG007|All Cohorts Except 15E|Physician Decision|1|||
170901902|NCT04889209|617644446|FG008|All Cohorts Except 15E|Physician Decision|0|||
170803648|NCT05580003|617290618|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803649|NCT05580003|617290619|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803650|NCT05580003|617290620|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803651|NCT05580003|617290621|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170901903|NCT04889209|617644447|FG009|All Cohorts Except 15E|Physician Decision|1|||
170901904|NCT04889209|617644448|FG010|All Cohorts Except 15E|Physician Decision|0|||
170901905|NCT04889209|617644449|FG011|All Cohorts Except 15E|Physician Decision|1|||
170901906|NCT04889209|617644450|FG012|All Cohorts Except 15E|Physician Decision|1|||
170901907|NCT04889209|617644451|FG013|All Cohorts Except 15E|Physician Decision|0|||
170901908|NCT04889209|617644452|FG014|All Cohorts Except 15E|Physician Decision|0|||
170901909|NCT04889209|617644453|FG015|All Cohorts Except 15E|Physician Decision|0|||
170901910|NCT04889209|617644454|FG016|All Cohorts Except 15E|Physician Decision|0|||
170901911|NCT04889209|617644455|FG017|All Cohorts Except 15E|Physician Decision|0|||
170901912|NCT04889209|617644438|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
170901913|NCT04889209|617644439|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
170901914|NCT04889209|617644440|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
170901915|NCT04889209|617644441|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
170901916|NCT04889209|617644442|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
170901917|NCT04889209|617644443|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
170901918|NCT04889209|617644444|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
170901919|NCT04889209|617644445|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
170901920|NCT04889209|617644446|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
170803652|NCT05580003|617290622|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170901921|NCT04889209|617644447|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
170901922|NCT04889209|617644448|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
170901923|NCT04889209|617644449|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
170803653|NCT05580003|617290623|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803654|NCT05580003|617290624|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
170803655|NCT05580003|617290597|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803656|NCT05580003|617290598|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803657|NCT05580003|617290599|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803658|NCT05580003|617290600|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803659|NCT05580003|617290601|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803660|NCT05580003|617290602|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803661|NCT05580003|617290603|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803662|NCT05580003|617290604|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803663|NCT05580003|617290605|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803664|NCT05580003|617290606|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803665|NCT05580003|617290607|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803666|NCT05580003|617290608|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803667|NCT05580003|617290609|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803668|NCT05580003|617290610|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803669|NCT05580003|617290611|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803670|NCT05580003|617290612|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170901924|NCT04889209|617644450|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
170901925|NCT04889209|617644451|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
170901926|NCT04889209|617644452|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
170901927|NCT04889209|617644453|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
170901928|NCT04889209|617644454|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
170901929|NCT04889209|617644455|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
170901930|NCT04889209|617644438|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
170901931|NCT04889209|617644439|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
170901932|NCT04889209|617644440|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901933|NCT04889209|617644441|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901934|NCT04889209|617644442|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901935|NCT04889209|617644443|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
170901936|NCT04889209|617644444|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901937|NCT04889209|617644445|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
170901938|NCT04889209|617644446|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901939|NCT04889209|617644447|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
170901940|NCT04889209|617644448|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901941|NCT04889209|617644449|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901942|NCT04889209|617644450|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901943|NCT04889209|617644451|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901944|NCT04889209|617644452|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170642357|NCT02248675|616705205|FG000|Overall Study|Lost to Follow-up|3|||
170901945|NCT04889209|617644453|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901946|NCT04889209|617644454|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
170901947|NCT04889209|617644455|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
170901948|NCT04889209|617644438|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901949|NCT04889209|617644439|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901950|NCT04889209|617644440|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901951|NCT04889209|617644441|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
170901952|NCT04889209|617644442|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901953|NCT04889209|617644443|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901954|NCT04889209|617644444|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901955|NCT04889209|617644445|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901956|NCT04889209|617644446|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901957|NCT04889209|617644447|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901958|NCT04889209|617644448|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170803671|NCT05580003|617290613|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803672|NCT05580003|617290614|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803673|NCT05580003|617290615|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803674|NCT05580003|617290616|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803675|NCT05580003|617290617|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803676|NCT05580003|617290618|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
170803677|NCT05580003|617290619|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803678|NCT05580003|617290620|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803679|NCT05580003|617290621|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803680|NCT05580003|617290622|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803681|NCT05580003|617290623|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803682|NCT05580003|617290624|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
170803683|NCT05580003|617290597|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803684|NCT05580003|617290598|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803685|NCT05580003|617290599|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803686|NCT05580003|617290600|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803687|NCT05580003|617290601|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803688|NCT05580003|617290602|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803689|NCT05580003|617290603|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803690|NCT05580003|617290604|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803691|NCT05580003|617290605|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803692|NCT05580003|617290606|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803693|NCT05580003|617290607|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803694|NCT05580003|617290608|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803695|NCT05580003|617290609|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803696|NCT05580003|617290610|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803697|NCT05580003|617290611|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803698|NCT05580003|617290612|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803699|NCT05580003|617290613|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803700|NCT05580003|617290614|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803701|NCT05580003|617290615|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803702|NCT05580003|617290616|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803703|NCT05580003|617290617|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803704|NCT05580003|617290618|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803705|NCT05580003|617290619|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803706|NCT05580003|617290620|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803707|NCT05580003|617290621|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803708|NCT05580003|617290622|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803709|NCT05580003|617290623|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
170803710|NCT05580003|617290624|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
170901959|NCT04889209|617644449|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901960|NCT04889209|617644450|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901961|NCT04889209|617644451|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901962|NCT04889209|617644452|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170803711|NCT05580003|617290597|FG000|Part 6 Period 2 (Day 1)|Other|0|||
170803712|NCT05580003|617290598|FG001|Part 6 Period 2 (Day 1)|Other|0|||
170803713|NCT05580003|617290599|FG002|Part 6 Period 2 (Day 1)|Other|0|||
170803714|NCT05580003|617290600|FG003|Part 6 Period 2 (Day 1)|Other|0|||
170803715|NCT05580003|617290601|FG004|Part 6 Period 2 (Day 1)|Other|0|||
170803716|NCT05580003|617290602|FG005|Part 6 Period 2 (Day 1)|Other|0|||
170803717|NCT05580003|617290603|FG006|Part 6 Period 2 (Day 1)|Other|0|||
170803718|NCT05580003|617290604|FG007|Part 6 Period 2 (Day 1)|Other|0|||
170803719|NCT05580003|617290605|FG008|Part 6 Period 2 (Day 1)|Other|0|||
170803720|NCT05580003|617290606|FG009|Part 6 Period 2 (Day 1)|Other|0|||
170803721|NCT05580003|617290607|FG010|Part 6 Period 2 (Day 1)|Other|0|||
170803722|NCT05580003|617290608|FG011|Part 6 Period 2 (Day 1)|Other|0|||
170803723|NCT05580003|617290609|FG012|Part 6 Period 2 (Day 1)|Other|0|||
170803724|NCT05580003|617290610|FG013|Part 6 Period 2 (Day 1)|Other|0|||
170803725|NCT05580003|617290611|FG014|Part 6 Period 2 (Day 1)|Other|0|||
170803726|NCT05580003|617290612|FG015|Part 6 Period 2 (Day 1)|Other|0|||
170803727|NCT05580003|617290613|FG016|Part 6 Period 2 (Day 1)|Other|0|||
170803728|NCT05580003|617290614|FG017|Part 6 Period 2 (Day 1)|Other|0|||
170803729|NCT05580003|617290615|FG018|Part 6 Period 2 (Day 1)|Other|0|||
170803730|NCT05580003|617290616|FG019|Part 6 Period 2 (Day 1)|Other|0|||
170803731|NCT05580003|617290617|FG020|Part 6 Period 2 (Day 1)|Other|0|||
170803732|NCT05580003|617290618|FG021|Part 6 Period 2 (Day 1)|Other|0|||
170803733|NCT05580003|617290619|FG022|Part 6 Period 2 (Day 1)|Other|0|||
170803734|NCT05580003|617290620|FG023|Part 6 Period 2 (Day 1)|Other|0|||
170803735|NCT05580003|617290621|FG024|Part 6 Period 2 (Day 1)|Other|1|||
170803736|NCT05580003|617290622|FG025|Part 6 Period 2 (Day 1)|Other|0|||
170803737|NCT05580003|617290623|FG026|Part 6 Period 2 (Day 1)|Other|0|||
170803738|NCT05580003|617290624|FG027|Part 6 Period 2 (Day 1)|Other|0|||
170803739|NCT03516812|617290625|FG000|Overall Study|Adverse Event|4|||
170803740|NCT03516812|617290625|FG000|Overall Study|Lack of Efficacy|2|||
170803741|NCT03170648|617290630|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
170803742|NCT03170648|617290630|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
170803743|NCT03509909|617290634|FG000|Overall Study|Withdrawal by Subject|16|||
170803744|NCT03509909|617290635|FG001|Overall Study|Withdrawal by Subject|9|||
170803745|NCT03509909|617290634|FG000|Overall Study|Lost to Follow-up|3|||
170803746|NCT03509909|617290635|FG001|Overall Study|Lost to Follow-up|4|||
170803747|NCT03509909|617290634|FG000|Overall Study|Adverse Event|2|||
170803748|NCT03509909|617290635|FG001|Overall Study|Adverse Event|0|||
170803749|NCT03611075|617290636|FG000|Overall Study|Physician Decision|0|||
170803750|NCT03611075|617290637|FG001|Overall Study|Physician Decision|1|||
170803751|NCT03611075|617290638|FG002|Overall Study|Physician Decision|1|||
170803752|NCT03611075|617290639|FG003|Overall Study|Physician Decision|0|||
170803753|NCT03611075|617290640|FG004|Overall Study|Physician Decision|0|||
170803754|NCT03611075|617290641|FG005|Overall Study|Physician Decision|0|||
170803755|NCT03611075|617290642|FG006|Overall Study|Physician Decision|0|||
170803756|NCT03611075|617290643|FG007|Overall Study|Physician Decision|0|||
170803757|NCT03611075|617290644|FG008|Overall Study|Physician Decision|0|||
170803758|NCT03611075|617290636|FG000|Overall Study|Lost to Follow-up|1|||
170642358|NCT02248675|616705206|FG001|Overall Study|Lost to Follow-up|1|||
170803759|NCT03611075|617290637|FG001|Overall Study|Lost to Follow-up|0|||
170803760|NCT03611075|617290638|FG002|Overall Study|Lost to Follow-up|0|||
170803761|NCT03611075|617290639|FG003|Overall Study|Lost to Follow-up|2|||
170803762|NCT03611075|617290640|FG004|Overall Study|Lost to Follow-up|0|||
170642359|NCT00617669|616705207|FG000|Overall Study|Withdrawal by Subject|71|||
170803763|NCT03611075|617290641|FG005|Overall Study|Lost to Follow-up|0|||
170803764|NCT03611075|617290642|FG006|Overall Study|Lost to Follow-up|0|||
170803765|NCT03611075|617290643|FG007|Overall Study|Lost to Follow-up|0|||
170803766|NCT03611075|617290644|FG008|Overall Study|Lost to Follow-up|0|||
170803767|NCT03611075|617290636|FG000|Overall Study|Withdrawal by Subject|0|||
170803768|NCT03611075|617290637|FG001|Overall Study|Withdrawal by Subject|1|||
170803769|NCT03611075|617290638|FG002|Overall Study|Withdrawal by Subject|1|||
170803770|NCT03611075|617290639|FG003|Overall Study|Withdrawal by Subject|1|||
170803771|NCT03611075|617290640|FG004|Overall Study|Withdrawal by Subject|0|||
170803772|NCT03611075|617290641|FG005|Overall Study|Withdrawal by Subject|0|||
170803773|NCT03611075|617290642|FG006|Overall Study|Withdrawal by Subject|1|||
170803774|NCT03611075|617290643|FG007|Overall Study|Withdrawal by Subject|0|||
170803775|NCT03611075|617290644|FG008|Overall Study|Withdrawal by Subject|0|||
170803776|NCT03611075|617290636|FG000|Overall Study|Reason unknown|0|||
170803777|NCT03611075|617290637|FG001|Overall Study|Reason unknown|0|||
170803778|NCT03611075|617290638|FG002|Overall Study|Reason unknown|0|||
170803779|NCT03611075|617290639|FG003|Overall Study|Reason unknown|1|||
170803780|NCT03611075|617290640|FG004|Overall Study|Reason unknown|0|||
170803781|NCT03611075|617290641|FG005|Overall Study|Reason unknown|0|||
170803782|NCT03611075|617290642|FG006|Overall Study|Reason unknown|1|||
170803783|NCT03611075|617290643|FG007|Overall Study|Reason unknown|0|||
170803784|NCT03611075|617290644|FG008|Overall Study|Reason unknown|0|||
170803785|NCT02928172|617290645|FG000|Overall Study|Device did not record data|1|||
170803786|NCT05601882|617290646|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
170803787|NCT05601882|617290647|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
170803788|NCT05601882|617290648|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
170803789|NCT05601882|617290649|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
170803790|NCT05601882|617290646|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
170803791|NCT05601882|617290647|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
170803792|NCT05601882|617290648|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
170803793|NCT05601882|617290649|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
170803794|NCT05601882|617290646|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
170803795|NCT05601882|617290647|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
170803796|NCT05601882|617290648|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
170803797|NCT05601882|617290649|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
170803798|NCT05601882|617290646|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
170803799|NCT05601882|617290647|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
170803800|NCT05601882|617290648|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
170803801|NCT05601882|617290649|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
170803802|NCT05601882|617290646|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
170803803|NCT05601882|617290647|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
170803804|NCT05601882|617290648|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
170803805|NCT05601882|617290649|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
170803806|NCT05601882|617290646|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
170803807|NCT05601882|617290647|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
170803808|NCT05601882|617290648|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
170803809|NCT05601882|617290649|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
170803810|NCT05464732|617290653|FG000|Overall Study|Lost to Follow-up|0|||
170803811|NCT05464732|617290654|FG001|Overall Study|Lost to Follow-up|1|||
170803812|NCT05464732|617290653|FG000|Overall Study|Adverse Event|1|||
170803813|NCT05464732|617290654|FG001|Overall Study|Adverse Event|0|||
170803814|NCT04306367|617290663|FG000|Overall Study|Progression of Disease|9|||
170803815|NCT04306367|617290663|FG000|Overall Study|Adverse Event|3|||
170803816|NCT04306367|617290663|FG000|Overall Study|Withdrawal by Subject|1|||
170803817|NCT00490139|617290664|FG000|Overall Study|Lost to Follow-up|249|||
170803818|NCT00490139|617290665|FG001|Overall Study|Lost to Follow-up|216|||
170803819|NCT00490139|617290666|FG002|Overall Study|Lost to Follow-up|205|||
170803820|NCT00490139|617290667|FG003|Overall Study|Lost to Follow-up|229|||
170803821|NCT00490139|617290664|FG000|Overall Study|Withdrawal by Subject|333|||
170803822|NCT00490139|617290665|FG001|Overall Study|Withdrawal by Subject|322|||
170803823|NCT00490139|617290666|FG002|Overall Study|Withdrawal by Subject|396|||
170803824|NCT00490139|617290667|FG003|Overall Study|Withdrawal by Subject|295|||
170803825|NCT00490139|617290664|FG000|Overall Study|Patient did not sign ICF 12|169|||
170803826|NCT00490139|617290665|FG001|Overall Study|Patient did not sign ICF 12|176|||
170803827|NCT00490139|617290666|FG002|Overall Study|Patient did not sign ICF 12|139|||
170803828|NCT00490139|617290667|FG003|Overall Study|Patient did not sign ICF 12|167|||
170803829|NCT00490139|617290664|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
170803830|NCT00490139|617290665|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
170803831|NCT00490139|617290666|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
170803832|NCT00490139|617290667|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
170803833|NCT00490139|617290664|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
170803834|NCT00490139|617290665|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
170803835|NCT00490139|617290666|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
170803836|NCT00490139|617290667|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
170803837|NCT00490139|617290664|FG000|Overall Study|Other reasons as defined per protocol|98|||
170803838|NCT00490139|617290665|FG001|Overall Study|Other reasons as defined per protocol|84|||
170803839|NCT00490139|617290666|FG002|Overall Study|Other reasons as defined per protocol|82|||
170803840|NCT00490139|617290667|FG003|Overall Study|Other reasons as defined per protocol|105|||
170803841|NCT03762850|617291912|FG000|Overall Study|Death|0|||
170803842|NCT03762850|617291913|FG001|Overall Study|Death|1|||
170901963|NCT04889209|617644453|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901964|NCT04889209|617644454|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901965|NCT04889209|617644455|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
170901966|NCT04889209|617644438|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901967|NCT04889209|617644439|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901968|NCT04889209|617644440|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901969|NCT04889209|617644441|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901970|NCT04889209|617644442|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
170901971|NCT04889209|617644443|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901972|NCT04889209|617644444|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
170901973|NCT04889209|617644445|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
170901974|NCT04889209|617644446|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901975|NCT04889209|617644447|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
170901976|NCT04889209|617644448|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
170901977|NCT04889209|617644449|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901978|NCT04889209|617644450|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
170901979|NCT04889209|617644451|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901980|NCT04889209|617644452|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901981|NCT04889209|617644453|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170901982|NCT04889209|617644454|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
170901983|NCT04889209|617644455|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
170551418|NCT02965976|616364784|FG000|Overall Study|Withdrawal by Subject|2|||
170901984|NCT04889209|617644438|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901985|NCT04889209|617644439|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901986|NCT04889209|617644440|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901987|NCT04889209|617644441|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901988|NCT04889209|617644442|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901989|NCT04889209|617644443|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901990|NCT04889209|617644444|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901991|NCT04889209|617644445|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901992|NCT04889209|617644446|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901993|NCT04889209|617644447|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901994|NCT04889209|617644448|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901995|NCT04889209|617644449|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901996|NCT04889209|617644450|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901997|NCT04889209|617644451|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901998|NCT04889209|617644452|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170901999|NCT04889209|617644453|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170902000|NCT04889209|617644454|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
170902001|NCT04889209|617644455|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
170902002|NCT04889209|617644438|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902003|NCT04889209|617644439|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902004|NCT04889209|617644440|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902005|NCT04889209|617644441|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902006|NCT04889209|617644442|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902007|NCT04889209|617644443|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902008|NCT04889209|617644444|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902009|NCT04889209|617644445|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902010|NCT04889209|617644446|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902011|NCT04889209|617644447|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902012|NCT04889209|617644448|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902013|NCT04889209|617644449|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902014|NCT04889209|617644450|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902015|NCT04889209|617644451|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902016|NCT04889209|617644452|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170803843|NCT03762850|617291912|FG000|Overall Study|Lost to Follow-up|0|||
170803844|NCT03762850|617291913|FG001|Overall Study|Lost to Follow-up|1|||
170803845|NCT03762850|617291912|FG000|Overall Study|Physician Decision|0|||
170803846|NCT03762850|617291913|FG001|Overall Study|Physician Decision|1|||
170803847|NCT03762850|617291912|FG000|Overall Study|Withdrawal by Subject|4|||
170803848|NCT03762850|617291913|FG001|Overall Study|Withdrawal by Subject|9|||
170803849|NCT02232737|617291914|FG000|Overall Study|Lost to Follow-up|18|||
170803850|NCT02232737|617291915|FG001|Overall Study|Lost to Follow-up|28|||
170803851|NCT02232737|617291916|FG002|Overall Study|Lost to Follow-up|33|||
170803852|NCT02232737|617291914|FG000|Overall Study|Personal reasons|7|||
170803853|NCT02232737|617291915|FG001|Overall Study|Personal reasons|8|||
170803854|NCT02232737|617291916|FG002|Overall Study|Personal reasons|14|||
170803855|NCT02232737|617291914|FG000|Overall Study|Adverse Event|6|||
170902017|NCT04889209|617644453|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902018|NCT04889209|617644454|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
170902019|NCT04889209|617644455|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
170902020|NCT04889209|617644438|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902021|NCT04889209|617644439|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902022|NCT04889209|617644440|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902023|NCT04889209|617644441|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902024|NCT04889209|617644442|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902025|NCT04889209|617644443|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902026|NCT04889209|617644444|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902027|NCT04889209|617644445|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902028|NCT04889209|617644446|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902029|NCT04889209|617644447|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902030|NCT04889209|617644448|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902031|NCT04889209|617644449|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902032|NCT04889209|617644450|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902033|NCT04889209|617644451|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902034|NCT04889209|617644452|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
170902035|NCT04889209|617644453|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902036|NCT04889209|617644454|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902037|NCT04889209|617644455|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
170902038|NCT05424276|617644462|FG000|Overall Study|Adverse Event|1|||
170902039|NCT05424276|617644463|FG001|Overall Study|Adverse Event|0|||
170902040|NCT05424276|617644464|FG002|Overall Study|Adverse Event|0|||
170902041|NCT05424276|617644465|FG003|Overall Study|Adverse Event|2|||
170902042|NCT05424276|617644462|FG000|Overall Study|Withdrawal by Subject|0|||
170902043|NCT05424276|617644463|FG001|Overall Study|Withdrawal by Subject|0|||
170902044|NCT05424276|617644464|FG002|Overall Study|Withdrawal by Subject|2|||
170902045|NCT05424276|617644465|FG003|Overall Study|Withdrawal by Subject|0|||
170902046|NCT05424276|617644462|FG000|Overall Study|Protocol Violation|0|||
170902047|NCT05424276|617644463|FG001|Overall Study|Protocol Violation|1|||
170902048|NCT05424276|617644464|FG002|Overall Study|Protocol Violation|0|||
170902049|NCT05424276|617644465|FG003|Overall Study|Protocol Violation|0|||
170902050|NCT05424276|617644462|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
170902051|NCT05424276|617644463|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
170902052|NCT05424276|617644464|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
170902053|NCT05424276|617644465|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
170902054|NCT05113940|617644468|FG000|Part A (18 Days)|Adverse Event|0|||
170902055|NCT05113940|617644469|FG001|Part A (18 Days)|Adverse Event|0|||
170902056|NCT05113940|617644470|FG002|Part A (18 Days)|Adverse Event|1|||
170902057|NCT05113940|617644471|FG003|Part A (18 Days)|Adverse Event|1|||
170902058|NCT05113940|617644472|FG004|Part A (18 Days)|Adverse Event|1|||
170902059|NCT05113940|617644473|FG005|Part A (18 Days)|Adverse Event|0|||
170902060|NCT05113940|617644474|FG006|Part A (18 Days)|Adverse Event|0|||
170902061|NCT05113940|617644475|FG007|Part A (18 Days)|Adverse Event|0|||
170902062|NCT05113940|617644476|FG008|Part A (18 Days)|Adverse Event|0|||
170902063|NCT05113940|617644477|FG009|Part A (18 Days)|Adverse Event|0|||
170803856|NCT02232737|617291915|FG001|Overall Study|Adverse Event|3|||
170803857|NCT02232737|617291916|FG002|Overall Study|Adverse Event|8|||
170902064|NCT05113940|617644478|FG010|Part A (18 Days)|Adverse Event|0|||
170902065|NCT05113940|617644479|FG011|Part A (18 Days)|Adverse Event|2|||
170902066|NCT05113940|617644480|FG012|Part A (18 Days)|Adverse Event|0|||
170902067|NCT05113940|617644481|FG013|Part A (18 Days)|Adverse Event|0|||
170902068|NCT05113940|617644482|FG014|Part A (18 Days)|Adverse Event|0|||
170902069|NCT05113940|617644468|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902070|NCT05113940|617644469|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902071|NCT05113940|617644470|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902072|NCT05113940|617644471|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
170803858|NCT02232737|617291914|FG000|Overall Study|Incarcerated|2|||
170803859|NCT02232737|617291915|FG001|Overall Study|Incarcerated|1|||
170902073|NCT05113940|617644472|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902074|NCT05113940|617644473|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902075|NCT05113940|617644474|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902076|NCT05113940|617644475|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902077|NCT05113940|617644476|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902078|NCT05113940|617644477|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902079|NCT05113940|617644478|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902080|NCT05113940|617644479|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
170803860|NCT02232737|617291916|FG002|Overall Study|Incarcerated|2|||
170803861|NCT02232737|617291914|FG000|Overall Study|Withdrawal by Subject|0|||
170803862|NCT02232737|617291915|FG001|Overall Study|Withdrawal by Subject|1|||
170803863|NCT02232737|617291916|FG002|Overall Study|Withdrawal by Subject|2|||
170803864|NCT02232737|617291914|FG000|Overall Study|Death|0|||
170803865|NCT02232737|617291915|FG001|Overall Study|Death|1|||
170803866|NCT02232737|617291916|FG002|Overall Study|Death|1|||
170803867|NCT02232737|617291914|FG000|Overall Study|Physician Decision|1|||
170803868|NCT02232737|617291915|FG001|Overall Study|Physician Decision|3|||
170803869|NCT02232737|617291916|FG002|Overall Study|Physician Decision|1|||
170803870|NCT02232737|617291914|FG000|Overall Study|Protocol Violation|1|||
170803871|NCT02232737|617291915|FG001|Overall Study|Protocol Violation|0|||
170803872|NCT02232737|617291916|FG002|Overall Study|Protocol Violation|1|||
170803873|NCT02232737|617291914|FG000|Overall Study|Reason unknown|1|||
170803874|NCT02232737|617291915|FG001|Overall Study|Reason unknown|0|||
170803875|NCT02232737|617291916|FG002|Overall Study|Reason unknown|0|||
170803876|NCT03801148|617291917|FG000|Period 1 (2 Days)|Adverse Event|1|||
170803877|NCT03801148|617291918|FG001|Period 1 (2 Days)|Adverse Event|1|||
170803878|NCT03801148|617291919|FG002|Period 1 (2 Days)|Adverse Event|0|||
170803879|NCT03801148|617291920|FG003|Period 1 (2 Days)|Adverse Event|0|||
170803880|NCT03801148|617291917|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
170902081|NCT05113940|617644480|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902082|NCT05113940|617644481|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
170902083|NCT05113940|617644482|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
170902084|NCT03619213|617644484|FG000|Overall Study|Lost to Follow-up|2|||
170902085|NCT03619213|617644485|FG001|Overall Study|Lost to Follow-up|1|||
170902086|NCT03619213|617644484|FG000|Overall Study|Withdrawal by Subject|8|||
170902087|NCT03619213|617644485|FG001|Overall Study|Withdrawal by Subject|10|||
170902088|NCT00382967|617644486|FG000|Overall Study|Protocol Violation|1|||
170551419|NCT02965976|616364785|FG001|Overall Study|Withdrawal by Subject|0|||
170551420|NCT00806026|616364786|FG000|Overall Study|Death|0|||
170551421|NCT00806026|616364787|FG001|Overall Study|Death|0|||
170551422|NCT00806026|616364788|FG002|Overall Study|Death|0|||
170551423|NCT00806026|616364789|FG003|Overall Study|Death|1|||
170551424|NCT00806026|616364790|FG004|Overall Study|Death|0|||
170551425|NCT00806026|616364791|FG005|Overall Study|Death|0|||
170551426|NCT00806026|616364786|FG000|Overall Study|Did not meet entrance criteria|4|||
170551427|NCT00806026|616364787|FG001|Overall Study|Did not meet entrance criteria|1|||
170551428|NCT00806026|616364788|FG002|Overall Study|Did not meet entrance criteria|2|||
170902089|NCT00382967|617644487|FG001|Overall Study|Protocol Violation|1|||
170902090|NCT00442598|617644489|FG000|Overall Study|Adverse Event|1|||
170902091|NCT00442598|617644490|FG001|Overall Study|Adverse Event|0|||
170551429|NCT00806026|616364789|FG003|Overall Study|Did not meet entrance criteria|1|||
170803881|NCT03801148|617291918|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
170803882|NCT03801148|617291919|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
170902092|NCT00442598|617644491|FG002|Overall Study|Adverse Event|0|||
170902093|NCT00442598|617644489|FG000|Overall Study|Tumor progression|3|||
170902094|NCT00442598|617644490|FG001|Overall Study|Tumor progression|4|||
170902095|NCT00442598|617644491|FG002|Overall Study|Tumor progression|0|||
170902096|NCT00442598|617644489|FG000|Overall Study|Clinical deterioration|1|||
170902097|NCT00442598|617644490|FG001|Overall Study|Clinical deterioration|2|||
170902098|NCT00442598|617644491|FG002|Overall Study|Clinical deterioration|0|||
170902099|NCT00442598|617644489|FG000|Overall Study|CA125 progression|0|||
170551430|NCT00806026|616364790|FG004|Overall Study|Did not meet entrance criteria|0|||
170551431|NCT00806026|616364791|FG005|Overall Study|Did not meet entrance criteria|0|||
170551432|NCT00806026|616364786|FG000|Overall Study|Lack of Efficacy|5|||
170551433|NCT00806026|616364787|FG001|Overall Study|Lack of Efficacy|18|||
170551434|NCT00806026|616364788|FG002|Overall Study|Lack of Efficacy|13|||
170551435|NCT00806026|616364789|FG003|Overall Study|Lack of Efficacy|4|||
170803883|NCT03801148|617291920|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
170803884|NCT03801148|617291917|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170803885|NCT03801148|617291918|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170803886|NCT03801148|617291919|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
170803887|NCT03801148|617291920|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
170803888|NCT03801148|617291917|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
170803889|NCT03801148|617291918|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
170803890|NCT03801148|617291919|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
170803891|NCT03801148|617291920|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
170803892|NCT01641900|617291921|FG000|Overall Study|Withdrawal by Subject|2|||
170803893|NCT01641900|617291922|FG001|Overall Study|Withdrawal by Subject|2|||
170803894|NCT03244800|617291925|FG000|Overall Study|Adverse Event|0|||
170803895|NCT03244800|617291926|FG001|Overall Study|Adverse Event|1|||
170803896|NCT03244800|617291927|FG002|Overall Study|Adverse Event|0|||
170803897|NCT03244800|617291928|FG003|Overall Study|Adverse Event|1|||
170803898|NCT03244800|617291925|FG000|Overall Study|Withdrew treatment|0|||
170803899|NCT03244800|617291926|FG001|Overall Study|Withdrew treatment|0|||
170803900|NCT03244800|617291927|FG002|Overall Study|Withdrew treatment|0|||
170803901|NCT03244800|617291928|FG003|Overall Study|Withdrew treatment|1|||
170803902|NCT00371345|617291931|FG000|Overall Study|Disease Progression|21|||
170803903|NCT00371345|617291932|FG001|Overall Study|Disease Progression|35|||
170803904|NCT00371345|617291931|FG000|Overall Study|Study Drug Toxicity|1|||
170803905|NCT00371345|617291932|FG001|Overall Study|Study Drug Toxicity|7|||
170803906|NCT00371345|617291931|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
170803907|NCT00371345|617291932|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
170803908|NCT00371345|617291931|FG000|Overall Study|Participant Request|1|||
170803909|NCT00371345|617291932|FG001|Overall Study|Participant Request|1|||
170803910|NCT00371345|617291931|FG000|Overall Study|Participant Withdrew Consent|0|||
170803911|NCT00371345|617291932|FG001|Overall Study|Participant Withdrew Consent|1|||
170803912|NCT00442104|617291933|FG000|Overall Study|Adverse Event|5|||
170803913|NCT00442104|617291933|FG000|Overall Study|Death|2|||
170803914|NCT00442104|617291933|FG000|Overall Study|Lost to Follow-up|3|||
170803915|NCT00442104|617291933|FG000|Overall Study|Withdrawal by Subject|5|||
170803916|NCT00442104|617291933|FG000|Overall Study|Insufficient Clinical Response|10|||
170803917|NCT00442104|617291933|FG000|Overall Study|Other|21|||
170803918|NCT00442104|617291933|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
170803919|NCT00263757|617291934|FG000|Overall Study|Withdrawal by Subject|5|||
170803920|NCT00263757|617291935|FG001|Overall Study|Withdrawal by Subject|4|||
170803921|NCT00263757|617291934|FG000|Overall Study|Screen failure|0|||
170803922|NCT00263757|617291935|FG001|Overall Study|Screen failure|1|||
170803923|NCT00263757|617291934|FG000|Overall Study|Adverse Event|3|||
170803924|NCT00263757|617291935|FG001|Overall Study|Adverse Event|3|||
170803925|NCT00713596|617291936|FG000|Overall Study|Study was terminated|2|||
170803926|NCT00713596|617291937|FG001|Overall Study|Study was terminated|3|||
170803927|NCT00713596|617291938|FG002|Overall Study|Study was terminated|2|||
170803928|NCT00975585|617291939|FG000|Overall Study|Adverse Event|0|||
170803929|NCT00975585|617291940|FG001|Overall Study|Adverse Event|4|||
170803930|NCT00975585|617291939|FG000|Overall Study|Lost to Follow-up|3|||
170803931|NCT00975585|617291940|FG001|Overall Study|Lost to Follow-up|5|||
170803932|NCT00975585|617291939|FG000|Overall Study|Withdrawal by Subject|2|||
170803933|NCT00975585|617291940|FG001|Overall Study|Withdrawal by Subject|1|||
170803934|NCT00975585|617291939|FG000|Overall Study|Lens issue|2|||
170803935|NCT00975585|617291940|FG001|Overall Study|Lens issue|2|||
170551436|NCT00806026|616364790|FG004|Overall Study|Lack of Efficacy|8|||
170551437|NCT00806026|616364791|FG005|Overall Study|Lack of Efficacy|7|||
170551438|NCT00806026|616364786|FG000|Overall Study|Lost to Follow-up|8|||
170551439|NCT00806026|616364787|FG001|Overall Study|Lost to Follow-up|15|||
170551440|NCT00806026|616364788|FG002|Overall Study|Lost to Follow-up|8|||
170803936|NCT01211184|617291943|FG000|Overall Study|Withdrawal by Subject|0|||
170803937|NCT01211184|617291944|FG001|Overall Study|Withdrawal by Subject|2|||
170902100|NCT00442598|617644490|FG001|Overall Study|CA125 progression|1|||
170902101|NCT00442598|617644491|FG002|Overall Study|CA125 progression|0|||
170551441|NCT00806026|616364789|FG003|Overall Study|Lost to Follow-up|2|||
170551442|NCT00806026|616364790|FG004|Overall Study|Lost to Follow-up|6|||
170551443|NCT00806026|616364791|FG005|Overall Study|Lost to Follow-up|6|||
170551444|NCT00806026|616364786|FG000|Overall Study|Withdrawal by Subject|14|||
170551445|NCT00806026|616364787|FG001|Overall Study|Withdrawal by Subject|17|||
170551446|NCT00806026|616364788|FG002|Overall Study|Withdrawal by Subject|9|||
170497087|NCT01827267|616159068|FG000|Overall Study|Sponsor Discontinued Study|2|||
170497088|NCT01827267|616159069|FG001|Overall Study|Sponsor Discontinued Study|8|||
170497089|NCT01827267|616159068|FG000|Overall Study|Still on study|0|||
170497090|NCT01827267|616159069|FG001|Overall Study|Still on study|2|||
170497091|NCT01732640|616159071|FG000|Overall Study|Adverse Event|0|||
170497092|NCT01732640|616159072|FG001|Overall Study|Adverse Event|1|||
170497093|NCT01732640|616159071|FG000|Overall Study|Death|0|||
170497094|NCT01732640|616159072|FG001|Overall Study|Death|1|||
170497095|NCT00877487|616159079|FG000|Open-label Treatment Phase|Adverse Event|1|||
170497096|NCT00877487|616159080|FG001|Open-label Treatment Phase|Adverse Event|0|||
170497097|NCT00877487|616159079|FG000|Open-label Treatment Phase|Protocol Violation|3|||
170497098|NCT00877487|616159080|FG001|Open-label Treatment Phase|Protocol Violation|0|||
170497099|NCT00877487|616159079|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
170497100|NCT00877487|616159080|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
170902102|NCT00442598|617644489|FG000|Overall Study|Reduced creatinine clearance|1|||
170902103|NCT00442598|617644490|FG001|Overall Study|Reduced creatinine clearance|0|||
170902104|NCT00442598|617644491|FG002|Overall Study|Reduced creatinine clearance|0|||
170902105|NCT00442598|617644489|FG000|Overall Study|Death|0|||
170902106|NCT00442598|617644490|FG001|Overall Study|Death|1|||
170902107|NCT00442598|617644491|FG002|Overall Study|Death|0|||
170902108|NCT02886702|617644492|FG000|Overall Study|Other|4|||
170902109|NCT02886702|617644493|FG001|Overall Study|Other|3|||
170902110|NCT02886702|617644494|FG002|Overall Study|Other|9|||
170902111|NCT02886702|617644492|FG000|Overall Study|Withdrawal by Subject|24|||
170902112|NCT02886702|617644493|FG001|Overall Study|Withdrawal by Subject|18|||
170902113|NCT02886702|617644494|FG002|Overall Study|Withdrawal by Subject|22|||
170902114|NCT02886702|617644492|FG000|Overall Study|Significant Worsening of Condition|0|||
170902115|NCT02886702|617644493|FG001|Overall Study|Significant Worsening of Condition|1|||
170902116|NCT02886702|617644494|FG002|Overall Study|Significant Worsening of Condition|0|||
170902117|NCT02886702|617644492|FG000|Overall Study|Protocol Violation|2|||
170902118|NCT02886702|617644493|FG001|Overall Study|Protocol Violation|2|||
170902119|NCT02886702|617644494|FG002|Overall Study|Protocol Violation|1|||
170902120|NCT02886702|617644492|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170902121|NCT02886702|617644493|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170902122|NCT02886702|617644494|FG002|Overall Study|Non-Compliance With Study Drug|4|||
170902123|NCT02886702|617644492|FG000|Overall Study|Lost to Follow-up|11|||
170902124|NCT02886702|617644493|FG001|Overall Study|Lost to Follow-up|13|||
170902125|NCT02886702|617644494|FG002|Overall Study|Lost to Follow-up|8|||
170902126|NCT02886702|617644492|FG000|Overall Study|Lack of Efficacy|3|||
170902127|NCT02886702|617644493|FG001|Overall Study|Lack of Efficacy|4|||
170902128|NCT02886702|617644494|FG002|Overall Study|Lack of Efficacy|5|||
170902129|NCT02886702|617644492|FG000|Overall Study|Adverse Event|4|||
170902130|NCT02886702|617644493|FG001|Overall Study|Adverse Event|9|||
170902131|NCT02886702|617644494|FG002|Overall Study|Adverse Event|3|||
170902132|NCT02886702|617644492|FG000|Overall Study|Administrative Reasons|0|||
170902133|NCT02886702|617644493|FG001|Overall Study|Administrative Reasons|0|||
170902134|NCT02886702|617644494|FG002|Overall Study|Administrative Reasons|1|||
170902135|NCT01147497|617644498|FG000|Overall Study|failed insertion|2|||
170902136|NCT01147497|617644499|FG001|Overall Study|failed insertion|0|||
170902137|NCT00501228|617644500|FG000|Overall Study|Withdrawal by Subject|1|||
170902138|NCT01147926|617644501|FG000|Overall Study|Subject Withdrew Consent|9|||
170902139|NCT01147926|617644502|FG001|Overall Study|Subject Withdrew Consent|10|||
170902140|NCT01147926|617644501|FG000|Overall Study|Adverse Event|7|||
170902141|NCT01147926|617644502|FG001|Overall Study|Adverse Event|6|||
170902142|NCT01147926|617644501|FG000|Overall Study|Subject Non-Compliant|5|||
170902143|NCT01147926|617644502|FG001|Overall Study|Subject Non-Compliant|4|||
170902144|NCT01147926|617644501|FG000|Overall Study|Principal investigator left hospital|1|||
170902145|NCT01147926|617644502|FG001|Overall Study|Principal investigator left hospital|3|||
170902146|NCT01147926|617644501|FG000|Overall Study|Selection criteria not met|3|||
170902147|NCT01147926|617644502|FG001|Overall Study|Selection criteria not met|1|||
170902148|NCT01147926|617644501|FG000|Overall Study|Lost to Follow-up|0|||
170902149|NCT01147926|617644502|FG001|Overall Study|Lost to Follow-up|2|||
170902150|NCT01147926|617644501|FG000|Overall Study|Sponsor's Decision|0|||
170902151|NCT01147926|617644502|FG001|Overall Study|Sponsor's Decision|1|||
170902152|NCT01147926|617644501|FG000|Overall Study|Lack of Efficacy|1|||
170902153|NCT01147926|617644502|FG001|Overall Study|Lack of Efficacy|0|||
170902154|NCT01147926|617644501|FG000|Overall Study|Too busy, no time for study|1|||
170902155|NCT01147926|617644502|FG001|Overall Study|Too busy, no time for study|0|||
170902156|NCT01147926|617644501|FG000|Overall Study|Went on holiday|0|||
170902157|NCT01147926|617644502|FG001|Overall Study|Went on holiday|1|||
170902158|NCT01147926|617644501|FG000|Overall Study|Colonoscopy result|0|||
170902159|NCT01147926|617644502|FG001|Overall Study|Colonoscopy result|1|||
170902160|NCT03417440|617644503|FG000|Overall Study|Lost to Follow-up|0|||
170902161|NCT03417440|617644504|FG001|Overall Study|Lost to Follow-up|1|||
170902162|NCT03417440|617644505|FG002|Overall Study|Lost to Follow-up|0|||
170902163|NCT03417440|617644506|FG003|Overall Study|Lost to Follow-up|0|||
170902164|NCT03417440|617644507|FG004|Overall Study|Lost to Follow-up|1|||
170902165|NCT03417440|617644508|FG005|Overall Study|Lost to Follow-up|0|||
170497101|NCT00877487|616159079|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
170497102|NCT00877487|616159080|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
170497103|NCT00877487|616159079|FG000|Open-label Treatment Phase|Out of country for business|1|||
170497104|NCT00877487|616159080|FG001|Open-label Treatment Phase|Out of country for business|0|||
170497105|NCT00877487|616159079|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
170497106|NCT00877487|616159080|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
170497107|NCT00877487|616159079|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
170497108|NCT00877487|616159080|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
170497109|NCT00877487|616159079|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
170497110|NCT00877487|616159080|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
170497111|NCT00877487|616159079|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
170497112|NCT00877487|616159080|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
170497113|NCT02147158|616159085|FG000|Treatment Course 1|Adverse Event|1|||
170497114|NCT02147158|616159086|FG001|Treatment Course 1|Adverse Event|4|||
170497115|NCT02147158|616159087|FG002|Treatment Course 1|Adverse Event|3|||
170497116|NCT02147158|616159088|FG003|Treatment Course 1|Adverse Event|4|||
170497117|NCT02147158|616159089|FG004|Treatment Course 1|Adverse Event|1|||
170497118|NCT02147158|616159090|FG005|Treatment Course 1|Adverse Event|2|||
170497119|NCT02147158|616159085|FG000|Treatment Course 1|Lost to Follow-up|2|||
170497120|NCT02147158|616159086|FG001|Treatment Course 1|Lost to Follow-up|4|||
170497121|NCT02147158|616159087|FG002|Treatment Course 1|Lost to Follow-up|3|||
170497122|NCT02147158|616159088|FG003|Treatment Course 1|Lost to Follow-up|3|||
170497123|NCT02147158|616159089|FG004|Treatment Course 1|Lost to Follow-up|2|||
170497124|NCT02147158|616159090|FG005|Treatment Course 1|Lost to Follow-up|4|||
170902166|NCT03417440|617644509|FG006|Overall Study|Lost to Follow-up|0|||
170497125|NCT02147158|616159085|FG000|Treatment Course 1|Protocol Violation|0|||
170497126|NCT02147158|616159086|FG001|Treatment Course 1|Protocol Violation|0|||
170497127|NCT02147158|616159087|FG002|Treatment Course 1|Protocol Violation|1|||
170497128|NCT02147158|616159088|FG003|Treatment Course 1|Protocol Violation|1|||
170497129|NCT02147158|616159089|FG004|Treatment Course 1|Protocol Violation|0|||
170497130|NCT02147158|616159090|FG005|Treatment Course 1|Protocol Violation|0|||
170497131|NCT02147158|616159085|FG000|Treatment Course 1|Withdrawal of Consent|1|||
170497132|NCT02147158|616159086|FG001|Treatment Course 1|Withdrawal of Consent|1|||
170497133|NCT02147158|616159087|FG002|Treatment Course 1|Withdrawal of Consent|1|||
170497134|NCT02147158|616159088|FG003|Treatment Course 1|Withdrawal of Consent|5|||
170497135|NCT02147158|616159089|FG004|Treatment Course 1|Withdrawal of Consent|3|||
170497136|NCT02147158|616159090|FG005|Treatment Course 1|Withdrawal of Consent|2|||
170497137|NCT02147158|616159085|FG000|Off-Treatment Interval 1|Adverse Event|1|||
170497138|NCT02147158|616159086|FG001|Off-Treatment Interval 1|Adverse Event|0|||
170497139|NCT02147158|616159087|FG002|Off-Treatment Interval 1|Adverse Event|0|||
170497140|NCT02147158|616159088|FG003|Off-Treatment Interval 1|Adverse Event|1|||
170497141|NCT02147158|616159089|FG004|Off-Treatment Interval 1|Adverse Event|0|||
170497142|NCT02147158|616159090|FG005|Off-Treatment Interval 1|Adverse Event|0|||
170497143|NCT02147158|616159085|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
170497144|NCT02147158|616159086|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
170497145|NCT02147158|616159087|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
170497146|NCT02147158|616159088|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
170497147|NCT02147158|616159089|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
170497148|NCT02147158|616159090|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
170497149|NCT02147158|616159085|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
170497150|NCT02147158|616159086|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
170497151|NCT02147158|616159087|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
170497152|NCT02147158|616159088|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
170497153|NCT02147158|616159089|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
170902167|NCT03417440|617644510|FG007|Overall Study|Lost to Follow-up|0|||
170902168|NCT03417440|617644503|FG000|Overall Study|Withdrawal by Subject|2|||
170497154|NCT02147158|616159090|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
170497155|NCT02147158|616159085|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
170803938|NCT01211184|617291945|FG002|Overall Study|Withdrawal by Subject|1|||
170803939|NCT00853593|617291951|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
170803940|NCT00853593|617291951|FG000|Overall Study|Model 4396 lead not attempted|29|||
170803941|NCT00853593|617291951|FG000|Overall Study|Implant not attempted|4|||
170803942|NCT02350634|617291955|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
170803943|NCT02408887|617291964|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
170803944|NCT02408887|617291965|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
170803945|NCT02408887|617291964|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
170803946|NCT02408887|617291965|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
170803947|NCT03357952|617291974|FG000|Overall Study|Withdrawal by Subject|0|||
170803948|NCT03357952|617291975|FG001|Overall Study|Withdrawal by Subject|1|||
170803949|NCT03357952|617291974|FG000|Overall Study|Sponsor Decision|9|||
170803950|NCT03357952|617291975|FG001|Overall Study|Sponsor Decision|0|||
170803951|NCT03598907|617291976|FG000|Overall Study|Physician Decision|14|||
170803952|NCT03598907|617291977|FG001|Overall Study|Physician Decision|19|||
170803953|NCT03593226|617291994|FG000|Overall Study|Disease progression|6|||
170803954|NCT03593226|617291995|FG001|Overall Study|Disease progression|13|||
170803955|NCT03593226|617291996|FG002|Overall Study|Disease progression|5|||
170803956|NCT03593226|617291997|FG003|Overall Study|Disease progression|6|||
170803957|NCT03593226|617291994|FG000|Overall Study|Adverse Event|0|||
170803958|NCT03593226|617291995|FG001|Overall Study|Adverse Event|1|||
170803959|NCT03593226|617291996|FG002|Overall Study|Adverse Event|0|||
170803960|NCT03593226|617291997|FG003|Overall Study|Adverse Event|0|||
170803961|NCT03593226|617291994|FG000|Overall Study|Withdrawal by Subject|0|||
170803962|NCT03593226|617291995|FG001|Overall Study|Withdrawal by Subject|4|||
170803963|NCT03593226|617291996|FG002|Overall Study|Withdrawal by Subject|1|||
170803964|NCT03593226|617291997|FG003|Overall Study|Withdrawal by Subject|0|||
170803965|NCT03593226|617291994|FG000|Overall Study|Physician Decision|0|||
170803966|NCT03593226|617291995|FG001|Overall Study|Physician Decision|1|||
170803967|NCT03593226|617291996|FG002|Overall Study|Physician Decision|0|||
170803968|NCT03593226|617291997|FG003|Overall Study|Physician Decision|0|||
170803969|NCT03593226|617291994|FG000|Overall Study|Clinical disease progression|0|||
170803970|NCT03593226|617291995|FG001|Overall Study|Clinical disease progression|0|||
170803971|NCT03593226|617291996|FG002|Overall Study|Clinical disease progression|1|||
170803972|NCT03593226|617291997|FG003|Overall Study|Clinical disease progression|0|||
170803973|NCT04517435|617291998|FG000|Overall Study|Withdrawal by Subject|0|||
170803974|NCT04517435|617291999|FG001|Overall Study|Withdrawal by Subject|0|||
170902169|NCT03417440|617644504|FG001|Overall Study|Withdrawal by Subject|0|||
170902170|NCT03417440|617644505|FG002|Overall Study|Withdrawal by Subject|2|||
170902171|NCT03417440|617644506|FG003|Overall Study|Withdrawal by Subject|1|||
170497156|NCT02147158|616159086|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
170497157|NCT02147158|616159087|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
170497158|NCT02147158|616159088|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
170497159|NCT02147158|616159089|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
170497160|NCT02147158|616159090|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
170497161|NCT02147158|616159085|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
170497162|NCT02147158|616159086|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
170497163|NCT02147158|616159087|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
170497164|NCT02147158|616159088|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
170497165|NCT02147158|616159089|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
170497166|NCT02147158|616159090|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
170497167|NCT02147158|616159085|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
170497168|NCT02147158|616159086|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
170497169|NCT02147158|616159087|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
170497170|NCT02147158|616159088|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
170497171|NCT02147158|616159089|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
170497172|NCT02147158|616159090|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
170497173|NCT02147158|616159085|FG000|Treatment Course 2|Adverse Event|0|||
170497174|NCT02147158|616159086|FG001|Treatment Course 2|Adverse Event|4|||
170497175|NCT02147158|616159087|FG002|Treatment Course 2|Adverse Event|2|||
170497176|NCT02147158|616159088|FG003|Treatment Course 2|Adverse Event|1|||
170497177|NCT02147158|616159089|FG004|Treatment Course 2|Adverse Event|0|||
170497178|NCT02147158|616159090|FG005|Treatment Course 2|Adverse Event|1|||
170497179|NCT02147158|616159085|FG000|Treatment Course 2|Withdrawal of Consent|0|||
170497180|NCT02147158|616159086|FG001|Treatment Course 2|Withdrawal of Consent|1|||
170497181|NCT02147158|616159087|FG002|Treatment Course 2|Withdrawal of Consent|2|||
170497182|NCT02147158|616159088|FG003|Treatment Course 2|Withdrawal of Consent|3|||
170497183|NCT02147158|616159089|FG004|Treatment Course 2|Withdrawal of Consent|0|||
170497184|NCT02147158|616159090|FG005|Treatment Course 2|Withdrawal of Consent|0|||
170497185|NCT02147158|616159085|FG000|Treatment Course 2|Lost to Follow-up|1|||
170497186|NCT02147158|616159086|FG001|Treatment Course 2|Lost to Follow-up|0|||
170497187|NCT02147158|616159087|FG002|Treatment Course 2|Lost to Follow-up|1|||
170497188|NCT02147158|616159088|FG003|Treatment Course 2|Lost to Follow-up|1|||
170497189|NCT02147158|616159089|FG004|Treatment Course 2|Lost to Follow-up|0|||
170497190|NCT02147158|616159090|FG005|Treatment Course 2|Lost to Follow-up|1|||
170497191|NCT02147158|616159085|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
170497192|NCT02147158|616159086|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
170497193|NCT02147158|616159087|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
170497194|NCT02147158|616159088|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
170497195|NCT02147158|616159089|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
170497196|NCT02147158|616159090|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
170803975|NCT04517435|617292000|FG002|Overall Study|Withdrawal by Subject|1|||
170803976|NCT04517435|617291998|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
170803977|NCT04517435|617291999|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
170803978|NCT04517435|617292000|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
170803979|NCT03656718|617292001|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
170803980|NCT03656718|617292002|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
170803981|NCT03656718|617292003|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
170803982|NCT03656718|617292004|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
170803983|NCT03656718|617292005|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
170803984|NCT03656718|617292006|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
170803985|NCT03656718|617292007|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
170803986|NCT03656718|617292001|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
170803987|NCT03656718|617292002|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
170803988|NCT03656718|617292003|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
170803989|NCT03656718|617292004|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
170803990|NCT03656718|617292005|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
170803991|NCT03656718|617292006|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
170803992|NCT03656718|617292007|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
170803993|NCT03656718|617292001|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
170803994|NCT03656718|617292002|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
170803995|NCT03656718|617292003|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
170803996|NCT03656718|617292004|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
170803997|NCT03656718|617292005|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
170803998|NCT03656718|617292006|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
170803999|NCT03656718|617292007|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
170804000|NCT03656718|617292001|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
170804001|NCT03656718|617292002|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
170804002|NCT03656718|617292003|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
170804003|NCT03656718|617292004|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
170804004|NCT03656718|617292005|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
170804005|NCT03656718|617292006|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
170804006|NCT03656718|617292007|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
170804007|NCT03656718|617292001|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
170804008|NCT03656718|617292002|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
170804009|NCT03656718|617292003|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
170497197|NCT02147158|616159085|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
170497198|NCT02147158|616159086|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
170497199|NCT02147158|616159087|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
170497200|NCT02147158|616159088|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
170497201|NCT02147158|616159089|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
170497202|NCT02147158|616159090|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
170497203|NCT02147158|616159085|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
170497204|NCT02147158|616159086|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
170497205|NCT02147158|616159087|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
170497206|NCT02147158|616159088|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
170497207|NCT02147158|616159089|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
170497208|NCT02147158|616159090|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
170497209|NCT02147158|616159085|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
170497210|NCT02147158|616159086|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
170497211|NCT02147158|616159087|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
170497212|NCT02147158|616159088|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
170497213|NCT02147158|616159089|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
170497214|NCT02147158|616159090|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
170497215|NCT02147158|616159085|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
170497216|NCT02147158|616159086|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
170497217|NCT02147158|616159087|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
170497218|NCT02147158|616159088|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
170497219|NCT02147158|616159089|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
170497220|NCT02147158|616159090|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
170497221|NCT03033602|616159091|FG000|Overall Study|Withdrawal by Subject|11|||
170497222|NCT03033602|616159092|FG001|Overall Study|Withdrawal by Subject|21|||
170497223|NCT03033602|616159091|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
170497224|NCT03033602|616159092|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
170497225|NCT04520997|616159093|FG000|Overall Study|Lost to Follow-up|1|||
170497226|NCT04520997|616159094|FG001|Overall Study|Lost to Follow-up|1|||
170497227|NCT04520997|616159093|FG000|Overall Study|Withdrawal by Subject|1|||
170497228|NCT04520997|616159094|FG001|Overall Study|Withdrawal by Subject|0|||
170497229|NCT04520997|616159093|FG000|Overall Study|Not Treated|0|||
170804010|NCT03656718|617292004|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
170497230|NCT04520997|616159094|FG001|Overall Study|Not Treated|1|||
170497231|NCT01758731|616159095|FG000|Overall Study|Physician Decision|1|||
170497232|NCT04445714|616159096|FG000|Overall Study|Discontinuation of the study|14|||
170497233|NCT04445714|616159096|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
170497234|NCT04445714|616159096|FG000|Overall Study|Withdrawal of Informed Consent|8|||
170497235|NCT02396420|616159100|FG000|Overall Study|Death|1|||
170497236|NCT01684943|616159101|FG000|Overall Study|Inadequate Venous Access|3|||
170497237|NCT01684943|616159102|FG001|Overall Study|Inadequate Venous Access|0|||
170497238|NCT01684943|616159103|FG002|Overall Study|Inadequate Venous Access|0|||
170497239|NCT01684943|616159101|FG000|Overall Study|Principal Investigator Determination|1|||
170497240|NCT01684943|616159102|FG001|Overall Study|Principal Investigator Determination|0|||
170497241|NCT01684943|616159103|FG002|Overall Study|Principal Investigator Determination|0|||
170804011|NCT03656718|617292005|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
170804012|NCT03656718|617292006|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
170804013|NCT03656718|617292007|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
170804014|NCT03656718|617292001|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
170804015|NCT03656718|617292002|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
170804016|NCT03656718|617292003|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
170804017|NCT03656718|617292004|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
170804018|NCT03656718|617292005|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
170804019|NCT03656718|617292006|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
170804020|NCT03656718|617292007|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
170804021|NCT03656718|617292001|FG000|Treatment Period Part C|Disease progression|0|||
170804022|NCT03656718|617292002|FG001|Treatment Period Part C|Disease progression|0|||
170497242|NCT01684943|616159101|FG000|Overall Study|Excluded from Analysis|1|||
170642360|NCT00617669|616705208|FG001|Overall Study|Withdrawal by Subject|77|||
170902172|NCT03417440|617644507|FG004|Overall Study|Withdrawal by Subject|1|||
170497243|NCT01684943|616159102|FG001|Overall Study|Excluded from Analysis|1|||
170497244|NCT01684943|616159103|FG002|Overall Study|Excluded from Analysis|1|||
170497245|NCT01684943|616159101|FG000|Overall Study|Lost to Follow-up|3|||
170497246|NCT01684943|616159102|FG001|Overall Study|Lost to Follow-up|0|||
170902173|NCT03417440|617644508|FG005|Overall Study|Withdrawal by Subject|0|||
170902174|NCT03417440|617644509|FG006|Overall Study|Withdrawal by Subject|0|||
170902175|NCT03417440|617644510|FG007|Overall Study|Withdrawal by Subject|1|||
170902176|NCT00755079|617644511|FG000|Overall Study|Lost to Follow-up|1|||
170902177|NCT00755079|617644512|FG001|Overall Study|Lost to Follow-up|3|||
170902178|NCT00755079|617644511|FG000|Overall Study|Adverse Event|0|||
170902179|NCT00755079|617644512|FG001|Overall Study|Adverse Event|1|||
170902180|NCT00755079|617644511|FG000|Overall Study|Withdrawal by Subject|0|||
170902181|NCT00755079|617644512|FG001|Overall Study|Withdrawal by Subject|2|||
170902182|NCT01499290|617644517|FG000|Overall Study|Withdrawal by Subject|22|||
170902183|NCT01499290|617644518|FG001|Overall Study|Withdrawal by Subject|15|||
170902184|NCT01499290|617644517|FG000|Overall Study|Not specified in study report|11|||
170902185|NCT01499290|617644518|FG001|Overall Study|Not specified in study report|5|||
170902186|NCT01499290|617644517|FG000|Overall Study|Condition improved/subject recovered|1|||
170902187|NCT01499290|617644518|FG001|Overall Study|Condition improved/subject recovered|0|||
170902188|NCT01499290|617644517|FG000|Overall Study|Lack of Efficacy|7|||
170902189|NCT01499290|617644518|FG001|Overall Study|Lack of Efficacy|8|||
170902190|NCT01499290|617644517|FG000|Overall Study|Adverse Event|14|||
170902191|NCT01499290|617644518|FG001|Overall Study|Adverse Event|7|||
170902192|NCT01818297|617644519|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
170902193|NCT01818297|617644520|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
170902194|NCT01818297|617644519|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
170902195|NCT01818297|617644520|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
170902196|NCT01818297|617644519|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
170902197|NCT01818297|617644520|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
170902198|NCT01791855|617644521|FG000|Overall Study|Adverse Event|0|||
170902199|NCT01791855|617644522|FG001|Overall Study|Adverse Event|0|||
170902200|NCT01791855|617644523|FG002|Overall Study|Adverse Event|0|||
170902201|NCT01791855|617644524|FG003|Overall Study|Adverse Event|1|||
170902202|NCT01791855|617644521|FG000|Overall Study|Randomized, not treated|0|||
170902203|NCT01791855|617644522|FG001|Overall Study|Randomized, not treated|1|||
170902204|NCT01791855|617644523|FG002|Overall Study|Randomized, not treated|0|||
170902205|NCT01791855|617644524|FG003|Overall Study|Randomized, not treated|0|||
170902206|NCT00772447|617644525|FG000|Overall Study|Withdrawal by Subject|9|||
170902207|NCT00772447|617644526|FG001|Overall Study|Withdrawal by Subject|5|||
170902208|NCT00772447|617644525|FG000|Overall Study|Physician Decision|4|||
170902209|NCT00772447|617644526|FG001|Overall Study|Physician Decision|8|||
170902210|NCT00772447|617644525|FG000|Overall Study|Lost to Follow-up|2|||
170902211|NCT00772447|617644526|FG001|Overall Study|Lost to Follow-up|4|||
170902212|NCT00772447|617644525|FG000|Overall Study|incorrect enrolment|3|||
170902213|NCT00772447|617644526|FG001|Overall Study|incorrect enrolment|4|||
170902214|NCT00772447|617644525|FG000|Overall Study|Protocol Violation|0|||
170902215|NCT00772447|617644526|FG001|Overall Study|Protocol Violation|1|||
170902216|NCT00772447|617644525|FG000|Overall Study|all others|2|||
170902217|NCT00772447|617644526|FG001|Overall Study|all others|2|||
170902218|NCT01957137|617644527|FG000|Randomized Portion|Adverse Event|1|||
170902219|NCT01957137|617644527|FG000|Randomized Portion|Withdrawal by Subject|1|||
170902220|NCT03029832|617644538|FG000|Overall Study|Safety Follow-Up Completed|2|||
170902221|NCT03029832|617644539|FG001|Overall Study|Safety Follow-Up Completed|0|||
170902222|NCT03029832|617644538|FG000|Overall Study|Death due to Disease Progression|1|||
170902223|NCT03029832|617644539|FG001|Overall Study|Death due to Disease Progression|0|||
170902224|NCT03029832|617644538|FG000|Overall Study|Study Terminated By Sponsor|1|||
170497247|NCT01684943|616159103|FG002|Overall Study|Lost to Follow-up|0|||
170497248|NCT01684943|616159101|FG000|Overall Study|Planning Pregnancy|1|||
170497249|NCT01684943|616159102|FG001|Overall Study|Planning Pregnancy|0|||
170497250|NCT01684943|616159103|FG002|Overall Study|Planning Pregnancy|0|||
170497251|NCT01273623|616159109|FG000|Overall Study|did not meet IVUS criteria|29|||
170497252|NCT03395184|616159112|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
170902225|NCT03029832|617644539|FG001|Overall Study|Study Terminated By Sponsor|1|||
170497253|NCT03395184|616159113|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
170497254|NCT03395184|616159114|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
170497255|NCT03395184|616159115|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
170902226|NCT00700804|617644543|FG000|Overall Study|Withdrawal by Subject|1|||
170902227|NCT00700804|617644544|FG001|Overall Study|Withdrawal by Subject|2|||
170902228|NCT00700804|617644543|FG000|Overall Study|Protocol Violation|1|||
170902229|NCT00700804|617644544|FG001|Overall Study|Protocol Violation|1|||
170902230|NCT00700804|617644543|FG000|Overall Study|Loose Stools|1|||
170902231|NCT00700804|617644544|FG001|Overall Study|Loose Stools|1|||
170902232|NCT02901431|617644545|FG000|PK Part|Adverse Event|0|||
170902233|NCT02901431|617644546|FG001|PK Part|Adverse Event|1|||
170902234|NCT02901431|617644547|FG002|PK Part|Adverse Event|0|||
170902235|NCT02901431|617644548|FG003|PK Part|Adverse Event|0|||
170497256|NCT03395184|616159116|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
170497257|NCT03395184|616159117|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
170497258|NCT03395184|616159118|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
170497259|NCT03395184|616159112|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
170497260|NCT03395184|616159113|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
170497261|NCT03395184|616159114|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
170497262|NCT03395184|616159115|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
170497263|NCT03395184|616159116|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
170497264|NCT03395184|616159117|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
170804023|NCT03656718|617292003|FG002|Treatment Period Part C|Disease progression|0|||
170804024|NCT03656718|617292004|FG003|Treatment Period Part C|Disease progression|0|||
170804025|NCT03656718|617292005|FG004|Treatment Period Part C|Disease progression|12|||
170804026|NCT03656718|617292006|FG005|Treatment Period Part C|Disease progression|0|||
170804027|NCT03656718|617292007|FG006|Treatment Period Part C|Disease progression|0|||
170804028|NCT03656718|617292001|FG000|Treatment Period Part C|Death|0|||
170804029|NCT03656718|617292002|FG001|Treatment Period Part C|Death|0|||
170804030|NCT03656718|617292003|FG002|Treatment Period Part C|Death|0|||
170804031|NCT03656718|617292004|FG003|Treatment Period Part C|Death|0|||
170804032|NCT03656718|617292005|FG004|Treatment Period Part C|Death|1|||
170804033|NCT03656718|617292006|FG005|Treatment Period Part C|Death|0|||
170804034|NCT03656718|617292007|FG006|Treatment Period Part C|Death|0|||
170804035|NCT03656718|617292001|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
170804036|NCT03656718|617292002|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
170804037|NCT03656718|617292003|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
170804038|NCT03656718|617292004|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
170804039|NCT03656718|617292005|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
170804040|NCT03656718|617292006|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
170804041|NCT03656718|617292007|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
170804042|NCT03656718|617292001|FG000|Treatment Period Part C|Other reasons|0|||
170804043|NCT03656718|617292002|FG001|Treatment Period Part C|Other reasons|0|||
170804044|NCT03656718|617292003|FG002|Treatment Period Part C|Other reasons|0|||
170804045|NCT03656718|617292004|FG003|Treatment Period Part C|Other reasons|0|||
170804046|NCT03656718|617292005|FG004|Treatment Period Part C|Other reasons|1|||
170804047|NCT03656718|617292006|FG005|Treatment Period Part C|Other reasons|0|||
170804048|NCT03656718|617292007|FG006|Treatment Period Part C|Other reasons|0|||
170804049|NCT03656718|617292001|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
170497265|NCT03395184|616159118|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
170497266|NCT03395184|616159112|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
170497267|NCT03395184|616159113|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
170497268|NCT03395184|616159114|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
170497269|NCT03395184|616159115|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
170497270|NCT03395184|616159116|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
170642361|NCT00617669|616705207|FG000|Overall Study|Lost to Follow-up|3|||
170804050|NCT03656718|617292002|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
170804051|NCT03656718|617292003|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
170804052|NCT03656718|617292004|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
170804053|NCT03656718|617292005|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
170804054|NCT03656718|617292006|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
170804055|NCT03656718|617292007|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
170804056|NCT06191679|617292008|FG000|Baseline|Lost to Follow-up|1|||
170804057|NCT06191679|617292009|FG001|Baseline|Lost to Follow-up|0|||
170804058|NCT06191679|617292010|FG002|Baseline|Lost to Follow-up|1|||
170804059|NCT06191679|617292011|FG003|Baseline|Lost to Follow-up|0|||
170804060|NCT06191679|617292008|FG000|Allocation to Group|Withdrawal by Subject|0|||
170804061|NCT06191679|617292009|FG001|Allocation to Group|Withdrawal by Subject|1|||
170804062|NCT06191679|617292010|FG002|Allocation to Group|Withdrawal by Subject|2|||
170804063|NCT06191679|617292011|FG003|Allocation to Group|Withdrawal by Subject|0|||
170804064|NCT06191679|617292008|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
170804065|NCT06191679|617292009|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
170804066|NCT06191679|617292010|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
170804067|NCT06191679|617292011|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
170804068|NCT06191679|617292008|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
170804069|NCT06191679|617292009|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
170804070|NCT06191679|617292010|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
170804071|NCT06191679|617292011|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
170804072|NCT06191679|617292008|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
170804073|NCT06191679|617292009|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
170902236|NCT02901431|617644549|FG004|PK Part|Adverse Event|0|||
170497271|NCT03395184|616159117|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
170497272|NCT03395184|616159118|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
170497273|NCT03395184|616159112|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
170497274|NCT03395184|616159113|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
170497275|NCT03395184|616159114|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
170497276|NCT03395184|616159115|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
170497277|NCT03395184|616159116|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
170497278|NCT03395184|616159117|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
170497279|NCT03395184|616159118|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
170497280|NCT03395184|616159112|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
170497281|NCT03395184|616159113|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170497282|NCT03395184|616159114|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
170497283|NCT03395184|616159115|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170497284|NCT03395184|616159116|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170497285|NCT03395184|616159117|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170497286|NCT03395184|616159118|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170497287|NCT03395184|616159112|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
170497288|NCT03395184|616159113|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
170497289|NCT03395184|616159114|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
170497290|NCT03395184|616159115|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
170497291|NCT03395184|616159116|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
170497292|NCT03395184|616159117|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
170497293|NCT03395184|616159118|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
170497294|NCT03395184|616159112|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
170497295|NCT03395184|616159113|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
170497296|NCT03395184|616159114|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
170497297|NCT03395184|616159115|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
170497298|NCT03395184|616159116|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
170497299|NCT03395184|616159117|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
170497300|NCT03395184|616159118|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
170497301|NCT03395184|616159112|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
170497302|NCT03395184|616159113|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
170497303|NCT03395184|616159114|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
170497304|NCT03395184|616159115|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
170497305|NCT03395184|616159116|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
170497306|NCT03395184|616159117|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
170497307|NCT03395184|616159118|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
170497308|NCT03395184|616159112|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
170497309|NCT03395184|616159113|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
170497310|NCT03395184|616159114|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
170497311|NCT03395184|616159115|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
170497312|NCT03395184|616159116|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
170497313|NCT03395184|616159117|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
170497314|NCT03395184|616159118|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
170497315|NCT03395184|616159112|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
170497316|NCT03395184|616159113|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
170497317|NCT03395184|616159114|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
170497318|NCT03395184|616159115|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
170497319|NCT03395184|616159116|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
170497320|NCT03395184|616159117|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
170497321|NCT03395184|616159118|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
170497322|NCT03395184|616159112|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
170642362|NCT00617669|616705208|FG001|Overall Study|Lost to Follow-up|2|||
170642363|NCT00617669|616705207|FG000|Overall Study|Adverse Event|87|||
170642364|NCT00617669|616705208|FG001|Overall Study|Adverse Event|76|||
170642365|NCT00617669|616705207|FG000|Overall Study|Protocol Violation|2|||
170642366|NCT00617669|616705208|FG001|Overall Study|Protocol Violation|3|||
170642367|NCT00617669|616705207|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
170642368|NCT00617669|616705208|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
170642369|NCT00617669|616705207|FG000|Overall Study|Patients randomized but not treated|2|||
170642370|NCT00617669|616705208|FG001|Overall Study|Patients randomized but not treated|3|||
170497323|NCT03395184|616159113|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
170497324|NCT03395184|616159114|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
170902237|NCT02901431|617644550|FG005|PK Part|Adverse Event|0|||
170497325|NCT03395184|616159115|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
170642371|NCT04491604|616705209|FG000|Overall Study|Withdrawal by Subject|3|||
170642372|NCT01410357|616705214|FG000|Overall Study|Death|2|||
170902238|NCT02901431|617644551|FG006|PK Part|Adverse Event|0|||
170642373|NCT01410357|616705215|FG001|Overall Study|Death|1|||
170642374|NCT01410357|616705214|FG000|Overall Study|Withdrawal by Subject|1|||
170642375|NCT01410357|616705215|FG001|Overall Study|Withdrawal by Subject|2|||
170902239|NCT02901431|617644552|FG007|PK Part|Adverse Event|0|||
170497326|NCT03395184|616159116|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
170497327|NCT03395184|616159117|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
170497328|NCT03395184|616159118|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
170497329|NCT03395184|616159112|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
170497330|NCT03395184|616159113|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
170497331|NCT03395184|616159114|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
170497332|NCT03395184|616159115|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
170497333|NCT03395184|616159116|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
170497334|NCT03395184|616159117|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
170497335|NCT03395184|616159118|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
170497336|NCT05033262|616159126|FG000|Overall Study|Lost to Follow-up|1|||
170497337|NCT05033262|616159127|FG001|Overall Study|Lost to Follow-up|0|||
170497338|NCT05033262|616159128|FG002|Overall Study|Lost to Follow-up|0|||
170497339|NCT05033262|616159129|FG003|Overall Study|Lost to Follow-up|1|||
170497340|NCT03197467|616160563|FG000|Overall Study|Withdrawal by Subject|1|||
170497341|NCT03666533|616160564|FG000|Overall Study|Lost to Follow-up|2|||
170497342|NCT03666533|616160565|FG001|Overall Study|Lost to Follow-up|2|||
170497343|NCT00197002|616160566|FG000|Overall Study|Adverse Event|0|||
170497344|NCT00197002|616160567|FG001|Overall Study|Adverse Event|1|||
170497345|NCT00197002|616160568|FG002|Overall Study|Adverse Event|0|||
170497346|NCT00197002|616160566|FG000|Overall Study|Protocol Violation|1|||
170497347|NCT00197002|616160567|FG001|Overall Study|Protocol Violation|0|||
170497348|NCT00197002|616160568|FG002|Overall Study|Protocol Violation|2|||
170497349|NCT00197002|616160566|FG000|Overall Study|Withdrawal by Subject|9|||
170497350|NCT00197002|616160567|FG001|Overall Study|Withdrawal by Subject|5|||
170497351|NCT00197002|616160568|FG002|Overall Study|Withdrawal by Subject|7|||
170497352|NCT00197002|616160566|FG000|Overall Study|Migrated/moved from study area|3|||
170902240|NCT02901431|617644553|FG008|PK Part|Adverse Event|0|||
170497353|NCT00197002|616160567|FG001|Overall Study|Migrated/moved from study area|5|||
170497354|NCT00197002|616160568|FG002|Overall Study|Migrated/moved from study area|1|||
170497355|NCT00197002|616160566|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
170497356|NCT00197002|616160567|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
170497357|NCT00197002|616160568|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
170497358|NCT00197002|616160566|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
170497359|NCT00197002|616160567|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
170497360|NCT00197002|616160568|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
170497361|NCT00197002|616160566|FG000|Overall Study|Others|3|||
170497362|NCT00197002|616160567|FG001|Overall Study|Others|1|||
170497363|NCT00197002|616160568|FG002|Overall Study|Others|1|||
170497364|NCT02017717|616160569|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
170497365|NCT02017717|616160570|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
170497366|NCT02017717|616160571|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
170497367|NCT02017717|616160572|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
170497368|NCT02017717|616160573|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
170497369|NCT02017717|616160574|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
170497370|NCT02017717|616160575|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
170497371|NCT02017717|616160576|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
170497372|NCT02017717|616160577|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
170497373|NCT02017717|616160569|FG000|Before Treatment Period|Participant request to stop therapy|0|||
170497374|NCT02017717|616160570|FG001|Before Treatment Period|Participant request to stop therapy|0|||
170497375|NCT02017717|616160571|FG002|Before Treatment Period|Participant request to stop therapy|0|||
170497376|NCT02017717|616160572|FG003|Before Treatment Period|Participant request to stop therapy|0|||
170497377|NCT02017717|616160573|FG004|Before Treatment Period|Participant request to stop therapy|0|||
170497378|NCT02017717|616160574|FG005|Before Treatment Period|Participant request to stop therapy|0|||
170497379|NCT02017717|616160575|FG006|Before Treatment Period|Participant request to stop therapy|0|||
170497380|NCT02017717|616160576|FG007|Before Treatment Period|Participant request to stop therapy|0|||
170497381|NCT02017717|616160577|FG008|Before Treatment Period|Participant request to stop therapy|5|||
170497382|NCT02017717|616160569|FG000|Before Treatment Period|Participant withdrew consent|0|||
170497383|NCT02017717|616160570|FG001|Before Treatment Period|Participant withdrew consent|0|||
170497384|NCT02017717|616160571|FG002|Before Treatment Period|Participant withdrew consent|0|||
170902241|NCT02901431|617644554|FG009|PK Part|Adverse Event|0|||
170497385|NCT02017717|616160572|FG003|Before Treatment Period|Participant withdrew consent|0|||
170497386|NCT02017717|616160573|FG004|Before Treatment Period|Participant withdrew consent|0|||
170497387|NCT02017717|616160574|FG005|Before Treatment Period|Participant withdrew consent|0|||
170497388|NCT02017717|616160575|FG006|Before Treatment Period|Participant withdrew consent|2|||
170497389|NCT02017717|616160576|FG007|Before Treatment Period|Participant withdrew consent|0|||
170497390|NCT02017717|616160577|FG008|Before Treatment Period|Participant withdrew consent|11|||
170551447|NCT00806026|616364789|FG003|Overall Study|Withdrawal by Subject|2|||
170551448|NCT00806026|616364790|FG004|Overall Study|Withdrawal by Subject|5|||
170902242|NCT02901431|617644555|FG010|PK Part|Adverse Event|0|||
170497391|NCT02017717|616160569|FG000|Before Treatment Period|Lost to Follow-up|0|||
170497392|NCT02017717|616160570|FG001|Before Treatment Period|Lost to Follow-up|0|||
170497393|NCT02017717|616160571|FG002|Before Treatment Period|Lost to Follow-up|0|||
170497394|NCT02017717|616160572|FG003|Before Treatment Period|Lost to Follow-up|0|||
170497395|NCT02017717|616160573|FG004|Before Treatment Period|Lost to Follow-up|0|||
170497396|NCT02017717|616160574|FG005|Before Treatment Period|Lost to Follow-up|0|||
170497397|NCT02017717|616160575|FG006|Before Treatment Period|Lost to Follow-up|0|||
170497398|NCT02017717|616160576|FG007|Before Treatment Period|Lost to Follow-up|0|||
170497399|NCT02017717|616160577|FG008|Before Treatment Period|Lost to Follow-up|1|||
170497400|NCT02017717|616160569|FG000|Before Treatment Period|Participant no longer met criteria|0|||
170497401|NCT02017717|616160570|FG001|Before Treatment Period|Participant no longer met criteria|0|||
170497402|NCT02017717|616160571|FG002|Before Treatment Period|Participant no longer met criteria|0|||
170497403|NCT02017717|616160572|FG003|Before Treatment Period|Participant no longer met criteria|0|||
170497404|NCT02017717|616160573|FG004|Before Treatment Period|Participant no longer met criteria|0|||
170497405|NCT02017717|616160574|FG005|Before Treatment Period|Participant no longer met criteria|1|||
170497406|NCT02017717|616160575|FG006|Before Treatment Period|Participant no longer met criteria|0|||
170497407|NCT02017717|616160576|FG007|Before Treatment Period|Participant no longer met criteria|1|||
170497408|NCT02017717|616160577|FG008|Before Treatment Period|Participant no longer met criteria|2|||
170497409|NCT02017717|616160569|FG000|Before Treatment Period|other reason|0|||
170497410|NCT02017717|616160570|FG001|Before Treatment Period|other reason|0|||
170497411|NCT02017717|616160571|FG002|Before Treatment Period|other reason|0|||
170497412|NCT02017717|616160572|FG003|Before Treatment Period|other reason|0|||
170497413|NCT02017717|616160573|FG004|Before Treatment Period|other reason|0|||
170497414|NCT02017717|616160574|FG005|Before Treatment Period|other reason|0|||
170497415|NCT02017717|616160575|FG006|Before Treatment Period|other reason|0|||
170497416|NCT02017717|616160576|FG007|Before Treatment Period|other reason|0|||
170497417|NCT02017717|616160577|FG008|Before Treatment Period|other reason|1|||
170497418|NCT02017717|616160569|FG000|Treatment Period|Disease progression|7|||
170497419|NCT02017717|616160570|FG001|Treatment Period|Disease progression|9|||
170497420|NCT02017717|616160571|FG002|Treatment Period|Disease progression|12|||
170497421|NCT02017717|616160572|FG003|Treatment Period|Disease progression|20|||
170497422|NCT02017717|616160573|FG004|Treatment Period|Disease progression|26|||
170497423|NCT02017717|616160574|FG005|Treatment Period|Disease progression|16|||
170497424|NCT02017717|616160575|FG006|Treatment Period|Disease progression|22|||
170497425|NCT02017717|616160576|FG007|Treatment Period|Disease progression|165|||
170497426|NCT02017717|616160577|FG008|Treatment Period|Disease progression|135|||
170497427|NCT02017717|616160569|FG000|Treatment Period|Study drug toxicity|3|||
170497428|NCT02017717|616160570|FG001|Treatment Period|Study drug toxicity|0|||
170497429|NCT02017717|616160571|FG002|Treatment Period|Study drug toxicity|1|||
170497430|NCT02017717|616160572|FG003|Treatment Period|Study drug toxicity|4|||
170497431|NCT02017717|616160573|FG004|Treatment Period|Study drug toxicity|4|||
170497432|NCT02017717|616160574|FG005|Treatment Period|Study drug toxicity|5|||
170497433|NCT02017717|616160575|FG006|Treatment Period|Study drug toxicity|3|||
170497434|NCT02017717|616160576|FG007|Treatment Period|Study drug toxicity|7|||
170497435|NCT02017717|616160577|FG008|Treatment Period|Study drug toxicity|11|||
170497436|NCT02017717|616160569|FG000|Treatment Period|Death|0|||
170497437|NCT02017717|616160570|FG001|Treatment Period|Death|0|||
170497438|NCT02017717|616160571|FG002|Treatment Period|Death|1|||
170497439|NCT02017717|616160572|FG003|Treatment Period|Death|0|||
170497440|NCT02017717|616160573|FG004|Treatment Period|Death|0|||
170497441|NCT02017717|616160574|FG005|Treatment Period|Death|2|||
170497442|NCT02017717|616160575|FG006|Treatment Period|Death|0|||
170497443|NCT02017717|616160576|FG007|Treatment Period|Death|0|||
170497444|NCT02017717|616160577|FG008|Treatment Period|Death|0|||
170497445|NCT02017717|616160569|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
170497446|NCT02017717|616160570|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
170497447|NCT02017717|616160571|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
170497448|NCT02017717|616160572|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
170497449|NCT02017717|616160573|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
170642376|NCT01410357|616705214|FG000|Overall Study|Lost to Follow-up|23|||
170804074|NCT06191679|617292010|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
170804075|NCT06191679|617292011|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
170804076|NCT00545545|617292012|FG000|Overall Study|Progressive Neoplastic Disease|1|||
170804077|NCT00545545|617292013|FG001|Overall Study|Progressive Neoplastic Disease|5|||
170804078|NCT00545545|617292014|FG002|Overall Study|Progressive Neoplastic Disease|0|||
170804079|NCT00545545|617292015|FG003|Overall Study|Progressive Neoplastic Disease|4|||
170804080|NCT00545545|617292016|FG004|Overall Study|Progressive Neoplastic Disease|8|||
170804081|NCT00545545|617292017|FG005|Overall Study|Progressive Neoplastic Disease|7|||
170804082|NCT00545545|617292012|FG000|Overall Study|Withdrawal by Subject|0|||
170804083|NCT00545545|617292013|FG001|Overall Study|Withdrawal by Subject|1|||
170804084|NCT00545545|617292014|FG002|Overall Study|Withdrawal by Subject|0|||
170804085|NCT00545545|617292015|FG003|Overall Study|Withdrawal by Subject|0|||
170642377|NCT01410357|616705215|FG001|Overall Study|Lost to Follow-up|21|||
170642378|NCT00615901|616705216|FG000|Overall Study|Withdrawal by Subject|2|||
170642379|NCT00615901|616705216|FG000|Overall Study|Adverse Event|7|||
170642380|NCT01206322|616705219|FG000|Overall Study|Adverse Event|0|||
170642381|NCT01206322|616705220|FG001|Overall Study|Adverse Event|0|||
170642382|NCT01206322|616705221|FG002|Overall Study|Adverse Event|0|||
170642383|NCT01206322|616705222|FG003|Overall Study|Adverse Event|1|||
170642384|NCT01250496|616705223|FG000|Overall Study|Study terminated|124|||
170642385|NCT01250496|616705224|FG001|Overall Study|Study terminated|124|||
170642386|NCT00003590|616705228|FG000|Overall Study|Ineligible Patient|1|||
170642387|NCT00003590|616705228|FG000|Overall Study|Adverse Event|7|||
170642388|NCT00003590|616705228|FG000|Overall Study|Withdrawal by Subject|1|||
170642389|NCT00003590|616705228|FG000|Overall Study|Lack of Efficacy|11|||
170642390|NCT00003590|616705228|FG000|Overall Study|Death|1|||
170642391|NCT00003590|616705228|FG000|Overall Study|Physician Decision|1|||
170642392|NCT03319745|616705231|FG000|Overall Study|Death|1|||
170642393|NCT03319745|616705231|FG000|Overall Study|Toxicity Precluding Surgery|1|||
170642394|NCT03179202|616705232|FG000|Overall Study|Screen Failure|67|||
170642395|NCT03179202|616705232|FG000|Overall Study|Subject Lost to Follow Up|12|||
170642396|NCT03179202|616705232|FG000|Overall Study|Withdrawal by Subject|7|||
170642397|NCT03179202|616705232|FG000|Overall Study|Adverse Event|3|||
170642398|NCT03179202|616705232|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
170642399|NCT03179202|616705232|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
170642400|NCT01970358|616705233|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
170642401|NCT01970358|616705233|FG000|Overall Study|Ineligible at time of second consent|4|||
170642402|NCT03899805|616705234|FG000|Overall Study|Physician Decision|3|||
170642403|NCT03899805|616705235|FG001|Overall Study|Physician Decision|0|||
170642404|NCT03899805|616705236|FG002|Overall Study|Physician Decision|2|||
170804086|NCT00545545|617292016|FG004|Overall Study|Withdrawal by Subject|0|||
170804087|NCT00545545|617292017|FG005|Overall Study|Withdrawal by Subject|0|||
170804088|NCT00545545|617292012|FG000|Overall Study|Physician Decision|1|||
170804089|NCT00545545|617292013|FG001|Overall Study|Physician Decision|0|||
170804090|NCT00545545|617292014|FG002|Overall Study|Physician Decision|0|||
170804091|NCT00545545|617292015|FG003|Overall Study|Physician Decision|0|||
170497450|NCT02017717|616160574|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
170497451|NCT02017717|616160575|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
170497452|NCT02017717|616160576|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
170497453|NCT02017717|616160577|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
170497454|NCT02017717|616160569|FG000|Treatment Period|Participant request to stop therapy|0|||
170497455|NCT02017717|616160570|FG001|Treatment Period|Participant request to stop therapy|0|||
170497456|NCT02017717|616160571|FG002|Treatment Period|Participant request to stop therapy|3|||
170497457|NCT02017717|616160572|FG003|Treatment Period|Participant request to stop therapy|6|||
170497458|NCT02017717|616160573|FG004|Treatment Period|Participant request to stop therapy|0|||
170497459|NCT02017717|616160574|FG005|Treatment Period|Participant request to stop therapy|2|||
170497460|NCT02017717|616160575|FG006|Treatment Period|Participant request to stop therapy|1|||
170804092|NCT00545545|617292016|FG004|Overall Study|Physician Decision|0|||
170804093|NCT00545545|617292017|FG005|Overall Study|Physician Decision|1|||
170804094|NCT00545545|617292012|FG000|Overall Study|Irinotecan intolerance|1|||
170804095|NCT00545545|617292013|FG001|Overall Study|Irinotecan intolerance|1|||
170497461|NCT02017717|616160576|FG007|Treatment Period|Participant request to stop therapy|4|||
170497462|NCT02017717|616160577|FG008|Treatment Period|Participant request to stop therapy|7|||
170497463|NCT02017717|616160569|FG000|Treatment Period|Participant withdrew consent|0|||
170497464|NCT02017717|616160570|FG001|Treatment Period|Participant withdrew consent|0|||
170497465|NCT02017717|616160571|FG002|Treatment Period|Participant withdrew consent|1|||
170497466|NCT02017717|616160572|FG003|Treatment Period|Participant withdrew consent|0|||
170497467|NCT02017717|616160573|FG004|Treatment Period|Participant withdrew consent|0|||
170497468|NCT02017717|616160574|FG005|Treatment Period|Participant withdrew consent|2|||
170497469|NCT02017717|616160575|FG006|Treatment Period|Participant withdrew consent|0|||
170497470|NCT02017717|616160576|FG007|Treatment Period|Participant withdrew consent|1|||
170804096|NCT00545545|617292014|FG002|Overall Study|Irinotecan intolerance|0|||
170497471|NCT02017717|616160577|FG008|Treatment Period|Participant withdrew consent|4|||
170497472|NCT02017717|616160569|FG000|Treatment Period|Participant no longer met criteria|0|||
170497473|NCT02017717|616160570|FG001|Treatment Period|Participant no longer met criteria|0|||
170497474|NCT02017717|616160571|FG002|Treatment Period|Participant no longer met criteria|0|||
170497475|NCT02017717|616160572|FG003|Treatment Period|Participant no longer met criteria|0|||
170497476|NCT02017717|616160573|FG004|Treatment Period|Participant no longer met criteria|0|||
170497477|NCT02017717|616160574|FG005|Treatment Period|Participant no longer met criteria|0|||
170497478|NCT02017717|616160575|FG006|Treatment Period|Participant no longer met criteria|0|||
170497479|NCT02017717|616160576|FG007|Treatment Period|Participant no longer met criteria|0|||
170497480|NCT02017717|616160577|FG008|Treatment Period|Participant no longer met criteria|1|||
170497481|NCT02017717|616160569|FG000|Treatment Period|Other reasons|0|||
170497482|NCT02017717|616160570|FG001|Treatment Period|Other reasons|0|||
170497483|NCT02017717|616160571|FG002|Treatment Period|Other reasons|0|||
170902243|NCT02901431|617644556|FG011|PK Part|Adverse Event|0|||
170902244|NCT02901431|617644557|FG012|PK Part|Adverse Event|0|||
170902245|NCT02901431|617644545|FG000|PK Part|Lost to Follow-up|0|||
170902246|NCT02901431|617644546|FG001|PK Part|Lost to Follow-up|0|||
170902247|NCT02901431|617644547|FG002|PK Part|Lost to Follow-up|1|||
170902248|NCT02901431|617644548|FG003|PK Part|Lost to Follow-up|0|||
170902249|NCT02901431|617644549|FG004|PK Part|Lost to Follow-up|0|||
170497484|NCT02017717|616160572|FG003|Treatment Period|Other reasons|1|||
170497485|NCT02017717|616160573|FG004|Treatment Period|Other reasons|0|||
170497486|NCT02017717|616160574|FG005|Treatment Period|Other reasons|1|||
170497487|NCT02017717|616160575|FG006|Treatment Period|Other reasons|1|||
170497488|NCT02017717|616160576|FG007|Treatment Period|Other reasons|1|||
170497489|NCT02017717|616160577|FG008|Treatment Period|Other reasons|1|||
170497490|NCT02017717|616160569|FG000|Treatment Period|Maximum clinical benefit|0|||
170497491|NCT02017717|616160570|FG001|Treatment Period|Maximum clinical benefit|0|||
170497492|NCT02017717|616160571|FG002|Treatment Period|Maximum clinical benefit|0|||
170497493|NCT02017717|616160572|FG003|Treatment Period|Maximum clinical benefit|0|||
170497494|NCT02017717|616160573|FG004|Treatment Period|Maximum clinical benefit|0|||
170497495|NCT02017717|616160574|FG005|Treatment Period|Maximum clinical benefit|0|||
170497496|NCT02017717|616160575|FG006|Treatment Period|Maximum clinical benefit|0|||
170497497|NCT02017717|616160576|FG007|Treatment Period|Maximum clinical benefit|0|||
170497498|NCT02017717|616160577|FG008|Treatment Period|Maximum clinical benefit|1|||
170497499|NCT02017717|616160569|FG000|Treatment Period|Not reported|0|||
170497500|NCT02017717|616160570|FG001|Treatment Period|Not reported|1|||
170497501|NCT02017717|616160571|FG002|Treatment Period|Not reported|0|||
170497502|NCT02017717|616160572|FG003|Treatment Period|Not reported|0|||
170497503|NCT02017717|616160573|FG004|Treatment Period|Not reported|0|||
170497504|NCT02017717|616160574|FG005|Treatment Period|Not reported|0|||
170497505|NCT02017717|616160575|FG006|Treatment Period|Not reported|0|||
170497506|NCT02017717|616160576|FG007|Treatment Period|Not reported|0|||
170902250|NCT02901431|617644550|FG005|PK Part|Lost to Follow-up|0|||
170902251|NCT02901431|617644551|FG006|PK Part|Lost to Follow-up|0|||
170902252|NCT02901431|617644552|FG007|PK Part|Lost to Follow-up|0|||
170902253|NCT02901431|617644553|FG008|PK Part|Lost to Follow-up|0|||
170902254|NCT02901431|617644554|FG009|PK Part|Lost to Follow-up|0|||
170902255|NCT02901431|617644555|FG010|PK Part|Lost to Follow-up|0|||
170902256|NCT02901431|617644556|FG011|PK Part|Lost to Follow-up|0|||
170902257|NCT02901431|617644557|FG012|PK Part|Lost to Follow-up|0|||
170902258|NCT02901431|617644545|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
170902259|NCT02901431|617644546|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902260|NCT02901431|617644547|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902261|NCT02901431|617644548|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902262|NCT02901431|617644549|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902263|NCT02901431|617644550|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902264|NCT02901431|617644551|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902265|NCT02901431|617644552|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902266|NCT02901431|617644553|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902267|NCT02901431|617644554|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902268|NCT02901431|617644555|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902269|NCT02901431|617644556|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902270|NCT02901431|617644557|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
170902271|NCT02901431|617644545|FG000|PK Part|Pending dose confirmation|0|||
170497507|NCT02017717|616160577|FG008|Treatment Period|Not reported|0|||
170497508|NCT04488419|616160579|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
170497509|NCT04488419|616160580|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
170497510|NCT04488419|616160581|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
170902272|NCT02901431|617644546|FG001|PK Part|Pending dose confirmation|1|||
170902273|NCT02901431|617644547|FG002|PK Part|Pending dose confirmation|0|||
170497511|NCT04488419|616160579|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
170497512|NCT04488419|616160580|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
170497513|NCT04488419|616160581|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
170497514|NCT04488419|616160579|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
170497515|NCT04488419|616160580|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
170497516|NCT04488419|616160581|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
170497517|NCT04488419|616160579|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
170497518|NCT04488419|616160580|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
170497519|NCT04488419|616160581|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
170497520|NCT04488419|616160579|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
170902274|NCT02901431|617644548|FG003|PK Part|Pending dose confirmation|0|||
170902275|NCT02901431|617644549|FG004|PK Part|Pending dose confirmation|0|||
170902276|NCT02901431|617644550|FG005|PK Part|Pending dose confirmation|0|||
170902277|NCT02901431|617644551|FG006|PK Part|Pending dose confirmation|0|||
170902278|NCT02901431|617644552|FG007|PK Part|Pending dose confirmation|0|||
170902279|NCT02901431|617644553|FG008|PK Part|Pending dose confirmation|0|||
170902280|NCT02901431|617644554|FG009|PK Part|Pending dose confirmation|0|||
170902281|NCT02901431|617644555|FG010|PK Part|Pending dose confirmation|0|||
170902282|NCT02901431|617644556|FG011|PK Part|Pending dose confirmation|0|||
170497521|NCT04488419|616160580|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
170497522|NCT04488419|616160581|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
170902283|NCT02901431|617644557|FG012|PK Part|Pending dose confirmation|0|||
170902284|NCT02901431|617644545|FG000|PK Part|8 weeks of treatment ran out|2|||
170902285|NCT02901431|617644546|FG001|PK Part|8 weeks of treatment ran out|0|||
170902286|NCT02901431|617644547|FG002|PK Part|8 weeks of treatment ran out|0|||
170902287|NCT02901431|617644548|FG003|PK Part|8 weeks of treatment ran out|0|||
170902288|NCT02901431|617644549|FG004|PK Part|8 weeks of treatment ran out|0|||
170902289|NCT02901431|617644550|FG005|PK Part|8 weeks of treatment ran out|0|||
170902290|NCT02901431|617644551|FG006|PK Part|8 weeks of treatment ran out|0|||
170902291|NCT02901431|617644552|FG007|PK Part|8 weeks of treatment ran out|0|||
170902292|NCT02901431|617644553|FG008|PK Part|8 weeks of treatment ran out|0|||
170902293|NCT02901431|617644554|FG009|PK Part|8 weeks of treatment ran out|0|||
170902294|NCT02901431|617644555|FG010|PK Part|8 weeks of treatment ran out|0|||
170902295|NCT02901431|617644556|FG011|PK Part|8 weeks of treatment ran out|0|||
170902296|NCT02901431|617644557|FG012|PK Part|8 weeks of treatment ran out|0|||
170902297|NCT02901431|617644545|FG000|PK Part|Stopped treatment after 8 weeks|1|||
170902298|NCT02901431|617644546|FG001|PK Part|Stopped treatment after 8 weeks|0|||
170902299|NCT02901431|617644547|FG002|PK Part|Stopped treatment after 8 weeks|1|||
170902300|NCT02901431|617644548|FG003|PK Part|Stopped treatment after 8 weeks|0|||
170902301|NCT02901431|617644549|FG004|PK Part|Stopped treatment after 8 weeks|0|||
170902302|NCT02901431|617644550|FG005|PK Part|Stopped treatment after 8 weeks|0|||
170902303|NCT02901431|617644551|FG006|PK Part|Stopped treatment after 8 weeks|0|||
170902304|NCT02901431|617644552|FG007|PK Part|Stopped treatment after 8 weeks|0|||
170902305|NCT02901431|617644553|FG008|PK Part|Stopped treatment after 8 weeks|0|||
170902306|NCT02901431|617644554|FG009|PK Part|Stopped treatment after 8 weeks|0|||
170902307|NCT02901431|617644555|FG010|PK Part|Stopped treatment after 8 weeks|0|||
170902308|NCT02901431|617644556|FG011|PK Part|Stopped treatment after 8 weeks|0|||
170902309|NCT02901431|617644557|FG012|PK Part|Stopped treatment after 8 weeks|0|||
170902310|NCT02901431|617644545|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
170902311|NCT02901431|617644546|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902312|NCT02901431|617644547|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
170902313|NCT02901431|617644548|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902314|NCT02901431|617644549|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902315|NCT02901431|617644550|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902316|NCT02901431|617644551|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902317|NCT02901431|617644552|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902318|NCT02901431|617644553|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902319|NCT02901431|617644554|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902320|NCT02901431|617644555|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902321|NCT02901431|617644556|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902322|NCT02901431|617644557|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
170902323|NCT02901431|617644545|FG000|PK Part|Discontinued per Sponsor|0|||
170902324|NCT02901431|617644546|FG001|PK Part|Discontinued per Sponsor|3|||
170902325|NCT02901431|617644547|FG002|PK Part|Discontinued per Sponsor|0|||
170902326|NCT02901431|617644548|FG003|PK Part|Discontinued per Sponsor|0|||
170902327|NCT02901431|617644549|FG004|PK Part|Discontinued per Sponsor|0|||
170902328|NCT02901431|617644550|FG005|PK Part|Discontinued per Sponsor|0|||
170902329|NCT02901431|617644551|FG006|PK Part|Discontinued per Sponsor|0|||
170902330|NCT02901431|617644552|FG007|PK Part|Discontinued per Sponsor|0|||
170902331|NCT02901431|617644553|FG008|PK Part|Discontinued per Sponsor|0|||
170902332|NCT02901431|617644554|FG009|PK Part|Discontinued per Sponsor|0|||
170902333|NCT02901431|617644555|FG010|PK Part|Discontinued per Sponsor|0|||
170902334|NCT02901431|617644556|FG011|PK Part|Discontinued per Sponsor|0|||
170902335|NCT02901431|617644557|FG012|PK Part|Discontinued per Sponsor|0|||
170902336|NCT02901431|617644545|FG000|PK Part|Withdrawal by Subject|1|||
170497523|NCT04488419|616160579|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
170497524|NCT04488419|616160580|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
170497525|NCT04488419|616160581|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
170497526|NCT04488419|616160579|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
170497527|NCT04488419|616160580|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
170497528|NCT04488419|616160581|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
170551449|NCT00806026|616364791|FG005|Overall Study|Withdrawal by Subject|3|||
170551450|NCT00806026|616364786|FG000|Overall Study|Other|3|||
170551451|NCT00806026|616364787|FG001|Overall Study|Other|6|||
170551452|NCT00806026|616364788|FG002|Overall Study|Other|8|||
170902337|NCT02901431|617644546|FG001|PK Part|Withdrawal by Subject|1|||
170902338|NCT02901431|617644547|FG002|PK Part|Withdrawal by Subject|3|||
170902339|NCT02901431|617644548|FG003|PK Part|Withdrawal by Subject|0|||
170902340|NCT02901431|617644549|FG004|PK Part|Withdrawal by Subject|0|||
170902341|NCT02901431|617644550|FG005|PK Part|Withdrawal by Subject|0|||
170902342|NCT02901431|617644551|FG006|PK Part|Withdrawal by Subject|0|||
170902343|NCT02901431|617644552|FG007|PK Part|Withdrawal by Subject|0|||
170497529|NCT04488419|616160579|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
170497530|NCT04488419|616160580|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
170497531|NCT04488419|616160581|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
170497532|NCT04488419|616160579|FG000|Primary Analysis Population|Adverse Event|6|||
170497533|NCT04488419|616160580|FG001|Primary Analysis Population|Adverse Event|9|||
170497534|NCT04488419|616160581|FG002|Primary Analysis Population|Adverse Event|0|||
170497535|NCT04488419|616160579|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
170497536|NCT04488419|616160580|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
170497537|NCT04488419|616160581|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
170497538|NCT04488419|616160579|FG000|Primary Analysis Population|Protocol Violation|1|||
170497539|NCT04488419|616160580|FG001|Primary Analysis Population|Protocol Violation|1|||
170497540|NCT04488419|616160581|FG002|Primary Analysis Population|Protocol Violation|0|||
170497541|NCT04488419|616160579|FG000|Primary Analysis Population|Undetermined|7|||
170497542|NCT04488419|616160580|FG001|Primary Analysis Population|Undetermined|3|||
170497543|NCT04488419|616160581|FG002|Primary Analysis Population|Undetermined|0|||
170497544|NCT04488419|616160579|FG000|Primary Analysis Population|>1 Reason|2|||
170497545|NCT04488419|616160580|FG001|Primary Analysis Population|>1 Reason|4|||
170497546|NCT04488419|616160581|FG002|Primary Analysis Population|>1 Reason|0|||
170497547|NCT00970632|616160585|FG000|Overall Study|Adverse Event|2|||
170497548|NCT00970632|616160586|FG001|Overall Study|Adverse Event|2|||
170804097|NCT00545545|617292015|FG003|Overall Study|Irinotecan intolerance|0|||
170804098|NCT00545545|617292016|FG004|Overall Study|Irinotecan intolerance|0|||
170804099|NCT00545545|617292017|FG005|Overall Study|Irinotecan intolerance|0|||
170804100|NCT00545545|617292012|FG000|Overall Study|No target lesions to track post surgery|0|||
170804101|NCT00545545|617292013|FG001|Overall Study|No target lesions to track post surgery|0|||
170804102|NCT00545545|617292014|FG002|Overall Study|No target lesions to track post surgery|0|||
170804103|NCT00545545|617292015|FG003|Overall Study|No target lesions to track post surgery|0|||
170804104|NCT00545545|617292016|FG004|Overall Study|No target lesions to track post surgery|1|||
170804105|NCT00545545|617292017|FG005|Overall Study|No target lesions to track post surgery|1|||
170804106|NCT02500576|617292018|FG000|Overall Study|Adverse Event|0|||
170804107|NCT02500576|617292019|FG001|Overall Study|Adverse Event|1|||
170804108|NCT02500576|617292018|FG000|Overall Study|Death|2|||
170804109|NCT02500576|617292019|FG001|Overall Study|Death|1|||
170804110|NCT02500576|617292018|FG000|Overall Study|Lack of Efficacy|5|||
170804111|NCT02500576|617292019|FG001|Overall Study|Lack of Efficacy|5|||
170804112|NCT02500576|617292018|FG000|Overall Study|Withdrawal by Subject|1|||
170804113|NCT02500576|617292019|FG001|Overall Study|Withdrawal by Subject|1|||
170804114|NCT03610581|617292020|FG000|Overall Study|Study terminated by sponsor|2|||
170804115|NCT03610581|617292021|FG001|Overall Study|Study terminated by sponsor|0|||
170804116|NCT03610581|617292020|FG000|Overall Study|Other|0|||
170804117|NCT03610581|617292021|FG001|Overall Study|Other|1|||
170804118|NCT03610581|617292020|FG000|Overall Study|Withdrawal by Subject|1|||
170804119|NCT03610581|617292021|FG001|Overall Study|Withdrawal by Subject|0|||
170804120|NCT05630833|617292025|FG000|Overall Study|Adverse Event|3|||
170804121|NCT05630833|617292026|FG001|Overall Study|Adverse Event|0|||
170804122|NCT05630833|617292025|FG000|Overall Study|Lack of Efficacy|0|||
170804123|NCT05630833|617292026|FG001|Overall Study|Lack of Efficacy|1|||
170804124|NCT05630833|617292025|FG000|Overall Study|Lost to Follow-up|1|||
170804125|NCT05630833|617292026|FG001|Overall Study|Lost to Follow-up|0|||
170804126|NCT05630833|617292025|FG000|Overall Study|Withdrawal by Subject|3|||
170804127|NCT05630833|617292026|FG001|Overall Study|Withdrawal by Subject|1|||
170804128|NCT05704725|617292027|FG000|Overall Study|Lost to Follow-up|0|||
170804129|NCT05704725|617292028|FG001|Overall Study|Lost to Follow-up|1|||
170804130|NCT05704725|617292027|FG000|Overall Study|Withdrawal by Subject|1|||
170804131|NCT05704725|617292028|FG001|Overall Study|Withdrawal by Subject|0|||
170804132|NCT02751528|617292033|FG000|Overall Study|Withdrawal by Subject|1|||
170804133|NCT02751528|617292033|FG000|Overall Study|Adverse Event|1|||
170804134|NCT05485805|617292034|FG000|Overall Study|Withdrawal by Subject|1|||
170804135|NCT05485805|617292035|FG001|Overall Study|Withdrawal by Subject|2|||
170804136|NCT05485805|617292036|FG002|Overall Study|Withdrawal by Subject|2|||
170804137|NCT05485805|617292037|FG003|Overall Study|Withdrawal by Subject|0|||
170804138|NCT05485805|617292038|FG004|Overall Study|Withdrawal by Subject|2|||
170804139|NCT05485805|617292034|FG000|Overall Study|Adverse Event|0|||
170804140|NCT05485805|617292035|FG001|Overall Study|Adverse Event|1|||
170804141|NCT05485805|617292036|FG002|Overall Study|Adverse Event|0|||
170804142|NCT05485805|617292037|FG003|Overall Study|Adverse Event|0|||
170804143|NCT05485805|617292038|FG004|Overall Study|Adverse Event|0|||
170804144|NCT05485805|617292034|FG000|Overall Study|Lost to Follow-up|1|||
170804145|NCT05485805|617292035|FG001|Overall Study|Lost to Follow-up|1|||
170804146|NCT05485805|617292036|FG002|Overall Study|Lost to Follow-up|3|||
170804147|NCT05485805|617292037|FG003|Overall Study|Lost to Follow-up|1|||
170804148|NCT05485805|617292038|FG004|Overall Study|Lost to Follow-up|0|||
170804149|NCT05349838|617292039|FG000|Overall Study|Virological Failure|1|||
170804150|NCT05349838|617292040|FG001|Overall Study|Virological Failure|2|||
170804151|NCT05349838|617292039|FG000|Overall Study|Withdrawal by Subject|2|||
170804152|NCT05349838|617292040|FG001|Overall Study|Withdrawal by Subject|3|||
170804153|NCT05349838|617292039|FG000|Overall Study|Adverse Event|3|||
170804154|NCT05349838|617292040|FG001|Overall Study|Adverse Event|1|||
170804155|NCT05349838|617292039|FG000|Overall Study|Lost to Follow-up|1|||
170804156|NCT05349838|617292040|FG001|Overall Study|Lost to Follow-up|2|||
170804157|NCT05349838|617292039|FG000|Overall Study|Other reasons|5|||
170902344|NCT02901431|617644553|FG008|PK Part|Withdrawal by Subject|0|||
170902345|NCT02901431|617644554|FG009|PK Part|Withdrawal by Subject|0|||
170902346|NCT02901431|617644555|FG010|PK Part|Withdrawal by Subject|0|||
170902347|NCT02901431|617644556|FG011|PK Part|Withdrawal by Subject|0|||
170902348|NCT02901431|617644557|FG012|PK Part|Withdrawal by Subject|0|||
170902349|NCT02901431|617644545|FG000|Main Treatment Part|Adverse Event|0|||
170902350|NCT02901431|617644546|FG001|Main Treatment Part|Adverse Event|0|||
170902351|NCT02901431|617644547|FG002|Main Treatment Part|Adverse Event|0|||
170902352|NCT02901431|617644548|FG003|Main Treatment Part|Adverse Event|3|||
170902353|NCT02901431|617644549|FG004|Main Treatment Part|Adverse Event|3|||
170902354|NCT02901431|617644550|FG005|Main Treatment Part|Adverse Event|4|||
170902355|NCT02901431|617644551|FG006|Main Treatment Part|Adverse Event|1|||
170902356|NCT02901431|617644552|FG007|Main Treatment Part|Adverse Event|0|||
170902357|NCT02901431|617644553|FG008|Main Treatment Part|Adverse Event|0|||
170902358|NCT02901431|617644554|FG009|Main Treatment Part|Adverse Event|0|||
170902359|NCT02901431|617644555|FG010|Main Treatment Part|Adverse Event|0|||
170902360|NCT02901431|617644556|FG011|Main Treatment Part|Adverse Event|0|||
170902361|NCT02901431|617644557|FG012|Main Treatment Part|Adverse Event|0|||
170804158|NCT05349838|617292040|FG001|Overall Study|Other reasons|1|||
170804159|NCT05071430|617292041|FG000|Overall Study|Adverse Event|1|||
170804160|NCT05071430|617292042|FG001|Overall Study|Adverse Event|2|||
170804161|NCT05071430|617292041|FG000|Overall Study|Lost to Follow-up|4|||
170804162|NCT05071430|617292042|FG001|Overall Study|Lost to Follow-up|4|||
170804163|NCT05071430|617292041|FG000|Overall Study|Protocol Violation|1|||
170804164|NCT05071430|617292042|FG001|Overall Study|Protocol Violation|0|||
170804165|NCT05071430|617292041|FG000|Overall Study|Withdrawal by Subject|3|||
170804166|NCT05071430|617292042|FG001|Overall Study|Withdrawal by Subject|2|||
170804167|NCT05071430|617292041|FG000|Overall Study|Other|1|||
170804168|NCT05071430|617292042|FG001|Overall Study|Other|1|||
170804169|NCT01958021|617292043|FG000|Treatment|Progressive disease|206|||
170804170|NCT01958021|617292044|FG001|Treatment|Progressive disease|265|||
170804171|NCT01958021|617292043|FG000|Treatment|Adverse Event|38|||
170804172|NCT01958021|617292044|FG001|Treatment|Adverse Event|10|||
170804173|NCT01958021|617292043|FG000|Treatment|Subject/guardian decision|29|||
170804174|NCT01958021|617292044|FG001|Treatment|Subject/guardian decision|25|||
170804175|NCT01958021|617292043|FG000|Treatment|Physician Decision|28|||
170804176|NCT01958021|617292044|FG001|Treatment|Physician Decision|21|||
170804177|NCT01958021|617292043|FG000|Treatment|Death|6|||
170804178|NCT01958021|617292044|FG001|Treatment|Death|1|||
170804179|NCT01958021|617292043|FG000|Treatment|Protocol deviation|3|||
170804180|NCT01958021|617292044|FG001|Treatment|Protocol deviation|1|||
170804181|NCT01958021|617292043|FG000|Treatment|Sponsor decision|24|||
170804182|NCT01958021|617292044|FG001|Treatment|Sponsor decision|11|||
170804183|NCT01958021|617292043|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
170804184|NCT01958021|617292044|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170804185|NCT01958021|617292043|FG000|Post-treatment Efficacy Follow-up|Death|1|||
170804186|NCT01958021|617292044|FG001|Post-treatment Efficacy Follow-up|Death|0|||
170804187|NCT01958021|617292043|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
170804188|NCT01958021|617292044|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170804189|NCT01958021|617292043|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
170804190|NCT01958021|617292044|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
170902362|NCT02901431|617644545|FG000|Main Treatment Part|Lack of Efficacy|0|||
170902363|NCT02901431|617644546|FG001|Main Treatment Part|Lack of Efficacy|0|||
170902364|NCT02901431|617644547|FG002|Main Treatment Part|Lack of Efficacy|0|||
170902365|NCT02901431|617644548|FG003|Main Treatment Part|Lack of Efficacy|1|||
170902366|NCT02901431|617644549|FG004|Main Treatment Part|Lack of Efficacy|0|||
170902367|NCT02901431|617644550|FG005|Main Treatment Part|Lack of Efficacy|0|||
170902368|NCT02901431|617644551|FG006|Main Treatment Part|Lack of Efficacy|0|||
170902369|NCT02901431|617644552|FG007|Main Treatment Part|Lack of Efficacy|0|||
170902370|NCT02901431|617644553|FG008|Main Treatment Part|Lack of Efficacy|0|||
170902371|NCT02901431|617644554|FG009|Main Treatment Part|Lack of Efficacy|0|||
170902372|NCT02901431|617644555|FG010|Main Treatment Part|Lack of Efficacy|0|||
170902373|NCT02901431|617644556|FG011|Main Treatment Part|Lack of Efficacy|0|||
170902374|NCT02901431|617644557|FG012|Main Treatment Part|Lack of Efficacy|0|||
170902375|NCT02901431|617644545|FG000|Main Treatment Part|Lost to Follow-up|0|||
170902376|NCT02901431|617644546|FG001|Main Treatment Part|Lost to Follow-up|0|||
170902377|NCT02901431|617644547|FG002|Main Treatment Part|Lost to Follow-up|0|||
170497549|NCT00970632|616160587|FG002|Overall Study|Adverse Event|1|||
170497550|NCT00970632|616160585|FG000|Overall Study|Lack of Efficacy|3|||
170497551|NCT00970632|616160586|FG001|Overall Study|Lack of Efficacy|0|||
170497552|NCT00970632|616160587|FG002|Overall Study|Lack of Efficacy|0|||
170497553|NCT00970632|616160585|FG000|Overall Study|Lost to Follow-up|3|||
170497554|NCT00970632|616160586|FG001|Overall Study|Lost to Follow-up|0|||
170497555|NCT00970632|616160587|FG002|Overall Study|Lost to Follow-up|2|||
170497556|NCT00970632|616160585|FG000|Overall Study|Protocol Violation|8|||
170497557|NCT00970632|616160586|FG001|Overall Study|Protocol Violation|5|||
170497558|NCT00970632|616160587|FG002|Overall Study|Protocol Violation|8|||
170804191|NCT01958021|617292043|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
170804192|NCT01958021|617292044|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
170902378|NCT02901431|617644548|FG003|Main Treatment Part|Lost to Follow-up|3|||
170902379|NCT02901431|617644549|FG004|Main Treatment Part|Lost to Follow-up|1|||
170902380|NCT02901431|617644550|FG005|Main Treatment Part|Lost to Follow-up|2|||
170497559|NCT00970632|616160585|FG000|Overall Study|Withdrawal by Subject|7|||
170497560|NCT00970632|616160586|FG001|Overall Study|Withdrawal by Subject|6|||
170804193|NCT01958021|617292043|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
170804194|NCT01958021|617292044|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
170804195|NCT01958021|617292043|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
170804196|NCT01958021|617292044|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
170804197|NCT01470144|617292045|FG000|Overall Study|Adverse Event|2|||
170804198|NCT01470144|617292045|FG000|Overall Study|Death|1|||
170804199|NCT01470144|617292045|FG000|Overall Study|Lung transplant|6|||
170804200|NCT01470144|617292045|FG000|Overall Study|Patient's and investigator's decision|1|||
170804201|NCT02798471|617292046|FG000|Overall Study|Adverse Event|7|||
170804202|NCT02798471|617292047|FG001|Overall Study|Adverse Event|2|||
170804203|NCT02798471|617292046|FG000|Overall Study|Physician Decision|3|||
170804204|NCT02798471|617292047|FG001|Overall Study|Physician Decision|7|||
170804205|NCT02798471|617292046|FG000|Overall Study|Death|2|||
170804206|NCT02798471|617292047|FG001|Overall Study|Death|3|||
170804207|NCT02798471|617292046|FG000|Overall Study|Lost to Follow-up|0|||
170804208|NCT02798471|617292047|FG001|Overall Study|Lost to Follow-up|1|||
170804209|NCT02798471|617292046|FG000|Overall Study|Other|5|||
170804210|NCT02798471|617292047|FG001|Overall Study|Other|3|||
170804211|NCT02798471|617292046|FG000|Overall Study|Subject withdrew consent|0|||
170804212|NCT02798471|617292047|FG001|Overall Study|Subject withdrew consent|6|||
170804213|NCT02798471|617292046|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
170804214|NCT02798471|617292047|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
170804215|NCT02798471|617292046|FG000|Overall Study|Randomized, but not treated|0|||
170804216|NCT02798471|617292047|FG001|Overall Study|Randomized, but not treated|2|||
170804217|NCT05422339|617293555|FG000|Overall Study|Withdrawal by Subject|17|||
170804218|NCT05422339|617293556|FG001|Overall Study|Withdrawal by Subject|15|||
170804219|NCT04172675|617293557|FG000|Overall Study|Withdrawal by Subject|7|||
170804220|NCT04172675|617293558|FG001|Overall Study|Withdrawal by Subject|5|||
170804221|NCT04172675|617293559|FG002|Overall Study|Withdrawal by Subject|1|||
170804222|NCT04172675|617293560|FG003|Overall Study|Withdrawal by Subject|4|||
170804223|NCT02386098|617293563|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
170804224|NCT02386098|617293564|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
170804225|NCT02386098|617293565|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
170804226|NCT02386098|617293566|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
170804227|NCT02386098|617293567|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
170804228|NCT02386098|617293563|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
170804229|NCT02386098|617293564|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
170804230|NCT02386098|617293565|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
170804231|NCT02386098|617293566|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
170804232|NCT02386098|617293567|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
170804233|NCT02386098|617293563|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
170804234|NCT02386098|617293564|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
170804235|NCT02386098|617293565|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
170804236|NCT02386098|617293566|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
170804237|NCT02386098|617293567|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
170902381|NCT02901431|617644551|FG006|Main Treatment Part|Lost to Follow-up|3|||
170902382|NCT02901431|617644552|FG007|Main Treatment Part|Lost to Follow-up|0|||
170497561|NCT00970632|616160587|FG002|Overall Study|Withdrawal by Subject|4|||
170497562|NCT00970632|616160585|FG000|Overall Study|Entry criteria not met|0|||
170804238|NCT02386098|617293563|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
170804239|NCT02386098|617293564|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
170804240|NCT02386098|617293565|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
170804241|NCT02386098|617293566|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
170804242|NCT02386098|617293567|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
170804243|NCT02386098|617293563|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
170804244|NCT02386098|617293564|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
170497563|NCT00970632|616160586|FG001|Overall Study|Entry criteria not met|2|||
170497564|NCT00970632|616160587|FG002|Overall Study|Entry criteria not met|2|||
170497565|NCT00970632|616160585|FG000|Overall Study|Sponsor decision|1|||
170497566|NCT00970632|616160586|FG001|Overall Study|Sponsor decision|0|||
170497567|NCT00970632|616160587|FG002|Overall Study|Sponsor decision|1|||
170497568|NCT01286168|616160593|FG000|Overall Study|Withdrawal by Subject|1|||
170497569|NCT01286168|616160593|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
170497570|NCT02487771|616160594|FG000|Overall Study|Lost to Follow-up|2|||
170497571|NCT02487771|616160595|FG001|Overall Study|Lost to Follow-up|3|||
170497572|NCT02487771|616160594|FG000|Overall Study|Moved out of area|5|||
170497573|NCT02487771|616160595|FG001|Overall Study|Moved out of area|6|||
170497574|NCT02487771|616160594|FG000|Overall Study|Withdrawal by Subject|3|||
170497575|NCT02487771|616160595|FG001|Overall Study|Withdrawal by Subject|5|||
170497576|NCT02879994|616160602|FG000|Overall Study|off treatment early|7|||
170497577|NCT02879994|616160602|FG000|Overall Study|Adverse Event|2|||
170497578|NCT02879994|616160602|FG000|Overall Study|Death|2|||
170497579|NCT02143791|616160603|FG000|Enrolled|Withdrawal by Subject|4|||
170497580|NCT02143791|616160603|FG000|Trial Stimulation|Lack of Efficacy|21|||
170497581|NCT02143791|616160603|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
170497582|NCT02143791|616160603|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
170497583|NCT02143791|616160603|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
170497584|NCT02143791|616160603|FG000|Any Programming (3-6 Months)|Missing Data|1|||
170497585|NCT02143791|616160603|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
170497586|NCT01871402|616160604|FG000|Overall Study|Lost to Follow-up|1|||
170497587|NCT01871402|616160605|FG001|Overall Study|Lost to Follow-up|0|||
170497588|NCT01871402|616160604|FG000|Overall Study|Withdrawal by Subject|0|||
170497589|NCT01871402|616160605|FG001|Overall Study|Withdrawal by Subject|2|||
170497590|NCT01871402|616160604|FG000|Overall Study|Non-compliance|0|||
170497591|NCT01871402|616160605|FG001|Overall Study|Non-compliance|1|||
170497592|NCT04594941|616160606|FG000|Overall Study|Other|0|||
170497593|NCT04594941|616160607|FG001|Overall Study|Other|3|||
170497594|NCT04594941|616160608|FG002|Overall Study|Other|1|||
170497595|NCT04594941|616160609|FG003|Overall Study|Other|0|||
170497596|NCT04327661|616160610|FG000|Overall Study|Withdrawal by Subject|1|||
170497597|NCT04327661|616160611|FG001|Overall Study|Withdrawal by Subject|0|||
170497598|NCT04327661|616160612|FG002|Overall Study|Withdrawal by Subject|0|||
170497599|NCT01482065|616160623|FG000|Overall Study|Withdrawal by Subject|0|||
170497600|NCT01482065|616160624|FG001|Overall Study|Withdrawal by Subject|1|||
170497601|NCT01942486|616160625|FG000|Overall Study|Lost to Follow-up|27|||
170497602|NCT00231114|616160628|FG000|Randomized|Withdrawal by Subject|6|||
170497603|NCT00231114|616160629|FG001|Randomized|Withdrawal by Subject|3|||
170497604|NCT00231114|616160628|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
170497605|NCT00231114|616160629|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
170497606|NCT00231114|616160628|FG000|Post-Treatment Period|Lost to Follow-up|6|||
170497607|NCT00231114|616160629|FG001|Post-Treatment Period|Lost to Follow-up|1|||
170497608|NCT00231114|616160628|FG000|Post-Treatment Period|Physician Decision|1|||
170497609|NCT00231114|616160629|FG001|Post-Treatment Period|Physician Decision|0|||
170497610|NCT00231114|616160628|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
170497611|NCT00231114|616160629|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
170497612|NCT02637895|616160631|FG000|Overall Study|Lost to Follow-up|4|||
170497613|NCT02637895|616160632|FG001|Overall Study|Lost to Follow-up|0|||
170497614|NCT02637895|616160631|FG000|Overall Study|Protocol Violation|0|||
170804245|NCT02386098|617293565|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
170804246|NCT02386098|617293566|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
170804247|NCT02386098|617293567|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
170804248|NCT02386098|617293563|FG000|Stage 1 (96 Weeks)|Other|1|||
170804249|NCT02386098|617293564|FG001|Stage 1 (96 Weeks)|Other|0|||
170804250|NCT02386098|617293565|FG002|Stage 1 (96 Weeks)|Other|0|||
170804251|NCT02386098|617293566|FG003|Stage 1 (96 Weeks)|Other|0|||
170804252|NCT02386098|617293567|FG004|Stage 1 (96 Weeks)|Other|0|||
170804253|NCT02386098|617293563|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
170804254|NCT02386098|617293564|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
170804255|NCT02386098|617293565|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
170804256|NCT02386098|617293566|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
170804257|NCT02386098|617293567|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
170804258|NCT02702843|617293568|FG000|Overall Study|Insufficient data to analyze|15|||
170804259|NCT02702843|617293569|FG001|Overall Study|Insufficient data to analyze|23|||
170804260|NCT05029284|617293570|FG000|Overall Study|Lost to Follow-up|1|||
170804261|NCT03002194|617293574|FG000|Overall Study|Lost to Follow-up|6|||
170804262|NCT03002194|617293574|FG000|Overall Study|Adverse Event|1|||
170902383|NCT02901431|617644553|FG008|Main Treatment Part|Lost to Follow-up|0|||
170497615|NCT02637895|616160632|FG001|Overall Study|Protocol Violation|1|||
170497616|NCT02637895|616160631|FG000|Overall Study|Lack of Efficacy|1|||
170497617|NCT02637895|616160632|FG001|Overall Study|Lack of Efficacy|0|||
170497618|NCT02637895|616160631|FG000|Overall Study|Withdrawal by Subject|1|||
170497619|NCT02637895|616160632|FG001|Overall Study|Withdrawal by Subject|1|||
170902384|NCT02901431|617644554|FG009|Main Treatment Part|Lost to Follow-up|0|||
170902385|NCT02901431|617644555|FG010|Main Treatment Part|Lost to Follow-up|0|||
170902386|NCT02901431|617644556|FG011|Main Treatment Part|Lost to Follow-up|0|||
170902387|NCT02901431|617644557|FG012|Main Treatment Part|Lost to Follow-up|0|||
170902388|NCT02901431|617644545|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
170902389|NCT02901431|617644546|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
170902390|NCT02901431|617644547|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
170902391|NCT02901431|617644548|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
170902392|NCT02901431|617644549|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
170902393|NCT02901431|617644550|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
170902394|NCT02901431|617644551|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
170902395|NCT02901431|617644552|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
170902396|NCT02901431|617644553|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
170902397|NCT02901431|617644554|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
170902398|NCT02901431|617644555|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
170902399|NCT02901431|617644556|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
170902400|NCT02901431|617644557|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
170902401|NCT02901431|617644545|FG000|Main Treatment Part|Physician Decision|0|||
170902402|NCT02901431|617644546|FG001|Main Treatment Part|Physician Decision|0|||
170902403|NCT02901431|617644547|FG002|Main Treatment Part|Physician Decision|0|||
170902404|NCT02901431|617644548|FG003|Main Treatment Part|Physician Decision|1|||
170902405|NCT02901431|617644549|FG004|Main Treatment Part|Physician Decision|0|||
170902406|NCT02901431|617644550|FG005|Main Treatment Part|Physician Decision|0|||
170902407|NCT02901431|617644551|FG006|Main Treatment Part|Physician Decision|1|||
170902408|NCT02901431|617644552|FG007|Main Treatment Part|Physician Decision|0|||
170902409|NCT02901431|617644553|FG008|Main Treatment Part|Physician Decision|0|||
170902410|NCT02901431|617644554|FG009|Main Treatment Part|Physician Decision|0|||
170902411|NCT02901431|617644555|FG010|Main Treatment Part|Physician Decision|0|||
170902412|NCT02901431|617644556|FG011|Main Treatment Part|Physician Decision|0|||
170902413|NCT02901431|617644557|FG012|Main Treatment Part|Physician Decision|0|||
170902414|NCT02901431|617644545|FG000|Main Treatment Part|Withdrawal by Subject|0|||
170902415|NCT02901431|617644546|FG001|Main Treatment Part|Withdrawal by Subject|0|||
170902416|NCT02901431|617644547|FG002|Main Treatment Part|Withdrawal by Subject|0|||
170902417|NCT02901431|617644548|FG003|Main Treatment Part|Withdrawal by Subject|18|||
170902418|NCT02901431|617644549|FG004|Main Treatment Part|Withdrawal by Subject|3|||
170902419|NCT02901431|617644550|FG005|Main Treatment Part|Withdrawal by Subject|5|||
170902420|NCT02901431|617644551|FG006|Main Treatment Part|Withdrawal by Subject|6|||
170902421|NCT02901431|617644552|FG007|Main Treatment Part|Withdrawal by Subject|0|||
170902422|NCT02901431|617644553|FG008|Main Treatment Part|Withdrawal by Subject|0|||
170902423|NCT02901431|617644554|FG009|Main Treatment Part|Withdrawal by Subject|0|||
170902424|NCT02901431|617644555|FG010|Main Treatment Part|Withdrawal by Subject|0|||
170902425|NCT02901431|617644556|FG011|Main Treatment Part|Withdrawal by Subject|0|||
170902426|NCT02901431|617644557|FG012|Main Treatment Part|Withdrawal by Subject|0|||
170902427|NCT02901431|617644545|FG000|Open Label Part|Adverse Event|0|||
170902428|NCT02901431|617644546|FG001|Open Label Part|Adverse Event|0|||
170902429|NCT02901431|617644547|FG002|Open Label Part|Adverse Event|0|||
170902430|NCT02901431|617644548|FG003|Open Label Part|Adverse Event|0|||
170902431|NCT02901431|617644549|FG004|Open Label Part|Adverse Event|0|||
170902432|NCT02901431|617644550|FG005|Open Label Part|Adverse Event|0|||
170902433|NCT02901431|617644551|FG006|Open Label Part|Adverse Event|0|||
170902434|NCT02901431|617644552|FG007|Open Label Part|Adverse Event|0|||
170902435|NCT02901431|617644553|FG008|Open Label Part|Adverse Event|4|||
170902436|NCT02901431|617644554|FG009|Open Label Part|Adverse Event|4|||
170902437|NCT02901431|617644555|FG010|Open Label Part|Adverse Event|0|||
170902438|NCT02901431|617644556|FG011|Open Label Part|Adverse Event|4|||
170902439|NCT02901431|617644557|FG012|Open Label Part|Adverse Event|1|||
170902440|NCT02901431|617644545|FG000|Open Label Part|Lost to Follow-up|0|||
170902441|NCT02901431|617644546|FG001|Open Label Part|Lost to Follow-up|0|||
170902442|NCT02901431|617644547|FG002|Open Label Part|Lost to Follow-up|0|||
170902443|NCT02901431|617644548|FG003|Open Label Part|Lost to Follow-up|0|||
170551453|NCT00806026|616364789|FG003|Overall Study|Other|2|||
170551454|NCT00806026|616364790|FG004|Overall Study|Other|0|||
170551455|NCT00806026|616364791|FG005|Overall Study|Other|4|||
170551456|NCT00806026|616364786|FG000|Overall Study|Protocol Violation|6|||
170902444|NCT02901431|617644549|FG004|Open Label Part|Lost to Follow-up|0|||
170902445|NCT02901431|617644550|FG005|Open Label Part|Lost to Follow-up|0|||
170902446|NCT02901431|617644551|FG006|Open Label Part|Lost to Follow-up|0|||
170902447|NCT02901431|617644552|FG007|Open Label Part|Lost to Follow-up|0|||
170551457|NCT00806026|616364787|FG001|Overall Study|Protocol Violation|9|||
170551458|NCT00806026|616364788|FG002|Overall Study|Protocol Violation|9|||
170551459|NCT00806026|616364789|FG003|Overall Study|Protocol Violation|0|||
170902448|NCT02901431|617644553|FG008|Open Label Part|Lost to Follow-up|2|||
170902449|NCT02901431|617644554|FG009|Open Label Part|Lost to Follow-up|2|||
170902450|NCT02901431|617644555|FG010|Open Label Part|Lost to Follow-up|1|||
170902451|NCT02901431|617644556|FG011|Open Label Part|Lost to Follow-up|1|||
170902452|NCT02901431|617644557|FG012|Open Label Part|Lost to Follow-up|1|||
170902453|NCT02901431|617644545|FG000|Open Label Part|Physician Decision|0|||
170902454|NCT02901431|617644546|FG001|Open Label Part|Physician Decision|0|||
170902455|NCT02901431|617644547|FG002|Open Label Part|Physician Decision|0|||
170902456|NCT02901431|617644548|FG003|Open Label Part|Physician Decision|0|||
170902457|NCT02901431|617644549|FG004|Open Label Part|Physician Decision|0|||
170902458|NCT02901431|617644550|FG005|Open Label Part|Physician Decision|0|||
170902459|NCT02901431|617644551|FG006|Open Label Part|Physician Decision|0|||
170902460|NCT02901431|617644552|FG007|Open Label Part|Physician Decision|0|||
170902461|NCT02901431|617644553|FG008|Open Label Part|Physician Decision|1|||
170902462|NCT02901431|617644554|FG009|Open Label Part|Physician Decision|1|||
170902463|NCT02901431|617644555|FG010|Open Label Part|Physician Decision|0|||
170902464|NCT02901431|617644556|FG011|Open Label Part|Physician Decision|0|||
170902465|NCT02901431|617644557|FG012|Open Label Part|Physician Decision|0|||
170902466|NCT02901431|617644545|FG000|Open Label Part|Study Terminated By Sponsor|0|||
170902467|NCT02901431|617644546|FG001|Open Label Part|Study Terminated By Sponsor|0|||
170902468|NCT02901431|617644547|FG002|Open Label Part|Study Terminated By Sponsor|0|||
170902469|NCT02901431|617644548|FG003|Open Label Part|Study Terminated By Sponsor|0|||
170902470|NCT02901431|617644549|FG004|Open Label Part|Study Terminated By Sponsor|0|||
170902471|NCT02901431|617644550|FG005|Open Label Part|Study Terminated By Sponsor|0|||
170902472|NCT02901431|617644551|FG006|Open Label Part|Study Terminated By Sponsor|0|||
170902473|NCT02901431|617644552|FG007|Open Label Part|Study Terminated By Sponsor|0|||
170902474|NCT02901431|617644553|FG008|Open Label Part|Study Terminated By Sponsor|35|||
170902475|NCT02901431|617644554|FG009|Open Label Part|Study Terminated By Sponsor|12|||
170902476|NCT02901431|617644555|FG010|Open Label Part|Study Terminated By Sponsor|21|||
170902477|NCT02901431|617644556|FG011|Open Label Part|Study Terminated By Sponsor|31|||
170902478|NCT02901431|617644557|FG012|Open Label Part|Study Terminated By Sponsor|0|||
170902479|NCT02901431|617644545|FG000|Open Label Part|Withdrawal by Subject|0|||
170902480|NCT02901431|617644546|FG001|Open Label Part|Withdrawal by Subject|0|||
170902481|NCT02901431|617644547|FG002|Open Label Part|Withdrawal by Subject|0|||
170902482|NCT02901431|617644548|FG003|Open Label Part|Withdrawal by Subject|0|||
170902483|NCT02901431|617644549|FG004|Open Label Part|Withdrawal by Subject|0|||
170902484|NCT02901431|617644550|FG005|Open Label Part|Withdrawal by Subject|0|||
170902485|NCT02901431|617644551|FG006|Open Label Part|Withdrawal by Subject|0|||
170902486|NCT02901431|617644552|FG007|Open Label Part|Withdrawal by Subject|0|||
170902487|NCT02901431|617644553|FG008|Open Label Part|Withdrawal by Subject|6|||
170902488|NCT02901431|617644554|FG009|Open Label Part|Withdrawal by Subject|5|||
170497620|NCT02637895|616160631|FG000|Overall Study|Abnormal baseline lab|0|||
170497621|NCT02637895|616160632|FG001|Overall Study|Abnormal baseline lab|1|||
170497622|NCT01194999|616160635|FG000|Overall Study|Lost to Follow-up|17|||
170497623|NCT01895270|616160636|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
170497624|NCT01895270|616160637|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
170497625|NCT01895270|616160636|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
170497626|NCT01895270|616160637|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
170497627|NCT01895270|616160636|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
170497628|NCT01895270|616160637|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
170497629|NCT01895270|616160636|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
170497630|NCT01895270|616160637|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
170497631|NCT01895270|616160636|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
170497632|NCT01895270|616160637|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
170497633|NCT01895270|616160636|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
170497634|NCT01895270|616160637|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
170497635|NCT01895270|616160636|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
170497636|NCT01895270|616160637|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
170497637|NCT00654875|616160640|FG000|Overall Study|Adverse Event|5|||
170497638|NCT00654875|616160641|FG001|Overall Study|Adverse Event|5|||
170497639|NCT00654875|616160640|FG000|Overall Study|Withdrawal by Subject|4|||
170497640|NCT00654875|616160641|FG001|Overall Study|Withdrawal by Subject|4|||
170497641|NCT00654875|616160640|FG000|Overall Study|Protocol Violation|3|||
170497642|NCT00654875|616160641|FG001|Overall Study|Protocol Violation|3|||
170497643|NCT00654875|616160640|FG000|Overall Study|Lack of Efficacy|2|||
170497644|NCT00654875|616160641|FG001|Overall Study|Lack of Efficacy|2|||
170497645|NCT00654875|616160640|FG000|Overall Study|Lost to Follow-up|1|||
170497646|NCT00654875|616160641|FG001|Overall Study|Lost to Follow-up|3|||
170902489|NCT02901431|617644555|FG010|Open Label Part|Withdrawal by Subject|7|||
170902490|NCT02901431|617644556|FG011|Open Label Part|Withdrawal by Subject|3|||
170497647|NCT00654875|616160640|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
170497648|NCT00654875|616160641|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
170902491|NCT02901431|617644557|FG012|Open Label Part|Withdrawal by Subject|1|||
170902492|NCT04223609|617644560|FG000|Overall Study|Adverse Event|0|||
170497649|NCT00654875|616160640|FG000|Overall Study|Administrative Problems|1|||
170497650|NCT00654875|616160641|FG001|Overall Study|Administrative Problems|0|||
170497651|NCT01995175|616160642|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
170497652|NCT01995175|616160642|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
170497653|NCT01995175|616160642|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
170497654|NCT01995175|616160642|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
170497655|NCT01995175|616160642|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
170497656|NCT01995175|616160642|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
170497657|NCT01995175|616160642|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
170497658|NCT01995175|616160642|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
170497659|NCT01995175|616160642|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
170497660|NCT01741792|616160643|FG000|Overall Study|Death|6|||
170497661|NCT01741792|616160644|FG001|Overall Study|Death|1|||
170497662|NCT01741792|616160645|FG002|Overall Study|Death|12|||
170497663|NCT00984061|616160646|FG000|Clarithromycin Alone|Protocol Violation|1|||
170497664|NCT00782184|616160649|FG000|Overall Study|Adverse Event|1|||
170497665|NCT00782184|616160650|FG001|Overall Study|Adverse Event|2|||
170497666|NCT00782184|616160649|FG000|Overall Study|Protocol Violation|0|||
170497667|NCT00782184|616160650|FG001|Overall Study|Protocol Violation|1|||
170497668|NCT00782184|616160649|FG000|Overall Study|Withdrawal by Subject|3|||
170497669|NCT00782184|616160650|FG001|Overall Study|Withdrawal by Subject|2|||
170497670|NCT03614078|616160655|FG000|Overall Study|Withdrawal by Subject|2|||
170497671|NCT03614078|616160656|FG001|Overall Study|Withdrawal by Subject|2|||
170497672|NCT03614078|616160657|FG002|Overall Study|Withdrawal by Subject|3|||
170497673|NCT03614078|616160655|FG000|Overall Study|Participant Did Not Return for Visit|0|||
170497674|NCT03614078|616160656|FG001|Overall Study|Participant Did Not Return for Visit|1|||
170497675|NCT03614078|616160657|FG002|Overall Study|Participant Did Not Return for Visit|0|||
170497676|NCT03614078|616160655|FG000|Overall Study|High Neutrophils|0|||
170497677|NCT03614078|616160656|FG001|Overall Study|High Neutrophils|0|||
170497678|NCT03614078|616160657|FG002|Overall Study|High Neutrophils|2|||
170497679|NCT03614078|616160655|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
170497680|NCT03614078|616160656|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
170497681|NCT03614078|616160657|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
170497682|NCT03614078|616160655|FG000|Overall Study|Exacerbation of Psoriasis|0|||
170497683|NCT03614078|616160656|FG001|Overall Study|Exacerbation of Psoriasis|1|||
170497684|NCT03614078|616160657|FG002|Overall Study|Exacerbation of Psoriasis|0|||
170497685|NCT03614078|616160655|FG000|Overall Study|Adverse Event|0|||
170497686|NCT03614078|616160656|FG001|Overall Study|Adverse Event|2|||
170497687|NCT03614078|616160657|FG002|Overall Study|Adverse Event|0|||
170497688|NCT03614078|616160655|FG000|Overall Study|Dizziness and Rash|0|||
170497689|NCT03614078|616160656|FG001|Overall Study|Dizziness and Rash|1|||
170497690|NCT03614078|616160657|FG002|Overall Study|Dizziness and Rash|0|||
170497691|NCT04964544|616160660|FG000|Overall Study|Screen failure or other uncategorised|10|||
170497692|NCT04964544|616160660|FG000|Overall Study|Physician Decision|4|||
170497693|NCT04964544|616160660|FG000|Overall Study|Lost to Follow-up|9|||
170497694|NCT04964544|616160660|FG000|Overall Study|Withdrawal by Subject|18|||
170497695|NCT04964544|616160660|FG000|Overall Study|Death|1|||
170497696|NCT01613222|616160661|FG000|Overall Study|Physician Decision|1|||
170497697|NCT01613222|616160661|FG000|Overall Study|Unable to place arterial line|1|||
170497698|NCT01613222|616160661|FG000|Overall Study|Reused disposable sensors|10|||
170497699|NCT00749684|616160664|FG000|Overall Study|Death|1|||
170497700|NCT00749684|616160664|FG000|Overall Study|Adverse Event|27|||
170497701|NCT00749684|616160664|FG000|Overall Study|Participant's Wish|10|||
170497702|NCT00749684|616160664|FG000|Overall Study|Not Documented|1|||
170551460|NCT00806026|616364790|FG004|Overall Study|Protocol Violation|2|||
170551461|NCT00806026|616364791|FG005|Overall Study|Protocol Violation|3|||
170551462|NCT00806026|616364786|FG000|Overall Study|Adverse Event|52|||
170551463|NCT00806026|616364787|FG001|Overall Study|Adverse Event|35|||
170902493|NCT04223609|617644561|FG001|Overall Study|Adverse Event|1|||
170902494|NCT04223609|617644560|FG000|Overall Study|Missed last visit|0|||
170902495|NCT04223609|617644561|FG001|Overall Study|Missed last visit|1|||
170902496|NCT02500537|617644562|FG000|Overall Study|Death|2|||
170902497|NCT02500537|617644563|FG001|Overall Study|Death|0|||
170902498|NCT02500537|617644562|FG000|Overall Study|Lost to Follow-up|0|||
170902499|NCT02500537|617644563|FG001|Overall Study|Lost to Follow-up|1|||
170902500|NCT02500537|617644562|FG000|Overall Study|Withdrawal by Subject|1|||
170902501|NCT02500537|617644563|FG001|Overall Study|Withdrawal by Subject|0|||
170902502|NCT04672083|617644564|FG000|Overall Study|Lost to Follow-up|1|||
170902503|NCT04672083|617644565|FG001|Overall Study|Lost to Follow-up|0|||
170902504|NCT04672083|617644566|FG002|Overall Study|Lost to Follow-up|0|||
170902505|NCT04672083|617644567|FG003|Overall Study|Lost to Follow-up|0|||
170902506|NCT04672083|617644568|FG004|Overall Study|Lost to Follow-up|0|||
170902507|NCT03136107|617644573|FG000|Overall Study|Other (Not specified)|1|||
170902508|NCT05630846|617646790|FG000|Overall Study|Death|1|||
170902509|NCT05630846|617646791|FG001|Overall Study|Death|0|||
170902510|NCT05630846|617646792|FG002|Overall Study|Death|0|||
170902511|NCT05630846|617646793|FG003|Overall Study|Death|0|||
170902512|NCT05630846|617646790|FG000|Overall Study|Withdrawal by Subject|3|||
170902513|NCT05630846|617646791|FG001|Overall Study|Withdrawal by Subject|3|||
170902514|NCT05630846|617646792|FG002|Overall Study|Withdrawal by Subject|4|||
170902515|NCT05630846|617646793|FG003|Overall Study|Withdrawal by Subject|1|||
170902516|NCT05630846|617646790|FG000|Overall Study|Lost to Follow-up|6|||
170902517|NCT05630846|617646791|FG001|Overall Study|Lost to Follow-up|5|||
170902518|NCT05630846|617646792|FG002|Overall Study|Lost to Follow-up|2|||
170902519|NCT05630846|617646793|FG003|Overall Study|Lost to Follow-up|5|||
170902520|NCT05630846|617646790|FG000|Overall Study|Other|1|||
170902521|NCT05630846|617646791|FG001|Overall Study|Other|0|||
170902522|NCT05630846|617646792|FG002|Overall Study|Other|0|||
170902523|NCT05630846|617646793|FG003|Overall Study|Other|0|||
170902524|NCT01431287|617646806|FG000|Overall Study|not treated|0|||
170902525|NCT01431287|617646807|FG001|Overall Study|not treated|0|||
170902526|NCT01431287|617646808|FG002|Overall Study|not treated|1|||
170902527|NCT01431287|617646809|FG003|Overall Study|not treated|0|||
170902528|NCT01431287|617646810|FG004|Overall Study|not treated|0|||
170902529|NCT01431287|617646806|FG000|Overall Study|Adverse Event|59|||
170902530|NCT01431287|617646807|FG001|Overall Study|Adverse Event|57|||
170902531|NCT01431287|617646808|FG002|Overall Study|Adverse Event|53|||
170902532|NCT01431287|617646809|FG003|Overall Study|Adverse Event|33|||
170902533|NCT01431287|617646810|FG004|Overall Study|Adverse Event|41|||
170902534|NCT01431287|617646806|FG000|Overall Study|Non compliant with protocol|6|||
170902535|NCT01431287|617646807|FG001|Overall Study|Non compliant with protocol|6|||
170902536|NCT01431287|617646808|FG002|Overall Study|Non compliant with protocol|5|||
170902537|NCT01431287|617646809|FG003|Overall Study|Non compliant with protocol|6|||
170902538|NCT01431287|617646810|FG004|Overall Study|Non compliant with protocol|5|||
170902539|NCT01431287|617646806|FG000|Overall Study|Lost to Follow-up|0|||
170902540|NCT01431287|617646807|FG001|Overall Study|Lost to Follow-up|3|||
170902541|NCT01431287|617646808|FG002|Overall Study|Lost to Follow-up|2|||
170902542|NCT01431287|617646809|FG003|Overall Study|Lost to Follow-up|3|||
170902543|NCT01431287|617646810|FG004|Overall Study|Lost to Follow-up|1|||
170902544|NCT01431287|617646806|FG000|Overall Study|Consent withdrawn not due to AE|29|||
170902545|NCT01431287|617646807|FG001|Overall Study|Consent withdrawn not due to AE|30|||
170902546|NCT01431287|617646808|FG002|Overall Study|Consent withdrawn not due to AE|34|||
170902547|NCT01431287|617646809|FG003|Overall Study|Consent withdrawn not due to AE|19|||
170902548|NCT01431287|617646810|FG004|Overall Study|Consent withdrawn not due to AE|29|||
170902549|NCT01431287|617646806|FG000|Overall Study|not stated above|4|||
170902550|NCT01431287|617646807|FG001|Overall Study|not stated above|2|||
170902551|NCT01431287|617646808|FG002|Overall Study|not stated above|2|||
170902552|NCT01431287|617646809|FG003|Overall Study|not stated above|2|||
170902553|NCT01431287|617646810|FG004|Overall Study|not stated above|1|||
170902554|NCT00496366|617646811|FG000|Overall Study|Death|1|||
170902555|NCT00260208|617646812|FG000|Overall Study|Subject withdrew consent|11|||
170902556|NCT00260208|617646813|FG001|Overall Study|Subject withdrew consent|7|||
170497703|NCT00749684|616160664|FG000|Overall Study|Progressive Desease|31|||
170497704|NCT00749684|616160664|FG000|Overall Study|Therapy according to protocol + AE|2|||
170902557|NCT00260208|617646812|FG000|Overall Study|Lost to Follow-up|6|||
170497705|NCT00749684|616160664|FG000|Overall Study|AE+discontinuation on participants wish|1|||
170902558|NCT00260208|617646813|FG001|Overall Study|Lost to Follow-up|1|||
170902559|NCT00260208|617646812|FG000|Overall Study|Death|12|||
170902560|NCT00260208|617646813|FG001|Overall Study|Death|10|||
170902561|NCT00260208|617646812|FG000|Overall Study|Missing|18|||
170902562|NCT00260208|617646813|FG001|Overall Study|Missing|16|||
170902563|NCT00278629|617646820|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
170902564|NCT03323749|617646821|FG000|Double-blind Period|Lost to Follow-up|4|||
170902565|NCT03323749|617646822|FG001|Double-blind Period|Lost to Follow-up|5|||
170902566|NCT03323749|617646821|FG000|Double-blind Period|Adverse Event|3|||
170902567|NCT03323749|617646822|FG001|Double-blind Period|Adverse Event|1|||
170902568|NCT03323749|617646821|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
170902569|NCT03323749|617646822|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
170902570|NCT03323749|617646821|FG000|Open-Label Period|Adverse Event|3|||
170902571|NCT03323749|617646822|FG001|Open-Label Period|Adverse Event|10|||
170902572|NCT03323749|617646821|FG000|Open-Label Period|Withdrawal by Subject|7|||
170902573|NCT03323749|617646822|FG001|Open-Label Period|Withdrawal by Subject|5|||
170902574|NCT00783289|617646823|FG000|Overall Study|Protocol Violation|0|||
170902575|NCT00783289|617646824|FG001|Overall Study|Protocol Violation|1|||
170902576|NCT00783289|617646825|FG002|Overall Study|Protocol Violation|0|||
170902577|NCT00783289|617646826|FG003|Overall Study|Protocol Violation|0|||
170902578|NCT00265941|617646827|FG000|Overall Study|Protocol Violation|22|||
170902579|NCT00265941|617646828|FG001|Overall Study|Protocol Violation|25|||
170902580|NCT00265941|617646827|FG000|Overall Study|Lost to Follow-up|1|||
170902581|NCT00265941|617646828|FG001|Overall Study|Lost to Follow-up|1|||
170902582|NCT01381094|617646829|FG000|Overall Study|Adverse Event|1|||
170902583|NCT01381094|617646830|FG001|Overall Study|Adverse Event|2|||
170902584|NCT01381094|617646831|FG002|Overall Study|Adverse Event|0|||
170902585|NCT01381094|617646832|FG003|Overall Study|Adverse Event|1|||
170902586|NCT01381094|617646833|FG004|Overall Study|Adverse Event|0|||
170902587|NCT01381094|617646829|FG000|Overall Study|Lost to Follow-up|0|||
170902588|NCT01381094|617646830|FG001|Overall Study|Lost to Follow-up|0|||
170902589|NCT01381094|617646831|FG002|Overall Study|Lost to Follow-up|0|||
170902590|NCT01381094|617646832|FG003|Overall Study|Lost to Follow-up|0|||
170902591|NCT01381094|617646833|FG004|Overall Study|Lost to Follow-up|1|||
170902592|NCT01381094|617646829|FG000|Overall Study|Withdrawal of informed consent|0|||
170902593|NCT01381094|617646830|FG001|Overall Study|Withdrawal of informed consent|1|||
170902594|NCT01381094|617646831|FG002|Overall Study|Withdrawal of informed consent|0|||
170902595|NCT01381094|617646832|FG003|Overall Study|Withdrawal of informed consent|0|||
170902596|NCT01381094|617646833|FG004|Overall Study|Withdrawal of informed consent|0|||
170902597|NCT01381094|617646829|FG000|Overall Study|Participant given Aranesp injection|1|||
170902598|NCT01381094|617646830|FG001|Overall Study|Participant given Aranesp injection|0|||
170902599|NCT01381094|617646831|FG002|Overall Study|Participant given Aranesp injection|0|||
170902600|NCT01381094|617646832|FG003|Overall Study|Participant given Aranesp injection|0|||
170902601|NCT01381094|617646833|FG004|Overall Study|Participant given Aranesp injection|0|||
170902602|NCT01934504|617646839|FG000|Overall Study|Protocol Deviation|0|||
170902603|NCT01934504|617646840|FG001|Overall Study|Protocol Deviation|0|||
170902604|NCT01934504|617646841|FG002|Overall Study|Protocol Deviation|0|||
170902605|NCT01934504|617646842|FG003|Overall Study|Protocol Deviation|2|||
170902606|NCT01934504|617646839|FG000|Overall Study|Study Terminated by Sponsor|1|||
170902607|NCT01934504|617646840|FG001|Overall Study|Study Terminated by Sponsor|0|||
170902608|NCT01934504|617646841|FG002|Overall Study|Study Terminated by Sponsor|5|||
170902609|NCT01934504|617646842|FG003|Overall Study|Study Terminated by Sponsor|5|||
170902610|NCT02665689|617646843|FG000|Overall Study|Adverse Event|1|||
170902611|NCT02665689|617646844|FG001|Overall Study|Adverse Event|0|||
170902612|NCT02665689|617646843|FG000|Overall Study|Trial termination|1|||
170902613|NCT02665689|617646844|FG001|Overall Study|Trial termination|1|||
170902614|NCT02665689|617646843|FG000|Overall Study|Lost to Follow-up|0|||
170902615|NCT02665689|617646844|FG001|Overall Study|Lost to Follow-up|1|||
170902616|NCT01389245|617646845|FG000|Overall Study|Protocol Violation|10|||
170902617|NCT01389245|617646845|FG000|Overall Study|Lost to Follow-up|3|||
170902618|NCT01389245|617646845|FG000|Overall Study|Withdrawal by Subject|2|||
170902619|NCT03976401|617646846|FG000|Overall Study|Adverse Event|2|||
170902620|NCT03976401|617646847|FG001|Overall Study|Adverse Event|0|||
170902621|NCT03976401|617646848|FG002|Overall Study|Adverse Event|4|||
170902622|NCT03976401|617646849|FG003|Overall Study|Adverse Event|1|||
170902623|NCT03976401|617646850|FG004|Overall Study|Adverse Event|1|||
170902624|NCT03976401|617646851|FG005|Overall Study|Adverse Event|0|||
170902625|NCT03976401|617646846|FG000|Overall Study|Withdrawal by Subject|0|||
170902626|NCT03976401|617646847|FG001|Overall Study|Withdrawal by Subject|1|||
170902627|NCT03976401|617646848|FG002|Overall Study|Withdrawal by Subject|0|||
170902628|NCT03976401|617646849|FG003|Overall Study|Withdrawal by Subject|0|||
170902629|NCT03976401|617646850|FG004|Overall Study|Withdrawal by Subject|0|||
170902630|NCT03976401|617646851|FG005|Overall Study|Withdrawal by Subject|1|||
170902631|NCT03976401|617646846|FG000|Overall Study|Physician Decision|0|||
170902632|NCT03976401|617646847|FG001|Overall Study|Physician Decision|0|||
170902633|NCT03976401|617646848|FG002|Overall Study|Physician Decision|1|||
170902634|NCT03976401|617646849|FG003|Overall Study|Physician Decision|0|||
170902635|NCT03976401|617646850|FG004|Overall Study|Physician Decision|0|||
170902636|NCT03976401|617646851|FG005|Overall Study|Physician Decision|0|||
170902637|NCT03976401|617646846|FG000|Overall Study|Lost to Follow-up|1|||
170902638|NCT03976401|617646847|FG001|Overall Study|Lost to Follow-up|2|||
170902639|NCT03976401|617646848|FG002|Overall Study|Lost to Follow-up|0|||
170902640|NCT03976401|617646849|FG003|Overall Study|Lost to Follow-up|0|||
170902641|NCT03976401|617646850|FG004|Overall Study|Lost to Follow-up|0|||
170902642|NCT03976401|617646851|FG005|Overall Study|Lost to Follow-up|0|||
170902643|NCT03976401|617646846|FG000|Overall Study|Protocol Violation|0|||
170902644|NCT03976401|617646847|FG001|Overall Study|Protocol Violation|1|||
170902645|NCT03976401|617646848|FG002|Overall Study|Protocol Violation|0|||
170902646|NCT03976401|617646849|FG003|Overall Study|Protocol Violation|0|||
170902647|NCT03976401|617646850|FG004|Overall Study|Protocol Violation|0|||
170902648|NCT03976401|617646851|FG005|Overall Study|Protocol Violation|0|||
170902649|NCT03976401|617646846|FG000|Overall Study|Withdrew Consent|0|||
170902650|NCT03976401|617646847|FG001|Overall Study|Withdrew Consent|0|||
170902651|NCT03976401|617646848|FG002|Overall Study|Withdrew Consent|0|||
170902652|NCT03976401|617646849|FG003|Overall Study|Withdrew Consent|1|||
170902653|NCT03976401|617646850|FG004|Overall Study|Withdrew Consent|0|||
170902654|NCT03976401|617646851|FG005|Overall Study|Withdrew Consent|0|||
170902655|NCT02210780|617646853|FG000|Overall Study|Adverse Event|0|||
170902656|NCT02210780|617646854|FG001|Overall Study|Adverse Event|5|||
170902657|NCT02210780|617646853|FG000|Overall Study|Lost to Follow-up|2|||
170902658|NCT02210780|617646854|FG001|Overall Study|Lost to Follow-up|1|||
170902659|NCT02210780|617646853|FG000|Overall Study|Withdrawal by Subject|1|||
170902660|NCT02210780|617646854|FG001|Overall Study|Withdrawal by Subject|1|||
170902661|NCT02210780|617646853|FG000|Overall Study|Physician Decision|1|||
170902662|NCT02210780|617646854|FG001|Overall Study|Physician Decision|0|||
170902663|NCT02210780|617646853|FG000|Overall Study|Protocol Violation|1|||
170902664|NCT02210780|617646854|FG001|Overall Study|Protocol Violation|0|||
170902665|NCT02210780|617646853|FG000|Overall Study|Other than specified above|0|||
170497706|NCT00749684|616160664|FG000|Overall Study|Missing|9|||
170497707|NCT03696108|616160665|FG000|Overall Study|Physician Decision|1|||
170497708|NCT03696108|616160666|FG001|Overall Study|Physician Decision|0|||
170902666|NCT02210780|617646854|FG001|Overall Study|Other than specified above|1|||
170497709|NCT03696108|616160665|FG000|Overall Study|Withdrawal by Subject|3|||
170497710|NCT03696108|616160666|FG001|Overall Study|Withdrawal by Subject|6|||
170497711|NCT03505593|616160667|FG000|Overall Study|Withdrawal by Subject|1|||
170497712|NCT03505593|616160667|FG000|Overall Study|Died before procedure|1|||
170497713|NCT03505593|616160667|FG000|Overall Study|Anatomical abnormality|1|||
170497714|NCT03505593|616160667|FG000|Overall Study|Unable to pass through esophagus|1|||
170497715|NCT03505593|616160667|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
170497716|NCT03891862|616160668|FG000|Open-label Period|Adverse Event|2|||
170497717|NCT03891862|616160669|FG001|Open-label Period|Adverse Event|0|||
170497718|NCT03891862|616160670|FG002|Open-label Period|Adverse Event|0|||
170497719|NCT03891862|616160668|FG000|Open-label Period|Protocol Violation|5|||
170902667|NCT00097539|617646855|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
170902668|NCT00097539|617646856|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
170497720|NCT03891862|616160669|FG001|Open-label Period|Protocol Violation|0|||
170497721|NCT03891862|616160670|FG002|Open-label Period|Protocol Violation|0|||
170497722|NCT03891862|616160668|FG000|Open-label Period|Withdrawal by Subject|6|||
170497723|NCT03891862|616160669|FG001|Open-label Period|Withdrawal by Subject|0|||
170902669|NCT00097539|617646857|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
170902670|NCT00097539|617646858|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
170902671|NCT00097539|617646859|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
170902672|NCT00097539|617646860|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
170902673|NCT00097539|617646861|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
170902674|NCT00097539|617646855|FG000|Overall Study|Withdrawal by Subject|925|||
170902675|NCT00097539|617646856|FG001|Overall Study|Withdrawal by Subject|323|||
170902676|NCT00097539|617646857|FG002|Overall Study|Withdrawal by Subject|346|||
170902677|NCT00097539|617646858|FG003|Overall Study|Withdrawal by Subject|217|||
170902678|NCT00097539|617646859|FG004|Overall Study|Withdrawal by Subject|68|||
170902679|NCT00097539|617646860|FG005|Overall Study|Withdrawal by Subject|229|||
170902680|NCT00097539|617646861|FG006|Overall Study|Withdrawal by Subject|3|||
170902681|NCT00097539|617646855|FG000|Overall Study|Participant Non-compliant|2140|||
170902682|NCT00097539|617646856|FG001|Overall Study|Participant Non-compliant|567|||
170902683|NCT00097539|617646857|FG002|Overall Study|Participant Non-compliant|1067|||
170902684|NCT00097539|617646858|FG003|Overall Study|Participant Non-compliant|353|||
170902685|NCT00097539|617646859|FG004|Overall Study|Participant Non-compliant|136|||
170902686|NCT00097539|617646860|FG005|Overall Study|Participant Non-compliant|543|||
170902687|NCT00097539|617646861|FG006|Overall Study|Participant Non-compliant|18|||
170902688|NCT00097539|617646855|FG000|Overall Study|Lack of Efficacy|249|||
170902689|NCT00097539|617646856|FG001|Overall Study|Lack of Efficacy|122|||
170902690|NCT00097539|617646857|FG002|Overall Study|Lack of Efficacy|202|||
170902691|NCT00097539|617646858|FG003|Overall Study|Lack of Efficacy|105|||
170902692|NCT00097539|617646859|FG004|Overall Study|Lack of Efficacy|45|||
170902693|NCT00097539|617646860|FG005|Overall Study|Lack of Efficacy|228|||
170902694|NCT00097539|617646861|FG006|Overall Study|Lack of Efficacy|5|||
170902695|NCT00097539|617646855|FG000|Overall Study|Adverse Event|78|||
170902696|NCT00097539|617646856|FG001|Overall Study|Adverse Event|133|||
170902697|NCT00097539|617646857|FG002|Overall Study|Adverse Event|37|||
170902698|NCT00097539|617646858|FG003|Overall Study|Adverse Event|27|||
170902699|NCT00097539|617646859|FG004|Overall Study|Adverse Event|30|||
170902700|NCT00097539|617646860|FG005|Overall Study|Adverse Event|59|||
170902701|NCT00097539|617646861|FG006|Overall Study|Adverse Event|1|||
170902702|NCT00097539|617646855|FG000|Overall Study|Death|2|||
170902703|NCT00097539|617646856|FG001|Overall Study|Death|7|||
170902704|NCT00097539|617646857|FG002|Overall Study|Death|0|||
170902705|NCT00097539|617646858|FG003|Overall Study|Death|0|||
170902706|NCT00097539|617646859|FG004|Overall Study|Death|1|||
170902707|NCT00097539|617646860|FG005|Overall Study|Death|3|||
170902708|NCT00097539|617646861|FG006|Overall Study|Death|0|||
170902709|NCT00097539|617646855|FG000|Overall Study|Reasons Other Than Above|3602|||
170902710|NCT00097539|617646856|FG001|Overall Study|Reasons Other Than Above|1382|||
170902711|NCT00097539|617646857|FG002|Overall Study|Reasons Other Than Above|1757|||
170902712|NCT00097539|617646858|FG003|Overall Study|Reasons Other Than Above|692|||
170902713|NCT00097539|617646859|FG004|Overall Study|Reasons Other Than Above|361|||
170902714|NCT00097539|617646860|FG005|Overall Study|Reasons Other Than Above|1244|||
170902715|NCT00097539|617646861|FG006|Overall Study|Reasons Other Than Above|34|||
170902716|NCT00097539|617646855|FG000|Overall Study|Reason not Specified|111|||
170902717|NCT00097539|617646856|FG001|Overall Study|Reason not Specified|49|||
170902718|NCT00097539|617646857|FG002|Overall Study|Reason not Specified|53|||
170902719|NCT00097539|617646858|FG003|Overall Study|Reason not Specified|21|||
170902720|NCT00097539|617646859|FG004|Overall Study|Reason not Specified|11|||
170902721|NCT00097539|617646860|FG005|Overall Study|Reason not Specified|40|||
170902722|NCT00097539|617646861|FG006|Overall Study|Reason not Specified|2|||
170902723|NCT04938648|617646862|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
170902724|NCT04938648|617646863|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
170902725|NCT04938648|617646862|FG000|Overall Study|Patient too ill|0|||
170902726|NCT04938648|617646863|FG001|Overall Study|Patient too ill|1|||
170902727|NCT04938648|617646862|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
170902728|NCT04938648|617646863|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
170902729|NCT04938648|617646862|FG000|Overall Study|Patient did not have memory problems|1|||
170902730|NCT04938648|617646863|FG001|Overall Study|Patient did not have memory problems|1|||
170902731|NCT04938648|617646862|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
170902732|NCT04938648|617646863|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
170902733|NCT04938648|617646862|FG000|Overall Study|Care partner could not be reached|0|||
170902734|NCT04938648|617646863|FG001|Overall Study|Care partner could not be reached|1|||
170902735|NCT04938648|617646862|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
170902736|NCT04938648|617646863|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
170497724|NCT03891862|616160670|FG002|Open-label Period|Withdrawal by Subject|0|||
170902737|NCT04938648|617646862|FG000|Overall Study|Withdrawal by Subject|2|||
170902738|NCT04938648|617646863|FG001|Overall Study|Withdrawal by Subject|1|||
170902739|NCT02966314|617646864|FG000|Overall Study|Lost to Follow-up|1|||
170902740|NCT02966314|617646865|FG001|Overall Study|Lost to Follow-up|0|||
170902741|NCT00049127|617646866|FG000|Overall Study|Withdrawal by Subject|0|||
170902742|NCT00049127|617646867|FG001|Overall Study|Withdrawal by Subject|0|||
170902743|NCT00049127|617646868|FG002|Overall Study|Withdrawal by Subject|1|||
170902744|NCT00049127|617646869|FG003|Overall Study|Withdrawal by Subject|0|||
170902745|NCT00049127|617646870|FG004|Overall Study|Withdrawal by Subject|0|||
170902746|NCT03093402|617646871|FG000|Overall Study|Lost to Follow-up|1|||
170902747|NCT03093402|617646872|FG001|Overall Study|Lost to Follow-up|0|||
170902748|NCT03093402|617646873|FG002|Overall Study|Lost to Follow-up|0|||
170902749|NCT03093402|617646874|FG003|Overall Study|Lost to Follow-up|0|||
170497725|NCT03891862|616160668|FG000|Open-label Period|Death|1|||
170497726|NCT03891862|616160669|FG001|Open-label Period|Death|0|||
170497727|NCT03891862|616160670|FG002|Open-label Period|Death|0|||
170497728|NCT03891862|616160668|FG000|Open-label Period|Lost to Follow-up|2|||
170497729|NCT03891862|616160669|FG001|Open-label Period|Lost to Follow-up|0|||
170497730|NCT03891862|616160670|FG002|Open-label Period|Lost to Follow-up|0|||
170497731|NCT03891862|616160668|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
170497732|NCT03891862|616160669|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
170497733|NCT03891862|616160670|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
170497734|NCT03891862|616160668|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
170497735|NCT03891862|616160669|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
170497736|NCT03891862|616160670|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
170497737|NCT03891862|616160668|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
170497738|NCT03891862|616160669|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
170497739|NCT03891862|616160670|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
170497740|NCT03891862|616160668|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
170497741|NCT03891862|616160669|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
170497742|NCT03891862|616160670|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
170497743|NCT01194531|616160672|FG000|Overall Study|Withdrawal by Subject|1|||
170497744|NCT01194531|616160673|FG001|Overall Study|Withdrawal by Subject|0|||
170497745|NCT01194531|616160672|FG000|Overall Study|Protocol Violation|4|||
170497746|NCT01194531|616160673|FG001|Overall Study|Protocol Violation|1|||
170497747|NCT01194531|616160672|FG000|Overall Study|Physician Decision|0|||
170497748|NCT01194531|616160673|FG001|Overall Study|Physician Decision|2|||
170497749|NCT02474589|616160676|FG000|Overall Study|Adverse Event|6|||
170497750|NCT02474589|616160677|FG001|Overall Study|Adverse Event|2|||
170497751|NCT02474589|616160676|FG000|Overall Study|Lost to Follow-up|6|||
170497752|NCT02474589|616160677|FG001|Overall Study|Lost to Follow-up|1|||
170497753|NCT02474589|616160676|FG000|Overall Study|Protocol Violation|4|||
170497754|NCT02474589|616160677|FG001|Overall Study|Protocol Violation|1|||
170497755|NCT02474589|616160676|FG000|Overall Study|Withdrawal by Subject|4|||
170497756|NCT02474589|616160677|FG001|Overall Study|Withdrawal by Subject|0|||
170497757|NCT02474589|616160676|FG000|Overall Study|Inability to complete study procedures|5|||
170497758|NCT02474589|616160677|FG001|Overall Study|Inability to complete study procedures|1|||
170497759|NCT02447497|616160678|FG000|Overall Study|Did not meet treatment day baseline.|6|||
170497760|NCT02447497|616160679|FG001|Overall Study|Did not meet treatment day baseline.|5|||
170497761|NCT02447497|616160680|FG002|Overall Study|Did not meet treatment day baseline.|2|||
170804263|NCT03002194|617293574|FG000|Overall Study|Lack of Efficacy|1|||
170804264|NCT03002194|617293574|FG000|Overall Study|Withdrawal by Subject|2|||
170804265|NCT02200705|617293575|FG000|Overall Study|Excluded|12|||
170804266|NCT02200705|617293575|FG000|Overall Study|Death|21|||
170804267|NCT02200705|617293575|FG000|Overall Study|Withdrawal by Subject|22|||
170804268|NCT02200705|617293575|FG000|Overall Study|Lost to Follow-up|13|||
170804269|NCT02200705|617293575|FG000|Overall Study|Physician Decision|5|||
170804270|NCT02200705|617293575|FG000|Overall Study|Adverse Event|2|||
170804271|NCT01278030|617293576|FG000|Overall Study|Withdrawal by Subject|8|||
170804272|NCT01278030|617293577|FG001|Overall Study|Withdrawal by Subject|4|||
170804273|NCT00731692|617293578|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
170804274|NCT00731692|617293579|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
170804275|NCT00731692|617293580|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
170804276|NCT00731692|617293578|FG000|Core Study (36 Months)|Physician Decision|1|||
170804277|NCT00731692|617293579|FG001|Core Study (36 Months)|Physician Decision|0|||
170804278|NCT00731692|617293580|FG002|Core Study (36 Months)|Physician Decision|2|||
170804279|NCT00731692|617293578|FG000|Core Study (36 Months)|Death|2|||
170804280|NCT00731692|617293579|FG001|Core Study (36 Months)|Death|1|||
170804281|NCT00731692|617293580|FG002|Core Study (36 Months)|Death|2|||
170804282|NCT00731692|617293578|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
170804283|NCT00731692|617293579|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
170804284|NCT00731692|617293580|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
170804285|NCT00731692|617293578|FG000|Core Study (36 Months)|Administrative|2|||
170804286|NCT00731692|617293579|FG001|Core Study (36 Months)|Administrative|2|||
170804287|NCT00731692|617293580|FG002|Core Study (36 Months)|Administrative|6|||
170804288|NCT00731692|617293578|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
170804289|NCT00731692|617293579|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
170804290|NCT00731692|617293580|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
170804291|NCT00731692|617293578|FG000|Core Study (36 Months)|Protocol Violation|4|||
170804292|NCT00731692|617293579|FG001|Core Study (36 Months)|Protocol Violation|5|||
170804293|NCT00731692|617293580|FG002|Core Study (36 Months)|Protocol Violation|8|||
170804294|NCT00731692|617293578|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
170804295|NCT00731692|617293579|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
170804296|NCT00731692|617293580|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
170804297|NCT00731692|617293578|FG000|Core Study (36 Months)|Adverse Event|25|||
170497762|NCT02447497|616160681|FG003|Overall Study|Did not meet treatment day baseline.|2|||
170497763|NCT02447497|616160678|FG000|Overall Study|Dressing was compromised|0|||
170497764|NCT02447497|616160679|FG001|Overall Study|Dressing was compromised|1|||
170497765|NCT02447497|616160680|FG002|Overall Study|Dressing was compromised|0|||
170497766|NCT02447497|616160681|FG003|Overall Study|Dressing was compromised|0|||
170497767|NCT00985959|616160693|FG000|Overall Study|Adverse Event|0|||
170497768|NCT00985959|616160694|FG001|Overall Study|Adverse Event|0|||
170497769|NCT00985959|616160695|FG002|Overall Study|Adverse Event|19|||
170497770|NCT00985959|616160693|FG000|Overall Study|Withdrawal by Subject|0|||
170497771|NCT00985959|616160694|FG001|Overall Study|Withdrawal by Subject|0|||
170497772|NCT00985959|616160695|FG002|Overall Study|Withdrawal by Subject|8|||
170497773|NCT00985959|616160693|FG000|Overall Study|Progressive disease|1|||
170497774|NCT00985959|616160694|FG001|Overall Study|Progressive disease|2|||
170497775|NCT00985959|616160695|FG002|Overall Study|Progressive disease|8|||
170497776|NCT00985959|616160693|FG000|Overall Study|Unrecovered toxicity|0|||
170497777|NCT00985959|616160694|FG001|Overall Study|Unrecovered toxicity|0|||
170497778|NCT00985959|616160695|FG002|Overall Study|Unrecovered toxicity|7|||
170497779|NCT00985959|616160693|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
170497780|NCT00985959|616160694|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
170497781|NCT00985959|616160695|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
170497782|NCT00985959|616160693|FG000|Overall Study|Complete response observed over 2 cycles|0|||
170497783|NCT00985959|616160694|FG001|Overall Study|Complete response observed over 2 cycles|1|||
170497784|NCT00985959|616160695|FG002|Overall Study|Complete response observed over 2 cycles|4|||
170497785|NCT00985959|616160693|FG000|Overall Study|Other|0|||
170551464|NCT00806026|616364788|FG002|Overall Study|Adverse Event|44|||
170804298|NCT00731692|617293579|FG001|Core Study (36 Months)|Adverse Event|28|||
170804299|NCT00731692|617293580|FG002|Core Study (36 Months)|Adverse Event|29|||
170804300|NCT00731692|617293578|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
170804301|NCT00731692|617293579|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
170804302|NCT00731692|617293580|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
170804303|NCT00731692|617293578|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
170804304|NCT00731692|617293579|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
170804305|NCT00731692|617293580|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
170804306|NCT00731692|617293578|FG000|Extension Phase|Abnormal test procedure|0|||
170804307|NCT00731692|617293579|FG001|Extension Phase|Abnormal test procedure|0|||
170804308|NCT00731692|617293580|FG002|Extension Phase|Abnormal test procedure|1|||
170804309|NCT00731692|617293578|FG000|Extension Phase|Abnormal lab values|0|||
170804310|NCT00731692|617293579|FG001|Extension Phase|Abnormal lab values|0|||
170804311|NCT00731692|617293580|FG002|Extension Phase|Abnormal lab values|1|||
170804312|NCT00731692|617293578|FG000|Extension Phase|Lost to Follow-up|0|||
170804313|NCT00731692|617293579|FG001|Extension Phase|Lost to Follow-up|1|||
170804314|NCT00731692|617293580|FG002|Extension Phase|Lost to Follow-up|4|||
170804315|NCT00731692|617293578|FG000|Extension Phase|Withdrawal by Subject|4|||
170804316|NCT00731692|617293579|FG001|Extension Phase|Withdrawal by Subject|5|||
170804317|NCT00731692|617293580|FG002|Extension Phase|Withdrawal by Subject|3|||
170804318|NCT00731692|617293578|FG000|Extension Phase|Adverse Event|1|||
170804319|NCT00731692|617293579|FG001|Extension Phase|Adverse Event|1|||
170804320|NCT00731692|617293580|FG002|Extension Phase|Adverse Event|15|||
170804321|NCT00458783|617293581|FG000|Overall Study|Protocol Violation|1228|||
170804322|NCT00458783|617293582|FG001|Overall Study|Protocol Violation|1220|||
170804323|NCT03116464|617293584|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
170804324|NCT02568215|617293585|FG000|Overall Study|Death|1|||
170804325|NCT02568215|617293586|FG001|Overall Study|Death|2|||
170804326|NCT02568215|617293587|FG002|Overall Study|Death|0|||
170804327|NCT02568215|617293585|FG000|Overall Study|Physician Decision|2|||
170804328|NCT02568215|617293586|FG001|Overall Study|Physician Decision|2|||
170804329|NCT02568215|617293587|FG002|Overall Study|Physician Decision|2|||
170804330|NCT02568215|617293585|FG000|Overall Study|Lost to Follow-up|29|||
170804331|NCT02568215|617293586|FG001|Overall Study|Lost to Follow-up|32|||
170804332|NCT02568215|617293587|FG002|Overall Study|Lost to Follow-up|41|||
170804333|NCT02568215|617293585|FG000|Overall Study|Withdrawal by Subject|21|||
170804334|NCT02568215|617293586|FG001|Overall Study|Withdrawal by Subject|19|||
170804335|NCT02568215|617293587|FG002|Overall Study|Withdrawal by Subject|22|||
170804336|NCT02568215|617293585|FG000|Overall Study|Protocol Violation|1|||
170902750|NCT03093402|617646871|FG000|Overall Study|Withdrawal by Subject|3|||
170902751|NCT03093402|617646872|FG001|Overall Study|Withdrawal by Subject|3|||
170902752|NCT03093402|617646873|FG002|Overall Study|Withdrawal by Subject|0|||
170902753|NCT03093402|617646874|FG003|Overall Study|Withdrawal by Subject|1|||
170902754|NCT03093402|617646871|FG000|Overall Study|Withdrew prior to dosing|2|||
170902755|NCT03093402|617646872|FG001|Overall Study|Withdrew prior to dosing|1|||
170902756|NCT03093402|617646873|FG002|Overall Study|Withdrew prior to dosing|2|||
170902757|NCT03093402|617646874|FG003|Overall Study|Withdrew prior to dosing|3|||
170902758|NCT03093402|617646871|FG000|Overall Study|Ineligible for study|1|||
170902759|NCT03093402|617646872|FG001|Overall Study|Ineligible for study|0|||
170902760|NCT03093402|617646873|FG002|Overall Study|Ineligible for study|0|||
170497786|NCT00985959|616160694|FG001|Overall Study|Other|0|||
170497787|NCT00985959|616160695|FG002|Overall Study|Other|11|||
170497788|NCT00979420|616160696|FG000|Overall Study|Adverse Event|1|||
170497789|NCT00979420|616160697|FG001|Overall Study|Adverse Event|0|||
170497790|NCT00979420|616160698|FG002|Overall Study|Adverse Event|0|||
170497791|NCT00979420|616160699|FG003|Overall Study|Adverse Event|0|||
170497792|NCT00979420|616160696|FG000|Overall Study|Lack of Efficacy|3|||
170497793|NCT00979420|616160697|FG001|Overall Study|Lack of Efficacy|0|||
170497794|NCT00979420|616160698|FG002|Overall Study|Lack of Efficacy|1|||
170497795|NCT00979420|616160699|FG003|Overall Study|Lack of Efficacy|1|||
170497796|NCT00979420|616160696|FG000|Overall Study|Other reasons not related to Viramune|3|||
170497797|NCT00979420|616160697|FG001|Overall Study|Other reasons not related to Viramune|0|||
170497798|NCT00979420|616160698|FG002|Overall Study|Other reasons not related to Viramune|0|||
170497799|NCT00979420|616160699|FG003|Overall Study|Other reasons not related to Viramune|1|||
170497800|NCT01054196|616160701|FG000|Overall Study|Physician Decision|0|||
170497801|NCT01054196|616160702|FG001|Overall Study|Physician Decision|0|||
170497802|NCT01054196|616160703|FG002|Overall Study|Physician Decision|0|||
170497803|NCT01054196|616160704|FG003|Overall Study|Physician Decision|1|||
170497804|NCT01054196|616160705|FG004|Overall Study|Physician Decision|0|||
170497805|NCT01054196|616160706|FG005|Overall Study|Physician Decision|0|||
170497806|NCT01054196|616160707|FG006|Overall Study|Physician Decision|1|||
170497807|NCT02235077|616160708|FG000|Overall Study|Death|5|||
170497808|NCT02235077|616160709|FG001|Overall Study|Death|7|||
170497809|NCT02235077|616160708|FG000|Overall Study|Lost to Follow-up|5|||
170497810|NCT02235077|616160709|FG001|Overall Study|Lost to Follow-up|6|||
170497811|NCT02235077|616160708|FG000|Overall Study|Withdrawal by Subject|8|||
170497812|NCT02235077|616160709|FG001|Overall Study|Withdrawal by Subject|5|||
170497813|NCT02235077|616160708|FG000|Overall Study|Physician Decision|0|||
170497814|NCT02235077|616160709|FG001|Overall Study|Physician Decision|1|||
170497815|NCT04013672|616160710|FG000|Overall Study|Withdrawal by Subject|3|||
170497816|NCT04013672|616160711|FG001|Overall Study|Withdrawal by Subject|0|||
170497817|NCT04013672|616160710|FG000|Overall Study|Death|1|||
170497818|NCT04013672|616160711|FG001|Overall Study|Death|0|||
170497819|NCT04013672|616160710|FG000|Overall Study|Physician Decision|5|||
170497820|NCT04013672|616160711|FG001|Overall Study|Physician Decision|0|||
170497821|NCT02847494|616160712|FG000|Overall Study|Lost to Follow-up|8|||
170551465|NCT00806026|616364789|FG003|Overall Study|Adverse Event|17|||
170551466|NCT00806026|616364790|FG004|Overall Study|Adverse Event|9|||
170804337|NCT02568215|617293586|FG001|Overall Study|Protocol Violation|1|||
170804338|NCT02568215|617293587|FG002|Overall Study|Protocol Violation|0|||
170804339|NCT02568215|617293585|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
170804340|NCT02568215|617293586|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
170804341|NCT02568215|617293587|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
170804342|NCT02568215|617293585|FG000|Overall Study|Other|0|||
170804343|NCT02568215|617293586|FG001|Overall Study|Other|1|||
170804344|NCT02568215|617293587|FG002|Overall Study|Other|4|||
170804345|NCT00019604|617293588|FG000|Overall Study|Death|1|||
170804346|NCT00019604|617293588|FG000|Overall Study|Progressive disease|23|||
170804347|NCT00019604|617293588|FG000|Overall Study|Refused treatment|1|||
170804348|NCT00019604|617293588|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
170804349|NCT00019604|617293588|FG000|Overall Study|Going to have liver transplant|1|||
170804350|NCT00019604|617293588|FG000|Overall Study|Move to a different study|1|||
170804351|NCT00019604|617293588|FG000|Overall Study|Non compliant on systemic CH|1|||
170804352|NCT00019604|617293588|FG000|Overall Study|Non compliant|1|||
170804353|NCT00019604|617293588|FG000|Overall Study|Resectable disease|1|||
170804354|NCT00019604|617293588|FG000|Overall Study|Started new chemo regimen|1|||
170804355|NCT00019604|617293588|FG000|Overall Study|Pt going to immunotherapy study|1|||
170804356|NCT00019604|617293588|FG000|Overall Study|Too much disease|1|||
170804357|NCT00019604|617293588|FG000|Overall Study|Unable to evaluate|1|||
170804358|NCT00019604|617293588|FG000|Overall Study|Details for other not available|4|||
170804359|NCT04497415|617293592|FG000|Overall Study|Lost to Follow-up|43|||
170804360|NCT04497415|617293593|FG001|Overall Study|Lost to Follow-up|27|||
170804361|NCT00620854|617293594|FG000|Washout 1|Withdrawal by Subject|0|||
170804362|NCT00620854|617293595|FG001|Washout 1|Withdrawal by Subject|0|||
170804363|NCT00620854|617293596|FG002|Washout 1|Withdrawal by Subject|1|||
170804364|NCT00620854|617293597|FG003|Washout 1|Withdrawal by Subject|1|||
170804365|NCT00620854|617293598|FG004|Washout 1|Withdrawal by Subject|0|||
170804366|NCT00620854|617293599|FG005|Washout 1|Withdrawal by Subject|0|||
170497822|NCT02847494|616160713|FG001|Overall Study|Lost to Follow-up|5|||
170497823|NCT00767455|616160717|FG000|Overall Study|Investigator error|19|||
170497824|NCT00022698|616160720|FG000|Overall Study|Adverse Event|5|||
170551467|NCT00806026|616364791|FG005|Overall Study|Adverse Event|9|||
170804367|NCT04545619|617293603|FG000|Overall Study|due to equipment challenges|1|||
170804368|NCT02157116|617293611|FG000|Overall Study|Withdrawal by Subject|4|||
170497825|NCT00022698|616160721|FG001|Overall Study|Adverse Event|9|||
170497826|NCT00022698|616160720|FG000|Overall Study|Death|0|||
170497827|NCT00022698|616160721|FG001|Overall Study|Death|2|||
170497828|NCT00022698|616160720|FG000|Overall Study|Failure to return|0|||
170497829|NCT00022698|616160721|FG001|Overall Study|Failure to return|1|||
170497830|NCT00022698|616160720|FG000|Overall Study|Refused treatment|0|||
170497831|NCT00022698|616160721|FG001|Overall Study|Refused treatment|2|||
170497832|NCT00022698|616160720|FG000|Overall Study|Insufficient therapeutic response|2|||
170497833|NCT00022698|616160721|FG001|Overall Study|Insufficient therapeutic response|14|||
170497834|NCT00022698|616160720|FG000|Overall Study|Administrative /other|1|||
170497835|NCT00022698|616160721|FG001|Overall Study|Administrative /other|7|||
170642405|NCT03899805|616705234|FG000|Overall Study|Withdrawal by Subject|1|||
170642406|NCT03899805|616705235|FG001|Overall Study|Withdrawal by Subject|0|||
170642407|NCT03899805|616705236|FG002|Overall Study|Withdrawal by Subject|2|||
170642408|NCT03899805|616705234|FG000|Overall Study|Progressive Disease|10|||
170642409|NCT03899805|616705235|FG001|Overall Study|Progressive Disease|18|||
170642410|NCT03899805|616705236|FG002|Overall Study|Progressive Disease|12|||
170642411|NCT03899805|616705234|FG000|Overall Study|Adverse Event|3|||
170642412|NCT03899805|616705235|FG001|Overall Study|Adverse Event|1|||
170642413|NCT03899805|616705236|FG002|Overall Study|Adverse Event|0|||
170642414|NCT03899805|616705234|FG000|Overall Study|Death|2|||
170642415|NCT03899805|616705235|FG001|Overall Study|Death|0|||
170642416|NCT03899805|616705236|FG002|Overall Study|Death|0|||
170902761|NCT03093402|617646874|FG003|Overall Study|Ineligible for study|0|||
170902762|NCT03093402|617646871|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
170902763|NCT03093402|617646872|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
170902764|NCT03093402|617646873|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
170902765|NCT03093402|617646874|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
170902766|NCT02731742|617646879|FG000|Overall Study|Death|1|||
170902767|NCT02731742|617646880|FG001|Overall Study|Death|2|||
170902768|NCT02731742|617646881|FG002|Overall Study|Death|5|||
170902769|NCT02731742|617646882|FG003|Overall Study|Death|0|||
170902770|NCT02731742|617646879|FG000|Overall Study|Physician Decision|0|||
170902771|NCT02731742|617646880|FG001|Overall Study|Physician Decision|0|||
170902772|NCT02731742|617646881|FG002|Overall Study|Physician Decision|0|||
170902773|NCT02731742|617646882|FG003|Overall Study|Physician Decision|1|||
170902774|NCT02731742|617646879|FG000|Overall Study|Study Terminated by Sponsor|2|||
170902775|NCT02731742|617646880|FG001|Overall Study|Study Terminated by Sponsor|1|||
170902776|NCT02731742|617646881|FG002|Overall Study|Study Terminated by Sponsor|1|||
170902777|NCT02731742|617646882|FG003|Overall Study|Study Terminated by Sponsor|1|||
170902778|NCT04026568|617646883|FG000|Overall Study|study terminated|0|||
170902779|NCT04026568|617646884|FG001|Overall Study|study terminated|1|||
170902780|NCT02197377|617646887|FG000|Overall Study|Insertion Failure|0|||
170902781|NCT02197377|617646888|FG001|Overall Study|Insertion Failure|3|||
170902782|NCT01974323|617646889|FG000|Overall Study|Other Reasons|25|||
170902783|NCT01974323|617646890|FG001|Overall Study|Other Reasons|28|||
170902784|NCT01974323|617646889|FG000|Overall Study|Protocol Violation|2|||
170902785|NCT01974323|617646890|FG001|Overall Study|Protocol Violation|2|||
170902786|NCT01974323|617646889|FG000|Overall Study|Personal Reasons|15|||
170902787|NCT01974323|617646890|FG001|Overall Study|Personal Reasons|19|||
170902788|NCT01974323|617646889|FG000|Overall Study|Lost to Follow-up|45|||
170902789|NCT01974323|617646890|FG001|Overall Study|Lost to Follow-up|40|||
170902790|NCT01974323|617646889|FG000|Overall Study|Pregnancy|2|||
170642417|NCT03899805|616705234|FG000|Overall Study|Came off for surgery|0|||
170642418|NCT03899805|616705235|FG001|Overall Study|Came off for surgery|0|||
170804369|NCT02157116|617293611|FG000|Overall Study|Physician Decision|3|||
170804370|NCT02157116|617293611|FG000|Overall Study|Failed Screening|2|||
170804371|NCT02463448|617293612|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
170804372|NCT02463448|617293612|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
170804373|NCT02463448|617293612|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
170804374|NCT02463448|617293612|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
170804375|NCT00683800|617293614|FG000|Overall Study|Adverse Event|195|||
170804376|NCT00683800|617293615|FG001|Overall Study|Adverse Event|102|||
170804377|NCT00683800|617293614|FG000|Overall Study|Death|0|||
170804378|NCT00683800|617293615|FG001|Overall Study|Death|1|||
170804379|NCT00683800|617293614|FG000|Overall Study|Lost to Follow-up|57|||
170804380|NCT00683800|617293615|FG001|Overall Study|Lost to Follow-up|44|||
170804381|NCT00683800|617293614|FG000|Overall Study|Other|5|||
170804382|NCT00683800|617293615|FG001|Overall Study|Other|2|||
170804383|NCT00683800|617293614|FG000|Overall Study|Protocol Violation|13|||
170804384|NCT00683800|617293615|FG001|Overall Study|Protocol Violation|16|||
170804385|NCT00683800|617293614|FG000|Overall Study|Withdrawal by Subject|66|||
170804386|NCT00683800|617293615|FG001|Overall Study|Withdrawal by Subject|64|||
170804387|NCT00683800|617293614|FG000|Overall Study|Lack of Efficacy|61|||
170804388|NCT00683800|617293615|FG001|Overall Study|Lack of Efficacy|104|||
170804389|NCT00683800|617293614|FG000|Overall Study|Randomized, not treated|35|||
170804390|NCT00683800|617293615|FG001|Overall Study|Randomized, not treated|33|||
170902791|NCT01974323|617646890|FG001|Overall Study|Pregnancy|1|||
170902792|NCT01974323|617646889|FG000|Overall Study|Lack of Efficacy|1|||
170902793|NCT01974323|617646890|FG001|Overall Study|Lack of Efficacy|1|||
170902794|NCT01974323|617646889|FG000|Overall Study|Adverse Event|2|||
170902795|NCT01974323|617646890|FG001|Overall Study|Adverse Event|2|||
170902796|NCT00331760|617646891|FG000|Overall Study|Ineligible / no protocol treatment|15|||
170902797|NCT00331760|617646892|FG001|Overall Study|Ineligible / no protocol treatment|8|||
170902798|NCT00461175|617646893|FG000|Overall Study|Protocol Violation|522|||
170497836|NCT03386994|616160722|FG000|Overall Study|Lung transplant|1|||
170497837|NCT03386994|616160722|FG000|Overall Study|Adverse Event|14|||
170497838|NCT03386994|616160722|FG000|Overall Study|Lost to Follow-up|4|||
170497839|NCT03386994|616160722|FG000|Overall Study|Withdrawal by Subject|3|||
170497840|NCT03386994|616160722|FG000|Overall Study|Death|16|||
170497841|NCT05376241|616162748|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
170497842|NCT05376241|616162748|FG000|Overall Study|103 did not complete the survey|103|||
170497843|NCT05376241|616162748|FG000|Overall Study|17 failed 2 attention check questions|17|||
170497844|NCT04984681|616162749|FG000|Overall Study|Lost to Follow-up|3|||
170497845|NCT04984681|616162750|FG001|Overall Study|Lost to Follow-up|1|||
170497846|NCT02091960|616162751|FG000|Overall Study|Death|7|||
170902799|NCT00461175|617646894|FG001|Overall Study|Protocol Violation|365|||
170902800|NCT01773473|617646895|FG000|Overall Study|Adverse Event|3|||
170902801|NCT01773473|617646896|FG001|Overall Study|Adverse Event|2|||
170902802|NCT01773473|617646895|FG000|Overall Study|Protocol Violation|0|||
170902803|NCT01773473|617646896|FG001|Overall Study|Protocol Violation|4|||
170902804|NCT01773473|617646895|FG000|Overall Study|Physician Decision|3|||
170902805|NCT01773473|617646896|FG001|Overall Study|Physician Decision|5|||
170902806|NCT01773473|617646895|FG000|Overall Study|Sponsor Decision|2|||
170902807|NCT01773473|617646896|FG001|Overall Study|Sponsor Decision|0|||
170902808|NCT01773473|617646895|FG000|Overall Study|Lack of Efficacy|0|||
170902809|NCT01773473|617646896|FG001|Overall Study|Lack of Efficacy|1|||
170902810|NCT01773473|617646895|FG000|Overall Study|Non-Compliance with study drug|1|||
170902811|NCT01773473|617646896|FG001|Overall Study|Non-Compliance with study drug|4|||
170902812|NCT01773473|617646895|FG000|Overall Study|Withdrawal by Subject|5|||
170902813|NCT01773473|617646896|FG001|Overall Study|Withdrawal by Subject|3|||
170902814|NCT01773473|617646895|FG000|Overall Study|Lost to Follow-up|2|||
170902815|NCT01773473|617646896|FG001|Overall Study|Lost to Follow-up|0|||
170902816|NCT00826514|617646897|FG000|Overall Study|Adverse Event|1|||
170902817|NCT00826514|617646898|FG001|Overall Study|Adverse Event|1|||
170902818|NCT00826514|617646897|FG000|Overall Study|Lack of Efficacy|0|||
170497847|NCT02091960|616162751|FG000|Overall Study|Withdrawal by Subject|1|||
170497848|NCT02091960|616162751|FG000|Overall Study|Miscellaneous Reasons|37|||
170497849|NCT03728426|616162752|FG000|Overall Study|Death|3|||
170497850|NCT05139303|616162754|FG000|Overall Study|Lost to Follow-up|3|||
170497851|NCT05139303|616162755|FG001|Overall Study|Lost to Follow-up|0|||
170497852|NCT05139303|616162754|FG000|Overall Study|Adverse Event|1|||
170497853|NCT05139303|616162755|FG001|Overall Study|Adverse Event|0|||
170497854|NCT04720911|616162756|FG000|Overall Study|Withdrawal by Subject|0|||
170497855|NCT04720911|616162757|FG001|Overall Study|Withdrawal by Subject|1|||
170497856|NCT04720911|616162758|FG002|Overall Study|Withdrawal by Subject|0|||
170497857|NCT00761280|616162759|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
170497858|NCT00761280|616162760|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
170497859|NCT00761280|616162759|FG000|Randomization to First Dose|Sponsor decision|1|||
170497860|NCT00761280|616162760|FG001|Randomization to First Dose|Sponsor decision|0|||
170497861|NCT00761280|616162759|FG000|Randomization to First Dose|Other|1|||
170497862|NCT00761280|616162760|FG001|Randomization to First Dose|Other|0|||
170497863|NCT00761280|616162759|FG000|First Dose to End of Study|End of trial|5|||
170497864|NCT00761280|616162760|FG001|First Dose to End of Study|End of trial|5|||
170497865|NCT00761280|616162759|FG000|First Dose to End of Study|Progressive disease|5|||
170497866|NCT00761280|616162760|FG001|First Dose to End of Study|Progressive disease|3|||
170497867|NCT00761280|616162759|FG000|First Dose to End of Study|Sponsor decision|1|||
170497868|NCT00761280|616162760|FG001|First Dose to End of Study|Sponsor decision|2|||
170497869|NCT00761280|616162759|FG000|First Dose to End of Study|Death|1|||
170497870|NCT00761280|616162760|FG001|First Dose to End of Study|Death|0|||
170497871|NCT00761280|616162759|FG000|First Dose to End of Study|Lost to Follow-up|0|||
170497872|NCT00761280|616162760|FG001|First Dose to End of Study|Lost to Follow-up|1|||
170497873|NCT04533412|616162764|FG000|Overall Study|Withdrawal by Subject|1|||
170497874|NCT04533412|616162765|FG001|Overall Study|Withdrawal by Subject|1|||
170497875|NCT04533412|616162764|FG000|Overall Study|Lost to Follow-up|1|||
170497876|NCT04533412|616162765|FG001|Overall Study|Lost to Follow-up|4|||
170497877|NCT03261674|616162773|FG000|Overall Study|Lost to Follow-up|6|||
170497878|NCT03261674|616162774|FG001|Overall Study|Lost to Follow-up|7|||
170497879|NCT03261674|616162773|FG000|Overall Study|Protocol Violation|1|||
170497880|NCT03261674|616162774|FG001|Overall Study|Protocol Violation|4|||
170497881|NCT03261674|616162773|FG000|Overall Study|Withdrawal by Subject|1|||
170497882|NCT03261674|616162774|FG001|Overall Study|Withdrawal by Subject|4|||
170497883|NCT03261674|616162773|FG000|Overall Study|Physician Decision|1|||
170497884|NCT03261674|616162774|FG001|Overall Study|Physician Decision|0|||
170497885|NCT02045862|616162775|FG000|Overall Study|Death|0|||
170902819|NCT00826514|617646898|FG001|Overall Study|Lack of Efficacy|1|||
170902820|NCT00826514|617646897|FG000|Overall Study|Withdrawal by Subject|2|||
170902821|NCT00826514|617646898|FG001|Overall Study|Withdrawal by Subject|3|||
170902822|NCT01451645|617646899|FG000|Overall Study|Protocol Violation|1|||
170902823|NCT01451645|617646900|FG001|Overall Study|Protocol Violation|0|||
170497886|NCT02045862|616162776|FG001|Overall Study|Death|0|||
170497887|NCT02045862|616162777|FG002|Overall Study|Death|1|||
170497888|NCT02045862|616162775|FG000|Overall Study|Miscellaneous|5|||
170497889|NCT02045862|616162776|FG001|Overall Study|Miscellaneous|0|||
170497890|NCT02045862|616162777|FG002|Overall Study|Miscellaneous|8|||
170497891|NCT02045862|616162775|FG000|Overall Study|Withdrawal by Patient|18|||
170497892|NCT02045862|616162776|FG001|Overall Study|Withdrawal by Patient|27|||
170497893|NCT02045862|616162777|FG002|Overall Study|Withdrawal by Patient|57|||
170497894|NCT02045862|616162775|FG000|Overall Study|Protocol Violation|0|||
170497895|NCT02045862|616162776|FG001|Overall Study|Protocol Violation|0|||
170497896|NCT02045862|616162777|FG002|Overall Study|Protocol Violation|6|||
170497897|NCT02045862|616162775|FG000|Overall Study|Lack of Efficacy|8|||
170497898|NCT02045862|616162776|FG001|Overall Study|Lack of Efficacy|4|||
170497899|NCT02045862|616162777|FG002|Overall Study|Lack of Efficacy|13|||
170497900|NCT02045862|616162775|FG000|Overall Study|Randomized but not Received Study Drug|0|||
170497901|NCT02045862|616162776|FG001|Overall Study|Randomized but not Received Study Drug|2|||
170497902|NCT02045862|616162777|FG002|Overall Study|Randomized but not Received Study Drug|8|||
170497903|NCT02045862|616162775|FG000|Overall Study|Adverse Event|7|||
170497904|NCT02045862|616162776|FG001|Overall Study|Adverse Event|5|||
170497905|NCT02045862|616162777|FG002|Overall Study|Adverse Event|27|||
170902824|NCT01451645|617646899|FG000|Overall Study|Adverse Event|0|||
170902825|NCT01451645|617646900|FG001|Overall Study|Adverse Event|3|||
170902826|NCT01451645|617646899|FG000|Overall Study|Withdrawal by Subject|4|||
170902827|NCT01451645|617646900|FG001|Overall Study|Withdrawal by Subject|2|||
170902828|NCT01451645|617646899|FG000|Overall Study|Lost to Follow-up|4|||
170902829|NCT01451645|617646900|FG001|Overall Study|Lost to Follow-up|3|||
170902830|NCT03663166|617646901|FG000|Overall Study|Withdrawal by Subject|1|||
170497906|NCT02045862|616162775|FG000|Overall Study|Lost to Follow-up|1|||
170497907|NCT02045862|616162776|FG001|Overall Study|Lost to Follow-up|2|||
170497908|NCT02045862|616162777|FG002|Overall Study|Lost to Follow-up|6|||
170497909|NCT02353442|616162782|FG000|Overall Study|Withdrawal by Subject|3|||
170497910|NCT02353442|616162783|FG001|Overall Study|Withdrawal by Subject|4|||
170497911|NCT01075646|616162784|FG000|Overall Study|Lost to Follow-up|4|||
170497912|NCT01075646|616162785|FG001|Overall Study|Lost to Follow-up|3|||
170497913|NCT01075646|616162786|FG002|Overall Study|Lost to Follow-up|1|||
170497914|NCT01075646|616162787|FG003|Overall Study|Lost to Follow-up|2|||
170497915|NCT02004886|616162791|FG000|Overall Study|Adverse Event|0|||
170497916|NCT02004886|616162792|FG001|Overall Study|Adverse Event|1|||
170497917|NCT02004886|616162793|FG002|Overall Study|Adverse Event|0|||
170497918|NCT02004886|616162794|FG003|Overall Study|Adverse Event|0|||
170497919|NCT02004886|616162791|FG000|Overall Study|Unable to attend future visits|1|||
170497920|NCT02004886|616162792|FG001|Overall Study|Unable to attend future visits|0|||
170497921|NCT02004886|616162793|FG002|Overall Study|Unable to attend future visits|0|||
170497922|NCT02004886|616162794|FG003|Overall Study|Unable to attend future visits|0|||
170497923|NCT01895608|616162796|FG000|Overall Study|change in health status|0|||
170497924|NCT01895608|616162797|FG001|Overall Study|change in health status|1|||
170497925|NCT01895608|616162798|FG002|Overall Study|change in health status|1|||
170497926|NCT01895608|616162799|FG003|Overall Study|change in health status|0|||
170497927|NCT01895608|616162796|FG000|Overall Study|Withdrawal by Subject|0|||
170497928|NCT01895608|616162797|FG001|Overall Study|Withdrawal by Subject|0|||
170497929|NCT01895608|616162798|FG002|Overall Study|Withdrawal by Subject|2|||
170497930|NCT01895608|616162799|FG003|Overall Study|Withdrawal by Subject|0|||
170497931|NCT02822573|616162801|FG000|Overall Study|Lost to Follow-up|5|||
170497932|NCT02822573|616162802|FG001|Overall Study|Lost to Follow-up|3|||
170497933|NCT02822573|616162801|FG000|Overall Study|Physician Decision|1|||
170497934|NCT02822573|616162802|FG001|Overall Study|Physician Decision|1|||
170902831|NCT01241786|617646909|FG000|Overall Study|Lack of Efficacy|5|||
170902832|NCT03751111|617646910|FG000|Overall Study|Lack of Efficacy|9|||
170902833|NCT03751111|617646911|FG001|Overall Study|Lack of Efficacy|30|||
170902834|NCT03751111|617646910|FG000|Overall Study|Adverse Event|3|||
170497935|NCT02822573|616162801|FG000|Overall Study|Withdrawal by Subject|9|||
170497936|NCT02822573|616162802|FG001|Overall Study|Withdrawal by Subject|5|||
170497937|NCT02822573|616162801|FG000|Overall Study|Protocol Violation|6|||
170497938|NCT02822573|616162802|FG001|Overall Study|Protocol Violation|4|||
170497939|NCT02822573|616162801|FG000|Overall Study|Too sick or ill|2|||
170497940|NCT02822573|616162802|FG001|Overall Study|Too sick or ill|1|||
170497941|NCT02822573|616162801|FG000|Overall Study|Disease Progression|1|||
170497942|NCT02822573|616162802|FG001|Overall Study|Disease Progression|1|||
170497943|NCT02822573|616162801|FG000|Overall Study|No reason given|6|||
170497944|NCT02822573|616162802|FG001|Overall Study|No reason given|4|||
170497945|NCT05239494|616162803|FG000|Overall Study|Lost to Follow-up|1|||
170497946|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Adverse Event|6|||
170497947|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Adverse Event|14|||
170497948|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Death|3|||
170497949|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Death|1|||
170902835|NCT03751111|617646911|FG001|Overall Study|Adverse Event|2|||
170902836|NCT01276288|617646912|FG000|Overall Study|Adverse Event|1|||
170902837|NCT01276288|617646913|FG001|Overall Study|Adverse Event|1|||
170497950|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
170497951|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
170497952|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
170497953|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
170497954|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
170497955|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
170497956|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
170497957|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
170497958|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
170497959|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
170497960|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Physician Decision|2|||
170497961|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Physician Decision|4|||
170497962|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Pregnancy|2|||
170497963|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Pregnancy|1|||
170497964|NCT02275780|616162804|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
170497965|NCT02275780|616162805|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
170497966|NCT02275780|616162804|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
170497967|NCT02275780|616162805|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
170497968|NCT02275780|616162804|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
170497969|NCT02275780|616162805|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
170497970|NCT02275780|616162804|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
170497971|NCT02275780|616162805|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
170804391|NCT00205179|617293618|FG000|Overall Study|Death|0|||
170804392|NCT00205179|617293619|FG001|Overall Study|Death|2|||
170804393|NCT00205179|617293618|FG000|Overall Study|Physician Decision|1|||
170804394|NCT00205179|617293619|FG001|Overall Study|Physician Decision|1|||
170804395|NCT00205179|617293618|FG000|Overall Study|Adverse Event|1|||
170804396|NCT00205179|617293619|FG001|Overall Study|Adverse Event|1|||
170804397|NCT00463229|617293622|FG000|Overall Study|Lost to Follow-up|5|||
170804398|NCT00463229|617293623|FG001|Overall Study|Lost to Follow-up|7|||
170804399|NCT00463229|617293622|FG000|Overall Study|Death|4|||
170804400|NCT00463229|617293623|FG001|Overall Study|Death|3|||
170804401|NCT04949542|617293624|FG000|Overall Study|Lost to Follow-up|4|||
170804402|NCT04949542|617293625|FG001|Overall Study|Lost to Follow-up|1|||
170804403|NCT00388726|617293626|FG000|Overall Study|Adverse Event|50|||
170804404|NCT00388726|617293627|FG001|Overall Study|Adverse Event|24|||
170804405|NCT00388726|617293626|FG000|Overall Study|Progressive Disease|336|||
170804406|NCT00388726|617293627|FG001|Overall Study|Progressive Disease|153|||
170804407|NCT00388726|617293626|FG000|Overall Study|Clinical Progression|61|||
170804408|NCT00388726|617293627|FG001|Overall Study|Clinical Progression|36|||
170804409|NCT00388726|617293626|FG000|Overall Study|Withdrawal by Subject|10|||
170804410|NCT00388726|617293627|FG001|Overall Study|Withdrawal by Subject|7|||
170804411|NCT00388726|617293626|FG000|Overall Study|Administrative|6|||
170804412|NCT00388726|617293627|FG001|Overall Study|Administrative|9|||
170804413|NCT00388726|617293626|FG000|Overall Study|Physician Decision|18|||
170804414|NCT00388726|617293627|FG001|Overall Study|Physician Decision|13|||
170804415|NCT00388726|617293626|FG000|Overall Study|Death|3|||
170804416|NCT00388726|617293627|FG001|Overall Study|Death|2|||
170804417|NCT02078648|617293629|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
170902838|NCT01276288|617646914|FG002|Overall Study|Adverse Event|0|||
170902839|NCT01276288|617646915|FG003|Overall Study|Adverse Event|0|||
170902840|NCT01276288|617646912|FG000|Overall Study|not treated|1|||
170902841|NCT01276288|617646913|FG001|Overall Study|not treated|0|||
170902842|NCT01276288|617646914|FG002|Overall Study|not treated|0|||
170902843|NCT01276288|617646915|FG003|Overall Study|not treated|0|||
170902844|NCT02537678|617646916|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
170902845|NCT02537678|617646917|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
170902846|NCT02537678|617646916|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
170902847|NCT02537678|617646917|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
170902848|NCT02537678|617646916|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
170902849|NCT02537678|617646917|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
170902850|NCT02537678|617646916|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
170902851|NCT02537678|617646917|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
170902852|NCT02537678|617646916|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
170497972|NCT02275780|616162804|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
170497973|NCT02275780|616162805|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
170497974|NCT02275780|616162804|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
170804418|NCT02078648|617293630|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
170804419|NCT02078648|617293629|FG000|Overall Study|Adverse Event|0|||
170804420|NCT02078648|617293630|FG001|Overall Study|Adverse Event|1|||
170804421|NCT02078648|617293629|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
170902853|NCT02537678|617646917|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
170804422|NCT02078648|617293630|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
170804423|NCT02078648|617293629|FG000|Overall Study|Withdrawal by Subject|3|||
170804424|NCT02078648|617293630|FG001|Overall Study|Withdrawal by Subject|1|||
170804425|NCT02078648|617293629|FG000|Overall Study|Investigator Decision|5|||
170804426|NCT02078648|617293630|FG001|Overall Study|Investigator Decision|7|||
170804427|NCT02078648|617293629|FG000|Overall Study|Death|1|||
170804428|NCT02078648|617293630|FG001|Overall Study|Death|1|||
170804429|NCT02078648|617293629|FG000|Overall Study|Undefined|0|||
170804430|NCT02078648|617293630|FG001|Overall Study|Undefined|1|||
170804431|NCT01675492|617293631|FG000|Overall Study|study completed early - product approval|42|||
170804432|NCT03211247|617293632|FG000|Overall Study|Adverse Event|8|||
170804433|NCT03211247|617293633|FG001|Overall Study|Adverse Event|0|||
170804434|NCT03211247|617293634|FG002|Overall Study|Adverse Event|1|||
170804435|NCT03211247|617293635|FG003|Overall Study|Adverse Event|0|||
170804436|NCT03211247|617293636|FG004|Overall Study|Adverse Event|0|||
170804437|NCT03211247|617293632|FG000|Overall Study|Lost to Follow-up|2|||
170804438|NCT03211247|617293633|FG001|Overall Study|Lost to Follow-up|1|||
170804439|NCT03211247|617293634|FG002|Overall Study|Lost to Follow-up|0|||
170804440|NCT03211247|617293635|FG003|Overall Study|Lost to Follow-up|0|||
170804441|NCT03211247|617293636|FG004|Overall Study|Lost to Follow-up|0|||
170804442|NCT03211247|617293632|FG000|Overall Study|Physician Decision|1|||
170804443|NCT03211247|617293633|FG001|Overall Study|Physician Decision|2|||
170804444|NCT03211247|617293634|FG002|Overall Study|Physician Decision|0|||
170804445|NCT03211247|617293635|FG003|Overall Study|Physician Decision|0|||
170804446|NCT03211247|617293636|FG004|Overall Study|Physician Decision|0|||
170804447|NCT03211247|617293632|FG000|Overall Study|Non-compliance with study drug|2|||
170804448|NCT03211247|617293633|FG001|Overall Study|Non-compliance with study drug|0|||
170804449|NCT03211247|617293634|FG002|Overall Study|Non-compliance with study drug|0|||
170804450|NCT03211247|617293635|FG003|Overall Study|Non-compliance with study drug|0|||
170804451|NCT03211247|617293636|FG004|Overall Study|Non-compliance with study drug|0|||
170804452|NCT03211247|617293632|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
170804453|NCT03211247|617293633|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
170804454|NCT03211247|617293634|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
170804455|NCT03211247|617293635|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
170804456|NCT03211247|617293636|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
170804457|NCT03211247|617293632|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
170804458|NCT03211247|617293633|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
170902854|NCT02537678|617646916|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
170902855|NCT02537678|617646917|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
170902856|NCT02537678|617646916|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
170902857|NCT02537678|617646917|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
170902858|NCT01128387|617646918|FG000|Overall Study|Physician Decision|0|||
170902859|NCT01128387|617646919|FG001|Overall Study|Physician Decision|1|||
170902860|NCT05292755|617646920|FG000|Overall Study|Lost to Follow-up|5|||
170902861|NCT05292755|617646921|FG001|Overall Study|Lost to Follow-up|9|||
170902862|NCT02499952|617646925|FG000|Overall Study|Lost to Follow-up|1|||
170902863|NCT02499952|617646925|FG000|Overall Study|Death|9|||
170902864|NCT03308188|617646927|FG000|Overall Study|Withdrawal by Subject|0|||
170902865|NCT03308188|617646928|FG001|Overall Study|Withdrawal by Subject|3|||
170902866|NCT03308188|617646927|FG000|Overall Study|Death|0|||
170902867|NCT03308188|617646928|FG001|Overall Study|Death|1|||
170902868|NCT03770403|617646932|FG000|Overall Study|Adverse Event|8|||
170902869|NCT03770403|617646932|FG000|Overall Study|Death|5|||
170902870|NCT03770403|617646932|FG000|Overall Study|Physician Decision|1|||
170902871|NCT03770403|617646932|FG000|Overall Study|Sponsor decision|1|||
170902872|NCT03770403|617646932|FG000|Overall Study|Study terminated by Sponsor|1|||
170902873|NCT03770403|617646932|FG000|Overall Study|Withdrawal by Subject|13|||
170902874|NCT03770403|617646932|FG000|Overall Study|Other|88|||
170902875|NCT00552110|617646933|FG000|Overall Study|Serious or Life-Threatening AE|0|||
170902876|NCT00552110|617646934|FG001|Overall Study|Serious or Life-Threatening AE|0|||
170902877|NCT00552110|617646935|FG002|Overall Study|Serious or Life-Threatening AE|1|||
170902878|NCT00552110|617646936|FG003|Overall Study|Serious or Life-Threatening AE|0|||
170902879|NCT00552110|617646937|FG004|Overall Study|Serious or Life-Threatening AE|0|||
170804459|NCT03211247|617293634|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
170902880|NCT00552110|617646933|FG000|Overall Study|Lack of Efficacy|1|||
170902881|NCT00552110|617646934|FG001|Overall Study|Lack of Efficacy|0|||
170902882|NCT00552110|617646935|FG002|Overall Study|Lack of Efficacy|0|||
170804460|NCT03211247|617293635|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
170804461|NCT03211247|617293636|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
170902883|NCT00552110|617646936|FG003|Overall Study|Lack of Efficacy|1|||
170902884|NCT00552110|617646937|FG004|Overall Study|Lack of Efficacy|4|||
170902885|NCT00552110|617646933|FG000|Overall Study|Withdrawal by Subject|0|||
170902886|NCT00552110|617646934|FG001|Overall Study|Withdrawal by Subject|2|||
170902887|NCT00552110|617646935|FG002|Overall Study|Withdrawal by Subject|0|||
170902888|NCT00552110|617646936|FG003|Overall Study|Withdrawal by Subject|3|||
170497975|NCT02275780|616162805|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
170497976|NCT02275780|616162804|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
170497977|NCT02275780|616162805|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
170497978|NCT02275780|616162804|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
170497979|NCT02275780|616162805|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
170497980|NCT02275780|616162804|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
170804462|NCT03211247|617293632|FG000|Overall Study|Protocol Violation|0|||
170902889|NCT00552110|617646937|FG004|Overall Study|Withdrawal by Subject|2|||
170902890|NCT00552110|617646933|FG000|Overall Study|Lost to Follow-up|0|||
170902891|NCT00552110|617646934|FG001|Overall Study|Lost to Follow-up|0|||
170902892|NCT00552110|617646935|FG002|Overall Study|Lost to Follow-up|0|||
170902893|NCT00552110|617646936|FG003|Overall Study|Lost to Follow-up|1|||
170902894|NCT00552110|617646937|FG004|Overall Study|Lost to Follow-up|1|||
170902895|NCT00552110|617646933|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
170902896|NCT00552110|617646934|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
170902897|NCT00552110|617646935|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
170902898|NCT00552110|617646936|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
170902899|NCT00552110|617646937|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
170902900|NCT00552110|617646933|FG000|Overall Study|Withdrawn per Sponsor|0|||
170902901|NCT00552110|617646934|FG001|Overall Study|Withdrawn per Sponsor|1|||
170902902|NCT00552110|617646935|FG002|Overall Study|Withdrawn per Sponsor|0|||
170902903|NCT00552110|617646936|FG003|Overall Study|Withdrawn per Sponsor|0|||
170902904|NCT00552110|617646937|FG004|Overall Study|Withdrawn per Sponsor|1|||
170902905|NCT00552110|617646933|FG000|Overall Study|Use of Prohibited Medication|1|||
170902906|NCT00552110|617646934|FG001|Overall Study|Use of Prohibited Medication|1|||
170902907|NCT00552110|617646935|FG002|Overall Study|Use of Prohibited Medication|0|||
170902908|NCT00552110|617646936|FG003|Overall Study|Use of Prohibited Medication|0|||
170902909|NCT00552110|617646937|FG004|Overall Study|Use of Prohibited Medication|0|||
170902910|NCT00552110|617646933|FG000|Overall Study|Delay of Study due to Relabeling|0|||
170902911|NCT00552110|617646934|FG001|Overall Study|Delay of Study due to Relabeling|0|||
170902912|NCT00552110|617646935|FG002|Overall Study|Delay of Study due to Relabeling|0|||
170902913|NCT00552110|617646936|FG003|Overall Study|Delay of Study due to Relabeling|1|||
170902914|NCT00552110|617646937|FG004|Overall Study|Delay of Study due to Relabeling|0|||
170902915|NCT00552110|617646933|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
170902916|NCT00552110|617646934|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
170902917|NCT00552110|617646935|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
170902918|NCT00552110|617646936|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
170902919|NCT00552110|617646937|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
170902920|NCT00552110|617646933|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
170804463|NCT03211247|617293633|FG001|Overall Study|Protocol Violation|1|||
170804464|NCT03211247|617293634|FG002|Overall Study|Protocol Violation|0|||
170804465|NCT03211247|617293635|FG003|Overall Study|Protocol Violation|0|||
170804466|NCT03211247|617293636|FG004|Overall Study|Protocol Violation|0|||
170804467|NCT03371017|617293637|FG000|Overall Study|Physician Decision|0|||
170804468|NCT03371017|617293638|FG001|Overall Study|Physician Decision|1|||
170804469|NCT03371017|617293637|FG000|Overall Study|Reason not Specified|0|||
170804470|NCT03371017|617293638|FG001|Overall Study|Reason not Specified|1|||
170804471|NCT03371017|617293637|FG000|Overall Study|Lost to Follow-up|13|||
170902921|NCT00552110|617646934|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
170902922|NCT00552110|617646935|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
170902923|NCT00552110|617646936|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
170902924|NCT00552110|617646937|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
170902925|NCT02949830|617646939|FG000|Overall Study|Adverse Event|1|||
170497981|NCT02275780|616162805|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
170497982|NCT02275780|616162804|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
170497983|NCT02275780|616162805|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
170497984|NCT02275780|616162804|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
170497985|NCT02275780|616162805|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
170497986|NCT02275780|616162804|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
170497987|NCT02275780|616162805|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
170497988|NCT02275780|616162804|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
170497989|NCT02275780|616162805|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
170497990|NCT02275780|616162804|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
170497991|NCT02275780|616162805|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
170497992|NCT02275780|616162804|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
170497993|NCT02275780|616162805|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
170497994|NCT02275780|616162804|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
170497995|NCT02275780|616162805|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
170497996|NCT02275780|616162804|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
170497997|NCT02275780|616162805|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
170497998|NCT02275780|616162804|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
170497999|NCT02275780|616162805|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
170498000|NCT02275780|616162804|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
170498001|NCT02275780|616162805|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
170498002|NCT02275780|616162804|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
170498003|NCT02275780|616162805|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
170498004|NCT02275780|616162804|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
170498005|NCT02275780|616162805|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
170498006|NCT02275780|616162804|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
170498007|NCT02275780|616162805|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
170498008|NCT02892422|616162808|FG000|Overall Study|Enrolled not treated|4|||
170498009|NCT02892422|616162808|FG000|Overall Study|Adverse Event|38|||
170551468|NCT00819832|616364792|FG000|Overall Study|Sponsor Termination of Study|3|||
170551469|NCT00819832|616364793|FG001|Overall Study|Sponsor Termination of Study|0|||
170551470|NCT00819832|616364794|FG002|Overall Study|Sponsor Termination of Study|0|||
170551471|NCT00819832|616364795|FG003|Overall Study|Sponsor Termination of Study|0|||
170551472|NCT00819832|616364796|FG004|Overall Study|Sponsor Termination of Study|0|||
170902926|NCT02949830|617646939|FG000|Overall Study|Withdrawal by Subject|1|||
170902927|NCT01628926|617646940|FG000|Overall Study|Adverse Event|13|||
170902928|NCT01628926|617646941|FG001|Overall Study|Adverse Event|11|||
170498010|NCT02892422|616162808|FG000|Overall Study|Lack of Efficacy|32|||
170498011|NCT02892422|616162808|FG000|Overall Study|Non-compliance with study drug|11|||
170498012|NCT02892422|616162808|FG000|Overall Study|Protocol Violation|4|||
170498013|NCT02892422|616162808|FG000|Overall Study|Withdrawal by Subject|56|||
170498014|NCT02892422|616162808|FG000|Overall Study|Lost to Follow-up|5|||
170498015|NCT02892422|616162808|FG000|Overall Study|sponsor information 16159A results|21|||
170498016|NCT02892422|616162808|FG000|Overall Study|withdrawal of consent|13|||
170498017|NCT02892422|616162808|FG000|Overall Study|exclusion criteria met|3|||
170498018|NCT02892422|616162808|FG000|Overall Study|moving elsewhere|4|||
170498019|NCT02892422|616162808|FG000|Overall Study|non-compliance|10|||
170498020|NCT02892422|616162808|FG000|Overall Study|patient legally incapable|1|||
170498021|NCT02892422|616162808|FG000|Overall Study|patient decision|7|||
170498022|NCT02892422|616162808|FG000|Overall Study|Investigator decision|1|||
170498023|NCT02855359|616162809|FG000|Overall Study|Death|2|||
170498024|NCT02855359|616162810|FG001|Overall Study|Death|2|||
170498025|NCT02855359|616162811|FG002|Overall Study|Death|0|||
170498026|NCT02855359|616162812|FG003|Overall Study|Death|0|||
170498027|NCT02855359|616162809|FG000|Overall Study|Study Termination by Sponsor|9|||
170498028|NCT02855359|616162810|FG001|Overall Study|Study Termination by Sponsor|11|||
170498029|NCT02855359|616162811|FG002|Overall Study|Study Termination by Sponsor|0|||
170498030|NCT02855359|616162812|FG003|Overall Study|Study Termination by Sponsor|0|||
170498031|NCT03155178|616162813|FG000|Overall Study|Did not meet treatment day baseline|7|||
170498032|NCT03155178|616162814|FG001|Overall Study|Did not meet treatment day baseline|7|||
170498033|NCT03155178|616162815|FG002|Overall Study|Did not meet treatment day baseline|7|||
170498034|NCT03155178|616162816|FG003|Overall Study|Did not meet treatment day baseline|7|||
170498035|NCT02833844|616162817|FG000|Double-Blind Period|Withdrawal by Subject|2|||
170498036|NCT02833844|616162818|FG001|Double-Blind Period|Withdrawal by Subject|3|||
170498037|NCT02833844|616162817|FG000|Double-Blind Period|Protocol Violation|0|||
170498038|NCT02833844|616162818|FG001|Double-Blind Period|Protocol Violation|4|||
170498039|NCT02833844|616162817|FG000|Open-Label Period|Death|0|||
170498040|NCT02833844|616162818|FG001|Open-Label Period|Death|2|||
170498041|NCT02833844|616162817|FG000|Open-Label Period|Lost to Follow-up|1|||
170498042|NCT02833844|616162818|FG001|Open-Label Period|Lost to Follow-up|0|||
170498043|NCT02833844|616162817|FG000|Open-Label Period|Withdrawal by Subject|1|||
170498044|NCT02833844|616162818|FG001|Open-Label Period|Withdrawal by Subject|0|||
170498045|NCT04323306|616162820|FG000|Overall Study|Physician Decision|1|||
170498046|NCT04323306|616162821|FG001|Overall Study|Physician Decision|0|||
170498047|NCT04323306|616162822|FG002|Overall Study|Physician Decision|0|||
170498048|NCT04323306|616162823|FG003|Overall Study|Physician Decision|0|||
170498049|NCT04323306|616162824|FG004|Overall Study|Physician Decision|0|||
170498050|NCT04323306|616162825|FG005|Overall Study|Physician Decision|0|||
170498051|NCT04323306|616162826|FG006|Overall Study|Physician Decision|0|||
170498052|NCT04323306|616162827|FG007|Overall Study|Physician Decision|0|||
170498053|NCT04323306|616162828|FG008|Overall Study|Physician Decision|0|||
170498054|NCT04323306|616162820|FG000|Overall Study|Withdrawal by Subject|0|||
170498055|NCT04323306|616162821|FG001|Overall Study|Withdrawal by Subject|0|||
170498056|NCT04323306|616162822|FG002|Overall Study|Withdrawal by Subject|0|||
170498057|NCT04323306|616162823|FG003|Overall Study|Withdrawal by Subject|0|||
170498058|NCT04323306|616162824|FG004|Overall Study|Withdrawal by Subject|0|||
170498059|NCT04323306|616162825|FG005|Overall Study|Withdrawal by Subject|1|||
170498060|NCT04323306|616162826|FG006|Overall Study|Withdrawal by Subject|3|||
170498061|NCT04323306|616162827|FG007|Overall Study|Withdrawal by Subject|0|||
170498062|NCT04323306|616162828|FG008|Overall Study|Withdrawal by Subject|1|||
170498063|NCT00759785|616162829|FG000|Overall Study|Participant sample not evaluable|11|||
170498064|NCT00759785|616162830|FG001|Overall Study|Participant sample not evaluable|2|||
170498065|NCT00759785|616162829|FG000|Overall Study|Participant sample lost|0|||
170498066|NCT00759785|616162830|FG001|Overall Study|Participant sample lost|1|||
170498067|NCT00759785|616162829|FG000|Overall Study|Protocol Violation|1|||
170498068|NCT00759785|616162830|FG001|Overall Study|Protocol Violation|0|||
170498069|NCT00759785|616162829|FG000|Overall Study|Physician Decision|0|||
170498070|NCT00759785|616162830|FG001|Overall Study|Physician Decision|1|||
170498071|NCT00759785|616162829|FG000|Overall Study|Withdrawal by Subject|0|||
170498072|NCT00759785|616162830|FG001|Overall Study|Withdrawal by Subject|1|||
170498073|NCT00089778|616162831|FG000|Overall Study|Protocol Violation|0|||
170498074|NCT00089778|616162832|FG001|Overall Study|Protocol Violation|0|||
170498075|NCT00089778|616162833|FG002|Overall Study|Protocol Violation|1|||
170498076|NCT01646021|616162835|FG000|Overall Study|Death|77|||
170498077|NCT01646021|616162836|FG001|Overall Study|Death|83|||
170498078|NCT01646021|616162835|FG000|Overall Study|Study Terminated by Sponsor|50|||
170498079|NCT01646021|616162836|FG001|Overall Study|Study Terminated by Sponsor|41|||
170498080|NCT01646021|616162835|FG000|Overall Study|Lost to Follow-up|2|||
170498081|NCT01646021|616162836|FG001|Overall Study|Lost to Follow-up|2|||
170498082|NCT01646021|616162835|FG000|Overall Study|Withdrawal by Subject|10|||
170498083|NCT01646021|616162836|FG001|Overall Study|Withdrawal by Subject|15|||
170498084|NCT04712019|616162837|FG000|Overall Study|Withdrawal by Subject|2|||
170498085|NCT04712019|616162838|FG001|Overall Study|Withdrawal by Subject|2|||
170498086|NCT04712019|616162837|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
170498087|NCT04712019|616162838|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
170498088|NCT02347891|616162844|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
170498089|NCT02347891|616162845|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
170498090|NCT02347891|616162844|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
170498091|NCT02347891|616162845|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
170498092|NCT02231879|616162848|FG000|Overall Study|Adverse Event|2|||
170498093|NCT02231879|616162849|FG001|Overall Study|Adverse Event|1|||
170498094|NCT02231879|616162848|FG000|Overall Study|Lack of Efficacy|0|||
170498095|NCT02231879|616162849|FG001|Overall Study|Lack of Efficacy|1|||
170498096|NCT01322035|616162850|FG000|Overall Study|Lost to Follow-up|8|||
170498097|NCT01322035|616162851|FG001|Overall Study|Lost to Follow-up|3|||
170498098|NCT04569968|616162852|FG000|Overall Study|Lost to Follow-up|2|||
170498099|NCT04569968|616162853|FG001|Overall Study|Lost to Follow-up|5|||
170498100|NCT04569968|616162852|FG000|Overall Study|Story of head and/or neck surgery|2|||
170498101|NCT04569968|616162853|FG001|Overall Study|Story of head and/or neck surgery|2|||
170498102|NCT04569968|616162852|FG000|Overall Study|Time of stroke onset|8|||
170498103|NCT04569968|616162853|FG001|Overall Study|Time of stroke onset|7|||
170498104|NCT04569968|616162852|FG000|Overall Study|Type of strokr|12|||
170498105|NCT04569968|616162853|FG001|Overall Study|Type of strokr|8|||
170498106|NCT04569968|616162852|FG000|Overall Study|Cooperation|8|||
170498107|NCT04569968|616162853|FG001|Overall Study|Cooperation|8|||
170498108|NCT04569968|616162852|FG000|Overall Study|Age interval|17|||
170498109|NCT04569968|616162853|FG001|Overall Study|Age interval|6|||
170498110|NCT04569968|616162852|FG000|Overall Study|Denial of participation to the study|0|||
170498111|NCT04569968|616162853|FG001|Overall Study|Denial of participation to the study|3|||
170498112|NCT04569968|616162852|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
170498113|NCT04569968|616162853|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
170498114|NCT04569968|616162852|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
170498115|NCT04569968|616162853|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
170498116|NCT04569968|616162852|FG000|Overall Study|Quarantine|1|||
170498117|NCT04569968|616162853|FG001|Overall Study|Quarantine|0|||
170498118|NCT04569968|616162852|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
170498119|NCT04569968|616162853|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
170498120|NCT04569968|616162852|FG000|Overall Study|Repetitive stroke|8|||
170498121|NCT04569968|616162853|FG001|Overall Study|Repetitive stroke|0|||
170498122|NCT04569968|616162852|FG000|Overall Study|Insufficient mastication|1|||
170498123|NCT04569968|616162853|FG001|Overall Study|Insufficient mastication|0|||
170498124|NCT04569968|616162852|FG000|Overall Study|Infection|1|||
170498125|NCT04569968|616162853|FG001|Overall Study|Infection|0|||
170498126|NCT02612610|616162854|FG000|Overall Study|Withdrawal by Subject|1|||
170498127|NCT02612610|616162855|FG001|Overall Study|Withdrawal by Subject|1|||
170498128|NCT02612610|616162856|FG002|Overall Study|Withdrawal by Subject|0|||
170498129|NCT02612610|616162857|FG003|Overall Study|Withdrawal by Subject|2|||
170498130|NCT02612610|616162854|FG000|Overall Study|Adverse Event|2|||
170498131|NCT02612610|616162855|FG001|Overall Study|Adverse Event|2|||
170498132|NCT02612610|616162856|FG002|Overall Study|Adverse Event|3|||
170498133|NCT02612610|616162857|FG003|Overall Study|Adverse Event|10|||
170498134|NCT02612610|616162854|FG000|Overall Study|Lost to Follow-up|0|||
170498135|NCT02612610|616162855|FG001|Overall Study|Lost to Follow-up|1|||
170498136|NCT02612610|616162856|FG002|Overall Study|Lost to Follow-up|0|||
170498137|NCT02612610|616162857|FG003|Overall Study|Lost to Follow-up|0|||
170498138|NCT02612610|616162854|FG000|Overall Study|Protocol Violation|0|||
170498139|NCT02612610|616162855|FG001|Overall Study|Protocol Violation|1|||
170498140|NCT02612610|616162856|FG002|Overall Study|Protocol Violation|1|||
170498141|NCT02612610|616162857|FG003|Overall Study|Protocol Violation|0|||
170498142|NCT02612610|616162854|FG000|Overall Study|Lack of Efficacy|1|||
170498143|NCT02612610|616162855|FG001|Overall Study|Lack of Efficacy|2|||
170498144|NCT02612610|616162856|FG002|Overall Study|Lack of Efficacy|0|||
170498145|NCT02612610|616162857|FG003|Overall Study|Lack of Efficacy|1|||
170498146|NCT02612610|616162854|FG000|Overall Study|Physician Decision|0|||
170498147|NCT02612610|616162855|FG001|Overall Study|Physician Decision|1|||
170498148|NCT02612610|616162856|FG002|Overall Study|Physician Decision|0|||
170498149|NCT02612610|616162857|FG003|Overall Study|Physician Decision|0|||
170498150|NCT02612610|616162854|FG000|Overall Study|Noncompliance|1|||
170551473|NCT00819832|616364797|FG005|Overall Study|Sponsor Termination of Study|0|||
170498151|NCT02612610|616162855|FG001|Overall Study|Noncompliance|0|||
170498152|NCT02612610|616162856|FG002|Overall Study|Noncompliance|0|||
170498153|NCT02612610|616162857|FG003|Overall Study|Noncompliance|0|||
170498154|NCT02612610|616162854|FG000|Overall Study|Cough Improvement|0|||
170498155|NCT02612610|616162855|FG001|Overall Study|Cough Improvement|0|||
170498156|NCT02612610|616162856|FG002|Overall Study|Cough Improvement|1|||
170498157|NCT02612610|616162857|FG003|Overall Study|Cough Improvement|0|||
170804472|NCT03371017|617293638|FG001|Overall Study|Lost to Follow-up|16|||
170498158|NCT03843632|616162861|FG000|Overall Study|Withdrawal by Subject|1|||
170498159|NCT03843632|616162862|FG001|Overall Study|Withdrawal by Subject|0|||
170498160|NCT03843632|616162863|FG002|Overall Study|Withdrawal by Subject|0|||
170498161|NCT03843632|616162864|FG003|Overall Study|Withdrawal by Subject|0|||
170498162|NCT03403751|616162865|FG000|Overall Study|Death|5|||
170498163|NCT03403751|616162866|FG001|Overall Study|Death|6|||
170498164|NCT03403751|616162865|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
170498165|NCT03403751|616162866|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
170498166|NCT01820572|616162868|FG000|Randomization|Not Treated|2|||
170498167|NCT01820572|616162869|FG001|Randomization|Not Treated|1|||
170498168|NCT01820572|616162868|FG000|Treatment Period|Adverse Event|12|||
170498169|NCT01820572|616162869|FG001|Treatment Period|Adverse Event|7|||
170498170|NCT01820572|616162868|FG000|Treatment Period|Death|3|||
170498171|NCT01820572|616162869|FG001|Treatment Period|Death|3|||
170498172|NCT01820572|616162868|FG000|Treatment Period|Lack of Efficacy|1|||
170498173|NCT01820572|616162869|FG001|Treatment Period|Lack of Efficacy|0|||
170498174|NCT01820572|616162868|FG000|Treatment Period|poor/non compliance|0|||
170498175|NCT01820572|616162869|FG001|Treatment Period|poor/non compliance|3|||
170498176|NCT01820572|616162868|FG000|Treatment Period|request to discontinue|6|||
170902929|NCT01628926|617646942|FG002|Overall Study|Adverse Event|9|||
170902930|NCT01628926|617646940|FG000|Overall Study|Lack of Efficacy|2|||
170902931|NCT01628926|617646941|FG001|Overall Study|Lack of Efficacy|1|||
170902932|NCT01628926|617646942|FG002|Overall Study|Lack of Efficacy|5|||
170902933|NCT01628926|617646940|FG000|Overall Study|Withdrawal by Subject|6|||
170902934|NCT01628926|617646941|FG001|Overall Study|Withdrawal by Subject|4|||
170902935|NCT01628926|617646942|FG002|Overall Study|Withdrawal by Subject|2|||
170902936|NCT01628926|617646940|FG000|Overall Study|Protocol Violation|0|||
170902937|NCT01628926|617646941|FG001|Overall Study|Protocol Violation|1|||
170902938|NCT01628926|617646942|FG002|Overall Study|Protocol Violation|0|||
170902939|NCT01628926|617646940|FG000|Overall Study|Discontinuation criteria|3|||
170902940|NCT01628926|617646941|FG001|Overall Study|Discontinuation criteria|4|||
170902941|NCT01628926|617646942|FG002|Overall Study|Discontinuation criteria|0|||
170902942|NCT01628926|617646940|FG000|Overall Study|Physician Decision|2|||
170902943|NCT01628926|617646941|FG001|Overall Study|Physician Decision|2|||
170902944|NCT01628926|617646942|FG002|Overall Study|Physician Decision|1|||
170902945|NCT00490542|617646945|FG000|Overall Study|Lost to Follow-up|3|||
170902946|NCT00490542|617646946|FG001|Overall Study|Lost to Follow-up|0|||
170902947|NCT00490542|617646945|FG000|Overall Study|Adverse Event|3|||
170902948|NCT00490542|617646946|FG001|Overall Study|Adverse Event|3|||
170902949|NCT00490542|617646945|FG000|Overall Study|Lack of Efficacy|1|||
170902950|NCT00490542|617646946|FG001|Overall Study|Lack of Efficacy|1|||
170902951|NCT02875223|617646947|FG000|Overall Study|Other reasons|0|||
170902952|NCT02875223|617646948|FG001|Overall Study|Other reasons|0|||
170902953|NCT02875223|617646949|FG002|Overall Study|Other reasons|1|||
170902954|NCT02875223|617646950|FG003|Overall Study|Other reasons|0|||
170902955|NCT02875223|617646951|FG004|Overall Study|Other reasons|1|||
170902956|NCT02875223|617646952|FG005|Overall Study|Other reasons|2|||
170902957|NCT02875223|617646953|FG006|Overall Study|Other reasons|0|||
170902958|NCT02875223|617646954|FG007|Overall Study|Other reasons|2|||
170902959|NCT02875223|617646955|FG008|Overall Study|Other reasons|0|||
170902960|NCT02875223|617646956|FG009|Overall Study|Other reasons|0|||
170902961|NCT02875223|617646957|FG010|Overall Study|Other reasons|0|||
170902962|NCT02875223|617646958|FG011|Overall Study|Other reasons|0|||
170902963|NCT02875223|617646959|FG012|Overall Study|Other reasons|0|||
170902964|NCT02875223|617646947|FG000|Overall Study|Withdrawal by Subject|0|||
170902965|NCT02875223|617646948|FG001|Overall Study|Withdrawal by Subject|0|||
170498177|NCT01820572|616162869|FG001|Treatment Period|request to discontinue|11|||
170498178|NCT01820572|616162868|FG000|Treatment Period|No longer meets study criteria|3|||
170498179|NCT01820572|616162869|FG001|Treatment Period|No longer meets study criteria|10|||
170902966|NCT02875223|617646949|FG002|Overall Study|Withdrawal by Subject|0|||
170902967|NCT02875223|617646950|FG003|Overall Study|Withdrawal by Subject|0|||
170902968|NCT02875223|617646951|FG004|Overall Study|Withdrawal by Subject|1|||
170902969|NCT02875223|617646952|FG005|Overall Study|Withdrawal by Subject|1|||
170902970|NCT02875223|617646953|FG006|Overall Study|Withdrawal by Subject|0|||
170902971|NCT02875223|617646954|FG007|Overall Study|Withdrawal by Subject|0|||
170902972|NCT02875223|617646955|FG008|Overall Study|Withdrawal by Subject|1|||
170902973|NCT02875223|617646956|FG009|Overall Study|Withdrawal by Subject|0|||
170902974|NCT02875223|617646957|FG010|Overall Study|Withdrawal by Subject|0|||
170902975|NCT02875223|617646958|FG011|Overall Study|Withdrawal by Subject|0|||
170902976|NCT02875223|617646959|FG012|Overall Study|Withdrawal by Subject|0|||
170902977|NCT02875223|617646947|FG000|Overall Study|Progressive disease|0|||
170902978|NCT02875223|617646948|FG001|Overall Study|Progressive disease|0|||
170902979|NCT02875223|617646949|FG002|Overall Study|Progressive disease|1|||
170902980|NCT02875223|617646950|FG003|Overall Study|Progressive disease|0|||
170902981|NCT02875223|617646951|FG004|Overall Study|Progressive disease|0|||
170902982|NCT02875223|617646952|FG005|Overall Study|Progressive disease|0|||
170902983|NCT02875223|617646953|FG006|Overall Study|Progressive disease|0|||
170902984|NCT02875223|617646954|FG007|Overall Study|Progressive disease|0|||
170902985|NCT02875223|617646955|FG008|Overall Study|Progressive disease|0|||
170902986|NCT02875223|617646956|FG009|Overall Study|Progressive disease|12|||
170902987|NCT02875223|617646957|FG010|Overall Study|Progressive disease|2|||
170902988|NCT02875223|617646958|FG011|Overall Study|Progressive disease|3|||
170902989|NCT02875223|617646959|FG012|Overall Study|Progressive disease|6|||
170902990|NCT02875223|617646947|FG000|Overall Study|Death|4|||
170902991|NCT02875223|617646948|FG001|Overall Study|Death|4|||
170902992|NCT02875223|617646949|FG002|Overall Study|Death|3|||
170551474|NCT04191733|616364799|FG000|Overall Study|Withdrawn due to study closure|13|||
170551475|NCT04191733|616364800|FG001|Overall Study|Withdrawn due to study closure|14|||
170551476|NCT04191733|616364799|FG000|Overall Study|Withdrawal by Subject|2|||
170551477|NCT04191733|616364800|FG001|Overall Study|Withdrawal by Subject|4|||
170551478|NCT04191733|616364799|FG000|Overall Study|Physician Decision|1|||
170551479|NCT04191733|616364800|FG001|Overall Study|Physician Decision|1|||
170551480|NCT04191733|616364799|FG000|Overall Study|Lost to Follow-up|5|||
170551481|NCT04191733|616364800|FG001|Overall Study|Lost to Follow-up|6|||
170551482|NCT04191733|616364799|FG000|Overall Study|Death|0|||
170551483|NCT04191733|616364800|FG001|Overall Study|Death|1|||
170551484|NCT01903733|616364801|FG000|Overall Study|Death|23|||
170551485|NCT01903733|616364802|FG001|Overall Study|Death|54|||
170551486|NCT01903733|616364803|FG002|Overall Study|Death|30|||
170551487|NCT01903733|616364804|FG003|Overall Study|Death|98|||
170551488|NCT01903733|616364801|FG000|Overall Study|Participant refused further follow-up|35|||
170551489|NCT01903733|616364802|FG001|Overall Study|Participant refused further follow-up|38|||
170551490|NCT01903733|616364803|FG002|Overall Study|Participant refused further follow-up|13|||
170551491|NCT01903733|616364804|FG003|Overall Study|Participant refused further follow-up|9|||
170551492|NCT01903733|616364801|FG000|Overall Study|Lost to Follow-up|18|||
170551493|NCT01903733|616364802|FG001|Overall Study|Lost to Follow-up|19|||
170551494|NCT01903733|616364803|FG002|Overall Study|Lost to Follow-up|6|||
170551495|NCT01903733|616364804|FG003|Overall Study|Lost to Follow-up|9|||
170804473|NCT03371017|617293637|FG000|Overall Study|Death|228|||
170804474|NCT03371017|617293638|FG001|Overall Study|Death|215|||
170804475|NCT03371017|617293637|FG000|Overall Study|Withdrawal by Subject|20|||
170804476|NCT03371017|617293638|FG001|Overall Study|Withdrawal by Subject|25|||
170804477|NCT03371017|617293637|FG000|Overall Study|Study Ended by Sponsor|37|||
170804478|NCT03371017|617293638|FG001|Overall Study|Study Ended by Sponsor|38|||
170804479|NCT03371017|617293637|FG000|Overall Study|Protocol Deviation|0|||
170804480|NCT03371017|617293638|FG001|Overall Study|Protocol Deviation|1|||
170804481|NCT03160885|617293639|FG000|Initial Treatment Period|Not dosed|2|||
170804482|NCT03160885|617293640|FG001|Initial Treatment Period|Not dosed|0|||
170804483|NCT03160885|617293641|FG002|Initial Treatment Period|Not dosed|0|||
170804484|NCT03160885|617293642|FG003|Initial Treatment Period|Not dosed|0|||
170804485|NCT03160885|617293643|FG004|Initial Treatment Period|Not dosed|0|||
170804486|NCT03160885|617293644|FG005|Initial Treatment Period|Not dosed|0|||
170804487|NCT03160885|617293645|FG006|Initial Treatment Period|Not dosed|0|||
170804488|NCT03160885|617293639|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
170804489|NCT03160885|617293640|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
170804490|NCT03160885|617293641|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170804491|NCT03160885|617293642|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170804492|NCT03160885|617293643|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170804493|NCT03160885|617293644|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170902993|NCT02875223|617646950|FG003|Overall Study|Death|4|||
170551496|NCT01903733|616364801|FG000|Overall Study|Other|10|||
170551497|NCT01903733|616364802|FG001|Overall Study|Other|15|||
170551498|NCT01903733|616364803|FG002|Overall Study|Other|12|||
170551499|NCT01903733|616364804|FG003|Overall Study|Other|3|||
170551500|NCT01903733|616364801|FG000|Overall Study|Missing|2|||
170551501|NCT01903733|616364802|FG001|Overall Study|Missing|0|||
170804494|NCT03160885|617293645|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
170804495|NCT03160885|617293639|FG000|Open-label Treatment|Not dosed|0|||
170804496|NCT03160885|617293640|FG001|Open-label Treatment|Not dosed|0|||
170804497|NCT03160885|617293641|FG002|Open-label Treatment|Not dosed|0|||
170804498|NCT03160885|617293642|FG003|Open-label Treatment|Not dosed|0|||
170902994|NCT02875223|617646951|FG004|Overall Study|Death|2|||
170902995|NCT02875223|617646952|FG005|Overall Study|Death|3|||
170902996|NCT02875223|617646953|FG006|Overall Study|Death|5|||
170902997|NCT02875223|617646954|FG007|Overall Study|Death|7|||
170551502|NCT01903733|616364803|FG002|Overall Study|Missing|0|||
170551503|NCT01903733|616364804|FG003|Overall Study|Missing|0|||
170902998|NCT02875223|617646955|FG008|Overall Study|Death|3|||
170902999|NCT02875223|617646956|FG009|Overall Study|Death|2|||
170903000|NCT02875223|617646957|FG010|Overall Study|Death|0|||
170903001|NCT02875223|617646958|FG011|Overall Study|Death|0|||
170903002|NCT02875223|617646959|FG012|Overall Study|Death|0|||
170903003|NCT02875223|617646947|FG000|Overall Study|Lost to Follow-up|0|||
170903004|NCT02875223|617646948|FG001|Overall Study|Lost to Follow-up|1|||
170498180|NCT01820572|616162868|FG000|Treatment Period|withdrew consent|1|||
170498181|NCT01820572|616162869|FG001|Treatment Period|withdrew consent|2|||
170498182|NCT00595517|616162870|FG000|Overall Study|Adverse Event|6|||
170498183|NCT00595517|616162870|FG000|Overall Study|Withdrawal by Subject|4|||
170498184|NCT00595517|616162870|FG000|Overall Study|Protocol Violation|2|||
170498185|NCT00595517|616162870|FG000|Overall Study|Recurrence of ulcer|5|||
170903005|NCT02875223|617646949|FG002|Overall Study|Lost to Follow-up|1|||
170903006|NCT02875223|617646950|FG003|Overall Study|Lost to Follow-up|0|||
170903007|NCT02875223|617646951|FG004|Overall Study|Lost to Follow-up|1|||
170903008|NCT02875223|617646952|FG005|Overall Study|Lost to Follow-up|0|||
170903009|NCT02875223|617646953|FG006|Overall Study|Lost to Follow-up|1|||
170903010|NCT02875223|617646954|FG007|Overall Study|Lost to Follow-up|1|||
170903011|NCT02875223|617646955|FG008|Overall Study|Lost to Follow-up|0|||
170903012|NCT02875223|617646956|FG009|Overall Study|Lost to Follow-up|0|||
170903013|NCT02875223|617646957|FG010|Overall Study|Lost to Follow-up|0|||
170903014|NCT02875223|617646958|FG011|Overall Study|Lost to Follow-up|0|||
170903015|NCT02875223|617646959|FG012|Overall Study|Lost to Follow-up|0|||
170903016|NCT01870739|617646960|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
170903017|NCT01870739|617646961|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
170903018|NCT01870739|617646960|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
170903019|NCT01870739|617646961|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
170903020|NCT01870739|617646960|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
170903021|NCT01870739|617646961|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
170903022|NCT01870739|617646960|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
170903023|NCT01870739|617646961|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
170903024|NCT01870739|617646960|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
170903025|NCT01870739|617646961|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
170903026|NCT01870739|617646960|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
170903027|NCT01870739|617646961|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
170903028|NCT01870739|617646960|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
170903029|NCT01870739|617646961|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
170903030|NCT01986062|617646962|FG000|Overall Study|Lost to Follow-up|1|||
170903031|NCT01986062|617646963|FG001|Overall Study|Lost to Follow-up|0|||
170903032|NCT01986062|617646962|FG000|Overall Study|Withdrawal by Subject|0|||
170903033|NCT01986062|617646963|FG001|Overall Study|Withdrawal by Subject|1|||
170903034|NCT03538743|617646964|FG000|Overall Study|Adverse Event|0|||
170903035|NCT03538743|617646965|FG001|Overall Study|Adverse Event|0|||
170903036|NCT03538743|617646966|FG002|Overall Study|Adverse Event|1|||
170903037|NCT03538743|617646967|FG003|Overall Study|Adverse Event|1|||
170903038|NCT03538743|617646968|FG004|Overall Study|Adverse Event|0|||
170903039|NCT03538743|617646969|FG005|Overall Study|Adverse Event|0|||
170903040|NCT03538743|617646970|FG006|Overall Study|Adverse Event|0|||
170903041|NCT03538743|617646971|FG007|Overall Study|Adverse Event|0|||
170903042|NCT03538743|617646972|FG008|Overall Study|Adverse Event|0|||
170903043|NCT03538743|617646964|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
170903044|NCT03538743|617646965|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
170903045|NCT03538743|617646966|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
170903046|NCT03538743|617646967|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
170903047|NCT03538743|617646968|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
170903048|NCT03538743|617646969|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
170903049|NCT03538743|617646970|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
170498186|NCT00595517|616162870|FG000|Overall Study|usage of prohibited treatment|1|||
170498187|NCT00595517|616162870|FG000|Overall Study|No intention to attend regularly|1|||
170498188|NCT02107859|616162873|FG000|Overall Study|Withdrawal by Subject|14|||
170498189|NCT02107859|616162873|FG000|Overall Study|Adverse Event|3|||
170498190|NCT02107859|616162873|FG000|Overall Study|Study closure|41|||
170498191|NCT02107859|616162873|FG000|Overall Study|Other than specified|3|||
170903050|NCT03538743|617646971|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
170903051|NCT03538743|617646972|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
170903052|NCT03538743|617646964|FG000|Overall Study|Withdrawal by Subject|0|||
170903053|NCT03538743|617646965|FG001|Overall Study|Withdrawal by Subject|0|||
170903054|NCT03538743|617646966|FG002|Overall Study|Withdrawal by Subject|0|||
170903055|NCT03538743|617646967|FG003|Overall Study|Withdrawal by Subject|1|||
170903056|NCT03538743|617646968|FG004|Overall Study|Withdrawal by Subject|0|||
170498192|NCT00101166|616162876|FG000|Overall Study|progressive disease|10|||
170498193|NCT01868022|616162877|FG000|Overall Study|Withdrawal by Subject|0|||
170903057|NCT03538743|617646969|FG005|Overall Study|Withdrawal by Subject|0|||
170903058|NCT03538743|617646970|FG006|Overall Study|Withdrawal by Subject|0|||
170498194|NCT01868022|616162878|FG001|Overall Study|Withdrawal by Subject|0|||
170498195|NCT01868022|616162879|FG002|Overall Study|Withdrawal by Subject|1|||
170498196|NCT01868022|616162880|FG003|Overall Study|Withdrawal by Subject|1|||
170498197|NCT01868022|616162881|FG004|Overall Study|Withdrawal by Subject|0|||
170498198|NCT01868022|616162882|FG005|Overall Study|Withdrawal by Subject|0|||
170498199|NCT01868022|616162883|FG006|Overall Study|Withdrawal by Subject|0|||
170498200|NCT01868022|616162884|FG007|Overall Study|Withdrawal by Subject|1|||
170498201|NCT01868022|616162885|FG008|Overall Study|Withdrawal by Subject|0|||
170498202|NCT01868022|616162877|FG000|Overall Study|Adverse Event|0|||
170498203|NCT01868022|616162878|FG001|Overall Study|Adverse Event|0|||
170498204|NCT01868022|616162879|FG002|Overall Study|Adverse Event|0|||
170498205|NCT01868022|616162880|FG003|Overall Study|Adverse Event|0|||
170498206|NCT01868022|616162881|FG004|Overall Study|Adverse Event|2|||
170498207|NCT01868022|616162882|FG005|Overall Study|Adverse Event|0|||
170498208|NCT01868022|616162883|FG006|Overall Study|Adverse Event|0|||
170498209|NCT01868022|616162884|FG007|Overall Study|Adverse Event|2|||
170498210|NCT01868022|616162885|FG008|Overall Study|Adverse Event|2|||
170498211|NCT01868022|616162877|FG000|Overall Study|Physician Decision|0|||
170498212|NCT01868022|616162878|FG001|Overall Study|Physician Decision|0|||
170498213|NCT01868022|616162879|FG002|Overall Study|Physician Decision|0|||
170498214|NCT01868022|616162880|FG003|Overall Study|Physician Decision|0|||
170498215|NCT01868022|616162881|FG004|Overall Study|Physician Decision|0|||
170498216|NCT01868022|616162882|FG005|Overall Study|Physician Decision|1|||
170498217|NCT01868022|616162883|FG006|Overall Study|Physician Decision|0|||
170498218|NCT01868022|616162884|FG007|Overall Study|Physician Decision|2|||
170498219|NCT01868022|616162885|FG008|Overall Study|Physician Decision|0|||
170498220|NCT01868022|616162877|FG000|Overall Study|Study closed/terminated|0|||
170498221|NCT01868022|616162878|FG001|Overall Study|Study closed/terminated|0|||
170903059|NCT03538743|617646971|FG007|Overall Study|Withdrawal by Subject|0|||
170903060|NCT03538743|617646972|FG008|Overall Study|Withdrawal by Subject|0|||
170903061|NCT01827384|617646975|FG000|Overall Study|Switched to alternative treatment|0|||
170903062|NCT01827384|617646976|FG001|Overall Study|Switched to alternative treatment|0|||
170903063|NCT01827384|617646977|FG002|Overall Study|Switched to alternative treatment|0|||
170903064|NCT01827384|617646978|FG003|Overall Study|Switched to alternative treatment|0|||
170903065|NCT01827384|617646979|FG004|Overall Study|Switched to alternative treatment|0|||
170903066|NCT01827384|617646980|FG005|Overall Study|Switched to alternative treatment|0|||
170903067|NCT01827384|617646981|FG006|Overall Study|Switched to alternative treatment|0|||
170903068|NCT01827384|617646982|FG007|Overall Study|Switched to alternative treatment|0|||
170903069|NCT01827384|617646983|FG008|Overall Study|Switched to alternative treatment|0|||
170903070|NCT01827384|617646984|FG009|Overall Study|Switched to alternative treatment|0|||
170903071|NCT01827384|617646985|FG010|Overall Study|Switched to alternative treatment|0|||
170903072|NCT01827384|617646986|FG011|Overall Study|Switched to alternative treatment|0|||
170903073|NCT01827384|617646987|FG012|Overall Study|Switched to alternative treatment|0|||
170903074|NCT01827384|617646988|FG013|Overall Study|Switched to alternative treatment|2|||
170903075|NCT01827384|617646975|FG000|Overall Study|Disease progression before treatment|0|||
170903076|NCT01827384|617646976|FG001|Overall Study|Disease progression before treatment|0|||
170903077|NCT01827384|617646977|FG002|Overall Study|Disease progression before treatment|0|||
170903078|NCT01827384|617646978|FG003|Overall Study|Disease progression before treatment|0|||
170903079|NCT01827384|617646979|FG004|Overall Study|Disease progression before treatment|0|||
170903080|NCT01827384|617646980|FG005|Overall Study|Disease progression before treatment|0|||
170903081|NCT01827384|617646981|FG006|Overall Study|Disease progression before treatment|0|||
170903082|NCT01827384|617646982|FG007|Overall Study|Disease progression before treatment|0|||
170498222|NCT01868022|616162879|FG002|Overall Study|Study closed/terminated|0|||
170498223|NCT01868022|616162880|FG003|Overall Study|Study closed/terminated|0|||
170498224|NCT01868022|616162881|FG004|Overall Study|Study closed/terminated|0|||
170498225|NCT01868022|616162882|FG005|Overall Study|Study closed/terminated|0|||
170498226|NCT01868022|616162883|FG006|Overall Study|Study closed/terminated|0|||
170498227|NCT01868022|616162884|FG007|Overall Study|Study closed/terminated|1|||
170498228|NCT01868022|616162885|FG008|Overall Study|Study closed/terminated|0|||
170498229|NCT01868022|616162877|FG000|Overall Study|Ongoing|0|||
170498230|NCT01868022|616162878|FG001|Overall Study|Ongoing|0|||
170498231|NCT01868022|616162879|FG002|Overall Study|Ongoing|0|||
170498232|NCT01868022|616162880|FG003|Overall Study|Ongoing|0|||
170498233|NCT01868022|616162881|FG004|Overall Study|Ongoing|0|||
170903083|NCT01827384|617646983|FG008|Overall Study|Disease progression before treatment|0|||
170498234|NCT01868022|616162882|FG005|Overall Study|Ongoing|0|||
170498235|NCT01868022|616162883|FG006|Overall Study|Ongoing|0|||
170498236|NCT01868022|616162884|FG007|Overall Study|Ongoing|3|||
170498237|NCT01868022|616162885|FG008|Overall Study|Ongoing|0|||
170498238|NCT00746564|616162886|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
170498239|NCT01628198|616162887|FG000|Overall Study|Lost to Follow-up|7|||
170498240|NCT01628198|616162887|FG000|Overall Study|Withdrawal by Subject|10|||
170498241|NCT01628198|616162887|FG000|Overall Study|Screen failure|1|||
170498242|NCT03226769|616162890|FG000|Overall Study|Withdrawal by Subject|0|||
170498243|NCT03226769|616162891|FG001|Overall Study|Withdrawal by Subject|1|||
170498244|NCT01516008|616162892|FG000|Overall Study|Adverse Event|0|||
170498245|NCT01516008|616162893|FG001|Overall Study|Adverse Event|2|||
170498246|NCT01516008|616162894|FG002|Overall Study|Adverse Event|7|||
170498247|NCT01516008|616162892|FG000|Overall Study|Lack of Efficacy|44|||
170498248|NCT01516008|616162893|FG001|Overall Study|Lack of Efficacy|14|||
170498249|NCT01516008|616162894|FG002|Overall Study|Lack of Efficacy|10|||
170498250|NCT01516008|616162892|FG000|Overall Study|Protocol Violation|1|||
170498251|NCT01516008|616162893|FG001|Overall Study|Protocol Violation|0|||
170498252|NCT01516008|616162894|FG002|Overall Study|Protocol Violation|0|||
170498253|NCT01516008|616162892|FG000|Overall Study|Reason not specified|0|||
170498254|NCT01516008|616162893|FG001|Overall Study|Reason not specified|0|||
170498255|NCT01516008|616162894|FG002|Overall Study|Reason not specified|1|||
170498256|NCT01217476|616162895|FG000|Overall Study|Adverse Event|6|||
170498257|NCT01217476|616162896|FG001|Overall Study|Adverse Event|1|||
170498258|NCT01217476|616162895|FG000|Overall Study|Physician Decision|0|||
170498259|NCT01217476|616162896|FG001|Overall Study|Physician Decision|1|||
170551504|NCT01903733|616364801|FG000|Overall Study|Investigator request|18|||
170551505|NCT01903733|616364802|FG001|Overall Study|Investigator request|0|||
170551506|NCT01903733|616364803|FG002|Overall Study|Investigator request|0|||
170903084|NCT01827384|617646984|FG009|Overall Study|Disease progression before treatment|0|||
170903085|NCT01827384|617646985|FG010|Overall Study|Disease progression before treatment|0|||
170903086|NCT01827384|617646986|FG011|Overall Study|Disease progression before treatment|0|||
170551507|NCT01903733|616364804|FG003|Overall Study|Investigator request|0|||
170551508|NCT01340170|616364805|FG000|Overall Study|Lost to Follow-up|2|||
170551509|NCT01340170|616364806|FG001|Overall Study|Lost to Follow-up|4|||
170551510|NCT01340170|616364807|FG002|Overall Study|Lost to Follow-up|0|||
170551511|NCT01340170|616364805|FG000|Overall Study|Implant failure|1|||
170551512|NCT01340170|616364806|FG001|Overall Study|Implant failure|3|||
170551513|NCT01340170|616364807|FG002|Overall Study|Implant failure|0|||
170551514|NCT00147537|616364808|FG000|Phase 1b|Death|0|||
170551515|NCT00147537|616364809|FG001|Phase 1b|Death|1|||
170903087|NCT01827384|617646987|FG012|Overall Study|Disease progression before treatment|0|||
170903088|NCT01827384|617646988|FG013|Overall Study|Disease progression before treatment|4|||
170903089|NCT01827384|617646975|FG000|Overall Study|Ineligible|0|||
170903090|NCT01827384|617646976|FG001|Overall Study|Ineligible|0|||
170903091|NCT01827384|617646977|FG002|Overall Study|Ineligible|0|||
170903092|NCT01827384|617646978|FG003|Overall Study|Ineligible|0|||
170903093|NCT01827384|617646979|FG004|Overall Study|Ineligible|0|||
170903094|NCT01827384|617646980|FG005|Overall Study|Ineligible|0|||
170903095|NCT01827384|617646981|FG006|Overall Study|Ineligible|0|||
170903096|NCT01827384|617646982|FG007|Overall Study|Ineligible|0|||
170903097|NCT01827384|617646983|FG008|Overall Study|Ineligible|0|||
170903098|NCT01827384|617646984|FG009|Overall Study|Ineligible|0|||
170903099|NCT01827384|617646985|FG010|Overall Study|Ineligible|0|||
170903100|NCT01827384|617646986|FG011|Overall Study|Ineligible|0|||
170903101|NCT01827384|617646987|FG012|Overall Study|Ineligible|0|||
170903102|NCT01827384|617646988|FG013|Overall Study|Ineligible|19|||
170903103|NCT01827384|617646975|FG000|Overall Study|Participant died before treatment|0|||
170498260|NCT01217476|616162895|FG000|Overall Study|Withdrawal by Subject|3|||
170498261|NCT01217476|616162896|FG001|Overall Study|Withdrawal by Subject|3|||
170498262|NCT01217476|616162895|FG000|Overall Study|Surgery on the Target Limb|0|||
170551516|NCT00147537|616364810|FG002|Phase 1b|Death|2|||
170903104|NCT01827384|617646976|FG001|Overall Study|Participant died before treatment|0|||
170903105|NCT01827384|617646977|FG002|Overall Study|Participant died before treatment|0|||
170903106|NCT01827384|617646978|FG003|Overall Study|Participant died before treatment|0|||
170903107|NCT01827384|617646979|FG004|Overall Study|Participant died before treatment|0|||
170498263|NCT01217476|616162896|FG001|Overall Study|Surgery on the Target Limb|2|||
170498264|NCT01217476|616162895|FG000|Overall Study|Protocol Deviation|1|||
170498265|NCT01217476|616162896|FG001|Overall Study|Protocol Deviation|0|||
170498266|NCT01217476|616162895|FG000|Overall Study|Other|2|||
170498267|NCT01217476|616162896|FG001|Overall Study|Other|0|||
170903108|NCT01827384|617646980|FG005|Overall Study|Participant died before treatment|0|||
170903109|NCT01827384|617646981|FG006|Overall Study|Participant died before treatment|0|||
170903110|NCT01827384|617646982|FG007|Overall Study|Participant died before treatment|0|||
170903111|NCT01827384|617646983|FG008|Overall Study|Participant died before treatment|0|||
170903112|NCT01827384|617646984|FG009|Overall Study|Participant died before treatment|0|||
170903113|NCT01827384|617646985|FG010|Overall Study|Participant died before treatment|0|||
170903114|NCT01827384|617646986|FG011|Overall Study|Participant died before treatment|0|||
170498268|NCT00325156|616162897|FG000|Overall Study|Protocol Violation|8|||
170498269|NCT00325156|616162897|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
170498270|NCT00325156|616162897|FG000|Overall Study|Migrated/moved from study area|12|||
170498271|NCT00325156|616162897|FG000|Overall Study|Adverse event, non-fatal|3|||
170498272|NCT00325156|616162897|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
170498273|NCT00325156|616162897|FG000|Overall Study|Other|1|||
170498274|NCT00325156|616162897|FG000|Overall Study|Withdrawal by Subject|31|||
170498275|NCT04064411|616162898|FG000|Overall Study|Adverse Event|29|||
170498276|NCT04064411|616162899|FG001|Overall Study|Adverse Event|19|||
170498277|NCT04064411|616162898|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
170498278|NCT04064411|616162899|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
170498279|NCT04064411|616162898|FG000|Overall Study|Protocol Deviation|0|||
170498280|NCT04064411|616162899|FG001|Overall Study|Protocol Deviation|2|||
170498281|NCT04064411|616162898|FG000|Overall Study|Withdrawal by Subject|25|||
170498282|NCT04064411|616162899|FG001|Overall Study|Withdrawal by Subject|29|||
170498283|NCT04064411|616162898|FG000|Overall Study|Lost to Follow-up|5|||
170498284|NCT04064411|616162899|FG001|Overall Study|Lost to Follow-up|2|||
170498285|NCT04064411|616162898|FG000|Overall Study|Other than Specified|4|||
170498286|NCT04064411|616162899|FG001|Overall Study|Other than Specified|1|||
170498287|NCT04064411|616162898|FG000|Overall Study|Death|1|||
170498288|NCT04064411|616162899|FG001|Overall Study|Death|0|||
170498289|NCT03512210|616162902|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
170498290|NCT03512210|616162902|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
170498291|NCT03512210|616162902|FG000|Step 2:Post-MINMON|Death|2|||
170498292|NCT03512210|616162902|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
170498293|NCT03512210|616162902|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
170498294|NCT01672710|616162905|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
170903115|NCT01827384|617646987|FG012|Overall Study|Participant died before treatment|0|||
170903116|NCT01827384|617646988|FG013|Overall Study|Participant died before treatment|5|||
170903117|NCT01827384|617646975|FG000|Overall Study|Insufficient tumor cells|0|||
170903118|NCT01827384|617646976|FG001|Overall Study|Insufficient tumor cells|0|||
170903119|NCT01827384|617646977|FG002|Overall Study|Insufficient tumor cells|0|||
170903120|NCT01827384|617646978|FG003|Overall Study|Insufficient tumor cells|0|||
170903121|NCT01827384|617646979|FG004|Overall Study|Insufficient tumor cells|0|||
170903122|NCT01827384|617646980|FG005|Overall Study|Insufficient tumor cells|0|||
170903123|NCT01827384|617646981|FG006|Overall Study|Insufficient tumor cells|0|||
170903124|NCT01827384|617646982|FG007|Overall Study|Insufficient tumor cells|0|||
170903125|NCT01827384|617646983|FG008|Overall Study|Insufficient tumor cells|0|||
170903126|NCT01827384|617646984|FG009|Overall Study|Insufficient tumor cells|0|||
170903127|NCT01827384|617646985|FG010|Overall Study|Insufficient tumor cells|0|||
170903128|NCT01827384|617646986|FG011|Overall Study|Insufficient tumor cells|0|||
170903129|NCT01827384|617646987|FG012|Overall Study|Insufficient tumor cells|0|||
170903130|NCT01827384|617646988|FG013|Overall Study|Insufficient tumor cells|13|||
170903131|NCT01827384|617646975|FG000|Overall Study|No actionable mutation|0|||
170903132|NCT01827384|617646976|FG001|Overall Study|No actionable mutation|0|||
170498295|NCT01672710|616162906|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
170498296|NCT01672710|616162905|FG000|3 Month Follow up|Lost to Follow-up|2|||
170498297|NCT01672710|616162906|FG001|3 Month Follow up|Lost to Follow-up|3|||
170903133|NCT01827384|617646977|FG002|Overall Study|No actionable mutation|0|||
170903134|NCT01827384|617646978|FG003|Overall Study|No actionable mutation|0|||
170903135|NCT01827384|617646979|FG004|Overall Study|No actionable mutation|0|||
170903136|NCT01827384|617646980|FG005|Overall Study|No actionable mutation|0|||
170903137|NCT01827384|617646981|FG006|Overall Study|No actionable mutation|0|||
170498298|NCT01672710|616162905|FG000|3 Month Follow up|follow up due after termination date|4|||
170498299|NCT01672710|616162906|FG001|3 Month Follow up|follow up due after termination date|1|||
170498300|NCT02122887|616162907|FG000|Overall Study|Withdrawal by Subject|20|||
170498301|NCT02122887|616162908|FG001|Overall Study|Withdrawal by Subject|2|||
170498302|NCT03725761|616162909|FG000|Overall Study|still on study|1|||
170498303|NCT03055494|616165109|FG000|Overall Study|Lost to Follow-up|6|||
170498304|NCT03055494|616165110|FG001|Overall Study|Lost to Follow-up|0|||
170498305|NCT03055494|616165109|FG000|Overall Study|Physician Decision|2|||
170498306|NCT03055494|616165110|FG001|Overall Study|Physician Decision|0|||
170642419|NCT03899805|616705236|FG002|Overall Study|Came off for surgery|1|||
170642420|NCT01802073|616705237|FG000|Overall Study|Lost to Follow-up|0|||
170642421|NCT01802073|616705238|FG001|Overall Study|Lost to Follow-up|1|||
170804499|NCT03160885|617293643|FG004|Open-label Treatment|Not dosed|0|||
170804500|NCT03160885|617293644|FG005|Open-label Treatment|Not dosed|0|||
170804501|NCT03160885|617293645|FG006|Open-label Treatment|Not dosed|2|||
170498307|NCT03055494|616165109|FG000|Overall Study|Withdrawal by Subject|1|||
170498308|NCT03055494|616165110|FG001|Overall Study|Withdrawal by Subject|0|||
170804502|NCT03160885|617293639|FG000|Open-label Treatment|Discontinued IMP|0|||
170804503|NCT03160885|617293640|FG001|Open-label Treatment|Discontinued IMP|0|||
170498309|NCT03055494|616165109|FG000|Overall Study|Adverse Event|0|||
170498310|NCT03055494|616165110|FG001|Overall Study|Adverse Event|1|||
170498311|NCT03055494|616165109|FG000|Overall Study|Non-compliance with study treatment|1|||
170498312|NCT03055494|616165110|FG001|Overall Study|Non-compliance with study treatment|0|||
170498313|NCT05072106|616165113|FG000|Overall Study|Progressive disease|3|||
170498314|NCT05072106|616165114|FG001|Overall Study|Progressive disease|3|||
170498315|NCT05072106|616165113|FG000|Overall Study|Compassionate use|3|||
170498316|NCT05072106|616165114|FG001|Overall Study|Compassionate use|1|||
170498317|NCT05072106|616165113|FG000|Overall Study|Withdrawal by Subject|1|||
170498318|NCT05072106|616165114|FG001|Overall Study|Withdrawal by Subject|0|||
170498319|NCT03036098|616165115|FG000|Pre-Treatment|Other Reasons|1|||
170498320|NCT03036098|616165116|FG001|Pre-Treatment|Other Reasons|2|||
170498321|NCT03036098|616165117|FG002|Pre-Treatment|Other Reasons|0|||
170498322|NCT03036098|616165118|FG003|Pre-Treatment|Other Reasons|5|||
170498323|NCT03036098|616165115|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
170498324|NCT03036098|616165116|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
170498325|NCT03036098|616165117|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
170498326|NCT03036098|616165118|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
170498327|NCT03036098|616165115|FG000|Pre-Treatment|Withdrawal by Subject|1|||
170498328|NCT03036098|616165116|FG001|Pre-Treatment|Withdrawal by Subject|14|||
170498329|NCT03036098|616165117|FG002|Pre-Treatment|Withdrawal by Subject|0|||
170498330|NCT03036098|616165118|FG003|Pre-Treatment|Withdrawal by Subject|5|||
170498331|NCT03036098|616165115|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
170498332|NCT03036098|616165116|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
170498333|NCT03036098|616165117|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
170498334|NCT03036098|616165118|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
170498335|NCT03036098|616165115|FG000|Treatment|Disease Progression|130|||
170498336|NCT03036098|616165116|FG001|Treatment|Disease Progression|77|||
170498337|NCT03036098|616165117|FG002|Treatment|Disease Progression|168|||
170498338|NCT03036098|616165118|FG003|Treatment|Disease Progression|50|||
170498339|NCT03036098|616165115|FG000|Treatment|Study Drug Toxicity|95|||
170498340|NCT03036098|616165116|FG001|Treatment|Study Drug Toxicity|45|||
170498341|NCT03036098|616165117|FG002|Treatment|Study Drug Toxicity|26|||
170498342|NCT03036098|616165118|FG003|Treatment|Study Drug Toxicity|22|||
170498343|NCT03036098|616165115|FG000|Treatment|Death|9|||
170498344|NCT03036098|616165116|FG001|Treatment|Death|3|||
170498345|NCT03036098|616165117|FG002|Treatment|Death|1|||
170498346|NCT03036098|616165118|FG003|Treatment|Death|2|||
170804504|NCT03160885|617293641|FG002|Open-label Treatment|Discontinued IMP|0|||
170498347|NCT03036098|616165115|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
170498348|NCT03036098|616165116|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
170642422|NCT01802073|616705237|FG000|Overall Study|Non-compliant|4|||
170642423|NCT01802073|616705238|FG001|Overall Study|Non-compliant|2|||
170642424|NCT01802073|616705237|FG000|Overall Study|Withdrawal by Subject|1|||
170804505|NCT03160885|617293642|FG003|Open-label Treatment|Discontinued IMP|0|||
170804506|NCT03160885|617293643|FG004|Open-label Treatment|Discontinued IMP|0|||
170804507|NCT03160885|617293644|FG005|Open-label Treatment|Discontinued IMP|0|||
170804508|NCT03160885|617293645|FG006|Open-label Treatment|Discontinued IMP|131|||
170804509|NCT03160885|617293639|FG000|Open-label Treatment|Completed Week 50|0|||
170804510|NCT03160885|617293640|FG001|Open-label Treatment|Completed Week 50|0|||
170804511|NCT03160885|617293641|FG002|Open-label Treatment|Completed Week 50|0|||
170804512|NCT03160885|617293642|FG003|Open-label Treatment|Completed Week 50|0|||
170804513|NCT03160885|617293643|FG004|Open-label Treatment|Completed Week 50|0|||
170804514|NCT03160885|617293644|FG005|Open-label Treatment|Completed Week 50|0|||
170804515|NCT03160885|617293645|FG006|Open-label Treatment|Completed Week 50|4|||
170804516|NCT03160885|617293639|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
170804517|NCT03160885|617293640|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
170804518|NCT03160885|617293641|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
170642425|NCT01802073|616705238|FG001|Overall Study|Withdrawal by Subject|1|||
170498349|NCT03036098|616165117|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
170498350|NCT03036098|616165118|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
170498351|NCT03036098|616165115|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
170804519|NCT03160885|617293642|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
170804520|NCT03160885|617293643|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
170903138|NCT01827384|617646982|FG007|Overall Study|No actionable mutation|0|||
170903139|NCT01827384|617646983|FG008|Overall Study|No actionable mutation|0|||
170903140|NCT01827384|617646984|FG009|Overall Study|No actionable mutation|0|||
170903141|NCT01827384|617646985|FG010|Overall Study|No actionable mutation|0|||
170903142|NCT01827384|617646986|FG011|Overall Study|No actionable mutation|0|||
170903143|NCT01827384|617646987|FG012|Overall Study|No actionable mutation|0|||
170903144|NCT01827384|617646988|FG013|Overall Study|No actionable mutation|73|||
170498352|NCT03036098|616165116|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
170498353|NCT03036098|616165117|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
170498354|NCT03036098|616165118|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
170498355|NCT03036098|616165115|FG000|Treatment|Withdrawal by Subject|2|||
170498356|NCT03036098|616165116|FG001|Treatment|Withdrawal by Subject|9|||
170498357|NCT03036098|616165117|FG002|Treatment|Withdrawal by Subject|2|||
170498358|NCT03036098|616165118|FG003|Treatment|Withdrawal by Subject|4|||
170498359|NCT03036098|616165115|FG000|Treatment|Maximum Clinical Benefit|6|||
170498360|NCT03036098|616165116|FG001|Treatment|Maximum Clinical Benefit|1|||
170498361|NCT03036098|616165117|FG002|Treatment|Maximum Clinical Benefit|6|||
170498362|NCT03036098|616165118|FG003|Treatment|Maximum Clinical Benefit|10|||
170498363|NCT03036098|616165115|FG000|Treatment|Poor/Non Compliance|1|||
170498364|NCT03036098|616165116|FG001|Treatment|Poor/Non Compliance|2|||
170498365|NCT03036098|616165117|FG002|Treatment|Poor/Non Compliance|0|||
170498366|NCT03036098|616165118|FG003|Treatment|Poor/Non Compliance|1|||
170498367|NCT03036098|616165115|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
170498368|NCT03036098|616165116|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
170498369|NCT03036098|616165117|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
170498370|NCT03036098|616165118|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
170498371|NCT03036098|616165115|FG000|Treatment|Administrative Reason by Sponsor|1|||
170498372|NCT03036098|616165116|FG001|Treatment|Administrative Reason by Sponsor|0|||
170903145|NCT01827384|617646975|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
170903146|NCT01827384|617646976|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
170903147|NCT01827384|617646977|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
170903148|NCT01827384|617646978|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
170903149|NCT01827384|617646979|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
170498373|NCT03036098|616165117|FG002|Treatment|Administrative Reason by Sponsor|2|||
170498374|NCT03036098|616165118|FG003|Treatment|Administrative Reason by Sponsor|1|||
170498375|NCT03036098|616165115|FG000|Treatment|Other Reasons|31|||
170498376|NCT03036098|616165116|FG001|Treatment|Other Reasons|5|||
170498377|NCT03036098|616165117|FG002|Treatment|Other Reasons|21|||
170498378|NCT03036098|616165118|FG003|Treatment|Other Reasons|8|||
170498379|NCT03036098|616165115|FG000|Treatment|Ongoing Treatment|0|||
170498380|NCT03036098|616165116|FG001|Treatment|Ongoing Treatment|0|||
170498381|NCT03036098|616165117|FG002|Treatment|Ongoing Treatment|23|||
170551517|NCT00147537|616364811|FG003|Phase 1b|Death|1|||
170551518|NCT00147537|616364812|FG004|Phase 1b|Death|2|||
170551519|NCT00147537|616364813|FG005|Phase 1b|Death|2|||
170551520|NCT00147537|616364814|FG006|Phase 1b|Death|1|||
170551521|NCT00147537|616364815|FG007|Phase 1b|Death|3|||
170551522|NCT00147537|616364816|FG008|Phase 1b|Death|9|||
170551523|NCT00147537|616364817|FG009|Phase 1b|Death|0|||
170551524|NCT00147537|616364818|FG010|Phase 1b|Death|0|||
170551525|NCT00147537|616364808|FG000|Phase 1b|Lost to Follow-up|2|||
170551526|NCT00147537|616364809|FG001|Phase 1b|Lost to Follow-up|1|||
170551527|NCT00147537|616364810|FG002|Phase 1b|Lost to Follow-up|0|||
170551528|NCT00147537|616364811|FG003|Phase 1b|Lost to Follow-up|0|||
170551529|NCT00147537|616364812|FG004|Phase 1b|Lost to Follow-up|0|||
170551530|NCT00147537|616364813|FG005|Phase 1b|Lost to Follow-up|0|||
170551531|NCT00147537|616364814|FG006|Phase 1b|Lost to Follow-up|2|||
170551532|NCT00147537|616364815|FG007|Phase 1b|Lost to Follow-up|0|||
170642426|NCT01802073|616705237|FG000|Overall Study|Physician Decision|0|||
170903150|NCT01827384|617646980|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
170903151|NCT01827384|617646981|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
170903152|NCT01827384|617646982|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
170903153|NCT01827384|617646983|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
170903154|NCT01827384|617646984|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
170903155|NCT01827384|617646985|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
170903156|NCT01827384|617646986|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
170903157|NCT01827384|617646987|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
170903158|NCT01827384|617646988|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
170903159|NCT00075881|617649028|FG000|Overall Study|Lack of Efficacy|18|||
170498382|NCT03036098|616165118|FG003|Treatment|Ongoing Treatment|0|||
170498383|NCT04240886|616165121|FG000|Treatment Phase|Death|4|||
170551533|NCT00147537|616364816|FG008|Phase 1b|Lost to Follow-up|1|||
170551534|NCT00147537|616364817|FG009|Phase 1b|Lost to Follow-up|0|||
170551535|NCT00147537|616364818|FG010|Phase 1b|Lost to Follow-up|0|||
170551536|NCT00147537|616364808|FG000|Phase 1b|Other|0|||
170551537|NCT00147537|616364809|FG001|Phase 1b|Other|0|||
170551538|NCT00147537|616364810|FG002|Phase 1b|Other|2|||
170551539|NCT00147537|616364811|FG003|Phase 1b|Other|1|||
170551540|NCT00147537|616364812|FG004|Phase 1b|Other|1|||
170551541|NCT00147537|616364813|FG005|Phase 1b|Other|1|||
170551542|NCT00147537|616364814|FG006|Phase 1b|Other|14|||
170551543|NCT00147537|616364815|FG007|Phase 1b|Other|4|||
170551544|NCT00147537|616364816|FG008|Phase 1b|Other|4|||
170551545|NCT00147537|616364817|FG009|Phase 1b|Other|0|||
170551546|NCT00147537|616364818|FG010|Phase 1b|Other|0|||
170551547|NCT00147537|616364808|FG000|Phase 1b|Withdrawal by Subject|0|||
170551548|NCT00147537|616364809|FG001|Phase 1b|Withdrawal by Subject|0|||
170551549|NCT00147537|616364810|FG002|Phase 1b|Withdrawal by Subject|0|||
170551550|NCT00147537|616364811|FG003|Phase 1b|Withdrawal by Subject|0|||
170551551|NCT00147537|616364812|FG004|Phase 1b|Withdrawal by Subject|0|||
170551552|NCT00147537|616364813|FG005|Phase 1b|Withdrawal by Subject|0|||
170551553|NCT00147537|616364814|FG006|Phase 1b|Withdrawal by Subject|0|||
170551554|NCT00147537|616364815|FG007|Phase 1b|Withdrawal by Subject|0|||
170903160|NCT00075881|617649028|FG000|Overall Study|Adverse Event|7|||
170903161|NCT00075881|617649028|FG000|Overall Study|Death|1|||
170903162|NCT00075881|617649028|FG000|Overall Study|Withdrawal by Subject|2|||
170903163|NCT00075881|617649028|FG000|Overall Study|Protocol Violation|4|||
170903164|NCT00075881|617649028|FG000|Overall Study|other complicating disease|3|||
170903165|NCT00075881|617649028|FG000|Overall Study|other|4|||
170903166|NCT00075881|617649028|FG000|Overall Study|missing data|2|||
170903167|NCT00075881|617649028|FG000|Overall Study|Ineligible|1|||
170903168|NCT00075881|617649028|FG000|Overall Study|never start protocol therapy|1|||
170903169|NCT02224664|617649029|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
170903170|NCT02224664|617649030|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
170903171|NCT02224664|617649031|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
170903172|NCT02224664|617649032|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
170903173|NCT02224664|617649033|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
170903174|NCT02224664|617649029|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
170903175|NCT02224664|617649030|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
170903176|NCT02224664|617649031|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
170903177|NCT02224664|617649032|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
170903178|NCT02224664|617649033|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
170903179|NCT02224664|617649029|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
170903180|NCT02224664|617649030|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
170903181|NCT02224664|617649031|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
170903182|NCT02224664|617649032|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
170903183|NCT02224664|617649033|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
170903184|NCT03019549|617649034|FG000|Washout|DId not meet genotype criteria|11|||
170903185|NCT03019549|617649034|FG000|Period 2|Adverse Event|2|||
170903186|NCT03019549|617649034|FG000|Period 2|Physician Decision|2|||
170903187|NCT03019549|617649034|FG000|Period 2|Withdrawal by Subject|1|||
170903188|NCT04030195|617649037|FG000|Overall Study|Withdrawal by Subject|2|||
170903189|NCT04030195|617649038|FG001|Overall Study|Withdrawal by Subject|0|||
170903190|NCT04030195|617649039|FG002|Overall Study|Withdrawal by Subject|0|||
170903191|NCT01412879|617649040|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
170903192|NCT01412879|617649041|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
170903193|NCT01412879|617649042|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
170903194|NCT01412879|617649040|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
170903195|NCT01412879|617649041|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
170903196|NCT01412879|617649042|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
170903197|NCT01412879|617649040|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
170903198|NCT01412879|617649041|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
170903199|NCT01412879|617649042|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
170903200|NCT01412879|617649040|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
170551555|NCT00147537|616364816|FG008|Phase 1b|Withdrawal by Subject|2|||
170551556|NCT00147537|616364817|FG009|Phase 1b|Withdrawal by Subject|0|||
170551557|NCT00147537|616364818|FG010|Phase 1b|Withdrawal by Subject|0|||
170551558|NCT00147537|616364808|FG000|Phase 1b|Randomized but not treated|0|||
170551559|NCT00147537|616364809|FG001|Phase 1b|Randomized but not treated|0|||
170551560|NCT00147537|616364810|FG002|Phase 1b|Randomized but not treated|0|||
170551561|NCT00147537|616364811|FG003|Phase 1b|Randomized but not treated|0|||
170551562|NCT00147537|616364812|FG004|Phase 1b|Randomized but not treated|0|||
170903201|NCT01412879|617649041|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
170551563|NCT00147537|616364813|FG005|Phase 1b|Randomized but not treated|0|||
170551564|NCT00147537|616364814|FG006|Phase 1b|Randomized but not treated|1|||
170551565|NCT00147537|616364815|FG007|Phase 1b|Randomized but not treated|0|||
170903202|NCT01412879|617649042|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
170903203|NCT01412879|617649040|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
170903204|NCT01412879|617649041|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
170903205|NCT01412879|617649042|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
170903206|NCT02109029|617649043|FG000|Part B|Adverse Event|0|||
170903207|NCT02109029|617649044|FG001|Part B|Adverse Event|0|||
170903208|NCT02109029|617649045|FG002|Part B|Adverse Event|0|||
170903209|NCT02109029|617649046|FG003|Part B|Adverse Event|0|||
170903210|NCT02109029|617649047|FG004|Part B|Adverse Event|1|||
170903211|NCT02109029|617649048|FG005|Part B|Adverse Event|1|||
170903212|NCT03195894|617649049|FG000|Overall Study|"An example is Started other treatment."|4|||
170903213|NCT03195894|617649050|FG001|Overall Study|"An example is Started other treatment."|5|||
170903214|NCT03195894|617649049|FG000|Overall Study|Withdrawal by Subject|15|||
170903215|NCT03195894|617649050|FG001|Overall Study|Withdrawal by Subject|4|||
170903216|NCT03195894|617649049|FG000|Overall Study|Lost to Follow-up|14|||
170642427|NCT01802073|616705238|FG001|Overall Study|Physician Decision|7|||
170642428|NCT02625909|616705248|FG000|Overall Study|Death|2|||
170642429|NCT02625909|616705249|FG001|Overall Study|Death|0|||
170642430|NCT02625909|616705248|FG000|Overall Study|Lost to Follow-up|3|||
170642431|NCT02625909|616705249|FG001|Overall Study|Lost to Follow-up|5|||
170642432|NCT02625909|616705248|FG000|Overall Study|Lack of Efficacy|9|||
170642433|NCT02625909|616705249|FG001|Overall Study|Lack of Efficacy|2|||
170642434|NCT02625909|616705248|FG000|Overall Study|Reinfection|3|||
170642435|NCT02625909|616705249|FG001|Overall Study|Reinfection|2|||
170642436|NCT00567255|616705250|FG000|Overall Study|Adverse Event|241|||
170642437|NCT00567255|616705251|FG001|Overall Study|Adverse Event|68|||
170642438|NCT00567255|616705250|FG000|Overall Study|Lost to Follow-up|77|||
170642439|NCT00567255|616705251|FG001|Overall Study|Lost to Follow-up|48|||
170642440|NCT00567255|616705250|FG000|Overall Study|Withdrawal by Subject|75|||
170642441|NCT00567255|616705251|FG001|Overall Study|Withdrawal by Subject|56|||
170642442|NCT00567255|616705250|FG000|Overall Study|Lack of Efficacy|19|||
170642443|NCT00567255|616705251|FG001|Overall Study|Lack of Efficacy|33|||
170903217|NCT03195894|617649050|FG001|Overall Study|Lost to Follow-up|19|||
170903218|NCT01056107|617649059|FG000|Overall Study|Withdrawal by Subject|0|||
170903219|NCT01056107|617649060|FG001|Overall Study|Withdrawal by Subject|1|||
170903220|NCT01056107|617649061|FG002|Overall Study|Withdrawal by Subject|3|||
170903221|NCT01056107|617649062|FG003|Overall Study|Withdrawal by Subject|0|||
170903222|NCT00215150|617649065|FG000|Open Label Phase|Lost to Follow-up|7|||
170903223|NCT00215150|617649065|FG000|Open Label Phase|Withdrawal by Subject|1|||
170903224|NCT00215150|617649065|FG000|Open Label Phase|Did not complete a post base visit|13|||
170903225|NCT00215150|617649065|FG000|Open Label Phase|Did not meet randomization criteria|9|||
170903226|NCT00215150|617649065|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
170903227|NCT00215150|617649065|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
170903228|NCT00215150|617649065|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
170903229|NCT00377962|617649066|FG000|Core Study: 0-12 Months|Adverse Event|18|||
170903230|NCT00377962|617649067|FG001|Core Study: 0-12 Months|Adverse Event|2|||
170903231|NCT00377962|617649066|FG000|Core Study: 0-12 Months|Death|3|||
170903232|NCT00377962|617649067|FG001|Core Study: 0-12 Months|Death|0|||
170903233|NCT00377962|617649066|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
170903234|NCT00377962|617649067|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
170903235|NCT00377962|617649066|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
170903236|NCT00377962|617649067|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
170903237|NCT00377962|617649066|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
170903238|NCT00377962|617649067|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
170903239|NCT00377962|617649066|FG000|Extension Study: 12-24 Months|Death|1|||
170903240|NCT00377962|617649067|FG001|Extension Study: 12-24 Months|Death|1|||
170903241|NCT00377962|617649066|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
170903242|NCT00377962|617649067|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
170498384|NCT04240886|616165121|FG000|Treatment Phase|Discontinuation by Subject|1|||
170498385|NCT04240886|616165121|FG000|Treatment Phase|Adverse Event|5|||
170498386|NCT04240886|616165121|FG000|Follow-up Phase|Withdrawal by Subject|1|||
170498387|NCT04240886|616165121|FG000|Follow-up Phase|Discontinuation by Subject|1|||
170498388|NCT04240886|616165121|FG000|Follow-up Phase|Death|2|||
170903243|NCT00377962|617649066|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
170498389|NCT04743804|616165124|FG000|Overall Study|Other|1|||
170498390|NCT04743804|616165125|FG001|Overall Study|Other|0|||
170642444|NCT00567255|616705250|FG000|Overall Study|Protocol Violation|20|||
170642445|NCT00567255|616705251|FG001|Overall Study|Protocol Violation|8|||
170642446|NCT00567255|616705250|FG000|Overall Study|Pregnancy|6|||
170642447|NCT00567255|616705251|FG001|Overall Study|Pregnancy|0|||
170642448|NCT00567255|616705250|FG000|Overall Study|Drug noncompliance,moved,other|25|||
170642449|NCT00567255|616705251|FG001|Overall Study|Drug noncompliance,moved,other|15|||
170642450|NCT01297491|616705256|FG000|Overall Study|Adverse Event|11|||
170642451|NCT01297491|616705257|FG001|Overall Study|Adverse Event|6|||
170903244|NCT00377962|617649067|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
170903245|NCT00377962|617649066|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
170498391|NCT04743804|616165124|FG000|Overall Study|Withdrawal by Subject|0|||
170498392|NCT04743804|616165125|FG001|Overall Study|Withdrawal by Subject|1|||
170498393|NCT04743804|616165124|FG000|Overall Study|Study Terminated by Sponsor|1|||
170498394|NCT04743804|616165125|FG001|Overall Study|Study Terminated by Sponsor|4|||
170498395|NCT04743804|616165124|FG000|Overall Study|Physician Decision|0|||
170498396|NCT04743804|616165125|FG001|Overall Study|Physician Decision|1|||
170498397|NCT04743804|616165124|FG000|Overall Study|Death|3|||
170498398|NCT04743804|616165125|FG001|Overall Study|Death|0|||
170498399|NCT02928770|616165128|FG000|Overall Study|Withdrawal by Subject|2|||
170498400|NCT02515994|616165134|FG000|Overall Study|Protocol Violation|3|||
170498401|NCT02515994|616165135|FG001|Overall Study|Protocol Violation|5|||
170498402|NCT02515994|616165134|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
170498403|NCT02515994|616165135|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
170498404|NCT02515994|616165134|FG000|Overall Study|Adverse Event|3|||
170551566|NCT00147537|616364816|FG008|Phase 1b|Randomized but not treated|1|||
170551567|NCT00147537|616364817|FG009|Phase 1b|Randomized but not treated|0|||
170804521|NCT03160885|617293644|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
170804522|NCT03160885|617293645|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
170804523|NCT03160885|617293639|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
170804524|NCT03160885|617293640|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
170804525|NCT03160885|617293641|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
170804526|NCT03160885|617293642|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
170804527|NCT03160885|617293643|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
170804528|NCT03160885|617293644|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
170804529|NCT03160885|617293645|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
170804530|NCT03160885|617293639|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
170804531|NCT03160885|617293640|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
170804532|NCT03160885|617293641|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
170804533|NCT03160885|617293642|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
170804534|NCT03160885|617293643|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
170804535|NCT03160885|617293644|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
170804536|NCT03160885|617293645|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
170804537|NCT03160885|617293639|FG000|Maintenance Treatment Period|Completed Week 50|0|||
170804538|NCT03160885|617293640|FG001|Maintenance Treatment Period|Completed Week 50|0|||
170804539|NCT03160885|617293641|FG002|Maintenance Treatment Period|Completed Week 50|1|||
170804540|NCT03160885|617293642|FG003|Maintenance Treatment Period|Completed Week 50|0|||
170804541|NCT03160885|617293643|FG004|Maintenance Treatment Period|Completed Week 50|0|||
170804542|NCT03160885|617293644|FG005|Maintenance Treatment Period|Completed Week 50|0|||
170804543|NCT03160885|617293645|FG006|Maintenance Treatment Period|Completed Week 50|0|||
170804544|NCT03425682|617293646|FG000|Overall Study|Lost to Follow-up|2|||
170804545|NCT03425682|617293647|FG001|Overall Study|Lost to Follow-up|4|||
170804546|NCT03425682|617293646|FG000|Overall Study|Withdrawal by Subject|0|||
170804547|NCT03425682|617293647|FG001|Overall Study|Withdrawal by Subject|3|||
170804548|NCT03425682|617293646|FG000|Overall Study|Subject did not meet I/E|4|||
170804549|NCT03425682|617293647|FG001|Overall Study|Subject did not meet I/E|10|||
170804550|NCT04153890|617293648|FG000|Overall Study|Lost to Follow-up|9|||
170804551|NCT04153890|617293649|FG001|Overall Study|Lost to Follow-up|0|||
170804552|NCT04153890|617293650|FG002|Overall Study|Lost to Follow-up|9|||
170804553|NCT04153890|617293651|FG003|Overall Study|Lost to Follow-up|0|||
170804554|NCT04153890|617293648|FG000|Overall Study|Death|0|||
170804555|NCT04153890|617293649|FG001|Overall Study|Death|2|||
170804556|NCT04153890|617293650|FG002|Overall Study|Death|0|||
170804557|NCT04153890|617293651|FG003|Overall Study|Death|0|||
170804558|NCT04153890|617293648|FG000|Overall Study|Withdrawal by Subject|0|||
170804559|NCT04153890|617293649|FG001|Overall Study|Withdrawal by Subject|0|||
170804560|NCT04153890|617293650|FG002|Overall Study|Withdrawal by Subject|0|||
170804561|NCT04153890|617293651|FG003|Overall Study|Withdrawal by Subject|2|||
170804562|NCT00489307|617293652|FG000|Overall Study|Death|1|||
170804563|NCT00489307|617293653|FG001|Overall Study|Death|1|||
170804564|NCT00489307|617293652|FG000|Overall Study|Lost to Follow-up|2|||
170804565|NCT00489307|617293653|FG001|Overall Study|Lost to Follow-up|2|||
170804566|NCT00489307|617293652|FG000|Overall Study|Physician Decision|1|||
170804567|NCT00489307|617293653|FG001|Overall Study|Physician Decision|0|||
170804568|NCT00489307|617293652|FG000|Overall Study|Withdrawal by Subject|2|||
170804569|NCT00489307|617293653|FG001|Overall Study|Withdrawal by Subject|4|||
170804570|NCT00489307|617293652|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
170804571|NCT00489307|617293653|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
170804572|NCT00489307|617293652|FG000|Overall Study|Surgery after assignment|1|||
170804573|NCT00489307|617293653|FG001|Overall Study|Surgery after assignment|0|||
170804574|NCT00489307|617293652|FG000|Overall Study|Did not fill up the forms|2|||
170804575|NCT00489307|617293653|FG001|Overall Study|Did not fill up the forms|1|||
170804576|NCT00489307|617293652|FG000|Overall Study|Patient or family refusal|5|||
170804577|NCT00489307|617293653|FG001|Overall Study|Patient or family refusal|9|||
170804578|NCT02307682|617293654|FG000|Overall Study|Adverse Event|9|||
170804579|NCT02307682|617293655|FG001|Overall Study|Adverse Event|8|||
170804580|NCT02307682|617293656|FG002|Overall Study|Adverse Event|12|||
170498405|NCT02515994|616165135|FG001|Overall Study|Adverse Event|1|||
170498406|NCT02515994|616165134|FG000|Overall Study|Withdrawal by Subject|2|||
170498407|NCT02515994|616165135|FG001|Overall Study|Withdrawal by Subject|0|||
170498408|NCT01424514|616165136|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
170498409|NCT01424514|616165137|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
170498410|NCT01424514|616165136|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
170498411|NCT01424514|616165137|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
170498412|NCT01214252|616165142|FG000|Overall Study|Not eligible per protocol|82|||
170498413|NCT01371877|616165144|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
170498414|NCT01371877|616165145|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
170498415|NCT05932225|616165146|FG000|Overall Study|Lost to Follow-up|0|||
170498416|NCT05932225|616165147|FG001|Overall Study|Lost to Follow-up|1|||
170498417|NCT05932225|616165148|FG002|Overall Study|Lost to Follow-up|0|||
170498418|NCT05932225|616165146|FG000|Overall Study|Withdrawal by Subject|1|||
170551568|NCT00147537|616364818|FG010|Phase 1b|Randomized but not treated|0|||
170551569|NCT00147537|616364808|FG000|Phase 2|Death|0|||
170551570|NCT00147537|616364809|FG001|Phase 2|Death|0|||
170551571|NCT00147537|616364810|FG002|Phase 2|Death|0|||
170551572|NCT00147537|616364811|FG003|Phase 2|Death|0|||
170551573|NCT00147537|616364812|FG004|Phase 2|Death|0|||
170551574|NCT00147537|616364813|FG005|Phase 2|Death|0|||
170551575|NCT00147537|616364814|FG006|Phase 2|Death|0|||
170551576|NCT00147537|616364815|FG007|Phase 2|Death|0|||
170551577|NCT00147537|616364816|FG008|Phase 2|Death|0|||
170551578|NCT00147537|616364817|FG009|Phase 2|Death|85|||
170551579|NCT00147537|616364818|FG010|Phase 2|Death|31|||
170551580|NCT00147537|616364808|FG000|Phase 2|Lost to Follow-up|0|||
170551581|NCT00147537|616364809|FG001|Phase 2|Lost to Follow-up|0|||
170551582|NCT00147537|616364810|FG002|Phase 2|Lost to Follow-up|0|||
170551583|NCT00147537|616364811|FG003|Phase 2|Lost to Follow-up|0|||
170551584|NCT00147537|616364812|FG004|Phase 2|Lost to Follow-up|0|||
170551585|NCT00147537|616364813|FG005|Phase 2|Lost to Follow-up|0|||
170804581|NCT02307682|617293654|FG000|Overall Study|Lack of Efficacy|1|||
170804582|NCT02307682|617293655|FG001|Overall Study|Lack of Efficacy|0|||
170804583|NCT02307682|617293656|FG002|Overall Study|Lack of Efficacy|1|||
170804584|NCT02307682|617293654|FG000|Overall Study|Physician Decision|2|||
170804585|NCT02307682|617293655|FG001|Overall Study|Physician Decision|2|||
170804586|NCT02307682|617293656|FG002|Overall Study|Physician Decision|8|||
170804587|NCT02307682|617293654|FG000|Overall Study|Progressive Disease|1|||
170804588|NCT02307682|617293655|FG001|Overall Study|Progressive Disease|0|||
170804589|NCT02307682|617293656|FG002|Overall Study|Progressive Disease|0|||
170804590|NCT02307682|617293654|FG000|Overall Study|Withdrawal by Subject|26|||
170804591|NCT02307682|617293655|FG001|Overall Study|Withdrawal by Subject|34|||
170804592|NCT02307682|617293656|FG002|Overall Study|Withdrawal by Subject|23|||
170804593|NCT02307682|617293654|FG000|Overall Study|Death|9|||
170804594|NCT02307682|617293655|FG001|Overall Study|Death|7|||
170804595|NCT02307682|617293656|FG002|Overall Study|Death|12|||
170804596|NCT02307682|617293654|FG000|Overall Study|Lost to Follow-up|1|||
170804597|NCT02307682|617293655|FG001|Overall Study|Lost to Follow-up|5|||
170804598|NCT02307682|617293656|FG002|Overall Study|Lost to Follow-up|6|||
170804599|NCT02307682|617293654|FG000|Overall Study|Protocol Deviation|0|||
170804600|NCT02307682|617293655|FG001|Overall Study|Protocol Deviation|0|||
170804601|NCT02307682|617293656|FG002|Overall Study|Protocol Deviation|2|||
170804602|NCT02307682|617293654|FG000|Overall Study|Other|1|||
170804603|NCT02307682|617293655|FG001|Overall Study|Other|1|||
170804604|NCT02307682|617293656|FG002|Overall Study|Other|0|||
170804605|NCT04218357|617293661|FG000|1st Allocation|Withdrawal by Subject|1|||
170804606|NCT04218357|617293662|FG001|1st Allocation|Withdrawal by Subject|0|||
170804607|NCT05810285|617293673|FG000|Overall Study|Death|4|||
170804608|NCT05810285|617293674|FG001|Overall Study|Death|21|||
170804609|NCT05810285|617293673|FG000|Overall Study|Adverse Event|18|||
170804610|NCT05810285|617293674|FG001|Overall Study|Adverse Event|16|||
170804611|NCT05037513|617293675|FG000|Intervention Period|Lost to Follow-up|1|||
170498419|NCT05932225|616165147|FG001|Overall Study|Withdrawal by Subject|0|||
170498420|NCT05932225|616165148|FG002|Overall Study|Withdrawal by Subject|0|||
170498421|NCT05932225|616165146|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
170551586|NCT00147537|616364814|FG006|Phase 2|Lost to Follow-up|0|||
170551587|NCT00147537|616364815|FG007|Phase 2|Lost to Follow-up|0|||
170551588|NCT00147537|616364816|FG008|Phase 2|Lost to Follow-up|0|||
170551589|NCT00147537|616364817|FG009|Phase 2|Lost to Follow-up|12|||
170551590|NCT00147537|616364818|FG010|Phase 2|Lost to Follow-up|4|||
170804612|NCT05037513|617293676|FG001|Intervention Period|Lost to Follow-up|2|||
170804613|NCT05037513|617293675|FG000|Follow Up Period|Lost to Follow-up|16|||
170804614|NCT05037513|617293676|FG001|Follow Up Period|Lost to Follow-up|21|||
170804615|NCT05037513|617293675|FG000|Follow Up Period|Death|0|||
170804616|NCT05037513|617293676|FG001|Follow Up Period|Death|1|||
170804617|NCT05037513|617293675|FG000|Follow Up Period|Incarcerated|4|||
170804618|NCT05037513|617293676|FG001|Follow Up Period|Incarcerated|2|||
170804619|NCT05886777|617293677|FG000|Overall Study|Lost to Follow-up|1|||
170498422|NCT05932225|616165147|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
170498423|NCT05932225|616165148|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
170498424|NCT01473394|616165149|FG000|Overall Study|Adverse Event|13|||
170498425|NCT01473394|616165150|FG001|Overall Study|Adverse Event|16|||
170498426|NCT01473394|616165149|FG000|Overall Study|Insufficient Therapeutic Response|4|||
170498427|NCT01473394|616165150|FG001|Overall Study|Insufficient Therapeutic Response|1|||
170498428|NCT01473394|616165149|FG000|Overall Study|Protocol Violation|7|||
170498429|NCT01473394|616165150|FG001|Overall Study|Protocol Violation|5|||
170804620|NCT05886777|617293678|FG001|Overall Study|Lost to Follow-up|0|||
170804621|NCT05886777|617293679|FG002|Overall Study|Lost to Follow-up|2|||
170804622|NCT05886777|617293680|FG003|Overall Study|Lost to Follow-up|1|||
170804623|NCT05886777|617293681|FG004|Overall Study|Lost to Follow-up|0|||
170804624|NCT05886777|617293682|FG005|Overall Study|Lost to Follow-up|2|||
170804625|NCT05886777|617293683|FG006|Overall Study|Lost to Follow-up|0|||
170804626|NCT05886777|617293677|FG000|Overall Study|Other|0|||
170804627|NCT05886777|617293678|FG001|Overall Study|Other|2|||
170804628|NCT05886777|617293679|FG002|Overall Study|Other|1|||
170804629|NCT05886777|617293680|FG003|Overall Study|Other|0|||
170804630|NCT05886777|617293681|FG004|Overall Study|Other|0|||
170804631|NCT05886777|617293682|FG005|Overall Study|Other|0|||
170804632|NCT05886777|617293683|FG006|Overall Study|Other|0|||
170804633|NCT05886777|617293677|FG000|Overall Study|Withdrawal by Subject|1|||
170804634|NCT05886777|617293678|FG001|Overall Study|Withdrawal by Subject|0|||
170804635|NCT05886777|617293679|FG002|Overall Study|Withdrawal by Subject|1|||
170804636|NCT05886777|617293680|FG003|Overall Study|Withdrawal by Subject|4|||
170804637|NCT05886777|617293681|FG004|Overall Study|Withdrawal by Subject|3|||
170804638|NCT05886777|617293682|FG005|Overall Study|Withdrawal by Subject|1|||
170804639|NCT05886777|617293683|FG006|Overall Study|Withdrawal by Subject|1|||
170804640|NCT05886777|617293677|FG000|Overall Study|Protocol Violation|0|||
170804641|NCT05886777|617293678|FG001|Overall Study|Protocol Violation|0|||
170804642|NCT05886777|617293679|FG002|Overall Study|Protocol Violation|1|||
170804643|NCT05886777|617293680|FG003|Overall Study|Protocol Violation|0|||
170804644|NCT05886777|617293681|FG004|Overall Study|Protocol Violation|0|||
170804645|NCT05886777|617293682|FG005|Overall Study|Protocol Violation|0|||
170804646|NCT05886777|617293683|FG006|Overall Study|Protocol Violation|0|||
170804647|NCT05886777|617293677|FG000|Overall Study|No longer met eligibility criteria|0|||
170804648|NCT05886777|617293678|FG001|Overall Study|No longer met eligibility criteria|1|||
170804649|NCT05886777|617293679|FG002|Overall Study|No longer met eligibility criteria|0|||
170804650|NCT05886777|617293680|FG003|Overall Study|No longer met eligibility criteria|0|||
170804651|NCT05886777|617293681|FG004|Overall Study|No longer met eligibility criteria|0|||
170804652|NCT05886777|617293682|FG005|Overall Study|No longer met eligibility criteria|0|||
170804653|NCT05886777|617293683|FG006|Overall Study|No longer met eligibility criteria|0|||
170804654|NCT03664804|617293685|FG000|Overall Study|Withdrawal by Subject|7|||
170804655|NCT05529992|617293686|FG000|Overall Study|Withdrawal by Subject|1|||
170804656|NCT06140290|617293687|FG000|Period 1|Adverse Event|1|||
170804657|NCT06140290|617293688|FG001|Period 1|Adverse Event|0|||
170804658|NCT06140290|617293687|FG000|Period 2|Assigned but not treated|0|||
170804659|NCT06140290|617293688|FG001|Period 2|Assigned but not treated|1|||
170804660|NCT06140290|617293687|FG000|Period 2|Withdrawal by Subject|0|||
170804661|NCT06140290|617293688|FG001|Period 2|Withdrawal by Subject|1|||
170804662|NCT02036970|617294663|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
170804663|NCT02036970|617294664|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
170804664|NCT02036970|617294665|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
170804665|NCT02036970|617294666|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
170804666|NCT02036970|617294667|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
170804667|NCT02036970|617294668|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
170804668|NCT02036970|617294669|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
170804669|NCT02036970|617294670|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
170804670|NCT02036970|617294671|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
170804671|NCT02036970|617294672|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
170804672|NCT02036970|617294663|FG000|Part 1: Day 1 Through Week 16|Death|0|||
170804673|NCT02036970|617294664|FG001|Part 1: Day 1 Through Week 16|Death|0|||
170804674|NCT02036970|617294665|FG002|Part 1: Day 1 Through Week 16|Death|0|||
170804675|NCT02036970|617294666|FG003|Part 1: Day 1 Through Week 16|Death|0|||
170804676|NCT02036970|617294667|FG004|Part 1: Day 1 Through Week 16|Death|0|||
170804677|NCT02036970|617294668|FG005|Part 1: Day 1 Through Week 16|Death|0|||
170804678|NCT02036970|617294669|FG006|Part 1: Day 1 Through Week 16|Death|0|||
170804679|NCT02036970|617294670|FG007|Part 1: Day 1 Through Week 16|Death|0|||
170804680|NCT02036970|617294671|FG008|Part 1: Day 1 Through Week 16|Death|1|||
170804681|NCT02036970|617294672|FG009|Part 1: Day 1 Through Week 16|Death|0|||
170804682|NCT02036970|617294663|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
170804683|NCT02036970|617294664|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
170498430|NCT01473394|616165149|FG000|Overall Study|Withdrew Consent|12|||
170804684|NCT02036970|617294665|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
170804685|NCT02036970|617294666|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
170498431|NCT01473394|616165150|FG001|Overall Study|Withdrew Consent|10|||
170498432|NCT01473394|616165149|FG000|Overall Study|Lost to Follow-up|9|||
170498433|NCT01473394|616165150|FG001|Overall Study|Lost to Follow-up|11|||
170498434|NCT00345878|616165151|FG000|Overall Study|Adverse Event|1|||
170498435|NCT00345878|616165152|FG001|Overall Study|Adverse Event|0|||
170498436|NCT00345878|616165151|FG000|Overall Study|Lost to Follow-up|2|||
170498437|NCT00345878|616165152|FG001|Overall Study|Lost to Follow-up|1|||
170498438|NCT00345878|616165151|FG000|Overall Study|Other|1|||
170498439|NCT00345878|616165152|FG001|Overall Study|Other|0|||
170498440|NCT00552032|616165153|FG000|Overall Study|Withdrawal by Subject|2|||
170498441|NCT00552032|616165154|FG001|Overall Study|Withdrawal by Subject|2|||
170498442|NCT00552032|616165153|FG000|Overall Study|Protocol Violation|7|||
170498443|NCT00552032|616165154|FG001|Overall Study|Protocol Violation|12|||
170498444|NCT00552032|616165153|FG000|Overall Study|Lost to Follow-up|8|||
170498445|NCT00552032|616165154|FG001|Overall Study|Lost to Follow-up|5|||
170498446|NCT03391232|616165155|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
170498447|NCT03391232|616165156|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
170498448|NCT03391232|616165155|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
170498449|NCT03391232|616165156|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
170498450|NCT02424630|616165160|FG000|Overall Study|No rotator cuff tear|1|||
170498451|NCT02424630|616165161|FG001|Overall Study|No rotator cuff tear|2|||
170498452|NCT02424630|616165160|FG000|Overall Study|Open procedure|0|||
170498453|NCT02424630|616165161|FG001|Overall Study|Open procedure|1|||
170498454|NCT01877551|616165163|FG000|Overall Study|Physician Decision|0|||
170498455|NCT01877551|616165164|FG001|Overall Study|Physician Decision|1|||
170498456|NCT04777201|616165165|FG000|Main Study|Withdrawal by Subject|19|||
170498457|NCT04777201|616165166|FG001|Main Study|Withdrawal by Subject|27|||
170498458|NCT04777201|616165167|FG002|Main Study|Withdrawal by Subject|0|||
170903246|NCT00377962|617649067|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
170903247|NCT02091440|617649078|FG000|Overall Study|Death|2|||
170903248|NCT00768222|617649079|FG000|Overall Study|Lost to Follow-up|1|||
170903249|NCT00768222|617649080|FG001|Overall Study|Lost to Follow-up|1|||
170903250|NCT00768222|617649079|FG000|Overall Study|Withdrawal by Subject|3|||
170903251|NCT00768222|617649080|FG001|Overall Study|Withdrawal by Subject|1|||
170903252|NCT00768222|617649079|FG000|Overall Study|Protocol Violation|0|||
170903253|NCT00768222|617649080|FG001|Overall Study|Protocol Violation|2|||
170903254|NCT03263091|617649082|FG000|OL Component|Withdrawal by Subject|1|||
170903255|NCT03263091|617649083|FG001|OL Component|Withdrawal by Subject|1|||
170903256|NCT03263091|617649084|FG002|OL Component|Withdrawal by Subject|0|||
170903257|NCT03263091|617649085|FG003|OL Component|Withdrawal by Subject|0|||
170903258|NCT03263091|617649086|FG004|OL Component|Withdrawal by Subject|0|||
170903259|NCT03263091|617649087|FG005|OL Component|Withdrawal by Subject|0|||
170903260|NCT03263091|617649082|FG000|OL Component|Physician Decision|0|||
170903261|NCT03263091|617649083|FG001|OL Component|Physician Decision|1|||
170903262|NCT03263091|617649084|FG002|OL Component|Physician Decision|2|||
170903263|NCT03263091|617649085|FG003|OL Component|Physician Decision|0|||
170903264|NCT03263091|617649086|FG004|OL Component|Physician Decision|0|||
170903265|NCT03263091|617649087|FG005|OL Component|Physician Decision|0|||
170903266|NCT03263091|617649082|FG000|OL Component|Death|1|||
170903267|NCT03263091|617649083|FG001|OL Component|Death|0|||
170903268|NCT03263091|617649084|FG002|OL Component|Death|0|||
170903269|NCT03263091|617649085|FG003|OL Component|Death|0|||
170903270|NCT03263091|617649086|FG004|OL Component|Death|0|||
170903271|NCT03263091|617649087|FG005|OL Component|Death|0|||
170903272|NCT03263091|617649082|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
170903273|NCT03263091|617649083|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
170903274|NCT03263091|617649084|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
170903275|NCT03263091|617649085|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
170903276|NCT03263091|617649086|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
170903277|NCT03263091|617649087|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
170903278|NCT03263091|617649082|FG000|OL High-EPO Component|Physician Decision|0|||
170903279|NCT03263091|617649083|FG001|OL High-EPO Component|Physician Decision|0|||
170903280|NCT03263091|617649084|FG002|OL High-EPO Component|Physician Decision|0|||
170903281|NCT03263091|617649085|FG003|OL High-EPO Component|Physician Decision|1|||
170903282|NCT03263091|617649086|FG004|OL High-EPO Component|Physician Decision|0|||
170903283|NCT03263091|617649087|FG005|OL High-EPO Component|Physician Decision|0|||
170903284|NCT03263091|617649082|FG000|OL High-EPO Component|Death|0|||
170498459|NCT04777201|616165165|FG000|Main Study|Death|13|||
170498460|NCT04777201|616165166|FG001|Main Study|Death|27|||
170498461|NCT04777201|616165167|FG002|Main Study|Death|0|||
170498462|NCT04777201|616165165|FG000|Main Study|Subject missed the safety follow-up visit|9|||
170498463|NCT04777201|616165166|FG001|Main Study|Subject missed the safety follow-up visit|10|||
170498464|NCT04777201|616165167|FG002|Main Study|Subject missed the safety follow-up visit|0|||
170498465|NCT04777201|616165165|FG000|Main Study|Physician Decision|8|||
170903285|NCT03263091|617649083|FG001|OL High-EPO Component|Death|0|||
170903286|NCT03263091|617649084|FG002|OL High-EPO Component|Death|0|||
170498466|NCT04777201|616165166|FG001|Main Study|Physician Decision|10|||
170903287|NCT03263091|617649085|FG003|OL High-EPO Component|Death|3|||
170903288|NCT03263091|617649086|FG004|OL High-EPO Component|Death|0|||
170498467|NCT04777201|616165167|FG002|Main Study|Physician Decision|0|||
170498468|NCT04777201|616165165|FG000|Main Study|Adverse Event|8|||
170498469|NCT04777201|616165166|FG001|Main Study|Adverse Event|8|||
170498470|NCT04777201|616165167|FG002|Main Study|Adverse Event|0|||
170498471|NCT04777201|616165165|FG000|Main Study|Lost to Follow-up|9|||
170498472|NCT04777201|616165166|FG001|Main Study|Lost to Follow-up|4|||
170498473|NCT04777201|616165167|FG002|Main Study|Lost to Follow-up|0|||
170498474|NCT04777201|616165165|FG000|Main Study|Reason not specified|3|||
170498475|NCT04777201|616165166|FG001|Main Study|Reason not specified|3|||
170498476|NCT04777201|616165167|FG002|Main Study|Reason not specified|0|||
170498477|NCT04777201|616165165|FG000|Main Study|Lack of Efficacy|1|||
170498478|NCT04777201|616165166|FG001|Main Study|Lack of Efficacy|1|||
170498479|NCT04777201|616165167|FG002|Main Study|Lack of Efficacy|0|||
170498480|NCT04777201|616165165|FG000|Main Study|Protocol Violation|1|||
170498481|NCT04777201|616165166|FG001|Main Study|Protocol Violation|0|||
170498482|NCT04777201|616165167|FG002|Main Study|Protocol Violation|0|||
170498483|NCT04777201|616165165|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
170498484|NCT04777201|616165166|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
170498485|NCT04777201|616165167|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
170498486|NCT04777201|616165165|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
170498487|NCT04777201|616165166|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
170498488|NCT04777201|616165167|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
170498489|NCT04777201|616165165|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
170498490|NCT04777201|616165166|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
170498491|NCT04777201|616165167|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
170498492|NCT04777201|616165165|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
170498493|NCT04777201|616165166|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
170498494|NCT04777201|616165167|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
170498495|NCT04777201|616165165|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
170498496|NCT04777201|616165166|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
170498497|NCT04777201|616165167|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
170903289|NCT03263091|617649087|FG005|OL High-EPO Component|Death|0|||
170903290|NCT03263091|617649082|FG000|DB Component|Withdrawal by Subject|0|||
170903291|NCT03263091|617649083|FG001|DB Component|Withdrawal by Subject|0|||
170903292|NCT03263091|617649084|FG002|DB Component|Withdrawal by Subject|0|||
170903293|NCT03263091|617649085|FG003|DB Component|Withdrawal by Subject|0|||
170903294|NCT03263091|617649086|FG004|DB Component|Withdrawal by Subject|22|||
170903295|NCT03263091|617649087|FG005|DB Component|Withdrawal by Subject|8|||
170903296|NCT03263091|617649082|FG000|DB Component|Physician Decision|0|||
170903297|NCT03263091|617649083|FG001|DB Component|Physician Decision|0|||
170903298|NCT03263091|617649084|FG002|DB Component|Physician Decision|0|||
170903299|NCT03263091|617649085|FG003|DB Component|Physician Decision|0|||
170903300|NCT03263091|617649086|FG004|DB Component|Physician Decision|3|||
170903301|NCT03263091|617649087|FG005|DB Component|Physician Decision|1|||
170903302|NCT03263091|617649082|FG000|DB Component|Adverse Event|0|||
170903303|NCT03263091|617649083|FG001|DB Component|Adverse Event|0|||
170903304|NCT03263091|617649084|FG002|DB Component|Adverse Event|0|||
170903305|NCT03263091|617649085|FG003|DB Component|Adverse Event|0|||
170903306|NCT03263091|617649086|FG004|DB Component|Adverse Event|2|||
170903307|NCT03263091|617649087|FG005|DB Component|Adverse Event|1|||
170903308|NCT03263091|617649082|FG000|DB Component|Lost to Follow-up|0|||
170903309|NCT03263091|617649083|FG001|DB Component|Lost to Follow-up|0|||
170498498|NCT04777201|616165165|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
170498499|NCT04777201|616165166|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
170903310|NCT03263091|617649084|FG002|DB Component|Lost to Follow-up|0|||
170903311|NCT03263091|617649085|FG003|DB Component|Lost to Follow-up|0|||
170903312|NCT03263091|617649086|FG004|DB Component|Lost to Follow-up|2|||
170903313|NCT03263091|617649087|FG005|DB Component|Lost to Follow-up|1|||
170498500|NCT04777201|616165167|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
170498501|NCT02691013|616165170|FG000|Overall Study|Withdrawal by Subject|3|||
170498502|NCT02691013|616165171|FG001|Overall Study|Withdrawal by Subject|0|||
170498503|NCT02256982|616165176|FG000|Overall Study|Disease Progression|0|||
170498504|NCT02256982|616165177|FG001|Overall Study|Disease Progression|1|||
170498505|NCT01899742|616165178|FG000|Overall Study|Adverse Event|5|||
170498506|NCT01899742|616165179|FG001|Overall Study|Adverse Event|4|||
170498507|NCT01899742|616165178|FG000|Overall Study|Lack of Efficacy|1|||
170498508|NCT01899742|616165179|FG001|Overall Study|Lack of Efficacy|5|||
170903314|NCT03263091|617649082|FG000|DB Component|Death|0|||
170903315|NCT03263091|617649083|FG001|DB Component|Death|0|||
170903316|NCT03263091|617649084|FG002|DB Component|Death|0|||
170903317|NCT03263091|617649085|FG003|DB Component|Death|0|||
170903318|NCT03263091|617649086|FG004|DB Component|Death|7|||
170903319|NCT03263091|617649087|FG005|DB Component|Death|4|||
170903320|NCT03263091|617649082|FG000|DB Component|Other than specified|0|||
170903321|NCT03263091|617649083|FG001|DB Component|Other than specified|0|||
170903322|NCT03263091|617649084|FG002|DB Component|Other than specified|0|||
170498509|NCT01899742|616165178|FG000|Overall Study|Protocol Violation|2|||
170498510|NCT01899742|616165179|FG001|Overall Study|Protocol Violation|2|||
170498511|NCT01899742|616165178|FG000|Overall Study|Withdrawal by Subject|9|||
170498512|NCT01899742|616165179|FG001|Overall Study|Withdrawal by Subject|5|||
170498513|NCT00738881|616165180|FG000|Overall Study|Withdrawal by Subject|0|||
170498514|NCT00738881|616165181|FG001|Overall Study|Withdrawal by Subject|2|||
170498515|NCT02677038|616165187|FG000|Overall Study|Physician Decision|1|||
170498516|NCT02677038|616165187|FG000|Overall Study|Withdrawal by Subject|1|||
170498517|NCT02777970|616165193|FG000|Overall Study|Lost to Follow-up|0|||
170498518|NCT02777970|616165194|FG001|Overall Study|Lost to Follow-up|1|||
170498519|NCT02777970|616165195|FG002|Overall Study|Lost to Follow-up|0|||
170498520|NCT02777970|616165193|FG000|Overall Study|Protocol Violation|1|||
170498521|NCT02777970|616165194|FG001|Overall Study|Protocol Violation|0|||
170498522|NCT02777970|616165195|FG002|Overall Study|Protocol Violation|0|||
170498523|NCT02541669|616165201|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
170498524|NCT02541669|616165202|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
170498525|NCT02541669|616165203|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
170498526|NCT02541669|616165204|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
170498527|NCT02541669|616165205|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
170498528|NCT00834639|616165208|FG000|Second Intervention|Physician Decision|0|||
170903323|NCT03263091|617649085|FG003|DB Component|Other than specified|0|||
170903324|NCT03263091|617649086|FG004|DB Component|Other than specified|8|||
170903325|NCT03263091|617649087|FG005|DB Component|Other than specified|6|||
170903326|NCT03874234|617649088|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903327|NCT03874234|617649089|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903328|NCT03874234|617649090|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903329|NCT03874234|617649091|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
170903330|NCT03874234|617649092|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903331|NCT03874234|617649093|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170498529|NCT00834639|616165209|FG001|Second Intervention|Physician Decision|2|||
170903332|NCT03874234|617649094|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903333|NCT03874234|617649095|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903334|NCT03874234|617649096|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903335|NCT03874234|617649097|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903336|NCT03874234|617649098|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903337|NCT03874234|617649099|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903338|NCT03874234|617649100|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
170903339|NCT03874234|617649088|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
170903340|NCT03874234|617649089|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903341|NCT03874234|617649090|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903342|NCT03874234|617649091|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903343|NCT03874234|617649092|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903344|NCT03874234|617649093|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903345|NCT03874234|617649094|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903346|NCT03874234|617649095|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903347|NCT03874234|617649096|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903348|NCT03874234|617649097|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903349|NCT03874234|617649098|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903350|NCT03874234|617649099|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170498530|NCT04739722|616165213|FG000|Overall Study|Lost to Follow-up|5301|||
170498531|NCT04739722|616165213|FG000|Overall Study|Withdrawal by Subject|42|||
170498532|NCT04739722|616165213|FG000|Overall Study|Non Average-risk|1157|||
170498533|NCT00725608|616165214|FG000|Overall Study|Lost to Follow-up|60|||
170551591|NCT00147537|616364808|FG000|Phase 2|Other|0|||
170551592|NCT00147537|616364809|FG001|Phase 2|Other|0|||
170551593|NCT00147537|616364810|FG002|Phase 2|Other|0|||
170551594|NCT00147537|616364811|FG003|Phase 2|Other|0|||
170551595|NCT00147537|616364812|FG004|Phase 2|Other|0|||
170551596|NCT00147537|616364813|FG005|Phase 2|Other|0|||
170551597|NCT00147537|616364814|FG006|Phase 2|Other|0|||
170551598|NCT00147537|616364815|FG007|Phase 2|Other|0|||
170551599|NCT00147537|616364816|FG008|Phase 2|Other|0|||
170551600|NCT00147537|616364817|FG009|Phase 2|Other|47|||
170551601|NCT00147537|616364818|FG010|Phase 2|Other|12|||
170551602|NCT00147537|616364808|FG000|Phase 2|Withdrawal by Subject|0|||
170551603|NCT00147537|616364809|FG001|Phase 2|Withdrawal by Subject|0|||
170551604|NCT00147537|616364810|FG002|Phase 2|Withdrawal by Subject|0|||
170551605|NCT00147537|616364811|FG003|Phase 2|Withdrawal by Subject|0|||
170498534|NCT00725608|616165214|FG000|Overall Study|Adverse Event|14|||
170498535|NCT00725608|616165214|FG000|Overall Study|Individual reasons|86|||
170498536|NCT00725608|616165214|FG000|Overall Study|Other|7|||
170498537|NCT01968707|616165218|FG000|Overall Study|Did not meet treatment day baseline|49|||
170498538|NCT01968707|616165219|FG001|Overall Study|Did not meet treatment day baseline|12|||
170498539|NCT01968707|616165220|FG002|Overall Study|Did not meet treatment day baseline|41|||
170498540|NCT01968707|616165221|FG003|Overall Study|Did not meet treatment day baseline|44|||
170498541|NCT01968707|616165222|FG004|Overall Study|Did not meet treatment day baseline|36|||
170498542|NCT01968707|616165223|FG005|Overall Study|Did not meet treatment day baseline|11|||
170498543|NCT01968707|616165224|FG006|Overall Study|Did not meet treatment day baseline|34|||
170498544|NCT01968707|616165225|FG007|Overall Study|Did not meet treatment day baseline|35|||
170498545|NCT05129137|616165229|FG000|Second Period|Adverse Event|1|||
170498546|NCT05129137|616165230|FG001|Second Period|Adverse Event|0|||
170498547|NCT05129137|616165231|FG002|Second Period|Adverse Event|0|||
170498548|NCT05129137|616165232|FG003|Second Period|Adverse Event|0|||
170498549|NCT05129137|616165229|FG000|Second Period|Protocol Violation|0|||
170498550|NCT05129137|616165230|FG001|Second Period|Protocol Violation|0|||
170498551|NCT05129137|616165231|FG002|Second Period|Protocol Violation|0|||
170498552|NCT05129137|616165232|FG003|Second Period|Protocol Violation|1|||
170498553|NCT05129137|616165229|FG000|Third Period|Protocol Violation|0|||
170642452|NCT01297491|616705256|FG000|Overall Study|Physician Decision|3|||
170804686|NCT02036970|617294667|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
170804687|NCT02036970|617294668|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
170804688|NCT02036970|617294669|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
170804689|NCT02036970|617294670|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
170804690|NCT02036970|617294671|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
170804691|NCT02036970|617294672|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
170804692|NCT02036970|617294663|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
170804693|NCT02036970|617294664|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
170804694|NCT02036970|617294665|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
170804695|NCT02036970|617294666|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
170804696|NCT02036970|617294667|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
170804697|NCT02036970|617294668|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
170804698|NCT02036970|617294669|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
170804699|NCT02036970|617294670|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
170804700|NCT02036970|617294671|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
170804701|NCT02036970|617294672|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
170804702|NCT02036970|617294663|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804703|NCT02036970|617294664|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804704|NCT02036970|617294665|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804705|NCT02036970|617294666|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
170804706|NCT02036970|617294667|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804707|NCT02036970|617294668|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804708|NCT02036970|617294669|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804709|NCT02036970|617294670|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804710|NCT02036970|617294671|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804711|NCT02036970|617294672|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
170804712|NCT02036970|617294663|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
170804713|NCT02036970|617294664|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
170804714|NCT02036970|617294665|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
170804715|NCT02036970|617294666|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
170804716|NCT02036970|617294667|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
170804717|NCT02036970|617294668|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
170804718|NCT02036970|617294669|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
170804719|NCT02036970|617294670|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
170804720|NCT02036970|617294671|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
170804721|NCT02036970|617294672|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
170804722|NCT02036970|617294663|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
170804723|NCT02036970|617294664|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
170804724|NCT02036970|617294665|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
170804725|NCT02036970|617294666|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
170804726|NCT02036970|617294667|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
170804727|NCT02036970|617294668|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
170804728|NCT02036970|617294669|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
170804729|NCT02036970|617294670|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
170804730|NCT02036970|617294671|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
170498554|NCT05129137|616165230|FG001|Third Period|Protocol Violation|0|||
170498555|NCT05129137|616165231|FG002|Third Period|Protocol Violation|0|||
170498556|NCT05129137|616165232|FG003|Third Period|Protocol Violation|1|||
170498557|NCT05129137|616165229|FG000|Forth Period|Protocol Violation|0|||
170498558|NCT05129137|616165230|FG001|Forth Period|Protocol Violation|1|||
170498559|NCT05129137|616165231|FG002|Forth Period|Protocol Violation|0|||
170498560|NCT05129137|616165232|FG003|Forth Period|Protocol Violation|0|||
170498561|NCT05129137|616165229|FG000|Forth Period|Withdrawal by Subject|0|||
170498562|NCT05129137|616165230|FG001|Forth Period|Withdrawal by Subject|0|||
170498563|NCT05129137|616165231|FG002|Forth Period|Withdrawal by Subject|1|||
170498564|NCT05129137|616165232|FG003|Forth Period|Withdrawal by Subject|0|||
170498565|NCT01084668|616165233|FG000|Overall Study|Lack of Efficacy|5|||
170498566|NCT01084668|616165233|FG000|Overall Study|Withdrawal by Subject|2|||
170498567|NCT01084668|616165233|FG000|Overall Study|Pregnancy|1|||
170903351|NCT03874234|617649100|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
170903352|NCT03874234|617649088|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903353|NCT03874234|617649089|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903354|NCT03874234|617649090|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903355|NCT03874234|617649091|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
170903356|NCT03874234|617649092|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903357|NCT03874234|617649093|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903358|NCT03874234|617649094|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903359|NCT03874234|617649095|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903360|NCT03874234|617649096|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903361|NCT03874234|617649097|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903362|NCT03874234|617649098|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903363|NCT03874234|617649099|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903364|NCT03874234|617649100|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
170903365|NCT03874234|617649088|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903366|NCT03874234|617649089|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903367|NCT03874234|617649090|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903368|NCT03874234|617649091|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903369|NCT03874234|617649092|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
170903370|NCT03874234|617649093|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903371|NCT03874234|617649094|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903372|NCT03874234|617649095|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903373|NCT03874234|617649096|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903374|NCT03874234|617649097|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903375|NCT03874234|617649098|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903376|NCT03874234|617649099|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903377|NCT03874234|617649100|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
170903378|NCT03874234|617649088|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903379|NCT03874234|617649089|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903380|NCT03874234|617649090|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903381|NCT03874234|617649091|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903382|NCT03874234|617649092|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903383|NCT03874234|617649093|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903384|NCT03874234|617649094|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170498568|NCT01084668|616165233|FG000|Overall Study|Non-compliance|1|||
170498569|NCT00631410|616165235|FG000|Overall Study|Adverse Event|1|||
170498570|NCT00631410|616165236|FG001|Overall Study|Adverse Event|3|||
170498571|NCT00631410|616165235|FG000|Overall Study|Objective Progression or Relapse|4|||
170498572|NCT00631410|616165236|FG001|Overall Study|Objective Progression or Relapse|3|||
170498573|NCT00631410|616165235|FG000|Overall Study|Surgery|1|||
170498574|NCT00631410|616165236|FG001|Overall Study|Surgery|0|||
170498575|NCT02083185|616165238|FG000|Overall Study|Lost to Follow-up|0|||
170498576|NCT02083185|616165239|FG001|Overall Study|Lost to Follow-up|3|||
170498577|NCT02083185|616165240|FG002|Overall Study|Lost to Follow-up|0|||
170498578|NCT02083185|616165238|FG000|Overall Study|Withdrawal by Subject|9|||
170498579|NCT02083185|616165239|FG001|Overall Study|Withdrawal by Subject|15|||
170498580|NCT02083185|616165240|FG002|Overall Study|Withdrawal by Subject|1|||
170498581|NCT02083185|616165238|FG000|Overall Study|Death|2|||
170498582|NCT02083185|616165239|FG001|Overall Study|Death|2|||
170498583|NCT02083185|616165240|FG002|Overall Study|Death|1|||
170498584|NCT02083185|616165238|FG000|Overall Study|Reason not Specified|9|||
170498585|NCT02083185|616165239|FG001|Overall Study|Reason not Specified|6|||
170498586|NCT02083185|616165240|FG002|Overall Study|Reason not Specified|5|||
170498587|NCT02083185|616165238|FG000|Overall Study|Study Terminated by Sponsor|0|||
170498588|NCT02083185|616165239|FG001|Overall Study|Study Terminated by Sponsor|1|||
170498589|NCT02083185|616165240|FG002|Overall Study|Study Terminated by Sponsor|0|||
170498590|NCT02083185|616165238|FG000|Overall Study|Did not Receive Study Drug|0|||
170498591|NCT02083185|616165239|FG001|Overall Study|Did not Receive Study Drug|2|||
170498592|NCT02083185|616165240|FG002|Overall Study|Did not Receive Study Drug|0|||
170903385|NCT03874234|617649095|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
170498593|NCT00189306|616165243|FG000|Treatment Period|Withdrawal by Subject|2|||
170498594|NCT00189306|616165243|FG000|Treatment Period|Adverse Event|2|||
170498595|NCT00189306|616165243|FG000|Treatment Period|Protocol Violation|1|||
170498596|NCT00189306|616165243|FG000|Posttreatment Period|Death|1|||
170498597|NCT00189306|616165243|FG000|Posttreatment Period|Withdrawal by Subject|2|||
170498598|NCT00189306|616165243|FG000|Posttreatment Period|Noncompliance|1|||
170498599|NCT00189306|616165243|FG000|Posttreatment Period|Target lesion excised|1|||
170498600|NCT00189306|616165243|FG000|Posttreatment Period|Protocol Violation|1|||
170498601|NCT00189306|616165243|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
170498602|NCT00189306|616165243|FG000|Posttreatment Period|Local skin reaction/sign|1|||
170498603|NCT00189306|616165243|FG000|Long-Term Follow-up|Adverse Event|2|||
170498604|NCT00189306|616165243|FG000|Long-Term Follow-up|Death|4|||
170498605|NCT00189306|616165243|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
170498606|NCT00189306|616165243|FG000|Long-Term Follow-up|Intercurrent disease|2|||
170498607|NCT00189306|616165243|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
170498608|NCT00189306|616165243|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
170498609|NCT01546168|616165244|FG000|Overall Study|Lost to Follow-up|1|||
170498610|NCT01546168|616165245|FG001|Overall Study|Lost to Follow-up|0|||
170498611|NCT01546168|616165244|FG000|Overall Study|Withdrawal by Subject|1|||
170498612|NCT01546168|616165245|FG001|Overall Study|Withdrawal by Subject|0|||
170498613|NCT01546168|616165244|FG000|Overall Study|ineligible after signing consent|2|||
170498614|NCT01546168|616165245|FG001|Overall Study|ineligible after signing consent|0|||
170498615|NCT02850016|616165246|FG000|Overall Study|Withdrawal by Subject|1|||
170498616|NCT02850016|616165247|FG001|Overall Study|Withdrawal by Subject|2|||
170498617|NCT02939716|616165248|FG000|Overall Study|scanner failure|0|||
170498618|NCT02939716|616165249|FG001|Overall Study|scanner failure|0|||
170498619|NCT02939716|616165250|FG002|Overall Study|scanner failure|0|||
170498620|NCT02939716|616165251|FG003|Overall Study|scanner failure|1|||
170498621|NCT02939716|616165252|FG004|Overall Study|scanner failure|1|||
170498622|NCT02939716|616165253|FG005|Overall Study|scanner failure|1|||
170498623|NCT03197870|616165256|FG000|Overall Study|Adverse Event|9|||
170498624|NCT03197870|616165257|FG001|Overall Study|Adverse Event|4|||
170498625|NCT03197870|616165258|FG002|Overall Study|Adverse Event|6|||
170498626|NCT03197870|616165256|FG000|Overall Study|Withdrawal by Subject|2|||
170498627|NCT03197870|616165257|FG001|Overall Study|Withdrawal by Subject|3|||
170498628|NCT03197870|616165258|FG002|Overall Study|Withdrawal by Subject|0|||
170498629|NCT03197870|616165256|FG000|Overall Study|Lost to Follow-up|2|||
170498630|NCT03197870|616165257|FG001|Overall Study|Lost to Follow-up|2|||
170498631|NCT03197870|616165258|FG002|Overall Study|Lost to Follow-up|0|||
170498632|NCT03197870|616165256|FG000|Overall Study|data not available|1|||
170498633|NCT03197870|616165257|FG001|Overall Study|data not available|1|||
170498634|NCT03197870|616165258|FG002|Overall Study|data not available|0|||
170498635|NCT00478699|616165262|FG000|Overall Study|Inclusion Error|1|||
170498636|NCT00478699|616165263|FG001|Overall Study|Inclusion Error|7|||
170498637|NCT00478699|616165262|FG000|Overall Study|Not receive study treatment|6|||
170498638|NCT00478699|616165263|FG001|Overall Study|Not receive study treatment|30|||
170498639|NCT01508130|616165264|FG000|Overall Study|Adverse Event|81|||
170498640|NCT01508130|616165265|FG001|Overall Study|Adverse Event|28|||
170498641|NCT01508130|616165264|FG000|Overall Study|Death|3|||
170498642|NCT01508130|616165265|FG001|Overall Study|Death|1|||
170498643|NCT01508130|616165264|FG000|Overall Study|Protocol Violation|2|||
170498644|NCT01508130|616165265|FG001|Overall Study|Protocol Violation|0|||
170498645|NCT01508130|616165264|FG000|Overall Study|Lost to Follow-up|25|||
170498646|NCT01508130|616165265|FG001|Overall Study|Lost to Follow-up|2|||
170498647|NCT01508130|616165264|FG000|Overall Study|Withdrawal by Subject|3|||
170498648|NCT01508130|616165265|FG001|Overall Study|Withdrawal by Subject|3|||
170498649|NCT01508130|616165264|FG000|Overall Study|Subject's substantial non-compliance|25|||
170804731|NCT02036970|617294672|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
170804732|NCT02036970|617294663|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
170498650|NCT01508130|616165265|FG001|Overall Study|Subject's substantial non-compliance|9|||
170498651|NCT01508130|616165264|FG000|Overall Study|Insufficient therapeutic response|74|||
170804733|NCT02036970|617294664|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
170804734|NCT02036970|617294665|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
170804735|NCT02036970|617294666|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
170498652|NCT01508130|616165265|FG001|Overall Study|Insufficient therapeutic response|23|||
170498653|NCT01508130|616165264|FG000|Overall Study|Administrative|14|||
170498654|NCT01508130|616165265|FG001|Overall Study|Administrative|3|||
170498655|NCT01880086|616165270|FG000|Overall Study|Lost to Follow-up|1|||
170498656|NCT01880086|616165271|FG001|Overall Study|Lost to Follow-up|1|||
170498657|NCT02288091|616165274|FG000|Overall Study|Lost to Follow-up|1|||
170498658|NCT02288091|616165274|FG000|Overall Study|Screen fail|7|||
170498659|NCT01446237|616165281|FG000|Overall Study|Adverse Event|1|||
170498660|NCT01446237|616165281|FG000|Overall Study|Lost to Follow-up|2|||
170498661|NCT01446237|616165281|FG000|Overall Study|Withdrawal by Subject|7|||
170498662|NCT03852628|616165291|FG000|Overall Study|Lost to Follow-up|7|||
170498663|NCT03852628|616165292|FG001|Overall Study|Lost to Follow-up|6|||
170498664|NCT03852628|616165291|FG000|Overall Study|Lack of Efficacy|6|||
170498665|NCT03852628|616165292|FG001|Overall Study|Lack of Efficacy|6|||
170498666|NCT01931956|616165293|FG000|Overall Study|Death|42|||
170498667|NCT01931956|616165294|FG001|Overall Study|Death|7|||
170498668|NCT01931956|616165295|FG002|Overall Study|Death|379|||
170498669|NCT01931956|616165296|FG003|Overall Study|Death|96|||
170498670|NCT01931956|616165293|FG000|Overall Study|Withdrawal by Subject|5|||
170498671|NCT01931956|616165294|FG001|Overall Study|Withdrawal by Subject|0|||
170498672|NCT01931956|616165295|FG002|Overall Study|Withdrawal by Subject|70|||
170498673|NCT01931956|616165296|FG003|Overall Study|Withdrawal by Subject|30|||
170498674|NCT01931956|616165293|FG000|Overall Study|Lost to Follow-up|2|||
170498675|NCT01931956|616165294|FG001|Overall Study|Lost to Follow-up|0|||
170498676|NCT01931956|616165295|FG002|Overall Study|Lost to Follow-up|11|||
170498677|NCT01931956|616165296|FG003|Overall Study|Lost to Follow-up|7|||
170498678|NCT01931956|616165293|FG000|Overall Study|Expected|2|||
170498679|NCT01931956|616165294|FG001|Overall Study|Expected|0|||
170498680|NCT01931956|616165295|FG002|Overall Study|Expected|6|||
170498681|NCT01931956|616165296|FG003|Overall Study|Expected|0|||
170498682|NCT01931956|616165293|FG000|Overall Study|Not due|0|||
170498683|NCT01931956|616165294|FG001|Overall Study|Not due|0|||
170498684|NCT01931956|616165295|FG002|Overall Study|Not due|21|||
170498685|NCT01931956|616165296|FG003|Overall Study|Not due|0|||
170498686|NCT02548351|616165297|FG000|Overall Study|Withdrawal by Subject|149|||
170498687|NCT02548351|616165298|FG001|Overall Study|Withdrawal by Subject|154|||
170498688|NCT02548351|616165299|FG002|Overall Study|Withdrawal by Subject|152|||
170498689|NCT02548351|616165297|FG000|Overall Study|Death|11|||
170498690|NCT02548351|616165298|FG001|Overall Study|Death|15|||
170498691|NCT02548351|616165299|FG002|Overall Study|Death|12|||
170498692|NCT02548351|616165297|FG000|Overall Study|Adverse Event|22|||
170498693|NCT02548351|616165298|FG001|Overall Study|Adverse Event|56|||
170498694|NCT02548351|616165299|FG002|Overall Study|Adverse Event|36|||
170498695|NCT02548351|616165297|FG000|Overall Study|Study Terminated by Sponsor|549|||
170498696|NCT02548351|616165298|FG001|Overall Study|Study Terminated by Sponsor|509|||
170498697|NCT02548351|616165299|FG002|Overall Study|Study Terminated by Sponsor|528|||
170498698|NCT02548351|616165297|FG000|Overall Study|Site Closure|14|||
170498699|NCT02548351|616165298|FG001|Overall Study|Site Closure|5|||
170498700|NCT02548351|616165299|FG002|Overall Study|Site Closure|7|||
170498701|NCT02548351|616165297|FG000|Overall Study|Non-compliance with Study Drug|4|||
170498702|NCT02548351|616165298|FG001|Overall Study|Non-compliance with Study Drug|2|||
170498703|NCT02548351|616165299|FG002|Overall Study|Non-compliance with Study Drug|0|||
170498704|NCT02548351|616165297|FG000|Overall Study|Protocol Violation|2|||
170498705|NCT02548351|616165298|FG001|Overall Study|Protocol Violation|1|||
170498706|NCT02548351|616165299|FG002|Overall Study|Protocol Violation|2|||
170498707|NCT02548351|616165297|FG000|Overall Study|Physician Decision|11|||
170498708|NCT02548351|616165298|FG001|Overall Study|Physician Decision|18|||
170498709|NCT02548351|616165299|FG002|Overall Study|Physician Decision|11|||
170498710|NCT02548351|616165297|FG000|Overall Study|Lost to Follow-up|43|||
170498711|NCT02548351|616165298|FG001|Overall Study|Lost to Follow-up|50|||
170498712|NCT02548351|616165299|FG002|Overall Study|Lost to Follow-up|57|||
170498713|NCT02548351|616165297|FG000|Overall Study|Other|19|||
170498714|NCT02548351|616165298|FG001|Overall Study|Other|16|||
170498715|NCT02548351|616165299|FG002|Overall Study|Other|20|||
170498716|NCT02548351|616165297|FG000|Overall Study|Missing|1|||
170498717|NCT02548351|616165298|FG001|Overall Study|Missing|1|||
170498718|NCT02548351|616165299|FG002|Overall Study|Missing|0|||
170498719|NCT01295827|616165306|FG000|Overall Study|Adverse Event|1|||
170498720|NCT01295827|616165307|FG001|Overall Study|Adverse Event|2|||
170498721|NCT01295827|616165308|FG002|Overall Study|Adverse Event|2|||
170498722|NCT01295827|616165309|FG003|Overall Study|Adverse Event|1|||
170498723|NCT01295827|616165310|FG004|Overall Study|Adverse Event|1|||
170498724|NCT01295827|616165311|FG005|Overall Study|Adverse Event|4|||
170498725|NCT01295827|616165312|FG006|Overall Study|Adverse Event|15|||
170551606|NCT00147537|616364812|FG004|Phase 2|Withdrawal by Subject|0|||
170804736|NCT02036970|617294667|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
170498726|NCT01295827|616165313|FG007|Overall Study|Adverse Event|49|||
170498727|NCT01295827|616165314|FG008|Overall Study|Adverse Event|22|||
170498728|NCT01295827|616165315|FG009|Overall Study|Adverse Event|7|||
170498729|NCT01295827|616165316|FG010|Overall Study|Adverse Event|50|||
170498730|NCT01295827|616165317|FG011|Overall Study|Adverse Event|21|||
170498731|NCT01295827|616165318|FG012|Overall Study|Adverse Event|0|||
170498732|NCT01295827|616165319|FG013|Overall Study|Adverse Event|0|||
170498733|NCT01295827|616165320|FG014|Overall Study|Adverse Event|0|||
170498734|NCT01295827|616165306|FG000|Overall Study|Lost to Follow-up|0|||
170498735|NCT01295827|616165307|FG001|Overall Study|Lost to Follow-up|0|||
170498736|NCT01295827|616165308|FG002|Overall Study|Lost to Follow-up|3|||
170498737|NCT01295827|616165309|FG003|Overall Study|Lost to Follow-up|0|||
170498738|NCT01295827|616165310|FG004|Overall Study|Lost to Follow-up|1|||
170498739|NCT01295827|616165311|FG005|Overall Study|Lost to Follow-up|0|||
170498740|NCT01295827|616165312|FG006|Overall Study|Lost to Follow-up|4|||
170498741|NCT01295827|616165313|FG007|Overall Study|Lost to Follow-up|8|||
170498742|NCT01295827|616165314|FG008|Overall Study|Lost to Follow-up|7|||
170498743|NCT01295827|616165315|FG009|Overall Study|Lost to Follow-up|4|||
170498744|NCT01295827|616165316|FG010|Overall Study|Lost to Follow-up|7|||
170498745|NCT01295827|616165317|FG011|Overall Study|Lost to Follow-up|3|||
170498746|NCT01295827|616165318|FG012|Overall Study|Lost to Follow-up|0|||
170498747|NCT01295827|616165319|FG013|Overall Study|Lost to Follow-up|0|||
170498748|NCT01295827|616165320|FG014|Overall Study|Lost to Follow-up|0|||
170498749|NCT01295827|616165306|FG000|Overall Study|Not Reported|0|||
170498750|NCT01295827|616165307|FG001|Overall Study|Not Reported|0|||
170498751|NCT01295827|616165308|FG002|Overall Study|Not Reported|0|||
170498752|NCT01295827|616165309|FG003|Overall Study|Not Reported|1|||
170498753|NCT01295827|616165310|FG004|Overall Study|Not Reported|0|||
170498754|NCT01295827|616165311|FG005|Overall Study|Not Reported|0|||
170498755|NCT01295827|616165312|FG006|Overall Study|Not Reported|24|||
170498756|NCT01295827|616165313|FG007|Overall Study|Not Reported|58|||
170498757|NCT01295827|616165314|FG008|Overall Study|Not Reported|41|||
170498758|NCT01295827|616165315|FG009|Overall Study|Not Reported|2|||
170498759|NCT01295827|616165316|FG010|Overall Study|Not Reported|23|||
170498760|NCT01295827|616165317|FG011|Overall Study|Not Reported|13|||
170498761|NCT01295827|616165318|FG012|Overall Study|Not Reported|0|||
170498762|NCT01295827|616165319|FG013|Overall Study|Not Reported|0|||
170498763|NCT01295827|616165320|FG014|Overall Study|Not Reported|0|||
170498764|NCT01295827|616165306|FG000|Overall Study|Progressive Disease|2|||
170498765|NCT01295827|616165307|FG001|Overall Study|Progressive Disease|1|||
170498766|NCT01295827|616165308|FG002|Overall Study|Progressive Disease|5|||
170498767|NCT01295827|616165309|FG003|Overall Study|Progressive Disease|2|||
170498768|NCT01295827|616165310|FG004|Overall Study|Progressive Disease|0|||
170498769|NCT01295827|616165311|FG005|Overall Study|Progressive Disease|1|||
170498770|NCT01295827|616165312|FG006|Overall Study|Progressive Disease|87|||
170498771|NCT01295827|616165313|FG007|Overall Study|Progressive Disease|144|||
170498772|NCT01295827|616165314|FG008|Overall Study|Progressive Disease|85|||
170498773|NCT01295827|616165315|FG009|Overall Study|Progressive Disease|40|||
170498774|NCT01295827|616165316|FG010|Overall Study|Progressive Disease|175|||
170498775|NCT01295827|616165317|FG011|Overall Study|Progressive Disease|136|||
170498776|NCT01295827|616165318|FG012|Overall Study|Progressive Disease|0|||
170498777|NCT01295827|616165319|FG013|Overall Study|Progressive Disease|0|||
170498778|NCT01295827|616165320|FG014|Overall Study|Progressive Disease|0|||
170498779|NCT01295827|616165306|FG000|Overall Study|Screen Failure|0|||
170498780|NCT01295827|616165307|FG001|Overall Study|Screen Failure|0|||
170498781|NCT01295827|616165308|FG002|Overall Study|Screen Failure|0|||
170498782|NCT01295827|616165309|FG003|Overall Study|Screen Failure|0|||
170498783|NCT01295827|616165310|FG004|Overall Study|Screen Failure|0|||
170498784|NCT01295827|616165311|FG005|Overall Study|Screen Failure|0|||
170498785|NCT01295827|616165312|FG006|Overall Study|Screen Failure|2|||
170498786|NCT01295827|616165313|FG007|Overall Study|Screen Failure|2|||
170498787|NCT01295827|616165314|FG008|Overall Study|Screen Failure|2|||
170498788|NCT01295827|616165315|FG009|Overall Study|Screen Failure|0|||
170498789|NCT01295827|616165316|FG010|Overall Study|Screen Failure|1|||
170498790|NCT01295827|616165317|FG011|Overall Study|Screen Failure|0|||
170498791|NCT01295827|616165318|FG012|Overall Study|Screen Failure|0|||
170498792|NCT01295827|616165319|FG013|Overall Study|Screen Failure|0|||
170498793|NCT01295827|616165320|FG014|Overall Study|Screen Failure|0|||
170498794|NCT01295827|616165306|FG000|Overall Study|Withdrawal by Subject|1|||
170498795|NCT01295827|616165307|FG001|Overall Study|Withdrawal by Subject|0|||
170498796|NCT01295827|616165308|FG002|Overall Study|Withdrawal by Subject|2|||
170498797|NCT01295827|616165309|FG003|Overall Study|Withdrawal by Subject|0|||
170498798|NCT01295827|616165310|FG004|Overall Study|Withdrawal by Subject|0|||
170642453|NCT01297491|616705257|FG001|Overall Study|Physician Decision|2|||
170903386|NCT03874234|617649096|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903387|NCT03874234|617649097|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903388|NCT03874234|617649098|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903389|NCT03874234|617649099|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903390|NCT03874234|617649100|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
170903391|NCT03874234|617649088|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170498799|NCT01295827|616165311|FG005|Overall Study|Withdrawal by Subject|1|||
170498800|NCT01295827|616165312|FG006|Overall Study|Withdrawal by Subject|13|||
170498801|NCT01295827|616165313|FG007|Overall Study|Withdrawal by Subject|35|||
170498802|NCT01295827|616165314|FG008|Overall Study|Withdrawal by Subject|11|||
170498803|NCT01295827|616165315|FG009|Overall Study|Withdrawal by Subject|2|||
170498804|NCT01295827|616165316|FG010|Overall Study|Withdrawal by Subject|18|||
170498805|NCT01295827|616165317|FG011|Overall Study|Withdrawal by Subject|13|||
170498806|NCT01295827|616165318|FG012|Overall Study|Withdrawal by Subject|0|||
170498807|NCT01295827|616165319|FG013|Overall Study|Withdrawal by Subject|0|||
170498808|NCT01295827|616165320|FG014|Overall Study|Withdrawal by Subject|0|||
170498809|NCT01295827|616165306|FG000|Overall Study|Other|0|||
170498810|NCT01295827|616165307|FG001|Overall Study|Other|0|||
170498811|NCT01295827|616165308|FG002|Overall Study|Other|0|||
170498812|NCT01295827|616165309|FG003|Overall Study|Other|0|||
170498813|NCT01295827|616165310|FG004|Overall Study|Other|0|||
170498814|NCT01295827|616165311|FG005|Overall Study|Other|0|||
170498815|NCT01295827|616165312|FG006|Overall Study|Other|1|||
170498816|NCT01295827|616165313|FG007|Overall Study|Other|1|||
170498817|NCT01295827|616165314|FG008|Overall Study|Other|1|||
170498818|NCT01295827|616165315|FG009|Overall Study|Other|0|||
170804737|NCT02036970|617294668|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
170804738|NCT02036970|617294669|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
170804739|NCT02036970|617294670|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
170498819|NCT01295827|616165316|FG010|Overall Study|Other|2|||
170498820|NCT01295827|616165317|FG011|Overall Study|Other|0|||
170498821|NCT01295827|616165318|FG012|Overall Study|Other|0|||
170498822|NCT01295827|616165319|FG013|Overall Study|Other|0|||
170498823|NCT01295827|616165320|FG014|Overall Study|Other|0|||
170498824|NCT02640677|616165321|FG000|Overall Study|Lost to Follow-up|1|||
170498825|NCT02640677|616165321|FG000|Overall Study|Withdrawal by Subject|1|||
170498826|NCT01493284|616165330|FG000|Overall Study|Death|29|||
170498827|NCT01493284|616165330|FG000|Overall Study|Withdrawal by Subject|32|||
170498828|NCT02276053|616166824|FG000|Overall Study|Death|2|||
170498829|NCT02276053|616166824|FG000|Overall Study|Adverse Event|5|||
170498830|NCT02276053|616166824|FG000|Overall Study|Lack of Efficacy|2|||
170498831|NCT02276053|616166824|FG000|Overall Study|Withdrawal by Subject|1|||
170498832|NCT02276053|616166824|FG000|Overall Study|Patient does not meet selection criteria|3|||
170498833|NCT02276053|616166824|FG000|Overall Study|Patient needs to increase baseline AED|1|||
170498834|NCT02059434|616166825|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
170498835|NCT02059434|616166826|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
170498836|NCT02059434|616166827|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
170498837|NCT02059434|616166828|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
170498838|NCT02059434|616166829|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
170498839|NCT02059434|616166830|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
170498840|NCT02059434|616166831|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
170498841|NCT02059434|616166832|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
170498842|NCT02059434|616166833|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
170498843|NCT02059434|616166825|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
170498844|NCT02059434|616166826|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
170498845|NCT02059434|616166827|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
170498846|NCT02059434|616166828|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
170498847|NCT02059434|616166829|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
170498848|NCT02059434|616166830|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
170498849|NCT02059434|616166831|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
170498850|NCT02059434|616166832|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
170498851|NCT02059434|616166833|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
170498852|NCT02059434|616166825|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
170498853|NCT02059434|616166826|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
170498854|NCT02059434|616166827|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
170498855|NCT02059434|616166828|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
170498856|NCT02059434|616166829|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
170498857|NCT02059434|616166830|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
170498858|NCT02059434|616166831|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
170498859|NCT02059434|616166832|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
170498860|NCT02059434|616166833|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
170804740|NCT02036970|617294671|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
170804741|NCT02036970|617294672|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
170804742|NCT02036970|617294663|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
170804743|NCT02036970|617294664|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
170804744|NCT02036970|617294665|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
170804745|NCT02036970|617294666|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
170804746|NCT02036970|617294667|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
170804747|NCT02036970|617294668|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
170498861|NCT02059434|616166825|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
170498862|NCT02059434|616166826|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
170498863|NCT02059434|616166827|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
170498864|NCT02059434|616166828|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
170498865|NCT02059434|616166829|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
170498866|NCT02059434|616166830|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
170498867|NCT02059434|616166831|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
170498868|NCT02059434|616166832|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
170804748|NCT02036970|617294669|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
170498869|NCT02059434|616166833|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
170498870|NCT02059434|616166825|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
170498871|NCT02059434|616166826|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
170498872|NCT02059434|616166827|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
170551607|NCT00147537|616364813|FG005|Phase 2|Withdrawal by Subject|0|||
170498873|NCT02059434|616166828|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
170498874|NCT02059434|616166829|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
170498875|NCT02059434|616166830|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
170498876|NCT02059434|616166831|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
170498877|NCT02059434|616166832|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
170498878|NCT02059434|616166833|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
170498879|NCT05128773|616166836|FG000|Overall Study|Sponsor decision to terminate study|3|||
170498880|NCT02759055|616166839|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
170498881|NCT02759055|616166840|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
170498882|NCT00623597|616166841|FG000|Overall Study|Failed to return|1|||
170498883|NCT00623597|616166842|FG001|Overall Study|Failed to return|0|||
170498884|NCT04045132|616166843|FG000|Overall Study|Lost to Follow-up|3|||
170498885|NCT04045132|616166844|FG001|Overall Study|Lost to Follow-up|6|||
170498886|NCT04598451|616166845|FG000|Overall Study|Adverse Event|3|||
170498887|NCT04598451|616166846|FG001|Overall Study|Adverse Event|2|||
170498888|NCT04598451|616166845|FG000|Overall Study|Withdrawal by Subject|3|||
170498889|NCT04598451|616166846|FG001|Overall Study|Withdrawal by Subject|7|||
170498890|NCT04598451|616166845|FG000|Overall Study|Lost to Follow-up|2|||
170498891|NCT04598451|616166846|FG001|Overall Study|Lost to Follow-up|0|||
170498892|NCT04598451|616166845|FG000|Overall Study|Physician Decision|4|||
170498893|NCT04598451|616166846|FG001|Overall Study|Physician Decision|1|||
170498894|NCT04598451|616166845|FG000|Overall Study|Requires Prohibited Medication|1|||
170498895|NCT04598451|616166846|FG001|Overall Study|Requires Prohibited Medication|0|||
170498896|NCT04598451|616166845|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
170498897|NCT04598451|616166846|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
170498898|NCT02653170|616166847|FG000|Overall Study|Withdrawal by Subject|3|||
170498899|NCT02653170|616166848|FG001|Overall Study|Withdrawal by Subject|8|||
170498900|NCT02653170|616166849|FG002|Overall Study|Withdrawal by Subject|3|||
170498901|NCT02653170|616166847|FG000|Overall Study|withdrawn by study team|2|||
170498902|NCT02653170|616166848|FG001|Overall Study|withdrawn by study team|4|||
170498903|NCT02653170|616166849|FG002|Overall Study|withdrawn by study team|5|||
170498904|NCT02653170|616166847|FG000|Overall Study|Lost to Follow-up|12|||
170498905|NCT02653170|616166848|FG001|Overall Study|Lost to Follow-up|4|||
170498906|NCT02653170|616166849|FG002|Overall Study|Lost to Follow-up|10|||
170498907|NCT01632150|616166850|FG000|Overall Study|Disease progression|27|||
170498908|NCT01632150|616166850|FG000|Overall Study|Study drug toxicity|1|||
170498909|NCT01632150|616166850|FG000|Overall Study|Unrelated adverse event|7|||
170498910|NCT01632150|616166850|FG000|Overall Study|Withdrawal by Subject|2|||
170498911|NCT01632150|616166850|FG000|Overall Study|Patient underwent autologous transplant|1|||
170498912|NCT01632150|616166850|FG000|Overall Study|Moved to compassionate program|2|||
170498913|NCT02963558|616166853|FG000|Overall Study|Withdrawn by investigator|1|||
170498914|NCT02963558|616166854|FG001|Overall Study|Withdrawn by investigator|0|||
170498915|NCT02963558|616166853|FG000|Overall Study|Withdrawal by Subject|0|||
170498916|NCT02963558|616166854|FG001|Overall Study|Withdrawal by Subject|1|||
170498917|NCT04063657|616166858|FG000|Overall Study|Lost to Follow-up|1|||
170498918|NCT04063657|616166859|FG001|Overall Study|Lost to Follow-up|0|||
170498919|NCT03875482|616166860|FG000|Overall Study|Adverse Event|0|||
170498920|NCT03875482|616166861|FG001|Overall Study|Adverse Event|1|||
170498921|NCT03875482|616166860|FG000|Overall Study|Withdrew consent|5|||
170498922|NCT03875482|616166861|FG001|Overall Study|Withdrew consent|6|||
170498923|NCT03875482|616166860|FG000|Overall Study|Lost to Follow-up|8|||
170498924|NCT03875482|616166861|FG001|Overall Study|Lost to Follow-up|2|||
170498925|NCT03875482|616166860|FG000|Overall Study|Lack of Efficacy|0|||
170498926|NCT03875482|616166861|FG001|Overall Study|Lack of Efficacy|11|||
170498927|NCT00614120|616166865|FG000|Overall Study|Adverse Event|9|||
170498928|NCT00614120|616166866|FG001|Overall Study|Adverse Event|22|||
170498929|NCT00614120|616166867|FG002|Overall Study|Adverse Event|30|||
170498930|NCT00614120|616166868|FG003|Overall Study|Adverse Event|3|||
170498931|NCT00614120|616166865|FG000|Overall Study|Lack of Efficacy|3|||
170498932|NCT00614120|616166866|FG001|Overall Study|Lack of Efficacy|3|||
170498933|NCT00614120|616166867|FG002|Overall Study|Lack of Efficacy|2|||
170498934|NCT00614120|616166868|FG003|Overall Study|Lack of Efficacy|2|||
170498935|NCT00614120|616166865|FG000|Overall Study|Protocol Violation|2|||
170498936|NCT00614120|616166866|FG001|Overall Study|Protocol Violation|5|||
170498937|NCT00614120|616166867|FG002|Overall Study|Protocol Violation|3|||
170498938|NCT00614120|616166868|FG003|Overall Study|Protocol Violation|1|||
170498939|NCT00614120|616166865|FG000|Overall Study|Withdrawal criteria|1|||
170498940|NCT00614120|616166866|FG001|Overall Study|Withdrawal criteria|0|||
170498941|NCT00614120|616166867|FG002|Overall Study|Withdrawal criteria|0|||
170498942|NCT00614120|616166868|FG003|Overall Study|Withdrawal criteria|0|||
170498943|NCT00614120|616166865|FG000|Overall Study|Withdrawal by Subject|9|||
170498944|NCT00614120|616166866|FG001|Overall Study|Withdrawal by Subject|10|||
170498945|NCT00614120|616166867|FG002|Overall Study|Withdrawal by Subject|16|||
170498946|NCT00614120|616166868|FG003|Overall Study|Withdrawal by Subject|3|||
170551608|NCT00147537|616364814|FG006|Phase 2|Withdrawal by Subject|0|||
170498947|NCT00614120|616166865|FG000|Overall Study|Did not meet trial criteria|0|||
170498948|NCT00614120|616166866|FG001|Overall Study|Did not meet trial criteria|1|||
170498949|NCT00614120|616166867|FG002|Overall Study|Did not meet trial criteria|1|||
170498950|NCT00614120|616166868|FG003|Overall Study|Did not meet trial criteria|1|||
170498951|NCT00614120|616166865|FG000|Overall Study|hCG positive (not pregnant)|0|||
170498952|NCT00614120|616166866|FG001|Overall Study|hCG positive (not pregnant)|0|||
170498953|NCT00614120|616166867|FG002|Overall Study|hCG positive (not pregnant)|1|||
170498954|NCT00614120|616166868|FG003|Overall Study|hCG positive (not pregnant)|0|||
170498955|NCT00614120|616166865|FG000|Overall Study|Hypoglycaemia|0|||
170498956|NCT00614120|616166866|FG001|Overall Study|Hypoglycaemia|0|||
170498957|NCT00614120|616166867|FG002|Overall Study|Hypoglycaemia|0|||
170498958|NCT00614120|616166868|FG003|Overall Study|Hypoglycaemia|1|||
170498959|NCT00614120|616166865|FG000|Overall Study|Lack of trial product|3|||
170498960|NCT00614120|616166866|FG001|Overall Study|Lack of trial product|3|||
170498961|NCT00614120|616166867|FG002|Overall Study|Lack of trial product|2|||
170498962|NCT00614120|616166868|FG003|Overall Study|Lack of trial product|0|||
170498963|NCT00614120|616166865|FG000|Overall Study|Late syphilis, latent|1|||
170498964|NCT00614120|616166866|FG001|Overall Study|Late syphilis, latent|0|||
170498965|NCT00614120|616166867|FG002|Overall Study|Late syphilis, latent|0|||
170498966|NCT00614120|616166868|FG003|Overall Study|Late syphilis, latent|0|||
170498967|NCT00614120|616166865|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
170498968|NCT00614120|616166866|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
170498969|NCT00614120|616166867|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
170498970|NCT00614120|616166868|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
170498971|NCT00614120|616166865|FG000|Overall Study|Lost to Follow-up|1|||
170498972|NCT00614120|616166866|FG001|Overall Study|Lost to Follow-up|2|||
170498973|NCT00614120|616166867|FG002|Overall Study|Lost to Follow-up|3|||
170498974|NCT00614120|616166868|FG003|Overall Study|Lost to Follow-up|4|||
170498975|NCT05178641|616166875|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
170498976|NCT05178641|616166876|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
170498977|NCT05178641|616166875|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
170498978|NCT05178641|616166876|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
170498979|NCT01869699|616166877|FG000|Overall Study|Withdrawal by Subject|1|||
170498980|NCT01869699|616166878|FG001|Overall Study|Withdrawal by Subject|0|||
170498981|NCT01041976|616166882|FG000|Overall Study|Withdrawal by Subject|3|||
170498982|NCT01041976|616166883|FG001|Overall Study|Withdrawal by Subject|0|||
170498983|NCT01041976|616166882|FG000|Overall Study|Incarceration|2|||
170498984|NCT01041976|616166883|FG001|Overall Study|Incarceration|0|||
170498985|NCT01041976|616166882|FG000|Overall Study|Death|0|||
170498986|NCT01041976|616166883|FG001|Overall Study|Death|4|||
170498987|NCT03640481|616166884|FG000|Overall Study|Death|14|||
170498988|NCT03640481|616166885|FG001|Overall Study|Death|14|||
170498989|NCT03640481|616166886|FG002|Overall Study|Death|0|||
170498990|NCT03640481|616166887|FG003|Overall Study|Death|0|||
170498991|NCT03640481|616166884|FG000|Overall Study|Lost to Follow-up|2|||
170498992|NCT03640481|616166885|FG001|Overall Study|Lost to Follow-up|0|||
170498993|NCT03640481|616166886|FG002|Overall Study|Lost to Follow-up|0|||
170498994|NCT03640481|616166887|FG003|Overall Study|Lost to Follow-up|0|||
170498995|NCT03640481|616166884|FG000|Overall Study|Site terminated by sponsor|1|||
170498996|NCT03640481|616166885|FG001|Overall Study|Site terminated by sponsor|3|||
170498997|NCT03640481|616166886|FG002|Overall Study|Site terminated by sponsor|0|||
170498998|NCT03640481|616166887|FG003|Overall Study|Site terminated by sponsor|0|||
170498999|NCT03640481|616166884|FG000|Overall Study|Study terminated by sponsor|29|||
170804749|NCT02036970|617294670|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
170804750|NCT02036970|617294671|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
170804751|NCT02036970|617294672|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
170804752|NCT02000752|617294676|FG000|Overall Study|Dystocic delivery|19|||
170804753|NCT02000752|617294677|FG001|Overall Study|Dystocic delivery|8|||
170804754|NCT02000752|617294676|FG000|Overall Study|Shift Changes|12|||
170804755|NCT02000752|617294677|FG001|Overall Study|Shift Changes|5|||
170804756|NCT04608409|617294681|FG000|Overall Study|Physician Decision|1|||
170804757|NCT04608409|617294682|FG001|Overall Study|Physician Decision|1|||
170804758|NCT04608409|617294683|FG002|Overall Study|Physician Decision|2|||
170804759|NCT00047385|617294684|FG000|Overall Study|Death before any screening|2|||
170903392|NCT03874234|617649089|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170903393|NCT03874234|617649090|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170903394|NCT03874234|617649091|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170499000|NCT03640481|616166885|FG001|Overall Study|Study terminated by sponsor|42|||
170499001|NCT03640481|616166886|FG002|Overall Study|Study terminated by sponsor|1|||
170499002|NCT03640481|616166887|FG003|Overall Study|Study terminated by sponsor|0|||
170499003|NCT03640481|616166884|FG000|Overall Study|Withdrawal by Subject|5|||
170499004|NCT03640481|616166885|FG001|Overall Study|Withdrawal by Subject|4|||
170499005|NCT03640481|616166886|FG002|Overall Study|Withdrawal by Subject|0|||
170499006|NCT03640481|616166887|FG003|Overall Study|Withdrawal by Subject|1|||
170499007|NCT03640481|616166884|FG000|Overall Study|Other|26|||
170499008|NCT03640481|616166885|FG001|Overall Study|Other|12|||
170499009|NCT03640481|616166886|FG002|Overall Study|Other|1|||
170499010|NCT03640481|616166887|FG003|Overall Study|Other|0|||
170499011|NCT03640481|616166884|FG000|Overall Study|Randomized, but not treated|1|||
170499012|NCT03640481|616166885|FG001|Overall Study|Randomized, but not treated|3|||
170499013|NCT03640481|616166886|FG002|Overall Study|Randomized, but not treated|0|||
170499014|NCT03640481|616166887|FG003|Overall Study|Randomized, but not treated|0|||
170499015|NCT00070018|616166890|FG000|Overall Study|Adverse Event|2|||
170499016|NCT00070018|616166890|FG000|Overall Study|Lack of Efficacy|1|||
170499017|NCT00070018|616166890|FG000|Overall Study|Withdrawal by Subject|1|||
170499018|NCT00574249|616166891|FG000|Overall Study|Adverse Event|6|||
170499019|NCT00574249|616166892|FG001|Overall Study|Adverse Event|18|||
170499020|NCT00574249|616166891|FG000|Overall Study|Lack of Efficacy|5|||
170499021|NCT00574249|616166892|FG001|Overall Study|Lack of Efficacy|3|||
170499022|NCT00574249|616166891|FG000|Overall Study|Lost to Follow-up|4|||
170499023|NCT00574249|616166892|FG001|Overall Study|Lost to Follow-up|3|||
170499024|NCT00574249|616166891|FG000|Overall Study|Protocol Violation|5|||
170499025|NCT00574249|616166892|FG001|Overall Study|Protocol Violation|2|||
170499026|NCT00574249|616166891|FG000|Overall Study|History of carcinoma|1|||
170499027|NCT00574249|616166892|FG001|Overall Study|History of carcinoma|0|||
170499028|NCT00574249|616166891|FG000|Overall Study|Withdrawal by Subject|3|||
170499029|NCT00574249|616166892|FG001|Overall Study|Withdrawal by Subject|0|||
170499030|NCT00574249|616166891|FG000|Overall Study|Physician Decision|1|||
170499031|NCT00574249|616166892|FG001|Overall Study|Physician Decision|0|||
170499032|NCT00574249|616166891|FG000|Overall Study|Pregnancy|1|||
170499033|NCT00574249|616166892|FG001|Overall Study|Pregnancy|0|||
170499034|NCT00574249|616166891|FG000|Overall Study|Excluded by company|0|||
170499035|NCT00574249|616166892|FG001|Overall Study|Excluded by company|1|||
170499036|NCT00574249|616166891|FG000|Overall Study|PPD test taken twice|0|||
170499037|NCT00574249|616166892|FG001|Overall Study|PPD test taken twice|1|||
170499038|NCT01542034|616166893|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
170499039|NCT01542034|616166894|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
170499040|NCT01542034|616166893|FG000|Overall Study|Administrative decision|0|||
170499041|NCT01542034|616166894|FG001|Overall Study|Administrative decision|3|||
170499042|NCT01542034|616166893|FG000|Overall Study|Subject Noncompliance|1|||
170499043|NCT01542034|616166894|FG001|Overall Study|Subject Noncompliance|0|||
170499044|NCT01542034|616166893|FG000|Overall Study|Adverse Event|2|||
170499045|NCT01542034|616166894|FG001|Overall Study|Adverse Event|2|||
170499046|NCT01542034|616166893|FG000|Overall Study|Lost to Follow-up|7|||
170499047|NCT01542034|616166894|FG001|Overall Study|Lost to Follow-up|6|||
170499048|NCT04442269|616166898|FG000|Overall Study|Adverse Event|1|||
170499049|NCT04442269|616166899|FG001|Overall Study|Adverse Event|0|||
170499050|NCT04442269|616166898|FG000|Overall Study|Death|0|||
170499051|NCT04442269|616166899|FG001|Overall Study|Death|1|||
170499052|NCT04442269|616166898|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
170499053|NCT04442269|616166899|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
170499054|NCT04442269|616166898|FG000|Overall Study|Lost to Follow-up|1|||
170499055|NCT04442269|616166899|FG001|Overall Study|Lost to Follow-up|0|||
170499056|NCT04442269|616166898|FG000|Overall Study|Withdrawal by Subject|3|||
170499057|NCT04442269|616166899|FG001|Overall Study|Withdrawal by Subject|2|||
170499058|NCT04442269|616166898|FG000|Overall Study|Protocol Deviation|0|||
170499059|NCT04442269|616166899|FG001|Overall Study|Protocol Deviation|1|||
170499060|NCT04442269|616166898|FG000|Overall Study|Travel Limitations|1|||
170499061|NCT04442269|616166899|FG001|Overall Study|Travel Limitations|1|||
170499062|NCT00430352|616166900|FG000|Overall Study|Disease progression|58|||
170499063|NCT00430352|616166900|FG000|Overall Study|Withdrawal by Subject|11|||
170499064|NCT00430352|616166900|FG000|Overall Study|Adverse Event|16|||
170499065|NCT00430352|616166900|FG000|Overall Study|Death|5|||
170499066|NCT00430352|616166900|FG000|Overall Study|Other|48|||
170499067|NCT01167881|616166901|FG000|Overall Study|Adverse Event|47|||
170499068|NCT01167881|616166902|FG001|Overall Study|Adverse Event|51|||
170499069|NCT01167881|616166901|FG000|Overall Study|Lack of Efficacy|4|||
170499070|NCT01167881|616166902|FG001|Overall Study|Lack of Efficacy|7|||
170499071|NCT01167881|616166901|FG000|Overall Study|Non compliant with protocol|9|||
170499072|NCT01167881|616166902|FG001|Overall Study|Non compliant with protocol|18|||
170499073|NCT01167881|616166901|FG000|Overall Study|Lost to Follow-up|19|||
170499074|NCT01167881|616166902|FG001|Overall Study|Lost to Follow-up|20|||
170499075|NCT01167881|616166901|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
170499076|NCT01167881|616166902|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
170551609|NCT00147537|616364815|FG007|Phase 2|Withdrawal by Subject|0|||
170551610|NCT00147537|616364816|FG008|Phase 2|Withdrawal by Subject|0|||
170499077|NCT01167881|616166901|FG000|Overall Study|Not treated|4|||
170499078|NCT01167881|616166902|FG001|Overall Study|Not treated|0|||
170499079|NCT01167881|616166901|FG000|Overall Study|Other not defined above|31|||
170499080|NCT01167881|616166902|FG001|Overall Study|Other not defined above|55|||
170499081|NCT02291601|616166903|FG000|Abdomen|Did not qualify|333|||
170499082|NCT02291601|616166904|FG001|Abdomen|Did not qualify|54|||
170499083|NCT02291601|616166905|FG002|Abdomen|Did not qualify|339|||
170499084|NCT02291601|616166903|FG000|Groin|Did not qualify|183|||
170499085|NCT02291601|616166904|FG001|Groin|Did not qualify|30|||
170499086|NCT02291601|616166905|FG002|Groin|Did not qualify|177|||
170499087|NCT00471718|616166911|FG000|Overall Study|Adverse Event|3|||
170499088|NCT00471718|616166911|FG000|Overall Study|other complicating disease|1|||
170499089|NCT00471718|616166911|FG000|Overall Study|disease progression|22|||
170499090|NCT00471718|616166911|FG000|Overall Study|Withdrawal by Subject|1|||
170499091|NCT02294175|616166912|FG000|Overall Study|Withdrawal by Subject|1|||
170499092|NCT02294175|616166913|FG001|Overall Study|Withdrawal by Subject|2|||
170499093|NCT02294175|616166912|FG000|Overall Study|pt taking excluded medication|3|||
170499094|NCT02294175|616166913|FG001|Overall Study|pt taking excluded medication|1|||
170499095|NCT02294175|616166912|FG000|Overall Study|Protocol Violation|1|||
170499096|NCT02294175|616166913|FG001|Overall Study|Protocol Violation|0|||
170499097|NCT02294175|616166912|FG000|Overall Study|Lost to Follow-up|0|||
170499098|NCT02294175|616166913|FG001|Overall Study|Lost to Follow-up|1|||
170499099|NCT02294175|616166912|FG000|Overall Study|wound healed|0|||
170499100|NCT02294175|616166913|FG001|Overall Study|wound healed|2|||
170499101|NCT01901653|616166914|FG000|Overall Study|Death|2|||
170499102|NCT01901653|616166915|FG001|Overall Study|Death|1|||
170499103|NCT01901653|616166916|FG002|Overall Study|Death|8|||
170499104|NCT01901653|616166917|FG003|Overall Study|Death|3|||
170499105|NCT01901653|616166918|FG004|Overall Study|Death|2|||
170499106|NCT01901653|616166919|FG005|Overall Study|Death|2|||
170499107|NCT01901653|616166920|FG006|Overall Study|Death|6|||
170499108|NCT01901653|616166921|FG007|Overall Study|Death|9|||
170499109|NCT01901653|616166922|FG008|Overall Study|Death|1|||
170499110|NCT01901653|616166923|FG009|Overall Study|Death|16|||
170499111|NCT01901653|616166924|FG010|Overall Study|Death|2|||
170499112|NCT01901653|616166925|FG011|Overall Study|Death|15|||
170499113|NCT01901653|616166926|FG012|Overall Study|Death|4|||
170499114|NCT01901653|616166914|FG000|Overall Study|Lost to Follow-up|1|||
170499115|NCT01901653|616166915|FG001|Overall Study|Lost to Follow-up|0|||
170499116|NCT01901653|616166916|FG002|Overall Study|Lost to Follow-up|2|||
170499117|NCT01901653|616166917|FG003|Overall Study|Lost to Follow-up|0|||
170499118|NCT01901653|616166918|FG004|Overall Study|Lost to Follow-up|0|||
170499119|NCT01901653|616166919|FG005|Overall Study|Lost to Follow-up|1|||
170499120|NCT01901653|616166920|FG006|Overall Study|Lost to Follow-up|0|||
170499121|NCT01901653|616166921|FG007|Overall Study|Lost to Follow-up|1|||
170499122|NCT01901653|616166922|FG008|Overall Study|Lost to Follow-up|0|||
170499123|NCT01901653|616166923|FG009|Overall Study|Lost to Follow-up|0|||
170499124|NCT01901653|616166924|FG010|Overall Study|Lost to Follow-up|0|||
170499125|NCT01901653|616166925|FG011|Overall Study|Lost to Follow-up|0|||
170499126|NCT01901653|616166926|FG012|Overall Study|Lost to Follow-up|0|||
170499127|NCT01901653|616166914|FG000|Overall Study|Withdrawal by Subject|0|||
170499128|NCT01901653|616166915|FG001|Overall Study|Withdrawal by Subject|0|||
170642454|NCT01297491|616705256|FG000|Overall Study|Progressive disease|11|||
170642455|NCT01297491|616705257|FG001|Overall Study|Progressive disease|20|||
170642456|NCT01297491|616705256|FG000|Overall Study|Patient/Guardian decision|3|||
170903395|NCT03874234|617649092|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
170499129|NCT01901653|616166916|FG002|Overall Study|Withdrawal by Subject|0|||
170499130|NCT01901653|616166917|FG003|Overall Study|Withdrawal by Subject|0|||
170499131|NCT01901653|616166918|FG004|Overall Study|Withdrawal by Subject|0|||
170499132|NCT01901653|616166919|FG005|Overall Study|Withdrawal by Subject|0|||
170499133|NCT01901653|616166920|FG006|Overall Study|Withdrawal by Subject|1|||
170499134|NCT01901653|616166921|FG007|Overall Study|Withdrawal by Subject|0|||
170499135|NCT01901653|616166922|FG008|Overall Study|Withdrawal by Subject|0|||
170499136|NCT01901653|616166923|FG009|Overall Study|Withdrawal by Subject|0|||
170499137|NCT01901653|616166924|FG010|Overall Study|Withdrawal by Subject|0|||
170499138|NCT01901653|616166925|FG011|Overall Study|Withdrawal by Subject|0|||
170499139|NCT01901653|616166926|FG012|Overall Study|Withdrawal by Subject|0|||
170499140|NCT01901653|616166914|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
170903396|NCT03874234|617649093|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
170903397|NCT03874234|617649094|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170499141|NCT01901653|616166915|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
170499142|NCT01901653|616166916|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
170499143|NCT01901653|616166917|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
170499144|NCT01901653|616166918|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
170499145|NCT01901653|616166919|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
170499146|NCT01901653|616166920|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
170499147|NCT01901653|616166921|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
170499148|NCT01901653|616166922|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
170499149|NCT01901653|616166923|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
170499150|NCT01901653|616166924|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
170499151|NCT01901653|616166925|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
170499152|NCT01901653|616166926|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
170499153|NCT01668173|616166927|FG000|Overall Study|Adverse Event|3|||
170499154|NCT01668173|616166927|FG000|Overall Study|Trial suspension|4|||
170499155|NCT02805660|616166928|FG000|Overall Study|Death|5|||
170903398|NCT03874234|617649095|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170499156|NCT02805660|616166929|FG001|Overall Study|Death|2|||
170499157|NCT02805660|616166930|FG002|Overall Study|Death|9|||
170499158|NCT02805660|616166931|FG003|Overall Study|Death|5|||
170499159|NCT02805660|616166932|FG004|Overall Study|Death|0|||
170499160|NCT02805660|616166933|FG005|Overall Study|Death|14|||
170499161|NCT02805660|616166934|FG006|Overall Study|Death|12|||
170499162|NCT02805660|616166928|FG000|Overall Study|Lost to Follow-up|0|||
170499163|NCT02805660|616166929|FG001|Overall Study|Lost to Follow-up|1|||
170499164|NCT02805660|616166930|FG002|Overall Study|Lost to Follow-up|1|||
170499165|NCT02805660|616166931|FG003|Overall Study|Lost to Follow-up|2|||
170499166|NCT02805660|616166932|FG004|Overall Study|Lost to Follow-up|0|||
170499167|NCT02805660|616166933|FG005|Overall Study|Lost to Follow-up|0|||
170499168|NCT02805660|616166934|FG006|Overall Study|Lost to Follow-up|0|||
170499169|NCT02805660|616166928|FG000|Overall Study|Withdrawal by Subject|0|||
170499170|NCT02805660|616166929|FG001|Overall Study|Withdrawal by Subject|0|||
170499171|NCT02805660|616166930|FG002|Overall Study|Withdrawal by Subject|0|||
170499172|NCT02805660|616166931|FG003|Overall Study|Withdrawal by Subject|3|||
170499173|NCT02805660|616166932|FG004|Overall Study|Withdrawal by Subject|1|||
170499174|NCT02805660|616166933|FG005|Overall Study|Withdrawal by Subject|0|||
170499175|NCT02805660|616166934|FG006|Overall Study|Withdrawal by Subject|2|||
170499176|NCT02805660|616166928|FG000|Overall Study|Study terminated by Sponsor|0|||
170499177|NCT02805660|616166929|FG001|Overall Study|Study terminated by Sponsor|0|||
170499178|NCT02805660|616166930|FG002|Overall Study|Study terminated by Sponsor|1|||
170499179|NCT02805660|616166931|FG003|Overall Study|Study terminated by Sponsor|4|||
170499180|NCT02805660|616166932|FG004|Overall Study|Study terminated by Sponsor|2|||
170499181|NCT02805660|616166933|FG005|Overall Study|Study terminated by Sponsor|3|||
170499182|NCT02805660|616166934|FG006|Overall Study|Study terminated by Sponsor|1|||
170499183|NCT02805660|616166928|FG000|Overall Study|Miscellaneous|0|||
170499184|NCT02805660|616166929|FG001|Overall Study|Miscellaneous|1|||
170499185|NCT02805660|616166930|FG002|Overall Study|Miscellaneous|0|||
170499186|NCT02805660|616166931|FG003|Overall Study|Miscellaneous|4|||
170499187|NCT02805660|616166932|FG004|Overall Study|Miscellaneous|0|||
170499188|NCT02805660|616166933|FG005|Overall Study|Miscellaneous|6|||
170499189|NCT02805660|616166934|FG006|Overall Study|Miscellaneous|4|||
170499190|NCT02572076|616166935|FG000|Overall Study|Protocol Violation|1|||
170499191|NCT02778074|616166936|FG000|Overall Study|Lost to Follow-up|7|||
170499192|NCT02778074|616166937|FG001|Overall Study|Lost to Follow-up|10|||
170499193|NCT03489707|616166940|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
170499194|NCT03489707|616166941|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
170499195|NCT03489707|616166940|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
170499196|NCT03489707|616166941|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
170499197|NCT01817582|616166947|FG000|Overall Study|Withdrawal by Subject|0|||
170499198|NCT01817582|616166948|FG001|Overall Study|Withdrawal by Subject|1|||
170499199|NCT01817582|616166949|FG002|Overall Study|Withdrawal by Subject|0|||
170499200|NCT01817582|616166947|FG000|Overall Study|Participant revealed masked treatment|1|||
170499201|NCT01817582|616166948|FG001|Overall Study|Participant revealed masked treatment|0|||
170499202|NCT01817582|616166949|FG002|Overall Study|Participant revealed masked treatment|0|||
170499203|NCT01817582|616166947|FG000|Overall Study|Randomized but exclusion criteria met|1|||
170499204|NCT01817582|616166948|FG001|Overall Study|Randomized but exclusion criteria met|0|||
170499205|NCT01817582|616166949|FG002|Overall Study|Randomized but exclusion criteria met|0|||
170499206|NCT03053063|616166955|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
170499207|NCT03053063|616166956|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
170499208|NCT03053063|616166957|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
170499209|NCT03053063|616166958|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
170499210|NCT03053063|616166955|FG000|Randomized Phase|Withdrew consent|8|||
170499211|NCT03053063|616166956|FG001|Randomized Phase|Withdrew consent|11|||
170499212|NCT03053063|616166957|FG002|Randomized Phase|Withdrew consent|5|||
170499213|NCT03053063|616166958|FG003|Randomized Phase|Withdrew consent|0|||
170499214|NCT03053063|616166955|FG000|Randomized Phase|Investigator's Discretion|8|||
170499215|NCT03053063|616166956|FG001|Randomized Phase|Investigator's Discretion|6|||
170499216|NCT03053063|616166957|FG002|Randomized Phase|Investigator's Discretion|2|||
170499217|NCT03053063|616166958|FG003|Randomized Phase|Investigator's Discretion|0|||
170499218|NCT03053063|616166955|FG000|Randomized Phase|Lost to Follow-up|3|||
170499219|NCT03053063|616166956|FG001|Randomized Phase|Lost to Follow-up|5|||
170499220|NCT03053063|616166957|FG002|Randomized Phase|Lost to Follow-up|1|||
170499221|NCT03053063|616166958|FG003|Randomized Phase|Lost to Follow-up|0|||
170499222|NCT03053063|616166955|FG000|Randomized Phase|Adverse Event|0|||
170499223|NCT03053063|616166956|FG001|Randomized Phase|Adverse Event|1|||
170499224|NCT03053063|616166957|FG002|Randomized Phase|Adverse Event|0|||
170499225|NCT03053063|616166958|FG003|Randomized Phase|Adverse Event|0|||
170499226|NCT03053063|616166955|FG000|Randomized Phase|Randomized but Never Treated|1|||
170499227|NCT03053063|616166956|FG001|Randomized Phase|Randomized but Never Treated|3|||
170499228|NCT03053063|616166957|FG002|Randomized Phase|Randomized but Never Treated|2|||
170499229|NCT03053063|616166958|FG003|Randomized Phase|Randomized but Never Treated|0|||
170499230|NCT03053063|616166955|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
170499231|NCT03053063|616166956|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
170499232|NCT03053063|616166957|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
170499233|NCT03053063|616166958|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
170499234|NCT03053063|616166955|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
170499235|NCT03053063|616166956|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
170499236|NCT03053063|616166957|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
170499237|NCT03053063|616166958|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
170499238|NCT03053063|616166955|FG000|Open-Label Phase|Death|0|||
170499239|NCT03053063|616166956|FG001|Open-Label Phase|Death|0|||
170499240|NCT03053063|616166957|FG002|Open-Label Phase|Death|0|||
170499241|NCT03053063|616166958|FG003|Open-Label Phase|Death|2|||
170499242|NCT03053063|616166955|FG000|Open-Label Phase|Investigator's discretion|0|||
170499243|NCT03053063|616166956|FG001|Open-Label Phase|Investigator's discretion|0|||
170499244|NCT03053063|616166957|FG002|Open-Label Phase|Investigator's discretion|0|||
170499245|NCT03053063|616166958|FG003|Open-Label Phase|Investigator's discretion|2|||
170499246|NCT02600845|616166959|FG000|Overall Study|Reason Not Specified|3|||
170499247|NCT02600845|616166959|FG000|Overall Study|Non-compliance with Study Procedures|10|||
170499248|NCT02600845|616166959|FG000|Overall Study|Consent Withdrawal|5|||
170499249|NCT03963232|616166960|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
170499250|NCT03963232|616166961|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
170499251|NCT03963232|616166960|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
170499252|NCT03963232|616166961|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
170499253|NCT03963232|616166960|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
170499254|NCT03963232|616166961|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
170499255|NCT03963232|616166960|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
170499256|NCT03963232|616166961|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
170499257|NCT03963232|616166960|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
170499258|NCT03963232|616166961|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
170499259|NCT03963232|616166960|FG000|Open-Label Treatment Phase|Adverse Event|1|||
170499260|NCT03963232|616166961|FG001|Open-Label Treatment Phase|Adverse Event|2|||
170499261|NCT03963232|616166960|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
170499262|NCT03963232|616166961|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
170499263|NCT03963232|616166960|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
170499264|NCT03963232|616166961|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
170499265|NCT03963232|616166960|FG000|Open-Label Treatment Phase|Pregnancy|1|||
170499266|NCT03963232|616166961|FG001|Open-Label Treatment Phase|Pregnancy|0|||
170499267|NCT03963232|616166960|FG000|Follow-up Phase|Withdrawal by Subject|7|||
170499268|NCT03963232|616166961|FG001|Follow-up Phase|Withdrawal by Subject|5|||
170499269|NCT03963232|616166960|FG000|Follow-up Phase|Protocol Violation|0|||
170499270|NCT03963232|616166961|FG001|Follow-up Phase|Protocol Violation|2|||
170499271|NCT03963232|616166960|FG000|Follow-up Phase|Adverse Event|0|||
170499272|NCT03963232|616166961|FG001|Follow-up Phase|Adverse Event|1|||
170499273|NCT03963232|616166960|FG000|Follow-up Phase|Lost to Follow-up|0|||
170499274|NCT03963232|616166961|FG001|Follow-up Phase|Lost to Follow-up|1|||
170499275|NCT03569293|616169083|FG000|Overall Study|Adverse Event|4|||
170499276|NCT03569293|616169084|FG001|Overall Study|Adverse Event|1|||
170499277|NCT03569293|616169085|FG002|Overall Study|Adverse Event|5|||
170499278|NCT03569293|616169086|FG003|Overall Study|Adverse Event|1|||
170499279|NCT03569293|616169087|FG004|Overall Study|Adverse Event|0|||
170499280|NCT03569293|616169088|FG005|Overall Study|Adverse Event|0|||
170499281|NCT03569293|616169083|FG000|Overall Study|Withdrawal by Subject|16|||
170499282|NCT03569293|616169084|FG001|Overall Study|Withdrawal by Subject|2|||
170499283|NCT03569293|616169085|FG002|Overall Study|Withdrawal by Subject|4|||
170804760|NCT00047385|617294685|FG001|Overall Study|Death before any screening|5|||
170499284|NCT03569293|616169086|FG003|Overall Study|Withdrawal by Subject|1|||
170499285|NCT03569293|616169087|FG004|Overall Study|Withdrawal by Subject|0|||
170499286|NCT03569293|616169088|FG005|Overall Study|Withdrawal by Subject|0|||
170499287|NCT03569293|616169083|FG000|Overall Study|Lost to Follow-up|1|||
170499288|NCT03569293|616169084|FG001|Overall Study|Lost to Follow-up|3|||
170499289|NCT03569293|616169085|FG002|Overall Study|Lost to Follow-up|1|||
170499290|NCT03569293|616169086|FG003|Overall Study|Lost to Follow-up|1|||
170499291|NCT03569293|616169087|FG004|Overall Study|Lost to Follow-up|0|||
170499292|NCT03569293|616169088|FG005|Overall Study|Lost to Follow-up|0|||
170499293|NCT03569293|616169083|FG000|Overall Study|Other|8|||
170499294|NCT03569293|616169084|FG001|Overall Study|Other|2|||
170499295|NCT03569293|616169085|FG002|Overall Study|Other|1|||
170499296|NCT03569293|616169086|FG003|Overall Study|Other|1|||
170499297|NCT03569293|616169087|FG004|Overall Study|Other|0|||
170499298|NCT03569293|616169088|FG005|Overall Study|Other|0|||
170499299|NCT03569293|616169083|FG000|Overall Study|Ongoing at Time of Analysis|8|||
170499300|NCT03569293|616169084|FG001|Overall Study|Ongoing at Time of Analysis|1|||
170499301|NCT03569293|616169085|FG002|Overall Study|Ongoing at Time of Analysis|3|||
170499302|NCT03569293|616169086|FG003|Overall Study|Ongoing at Time of Analysis|0|||
170499303|NCT03569293|616169087|FG004|Overall Study|Ongoing at Time of Analysis|0|||
170499304|NCT03569293|616169088|FG005|Overall Study|Ongoing at Time of Analysis|0|||
170903399|NCT03874234|617649096|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170903400|NCT03874234|617649097|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170903401|NCT03874234|617649098|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170903402|NCT03874234|617649099|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170903403|NCT03874234|617649100|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
170499305|NCT01004406|616169089|FG000|Overall Study|Withdrawal by Subject|2|||
170499306|NCT01004406|616169090|FG001|Overall Study|Withdrawal by Subject|0|||
170499307|NCT01004406|616169089|FG000|Overall Study|Lost to Follow-up|1|||
170499308|NCT01004406|616169090|FG001|Overall Study|Lost to Follow-up|0|||
170499309|NCT03201874|616169091|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
170499310|NCT03201874|616169092|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
170499311|NCT03201874|616169091|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
170499312|NCT03201874|616169092|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
170499313|NCT01944670|616169095|FG000|Overall Study|Lost to Follow-up|2|||
170499314|NCT02907593|616169096|FG000|Overall Study|Withdrawal by Subject|0|||
170499315|NCT02907593|616169097|FG001|Overall Study|Withdrawal by Subject|0|||
170499316|NCT02907593|616169098|FG002|Overall Study|Withdrawal by Subject|1|||
170499317|NCT02907593|616169099|FG003|Overall Study|Withdrawal by Subject|0|||
170499318|NCT01702532|616169103|FG000|Overall Study|Adverse Event|0|||
170499319|NCT01702532|616169104|FG001|Overall Study|Adverse Event|1|||
170499320|NCT01451164|616169105|FG000|Overall Study|Adverse Event|19|||
170499321|NCT01451164|616169106|FG001|Overall Study|Adverse Event|12|||
170499322|NCT01451164|616169107|FG002|Overall Study|Adverse Event|18|||
170499323|NCT01451164|616169108|FG003|Overall Study|Adverse Event|21|||
170499324|NCT01451164|616169105|FG000|Overall Study|Withdrawal Criteria|1|||
170499325|NCT01451164|616169106|FG001|Overall Study|Withdrawal Criteria|1|||
170903404|NCT03874234|617649088|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170499326|NCT01451164|616169107|FG002|Overall Study|Withdrawal Criteria|1|||
170499327|NCT01451164|616169108|FG003|Overall Study|Withdrawal Criteria|1|||
170499328|NCT01451164|616169105|FG000|Overall Study|Physician Decision|2|||
170499329|NCT01451164|616169106|FG001|Overall Study|Physician Decision|0|||
170499330|NCT01451164|616169107|FG002|Overall Study|Physician Decision|1|||
170499331|NCT01451164|616169108|FG003|Overall Study|Physician Decision|0|||
170499332|NCT01451164|616169105|FG000|Overall Study|Withdrawal by Subject|14|||
170499333|NCT01451164|616169106|FG001|Overall Study|Withdrawal by Subject|11|||
170499334|NCT01451164|616169107|FG002|Overall Study|Withdrawal by Subject|16|||
170499335|NCT01451164|616169108|FG003|Overall Study|Withdrawal by Subject|17|||
170499336|NCT01451164|616169105|FG000|Overall Study|Protocol Violation|0|||
170499337|NCT01451164|616169106|FG001|Overall Study|Protocol Violation|1|||
170499338|NCT01451164|616169107|FG002|Overall Study|Protocol Violation|0|||
170499339|NCT01451164|616169108|FG003|Overall Study|Protocol Violation|0|||
170499340|NCT01451164|616169105|FG000|Overall Study|Lack of Efficacy|7|||
170499341|NCT01451164|616169106|FG001|Overall Study|Lack of Efficacy|9|||
170499342|NCT01451164|616169107|FG002|Overall Study|Lack of Efficacy|9|||
170499343|NCT01451164|616169108|FG003|Overall Study|Lack of Efficacy|7|||
170499344|NCT00308750|616169113|FG000|Overall Study|Adverse Event|9|||
170499345|NCT00308750|616169114|FG001|Overall Study|Adverse Event|9|||
170499346|NCT00308750|616169115|FG002|Overall Study|Adverse Event|13|||
170499347|NCT00308750|616169113|FG000|Overall Study|Withdrawal by Subject|6|||
170499348|NCT00308750|616169114|FG001|Overall Study|Withdrawal by Subject|2|||
170499349|NCT00308750|616169115|FG002|Overall Study|Withdrawal by Subject|3|||
170499350|NCT00308750|616169113|FG000|Overall Study|Physician Decision|3|||
170499351|NCT00308750|616169114|FG001|Overall Study|Physician Decision|4|||
170499352|NCT00308750|616169115|FG002|Overall Study|Physician Decision|3|||
170499353|NCT00308750|616169113|FG000|Overall Study|Sponsor Decision|1|||
170499354|NCT00308750|616169114|FG001|Overall Study|Sponsor Decision|0|||
170499355|NCT00308750|616169115|FG002|Overall Study|Sponsor Decision|0|||
170499356|NCT00308750|616169113|FG000|Overall Study|Disease Progression|47|||
170499357|NCT00308750|616169114|FG001|Overall Study|Disease Progression|24|||
170499358|NCT00308750|616169115|FG002|Overall Study|Disease Progression|28|||
170499359|NCT00308750|616169113|FG000|Overall Study|Unrelated Complication|3|||
170499360|NCT00308750|616169114|FG001|Overall Study|Unrelated Complication|0|||
170499361|NCT00308750|616169115|FG002|Overall Study|Unrelated Complication|1|||
170499362|NCT00308750|616169113|FG000|Overall Study|Death|1|||
170499363|NCT00308750|616169114|FG001|Overall Study|Death|0|||
170499364|NCT00308750|616169115|FG002|Overall Study|Death|1|||
170499365|NCT00308750|616169113|FG000|Overall Study|Protocol Violation|1|||
170903405|NCT03874234|617649089|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170499366|NCT00308750|616169114|FG001|Overall Study|Protocol Violation|0|||
170499367|NCT00308750|616169115|FG002|Overall Study|Protocol Violation|0|||
170499368|NCT00308750|616169113|FG000|Overall Study|New Primary Disease Identified|1|||
170499369|NCT00308750|616169114|FG001|Overall Study|New Primary Disease Identified|1|||
170499370|NCT00308750|616169115|FG002|Overall Study|New Primary Disease Identified|0|||
170499371|NCT01358578|616169116|FG000|Induction Period|Adverse Event|2|||
170903406|NCT03874234|617649090|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170499372|NCT01358578|616169117|FG001|Induction Period|Adverse Event|4|||
170499373|NCT01358578|616169118|FG002|Induction Period|Adverse Event|2|||
170499374|NCT01358578|616169119|FG003|Induction Period|Adverse Event|6|||
170499375|NCT01358578|616169120|FG004|Induction Period|Adverse Event|0|||
170499376|NCT01358578|616169121|FG005|Induction Period|Adverse Event|0|||
170499377|NCT01358578|616169116|FG000|Induction Period|Lack of Efficacy|0|||
170499378|NCT01358578|616169117|FG001|Induction Period|Lack of Efficacy|0|||
170499379|NCT01358578|616169118|FG002|Induction Period|Lack of Efficacy|9|||
170499380|NCT01358578|616169119|FG003|Induction Period|Lack of Efficacy|1|||
170499381|NCT01358578|616169120|FG004|Induction Period|Lack of Efficacy|0|||
170499382|NCT01358578|616169121|FG005|Induction Period|Lack of Efficacy|0|||
170499383|NCT01358578|616169116|FG000|Induction Period|Lost to Follow-up|0|||
170499384|NCT01358578|616169117|FG001|Induction Period|Lost to Follow-up|0|||
170499385|NCT01358578|616169118|FG002|Induction Period|Lost to Follow-up|1|||
170499386|NCT01358578|616169119|FG003|Induction Period|Lost to Follow-up|4|||
170499387|NCT01358578|616169120|FG004|Induction Period|Lost to Follow-up|0|||
170499388|NCT01358578|616169121|FG005|Induction Period|Lost to Follow-up|0|||
170499389|NCT01358578|616169116|FG000|Induction Period|Physician Decision|2|||
170499390|NCT01358578|616169117|FG001|Induction Period|Physician Decision|1|||
170499391|NCT01358578|616169118|FG002|Induction Period|Physician Decision|2|||
170499392|NCT01358578|616169119|FG003|Induction Period|Physician Decision|0|||
170499393|NCT01358578|616169120|FG004|Induction Period|Physician Decision|0|||
170499394|NCT01358578|616169121|FG005|Induction Period|Physician Decision|0|||
170499395|NCT01358578|616169116|FG000|Induction Period|Protocol Deviation|3|||
170499396|NCT01358578|616169117|FG001|Induction Period|Protocol Deviation|5|||
170499397|NCT01358578|616169118|FG002|Induction Period|Protocol Deviation|0|||
170499398|NCT01358578|616169119|FG003|Induction Period|Protocol Deviation|3|||
170499399|NCT01358578|616169120|FG004|Induction Period|Protocol Deviation|0|||
170499400|NCT01358578|616169121|FG005|Induction Period|Protocol Deviation|0|||
170499401|NCT01358578|616169116|FG000|Induction Period|technical problems|0|||
170499402|NCT01358578|616169117|FG001|Induction Period|technical problems|0|||
170499403|NCT01358578|616169118|FG002|Induction Period|technical problems|1|||
170499404|NCT01358578|616169119|FG003|Induction Period|technical problems|1|||
170499405|NCT01358578|616169120|FG004|Induction Period|technical problems|0|||
170499406|NCT01358578|616169121|FG005|Induction Period|technical problems|0|||
170499407|NCT01358578|616169116|FG000|Induction Period|Withdrawal by Subject|5|||
170499408|NCT01358578|616169117|FG001|Induction Period|Withdrawal by Subject|5|||
170499409|NCT01358578|616169118|FG002|Induction Period|Withdrawal by Subject|10|||
170499410|NCT01358578|616169119|FG003|Induction Period|Withdrawal by Subject|6|||
170499411|NCT01358578|616169120|FG004|Induction Period|Withdrawal by Subject|0|||
170499412|NCT01358578|616169121|FG005|Induction Period|Withdrawal by Subject|0|||
170499413|NCT01358578|616169116|FG000|Maintenance Period|Adverse Event|2|||
170499414|NCT01358578|616169117|FG001|Maintenance Period|Adverse Event|7|||
170499415|NCT01358578|616169118|FG002|Maintenance Period|Adverse Event|0|||
170499416|NCT01358578|616169119|FG003|Maintenance Period|Adverse Event|6|||
170499417|NCT01358578|616169120|FG004|Maintenance Period|Adverse Event|4|||
170499418|NCT01358578|616169121|FG005|Maintenance Period|Adverse Event|3|||
170499419|NCT01358578|616169116|FG000|Maintenance Period|Lack of Efficacy|10|||
170499420|NCT01358578|616169117|FG001|Maintenance Period|Lack of Efficacy|2|||
170499421|NCT01358578|616169118|FG002|Maintenance Period|Lack of Efficacy|0|||
170499422|NCT01358578|616169119|FG003|Maintenance Period|Lack of Efficacy|11|||
170499423|NCT01358578|616169120|FG004|Maintenance Period|Lack of Efficacy|3|||
170499424|NCT01358578|616169121|FG005|Maintenance Period|Lack of Efficacy|0|||
170499425|NCT01358578|616169116|FG000|Maintenance Period|Lost to Follow-up|4|||
170499426|NCT01358578|616169117|FG001|Maintenance Period|Lost to Follow-up|0|||
170499427|NCT01358578|616169118|FG002|Maintenance Period|Lost to Follow-up|0|||
170499428|NCT01358578|616169119|FG003|Maintenance Period|Lost to Follow-up|5|||
170499429|NCT01358578|616169120|FG004|Maintenance Period|Lost to Follow-up|1|||
170499430|NCT01358578|616169121|FG005|Maintenance Period|Lost to Follow-up|1|||
170499431|NCT01358578|616169116|FG000|Maintenance Period|Non-compliance with study treatment|3|||
170499432|NCT01358578|616169117|FG001|Maintenance Period|Non-compliance with study treatment|1|||
170499433|NCT01358578|616169118|FG002|Maintenance Period|Non-compliance with study treatment|0|||
170499434|NCT01358578|616169119|FG003|Maintenance Period|Non-compliance with study treatment|2|||
170499435|NCT01358578|616169120|FG004|Maintenance Period|Non-compliance with study treatment|1|||
170499436|NCT01358578|616169121|FG005|Maintenance Period|Non-compliance with study treatment|2|||
170499437|NCT01358578|616169116|FG000|Maintenance Period|Physician Decision|0|||
170499438|NCT01358578|616169117|FG001|Maintenance Period|Physician Decision|1|||
170499439|NCT01358578|616169118|FG002|Maintenance Period|Physician Decision|0|||
170499440|NCT01358578|616169119|FG003|Maintenance Period|Physician Decision|1|||
170499441|NCT01358578|616169120|FG004|Maintenance Period|Physician Decision|0|||
170499442|NCT01358578|616169121|FG005|Maintenance Period|Physician Decision|0|||
170499443|NCT01358578|616169116|FG000|Maintenance Period|Pregnancy|1|||
170499444|NCT01358578|616169117|FG001|Maintenance Period|Pregnancy|0|||
170499445|NCT01358578|616169118|FG002|Maintenance Period|Pregnancy|0|||
170499446|NCT01358578|616169119|FG003|Maintenance Period|Pregnancy|0|||
170499447|NCT01358578|616169120|FG004|Maintenance Period|Pregnancy|0|||
170642457|NCT01297491|616705257|FG001|Overall Study|Patient/Guardian decision|4|||
170642458|NCT01297491|616705256|FG000|Overall Study|Death|2|||
170642459|NCT01297491|616705257|FG001|Overall Study|Death|1|||
170642460|NCT01327482|616705260|FG000|Overall Study|Adverse Event|1|||
170903407|NCT03874234|617649091|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170499448|NCT01358578|616169121|FG005|Maintenance Period|Pregnancy|0|||
170903408|NCT03874234|617649092|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170903409|NCT03874234|617649093|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170903410|NCT03874234|617649094|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
170903411|NCT03874234|617649095|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170903412|NCT03874234|617649096|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170903413|NCT03874234|617649097|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170903414|NCT03874234|617649098|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170499449|NCT01358578|616169116|FG000|Maintenance Period|Protocol deviation|7|||
170499450|NCT01358578|616169117|FG001|Maintenance Period|Protocol deviation|4|||
170499451|NCT01358578|616169118|FG002|Maintenance Period|Protocol deviation|0|||
170499452|NCT01358578|616169119|FG003|Maintenance Period|Protocol deviation|2|||
170499453|NCT01358578|616169120|FG004|Maintenance Period|Protocol deviation|2|||
170499454|NCT01358578|616169121|FG005|Maintenance Period|Protocol deviation|2|||
170499455|NCT01358578|616169116|FG000|Maintenance Period|Withdrawal by Subject|12|||
170499456|NCT01358578|616169117|FG001|Maintenance Period|Withdrawal by Subject|7|||
170499457|NCT01358578|616169118|FG002|Maintenance Period|Withdrawal by Subject|2|||
170499458|NCT01358578|616169119|FG003|Maintenance Period|Withdrawal by Subject|15|||
170499459|NCT01358578|616169120|FG004|Maintenance Period|Withdrawal by Subject|6|||
170903415|NCT03874234|617649099|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170903416|NCT03874234|617649100|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
170903417|NCT03874234|617649088|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903418|NCT03874234|617649089|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903419|NCT03874234|617649090|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903420|NCT03874234|617649091|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903421|NCT03874234|617649092|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
170903422|NCT03874234|617649093|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903423|NCT03874234|617649094|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903424|NCT03874234|617649095|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903425|NCT03874234|617649096|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903426|NCT03874234|617649097|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903427|NCT03874234|617649098|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903428|NCT03874234|617649099|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903429|NCT03874234|617649100|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
170903430|NCT01821963|617649101|FG000|Overall Study|Adverse Event|1|||
170903431|NCT03539432|617649103|FG000|Overall Study|Lost to Follow-up|0|||
170903432|NCT03539432|617649104|FG001|Overall Study|Lost to Follow-up|1|||
170903433|NCT00603239|617649114|FG000|Overall Study|Adverse Event|4|||
170903434|NCT00603239|617649115|FG001|Overall Study|Adverse Event|1|||
170903435|NCT00603239|617649114|FG000|Overall Study|Entry criteria not met|0|||
170903436|NCT00603239|617649115|FG001|Overall Study|Entry criteria not met|1|||
170903437|NCT00603239|617649114|FG000|Overall Study|Loss of glucose control|3|||
170903438|NCT00603239|617649115|FG001|Overall Study|Loss of glucose control|0|||
170903439|NCT00603239|617649114|FG000|Overall Study|Lost to Follow-up|2|||
170903440|NCT00603239|617649115|FG001|Overall Study|Lost to Follow-up|1|||
170903441|NCT00603239|617649114|FG000|Overall Study|Physician Decision|2|||
170903442|NCT00603239|617649115|FG001|Overall Study|Physician Decision|0|||
170903443|NCT00603239|617649114|FG000|Overall Study|Protocol Violation|2|||
170903444|NCT00603239|617649115|FG001|Overall Study|Protocol Violation|0|||
170499460|NCT01358578|616169121|FG005|Maintenance Period|Withdrawal by Subject|3|||
170499461|NCT01358578|616169116|FG000|Follow-up Period|Adverse Event|1|||
170499462|NCT01358578|616169117|FG001|Follow-up Period|Adverse Event|1|||
170499463|NCT01358578|616169118|FG002|Follow-up Period|Adverse Event|0|||
170499464|NCT01358578|616169119|FG003|Follow-up Period|Adverse Event|0|||
170499465|NCT01358578|616169120|FG004|Follow-up Period|Adverse Event|0|||
170499466|NCT01358578|616169121|FG005|Follow-up Period|Adverse Event|0|||
170499467|NCT01358578|616169116|FG000|Follow-up Period|Lack of Efficacy|3|||
170642461|NCT04145219|616705261|FG000|Overall Study|Adverse Event|18|||
170499468|NCT01358578|616169117|FG001|Follow-up Period|Lack of Efficacy|0|||
170499469|NCT01358578|616169118|FG002|Follow-up Period|Lack of Efficacy|4|||
170499470|NCT01358578|616169119|FG003|Follow-up Period|Lack of Efficacy|1|||
170499471|NCT01358578|616169120|FG004|Follow-up Period|Lack of Efficacy|0|||
170499472|NCT01358578|616169121|FG005|Follow-up Period|Lack of Efficacy|0|||
170499473|NCT01358578|616169116|FG000|Follow-up Period|Lost to Follow-up|0|||
170804761|NCT00047385|617294684|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
170804762|NCT00047385|617294685|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
170804763|NCT00047385|617294684|FG000|Overall Study|Eligible for screening but had no screen|260|||
170804764|NCT00047385|617294685|FG001|Overall Study|Eligible for screening but had no screen|492|||
170804765|NCT01728324|617294689|FG000|Termination of DBV|Adverse Event|14|||
170804766|NCT01728324|617294690|FG001|Termination of DBV|Adverse Event|13|||
170804767|NCT01728324|617294691|FG002|Termination of DBV|Adverse Event|4|||
170804768|NCT01728324|617294689|FG000|Termination of DBV|Lack of Efficacy|14|||
170804769|NCT01728324|617294690|FG001|Termination of DBV|Lack of Efficacy|12|||
170804770|NCT01728324|617294691|FG002|Termination of DBV|Lack of Efficacy|8|||
170804771|NCT01728324|617294689|FG000|Termination of DBV|Withdrawal by Subject|9|||
170804772|NCT01728324|617294690|FG001|Termination of DBV|Withdrawal by Subject|6|||
170804773|NCT01728324|617294691|FG002|Termination of DBV|Withdrawal by Subject|2|||
170804774|NCT01728324|617294689|FG000|Termination of DBV|Other than stated|1|||
170804775|NCT01728324|617294690|FG001|Termination of DBV|Other than stated|3|||
170804776|NCT01728324|617294691|FG002|Termination of DBV|Other than stated|0|||
170804777|NCT01728324|617294689|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
170804778|NCT01728324|617294690|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
170804779|NCT01728324|617294691|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
170804780|NCT01728324|617294689|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
170804781|NCT01728324|617294690|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
170804782|NCT01728324|617294691|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
170804783|NCT01728324|617294689|FG000|Termination of FDV|Adverse Event|14|||
170903445|NCT00603239|617649114|FG000|Overall Study|Subject decision|2|||
170903446|NCT00603239|617649115|FG001|Overall Study|Subject decision|1|||
170903447|NCT04125680|617649116|FG000|Overall Study|Lost to Follow-up|15|||
170903448|NCT00364793|617649119|FG000|Overall Study|Adverse Event|2|||
170903449|NCT00364793|617649120|FG001|Overall Study|Adverse Event|0|||
170903450|NCT00364793|617649121|FG002|Overall Study|Adverse Event|0|||
170499474|NCT01358578|616169117|FG001|Follow-up Period|Lost to Follow-up|1|||
170499475|NCT01358578|616169118|FG002|Follow-up Period|Lost to Follow-up|0|||
170499476|NCT01358578|616169119|FG003|Follow-up Period|Lost to Follow-up|4|||
170499477|NCT01358578|616169120|FG004|Follow-up Period|Lost to Follow-up|0|||
170499478|NCT01358578|616169121|FG005|Follow-up Period|Lost to Follow-up|0|||
170499479|NCT01358578|616169116|FG000|Follow-up Period|non- compliance with study treatment|1|||
170499480|NCT01358578|616169117|FG001|Follow-up Period|non- compliance with study treatment|0|||
170499481|NCT01358578|616169118|FG002|Follow-up Period|non- compliance with study treatment|0|||
170499482|NCT01358578|616169119|FG003|Follow-up Period|non- compliance with study treatment|0|||
170499483|NCT01358578|616169120|FG004|Follow-up Period|non- compliance with study treatment|0|||
170499484|NCT01358578|616169121|FG005|Follow-up Period|non- compliance with study treatment|0|||
170499485|NCT01358578|616169116|FG000|Follow-up Period|Pregnancy|1|||
170499486|NCT01358578|616169117|FG001|Follow-up Period|Pregnancy|0|||
170499487|NCT01358578|616169118|FG002|Follow-up Period|Pregnancy|0|||
170499488|NCT01358578|616169119|FG003|Follow-up Period|Pregnancy|0|||
170499489|NCT01358578|616169120|FG004|Follow-up Period|Pregnancy|0|||
170499490|NCT01358578|616169121|FG005|Follow-up Period|Pregnancy|0|||
170499491|NCT01358578|616169116|FG000|Follow-up Period|Withdrawal by Subject|3|||
170499492|NCT01358578|616169117|FG001|Follow-up Period|Withdrawal by Subject|3|||
170499493|NCT01358578|616169118|FG002|Follow-up Period|Withdrawal by Subject|1|||
170499494|NCT01358578|616169119|FG003|Follow-up Period|Withdrawal by Subject|12|||
170499495|NCT01358578|616169120|FG004|Follow-up Period|Withdrawal by Subject|0|||
170499496|NCT01358578|616169121|FG005|Follow-up Period|Withdrawal by Subject|0|||
170499497|NCT01358578|616169116|FG000|Follow-up Period|Physician Decision|1|||
170499498|NCT01358578|616169117|FG001|Follow-up Period|Physician Decision|1|||
170499499|NCT01358578|616169118|FG002|Follow-up Period|Physician Decision|0|||
170499500|NCT01358578|616169119|FG003|Follow-up Period|Physician Decision|2|||
170903451|NCT00364793|617649122|FG003|Overall Study|Adverse Event|0|||
170499501|NCT01358578|616169120|FG004|Follow-up Period|Physician Decision|0|||
170903452|NCT00364793|617649119|FG000|Overall Study|Death|1|||
170903453|NCT00364793|617649120|FG001|Overall Study|Death|0|||
170903454|NCT00364793|617649121|FG002|Overall Study|Death|1|||
170499502|NCT01358578|616169121|FG005|Follow-up Period|Physician Decision|0|||
170804784|NCT01728324|617294690|FG001|Termination of FDV|Adverse Event|13|||
170804785|NCT01728324|617294691|FG002|Termination of FDV|Adverse Event|4|||
170804786|NCT01728324|617294689|FG000|Termination of FDV|Lack of Efficacy|14|||
170804787|NCT01728324|617294690|FG001|Termination of FDV|Lack of Efficacy|12|||
170903455|NCT00364793|617649122|FG003|Overall Study|Death|0|||
170903456|NCT00364793|617649119|FG000|Overall Study|Lack of Efficacy|3|||
170499503|NCT01643798|616169122|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
170499504|NCT01643798|616169123|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
170499505|NCT03605849|616169124|FG000|Overall Study|Adverse Event|20|||
170499506|NCT03605849|616169125|FG001|Overall Study|Adverse Event|21|||
170499507|NCT03605849|616169126|FG002|Overall Study|Adverse Event|29|||
170903457|NCT00364793|617649120|FG001|Overall Study|Lack of Efficacy|3|||
170903458|NCT00364793|617649121|FG002|Overall Study|Lack of Efficacy|1|||
170499508|NCT03605849|616169127|FG003|Overall Study|Adverse Event|11|||
170499509|NCT03605849|616169124|FG000|Overall Study|Lack of Efficacy|4|||
170499510|NCT03605849|616169125|FG001|Overall Study|Lack of Efficacy|7|||
170499511|NCT03605849|616169126|FG002|Overall Study|Lack of Efficacy|9|||
170499512|NCT03605849|616169127|FG003|Overall Study|Lack of Efficacy|2|||
170499513|NCT03605849|616169124|FG000|Overall Study|Lost to Follow-up|8|||
170499514|NCT03605849|616169125|FG001|Overall Study|Lost to Follow-up|8|||
170499515|NCT03605849|616169126|FG002|Overall Study|Lost to Follow-up|14|||
170499516|NCT03605849|616169127|FG003|Overall Study|Lost to Follow-up|11|||
170499517|NCT03605849|616169124|FG000|Overall Study|Non-compliance With IMP|6|||
170499518|NCT03605849|616169125|FG001|Overall Study|Non-compliance With IMP|5|||
170499519|NCT03605849|616169126|FG002|Overall Study|Non-compliance With IMP|2|||
170499520|NCT03605849|616169127|FG003|Overall Study|Non-compliance With IMP|1|||
170499521|NCT03605849|616169124|FG000|Overall Study|Protocol Deviation|1|||
170499522|NCT03605849|616169125|FG001|Overall Study|Protocol Deviation|2|||
170499523|NCT03605849|616169126|FG002|Overall Study|Protocol Deviation|1|||
170499524|NCT03605849|616169127|FG003|Overall Study|Protocol Deviation|3|||
170499525|NCT03605849|616169124|FG000|Overall Study|Withdrawal by Subject|33|||
170499526|NCT03605849|616169125|FG001|Overall Study|Withdrawal by Subject|28|||
170499527|NCT03605849|616169126|FG002|Overall Study|Withdrawal by Subject|30|||
170499528|NCT03605849|616169127|FG003|Overall Study|Withdrawal by Subject|28|||
170499529|NCT03605849|616169124|FG000|Overall Study|Site Terminated by Sponsor|0|||
170499530|NCT03605849|616169125|FG001|Overall Study|Site Terminated by Sponsor|0|||
170499531|NCT03605849|616169126|FG002|Overall Study|Site Terminated by Sponsor|0|||
170499532|NCT03605849|616169127|FG003|Overall Study|Site Terminated by Sponsor|1|||
170499533|NCT03605849|616169124|FG000|Overall Study|Physician Decision|2|||
170499534|NCT03605849|616169125|FG001|Overall Study|Physician Decision|1|||
170499535|NCT03605849|616169126|FG002|Overall Study|Physician Decision|2|||
170499536|NCT03605849|616169127|FG003|Overall Study|Physician Decision|1|||
170499537|NCT03605849|616169124|FG000|Overall Study|Enrolled, but not Treated|2|||
170499538|NCT03605849|616169125|FG001|Overall Study|Enrolled, but not Treated|2|||
170499539|NCT03605849|616169126|FG002|Overall Study|Enrolled, but not Treated|3|||
170499540|NCT03605849|616169127|FG003|Overall Study|Enrolled, but not Treated|2|||
170499541|NCT03605849|616169124|FG000|Overall Study|Other (COVID-19 Related)|0|||
170499542|NCT03605849|616169125|FG001|Overall Study|Other (COVID-19 Related)|1|||
170499543|NCT03605849|616169126|FG002|Overall Study|Other (COVID-19 Related)|1|||
170499544|NCT03605849|616169127|FG003|Overall Study|Other (COVID-19 Related)|0|||
170499545|NCT03605849|616169124|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
170499546|NCT03605849|616169125|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
170499547|NCT03605849|616169126|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
170499548|NCT03605849|616169127|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
170499549|NCT02045732|616169128|FG000|Overall Study|At the discretion of the investigator|1|||
170642462|NCT04145219|616705262|FG001|Overall Study|Adverse Event|6|||
170642463|NCT04145219|616705261|FG000|Overall Study|Lost to Follow-up|2|||
170642464|NCT04145219|616705262|FG001|Overall Study|Lost to Follow-up|3|||
170642465|NCT04145219|616705261|FG000|Overall Study|Physician Decision|0|||
170642466|NCT04145219|616705262|FG001|Overall Study|Physician Decision|2|||
170642467|NCT04145219|616705261|FG000|Overall Study|Withdrawal by Subject|12|||
170804788|NCT01728324|617294691|FG002|Termination of FDV|Lack of Efficacy|8|||
170804789|NCT01728324|617294689|FG000|Termination of FDV|Withdrawal by Subject|9|||
170804790|NCT01728324|617294690|FG001|Termination of FDV|Withdrawal by Subject|6|||
170804791|NCT01728324|617294691|FG002|Termination of FDV|Withdrawal by Subject|2|||
170804792|NCT01728324|617294689|FG000|Termination of FDV|Other than stated|1|||
170804793|NCT01728324|617294690|FG001|Termination of FDV|Other than stated|3|||
170804794|NCT01728324|617294691|FG002|Termination of FDV|Other than stated|0|||
170804795|NCT01728324|617294689|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
170804796|NCT01728324|617294690|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
170804797|NCT01728324|617294691|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
170804798|NCT01728324|617294689|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
170804799|NCT01728324|617294690|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
170804800|NCT01728324|617294691|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
170804801|NCT01728324|617294689|FG000|Termination of RBV|Adverse Event|15|||
170804802|NCT01728324|617294690|FG001|Termination of RBV|Adverse Event|16|||
170804803|NCT01728324|617294691|FG002|Termination of RBV|Adverse Event|5|||
170804804|NCT01728324|617294689|FG000|Termination of RBV|Lack of Efficacy|14|||
170804805|NCT01728324|617294690|FG001|Termination of RBV|Lack of Efficacy|11|||
170804806|NCT01728324|617294691|FG002|Termination of RBV|Lack of Efficacy|7|||
170804807|NCT01728324|617294689|FG000|Termination of RBV|Withdrawal by Subject|9|||
170499550|NCT02045732|616169129|FG001|Overall Study|At the discretion of the investigator|1|||
170499551|NCT00507819|616169130|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
170642468|NCT04145219|616705262|FG001|Overall Study|Withdrawal by Subject|8|||
170642469|NCT04145219|616705261|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
170499552|NCT00507819|616169131|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
170499553|NCT04507256|616169132|FG000|Overall Study|Withdrawal by Subject|1|||
170499554|NCT04507256|616169133|FG001|Overall Study|Withdrawal by Subject|0|||
170903459|NCT00364793|617649122|FG003|Overall Study|Lack of Efficacy|1|||
170499555|NCT04507256|616169134|FG002|Overall Study|Withdrawal by Subject|0|||
170499556|NCT04507256|616169135|FG003|Overall Study|Withdrawal by Subject|1|||
170499557|NCT04507256|616169136|FG004|Overall Study|Withdrawal by Subject|0|||
170499558|NCT04507256|616169137|FG005|Overall Study|Withdrawal by Subject|0|||
170499559|NCT02111785|616169138|FG000|Overall Study|Death|0|||
170499560|NCT02111785|616169139|FG001|Overall Study|Death|1|||
170499561|NCT02111785|616169140|FG002|Overall Study|Death|0|||
170499562|NCT02111785|616169141|FG003|Overall Study|Death|0|||
170499563|NCT01054300|616169148|FG000|Period 1|Adverse Event|1|||
170499564|NCT01054300|616169149|FG001|Period 1|Adverse Event|0|||
170499565|NCT01054300|616169150|FG002|Period 1|Adverse Event|0|||
170499566|NCT01054300|616169151|FG003|Period 1|Adverse Event|0|||
170499567|NCT01054300|616169148|FG000|Period 2|Withdrawal by Subject|0|||
170499568|NCT01054300|616169149|FG001|Period 2|Withdrawal by Subject|0|||
170499569|NCT01054300|616169150|FG002|Period 2|Withdrawal by Subject|1|||
170499570|NCT01054300|616169151|FG003|Period 2|Withdrawal by Subject|0|||
170499571|NCT02662764|616169155|FG000|Overall Study|Adverse Event|6|||
170499572|NCT02662764|616169155|FG000|Overall Study|Lack of Efficacy|8|||
170499573|NCT02662764|616169155|FG000|Overall Study|Protocol Violation|1|||
170499574|NCT02662764|616169155|FG000|Overall Study|Withdrawal by Subject|5|||
170499575|NCT02662764|616169155|FG000|Overall Study|Device failure|4|||
170499576|NCT02662764|616169155|FG000|Overall Study|Patient changed treatment|1|||
170499577|NCT02662764|616169155|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
170499578|NCT01282164|616169156|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
170499579|NCT01282164|616169157|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
170499580|NCT05845567|616169158|FG000|Overall Study|Withdrawal by Subject|1|||
170499581|NCT01104246|616169159|FG000|Overall Study|Withdrawal by Subject|1|||
170499582|NCT01104246|616169159|FG000|Overall Study|did not meet inclusion criteria|4|||
170499583|NCT01083186|616169160|FG000|Overall Study|Lost to Follow-up|48|||
170499584|NCT01083186|616169160|FG000|Overall Study|Consent Withdrawal|7|||
170499585|NCT01083186|616169160|FG000|Overall Study|Death|3|||
170499586|NCT01083186|616169160|FG000|Overall Study|Adverse Event|3|||
170499587|NCT01083186|616169160|FG000|Overall Study|Lack of Efficacy|2|||
170499588|NCT01083186|616169160|FG000|Overall Study|Hemodialysis Initiation|28|||
170499589|NCT01083186|616169160|FG000|Overall Study|Administrative Reasons|2|||
170499590|NCT01083186|616169160|FG000|Overall Study|Non-compliance to Study Treatment|1|||
170499591|NCT01867294|616169166|FG000|Overall Study|Withdrawal by Subject|1|||
170499592|NCT01867294|616169167|FG001|Overall Study|Withdrawal by Subject|1|||
170499593|NCT01867294|616169168|FG002|Overall Study|Withdrawal by Subject|0|||
170499594|NCT01867294|616169169|FG003|Overall Study|Withdrawal by Subject|0|||
170499595|NCT02035748|616169170|FG000|Overall Study|Adverse Event|5|||
170499596|NCT02035748|616169170|FG000|Overall Study|Death|3|||
170499597|NCT02035748|616169170|FG000|Overall Study|Lost to Follow-up|2|||
170499598|NCT02035748|616169170|FG000|Overall Study|Physician Decision|3|||
170499599|NCT02035748|616169170|FG000|Overall Study|Withdrawal by Subject|6|||
170499600|NCT02035748|616169170|FG000|Overall Study|Progressive Disease|1|||
170499601|NCT03419598|616169171|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
170903460|NCT00364793|617649119|FG000|Overall Study|Lost to Follow-up|1|||
170903461|NCT00364793|617649120|FG001|Overall Study|Lost to Follow-up|0|||
170903462|NCT00364793|617649121|FG002|Overall Study|Lost to Follow-up|2|||
170903463|NCT00364793|617649122|FG003|Overall Study|Lost to Follow-up|0|||
170903464|NCT00364793|617649119|FG000|Overall Study|Poor or non-compliance|1|||
170903465|NCT00364793|617649120|FG001|Overall Study|Poor or non-compliance|1|||
170903466|NCT00364793|617649121|FG002|Overall Study|Poor or non-compliance|0|||
170903467|NCT00364793|617649122|FG003|Overall Study|Poor or non-compliance|1|||
170903468|NCT00364793|617649119|FG000|Overall Study|No longer meets criteria|0|||
170903469|NCT00364793|617649120|FG001|Overall Study|No longer meets criteria|0|||
170903470|NCT00364793|617649121|FG002|Overall Study|No longer meets criteria|0|||
170903471|NCT00364793|617649122|FG003|Overall Study|No longer meets criteria|1|||
170903472|NCT00364793|617649119|FG000|Overall Study|Withdrawal by Subject|0|||
170903473|NCT00364793|617649120|FG001|Overall Study|Withdrawal by Subject|1|||
170903474|NCT00364793|617649121|FG002|Overall Study|Withdrawal by Subject|0|||
170903475|NCT00364793|617649122|FG003|Overall Study|Withdrawal by Subject|0|||
170903476|NCT03093155|617649124|FG000|Overall Study|Not Eligible|1|||
170903477|NCT03093155|617649125|FG001|Overall Study|Not Eligible|0|||
170903478|NCT03093155|617649124|FG000|Overall Study|Withdrawal by Subject|0|||
170903479|NCT03093155|617649125|FG001|Overall Study|Withdrawal by Subject|1|||
170499602|NCT01740128|616169172|FG000|Overall Study|Pregnancy|0|||
170499603|NCT01740128|616169173|FG001|Overall Study|Pregnancy|1|||
170499604|NCT01740128|616169172|FG000|Overall Study|Protocol Violation|1|||
170499605|NCT01740128|616169173|FG001|Overall Study|Protocol Violation|2|||
170499606|NCT01740128|616169172|FG000|Overall Study|Lost to Follow-up|2|||
170499607|NCT01740128|616169173|FG001|Overall Study|Lost to Follow-up|2|||
170499608|NCT01740128|616169172|FG000|Overall Study|Withdrawal by Subject|1|||
170499609|NCT01740128|616169173|FG001|Overall Study|Withdrawal by Subject|0|||
170499610|NCT01740128|616169172|FG000|Overall Study|Insufficient protocol compliance|2|||
170499611|NCT01740128|616169173|FG001|Overall Study|Insufficient protocol compliance|2|||
170499612|NCT00380081|616169174|FG000|Overall Study|Withdrawal by Subject|0|||
170499613|NCT00380081|616169175|FG001|Overall Study|Withdrawal by Subject|0|||
170499614|NCT00380081|616169176|FG002|Overall Study|Withdrawal by Subject|0|||
170499615|NCT00380081|616169177|FG003|Overall Study|Withdrawal by Subject|0|||
170499616|NCT00380081|616169178|FG004|Overall Study|Withdrawal by Subject|1|||
170499617|NCT00380081|616169179|FG005|Overall Study|Withdrawal by Subject|0|||
170499618|NCT00380081|616169174|FG000|Overall Study|Family Emergency|0|||
170499619|NCT00380081|616169175|FG001|Overall Study|Family Emergency|0|||
170499620|NCT00380081|616169176|FG002|Overall Study|Family Emergency|0|||
170499621|NCT00380081|616169177|FG003|Overall Study|Family Emergency|0|||
170499622|NCT00380081|616169178|FG004|Overall Study|Family Emergency|0|||
170499623|NCT00380081|616169179|FG005|Overall Study|Family Emergency|1|||
170499624|NCT04240457|616169182|FG000|Overall Study|Lost to Follow-up|5|||
170499625|NCT04240457|616169183|FG001|Overall Study|Lost to Follow-up|1|||
170499626|NCT00976209|616169184|FG000|Treatment Period 1|Protocol Violation|1|||
170499627|NCT00976209|616169185|FG001|Treatment Period 1|Protocol Violation|0|||
170499628|NCT00976209|616169184|FG000|Treatment Period 1|Lost to Follow-up|2|||
170499629|NCT00976209|616169185|FG001|Treatment Period 1|Lost to Follow-up|0|||
170499630|NCT00976209|616169184|FG000|Treatment Period 1|Other|0|||
170499631|NCT00976209|616169185|FG001|Treatment Period 1|Other|1|||
170499632|NCT00976209|616169184|FG000|Wash-out Period|Adverse Event|1|||
170499633|NCT00976209|616169185|FG001|Wash-out Period|Adverse Event|2|||
170499634|NCT00976209|616169184|FG000|Wash-out Period|Lost to Follow-up|1|||
170499635|NCT00976209|616169185|FG001|Wash-out Period|Lost to Follow-up|0|||
170499636|NCT00976209|616169184|FG000|Wash-out Period|Protocol Violation|1|||
170499637|NCT00976209|616169185|FG001|Wash-out Period|Protocol Violation|0|||
170499638|NCT00976209|616169184|FG000|Wash-out Period|Other|1|||
170499639|NCT00976209|616169185|FG001|Wash-out Period|Other|0|||
170499640|NCT00976209|616169184|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170499641|NCT00976209|616169185|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170499642|NCT00976209|616169184|FG000|Treatment Period 2|Lost to Follow-up|0|||
170499643|NCT00976209|616169185|FG001|Treatment Period 2|Lost to Follow-up|1|||
170499644|NCT00844480|616169190|FG000|Overall Study|Withdrawal by Subject|2|||
170499645|NCT00844480|616169191|FG001|Overall Study|Withdrawal by Subject|3|||
170499646|NCT01618019|616169193|FG000|Overall Study|Withdrawal by Subject|14|||
170499647|NCT01618019|616169194|FG001|Overall Study|Withdrawal by Subject|14|||
170499648|NCT01546571|616169195|FG000|Overall Study|Adverse Event|1|||
170499649|NCT01546571|616169196|FG001|Overall Study|Adverse Event|0|||
170499650|NCT01546571|616169197|FG002|Overall Study|Adverse Event|0|||
170499651|NCT01546571|616169198|FG003|Overall Study|Adverse Event|1|||
170499652|NCT01546571|616169199|FG004|Overall Study|Adverse Event|0|||
170551611|NCT00147537|616364817|FG009|Phase 2|Withdrawal by Subject|16|||
170551612|NCT00147537|616364818|FG010|Phase 2|Withdrawal by Subject|4|||
170551613|NCT00147537|616364808|FG000|Phase 2|Randomized but not treated|0|||
170551614|NCT00147537|616364809|FG001|Phase 2|Randomized but not treated|0|||
170551615|NCT00147537|616364810|FG002|Phase 2|Randomized but not treated|0|||
170551616|NCT00147537|616364811|FG003|Phase 2|Randomized but not treated|0|||
170551617|NCT00147537|616364812|FG004|Phase 2|Randomized but not treated|0|||
170499653|NCT01546571|616169195|FG000|Overall Study|assigned placebo in Part A|0|||
170499654|NCT01546571|616169196|FG001|Overall Study|assigned placebo in Part A|0|||
170499655|NCT01546571|616169197|FG002|Overall Study|assigned placebo in Part A|22|||
170499656|NCT01546571|616169198|FG003|Overall Study|assigned placebo in Part A|0|||
170499657|NCT01546571|616169199|FG004|Overall Study|assigned placebo in Part A|0|||
170499658|NCT01546571|616169195|FG000|Overall Study|Death|0|||
170499659|NCT01546571|616169196|FG001|Overall Study|Death|1|||
170499660|NCT01546571|616169197|FG002|Overall Study|Death|0|||
170499661|NCT01546571|616169198|FG003|Overall Study|Death|0|||
170499662|NCT01546571|616169199|FG004|Overall Study|Death|0|||
170499663|NCT01546571|616169195|FG000|Overall Study|Lost to Follow-up|0|||
170499664|NCT01546571|616169196|FG001|Overall Study|Lost to Follow-up|0|||
170499665|NCT01546571|616169197|FG002|Overall Study|Lost to Follow-up|2|||
170551618|NCT00147537|616364813|FG005|Phase 2|Randomized but not treated|0|||
170551619|NCT00147537|616364814|FG006|Phase 2|Randomized but not treated|0|||
170551620|NCT00147537|616364815|FG007|Phase 2|Randomized but not treated|0|||
170551621|NCT00147537|616364816|FG008|Phase 2|Randomized but not treated|0|||
170804808|NCT01728324|617294690|FG001|Termination of RBV|Withdrawal by Subject|5|||
170804809|NCT01728324|617294691|FG002|Termination of RBV|Withdrawal by Subject|2|||
170804810|NCT01728324|617294689|FG000|Termination of RBV|Other than stated|1|||
170804811|NCT01728324|617294690|FG001|Termination of RBV|Other than stated|3|||
170804812|NCT01728324|617294691|FG002|Termination of RBV|Other than stated|1|||
170804813|NCT01728324|617294689|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
170804814|NCT01728324|617294690|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
170499666|NCT01546571|616169198|FG003|Overall Study|Lost to Follow-up|2|||
170499667|NCT01546571|616169199|FG004|Overall Study|Lost to Follow-up|3|||
170499668|NCT01546571|616169195|FG000|Overall Study|Pregnancy|0|||
170499669|NCT01546571|616169196|FG001|Overall Study|Pregnancy|0|||
170499670|NCT01546571|616169197|FG002|Overall Study|Pregnancy|0|||
170499671|NCT01546571|616169198|FG003|Overall Study|Pregnancy|1|||
170804815|NCT01728324|617294691|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
170499672|NCT01546571|616169199|FG004|Overall Study|Pregnancy|0|||
170499673|NCT01546571|616169195|FG000|Overall Study|Disease Progression|20|||
170499674|NCT01546571|616169196|FG001|Overall Study|Disease Progression|18|||
170499675|NCT01546571|616169197|FG002|Overall Study|Disease Progression|15|||
170499676|NCT01546571|616169198|FG003|Overall Study|Disease Progression|73|||
170499677|NCT01546571|616169199|FG004|Overall Study|Disease Progression|37|||
170499678|NCT01546571|616169195|FG000|Overall Study|Withdrawal by Subject|1|||
170499679|NCT01546571|616169196|FG001|Overall Study|Withdrawal by Subject|2|||
170499680|NCT01546571|616169197|FG002|Overall Study|Withdrawal by Subject|4|||
170499681|NCT01546571|616169198|FG003|Overall Study|Withdrawal by Subject|9|||
170499682|NCT01546571|616169199|FG004|Overall Study|Withdrawal by Subject|2|||
170903480|NCT00833092|617649126|FG000|Overall Study|Withdrawal by Subject|2|||
170903481|NCT00833092|617649127|FG001|Overall Study|Withdrawal by Subject|3|||
170499683|NCT01546571|616169195|FG000|Overall Study|Intercurrent Illness|1|||
170499684|NCT01546571|616169196|FG001|Overall Study|Intercurrent Illness|2|||
170499685|NCT01546571|616169197|FG002|Overall Study|Intercurrent Illness|0|||
170499686|NCT01546571|616169198|FG003|Overall Study|Intercurrent Illness|0|||
170499687|NCT01546571|616169199|FG004|Overall Study|Intercurrent Illness|0|||
170499688|NCT01546571|616169195|FG000|Overall Study|Other Cancers|0|||
170499689|NCT01546571|616169196|FG001|Overall Study|Other Cancers|0|||
170499690|NCT01546571|616169197|FG002|Overall Study|Other Cancers|0|||
170499691|NCT01546571|616169198|FG003|Overall Study|Other Cancers|3|||
170499692|NCT01546571|616169199|FG004|Overall Study|Other Cancers|1|||
170499693|NCT01546571|616169195|FG000|Overall Study|Other|0|||
170499694|NCT01546571|616169196|FG001|Overall Study|Other|0|||
170499695|NCT01546571|616169197|FG002|Overall Study|Other|3|||
170499696|NCT01546571|616169198|FG003|Overall Study|Other|0|||
170499697|NCT01546571|616169199|FG004|Overall Study|Other|0|||
170499698|NCT01866657|616169205|FG000|Overall Study|Surgery canceled|2|||
170499699|NCT01866657|616169206|FG001|Overall Study|Surgery canceled|0|||
170499700|NCT02951533|616169207|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
170499701|NCT02951533|616169208|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
170499702|NCT02951533|616169209|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
170499703|NCT02951533|616169207|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
170499704|NCT02951533|616169208|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
170499705|NCT02951533|616169209|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
170499706|NCT02951533|616169207|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
170499707|NCT02951533|616169208|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
170499708|NCT02951533|616169209|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
170499709|NCT02951533|616169207|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
170499710|NCT02951533|616169208|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
170499711|NCT02951533|616169209|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
170499712|NCT02951533|616169207|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
170499713|NCT02951533|616169208|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
170903482|NCT00833092|617649126|FG000|Overall Study|Protocol Violation|2|||
170903483|NCT00833092|617649127|FG001|Overall Study|Protocol Violation|1|||
170903484|NCT00833092|617649126|FG000|Overall Study|Diarrhea|0|||
170903485|NCT00833092|617649127|FG001|Overall Study|Diarrhea|2|||
170903486|NCT00833092|617649126|FG000|Overall Study|constipation|0|||
170903487|NCT00833092|617649127|FG001|Overall Study|constipation|1|||
170903488|NCT00355264|617649128|FG000|Extension (Variable Duration)|Adverse Event|1|||
170903489|NCT00355264|617649128|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
170499714|NCT02951533|616169209|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
170499715|NCT02951533|616169207|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
170499716|NCT02951533|616169208|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
170499717|NCT02951533|616169209|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
170499718|NCT02951533|616169207|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
170499719|NCT02951533|616169208|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
170499720|NCT02951533|616169209|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
170499721|NCT02951533|616169207|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
170499722|NCT02951533|616169208|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
170499723|NCT02951533|616169209|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
170499724|NCT02951533|616169207|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
170499725|NCT02951533|616169208|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
170903490|NCT03182738|617649149|FG000|Overall Study|Lost to Follow-up|9|||
170903491|NCT03182738|617649150|FG001|Overall Study|Lost to Follow-up|3|||
170499726|NCT02951533|616169209|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
170499727|NCT02951533|616169207|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
170499728|NCT02951533|616169208|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
170499729|NCT02951533|616169209|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
170499730|NCT02951533|616169207|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
170903492|NCT03182738|617649149|FG000|Overall Study|Pregnancy|0|||
170499731|NCT02951533|616169208|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
170903493|NCT03182738|617649150|FG001|Overall Study|Pregnancy|1|||
170499732|NCT02951533|616169209|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
170499733|NCT00387010|616169215|FG000|Dose Titration Period|Adverse Event|12|||
170499734|NCT00387010|616169215|FG000|Dose Titration Period|Lack of Efficacy|5|||
170499735|NCT00387010|616169215|FG000|Dose Titration Period|Withdrawal by Subject|3|||
170499736|NCT00387010|616169215|FG000|Dose Titration Period|Protocol Violation|1|||
170499737|NCT00387010|616169215|FG000|Dose Titration Period|Lost to Follow-up|2|||
170499738|NCT00387010|616169215|FG000|Dose Titration Period|Noncompliance with study medication|8|||
170499739|NCT00387010|616169215|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
170499740|NCT00387010|616169215|FG000|Treatment Period|Adverse Event|4|||
170499741|NCT00387010|616169215|FG000|Treatment Period|Withdrawal by Subject|1|||
170499742|NCT00387010|616169215|FG000|Treatment Period|Noncompliance with study medication|2|||
170499743|NCT00387010|616169215|FG000|Treatment Period|Noncompliance with study procedures|3|||
170499744|NCT00387010|616169215|FG000|Treatment Period|Participant reported study drug stolen|1|||
170499745|NCT03802565|616169216|FG000|Overall Study|Adverse Event|0|||
170499746|NCT03802565|616169217|FG001|Overall Study|Adverse Event|1|||
170499747|NCT03802565|616169218|FG002|Overall Study|Adverse Event|2|||
170499748|NCT03802565|616169219|FG003|Overall Study|Adverse Event|1|||
170499749|NCT03802565|616169220|FG004|Overall Study|Adverse Event|1|||
170499750|NCT03802565|616169216|FG000|Overall Study|Withdrawal by Subject|2|||
170499751|NCT03802565|616169217|FG001|Overall Study|Withdrawal by Subject|2|||
170499752|NCT03802565|616169218|FG002|Overall Study|Withdrawal by Subject|2|||
170499753|NCT03802565|616169219|FG003|Overall Study|Withdrawal by Subject|0|||
170499754|NCT03802565|616169220|FG004|Overall Study|Withdrawal by Subject|1|||
170499755|NCT03802565|616169216|FG000|Overall Study|Protocol Violation|2|||
170499756|NCT03802565|616169217|FG001|Overall Study|Protocol Violation|1|||
170499757|NCT03802565|616169218|FG002|Overall Study|Protocol Violation|4|||
170499758|NCT03802565|616169219|FG003|Overall Study|Protocol Violation|5|||
170499759|NCT03802565|616169220|FG004|Overall Study|Protocol Violation|1|||
170499760|NCT03802565|616169216|FG000|Overall Study|Lost to Follow-up|0|||
170499761|NCT03802565|616169217|FG001|Overall Study|Lost to Follow-up|0|||
170499762|NCT03802565|616169218|FG002|Overall Study|Lost to Follow-up|1|||
170499763|NCT03802565|616169219|FG003|Overall Study|Lost to Follow-up|0|||
170804816|NCT01728324|617294689|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
170499764|NCT03802565|616169220|FG004|Overall Study|Lost to Follow-up|0|||
170499765|NCT03802565|616169216|FG000|Overall Study|Subjects Related to Each Other|1|||
170499766|NCT03802565|616169217|FG001|Overall Study|Subjects Related to Each Other|0|||
170499767|NCT03802565|616169218|FG002|Overall Study|Subjects Related to Each Other|0|||
170499768|NCT03802565|616169219|FG003|Overall Study|Subjects Related to Each Other|2|||
170499769|NCT03802565|616169220|FG004|Overall Study|Subjects Related to Each Other|1|||
170499770|NCT03802565|616169216|FG000|Overall Study|Elevated Enzymes|0|||
170499771|NCT03802565|616169217|FG001|Overall Study|Elevated Enzymes|0|||
170499772|NCT03802565|616169218|FG002|Overall Study|Elevated Enzymes|0|||
170499773|NCT03802565|616169219|FG003|Overall Study|Elevated Enzymes|0|||
170499774|NCT03802565|616169220|FG004|Overall Study|Elevated Enzymes|2|||
170499775|NCT03099694|616169224|FG000|Overall Study|Withdrawal by Subject|11|||
170499776|NCT03099694|616169225|FG001|Overall Study|Withdrawal by Subject|13|||
170499777|NCT03099694|616169224|FG000|Overall Study|Lost to Follow-up|9|||
170499778|NCT03099694|616169225|FG001|Overall Study|Lost to Follow-up|5|||
170499779|NCT04326439|616169226|FG000|Overall Study|Withdrawal by Subject|1|||
170499780|NCT04326439|616169227|FG001|Overall Study|Withdrawal by Subject|0|||
170499781|NCT04326439|616169226|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
170499782|NCT04326439|616169227|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
170499783|NCT04326439|616169226|FG000|Overall Study|Relapse after Induction 2|0|||
170499784|NCT04326439|616169227|FG001|Overall Study|Relapse after Induction 2|1|||
170499785|NCT04326439|616169226|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
170499786|NCT04326439|616169227|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
170499787|NCT00957268|616169240|FG000|Overall Study|Voluntary Withdrawal|0|||
170499788|NCT00957268|616169241|FG001|Overall Study|Voluntary Withdrawal|0|||
170499789|NCT00957268|616169242|FG002|Overall Study|Voluntary Withdrawal|1|||
170499790|NCT00957268|616169243|FG003|Overall Study|Voluntary Withdrawal|0|||
170499791|NCT00957268|616169244|FG004|Overall Study|Voluntary Withdrawal|0|||
170499792|NCT03003494|616169245|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
170499793|NCT01738503|616169246|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
170499794|NCT01738503|616169247|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
170499795|NCT01738503|616169248|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
170499796|NCT01738503|616169249|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
170499797|NCT01738503|616169250|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
170499798|NCT01738503|616169251|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
170499799|NCT01738503|616169252|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
170499800|NCT01738503|616169246|FG000|Treatment Period|Adverse Event|0|||
170499801|NCT01738503|616169247|FG001|Treatment Period|Adverse Event|1|||
170499802|NCT01738503|616169248|FG002|Treatment Period|Adverse Event|0|||
170804817|NCT01728324|617294690|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
170804818|NCT01728324|617294691|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
170903494|NCT03182738|617649149|FG000|Overall Study|Withdrawal by Subject|0|||
170903495|NCT03182738|617649150|FG001|Overall Study|Withdrawal by Subject|1|||
170903496|NCT00098787|617649151|FG000|Overall Study|Never started treatment|3|||
170903497|NCT00098787|617649152|FG001|Overall Study|Never started treatment|2|||
170499803|NCT01738503|616169249|FG003|Treatment Period|Adverse Event|1|||
170499804|NCT01738503|616169250|FG004|Treatment Period|Adverse Event|2|||
170499805|NCT01738503|616169251|FG005|Treatment Period|Adverse Event|2|||
170499806|NCT01738503|616169252|FG006|Treatment Period|Adverse Event|2|||
170499807|NCT01738503|616169246|FG000|Treatment Period|Lost to Follow-up|0|||
170499808|NCT01738503|616169247|FG001|Treatment Period|Lost to Follow-up|0|||
170499809|NCT01738503|616169248|FG002|Treatment Period|Lost to Follow-up|3|||
170499810|NCT01738503|616169249|FG003|Treatment Period|Lost to Follow-up|4|||
170499811|NCT01738503|616169250|FG004|Treatment Period|Lost to Follow-up|1|||
170499812|NCT01738503|616169251|FG005|Treatment Period|Lost to Follow-up|1|||
170903498|NCT00098787|617649153|FG002|Overall Study|Never started treatment|1|||
170903499|NCT00098787|617649151|FG000|Overall Study|Ineligible|9|||
170551622|NCT00147537|616364817|FG009|Phase 2|Randomized but not treated|1|||
170903500|NCT00098787|617649152|FG001|Overall Study|Ineligible|7|||
170903501|NCT00098787|617649153|FG002|Overall Study|Ineligible|3|||
170903502|NCT00098787|617649151|FG000|Overall Study|Disease progression|28|||
170903503|NCT00098787|617649152|FG001|Overall Study|Disease progression|17|||
170903504|NCT00098787|617649153|FG002|Overall Study|Disease progression|23|||
170499813|NCT01738503|616169252|FG006|Treatment Period|Lost to Follow-up|5|||
170499814|NCT01738503|616169246|FG000|Treatment Period|Withdrawal by Subject|0|||
170499815|NCT01738503|616169247|FG001|Treatment Period|Withdrawal by Subject|1|||
170499816|NCT01738503|616169248|FG002|Treatment Period|Withdrawal by Subject|0|||
170903505|NCT00098787|617649151|FG000|Overall Study|Adverse Event|8|||
170903506|NCT00098787|617649152|FG001|Overall Study|Adverse Event|17|||
170903507|NCT00098787|617649153|FG002|Overall Study|Adverse Event|8|||
170499817|NCT01738503|616169249|FG003|Treatment Period|Withdrawal by Subject|1|||
170499818|NCT01738503|616169250|FG004|Treatment Period|Withdrawal by Subject|1|||
170499819|NCT01738503|616169251|FG005|Treatment Period|Withdrawal by Subject|1|||
170499820|NCT01738503|616169252|FG006|Treatment Period|Withdrawal by Subject|1|||
170499821|NCT01738503|616169246|FG000|Treatment Period|Protocol Violation|0|||
170499822|NCT01738503|616169247|FG001|Treatment Period|Protocol Violation|3|||
170499823|NCT01738503|616169248|FG002|Treatment Period|Protocol Violation|1|||
170499824|NCT01738503|616169249|FG003|Treatment Period|Protocol Violation|0|||
170499825|NCT01738503|616169250|FG004|Treatment Period|Protocol Violation|4|||
170499826|NCT01738503|616169251|FG005|Treatment Period|Protocol Violation|2|||
170499827|NCT01738503|616169252|FG006|Treatment Period|Protocol Violation|0|||
170499828|NCT01738503|616169246|FG000|Treatment Period|Other|0|||
170499829|NCT01738503|616169247|FG001|Treatment Period|Other|0|||
170499830|NCT01738503|616169248|FG002|Treatment Period|Other|1|||
170499831|NCT01738503|616169249|FG003|Treatment Period|Other|0|||
170499832|NCT01738503|616169250|FG004|Treatment Period|Other|0|||
170499833|NCT01738503|616169251|FG005|Treatment Period|Other|0|||
170499834|NCT01738503|616169252|FG006|Treatment Period|Other|0|||
170499835|NCT01738503|616169246|FG000|PET Imaging Sub-study|Adverse Event|0|||
170499836|NCT01738503|616169247|FG001|PET Imaging Sub-study|Adverse Event|0|||
170499837|NCT01738503|616169248|FG002|PET Imaging Sub-study|Adverse Event|0|||
170499838|NCT01738503|616169249|FG003|PET Imaging Sub-study|Adverse Event|0|||
170499839|NCT01738503|616169250|FG004|PET Imaging Sub-study|Adverse Event|0|||
170499840|NCT01738503|616169251|FG005|PET Imaging Sub-study|Adverse Event|1|||
170499841|NCT01738503|616169252|FG006|PET Imaging Sub-study|Adverse Event|0|||
170499842|NCT01738503|616169246|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
170499843|NCT01738503|616169247|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
170499844|NCT01738503|616169248|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
170499845|NCT01738503|616169249|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
170499846|NCT01738503|616169250|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
170499847|NCT01738503|616169251|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
170499848|NCT01738503|616169252|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
170499849|NCT03005327|616169253|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
170499850|NCT03005327|616169254|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
170499851|NCT03005327|616169255|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
170499852|NCT03005327|616169256|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
170499853|NCT03005327|616169253|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170499854|NCT03005327|616169254|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
170499855|NCT03005327|616169255|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170499856|NCT03005327|616169256|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170499857|NCT00915876|616169257|FG000|Overall Study|Adverse Event|0|||
170499858|NCT00915876|616169258|FG001|Overall Study|Adverse Event|1|||
170499859|NCT02000882|616171247|FG000|Overall Study|Adverse Event|3|||
170499860|NCT02000882|616171247|FG000|Overall Study|Physician Decision|2|||
170499861|NCT02000882|616171247|FG000|Overall Study|Withdrawal by Subject|1|||
170499862|NCT02417961|616171248|FG000|Overall Study|Adverse Event|1|||
170499863|NCT02417961|616171248|FG000|Overall Study|Lost to Follow-up|1|||
170499864|NCT02417961|616171248|FG000|Overall Study|Withdrawal by Subject|2|||
170499865|NCT01390428|616171249|FG000|Overall Study|Elective Surgery|0|||
170499866|NCT01390428|616171250|FG001|Overall Study|Elective Surgery|0|||
170499867|NCT01390428|616171251|FG002|Overall Study|Elective Surgery|0|||
170499868|NCT01390428|616171252|FG003|Overall Study|Elective Surgery|0|||
170499869|NCT01390428|616171253|FG004|Overall Study|Elective Surgery|1|||
170499870|NCT01390428|616171254|FG005|Overall Study|Elective Surgery|0|||
170499871|NCT01390428|616171249|FG000|Overall Study|Withdrawal by Subject|0|||
170499872|NCT01390428|616171250|FG001|Overall Study|Withdrawal by Subject|0|||
170499873|NCT01390428|616171251|FG002|Overall Study|Withdrawal by Subject|1|||
170499874|NCT01390428|616171252|FG003|Overall Study|Withdrawal by Subject|0|||
170499875|NCT01390428|616171253|FG004|Overall Study|Withdrawal by Subject|0|||
170499876|NCT01390428|616171254|FG005|Overall Study|Withdrawal by Subject|0|||
170499877|NCT05079750|616171255|FG000|Overall Study|Lost to Follow-up|0|||
170499878|NCT05079750|616171256|FG001|Overall Study|Lost to Follow-up|0|||
170499879|NCT05079750|616171257|FG002|Overall Study|Lost to Follow-up|1|||
170499880|NCT01632904|616171260|FG000|Overall Study|Adverse Event|4|||
170499881|NCT01632904|616171261|FG001|Overall Study|Adverse Event|1|||
170499882|NCT01632904|616171260|FG000|Overall Study|Physician Decision|0|||
170804819|NCT01619059|617294698|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
170499883|NCT01632904|616171261|FG001|Overall Study|Physician Decision|1|||
170499884|NCT01632904|616171260|FG000|Overall Study|Subject decision|3|||
170499885|NCT01632904|616171261|FG001|Overall Study|Subject decision|2|||
170499886|NCT01632904|616171260|FG000|Overall Study|Disease Progression|0|||
170804820|NCT01619059|617294699|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
170903508|NCT00098787|617649151|FG000|Overall Study|Death|6|||
170903509|NCT00098787|617649152|FG001|Overall Study|Death|1|||
170903510|NCT00098787|617649153|FG002|Overall Study|Death|0|||
170903511|NCT00098787|617649151|FG000|Overall Study|Withdrawal by Subject|4|||
170903512|NCT00098787|617649152|FG001|Overall Study|Withdrawal by Subject|12|||
170903513|NCT00098787|617649153|FG002|Overall Study|Withdrawal by Subject|6|||
170903514|NCT00098787|617649151|FG000|Overall Study|Alternative therapy|8|||
170903515|NCT00098787|617649152|FG001|Overall Study|Alternative therapy|13|||
170903516|NCT00098787|617649153|FG002|Overall Study|Alternative therapy|13|||
170903517|NCT00098787|617649151|FG000|Overall Study|Other|7|||
170903518|NCT00098787|617649152|FG001|Overall Study|Other|6|||
170903519|NCT00098787|617649153|FG002|Overall Study|Other|9|||
170903520|NCT02203149|617649154|FG000|Part 1|Adverse Event|0|||
170903521|NCT02203149|617649155|FG001|Part 1|Adverse Event|1|||
170903522|NCT02203149|617649156|FG002|Part 1|Adverse Event|0|||
170499887|NCT01632904|616171261|FG001|Overall Study|Disease Progression|1|||
170499888|NCT01632904|616171260|FG000|Overall Study|Reason for discontinuation not available|0|||
170499889|NCT01632904|616171261|FG001|Overall Study|Reason for discontinuation not available|1|||
170499890|NCT04599933|616171268|FG000|Overall Study|Adverse Event|4|||
170499891|NCT04599933|616171269|FG001|Overall Study|Adverse Event|1|||
170499892|NCT04599933|616171268|FG000|Overall Study|Withdrawal by Subject|4|||
170499893|NCT04599933|616171269|FG001|Overall Study|Withdrawal by Subject|2|||
170499894|NCT04599933|616171268|FG000|Overall Study|Lost to Follow-up|0|||
170499895|NCT04599933|616171269|FG001|Overall Study|Lost to Follow-up|1|||
170499896|NCT04599933|616171268|FG000|Overall Study|Physician Decision|0|||
170499897|NCT04599933|616171269|FG001|Overall Study|Physician Decision|1|||
170499898|NCT04599933|616171268|FG000|Overall Study|Screen Failure|1|||
170499899|NCT04599933|616171269|FG001|Overall Study|Screen Failure|2|||
170499900|NCT02659514|616171278|FG000|Overall Study|Adverse Event|3|||
170499901|NCT02659514|616171279|FG001|Overall Study|Adverse Event|12|||
170499902|NCT02659514|616171278|FG000|Overall Study|Disease Progression|23|||
170499903|NCT02659514|616171279|FG001|Overall Study|Disease Progression|13|||
170499904|NCT02659514|616171278|FG000|Overall Study|Withdrawal by Subject|0|||
170499905|NCT02659514|616171279|FG001|Overall Study|Withdrawal by Subject|4|||
170499906|NCT02659514|616171278|FG000|Overall Study|Lost to Follow-up|0|||
170499907|NCT02659514|616171279|FG001|Overall Study|Lost to Follow-up|1|||
170499908|NCT02659514|616171278|FG000|Overall Study|Death|6|||
170499909|NCT02659514|616171279|FG001|Overall Study|Death|1|||
170499910|NCT02659514|616171278|FG000|Overall Study|Reason Unspecified|0|||
170499911|NCT02659514|616171279|FG001|Overall Study|Reason Unspecified|3|||
170499912|NCT00348790|616171282|FG000|Completed Treatment|Withdrawal by Subject|4|||
170499913|NCT00348790|616171282|FG000|Completed Treatment|Disease progression|14|||
170499914|NCT00348790|616171282|FG000|Completed Treatment|Adverse Event|4|||
170499915|NCT00348790|616171282|FG000|Completed Treatment|Required surgery|2|||
170551623|NCT00147537|616364818|FG010|Phase 2|Randomized but not treated|1|||
170551624|NCT00987935|616364819|FG000|Overall Study|Progressive disease|3|||
170903523|NCT02203149|617649157|FG003|Part 1|Adverse Event|0|||
170903524|NCT02203149|617649158|FG004|Part 1|Adverse Event|0|||
170903525|NCT02203149|617649154|FG000|Part 2|Death|0|||
170903526|NCT02203149|617649155|FG001|Part 2|Death|0|||
170903527|NCT02203149|617649156|FG002|Part 2|Death|1|||
170903528|NCT02203149|617649157|FG003|Part 2|Death|1|||
170903529|NCT02203149|617649158|FG004|Part 2|Death|0|||
170903530|NCT02203149|617649154|FG000|Part 2|Withdrawal by Subject|0|||
170903531|NCT02203149|617649155|FG001|Part 2|Withdrawal by Subject|0|||
170903532|NCT02203149|617649156|FG002|Part 2|Withdrawal by Subject|0|||
170903533|NCT02203149|617649157|FG003|Part 2|Withdrawal by Subject|1|||
170903534|NCT02203149|617649158|FG004|Part 2|Withdrawal by Subject|0|||
170903535|NCT02203149|617649154|FG000|Part 2|Adverse Event|0|||
170903536|NCT02203149|617649155|FG001|Part 2|Adverse Event|0|||
170903537|NCT02203149|617649156|FG002|Part 2|Adverse Event|0|||
170903538|NCT02203149|617649157|FG003|Part 2|Adverse Event|1|||
170903539|NCT02203149|617649158|FG004|Part 2|Adverse Event|1|||
170903540|NCT00684814|617649159|FG000|Washout Period of 7 Days|Adverse Event|1|||
170903541|NCT00684814|617649160|FG001|Washout Period of 7 Days|Adverse Event|2|||
170903542|NCT00684814|617649159|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
170903543|NCT00684814|617649160|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
170903544|NCT00684814|617649159|FG000|Second Intervention|Adverse Event|1|||
170903545|NCT00684814|617649160|FG001|Second Intervention|Adverse Event|0|||
170499916|NCT00348790|616171282|FG000|Completed Treatment|Unable to travel to study site|1|||
170551625|NCT00987935|616364820|FG001|Overall Study|Progressive disease|2|||
170551626|NCT00987935|616364821|FG002|Overall Study|Progressive disease|3|||
170551627|NCT00987935|616364822|FG003|Overall Study|Progressive disease|2|||
170551628|NCT00987935|616364823|FG004|Overall Study|Progressive disease|5|||
170551629|NCT00987935|616364824|FG005|Overall Study|Progressive disease|3|||
170551630|NCT00987935|616364825|FG006|Overall Study|Progressive disease|9|||
170551631|NCT00987935|616364826|FG007|Overall Study|Progressive disease|48|||
170551632|NCT00987935|616364827|FG008|Overall Study|Progressive disease|23|||
170499917|NCT00177307|616171285|FG000|Overall Study|Withdrawal by Subject|1|||
170499918|NCT04521621|616171286|FG000|Overall Study|Death|17|||
170499919|NCT04521621|616171287|FG001|Overall Study|Death|8|||
170499920|NCT04521621|616171288|FG002|Overall Study|Death|8|||
170499921|NCT04521621|616171289|FG003|Overall Study|Death|5|||
170499922|NCT04521621|616171290|FG004|Overall Study|Death|2|||
170499923|NCT04521621|616171291|FG005|Overall Study|Death|7|||
170499924|NCT04521621|616171292|FG006|Overall Study|Death|0|||
170499925|NCT04521621|616171293|FG007|Overall Study|Death|0|||
170551633|NCT00987935|616364819|FG000|Overall Study|Adverse Event|0|||
170551634|NCT00987935|616364820|FG001|Overall Study|Adverse Event|1|||
170903546|NCT00446030|617649161|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
170903547|NCT00446030|617649162|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
170903548|NCT00446030|617649161|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
170903549|NCT00446030|617649162|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
170903550|NCT00446030|617649161|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
170903551|NCT00446030|617649162|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
170499926|NCT04521621|616171286|FG000|Overall Study|Study Terminated by Sponsor|4|||
170499927|NCT04521621|616171287|FG001|Overall Study|Study Terminated by Sponsor|6|||
170499928|NCT04521621|616171288|FG002|Overall Study|Study Terminated by Sponsor|8|||
170499929|NCT04521621|616171289|FG003|Overall Study|Study Terminated by Sponsor|0|||
170499930|NCT04521621|616171290|FG004|Overall Study|Study Terminated by Sponsor|1|||
170499931|NCT04521621|616171291|FG005|Overall Study|Study Terminated by Sponsor|7|||
170499932|NCT04521621|616171292|FG006|Overall Study|Study Terminated by Sponsor|0|||
170499933|NCT04521621|616171293|FG007|Overall Study|Study Terminated by Sponsor|0|||
170499934|NCT04521621|616171286|FG000|Overall Study|Withdrawal by Subject|0|||
170903552|NCT00446030|617649161|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
170499935|NCT04521621|616171287|FG001|Overall Study|Withdrawal by Subject|0|||
170499936|NCT04521621|616171288|FG002|Overall Study|Withdrawal by Subject|1|||
170499937|NCT04521621|616171289|FG003|Overall Study|Withdrawal by Subject|1|||
170551635|NCT00987935|616364821|FG002|Overall Study|Adverse Event|0|||
170804821|NCT01619059|617294698|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
170804822|NCT01619059|617294699|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
170804823|NCT01619059|617294698|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
170804824|NCT01619059|617294699|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
170804825|NCT01619059|617294698|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
170804826|NCT01619059|617294699|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
170804827|NCT01619059|617294698|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
170804828|NCT01619059|617294699|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
170804829|NCT01619059|617294698|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
170804830|NCT01619059|617294699|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
170804831|NCT01619059|617294698|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
170804832|NCT01619059|617294699|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
170804833|NCT01619059|617294698|FG000|Long-Term (LT) Treatment Period|Death|1|||
170804834|NCT01619059|617294699|FG001|Long-Term (LT) Treatment Period|Death|0|||
170804835|NCT01619059|617294698|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
170804836|NCT01619059|617294699|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
170804837|NCT01619059|617294698|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
170804838|NCT01619059|617294699|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
170804839|NCT01170208|617294700|FG000|Overall Study|Withdrawal by Subject|5|||
170804840|NCT01170208|617294701|FG001|Overall Study|Withdrawal by Subject|0|||
170804841|NCT01170208|617294702|FG002|Overall Study|Withdrawal by Subject|1|||
170804842|NCT01170208|617294700|FG000|Overall Study|Protocol Violation|1|||
170804843|NCT01170208|617294701|FG001|Overall Study|Protocol Violation|0|||
170804844|NCT01170208|617294702|FG002|Overall Study|Protocol Violation|1|||
170804845|NCT03113409|617294705|FG000|Overall Study|Withdrawal by Subject|5|||
170804846|NCT03113409|617294706|FG001|Overall Study|Withdrawal by Subject|0|||
170804847|NCT03113409|617294707|FG002|Overall Study|Withdrawal by Subject|0|||
170804848|NCT01787032|617294708|FG000|Overall Study|Protocol Violation|0|||
170804849|NCT01787032|617294709|FG001|Overall Study|Protocol Violation|0|||
170804850|NCT01787032|617294710|FG002|Overall Study|Protocol Violation|0|||
170804851|NCT01787032|617294711|FG003|Overall Study|Protocol Violation|0|||
170804852|NCT01787032|617294712|FG004|Overall Study|Protocol Violation|1|||
170804853|NCT01787032|617294713|FG005|Overall Study|Protocol Violation|1|||
170804854|NCT02203799|617294716|FG000|Overall Study|Withdrawal by Subject|3|||
170804855|NCT02040870|617294717|FG000|Overall Study|Completed treatment phase|6|||
170804856|NCT02040870|617294717|FG000|Overall Study|Adverse Event|7|||
170804857|NCT02040870|617294717|FG000|Overall Study|Progressive disease|58|||
170804858|NCT02040870|617294717|FG000|Overall Study|Physician Decision|6|||
170804859|NCT02040870|617294717|FG000|Overall Study|Subject/guardian decision|10|||
170804860|NCT02040870|617294717|FG000|Overall Study|Lost to Follow-up|3|||
170804861|NCT02040870|617294717|FG000|Overall Study|Death|13|||
170804862|NCT03335488|617294720|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
170804863|NCT03335488|617294721|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
170804864|NCT03335488|617294720|FG000|Safety Extension Period|Adverse Event|1|||
170804865|NCT03335488|617294721|FG001|Safety Extension Period|Adverse Event|0|||
170804866|NCT03335488|617294720|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
170804867|NCT03335488|617294721|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
170804868|NCT02101775|617294724|FG000|Overall Study|Adverse Event|4|||
170804869|NCT02101775|617294725|FG001|Overall Study|Adverse Event|0|||
170804870|NCT02101775|617294726|FG002|Overall Study|Adverse Event|0|||
170804871|NCT02101775|617294724|FG000|Overall Study|Admission to Hospital|0|||
170804872|NCT02101775|617294725|FG001|Overall Study|Admission to Hospital|1|||
170804873|NCT02101775|617294726|FG002|Overall Study|Admission to Hospital|0|||
170804874|NCT02406092|617294734|FG000|Overall Study|Screen failure|10|||
170804875|NCT02406092|617294735|FG001|Overall Study|Screen failure|7|||
170804876|NCT02406092|617294734|FG000|Overall Study|Death|22|||
170804877|NCT02406092|617294735|FG001|Overall Study|Death|5|||
170804878|NCT02406092|617294734|FG000|Overall Study|Lost to Follow-up|4|||
170804879|NCT02406092|617294735|FG001|Overall Study|Lost to Follow-up|1|||
170804880|NCT02406092|617294734|FG000|Overall Study|Adverse Event|1|||
170499938|NCT04521621|616171290|FG004|Overall Study|Withdrawal by Subject|0|||
170499939|NCT04521621|616171291|FG005|Overall Study|Withdrawal by Subject|0|||
170499940|NCT04521621|616171292|FG006|Overall Study|Withdrawal by Subject|0|||
170499941|NCT04521621|616171293|FG007|Overall Study|Withdrawal by Subject|0|||
170499942|NCT04521621|616171286|FG000|Overall Study|Allocated in error without study intervention|1|||
170499943|NCT04521621|616171287|FG001|Overall Study|Allocated in error without study intervention|0|||
170499944|NCT04521621|616171288|FG002|Overall Study|Allocated in error without study intervention|0|||
170499945|NCT04521621|616171289|FG003|Overall Study|Allocated in error without study intervention|0|||
170499946|NCT04521621|616171290|FG004|Overall Study|Allocated in error without study intervention|0|||
170499947|NCT04521621|616171291|FG005|Overall Study|Allocated in error without study intervention|0|||
170499948|NCT04521621|616171292|FG006|Overall Study|Allocated in error without study intervention|0|||
170499949|NCT04521621|616171293|FG007|Overall Study|Allocated in error without study intervention|0|||
170499950|NCT03671564|616171294|FG000|Overall Study|Progressive Disease|3|||
170499951|NCT03671564|616171295|FG001|Overall Study|Progressive Disease|5|||
170499952|NCT03671564|616171296|FG002|Overall Study|Progressive Disease|3|||
170499953|NCT03671564|616171294|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
170499954|NCT03671564|616171295|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
170499955|NCT03671564|616171296|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
170499956|NCT03671564|616171294|FG000|Overall Study|Withdrawal by Subject|1|||
170499957|NCT03671564|616171295|FG001|Overall Study|Withdrawal by Subject|1|||
170499958|NCT03671564|616171296|FG002|Overall Study|Withdrawal by Subject|0|||
170499959|NCT03409107|616171299|FG000|Overall Study|Withdrawal by Subject|4|||
170499960|NCT03409107|616171300|FG001|Overall Study|Withdrawal by Subject|2|||
170499961|NCT03409107|616171299|FG000|Overall Study|Physician Decision|1|||
170499962|NCT03409107|616171300|FG001|Overall Study|Physician Decision|0|||
170499963|NCT03409107|616171299|FG000|Overall Study|Lost to Follow-up|7|||
170499964|NCT03409107|616171300|FG001|Overall Study|Lost to Follow-up|2|||
170499965|NCT03409107|616171299|FG000|Overall Study|Adverse Event|5|||
170499966|NCT03409107|616171300|FG001|Overall Study|Adverse Event|3|||
170499967|NCT01185509|616171301|FG000|Overall Study|Progression/Relapse|9|||
170499968|NCT01185509|616171302|FG001|Overall Study|Progression/Relapse|15|||
170499969|NCT01185509|616171301|FG000|Overall Study|Physician Decision|2|||
170499970|NCT01185509|616171302|FG001|Overall Study|Physician Decision|2|||
170499971|NCT01185509|616171301|FG000|Overall Study|Withdrawal by Subject|0|||
170499972|NCT01185509|616171302|FG001|Overall Study|Withdrawal by Subject|1|||
170499973|NCT01185509|616171301|FG000|Overall Study|Death|0|||
170499974|NCT01185509|616171302|FG001|Overall Study|Death|1|||
170499975|NCT01185509|616171301|FG000|Overall Study|Intercurrent Illness|0|||
170499976|NCT01185509|616171302|FG001|Overall Study|Intercurrent Illness|1|||
170499977|NCT02062944|616171306|FG000|Overall Study|Lost to Follow-up|1|||
170499978|NCT02062944|616171306|FG000|Overall Study|New hemotological disorder identified|1|||
170499979|NCT02062944|616171306|FG000|Overall Study|Uncontrolled Hypertension|1|||
170499980|NCT02062944|616171306|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
170499981|NCT01482962|616171307|FG000|Overall Study|Progressive Disease|65|||
170499982|NCT01482962|616171308|FG001|Overall Study|Progressive Disease|53|||
170499983|NCT01482962|616171307|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
170499984|NCT01482962|616171308|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
170499985|NCT01482962|616171307|FG000|Overall Study|Adverse Event|18|||
170499986|NCT01482962|616171308|FG001|Overall Study|Adverse Event|22|||
170499987|NCT01482962|616171307|FG000|Overall Study|Withdrawal by Participant|8|||
170499988|NCT01482962|616171308|FG001|Overall Study|Withdrawal by Participant|13|||
170499989|NCT01482962|616171307|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
170499990|NCT01482962|616171308|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
170499991|NCT01482962|616171307|FG000|Overall Study|Other Reason|1|||
170499992|NCT01482962|616171308|FG001|Overall Study|Other Reason|5|||
170499993|NCT01482962|616171307|FG000|Overall Study|Study Terminated by Sponsor|5|||
170499994|NCT01482962|616171308|FG001|Overall Study|Study Terminated by Sponsor|2|||
170499995|NCT01482962|616171307|FG000|Overall Study|Did not Receive Study Drug|1|||
170804881|NCT02406092|617294735|FG001|Overall Study|Adverse Event|0|||
170804882|NCT02406092|617294734|FG000|Overall Study|Withdrawal by Subject|1|||
170804883|NCT02406092|617294735|FG001|Overall Study|Withdrawal by Subject|0|||
170804884|NCT01421667|617294736|FG000|Overall Study|Withdrawal by Subject|0|||
170804885|NCT01421667|617294737|FG001|Overall Study|Withdrawal by Subject|1|||
170804886|NCT01421667|617294738|FG002|Overall Study|Withdrawal by Subject|2|||
170499996|NCT01482962|616171308|FG001|Overall Study|Did not Receive Study Drug|6|||
170499997|NCT02658734|616171310|FG000|Overall Study|Adverse Event|2|||
170499998|NCT02658734|616171310|FG000|Overall Study|Death|4|||
170804887|NCT01421667|617294739|FG003|Overall Study|Withdrawal by Subject|1|||
170499999|NCT02658734|616171310|FG000|Overall Study|Lost to Follow-up|7|||
170500000|NCT02658734|616171310|FG000|Overall Study|Withdrawal of Consent|16|||
170500001|NCT02658734|616171310|FG000|Overall Study|Disease Progression|28|||
170500002|NCT05007041|616171318|FG000|Overall Study|Missing Diary Entries|0|||
170500003|NCT05007041|616171319|FG001|Overall Study|Missing Diary Entries|1|||
170500004|NCT04495816|616171320|FG000|Overall Study|Lost to Follow-up|10|||
170500005|NCT04495816|616171321|FG001|Overall Study|Lost to Follow-up|4|||
170500006|NCT04495816|616171320|FG000|Overall Study|Withdrawal by Subject|3|||
170500007|NCT04495816|616171321|FG001|Overall Study|Withdrawal by Subject|5|||
170500008|NCT03536949|616171322|FG000|Overall Study|Adverse Event|4|||
170500009|NCT03536949|616171323|FG001|Overall Study|Adverse Event|0|||
170500010|NCT03536949|616171322|FG000|Overall Study|Lost to Follow-up|2|||
170500011|NCT03536949|616171323|FG001|Overall Study|Lost to Follow-up|1|||
170500012|NCT03536949|616171322|FG000|Overall Study|Withdrawal by Subject|6|||
170500013|NCT03536949|616171323|FG001|Overall Study|Withdrawal by Subject|0|||
170903553|NCT00446030|617649162|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
170903554|NCT00446030|617649161|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
170903555|NCT00446030|617649162|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
170903556|NCT00446030|617649161|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
170903557|NCT00446030|617649162|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
170903558|NCT00446030|617649161|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
170903559|NCT00446030|617649162|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
170903560|NCT00446030|617649161|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
170903561|NCT00446030|617649162|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
170903562|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
170903563|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
170903564|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
170903565|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
170903566|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
170903567|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
170903568|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
170903569|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
170903570|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
170903571|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
170903572|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
170903573|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
170903574|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
170903575|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
170903576|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
170903577|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
170500014|NCT03536949|616171322|FG000|Overall Study|Non-compliance|2|||
170500015|NCT03536949|616171323|FG001|Overall Study|Non-compliance|1|||
170500016|NCT01210495|616171324|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
170500017|NCT01210495|616171325|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
170500018|NCT01210495|616171326|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
170500019|NCT01210495|616171327|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
170500020|NCT01210495|616171324|FG000|Overall Study|Death|14|||
170500021|NCT01210495|616171325|FG001|Overall Study|Death|7|||
170500022|NCT01210495|616171326|FG002|Overall Study|Death|112|||
170500023|NCT01210495|616171327|FG003|Overall Study|Death|54|||
170500024|NCT01210495|616171324|FG000|Overall Study|Study Terminated by Sponsor|0|||
170500025|NCT01210495|616171325|FG001|Overall Study|Study Terminated by Sponsor|0|||
170500026|NCT01210495|616171326|FG002|Overall Study|Study Terminated by Sponsor|4|||
170500027|NCT01210495|616171327|FG003|Overall Study|Study Terminated by Sponsor|11|||
170500028|NCT01210495|616171324|FG000|Overall Study|Lost to Follow-up|0|||
170500029|NCT01210495|616171325|FG001|Overall Study|Lost to Follow-up|0|||
170500030|NCT01210495|616171326|FG002|Overall Study|Lost to Follow-up|1|||
170500031|NCT01210495|616171327|FG003|Overall Study|Lost to Follow-up|1|||
170500032|NCT01210495|616171324|FG000|Overall Study|Other unspecified|0|||
170500033|NCT01210495|616171325|FG001|Overall Study|Other unspecified|0|||
170500034|NCT01210495|616171326|FG002|Overall Study|Other unspecified|6|||
170500035|NCT01210495|616171327|FG003|Overall Study|Other unspecified|0|||
170500036|NCT01459718|616171328|FG000|Overall Study|Physician Decision|1|||
170500037|NCT01459718|616171328|FG000|Overall Study|Lost to Follow-up|1|||
170500038|NCT01459718|616171328|FG000|Overall Study|Adverse Event|1|||
170500039|NCT01258075|616171331|FG000|Overall Study|Adverse Event|8|||
170500040|NCT01258075|616171332|FG001|Overall Study|Adverse Event|3|||
170903578|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
170500041|NCT01258075|616171331|FG000|Overall Study|Lost to Follow-up|11|||
170500042|NCT01258075|616171332|FG001|Overall Study|Lost to Follow-up|6|||
170500043|NCT01258075|616171331|FG000|Overall Study|Withdrawal by Subject|10|||
170551636|NCT00987935|616364822|FG003|Overall Study|Adverse Event|1|||
170500044|NCT01258075|616171332|FG001|Overall Study|Withdrawal by Subject|7|||
170500045|NCT01258075|616171331|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
170500046|NCT01258075|616171332|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
170500047|NCT01258075|616171331|FG000|Overall Study|Other|12|||
170500048|NCT01258075|616171332|FG001|Overall Study|Other|5|||
170500049|NCT02858180|616171333|FG000|Overall Study|Lost to Follow-up|0|||
170500050|NCT02858180|616171334|FG001|Overall Study|Lost to Follow-up|2|||
170500051|NCT01801280|616171339|FG000|Period 1|Withdrawal by Subject|0|||
170500052|NCT01801280|616171340|FG001|Period 1|Withdrawal by Subject|1|||
170500053|NCT01801280|616171341|FG002|Period 1|Withdrawal by Subject|0|||
170500054|NCT01801280|616171342|FG003|Period 1|Withdrawal by Subject|0|||
170500055|NCT01801280|616171339|FG000|Period 2|Withdrawal by Subject|1|||
170500056|NCT01801280|616171340|FG001|Period 2|Withdrawal by Subject|0|||
170500057|NCT01801280|616171341|FG002|Period 2|Withdrawal by Subject|0|||
170500058|NCT01801280|616171342|FG003|Period 2|Withdrawal by Subject|0|||
170500059|NCT01801280|616171339|FG000|Period 4|Protocol Violation|0|||
170500060|NCT01801280|616171340|FG001|Period 4|Protocol Violation|0|||
170500061|NCT01801280|616171341|FG002|Period 4|Protocol Violation|1|||
170500062|NCT01801280|616171342|FG003|Period 4|Protocol Violation|0|||
170500063|NCT01252563|616171343|FG000|Overall Study|Contract Deviation|41|||
170500064|NCT01252563|616171343|FG000|Overall Study|Centralized Registration Deviation|30|||
170500065|NCT01252563|616171343|FG000|Overall Study|Lost to Follow-up|161|||
170500066|NCT01252563|616171343|FG000|Overall Study|No visit after first day of treatment|194|||
170500067|NCT01252563|616171343|FG000|Overall Study|No drug administration|6|||
170500068|NCT00978250|616171349|FG000|Overall Study|Late determination of ineligibility|0|||
170500069|NCT00978250|616171350|FG001|Overall Study|Late determination of ineligibility|1|||
170500070|NCT00978250|616171351|FG002|Overall Study|Late determination of ineligibility|0|||
170500071|NCT00978250|616171352|FG003|Overall Study|Late determination of ineligibility|1|||
170500072|NCT05174949|616171355|FG000|Overall Study|Physician Decision|1|||
170500073|NCT05174949|616171356|FG001|Overall Study|Physician Decision|2|||
170500074|NCT05174949|616171357|FG002|Overall Study|Physician Decision|0|||
170500075|NCT05174949|616171358|FG003|Overall Study|Physician Decision|1|||
170500076|NCT05174949|616171359|FG004|Overall Study|Physician Decision|0|||
170500077|NCT05174949|616171360|FG005|Overall Study|Physician Decision|0|||
170500078|NCT05174949|616171355|FG000|Overall Study|Withdrawal by Subject|0|||
170500079|NCT05174949|616171356|FG001|Overall Study|Withdrawal by Subject|1|||
170500080|NCT05174949|616171357|FG002|Overall Study|Withdrawal by Subject|0|||
170500081|NCT05174949|616171358|FG003|Overall Study|Withdrawal by Subject|0|||
170500082|NCT05174949|616171359|FG004|Overall Study|Withdrawal by Subject|0|||
170500083|NCT05174949|616171360|FG005|Overall Study|Withdrawal by Subject|0|||
170500084|NCT05174949|616171355|FG000|Overall Study|Lost to Follow-up|0|||
170500085|NCT05174949|616171356|FG001|Overall Study|Lost to Follow-up|0|||
170500086|NCT05174949|616171357|FG002|Overall Study|Lost to Follow-up|0|||
170500087|NCT05174949|616171358|FG003|Overall Study|Lost to Follow-up|1|||
170500088|NCT05174949|616171359|FG004|Overall Study|Lost to Follow-up|0|||
170500089|NCT05174949|616171360|FG005|Overall Study|Lost to Follow-up|0|||
170500090|NCT02029989|616171361|FG000|Overall Study|Withdrawal by Subject|1|||
170500091|NCT02029989|616171362|FG001|Overall Study|Withdrawal by Subject|0|||
170500092|NCT02029989|616171361|FG000|Overall Study|Withdrawal: Fear of needles|1|||
170500093|NCT02029989|616171362|FG001|Overall Study|Withdrawal: Fear of needles|0|||
170500094|NCT02029989|616171361|FG000|Overall Study|Change of location|2|||
170500095|NCT02029989|616171362|FG001|Overall Study|Change of location|3|||
170500096|NCT02029989|616171361|FG000|Overall Study|Physician Decision|2|||
170500097|NCT02029989|616171362|FG001|Overall Study|Physician Decision|0|||
170903579|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
170903580|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
170903581|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
170903582|NCT00446030|617649161|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
170903583|NCT00446030|617649162|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
170903584|NCT02886715|617649164|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170903585|NCT02886715|617649165|FG001|Overall Study|Non-Compliance With Study Drug|2|||
170500098|NCT02029989|616171361|FG000|Overall Study|Lost to Follow-up|9|||
170500099|NCT02029989|616171362|FG001|Overall Study|Lost to Follow-up|7|||
170500100|NCT02029989|616171361|FG000|Overall Study|Death|0|||
170500101|NCT02029989|616171362|FG001|Overall Study|Death|1|||
170500102|NCT02029989|616171361|FG000|Overall Study|Protocol Violation|1|||
170500103|NCT02029989|616171362|FG001|Overall Study|Protocol Violation|0|||
170500104|NCT04351373|616171363|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
170500105|NCT01123941|616171364|FG000|Overall Study|Lost to Follow-up|2|||
170500106|NCT01123941|616171365|FG001|Overall Study|Lost to Follow-up|1|||
170500107|NCT05036668|616171366|FG000|Overall Study|lost to follow Up|0|||
170500108|NCT05036668|616171367|FG001|Overall Study|lost to follow Up|0|||
170500109|NCT05036668|616171368|FG002|Overall Study|lost to follow Up|1|||
170500110|NCT01537068|616171378|FG000|Overall Study|Lost to Follow-up|2|||
170500111|NCT01537068|616171379|FG001|Overall Study|Lost to Follow-up|1|||
170500112|NCT01537068|616171378|FG000|Overall Study|Adverse Event|0|||
170500113|NCT01537068|616171379|FG001|Overall Study|Adverse Event|1|||
170500114|NCT01537068|616171378|FG000|Overall Study|Withdrawal by Subject|1|||
170500115|NCT01537068|616171379|FG001|Overall Study|Withdrawal by Subject|1|||
170500116|NCT01537068|616171378|FG000|Overall Study|Lack of Efficacy|1|||
170500117|NCT01537068|616171379|FG001|Overall Study|Lack of Efficacy|0|||
170500118|NCT01785849|616171382|FG000|Overall Study|Death|7|||
170500119|NCT01785849|616171383|FG001|Overall Study|Death|9|||
170500120|NCT01785849|616171382|FG000|Overall Study|Protocol Specified Criteria|29|||
170903586|NCT02886715|617649166|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170500121|NCT01785849|616171383|FG001|Overall Study|Protocol Specified Criteria|1|||
170500122|NCT01785849|616171382|FG000|Overall Study|Withdrawal by Subject|15|||
170500123|NCT01785849|616171383|FG001|Overall Study|Withdrawal by Subject|12|||
170500124|NCT01785849|616171382|FG000|Overall Study|Sponsor Decision|0|||
170500125|NCT01785849|616171383|FG001|Overall Study|Sponsor Decision|1|||
170500126|NCT01785849|616171382|FG000|Overall Study|Lost to Follow-up|10|||
170500127|NCT01785849|616171383|FG001|Overall Study|Lost to Follow-up|11|||
170500128|NCT01597375|616171386|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
170500129|NCT01597375|616171387|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
170500130|NCT01597375|616171386|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
170500131|NCT01597375|616171387|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
170500132|NCT01597375|616171386|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
170500133|NCT01597375|616171387|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
170500134|NCT01597375|616171386|FG000|Washout (2 Weeks)|Adverse Event|1|||
170500135|NCT01597375|616171387|FG001|Washout (2 Weeks)|Adverse Event|0|||
170500136|NCT01597375|616171386|FG000|Second Intervention|Failed to react at both Aspirin|1|||
170500137|NCT01597375|616171387|FG001|Second Intervention|Failed to react at both Aspirin|1|||
170500138|NCT02375555|616171388|FG000|Induction Period|Adverse Event|7|||
170500139|NCT02375555|616171388|FG000|Induction Period|Withdrawal by Subject|2|||
170500140|NCT02375555|616171388|FG000|Induction Period|Other|1|||
170500141|NCT02375555|616171388|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
170500142|NCT02375555|616171388|FG000|Maintenance Period|Adverse Event|2|||
170500143|NCT02375555|616171388|FG000|Maintenance Period|Withdrawal by Subject|4|||
170500144|NCT02375555|616171388|FG000|Maintenance Period|Death|1|||
170500145|NCT02375555|616171388|FG000|Maintenance Period|Disease Progression|5|||
170500146|NCT02375555|616171388|FG000|Maintenance Period|Patient Non-compliance|1|||
170500147|NCT02375555|616171388|FG000|Maintenance Period|Still on maintenance|16|||
170500148|NCT00072280|616171391|FG000|Treatment|Found ineligible|1|||
170500149|NCT00072280|616171392|FG001|Treatment|Found ineligible|2|||
170500150|NCT00072280|616171391|FG000|Follow-up|Early termination of study|2|||
170500151|NCT00072280|616171392|FG001|Follow-up|Early termination of study|2|||
170500152|NCT02091986|616171393|FG000|Overall Study|7 rand in error 1 patient decision|2|||
170500153|NCT02091986|616171394|FG001|Overall Study|7 rand in error 1 patient decision|3|||
170500154|NCT02091986|616171395|FG002|Overall Study|7 rand in error 1 patient decision|3|||
170500155|NCT02091986|616171393|FG000|Overall Study|Lost to Follow-up|1|||
170500156|NCT02091986|616171394|FG001|Overall Study|Lost to Follow-up|0|||
170500157|NCT02091986|616171395|FG002|Overall Study|Lost to Follow-up|0|||
170500158|NCT02091986|616171393|FG000|Overall Study|Withdrawal by Subject|4|||
170500159|NCT02091986|616171394|FG001|Overall Study|Withdrawal by Subject|8|||
170500160|NCT02091986|616171395|FG002|Overall Study|Withdrawal by Subject|3|||
170500161|NCT02091986|616171393|FG000|Overall Study|Adverse Event|0|||
170500162|NCT02091986|616171394|FG001|Overall Study|Adverse Event|0|||
170500163|NCT02091986|616171395|FG002|Overall Study|Adverse Event|2|||
170500164|NCT02841280|616171396|FG000|Overall Study|Adverse Event|2|||
170500165|NCT02841280|616171397|FG001|Overall Study|Adverse Event|1|||
170500166|NCT02841280|616171396|FG000|Overall Study|Death|1|||
170500167|NCT02841280|616171397|FG001|Overall Study|Death|0|||
170500168|NCT02841280|616171396|FG000|Overall Study|Lost to Follow-up|2|||
170500169|NCT02841280|616171397|FG001|Overall Study|Lost to Follow-up|2|||
170500170|NCT02841280|616171396|FG000|Overall Study|Withdrawal by Subject|7|||
170500171|NCT02841280|616171397|FG001|Overall Study|Withdrawal by Subject|3|||
170500172|NCT02841280|616171396|FG000|Overall Study|Stop Point: BP above threshold|2|||
170500173|NCT02841280|616171397|FG001|Overall Study|Stop Point: BP above threshold|0|||
170500174|NCT02727777|616171399|FG000|Overall Study|Screen Failure|2|||
170500175|NCT02727777|616171400|FG001|Overall Study|Screen Failure|0|||
170500176|NCT02727777|616171401|FG002|Overall Study|Screen Failure|0|||
170500177|NCT02727777|616171399|FG000|Overall Study|Progressive disease|2|||
170500178|NCT02727777|616171400|FG001|Overall Study|Progressive disease|0|||
170500179|NCT02727777|616171401|FG002|Overall Study|Progressive disease|0|||
170500180|NCT01340027|616171403|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
170500181|NCT01340027|616171404|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
170500182|NCT01340027|616171405|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
170500183|NCT01340027|616171406|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
170500184|NCT01340027|616171407|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
170500185|NCT01340027|616171408|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
170500186|NCT01340027|616171409|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
170500187|NCT01340027|616171410|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
170500188|NCT01340027|616171411|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
170500189|NCT01340027|616171412|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
170500190|NCT01340027|616171413|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
170500191|NCT01340027|616171414|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
170500192|NCT01340027|616171403|FG000|Overall Study|Adverse Event|0|||
170500193|NCT01340027|616171404|FG001|Overall Study|Adverse Event|1|||
170500194|NCT01340027|616171405|FG002|Overall Study|Adverse Event|2|||
170500195|NCT01340027|616171406|FG003|Overall Study|Adverse Event|0|||
170500196|NCT01340027|616171407|FG004|Overall Study|Adverse Event|1|||
170500197|NCT01340027|616171408|FG005|Overall Study|Adverse Event|2|||
170500198|NCT01340027|616171409|FG006|Overall Study|Adverse Event|2|||
170500199|NCT01340027|616171410|FG007|Overall Study|Adverse Event|1|||
170500200|NCT01340027|616171411|FG008|Overall Study|Adverse Event|4|||
170500201|NCT01340027|616171412|FG009|Overall Study|Adverse Event|1|||
170500202|NCT01340027|616171413|FG010|Overall Study|Adverse Event|1|||
170500203|NCT01340027|616171414|FG011|Overall Study|Adverse Event|3|||
170500204|NCT01340027|616171403|FG000|Overall Study|Lack of Efficacy|0|||
170500205|NCT01340027|616171404|FG001|Overall Study|Lack of Efficacy|0|||
170500206|NCT01340027|616171405|FG002|Overall Study|Lack of Efficacy|0|||
170500207|NCT01340027|616171406|FG003|Overall Study|Lack of Efficacy|0|||
170500208|NCT01340027|616171407|FG004|Overall Study|Lack of Efficacy|0|||
170500209|NCT01340027|616171408|FG005|Overall Study|Lack of Efficacy|0|||
170500210|NCT01340027|616171409|FG006|Overall Study|Lack of Efficacy|1|||
170500211|NCT01340027|616171410|FG007|Overall Study|Lack of Efficacy|1|||
170500212|NCT01340027|616171411|FG008|Overall Study|Lack of Efficacy|1|||
170500213|NCT01340027|616171412|FG009|Overall Study|Lack of Efficacy|0|||
170500214|NCT01340027|616171413|FG010|Overall Study|Lack of Efficacy|0|||
170500215|NCT01340027|616171414|FG011|Overall Study|Lack of Efficacy|0|||
170500216|NCT01340027|616171403|FG000|Overall Study|Lost to Follow-up|0|||
170500217|NCT01340027|616171404|FG001|Overall Study|Lost to Follow-up|1|||
170500218|NCT01340027|616171405|FG002|Overall Study|Lost to Follow-up|0|||
170500219|NCT01340027|616171406|FG003|Overall Study|Lost to Follow-up|0|||
170500220|NCT01340027|616171407|FG004|Overall Study|Lost to Follow-up|0|||
170500221|NCT01340027|616171408|FG005|Overall Study|Lost to Follow-up|0|||
170500222|NCT01340027|616171409|FG006|Overall Study|Lost to Follow-up|1|||
170500223|NCT01340027|616171410|FG007|Overall Study|Lost to Follow-up|0|||
170500224|NCT01340027|616171411|FG008|Overall Study|Lost to Follow-up|0|||
170500225|NCT01340027|616171412|FG009|Overall Study|Lost to Follow-up|1|||
170500226|NCT01340027|616171413|FG010|Overall Study|Lost to Follow-up|0|||
170500227|NCT01340027|616171414|FG011|Overall Study|Lost to Follow-up|0|||
170500228|NCT01340027|616171403|FG000|Overall Study|Protocol Violation|1|||
170500229|NCT01340027|616171404|FG001|Overall Study|Protocol Violation|2|||
170500230|NCT01340027|616171405|FG002|Overall Study|Protocol Violation|0|||
170500231|NCT01340027|616171406|FG003|Overall Study|Protocol Violation|0|||
170500232|NCT01340027|616171407|FG004|Overall Study|Protocol Violation|6|||
170500233|NCT01340027|616171408|FG005|Overall Study|Protocol Violation|0|||
170500234|NCT01340027|616171409|FG006|Overall Study|Protocol Violation|0|||
170500235|NCT01340027|616171410|FG007|Overall Study|Protocol Violation|1|||
170500236|NCT01340027|616171411|FG008|Overall Study|Protocol Violation|2|||
170500237|NCT01340027|616171412|FG009|Overall Study|Protocol Violation|2|||
170500238|NCT01340027|616171413|FG010|Overall Study|Protocol Violation|0|||
170500239|NCT01340027|616171414|FG011|Overall Study|Protocol Violation|0|||
170500240|NCT01340027|616171403|FG000|Overall Study|Withdrawal by Subject|4|||
170500241|NCT01340027|616171404|FG001|Overall Study|Withdrawal by Subject|3|||
170500242|NCT01340027|616171405|FG002|Overall Study|Withdrawal by Subject|1|||
170500243|NCT01340027|616171406|FG003|Overall Study|Withdrawal by Subject|3|||
170500244|NCT01340027|616171407|FG004|Overall Study|Withdrawal by Subject|3|||
170500245|NCT01340027|616171408|FG005|Overall Study|Withdrawal by Subject|2|||
170500246|NCT01340027|616171409|FG006|Overall Study|Withdrawal by Subject|3|||
170500247|NCT01340027|616171410|FG007|Overall Study|Withdrawal by Subject|4|||
170500248|NCT01340027|616171411|FG008|Overall Study|Withdrawal by Subject|1|||
170500249|NCT01340027|616171412|FG009|Overall Study|Withdrawal by Subject|2|||
170500250|NCT01340027|616171413|FG010|Overall Study|Withdrawal by Subject|0|||
170500251|NCT01340027|616171414|FG011|Overall Study|Withdrawal by Subject|1|||
170500252|NCT01340027|616171403|FG000|Overall Study|Miscellaneous|0|||
170500253|NCT01340027|616171404|FG001|Overall Study|Miscellaneous|0|||
170804888|NCT01421667|617294736|FG000|Overall Study|Lost to Follow-up|0|||
170500254|NCT01340027|616171405|FG002|Overall Study|Miscellaneous|0|||
170500255|NCT01340027|616171406|FG003|Overall Study|Miscellaneous|1|||
170500256|NCT01340027|616171407|FG004|Overall Study|Miscellaneous|0|||
170500257|NCT01340027|616171408|FG005|Overall Study|Miscellaneous|0|||
170500258|NCT01340027|616171409|FG006|Overall Study|Miscellaneous|0|||
170500259|NCT01340027|616171410|FG007|Overall Study|Miscellaneous|0|||
170500260|NCT01340027|616171411|FG008|Overall Study|Miscellaneous|0|||
170500261|NCT01340027|616171412|FG009|Overall Study|Miscellaneous|0|||
170500262|NCT01340027|616171413|FG010|Overall Study|Miscellaneous|1|||
170500263|NCT01340027|616171414|FG011|Overall Study|Miscellaneous|0|||
170500264|NCT02272842|616171419|FG000|Overall Study|Lost to Follow-up|8|||
170500265|NCT02272842|616171420|FG001|Overall Study|Lost to Follow-up|8|||
170500266|NCT02272842|616171419|FG000|Overall Study|Withdrawal by Subject|8|||
170500267|NCT02272842|616171420|FG001|Overall Study|Withdrawal by Subject|2|||
170500268|NCT01984892|616171425|FG000|Overall Study|Progressive disease|7|||
170500269|NCT00356135|616171427|FG000|Overall Study|Protocol Violation|1|||
170500270|NCT00356135|616171428|FG001|Overall Study|Protocol Violation|0|||
170500271|NCT00356135|616171429|FG002|Overall Study|Protocol Violation|0|||
170500272|NCT00356135|616171427|FG000|Overall Study|Adverse Event|1|||
170500273|NCT00356135|616171428|FG001|Overall Study|Adverse Event|0|||
170500274|NCT00356135|616171429|FG002|Overall Study|Adverse Event|0|||
170500275|NCT00356135|616171427|FG000|Overall Study|Lost to Follow-up|0|||
170500276|NCT00356135|616171428|FG001|Overall Study|Lost to Follow-up|0|||
170500277|NCT00356135|616171429|FG002|Overall Study|Lost to Follow-up|1|||
170500278|NCT00356135|616171427|FG000|Overall Study|Physician Decision|1|||
170500279|NCT00356135|616171428|FG001|Overall Study|Physician Decision|1|||
170500280|NCT00356135|616171429|FG002|Overall Study|Physician Decision|1|||
170500281|NCT00356135|616171427|FG000|Overall Study|Subject non-compliance|1|||
170500282|NCT00356135|616171428|FG001|Overall Study|Subject non-compliance|1|||
170500283|NCT00356135|616171429|FG002|Overall Study|Subject non-compliance|3|||
170500284|NCT05270395|616171436|FG000|Overall Study|Lost to Follow-up|2|||
170500285|NCT05270395|616171437|FG001|Overall Study|Lost to Follow-up|2|||
170500286|NCT05270395|616171436|FG000|Overall Study|Death|1|||
170500287|NCT05270395|616171437|FG001|Overall Study|Death|2|||
170500288|NCT05270395|616171436|FG000|Overall Study|Study Team Withdrew|1|||
170500289|NCT05270395|616171437|FG001|Overall Study|Study Team Withdrew|0|||
170500290|NCT01752634|616173078|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
170500291|NCT01752634|616173079|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
170500292|NCT01752634|616173080|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
170500293|NCT01752634|616173081|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
170500294|NCT01752634|616173082|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
170500295|NCT01752634|616173083|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
170500296|NCT01752634|616173078|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
170500297|NCT01752634|616173079|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
170500298|NCT01752634|616173080|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
170500299|NCT01752634|616173081|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
170500300|NCT01752634|616173082|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
170500301|NCT01752634|616173083|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
170551637|NCT00987935|616364823|FG004|Overall Study|Adverse Event|1|||
170551638|NCT00987935|616364824|FG005|Overall Study|Adverse Event|0|||
170551639|NCT00987935|616364825|FG006|Overall Study|Adverse Event|2|||
170551640|NCT00987935|616364826|FG007|Overall Study|Adverse Event|10|||
170551641|NCT00987935|616364827|FG008|Overall Study|Adverse Event|6|||
170551642|NCT00987935|616364819|FG000|Overall Study|Refused to continue taking trial med.|1|||
170551643|NCT00987935|616364820|FG001|Overall Study|Refused to continue taking trial med.|0|||
170551644|NCT00987935|616364821|FG002|Overall Study|Refused to continue taking trial med.|0|||
170500302|NCT01752634|616173078|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
170500303|NCT01752634|616173079|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
170500304|NCT01752634|616173080|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
170551645|NCT00987935|616364822|FG003|Overall Study|Refused to continue taking trial med.|0|||
170551646|NCT00987935|616364823|FG004|Overall Study|Refused to continue taking trial med.|1|||
170551647|NCT00987935|616364824|FG005|Overall Study|Refused to continue taking trial med.|0|||
170500305|NCT01752634|616173081|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
170500306|NCT01752634|616173082|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
170500307|NCT01752634|616173083|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
170500308|NCT01752634|616173078|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
170500309|NCT01752634|616173079|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
170500310|NCT01752634|616173080|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
170500311|NCT01752634|616173081|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
170500312|NCT01752634|616173082|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
170500313|NCT01752634|616173083|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
170500314|NCT01752634|616173078|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
170500315|NCT01752634|616173079|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
170500316|NCT01752634|616173080|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
170500317|NCT01752634|616173081|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
170500318|NCT01752634|616173082|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
170500319|NCT01752634|616173083|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
170500320|NCT01752634|616173078|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
170500321|NCT01752634|616173079|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
170500322|NCT01752634|616173080|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
170500323|NCT01752634|616173081|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
170500324|NCT01752634|616173082|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
170500325|NCT01752634|616173083|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
170500326|NCT01752634|616173078|FG000|Week 24 to Week 260|Physician Decision|1|||
170500327|NCT01752634|616173079|FG001|Week 24 to Week 260|Physician Decision|2|||
170500328|NCT01752634|616173080|FG002|Week 24 to Week 260|Physician Decision|4|||
170500329|NCT01752634|616173081|FG003|Week 24 to Week 260|Physician Decision|2|||
170500330|NCT01752634|616173082|FG004|Week 24 to Week 260|Physician Decision|1|||
170500331|NCT01752634|616173083|FG005|Week 24 to Week 260|Physician Decision|0|||
170500332|NCT01752634|616173078|FG000|Week 24 to Week 260|Death|0|||
170500333|NCT01752634|616173079|FG001|Week 24 to Week 260|Death|1|||
170500334|NCT01752634|616173080|FG002|Week 24 to Week 260|Death|0|||
170500335|NCT01752634|616173081|FG003|Week 24 to Week 260|Death|0|||
170500336|NCT01752634|616173082|FG004|Week 24 to Week 260|Death|0|||
170500337|NCT01752634|616173083|FG005|Week 24 to Week 260|Death|0|||
170500338|NCT01752634|616173078|FG000|Week 24 to Week 260|Pregnancy|0|||
170500339|NCT01752634|616173079|FG001|Week 24 to Week 260|Pregnancy|0|||
170500340|NCT01752634|616173080|FG002|Week 24 to Week 260|Pregnancy|1|||
170500341|NCT01752634|616173081|FG003|Week 24 to Week 260|Pregnancy|0|||
170500342|NCT01752634|616173082|FG004|Week 24 to Week 260|Pregnancy|0|||
170500343|NCT01752634|616173083|FG005|Week 24 to Week 260|Pregnancy|0|||
170500344|NCT01752634|616173078|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
170500345|NCT01752634|616173079|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
170500346|NCT01752634|616173080|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
170500347|NCT01752634|616173081|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
170500348|NCT01752634|616173082|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
170500349|NCT01752634|616173083|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
170500350|NCT01752634|616173078|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
170500351|NCT01752634|616173079|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
170500352|NCT01752634|616173080|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
170500353|NCT01752634|616173081|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
170500354|NCT01752634|616173082|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
170500355|NCT01752634|616173083|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
170500356|NCT01752634|616173078|FG000|Week 24 to Week 260|Adverse Event|4|||
170500357|NCT01752634|616173079|FG001|Week 24 to Week 260|Adverse Event|8|||
170500358|NCT01752634|616173080|FG002|Week 24 to Week 260|Adverse Event|8|||
170500359|NCT01752634|616173081|FG003|Week 24 to Week 260|Adverse Event|4|||
170500360|NCT01752634|616173082|FG004|Week 24 to Week 260|Adverse Event|2|||
170500361|NCT01752634|616173083|FG005|Week 24 to Week 260|Adverse Event|0|||
170500362|NCT04250714|616173091|FG000|Overall Study|Treatment - withdrawal by subject|14|||
170500363|NCT04250714|616173091|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
170500364|NCT04250714|616173091|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
170500365|NCT04250714|616173091|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
170500366|NCT04250714|616173091|FG000|Overall Study|Treatment - Death|1|||
170500367|NCT04250714|616173091|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
170500368|NCT04250714|616173091|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
170500369|NCT04250714|616173091|FG000|Overall Study|Attempt|2|||
170804889|NCT01421667|617294737|FG001|Overall Study|Lost to Follow-up|1|||
170804890|NCT01421667|617294738|FG002|Overall Study|Lost to Follow-up|0|||
170804891|NCT01421667|617294739|FG003|Overall Study|Lost to Follow-up|0|||
170551648|NCT00987935|616364825|FG006|Overall Study|Refused to continue taking trial med.|4|||
170804892|NCT01160354|617294740|FG000|Overall Study|Death|0|||
170500370|NCT04250714|616173091|FG000|Overall Study|Intent|7|||
170500371|NCT04697056|616173092|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
170804893|NCT01160354|617294741|FG001|Overall Study|Death|1|||
170500372|NCT04697056|616173093|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
170500373|NCT03339726|616173094|FG000|Overall Study|Withdrawal by Subject|1|||
170500374|NCT03339726|616173095|FG001|Overall Study|Withdrawal by Subject|0|||
170500375|NCT03339726|616173096|FG002|Overall Study|Withdrawal by Subject|0|||
170500376|NCT03339726|616173094|FG000|Overall Study|Lost to Follow-up|0|||
170804894|NCT01160354|617294742|FG002|Overall Study|Death|1|||
170804895|NCT04200664|617294743|FG000|Overall Study|Withdrawal by Subject|1|||
170804896|NCT04200664|617294744|FG001|Overall Study|Withdrawal by Subject|0|||
170804897|NCT04200664|617294745|FG002|Overall Study|Withdrawal by Subject|0|||
170804898|NCT03840902|617294750|FG000|Overall Study|Randomized but not treated|1|||
170804899|NCT03840902|617294751|FG001|Overall Study|Randomized but not treated|1|||
170804900|NCT02235298|617294756|FG000|Overall Study|Lost to Follow-up|6|||
170903587|NCT02886715|617649164|FG000|Overall Study|Adverse Event|4|||
170903588|NCT02886715|617649165|FG001|Overall Study|Adverse Event|2|||
170903589|NCT02886715|617649166|FG002|Overall Study|Adverse Event|0|||
170903590|NCT02886715|617649164|FG000|Overall Study|Lack of Efficacy|0|||
170500377|NCT03339726|616173095|FG001|Overall Study|Lost to Follow-up|1|||
170500378|NCT03339726|616173096|FG002|Overall Study|Lost to Follow-up|0|||
170500379|NCT05906836|616173097|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
170500380|NCT05906836|616173097|FG000|Overall Study|Lost to Follow-up|1|||
170500381|NCT04035434|616173100|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500382|NCT04035434|616173101|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
170500383|NCT04035434|616173102|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500384|NCT04035434|616173103|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
170500385|NCT04035434|616173104|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
170500386|NCT04035434|616173105|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500387|NCT04035434|616173106|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500388|NCT04035434|616173107|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500389|NCT04035434|616173108|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500390|NCT04035434|616173109|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500391|NCT04035434|616173110|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
170500392|NCT04035434|616173111|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
170500393|NCT04035434|616173112|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500394|NCT04035434|616173100|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
170500395|NCT04035434|616173101|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
170500396|NCT04035434|616173102|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
170500397|NCT04035434|616173103|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
170500398|NCT04035434|616173104|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
170500399|NCT04035434|616173105|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
170500400|NCT04035434|616173106|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
170500401|NCT04035434|616173107|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
170500402|NCT04035434|616173108|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
170642470|NCT04145219|616705262|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
170903591|NCT02886715|617649165|FG001|Overall Study|Lack of Efficacy|2|||
170903592|NCT02886715|617649166|FG002|Overall Study|Lack of Efficacy|1|||
170903593|NCT02886715|617649164|FG000|Overall Study|Lost to Follow-up|29|||
170903594|NCT02886715|617649165|FG001|Overall Study|Lost to Follow-up|26|||
170500403|NCT04035434|616173109|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
170500404|NCT04035434|616173110|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
170500405|NCT04035434|616173111|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
170500406|NCT04035434|616173112|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
170642471|NCT02657408|616705263|FG000|Overall Study|Adverse Event|3|||
170642472|NCT02657408|616705264|FG001|Overall Study|Adverse Event|7|||
170642473|NCT03672097|616705265|FG000|Period 1|Withdrawal by Subject|2|||
170642474|NCT03672097|616705265|FG000|Period 1|Adverse Event|1|||
170642475|NCT03672097|616705265|FG000|Period 1|Did not receive treatment|1|||
170642476|NCT03672097|616705265|FG000|Period 2|Withdrawal by Subject|3|||
170642477|NCT03672097|616705265|FG000|Period 2|Other|1|||
170804901|NCT02235298|617294757|FG001|Overall Study|Lost to Follow-up|5|||
170903595|NCT02886715|617649166|FG002|Overall Study|Lost to Follow-up|10|||
170903596|NCT02886715|617649164|FG000|Overall Study|Pregnancy|1|||
170903597|NCT02886715|617649165|FG001|Overall Study|Pregnancy|1|||
170903598|NCT02886715|617649166|FG002|Overall Study|Pregnancy|1|||
170903599|NCT02886715|617649164|FG000|Overall Study|Protocol Violation|3|||
170804902|NCT02235298|617294756|FG000|Overall Study|Adverse Event|2|||
170804903|NCT02235298|617294757|FG001|Overall Study|Adverse Event|2|||
170804904|NCT02235298|617294756|FG000|Overall Study|Withdrawal by Subject|0|||
170903600|NCT02886715|617649165|FG001|Overall Study|Protocol Violation|2|||
170903601|NCT02886715|617649166|FG002|Overall Study|Protocol Violation|1|||
170903602|NCT02886715|617649164|FG000|Overall Study|Withdrawal by Subject|20|||
170804905|NCT02235298|617294757|FG001|Overall Study|Withdrawal by Subject|1|||
170903603|NCT02886715|617649165|FG001|Overall Study|Withdrawal by Subject|18|||
170903604|NCT02886715|617649166|FG002|Overall Study|Withdrawal by Subject|5|||
170500407|NCT04035434|616173100|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500408|NCT04035434|616173101|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
170500409|NCT04035434|616173102|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
170500410|NCT04035434|616173103|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500411|NCT04035434|616173104|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
170500412|NCT04035434|616173105|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
170500413|NCT04035434|616173106|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500414|NCT04035434|616173107|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500415|NCT04035434|616173108|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
170500416|NCT04035434|616173109|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
170500417|NCT04035434|616173110|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500418|NCT04035434|616173111|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
170500419|NCT04035434|616173112|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
170500420|NCT04035434|616173100|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500421|NCT04035434|616173101|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500422|NCT04035434|616173102|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500423|NCT04035434|616173103|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
170500424|NCT04035434|616173104|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500425|NCT04035434|616173105|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500426|NCT04035434|616173106|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500427|NCT04035434|616173107|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500428|NCT04035434|616173108|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500429|NCT04035434|616173109|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170551649|NCT00987935|616364826|FG007|Overall Study|Refused to continue taking trial med.|4|||
170551650|NCT00987935|616364827|FG008|Overall Study|Refused to continue taking trial med.|2|||
170551651|NCT00987935|616364819|FG000|Overall Study|Reason other than those specified above|0|||
170551652|NCT00987935|616364820|FG001|Overall Study|Reason other than those specified above|0|||
170551653|NCT00987935|616364821|FG002|Overall Study|Reason other than those specified above|0|||
170551654|NCT00987935|616364822|FG003|Overall Study|Reason other than those specified above|0|||
170551655|NCT00987935|616364823|FG004|Overall Study|Reason other than those specified above|0|||
170551656|NCT00987935|616364824|FG005|Overall Study|Reason other than those specified above|0|||
170551657|NCT00987935|616364825|FG006|Overall Study|Reason other than those specified above|0|||
170551658|NCT00987935|616364826|FG007|Overall Study|Reason other than those specified above|0|||
170551659|NCT00987935|616364827|FG008|Overall Study|Reason other than those specified above|1|||
170551660|NCT01089543|616364828|FG000|Overall Study|Withdrawal by Subject|2|||
170551661|NCT01089543|616364829|FG001|Overall Study|Withdrawal by Subject|3|||
170551662|NCT01089543|616364830|FG002|Overall Study|Withdrawal by Subject|3|||
170551663|NCT01089543|616364831|FG003|Overall Study|Withdrawal by Subject|1|||
170551664|NCT01089543|616364828|FG000|Overall Study|Physician Decision|1|||
170551665|NCT01089543|616364829|FG001|Overall Study|Physician Decision|0|||
170551666|NCT01089543|616364830|FG002|Overall Study|Physician Decision|0|||
170551667|NCT01089543|616364831|FG003|Overall Study|Physician Decision|1|||
170551668|NCT01089543|616364828|FG000|Overall Study|Adverse Event|0|||
170551669|NCT01089543|616364829|FG001|Overall Study|Adverse Event|1|||
170551670|NCT01089543|616364830|FG002|Overall Study|Adverse Event|0|||
170551671|NCT01089543|616364831|FG003|Overall Study|Adverse Event|0|||
170551672|NCT02633527|616364832|FG000|Overall Study|Failed to meet eligibility|0|||
170551673|NCT02633527|616364833|FG001|Overall Study|Failed to meet eligibility|1|||
170551674|NCT02633527|616364834|FG002|Overall Study|Failed to meet eligibility|1|||
170551675|NCT02633527|616364835|FG003|Overall Study|Failed to meet eligibility|0|||
170551676|NCT02633527|616364836|FG004|Overall Study|Failed to meet eligibility|1|||
170551677|NCT02633527|616364832|FG000|Overall Study|Adverse Event|0|||
170551678|NCT02633527|616364833|FG001|Overall Study|Adverse Event|4|||
170551679|NCT02633527|616364834|FG002|Overall Study|Adverse Event|3|||
170551680|NCT02633527|616364835|FG003|Overall Study|Adverse Event|1|||
170551681|NCT02633527|616364836|FG004|Overall Study|Adverse Event|5|||
170551682|NCT02633527|616364832|FG000|Overall Study|Lost to Follow-up|1|||
170551683|NCT02633527|616364833|FG001|Overall Study|Lost to Follow-up|2|||
170804906|NCT02972359|617294761|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
170500430|NCT04035434|616173110|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170551684|NCT02633527|616364834|FG002|Overall Study|Lost to Follow-up|5|||
170551685|NCT02633527|616364835|FG003|Overall Study|Lost to Follow-up|5|||
170551686|NCT02633527|616364836|FG004|Overall Study|Lost to Follow-up|4|||
170551687|NCT02633527|616364832|FG000|Overall Study|Withdrawal by Subject|0|||
170551688|NCT02633527|616364833|FG001|Overall Study|Withdrawal by Subject|3|||
170551689|NCT02633527|616364834|FG002|Overall Study|Withdrawal by Subject|5|||
170551690|NCT02633527|616364835|FG003|Overall Study|Withdrawal by Subject|4|||
170551691|NCT02633527|616364836|FG004|Overall Study|Withdrawal by Subject|4|||
170804907|NCT02972359|617294761|FG000|Overall Study|Lack of Efficacy|1|||
170804908|NCT02972359|617294761|FG000|Overall Study|Adverse Event|4|||
170804909|NCT02972359|617294761|FG000|Overall Study|Death|1|||
170804910|NCT02972359|617294761|FG000|Overall Study|Withdrawal by Subject|30|||
170804911|NCT02972359|617294761|FG000|Overall Study|Protocol Violation|1|||
170804912|NCT02972359|617294761|FG000|Overall Study|Lost to Follow-up|26|||
170804913|NCT02972359|617294761|FG000|Overall Study|Other reasons|5|||
170804914|NCT02972359|617294761|FG000|Overall Study|Missing|1|||
170804915|NCT04088227|617294768|FG000|Overall Study|Withdrawal by Subject|1|||
170804916|NCT04088227|617294769|FG001|Overall Study|Withdrawal by Subject|0|||
170804917|NCT04088227|617294768|FG000|Overall Study|Surgery postponed >5weeks|1|||
170500431|NCT04035434|616173111|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170500432|NCT04035434|616173112|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
170804918|NCT04088227|617294769|FG001|Overall Study|Surgery postponed >5weeks|0|||
170804919|NCT04021862|617294770|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
170804920|NCT04021862|617294771|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
170804921|NCT04021862|617294772|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
170804922|NCT04021862|617294773|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
170500433|NCT04035434|616173100|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500434|NCT04035434|616173101|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500435|NCT04035434|616173102|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500436|NCT04035434|616173103|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500437|NCT04035434|616173104|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500438|NCT04035434|616173105|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
170500439|NCT04035434|616173106|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
170500440|NCT04035434|616173107|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500441|NCT04035434|616173108|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500442|NCT04035434|616173109|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500443|NCT04035434|616173110|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500444|NCT04035434|616173111|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500445|NCT04035434|616173112|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
170500446|NCT04035434|616173100|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500447|NCT04035434|616173101|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500448|NCT04035434|616173102|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500449|NCT04035434|616173103|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500450|NCT04035434|616173104|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500451|NCT04035434|616173105|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
170500452|NCT04035434|616173106|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
170500453|NCT04035434|616173107|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500454|NCT04035434|616173108|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500455|NCT04035434|616173109|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500456|NCT04035434|616173110|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500457|NCT04035434|616173111|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500458|NCT04035434|616173112|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
170500459|NCT04035434|616173100|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500460|NCT04035434|616173101|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500461|NCT04035434|616173102|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500462|NCT04035434|616173103|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500463|NCT04035434|616173104|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500464|NCT04035434|616173105|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
170500465|NCT04035434|616173106|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
170500466|NCT04035434|616173107|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500467|NCT04035434|616173108|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500468|NCT04035434|616173109|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500469|NCT04035434|616173110|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170642478|NCT01403948|616705267|FG000|Overall Study|Progressive disease|0|||
170903605|NCT02886715|617649164|FG000|Overall Study|missing|7|||
170903606|NCT02886715|617649165|FG001|Overall Study|missing|2|||
170903607|NCT02886715|617649166|FG002|Overall Study|missing|2|||
170903608|NCT00503399|617649169|FG000|Overall Study|Death|2|||
170903609|NCT00503399|617649170|FG001|Overall Study|Death|1|||
170903610|NCT00503399|617649169|FG000|Overall Study|Protocol Violation|1|||
170903611|NCT00503399|617649170|FG001|Overall Study|Protocol Violation|0|||
170804923|NCT04021862|617294774|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
170804924|NCT04021862|617294775|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
170804925|NCT04021862|617294770|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
170903612|NCT00503399|617649169|FG000|Overall Study|Withdrawal by Subject|4|||
170804926|NCT04021862|617294771|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
170804927|NCT04021862|617294772|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
170804928|NCT04021862|617294773|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
170804929|NCT04021862|617294774|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
170804930|NCT04021862|617294775|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
170804931|NCT04021862|617294770|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
170804932|NCT04021862|617294771|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
170804933|NCT04021862|617294772|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
170804934|NCT04021862|617294773|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
170804935|NCT04021862|617294774|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
170804936|NCT04021862|617294775|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
170804937|NCT04021862|617294770|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
170804938|NCT04021862|617294771|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
170804939|NCT04021862|617294772|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
170804940|NCT04021862|617294773|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
170804941|NCT04021862|617294774|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
170804942|NCT04021862|617294775|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
170804943|NCT04021862|617294770|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
170804944|NCT04021862|617294771|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
170804945|NCT04021862|617294772|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
170804946|NCT04021862|617294773|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
170804947|NCT04021862|617294774|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
170804948|NCT04021862|617294775|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
170804949|NCT02415127|617294776|FG000|Overall Study|Adverse Event|1|||
170804950|NCT02415127|617294777|FG001|Overall Study|Adverse Event|0|||
170500470|NCT04035434|616173111|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500471|NCT04035434|616173112|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
170500472|NCT04322539|616173113|FG000|Overall Study|Adverse Event|2|||
170500473|NCT04322539|616173114|FG001|Overall Study|Adverse Event|0|||
170500474|NCT04322539|616173113|FG000|Overall Study|Death|411|||
170500475|NCT04322539|616173114|FG001|Overall Study|Death|203|||
170500476|NCT04322539|616173113|FG000|Overall Study|Lost to Follow-up|3|||
170500477|NCT04322539|616173114|FG001|Overall Study|Lost to Follow-up|1|||
170500478|NCT04322539|616173113|FG000|Overall Study|Withdrawal of consent|14|||
170500479|NCT04322539|616173114|FG001|Overall Study|Withdrawal of consent|8|||
170500480|NCT04322539|616173113|FG000|Overall Study|Radiological Disease Progression|6|||
170500481|NCT04322539|616173114|FG001|Overall Study|Radiological Disease Progression|0|||
170500482|NCT04322539|616173113|FG000|Overall Study|Sponsor Decision|19|||
170500483|NCT04322539|616173114|FG001|Overall Study|Sponsor Decision|14|||
170500484|NCT04322539|616173113|FG000|Overall Study|Other|6|||
170500485|NCT04322539|616173114|FG001|Overall Study|Other|4|||
170500486|NCT04161079|616173117|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
170500487|NCT03617861|616173118|FG000|Second Intervention (1 Day)|Adverse Event|0|||
170500488|NCT03617861|616173119|FG001|Second Intervention (1 Day)|Adverse Event|0|||
170500489|NCT03617861|616173120|FG002|Second Intervention (1 Day)|Adverse Event|1|||
170500490|NCT03617861|616173121|FG003|Second Intervention (1 Day)|Adverse Event|0|||
170500491|NCT00655733|616173132|FG000|Overall Study|Lost to Follow-up|2|||
170500492|NCT00655733|616173133|FG001|Overall Study|Lost to Follow-up|2|||
170500493|NCT00655733|616173132|FG000|Overall Study|Adverse Event|2|||
170500494|NCT00655733|616173133|FG001|Overall Study|Adverse Event|2|||
170500495|NCT00655733|616173132|FG000|Overall Study|Withdrawal by Subject|3|||
170500496|NCT00655733|616173133|FG001|Overall Study|Withdrawal by Subject|3|||
170500497|NCT00655733|616173132|FG000|Overall Study|Physician Decision|0|||
170500498|NCT00655733|616173133|FG001|Overall Study|Physician Decision|1|||
170500499|NCT02407457|616173134|FG000|1 Month|Death|3|||
170500500|NCT02407457|616173135|FG001|1 Month|Death|0|||
170500501|NCT02407457|616173134|FG000|1 Month|Lost to Follow-up|1|||
170500502|NCT02407457|616173135|FG001|1 Month|Lost to Follow-up|1|||
170804951|NCT01855750|617294778|FG000|Overall Study|Death|78|||
170804952|NCT01855750|617294779|FG001|Overall Study|Death|78|||
170804953|NCT01855750|617294778|FG000|Overall Study|Lost to Follow-up|9|||
170500503|NCT02407457|616173134|FG000|1 Month|missed visit|2|||
170500504|NCT02407457|616173135|FG001|1 Month|missed visit|5|||
170500505|NCT02407457|616173134|FG000|6-Month|Death|2|||
170500506|NCT02407457|616173135|FG001|6-Month|Death|8|||
170551692|NCT02633527|616364832|FG000|Overall Study|Protocol Violation|0|||
170500507|NCT02407457|616173134|FG000|6-Month|Lost to Follow-up|2|||
170500508|NCT02407457|616173135|FG001|6-Month|Lost to Follow-up|2|||
170500509|NCT02407457|616173134|FG000|6-Month|missed visit|16|||
170500510|NCT02407457|616173135|FG001|6-Month|missed visit|14|||
170500511|NCT02407457|616173134|FG000|6-Month|Open Repair|0|||
170500512|NCT02407457|616173135|FG001|6-Month|Open Repair|1|||
170500513|NCT02407457|616173134|FG000|1 Year|Death|6|||
170500514|NCT02407457|616173135|FG001|1 Year|Death|11|||
170500515|NCT02407457|616173134|FG000|1 Year|Lost to Follow-up|3|||
170500516|NCT02407457|616173135|FG001|1 Year|Lost to Follow-up|2|||
170500517|NCT02407457|616173134|FG000|1 Year|Missed Visit|24|||
170500518|NCT02407457|616173135|FG001|1 Year|Missed Visit|14|||
170500519|NCT02407457|616173134|FG000|1 Year|Open Repair|0|||
170500520|NCT02407457|616173135|FG001|1 Year|Open Repair|1|||
170500521|NCT02407457|616173134|FG000|2-year|Death|14|||
170500522|NCT02407457|616173135|FG001|2-year|Death|8|||
170500523|NCT02407457|616173134|FG000|2-year|Lost to Follow-up|7|||
170500524|NCT02407457|616173135|FG001|2-year|Lost to Follow-up|10|||
170500525|NCT02407457|616173134|FG000|2-year|Missed Visit|13|||
170500526|NCT02407457|616173135|FG001|2-year|Missed Visit|15|||
170500527|NCT02407457|616173134|FG000|2-year|Open Repair|0|||
170500528|NCT02407457|616173135|FG001|2-year|Open Repair|2|||
170500529|NCT02407457|616173134|FG000|3-year|Death|11|||
170500530|NCT02407457|616173135|FG001|3-year|Death|10|||
170500531|NCT02407457|616173134|FG000|3-year|Lost to Follow-up|9|||
170500532|NCT02407457|616173135|FG001|3-year|Lost to Follow-up|10|||
170500533|NCT02407457|616173134|FG000|3-year|Missed Visit|19|||
170500534|NCT02407457|616173135|FG001|3-year|Missed Visit|16|||
170500535|NCT02407457|616173134|FG000|4-year|Death|18|||
170500536|NCT02407457|616173135|FG001|4-year|Death|10|||
170500537|NCT02407457|616173134|FG000|4-year|Lost to Follow-up|10|||
170500538|NCT02407457|616173135|FG001|4-year|Lost to Follow-up|12|||
170500539|NCT02407457|616173134|FG000|4-year|Missed Visit|18|||
170500540|NCT02407457|616173135|FG001|4-year|Missed Visit|16|||
170500541|NCT02407457|616173134|FG000|5-year|Death|10|||
170500542|NCT02407457|616173135|FG001|5-year|Death|3|||
170500543|NCT02407457|616173134|FG000|5-year|Lost to Follow-up|22|||
170500544|NCT02407457|616173135|FG001|5-year|Lost to Follow-up|13|||
170500545|NCT02407457|616173134|FG000|5-year|Missed Visit|9|||
170500546|NCT02407457|616173135|FG001|5-year|Missed Visit|1|||
170500547|NCT00705718|616173136|FG000|Overall Study|Death|6|||
170500548|NCT00705718|616173137|FG001|Overall Study|Death|6|||
170500549|NCT00705718|616173136|FG000|Overall Study|Not due for Visit|0|||
170500550|NCT00705718|616173137|FG001|Overall Study|Not due for Visit|12|||
170500551|NCT00705718|616173136|FG000|Overall Study|Follow up not done|1|||
170500552|NCT00705718|616173137|FG001|Overall Study|Follow up not done|4|||
170500553|NCT01826370|616173143|FG000|Overall Study|Protocol Violation|6|||
170500554|NCT01826370|616173143|FG000|Overall Study|Lost to Follow-up|12|||
170500555|NCT01826370|616173143|FG000|Overall Study|Other reason not defined above|2|||
170500556|NCT02543892|616173144|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
170500557|NCT02543892|616173145|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
170500558|NCT02543892|616173146|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
170500559|NCT02543892|616173147|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
170500560|NCT02543892|616173148|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
170500561|NCT02543892|616173149|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
170500562|NCT02543892|616173150|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
170500563|NCT02543892|616173151|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
170500564|NCT02543892|616173144|FG000|Received Vaccination 2|Physician Decision|0|||
170500565|NCT02543892|616173145|FG001|Received Vaccination 2|Physician Decision|0|||
170500566|NCT02543892|616173146|FG002|Received Vaccination 2|Physician Decision|0|||
170500567|NCT02543892|616173147|FG003|Received Vaccination 2|Physician Decision|0|||
170500568|NCT02543892|616173148|FG004|Received Vaccination 2|Physician Decision|0|||
170500569|NCT02543892|616173149|FG005|Received Vaccination 2|Physician Decision|1|||
170500570|NCT02543892|616173150|FG006|Received Vaccination 2|Physician Decision|0|||
170551693|NCT02633527|616364833|FG001|Overall Study|Protocol Violation|1|||
170551694|NCT02633527|616364834|FG002|Overall Study|Protocol Violation|1|||
170551695|NCT02633527|616364835|FG003|Overall Study|Protocol Violation|1|||
170551696|NCT02633527|616364836|FG004|Overall Study|Protocol Violation|1|||
170551697|NCT02633527|616364832|FG000|Overall Study|Physician Decision|0|||
170500571|NCT02543892|616173151|FG007|Received Vaccination 2|Physician Decision|0|||
170500572|NCT02543892|616173144|FG000|Received Vaccination 2|Adverse Event|0|||
170500573|NCT02543892|616173145|FG001|Received Vaccination 2|Adverse Event|1|||
170500574|NCT02543892|616173146|FG002|Received Vaccination 2|Adverse Event|0|||
170500575|NCT02543892|616173147|FG003|Received Vaccination 2|Adverse Event|0|||
170500576|NCT02543892|616173148|FG004|Received Vaccination 2|Adverse Event|0|||
170500577|NCT02543892|616173149|FG005|Received Vaccination 2|Adverse Event|0|||
170500578|NCT02543892|616173150|FG006|Received Vaccination 2|Adverse Event|0|||
170500579|NCT02543892|616173151|FG007|Received Vaccination 2|Adverse Event|0|||
170500580|NCT02543892|616173144|FG000|Had Immunology Data|Withdrawal by Subject|0|||
170500581|NCT02543892|616173145|FG001|Had Immunology Data|Withdrawal by Subject|0|||
170500582|NCT02543892|616173146|FG002|Had Immunology Data|Withdrawal by Subject|0|||
170500583|NCT02543892|616173147|FG003|Had Immunology Data|Withdrawal by Subject|0|||
170500584|NCT02543892|616173148|FG004|Had Immunology Data|Withdrawal by Subject|0|||
170500585|NCT02543892|616173149|FG005|Had Immunology Data|Withdrawal by Subject|0|||
170500586|NCT02543892|616173150|FG006|Had Immunology Data|Withdrawal by Subject|1|||
170500587|NCT02543892|616173151|FG007|Had Immunology Data|Withdrawal by Subject|0|||
170500588|NCT01199822|616173152|FG000|Overall Study|Investigator discontinued therapy|0|||
170500589|NCT01199822|616173153|FG001|Overall Study|Investigator discontinued therapy|1|||
170500590|NCT01199822|616173154|FG002|Overall Study|Investigator discontinued therapy|0|||
170500591|NCT01195844|616173155|FG000|Overall Study|Fecal sample not collected|40|||
170500592|NCT04021121|616173157|FG000|Overall Study|Death|3|||
170500593|NCT04021121|616173158|FG001|Overall Study|Death|3|||
170500594|NCT04021121|616173159|FG002|Overall Study|Death|5|||
170500595|NCT04021121|616173160|FG003|Overall Study|Death|4|||
170500596|NCT04050124|616173168|FG000|Overall Study|Death|1|||
170500597|NCT04050124|616173169|FG001|Overall Study|Death|0|||
170500598|NCT05083923|616173170|FG000|Overall Study|Adverse Event|2|||
170500599|NCT05083923|616173171|FG001|Overall Study|Adverse Event|0|||
170500600|NCT05083923|616173170|FG000|Overall Study|Lack of Efficacy|1|||
170500601|NCT05083923|616173171|FG001|Overall Study|Lack of Efficacy|3|||
170500602|NCT05083923|616173170|FG000|Overall Study|Withdrawal by Subject|2|||
170500603|NCT05083923|616173171|FG001|Overall Study|Withdrawal by Subject|6|||
170500604|NCT05083923|616173170|FG000|Overall Study|Reason Not Specified|0|||
170500605|NCT05083923|616173171|FG001|Overall Study|Reason Not Specified|1|||
170551698|NCT02633527|616364833|FG001|Overall Study|Physician Decision|0|||
170551699|NCT02633527|616364834|FG002|Overall Study|Physician Decision|0|||
170551700|NCT02633527|616364835|FG003|Overall Study|Physician Decision|0|||
170551701|NCT02633527|616364836|FG004|Overall Study|Physician Decision|1|||
170551702|NCT02633527|616364832|FG000|Overall Study|Administrative reason|1|||
170551703|NCT02633527|616364833|FG001|Overall Study|Administrative reason|0|||
170551704|NCT02633527|616364834|FG002|Overall Study|Administrative reason|0|||
170551705|NCT02633527|616364835|FG003|Overall Study|Administrative reason|1|||
170551706|NCT02633527|616364836|FG004|Overall Study|Administrative reason|0|||
170551707|NCT02633527|616364832|FG000|Overall Study|Multiple reasons|1|||
170551708|NCT02633527|616364833|FG001|Overall Study|Multiple reasons|0|||
170551709|NCT02633527|616364834|FG002|Overall Study|Multiple reasons|2|||
170551710|NCT02633527|616364835|FG003|Overall Study|Multiple reasons|2|||
170551711|NCT02633527|616364836|FG004|Overall Study|Multiple reasons|1|||
170551712|NCT00452530|616364837|FG000|Overall Study|Death|1|||
170551713|NCT00452530|616364838|FG001|Overall Study|Death|0|||
170551714|NCT00452530|616364837|FG000|Overall Study|Adverse Event|40|||
170551715|NCT00452530|616364838|FG001|Overall Study|Adverse Event|44|||
170551716|NCT00452530|616364837|FG000|Overall Study|Withdrawal by Subject|68|||
170551717|NCT00452530|616364838|FG001|Overall Study|Withdrawal by Subject|57|||
170551718|NCT00452530|616364837|FG000|Overall Study|Lost to Follow-up|1|||
170551719|NCT00452530|616364838|FG001|Overall Study|Lost to Follow-up|0|||
170551720|NCT00452530|616364837|FG000|Overall Study|Poor compliance/noncompliance|1|||
170551721|NCT00452530|616364838|FG001|Overall Study|Poor compliance/noncompliance|2|||
170551722|NCT00452530|616364837|FG000|Overall Study|No longer met study criteria|18|||
170551723|NCT00452530|616364838|FG001|Overall Study|No longer met study criteria|22|||
170551724|NCT00452530|616364837|FG000|Overall Study|Other|7|||
170551725|NCT00452530|616364838|FG001|Overall Study|Other|11|||
170551726|NCT06091956|616364839|FG000|Overall Study|Withdrawal by Subject|1|||
170551727|NCT06091956|616364839|FG000|Overall Study|Complicating Disease|1|||
170551728|NCT01248468|616364840|FG000|Overall Study|Administrative problem|1|||
170551729|NCT01248468|616364841|FG001|Overall Study|Administrative problem|0|||
170551730|NCT01248468|616364842|FG002|Overall Study|Administrative problem|0|||
170551731|NCT01248468|616364840|FG000|Overall Study|Lost to Follow-up|9|||
170551732|NCT01248468|616364841|FG001|Overall Study|Lost to Follow-up|12|||
170551733|NCT01248468|616364842|FG002|Overall Study|Lost to Follow-up|4|||
170551734|NCT01248468|616364840|FG000|Overall Study|Pregnancy|1|||
170551735|NCT01248468|616364841|FG001|Overall Study|Pregnancy|0|||
170500606|NCT00520481|616173174|FG000|Overall Study|Adverse Event|4|||
170500607|NCT00520481|616173175|FG001|Overall Study|Adverse Event|1|||
170500608|NCT00520481|616173174|FG000|Overall Study|Withdrawal by Subject|3|||
170500609|NCT00520481|616173175|FG001|Overall Study|Withdrawal by Subject|0|||
170500610|NCT06011161|616173176|FG000|Overall Study|Withdrawal by Subject|2|||
170500611|NCT06011161|616173176|FG000|Overall Study|Lost to Follow-up|5|||
170500612|NCT00381043|616173177|FG000|Overall Study|Lost to Follow-up|8|||
170500613|NCT00381043|616173178|FG001|Overall Study|Lost to Follow-up|6|||
170804954|NCT01855750|617294779|FG001|Overall Study|Lost to Follow-up|23|||
170804955|NCT01855750|617294778|FG000|Overall Study|Withdrawal by Subject|35|||
170804956|NCT01855750|617294779|FG001|Overall Study|Withdrawal by Subject|28|||
170804957|NCT01855750|617294778|FG000|Overall Study|Sponsor ends the study|297|||
170804958|NCT01855750|617294779|FG001|Overall Study|Sponsor ends the study|290|||
170804959|NCT05379270|617294780|FG000|Overall Study|Withdrawal by Subject|1|||
170804960|NCT05379270|617294781|FG001|Overall Study|Withdrawal by Subject|1|||
170804961|NCT05525572|617294782|FG000|Overall Study|Lost to Follow-up|2|||
170804962|NCT05025384|617294789|FG000|Overall Study|Physician Decision|5|||
170804963|NCT05025384|617294790|FG001|Overall Study|Physician Decision|6|||
170804964|NCT03997474|617294791|FG000|Overall Study|Death|6|||
170804965|NCT03997474|617294792|FG001|Overall Study|Death|2|||
170804966|NCT03997474|617294793|FG002|Overall Study|Death|1|||
170804967|NCT03997474|617294791|FG000|Overall Study|Physician Decision|2|||
170804968|NCT03997474|617294792|FG001|Overall Study|Physician Decision|0|||
170804969|NCT03997474|617294793|FG002|Overall Study|Physician Decision|0|||
170804970|NCT03997474|617294791|FG000|Overall Study|study terminated by sponsor|1|||
170804971|NCT03997474|617294792|FG001|Overall Study|study terminated by sponsor|0|||
170804972|NCT03997474|617294793|FG002|Overall Study|study terminated by sponsor|1|||
170804973|NCT04511702|617295975|FG000|Overall Study|Lost to Follow-up|3|||
170804974|NCT04511702|617295976|FG001|Overall Study|Lost to Follow-up|0|||
170804975|NCT04511702|617295977|FG002|Overall Study|Lost to Follow-up|4|||
170804976|NCT04511702|617295975|FG000|Overall Study|Withdrawal by Subject|17|||
170804977|NCT04511702|617295976|FG001|Overall Study|Withdrawal by Subject|1|||
170804978|NCT04511702|617295977|FG002|Overall Study|Withdrawal by Subject|8|||
170804979|NCT03070392|617295978|FG000|Overall Study|Not Treated|7|||
170804980|NCT03070392|617295979|FG001|Overall Study|Not Treated|0|||
170804981|NCT03070392|617295980|FG002|Overall Study|Not Treated|3|||
170804982|NCT03070392|617295981|FG003|Overall Study|Not Treated|12|||
170804983|NCT03070392|617295978|FG000|Overall Study|Death|3|||
170804984|NCT03070392|617295979|FG001|Overall Study|Death|0|||
170804985|NCT03070392|617295980|FG002|Overall Study|Death|0|||
170804986|NCT03070392|617295981|FG003|Overall Study|Death|1|||
170804987|NCT03070392|617295978|FG000|Overall Study|Withdrawal by Subject|7|||
170804988|NCT03070392|617295979|FG001|Overall Study|Withdrawal by Subject|0|||
170804989|NCT03070392|617295980|FG002|Overall Study|Withdrawal by Subject|0|||
170804990|NCT03070392|617295981|FG003|Overall Study|Withdrawal by Subject|3|||
170804991|NCT03070392|617295978|FG000|Overall Study|Physician Decision|1|||
170804992|NCT03070392|617295979|FG001|Overall Study|Physician Decision|0|||
170804993|NCT03070392|617295980|FG002|Overall Study|Physician Decision|0|||
170804994|NCT03070392|617295981|FG003|Overall Study|Physician Decision|2|||
170804995|NCT03070392|617295978|FG000|Overall Study|Progressive Disease|154|||
170804996|NCT03070392|617295979|FG001|Overall Study|Progressive Disease|6|||
170804997|NCT03070392|617295980|FG002|Overall Study|Progressive Disease|2|||
170804998|NCT03070392|617295981|FG003|Overall Study|Progressive Disease|70|||
170804999|NCT03070392|617295978|FG000|Overall Study|Adverse Event|6|||
170805000|NCT03070392|617295979|FG001|Overall Study|Adverse Event|1|||
170805001|NCT03070392|617295980|FG002|Overall Study|Adverse Event|1|||
170805002|NCT03070392|617295981|FG003|Overall Study|Adverse Event|3|||
170805003|NCT03070392|617295978|FG000|Overall Study|Alternate anticancer treatment|1|||
170805004|NCT03070392|617295979|FG001|Overall Study|Alternate anticancer treatment|0|||
170805005|NCT03070392|617295980|FG002|Overall Study|Alternate anticancer treatment|0|||
170805006|NCT03070392|617295981|FG003|Overall Study|Alternate anticancer treatment|1|||
170805007|NCT03070392|617295978|FG000|Overall Study|Ongoing|73|||
170805008|NCT03070392|617295979|FG001|Overall Study|Ongoing|0|||
170805009|NCT03070392|617295980|FG002|Overall Study|Ongoing|0|||
170805010|NCT03070392|617295981|FG003|Overall Study|Ongoing|11|||
170805011|NCT00378898|617295982|FG000|Overall Study|Withdrawal by Subject|10|||
170805012|NCT00378898|617295983|FG001|Overall Study|Withdrawal by Subject|5|||
170805013|NCT00378898|617295982|FG000|Overall Study|Protocol Violation|1|||
170805014|NCT00378898|617295983|FG001|Overall Study|Protocol Violation|1|||
170805015|NCT00551421|617295984|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
170805016|NCT03136159|617295985|FG000|Overall Study|chorioamnionitis|2|||
170805017|NCT03136159|617295986|FG001|Overall Study|chorioamnionitis|0|||
170805018|NCT03136159|617295985|FG000|Overall Study|vertical skin incision|1|||
170805019|NCT03136159|617295986|FG001|Overall Study|vertical skin incision|0|||
170500614|NCT00381043|616173177|FG000|Overall Study|Withdrawal by Subject|3|||
170903613|NCT00503399|617649170|FG001|Overall Study|Withdrawal by Subject|2|||
170903614|NCT00503399|617649169|FG000|Overall Study|Adverse Event|0|||
170500615|NCT00381043|616173178|FG001|Overall Study|Withdrawal by Subject|1|||
170500616|NCT00381043|616173177|FG000|Overall Study|wanted more care|0|||
170500617|NCT00381043|616173178|FG001|Overall Study|wanted more care|1|||
170500618|NCT00381043|616173177|FG000|Overall Study|incarcerated|1|||
170500619|NCT00381043|616173178|FG001|Overall Study|incarcerated|0|||
170500620|NCT02880865|616173181|FG000|Overall Study|Adverse Event|1|||
170500621|NCT02880865|616173182|FG001|Overall Study|Adverse Event|0|||
170500622|NCT02880865|616173181|FG000|Overall Study|Withdrawal by Subject|0|||
170500623|NCT02880865|616173182|FG001|Overall Study|Withdrawal by Subject|2|||
170500624|NCT02880865|616173181|FG000|Overall Study|Physician Decision|0|||
170500625|NCT02880865|616173182|FG001|Overall Study|Physician Decision|1|||
170500626|NCT03045276|616173183|FG000|Intervention Phase|Withdrawal by Subject|7|||
170500627|NCT03045276|616173184|FG001|Intervention Phase|Withdrawal by Subject|2|||
170500628|NCT03045276|616173185|FG002|Intervention Phase|Withdrawal by Subject|3|||
170500629|NCT03045276|616173186|FG003|Intervention Phase|Withdrawal by Subject|7|||
170500630|NCT03045276|616173183|FG000|Intervention Phase|Developed exclusionary criteria|3|||
170500631|NCT03045276|616173184|FG001|Intervention Phase|Developed exclusionary criteria|3|||
170500632|NCT03045276|616173185|FG002|Intervention Phase|Developed exclusionary criteria|0|||
170500633|NCT03045276|616173186|FG003|Intervention Phase|Developed exclusionary criteria|0|||
170500634|NCT03045276|616173183|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
170500635|NCT03045276|616173184|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
170903615|NCT00503399|617649170|FG001|Overall Study|Adverse Event|3|||
170903616|NCT00503399|617649169|FG000|Overall Study|Lost to Follow-up|0|||
170903617|NCT00503399|617649170|FG001|Overall Study|Lost to Follow-up|2|||
170903618|NCT01676961|617649171|FG000|Overall Study|Death|3|||
170903619|NCT01676961|617649171|FG000|Overall Study|Lost to Follow-up|1|||
170903620|NCT01676961|617649171|FG000|Overall Study|Withdrawal by Subject|1|||
170903621|NCT04348851|617649174|FG000|Post-Test 1|Withdrawal by Subject|0|||
170903622|NCT04348851|617649175|FG001|Post-Test 1|Withdrawal by Subject|1|||
170903623|NCT04348851|617649176|FG002|Post-Test 1|Withdrawal by Subject|0|||
170903624|NCT04348851|617649177|FG003|Post-Test 1|Withdrawal by Subject|0|||
170903625|NCT04348851|617649174|FG000|Post-Test 1|Lost to Follow-up|0|||
170903626|NCT04348851|617649175|FG001|Post-Test 1|Lost to Follow-up|1|||
170903627|NCT04348851|617649176|FG002|Post-Test 1|Lost to Follow-up|0|||
170903628|NCT04348851|617649177|FG003|Post-Test 1|Lost to Follow-up|0|||
170903629|NCT04348851|617649174|FG000|Post-Test 2|Stroke survivor death|0|||
170903630|NCT04348851|617649175|FG001|Post-Test 2|Stroke survivor death|1|||
170903631|NCT04348851|617649176|FG002|Post-Test 2|Stroke survivor death|0|||
170903632|NCT04348851|617649177|FG003|Post-Test 2|Stroke survivor death|1|||
170903633|NCT04052139|617649179|FG000|Overall Study|Lost to Follow-up|2|||
170903634|NCT04052139|617649180|FG001|Overall Study|Lost to Follow-up|0|||
170903635|NCT04052139|617649181|FG002|Overall Study|Lost to Follow-up|0|||
170500636|NCT03045276|616173185|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
170500637|NCT03045276|616173186|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
170500638|NCT03045276|616173183|FG000|Follow-Up Phase|Lost to Follow-up|0|||
170500639|NCT03045276|616173184|FG001|Follow-Up Phase|Lost to Follow-up|1|||
170805020|NCT03136159|617295985|FG000|Overall Study|additional dressing|1|||
170805021|NCT03136159|617295986|FG001|Overall Study|additional dressing|0|||
170805022|NCT03136159|617295985|FG000|Overall Study|never got dressing placed|1|||
170805023|NCT03136159|617295986|FG001|Overall Study|never got dressing placed|0|||
170805024|NCT02372799|617295989|FG000|Treatment Period|Adverse Event|3|||
170805025|NCT02372799|617295990|FG001|Treatment Period|Adverse Event|10|||
170805026|NCT02372799|617295991|FG002|Treatment Period|Adverse Event|6|||
170805027|NCT02372799|617295989|FG000|Treatment Period|Insufficient therapeutic response|2|||
170500640|NCT03045276|616173185|FG002|Follow-Up Phase|Lost to Follow-up|0|||
170500641|NCT03045276|616173186|FG003|Follow-Up Phase|Lost to Follow-up|1|||
170551736|NCT01248468|616364842|FG002|Overall Study|Pregnancy|0|||
170551737|NCT01248468|616364840|FG000|Overall Study|Withdrawal by Subject|4|||
170551738|NCT01248468|616364841|FG001|Overall Study|Withdrawal by Subject|2|||
170551739|NCT01248468|616364842|FG002|Overall Study|Withdrawal by Subject|0|||
170551740|NCT02191397|616364843|FG000|Overall Study|Adverse Event|28|||
170551741|NCT02191397|616364844|FG001|Overall Study|Adverse Event|17|||
170551742|NCT02191397|616364843|FG000|Overall Study|Lack of Efficacy|10|||
170805028|NCT02372799|617295990|FG001|Treatment Period|Insufficient therapeutic response|2|||
170805029|NCT02372799|617295991|FG002|Treatment Period|Insufficient therapeutic response|0|||
170903636|NCT04052139|617649179|FG000|Overall Study|Withdrawal by Subject|1|||
170903637|NCT04052139|617649180|FG001|Overall Study|Withdrawal by Subject|0|||
170903638|NCT04052139|617649181|FG002|Overall Study|Withdrawal by Subject|0|||
170500642|NCT03045276|616173183|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
170500643|NCT03045276|616173184|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
170500644|NCT03045276|616173185|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
170500645|NCT03045276|616173186|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
170500646|NCT03379753|616173187|FG000|Overall Study|Withdrawal by Subject|2|||
170500647|NCT03379753|616173188|FG001|Overall Study|Withdrawal by Subject|1|||
170500648|NCT03379753|616173187|FG000|Overall Study|not having correct procedure|1|||
170500649|NCT03379753|616173188|FG001|Overall Study|not having correct procedure|2|||
170500650|NCT03379753|616173187|FG000|Overall Study|No primary outcome|12|||
170500651|NCT03379753|616173188|FG001|Overall Study|No primary outcome|22|||
170500652|NCT04017832|616173191|FG000|Overall Study|Withdrawal by Subject|13|||
170500653|NCT04017832|616173192|FG001|Overall Study|Withdrawal by Subject|12|||
170500654|NCT04017832|616173193|FG002|Overall Study|Withdrawal by Subject|21|||
170500655|NCT04017832|616173194|FG003|Overall Study|Withdrawal by Subject|7|||
170500656|NCT04017832|616173191|FG000|Overall Study|Lost to Follow-up|0|||
170500657|NCT04017832|616173192|FG001|Overall Study|Lost to Follow-up|3|||
170500658|NCT04017832|616173193|FG002|Overall Study|Lost to Follow-up|3|||
170500659|NCT04017832|616173194|FG003|Overall Study|Lost to Follow-up|1|||
170500660|NCT04017832|616173191|FG000|Overall Study|Physician Decision|1|||
170500661|NCT04017832|616173192|FG001|Overall Study|Physician Decision|1|||
170500662|NCT04017832|616173193|FG002|Overall Study|Physician Decision|1|||
170500663|NCT04017832|616173194|FG003|Overall Study|Physician Decision|1|||
170500664|NCT04017832|616173191|FG000|Overall Study|Death|2|||
170500665|NCT04017832|616173192|FG001|Overall Study|Death|2|||
170500666|NCT04017832|616173193|FG002|Overall Study|Death|1|||
170500667|NCT04017832|616173194|FG003|Overall Study|Death|0|||
170500668|NCT05513703|616173196|FG000|Overall Study|Death|4|||
170500669|NCT05513703|616173196|FG000|Overall Study|Study terminated by sponsor|5|||
170500670|NCT04450407|616173204|FG000|Overall Study|Withdrawal by Subject|10|||
170500671|NCT04450407|616173205|FG001|Overall Study|Withdrawal by Subject|1|||
170500672|NCT04450407|616173206|FG002|Overall Study|Withdrawal by Subject|4|||
170500673|NCT04450407|616173204|FG000|Overall Study|Adverse Event|0|||
170500674|NCT04450407|616173205|FG001|Overall Study|Adverse Event|0|||
170500675|NCT04450407|616173206|FG002|Overall Study|Adverse Event|1|||
170500676|NCT04450407|616173204|FG000|Overall Study|Lost to Follow-up|1|||
170500677|NCT04450407|616173205|FG001|Overall Study|Lost to Follow-up|0|||
170500678|NCT04450407|616173206|FG002|Overall Study|Lost to Follow-up|0|||
170500679|NCT04450407|616173204|FG000|Overall Study|Physician Decision|0|||
170500680|NCT04450407|616173205|FG001|Overall Study|Physician Decision|0|||
170500681|NCT04450407|616173206|FG002|Overall Study|Physician Decision|1|||
170500682|NCT04450407|616173204|FG000|Overall Study|Pregnancy|1|||
170500683|NCT04450407|616173205|FG001|Overall Study|Pregnancy|0|||
170500684|NCT04450407|616173206|FG002|Overall Study|Pregnancy|0|||
170500685|NCT04450407|616173204|FG000|Overall Study|Protocol Violation|2|||
170500686|NCT04450407|616173205|FG001|Overall Study|Protocol Violation|0|||
170500687|NCT04450407|616173206|FG002|Overall Study|Protocol Violation|0|||
170500688|NCT04450407|616173204|FG000|Overall Study|Investigational site terminated by sponsor|3|||
170500689|NCT04450407|616173205|FG001|Overall Study|Investigational site terminated by sponsor|0|||
170500690|NCT04450407|616173206|FG002|Overall Study|Investigational site terminated by sponsor|2|||
170500691|NCT01744184|616173207|FG000|Overall Study|Adverse Event|1|||
170500692|NCT01744184|616173208|FG001|Overall Study|Adverse Event|0|||
170500693|NCT01744184|616173207|FG000|Overall Study|Withdrawal by Subject|0|||
170500694|NCT01744184|616173208|FG001|Overall Study|Withdrawal by Subject|1|||
170500695|NCT00125242|616173209|FG000|Overall Study|did not qualify|7|||
170500696|NCT00125242|616173210|FG001|Overall Study|did not qualify|2|||
170500697|NCT01664949|616173211|FG000|Overall Study|Adverse Event|11|||
170500698|NCT01664949|616173212|FG001|Overall Study|Adverse Event|12|||
170500699|NCT01664949|616173211|FG000|Overall Study|Lack of Efficacy|1|||
170500700|NCT01664949|616173212|FG001|Overall Study|Lack of Efficacy|1|||
170500701|NCT01664949|616173211|FG000|Overall Study|Lost to Follow-up|1|||
170500702|NCT01664949|616173212|FG001|Overall Study|Lost to Follow-up|2|||
170500703|NCT01664949|616173211|FG000|Overall Study|Personal Reasons|3|||
170500704|NCT01664949|616173212|FG001|Overall Study|Personal Reasons|4|||
170500705|NCT01664949|616173211|FG000|Overall Study|Protocol Violation|5|||
170500706|NCT01664949|616173212|FG001|Overall Study|Protocol Violation|5|||
170500707|NCT01664949|616173211|FG000|Overall Study|Other Miscellaneous Reasons|3|||
170500708|NCT01664949|616173212|FG001|Overall Study|Other Miscellaneous Reasons|1|||
170500709|NCT04696354|616173215|FG000|Overall Study|Study termination|6|||
170500710|NCT04696354|616173216|FG001|Overall Study|Study termination|6|||
170500711|NCT00833482|616173218|FG000|Days 11-20|Adverse Event|0|||
170500712|NCT00833482|616173219|FG001|Days 11-20|Adverse Event|2|||
170500713|NCT00833482|616173220|FG002|Days 11-20|Adverse Event|0|||
170500714|NCT00833482|616173221|FG003|Days 11-20|Adverse Event|0|||
170500715|NCT00833482|616173222|FG004|Days 11-20|Adverse Event|0|||
170551743|NCT02191397|616364844|FG001|Overall Study|Lack of Efficacy|5|||
170551744|NCT02191397|616364843|FG000|Overall Study|Protocol Violation|0|||
170500716|NCT00833482|616173223|FG005|Days 11-20|Adverse Event|0|||
170500717|NCT00833482|616173218|FG000|Days 11-20|Withdrawal by Subject|0|||
170500718|NCT00833482|616173219|FG001|Days 11-20|Withdrawal by Subject|1|||
170500719|NCT00833482|616173220|FG002|Days 11-20|Withdrawal by Subject|0|||
170500720|NCT00833482|616173221|FG003|Days 11-20|Withdrawal by Subject|0|||
170500721|NCT00833482|616173222|FG004|Days 11-20|Withdrawal by Subject|0|||
170500722|NCT00833482|616173223|FG005|Days 11-20|Withdrawal by Subject|0|||
170500723|NCT00833482|616173218|FG000|Days 21-30|Adverse Event|0|||
170500724|NCT00833482|616173219|FG001|Days 21-30|Adverse Event|0|||
170500725|NCT00833482|616173220|FG002|Days 21-30|Adverse Event|1|||
170500726|NCT00833482|616173221|FG003|Days 21-30|Adverse Event|0|||
170500727|NCT00833482|616173222|FG004|Days 21-30|Adverse Event|0|||
170500728|NCT00833482|616173223|FG005|Days 21-30|Adverse Event|0|||
170500729|NCT00833482|616173218|FG000|Days 21-30|Withdrawal by Subject|0|||
170500730|NCT00833482|616173219|FG001|Days 21-30|Withdrawal by Subject|0|||
170805030|NCT02372799|617295989|FG000|Treatment Period|Withdrawal by Subject|10|||
170805031|NCT02372799|617295990|FG001|Treatment Period|Withdrawal by Subject|10|||
170805032|NCT02372799|617295991|FG002|Treatment Period|Withdrawal by Subject|2|||
170805033|NCT02372799|617295989|FG000|Treatment Period|Lost to Follow-up|11|||
170805034|NCT02372799|617295990|FG001|Treatment Period|Lost to Follow-up|5|||
170805035|NCT02372799|617295991|FG002|Treatment Period|Lost to Follow-up|3|||
170805036|NCT02372799|617295989|FG000|Treatment Period|Protocol Violation|3|||
170805037|NCT02372799|617295990|FG001|Treatment Period|Protocol Violation|0|||
170805038|NCT02372799|617295991|FG002|Treatment Period|Protocol Violation|0|||
170805039|NCT02372799|617295989|FG000|Treatment Period|Non-compliance with study drug|4|||
170805040|NCT02372799|617295990|FG001|Treatment Period|Non-compliance with study drug|4|||
170500731|NCT00833482|616173220|FG002|Days 21-30|Withdrawal by Subject|0|||
170500732|NCT00833482|616173221|FG003|Days 21-30|Withdrawal by Subject|0|||
170500733|NCT00833482|616173222|FG004|Days 21-30|Withdrawal by Subject|1|||
170500734|NCT00833482|616173223|FG005|Days 21-30|Withdrawal by Subject|0|||
170500735|NCT02496091|616173224|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
170500736|NCT00533702|616173225|FG000|Overall Study|Withdrawal by Subject|3|||
170500737|NCT00533702|616173226|FG001|Overall Study|Withdrawal by Subject|1|||
170500738|NCT00533702|616173225|FG000|Overall Study|Found ineligible after randomization|2|||
170500739|NCT00533702|616173226|FG001|Overall Study|Found ineligible after randomization|1|||
170500740|NCT04464720|616173227|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
170500741|NCT05723328|616173228|FG000|Overall Study|Investigator's Decision|5|||
170500742|NCT05723328|616173229|FG001|Overall Study|Investigator's Decision|2|||
170500743|NCT01794793|616173231|FG000|Treatment Period|Withdrawal by Subject|24|||
170805041|NCT02372799|617295991|FG002|Treatment Period|Non-compliance with study drug|4|||
170805042|NCT02372799|617295989|FG000|Treatment Period|Miscellaneous Reasons|1|||
170805043|NCT02372799|617295990|FG001|Treatment Period|Miscellaneous Reasons|1|||
170805044|NCT02372799|617295991|FG002|Treatment Period|Miscellaneous Reasons|0|||
170805045|NCT02372799|617295989|FG000|Down-taper Period|Lost to Follow-up|1|||
170805046|NCT02372799|617295990|FG001|Down-taper Period|Lost to Follow-up|2|||
170805047|NCT02372799|617295991|FG002|Down-taper Period|Lost to Follow-up|2|||
170805048|NCT00089609|617295992|FG000|Overall Study|Withdrawal by Subject|3|||
170805049|NCT00089609|617295993|FG001|Overall Study|Withdrawal by Subject|1|||
170805050|NCT01779700|617295997|FG000|Overall Study|Adverse Event|4|||
170805051|NCT01779700|617295998|FG001|Overall Study|Adverse Event|3|||
170805052|NCT01779700|617295997|FG000|Overall Study|Withdrawal by Subject|0|||
170500744|NCT01794793|616173231|FG000|Treatment Period|Lack of Efficacy|22|||
170500745|NCT01794793|616173231|FG000|Treatment Period|Adverse Event|17|||
170500746|NCT01794793|616173231|FG000|Treatment Period|Physician Decision|14|||
170500747|NCT01794793|616173231|FG000|Treatment Period|Lost to Follow-up|7|||
170805053|NCT01779700|617295998|FG001|Overall Study|Withdrawal by Subject|2|||
170805054|NCT03865732|617295999|FG000|Overall Study|Adverse Event|0|||
170805055|NCT03865732|617296000|FG001|Overall Study|Adverse Event|1|||
170805056|NCT00503906|617296001|FG000|Overall Study|Withdrawal by Subject|1|||
170805057|NCT03041233|617296002|FG000|Overall Study|Death|5|||
170805058|NCT03041233|617296002|FG000|Overall Study|Physician Decision|1|||
170805059|NCT03041233|617296002|FG000|Overall Study|Lost to Follow-up|16|||
170805060|NCT03041233|617296002|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
170805061|NCT03041233|617296002|FG000|Overall Study|Sponsor Request|1|||
170805062|NCT03041233|617296002|FG000|Overall Study|Duplicate subject|1|||
170805063|NCT03041233|617296002|FG000|Overall Study|Re-ablation|1|||
170805064|NCT03229408|617296008|FG000|Overall Study|Withdrawal by Subject|4|||
170805065|NCT03229408|617296009|FG001|Overall Study|Withdrawal by Subject|1|||
170805066|NCT03229408|617296008|FG000|Overall Study|Adverse Event|2|||
170805067|NCT03229408|617296009|FG001|Overall Study|Adverse Event|0|||
170805068|NCT03229408|617296008|FG000|Overall Study|Pregnancy|0|||
170805069|NCT03229408|617296009|FG001|Overall Study|Pregnancy|1|||
170805070|NCT03229408|617296008|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
170805071|NCT03229408|617296009|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
170805072|NCT01367236|617296011|FG000|Overall Study|Withdrawal by Subject|3|||
170805073|NCT01367236|617296012|FG001|Overall Study|Withdrawal by Subject|1|||
170500748|NCT01794793|616173231|FG000|Treatment Period|Death|6|||
170500749|NCT01794793|616173231|FG000|Treatment Period|Protocol Violation|5|||
170500750|NCT01794793|616173231|FG000|Treatment Period|administrative problem|3|||
170500751|NCT01794793|616173231|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
170500752|NCT01794793|616173231|FG000|Post-treatment Follow-up|Adverse Event|8|||
170500753|NCT01794793|616173231|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
170500754|NCT01794793|616173231|FG000|Post-treatment Follow-up|administrative problem|5|||
170500755|NCT01794793|616173231|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
170500756|NCT01794793|616173231|FG000|Post-treatment Follow-up|Protocol Violation|3|||
170500757|NCT03617770|616173232|FG000|Overall Study|Lost to Follow-up|1|||
170500758|NCT03617770|616173233|FG001|Overall Study|Lost to Follow-up|0|||
170500759|NCT02234596|616173234|FG000|Overall Study|Participant not treated|2|||
170500760|NCT04852679|616173239|FG000|Main Intervention Period|Withdrawal by Subject|3|||
170500761|NCT04852679|616173239|FG000|Main Intervention Period|Adverse Event|1|||
170500762|NCT04852679|616173239|FG000|Main Intervention Period|Progressive Disease|16|||
170500763|NCT04852679|616173239|FG000|Main Intervention Period|Refused study visit|1|||
170500764|NCT04852679|616173239|FG000|Independent Injection Period|Missed study visit|1|||
170500765|NCT05897827|616174796|FG000|Overall Study|Lost to Follow-up|33|||
170500766|NCT05897827|616174797|FG001|Overall Study|Lost to Follow-up|14|||
170500767|NCT05897827|616174796|FG000|Overall Study|Withdrawal by Subject|1|||
170500768|NCT05897827|616174797|FG001|Overall Study|Withdrawal by Subject|1|||
170500769|NCT05741346|616174801|FG000|Overall Study|Withdrawn due to termination of study|28|||
170500770|NCT04542499|616174805|FG000|Overall Study|Adverse Event|23|||
170500771|NCT04542499|616174806|FG001|Overall Study|Adverse Event|43|||
170500772|NCT04542499|616174805|FG000|Overall Study|Lack of Efficacy|5|||
170500773|NCT04542499|616174806|FG001|Overall Study|Lack of Efficacy|2|||
170500774|NCT04542499|616174805|FG000|Overall Study|Lost to Follow-up|3|||
170500775|NCT04542499|616174806|FG001|Overall Study|Lost to Follow-up|4|||
170500776|NCT04542499|616174805|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
170500777|NCT04542499|616174806|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
170500778|NCT04542499|616174805|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
170500779|NCT04542499|616174806|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
170500780|NCT04542499|616174805|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170500781|NCT04542499|616174806|FG001|Overall Study|Non-Compliance with Study Drug|2|||
170500782|NCT04542499|616174805|FG000|Overall Study|Physician Decision|0|||
170500783|NCT04542499|616174806|FG001|Overall Study|Physician Decision|1|||
170500784|NCT04542499|616174805|FG000|Overall Study|Site Terminated by Sponsor|3|||
170500785|NCT04542499|616174806|FG001|Overall Study|Site Terminated by Sponsor|5|||
170500786|NCT04542499|616174805|FG000|Overall Study|Withdrawal by Subject|12|||
170500787|NCT04542499|616174806|FG001|Overall Study|Withdrawal by Subject|33|||
170500788|NCT04542499|616174805|FG000|Overall Study|Other|2|||
170500789|NCT04542499|616174806|FG001|Overall Study|Other|2|||
170500790|NCT04488497|616174807|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
170500791|NCT04488497|616174808|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
170500792|NCT04488497|616174807|FG000|Intervention|Physician Decision|2|||
170500793|NCT04488497|616174808|FG001|Intervention|Physician Decision|1|||
170500794|NCT04488497|616174807|FG000|Intervention|Withdrawal by Subject|5|||
170500795|NCT04488497|616174808|FG001|Intervention|Withdrawal by Subject|6|||
170500796|NCT04488497|616174807|FG000|Intervention|Lost to Follow-up|2|||
170500797|NCT04488497|616174808|FG001|Intervention|Lost to Follow-up|0|||
170500798|NCT04488497|616174807|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
170500799|NCT04488497|616174808|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
170500800|NCT04488497|616174807|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
170500801|NCT04488497|616174808|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
170500802|NCT01573767|616174815|FG000|Overall Study|Adverse Event|0|||
170500803|NCT01573767|616174816|FG001|Overall Study|Adverse Event|1|||
170500804|NCT01573767|616174817|FG002|Overall Study|Adverse Event|0|||
170500805|NCT01573767|616174818|FG003|Overall Study|Adverse Event|1|||
170500806|NCT01573767|616174815|FG000|Overall Study|Lack of Efficacy|18|||
170500807|NCT01573767|616174816|FG001|Overall Study|Lack of Efficacy|15|||
170805074|NCT02628626|617296023|FG000|Overall Study|Withdrawal by Subject|2|||
170805075|NCT02628626|617296024|FG001|Overall Study|Withdrawal by Subject|2|||
170805076|NCT01593020|617296025|FG000|Overall Study|Adverse Event|1|||
170805077|NCT01593020|617296026|FG001|Overall Study|Adverse Event|1|||
170805078|NCT01593020|617296025|FG000|Overall Study|Death|0|||
170805079|NCT01593020|617296026|FG001|Overall Study|Death|1|||
170805080|NCT01593020|617296025|FG000|Overall Study|Ineligible|1|||
170500808|NCT01573767|616174817|FG002|Overall Study|Lack of Efficacy|12|||
170500809|NCT01573767|616174818|FG003|Overall Study|Lack of Efficacy|17|||
170500810|NCT01573767|616174815|FG000|Overall Study|Protocol Violation|3|||
170500811|NCT01573767|616174816|FG001|Overall Study|Protocol Violation|1|||
170500812|NCT01573767|616174817|FG002|Overall Study|Protocol Violation|1|||
170500813|NCT01573767|616174818|FG003|Overall Study|Protocol Violation|3|||
170500814|NCT01573767|616174815|FG000|Overall Study|Lost to Follow-up|0|||
170500815|NCT01573767|616174816|FG001|Overall Study|Lost to Follow-up|1|||
170500816|NCT01573767|616174817|FG002|Overall Study|Lost to Follow-up|1|||
170500817|NCT01573767|616174818|FG003|Overall Study|Lost to Follow-up|1|||
170500818|NCT01573767|616174815|FG000|Overall Study|Physician Decision|1|||
170805081|NCT01593020|617296026|FG001|Overall Study|Ineligible|0|||
170805082|NCT02454959|617296027|FG000|Overall Study|Protocol-Specified Criteria|3|||
170805083|NCT02454959|617296027|FG000|Overall Study|Physician Decision|1|||
170805084|NCT02454959|617296027|FG000|Overall Study|Withdrawal by Subject|3|||
170805085|NCT02454959|617296027|FG000|Overall Study|Adverse Event|2|||
170805086|NCT03102034|617296031|FG000|Overall Study|Withdrawal by Subject|1|||
170805087|NCT03102034|617296032|FG001|Overall Study|Withdrawal by Subject|0|||
170500819|NCT01573767|616174816|FG001|Overall Study|Physician Decision|2|||
170500820|NCT01573767|616174817|FG002|Overall Study|Physician Decision|0|||
170500821|NCT01573767|616174818|FG003|Overall Study|Physician Decision|2|||
170500822|NCT01573767|616174815|FG000|Overall Study|Withdrawal by Subject|0|||
170500823|NCT01573767|616174816|FG001|Overall Study|Withdrawal by Subject|1|||
170500824|NCT01573767|616174817|FG002|Overall Study|Withdrawal by Subject|0|||
170500825|NCT01573767|616174818|FG003|Overall Study|Withdrawal by Subject|0|||
170500826|NCT02339155|616174819|FG000|Overall Study|Adverse Event|0|||
170500827|NCT02339155|616174820|FG001|Overall Study|Adverse Event|6|||
170500828|NCT02339155|616174819|FG000|Overall Study|Death|1|||
170500829|NCT02339155|616174820|FG001|Overall Study|Death|1|||
170500830|NCT02339155|616174819|FG000|Overall Study|Lost to Follow-up|8|||
170500831|NCT02339155|616174820|FG001|Overall Study|Lost to Follow-up|9|||
170500832|NCT02339155|616174819|FG000|Overall Study|Physician Decision|2|||
170500833|NCT02339155|616174820|FG001|Overall Study|Physician Decision|1|||
170500834|NCT02339155|616174819|FG000|Overall Study|Withdrawal by Subject|4|||
170500835|NCT02339155|616174820|FG001|Overall Study|Withdrawal by Subject|4|||
170500836|NCT01911780|616174836|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
170500837|NCT01911780|616174837|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
170500838|NCT01911780|616174836|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
170500839|NCT01911780|616174837|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
170500840|NCT01911780|616174836|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
170500841|NCT01911780|616174837|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
170500842|NCT01911780|616174836|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
170500843|NCT01911780|616174837|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
170500844|NCT01911780|616174836|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
170500845|NCT01911780|616174837|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
170500846|NCT01911780|616174836|FG000|Extension Period (52 Weeks)|Personal reason|1|||
170500847|NCT01911780|616174837|FG001|Extension Period (52 Weeks)|Personal reason|1|||
170500848|NCT04247880|616174838|FG000|Overall Study|Lost to Follow-up|24|||
170500849|NCT04247880|616174839|FG001|Overall Study|Lost to Follow-up|17|||
170500850|NCT04247880|616174838|FG000|Overall Study|Withdrawal by Subject|3|||
170500851|NCT04247880|616174839|FG001|Overall Study|Withdrawal by Subject|0|||
170500852|NCT02677896|616174850|FG000|Double Blind Period (up to 35 Months)|Death|117|||
170500853|NCT02677896|616174851|FG001|Double Blind Period (up to 35 Months)|Death|197|||
170500854|NCT02677896|616174850|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
170500855|NCT02677896|616174851|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
170500856|NCT02677896|616174850|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
170500857|NCT02677896|616174851|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
170500858|NCT02677896|616174850|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
170500859|NCT02677896|616174851|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
170500860|NCT02677896|616174850|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
170500861|NCT02677896|616174851|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
170500862|NCT02677896|616174850|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
170500863|NCT02677896|616174851|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
170500864|NCT02677896|616174850|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
170500865|NCT02677896|616174851|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
170500866|NCT02677896|616174850|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
170500867|NCT02677896|616174851|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
170805088|NCT00676091|617296034|FG000|Infant Series|Parent or legal guardian request|10|||
170805089|NCT00676091|617296035|FG001|Infant Series|Parent or legal guardian request|8|||
170805090|NCT00676091|617296034|FG000|Infant Series|Protocol Violation|6|||
170805091|NCT00676091|617296035|FG001|Infant Series|Protocol Violation|3|||
170805092|NCT00676091|617296034|FG000|Infant Series|Adverse Event|2|||
170805093|NCT00676091|617296035|FG001|Infant Series|Adverse Event|3|||
170805094|NCT00676091|617296034|FG000|Infant Series|Failed to return|1|||
170805095|NCT00676091|617296035|FG001|Infant Series|Failed to return|3|||
170805096|NCT00676091|617296034|FG000|Infant Series|Lost to Follow-up|1|||
170805097|NCT00676091|617296035|FG001|Infant Series|Lost to Follow-up|0|||
170805098|NCT00676091|617296034|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
170805099|NCT00676091|617296035|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
170805100|NCT00676091|617296034|FG000|After Infant Series|Adverse Event|0|||
170805101|NCT00676091|617296035|FG001|After Infant Series|Adverse Event|1|||
170500868|NCT02677896|616174850|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
170500869|NCT02677896|616174851|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
170551745|NCT02191397|616364844|FG001|Overall Study|Protocol Violation|3|||
170805102|NCT00676091|617296034|FG000|After Infant Series|Protocol Violation|0|||
170500870|NCT02677896|616174850|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
170500871|NCT02677896|616174851|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
170500872|NCT02677896|616174850|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
170500873|NCT02677896|616174851|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
170500874|NCT02677896|616174850|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
170500875|NCT02677896|616174851|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
170500876|NCT02677896|616174850|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
170500877|NCT02677896|616174851|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
170500878|NCT02677896|616174850|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
170500879|NCT02677896|616174851|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
170500880|NCT03687372|616174854|FG000|Overall Study|Lost to Follow-up|12|||
170500881|NCT03687372|616174855|FG001|Overall Study|Lost to Follow-up|21|||
170500882|NCT03687372|616174854|FG000|Overall Study|Withdrawal by Subject|4|||
170500883|NCT03687372|616174855|FG001|Overall Study|Withdrawal by Subject|17|||
170500884|NCT03687372|616174854|FG000|Overall Study|Investigator Decision|1|||
170500885|NCT03687372|616174855|FG001|Overall Study|Investigator Decision|1|||
170500886|NCT00108485|616174858|FG000|Overall Study|Withdrawal by Subject|3|||
170500887|NCT00108485|616174859|FG001|Overall Study|Withdrawal by Subject|0|||
170500888|NCT00108485|616174858|FG000|Overall Study|Lost to Follow-up|0|||
170500889|NCT00108485|616174859|FG001|Overall Study|Lost to Follow-up|2|||
170500890|NCT00878969|616174862|FG000|Overall Study|Physician Decision|5|||
170500891|NCT00878969|616174863|FG001|Overall Study|Physician Decision|3|||
170500892|NCT00878969|616174864|FG002|Overall Study|Physician Decision|2|||
170500893|NCT00878969|616174862|FG000|Overall Study|Withdrawal by Subject|1|||
170500894|NCT00878969|616174863|FG001|Overall Study|Withdrawal by Subject|6|||
170500895|NCT00878969|616174864|FG002|Overall Study|Withdrawal by Subject|3|||
170500896|NCT00878969|616174862|FG000|Overall Study|kidney transplant|2|||
170500897|NCT00878969|616174863|FG001|Overall Study|kidney transplant|3|||
170500898|NCT00878969|616174864|FG002|Overall Study|kidney transplant|2|||
170500899|NCT00878969|616174862|FG000|Overall Study|Adverse Event|3|||
170500900|NCT00878969|616174863|FG001|Overall Study|Adverse Event|1|||
170642479|NCT01403948|616705268|FG001|Overall Study|Progressive disease|2|||
170805103|NCT00676091|617296035|FG001|After Infant Series|Protocol Violation|1|||
170805104|NCT00676091|617296034|FG000|After Infant Series|Failed to return|1|||
170500901|NCT00878969|616174864|FG002|Overall Study|Adverse Event|2|||
170500902|NCT00878969|616174862|FG000|Overall Study|Lost to Follow-up|2|||
170500903|NCT00878969|616174863|FG001|Overall Study|Lost to Follow-up|1|||
170500904|NCT00878969|616174864|FG002|Overall Study|Lost to Follow-up|0|||
170500905|NCT00878969|616174862|FG000|Overall Study|Protocol Violation|2|||
170500906|NCT00878969|616174863|FG001|Overall Study|Protocol Violation|0|||
170500907|NCT00878969|616174864|FG002|Overall Study|Protocol Violation|0|||
170500908|NCT00878969|616174862|FG000|Overall Study|Death|0|||
170500909|NCT00878969|616174863|FG001|Overall Study|Death|0|||
170500910|NCT00878969|616174864|FG002|Overall Study|Death|2|||
170500911|NCT00878969|616174862|FG000|Overall Study|Pregnancy|0|||
170500912|NCT00878969|616174863|FG001|Overall Study|Pregnancy|1|||
170500913|NCT00878969|616174864|FG002|Overall Study|Pregnancy|0|||
170500914|NCT00278148|616174867|FG000|Phase II - Expansion Phase|Disease progression|0|||
170500915|NCT00278148|616174868|FG001|Phase II - Expansion Phase|Disease progression|0|||
170500916|NCT00278148|616174869|FG002|Phase II - Expansion Phase|Disease progression|4|||
170500917|NCT00278148|616174867|FG000|Phase II - Expansion Phase|Adverse Event|0|||
170500918|NCT00278148|616174868|FG001|Phase II - Expansion Phase|Adverse Event|0|||
170500919|NCT00278148|616174869|FG002|Phase II - Expansion Phase|Adverse Event|2|||
170500920|NCT01088243|616174870|FG000|Overall Study|Adverse Event|1|||
170500921|NCT01088243|616174871|FG001|Overall Study|Adverse Event|0|||
170500922|NCT02370667|616174878|FG000|Overall Study|Lost to Follow-up|0|||
170500923|NCT02370667|616174879|FG001|Overall Study|Lost to Follow-up|1|||
170500924|NCT02370667|616174880|FG002|Overall Study|Lost to Follow-up|0|||
170500925|NCT02954653|616174881|FG000|Overall Study|Death|3|||
170500926|NCT02954653|616174882|FG001|Overall Study|Death|1|||
170500927|NCT02954653|616174883|FG002|Overall Study|Death|0|||
170500928|NCT02954653|616174884|FG003|Overall Study|Death|0|||
170500929|NCT02954653|616174885|FG004|Overall Study|Death|0|||
170500930|NCT02954653|616174886|FG005|Overall Study|Death|0|||
170500931|NCT02954653|616174887|FG006|Overall Study|Death|0|||
170500932|NCT02954653|616174888|FG007|Overall Study|Death|0|||
170500933|NCT02954653|616174889|FG008|Overall Study|Death|0|||
170500934|NCT02954653|616174881|FG000|Overall Study|Randomized but did not receive treatment|1|||
170500935|NCT02954653|616174882|FG001|Overall Study|Randomized but did not receive treatment|0|||
170500936|NCT02954653|616174883|FG002|Overall Study|Randomized but did not receive treatment|0|||
170500937|NCT02954653|616174884|FG003|Overall Study|Randomized but did not receive treatment|0|||
170500938|NCT02954653|616174885|FG004|Overall Study|Randomized but did not receive treatment|0|||
170500939|NCT02954653|616174886|FG005|Overall Study|Randomized but did not receive treatment|0|||
170500940|NCT02954653|616174887|FG006|Overall Study|Randomized but did not receive treatment|0|||
170500941|NCT02954653|616174888|FG007|Overall Study|Randomized but did not receive treatment|0|||
170500942|NCT02954653|616174889|FG008|Overall Study|Randomized but did not receive treatment|0|||
170500943|NCT02954653|616174881|FG000|Overall Study|Started another anti-cancer therapy|0|||
170500944|NCT02954653|616174882|FG001|Overall Study|Started another anti-cancer therapy|1|||
170500945|NCT02954653|616174883|FG002|Overall Study|Started another anti-cancer therapy|0|||
170500946|NCT02954653|616174884|FG003|Overall Study|Started another anti-cancer therapy|0|||
170500947|NCT02954653|616174885|FG004|Overall Study|Started another anti-cancer therapy|0|||
170500948|NCT02954653|616174886|FG005|Overall Study|Started another anti-cancer therapy|0|||
170500949|NCT02954653|616174887|FG006|Overall Study|Started another anti-cancer therapy|0|||
170500950|NCT02954653|616174888|FG007|Overall Study|Started another anti-cancer therapy|0|||
170500951|NCT02954653|616174889|FG008|Overall Study|Started another anti-cancer therapy|0|||
170500952|NCT02954653|616174881|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
170500953|NCT02954653|616174882|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
170500954|NCT02954653|616174883|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
170500955|NCT02954653|616174884|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
170500956|NCT02954653|616174885|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
170500957|NCT02954653|616174886|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
170500958|NCT02954653|616174887|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
170500959|NCT02954653|616174888|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
170500960|NCT02954653|616174889|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
170500961|NCT03054064|616174890|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
170500962|NCT03054064|616174890|FG000|Overall Study|Investigator Decision|2|||
170500963|NCT03054064|616174890|FG000|Overall Study|Bladder Issue|1|||
170500964|NCT03054064|616174890|FG000|Overall Study|High Blood Pressure|1|||
170500965|NCT03054064|616174890|FG000|Overall Study|Change in Status|1|||
170500966|NCT04329091|616174894|FG000|Overall Study|Physician Decision|5|||
170500967|NCT00423189|616174897|FG000|Overall Study|Death|0|||
170500968|NCT00423189|616174898|FG001|Overall Study|Death|1|||
170500969|NCT00423189|616174899|FG002|Overall Study|Death|0|||
170500970|NCT03787303|616174900|FG000|Overall Study|Death|1|||
170500971|NCT03787303|616174900|FG000|Overall Study|Premature Termination of Study|1|||
170500972|NCT01527487|616174901|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
170500973|NCT01527487|616174902|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
170500974|NCT01527487|616174901|FG000|Overall Study|Disease Progression|4|||
170500975|NCT01527487|616174902|FG001|Overall Study|Disease Progression|1|||
170500976|NCT01527487|616174901|FG000|Overall Study|Adverse Event|1|||
170500977|NCT01527487|616174902|FG001|Overall Study|Adverse Event|1|||
170500978|NCT01527487|616174901|FG000|Overall Study|Death|0|||
170500979|NCT01527487|616174902|FG001|Overall Study|Death|1|||
170500980|NCT01384019|616174907|FG000|Overall Study|Withdrawal by Subject|3|||
170500981|NCT01384019|616174908|FG001|Overall Study|Withdrawal by Subject|0|||
170500982|NCT01384019|616174907|FG000|Overall Study|Death|1|||
170500983|NCT01384019|616174908|FG001|Overall Study|Death|0|||
170500984|NCT01384019|616174907|FG000|Overall Study|MRI refusal|6|||
170500985|NCT01384019|616174908|FG001|Overall Study|MRI refusal|6|||
170500986|NCT01892085|616174909|FG000|Overall Study|Death|4|||
170500987|NCT01892085|616174910|FG001|Overall Study|Death|1|||
170500988|NCT01892085|616174911|FG002|Overall Study|Death|3|||
170500989|NCT01892085|616174909|FG000|Overall Study|Withdrawal by Subject|2|||
170500990|NCT01892085|616174910|FG001|Overall Study|Withdrawal by Subject|0|||
170500991|NCT01892085|616174911|FG002|Overall Study|Withdrawal by Subject|2|||
170500992|NCT04416737|616174913|FG000|Week 1 (First Injection)|Physician Decision|0|||
170500993|NCT04416737|616174914|FG001|Week 1 (First Injection)|Physician Decision|1|||
170500994|NCT03332628|616174915|FG000|Overall Study|Physician Decision|2|||
170500995|NCT04489381|616174925|FG000|Overall Study|Lost to Follow-up|2|||
170551746|NCT02191397|616364843|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
170551747|NCT02191397|616364844|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
170551748|NCT02191397|616364843|FG000|Overall Study|Lost to Follow-up|10|||
170551749|NCT02191397|616364844|FG001|Overall Study|Lost to Follow-up|11|||
170551750|NCT02191397|616364843|FG000|Overall Study|Physician Decision|8|||
170551751|NCT02191397|616364844|FG001|Overall Study|Physician Decision|3|||
170551752|NCT02191397|616364843|FG000|Overall Study|Withdrawal by Subject|22|||
170551753|NCT02191397|616364844|FG001|Overall Study|Withdrawal by Subject|27|||
170551754|NCT00455455|616364846|FG000|Washout|Withdrawal by Subject|0|||
170500996|NCT04489381|616174926|FG001|Overall Study|Lost to Follow-up|3|||
170500997|NCT04489381|616174925|FG000|Overall Study|Withdrawal by Subject|1|||
170500998|NCT04489381|616174926|FG001|Overall Study|Withdrawal by Subject|0|||
170551755|NCT00455455|616364847|FG001|Washout|Withdrawal by Subject|1|||
170551756|NCT00455455|616364846|FG000|Washout|Withdrawal by Subject|1|||
170551757|NCT00455455|616364847|FG001|Washout|Withdrawal by Subject|0|||
170500999|NCT03199612|616174927|FG000|Overall Study|Adverse Event|1|||
170501000|NCT03199612|616174928|FG001|Overall Study|Adverse Event|0|||
170501001|NCT01500213|616174934|FG000|Overall Study|Adverse Event|35|||
170501002|NCT01500213|616174935|FG001|Overall Study|Adverse Event|35|||
170501003|NCT01500213|616174934|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
170501004|NCT01500213|616174935|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
170501005|NCT01500213|616174934|FG000|Overall Study|Withdrawal by Subject|28|||
170501006|NCT01500213|616174935|FG001|Overall Study|Withdrawal by Subject|37|||
170501007|NCT01500213|616174934|FG000|Overall Study|Death|7|||
170501008|NCT01500213|616174935|FG001|Overall Study|Death|3|||
170501009|NCT01500213|616174934|FG000|Overall Study|Disease Progression|13|||
170501010|NCT01500213|616174935|FG001|Overall Study|Disease Progression|21|||
170501011|NCT01500213|616174934|FG000|Overall Study|Protocol Violation|19|||
170501012|NCT01500213|616174935|FG001|Overall Study|Protocol Violation|19|||
170501013|NCT01500213|616174934|FG000|Overall Study|Physician Decision|12|||
170501014|NCT01500213|616174935|FG001|Overall Study|Physician Decision|10|||
170501015|NCT01500213|616174934|FG000|Overall Study|Lack of Efficacy|9|||
170501016|NCT01500213|616174935|FG001|Overall Study|Lack of Efficacy|7|||
170501017|NCT01500213|616174934|FG000|Overall Study|Lost to Follow-up|3|||
170501018|NCT01500213|616174935|FG001|Overall Study|Lost to Follow-up|6|||
170501019|NCT01500213|616174934|FG000|Overall Study|Other Reasons|7|||
170501020|NCT01500213|616174935|FG001|Overall Study|Other Reasons|5|||
170501021|NCT04027075|616174936|FG000|Overall Study|Lost to Follow-up|41|||
170501022|NCT04027075|616174937|FG001|Overall Study|Lost to Follow-up|22|||
170501023|NCT00455520|616174939|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
170501024|NCT00455520|616174940|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
170501025|NCT00455520|616174939|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
170501026|NCT00455520|616174940|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
170501027|NCT00455520|616174939|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
170501028|NCT00455520|616174940|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
170501029|NCT00455520|616174939|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
170501030|NCT00455520|616174940|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
170501031|NCT00455520|616174939|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
170501032|NCT00455520|616174940|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
170501033|NCT00455520|616174939|FG000|Open Label Tapentadol Extended Release|All other|33|||
170501034|NCT00455520|616174940|FG001|Open Label Tapentadol Extended Release|All other|0|||
170501035|NCT00455520|616174939|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
170501036|NCT00455520|616174940|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
170501037|NCT00455520|616174939|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
170501038|NCT00455520|616174940|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
170501039|NCT00455520|616174939|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
170501040|NCT00455520|616174940|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
170501041|NCT00455520|616174939|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
170551758|NCT01370538|616364848|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
170551759|NCT01370538|616364849|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
170551760|NCT01370538|616364848|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170551761|NCT01370538|616364849|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170551762|NCT01370538|616364848|FG000|Overall Study|Adverse Event|1|||
170551763|NCT01370538|616364849|FG001|Overall Study|Adverse Event|0|||
170551764|NCT01370538|616364848|FG000|Overall Study|Protocol Violation|8|||
170551765|NCT01370538|616364849|FG001|Overall Study|Protocol Violation|5|||
170551766|NCT01370538|616364848|FG000|Overall Study|Development of study specific withdrawal|1|||
170551767|NCT01370538|616364849|FG001|Overall Study|Development of study specific withdrawal|1|||
170551768|NCT01370538|616364848|FG000|Overall Study|Lost to follow up|6|||
170551769|NCT01370538|616364849|FG001|Overall Study|Lost to follow up|10|||
170551770|NCT00478140|616364850|FG000|Overall Study|Clinical Disease Progression|1|||
170551771|NCT04223687|616364852|FG000|Overall Study|Missing primary outcome|1|||
170551772|NCT04223687|616364853|FG001|Overall Study|Missing primary outcome|0|||
170551773|NCT02945046|616364854|FG000|Overall Study|Adverse Event|1|||
170551774|NCT02945046|616364855|FG001|Overall Study|Adverse Event|0|||
170551775|NCT02945046|616364856|FG002|Overall Study|Adverse Event|2|||
170551776|NCT02945046|616364854|FG000|Overall Study|Withdrawal by Subject|3|||
170551777|NCT02945046|616364855|FG001|Overall Study|Withdrawal by Subject|3|||
170551778|NCT02945046|616364856|FG002|Overall Study|Withdrawal by Subject|3|||
170551779|NCT02945046|616364854|FG000|Overall Study|Protocol Violation|2|||
170551780|NCT02945046|616364855|FG001|Overall Study|Protocol Violation|3|||
170551781|NCT02945046|616364856|FG002|Overall Study|Protocol Violation|2|||
170551782|NCT02945046|616364854|FG000|Overall Study|Lost to Follow-up|1|||
170551783|NCT02945046|616364855|FG001|Overall Study|Lost to Follow-up|1|||
170551784|NCT02945046|616364856|FG002|Overall Study|Lost to Follow-up|0|||
170551785|NCT02945046|616364854|FG000|Overall Study|Lack of Efficacy|1|||
170551786|NCT02945046|616364855|FG001|Overall Study|Lack of Efficacy|2|||
170805105|NCT00676091|617296035|FG001|After Infant Series|Failed to return|1|||
170501042|NCT00455520|616174940|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
170501043|NCT00455520|616174939|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
170501044|NCT00455520|616174940|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
170501045|NCT00455520|616174939|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
170551787|NCT02945046|616364856|FG002|Overall Study|Lack of Efficacy|1|||
170805106|NCT00676091|617296034|FG000|Toddler Dose|Failed to return|2|||
170501046|NCT00455520|616174940|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
170551788|NCT02945046|616364854|FG000|Overall Study|Other than specified|5|||
170501047|NCT00033657|616174942|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
170501048|NCT00033657|616174943|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
170501049|NCT00033657|616174942|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
170501050|NCT00033657|616174943|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
170501051|NCT00033657|616174942|FG000|Neoadjuvant Chemotherapy|Death|1|||
170501052|NCT00033657|616174943|FG001|Neoadjuvant Chemotherapy|Death|1|||
170501053|NCT00033657|616174942|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
170501054|NCT00033657|616174943|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
170501055|NCT00033657|616174942|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
170501056|NCT00033657|616174943|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
170501057|NCT00033657|616174942|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
170501058|NCT00033657|616174943|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
170501059|NCT00033657|616174942|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
170501060|NCT00033657|616174943|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
170501061|NCT00033657|616174942|FG000|Surgical Resection|not complete resection|0|||
170501062|NCT00033657|616174943|FG001|Surgical Resection|not complete resection|3|||
170501063|NCT00033657|616174942|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
170501064|NCT00033657|616174943|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
170501065|NCT00033657|616174942|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
170501066|NCT00033657|616174943|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
170501067|NCT00033657|616174942|FG000|Adjuvant Chemotherapy|Death|2|||
170501068|NCT00033657|616174943|FG001|Adjuvant Chemotherapy|Death|1|||
170501069|NCT00033657|616174942|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
170501070|NCT00033657|616174943|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
170501071|NCT00033657|616174942|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
170501072|NCT00033657|616174943|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
170551789|NCT02945046|616364855|FG001|Overall Study|Other than specified|4|||
170551790|NCT02945046|616364856|FG002|Overall Study|Other than specified|7|||
170551791|NCT05661734|616364860|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
170551792|NCT05661734|616364860|FG000|Overall Study|Lost to Follow-up|13|||
170551793|NCT05661734|616364860|FG000|Overall Study|Enrolled but not dosed|2|||
170551794|NCT03443401|616366375|FG000|Overall Study|Lost to Follow-up|13|||
170551795|NCT03443401|616366375|FG000|Overall Study|Influential outlier|1|||
170551796|NCT02363283|616366376|FG000|Overall Study|Withdrawal by Subject|1|||
170551797|NCT02363283|616366376|FG000|Overall Study|Not eligible due to transaminitis|1|||
170551798|NCT01313676|616366382|FG000|Overall Study|Adverse Event|395|||
170551799|NCT01313676|616366383|FG001|Overall Study|Adverse Event|365|||
170551800|NCT01313676|616366384|FG002|Overall Study|Adverse Event|372|||
170551801|NCT01313676|616366385|FG003|Overall Study|Adverse Event|333|||
170501073|NCT00033657|616174942|FG000|Adjuvant Chemotherapy|Other|0|||
170501074|NCT00033657|616174943|FG001|Adjuvant Chemotherapy|Other|2|||
170501075|NCT03448939|616174945|FG000|Overall Study|Adverse Event|5|||
170501076|NCT03448939|616174946|FG001|Overall Study|Adverse Event|1|||
170551802|NCT01313676|616366382|FG000|Overall Study|Lack of Efficacy|98|||
170551803|NCT01313676|616366383|FG001|Overall Study|Lack of Efficacy|90|||
170551804|NCT01313676|616366384|FG002|Overall Study|Lack of Efficacy|65|||
170501077|NCT03448939|616174945|FG000|Overall Study|Lost to Follow-up|6|||
170501078|NCT03448939|616174946|FG001|Overall Study|Lost to Follow-up|6|||
170501079|NCT03448939|616174945|FG000|Overall Study|Pregnancy|1|||
170501080|NCT03448939|616174946|FG001|Overall Study|Pregnancy|1|||
170501081|NCT03448939|616174945|FG000|Overall Study|Withdrawal by Subject|9|||
170501082|NCT03448939|616174946|FG001|Overall Study|Withdrawal by Subject|3|||
170501083|NCT00986986|616174947|FG000|Overall Study|Lost to Follow-up|0|||
170501084|NCT00986986|616174948|FG001|Overall Study|Lost to Follow-up|1|||
170501085|NCT03235115|616174949|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
170501086|NCT03235115|616174950|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
170501087|NCT03235115|616174951|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
170501088|NCT03235115|616174952|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
170501089|NCT03235115|616174953|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
170501090|NCT03235115|616174954|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
170501091|NCT00503997|616174957|FG000|Overall Study|disease progression|1|||
170501092|NCT00503997|616174957|FG000|Overall Study|Adverse Event|5|||
170501093|NCT00503997|616174957|FG000|Overall Study|Death|1|||
170501094|NCT00503997|616174957|FG000|Overall Study|Withdrawal by Subject|1|||
170501095|NCT00581542|616174958|FG000|Overall Study|they met an exclusion criteria|2|||
170501096|NCT00581542|616174959|FG001|Overall Study|they met an exclusion criteria|2|||
170501097|NCT00581542|616174958|FG000|Overall Study|Lost to Follow-up|9|||
170501098|NCT00581542|616174959|FG001|Overall Study|Lost to Follow-up|21|||
170501099|NCT05020366|616174960|FG000|Overall Study|Lost to Follow-up|2|||
170501100|NCT05020366|616174961|FG001|Overall Study|Lost to Follow-up|0|||
170501101|NCT05020366|616174960|FG000|Overall Study|Withdrawal by Subject|2|||
170501102|NCT05020366|616174961|FG001|Overall Study|Withdrawal by Subject|0|||
170501103|NCT00195494|616174965|FG000|Year 1|Adverse Event|0|||
170501104|NCT00195494|616174966|FG001|Year 1|Adverse Event|0|||
170501105|NCT00195494|616174967|FG002|Year 1|Adverse Event|0|||
170501106|NCT00195494|616174968|FG003|Year 1|Adverse Event|0|||
170501107|NCT00195494|616174969|FG004|Year 1|Adverse Event|34|||
170501108|NCT00195494|616174970|FG005|Year 1|Adverse Event|27|||
170501109|NCT00195494|616174965|FG000|Year 1|System Toxicity|0|||
170501110|NCT00195494|616174966|FG001|Year 1|System Toxicity|0|||
170501111|NCT00195494|616174967|FG002|Year 1|System Toxicity|0|||
170501112|NCT00195494|616174968|FG003|Year 1|System Toxicity|0|||
170501113|NCT00195494|616174969|FG004|Year 1|System Toxicity|0|||
170903639|NCT00707577|617649182|FG000|Overall Study|Withdrawal by Subject|3|||
170903640|NCT00707577|617649183|FG001|Overall Study|Withdrawal by Subject|2|||
170501114|NCT00195494|616174970|FG005|Year 1|System Toxicity|1|||
170501115|NCT00195494|616174965|FG000|Year 1|Lack of Efficacy|0|||
170501116|NCT00195494|616174966|FG001|Year 1|Lack of Efficacy|0|||
170501117|NCT00195494|616174967|FG002|Year 1|Lack of Efficacy|0|||
170501118|NCT00195494|616174968|FG003|Year 1|Lack of Efficacy|0|||
170501119|NCT00195494|616174969|FG004|Year 1|Lack of Efficacy|24|||
170501120|NCT00195494|616174970|FG005|Year 1|Lack of Efficacy|9|||
170501121|NCT00195494|616174965|FG000|Year 1|Compliance|0|||
170501122|NCT00195494|616174966|FG001|Year 1|Compliance|0|||
170501123|NCT00195494|616174967|FG002|Year 1|Compliance|0|||
170501124|NCT00195494|616174968|FG003|Year 1|Compliance|0|||
170501125|NCT00195494|616174969|FG004|Year 1|Compliance|5|||
170501126|NCT00195494|616174970|FG005|Year 1|Compliance|1|||
170501127|NCT00195494|616174965|FG000|Year 1|Lost to Follow-up|0|||
170501128|NCT00195494|616174966|FG001|Year 1|Lost to Follow-up|0|||
170501129|NCT00195494|616174967|FG002|Year 1|Lost to Follow-up|0|||
170501130|NCT00195494|616174968|FG003|Year 1|Lost to Follow-up|0|||
170501131|NCT00195494|616174969|FG004|Year 1|Lost to Follow-up|1|||
170501132|NCT00195494|616174970|FG005|Year 1|Lost to Follow-up|0|||
170501133|NCT00195494|616174965|FG000|Year 1|Missed >4 consecutive doses|0|||
170501134|NCT00195494|616174966|FG001|Year 1|Missed >4 consecutive doses|0|||
170501135|NCT00195494|616174967|FG002|Year 1|Missed >4 consecutive doses|0|||
170501136|NCT00195494|616174968|FG003|Year 1|Missed >4 consecutive doses|0|||
170501137|NCT00195494|616174969|FG004|Year 1|Missed >4 consecutive doses|3|||
170501138|NCT00195494|616174970|FG005|Year 1|Missed >4 consecutive doses|2|||
170501139|NCT00195494|616174965|FG000|Year 1|Protocol deviation|0|||
170501140|NCT00195494|616174966|FG001|Year 1|Protocol deviation|0|||
170501141|NCT00195494|616174967|FG002|Year 1|Protocol deviation|0|||
170501142|NCT00195494|616174968|FG003|Year 1|Protocol deviation|0|||
170501143|NCT00195494|616174969|FG004|Year 1|Protocol deviation|2|||
170501144|NCT00195494|616174970|FG005|Year 1|Protocol deviation|3|||
170501145|NCT00195494|616174965|FG000|Year 1|Physician Decision|0|||
170501146|NCT00195494|616174966|FG001|Year 1|Physician Decision|0|||
170501147|NCT00195494|616174967|FG002|Year 1|Physician Decision|0|||
170501148|NCT00195494|616174968|FG003|Year 1|Physician Decision|0|||
170903641|NCT00707577|617649182|FG000|Overall Study|Lost to Follow-up|34|||
170501149|NCT00195494|616174969|FG004|Year 1|Physician Decision|1|||
170501150|NCT00195494|616174970|FG005|Year 1|Physician Decision|0|||
170501151|NCT00195494|616174965|FG000|Year 1|Withdrawal by Subject|0|||
170501152|NCT00195494|616174966|FG001|Year 1|Withdrawal by Subject|0|||
170501153|NCT00195494|616174967|FG002|Year 1|Withdrawal by Subject|0|||
170501154|NCT00195494|616174968|FG003|Year 1|Withdrawal by Subject|0|||
170501155|NCT00195494|616174969|FG004|Year 1|Withdrawal by Subject|8|||
170501156|NCT00195494|616174970|FG005|Year 1|Withdrawal by Subject|9|||
170501157|NCT00195494|616174965|FG000|Year 1|Protocol Violation|0|||
170501158|NCT00195494|616174966|FG001|Year 1|Protocol Violation|0|||
170501159|NCT00195494|616174967|FG002|Year 1|Protocol Violation|0|||
170501160|NCT00195494|616174968|FG003|Year 1|Protocol Violation|0|||
170501161|NCT00195494|616174969|FG004|Year 1|Protocol Violation|1|||
170501162|NCT00195494|616174970|FG005|Year 1|Protocol Violation|1|||
170501163|NCT00195494|616174965|FG000|Year 2|Adverse Event|3|||
170501164|NCT00195494|616174966|FG001|Year 2|Adverse Event|7|||
170501165|NCT00195494|616174967|FG002|Year 2|Adverse Event|5|||
170501166|NCT00195494|616174968|FG003|Year 2|Adverse Event|9|||
170501167|NCT00195494|616174969|FG004|Year 2|Adverse Event|0|||
170501168|NCT00195494|616174970|FG005|Year 2|Adverse Event|0|||
170501169|NCT00195494|616174965|FG000|Year 2|Lack of Efficacy|0|||
170501170|NCT00195494|616174966|FG001|Year 2|Lack of Efficacy|1|||
170501171|NCT00195494|616174967|FG002|Year 2|Lack of Efficacy|7|||
170501172|NCT00195494|616174968|FG003|Year 2|Lack of Efficacy|7|||
170501173|NCT00195494|616174969|FG004|Year 2|Lack of Efficacy|0|||
170501174|NCT00195494|616174970|FG005|Year 2|Lack of Efficacy|0|||
170501175|NCT00195494|616174965|FG000|Year 2|Compliance|1|||
170501176|NCT00195494|616174966|FG001|Year 2|Compliance|0|||
170501177|NCT00195494|616174967|FG002|Year 2|Compliance|0|||
170501178|NCT00195494|616174968|FG003|Year 2|Compliance|2|||
170501179|NCT00195494|616174969|FG004|Year 2|Compliance|0|||
170501180|NCT00195494|616174970|FG005|Year 2|Compliance|0|||
170501181|NCT00195494|616174965|FG000|Year 2|Lost to Follow-up|0|||
170501182|NCT00195494|616174966|FG001|Year 2|Lost to Follow-up|0|||
170501183|NCT00195494|616174967|FG002|Year 2|Lost to Follow-up|1|||
170501184|NCT00195494|616174968|FG003|Year 2|Lost to Follow-up|1|||
170501185|NCT00195494|616174969|FG004|Year 2|Lost to Follow-up|0|||
170501186|NCT00195494|616174970|FG005|Year 2|Lost to Follow-up|0|||
170501187|NCT00195494|616174965|FG000|Year 2|Missed >4 consecutive doses|1|||
170501188|NCT00195494|616174966|FG001|Year 2|Missed >4 consecutive doses|1|||
170501189|NCT00195494|616174967|FG002|Year 2|Missed >4 consecutive doses|1|||
170501190|NCT00195494|616174968|FG003|Year 2|Missed >4 consecutive doses|0|||
170501191|NCT00195494|616174969|FG004|Year 2|Missed >4 consecutive doses|0|||
170501192|NCT00195494|616174970|FG005|Year 2|Missed >4 consecutive doses|0|||
170501193|NCT00195494|616174965|FG000|Year 2|Protocol deviation|0|||
170501194|NCT00195494|616174966|FG001|Year 2|Protocol deviation|1|||
170501195|NCT00195494|616174967|FG002|Year 2|Protocol deviation|0|||
170501196|NCT00195494|616174968|FG003|Year 2|Protocol deviation|0|||
170501197|NCT00195494|616174969|FG004|Year 2|Protocol deviation|0|||
170501198|NCT00195494|616174970|FG005|Year 2|Protocol deviation|0|||
170501199|NCT00195494|616174965|FG000|Year 2|Physician Decision|1|||
170501200|NCT00195494|616174966|FG001|Year 2|Physician Decision|1|||
170501201|NCT00195494|616174967|FG002|Year 2|Physician Decision|0|||
170501202|NCT00195494|616174968|FG003|Year 2|Physician Decision|0|||
170501203|NCT00195494|616174969|FG004|Year 2|Physician Decision|0|||
170501204|NCT00195494|616174970|FG005|Year 2|Physician Decision|0|||
170501205|NCT00195494|616174965|FG000|Year 2|Withdrawal by Subject|1|||
170501206|NCT00195494|616174966|FG001|Year 2|Withdrawal by Subject|5|||
170501207|NCT00195494|616174967|FG002|Year 2|Withdrawal by Subject|4|||
170501208|NCT00195494|616174968|FG003|Year 2|Withdrawal by Subject|3|||
170501209|NCT00195494|616174969|FG004|Year 2|Withdrawal by Subject|0|||
170501210|NCT00195494|616174970|FG005|Year 2|Withdrawal by Subject|0|||
170501211|NCT00195494|616174965|FG000|Year 2|System toxicity|0|||
170501212|NCT00195494|616174966|FG001|Year 2|System toxicity|0|||
170501213|NCT00195494|616174967|FG002|Year 2|System toxicity|0|||
170501214|NCT00195494|616174968|FG003|Year 2|System toxicity|1|||
170501215|NCT00195494|616174969|FG004|Year 2|System toxicity|0|||
170551805|NCT01313676|616366385|FG003|Overall Study|Lack of Efficacy|46|||
170551806|NCT01313676|616366382|FG000|Overall Study|Protocol Violation|37|||
170551807|NCT01313676|616366383|FG001|Overall Study|Protocol Violation|44|||
170551808|NCT01313676|616366384|FG002|Overall Study|Protocol Violation|46|||
170551809|NCT01313676|616366385|FG003|Overall Study|Protocol Violation|44|||
170501216|NCT00195494|616174970|FG005|Year 2|System toxicity|0|||
170501217|NCT00549601|616176517|FG000|Randomized|Protocol Violation|0|||
170501218|NCT00549601|616176518|FG001|Randomized|Protocol Violation|0|||
170501219|NCT00549601|616176519|FG002|Randomized|Protocol Violation|1|||
170501220|NCT00549601|616176517|FG000|Randomized|Withdrawal by Subject|0|||
170501221|NCT00549601|616176518|FG001|Randomized|Withdrawal by Subject|1|||
170501222|NCT00549601|616176519|FG002|Randomized|Withdrawal by Subject|1|||
170501223|NCT00549601|616176517|FG000|Received Study Drug|Adverse Event|2|||
170501224|NCT00549601|616176518|FG001|Received Study Drug|Adverse Event|5|||
170501225|NCT00549601|616176519|FG002|Received Study Drug|Adverse Event|1|||
170501226|NCT00549601|616176517|FG000|Received Study Drug|Death|0|||
170501227|NCT00549601|616176518|FG001|Received Study Drug|Death|1|||
170501228|NCT00549601|616176519|FG002|Received Study Drug|Death|0|||
170501229|NCT00549601|616176517|FG000|Received Study Drug|Lost to Follow-up|0|||
170501230|NCT00549601|616176518|FG001|Received Study Drug|Lost to Follow-up|1|||
170501231|NCT00549601|616176519|FG002|Received Study Drug|Lost to Follow-up|1|||
170501232|NCT00549601|616176517|FG000|Received Study Drug|Protocol Violation|3|||
170501233|NCT00549601|616176518|FG001|Received Study Drug|Protocol Violation|4|||
170501234|NCT00549601|616176519|FG002|Received Study Drug|Protocol Violation|1|||
170501235|NCT00549601|616176517|FG000|Received Study Drug|Withdrawal by Subject|2|||
170501236|NCT00549601|616176518|FG001|Received Study Drug|Withdrawal by Subject|0|||
170501237|NCT00549601|616176519|FG002|Received Study Drug|Withdrawal by Subject|1|||
170501238|NCT01556997|616176522|FG000|Overall Study|Adverse Event|10|||
170501239|NCT01556997|616176523|FG001|Overall Study|Adverse Event|12|||
170501240|NCT01556997|616176524|FG002|Overall Study|Adverse Event|12|||
170501241|NCT01556997|616176522|FG000|Overall Study|Lost to Follow-up|6|||
170501242|NCT01556997|616176523|FG001|Overall Study|Lost to Follow-up|6|||
170501243|NCT01556997|616176524|FG002|Overall Study|Lost to Follow-up|4|||
170501244|NCT01556997|616176522|FG000|Overall Study|Physician Decision|1|||
170501245|NCT01556997|616176523|FG001|Overall Study|Physician Decision|1|||
170501246|NCT01556997|616176524|FG002|Overall Study|Physician Decision|1|||
170501247|NCT01556997|616176522|FG000|Overall Study|Withdrawal by Subject|7|||
170501248|NCT01556997|616176523|FG001|Overall Study|Withdrawal by Subject|6|||
170501249|NCT01556997|616176524|FG002|Overall Study|Withdrawal by Subject|8|||
170501250|NCT01556997|616176522|FG000|Overall Study|Other|2|||
170501251|NCT01556997|616176523|FG001|Overall Study|Other|3|||
170501252|NCT01556997|616176524|FG002|Overall Study|Other|7|||
170501253|NCT04480840|616176525|FG000|Overall Study|Adverse Event|2|||
170501254|NCT04480840|616176526|FG001|Overall Study|Adverse Event|1|||
170501255|NCT04480840|616176527|FG002|Overall Study|Adverse Event|1|||
170501256|NCT04480840|616176528|FG003|Overall Study|Adverse Event|1|||
170501257|NCT04480840|616176529|FG004|Overall Study|Adverse Event|1|||
170501258|NCT04480840|616176525|FG000|Overall Study|Withdrawal by Subject|0|||
170501259|NCT04480840|616176526|FG001|Overall Study|Withdrawal by Subject|0|||
170501260|NCT04480840|616176527|FG002|Overall Study|Withdrawal by Subject|0|||
170501261|NCT04480840|616176528|FG003|Overall Study|Withdrawal by Subject|0|||
170501262|NCT04480840|616176529|FG004|Overall Study|Withdrawal by Subject|2|||
170501263|NCT04480840|616176525|FG000|Overall Study|Protocol Violation|0|||
170501264|NCT04480840|616176526|FG001|Overall Study|Protocol Violation|1|||
170501265|NCT04480840|616176527|FG002|Overall Study|Protocol Violation|0|||
170501266|NCT04480840|616176528|FG003|Overall Study|Protocol Violation|0|||
170501267|NCT04480840|616176529|FG004|Overall Study|Protocol Violation|0|||
170501268|NCT04480840|616176525|FG000|Overall Study|illicit drug use|0|||
170501269|NCT04480840|616176526|FG001|Overall Study|illicit drug use|0|||
170501270|NCT04480840|616176527|FG002|Overall Study|illicit drug use|0|||
170501271|NCT04480840|616176528|FG003|Overall Study|illicit drug use|0|||
170501272|NCT04480840|616176529|FG004|Overall Study|illicit drug use|1|||
170501273|NCT03246347|616176530|FG000|Overall Study|On Study|23|||
170501274|NCT03291067|616176531|FG000|Overall Study|Adverse Event|0|||
170501275|NCT03291067|616176532|FG001|Overall Study|Adverse Event|2|||
170501276|NCT03291067|616176533|FG002|Overall Study|Adverse Event|17|||
170501277|NCT03291067|616176534|FG003|Overall Study|Adverse Event|3|||
170501278|NCT03291067|616176531|FG000|Overall Study|Lost to Follow-up|2|||
170501279|NCT03291067|616176532|FG001|Overall Study|Lost to Follow-up|1|||
170501280|NCT03291067|616176533|FG002|Overall Study|Lost to Follow-up|0|||
170501281|NCT03291067|616176534|FG003|Overall Study|Lost to Follow-up|1|||
170501282|NCT03291067|616176531|FG000|Overall Study|Physician Decision|0|||
170501283|NCT03291067|616176532|FG001|Overall Study|Physician Decision|0|||
170501284|NCT03291067|616176533|FG002|Overall Study|Physician Decision|1|||
170501285|NCT03291067|616176534|FG003|Overall Study|Physician Decision|0|||
170501286|NCT03291067|616176531|FG000|Overall Study|Protocol Violation|5|||
170501287|NCT03291067|616176532|FG001|Overall Study|Protocol Violation|3|||
170501288|NCT03291067|616176533|FG002|Overall Study|Protocol Violation|4|||
170501289|NCT03291067|616176534|FG003|Overall Study|Protocol Violation|2|||
170501290|NCT03291067|616176531|FG000|Overall Study|Withdrawal by Subject|3|||
170501291|NCT03291067|616176532|FG001|Overall Study|Withdrawal by Subject|4|||
170501292|NCT03291067|616176533|FG002|Overall Study|Withdrawal by Subject|7|||
170501293|NCT03291067|616176534|FG003|Overall Study|Withdrawal by Subject|5|||
170501294|NCT03291067|616176531|FG000|Overall Study|Other|0|||
170501295|NCT03291067|616176532|FG001|Overall Study|Other|4|||
170805107|NCT00676091|617296035|FG001|Toddler Dose|Failed to return|0|||
170805108|NCT00676091|617296034|FG000|Toddler Dose|Parent or legal guardian request|1|||
170805109|NCT00676091|617296035|FG001|Toddler Dose|Parent or legal guardian request|0|||
170805110|NCT03488719|617296036|FG000|Overall Study|Adverse Event|0|||
170501296|NCT03291067|616176533|FG002|Overall Study|Other|4|||
170805111|NCT03488719|617296037|FG001|Overall Study|Adverse Event|4|||
170501297|NCT03291067|616176534|FG003|Overall Study|Other|6|||
170501298|NCT02255435|616176535|FG000|Overall Study|Patient's Limited Time Availability|0|||
170501299|NCT02255435|616176536|FG001|Overall Study|Patient's Limited Time Availability|0|||
170501300|NCT02255435|616176537|FG002|Overall Study|Patient's Limited Time Availability|0|||
170501301|NCT02255435|616176538|FG003|Overall Study|Patient's Limited Time Availability|0|||
170501302|NCT02255435|616176539|FG004|Overall Study|Patient's Limited Time Availability|0|||
170642480|NCT01403948|616705269|FG002|Overall Study|Progressive disease|2|||
170805112|NCT03488719|617296038|FG002|Overall Study|Adverse Event|2|||
170501303|NCT02255435|616176540|FG005|Overall Study|Patient's Limited Time Availability|0|||
170501304|NCT02255435|616176541|FG006|Overall Study|Patient's Limited Time Availability|0|||
170501305|NCT02255435|616176542|FG007|Overall Study|Patient's Limited Time Availability|1|||
170501306|NCT02255435|616176543|FG008|Overall Study|Patient's Limited Time Availability|0|||
170501307|NCT02255435|616176544|FG009|Overall Study|Patient's Limited Time Availability|0|||
170501308|NCT02255435|616176535|FG000|Overall Study|Withdrawal by Subject|0|||
170501309|NCT02255435|616176536|FG001|Overall Study|Withdrawal by Subject|0|||
170501310|NCT02255435|616176537|FG002|Overall Study|Withdrawal by Subject|0|||
170501311|NCT02255435|616176538|FG003|Overall Study|Withdrawal by Subject|0|||
170501312|NCT02255435|616176539|FG004|Overall Study|Withdrawal by Subject|0|||
170501313|NCT02255435|616176540|FG005|Overall Study|Withdrawal by Subject|0|||
170501314|NCT02255435|616176541|FG006|Overall Study|Withdrawal by Subject|0|||
170501315|NCT02255435|616176542|FG007|Overall Study|Withdrawal by Subject|0|||
170501316|NCT02255435|616176543|FG008|Overall Study|Withdrawal by Subject|1|||
170501317|NCT02255435|616176544|FG009|Overall Study|Withdrawal by Subject|4|||
170501318|NCT02255435|616176535|FG000|Overall Study|Administrative reasons|0|||
170501319|NCT02255435|616176536|FG001|Overall Study|Administrative reasons|0|||
170501320|NCT02255435|616176537|FG002|Overall Study|Administrative reasons|0|||
170501321|NCT02255435|616176538|FG003|Overall Study|Administrative reasons|0|||
170501322|NCT02255435|616176539|FG004|Overall Study|Administrative reasons|0|||
170501323|NCT02255435|616176540|FG005|Overall Study|Administrative reasons|0|||
170501324|NCT02255435|616176541|FG006|Overall Study|Administrative reasons|0|||
170501325|NCT02255435|616176542|FG007|Overall Study|Administrative reasons|0|||
170501326|NCT02255435|616176543|FG008|Overall Study|Administrative reasons|0|||
170501327|NCT02255435|616176544|FG009|Overall Study|Administrative reasons|2|||
170501328|NCT04249596|616176546|FG000|Overall Study|Withdrawal by Subject|5|||
170501329|NCT04249596|616176546|FG000|Overall Study|Lost to Follow-up|3|||
170501330|NCT05459558|616176547|FG000|Overall Study|Adverse Event|1|||
170501331|NCT05459558|616176548|FG001|Overall Study|Adverse Event|0|||
170501332|NCT05459558|616176549|FG002|Overall Study|Adverse Event|0|||
170501333|NCT05459558|616176547|FG000|Overall Study|Scheduling issue|0|||
170501334|NCT05459558|616176548|FG001|Overall Study|Scheduling issue|1|||
170501335|NCT05459558|616176549|FG002|Overall Study|Scheduling issue|3|||
170501336|NCT05459558|616176547|FG000|Overall Study|Withdrawal by Subject|0|||
170501337|NCT05459558|616176548|FG001|Overall Study|Withdrawal by Subject|0|||
170501338|NCT05459558|616176549|FG002|Overall Study|Withdrawal by Subject|2|||
170501339|NCT05091346|616176554|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
170501340|NCT05091346|616176555|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
170501341|NCT05091346|616176556|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
170501342|NCT05091346|616176557|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
170501343|NCT05091346|616176558|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
170501344|NCT05091346|616176554|FG000|Overall Study|Death|6|||
170501345|NCT05091346|616176555|FG001|Overall Study|Death|5|||
170501346|NCT05091346|616176556|FG002|Overall Study|Death|8|||
170805113|NCT03488719|617296036|FG000|Overall Study|Other|0|||
170805114|NCT03488719|617296037|FG001|Overall Study|Other|0|||
170805115|NCT03488719|617296038|FG002|Overall Study|Other|5|||
170805116|NCT03414684|617296046|FG000|First-course Treatment|Complete response|0|||
170805117|NCT03414684|617296047|FG001|First-course Treatment|Complete response|1|||
170805118|NCT03414684|617296046|FG000|First-course Treatment|Intercurrent illness|1|||
170805119|NCT03414684|617296047|FG001|First-course Treatment|Intercurrent illness|0|||
170501347|NCT05091346|616176557|FG003|Overall Study|Death|16|||
170501348|NCT05091346|616176558|FG004|Overall Study|Death|26|||
170501349|NCT05091346|616176554|FG000|Overall Study|Lost to Follow-up|0|||
170805120|NCT03414684|617296046|FG000|First-course Treatment|Progressive Disease|31|||
170805121|NCT03414684|617296047|FG001|First-course Treatment|Progressive Disease|32|||
170805122|NCT03414684|617296046|FG000|First-course Treatment|Adverse Event|1|||
170805123|NCT03414684|617296047|FG001|First-course Treatment|Adverse Event|2|||
170805124|NCT03414684|617296046|FG000|First-course Treatment|Physician Decision|0|||
170805125|NCT03414684|617296047|FG001|First-course Treatment|Physician Decision|1|||
170805126|NCT03414684|617296046|FG000|First-course Treatment|Withdrawal by Subject|0|||
170805127|NCT03414684|617296047|FG001|First-course Treatment|Withdrawal by Subject|1|||
170805128|NCT03414684|617296046|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
170805129|NCT03414684|617296047|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
170805130|NCT03414684|617296046|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
170805131|NCT03414684|617296047|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
170805132|NCT03414684|617296046|FG000|First-course Treatment|Still on treatment|3|||
170805133|NCT03414684|617296047|FG001|First-course Treatment|Still on treatment|0|||
170805134|NCT03414684|617296046|FG000|First-course Treatment|Never started protocol therapy|2|||
170805135|NCT03414684|617296047|FG001|First-course Treatment|Never started protocol therapy|1|||
170805136|NCT03414684|617296046|FG000|Crossover Treatment|Progressive disease|0|||
170805137|NCT03414684|617296047|FG001|Crossover Treatment|Progressive disease|12|||
170805138|NCT03414684|617296046|FG000|Crossover Treatment|Adverse Event|0|||
170805139|NCT03414684|617296047|FG001|Crossover Treatment|Adverse Event|3|||
170805140|NCT03414684|617296046|FG000|Crossover Treatment|Physician Decision|0|||
170501350|NCT05091346|616176555|FG001|Overall Study|Lost to Follow-up|0|||
170501351|NCT05091346|616176556|FG002|Overall Study|Lost to Follow-up|0|||
170501352|NCT05091346|616176557|FG003|Overall Study|Lost to Follow-up|1|||
170501353|NCT05091346|616176558|FG004|Overall Study|Lost to Follow-up|0|||
170805141|NCT03414684|617296047|FG001|Crossover Treatment|Physician Decision|1|||
170805142|NCT03414684|617296046|FG000|Crossover Treatment|Still on treatment|0|||
170805143|NCT03414684|617296047|FG001|Crossover Treatment|Still on treatment|2|||
170805144|NCT04038580|617296048|FG000|Washout 1|Death|0|||
170805145|NCT04038580|617296049|FG001|Washout 1|Death|0|||
170805146|NCT04038580|617296050|FG002|Washout 1|Death|0|||
170805147|NCT04038580|617296051|FG003|Washout 1|Death|1|||
170805148|NCT04038580|617296052|FG004|Washout 1|Death|0|||
170805149|NCT04038580|617296053|FG005|Washout 1|Death|0|||
170805150|NCT04038580|617296048|FG000|Washout 1|Withdrawal by Subject|0|||
170805151|NCT04038580|617296049|FG001|Washout 1|Withdrawal by Subject|0|||
170903642|NCT00707577|617649183|FG001|Overall Study|Lost to Follow-up|25|||
170903643|NCT00707577|617649182|FG000|Overall Study|Left employment|13|||
170903644|NCT00707577|617649183|FG001|Overall Study|Left employment|10|||
170501354|NCT05091346|616176554|FG000|Overall Study|Withdrawal by Subject|0|||
170501355|NCT05091346|616176555|FG001|Overall Study|Withdrawal by Subject|1|||
170501356|NCT05091346|616176556|FG002|Overall Study|Withdrawal by Subject|2|||
170501357|NCT05091346|616176557|FG003|Overall Study|Withdrawal by Subject|2|||
170501358|NCT05091346|616176558|FG004|Overall Study|Withdrawal by Subject|1|||
170501359|NCT04757519|616176565|FG000|Overall Study|Lost to Follow-up|17|||
170501360|NCT04757519|616176566|FG001|Overall Study|Lost to Follow-up|18|||
170501361|NCT06507566|616176567|FG000|Overall Study|Lost to Follow-up|9|||
170501362|NCT06507566|616176568|FG001|Overall Study|Lost to Follow-up|7|||
170501363|NCT06507566|616176567|FG000|Overall Study|Withdrawal by Subject|5|||
170501364|NCT06507566|616176568|FG001|Overall Study|Withdrawal by Subject|2|||
170501365|NCT01668966|616176569|FG000|Overall Study|Withdrawal by Subject|1|||
170501366|NCT01668966|616176569|FG000|Overall Study|Death|1|||
170501367|NCT01668966|616176569|FG000|Overall Study|Not treated|2|||
170501368|NCT01701193|616176577|FG000|Overall Study|Withdrawal by Subject|2|||
170501369|NCT01701193|616176578|FG001|Overall Study|Withdrawal by Subject|2|||
170501370|NCT01701193|616176579|FG002|Overall Study|Withdrawal by Subject|1|||
170501371|NCT01701193|616176580|FG003|Overall Study|Withdrawal by Subject|2|||
170501372|NCT01701193|616176577|FG000|Overall Study|Adverse Event|1|||
170501373|NCT01701193|616176578|FG001|Overall Study|Adverse Event|0|||
170501374|NCT01701193|616176579|FG002|Overall Study|Adverse Event|0|||
170501375|NCT01701193|616176580|FG003|Overall Study|Adverse Event|0|||
170501376|NCT00250458|616176581|FG000|Overall Study|Lost to Follow-up|4|||
170501377|NCT00250458|616176582|FG001|Overall Study|Lost to Follow-up|2|||
170501378|NCT00250458|616176581|FG000|Overall Study|Protocol Violation|0|||
170551810|NCT01313676|616366382|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
170551811|NCT01313676|616366383|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
170551812|NCT01313676|616366384|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
170551813|NCT01313676|616366385|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
170551814|NCT01313676|616366382|FG000|Overall Study|Study Closed/terminated|7|||
170551815|NCT01313676|616366383|FG001|Overall Study|Study Closed/terminated|6|||
170551816|NCT01313676|616366384|FG002|Overall Study|Study Closed/terminated|9|||
170551817|NCT01313676|616366385|FG003|Overall Study|Study Closed/terminated|9|||
170551818|NCT01313676|616366382|FG000|Overall Study|Lost to Follow-up|0|||
170551819|NCT01313676|616366383|FG001|Overall Study|Lost to Follow-up|0|||
170551820|NCT01313676|616366384|FG002|Overall Study|Lost to Follow-up|1|||
170551821|NCT01313676|616366385|FG003|Overall Study|Lost to Follow-up|0|||
170551822|NCT01313676|616366382|FG000|Overall Study|Physician Decision|53|||
170551823|NCT01313676|616366383|FG001|Overall Study|Physician Decision|64|||
170551824|NCT01313676|616366384|FG002|Overall Study|Physician Decision|62|||
170551825|NCT01313676|616366385|FG003|Overall Study|Physician Decision|48|||
170551826|NCT01313676|616366382|FG000|Overall Study|Decision by Participant or Proxy|643|||
170551827|NCT01313676|616366383|FG001|Overall Study|Decision by Participant or Proxy|527|||
170551828|NCT01313676|616366384|FG002|Overall Study|Decision by Participant or Proxy|515|||
170551829|NCT01313676|616366385|FG003|Overall Study|Decision by Participant or Proxy|492|||
170551830|NCT01313676|616366382|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
170551831|NCT01313676|616366383|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
170551832|NCT01313676|616366384|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
170551833|NCT01313676|616366385|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
170551834|NCT01313676|616366382|FG000|Overall Study|Investigator Site Closed|12|||
170551835|NCT01313676|616366383|FG001|Overall Study|Investigator Site Closed|11|||
170805152|NCT04038580|617296050|FG002|Washout 1|Withdrawal by Subject|0|||
170501379|NCT00250458|616176582|FG001|Overall Study|Protocol Violation|1|||
170551836|NCT01313676|616366384|FG002|Overall Study|Investigator Site Closed|15|||
170551837|NCT01313676|616366385|FG003|Overall Study|Investigator Site Closed|10|||
170551838|NCT01313676|616366382|FG000|Overall Study|Missing|1|||
170805153|NCT04038580|617296051|FG003|Washout 1|Withdrawal by Subject|0|||
170805154|NCT04038580|617296052|FG004|Washout 1|Withdrawal by Subject|1|||
170805155|NCT04038580|617296053|FG005|Washout 1|Withdrawal by Subject|0|||
170805156|NCT04038580|617296048|FG000|Wash-out 2|Withdrawal by Subject|1|||
170805157|NCT04038580|617296049|FG001|Wash-out 2|Withdrawal by Subject|0|||
170501380|NCT00250458|616176581|FG000|Overall Study|Withdrawal by Subject|4|||
170501381|NCT00250458|616176582|FG001|Overall Study|Withdrawal by Subject|2|||
170501382|NCT00250458|616176581|FG000|Overall Study|Lack of Migraine Attack|20|||
170501383|NCT00250458|616176582|FG001|Overall Study|Lack of Migraine Attack|9|||
170501384|NCT00250458|616176581|FG000|Overall Study|Qualifying migraine but did not treat|3|||
170501385|NCT00250458|616176582|FG001|Overall Study|Qualifying migraine but did not treat|3|||
170501386|NCT00250458|616176581|FG000|Overall Study|Other|1|||
170501387|NCT00250458|616176582|FG001|Overall Study|Other|0|||
170501388|NCT01472757|616176583|FG000|Overall Study|Withdrawal by Subject|1|||
170501389|NCT01472757|616176584|FG001|Overall Study|Withdrawal by Subject|2|||
170501390|NCT01472757|616176585|FG002|Overall Study|Withdrawal by Subject|2|||
170501391|NCT01472757|616176586|FG003|Overall Study|Withdrawal by Subject|0|||
170501392|NCT01472757|616176583|FG000|Overall Study|Asthma exacerbation|4|||
170501393|NCT01472757|616176584|FG001|Overall Study|Asthma exacerbation|1|||
170501394|NCT01472757|616176585|FG002|Overall Study|Asthma exacerbation|2|||
170501395|NCT01472757|616176586|FG003|Overall Study|Asthma exacerbation|1|||
170501396|NCT01472757|616176583|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
170501397|NCT01472757|616176584|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
170501398|NCT01472757|616176585|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
170501399|NCT01472757|616176586|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
170501400|NCT01472757|616176583|FG000|Overall Study|Protocol Violation|3|||
170501401|NCT01472757|616176584|FG001|Overall Study|Protocol Violation|2|||
170501402|NCT01472757|616176585|FG002|Overall Study|Protocol Violation|4|||
170501403|NCT01472757|616176586|FG003|Overall Study|Protocol Violation|4|||
170501404|NCT01472757|616176583|FG000|Overall Study|Other reasons|1|||
170501405|NCT01472757|616176584|FG001|Overall Study|Other reasons|0|||
170501406|NCT01472757|616176585|FG002|Overall Study|Other reasons|2|||
170501407|NCT01472757|616176586|FG003|Overall Study|Other reasons|2|||
170501408|NCT00597506|616176587|FG000|Overall Study|Subject is being followed for survival|1|||
170501409|NCT01629823|616176591|FG000|Trial Period|Missed visit|11|||
170501410|NCT01629823|616176592|FG001|Trial Period|Missed visit|9|||
170501411|NCT01629823|616176593|FG002|Trial Period|Missed visit|8|||
170501412|NCT01629823|616176591|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
170501413|NCT01629823|616176592|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
170501414|NCT01629823|616176593|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
170501415|NCT01629823|616176591|FG000|Trial Period|Pregnancy|1|||
170501416|NCT01629823|616176592|FG001|Trial Period|Pregnancy|0|||
170501417|NCT01629823|616176593|FG002|Trial Period|Pregnancy|0|||
170501418|NCT01629823|616176591|FG000|Trial Period|Adverse Event|0|||
170501419|NCT01629823|616176592|FG001|Trial Period|Adverse Event|1|||
170501420|NCT01629823|616176593|FG002|Trial Period|Adverse Event|0|||
170501421|NCT01629823|616176591|FG000|Trial Period|Out-of-window visit|0|||
170501422|NCT01629823|616176592|FG001|Trial Period|Out-of-window visit|2|||
170501423|NCT01629823|616176593|FG002|Trial Period|Out-of-window visit|0|||
170501424|NCT01629823|616176591|FG000|Trial Period|Failed to hold medication|0|||
170501425|NCT01629823|616176592|FG001|Trial Period|Failed to hold medication|0|||
170501426|NCT01629823|616176593|FG002|Trial Period|Failed to hold medication|1|||
170501427|NCT01629823|616176591|FG000|Washout Period|Safety|2|||
170501428|NCT01629823|616176592|FG001|Washout Period|Safety|5|||
170501429|NCT01629823|616176593|FG002|Washout Period|Safety|0|||
170501430|NCT01629823|616176591|FG000|Washout Period|Pregnancy|1|||
170501431|NCT01629823|616176592|FG001|Washout Period|Pregnancy|0|||
170501432|NCT01629823|616176593|FG002|Washout Period|Pregnancy|0|||
170501433|NCT01629823|616176591|FG000|Washout Period|Protocol Violation|0|||
170501434|NCT01629823|616176592|FG001|Washout Period|Protocol Violation|1|||
170501435|NCT01629823|616176593|FG002|Washout Period|Protocol Violation|0|||
170501436|NCT02386345|616176594|FG000|Overall Study|Not treated|14|||
170501437|NCT02386345|616176594|FG000|Overall Study|Lost to Follow-up|1|||
170501438|NCT02386345|616176594|FG000|Overall Study|Adverse Event|5|||
170501439|NCT02386345|616176594|FG000|Overall Study|Repeat Procedure|10|||
170501440|NCT02386345|616176594|FG000|Overall Study|Did not complete 12-month follow-up|72|||
170501441|NCT00480493|616176595|FG000|Overall Study|moved|2|||
170501442|NCT00480493|616176596|FG001|Overall Study|moved|7|||
170501443|NCT01043705|616176604|FG000|Overall Study|Death|28|||
170501444|NCT01043705|616176605|FG001|Overall Study|Death|60|||
170501445|NCT01043705|616176606|FG002|Overall Study|Death|26|||
170501446|NCT01043705|616176604|FG000|Overall Study|Lost to Follow-up|27|||
170501447|NCT01043705|616176605|FG001|Overall Study|Lost to Follow-up|12|||
170501448|NCT01043705|616176606|FG002|Overall Study|Lost to Follow-up|0|||
170501449|NCT01043705|616176604|FG000|Overall Study|Multiple Reasons|4|||
170501450|NCT01043705|616176605|FG001|Overall Study|Multiple Reasons|7|||
170501451|NCT01043705|616176606|FG002|Overall Study|Multiple Reasons|0|||
170501452|NCT01043705|616176604|FG000|Overall Study|Protocol Violation|2|||
170501453|NCT01043705|616176605|FG001|Overall Study|Protocol Violation|1|||
170501454|NCT01043705|616176606|FG002|Overall Study|Protocol Violation|0|||
170501455|NCT01043705|616176604|FG000|Overall Study|Withdrawal by Subject|8|||
170501456|NCT01043705|616176605|FG001|Overall Study|Withdrawal by Subject|6|||
170805158|NCT04038580|617296050|FG002|Wash-out 2|Withdrawal by Subject|0|||
170805159|NCT04038580|617296051|FG003|Wash-out 2|Withdrawal by Subject|2|||
170501457|NCT01043705|616176606|FG002|Overall Study|Withdrawal by Subject|0|||
170501458|NCT01043705|616176604|FG000|Overall Study|Site Closure|8|||
170501459|NCT01043705|616176605|FG001|Overall Study|Site Closure|0|||
170501460|NCT01043705|616176606|FG002|Overall Study|Site Closure|0|||
170501461|NCT01043705|616176604|FG000|Overall Study|Subsequent Procedure|9|||
170501462|NCT01043705|616176605|FG001|Overall Study|Subsequent Procedure|24|||
170501463|NCT01043705|616176606|FG002|Overall Study|Subsequent Procedure|29|||
170501464|NCT01043705|616176604|FG000|Overall Study|Adverse Event|0|||
170501465|NCT01043705|616176605|FG001|Overall Study|Adverse Event|2|||
170501466|NCT01043705|616176606|FG002|Overall Study|Adverse Event|0|||
170501467|NCT01043705|616176604|FG000|Overall Study|Screen Fail|21|||
170501468|NCT01043705|616176605|FG001|Overall Study|Screen Fail|0|||
170501469|NCT01043705|616176606|FG002|Overall Study|Screen Fail|0|||
170501470|NCT01043705|616176604|FG000|Overall Study|Other|0|||
170501471|NCT01043705|616176605|FG001|Overall Study|Other|19|||
170501472|NCT01043705|616176606|FG002|Overall Study|Other|25|||
170501473|NCT02945254|616176607|FG000|Overall Study|Lost to Follow-up|1|||
170501474|NCT02945254|616176608|FG001|Overall Study|Lost to Follow-up|0|||
170501475|NCT02945254|616176607|FG000|Overall Study|Withdrawal by Subject|1|||
170501476|NCT02945254|616176608|FG001|Overall Study|Withdrawal by Subject|0|||
170501477|NCT02003963|616176609|FG000|Overall Study|Lost to Follow-up|2|||
170501478|NCT02003963|616176610|FG001|Overall Study|Lost to Follow-up|1|||
170501479|NCT00176644|616176612|FG000|Overall Study|Withdrawal by Subject|1|||
170501480|NCT03973918|616176616|FG000|Overall Study|Adverse Event|0|||
170501481|NCT03973918|616176617|FG001|Overall Study|Adverse Event|0|||
170903645|NCT00707577|617649182|FG000|Overall Study|Pregnancy|4|||
170903646|NCT00707577|617649183|FG001|Overall Study|Pregnancy|1|||
170903647|NCT00190775|617649184|FG000|Overall Study|Adverse Event|57|||
170903648|NCT00190775|617649185|FG001|Overall Study|Adverse Event|22|||
170903649|NCT00190775|617649184|FG000|Overall Study|Satisfactory Response|1|||
170903650|NCT00190775|617649185|FG001|Overall Study|Satisfactory Response|0|||
170903651|NCT00190775|617649184|FG000|Overall Study|Lack of Efficacy|28|||
170903652|NCT00190775|617649185|FG001|Overall Study|Lack of Efficacy|32|||
170903653|NCT00190775|617649184|FG000|Overall Study|Lost to Follow-up|31|||
170903654|NCT00190775|617649185|FG001|Overall Study|Lost to Follow-up|23|||
170903655|NCT00190775|617649184|FG000|Overall Study|Participant Moved|0|||
170903656|NCT00190775|617649185|FG001|Overall Study|Participant Moved|1|||
170903657|NCT00190775|617649184|FG000|Overall Study|Withdrawal by Subject|24|||
170903658|NCT00190775|617649185|FG001|Overall Study|Withdrawal by Subject|13|||
170903659|NCT00190775|617649184|FG000|Overall Study|Sponsor Decision|1|||
170903660|NCT00190775|617649185|FG001|Overall Study|Sponsor Decision|0|||
170903661|NCT00190775|617649184|FG000|Overall Study|Physician Decision|3|||
170903662|NCT00190775|617649185|FG001|Overall Study|Physician Decision|0|||
170903663|NCT00190775|617649184|FG000|Overall Study|Noncompliance|3|||
170903664|NCT00190775|617649185|FG001|Overall Study|Noncompliance|5|||
170903665|NCT00190775|617649184|FG000|Overall Study|Protocol Violation|0|||
170903666|NCT00190775|617649185|FG001|Overall Study|Protocol Violation|1|||
170903667|NCT00190775|617649184|FG000|Overall Study|Exclusion Criteria Met|1|||
170903668|NCT00190775|617649185|FG001|Overall Study|Exclusion Criteria Met|3|||
170903669|NCT01794780|617649186|FG000|Overall Study|Adverse Event|0|||
170903670|NCT01794780|617649187|FG001|Overall Study|Adverse Event|1|||
170903671|NCT01794780|617649188|FG002|Overall Study|Adverse Event|2|||
170903672|NCT01794780|617649189|FG003|Overall Study|Adverse Event|0|||
170903673|NCT01794780|617649190|FG004|Overall Study|Adverse Event|0|||
170903674|NCT01794780|617649191|FG005|Overall Study|Adverse Event|0|||
170903675|NCT01794780|617649192|FG006|Overall Study|Adverse Event|0|||
170903676|NCT01794780|617649193|FG007|Overall Study|Adverse Event|0|||
170903677|NCT01794780|617649186|FG000|Overall Study|Death|0|||
170903678|NCT01794780|617649187|FG001|Overall Study|Death|2|||
170903679|NCT01794780|617649188|FG002|Overall Study|Death|14|||
170903680|NCT01794780|617649189|FG003|Overall Study|Death|1|||
170903681|NCT01794780|617649190|FG004|Overall Study|Death|0|||
170903682|NCT01794780|617649191|FG005|Overall Study|Death|9|||
170903683|NCT01794780|617649192|FG006|Overall Study|Death|4|||
170903684|NCT01794780|617649193|FG007|Overall Study|Death|0|||
170903685|NCT01794780|617649186|FG000|Overall Study|Lost to Follow-up|10|||
170903686|NCT01794780|617649187|FG001|Overall Study|Lost to Follow-up|64|||
170903687|NCT01794780|617649188|FG002|Overall Study|Lost to Follow-up|165|||
170903688|NCT01794780|617649189|FG003|Overall Study|Lost to Follow-up|53|||
170903689|NCT01794780|617649190|FG004|Overall Study|Lost to Follow-up|2|||
170903690|NCT01794780|617649191|FG005|Overall Study|Lost to Follow-up|99|||
170903691|NCT01794780|617649192|FG006|Overall Study|Lost to Follow-up|30|||
170903692|NCT01794780|617649193|FG007|Overall Study|Lost to Follow-up|5|||
170903693|NCT01794780|617649186|FG000|Overall Study|Withdrew informed consent|7|||
170903694|NCT01794780|617649187|FG001|Overall Study|Withdrew informed consent|17|||
170903695|NCT01794780|617649188|FG002|Overall Study|Withdrew informed consent|36|||
170501482|NCT03973918|616176618|FG002|Overall Study|Adverse Event|0|||
170501483|NCT03973918|616176619|FG003|Overall Study|Adverse Event|1|||
170903696|NCT01794780|617649189|FG003|Overall Study|Withdrew informed consent|9|||
170903697|NCT01794780|617649190|FG004|Overall Study|Withdrew informed consent|0|||
170903698|NCT01794780|617649191|FG005|Overall Study|Withdrew informed consent|48|||
170903699|NCT01794780|617649192|FG006|Overall Study|Withdrew informed consent|4|||
170501484|NCT03973918|616176616|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
170903700|NCT01794780|617649193|FG007|Overall Study|Withdrew informed consent|3|||
170501485|NCT03973918|616176617|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
170501486|NCT03973918|616176618|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
170501487|NCT03973918|616176619|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
170501488|NCT00955968|616176634|FG000|Overall Study|Death|2|||
170501489|NCT00955968|616176635|FG001|Overall Study|Death|4|||
170501490|NCT00955968|616176634|FG000|Overall Study|Withdrawal by Subject|35|||
170501491|NCT00955968|616176635|FG001|Overall Study|Withdrawal by Subject|31|||
170501492|NCT00955968|616176634|FG000|Overall Study|Lost to Follow-up|45|||
170501493|NCT00955968|616176635|FG001|Overall Study|Lost to Follow-up|39|||
170501494|NCT00955968|616176634|FG000|Overall Study|Site closed|55|||
170501495|NCT00955968|616176635|FG001|Overall Study|Site closed|52|||
170501496|NCT00347919|616176640|FG000|Overall Study|Lost to Follow-up|11|||
170501497|NCT00347919|616176641|FG001|Overall Study|Lost to Follow-up|13|||
170501498|NCT00347919|616176642|FG002|Overall Study|Lost to Follow-up|0|||
170501499|NCT00347919|616176640|FG000|Overall Study|Withdrawal by Subject|6|||
170501500|NCT00347919|616176641|FG001|Overall Study|Withdrawal by Subject|8|||
170501501|NCT00347919|616176642|FG002|Overall Study|Withdrawal by Subject|0|||
170501502|NCT00347919|616176640|FG000|Overall Study|Physician Decision|1|||
170501503|NCT00347919|616176641|FG001|Overall Study|Physician Decision|1|||
170501504|NCT00347919|616176642|FG002|Overall Study|Physician Decision|0|||
170501505|NCT00347919|616176640|FG000|Overall Study|Sponsor terminated study|15|||
170501506|NCT00347919|616176641|FG001|Overall Study|Sponsor terminated study|10|||
170805160|NCT04038580|617296052|FG004|Wash-out 2|Withdrawal by Subject|0|||
170805161|NCT04038580|617296053|FG005|Wash-out 2|Withdrawal by Subject|1|||
170805162|NCT04038580|617296048|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
170805163|NCT04038580|617296049|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
170805164|NCT04038580|617296050|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
170501507|NCT00347919|616176642|FG002|Overall Study|Sponsor terminated study|16|||
170501508|NCT00347919|616176640|FG000|Overall Study|Death|35|||
170501509|NCT00347919|616176641|FG001|Overall Study|Death|42|||
170501510|NCT00347919|616176642|FG002|Overall Study|Death|19|||
170501511|NCT00347919|616176640|FG000|Overall Study|Par. Started Other Treatment|1|||
170501512|NCT00347919|616176641|FG001|Overall Study|Par. Started Other Treatment|1|||
170501513|NCT00347919|616176642|FG002|Overall Study|Par. Started Other Treatment|1|||
170501514|NCT00347919|616176640|FG000|Overall Study|Missing|2|||
170501515|NCT00347919|616176641|FG001|Overall Study|Missing|1|||
170501516|NCT00347919|616176642|FG002|Overall Study|Missing|2|||
170501517|NCT01190267|616176645|FG000|Overall Study|Adverse Event|10|||
170501518|NCT01190267|616176646|FG001|Overall Study|Adverse Event|0|||
170501519|NCT01190267|616176645|FG000|Overall Study|Treatment Failure|8|||
170501520|NCT01190267|616176646|FG001|Overall Study|Treatment Failure|2|||
170501521|NCT01190267|616176645|FG000|Overall Study|Lost to Follow-up|2|||
170501522|NCT01190267|616176646|FG001|Overall Study|Lost to Follow-up|0|||
170501523|NCT01190267|616176645|FG000|Overall Study|Withdrawal by Subject|13|||
170501524|NCT01190267|616176646|FG001|Overall Study|Withdrawal by Subject|1|||
170501525|NCT01190267|616176645|FG000|Overall Study|Protocol Violation|8|||
170501526|NCT01190267|616176646|FG001|Overall Study|Protocol Violation|1|||
170501527|NCT03782298|616176647|FG000|Overall Study|Protocol Deviation|4|||
170501528|NCT00742508|616176648|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
170501529|NCT00742508|616176649|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
170501530|NCT00742508|616176648|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
170501531|NCT00742508|616176649|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
170501532|NCT00742508|616176648|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
170501533|NCT00742508|616176649|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
170501534|NCT00742508|616176648|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
170501535|NCT00742508|616176649|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
170501536|NCT00742508|616176648|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
170501537|NCT00742508|616176649|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
170501538|NCT04972968|616176658|FG000|Overall Study|Adverse Event|3|||
170501539|NCT04972968|616176659|FG001|Overall Study|Adverse Event|1|||
170501540|NCT04972968|616176660|FG002|Overall Study|Adverse Event|1|||
170501541|NCT04972968|616176661|FG003|Overall Study|Adverse Event|7|||
170501542|NCT04972968|616176658|FG000|Overall Study|Lack of Efficacy|2|||
170501543|NCT04972968|616176659|FG001|Overall Study|Lack of Efficacy|1|||
170501544|NCT04972968|616176660|FG002|Overall Study|Lack of Efficacy|0|||
170501545|NCT04972968|616176661|FG003|Overall Study|Lack of Efficacy|0|||
170501546|NCT04972968|616176658|FG000|Overall Study|Withdrawal by Subject|7|||
170501547|NCT04972968|616176659|FG001|Overall Study|Withdrawal by Subject|4|||
170501548|NCT04972968|616176660|FG002|Overall Study|Withdrawal by Subject|3|||
170501549|NCT04972968|616176661|FG003|Overall Study|Withdrawal by Subject|2|||
170501550|NCT04972968|616176658|FG000|Overall Study|Study Terminated by Sponsor|25|||
170501551|NCT04972968|616176659|FG001|Overall Study|Study Terminated by Sponsor|28|||
170501552|NCT04972968|616176660|FG002|Overall Study|Study Terminated by Sponsor|32|||
170501553|NCT04972968|616176661|FG003|Overall Study|Study Terminated by Sponsor|27|||
170501554|NCT04972968|616176658|FG000|Overall Study|Other|1|||
170501555|NCT04972968|616176659|FG001|Overall Study|Other|0|||
170501556|NCT04972968|616176660|FG002|Overall Study|Other|1|||
170501557|NCT04972968|616176661|FG003|Overall Study|Other|1|||
170501558|NCT01698879|616176662|FG000|Overall Study|Withdrawal by Subject|1|||
170501559|NCT01698879|616176663|FG001|Overall Study|Withdrawal by Subject|0|||
170501560|NCT01698879|616176664|FG002|Overall Study|Withdrawal by Subject|0|||
170501561|NCT00150800|616176665|FG000|Overall Study|Adverse Event|89|||
170501562|NCT00150800|616176665|FG000|Overall Study|Death|18|||
170501563|NCT00150800|616176665|FG000|Overall Study|Lack of Efficacy|166|||
170501564|NCT00150800|616176665|FG000|Overall Study|Lost to Follow-up|58|||
170501565|NCT00150800|616176665|FG000|Overall Study|Subject's choice|90|||
170501566|NCT00150800|616176665|FG000|Overall Study|No compliance|18|||
170501567|NCT00150800|616176665|FG000|Overall Study|IP misshandling|1|||
170501568|NCT00150800|616176665|FG000|Overall Study|Site closure|24|||
170501569|NCT00150800|616176665|FG000|Overall Study|Protocol non-adherence|2|||
170501570|NCT00150800|616176665|FG000|Overall Study|Nobody to accompany patient|1|||
170501571|NCT00150800|616176665|FG000|Overall Study|Distance too long for patient|1|||
170501572|NCT00150800|616176665|FG000|Overall Study|Neurosurgery|2|||
170501573|NCT00150800|616176665|FG000|Overall Study|BRV monotherapy|1|||
170501574|NCT00150800|616176665|FG000|Overall Study|Visit refusal|3|||
170501575|NCT00150800|616176665|FG000|Overall Study|Sponsor's request|2|||
170501576|NCT00150800|616176665|FG000|Overall Study|Generalized Epilepsy|1|||
170501577|NCT00150800|616176665|FG000|Overall Study|Moved from area/country|8|||
170501578|NCT00150800|616176665|FG000|Overall Study|PI retiring|2|||
170501579|NCT00150800|616176665|FG000|Overall Study|PI leaving site|2|||
170501580|NCT00150800|616176665|FG000|Overall Study|Patient insurance|1|||
170501581|NCT00150800|616176665|FG000|Overall Study|Surgical intervention|4|||
170501582|NCT00150800|616176665|FG000|Overall Study|Pregnancy planned|1|||
170501583|NCT00150800|616176665|FG000|Overall Study|PI discontinuation request|1|||
170501584|NCT01263782|616176671|FG000|Overall Study|Death|0|||
170501585|NCT01263782|616176672|FG001|Overall Study|Death|0|||
170501586|NCT01263782|616176673|FG002|Overall Study|Death|1|||
170501587|NCT01263782|616176674|FG003|Overall Study|Death|0|||
170501588|NCT01263782|616176671|FG000|Overall Study|Progressive disease|0|||
170501589|NCT01263782|616176672|FG001|Overall Study|Progressive disease|0|||
170501590|NCT01263782|616176673|FG002|Overall Study|Progressive disease|0|||
170501591|NCT01263782|616176674|FG003|Overall Study|Progressive disease|1|||
170501592|NCT01263782|616176671|FG000|Overall Study|Too early|0|||
170501593|NCT01263782|616176672|FG001|Overall Study|Too early|0|||
170501594|NCT01263782|616176673|FG002|Overall Study|Too early|1|||
170501595|NCT01263782|616176674|FG003|Overall Study|Too early|0|||
170501596|NCT01263782|616176671|FG000|Overall Study|Inevaluable|0|||
170501597|NCT01263782|616176672|FG001|Overall Study|Inevaluable|0|||
170501598|NCT01263782|616176673|FG002|Overall Study|Inevaluable|1|||
170501599|NCT01263782|616176674|FG003|Overall Study|Inevaluable|0|||
170501600|NCT03626363|616176678|FG000|Overall Study|Protocol Violation|4|||
170501601|NCT03626363|616176679|FG001|Overall Study|Protocol Violation|0|||
170501602|NCT03626363|616176678|FG000|Overall Study|Lost to Follow-up|5|||
170501603|NCT03626363|616176679|FG001|Overall Study|Lost to Follow-up|7|||
170501604|NCT00965341|616176682|FG000|Overall Study|Withdrew consent|1|||
170501605|NCT00965341|616176683|FG001|Overall Study|Withdrew consent|5|||
170501606|NCT00965341|616176682|FG000|Overall Study|Lost to Follow-up|1|||
170501607|NCT00965341|616176683|FG001|Overall Study|Lost to Follow-up|0|||
170501608|NCT00965341|616176682|FG000|Overall Study|Transportation issues|4|||
170805165|NCT04038580|617296051|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
170501609|NCT00965341|616176683|FG001|Overall Study|Transportation issues|3|||
170501610|NCT01970475|616176684|FG000|Overall Study|Withdrawal by Subject|11|||
170501611|NCT01970475|616176685|FG001|Overall Study|Withdrawal by Subject|6|||
170501612|NCT01970475|616176684|FG000|Overall Study|Adverse Event|7|||
170501613|NCT01970475|616176685|FG001|Overall Study|Adverse Event|3|||
170501614|NCT01970475|616176684|FG000|Overall Study|Lost to Follow-up|2|||
170501615|NCT01970475|616176685|FG001|Overall Study|Lost to Follow-up|2|||
170501616|NCT01970475|616176684|FG000|Overall Study|Protocol Violation|1|||
170501617|NCT01970475|616176685|FG001|Overall Study|Protocol Violation|0|||
170501618|NCT00877071|616176686|FG000|Overall Study|disease progression|2|||
170501619|NCT04413552|616176691|FG000|Overall Study|Adverse Event|0|||
170501620|NCT04413552|616176692|FG001|Overall Study|Adverse Event|0|||
170501621|NCT04413552|616176693|FG002|Overall Study|Adverse Event|0|||
170501622|NCT04413552|616176694|FG003|Overall Study|Adverse Event|0|||
170501623|NCT04413552|616176695|FG004|Overall Study|Adverse Event|0|||
170501624|NCT04413552|616176696|FG005|Overall Study|Adverse Event|0|||
170501625|NCT04413552|616176697|FG006|Overall Study|Adverse Event|1|||
170501626|NCT04413552|616176698|FG007|Overall Study|Adverse Event|0|||
170501627|NCT04413552|616176699|FG008|Overall Study|Adverse Event|0|||
170501628|NCT04413552|616176700|FG009|Overall Study|Adverse Event|0|||
170501629|NCT03026530|616176701|FG000|Overall Study|Lost to Follow-up|19|||
170501630|NCT03026530|616176702|FG001|Overall Study|Lost to Follow-up|24|||
170501631|NCT03026530|616176701|FG000|Overall Study|Protocol Violation|2|||
170501632|NCT03026530|616176702|FG001|Overall Study|Protocol Violation|5|||
170501633|NCT01494662|616177983|FG000|Overall Study|Withdrawal by Subject|0|||
170501634|NCT01494662|616177984|FG001|Overall Study|Withdrawal by Subject|0|||
170501635|NCT01494662|616177985|FG002|Overall Study|Withdrawal by Subject|1|||
170501636|NCT01494662|616177986|FG003|Overall Study|Withdrawal by Subject|0|||
170501637|NCT01494662|616177987|FG004|Overall Study|Withdrawal by Subject|0|||
170501638|NCT01494662|616177988|FG005|Overall Study|Withdrawal by Subject|0|||
170501639|NCT01494662|616177989|FG006|Overall Study|Withdrawal by Subject|0|||
170501640|NCT01494662|616177983|FG000|Overall Study|Physician Decision|0|||
170501641|NCT01494662|616177984|FG001|Overall Study|Physician Decision|0|||
170501642|NCT01494662|616177985|FG002|Overall Study|Physician Decision|1|||
170501643|NCT01494662|616177986|FG003|Overall Study|Physician Decision|0|||
170501644|NCT01494662|616177987|FG004|Overall Study|Physician Decision|0|||
170501645|NCT01494662|616177988|FG005|Overall Study|Physician Decision|0|||
170501646|NCT01494662|616177989|FG006|Overall Study|Physician Decision|0|||
170501647|NCT03361306|616177993|FG000|Overall Study|Death|6|||
170501648|NCT03468218|616177994|FG000|Overall Study|Adverse Event|5|||
170501649|NCT03468218|616177994|FG000|Overall Study|Progressive Disease|16|||
170501650|NCT03468218|616177994|FG000|Overall Study|Death|1|||
170501651|NCT03468218|616177994|FG000|Overall Study|Alternate therapy|1|||
170501652|NCT03468218|616177994|FG000|Overall Study|Withdrawal by Subject|2|||
170501653|NCT04504942|616177995|FG000|Overall Study|Withdrawal by Subject|2|||
170501654|NCT04504942|616177995|FG000|Overall Study|7 patients were on-going at the time when study was closed by sponsor.|7|||
170501655|NCT04504942|616177995|FG000|Overall Study|Disease Progression|1|||
170501656|NCT03541200|616177998|FG000|Overall Study|Adverse Event|19|||
170501657|NCT03541200|616177998|FG000|Overall Study|Death|1|||
170501658|NCT03541200|616177998|FG000|Overall Study|Lost to Follow-up|10|||
170501659|NCT03541200|616177998|FG000|Overall Study|Physician Decision|1|||
170501660|NCT03541200|616177998|FG000|Overall Study|Protocol Violation|51|||
170501661|NCT03541200|616177998|FG000|Overall Study|Withdrawal by Subject|23|||
170501662|NCT03541200|616177998|FG000|Overall Study|other|8|||
170501663|NCT04439357|616177999|FG000|Overall Study|Disease Progression|4|||
170501664|NCT03226678|616178012|FG000|Part A (Core Study Phase)|Adverse Event|0|||
170501665|NCT03226678|616178013|FG001|Part A (Core Study Phase)|Adverse Event|1|||
170501666|NCT03226678|616178014|FG002|Part A (Core Study Phase)|Adverse Event|0|||
170501667|NCT03226678|616178015|FG003|Part A (Core Study Phase)|Adverse Event|0|||
170501668|NCT03226678|616178016|FG004|Part A (Core Study Phase)|Adverse Event|0|||
170501669|NCT03226678|616178017|FG005|Part A (Core Study Phase)|Adverse Event|0|||
170501670|NCT03226678|616178012|FG000|Part A (Core Study Phase)|Death|0|||
170501671|NCT03226678|616178013|FG001|Part A (Core Study Phase)|Death|0|||
170501672|NCT03226678|616178014|FG002|Part A (Core Study Phase)|Death|1|||
170501673|NCT03226678|616178015|FG003|Part A (Core Study Phase)|Death|0|||
170501674|NCT03226678|616178016|FG004|Part A (Core Study Phase)|Death|0|||
170501675|NCT03226678|616178017|FG005|Part A (Core Study Phase)|Death|0|||
170501676|NCT03226678|616178012|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
170501677|NCT03226678|616178013|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
170501678|NCT03226678|616178014|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
170501679|NCT03226678|616178015|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
170501680|NCT03226678|616178016|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
170501681|NCT03226678|616178017|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
170501682|NCT03226678|616178012|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
170501683|NCT03226678|616178013|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
170501684|NCT03226678|616178014|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
170501685|NCT03226678|616178015|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
170501686|NCT03226678|616178016|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
170501687|NCT03226678|616178017|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
170501688|NCT03226678|616178012|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
170501689|NCT03226678|616178013|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
170501690|NCT03226678|616178014|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
170501691|NCT03226678|616178015|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
170501692|NCT03226678|616178016|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
170501693|NCT03226678|616178017|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
170501694|NCT03226678|616178012|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
170501695|NCT03226678|616178013|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
170501696|NCT03226678|616178014|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
170501697|NCT03226678|616178015|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
170501698|NCT03226678|616178016|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
170501699|NCT03226678|616178017|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
170501700|NCT03226678|616178012|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
170501701|NCT03226678|616178013|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
170501702|NCT03226678|616178014|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
170501703|NCT03226678|616178015|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
170501704|NCT03226678|616178016|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
170501705|NCT03226678|616178017|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
170501706|NCT03226678|616178012|FG000|Part B (Long-Term Extension Phase)|Death|0|||
170501707|NCT03226678|616178013|FG001|Part B (Long-Term Extension Phase)|Death|0|||
170501708|NCT03226678|616178014|FG002|Part B (Long-Term Extension Phase)|Death|0|||
170805166|NCT04038580|617296052|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
170805167|NCT04038580|617296053|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
170805168|NCT04038580|617296048|FG000|Wash-out 3|Withdrawal by Subject|1|||
170805169|NCT04038580|617296049|FG001|Wash-out 3|Withdrawal by Subject|0|||
170805170|NCT04038580|617296050|FG002|Wash-out 3|Withdrawal by Subject|2|||
170805171|NCT04038580|617296051|FG003|Wash-out 3|Withdrawal by Subject|0|||
170805172|NCT04038580|617296052|FG004|Wash-out 3|Withdrawal by Subject|0|||
170805173|NCT04038580|617296053|FG005|Wash-out 3|Withdrawal by Subject|0|||
170805174|NCT03477175|617296054|FG000|Overall Study|Unable to travel due to COVID-19|0|||
170805175|NCT03477175|617296055|FG001|Overall Study|Unable to travel due to COVID-19|1|||
170805176|NCT03477175|617296054|FG000|Overall Study|Physician Decision|1|||
170805177|NCT03477175|617296055|FG001|Overall Study|Physician Decision|0|||
170805178|NCT03477175|617296054|FG000|Overall Study|Transitioned to commercial drug|6|||
170805179|NCT03477175|617296055|FG001|Overall Study|Transitioned to commercial drug|6|||
170805180|NCT03477175|617296054|FG000|Overall Study|Lost to Follow-up|1|||
170805181|NCT03477175|617296055|FG001|Overall Study|Lost to Follow-up|1|||
170903701|NCT01794780|617649186|FG000|Overall Study|Other|0|||
170903702|NCT01794780|617649187|FG001|Overall Study|Other|12|||
170551839|NCT01313676|616366383|FG001|Overall Study|Missing|1|||
170551840|NCT01313676|616366384|FG002|Overall Study|Missing|1|||
170551841|NCT01313676|616366385|FG003|Overall Study|Missing|0|||
170551842|NCT00368849|616366389|FG000|Overall Study|Withdrawal by Subject|0|||
170551843|NCT00368849|616366390|FG001|Overall Study|Withdrawal by Subject|1|||
170551844|NCT00368849|616366389|FG000|Overall Study|Physician Decision|0|||
170551845|NCT00368849|616366390|FG001|Overall Study|Physician Decision|1|||
170551846|NCT01902303|616366391|FG000|Overall Study|Adverse Event|0|||
170551847|NCT01902303|616366392|FG001|Overall Study|Adverse Event|1|||
170551848|NCT01902303|616366391|FG000|Overall Study|Lost to Follow-up|0|||
170551849|NCT01902303|616366392|FG001|Overall Study|Lost to Follow-up|1|||
170551850|NCT01902303|616366391|FG000|Overall Study|Protocol Violation|2|||
170551851|NCT01902303|616366392|FG001|Overall Study|Protocol Violation|2|||
170551852|NCT01902303|616366391|FG000|Overall Study|subject lost investigational product|0|||
170551853|NCT01902303|616366392|FG001|Overall Study|subject lost investigational product|1|||
170551854|NCT01902303|616366391|FG000|Overall Study|Did not develop a cold sore|21|||
170551855|NCT01902303|616366392|FG001|Overall Study|Did not develop a cold sore|19|||
170551856|NCT03635996|616366393|FG000|Overall Study|Study terminated by Sponsor|94|||
170551857|NCT03635996|616366393|FG000|Overall Study|Withdrawal by Subject|20|||
170551858|NCT03635996|616366393|FG000|Overall Study|Ablation|26|||
170551859|NCT03635996|616366393|FG000|Overall Study|Adverse Event|7|||
170551860|NCT03635996|616366393|FG000|Overall Study|Physician Decision|3|||
170551861|NCT03635996|616366393|FG000|Overall Study|Prohibited medication|5|||
170551862|NCT03635996|616366393|FG000|Overall Study|Did not meet eligibility criteria|5|||
170551863|NCT03635996|616366393|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
170551864|NCT03635996|616366393|FG000|Overall Study|Protocol Violation|1|||
170551865|NCT03635996|616366393|FG000|Overall Study|Lost to Follow-up|1|||
170551866|NCT02821000|616366394|FG000|Overall Study|Death|89|||
170551867|NCT02821000|616366394|FG000|Overall Study|Sponsor Decision|12|||
170551868|NCT02821000|616366394|FG000|Overall Study|Withdrawal by Subject|2|||
170551869|NCT05058456|616366395|FG000|Overall Study|Death|1|||
170551870|NCT05058456|616366395|FG000|Overall Study|End of Study data not yet due for release|34|||
170551871|NCT04359680|616366396|FG000|Overall Study|Withdrawal by Subject|29|||
170551872|NCT04359680|616366397|FG001|Overall Study|Withdrawal by Subject|24|||
170551873|NCT04359680|616366396|FG000|Overall Study|Adverse Event|6|||
170551874|NCT04359680|616366397|FG001|Overall Study|Adverse Event|2|||
170551875|NCT04359680|616366396|FG000|Overall Study|Lost to Follow-up|56|||
170551876|NCT04359680|616366397|FG001|Overall Study|Lost to Follow-up|59|||
170551877|NCT04359680|616366396|FG000|Overall Study|Protocol Violation|3|||
170551878|NCT04359680|616366397|FG001|Overall Study|Protocol Violation|5|||
170551879|NCT04359680|616366396|FG000|Overall Study|Physician Decision|1|||
170551880|NCT04359680|616366397|FG001|Overall Study|Physician Decision|1|||
170551881|NCT04359680|616366396|FG000|Overall Study|Sponsor Decision|0|||
170551882|NCT04359680|616366397|FG001|Overall Study|Sponsor Decision|1|||
170551883|NCT03160573|616366400|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
170551884|NCT03160573|616366401|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
170551885|NCT03160573|616366402|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
170551886|NCT03160573|616366403|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
170551887|NCT05333965|616366428|FG000|First Intervention|Adverse Event|0|||
170551888|NCT05333965|616366429|FG001|First Intervention|Adverse Event|1|||
170903703|NCT01794780|617649188|FG002|Overall Study|Other|25|||
170551889|NCT05333965|616366428|FG000|First Intervention|Withdrawal by Subject|0|||
170551890|NCT05333965|616366429|FG001|First Intervention|Withdrawal by Subject|1|||
170551891|NCT02144337|616366430|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
170551892|NCT02144337|616366431|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
170551893|NCT02144337|616366430|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
170805182|NCT03477175|617296054|FG000|Overall Study|Withdrawal by Subject|3|||
170805183|NCT03477175|617296055|FG001|Overall Study|Withdrawal by Subject|1|||
170903704|NCT01794780|617649189|FG003|Overall Study|Other|20|||
170501709|NCT03226678|616178015|FG003|Part B (Long-Term Extension Phase)|Death|0|||
170501710|NCT03226678|616178016|FG004|Part B (Long-Term Extension Phase)|Death|0|||
170501711|NCT03226678|616178017|FG005|Part B (Long-Term Extension Phase)|Death|1|||
170501712|NCT03226678|616178012|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
170501713|NCT03226678|616178013|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
170501714|NCT03226678|616178014|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
170501715|NCT03226678|616178015|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
170501716|NCT03226678|616178016|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
170551894|NCT02144337|616366431|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
170501717|NCT03226678|616178017|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
170501718|NCT03226678|616178012|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
170501719|NCT03226678|616178013|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
170501720|NCT03226678|616178014|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
170501721|NCT03226678|616178015|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
170501722|NCT03226678|616178016|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
170501723|NCT03226678|616178017|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
170501724|NCT03226678|616178012|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
170501725|NCT03226678|616178013|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
170501726|NCT03226678|616178014|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
170501727|NCT03226678|616178015|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
170501728|NCT03226678|616178016|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
170501729|NCT03226678|616178017|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
170501730|NCT05965778|616178020|FG000|Overall Study|Adverse Event|2|||
170501731|NCT05965778|616178021|FG001|Overall Study|Adverse Event|3|||
170501732|NCT05965778|616178020|FG000|Overall Study|Lack of Efficacy|0|||
170501733|NCT05965778|616178021|FG001|Overall Study|Lack of Efficacy|2|||
170501734|NCT05965778|616178020|FG000|Overall Study|Protocol Violation|1|||
170501735|NCT05965778|616178021|FG001|Overall Study|Protocol Violation|1|||
170501736|NCT05965778|616178020|FG000|Overall Study|Withdrawal by Subject|0|||
170501737|NCT05965778|616178021|FG001|Overall Study|Withdrawal by Subject|2|||
170501738|NCT05965778|616178020|FG000|Overall Study|divers reasons(patient or doctor not available for visit...),|9|||
170501739|NCT05965778|616178021|FG001|Overall Study|divers reasons(patient or doctor not available for visit...),|7|||
170501740|NCT05014815|616178022|FG000|Overall Study|Death|63|||
170501741|NCT05014815|616178023|FG001|Overall Study|Death|70|||
170501742|NCT05014815|616178022|FG000|Overall Study|Withdrawal by Subject|10|||
170501743|NCT05014815|616178023|FG001|Overall Study|Withdrawal by Subject|10|||
170501744|NCT05014815|616178022|FG000|Overall Study|Lost to Follow-up|4|||
170501745|NCT05014815|616178023|FG001|Overall Study|Lost to Follow-up|2|||
170501746|NCT05014815|616178022|FG000|Overall Study|Physician Decision|2|||
170501747|NCT05014815|616178023|FG001|Overall Study|Physician Decision|4|||
170501748|NCT06303167|616178024|FG000|Overall Study|Ineligible|1|||
170501749|NCT06303167|616178024|FG000|Overall Study|Never start protocol therapy|2|||
170501750|NCT06303167|616178024|FG000|Overall Study|Disease progression|16|||
170501751|NCT00916344|616178025|FG000|Overall Study|Death|2|||
170642481|NCT01403948|616705270|FG003|Overall Study|Progressive disease|4|||
170642482|NCT01403948|616705271|FG004|Overall Study|Progressive disease|2|||
170642483|NCT01403948|616705272|FG005|Overall Study|Progressive disease|6|||
170642484|NCT01403948|616705273|FG006|Overall Study|Progressive disease|2|||
170642485|NCT01403948|616705274|FG007|Overall Study|Progressive disease|4|||
170642486|NCT01403948|616705275|FG008|Overall Study|Progressive disease|5|||
170501752|NCT00916344|616178025|FG000|Overall Study|ICD upgrade|1|||
170501753|NCT00916344|616178025|FG000|Overall Study|Drop-out|5|||
170501754|NCT03602391|616178026|FG000|Overall Study|COVID-19|7|||
170551895|NCT02144337|616366430|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
170551896|NCT02144337|616366431|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
170551897|NCT02144337|616366430|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
170551898|NCT02144337|616366431|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
170551899|NCT02144337|616366430|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
170551900|NCT02144337|616366431|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
170551901|NCT02402907|616366438|FG000|Overall Study|Delivered vaginally|9|||
170551902|NCT02402907|616366439|FG001|Overall Study|Delivered vaginally|3|||
170551903|NCT02402907|616366438|FG000|Overall Study|Delivered outside of Sinai|1|||
170642487|NCT01403948|616705276|FG009|Overall Study|Progressive disease|5|||
170501755|NCT03602391|616178027|FG001|Overall Study|COVID-19|6|||
170501756|NCT00081731|616178041|FG000|Overall Study|scientific integrity issue|8|||
170501757|NCT00081731|616178042|FG001|Overall Study|scientific integrity issue|8|||
170501758|NCT00785213|616178046|FG000|Quinine Sulfate Alone|Adverse Event|4|||
170551904|NCT02402907|616366439|FG001|Overall Study|Delivered outside of Sinai|1|||
170642488|NCT01403948|616705267|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
170642489|NCT01403948|616705268|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
170642490|NCT01403948|616705269|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
170642491|NCT01403948|616705270|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
170501759|NCT00785213|616178046|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
170501760|NCT00525902|616178047|FG000|Overall Study|Lack of Efficacy|1|||
170501761|NCT03747302|616178048|FG000|Overall Study|Withdrawal by Subject|1|||
170501762|NCT03747302|616178049|FG001|Overall Study|Withdrawal by Subject|2|||
170501763|NCT03769675|616178050|FG000|Overall Study|Lost to Follow-up|1|||
170501764|NCT00738062|616178051|FG000|Open Label Treatment|Lack of Efficacy|5|||
170501765|NCT00738062|616178052|FG001|Open Label Treatment|Lack of Efficacy|0|||
170501766|NCT00738062|616178053|FG002|Open Label Treatment|Lack of Efficacy|0|||
170501767|NCT00738062|616178051|FG000|Open Label Treatment|Adverse Event|11|||
170501768|NCT00738062|616178052|FG001|Open Label Treatment|Adverse Event|0|||
170501769|NCT00738062|616178053|FG002|Open Label Treatment|Adverse Event|0|||
170501770|NCT00738062|616178051|FG000|Open Label Treatment|Protocol Violation|2|||
170501771|NCT00738062|616178052|FG001|Open Label Treatment|Protocol Violation|0|||
170501772|NCT00738062|616178053|FG002|Open Label Treatment|Protocol Violation|0|||
170501773|NCT00738062|616178051|FG000|Open Label Treatment|Withdrawal by Subject|9|||
170501774|NCT00738062|616178052|FG001|Open Label Treatment|Withdrawal by Subject|0|||
170501775|NCT00738062|616178053|FG002|Open Label Treatment|Withdrawal by Subject|0|||
170501776|NCT00738062|616178051|FG000|Open Label Treatment|Investigator Decision|1|||
170501777|NCT00738062|616178052|FG001|Open Label Treatment|Investigator Decision|0|||
170501778|NCT00738062|616178053|FG002|Open Label Treatment|Investigator Decision|0|||
170501779|NCT00738062|616178051|FG000|Open-Label Extension|Adverse Event|5|||
170501780|NCT00738062|616178052|FG001|Open-Label Extension|Adverse Event|0|||
170501781|NCT00738062|616178053|FG002|Open-Label Extension|Adverse Event|0|||
170501782|NCT00738062|616178051|FG000|Open-Label Extension|Physician Decision|1|||
170501783|NCT00738062|616178052|FG001|Open-Label Extension|Physician Decision|0|||
170501784|NCT00738062|616178053|FG002|Open-Label Extension|Physician Decision|0|||
170501785|NCT00738062|616178051|FG000|Open-Label Extension|Lack of Efficacy|2|||
170501786|NCT00738062|616178052|FG001|Open-Label Extension|Lack of Efficacy|0|||
170501787|NCT00738062|616178053|FG002|Open-Label Extension|Lack of Efficacy|0|||
170501788|NCT00738062|616178051|FG000|Open-Label Extension|Withdrawal by Subject|6|||
170501789|NCT00738062|616178052|FG001|Open-Label Extension|Withdrawal by Subject|0|||
170501790|NCT00738062|616178053|FG002|Open-Label Extension|Withdrawal by Subject|0|||
170501791|NCT00738062|616178051|FG000|Open-Label Extension|Protocol Violation|1|||
170501792|NCT00738062|616178052|FG001|Open-Label Extension|Protocol Violation|0|||
170501793|NCT00738062|616178053|FG002|Open-Label Extension|Protocol Violation|0|||
170501794|NCT00738062|616178051|FG000|Open-Label Extension|Study Terminated|2|||
170501795|NCT00738062|616178052|FG001|Open-Label Extension|Study Terminated|0|||
170501796|NCT00738062|616178053|FG002|Open-Label Extension|Study Terminated|0|||
170501797|NCT00526331|616178054|FG000|Overall Study|Sponsor Termination|55|||
170501798|NCT01259375|616178055|FG000|Overall Study|Adverse Event|1|||
170501799|NCT00628095|616178056|FG000|Overall Study|Adverse Event|5|||
170501800|NCT00628095|616178057|FG001|Overall Study|Adverse Event|3|||
170501801|NCT00628095|616178056|FG000|Overall Study|Lack of Efficacy|0|||
170501802|NCT00628095|616178057|FG001|Overall Study|Lack of Efficacy|3|||
170501803|NCT00628095|616178056|FG000|Overall Study|Withdrawal by Subject|2|||
170501804|NCT00628095|616178057|FG001|Overall Study|Withdrawal by Subject|0|||
170501805|NCT00628095|616178056|FG000|Overall Study|Other|0|||
170501806|NCT00628095|616178057|FG001|Overall Study|Other|1|||
170501807|NCT00783224|616178060|FG000|Overall Study|Adverse Event|0|||
170501808|NCT00783224|616178061|FG001|Overall Study|Adverse Event|0|||
170501809|NCT00783224|616178062|FG002|Overall Study|Adverse Event|1|||
170501810|NCT00783224|616178063|FG003|Overall Study|Adverse Event|0|||
170501811|NCT00783224|616178060|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
170501812|NCT00783224|616178061|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
170501813|NCT00783224|616178062|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
170501814|NCT00783224|616178063|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
170501815|NCT00783224|616178060|FG000|Overall Study|Inappropriate as a study subject|0|||
170501816|NCT00783224|616178061|FG001|Overall Study|Inappropriate as a study subject|0|||
170501817|NCT00783224|616178062|FG002|Overall Study|Inappropriate as a study subject|0|||
170501818|NCT00783224|616178063|FG003|Overall Study|Inappropriate as a study subject|1|||
170501819|NCT03422159|616178064|FG000|Overall Study|Exclusion due to terminal disease|2|||
170501820|NCT03422159|616178065|FG001|Overall Study|Exclusion due to terminal disease|1|||
170501821|NCT01032239|616178072|FG000|Overall Study|Lost to Follow-up|3|||
170501822|NCT01032239|616178073|FG001|Overall Study|Lost to Follow-up|2|||
170501823|NCT01032239|616178072|FG000|Overall Study|Withdrawal by Subject|2|||
170501824|NCT01032239|616178073|FG001|Overall Study|Withdrawal by Subject|3|||
170501825|NCT01032239|616178072|FG000|Overall Study|Death|1|||
170501826|NCT01032239|616178073|FG001|Overall Study|Death|0|||
170501827|NCT01032239|616178072|FG000|Overall Study|Protocol Violation|1|||
170501828|NCT01032239|616178073|FG001|Overall Study|Protocol Violation|0|||
170501829|NCT00204477|616178076|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
170501830|NCT00204477|616178077|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
170501831|NCT00204477|616178076|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
170501832|NCT00204477|616178077|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
170501833|NCT02225366|616178078|FG000|Overall Study|Lack of Efficacy|1|||
170501834|NCT02225366|616178079|FG001|Overall Study|Lack of Efficacy|0|||
170501835|NCT01382225|616178080|FG000|Overall Study|Adverse Event|3|||
170501836|NCT01382225|616178081|FG001|Overall Study|Adverse Event|2|||
170501837|NCT01382225|616178080|FG000|Overall Study|Protocol Violation|2|||
170501838|NCT01382225|616178081|FG001|Overall Study|Protocol Violation|1|||
170501839|NCT01382225|616178080|FG000|Overall Study|Subject Withdrew Consent|5|||
170501840|NCT01382225|616178081|FG001|Overall Study|Subject Withdrew Consent|2|||
170501841|NCT01382225|616178080|FG000|Overall Study|Other|4|||
170501842|NCT01382225|616178081|FG001|Overall Study|Other|2|||
170501843|NCT01797081|616178082|FG000|Overall Study|Adverse Event|1|||
170501844|NCT01797081|616178083|FG001|Overall Study|Adverse Event|0|||
170501845|NCT01797081|616178084|FG002|Overall Study|Adverse Event|1|||
170501846|NCT01797081|616178085|FG003|Overall Study|Adverse Event|0|||
170501847|NCT01797081|616178082|FG000|Overall Study|Pregnancy|1|||
170501848|NCT01797081|616178083|FG001|Overall Study|Pregnancy|0|||
170501849|NCT01797081|616178084|FG002|Overall Study|Pregnancy|0|||
170501850|NCT01797081|616178085|FG003|Overall Study|Pregnancy|0|||
170501851|NCT01797081|616178082|FG000|Overall Study|Personal Reasons|12|||
170501852|NCT01797081|616178083|FG001|Overall Study|Personal Reasons|4|||
170501853|NCT01797081|616178084|FG002|Overall Study|Personal Reasons|4|||
170501854|NCT01797081|616178085|FG003|Overall Study|Personal Reasons|8|||
170501855|NCT01797081|616178082|FG000|Overall Study|Protocol Violation|0|||
170501856|NCT01797081|616178083|FG001|Overall Study|Protocol Violation|0|||
170501857|NCT01797081|616178084|FG002|Overall Study|Protocol Violation|0|||
170501858|NCT01797081|616178085|FG003|Overall Study|Protocol Violation|1|||
170501859|NCT01793688|616178086|FG000|Overall Study|Protocol Violation|2|||
170501860|NCT02484651|616178087|FG000|Overall Study|Patients' data files were corrupted.|1|||
170501861|NCT02484651|616178088|FG001|Overall Study|Patients' data files were corrupted.|1|||
170501862|NCT02484651|616178087|FG000|Overall Study|BIS monitoring failed.|1|||
170501863|NCT02484651|616178088|FG001|Overall Study|BIS monitoring failed.|1|||
170501864|NCT02484651|616178087|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
170501865|NCT02484651|616178088|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
170501866|NCT03619902|616178089|FG000|Overall Study|Termination of Study by Investigator|1|||
170501867|NCT03619902|616178089|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
170501868|NCT00794040|616178092|FG000|Overall Study|Withdrawal by Subject|3|||
170501869|NCT00794040|616178093|FG001|Overall Study|Withdrawal by Subject|4|||
170501870|NCT00794040|616178092|FG000|Overall Study|Physician Decision|0|||
170501871|NCT00794040|616178093|FG001|Overall Study|Physician Decision|1|||
170501872|NCT01095978|616178097|FG000|Overall Study|Did not take Klacid SR|2|||
170501873|NCT01095978|616178097|FG000|Overall Study|Adverse Event|1|||
170501874|NCT01077739|616178099|FG000|Overall Study|Premature withdrawal|1|||
170501875|NCT01077739|616178100|FG001|Overall Study|Premature withdrawal|3|||
170501876|NCT01077739|616178099|FG000|Overall Study|Withdrawal by Subject|1|||
170501877|NCT01077739|616178100|FG001|Overall Study|Withdrawal by Subject|0|||
170501878|NCT01077739|616178099|FG000|Overall Study|Death|0|||
170501879|NCT01077739|616178100|FG001|Overall Study|Death|3|||
170501880|NCT01077739|616178099|FG000|Overall Study|Unacceptable toxicity|1|||
170501881|NCT01077739|616178100|FG001|Overall Study|Unacceptable toxicity|2|||
170501882|NCT01077739|616178099|FG000|Overall Study|Other|2|||
170501883|NCT01077739|616178100|FG001|Overall Study|Other|2|||
170551905|NCT02402907|616366438|FG000|Overall Study|Lost to follow up after C-Section|10|||
170551906|NCT02402907|616366439|FG001|Overall Study|Lost to follow up after C-Section|23|||
170551907|NCT00203242|616366440|FG000|Overall Study|Lost to Follow-up|1|||
170551908|NCT02595437|616366442|FG000|Triferic Via IV|Withdrawal by Subject|1|||
170551909|NCT02094885|616366444|FG000|Overall Study|Death|1|||
170551910|NCT02094885|616366445|FG001|Overall Study|Death|5|||
170551911|NCT02094885|616366444|FG000|Overall Study|Withdrawn due to age|1|||
170551912|NCT02094885|616366445|FG001|Overall Study|Withdrawn due to age|0|||
170642492|NCT01403948|616705271|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
170501884|NCT02089334|616178101|FG000|Overall Study|Withdrawal by Subject|0|||
170501885|NCT02089334|616178102|FG001|Overall Study|Withdrawal by Subject|0|||
170501886|NCT02089334|616178103|FG002|Overall Study|Withdrawal by Subject|0|||
170501887|NCT02089334|616178104|FG003|Overall Study|Withdrawal by Subject|2|||
170501888|NCT02089334|616178101|FG000|Overall Study|Adverse Event|0|||
170501889|NCT02089334|616178102|FG001|Overall Study|Adverse Event|0|||
170501890|NCT02089334|616178103|FG002|Overall Study|Adverse Event|0|||
170501891|NCT02089334|616178104|FG003|Overall Study|Adverse Event|2|||
170501892|NCT02089334|616178101|FG000|Overall Study|Progressive disease|0|||
170805184|NCT03477175|617296054|FG000|Overall Study|Adverse Event|1|||
170501893|NCT02089334|616178102|FG001|Overall Study|Progressive disease|0|||
170501894|NCT02089334|616178103|FG002|Overall Study|Progressive disease|0|||
170501895|NCT02089334|616178104|FG003|Overall Study|Progressive disease|2|||
170501896|NCT02089334|616178101|FG000|Overall Study|Physician Decision|0|||
170501897|NCT02089334|616178102|FG001|Overall Study|Physician Decision|0|||
170501898|NCT02089334|616178103|FG002|Overall Study|Physician Decision|1|||
170501899|NCT02089334|616178104|FG003|Overall Study|Physician Decision|1|||
170501900|NCT04778059|616178105|FG000|Overall Study|Death|2|||
170551913|NCT01537432|616366446|FG000|Overall Study|Lost to Follow-up|3|||
170501901|NCT04778059|616178106|FG001|Overall Study|Death|2|||
170501902|NCT04778059|616178107|FG002|Overall Study|Death|1|||
170501903|NCT04778059|616178108|FG003|Overall Study|Death|1|||
170501904|NCT04778059|616178109|FG004|Overall Study|Death|1|||
170501905|NCT04778059|616178105|FG000|Overall Study|Lost to Follow-up|0|||
170501906|NCT04778059|616178106|FG001|Overall Study|Lost to Follow-up|0|||
170501907|NCT04778059|616178107|FG002|Overall Study|Lost to Follow-up|0|||
170501908|NCT04778059|616178108|FG003|Overall Study|Lost to Follow-up|0|||
170501909|NCT04778059|616178109|FG004|Overall Study|Lost to Follow-up|1|||
170501910|NCT04778059|616178105|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
170501911|NCT04778059|616178106|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
170501912|NCT04778059|616178107|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
170501913|NCT04778059|616178108|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
170501914|NCT04778059|616178109|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
170501915|NCT02832375|616178110|FG000|Overall Study|Lost to Follow-up|1|||
170501916|NCT02832375|616178111|FG001|Overall Study|Lost to Follow-up|0|||
170501917|NCT02832375|616178110|FG000|Overall Study|Withdrawal of Consent|1|||
170501918|NCT02832375|616178111|FG001|Overall Study|Withdrawal of Consent|0|||
170501919|NCT01317797|616178112|FG000|Overall Study|Other|0|||
170501920|NCT01317797|616178113|FG001|Overall Study|Other|1|||
170501921|NCT01317797|616178114|FG002|Overall Study|Other|0|||
170501922|NCT01317797|616178112|FG000|Overall Study|Withdrawal of Patient|0|||
170501923|NCT01317797|616178113|FG001|Overall Study|Withdrawal of Patient|0|||
170501924|NCT01317797|616178114|FG002|Overall Study|Withdrawal of Patient|1|||
170501925|NCT03721835|616178120|FG000|Overall Study|Participant not able to return|1|||
170501926|NCT03721835|616178120|FG000|Overall Study|Lost to Follow-up|1|||
170501927|NCT03721835|616178120|FG000|Overall Study|Revision of the components of the study device|2|||
170501928|NCT03721835|616178120|FG000|Overall Study|Sponsor terminated study|6|||
170501929|NCT03721835|616178120|FG000|Overall Study|Death|1|||
170501930|NCT03721835|616178120|FG000|Overall Study|Sponsor decision|1|||
170501931|NCT03495154|616178121|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
170501932|NCT03495154|616178121|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
170501933|NCT03495154|616178121|FG000|Overall Study|Screen Failures During Surgery|6|||
170501934|NCT03495154|616178121|FG000|Overall Study|Death|2|||
170501935|NCT03495154|616178121|FG000|Overall Study|Lost to Follow-up|16|||
170501936|NCT03495154|616178121|FG000|Overall Study|Withdrawal by Subject|2|||
170501937|NCT03495154|616178121|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
170501938|NCT02100670|616178122|FG000|Overall Study|Adverse Event|10|||
170501939|NCT02100670|616178123|FG001|Overall Study|Adverse Event|3|||
170501940|NCT02100670|616178124|FG002|Overall Study|Adverse Event|3|||
170551914|NCT01537432|616366447|FG001|Overall Study|Lost to Follow-up|1|||
170551915|NCT01537432|616366446|FG000|Overall Study|Withdrawal by Subject|0|||
170551916|NCT01537432|616366447|FG001|Overall Study|Withdrawal by Subject|1|||
170551917|NCT01537432|616366446|FG000|Overall Study|Administrative problems|1|||
170551918|NCT01537432|616366447|FG001|Overall Study|Administrative problems|0|||
170551919|NCT01537432|616366446|FG000|Overall Study|Adverse Event|1|||
170551920|NCT01537432|616366447|FG001|Overall Study|Adverse Event|0|||
170551921|NCT01537432|616366446|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170501941|NCT02100670|616178125|FG003|Overall Study|Adverse Event|0|||
170501942|NCT02100670|616178122|FG000|Overall Study|Lost to Follow-up|1|||
170501943|NCT02100670|616178123|FG001|Overall Study|Lost to Follow-up|0|||
170501944|NCT02100670|616178124|FG002|Overall Study|Lost to Follow-up|0|||
170501945|NCT02100670|616178125|FG003|Overall Study|Lost to Follow-up|0|||
170501946|NCT02100670|616178122|FG000|Overall Study|Protocol Violation|0|||
170501947|NCT02100670|616178123|FG001|Overall Study|Protocol Violation|1|||
170501948|NCT02100670|616178124|FG002|Overall Study|Protocol Violation|0|||
170501949|NCT02100670|616178125|FG003|Overall Study|Protocol Violation|1|||
170501950|NCT02100670|616178122|FG000|Overall Study|Withdrawal of Consent|0|||
170501951|NCT02100670|616178123|FG001|Overall Study|Withdrawal of Consent|1|||
170501952|NCT02100670|616178124|FG002|Overall Study|Withdrawal of Consent|1|||
170501953|NCT02100670|616178125|FG003|Overall Study|Withdrawal of Consent|0|||
170501954|NCT02100670|616178122|FG000|Overall Study|No swelling no pain|1|||
170551922|NCT01537432|616366447|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170501955|NCT02100670|616178123|FG001|Overall Study|No swelling no pain|0|||
170551923|NCT03682367|616366448|FG000|Overall Study|Protocol Violation|2|||
170551924|NCT03682367|616366449|FG001|Overall Study|Protocol Violation|1|||
170551925|NCT03682367|616366448|FG000|Overall Study|Closed Study Early|0|||
170551926|NCT03682367|616366449|FG001|Overall Study|Closed Study Early|3|||
170551927|NCT05166902|616366450|FG000|First Intervention|Lost to Follow-up|0|||
170501956|NCT02100670|616178124|FG002|Overall Study|No swelling no pain|0|||
170501957|NCT02100670|616178125|FG003|Overall Study|No swelling no pain|0|||
170501958|NCT02100670|616178122|FG000|Overall Study|Poor Efficacy|0|||
170501959|NCT02100670|616178123|FG001|Overall Study|Poor Efficacy|1|||
170501960|NCT02100670|616178124|FG002|Overall Study|Poor Efficacy|0|||
170501961|NCT02100670|616178125|FG003|Overall Study|Poor Efficacy|0|||
170501962|NCT02100670|616178122|FG000|Overall Study|Physician Decision|0|||
170501963|NCT02100670|616178123|FG001|Overall Study|Physician Decision|1|||
170501964|NCT02100670|616178124|FG002|Overall Study|Physician Decision|0|||
170501965|NCT02100670|616178125|FG003|Overall Study|Physician Decision|0|||
170501966|NCT02100670|616178122|FG000|Overall Study|Withdrawal by Subject|1|||
170501967|NCT02100670|616178123|FG001|Overall Study|Withdrawal by Subject|0|||
170501968|NCT02100670|616178124|FG002|Overall Study|Withdrawal by Subject|0|||
170501969|NCT02100670|616178125|FG003|Overall Study|Withdrawal by Subject|0|||
170501970|NCT01294696|616178127|FG000|Overall Study|Screening failures|7|||
170501971|NCT01294696|616178127|FG000|Overall Study|Protocol Violation|8|||
170501972|NCT01294696|616178127|FG000|Overall Study|Missing BPI Response|7|||
170501973|NCT01294696|616178127|FG000|Overall Study|Site closure|52|||
170501974|NCT04825275|616179371|FG000|Overall Study|Withdrawal by Subject|1|||
170501975|NCT04825275|616179372|FG001|Overall Study|Withdrawal by Subject|0|||
170501976|NCT04993079|616179373|FG000|Overall Study|Screen Failure|4|||
170501977|NCT04993079|616179373|FG000|Overall Study|Failure to provide full consent|2|||
170501978|NCT05569174|616179385|FG000|Overall Study|Adverse Event|0|||
170501979|NCT05569174|616179386|FG001|Overall Study|Adverse Event|1|||
170501980|NCT05569174|616179385|FG000|Overall Study|Lack of compliance|0|||
170501981|NCT05569174|616179386|FG001|Overall Study|Lack of compliance|1|||
170501982|NCT05569174|616179385|FG000|Overall Study|Withdrawal of consent|0|||
170501983|NCT05569174|616179386|FG001|Overall Study|Withdrawal of consent|1|||
170501984|NCT05569174|616179385|FG000|Overall Study|Participant wish|0|||
170501985|NCT05569174|616179386|FG001|Overall Study|Participant wish|1|||
170501986|NCT05569174|616179385|FG000|Overall Study|Lost to Follow-up|0|||
170501987|NCT05569174|616179386|FG001|Overall Study|Lost to Follow-up|1|||
170501988|NCT02503657|616179387|FG000|Open-label Period|Physician Decision|0|||
170501989|NCT02503657|616179388|FG001|Open-label Period|Physician Decision|1|||
170501990|NCT01175356|616179395|FG000|Overall Study|Death|1|||
170501991|NCT01175356|616179395|FG000|Overall Study|Lack of Efficacy|12|||
170501992|NCT01175356|616179395|FG000|Overall Study|Lost to Follow-up|1|||
170501993|NCT01175356|616179395|FG000|Overall Study|Physician Decision|23|||
170501994|NCT01175356|616179395|FG000|Overall Study|Ineligible|1|||
170501995|NCT01175356|616179395|FG000|Overall Study|Treatment Slot Not Available|18|||
170501996|NCT01175356|616179395|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
170501997|NCT01175356|616179395|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
170501998|NCT01175356|616179395|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
170501999|NCT01175356|616179395|FG000|Overall Study|Inadequate stem cell for transplant|1|||
170502000|NCT01175356|616179395|FG000|Overall Study|Initiation other tx prior to completion|9|||
170502001|NCT02750202|616179396|FG000|Overall Study|Lost to Follow-up|3|||
170502002|NCT02750202|616179397|FG001|Overall Study|Lost to Follow-up|1|||
170502003|NCT01458951|616179407|FG000|Overall Study|Other|1|||
170502004|NCT01458951|616179408|FG001|Overall Study|Other|0|||
170502005|NCT01458951|616179409|FG002|Overall Study|Other|0|||
170502006|NCT01458951|616179407|FG000|Overall Study|Protocol Violation|5|||
170502007|NCT01458951|616179408|FG001|Overall Study|Protocol Violation|1|||
170502008|NCT01458951|616179409|FG002|Overall Study|Protocol Violation|0|||
170502009|NCT01458951|616179407|FG000|Overall Study|Withdrawal by Subject|2|||
170502010|NCT01458951|616179408|FG001|Overall Study|Withdrawal by Subject|0|||
170502011|NCT01458951|616179409|FG002|Overall Study|Withdrawal by Subject|2|||
170502012|NCT01458951|616179407|FG000|Overall Study|Adverse Event|7|||
170502013|NCT01458951|616179408|FG001|Overall Study|Adverse Event|0|||
170502014|NCT01458951|616179409|FG002|Overall Study|Adverse Event|2|||
170502015|NCT01458951|616179407|FG000|Overall Study|Insufficient Clinical Response|17|||
170502016|NCT01458951|616179408|FG001|Overall Study|Insufficient Clinical Response|0|||
170551928|NCT05166902|616366451|FG001|First Intervention|Lost to Follow-up|1|||
170551929|NCT00337194|616366452|FG000|Overall Study|Adverse Event|5|||
170551930|NCT00337194|616366453|FG001|Overall Study|Adverse Event|1|||
170551931|NCT00337194|616366452|FG000|Overall Study|Death|2|||
170551932|NCT00337194|616366453|FG001|Overall Study|Death|0|||
170551933|NCT00337194|616366452|FG000|Overall Study|Withdrawal by Subject|1|||
170551934|NCT00337194|616366453|FG001|Overall Study|Withdrawal by Subject|0|||
170551935|NCT00337194|616366452|FG000|Overall Study|Disease progression|1|||
170551936|NCT00337194|616366453|FG001|Overall Study|Disease progression|2|||
170551937|NCT00337194|616366452|FG000|Overall Study|Subsequent non-protocol therapy|3|||
170551938|NCT00337194|616366453|FG001|Overall Study|Subsequent non-protocol therapy|1|||
170502017|NCT01458951|616179409|FG002|Overall Study|Insufficient Clinical Response|11|||
170502018|NCT07265245|616179410|FG000|Overall Study|Lost to Follow-up|17|||
170502019|NCT04392167|616179411|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
170551939|NCT00128492|616366454|FG000|Overall Study|AE unrelated to study|2|||
170551940|NCT00128492|616366455|FG001|Overall Study|AE unrelated to study|9|||
170551941|NCT00128492|616366454|FG000|Overall Study|Study drug intolerance (AE)|2|||
170551942|NCT00128492|616366455|FG001|Overall Study|Study drug intolerance (AE)|8|||
170502020|NCT05770895|616179412|FG000|Overall Study|Randomized but never treated|0|||
170502021|NCT05770895|616179413|FG001|Overall Study|Randomized but never treated|0|||
170502022|NCT05770895|616179414|FG002|Overall Study|Randomized but never treated|2|||
170502023|NCT05770895|616179415|FG003|Overall Study|Randomized but never treated|0|||
170502024|NCT05770895|616179416|FG004|Overall Study|Randomized but never treated|0|||
170502025|NCT05770895|616179417|FG005|Overall Study|Randomized but never treated|0|||
170551943|NCT00128492|616366454|FG000|Overall Study|AE related to study|1|||
170551944|NCT00128492|616366455|FG001|Overall Study|AE related to study|4|||
170551945|NCT00128492|616366454|FG000|Overall Study|Death|1|||
170551946|NCT00128492|616366455|FG001|Overall Study|Death|0|||
170551947|NCT00128492|616366454|FG000|Overall Study|Lost to Follow-up|1|||
170551948|NCT00128492|616366455|FG001|Overall Study|Lost to Follow-up|5|||
170551949|NCT00128492|616366454|FG000|Overall Study|Noncompliance|0|||
170551950|NCT00128492|616366455|FG001|Overall Study|Noncompliance|5|||
170551951|NCT00128492|616366454|FG000|Overall Study|Personal or administrative|10|||
170551952|NCT00128492|616366455|FG001|Overall Study|Personal or administrative|22|||
170551953|NCT00128492|616366454|FG000|Overall Study|Withdrawal by Subject|3|||
170551954|NCT00128492|616366455|FG001|Overall Study|Withdrawal by Subject|5|||
170551955|NCT00128492|616366454|FG000|Overall Study|Pregnancy|0|||
170551956|NCT00128492|616366455|FG001|Overall Study|Pregnancy|1|||
170551957|NCT03436420|616366456|FG000|Overall Study|Lack of Efficacy|3|||
170551958|NCT00756314|616366459|FG000|Overall Study|Lost to Follow-up|2|||
170502026|NCT05770895|616179418|FG006|Overall Study|Randomized but never treated|0|||
170502027|NCT05770895|616179419|FG007|Overall Study|Randomized but never treated|0|||
170502028|NCT05770895|616179420|FG008|Overall Study|Randomized but never treated|0|||
170502029|NCT05770895|616179421|FG009|Overall Study|Randomized but never treated|0|||
170502030|NCT05770895|616179412|FG000|Overall Study|Withdrew consent|0|||
170502031|NCT05770895|616179413|FG001|Overall Study|Withdrew consent|0|||
170502032|NCT05770895|616179414|FG002|Overall Study|Withdrew consent|0|||
170502033|NCT05770895|616179415|FG003|Overall Study|Withdrew consent|0|||
170502034|NCT05770895|616179416|FG004|Overall Study|Withdrew consent|2|||
170502035|NCT05770895|616179417|FG005|Overall Study|Withdrew consent|0|||
170502036|NCT05770895|616179418|FG006|Overall Study|Withdrew consent|0|||
170502037|NCT05770895|616179419|FG007|Overall Study|Withdrew consent|0|||
170502038|NCT05770895|616179420|FG008|Overall Study|Withdrew consent|0|||
170502039|NCT05770895|616179421|FG009|Overall Study|Withdrew consent|0|||
170502040|NCT03309696|616179422|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
170502041|NCT03309696|616179423|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
170502042|NCT03309696|616179424|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
170502043|NCT03309696|616179425|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
170502044|NCT04803214|616179426|FG000|Overall Study|Adverse Event|1|||
170502045|NCT04803214|616179427|FG001|Overall Study|Adverse Event|0|||
170502046|NCT04803214|616179426|FG000|Overall Study|Withdrawal by Subject|1|||
170502047|NCT04803214|616179427|FG001|Overall Study|Withdrawal by Subject|2|||
170502048|NCT04803214|616179426|FG000|Overall Study|Lost to Follow-up|2|||
170502049|NCT04803214|616179427|FG001|Overall Study|Lost to Follow-up|4|||
170502050|NCT04803214|616179426|FG000|Overall Study|Physician Decision|1|||
170502051|NCT04803214|616179427|FG001|Overall Study|Physician Decision|1|||
170502052|NCT04803214|616179426|FG000|Overall Study|Missed 12 month visit|0|||
170502053|NCT04803214|616179427|FG001|Overall Study|Missed 12 month visit|3|||
170502054|NCT05071209|616179429|FG000|Overall Study|Lack of Efficacy|8|||
170502055|NCT05071209|616179430|FG001|Overall Study|Lack of Efficacy|1|||
170502056|NCT05071209|616179431|FG002|Overall Study|Lack of Efficacy|9|||
170502057|NCT05071209|616179432|FG003|Overall Study|Lack of Efficacy|8|||
170502058|NCT05071209|616179433|FG004|Overall Study|Lack of Efficacy|2|||
170502059|NCT05071209|616179429|FG000|Overall Study|Withdrawal by Subject|0|||
170502060|NCT05071209|616179430|FG001|Overall Study|Withdrawal by Subject|0|||
170502061|NCT05071209|616179431|FG002|Overall Study|Withdrawal by Subject|1|||
170502062|NCT05071209|616179432|FG003|Overall Study|Withdrawal by Subject|1|||
170502063|NCT05071209|616179433|FG004|Overall Study|Withdrawal by Subject|1|||
170502064|NCT02411656|616179434|FG000|Overall Study|Adverse Event|4|||
170502065|NCT02411656|616179434|FG000|Overall Study|Clinical Progression|33|||
170502066|NCT04619004|616179440|FG000|Overall Study|Death|114|||
170502067|NCT04619004|616179441|FG001|Overall Study|Death|28|||
170502068|NCT04619004|616179440|FG000|Overall Study|Lost to Follow-up|1|||
170502069|NCT04619004|616179441|FG001|Overall Study|Lost to Follow-up|1|||
170502070|NCT04619004|616179440|FG000|Overall Study|Withdrawal by Subject|24|||
170502071|NCT04619004|616179441|FG001|Overall Study|Withdrawal by Subject|7|||
170502072|NCT04619004|616179440|FG000|Overall Study|Other - Not specified|0|||
170551959|NCT00756314|616366460|FG001|Overall Study|Lost to Follow-up|59|||
170551960|NCT01903720|616366461|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
170551961|NCT01903720|616366461|FG000|Overall Study|Adverse Event|1|||
170551962|NCT01903720|616366461|FG000|Overall Study|Rescinding of informed consent|2|||
170551963|NCT01903720|616366461|FG000|Overall Study|Lost to Follow-up|2|||
170502073|NCT04619004|616179441|FG001|Overall Study|Other - Not specified|1|||
170502074|NCT00741091|616179446|FG000|Overall Study|Death|13|||
170502075|NCT00741091|616179446|FG000|Overall Study|Lost to Follow-up|16|||
170502076|NCT00741091|616179446|FG000|Overall Study|Withdrawal by Subject|6|||
170502077|NCT00741091|616179446|FG000|Overall Study|Missed Visit|22|||
170502078|NCT04093492|616179451|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
170502079|NCT04093492|616179452|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
170502080|NCT04093492|616179453|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
170551964|NCT01903720|616366461|FG000|Overall Study|Treatment with alternative drug|1|||
170502081|NCT04093492|616179454|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
170502082|NCT04093492|616179451|FG000|25 Weeks Gestational Age (GA)|No response|5|||
170502083|NCT04093492|616179452|FG001|25 Weeks Gestational Age (GA)|No response|5|||
170502084|NCT04093492|616179453|FG002|25 Weeks Gestational Age (GA)|No response|5|||
170502085|NCT04093492|616179454|FG003|25 Weeks Gestational Age (GA)|No response|2|||
170502086|NCT04093492|616179451|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
170502087|NCT04093492|616179452|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
170502088|NCT04093492|616179453|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
170502089|NCT04093492|616179454|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
170502090|NCT04093492|616179451|FG000|30 Weeks GA|Delivered before assessment|1|||
170903705|NCT01794780|617649190|FG004|Overall Study|Other|1|||
170903706|NCT01794780|617649191|FG005|Overall Study|Other|24|||
170502091|NCT04093492|616179452|FG001|30 Weeks GA|Delivered before assessment|2|||
170502092|NCT04093492|616179453|FG002|30 Weeks GA|Delivered before assessment|0|||
170502093|NCT04093492|616179454|FG003|30 Weeks GA|Delivered before assessment|0|||
170502094|NCT04093492|616179451|FG000|30 Weeks GA|No response|7|||
170502095|NCT04093492|616179452|FG001|30 Weeks GA|No response|5|||
170502096|NCT04093492|616179453|FG002|30 Weeks GA|No response|5|||
170502097|NCT04093492|616179454|FG003|30 Weeks GA|No response|2|||
170502098|NCT04093492|616179451|FG000|30 Weeks GA|Lost to Follow-up|0|||
170502099|NCT04093492|616179452|FG001|30 Weeks GA|Lost to Follow-up|1|||
170903707|NCT01794780|617649192|FG006|Overall Study|Other|4|||
170903708|NCT01794780|617649193|FG007|Overall Study|Other|1|||
170903709|NCT00519077|617649194|FG000|Overall Study|Death|6|||
170903710|NCT00519077|617649194|FG000|Overall Study|Other|2|||
170502100|NCT04093492|616179453|FG002|30 Weeks GA|Lost to Follow-up|0|||
170502101|NCT04093492|616179454|FG003|30 Weeks GA|Lost to Follow-up|0|||
170502102|NCT04093492|616179451|FG000|34 Weeks GA|Delivered before assessment|6|||
170502103|NCT04093492|616179452|FG001|34 Weeks GA|Delivered before assessment|3|||
170502104|NCT04093492|616179453|FG002|34 Weeks GA|Delivered before assessment|0|||
170502105|NCT04093492|616179454|FG003|34 Weeks GA|Delivered before assessment|0|||
170502106|NCT04093492|616179451|FG000|34 Weeks GA|No response|0|||
170502107|NCT04093492|616179452|FG001|34 Weeks GA|No response|7|||
170502108|NCT04093492|616179453|FG002|34 Weeks GA|No response|5|||
170502109|NCT04093492|616179454|FG003|34 Weeks GA|No response|3|||
170502110|NCT04093492|616179451|FG000|34 Weeks GA|Lost to Follow-up|0|||
170502111|NCT04093492|616179452|FG001|34 Weeks GA|Lost to Follow-up|1|||
170502112|NCT04093492|616179453|FG002|34 Weeks GA|Lost to Follow-up|0|||
170502113|NCT04093492|616179454|FG003|34 Weeks GA|Lost to Follow-up|0|||
170502114|NCT01711619|616179458|FG000|Overall Study|Early study termination|10|||
170502115|NCT01711619|616179459|FG001|Overall Study|Early study termination|14|||
170502116|NCT01711619|616179458|FG000|Overall Study|Withdrawal by Subject|3|||
170502117|NCT01711619|616179459|FG001|Overall Study|Withdrawal by Subject|7|||
170502118|NCT01711619|616179458|FG000|Overall Study|Protocol Violation|2|||
170502119|NCT01711619|616179459|FG001|Overall Study|Protocol Violation|3|||
170903711|NCT02286102|617649196|FG000|Overall Study|Screen Failure|1|||
170903712|NCT02286102|617649197|FG001|Overall Study|Screen Failure|1|||
170903713|NCT01967225|617649198|FG000|Overall Study|Adverse Event|3|||
170903714|NCT01967225|617649199|FG001|Overall Study|Adverse Event|1|||
170903715|NCT01967225|617649198|FG000|Overall Study|Withdrawal by Subject|2|||
170903716|NCT01967225|617649199|FG001|Overall Study|Withdrawal by Subject|1|||
170903717|NCT01967225|617649198|FG000|Overall Study|Lack of Efficacy|1|||
170903718|NCT01967225|617649199|FG001|Overall Study|Lack of Efficacy|1|||
170903719|NCT01967225|617649198|FG000|Overall Study|Switching to other therapy|2|||
170903720|NCT01967225|617649199|FG001|Overall Study|Switching to other therapy|0|||
170903721|NCT01967225|617649198|FG000|Overall Study|Protocol driven decision point|1|||
170903722|NCT01967225|617649199|FG001|Overall Study|Protocol driven decision point|0|||
170903723|NCT01967225|617649198|FG000|Overall Study|Logistical difficulties|1|||
170903724|NCT01967225|617649199|FG001|Overall Study|Logistical difficulties|0|||
170903725|NCT01967225|617649198|FG000|Overall Study|Protocol Violation|2|||
170502120|NCT01711619|616179458|FG000|Overall Study|Adverse Event|2|||
170502121|NCT01711619|616179459|FG001|Overall Study|Adverse Event|0|||
170502122|NCT01711619|616179458|FG000|Overall Study|Lost to Follow-up|1|||
170502123|NCT01711619|616179459|FG001|Overall Study|Lost to Follow-up|0|||
170502124|NCT04631107|616179460|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
170551965|NCT03627468|616366462|FG000|Overall Study|Adverse Event|5|||
170903726|NCT01967225|617649199|FG001|Overall Study|Protocol Violation|0|||
170903727|NCT02120417|617649200|FG000|Overall Study|Death|5|||
170903728|NCT02120417|617649201|FG001|Overall Study|Death|1|||
170502125|NCT04631107|616179460|FG000|Second Intervention (1 Night)|Adverse Event|1|||
170502126|NCT04631107|616179460|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
170502127|NCT04631107|616179460|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
170502128|NCT04158648|616179461|FG000|Overall Study|Ongoing in the Study|69|||
170502129|NCT04158648|616179461|FG000|Overall Study|Withdrawal by Subject|4|||
170502130|NCT01231906|616179462|FG000|Overall Study|Lack of Efficacy|75|||
170551966|NCT03627468|616366463|FG001|Overall Study|Adverse Event|33|||
170903729|NCT02120417|617649200|FG000|Overall Study|Adverse Event|3|||
170903730|NCT02120417|617649201|FG001|Overall Study|Adverse Event|9|||
170903731|NCT02120417|617649200|FG000|Overall Study|Participant decision|4|||
170903732|NCT02120417|617649201|FG001|Overall Study|Participant decision|4|||
170903733|NCT02120417|617649200|FG000|Overall Study|Disease progression|41|||
170903734|NCT02120417|617649201|FG001|Overall Study|Disease progression|45|||
170903735|NCT02120417|617649200|FG000|Overall Study|Noncompliance with study treatment|0|||
170903736|NCT02120417|617649201|FG001|Overall Study|Noncompliance with study treatment|2|||
170903737|NCT02120417|617649200|FG000|Overall Study|Physician Decision|2|||
170903738|NCT02120417|617649201|FG001|Overall Study|Physician Decision|3|||
170903739|NCT02120417|617649200|FG000|Overall Study|Other unspecified|5|||
170903740|NCT02120417|617649201|FG001|Overall Study|Other unspecified|4|||
170903741|NCT00927485|617649202|FG000|Overall Study|Adverse Event|4|||
170903742|NCT00927485|617649203|FG001|Overall Study|Adverse Event|2|||
170903743|NCT00927485|617649202|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
170903744|NCT00927485|617649203|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
170903745|NCT00327444|617649204|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
170903746|NCT00327444|617649205|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
170903747|NCT00327444|617649204|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
170903748|NCT00327444|617649205|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
170903749|NCT00327444|617649204|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
170903750|NCT00327444|617649205|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
170903751|NCT00327444|617649204|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
170903752|NCT00327444|617649205|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
170903753|NCT00327444|617649204|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
170903754|NCT00327444|617649205|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
170903755|NCT00327444|617649204|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
170903756|NCT00327444|617649205|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
170903757|NCT00327444|617649204|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
170903758|NCT00327444|617649205|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
170903759|NCT00327444|617649204|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
170903760|NCT00327444|617649205|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
170903761|NCT02337387|617649207|FG000|Overall Study|Adverse Event|0|||
170903762|NCT02337387|617649208|FG001|Overall Study|Adverse Event|1|||
170903763|NCT02337387|617649209|FG002|Overall Study|Adverse Event|0|||
170903764|NCT02337387|617649210|FG003|Overall Study|Adverse Event|0|||
170903765|NCT02337387|617649207|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
170903766|NCT02337387|617649208|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
170903767|NCT02337387|617649209|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
170502131|NCT01231906|616179463|FG001|Overall Study|Lack of Efficacy|68|||
170502132|NCT01231906|616179462|FG000|Overall Study|Lost to Follow-up|1|||
170502133|NCT01231906|616179463|FG001|Overall Study|Lost to Follow-up|0|||
170502134|NCT01231906|616179462|FG000|Overall Study|Physician Decision|34|||
170502135|NCT01231906|616179463|FG001|Overall Study|Physician Decision|24|||
170502136|NCT01231906|616179462|FG000|Overall Study|Withdrawal by Subject|0|||
170502137|NCT01231906|616179463|FG001|Overall Study|Withdrawal by Subject|4|||
170502138|NCT01231906|616179462|FG000|Overall Study|Ineligible|10|||
170502139|NCT01231906|616179463|FG001|Overall Study|Ineligible|3|||
170502140|NCT01231906|616179462|FG000|Overall Study|No treatment|1|||
170502141|NCT01231906|616179463|FG001|Overall Study|No treatment|2|||
170502142|NCT04601103|616179465|FG000|Overall Study|Needed crown & cleaning|0|||
170502143|NCT04601103|616179466|FG001|Overall Study|Needed crown & cleaning|0|||
170502144|NCT04601103|616179467|FG002|Overall Study|Needed crown & cleaning|1|||
170502145|NCT04601103|616179465|FG000|Overall Study|study was terminated|18|||
170502146|NCT04601103|616179466|FG001|Overall Study|study was terminated|18|||
170642493|NCT01403948|616705272|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
170903768|NCT02337387|617649210|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
170903769|NCT02330419|617649215|FG000|Overall Study|Lost to Follow-up|3|||
170903770|NCT02330419|617649216|FG001|Overall Study|Lost to Follow-up|7|||
170903771|NCT01587989|617649220|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
170903772|NCT01587989|617649221|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
170502147|NCT04601103|616179467|FG002|Overall Study|study was terminated|16|||
170502148|NCT05020899|616179468|FG000|8 Week Follow-up|Lost to Follow-up|3|||
170502149|NCT05020899|616179469|FG001|8 Week Follow-up|Lost to Follow-up|6|||
170502150|NCT05020899|616179468|FG000|12 Week Follow-up|Lost to Follow-up|1|||
170502151|NCT05020899|616179469|FG001|12 Week Follow-up|Lost to Follow-up|0|||
170502152|NCT05020899|616179468|FG000|12 Week Follow-up|Death|0|||
170502153|NCT05020899|616179469|FG001|12 Week Follow-up|Death|1|||
170502154|NCT01068626|616179470|FG000|Overall Study|Adverse Event|3|||
170502155|NCT01068626|616179471|FG001|Overall Study|Adverse Event|0|||
170502156|NCT01068626|616179470|FG000|Overall Study|Withdrawal by Subject|0|||
170502157|NCT01068626|616179471|FG001|Overall Study|Withdrawal by Subject|2|||
170502158|NCT04158739|616179472|FG000|Overall Study|Adverse Event|1|||
170502159|NCT04158739|616179473|FG001|Overall Study|Adverse Event|0|||
170502160|NCT04158739|616179472|FG000|Overall Study|Death|0|||
170502161|NCT04158739|616179473|FG001|Overall Study|Death|1|||
170502162|NCT04158739|616179472|FG000|Overall Study|Lack of Efficacy|3|||
170502163|NCT04158739|616179473|FG001|Overall Study|Lack of Efficacy|7|||
170502164|NCT04158739|616179472|FG000|Overall Study|Physician Decision|0|||
170502165|NCT04158739|616179473|FG001|Overall Study|Physician Decision|1|||
170502166|NCT04158739|616179472|FG000|Overall Study|Withdrawal by Subject|3|||
170502167|NCT04158739|616179473|FG001|Overall Study|Withdrawal by Subject|0|||
170502168|NCT01940900|616179474|FG000|Overall Study|Physician Decision|4|||
170502169|NCT01940900|616179475|FG001|Overall Study|Physician Decision|0|||
170502170|NCT01940900|616179474|FG000|Overall Study|Adverse Event|10|||
170502171|NCT01940900|616179475|FG001|Overall Study|Adverse Event|15|||
170502172|NCT01940900|616179474|FG000|Overall Study|Withdrawal by Subject|11|||
170903773|NCT01587989|617649222|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
170903774|NCT01587989|617649220|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
170903775|NCT01587989|617649221|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
170903776|NCT01587989|617649222|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
170903777|NCT01587989|617649220|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
170903778|NCT01587989|617649221|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
170903779|NCT01587989|617649222|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
170903780|NCT01587989|617649220|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
170903781|NCT01587989|617649221|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
170903782|NCT01587989|617649222|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
170502173|NCT01940900|616179475|FG001|Overall Study|Withdrawal by Subject|15|||
170502174|NCT01940900|616179474|FG000|Overall Study|Lost to Follow-up|1|||
170502175|NCT01940900|616179475|FG001|Overall Study|Lost to Follow-up|0|||
170502176|NCT01940900|616179474|FG000|Overall Study|Sponsor Decision|1|||
170502177|NCT01940900|616179475|FG001|Overall Study|Sponsor Decision|0|||
170502178|NCT01940900|616179474|FG000|Overall Study|subject non-compliance|1|||
170502179|NCT01940900|616179475|FG001|Overall Study|subject non-compliance|1|||
170502180|NCT01940900|616179474|FG000|Overall Study|other|1|||
170502181|NCT01940900|616179475|FG001|Overall Study|other|0|||
170903783|NCT01587989|617649220|FG000|Randomized Study Treatment|Screening failure|0|||
170903784|NCT01587989|617649221|FG001|Randomized Study Treatment|Screening failure|1|||
170903785|NCT01587989|617649222|FG002|Randomized Study Treatment|Screening failure|0|||
170903786|NCT01587989|617649220|FG000|Randomized Study Treatment|Physician Decision|0|||
170903787|NCT01587989|617649221|FG001|Randomized Study Treatment|Physician Decision|0|||
170502182|NCT04713592|616179480|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
170502183|NCT04713592|616179481|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
170903788|NCT01587989|617649222|FG002|Randomized Study Treatment|Physician Decision|1|||
170903789|NCT01392183|617649223|FG000|First Drug Administration|Adverse Event|3|||
170903790|NCT01392183|617649224|FG001|First Drug Administration|Adverse Event|2|||
170903791|NCT01392183|617649223|FG000|First Drug Administration|Death|1|||
170903792|NCT01392183|617649224|FG001|First Drug Administration|Death|0|||
170903793|NCT01392183|617649223|FG000|First Drug Administration|Withdrawal by Subject|10|||
170903794|NCT01392183|617649224|FG001|First Drug Administration|Withdrawal by Subject|17|||
170903795|NCT00963807|617649227|FG000|Overall Study|Physician Decision|2|||
170903796|NCT00963807|617649227|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
170903797|NCT00963807|617649227|FG000|Overall Study|Disease progression|15|||
170903798|NCT03313050|617649229|FG000|Stage 2: 12 Months|Adverse Event|0|||
170903799|NCT03313050|617649230|FG001|Stage 2: 12 Months|Adverse Event|0|||
170903800|NCT03313050|617649231|FG002|Stage 2: 12 Months|Adverse Event|0|||
170903801|NCT03313050|617649232|FG003|Stage 2: 12 Months|Adverse Event|1|||
170502184|NCT04713592|616179482|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
170502185|NCT04713592|616179483|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
170502186|NCT04713592|616179480|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
170502187|NCT04713592|616179481|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
170502188|NCT04713592|616179482|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
170502189|NCT04713592|616179483|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
170502190|NCT04713592|616179480|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
170502191|NCT04713592|616179481|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
170502192|NCT04713592|616179482|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
170502193|NCT04713592|616179483|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
170502194|NCT04713592|616179480|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170903802|NCT03313050|617649229|FG000|Stage 2: 12 Months|Death|0|||
170903803|NCT03313050|617649230|FG001|Stage 2: 12 Months|Death|0|||
170903804|NCT03313050|617649231|FG002|Stage 2: 12 Months|Death|3|||
170903805|NCT03313050|617649232|FG003|Stage 2: 12 Months|Death|0|||
170502195|NCT04713592|616179481|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170551967|NCT03627468|616366462|FG000|Overall Study|Withdrawal by Subject|13|||
170502196|NCT04713592|616179482|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
170551968|NCT03627468|616366463|FG001|Overall Study|Withdrawal by Subject|23|||
170502197|NCT04713592|616179483|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
170502198|NCT04713592|616179480|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
170502199|NCT04713592|616179481|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
170502200|NCT04713592|616179482|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
170502201|NCT04713592|616179483|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
170502202|NCT04713592|616179480|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170502203|NCT04713592|616179481|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170502204|NCT04713592|616179482|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
170502205|NCT04713592|616179483|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
170502206|NCT04713592|616179480|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
170502207|NCT04713592|616179481|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
170502208|NCT04713592|616179482|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
170502209|NCT04713592|616179483|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
170903806|NCT03313050|617649229|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
170903807|NCT03313050|617649230|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
170903808|NCT03313050|617649231|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
170903809|NCT03313050|617649232|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
170903810|NCT03313050|617649229|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
170903811|NCT03313050|617649230|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
170903812|NCT03313050|617649231|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
170502210|NCT02431806|616179486|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
170502211|NCT02431806|616179487|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
170502212|NCT02431806|616179488|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
170502213|NCT02431806|616179489|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
170502214|NCT02431806|616179486|FG000|Double-blind Treatment Period|Adverse Event|4|||
170502215|NCT02431806|616179487|FG001|Double-blind Treatment Period|Adverse Event|7|||
170502216|NCT02431806|616179488|FG002|Double-blind Treatment Period|Adverse Event|11|||
170502217|NCT02431806|616179489|FG003|Double-blind Treatment Period|Adverse Event|7|||
170502218|NCT02431806|616179486|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
170502219|NCT02431806|616179487|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
170502220|NCT02431806|616179488|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
170502221|NCT02431806|616179489|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
170502222|NCT02431806|616179486|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
170502223|NCT02431806|616179487|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
170502224|NCT02431806|616179488|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
170502225|NCT02431806|616179489|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
170502226|NCT02431806|616179486|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
170502227|NCT02431806|616179487|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
170502228|NCT02431806|616179488|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
170502229|NCT02431806|616179489|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
170502230|NCT02431806|616179486|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
170502231|NCT02431806|616179487|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
170502232|NCT02431806|616179488|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
170502233|NCT02431806|616179489|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
170502234|NCT02431806|616179486|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
170502235|NCT02431806|616179487|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
170502236|NCT02431806|616179488|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
170502237|NCT02431806|616179489|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
170502238|NCT03649178|616179490|FG000|Overall Study|Adverse Event|1|||
170502239|NCT03649178|616179491|FG001|Overall Study|Adverse Event|2|||
170502240|NCT03649178|616179490|FG000|Overall Study|Withdrawal by Subject|0|||
170502241|NCT03649178|616179491|FG001|Overall Study|Withdrawal by Subject|2|||
170502242|NCT03649178|616179490|FG000|Overall Study|COVID regulation required halt in protocol|1|||
170502243|NCT03649178|616179491|FG001|Overall Study|COVID regulation required halt in protocol|0|||
170502244|NCT04687072|616179494|FG000|Overall Study|Adverse Event|2|||
170502245|NCT04687072|616179495|FG001|Overall Study|Adverse Event|0|||
170502246|NCT04687072|616179494|FG000|Overall Study|Death|1|||
170502247|NCT04687072|616179495|FG001|Overall Study|Death|0|||
170502248|NCT04687072|616179494|FG000|Overall Study|Lack of Efficacy|2|||
170502249|NCT04687072|616179495|FG001|Overall Study|Lack of Efficacy|1|||
170502250|NCT04687072|616179494|FG000|Overall Study|Physician Decision|1|||
170502251|NCT04687072|616179495|FG001|Overall Study|Physician Decision|0|||
170903813|NCT03313050|617649232|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
170502252|NCT04687072|616179494|FG000|Overall Study|Pregnancy|1|||
170502253|NCT04687072|616179495|FG001|Overall Study|Pregnancy|0|||
170502254|NCT04687072|616179494|FG000|Overall Study|Requires Prohibited Medication|2|||
170502255|NCT04687072|616179495|FG001|Overall Study|Requires Prohibited Medication|0|||
170502256|NCT04687072|616179494|FG000|Overall Study|Withdrawal of Consent|11|||
170502257|NCT04687072|616179495|FG001|Overall Study|Withdrawal of Consent|6|||
170502258|NCT04687072|616179494|FG000|Overall Study|Miscellaneous|4|||
170502259|NCT04687072|616179495|FG001|Overall Study|Miscellaneous|1|||
170502260|NCT00474045|616179498|FG000|Overall Study|Adverse Event|18|||
170903814|NCT03313050|617649229|FG000|Stage 2: 12 Months|Protocol deviation|0|||
170903815|NCT03313050|617649230|FG001|Stage 2: 12 Months|Protocol deviation|0|||
170903816|NCT03313050|617649231|FG002|Stage 2: 12 Months|Protocol deviation|7|||
170903817|NCT03313050|617649232|FG003|Stage 2: 12 Months|Protocol deviation|7|||
170903818|NCT03313050|617649229|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
170903819|NCT03313050|617649230|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
170903820|NCT03313050|617649231|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
170903821|NCT03313050|617649232|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
170903822|NCT03313050|617649229|FG000|Stage 2: 12 Months|Other|0|||
170903823|NCT03313050|617649230|FG001|Stage 2: 12 Months|Other|0|||
170903824|NCT03313050|617649231|FG002|Stage 2: 12 Months|Other|0|||
170903825|NCT03313050|617649232|FG003|Stage 2: 12 Months|Other|1|||
170903826|NCT02432807|617650804|FG000|Overall Study|Adverse Event|0|||
170903827|NCT02432807|617650805|FG001|Overall Study|Adverse Event|2|||
170903828|NCT02432807|617650804|FG000|Overall Study|Lost to Follow-up|1|||
170903829|NCT02432807|617650805|FG001|Overall Study|Lost to Follow-up|0|||
170903830|NCT02432807|617650804|FG000|Overall Study|Withdrawal by Subject|1|||
170903831|NCT02432807|617650805|FG001|Overall Study|Withdrawal by Subject|1|||
170903832|NCT02432807|617650804|FG000|Overall Study|Other|1|||
170903833|NCT02432807|617650805|FG001|Overall Study|Other|1|||
170903834|NCT01503021|617650808|FG000|Overall Study|Adverse Event|7|||
170903835|NCT01503021|617650809|FG001|Overall Study|Adverse Event|6|||
170903836|NCT01503021|617650808|FG000|Overall Study|Death|0|||
170903837|NCT01503021|617650809|FG001|Overall Study|Death|2|||
170903838|NCT01503021|617650808|FG000|Overall Study|Lost to Follow-up|2|||
170903839|NCT01503021|617650809|FG001|Overall Study|Lost to Follow-up|0|||
170903840|NCT01503021|617650808|FG000|Overall Study|Physician Decision|3|||
170903841|NCT01503021|617650809|FG001|Overall Study|Physician Decision|0|||
170903842|NCT01503021|617650808|FG000|Overall Study|Protocol Violation|1|||
170903843|NCT01503021|617650809|FG001|Overall Study|Protocol Violation|3|||
170903844|NCT01503021|617650808|FG000|Overall Study|Withdrawal by Subject|9|||
170903845|NCT01503021|617650809|FG001|Overall Study|Withdrawal by Subject|8|||
170903846|NCT01503021|617650808|FG000|Overall Study|Moved, received transplant, etc.|5|||
170903847|NCT01503021|617650809|FG001|Overall Study|Moved, received transplant, etc.|7|||
170903848|NCT00391976|617650810|FG000|Overall Study|Adverse Event|0|||
170903849|NCT00391976|617650811|FG001|Overall Study|Adverse Event|0|||
170903850|NCT00391976|617650812|FG002|Overall Study|Adverse Event|1|||
170903851|NCT00391976|617650810|FG000|Overall Study|Withdrawal of consent|0|||
170903852|NCT00391976|617650811|FG001|Overall Study|Withdrawal of consent|1|||
170903853|NCT00391976|617650812|FG002|Overall Study|Withdrawal of consent|1|||
170903854|NCT00391976|617650810|FG000|Overall Study|Lost to Follow-up|1|||
170903855|NCT00391976|617650811|FG001|Overall Study|Lost to Follow-up|2|||
170903856|NCT00391976|617650812|FG002|Overall Study|Lost to Follow-up|0|||
170903857|NCT00391976|617650810|FG000|Overall Study|Inappropriate enrollment|1|||
170903858|NCT00391976|617650811|FG001|Overall Study|Inappropriate enrollment|1|||
170903859|NCT00391976|617650812|FG002|Overall Study|Inappropriate enrollment|0|||
170903860|NCT00391976|617650810|FG000|Overall Study|Protocol deviation/violation|4|||
170903861|NCT00391976|617650811|FG001|Overall Study|Protocol deviation/violation|2|||
170903862|NCT00391976|617650812|FG002|Overall Study|Protocol deviation/violation|1|||
170903863|NCT00391976|617650810|FG000|Overall Study|Recurrence/no eradication of infection|21|||
170903864|NCT00391976|617650811|FG001|Overall Study|Recurrence/no eradication of infection|19|||
170903865|NCT00391976|617650812|FG002|Overall Study|Recurrence/no eradication of infection|0|||
170903866|NCT00391976|617650810|FG000|Overall Study|Unable to classify|0|||
170903867|NCT00391976|617650811|FG001|Overall Study|Unable to classify|0|||
170903868|NCT00391976|617650812|FG002|Overall Study|Unable to classify|1|||
170903869|NCT00391976|617650810|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
170903870|NCT00391976|617650811|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
170903871|NCT00391976|617650812|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
170903872|NCT05127486|617650813|FG000|Overall Study|Adverse Event|2|||
170903873|NCT05127486|617650814|FG001|Overall Study|Adverse Event|4|||
170903874|NCT05127486|617650813|FG000|Overall Study|Lack of Efficacy|1|||
170551969|NCT03627468|616366462|FG000|Overall Study|Physician Decision|1|||
170551970|NCT03627468|616366463|FG001|Overall Study|Physician Decision|0|||
170551971|NCT03627468|616366462|FG000|Overall Study|Protocol Violation|0|||
170551972|NCT03627468|616366463|FG001|Overall Study|Protocol Violation|2|||
170551973|NCT03627468|616366462|FG000|Overall Study|Lost to Follow-up|10|||
170551974|NCT03627468|616366463|FG001|Overall Study|Lost to Follow-up|16|||
170903875|NCT05127486|617650814|FG001|Overall Study|Lack of Efficacy|0|||
170903876|NCT05127486|617650813|FG000|Overall Study|Pregnancy|0|||
170903877|NCT05127486|617650814|FG001|Overall Study|Pregnancy|1|||
170551975|NCT03627468|616366462|FG000|Overall Study|Death|1|||
170903878|NCT05127486|617650813|FG000|Overall Study|Physician Decision|4|||
170903879|NCT05127486|617650814|FG001|Overall Study|Physician Decision|1|||
170551976|NCT03627468|616366463|FG001|Overall Study|Death|0|||
170551977|NCT03627468|616366462|FG000|Overall Study|Pregnancy|1|||
170903880|NCT05127486|617650813|FG000|Overall Study|Withdrawal by Subject|14|||
170903881|NCT05127486|617650814|FG001|Overall Study|Withdrawal by Subject|13|||
170903882|NCT05127486|617650813|FG000|Overall Study|Lost to Follow-up|5|||
170903883|NCT05127486|617650814|FG001|Overall Study|Lost to Follow-up|8|||
170903884|NCT02582515|617650815|FG000|Overall Study|Withdrawal by Subject|0|||
170903885|NCT02582515|617650816|FG001|Overall Study|Withdrawal by Subject|1|||
170903886|NCT02725788|617650821|FG000|Overall Study|Lost to Follow-up|1|||
170903887|NCT02725788|617650822|FG001|Overall Study|Lost to Follow-up|1|||
170903888|NCT02725788|617650821|FG000|Overall Study|Protocol Violation|0|||
170903889|NCT02725788|617650822|FG001|Overall Study|Protocol Violation|1|||
170903890|NCT02688647|617650823|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
170903891|NCT02688647|617650824|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
170903892|NCT02688647|617650823|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
170903893|NCT02688647|617650824|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
170903894|NCT02688647|617650823|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
170903895|NCT02688647|617650824|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
170903896|NCT02688647|617650823|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
170502261|NCT00474045|616179499|FG001|Overall Study|Adverse Event|8|||
170502262|NCT00474045|616179498|FG000|Overall Study|Unclassified|1|||
170502263|NCT00474045|616179499|FG001|Overall Study|Unclassified|3|||
170502264|NCT00474045|616179498|FG000|Overall Study|Lack of Efficacy|0|||
170502265|NCT00474045|616179499|FG001|Overall Study|Lack of Efficacy|9|||
170502266|NCT00474045|616179498|FG000|Overall Study|Lost to Follow-up|1|||
170502267|NCT00474045|616179499|FG001|Overall Study|Lost to Follow-up|1|||
170502268|NCT00474045|616179498|FG000|Overall Study|Protocol Violation|10|||
170502269|NCT00474045|616179499|FG001|Overall Study|Protocol Violation|12|||
170502270|NCT00474045|616179498|FG000|Overall Study|Withdrawal by Subject|16|||
170502271|NCT00474045|616179499|FG001|Overall Study|Withdrawal by Subject|18|||
170502272|NCT00474045|616179498|FG000|Overall Study|Withdrawal criteria|60|||
170502273|NCT00474045|616179499|FG001|Overall Study|Withdrawal criteria|50|||
170502274|NCT02009397|616179508|FG000|Overall Study|Protocol Violation|6|||
170502275|NCT02009397|616179508|FG000|Overall Study|Death|8|||
170502276|NCT02009397|616179508|FG000|Overall Study|Lost to Follow-up|6|||
170502277|NCT00087126|616180524|FG000|Overall Study|Ineligible - second primary|1|||
170502278|NCT00087126|616180524|FG000|Overall Study|Never treated|1|||
170502279|NCT00096993|616180531|FG000|Overall Study|Death|1|||
170502280|NCT00096993|616180532|FG001|Overall Study|Death|0|||
170502281|NCT00096993|616180531|FG000|Overall Study|Disease progression|56|||
170502282|NCT00096993|616180532|FG001|Overall Study|Disease progression|53|||
170502283|NCT00096993|616180531|FG000|Overall Study|Adverse Event|2|||
170903897|NCT02688647|617650824|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
170903898|NCT02688647|617650823|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
170903899|NCT02688647|617650824|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
170903900|NCT02688647|617650823|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
170903901|NCT02688647|617650824|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
170903902|NCT02688647|617650823|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
170903903|NCT02688647|617650824|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
170903904|NCT02542267|617650825|FG000|Overall Study|Withdrawal by Subject|10|||
170903905|NCT02542267|617650825|FG000|Overall Study|Physician Decision|6|||
170903906|NCT02542267|617650825|FG000|Overall Study|Lost to Follow-up|4|||
170903907|NCT02542267|617650825|FG000|Overall Study|Death|13|||
170903908|NCT02542267|617650825|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
170903909|NCT02542267|617650825|FG000|Overall Study|Other|9|||
170903910|NCT00474240|617650826|FG000|Overall Study|Withdrawal by Subject|1|||
170903911|NCT00474240|617650827|FG001|Overall Study|Withdrawal by Subject|1|||
170903912|NCT00474240|617650828|FG002|Overall Study|Withdrawal by Subject|0|||
170903913|NCT00474240|617650829|FG003|Overall Study|Withdrawal by Subject|2|||
170903914|NCT00474240|617650830|FG004|Overall Study|Withdrawal by Subject|3|||
170903915|NCT00474240|617650831|FG005|Overall Study|Withdrawal by Subject|1|||
170903916|NCT00474240|617650826|FG000|Overall Study|Adverse Event|0|||
170903917|NCT00474240|617650827|FG001|Overall Study|Adverse Event|0|||
170903918|NCT00474240|617650828|FG002|Overall Study|Adverse Event|9|||
170903919|NCT00474240|617650829|FG003|Overall Study|Adverse Event|14|||
170903920|NCT00474240|617650830|FG004|Overall Study|Adverse Event|5|||
170903921|NCT00474240|617650831|FG005|Overall Study|Adverse Event|16|||
170903922|NCT00474240|617650826|FG000|Overall Study|Removed due to lab value|0|||
170502284|NCT00096993|616180532|FG001|Overall Study|Adverse Event|8|||
170502285|NCT00096993|616180531|FG000|Overall Study|Subject's decision|3|||
170502286|NCT00096993|616180532|FG001|Overall Study|Subject's decision|1|||
170502287|NCT00096993|616180531|FG000|Overall Study|Physician Decision|2|||
170502288|NCT00096993|616180532|FG001|Overall Study|Physician Decision|1|||
170502289|NCT00096993|616180531|FG000|Overall Study|Non-compliance|0|||
170502290|NCT00096993|616180532|FG001|Overall Study|Non-compliance|1|||
170502291|NCT00096993|616180531|FG000|Overall Study|Other unspecified|1|||
170502292|NCT00096993|616180532|FG001|Overall Study|Other unspecified|1|||
170903923|NCT00474240|617650827|FG001|Overall Study|Removed due to lab value|0|||
170903924|NCT00474240|617650828|FG002|Overall Study|Removed due to lab value|0|||
170903925|NCT00474240|617650829|FG003|Overall Study|Removed due to lab value|0|||
170903926|NCT00474240|617650830|FG004|Overall Study|Removed due to lab value|0|||
170903927|NCT00474240|617650831|FG005|Overall Study|Removed due to lab value|1|||
170903928|NCT00502840|617650832|FG000|Overall Study|Adverse Event|5|||
170903929|NCT00502840|617650832|FG000|Overall Study|Additional or changed therapy|48|||
170903930|NCT00502840|617650832|FG000|Overall Study|Lack of Efficacy|11|||
170903931|NCT00502840|617650832|FG000|Overall Study|Protocol Violation|4|||
170903932|NCT00502840|617650832|FG000|Overall Study|Withdrawal by Subject|5|||
170903933|NCT00502840|617650832|FG000|Overall Study|Lost to Follow-up|6|||
170903934|NCT00502840|617650832|FG000|Overall Study|Administrative problems|1|||
170502293|NCT00513357|616180533|FG000|Overall Study|did not receive allocated placebo|2|||
170502294|NCT00513357|616180534|FG001|Overall Study|did not receive allocated placebo|3|||
170502295|NCT00513357|616180533|FG000|Overall Study|Adverse Event|4|||
170502296|NCT00513357|616180534|FG001|Overall Study|Adverse Event|2|||
170502297|NCT00513357|616180533|FG000|Overall Study|Death|2|||
170502298|NCT00513357|616180534|FG001|Overall Study|Death|0|||
170502299|NCT00513357|616180533|FG000|Overall Study|Withdrawal by Subject|5|||
170502300|NCT00513357|616180534|FG001|Overall Study|Withdrawal by Subject|4|||
170502301|NCT00513357|616180533|FG000|Overall Study|Disease Progression|2|||
170502302|NCT00513357|616180534|FG001|Overall Study|Disease Progression|1|||
170502303|NCT01162122|616180535|FG000|Overall Study|Withdrawal by Subject|52|||
170502304|NCT01162122|616180536|FG001|Overall Study|Withdrawal by Subject|43|||
170502305|NCT01162122|616180535|FG000|Overall Study|Lost to Follow-up|73|||
170502306|NCT01162122|616180536|FG001|Overall Study|Lost to Follow-up|91|||
170502307|NCT01162122|616180535|FG000|Overall Study|Adverse Event|3|||
170502308|NCT01162122|616180536|FG001|Overall Study|Adverse Event|2|||
170502309|NCT01162122|616180535|FG000|Overall Study|Death|51|||
170502310|NCT01162122|616180536|FG001|Overall Study|Death|46|||
170502311|NCT01162122|616180535|FG000|Overall Study|Protocol Violation|2|||
170502312|NCT01162122|616180536|FG001|Overall Study|Protocol Violation|2|||
170502313|NCT01162122|616180535|FG000|Overall Study|Inappropriate enrollment|5|||
170502314|NCT01162122|616180536|FG001|Overall Study|Inappropriate enrollment|4|||
170502315|NCT01162122|616180535|FG000|Overall Study|Administrative reason|1|||
170502316|NCT01162122|616180536|FG001|Overall Study|Administrative reason|1|||
170502317|NCT01162122|616180535|FG000|Overall Study|Unable to classify|3|||
170502318|NCT01162122|616180536|FG001|Overall Study|Unable to classify|7|||
170502319|NCT01162122|616180535|FG000|Overall Study|Missing primary reason|1|||
170502320|NCT01162122|616180536|FG001|Overall Study|Missing primary reason|0|||
170502321|NCT02020512|616180537|FG000|Overall Study|Adverse Event|1|||
170502322|NCT02020512|616180537|FG000|Overall Study|Lost to Follow-up|3|||
170502323|NCT02020512|616180537|FG000|Overall Study|Protocol Violation|4|||
170502324|NCT00656851|616180541|FG000|Overall Study|Withdrawal by Subject|0|||
170502325|NCT00656851|616180542|FG001|Overall Study|Withdrawal by Subject|4|||
170502326|NCT00835679|616180543|FG000|Overall Study|Withdrawal by Subject|1|||
170502327|NCT00835679|616180544|FG001|Overall Study|Withdrawal by Subject|0|||
170502328|NCT00835679|616180545|FG002|Overall Study|Withdrawal by Subject|0|||
170502329|NCT00835679|616180546|FG003|Overall Study|Withdrawal by Subject|0|||
170502330|NCT03091192|616180549|FG000|Overall Study|Study terminated by sponsor|21|||
170502331|NCT03091192|616180550|FG001|Overall Study|Study terminated by sponsor|14|||
170502332|NCT03091192|616180549|FG000|Overall Study|Death|9|||
170502333|NCT03091192|616180550|FG001|Overall Study|Death|13|||
170502334|NCT03091192|616180549|FG000|Overall Study|Withdrawal by Subject|2|||
170502335|NCT03091192|616180550|FG001|Overall Study|Withdrawal by Subject|0|||
170502336|NCT03091192|616180549|FG000|Overall Study|Lost to Follow-up|1|||
170502337|NCT03091192|616180550|FG001|Overall Study|Lost to Follow-up|0|||
170502338|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|3|||
170903935|NCT00502840|617650832|FG000|Overall Study|Other|20|||
170903936|NCT02945657|617650833|FG000|Overall Study|Adverse Event|1|||
170903937|NCT02945657|617650833|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
170903938|NCT00809133|617650834|FG000|Overall Study|Progressive disease|2|||
170903939|NCT00809133|617650835|FG001|Overall Study|Progressive disease|5|||
170502339|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
170502340|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
170903940|NCT00809133|617650836|FG002|Overall Study|Progressive disease|5|||
170903941|NCT00809133|617650837|FG003|Overall Study|Progressive disease|3|||
170502341|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
170502342|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
170502343|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
170502344|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
170502345|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
170502346|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|10|||
170502347|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
170502348|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
170502349|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
170903942|NCT00809133|617650838|FG004|Overall Study|Progressive disease|4|||
170903943|NCT00809133|617650839|FG005|Overall Study|Progressive disease|1|||
170502350|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
170502351|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
170903944|NCT00809133|617650840|FG006|Overall Study|Progressive disease|3|||
170903945|NCT00809133|617650841|FG007|Overall Study|Progressive disease|3|||
170903946|NCT00809133|617650842|FG008|Overall Study|Progressive disease|3|||
170903947|NCT00809133|617650843|FG009|Overall Study|Progressive disease|9|||
170903948|NCT00809133|617650844|FG010|Overall Study|Progressive disease|5|||
170903949|NCT00809133|617650845|FG011|Overall Study|Progressive disease|7|||
170903950|NCT00809133|617650846|FG012|Overall Study|Progressive disease|5|||
170903951|NCT00809133|617650847|FG013|Overall Study|Progressive disease|4|||
170903952|NCT00809133|617650834|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903953|NCT00809133|617650835|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903954|NCT00809133|617650836|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903955|NCT00809133|617650837|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903956|NCT00809133|617650838|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903957|NCT00809133|617650839|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
170903958|NCT00809133|617650840|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
170903959|NCT00809133|617650841|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
170903960|NCT00809133|617650842|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903961|NCT00809133|617650843|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903962|NCT00809133|617650844|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170502352|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
170502353|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
170502354|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|11|||
170903963|NCT00809133|617650845|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903964|NCT00809133|617650846|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170903965|NCT00809133|617650847|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
170502355|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
170903966|NCT00809133|617650834|FG000|Overall Study|Other adverse event|1|||
170502356|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
170502357|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
170502358|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
170502359|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
170502360|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
170502361|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
170502362|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|8|||
170502363|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
170502364|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
170502365|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
170502366|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
170502367|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
170502368|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
170502369|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
170502370|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|1|||
170502371|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
170502372|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
170502373|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
170502374|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
170502375|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
170502376|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
170502377|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
170502378|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|16|||
170502379|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
170502380|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
170502381|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
170903967|NCT00809133|617650835|FG001|Overall Study|Other adverse event|1|||
170903968|NCT00809133|617650836|FG002|Overall Study|Other adverse event|1|||
170502382|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
170502383|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
170502384|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
170502385|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
170903969|NCT00809133|617650837|FG003|Overall Study|Other adverse event|0|||
170903970|NCT00809133|617650838|FG004|Overall Study|Other adverse event|0|||
170903971|NCT00809133|617650839|FG005|Overall Study|Other adverse event|3|||
170502386|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|1|||
170502387|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
170502388|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
170502389|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
170502390|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
170502391|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
170502392|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
170502393|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
170502394|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Other|7|||
170502395|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
170502396|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
170805185|NCT03477175|617296055|FG001|Overall Study|Adverse Event|5|||
170805186|NCT03477175|617296054|FG000|Overall Study|Disease Progression|7|||
170502397|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
170502398|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
170502399|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
170502400|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
170502401|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
170502402|NCT03818035|616180551|FG000|Part 1: Open-label (Week 0 to Week 8)|Death|1|||
170502403|NCT03818035|616180552|FG001|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
170502404|NCT03818035|616180553|FG002|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
170502405|NCT03818035|616180554|FG003|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
170502406|NCT03818035|616180555|FG004|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
170502407|NCT03818035|616180556|FG005|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
170805187|NCT03477175|617296055|FG001|Overall Study|Disease Progression|7|||
170805188|NCT04300023|617296056|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
170805189|NCT04300023|617296057|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
170805190|NCT04057131|617296058|FG000|Overall Study|Protocol Violation|24|||
170805191|NCT03227861|617296063|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
170805192|NCT03227861|617296063|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
170805193|NCT03227861|617296063|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
170805194|NCT03227861|617296063|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
170805195|NCT03227861|617296063|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
170805196|NCT03227861|617296063|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
170805197|NCT03227861|617296063|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
170805198|NCT03227861|617296063|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
170805199|NCT03227861|617296063|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
170805200|NCT03227861|617296063|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
170805201|NCT04484623|617296064|FG000|Overall Study|Lost to Follow-up|0|||
170805202|NCT04484623|617296065|FG001|Overall Study|Lost to Follow-up|1|||
170805203|NCT04484623|617296064|FG000|Overall Study|Protocol Deviation|1|||
170805204|NCT04484623|617296065|FG001|Overall Study|Protocol Deviation|0|||
170805205|NCT04484623|617296064|FG000|Overall Study|Physician Decision|1|||
170805206|NCT04484623|617296065|FG001|Overall Study|Physician Decision|0|||
170805207|NCT04484623|617296064|FG000|Overall Study|Withdrawal by Subject|11|||
170805208|NCT04484623|617296065|FG001|Overall Study|Withdrawal by Subject|8|||
170805209|NCT04484623|617296064|FG000|Overall Study|Ongoing|94|||
170805210|NCT04484623|617296065|FG001|Overall Study|Ongoing|84|||
170805211|NCT00491894|617296067|FG000|Overall Study|Adverse Event|14|||
170805212|NCT00491894|617296067|FG000|Overall Study|Withdrawal by Subject|5|||
170805213|NCT00491894|617296067|FG000|Overall Study|Death|3|||
170805214|NCT00491894|617296067|FG000|Overall Study|Lost to Follow-up|3|||
170805215|NCT00491894|617296067|FG000|Overall Study|Lack of Efficacy|2|||
170805216|NCT00491894|617296067|FG000|Overall Study|Other-Failed to meet any criteria|2|||
170805217|NCT00491894|617296067|FG000|Overall Study|Physician Decision|2|||
170805218|NCT00491894|617296067|FG000|Overall Study|Protocol Violation|2|||
170805219|NCT00491894|617296067|FG000|Overall Study|Other-Intake of prohibited medication|1|||
170805220|NCT07204444|617296068|FG000|Overall Study|Medical/Hospitalization|6|||
170805221|NCT07204444|617296069|FG001|Overall Study|Medical/Hospitalization|9|||
170805222|NCT07204444|617296070|FG002|Overall Study|Medical/Hospitalization|6|||
170805223|NCT07204444|617296068|FG000|Overall Study|Treatment Provider Issue|1|||
170805224|NCT07204444|617296069|FG001|Overall Study|Treatment Provider Issue|3|||
170805225|NCT07204444|617296070|FG002|Overall Study|Treatment Provider Issue|0|||
170805226|NCT07204444|617296068|FG000|Overall Study|Withdrawal by Subject|11|||
170805227|NCT07204444|617296069|FG001|Overall Study|Withdrawal by Subject|5|||
170805228|NCT07204444|617296070|FG002|Overall Study|Withdrawal by Subject|5|||
170805229|NCT07204444|617296068|FG000|Overall Study|Death|3|||
170805230|NCT07204444|617296069|FG001|Overall Study|Death|6|||
170805231|NCT07204444|617296070|FG002|Overall Study|Death|1|||
170805232|NCT07204444|617296068|FG000|Overall Study|Unable To Reach|29|||
170805233|NCT07204444|617296069|FG001|Overall Study|Unable To Reach|26|||
170805234|NCT07204444|617296070|FG002|Overall Study|Unable To Reach|17|||
170502408|NCT03818035|616180557|FG006|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
170502409|NCT03818035|616180558|FG007|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
170502410|NCT03818035|616180551|FG000|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
170502411|NCT03818035|616180552|FG001|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
170502412|NCT03818035|616180553|FG002|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
170502413|NCT03818035|616180554|FG003|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|4|||
170502414|NCT03818035|616180555|FG004|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
170502415|NCT03818035|616180556|FG005|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
170502416|NCT03818035|616180557|FG006|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
170502417|NCT03818035|616180558|FG007|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
170502418|NCT03818035|616180551|FG000|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
170502419|NCT03818035|616180552|FG001|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|6|||
170502420|NCT03818035|616180553|FG002|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|1|||
170502421|NCT03818035|616180554|FG003|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|9|||
170502422|NCT03818035|616180555|FG004|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
170502423|NCT03818035|616180556|FG005|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
170502424|NCT03818035|616180557|FG006|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
170502425|NCT03818035|616180558|FG007|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
170502426|NCT03818035|616180551|FG000|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
170502427|NCT03818035|616180552|FG001|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
170502428|NCT03818035|616180553|FG002|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
170502429|NCT03818035|616180554|FG003|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|8|||
170502430|NCT03818035|616180555|FG004|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
170502431|NCT03818035|616180556|FG005|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
170502432|NCT03818035|616180557|FG006|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
170502433|NCT03818035|616180558|FG007|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
170502434|NCT03818035|616180551|FG000|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
170502435|NCT03818035|616180552|FG001|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|3|||
170502436|NCT03818035|616180553|FG002|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|4|||
170502437|NCT03818035|616180554|FG003|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|6|||
170502438|NCT03818035|616180555|FG004|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
170502439|NCT03818035|616180556|FG005|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
170502440|NCT03818035|616180557|FG006|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
170903972|NCT00809133|617650840|FG006|Overall Study|Other adverse event|2|||
170903973|NCT00809133|617650841|FG007|Overall Study|Other adverse event|4|||
170903974|NCT00809133|617650842|FG008|Overall Study|Other adverse event|0|||
170903975|NCT00809133|617650843|FG009|Overall Study|Other adverse event|0|||
170903976|NCT00809133|617650844|FG010|Overall Study|Other adverse event|1|||
170903977|NCT00809133|617650845|FG011|Overall Study|Other adverse event|1|||
170502441|NCT03818035|616180558|FG007|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
170502442|NCT03818035|616180551|FG000|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
170502443|NCT03818035|616180552|FG001|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
170502444|NCT03818035|616180553|FG002|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
170502445|NCT03818035|616180554|FG003|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|1|||
170502446|NCT03818035|616180555|FG004|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
170502447|NCT03818035|616180556|FG005|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
170502448|NCT03818035|616180557|FG006|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
170502449|NCT03818035|616180558|FG007|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
170502450|NCT03818035|616180551|FG000|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
170502451|NCT03818035|616180552|FG001|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|1|||
170502452|NCT03818035|616180553|FG002|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|2|||
170805235|NCT07204444|617296068|FG000|Overall Study|Protocol Deviation|3|||
170805236|NCT07204444|617296069|FG001|Overall Study|Protocol Deviation|2|||
170805237|NCT07204444|617296070|FG002|Overall Study|Protocol Deviation|0|||
170805238|NCT05815342|617297296|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
170805239|NCT05815342|617297296|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
170805240|NCT05815342|617297296|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
170805241|NCT05815342|617297296|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
170805242|NCT05815342|617297296|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
170805243|NCT00747006|617297297|FG000|Overall Study|Adverse Event|1|||
170805244|NCT00747006|617297298|FG001|Overall Study|Adverse Event|0|||
170805245|NCT00747006|617297299|FG002|Overall Study|Adverse Event|0|||
170805246|NCT00747006|617297297|FG000|Overall Study|Lost to Follow-up|0|||
170805247|NCT00747006|617297298|FG001|Overall Study|Lost to Follow-up|1|||
170805248|NCT00747006|617297299|FG002|Overall Study|Lost to Follow-up|0|||
170502453|NCT03818035|616180554|FG003|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
170502454|NCT03818035|616180555|FG004|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
170502455|NCT03818035|616180556|FG005|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
170502456|NCT03818035|616180557|FG006|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
170502457|NCT03818035|616180558|FG007|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
170502458|NCT03818035|616180551|FG000|Part 2: Double-blind (Week28 to Week68)|Other|0|||
170502459|NCT03818035|616180552|FG001|Part 2: Double-blind (Week28 to Week68)|Other|1|||
170502460|NCT03818035|616180553|FG002|Part 2: Double-blind (Week28 to Week68)|Other|1|||
170502461|NCT03818035|616180554|FG003|Part 2: Double-blind (Week28 to Week68)|Other|1|||
170502462|NCT03818035|616180555|FG004|Part 2: Double-blind (Week28 to Week68)|Other|0|||
170551978|NCT03627468|616366463|FG001|Overall Study|Pregnancy|1|||
170551979|NCT03627468|616366462|FG000|Overall Study|Lack of Efficacy|0|||
170805249|NCT00747006|617297297|FG000|Overall Study|Physician Decision|2|||
170805250|NCT00747006|617297298|FG001|Overall Study|Physician Decision|0|||
170805251|NCT00747006|617297299|FG002|Overall Study|Physician Decision|1|||
170805252|NCT00345046|617297300|FG000|Overall Study|Protocol Violation|1|||
170805253|NCT00345046|617297301|FG001|Overall Study|Protocol Violation|1|||
170805254|NCT00345046|617297302|FG002|Overall Study|Protocol Violation|2|||
170805255|NCT01613417|617297305|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
170805256|NCT01613417|617297306|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
170805257|NCT00512252|617297307|FG000|Overall Study|Lost to Follow-up|0|||
170805258|NCT00512252|617297308|FG001|Overall Study|Lost to Follow-up|0|||
170805259|NCT00512252|617297309|FG002|Overall Study|Lost to Follow-up|1|||
170805260|NCT00512252|617297307|FG000|Overall Study|Protocol Violation|0|||
170805261|NCT00512252|617297308|FG001|Overall Study|Protocol Violation|0|||
170805262|NCT00512252|617297309|FG002|Overall Study|Protocol Violation|1|||
170805263|NCT00512252|617297307|FG000|Overall Study|Death|0|||
170805264|NCT00512252|617297308|FG001|Overall Study|Death|0|||
170805265|NCT00512252|617297309|FG002|Overall Study|Death|1|||
170805266|NCT01767467|617297315|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
170805267|NCT01767467|617297316|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
170805268|NCT01767467|617297315|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
170805269|NCT01767467|617297316|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
170805270|NCT01767467|617297315|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
170805271|NCT01767467|617297316|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
170805272|NCT01767467|617297315|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
170805273|NCT01767467|617297316|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
170805274|NCT01767467|617297315|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
170805275|NCT01767467|617297316|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
170805276|NCT01767467|617297315|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
170805277|NCT01767467|617297316|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
170805278|NCT01767467|617297315|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
170805279|NCT01767467|617297316|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
170805280|NCT01767467|617297315|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
170805281|NCT01767467|617297316|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
170805282|NCT01767467|617297315|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
170805283|NCT01767467|617297316|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
170805284|NCT01767467|617297315|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
170805285|NCT01767467|617297316|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
170805286|NCT01767467|617297315|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
170805287|NCT01767467|617297316|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
170805288|NCT01767467|617297315|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
170805289|NCT01767467|617297316|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
170805290|NCT01767467|617297315|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
170805291|NCT01767467|617297316|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
170805292|NCT01767467|617297315|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
170805293|NCT01767467|617297316|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
170805294|NCT01359150|617297317|FG000|Overall Study|Lack of Efficacy|1|||
170805295|NCT01359150|617297318|FG001|Overall Study|Lack of Efficacy|1|||
170805296|NCT01359150|617297317|FG000|Overall Study|Withdrawal by Subject|1|||
170805297|NCT01359150|617297318|FG001|Overall Study|Withdrawal by Subject|1|||
170805298|NCT01359150|617297317|FG000|Overall Study|Adverse Event|4|||
170805299|NCT01359150|617297318|FG001|Overall Study|Adverse Event|3|||
170805300|NCT01359150|617297317|FG000|Overall Study|Other|1|||
170805301|NCT01359150|617297318|FG001|Overall Study|Other|0|||
170805302|NCT01700205|617297319|FG000|Overall Study|Withdrawal by Subject|13|||
170805303|NCT01700205|617297320|FG001|Overall Study|Withdrawal by Subject|13|||
170805304|NCT01700205|617297319|FG000|Overall Study|Protocol Violation|2|||
170805305|NCT01700205|617297320|FG001|Overall Study|Protocol Violation|2|||
170502463|NCT03818035|616180556|FG005|Part 2: Double-blind (Week28 to Week68)|Other|0|||
170502464|NCT03818035|616180557|FG006|Part 2: Double-blind (Week28 to Week68)|Other|0|||
170502465|NCT03818035|616180558|FG007|Part 2: Double-blind (Week28 to Week68)|Other|0|||
170502466|NCT03818035|616180551|FG000|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
170502467|NCT03818035|616180552|FG001|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
170502468|NCT03818035|616180553|FG002|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
170502469|NCT03818035|616180554|FG003|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
170502470|NCT03818035|616180555|FG004|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
170502471|NCT03818035|616180556|FG005|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
170502472|NCT03818035|616180557|FG006|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|5|||
170502473|NCT03818035|616180558|FG007|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
170502474|NCT03818035|616180551|FG000|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
170502475|NCT03818035|616180552|FG001|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
170502476|NCT03818035|616180553|FG002|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
170502477|NCT03818035|616180554|FG003|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
170502478|NCT03818035|616180555|FG004|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
170502479|NCT03818035|616180556|FG005|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|9|||
170502480|NCT03818035|616180557|FG006|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|3|||
170502481|NCT03818035|616180558|FG007|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
170502482|NCT03818035|616180551|FG000|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
170502483|NCT03818035|616180552|FG001|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
170502484|NCT03818035|616180553|FG002|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
170502485|NCT03818035|616180554|FG003|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
170502486|NCT03818035|616180555|FG004|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
170502487|NCT03818035|616180556|FG005|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
170502488|NCT03818035|616180557|FG006|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|2|||
170502489|NCT03818035|616180558|FG007|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
170502490|NCT03818035|616180551|FG000|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
170502491|NCT03818035|616180552|FG001|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
170502492|NCT03818035|616180553|FG002|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
170502493|NCT03818035|616180554|FG003|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
170502494|NCT03818035|616180555|FG004|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
170502495|NCT03818035|616180556|FG005|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|3|||
170502496|NCT03818035|616180557|FG006|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
170502497|NCT03818035|616180558|FG007|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
170502498|NCT03818035|616180551|FG000|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
170502499|NCT03818035|616180552|FG001|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
170502500|NCT03818035|616180553|FG002|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
170502501|NCT03818035|616180554|FG003|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
170502502|NCT03818035|616180555|FG004|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
170502503|NCT03818035|616180556|FG005|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|5|||
170502504|NCT03818035|616180557|FG006|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|4|||
170502505|NCT03818035|616180558|FG007|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
170502506|NCT03818035|616180551|FG000|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
170502507|NCT03818035|616180552|FG001|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
170502508|NCT03818035|616180553|FG002|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
170502509|NCT03818035|616180554|FG003|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
170502510|NCT03818035|616180555|FG004|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
170502511|NCT03818035|616180556|FG005|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
170502512|NCT03818035|616180557|FG006|Part3: Withdrawal (Week 68 to Week 220)|Other|2|||
170502513|NCT03818035|616180558|FG007|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
170502514|NCT03818035|616180551|FG000|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
170502515|NCT03818035|616180552|FG001|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
170502516|NCT03818035|616180553|FG002|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
170502517|NCT03818035|616180554|FG003|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
170502518|NCT03818035|616180555|FG004|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
170502519|NCT03818035|616180556|FG005|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|112|||
170502520|NCT03818035|616180557|FG006|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|115|||
170502521|NCT03818035|616180558|FG007|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
170502522|NCT03818035|616180551|FG000|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
170502523|NCT03818035|616180552|FG001|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
170551980|NCT03627468|616366463|FG001|Overall Study|Lack of Efficacy|2|||
170805306|NCT04971733|617297325|FG000|Overall Study|Adverse Event|1|||
170805307|NCT04971733|617297326|FG001|Overall Study|Adverse Event|1|||
170502524|NCT03818035|616180553|FG002|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
170502525|NCT03818035|616180554|FG003|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
170502526|NCT03818035|616180555|FG004|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
170502527|NCT03818035|616180556|FG005|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
170502528|NCT03818035|616180557|FG006|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
170502529|NCT03818035|616180558|FG007|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|3|||
170502530|NCT03818035|616180551|FG000|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
170502531|NCT03818035|616180552|FG001|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
170502532|NCT03818035|616180553|FG002|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
170502533|NCT03818035|616180554|FG003|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
170502534|NCT03818035|616180555|FG004|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
170502535|NCT03818035|616180556|FG005|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
170502536|NCT03818035|616180557|FG006|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
170502537|NCT03818035|616180558|FG007|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|1|||
170502538|NCT03818035|616180551|FG000|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
170502539|NCT03818035|616180552|FG001|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
170502540|NCT03818035|616180553|FG002|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
170502541|NCT03818035|616180554|FG003|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
170502542|NCT03818035|616180555|FG004|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
170502543|NCT03818035|616180556|FG005|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
170502544|NCT03818035|616180557|FG006|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
170502545|NCT03818035|616180558|FG007|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|1|||
170502546|NCT03818035|616180551|FG000|Re-treatment (Week R0 Through Week R28)|Other|0|||
170502547|NCT03818035|616180552|FG001|Re-treatment (Week R0 Through Week R28)|Other|0|||
170502548|NCT03818035|616180553|FG002|Re-treatment (Week R0 Through Week R28)|Other|0|||
170502549|NCT03818035|616180554|FG003|Re-treatment (Week R0 Through Week R28)|Other|0|||
170502550|NCT03818035|616180555|FG004|Re-treatment (Week R0 Through Week R28)|Other|0|||
170502551|NCT03818035|616180556|FG005|Re-treatment (Week R0 Through Week R28)|Other|0|||
170502552|NCT03818035|616180557|FG006|Re-treatment (Week R0 Through Week R28)|Other|0|||
170502553|NCT03818035|616180558|FG007|Re-treatment (Week R0 Through Week R28)|Other|3|||
170502554|NCT03814720|616180559|FG000|Overall Study|Lost to Follow-up|0|||
170502555|NCT03814720|616180560|FG001|Overall Study|Lost to Follow-up|1|||
170502556|NCT03814720|616180561|FG002|Overall Study|Lost to Follow-up|0|||
170502557|NCT03814720|616180562|FG003|Overall Study|Lost to Follow-up|0|||
170502558|NCT03814720|616180563|FG004|Overall Study|Lost to Follow-up|0|||
170502559|NCT02135107|616180564|FG000|Treatment Period|Withdrawal by Subject|11|||
170502560|NCT02135107|616180565|FG001|Treatment Period|Withdrawal by Subject|0|||
170502561|NCT02135107|616180566|FG002|Treatment Period|Withdrawal by Subject|0|||
170502562|NCT02135107|616180567|FG003|Treatment Period|Withdrawal by Subject|0|||
170502563|NCT02135107|616180564|FG000|Treatment Period|Adverse Event|5|||
170502564|NCT02135107|616180565|FG001|Treatment Period|Adverse Event|2|||
170502565|NCT02135107|616180566|FG002|Treatment Period|Adverse Event|0|||
170502566|NCT02135107|616180567|FG003|Treatment Period|Adverse Event|0|||
170502567|NCT02135107|616180564|FG000|Treatment Period|Pregnancy|1|||
170502568|NCT02135107|616180565|FG001|Treatment Period|Pregnancy|0|||
170502569|NCT02135107|616180566|FG002|Treatment Period|Pregnancy|0|||
170502570|NCT02135107|616180567|FG003|Treatment Period|Pregnancy|0|||
170502571|NCT02135107|616180564|FG000|Treatment Period|Other|115|||
170502572|NCT02135107|616180565|FG001|Treatment Period|Other|24|||
170903978|NCT00809133|617650846|FG012|Overall Study|Other adverse event|0|||
170903979|NCT00809133|617650847|FG013|Overall Study|Other adverse event|1|||
170903980|NCT00809133|617650834|FG000|Overall Study|Lost to Follow-up|0|||
170502573|NCT02135107|616180566|FG002|Treatment Period|Other|0|||
170502574|NCT02135107|616180567|FG003|Treatment Period|Other|0|||
170502575|NCT02135107|616180564|FG000|Maintenance Therapy Period|Adverse Event|0|||
170502576|NCT02135107|616180565|FG001|Maintenance Therapy Period|Adverse Event|0|||
170502577|NCT02135107|616180566|FG002|Maintenance Therapy Period|Adverse Event|3|||
170502578|NCT02135107|616180567|FG003|Maintenance Therapy Period|Adverse Event|7|||
170502579|NCT02135107|616180564|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
170502580|NCT02135107|616180565|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
170502581|NCT02135107|616180566|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
170502582|NCT02135107|616180567|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
170502583|NCT02135107|616180564|FG000|Maintenance Therapy Period|Pregnancy|0|||
170502584|NCT02135107|616180565|FG001|Maintenance Therapy Period|Pregnancy|0|||
170502585|NCT02135107|616180566|FG002|Maintenance Therapy Period|Pregnancy|0|||
170502586|NCT02135107|616180567|FG003|Maintenance Therapy Period|Pregnancy|1|||
170502587|NCT02135107|616180564|FG000|Maintenance Therapy Period|Other|0|||
170502588|NCT02135107|616180565|FG001|Maintenance Therapy Period|Other|0|||
170502589|NCT02135107|616180566|FG002|Maintenance Therapy Period|Other|7|||
170903981|NCT00809133|617650835|FG001|Overall Study|Lost to Follow-up|0|||
170903982|NCT00809133|617650836|FG002|Overall Study|Lost to Follow-up|0|||
170903983|NCT00809133|617650837|FG003|Overall Study|Lost to Follow-up|0|||
170502590|NCT02135107|616180567|FG003|Maintenance Therapy Period|Other|8|||
170502591|NCT02278120|616180568|FG000|Treatment Period|Progressive disease|234|||
170502592|NCT02278120|616180569|FG001|Treatment Period|Progressive disease|260|||
170502593|NCT02278120|616180568|FG000|Treatment Period|Subject/guardian decision|23|||
170502594|NCT02278120|616180569|FG001|Treatment Period|Subject/guardian decision|20|||
170502595|NCT02278120|616180568|FG000|Treatment Period|Adverse Event|16|||
170502596|NCT02278120|616180569|FG001|Treatment Period|Adverse Event|14|||
170502597|NCT02278120|616180568|FG000|Treatment Period|Physician Decision|14|||
170502598|NCT02278120|616180569|FG001|Treatment Period|Physician Decision|27|||
170502599|NCT02278120|616180568|FG000|Treatment Period|Death|3|||
170502600|NCT02278120|616180569|FG001|Treatment Period|Death|3|||
170502601|NCT02278120|616180568|FG000|Treatment Period|Lost to Follow-up|2|||
170502602|NCT02278120|616180569|FG001|Treatment Period|Lost to Follow-up|0|||
170502603|NCT02278120|616180568|FG000|Treatment Period|Protocol deviation|0|||
170502604|NCT02278120|616180569|FG001|Treatment Period|Protocol deviation|2|||
170502605|NCT02278120|616180568|FG000|Treatment Period|Study terminated as per protocol|43|||
170502606|NCT02278120|616180569|FG001|Treatment Period|Study terminated as per protocol|11|||
170502607|NCT02278120|616180568|FG000|Post-treatment Efficacy Follow-up|Death|0|||
170502608|NCT02278120|616180569|FG001|Post-treatment Efficacy Follow-up|Death|1|||
170502609|NCT02278120|616180568|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
170502610|NCT02278120|616180569|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
170502611|NCT02278120|616180568|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
170502612|NCT02278120|616180569|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
170502613|NCT02278120|616180568|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
170502614|NCT02278120|616180569|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
170502615|NCT02278120|616180568|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
170502616|NCT02278120|616180569|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
170502617|NCT01966068|616180573|FG000|Overall Study|Withdrawal by Subject|57|||
170502618|NCT01966068|616180573|FG000|Overall Study|Lost to Follow-up|81|||
170502619|NCT00808639|616180574|FG000|Overall Study|Disease progression before surgery.|1|||
170502620|NCT03197324|616180577|FG000|Overall Study|Adverse Event|0|||
170502621|NCT03197324|616180578|FG001|Overall Study|Adverse Event|1|||
170502622|NCT00191282|616180580|FG000|Overall Study|Adverse Event|5|||
170502623|NCT00191282|616180581|FG001|Overall Study|Adverse Event|6|||
170502624|NCT00191282|616180580|FG000|Overall Study|Death|51|||
170502625|NCT00191282|616180581|FG001|Overall Study|Death|51|||
170502626|NCT00191282|616180580|FG000|Overall Study|Lack of Efficacy|11|||
170502627|NCT00191282|616180581|FG001|Overall Study|Lack of Efficacy|6|||
170502628|NCT00191282|616180580|FG000|Overall Study|Noncompliance|14|||
170502629|NCT00191282|616180581|FG001|Overall Study|Noncompliance|17|||
170502630|NCT00191282|616180580|FG000|Overall Study|Patient moved|11|||
170502631|NCT00191282|616180581|FG001|Overall Study|Patient moved|14|||
170502632|NCT00191282|616180580|FG000|Overall Study|Withdrawal by Subject|59|||
170502633|NCT00191282|616180581|FG001|Overall Study|Withdrawal by Subject|44|||
170502634|NCT00191282|616180580|FG000|Overall Study|Physician Decision|18|||
170502635|NCT00191282|616180581|FG001|Overall Study|Physician Decision|15|||
170502636|NCT00191282|616180580|FG000|Overall Study|Protocol entry criteria not met|14|||
170502637|NCT00191282|616180581|FG001|Overall Study|Protocol entry criteria not met|9|||
170502638|NCT00191282|616180580|FG000|Overall Study|Protocol Violation|9|||
170502639|NCT00191282|616180581|FG001|Overall Study|Protocol Violation|12|||
170502640|NCT00191282|616180580|FG000|Overall Study|Severity of outcome|2|||
170502641|NCT00191282|616180581|FG001|Overall Study|Severity of outcome|5|||
170502642|NCT00191282|616180580|FG000|Overall Study|Sponsor's decision|2|||
170502643|NCT00191282|616180581|FG001|Overall Study|Sponsor's decision|2|||
170502644|NCT00191282|616180580|FG000|Overall Study|Lost to Follow-up|24|||
170502645|NCT00191282|616180581|FG001|Overall Study|Lost to Follow-up|31|||
170502646|NCT03589976|616180582|FG000|Overall Study|Death|5|||
170502647|NCT03589976|616180583|FG001|Overall Study|Death|1|||
170502648|NCT03589976|616180582|FG000|Overall Study|Adverse Event|5|||
170502649|NCT03589976|616180583|FG001|Overall Study|Adverse Event|1|||
170502650|NCT03589976|616180582|FG000|Overall Study|Withdrawal by Subject|4|||
170502651|NCT03589976|616180583|FG001|Overall Study|Withdrawal by Subject|1|||
170502652|NCT03589976|616180582|FG000|Overall Study|Lost to Follow-up|1|||
170502653|NCT03589976|616180583|FG001|Overall Study|Lost to Follow-up|0|||
170502654|NCT03589976|616180582|FG000|Overall Study|Other|4|||
170502655|NCT03589976|616180583|FG001|Overall Study|Other|3|||
170502656|NCT00336024|616180586|FG000|Overall Study|Death|2|||
170502657|NCT00336024|616180587|FG001|Overall Study|Death|1|||
170502658|NCT00336024|616180586|FG000|Overall Study|Physician Decision|4|||
170502659|NCT00336024|616180587|FG001|Overall Study|Physician Decision|1|||
170502660|NCT00336024|616180586|FG000|Overall Study|Protocol Violation|1|||
170502661|NCT00336024|616180587|FG001|Overall Study|Protocol Violation|0|||
170502662|NCT00336024|616180586|FG000|Overall Study|Withdrawal by Subject|1|||
170502663|NCT00336024|616180587|FG001|Overall Study|Withdrawal by Subject|2|||
170502664|NCT00336024|616180586|FG000|Overall Study|Failure to fulfill consolidation|1|||
170502665|NCT00336024|616180587|FG001|Overall Study|Failure to fulfill consolidation|1|||
170502666|NCT00336024|616180586|FG000|Overall Study|Progressive Disease|4|||
170502667|NCT00336024|616180587|FG001|Overall Study|Progressive Disease|7|||
170502668|NCT00336024|616180586|FG000|Overall Study|Ineligible|7|||
170502669|NCT00336024|616180587|FG001|Overall Study|Ineligible|7|||
170502670|NCT00084318|616180588|FG000|Overall Study|Withdrawal by Subject|5|||
170502671|NCT00084318|616180589|FG001|Overall Study|Withdrawal by Subject|2|||
170502672|NCT00084318|616180588|FG000|Overall Study|Protocol Violation|15|||
170502673|NCT00084318|616180589|FG001|Overall Study|Protocol Violation|11|||
170502674|NCT00084318|616180588|FG000|Overall Study|No protocol treatment|2|||
170502675|NCT00084318|616180589|FG001|Overall Study|No protocol treatment|0|||
170502676|NCT00778102|616180590|FG000|Overall Study|Adverse Event|8|||
170502677|NCT00778102|616180591|FG001|Overall Study|Adverse Event|5|||
170502678|NCT00778102|616180590|FG000|Overall Study|Death|1|||
170502679|NCT00778102|616180591|FG001|Overall Study|Death|1|||
170502680|NCT00778102|616180590|FG000|Overall Study|Lost to Follow-up|1|||
170502681|NCT00778102|616180591|FG001|Overall Study|Lost to Follow-up|0|||
170502682|NCT00778102|616180590|FG000|Overall Study|Violation of Selection Criteria|1|||
170502683|NCT00778102|616180591|FG001|Overall Study|Violation of Selection Criteria|1|||
170502684|NCT00778102|616180590|FG000|Overall Study|Protocol Violation|0|||
170502685|NCT00778102|616180591|FG001|Overall Study|Protocol Violation|1|||
170502686|NCT00778102|616180590|FG000|Overall Study|Refused Treatment|2|||
170502687|NCT00778102|616180591|FG001|Overall Study|Refused Treatment|3|||
170502688|NCT00778102|616180590|FG000|Overall Study|Withdrawal by Subject|1|||
170502689|NCT00778102|616180591|FG001|Overall Study|Withdrawal by Subject|1|||
170502690|NCT00778102|616180590|FG000|Overall Study|Administrative Reason|7|||
170502691|NCT00778102|616180591|FG001|Overall Study|Administrative Reason|10|||
170502692|NCT05008484|616180593|FG000|Overall Study|Withdrawal by Subject|1|||
170502693|NCT05008484|616180594|FG001|Overall Study|Withdrawal by Subject|1|||
170502694|NCT01328548|616180598|FG000|Overall Study|Death|3|||
170502695|NCT01328548|616180599|FG001|Overall Study|Death|0|||
170502696|NCT01328548|616180598|FG000|Overall Study|Protocol Violation|1|||
170502697|NCT01328548|616180599|FG001|Overall Study|Protocol Violation|0|||
170502698|NCT04095689|616180600|FG000|Overall Study|Adverse Event|3|||
170502699|NCT04095689|616180600|FG000|Overall Study|Lack of Efficacy|1|||
170502700|NCT04095689|616180600|FG000|Overall Study|Death|1|||
170502701|NCT02824562|616182048|FG000|Overall Study|Lost to Follow-up|3|||
170502702|NCT02824562|616182049|FG001|Overall Study|Lost to Follow-up|4|||
170502703|NCT02824562|616182048|FG000|Overall Study|Death|0|||
170502704|NCT02824562|616182049|FG001|Overall Study|Death|1|||
170502705|NCT00908596|616182050|FG000|Overall Study|Other reasons|46|||
170502706|NCT00908596|616182051|FG001|Overall Study|Other reasons|6|||
170502707|NCT00908596|616182052|FG002|Overall Study|Other reasons|2|||
170502708|NCT00908596|616182053|FG003|Overall Study|Other reasons|0|||
170502709|NCT00908596|616182050|FG000|Overall Study|Lost to Follow-up|0|||
170502710|NCT00908596|616182051|FG001|Overall Study|Lost to Follow-up|1|||
170502711|NCT00908596|616182052|FG002|Overall Study|Lost to Follow-up|12|||
170502712|NCT00908596|616182053|FG003|Overall Study|Lost to Follow-up|4|||
170502713|NCT00908596|616182050|FG000|Overall Study|Death|0|||
170502714|NCT00908596|616182051|FG001|Overall Study|Death|5|||
170502715|NCT00908596|616182052|FG002|Overall Study|Death|57|||
170502716|NCT00908596|616182053|FG003|Overall Study|Death|32|||
170502717|NCT00908596|616182050|FG000|Overall Study|Protocol Violation|1|||
170502718|NCT00908596|616182051|FG001|Overall Study|Protocol Violation|0|||
170551981|NCT03627468|616366462|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
170551982|NCT03627468|616366463|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
170551983|NCT04829214|616366468|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
170551984|NCT04829214|616366469|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
170805308|NCT04971733|617297325|FG000|Overall Study|Subject choice|2|||
170805309|NCT04971733|617297326|FG001|Overall Study|Subject choice|0|||
170805310|NCT04971733|617297325|FG000|Overall Study|Withdrawal by Subject|1|||
170805311|NCT04971733|617297326|FG001|Overall Study|Withdrawal by Subject|0|||
170805312|NCT04971733|617297325|FG000|Overall Study|Other|1|||
170805313|NCT04971733|617297326|FG001|Overall Study|Other|0|||
170805314|NCT03021993|617297327|FG000|Overall Study|Withdrawal by Subject|4|||
170805315|NCT03021993|617297327|FG000|Overall Study|Physician Decision|1|||
170805316|NCT03021993|617297327|FG000|Overall Study|enrolled but were not treated|1|||
170805317|NCT03021993|617297327|FG000|Overall Study|Death|3|||
170805318|NCT00600353|617297330|FG000|Overall Study|history of malignancy within 5 years|1|||
170805319|NCT00600353|617297331|FG001|Overall Study|history of malignancy within 5 years|0|||
170805320|NCT00600353|617297330|FG000|Overall Study|History of prepartive regimen|0|||
170805321|NCT00600353|617297331|FG001|Overall Study|History of prepartive regimen|1|||
170805322|NCT04941482|617297332|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
170805323|NCT04941482|617297333|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
170805324|NCT03745313|617297336|FG000|At 30 Days Follow-up|Death|2|||
170502719|NCT00908596|616182052|FG002|Overall Study|Protocol Violation|0|||
170502720|NCT00908596|616182053|FG003|Overall Study|Protocol Violation|0|||
170502721|NCT00908596|616182050|FG000|Overall Study|Withdrawal by Subject|0|||
170502722|NCT00908596|616182051|FG001|Overall Study|Withdrawal by Subject|1|||
170502723|NCT00908596|616182052|FG002|Overall Study|Withdrawal by Subject|3|||
170502724|NCT00908596|616182053|FG003|Overall Study|Withdrawal by Subject|1|||
170502725|NCT00224406|616182054|FG000|Overall Study|Re-transplant|0|||
170903984|NCT00809133|617650838|FG004|Overall Study|Lost to Follow-up|0|||
170903985|NCT00809133|617650839|FG005|Overall Study|Lost to Follow-up|1|||
170502726|NCT00224406|616182055|FG001|Overall Study|Re-transplant|2|||
170502727|NCT00224406|616182054|FG000|Overall Study|Death|0|||
170502728|NCT00224406|616182055|FG001|Overall Study|Death|1|||
170502729|NCT00224406|616182054|FG000|Overall Study|Transplant cancelled|0|||
170502730|NCT00224406|616182055|FG001|Overall Study|Transplant cancelled|4|||
170502731|NCT00224406|616182054|FG000|Overall Study|Drug not delivered|2|||
170502732|NCT00224406|616182055|FG001|Overall Study|Drug not delivered|0|||
170502733|NCT00224406|616182054|FG000|Overall Study|Other|4|||
170502734|NCT00224406|616182055|FG001|Overall Study|Other|0|||
170502735|NCT00224406|616182054|FG000|Overall Study|Transplant cancelled|3|||
170502736|NCT00224406|616182055|FG001|Overall Study|Transplant cancelled|0|||
170502737|NCT02921750|616182059|FG000|Overall Study|Adverse Event|1|||
170502738|NCT02921750|616182060|FG001|Overall Study|Adverse Event|2|||
170551985|NCT04829214|616366468|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
170551986|NCT04829214|616366469|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
170551987|NCT00609973|616366470|FG000|Overall Study|Adverse Event|2|||
170551988|NCT00609973|616366471|FG001|Overall Study|Adverse Event|1|||
170551989|NCT00609973|616366470|FG000|Overall Study|Protocol Violation|4|||
170551990|NCT00609973|616366471|FG001|Overall Study|Protocol Violation|3|||
170903986|NCT00809133|617650840|FG006|Overall Study|Lost to Follow-up|0|||
170903987|NCT00809133|617650841|FG007|Overall Study|Lost to Follow-up|0|||
170903988|NCT00809133|617650842|FG008|Overall Study|Lost to Follow-up|0|||
170903989|NCT00809133|617650843|FG009|Overall Study|Lost to Follow-up|0|||
170903990|NCT00809133|617650844|FG010|Overall Study|Lost to Follow-up|0|||
170903991|NCT00809133|617650845|FG011|Overall Study|Lost to Follow-up|0|||
170903992|NCT00809133|617650846|FG012|Overall Study|Lost to Follow-up|0|||
170903993|NCT00809133|617650847|FG013|Overall Study|Lost to Follow-up|0|||
170903994|NCT00809133|617650834|FG000|Overall Study|Consent withdrawn|0|||
170903995|NCT00809133|617650835|FG001|Overall Study|Consent withdrawn|0|||
170903996|NCT00809133|617650836|FG002|Overall Study|Consent withdrawn|0|||
170903997|NCT00809133|617650837|FG003|Overall Study|Consent withdrawn|0|||
170903998|NCT00809133|617650838|FG004|Overall Study|Consent withdrawn|1|||
170903999|NCT00809133|617650839|FG005|Overall Study|Consent withdrawn|0|||
170904000|NCT00809133|617650840|FG006|Overall Study|Consent withdrawn|0|||
170904001|NCT00809133|617650841|FG007|Overall Study|Consent withdrawn|0|||
170904002|NCT00809133|617650842|FG008|Overall Study|Consent withdrawn|0|||
170904003|NCT00809133|617650843|FG009|Overall Study|Consent withdrawn|0|||
170904004|NCT00809133|617650844|FG010|Overall Study|Consent withdrawn|0|||
170904005|NCT00809133|617650845|FG011|Overall Study|Consent withdrawn|0|||
170904006|NCT00809133|617650846|FG012|Overall Study|Consent withdrawn|0|||
170551991|NCT00609973|616366470|FG000|Overall Study|Lost to Follow-up|2|||
170551992|NCT00609973|616366471|FG001|Overall Study|Lost to Follow-up|1|||
170551993|NCT00609973|616366470|FG000|Overall Study|Withdrawal by Subject|0|||
170551994|NCT00609973|616366471|FG001|Overall Study|Withdrawal by Subject|1|||
170551995|NCT04008069|616366472|FG000|Open-Label Period|Adverse Event|1|||
170551996|NCT04008069|616366473|FG001|Open-Label Period|Adverse Event|0|||
170551997|NCT04008069|616366474|FG002|Open-Label Period|Adverse Event|0|||
170551998|NCT04008069|616366472|FG000|Open-Label Period|Lack of Efficacy|4|||
170551999|NCT04008069|616366473|FG001|Open-Label Period|Lack of Efficacy|0|||
170552000|NCT04008069|616366474|FG002|Open-Label Period|Lack of Efficacy|0|||
170552001|NCT04008069|616366472|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
170552002|NCT04008069|616366473|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
170552003|NCT04008069|616366474|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
170552004|NCT04008069|616366472|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
170552005|NCT04008069|616366473|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
170552006|NCT04008069|616366474|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
170904007|NCT00809133|617650847|FG013|Overall Study|Consent withdrawn|0|||
170904008|NCT00809133|617650834|FG000|Overall Study|Other not mentioned above|0|||
170904009|NCT00809133|617650835|FG001|Overall Study|Other not mentioned above|1|||
170904010|NCT00809133|617650836|FG002|Overall Study|Other not mentioned above|0|||
170904011|NCT00809133|617650837|FG003|Overall Study|Other not mentioned above|0|||
170904012|NCT00809133|617650838|FG004|Overall Study|Other not mentioned above|0|||
170552007|NCT02369159|616366476|FG000|Overall Study|Adverse Event|0|||
170552008|NCT02369159|616366477|FG001|Overall Study|Adverse Event|1|||
170552009|NCT02369159|616366476|FG000|Overall Study|Lost to Follow-up|1|||
170904013|NCT00809133|617650839|FG005|Overall Study|Other not mentioned above|1|||
170904014|NCT00809133|617650840|FG006|Overall Study|Other not mentioned above|0|||
170904015|NCT00809133|617650841|FG007|Overall Study|Other not mentioned above|0|||
170904016|NCT00809133|617650842|FG008|Overall Study|Other not mentioned above|0|||
170904017|NCT00809133|617650843|FG009|Overall Study|Other not mentioned above|0|||
170502739|NCT02921750|616182059|FG000|Overall Study|Withdrawal by Subject|1|||
170502740|NCT02921750|616182060|FG001|Overall Study|Withdrawal by Subject|1|||
170502741|NCT02921750|616182059|FG000|Overall Study|Lost to Follow-up|3|||
170904018|NCT00809133|617650844|FG010|Overall Study|Other not mentioned above|0|||
170904019|NCT00809133|617650845|FG011|Overall Study|Other not mentioned above|0|||
170904020|NCT00809133|617650846|FG012|Overall Study|Other not mentioned above|0|||
170904021|NCT00809133|617650847|FG013|Overall Study|Other not mentioned above|0|||
170904022|NCT00619229|617650851|FG000|Overall Study|Withdrawal by Subject|1|||
170904023|NCT00619229|617650852|FG001|Overall Study|Withdrawal by Subject|1|||
170904024|NCT00619229|617650851|FG000|Overall Study|Lost to Follow-up|1|||
170904025|NCT00619229|617650852|FG001|Overall Study|Lost to Follow-up|0|||
170904026|NCT00619229|617650851|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
170904027|NCT00619229|617650852|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
170904028|NCT00619229|617650851|FG000|Overall Study|Investigator planned Cataract Operation|1|||
170904029|NCT00619229|617650852|FG001|Overall Study|Investigator planned Cataract Operation|0|||
170904030|NCT01700829|617650853|FG000|Overall Study|Withdrawal by Subject|1|||
170904031|NCT01700829|617650854|FG001|Overall Study|Withdrawal by Subject|1|||
170904032|NCT01075178|617650855|FG000|Subject Matching|eligible but not matched|130|||
170904033|NCT01075178|617650856|FG001|Subject Matching|eligible but not matched|403|||
170904034|NCT01075178|617650855|FG000|Subject Chart Review|died before chart review period|0|||
170904035|NCT01075178|617650856|FG001|Subject Chart Review|died before chart review period|2|||
170904036|NCT01075178|617650855|FG000|Subject Chart Review|no data collected due to site closure|3|||
170904037|NCT01075178|617650856|FG001|Subject Chart Review|no data collected due to site closure|4|||
170904038|NCT01075178|617650855|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
170904039|NCT01075178|617650856|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
170904040|NCT00316264|617650858|FG000|Overall Study|Lost to Follow-up|0|||
170904041|NCT00316264|617650859|FG001|Overall Study|Lost to Follow-up|1|||
170904042|NCT00316264|617650860|FG002|Overall Study|Lost to Follow-up|0|||
170904043|NCT00316264|617650858|FG000|Overall Study|Withdrawal of Consent|3|||
170904044|NCT00316264|617650859|FG001|Overall Study|Withdrawal of Consent|5|||
170904045|NCT00316264|617650860|FG002|Overall Study|Withdrawal of Consent|6|||
170904046|NCT00316264|617650858|FG000|Overall Study|Death|2|||
170904047|NCT00316264|617650859|FG001|Overall Study|Death|0|||
170904048|NCT00316264|617650860|FG002|Overall Study|Death|0|||
170904049|NCT00316264|617650858|FG000|Overall Study|Other|1|||
170904050|NCT00316264|617650859|FG001|Overall Study|Other|1|||
170502742|NCT02921750|616182060|FG001|Overall Study|Lost to Follow-up|3|||
170502743|NCT02921750|616182059|FG000|Overall Study|Wound healed|3|||
170502744|NCT02921750|616182060|FG001|Overall Study|Wound healed|3|||
170502745|NCT02921750|616182059|FG000|Overall Study|Serious Adverse Event|1|||
170502746|NCT02921750|616182060|FG001|Overall Study|Serious Adverse Event|2|||
170502747|NCT01250171|616182062|FG000|Overall Study|Administrative reasons|1|||
170904051|NCT00316264|617650860|FG002|Overall Study|Other|0|||
170904052|NCT00607048|617650861|FG000|Overall Study|Adverse Event|0|||
170904053|NCT00607048|617650862|FG001|Overall Study|Adverse Event|1|||
170904054|NCT00607048|617650863|FG002|Overall Study|Adverse Event|0|||
170904055|NCT00607048|617650864|FG003|Overall Study|Adverse Event|0|||
170904056|NCT00607048|617650865|FG004|Overall Study|Adverse Event|4|||
170904057|NCT00607048|617650866|FG005|Overall Study|Adverse Event|0|||
170904058|NCT00607048|617650861|FG000|Overall Study|Global deterioration of health|1|||
170904059|NCT00607048|617650862|FG001|Overall Study|Global deterioration of health|0|||
170904060|NCT00607048|617650863|FG002|Overall Study|Global deterioration of health|0|||
170904061|NCT00607048|617650864|FG003|Overall Study|Global deterioration of health|0|||
170904062|NCT00607048|617650865|FG004|Overall Study|Global deterioration of health|0|||
170904063|NCT00607048|617650866|FG005|Overall Study|Global deterioration of health|0|||
170904064|NCT00607048|617650861|FG000|Overall Study|Objective disease progression - relapse|1|||
170904065|NCT00607048|617650862|FG001|Overall Study|Objective disease progression - relapse|2|||
170904066|NCT00607048|617650863|FG002|Overall Study|Objective disease progression - relapse|4|||
170904067|NCT00607048|617650864|FG003|Overall Study|Objective disease progression - relapse|2|||
170904068|NCT00607048|617650865|FG004|Overall Study|Objective disease progression - relapse|2|||
170904069|NCT00607048|617650866|FG005|Overall Study|Objective disease progression - relapse|2|||
170904070|NCT00607048|617650861|FG000|Overall Study|Withdrawal by Subject|0|||
170904071|NCT00607048|617650862|FG001|Overall Study|Withdrawal by Subject|0|||
170904072|NCT00607048|617650863|FG002|Overall Study|Withdrawal by Subject|0|||
170502748|NCT01250171|616182063|FG001|Overall Study|Administrative reasons|0|||
170502749|NCT01250171|616182064|FG002|Overall Study|Administrative reasons|0|||
170552010|NCT02369159|616366477|FG001|Overall Study|Lost to Follow-up|1|||
170904073|NCT00607048|617650864|FG003|Overall Study|Withdrawal by Subject|1|||
170904074|NCT00607048|617650865|FG004|Overall Study|Withdrawal by Subject|0|||
170904075|NCT00607048|617650866|FG005|Overall Study|Withdrawal by Subject|2|||
170904076|NCT00607048|617650861|FG000|Overall Study|Other|1|||
170904077|NCT00607048|617650862|FG001|Overall Study|Other|1|||
170904078|NCT00607048|617650863|FG002|Overall Study|Other|0|||
170904079|NCT00607048|617650864|FG003|Overall Study|Other|0|||
170904080|NCT00607048|617650865|FG004|Overall Study|Other|0|||
170904081|NCT00607048|617650866|FG005|Overall Study|Other|1|||
170904082|NCT00466505|617650867|FG000|Overall Study|disease progression|13|||
170502750|NCT04676412|616182068|FG000|Overall Study|Death|28|||
170904083|NCT00466505|617650867|FG000|Overall Study|Adverse Event|4|||
170904084|NCT00699192|617650868|FG000|Overall Study|Missing|1|||
170904085|NCT00699192|617650869|FG001|Overall Study|Missing|1|||
170904086|NCT00699192|617650870|FG002|Overall Study|Missing|1|||
170904087|NCT00699192|617650868|FG000|Overall Study|Adverse Event|9|||
170904088|NCT00699192|617650869|FG001|Overall Study|Adverse Event|4|||
170904089|NCT00699192|617650870|FG002|Overall Study|Adverse Event|3|||
170904090|NCT00699192|617650868|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170904091|NCT00699192|617650869|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170904092|NCT00699192|617650870|FG002|Overall Study|Abnormal test procedure result(s)|1|||
170904093|NCT00699192|617650868|FG000|Overall Study|Lack of Efficacy|0|||
170904094|NCT00699192|617650869|FG001|Overall Study|Lack of Efficacy|0|||
170904095|NCT00699192|617650870|FG002|Overall Study|Lack of Efficacy|1|||
170502751|NCT04676412|616182069|FG001|Overall Study|Death|31|||
170502752|NCT04676412|616182068|FG000|Overall Study|Lost to Follow-up|1|||
170502753|NCT04676412|616182069|FG001|Overall Study|Lost to Follow-up|2|||
170502754|NCT04676412|616182068|FG000|Overall Study|Sponsor Decision|20|||
170502755|NCT04676412|616182069|FG001|Overall Study|Sponsor Decision|23|||
170502756|NCT04676412|616182068|FG000|Overall Study|Withdrawal by Subject|0|||
170502757|NCT04676412|616182069|FG001|Overall Study|Withdrawal by Subject|2|||
170502758|NCT04550832|616182070|FG000|Overall Study|Adverse Event|0|||
170502759|NCT04550832|616182071|FG001|Overall Study|Adverse Event|0|||
170502760|NCT04550832|616182072|FG002|Overall Study|Adverse Event|2|||
170502761|NCT04550832|616182073|FG003|Overall Study|Adverse Event|0|||
170502762|NCT04550832|616182074|FG004|Overall Study|Adverse Event|1|||
170502763|NCT04823130|616182075|FG000|Overall Study|Withdrawal by Subject|2|||
170502764|NCT04823130|616182076|FG001|Overall Study|Withdrawal by Subject|3|||
170502765|NCT04823130|616182075|FG000|Overall Study|Failure to meet inclusion criteria|6|||
170502766|NCT04823130|616182076|FG001|Overall Study|Failure to meet inclusion criteria|4|||
170502767|NCT04823130|616182075|FG000|Overall Study|Other-unspecified|1|||
170502768|NCT04823130|616182076|FG001|Overall Study|Other-unspecified|0|||
170502769|NCT03315455|616182077|FG000|Overall Study|Ongoing in the Study|13|||
170502770|NCT03315455|616182078|FG001|Overall Study|Ongoing in the Study|24|||
170502771|NCT03315455|616182079|FG002|Overall Study|Ongoing in the Study|17|||
170502772|NCT03315455|616182080|FG003|Overall Study|Ongoing in the Study|15|||
170502773|NCT03315455|616182077|FG000|Overall Study|Withdrawal by Subject|0|||
170502774|NCT03315455|616182078|FG001|Overall Study|Withdrawal by Subject|1|||
170502775|NCT03315455|616182079|FG002|Overall Study|Withdrawal by Subject|0|||
170502776|NCT03315455|616182080|FG003|Overall Study|Withdrawal by Subject|0|||
170502777|NCT02667626|616182087|FG000|Overall Study|Withdrawal by Subject|0|||
170502778|NCT02667626|616182088|FG001|Overall Study|Withdrawal by Subject|1|||
170502779|NCT00473824|616182089|FG000|Overall Study|Virologic Breakthrough|1|||
170502780|NCT00473824|616182090|FG001|Overall Study|Virologic Breakthrough|0|||
170502781|NCT00473824|616182089|FG000|Overall Study|Adverse Event|1|||
170502782|NCT00473824|616182090|FG001|Overall Study|Adverse Event|0|||
170502783|NCT00473824|616182089|FG000|Overall Study|Death|1|||
170502784|NCT00473824|616182090|FG001|Overall Study|Death|0|||
170502785|NCT00473824|616182089|FG000|Overall Study|Lost to Follow-up|1|||
170502786|NCT00473824|616182090|FG001|Overall Study|Lost to Follow-up|0|||
170502787|NCT00473824|616182089|FG000|Overall Study|Withdrawal by physician|1|||
170502788|NCT00473824|616182090|FG001|Overall Study|Withdrawal by physician|0|||
170502789|NCT02560623|616182091|FG000|Overall Study|Unable to swallow sponge|0|||
170502790|NCT02560623|616182092|FG001|Overall Study|Unable to swallow sponge|1|||
170502791|NCT02560623|616182093|FG002|Overall Study|Unable to swallow sponge|0|||
170502792|NCT02560623|616182094|FG003|Overall Study|Unable to swallow sponge|0|||
170502793|NCT02560623|616182091|FG000|Overall Study|Intervention prior to sponge administration|0|||
170502794|NCT02560623|616182092|FG001|Overall Study|Intervention prior to sponge administration|1|||
170502795|NCT02560623|616182093|FG002|Overall Study|Intervention prior to sponge administration|0|||
170502796|NCT02560623|616182094|FG003|Overall Study|Intervention prior to sponge administration|0|||
170502797|NCT01125813|616182095|FG000|Overall Study|Death|1|||
170502798|NCT01125813|616182095|FG000|Overall Study|Withdrawal by Subject|1|||
170502799|NCT01125813|616182095|FG000|Overall Study|Screen Failures|4|||
170502800|NCT01349322|616182096|FG000|Overall Study|Protocol Violation|45|||
170502801|NCT01349322|616182097|FG001|Overall Study|Protocol Violation|47|||
170502802|NCT04294641|616182098|FG000|Overall Study|Screen failure|4|||
170502803|NCT01549041|616182101|FG000|Overall Study|Lack of Efficacy|2|||
170904096|NCT00699192|617650868|FG000|Overall Study|Withdrawal by Subject|3|||
170502804|NCT01549041|616182102|FG001|Overall Study|Lack of Efficacy|4|||
170502805|NCT01549041|616182101|FG000|Overall Study|Adverse Event|0|||
170502806|NCT01549041|616182102|FG001|Overall Study|Adverse Event|4|||
170502807|NCT04679051|616182103|FG000|Overall Study|felt tired after restricted time in bed|3|||
170552011|NCT02369159|616366476|FG000|Overall Study|Withdrawal by Subject|7|||
170552012|NCT02369159|616366477|FG001|Overall Study|Withdrawal by Subject|0|||
170502808|NCT04679051|616182104|FG001|Overall Study|felt tired after restricted time in bed|0|||
170904097|NCT00699192|617650869|FG001|Overall Study|Withdrawal by Subject|2|||
170904098|NCT00699192|617650870|FG002|Overall Study|Withdrawal by Subject|4|||
170502809|NCT04679051|616182103|FG000|Overall Study|discomfort with blood pressure cuff|2|||
170502810|NCT04679051|616182104|FG001|Overall Study|discomfort with blood pressure cuff|0|||
170502811|NCT04679051|616182103|FG000|Overall Study|scheduling conflict|1|||
170502812|NCT04679051|616182104|FG001|Overall Study|scheduling conflict|1|||
170502813|NCT04679051|616182103|FG000|Overall Study|Protocol Violation|0|||
170502814|NCT04679051|616182104|FG001|Overall Study|Protocol Violation|4|||
170502815|NCT02772276|616182105|FG000|Overall Study|Lost to Follow-up|0|||
170502816|NCT02772276|616182106|FG001|Overall Study|Lost to Follow-up|0|||
170502817|NCT02772276|616182107|FG002|Overall Study|Lost to Follow-up|0|||
170502818|NCT02772276|616182108|FG003|Overall Study|Lost to Follow-up|0|||
170502819|NCT02772276|616182109|FG004|Overall Study|Lost to Follow-up|0|||
170502820|NCT02772276|616182110|FG005|Overall Study|Lost to Follow-up|0|||
170502821|NCT02772276|616182111|FG006|Overall Study|Lost to Follow-up|1|||
170502822|NCT02772276|616182112|FG007|Overall Study|Lost to Follow-up|0|||
170502823|NCT02772276|616182113|FG008|Overall Study|Lost to Follow-up|0|||
170502824|NCT02772276|616182114|FG009|Overall Study|Lost to Follow-up|0|||
170502825|NCT02772276|616182115|FG010|Overall Study|Lost to Follow-up|0|||
170502826|NCT02772276|616182116|FG011|Overall Study|Lost to Follow-up|0|||
170502827|NCT02772276|616182117|FG012|Overall Study|Lost to Follow-up|0|||
170502828|NCT02772276|616182105|FG000|Overall Study|Withdrew consent|0|||
170502829|NCT02772276|616182106|FG001|Overall Study|Withdrew consent|0|||
170502830|NCT02772276|616182107|FG002|Overall Study|Withdrew consent|0|||
170502831|NCT02772276|616182108|FG003|Overall Study|Withdrew consent|0|||
170502832|NCT02772276|616182109|FG004|Overall Study|Withdrew consent|0|||
170502833|NCT02772276|616182110|FG005|Overall Study|Withdrew consent|0|||
170502834|NCT02772276|616182111|FG006|Overall Study|Withdrew consent|0|||
170502835|NCT02772276|616182112|FG007|Overall Study|Withdrew consent|1|||
170502836|NCT02772276|616182113|FG008|Overall Study|Withdrew consent|0|||
170502837|NCT02772276|616182114|FG009|Overall Study|Withdrew consent|0|||
170502838|NCT02772276|616182115|FG010|Overall Study|Withdrew consent|0|||
170502839|NCT02772276|616182116|FG011|Overall Study|Withdrew consent|0|||
170502840|NCT02772276|616182117|FG012|Overall Study|Withdrew consent|0|||
170502841|NCT03436199|616182118|FG000|Overall Study|Adverse Event|15|||
170502842|NCT03436199|616182119|FG001|Overall Study|Adverse Event|40|||
170502843|NCT03436199|616182120|FG002|Overall Study|Adverse Event|7|||
170502844|NCT03436199|616182118|FG000|Overall Study|Withdrawal by Subject|4|||
170502845|NCT03436199|616182119|FG001|Overall Study|Withdrawal by Subject|10|||
170502846|NCT03436199|616182120|FG002|Overall Study|Withdrawal by Subject|3|||
170502847|NCT03436199|616182118|FG000|Overall Study|Lost to Follow-up|1|||
170502848|NCT03436199|616182119|FG001|Overall Study|Lost to Follow-up|0|||
170502849|NCT03436199|616182120|FG002|Overall Study|Lost to Follow-up|2|||
170502850|NCT03436199|616182118|FG000|Overall Study|Protocol Violation|1|||
170502851|NCT03436199|616182119|FG001|Overall Study|Protocol Violation|1|||
170502852|NCT03436199|616182120|FG002|Overall Study|Protocol Violation|0|||
170502853|NCT03436199|616182118|FG000|Overall Study|Physician Decision|0|||
170502854|NCT03436199|616182119|FG001|Overall Study|Physician Decision|1|||
170502855|NCT03436199|616182120|FG002|Overall Study|Physician Decision|0|||
170502856|NCT03436199|616182118|FG000|Overall Study|Could not return to clinic|1|||
170502857|NCT03436199|616182119|FG001|Overall Study|Could not return to clinic|0|||
170502858|NCT03436199|616182120|FG002|Overall Study|Could not return to clinic|0|||
170502859|NCT03436199|616182118|FG000|Overall Study|Withdrawn per physician|0|||
170502860|NCT03436199|616182119|FG001|Overall Study|Withdrawn per physician|1|||
170502861|NCT03436199|616182120|FG002|Overall Study|Withdrawn per physician|0|||
170502862|NCT01432275|616182124|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
170502863|NCT01432275|616182125|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
170502864|NCT01432275|616182124|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
170502865|NCT01432275|616182125|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
170502866|NCT01432275|616182124|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
170502867|NCT01432275|616182125|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
170502868|NCT01432275|616182124|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
170502869|NCT01432275|616182125|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
170502870|NCT01432275|616182124|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
170502871|NCT01432275|616182125|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
170502872|NCT01432275|616182124|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
170502873|NCT01432275|616182125|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
170502874|NCT01432275|616182124|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
170502875|NCT01432275|616182125|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
170502876|NCT01432275|616182124|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
170502877|NCT01432275|616182125|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
170502878|NCT01432275|616182124|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
170502879|NCT01432275|616182125|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
170502880|NCT01739764|616182129|FG000|Overall Study|Adverse Event|0|||
170502881|NCT01739764|616182130|FG001|Overall Study|Adverse Event|3|||
170502882|NCT01739764|616182131|FG002|Overall Study|Adverse Event|4|||
170502883|NCT01739764|616182129|FG000|Overall Study|Death|4|||
170502884|NCT01739764|616182130|FG001|Overall Study|Death|6|||
170502885|NCT01739764|616182131|FG002|Overall Study|Death|38|||
170502886|NCT01739764|616182129|FG000|Overall Study|Lost to Follow-up|0|||
170502887|NCT01739764|616182130|FG001|Overall Study|Lost to Follow-up|0|||
170502888|NCT01739764|616182131|FG002|Overall Study|Lost to Follow-up|5|||
170502889|NCT01739764|616182129|FG000|Overall Study|Non-Compliance|0|||
170502890|NCT01739764|616182130|FG001|Overall Study|Non-Compliance|0|||
170502891|NCT01739764|616182131|FG002|Overall Study|Non-Compliance|1|||
170502892|NCT01739764|616182129|FG000|Overall Study|Multiple Reasons|3|||
170502893|NCT01739764|616182130|FG001|Overall Study|Multiple Reasons|2|||
170502894|NCT01739764|616182131|FG002|Overall Study|Multiple Reasons|3|||
170502895|NCT01739764|616182129|FG000|Overall Study|Physician Decision|2|||
170502896|NCT01739764|616182130|FG001|Overall Study|Physician Decision|2|||
170502897|NCT01739764|616182131|FG002|Overall Study|Physician Decision|4|||
170502898|NCT01739764|616182129|FG000|Overall Study|Progressive Disease|3|||
170502899|NCT01739764|616182130|FG001|Overall Study|Progressive Disease|5|||
170502900|NCT01739764|616182131|FG002|Overall Study|Progressive Disease|16|||
170502901|NCT01739764|616182129|FG000|Overall Study|Protocol Violation|0|||
170502902|NCT01739764|616182130|FG001|Overall Study|Protocol Violation|0|||
170502903|NCT01739764|616182131|FG002|Overall Study|Protocol Violation|2|||
170502904|NCT01739764|616182129|FG000|Overall Study|Study Terminated by Sponsor|8|||
170502905|NCT01739764|616182130|FG001|Overall Study|Study Terminated by Sponsor|13|||
170502906|NCT01739764|616182131|FG002|Overall Study|Study Terminated by Sponsor|26|||
170502907|NCT01739764|616182129|FG000|Overall Study|Withdrawal by Subject|6|||
170502908|NCT01739764|616182130|FG001|Overall Study|Withdrawal by Subject|5|||
170502909|NCT01739764|616182131|FG002|Overall Study|Withdrawal by Subject|27|||
170502910|NCT00404924|616182132|FG000|Overall Study|Adverse Event|75|||
170502911|NCT00404924|616182133|FG001|Overall Study|Adverse Event|16|||
170502912|NCT00404924|616182132|FG000|Overall Study|Condition under investigation worsened|475|||
170502913|NCT00404924|616182133|FG001|Overall Study|Condition under investigation worsened|264|||
170502914|NCT00404924|616182132|FG000|Overall Study|Lost to Follow-up|1|||
170502915|NCT00404924|616182133|FG001|Overall Study|Lost to Follow-up|1|||
170502916|NCT00404924|616182132|FG000|Overall Study|Withdrawal by Subject|26|||
170502917|NCT00404924|616182133|FG001|Overall Study|Withdrawal by Subject|13|||
170502918|NCT00404924|616182132|FG000|Overall Study|Other|25|||
170502919|NCT00404924|616182133|FG001|Overall Study|Other|11|||
170502920|NCT00404924|616182132|FG000|Overall Study|Randomised but not received treatment|1|||
170502921|NCT00404924|616182133|FG001|Overall Study|Randomised but not received treatment|1|||
170502922|NCT01419080|616182145|FG000|Overall Study|Withdrawal by Subject|75|||
170502923|NCT01419080|616182145|FG000|Overall Study|Death|30|||
170502924|NCT01419080|616182145|FG000|Overall Study|Lost to Follow-up|23|||
170502925|NCT01419080|616182145|FG000|Overall Study|Too Ill|3|||
170502926|NCT05238025|616182148|FG000|Overall Study|Adverse Event|2|||
170502927|NCT05238025|616182149|FG001|Overall Study|Adverse Event|2|||
170502928|NCT05238025|616182148|FG000|Overall Study|Lost to Follow-up|334|||
170502929|NCT05238025|616182149|FG001|Overall Study|Lost to Follow-up|339|||
170502930|NCT05238025|616182148|FG000|Overall Study|Withdrawal by Subject|203|||
170502931|NCT05238025|616182149|FG001|Overall Study|Withdrawal by Subject|222|||
170502932|NCT05238025|616182148|FG000|Overall Study|Physician Decision|20|||
170502933|NCT05238025|616182149|FG001|Overall Study|Physician Decision|8|||
170502934|NCT05238025|616182148|FG000|Overall Study|Protocol Violation|6|||
170502935|NCT05238025|616182149|FG001|Overall Study|Protocol Violation|2|||
170502936|NCT05238025|616182148|FG000|Overall Study|Death|38|||
170502937|NCT05238025|616182149|FG001|Overall Study|Death|32|||
170502938|NCT05238025|616182148|FG000|Overall Study|Study terminated by Sponsor|6358|||
170502939|NCT05238025|616182149|FG001|Overall Study|Study terminated by Sponsor|6358|||
170502940|NCT05238025|616182148|FG000|Overall Study|Other Reason|669|||
170502941|NCT05238025|616182149|FG001|Overall Study|Other Reason|690|||
170502942|NCT04545567|616182150|FG000|Overall Study|tested positive for SARS-co-V2|1|||
170502943|NCT04545567|616182151|FG001|Overall Study|tested positive for SARS-co-V2|1|||
170502944|NCT04545567|616182150|FG000|Overall Study|Withdrawal by Subject|0|||
170502945|NCT04545567|616182151|FG001|Overall Study|Withdrawal by Subject|1|||
170502946|NCT00102531|616182153|FG000|Overall Study|Adverse Event|0|||
170502947|NCT00102531|616182154|FG001|Overall Study|Adverse Event|1|||
170502948|NCT00102531|616182153|FG000|Overall Study|Disease Progression|5|||
170502949|NCT00102531|616182154|FG001|Overall Study|Disease Progression|9|||
170502950|NCT00102531|616182153|FG000|Overall Study|Physician Decision|0|||
170502951|NCT00102531|616182154|FG001|Overall Study|Physician Decision|1|||
170502952|NCT04756154|616182160|FG000|Overall Study|Did not meet treatment day baseline|30|||
170552013|NCT00425854|616366485|FG000|Overall Study|Progressive Disease|19|||
170552014|NCT00425854|616366486|FG001|Overall Study|Progressive Disease|12|||
170552015|NCT00425854|616366485|FG000|Overall Study|Dose reduction toxicity AE|8|||
170502953|NCT04756154|616182161|FG001|Overall Study|Did not meet treatment day baseline|28|||
170502954|NCT04756154|616182162|FG002|Overall Study|Did not meet treatment day baseline|7|||
170502955|NCT04756154|616182160|FG000|Overall Study|Did not return for final sample collection|1|||
170805325|NCT03745313|617297336|FG000|At 6 Months Follow-up|Death|1|||
170502956|NCT04756154|616182161|FG001|Overall Study|Did not return for final sample collection|1|||
170502957|NCT04756154|616182162|FG002|Overall Study|Did not return for final sample collection|0|||
170502958|NCT00960986|616182164|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
170502959|NCT00960986|616182165|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
170502960|NCT00960986|616182166|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
170502961|NCT00960986|616182167|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
170502962|NCT00960986|616182164|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
170502963|NCT00960986|616182165|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
170502964|NCT00960986|616182166|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
170502965|NCT00960986|616182167|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
170502966|NCT00960986|616182164|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
170502967|NCT00960986|616182165|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
170502968|NCT00960986|616182166|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
170502969|NCT00960986|616182167|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
170502970|NCT00960986|616182164|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
170502971|NCT00960986|616182165|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
170502972|NCT00960986|616182166|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
170502973|NCT00960986|616182167|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
170502974|NCT00960986|616182164|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
170502975|NCT00960986|616182165|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
170502976|NCT00960986|616182166|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
170502977|NCT00960986|616182167|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
170502978|NCT00960986|616182164|FG000|Period 3 (7-week Therapy Period)|Death|0|||
170502979|NCT00960986|616182165|FG001|Period 3 (7-week Therapy Period)|Death|0|||
170502980|NCT00960986|616182166|FG002|Period 3 (7-week Therapy Period)|Death|1|||
170502981|NCT00960986|616182167|FG003|Period 3 (7-week Therapy Period)|Death|0|||
170502982|NCT00960986|616182164|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
170502983|NCT00960986|616182165|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
170502984|NCT00960986|616182166|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
170502985|NCT00960986|616182167|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
170502986|NCT00960986|616182164|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
170502987|NCT00960986|616182165|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
170502988|NCT00960986|616182166|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
170502989|NCT00960986|616182167|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
170502990|NCT00960986|616182164|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
170502991|NCT00960986|616182165|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
170502992|NCT00960986|616182166|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
170502993|NCT00960986|616182167|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
170502994|NCT00960986|616182164|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
170502995|NCT00960986|616182165|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
170502996|NCT00960986|616182166|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
170502997|NCT00960986|616182167|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
170502998|NCT01790828|616182168|FG000|Overall Study|Other|34|||
170502999|NCT00710684|616182170|FG000|Overall Study|Adverse Event|11|||
170503000|NCT00710684|616182171|FG001|Overall Study|Adverse Event|19|||
170503001|NCT00710684|616182172|FG002|Overall Study|Adverse Event|16|||
170503002|NCT00710684|616182170|FG000|Overall Study|Lack of Efficacy|4|||
170503003|NCT00710684|616182171|FG001|Overall Study|Lack of Efficacy|3|||
170503004|NCT00710684|616182172|FG002|Overall Study|Lack of Efficacy|5|||
170503005|NCT00710684|616182170|FG000|Overall Study|Protocol Violation|5|||
170503006|NCT00710684|616182171|FG001|Overall Study|Protocol Violation|5|||
170503007|NCT00710684|616182172|FG002|Overall Study|Protocol Violation|5|||
170503008|NCT00710684|616182170|FG000|Overall Study|Lost to Follow-up|4|||
170503009|NCT00710684|616182171|FG001|Overall Study|Lost to Follow-up|6|||
170503010|NCT00710684|616182172|FG002|Overall Study|Lost to Follow-up|7|||
170503011|NCT00710684|616182170|FG000|Overall Study|Physician Decision|0|||
170552016|NCT00425854|616366486|FG001|Overall Study|Dose reduction toxicity AE|7|||
170552017|NCT00425854|616366485|FG000|Overall Study|Other Adverse Event|2|||
170552018|NCT00425854|616366486|FG001|Overall Study|Other Adverse Event|2|||
170552019|NCT01514422|616366487|FG000|Overall Study|Lost to Follow-up|1|||
170552020|NCT01630811|616366490|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
170503012|NCT00710684|616182171|FG001|Overall Study|Physician Decision|2|||
170503013|NCT00710684|616182172|FG002|Overall Study|Physician Decision|4|||
170503014|NCT00710684|616182170|FG000|Overall Study|Withdrawal by Subject|24|||
170503015|NCT00710684|616182171|FG001|Overall Study|Withdrawal by Subject|18|||
170503016|NCT00710684|616182172|FG002|Overall Study|Withdrawal by Subject|11|||
170503017|NCT00710684|616182170|FG000|Overall Study|Missing|1|||
170552021|NCT01630811|616366491|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
170503018|NCT00710684|616182171|FG001|Overall Study|Missing|0|||
170503019|NCT00710684|616182172|FG002|Overall Study|Missing|0|||
170503020|NCT00710684|616182170|FG000|Overall Study|Did not continue after week 24|25|||
170503021|NCT00710684|616182171|FG001|Overall Study|Did not continue after week 24|21|||
170503022|NCT00710684|616182172|FG002|Overall Study|Did not continue after week 24|16|||
170552022|NCT01725308|616366494|FG000|Treatment Period I|Did Not Receive Drug|1|||
170503023|NCT00514904|616182173|FG000|Overall Study|Withdrawal by Subject|3|||
170503024|NCT00514904|616182174|FG001|Overall Study|Withdrawal by Subject|2|||
170503025|NCT00514904|616182173|FG000|Overall Study|Lost to Follow-up|21|||
170503026|NCT00514904|616182174|FG001|Overall Study|Lost to Follow-up|3|||
170503027|NCT04216589|616182175|FG000|Overall Study|Withdrawal by Subject|2|||
170503028|NCT04216589|616182175|FG000|Overall Study|Protocol Violation|1|||
170503029|NCT04216589|616182175|FG000|Overall Study|Incarceration|1|||
170503030|NCT02326298|616182178|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503031|NCT02326298|616182179|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503032|NCT02326298|616182180|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
170503033|NCT02326298|616182181|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503034|NCT02326298|616182182|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503035|NCT02326298|616182183|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503036|NCT02326298|616182184|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503037|NCT02326298|616182185|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503038|NCT02326298|616182186|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503039|NCT02326298|616182187|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503040|NCT02326298|616182188|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503041|NCT02326298|616182189|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503042|NCT02326298|616182190|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503043|NCT02326298|616182191|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170503044|NCT02326298|616182178|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
170503045|NCT02326298|616182179|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503046|NCT02326298|616182180|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503047|NCT02326298|616182181|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503048|NCT02326298|616182182|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503049|NCT02326298|616182183|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503050|NCT02326298|616182184|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503051|NCT02326298|616182185|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503052|NCT02326298|616182186|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503053|NCT02326298|616182187|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503054|NCT02326298|616182188|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503055|NCT02326298|616182189|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503056|NCT02326298|616182190|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503057|NCT02326298|616182191|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
170503058|NCT02326298|616182178|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
170503059|NCT02326298|616182179|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
170503060|NCT02326298|616182180|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503061|NCT02326298|616182181|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503062|NCT02326298|616182182|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503063|NCT02326298|616182183|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503064|NCT02326298|616182184|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503065|NCT02326298|616182185|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503066|NCT02326298|616182186|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503067|NCT02326298|616182187|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503068|NCT02326298|616182188|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503069|NCT02326298|616182189|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503070|NCT02326298|616182190|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503071|NCT02326298|616182191|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
170503072|NCT02326298|616182178|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
170503073|NCT02326298|616182179|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
170503074|NCT02326298|616182180|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503075|NCT02326298|616182181|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503076|NCT02326298|616182182|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503077|NCT02326298|616182183|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503078|NCT02326298|616182184|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503079|NCT02326298|616182185|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503080|NCT02326298|616182186|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503081|NCT02326298|616182187|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503082|NCT02326298|616182188|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503083|NCT02326298|616182189|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503084|NCT02326298|616182190|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503085|NCT02326298|616182191|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170503086|NCT02326298|616182178|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503087|NCT02326298|616182179|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503088|NCT02326298|616182180|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
170503089|NCT02326298|616182181|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503090|NCT02326298|616182182|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503091|NCT02326298|616182183|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503092|NCT02326298|616182184|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503093|NCT02326298|616182185|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503094|NCT02326298|616182186|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503095|NCT02326298|616182187|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503096|NCT02326298|616182188|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503097|NCT02326298|616182189|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503098|NCT02326298|616182190|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503099|NCT02326298|616182191|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
170503100|NCT02326298|616182178|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503101|NCT02326298|616182179|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503102|NCT02326298|616182180|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503103|NCT02326298|616182181|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503104|NCT02326298|616182182|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503105|NCT02326298|616182183|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170503106|NCT02326298|616182184|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
170503107|NCT02326298|616182185|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170503108|NCT02326298|616182186|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170503109|NCT02326298|616182187|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170503110|NCT02326298|616182188|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503111|NCT02326298|616182189|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503112|NCT02326298|616182190|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503113|NCT02326298|616182191|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170503114|NCT02326298|616182178|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503115|NCT02326298|616182179|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503116|NCT02326298|616182180|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503117|NCT02326298|616182181|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503118|NCT02326298|616182182|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503119|NCT02326298|616182183|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
170503120|NCT02326298|616182184|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
170503121|NCT02326298|616182185|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503122|NCT02326298|616182186|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
170503123|NCT02326298|616182187|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503124|NCT02326298|616182188|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503125|NCT02326298|616182189|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503126|NCT02326298|616182190|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503127|NCT02326298|616182191|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
170503128|NCT02326298|616182178|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503129|NCT02326298|616182179|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503130|NCT02326298|616182180|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503131|NCT02326298|616182181|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503132|NCT02326298|616182182|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503133|NCT02326298|616182183|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
170503134|NCT02326298|616182184|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503135|NCT02326298|616182185|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503136|NCT02326298|616182186|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503137|NCT02326298|616182187|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503138|NCT02326298|616182188|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503139|NCT02326298|616182189|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503140|NCT02326298|616182190|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503141|NCT02326298|616182191|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
170503142|NCT02326298|616182178|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503143|NCT02326298|616182179|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503144|NCT02326298|616182180|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503145|NCT02326298|616182181|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503146|NCT02326298|616182182|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503147|NCT02326298|616182183|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170904099|NCT00699192|617650868|FG000|Overall Study|Administrative problems|1|||
170503148|NCT02326298|616182184|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
170503149|NCT02326298|616182185|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503150|NCT02326298|616182186|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503151|NCT02326298|616182187|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503152|NCT02326298|616182188|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503153|NCT02326298|616182189|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503154|NCT02326298|616182190|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503155|NCT02326298|616182191|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
170503156|NCT02326298|616182178|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503157|NCT02326298|616182179|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503158|NCT02326298|616182180|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503159|NCT02326298|616182181|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503160|NCT02326298|616182182|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503161|NCT02326298|616182183|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503162|NCT02326298|616182184|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503163|NCT02326298|616182185|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
170503164|NCT02326298|616182186|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503165|NCT02326298|616182187|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503166|NCT02326298|616182188|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503167|NCT02326298|616182189|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503168|NCT02326298|616182190|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503169|NCT02326298|616182191|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
170503170|NCT02326298|616182178|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503171|NCT02326298|616182179|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503172|NCT02326298|616182180|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503173|NCT02326298|616182181|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503174|NCT02326298|616182182|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503175|NCT02326298|616182183|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503176|NCT02326298|616182184|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
170503177|NCT02326298|616182185|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
170503178|NCT02326298|616182186|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503179|NCT02326298|616182187|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503180|NCT02326298|616182188|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503181|NCT02326298|616182189|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503182|NCT02326298|616182190|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503183|NCT02326298|616182191|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170503184|NCT02326298|616182178|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503185|NCT02326298|616182179|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503186|NCT02326298|616182180|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503187|NCT02326298|616182181|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503188|NCT02326298|616182182|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503189|NCT02326298|616182183|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503190|NCT02326298|616182184|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503191|NCT02326298|616182185|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
170503192|NCT02326298|616182186|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503193|NCT02326298|616182187|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503194|NCT02326298|616182188|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503195|NCT02326298|616182189|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503196|NCT02326298|616182190|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503197|NCT02326298|616182191|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170503198|NCT02326298|616182178|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503199|NCT02326298|616182179|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503200|NCT02326298|616182180|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503201|NCT02326298|616182181|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503202|NCT02326298|616182182|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503203|NCT02326298|616182183|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
170503204|NCT02326298|616182184|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503205|NCT02326298|616182185|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503206|NCT02326298|616182186|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503207|NCT02326298|616182187|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503208|NCT02326298|616182188|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503209|NCT02326298|616182189|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170805326|NCT03745313|617297336|FG000|At 6 Months Follow-up|Missed Visit|1|||
170805327|NCT03745313|617297336|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
170805328|NCT03745313|617297336|FG000|At 1 Year Follow-up|Death|2|||
170503210|NCT02326298|616182190|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503211|NCT02326298|616182191|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
170503212|NCT02326298|616182178|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
170503213|NCT02326298|616182179|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
170503214|NCT02326298|616182180|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
170503215|NCT02326298|616182181|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
170503216|NCT02326298|616182182|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
170503217|NCT02326298|616182183|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
170503218|NCT02326298|616182184|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
170503219|NCT02326298|616182185|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
170503220|NCT02326298|616182186|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
170503221|NCT02326298|616182187|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
170503222|NCT02326298|616182188|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
170503223|NCT02326298|616182189|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
170503224|NCT02326298|616182190|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
170503225|NCT02326298|616182191|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
170503226|NCT02326298|616182178|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503227|NCT02326298|616182179|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503228|NCT02326298|616182180|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503229|NCT02326298|616182181|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503230|NCT02326298|616182182|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503231|NCT02326298|616182183|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503232|NCT02326298|616182184|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503233|NCT02326298|616182185|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503234|NCT02326298|616182186|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503235|NCT02326298|616182187|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503236|NCT02326298|616182188|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503237|NCT02326298|616182189|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
170503238|NCT02326298|616182190|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
170503239|NCT02326298|616182191|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
170503240|NCT02326298|616182178|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503241|NCT02326298|616182179|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503242|NCT02326298|616182180|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503243|NCT02326298|616182181|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503244|NCT02326298|616182182|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503245|NCT02326298|616182183|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503246|NCT02326298|616182184|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503247|NCT02326298|616182185|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503248|NCT02326298|616182186|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503249|NCT02326298|616182187|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503250|NCT02326298|616182188|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503251|NCT02326298|616182189|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
170503252|NCT02326298|616182190|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
170503253|NCT02326298|616182191|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170503254|NCT02326298|616182178|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503255|NCT02326298|616182179|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503256|NCT02326298|616182180|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503257|NCT02326298|616182181|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503258|NCT02326298|616182182|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503259|NCT02326298|616182183|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503260|NCT02326298|616182184|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503261|NCT02326298|616182185|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503262|NCT02326298|616182186|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503263|NCT02326298|616182187|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503264|NCT02326298|616182188|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170805329|NCT03745313|617297336|FG000|At 1 Year Follow-up|Missed Visit|2|||
170805330|NCT03745313|617297336|FG000|At 2 Year Follow-up|Missed Visit|1|||
170805331|NCT01706159|617297339|FG000|Overall Study|Withdrawal Criteria|2|||
170503265|NCT02326298|616182189|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503266|NCT02326298|616182190|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
170503267|NCT02326298|616182191|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
170503268|NCT02326298|616182178|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503269|NCT02326298|616182179|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503270|NCT02326298|616182180|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503271|NCT02326298|616182181|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503272|NCT02326298|616182182|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503273|NCT02326298|616182183|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503274|NCT02326298|616182184|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503275|NCT02326298|616182185|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503276|NCT02326298|616182186|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503277|NCT02326298|616182187|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503278|NCT02326298|616182188|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170503279|NCT02326298|616182189|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
170503280|NCT02326298|616182190|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
170503281|NCT02326298|616182191|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
170503282|NCT02326298|616182178|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503283|NCT02326298|616182179|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503284|NCT02326298|616182180|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503285|NCT02326298|616182181|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503286|NCT02326298|616182182|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503287|NCT02326298|616182183|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503288|NCT02326298|616182184|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503289|NCT02326298|616182185|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503290|NCT02326298|616182186|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503291|NCT02326298|616182187|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503292|NCT02326298|616182188|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
170503293|NCT02326298|616182189|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
170503294|NCT02326298|616182190|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
170503295|NCT02326298|616182191|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
170503296|NCT02326298|616182178|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503297|NCT02326298|616182179|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503298|NCT02326298|616182180|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503299|NCT02326298|616182181|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503300|NCT02326298|616182182|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503301|NCT02326298|616182183|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503302|NCT02326298|616182184|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503303|NCT02326298|616182185|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503304|NCT02326298|616182186|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503305|NCT02326298|616182187|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503306|NCT02326298|616182188|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170503307|NCT02326298|616182189|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
170503308|NCT02326298|616182190|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
170503309|NCT02326298|616182191|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
170503310|NCT03521817|616182192|FG000|Overall Study|Protocol Violation|0|||
170503311|NCT03521817|616182193|FG001|Overall Study|Protocol Violation|1|||
170503312|NCT00787917|616182194|FG000|Blinded Treatment|Adverse Event|1|||
170503313|NCT00787917|616182195|FG001|Blinded Treatment|Adverse Event|0|||
170503314|NCT00787917|616182194|FG000|Blinded Treatment|Lack of Efficacy|1|||
170503315|NCT00787917|616182195|FG001|Blinded Treatment|Lack of Efficacy|0|||
170503316|NCT00787917|616182194|FG000|Blinded Treatment|Administrative problems|3|||
170503317|NCT00787917|616182195|FG001|Blinded Treatment|Administrative problems|2|||
170503318|NCT00787917|616182194|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
170503319|NCT00787917|616182195|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
170503320|NCT00787917|616182194|FG000|Open Label|Administrative problems|3|||
170503321|NCT00787917|616182195|FG001|Open Label|Administrative problems|0|||
170503322|NCT05685732|616182197|FG000|Overall Study|Withdrawal by Subject|2|||
170503323|NCT05685732|616182198|FG001|Overall Study|Withdrawal by Subject|0|||
170503324|NCT05685732|616182199|FG002|Overall Study|Withdrawal by Subject|2|||
170503325|NCT05685732|616182200|FG003|Overall Study|Withdrawal by Subject|3|||
170503326|NCT05685732|616182197|FG000|Overall Study|Protocol Violation|1|||
170503327|NCT05685732|616182198|FG001|Overall Study|Protocol Violation|2|||
170503328|NCT05685732|616182199|FG002|Overall Study|Protocol Violation|4|||
170503329|NCT05685732|616182200|FG003|Overall Study|Protocol Violation|1|||
170503330|NCT05685732|616182197|FG000|Overall Study|Lost to Follow-up|5|||
170503331|NCT05685732|616182198|FG001|Overall Study|Lost to Follow-up|1|||
170503332|NCT05685732|616182199|FG002|Overall Study|Lost to Follow-up|3|||
170503333|NCT05685732|616182200|FG003|Overall Study|Lost to Follow-up|1|||
170503334|NCT05685732|616182197|FG000|Overall Study|Adverse Event|2|||
170503335|NCT05685732|616182198|FG001|Overall Study|Adverse Event|1|||
170503336|NCT05685732|616182199|FG002|Overall Study|Adverse Event|0|||
170503337|NCT05685732|616182200|FG003|Overall Study|Adverse Event|0|||
170503338|NCT05685732|616182197|FG000|Overall Study|Physician Decision|1|||
170503339|NCT05685732|616182198|FG001|Overall Study|Physician Decision|0|||
170503340|NCT05685732|616182199|FG002|Overall Study|Physician Decision|0|||
170503341|NCT05685732|616182200|FG003|Overall Study|Physician Decision|0|||
170503342|NCT02640404|616182201|FG000|Overall Study|Protocol Violation|1|||
170503343|NCT02640404|616182202|FG001|Overall Study|Protocol Violation|0|||
170503344|NCT02640404|616182201|FG000|Overall Study|Withdrawal by Subject|1|||
170503345|NCT02640404|616182202|FG001|Overall Study|Withdrawal by Subject|0|||
170503346|NCT03427268|616184004|FG000|Overall Study|Progressive disease|25|||
170503347|NCT03427268|616184004|FG000|Overall Study|Never treated|2|||
170503348|NCT03427268|616184004|FG000|Overall Study|Compassionate use|1|||
170503349|NCT03427268|616184004|FG000|Overall Study|Withdrawal by Subject|1|||
170503350|NCT03427268|616184004|FG000|Overall Study|Adverse Event|3|||
170503351|NCT02638129|616184005|FG000|Overall Study|Study terminated|28|||
170503352|NCT02638129|616184006|FG001|Overall Study|Study terminated|30|||
170503353|NCT03117881|616184007|FG000|Baseline|Withdrawal by Subject|21|||
170503354|NCT03117881|616184008|FG001|Baseline|Withdrawal by Subject|10|||
170503355|NCT03117881|616184009|FG002|Baseline|Withdrawal by Subject|0|||
170503356|NCT03117881|616184007|FG000|Baseline|Lost to Follow-up|22|||
170503357|NCT03117881|616184008|FG001|Baseline|Lost to Follow-up|25|||
170503358|NCT03117881|616184009|FG002|Baseline|Lost to Follow-up|0|||
170503359|NCT03117881|616184007|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
170503360|NCT03117881|616184008|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
170503361|NCT03117881|616184009|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
170503362|NCT03117881|616184007|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
170503363|NCT03117881|616184008|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
170503364|NCT03117881|616184009|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
170503365|NCT03117881|616184007|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
170503366|NCT03117881|616184008|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
170503367|NCT03117881|616184009|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
170503368|NCT03117881|616184007|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
170503369|NCT03117881|616184008|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
170503370|NCT03117881|616184009|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
170503371|NCT03117881|616184007|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
170503372|NCT03117881|616184008|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
170503373|NCT03117881|616184009|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
170503374|NCT03117881|616184007|FG000|6-Month Follow-Up|Did not complete test|53|||
170503375|NCT03117881|616184008|FG001|6-Month Follow-Up|Did not complete test|25|||
170503376|NCT03117881|616184009|FG002|6-Month Follow-Up|Did not complete test|7|||
170503377|NCT03117881|616184007|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
170503378|NCT03117881|616184008|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
170503379|NCT03117881|616184009|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
170503380|NCT03117881|616184007|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
170503381|NCT03117881|616184008|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
170503382|NCT03117881|616184009|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
170503383|NCT03117881|616184007|FG000|12-Month Follow-Up|Did not complete test|40|||
170503384|NCT03117881|616184008|FG001|12-Month Follow-Up|Did not complete test|0|||
170552023|NCT01725308|616366495|FG001|Treatment Period I|Did Not Receive Drug|0|||
170552024|NCT01725308|616366496|FG002|Treatment Period I|Did Not Receive Drug|0|||
170552025|NCT01725308|616366494|FG000|Treatment Period I|Adverse Event|5|||
170552026|NCT01725308|616366495|FG001|Treatment Period I|Adverse Event|4|||
170552027|NCT01725308|616366496|FG002|Treatment Period I|Adverse Event|21|||
170552028|NCT01725308|616366494|FG000|Treatment Period I|Insufficient Response|7|||
170552029|NCT01725308|616366495|FG001|Treatment Period I|Insufficient Response|0|||
170552030|NCT01725308|616366496|FG002|Treatment Period I|Insufficient Response|5|||
170552031|NCT01725308|616366494|FG000|Treatment Period I|Worsening of the Target Disease|8|||
170805332|NCT01706159|617297340|FG001|Overall Study|Withdrawal Criteria|1|||
170805333|NCT01706159|617297339|FG000|Overall Study|Unclassified|6|||
170805334|NCT01706159|617297340|FG001|Overall Study|Unclassified|1|||
170805335|NCT03362190|617297342|FG000|Overall Study|Adverse Event|0|||
170805336|NCT03362190|617297343|FG001|Overall Study|Adverse Event|0|||
170805337|NCT03362190|617297344|FG002|Overall Study|Adverse Event|0|||
170503385|NCT03117881|616184009|FG002|12-Month Follow-Up|Did not complete test|0|||
170503386|NCT02304380|616184011|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
170503387|NCT02304380|616184012|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
170503388|NCT02304380|616184013|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
170503389|NCT02304380|616184014|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
170503390|NCT02304380|616184015|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
170503391|NCT02304380|616184016|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
170503392|NCT01027897|616184017|FG000|Overall Study|Protocol Violation|1|||
170552032|NCT01725308|616366495|FG001|Treatment Period I|Worsening of the Target Disease|0|||
170805338|NCT03362190|617297345|FG003|Overall Study|Adverse Event|1|||
170805339|NCT03362190|617297342|FG000|Overall Study|Withdrawal by Subject|0|||
170503393|NCT01027897|616184017|FG000|Overall Study|Withdrawal by Subject|1|||
170503394|NCT02607280|616184018|FG000|Overall Study|Adverse Event|4|||
170503395|NCT02607280|616184019|FG001|Overall Study|Adverse Event|0|||
170503396|NCT02607280|616184018|FG000|Overall Study|Decrease in CrCl <15|0|||
170503397|NCT02607280|616184019|FG001|Overall Study|Decrease in CrCl <15|1|||
170503398|NCT00328094|616184020|FG000|Overall Study|Physician Decision|3|||
170503399|NCT00328094|616184021|FG001|Overall Study|Physician Decision|3|||
170503400|NCT02368210|616184022|FG000|Overall Study|Withdrawal by Subject|1|||
170503401|NCT02368210|616184023|FG001|Overall Study|Withdrawal by Subject|0|||
170503402|NCT02368210|616184022|FG000|Overall Study|Adverse Event|0|||
170503403|NCT02368210|616184023|FG001|Overall Study|Adverse Event|1|||
170503404|NCT00078949|616184024|FG000|Overall Study|No treated|4|||
170503405|NCT00078949|616184025|FG001|Overall Study|No treated|5|||
170503406|NCT00078949|616184026|FG002|Overall Study|No treated|3|||
170503407|NCT00078949|616184027|FG003|Overall Study|No treated|3|||
170503408|NCT00577005|616184028|FG000|Overall Study|Lost to Follow-up|3|||
170503409|NCT00577005|616184029|FG001|Overall Study|Lost to Follow-up|2|||
170503410|NCT00577005|616184028|FG000|Overall Study|Withdrawal by Subject|2|||
170503411|NCT00577005|616184029|FG001|Overall Study|Withdrawal by Subject|1|||
170503412|NCT00590538|616184030|FG000|Overall Study|Study terminated before completed|2|||
170503413|NCT02309723|616184031|FG000|Overall Study|Withdrawal by Subject|24|||
170503414|NCT02309723|616184032|FG001|Overall Study|Withdrawal by Subject|23|||
170503415|NCT02309723|616184033|FG002|Overall Study|Withdrawal by Subject|24|||
170503416|NCT02539134|616184039|FG000|Overall Study|Lost to Follow-up|1|||
170503417|NCT02539134|616184040|FG001|Overall Study|Lost to Follow-up|0|||
170503418|NCT02539134|616184041|FG002|Overall Study|Lost to Follow-up|0|||
170503419|NCT02539134|616184042|FG003|Overall Study|Lost to Follow-up|0|||
170503420|NCT02539134|616184043|FG004|Overall Study|Lost to Follow-up|0|||
170503421|NCT02539134|616184044|FG005|Overall Study|Lost to Follow-up|0|||
170503422|NCT01143064|616184045|FG000|Overall Study|Death|109|||
170503423|NCT01143064|616184046|FG001|Overall Study|Death|91|||
170503424|NCT01143064|616184045|FG000|Overall Study|Adverse Event|0|||
170503425|NCT01143064|616184046|FG001|Overall Study|Adverse Event|1|||
170503426|NCT01143064|616184045|FG000|Overall Study|Withdrawal by Subject|7|||
170503427|NCT01143064|616184046|FG001|Overall Study|Withdrawal by Subject|5|||
170503428|NCT01143064|616184045|FG000|Overall Study|Lost to Follow-up|17|||
170503429|NCT01143064|616184046|FG001|Overall Study|Lost to Follow-up|14|||
170503430|NCT01143064|616184045|FG000|Overall Study|Physician Decision|0|||
170503431|NCT01143064|616184046|FG001|Overall Study|Physician Decision|4|||
170503432|NCT02453282|616184047|FG000|Overall Study|Death|275|||
170503433|NCT02453282|616184048|FG001|Overall Study|Death|277|||
170503434|NCT02453282|616184049|FG002|Overall Study|Death|296|||
170503435|NCT02453282|616184047|FG000|Overall Study|Lost to Follow-up|1|||
170503436|NCT02453282|616184048|FG001|Overall Study|Lost to Follow-up|0|||
170503437|NCT02453282|616184049|FG002|Overall Study|Lost to Follow-up|2|||
170503438|NCT02453282|616184047|FG000|Overall Study|Withdrawal by Subject|12|||
170503439|NCT02453282|616184048|FG001|Overall Study|Withdrawal by Subject|10|||
170503440|NCT02453282|616184049|FG002|Overall Study|Withdrawal by Subject|11|||
170503441|NCT02453282|616184047|FG000|Overall Study|Participants ongoing at data cut-off|85|||
170503442|NCT02453282|616184048|FG001|Overall Study|Participants ongoing at data cut-off|84|||
170503443|NCT02453282|616184049|FG002|Overall Study|Participants ongoing at data cut-off|62|||
170503444|NCT02453282|616184047|FG000|Overall Study|Other|1|||
170503445|NCT02453282|616184048|FG001|Overall Study|Other|1|||
170503446|NCT02453282|616184049|FG002|Overall Study|Other|1|||
170503447|NCT00985426|616184050|FG000|Overall Study|Adverse Event|0|||
170503448|NCT00985426|616184051|FG001|Overall Study|Adverse Event|1|||
170503449|NCT00985426|616184050|FG000|Overall Study|Subject Non-Compliance|3|||
170503450|NCT00985426|616184051|FG001|Overall Study|Subject Non-Compliance|3|||
170503451|NCT00985426|616184050|FG000|Overall Study|Withdrawal by Subject|12|||
170503452|NCT00985426|616184051|FG001|Overall Study|Withdrawal by Subject|16|||
170503453|NCT00985426|616184050|FG000|Overall Study|Lost to Follow-up|8|||
170503454|NCT00985426|616184051|FG001|Overall Study|Lost to Follow-up|10|||
170503455|NCT00985426|616184050|FG000|Overall Study|Death|7|||
170503456|NCT00985426|616184051|FG001|Overall Study|Death|3|||
170503457|NCT00985426|616184050|FG000|Overall Study|Protocol Violation|2|||
170503458|NCT00985426|616184051|FG001|Overall Study|Protocol Violation|0|||
170503459|NCT00985426|616184050|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
170503460|NCT00985426|616184051|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
170503461|NCT02380859|616184052|FG000|Overall Study|Withdrawal by Subject|2|||
170503462|NCT02380859|616184053|FG001|Overall Study|Withdrawal by Subject|0|||
170503463|NCT01661933|616184057|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
170503464|NCT01661933|616184057|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
170503465|NCT03385304|616184058|FG000|Overall Study|Death|19|||
170503466|NCT03385304|616184059|FG001|Overall Study|Death|7|||
170503467|NCT03385304|616184058|FG000|Overall Study|Lost to Follow-up|17|||
170503468|NCT03385304|616184059|FG001|Overall Study|Lost to Follow-up|14|||
170503469|NCT03385304|616184058|FG000|Overall Study|Withdrawal by Subject|3|||
170503470|NCT03385304|616184059|FG001|Overall Study|Withdrawal by Subject|2|||
170503471|NCT03385304|616184058|FG000|Overall Study|Incarceration|2|||
170503472|NCT03385304|616184059|FG001|Overall Study|Incarceration|3|||
170503473|NCT01565668|616184060|FG000|Overall Study|Death|2|||
170503474|NCT01565668|616184061|FG001|Overall Study|Death|1|||
170503475|NCT01565668|616184060|FG000|Overall Study|Lack of Efficacy|4|||
170503476|NCT01565668|616184061|FG001|Overall Study|Lack of Efficacy|2|||
170503477|NCT01565668|616184060|FG000|Overall Study|Participant went on Hospice Care|1|||
170503478|NCT01565668|616184061|FG001|Overall Study|Participant went on Hospice Care|0|||
170503479|NCT01565668|616184060|FG000|Overall Study|Adverse Event|6|||
170503480|NCT01565668|616184061|FG001|Overall Study|Adverse Event|1|||
170503481|NCT01565668|616184060|FG000|Overall Study|Randomized, but never received drug|0|||
170503482|NCT01565668|616184061|FG001|Overall Study|Randomized, but never received drug|2|||
170503483|NCT01565668|616184060|FG000|Overall Study|Progressive disease|13|||
170503484|NCT01565668|616184061|FG001|Overall Study|Progressive disease|14|||
170503485|NCT01565668|616184060|FG000|Overall Study|Withdrawal by Subject|1|||
170503486|NCT01565668|616184061|FG001|Overall Study|Withdrawal by Subject|3|||
170503487|NCT01565668|616184060|FG000|Overall Study|HSCT Transplant|11|||
170503488|NCT01565668|616184061|FG001|Overall Study|HSCT Transplant|15|||
170503489|NCT01097421|616184062|FG000|Overall Study|Adverse Event|8|||
170503490|NCT01097421|616184062|FG000|Overall Study|Protocol Violation|2|||
170503491|NCT01097421|616184062|FG000|Overall Study|Lost to Follow-up|1|||
170503492|NCT01097421|616184062|FG000|Overall Study|Withdrawal by Subject|3|||
170503493|NCT01120249|616184063|FG000|Overall Study|No protocol treatment received|21|||
170503494|NCT01120249|616184064|FG001|Overall Study|No protocol treatment received|15|||
170503495|NCT01120249|616184063|FG000|Overall Study|Disease recurrence|107|||
170503496|NCT01120249|616184064|FG001|Overall Study|Disease recurrence|57|||
170503497|NCT01120249|616184063|FG000|Overall Study|Death|1|||
170503498|NCT01120249|616184064|FG001|Overall Study|Death|0|||
170503499|NCT01120249|616184063|FG000|Overall Study|Adverse Event|40|||
170503500|NCT01120249|616184064|FG001|Overall Study|Adverse Event|276|||
170503501|NCT01120249|616184063|FG000|Overall Study|Participant refusal|34|||
170503502|NCT01120249|616184064|FG001|Overall Study|Participant refusal|42|||
170503503|NCT01120249|616184063|FG000|Overall Study|Other reasons, not protocol specified|29|||
170503504|NCT01120249|616184064|FG001|Overall Study|Other reasons, not protocol specified|22|||
170503505|NCT02720744|616184065|FG000|Overall Study|Protocol Violation|0|||
170503506|NCT02720744|616184066|FG001|Overall Study|Protocol Violation|2|||
170503507|NCT02720744|616184065|FG000|Overall Study|Pregnancy|2|||
170503508|NCT02720744|616184066|FG001|Overall Study|Pregnancy|0|||
170503509|NCT02720744|616184065|FG000|Overall Study|Lack of Efficacy|2|||
170503510|NCT02720744|616184066|FG001|Overall Study|Lack of Efficacy|8|||
170503511|NCT02720744|616184065|FG000|Overall Study|Adverse Event|21|||
170503512|NCT02720744|616184066|FG001|Overall Study|Adverse Event|3|||
170503513|NCT02720744|616184065|FG000|Overall Study|Withdrawal by Subject|11|||
170503514|NCT02720744|616184066|FG001|Overall Study|Withdrawal by Subject|11|||
170503515|NCT02720744|616184065|FG000|Overall Study|Lost to follow up|2|||
170503516|NCT02720744|616184066|FG001|Overall Study|Lost to follow up|0|||
170503517|NCT02720744|616184065|FG000|Overall Study|Non Compliance with Investigational Product|0|||
170503518|NCT02720744|616184066|FG001|Overall Study|Non Compliance with Investigational Product|1|||
170503519|NCT02720744|616184065|FG000|Overall Study|Excluded Concomitant Medication|0|||
170503520|NCT02720744|616184066|FG001|Overall Study|Excluded Concomitant Medication|1|||
170503521|NCT02122770|616184067|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
170503522|NCT02122770|616184068|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
170503523|NCT02122770|616184069|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
170503524|NCT02122770|616184070|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
170503525|NCT02122770|616184071|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
170503526|NCT02122770|616184072|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
170503527|NCT02122770|616184067|FG000|Part A: Drug-drug Interaction 2|Other|0|||
170503528|NCT02122770|616184068|FG001|Part A: Drug-drug Interaction 2|Other|0|||
170503529|NCT02122770|616184069|FG002|Part A: Drug-drug Interaction 2|Other|1|||
170503530|NCT02122770|616184070|FG003|Part A: Drug-drug Interaction 2|Other|0|||
170503531|NCT02122770|616184071|FG004|Part A: Drug-drug Interaction 2|Other|0|||
170552033|NCT01725308|616366496|FG002|Treatment Period I|Worsening of the Target Disease|2|||
170552034|NCT01725308|616366494|FG000|Treatment Period I|Changes in the Episodes|3|||
170552035|NCT01725308|616366495|FG001|Treatment Period I|Changes in the Episodes|0|||
170552036|NCT01725308|616366496|FG002|Treatment Period I|Changes in the Episodes|2|||
170503532|NCT02122770|616184072|FG005|Part A: Drug-drug Interaction 2|Other|0|||
170503533|NCT02122770|616184067|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
170503534|NCT02122770|616184068|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
170503535|NCT02122770|616184069|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
170503536|NCT02122770|616184070|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
170503537|NCT02122770|616184071|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
170503538|NCT02122770|616184072|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
170503539|NCT02122770|616184067|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
170503540|NCT02122770|616184068|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
170503541|NCT02122770|616184069|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
170503542|NCT02122770|616184070|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
170503543|NCT02122770|616184071|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
170503544|NCT02122770|616184072|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
170503545|NCT02122770|616184067|FG000|Part B: Standard of Care|Adverse Event|0|||
170503546|NCT02122770|616184068|FG001|Part B: Standard of Care|Adverse Event|0|||
170503547|NCT02122770|616184069|FG002|Part B: Standard of Care|Adverse Event|0|||
170503548|NCT02122770|616184070|FG003|Part B: Standard of Care|Adverse Event|0|||
170503549|NCT02122770|616184071|FG004|Part B: Standard of Care|Adverse Event|4|||
170503550|NCT02122770|616184072|FG005|Part B: Standard of Care|Adverse Event|1|||
170503551|NCT02122770|616184067|FG000|Part B: Standard of Care|Other|0|||
170503552|NCT02122770|616184068|FG001|Part B: Standard of Care|Other|0|||
170503553|NCT02122770|616184069|FG002|Part B: Standard of Care|Other|0|||
170503554|NCT02122770|616184070|FG003|Part B: Standard of Care|Other|0|||
170503555|NCT02122770|616184071|FG004|Part B: Standard of Care|Other|0|||
170503556|NCT02122770|616184072|FG005|Part B: Standard of Care|Other|2|||
170503557|NCT02122770|616184067|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
170503558|NCT02122770|616184068|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
170503559|NCT02122770|616184069|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
170503560|NCT02122770|616184070|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
170503561|NCT02122770|616184071|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
170503562|NCT02122770|616184072|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
170503563|NCT02122770|616184067|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
170503564|NCT02122770|616184068|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
170503565|NCT02122770|616184069|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
170503566|NCT02122770|616184070|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
170503567|NCT02122770|616184071|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
170503568|NCT02122770|616184072|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
170503569|NCT02122770|616184067|FG000|Part B: Standard of Care|Progressive Disease|0|||
170503570|NCT02122770|616184068|FG001|Part B: Standard of Care|Progressive Disease|0|||
170503571|NCT02122770|616184069|FG002|Part B: Standard of Care|Progressive Disease|0|||
170503572|NCT02122770|616184070|FG003|Part B: Standard of Care|Progressive Disease|0|||
170503573|NCT02122770|616184071|FG004|Part B: Standard of Care|Progressive Disease|10|||
170503574|NCT02122770|616184072|FG005|Part B: Standard of Care|Progressive Disease|8|||
170503575|NCT00558896|616184073|FG000|Overall Study|Adverse Event|1|||
170503576|NCT00558896|616184074|FG001|Overall Study|Adverse Event|1|||
170503577|NCT00558896|616184075|FG002|Overall Study|Adverse Event|1|||
170503578|NCT00558896|616184076|FG003|Overall Study|Adverse Event|3|||
170503579|NCT00558896|616184077|FG004|Overall Study|Adverse Event|4|||
170503580|NCT00558896|616184078|FG005|Overall Study|Adverse Event|10|||
170503581|NCT00558896|616184079|FG006|Overall Study|Adverse Event|3|||
170503582|NCT00558896|616184073|FG000|Overall Study|Death|3|||
170503583|NCT00558896|616184074|FG001|Overall Study|Death|0|||
170552037|NCT01725308|616366494|FG000|Treatment Period I|Withdrawal of Consent|12|||
170552038|NCT01725308|616366495|FG001|Treatment Period I|Withdrawal of Consent|7|||
170552039|NCT01725308|616366496|FG002|Treatment Period I|Withdrawal of Consent|5|||
170552040|NCT01725308|616366494|FG000|Treatment Period I|Lost to Follow-up|3|||
170552041|NCT01725308|616366495|FG001|Treatment Period I|Lost to Follow-up|2|||
170552042|NCT01725308|616366496|FG002|Treatment Period I|Lost to Follow-up|2|||
170552043|NCT01725308|616366494|FG000|Treatment Period I|Protocol Deviations|3|||
170552044|NCT01725308|616366495|FG001|Treatment Period I|Protocol Deviations|1|||
170552045|NCT01725308|616366496|FG002|Treatment Period I|Protocol Deviations|1|||
170552046|NCT01725308|616366494|FG000|Treatment Period I|Miscellaneous|2|||
170552047|NCT01725308|616366495|FG001|Treatment Period I|Miscellaneous|0|||
170552048|NCT01725308|616366496|FG002|Treatment Period I|Miscellaneous|3|||
170552049|NCT01725308|616366494|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
170552050|NCT01725308|616366495|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
170552051|NCT01725308|616366496|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
170552052|NCT01725308|616366494|FG000|Treatment Period II|Did Not Receive Drug|4|||
170552053|NCT01725308|616366495|FG001|Treatment Period II|Did Not Receive Drug|0|||
170552054|NCT01725308|616366496|FG002|Treatment Period II|Did Not Receive Drug|0|||
170552055|NCT01725308|616366494|FG000|Treatment Period II|Adverse Event|13|||
170552056|NCT01725308|616366495|FG001|Treatment Period II|Adverse Event|8|||
170552057|NCT01725308|616366496|FG002|Treatment Period II|Adverse Event|20|||
170552058|NCT01725308|616366494|FG000|Treatment Period II|Insufficient Response|2|||
170503584|NCT00558896|616184075|FG002|Overall Study|Death|2|||
170552059|NCT01725308|616366495|FG001|Treatment Period II|Insufficient Response|4|||
170552060|NCT01725308|616366496|FG002|Treatment Period II|Insufficient Response|6|||
170552061|NCT01725308|616366494|FG000|Treatment Period II|Worsening of the Target Disease|1|||
170503585|NCT00558896|616184076|FG003|Overall Study|Death|3|||
170503586|NCT00558896|616184077|FG004|Overall Study|Death|2|||
170503587|NCT00558896|616184078|FG005|Overall Study|Death|2|||
170503588|NCT00558896|616184079|FG006|Overall Study|Death|6|||
170503589|NCT00558896|616184073|FG000|Overall Study|Withdrawal by Subject|2|||
170503590|NCT00558896|616184074|FG001|Overall Study|Withdrawal by Subject|1|||
170503591|NCT00558896|616184075|FG002|Overall Study|Withdrawal by Subject|1|||
170503592|NCT00558896|616184076|FG003|Overall Study|Withdrawal by Subject|1|||
170503593|NCT00558896|616184077|FG004|Overall Study|Withdrawal by Subject|1|||
170503594|NCT00558896|616184078|FG005|Overall Study|Withdrawal by Subject|5|||
170503595|NCT00558896|616184079|FG006|Overall Study|Withdrawal by Subject|5|||
170503596|NCT00558896|616184073|FG000|Overall Study|Alternative Treatment|2|||
170503597|NCT00558896|616184074|FG001|Overall Study|Alternative Treatment|2|||
170503598|NCT00558896|616184075|FG002|Overall Study|Alternative Treatment|0|||
170503599|NCT00558896|616184076|FG003|Overall Study|Alternative Treatment|2|||
170503600|NCT00558896|616184077|FG004|Overall Study|Alternative Treatment|6|||
170503601|NCT00558896|616184078|FG005|Overall Study|Alternative Treatment|7|||
170503602|NCT00558896|616184079|FG006|Overall Study|Alternative Treatment|1|||
170503603|NCT00558896|616184073|FG000|Overall Study|Physician discretion|3|||
170503604|NCT00558896|616184074|FG001|Overall Study|Physician discretion|2|||
170503605|NCT00558896|616184075|FG002|Overall Study|Physician discretion|1|||
170503606|NCT00558896|616184076|FG003|Overall Study|Physician discretion|2|||
170503607|NCT00558896|616184077|FG004|Overall Study|Physician discretion|1|||
170503608|NCT00558896|616184078|FG005|Overall Study|Physician discretion|3|||
170503609|NCT00558896|616184079|FG006|Overall Study|Physician discretion|3|||
170503610|NCT00558896|616184073|FG000|Overall Study|Continues on treatment|10|||
170503611|NCT00558896|616184074|FG001|Overall Study|Continues on treatment|1|||
170503612|NCT00558896|616184075|FG002|Overall Study|Continues on treatment|0|||
170503613|NCT00558896|616184076|FG003|Overall Study|Continues on treatment|1|||
170503614|NCT00558896|616184077|FG004|Overall Study|Continues on treatment|9|||
170503615|NCT00558896|616184078|FG005|Overall Study|Continues on treatment|25|||
170503616|NCT00558896|616184079|FG006|Overall Study|Continues on treatment|6|||
170503617|NCT06137703|616184082|FG000|Overall Study|Other|0|||
170503618|NCT06137703|616184083|FG001|Overall Study|Other|1|||
170503619|NCT06137703|616184084|FG002|Overall Study|Other|0|||
170503620|NCT06137703|616184085|FG003|Overall Study|Other|0|||
170503621|NCT06137703|616184082|FG000|Overall Study|Adverse Event|0|||
170503622|NCT06137703|616184083|FG001|Overall Study|Adverse Event|0|||
170503623|NCT06137703|616184084|FG002|Overall Study|Adverse Event|1|||
170503624|NCT06137703|616184085|FG003|Overall Study|Adverse Event|0|||
170503625|NCT00723190|616184086|FG000|Overall Study|Withdrawal by Subject|45|||
170503626|NCT00723190|616184086|FG000|Overall Study|Lost to Follow-up|37|||
170503627|NCT00723190|616184086|FG000|Overall Study|Adverse Event|18|||
170503628|NCT00723190|616184086|FG000|Overall Study|Lack of Efficacy|16|||
170503629|NCT00723190|616184086|FG000|Overall Study|Protocol Violation|15|||
170503630|NCT00723190|616184086|FG000|Overall Study|Other-Premature Discontinuation|9|||
170503631|NCT00723190|616184086|FG000|Overall Study|Other-Not included in safety population|2|||
170503632|NCT00767039|616184088|FG000|Overall Study|Death|5|||
170503633|NCT00767039|616184089|FG001|Overall Study|Death|2|||
170503634|NCT02505334|616184090|FG000|Main Treatment Period|Adverse Event|3|||
170503635|NCT02505334|616184091|FG001|Main Treatment Period|Adverse Event|3|||
170503636|NCT02505334|616184090|FG000|Main Treatment Period|Lack of Efficacy|7|||
170503637|NCT02505334|616184091|FG001|Main Treatment Period|Lack of Efficacy|17|||
170503638|NCT02505334|616184090|FG000|Main Treatment Period|Protocol Violation|0|||
170503639|NCT02505334|616184091|FG001|Main Treatment Period|Protocol Violation|1|||
170503640|NCT02505334|616184090|FG000|Main Treatment Period|Withdrawal by Subject|1|||
170503641|NCT02505334|616184091|FG001|Main Treatment Period|Withdrawal by Subject|8|||
170503642|NCT02505334|616184090|FG000|Main Treatment Period|Unclassified|4|||
170503643|NCT02505334|616184091|FG001|Main Treatment Period|Unclassified|10|||
170503644|NCT02505334|616184090|FG000|Extension Treatment Period|Adverse Event|5|||
170552062|NCT01725308|616366495|FG001|Treatment Period II|Worsening of the Target Disease|4|||
170552063|NCT01725308|616366496|FG002|Treatment Period II|Worsening of the Target Disease|2|||
170552064|NCT01725308|616366494|FG000|Treatment Period II|Changes in the Episodes|1|||
170552065|NCT01725308|616366495|FG001|Treatment Period II|Changes in the Episodes|0|||
170552066|NCT01725308|616366496|FG002|Treatment Period II|Changes in the Episodes|5|||
170552067|NCT01725308|616366494|FG000|Treatment Period II|Withdrawal of Consent|28|||
170552068|NCT01725308|616366495|FG001|Treatment Period II|Withdrawal of Consent|2|||
170552069|NCT01725308|616366496|FG002|Treatment Period II|Withdrawal of Consent|16|||
170552070|NCT01725308|616366494|FG000|Treatment Period II|Lost to Follow-up|1|||
170552071|NCT01725308|616366495|FG001|Treatment Period II|Lost to Follow-up|5|||
170503645|NCT02505334|616184091|FG001|Extension Treatment Period|Adverse Event|0|||
170503646|NCT02505334|616184090|FG000|Extension Treatment Period|Lack of Efficacy|4|||
170503647|NCT02505334|616184091|FG001|Extension Treatment Period|Lack of Efficacy|0|||
170503648|NCT02505334|616184090|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
170552072|NCT01725308|616366496|FG002|Treatment Period II|Lost to Follow-up|3|||
170503649|NCT02505334|616184091|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
170503650|NCT02505334|616184090|FG000|Extension Treatment Period|Unclassified|3|||
170503651|NCT02505334|616184091|FG001|Extension Treatment Period|Unclassified|0|||
170503652|NCT04472026|616184096|FG000|Overall Study|Lost to Follow-up|5|||
170503653|NCT01404208|616184099|FG000|Overall Study|Discontinued|3|||
170503654|NCT01404208|616184100|FG001|Overall Study|Discontinued|0|||
170503655|NCT02382796|616184101|FG000|Overall Study|Global deterioration of health status|1|||
170503656|NCT02382796|616184101|FG000|Overall Study|Objective progression or relapse|3|||
170503657|NCT02382796|616184101|FG000|Overall Study|Commercial dacomitinib became available|3|||
170503658|NCT03077659|616184102|FG000|Overall Study|Withdrawal by Subject|0|||
170503659|NCT03077659|616184103|FG001|Overall Study|Withdrawal by Subject|0|||
170503660|NCT03077659|616184104|FG002|Overall Study|Withdrawal by Subject|1|||
170503661|NCT02844907|616184111|FG000|With Dexamethasone|No IV access|1|||
170503662|NCT00550862|616184112|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
170503663|NCT00550862|616184113|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
170503664|NCT00550862|616184114|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
170503665|NCT00550862|616184115|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
170503666|NCT00550862|616184116|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
170503667|NCT00550862|616184112|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
170503668|NCT00550862|616184113|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
170503669|NCT00550862|616184114|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
170503670|NCT00550862|616184115|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
170503671|NCT00550862|616184116|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
170503672|NCT00550862|616184112|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
170552073|NCT01725308|616366494|FG000|Treatment Period II|Protocol Deviations|0|||
170552074|NCT01725308|616366495|FG001|Treatment Period II|Protocol Deviations|0|||
170552075|NCT01725308|616366496|FG002|Treatment Period II|Protocol Deviations|1|||
170503673|NCT00550862|616184113|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
170503674|NCT00550862|616184114|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
170503675|NCT00550862|616184115|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
170503676|NCT00550862|616184116|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
170503677|NCT00550862|616184112|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
170503678|NCT00550862|616184113|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
170503679|NCT00550862|616184114|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
170503680|NCT00550862|616184115|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
170503681|NCT00550862|616184116|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
170503682|NCT00550862|616184112|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
170503683|NCT00550862|616184113|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
170503684|NCT00550862|616184114|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
170503685|NCT00550862|616184115|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
170503686|NCT00550862|616184116|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
170503687|NCT00550862|616184112|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
170503688|NCT00550862|616184113|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
170503689|NCT00550862|616184114|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
170552076|NCT01725308|616366494|FG000|Treatment Period II|Miscellaneous|5|||
170552077|NCT01725308|616366495|FG001|Treatment Period II|Miscellaneous|3|||
170552078|NCT01725308|616366496|FG002|Treatment Period II|Miscellaneous|7|||
170552079|NCT06048705|616366500|FG000|Overall Study|Physician Decision|1|||
170552080|NCT06048705|616366501|FG001|Overall Study|Physician Decision|0|||
170552081|NCT06048705|616366502|FG002|Overall Study|Physician Decision|0|||
170552082|NCT06048705|616366500|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
170552083|NCT06048705|616366501|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
170552084|NCT06048705|616366502|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
170552085|NCT06048705|616366500|FG000|Overall Study|Death prior to lymphodepletion|0|||
170552086|NCT06048705|616366501|FG001|Overall Study|Death prior to lymphodepletion|0|||
170552087|NCT06048705|616366502|FG002|Overall Study|Death prior to lymphodepletion|1|||
170552088|NCT03163264|616366503|FG000|Overall Study|Withdrawal by Subject|13|||
170552089|NCT03163264|616366504|FG001|Overall Study|Withdrawal by Subject|3|||
170552090|NCT03163264|616366505|FG002|Overall Study|Withdrawal by Subject|4|||
170552091|NCT03163264|616366506|FG003|Overall Study|Withdrawal by Subject|2|||
170552092|NCT03163264|616366503|FG000|Overall Study|Lost to Follow-up|17|||
170552093|NCT03163264|616366504|FG001|Overall Study|Lost to Follow-up|20|||
170552094|NCT03163264|616366505|FG002|Overall Study|Lost to Follow-up|0|||
170552095|NCT03163264|616366506|FG003|Overall Study|Lost to Follow-up|0|||
170552096|NCT03163264|616366503|FG000|Overall Study|Death|0|||
170552097|NCT03163264|616366504|FG001|Overall Study|Death|2|||
170552098|NCT03163264|616366505|FG002|Overall Study|Death|0|||
170552099|NCT03163264|616366506|FG003|Overall Study|Death|0|||
170904100|NCT00699192|617650869|FG001|Overall Study|Administrative problems|3|||
170904101|NCT00699192|617650870|FG002|Overall Study|Administrative problems|1|||
170904102|NCT00699192|617650868|FG000|Overall Study|Protocol Violation|2|||
170552100|NCT02614066|616366507|FG000|Overall Study|Death|6|||
170552101|NCT02614066|616366508|FG001|Overall Study|Death|14|||
170552102|NCT02614066|616366509|FG002|Overall Study|Death|11|||
170552103|NCT02614066|616366510|FG003|Overall Study|Death|29|||
170552104|NCT02614066|616366507|FG000|Overall Study|Full consent withdrawn|0|||
170503690|NCT00550862|616184115|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
170503691|NCT00550862|616184116|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
170503692|NCT00550862|616184112|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
170503693|NCT00550862|616184113|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
170503694|NCT00550862|616184114|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
170503695|NCT00550862|616184115|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
170503696|NCT00550862|616184116|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
170503697|NCT00550862|616184112|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
170503698|NCT00550862|616184113|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
170503699|NCT00550862|616184114|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
170503700|NCT00550862|616184115|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
170503701|NCT00550862|616184116|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
170503702|NCT00550862|616184112|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
170503703|NCT00550862|616184113|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
170503704|NCT00550862|616184114|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
170503705|NCT00550862|616184115|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
170503706|NCT00550862|616184116|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
170503707|NCT00550862|616184112|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
170503708|NCT00550862|616184113|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
170503709|NCT00550862|616184114|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
170503710|NCT00550862|616184115|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
170503711|NCT00550862|616184116|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
170503712|NCT03488225|616184117|FG000|Overall Study|Off Protocol Therapy|2|||
170503713|NCT03488225|616184117|FG000|Overall Study|Stem Cell Transplant|2|||
170503714|NCT00085098|616184123|FG000|Overall Study|Withdrawal by Subject|0|||
170503715|NCT00085098|616184124|FG001|Overall Study|Withdrawal by Subject|1|||
170503716|NCT00085098|616184123|FG000|Overall Study|Ineligible|1|||
170503717|NCT00085098|616184124|FG001|Overall Study|Ineligible|1|||
170503718|NCT00980018|616184129|FG000|Overall Study|Adverse Event|8|||
170503719|NCT00980018|616184129|FG000|Overall Study|Patient withdrew consent|3|||
170503720|NCT00980018|616184129|FG000|Overall Study|Lost to Follow-up|1|||
170503721|NCT01935128|616184132|FG000|Overall Study|Death|1|||
170503722|NCT01935128|616184132|FG000|Overall Study|Adverse Event|6|||
170503723|NCT01273155|616184133|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
170503724|NCT01273155|616184134|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
170503725|NCT01273155|616184135|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
170503726|NCT01273155|616184136|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
170503727|NCT01273155|616184137|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
170503728|NCT01273155|616184138|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
170503729|NCT01273155|616184139|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
170503730|NCT01273155|616184133|FG000|Overall Study|Change in liver function/no longer eval.|0|||
170503731|NCT01273155|616184134|FG001|Overall Study|Change in liver function/no longer eval.|1|||
170503732|NCT01273155|616184135|FG002|Overall Study|Change in liver function/no longer eval.|0|||
170503733|NCT01273155|616184136|FG003|Overall Study|Change in liver function/no longer eval.|0|||
170503734|NCT01273155|616184137|FG004|Overall Study|Change in liver function/no longer eval.|1|||
170503735|NCT01273155|616184138|FG005|Overall Study|Change in liver function/no longer eval.|0|||
170503736|NCT01273155|616184139|FG006|Overall Study|Change in liver function/no longer eval.|0|||
170503737|NCT01273155|616184133|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
170503738|NCT01273155|616184134|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
170503739|NCT01273155|616184135|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
170503740|NCT01273155|616184136|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
170503741|NCT01273155|616184137|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
170503742|NCT01273155|616184138|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
170503743|NCT01273155|616184139|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
170503744|NCT01273155|616184133|FG000|Overall Study|Died during Cycle 1|0|||
170503745|NCT01273155|616184134|FG001|Overall Study|Died during Cycle 1|0|||
170503746|NCT01273155|616184135|FG002|Overall Study|Died during Cycle 1|1|||
170503747|NCT01273155|616184136|FG003|Overall Study|Died during Cycle 1|1|||
170503748|NCT01273155|616184137|FG004|Overall Study|Died during Cycle 1|0|||
170552105|NCT02614066|616366508|FG001|Overall Study|Full consent withdrawn|1|||
170552106|NCT02614066|616366509|FG002|Overall Study|Full consent withdrawn|0|||
170805340|NCT03362190|617297343|FG001|Overall Study|Withdrawal by Subject|0|||
170503749|NCT01273155|616184138|FG005|Overall Study|Died during Cycle 1|2|||
170805341|NCT03362190|617297344|FG002|Overall Study|Withdrawal by Subject|0|||
170805342|NCT03362190|617297345|FG003|Overall Study|Withdrawal by Subject|1|||
170805343|NCT00687219|617297346|FG000|Overall Study|Adverse Event|8|||
170805344|NCT00687219|617297346|FG000|Overall Study|Discontinuance criteria met|7|||
170805345|NCT00687219|617297346|FG000|Overall Study|HCV-RNA positive conversion|34|||
170805346|NCT00687219|617297346|FG000|Overall Study|Withdrawal by Subject|1|||
170503750|NCT01273155|616184139|FG006|Overall Study|Died during Cycle 1|2|||
170503751|NCT01273155|616184133|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
170503752|NCT01273155|616184134|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
170503753|NCT01273155|616184135|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
170503754|NCT01273155|616184136|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
170503755|NCT01273155|616184137|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
170503756|NCT01273155|616184138|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
170503757|NCT01273155|616184139|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
170503758|NCT02968433|616184141|FG000|Overall Study|Withdrawal by Subject|1|||
170503759|NCT03912428|616184142|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
170503760|NCT03912428|616184143|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
170503761|NCT03912428|616184144|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
170503762|NCT03912428|616184145|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
170503763|NCT03912428|616184142|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
170503764|NCT03912428|616184143|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
170503765|NCT03912428|616184144|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
170503766|NCT03912428|616184145|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
170503767|NCT03912428|616184142|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
170503768|NCT03912428|616184143|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
170503769|NCT03912428|616184144|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
170503770|NCT03912428|616184145|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
170503771|NCT01645891|616184146|FG000|Overall Study|Adverse Event|6|||
170503772|NCT01645891|616184147|FG001|Overall Study|Adverse Event|10|||
170503773|NCT01645891|616184146|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
170503774|NCT01645891|616184147|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
170503775|NCT01645891|616184146|FG000|Overall Study|Withdrawal by Subject|3|||
170503776|NCT01645891|616184147|FG001|Overall Study|Withdrawal by Subject|3|||
170503777|NCT01645891|616184146|FG000|Overall Study|Protocol Violation|4|||
170503778|NCT01645891|616184147|FG001|Overall Study|Protocol Violation|0|||
170503779|NCT01645891|616184146|FG000|Overall Study|Lost to Follow-up|4|||
170503780|NCT01645891|616184147|FG001|Overall Study|Lost to Follow-up|1|||
170503781|NCT01645891|616184146|FG000|Overall Study|Death|0|||
170503782|NCT01645891|616184147|FG001|Overall Study|Death|2|||
170503783|NCT00954512|616184148|FG000|Overall Study|Withdrawal by Subject|0|||
170503784|NCT00954512|616184149|FG001|Overall Study|Withdrawal by Subject|0|||
170503785|NCT00954512|616184150|FG002|Overall Study|Withdrawal by Subject|0|||
170503786|NCT00954512|616184151|FG003|Overall Study|Withdrawal by Subject|0|||
170503787|NCT00954512|616184152|FG004|Overall Study|Withdrawal by Subject|0|||
170503788|NCT00954512|616184153|FG005|Overall Study|Withdrawal by Subject|1|||
170503789|NCT00954512|616184148|FG000|Overall Study|Adverse Event|0|||
170503790|NCT00954512|616184149|FG001|Overall Study|Adverse Event|0|||
170503791|NCT00954512|616184150|FG002|Overall Study|Adverse Event|0|||
170503792|NCT00954512|616184151|FG003|Overall Study|Adverse Event|0|||
170503793|NCT00954512|616184152|FG004|Overall Study|Adverse Event|1|||
170503794|NCT00954512|616184153|FG005|Overall Study|Adverse Event|2|||
170503795|NCT00954512|616184148|FG000|Overall Study|Physician Decision|0|||
170503796|NCT00954512|616184149|FG001|Overall Study|Physician Decision|1|||
170503797|NCT00954512|616184150|FG002|Overall Study|Physician Decision|0|||
170503798|NCT00954512|616184151|FG003|Overall Study|Physician Decision|1|||
170503799|NCT00954512|616184152|FG004|Overall Study|Physician Decision|0|||
170503800|NCT00954512|616184153|FG005|Overall Study|Physician Decision|0|||
170503801|NCT00954512|616184148|FG000|Overall Study|Symptomatic Deterioration|0|||
170503802|NCT00954512|616184149|FG001|Overall Study|Symptomatic Deterioration|1|||
170503803|NCT00954512|616184150|FG002|Overall Study|Symptomatic Deterioration|0|||
170503804|NCT00954512|616184151|FG003|Overall Study|Symptomatic Deterioration|0|||
170503805|NCT00954512|616184152|FG004|Overall Study|Symptomatic Deterioration|2|||
170503806|NCT00954512|616184153|FG005|Overall Study|Symptomatic Deterioration|0|||
170503807|NCT00954512|616184148|FG000|Overall Study|Progression of Disease|2|||
170503808|NCT00954512|616184149|FG001|Overall Study|Progression of Disease|1|||
170503809|NCT00954512|616184150|FG002|Overall Study|Progression of Disease|0|||
170503810|NCT00954512|616184151|FG003|Overall Study|Progression of Disease|1|||
170503811|NCT00954512|616184152|FG004|Overall Study|Progression of Disease|1|||
170503812|NCT00954512|616184153|FG005|Overall Study|Progression of Disease|1|||
170503813|NCT01173055|616184154|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
170503814|NCT01173055|616184155|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
170642494|NCT01403948|616705273|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
170503815|NCT01173055|616184154|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
170503816|NCT01173055|616184155|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
170503817|NCT04814368|616184157|FG000|Overall Study|Study Terminated by Sponsor|0|||
170503818|NCT04814368|616184158|FG001|Overall Study|Study Terminated by Sponsor|3|||
170503819|NCT04814368|616184159|FG002|Overall Study|Study Terminated by Sponsor|0|||
170503820|NCT04814368|616184160|FG003|Overall Study|Study Terminated by Sponsor|2|||
170503821|NCT04814368|616184157|FG000|Overall Study|Subject Decision|1|||
170503822|NCT04814368|616184158|FG001|Overall Study|Subject Decision|2|||
170503823|NCT04814368|616184159|FG002|Overall Study|Subject Decision|0|||
170503824|NCT04814368|616184160|FG003|Overall Study|Subject Decision|0|||
170503825|NCT00962091|616184161|FG000|Overall Study|Withdrawal by Subject|1|||
170503826|NCT00962091|616184162|FG001|Overall Study|Withdrawal by Subject|2|||
170503827|NCT00962091|616184163|FG002|Overall Study|Withdrawal by Subject|1|||
170503828|NCT00962091|616184164|FG003|Overall Study|Withdrawal by Subject|1|||
170503829|NCT00962091|616184165|FG004|Overall Study|Withdrawal by Subject|0|||
170503830|NCT00962091|616184166|FG005|Overall Study|Withdrawal by Subject|1|||
170503831|NCT00962091|616184167|FG006|Overall Study|Withdrawal by Subject|0|||
170503832|NCT00962091|616184161|FG000|Overall Study|Adverse Event|0|||
170503833|NCT00962091|616184162|FG001|Overall Study|Adverse Event|0|||
170503834|NCT00962091|616184163|FG002|Overall Study|Adverse Event|0|||
170503835|NCT00962091|616184164|FG003|Overall Study|Adverse Event|0|||
170503836|NCT00962091|616184165|FG004|Overall Study|Adverse Event|0|||
170503837|NCT00962091|616184166|FG005|Overall Study|Adverse Event|0|||
170503838|NCT00962091|616184167|FG006|Overall Study|Adverse Event|1|||
170503839|NCT02987972|616184175|FG000|Overall Study|Adverse Event|1|||
170503840|NCT02987972|616184176|FG001|Overall Study|Adverse Event|1|||
170503841|NCT02987972|616184177|FG002|Overall Study|Adverse Event|0|||
170503842|NCT02987972|616184175|FG000|Overall Study|Death|1|||
170503843|NCT02987972|616184176|FG001|Overall Study|Death|0|||
170503844|NCT02987972|616184177|FG002|Overall Study|Death|0|||
170503845|NCT02987972|616184175|FG000|Overall Study|Lack of Efficacy|9|||
170503846|NCT02987972|616184176|FG001|Overall Study|Lack of Efficacy|12|||
170503847|NCT02987972|616184177|FG002|Overall Study|Lack of Efficacy|12|||
170503848|NCT02987972|616184175|FG000|Overall Study|Lost to Follow-up|7|||
170503849|NCT02987972|616184176|FG001|Overall Study|Lost to Follow-up|8|||
170503850|NCT02987972|616184177|FG002|Overall Study|Lost to Follow-up|4|||
170503851|NCT02987972|616184175|FG000|Overall Study|Physician Decision|1|||
170503852|NCT02987972|616184176|FG001|Overall Study|Physician Decision|6|||
170503853|NCT02987972|616184177|FG002|Overall Study|Physician Decision|0|||
170503854|NCT02987972|616184175|FG000|Overall Study|Protocol Violation|2|||
170503855|NCT02987972|616184176|FG001|Overall Study|Protocol Violation|1|||
170503856|NCT02987972|616184177|FG002|Overall Study|Protocol Violation|5|||
170503857|NCT02987972|616184175|FG000|Overall Study|Withdrawal by Subject|22|||
170503858|NCT02987972|616184176|FG001|Overall Study|Withdrawal by Subject|17|||
170503859|NCT02987972|616184177|FG002|Overall Study|Withdrawal by Subject|21|||
170503860|NCT01066793|616187118|FG000|Overall Study|Death|4|||
170503861|NCT01066793|616187119|FG001|Overall Study|Death|1|||
170503862|NCT01066793|616187120|FG002|Overall Study|Death|1|||
170503863|NCT01066793|616187121|FG003|Overall Study|Death|0|||
170503864|NCT01066793|616187122|FG004|Overall Study|Death|0|||
170503865|NCT01066793|616187123|FG005|Overall Study|Death|0|||
170503866|NCT01066793|616187118|FG000|Overall Study|Lack of Efficacy|2|||
170503867|NCT01066793|616187119|FG001|Overall Study|Lack of Efficacy|1|||
170503868|NCT01066793|616187120|FG002|Overall Study|Lack of Efficacy|0|||
170503869|NCT01066793|616187121|FG003|Overall Study|Lack of Efficacy|0|||
170503870|NCT01066793|616187122|FG004|Overall Study|Lack of Efficacy|0|||
170503871|NCT01066793|616187123|FG005|Overall Study|Lack of Efficacy|0|||
170503872|NCT01066793|616187118|FG000|Overall Study|Lost to Follow-up|180|||
170503873|NCT01066793|616187119|FG001|Overall Study|Lost to Follow-up|39|||
170503874|NCT01066793|616187120|FG002|Overall Study|Lost to Follow-up|82|||
170503875|NCT01066793|616187121|FG003|Overall Study|Lost to Follow-up|16|||
170503876|NCT01066793|616187122|FG004|Overall Study|Lost to Follow-up|0|||
170805347|NCT00687219|617297346|FG000|Overall Study|Lack of Efficacy|1|||
170805348|NCT02052440|617297351|FG000|Overall Study|Withdrawal by Subject|0|||
170805349|NCT02052440|617297352|FG001|Overall Study|Withdrawal by Subject|1|||
170503877|NCT01066793|616187123|FG005|Overall Study|Lost to Follow-up|1|||
170503878|NCT01066793|616187118|FG000|Overall Study|Physician Decision|3|||
170503879|NCT01066793|616187119|FG001|Overall Study|Physician Decision|0|||
170503880|NCT01066793|616187120|FG002|Overall Study|Physician Decision|0|||
170503881|NCT01066793|616187121|FG003|Overall Study|Physician Decision|0|||
170503882|NCT01066793|616187122|FG004|Overall Study|Physician Decision|0|||
170503883|NCT01066793|616187123|FG005|Overall Study|Physician Decision|0|||
170503884|NCT01066793|616187118|FG000|Overall Study|Protocol Violation|3|||
170503885|NCT01066793|616187119|FG001|Overall Study|Protocol Violation|2|||
170503886|NCT01066793|616187120|FG002|Overall Study|Protocol Violation|2|||
170503887|NCT01066793|616187121|FG003|Overall Study|Protocol Violation|0|||
170503888|NCT01066793|616187122|FG004|Overall Study|Protocol Violation|0|||
170503889|NCT01066793|616187123|FG005|Overall Study|Protocol Violation|0|||
170503890|NCT01066793|616187118|FG000|Overall Study|Withdrawal by Subject|7|||
170805350|NCT00553332|617297353|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
170503891|NCT01066793|616187119|FG001|Overall Study|Withdrawal by Subject|4|||
170503892|NCT01066793|616187120|FG002|Overall Study|Withdrawal by Subject|1|||
170503893|NCT01066793|616187121|FG003|Overall Study|Withdrawal by Subject|0|||
170503894|NCT01066793|616187122|FG004|Overall Study|Withdrawal by Subject|0|||
170503895|NCT01066793|616187123|FG005|Overall Study|Withdrawal by Subject|0|||
170503896|NCT01066793|616187118|FG000|Overall Study|Early Termination|3|||
170503897|NCT01066793|616187119|FG001|Overall Study|Early Termination|0|||
170503898|NCT01066793|616187120|FG002|Overall Study|Early Termination|0|||
170503899|NCT01066793|616187121|FG003|Overall Study|Early Termination|0|||
170503900|NCT01066793|616187122|FG004|Overall Study|Early Termination|0|||
170503901|NCT01066793|616187123|FG005|Overall Study|Early Termination|0|||
170503902|NCT01066793|616187118|FG000|Overall Study|Lab test not done|7|||
170503903|NCT01066793|616187119|FG001|Overall Study|Lab test not done|0|||
170503904|NCT01066793|616187120|FG002|Overall Study|Lab test not done|0|||
170503905|NCT01066793|616187121|FG003|Overall Study|Lab test not done|1|||
170503906|NCT01066793|616187122|FG004|Overall Study|Lab test not done|0|||
170503907|NCT01066793|616187123|FG005|Overall Study|Lab test not done|0|||
170503908|NCT01066793|616187118|FG000|Overall Study|Miscellaneous|4|||
170503909|NCT01066793|616187119|FG001|Overall Study|Miscellaneous|5|||
170503910|NCT01066793|616187120|FG002|Overall Study|Miscellaneous|6|||
170503911|NCT01066793|616187121|FG003|Overall Study|Miscellaneous|0|||
170503912|NCT01066793|616187122|FG004|Overall Study|Miscellaneous|0|||
170503913|NCT01066793|616187123|FG005|Overall Study|Miscellaneous|0|||
170503914|NCT01066793|616187118|FG000|Overall Study|Non-responders|104|||
170503915|NCT01066793|616187119|FG001|Overall Study|Non-responders|5|||
170503916|NCT01066793|616187120|FG002|Overall Study|Non-responders|11|||
170503917|NCT01066793|616187121|FG003|Overall Study|Non-responders|25|||
170503918|NCT01066793|616187122|FG004|Overall Study|Non-responders|0|||
170503919|NCT01066793|616187123|FG005|Overall Study|Non-responders|0|||
170503920|NCT01066793|616187118|FG000|Overall Study|Other|15|||
170503921|NCT01066793|616187119|FG001|Overall Study|Other|5|||
170503922|NCT01066793|616187120|FG002|Overall Study|Other|6|||
170503923|NCT01066793|616187121|FG003|Overall Study|Other|2|||
170503924|NCT01066793|616187122|FG004|Overall Study|Other|0|||
170503925|NCT01066793|616187123|FG005|Overall Study|Other|0|||
170503926|NCT01066793|616187118|FG000|Overall Study|Relapse|20|||
170503927|NCT01066793|616187119|FG001|Overall Study|Relapse|8|||
170503928|NCT01066793|616187120|FG002|Overall Study|Relapse|2|||
170503929|NCT01066793|616187121|FG003|Overall Study|Relapse|3|||
170503930|NCT01066793|616187122|FG004|Overall Study|Relapse|0|||
170503931|NCT01066793|616187123|FG005|Overall Study|Relapse|0|||
170503932|NCT01066793|616187118|FG000|Overall Study|Result Not Available|1|||
170503933|NCT01066793|616187119|FG001|Overall Study|Result Not Available|0|||
170503934|NCT01066793|616187120|FG002|Overall Study|Result Not Available|0|||
170503935|NCT01066793|616187121|FG003|Overall Study|Result Not Available|0|||
170503936|NCT01066793|616187122|FG004|Overall Study|Result Not Available|0|||
170503937|NCT01066793|616187123|FG005|Overall Study|Result Not Available|0|||
170503938|NCT01066793|616187118|FG000|Overall Study|Treatment Interrupted|1|||
170503939|NCT01066793|616187119|FG001|Overall Study|Treatment Interrupted|1|||
170503940|NCT01066793|616187120|FG002|Overall Study|Treatment Interrupted|0|||
170503941|NCT01066793|616187121|FG003|Overall Study|Treatment Interrupted|0|||
170503942|NCT01066793|616187122|FG004|Overall Study|Treatment Interrupted|0|||
170503943|NCT01066793|616187123|FG005|Overall Study|Treatment Interrupted|0|||
170503944|NCT01066793|616187118|FG000|Overall Study|Treatment Never Started|18|||
170503945|NCT01066793|616187119|FG001|Overall Study|Treatment Never Started|5|||
170503946|NCT01066793|616187120|FG002|Overall Study|Treatment Never Started|4|||
170503947|NCT01066793|616187121|FG003|Overall Study|Treatment Never Started|1|||
170503948|NCT01066793|616187122|FG004|Overall Study|Treatment Never Started|0|||
170552107|NCT02614066|616366510|FG003|Overall Study|Full consent withdrawn|8|||
170552108|NCT02614066|616366507|FG000|Overall Study|Lost to Follow-up|0|||
170552109|NCT02614066|616366508|FG001|Overall Study|Lost to Follow-up|2|||
170552110|NCT02614066|616366509|FG002|Overall Study|Lost to Follow-up|2|||
170552111|NCT02614066|616366510|FG003|Overall Study|Lost to Follow-up|2|||
170552112|NCT02614066|616366507|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
170552113|NCT02614066|616366508|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
170552114|NCT02614066|616366509|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
170552115|NCT02614066|616366510|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
170904103|NCT00699192|617650869|FG001|Overall Study|Protocol Violation|2|||
170503949|NCT01066793|616187123|FG005|Overall Study|Treatment Never Started|0|||
170503950|NCT01066793|616187118|FG000|Overall Study|Treatment Stopped|2|||
170503951|NCT01066793|616187119|FG001|Overall Study|Treatment Stopped|1|||
170503952|NCT01066793|616187120|FG002|Overall Study|Treatment Stopped|0|||
170503953|NCT01066793|616187121|FG003|Overall Study|Treatment Stopped|1|||
170503954|NCT01066793|616187122|FG004|Overall Study|Treatment Stopped|0|||
170503955|NCT01066793|616187123|FG005|Overall Study|Treatment Stopped|0|||
170503956|NCT02697916|616187125|FG000|Overall Study|Death|357|||
170503957|NCT02697916|616187126|FG001|Overall Study|Death|315|||
170503958|NCT02697916|616187125|FG000|Overall Study|Withdrawal by Subject|221|||
170503959|NCT02697916|616187126|FG001|Overall Study|Withdrawal by Subject|393|||
170503960|NCT01313221|616187127|FG000|Overall Study|Protocol Violation|0|||
170503961|NCT01313221|616187128|FG001|Overall Study|Protocol Violation|1|||
170503962|NCT01313221|616187129|FG002|Overall Study|Protocol Violation|1|||
170503963|NCT01313221|616187127|FG000|Overall Study|Non-compliance|3|||
170503964|NCT01313221|616187128|FG001|Overall Study|Non-compliance|0|||
170552116|NCT02614066|616366507|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
170552117|NCT02614066|616366508|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
170904104|NCT00699192|617650870|FG002|Overall Study|Protocol Violation|0|||
170503965|NCT01313221|616187129|FG002|Overall Study|Non-compliance|2|||
170503966|NCT01313221|616187127|FG000|Overall Study|Withdrawal by Subject|2|||
170503967|NCT01313221|616187128|FG001|Overall Study|Withdrawal by Subject|3|||
170503968|NCT01313221|616187129|FG002|Overall Study|Withdrawal by Subject|5|||
170503969|NCT01313221|616187127|FG000|Overall Study|Requirement for alternative therapy|0|||
170503970|NCT01313221|616187128|FG001|Overall Study|Requirement for alternative therapy|1|||
170503971|NCT01313221|616187129|FG002|Overall Study|Requirement for alternative therapy|1|||
170503972|NCT01313221|616187127|FG000|Overall Study|Lost to Follow-up|6|||
170503973|NCT01313221|616187128|FG001|Overall Study|Lost to Follow-up|3|||
170503974|NCT01313221|616187129|FG002|Overall Study|Lost to Follow-up|1|||
170503975|NCT01313221|616187127|FG000|Overall Study|Other|1|||
170503976|NCT01313221|616187128|FG001|Overall Study|Other|0|||
170503977|NCT01313221|616187129|FG002|Overall Study|Other|0|||
170503978|NCT01313221|616187127|FG000|Overall Study|Adverse Event|0|||
170503979|NCT01313221|616187128|FG001|Overall Study|Adverse Event|0|||
170503980|NCT01313221|616187129|FG002|Overall Study|Adverse Event|7|||
170503981|NCT01313221|616187127|FG000|Overall Study|Disease progression|0|||
170503982|NCT01313221|616187128|FG001|Overall Study|Disease progression|0|||
170503983|NCT01313221|616187129|FG002|Overall Study|Disease progression|2|||
170503984|NCT01313221|616187127|FG000|Overall Study|Physician Decision|0|||
170503985|NCT01313221|616187128|FG001|Overall Study|Physician Decision|0|||
170503986|NCT01313221|616187129|FG002|Overall Study|Physician Decision|2|||
170503987|NCT01313221|616187127|FG000|Overall Study|Pregnancy|0|||
170503988|NCT01313221|616187128|FG001|Overall Study|Pregnancy|0|||
170503989|NCT01313221|616187129|FG002|Overall Study|Pregnancy|2|||
170503990|NCT02864316|616187130|FG000|Overall Study|Progressive Disease|2|||
170503991|NCT02864316|616187131|FG001|Overall Study|Progressive Disease|1|||
170503992|NCT02864316|616187130|FG000|Overall Study|Adverse Event|0|||
170503993|NCT02864316|616187131|FG001|Overall Study|Adverse Event|1|||
170503994|NCT01846221|616187135|FG000|Overall Study|Catheter Failure|2|||
170503995|NCT01846221|616187136|FG001|Overall Study|Catheter Failure|0|||
170503996|NCT01846221|616187135|FG000|Overall Study|Age Exclusion|1|||
170503997|NCT01846221|616187136|FG001|Overall Study|Age Exclusion|0|||
170503998|NCT04643964|616187137|FG000|Overall Study|Lost to Follow-up|55|||
170503999|NCT04643964|616187138|FG001|Overall Study|Lost to Follow-up|59|||
170504000|NCT04643964|616187139|FG002|Overall Study|Lost to Follow-up|54|||
170504001|NCT04643964|616187140|FG003|Overall Study|Lost to Follow-up|129|||
170504002|NCT04643964|616187141|FG004|Overall Study|Lost to Follow-up|48|||
170504003|NCT04643964|616187137|FG000|Overall Study|Failed attention check|1|||
170504004|NCT04643964|616187138|FG001|Overall Study|Failed attention check|8|||
170504005|NCT04643964|616187139|FG002|Overall Study|Failed attention check|2|||
170504006|NCT04643964|616187140|FG003|Overall Study|Failed attention check|14|||
170504007|NCT04643964|616187141|FG004|Overall Study|Failed attention check|11|||
170504008|NCT02949908|616187142|FG000|Overall Study|Study termination|2|||
170504009|NCT02327013|616187146|FG000|Overall Study|Adverse Event|4|||
170504010|NCT02327013|616187147|FG001|Overall Study|Adverse Event|4|||
170504011|NCT02327013|616187148|FG002|Overall Study|Adverse Event|3|||
170504012|NCT02327013|616187149|FG003|Overall Study|Adverse Event|0|||
170504013|NCT02327013|616187150|FG004|Overall Study|Adverse Event|1|||
170504014|NCT02327013|616187146|FG000|Overall Study|Lack of Efficacy|2|||
170504015|NCT02327013|616187147|FG001|Overall Study|Lack of Efficacy|0|||
170504016|NCT02327013|616187148|FG002|Overall Study|Lack of Efficacy|5|||
170504017|NCT02327013|616187149|FG003|Overall Study|Lack of Efficacy|0|||
170504018|NCT02327013|616187150|FG004|Overall Study|Lack of Efficacy|1|||
170504019|NCT02327013|616187146|FG000|Overall Study|Non-compliance with IMP|1|||
170504020|NCT02327013|616187147|FG001|Overall Study|Non-compliance with IMP|2|||
170504021|NCT02327013|616187148|FG002|Overall Study|Non-compliance with IMP|7|||
170504022|NCT02327013|616187149|FG003|Overall Study|Non-compliance with IMP|0|||
170504023|NCT02327013|616187150|FG004|Overall Study|Non-compliance with IMP|0|||
170504024|NCT02327013|616187146|FG000|Overall Study|Withdrawal of Consent|1|||
170504025|NCT02327013|616187147|FG001|Overall Study|Withdrawal of Consent|0|||
170805351|NCT00989196|617297361|FG000|Treatment Period|Lost to Follow-up|1|||
170805352|NCT00989196|617297362|FG001|Treatment Period|Lost to Follow-up|0|||
170504026|NCT02327013|616187148|FG002|Overall Study|Withdrawal of Consent|3|||
170504027|NCT02327013|616187149|FG003|Overall Study|Withdrawal of Consent|0|||
170504028|NCT02327013|616187150|FG004|Overall Study|Withdrawal of Consent|0|||
170504029|NCT02327013|616187146|FG000|Overall Study|Lost to Follow-up|2|||
170504030|NCT02327013|616187147|FG001|Overall Study|Lost to Follow-up|4|||
170504031|NCT02327013|616187148|FG002|Overall Study|Lost to Follow-up|5|||
170504032|NCT02327013|616187149|FG003|Overall Study|Lost to Follow-up|0|||
170504033|NCT02327013|616187150|FG004|Overall Study|Lost to Follow-up|0|||
170504034|NCT02327013|616187146|FG000|Overall Study|Administrative or other reason(s)|1|||
170504035|NCT02327013|616187147|FG001|Overall Study|Administrative or other reason(s)|5|||
170504036|NCT02327013|616187148|FG002|Overall Study|Administrative or other reason(s)|11|||
170504037|NCT02327013|616187149|FG003|Overall Study|Administrative or other reason(s)|1|||
170504038|NCT02327013|616187150|FG004|Overall Study|Administrative or other reason(s)|1|||
170504039|NCT02327013|616187146|FG000|Overall Study|Protocol Violation|0|||
170504040|NCT02327013|616187147|FG001|Overall Study|Protocol Violation|0|||
170504041|NCT02327013|616187148|FG002|Overall Study|Protocol Violation|3|||
170504042|NCT02327013|616187149|FG003|Overall Study|Protocol Violation|0|||
170504043|NCT02327013|616187150|FG004|Overall Study|Protocol Violation|1|||
170504044|NCT02327013|616187146|FG000|Overall Study|Withdrawal before treatment|2|||
170504045|NCT02327013|616187147|FG001|Overall Study|Withdrawal before treatment|1|||
170504046|NCT02327013|616187148|FG002|Overall Study|Withdrawal before treatment|5|||
170504047|NCT02327013|616187149|FG003|Overall Study|Withdrawal before treatment|0|||
170504048|NCT02327013|616187150|FG004|Overall Study|Withdrawal before treatment|0|||
170504049|NCT04186806|616187151|FG000|Period 1: 7 Days|Adverse Event|1|||
170504050|NCT04186806|616187152|FG001|Period 1: 7 Days|Adverse Event|0|||
170504051|NCT04258254|616187153|FG000|Overall Study|Withdrawal by Subject|0|||
170504052|NCT04258254|616187154|FG001|Overall Study|Withdrawal by Subject|1|||
170504053|NCT04258254|616187155|FG002|Overall Study|Withdrawal by Subject|0|||
170504054|NCT02255552|616187156|FG000|Overall Study|Participants enrolled into another study|0|||
170504055|NCT02255552|616187157|FG001|Overall Study|Participants enrolled into another study|11|||
170504056|NCT02255552|616187156|FG000|Overall Study|Withdrawal by Subject|1|||
170504057|NCT02255552|616187157|FG001|Overall Study|Withdrawal by Subject|4|||
170504058|NCT02052596|616187158|FG000|Active Phase|Adverse Event|3|||
170504059|NCT02052596|616187159|FG001|Active Phase|Adverse Event|2|||
170504060|NCT02052596|616187158|FG000|Active Phase|Lost to Follow-up|8|||
170504061|NCT02052596|616187159|FG001|Active Phase|Lost to Follow-up|11|||
170504062|NCT02052596|616187158|FG000|Active Phase|Protocol Violation|1|||
170504063|NCT02052596|616187159|FG001|Active Phase|Protocol Violation|2|||
170504064|NCT02052596|616187158|FG000|Active Phase|Withdrawal by Subject|3|||
170504065|NCT02052596|616187159|FG001|Active Phase|Withdrawal by Subject|4|||
170504066|NCT02052596|616187158|FG000|Active Phase|Enrolled in error|1|||
170504067|NCT02052596|616187159|FG001|Active Phase|Enrolled in error|0|||
170504068|NCT02052596|616187158|FG000|Active Phase|Lost due to Crohn's disease|0|||
170504069|NCT02052596|616187159|FG001|Active Phase|Lost due to Crohn's disease|1|||
170504070|NCT02052596|616187158|FG000|Safety Phase|Adverse Event|6|||
170504071|NCT02052596|616187159|FG001|Safety Phase|Adverse Event|3|||
170504072|NCT02052596|616187158|FG000|Safety Phase|Lost to Follow-up|11|||
170504073|NCT02052596|616187159|FG001|Safety Phase|Lost to Follow-up|18|||
170504074|NCT02052596|616187158|FG000|Safety Phase|Protocol Violation|1|||
170504075|NCT02052596|616187159|FG001|Safety Phase|Protocol Violation|2|||
170504076|NCT02052596|616187158|FG000|Safety Phase|Withdrawal by Subject|8|||
170504077|NCT02052596|616187159|FG001|Safety Phase|Withdrawal by Subject|11|||
170504078|NCT02052596|616187158|FG000|Safety Phase|Enrolled in error|1|||
170504079|NCT02052596|616187159|FG001|Safety Phase|Enrolled in error|0|||
170504080|NCT02052596|616187158|FG000|Safety Phase|Lost due to Crohn's disease|0|||
170504081|NCT02052596|616187159|FG001|Safety Phase|Lost due to Crohn's disease|1|||
170504082|NCT01801358|616187162|FG000|Overall Study|Adverse Event|0|||
170504083|NCT01801358|616187163|FG001|Overall Study|Adverse Event|2|||
170504084|NCT01801358|616187164|FG002|Overall Study|Adverse Event|1|||
170504085|NCT01801358|616187165|FG003|Overall Study|Adverse Event|0|||
170504086|NCT01801358|616187166|FG004|Overall Study|Adverse Event|0|||
170504087|NCT01801358|616187167|FG005|Overall Study|Adverse Event|1|||
170504088|NCT01801358|616187162|FG000|Overall Study|Physician Decision|0|||
170504089|NCT01801358|616187163|FG001|Overall Study|Physician Decision|0|||
170504090|NCT01801358|616187164|FG002|Overall Study|Physician Decision|1|||
170504091|NCT01801358|616187165|FG003|Overall Study|Physician Decision|0|||
170504092|NCT01801358|616187166|FG004|Overall Study|Physician Decision|0|||
170504093|NCT01801358|616187167|FG005|Overall Study|Physician Decision|0|||
170504094|NCT01801358|616187162|FG000|Overall Study|Progressive Disease|6|||
170504095|NCT01801358|616187163|FG001|Overall Study|Progressive Disease|4|||
170504096|NCT01801358|616187164|FG002|Overall Study|Progressive Disease|4|||
170504097|NCT01801358|616187165|FG003|Overall Study|Progressive Disease|5|||
170504098|NCT01801358|616187166|FG004|Overall Study|Progressive Disease|6|||
170504099|NCT01801358|616187167|FG005|Overall Study|Progressive Disease|5|||
170504100|NCT01801358|616187162|FG000|Overall Study|Withdrawal by Subject|0|||
170504101|NCT01801358|616187163|FG001|Overall Study|Withdrawal by Subject|0|||
170504102|NCT01801358|616187164|FG002|Overall Study|Withdrawal by Subject|0|||
170504103|NCT01801358|616187165|FG003|Overall Study|Withdrawal by Subject|1|||
170504104|NCT01801358|616187166|FG004|Overall Study|Withdrawal by Subject|0|||
170504105|NCT01801358|616187167|FG005|Overall Study|Withdrawal by Subject|2|||
170504106|NCT03181503|616187170|FG000|Overall Study|Adverse Event|2|||
170504107|NCT03181503|616187171|FG001|Overall Study|Adverse Event|2|||
170504108|NCT03181503|616187170|FG000|Overall Study|Protocol Violation|1|||
170504109|NCT03181503|616187171|FG001|Overall Study|Protocol Violation|0|||
170904105|NCT04336163|617650871|FG000|Overall Study|Lost to Follow-up|55|||
170504110|NCT03181503|616187170|FG000|Overall Study|Withdrawal by Subject|3|||
170904106|NCT04336163|617650872|FG001|Overall Study|Lost to Follow-up|0|||
170504111|NCT03181503|616187171|FG001|Overall Study|Withdrawal by Subject|0|||
170504112|NCT03181503|616187170|FG000|Overall Study|Lost to Follow-up|1|||
170504113|NCT03181503|616187171|FG001|Overall Study|Lost to Follow-up|1|||
170504114|NCT02604550|616187179|FG000|Overall Study|Lost to Follow-up|7|||
170504115|NCT02604550|616187180|FG001|Overall Study|Lost to Follow-up|6|||
170504116|NCT02604550|616187179|FG000|Overall Study|Withdrawal by Subject|0|||
170504117|NCT02604550|616187180|FG001|Overall Study|Withdrawal by Subject|1|||
170504118|NCT02604550|616187179|FG000|Overall Study|Incomplete data using paper journal|18|||
170504119|NCT02604550|616187180|FG001|Overall Study|Incomplete data using paper journal|19|||
170504120|NCT02258542|616187181|FG000|Overall Study|eg. not made to the visit|7|||
170504121|NCT02258542|616187182|FG001|Overall Study|eg. not made to the visit|4|||
170504122|NCT02258542|616187183|FG002|Overall Study|eg. not made to the visit|0|||
170504123|NCT02258542|616187184|FG003|Overall Study|eg. not made to the visit|1|||
170504124|NCT02258542|616187181|FG000|Overall Study|study specific discount. criteria|1|||
170504125|NCT02258542|616187182|FG001|Overall Study|study specific discount. criteria|1|||
170504126|NCT02258542|616187183|FG002|Overall Study|study specific discount. criteria|0|||
170504127|NCT02258542|616187184|FG003|Overall Study|study specific discount. criteria|0|||
170504128|NCT02258542|616187181|FG000|Overall Study|Withdrawal by Subject|20|||
170504129|NCT02258542|616187182|FG001|Overall Study|Withdrawal by Subject|20|||
170504130|NCT02258542|616187183|FG002|Overall Study|Withdrawal by Subject|7|||
170504131|NCT02258542|616187184|FG003|Overall Study|Withdrawal by Subject|1|||
170504132|NCT02258542|616187181|FG000|Overall Study|Lost to Follow-up|5|||
170504133|NCT02258542|616187182|FG001|Overall Study|Lost to Follow-up|12|||
170504134|NCT02258542|616187183|FG002|Overall Study|Lost to Follow-up|1|||
170504135|NCT02258542|616187184|FG003|Overall Study|Lost to Follow-up|2|||
170504136|NCT02258542|616187181|FG000|Overall Study|Death|5|||
170504137|NCT02258542|616187182|FG001|Overall Study|Death|4|||
170504138|NCT02258542|616187183|FG002|Overall Study|Death|0|||
170504139|NCT02258542|616187184|FG003|Overall Study|Death|1|||
170504140|NCT02258542|616187181|FG000|Overall Study|Adverse Event|3|||
170504141|NCT02258542|616187182|FG001|Overall Study|Adverse Event|4|||
170504142|NCT02258542|616187183|FG002|Overall Study|Adverse Event|0|||
170504143|NCT02258542|616187184|FG003|Overall Study|Adverse Event|0|||
170504144|NCT02258542|616187181|FG000|Overall Study|Protocol Violation|1|||
170504145|NCT02258542|616187182|FG001|Overall Study|Protocol Violation|2|||
170504146|NCT02258542|616187183|FG002|Overall Study|Protocol Violation|0|||
170504147|NCT02258542|616187184|FG003|Overall Study|Protocol Violation|0|||
170504148|NCT02258542|616187181|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170504149|NCT02258542|616187182|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
170504150|NCT02258542|616187183|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
170504151|NCT02258542|616187184|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
170504152|NCT04068688|616187185|FG000|Overall Study|Lost to Follow-up|1|||
170504153|NCT04068688|616187186|FG001|Overall Study|Lost to Follow-up|1|||
170504154|NCT04068688|616187187|FG002|Overall Study|Lost to Follow-up|0|||
170504155|NCT04068688|616187188|FG003|Overall Study|Lost to Follow-up|0|||
170504156|NCT04068688|616187189|FG004|Overall Study|Lost to Follow-up|5|||
170504157|NCT04068688|616187190|FG005|Overall Study|Lost to Follow-up|5|||
170504158|NCT04068688|616187191|FG006|Overall Study|Lost to Follow-up|0|||
170504159|NCT04068688|616187192|FG007|Overall Study|Lost to Follow-up|0|||
170504160|NCT04068688|616187193|FG008|Overall Study|Lost to Follow-up|1|||
170504161|NCT04068688|616187194|FG009|Overall Study|Lost to Follow-up|0|||
170504162|NCT04068688|616187185|FG000|Overall Study|Withdrawal by Subject|1|||
170504163|NCT04068688|616187186|FG001|Overall Study|Withdrawal by Subject|1|||
170504164|NCT04068688|616187187|FG002|Overall Study|Withdrawal by Subject|0|||
170504165|NCT04068688|616187188|FG003|Overall Study|Withdrawal by Subject|0|||
170504166|NCT04068688|616187189|FG004|Overall Study|Withdrawal by Subject|0|||
170504167|NCT04068688|616187190|FG005|Overall Study|Withdrawal by Subject|0|||
170504168|NCT04068688|616187191|FG006|Overall Study|Withdrawal by Subject|0|||
170504169|NCT04068688|616187192|FG007|Overall Study|Withdrawal by Subject|0|||
170504170|NCT04068688|616187193|FG008|Overall Study|Withdrawal by Subject|0|||
170504171|NCT04068688|616187194|FG009|Overall Study|Withdrawal by Subject|0|||
170504172|NCT04068688|616187185|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
170504173|NCT04068688|616187186|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
170504174|NCT04068688|616187187|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
170504175|NCT04068688|616187188|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
170504176|NCT04068688|616187189|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
170504177|NCT04068688|616187190|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
170504178|NCT04068688|616187191|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
170504179|NCT04068688|616187192|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
170504180|NCT04068688|616187193|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
170504181|NCT04068688|616187194|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
170504182|NCT02248974|616187195|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
170504183|NCT02248974|616187196|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
170504184|NCT02248974|616187195|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
170504185|NCT02248974|616187196|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
170504186|NCT02248974|616187195|FG000|1-Day Follow-Up|Enrolled in another study|1|||
170504187|NCT02248974|616187196|FG001|1-Day Follow-Up|Enrolled in another study|0|||
170504188|NCT02248974|616187195|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
170504189|NCT02248974|616187196|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
170504190|NCT02248974|616187195|FG000|1-Week Follow-Up|Enrolled in another study|1|||
170504191|NCT02248974|616187196|FG001|1-Week Follow-Up|Enrolled in another study|1|||
170504192|NCT02248974|616187195|FG000|1-Week Follow-Up|Transferred to another facility|1|||
170504193|NCT02248974|616187196|FG001|1-Week Follow-Up|Transferred to another facility|0|||
170504194|NCT02248974|616187195|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
170504195|NCT02248974|616187196|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
170504196|NCT02248974|616187195|FG000|1-Week Follow-Up|Death|1|||
170504197|NCT02248974|616187196|FG001|1-Week Follow-Up|Death|1|||
170504198|NCT02248974|616187195|FG000|1-Week Follow-Up|Excluded because of age|0|||
170504199|NCT02248974|616187196|FG001|1-Week Follow-Up|Excluded because of age|1|||
170504200|NCT02248974|616187195|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
170504201|NCT02248974|616187196|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
170504202|NCT02248974|616187195|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
170504203|NCT02248974|616187196|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
170504204|NCT02248974|616187195|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
170504205|NCT02248974|616187196|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
170504206|NCT02248974|616187195|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
170504207|NCT02248974|616187196|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
170504208|NCT02248974|616187195|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
170504209|NCT02248974|616187196|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
170504210|NCT00662558|616187197|FG000|Overall Study|Adverse Event|21|||
170504211|NCT00662558|616187198|FG001|Overall Study|Adverse Event|59|||
170504212|NCT00662558|616187197|FG000|Overall Study|Lack of Efficacy|4|||
170504213|NCT00662558|616187198|FG001|Overall Study|Lack of Efficacy|7|||
170504214|NCT00662558|616187197|FG000|Overall Study|Lost to Follow-up|13|||
170504215|NCT00662558|616187198|FG001|Overall Study|Lost to Follow-up|10|||
170504216|NCT00662558|616187197|FG000|Overall Study|Other|9|||
170504217|NCT00662558|616187198|FG001|Overall Study|Other|14|||
170504218|NCT00662558|616187197|FG000|Overall Study|Withdrawal by Subject|7|||
170504219|NCT00662558|616187198|FG001|Overall Study|Withdrawal by Subject|12|||
170504220|NCT00662558|616187197|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
170504221|NCT00662558|616187198|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
170504222|NCT00329641|616187199|FG000|Overall Study|Did not start treatment|1|||
170504223|NCT00329641|616187199|FG000|Overall Study|Not eligible|1|||
170504224|NCT00329641|616187199|FG000|Overall Study|Adverse Event|3|||
170504225|NCT00329641|616187199|FG000|Overall Study|Other reason, not protocol specified|1|||
170504226|NCT00115037|616187201|FG000|Phase1|Lost to Follow-up|16|||
170504227|NCT00115037|616187202|FG001|Phase1|Lost to Follow-up|23|||
170504228|NCT00115037|616187203|FG002|Phase1|Lost to Follow-up|0|||
170504229|NCT00115037|616187204|FG003|Phase1|Lost to Follow-up|0|||
170504230|NCT00115037|616187205|FG004|Phase1|Lost to Follow-up|0|||
170504231|NCT00115037|616187206|FG005|Phase1|Lost to Follow-up|0|||
170504232|NCT00115037|616187201|FG000|Phase1|Withdrawal by Subject|9|||
170504233|NCT00115037|616187202|FG001|Phase1|Withdrawal by Subject|4|||
170504234|NCT00115037|616187203|FG002|Phase1|Withdrawal by Subject|0|||
170504235|NCT00115037|616187204|FG003|Phase1|Withdrawal by Subject|0|||
170504236|NCT00115037|616187205|FG004|Phase1|Withdrawal by Subject|0|||
170504237|NCT00115037|616187206|FG005|Phase1|Withdrawal by Subject|0|||
170504238|NCT00115037|616187201|FG000|Phase2|Death|0|||
170504239|NCT00115037|616187202|FG001|Phase2|Death|0|||
170504240|NCT00115037|616187203|FG002|Phase2|Death|1|||
170504241|NCT00115037|616187204|FG003|Phase2|Death|0|||
170504242|NCT00115037|616187205|FG004|Phase2|Death|0|||
170504243|NCT00115037|616187206|FG005|Phase2|Death|1|||
170504244|NCT00115037|616187201|FG000|Phase2|Withdrawal by Subject|0|||
170504245|NCT00115037|616187202|FG001|Phase2|Withdrawal by Subject|0|||
170504246|NCT00115037|616187203|FG002|Phase2|Withdrawal by Subject|2|||
170504247|NCT00115037|616187204|FG003|Phase2|Withdrawal by Subject|1|||
170504248|NCT00115037|616187205|FG004|Phase2|Withdrawal by Subject|2|||
170504249|NCT00115037|616187206|FG005|Phase2|Withdrawal by Subject|1|||
170504250|NCT00115037|616187201|FG000|Phase2|Lost to Follow-up|0|||
170504251|NCT00115037|616187202|FG001|Phase2|Lost to Follow-up|0|||
170504252|NCT00115037|616187203|FG002|Phase2|Lost to Follow-up|12|||
170504253|NCT00115037|616187204|FG003|Phase2|Lost to Follow-up|14|||
170504254|NCT00115037|616187205|FG004|Phase2|Lost to Follow-up|4|||
170504255|NCT00115037|616187206|FG005|Phase2|Lost to Follow-up|10|||
170504256|NCT01398410|616187207|FG000|Overall Study|Adverse Event|12|||
170504257|NCT01398410|616187208|FG001|Overall Study|Adverse Event|16|||
170504258|NCT01398410|616187207|FG000|Overall Study|Participants Choice|8|||
170504259|NCT01398410|616187208|FG001|Overall Study|Participants Choice|11|||
170504260|NCT01398410|616187207|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
170504261|NCT01398410|616187208|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
170504262|NCT01398410|616187207|FG000|Overall Study|Other|36|||
170504263|NCT01398410|616187208|FG001|Overall Study|Other|29|||
170504264|NCT00551161|616187210|FG000|Overall Study|Withdrawal by Subject|1|||
170504265|NCT01935700|616187211|FG000|Overall Study|Withdrawal by Subject|1|||
170504266|NCT01935700|616187212|FG001|Overall Study|Withdrawal by Subject|0|||
170504267|NCT01935700|616187211|FG000|Overall Study|Physician Decision|4|||
170504268|NCT01935700|616187212|FG001|Overall Study|Physician Decision|0|||
170504269|NCT03379792|616187213|FG000|Overall Study|Physician Decision|0|||
170504270|NCT03379792|616187214|FG001|Overall Study|Physician Decision|0|||
170504271|NCT03379792|616187215|FG002|Overall Study|Physician Decision|0|||
170504272|NCT03379792|616187216|FG003|Overall Study|Physician Decision|1|||
170504273|NCT03379792|616187217|FG004|Overall Study|Physician Decision|0|||
170504274|NCT03379792|616187218|FG005|Overall Study|Physician Decision|0|||
170504275|NCT03379792|616187213|FG000|Overall Study|Withdrawal by Subject|0|||
170504276|NCT03379792|616187214|FG001|Overall Study|Withdrawal by Subject|0|||
170504277|NCT03379792|616187215|FG002|Overall Study|Withdrawal by Subject|0|||
170504278|NCT03379792|616187216|FG003|Overall Study|Withdrawal by Subject|0|||
170552118|NCT02614066|616366509|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
170552119|NCT02614066|616366510|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
170552120|NCT02614066|616366507|FG000|Overall Study|Reason not specified|0|||
170504279|NCT03379792|616187217|FG004|Overall Study|Withdrawal by Subject|1|||
170504280|NCT03379792|616187218|FG005|Overall Study|Withdrawal by Subject|1|||
170504281|NCT00772005|616187220|FG000|Overall Study|Adverse Event|9|||
170504282|NCT00772005|616187221|FG001|Overall Study|Adverse Event|14|||
170504283|NCT00772005|616187222|FG002|Overall Study|Adverse Event|10|||
170504284|NCT00772005|616187223|FG003|Overall Study|Adverse Event|13|||
170504285|NCT00772005|616187220|FG000|Overall Study|Lack of Efficacy|0|||
170504286|NCT00772005|616187221|FG001|Overall Study|Lack of Efficacy|1|||
170504287|NCT00772005|616187222|FG002|Overall Study|Lack of Efficacy|0|||
170504288|NCT00772005|616187223|FG003|Overall Study|Lack of Efficacy|0|||
170504289|NCT00772005|616187220|FG000|Overall Study|Withdrawal by Subject|3|||
170504290|NCT00772005|616187221|FG001|Overall Study|Withdrawal by Subject|7|||
170504291|NCT00772005|616187222|FG002|Overall Study|Withdrawal by Subject|10|||
170504292|NCT00772005|616187223|FG003|Overall Study|Withdrawal by Subject|2|||
170504293|NCT00772005|616187220|FG000|Overall Study|Protocol Violation|2|||
170504294|NCT00772005|616187221|FG001|Overall Study|Protocol Violation|4|||
170504295|NCT00772005|616187222|FG002|Overall Study|Protocol Violation|1|||
170504296|NCT00772005|616187223|FG003|Overall Study|Protocol Violation|6|||
170504297|NCT00772005|616187220|FG000|Overall Study|Lost to Follow-up|7|||
170504298|NCT00772005|616187221|FG001|Overall Study|Lost to Follow-up|3|||
170504299|NCT00772005|616187222|FG002|Overall Study|Lost to Follow-up|6|||
170504300|NCT00772005|616187223|FG003|Overall Study|Lost to Follow-up|3|||
170504301|NCT00772005|616187220|FG000|Overall Study|Non-compliance with study procedures|1|||
170504302|NCT00772005|616187221|FG001|Overall Study|Non-compliance with study procedures|1|||
170504303|NCT00772005|616187222|FG002|Overall Study|Non-compliance with study procedures|0|||
170504304|NCT00772005|616187223|FG003|Overall Study|Non-compliance with study procedures|1|||
170504305|NCT00772005|616187220|FG000|Overall Study|Non-compliance with drug administration|3|||
170504306|NCT00772005|616187221|FG001|Overall Study|Non-compliance with drug administration|0|||
170504307|NCT00772005|616187222|FG002|Overall Study|Non-compliance with drug administration|1|||
170504308|NCT00772005|616187223|FG003|Overall Study|Non-compliance with drug administration|1|||
170504309|NCT01440569|616187227|FG000|Main Study|Enrolled but not treated|1|||
170504310|NCT01440569|616187228|FG001|Main Study|Enrolled but not treated|0|||
170504311|NCT01440569|616187227|FG000|Main Study|Adverse Event|9|||
170504312|NCT01440569|616187228|FG001|Main Study|Adverse Event|0|||
170504313|NCT01440569|616187227|FG000|Main Study|Pregnancy|1|||
170504314|NCT01440569|616187228|FG001|Main Study|Pregnancy|0|||
170504315|NCT01440569|616187227|FG000|Main Study|Investigator's Discretion|1|||
170504316|NCT01440569|616187228|FG001|Main Study|Investigator's Discretion|1|||
170504317|NCT01440569|616187227|FG000|Main Study|Withdrew Consent|7|||
170504318|NCT01440569|616187228|FG001|Main Study|Withdrew Consent|1|||
170504319|NCT01440569|616187227|FG000|Main Study|Lost to Follow-up|13|||
170504320|NCT01440569|616187228|FG001|Main Study|Lost to Follow-up|2|||
170504321|NCT01440569|616187227|FG000|Main Study|Subject Non-Compliance|3|||
170504322|NCT01440569|616187228|FG001|Main Study|Subject Non-Compliance|0|||
170504323|NCT01440569|616187227|FG000|Main Study|Protocol Violation|1|||
170504324|NCT01440569|616187228|FG001|Main Study|Protocol Violation|0|||
170504325|NCT01440569|616187227|FG000|Open-Label Rollover Phase|Adverse Event|3|||
170504326|NCT01440569|616187228|FG001|Open-Label Rollover Phase|Adverse Event|0|||
170504327|NCT01440569|616187227|FG000|Open-Label Rollover Phase|Pregnancy|1|||
170504328|NCT01440569|616187228|FG001|Open-Label Rollover Phase|Pregnancy|0|||
170504329|NCT01440569|616187227|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
170504330|NCT01440569|616187228|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
170504331|NCT01440569|616187227|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
170504332|NCT01440569|616187228|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
170904107|NCT04919564|617650873|FG000|Overall Study|Lost to Follow-up|1|||
170504333|NCT01440569|616187227|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
170504334|NCT01440569|616187228|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
170504335|NCT01440569|616187227|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
170904108|NCT04919564|617650874|FG001|Overall Study|Lost to Follow-up|0|||
170904109|NCT04919564|617650873|FG000|Overall Study|Physician Decision|1|||
170904110|NCT04919564|617650874|FG001|Overall Study|Physician Decision|1|||
170904111|NCT02620020|617650881|FG000|Overall Study|Adverse Event|8|||
170904112|NCT02620020|617650882|FG001|Overall Study|Adverse Event|4|||
170904113|NCT02620020|617650883|FG002|Overall Study|Adverse Event|3|||
170904114|NCT02620020|617650884|FG003|Overall Study|Adverse Event|5|||
170904115|NCT02620020|617650881|FG000|Overall Study|Lost to Follow-up|4|||
170904116|NCT02620020|617650882|FG001|Overall Study|Lost to Follow-up|8|||
170904117|NCT02620020|617650883|FG002|Overall Study|Lost to Follow-up|1|||
170904118|NCT02620020|617650884|FG003|Overall Study|Lost to Follow-up|4|||
170904119|NCT02620020|617650881|FG000|Overall Study|Physician Decision|7|||
170904120|NCT02620020|617650882|FG001|Overall Study|Physician Decision|4|||
170904121|NCT02620020|617650883|FG002|Overall Study|Physician Decision|3|||
170904122|NCT02620020|617650884|FG003|Overall Study|Physician Decision|4|||
170904123|NCT02620020|617650881|FG000|Overall Study|Protocol Violation|5|||
170904124|NCT02620020|617650882|FG001|Overall Study|Protocol Violation|2|||
170904125|NCT02620020|617650883|FG002|Overall Study|Protocol Violation|1|||
170504336|NCT01440569|616187228|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
170504337|NCT01440569|616187227|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
170504338|NCT01440569|616187228|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
170504339|NCT00306787|616187229|FG000|Overall Study|Discontinued without taking study drug|208|||
170504340|NCT00306787|616187230|FG001|Overall Study|Discontinued without taking study drug|215|||
170504341|NCT00306787|616187229|FG000|Overall Study|Adverse Event|1|||
170504342|NCT00306787|616187230|FG001|Overall Study|Adverse Event|1|||
170504343|NCT00306787|616187229|FG000|Overall Study|Lack of Efficacy|1|||
170504344|NCT00306787|616187230|FG001|Overall Study|Lack of Efficacy|0|||
170504345|NCT00306787|616187229|FG000|Overall Study|Protocol Violation|8|||
170504346|NCT00306787|616187230|FG001|Overall Study|Protocol Violation|10|||
170504347|NCT00306787|616187229|FG000|Overall Study|Withdrawal by Subject|2|||
170504348|NCT00306787|616187230|FG001|Overall Study|Withdrawal by Subject|9|||
170504349|NCT00306787|616187229|FG000|Overall Study|Lost to Follow-up|9|||
170504350|NCT00306787|616187230|FG001|Overall Study|Lost to Follow-up|6|||
170504351|NCT00306787|616187229|FG000|Overall Study|Administrative problems|4|||
170504352|NCT00306787|616187230|FG001|Overall Study|Administrative problems|0|||
170504353|NCT00306787|616187229|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170504354|NCT00306787|616187230|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170504355|NCT01438814|616187231|FG000|Overall Study|Adverse Event|3|||
170504356|NCT01438814|616187232|FG001|Overall Study|Adverse Event|3|||
170504357|NCT01438814|616187231|FG000|Overall Study|Protocol Violation|1|||
170504358|NCT01438814|616187232|FG001|Overall Study|Protocol Violation|2|||
170504359|NCT01438814|616187231|FG000|Overall Study|Lost to Follow-up|4|||
170504360|NCT01438814|616187232|FG001|Overall Study|Lost to Follow-up|3|||
170504361|NCT01438814|616187231|FG000|Overall Study|Withdrawal by Subject|4|||
170504362|NCT01438814|616187232|FG001|Overall Study|Withdrawal by Subject|2|||
170504363|NCT01438814|616187231|FG000|Overall Study|Other|2|||
170504364|NCT01438814|616187232|FG001|Overall Study|Other|4|||
170504365|NCT02273908|616187242|FG000|Overall Study|Adverse Event|16|||
170504366|NCT02273908|616187243|FG001|Overall Study|Adverse Event|0|||
170504367|NCT02273908|616187242|FG000|Overall Study|Lost to Follow-up|10|||
170504368|NCT02273908|616187243|FG001|Overall Study|Lost to Follow-up|1|||
170504369|NCT02273908|616187242|FG000|Overall Study|Did not meet entrance criteria|3|||
170504370|NCT02273908|616187243|FG001|Overall Study|Did not meet entrance criteria|2|||
170504371|NCT02273908|616187242|FG000|Overall Study|Withdrawal by Subject|4|||
170504372|NCT02273908|616187243|FG001|Overall Study|Withdrawal by Subject|2|||
170504373|NCT03887117|616187244|FG000|Overall Study|Discontinued prematurely|0|||
170504374|NCT03887117|616187245|FG001|Overall Study|Discontinued prematurely|1|||
170504375|NCT03887117|616187246|FG002|Overall Study|Discontinued prematurely|1|||
170504376|NCT03887117|616187247|FG003|Overall Study|Discontinued prematurely|2|||
170504377|NCT00435487|616187249|FG000|Overall Study|Death|3|||
170504378|NCT00435487|616187250|FG001|Overall Study|Death|4|||
170504379|NCT00435487|616187249|FG000|Overall Study|Adverse Event|0|||
170504380|NCT00435487|616187250|FG001|Overall Study|Adverse Event|3|||
170504381|NCT00435487|616187249|FG000|Overall Study|Lost to Follow-up|2|||
170504382|NCT00435487|616187250|FG001|Overall Study|Lost to Follow-up|2|||
170504383|NCT00435487|616187249|FG000|Overall Study|Other|5|||
170504384|NCT00435487|616187250|FG001|Overall Study|Other|2|||
170504385|NCT00435487|616187249|FG000|Overall Study|Withdrawal by Subject|2|||
170504386|NCT00435487|616187250|FG001|Overall Study|Withdrawal by Subject|1|||
170504387|NCT00435487|616187249|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
170504388|NCT00435487|616187250|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
170504389|NCT00435487|616187249|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
170504390|NCT00435487|616187250|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
170504391|NCT03301844|616187252|FG000|Overall Study|suspected colon cancer|1|||
170504392|NCT03301844|616187253|FG001|Overall Study|suspected colon cancer|1|||
170504393|NCT05087966|616187254|FG000|Overall Study|Lost to Follow-up|1|||
170504394|NCT05087966|616187254|FG000|Overall Study|Withdrawal by Subject|5|||
170504395|NCT01267201|616187256|FG000|First Intervention Period|Withdrawal by Subject|1|||
170504396|NCT01267201|616187257|FG001|First Intervention Period|Withdrawal by Subject|0|||
170504397|NCT01267201|616187258|FG002|First Intervention Period|Withdrawal by Subject|0|||
170504398|NCT01267201|616187259|FG003|First Intervention Period|Withdrawal by Subject|0|||
170504399|NCT01267201|616187260|FG004|First Intervention Period|Withdrawal by Subject|0|||
170504400|NCT01267201|616187261|FG005|First Intervention Period|Withdrawal by Subject|0|||
170504401|NCT01267201|616187256|FG000|Second Intervention Period|Withdrawal by Subject|0|||
170504402|NCT01267201|616187257|FG001|Second Intervention Period|Withdrawal by Subject|1|||
170504403|NCT01267201|616187258|FG002|Second Intervention Period|Withdrawal by Subject|0|||
170504404|NCT01267201|616187259|FG003|Second Intervention Period|Withdrawal by Subject|0|||
170504405|NCT01267201|616187260|FG004|Second Intervention Period|Withdrawal by Subject|0|||
170504406|NCT01267201|616187261|FG005|Second Intervention Period|Withdrawal by Subject|0|||
170504407|NCT00483704|616187262|FG000|Randomization|Withdrawal by Subject|19|||
170504408|NCT00483704|616187263|FG001|Randomization|Withdrawal by Subject|28|||
170504409|NCT00483704|616187264|FG002|Randomization|Withdrawal by Subject|18|||
170504410|NCT00483704|616187262|FG000|Randomization|Protocol Violation|14|||
170504411|NCT00483704|616187263|FG001|Randomization|Protocol Violation|25|||
170504412|NCT00483704|616187264|FG002|Randomization|Protocol Violation|22|||
170504413|NCT00483704|616187262|FG000|Randomization|Lost to Follow-up|14|||
170504414|NCT00483704|616187263|FG001|Randomization|Lost to Follow-up|14|||
170504415|NCT00483704|616187264|FG002|Randomization|Lost to Follow-up|19|||
170504416|NCT00483704|616187262|FG000|Randomization|Pregnancy|1|||
170504417|NCT00483704|616187263|FG001|Randomization|Pregnancy|0|||
170504418|NCT00483704|616187264|FG002|Randomization|Pregnancy|0|||
170504419|NCT00483704|616187262|FG000|Randomization|Physician Decision|2|||
170504420|NCT00483704|616187263|FG001|Randomization|Physician Decision|4|||
170504421|NCT00483704|616187264|FG002|Randomization|Physician Decision|0|||
170504422|NCT00483704|616187262|FG000|Randomization|Progressive disease|0|||
170504423|NCT00483704|616187263|FG001|Randomization|Progressive disease|0|||
170504424|NCT00483704|616187264|FG002|Randomization|Progressive disease|1|||
170504425|NCT00483704|616187262|FG000|Randomization|Lack of qualifying migraines|21|||
170504426|NCT00483704|616187263|FG001|Randomization|Lack of qualifying migraines|25|||
170504427|NCT00483704|616187264|FG002|Randomization|Lack of qualifying migraines|31|||
170504428|NCT00483704|616187262|FG000|Treatment|Lack of qualifying migraines|101|||
170504429|NCT00483704|616187263|FG001|Treatment|Lack of qualifying migraines|99|||
170504430|NCT00483704|616187264|FG002|Treatment|Lack of qualifying migraines|116|||
170504431|NCT00483704|616187262|FG000|Treatment|Adverse Event|3|||
170504432|NCT00483704|616187263|FG001|Treatment|Adverse Event|5|||
170504433|NCT00483704|616187264|FG002|Treatment|Adverse Event|4|||
170504434|NCT00483704|616187262|FG000|Treatment|Withdrawal by Subject|16|||
170504435|NCT00483704|616187263|FG001|Treatment|Withdrawal by Subject|12|||
170504436|NCT00483704|616187264|FG002|Treatment|Withdrawal by Subject|21|||
170504437|NCT00483704|616187262|FG000|Treatment|Protocol Violation|6|||
170504438|NCT00483704|616187263|FG001|Treatment|Protocol Violation|3|||
170504439|NCT00483704|616187264|FG002|Treatment|Protocol Violation|5|||
170552121|NCT02614066|616366508|FG001|Overall Study|Reason not specified|2|||
170552122|NCT02614066|616366509|FG002|Overall Study|Reason not specified|1|||
170552123|NCT02614066|616366510|FG003|Overall Study|Reason not specified|1|||
170904126|NCT02620020|617650884|FG003|Overall Study|Protocol Violation|1|||
170904127|NCT02620020|617650881|FG000|Overall Study|Withdrawal by Subject|20|||
170904128|NCT02620020|617650882|FG001|Overall Study|Withdrawal by Subject|16|||
170904129|NCT02620020|617650883|FG002|Overall Study|Withdrawal by Subject|17|||
170904130|NCT02620020|617650884|FG003|Overall Study|Withdrawal by Subject|12|||
170904131|NCT02620020|617650881|FG000|Overall Study|Death|0|||
170904132|NCT02620020|617650882|FG001|Overall Study|Death|1|||
170904133|NCT02620020|617650883|FG002|Overall Study|Death|0|||
170904134|NCT02620020|617650884|FG003|Overall Study|Death|0|||
170904135|NCT02209506|617650888|FG000|Overall Study|Withdrawal by Subject|0|||
170904136|NCT02209506|617650889|FG001|Overall Study|Withdrawal by Subject|0|||
170904137|NCT02209506|617650890|FG002|Overall Study|Withdrawal by Subject|0|||
170904138|NCT02209506|617650891|FG003|Overall Study|Withdrawal by Subject|0|||
170904139|NCT02209506|617650892|FG004|Overall Study|Withdrawal by Subject|1|||
170904140|NCT03812510|617650893|FG000|Overall Study|Lost to Follow-up|39|||
170904141|NCT03812510|617650893|FG000|Overall Study|Withdrawal by Subject|42|||
170904142|NCT03812510|617650893|FG000|Overall Study|Physician Decision|2|||
170904143|NCT03812510|617650893|FG000|Overall Study|Study Terminated by Sponsor|9|||
170904144|NCT03812510|617650893|FG000|Overall Study|Did Not Start Study Medication|55|||
170904145|NCT03812510|617650893|FG000|Overall Study|Adverse Event|5|||
170904146|NCT00117312|617650894|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
170904147|NCT00117312|617650895|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
170904148|NCT00117312|617650896|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
170904149|NCT00117312|617650897|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
170904150|NCT00117312|617650894|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
170904151|NCT00117312|617650895|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
170904152|NCT00117312|617650896|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
170504440|NCT00483704|616187262|FG000|Treatment|Lost to Follow-up|2|||
170504441|NCT00483704|616187263|FG001|Treatment|Lost to Follow-up|7|||
170504442|NCT00483704|616187264|FG002|Treatment|Lost to Follow-up|5|||
170504443|NCT00483704|616187262|FG000|Treatment|Lack of Efficacy|1|||
170504444|NCT00483704|616187263|FG001|Treatment|Lack of Efficacy|1|||
170504445|NCT00483704|616187264|FG002|Treatment|Lack of Efficacy|1|||
170552124|NCT04565756|616366511|FG000|Overall Study|Withdrawal by Subject|0|||
170904153|NCT00117312|617650897|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
170904154|NCT00117312|617650894|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
170904155|NCT00117312|617650895|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
170904156|NCT00117312|617650896|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
170904157|NCT00117312|617650897|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
170904158|NCT00117312|617650894|FG000|Overall Study|Other|0|||
170904159|NCT00117312|617650895|FG001|Overall Study|Other|1|||
170904160|NCT00117312|617650896|FG002|Overall Study|Other|3|||
170904161|NCT00117312|617650897|FG003|Overall Study|Other|1|||
170504446|NCT00483704|616187262|FG000|Treatment|Pregnancy|0|||
170504447|NCT00483704|616187263|FG001|Treatment|Pregnancy|1|||
170904162|NCT00117312|617650894|FG000|Overall Study|Patient choice|0|||
170904163|NCT00117312|617650895|FG001|Overall Study|Patient choice|0|||
170504448|NCT00483704|616187264|FG002|Treatment|Pregnancy|0|||
170504449|NCT00483704|616187262|FG000|Treatment|Physician Decision|0|||
170504450|NCT00483704|616187263|FG001|Treatment|Physician Decision|1|||
170504451|NCT00483704|616187264|FG002|Treatment|Physician Decision|4|||
170504452|NCT00875433|616187265|FG000|Overall Study|Progressive disease|41|||
170504453|NCT00875433|616187265|FG000|Overall Study|Other Adverse Event|14|||
170504454|NCT00875433|616187265|FG000|Overall Study|Withdrawal by Subject|2|||
170504455|NCT00875433|616187265|FG000|Overall Study|Other|3|||
170504456|NCT04272606|616187266|FG000|Overall Study|Protocol Violation|1|||
170504457|NCT04272606|616187267|FG001|Overall Study|Protocol Violation|1|||
170504458|NCT04272606|616187266|FG000|Overall Study|Physician Decision|0|||
170504459|NCT04272606|616187267|FG001|Overall Study|Physician Decision|1|||
170504460|NCT00725101|616187268|FG000|Overall Study|Death|3|||
170504461|NCT00725101|616187268|FG000|Overall Study|Lost to Follow-up|353|||
170504462|NCT00725101|616187268|FG000|Overall Study|Protocol Violation|1|||
170504463|NCT00725101|616187268|FG000|Overall Study|Withdrawal by Subject|127|||
170504464|NCT00725101|616187268|FG000|Overall Study|not specified/no reason given|11|||
170504465|NCT02537431|616187280|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
170504466|NCT03430895|616187290|FG000|Overall Study|Not Treated|2|||
170504467|NCT02847182|616187295|FG000|Overall Study|Withdrawal by Subject|0|||
170504468|NCT02847182|616187296|FG001|Overall Study|Withdrawal by Subject|1|||
170504469|NCT00290693|616188763|FG000|Overall Study|Withdrawal by Subject|2|||
170504470|NCT01716520|616188764|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
170504471|NCT01716520|616188765|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
170504472|NCT01716520|616188766|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
170504473|NCT01716520|616188767|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
170504474|NCT01716520|616188768|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
170504475|NCT01716520|616188769|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
170504476|NCT01716520|616188764|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
170504477|NCT01716520|616188765|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
170504478|NCT01716520|616188766|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
170504479|NCT01716520|616188767|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
170504480|NCT01716520|616188768|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
170504481|NCT01716520|616188769|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
170504482|NCT01716520|616188764|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170504483|NCT01716520|616188765|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170504484|NCT01716520|616188766|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170504485|NCT01716520|616188767|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170504486|NCT01716520|616188768|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170504487|NCT01716520|616188769|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170504488|NCT01716520|616188764|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
170504489|NCT01716520|616188765|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
170504490|NCT01716520|616188766|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
170504491|NCT01716520|616188767|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
170504492|NCT01716520|616188768|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
170504493|NCT01716520|616188769|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
170504494|NCT01716520|616188764|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170504495|NCT01716520|616188765|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170504496|NCT01716520|616188766|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170504497|NCT01716520|616188767|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170504498|NCT01716520|616188768|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170504499|NCT01716520|616188769|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
170504500|NCT01716520|616188764|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
170504501|NCT01716520|616188765|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
170504502|NCT01716520|616188766|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
170504503|NCT01716520|616188767|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
170504504|NCT01716520|616188768|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
170504505|NCT01716520|616188769|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
170504506|NCT01716520|616188764|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
170504507|NCT01716520|616188765|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
170504508|NCT01716520|616188766|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
170504509|NCT01716520|616188767|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
170504510|NCT01716520|616188768|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
170504511|NCT01716520|616188769|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
170504512|NCT01716520|616188764|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170504513|NCT01716520|616188765|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170504514|NCT01716520|616188766|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170504515|NCT01716520|616188767|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170904164|NCT00117312|617650896|FG002|Overall Study|Patient choice|2|||
170904165|NCT00117312|617650897|FG003|Overall Study|Patient choice|1|||
170904166|NCT00117312|617650894|FG000|Overall Study|Adverse Event|0|||
170504516|NCT01716520|616188768|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
170504517|NCT01716520|616188769|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170504518|NCT01716520|616188764|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
170504519|NCT01716520|616188765|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
170504520|NCT01716520|616188766|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
170504521|NCT01716520|616188767|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
170504522|NCT01716520|616188768|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
170504523|NCT01716520|616188769|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
170504524|NCT01716520|616188764|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
170504525|NCT01716520|616188765|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
170504526|NCT01716520|616188766|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
170504527|NCT01716520|616188767|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
170504528|NCT01716520|616188768|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
170504529|NCT01716520|616188769|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
170504530|NCT01716520|616188764|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
170504531|NCT01716520|616188765|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
170504532|NCT01716520|616188766|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
170504533|NCT01716520|616188767|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
170504534|NCT01716520|616188768|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
170504535|NCT01716520|616188769|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
170504536|NCT01716520|616188764|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
170504537|NCT01716520|616188765|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
170504538|NCT01716520|616188766|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
170504539|NCT01716520|616188767|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
170504540|NCT01716520|616188768|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
170504541|NCT01716520|616188769|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
170504542|NCT01716520|616188764|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
170504543|NCT01716520|616188765|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
170504544|NCT01716520|616188766|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
170504545|NCT01716520|616188767|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
170504546|NCT01716520|616188768|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
170504547|NCT01716520|616188769|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
170504548|NCT01716520|616188764|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170504549|NCT01716520|616188765|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170504550|NCT01716520|616188766|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170504551|NCT01716520|616188767|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170504552|NCT01716520|616188768|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170504553|NCT01716520|616188769|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
170504554|NCT01716520|616188764|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170504555|NCT01716520|616188765|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170504556|NCT01716520|616188766|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
170504557|NCT01716520|616188767|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170504558|NCT01716520|616188768|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170504559|NCT01716520|616188769|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170504560|NCT01430624|616188772|FG000|Overall Study|Lost to Follow-up|23|||
170504561|NCT01430624|616188773|FG001|Overall Study|Lost to Follow-up|29|||
170504562|NCT01430624|616188774|FG002|Overall Study|Lost to Follow-up|27|||
170504563|NCT01430624|616188772|FG000|Overall Study|technical or eligibility|5|||
170504564|NCT01430624|616188773|FG001|Overall Study|technical or eligibility|5|||
170504565|NCT01430624|616188774|FG002|Overall Study|technical or eligibility|2|||
170504566|NCT00934856|616188778|FG000|Feasibility Part|Progressive disease|4|||
170504567|NCT00934856|616188779|FG001|Feasibility Part|Progressive disease|4|||
170504568|NCT00934856|616188780|FG002|Feasibility Part|Progressive disease|2|||
170504569|NCT00934856|616188781|FG003|Feasibility Part|Progressive disease|3|||
170552125|NCT04565756|616366512|FG001|Overall Study|Withdrawal by Subject|0|||
170552126|NCT04565756|616366513|FG002|Overall Study|Withdrawal by Subject|0|||
170552127|NCT04565756|616366514|FG003|Overall Study|Withdrawal by Subject|0|||
170552128|NCT04565756|616366515|FG004|Overall Study|Withdrawal by Subject|1|||
170552129|NCT04565756|616366516|FG005|Overall Study|Withdrawal by Subject|0|||
170552130|NCT04565756|616366511|FG000|Overall Study|Protocol Violation|0|||
170552131|NCT04565756|616366512|FG001|Overall Study|Protocol Violation|0|||
170552132|NCT04565756|616366513|FG002|Overall Study|Protocol Violation|0|||
170504570|NCT00934856|616188782|FG004|Feasibility Part|Progressive disease|0|||
170504571|NCT00934856|616188783|FG005|Feasibility Part|Progressive disease|0|||
170504572|NCT00934856|616188778|FG000|Feasibility Part|Physician Decision|0|||
170504573|NCT00934856|616188779|FG001|Feasibility Part|Physician Decision|0|||
170504574|NCT00934856|616188780|FG002|Feasibility Part|Physician Decision|1|||
170552133|NCT04565756|616366514|FG003|Overall Study|Protocol Violation|0|||
170552134|NCT04565756|616366515|FG004|Overall Study|Protocol Violation|0|||
170504575|NCT00934856|616188781|FG003|Feasibility Part|Physician Decision|0|||
170504576|NCT00934856|616188782|FG004|Feasibility Part|Physician Decision|0|||
170504577|NCT00934856|616188783|FG005|Feasibility Part|Physician Decision|0|||
170504578|NCT00934856|616188778|FG000|Feasibility Part|Adverse Event|1|||
170504579|NCT00934856|616188779|FG001|Feasibility Part|Adverse Event|1|||
170504580|NCT00934856|616188780|FG002|Feasibility Part|Adverse Event|0|||
170504581|NCT00934856|616188781|FG003|Feasibility Part|Adverse Event|1|||
170504582|NCT00934856|616188782|FG004|Feasibility Part|Adverse Event|0|||
170504583|NCT00934856|616188783|FG005|Feasibility Part|Adverse Event|2|||
170504584|NCT00934856|616188778|FG000|Feasibility Part|Withdrawal by Subject|0|||
170504585|NCT00934856|616188779|FG001|Feasibility Part|Withdrawal by Subject|0|||
170504586|NCT00934856|616188780|FG002|Feasibility Part|Withdrawal by Subject|0|||
170504587|NCT00934856|616188781|FG003|Feasibility Part|Withdrawal by Subject|1|||
170504588|NCT00934856|616188782|FG004|Feasibility Part|Withdrawal by Subject|0|||
170504589|NCT00934856|616188783|FG005|Feasibility Part|Withdrawal by Subject|1|||
170504590|NCT00934856|616188778|FG000|Extension Part|Adverse Event|0|||
170504591|NCT00934856|616188779|FG001|Extension Part|Adverse Event|0|||
170504592|NCT00934856|616188780|FG002|Extension Part|Adverse Event|0|||
170504593|NCT00934856|616188781|FG003|Extension Part|Adverse Event|1|||
170504594|NCT00934856|616188782|FG004|Extension Part|Adverse Event|4|||
170504595|NCT00934856|616188783|FG005|Extension Part|Adverse Event|4|||
170504596|NCT00934856|616188778|FG000|Extension Part|Progressive disease|0|||
170504597|NCT00934856|616188779|FG001|Extension Part|Progressive disease|0|||
170504598|NCT00934856|616188780|FG002|Extension Part|Progressive disease|0|||
170504599|NCT00934856|616188781|FG003|Extension Part|Progressive disease|1|||
170504600|NCT00934856|616188782|FG004|Extension Part|Progressive disease|0|||
170504601|NCT00934856|616188783|FG005|Extension Part|Progressive disease|0|||
170504602|NCT00934856|616188778|FG000|Extension Part|Non-compliance with drug|0|||
170504603|NCT00934856|616188779|FG001|Extension Part|Non-compliance with drug|0|||
170504604|NCT00934856|616188780|FG002|Extension Part|Non-compliance with drug|0|||
170504605|NCT00934856|616188781|FG003|Extension Part|Non-compliance with drug|0|||
170504606|NCT00934856|616188782|FG004|Extension Part|Non-compliance with drug|0|||
170504607|NCT00934856|616188783|FG005|Extension Part|Non-compliance with drug|1|||
170504608|NCT01672294|616188785|FG000|Overall Study|Withdrawal by Subject|4|||
170504609|NCT01672294|616188786|FG001|Overall Study|Withdrawal by Subject|4|||
170504610|NCT01672294|616188787|FG002|Overall Study|Withdrawal by Subject|4|||
170504611|NCT01672294|616188788|FG003|Overall Study|Withdrawal by Subject|4|||
170504612|NCT01672294|616188785|FG000|Overall Study|Excluded by study|1|||
170504613|NCT01672294|616188786|FG001|Overall Study|Excluded by study|1|||
170504614|NCT01672294|616188787|FG002|Overall Study|Excluded by study|0|||
170504615|NCT01672294|616188788|FG003|Overall Study|Excluded by study|0|||
170504616|NCT01672294|616188785|FG000|Overall Study|Lost to Follow-up|1|||
170504617|NCT01672294|616188786|FG001|Overall Study|Lost to Follow-up|16|||
170504618|NCT01672294|616188787|FG002|Overall Study|Lost to Follow-up|7|||
170504619|NCT01672294|616188788|FG003|Overall Study|Lost to Follow-up|9|||
170504620|NCT01256385|616188789|FG000|Overall Study|Physician Decision|1|||
170504621|NCT01256385|616188790|FG001|Overall Study|Physician Decision|1|||
170504622|NCT01256385|616188789|FG000|Overall Study|Withdrawal by Subject|2|||
170504623|NCT01256385|616188790|FG001|Overall Study|Withdrawal by Subject|2|||
170504624|NCT04908475|616188796|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
170504625|NCT04908475|616188797|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170504626|NCT04908475|616188798|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170504627|NCT04908475|616188799|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170504628|NCT04908475|616188800|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170504629|NCT04908475|616188801|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170504630|NCT04908475|616188796|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
170504631|NCT04908475|616188797|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
170504632|NCT04908475|616188798|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
170504633|NCT04908475|616188799|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
170504634|NCT04908475|616188800|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
170504635|NCT04908475|616188801|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
170552135|NCT04565756|616366516|FG005|Overall Study|Protocol Violation|1|||
170552136|NCT01026038|616366521|FG000|Overall Study|Lost to Follow-up|1|||
170504636|NCT04908475|616188796|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
170504637|NCT04908475|616188797|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
170504638|NCT04908475|616188798|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
170504639|NCT04908475|616188799|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
170504640|NCT04908475|616188800|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
170504641|NCT04908475|616188801|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
170504642|NCT04908475|616188796|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
170504643|NCT04908475|616188797|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
170504644|NCT04908475|616188798|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
170504645|NCT04908475|616188799|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
170504646|NCT04908475|616188800|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
170504647|NCT04908475|616188801|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
170504648|NCT04908475|616188796|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
170504649|NCT04908475|616188797|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
170504650|NCT04908475|616188798|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
170504651|NCT04908475|616188799|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
170504652|NCT04908475|616188800|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
170504653|NCT04908475|616188801|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
170504654|NCT04908475|616188796|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
170504655|NCT04908475|616188797|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
170504656|NCT04908475|616188798|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
170504657|NCT04908475|616188799|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
170504658|NCT04908475|616188800|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
170504659|NCT04908475|616188801|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
170504660|NCT02584959|616188802|FG000|Period 1|Withdrawn from study|3|||
170504661|NCT02584959|616188803|FG001|Period 1|Withdrawn from study|4|||
170504662|NCT02584959|616188804|FG002|Period 1|Withdrawn from study|0|||
170504663|NCT02584959|616188802|FG000|Period 2|Withdrawn from study|6|||
170504664|NCT02584959|616188803|FG001|Period 2|Withdrawn from study|1|||
170504665|NCT02584959|616188804|FG002|Period 2|Withdrawn from study|2|||
170504666|NCT00422422|616188807|FG000|Overall Study|Lack of Efficacy|1|||
170504667|NCT00422422|616188807|FG000|Overall Study|Protocol Violation|1|||
170504668|NCT00422422|616188807|FG000|Overall Study|Withdrawal by Subject|2|||
170504669|NCT00422422|616188807|FG000|Overall Study|SAE, non-fatal|1|||
170504670|NCT00422422|616188807|FG000|Overall Study|AE, non-serious non-fatal|5|||
170504671|NCT00926536|616188812|FG000|Overall Study|Physician Decision|1|||
170504672|NCT00926536|616188813|FG001|Overall Study|Physician Decision|2|||
170504673|NCT00501059|616188814|FG000|Overall Study|Protocol Violation|80|||
170504674|NCT00501059|616188815|FG001|Overall Study|Protocol Violation|69|||
170504675|NCT00501059|616188814|FG000|Overall Study|Death|140|||
170504676|NCT00501059|616188815|FG001|Overall Study|Death|137|||
170504677|NCT00501059|616188814|FG000|Overall Study|Other|236|||
170504678|NCT00501059|616188815|FG001|Overall Study|Other|239|||
170504679|NCT00501059|616188814|FG000|Overall Study|Missing end-of-study page|91|||
170504680|NCT00501059|616188815|FG001|Overall Study|Missing end-of-study page|92|||
170504681|NCT00501059|616188814|FG000|Overall Study|Clinical endpoint reached|110|||
170504682|NCT00501059|616188815|FG001|Overall Study|Clinical endpoint reached|123|||
170504683|NCT00501059|616188814|FG000|Overall Study|Insufficient therapeutic effect|4|||
170504684|NCT00501059|616188815|FG001|Overall Study|Insufficient therapeutic effect|5|||
170504685|NCT00501059|616188814|FG000|Overall Study|Consent withdrawn by subject|817|||
170504686|NCT00501059|616188815|FG001|Overall Study|Consent withdrawn by subject|873|||
170504687|NCT00501059|616188814|FG000|Overall Study|Non-compliant with study treatment|23|||
170504688|NCT00501059|616188815|FG001|Overall Study|Non-compliant with study treatment|16|||
170504689|NCT00501059|616188814|FG000|Overall Study|Reason not given|3|||
170504690|NCT00501059|616188815|FG001|Overall Study|Reason not given|1|||
170504691|NCT00501059|616188814|FG000|Overall Study|Adverse Event|129|||
170504692|NCT00501059|616188815|FG001|Overall Study|Adverse Event|122|||
170504693|NCT00501059|616188814|FG000|Overall Study|Lost to Follow-up|210|||
170504694|NCT00501059|616188815|FG001|Overall Study|Lost to Follow-up|198|||
170504695|NCT00501059|616188814|FG000|Overall Study|Not treated|25|||
170504696|NCT00501059|616188815|FG001|Overall Study|Not treated|17|||
170504697|NCT02124759|616188818|FG000|Overall Study|Withdrawal by Subject|3|||
170504698|NCT02124759|616188819|FG001|Overall Study|Withdrawal by Subject|1|||
170504699|NCT02124759|616188820|FG002|Overall Study|Withdrawal by Subject|1|||
170504700|NCT02124759|616188818|FG000|Overall Study|Screen Fail|2|||
170504701|NCT02124759|616188819|FG001|Overall Study|Screen Fail|2|||
170504702|NCT02124759|616188820|FG002|Overall Study|Screen Fail|3|||
170504703|NCT04249622|616188821|FG000|Overall Study|Withdrawal by Subject|1|||
170504704|NCT04249622|616188822|FG001|Overall Study|Withdrawal by Subject|1|||
170504705|NCT04249622|616188821|FG000|Overall Study|Alternative therapy|1|||
170504706|NCT04249622|616188822|FG001|Overall Study|Alternative therapy|0|||
170504707|NCT04249622|616188821|FG000|Overall Study|Discontinuation of pertuzumab|1|||
170504708|NCT04249622|616188822|FG001|Overall Study|Discontinuation of pertuzumab|0|||
170504709|NCT03689543|616188824|FG000|Overall Study|Adverse Event|0|||
170504710|NCT03689543|616188825|FG001|Overall Study|Adverse Event|0|||
170504711|NCT03689543|616188826|FG002|Overall Study|Adverse Event|1|||
170504712|NCT00586508|616188827|FG000|Overall Study|Progressive disease|52|||
170504713|NCT00586508|616188828|FG001|Overall Study|Progressive disease|8|||
170504714|NCT00586508|616188827|FG000|Overall Study|Death|0|||
170504715|NCT00586508|616188828|FG001|Overall Study|Death|1|||
170504716|NCT00586508|616188827|FG000|Overall Study|Adverse Event|12|||
170504717|NCT00586508|616188828|FG001|Overall Study|Adverse Event|4|||
170504718|NCT00586508|616188827|FG000|Overall Study|Withdrawal by Subject|4|||
170504719|NCT00586508|616188828|FG001|Overall Study|Withdrawal by Subject|0|||
170504720|NCT01294371|616188829|FG000|Overall Study|Adverse Event|1|||
170552137|NCT01026038|616366522|FG001|Overall Study|Lost to Follow-up|1|||
170552138|NCT01026038|616366523|FG002|Overall Study|Lost to Follow-up|0|||
170552139|NCT00992394|616366533|FG000|Overall Study|Lack of Efficacy|6|||
170504721|NCT01294371|616188829|FG000|Overall Study|Withdrawal by Subject|12|||
170504722|NCT01294371|616188829|FG000|Overall Study|Lost to Follow-up|6|||
170504723|NCT01294371|616188829|FG000|Overall Study|Administrative Reason|1|||
170504724|NCT01294371|616188829|FG000|Overall Study|Other|14|||
170504725|NCT05619536|616188830|FG000|Overall Study|Withdrawal by Subject|0|||
170504726|NCT05619536|616188831|FG001|Overall Study|Withdrawal by Subject|1|||
170504727|NCT05619536|616188832|FG002|Overall Study|Withdrawal by Subject|0|||
170504728|NCT05619536|616188833|FG003|Overall Study|Withdrawal by Subject|1|||
170504729|NCT05619536|616188830|FG000|Overall Study|Lost to Follow-up|0|||
170504730|NCT05619536|616188831|FG001|Overall Study|Lost to Follow-up|1|||
170504731|NCT05619536|616188832|FG002|Overall Study|Lost to Follow-up|1|||
170504732|NCT05619536|616188833|FG003|Overall Study|Lost to Follow-up|0|||
170504733|NCT03325894|616188834|FG000|Overall Study|Adverse Event|2|||
170504734|NCT03325894|616188835|FG001|Overall Study|Adverse Event|3|||
170504735|NCT03325894|616188834|FG000|Overall Study|Protocol Violation|1|||
170504736|NCT03325894|616188835|FG001|Overall Study|Protocol Violation|2|||
170504737|NCT03325894|616188834|FG000|Overall Study|Withdrawal by Subject|10|||
170504738|NCT03325894|616188835|FG001|Overall Study|Withdrawal by Subject|6|||
170504739|NCT03325894|616188834|FG000|Overall Study|Lost to Follow-up|4|||
170504740|NCT03325894|616188835|FG001|Overall Study|Lost to Follow-up|9|||
170504741|NCT03325894|616188834|FG000|Overall Study|Lack of Efficacy|8|||
170504742|NCT03325894|616188835|FG001|Overall Study|Lack of Efficacy|14|||
170504743|NCT03325894|616188834|FG000|Overall Study|Study Terminated by Sponsor|38|||
170504744|NCT03325894|616188835|FG001|Overall Study|Study Terminated by Sponsor|43|||
170504745|NCT03325894|616188834|FG000|Overall Study|Other (Not received Treatment)|1|||
170504746|NCT03325894|616188835|FG001|Overall Study|Other (Not received Treatment)|0|||
170504747|NCT03482167|616188838|FG000|Allocated to Intervention|Physician Decision|1|||
170504748|NCT03482167|616188839|FG001|Allocated to Intervention|Physician Decision|2|||
170504749|NCT03482167|616188838|FG000|Received Intervention|Adverse Event|3|||
170504750|NCT03482167|616188839|FG001|Received Intervention|Adverse Event|1|||
170504751|NCT03482167|616188838|FG000|Received Intervention|Physician Decision|1|||
170504752|NCT03482167|616188839|FG001|Received Intervention|Physician Decision|1|||
170504753|NCT03482167|616188838|FG000|Received Intervention|Withdrawal by Subject|1|||
170504754|NCT03482167|616188839|FG001|Received Intervention|Withdrawal by Subject|0|||
170504755|NCT00819780|616188841|FG000|Overall Study|Did not receive study drug|3|||
170504756|NCT00819780|616188842|FG001|Overall Study|Did not receive study drug|4|||
170504757|NCT00819780|616188841|FG000|Overall Study|Still in treatment|25|||
170504758|NCT00819780|616188842|FG001|Overall Study|Still in treatment|17|||
170504759|NCT00622336|616188843|FG000|Treatment Phase|Progression of Disease|181|||
170504760|NCT00622336|616188843|FG000|Treatment Phase|Adverse Event|46|||
170504761|NCT00622336|616188843|FG000|Treatment Phase|Other|40|||
170504762|NCT00622336|616188843|FG000|Treatment Phase|Death|14|||
170504763|NCT00622336|616188843|FG000|Treatment Phase|Lack of therapeutic effect|13|||
170504764|NCT00622336|616188843|FG000|Treatment Phase|Withdrawal by Subject|13|||
170504765|NCT00622336|616188843|FG000|Treatment Phase|Lost to Follow-up|2|||
170504766|NCT00622336|616188843|FG000|Extension Phase|Adverse Event|2|||
170504767|NCT00622336|616188843|FG000|Extension Phase|Progressive Disease|6|||
170504768|NCT00622336|616188843|FG000|Extension Phase|Lack of therapeutic effect|2|||
170504769|NCT00622336|616188843|FG000|Extension Phase|Withdrawal by Subject|1|||
170504770|NCT00622336|616188843|FG000|Extension Phase|Lost to Follow-up|1|||
170504771|NCT00622336|616188843|FG000|Extension Phase|Other|9|||
170504772|NCT04148287|616188846|FG000|Overall Study|Death|2|||
170504773|NCT00106639|616188847|FG000|Overall Study|Adverse Event|3|||
170504774|NCT00106639|616188848|FG001|Overall Study|Adverse Event|4|||
170504775|NCT00106639|616188849|FG002|Overall Study|Adverse Event|1|||
170504776|NCT00106639|616188847|FG000|Overall Study|Protocol Violation|0|||
170504777|NCT00106639|616188848|FG001|Overall Study|Protocol Violation|1|||
170504778|NCT00106639|616188849|FG002|Overall Study|Protocol Violation|0|||
170504779|NCT00106639|616188847|FG000|Overall Study|Withdrawal by Subject|0|||
170504780|NCT00106639|616188848|FG001|Overall Study|Withdrawal by Subject|1|||
170504781|NCT00106639|616188849|FG002|Overall Study|Withdrawal by Subject|0|||
170504782|NCT00106639|616188847|FG000|Overall Study|Participant defaulted|0|||
170504783|NCT00106639|616188848|FG001|Overall Study|Participant defaulted|1|||
170504784|NCT00106639|616188849|FG002|Overall Study|Participant defaulted|1|||
170504785|NCT02419612|616188850|FG000|Short-term Treatment Period|Adverse Event|1|||
170504786|NCT02419612|616188851|FG001|Short-term Treatment Period|Adverse Event|1|||
170504787|NCT02419612|616188850|FG000|Short-term Treatment Period|Death|0|||
170504788|NCT02419612|616188851|FG001|Short-term Treatment Period|Death|2|||
170504789|NCT02419612|616188850|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
170504790|NCT02419612|616188851|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
170504791|NCT02419612|616188850|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
170504792|NCT02419612|616188851|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
170504793|NCT02419612|616188850|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
170504794|NCT02419612|616188851|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
170504795|NCT02419612|616188850|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
170504796|NCT02419612|616188851|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
170504797|NCT02419612|616188850|FG000|Short-term Treatment Period|Worsening of liver function|0|||
170504798|NCT02419612|616188851|FG001|Short-term Treatment Period|Worsening of liver function|1|||
170504799|NCT02419612|616188850|FG000|Short-term Treatment Period|Subject moved out of state|0|||
170504800|NCT02419612|616188851|FG001|Short-term Treatment Period|Subject moved out of state|1|||
170504801|NCT02419612|616188850|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
170504802|NCT02419612|616188851|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
170504803|NCT02419612|616188850|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
170504804|NCT02419612|616188851|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
170504805|NCT02419612|616188850|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
170504806|NCT02419612|616188851|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
170504807|NCT02419612|616188850|FG000|Long-term Treatment Period|Death|0|||
170504808|NCT02419612|616188851|FG001|Long-term Treatment Period|Death|1|||
170504809|NCT02419612|616188850|FG000|Long-term Treatment Period|Adverse Event|0|||
170504810|NCT02419612|616188851|FG001|Long-term Treatment Period|Adverse Event|5|||
170504811|NCT02419612|616188850|FG000|Long-term Treatment Period|Other|4|||
170504812|NCT02419612|616188851|FG001|Long-term Treatment Period|Other|4|||
170504813|NCT02419612|616188850|FG000|Long-term Treatment Period|Subject Decision|2|||
170504814|NCT02419612|616188851|FG001|Long-term Treatment Period|Subject Decision|4|||
170504815|NCT02419612|616188850|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
170504816|NCT02419612|616188851|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
170504817|NCT00138073|616188858|FG000|Overall Study|lack of resources|55|||
170504818|NCT03301740|616188859|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
170504819|NCT03301740|616188860|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
170504820|NCT03301740|616188859|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
170504821|NCT03301740|616188860|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
170504822|NCT01037127|616188862|FG000|Overall Study|Lost to Follow-up|2|||
170504823|NCT01037127|616188863|FG001|Overall Study|Lost to Follow-up|4|||
170504824|NCT01037127|616188862|FG000|Overall Study|Physician Decision|1|||
170504825|NCT01037127|616188863|FG001|Overall Study|Physician Decision|0|||
170504826|NCT01037127|616188862|FG000|Overall Study|Study Closed Terminated|2|||
170504827|NCT01037127|616188863|FG001|Overall Study|Study Closed Terminated|17|||
170504828|NCT04325698|616188867|FG000|Overall Study|Study Terminated By Sponsor|1|||
170504829|NCT04325698|616188868|FG001|Overall Study|Study Terminated By Sponsor|1|||
170504830|NCT04325698|616188867|FG000|Overall Study|Withdrawal by Subject|0|||
170504831|NCT04325698|616188868|FG001|Overall Study|Withdrawal by Subject|2|||
170504832|NCT04253782|616188869|FG000|Overall Study|Death|2|||
170504833|NCT04253782|616188870|FG001|Overall Study|Death|0|||
170504834|NCT01306045|616188871|FG000|Met General Eligibility Criteria|Screen failures|193|||
170504835|NCT01306045|616188872|FG001|Met General Eligibility Criteria|Screen failures|11|||
170504836|NCT01306045|616188873|FG002|Met General Eligibility Criteria|Screen failures|8|||
170504837|NCT02889835|616188874|FG000|Overall Study|Lost to Follow-up|13|||
170504838|NCT02889835|616188875|FG001|Overall Study|Lost to Follow-up|13|||
170504839|NCT02889835|616188876|FG002|Overall Study|Lost to Follow-up|13|||
170504840|NCT02889835|616188874|FG000|Overall Study|Withdrawal by Subject|2|||
170504841|NCT02889835|616188875|FG001|Overall Study|Withdrawal by Subject|2|||
170504842|NCT02889835|616188876|FG002|Overall Study|Withdrawal by Subject|2|||
170504843|NCT02889835|616188874|FG000|Overall Study|Protocol Violation|1|||
170504844|NCT02889835|616188875|FG001|Overall Study|Protocol Violation|1|||
170504845|NCT02889835|616188876|FG002|Overall Study|Protocol Violation|1|||
170504846|NCT02889835|616188874|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
170504847|NCT02889835|616188875|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
170504848|NCT02889835|616188876|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
170504849|NCT02889835|616188874|FG000|Overall Study|Death|1|||
170504850|NCT02889835|616188875|FG001|Overall Study|Death|1|||
170504851|NCT02889835|616188876|FG002|Overall Study|Death|1|||
170504852|NCT05072964|616188879|FG000|Overall Study|Withdrawal by Subject|4|||
170504853|NCT05072964|616188879|FG000|Overall Study|Death|1|||
170504854|NCT02342548|616188880|FG000|Overall Study|Adverse Event|12|||
170504855|NCT02342548|616188881|FG001|Overall Study|Adverse Event|17|||
170504856|NCT02342548|616188882|FG002|Overall Study|Adverse Event|13|||
170504857|NCT02342548|616188880|FG000|Overall Study|Lost to Follow-up|0|||
170504858|NCT02342548|616188881|FG001|Overall Study|Lost to Follow-up|1|||
170504859|NCT02342548|616188882|FG002|Overall Study|Lost to Follow-up|0|||
170504860|NCT02342548|616188880|FG000|Overall Study|Study terminated by sponsor|20|||
170504861|NCT02342548|616188881|FG001|Overall Study|Study terminated by sponsor|39|||
170504862|NCT02342548|616188882|FG002|Overall Study|Study terminated by sponsor|25|||
170504863|NCT02342548|616188880|FG000|Overall Study|Protocol Violation|0|||
170504864|NCT02342548|616188881|FG001|Overall Study|Protocol Violation|1|||
170504865|NCT02342548|616188882|FG002|Overall Study|Protocol Violation|0|||
170504866|NCT02342548|616188880|FG000|Overall Study|Withdrawal by Subject|1|||
170504867|NCT02342548|616188881|FG001|Overall Study|Withdrawal by Subject|3|||
170504868|NCT02342548|616188882|FG002|Overall Study|Withdrawal by Subject|4|||
170504869|NCT02342548|616188880|FG000|Overall Study|Other|1|||
170504870|NCT02342548|616188881|FG001|Overall Study|Other|1|||
170504871|NCT02342548|616188882|FG002|Overall Study|Other|1|||
170504872|NCT02172040|616188890|FG000|Overall Study|Adverse Event|0|||
170504873|NCT02172040|616188891|FG001|Overall Study|Adverse Event|2|||
170504874|NCT02172040|616188892|FG002|Overall Study|Adverse Event|0|||
170504875|NCT02172040|616188893|FG003|Overall Study|Adverse Event|0|||
170504876|NCT02172040|616188890|FG000|Overall Study|Protocol Violation|0|||
170504877|NCT02172040|616188891|FG001|Overall Study|Protocol Violation|1|||
170504878|NCT02172040|616188892|FG002|Overall Study|Protocol Violation|0|||
170504879|NCT02172040|616188893|FG003|Overall Study|Protocol Violation|0|||
170504880|NCT02172040|616188890|FG000|Overall Study|Withdrawal by Subject|0|||
170504881|NCT02172040|616188891|FG001|Overall Study|Withdrawal by Subject|0|||
170504882|NCT02172040|616188892|FG002|Overall Study|Withdrawal by Subject|1|||
170504883|NCT02172040|616188893|FG003|Overall Study|Withdrawal by Subject|0|||
170504884|NCT02172040|616188890|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
170504885|NCT02172040|616188891|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
170504886|NCT02172040|616188892|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
170504887|NCT02172040|616188893|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
170504888|NCT02172040|616188890|FG000|Overall Study|Family emergency abroad|0|||
170504889|NCT02172040|616188891|FG001|Overall Study|Family emergency abroad|0|||
170504890|NCT02172040|616188892|FG002|Overall Study|Family emergency abroad|0|||
170504891|NCT02172040|616188893|FG003|Overall Study|Family emergency abroad|1|||
170504892|NCT04506905|616188894|FG000|Overall Study|Lost to Follow-up|1|||
170504893|NCT04506905|616188895|FG001|Overall Study|Lost to Follow-up|0|||
170552140|NCT00992394|616366534|FG001|Overall Study|Lack of Efficacy|3|||
170552141|NCT00992394|616366533|FG000|Overall Study|Adverse Event|4|||
170552142|NCT00992394|616366534|FG001|Overall Study|Adverse Event|5|||
170552143|NCT00992394|616366533|FG000|Overall Study|Withdrawal by Subject|8|||
170552144|NCT00992394|616366534|FG001|Overall Study|Withdrawal by Subject|2|||
170552145|NCT00992394|616366533|FG000|Overall Study|Physician Decision|1|||
170552146|NCT00992394|616366534|FG001|Overall Study|Physician Decision|0|||
170552147|NCT00992394|616366533|FG000|Overall Study|Protocol Violation|2|||
170552148|NCT00992394|616366534|FG001|Overall Study|Protocol Violation|4|||
170552149|NCT00992394|616366533|FG000|Overall Study|Lost to Follow-up|2|||
170552150|NCT00992394|616366534|FG001|Overall Study|Lost to Follow-up|0|||
170552151|NCT00992394|616366533|FG000|Overall Study|Other event|1|||
170552152|NCT00992394|616366534|FG001|Overall Study|Other event|0|||
170552153|NCT06097273|616366536|FG000|Overall Study|Death|2|||
170552154|NCT06097273|616366537|FG001|Overall Study|Death|1|||
170904167|NCT00117312|617650895|FG001|Overall Study|Adverse Event|2|||
170904168|NCT00117312|617650896|FG002|Overall Study|Adverse Event|0|||
170904169|NCT00117312|617650897|FG003|Overall Study|Adverse Event|0|||
170904170|NCT00117312|617650894|FG000|Overall Study|Protocol Violation|0|||
170504894|NCT04506905|616188896|FG002|Overall Study|Lost to Follow-up|0|||
170504895|NCT04506905|616188897|FG003|Overall Study|Lost to Follow-up|1|||
170504896|NCT04506905|616188898|FG004|Overall Study|Lost to Follow-up|0|||
170904171|NCT00117312|617650895|FG001|Overall Study|Protocol Violation|1|||
170904172|NCT00117312|617650896|FG002|Overall Study|Protocol Violation|3|||
170904173|NCT00117312|617650897|FG003|Overall Study|Protocol Violation|0|||
170904174|NCT00117312|617650894|FG000|Overall Study|PSA decrease <=50%|0|||
170904175|NCT00117312|617650895|FG001|Overall Study|PSA decrease <=50%|2|||
170904176|NCT00117312|617650896|FG002|Overall Study|PSA decrease <=50%|2|||
170504897|NCT04506905|616188899|FG005|Overall Study|Lost to Follow-up|0|||
170552155|NCT06097273|616366538|FG002|Overall Study|Death|2|||
170552156|NCT06097273|616366539|FG003|Overall Study|Death|2|||
170552157|NCT06097273|616366536|FG000|Overall Study|Lost to Follow-up|27|||
170904177|NCT00117312|617650897|FG003|Overall Study|PSA decrease <=50%|4|||
170504898|NCT04506905|616188900|FG006|Overall Study|Lost to Follow-up|0|||
170504899|NCT04506905|616188901|FG007|Overall Study|Lost to Follow-up|0|||
170504900|NCT04506905|616188902|FG008|Overall Study|Lost to Follow-up|0|||
170504901|NCT04506905|616188894|FG000|Overall Study|Withdrawal by Subject|0|||
170504902|NCT04506905|616188895|FG001|Overall Study|Withdrawal by Subject|0|||
170504903|NCT04506905|616188896|FG002|Overall Study|Withdrawal by Subject|0|||
170504904|NCT04506905|616188897|FG003|Overall Study|Withdrawal by Subject|2|||
170504905|NCT04506905|616188898|FG004|Overall Study|Withdrawal by Subject|0|||
170504906|NCT04506905|616188899|FG005|Overall Study|Withdrawal by Subject|0|||
170504907|NCT04506905|616188900|FG006|Overall Study|Withdrawal by Subject|0|||
170504908|NCT04506905|616188901|FG007|Overall Study|Withdrawal by Subject|0|||
170504909|NCT04506905|616188902|FG008|Overall Study|Withdrawal by Subject|0|||
170504910|NCT02913105|616190633|FG000|Overall Study|Adverse Event|11|||
170504911|NCT02913105|616190634|FG001|Overall Study|Adverse Event|0|||
170504912|NCT02913105|616190635|FG002|Overall Study|Adverse Event|4|||
170504913|NCT02913105|616190633|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170504914|NCT02913105|616190634|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170504915|NCT02913105|616190635|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170504916|NCT02913105|616190633|FG000|Overall Study|Reason Not Specified|3|||
170504917|NCT02913105|616190634|FG001|Overall Study|Reason Not Specified|1|||
170504918|NCT02913105|616190635|FG002|Overall Study|Reason Not Specified|1|||
170504919|NCT02913105|616190633|FG000|Overall Study|Physician Decision|1|||
170504920|NCT02913105|616190634|FG001|Overall Study|Physician Decision|1|||
170504921|NCT02913105|616190635|FG002|Overall Study|Physician Decision|0|||
170504922|NCT02913105|616190633|FG000|Overall Study|Withdrawal by Subject|0|||
170504923|NCT02913105|616190634|FG001|Overall Study|Withdrawal by Subject|3|||
170504924|NCT02913105|616190635|FG002|Overall Study|Withdrawal by Subject|1|||
170504925|NCT01709864|616190636|FG000|Overall Study|Physician Decision|0|||
170504926|NCT01709864|616190637|FG001|Overall Study|Physician Decision|1|||
170504927|NCT01709864|616190636|FG000|Overall Study|subject/guardian decision|5|||
170504928|NCT01709864|616190637|FG001|Overall Study|subject/guardian decision|6|||
170504929|NCT01709864|616190636|FG000|Overall Study|Lost to Follow-up|1|||
170504930|NCT01709864|616190637|FG001|Overall Study|Lost to Follow-up|0|||
170504931|NCT01709864|616190636|FG000|Overall Study|non-compliance with study treatment|1|||
170504932|NCT01709864|616190637|FG001|Overall Study|non-compliance with study treatment|1|||
170504933|NCT01709864|616190636|FG000|Overall Study|Adverse Event|0|||
170504934|NCT01709864|616190637|FG001|Overall Study|Adverse Event|2|||
170504935|NCT01709864|616190636|FG000|Overall Study|Death|0|||
170504936|NCT01709864|616190637|FG001|Overall Study|Death|1|||
170504937|NCT03774394|616190640|FG000|Overall Study|Withdrawal by Subject|2|||
170504938|NCT03774394|616190641|FG001|Overall Study|Withdrawal by Subject|0|||
170504939|NCT05625477|616190648|FG000|Overall Study|Lost to Follow-up|2|||
170504940|NCT05625477|616190649|FG001|Overall Study|Lost to Follow-up|2|||
170504941|NCT05625477|616190650|FG002|Overall Study|Lost to Follow-up|1|||
170504942|NCT05625477|616190651|FG003|Overall Study|Lost to Follow-up|1|||
170504943|NCT05625477|616190652|FG004|Overall Study|Lost to Follow-up|0|||
170504944|NCT05625477|616190648|FG000|Overall Study|Covid quarantine|1|||
170504945|NCT05625477|616190649|FG001|Overall Study|Covid quarantine|0|||
170504946|NCT05625477|616190650|FG002|Overall Study|Covid quarantine|0|||
170504947|NCT05625477|616190651|FG003|Overall Study|Covid quarantine|0|||
170504948|NCT05625477|616190652|FG004|Overall Study|Covid quarantine|0|||
170504949|NCT03341936|616190655|FG000|Overall Study|Ineligible|1|||
170504950|NCT03341936|616190655|FG000|Overall Study|Disease Progression|2|||
170504951|NCT03341936|616190655|FG000|Overall Study|Withdrew Consent|4|||
170504952|NCT03341936|616190655|FG000|Overall Study|Non-Compliance|1|||
170642495|NCT01403948|616705274|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
170504953|NCT03341936|616190655|FG000|Overall Study|Physician Decision|1|||
170504954|NCT03341936|616190655|FG000|Overall Study|Withdrawal by Subject|1|||
170504955|NCT03341936|616190655|FG000|Overall Study|Other|1|||
170504956|NCT01092637|616190656|FG000|Overall Study|Death|47|||
170504957|NCT01092637|616190657|FG001|Overall Study|Death|49|||
170504958|NCT05916131|616190664|FG000|Overall Study|Lost to Follow-up|0|||
170504959|NCT05916131|616190665|FG001|Overall Study|Lost to Follow-up|0|||
170504960|NCT05916131|616190666|FG002|Overall Study|Lost to Follow-up|1|||
170504961|NCT05916131|616190667|FG003|Overall Study|Lost to Follow-up|0|||
170504962|NCT02278367|616190670|FG000|Overall Study|Physician Decision|5|||
170504963|NCT02278367|616190671|FG001|Overall Study|Physician Decision|0|||
170504964|NCT02278367|616190670|FG000|Overall Study|Withdrawal by Subject|5|||
170504965|NCT02278367|616190671|FG001|Overall Study|Withdrawal by Subject|0|||
170504966|NCT00869557|616190672|FG000|Randomized Phase|Lost to Follow-up|2|||
170504967|NCT00869557|616190673|FG001|Randomized Phase|Lost to Follow-up|1|||
170504968|NCT00869557|616190672|FG000|Randomized Phase|Investigator's Discretion|1|||
170504969|NCT00869557|616190673|FG001|Randomized Phase|Investigator's Discretion|0|||
170504970|NCT00869557|616190672|FG000|Randomized Phase|Withdrew Consent|0|||
170504971|NCT00869557|616190673|FG001|Randomized Phase|Withdrew Consent|1|||
170504972|NCT00869557|616190672|FG000|Extension Phase|Adverse Event|2|||
170504973|NCT00869557|616190673|FG001|Extension Phase|Adverse Event|2|||
170504974|NCT00869557|616190672|FG000|Extension Phase|Lack of Efficacy|1|||
170504975|NCT00869557|616190673|FG001|Extension Phase|Lack of Efficacy|0|||
170504976|NCT00869557|616190672|FG000|Extension Phase|Lost to Follow-up|3|||
170504977|NCT00869557|616190673|FG001|Extension Phase|Lost to Follow-up|1|||
170504978|NCT00869557|616190672|FG000|Extension Phase|Investigator's Discretion|2|||
170504979|NCT00869557|616190673|FG001|Extension Phase|Investigator's Discretion|0|||
170504980|NCT00869557|616190672|FG000|Extension Phase|Withdrew Consent|2|||
170504981|NCT00869557|616190673|FG001|Extension Phase|Withdrew Consent|0|||
170504982|NCT04105010|616190674|FG000|Overall Study|Death|3|||
170504983|NCT04105010|616190675|FG001|Overall Study|Death|1|||
170504984|NCT04105010|616190676|FG002|Overall Study|Death|1|||
170504985|NCT04105010|616190677|FG003|Overall Study|Death|54|||
170504986|NCT04105010|616190674|FG000|Overall Study|Lost to Follow-up|0|||
170504987|NCT04105010|616190675|FG001|Overall Study|Lost to Follow-up|0|||
170504988|NCT04105010|616190676|FG002|Overall Study|Lost to Follow-up|0|||
170504989|NCT04105010|616190677|FG003|Overall Study|Lost to Follow-up|4|||
170504990|NCT04105010|616190674|FG000|Overall Study|Withdrawal by Subject|8|||
170504991|NCT04105010|616190675|FG001|Overall Study|Withdrawal by Subject|1|||
170504992|NCT04105010|616190676|FG002|Overall Study|Withdrawal by Subject|1|||
170504993|NCT04105010|616190677|FG003|Overall Study|Withdrawal by Subject|4|||
170504994|NCT04105010|616190674|FG000|Overall Study|Other reason|4|||
170504995|NCT04105010|616190675|FG001|Overall Study|Other reason|7|||
170504996|NCT04105010|616190676|FG002|Overall Study|Other reason|0|||
170504997|NCT04105010|616190677|FG003|Overall Study|Other reason|19|||
170504998|NCT01211483|616190678|FG000|Phase 1b|Death|6|||
170504999|NCT01211483|616190679|FG001|Phase 1b|Death|0|||
170505000|NCT01211483|616190680|FG002|Phase 1b|Death|0|||
170505001|NCT01211483|616190681|FG003|Phase 1b|Death|0|||
170505002|NCT01211483|616190678|FG000|Phase 1b|Withdrawal by Subject|1|||
170505003|NCT01211483|616190679|FG001|Phase 1b|Withdrawal by Subject|0|||
170505004|NCT01211483|616190680|FG002|Phase 1b|Withdrawal by Subject|0|||
170505005|NCT01211483|616190681|FG003|Phase 1b|Withdrawal by Subject|0|||
170505006|NCT01211483|616190678|FG000|Phase 2|Lost to Follow-up|0|||
170505007|NCT01211483|616190679|FG001|Phase 2|Lost to Follow-up|1|||
170505008|NCT01211483|616190680|FG002|Phase 2|Lost to Follow-up|1|||
170505009|NCT01211483|616190681|FG003|Phase 2|Lost to Follow-up|2|||
170505010|NCT01211483|616190678|FG000|Phase 2|Death|0|||
170505011|NCT01211483|616190679|FG001|Phase 2|Death|64|||
170505012|NCT01211483|616190680|FG002|Phase 2|Death|53|||
170505013|NCT01211483|616190681|FG003|Phase 2|Death|53|||
170505014|NCT01211483|616190678|FG000|Phase 2|Withdrawal by Subject|0|||
170505015|NCT01211483|616190679|FG001|Phase 2|Withdrawal by Subject|1|||
170505016|NCT01211483|616190680|FG002|Phase 2|Withdrawal by Subject|10|||
170505017|NCT01211483|616190681|FG003|Phase 2|Withdrawal by Subject|5|||
170505018|NCT01211483|616190678|FG000|Phase 2|Study terminated by Sponsor|0|||
170505019|NCT01211483|616190679|FG001|Phase 2|Study terminated by Sponsor|6|||
170505020|NCT01211483|616190680|FG002|Phase 2|Study terminated by Sponsor|8|||
170505021|NCT01211483|616190681|FG003|Phase 2|Study terminated by Sponsor|11|||
170505022|NCT02971800|616190684|FG000|Overall Study|Protocol Violation|1|||
170505023|NCT02971800|616190684|FG000|Overall Study|Withdrawal by Subject|1|||
170505024|NCT02971800|616190684|FG000|Overall Study|Exclusion criteria prior intervention|1|||
170505025|NCT02971800|616190684|FG000|Overall Study|Number evaluable participant already reached|4|||
170505026|NCT01447446|616190685|FG000|Overall Study|Death|6|||
170505027|NCT01447446|616190686|FG001|Overall Study|Death|3|||
170505028|NCT01447446|616190687|FG002|Overall Study|Death|2|||
170505029|NCT01447446|616190688|FG003|Overall Study|Death|1|||
170904178|NCT00117312|617650894|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
170904179|NCT00117312|617650895|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
170505030|NCT01447446|616190689|FG004|Overall Study|Death|7|||
170505031|NCT01447446|616190690|FG005|Overall Study|Death|0|||
170505032|NCT01447446|616190685|FG000|Overall Study|Adverse Event|3|||
170505033|NCT01447446|616190686|FG001|Overall Study|Adverse Event|0|||
170505034|NCT01447446|616190687|FG002|Overall Study|Adverse Event|1|||
170505035|NCT01447446|616190688|FG003|Overall Study|Adverse Event|0|||
170505036|NCT01447446|616190689|FG004|Overall Study|Adverse Event|2|||
170505037|NCT01447446|616190690|FG005|Overall Study|Adverse Event|0|||
170505038|NCT01447446|616190685|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
170505039|NCT01447446|616190686|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
170505040|NCT01447446|616190687|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
170505041|NCT01447446|616190688|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
170505042|NCT01447446|616190689|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
170505043|NCT01447446|616190690|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
170505044|NCT01447446|616190685|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
170505045|NCT01447446|616190686|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
170552158|NCT06097273|616366537|FG001|Overall Study|Lost to Follow-up|18|||
170552159|NCT06097273|616366538|FG002|Overall Study|Lost to Follow-up|36|||
170505046|NCT01447446|616190687|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
170505047|NCT01447446|616190688|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
170505048|NCT01447446|616190689|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
170505049|NCT01447446|616190690|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
170505050|NCT01447446|616190685|FG000|Overall Study|Administrative/Other|34|||
170505051|NCT01447446|616190686|FG001|Overall Study|Administrative/Other|9|||
170505052|NCT01447446|616190687|FG002|Overall Study|Administrative/Other|10|||
170505053|NCT01447446|616190688|FG003|Overall Study|Administrative/Other|2|||
170505054|NCT01447446|616190689|FG004|Overall Study|Administrative/Other|33|||
170505055|NCT01447446|616190690|FG005|Overall Study|Administrative/Other|4|||
170505056|NCT01447446|616190685|FG000|Overall Study|SVR12 Assessment|13|||
170505057|NCT01447446|616190686|FG001|Overall Study|SVR12 Assessment|1|||
170505058|NCT01447446|616190687|FG002|Overall Study|SVR12 Assessment|2|||
170505059|NCT01447446|616190688|FG003|Overall Study|SVR12 Assessment|1|||
170505060|NCT01447446|616190689|FG004|Overall Study|SVR12 Assessment|5|||
170505061|NCT01447446|616190690|FG005|Overall Study|SVR12 Assessment|5|||
170505062|NCT01447446|616190685|FG000|Overall Study|New Treatment Started|8|||
170505063|NCT01447446|616190686|FG001|Overall Study|New Treatment Started|2|||
170505064|NCT01447446|616190687|FG002|Overall Study|New Treatment Started|1|||
170505065|NCT01447446|616190688|FG003|Overall Study|New Treatment Started|0|||
170505066|NCT01447446|616190689|FG004|Overall Study|New Treatment Started|2|||
170505067|NCT01447446|616190690|FG005|Overall Study|New Treatment Started|0|||
170505068|NCT01447446|616190685|FG000|Overall Study|Reason not Specified|1|||
170505069|NCT01447446|616190686|FG001|Overall Study|Reason not Specified|1|||
170505070|NCT01447446|616190687|FG002|Overall Study|Reason not Specified|1|||
170505071|NCT01447446|616190688|FG003|Overall Study|Reason not Specified|1|||
170505072|NCT01447446|616190689|FG004|Overall Study|Reason not Specified|1|||
170505073|NCT01447446|616190690|FG005|Overall Study|Reason not Specified|0|||
170505074|NCT04829331|616190691|FG000|Overall Study|Lost to Follow-up|1|||
170505075|NCT04829331|616190692|FG001|Overall Study|Lost to Follow-up|0|||
170505076|NCT05323994|616190693|FG000|Overall Study|Protocol Violation|1|||
170505077|NCT00454818|616190697|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
170505078|NCT00454818|616190698|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
170505079|NCT00454818|616190699|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
170505080|NCT00454818|616190700|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
170505081|NCT00454818|616190701|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
170505082|NCT00454818|616190697|FG000|Phase I: Open-label Dose-escalation|Death|0|||
170505083|NCT00454818|616190698|FG001|Phase I: Open-label Dose-escalation|Death|1|||
170505084|NCT00454818|616190699|FG002|Phase I: Open-label Dose-escalation|Death|0|||
170505085|NCT00454818|616190700|FG003|Phase I: Open-label Dose-escalation|Death|0|||
170505086|NCT00454818|616190701|FG004|Phase I: Open-label Dose-escalation|Death|0|||
170505087|NCT00454818|616190697|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
170505088|NCT00454818|616190698|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
170505089|NCT00454818|616190699|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
170505090|NCT00454818|616190700|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
170505091|NCT00454818|616190701|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
170505092|NCT00454818|616190697|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
170505093|NCT00454818|616190698|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
170505094|NCT00454818|616190699|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
170505095|NCT00454818|616190700|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
170505096|NCT00454818|616190701|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
170505097|NCT00454818|616190697|FG000|Phase 2: Randomized Double-blind|Death|0|||
170505098|NCT00454818|616190698|FG001|Phase 2: Randomized Double-blind|Death|1|||
170505099|NCT00454818|616190699|FG002|Phase 2: Randomized Double-blind|Death|0|||
170505100|NCT00454818|616190700|FG003|Phase 2: Randomized Double-blind|Death|0|||
170505101|NCT00454818|616190701|FG004|Phase 2: Randomized Double-blind|Death|1|||
170505102|NCT00454818|616190697|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
170505103|NCT00454818|616190698|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
170505104|NCT00454818|616190699|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
170505105|NCT00454818|616190700|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
170505106|NCT00454818|616190701|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
170505107|NCT00454818|616190697|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
170505108|NCT00454818|616190698|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
170505109|NCT00454818|616190699|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
170505110|NCT00454818|616190700|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
170505111|NCT00454818|616190701|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
170505112|NCT00616603|616190702|FG000|Overall Study|Physician Decision|2|||
170505113|NCT00616603|616190703|FG001|Overall Study|Physician Decision|0|||
170805353|NCT04762277|617297365|FG000|Overall Study|Withdrawal by Subject|0|||
170805354|NCT04762277|617297366|FG001|Overall Study|Withdrawal by Subject|2|||
170505114|NCT00616603|616190704|FG002|Overall Study|Physician Decision|2|||
170505115|NCT00766467|616190707|FG000|Overall Study|Withdrawal by Subject|7|||
170505116|NCT00766467|616190708|FG001|Overall Study|Withdrawal by Subject|2|||
170505117|NCT00766467|616190707|FG000|Overall Study|Adverse Event|1|||
170505118|NCT00766467|616190708|FG001|Overall Study|Adverse Event|1|||
170505119|NCT00766467|616190707|FG000|Overall Study|Protocol Violation|2|||
170505120|NCT00766467|616190708|FG001|Overall Study|Protocol Violation|4|||
170505121|NCT00766467|616190707|FG000|Overall Study|Tumor Progression on Study|0|||
170505122|NCT00766467|616190708|FG001|Overall Study|Tumor Progression on Study|1|||
170505123|NCT00766467|616190707|FG000|Overall Study|Physician Decision|1|||
170505124|NCT00766467|616190708|FG001|Overall Study|Physician Decision|0|||
170505125|NCT02223819|616190711|FG000|Overall Study|Lost to Follow-up|2|||
170505126|NCT00943670|616190714|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
170505127|NCT00943670|616190714|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
170505128|NCT00943670|616190714|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
170505129|NCT00943670|616190714|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
170505130|NCT00943670|616190714|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
170505131|NCT00943670|616190714|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
170505132|NCT00943670|616190714|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
170505133|NCT00943670|616190714|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
170505134|NCT00943670|616190714|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
170505135|NCT00943670|616190714|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
170505136|NCT00908076|616190715|FG000|Overall Study|Lack of Efficacy|1|||
170505137|NCT00908076|616190716|FG001|Overall Study|Lack of Efficacy|1|||
170505138|NCT04526574|616190717|FG000|Overall Study|Protocol Violation|3|||
170505139|NCT04526574|616190718|FG001|Overall Study|Protocol Violation|1|||
170505140|NCT04526574|616190717|FG000|Overall Study|Withdrawal by Subject|12|||
170505141|NCT04526574|616190718|FG001|Overall Study|Withdrawal by Subject|9|||
170505142|NCT04526574|616190717|FG000|Overall Study|Other|1|||
170505143|NCT04526574|616190718|FG001|Overall Study|Other|2|||
170505144|NCT04526574|616190717|FG000|Overall Study|Adverse Event|1|||
170505145|NCT04526574|616190718|FG001|Overall Study|Adverse Event|1|||
170505146|NCT04526574|616190717|FG000|Overall Study|Death|2|||
170505147|NCT04526574|616190718|FG001|Overall Study|Death|3|||
170505148|NCT04526574|616190717|FG000|Overall Study|Lost to Follow-up|9|||
170505149|NCT04526574|616190718|FG001|Overall Study|Lost to Follow-up|9|||
170505150|NCT04526574|616190717|FG000|Overall Study|No longer meets eligibility criteria|8|||
170505151|NCT04526574|616190718|FG001|Overall Study|No longer meets eligibility criteria|8|||
170505152|NCT01032070|616190719|FG000|Overall Study|Disease progression|13|||
170505153|NCT01032070|616190720|FG001|Overall Study|Disease progression|8|||
170505154|NCT01032070|616190719|FG000|Overall Study|Medical or ethical reasons|0|||
170505155|NCT01032070|616190720|FG001|Overall Study|Medical or ethical reasons|2|||
170505156|NCT01032070|616190719|FG000|Overall Study|Withdrawal by Subject|0|||
170505157|NCT01032070|616190720|FG001|Overall Study|Withdrawal by Subject|2|||
170505158|NCT02554318|616190721|FG000|Overall Study|Withdrawal by Subject|10|||
170505159|NCT02554318|616190722|FG001|Overall Study|Withdrawal by Subject|8|||
170505160|NCT00894790|616190725|FG000|Overall Study|Protocol Violation|0|||
170505161|NCT00894790|616190726|FG001|Overall Study|Protocol Violation|1|||
170505162|NCT00894790|616190725|FG000|Overall Study|Lost to Follow-up|0|||
170505163|NCT00894790|616190726|FG001|Overall Study|Lost to Follow-up|1|||
170505164|NCT00894790|616190725|FG000|Overall Study|Did not meet entrance criteria|1|||
170505165|NCT00894790|616190726|FG001|Overall Study|Did not meet entrance criteria|0|||
170505166|NCT01472965|616190727|FG000|Overall Study|Withdrawal by Subject|1|||
170505167|NCT01472965|616190728|FG001|Overall Study|Withdrawal by Subject|0|||
170505168|NCT00396877|616190729|FG000|Overall Study|Lost to Follow-up|2|||
170505169|NCT00396877|616190730|FG001|Overall Study|Lost to Follow-up|1|||
170505170|NCT00396877|616190729|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
170505171|NCT00396877|616190730|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
170505172|NCT00334802|616190733|FG000|Overall Study|Progressive Disease|2|||
170552160|NCT06097273|616366539|FG003|Overall Study|Lost to Follow-up|31|||
170552161|NCT06097273|616366536|FG000|Overall Study|Physician Decision|0|||
170552162|NCT06097273|616366537|FG001|Overall Study|Physician Decision|1|||
170505173|NCT00334802|616190734|FG001|Overall Study|Progressive Disease|24|||
170505174|NCT00334802|616190733|FG000|Overall Study|Toxicity|1|||
170505175|NCT00334802|616190734|FG001|Overall Study|Toxicity|5|||
170505176|NCT00334802|616190733|FG000|Overall Study|Lack of Efficacy|1|||
170505177|NCT00334802|616190734|FG001|Overall Study|Lack of Efficacy|3|||
170505178|NCT00334802|616190733|FG000|Overall Study|Patient Condition Aggrevated|1|||
170505179|NCT00334802|616190734|FG001|Overall Study|Patient Condition Aggrevated|0|||
170505180|NCT00334802|616190733|FG000|Overall Study|Physician Decision|1|||
170505181|NCT00334802|616190734|FG001|Overall Study|Physician Decision|0|||
170552163|NCT06097273|616366538|FG002|Overall Study|Physician Decision|0|||
170505182|NCT00334802|616190733|FG000|Overall Study|Withdrawal by Subject|0|||
170505183|NCT00334802|616190734|FG001|Overall Study|Withdrawal by Subject|4|||
170505184|NCT00334802|616190733|FG000|Overall Study|Adverse Event|0|||
170505185|NCT00334802|616190734|FG001|Overall Study|Adverse Event|3|||
170505186|NCT00334802|616190733|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
170505187|NCT00334802|616190734|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
170505188|NCT03515629|616190745|FG000|Overall Study|Death|0|||
170505189|NCT03515629|616190746|FG001|Overall Study|Death|1|||
170505190|NCT03515629|616190747|FG002|Overall Study|Death|1|||
170505191|NCT03515629|616190745|FG000|Overall Study|Progressive disease|0|||
170505192|NCT03515629|616190746|FG001|Overall Study|Progressive disease|1|||
170505193|NCT03515629|616190747|FG002|Overall Study|Progressive disease|0|||
170505194|NCT03329248|616190748|FG000|Overall Study|Progressive Disease|6|||
170505195|NCT01886781|616190749|FG000|Overall Study|Protocol Violation|5|||
170505196|NCT01886781|616190750|FG001|Overall Study|Protocol Violation|0|||
170505197|NCT01886781|616190749|FG000|Overall Study|Adverse Event|1|||
170505198|NCT01886781|616190750|FG001|Overall Study|Adverse Event|0|||
170505199|NCT01886781|616190749|FG000|Overall Study|Lost to Follow-up|5|||
170505200|NCT01886781|616190750|FG001|Overall Study|Lost to Follow-up|0|||
170505201|NCT01886781|616190749|FG000|Overall Study|Withdrawal by Subject|2|||
170505202|NCT01886781|616190750|FG001|Overall Study|Withdrawal by Subject|1|||
170505203|NCT01886781|616190749|FG000|Overall Study|Worsening of symptoms|1|||
170505204|NCT01886781|616190750|FG001|Overall Study|Worsening of symptoms|1|||
170505205|NCT00987402|616190751|FG000|Overall Study|Insufficient data entry|86|||
170505206|NCT00987402|616190752|FG001|Overall Study|Insufficient data entry|98|||
170505207|NCT03000530|616190753|FG000|Overall Study|Adverse Event|0|||
170505208|NCT03000530|616190754|FG001|Overall Study|Adverse Event|0|||
170505209|NCT03000530|616190755|FG002|Overall Study|Adverse Event|2|||
170505210|NCT03000530|616190753|FG000|Overall Study|Lost to Follow-up|0|||
170505211|NCT03000530|616190754|FG001|Overall Study|Lost to Follow-up|3|||
170505212|NCT03000530|616190755|FG002|Overall Study|Lost to Follow-up|1|||
170505213|NCT03000530|616190753|FG000|Overall Study|Withdrawal by Subject|0|||
170505214|NCT03000530|616190754|FG001|Overall Study|Withdrawal by Subject|2|||
170505215|NCT03000530|616190755|FG002|Overall Study|Withdrawal by Subject|1|||
170505216|NCT03597022|616190759|FG000|Overall Study|Premature termination of the study|7|||
170505217|NCT03597022|616190760|FG001|Overall Study|Premature termination of the study|7|||
170505218|NCT03597022|616190761|FG002|Overall Study|Premature termination of the study|8|||
170505219|NCT03597022|616190759|FG000|Overall Study|Serious adverse event|1|||
170505220|NCT03597022|616190760|FG001|Overall Study|Serious adverse event|1|||
170505221|NCT03597022|616190761|FG002|Overall Study|Serious adverse event|0|||
170505222|NCT01285492|616190762|FG000|Overall Study|Adverse Event|11|||
170505223|NCT01285492|616190763|FG001|Overall Study|Adverse Event|0|||
170505224|NCT01285492|616190762|FG000|Overall Study|Protocol Violation|3|||
170505225|NCT01285492|616190763|FG001|Overall Study|Protocol Violation|0|||
170552164|NCT06097273|616366539|FG003|Overall Study|Physician Decision|3|||
170552165|NCT06097273|616366536|FG000|Overall Study|Protocol Violation|1|||
170552166|NCT06097273|616366537|FG001|Overall Study|Protocol Violation|1|||
170505226|NCT01285492|616190762|FG000|Overall Study|Withdrawal by Subject|2|||
170552167|NCT06097273|616366538|FG002|Overall Study|Protocol Violation|2|||
170552168|NCT06097273|616366539|FG003|Overall Study|Protocol Violation|1|||
170552169|NCT06097273|616366536|FG000|Overall Study|Withdrawal by Subject|14|||
170552170|NCT06097273|616366537|FG001|Overall Study|Withdrawal by Subject|11|||
170552171|NCT06097273|616366538|FG002|Overall Study|Withdrawal by Subject|14|||
170552172|NCT06097273|616366539|FG003|Overall Study|Withdrawal by Subject|15|||
170552173|NCT06097273|616366536|FG000|Overall Study|Other Than Specified|7|||
170552174|NCT06097273|616366537|FG001|Overall Study|Other Than Specified|3|||
170552175|NCT06097273|616366538|FG002|Overall Study|Other Than Specified|11|||
170552176|NCT06097273|616366539|FG003|Overall Study|Other Than Specified|6|||
170552177|NCT01394185|616367898|FG000|Overall Study|Withdrawal by Subject|2|||
170552178|NCT01394185|616367899|FG001|Overall Study|Withdrawal by Subject|0|||
170552179|NCT01394185|616367900|FG002|Overall Study|Withdrawal by Subject|0|||
170552180|NCT01394185|616367901|FG003|Overall Study|Withdrawal by Subject|0|||
170552181|NCT01394185|616367902|FG004|Overall Study|Withdrawal by Subject|1|||
170552182|NCT01394185|616367903|FG005|Overall Study|Withdrawal by Subject|0|||
170642496|NCT01403948|616705275|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
170642497|NCT01403948|616705276|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
170505227|NCT01285492|616190763|FG001|Overall Study|Withdrawal by Subject|1|||
170552183|NCT01394185|616367898|FG000|Overall Study|Change in protocol|3|||
170505228|NCT01285492|616190762|FG000|Overall Study|Death|1|||
170552184|NCT01394185|616367899|FG001|Overall Study|Change in protocol|0|||
170552185|NCT01394185|616367900|FG002|Overall Study|Change in protocol|0|||
170552186|NCT01394185|616367901|FG003|Overall Study|Change in protocol|0|||
170552187|NCT01394185|616367902|FG004|Overall Study|Change in protocol|3|||
170552188|NCT01394185|616367903|FG005|Overall Study|Change in protocol|0|||
170505229|NCT01285492|616190763|FG001|Overall Study|Death|0|||
170505230|NCT01121536|616190765|FG000|Overall Study|Adverse Event|63|||
170505231|NCT01121536|616190765|FG000|Overall Study|Lack of Efficacy|35|||
170505232|NCT01121536|616190765|FG000|Overall Study|Withdrawal by Subject|65|||
170505233|NCT01121536|616190765|FG000|Overall Study|Protocol Violation|20|||
170505234|NCT01121536|616190765|FG000|Overall Study|Noncompliance with study medication|12|||
170505235|NCT01121536|616190765|FG000|Overall Study|Noncompliance with study procedures|9|||
170505236|NCT01121536|616190765|FG000|Overall Study|Lost to Follow-up|39|||
170505237|NCT01121536|616190765|FG000|Overall Study|Other|118|||
170505238|NCT02649426|616190766|FG000|Overall Study|Follow-up on going|1|||
170505239|NCT02649426|616190767|FG001|Overall Study|Follow-up on going|26|||
170505240|NCT02649426|616190768|FG002|Overall Study|Follow-up on going|28|||
170505241|NCT02649426|616190769|FG003|Overall Study|Follow-up on going|31|||
170505242|NCT00369161|616190770|FG000|Overall Study|Adverse Event|15|||
170505243|NCT00369161|616190771|FG001|Overall Study|Adverse Event|13|||
170505244|NCT00369161|616190770|FG000|Overall Study|Abnormal laboratory value|0|||
170505245|NCT00369161|616190771|FG001|Overall Study|Abnormal laboratory value|1|||
170505246|NCT00369161|616190770|FG000|Overall Study|Lack of Efficacy|3|||
170505247|NCT00369161|616190771|FG001|Overall Study|Lack of Efficacy|1|||
170505248|NCT00369161|616190770|FG000|Overall Study|Protocol Violation|0|||
170505249|NCT00369161|616190771|FG001|Overall Study|Protocol Violation|2|||
170505250|NCT00369161|616190770|FG000|Overall Study|Withdrawal by Subject|2|||
170505251|NCT00369161|616190771|FG001|Overall Study|Withdrawal by Subject|3|||
170505252|NCT00369161|616190770|FG000|Overall Study|Death|1|||
170505253|NCT00369161|616190771|FG001|Overall Study|Death|2|||
170505254|NCT00369161|616190770|FG000|Overall Study|Graft loss|4|||
170505255|NCT00369161|616190771|FG001|Overall Study|Graft loss|0|||
170505256|NCT00369161|616190770|FG000|Overall Study|Administrative Problem|2|||
170505257|NCT00369161|616190771|FG001|Overall Study|Administrative Problem|2|||
170505258|NCT01870297|616190772|FG000|Overall Study|Adverse Event|0|||
170505259|NCT01870297|616190773|FG001|Overall Study|Adverse Event|0|||
170505260|NCT01870297|616190774|FG002|Overall Study|Adverse Event|0|||
170505261|NCT01870297|616190775|FG003|Overall Study|Adverse Event|0|||
170505262|NCT01870297|616190776|FG004|Overall Study|Adverse Event|2|||
170505263|NCT01870297|616190777|FG005|Overall Study|Adverse Event|0|||
170505264|NCT01870297|616190778|FG006|Overall Study|Adverse Event|0|||
170505265|NCT01870297|616190772|FG000|Overall Study|Lost to Follow-up|0|||
170505266|NCT01870297|616190773|FG001|Overall Study|Lost to Follow-up|1|||
170505267|NCT01870297|616190774|FG002|Overall Study|Lost to Follow-up|1|||
170505268|NCT01870297|616190775|FG003|Overall Study|Lost to Follow-up|0|||
170505269|NCT01870297|616190776|FG004|Overall Study|Lost to Follow-up|0|||
170505270|NCT01870297|616190777|FG005|Overall Study|Lost to Follow-up|0|||
170505271|NCT01870297|616190778|FG006|Overall Study|Lost to Follow-up|0|||
170505272|NCT01870297|616190772|FG000|Overall Study|Withdrawal by Subject|0|||
170505273|NCT01870297|616190773|FG001|Overall Study|Withdrawal by Subject|0|||
170505274|NCT01870297|616190774|FG002|Overall Study|Withdrawal by Subject|0|||
170505275|NCT01870297|616190775|FG003|Overall Study|Withdrawal by Subject|0|||
170505276|NCT01870297|616190776|FG004|Overall Study|Withdrawal by Subject|1|||
170505277|NCT01870297|616190777|FG005|Overall Study|Withdrawal by Subject|1|||
170505278|NCT01870297|616190778|FG006|Overall Study|Withdrawal by Subject|1|||
170505279|NCT01870297|616190772|FG000|Overall Study|Sponsor Decision|0|||
170505280|NCT01870297|616190773|FG001|Overall Study|Sponsor Decision|6|||
170505281|NCT01870297|616190774|FG002|Overall Study|Sponsor Decision|0|||
170505282|NCT01870297|616190775|FG003|Overall Study|Sponsor Decision|0|||
170505283|NCT01870297|616190776|FG004|Overall Study|Sponsor Decision|0|||
170505284|NCT01870297|616190777|FG005|Overall Study|Sponsor Decision|0|||
170505285|NCT01870297|616190778|FG006|Overall Study|Sponsor Decision|1|||
170505286|NCT02044874|616190781|FG000|Overall Study|Adverse Event|5|||
170505287|NCT02044874|616190782|FG001|Overall Study|Adverse Event|6|||
170505288|NCT02044874|616190783|FG002|Overall Study|Adverse Event|6|||
170505289|NCT02044874|616190781|FG000|Overall Study|Withdrawal by Subject|8|||
170505290|NCT02044874|616190782|FG001|Overall Study|Withdrawal by Subject|16|||
170505291|NCT02044874|616190783|FG002|Overall Study|Withdrawal by Subject|23|||
170505292|NCT02044874|616190781|FG000|Overall Study|Physician Decision|0|||
170505293|NCT02044874|616190782|FG001|Overall Study|Physician Decision|2|||
170505294|NCT02044874|616190783|FG002|Overall Study|Physician Decision|1|||
170505295|NCT02044874|616190781|FG000|Overall Study|Lost to Follow-up|10|||
170505296|NCT02044874|616190782|FG001|Overall Study|Lost to Follow-up|27|||
170505297|NCT02044874|616190783|FG002|Overall Study|Lost to Follow-up|21|||
170642498|NCT01403948|616705267|FG000|Overall Study|Lost to Follow-up|0|||
170642499|NCT01403948|616705268|FG001|Overall Study|Lost to Follow-up|0|||
170505298|NCT02044874|616190781|FG000|Overall Study|Sponsor Decision|0|||
170505299|NCT02044874|616190782|FG001|Overall Study|Sponsor Decision|1|||
170505300|NCT02044874|616190783|FG002|Overall Study|Sponsor Decision|1|||
170505301|NCT02044874|616190781|FG000|Overall Study|Other|7|||
170505302|NCT02044874|616190782|FG001|Overall Study|Other|3|||
170505303|NCT02044874|616190783|FG002|Overall Study|Other|8|||
170642500|NCT01403948|616705269|FG002|Overall Study|Lost to Follow-up|0|||
170505304|NCT01047332|616190784|FG000|Overall Study|SEMS Obstruction|11|||
170505305|NCT01047332|616190785|FG001|Overall Study|SEMS Obstruction|20|||
170505306|NCT01047332|616190784|FG000|Overall Study|Died Unobstructed|38|||
170505307|NCT01047332|616190785|FG001|Overall Study|Died Unobstructed|41|||
170505308|NCT01047332|616190784|FG000|Overall Study|Lost to Follow-up|8|||
170505309|NCT01047332|616190785|FG001|Overall Study|Lost to Follow-up|3|||
170505310|NCT04908202|616190787|FG000|Pre-Treatment Period|OTHER REASONS|3|||
170505311|NCT04908202|616190788|FG001|Pre-Treatment Period|OTHER REASONS|1|||
170505312|NCT04908202|616190789|FG002|Pre-Treatment Period|OTHER REASONS|0|||
170505313|NCT04908202|616190790|FG003|Pre-Treatment Period|OTHER REASONS|0|||
170505314|NCT04908202|616190787|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
170505315|NCT04908202|616190788|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
170505316|NCT04908202|616190789|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
170505317|NCT04908202|616190790|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
170505318|NCT04908202|616190787|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
170505319|NCT04908202|616190788|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
170505320|NCT04908202|616190789|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
170505321|NCT04908202|616190790|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
170505322|NCT04908202|616190787|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
170505323|NCT04908202|616190788|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
170505324|NCT04908202|616190789|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
170505325|NCT04908202|616190790|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
170505326|NCT04908202|616190787|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
170505327|NCT04908202|616190788|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
170505328|NCT04908202|616190789|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170505329|NCT04908202|616190790|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170505330|NCT04908202|616190787|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
170505331|NCT04908202|616190788|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
170505332|NCT04908202|616190789|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
170505333|NCT04908202|616190790|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
170505334|NCT04908202|616190787|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
170505335|NCT04908202|616190788|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
170505336|NCT04908202|616190789|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
170505337|NCT04908202|616190790|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
170505338|NCT04908202|616190787|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
170505339|NCT04908202|616190788|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
170505340|NCT04908202|616190789|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
170505341|NCT04908202|616190790|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
170505342|NCT04908202|616190787|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
170505343|NCT04908202|616190788|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
170505344|NCT04908202|616190789|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
170505345|NCT04908202|616190790|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
170505346|NCT04908202|616190787|FG000|Active Treatment Period|OTHER REASONS|0|||
170505347|NCT04908202|616190788|FG001|Active Treatment Period|OTHER REASONS|0|||
170505348|NCT04908202|616190789|FG002|Active Treatment Period|OTHER REASONS|1|||
170505349|NCT04908202|616190790|FG003|Active Treatment Period|OTHER REASONS|3|||
170505350|NCT04908202|616190787|FG000|Active Treatment Period|Lack of Efficacy|0|||
170505351|NCT04908202|616190788|FG001|Active Treatment Period|Lack of Efficacy|0|||
170505352|NCT04908202|616190789|FG002|Active Treatment Period|Lack of Efficacy|4|||
170505353|NCT04908202|616190790|FG003|Active Treatment Period|Lack of Efficacy|5|||
170505354|NCT04908202|616190787|FG000|Active Treatment Period|Adverse Event|0|||
170505355|NCT04908202|616190788|FG001|Active Treatment Period|Adverse Event|0|||
170505356|NCT04908202|616190789|FG002|Active Treatment Period|Adverse Event|5|||
170505357|NCT04908202|616190790|FG003|Active Treatment Period|Adverse Event|8|||
170505358|NCT04908202|616190787|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170505359|NCT04908202|616190788|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
170505360|NCT04908202|616190789|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
170505361|NCT04908202|616190790|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
170505362|NCT04908202|616190787|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
170505363|NCT04908202|616190788|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
170505364|NCT04908202|616190789|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
170505365|NCT04908202|616190790|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
170505366|NCT04908202|616190787|FG000|Active Treatment Period|Lost to Follow-up|0|||
170505367|NCT04908202|616190788|FG001|Active Treatment Period|Lost to Follow-up|0|||
170505368|NCT04908202|616190789|FG002|Active Treatment Period|Lost to Follow-up|2|||
170505369|NCT04908202|616190790|FG003|Active Treatment Period|Lost to Follow-up|2|||
170505370|NCT04908202|616190787|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
170505371|NCT04908202|616190788|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
170505372|NCT04908202|616190789|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
170505373|NCT04908202|616190790|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
170505374|NCT04908202|616190787|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
170505375|NCT04908202|616190788|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
170505376|NCT04908202|616190789|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
170505377|NCT04908202|616190790|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
170505378|NCT04908202|616190787|FG000|Active Treatment Period|ONGOING Treatment|0|||
170505379|NCT04908202|616190788|FG001|Active Treatment Period|ONGOING Treatment|0|||
170505380|NCT04908202|616190789|FG002|Active Treatment Period|ONGOING Treatment|117|||
170505381|NCT04908202|616190790|FG003|Active Treatment Period|ONGOING Treatment|114|||
170505382|NCT05397171|616190791|FG000|Overall Study|Death|2|||
170505383|NCT05397171|616190792|FG001|Overall Study|Death|3|||
170505384|NCT05397171|616190793|FG002|Overall Study|Death|3|||
170505385|NCT05397171|616190791|FG000|Overall Study|Study Terminated By Sponsor|1|||
170505386|NCT05397171|616190792|FG001|Overall Study|Study Terminated By Sponsor|2|||
170505387|NCT05397171|616190793|FG002|Overall Study|Study Terminated By Sponsor|3|||
170505388|NCT05397171|616190791|FG000|Overall Study|Withdrawal by Subject|0|||
170505389|NCT05397171|616190792|FG001|Overall Study|Withdrawal by Subject|1|||
170505390|NCT05397171|616190793|FG002|Overall Study|Withdrawal by Subject|1|||
170505391|NCT02227368|616192474|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
170505392|NCT02227368|616192475|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
170505393|NCT02227368|616192474|FG000|Overall Study|Lost to Follow-up|1|||
170505394|NCT02227368|616192475|FG001|Overall Study|Lost to Follow-up|0|||
170505395|NCT02227368|616192474|FG000|Overall Study|Adverse Event|1|||
170505396|NCT02227368|616192475|FG001|Overall Study|Adverse Event|0|||
170505397|NCT03046056|616192476|FG000|Overall Study|Non-responder at Week 10|6|||
170505398|NCT03046056|616192477|FG001|Overall Study|Non-responder at Week 10|6|||
170505399|NCT03046056|616192478|FG002|Overall Study|Non-responder at Week 10|4|||
170505400|NCT03046056|616192476|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
170505401|NCT03046056|616192477|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
170505402|NCT03046056|616192478|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
170505403|NCT03046056|616192476|FG000|Overall Study|Adverse Event|1|||
170505404|NCT03046056|616192477|FG001|Overall Study|Adverse Event|5|||
170505405|NCT03046056|616192478|FG002|Overall Study|Adverse Event|0|||
170505406|NCT03046056|616192476|FG000|Overall Study|Non-compliance With Study Drug|0|||
170505407|NCT03046056|616192477|FG001|Overall Study|Non-compliance With Study Drug|0|||
170505408|NCT03046056|616192478|FG002|Overall Study|Non-compliance With Study Drug|2|||
170505409|NCT03046056|616192476|FG000|Overall Study|Protocol Violation|1|||
170505410|NCT03046056|616192477|FG001|Overall Study|Protocol Violation|1|||
170505411|NCT03046056|616192478|FG002|Overall Study|Protocol Violation|0|||
170505412|NCT03046056|616192476|FG000|Overall Study|Investigator's Discretion|0|||
170505413|NCT03046056|616192477|FG001|Overall Study|Investigator's Discretion|1|||
170505414|NCT03046056|616192478|FG002|Overall Study|Investigator's Discretion|0|||
170505415|NCT03046056|616192476|FG000|Overall Study|Withdrew Consent|1|||
170505416|NCT03046056|616192477|FG001|Overall Study|Withdrew Consent|0|||
170505417|NCT03046056|616192478|FG002|Overall Study|Withdrew Consent|0|||
170505418|NCT02168777|616192479|FG000|Overall Study|Withdrawal by Subject|1|||
170505419|NCT02168777|616192480|FG001|Overall Study|Withdrawal by Subject|0|||
170505420|NCT02168777|616192481|FG002|Overall Study|Withdrawal by Subject|2|||
170505421|NCT02168777|616192479|FG000|Overall Study|Adverse Event|1|||
170505422|NCT02168777|616192480|FG001|Overall Study|Adverse Event|0|||
170505423|NCT02168777|616192481|FG002|Overall Study|Adverse Event|1|||
170904180|NCT00117312|617650896|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
170904181|NCT00117312|617650897|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
170904182|NCT00117312|617650894|FG000|Overall Study|Hepatic abnormality|0|||
170904183|NCT00117312|617650895|FG001|Overall Study|Hepatic abnormality|1|||
170904184|NCT00117312|617650896|FG002|Overall Study|Hepatic abnormality|0|||
170904185|NCT00117312|617650897|FG003|Overall Study|Hepatic abnormality|1|||
170904186|NCT00117312|617650894|FG000|Overall Study|Withdrawal by Subject|0|||
170904187|NCT00117312|617650895|FG001|Overall Study|Withdrawal by Subject|2|||
170904188|NCT00117312|617650896|FG002|Overall Study|Withdrawal by Subject|0|||
170904189|NCT00117312|617650897|FG003|Overall Study|Withdrawal by Subject|0|||
170904190|NCT01120626|617650898|FG000|Overall Study|Withdrawal by Subject|1|||
170904191|NCT01120626|617650899|FG001|Overall Study|Withdrawal by Subject|0|||
170904192|NCT01535235|617650901|FG000|Overall Study|Adverse Event|1|||
170904193|NCT01535235|617650902|FG001|Overall Study|Adverse Event|0|||
170904194|NCT00858832|617650903|FG000|Overall Study|became ineligible: delivered vaginally|1|||
170904195|NCT00858832|617650904|FG001|Overall Study|became ineligible: delivered vaginally|0|||
170904196|NCT00858832|617650903|FG000|Overall Study|Adverse Event|0|||
170904197|NCT00858832|617650904|FG001|Overall Study|Adverse Event|1|||
170904198|NCT03075839|617650905|FG000|Overall Study|Lost to Follow-up|4|||
170904199|NCT02500550|617650909|FG000|Overall Study|Death|7|||
170505424|NCT02168777|616192479|FG000|Overall Study|Disease recurrence|0|||
170904200|NCT01658514|617650912|FG000|Overall Study|Protocol Violation|1|||
170904201|NCT01658514|617650913|FG001|Overall Study|Protocol Violation|0|||
170904202|NCT01658514|617650914|FG002|Overall Study|Protocol Violation|2|||
170904203|NCT04996797|617650917|FG000|Overall Study|Adverse Event|0|||
170505425|NCT02168777|616192480|FG001|Overall Study|Disease recurrence|0|||
170505426|NCT02168777|616192481|FG002|Overall Study|Disease recurrence|1|||
170505427|NCT02168777|616192479|FG000|Overall Study|Radiological disease progression|0|||
170505428|NCT02168777|616192480|FG001|Overall Study|Radiological disease progression|5|||
170505429|NCT02168777|616192481|FG002|Overall Study|Radiological disease progression|5|||
170904204|NCT04996797|617650918|FG001|Overall Study|Adverse Event|2|||
170505430|NCT02168777|616192479|FG000|Overall Study|Clinical disease progression|0|||
170505431|NCT02168777|616192480|FG001|Overall Study|Clinical disease progression|1|||
170505432|NCT02168777|616192481|FG002|Overall Study|Clinical disease progression|2|||
170505433|NCT02168777|616192479|FG000|Overall Study|Other reason|0|||
170505434|NCT02168777|616192480|FG001|Overall Study|Other reason|1|||
170642501|NCT01403948|616705270|FG003|Overall Study|Lost to Follow-up|0|||
170505435|NCT02168777|616192481|FG002|Overall Study|Other reason|0|||
170505436|NCT02470403|616192482|FG000|Overall Study|Adverse Event|1|||
170505437|NCT02470403|616192483|FG001|Overall Study|Adverse Event|0|||
170505438|NCT02470403|616192484|FG002|Overall Study|Adverse Event|0|||
170505439|NCT02470403|616192485|FG003|Overall Study|Adverse Event|0|||
170505440|NCT02470403|616192486|FG004|Overall Study|Adverse Event|0|||
170505441|NCT02470403|616192482|FG000|Overall Study|Lost to Follow-up|0|||
170505442|NCT02470403|616192483|FG001|Overall Study|Lost to Follow-up|1|||
170505443|NCT02470403|616192484|FG002|Overall Study|Lost to Follow-up|0|||
170505444|NCT02470403|616192485|FG003|Overall Study|Lost to Follow-up|0|||
170505445|NCT02470403|616192486|FG004|Overall Study|Lost to Follow-up|0|||
170505446|NCT02470403|616192482|FG000|Overall Study|Subject/guardian decision|1|||
170505447|NCT02470403|616192483|FG001|Overall Study|Subject/guardian decision|0|||
170505448|NCT02470403|616192484|FG002|Overall Study|Subject/guardian decision|0|||
170505449|NCT02470403|616192485|FG003|Overall Study|Subject/guardian decision|4|||
170505450|NCT02470403|616192486|FG004|Overall Study|Subject/guardian decision|0|||
170505451|NCT01133288|616192489|FG000|Eligibility Assessment|met exclusion criteria|5|||
170505452|NCT01133288|616192489|FG000|Intervention Allocation|study terminated|2|||
170505453|NCT03209518|616192490|FG000|Overall Study|Case Report Forms Uncollected|1|||
170505454|NCT03209518|616192490|FG000|Overall Study|Protocol Deviation|1|||
170505455|NCT00236899|616192495|FG000|Overall Study|Adverse Event (Study Related)|1|||
170505456|NCT00236899|616192496|FG001|Overall Study|Adverse Event (Study Related)|1|||
170505457|NCT00236899|616192497|FG002|Overall Study|Adverse Event (Study Related)|2|||
170505458|NCT00236899|616192498|FG003|Overall Study|Adverse Event (Study Related)|1|||
170505459|NCT00236899|616192495|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
170505460|NCT00236899|616192496|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
170505461|NCT00236899|616192497|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
170505462|NCT00236899|616192498|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
170505463|NCT00236899|616192495|FG000|Overall Study|Death (Study Disease)|1|||
170505464|NCT00236899|616192496|FG001|Overall Study|Death (Study Disease)|4|||
170505465|NCT00236899|616192497|FG002|Overall Study|Death (Study Disease)|0|||
170505466|NCT00236899|616192498|FG003|Overall Study|Death (Study Disease)|0|||
170505467|NCT00236899|616192495|FG000|Overall Study|Death (Not Study Related)|2|||
170505468|NCT00236899|616192496|FG001|Overall Study|Death (Not Study Related)|0|||
170505469|NCT00236899|616192497|FG002|Overall Study|Death (Not Study Related)|0|||
170505470|NCT00236899|616192498|FG003|Overall Study|Death (Not Study Related)|0|||
170505471|NCT00236899|616192495|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
170505472|NCT00236899|616192496|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
170505473|NCT00236899|616192497|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
170505474|NCT00236899|616192498|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
170505475|NCT00236899|616192495|FG000|Overall Study|Lost to Follow-up|0|||
170505476|NCT00236899|616192496|FG001|Overall Study|Lost to Follow-up|1|||
170505477|NCT00236899|616192497|FG002|Overall Study|Lost to Follow-up|0|||
170505478|NCT00236899|616192498|FG003|Overall Study|Lost to Follow-up|0|||
170505479|NCT00236899|616192495|FG000|Overall Study|Entry Criteria Exclusion|0|||
170505480|NCT00236899|616192496|FG001|Overall Study|Entry Criteria Exclusion|1|||
170505481|NCT00236899|616192497|FG002|Overall Study|Entry Criteria Exclusion|1|||
170505482|NCT00236899|616192498|FG003|Overall Study|Entry Criteria Exclusion|0|||
170505483|NCT00236899|616192495|FG000|Overall Study|Protocol Violation|1|||
170505484|NCT00236899|616192496|FG001|Overall Study|Protocol Violation|0|||
170505485|NCT00236899|616192497|FG002|Overall Study|Protocol Violation|0|||
170505486|NCT00236899|616192498|FG003|Overall Study|Protocol Violation|0|||
170505487|NCT00236899|616192495|FG000|Overall Study|Withdrawal by Subject|6|||
170505488|NCT00236899|616192496|FG001|Overall Study|Withdrawal by Subject|4|||
170505489|NCT00236899|616192497|FG002|Overall Study|Withdrawal by Subject|5|||
170505490|NCT00236899|616192498|FG003|Overall Study|Withdrawal by Subject|2|||
170505491|NCT00236899|616192495|FG000|Overall Study|Physician Decision|7|||
170642502|NCT01403948|616705271|FG004|Overall Study|Lost to Follow-up|0|||
170642503|NCT01403948|616705272|FG005|Overall Study|Lost to Follow-up|0|||
170505492|NCT00236899|616192496|FG001|Overall Study|Physician Decision|8|||
170505493|NCT00236899|616192497|FG002|Overall Study|Physician Decision|7|||
170505494|NCT00236899|616192498|FG003|Overall Study|Physician Decision|6|||
170505495|NCT00236899|616192495|FG000|Overall Study|Satisfactory Response|2|||
170505496|NCT00236899|616192496|FG001|Overall Study|Satisfactory Response|0|||
170505497|NCT00236899|616192497|FG002|Overall Study|Satisfactory Response|0|||
170505498|NCT00236899|616192498|FG003|Overall Study|Satisfactory Response|1|||
170505499|NCT00236899|616192495|FG000|Overall Study|Lack of Efficacy|18|||
170505500|NCT00236899|616192496|FG001|Overall Study|Lack of Efficacy|18|||
170505501|NCT00236899|616192497|FG002|Overall Study|Lack of Efficacy|25|||
170642504|NCT01403948|616705273|FG006|Overall Study|Lost to Follow-up|0|||
170505502|NCT00236899|616192498|FG003|Overall Study|Lack of Efficacy|23|||
170505503|NCT02565706|616192499|FG000|Overall Study|Withdrawal by Subject|5|||
170505504|NCT02565706|616192500|FG001|Overall Study|Withdrawal by Subject|7|||
170505505|NCT02565706|616192501|FG002|Overall Study|Withdrawal by Subject|7|||
170505506|NCT02565706|616192502|FG003|Overall Study|Withdrawal by Subject|11|||
170505507|NCT02565706|616192499|FG000|Overall Study|Lost to Follow-up|72|||
170505508|NCT02565706|616192500|FG001|Overall Study|Lost to Follow-up|75|||
170505509|NCT02565706|616192501|FG002|Overall Study|Lost to Follow-up|82|||
170505510|NCT02565706|616192502|FG003|Overall Study|Lost to Follow-up|74|||
170505511|NCT00401960|616192503|FG000|Overall Study|Lost to Follow-up|3|||
170505512|NCT00401960|616192504|FG001|Overall Study|Lost to Follow-up|0|||
170505513|NCT00401960|616192503|FG000|Overall Study|Death|2|||
170505514|NCT00401960|616192504|FG001|Overall Study|Death|0|||
170505515|NCT03313310|616192505|FG000|Phase 2|Lost to Follow-up|4|||
170505516|NCT03313310|616192506|FG001|Phase 2|Lost to Follow-up|0|||
170505517|NCT03313310|616192505|FG000|Phase 3|Lost to Follow-up|0|||
170505518|NCT03313310|616192506|FG001|Phase 3|Lost to Follow-up|1|||
170505519|NCT01593254|616192509|FG000|Overall Study|Disease progression|2|||
170505520|NCT01593254|616192510|FG001|Overall Study|Disease progression|7|||
170505521|NCT01593254|616192509|FG000|Overall Study|Study drug toxicity|6|||
170505522|NCT01593254|616192510|FG001|Overall Study|Study drug toxicity|20|||
170505523|NCT01593254|616192509|FG000|Overall Study|Death|3|||
170552189|NCT01394185|616367898|FG000|Overall Study|Protocol Violation|1|||
170552190|NCT01394185|616367899|FG001|Overall Study|Protocol Violation|0|||
170552191|NCT01394185|616367900|FG002|Overall Study|Protocol Violation|0|||
170552192|NCT01394185|616367901|FG003|Overall Study|Protocol Violation|1|||
170552193|NCT01394185|616367902|FG004|Overall Study|Protocol Violation|0|||
170552194|NCT01394185|616367903|FG005|Overall Study|Protocol Violation|1|||
170552195|NCT04110145|616367904|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
170552196|NCT04110145|616367905|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
170552197|NCT04110145|616367906|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
170552198|NCT04110145|616367907|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
170904205|NCT04996797|617650919|FG002|Overall Study|Adverse Event|0|||
170904206|NCT04996797|617650920|FG003|Overall Study|Adverse Event|1|||
170904207|NCT04996797|617650917|FG000|Overall Study|Lack of Efficacy|0|||
170552199|NCT04110145|616367908|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
170552200|NCT05401409|616367909|FG000|Overall Study|Lost to Follow-up|1|||
170552201|NCT05401409|616367910|FG001|Overall Study|Lost to Follow-up|0|||
170552202|NCT02371889|616367911|FG000|Overall Study|Adverse medication effect|11|||
170552203|NCT02371889|616367912|FG001|Overall Study|Adverse medication effect|2|||
170552204|NCT02371889|616367911|FG000|Overall Study|Lost to Follow-up|6|||
170552205|NCT02371889|616367912|FG001|Overall Study|Lost to Follow-up|5|||
170552206|NCT02371889|616367911|FG000|Overall Study|Personal time constraints|2|||
170552207|NCT02371889|616367912|FG001|Overall Study|Personal time constraints|4|||
170552208|NCT02371889|616367911|FG000|Overall Study|Lack of Efficacy|0|||
170552209|NCT02371889|616367912|FG001|Overall Study|Lack of Efficacy|2|||
170552210|NCT02371889|616367911|FG000|Overall Study|Relapse|0|||
170552211|NCT02371889|616367912|FG001|Overall Study|Relapse|1|||
170552212|NCT02562040|616367913|FG000|Overall Study|Lost to Follow-up|20|||
170552213|NCT02562040|616367914|FG001|Overall Study|Lost to Follow-up|28|||
170552214|NCT02562040|616367913|FG000|Overall Study|Withdrawal by Subject|8|||
170552215|NCT02562040|616367914|FG001|Overall Study|Withdrawal by Subject|7|||
170552216|NCT02562040|616367913|FG000|Overall Study|Adverse Event|1|||
170552217|NCT02562040|616367914|FG001|Overall Study|Adverse Event|0|||
170552218|NCT05130281|616367915|FG000|Overall Study|Withdrawal by Subject|0|||
170552219|NCT05130281|616367916|FG001|Overall Study|Withdrawal by Subject|0|||
170904208|NCT04996797|617650918|FG001|Overall Study|Lack of Efficacy|2|||
170552220|NCT05130281|616367917|FG002|Overall Study|Withdrawal by Subject|1|||
170552221|NCT06844812|616367918|FG000|Overall Study|Lost to Follow-up|5|||
170552222|NCT06844812|616367918|FG000|Overall Study|stigmatization concerns|2|||
170552223|NCT06844812|616367918|FG000|Overall Study|medication refusal|2|||
170552224|NCT06844812|616367918|FG000|Overall Study|concerns about possible side effects|2|||
170552225|NCT06844812|616367918|FG000|Overall Study|wanting to seek another specialist opinion|2|||
170552226|NCT06844812|616367918|FG000|Overall Study|side effects (dizziness)|1|||
170904209|NCT04996797|617650919|FG002|Overall Study|Lack of Efficacy|0|||
170904210|NCT04996797|617650920|FG003|Overall Study|Lack of Efficacy|0|||
170904211|NCT04996797|617650917|FG000|Overall Study|Prohibited Medication|0|||
170505524|NCT01593254|616192510|FG001|Overall Study|Death|3|||
170505525|NCT01593254|616192509|FG000|Overall Study|AE unrelated to study drug|0|||
170552227|NCT02255279|616367920|FG000|Overall Study|Lost to Follow-up|2|||
170552228|NCT02255279|616367921|FG001|Overall Study|Lost to Follow-up|2|||
170552229|NCT02255279|616367920|FG000|Overall Study|Protocol Violation|0|||
170552230|NCT02255279|616367921|FG001|Overall Study|Protocol Violation|1|||
170552231|NCT02255279|616367920|FG000|Overall Study|Withdrawal by Subject|3|||
170552232|NCT02255279|616367921|FG001|Overall Study|Withdrawal by Subject|6|||
170552233|NCT00432991|616367923|FG000|Overall Study|Protocol Violation|7|||
170904212|NCT04996797|617650918|FG001|Overall Study|Prohibited Medication|1|||
170505526|NCT01593254|616192510|FG001|Overall Study|AE unrelated to study drug|1|||
170505527|NCT01593254|616192509|FG000|Overall Study|participant request to discontinue study treatment|1|||
170505528|NCT01593254|616192510|FG001|Overall Study|participant request to discontinue study treatment|3|||
170505529|NCT01593254|616192509|FG000|Overall Study|participant withdrew consent|0|||
170505530|NCT01593254|616192510|FG001|Overall Study|participant withdrew consent|9|||
170505531|NCT01593254|616192509|FG000|Overall Study|lost to follow up|1|||
170505532|NCT01593254|616192510|FG001|Overall Study|lost to follow up|6|||
170505533|NCT01593254|616192509|FG000|Overall Study|maximum clinical benefit|1|||
170505534|NCT01593254|616192510|FG001|Overall Study|maximum clinical benefit|2|||
170505535|NCT01593254|616192509|FG000|Overall Study|Poor/non compliance|1|||
170505536|NCT01593254|616192510|FG001|Overall Study|Poor/non compliance|1|||
170505537|NCT01593254|616192509|FG000|Overall Study|Pregnancy|0|||
170505538|NCT01593254|616192510|FG001|Overall Study|Pregnancy|3|||
170505539|NCT01593254|616192509|FG000|Overall Study|participant no longer meets study criteria|1|||
170505540|NCT01593254|616192510|FG001|Overall Study|participant no longer meets study criteria|1|||
170505541|NCT01593254|616192509|FG000|Overall Study|Admin reason by sponsor|7|||
170505542|NCT01593254|616192510|FG001|Overall Study|Admin reason by sponsor|3|||
170505543|NCT01593254|616192509|FG000|Overall Study|Imatinib treatment failure|2|||
170505544|NCT01593254|616192510|FG001|Overall Study|Imatinib treatment failure|0|||
170505545|NCT01593254|616192509|FG000|Overall Study|Other Reasons|61|||
170505546|NCT01593254|616192510|FG001|Overall Study|Other Reasons|115|||
170505547|NCT00932451|616192526|FG000|Overall Study|Withdrawal by Subject|69|||
170805355|NCT04762277|617297365|FG000|Overall Study|Protocol Violation|0|||
170805356|NCT04762277|617297366|FG001|Overall Study|Protocol Violation|1|||
170805357|NCT04762277|617297365|FG000|Overall Study|Adverse Event|1|||
170505548|NCT00932451|616192526|FG000|Overall Study|Lost to Follow-up|22|||
170505549|NCT00932451|616192526|FG000|Overall Study|Death|726|||
170505550|NCT00932451|616192526|FG000|Overall Study|Other reasons|5|||
170505551|NCT03627416|616192532|FG000|Overall Study|Adverse Event|0|||
170505552|NCT03627416|616192533|FG001|Overall Study|Adverse Event|1|||
170505553|NCT02079636|616192534|FG000|Overall Study|Death|2|||
170505554|NCT02079636|616192535|FG001|Overall Study|Death|1|||
170505555|NCT02079636|616192536|FG002|Overall Study|Death|0|||
170505556|NCT02079636|616192537|FG003|Overall Study|Death|5|||
170505557|NCT02079636|616192538|FG004|Overall Study|Death|1|||
170505558|NCT02079636|616192539|FG005|Overall Study|Death|2|||
170505559|NCT02079636|616192540|FG006|Overall Study|Death|1|||
170505560|NCT02079636|616192541|FG007|Overall Study|Death|0|||
170505561|NCT02079636|616192542|FG008|Overall Study|Death|0|||
170505562|NCT02079636|616192543|FG009|Overall Study|Death|0|||
170505563|NCT02079636|616192544|FG010|Overall Study|Death|0|||
170505564|NCT02079636|616192545|FG011|Overall Study|Death|1|||
170505565|NCT02079636|616192546|FG012|Overall Study|Death|1|||
170505566|NCT02079636|616192547|FG013|Overall Study|Death|0|||
170505567|NCT02079636|616192548|FG014|Overall Study|Death|2|||
170505568|NCT02079636|616192534|FG000|Overall Study|Adverse Event|1|||
170505569|NCT02079636|616192535|FG001|Overall Study|Adverse Event|1|||
170505570|NCT02079636|616192536|FG002|Overall Study|Adverse Event|0|||
170505571|NCT02079636|616192537|FG003|Overall Study|Adverse Event|1|||
170505572|NCT02079636|616192538|FG004|Overall Study|Adverse Event|1|||
170505573|NCT02079636|616192539|FG005|Overall Study|Adverse Event|2|||
170505574|NCT02079636|616192540|FG006|Overall Study|Adverse Event|0|||
170505575|NCT02079636|616192541|FG007|Overall Study|Adverse Event|0|||
170505576|NCT02079636|616192542|FG008|Overall Study|Adverse Event|0|||
170505577|NCT02079636|616192543|FG009|Overall Study|Adverse Event|0|||
170505578|NCT02079636|616192544|FG010|Overall Study|Adverse Event|0|||
170505579|NCT02079636|616192545|FG011|Overall Study|Adverse Event|0|||
170505580|NCT02079636|616192546|FG012|Overall Study|Adverse Event|0|||
170505581|NCT02079636|616192547|FG013|Overall Study|Adverse Event|0|||
170505582|NCT02079636|616192548|FG014|Overall Study|Adverse Event|0|||
170805358|NCT04762277|617297366|FG001|Overall Study|Adverse Event|0|||
170505583|NCT02079636|616192534|FG000|Overall Study|Progressive disease|0|||
170505584|NCT02079636|616192535|FG001|Overall Study|Progressive disease|0|||
170505585|NCT02079636|616192536|FG002|Overall Study|Progressive disease|0|||
170505586|NCT02079636|616192537|FG003|Overall Study|Progressive disease|2|||
170505587|NCT02079636|616192538|FG004|Overall Study|Progressive disease|0|||
170805359|NCT04801420|617297367|FG000|Overall Study|Other|1|||
170505588|NCT02079636|616192539|FG005|Overall Study|Progressive disease|0|||
170505589|NCT02079636|616192540|FG006|Overall Study|Progressive disease|0|||
170805360|NCT04801420|617297368|FG001|Overall Study|Other|2|||
170505590|NCT02079636|616192541|FG007|Overall Study|Progressive disease|0|||
170505591|NCT02079636|616192542|FG008|Overall Study|Progressive disease|0|||
170505592|NCT02079636|616192543|FG009|Overall Study|Progressive disease|0|||
170505593|NCT02079636|616192544|FG010|Overall Study|Progressive disease|0|||
170505594|NCT02079636|616192545|FG011|Overall Study|Progressive disease|0|||
170505595|NCT02079636|616192546|FG012|Overall Study|Progressive disease|1|||
170505596|NCT02079636|616192547|FG013|Overall Study|Progressive disease|0|||
170505597|NCT02079636|616192548|FG014|Overall Study|Progressive disease|0|||
170505598|NCT02079636|616192534|FG000|Overall Study|Withdrawal by Subject|0|||
170505599|NCT02079636|616192535|FG001|Overall Study|Withdrawal by Subject|0|||
170505600|NCT02079636|616192536|FG002|Overall Study|Withdrawal by Subject|0|||
170505601|NCT02079636|616192537|FG003|Overall Study|Withdrawal by Subject|4|||
170505602|NCT02079636|616192538|FG004|Overall Study|Withdrawal by Subject|0|||
170505603|NCT02079636|616192539|FG005|Overall Study|Withdrawal by Subject|1|||
170505604|NCT02079636|616192540|FG006|Overall Study|Withdrawal by Subject|0|||
170505605|NCT02079636|616192541|FG007|Overall Study|Withdrawal by Subject|0|||
170505606|NCT02079636|616192542|FG008|Overall Study|Withdrawal by Subject|0|||
170505607|NCT02079636|616192543|FG009|Overall Study|Withdrawal by Subject|2|||
170505608|NCT02079636|616192544|FG010|Overall Study|Withdrawal by Subject|1|||
170505609|NCT02079636|616192545|FG011|Overall Study|Withdrawal by Subject|1|||
170505610|NCT02079636|616192546|FG012|Overall Study|Withdrawal by Subject|1|||
170505611|NCT02079636|616192547|FG013|Overall Study|Withdrawal by Subject|0|||
170505612|NCT02079636|616192548|FG014|Overall Study|Withdrawal by Subject|2|||
170505613|NCT02079636|616192534|FG000|Overall Study|Physician Decision|0|||
170505614|NCT02079636|616192535|FG001|Overall Study|Physician Decision|0|||
170505615|NCT02079636|616192536|FG002|Overall Study|Physician Decision|0|||
170505616|NCT02079636|616192537|FG003|Overall Study|Physician Decision|0|||
170505617|NCT02079636|616192538|FG004|Overall Study|Physician Decision|0|||
170505618|NCT02079636|616192539|FG005|Overall Study|Physician Decision|1|||
170505619|NCT02079636|616192540|FG006|Overall Study|Physician Decision|0|||
170505620|NCT02079636|616192541|FG007|Overall Study|Physician Decision|0|||
170505621|NCT02079636|616192542|FG008|Overall Study|Physician Decision|0|||
170505622|NCT02079636|616192543|FG009|Overall Study|Physician Decision|1|||
170505623|NCT02079636|616192544|FG010|Overall Study|Physician Decision|1|||
170505624|NCT02079636|616192545|FG011|Overall Study|Physician Decision|0|||
170505625|NCT02079636|616192546|FG012|Overall Study|Physician Decision|0|||
170505626|NCT02079636|616192547|FG013|Overall Study|Physician Decision|0|||
170505627|NCT02079636|616192548|FG014|Overall Study|Physician Decision|1|||
170505628|NCT02079636|616192534|FG000|Overall Study|Lost to Follow-up|0|||
170505629|NCT02079636|616192535|FG001|Overall Study|Lost to Follow-up|0|||
170505630|NCT02079636|616192536|FG002|Overall Study|Lost to Follow-up|0|||
170552234|NCT00432991|616367924|FG001|Overall Study|Protocol Violation|12|||
170552235|NCT00363467|616367925|FG000|Overall Study|Physician Decision|1|||
170552236|NCT00395447|616367926|FG000|Overall Study|Death|37|||
170552237|NCT00395447|616367927|FG001|Overall Study|Death|32|||
170552238|NCT00395447|616367926|FG000|Overall Study|Lost to Follow-up|52|||
170552239|NCT00395447|616367927|FG001|Overall Study|Lost to Follow-up|43|||
170552240|NCT00395447|616367926|FG000|Overall Study|Withdrawal by Subject|24|||
170552241|NCT00395447|616367927|FG001|Overall Study|Withdrawal by Subject|19|||
170552242|NCT00395447|616367926|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
170552243|NCT00395447|616367927|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
170552244|NCT00489359|616367932|FG000|Overall Study|Death|0|||
170552245|NCT00489359|616367933|FG001|Overall Study|Death|2|||
170552246|NCT00489359|616367932|FG000|Overall Study|Progressive Disease|5|||
170552247|NCT00489359|616367933|FG001|Overall Study|Progressive Disease|6|||
170552248|NCT00489359|616367932|FG000|Overall Study|Lost to Follow-up|1|||
170552249|NCT00489359|616367933|FG001|Overall Study|Lost to Follow-up|0|||
170552250|NCT00489359|616367932|FG000|Overall Study|Withdrawal by Subject|1|||
170552251|NCT00489359|616367933|FG001|Overall Study|Withdrawal by Subject|5|||
170552252|NCT00489359|616367932|FG000|Overall Study|Adverse Event|0|||
170552253|NCT00489359|616367933|FG001|Overall Study|Adverse Event|16|||
170505631|NCT02079636|616192537|FG003|Overall Study|Lost to Follow-up|0|||
170505632|NCT02079636|616192538|FG004|Overall Study|Lost to Follow-up|0|||
170505633|NCT02079636|616192539|FG005|Overall Study|Lost to Follow-up|0|||
170505634|NCT02079636|616192540|FG006|Overall Study|Lost to Follow-up|0|||
170505635|NCT02079636|616192541|FG007|Overall Study|Lost to Follow-up|1|||
170505636|NCT02079636|616192542|FG008|Overall Study|Lost to Follow-up|0|||
170552254|NCT02202577|616367935|FG000|Overall Study|Lost to Follow-up|6|||
170552255|NCT02202577|616367936|FG001|Overall Study|Lost to Follow-up|16|||
170552256|NCT02202577|616367935|FG000|Overall Study|Protocol Violation|7|||
170505637|NCT02079636|616192543|FG009|Overall Study|Lost to Follow-up|0|||
170505638|NCT02079636|616192544|FG010|Overall Study|Lost to Follow-up|0|||
170505639|NCT02079636|616192545|FG011|Overall Study|Lost to Follow-up|0|||
170505640|NCT02079636|616192546|FG012|Overall Study|Lost to Follow-up|0|||
170505641|NCT02079636|616192547|FG013|Overall Study|Lost to Follow-up|0|||
170505642|NCT02079636|616192548|FG014|Overall Study|Lost to Follow-up|0|||
170505643|NCT00637806|616192549|FG000|Double-blind Phase|Study Discontinued|2|||
170552257|NCT02202577|616367936|FG001|Overall Study|Protocol Violation|3|||
170505644|NCT00637806|616192550|FG001|Double-blind Phase|Study Discontinued|0|||
170505645|NCT00637806|616192551|FG002|Double-blind Phase|Study Discontinued|1|||
170505646|NCT00637806|616192552|FG003|Double-blind Phase|Study Discontinued|0|||
170505647|NCT00637806|616192549|FG000|Extension Phase|Study Discontinued|0|||
170505648|NCT00637806|616192550|FG001|Extension Phase|Study Discontinued|0|||
170505649|NCT00637806|616192551|FG002|Extension Phase|Study Discontinued|0|||
170505650|NCT00637806|616192552|FG003|Extension Phase|Study Discontinued|1|||
170505651|NCT00561470|616192553|FG000|Overall Study|Adverse Event|74|||
170505652|NCT00561470|616192554|FG001|Overall Study|Adverse Event|163|||
170505653|NCT00561470|616192553|FG000|Overall Study|Disease progression|437|||
170505654|NCT00561470|616192554|FG001|Overall Study|Disease progression|305|||
170505655|NCT00561470|616192553|FG000|Overall Study|poor compliance to protocol|4|||
170505656|NCT00561470|616192554|FG001|Overall Study|poor compliance to protocol|4|||
170505657|NCT00561470|616192553|FG000|Overall Study|Lost to Follow-up|2|||
170505658|NCT00561470|616192554|FG001|Overall Study|Lost to Follow-up|0|||
170505659|NCT00561470|616192553|FG000|Overall Study|Physician Decision|21|||
170505660|NCT00561470|616192554|FG001|Overall Study|Physician Decision|20|||
170505661|NCT00561470|616192553|FG000|Overall Study|Consent Withdrawn|2|||
170505662|NCT00561470|616192554|FG001|Overall Study|Consent Withdrawn|6|||
170505663|NCT00561470|616192553|FG000|Overall Study|Subject request|43|||
170505664|NCT00561470|616192554|FG001|Overall Study|Subject request|77|||
170505665|NCT00561470|616192553|FG000|Overall Study|Metastatic surgery|10|||
170505666|NCT00561470|616192554|FG001|Overall Study|Metastatic surgery|12|||
170505667|NCT00561470|616192553|FG000|Overall Study|Unauthorized procedure|3|||
170505668|NCT00561470|616192554|FG001|Overall Study|Unauthorized procedure|1|||
170505669|NCT00561470|616192553|FG000|Overall Study|Randomized but not treated|5|||
170505670|NCT00561470|616192554|FG001|Overall Study|Randomized but not treated|5|||
170505671|NCT00561470|616192553|FG000|Overall Study|Missed visit window|1|||
170505672|NCT00561470|616192554|FG001|Overall Study|Missed visit window|4|||
170505673|NCT00561470|616192553|FG000|Overall Study|Planning surgery|1|||
170505674|NCT00561470|616192554|FG001|Overall Study|Planning surgery|1|||
170505675|NCT00561470|616192553|FG000|Overall Study|Ongoing Treatment|11|||
170505676|NCT00561470|616192554|FG001|Overall Study|Ongoing Treatment|14|||
170505677|NCT01592292|616192555|FG000|Overall Study|Follow-up loss|3|||
170505678|NCT01592292|616192556|FG001|Overall Study|Follow-up loss|3|||
170505679|NCT01592292|616192557|FG002|Overall Study|Follow-up loss|1|||
170505680|NCT01592292|616192558|FG003|Overall Study|Follow-up loss|0|||
170505681|NCT01592292|616192555|FG000|Overall Study|Withdrew consent|2|||
170505682|NCT01592292|616192556|FG001|Overall Study|Withdrew consent|1|||
170505683|NCT01592292|616192557|FG002|Overall Study|Withdrew consent|0|||
170505684|NCT01592292|616192558|FG003|Overall Study|Withdrew consent|0|||
170505685|NCT01592292|616192555|FG000|Overall Study|Other|1|||
170505686|NCT01592292|616192556|FG001|Overall Study|Other|1|||
170505687|NCT01592292|616192557|FG002|Overall Study|Other|2|||
170505688|NCT01592292|616192558|FG003|Overall Study|Other|1|||
170505689|NCT02240069|616192566|FG000|Overall Study|Withdrawal by Subject|5|||
170505690|NCT02240069|616192567|FG001|Overall Study|Withdrawal by Subject|5|||
170505691|NCT02240069|616192568|FG002|Overall Study|Withdrawal by Subject|2|||
170505692|NCT01096589|616192569|FG000|Overall Study|Adverse Event|2|||
170505693|NCT01096589|616192570|FG001|Overall Study|Adverse Event|1|||
170505694|NCT01096589|616192571|FG002|Overall Study|Adverse Event|2|||
170505695|NCT01096589|616192572|FG003|Overall Study|Adverse Event|1|||
170505696|NCT01096589|616192569|FG000|Overall Study|Withdrawal by Subject|2|||
170505697|NCT01096589|616192570|FG001|Overall Study|Withdrawal by Subject|1|||
170505698|NCT01096589|616192571|FG002|Overall Study|Withdrawal by Subject|1|||
170505699|NCT01096589|616192572|FG003|Overall Study|Withdrawal by Subject|1|||
170505700|NCT01096589|616192569|FG000|Overall Study|Compliance with protocol|0|||
170505701|NCT01096589|616192570|FG001|Overall Study|Compliance with protocol|0|||
170505702|NCT01096589|616192571|FG002|Overall Study|Compliance with protocol|1|||
170505703|NCT01096589|616192572|FG003|Overall Study|Compliance with protocol|0|||
170505704|NCT01096589|616192569|FG000|Overall Study|found treatment exhausting|0|||
170505705|NCT01096589|616192570|FG001|Overall Study|found treatment exhausting|0|||
170505706|NCT01096589|616192571|FG002|Overall Study|found treatment exhausting|0|||
170505707|NCT01096589|616192572|FG003|Overall Study|found treatment exhausting|1|||
170505708|NCT02923245|616192573|FG000|Overall Study|ultrasound order was cancelled|2|||
170505709|NCT02923245|616192574|FG001|Overall Study|ultrasound order was cancelled|1|||
170505710|NCT00157248|616192578|FG000|Overall Study|Adverse Event|36|||
170505711|NCT00157248|616192579|FG001|Overall Study|Adverse Event|25|||
170505712|NCT00157248|616192580|FG002|Overall Study|Adverse Event|13|||
170505713|NCT00157248|616192581|FG003|Overall Study|Adverse Event|33|||
170505714|NCT00157248|616192578|FG000|Overall Study|Protocol Violation|4|||
170505715|NCT00157248|616192579|FG001|Overall Study|Protocol Violation|0|||
170505716|NCT00157248|616192580|FG002|Overall Study|Protocol Violation|2|||
170505717|NCT00157248|616192581|FG003|Overall Study|Protocol Violation|2|||
170505718|NCT00157248|616192578|FG000|Overall Study|Lost to Follow-up|0|||
170505719|NCT00157248|616192579|FG001|Overall Study|Lost to Follow-up|1|||
170505720|NCT00157248|616192580|FG002|Overall Study|Lost to Follow-up|0|||
170505721|NCT00157248|616192581|FG003|Overall Study|Lost to Follow-up|0|||
170505722|NCT00157248|616192578|FG000|Overall Study|Withdrawal by Subject|1|||
170505723|NCT00157248|616192579|FG001|Overall Study|Withdrawal by Subject|4|||
170642505|NCT01403948|616705274|FG007|Overall Study|Lost to Follow-up|0|||
170505724|NCT00157248|616192580|FG002|Overall Study|Withdrawal by Subject|3|||
170505725|NCT00157248|616192581|FG003|Overall Study|Withdrawal by Subject|3|||
170505726|NCT00157248|616192578|FG000|Overall Study|site closures, subject moving|7|||
170505727|NCT00157248|616192579|FG001|Overall Study|site closures, subject moving|7|||
170505728|NCT00157248|616192580|FG002|Overall Study|site closures, subject moving|3|||
170505729|NCT00157248|616192581|FG003|Overall Study|site closures, subject moving|9|||
170505730|NCT00232596|616192582|FG000|6-Week Titration Phase|Adverse Event|6|||
170505731|NCT00232596|616192583|FG001|6-Week Titration Phase|Adverse Event|19|||
170505732|NCT00232596|616192582|FG000|6-Week Titration Phase|Failed to Return|2|||
170505733|NCT00232596|616192583|FG001|6-Week Titration Phase|Failed to Return|1|||
170505734|NCT00232596|616192582|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
170642506|NCT01403948|616705275|FG008|Overall Study|Lost to Follow-up|0|||
170505735|NCT00232596|616192583|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
170552258|NCT01646216|616367937|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
170552259|NCT01646216|616367938|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
170552260|NCT01646216|616367937|FG000|Overall Study|Did not complete training|0|||
170552261|NCT01646216|616367938|FG001|Overall Study|Did not complete training|2|||
170552262|NCT01646216|616367937|FG000|Overall Study|Investigator decision|1|||
170552263|NCT01646216|616367938|FG001|Overall Study|Investigator decision|1|||
170552264|NCT00563316|616367942|FG000|Overall Study|Adverse Event|2|||
170552265|NCT00563316|616367942|FG000|Overall Study|Physician Decision|1|||
170552266|NCT00563316|616367942|FG000|Overall Study|Lost to Follow-up|2|||
170552267|NCT00563316|616367942|FG000|Overall Study|Death|1|||
170552268|NCT00563316|616367942|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
170552269|NCT00563316|616367942|FG000|Overall Study|Other|1|||
170552270|NCT01767857|616367946|FG000|Overall Study|Adverse Event|27|||
170552271|NCT01767857|616367947|FG001|Overall Study|Adverse Event|7|||
170552272|NCT01767857|616367946|FG000|Overall Study|Death|28|||
170552273|NCT01767857|616367947|FG001|Overall Study|Death|13|||
170552274|NCT01767857|616367946|FG000|Overall Study|Lack of Efficacy|299|||
170552275|NCT01767857|616367947|FG001|Overall Study|Lack of Efficacy|151|||
170552276|NCT01767857|616367946|FG000|Overall Study|Lost to Follow-up|1|||
170552277|NCT01767857|616367947|FG001|Overall Study|Lost to Follow-up|1|||
170552278|NCT01767857|616367946|FG000|Overall Study|Withdrawal by Subject|38|||
170552279|NCT01767857|616367947|FG001|Overall Study|Withdrawal by Subject|18|||
170552280|NCT01767857|616367946|FG000|Overall Study|Physician Decision|17|||
170552281|NCT01767857|616367947|FG001|Overall Study|Physician Decision|10|||
170552282|NCT01767857|616367946|FG000|Overall Study|Protocol Terminated|1|||
170552283|NCT01767857|616367947|FG001|Overall Study|Protocol Terminated|0|||
170552284|NCT01767857|616367946|FG000|Overall Study|Randomized But Never Treated|19|||
170552285|NCT01767857|616367947|FG001|Overall Study|Randomized But Never Treated|13|||
170552286|NCT04818229|616367950|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
170552287|NCT04818229|616367951|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
170552288|NCT04818229|616367952|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
170552289|NCT04818229|616367950|FG000|Overall Study|Adverse Event|3|||
170552290|NCT04818229|616367951|FG001|Overall Study|Adverse Event|1|||
170552291|NCT04818229|616367952|FG002|Overall Study|Adverse Event|1|||
170552292|NCT04818229|616367950|FG000|Overall Study|Withdrawal by Subject|0|||
170552293|NCT04818229|616367951|FG001|Overall Study|Withdrawal by Subject|0|||
170552294|NCT04818229|616367952|FG002|Overall Study|Withdrawal by Subject|2|||
170505736|NCT00232596|616192582|FG000|6-Week Titration Phase|Protocol Violation|1|||
170505737|NCT00232596|616192583|FG001|6-Week Titration Phase|Protocol Violation|3|||
170505738|NCT00232596|616192582|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
170505739|NCT00232596|616192583|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
170505740|NCT00232596|616192582|FG000|6-Week Titration Phase|Other|3|||
170505741|NCT00232596|616192583|FG001|6-Week Titration Phase|Other|3|||
170505742|NCT00232596|616192582|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
170505743|NCT00232596|616192583|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
170505744|NCT00232596|616192582|FG000|12-Week Maintenance Phase|Adverse Event|7|||
170505745|NCT00232596|616192583|FG001|12-Week Maintenance Phase|Adverse Event|22|||
170505746|NCT00232596|616192582|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
170505747|NCT00232596|616192583|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
170505748|NCT00232596|616192582|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
170505749|NCT00232596|616192583|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
170505750|NCT00232596|616192582|FG000|12-Week Maintenance Phase|Other|1|||
170505751|NCT00232596|616192583|FG001|12-Week Maintenance Phase|Other|3|||
170505752|NCT01712334|616192584|FG000|Treatment Period 1|Randomized in Error|0|||
170505753|NCT01712334|616192585|FG001|Treatment Period 1|Randomized in Error|2|||
170505754|NCT02345889|616192588|FG000|Overall Study|Inadequate Bowel Prep|17|||
170505755|NCT02345889|616192589|FG001|Overall Study|Inadequate Bowel Prep|16|||
170505756|NCT02345889|616192590|FG002|Overall Study|Inadequate Bowel Prep|18|||
170505757|NCT02345889|616192591|FG003|Overall Study|Inadequate Bowel Prep|14|||
170505758|NCT02345889|616192588|FG000|Overall Study|Polyposis identified during procedure|1|||
170505759|NCT02345889|616192589|FG001|Overall Study|Polyposis identified during procedure|1|||
170505760|NCT02345889|616192590|FG002|Overall Study|Polyposis identified during procedure|0|||
170505761|NCT02345889|616192591|FG003|Overall Study|Polyposis identified during procedure|1|||
170505762|NCT02345889|616192588|FG000|Overall Study|Recognized ineligible post-randomization|1|||
170552295|NCT04818229|616367950|FG000|Overall Study|Lost to Follow-up|0|||
170552296|NCT04818229|616367951|FG001|Overall Study|Lost to Follow-up|0|||
170552297|NCT04818229|616367952|FG002|Overall Study|Lost to Follow-up|1|||
170552298|NCT02971137|616367954|FG000|Overall Study|Lost to Follow-up|44|||
170552299|NCT02971137|616367955|FG001|Overall Study|Lost to Follow-up|56|||
170552300|NCT02757963|616367956|FG000|Overall Study|Adverse Event|3|||
170552301|NCT02757963|616367956|FG000|Overall Study|Reached Stopping Criteria|1054|||
170552302|NCT02757963|616367956|FG000|Overall Study|Lost to Follow-up|5|||
170552303|NCT02757963|616367956|FG000|Overall Study|Physician Decision|1|||
170805361|NCT04801420|617297369|FG002|Overall Study|Other|1|||
170505763|NCT02345889|616192589|FG001|Overall Study|Recognized ineligible post-randomization|0|||
170505764|NCT02345889|616192590|FG002|Overall Study|Recognized ineligible post-randomization|2|||
170505765|NCT02345889|616192591|FG003|Overall Study|Recognized ineligible post-randomization|1|||
170505766|NCT02345889|616192588|FG000|Overall Study|Ulcerative Colitis identified|1|||
170505767|NCT02345889|616192589|FG001|Overall Study|Ulcerative Colitis identified|0|||
170505768|NCT02345889|616192590|FG002|Overall Study|Ulcerative Colitis identified|0|||
170505769|NCT02345889|616192591|FG003|Overall Study|Ulcerative Colitis identified|0|||
170505770|NCT02345889|616192588|FG000|Overall Study|Cecum not intubated|1|||
170505771|NCT02345889|616192589|FG001|Overall Study|Cecum not intubated|0|||
170505772|NCT02345889|616192590|FG002|Overall Study|Cecum not intubated|0|||
170505773|NCT02345889|616192591|FG003|Overall Study|Cecum not intubated|0|||
170505774|NCT03191864|616192593|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
170505775|NCT03191864|616192594|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
170505776|NCT03191864|616192595|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
170505777|NCT03191864|616192596|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
170505778|NCT03191864|616192597|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
170505779|NCT03191864|616192598|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
170505780|NCT03191864|616192593|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
170505781|NCT03191864|616192594|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
170505782|NCT03191864|616192595|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
170505783|NCT03191864|616192596|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
170505784|NCT03191864|616192597|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
170505785|NCT03191864|616192598|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
170505786|NCT03191864|616192593|FG000|Baseline Symptom Assessment|Adverse Event|0|||
170505787|NCT03191864|616192594|FG001|Baseline Symptom Assessment|Adverse Event|0|||
170505788|NCT03191864|616192595|FG002|Baseline Symptom Assessment|Adverse Event|0|||
170505789|NCT03191864|616192596|FG003|Baseline Symptom Assessment|Adverse Event|0|||
170552304|NCT02757963|616367956|FG000|Overall Study|Withdrawal by Subject|34|||
170552305|NCT04755231|616367957|FG000|Overall Study|Lost to Follow-up|5|||
170552306|NCT04755231|616367957|FG000|Overall Study|Withdrawal by Subject|5|||
170552307|NCT00215657|616367958|FG000|Overall Study|Adverse Event|5|||
170552308|NCT00215657|616367959|FG001|Overall Study|Adverse Event|1|||
170552309|NCT00215657|616367960|FG002|Overall Study|Adverse Event|3|||
170552310|NCT00215657|616367961|FG003|Overall Study|Adverse Event|0|||
170552311|NCT00215657|616367962|FG004|Overall Study|Adverse Event|3|||
170552312|NCT00215657|616367963|FG005|Overall Study|Adverse Event|1|||
170552313|NCT00215657|616367964|FG006|Overall Study|Adverse Event|0|||
170552314|NCT00215657|616367965|FG007|Overall Study|Adverse Event|3|||
170552315|NCT00215657|616367958|FG000|Overall Study|Withdrawal by Subject|6|||
170552316|NCT00215657|616367959|FG001|Overall Study|Withdrawal by Subject|3|||
170552317|NCT00215657|616367960|FG002|Overall Study|Withdrawal by Subject|3|||
170552318|NCT00215657|616367961|FG003|Overall Study|Withdrawal by Subject|1|||
170552319|NCT00215657|616367962|FG004|Overall Study|Withdrawal by Subject|6|||
170552320|NCT00215657|616367963|FG005|Overall Study|Withdrawal by Subject|1|||
170805362|NCT04801420|617297367|FG000|Overall Study|Lost to Follow-up|7|||
170805363|NCT04801420|617297368|FG001|Overall Study|Lost to Follow-up|9|||
170805364|NCT04801420|617297369|FG002|Overall Study|Lost to Follow-up|10|||
170805365|NCT04801420|617297367|FG000|Overall Study|Moved from study area|0|||
170805366|NCT04801420|617297368|FG001|Overall Study|Moved from study area|1|||
170805367|NCT04801420|617297369|FG002|Overall Study|Moved from study area|1|||
170805368|NCT04801420|617297367|FG000|Overall Study|Withdrawal by Subject|5|||
170805369|NCT04801420|617297368|FG001|Overall Study|Withdrawal by Subject|1|||
170805370|NCT04801420|617297369|FG002|Overall Study|Withdrawal by Subject|4|||
170805371|NCT04801420|617297367|FG000|Overall Study|Individual stopping criteria reached|0|||
170805372|NCT04801420|617297368|FG001|Overall Study|Individual stopping criteria reached|1|||
170805373|NCT04801420|617297369|FG002|Overall Study|Individual stopping criteria reached|0|||
170805374|NCT04801420|617297367|FG000|Overall Study|Ongoing in the study|195|||
170805375|NCT04801420|617297368|FG001|Overall Study|Ongoing in the study|195|||
170805376|NCT04801420|617297369|FG002|Overall Study|Ongoing in the study|192|||
170805377|NCT05251363|617297370|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
170805378|NCT05251363|617297370|FG000|Overall Study After Implant Period|Death|9|||
170805379|NCT05251363|617297370|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
170505790|NCT03191864|616192597|FG004|Baseline Symptom Assessment|Adverse Event|0|||
170552321|NCT00215657|616367964|FG006|Overall Study|Withdrawal by Subject|10|||
170552322|NCT00215657|616367965|FG007|Overall Study|Withdrawal by Subject|3|||
170552323|NCT00215657|616367958|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
170805380|NCT05251363|617297370|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
170805381|NCT05251363|617297370|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
170505791|NCT03191864|616192598|FG005|Baseline Symptom Assessment|Adverse Event|2|||
170505792|NCT03191864|616192593|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
170505793|NCT03191864|616192594|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
170505794|NCT03191864|616192595|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
170505795|NCT03191864|616192596|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
170505796|NCT03191864|616192597|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
170505797|NCT03191864|616192598|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
170505798|NCT03191864|616192593|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
170505799|NCT03191864|616192594|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
170505800|NCT03191864|616192595|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
170505801|NCT03191864|616192596|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
170505802|NCT03191864|616192597|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
170505803|NCT03191864|616192598|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
170505804|NCT03191864|616192593|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
170505805|NCT03191864|616192594|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
170505806|NCT03191864|616192595|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
170505807|NCT03191864|616192596|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
170505808|NCT03191864|616192597|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
170505809|NCT03191864|616192598|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
170505810|NCT03191864|616192593|FG000|Part 1 - Induction|Adverse Event|0|||
170505811|NCT03191864|616192594|FG001|Part 1 - Induction|Adverse Event|2|||
170505812|NCT03191864|616192595|FG002|Part 1 - Induction|Adverse Event|0|||
170505813|NCT03191864|616192596|FG003|Part 1 - Induction|Adverse Event|1|||
170505814|NCT03191864|616192597|FG004|Part 1 - Induction|Adverse Event|0|||
170505815|NCT03191864|616192598|FG005|Part 1 - Induction|Adverse Event|2|||
170505816|NCT03191864|616192593|FG000|Part 1 - Induction|Randomized but never dosed|0|||
170505817|NCT03191864|616192594|FG001|Part 1 - Induction|Randomized but never dosed|0|||
170505818|NCT03191864|616192595|FG002|Part 1 - Induction|Randomized but never dosed|1|||
170505819|NCT03191864|616192596|FG003|Part 1 - Induction|Randomized but never dosed|0|||
170505820|NCT03191864|616192597|FG004|Part 1 - Induction|Randomized but never dosed|0|||
170505821|NCT03191864|616192598|FG005|Part 1 - Induction|Randomized but never dosed|0|||
170505822|NCT03191864|616192593|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
170505823|NCT03191864|616192594|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
170505824|NCT03191864|616192595|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
170505825|NCT03191864|616192596|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
170505826|NCT03191864|616192597|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
170505827|NCT03191864|616192598|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
170505828|NCT03191864|616192593|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
170505829|NCT03191864|616192594|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
170505830|NCT03191864|616192595|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
170505831|NCT03191864|616192596|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
170505832|NCT03191864|616192597|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
170505833|NCT03191864|616192598|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
170505834|NCT03191864|616192593|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
170505835|NCT03191864|616192594|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
170505836|NCT03191864|616192595|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
170505837|NCT03191864|616192596|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
170505838|NCT03191864|616192597|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
170505839|NCT03191864|616192598|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
170505840|NCT03191864|616192593|FG000|Part 2 - Maintenance|Physician Decision|1|||
170505841|NCT03191864|616192594|FG001|Part 2 - Maintenance|Physician Decision|0|||
170505842|NCT03191864|616192595|FG002|Part 2 - Maintenance|Physician Decision|0|||
170505843|NCT03191864|616192596|FG003|Part 2 - Maintenance|Physician Decision|0|||
170505844|NCT03191864|616192597|FG004|Part 2 - Maintenance|Physician Decision|0|||
170505845|NCT03191864|616192598|FG005|Part 2 - Maintenance|Physician Decision|0|||
170505846|NCT03191864|616192593|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
170505847|NCT03191864|616192594|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
170505848|NCT03191864|616192595|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
170505849|NCT03191864|616192596|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
170505850|NCT03191864|616192597|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
170505851|NCT03191864|616192598|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
170505852|NCT03191864|616192593|FG000|Part 2 - Maintenance|Adverse Event|0|||
170505853|NCT03191864|616192594|FG001|Part 2 - Maintenance|Adverse Event|0|||
170505854|NCT03191864|616192595|FG002|Part 2 - Maintenance|Adverse Event|0|||
170505855|NCT03191864|616192596|FG003|Part 2 - Maintenance|Adverse Event|0|||
170505856|NCT03191864|616192597|FG004|Part 2 - Maintenance|Adverse Event|1|||
170505857|NCT03191864|616192598|FG005|Part 2 - Maintenance|Adverse Event|0|||
170552324|NCT00215657|616367959|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
170552325|NCT00215657|616367960|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
170642507|NCT01403948|616705276|FG009|Overall Study|Lost to Follow-up|1|||
170505858|NCT03191864|616192593|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
170505859|NCT03191864|616192594|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
170505860|NCT03191864|616192595|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
170505861|NCT03191864|616192596|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
170505862|NCT03191864|616192597|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
170505863|NCT03191864|616192598|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
170505864|NCT03191864|616192593|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
170505865|NCT03191864|616192594|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
170505866|NCT03191864|616192595|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
170505867|NCT03191864|616192596|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
170505868|NCT03191864|616192597|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
170505869|NCT03191864|616192598|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
170505870|NCT00415597|616192601|FG000|Enrollment|Withdrawal by Subject|1|||
170505871|NCT00415597|616192601|FG000|Enrollment|Protocol Violation|1|||
170505872|NCT00415597|616192601|FG000|Treatment|Adverse Event|110|||
170505873|NCT00415597|616192601|FG000|Treatment|Lack of Efficacy|39|||
170505874|NCT00415597|616192601|FG000|Treatment|Protocol Violation|67|||
170505875|NCT00415597|616192601|FG000|Treatment|Physician Decision|3|||
170505876|NCT00415597|616192601|FG000|Treatment|Withdrawal by Subject|51|||
170505877|NCT00415597|616192601|FG000|Treatment|Lost to Follow-up|28|||
170505878|NCT00415597|616192601|FG000|Treatment|Drug Screen|2|||
170505879|NCT00415597|616192601|FG000|Treatment|Administrative|3|||
170505880|NCT00415597|616192601|FG000|Treatment|Sponsor Decision|1|||
170505881|NCT00415597|616192601|FG000|Treatment|Multiple Reasons|1|||
170505882|NCT02073565|616192602|FG000|Cohort A|Withdrawal by Subject|1|||
170505883|NCT02073565|616192603|FG001|Cohort A|Withdrawal by Subject|0|||
170505884|NCT02073565|616192602|FG000|Cohort B|Withdrawal by Subject|1|||
170505885|NCT02073565|616192603|FG001|Cohort B|Withdrawal by Subject|2|||
170505886|NCT02073565|616192602|FG000|Cohort C|Withdrawal by Subject|0|||
170505887|NCT02073565|616192603|FG001|Cohort C|Withdrawal by Subject|2|||
170505888|NCT02073565|616192602|FG000|Cohort C|Lost to Follow-up|0|||
170505889|NCT02073565|616192603|FG001|Cohort C|Lost to Follow-up|2|||
170505890|NCT04102865|616192604|FG000|Overall Study|Adverse Event|4|||
170505891|NCT04102865|616192605|FG001|Overall Study|Adverse Event|0|||
170505892|NCT04102865|616192604|FG000|Overall Study|Lost to Follow-up|1|||
170505893|NCT04102865|616192605|FG001|Overall Study|Lost to Follow-up|0|||
170505894|NCT04102865|616192604|FG000|Overall Study|Withdrawal by Subject|2|||
170552326|NCT00215657|616367961|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
170552327|NCT00215657|616367962|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
170552328|NCT00215657|616367963|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
170552329|NCT00215657|616367964|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
170552330|NCT00215657|616367965|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
170552331|NCT00215657|616367958|FG000|Overall Study|Insufficient testosterone response|5|||
170552332|NCT00215657|616367959|FG001|Overall Study|Insufficient testosterone response|4|||
170552333|NCT00215657|616367960|FG002|Overall Study|Insufficient testosterone response|1|||
170552334|NCT00215657|616367961|FG003|Overall Study|Insufficient testosterone response|12|||
170552335|NCT00215657|616367962|FG004|Overall Study|Insufficient testosterone response|8|||
170552336|NCT00215657|616367963|FG005|Overall Study|Insufficient testosterone response|12|||
170552337|NCT00215657|616367964|FG006|Overall Study|Insufficient testosterone response|4|||
170552338|NCT00215657|616367965|FG007|Overall Study|Insufficient testosterone response|7|||
170552339|NCT00215657|616367958|FG000|Overall Study|Other|3|||
170552340|NCT00215657|616367959|FG001|Overall Study|Other|1|||
170552341|NCT00215657|616367960|FG002|Overall Study|Other|2|||
170552342|NCT00215657|616367961|FG003|Overall Study|Other|3|||
170552343|NCT00215657|616367962|FG004|Overall Study|Other|5|||
170552344|NCT00215657|616367963|FG005|Overall Study|Other|4|||
170552345|NCT00215657|616367964|FG006|Overall Study|Other|6|||
170552346|NCT00215657|616367965|FG007|Overall Study|Other|1|||
170552347|NCT00968968|616367967|FG000|Overall Study|Study closed/terminated|10|||
170552348|NCT00968968|616367968|FG001|Overall Study|Study closed/terminated|10|||
170552349|NCT00968968|616367967|FG000|Overall Study|Protocol defined stopping criteria|3|||
170552350|NCT00968968|616367968|FG001|Overall Study|Protocol defined stopping criteria|1|||
170805382|NCT05251363|617297370|FG000|Overall Study After Implant Period|Physician Decision|1|||
170552351|NCT00968968|616367967|FG000|Overall Study|Withdrawal by Subject|2|||
170552352|NCT00968968|616367968|FG001|Overall Study|Withdrawal by Subject|0|||
170552353|NCT00968968|616367967|FG000|Overall Study|Physician Decision|1|||
170805383|NCT05251363|617297370|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
170505895|NCT04102865|616192605|FG001|Overall Study|Withdrawal by Subject|0|||
170505896|NCT01764997|616192610|FG000|Run-in Period|Adverse Event|15|||
170505897|NCT01764997|616192611|FG001|Run-in Period|Adverse Event|0|||
170505898|NCT01764997|616192612|FG002|Run-in Period|Adverse Event|0|||
170505899|NCT01764997|616192613|FG003|Run-in Period|Adverse Event|0|||
170552354|NCT00968968|616367968|FG001|Overall Study|Physician Decision|2|||
170552355|NCT00968968|616367967|FG000|Overall Study|Lost to Follow-up|0|||
170805384|NCT03835754|617297371|FG000|Overall Study|Death|4|||
170505900|NCT01764997|616192614|FG004|Run-in Period|Adverse Event|0|||
170505901|NCT01764997|616192610|FG000|Run-in Period|Lack of Efficacy|5|||
170505902|NCT01764997|616192611|FG001|Run-in Period|Lack of Efficacy|0|||
170505903|NCT01764997|616192612|FG002|Run-in Period|Lack of Efficacy|0|||
170505904|NCT01764997|616192613|FG003|Run-in Period|Lack of Efficacy|0|||
170505905|NCT01764997|616192614|FG004|Run-in Period|Lack of Efficacy|0|||
170505906|NCT01764997|616192610|FG000|Run-in Period|Poor compliance to protocol|1|||
170505907|NCT01764997|616192611|FG001|Run-in Period|Poor compliance to protocol|0|||
170505908|NCT01764997|616192612|FG002|Run-in Period|Poor compliance to protocol|0|||
170505909|NCT01764997|616192613|FG003|Run-in Period|Poor compliance to protocol|0|||
170505910|NCT01764997|616192614|FG004|Run-in Period|Poor compliance to protocol|0|||
170505911|NCT01764997|616192610|FG000|Run-in Period|Other than specified above|17|||
170505912|NCT01764997|616192611|FG001|Run-in Period|Other than specified above|0|||
170505913|NCT01764997|616192612|FG002|Run-in Period|Other than specified above|0|||
170505914|NCT01764997|616192613|FG003|Run-in Period|Other than specified above|0|||
170505915|NCT01764997|616192614|FG004|Run-in Period|Other than specified above|0|||
170505916|NCT01764997|616192610|FG000|Study Drug Treatment Period|Adverse Event|0|||
170505917|NCT01764997|616192611|FG001|Study Drug Treatment Period|Adverse Event|1|||
170505918|NCT01764997|616192612|FG002|Study Drug Treatment Period|Adverse Event|0|||
170505919|NCT01764997|616192613|FG003|Study Drug Treatment Period|Adverse Event|0|||
170505920|NCT01764997|616192614|FG004|Study Drug Treatment Period|Adverse Event|24|||
170505921|NCT01764997|616192610|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
170505922|NCT01764997|616192611|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
170505923|NCT01764997|616192612|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
170505924|NCT01764997|616192613|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
170505925|NCT01764997|616192614|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
170505926|NCT01764997|616192610|FG000|Study Drug Treatment Period|Other than specified above|0|||
170505927|NCT01764997|616192611|FG001|Study Drug Treatment Period|Other than specified above|0|||
170505928|NCT01764997|616192612|FG002|Study Drug Treatment Period|Other than specified above|0|||
170505929|NCT01764997|616192613|FG003|Study Drug Treatment Period|Other than specified above|0|||
170505930|NCT01764997|616192614|FG004|Study Drug Treatment Period|Other than specified above|10|||
170505931|NCT02093390|616192618|FG000|Overall Study|Withdrawal by Subject|0|||
170505932|NCT02093390|616192619|FG001|Overall Study|Withdrawal by Subject|1|||
170505933|NCT00073983|616192620|FG000|Overall Study|not evaluable|1|||
170505934|NCT03976323|616192623|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
170505935|NCT03976323|616192624|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
170505936|NCT03976323|616192625|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
170505937|NCT03976323|616192623|FG000|Induction Phase|Death|80|||
170505938|NCT03976323|616192624|FG001|Induction Phase|Death|0|||
170505939|NCT03976323|616192625|FG002|Induction Phase|Death|0|||
170505940|NCT03976323|616192623|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
170505941|NCT03976323|616192624|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
170505942|NCT03976323|616192625|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
170505943|NCT03976323|616192623|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170505944|NCT03976323|616192624|FG001|Maintenance Phase|Withdrawal by Subject|9|||
170505945|NCT03976323|616192625|FG002|Maintenance Phase|Withdrawal by Subject|3|||
170505946|NCT03976323|616192623|FG000|Maintenance Phase|Physician Decision|0|||
170505947|NCT03976323|616192624|FG001|Maintenance Phase|Physician Decision|0|||
170505948|NCT03976323|616192625|FG002|Maintenance Phase|Physician Decision|1|||
170505949|NCT03976323|616192623|FG000|Maintenance Phase|Death|0|||
170505950|NCT03976323|616192624|FG001|Maintenance Phase|Death|228|||
170505951|NCT03976323|616192625|FG002|Maintenance Phase|Death|234|||
170505952|NCT03800836|616192626|FG000|Overall Study|Other|2|||
170505953|NCT03800836|616192627|FG001|Overall Study|Other|1|||
170505954|NCT03800836|616192628|FG002|Overall Study|Other|0|||
170505955|NCT03800836|616192629|FG003|Overall Study|Other|2|||
170505956|NCT03800836|616192630|FG004|Overall Study|Other|0|||
170505957|NCT03800836|616192631|FG005|Overall Study|Other|1|||
170505958|NCT03800836|616192626|FG000|Overall Study|Lost to Follow-up|2|||
170505959|NCT03800836|616192627|FG001|Overall Study|Lost to Follow-up|0|||
170505960|NCT03800836|616192628|FG002|Overall Study|Lost to Follow-up|1|||
170552356|NCT00968968|616367968|FG001|Overall Study|Lost to Follow-up|1|||
170552357|NCT04401293|616367969|FG000|Overall Study|Withdrawal by Subject|1|||
170552358|NCT04401293|616367970|FG001|Overall Study|Withdrawal by Subject|3|||
170805385|NCT02830204|617297372|FG000|Overall Study|Death|9|||
170805386|NCT02830204|617297372|FG000|Overall Study|Withdrawal by Subject|1|||
170805387|NCT02401815|617297373|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170805388|NCT02401815|617297374|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170505961|NCT03800836|616192629|FG003|Overall Study|Lost to Follow-up|1|||
170505962|NCT03800836|616192630|FG004|Overall Study|Lost to Follow-up|3|||
170505963|NCT03800836|616192631|FG005|Overall Study|Lost to Follow-up|0|||
170505964|NCT03800836|616192626|FG000|Overall Study|Withdrawal by Subject|1|||
170505965|NCT03800836|616192627|FG001|Overall Study|Withdrawal by Subject|0|||
170505966|NCT03800836|616192628|FG002|Overall Study|Withdrawal by Subject|0|||
170552359|NCT03679884|616367971|FG000|Overall Study|Other|12|||
170805389|NCT02401815|617297375|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170505967|NCT03800836|616192629|FG003|Overall Study|Withdrawal by Subject|0|||
170505968|NCT03800836|616192630|FG004|Overall Study|Withdrawal by Subject|0|||
170505969|NCT03800836|616192631|FG005|Overall Study|Withdrawal by Subject|0|||
170505970|NCT03800836|616192626|FG000|Overall Study|Physician Decision|31|||
170505971|NCT03800836|616192627|FG001|Overall Study|Physician Decision|3|||
170505972|NCT03800836|616192628|FG002|Overall Study|Physician Decision|6|||
170505973|NCT03800836|616192629|FG003|Overall Study|Physician Decision|4|||
170505974|NCT03800836|616192630|FG004|Overall Study|Physician Decision|4|||
170505975|NCT03800836|616192631|FG005|Overall Study|Physician Decision|5|||
170505976|NCT03800836|616192626|FG000|Overall Study|Death|34|||
170505977|NCT03800836|616192627|FG001|Overall Study|Death|16|||
170505978|NCT03800836|616192628|FG002|Overall Study|Death|5|||
170505979|NCT03800836|616192629|FG003|Overall Study|Death|5|||
170505980|NCT03800836|616192630|FG004|Overall Study|Death|10|||
170505981|NCT03800836|616192631|FG005|Overall Study|Death|0|||
170505982|NCT03800836|616192626|FG000|Overall Study|Symptomatic Deterioration|1|||
170505983|NCT03800836|616192627|FG001|Overall Study|Symptomatic Deterioration|0|||
170505984|NCT03800836|616192628|FG002|Overall Study|Symptomatic Deterioration|1|||
170505985|NCT03800836|616192629|FG003|Overall Study|Symptomatic Deterioration|0|||
170505986|NCT03800836|616192630|FG004|Overall Study|Symptomatic Deterioration|0|||
170505987|NCT03800836|616192631|FG005|Overall Study|Symptomatic Deterioration|0|||
170505988|NCT05243563|616195285|FG000|Overall Study|Withdrawal by Subject|1|||
170505989|NCT05243563|616195286|FG001|Overall Study|Withdrawal by Subject|0|||
170505990|NCT05243563|616195285|FG000|Overall Study|Physician Decision|1|||
170505991|NCT05243563|616195286|FG001|Overall Study|Physician Decision|0|||
170505992|NCT00441363|616195287|FG000|Overall Study|Adverse Event|4|||
170505993|NCT00441363|616195288|FG001|Overall Study|Adverse Event|2|||
170505994|NCT00441363|616195287|FG000|Overall Study|Withdrawal by Subject|3|||
170505995|NCT00441363|616195288|FG001|Overall Study|Withdrawal by Subject|4|||
170505996|NCT00441363|616195287|FG000|Overall Study|Physician Decision|6|||
170505997|NCT00441363|616195288|FG001|Overall Study|Physician Decision|7|||
170505998|NCT00441363|616195287|FG000|Overall Study|Lost to Follow-up|2|||
170505999|NCT00441363|616195288|FG001|Overall Study|Lost to Follow-up|2|||
170506000|NCT00441363|616195287|FG000|Overall Study|Other|2|||
170506001|NCT00441363|616195288|FG001|Overall Study|Other|0|||
170506002|NCT02437188|616195291|FG000|Overall Study|Randomized but did not receive surgery|4|||
170506003|NCT02437188|616195292|FG001|Overall Study|Randomized but did not receive surgery|8|||
170506004|NCT02437188|616195291|FG000|Overall Study|Adverse Event|0|||
170506005|NCT02437188|616195292|FG001|Overall Study|Adverse Event|1|||
170506006|NCT01663857|616195293|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
170506007|NCT01663857|616195294|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
170506008|NCT01663857|616195295|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
170506009|NCT01663857|616195296|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
170506010|NCT01663857|616195293|FG000|Overall Study|Lost to Follow-up|0|||
170506011|NCT01663857|616195294|FG001|Overall Study|Lost to Follow-up|0|||
170506012|NCT01663857|616195295|FG002|Overall Study|Lost to Follow-up|3|||
170506013|NCT01663857|616195296|FG003|Overall Study|Lost to Follow-up|1|||
170506014|NCT01172808|616195299|FG000|Overall Study|Adverse Event|8|||
170506015|NCT01172808|616195300|FG001|Overall Study|Adverse Event|4|||
170506016|NCT01172808|616195301|FG002|Overall Study|Adverse Event|8|||
170506017|NCT01172808|616195302|FG003|Overall Study|Adverse Event|3|||
170506018|NCT01172808|616195299|FG000|Overall Study|Lack of Efficacy|1|||
170506019|NCT01172808|616195300|FG001|Overall Study|Lack of Efficacy|0|||
170506020|NCT01172808|616195301|FG002|Overall Study|Lack of Efficacy|0|||
170506021|NCT01172808|616195302|FG003|Overall Study|Lack of Efficacy|0|||
170506022|NCT01172808|616195299|FG000|Overall Study|Protocol Violation|2|||
170506023|NCT01172808|616195300|FG001|Overall Study|Protocol Violation|2|||
170506024|NCT01172808|616195301|FG002|Overall Study|Protocol Violation|2|||
170506025|NCT01172808|616195302|FG003|Overall Study|Protocol Violation|0|||
170506026|NCT01172808|616195299|FG000|Overall Study|Lost to Follow-up|0|||
170506027|NCT01172808|616195300|FG001|Overall Study|Lost to Follow-up|1|||
170506028|NCT01172808|616195301|FG002|Overall Study|Lost to Follow-up|1|||
170904213|NCT04996797|617650919|FG002|Overall Study|Prohibited Medication|0|||
170904214|NCT04996797|617650920|FG003|Overall Study|Prohibited Medication|0|||
170506029|NCT01172808|616195302|FG003|Overall Study|Lost to Follow-up|3|||
170506030|NCT01172808|616195299|FG000|Overall Study|Withdrawal by Subject|4|||
170506031|NCT01172808|616195300|FG001|Overall Study|Withdrawal by Subject|1|||
170506032|NCT01172808|616195301|FG002|Overall Study|Withdrawal by Subject|3|||
170506033|NCT01172808|616195302|FG003|Overall Study|Withdrawal by Subject|2|||
170506034|NCT01172808|616195299|FG000|Overall Study|Other|6|||
170506035|NCT01172808|616195300|FG001|Overall Study|Other|5|||
170506036|NCT01172808|616195301|FG002|Overall Study|Other|9|||
170506037|NCT01172808|616195302|FG003|Overall Study|Other|7|||
170506038|NCT02578940|616195307|FG000|Overall Study|Screening failure|5|||
170506039|NCT02578940|616195307|FG000|Overall Study|Lost to Follow-up|1|||
170506040|NCT01911793|616195308|FG000|Overall Study|Physician Decision|1|||
170506041|NCT01911793|616195309|FG001|Overall Study|Physician Decision|5|||
170506042|NCT03334422|616195310|FG000|Overall Study|Adverse Event|1|||
170506043|NCT03334422|616195311|FG001|Overall Study|Adverse Event|3|||
170805390|NCT02401815|617297376|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
170805391|NCT02401815|617297377|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170805392|NCT02401815|617297378|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170805393|NCT02401815|617297379|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170805394|NCT02401815|617297380|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170805395|NCT02401815|617297381|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170805396|NCT02401815|617297382|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
170805397|NCT02401815|617297373|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
170805398|NCT02401815|617297374|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
170805399|NCT02401815|617297375|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
170506044|NCT03334422|616195312|FG002|Overall Study|Adverse Event|2|||
170506045|NCT03334422|616195313|FG003|Overall Study|Adverse Event|2|||
170506046|NCT03334422|616195310|FG000|Overall Study|Lack of Efficacy|10|||
170506047|NCT03334422|616195311|FG001|Overall Study|Lack of Efficacy|2|||
170506048|NCT03334422|616195312|FG002|Overall Study|Lack of Efficacy|7|||
170506049|NCT03334422|616195313|FG003|Overall Study|Lack of Efficacy|3|||
170506050|NCT03334422|616195310|FG000|Overall Study|Withdrawal by Subject|8|||
170506051|NCT03334422|616195311|FG001|Overall Study|Withdrawal by Subject|3|||
170506052|NCT03334422|616195312|FG002|Overall Study|Withdrawal by Subject|1|||
170506053|NCT03334422|616195313|FG003|Overall Study|Withdrawal by Subject|0|||
170506054|NCT03334422|616195310|FG000|Overall Study|Lost to Follow-up|0|||
170506055|NCT03334422|616195311|FG001|Overall Study|Lost to Follow-up|0|||
170506056|NCT03334422|616195312|FG002|Overall Study|Lost to Follow-up|0|||
170506057|NCT03334422|616195313|FG003|Overall Study|Lost to Follow-up|1|||
170552360|NCT03679884|616367972|FG001|Overall Study|Other|12|||
170552361|NCT03679884|616367973|FG002|Overall Study|Other|12|||
170552362|NCT03679884|616367974|FG003|Overall Study|Other|7|||
170552363|NCT03679884|616367975|FG004|Overall Study|Other|8|||
170552364|NCT03679884|616367971|FG000|Overall Study|Lack of Efficacy|15|||
170552365|NCT03679884|616367972|FG001|Overall Study|Lack of Efficacy|29|||
170552366|NCT03679884|616367973|FG002|Overall Study|Lack of Efficacy|13|||
170552367|NCT03679884|616367974|FG003|Overall Study|Lack of Efficacy|29|||
170552368|NCT03679884|616367975|FG004|Overall Study|Lack of Efficacy|10|||
170552369|NCT03679884|616367971|FG000|Overall Study|Death|1|||
170552370|NCT03679884|616367972|FG001|Overall Study|Death|0|||
170552371|NCT03679884|616367973|FG002|Overall Study|Death|0|||
170552372|NCT03679884|616367974|FG003|Overall Study|Death|0|||
170552373|NCT03679884|616367975|FG004|Overall Study|Death|0|||
170552374|NCT03679884|616367971|FG000|Overall Study|Adverse Event|2|||
170552375|NCT03679884|616367972|FG001|Overall Study|Adverse Event|10|||
170552376|NCT03679884|616367973|FG002|Overall Study|Adverse Event|9|||
170552377|NCT03679884|616367974|FG003|Overall Study|Adverse Event|6|||
170552378|NCT03679884|616367975|FG004|Overall Study|Adverse Event|6|||
170552379|NCT03679884|616367971|FG000|Overall Study|Withdrawal by Subject|12|||
170552380|NCT03679884|616367972|FG001|Overall Study|Withdrawal by Subject|23|||
170552381|NCT03679884|616367973|FG002|Overall Study|Withdrawal by Subject|8|||
170552382|NCT03679884|616367974|FG003|Overall Study|Withdrawal by Subject|8|||
170552383|NCT03679884|616367975|FG004|Overall Study|Withdrawal by Subject|9|||
170552384|NCT03679884|616367971|FG000|Overall Study|Lost to Follow-up|1|||
170552385|NCT03679884|616367972|FG001|Overall Study|Lost to Follow-up|4|||
170552386|NCT03679884|616367973|FG002|Overall Study|Lost to Follow-up|2|||
170552387|NCT03679884|616367974|FG003|Overall Study|Lost to Follow-up|0|||
170552388|NCT03679884|616367975|FG004|Overall Study|Lost to Follow-up|3|||
170552389|NCT01783938|616367984|FG000|Overall Study|Disease Progression|18|||
170552390|NCT01783938|616367985|FG001|Overall Study|Disease Progression|41|||
170552391|NCT01783938|616367984|FG000|Overall Study|Study Drug Toxicity|27|||
170552392|NCT01783938|616367985|FG001|Overall Study|Study Drug Toxicity|14|||
170552393|NCT01783938|616367984|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
170552394|NCT01783938|616367985|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
170552395|NCT01783938|616367984|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
170552396|NCT01783938|616367985|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
170552397|NCT01783938|616367984|FG000|Overall Study|Participant Withdrew Consent|2|||
170805400|NCT02401815|617297376|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
170805401|NCT02401815|617297377|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
170506058|NCT03334422|616195310|FG000|Overall Study|Inability to obtain laboratory samples|0|||
170506059|NCT03334422|616195311|FG001|Overall Study|Inability to obtain laboratory samples|1|||
170506060|NCT03334422|616195312|FG002|Overall Study|Inability to obtain laboratory samples|0|||
170642508|NCT01403948|616705267|FG000|Overall Study|Refused cont. medication|0|||
170805402|NCT02401815|617297378|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
170552398|NCT01783938|616367985|FG001|Overall Study|Participant Withdrew Consent|0|||
170552399|NCT01783938|616367984|FG000|Overall Study|Maximum Clinical Benefit|1|||
170552400|NCT01783938|616367985|FG001|Overall Study|Maximum Clinical Benefit|0|||
170552401|NCT01783938|616367984|FG000|Overall Study|Other Reasons|3|||
170552402|NCT01783938|616367985|FG001|Overall Study|Other Reasons|1|||
170552403|NCT00498485|616367986|FG000|Overall Study|Adverse Event|1|||
170552404|NCT00498485|616367987|FG001|Overall Study|Adverse Event|5|||
170506061|NCT03334422|616195313|FG003|Overall Study|Inability to obtain laboratory samples|0|||
170506062|NCT03334422|616195310|FG000|Overall Study|Pregnancy|0|||
170506063|NCT03334422|616195311|FG001|Overall Study|Pregnancy|1|||
170506064|NCT03334422|616195312|FG002|Overall Study|Pregnancy|0|||
170506065|NCT03334422|616195313|FG003|Overall Study|Pregnancy|0|||
170506066|NCT00994214|616195319|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
170506067|NCT00994214|616195320|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
170506068|NCT00994214|616195321|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
170506069|NCT00994214|616195322|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
170506070|NCT00994214|616195319|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
170506071|NCT00994214|616195320|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
170506072|NCT00994214|616195321|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
170506073|NCT00994214|616195322|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
170506074|NCT00994214|616195319|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
170506075|NCT00994214|616195320|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
170506076|NCT00994214|616195321|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
170506077|NCT00994214|616195322|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
170506078|NCT00994214|616195319|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
170506079|NCT00994214|616195320|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
170506080|NCT00994214|616195321|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
170506081|NCT00994214|616195322|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
170506082|NCT00994214|616195319|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
170506083|NCT00994214|616195320|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
170506084|NCT00994214|616195321|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
170506085|NCT00994214|616195322|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
170506086|NCT00994214|616195319|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
170506087|NCT00994214|616195320|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
170506088|NCT00994214|616195321|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
170506089|NCT00994214|616195322|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
170506090|NCT03246061|616195323|FG000|Overall Study|Still in follow-up|15|||
170506091|NCT03246061|616195324|FG001|Overall Study|Still in follow-up|21|||
170506092|NCT04710368|616195325|FG000|Overall Study|Withdrawal by Subject|9|||
170506093|NCT04710368|616195325|FG000|Overall Study|Lost to Follow-up|4|||
170506094|NCT04710368|616195325|FG000|Overall Study|Death|2|||
170506095|NCT04710368|616195325|FG000|Overall Study|Patient preference|11|||
170506096|NCT04710368|616195325|FG000|Overall Study|Treatment discontinuation|1|||
170506097|NCT01777139|616195328|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
170506098|NCT01777139|616195329|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
170506099|NCT01777139|616195328|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
170506100|NCT01777139|616195329|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
170506101|NCT01777139|616195328|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
170506102|NCT01777139|616195329|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
170506103|NCT01777139|616195328|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
170506104|NCT01777139|616195329|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
170506105|NCT01777139|616195328|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
170506106|NCT01777139|616195329|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
170506107|NCT01777139|616195328|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
170506108|NCT01777139|616195329|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
170506109|NCT01777139|616195328|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
170506110|NCT01777139|616195329|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
170506111|NCT01777139|616195328|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
170506112|NCT01777139|616195329|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
170506113|NCT03959488|616195330|FG000|Season 1|Other|6|||
170506114|NCT03959488|616195331|FG001|Season 1|Other|7|||
170506115|NCT03959488|616195332|FG002|Season 1|Other|0|||
170506116|NCT03959488|616195333|FG003|Season 1|Other|0|||
170506117|NCT03959488|616195334|FG004|Season 1|Other|0|||
170506118|NCT03959488|616195330|FG000|Season 1|Withdrawal by parent/guardian|43|||
170506119|NCT03959488|616195331|FG001|Season 1|Withdrawal by parent/guardian|28|||
170506120|NCT03959488|616195332|FG002|Season 1|Withdrawal by parent/guardian|0|||
170506121|NCT03959488|616195333|FG003|Season 1|Withdrawal by parent/guardian|0|||
170506122|NCT03959488|616195334|FG004|Season 1|Withdrawal by parent/guardian|0|||
170506123|NCT03959488|616195330|FG000|Season 1|Due to COVID-19 pandemic|2|||
170506124|NCT03959488|616195331|FG001|Season 1|Due to COVID-19 pandemic|3|||
170506125|NCT03959488|616195332|FG002|Season 1|Due to COVID-19 pandemic|0|||
170506126|NCT03959488|616195333|FG003|Season 1|Due to COVID-19 pandemic|0|||
170506127|NCT03959488|616195334|FG004|Season 1|Due to COVID-19 pandemic|0|||
170506128|NCT03959488|616195330|FG000|Season 1|Lost to Follow-up|17|||
170506129|NCT03959488|616195331|FG001|Season 1|Lost to Follow-up|7|||
170506130|NCT03959488|616195332|FG002|Season 1|Lost to Follow-up|0|||
170506131|NCT03959488|616195333|FG003|Season 1|Lost to Follow-up|0|||
170506132|NCT03959488|616195334|FG004|Season 1|Lost to Follow-up|0|||
170506133|NCT03959488|616195330|FG000|Season 1|Death|5|||
170506134|NCT03959488|616195331|FG001|Season 1|Death|1|||
170506135|NCT03959488|616195332|FG002|Season 1|Death|0|||
170506136|NCT03959488|616195333|FG003|Season 1|Death|0|||
170506137|NCT03959488|616195334|FG004|Season 1|Death|0|||
170506138|NCT03959488|616195330|FG000|Season 2|Other|0|||
170506139|NCT03959488|616195331|FG001|Season 2|Other|0|||
170506140|NCT03959488|616195332|FG002|Season 2|Other|2|||
170506141|NCT03959488|616195333|FG003|Season 2|Other|0|||
170506142|NCT03959488|616195334|FG004|Season 2|Other|0|||
170506143|NCT03959488|616195330|FG000|Season 2|Withdrawal by parent/guardian|0|||
170506144|NCT03959488|616195331|FG001|Season 2|Withdrawal by parent/guardian|0|||
170506145|NCT03959488|616195332|FG002|Season 2|Withdrawal by parent/guardian|3|||
170506146|NCT03959488|616195333|FG003|Season 2|Withdrawal by parent/guardian|1|||
170506147|NCT03959488|616195334|FG004|Season 2|Withdrawal by parent/guardian|1|||
170506148|NCT03959488|616195330|FG000|Season 2|Lost to Follow-up|0|||
170506149|NCT03959488|616195331|FG001|Season 2|Lost to Follow-up|0|||
170506150|NCT03959488|616195332|FG002|Season 2|Lost to Follow-up|1|||
170506151|NCT03959488|616195333|FG003|Season 2|Lost to Follow-up|0|||
170506152|NCT03959488|616195334|FG004|Season 2|Lost to Follow-up|1|||
170506153|NCT01887288|616195335|FG000|Overall Study|The study was terminated and the PI has|16|||
170506154|NCT03539484|616195336|FG000|Overall Study|Death|1|||
170506155|NCT03539484|616195337|FG001|Overall Study|Death|0|||
170506156|NCT03539484|616195338|FG002|Overall Study|Death|0|||
170506157|NCT03539484|616195339|FG003|Overall Study|Death|2|||
170506158|NCT03539484|616195340|FG004|Overall Study|Death|8|||
170506159|NCT03539484|616195341|FG005|Overall Study|Death|3|||
170506160|NCT03539484|616195342|FG006|Overall Study|Death|0|||
170506161|NCT03539484|616195336|FG000|Overall Study|Lost to Follow-up|0|||
170506162|NCT03539484|616195337|FG001|Overall Study|Lost to Follow-up|1|||
170506163|NCT03539484|616195338|FG002|Overall Study|Lost to Follow-up|0|||
170506164|NCT03539484|616195339|FG003|Overall Study|Lost to Follow-up|0|||
170506165|NCT03539484|616195340|FG004|Overall Study|Lost to Follow-up|1|||
170506166|NCT03539484|616195341|FG005|Overall Study|Lost to Follow-up|0|||
170506167|NCT03539484|616195342|FG006|Overall Study|Lost to Follow-up|0|||
170506168|NCT03539484|616195336|FG000|Overall Study|Withdrawal by Subject|0|||
170506169|NCT03539484|616195337|FG001|Overall Study|Withdrawal by Subject|0|||
170506170|NCT03539484|616195338|FG002|Overall Study|Withdrawal by Subject|0|||
170506171|NCT03539484|616195339|FG003|Overall Study|Withdrawal by Subject|0|||
170506172|NCT03539484|616195340|FG004|Overall Study|Withdrawal by Subject|2|||
170506173|NCT03539484|616195341|FG005|Overall Study|Withdrawal by Subject|0|||
170506174|NCT03539484|616195342|FG006|Overall Study|Withdrawal by Subject|1|||
170506175|NCT03539484|616195336|FG000|Overall Study|Study Terminated by Sponsor|0|||
170552405|NCT00930176|616367989|FG000|Overall Study|Death|1|||
170552406|NCT01712074|616367994|FG000|Placebo Run-in Period|Adverse Event|2|||
170552407|NCT01712074|616367995|FG001|Placebo Run-in Period|Adverse Event|0|||
170552408|NCT01712074|616367996|FG002|Placebo Run-in Period|Adverse Event|0|||
170552409|NCT01712074|616367994|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
170805403|NCT02401815|617297379|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
170506176|NCT03539484|616195337|FG001|Overall Study|Study Terminated by Sponsor|0|||
170506177|NCT03539484|616195338|FG002|Overall Study|Study Terminated by Sponsor|1|||
170506178|NCT03539484|616195339|FG003|Overall Study|Study Terminated by Sponsor|1|||
170506179|NCT03539484|616195340|FG004|Overall Study|Study Terminated by Sponsor|2|||
170506180|NCT03539484|616195341|FG005|Overall Study|Study Terminated by Sponsor|2|||
170506181|NCT03539484|616195342|FG006|Overall Study|Study Terminated by Sponsor|1|||
170552410|NCT01712074|616367995|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
170552411|NCT01712074|616367996|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
170805404|NCT02401815|617297380|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
170506182|NCT03030118|616195343|FG000|Overall Study|Achieved SLE Diagnosis|11|||
170506183|NCT03030118|616195344|FG001|Overall Study|Achieved SLE Diagnosis|10|||
170506184|NCT03030118|616195343|FG000|Overall Study|Adverse Event|1|||
170506185|NCT03030118|616195344|FG001|Overall Study|Adverse Event|1|||
170506186|NCT03030118|616195343|FG000|Overall Study|Pregnancy|2|||
170506187|NCT03030118|616195344|FG001|Overall Study|Pregnancy|2|||
170552412|NCT01712074|616367994|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
170506188|NCT03030118|616195343|FG000|Overall Study|Lost to Follow-up|5|||
170506189|NCT03030118|616195344|FG001|Overall Study|Lost to Follow-up|6|||
170506190|NCT03030118|616195343|FG000|Overall Study|Concomitant Medications|1|||
170506191|NCT03030118|616195344|FG001|Overall Study|Concomitant Medications|1|||
170506192|NCT03030118|616195343|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
170506193|NCT03030118|616195344|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
170506194|NCT03030118|616195343|FG000|Overall Study|Other|2|||
170506195|NCT03030118|616195344|FG001|Overall Study|Other|0|||
170552413|NCT01712074|616367995|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
170552414|NCT01712074|616367996|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
170552415|NCT01712074|616367994|FG000|Placebo Run-in Period|Other|1|||
170552416|NCT01712074|616367995|FG001|Placebo Run-in Period|Other|0|||
170552417|NCT01712074|616367996|FG002|Placebo Run-in Period|Other|0|||
170552418|NCT01712074|616367994|FG000|Placebo Run-in Period|No longer willing to participate|1|||
170552419|NCT01712074|616367995|FG001|Placebo Run-in Period|No longer willing to participate|0|||
170552420|NCT01712074|616367996|FG002|Placebo Run-in Period|No longer willing to participate|0|||
170552421|NCT01712074|616367994|FG000|Double Blind Period|Adverse Event|0|||
170552422|NCT01712074|616367995|FG001|Double Blind Period|Adverse Event|2|||
170552423|NCT01712074|616367996|FG002|Double Blind Period|Adverse Event|1|||
170552424|NCT01712074|616367994|FG000|Double Blind Period|No longer willing to participate|0|||
170552425|NCT01712074|616367995|FG001|Double Blind Period|No longer willing to participate|2|||
170552426|NCT01712074|616367996|FG002|Double Blind Period|No longer willing to participate|4|||
170552427|NCT01712074|616367994|FG000|Double Blind Period|Death|0|||
170552428|NCT01712074|616367995|FG001|Double Blind Period|Death|1|||
170552429|NCT01712074|616367996|FG002|Double Blind Period|Death|0|||
170552430|NCT01712074|616367994|FG000|Double Blind Period|Lost to Follow-up|0|||
170552431|NCT01712074|616367995|FG001|Double Blind Period|Lost to Follow-up|2|||
170552432|NCT01712074|616367996|FG002|Double Blind Period|Lost to Follow-up|1|||
170552433|NCT01712074|616367994|FG000|Double Blind Period|Other|0|||
170506196|NCT03030118|616195343|FG000|Overall Study|Withdrawal by Subject|26|||
170506197|NCT03030118|616195344|FG001|Overall Study|Withdrawal by Subject|21|||
170506198|NCT03030118|616195343|FG000|Overall Study|Protocol Violation|1|||
170506199|NCT03030118|616195344|FG001|Overall Study|Protocol Violation|6|||
170506200|NCT04529850|616195345|FG000|Overall Study|Death|2|||
170506201|NCT04529850|616195345|FG000|Overall Study|Physician Decision|1|||
170506202|NCT04529850|616195345|FG000|Overall Study|Withdrawal by Subject|2|||
170506203|NCT00593606|616195348|FG000|Overall Study|Adverse Event|13|||
170506204|NCT00593606|616195348|FG000|Overall Study|Withdrawal by Subject|1|||
170506205|NCT00593606|616195348|FG000|Overall Study|Protocol Violation|3|||
170506206|NCT00593606|616195348|FG000|Overall Study|Lost to Follow-up|2|||
170506207|NCT00593606|616195348|FG000|Overall Study|Run-In Failure|5|||
170506208|NCT00593606|616195348|FG000|Overall Study|Screen Failure|3|||
170506209|NCT01472939|616195352|FG000|Overall Study|Adverse Event|3|||
170506210|NCT01472939|616195353|FG001|Overall Study|Adverse Event|7|||
170506211|NCT01472939|616195354|FG002|Overall Study|Adverse Event|7|||
170506212|NCT01472939|616195355|FG003|Overall Study|Adverse Event|14|||
170506213|NCT01472939|616195352|FG000|Overall Study|Lack of Efficacy|1|||
170506214|NCT01472939|616195353|FG001|Overall Study|Lack of Efficacy|0|||
170506215|NCT01472939|616195354|FG002|Overall Study|Lack of Efficacy|0|||
170506216|NCT01472939|616195355|FG003|Overall Study|Lack of Efficacy|1|||
170506217|NCT01472939|616195352|FG000|Overall Study|Lost to Follow-up|3|||
170506218|NCT01472939|616195353|FG001|Overall Study|Lost to Follow-up|0|||
170506219|NCT01472939|616195354|FG002|Overall Study|Lost to Follow-up|2|||
170506220|NCT01472939|616195355|FG003|Overall Study|Lost to Follow-up|0|||
170506221|NCT01472939|616195352|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
170506222|NCT01472939|616195353|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
170506223|NCT01472939|616195354|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
170506224|NCT01472939|616195355|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
170506225|NCT01472939|616195352|FG000|Overall Study|Prohibited Medication|0|||
170506226|NCT01472939|616195353|FG001|Overall Study|Prohibited Medication|1|||
170552434|NCT01712074|616367995|FG001|Double Blind Period|Other|4|||
170552435|NCT01712074|616367996|FG002|Double Blind Period|Other|1|||
170552436|NCT01712074|616367994|FG000|Double Blind Period|Protocol Violation|0|||
170506227|NCT01472939|616195354|FG002|Overall Study|Prohibited Medication|0|||
170552437|NCT01712074|616367995|FG001|Double Blind Period|Protocol Violation|0|||
170552438|NCT01712074|616367996|FG002|Double Blind Period|Protocol Violation|1|||
170552439|NCT01712074|616367994|FG000|Double Blind Period|No longer met eligibility criteria|0|||
170552440|NCT01712074|616367995|FG001|Double Blind Period|No longer met eligibility criteria|3|||
170552441|NCT01712074|616367996|FG002|Double Blind Period|No longer met eligibility criteria|0|||
170642509|NCT01403948|616705268|FG001|Overall Study|Refused cont. medication|0|||
170506228|NCT01472939|616195355|FG003|Overall Study|Prohibited Medication|0|||
170506229|NCT01472939|616195352|FG000|Overall Study|Withdrawal By PI|1|||
170506230|NCT01472939|616195353|FG001|Overall Study|Withdrawal By PI|0|||
170506231|NCT01472939|616195354|FG002|Overall Study|Withdrawal By PI|0|||
170506232|NCT01472939|616195355|FG003|Overall Study|Withdrawal By PI|0|||
170506233|NCT01472939|616195352|FG000|Overall Study|Protocol Violation|3|||
170506234|NCT01472939|616195353|FG001|Overall Study|Protocol Violation|3|||
170506235|NCT01472939|616195354|FG002|Overall Study|Protocol Violation|0|||
170506236|NCT01472939|616195355|FG003|Overall Study|Protocol Violation|1|||
170506237|NCT01472939|616195352|FG000|Overall Study|Withdrawal by Subject|9|||
170506238|NCT01472939|616195353|FG001|Overall Study|Withdrawal by Subject|3|||
170506239|NCT01472939|616195354|FG002|Overall Study|Withdrawal by Subject|1|||
170506240|NCT01472939|616195355|FG003|Overall Study|Withdrawal by Subject|4|||
170506241|NCT00114738|616195356|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
170506242|NCT00114738|616195357|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
170506243|NCT00114738|616195358|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
170506244|NCT00114738|616195356|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
170506245|NCT00114738|616195357|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
170506246|NCT00114738|616195358|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
170506247|NCT00114738|616195356|FG000|Screening for Randomization|Neuropathy|17|||
170506248|NCT00114738|616195357|FG001|Screening for Randomization|Neuropathy|0|||
170506249|NCT00114738|616195358|FG002|Screening for Randomization|Neuropathy|0|||
170506250|NCT00114738|616195356|FG000|Screening for Randomization|Progressive disease|2|||
170506251|NCT00114738|616195357|FG001|Screening for Randomization|Progressive disease|0|||
170506252|NCT00114738|616195358|FG002|Screening for Randomization|Progressive disease|0|||
170506253|NCT00114738|616195356|FG000|Screening for Randomization|CNS Hemorrhage|1|||
170506254|NCT00114738|616195357|FG001|Screening for Randomization|CNS Hemorrhage|0|||
170506255|NCT00114738|616195358|FG002|Screening for Randomization|CNS Hemorrhage|0|||
170506256|NCT00114738|616195356|FG000|Screening for Randomization|Other|1|||
170506257|NCT00114738|616195357|FG001|Screening for Randomization|Other|0|||
170506258|NCT00114738|616195358|FG002|Screening for Randomization|Other|0|||
170506259|NCT05940077|616195359|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
170506260|NCT01004432|616195360|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
170506261|NCT01004432|616195361|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
170506262|NCT01004432|616195362|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
170506263|NCT01004432|616195363|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
170506264|NCT01004432|616195364|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
170506265|NCT01004432|616195360|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
170506266|NCT01004432|616195361|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
170506267|NCT01004432|616195362|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
170506268|NCT01004432|616195363|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
170506269|NCT01004432|616195364|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
170506270|NCT01004432|616195360|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
170506271|NCT01004432|616195361|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
170506272|NCT01004432|616195362|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
170506273|NCT01004432|616195363|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
170506274|NCT01004432|616195364|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
170506275|NCT01004432|616195360|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
170506276|NCT01004432|616195361|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
170506277|NCT01004432|616195362|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
170506278|NCT01004432|616195363|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
170506279|NCT01004432|616195364|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
170506280|NCT01004432|616195360|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
170506281|NCT01004432|616195361|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
170506282|NCT01004432|616195362|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
170506283|NCT01004432|616195363|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
170506284|NCT01004432|616195364|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
170506285|NCT01004432|616195360|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
170506286|NCT01004432|616195361|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
170506287|NCT01004432|616195362|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
170506288|NCT01004432|616195363|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
170506289|NCT01004432|616195364|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
170506290|NCT01004432|616195360|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
170506291|NCT01004432|616195361|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
170506292|NCT01004432|616195362|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
170506293|NCT01004432|616195363|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
170506294|NCT01004432|616195364|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
170506295|NCT01004432|616195360|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
170506296|NCT01004432|616195361|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
170506297|NCT01004432|616195362|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
170506298|NCT01004432|616195363|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
170506299|NCT01004432|616195364|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
170904215|NCT04996797|617650917|FG000|Overall Study|Ongoing|68|||
170805405|NCT02401815|617297381|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
170506300|NCT01004432|616195360|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
170506301|NCT01004432|616195361|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
170506302|NCT01004432|616195362|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
170506303|NCT01004432|616195363|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
170506304|NCT01004432|616195364|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
170506305|NCT01004432|616195360|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
170805406|NCT02401815|617297382|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
170805407|NCT02401815|617297373|FG000|Dose Escalation (up to 670 Days)|Death|1|||
170805408|NCT02401815|617297374|FG001|Dose Escalation (up to 670 Days)|Death|2|||
170805409|NCT02401815|617297375|FG002|Dose Escalation (up to 670 Days)|Death|3|||
170805410|NCT02401815|617297376|FG003|Dose Escalation (up to 670 Days)|Death|5|||
170805411|NCT02401815|617297377|FG004|Dose Escalation (up to 670 Days)|Death|4|||
170805412|NCT02401815|617297378|FG005|Dose Escalation (up to 670 Days)|Death|0|||
170805413|NCT02401815|617297379|FG006|Dose Escalation (up to 670 Days)|Death|0|||
170805414|NCT02401815|617297380|FG007|Dose Escalation (up to 670 Days)|Death|0|||
170805415|NCT02401815|617297381|FG008|Dose Escalation (up to 670 Days)|Death|0|||
170805416|NCT02401815|617297382|FG009|Dose Escalation (up to 670 Days)|Death|0|||
170805417|NCT02401815|617297373|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
170805418|NCT02401815|617297374|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
170805419|NCT02401815|617297375|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
170805420|NCT02401815|617297376|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
170805421|NCT02401815|617297377|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
170805422|NCT02401815|617297378|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
170506306|NCT01004432|616195361|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
170506307|NCT01004432|616195362|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
170506308|NCT01004432|616195363|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
170506309|NCT01004432|616195364|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
170506310|NCT01004432|616195360|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
170506311|NCT01004432|616195361|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
170506312|NCT01004432|616195362|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
170506313|NCT01004432|616195363|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
170506314|NCT01004432|616195364|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
170506315|NCT01004432|616195360|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
170506316|NCT01004432|616195361|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
170506317|NCT01004432|616195362|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
170506318|NCT01004432|616195363|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
170506319|NCT01004432|616195364|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
170506320|NCT01004432|616195360|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
170506321|NCT01004432|616195361|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
170506322|NCT01004432|616195362|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
170506323|NCT01004432|616195363|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
170506324|NCT01004432|616195364|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
170552442|NCT03478787|616367997|FG000|Overall Study|Adverse Event|5|||
170552443|NCT03478787|616367998|FG001|Overall Study|Adverse Event|1|||
170552444|NCT03478787|616367997|FG000|Overall Study|Protocol Violation|3|||
170552445|NCT03478787|616367998|FG001|Overall Study|Protocol Violation|0|||
170552446|NCT03478787|616367997|FG000|Overall Study|Lack of Efficacy|7|||
170552447|NCT03478787|616367998|FG001|Overall Study|Lack of Efficacy|1|||
170552448|NCT03478787|616367997|FG000|Overall Study|Lost to Follow-up|9|||
170552449|NCT03478787|616367998|FG001|Overall Study|Lost to Follow-up|5|||
170552450|NCT03478787|616367997|FG000|Overall Study|Withdrawal by Subject|2|||
170552451|NCT03478787|616367998|FG001|Overall Study|Withdrawal by Subject|6|||
170552452|NCT03478787|616367997|FG000|Overall Study|Other, Not Specified|3|||
170552453|NCT03478787|616367998|FG001|Overall Study|Other, Not Specified|0|||
170552454|NCT03378635|616367999|FG000|Overall Study|Adverse Event|1|||
170552455|NCT03378635|616368000|FG001|Overall Study|Adverse Event|0|||
170552456|NCT03378635|616368001|FG002|Overall Study|Adverse Event|0|||
170805423|NCT02401815|617297379|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
170805424|NCT02401815|617297380|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
170805425|NCT02401815|617297381|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
170904216|NCT04996797|617650918|FG001|Overall Study|Ongoing|60|||
170552457|NCT03378635|616367999|FG000|Overall Study|Withdrawal by Subject|1|||
170552458|NCT03378635|616368000|FG001|Overall Study|Withdrawal by Subject|0|||
170552459|NCT03378635|616368001|FG002|Overall Study|Withdrawal by Subject|0|||
170552460|NCT02413346|616368002|FG000|Overall Study|Adverse Event|6|||
170552461|NCT02413346|616368003|FG001|Overall Study|Adverse Event|6|||
170552462|NCT02413346|616368002|FG000|Overall Study|Withdrawal by Subject|30|||
170552463|NCT02413346|616368003|FG001|Overall Study|Withdrawal by Subject|40|||
170552464|NCT02413346|616368002|FG000|Overall Study|Lost to Follow-up|17|||
170552465|NCT02413346|616368003|FG001|Overall Study|Lost to Follow-up|21|||
170506325|NCT01004432|616195360|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
170506326|NCT01004432|616195361|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
170506327|NCT01004432|616195362|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
170506328|NCT01004432|616195363|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
170506329|NCT01004432|616195364|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
170506330|NCT01004432|616195360|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
170506331|NCT01004432|616195361|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
170506332|NCT01004432|616195362|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
170506333|NCT01004432|616195363|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
170506334|NCT01004432|616195364|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
170506335|NCT01675154|616195372|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
170506336|NCT01675154|616195373|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
170506337|NCT01675154|616195374|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
170506338|NCT01675154|616195375|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
170506339|NCT01149421|616195377|FG000|Overall Study|Adverse Event|22|||
170506340|NCT01149421|616195378|FG001|Overall Study|Adverse Event|6|||
170506341|NCT01149421|616195379|FG002|Overall Study|Adverse Event|11|||
170506342|NCT01149421|616195377|FG000|Overall Study|Withdrawal by Subject|20|||
170506343|NCT01149421|616195378|FG001|Overall Study|Withdrawal by Subject|12|||
170506344|NCT01149421|616195379|FG002|Overall Study|Withdrawal by Subject|13|||
170506345|NCT01149421|616195377|FG000|Overall Study|Sponsor Decision|0|||
170506346|NCT01149421|616195378|FG001|Overall Study|Sponsor Decision|1|||
170506347|NCT01149421|616195379|FG002|Overall Study|Sponsor Decision|1|||
170506348|NCT01149421|616195377|FG000|Overall Study|Lost to Follow-up|2|||
170506349|NCT01149421|616195378|FG001|Overall Study|Lost to Follow-up|4|||
170506350|NCT01149421|616195379|FG002|Overall Study|Lost to Follow-up|5|||
170506351|NCT01149421|616195377|FG000|Overall Study|Physician Decision|5|||
170506352|NCT01149421|616195378|FG001|Overall Study|Physician Decision|3|||
170506353|NCT01149421|616195379|FG002|Overall Study|Physician Decision|6|||
170506354|NCT01149421|616195377|FG000|Overall Study|Entry Criteria Not Met|1|||
170506355|NCT01149421|616195378|FG001|Overall Study|Entry Criteria Not Met|1|||
170506356|NCT01149421|616195379|FG002|Overall Study|Entry Criteria Not Met|2|||
170506357|NCT01149421|616195377|FG000|Overall Study|Protocol Violation|2|||
170506358|NCT01149421|616195378|FG001|Overall Study|Protocol Violation|2|||
170506359|NCT01149421|616195379|FG002|Overall Study|Protocol Violation|6|||
170506360|NCT03738800|616195385|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
170506361|NCT03738800|616195386|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
170506362|NCT03738800|616195387|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170506363|NCT03738800|616195385|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
170506364|NCT03738800|616195386|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
170506365|NCT03738800|616195387|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
170506366|NCT03738800|616195385|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
170506367|NCT03738800|616195386|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
170506368|NCT03738800|616195387|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
170506369|NCT02719353|616195388|FG000|First Intervention|Physician Decision|0|||
170506370|NCT02719353|616195389|FG001|First Intervention|Physician Decision|1|||
170506371|NCT03435224|616195393|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
170506372|NCT00367484|616195394|FG000|Overall Study|Adverse Event|7|||
170506373|NCT00367484|616195394|FG000|Overall Study|Withdrew informed consent|5|||
170506374|NCT00367484|616195394|FG000|Overall Study|Travel to USA|1|||
170506375|NCT00367484|616195394|FG000|Overall Study|Lost to Follow-up|1|||
170506376|NCT00367484|616195394|FG000|Overall Study|Protocol Violation|1|||
170506377|NCT00367484|616195394|FG000|Overall Study|The choice of the patient|1|||
170506378|NCT00367484|616195394|FG000|Overall Study|Lack of Efficacy|1|||
170506379|NCT00412217|616195395|FG000|Overall Study|Insufficient Data Available|8|||
170506380|NCT00412217|616195396|FG001|Overall Study|Insufficient Data Available|3|||
170506381|NCT00412217|616195395|FG000|Overall Study|Death|5|||
170506382|NCT00412217|616195396|FG001|Overall Study|Death|4|||
170506383|NCT00412217|616195395|FG000|Overall Study|Disease Progression|2|||
170506384|NCT00412217|616195396|FG001|Overall Study|Disease Progression|3|||
170506385|NCT00412217|616195395|FG000|Overall Study|Investigator Decision|1|||
170506386|NCT00412217|616195396|FG001|Overall Study|Investigator Decision|0|||
170506387|NCT00412217|616195395|FG000|Overall Study|Withdrawal by Subject|2|||
170506388|NCT00412217|616195396|FG001|Overall Study|Withdrawal by Subject|0|||
170805426|NCT02401815|617297382|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
170506389|NCT00412217|616195395|FG000|Overall Study|Lost to Follow-up|1|||
170506390|NCT00412217|616195396|FG001|Overall Study|Lost to Follow-up|4|||
170506391|NCT00412217|616195395|FG000|Overall Study|Study Terminated by Sponsor|26|||
170506392|NCT00412217|616195396|FG001|Overall Study|Study Terminated by Sponsor|33|||
170506393|NCT00412217|616195395|FG000|Overall Study|Other|1|||
170506394|NCT00412217|616195396|FG001|Overall Study|Other|1|||
170506395|NCT01777295|616195397|FG000|Overall Study|Withdrawal by Subject|2|||
170506396|NCT01777295|616195398|FG001|Overall Study|Withdrawal by Subject|2|||
170506397|NCT01777295|616195397|FG000|Overall Study|Pregnancy|0|||
170506398|NCT01777295|616195398|FG001|Overall Study|Pregnancy|1|||
170506399|NCT01777295|616195397|FG000|Overall Study|Personal problem|1|||
170506400|NCT01777295|616195398|FG001|Overall Study|Personal problem|0|||
170506401|NCT01777295|616195397|FG000|Overall Study|Investigator call for AEs check|1|||
170506402|NCT01777295|616195398|FG001|Overall Study|Investigator call for AEs check|0|||
170506403|NCT02609724|616195399|FG000|Overall Study|Death|2|||
170506404|NCT02609724|616195400|FG001|Overall Study|Death|0|||
170506405|NCT02609724|616195401|FG002|Overall Study|Death|1|||
170506406|NCT02609724|616195399|FG000|Overall Study|Withdrawal by Subject|1|||
170506407|NCT02609724|616195400|FG001|Overall Study|Withdrawal by Subject|2|||
170506408|NCT02609724|616195401|FG002|Overall Study|Withdrawal by Subject|3|||
170506409|NCT02609724|616195399|FG000|Overall Study|Illness|2|||
170506410|NCT02609724|616195400|FG001|Overall Study|Illness|1|||
170506411|NCT02609724|616195401|FG002|Overall Study|Illness|0|||
170506412|NCT04007107|616195402|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
170506413|NCT04007107|616195403|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
170506414|NCT04007107|616195404|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
170506415|NCT04007107|616195405|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
170506416|NCT00980174|616195411|FG000|Overall Study|Withdrawal by Subject|1|||
170506417|NCT00980174|616195412|FG001|Overall Study|Withdrawal by Subject|4|||
170506418|NCT00980174|616195411|FG000|Overall Study|Adverse Event|0|||
170506419|NCT00980174|616195412|FG001|Overall Study|Adverse Event|3|||
170506420|NCT00980174|616195411|FG000|Overall Study|Ineligibility determined|2|||
170506421|NCT00980174|616195412|FG001|Overall Study|Ineligibility determined|1|||
170506422|NCT00980174|616195411|FG000|Overall Study|Death|1|||
170506423|NCT00980174|616195412|FG001|Overall Study|Death|1|||
170506424|NCT00980174|616195411|FG000|Overall Study|Other|0|||
170506425|NCT00980174|616195412|FG001|Overall Study|Other|1|||
170506426|NCT02332239|616195413|FG000|Overall Study|Lost to Follow-up|4|||
170506427|NCT02332239|616195414|FG001|Overall Study|Lost to Follow-up|6|||
170506428|NCT00006305|616195415|FG000|Overall Study|Withdrawal by Subject|17|||
170506429|NCT00006305|616195416|FG001|Overall Study|Withdrawal by Subject|10|||
170506430|NCT00006305|616195417|FG002|Overall Study|Withdrawal by Subject|15|||
170506431|NCT00006305|616195418|FG003|Overall Study|Withdrawal by Subject|14|||
170506432|NCT04245202|616195421|FG000|Overall Study|Lack of Efficacy|10|||
170506433|NCT04245202|616195422|FG001|Overall Study|Lack of Efficacy|1|||
170506434|NCT01522235|616195424|FG000|Overall Study|Physician Decision|1|||
170506435|NCT01522235|616195425|FG001|Overall Study|Physician Decision|1|||
170506436|NCT00312572|616195429|FG000|Overall Study|Adverse Event|10|||
170506437|NCT00312572|616195430|FG001|Overall Study|Adverse Event|16|||
170506438|NCT00312572|616195429|FG000|Overall Study|Lost to Follow-up|1|||
170506439|NCT00312572|616195430|FG001|Overall Study|Lost to Follow-up|1|||
170506440|NCT00312572|616195429|FG000|Overall Study|Administrative|4|||
170506441|NCT00312572|616195430|FG001|Overall Study|Administrative|2|||
170506442|NCT00312572|616195429|FG000|Overall Study|Lack of Efficacy|1|||
170506443|NCT00312572|616195430|FG001|Overall Study|Lack of Efficacy|2|||
170506444|NCT05385224|616195431|FG000|Overall Study|Unable to swallow capsule|2|||
170506445|NCT05385224|616195431|FG000|Overall Study|Withdrawal by Subject|2|||
170506446|NCT05385224|616195431|FG000|Overall Study|Did not meet study criteria|1|||
170506447|NCT04521114|616195434|FG000|Overall Study|Lost to Follow-up|1|||
170506448|NCT04521114|616195435|FG001|Overall Study|Lost to Follow-up|2|||
170506449|NCT04521114|616195436|FG002|Overall Study|Lost to Follow-up|0|||
170506450|NCT04521114|616195434|FG000|Overall Study|Withdrawal by Subject|1|||
170506451|NCT04521114|616195435|FG001|Overall Study|Withdrawal by Subject|2|||
170506452|NCT04521114|616195436|FG002|Overall Study|Withdrawal by Subject|2|||
170506453|NCT04521114|616195434|FG000|Overall Study|Adverse Event|1|||
170506454|NCT04521114|616195435|FG001|Overall Study|Adverse Event|0|||
170506455|NCT04521114|616195436|FG002|Overall Study|Adverse Event|0|||
170506456|NCT04521114|616195434|FG000|Overall Study|Sponsor Wish|1|||
170506457|NCT04521114|616195435|FG001|Overall Study|Sponsor Wish|0|||
170506458|NCT04521114|616195436|FG002|Overall Study|Sponsor Wish|0|||
170506459|NCT04521114|616195434|FG000|Overall Study|Withdrawal of Consent|2|||
170506460|NCT04521114|616195435|FG001|Overall Study|Withdrawal of Consent|2|||
170506461|NCT04521114|616195436|FG002|Overall Study|Withdrawal of Consent|0|||
170506462|NCT01362517|616195437|FG000|Overall Study|Protocol Violation|1|||
170506463|NCT01362517|616195437|FG000|Overall Study|Lost to Follow-up|1|||
170506464|NCT02614131|616195440|FG000|Overall Study|Withdrawal by Subject|1|||
170506465|NCT02614131|616195441|FG001|Overall Study|Withdrawal by Subject|0|||
170506466|NCT02614131|616195442|FG002|Overall Study|Withdrawal by Subject|0|||
170506467|NCT02614131|616195443|FG003|Overall Study|Withdrawal by Subject|0|||
170506468|NCT02614131|616195444|FG004|Overall Study|Withdrawal by Subject|0|||
170506469|NCT02614131|616195445|FG005|Overall Study|Withdrawal by Subject|0|||
170506470|NCT02614131|616195446|FG006|Overall Study|Withdrawal by Subject|0|||
170506471|NCT02614131|616195440|FG000|Overall Study|Adverse Event|0|||
170506472|NCT02614131|616195441|FG001|Overall Study|Adverse Event|0|||
170506473|NCT02614131|616195442|FG002|Overall Study|Adverse Event|0|||
170506474|NCT02614131|616195443|FG003|Overall Study|Adverse Event|0|||
170506475|NCT02614131|616195444|FG004|Overall Study|Adverse Event|0|||
170506476|NCT02614131|616195445|FG005|Overall Study|Adverse Event|0|||
170506477|NCT02614131|616195446|FG006|Overall Study|Adverse Event|1|||
170506478|NCT01832818|616195447|FG000|Overall Study|Lost to Follow-up|6|||
170506479|NCT01897571|616195448|FG000|Overall Study|Lost to Follow-up|3|||
170506480|NCT01897571|616195449|FG001|Overall Study|Lost to Follow-up|0|||
170506481|NCT01897571|616195450|FG002|Overall Study|Lost to Follow-up|0|||
170506482|NCT01897571|616195451|FG003|Overall Study|Lost to Follow-up|0|||
170506483|NCT01897571|616195452|FG004|Overall Study|Lost to Follow-up|2|||
170506484|NCT01897571|616195453|FG005|Overall Study|Lost to Follow-up|0|||
170506485|NCT01897571|616195454|FG006|Overall Study|Lost to Follow-up|0|||
170506486|NCT01897571|616195455|FG007|Overall Study|Lost to Follow-up|0|||
170506487|NCT01897571|616195456|FG008|Overall Study|Lost to Follow-up|1|||
170506488|NCT01897571|616195457|FG009|Overall Study|Lost to Follow-up|2|||
170506489|NCT01897571|616195458|FG010|Overall Study|Lost to Follow-up|4|||
170506490|NCT01897571|616195448|FG000|Overall Study|Withdrawal by Subject|0|||
170506491|NCT01897571|616195449|FG001|Overall Study|Withdrawal by Subject|0|||
170506492|NCT01897571|616195450|FG002|Overall Study|Withdrawal by Subject|0|||
170506493|NCT01897571|616195451|FG003|Overall Study|Withdrawal by Subject|0|||
170506494|NCT01897571|616195452|FG004|Overall Study|Withdrawal by Subject|0|||
170506495|NCT01897571|616195453|FG005|Overall Study|Withdrawal by Subject|0|||
170506496|NCT01897571|616195454|FG006|Overall Study|Withdrawal by Subject|0|||
170506497|NCT01897571|616195455|FG007|Overall Study|Withdrawal by Subject|1|||
170506498|NCT01897571|616195456|FG008|Overall Study|Withdrawal by Subject|4|||
170506499|NCT01897571|616195457|FG009|Overall Study|Withdrawal by Subject|3|||
170506500|NCT01897571|616195458|FG010|Overall Study|Withdrawal by Subject|1|||
170506501|NCT01897571|616195448|FG000|Overall Study|Other|1|||
170506502|NCT01897571|616195449|FG001|Overall Study|Other|0|||
170506503|NCT01897571|616195450|FG002|Overall Study|Other|0|||
170506504|NCT01897571|616195451|FG003|Overall Study|Other|3|||
170506505|NCT01897571|616195452|FG004|Overall Study|Other|3|||
170506506|NCT01897571|616195453|FG005|Overall Study|Other|4|||
170506507|NCT01897571|616195454|FG006|Overall Study|Other|7|||
170506508|NCT01897571|616195455|FG007|Overall Study|Other|0|||
170506509|NCT01897571|616195456|FG008|Overall Study|Other|0|||
170506510|NCT01897571|616195457|FG009|Overall Study|Other|0|||
170506511|NCT01897571|616195458|FG010|Overall Study|Other|0|||
170506512|NCT01897571|616195448|FG000|Overall Study|Enrolled in rollover study|0|||
170506513|NCT01897571|616195449|FG001|Overall Study|Enrolled in rollover study|0|||
170506514|NCT01897571|616195450|FG002|Overall Study|Enrolled in rollover study|0|||
170506515|NCT01897571|616195451|FG003|Overall Study|Enrolled in rollover study|0|||
170506516|NCT01897571|616195452|FG004|Overall Study|Enrolled in rollover study|0|||
170506517|NCT01897571|616195453|FG005|Overall Study|Enrolled in rollover study|0|||
170506518|NCT01897571|616195454|FG006|Overall Study|Enrolled in rollover study|0|||
170506519|NCT01897571|616195455|FG007|Overall Study|Enrolled in rollover study|9|||
170506520|NCT01897571|616195456|FG008|Overall Study|Enrolled in rollover study|7|||
170552466|NCT02413346|616368002|FG000|Overall Study|Protocol Violation|2|||
170506521|NCT01897571|616195457|FG009|Overall Study|Enrolled in rollover study|9|||
170506522|NCT01897571|616195458|FG010|Overall Study|Enrolled in rollover study|1|||
170506523|NCT01897571|616195448|FG000|Overall Study|Death|2|||
170506524|NCT01897571|616195449|FG001|Overall Study|Death|2|||
170506525|NCT01897571|616195450|FG002|Overall Study|Death|3|||
170506526|NCT01897571|616195451|FG003|Overall Study|Death|6|||
170506527|NCT01897571|616195452|FG004|Overall Study|Death|7|||
170506528|NCT01897571|616195453|FG005|Overall Study|Death|9|||
170506529|NCT01897571|616195454|FG006|Overall Study|Death|5|||
170506530|NCT01897571|616195455|FG007|Overall Study|Death|22|||
170506531|NCT01897571|616195456|FG008|Overall Study|Death|23|||
170506532|NCT01897571|616195457|FG009|Overall Study|Death|129|||
170506533|NCT01897571|616195458|FG010|Overall Study|Death|59|||
170506534|NCT01797094|616195459|FG000|Overall Study|Adverse Event|1|||
170506535|NCT01797094|616195460|FG001|Overall Study|Adverse Event|1|||
170506536|NCT01797094|616195459|FG000|Overall Study|Personal Reasons|4|||
170506537|NCT01797094|616195460|FG001|Overall Study|Personal Reasons|0|||
170506538|NCT01797094|616195459|FG000|Overall Study|Protocol Violation|0|||
170506539|NCT01797094|616195460|FG001|Overall Study|Protocol Violation|1|||
170506540|NCT01797094|616195459|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170506541|NCT01797094|616195460|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170506542|NCT03217968|616195463|FG000|Overall Study|Withdrawal by Subject|4|||
170506543|NCT03217968|616195463|FG000|Overall Study|Lost to Follow-up|1|||
170506544|NCT03217968|616195463|FG000|Overall Study|Protocol Violation|6|||
170506545|NCT04395274|616195471|FG000|Overall Study|Lost to Follow-up|20|||
170506546|NCT04395274|616195472|FG001|Overall Study|Lost to Follow-up|11|||
170506547|NCT04395274|616195471|FG000|Overall Study|Withdrawal by Subject|13|||
170506548|NCT04395274|616195472|FG001|Overall Study|Withdrawal by Subject|10|||
170506549|NCT04395274|616195471|FG000|Overall Study|Moved Abroad|0|||
170506550|NCT04395274|616195472|FG001|Overall Study|Moved Abroad|1|||
170506551|NCT02028169|616195473|FG000|Overall Study|Lost to Follow-up|21|||
170506552|NCT02028169|616195473|FG000|Overall Study|Lack of Efficacy|2|||
170506553|NCT02028169|616195473|FG000|Overall Study|Withdrawal by Subject|2|||
170506554|NCT02028169|616195473|FG000|Overall Study|Adverse Event|1|||
170506555|NCT02028169|616195473|FG000|Overall Study|Cessation of Drug|1|||
170642510|NCT01403948|616705269|FG002|Overall Study|Refused cont. medication|0|||
170642511|NCT01403948|616705270|FG003|Overall Study|Refused cont. medication|0|||
170642512|NCT01403948|616705271|FG004|Overall Study|Refused cont. medication|1|||
170642513|NCT01403948|616705272|FG005|Overall Study|Refused cont. medication|0|||
170642514|NCT01403948|616705273|FG006|Overall Study|Refused cont. medication|0|||
170642515|NCT01403948|616705274|FG007|Overall Study|Refused cont. medication|0|||
170642516|NCT01403948|616705275|FG008|Overall Study|Refused cont. medication|0|||
170642517|NCT01403948|616705276|FG009|Overall Study|Refused cont. medication|1|||
170642518|NCT01403948|616705267|FG000|Overall Study|other than above|1|||
170642519|NCT01403948|616705268|FG001|Overall Study|other than above|2|||
170642520|NCT01403948|616705269|FG002|Overall Study|other than above|1|||
170642521|NCT01403948|616705270|FG003|Overall Study|other than above|0|||
170642522|NCT01403948|616705271|FG004|Overall Study|other than above|1|||
170642523|NCT01403948|616705272|FG005|Overall Study|other than above|1|||
170642524|NCT01403948|616705273|FG006|Overall Study|other than above|2|||
170642525|NCT01403948|616705274|FG007|Overall Study|other than above|0|||
170642526|NCT01403948|616705275|FG008|Overall Study|other than above|0|||
170642527|NCT01403948|616705276|FG009|Overall Study|other than above|0|||
170642528|NCT03679754|616705282|FG000|Overall Study|Investigator request|1|||
170642529|NCT01459497|616705283|FG000|Overall Study|Inability to meet trial constraints.|1|||
170642530|NCT01459497|616705284|FG001|Overall Study|Inability to meet trial constraints.|0|||
170642531|NCT01459497|616705283|FG000|Overall Study|Physician Decision|1|||
170642532|NCT01459497|616705284|FG001|Overall Study|Physician Decision|1|||
170642533|NCT01459497|616705283|FG000|Overall Study|Hospitalization.|0|||
170642534|NCT01459497|616705284|FG001|Overall Study|Hospitalization.|3|||
170642535|NCT01459497|616705283|FG000|Overall Study|Disease progression.|0|||
170642536|NCT01459497|616705284|FG001|Overall Study|Disease progression.|1|||
170642537|NCT00329797|616705289|FG000|Overall Study|Protocol Violation|1|||
170642538|NCT00329797|616705290|FG001|Overall Study|Protocol Violation|0|||
170642539|NCT00329797|616705289|FG000|Overall Study|Withdrawal by Subject|6|||
170642540|NCT00329797|616705290|FG001|Overall Study|Withdrawal by Subject|6|||
170642541|NCT02379637|616705296|FG000|Overall Study|Protocol Violation|0|||
170642542|NCT02379637|616705297|FG001|Overall Study|Protocol Violation|1|||
170642543|NCT02379637|616705296|FG000|Overall Study|Adverse Event|1|||
170642544|NCT02379637|616705297|FG001|Overall Study|Adverse Event|0|||
170642545|NCT02379637|616705296|FG000|Overall Study|Withdrawal by Subject|1|||
170642546|NCT02379637|616705297|FG001|Overall Study|Withdrawal by Subject|0|||
170642547|NCT02791763|616705298|FG000|Overall Study|Protocol Violation|0|||
170642548|NCT02791763|616705299|FG001|Overall Study|Protocol Violation|0|||
170642549|NCT02791763|616705300|FG002|Overall Study|Protocol Violation|1|||
170506556|NCT02028169|616195473|FG000|Overall Study|Concomitant Medication Usage|1|||
170506557|NCT02680834|616195476|FG000|Overall Study|Physician Decision|5|||
170506558|NCT02680834|616195477|FG001|Overall Study|Physician Decision|2|||
170506559|NCT02680834|616195476|FG000|Overall Study|Withdrawal by Subject|6|||
170506560|NCT02680834|616195477|FG001|Overall Study|Withdrawal by Subject|0|||
170642550|NCT02791763|616705298|FG000|Overall Study|Withdrawal by Subject|5|||
170642551|NCT02791763|616705299|FG001|Overall Study|Withdrawal by Subject|1|||
170642552|NCT02791763|616705300|FG002|Overall Study|Withdrawal by Subject|0|||
170642553|NCT02791763|616705298|FG000|Overall Study|Physician Decision|0|||
170642554|NCT02791763|616705299|FG001|Overall Study|Physician Decision|1|||
170642555|NCT02791763|616705300|FG002|Overall Study|Physician Decision|0|||
170642556|NCT02791763|616705298|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
170642557|NCT02791763|616705299|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
170642558|NCT02791763|616705300|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
170642559|NCT02791763|616705298|FG000|Overall Study|Cancer event|1|||
170506561|NCT02680834|616195476|FG000|Overall Study|Lost to Follow-up|0|||
170506562|NCT02680834|616195477|FG001|Overall Study|Lost to Follow-up|1|||
170506563|NCT02520427|616195478|FG000|Overall Study|Decision by sponsor|0|||
170506564|NCT02520427|616195479|FG001|Overall Study|Decision by sponsor|0|||
170506565|NCT02520427|616195480|FG002|Overall Study|Decision by sponsor|0|||
170506566|NCT02520427|616195481|FG003|Overall Study|Decision by sponsor|0|||
170506567|NCT02520427|616195482|FG004|Overall Study|Decision by sponsor|0|||
170506568|NCT02520427|616195483|FG005|Overall Study|Decision by sponsor|0|||
170506569|NCT02520427|616195484|FG006|Overall Study|Decision by sponsor|0|||
170506570|NCT02520427|616195485|FG007|Overall Study|Decision by sponsor|0|||
170506571|NCT02520427|616195486|FG008|Overall Study|Decision by sponsor|1|||
170506572|NCT02520427|616195487|FG009|Overall Study|Decision by sponsor|1|||
170506573|NCT02520427|616195488|FG010|Overall Study|Decision by sponsor|0|||
170506574|NCT02520427|616195489|FG011|Overall Study|Decision by sponsor|0|||
170506575|NCT02520427|616195490|FG012|Overall Study|Decision by sponsor|0|||
170506576|NCT02520427|616195491|FG013|Overall Study|Decision by sponsor|0|||
170506577|NCT02520427|616195492|FG014|Overall Study|Decision by sponsor|0|||
170506578|NCT02520427|616195493|FG015|Overall Study|Decision by sponsor|0|||
170506579|NCT02520427|616195494|FG016|Overall Study|Decision by sponsor|0|||
170506580|NCT02520427|616195495|FG017|Overall Study|Decision by sponsor|0|||
170506581|NCT02520427|616195496|FG018|Overall Study|Decision by sponsor|0|||
170506582|NCT02520427|616195497|FG019|Overall Study|Decision by sponsor|0|||
170506583|NCT02520427|616195498|FG020|Overall Study|Decision by sponsor|0|||
170506584|NCT02520427|616195499|FG021|Overall Study|Decision by sponsor|0|||
170506585|NCT02520427|616195500|FG022|Overall Study|Decision by sponsor|0|||
170506586|NCT02520427|616195501|FG023|Overall Study|Decision by sponsor|0|||
170506587|NCT02520427|616195502|FG024|Overall Study|Decision by sponsor|0|||
170506588|NCT02520427|616195503|FG025|Overall Study|Decision by sponsor|0|||
170506589|NCT02520427|616195478|FG000|Overall Study|Withdrawal by Subject|0|||
170506590|NCT02520427|616195479|FG001|Overall Study|Withdrawal by Subject|0|||
170506591|NCT02520427|616195480|FG002|Overall Study|Withdrawal by Subject|1|||
170506592|NCT02520427|616195481|FG003|Overall Study|Withdrawal by Subject|0|||
170506593|NCT02520427|616195482|FG004|Overall Study|Withdrawal by Subject|0|||
170506594|NCT02520427|616195483|FG005|Overall Study|Withdrawal by Subject|0|||
170506595|NCT02520427|616195484|FG006|Overall Study|Withdrawal by Subject|0|||
170506596|NCT02520427|616195485|FG007|Overall Study|Withdrawal by Subject|0|||
170506597|NCT02520427|616195486|FG008|Overall Study|Withdrawal by Subject|0|||
170506598|NCT02520427|616195487|FG009|Overall Study|Withdrawal by Subject|0|||
170506599|NCT02520427|616195488|FG010|Overall Study|Withdrawal by Subject|0|||
170506600|NCT02520427|616195489|FG011|Overall Study|Withdrawal by Subject|0|||
170506601|NCT02520427|616195490|FG012|Overall Study|Withdrawal by Subject|1|||
170506602|NCT02520427|616195491|FG013|Overall Study|Withdrawal by Subject|1|||
170506603|NCT02520427|616195492|FG014|Overall Study|Withdrawal by Subject|1|||
170506604|NCT02520427|616195493|FG015|Overall Study|Withdrawal by Subject|0|||
170506605|NCT02520427|616195494|FG016|Overall Study|Withdrawal by Subject|1|||
170506606|NCT02520427|616195495|FG017|Overall Study|Withdrawal by Subject|0|||
170506607|NCT02520427|616195496|FG018|Overall Study|Withdrawal by Subject|0|||
170506608|NCT02520427|616195497|FG019|Overall Study|Withdrawal by Subject|3|||
170506609|NCT02520427|616195498|FG020|Overall Study|Withdrawal by Subject|2|||
170506610|NCT02520427|616195499|FG021|Overall Study|Withdrawal by Subject|0|||
170506611|NCT02520427|616195500|FG022|Overall Study|Withdrawal by Subject|0|||
170506612|NCT02520427|616195501|FG023|Overall Study|Withdrawal by Subject|0|||
170506613|NCT02520427|616195502|FG024|Overall Study|Withdrawal by Subject|0|||
170506614|NCT02520427|616195503|FG025|Overall Study|Withdrawal by Subject|0|||
170506615|NCT02520427|616195478|FG000|Overall Study|Death|1|||
170506616|NCT02520427|616195479|FG001|Overall Study|Death|0|||
170506617|NCT02520427|616195480|FG002|Overall Study|Death|0|||
170506618|NCT02520427|616195481|FG003|Overall Study|Death|0|||
170506619|NCT02520427|616195482|FG004|Overall Study|Death|0|||
170506620|NCT02520427|616195483|FG005|Overall Study|Death|0|||
170506621|NCT02520427|616195484|FG006|Overall Study|Death|0|||
170506622|NCT02520427|616195485|FG007|Overall Study|Death|0|||
170552467|NCT02413346|616368003|FG001|Overall Study|Protocol Violation|0|||
170552468|NCT02413346|616368002|FG000|Overall Study|Other Miscellaneous Reasons|4|||
170552469|NCT02413346|616368003|FG001|Overall Study|Other Miscellaneous Reasons|3|||
170552470|NCT01835431|616368006|FG000|Overall Study|Adverse Event|1|||
170552471|NCT01835431|616368007|FG001|Overall Study|Adverse Event|0|||
170805427|NCT02401815|617297373|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
170506623|NCT02520427|616195486|FG008|Overall Study|Death|0|||
170506624|NCT02520427|616195487|FG009|Overall Study|Death|0|||
170506625|NCT02520427|616195488|FG010|Overall Study|Death|0|||
170506626|NCT02520427|616195489|FG011|Overall Study|Death|0|||
170506627|NCT02520427|616195490|FG012|Overall Study|Death|0|||
170506628|NCT02520427|616195491|FG013|Overall Study|Death|0|||
170506629|NCT02520427|616195492|FG014|Overall Study|Death|0|||
170506630|NCT02520427|616195493|FG015|Overall Study|Death|0|||
170552472|NCT01835431|616368006|FG000|Overall Study|other|0|||
170552473|NCT01835431|616368007|FG001|Overall Study|other|2|||
170506631|NCT02520427|616195494|FG016|Overall Study|Death|2|||
170506632|NCT02520427|616195495|FG017|Overall Study|Death|1|||
170642560|NCT02791763|616705299|FG001|Overall Study|Cancer event|3|||
170642561|NCT02791763|616705300|FG002|Overall Study|Cancer event|0|||
170642562|NCT02791763|616705298|FG000|Overall Study|Participant had renal transplant|3|||
170642563|NCT02791763|616705299|FG001|Overall Study|Participant had renal transplant|0|||
170642564|NCT02791763|616705300|FG002|Overall Study|Participant had renal transplant|0|||
170642565|NCT02791763|616705298|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
170642566|NCT02791763|616705299|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
170642567|NCT02791763|616705300|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
170642568|NCT02791763|616705298|FG000|Overall Study|Adverse Event|12|||
170642569|NCT02791763|616705299|FG001|Overall Study|Adverse Event|13|||
170642570|NCT02791763|616705300|FG002|Overall Study|Adverse Event|7|||
170642571|NCT04534686|616705301|FG000|Baseline Measurement|Lost to Follow-up|4|||
170642572|NCT04534686|616705302|FG001|Baseline Measurement|Lost to Follow-up|6|||
170642573|NCT04534686|616705301|FG000|Baseline Measurement|Withdrawal by Subject|3|||
170642574|NCT04534686|616705302|FG001|Baseline Measurement|Withdrawal by Subject|1|||
170642575|NCT04534686|616705301|FG000|Intervention|Withdrawal by Subject|2|||
170642576|NCT04534686|616705302|FG001|Intervention|Withdrawal by Subject|2|||
170642577|NCT03179605|616705303|FG000|Overall Study|Withdrawal by Subject|1|||
170642578|NCT00711477|616705304|FG000|Overall Study|Adverse Event|3|||
170642579|NCT00711477|616705305|FG001|Overall Study|Adverse Event|1|||
170642580|NCT00711477|616705304|FG000|Overall Study|Lost to Follow-up|0|||
170642581|NCT00711477|616705305|FG001|Overall Study|Lost to Follow-up|1|||
170642582|NCT00711477|616705304|FG000|Overall Study|Noncompliance|0|||
170642583|NCT00711477|616705305|FG001|Overall Study|Noncompliance|1|||
170642584|NCT00934440|616705306|FG000|Overall Study|Lost to Follow-up|1|||
170642585|NCT02152956|616705307|FG000|Overall Study|Adverse Event|0|||
170642586|NCT02152956|616705308|FG001|Overall Study|Adverse Event|0|||
170642587|NCT02152956|616705309|FG002|Overall Study|Adverse Event|0|||
170642588|NCT02152956|616705310|FG003|Overall Study|Adverse Event|0|||
170642589|NCT02152956|616705311|FG004|Overall Study|Adverse Event|0|||
170642590|NCT02152956|616705312|FG005|Overall Study|Adverse Event|0|||
170642591|NCT02152956|616705313|FG006|Overall Study|Adverse Event|0|||
170642592|NCT02152956|616705314|FG007|Overall Study|Adverse Event|0|||
170642593|NCT02152956|616705315|FG008|Overall Study|Adverse Event|0|||
170642594|NCT02152956|616705316|FG009|Overall Study|Adverse Event|0|||
170642595|NCT02152956|616705317|FG010|Overall Study|Adverse Event|0|||
170642596|NCT02152956|616705318|FG011|Overall Study|Adverse Event|4|||
170642597|NCT02152956|616705319|FG012|Overall Study|Adverse Event|0|||
170642598|NCT02152956|616705307|FG000|Overall Study|Death|0|||
170642599|NCT02152956|616705308|FG001|Overall Study|Death|3|||
170642600|NCT02152956|616705309|FG002|Overall Study|Death|3|||
170642601|NCT02152956|616705310|FG003|Overall Study|Death|4|||
170642602|NCT02152956|616705311|FG004|Overall Study|Death|1|||
170642603|NCT02152956|616705312|FG005|Overall Study|Death|2|||
170642604|NCT02152956|616705313|FG006|Overall Study|Death|6|||
170642605|NCT02152956|616705314|FG007|Overall Study|Death|6|||
170506633|NCT02520427|616195496|FG018|Overall Study|Death|3|||
170506634|NCT02520427|616195497|FG019|Overall Study|Death|2|||
170506635|NCT02520427|616195498|FG020|Overall Study|Death|0|||
170506636|NCT02520427|616195499|FG021|Overall Study|Death|0|||
170506637|NCT02520427|616195500|FG022|Overall Study|Death|1|||
170506638|NCT02520427|616195501|FG023|Overall Study|Death|0|||
170506639|NCT02520427|616195502|FG024|Overall Study|Death|1|||
170506640|NCT02520427|616195503|FG025|Overall Study|Death|0|||
170506641|NCT00793624|616195504|FG000|Overall Study|Adverse Event|18|||
170506642|NCT00793624|616195505|FG001|Overall Study|Adverse Event|16|||
170642606|NCT02152956|616705315|FG008|Overall Study|Death|4|||
170642607|NCT02152956|616705316|FG009|Overall Study|Death|5|||
170642608|NCT02152956|616705317|FG010|Overall Study|Death|3|||
170642609|NCT02152956|616705318|FG011|Overall Study|Death|143|||
170642610|NCT02152956|616705319|FG012|Overall Study|Death|12|||
170642611|NCT02152956|616705307|FG000|Overall Study|Lost to Follow-up|0|||
170642612|NCT02152956|616705308|FG001|Overall Study|Lost to Follow-up|1|||
170642613|NCT02152956|616705309|FG002|Overall Study|Lost to Follow-up|0|||
170642614|NCT02152956|616705310|FG003|Overall Study|Lost to Follow-up|0|||
170642615|NCT02152956|616705311|FG004|Overall Study|Lost to Follow-up|0|||
170642616|NCT02152956|616705312|FG005|Overall Study|Lost to Follow-up|0|||
170642617|NCT02152956|616705313|FG006|Overall Study|Lost to Follow-up|0|||
170642618|NCT02152956|616705314|FG007|Overall Study|Lost to Follow-up|0|||
170642619|NCT02152956|616705315|FG008|Overall Study|Lost to Follow-up|0|||
170642620|NCT02152956|616705316|FG009|Overall Study|Lost to Follow-up|0|||
170904217|NCT04996797|617650919|FG002|Overall Study|Ongoing|22|||
170642621|NCT02152956|616705317|FG010|Overall Study|Lost to Follow-up|0|||
170642622|NCT02152956|616705318|FG011|Overall Study|Lost to Follow-up|3|||
170642623|NCT02152956|616705319|FG012|Overall Study|Lost to Follow-up|0|||
170642624|NCT02152956|616705307|FG000|Overall Study|Withdrawal by Subject|1|||
170642625|NCT02152956|616705308|FG001|Overall Study|Withdrawal by Subject|0|||
170904218|NCT04996797|617650920|FG003|Overall Study|Ongoing|20|||
170642626|NCT02152956|616705309|FG002|Overall Study|Withdrawal by Subject|1|||
170642627|NCT02152956|616705310|FG003|Overall Study|Withdrawal by Subject|0|||
170642628|NCT02152956|616705311|FG004|Overall Study|Withdrawal by Subject|2|||
170506643|NCT00793624|616195506|FG002|Overall Study|Adverse Event|15|||
170506644|NCT00793624|616195507|FG003|Overall Study|Adverse Event|20|||
170506645|NCT00793624|616195504|FG000|Overall Study|Lost to Follow-up|2|||
170506646|NCT00793624|616195505|FG001|Overall Study|Lost to Follow-up|2|||
170506647|NCT00793624|616195506|FG002|Overall Study|Lost to Follow-up|4|||
170506648|NCT00793624|616195507|FG003|Overall Study|Lost to Follow-up|0|||
170506649|NCT00793624|616195504|FG000|Overall Study|Withdrawal by Subject|20|||
170506650|NCT00793624|616195505|FG001|Overall Study|Withdrawal by Subject|9|||
170506651|NCT00793624|616195506|FG002|Overall Study|Withdrawal by Subject|11|||
170506652|NCT00793624|616195507|FG003|Overall Study|Withdrawal by Subject|14|||
170506653|NCT00793624|616195504|FG000|Overall Study|Lack of Efficacy|9|||
170506654|NCT00793624|616195505|FG001|Overall Study|Lack of Efficacy|2|||
170552474|NCT01835431|616368006|FG000|Overall Study|Withdrawal by Subject|6|||
170552475|NCT01835431|616368007|FG001|Overall Study|Withdrawal by Subject|10|||
170552476|NCT01835431|616368006|FG000|Overall Study|Protocol Violation|1|||
170552477|NCT01835431|616368007|FG001|Overall Study|Protocol Violation|0|||
170552478|NCT00655356|616368008|FG000|Overall Study|Withdrawal by Subject|3|||
170552479|NCT00655356|616368009|FG001|Overall Study|Withdrawal by Subject|4|||
170552480|NCT00655356|616368008|FG000|Overall Study|Sponsor Request|10|||
170552481|NCT00655356|616368009|FG001|Overall Study|Sponsor Request|4|||
170552482|NCT00655356|616368008|FG000|Overall Study|Adverse Event|1|||
170552483|NCT00655356|616368009|FG001|Overall Study|Adverse Event|1|||
170552484|NCT00655356|616368008|FG000|Overall Study|Protocol Violation|2|||
170552485|NCT00655356|616368009|FG001|Overall Study|Protocol Violation|1|||
170552486|NCT00655356|616368008|FG000|Overall Study|Other Reason|1|||
170552487|NCT00655356|616368009|FG001|Overall Study|Other Reason|0|||
170552488|NCT01684033|616368012|FG000|Period 1, First 30 Days|Adverse Event|1|||
170552489|NCT01684033|616368013|FG001|Period 1, First 30 Days|Adverse Event|1|||
170552490|NCT01684033|616368012|FG000|Period 1, First 30 Days|Noncompliance|1|||
170552491|NCT01684033|616368013|FG001|Period 1, First 30 Days|Noncompliance|0|||
170552492|NCT01684033|616368012|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
170552493|NCT01684033|616368013|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
170552494|NCT01684033|616368012|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
170552495|NCT01684033|616368013|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
170552496|NCT01684033|616368012|FG000|Period 2, Second 30 Days|Adverse Event|1|||
170552497|NCT01684033|616368013|FG001|Period 2, Second 30 Days|Adverse Event|0|||
170552498|NCT02792257|616368020|FG000|Overall Study|Lost to Follow-up|3|||
170552499|NCT02792257|616368021|FG001|Overall Study|Lost to Follow-up|4|||
170552500|NCT02792257|616368020|FG000|Overall Study|Allergy|0|||
170552501|NCT02792257|616368021|FG001|Overall Study|Allergy|1|||
170552502|NCT02792257|616368020|FG000|Overall Study|Protocol Violation|2|||
170552503|NCT02792257|616368021|FG001|Overall Study|Protocol Violation|0|||
170552504|NCT02792257|616368020|FG000|Overall Study|Excessive Agitation|0|||
170552505|NCT02792257|616368021|FG001|Overall Study|Excessive Agitation|1|||
170552506|NCT02792257|616368020|FG000|Overall Study|Not Feeling Well|0|||
170552507|NCT02792257|616368021|FG001|Overall Study|Not Feeling Well|1|||
170552508|NCT02766478|616368023|FG000|Overall Study|Withdrawal by Subject|1|||
170552509|NCT02766478|616368024|FG001|Overall Study|Withdrawal by Subject|1|||
170552510|NCT00682435|616368025|FG000|Overall Study|Insufficient data|5|||
170552511|NCT00682435|616368025|FG000|Overall Study|Erroneously enrolled twice|2|||
170552512|NCT01117350|616368026|FG000|Comparative Period|Not Treated|5|||
170552513|NCT01117350|616368027|FG001|Comparative Period|Not Treated|8|||
170552514|NCT01117350|616368026|FG000|Comparative Period|Adverse Event|6|||
170552515|NCT01117350|616368027|FG001|Comparative Period|Adverse Event|33|||
170552516|NCT01117350|616368026|FG000|Comparative Period|Lost to Follow-up|11|||
170904219|NCT04996797|617650917|FG000|Overall Study|Withdrawal by Subject|0|||
170904220|NCT04996797|617650918|FG001|Overall Study|Withdrawal by Subject|2|||
170506655|NCT00793624|616195506|FG002|Overall Study|Lack of Efficacy|1|||
170506656|NCT00793624|616195507|FG003|Overall Study|Lack of Efficacy|3|||
170506657|NCT00793624|616195504|FG000|Overall Study|Non compliance with protocol|2|||
170552517|NCT01117350|616368027|FG001|Comparative Period|Lost to Follow-up|7|||
170552518|NCT01117350|616368026|FG000|Comparative Period|Withdrawal by Subject|9|||
170552519|NCT01117350|616368027|FG001|Comparative Period|Withdrawal by Subject|13|||
170552520|NCT01117350|616368026|FG000|Comparative Period|Protocol Violation|8|||
170506658|NCT00793624|616195505|FG001|Overall Study|Non compliance with protocol|3|||
170506659|NCT00793624|616195506|FG002|Overall Study|Non compliance with protocol|2|||
170552521|NCT01117350|616368027|FG001|Comparative Period|Protocol Violation|12|||
170552522|NCT01117350|616368026|FG000|Comparative Period|Lack of Efficacy|1|||
170552523|NCT01117350|616368027|FG001|Comparative Period|Lack of Efficacy|0|||
170552524|NCT01117350|616368026|FG000|Comparative Period|Physician Decision|0|||
170552525|NCT01117350|616368027|FG001|Comparative Period|Physician Decision|1|||
170552526|NCT01117350|616368026|FG000|Comparative Period|Move to another city/country|2|||
170552527|NCT01117350|616368027|FG001|Comparative Period|Move to another city/country|1|||
170552528|NCT01117350|616368026|FG000|Extension Period|Not included in extension, not treated|0|||
170552529|NCT01117350|616368027|FG001|Extension Period|Not included in extension, not treated|50|||
170552530|NCT01117350|616368026|FG000|Extension Period|Adverse Event|0|||
170552531|NCT01117350|616368027|FG001|Extension Period|Adverse Event|2|||
170642629|NCT02152956|616705312|FG005|Overall Study|Withdrawal by Subject|2|||
170642630|NCT02152956|616705313|FG006|Overall Study|Withdrawal by Subject|0|||
170642631|NCT02152956|616705314|FG007|Overall Study|Withdrawal by Subject|0|||
170642632|NCT02152956|616705315|FG008|Overall Study|Withdrawal by Subject|1|||
170642633|NCT02152956|616705316|FG009|Overall Study|Withdrawal by Subject|0|||
170642634|NCT02152956|616705317|FG010|Overall Study|Withdrawal by Subject|0|||
170642635|NCT02152956|616705318|FG011|Overall Study|Withdrawal by Subject|4|||
170642636|NCT02152956|616705319|FG012|Overall Study|Withdrawal by Subject|0|||
170642637|NCT02152956|616705307|FG000|Overall Study|Physician Decision|0|||
170642638|NCT02152956|616705308|FG001|Overall Study|Physician Decision|0|||
170642639|NCT02152956|616705309|FG002|Overall Study|Physician Decision|0|||
170642640|NCT02152956|616705310|FG003|Overall Study|Physician Decision|0|||
170642641|NCT02152956|616705311|FG004|Overall Study|Physician Decision|0|||
170642642|NCT02152956|616705312|FG005|Overall Study|Physician Decision|0|||
170642643|NCT02152956|616705313|FG006|Overall Study|Physician Decision|0|||
170642644|NCT02152956|616705314|FG007|Overall Study|Physician Decision|0|||
170642645|NCT02152956|616705315|FG008|Overall Study|Physician Decision|0|||
170642646|NCT02152956|616705316|FG009|Overall Study|Physician Decision|0|||
170642647|NCT02152956|616705317|FG010|Overall Study|Physician Decision|0|||
170642648|NCT02152956|616705318|FG011|Overall Study|Physician Decision|1|||
170642649|NCT02152956|616705319|FG012|Overall Study|Physician Decision|0|||
170642650|NCT02152956|616705307|FG000|Overall Study|Study terminated by sponsor|0|||
170642651|NCT02152956|616705308|FG001|Overall Study|Study terminated by sponsor|0|||
170642652|NCT02152956|616705309|FG002|Overall Study|Study terminated by sponsor|0|||
170642653|NCT02152956|616705310|FG003|Overall Study|Study terminated by sponsor|0|||
170642654|NCT02152956|616705311|FG004|Overall Study|Study terminated by sponsor|0|||
170642655|NCT02152956|616705312|FG005|Overall Study|Study terminated by sponsor|0|||
170642656|NCT02152956|616705313|FG006|Overall Study|Study terminated by sponsor|0|||
170642657|NCT02152956|616705314|FG007|Overall Study|Study terminated by sponsor|0|||
170642658|NCT02152956|616705315|FG008|Overall Study|Study terminated by sponsor|0|||
170642659|NCT02152956|616705316|FG009|Overall Study|Study terminated by sponsor|0|||
170642660|NCT02152956|616705317|FG010|Overall Study|Study terminated by sponsor|0|||
170642661|NCT02152956|616705318|FG011|Overall Study|Study terminated by sponsor|29|||
170642662|NCT02152956|616705319|FG012|Overall Study|Study terminated by sponsor|0|||
170642663|NCT02152956|616705307|FG000|Overall Study|progressive disease|0|||
170642664|NCT02152956|616705308|FG001|Overall Study|progressive disease|0|||
170642665|NCT02152956|616705309|FG002|Overall Study|progressive disease|0|||
170642666|NCT02152956|616705310|FG003|Overall Study|progressive disease|0|||
170642667|NCT02152956|616705311|FG004|Overall Study|progressive disease|0|||
170642668|NCT02152956|616705312|FG005|Overall Study|progressive disease|0|||
170642669|NCT02152956|616705313|FG006|Overall Study|progressive disease|0|||
170642670|NCT02152956|616705314|FG007|Overall Study|progressive disease|0|||
170642671|NCT02152956|616705315|FG008|Overall Study|progressive disease|1|||
170642672|NCT02152956|616705316|FG009|Overall Study|progressive disease|0|||
170642673|NCT02152956|616705317|FG010|Overall Study|progressive disease|0|||
170642674|NCT02152956|616705318|FG011|Overall Study|progressive disease|1|||
170642675|NCT02152956|616705319|FG012|Overall Study|progressive disease|0|||
170642676|NCT05661851|616705320|FG000|Overall Study|Protocol Violation|1|||
170642677|NCT05661851|616705321|FG001|Overall Study|Protocol Violation|1|||
170642678|NCT05661851|616705320|FG000|Overall Study|Covid-19 Related|3|||
170642679|NCT05661851|616705321|FG001|Overall Study|Covid-19 Related|4|||
170642680|NCT05661851|616705320|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
170642681|NCT05661851|616705321|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
170642682|NCT05661851|616705320|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
170642683|NCT05661851|616705321|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
170642684|NCT01136785|616705322|FG000|Overall Study|Protocol Violation|2|||
170642685|NCT01136785|616705323|FG001|Overall Study|Protocol Violation|1|||
170642686|NCT00612807|616705324|FG000|Overall Study|Withdrawal by Subject|2|||
170642687|NCT00612807|616705325|FG001|Overall Study|Withdrawal by Subject|0|||
170642688|NCT01057589|616705326|FG000|Overall Study|Disease Progression|35|||
170642689|NCT01057589|616705326|FG000|Overall Study|Adverse Event|10|||
170642690|NCT01057589|616705326|FG000|Overall Study|Physician Decision|8|||
170642691|NCT01057589|616705326|FG000|Overall Study|Withdrawal by Subject|3|||
170642692|NCT01057589|616705326|FG000|Overall Study|Sponsor Decision|1|||
170642693|NCT01057589|616705326|FG000|Overall Study|Death|8|||
170642694|NCT01057589|616705326|FG000|Overall Study|Lost to Follow-up|1|||
170805428|NCT02401815|617297374|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
170805429|NCT02401815|617297375|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
170642695|NCT00744042|616705327|FG000|Overall Study|Withdrawal by Subject|1|||
170642696|NCT01519167|616705328|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
170805430|NCT02401815|617297376|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
170642697|NCT01519167|616705329|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
170642698|NCT01519167|616705328|FG000|Overall Study|Adverse Event|0|||
170642699|NCT01519167|616705329|FG001|Overall Study|Adverse Event|1|||
170642700|NCT01519167|616705328|FG000|Overall Study|Lack of Efficacy|0|||
170642701|NCT01519167|616705329|FG001|Overall Study|Lack of Efficacy|1|||
170552532|NCT01117350|616368026|FG000|Extension Period|Protocol Violation|0|||
170552533|NCT01117350|616368027|FG001|Extension Period|Protocol Violation|2|||
170552534|NCT01117350|616368026|FG000|Extension Period|Lost to Follow-up|0|||
170552535|NCT01117350|616368027|FG001|Extension Period|Lost to Follow-up|2|||
170552536|NCT01117350|616368026|FG000|Extension Period|Withdrawal by Subject|0|||
170552537|NCT01117350|616368027|FG001|Extension Period|Withdrawal by Subject|3|||
170506660|NCT00793624|616195507|FG003|Overall Study|Non compliance with protocol|3|||
170506661|NCT00793624|616195504|FG000|Overall Study|Other reason not described above|6|||
170506662|NCT00793624|616195505|FG001|Overall Study|Other reason not described above|4|||
170506663|NCT00793624|616195506|FG002|Overall Study|Other reason not described above|6|||
170506664|NCT00793624|616195507|FG003|Overall Study|Other reason not described above|3|||
170506665|NCT02637713|616195508|FG000|Overall Study|Screen Failure|2|||
170506666|NCT02267135|616195509|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
170506667|NCT02267135|616195510|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
170506668|NCT02267135|616195509|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
170506669|NCT02267135|616195510|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
170506670|NCT02267135|616195509|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
170506671|NCT02267135|616195510|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
170506672|NCT02267135|616195509|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
170506673|NCT02267135|616195510|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
170506674|NCT02267135|616195509|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
170506675|NCT02267135|616195510|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
170506676|NCT03806231|616195511|FG000|Overall Study|Physician Decision|1|||
170506677|NCT03806231|616195512|FG001|Overall Study|Physician Decision|0|||
170506678|NCT03806231|616195511|FG000|Overall Study|Withdrawal by Subject|1|||
170506679|NCT03806231|616195512|FG001|Overall Study|Withdrawal by Subject|0|||
170506680|NCT03467763|616195513|FG000|Overall Study|Lost to Follow-up|1|||
170506681|NCT03467763|616195513|FG000|Overall Study|Protocol Violation|2|||
170506682|NCT02407054|616195514|FG000|Overall Study|Adverse Event|1|||
170506683|NCT02407054|616195515|FG001|Overall Study|Adverse Event|4|||
170506684|NCT02407054|616195516|FG002|Overall Study|Adverse Event|1|||
170506685|NCT02407054|616195514|FG000|Overall Study|Non-compliance with Study|0|||
170506686|NCT02407054|616195515|FG001|Overall Study|Non-compliance with Study|2|||
170506687|NCT02407054|616195516|FG002|Overall Study|Non-compliance with Study|1|||
170506688|NCT02407054|616195514|FG000|Overall Study|Physician Decision|1|||
170506689|NCT02407054|616195515|FG001|Overall Study|Physician Decision|3|||
170506690|NCT02407054|616195516|FG002|Overall Study|Physician Decision|3|||
170506691|NCT02407054|616195514|FG000|Overall Study|Withdrawal by Subject|5|||
170506692|NCT02407054|616195515|FG001|Overall Study|Withdrawal by Subject|9|||
170506693|NCT02407054|616195516|FG002|Overall Study|Withdrawal by Subject|2|||
170506694|NCT03089853|616197350|FG000|Overall Study|Lost to Follow-up|2|||
170506695|NCT03089853|616197351|FG001|Overall Study|Lost to Follow-up|1|||
170506696|NCT00703326|616197356|FG000|Overall Study|Lost to Follow-up|47|||
170506697|NCT00703326|616197357|FG001|Overall Study|Lost to Follow-up|18|||
170506698|NCT00703326|616197356|FG000|Overall Study|Withdrawal by Subject|54|||
170506699|NCT00703326|616197357|FG001|Overall Study|Withdrawal by Subject|20|||
170506700|NCT00703326|616197356|FG000|Overall Study|Adverse Event|1|||
170506701|NCT00703326|616197357|FG001|Overall Study|Adverse Event|0|||
170506702|NCT02661061|616197359|FG000|Overall Study|Lack of Efficacy|1|||
170506703|NCT02661061|616197360|FG001|Overall Study|Lack of Efficacy|1|||
170506704|NCT02661061|616197359|FG000|Overall Study|Withdrawal by Subject|1|||
170506705|NCT02661061|616197360|FG001|Overall Study|Withdrawal by Subject|1|||
170506706|NCT02732015|616197361|FG000|Overall Study|Lost to Follow-up|0|||
170506707|NCT02732015|616197362|FG001|Overall Study|Lost to Follow-up|1|||
170506708|NCT03052920|616197363|FG000|Overall Study|Withdrawal by Subject|1|||
170506709|NCT01980628|616197364|FG000|Overall Study|Adverse Event|12|||
170506710|NCT01980628|616197364|FG000|Overall Study|Physician Decision|5|||
170506711|NCT01980628|616197364|FG000|Overall Study|Withdrawal by Subject|4|||
170506712|NCT01980628|616197364|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
170506713|NCT05437640|616197367|FG000|Washout (1 Week)|Adverse Event|1|||
170506714|NCT05437640|616197368|FG001|Washout (1 Week)|Adverse Event|0|||
170506715|NCT02474355|616197369|FG000|Overall Study|Other|43|||
170506716|NCT02474355|616197369|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
170552538|NCT01117350|616368026|FG000|Extension Period|Lack of Efficacy|0|||
170904221|NCT04996797|617650919|FG002|Overall Study|Withdrawal by Subject|0|||
170506717|NCT02474355|616197369|FG000|Overall Study|Lost to Follow-up|98|||
170506718|NCT02474355|616197369|FG000|Overall Study|Withdrawal by Subject|124|||
170506719|NCT02474355|616197369|FG000|Overall Study|Death|1361|||
170904222|NCT04996797|617650920|FG003|Overall Study|Withdrawal by Subject|0|||
170506720|NCT03015194|616197371|FG000|Overall Study|Death|10|||
170506721|NCT03015194|616197371|FG000|Overall Study|Withdrawal by Subject|2|||
170506722|NCT01937715|616197375|FG000|Overall Study|Death|0|||
170506723|NCT01937715|616197376|FG001|Overall Study|Death|0|||
170506724|NCT01937715|616197377|FG002|Overall Study|Death|0|||
170506725|NCT01937715|616197378|FG003|Overall Study|Death|1|||
170506726|NCT01937715|616197379|FG004|Overall Study|Death|0|||
170552539|NCT01117350|616368027|FG001|Extension Period|Lack of Efficacy|2|||
170506727|NCT01937715|616197375|FG000|Overall Study|Withdrawal by Subject|0|||
170506728|NCT01937715|616197376|FG001|Overall Study|Withdrawal by Subject|1|||
170506729|NCT01937715|616197377|FG002|Overall Study|Withdrawal by Subject|0|||
170506730|NCT01937715|616197378|FG003|Overall Study|Withdrawal by Subject|0|||
170506731|NCT01937715|616197379|FG004|Overall Study|Withdrawal by Subject|2|||
170506732|NCT01937715|616197375|FG000|Overall Study|Other|0|||
170506733|NCT01937715|616197376|FG001|Overall Study|Other|0|||
170506734|NCT01937715|616197377|FG002|Overall Study|Other|0|||
170506735|NCT01937715|616197378|FG003|Overall Study|Other|3|||
170506736|NCT01937715|616197379|FG004|Overall Study|Other|0|||
170506737|NCT01698268|616197382|FG000|Overall Study|Physician Decision|2|||
170506738|NCT01698268|616197383|FG001|Overall Study|Physician Decision|1|||
170506739|NCT00433017|616197384|FG000|Overall Study|Adverse Event|5|||
170506740|NCT00433017|616197385|FG001|Overall Study|Adverse Event|3|||
170506741|NCT00433017|616197384|FG000|Overall Study|Withdrawal by Subject|4|||
170506742|NCT00433017|616197385|FG001|Overall Study|Withdrawal by Subject|5|||
170506743|NCT00433017|616197384|FG000|Overall Study|Lost to Follow-up|3|||
170506744|NCT00433017|616197385|FG001|Overall Study|Lost to Follow-up|4|||
170506745|NCT00433017|616197384|FG000|Overall Study|Administrative problems|80|||
170506746|NCT00433017|616197385|FG001|Overall Study|Administrative problems|86|||
170506747|NCT00433017|616197384|FG000|Overall Study|Protocol Violation|1|||
170506748|NCT00433017|616197385|FG001|Overall Study|Protocol Violation|0|||
170506749|NCT00433017|616197384|FG000|Overall Study|Death|2|||
170506750|NCT00433017|616197385|FG001|Overall Study|Death|2|||
170506751|NCT00433017|616197384|FG000|Overall Study|Subject no longer requires study drug|1|||
170506752|NCT00433017|616197385|FG001|Overall Study|Subject no longer requires study drug|1|||
170506753|NCT00153816|616197386|FG000|Overall Study|Death|6|||
170506754|NCT00153816|616197387|FG001|Overall Study|Death|5|||
170506755|NCT00153816|616197388|FG002|Overall Study|Death|4|||
170506756|NCT00153816|616197389|FG003|Overall Study|Death|6|||
170506757|NCT00153816|616197390|FG004|Overall Study|Death|0|||
170506758|NCT00153816|616197391|FG005|Overall Study|Death|2|||
170506759|NCT00153816|616197386|FG000|Overall Study|Lost to Follow-up|7|||
170506760|NCT00153816|616197387|FG001|Overall Study|Lost to Follow-up|8|||
170506761|NCT00153816|616197388|FG002|Overall Study|Lost to Follow-up|5|||
170506762|NCT00153816|616197389|FG003|Overall Study|Lost to Follow-up|8|||
170506763|NCT00153816|616197390|FG004|Overall Study|Lost to Follow-up|7|||
170506764|NCT00153816|616197391|FG005|Overall Study|Lost to Follow-up|9|||
170506765|NCT00153816|616197386|FG000|Overall Study|Withdrawal by Subject|9|||
170506766|NCT00153816|616197387|FG001|Overall Study|Withdrawal by Subject|9|||
170506767|NCT00153816|616197388|FG002|Overall Study|Withdrawal by Subject|9|||
170506768|NCT00153816|616197389|FG003|Overall Study|Withdrawal by Subject|4|||
170506769|NCT00153816|616197390|FG004|Overall Study|Withdrawal by Subject|1|||
170506770|NCT00153816|616197391|FG005|Overall Study|Withdrawal by Subject|5|||
170506771|NCT00153816|616197386|FG000|Overall Study|Follow-up exam not done|8|||
170506772|NCT00153816|616197387|FG001|Overall Study|Follow-up exam not done|7|||
170506773|NCT00153816|616197388|FG002|Overall Study|Follow-up exam not done|11|||
170506774|NCT00153816|616197389|FG003|Overall Study|Follow-up exam not done|10|||
170506775|NCT00153816|616197390|FG004|Overall Study|Follow-up exam not done|8|||
170506776|NCT00153816|616197391|FG005|Overall Study|Follow-up exam not done|9|||
170506777|NCT00153816|616197386|FG000|Overall Study|Follow-up exam done, histology missing|2|||
170506778|NCT00153816|616197387|FG001|Overall Study|Follow-up exam done, histology missing|3|||
170506779|NCT00153816|616197388|FG002|Overall Study|Follow-up exam done, histology missing|3|||
170506780|NCT00153816|616197389|FG003|Overall Study|Follow-up exam done, histology missing|3|||
170506781|NCT00153816|616197390|FG004|Overall Study|Follow-up exam done, histology missing|1|||
170506782|NCT00153816|616197391|FG005|Overall Study|Follow-up exam done, histology missing|2|||
170506783|NCT02190721|616197392|FG000|Overall Study|Patient was out of the city|0|||
170506784|NCT02190721|616197393|FG001|Overall Study|Patient was out of the city|1|||
170506785|NCT02190721|616197394|FG002|Overall Study|Patient was out of the city|0|||
170506786|NCT02263729|616197395|FG000|Overall Study|Lost to Follow-up|1|||
170506787|NCT02263729|616197396|FG001|Overall Study|Lost to Follow-up|1|||
170552540|NCT01117350|616368026|FG000|Extension Period|Inclusion criteria not respected|0|||
170506788|NCT04591015|616197397|FG000|Overall Study|Death|6|||
170506789|NCT04591015|616197398|FG001|Overall Study|Death|4|||
170506790|NCT04591015|616197397|FG000|Overall Study|Withdrawal by Subject|6|||
170506791|NCT04591015|616197398|FG001|Overall Study|Withdrawal by Subject|3|||
170506792|NCT04591015|616197397|FG000|Overall Study|Lost to Follow-up|16|||
170506793|NCT04591015|616197398|FG001|Overall Study|Lost to Follow-up|11|||
170506794|NCT02509078|616197399|FG000|Overall Study|Protocol Violation|1|||
170506795|NCT02509078|616197400|FG001|Overall Study|Protocol Violation|1|||
170506796|NCT03326518|616197401|FG000|Overall Study|Protocol Violation|1|||
170506797|NCT03326518|616197402|FG001|Overall Study|Protocol Violation|0|||
170506798|NCT03326518|616197403|FG002|Overall Study|Protocol Violation|0|||
170506799|NCT03326518|616197401|FG000|Overall Study|Withdrawal by Subject|1|||
170506800|NCT03326518|616197402|FG001|Overall Study|Withdrawal by Subject|0|||
170506801|NCT03326518|616197403|FG002|Overall Study|Withdrawal by Subject|0|||
170506802|NCT03326518|616197401|FG000|Overall Study|Lost to Follow-up|1|||
170506803|NCT03326518|616197402|FG001|Overall Study|Lost to Follow-up|0|||
170506804|NCT03326518|616197403|FG002|Overall Study|Lost to Follow-up|1|||
170506805|NCT03594955|616197407|FG000|Overall Study|Adverse Event|1|||
170506806|NCT03594955|616197407|FG000|Overall Study|Progressive disease|5|||
170506807|NCT03594955|616197407|FG000|Overall Study|Sponsor's decision|1|||
170506808|NCT06439095|616197409|FG000|Overall Study|Lost to Follow-up|2|||
170506809|NCT02131636|616197415|FG000|Overall Study|Personal Reasons|4|||
170506810|NCT02131636|616197416|FG001|Overall Study|Personal Reasons|4|||
170506811|NCT02131636|616197415|FG000|Overall Study|Lost to Follow-up|4|||
170506812|NCT02131636|616197416|FG001|Overall Study|Lost to Follow-up|0|||
170506813|NCT02131636|616197415|FG000|Overall Study|Adverse Event|4|||
170506814|NCT02131636|616197416|FG001|Overall Study|Adverse Event|1|||
170506815|NCT03484403|616197417|FG000|Overall Study|Withdrawal by Subject|6|||
170506816|NCT03484403|616197418|FG001|Overall Study|Withdrawal by Subject|4|||
170506817|NCT02173379|616197419|FG000|Overall Study|Lost to Follow-up|89|||
170506818|NCT02173379|616197420|FG001|Overall Study|Lost to Follow-up|81|||
170506819|NCT02173379|616197419|FG000|Overall Study|Withdrawal by Subject|24|||
170506820|NCT02173379|616197420|FG001|Overall Study|Withdrawal by Subject|29|||
170506821|NCT02173379|616197419|FG000|Overall Study|Physician Decision|8|||
170506822|NCT02173379|616197420|FG001|Overall Study|Physician Decision|8|||
170506823|NCT02173379|616197419|FG000|Overall Study|Death|75|||
170506824|NCT02173379|616197420|FG001|Overall Study|Death|72|||
170506825|NCT02173379|616197419|FG000|Overall Study|Other Reason|1|||
170506826|NCT02173379|616197420|FG001|Overall Study|Other Reason|0|||
170506827|NCT06226649|616197422|FG000|Overall Study|Withdrawal by Subject|4|||
170506828|NCT06226649|616197423|FG001|Overall Study|Withdrawal by Subject|1|||
170506829|NCT00631163|616197428|FG000|Number of Participants in Year 1|Adverse Event|12|||
170506830|NCT00631163|616197428|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
170506831|NCT00631163|616197428|FG000|Number of Participants in Year 1|Death|6|||
170506832|NCT00631163|616197428|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
170506833|NCT00631163|616197428|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
170506834|NCT00631163|616197428|FG000|Number of Participants in Year 1|Administrative problems|6|||
170506835|NCT00631163|616197428|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
170506836|NCT00631163|616197428|FG000|Number of Participants in Year 2|Adverse Event|1|||
170506837|NCT00631163|616197428|FG000|Number of Participants in Year 2|Protocol Violation|1|||
170506838|NCT00631163|616197428|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
170506839|NCT02290925|616197434|FG000|First Period of Three Months|Lost to Follow-up|2|||
170506840|NCT02290925|616197435|FG001|First Period of Three Months|Lost to Follow-up|1|||
170506841|NCT02290925|616197434|FG000|First Period of Three Months|Death|1|||
170506842|NCT02290925|616197435|FG001|First Period of Three Months|Death|0|||
170506843|NCT02290925|616197434|FG000|First Period of Three Months|Insulin Started|1|||
170506844|NCT02290925|616197435|FG001|First Period of Three Months|Insulin Started|1|||
170506845|NCT02290925|616197434|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
170506846|NCT02290925|616197435|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
170506847|NCT02290925|616197434|FG000|Second Period of 3 Months|insulin started|0|||
170506848|NCT02290925|616197435|FG001|Second Period of 3 Months|insulin started|1|||
170506849|NCT00981058|616197443|FG000|Overall Study|Progressive Disease|38|||
170506850|NCT00981058|616197444|FG001|Overall Study|Progressive Disease|31|||
170506851|NCT00981058|616197443|FG000|Overall Study|Lost to Follow-up|3|||
170506852|NCT00981058|616197444|FG001|Overall Study|Lost to Follow-up|2|||
170506853|NCT00981058|616197443|FG000|Overall Study|Physician Decision|4|||
170506854|NCT00981058|616197444|FG001|Overall Study|Physician Decision|5|||
170506855|NCT00981058|616197443|FG000|Overall Study|Randomization Error|0|||
170552541|NCT01117350|616368027|FG001|Extension Period|Inclusion criteria not respected|1|||
170552542|NCT01117350|616368026|FG000|Extension Period|Prohibited medication|0|||
170552543|NCT01117350|616368027|FG001|Extension Period|Prohibited medication|1|||
170552544|NCT03760666|616368028|FG000|Overall Study|Adverse Event|2|||
170552545|NCT03760666|616368029|FG001|Overall Study|Adverse Event|4|||
170552546|NCT03760666|616368030|FG002|Overall Study|Adverse Event|1|||
170552547|NCT03760666|616368028|FG000|Overall Study|AML Disease Progression|3|||
170552548|NCT03760666|616368029|FG001|Overall Study|AML Disease Progression|3|||
170552549|NCT03760666|616368030|FG002|Overall Study|AML Disease Progression|0|||
170552550|NCT03760666|616368028|FG000|Overall Study|Physician Decision|0|||
170552551|NCT03760666|616368029|FG001|Overall Study|Physician Decision|3|||
170552552|NCT03760666|616368030|FG002|Overall Study|Physician Decision|0|||
170552553|NCT03760666|616368028|FG000|Overall Study|Withdrawal by Subject|0|||
170552554|NCT03760666|616368029|FG001|Overall Study|Withdrawal by Subject|1|||
170552555|NCT03760666|616368030|FG002|Overall Study|Withdrawal by Subject|0|||
170552556|NCT01064622|616368036|FG000|Randomized Phase II|Withdrawal by Subject|2|||
170552557|NCT01064622|616368037|FG001|Randomized Phase II|Withdrawal by Subject|2|||
170552558|NCT01064622|616368036|FG000|Randomized Phase II|Protocol Violation|0|||
170552559|NCT01064622|616368037|FG001|Randomized Phase II|Protocol Violation|1|||
170552560|NCT02946996|616368040|FG000|Overall Study|non-evaluable|3|||
170552561|NCT02946996|616368041|FG001|Overall Study|non-evaluable|6|||
170552562|NCT02946996|616368042|FG002|Overall Study|non-evaluable|5|||
170552563|NCT00176254|616368043|FG000|Overall Study|Lost to Follow-up|1|||
170552564|NCT05330429|616368046|FG000|Overall Study|Study Terminated by Sponsor|4|||
170552565|NCT05330429|616368047|FG001|Overall Study|Study Terminated by Sponsor|33|||
170552566|NCT05330429|616368048|FG002|Overall Study|Study Terminated by Sponsor|12|||
170552567|NCT05330429|616368046|FG000|Overall Study|Death|5|||
170552568|NCT05330429|616368047|FG001|Overall Study|Death|2|||
170552569|NCT05330429|616368048|FG002|Overall Study|Death|4|||
170552570|NCT05330429|616368046|FG000|Overall Study|Withdrew Consent|0|||
170552571|NCT05330429|616368047|FG001|Overall Study|Withdrew Consent|5|||
170552572|NCT05330429|616368048|FG002|Overall Study|Withdrew Consent|4|||
170552573|NCT05330429|616368046|FG000|Overall Study|Investigator's Discretion|0|||
170552574|NCT05330429|616368047|FG001|Overall Study|Investigator's Discretion|1|||
170552575|NCT05330429|616368048|FG002|Overall Study|Investigator's Discretion|3|||
170552576|NCT05330429|616368046|FG000|Overall Study|Subject Decision|1|||
170552577|NCT05330429|616368047|FG001|Overall Study|Subject Decision|2|||
170552578|NCT05330429|616368048|FG002|Overall Study|Subject Decision|0|||
170552579|NCT05330429|616368046|FG000|Overall Study|Lost to Follow-up|0|||
170552580|NCT05330429|616368047|FG001|Overall Study|Lost to Follow-up|1|||
170552581|NCT05330429|616368048|FG002|Overall Study|Lost to Follow-up|0|||
170552582|NCT00450749|616368050|FG000|Overall Study|Withdrawal by Subject|0|||
170552583|NCT00450749|616368051|FG001|Overall Study|Withdrawal by Subject|0|||
170552584|NCT00450749|616368052|FG002|Overall Study|Withdrawal by Subject|2|||
170552585|NCT00450749|616368050|FG000|Overall Study|Noncompliant|0|||
170552586|NCT00450749|616368051|FG001|Overall Study|Noncompliant|1|||
170552587|NCT00450749|616368052|FG002|Overall Study|Noncompliant|0|||
170552588|NCT01245049|616368053|FG000|Overall Study|Migrated/moved from study area|0|||
170552589|NCT01245049|616368054|FG001|Overall Study|Migrated/moved from study area|1|||
170552590|NCT01245049|616368053|FG000|Overall Study|Withdrawal by Subject|0|||
170552591|NCT01245049|616368054|FG001|Overall Study|Withdrawal by Subject|1|||
170552592|NCT01245049|616368053|FG000|Overall Study|Lost to Follow-up|1|||
170552593|NCT01245049|616368054|FG001|Overall Study|Lost to Follow-up|2|||
170552594|NCT00537082|616368055|FG000|Overall Study|Adverse Event|6|||
170552595|NCT00537082|616368056|FG001|Overall Study|Adverse Event|6|||
170552596|NCT00537082|616368057|FG002|Overall Study|Adverse Event|3|||
170552597|NCT00537082|616368055|FG000|Overall Study|Protocol Violation|0|||
170552598|NCT00537082|616368056|FG001|Overall Study|Protocol Violation|2|||
170552599|NCT00537082|616368057|FG002|Overall Study|Protocol Violation|1|||
170552600|NCT00537082|616368055|FG000|Overall Study|Lack of Efficacy|0|||
170552601|NCT00537082|616368056|FG001|Overall Study|Lack of Efficacy|0|||
170552602|NCT00537082|616368057|FG002|Overall Study|Lack of Efficacy|2|||
170552603|NCT00537082|616368055|FG000|Overall Study|Withdrawal by Subject|0|||
170552604|NCT00537082|616368056|FG001|Overall Study|Withdrawal by Subject|1|||
170552605|NCT00537082|616368057|FG002|Overall Study|Withdrawal by Subject|0|||
170552606|NCT00537082|616368055|FG000|Overall Study|Discontinued before initiating treatment|3|||
170552607|NCT00537082|616368056|FG001|Overall Study|Discontinued before initiating treatment|0|||
170552608|NCT00537082|616368057|FG002|Overall Study|Discontinued before initiating treatment|0|||
170552609|NCT02568254|616368058|FG000|Period 2|Adverse Event|0|||
170552610|NCT02568254|616368059|FG001|Period 2|Adverse Event|0|||
170552611|NCT02568254|616368060|FG002|Period 2|Adverse Event|1|||
170552612|NCT02568254|616368061|FG003|Period 2|Adverse Event|0|||
170552613|NCT02568254|616368062|FG004|Period 2|Adverse Event|0|||
170552614|NCT02568254|616368063|FG005|Period 2|Adverse Event|0|||
170552615|NCT02568254|616368058|FG000|Period 3|Unstatisfactory Lens fitting|0|||
170552616|NCT02568254|616368059|FG001|Period 3|Unstatisfactory Lens fitting|0|||
170552617|NCT02568254|616368060|FG002|Period 3|Unstatisfactory Lens fitting|0|||
170552618|NCT02568254|616368061|FG003|Period 3|Unstatisfactory Lens fitting|0|||
170552619|NCT02568254|616368062|FG004|Period 3|Unstatisfactory Lens fitting|1|||
170552620|NCT02568254|616368063|FG005|Period 3|Unstatisfactory Lens fitting|0|||
170552621|NCT02931539|616368064|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
170805431|NCT02401815|617297377|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
170552622|NCT02931539|616368065|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
170552623|NCT02931539|616368066|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
170552624|NCT02931539|616368064|FG000|Period 1: Treatment Phase|Adverse Event|5|||
170552625|NCT02931539|616368065|FG001|Period 1: Treatment Phase|Adverse Event|1|||
170552626|NCT02931539|616368066|FG002|Period 1: Treatment Phase|Adverse Event|0|||
170552627|NCT02931539|616368064|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
170552628|NCT02931539|616368065|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
170552629|NCT02931539|616368066|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
170552630|NCT02931539|616368064|FG000|Period 1: Treatment Phase|Death|8|||
170552631|NCT02931539|616368065|FG001|Period 1: Treatment Phase|Death|24|||
170552632|NCT02931539|616368066|FG002|Period 1: Treatment Phase|Death|0|||
170552633|NCT02931539|616368064|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
170552634|NCT02931539|616368065|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
170552635|NCT02931539|616368066|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
170642702|NCT01519167|616705328|FG000|Overall Study|Medical condition changes&deep sedation|0|||
170642703|NCT01519167|616705329|FG001|Overall Study|Medical condition changes&deep sedation|2|||
170642704|NCT01519167|616705328|FG000|Overall Study|Physician Decision|0|||
170642705|NCT01519167|616705329|FG001|Overall Study|Physician Decision|1|||
170642706|NCT02252939|616705335|FG000|Overall Study|Lost to Follow-up|3|||
170642707|NCT04270370|616705336|FG000|Overall Study|Lost to Follow-up|1|||
170506856|NCT00981058|616197444|FG001|Overall Study|Randomization Error|1|||
170506857|NCT00981058|616197443|FG000|Overall Study|Withdrawal by Subject|24|||
170506858|NCT00981058|616197444|FG001|Overall Study|Withdrawal by Subject|22|||
170506859|NCT02667587|616197445|FG000|Pre-Treatment|Not reported|1|||
170506860|NCT02667587|616197446|FG001|Pre-Treatment|Not reported|0|||
170506861|NCT02667587|616197445|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
170506862|NCT02667587|616197446|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
170506863|NCT02667587|616197445|FG000|Pre-Treatment|Participant withdrew consent|0|||
170506864|NCT02667587|616197446|FG001|Pre-Treatment|Participant withdrew consent|1|||
170506865|NCT02667587|616197445|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
170506866|NCT02667587|616197446|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
170506867|NCT02667587|616197445|FG000|End of Treatment|Disease Progression|193|||
170506868|NCT02667587|616197446|FG001|End of Treatment|Disease Progression|226|||
170506869|NCT02667587|616197445|FG000|End of Treatment|Study Drug Toxicity|75|||
170506870|NCT02667587|616197446|FG001|End of Treatment|Study Drug Toxicity|19|||
170506871|NCT02667587|616197445|FG000|End of Treatment|Death|2|||
170506872|NCT02667587|616197446|FG001|End of Treatment|Death|1|||
170506873|NCT02667587|616197445|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
170506874|NCT02667587|616197446|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
170506875|NCT02667587|616197445|FG000|End of Treatment|participant request to discontinue treatment|33|||
170506876|NCT02667587|616197446|FG001|End of Treatment|participant request to discontinue treatment|35|||
170506877|NCT02667587|616197445|FG000|End of Treatment|participant withdrew consent|5|||
170506878|NCT02667587|616197446|FG001|End of Treatment|participant withdrew consent|6|||
170506879|NCT02667587|616197445|FG000|End of Treatment|Lost to Follow-up|1|||
170506880|NCT02667587|616197446|FG001|End of Treatment|Lost to Follow-up|2|||
170506881|NCT02667587|616197445|FG000|End of Treatment|maximum clinical benefit|4|||
170506882|NCT02667587|616197446|FG001|End of Treatment|maximum clinical benefit|4|||
170506883|NCT02667587|616197445|FG000|End of Treatment|poor or non compliant|0|||
170506884|NCT02667587|616197446|FG001|End of Treatment|poor or non compliant|1|||
170506885|NCT02667587|616197445|FG000|End of Treatment|participant no longer meets study criteria|1|||
170506886|NCT02667587|616197446|FG001|End of Treatment|participant no longer meets study criteria|1|||
170506887|NCT02667587|616197445|FG000|End of Treatment|administrative reason by sponsor|1|||
170506888|NCT02667587|616197446|FG001|End of Treatment|administrative reason by sponsor|29|||
170506889|NCT02667587|616197445|FG000|End of Treatment|other reasonse|21|||
170506890|NCT02667587|616197446|FG001|End of Treatment|other reasonse|10|||
170506891|NCT02305446|616197453|FG000|Overall Study|Adverse Event|1|||
170506892|NCT01636947|616197454|FG000|Overall Study|Not Treated|2|||
170506893|NCT01636947|616197455|FG001|Overall Study|Not Treated|2|||
170506894|NCT01636947|616197454|FG000|Overall Study|Lost to Follow-up|4|||
170506895|NCT01636947|616197455|FG001|Overall Study|Lost to Follow-up|0|||
170506896|NCT01636947|616197454|FG000|Overall Study|Protocol Violation|1|||
170506897|NCT01636947|616197455|FG001|Overall Study|Protocol Violation|1|||
170506898|NCT01636947|616197454|FG000|Overall Study|Withdrawal by Subject|3|||
170506899|NCT01636947|616197455|FG001|Overall Study|Withdrawal by Subject|3|||
170506900|NCT01636947|616197454|FG000|Overall Study|Adverse Event|1|||
170506901|NCT01636947|616197455|FG001|Overall Study|Adverse Event|1|||
170506902|NCT01636947|616197454|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
170506903|NCT01636947|616197455|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
170506904|NCT01492101|616197456|FG000|Overall Study|Death|323|||
170506905|NCT01492101|616197457|FG001|Overall Study|Death|322|||
170506906|NCT01492101|616197456|FG000|Overall Study|Withdrawal by Subject|14|||
170506907|NCT01492101|616197457|FG001|Overall Study|Withdrawal by Subject|18|||
170506908|NCT01492101|616197456|FG000|Overall Study|Lost to Follow-up|0|||
170506909|NCT01492101|616197457|FG001|Overall Study|Lost to Follow-up|2|||
170642708|NCT04270370|616705337|FG001|Overall Study|Lost to Follow-up|0|||
170642709|NCT04270370|616705338|FG002|Overall Study|Lost to Follow-up|0|||
170642710|NCT04270370|616705339|FG003|Overall Study|Lost to Follow-up|0|||
170642711|NCT04270370|616705340|FG004|Overall Study|Lost to Follow-up|0|||
170642712|NCT04270370|616705341|FG005|Overall Study|Lost to Follow-up|0|||
170642713|NCT04270370|616705342|FG006|Overall Study|Lost to Follow-up|0|||
170506910|NCT00316914|616197460|FG000|Overall Study|Withdrawal by Subject|5|||
170506911|NCT00316914|616197461|FG001|Overall Study|Withdrawal by Subject|3|||
170506912|NCT00316914|616197460|FG000|Overall Study|Adverse Event|8|||
170506913|NCT00316914|616197461|FG001|Overall Study|Adverse Event|7|||
170506914|NCT00316914|616197460|FG000|Overall Study|Other Problems|6|||
170506915|NCT00316914|616197461|FG001|Overall Study|Other Problems|11|||
170506916|NCT00316914|616197460|FG000|Overall Study|Missing end of treatment documentation|14|||
170506917|NCT00316914|616197461|FG001|Overall Study|Missing end of treatment documentation|15|||
170642714|NCT04270370|616705343|FG007|Overall Study|Lost to Follow-up|0|||
170506918|NCT00717275|616197462|FG000|Overall Study|Premature study termination.|3|||
170506919|NCT00424021|616197463|FG000|NCT00046319 Study Period|Adverse Event|1|||
170506920|NCT00424021|616197464|FG001|NCT00046319 Study Period|Adverse Event|0|||
170506921|NCT00424021|616197465|FG002|NCT00046319 Study Period|Adverse Event|1|||
170506922|NCT00424021|616197466|FG003|NCT00046319 Study Period|Adverse Event|1|||
170506923|NCT00424021|616197463|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
170506924|NCT00424021|616197464|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
170506925|NCT00424021|616197465|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
170506926|NCT00424021|616197466|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
170506927|NCT00424021|616197463|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
170506928|NCT00424021|616197464|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
170552636|NCT02931539|616368064|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
170552637|NCT02931539|616368065|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
170552638|NCT02931539|616368066|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
170552639|NCT02931539|616368064|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
170552640|NCT02931539|616368065|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
170552641|NCT02931539|616368066|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
170552642|NCT02931539|616368064|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
170552643|NCT02931539|616368065|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
170552644|NCT02931539|616368066|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
170552645|NCT01197300|616370180|FG000|Overall Study|Lost to Follow-up|0|||
170552646|NCT01197300|616370181|FG001|Overall Study|Lost to Follow-up|1|||
170552647|NCT01197300|616370180|FG000|Overall Study|Protocol Violation|0|||
170552648|NCT01197300|616370181|FG001|Overall Study|Protocol Violation|1|||
170552649|NCT04280783|616370186|FG000|Overall Study|Family issues unrelated to the study.|1|||
170552650|NCT04280783|616370187|FG001|Overall Study|Family issues unrelated to the study.|0|||
170552651|NCT04280783|616370186|FG000|Overall Study|Withdrawal by Subject|0|||
170552652|NCT04280783|616370187|FG001|Overall Study|Withdrawal by Subject|1|||
170552653|NCT00530257|616370188|FG000|Overall Study|Lost to Follow-up|1|||
170552654|NCT02715856|616370190|FG000|Overall Study|Software Issues|12|||
170552655|NCT02715856|616370191|FG001|Overall Study|Software Issues|7|||
170552656|NCT02715856|616370190|FG000|Overall Study|Death|6|||
170552657|NCT02715856|616370191|FG001|Overall Study|Death|5|||
170552658|NCT02715856|616370190|FG000|Overall Study|Non- Compliant|0|||
170552659|NCT02715856|616370191|FG001|Overall Study|Non- Compliant|40|||
170552660|NCT02254460|616370192|FG000|Overall Study|Adverse Event|1|||
170552661|NCT02254460|616370193|FG001|Overall Study|Adverse Event|0|||
170552662|NCT03439072|616370196|FG000|Overall Study|Withdrawal by Subject|2|||
170552663|NCT03439072|616370197|FG001|Overall Study|Withdrawal by Subject|3|||
170552664|NCT03439072|616370196|FG000|Overall Study|Physician Decision|0|||
170552665|NCT03439072|616370197|FG001|Overall Study|Physician Decision|1|||
170552666|NCT02003898|616370204|FG000|Overall Study|Death|3|||
170552667|NCT02003898|616370204|FG000|Overall Study|Lost to Follow-up|12|||
170552668|NCT02003898|616370204|FG000|Overall Study|Withdrawal by Subject|52|||
170552669|NCT02872142|616370207|FG000|Overall Study|Adverse Event|2|||
170552670|NCT02872142|616370207|FG000|Overall Study|Death|1|||
170552671|NCT02872142|616370207|FG000|Overall Study|Participant Decision|3|||
170552672|NCT02605967|616370208|FG000|Overall Study|subject / guardian decision|1|||
170552673|NCT02605967|616370209|FG001|Overall Study|subject / guardian decision|2|||
170552674|NCT02605967|616370208|FG000|Overall Study|Physician Decision|10|||
170552675|NCT02605967|616370209|FG001|Overall Study|Physician Decision|1|||
170552676|NCT02605967|616370208|FG000|Overall Study|Death|4|||
170552677|NCT02605967|616370209|FG001|Overall Study|Death|2|||
170552678|NCT02605967|616370208|FG000|Overall Study|Adverse Event|1|||
170552679|NCT02605967|616370209|FG001|Overall Study|Adverse Event|0|||
170552680|NCT02605967|616370208|FG000|Overall Study|progressive disease|66|||
170552681|NCT02605967|616370209|FG001|Overall Study|progressive disease|35|||
170552682|NCT01475825|616370210|FG000|Overall Study|Adverse Event|41|||
170552683|NCT01475825|616370211|FG001|Overall Study|Adverse Event|15|||
170552684|NCT01475825|616370212|FG002|Overall Study|Adverse Event|27|||
170552685|NCT01475825|616370213|FG003|Overall Study|Adverse Event|11|||
170552686|NCT01475825|616370210|FG000|Overall Study|Death|1|||
170552687|NCT01475825|616370211|FG001|Overall Study|Death|0|||
170552688|NCT01475825|616370212|FG002|Overall Study|Death|1|||
170552689|NCT01475825|616370213|FG003|Overall Study|Death|0|||
170552690|NCT01475825|616370210|FG000|Overall Study|Lack of Efficacy|0|||
170552691|NCT01475825|616370211|FG001|Overall Study|Lack of Efficacy|0|||
170552692|NCT01475825|616370212|FG002|Overall Study|Lack of Efficacy|1|||
170552693|NCT01475825|616370213|FG003|Overall Study|Lack of Efficacy|0|||
170506929|NCT00424021|616197465|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
170506930|NCT00424021|616197466|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
170552694|NCT01475825|616370210|FG000|Overall Study|Lost to Follow-up|0|||
170552695|NCT01475825|616370211|FG001|Overall Study|Lost to Follow-up|0|||
170552696|NCT01475825|616370212|FG002|Overall Study|Lost to Follow-up|3|||
170552697|NCT01475825|616370213|FG003|Overall Study|Lost to Follow-up|1|||
170552698|NCT01475825|616370210|FG000|Overall Study|Non-compliance with Study Drug|1|||
170805432|NCT02401815|617297378|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
170805433|NCT02401815|617297379|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
170805434|NCT02401815|617297380|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
170805435|NCT02401815|617297381|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
170506931|NCT00424021|616197463|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
170506932|NCT00424021|616197464|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
170506933|NCT00424021|616197465|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
170506934|NCT00424021|616197466|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
170506935|NCT00424021|616197463|FG000|AMB-220-E Study Period|Adverse Event|1|||
170506936|NCT00424021|616197464|FG001|AMB-220-E Study Period|Adverse Event|1|||
170506937|NCT00424021|616197465|FG002|AMB-220-E Study Period|Adverse Event|3|||
170506938|NCT00424021|616197466|FG003|AMB-220-E Study Period|Adverse Event|7|||
170506939|NCT00424021|616197463|FG000|AMB-220-E Study Period|Death|0|||
170506940|NCT00424021|616197464|FG001|AMB-220-E Study Period|Death|0|||
170506941|NCT00424021|616197465|FG002|AMB-220-E Study Period|Death|1|||
170506942|NCT00424021|616197466|FG003|AMB-220-E Study Period|Death|1|||
170506943|NCT00424021|616197463|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
170506944|NCT00424021|616197464|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
170506945|NCT00424021|616197465|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
170506946|NCT00424021|616197466|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
170506947|NCT00424021|616197463|FG000|AMB-220-E Study Period|Physician Decision|0|||
170506948|NCT00424021|616197464|FG001|AMB-220-E Study Period|Physician Decision|0|||
170506949|NCT00424021|616197465|FG002|AMB-220-E Study Period|Physician Decision|0|||
170506950|NCT00424021|616197466|FG003|AMB-220-E Study Period|Physician Decision|1|||
170506951|NCT03769194|616197467|FG000|Overall Study|Withdrawal by Subject|0|||
170506952|NCT03769194|616197468|FG001|Overall Study|Withdrawal by Subject|7|||
170506953|NCT03769194|616197469|FG002|Overall Study|Withdrawal by Subject|4|||
170506954|NCT03769194|616197470|FG003|Overall Study|Withdrawal by Subject|1|||
170506955|NCT03769194|616197467|FG000|Overall Study|moved from study area|0|||
170506956|NCT03769194|616197468|FG001|Overall Study|moved from study area|2|||
170506957|NCT03769194|616197469|FG002|Overall Study|moved from study area|1|||
170506958|NCT03769194|616197470|FG003|Overall Study|moved from study area|1|||
170506959|NCT03769194|616197467|FG000|Overall Study|Lost to Follow-up|3|||
170506960|NCT03769194|616197468|FG001|Overall Study|Lost to Follow-up|6|||
170506961|NCT03769194|616197469|FG002|Overall Study|Lost to Follow-up|3|||
170506962|NCT03769194|616197470|FG003|Overall Study|Lost to Follow-up|6|||
170506963|NCT03769194|616197467|FG000|Overall Study|other|1|||
170506964|NCT03769194|616197468|FG001|Overall Study|other|3|||
170506965|NCT03769194|616197469|FG002|Overall Study|other|0|||
170506966|NCT03769194|616197470|FG003|Overall Study|other|1|||
170506967|NCT00568334|616197475|FG000|Overall Study|Withdrawal by Subject|0|||
170506968|NCT00568334|616197476|FG001|Overall Study|Withdrawal by Subject|1|||
170506969|NCT00568334|616197475|FG000|Overall Study|Lost to Follow-up|1|||
170506970|NCT00568334|616197476|FG001|Overall Study|Lost to Follow-up|0|||
170506971|NCT01606202|616197477|FG000|Overall Study|Adverse Event|5|||
170506972|NCT01606202|616197478|FG001|Overall Study|Adverse Event|0|||
170506973|NCT01606202|616197477|FG000|Overall Study|Withdrawal by Subject|2|||
170506974|NCT01606202|616197478|FG001|Overall Study|Withdrawal by Subject|1|||
170506975|NCT01606202|616197477|FG000|Overall Study|Personal problems|0|||
170506976|NCT01606202|616197478|FG001|Overall Study|Personal problems|1|||
170506977|NCT01606202|616197477|FG000|Overall Study|Problems with administration|0|||
170506978|NCT01606202|616197478|FG001|Overall Study|Problems with administration|1|||
170506979|NCT00337779|616197479|FG000|Overall Study|Withdrawal by Subject|10|||
170506980|NCT00337779|616197480|FG001|Overall Study|Withdrawal by Subject|12|||
170506981|NCT00337779|616197479|FG000|Overall Study|Sponsor decision|1|||
170506982|NCT00337779|616197480|FG001|Overall Study|Sponsor decision|1|||
170506983|NCT00337779|616197479|FG000|Overall Study|Physician Decision|3|||
170506984|NCT00337779|616197480|FG001|Overall Study|Physician Decision|6|||
170506985|NCT00337779|616197479|FG000|Overall Study|Protocol Violation|1|||
170506986|NCT00337779|616197480|FG001|Overall Study|Protocol Violation|1|||
170506987|NCT00337779|616197479|FG000|Overall Study|Lost to Follow-up|6|||
170506988|NCT00337779|616197480|FG001|Overall Study|Lost to Follow-up|5|||
170506989|NCT00337779|616197479|FG000|Overall Study|Adverse Event|28|||
170506990|NCT00337779|616197480|FG001|Overall Study|Adverse Event|51|||
170506991|NCT00337779|616197479|FG000|Overall Study|Pregnancy|3|||
170506992|NCT00337779|616197480|FG001|Overall Study|Pregnancy|2|||
170506993|NCT00337779|616197479|FG000|Overall Study|Death|0|||
170506994|NCT00337779|616197480|FG001|Overall Study|Death|1|||
170506995|NCT01074255|616197481|FG000|Overall Study|Did not receive EMEND|2|||
170506996|NCT01389258|616197482|FG000|Overall Study|Lost to Follow-up|5|||
170506997|NCT01904903|616197488|FG000|Overall Study|Withdrawal by Subject|1|||
170506998|NCT04769739|616197491|FG000|Overall Study|Colorectal cancer obstruction|2|||
170506999|NCT04769739|616197492|FG001|Overall Study|Colorectal cancer obstruction|0|||
170507000|NCT04769739|616197493|FG002|Overall Study|Colorectal cancer obstruction|0|||
170507001|NCT04769739|616197494|FG003|Overall Study|Colorectal cancer obstruction|0|||
170507002|NCT04769739|616197491|FG000|Overall Study|Failed cecal intubation|1|||
170507003|NCT04769739|616197492|FG001|Overall Study|Failed cecal intubation|0|||
170805436|NCT02401815|617297382|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
170507004|NCT04769739|616197493|FG002|Overall Study|Failed cecal intubation|0|||
170507005|NCT04769739|616197494|FG003|Overall Study|Failed cecal intubation|1|||
170507006|NCT04769739|616197491|FG000|Overall Study|Poor bowel preparation|0|||
170507007|NCT04769739|616197492|FG001|Overall Study|Poor bowel preparation|0|||
170507008|NCT04769739|616197493|FG002|Overall Study|Poor bowel preparation|0|||
170507009|NCT04769739|616197494|FG003|Overall Study|Poor bowel preparation|1|||
170507010|NCT02696434|616199072|FG000|Overall Study|Adverse Event|3|||
170642715|NCT04270370|616705344|FG008|Overall Study|Lost to Follow-up|1|||
170805437|NCT02401815|617297373|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170805438|NCT02401815|617297374|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170805439|NCT02401815|617297375|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170805440|NCT02401815|617297376|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170805441|NCT02401815|617297377|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170507011|NCT02696434|616199073|FG001|Overall Study|Adverse Event|1|||
170507012|NCT02696434|616199072|FG000|Overall Study|Lost to Follow-up|5|||
170507013|NCT02696434|616199073|FG001|Overall Study|Lost to Follow-up|4|||
170507014|NCT02696434|616199072|FG000|Overall Study|Withdrawal by Subject|14|||
170507015|NCT02696434|616199073|FG001|Overall Study|Withdrawal by Subject|12|||
170507016|NCT02696434|616199072|FG000|Overall Study|Physician Decision|0|||
170507017|NCT02696434|616199073|FG001|Overall Study|Physician Decision|1|||
170507018|NCT00427999|616199077|FG000|Overall Study|Adverse Event|6|||
170507019|NCT00427999|616199077|FG000|Overall Study|Abnormal laboratory values|1|||
170507020|NCT00427999|616199077|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
170507021|NCT00427999|616199077|FG000|Overall Study|Protocol Violation|2|||
170507022|NCT00427999|616199077|FG000|Overall Study|Withdrawal by Subject|9|||
170507023|NCT00427999|616199077|FG000|Overall Study|Death|1|||
170507024|NCT00460265|616199078|FG000|Overall Study|Lost to Follow-up|14|||
170507025|NCT00460265|616199079|FG001|Overall Study|Lost to Follow-up|15|||
170507026|NCT00460265|616199078|FG000|Overall Study|Physician Decision|1|||
170507027|NCT00460265|616199079|FG001|Overall Study|Physician Decision|2|||
170507028|NCT00460265|616199078|FG000|Overall Study|Withdrawal by Subject|10|||
170507029|NCT00460265|616199079|FG001|Overall Study|Withdrawal by Subject|25|||
170507030|NCT00460265|616199078|FG000|Overall Study|Ongoing|60|||
170507031|NCT00460265|616199079|FG001|Overall Study|Ongoing|47|||
170507032|NCT01917344|616199093|FG000|Overall Study|Withdrawal by Subject|1|||
170507033|NCT02956057|616199094|FG000|Overall Study|Discontinued intervention|14|||
170507034|NCT02956057|616199095|FG001|Overall Study|Discontinued intervention|10|||
170507035|NCT02956057|616199096|FG002|Overall Study|Discontinued intervention|7|||
170507036|NCT02956057|616199097|FG003|Overall Study|Discontinued intervention|14|||
170507037|NCT02956057|616199098|FG004|Overall Study|Discontinued intervention|4|||
170507038|NCT02956057|616199099|FG005|Overall Study|Discontinued intervention|17|||
170507039|NCT02956057|616199094|FG000|Overall Study|Lost to Follow-up|0|||
170507040|NCT02956057|616199095|FG001|Overall Study|Lost to Follow-up|2|||
170507041|NCT02956057|616199096|FG002|Overall Study|Lost to Follow-up|1|||
170507042|NCT02956057|616199097|FG003|Overall Study|Lost to Follow-up|1|||
170507043|NCT02956057|616199098|FG004|Overall Study|Lost to Follow-up|1|||
170507044|NCT02956057|616199099|FG005|Overall Study|Lost to Follow-up|0|||
170507045|NCT01420679|616199104|FG000|Overall Study|Disease Progression|3|||
170507046|NCT01420679|616199105|FG001|Overall Study|Disease Progression|2|||
170507047|NCT01420679|616199104|FG000|Overall Study|Adverse Event|4|||
170507048|NCT01420679|616199105|FG001|Overall Study|Adverse Event|0|||
170507049|NCT01420679|616199104|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
170507050|NCT01420679|616199105|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
170507051|NCT01420679|616199104|FG000|Overall Study|Patient Decision|1|||
170507052|NCT01420679|616199105|FG001|Overall Study|Patient Decision|0|||
170507053|NCT01420679|616199104|FG000|Overall Study|Investigator Decision|1|||
170507054|NCT01420679|616199105|FG001|Overall Study|Investigator Decision|2|||
170507055|NCT01420679|616199104|FG000|Overall Study|Sponsor Decision|3|||
170507056|NCT01420679|616199105|FG001|Overall Study|Sponsor Decision|3|||
170507057|NCT01420679|616199104|FG000|Overall Study|Other|1|||
170507058|NCT01420679|616199105|FG001|Overall Study|Other|0|||
170507059|NCT03956615|616199106|FG000|Overall Study|No multiple myeloma confirmed|2|||
170507060|NCT03956615|616199106|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
170507061|NCT03956615|616199106|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
170507062|NCT03956615|616199106|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
170507063|NCT01069419|616199107|FG000|Overall Study|Adverse Event|233|||
170507064|NCT01069419|616199107|FG000|Overall Study|Lack of Efficacy|332|||
170507065|NCT01069419|616199107|FG000|Overall Study|Lost to Follow-up|49|||
170507066|NCT01069419|616199107|FG000|Overall Study|Remission of disease|11|||
170507067|NCT01069419|616199107|FG000|Overall Study|Withdrawal by Subject|34|||
170507068|NCT01069419|616199107|FG000|Overall Study|Other Reason|43|||
170507069|NCT01069419|616199107|FG000|Overall Study|Missing termination information|13|||
170507070|NCT03114657|616199114|FG000|Overall Study|Adverse Event|9|||
170805442|NCT02401815|617297378|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
170805443|NCT02401815|617297379|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170805444|NCT02401815|617297380|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170805445|NCT02401815|617297381|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170805446|NCT02401815|617297382|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
170805447|NCT02401815|617297373|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805448|NCT02401815|617297374|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805449|NCT02401815|617297375|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805450|NCT02401815|617297376|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170642716|NCT04270370|616705345|FG009|Overall Study|Lost to Follow-up|0|||
170642717|NCT04270370|616705346|FG010|Overall Study|Lost to Follow-up|0|||
170642718|NCT04270370|616705347|FG011|Overall Study|Lost to Follow-up|0|||
170642719|NCT02560025|616705348|FG000|Overall Study|Ineligible after consent/ registration|3|||
170805451|NCT02401815|617297377|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170507071|NCT03114657|616199115|FG001|Overall Study|Adverse Event|6|||
170642720|NCT01497366|616705349|FG000|Overall Study|Virologic failure|2|||
170642721|NCT01497366|616705350|FG001|Overall Study|Virologic failure|50|||
170642722|NCT01497366|616705349|FG000|Overall Study|Lost to Follow-up|11|||
170642723|NCT01497366|616705350|FG001|Overall Study|Lost to Follow-up|10|||
170642724|NCT01497366|616705349|FG000|Overall Study|Withdrawal by Subject|6|||
170642725|NCT01497366|616705350|FG001|Overall Study|Withdrawal by Subject|6|||
170642726|NCT01497366|616705349|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
170642727|NCT01497366|616705350|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
170642728|NCT01497366|616705349|FG000|Overall Study|Other|5|||
170642729|NCT01497366|616705350|FG001|Overall Study|Other|0|||
170642730|NCT01497366|616705349|FG000|Overall Study|Death|1|||
170642731|NCT01497366|616705350|FG001|Overall Study|Death|1|||
170642732|NCT01497366|616705349|FG000|Overall Study|Randomized but not treated|7|||
170642733|NCT01497366|616705350|FG001|Overall Study|Randomized but not treated|21|||
170507072|NCT03114657|616199114|FG000|Overall Study|Death|4|||
170507073|NCT03114657|616199115|FG001|Overall Study|Death|0|||
170507074|NCT03114657|616199114|FG000|Overall Study|Multiple Reasons|1|||
170507075|NCT03114657|616199115|FG001|Overall Study|Multiple Reasons|2|||
170507076|NCT03114657|616199114|FG000|Overall Study|Physician Decision|2|||
170507077|NCT03114657|616199115|FG001|Overall Study|Physician Decision|2|||
170507078|NCT03114657|616199114|FG000|Overall Study|Study Terminated By Sponsor|355|||
170507079|NCT03114657|616199115|FG001|Overall Study|Study Terminated By Sponsor|374|||
170507080|NCT03114657|616199114|FG000|Overall Study|Symptomatic Deterioration|0|||
170507081|NCT03114657|616199115|FG001|Overall Study|Symptomatic Deterioration|1|||
170507082|NCT03114657|616199114|FG000|Overall Study|Withdrawal by Subject|28|||
170507083|NCT03114657|616199115|FG001|Overall Study|Withdrawal by Subject|22|||
170507084|NCT02631070|616199116|FG000|Overall Study|Withdrawal by Subject|35|||
170507085|NCT02631070|616199117|FG001|Overall Study|Withdrawal by Subject|13|||
170552699|NCT01475825|616370211|FG001|Overall Study|Non-compliance with Study Drug|2|||
170552700|NCT01475825|616370212|FG002|Overall Study|Non-compliance with Study Drug|4|||
170552701|NCT01475825|616370213|FG003|Overall Study|Non-compliance with Study Drug|0|||
170552702|NCT01475825|616370210|FG000|Overall Study|Other: Not available|0|||
170552703|NCT01475825|616370211|FG001|Overall Study|Other: Not available|0|||
170552704|NCT01475825|616370212|FG002|Overall Study|Other: Not available|2|||
170552705|NCT01475825|616370213|FG003|Overall Study|Other: Not available|0|||
170552706|NCT01475825|616370210|FG000|Overall Study|Protocol Violation|1|||
170552707|NCT01475825|616370211|FG001|Overall Study|Protocol Violation|0|||
170552708|NCT01475825|616370212|FG002|Overall Study|Protocol Violation|0|||
170552709|NCT01475825|616370213|FG003|Overall Study|Protocol Violation|0|||
170552710|NCT01475825|616370210|FG000|Overall Study|Physician Decision|0|||
170552711|NCT01475825|616370211|FG001|Overall Study|Physician Decision|1|||
170552712|NCT01475825|616370212|FG002|Overall Study|Physician Decision|0|||
170552713|NCT01475825|616370213|FG003|Overall Study|Physician Decision|0|||
170552714|NCT01475825|616370210|FG000|Overall Study|Withdrawal by Subject|8|||
170552715|NCT01475825|616370211|FG001|Overall Study|Withdrawal by Subject|3|||
170552716|NCT01475825|616370212|FG002|Overall Study|Withdrawal by Subject|11|||
170552717|NCT01475825|616370213|FG003|Overall Study|Withdrawal by Subject|7|||
170552718|NCT01475825|616370210|FG000|Overall Study|Did not enter OLC|15|||
170552719|NCT01475825|616370211|FG001|Overall Study|Did not enter OLC|11|||
170552720|NCT01475825|616370212|FG002|Overall Study|Did not enter OLC|15|||
170552721|NCT01475825|616370213|FG003|Overall Study|Did not enter OLC|11|||
170805452|NCT02401815|617297378|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170507086|NCT02631070|616199116|FG000|Overall Study|Death|45|||
170507087|NCT02631070|616199117|FG001|Overall Study|Death|24|||
170552722|NCT04157738|616370214|FG000|Overall Study|Moved out of state|0|||
170552723|NCT04157738|616370215|FG001|Overall Study|Moved out of state|2|||
170642734|NCT02745080|616705356|FG000|Overall Study|Adverse Event|13|||
170642735|NCT02745080|616705357|FG001|Overall Study|Adverse Event|21|||
170642736|NCT02745080|616705356|FG000|Overall Study|Lack of Efficacy|11|||
170642737|NCT02745080|616705357|FG001|Overall Study|Lack of Efficacy|23|||
170642738|NCT02745080|616705356|FG000|Overall Study|Lost to Follow-up|3|||
170642739|NCT02745080|616705357|FG001|Overall Study|Lost to Follow-up|3|||
170642740|NCT02745080|616705356|FG000|Overall Study|Physician Decision|3|||
170642741|NCT02745080|616705357|FG001|Overall Study|Physician Decision|0|||
170642742|NCT02745080|616705356|FG000|Overall Study|Protocol Violation|3|||
170642743|NCT02745080|616705357|FG001|Overall Study|Protocol Violation|1|||
170642744|NCT02745080|616705356|FG000|Overall Study|Withdrawal by Subject|22|||
170642745|NCT02745080|616705357|FG001|Overall Study|Withdrawal by Subject|41|||
170642746|NCT00829504|616705360|FG000|First Intervention|Adverse Event|1|||
170642747|NCT00829504|616705361|FG001|First Intervention|Adverse Event|0|||
170642748|NCT00829504|616705360|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
170642749|NCT00829504|616705361|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
170642750|NCT00829504|616705360|FG000|Second Intervention|Physician Decision|1|||
170642751|NCT00829504|616705361|FG001|Second Intervention|Physician Decision|0|||
170642752|NCT05564052|616705362|FG000|Overall Study|Withdrawal by Subject|0|||
170642753|NCT05564052|616705363|FG001|Overall Study|Withdrawal by Subject|0|||
170642754|NCT05564052|616705364|FG002|Overall Study|Withdrawal by Subject|0|||
170642755|NCT05564052|616705365|FG003|Overall Study|Withdrawal by Subject|1|||
170642756|NCT00843778|616706872|FG000|Overall Study|Adverse Event|15|||
170642757|NCT00843778|616706872|FG000|Overall Study|Lack of Efficacy|14|||
170642758|NCT00843778|616706872|FG000|Overall Study|Loss of efficacy|2|||
170642759|NCT00843778|616706872|FG000|Overall Study|Withdrawal by Subject|4|||
170642760|NCT03338959|616706873|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
170642761|NCT03338959|616706873|FG000|Overall Study|Physician Decision|1|||
170642762|NCT02894502|616706877|FG000|Baseline|Withdrawal by Subject|24|||
170642763|NCT02894502|616706878|FG001|Baseline|Withdrawal by Subject|31|||
170642764|NCT02894502|616706879|FG002|Baseline|Withdrawal by Subject|36|||
170642765|NCT02894502|616706877|FG000|Baseline|Death|3|||
170642766|NCT02894502|616706878|FG001|Baseline|Death|1|||
170642767|NCT02894502|616706879|FG002|Baseline|Death|9|||
170642768|NCT02894502|616706877|FG000|First Follow up|Withdrawal by Subject|32|||
170642769|NCT02894502|616706878|FG001|First Follow up|Withdrawal by Subject|29|||
170642770|NCT02894502|616706879|FG002|First Follow up|Withdrawal by Subject|37|||
170642771|NCT02894502|616706877|FG000|First Follow up|Death|2|||
170642772|NCT02894502|616706878|FG001|First Follow up|Death|2|||
170642773|NCT02894502|616706879|FG002|First Follow up|Death|3|||
170642774|NCT02894502|616706877|FG000|Second Follow up|Withdrawal by Subject|13|||
170642775|NCT02894502|616706878|FG001|Second Follow up|Withdrawal by Subject|15|||
170642776|NCT02894502|616706879|FG002|Second Follow up|Withdrawal by Subject|13|||
170642777|NCT02894502|616706877|FG000|Second Follow up|Death|2|||
170642778|NCT02894502|616706878|FG001|Second Follow up|Death|3|||
170642779|NCT02894502|616706879|FG002|Second Follow up|Death|1|||
170642780|NCT02894502|616706877|FG000|Third Follow up|Withdrawal by Subject|5|||
170642781|NCT02894502|616706878|FG001|Third Follow up|Withdrawal by Subject|6|||
170642782|NCT02894502|616706879|FG002|Third Follow up|Withdrawal by Subject|3|||
170642783|NCT02894502|616706877|FG000|Third Follow up|Death|1|||
170642784|NCT02894502|616706878|FG001|Third Follow up|Death|1|||
170642785|NCT02894502|616706879|FG002|Third Follow up|Death|0|||
170642786|NCT03467152|616706882|FG000|Overall Study|Adverse Event|4|||
170642787|NCT03467152|616706883|FG001|Overall Study|Adverse Event|5|||
170642788|NCT03467152|616706884|FG002|Overall Study|Adverse Event|0|||
170507088|NCT02631070|616199116|FG000|Overall Study|Lost to Follow-up|5|||
170507089|NCT02631070|616199117|FG001|Overall Study|Lost to Follow-up|1|||
170642789|NCT03467152|616706882|FG000|Overall Study|Subject Choice|1|||
170642790|NCT03467152|616706883|FG001|Overall Study|Subject Choice|3|||
170642791|NCT03467152|616706884|FG002|Overall Study|Subject Choice|0|||
170642792|NCT03467152|616706882|FG000|Overall Study|Lost to Follow-up|1|||
170642793|NCT03467152|616706883|FG001|Overall Study|Lost to Follow-up|0|||
170642794|NCT03467152|616706884|FG002|Overall Study|Lost to Follow-up|0|||
170642795|NCT03467152|616706882|FG000|Overall Study|Withdrawal by Subject|4|||
170507090|NCT02631070|616199116|FG000|Overall Study|Transition to rollover protocol|52|||
170507091|NCT02631070|616199117|FG001|Overall Study|Transition to rollover protocol|21|||
170642796|NCT03467152|616706883|FG001|Overall Study|Withdrawal by Subject|2|||
170642797|NCT03467152|616706884|FG002|Overall Study|Withdrawal by Subject|0|||
170642798|NCT03467152|616706882|FG000|Overall Study|Others|3|||
170642799|NCT03467152|616706883|FG001|Overall Study|Others|0|||
170642800|NCT03467152|616706884|FG002|Overall Study|Others|0|||
170642801|NCT03467152|616706882|FG000|Overall Study|Not treated|3|||
170642802|NCT03467152|616706883|FG001|Overall Study|Not treated|1|||
170642803|NCT03467152|616706884|FG002|Overall Study|Not treated|6|||
170642804|NCT01236547|616706886|FG000|Overall Study|Protocol Violation|0|||
170642805|NCT01236547|616706887|FG001|Overall Study|Protocol Violation|1|||
170642806|NCT01236547|616706888|FG002|Overall Study|Protocol Violation|1|||
170642807|NCT01236547|616706889|FG003|Overall Study|Protocol Violation|6|||
170642808|NCT01236547|616706890|FG004|Overall Study|Protocol Violation|12|||
170642809|NCT00435045|616706895|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
170642810|NCT00435045|616706896|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
170642811|NCT00435045|616706895|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
170642812|NCT00435045|616706896|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
170642813|NCT00435045|616706895|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
170642814|NCT00435045|616706896|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
170642815|NCT00435045|616706895|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
170642816|NCT00435045|616706896|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
170642817|NCT00435045|616706895|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
170642818|NCT00435045|616706896|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
170642819|NCT00435045|616706895|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
170642820|NCT00435045|616706896|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
170642821|NCT00435045|616706895|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
170642822|NCT00435045|616706896|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
170642823|NCT00435045|616706895|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
170642824|NCT00435045|616706896|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
170642825|NCT00435045|616706895|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
170642826|NCT00435045|616706896|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
170642827|NCT00435045|616706895|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
170642828|NCT00435045|616706896|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
170642829|NCT00435045|616706895|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
170642830|NCT00435045|616706896|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
170642831|NCT01743001|616706897|FG000|Overall Study|Physician Decision|1|||
170642832|NCT01743001|616706898|FG001|Overall Study|Physician Decision|0|||
170642833|NCT01743001|616706897|FG000|Overall Study|Pregnancy|1|||
170642834|NCT01743001|616706898|FG001|Overall Study|Pregnancy|0|||
170642835|NCT01743001|616706897|FG000|Overall Study|Death|1|||
170642836|NCT01743001|616706898|FG001|Overall Study|Death|0|||
170642837|NCT03052426|616706899|FG000|Overall Study|Withdrawal by Subject|0|||
170642838|NCT03052426|616706900|FG001|Overall Study|Withdrawal by Subject|1|||
170642839|NCT03052426|616706901|FG002|Overall Study|Withdrawal by Subject|0|||
170642840|NCT03052426|616706899|FG000|Overall Study|Lost to Follow-up|2|||
170642841|NCT03052426|616706900|FG001|Overall Study|Lost to Follow-up|0|||
170642842|NCT03052426|616706901|FG002|Overall Study|Lost to Follow-up|1|||
170642843|NCT04413617|616706902|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
170642844|NCT04413617|616706903|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
170642845|NCT04413617|616706904|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
170642846|NCT04413617|616706905|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
170642847|NCT04413617|616706906|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
170642848|NCT04413617|616706902|FG000|Overall Study|Protocol Violation|0|||
170642849|NCT04413617|616706903|FG001|Overall Study|Protocol Violation|1|||
170642850|NCT04413617|616706904|FG002|Overall Study|Protocol Violation|0|||
170642851|NCT04413617|616706905|FG003|Overall Study|Protocol Violation|0|||
170642852|NCT04413617|616706906|FG004|Overall Study|Protocol Violation|1|||
170642853|NCT04413617|616706902|FG000|Overall Study|Lack of Efficacy|2|||
170642854|NCT04413617|616706903|FG001|Overall Study|Lack of Efficacy|0|||
170642855|NCT04413617|616706904|FG002|Overall Study|Lack of Efficacy|2|||
170642856|NCT04413617|616706905|FG003|Overall Study|Lack of Efficacy|1|||
170642857|NCT04413617|616706906|FG004|Overall Study|Lack of Efficacy|0|||
170642858|NCT04413617|616706902|FG000|Overall Study|Withdrawal by Subject|3|||
170642859|NCT04413617|616706903|FG001|Overall Study|Withdrawal by Subject|4|||
170642860|NCT04413617|616706904|FG002|Overall Study|Withdrawal by Subject|2|||
170642861|NCT04413617|616706905|FG003|Overall Study|Withdrawal by Subject|5|||
170642862|NCT04413617|616706906|FG004|Overall Study|Withdrawal by Subject|3|||
170642863|NCT04413617|616706902|FG000|Overall Study|Death|1|||
170642864|NCT04413617|616706903|FG001|Overall Study|Death|0|||
170805453|NCT02401815|617297379|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
170805454|NCT02401815|617297380|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805455|NCT02401815|617297381|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805456|NCT02401815|617297382|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805457|NCT02401815|617297373|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
170805458|NCT02401815|617297374|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
170642865|NCT04413617|616706904|FG002|Overall Study|Death|0|||
170642866|NCT04413617|616706905|FG003|Overall Study|Death|0|||
170642867|NCT04413617|616706906|FG004|Overall Study|Death|0|||
170642868|NCT04413617|616706902|FG000|Overall Study|Adverse Event|1|||
170642869|NCT04413617|616706903|FG001|Overall Study|Adverse Event|0|||
170642870|NCT04413617|616706904|FG002|Overall Study|Adverse Event|0|||
170642871|NCT04413617|616706905|FG003|Overall Study|Adverse Event|1|||
170642872|NCT04413617|616706906|FG004|Overall Study|Adverse Event|1|||
170642873|NCT04413617|616706902|FG000|Overall Study|COVID-19|0|||
170642874|NCT04413617|616706903|FG001|Overall Study|COVID-19|1|||
170642875|NCT04413617|616706904|FG002|Overall Study|COVID-19|0|||
170642876|NCT04413617|616706905|FG003|Overall Study|COVID-19|0|||
170507092|NCT02631070|616199116|FG000|Overall Study|Other reasons|12|||
170507093|NCT02631070|616199117|FG001|Overall Study|Other reasons|5|||
170507094|NCT05268016|616199118|FG000|Overall Study|Unacceptable toxicity or AE|2|||
170507095|NCT05268016|616199119|FG001|Overall Study|Unacceptable toxicity or AE|2|||
170507096|NCT05268016|616199120|FG002|Overall Study|Unacceptable toxicity or AE|4|||
170507097|NCT05268016|616199121|FG003|Overall Study|Unacceptable toxicity or AE|3|||
170507098|NCT05268016|616199122|FG004|Overall Study|Unacceptable toxicity or AE|1|||
170507099|NCT05268016|616199118|FG000|Overall Study|Withdrawal by Subject|1|||
170507100|NCT05268016|616199119|FG001|Overall Study|Withdrawal by Subject|3|||
170507101|NCT05268016|616199120|FG002|Overall Study|Withdrawal by Subject|2|||
170507102|NCT05268016|616199121|FG003|Overall Study|Withdrawal by Subject|2|||
170507103|NCT05268016|616199122|FG004|Overall Study|Withdrawal by Subject|1|||
170507104|NCT05268016|616199118|FG000|Overall Study|Lost to Follow-up|4|||
170507105|NCT05268016|616199119|FG001|Overall Study|Lost to Follow-up|7|||
170507106|NCT05268016|616199120|FG002|Overall Study|Lost to Follow-up|1|||
170507107|NCT05268016|616199121|FG003|Overall Study|Lost to Follow-up|3|||
170507108|NCT05268016|616199122|FG004|Overall Study|Lost to Follow-up|5|||
170507109|NCT05268016|616199118|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
170507110|NCT05268016|616199119|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
170507111|NCT05268016|616199120|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
170507112|NCT05268016|616199121|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
170507113|NCT05268016|616199122|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
170507114|NCT05268016|616199118|FG000|Overall Study|Lack of Efficacy|0|||
170507115|NCT05268016|616199119|FG001|Overall Study|Lack of Efficacy|0|||
170507116|NCT05268016|616199120|FG002|Overall Study|Lack of Efficacy|0|||
170507117|NCT05268016|616199121|FG003|Overall Study|Lack of Efficacy|0|||
170507118|NCT05268016|616199122|FG004|Overall Study|Lack of Efficacy|4|||
170507119|NCT05268016|616199118|FG000|Overall Study|Physician Decision|0|||
170507120|NCT05268016|616199119|FG001|Overall Study|Physician Decision|0|||
170507121|NCT05268016|616199120|FG002|Overall Study|Physician Decision|0|||
170507122|NCT05268016|616199121|FG003|Overall Study|Physician Decision|1|||
170507123|NCT05268016|616199122|FG004|Overall Study|Physician Decision|0|||
170507124|NCT05268016|616199118|FG000|Overall Study|Other|1|||
170507125|NCT05268016|616199119|FG001|Overall Study|Other|0|||
170507126|NCT05268016|616199120|FG002|Overall Study|Other|1|||
170507127|NCT05268016|616199121|FG003|Overall Study|Other|2|||
170507128|NCT05268016|616199122|FG004|Overall Study|Other|0|||
170507129|NCT01964716|616199123|FG000|Overall Study|Withdrawal by Subject|2|||
170507130|NCT01964716|616199124|FG001|Overall Study|Withdrawal by Subject|3|||
170507131|NCT01964716|616199123|FG000|Overall Study|Lost to Follow-up|1|||
170507132|NCT01964716|616199124|FG001|Overall Study|Lost to Follow-up|2|||
170507133|NCT01964716|616199123|FG000|Overall Study|No longer met eligibility criteria|1|||
170507134|NCT01964716|616199124|FG001|Overall Study|No longer met eligibility criteria|1|||
170507135|NCT01964716|616199123|FG000|Overall Study|Death|1|||
170507136|NCT01964716|616199124|FG001|Overall Study|Death|0|||
170507137|NCT01281956|616199125|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
170507138|NCT01281956|616199126|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
170507139|NCT02638259|616199138|FG000|Treatment Period 1|Adverse Event|1|||
170507140|NCT02638259|616199139|FG001|Treatment Period 1|Adverse Event|5|||
170507141|NCT02638259|616199138|FG000|Treatment Period 1|Death|0|||
170507142|NCT02638259|616199139|FG001|Treatment Period 1|Death|1|||
170507143|NCT02638259|616199138|FG000|Treatment Period 1|Lack of Efficacy|0|||
170507144|NCT02638259|616199139|FG001|Treatment Period 1|Lack of Efficacy|1|||
170507145|NCT02638259|616199138|FG000|Treatment Period 1|Protocol Violation|0|||
170507146|NCT02638259|616199139|FG001|Treatment Period 1|Protocol Violation|3|||
170507147|NCT02638259|616199138|FG000|Treatment Period 1|Withdrawal by Subject|4|||
170507148|NCT02638259|616199139|FG001|Treatment Period 1|Withdrawal by Subject|6|||
170507149|NCT02638259|616199138|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
170507150|NCT02638259|616199139|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
170507151|NCT02638259|616199138|FG000|Treatment Period 2|Adverse Event|5|||
170507152|NCT02638259|616199139|FG001|Treatment Period 2|Adverse Event|4|||
170552724|NCT04157738|616370214|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
170552725|NCT04157738|616370215|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
170507153|NCT02638259|616199138|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170507154|NCT02638259|616199139|FG001|Treatment Period 2|Withdrawal by Subject|7|||
170507155|NCT03578146|616199140|FG000|Overall Study|Did Not Receive Treatment|1|||
170507156|NCT03578146|616199141|FG001|Overall Study|Did Not Receive Treatment|0|||
170507157|NCT03578146|616199142|FG002|Overall Study|Did Not Receive Treatment|0|||
170552726|NCT00160563|616370216|FG000|Overall Study|Adverse Event|1|||
170507158|NCT03578146|616199143|FG003|Overall Study|Did Not Receive Treatment|0|||
170507159|NCT03578146|616199144|FG004|Overall Study|Did Not Receive Treatment|0|||
170507160|NCT03578146|616199145|FG005|Overall Study|Did Not Receive Treatment|2|||
170507161|NCT03578146|616199140|FG000|Overall Study|Lost to Follow-up|0|||
170507162|NCT03578146|616199141|FG001|Overall Study|Lost to Follow-up|1|||
170507163|NCT03578146|616199142|FG002|Overall Study|Lost to Follow-up|1|||
170507164|NCT03578146|616199143|FG003|Overall Study|Lost to Follow-up|0|||
170642877|NCT04413617|616706906|FG004|Overall Study|COVID-19|0|||
170642878|NCT00775593|616706907|FG000|Overall Study|Unmet eligibility criteria|6|||
170642879|NCT00775593|616706907|FG000|Overall Study|Death|1|||
170642880|NCT00312195|616706908|FG000|Overall Study|Adverse Event|4|||
170642881|NCT00312195|616706909|FG001|Overall Study|Adverse Event|6|||
170642882|NCT00312195|616706908|FG000|Overall Study|Lost to Follow-up|1|||
170642883|NCT00312195|616706909|FG001|Overall Study|Lost to Follow-up|0|||
170642884|NCT00312195|616706908|FG000|Overall Study|Protocol Violation|1|||
170642885|NCT00312195|616706909|FG001|Overall Study|Protocol Violation|0|||
170642886|NCT01018810|616706912|FG000|Overall Study|Withdrawal by Subject|0|||
170642887|NCT01018810|616706913|FG001|Overall Study|Withdrawal by Subject|1|||
170642888|NCT01018810|616706914|FG002|Overall Study|Withdrawal by Subject|0|||
170642889|NCT01018810|616706915|FG003|Overall Study|Withdrawal by Subject|0|||
170642890|NCT01018810|616706916|FG004|Overall Study|Withdrawal by Subject|0|||
170642891|NCT01018810|616706912|FG000|Overall Study|Sponsor Decision|2|||
170642892|NCT01018810|616706913|FG001|Overall Study|Sponsor Decision|0|||
170642893|NCT01018810|616706914|FG002|Overall Study|Sponsor Decision|1|||
170642894|NCT01018810|616706915|FG003|Overall Study|Sponsor Decision|1|||
170642895|NCT01018810|616706916|FG004|Overall Study|Sponsor Decision|1|||
170642896|NCT01290796|616706917|FG000|Overall Study|Lost to Follow-up|21|||
170642897|NCT01290796|616706917|FG000|Overall Study|Withdrawal by Subject|4|||
170642898|NCT01290796|616706917|FG000|Overall Study|Physician Decision|2|||
170642899|NCT01290796|616706917|FG000|Overall Study|Secondary Surgical Intervention|2|||
170642900|NCT01290796|616706917|FG000|Overall Study|Withdrawal by Sponsor|1|||
170642901|NCT01090323|616706918|FG000|Overall Study|Adverse Event|12|||
170642902|NCT01090323|616706919|FG001|Overall Study|Adverse Event|2|||
170507165|NCT03578146|616199144|FG004|Overall Study|Lost to Follow-up|0|||
170507166|NCT03578146|616199145|FG005|Overall Study|Lost to Follow-up|1|||
170507167|NCT00314132|616199146|FG000|Overall Study|Lost to Follow-up|3|||
170507168|NCT00314132|616199147|FG001|Overall Study|Lost to Follow-up|13|||
170507169|NCT00314132|616199146|FG000|Overall Study|Withdrawal by Subject|3|||
170507170|NCT00314132|616199147|FG001|Overall Study|Withdrawal by Subject|5|||
170507171|NCT00314132|616199146|FG000|Overall Study|Adverse Event|1|||
170507172|NCT00314132|616199147|FG001|Overall Study|Adverse Event|0|||
170507173|NCT00314132|616199146|FG000|Overall Study|Physician Decision|1|||
170507174|NCT00314132|616199147|FG001|Overall Study|Physician Decision|0|||
170507175|NCT03677934|616199148|FG000|Overall Study|Adverse Event|1|||
170507176|NCT03677934|616199149|FG001|Overall Study|Adverse Event|1|||
170507177|NCT03677934|616199148|FG000|Overall Study|Death|8|||
170507178|NCT03677934|616199149|FG001|Overall Study|Death|4|||
170507179|NCT03677934|616199148|FG000|Overall Study|Lost to Follow-up|3|||
170507180|NCT03677934|616199149|FG001|Overall Study|Lost to Follow-up|0|||
170507181|NCT03677934|616199148|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170507182|NCT03677934|616199149|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170507183|NCT03677934|616199148|FG000|Overall Study|Physician Decision|0|||
170642903|NCT01090323|616706918|FG000|Overall Study|Abnormal Lab Values|3|||
170642904|NCT01090323|616706919|FG001|Overall Study|Abnormal Lab Values|1|||
170642905|NCT01090323|616706918|FG000|Overall Study|Abnormal Test Procedure Results|2|||
170642906|NCT01090323|616706919|FG001|Overall Study|Abnormal Test Procedure Results|0|||
170642907|NCT01090323|616706918|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170642908|NCT01090323|616706919|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170642909|NCT01090323|616706918|FG000|Overall Study|Condition no longer requires drug|5|||
170507184|NCT03677934|616199149|FG001|Overall Study|Physician Decision|1|||
170507185|NCT03677934|616199148|FG000|Overall Study|Withdrawal by Subject|1|||
170642910|NCT01090323|616706919|FG001|Overall Study|Condition no longer requires drug|4|||
170642911|NCT01090323|616706918|FG000|Overall Study|Protocol Violation|2|||
170507186|NCT03677934|616199149|FG001|Overall Study|Withdrawal by Subject|7|||
170507187|NCT00957905|616199150|FG000|Part B|Not Treated|0|||
170507188|NCT00957905|616199151|FG001|Part B|Not Treated|1|||
170507189|NCT00957905|616199150|FG000|Part B|Physician Decision|0|||
170507190|NCT00957905|616199151|FG001|Part B|Physician Decision|1|||
170642912|NCT01090323|616706919|FG001|Overall Study|Protocol Violation|1|||
170642913|NCT01090323|616706918|FG000|Overall Study|Withdrew consent|33|||
170642914|NCT01090323|616706919|FG001|Overall Study|Withdrew consent|11|||
170642915|NCT01090323|616706918|FG000|Overall Study|Lost to Follow-up|11|||
170642916|NCT01090323|616706919|FG001|Overall Study|Lost to Follow-up|6|||
170642917|NCT01090323|616706918|FG000|Overall Study|Administrative problems|6|||
170805459|NCT02401815|617297375|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
170507191|NCT00957905|616199150|FG000|Part B|Death|0|||
170507192|NCT00957905|616199151|FG001|Part B|Death|1|||
170507193|NCT00957905|616199150|FG000|Part B|Protocol Violation|0|||
170507194|NCT00957905|616199151|FG001|Part B|Protocol Violation|1|||
170642918|NCT01090323|616706919|FG001|Overall Study|Administrative problems|4|||
170642919|NCT01090323|616706918|FG000|Overall Study|Death|1|||
170642920|NCT01090323|616706919|FG001|Overall Study|Death|2|||
170642921|NCT01090323|616706918|FG000|Overall Study|Stopped end of core|7|||
170642922|NCT01090323|616706919|FG001|Overall Study|Stopped end of core|0|||
170507195|NCT01260584|616199152|FG000|Period 1|Protocol Violation|0|||
170507196|NCT01260584|616199153|FG001|Period 1|Protocol Violation|0|||
170507197|NCT01260584|616199154|FG002|Period 1|Protocol Violation|1|||
170507198|NCT01260584|616199155|FG003|Period 1|Protocol Violation|1|||
170642923|NCT01090323|616706918|FG000|Overall Study|Stopped end of extension 1#|3|||
170642924|NCT01090323|616706919|FG001|Overall Study|Stopped end of extension 1#|1|||
170642925|NCT05498701|616706920|FG000|Period 3|Adverse Event|1|||
170642926|NCT05498701|616706921|FG001|Period 3|Adverse Event|0|||
170642927|NCT02424578|616706922|FG000|Overall Study|Withdrawal by Subject|0|||
170642928|NCT02424578|616706923|FG001|Overall Study|Withdrawal by Subject|1|||
170642929|NCT01703754|616706926|FG000|Overall Study|Clinically significant disease progression|2|||
170642930|NCT01703754|616706927|FG001|Overall Study|Clinically significant disease progression|2|||
170642931|NCT01703754|616706928|FG002|Overall Study|Clinically significant disease progression|1|||
170642932|NCT01703754|616706926|FG000|Overall Study|Adverse Event|1|||
170642933|NCT01703754|616706927|FG001|Overall Study|Adverse Event|1|||
170642934|NCT01703754|616706928|FG002|Overall Study|Adverse Event|0|||
170642935|NCT01703754|616706926|FG000|Overall Study|Withdrawal by Subject|2|||
170642936|NCT01703754|616706927|FG001|Overall Study|Withdrawal by Subject|0|||
170642937|NCT01703754|616706928|FG002|Overall Study|Withdrawal by Subject|0|||
170642938|NCT00080899|616706929|FG000|Overall Study|Adverse Event|1|||
170642939|NCT02872935|616706930|FG000|Overall Study|Other|0|||
170642940|NCT02872935|616706931|FG001|Overall Study|Other|1|||
170642941|NCT03179319|616706933|FG000|Overall Study|Lost to Follow-up|6|||
170642942|NCT03179319|616706934|FG001|Overall Study|Lost to Follow-up|0|||
170642943|NCT05343624|616706935|FG000|Overall Study|Chart review not completed|1|||
170642944|NCT02640508|616706936|FG000|Overall Study|Death|19|||
170642945|NCT02640508|616706936|FG000|Overall Study|Withdrawal by Subject|8|||
170642946|NCT02640508|616706936|FG000|Overall Study|Physician Decision|1|||
170642947|NCT02640508|616706936|FG000|Overall Study|Lost to Follow-up|1|||
170642948|NCT00862082|616706937|FG000|Overall Study|Sponsor decision to terminate the study|5|||
170507199|NCT01260584|616199152|FG000|Period 1|Adverse Event|0|||
170642949|NCT00862082|616706938|FG001|Overall Study|Sponsor decision to terminate the study|0|||
170642950|NCT00862082|616706937|FG000|Overall Study|Withdrawal by Subject|0|||
170642951|NCT00862082|616706938|FG001|Overall Study|Withdrawal by Subject|1|||
170642952|NCT01763996|616706939|FG000|Treatment Period 2|Adverse Event|0|||
170642953|NCT01763996|616706940|FG001|Treatment Period 2|Adverse Event|1|||
170642954|NCT00947882|616706941|FG000|Overall Study|Adverse Event|0|||
170642955|NCT00947882|616706942|FG001|Overall Study|Adverse Event|1|||
170642956|NCT00947882|616706943|FG002|Overall Study|Adverse Event|4|||
170642957|NCT00947882|616706944|FG003|Overall Study|Adverse Event|4|||
170642958|NCT00947882|616706941|FG000|Overall Study|Withdrawal by Subject|2|||
170642959|NCT00947882|616706942|FG001|Overall Study|Withdrawal by Subject|0|||
170642960|NCT00947882|616706943|FG002|Overall Study|Withdrawal by Subject|8|||
170642961|NCT00947882|616706944|FG003|Overall Study|Withdrawal by Subject|2|||
170642962|NCT00947882|616706941|FG000|Overall Study|Protocol Violation|0|||
170642963|NCT00947882|616706942|FG001|Overall Study|Protocol Violation|0|||
170642964|NCT00947882|616706943|FG002|Overall Study|Protocol Violation|1|||
170642965|NCT00947882|616706944|FG003|Overall Study|Protocol Violation|0|||
170642966|NCT00947882|616706941|FG000|Overall Study|Lost to Follow-up|0|||
170642967|NCT00947882|616706942|FG001|Overall Study|Lost to Follow-up|2|||
170642968|NCT00947882|616706943|FG002|Overall Study|Lost to Follow-up|1|||
170642969|NCT00947882|616706944|FG003|Overall Study|Lost to Follow-up|0|||
170642970|NCT00947882|616706941|FG000|Overall Study|Other/Unknown|10|||
170642971|NCT00947882|616706942|FG001|Overall Study|Other/Unknown|13|||
170642972|NCT00947882|616706943|FG002|Overall Study|Other/Unknown|3|||
170642973|NCT00947882|616706944|FG003|Overall Study|Other/Unknown|6|||
170642974|NCT00947882|616706941|FG000|Overall Study|Trial Terminated by Sponsor|62|||
170642975|NCT00947882|616706942|FG001|Overall Study|Trial Terminated by Sponsor|61|||
170642976|NCT00947882|616706943|FG002|Overall Study|Trial Terminated by Sponsor|62|||
170642977|NCT00947882|616706944|FG003|Overall Study|Trial Terminated by Sponsor|70|||
170642978|NCT02636361|616706945|FG000|Period 4|Physician Decision|0|||
170642979|NCT02636361|616706946|FG001|Period 4|Physician Decision|0|||
170507200|NCT01260584|616199153|FG001|Period 1|Adverse Event|0|||
170642980|NCT02636361|616706947|FG002|Period 4|Physician Decision|0|||
170642981|NCT02636361|616706948|FG003|Period 4|Physician Decision|1|||
170642982|NCT02636361|616706949|FG004|Period 4|Physician Decision|0|||
170642983|NCT04535453|616706950|FG000|Overall Study|Death|0|||
170642984|NCT04535453|616706951|FG001|Overall Study|Death|1|||
170642985|NCT04535453|616706952|FG002|Overall Study|Death|0|||
170642986|NCT04535453|616706953|FG003|Overall Study|Death|0|||
170642987|NCT04535453|616706954|FG004|Overall Study|Death|0|||
170642988|NCT04535453|616706955|FG005|Overall Study|Death|0|||
170642989|NCT04535453|616706956|FG006|Overall Study|Death|0|||
170642990|NCT04535453|616706957|FG007|Overall Study|Death|0|||
170642991|NCT04535453|616706958|FG008|Overall Study|Death|0|||
170642992|NCT04535453|616706959|FG009|Overall Study|Death|0|||
170642993|NCT04535453|616706960|FG010|Overall Study|Death|0|||
170642994|NCT04535453|616706961|FG011|Overall Study|Death|0|||
170507201|NCT01260584|616199154|FG002|Period 1|Adverse Event|1|||
170642995|NCT04535453|616706950|FG000|Overall Study|Lost to Follow-up|1|||
170642996|NCT04535453|616706951|FG001|Overall Study|Lost to Follow-up|1|||
170642997|NCT04535453|616706952|FG002|Overall Study|Lost to Follow-up|1|||
170642998|NCT04535453|616706953|FG003|Overall Study|Lost to Follow-up|0|||
170507202|NCT01260584|616199155|FG003|Period 1|Adverse Event|0|||
170507203|NCT01260584|616199152|FG000|Period 2|Protocol Violation|0|||
170507204|NCT01260584|616199153|FG001|Period 2|Protocol Violation|2|||
170507205|NCT01260584|616199154|FG002|Period 2|Protocol Violation|3|||
170507206|NCT01260584|616199155|FG003|Period 2|Protocol Violation|1|||
170507207|NCT01260584|616199152|FG000|Period 2|Adverse Event|1|||
170507208|NCT01260584|616199153|FG001|Period 2|Adverse Event|0|||
170507209|NCT01260584|616199154|FG002|Period 2|Adverse Event|2|||
170507210|NCT01260584|616199155|FG003|Period 2|Adverse Event|0|||
170507211|NCT01260584|616199152|FG000|Period 2|Withdrawal by Subject|0|||
170507212|NCT01260584|616199153|FG001|Period 2|Withdrawal by Subject|1|||
170507213|NCT01260584|616199154|FG002|Period 2|Withdrawal by Subject|0|||
170507214|NCT01260584|616199155|FG003|Period 2|Withdrawal by Subject|0|||
170507215|NCT01634659|616199157|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
170507216|NCT01634659|616199158|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
170507217|NCT01634659|616199157|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
170507218|NCT01634659|616199158|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
170507219|NCT03434249|616199159|FG000|Overall Study|Adverse Event|1|||
170507220|NCT03434249|616199160|FG001|Overall Study|Adverse Event|0|||
170507221|NCT03434249|616199159|FG000|Overall Study|Lost to Follow-up|0|||
170507222|NCT03434249|616199160|FG001|Overall Study|Lost to Follow-up|1|||
170507223|NCT03434249|616199159|FG000|Overall Study|Non-compliance of family|2|||
170507224|NCT03434249|616199160|FG001|Overall Study|Non-compliance of family|1|||
170507225|NCT03434249|616199159|FG000|Overall Study|Difficulties in completing daily diary|2|||
170507226|NCT03434249|616199160|FG001|Overall Study|Difficulties in completing daily diary|1|||
170507227|NCT02918552|616199161|FG000|Overall Study|Failed Pharmacokinetics|1|||
170507228|NCT02918552|616199162|FG001|Overall Study|Failed Pharmacokinetics|0|||
170507229|NCT02918552|616199161|FG000|Overall Study|Withdrawal by Subject|0|||
170507230|NCT02918552|616199162|FG001|Overall Study|Withdrawal by Subject|1|||
170507231|NCT02918552|616199161|FG000|Overall Study|Lost to Follow-up|0|||
170507232|NCT02918552|616199162|FG001|Overall Study|Lost to Follow-up|1|||
170507233|NCT01969084|616199166|FG000|Overall Study|Adverse Event|0|||
170507234|NCT01969084|616199167|FG001|Overall Study|Adverse Event|1|||
170507235|NCT03164265|616199170|FG000|Overall Study|Physician Decision|3|||
170507236|NCT01876979|616199171|FG000|Overall Study|Physician Decision|2|||
170507237|NCT01876979|616199172|FG001|Overall Study|Physician Decision|3|||
170507238|NCT04907227|616199173|FG000|Overall Study|Death|12|||
170507239|NCT04907227|616199174|FG001|Overall Study|Death|8|||
170507240|NCT04907227|616199173|FG000|Overall Study|Withdrawal by Subject|2|||
170507241|NCT04907227|616199174|FG001|Overall Study|Withdrawal by Subject|2|||
170507242|NCT04907227|616199173|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
170507243|NCT04907227|616199174|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
170507244|NCT04907227|616199173|FG000|Overall Study|Sponsor Decision|25|||
170507245|NCT04907227|616199174|FG001|Overall Study|Sponsor Decision|30|||
170507246|NCT04907227|616199173|FG000|Overall Study|Physician Decision|1|||
170507247|NCT04907227|616199174|FG001|Overall Study|Physician Decision|0|||
170507248|NCT00948506|616199175|FG000|Overall Study|Withdrawal by Subject|3|||
170507249|NCT00948506|616199176|FG001|Overall Study|Withdrawal by Subject|1|||
170507250|NCT03233204|616199178|FG000|Overall Study|Adverse Event|1|||
170507251|NCT03233204|616199178|FG000|Overall Study|Death|1|||
170507252|NCT03233204|616199178|FG000|Overall Study|Withdrawal by Subject|1|||
170507253|NCT03233204|616199178|FG000|Overall Study|Progressive Disease|3|||
170507254|NCT01362244|616199179|FG000|Overall Study|Adverse Event|3|||
170507255|NCT01362244|616199180|FG001|Overall Study|Adverse Event|5|||
170507256|NCT01362244|616199179|FG000|Overall Study|Lack of Efficacy|5|||
170507257|NCT01362244|616199180|FG001|Overall Study|Lack of Efficacy|11|||
170507258|NCT01362244|616199179|FG000|Overall Study|Lost to Follow-up|0|||
170642999|NCT04535453|616706954|FG004|Overall Study|Lost to Follow-up|3|||
170643000|NCT04535453|616706955|FG005|Overall Study|Lost to Follow-up|1|||
170507259|NCT01362244|616199180|FG001|Overall Study|Lost to Follow-up|2|||
170507260|NCT01362244|616199179|FG000|Overall Study|Protocol Violation|5|||
170507261|NCT01362244|616199180|FG001|Overall Study|Protocol Violation|1|||
170507262|NCT01362244|616199179|FG000|Overall Study|Withdrawal by Subject|2|||
170507263|NCT01362244|616199180|FG001|Overall Study|Withdrawal by Subject|1|||
170507264|NCT01362244|616199179|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
170507265|NCT01362244|616199180|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
170507266|NCT01362244|616199179|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
170507267|NCT01362244|616199180|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
170507268|NCT01253174|616199181|FG000|Period 1|Randomized but not treated|0|||
170507269|NCT01253174|616199182|FG001|Period 1|Randomized but not treated|1|||
170507270|NCT01253174|616199183|FG002|Period 1|Randomized but not treated|1|||
170507271|NCT01253174|616199184|FG003|Period 1|Randomized but not treated|0|||
170507272|NCT01253174|616199185|FG004|Period 1|Randomized but not treated|1|||
170507273|NCT01253174|616199186|FG005|Period 1|Randomized but not treated|0|||
170507274|NCT01253174|616199181|FG000|Period 2|Adverse Event|0|||
170507275|NCT01253174|616199182|FG001|Period 2|Adverse Event|0|||
170507276|NCT01253174|616199183|FG002|Period 2|Adverse Event|1|||
170507277|NCT01253174|616199184|FG003|Period 2|Adverse Event|0|||
170643001|NCT04535453|616706956|FG006|Overall Study|Lost to Follow-up|0|||
170643002|NCT04535453|616706957|FG007|Overall Study|Lost to Follow-up|0|||
170643003|NCT04535453|616706958|FG008|Overall Study|Lost to Follow-up|1|||
170643004|NCT04535453|616706959|FG009|Overall Study|Lost to Follow-up|1|||
170643005|NCT04535453|616706960|FG010|Overall Study|Lost to Follow-up|0|||
170643006|NCT04535453|616706961|FG011|Overall Study|Lost to Follow-up|0|||
170643007|NCT04535453|616706950|FG000|Overall Study|Physician Decision|0|||
170643008|NCT04535453|616706951|FG001|Overall Study|Physician Decision|0|||
170643009|NCT04535453|616706952|FG002|Overall Study|Physician Decision|0|||
170643010|NCT04535453|616706953|FG003|Overall Study|Physician Decision|1|||
170507278|NCT01253174|616199185|FG004|Period 2|Adverse Event|0|||
170507279|NCT01253174|616199186|FG005|Period 2|Adverse Event|0|||
170507280|NCT01253174|616199181|FG000|Period 3|Withdrawal by Subject|0|||
170507281|NCT01253174|616199182|FG001|Period 3|Withdrawal by Subject|1|||
170507282|NCT01253174|616199183|FG002|Period 3|Withdrawal by Subject|0|||
170643011|NCT04535453|616706954|FG004|Overall Study|Physician Decision|0|||
170643012|NCT04535453|616706955|FG005|Overall Study|Physician Decision|0|||
170643013|NCT04535453|616706956|FG006|Overall Study|Physician Decision|0|||
170507283|NCT01253174|616199184|FG003|Period 3|Withdrawal by Subject|0|||
170507284|NCT01253174|616199185|FG004|Period 3|Withdrawal by Subject|1|||
170507285|NCT01253174|616199186|FG005|Period 3|Withdrawal by Subject|0|||
170507286|NCT01253174|616199181|FG000|Period 3|Pregnancy|0|||
170507287|NCT01253174|616199182|FG001|Period 3|Pregnancy|0|||
170507288|NCT01253174|616199183|FG002|Period 3|Pregnancy|1|||
170507289|NCT01253174|616199184|FG003|Period 3|Pregnancy|0|||
170507290|NCT01253174|616199185|FG004|Period 3|Pregnancy|0|||
170507291|NCT01253174|616199186|FG005|Period 3|Pregnancy|0|||
170507292|NCT02919267|616199187|FG000|Overall Study|Protocol Violation|0|||
170507293|NCT02919267|616199188|FG001|Overall Study|Protocol Violation|3|||
170552727|NCT00160563|616370217|FG001|Overall Study|Adverse Event|1|||
170552728|NCT00160563|616370218|FG002|Overall Study|Adverse Event|1|||
170552729|NCT00160563|616370216|FG000|Overall Study|Lost to Follow-up|1|||
170552730|NCT00160563|616370217|FG001|Overall Study|Lost to Follow-up|1|||
170552731|NCT00160563|616370218|FG002|Overall Study|Lost to Follow-up|2|||
170552732|NCT00160563|616370216|FG000|Overall Study|Protocol Violation|0|||
170552733|NCT00160563|616370217|FG001|Overall Study|Protocol Violation|0|||
170552734|NCT00160563|616370218|FG002|Overall Study|Protocol Violation|3|||
170552735|NCT00160563|616370216|FG000|Overall Study|Withdrawal by Subject|1|||
170643014|NCT04535453|616706957|FG007|Overall Study|Physician Decision|0|||
170643015|NCT04535453|616706958|FG008|Overall Study|Physician Decision|0|||
170643016|NCT04535453|616706959|FG009|Overall Study|Physician Decision|0|||
170643017|NCT04535453|616706960|FG010|Overall Study|Physician Decision|0|||
170643018|NCT04535453|616706961|FG011|Overall Study|Physician Decision|0|||
170643019|NCT04535453|616706950|FG000|Overall Study|Withdrawal by Subject|3|||
170643020|NCT04535453|616706951|FG001|Overall Study|Withdrawal by Subject|6|||
170643021|NCT04535453|616706952|FG002|Overall Study|Withdrawal by Subject|3|||
170643022|NCT04535453|616706953|FG003|Overall Study|Withdrawal by Subject|3|||
170643023|NCT04535453|616706954|FG004|Overall Study|Withdrawal by Subject|2|||
170643024|NCT04535453|616706955|FG005|Overall Study|Withdrawal by Subject|1|||
170643025|NCT04535453|616706956|FG006|Overall Study|Withdrawal by Subject|1|||
170643026|NCT04535453|616706957|FG007|Overall Study|Withdrawal by Subject|1|||
170643027|NCT04535453|616706958|FG008|Overall Study|Withdrawal by Subject|1|||
170643028|NCT04535453|616706959|FG009|Overall Study|Withdrawal by Subject|1|||
170643029|NCT04535453|616706960|FG010|Overall Study|Withdrawal by Subject|0|||
170643030|NCT04535453|616706961|FG011|Overall Study|Withdrawal by Subject|1|||
170552736|NCT00160563|616370217|FG001|Overall Study|Withdrawal by Subject|2|||
170552737|NCT00160563|616370218|FG002|Overall Study|Withdrawal by Subject|3|||
170552738|NCT00160563|616370216|FG000|Overall Study|Other (listed in the study report)|48|||
170552739|NCT00160563|616370217|FG001|Overall Study|Other (listed in the study report)|40|||
170552740|NCT00160563|616370218|FG002|Overall Study|Other (listed in the study report)|81|||
170643031|NCT04535453|616706950|FG000|Overall Study|Other|0|||
170643032|NCT04535453|616706951|FG001|Overall Study|Other|0|||
170643033|NCT04535453|616706952|FG002|Overall Study|Other|1|||
170643034|NCT04535453|616706953|FG003|Overall Study|Other|0|||
170643035|NCT04535453|616706954|FG004|Overall Study|Other|1|||
170643036|NCT04535453|616706955|FG005|Overall Study|Other|0|||
170643037|NCT04535453|616706956|FG006|Overall Study|Other|1|||
170643038|NCT04535453|616706957|FG007|Overall Study|Other|1|||
170643039|NCT04535453|616706958|FG008|Overall Study|Other|1|||
170507294|NCT02919267|616199189|FG002|Overall Study|Protocol Violation|3|||
170643040|NCT04535453|616706959|FG009|Overall Study|Other|0|||
170507295|NCT02919267|616199190|FG003|Overall Study|Protocol Violation|4|||
170507296|NCT00932698|616199191|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
170507297|NCT00932698|616199192|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
170643041|NCT04535453|616706960|FG010|Overall Study|Other|0|||
170507298|NCT00932698|616199193|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
170552741|NCT00160563|616370216|FG000|Overall Study|Missing reason|0|||
170643042|NCT04535453|616706961|FG011|Overall Study|Other|0|||
170643043|NCT02929407|616706962|FG000|Overall Study|Adverse Event|1|||
170643044|NCT00916929|616706963|FG000|Overall Study|Lost to Follow-up|1|||
170643045|NCT00916929|616706964|FG001|Overall Study|Lost to Follow-up|3|||
170507299|NCT00932698|616199194|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
170507300|NCT00932698|616199195|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
170507301|NCT00932698|616199196|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
170507302|NCT00932698|616199197|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
170507303|NCT00932698|616199198|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
170507304|NCT00932698|616199199|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
170507305|NCT00932698|616199200|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
170507306|NCT00932698|616199201|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
170507307|NCT00932698|616199191|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
170507308|NCT00932698|616199192|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
170507309|NCT00932698|616199193|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
170507310|NCT00932698|616199194|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
170507311|NCT00932698|616199195|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
170507312|NCT00932698|616199196|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
170507313|NCT00932698|616199197|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
170507314|NCT00932698|616199198|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
170507315|NCT00932698|616199199|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
170507316|NCT00932698|616199200|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
170507317|NCT00932698|616199201|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
170507318|NCT00932698|616199191|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
170507319|NCT00932698|616199192|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
170507320|NCT00932698|616199193|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
170507321|NCT00932698|616199194|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
170507322|NCT00932698|616199195|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
170507323|NCT00932698|616199196|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
170507324|NCT00932698|616199197|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
170507325|NCT00932698|616199198|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
170507326|NCT00932698|616199199|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
170507327|NCT00932698|616199200|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
170507328|NCT00932698|616199201|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
170507329|NCT00932698|616199191|FG000|Part 1 (Dose Escalation)|Other|0|||
170507330|NCT00932698|616199192|FG001|Part 1 (Dose Escalation)|Other|0|||
170507331|NCT00932698|616199193|FG002|Part 1 (Dose Escalation)|Other|1|||
170507332|NCT00932698|616199194|FG003|Part 1 (Dose Escalation)|Other|0|||
170507333|NCT00932698|616199195|FG004|Part 1 (Dose Escalation)|Other|0|||
170507334|NCT00932698|616199196|FG005|Part 1 (Dose Escalation)|Other|0|||
170507335|NCT00932698|616199197|FG006|Part 1 (Dose Escalation)|Other|1|||
170507336|NCT00932698|616199198|FG007|Part 1 (Dose Escalation)|Other|0|||
170507337|NCT00932698|616199199|FG008|Part 1 (Dose Escalation)|Other|0|||
170507338|NCT00932698|616199200|FG009|Part 1 (Dose Escalation)|Other|0|||
170507339|NCT00932698|616199201|FG010|Part 1 (Dose Escalation)|Other|0|||
170507340|NCT00932698|616199191|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
170507341|NCT00932698|616199192|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
170507342|NCT00932698|616199193|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
170507343|NCT00932698|616199194|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
170507344|NCT00932698|616199195|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
170507345|NCT00932698|616199196|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
170507346|NCT00932698|616199197|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
170507347|NCT00932698|616199198|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
170507348|NCT00932698|616199199|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
170507349|NCT00932698|616199200|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
170507350|NCT00932698|616199201|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
170507351|NCT00932698|616199191|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
170507352|NCT00932698|616199192|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
170507353|NCT00932698|616199193|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
170507354|NCT00932698|616199194|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
170507355|NCT00932698|616199195|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
170507356|NCT00932698|616199196|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
170507357|NCT00932698|616199197|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
170507358|NCT00932698|616199198|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
170507359|NCT00932698|616199199|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
170552742|NCT00160563|616370217|FG001|Overall Study|Missing reason|1|||
170552743|NCT00160563|616370218|FG002|Overall Study|Missing reason|0|||
170552744|NCT00309946|616370219|FG000|Overall Study|Withdrawal by Subject|1|||
170805460|NCT02401815|617297376|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
170805461|NCT02401815|617297377|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
170805462|NCT02401815|617297378|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
170507360|NCT00932698|616199200|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
170507361|NCT00932698|616199201|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
170507362|NCT00932698|616199191|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
170552745|NCT03111108|616370220|FG000|Overall Study|Death|0|||
170552746|NCT03111108|616370221|FG001|Overall Study|Death|1|||
170507363|NCT00932698|616199192|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
170507364|NCT00932698|616199193|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
170507365|NCT00932698|616199194|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
170507366|NCT00932698|616199195|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
170507367|NCT00932698|616199196|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
170507368|NCT00932698|616199197|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
170507369|NCT00932698|616199198|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
170507370|NCT00932698|616199199|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
170507371|NCT00932698|616199200|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
170507372|NCT00932698|616199201|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
170507373|NCT05249127|616199204|FG000|Overall Study|Protocol Violation|13|||
170507374|NCT05249127|616199204|FG000|Overall Study|Physician Decision|4|||
170507375|NCT05249127|616199204|FG000|Overall Study|Withdrawal by Subject|2|||
170507376|NCT05249127|616199204|FG000|Overall Study|Participant Non-compliance|1|||
170507377|NCT01447927|616199205|FG000|Overall Study|Adverse Event|4|||
170507378|NCT01447927|616199206|FG001|Overall Study|Adverse Event|3|||
170507379|NCT01447927|616199205|FG000|Overall Study|Withdrawal by Subject|1|||
170507380|NCT01447927|616199206|FG001|Overall Study|Withdrawal by Subject|0|||
170507381|NCT03646305|616199208|FG000|Overall Study|Lost to Follow-up|4|||
170507382|NCT03646305|616199209|FG001|Overall Study|Lost to Follow-up|2|||
170507383|NCT03646305|616199210|FG002|Overall Study|Lost to Follow-up|2|||
170507384|NCT03646305|616199211|FG003|Overall Study|Lost to Follow-up|1|||
170507385|NCT03646305|616199208|FG000|Overall Study|Withdrawal by Subject|1|||
170507386|NCT03646305|616199209|FG001|Overall Study|Withdrawal by Subject|0|||
170507387|NCT03646305|616199210|FG002|Overall Study|Withdrawal by Subject|0|||
170507388|NCT03646305|616199211|FG003|Overall Study|Withdrawal by Subject|1|||
170507389|NCT00642954|616200708|FG000|Overall Study|Progressive Disease|3|||
170507390|NCT00642954|616200709|FG001|Overall Study|Progressive Disease|3|||
170507391|NCT00642954|616200710|FG002|Overall Study|Progressive Disease|3|||
170507392|NCT00642954|616200711|FG003|Overall Study|Progressive Disease|3|||
170507393|NCT00642954|616200712|FG004|Overall Study|Progressive Disease|9|||
170507394|NCT00642954|616200708|FG000|Overall Study|Withdrawal by Subject|0|||
170507395|NCT00642954|616200709|FG001|Overall Study|Withdrawal by Subject|0|||
170507396|NCT00642954|616200710|FG002|Overall Study|Withdrawal by Subject|0|||
170507397|NCT00642954|616200711|FG003|Overall Study|Withdrawal by Subject|0|||
170507398|NCT00642954|616200712|FG004|Overall Study|Withdrawal by Subject|1|||
170507399|NCT00642954|616200708|FG000|Overall Study|Adverse Event|1|||
170507400|NCT00642954|616200709|FG001|Overall Study|Adverse Event|1|||
170507401|NCT00642954|616200710|FG002|Overall Study|Adverse Event|0|||
170507402|NCT00642954|616200711|FG003|Overall Study|Adverse Event|0|||
170507403|NCT00642954|616200712|FG004|Overall Study|Adverse Event|6|||
170507404|NCT01317004|616200713|FG000|Overall Study|Withdrawal by Subject|1|||
170507405|NCT01317004|616200714|FG001|Overall Study|Withdrawal by Subject|4|||
170507406|NCT01317004|616200713|FG000|Overall Study|Protocol Violation|0|||
170507407|NCT01317004|616200714|FG001|Overall Study|Protocol Violation|2|||
170507408|NCT01317004|616200713|FG000|Overall Study|Adverse Event|3|||
170507409|NCT01317004|616200714|FG001|Overall Study|Adverse Event|3|||
170507410|NCT01344759|616200715|FG000|Overall Study|Patients failed to reach sedation level|0|||
170507411|NCT01344759|616200716|FG001|Overall Study|Patients failed to reach sedation level|2|||
170507412|NCT01890759|616200717|FG000|Overall Study|Protocol Violation|0|||
170507413|NCT01890759|616200718|FG001|Overall Study|Protocol Violation|2|||
170507414|NCT01890759|616200717|FG000|Overall Study|Lost to Follow-up|0|||
170507415|NCT01890759|616200718|FG001|Overall Study|Lost to Follow-up|2|||
170507416|NCT01890759|616200717|FG000|Overall Study|Withdrawal by Subject|2|||
170507417|NCT01890759|616200718|FG001|Overall Study|Withdrawal by Subject|8|||
170507418|NCT01153009|616200719|FG000|Overall Study|Adverse Event|4|||
170507419|NCT01153009|616200720|FG001|Overall Study|Adverse Event|14|||
170507420|NCT01153009|616200721|FG002|Overall Study|Adverse Event|14|||
170507421|NCT01153009|616200722|FG003|Overall Study|Adverse Event|10|||
170507422|NCT01153009|616200719|FG000|Overall Study|Lack of Efficacy|9|||
170507423|NCT01153009|616200720|FG001|Overall Study|Lack of Efficacy|0|||
170507424|NCT01153009|616200721|FG002|Overall Study|Lack of Efficacy|2|||
170507425|NCT01153009|616200722|FG003|Overall Study|Lack of Efficacy|1|||
170507426|NCT01153009|616200719|FG000|Overall Study|Noncompliance with Study Medication|1|||
170507427|NCT01153009|616200720|FG001|Overall Study|Noncompliance with Study Medication|3|||
170507428|NCT01153009|616200721|FG002|Overall Study|Noncompliance with Study Medication|4|||
170507429|NCT01153009|616200722|FG003|Overall Study|Noncompliance with Study Medication|1|||
170507430|NCT01153009|616200719|FG000|Overall Study|Protocol Deviations|4|||
170507431|NCT01153009|616200720|FG001|Overall Study|Protocol Deviations|3|||
170507432|NCT01153009|616200721|FG002|Overall Study|Protocol Deviations|3|||
170507433|NCT01153009|616200722|FG003|Overall Study|Protocol Deviations|2|||
170507434|NCT01153009|616200719|FG000|Overall Study|Withdrawal of Consent|5|||
170507435|NCT01153009|616200720|FG001|Overall Study|Withdrawal of Consent|5|||
170507436|NCT01153009|616200721|FG002|Overall Study|Withdrawal of Consent|4|||
170507437|NCT01153009|616200722|FG003|Overall Study|Withdrawal of Consent|6|||
170507438|NCT01153009|616200719|FG000|Overall Study|Lost to Follow-up|8|||
170507439|NCT01153009|616200720|FG001|Overall Study|Lost to Follow-up|8|||
170507440|NCT01153009|616200721|FG002|Overall Study|Lost to Follow-up|11|||
170507441|NCT01153009|616200722|FG003|Overall Study|Lost to Follow-up|15|||
170507442|NCT01153009|616200719|FG000|Overall Study|Other|1|||
170507443|NCT01153009|616200720|FG001|Overall Study|Other|1|||
170507444|NCT01153009|616200721|FG002|Overall Study|Other|3|||
170507445|NCT01153009|616200722|FG003|Overall Study|Other|2|||
170507446|NCT04003623|616200727|FG000|Overall Study|Withdrawal by Subject|1|||
170507447|NCT04003623|616200728|FG001|Overall Study|Withdrawal by Subject|0|||
170507448|NCT04114656|616200730|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
170507449|NCT04114656|616200731|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
170507450|NCT04114656|616200730|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
170507451|NCT04114656|616200731|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
170507452|NCT04114656|616200730|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
170507453|NCT04114656|616200731|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
170507454|NCT04114656|616200730|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
170552747|NCT03111108|616370220|FG000|Overall Study|Withdrawal by Subject|1|||
170552748|NCT03111108|616370221|FG001|Overall Study|Withdrawal by Subject|0|||
170552749|NCT01514357|616370222|FG000|Overall Study|Screen failure|2|||
170552750|NCT01514357|616370223|FG001|Overall Study|Screen failure|0|||
170552751|NCT01514357|616370222|FG000|Overall Study|Withdrawal by Subject|2|||
170552752|NCT01514357|616370223|FG001|Overall Study|Withdrawal by Subject|0|||
170552753|NCT04691115|616370224|FG000|Overall Study|Withdrawal by Subject|0|||
170552754|NCT04691115|616370225|FG001|Overall Study|Withdrawal by Subject|0|||
170552755|NCT04691115|616370226|FG002|Overall Study|Withdrawal by Subject|0|||
170552756|NCT04691115|616370227|FG003|Overall Study|Withdrawal by Subject|0|||
170552757|NCT04691115|616370228|FG004|Overall Study|Withdrawal by Subject|0|||
170552758|NCT04691115|616370229|FG005|Overall Study|Withdrawal by Subject|1|||
170552759|NCT04691115|616370230|FG006|Overall Study|Withdrawal by Subject|0|||
170552760|NCT04691115|616370231|FG007|Overall Study|Withdrawal by Subject|0|||
170552761|NCT04691115|616370232|FG008|Overall Study|Withdrawal by Subject|0|||
170552762|NCT04691115|616370233|FG009|Overall Study|Withdrawal by Subject|0|||
170552763|NCT04691115|616370234|FG010|Overall Study|Withdrawal by Subject|0|||
170552764|NCT04691115|616370235|FG011|Overall Study|Withdrawal by Subject|0|||
170552765|NCT04691115|616370236|FG012|Overall Study|Withdrawal by Subject|0|||
170552766|NCT04691115|616370237|FG013|Overall Study|Withdrawal by Subject|0|||
170552767|NCT00830336|616370241|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
170552768|NCT00830336|616370242|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
170552769|NCT00867334|616370243|FG000|Overall Study|Withdrawal by Subject|0|||
170552770|NCT00867334|616370244|FG001|Overall Study|Withdrawal by Subject|1|||
170552771|NCT00867334|616370243|FG000|Overall Study|Withdrawal by Subject|1|||
170552772|NCT00867334|616370244|FG001|Overall Study|Withdrawal by Subject|0|||
170552773|NCT00867334|616370243|FG000|Overall Study|Withdrawal by Subject|1|||
170552774|NCT00867334|616370244|FG001|Overall Study|Withdrawal by Subject|0|||
170552775|NCT01148771|616370245|FG000|Washout Period|Withdrawal by Subject|0|||
170552776|NCT01148771|616370246|FG001|Washout Period|Withdrawal by Subject|1|||
170552777|NCT01047540|616370251|FG000|Overall Study|Protocol Violation|1|||
170552778|NCT01047540|616370252|FG001|Overall Study|Protocol Violation|0|||
170552779|NCT01047540|616370253|FG002|Overall Study|Protocol Violation|0|||
170552780|NCT01047540|616370254|FG003|Overall Study|Protocol Violation|0|||
170552781|NCT01047540|616370255|FG004|Overall Study|Protocol Violation|0|||
170552782|NCT01047540|616370251|FG000|Overall Study|Lost to Follow-up|1|||
170552783|NCT01047540|616370252|FG001|Overall Study|Lost to Follow-up|0|||
170552784|NCT01047540|616370253|FG002|Overall Study|Lost to Follow-up|0|||
170552785|NCT01047540|616370254|FG003|Overall Study|Lost to Follow-up|0|||
170552786|NCT01047540|616370255|FG004|Overall Study|Lost to Follow-up|0|||
170552787|NCT01047540|616370251|FG000|Overall Study|Withdrawal by Subject|1|||
170552788|NCT01047540|616370252|FG001|Overall Study|Withdrawal by Subject|0|||
170552789|NCT01047540|616370253|FG002|Overall Study|Withdrawal by Subject|3|||
170805463|NCT02401815|617297379|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
170507455|NCT04114656|616200731|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
170507456|NCT04114656|616200730|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
170552790|NCT01047540|616370254|FG003|Overall Study|Withdrawal by Subject|0|||
170552791|NCT01047540|616370255|FG004|Overall Study|Withdrawal by Subject|1|||
170552792|NCT01047540|616370251|FG000|Overall Study|Pregnancy|1|||
170552793|NCT01047540|616370252|FG001|Overall Study|Pregnancy|0|||
170552794|NCT01047540|616370253|FG002|Overall Study|Pregnancy|0|||
170552795|NCT01047540|616370254|FG003|Overall Study|Pregnancy|0|||
170552796|NCT01047540|616370255|FG004|Overall Study|Pregnancy|0|||
170552797|NCT01047540|616370251|FG000|Overall Study|Adverse Event|1|||
170552798|NCT01047540|616370252|FG001|Overall Study|Adverse Event|0|||
170552799|NCT01047540|616370253|FG002|Overall Study|Adverse Event|0|||
170552800|NCT01047540|616370254|FG003|Overall Study|Adverse Event|0|||
170552801|NCT01047540|616370255|FG004|Overall Study|Adverse Event|0|||
170552802|NCT00347269|616370259|FG000|Overall Study|Lost to Follow-up|74|||
170643046|NCT00916929|616706963|FG000|Overall Study|Death|5|||
170643047|NCT00916929|616706964|FG001|Overall Study|Death|10|||
170643048|NCT00916929|616706963|FG000|Overall Study|Withdrawal by Subject|1|||
170643049|NCT00916929|616706964|FG001|Overall Study|Withdrawal by Subject|5|||
170643050|NCT00916929|616706963|FG000|Overall Study|Left ventricular epicardial lead|1|||
170643051|NCT00916929|616706964|FG001|Overall Study|Left ventricular epicardial lead|2|||
170643052|NCT00916929|616706963|FG000|Overall Study|Transferred to hospice care|1|||
170643053|NCT00916929|616706964|FG001|Overall Study|Transferred to hospice care|1|||
170643054|NCT00916929|616706963|FG000|Overall Study|System explant|1|||
170643055|NCT00916929|616706964|FG001|Overall Study|System explant|0|||
170643056|NCT00916929|616706963|FG000|Overall Study|Moved to another state|0|||
170643057|NCT00916929|616706964|FG001|Overall Study|Moved to another state|1|||
170643058|NCT00916929|616706963|FG000|Overall Study|Device unable to process impedance data|0|||
170643059|NCT00916929|616706964|FG001|Overall Study|Device unable to process impedance data|7|||
170643060|NCT02036853|616706968|FG000|Overall Study|Adverse Event|0|||
170643061|NCT02036853|616706969|FG001|Overall Study|Adverse Event|2|||
170805464|NCT02401815|617297380|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
170805465|NCT02401815|617297381|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
170507457|NCT04114656|616200731|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
170507458|NCT01393106|616200736|FG000|Overall Study|Adverse Event|3|||
170507459|NCT01393106|616200736|FG000|Overall Study|Withdrawal by Subject|1|||
170507460|NCT01393106|616200736|FG000|Overall Study|Lack of Efficacy|1|||
170507461|NCT03307837|616200737|FG000|Overall Study|Withdrawal by Subject|0|||
170507462|NCT03307837|616200738|FG001|Overall Study|Withdrawal by Subject|0|||
170507463|NCT03307837|616200739|FG002|Overall Study|Withdrawal by Subject|1|||
170507464|NCT03307837|616200740|FG003|Overall Study|Withdrawal by Subject|0|||
170507465|NCT03307837|616200741|FG004|Overall Study|Withdrawal by Subject|0|||
170507466|NCT03307837|616200742|FG005|Overall Study|Withdrawal by Subject|1|||
170507467|NCT03307837|616200737|FG000|Overall Study|Lost to Follow-up|1|||
170507468|NCT03307837|616200738|FG001|Overall Study|Lost to Follow-up|1|||
170507469|NCT03307837|616200739|FG002|Overall Study|Lost to Follow-up|0|||
170507470|NCT03307837|616200740|FG003|Overall Study|Lost to Follow-up|0|||
170507471|NCT03307837|616200741|FG004|Overall Study|Lost to Follow-up|0|||
170507472|NCT03307837|616200742|FG005|Overall Study|Lost to Follow-up|1|||
170507473|NCT01744483|616200743|FG000|Overall Study|Death|9|||
170507474|NCT01744483|616200744|FG001|Overall Study|Death|4|||
170507475|NCT01744483|616200745|FG002|Overall Study|Death|11|||
170507476|NCT01744483|616200743|FG000|Overall Study|Lost to Follow-up|8|||
170507477|NCT01744483|616200744|FG001|Overall Study|Lost to Follow-up|9|||
170507478|NCT01744483|616200745|FG002|Overall Study|Lost to Follow-up|11|||
170507479|NCT01744483|616200743|FG000|Overall Study|Protocol Violation|1|||
170507480|NCT01744483|616200744|FG001|Overall Study|Protocol Violation|2|||
170507481|NCT01744483|616200745|FG002|Overall Study|Protocol Violation|1|||
170507482|NCT01744483|616200743|FG000|Overall Study|Withdrawal by Subject|4|||
170507483|NCT01744483|616200744|FG001|Overall Study|Withdrawal by Subject|6|||
170507484|NCT01744483|616200745|FG002|Overall Study|Withdrawal by Subject|2|||
170507485|NCT01744483|616200743|FG000|Overall Study|No ICU Admit|5|||
170507486|NCT01744483|616200744|FG001|Overall Study|No ICU Admit|1|||
170507487|NCT01744483|616200745|FG002|Overall Study|No ICU Admit|2|||
170507488|NCT01744483|616200743|FG000|Overall Study|Routed to OSH|2|||
170507489|NCT01744483|616200744|FG001|Overall Study|Routed to OSH|0|||
170507490|NCT01744483|616200745|FG002|Overall Study|Routed to OSH|1|||
170507491|NCT03041467|616200746|FG000|Overall Study|Death|46|||
170507492|NCT03041467|616200747|FG001|Overall Study|Death|39|||
170507493|NCT03041467|616200746|FG000|Overall Study|Withdrawal by Subject|36|||
170507494|NCT03041467|616200747|FG001|Overall Study|Withdrawal by Subject|37|||
170507495|NCT03041467|616200746|FG000|Overall Study|Lost to Follow-up|6|||
170507496|NCT03041467|616200747|FG001|Overall Study|Lost to Follow-up|8|||
170507497|NCT03041467|616200746|FG000|Overall Study|Declined consent for study extension|21|||
170507498|NCT03041467|616200747|FG001|Overall Study|Declined consent for study extension|33|||
170507499|NCT03041467|616200746|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
170507500|NCT03041467|616200747|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
170507501|NCT01937884|616200748|FG000|Overall Study|Withdrawal by Subject|1|||
170643062|NCT02036853|616706968|FG000|Overall Study|Lack of Efficacy|0|||
170643063|NCT02036853|616706969|FG001|Overall Study|Lack of Efficacy|2|||
170643064|NCT02036853|616706968|FG000|Overall Study|Physician Decision|0|||
170507502|NCT01937884|616200749|FG001|Overall Study|Withdrawal by Subject|0|||
170507503|NCT00388297|616200754|FG000|Overall Study|Lost to Follow-up|16|||
170507504|NCT00388297|616200755|FG001|Overall Study|Lost to Follow-up|12|||
170507505|NCT00388297|616200756|FG002|Overall Study|Lost to Follow-up|11|||
170507506|NCT00388297|616200757|FG003|Overall Study|Lost to Follow-up|8|||
170507507|NCT02284568|616200758|FG000|Overall Study|Adverse Event|2|||
170643065|NCT02036853|616706969|FG001|Overall Study|Physician Decision|1|||
170643066|NCT02036853|616706968|FG000|Overall Study|Withdrawal by Subject|0|||
170643067|NCT02036853|616706969|FG001|Overall Study|Withdrawal by Subject|1|||
170643068|NCT01309282|616706970|FG000|Overall Study|Lost to Follow-up|1|||
170507508|NCT02284568|616200759|FG001|Overall Study|Adverse Event|9|||
170507509|NCT02284568|616200760|FG002|Overall Study|Adverse Event|4|||
170507510|NCT02284568|616200758|FG000|Overall Study|Withdrawal by Subject|22|||
170507511|NCT02284568|616200759|FG001|Overall Study|Withdrawal by Subject|21|||
170805466|NCT02401815|617297382|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
170507512|NCT02284568|616200760|FG002|Overall Study|Withdrawal by Subject|1|||
170507513|NCT02284568|616200758|FG000|Overall Study|Noncompliance with study drug admin|1|||
170507514|NCT02284568|616200759|FG001|Overall Study|Noncompliance with study drug admin|2|||
170507515|NCT02284568|616200760|FG002|Overall Study|Noncompliance with study drug admin|0|||
170507516|NCT02284568|616200758|FG000|Overall Study|Noncompliance|1|||
170507517|NCT02284568|616200759|FG001|Overall Study|Noncompliance|0|||
170507518|NCT02284568|616200760|FG002|Overall Study|Noncompliance|0|||
170507519|NCT02284568|616200758|FG000|Overall Study|Protocol Violation|0|||
170507520|NCT02284568|616200759|FG001|Overall Study|Protocol Violation|1|||
170507521|NCT02284568|616200760|FG002|Overall Study|Protocol Violation|0|||
170507522|NCT02284568|616200758|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
170507523|NCT02284568|616200759|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
170507524|NCT02284568|616200760|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
170507525|NCT02284568|616200758|FG000|Overall Study|Lost to Follow-up|0|||
170507526|NCT02284568|616200759|FG001|Overall Study|Lost to Follow-up|3|||
170507527|NCT02284568|616200760|FG002|Overall Study|Lost to Follow-up|0|||
170507528|NCT02284568|616200758|FG000|Overall Study|Lack of Efficacy|4|||
170507529|NCT02284568|616200759|FG001|Overall Study|Lack of Efficacy|7|||
170507530|NCT02284568|616200760|FG002|Overall Study|Lack of Efficacy|0|||
170507531|NCT02284568|616200758|FG000|Overall Study|Other|1|||
170507532|NCT02284568|616200759|FG001|Overall Study|Other|2|||
170507533|NCT02284568|616200760|FG002|Overall Study|Other|0|||
170507534|NCT02284568|616200758|FG000|Overall Study|Withdrew before taking study drug|0|||
170507535|NCT02284568|616200759|FG001|Overall Study|Withdrew before taking study drug|1|||
170507536|NCT02284568|616200760|FG002|Overall Study|Withdrew before taking study drug|0|||
170507537|NCT03570554|616200761|FG000|Overall Study|Non-compliance with study drug|0|||
170507538|NCT03570554|616200762|FG001|Overall Study|Non-compliance with study drug|0|||
170507539|NCT03570554|616200763|FG002|Overall Study|Non-compliance with study drug|1|||
170507540|NCT03570554|616200764|FG003|Overall Study|Non-compliance with study drug|0|||
170507541|NCT03570554|616200761|FG000|Overall Study|Adverse Event|0|||
170507542|NCT03570554|616200762|FG001|Overall Study|Adverse Event|0|||
170507543|NCT03570554|616200763|FG002|Overall Study|Adverse Event|0|||
170507544|NCT03570554|616200764|FG003|Overall Study|Adverse Event|1|||
170507545|NCT00426660|616200765|FG000|Overall Study|Death|14|||
170507546|NCT00426660|616200765|FG000|Overall Study|Adverse Event|23|||
170507547|NCT00426660|616200765|FG000|Overall Study|Insufficient Clinical Response|22|||
170507548|NCT00426660|616200765|FG000|Overall Study|Lost to Follow-up|15|||
170507549|NCT00426660|616200765|FG000|Overall Study|Other|23|||
170507550|NCT00426660|616200765|FG000|Overall Study|Withdrawal by Subject|18|||
170507551|NCT00426660|616200765|FG000|Overall Study|Protocol Violation|1|||
170507552|NCT00426660|616200765|FG000|Overall Study|Enrolled Not Treated|15|||
170507553|NCT01179737|616200767|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
170507554|NCT01179737|616200768|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
170507555|NCT01179737|616200769|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
170507556|NCT01179737|616200770|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
170507557|NCT01179737|616200767|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
170507558|NCT01179737|616200768|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
170507559|NCT01179737|616200769|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
170507560|NCT01179737|616200770|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
170507561|NCT01179737|616200767|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
170507562|NCT01179737|616200768|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
170507563|NCT01179737|616200769|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
170507564|NCT01179737|616200770|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
170507565|NCT01179737|616200767|FG000|Cohort 1 & Cohort 2|Death|0|||
170507566|NCT01179737|616200768|FG001|Cohort 1 & Cohort 2|Death|0|||
170507567|NCT01179737|616200769|FG002|Cohort 1 & Cohort 2|Death|1|||
170805467|NCT02401815|617297373|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170507568|NCT01179737|616200770|FG003|Cohort 1 & Cohort 2|Death|0|||
170507569|NCT01179737|616200767|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
170507570|NCT01179737|616200768|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
170507571|NCT01179737|616200769|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
170507572|NCT01179737|616200770|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
170507573|NCT01179737|616200767|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
170507574|NCT01179737|616200768|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
170507575|NCT01179737|616200769|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
170507576|NCT01179737|616200770|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
170507577|NCT01179737|616200767|FG000|Extension|The study was terminated|3|||
170507578|NCT01179737|616200768|FG001|Extension|The study was terminated|0|||
170507579|NCT01179737|616200769|FG002|Extension|The study was terminated|0|||
170507580|NCT01179737|616200770|FG003|Extension|The study was terminated|0|||
170507581|NCT01546038|616200771|FG000|Overall Study|Death|15|||
170507582|NCT01546038|616200772|FG001|Overall Study|Death|6|||
170507583|NCT01546038|616200773|FG002|Overall Study|Death|4|||
170507584|NCT01546038|616200774|FG003|Overall Study|Death|2|||
170507585|NCT01546038|616200775|FG004|Overall Study|Death|9|||
170507586|NCT01546038|616200776|FG005|Overall Study|Death|3|||
170507587|NCT01546038|616200777|FG006|Overall Study|Death|46|||
170507588|NCT01546038|616200778|FG007|Overall Study|Death|76|||
170507589|NCT01546038|616200779|FG008|Overall Study|Death|39|||
170507590|NCT01546038|616200771|FG000|Overall Study|Lost to Follow-up|0|||
170507591|NCT01546038|616200772|FG001|Overall Study|Lost to Follow-up|0|||
170507592|NCT01546038|616200773|FG002|Overall Study|Lost to Follow-up|0|||
170507593|NCT01546038|616200774|FG003|Overall Study|Lost to Follow-up|0|||
170507594|NCT01546038|616200775|FG004|Overall Study|Lost to Follow-up|1|||
170507595|NCT01546038|616200776|FG005|Overall Study|Lost to Follow-up|0|||
170507596|NCT01546038|616200777|FG006|Overall Study|Lost to Follow-up|2|||
170507597|NCT01546038|616200778|FG007|Overall Study|Lost to Follow-up|1|||
170507598|NCT01546038|616200779|FG008|Overall Study|Lost to Follow-up|0|||
170507599|NCT01546038|616200771|FG000|Overall Study|Withdrawal by Subject|1|||
170507600|NCT01546038|616200772|FG001|Overall Study|Withdrawal by Subject|0|||
170507601|NCT01546038|616200773|FG002|Overall Study|Withdrawal by Subject|0|||
170507602|NCT01546038|616200774|FG003|Overall Study|Withdrawal by Subject|1|||
170507603|NCT01546038|616200775|FG004|Overall Study|Withdrawal by Subject|0|||
170507604|NCT01546038|616200776|FG005|Overall Study|Withdrawal by Subject|1|||
170507605|NCT01546038|616200777|FG006|Overall Study|Withdrawal by Subject|3|||
170507606|NCT01546038|616200778|FG007|Overall Study|Withdrawal by Subject|3|||
170507607|NCT01546038|616200779|FG008|Overall Study|Withdrawal by Subject|1|||
170507608|NCT01546038|616200771|FG000|Overall Study|: Randomized, not treated|0|||
170507609|NCT01546038|616200772|FG001|Overall Study|: Randomized, not treated|0|||
170507610|NCT01546038|616200773|FG002|Overall Study|: Randomized, not treated|0|||
170507611|NCT01546038|616200774|FG003|Overall Study|: Randomized, not treated|0|||
170507612|NCT01546038|616200775|FG004|Overall Study|: Randomized, not treated|0|||
170507613|NCT01546038|616200776|FG005|Overall Study|: Randomized, not treated|0|||
170507614|NCT01546038|616200777|FG006|Overall Study|: Randomized, not treated|2|||
170507615|NCT01546038|616200778|FG007|Overall Study|: Randomized, not treated|4|||
170507616|NCT01546038|616200779|FG008|Overall Study|: Randomized, not treated|3|||
170507617|NCT01955109|616200780|FG000|Overall Study|Adverse Event|2|||
170507618|NCT01955109|616200781|FG001|Overall Study|Adverse Event|0|||
170507619|NCT01955109|616200780|FG000|Overall Study|Participant unwilling to continue|35|||
170507620|NCT01955109|616200781|FG001|Overall Study|Participant unwilling to continue|7|||
170507621|NCT01955109|616200780|FG000|Overall Study|Physician Decision|2|||
170507622|NCT01955109|616200781|FG001|Overall Study|Physician Decision|0|||
170507623|NCT01955109|616200780|FG000|Overall Study|Lost to Follow-up|3|||
170507624|NCT01955109|616200781|FG001|Overall Study|Lost to Follow-up|1|||
170507625|NCT01955109|616200780|FG000|Overall Study|Non-compliance|3|||
170507626|NCT01955109|616200781|FG001|Overall Study|Non-compliance|1|||
170507627|NCT00904839|616200782|FG000|Overall Study|Adverse Event|0|||
170507628|NCT00904839|616200783|FG001|Overall Study|Adverse Event|5|||
170507629|NCT00904839|616200784|FG002|Overall Study|Adverse Event|4|||
170507630|NCT00904839|616200782|FG000|Overall Study|Protocol Violation|0|||
170507631|NCT00904839|616200783|FG001|Overall Study|Protocol Violation|1|||
170507632|NCT00904839|616200784|FG002|Overall Study|Protocol Violation|1|||
170507633|NCT00904839|616200782|FG000|Overall Study|Lost to Follow-up|0|||
170507634|NCT00904839|616200783|FG001|Overall Study|Lost to Follow-up|1|||
170507635|NCT00904839|616200784|FG002|Overall Study|Lost to Follow-up|2|||
170507636|NCT00904839|616200782|FG000|Overall Study|Withdrawal by Subject|0|||
170507637|NCT00904839|616200783|FG001|Overall Study|Withdrawal by Subject|2|||
170507638|NCT00904839|616200784|FG002|Overall Study|Withdrawal by Subject|0|||
170507639|NCT00904839|616200782|FG000|Overall Study|Not treated|1|||
170507640|NCT00904839|616200783|FG001|Overall Study|Not treated|0|||
170507641|NCT00904839|616200784|FG002|Overall Study|Not treated|1|||
170507642|NCT00904839|616200782|FG000|Overall Study|Other than above|0|||
170507643|NCT00904839|616200783|FG001|Overall Study|Other than above|9|||
170507644|NCT00904839|616200784|FG002|Overall Study|Other than above|7|||
170507645|NCT01853696|616200785|FG000|Overall Study|Withdrawal by Subject|1|||
170507646|NCT01853696|616200786|FG001|Overall Study|Withdrawal by Subject|1|||
170507647|NCT01853696|616200785|FG000|Overall Study|Lost to Follow-up|5|||
170507648|NCT01853696|616200786|FG001|Overall Study|Lost to Follow-up|4|||
170643069|NCT02087423|616706971|FG000|Overall Study|Withdrawal by Subject|20|||
170507649|NCT00076999|616200790|FG000|Overall Study|Adverse Event|2|||
170507650|NCT00076999|616200791|FG001|Overall Study|Adverse Event|8|||
170507651|NCT00076999|616200792|FG002|Overall Study|Adverse Event|6|||
170507652|NCT00076999|616200793|FG003|Overall Study|Adverse Event|0|||
170507653|NCT00076999|616200794|FG004|Overall Study|Adverse Event|2|||
170507654|NCT00076999|616200790|FG000|Overall Study|Protocol Violation|0|||
170507655|NCT00076999|616200791|FG001|Overall Study|Protocol Violation|3|||
170507656|NCT00076999|616200792|FG002|Overall Study|Protocol Violation|4|||
170507657|NCT00076999|616200793|FG003|Overall Study|Protocol Violation|0|||
170507658|NCT00076999|616200794|FG004|Overall Study|Protocol Violation|9|||
170507659|NCT00076999|616200790|FG000|Overall Study|Lost to Follow-up|2|||
170507660|NCT00076999|616200791|FG001|Overall Study|Lost to Follow-up|1|||
170507661|NCT00076999|616200792|FG002|Overall Study|Lost to Follow-up|0|||
170507662|NCT00076999|616200793|FG003|Overall Study|Lost to Follow-up|0|||
170507663|NCT00076999|616200794|FG004|Overall Study|Lost to Follow-up|0|||
170507664|NCT00076999|616200790|FG000|Overall Study|Withdrawal by Subject|0|||
170507665|NCT00076999|616200791|FG001|Overall Study|Withdrawal by Subject|4|||
170507666|NCT00076999|616200792|FG002|Overall Study|Withdrawal by Subject|3|||
170507667|NCT00076999|616200793|FG003|Overall Study|Withdrawal by Subject|0|||
170507668|NCT00076999|616200794|FG004|Overall Study|Withdrawal by Subject|1|||
170507669|NCT00076999|616200790|FG000|Overall Study|Other reason (not specified)|8|||
170507670|NCT00076999|616200791|FG001|Overall Study|Other reason (not specified)|8|||
170507671|NCT00076999|616200792|FG002|Overall Study|Other reason (not specified)|4|||
170507672|NCT00076999|616200793|FG003|Overall Study|Other reason (not specified)|1|||
170507673|NCT00076999|616200794|FG004|Overall Study|Other reason (not specified)|13|||
170507674|NCT01217385|616200796|FG000|Overall Study|Withdrawal by Subject|3|||
170507675|NCT01217385|616200796|FG000|Overall Study|DOSI not performed/not eval|12|||
170507676|NCT01217385|616200796|FG000|Overall Study|Central Path not Available|1|||
170507677|NCT01217385|616200796|FG000|Overall Study|Normal Breast TOI not available|10|||
170507678|NCT00090987|616200797|FG000|Overall Study|Adverse Event|5|||
170507679|NCT00090987|616200797|FG000|Overall Study|Lack of Efficacy|7|||
170507680|NCT00090987|616200797|FG000|Overall Study|Withdrawal by Subject|3|||
170507681|NCT00090987|616200797|FG000|Overall Study|alternative therapy|1|||
170507682|NCT00090987|616200797|FG000|Overall Study|Non-compliance|4|||
170507683|NCT00090987|616200797|FG000|Overall Study|Incarcerated|1|||
170507684|NCT02603562|616200802|FG000|Overall Study|Lost to Follow-up|1|||
170507685|NCT00270231|616200803|FG000|First Intervention|Lost to Follow-up|1|||
170507686|NCT00270231|616200804|FG001|First Intervention|Lost to Follow-up|1|||
170507687|NCT00270231|616200803|FG000|Washout Period|Lost to Follow-up|1|||
170507688|NCT00270231|616200804|FG001|Washout Period|Lost to Follow-up|0|||
170507689|NCT00270231|616200803|FG000|Second Intervention|Lost to Follow-up|0|||
170507690|NCT00270231|616200804|FG001|Second Intervention|Lost to Follow-up|1|||
170507691|NCT01534208|616200805|FG000|Overall Study|Lost to Follow-up|19|||
170507692|NCT01534208|616200806|FG001|Overall Study|Lost to Follow-up|14|||
170507693|NCT01534208|616200805|FG000|Overall Study|Withdrawal by Subject|6|||
170507694|NCT01534208|616200806|FG001|Overall Study|Withdrawal by Subject|20|||
170507695|NCT01534208|616200805|FG000|Overall Study|Adverse Event|15|||
170507696|NCT01534208|616200806|FG001|Overall Study|Adverse Event|8|||
170507697|NCT01534208|616200805|FG000|Overall Study|Physician Decision|2|||
170507698|NCT01534208|616200806|FG001|Overall Study|Physician Decision|0|||
170507699|NCT01534208|616200805|FG000|Overall Study|Lack of Efficacy|0|||
170507700|NCT01534208|616200806|FG001|Overall Study|Lack of Efficacy|3|||
170507701|NCT01534208|616200805|FG000|Overall Study|Protocol Violation|2|||
170507702|NCT01534208|616200806|FG001|Overall Study|Protocol Violation|2|||
170507703|NCT01534208|616200805|FG000|Overall Study|Sponsor decision|4|||
170507704|NCT01534208|616200806|FG001|Overall Study|Sponsor decision|1|||
170507705|NCT01534208|616200805|FG000|Overall Study|Subject relocation|2|||
170507706|NCT01534208|616200806|FG001|Overall Study|Subject relocation|0|||
170507707|NCT01534208|616200805|FG000|Overall Study|Lab assessment|2|||
170507708|NCT01534208|616200806|FG001|Overall Study|Lab assessment|1|||
170507709|NCT01534208|616200805|FG000|Overall Study|Eligibility error|3|||
170507710|NCT01534208|616200806|FG001|Overall Study|Eligibility error|0|||
170507711|NCT01534208|616200805|FG000|Overall Study|PCP decision|1|||
170507712|NCT01534208|616200806|FG001|Overall Study|PCP decision|0|||
170507713|NCT01534208|616200805|FG000|Overall Study|Needed prohibited meds|1|||
170507714|NCT01534208|616200806|FG001|Overall Study|Needed prohibited meds|0|||
170507715|NCT02117713|616200810|FG000|Week 48|Adverse Event|4|||
170507716|NCT02117713|616200810|FG000|Week 48|Withdrawal by caregiver|2|||
170507717|NCT02117713|616200810|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
170507718|NCT02117713|616200810|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
170507719|NCT02117713|616200810|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
170507720|NCT02117713|616200810|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
170507721|NCT00574795|616200811|FG000|Infant Series|Withdrawal by Subject|2|||
170507722|NCT00574795|616200811|FG000|Infant Series|Protocol Violation|2|||
170507723|NCT00574795|616200811|FG000|Infant Series|Adverse Event|1|||
170507724|NCT00574795|616200811|FG000|After Infant Series|Withdrawal by Subject|1|||
170507725|NCT00574795|616200811|FG000|After Infant Series|Adverse Event|2|||
170507726|NCT00574795|616200811|FG000|Toddler Dose|Withdrawal by Subject|1|||
170507727|NCT00672841|616200812|FG000|Overall Study|Comfort care|1|||
170507728|NCT00672841|616200813|FG001|Overall Study|Comfort care|4|||
170507729|NCT00672841|616200812|FG000|Overall Study|icteric specimens|0|||
170507730|NCT00672841|616200813|FG001|Overall Study|icteric specimens|3|||
170507731|NCT00672841|616200812|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
170507732|NCT00672841|616200813|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
170507733|NCT00672841|616200812|FG000|Overall Study|Adverse Event|0|||
170507734|NCT00672841|616200813|FG001|Overall Study|Adverse Event|3|||
170507735|NCT00672841|616200812|FG000|Overall Study|Pregnancy|0|||
170507736|NCT00672841|616200813|FG001|Overall Study|Pregnancy|1|||
170507737|NCT01094782|616200815|FG000|Overall Study|Withdrawal by Subject|5|||
170507738|NCT01094782|616200816|FG001|Overall Study|Withdrawal by Subject|5|||
170643070|NCT02087423|616706972|FG001|Overall Study|Withdrawal by Subject|20|||
170643071|NCT02087423|616706973|FG002|Overall Study|Withdrawal by Subject|3|||
170643072|NCT02087423|616706971|FG000|Overall Study|Death|68|||
170643073|NCT02087423|616706972|FG001|Overall Study|Death|207|||
170643074|NCT02087423|616706973|FG002|Overall Study|Death|40|||
170643075|NCT02087423|616706971|FG000|Overall Study|Lost to Follow-up|0|||
170643076|NCT02087423|616706972|FG001|Overall Study|Lost to Follow-up|2|||
170643077|NCT02087423|616706973|FG002|Overall Study|Lost to Follow-up|0|||
170643078|NCT02087423|616706971|FG000|Overall Study|Terminated from study at final DCO|23|||
170643079|NCT02087423|616706972|FG001|Overall Study|Terminated from study at final DCO|36|||
170643080|NCT02087423|616706973|FG002|Overall Study|Terminated from study at final DCO|25|||
170643081|NCT01233232|616706976|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
170643082|NCT01233232|616706977|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
170643083|NCT01233232|616706978|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
170643084|NCT02969655|616706979|FG000|Overall Study|Withdrawal by Subject|3|||
170643085|NCT02969655|616706980|FG001|Overall Study|Withdrawal by Subject|2|||
170643086|NCT02969655|616706979|FG000|Overall Study|Physician Decision|4|||
170643087|NCT02969655|616706980|FG001|Overall Study|Physician Decision|3|||
170643088|NCT02969655|616706979|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
170643089|NCT02969655|616706980|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
170643090|NCT02969655|616706979|FG000|Overall Study|Adverse Event|10|||
170643091|NCT02969655|616706980|FG001|Overall Study|Adverse Event|8|||
170643092|NCT00499590|616706983|FG000|Overall Study|Study Terminated|112|||
170643093|NCT00499590|616706984|FG001|Overall Study|Study Terminated|112|||
170643094|NCT00499590|616706985|FG002|Overall Study|Study Terminated|112|||
170805468|NCT02401815|617297374|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170805469|NCT02401815|617297375|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170805470|NCT02401815|617297376|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170805471|NCT02401815|617297377|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170805472|NCT02401815|617297378|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
170805473|NCT02401815|617297379|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170805474|NCT02401815|617297380|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170805475|NCT02401815|617297381|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170805476|NCT02401815|617297382|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
170805477|NCT02401815|617297373|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
170805478|NCT02401815|617297374|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
170805479|NCT02401815|617297375|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
170805480|NCT02401815|617297376|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
170805481|NCT02401815|617297377|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
170805482|NCT02401815|617297378|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
170805483|NCT02401815|617297379|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
170805484|NCT02401815|617297380|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
170805485|NCT02401815|617297381|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
170805486|NCT02401815|617297382|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
170805487|NCT02401815|617297373|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805488|NCT02401815|617297374|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805489|NCT02401815|617297375|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805490|NCT02401815|617297376|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805491|NCT02401815|617297377|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805492|NCT02401815|617297378|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805493|NCT02401815|617297379|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805494|NCT02401815|617297380|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
170805495|NCT02401815|617297381|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
170805496|NCT02401815|617297382|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
170805497|NCT02401815|617297373|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170805498|NCT02401815|617297374|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170805499|NCT02401815|617297375|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170643095|NCT00499590|616706983|FG000|Overall Study|Not treated|1|||
170643096|NCT00499590|616706984|FG001|Overall Study|Not treated|0|||
170805500|NCT02401815|617297376|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170805501|NCT02401815|617297377|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170904223|NCT01624142|617650921|FG000|Overall Study|Withdrawal by Subject|14|||
170904224|NCT01624142|617650922|FG001|Overall Study|Withdrawal by Subject|4|||
170904225|NCT01624142|617650921|FG000|Overall Study|Death|3|||
170904226|NCT01624142|617650922|FG001|Overall Study|Death|6|||
170643097|NCT00499590|616706985|FG002|Overall Study|Not treated|1|||
170643098|NCT02633020|616706989|FG000|Overall Study|Adverse Event|1|||
170643099|NCT02633020|616706990|FG001|Overall Study|Adverse Event|0|||
170643100|NCT02873429|616706991|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
170552803|NCT00347269|616370260|FG001|Overall Study|Lost to Follow-up|65|||
170552804|NCT00347269|616370259|FG000|Overall Study|Withdrawal by Subject|18|||
170552805|NCT00347269|616370260|FG001|Overall Study|Withdrawal by Subject|38|||
170552806|NCT00347269|616370259|FG000|Overall Study|Death|2|||
170552807|NCT00347269|616370260|FG001|Overall Study|Death|3|||
170552808|NCT00986102|616370265|FG000|Overall Study|Lost to Follow-up|0|||
170552809|NCT00986102|616370266|FG001|Overall Study|Lost to Follow-up|1|||
170552810|NCT00986102|616370267|FG002|Overall Study|Lost to Follow-up|0|||
170552811|NCT00986102|616370268|FG003|Overall Study|Lost to Follow-up|1|||
170552812|NCT00986102|616370265|FG000|Overall Study|Withdrawal by Subject|1|||
170552813|NCT00986102|616370266|FG001|Overall Study|Withdrawal by Subject|1|||
170552814|NCT00986102|616370267|FG002|Overall Study|Withdrawal by Subject|0|||
170552815|NCT00986102|616370268|FG003|Overall Study|Withdrawal by Subject|0|||
170552816|NCT01725282|616370269|FG000|Overall Study|Adverse Event|1|||
170552817|NCT01725282|616370270|FG001|Overall Study|Adverse Event|3|||
170552818|NCT01725282|616370271|FG002|Overall Study|Adverse Event|6|||
170552819|NCT01725282|616370272|FG003|Overall Study|Adverse Event|4|||
170552820|NCT01725282|616370269|FG000|Overall Study|Exacerbation of Target Disease|1|||
170552821|NCT01725282|616370270|FG001|Overall Study|Exacerbation of Target Disease|0|||
170552822|NCT01725282|616370271|FG002|Overall Study|Exacerbation of Target Disease|0|||
170552823|NCT01725282|616370272|FG003|Overall Study|Exacerbation of Target Disease|1|||
170552824|NCT01725282|616370269|FG000|Overall Study|Met Exclusion Criteria|0|||
170552825|NCT01725282|616370270|FG001|Overall Study|Met Exclusion Criteria|0|||
170552826|NCT01725282|616370271|FG002|Overall Study|Met Exclusion Criteria|1|||
170552827|NCT01725282|616370272|FG003|Overall Study|Met Exclusion Criteria|0|||
170552828|NCT01725282|616370269|FG000|Overall Study|Study Site Withdrawal|0|||
170552829|NCT01725282|616370270|FG001|Overall Study|Study Site Withdrawal|1|||
170552830|NCT01725282|616370271|FG002|Overall Study|Study Site Withdrawal|0|||
170552831|NCT01725282|616370272|FG003|Overall Study|Study Site Withdrawal|0|||
170552832|NCT01725282|616370269|FG000|Overall Study|Withdrawal by Subject|0|||
170552833|NCT01725282|616370270|FG001|Overall Study|Withdrawal by Subject|0|||
170552834|NCT01725282|616370271|FG002|Overall Study|Withdrawal by Subject|1|||
170552835|NCT01725282|616370272|FG003|Overall Study|Withdrawal by Subject|1|||
170552836|NCT01725282|616370269|FG000|Overall Study|Lack of Efficacy|0|||
170552837|NCT01725282|616370270|FG001|Overall Study|Lack of Efficacy|1|||
170552838|NCT01725282|616370271|FG002|Overall Study|Lack of Efficacy|0|||
170552839|NCT01725282|616370272|FG003|Overall Study|Lack of Efficacy|1|||
170552840|NCT04064567|616370273|FG000|Overall Study|Lost to Follow-up|23|||
170552841|NCT04064567|616370274|FG001|Overall Study|Lost to Follow-up|22|||
170552842|NCT04064567|616370273|FG000|Overall Study|Withdrawal by Subject|0|||
170552843|NCT04064567|616370274|FG001|Overall Study|Withdrawal by Subject|1|||
170552844|NCT04064567|616370273|FG000|Overall Study|Reincarcerated|7|||
170552845|NCT04064567|616370274|FG001|Overall Study|Reincarcerated|10|||
170552846|NCT04064567|616370273|FG000|Overall Study|Moved out of U.S.|0|||
170552847|NCT04064567|616370274|FG001|Overall Study|Moved out of U.S.|1|||
170552848|NCT05071027|616370275|FG000|Overall Study|Lost to Follow-up|1|||
170552849|NCT05071027|616370276|FG001|Overall Study|Lost to Follow-up|4|||
170552850|NCT04576481|616370277|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
170552851|NCT04576481|616370278|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
170552852|NCT04576481|616370279|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
170552853|NCT04576481|616370280|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
170552854|NCT03464461|616370283|FG000|Overall Study|exclusionary medication given ,|1|||
170552855|NCT03464461|616370284|FG001|Overall Study|exclusionary medication given ,|2|||
170552856|NCT03464461|616370285|FG002|Overall Study|exclusionary medication given ,|0|||
170552857|NCT03464461|616370283|FG000|Overall Study|Physician Decision|0|||
170552858|NCT03464461|616370284|FG001|Overall Study|Physician Decision|1|||
170552859|NCT03464461|616370285|FG002|Overall Study|Physician Decision|0|||
170552860|NCT05463952|616370286|FG000|Treatment|Progressive disease|4|||
170552861|NCT05463952|616370286|FG000|Treatment|Ongoing|2|||
170552862|NCT02739828|616370287|FG000|Overall Study|Adverse Event|1|||
170552863|NCT02739828|616370287|FG000|Overall Study|Lost to Follow-up|4|||
170552864|NCT01953354|616370288|FG000|Overall Study|Withdrawal by Subject|0|||
170552865|NCT01953354|616370289|FG001|Overall Study|Withdrawal by Subject|1|||
170552866|NCT01953354|616370288|FG000|Overall Study|Decision of Sponsor|0|||
170552867|NCT01953354|616370289|FG001|Overall Study|Decision of Sponsor|1|||
170552868|NCT01953354|616370288|FG000|Overall Study|Disease Exacerbation|1|||
170552869|NCT01953354|616370289|FG001|Overall Study|Disease Exacerbation|0|||
170552870|NCT03180138|616370292|FG000|Overall Study|Mobile-phone could not be verified|2|||
170552871|NCT03180138|616370293|FG001|Overall Study|Mobile-phone could not be verified|13|||
170552872|NCT03180138|616370294|FG002|Overall Study|Mobile-phone could not be verified|15|||
170552873|NCT03180138|616370292|FG000|Overall Study|No prior immunization records|17|||
170552874|NCT03180138|616370293|FG001|Overall Study|No prior immunization records|0|||
170552875|NCT03180138|616370294|FG002|Overall Study|No prior immunization records|6|||
170552876|NCT03180138|616370292|FG000|Overall Study|Found to be >24 mon after randomization|3|||
170552877|NCT03180138|616370293|FG001|Overall Study|Found to be >24 mon after randomization|0|||
170552878|NCT03180138|616370294|FG002|Overall Study|Found to be >24 mon after randomization|3|||
170507739|NCT01094782|616200817|FG002|Overall Study|Withdrawal by Subject|1|||
170507740|NCT01094782|616200818|FG003|Overall Study|Withdrawal by Subject|5|||
170507741|NCT01094782|616200819|FG004|Overall Study|Withdrawal by Subject|5|||
170507742|NCT01094782|616200820|FG005|Overall Study|Withdrawal by Subject|0|||
170507743|NCT01094782|616200815|FG000|Overall Study|Lost to Follow-up|1|||
170507744|NCT01094782|616200816|FG001|Overall Study|Lost to Follow-up|0|||
170507745|NCT01094782|616200817|FG002|Overall Study|Lost to Follow-up|0|||
170507746|NCT01094782|616200818|FG003|Overall Study|Lost to Follow-up|2|||
170507747|NCT01094782|616200819|FG004|Overall Study|Lost to Follow-up|1|||
170507748|NCT01094782|616200820|FG005|Overall Study|Lost to Follow-up|4|||
170507749|NCT01094782|616200815|FG000|Overall Study|Positive Drug Screen|2|||
170507750|NCT01094782|616200816|FG001|Overall Study|Positive Drug Screen|2|||
170507751|NCT01094782|616200817|FG002|Overall Study|Positive Drug Screen|1|||
170507752|NCT01094782|616200818|FG003|Overall Study|Positive Drug Screen|1|||
170507753|NCT01094782|616200819|FG004|Overall Study|Positive Drug Screen|3|||
170507754|NCT01094782|616200820|FG005|Overall Study|Positive Drug Screen|2|||
170507755|NCT01094782|616200815|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
170507756|NCT01094782|616200816|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
170507757|NCT01094782|616200817|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
170552879|NCT01714063|616370296|FG000|Overall Study|Equipment malfunction|2|||
170552880|NCT00979407|616370297|FG000|Overall Study|Withdrawal by Subject|3|||
170552881|NCT00979407|616370298|FG001|Overall Study|Withdrawal by Subject|4|||
170552882|NCT00979407|616370297|FG000|Overall Study|Lost to Follow-up|3|||
170552883|NCT00979407|616370298|FG001|Overall Study|Lost to Follow-up|3|||
170552884|NCT03721107|616370301|FG000|Overall Study|Adverse Event|1|||
170552885|NCT03721107|616370302|FG001|Overall Study|Adverse Event|1|||
170552886|NCT03721107|616370303|FG002|Overall Study|Adverse Event|6|||
170552887|NCT03721107|616370304|FG003|Overall Study|Adverse Event|5|||
170552888|NCT03721107|616370301|FG000|Overall Study|Lost to Follow-up|2|||
170552889|NCT03721107|616370302|FG001|Overall Study|Lost to Follow-up|0|||
170552890|NCT03721107|616370303|FG002|Overall Study|Lost to Follow-up|3|||
170552891|NCT03721107|616370304|FG003|Overall Study|Lost to Follow-up|0|||
170552892|NCT03721107|616370301|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
170552893|NCT03721107|616370302|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
170552894|NCT03721107|616370303|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
170552895|NCT03721107|616370304|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
170552896|NCT03721107|616370301|FG000|Overall Study|Physician Decision|0|||
170552897|NCT03721107|616370302|FG001|Overall Study|Physician Decision|1|||
170552898|NCT03721107|616370303|FG002|Overall Study|Physician Decision|0|||
170552899|NCT03721107|616370304|FG003|Overall Study|Physician Decision|0|||
170552900|NCT03721107|616370301|FG000|Overall Study|Pregnancy|0|||
170552901|NCT03721107|616370302|FG001|Overall Study|Pregnancy|0|||
170552902|NCT03721107|616370303|FG002|Overall Study|Pregnancy|1|||
170552903|NCT03721107|616370304|FG003|Overall Study|Pregnancy|0|||
170552904|NCT03721107|616370301|FG000|Overall Study|Withdrawal by Subject|1|||
170552905|NCT03721107|616370302|FG001|Overall Study|Withdrawal by Subject|1|||
170552906|NCT03721107|616370303|FG002|Overall Study|Withdrawal by Subject|5|||
170552907|NCT03721107|616370304|FG003|Overall Study|Withdrawal by Subject|5|||
170552908|NCT03721107|616370301|FG000|Overall Study|Other|1|||
170552909|NCT03721107|616370302|FG001|Overall Study|Other|0|||
170552910|NCT03721107|616370303|FG002|Overall Study|Other|0|||
170552911|NCT03721107|616370304|FG003|Overall Study|Other|1|||
170552912|NCT05652140|616370305|FG000|Overall Study|Lost to Follow-up|7|||
170552913|NCT05652140|616370306|FG001|Overall Study|Lost to Follow-up|16|||
170552914|NCT05652140|616370307|FG002|Overall Study|Lost to Follow-up|22|||
170552915|NCT05652140|616370308|FG003|Overall Study|Lost to Follow-up|31|||
170552916|NCT00127933|616370312|FG000|Overall Study|Randomized but not dosed|1|||
170552917|NCT00127933|616370313|FG001|Overall Study|Randomized but not dosed|0|||
170552918|NCT03111732|616370314|FG000|Overall Study|Enrolled in different study|1|||
170552919|NCT03111732|616370314|FG000|Overall Study|Progressive disease|3|||
170552920|NCT03111732|616370314|FG000|Overall Study|Withdrawal by Subject|1|||
170552921|NCT03072875|616370315|FG000|Overall Study|Lost to Follow-up|1|||
170805502|NCT02401815|617297378|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170507758|NCT01094782|616200818|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
170552922|NCT01943825|616370316|FG000|Overall Study|Lost to Follow-up|9|||
170552923|NCT01943825|616370317|FG001|Overall Study|Lost to Follow-up|3|||
170507759|NCT01094782|616200819|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
170507760|NCT01094782|616200820|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
170552924|NCT01943825|616370318|FG002|Overall Study|Lost to Follow-up|12|||
170552925|NCT01943825|616370319|FG003|Overall Study|Lost to Follow-up|8|||
170552926|NCT01943825|616370316|FG000|Overall Study|Withdrawal by Subject|1|||
170552927|NCT01943825|616370317|FG001|Overall Study|Withdrawal by Subject|0|||
170552928|NCT01943825|616370318|FG002|Overall Study|Withdrawal by Subject|3|||
170552929|NCT01943825|616370319|FG003|Overall Study|Withdrawal by Subject|2|||
170552930|NCT01943825|616370316|FG000|Overall Study|Other than specified above|0|||
170552931|NCT01943825|616370317|FG001|Overall Study|Other than specified above|1|||
170552932|NCT01943825|616370318|FG002|Overall Study|Other than specified above|0|||
170507761|NCT01094782|616200815|FG000|Overall Study|Unable to Complete Questionnaires|0|||
170507762|NCT01094782|616200816|FG001|Overall Study|Unable to Complete Questionnaires|1|||
170507763|NCT01094782|616200817|FG002|Overall Study|Unable to Complete Questionnaires|0|||
170643101|NCT02873429|616706992|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
170507764|NCT01094782|616200818|FG003|Overall Study|Unable to Complete Questionnaires|0|||
170507765|NCT01094782|616200819|FG004|Overall Study|Unable to Complete Questionnaires|0|||
170507766|NCT01094782|616200820|FG005|Overall Study|Unable to Complete Questionnaires|0|||
170507767|NCT01094782|616200815|FG000|Overall Study|Healthy Subject Had Pain|0|||
170507768|NCT01094782|616200816|FG001|Overall Study|Healthy Subject Had Pain|1|||
170507769|NCT01094782|616200817|FG002|Overall Study|Healthy Subject Had Pain|0|||
170507770|NCT01094782|616200818|FG003|Overall Study|Healthy Subject Had Pain|0|||
170507771|NCT01094782|616200819|FG004|Overall Study|Healthy Subject Had Pain|0|||
170507772|NCT01094782|616200820|FG005|Overall Study|Healthy Subject Had Pain|0|||
170507773|NCT01094782|616200815|FG000|Overall Study|Hypertension|0|||
170507774|NCT01094782|616200816|FG001|Overall Study|Hypertension|0|||
170507775|NCT01094782|616200817|FG002|Overall Study|Hypertension|1|||
170507776|NCT01094782|616200818|FG003|Overall Study|Hypertension|0|||
170643102|NCT02873429|616706991|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
170643103|NCT02873429|616706992|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
170643104|NCT02873429|616706991|FG000|16 Weeks|Lost to Follow-up|3|||
170643105|NCT02873429|616706992|FG001|16 Weeks|Lost to Follow-up|0|||
170643106|NCT01388985|616706993|FG000|Overall Study|Death|0|||
170643107|NCT01388985|616706994|FG001|Overall Study|Death|1|||
170643108|NCT01388985|616706993|FG000|Overall Study|Lost to Follow-up|30|||
170643109|NCT01388985|616706994|FG001|Overall Study|Lost to Follow-up|30|||
170643110|NCT01388985|616706993|FG000|Overall Study|Withdrawal by Subject|13|||
170643111|NCT01388985|616706994|FG001|Overall Study|Withdrawal by Subject|4|||
170643112|NCT01388985|616706993|FG000|Overall Study|Subject unavailable|1|||
170643113|NCT01388985|616706994|FG001|Overall Study|Subject unavailable|1|||
170643114|NCT01388985|616706993|FG000|Overall Study|Other (no reason)|0|||
170643115|NCT01388985|616706994|FG001|Overall Study|Other (no reason)|1|||
170643116|NCT01388985|616706993|FG000|Overall Study|Error of nurse|5|||
170643117|NCT01388985|616706994|FG001|Overall Study|Error of nurse|1|||
170643118|NCT00782834|616706997|FG000|Treatment Phase|fibrous tumor not GIST|1|||
170643119|NCT01516034|616706998|FG000|Overall Study|Physician Decision|1|||
170643120|NCT01516034|616706998|FG000|Overall Study|Lack of Efficacy|7|||
170643121|NCT01033448|616706999|FG000|Overall Study|Withdrawal by Subject|4|||
170643122|NCT01033448|616706999|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
170643123|NCT01033448|616706999|FG000|Overall Study|Lost to Follow-up|3|||
170643124|NCT01033448|616706999|FG000|Overall Study|Withdrew due to other reasons|3|||
170643125|NCT01033448|616706999|FG000|Overall Study|Unknown disposition|1|||
170643126|NCT01324141|616707000|FG000|Overall Study|Declined to participate before treatment started|1|||
170643127|NCT01324141|616707000|FG000|Overall Study|Disease progression on study|1|||
170643128|NCT04629066|616707001|FG000|Overall Study|Lost to Follow-up|3|||
170643129|NCT04629066|616707002|FG001|Overall Study|Lost to Follow-up|2|||
170643130|NCT00870584|616707008|FG000|Overall Study|Adverse Event|3|||
170643131|NCT00870584|616707009|FG001|Overall Study|Adverse Event|3|||
170643132|NCT00870584|616707008|FG000|Overall Study|Withdrawal by Subject|6|||
170643133|NCT00870584|616707009|FG001|Overall Study|Withdrawal by Subject|7|||
170643134|NCT00870584|616707008|FG000|Overall Study|Lost to Follow-up|5|||
170643135|NCT00870584|616707009|FG001|Overall Study|Lost to Follow-up|1|||
170643136|NCT00870584|616707008|FG000|Overall Study|Protocol Deviation|2|||
170643137|NCT00870584|616707009|FG001|Overall Study|Protocol Deviation|2|||
170643138|NCT00472030|616707021|FG000|Overall Study|Physician Decision|1|||
170643139|NCT00472030|616707022|FG001|Overall Study|Physician Decision|0|||
170643140|NCT00409331|616708295|FG000|Overall Study|Physician Decision|1|||
170643141|NCT03745820|616708298|FG000|Overall Study|Adverse Event|0|||
170643142|NCT03745820|616708299|FG001|Overall Study|Adverse Event|3|||
170507777|NCT01094782|616200819|FG004|Overall Study|Hypertension|0|||
170643143|NCT03745820|616708300|FG002|Overall Study|Adverse Event|2|||
170643144|NCT03745820|616708298|FG000|Overall Study|Non-Compliance with Study Drug|4|||
170643145|NCT03745820|616708299|FG001|Overall Study|Non-Compliance with Study Drug|3|||
170643146|NCT03745820|616708300|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170643147|NCT03745820|616708298|FG000|Overall Study|Withdrawal by Subject|4|||
170643148|NCT03745820|616708299|FG001|Overall Study|Withdrawal by Subject|4|||
170643149|NCT03745820|616708300|FG002|Overall Study|Withdrawal by Subject|4|||
170643150|NCT03745820|616708298|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
170643151|NCT03745820|616708299|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
170643152|NCT03745820|616708300|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
170643153|NCT03745820|616708298|FG000|Overall Study|Lost to Follow-up|2|||
170507778|NCT01094782|616200820|FG005|Overall Study|Hypertension|0|||
170507779|NCT01094782|616200815|FG000|Overall Study|Wrong Pain Condition|0|||
170507780|NCT01094782|616200816|FG001|Overall Study|Wrong Pain Condition|0|||
170507781|NCT01094782|616200817|FG002|Overall Study|Wrong Pain Condition|0|||
170507782|NCT01094782|616200818|FG003|Overall Study|Wrong Pain Condition|2|||
170643154|NCT03745820|616708299|FG001|Overall Study|Lost to Follow-up|0|||
170643155|NCT03745820|616708300|FG002|Overall Study|Lost to Follow-up|3|||
170643156|NCT03745820|616708298|FG000|Overall Study|Reason not Specified|2|||
170643157|NCT03745820|616708299|FG001|Overall Study|Reason not Specified|4|||
170643158|NCT03745820|616708300|FG002|Overall Study|Reason not Specified|1|||
170643159|NCT03680742|616708302|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
170643160|NCT01589653|616708304|FG000|Overall Study|Protocol Violation|3|||
170643161|NCT01589653|616708305|FG001|Overall Study|Protocol Violation|1|||
170643162|NCT01589653|616708304|FG000|Overall Study|Withdrawal criteria|4|||
170643163|NCT01589653|616708305|FG001|Overall Study|Withdrawal criteria|7|||
170643164|NCT01589653|616708304|FG000|Overall Study|Unclassified|0|||
170643165|NCT01589653|616708305|FG001|Overall Study|Unclassified|3|||
170805503|NCT02401815|617297379|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170805504|NCT02401815|617297380|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170805505|NCT02401815|617297381|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
170805506|NCT02401815|617297382|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
170507783|NCT01094782|616200819|FG004|Overall Study|Wrong Pain Condition|1|||
170507784|NCT01094782|616200820|FG005|Overall Study|Wrong Pain Condition|1|||
170507785|NCT01094782|616200815|FG000|Overall Study|Recent Interventional Injection|0|||
170507786|NCT01094782|616200816|FG001|Overall Study|Recent Interventional Injection|0|||
170507787|NCT01094782|616200817|FG002|Overall Study|Recent Interventional Injection|0|||
170507788|NCT01094782|616200818|FG003|Overall Study|Recent Interventional Injection|0|||
170507789|NCT01094782|616200819|FG004|Overall Study|Recent Interventional Injection|0|||
170507790|NCT01094782|616200820|FG005|Overall Study|Recent Interventional Injection|1|||
170507791|NCT01094782|616200815|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
170507792|NCT01094782|616200816|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
170507793|NCT01094782|616200817|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
170507794|NCT01094782|616200818|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
170507795|NCT01094782|616200819|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
170507796|NCT01094782|616200820|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
170507797|NCT01094782|616200815|FG000|Overall Study|Noncompliance With Study Schedule|0|||
170507798|NCT01094782|616200816|FG001|Overall Study|Noncompliance With Study Schedule|0|||
170507799|NCT01094782|616200817|FG002|Overall Study|Noncompliance With Study Schedule|0|||
170507800|NCT01094782|616200818|FG003|Overall Study|Noncompliance With Study Schedule|1|||
170507801|NCT01094782|616200819|FG004|Overall Study|Noncompliance With Study Schedule|0|||
170507802|NCT01094782|616200820|FG005|Overall Study|Noncompliance With Study Schedule|0|||
170507803|NCT00634049|616200821|FG000|Overall Study|Never received study drug|1|||
170507804|NCT00634049|616200821|FG000|Overall Study|Died prior to receiving study drug|1|||
170507805|NCT00634049|616200821|FG000|Overall Study|Screening failure|1|||
170507806|NCT01717391|616200822|FG000|Overall Study|Withdrawal by Subject|5|||
170507807|NCT01717391|616200822|FG000|Overall Study|Physician Decision|1|||
170507808|NCT01717391|616200822|FG000|Overall Study|FLT technical failure|3|||
170507809|NCT00335959|616200841|FG000|Overall Study|Adverse Event|2|||
170507810|NCT00335959|616200841|FG000|Overall Study|Ineligible|1|||
170507811|NCT01001598|616200842|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
170507812|NCT01001598|616200842|FG000|Overall Study|Adverse Event|1|||
170507813|NCT02920177|616200844|FG000|Overall Study|Withdrawal by Subject|1|||
170507814|NCT02920177|616200845|FG001|Overall Study|Withdrawal by Subject|1|||
170507815|NCT02920177|616200844|FG000|Overall Study|Physician Decision|1|||
170507816|NCT02920177|616200845|FG001|Overall Study|Physician Decision|0|||
170507817|NCT02920177|616200844|FG000|Overall Study|Lost to Follow-up|0|||
170507818|NCT02920177|616200845|FG001|Overall Study|Lost to Follow-up|1|||
170507819|NCT00131365|616200846|FG000|Overall Study|Withdrawal by Subject|1|||
170507820|NCT00131365|616200846|FG000|Overall Study|Alternative treatment|3|||
170507821|NCT02294461|616200847|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
170507822|NCT02294461|616200848|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
170507823|NCT02294461|616200849|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
170643166|NCT04250077|616708316|FG000|Overall Study|Withdrawal by Subject|0|||
170643167|NCT04250077|616708317|FG001|Overall Study|Withdrawal by Subject|1|||
170643168|NCT04250077|616708318|FG002|Overall Study|Withdrawal by Subject|0|||
170643169|NCT04250077|616708316|FG000|Overall Study|Lost to Follow-up|2|||
170805507|NCT02401815|617297373|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170805508|NCT02401815|617297374|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170507824|NCT02294461|616200847|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
170507825|NCT02294461|616200848|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
170507826|NCT02294461|616200849|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
170507827|NCT02294461|616200847|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
170507828|NCT02294461|616200848|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
170507829|NCT02294461|616200849|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
170507830|NCT02294461|616200847|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
170507831|NCT02294461|616200848|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
170507832|NCT02294461|616200849|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
170507833|NCT02294461|616200847|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
170507834|NCT02294461|616200848|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
170507835|NCT02294461|616200849|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
170507836|NCT02294461|616200847|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
170507837|NCT02294461|616200848|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
170507838|NCT02294461|616200849|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
170507839|NCT02294461|616200847|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
170507840|NCT02294461|616200848|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
170507841|NCT02294461|616200849|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
170507842|NCT02294461|616200847|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
170507843|NCT02294461|616200848|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
170507844|NCT02294461|616200849|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
170507845|NCT02294461|616200847|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
170507846|NCT02294461|616200848|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
170507847|NCT02294461|616200849|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
170507848|NCT02294461|616200847|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
170507849|NCT02294461|616200848|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
170507850|NCT02294461|616200849|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
170507851|NCT02294461|616200847|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
170507852|NCT02294461|616200848|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
170507853|NCT02294461|616200849|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
170552933|NCT01943825|616370319|FG003|Overall Study|Other than specified above|1|||
170552934|NCT00452400|616370322|FG000|Overall Study|Adverse Event|1|||
170552935|NCT00452400|616370323|FG001|Overall Study|Adverse Event|1|||
170552936|NCT00452400|616370324|FG002|Overall Study|Adverse Event|5|||
170552937|NCT00452400|616370325|FG003|Overall Study|Adverse Event|0|||
170552938|NCT00452400|616370326|FG004|Overall Study|Adverse Event|2|||
170552939|NCT00452400|616370322|FG000|Overall Study|Protocol Violation|0|||
170552940|NCT00452400|616370323|FG001|Overall Study|Protocol Violation|0|||
170552941|NCT00452400|616370324|FG002|Overall Study|Protocol Violation|1|||
170552942|NCT00452400|616370325|FG003|Overall Study|Protocol Violation|0|||
170552943|NCT00452400|616370326|FG004|Overall Study|Protocol Violation|0|||
170552944|NCT00452400|616370322|FG000|Overall Study|Lost to Follow-up|1|||
170552945|NCT00452400|616370323|FG001|Overall Study|Lost to Follow-up|0|||
170552946|NCT00452400|616370324|FG002|Overall Study|Lost to Follow-up|0|||
170552947|NCT00452400|616370325|FG003|Overall Study|Lost to Follow-up|0|||
170552948|NCT00452400|616370326|FG004|Overall Study|Lost to Follow-up|0|||
170552949|NCT00452400|616370322|FG000|Overall Study|Withdrawal by Subject|1|||
170552950|NCT00452400|616370323|FG001|Overall Study|Withdrawal by Subject|0|||
170552951|NCT00452400|616370324|FG002|Overall Study|Withdrawal by Subject|1|||
170552952|NCT00452400|616370325|FG003|Overall Study|Withdrawal by Subject|0|||
170552953|NCT00452400|616370326|FG004|Overall Study|Withdrawal by Subject|0|||
170552954|NCT00452400|616370322|FG000|Overall Study|Lack of Efficacy|2|||
170552955|NCT00452400|616370323|FG001|Overall Study|Lack of Efficacy|0|||
170552956|NCT00452400|616370324|FG002|Overall Study|Lack of Efficacy|0|||
170552957|NCT00452400|616370325|FG003|Overall Study|Lack of Efficacy|0|||
170552958|NCT00452400|616370326|FG004|Overall Study|Lack of Efficacy|0|||
170552959|NCT00452400|616370322|FG000|Overall Study|Other reasons not listed above|0|||
170552960|NCT00452400|616370323|FG001|Overall Study|Other reasons not listed above|0|||
170552961|NCT00452400|616370324|FG002|Overall Study|Other reasons not listed above|0|||
170552962|NCT00452400|616370325|FG003|Overall Study|Other reasons not listed above|1|||
170552963|NCT00452400|616370326|FG004|Overall Study|Other reasons not listed above|1|||
170552964|NCT01472835|616370331|FG000|Overall Study|Lost to Follow-up|2|||
170552965|NCT01472835|616370332|FG001|Overall Study|Lost to Follow-up|0|||
170552966|NCT01316900|616370349|FG000|Overall Study|Adverse Event|10|||
170552967|NCT01316900|616370350|FG001|Overall Study|Adverse Event|10|||
170552968|NCT01316900|616370351|FG002|Overall Study|Adverse Event|15|||
170552969|NCT01316900|616370352|FG003|Overall Study|Adverse Event|9|||
170552970|NCT01316900|616370349|FG000|Overall Study|Lack of Efficacy|17|||
170507854|NCT02294461|616200847|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
170552971|NCT01316900|616370350|FG001|Overall Study|Lack of Efficacy|9|||
170552972|NCT01316900|616370351|FG002|Overall Study|Lack of Efficacy|5|||
170552973|NCT01316900|616370352|FG003|Overall Study|Lack of Efficacy|7|||
170552974|NCT01316900|616370349|FG000|Overall Study|Protocol Violation|7|||
170552975|NCT01316900|616370350|FG001|Overall Study|Protocol Violation|1|||
170552976|NCT01316900|616370351|FG002|Overall Study|Protocol Violation|4|||
170552977|NCT01316900|616370352|FG003|Overall Study|Protocol Violation|0|||
170552978|NCT01316900|616370349|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
170552979|NCT01316900|616370350|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
170552980|NCT01316900|616370351|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
170904227|NCT01624142|617650921|FG000|Overall Study|Study Closure|12|||
170904228|NCT01624142|617650922|FG001|Overall Study|Study Closure|6|||
170904229|NCT01624142|617650921|FG000|Overall Study|Lost to Follow-up|2|||
170904230|NCT01624142|617650922|FG001|Overall Study|Lost to Follow-up|0|||
170904231|NCT01624142|617650921|FG000|Overall Study|Other|1|||
170904232|NCT01624142|617650922|FG001|Overall Study|Other|0|||
170904233|NCT01237951|617650923|FG000|Overall Study|Death|1|||
170507855|NCT02294461|616200848|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
170507856|NCT02294461|616200849|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
170507857|NCT02294461|616200847|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
170507858|NCT02294461|616200848|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
170507859|NCT02294461|616200849|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
170507860|NCT02294461|616200847|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
170507861|NCT02294461|616200848|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
170507862|NCT02294461|616200849|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
170507863|NCT01190189|616203143|FG000|Overall Study|Lost to Follow-up|4|||
170507864|NCT01190189|616203143|FG000|Overall Study|Withdrawal by Subject|1|||
170507865|NCT01190189|616203143|FG000|Overall Study|Migrated/moved from study area|1|||
170507866|NCT00734656|616203147|FG000|Lab Session 1|Withdrawal by Subject|2|||
170507867|NCT00734656|616203148|FG001|Lab Session 1|Withdrawal by Subject|0|||
170507868|NCT00734656|616203149|FG002|Lab Session 1|Withdrawal by Subject|0|||
170507869|NCT00734656|616203150|FG003|Lab Session 1|Withdrawal by Subject|0|||
170507870|NCT00734656|616203147|FG000|Washout 1|Withdrawal by Subject|1|||
170507871|NCT00734656|616203148|FG001|Washout 1|Withdrawal by Subject|5|||
170507872|NCT00734656|616203149|FG002|Washout 1|Withdrawal by Subject|2|||
170507873|NCT00734656|616203150|FG003|Washout 1|Withdrawal by Subject|3|||
170507874|NCT00734656|616203147|FG000|Lab Session 2|Withdrawal by Subject|1|||
170507875|NCT00734656|616203148|FG001|Lab Session 2|Withdrawal by Subject|0|||
170507876|NCT00734656|616203149|FG002|Lab Session 2|Withdrawal by Subject|0|||
170507877|NCT00734656|616203150|FG003|Lab Session 2|Withdrawal by Subject|1|||
170507878|NCT00734656|616203147|FG000|Washout 2|Withdrawal by Subject|1|||
170507879|NCT00734656|616203148|FG001|Washout 2|Withdrawal by Subject|1|||
170507880|NCT00734656|616203149|FG002|Washout 2|Withdrawal by Subject|1|||
170507881|NCT00734656|616203150|FG003|Washout 2|Withdrawal by Subject|0|||
170507882|NCT00734656|616203147|FG000|Washout 3|Withdrawal by Subject|1|||
170507883|NCT00734656|616203148|FG001|Washout 3|Withdrawal by Subject|0|||
170507884|NCT00734656|616203149|FG002|Washout 3|Withdrawal by Subject|0|||
170507885|NCT00734656|616203150|FG003|Washout 3|Withdrawal by Subject|1|||
170507886|NCT00734656|616203147|FG000|Lab Session 4|Withdrawal by Subject|0|||
170507887|NCT00734656|616203148|FG001|Lab Session 4|Withdrawal by Subject|0|||
170507888|NCT00734656|616203149|FG002|Lab Session 4|Withdrawal by Subject|0|||
170507889|NCT00734656|616203150|FG003|Lab Session 4|Withdrawal by Subject|1|||
170507890|NCT01533688|616203151|FG000|Overall Study|Withdrawal by Subject|5|||
170507891|NCT01533688|616203152|FG001|Overall Study|Withdrawal by Subject|4|||
170507892|NCT01533688|616203153|FG002|Overall Study|Withdrawal by Subject|3|||
170507893|NCT01533688|616203151|FG000|Overall Study|Medically unstable|1|||
170507894|NCT01533688|616203152|FG001|Overall Study|Medically unstable|3|||
170507895|NCT01533688|616203153|FG002|Overall Study|Medically unstable|3|||
170507896|NCT01533688|616203151|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
170507897|NCT01533688|616203152|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
170507898|NCT01533688|616203153|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
170507899|NCT01306214|616203155|FG000|Overall Study|Death|0|||
170507900|NCT01306214|616203156|FG001|Overall Study|Death|0|||
170507901|NCT01306214|616203157|FG002|Overall Study|Death|1|||
170507902|NCT01306214|616203155|FG000|Overall Study|Lost to Follow-up|3|||
170507903|NCT01306214|616203156|FG001|Overall Study|Lost to Follow-up|5|||
170507904|NCT01306214|616203157|FG002|Overall Study|Lost to Follow-up|4|||
170507905|NCT01306214|616203155|FG000|Overall Study|Withdrawal by Subject|24|||
170507906|NCT01306214|616203156|FG001|Overall Study|Withdrawal by Subject|22|||
170507907|NCT01306214|616203157|FG002|Overall Study|Withdrawal by Subject|16|||
170507908|NCT01306214|616203155|FG000|Overall Study|Not treated|1|||
170507909|NCT01306214|616203156|FG001|Overall Study|Not treated|1|||
170507910|NCT01306214|616203157|FG002|Overall Study|Not treated|1|||
170507911|NCT02686814|616203158|FG000|Overall Study|Physician Decision|14|||
170507912|NCT02686814|616203158|FG000|Overall Study|Withdrawal by Subject|4|||
170507913|NCT02686814|616203158|FG000|Overall Study|Death|1|||
170507914|NCT01760447|616203159|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
170507915|NCT01760447|616203160|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
170507916|NCT01760447|616203161|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
170643170|NCT04250077|616708317|FG001|Overall Study|Lost to Follow-up|3|||
170643171|NCT04250077|616708318|FG002|Overall Study|Lost to Follow-up|0|||
170904234|NCT02970929|617650924|FG000|Overall Study|Adverse Event|18|||
170507917|NCT01760447|616203162|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
170507918|NCT01760447|616203159|FG000|Weeks 0-20|Withdrawal by Subject|2|||
170507919|NCT01760447|616203160|FG001|Weeks 0-20|Withdrawal by Subject|0|||
170904235|NCT02970929|617650924|FG000|Overall Study|Lack of Efficacy|8|||
170904236|NCT02970929|617650924|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
170805509|NCT02401815|617297375|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170507920|NCT01760447|616203161|FG002|Weeks 0-20|Withdrawal by Subject|1|||
170507921|NCT01760447|616203162|FG003|Weeks 0-20|Withdrawal by Subject|0|||
170507922|NCT01760447|616203159|FG000|Weeks 0-20|Lost to Follow-up|1|||
170507923|NCT01760447|616203160|FG001|Weeks 0-20|Lost to Follow-up|0|||
170507924|NCT01760447|616203161|FG002|Weeks 0-20|Lost to Follow-up|1|||
170507925|NCT01760447|616203162|FG003|Weeks 0-20|Lost to Follow-up|1|||
170507926|NCT01760447|616203159|FG000|Weeks 0-20|Randomized but not treated|0|||
170507927|NCT01760447|616203160|FG001|Weeks 0-20|Randomized but not treated|0|||
170507928|NCT01760447|616203161|FG002|Weeks 0-20|Randomized but not treated|2|||
170507929|NCT01760447|616203162|FG003|Weeks 0-20|Randomized but not treated|0|||
170507930|NCT01760447|616203159|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
170507931|NCT01760447|616203160|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
170507932|NCT01760447|616203161|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
170507933|NCT01760447|616203162|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
170507934|NCT01760447|616203159|FG000|Weeks 20-54|Withdrawal by Subject|2|||
170507935|NCT01760447|616203160|FG001|Weeks 20-54|Withdrawal by Subject|1|||
170507936|NCT01760447|616203161|FG002|Weeks 20-54|Withdrawal by Subject|1|||
170507937|NCT01760447|616203162|FG003|Weeks 20-54|Withdrawal by Subject|2|||
170507938|NCT01760447|616203159|FG000|Weeks 20-54|Lost to Follow-up|0|||
170507939|NCT01760447|616203160|FG001|Weeks 20-54|Lost to Follow-up|0|||
170507940|NCT01760447|616203161|FG002|Weeks 20-54|Lost to Follow-up|1|||
170507941|NCT01760447|616203162|FG003|Weeks 20-54|Lost to Follow-up|2|||
170507942|NCT01214668|616203163|FG000|Overall Study|Adverse Event|0|||
170507943|NCT01214668|616203164|FG001|Overall Study|Adverse Event|1|||
170507944|NCT01214668|616203165|FG002|Overall Study|Adverse Event|0|||
170507945|NCT01214668|616203166|FG003|Overall Study|Adverse Event|2|||
170507946|NCT01214668|616203167|FG004|Overall Study|Adverse Event|1|||
170507947|NCT01214668|616203168|FG005|Overall Study|Adverse Event|1|||
170507948|NCT01214668|616203163|FG000|Overall Study|Death|0|||
170507949|NCT01214668|616203164|FG001|Overall Study|Death|0|||
170507950|NCT01214668|616203165|FG002|Overall Study|Death|1|||
170507951|NCT01214668|616203166|FG003|Overall Study|Death|0|||
170507952|NCT01214668|616203167|FG004|Overall Study|Death|0|||
170507953|NCT01214668|616203168|FG005|Overall Study|Death|0|||
170507954|NCT01214668|616203163|FG000|Overall Study|Progressive Disease|4|||
170507955|NCT01214668|616203164|FG001|Overall Study|Progressive Disease|2|||
170507956|NCT01214668|616203165|FG002|Overall Study|Progressive Disease|5|||
170507957|NCT01214668|616203166|FG003|Overall Study|Progressive Disease|4|||
170507958|NCT01214668|616203167|FG004|Overall Study|Progressive Disease|4|||
170507959|NCT01214668|616203168|FG005|Overall Study|Progressive Disease|5|||
170507960|NCT01214668|616203163|FG000|Overall Study|Withdrawal by Subject|0|||
170507961|NCT01214668|616203164|FG001|Overall Study|Withdrawal by Subject|0|||
170507962|NCT01214668|616203165|FG002|Overall Study|Withdrawal by Subject|0|||
170507963|NCT01214668|616203166|FG003|Overall Study|Withdrawal by Subject|0|||
170507964|NCT01214668|616203167|FG004|Overall Study|Withdrawal by Subject|1|||
170507965|NCT01214668|616203168|FG005|Overall Study|Withdrawal by Subject|0|||
170507966|NCT02907619|616203169|FG000|Overall Study|Study terminated by sponsor|18|||
170507967|NCT02907619|616203170|FG001|Overall Study|Study terminated by sponsor|18|||
170507968|NCT02907619|616203171|FG002|Overall Study|Study terminated by sponsor|19|||
170507969|NCT02907619|616203169|FG000|Overall Study|Death|0|||
170507970|NCT02907619|616203170|FG001|Overall Study|Death|0|||
170507971|NCT02907619|616203171|FG002|Overall Study|Death|1|||
170507972|NCT02907619|616203169|FG000|Overall Study|Withdrawal by Subject|1|||
170507973|NCT02907619|616203170|FG001|Overall Study|Withdrawal by Subject|1|||
170507974|NCT02907619|616203171|FG002|Overall Study|Withdrawal by Subject|0|||
170507975|NCT02907619|616203169|FG000|Overall Study|Other|0|||
170805510|NCT02401815|617297376|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170805511|NCT02401815|617297377|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170507976|NCT02907619|616203170|FG001|Overall Study|Other|1|||
170507977|NCT02907619|616203171|FG002|Overall Study|Other|0|||
170507978|NCT02065518|616203172|FG000|Overall Study|Lost to Follow-up|3|||
170507979|NCT02065518|616203173|FG001|Overall Study|Lost to Follow-up|4|||
170507980|NCT02065518|616203174|FG002|Overall Study|Lost to Follow-up|0|||
170507981|NCT02065518|616203175|FG003|Overall Study|Lost to Follow-up|3|||
170507982|NCT02065518|616203172|FG000|Overall Study|Withdrawal by Subject|3|||
170643172|NCT01120782|616708319|FG000|Overall Study|Test article shipping error|11|||
170507983|NCT02065518|616203173|FG001|Overall Study|Withdrawal by Subject|4|||
170507984|NCT02065518|616203174|FG002|Overall Study|Withdrawal by Subject|9|||
170507985|NCT02065518|616203175|FG003|Overall Study|Withdrawal by Subject|2|||
170507986|NCT00564278|616203177|FG000|Overall Study|Lost to Follow-up|35|||
170507987|NCT00564278|616203178|FG001|Overall Study|Lost to Follow-up|33|||
170507988|NCT00564278|616203177|FG000|Overall Study|Physician Decision|1|||
170507989|NCT00564278|616203178|FG001|Overall Study|Physician Decision|2|||
170507990|NCT00564278|616203177|FG000|Overall Study|Withdrawal by Subject|11|||
170507991|NCT00564278|616203178|FG001|Overall Study|Withdrawal by Subject|7|||
170507992|NCT00493311|616203179|FG000|Overall Study|Need for rescue medication|2|||
170507993|NCT00493311|616203180|FG001|Overall Study|Need for rescue medication|2|||
170507994|NCT00790556|616203181|FG000|Treatment Period 1|Physician Decision|1|||
170904237|NCT02970929|617650924|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
170904238|NCT02970929|617650924|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
170904239|NCT02970929|617650924|FG000|Overall Study|LOST TO FOLLOWUP|6|||
170904240|NCT02970929|617650924|FG000|Overall Study|MOVED OUT OF STATE|1|||
170904241|NCT02970929|617650924|FG000|Overall Study|Withdrawal by Subject|16|||
170904242|NCT00666562|617650925|FG000|Overall Study|Withdrawal by Subject|0|||
170507995|NCT00790556|616203182|FG001|Treatment Period 1|Physician Decision|0|||
170507996|NCT00790556|616203181|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170507997|NCT00790556|616203182|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170507998|NCT02368886|616203183|FG000|Overall Study|Cancel|1|||
170507999|NCT02368886|616203184|FG001|Overall Study|Cancel|1|||
170508000|NCT02368886|616203185|FG002|Overall Study|Cancel|1|||
170508001|NCT02368886|616203186|FG003|Overall Study|Cancel|3|||
170508002|NCT02368886|616203183|FG000|Overall Study|Ineligible|0|||
170508003|NCT02368886|616203184|FG001|Overall Study|Ineligible|0|||
170508004|NCT02368886|616203185|FG002|Overall Study|Ineligible|0|||
170508005|NCT02368886|616203186|FG003|Overall Study|Ineligible|1|||
170508006|NCT02476916|616203188|FG000|Core Period|Adverse Event|2|||
170508007|NCT02476916|616203189|FG001|Core Period|Adverse Event|2|||
170508008|NCT02476916|616203188|FG000|Core Period|Investigator decision|1|||
170508009|NCT02476916|616203189|FG001|Core Period|Investigator decision|1|||
170508010|NCT02476916|616203188|FG000|Core Period|Withdrawal by Subject|3|||
170508011|NCT02476916|616203189|FG001|Core Period|Withdrawal by Subject|0|||
170508012|NCT02476916|616203188|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
170508013|NCT02476916|616203189|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
170508014|NCT02476916|616203188|FG000|Extension Period|On Treatment|12|||
170508015|NCT02476916|616203189|FG001|Extension Period|On Treatment|17|||
170508016|NCT06010732|616203191|FG000|Crossover Period 1|Protocol Violation|0|||
170508017|NCT06010732|616203192|FG001|Crossover Period 1|Protocol Violation|0|||
170508018|NCT06010732|616203193|FG002|Crossover Period 1|Protocol Violation|1|||
170508019|NCT06010732|616203194|FG003|Crossover Period 1|Protocol Violation|0|||
170508020|NCT06010732|616203195|FG004|Crossover Period 1|Protocol Violation|1|||
170508021|NCT06010732|616203196|FG005|Crossover Period 1|Protocol Violation|0|||
170508022|NCT06010732|616203191|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
170508023|NCT06010732|616203192|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
170508024|NCT06010732|616203193|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
170508025|NCT06010732|616203194|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
170508026|NCT06010732|616203195|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
170508027|NCT06010732|616203196|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
170508028|NCT06010732|616203191|FG000|Crossover Period 2|Adverse Event|0|||
170508029|NCT06010732|616203192|FG001|Crossover Period 2|Adverse Event|1|||
170508030|NCT06010732|616203193|FG002|Crossover Period 2|Adverse Event|0|||
170508031|NCT06010732|616203194|FG003|Crossover Period 2|Adverse Event|0|||
170508032|NCT06010732|616203195|FG004|Crossover Period 2|Adverse Event|0|||
170508033|NCT06010732|616203196|FG005|Crossover Period 2|Adverse Event|0|||
170508034|NCT06010732|616203191|FG000|Crossover Period 2|broken denture|0|||
170508035|NCT06010732|616203192|FG001|Crossover Period 2|broken denture|0|||
170552981|NCT01316900|616370352|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
170552982|NCT01316900|616370349|FG000|Overall Study|Lost to Follow-up|1|||
170552983|NCT01316900|616370350|FG001|Overall Study|Lost to Follow-up|0|||
170552984|NCT01316900|616370351|FG002|Overall Study|Lost to Follow-up|1|||
170552985|NCT01316900|616370352|FG003|Overall Study|Lost to Follow-up|1|||
170552986|NCT01316900|616370349|FG000|Overall Study|Withdrawal by Subject|7|||
170508036|NCT06010732|616203193|FG002|Crossover Period 2|broken denture|1|||
170508037|NCT06010732|616203194|FG003|Crossover Period 2|broken denture|0|||
170508038|NCT06010732|616203195|FG004|Crossover Period 2|broken denture|0|||
170508039|NCT06010732|616203196|FG005|Crossover Period 2|broken denture|0|||
170508040|NCT00253370|616203199|FG000|Overall Study|Adverse Event|18|||
170508041|NCT00253370|616203199|FG000|Overall Study|Disease progression|13|||
170508042|NCT00253370|616203199|FG000|Overall Study|Death|2|||
170508043|NCT00253370|616203199|FG000|Overall Study|Withdrawal by Subject|6|||
170508044|NCT00253370|616203199|FG000|Overall Study|Non-protocol therapy|1|||
170508045|NCT00253370|616203199|FG000|Overall Study|Physician Decision|1|||
170508046|NCT00253370|616203199|FG000|Overall Study|Protocol Violation|1|||
170508047|NCT00253370|616203199|FG000|Overall Study|Abdominal pain due to disease|1|||
170508048|NCT04122625|616203200|FG000|Part A (up to 2.92 Years)|Death|2|||
170508049|NCT04122625|616203201|FG001|Part A (up to 2.92 Years)|Death|4|||
170508050|NCT04122625|616203202|FG002|Part A (up to 2.92 Years)|Death|0|||
170508051|NCT04122625|616203203|FG003|Part A (up to 2.92 Years)|Death|0|||
170508052|NCT04122625|616203204|FG004|Part A (up to 2.92 Years)|Death|0|||
170508053|NCT04122625|616203205|FG005|Part A (up to 2.92 Years)|Death|0|||
170508054|NCT04122625|616203200|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
170805512|NCT02401815|617297378|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170805513|NCT02401815|617297379|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170805514|NCT02401815|617297380|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170508055|NCT04122625|616203201|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
170508056|NCT04122625|616203202|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
170508057|NCT04122625|616203203|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
170508058|NCT04122625|616203204|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
170508059|NCT04122625|616203205|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
170508060|NCT04122625|616203200|FG000|Part B (up to 2.33 Years)|Death|0|||
170508061|NCT04122625|616203201|FG001|Part B (up to 2.33 Years)|Death|0|||
170508062|NCT04122625|616203202|FG002|Part B (up to 2.33 Years)|Death|5|||
170508063|NCT04122625|616203203|FG003|Part B (up to 2.33 Years)|Death|7|||
170508064|NCT04122625|616203204|FG004|Part B (up to 2.33 Years)|Death|6|||
170508065|NCT04122625|616203205|FG005|Part B (up to 2.33 Years)|Death|7|||
170508066|NCT03699540|616203206|FG000|Overall Study|Lost to Follow-up|1|||
170508067|NCT02697591|616203207|FG000|Overall Study|Lost to Follow-up|0|||
170508068|NCT02697591|616203208|FG001|Overall Study|Lost to Follow-up|0|||
170508069|NCT02697591|616203209|FG002|Overall Study|Lost to Follow-up|0|||
170508070|NCT02697591|616203210|FG003|Overall Study|Lost to Follow-up|0|||
170508071|NCT02697591|616203211|FG004|Overall Study|Lost to Follow-up|0|||
170508072|NCT02697591|616203212|FG005|Overall Study|Lost to Follow-up|1|||
170508073|NCT02697591|616203213|FG006|Overall Study|Lost to Follow-up|1|||
170508074|NCT02697591|616203214|FG007|Overall Study|Lost to Follow-up|0|||
170508075|NCT02697591|616203215|FG008|Overall Study|Lost to Follow-up|0|||
170508076|NCT02697591|616203216|FG009|Overall Study|Lost to Follow-up|1|||
170508077|NCT02697591|616203207|FG000|Overall Study|Withdrawal by Subject|1|||
170508078|NCT02697591|616203208|FG001|Overall Study|Withdrawal by Subject|1|||
170508079|NCT02697591|616203209|FG002|Overall Study|Withdrawal by Subject|2|||
170508080|NCT02697591|616203210|FG003|Overall Study|Withdrawal by Subject|1|||
170508081|NCT02697591|616203211|FG004|Overall Study|Withdrawal by Subject|7|||
170508082|NCT02697591|616203212|FG005|Overall Study|Withdrawal by Subject|6|||
170508083|NCT02697591|616203213|FG006|Overall Study|Withdrawal by Subject|9|||
170508084|NCT02697591|616203214|FG007|Overall Study|Withdrawal by Subject|1|||
170508085|NCT02697591|616203215|FG008|Overall Study|Withdrawal by Subject|6|||
170508086|NCT02697591|616203216|FG009|Overall Study|Withdrawal by Subject|10|||
170508087|NCT02697591|616203207|FG000|Overall Study|Physician Decision|1|||
170508088|NCT02697591|616203208|FG001|Overall Study|Physician Decision|0|||
170508089|NCT02697591|616203209|FG002|Overall Study|Physician Decision|0|||
170508090|NCT02697591|616203210|FG003|Overall Study|Physician Decision|0|||
170508091|NCT02697591|616203211|FG004|Overall Study|Physician Decision|1|||
170508092|NCT02697591|616203212|FG005|Overall Study|Physician Decision|2|||
170805515|NCT02401815|617297381|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
170805516|NCT02401815|617297382|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
170805517|NCT02401815|617297373|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
170805518|NCT02401815|617297374|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
170805519|NCT02401815|617297375|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
170805520|NCT02401815|617297376|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
170805521|NCT02401815|617297377|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
170805522|NCT02401815|617297378|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
170805523|NCT02401815|617297379|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
170904243|NCT00666562|617650926|FG001|Overall Study|Withdrawal by Subject|1|||
170904244|NCT00666562|617650927|FG002|Overall Study|Withdrawal by Subject|0|||
170904245|NCT00666562|617650925|FG000|Overall Study|Concomitant Medication|0|||
170904246|NCT00666562|617650926|FG001|Overall Study|Concomitant Medication|1|||
170904247|NCT00666562|617650927|FG002|Overall Study|Concomitant Medication|0|||
170508093|NCT02697591|616203213|FG006|Overall Study|Physician Decision|0|||
170508094|NCT02697591|616203214|FG007|Overall Study|Physician Decision|0|||
170508095|NCT02697591|616203215|FG008|Overall Study|Physician Decision|1|||
170508096|NCT02697591|616203216|FG009|Overall Study|Physician Decision|1|||
170508097|NCT02697591|616203207|FG000|Overall Study|Death|2|||
170508098|NCT02697591|616203208|FG001|Overall Study|Death|3|||
170508099|NCT02697591|616203209|FG002|Overall Study|Death|1|||
170508100|NCT02697591|616203210|FG003|Overall Study|Death|1|||
170508101|NCT02697591|616203211|FG004|Overall Study|Death|4|||
170508102|NCT02697591|616203212|FG005|Overall Study|Death|5|||
170508103|NCT02697591|616203213|FG006|Overall Study|Death|3|||
170508104|NCT02697591|616203214|FG007|Overall Study|Death|1|||
170508105|NCT02697591|616203215|FG008|Overall Study|Death|1|||
170508106|NCT02697591|616203216|FG009|Overall Study|Death|5|||
170805524|NCT02401815|617297380|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
170805525|NCT02401815|617297381|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
170805526|NCT02401815|617297382|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
170805527|NCT00748709|617297390|FG000|Overall Study|Progressive disease|15|||
170805528|NCT00748709|617297390|FG000|Overall Study|Drug reducing Toxity|2|||
170904248|NCT00655928|617650928|FG000|Overall Study|Withdrawal by Subject|2|||
170508107|NCT02697591|616203207|FG000|Overall Study|Reason not Specified|0|||
170508108|NCT02697591|616203208|FG001|Overall Study|Reason not Specified|0|||
170508109|NCT02697591|616203209|FG002|Overall Study|Reason not Specified|0|||
170508110|NCT02697591|616203210|FG003|Overall Study|Reason not Specified|1|||
170508111|NCT02697591|616203211|FG004|Overall Study|Reason not Specified|1|||
170508112|NCT02697591|616203212|FG005|Overall Study|Reason not Specified|2|||
170508113|NCT02697591|616203213|FG006|Overall Study|Reason not Specified|3|||
170508114|NCT02697591|616203214|FG007|Overall Study|Reason not Specified|1|||
170508115|NCT02697591|616203215|FG008|Overall Study|Reason not Specified|1|||
170508116|NCT02697591|616203216|FG009|Overall Study|Reason not Specified|3|||
170508117|NCT00004088|616203218|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
170508118|NCT00004088|616203218|FG000|Overall Study|Withdrawal by Subject|1|||
170508119|NCT00004088|616203218|FG000|Overall Study|Protocol Violation|3|||
170508120|NCT00004088|616203218|FG000|Overall Study|Physician Decision|1|||
170508121|NCT02636699|616203219|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
170508122|NCT02636699|616203220|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
170508123|NCT02636699|616203221|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
170508124|NCT02636699|616203219|FG000|Screening Period|Withdrawal by Subject|0|||
170508125|NCT02636699|616203220|FG001|Screening Period|Withdrawal by Subject|0|||
170508126|NCT02636699|616203221|FG002|Screening Period|Withdrawal by Subject|23|||
170508127|NCT02636699|616203219|FG000|Screening Period|Adverse Event|0|||
170508128|NCT02636699|616203220|FG001|Screening Period|Adverse Event|0|||
170508129|NCT02636699|616203221|FG002|Screening Period|Adverse Event|1|||
170508130|NCT02636699|616203219|FG000|Screening Period|Other not specified|0|||
170508131|NCT02636699|616203220|FG001|Screening Period|Other not specified|0|||
170508132|NCT02636699|616203221|FG002|Screening Period|Other not specified|3|||
170508133|NCT02636699|616203219|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
170508134|NCT02636699|616203220|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
170508135|NCT02636699|616203221|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
170508136|NCT02636699|616203219|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
170508137|NCT02636699|616203220|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
170508138|NCT02636699|616203221|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
170508139|NCT02636699|616203219|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
170552987|NCT01316900|616370350|FG001|Overall Study|Withdrawal by Subject|8|||
170552988|NCT01316900|616370351|FG002|Overall Study|Withdrawal by Subject|6|||
170552989|NCT01316900|616370352|FG003|Overall Study|Withdrawal by Subject|9|||
170904249|NCT00655928|617650929|FG001|Overall Study|Withdrawal by Subject|1|||
170904250|NCT00655928|617650928|FG000|Overall Study|Physician Decision|1|||
170904251|NCT00655928|617650929|FG001|Overall Study|Physician Decision|1|||
170904252|NCT02654002|617650936|FG000|Overall Study|Adverse Event|0|||
170904253|NCT02654002|617650937|FG001|Overall Study|Adverse Event|0|||
170552990|NCT00562861|616370353|FG000|Overall Study|Adverse Event|1|||
170552991|NCT00562861|616370354|FG001|Overall Study|Adverse Event|1|||
170552992|NCT00562861|616370353|FG000|Overall Study|Lack of Efficacy|5|||
170552993|NCT00562861|616370354|FG001|Overall Study|Lack of Efficacy|5|||
170552994|NCT00562861|616370353|FG000|Overall Study|noncompliance, moved|7|||
170552995|NCT00562861|616370354|FG001|Overall Study|noncompliance, moved|2|||
170552996|NCT00562861|616370353|FG000|Overall Study|Lost to Follow-up|7|||
170552997|NCT00562861|616370354|FG001|Overall Study|Lost to Follow-up|3|||
170552998|NCT03726879|616370355|FG000|Overall Study|Death|11|||
170552999|NCT03726879|616370356|FG001|Overall Study|Death|13|||
170553000|NCT03726879|616370355|FG000|Overall Study|Physician Decision|0|||
170553001|NCT03726879|616370356|FG001|Overall Study|Physician Decision|2|||
170553002|NCT03726879|616370355|FG000|Overall Study|Protocol Violation|0|||
170553003|NCT03726879|616370356|FG001|Overall Study|Protocol Violation|1|||
170553004|NCT03726879|616370355|FG000|Overall Study|Withdrawal by Subject|5|||
170553005|NCT03726879|616370356|FG001|Overall Study|Withdrawal by Subject|6|||
170553006|NCT03726879|616370355|FG000|Overall Study|TSH result is unstable|0|||
170553007|NCT03726879|616370356|FG001|Overall Study|TSH result is unstable|1|||
170553008|NCT03726879|616370355|FG000|Overall Study|Disease relapse|1|||
170553009|NCT03726879|616370356|FG001|Overall Study|Disease relapse|0|||
170553010|NCT03726879|616370355|FG000|Overall Study|Lost to Follow-up|3|||
170904254|NCT02654002|617650938|FG002|Overall Study|Adverse Event|0|||
170904255|NCT02654002|617650939|FG003|Overall Study|Adverse Event|0|||
170508140|NCT02636699|616203220|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
170904256|NCT02654002|617650940|FG004|Overall Study|Adverse Event|0|||
170508141|NCT02636699|616203221|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
170508142|NCT02636699|616203219|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
170508143|NCT02636699|616203220|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
170508144|NCT02636699|616203221|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
170553011|NCT03726879|616370356|FG001|Overall Study|Lost to Follow-up|0|||
170553012|NCT05626686|616370357|FG000|Overall Study|Protocol Violation|3|||
170553013|NCT05626686|616370357|FG000|Overall Study|Withdrawal by Subject|3|||
170553014|NCT01093573|616370358|FG000|Overall Study|Physician Decision|0|||
170904257|NCT02654002|617650941|FG005|Overall Study|Adverse Event|0|||
170508145|NCT02636699|616203219|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
170508146|NCT02636699|616203220|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
170508147|NCT02636699|616203221|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
170508148|NCT02636699|616203219|FG000|Treatment and Follow-up Periods|Other|3|||
170508149|NCT02636699|616203220|FG001|Treatment and Follow-up Periods|Other|1|||
170508150|NCT02636699|616203221|FG002|Treatment and Follow-up Periods|Other|0|||
170508151|NCT01939223|616203222|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
170508152|NCT01939223|616203223|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
170508153|NCT01939223|616203222|FG000|Overall Study|Disease recurrence (radiological)|1|||
170508154|NCT01939223|616203223|FG001|Overall Study|Disease recurrence (radiological)|3|||
170508155|NCT01939223|616203222|FG000|Overall Study|Study stopped by Sponsor|5|||
170508156|NCT01939223|616203223|FG001|Overall Study|Study stopped by Sponsor|7|||
170508157|NCT01939223|616203222|FG000|Overall Study|Withdrawal by Subject|6|||
170508158|NCT01939223|616203223|FG001|Overall Study|Withdrawal by Subject|0|||
170508159|NCT04379700|616203224|FG000|Overall Study|Withdrawal by Subject|10|||
170508160|NCT04379700|616203224|FG000|Overall Study|Screen Fail|4|||
170508161|NCT04379700|616203224|FG000|Overall Study|Lost to Follow-up|3|||
170508162|NCT03624569|616203225|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
170508163|NCT03624569|616203226|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
170508164|NCT03624569|616203225|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
170508165|NCT03624569|616203226|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
170508166|NCT01254721|616203253|FG000|Overall Study|Lost to Follow-up|0|||
170508167|NCT01254721|616203254|FG001|Overall Study|Lost to Follow-up|4|||
170508168|NCT01254721|616203253|FG000|Overall Study|Lack of Efficacy|4|||
170508169|NCT01254721|616203254|FG001|Overall Study|Lack of Efficacy|2|||
170508170|NCT01254721|616203253|FG000|Overall Study|Death|0|||
170508171|NCT01254721|616203254|FG001|Overall Study|Death|1|||
170508172|NCT01254721|616203253|FG000|Overall Study|technical problum|1|||
170508173|NCT01254721|616203254|FG001|Overall Study|technical problum|0|||
170508174|NCT01254721|616203253|FG000|Overall Study|Adverse Event|2|||
170508175|NCT01254721|616203254|FG001|Overall Study|Adverse Event|3|||
170508176|NCT01254721|616203253|FG000|Overall Study|Withdrawal by Subject|8|||
170508177|NCT01254721|616203254|FG001|Overall Study|Withdrawal by Subject|11|||
170508178|NCT01254721|616203253|FG000|Overall Study|Wrongly randomization|0|||
170508179|NCT01254721|616203254|FG001|Overall Study|Wrongly randomization|1|||
170508180|NCT01167634|616203257|FG000|Overall Study|Lost to Follow-up|1|||
170508181|NCT01167634|616203258|FG001|Overall Study|Lost to Follow-up|3|||
170508182|NCT01167634|616203259|FG002|Overall Study|Lost to Follow-up|3|||
170508183|NCT01167634|616203260|FG003|Overall Study|Lost to Follow-up|4|||
170508184|NCT01167634|616203257|FG000|Overall Study|Withdrawal by Subject|1|||
170508185|NCT01167634|616203258|FG001|Overall Study|Withdrawal by Subject|1|||
170508186|NCT01167634|616203259|FG002|Overall Study|Withdrawal by Subject|0|||
170508187|NCT01167634|616203260|FG003|Overall Study|Withdrawal by Subject|0|||
170508188|NCT03004924|616203261|FG000|Overall Study|Adverse Event|6|||
170508189|NCT03004924|616203262|FG001|Overall Study|Adverse Event|5|||
170508190|NCT03004924|616203263|FG002|Overall Study|Adverse Event|10|||
170508191|NCT03004924|616203261|FG000|Overall Study|Protocol Violation|4|||
170508192|NCT03004924|616203262|FG001|Overall Study|Protocol Violation|0|||
170508193|NCT03004924|616203263|FG002|Overall Study|Protocol Violation|1|||
170508194|NCT03004924|616203261|FG000|Overall Study|Withdrawal by Subject|5|||
170508195|NCT03004924|616203262|FG001|Overall Study|Withdrawal by Subject|3|||
170508196|NCT03004924|616203263|FG002|Overall Study|Withdrawal by Subject|5|||
170508197|NCT03004924|616203261|FG000|Overall Study|Lost to Follow-up|6|||
170508198|NCT03004924|616203262|FG001|Overall Study|Lost to Follow-up|1|||
170508199|NCT03004924|616203263|FG002|Overall Study|Lost to Follow-up|4|||
170508200|NCT03004924|616203261|FG000|Overall Study|Lack of Efficacy|2|||
170508201|NCT03004924|616203262|FG001|Overall Study|Lack of Efficacy|4|||
170508202|NCT03004924|616203263|FG002|Overall Study|Lack of Efficacy|2|||
170508203|NCT03004924|616203261|FG000|Overall Study|Physician Decision|1|||
170508204|NCT03004924|616203262|FG001|Overall Study|Physician Decision|0|||
170508205|NCT03004924|616203263|FG002|Overall Study|Physician Decision|1|||
170508206|NCT03004924|616203261|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170508207|NCT03004924|616203262|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170508208|NCT03004924|616203263|FG002|Overall Study|Withdrawal by parent/guardian|2|||
170508209|NCT03004924|616203261|FG000|Overall Study|Screen Failure|1|||
170553015|NCT01093573|616370359|FG001|Overall Study|Physician Decision|0|||
170553016|NCT01093573|616370360|FG002|Overall Study|Physician Decision|1|||
170553017|NCT01093573|616370358|FG000|Overall Study|Insurance Denied|0|||
170553018|NCT01093573|616370359|FG001|Overall Study|Insurance Denied|0|||
170508210|NCT03004924|616203262|FG001|Overall Study|Screen Failure|0|||
170508211|NCT03004924|616203263|FG002|Overall Study|Screen Failure|0|||
170508212|NCT03004924|616203261|FG000|Overall Study|Pregnancy|0|||
170508213|NCT03004924|616203262|FG001|Overall Study|Pregnancy|1|||
170508214|NCT03004924|616203263|FG002|Overall Study|Pregnancy|0|||
170508215|NCT03004924|616203261|FG000|Overall Study|Terminated by Sponsor|0|||
170508216|NCT03004924|616203262|FG001|Overall Study|Terminated by Sponsor|0|||
170553019|NCT01093573|616370360|FG002|Overall Study|Insurance Denied|1|||
170508217|NCT03004924|616203263|FG002|Overall Study|Terminated by Sponsor|1|||
170508218|NCT03004924|616203261|FG000|Overall Study|Missed Study Visit|0|||
170508219|NCT03004924|616203262|FG001|Overall Study|Missed Study Visit|0|||
170508220|NCT03004924|616203263|FG002|Overall Study|Missed Study Visit|2|||
170508221|NCT03004924|616203261|FG000|Overall Study|HSV1 Positive|1|||
170508222|NCT03004924|616203262|FG001|Overall Study|HSV1 Positive|0|||
170508223|NCT03004924|616203263|FG002|Overall Study|HSV1 Positive|0|||
170508224|NCT00553358|616203264|FG000|Overall Study|Randomized but did not receive treatment|3|||
170508225|NCT00553358|616203265|FG001|Overall Study|Randomized but did not receive treatment|3|||
170508226|NCT00553358|616203266|FG002|Overall Study|Randomized but did not receive treatment|1|||
170508227|NCT00553358|616203264|FG000|Overall Study|Lost to Follow-up|22|||
170508228|NCT00553358|616203265|FG001|Overall Study|Lost to Follow-up|26|||
170508229|NCT00553358|616203266|FG002|Overall Study|Lost to Follow-up|18|||
170508230|NCT00553358|616203264|FG000|Overall Study|Withdrew completely|23|||
170508231|NCT00553358|616203265|FG001|Overall Study|Withdrew completely|33|||
170508232|NCT00553358|616203266|FG002|Overall Study|Withdrew completely|34|||
170508233|NCT00553358|616203264|FG000|Overall Study|Died during clinical follow-up|25|||
170508234|NCT00553358|616203265|FG001|Overall Study|Died during clinical follow-up|29|||
170508235|NCT00553358|616203266|FG002|Overall Study|Died during clinical follow-up|32|||
170508236|NCT00553358|616203264|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
170508237|NCT00553358|616203265|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
170508238|NCT00553358|616203266|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
170553020|NCT02496156|616370361|FG000|Overall Study|Lost to Follow-up|5|||
170553021|NCT02496156|616370362|FG001|Overall Study|Lost to Follow-up|0|||
170553022|NCT02496156|616370361|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
170553023|NCT02496156|616370362|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
170553024|NCT00089583|616370363|FG000|Overall Study|Adverse Event|0|||
170553025|NCT00089583|616370364|FG001|Overall Study|Adverse Event|3|||
170553026|NCT00089583|616370363|FG000|Overall Study|Insufficient Viral Load Response|5|||
170553027|NCT00089583|616370364|FG001|Overall Study|Insufficient Viral Load Response|5|||
170553028|NCT00089583|616370363|FG000|Overall Study|Withdrawal by Subject|0|||
170553029|NCT00089583|616370364|FG001|Overall Study|Withdrawal by Subject|4|||
170553030|NCT00089583|616370363|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
170553031|NCT00089583|616370364|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
170553032|NCT00089583|616370363|FG000|Overall Study|Participant Refused Study Medication|0|||
170553033|NCT00089583|616370364|FG001|Overall Study|Participant Refused Study Medication|2|||
170553034|NCT00089583|616370363|FG000|Overall Study|Non-Compliance|0|||
170553035|NCT00089583|616370364|FG001|Overall Study|Non-Compliance|4|||
170553036|NCT00089583|616370363|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
170553037|NCT00089583|616370364|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
170553038|NCT00089583|616370363|FG000|Overall Study|Participant Management Criteria Met|0|||
170553039|NCT00089583|616370364|FG001|Overall Study|Participant Management Criteria Met|1|||
170553040|NCT00089583|616370363|FG000|Overall Study|Reason Not Provided|0|||
170553041|NCT00089583|616370364|FG001|Overall Study|Reason Not Provided|1|||
170553042|NCT00089583|616370363|FG000|Overall Study|Protocol Violation|0|||
170553043|NCT00089583|616370364|FG001|Overall Study|Protocol Violation|3|||
170553044|NCT00089583|616370363|FG000|Overall Study|Principal Investigator Decision|0|||
170553045|NCT00089583|616370364|FG001|Overall Study|Principal Investigator Decision|10|||
170553046|NCT00089583|616370363|FG000|Overall Study|Start of Disallowed Medication|0|||
170553047|NCT00089583|616370364|FG001|Overall Study|Start of Disallowed Medication|1|||
170553048|NCT00089583|616370363|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
170553049|NCT00089583|616370364|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
170553050|NCT00089583|616370363|FG000|Overall Study|Participant Incarcerated|0|||
170553051|NCT00089583|616370364|FG001|Overall Study|Participant Incarcerated|1|||
170553052|NCT00507507|616370365|FG000|Treatment Period|Lost to Follow-up|0|||
170553053|NCT00507507|616370366|FG001|Treatment Period|Lost to Follow-up|2|||
170553054|NCT00507507|616370365|FG000|Treatment Period|Physician Decision|4|||
170553055|NCT00507507|616370366|FG001|Treatment Period|Physician Decision|1|||
170553056|NCT00507507|616370365|FG000|Treatment Period|Protocol Violation|1|||
170553057|NCT00507507|616370366|FG001|Treatment Period|Protocol Violation|2|||
170553058|NCT00507507|616370365|FG000|Treatment Period|Adverse Event|1|||
170508239|NCT00553358|616203264|FG000|Overall Study|Died after clinical follow-up ended|1|||
170508240|NCT00553358|616203265|FG001|Overall Study|Died after clinical follow-up ended|2|||
170508241|NCT00553358|616203266|FG002|Overall Study|Died after clinical follow-up ended|0|||
170508242|NCT00553358|616203264|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
170508243|NCT00553358|616203265|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
170553059|NCT00507507|616370366|FG001|Treatment Period|Adverse Event|1|||
170553060|NCT00507507|616370365|FG000|Treatment Period|Withdrawal by Subject|46|||
170553061|NCT00507507|616370366|FG001|Treatment Period|Withdrawal by Subject|47|||
170553062|NCT00507507|616370365|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
170805529|NCT00748709|617297390|FG000|Overall Study|Other Adverse Event|1|||
170643173|NCT04140227|616708320|FG000|Overall Study|Withdrawal by Subject|26|||
170643174|NCT04140227|616708320|FG000|Overall Study|Lost to Follow-up|8|||
170643175|NCT04140227|616708320|FG000|Overall Study|Adverse Event|8|||
170643176|NCT04140227|616708320|FG000|Overall Study|Death|1|||
170643177|NCT04140227|616708320|FG000|Overall Study|Other|3|||
170643178|NCT04140227|616708320|FG000|Overall Study|Protocol Violation|2|||
170643179|NCT00926029|616708326|FG000|Overall Study|Lost to Follow-up|2|||
170643180|NCT00926029|616708327|FG001|Overall Study|Lost to Follow-up|1|||
170643181|NCT00926029|616708328|FG002|Overall Study|Lost to Follow-up|1|||
170643182|NCT02471612|616708329|FG000|Overall Study|Lost to Follow-up|2|||
170643183|NCT02082340|616708330|FG000|Overall Study|Lost to Follow-up|1|||
170643184|NCT02082340|616708331|FG001|Overall Study|Lost to Follow-up|1|||
170643185|NCT00833417|616708332|FG000|Overall Study|Adverse Event|5|||
170643186|NCT00833417|616708333|FG001|Overall Study|Adverse Event|16|||
170643187|NCT00833417|616708332|FG000|Overall Study|Death|1|||
170643188|NCT00833417|616708333|FG001|Overall Study|Death|3|||
170643189|NCT00833417|616708332|FG000|Overall Study|Lost to Follow-up|1|||
170643190|NCT00833417|616708333|FG001|Overall Study|Lost to Follow-up|2|||
170643191|NCT00833417|616708332|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
170643192|NCT00833417|616708333|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
170643193|NCT00833417|616708332|FG000|Overall Study|Patient Decision to Withdraw|4|||
170643194|NCT00833417|616708333|FG001|Overall Study|Patient Decision to Withdraw|23|||
170643195|NCT00833417|616708332|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
170643196|NCT00833417|616708333|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
170643197|NCT00833417|616708332|FG000|Overall Study|Disease Progression|18|||
170643198|NCT00833417|616708333|FG001|Overall Study|Disease Progression|17|||
170643199|NCT00833417|616708332|FG000|Overall Study|Reason Not Specified|0|||
170643200|NCT00833417|616708333|FG001|Overall Study|Reason Not Specified|1|||
170643201|NCT05315908|616708334|FG000|Overall Study|Lost to Follow-up|4477|||
170643202|NCT05315908|616708335|FG001|Overall Study|Lost to Follow-up|4606|||
170643203|NCT05246514|616708336|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
170643204|NCT05246514|616708336|FG000|Overall Study|Withdrawal by Subject|1|||
170643205|NCT05246514|616708336|FG000|Overall Study|Death|13|||
170643206|NCT04195893|616708337|FG000|Second Intervention|Withdrawal by Subject|1|||
170643207|NCT04195893|616708338|FG001|Second Intervention|Withdrawal by Subject|0|||
170643208|NCT03083990|616708347|FG000|Overall Study|Adverse Event|1|||
170643209|NCT03083990|616708348|FG001|Overall Study|Adverse Event|0|||
170643210|NCT02709538|616708349|FG000|Overall Study|Adverse Event|13|||
170643211|NCT02709538|616708350|FG001|Overall Study|Adverse Event|2|||
170643212|NCT02709538|616708351|FG002|Overall Study|Adverse Event|3|||
170643213|NCT02709538|616708349|FG000|Overall Study|Lack of Efficacy|1|||
170643214|NCT02709538|616708350|FG001|Overall Study|Lack of Efficacy|0|||
170508244|NCT00553358|616203266|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
170508245|NCT02854605|616203273|FG000|Overall Study|Adverse Event|1|||
170508246|NCT02854605|616203274|FG001|Overall Study|Adverse Event|5|||
170508247|NCT02854605|616203275|FG002|Overall Study|Adverse Event|2|||
170508248|NCT02854605|616203273|FG000|Overall Study|Lost to Follow-up|0|||
170508249|NCT02854605|616203274|FG001|Overall Study|Lost to Follow-up|2|||
170508250|NCT02854605|616203275|FG002|Overall Study|Lost to Follow-up|0|||
170508251|NCT02854605|616203273|FG000|Overall Study|Withdrew Consent|1|||
170508252|NCT02854605|616203274|FG001|Overall Study|Withdrew Consent|0|||
170508253|NCT02854605|616203275|FG002|Overall Study|Withdrew Consent|1|||
170508254|NCT02854605|616203273|FG000|Overall Study|Investigator's Discretion|1|||
170508255|NCT02854605|616203274|FG001|Overall Study|Investigator's Discretion|0|||
170508256|NCT02854605|616203275|FG002|Overall Study|Investigator's Discretion|0|||
170508257|NCT02854605|616203273|FG000|Overall Study|Protocol Violation|0|||
170508258|NCT02854605|616203274|FG001|Overall Study|Protocol Violation|0|||
170805530|NCT00748709|617297390|FG000|Overall Study|Withdrawal by Subject|1|||
170805531|NCT00748709|617297390|FG000|Overall Study|Other Reasons|1|||
170805532|NCT05325294|617297391|FG000|Overall Study|Adverse Event|3|||
170805533|NCT05325294|617297392|FG001|Overall Study|Adverse Event|3|||
170508259|NCT02854605|616203275|FG002|Overall Study|Protocol Violation|1|||
170508260|NCT03003000|616203280|FG000|Overall Study|Adverse Event|1|||
170643215|NCT02709538|616708351|FG002|Overall Study|Lack of Efficacy|0|||
170643216|NCT02709538|616708349|FG000|Overall Study|Lost to Follow-up|24|||
170643217|NCT02709538|616708350|FG001|Overall Study|Lost to Follow-up|8|||
170643218|NCT02709538|616708351|FG002|Overall Study|Lost to Follow-up|4|||
170643219|NCT02709538|616708349|FG000|Overall Study|Physician Decision|1|||
170643220|NCT02709538|616708350|FG001|Overall Study|Physician Decision|0|||
170805534|NCT05325294|617297391|FG000|Overall Study|Physician Decision|0|||
170805535|NCT05325294|617297392|FG001|Overall Study|Physician Decision|1|||
170643221|NCT02709538|616708351|FG002|Overall Study|Physician Decision|0|||
170643222|NCT02709538|616708349|FG000|Overall Study|Withdrawal by Subject|40|||
170643223|NCT02709538|616708350|FG001|Overall Study|Withdrawal by Subject|7|||
170643224|NCT02709538|616708351|FG002|Overall Study|Withdrawal by Subject|4|||
170643225|NCT02709538|616708349|FG000|Overall Study|Non-compliance with study procedures|5|||
170643226|NCT02709538|616708350|FG001|Overall Study|Non-compliance with study procedures|0|||
170805536|NCT05325294|617297391|FG000|Overall Study|Withdrawal by Subject|0|||
170508261|NCT03003000|616203281|FG001|Overall Study|Adverse Event|2|||
170508262|NCT03003000|616203282|FG002|Overall Study|Adverse Event|3|||
170508263|NCT03003000|616203280|FG000|Overall Study|Lack of Efficacy|1|||
170508264|NCT03003000|616203281|FG001|Overall Study|Lack of Efficacy|0|||
170508265|NCT03003000|616203282|FG002|Overall Study|Lack of Efficacy|0|||
170508266|NCT03003000|616203280|FG000|Overall Study|Non-compliant with protocol|0|||
170508267|NCT03003000|616203281|FG001|Overall Study|Non-compliant with protocol|1|||
170508268|NCT03003000|616203282|FG002|Overall Study|Non-compliant with protocol|1|||
170508269|NCT03003000|616203280|FG000|Overall Study|Refused to continue medication|2|||
170508270|NCT03003000|616203281|FG001|Overall Study|Refused to continue medication|0|||
170508271|NCT03003000|616203282|FG002|Overall Study|Refused to continue medication|0|||
170508272|NCT03003000|616203280|FG000|Overall Study|Other than listed|1|||
170508273|NCT03003000|616203281|FG001|Overall Study|Other than listed|1|||
170508274|NCT03003000|616203282|FG002|Overall Study|Other than listed|1|||
170508275|NCT04933617|616203283|FG000|Dose Escalation|Early closure of study|0|||
170508276|NCT04933617|616203284|FG001|Dose Escalation|Early closure of study|3|||
170508277|NCT04933617|616203285|FG002|Dose Escalation|Early closure of study|0|||
170508278|NCT04933617|616203286|FG003|Dose Escalation|Early closure of study|0|||
170508279|NCT04933617|616203287|FG004|Dose Escalation|Early closure of study|0|||
170508280|NCT02191046|616203288|FG000|Overall Study|low compliance|5|||
170508281|NCT02191046|616203289|FG001|Overall Study|low compliance|1|||
170508282|NCT02147067|616203290|FG000|Overall Study|Withdrawal by Subject|2|||
170508283|NCT02147067|616203291|FG001|Overall Study|Withdrawal by Subject|2|||
170508284|NCT03170609|616203294|FG000|Overall Study|Death|0|||
170508285|NCT03170609|616203295|FG001|Overall Study|Death|0|||
170508286|NCT03170609|616203296|FG002|Overall Study|Death|1|||
170508287|NCT03170609|616203297|FG003|Overall Study|Death|0|||
170508288|NCT03170609|616203298|FG004|Overall Study|Death|0|||
170553063|NCT00507507|616370366|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
170553064|NCT00507507|616370365|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
170553065|NCT00507507|616370366|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
170553066|NCT00507507|616370365|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
170553067|NCT00507507|616370366|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
170553068|NCT01623154|616370367|FG000|Overall Study|Did not drink Pranactin Citric|4|||
170553069|NCT04349098|616370368|FG000|Overall Study|Death|16|||
170553070|NCT04349098|616370369|FG001|Overall Study|Death|8|||
170553071|NCT04349098|616370368|FG000|Overall Study|Lost to Follow-up|11|||
170553072|NCT04349098|616370369|FG001|Overall Study|Lost to Follow-up|8|||
170553073|NCT04349098|616370368|FG000|Overall Study|Withdrawal by Subject|8|||
170553074|NCT04349098|616370369|FG001|Overall Study|Withdrawal by Subject|5|||
170553075|NCT04349098|616370368|FG000|Overall Study|Other|3|||
170553076|NCT04349098|616370369|FG001|Overall Study|Other|5|||
170553077|NCT01800058|616370370|FG000|Overall Study|Lost to Follow-up|1|||
170553078|NCT00800384|616370371|FG000|Overall Study|Withdrawal by Subject|24|||
170553079|NCT00800384|616370372|FG001|Overall Study|Withdrawal by Subject|17|||
170553080|NCT00800384|616370371|FG000|Overall Study|Lost to Follow-up|17|||
170553081|NCT00800384|616370372|FG001|Overall Study|Lost to Follow-up|26|||
170553082|NCT00289900|616370373|FG000|Overall Study|Adverse Event|28|||
170553083|NCT00289900|616370374|FG001|Overall Study|Adverse Event|40|||
170553084|NCT00289900|616370375|FG002|Overall Study|Adverse Event|13|||
170553085|NCT00289900|616370376|FG003|Overall Study|Adverse Event|19|||
170553086|NCT00289900|616370377|FG004|Overall Study|Adverse Event|20|||
170553087|NCT00289900|616370378|FG005|Overall Study|Adverse Event|33|||
170553088|NCT00289900|616370373|FG000|Overall Study|Lost to Follow-up|7|||
170553089|NCT00289900|616370374|FG001|Overall Study|Lost to Follow-up|7|||
170553090|NCT00289900|616370375|FG002|Overall Study|Lost to Follow-up|8|||
170508289|NCT03170609|616203299|FG005|Overall Study|Death|0|||
170553091|NCT00289900|616370376|FG003|Overall Study|Lost to Follow-up|8|||
170553092|NCT00289900|616370377|FG004|Overall Study|Lost to Follow-up|4|||
170508290|NCT03170609|616203300|FG006|Overall Study|Death|0|||
170508291|NCT03170609|616203294|FG000|Overall Study|Withdrawal by Subject|1|||
170508292|NCT03170609|616203295|FG001|Overall Study|Withdrawal by Subject|2|||
170508293|NCT03170609|616203296|FG002|Overall Study|Withdrawal by Subject|0|||
170508294|NCT03170609|616203297|FG003|Overall Study|Withdrawal by Subject|0|||
170508295|NCT03170609|616203298|FG004|Overall Study|Withdrawal by Subject|0|||
170508296|NCT03170609|616203299|FG005|Overall Study|Withdrawal by Subject|0|||
170508297|NCT03170609|616203300|FG006|Overall Study|Withdrawal by Subject|1|||
170508298|NCT03170609|616203294|FG000|Overall Study|Lost to Follow-up|1|||
170553093|NCT00289900|616370378|FG005|Overall Study|Lost to Follow-up|8|||
170553094|NCT00289900|616370373|FG000|Overall Study|Participant had flushing|18|||
170553095|NCT00289900|616370374|FG001|Overall Study|Participant had flushing|42|||
170553096|NCT00289900|616370375|FG002|Overall Study|Participant had flushing|1|||
170553097|NCT00289900|616370376|FG003|Overall Study|Participant had flushing|2|||
170553098|NCT00289900|616370377|FG004|Overall Study|Participant had flushing|0|||
170553099|NCT00289900|616370378|FG005|Overall Study|Participant had flushing|4|||
170508299|NCT03170609|616203295|FG001|Overall Study|Lost to Follow-up|0|||
170553100|NCT00289900|616370373|FG000|Overall Study|Other|0|||
170553101|NCT00289900|616370374|FG001|Overall Study|Other|0|||
170508300|NCT03170609|616203296|FG002|Overall Study|Lost to Follow-up|5|||
170508301|NCT03170609|616203297|FG003|Overall Study|Lost to Follow-up|2|||
170508302|NCT03170609|616203298|FG004|Overall Study|Lost to Follow-up|1|||
170508303|NCT03170609|616203299|FG005|Overall Study|Lost to Follow-up|1|||
170508304|NCT03170609|616203300|FG006|Overall Study|Lost to Follow-up|0|||
170508305|NCT03170609|616203294|FG000|Overall Study|Other|1|||
170508306|NCT03170609|616203295|FG001|Overall Study|Other|0|||
170508307|NCT03170609|616203296|FG002|Overall Study|Other|0|||
170508308|NCT03170609|616203297|FG003|Overall Study|Other|0|||
170508309|NCT03170609|616203298|FG004|Overall Study|Other|0|||
170508310|NCT03170609|616203299|FG005|Overall Study|Other|1|||
170508311|NCT03170609|616203300|FG006|Overall Study|Other|0|||
170508312|NCT03013985|616203303|FG000|Overall Study|Protocol Violation|2|||
170508313|NCT03013985|616203304|FG001|Overall Study|Protocol Violation|2|||
170508314|NCT03013985|616203303|FG000|Overall Study|Withdrawal by Subject|14|||
170508315|NCT03013985|616203304|FG001|Overall Study|Withdrawal by Subject|17|||
170508316|NCT00791492|616203306|FG000|Overall Study|Withdrawal by Subject|1|||
170508317|NCT00791492|616203307|FG001|Overall Study|Withdrawal by Subject|2|||
170508318|NCT00791492|616203306|FG000|Overall Study|Liver transplantation|5|||
170508319|NCT00791492|616203307|FG001|Overall Study|Liver transplantation|1|||
170508320|NCT01370616|616203308|FG000|Overall Study|Adverse Event|11|||
170508321|NCT01370616|616203309|FG001|Overall Study|Adverse Event|16|||
170508322|NCT01370616|616203308|FG000|Overall Study|Death|1|||
170508323|NCT01370616|616203309|FG001|Overall Study|Death|0|||
170508324|NCT01370616|616203308|FG000|Overall Study|Lack of Efficacy|6|||
170508325|NCT01370616|616203309|FG001|Overall Study|Lack of Efficacy|2|||
170508326|NCT01370616|616203308|FG000|Overall Study|Lost to Follow-up|0|||
170553102|NCT00289900|616370375|FG002|Overall Study|Other|0|||
170553103|NCT00289900|616370376|FG003|Overall Study|Other|5|||
170553104|NCT00289900|616370377|FG004|Overall Study|Other|1|||
170553105|NCT00289900|616370378|FG005|Overall Study|Other|0|||
170553106|NCT00289900|616370373|FG000|Overall Study|Participant moved|1|||
170553107|NCT00289900|616370374|FG001|Overall Study|Participant moved|0|||
170553108|NCT00289900|616370375|FG002|Overall Study|Participant moved|0|||
170553109|NCT00289900|616370376|FG003|Overall Study|Participant moved|1|||
170553110|NCT00289900|616370377|FG004|Overall Study|Participant moved|1|||
170553111|NCT00289900|616370378|FG005|Overall Study|Participant moved|1|||
170553112|NCT00289900|616370373|FG000|Overall Study|Withdrawal by Subject|10|||
170553113|NCT00289900|616370374|FG001|Overall Study|Withdrawal by Subject|21|||
170553114|NCT00289900|616370375|FG002|Overall Study|Withdrawal by Subject|8|||
170553115|NCT00289900|616370376|FG003|Overall Study|Withdrawal by Subject|18|||
170553116|NCT00289900|616370377|FG004|Overall Study|Withdrawal by Subject|12|||
170553117|NCT00289900|616370378|FG005|Overall Study|Withdrawal by Subject|11|||
170553118|NCT00289900|616370373|FG000|Overall Study|Protocol Violation|3|||
170553119|NCT00289900|616370374|FG001|Overall Study|Protocol Violation|9|||
170553120|NCT00289900|616370375|FG002|Overall Study|Protocol Violation|2|||
170553121|NCT00289900|616370376|FG003|Overall Study|Protocol Violation|6|||
170553122|NCT00289900|616370377|FG004|Overall Study|Protocol Violation|7|||
170553123|NCT00289900|616370378|FG005|Overall Study|Protocol Violation|4|||
170553124|NCT00289900|616370373|FG000|Overall Study|site terminated|1|||
170553125|NCT00289900|616370374|FG001|Overall Study|site terminated|0|||
170553126|NCT00289900|616370375|FG002|Overall Study|site terminated|1|||
170553127|NCT00289900|616370376|FG003|Overall Study|site terminated|0|||
170553128|NCT00289900|616370377|FG004|Overall Study|site terminated|0|||
170553129|NCT00289900|616370378|FG005|Overall Study|site terminated|0|||
170553130|NCT00289900|616370373|FG000|Overall Study|Not treated|0|||
170553131|NCT00289900|616370374|FG001|Overall Study|Not treated|1|||
170553132|NCT00289900|616370375|FG002|Overall Study|Not treated|0|||
170553133|NCT00289900|616370376|FG003|Overall Study|Not treated|0|||
170553134|NCT00289900|616370377|FG004|Overall Study|Not treated|0|||
170553135|NCT00289900|616370378|FG005|Overall Study|Not treated|0|||
170553136|NCT01703221|616370379|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
170553137|NCT01703221|616370380|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
170553138|NCT01703221|616370381|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
170904258|NCT02654002|617650942|FG006|Overall Study|Adverse Event|1|||
170508327|NCT01370616|616203309|FG001|Overall Study|Lost to Follow-up|3|||
170508328|NCT01370616|616203308|FG000|Overall Study|Physician Decision|6|||
170508329|NCT01370616|616203309|FG001|Overall Study|Physician Decision|6|||
170508330|NCT01370616|616203308|FG000|Overall Study|Progressive Disease|0|||
170508331|NCT01370616|616203309|FG001|Overall Study|Progressive Disease|1|||
170553139|NCT01703221|616370379|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
170553140|NCT01703221|616370380|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
170553141|NCT01703221|616370381|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
170553142|NCT01703221|616370379|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
170553143|NCT01703221|616370380|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170508332|NCT01370616|616203308|FG000|Overall Study|Recovery|1|||
170508333|NCT01370616|616203309|FG001|Overall Study|Recovery|0|||
170553144|NCT01703221|616370381|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170553145|NCT01703221|616370379|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
170553146|NCT01703221|616370380|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
170904259|NCT02654002|617650943|FG007|Overall Study|Adverse Event|0|||
170508334|NCT01370616|616203308|FG000|Overall Study|Technical Problems|3|||
170805537|NCT05325294|617297392|FG001|Overall Study|Withdrawal by Subject|3|||
170508335|NCT01370616|616203309|FG001|Overall Study|Technical Problems|5|||
170508336|NCT01370616|616203308|FG000|Overall Study|Withdrawal by Subject|34|||
170508337|NCT01370616|616203309|FG001|Overall Study|Withdrawal by Subject|34|||
170508338|NCT00045734|616203311|FG000|Overall Study|Protocol Violation|1|||
170508339|NCT00824382|616203312|FG000|Overall Study|Adverse Event|4|||
170508340|NCT00824382|616203313|FG001|Overall Study|Adverse Event|1|||
170508341|NCT00824382|616203314|FG002|Overall Study|Adverse Event|1|||
170508342|NCT00824382|616203315|FG003|Overall Study|Adverse Event|4|||
170508343|NCT00824382|616203312|FG000|Overall Study|Protocol Violation|1|||
170508344|NCT00824382|616203313|FG001|Overall Study|Protocol Violation|0|||
170508345|NCT00824382|616203314|FG002|Overall Study|Protocol Violation|0|||
170508346|NCT00824382|616203315|FG003|Overall Study|Protocol Violation|1|||
170508347|NCT00824382|616203312|FG000|Overall Study|Investigator's decision|0|||
170508348|NCT00824382|616203313|FG001|Overall Study|Investigator's decision|1|||
170508349|NCT00824382|616203314|FG002|Overall Study|Investigator's decision|2|||
170508350|NCT00824382|616203315|FG003|Overall Study|Investigator's decision|0|||
170508351|NCT03673345|616203316|FG000|Overall Study|Lost to Follow-up|1|||
170508352|NCT03673345|616203317|FG001|Overall Study|Lost to Follow-up|0|||
170508353|NCT03673345|616203318|FG002|Overall Study|Lost to Follow-up|3|||
170508354|NCT03673345|616203319|FG003|Overall Study|Lost to Follow-up|3|||
170508355|NCT03673345|616203320|FG004|Overall Study|Lost to Follow-up|2|||
170508356|NCT03673345|616203321|FG005|Overall Study|Lost to Follow-up|1|||
170508357|NCT03673345|616203322|FG006|Overall Study|Lost to Follow-up|0|||
170508358|NCT03673345|616203323|FG007|Overall Study|Lost to Follow-up|0|||
170508359|NCT03673345|616203316|FG000|Overall Study|Withdrawal by Subject|1|||
170508360|NCT03673345|616203317|FG001|Overall Study|Withdrawal by Subject|0|||
170508361|NCT03673345|616203318|FG002|Overall Study|Withdrawal by Subject|4|||
170508362|NCT03673345|616203319|FG003|Overall Study|Withdrawal by Subject|2|||
170508363|NCT03673345|616203320|FG004|Overall Study|Withdrawal by Subject|0|||
170508364|NCT03673345|616203321|FG005|Overall Study|Withdrawal by Subject|0|||
170508365|NCT03673345|616203322|FG006|Overall Study|Withdrawal by Subject|0|||
170508366|NCT03673345|616203323|FG007|Overall Study|Withdrawal by Subject|0|||
170508367|NCT03673345|616203316|FG000|Overall Study|Physician Decision|0|||
170508368|NCT03673345|616203317|FG001|Overall Study|Physician Decision|0|||
170508369|NCT03673345|616203318|FG002|Overall Study|Physician Decision|2|||
170508370|NCT03673345|616203319|FG003|Overall Study|Physician Decision|0|||
170508371|NCT03673345|616203320|FG004|Overall Study|Physician Decision|0|||
170508372|NCT03673345|616203321|FG005|Overall Study|Physician Decision|0|||
170508373|NCT03673345|616203322|FG006|Overall Study|Physician Decision|0|||
170508374|NCT03673345|616203323|FG007|Overall Study|Physician Decision|0|||
170508375|NCT02892513|616203324|FG000|Overall Study|Withdrawal by Subject|0|||
170508376|NCT02892513|616203325|FG001|Overall Study|Withdrawal by Subject|1|||
170508377|NCT00900731|616203326|FG000|Overall Study|Adverse Event|31|||
170508378|NCT00900731|616203327|FG001|Overall Study|Adverse Event|27|||
170508379|NCT00900731|616203326|FG000|Overall Study|Withdrawal by Subject|8|||
170508380|NCT00900731|616203327|FG001|Overall Study|Withdrawal by Subject|7|||
170508381|NCT00900731|616203326|FG000|Overall Study|Protocol Deviation|8|||
170805538|NCT05325294|617297391|FG000|Overall Study|Lost to Follow-up|1|||
170805539|NCT05325294|617297392|FG001|Overall Study|Lost to Follow-up|0|||
170805540|NCT05325294|617297391|FG000|Overall Study|Sponsor Request|0|||
170805541|NCT05325294|617297392|FG001|Overall Study|Sponsor Request|2|||
170805542|NCT04649047|617297393|FG000|Overall Study|Withdrawal by Subject|3|||
170508382|NCT00900731|616203327|FG001|Overall Study|Protocol Deviation|11|||
170508383|NCT00900731|616203326|FG000|Overall Study|Administrative Problems|5|||
170508384|NCT00900731|616203327|FG001|Overall Study|Administrative Problems|4|||
170508385|NCT00900731|616203326|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
170508386|NCT00900731|616203327|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
170805543|NCT02488408|617297394|FG000|Part A|Adverse Event|2|||
170805544|NCT02488408|617297395|FG001|Part A|Adverse Event|0|||
170805545|NCT02488408|617297396|FG002|Part A|Adverse Event|0|||
170508387|NCT00900731|616203326|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
170508388|NCT00900731|616203327|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
170508389|NCT00900731|616203326|FG000|Overall Study|Lost to Follow-up|2|||
170508390|NCT00900731|616203327|FG001|Overall Study|Lost to Follow-up|3|||
170508391|NCT00900731|616203326|FG000|Overall Study|Lack of Efficacy|1|||
170508392|NCT00900731|616203327|FG001|Overall Study|Lack of Efficacy|3|||
170508393|NCT00900731|616203326|FG000|Overall Study|Death|0|||
170508394|NCT00900731|616203327|FG001|Overall Study|Death|2|||
170508395|NCT04608344|616203328|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
170508396|NCT04608344|616203329|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
170508397|NCT04608344|616203328|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
170508398|NCT04608344|616203329|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
170508399|NCT00467961|616203330|FG000|Overall Study|Technical Failures|5|||
170805546|NCT02488408|617297397|FG003|Part A|Adverse Event|0|||
170805547|NCT02488408|617297398|FG004|Part A|Adverse Event|0|||
170805548|NCT02488408|617297399|FG005|Part A|Adverse Event|0|||
170553147|NCT01703221|616370381|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
170553148|NCT01703221|616370379|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170553149|NCT01703221|616370380|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170553150|NCT01703221|616370381|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
170553151|NCT01703221|616370379|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
170553152|NCT01703221|616370380|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
170553153|NCT01703221|616370381|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
170553154|NCT01703221|616370379|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
170553155|NCT01703221|616370380|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
170553156|NCT01703221|616370381|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
170553157|NCT01703221|616370379|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
170553158|NCT01703221|616370380|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
170553159|NCT01703221|616370381|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
170553160|NCT03289741|616370382|FG000|Overall Study|Adverse Event|1|||
170553161|NCT03289741|616370383|FG001|Overall Study|Adverse Event|1|||
170553162|NCT03289741|616370382|FG000|Overall Study|Physician Decision|2|||
170553163|NCT03289741|616370383|FG001|Overall Study|Physician Decision|2|||
170553164|NCT03289741|616370382|FG000|Overall Study|Withdrawal by Subject|1|||
170553165|NCT03289741|616370383|FG001|Overall Study|Withdrawal by Subject|0|||
170553166|NCT03449147|616370387|FG000|52-week Treatment Period|Death|0|||
170553167|NCT03449147|616370388|FG001|52-week Treatment Period|Death|1|||
170553168|NCT03449147|616370389|FG002|52-week Treatment Period|Death|0|||
170553169|NCT03449147|616370387|FG000|52-week Treatment Period|Lost to Follow-up|6|||
170553170|NCT03449147|616370388|FG001|52-week Treatment Period|Lost to Follow-up|2|||
170553171|NCT03449147|616370389|FG002|52-week Treatment Period|Lost to Follow-up|5|||
170553172|NCT03449147|616370387|FG000|52-week Treatment Period|Other|0|||
170553173|NCT03449147|616370388|FG001|52-week Treatment Period|Other|1|||
170553174|NCT03449147|616370389|FG002|52-week Treatment Period|Other|2|||
170553175|NCT03449147|616370387|FG000|52-week Treatment Period|Physician Decision|1|||
170553176|NCT03449147|616370388|FG001|52-week Treatment Period|Physician Decision|0|||
170553177|NCT03449147|616370389|FG002|52-week Treatment Period|Physician Decision|3|||
170553178|NCT03449147|616370387|FG000|52-week Treatment Period|Screen Failure|1|||
170553179|NCT03449147|616370388|FG001|52-week Treatment Period|Screen Failure|2|||
170553180|NCT03449147|616370389|FG002|52-week Treatment Period|Screen Failure|0|||
170553181|NCT03449147|616370387|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
170553182|NCT03449147|616370388|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
170553183|NCT03449147|616370389|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
170553184|NCT03449147|616370387|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
170553185|NCT03449147|616370388|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
170553186|NCT03449147|616370389|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
170553187|NCT03449147|616370387|FG000|12-Week Off-Treatment Durability Period|Other|0|||
170553188|NCT03449147|616370388|FG001|12-Week Off-Treatment Durability Period|Other|1|||
170553189|NCT03449147|616370389|FG002|12-Week Off-Treatment Durability Period|Other|0|||
170553190|NCT02037984|616370393|FG000|Overall Study|Lack of Efficacy|0|||
170553191|NCT02037984|616370394|FG001|Overall Study|Lack of Efficacy|0|||
170553192|NCT02037984|616370395|FG002|Overall Study|Lack of Efficacy|3|||
170553193|NCT02037984|616370396|FG003|Overall Study|Lack of Efficacy|10|||
170553194|NCT02037984|616370397|FG004|Overall Study|Lack of Efficacy|2|||
170553195|NCT02037984|616370398|FG005|Overall Study|Lack of Efficacy|2|||
170553196|NCT02037984|616370399|FG006|Overall Study|Lack of Efficacy|4|||
170553197|NCT02037984|616370400|FG007|Overall Study|Lack of Efficacy|3|||
170553198|NCT02037984|616370393|FG000|Overall Study|Lost to Follow-up|1|||
170553199|NCT02037984|616370394|FG001|Overall Study|Lost to Follow-up|0|||
170553200|NCT02037984|616370395|FG002|Overall Study|Lost to Follow-up|3|||
170553201|NCT02037984|616370396|FG003|Overall Study|Lost to Follow-up|5|||
170553202|NCT02037984|616370397|FG004|Overall Study|Lost to Follow-up|2|||
170643227|NCT02709538|616708351|FG002|Overall Study|Non-compliance with study procedures|0|||
170805549|NCT02488408|617297400|FG006|Part A|Adverse Event|0|||
170805550|NCT02488408|617297401|FG007|Part A|Adverse Event|0|||
170805551|NCT02488408|617297402|FG008|Part A|Adverse Event|0|||
170805552|NCT02488408|617297403|FG009|Part A|Adverse Event|0|||
170805553|NCT02488408|617297394|FG000|Part A|Death|1|||
170805554|NCT02488408|617297395|FG001|Part A|Death|5|||
170805555|NCT02488408|617297396|FG002|Part A|Death|0|||
170805556|NCT02488408|617297397|FG003|Part A|Death|0|||
170553203|NCT02037984|616370398|FG005|Overall Study|Lost to Follow-up|2|||
170553204|NCT02037984|616370399|FG006|Overall Study|Lost to Follow-up|2|||
170553205|NCT02037984|616370400|FG007|Overall Study|Lost to Follow-up|4|||
170553206|NCT02037984|616370393|FG000|Overall Study|Physician Decision|0|||
170553207|NCT02037984|616370394|FG001|Overall Study|Physician Decision|0|||
170553208|NCT02037984|616370395|FG002|Overall Study|Physician Decision|0|||
170553209|NCT02037984|616370396|FG003|Overall Study|Physician Decision|0|||
170553210|NCT02037984|616370397|FG004|Overall Study|Physician Decision|0|||
170553211|NCT02037984|616370398|FG005|Overall Study|Physician Decision|0|||
170805557|NCT02488408|617297398|FG004|Part A|Death|3|||
170508400|NCT00467961|616203330|FG000|Overall Study|Disease Progression|2|||
170508401|NCT02908074|616203332|FG000|Overall Study|sponsor/ICON decision|0|||
170508402|NCT02908074|616203333|FG001|Overall Study|sponsor/ICON decision|0|||
170508403|NCT02908074|616203334|FG002|Overall Study|sponsor/ICON decision|1|||
170508404|NCT02908074|616203335|FG003|Overall Study|sponsor/ICON decision|0|||
170508405|NCT02908074|616203336|FG004|Overall Study|sponsor/ICON decision|0|||
170508406|NCT02908074|616203337|FG005|Overall Study|sponsor/ICON decision|0|||
170508407|NCT02908074|616203332|FG000|Overall Study|Protocol Violation|0|||
170508408|NCT02908074|616203333|FG001|Overall Study|Protocol Violation|1|||
170508409|NCT02908074|616203334|FG002|Overall Study|Protocol Violation|0|||
170508410|NCT02908074|616203335|FG003|Overall Study|Protocol Violation|0|||
170508411|NCT02908074|616203336|FG004|Overall Study|Protocol Violation|0|||
170508412|NCT02908074|616203337|FG005|Overall Study|Protocol Violation|0|||
170508413|NCT02908074|616203332|FG000|Overall Study|Adverse Event|5|||
170508414|NCT02908074|616203333|FG001|Overall Study|Adverse Event|2|||
170508415|NCT02908074|616203334|FG002|Overall Study|Adverse Event|0|||
170508416|NCT02908074|616203335|FG003|Overall Study|Adverse Event|0|||
170508417|NCT02908074|616203336|FG004|Overall Study|Adverse Event|1|||
170508418|NCT02908074|616203337|FG005|Overall Study|Adverse Event|0|||
170508419|NCT02908074|616203332|FG000|Overall Study|AESI|1|||
170508420|NCT02908074|616203333|FG001|Overall Study|AESI|0|||
170508421|NCT02908074|616203334|FG002|Overall Study|AESI|1|||
170508422|NCT02908074|616203335|FG003|Overall Study|AESI|0|||
170508423|NCT02908074|616203336|FG004|Overall Study|AESI|1|||
170508424|NCT02908074|616203337|FG005|Overall Study|AESI|0|||
170508425|NCT02908074|616203332|FG000|Overall Study|Discontinuation criteria per protocol|0|||
170508426|NCT02908074|616203333|FG001|Overall Study|Discontinuation criteria per protocol|0|||
170508427|NCT02908074|616203334|FG002|Overall Study|Discontinuation criteria per protocol|1|||
170508428|NCT02908074|616203335|FG003|Overall Study|Discontinuation criteria per protocol|0|||
170508429|NCT02908074|616203336|FG004|Overall Study|Discontinuation criteria per protocol|0|||
170508430|NCT02908074|616203337|FG005|Overall Study|Discontinuation criteria per protocol|1|||
170508431|NCT02908074|616203332|FG000|Overall Study|Withdrawal by Subject|3|||
170508432|NCT02908074|616203333|FG001|Overall Study|Withdrawal by Subject|2|||
170508433|NCT02908074|616203334|FG002|Overall Study|Withdrawal by Subject|2|||
170508434|NCT02908074|616203335|FG003|Overall Study|Withdrawal by Subject|2|||
170508435|NCT02908074|616203336|FG004|Overall Study|Withdrawal by Subject|2|||
170508436|NCT02908074|616203337|FG005|Overall Study|Withdrawal by Subject|2|||
170508437|NCT02908074|616203332|FG000|Overall Study|Lost to Follow-up|0|||
170508438|NCT02908074|616203333|FG001|Overall Study|Lost to Follow-up|1|||
170508439|NCT02908074|616203334|FG002|Overall Study|Lost to Follow-up|1|||
170508440|NCT02908074|616203335|FG003|Overall Study|Lost to Follow-up|1|||
170508441|NCT02908074|616203336|FG004|Overall Study|Lost to Follow-up|0|||
170508442|NCT02908074|616203337|FG005|Overall Study|Lost to Follow-up|1|||
170508443|NCT02429310|616203338|FG000|Overall Study|Lost to Follow-up|1|||
170508444|NCT02429310|616203339|FG001|Overall Study|Lost to Follow-up|2|||
170508445|NCT02429310|616203338|FG000|Overall Study|Protocol Violation|1|||
170508446|NCT02429310|616203339|FG001|Overall Study|Protocol Violation|1|||
170508447|NCT00394433|616203340|FG000|Overall Study|Adverse Event|2|||
170508448|NCT00394433|616203340|FG000|Overall Study|Alternative Therapy|1|||
170508449|NCT01554176|616203341|FG000|Treatment Phase|Protocol Violation|1|||
170508450|NCT01554176|616203342|FG001|Treatment Phase|Protocol Violation|2|||
170508451|NCT01554176|616203343|FG002|Treatment Phase|Protocol Violation|0|||
170508452|NCT01554176|616203344|FG003|Treatment Phase|Protocol Violation|0|||
170508453|NCT01554176|616203345|FG004|Treatment Phase|Protocol Violation|0|||
170508454|NCT01554176|616203341|FG000|Treatment Phase|Physician Decision|1|||
170508455|NCT01554176|616203342|FG001|Treatment Phase|Physician Decision|1|||
170508456|NCT01554176|616203343|FG002|Treatment Phase|Physician Decision|0|||
170508457|NCT01554176|616203344|FG003|Treatment Phase|Physician Decision|0|||
170508458|NCT01554176|616203345|FG004|Treatment Phase|Physician Decision|0|||
170508459|NCT01554176|616203341|FG000|Treatment Phase|Lack of Efficacy|0|||
170508460|NCT01554176|616203342|FG001|Treatment Phase|Lack of Efficacy|1|||
170508461|NCT01554176|616203343|FG002|Treatment Phase|Lack of Efficacy|0|||
170508462|NCT01554176|616203344|FG003|Treatment Phase|Lack of Efficacy|0|||
170508463|NCT01554176|616203345|FG004|Treatment Phase|Lack of Efficacy|0|||
170508464|NCT01554176|616203341|FG000|Treatment Phase|Adverse event, non-fatal|1|||
170508465|NCT01554176|616203342|FG001|Treatment Phase|Adverse event, non-fatal|1|||
170508466|NCT01554176|616203343|FG002|Treatment Phase|Adverse event, non-fatal|0|||
170508467|NCT01554176|616203344|FG003|Treatment Phase|Adverse event, non-fatal|0|||
170508468|NCT01554176|616203345|FG004|Treatment Phase|Adverse event, non-fatal|0|||
170508469|NCT01554176|616203341|FG000|Treatment Phase|Non-compliance with study drug|1|||
170508470|NCT01554176|616203342|FG001|Treatment Phase|Non-compliance with study drug|0|||
170508471|NCT01554176|616203343|FG002|Treatment Phase|Non-compliance with study drug|0|||
170508472|NCT01554176|616203344|FG003|Treatment Phase|Non-compliance with study drug|0|||
170508473|NCT01554176|616203345|FG004|Treatment Phase|Non-compliance with study drug|0|||
170508474|NCT01554176|616203341|FG000|Treatment Phase|Withdrawal by Subject|1|||
170508475|NCT01554176|616203342|FG001|Treatment Phase|Withdrawal by Subject|0|||
170508476|NCT01554176|616203343|FG002|Treatment Phase|Withdrawal by Subject|0|||
170508477|NCT01554176|616203344|FG003|Treatment Phase|Withdrawal by Subject|0|||
170508478|NCT01554176|616203345|FG004|Treatment Phase|Withdrawal by Subject|0|||
170508479|NCT01554176|616203341|FG000|Treatment Phase|Lost to Follow-up|3|||
170508480|NCT01554176|616203342|FG001|Treatment Phase|Lost to Follow-up|0|||
170508481|NCT01554176|616203343|FG002|Treatment Phase|Lost to Follow-up|0|||
170508482|NCT01554176|616203344|FG003|Treatment Phase|Lost to Follow-up|0|||
170508483|NCT01554176|616203345|FG004|Treatment Phase|Lost to Follow-up|0|||
170508484|NCT01554176|616203341|FG000|Run-out Phase|Protocol Violation|0|||
170508485|NCT01554176|616203342|FG001|Run-out Phase|Protocol Violation|0|||
170508486|NCT01554176|616203343|FG002|Run-out Phase|Protocol Violation|0|||
170508487|NCT01554176|616203344|FG003|Run-out Phase|Protocol Violation|1|||
170508488|NCT01554176|616203345|FG004|Run-out Phase|Protocol Violation|0|||
170508489|NCT03053427|616203348|FG000|Overall Study|Adverse Event|4|||
170508490|NCT03053427|616203349|FG001|Overall Study|Adverse Event|4|||
170508491|NCT03053427|616203348|FG000|Overall Study|Lack of Efficacy|1|||
170508492|NCT03053427|616203349|FG001|Overall Study|Lack of Efficacy|3|||
170508493|NCT03053427|616203348|FG000|Overall Study|Lost to Follow-up|2|||
170508494|NCT03053427|616203349|FG001|Overall Study|Lost to Follow-up|2|||
170508495|NCT03053427|616203348|FG000|Overall Study|Worsening of the target disease|0|||
170508496|NCT03053427|616203349|FG001|Overall Study|Worsening of the target disease|1|||
170508497|NCT03053427|616203348|FG000|Overall Study|Protocol Deviation|3|||
170508498|NCT03053427|616203349|FG001|Overall Study|Protocol Deviation|3|||
170508499|NCT03053427|616203348|FG000|Overall Study|Withdrawal by Subject|3|||
170508500|NCT03053427|616203349|FG001|Overall Study|Withdrawal by Subject|2|||
170508501|NCT03053427|616203348|FG000|Overall Study|Miscellaneous|0|||
170508502|NCT03053427|616203349|FG001|Overall Study|Miscellaneous|1|||
170508503|NCT02607306|616203352|FG000|Overall Study|Adverse Event|8|||
170508504|NCT02607306|616203353|FG001|Overall Study|Adverse Event|6|||
170508505|NCT02607306|616203354|FG002|Overall Study|Adverse Event|6|||
170508506|NCT02607306|616203352|FG000|Overall Study|Unclassified|1|||
170508507|NCT02607306|616203353|FG001|Overall Study|Unclassified|4|||
170508508|NCT02607306|616203354|FG002|Overall Study|Unclassified|0|||
170508509|NCT02607306|616203352|FG000|Overall Study|Withdrawal by Subject|8|||
170508510|NCT02607306|616203353|FG001|Overall Study|Withdrawal by Subject|10|||
170508511|NCT02607306|616203354|FG002|Overall Study|Withdrawal by Subject|2|||
170508512|NCT02607306|616203352|FG000|Overall Study|Lack of Efficacy|0|||
170508513|NCT02607306|616203353|FG001|Overall Study|Lack of Efficacy|1|||
170508514|NCT02607306|616203354|FG002|Overall Study|Lack of Efficacy|1|||
170508515|NCT02607306|616203352|FG000|Overall Study|Protocol Violation|4|||
170508516|NCT02607306|616203353|FG001|Overall Study|Protocol Violation|2|||
170508517|NCT02607306|616203354|FG002|Overall Study|Protocol Violation|1|||
170508518|NCT02360475|616203359|FG000|Overall Study|Lost to Follow-up|4|||
170508519|NCT02360475|616203360|FG001|Overall Study|Lost to Follow-up|12|||
170508520|NCT02360475|616203361|FG002|Overall Study|Lost to Follow-up|6|||
170508521|NCT02360475|616203362|FG003|Overall Study|Lost to Follow-up|4|||
170508522|NCT02360475|616203359|FG000|Overall Study|Withdrawal by Subject|0|||
170508523|NCT02360475|616203360|FG001|Overall Study|Withdrawal by Subject|1|||
170508524|NCT02360475|616203361|FG002|Overall Study|Withdrawal by Subject|2|||
170508525|NCT02360475|616203362|FG003|Overall Study|Withdrawal by Subject|0|||
170508526|NCT02360475|616203359|FG000|Overall Study|Migrated/moved from study area|0|||
170508527|NCT02360475|616203360|FG001|Overall Study|Migrated/moved from study area|0|||
170508528|NCT02360475|616203361|FG002|Overall Study|Migrated/moved from study area|0|||
170508529|NCT02360475|616203362|FG003|Overall Study|Migrated/moved from study area|1|||
170508530|NCT02510820|616204853|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
170508531|NCT02510820|616204854|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170508532|NCT02510820|616204853|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
170508533|NCT02510820|616204854|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
170508534|NCT01859949|616204855|FG000|Overall Study|Family Matters|0|||
170508535|NCT01859949|616204856|FG001|Overall Study|Family Matters|1|||
170508536|NCT01859949|616204855|FG000|Overall Study|Physician Decision|2|||
170508537|NCT01859949|616204856|FG001|Overall Study|Physician Decision|4|||
170508538|NCT01859949|616204855|FG000|Overall Study|Withdrawal by Subject|11|||
170508539|NCT01859949|616204856|FG001|Overall Study|Withdrawal by Subject|10|||
170508540|NCT01859949|616204855|FG000|Overall Study|Protocol Violation|1|||
170508541|NCT01859949|616204856|FG001|Overall Study|Protocol Violation|1|||
170508542|NCT01859949|616204855|FG000|Overall Study|Adverse Event|0|||
170508543|NCT01859949|616204856|FG001|Overall Study|Adverse Event|1|||
170508544|NCT02469168|616204864|FG000|Overall Study|Trial closed|1|||
170508545|NCT02469168|616204865|FG001|Overall Study|Trial closed|0|||
170508546|NCT00135356|616204866|FG000|Overall Study|Adverse Event|6|||
170508547|NCT00135356|616204867|FG001|Overall Study|Adverse Event|2|||
170508548|NCT00135356|616204866|FG000|Overall Study|Lack of Efficacy|2|||
170508549|NCT00135356|616204867|FG001|Overall Study|Lack of Efficacy|0|||
170508550|NCT00135356|616204866|FG000|Overall Study|Lost to Follow-up|3|||
170508551|NCT00135356|616204867|FG001|Overall Study|Lost to Follow-up|1|||
170508552|NCT00135356|616204866|FG000|Overall Study|Surgery for abdominal fat|1|||
170508553|NCT00135356|616204867|FG001|Overall Study|Surgery for abdominal fat|0|||
170508554|NCT00135356|616204866|FG000|Overall Study|Change in antiviral regimen|0|||
170508555|NCT00135356|616204867|FG001|Overall Study|Change in antiviral regimen|1|||
170508556|NCT00135356|616204866|FG000|Overall Study|Poor/noncompliance|1|||
170508557|NCT00135356|616204867|FG001|Overall Study|Poor/noncompliance|1|||
170508558|NCT00135356|616204866|FG000|Overall Study|No longer meets study criteria|2|||
170508559|NCT00135356|616204867|FG001|Overall Study|No longer meets study criteria|0|||
170508560|NCT00135356|616204866|FG000|Overall Study|Withdrawal by Subject|2|||
170508561|NCT00135356|616204867|FG001|Overall Study|Withdrawal by Subject|4|||
170508562|NCT01928199|616204868|FG000|Overall Study|Lost to Follow-up|2|||
170508563|NCT01928199|616204869|FG001|Overall Study|Lost to Follow-up|1|||
170508564|NCT01928199|616204868|FG000|Overall Study|Withdrawal by Subject|3|||
170508565|NCT01928199|616204869|FG001|Overall Study|Withdrawal by Subject|5|||
170508566|NCT01090050|616204870|FG000|Overall Study|Lost to Follow-up|0|||
170508567|NCT01090050|616204871|FG001|Overall Study|Lost to Follow-up|1|||
170508568|NCT01090050|616204870|FG000|Overall Study|Lack of Efficacy|1|||
170508569|NCT01090050|616204871|FG001|Overall Study|Lack of Efficacy|5|||
170508570|NCT01090050|616204870|FG000|Overall Study|Physician Decision|0|||
170508571|NCT01090050|616204871|FG001|Overall Study|Physician Decision|1|||
170508572|NCT02232061|616204872|FG000|Overall Study|Administrative problems|1|||
170508573|NCT02232061|616204872|FG000|Overall Study|Withdrawal by Subject|1|||
170508574|NCT00571103|616204873|FG000|Overall Study|Withdrawal by Subject|1|||
170508575|NCT00571103|616204873|FG000|Overall Study|Lost to Follow-up|1|||
170508576|NCT02784288|616204875|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
170508577|NCT02734862|616204876|FG000|Part A|Death|3|||
170508578|NCT02734862|616204877|FG001|Part A|Death|4|||
170508579|NCT02734862|616204878|FG002|Part A|Death|6|||
170508580|NCT02734862|616204876|FG000|Part A|Lost to Follow-up|2|||
170508581|NCT02734862|616204877|FG001|Part A|Lost to Follow-up|1|||
170508582|NCT02734862|616204878|FG002|Part A|Lost to Follow-up|1|||
170508583|NCT02734862|616204876|FG000|Part A|Withdrawal by Subject|1|||
170508584|NCT02734862|616204877|FG001|Part A|Withdrawal by Subject|1|||
170508585|NCT02734862|616204878|FG002|Part A|Withdrawal by Subject|2|||
170508586|NCT02734862|616204876|FG000|Part A|Physician Decision|2|||
170508587|NCT02734862|616204877|FG001|Part A|Physician Decision|0|||
170508588|NCT02734862|616204878|FG002|Part A|Physician Decision|1|||
170508589|NCT02734862|616204876|FG000|Part A|Adverse Event|2|||
170508590|NCT02734862|616204877|FG001|Part A|Adverse Event|0|||
170508591|NCT02734862|616204878|FG002|Part A|Adverse Event|1|||
170508592|NCT02734862|616204876|FG000|Part A|Noncompliance|1|||
170508593|NCT02734862|616204877|FG001|Part A|Noncompliance|1|||
170508594|NCT02734862|616204878|FG002|Part A|Noncompliance|0|||
170508595|NCT02734862|616204876|FG000|Part A|Other|1|||
170508596|NCT02734862|616204877|FG001|Part A|Other|1|||
170508597|NCT02734862|616204878|FG002|Part A|Other|3|||
170508598|NCT02734862|616204876|FG000|Part B|Death|8|||
170508599|NCT02734862|616204877|FG001|Part B|Death|3|||
170508600|NCT02734862|616204878|FG002|Part B|Death|5|||
170508601|NCT02734862|616204876|FG000|Part B|Lost to Follow-up|2|||
170508602|NCT02734862|616204877|FG001|Part B|Lost to Follow-up|2|||
170508603|NCT02734862|616204878|FG002|Part B|Lost to Follow-up|0|||
170508604|NCT02734862|616204876|FG000|Part B|Withdrawal by Subject|3|||
170508605|NCT02734862|616204877|FG001|Part B|Withdrawal by Subject|1|||
170508606|NCT02734862|616204878|FG002|Part B|Withdrawal by Subject|0|||
170508607|NCT02734862|616204876|FG000|Part B|Other|0|||
170805558|NCT02488408|617297399|FG005|Part A|Death|0|||
170805559|NCT02488408|617297400|FG006|Part A|Death|0|||
170805560|NCT02488408|617297401|FG007|Part A|Death|0|||
170805561|NCT02488408|617297402|FG008|Part A|Death|0|||
170508608|NCT02734862|616204877|FG001|Part B|Other|1|||
170508609|NCT02734862|616204878|FG002|Part B|Other|0|||
170508610|NCT02757625|616204879|FG000|Overall Study|Investigator's discretion|0|||
170508611|NCT02757625|616204880|FG001|Overall Study|Investigator's discretion|0|||
170508612|NCT02757625|616204881|FG002|Overall Study|Investigator's discretion|1|||
170508613|NCT02757625|616204882|FG003|Overall Study|Investigator's discretion|0|||
170508614|NCT02757625|616204879|FG000|Overall Study|Adverse Event|0|||
170508615|NCT02757625|616204880|FG001|Overall Study|Adverse Event|0|||
170508616|NCT02757625|616204881|FG002|Overall Study|Adverse Event|1|||
170508617|NCT02757625|616204882|FG003|Overall Study|Adverse Event|0|||
170508618|NCT00645671|616204883|FG000|Overall Study|Protocol Violation|1|||
170805562|NCT02488408|617297403|FG009|Part A|Death|0|||
170805563|NCT02488408|617297394|FG000|Part A|Disease Progression|2|||
170805564|NCT02488408|617297395|FG001|Part A|Disease Progression|8|||
170508619|NCT00645671|616204884|FG001|Overall Study|Protocol Violation|0|||
170508620|NCT00645671|616204883|FG000|Overall Study|Withdrawal by Subject|0|||
170508621|NCT00645671|616204884|FG001|Overall Study|Withdrawal by Subject|4|||
170508622|NCT00645671|616204883|FG000|Overall Study|Adverse Event|0|||
170508623|NCT00645671|616204884|FG001|Overall Study|Adverse Event|1|||
170508624|NCT00645671|616204883|FG000|Overall Study|Physician Decision|0|||
170508625|NCT00645671|616204884|FG001|Overall Study|Physician Decision|1|||
170508626|NCT00560703|616204885|FG000|Overall Study|Adverse Event|0|||
170508627|NCT00560703|616204886|FG001|Overall Study|Adverse Event|2|||
170508628|NCT00560703|616204885|FG000|Overall Study|Protocol Violation|0|||
170805565|NCT02488408|617297396|FG002|Part A|Disease Progression|2|||
170508629|NCT00560703|616204886|FG001|Overall Study|Protocol Violation|2|||
170508630|NCT00560703|616204885|FG000|Overall Study|Withdrawal by Subject|0|||
170508631|NCT00560703|616204886|FG001|Overall Study|Withdrawal by Subject|1|||
170508632|NCT00560703|616204885|FG000|Overall Study|non-compliance|0|||
170508633|NCT00560703|616204886|FG001|Overall Study|non-compliance|1|||
170508634|NCT02095197|616204887|FG000|Overall Study|Lost to Follow-up|0|||
170508635|NCT02095197|616204888|FG001|Overall Study|Lost to Follow-up|3|||
170508636|NCT05600036|616204889|FG000|Overall Study|Adverse Event|0|||
170508637|NCT05600036|616204890|FG001|Overall Study|Adverse Event|2|||
170508638|NCT05600036|616204891|FG002|Overall Study|Adverse Event|1|||
170508639|NCT05600036|616204892|FG003|Overall Study|Adverse Event|0|||
170508640|NCT05600036|616204893|FG004|Overall Study|Adverse Event|1|||
170508641|NCT05600036|616204894|FG005|Overall Study|Adverse Event|0|||
170508642|NCT05600036|616204889|FG000|Overall Study|Lost to Follow-up|0|||
170508643|NCT05600036|616204890|FG001|Overall Study|Lost to Follow-up|2|||
170508644|NCT05600036|616204891|FG002|Overall Study|Lost to Follow-up|1|||
170508645|NCT05600036|616204892|FG003|Overall Study|Lost to Follow-up|1|||
170508646|NCT05600036|616204893|FG004|Overall Study|Lost to Follow-up|0|||
170508647|NCT05600036|616204894|FG005|Overall Study|Lost to Follow-up|0|||
170508648|NCT05600036|616204889|FG000|Overall Study|Protocol Violation|0|||
170508649|NCT05600036|616204890|FG001|Overall Study|Protocol Violation|0|||
170508650|NCT05600036|616204891|FG002|Overall Study|Protocol Violation|2|||
170508651|NCT05600036|616204892|FG003|Overall Study|Protocol Violation|0|||
170508652|NCT05600036|616204893|FG004|Overall Study|Protocol Violation|0|||
170508653|NCT05600036|616204894|FG005|Overall Study|Protocol Violation|0|||
170508654|NCT05600036|616204889|FG000|Overall Study|Withdrawal by Subject|0|||
170508655|NCT05600036|616204890|FG001|Overall Study|Withdrawal by Subject|1|||
170508656|NCT05600036|616204891|FG002|Overall Study|Withdrawal by Subject|2|||
170508657|NCT05600036|616204892|FG003|Overall Study|Withdrawal by Subject|0|||
170508658|NCT05600036|616204893|FG004|Overall Study|Withdrawal by Subject|3|||
170508659|NCT05600036|616204894|FG005|Overall Study|Withdrawal by Subject|5|||
170508660|NCT05600036|616204889|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
170508661|NCT05600036|616204890|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
170508662|NCT05600036|616204891|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
170508663|NCT05600036|616204892|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
170508664|NCT05600036|616204893|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
170508665|NCT05600036|616204894|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
170508666|NCT05600036|616204889|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
170508667|NCT05600036|616204890|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
170508668|NCT05600036|616204891|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
170508669|NCT05600036|616204892|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
170508670|NCT05600036|616204893|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
170508671|NCT05600036|616204894|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
170508672|NCT05600036|616204889|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
170508673|NCT05600036|616204890|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
170508674|NCT05600036|616204891|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
170508675|NCT05600036|616204892|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
170508676|NCT05600036|616204893|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
170508677|NCT05600036|616204894|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
170508678|NCT02722746|616204895|FG000|Overall Study|Withdrawal by Subject|0|||
170508679|NCT02722746|616204896|FG001|Overall Study|Withdrawal by Subject|1|||
170508680|NCT02722746|616204897|FG002|Overall Study|Withdrawal by Subject|0|||
170508681|NCT02722746|616204895|FG000|Overall Study|Protocol Violation|8|||
170508682|NCT02722746|616204896|FG001|Overall Study|Protocol Violation|4|||
170508683|NCT02722746|616204897|FG002|Overall Study|Protocol Violation|6|||
170508684|NCT01464619|616204907|FG000|Overall Study|Lost to Follow-up|3|||
170508685|NCT01464619|616204908|FG001|Overall Study|Lost to Follow-up|4|||
170805566|NCT02488408|617297397|FG003|Part A|Disease Progression|3|||
170805567|NCT02488408|617297398|FG004|Part A|Disease Progression|4|||
170805568|NCT02488408|617297399|FG005|Part A|Disease Progression|0|||
170805569|NCT02488408|617297400|FG006|Part A|Disease Progression|0|||
170805570|NCT02488408|617297401|FG007|Part A|Disease Progression|0|||
170805571|NCT02488408|617297402|FG008|Part A|Disease Progression|0|||
170805572|NCT02488408|617297403|FG009|Part A|Disease Progression|0|||
170805573|NCT02488408|617297394|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
170805574|NCT02488408|617297395|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
170508686|NCT00089635|616204909|FG000|Overall Study|Adverse Event|2|||
170508687|NCT00089635|616204909|FG000|Overall Study|Death|17|||
170508688|NCT00089635|616204909|FG000|Overall Study|Disease Progression|12|||
170805575|NCT02488408|617297396|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
170805576|NCT02488408|617297397|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
170508689|NCT00089635|616204909|FG000|Overall Study|Lost to Follow-up|3|||
170508690|NCT00089635|616204909|FG000|Overall Study|Withdrawal by Subject|6|||
170508691|NCT00089635|616204909|FG000|Overall Study|Ineligibility determined|1|||
170508692|NCT00089635|616204909|FG000|Overall Study|Other|2|||
170508693|NCT02943785|616204910|FG000|Overall Study|Adverse Event|112|||
170508694|NCT02943785|616204911|FG001|Overall Study|Adverse Event|97|||
170508695|NCT02943785|616204910|FG000|Overall Study|Withdrawal by Subject|63|||
170508696|NCT02943785|616204911|FG001|Overall Study|Withdrawal by Subject|126|||
170508697|NCT02943785|616204910|FG000|Overall Study|Physician Decision|23|||
170508698|NCT02943785|616204911|FG001|Overall Study|Physician Decision|47|||
170508699|NCT02943785|616204910|FG000|Overall Study|Death|46|||
170508700|NCT02943785|616204911|FG001|Overall Study|Death|46|||
170508701|NCT02943785|616204910|FG000|Overall Study|Lost to Follow-up|1|||
170508702|NCT02943785|616204911|FG001|Overall Study|Lost to Follow-up|0|||
170508703|NCT02943785|616204910|FG000|Overall Study|Other|16|||
170508704|NCT02943785|616204911|FG001|Overall Study|Other|19|||
170508705|NCT02943785|616204910|FG000|Overall Study|Did not receive any study medication|21|||
170508706|NCT02943785|616204911|FG001|Overall Study|Did not receive any study medication|28|||
170508707|NCT02603107|616204912|FG000|Randomized Phase|Withdrew consent|8|||
170508708|NCT02603107|616204913|FG001|Randomized Phase|Withdrew consent|15|||
170508709|NCT02603107|616204912|FG000|Randomized Phase|Lost to Follow-up|1|||
170508710|NCT02603107|616204913|FG001|Randomized Phase|Lost to Follow-up|3|||
170508711|NCT02603107|616204912|FG000|Randomized Phase|Adverse Event|2|||
170508712|NCT02603107|616204913|FG001|Randomized Phase|Adverse Event|0|||
170508713|NCT02603107|616204912|FG000|Randomized Phase|Death|1|||
170508714|NCT02603107|616204913|FG001|Randomized Phase|Death|1|||
170508715|NCT02603107|616204912|FG000|Randomized Phase|Non-compliance with study drug|1|||
170508716|NCT02603107|616204913|FG001|Randomized Phase|Non-compliance with study drug|1|||
170508717|NCT02603107|616204912|FG000|Randomized Phase|Investigator's discretion|0|||
170508718|NCT02603107|616204913|FG001|Randomized Phase|Investigator's discretion|1|||
170508719|NCT02603107|616204912|FG000|Randomized Phase|Lack of Efficacy|1|||
170508720|NCT02603107|616204913|FG001|Randomized Phase|Lack of Efficacy|0|||
170508721|NCT02603107|616204912|FG000|Randomized Phase|Protocol Violation|1|||
170508722|NCT02603107|616204913|FG001|Randomized Phase|Protocol Violation|0|||
170508723|NCT02603107|616204912|FG000|Optional Extension Phase|Lost to Follow-up|3|||
170508724|NCT02603107|616204913|FG001|Optional Extension Phase|Lost to Follow-up|3|||
170508725|NCT02603107|616204912|FG000|Optional Extension Phase|Withdrew consent|3|||
170508726|NCT02603107|616204913|FG001|Optional Extension Phase|Withdrew consent|2|||
170508727|NCT02603107|616204912|FG000|Optional Extension Phase|Investigator's discretion|2|||
170508728|NCT02603107|616204913|FG001|Optional Extension Phase|Investigator's discretion|2|||
170508729|NCT02603107|616204912|FG000|Optional Extension Phase|Pregnancy|0|||
170508730|NCT02603107|616204913|FG001|Optional Extension Phase|Pregnancy|3|||
170508731|NCT02603107|616204912|FG000|Optional Extension Phase|Adverse Event|0|||
170508732|NCT02603107|616204913|FG001|Optional Extension Phase|Adverse Event|2|||
170508733|NCT02603107|616204912|FG000|Optional Extension Phase|Not treated in extension phase|0|||
170508734|NCT02603107|616204913|FG001|Optional Extension Phase|Not treated in extension phase|1|||
170508735|NCT02603107|616204912|FG000|Optional Extension Phase|Protocol Violation|1|||
170508736|NCT02603107|616204913|FG001|Optional Extension Phase|Protocol Violation|0|||
170508737|NCT00821015|616204914|FG000|Overall Study|Lost to Follow-up|12|||
170508738|NCT01887678|616204918|FG000|Overall Study|Adverse Event|4|||
170508739|NCT01887678|616204919|FG001|Overall Study|Adverse Event|6|||
170508740|NCT01887678|616204918|FG000|Overall Study|Exceeded rescue medication dosage|4|||
170508741|NCT01887678|616204919|FG001|Overall Study|Exceeded rescue medication dosage|5|||
170508742|NCT01887678|616204918|FG000|Overall Study|Withdrawal of consent|3|||
170508743|NCT01887678|616204919|FG001|Overall Study|Withdrawal of consent|4|||
170508744|NCT01887678|616204918|FG000|Overall Study|Lost to Follow-up|4|||
170508745|NCT01887678|616204919|FG001|Overall Study|Lost to Follow-up|2|||
170805577|NCT02488408|617297398|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
170508746|NCT01887678|616204918|FG000|Overall Study|Deterioration of clinical condition|0|||
170508747|NCT01887678|616204919|FG001|Overall Study|Deterioration of clinical condition|4|||
170508748|NCT01887678|616204918|FG000|Overall Study|Lack of Efficacy|1|||
170508749|NCT01887678|616204919|FG001|Overall Study|Lack of Efficacy|2|||
170508750|NCT01887678|616204918|FG000|Overall Study|Non-compliance|0|||
170508751|NCT01887678|616204919|FG001|Overall Study|Non-compliance|3|||
170508752|NCT01887678|616204918|FG000|Overall Study|Specified|1|||
170508753|NCT01887678|616204919|FG001|Overall Study|Specified|2|||
170508754|NCT03411902|616204920|FG000|Overall Study|Lost to Follow-up|3|||
170508755|NCT03411902|616204921|FG001|Overall Study|Lost to Follow-up|0|||
170508756|NCT00048165|616204924|FG000|Completed 6 Months Study|Administration/Other|8|||
170508757|NCT00048165|616204925|FG001|Completed 6 Months Study|Administration/Other|8|||
170508758|NCT00048165|616204924|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
170508759|NCT00048165|616204925|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
170508760|NCT00048165|616204924|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
170508761|NCT00048165|616204925|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
170508762|NCT00048165|616204924|FG000|Completed 6 Months Study|Death|12|||
170508763|NCT00048165|616204925|FG001|Completed 6 Months Study|Death|6|||
170508764|NCT00048165|616204924|FG000|Completed 6 Months Study|Insufficient therapy|1|||
170508765|NCT00048165|616204925|FG001|Completed 6 Months Study|Insufficient therapy|4|||
170508766|NCT00048165|616204924|FG000|Completed 6 Months Study|Other violation|4|||
170508767|NCT00048165|616204925|FG001|Completed 6 Months Study|Other violation|6|||
170508768|NCT00048165|616204924|FG000|Completed 6 Months Study|Refused treatment|5|||
170508769|NCT00048165|616204925|FG001|Completed 6 Months Study|Refused treatment|5|||
170508770|NCT00048165|616204924|FG000|Completed 6 Months Study|Violation criteria|0|||
170508771|NCT00048165|616204925|FG001|Completed 6 Months Study|Violation criteria|2|||
170508772|NCT00048165|616204924|FG000|Completed 6 Months Study|Did not receive study drug|6|||
170508773|NCT00048165|616204925|FG001|Completed 6 Months Study|Did not receive study drug|6|||
170508774|NCT00048165|616204924|FG000|Completed 12 Months Study|Administration/Other|0|||
170508775|NCT00048165|616204925|FG001|Completed 12 Months Study|Administration/Other|2|||
170508776|NCT00048165|616204924|FG000|Completed 12 Months Study|Death|2|||
170508777|NCT00048165|616204925|FG001|Completed 12 Months Study|Death|1|||
170508778|NCT00048165|616204924|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
170508779|NCT00048165|616204925|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
170508780|NCT00419159|616204926|FG000|Overall Study|Adverse Event|7|||
170508781|NCT00419159|616204927|FG001|Overall Study|Adverse Event|15|||
170508782|NCT00419159|616204926|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170508783|NCT00419159|616204927|FG001|Overall Study|Abnormal laboratory value(s)|2|||
170508784|NCT00419159|616204926|FG000|Overall Study|Subject's no longer requires study drug|0|||
170508785|NCT00419159|616204927|FG001|Overall Study|Subject's no longer requires study drug|1|||
170508786|NCT00419159|616204926|FG000|Overall Study|Protocol Violation|1|||
170508787|NCT00419159|616204927|FG001|Overall Study|Protocol Violation|0|||
170508788|NCT00419159|616204926|FG000|Overall Study|Withdrawal by Subject|10|||
170508789|NCT00419159|616204927|FG001|Overall Study|Withdrawal by Subject|3|||
170508790|NCT00419159|616204926|FG000|Overall Study|Lost to Follow-up|0|||
170508791|NCT00419159|616204927|FG001|Overall Study|Lost to Follow-up|1|||
170508792|NCT00419159|616204926|FG000|Overall Study|Death|2|||
170508793|NCT00419159|616204927|FG001|Overall Study|Death|2|||
170508794|NCT00419159|616204926|FG000|Overall Study|Disease progression|79|||
170508795|NCT00419159|616204927|FG001|Overall Study|Disease progression|76|||
170508796|NCT01693185|616204932|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
170508797|NCT01693185|616204933|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
170508798|NCT01017601|616204934|FG000|Overall Study|Disease Progression|12|||
170508799|NCT01017601|616204935|FG001|Overall Study|Disease Progression|12|||
170508800|NCT01017601|616204934|FG000|Overall Study|Withdrawal by Subject|0|||
170508801|NCT01017601|616204935|FG001|Overall Study|Withdrawal by Subject|1|||
170508802|NCT00803205|616204937|FG000|Overall Study|Adverse Event|7|||
170508803|NCT00803205|616204938|FG001|Overall Study|Adverse Event|2|||
170508804|NCT00803205|616204937|FG000|Overall Study|Lost to Follow-up|1|||
170508805|NCT00803205|616204938|FG001|Overall Study|Lost to Follow-up|0|||
170508806|NCT00803205|616204937|FG000|Overall Study|Withdrawal by Subject|9|||
170508807|NCT00803205|616204938|FG001|Overall Study|Withdrawal by Subject|9|||
170508808|NCT00803205|616204937|FG000|Overall Study|Physician Decision|1|||
170508809|NCT00803205|616204938|FG001|Overall Study|Physician Decision|0|||
170508810|NCT00803205|616204937|FG000|Overall Study|Protocol Violation|1|||
170508811|NCT00803205|616204938|FG001|Overall Study|Protocol Violation|1|||
170508812|NCT00803205|616204937|FG000|Overall Study|Medical Monitor Decision|1|||
170508813|NCT00803205|616204938|FG001|Overall Study|Medical Monitor Decision|0|||
170508814|NCT00803205|616204937|FG000|Overall Study|Acquired a Lung Infection|0|||
170508815|NCT00803205|616204938|FG001|Overall Study|Acquired a Lung Infection|1|||
170508816|NCT00803205|616204937|FG000|Overall Study|Sponsor Decision|0|||
170508817|NCT00803205|616204938|FG001|Overall Study|Sponsor Decision|1|||
170508818|NCT01857102|616204939|FG000|Period 1|No longer meets Eligibility Criteria|0|||
170508819|NCT01857102|616204940|FG001|Period 1|No longer meets Eligibility Criteria|2|||
170508820|NCT01857102|616204939|FG000|Period 1|Lost to Follow-up|0|||
170508821|NCT01857102|616204940|FG001|Period 1|Lost to Follow-up|3|||
170508822|NCT01857102|616204939|FG000|Period 1|Unsatisfactory Lens Fit|1|||
170508823|NCT01857102|616204940|FG001|Period 1|Unsatisfactory Lens Fit|0|||
170508824|NCT01857102|616204939|FG000|Period 1|Unsatisfactory Visual Response|1|||
170508825|NCT01857102|616204940|FG001|Period 1|Unsatisfactory Visual Response|0|||
170508826|NCT01857102|616204939|FG000|Period 1|Physician Decision|1|||
170508827|NCT01857102|616204940|FG001|Period 1|Physician Decision|0|||
170508828|NCT01857102|616204939|FG000|Period 2|Lens Discomfort|1|||
170508829|NCT01857102|616204940|FG001|Period 2|Lens Discomfort|0|||
170508830|NCT01857102|616204939|FG000|Period 2|Unsatisfactory Lens Fit|1|||
170508831|NCT01857102|616204940|FG001|Period 2|Unsatisfactory Lens Fit|0|||
170508832|NCT00990665|616204945|FG000|Overall Study|Unsuccessful Implant|8|||
170508833|NCT00990665|616204945|FG000|Overall Study|Death|29|||
170508834|NCT00990665|616204945|FG000|Overall Study|Heart Transplant|1|||
170508835|NCT00990665|616204945|FG000|Overall Study|Withdrawal by Subject|6|||
170508836|NCT00990665|616204945|FG000|Overall Study|Lost to Follow-up|1|||
170508837|NCT00990665|616204945|FG000|Overall Study|System Explant|3|||
170508838|NCT02735096|616204946|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
170508839|NCT04299048|616204955|FG000|Overall Study|Death|1|||
170508840|NCT04299048|616204955|FG000|Overall Study|Global deterioration of health status|2|||
170508841|NCT04299048|616204955|FG000|Overall Study|Enrolled and not treated|1|||
170508842|NCT02083653|616204956|FG000|Overall Study|Randomized but not Treated|0|||
170508843|NCT02083653|616204957|FG001|Overall Study|Randomized but not Treated|2|||
170508844|NCT02083653|616204958|FG002|Overall Study|Randomized but not Treated|7|||
170508845|NCT02083653|616204956|FG000|Overall Study|Adverse Event|12|||
170508846|NCT02083653|616204957|FG001|Overall Study|Adverse Event|5|||
170508847|NCT02083653|616204958|FG002|Overall Study|Adverse Event|4|||
170508848|NCT02083653|616204956|FG000|Overall Study|Lost to Follow-up|1|||
170508849|NCT02083653|616204957|FG001|Overall Study|Lost to Follow-up|0|||
170508850|NCT02083653|616204958|FG002|Overall Study|Lost to Follow-up|0|||
170508851|NCT02083653|616204956|FG000|Overall Study|Death|2|||
170508852|NCT02083653|616204957|FG001|Overall Study|Death|2|||
170508853|NCT02083653|616204958|FG002|Overall Study|Death|2|||
170508854|NCT02083653|616204956|FG000|Overall Study|Progressive Disease|65|||
170508855|NCT02083653|616204957|FG001|Overall Study|Progressive Disease|73|||
170508856|NCT02083653|616204958|FG002|Overall Study|Progressive Disease|63|||
170508857|NCT02083653|616204956|FG000|Overall Study|Withdrawal by Subject|2|||
170508858|NCT02083653|616204957|FG001|Overall Study|Withdrawal by Subject|1|||
170508859|NCT02083653|616204958|FG002|Overall Study|Withdrawal by Subject|2|||
170508860|NCT02083653|616204956|FG000|Overall Study|Other Events|0|||
170508861|NCT02083653|616204957|FG001|Overall Study|Other Events|2|||
170508862|NCT02083653|616204958|FG002|Overall Study|Other Events|2|||
170508863|NCT02083653|616204956|FG000|Overall Study|Reason Missing|0|||
170508864|NCT02083653|616204957|FG001|Overall Study|Reason Missing|0|||
170508865|NCT02083653|616204958|FG002|Overall Study|Reason Missing|4|||
170508866|NCT03423147|616204962|FG000|Overall Study|Lost to Follow-up|5|||
170508867|NCT03423147|616204963|FG001|Overall Study|Lost to Follow-up|8|||
170508868|NCT03423147|616204962|FG000|Overall Study|Withdrawal by Subject|1|||
170508869|NCT03423147|616204963|FG001|Overall Study|Withdrawal by Subject|0|||
170508870|NCT03423147|616204962|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
170508871|NCT03423147|616204963|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
170508872|NCT03423147|616204962|FG000|Overall Study|Age < 18|1|||
170805578|NCT02488408|617297399|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
170805579|NCT02488408|617297400|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
170805580|NCT02488408|617297401|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
170805581|NCT02488408|617297402|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
170805582|NCT02488408|617297403|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
170805583|NCT02488408|617297394|FG000|Part A|Investigator Decision|0|||
170805584|NCT02488408|617297395|FG001|Part A|Investigator Decision|1|||
170805585|NCT02488408|617297396|FG002|Part A|Investigator Decision|1|||
170805586|NCT02488408|617297397|FG003|Part A|Investigator Decision|0|||
170805587|NCT02488408|617297398|FG004|Part A|Investigator Decision|0|||
170805588|NCT02488408|617297399|FG005|Part A|Investigator Decision|0|||
170805589|NCT02488408|617297400|FG006|Part A|Investigator Decision|0|||
170805590|NCT02488408|617297401|FG007|Part A|Investigator Decision|0|||
170805591|NCT02488408|617297402|FG008|Part A|Investigator Decision|0|||
170805592|NCT02488408|617297403|FG009|Part A|Investigator Decision|0|||
170805593|NCT02488408|617297394|FG000|Part A|Withdrawal by Subject|0|||
170805594|NCT02488408|617297395|FG001|Part A|Withdrawal by Subject|0|||
170805595|NCT02488408|617297396|FG002|Part A|Withdrawal by Subject|2|||
170805596|NCT02488408|617297397|FG003|Part A|Withdrawal by Subject|0|||
170805597|NCT02488408|617297398|FG004|Part A|Withdrawal by Subject|0|||
170805598|NCT02488408|617297399|FG005|Part A|Withdrawal by Subject|0|||
170553212|NCT02037984|616370399|FG006|Overall Study|Physician Decision|1|||
170805599|NCT02488408|617297400|FG006|Part A|Withdrawal by Subject|0|||
170805600|NCT02488408|617297401|FG007|Part A|Withdrawal by Subject|0|||
170805601|NCT02488408|617297402|FG008|Part A|Withdrawal by Subject|0|||
170805602|NCT02488408|617297403|FG009|Part A|Withdrawal by Subject|0|||
170508873|NCT03423147|616204963|FG001|Overall Study|Age < 18|0|||
170508874|NCT03423147|616204962|FG000|Overall Study|No Trial of Labor|0|||
170508875|NCT03423147|616204963|FG001|Overall Study|No Trial of Labor|1|||
170508876|NCT02069093|616204964|FG000|Overall Study|Disease progression|14|||
170508877|NCT02069093|616204964|FG000|Overall Study|New cancer therapy|1|||
170508878|NCT02069093|616204964|FG000|Overall Study|Death|1|||
170508879|NCT02069093|616204964|FG000|Overall Study|Administrative problems|1|||
170805603|NCT02488408|617297394|FG000|Part A|Other|1|||
170805604|NCT02488408|617297395|FG001|Part A|Other|0|||
170508880|NCT02069093|616204964|FG000|Overall Study|Withdrawal by Subject|2|||
170508881|NCT02069093|616204964|FG000|Overall Study|Abnormal laboratory values|1|||
170508882|NCT02069093|616204964|FG000|Overall Study|Adverse Event|10|||
170508883|NCT01731470|616204968|FG000|Overall Study|Withdrawal by Subject|1|||
170508884|NCT01731470|616204968|FG000|Overall Study|Did not meet study criteria|1|||
170508885|NCT01524783|616204970|FG000|Blinded Period|Adverse Event|64|||
170508886|NCT01524783|616204971|FG001|Blinded Period|Adverse Event|7|||
170508887|NCT01524783|616204972|FG002|Blinded Period|Adverse Event|0|||
170508888|NCT01524783|616204970|FG000|Blinded Period|Disease Progression|89|||
170508889|NCT01524783|616204971|FG001|Blinded Period|Disease Progression|75|||
170508890|NCT01524783|616204972|FG002|Blinded Period|Disease Progression|0|||
170508891|NCT01524783|616204970|FG000|Blinded Period|Withdrawal by Subject|19|||
170508892|NCT01524783|616204971|FG001|Blinded Period|Withdrawal by Subject|6|||
170508893|NCT01524783|616204972|FG002|Blinded Period|Withdrawal by Subject|0|||
170508894|NCT01524783|616204970|FG000|Blinded Period|Protocol deviation|2|||
170508895|NCT01524783|616204971|FG001|Blinded Period|Protocol deviation|1|||
170508896|NCT01524783|616204972|FG002|Blinded Period|Protocol deviation|0|||
170508897|NCT01524783|616204970|FG000|Blinded Period|Death|5|||
170508898|NCT01524783|616204971|FG001|Blinded Period|Death|2|||
170508899|NCT01524783|616204972|FG002|Blinded Period|Death|0|||
170508900|NCT01524783|616204970|FG000|Open-label Period|Disease progression|13|||
170508901|NCT01524783|616204971|FG001|Open-label Period|Disease progression|0|||
170508902|NCT01524783|616204972|FG002|Open-label Period|Disease progression|2|||
170508903|NCT01524783|616204970|FG000|Open-label Period|Administrative problems|5|||
170904260|NCT02654002|617650944|FG008|Overall Study|Adverse Event|0|||
170904261|NCT02654002|617650936|FG000|Overall Study|Withdrew Consent|0|||
170904262|NCT02654002|617650937|FG001|Overall Study|Withdrew Consent|0|||
170904263|NCT02654002|617650938|FG002|Overall Study|Withdrew Consent|0|||
170904264|NCT02654002|617650939|FG003|Overall Study|Withdrew Consent|0|||
170904265|NCT02654002|617650940|FG004|Overall Study|Withdrew Consent|0|||
170904266|NCT02654002|617650941|FG005|Overall Study|Withdrew Consent|1|||
170904267|NCT02654002|617650942|FG006|Overall Study|Withdrew Consent|0|||
170904268|NCT02654002|617650943|FG007|Overall Study|Withdrew Consent|1|||
170904269|NCT02654002|617650944|FG008|Overall Study|Withdrew Consent|0|||
170904270|NCT00275561|617650945|FG000|Overall Study|Withdrawal by Subject|0|||
170508904|NCT01524783|616204971|FG001|Open-label Period|Administrative problems|0|||
170508905|NCT01524783|616204972|FG002|Open-label Period|Administrative problems|2|||
170508906|NCT01524783|616204970|FG000|Open-label Period|Adverse Event|5|||
170508907|NCT01524783|616204971|FG001|Open-label Period|Adverse Event|0|||
170508908|NCT01524783|616204972|FG002|Open-label Period|Adverse Event|1|||
170508909|NCT01524783|616204970|FG000|Open-label Period|Withdrawal by Subject|2|||
170508910|NCT01524783|616204971|FG001|Open-label Period|Withdrawal by Subject|0|||
170508911|NCT01524783|616204972|FG002|Open-label Period|Withdrawal by Subject|1|||
170508912|NCT01524783|616204970|FG000|Open-label Period|Protocol deviation|1|||
170508913|NCT01524783|616204971|FG001|Open-label Period|Protocol deviation|0|||
170508914|NCT01524783|616204972|FG002|Open-label Period|Protocol deviation|0|||
170508915|NCT01625689|616204973|FG000|Overall Study|Migration|2|||
170508916|NCT01625689|616204974|FG001|Overall Study|Migration|1|||
170508917|NCT01732471|616204975|FG000|Overall Study|Withdrawal by Subject|1|||
170508918|NCT02678000|616204976|FG000|PART 2|Adverse Event|0|||
170508919|NCT02678000|616204977|FG001|PART 2|Adverse Event|0|||
170904271|NCT00275561|617650946|FG001|Overall Study|Withdrawal by Subject|1|||
170904272|NCT00275561|617650945|FG000|Overall Study|Travel|1|||
170904273|NCT00275561|617650946|FG001|Overall Study|Travel|1|||
170508920|NCT02678000|616204978|FG002|PART 2|Adverse Event|2|||
170508921|NCT02678000|616204979|FG003|PART 2|Adverse Event|1|||
170508922|NCT02678000|616204980|FG004|PART 2|Adverse Event|0|||
170508923|NCT02678000|616204976|FG000|PART 2|Withdrawal by Subject|0|||
170508924|NCT02678000|616204977|FG001|PART 2|Withdrawal by Subject|0|||
170508925|NCT02678000|616204978|FG002|PART 2|Withdrawal by Subject|1|||
170904274|NCT00275561|617650945|FG000|Overall Study|Scheduling|1|||
170904275|NCT00275561|617650946|FG001|Overall Study|Scheduling|2|||
170508926|NCT02678000|616204979|FG003|PART 2|Withdrawal by Subject|0|||
170508927|NCT02678000|616204980|FG004|PART 2|Withdrawal by Subject|0|||
170508928|NCT01687283|616206487|FG000|Overall Study|Adverse Event|11|||
170508929|NCT01687283|616206488|FG001|Overall Study|Adverse Event|4|||
170508930|NCT01687283|616206487|FG000|Overall Study|Lack of Efficacy|3|||
170508931|NCT01687283|616206488|FG001|Overall Study|Lack of Efficacy|1|||
170508932|NCT01687283|616206487|FG000|Overall Study|Protocol Violation|1|||
170508933|NCT01687283|616206488|FG001|Overall Study|Protocol Violation|3|||
170508934|NCT01687283|616206487|FG000|Overall Study|protocol defined stopping criteria|8|||
170508935|NCT01687283|616206488|FG001|Overall Study|protocol defined stopping criteria|10|||
170508936|NCT01687283|616206487|FG000|Overall Study|Lost to Follow-up|1|||
170508937|NCT01687283|616206488|FG001|Overall Study|Lost to Follow-up|1|||
170508938|NCT01687283|616206487|FG000|Overall Study|Investigator discretion|2|||
170508939|NCT01687283|616206488|FG001|Overall Study|Investigator discretion|0|||
170508940|NCT01687283|616206487|FG000|Overall Study|Withdrawal by Subject|9|||
170904276|NCT00275561|617650945|FG000|Overall Study|Family Issues|0|||
170904277|NCT00275561|617650946|FG001|Overall Study|Family Issues|2|||
170904278|NCT04211337|617650948|FG000|Overall Study|On Treatment|175|||
170508941|NCT01687283|616206488|FG001|Overall Study|Withdrawal by Subject|8|||
170508942|NCT00410072|616206492|FG000|Day 1 to Week 48|Adverse Event|1|||
170508943|NCT00410072|616206493|FG001|Day 1 to Week 48|Adverse Event|2|||
170508944|NCT00410072|616206492|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
170508945|NCT00410072|616206493|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
170508946|NCT00410072|616206492|FG000|Day 1 to Week 48|Other|0|||
170508947|NCT00410072|616206493|FG001|Day 1 to Week 48|Other|1|||
170508948|NCT00410072|616206492|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
170508949|NCT00410072|616206493|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
170508950|NCT00410072|616206492|FG000|Day 1 to Week 48|Pregnancy|0|||
170508951|NCT00410072|616206493|FG001|Day 1 to Week 48|Pregnancy|2|||
170508952|NCT00410072|616206492|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
170508953|NCT00410072|616206493|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
170508954|NCT00410072|616206492|FG000|After Week 48 to Week 96|Adverse Event|1|||
170508955|NCT00410072|616206493|FG001|After Week 48 to Week 96|Adverse Event|2|||
170508956|NCT00410072|616206492|FG000|After Week 48 to Week 96|Death|0|||
170508957|NCT00410072|616206493|FG001|After Week 48 to Week 96|Death|1|||
170508958|NCT00410072|616206492|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
170508959|NCT00410072|616206493|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
170508960|NCT00410072|616206492|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
170508961|NCT00410072|616206493|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
170508962|NCT00410072|616206492|FG000|After Week 48 to Week 96|Other|2|||
170508963|NCT00410072|616206493|FG001|After Week 48 to Week 96|Other|0|||
170508964|NCT00410072|616206492|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
170508965|NCT00410072|616206493|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
170508966|NCT00410072|616206492|FG000|After Week 48 to Week 96|Pregnancy|0|||
170508967|NCT00410072|616206493|FG001|After Week 48 to Week 96|Pregnancy|2|||
170508968|NCT00410072|616206492|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
170508969|NCT00410072|616206493|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
170508970|NCT04494425|616206494|FG000|Overall Study|Death|160|||
170508971|NCT04494425|616206495|FG001|Overall Study|Death|166|||
170508972|NCT04494425|616206494|FG000|Overall Study|Withdrawal by Subject|10|||
170508973|NCT04494425|616206495|FG001|Overall Study|Withdrawal by Subject|40|||
170508974|NCT04494425|616206494|FG000|Overall Study|Other|1|||
170553213|NCT02037984|616370400|FG007|Overall Study|Physician Decision|0|||
170553214|NCT02037984|616370393|FG000|Overall Study|Protocol Violation|0|||
170553215|NCT02037984|616370394|FG001|Overall Study|Protocol Violation|0|||
170553216|NCT02037984|616370395|FG002|Overall Study|Protocol Violation|0|||
170553217|NCT02037984|616370396|FG003|Overall Study|Protocol Violation|0|||
170553218|NCT02037984|616370397|FG004|Overall Study|Protocol Violation|0|||
170553219|NCT02037984|616370398|FG005|Overall Study|Protocol Violation|1|||
170553220|NCT02037984|616370399|FG006|Overall Study|Protocol Violation|2|||
170553221|NCT02037984|616370400|FG007|Overall Study|Protocol Violation|0|||
170553222|NCT02037984|616370393|FG000|Overall Study|Technical Problems|0|||
170553223|NCT02037984|616370394|FG001|Overall Study|Technical Problems|0|||
170553224|NCT02037984|616370395|FG002|Overall Study|Technical Problems|3|||
170553225|NCT02037984|616370396|FG003|Overall Study|Technical Problems|3|||
170553226|NCT02037984|616370397|FG004|Overall Study|Technical Problems|2|||
170553227|NCT02037984|616370398|FG005|Overall Study|Technical Problems|3|||
170553228|NCT02037984|616370399|FG006|Overall Study|Technical Problems|4|||
170643228|NCT02709538|616708349|FG000|Overall Study|Non-compliance with study drug|2|||
170805605|NCT02488408|617297396|FG002|Part A|Other|0|||
170805606|NCT02488408|617297397|FG003|Part A|Other|0|||
170805607|NCT02488408|617297398|FG004|Part A|Other|0|||
170805608|NCT02488408|617297399|FG005|Part A|Other|0|||
170805609|NCT02488408|617297400|FG006|Part A|Other|0|||
170805610|NCT02488408|617297401|FG007|Part A|Other|0|||
170805611|NCT02488408|617297402|FG008|Part A|Other|0|||
170805612|NCT02488408|617297403|FG009|Part A|Other|0|||
170805613|NCT02488408|617297394|FG000|Part B|Adverse Event|0|||
170805614|NCT02488408|617297395|FG001|Part B|Adverse Event|0|||
170805615|NCT02488408|617297396|FG002|Part B|Adverse Event|0|||
170805616|NCT02488408|617297397|FG003|Part B|Adverse Event|0|||
170805617|NCT02488408|617297398|FG004|Part B|Adverse Event|0|||
170508975|NCT04494425|616206495|FG001|Overall Study|Other|1|||
170508976|NCT04494425|616206494|FG000|Overall Study|Ongoing at the time of PCD|265|||
170508977|NCT04494425|616206495|FG001|Overall Study|Ongoing at the time of PCD|223|||
170508978|NCT01421147|616206496|FG000|Treatment Period|Adverse Event|2|||
170508979|NCT01421147|616206497|FG001|Treatment Period|Adverse Event|3|||
170508980|NCT01421147|616206496|FG000|Treatment Period|Lost to Follow-up|2|||
170508981|NCT01421147|616206497|FG001|Treatment Period|Lost to Follow-up|1|||
170508982|NCT01421147|616206496|FG000|Treatment Period|Physician Decision|2|||
170508983|NCT01421147|616206497|FG001|Treatment Period|Physician Decision|2|||
170508984|NCT01421147|616206496|FG000|Treatment Period|Withdrawal by Subject|10|||
170508985|NCT01421147|616206497|FG001|Treatment Period|Withdrawal by Subject|5|||
170508986|NCT01421147|616206496|FG000|Extension Period|Adverse Event|0|||
170508987|NCT01421147|616206497|FG001|Extension Period|Adverse Event|2|||
170508988|NCT01421147|616206496|FG000|Extension Period|Death|0|||
170805618|NCT02488408|617297399|FG005|Part B|Adverse Event|2|||
170805619|NCT02488408|617297400|FG006|Part B|Adverse Event|2|||
170643229|NCT02709538|616708350|FG001|Overall Study|Non-compliance with study drug|0|||
170643230|NCT02709538|616708351|FG002|Overall Study|Non-compliance with study drug|0|||
170805620|NCT02488408|617297401|FG007|Part B|Adverse Event|7|||
170508989|NCT01421147|616206497|FG001|Extension Period|Death|1|||
170508990|NCT01421147|616206496|FG000|Extension Period|Lost to Follow-up|2|||
170508991|NCT01421147|616206497|FG001|Extension Period|Lost to Follow-up|5|||
170508992|NCT01421147|616206496|FG000|Extension Period|Physician Decision|1|||
170508993|NCT01421147|616206497|FG001|Extension Period|Physician Decision|0|||
170508994|NCT01421147|616206496|FG000|Extension Period|Withdrawal by Subject|5|||
170508995|NCT01421147|616206497|FG001|Extension Period|Withdrawal by Subject|3|||
170508996|NCT01270321|616206498|FG000|Overall Study|Death|3|||
170508997|NCT01270321|616206499|FG001|Overall Study|Death|1|||
170508998|NCT01270321|616206500|FG002|Overall Study|Death|4|||
170508999|NCT01270321|616206498|FG000|Overall Study|Adverse Event|7|||
170509000|NCT01270321|616206499|FG001|Overall Study|Adverse Event|9|||
170509001|NCT01270321|616206500|FG002|Overall Study|Adverse Event|5|||
170509002|NCT00171158|616206502|FG000|Core Study|Death|27|||
170509003|NCT00171158|616206502|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
170509004|NCT00171158|616206502|FG000|Core Study|Protocol Violation|4|||
170509005|NCT00171158|616206502|FG000|Core Study|Administrative problems|1|||
170509006|NCT00171158|616206502|FG000|Core Study|Adverse event, non-fatal|21|||
170509007|NCT00171158|616206502|FG000|Core Study|Consent withdrawn by subject|6|||
170509008|NCT00171158|616206502|FG000|Core Study|No longer required drug (BMT)|14|||
170509009|NCT00171158|616206502|FG000|Core Study|Abnormal Laboratory Values|2|||
170509010|NCT00171158|616206502|FG000|Core Study|Lost to Follow-up|1|||
170509011|NCT00171158|616206502|FG000|E2 Extension|Other|7|||
170509012|NCT00762034|616206503|FG000|Induction Period|Protocol Violation|1|||
170509013|NCT00762034|616206504|FG001|Induction Period|Protocol Violation|2|||
170509014|NCT00762034|616206503|FG000|Induction Period|Entry Criterion Not Met|12|||
170509015|NCT00762034|616206504|FG001|Induction Period|Entry Criterion Not Met|11|||
170509016|NCT00762034|616206503|FG000|Induction Period|Adverse Event|27|||
170509017|NCT00762034|616206504|FG001|Induction Period|Adverse Event|38|||
170509018|NCT00762034|616206503|FG000|Induction Period|Lost to Follow-up|1|||
170509019|NCT00762034|616206504|FG001|Induction Period|Lost to Follow-up|1|||
170509020|NCT00762034|616206503|FG000|Induction Period|Progressive Disease|73|||
170509021|NCT00762034|616206504|FG001|Induction Period|Progressive Disease|55|||
170509022|NCT00762034|616206503|FG000|Induction Period|Physician Decision|21|||
170509023|NCT00762034|616206504|FG001|Induction Period|Physician Decision|20|||
170509024|NCT00762034|616206503|FG000|Induction Period|Withdrawal by Subject|15|||
170509025|NCT00762034|616206504|FG001|Induction Period|Withdrawal by Subject|19|||
170509026|NCT00762034|616206503|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
170509027|NCT00762034|616206504|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
170509028|NCT00762034|616206503|FG000|Induction Period|Deaths Due to Study Disease|9|||
170509029|NCT00762034|616206504|FG001|Induction Period|Deaths Due to Study Disease|9|||
170509030|NCT00762034|616206503|FG000|Maintenance Period|Protocol Violation|1|||
170509031|NCT00762034|616206504|FG001|Maintenance Period|Protocol Violation|3|||
170509032|NCT00762034|616206503|FG000|Maintenance Period|Entry Criterion Not Met|0|||
170509033|NCT00762034|616206504|FG001|Maintenance Period|Entry Criterion Not Met|2|||
170509034|NCT00762034|616206503|FG000|Maintenance Period|Adverse Event|42|||
170509035|NCT00762034|616206504|FG001|Maintenance Period|Adverse Event|26|||
170509036|NCT00762034|616206503|FG000|Maintenance Period|Progressive Disease|186|||
170509037|NCT00762034|616206504|FG001|Maintenance Period|Progressive Disease|224|||
170509038|NCT00762034|616206503|FG000|Maintenance Period|Physician Decision|25|||
170509039|NCT00762034|616206504|FG001|Maintenance Period|Physician Decision|20|||
170509040|NCT00762034|616206503|FG000|Maintenance Period|Withdrawal by Subject|34|||
170509041|NCT00762034|616206504|FG001|Maintenance Period|Withdrawal by Subject|14|||
170509042|NCT00762034|616206503|FG000|Maintenance Period|Death not due to study disease|2|||
170509043|NCT00762034|616206504|FG001|Maintenance Period|Death not due to study disease|5|||
170509044|NCT00762034|616206503|FG000|Maintenance Period|Death due to study disease|3|||
170509045|NCT00762034|616206504|FG001|Maintenance Period|Death due to study disease|3|||
170509046|NCT00762034|616206503|FG000|Maintenance Period|Other|1|||
170509047|NCT00762034|616206504|FG001|Maintenance Period|Other|1|||
170509048|NCT04228965|616206505|FG000|Overall Study|Lost to Follow-up|26|||
170509049|NCT04228965|616206506|FG001|Overall Study|Lost to Follow-up|11|||
170509050|NCT04228965|616206505|FG000|Overall Study|Withdrawal by Subject|18|||
170509051|NCT04228965|616206506|FG001|Overall Study|Withdrawal by Subject|5|||
170509052|NCT02442206|616206507|FG000|Period 1|Adverse Event|1|||
170805621|NCT02488408|617297402|FG008|Part B|Adverse Event|2|||
170805622|NCT02488408|617297403|FG009|Part B|Adverse Event|2|||
170805623|NCT02488408|617297394|FG000|Part B|Death|0|||
170509053|NCT02442206|616206508|FG001|Period 1|Adverse Event|1|||
170509054|NCT02442206|616206507|FG000|Period 1|withdrew consent|0|||
170509055|NCT02442206|616206508|FG001|Period 1|withdrew consent|1|||
170509056|NCT02442206|616206507|FG000|Period 1|COPD exacerbation|0|||
170509057|NCT02442206|616206508|FG001|Period 1|COPD exacerbation|1|||
170509058|NCT02442206|616206507|FG000|Period 2|Adverse Event|1|||
170643231|NCT02709538|616708349|FG000|Overall Study|Protocol deviation|10|||
170509059|NCT02442206|616206508|FG001|Period 2|Adverse Event|0|||
170509060|NCT00497146|616206509|FG000|Treatment Period|Adverse Event|6|||
170509061|NCT00497146|616206510|FG001|Treatment Period|Adverse Event|2|||
170509062|NCT00497146|616206509|FG000|Treatment Period|Withdrawal by Subject|5|||
170509063|NCT00497146|616206510|FG001|Treatment Period|Withdrawal by Subject|9|||
170509064|NCT00497146|616206509|FG000|Treatment Period|Lost to Follow-up|1|||
170509065|NCT00497146|616206510|FG001|Treatment Period|Lost to Follow-up|3|||
170509066|NCT00497146|616206509|FG000|Treatment Period|Required dialysis|4|||
170509067|NCT00497146|616206510|FG001|Treatment Period|Required dialysis|1|||
170509068|NCT00497146|616206509|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
170509069|NCT00497146|616206510|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
170509070|NCT00497146|616206509|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
170509071|NCT00497146|616206510|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
170509072|NCT00497146|616206509|FG000|Treatment Period|Other Reason|2|||
170509073|NCT00497146|616206510|FG001|Treatment Period|Other Reason|3|||
170509074|NCT00497146|616206509|FG000|Long-term Follow-up Period|Adverse Event|2|||
170509075|NCT00497146|616206510|FG001|Long-term Follow-up Period|Adverse Event|2|||
170509076|NCT00497146|616206509|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
170643232|NCT02709538|616708350|FG001|Overall Study|Protocol deviation|4|||
170643233|NCT02709538|616708351|FG002|Overall Study|Protocol deviation|4|||
170509077|NCT00497146|616206510|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
170509078|NCT00497146|616206509|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
170509079|NCT00497146|616206510|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
170509080|NCT00497146|616206509|FG000|Long-term Follow-up Period|Other|0|||
170509081|NCT00497146|616206510|FG001|Long-term Follow-up Period|Other|1|||
170509082|NCT01471444|616206511|FG000|Overall Study|Physician Decision|3|||
170509083|NCT01471444|616206512|FG001|Overall Study|Physician Decision|2|||
170509084|NCT01471444|616206511|FG000|Overall Study|Withdrawal by Subject|0|||
170509085|NCT01471444|616206512|FG001|Overall Study|Withdrawal by Subject|1|||
170509086|NCT03214679|616206513|FG000|Overall Study|Lost to Follow-up|12|||
170509087|NCT03214679|616206514|FG001|Overall Study|Lost to Follow-up|14|||
170509088|NCT03214679|616206513|FG000|Overall Study|not eligible|2|||
170509089|NCT03214679|616206514|FG001|Overall Study|not eligible|0|||
170509090|NCT04676152|616206515|FG000|Overall Study|screen fail|9|||
170509091|NCT01031004|616206518|FG000|Overall Study|Protocol Violation|0|||
170509092|NCT01031004|616206519|FG001|Overall Study|Protocol Violation|1|||
170509093|NCT01031004|616206518|FG000|Overall Study|Lost to Follow-up|1|||
170509094|NCT01031004|616206519|FG001|Overall Study|Lost to Follow-up|0|||
170509095|NCT04575584|616206520|FG000|Overall Study|Death|6|||
170509096|NCT04575584|616206521|FG001|Overall Study|Death|4|||
170509097|NCT04575584|616206522|FG002|Overall Study|Death|6|||
170509098|NCT04575584|616206523|FG003|Overall Study|Death|2|||
170509099|NCT04575584|616206524|FG004|Overall Study|Death|0|||
170509100|NCT04575584|616206525|FG005|Overall Study|Death|0|||
170509101|NCT04575584|616206520|FG000|Overall Study|Lost to Follow-up|1|||
170509102|NCT04575584|616206521|FG001|Overall Study|Lost to Follow-up|1|||
170509103|NCT04575584|616206522|FG002|Overall Study|Lost to Follow-up|1|||
170509104|NCT04575584|616206523|FG003|Overall Study|Lost to Follow-up|1|||
170509105|NCT04575584|616206524|FG004|Overall Study|Lost to Follow-up|0|||
170509106|NCT04575584|616206525|FG005|Overall Study|Lost to Follow-up|0|||
170509107|NCT04575584|616206520|FG000|Overall Study|Physician Decision|0|||
170509108|NCT04575584|616206521|FG001|Overall Study|Physician Decision|1|||
170509109|NCT04575584|616206522|FG002|Overall Study|Physician Decision|1|||
170509110|NCT04575584|616206523|FG003|Overall Study|Physician Decision|1|||
170509111|NCT04575584|616206524|FG004|Overall Study|Physician Decision|0|||
170509112|NCT04575584|616206525|FG005|Overall Study|Physician Decision|0|||
170509113|NCT04575584|616206520|FG000|Overall Study|Withdrawal by Subject|7|||
170643234|NCT02709538|616708349|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
170643235|NCT02709538|616708350|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
170643236|NCT02709538|616708351|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
170643237|NCT02709538|616708349|FG000|Overall Study|Other|16|||
170643238|NCT02709538|616708350|FG001|Overall Study|Other|7|||
170509114|NCT04575584|616206521|FG001|Overall Study|Withdrawal by Subject|9|||
170509115|NCT04575584|616206522|FG002|Overall Study|Withdrawal by Subject|5|||
170509116|NCT04575584|616206523|FG003|Overall Study|Withdrawal by Subject|3|||
170509117|NCT04575584|616206524|FG004|Overall Study|Withdrawal by Subject|0|||
170509118|NCT04575584|616206525|FG005|Overall Study|Withdrawal by Subject|0|||
170509119|NCT04575584|616206520|FG000|Overall Study|Not recorded|0|||
170509120|NCT04575584|616206521|FG001|Overall Study|Not recorded|0|||
170509121|NCT04575584|616206522|FG002|Overall Study|Not recorded|0|||
170509122|NCT04575584|616206523|FG003|Overall Study|Not recorded|1|||
170509123|NCT04575584|616206524|FG004|Overall Study|Not recorded|0|||
170509124|NCT04575584|616206525|FG005|Overall Study|Not recorded|0|||
170643239|NCT02709538|616708351|FG002|Overall Study|Other|5|||
170643240|NCT03087617|616708352|FG000|Overall Study|Lost to Follow-up|32|||
170805624|NCT02488408|617297395|FG001|Part B|Death|0|||
170805625|NCT02488408|617297396|FG002|Part B|Death|0|||
170509125|NCT02178358|616206526|FG000|Overall Study|Withdrawal by Subject|0|||
170509126|NCT02178358|616206527|FG001|Overall Study|Withdrawal by Subject|2|||
170805626|NCT02488408|617297397|FG003|Part B|Death|0|||
170509127|NCT02178358|616206528|FG002|Overall Study|Withdrawal by Subject|2|||
170509128|NCT02178358|616206526|FG000|Overall Study|Lost to Follow-up|1|||
170509129|NCT02178358|616206527|FG001|Overall Study|Lost to Follow-up|0|||
170509130|NCT02178358|616206528|FG002|Overall Study|Lost to Follow-up|0|||
170509131|NCT00055497|616206537|FG000|Overall Study|Adverse Event|1|||
170509132|NCT00055497|616206538|FG001|Overall Study|Adverse Event|1|||
170509133|NCT00055497|616206539|FG002|Overall Study|Adverse Event|1|||
170509134|NCT00055497|616206540|FG003|Overall Study|Adverse Event|28|||
170509135|NCT00055497|616206537|FG000|Overall Study|Withdrawal by Subject|3|||
170509136|NCT00055497|616206538|FG001|Overall Study|Withdrawal by Subject|1|||
170509137|NCT00055497|616206539|FG002|Overall Study|Withdrawal by Subject|1|||
170509138|NCT00055497|616206540|FG003|Overall Study|Withdrawal by Subject|15|||
170509139|NCT00055497|616206537|FG000|Overall Study|Lost to Follow-up|0|||
170509140|NCT00055497|616206538|FG001|Overall Study|Lost to Follow-up|1|||
170509141|NCT00055497|616206539|FG002|Overall Study|Lost to Follow-up|0|||
170509142|NCT00055497|616206540|FG003|Overall Study|Lost to Follow-up|5|||
170509143|NCT00055497|616206537|FG000|Overall Study|Protocol Violation|0|||
170509144|NCT00055497|616206538|FG001|Overall Study|Protocol Violation|0|||
170509145|NCT00055497|616206539|FG002|Overall Study|Protocol Violation|0|||
170509146|NCT00055497|616206540|FG003|Overall Study|Protocol Violation|3|||
170509147|NCT00055497|616206537|FG000|Overall Study|Lack of Efficacy|1|||
170509148|NCT00055497|616206538|FG001|Overall Study|Lack of Efficacy|0|||
170509149|NCT00055497|616206539|FG002|Overall Study|Lack of Efficacy|0|||
170509150|NCT00055497|616206540|FG003|Overall Study|Lack of Efficacy|27|||
170509151|NCT00055497|616206537|FG000|Overall Study|Administrative Reasons|0|||
170509152|NCT00055497|616206538|FG001|Overall Study|Administrative Reasons|0|||
170509153|NCT00055497|616206539|FG002|Overall Study|Administrative Reasons|0|||
170509154|NCT00055497|616206540|FG003|Overall Study|Administrative Reasons|1|||
170509155|NCT00055497|616206537|FG000|Overall Study|Other|0|||
170509156|NCT00055497|616206538|FG001|Overall Study|Other|0|||
170509157|NCT00055497|616206539|FG002|Overall Study|Other|0|||
170509158|NCT00055497|616206540|FG003|Overall Study|Other|11|||
170509159|NCT00731731|616206541|FG000|Overall Study|Protocol Violation|0|||
170509160|NCT00731731|616206542|FG001|Overall Study|Protocol Violation|0|||
170509161|NCT00731731|616206543|FG002|Overall Study|Protocol Violation|1|||
170509162|NCT00731731|616206541|FG000|Overall Study|Cancel prior to treatment|0|||
170509163|NCT00731731|616206542|FG001|Overall Study|Cancel prior to treatment|0|||
170509164|NCT00731731|616206543|FG002|Overall Study|Cancel prior to treatment|2|||
170509165|NCT01084538|616206547|FG000|Overall Study|Drug not available|30|||
170509166|NCT01084538|616206547|FG000|Overall Study|Adverse Event|9|||
170509167|NCT01084538|616206547|FG000|Overall Study|Kidney transplant|6|||
170509168|NCT01084538|616206547|FG000|Overall Study|Serious Adverse Event|3|||
170509169|NCT01084538|616206547|FG000|Overall Study|Lack of effectiveness|2|||
170509170|NCT01084538|616206547|FG000|Overall Study|Patient noncompliance|2|||
170509171|NCT01084538|616206547|FG000|Overall Study|Hyperphosphatemia|2|||
170509172|NCT01084538|616206547|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
170509173|NCT01084538|616206547|FG000|Overall Study|Change of residence|2|||
170509174|NCT01084538|616206547|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
170509175|NCT01084538|616206547|FG000|Overall Study|Reason unknown|8|||
170509176|NCT00187278|616206548|FG000|Overall Study|Protocol Violation|10|||
170643241|NCT03087617|616708353|FG001|Overall Study|Lost to Follow-up|30|||
170643242|NCT03087617|616708354|FG002|Overall Study|Lost to Follow-up|30|||
170643243|NCT03087617|616708355|FG003|Overall Study|Lost to Follow-up|39|||
170643244|NCT02160041|616708356|FG000|Overall Study|Adverse Event|11|||
170509177|NCT00187278|616206549|FG001|Overall Study|Protocol Violation|13|||
170509178|NCT01080391|616206550|FG000|Overall Study|Randomized but not treated|7|||
170509179|NCT01080391|616206551|FG001|Overall Study|Randomized but not treated|4|||
170509180|NCT02073656|616206562|FG000|Primary Study|Lost to Follow-up|6|||
170509181|NCT02073656|616206562|FG000|Primary Study|Death|1|||
170509182|NCT02073656|616206562|FG000|Primary Study|Withdrew Consent|1|||
170643245|NCT02160041|616708356|FG000|Overall Study|Death|2|||
170643246|NCT02160041|616708356|FG000|Overall Study|disease progression|57|||
170509183|NCT02536781|616206566|FG000|Overall Study|Lost to Follow-up|2|||
170509184|NCT02536781|616206567|FG001|Overall Study|Lost to Follow-up|0|||
170509185|NCT01048099|616206568|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
170509186|NCT01048099|616206568|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
170509187|NCT02450552|616206571|FG000|Overall Study|Withdrawal by Subject|4|||
170509188|NCT02450552|616206572|FG001|Overall Study|Withdrawal by Subject|0|||
170509189|NCT02450552|616206573|FG002|Overall Study|Withdrawal by Subject|4|||
170509190|NCT02450552|616206571|FG000|Overall Study|Physician Decision|1|||
170509191|NCT02450552|616206572|FG001|Overall Study|Physician Decision|0|||
170643247|NCT02160041|616708356|FG000|Overall Study|Protocol Violation|1|||
170643248|NCT02160041|616708356|FG000|Overall Study|non-compliance with study|1|||
170643249|NCT02160041|616708356|FG000|Overall Study|Physician Decision|3|||
170643250|NCT02160041|616708356|FG000|Overall Study|Withdrawal by Subject|8|||
170509192|NCT02450552|616206573|FG002|Overall Study|Physician Decision|1|||
170509193|NCT02258334|616206574|FG000|Overall Study|Adverse Event|1|||
170509194|NCT02258334|616206575|FG001|Overall Study|Adverse Event|0|||
170805627|NCT02488408|617297398|FG004|Part B|Death|0|||
170509195|NCT02258334|616206576|FG002|Overall Study|Adverse Event|0|||
170509196|NCT02258334|616206577|FG003|Overall Study|Adverse Event|0|||
170509197|NCT03564795|616206584|FG000|Overall Study|Withdrawal by Subject|3|||
170509198|NCT03564795|616206584|FG000|Overall Study|Lost to Follow-up|6|||
170509199|NCT03564795|616206584|FG000|Overall Study|Physician Decision|2|||
170509200|NCT05079230|616206585|FG000|Overall Study|Study Terminated by Sponsor|101|||
170509201|NCT05079230|616206586|FG001|Overall Study|Study Terminated by Sponsor|102|||
170509202|NCT05079230|616206585|FG000|Overall Study|Death|72|||
170509203|NCT05079230|616206586|FG001|Overall Study|Death|66|||
170509204|NCT05079230|616206585|FG000|Overall Study|Withdrew Consent|16|||
170509205|NCT05079230|616206586|FG001|Overall Study|Withdrew Consent|18|||
170509206|NCT05079230|616206585|FG000|Overall Study|Lost to Follow-up|0|||
170509207|NCT05079230|616206586|FG001|Overall Study|Lost to Follow-up|3|||
170509208|NCT00564395|616206591|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
170509209|NCT00564395|616206592|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
170509210|NCT00564395|616206591|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
170509211|NCT00564395|616206592|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
170509212|NCT02054910|616206594|FG000|Overall Study|Lost to Follow-up|4|||
170509213|NCT02054910|616206595|FG001|Overall Study|Lost to Follow-up|1|||
170509214|NCT02208050|616206602|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
170509215|NCT02208050|616206603|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
170509216|NCT00721279|616206605|FG000|Overall Study|Lack of Efficacy|6|||
170509217|NCT00721279|616206606|FG001|Overall Study|Lack of Efficacy|3|||
170509218|NCT00721279|616206605|FG000|Overall Study|Tolerability insufficient|5|||
170509219|NCT00721279|616206606|FG001|Overall Study|Tolerability insufficient|2|||
170509220|NCT00721279|616206605|FG000|Overall Study|Withdrawal by Subject|13|||
170509221|NCT00721279|616206606|FG001|Overall Study|Withdrawal by Subject|3|||
170509222|NCT00721279|616206605|FG000|Overall Study|Other|12|||
170509223|NCT00721279|616206606|FG001|Overall Study|Other|16|||
170509224|NCT05153148|616206607|FG000|Overall Study|Adverse Event|1|||
170509225|NCT05153148|616206608|FG001|Overall Study|Adverse Event|0|||
170509226|NCT05153148|616206609|FG002|Overall Study|Adverse Event|3|||
170509227|NCT05153148|616206610|FG003|Overall Study|Adverse Event|5|||
170509228|NCT05153148|616206607|FG000|Overall Study|Lost to Follow-up|1|||
170509229|NCT05153148|616206608|FG001|Overall Study|Lost to Follow-up|1|||
170509230|NCT05153148|616206609|FG002|Overall Study|Lost to Follow-up|2|||
170509231|NCT05153148|616206610|FG003|Overall Study|Lost to Follow-up|0|||
170509232|NCT05153148|616206607|FG000|Overall Study|Withdrawal by Subject|6|||
170509233|NCT05153148|616206608|FG001|Overall Study|Withdrawal by Subject|8|||
170509234|NCT05153148|616206609|FG002|Overall Study|Withdrawal by Subject|6|||
170509235|NCT05153148|616206610|FG003|Overall Study|Withdrawal by Subject|8|||
170509236|NCT05153148|616206607|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
170509237|NCT05153148|616206608|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
170509238|NCT05153148|616206609|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
170509239|NCT05153148|616206610|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
170509240|NCT05153148|616206607|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
170509241|NCT05153148|616206608|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
170509242|NCT05153148|616206609|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
170509243|NCT05153148|616206610|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
170509244|NCT05153148|616206607|FG000|Overall Study|Reason not Specified|1|||
170509245|NCT05153148|616206608|FG001|Overall Study|Reason not Specified|1|||
170509246|NCT05153148|616206609|FG002|Overall Study|Reason not Specified|1|||
170509247|NCT05153148|616206610|FG003|Overall Study|Reason not Specified|1|||
170509248|NCT00474786|616206611|FG000|Overall Study|Not Meeting Study Criteria|0|||
170509249|NCT00474786|616206612|FG001|Overall Study|Not Meeting Study Criteria|1|||
170509250|NCT00474786|616206611|FG000|Overall Study|Investigator Request|2|||
170509251|NCT00474786|616206612|FG001|Overall Study|Investigator Request|1|||
170509252|NCT00474786|616206611|FG000|Overall Study|Death|189|||
170553229|NCT02037984|616370400|FG007|Overall Study|Technical Problems|2|||
170553230|NCT02037984|616370393|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170904279|NCT04211337|617650949|FG001|Overall Study|On Treatment|40|||
170904280|NCT04211337|617650948|FG000|Overall Study|Withdrawal by Subject|0|||
170904281|NCT04211337|617650949|FG001|Overall Study|Withdrawal by Subject|2|||
170904282|NCT02786901|617652292|FG000|Overall Study|Adverse Event|1|||
170904283|NCT02786901|617652293|FG001|Overall Study|Adverse Event|1|||
170904284|NCT02786901|617652294|FG002|Overall Study|Adverse Event|2|||
170904285|NCT02786901|617652292|FG000|Overall Study|Physician Decision|1|||
170904286|NCT02786901|617652293|FG001|Overall Study|Physician Decision|0|||
170509253|NCT00474786|616206612|FG001|Overall Study|Death|170|||
170509254|NCT00474786|616206611|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
170509255|NCT00474786|616206612|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
170509256|NCT00474786|616206611|FG000|Overall Study|Lost to Follow-up|4|||
170509257|NCT00474786|616206612|FG001|Overall Study|Lost to Follow-up|7|||
170509258|NCT00474786|616206611|FG000|Overall Study|Protocol Violation|2|||
170904287|NCT02786901|617652294|FG002|Overall Study|Physician Decision|0|||
170904288|NCT02786901|617652292|FG000|Overall Study|Rescue Therapy Use|71|||
170509259|NCT00474786|616206612|FG001|Overall Study|Protocol Violation|0|||
170509260|NCT00474786|616206611|FG000|Overall Study|Withdrawal by Subject|15|||
170509261|NCT00474786|616206612|FG001|Overall Study|Withdrawal by Subject|15|||
170509262|NCT00474786|616206611|FG000|Overall Study|Other|5|||
170509263|NCT00474786|616206612|FG001|Overall Study|Other|0|||
170509264|NCT01324570|616206615|FG000|Overall Study|Adverse Event|4|||
170509265|NCT01324570|616206616|FG001|Overall Study|Adverse Event|7|||
170509266|NCT01324570|616206615|FG000|Overall Study|Withdrawal by Subject|0|||
170509267|NCT01324570|616206616|FG001|Overall Study|Withdrawal by Subject|3|||
170509268|NCT01324570|616206615|FG000|Overall Study|Lack of Efficacy|0|||
170509269|NCT01324570|616206616|FG001|Overall Study|Lack of Efficacy|1|||
170509270|NCT01324570|616206615|FG000|Overall Study|Confirmed or suspected diversion|0|||
170509271|NCT01324570|616206616|FG001|Overall Study|Confirmed or suspected diversion|1|||
170509272|NCT01324570|616206615|FG000|Overall Study|Administrative|0|||
170509273|NCT01324570|616206616|FG001|Overall Study|Administrative|2|||
170509274|NCT00505661|616206624|FG000|Overall Study|Not Eligible|4|||
170509275|NCT03611582|616206625|FG000|Overall Study|Adverse Event|26|||
170509276|NCT03611582|616206626|FG001|Overall Study|Adverse Event|6|||
170509277|NCT03611582|616206625|FG000|Overall Study|Protocol Violation|0|||
170509278|NCT03611582|616206626|FG001|Overall Study|Protocol Violation|1|||
170509279|NCT03611582|616206625|FG000|Overall Study|Pregnancy|1|||
170509280|NCT03611582|616206626|FG001|Overall Study|Pregnancy|2|||
170509281|NCT03611582|616206625|FG000|Overall Study|Lack of Efficacy|0|||
170509282|NCT03611582|616206626|FG001|Overall Study|Lack of Efficacy|1|||
170509283|NCT03611582|616206625|FG000|Overall Study|At the discretion of the investigator|1|||
170509284|NCT03611582|616206626|FG001|Overall Study|At the discretion of the investigator|0|||
170509285|NCT03611582|616206625|FG000|Overall Study|Safety concern as judged by the investigator|1|||
170509286|NCT03611582|616206626|FG001|Overall Study|Safety concern as judged by the investigator|2|||
170509287|NCT03611582|616206625|FG000|Overall Study|Withdrawal by Subject|4|||
170509288|NCT03611582|616206626|FG001|Overall Study|Withdrawal by Subject|3|||
170509289|NCT03611582|616206625|FG000|Overall Study|Lost to Follow-up|18|||
170509290|NCT03611582|616206626|FG001|Overall Study|Lost to Follow-up|7|||
170509291|NCT03611582|616206625|FG000|Overall Study|other|17|||
170509292|NCT03611582|616206626|FG001|Overall Study|other|16|||
170509293|NCT01573754|616206628|FG000|Overall Study|Noncompliance or remission not achieved|3|||
170509294|NCT01573754|616206629|FG001|Overall Study|Noncompliance or remission not achieved|15|||
170509295|NCT00463840|616206630|FG000|Overall Study|Disease progression|7|||
170509296|NCT00463840|616206630|FG000|Overall Study|Withdrawal by Subject|2|||
170509297|NCT00463840|616206630|FG000|Overall Study|Adverse Event|3|||
170509298|NCT04438499|616206631|FG000|Overall Study|Lack of Efficacy|3|||
170509299|NCT03915626|616208536|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
170509300|NCT01754766|616208544|FG000|Overall Study|Personal reasons|1|||
170509301|NCT01754766|616208545|FG001|Overall Study|Personal reasons|1|||
170509302|NCT01754766|616208546|FG002|Overall Study|Personal reasons|0|||
170509303|NCT00298363|616208547|FG000|Overall Study|Lost to Follow-up|0|||
170509304|NCT00298363|616208548|FG001|Overall Study|Lost to Follow-up|0|||
170509305|NCT00298363|616208549|FG002|Overall Study|Lost to Follow-up|1|||
170509306|NCT00298363|616208547|FG000|Overall Study|Physician Decision|4|||
170509307|NCT00298363|616208548|FG001|Overall Study|Physician Decision|1|||
170509308|NCT00298363|616208549|FG002|Overall Study|Physician Decision|0|||
170553231|NCT02037984|616370394|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170553232|NCT02037984|616370395|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
170805628|NCT02488408|617297399|FG005|Part B|Death|3|||
170805629|NCT02488408|617297400|FG006|Part B|Death|1|||
170805630|NCT02488408|617297401|FG007|Part B|Death|2|||
170805631|NCT02488408|617297402|FG008|Part B|Death|2|||
170805632|NCT02488408|617297403|FG009|Part B|Death|2|||
170805633|NCT02488408|617297394|FG000|Part B|Death due to Disease Progression|0|||
170805634|NCT02488408|617297395|FG001|Part B|Death due to Disease Progression|0|||
170805635|NCT02488408|617297396|FG002|Part B|Death due to Disease Progression|0|||
170805636|NCT02488408|617297397|FG003|Part B|Death due to Disease Progression|0|||
170805637|NCT02488408|617297398|FG004|Part B|Death due to Disease Progression|0|||
170805638|NCT02488408|617297399|FG005|Part B|Death due to Disease Progression|2|||
170805639|NCT02488408|617297400|FG006|Part B|Death due to Disease Progression|2|||
170805640|NCT02488408|617297401|FG007|Part B|Death due to Disease Progression|1|||
170805641|NCT02488408|617297402|FG008|Part B|Death due to Disease Progression|1|||
170904289|NCT02786901|617652293|FG001|Overall Study|Rescue Therapy Use|49|||
170904290|NCT02786901|617652294|FG002|Overall Study|Rescue Therapy Use|33|||
170509309|NCT00298363|616208547|FG000|Overall Study|Protocol Violation|1|||
170509310|NCT00298363|616208548|FG001|Overall Study|Protocol Violation|1|||
170509311|NCT00298363|616208549|FG002|Overall Study|Protocol Violation|0|||
170509312|NCT00298363|616208547|FG000|Overall Study|Withdrawal by Subject|5|||
170509313|NCT00298363|616208548|FG001|Overall Study|Withdrawal by Subject|1|||
170509314|NCT00298363|616208549|FG002|Overall Study|Withdrawal by Subject|3|||
170509315|NCT00298363|616208547|FG000|Overall Study|Adverse Event|5|||
170509316|NCT00298363|616208548|FG001|Overall Study|Adverse Event|2|||
170509317|NCT00298363|616208549|FG002|Overall Study|Adverse Event|2|||
170509318|NCT00298363|616208547|FG000|Overall Study|Lack of Efficacy|2|||
170509319|NCT00298363|616208548|FG001|Overall Study|Lack of Efficacy|3|||
170509320|NCT00298363|616208549|FG002|Overall Study|Lack of Efficacy|0|||
170509321|NCT01709409|616208554|FG000|Overall Study|Protocol Violation|1|||
170509322|NCT01709409|616208555|FG001|Overall Study|Protocol Violation|0|||
170509323|NCT02412878|616208556|FG000|Overall Study|Withdrawal by Subject|19|||
170509324|NCT02412878|616208557|FG001|Overall Study|Withdrawal by Subject|10|||
170509325|NCT02412878|616208556|FG000|Overall Study|Lost to Follow-up|2|||
170509326|NCT02412878|616208557|FG001|Overall Study|Lost to Follow-up|3|||
170509327|NCT04571385|616208558|FG000|Overall Study|Participant non-compliance|1|||
170509328|NCT04571385|616208559|FG001|Overall Study|Participant non-compliance|0|||
170509329|NCT04571385|616208560|FG002|Overall Study|Participant non-compliance|0|||
170509330|NCT04571385|616208558|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
170509331|NCT04571385|616208559|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
170509332|NCT04571385|616208560|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
170509333|NCT04571385|616208558|FG000|Overall Study|Screen failure|0|||
170509334|NCT04571385|616208559|FG001|Overall Study|Screen failure|0|||
170509335|NCT04571385|616208560|FG002|Overall Study|Screen failure|1|||
170509336|NCT02107313|616208570|FG000|Overall Study|One participant did not do the FED cohor|0|||
170509337|NCT02107313|616208571|FG001|Overall Study|One participant did not do the FED cohor|1|||
170509338|NCT01026818|616208572|FG000|Screening Period|Entry Criteria Not Met|105|||
170509339|NCT01026818|616208573|FG001|Screening Period|Entry Criteria Not Met|0|||
170509340|NCT01026818|616208574|FG002|Screening Period|Entry Criteria Not Met|0|||
170509341|NCT01026818|616208575|FG003|Screening Period|Entry Criteria Not Met|0|||
170509342|NCT01026818|616208572|FG000|Screening Period|Withdrawal by Subject|49|||
170509343|NCT01026818|616208573|FG001|Screening Period|Withdrawal by Subject|0|||
170509344|NCT01026818|616208574|FG002|Screening Period|Withdrawal by Subject|0|||
170509345|NCT01026818|616208575|FG003|Screening Period|Withdrawal by Subject|0|||
170509346|NCT01026818|616208572|FG000|Screening Period|Protocol Deviation|3|||
170509347|NCT01026818|616208573|FG001|Screening Period|Protocol Deviation|0|||
170509348|NCT01026818|616208574|FG002|Screening Period|Protocol Deviation|0|||
170509349|NCT01026818|616208575|FG003|Screening Period|Protocol Deviation|0|||
170509350|NCT01026818|616208572|FG000|Screening Period|Adverse Event|2|||
170509351|NCT01026818|616208573|FG001|Screening Period|Adverse Event|0|||
170509352|NCT01026818|616208574|FG002|Screening Period|Adverse Event|0|||
170509353|NCT01026818|616208575|FG003|Screening Period|Adverse Event|0|||
170509354|NCT01026818|616208572|FG000|Screening Period|Physician Decision|1|||
170509355|NCT01026818|616208573|FG001|Screening Period|Physician Decision|0|||
170509356|NCT01026818|616208574|FG002|Screening Period|Physician Decision|0|||
170509357|NCT01026818|616208575|FG003|Screening Period|Physician Decision|0|||
170509358|NCT01026818|616208572|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
170509359|NCT01026818|616208573|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
170509360|NCT01026818|616208574|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
170509361|NCT01026818|616208575|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
170509362|NCT01026818|616208572|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
170509363|NCT01026818|616208573|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
170509364|NCT01026818|616208574|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
170509365|NCT01026818|616208575|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
170553233|NCT02037984|616370396|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
170553234|NCT02037984|616370397|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
170553235|NCT02037984|616370398|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
170553236|NCT02037984|616370399|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
170553237|NCT02037984|616370400|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
170553238|NCT02037984|616370393|FG000|Overall Study|Withdrawal by Subject|0|||
170553239|NCT02037984|616370394|FG001|Overall Study|Withdrawal by Subject|0|||
170553240|NCT02037984|616370395|FG002|Overall Study|Withdrawal by Subject|0|||
170553241|NCT02037984|616370396|FG003|Overall Study|Withdrawal by Subject|1|||
170553242|NCT02037984|616370397|FG004|Overall Study|Withdrawal by Subject|1|||
170553243|NCT02037984|616370398|FG005|Overall Study|Withdrawal by Subject|3|||
170553244|NCT02037984|616370399|FG006|Overall Study|Withdrawal by Subject|0|||
170553245|NCT02037984|616370400|FG007|Overall Study|Withdrawal by Subject|1|||
170553246|NCT02151604|616370401|FG000|Overall Study|Lost to Follow-up|3|||
170553247|NCT02151604|616370401|FG000|Overall Study|Withdrawal by Subject|2|||
170553248|NCT02151604|616370401|FG000|Overall Study|Physician Decision|3|||
170553249|NCT02151604|616370401|FG000|Overall Study|Death|1|||
170509366|NCT01026818|616208572|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
170509367|NCT01026818|616208573|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
170509368|NCT01026818|616208574|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
170509369|NCT01026818|616208575|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
170509370|NCT01026818|616208572|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
170509371|NCT01026818|616208573|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
170509372|NCT01026818|616208574|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
170509373|NCT01026818|616208575|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
170509374|NCT01026818|616208572|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
170509375|NCT01026818|616208573|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
170509376|NCT01026818|616208574|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
170509377|NCT01026818|616208575|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
170509378|NCT01026818|616208572|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
170509379|NCT01026818|616208573|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
170509380|NCT01026818|616208574|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
170509381|NCT01026818|616208575|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
170509382|NCT01026818|616208572|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
170509383|NCT01026818|616208573|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
170509384|NCT01026818|616208574|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
170509385|NCT01026818|616208575|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
170509386|NCT01026818|616208572|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
170509387|NCT01026818|616208573|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
170509388|NCT01026818|616208574|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
170509389|NCT01026818|616208575|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
170509390|NCT01026818|616208572|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
170509391|NCT01026818|616208573|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
170509392|NCT01026818|616208574|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
170509393|NCT01026818|616208575|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
170509394|NCT01026818|616208572|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
170509395|NCT01026818|616208573|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
170509396|NCT01026818|616208574|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
170509397|NCT01026818|616208575|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
170509398|NCT01026818|616208572|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
170509399|NCT01026818|616208573|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
170509400|NCT01026818|616208574|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
170509401|NCT01026818|616208575|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
170509402|NCT01026818|616208572|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
170509403|NCT01026818|616208573|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
170509404|NCT01026818|616208574|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
170509405|NCT01026818|616208575|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
170509406|NCT01026818|616208572|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
170509407|NCT01026818|616208573|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
170509408|NCT01026818|616208574|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
170509409|NCT01026818|616208575|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
170509410|NCT01026818|616208572|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
170509411|NCT01026818|616208573|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
170509412|NCT01026818|616208574|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
170509413|NCT01026818|616208575|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
170509414|NCT01026818|616208572|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
170509415|NCT01026818|616208573|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
170509416|NCT01026818|616208574|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
170509417|NCT01026818|616208575|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
170509418|NCT01026818|616208572|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
170509419|NCT01026818|616208573|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
170509420|NCT01026818|616208574|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
170509421|NCT01026818|616208575|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
170509422|NCT01026818|616208572|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
170509423|NCT01026818|616208573|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
170509424|NCT01026818|616208574|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
170509425|NCT01026818|616208575|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
170509426|NCT01026818|616208572|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
170509427|NCT01026818|616208573|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
170509428|NCT01026818|616208574|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
170643251|NCT02160041|616708356|FG000|Overall Study|study terminated by by sponsor|1|||
170509429|NCT01026818|616208575|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
170509430|NCT01026818|616208572|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
170509431|NCT01026818|616208573|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
170509432|NCT01026818|616208574|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
170509433|NCT01026818|616208575|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
170509434|NCT01641471|616208576|FG000|Overall Study|Withdrawal by Subject|19|||
170509435|NCT01641471|616208577|FG001|Overall Study|Withdrawal by Subject|19|||
170509436|NCT01641471|616208576|FG000|Overall Study|Lost to Follow-up|2|||
170509437|NCT01641471|616208577|FG001|Overall Study|Lost to Follow-up|4|||
170509438|NCT01641471|616208576|FG000|Overall Study|Protocol Violation|2|||
170509439|NCT01641471|616208577|FG001|Overall Study|Protocol Violation|4|||
170509440|NCT02634801|616208578|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
170643252|NCT04450381|616708357|FG000|Overall Study|Protocol Violation|4|||
170643253|NCT04450381|616708357|FG000|Overall Study|Wrong device setting|2|||
170643254|NCT01864005|616708358|FG000|Overall Study|Protocol Violation|0|||
170643255|NCT01864005|616708359|FG001|Overall Study|Protocol Violation|1|||
170643256|NCT01864005|616708358|FG000|Overall Study|Withdrawal by Subject|0|||
170643257|NCT01864005|616708359|FG001|Overall Study|Withdrawal by Subject|1|||
170643258|NCT01864005|616708358|FG000|Overall Study|Incorrect enrolment|1|||
170805642|NCT02488408|617297403|FG009|Part B|Death due to Disease Progression|1|||
170509441|NCT02634801|616208579|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
170509442|NCT02634801|616208580|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
170509443|NCT02634801|616208578|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
170509444|NCT02634801|616208579|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
170509445|NCT02634801|616208580|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
170509446|NCT02634801|616208578|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
170509447|NCT02634801|616208579|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
170509448|NCT02634801|616208580|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
170509449|NCT02634801|616208578|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
170509450|NCT02634801|616208579|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
170509451|NCT02634801|616208580|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
170805643|NCT02488408|617297394|FG000|Part B|Disease Progression|0|||
170509452|NCT02634801|616208578|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
170509453|NCT02634801|616208579|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
170509454|NCT02634801|616208580|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
170509455|NCT02634801|616208578|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
170509456|NCT02634801|616208579|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
170509457|NCT02634801|616208580|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
170509458|NCT02634801|616208578|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
170509459|NCT02634801|616208579|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
170509460|NCT02634801|616208580|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
170509461|NCT02634801|616208578|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
170509462|NCT02634801|616208579|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
170509463|NCT02634801|616208580|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
170509464|NCT02634801|616208578|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
170805644|NCT02488408|617297395|FG001|Part B|Disease Progression|0|||
170805645|NCT02488408|617297396|FG002|Part B|Disease Progression|0|||
170509465|NCT02634801|616208579|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
170509466|NCT02634801|616208580|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
170509467|NCT02634801|616208578|FG000|Follow-up Period|Lost to Follow-up|3|||
170509468|NCT02634801|616208579|FG001|Follow-up Period|Lost to Follow-up|1|||
170509469|NCT02634801|616208580|FG002|Follow-up Period|Lost to Follow-up|2|||
170509470|NCT02634801|616208578|FG000|Follow-up Period|Physician Decision|0|||
170509471|NCT02634801|616208579|FG001|Follow-up Period|Physician Decision|0|||
170509472|NCT02634801|616208580|FG002|Follow-up Period|Physician Decision|1|||
170509473|NCT02634801|616208578|FG000|Follow-up Period|Withdrawal by Subject|1|||
170509474|NCT02634801|616208579|FG001|Follow-up Period|Withdrawal by Subject|2|||
170509475|NCT02634801|616208580|FG002|Follow-up Period|Withdrawal by Subject|5|||
170509476|NCT02634801|616208578|FG000|Follow-up Period|Adverse Event|1|||
170509477|NCT02634801|616208579|FG001|Follow-up Period|Adverse Event|5|||
170509478|NCT02634801|616208580|FG002|Follow-up Period|Adverse Event|0|||
170509479|NCT00199849|616208583|FG000|Overall Study|Unrelated illness or complication|0|||
170509480|NCT00199849|616208584|FG001|Overall Study|Unrelated illness or complication|1|||
170509481|NCT00199849|616208585|FG002|Overall Study|Unrelated illness or complication|0|||
170509482|NCT00199849|616208583|FG000|Overall Study|Progressive disease requiring intervention|0|||
170509483|NCT00199849|616208584|FG001|Overall Study|Progressive disease requiring intervention|0|||
170509484|NCT00199849|616208585|FG002|Overall Study|Progressive disease requiring intervention|1|||
170509485|NCT00199849|616208583|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
170509486|NCT00199849|616208584|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
170509487|NCT00199849|616208585|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
170509488|NCT01548768|616208588|FG000|Overall Study|Withdrawal by Subject|0|||
170509489|NCT01548768|616208589|FG001|Overall Study|Withdrawal by Subject|2|||
170509490|NCT01548768|616208590|FG002|Overall Study|Withdrawal by Subject|1|||
170509491|NCT01548768|616208591|FG003|Overall Study|Withdrawal by Subject|0|||
170643259|NCT01864005|616708359|FG001|Overall Study|Incorrect enrolment|0|||
170643260|NCT01864005|616708358|FG000|Overall Study|Disease need|1|||
170509492|NCT01548768|616208588|FG000|Overall Study|Physician Decision|1|||
170509493|NCT01548768|616208589|FG001|Overall Study|Physician Decision|0|||
170509494|NCT01548768|616208590|FG002|Overall Study|Physician Decision|0|||
170509495|NCT01548768|616208591|FG003|Overall Study|Physician Decision|0|||
170509496|NCT01548768|616208588|FG000|Overall Study|Adverse Event|0|||
170509497|NCT01548768|616208589|FG001|Overall Study|Adverse Event|0|||
170509498|NCT01548768|616208590|FG002|Overall Study|Adverse Event|0|||
170509499|NCT01548768|616208591|FG003|Overall Study|Adverse Event|1|||
170509500|NCT01548768|616208588|FG000|Overall Study|Non-Compliance|0|||
170509501|NCT01548768|616208589|FG001|Overall Study|Non-Compliance|0|||
170509502|NCT01548768|616208590|FG002|Overall Study|Non-Compliance|0|||
170509503|NCT01548768|616208591|FG003|Overall Study|Non-Compliance|3|||
170509504|NCT02499263|616208592|FG000|Overall Study|Lost to Follow-up|9|||
170509505|NCT02499263|616208592|FG000|Overall Study|Participant's withdrawal of consent|4|||
170509506|NCT02499263|616208592|FG000|Overall Study|Lack of Efficacy|22|||
170509507|NCT02499263|616208592|FG000|Overall Study|investigator's judgment|12|||
170509508|NCT02499263|616208592|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
170509509|NCT02499263|616208592|FG000|Overall Study|Participant's decision|3|||
170509510|NCT02499263|616208592|FG000|Overall Study|Pregnancy|1|||
170509511|NCT01375374|616208593|FG000|Overall Study|Adverse Event|1|||
170509512|NCT00424593|616208594|FG000|Acute Double-Blind Period|Adverse Event|16|||
170509513|NCT00424593|616208595|FG001|Acute Double-Blind Period|Adverse Event|7|||
170509514|NCT00424593|616208594|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
170509515|NCT00424593|616208595|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
170509516|NCT00424593|616208594|FG000|Acute Double-Blind Period|Protocol Violation|2|||
170509517|NCT00424593|616208595|FG001|Acute Double-Blind Period|Protocol Violation|2|||
170509518|NCT00424593|616208594|FG000|Acute Double-Blind Period|Physician Decision|1|||
170509519|NCT00424593|616208595|FG001|Acute Double-Blind Period|Physician Decision|2|||
170509520|NCT00424593|616208594|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
170509521|NCT00424593|616208595|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
170509522|NCT00424593|616208594|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
170509523|NCT00424593|616208595|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
170509524|NCT00424593|616208594|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
170509525|NCT00424593|616208595|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
170509526|NCT00424593|616208594|FG000|Dose-Blind Extension Period|Adverse Event|18|||
170509527|NCT00424593|616208595|FG001|Dose-Blind Extension Period|Adverse Event|0|||
170509528|NCT00424593|616208594|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
170509529|NCT00424593|616208595|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
170509530|NCT00424593|616208594|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
170509531|NCT00424593|616208595|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
170509532|NCT00424593|616208594|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
170509533|NCT00424593|616208595|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
170509534|NCT00424593|616208594|FG000|Dose-Blind Extension Period|Physician Decision|3|||
170509535|NCT00424593|616208595|FG001|Dose-Blind Extension Period|Physician Decision|0|||
170509536|NCT01066663|616208598|FG000|Overall Study|Adverse Event|0|||
170509537|NCT01066663|616208599|FG001|Overall Study|Adverse Event|0|||
170509538|NCT01066663|616208600|FG002|Overall Study|Adverse Event|1|||
170805646|NCT02488408|617297397|FG003|Part B|Disease Progression|0|||
170509539|NCT03297021|616208601|FG000|Overall Study|Incomplete/illegible data sheet|4|||
170553250|NCT00185614|616371844|FG000|Inter-treatment Period|Physician Decision|1|||
170805647|NCT02488408|617297398|FG004|Part B|Disease Progression|0|||
170805648|NCT02488408|617297399|FG005|Part B|Disease Progression|6|||
170805649|NCT02488408|617297400|FG006|Part B|Disease Progression|9|||
170805650|NCT02488408|617297401|FG007|Part B|Disease Progression|7|||
170805651|NCT02488408|617297402|FG008|Part B|Disease Progression|9|||
170805652|NCT02488408|617297403|FG009|Part B|Disease Progression|11|||
170805653|NCT02488408|617297394|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
170805654|NCT02488408|617297395|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
170805655|NCT02488408|617297396|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
170904291|NCT02786901|617652292|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
170904292|NCT02786901|617652293|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
170904293|NCT02786901|617652294|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
170904294|NCT02786901|617652292|FG000|Overall Study|Disallowed medication|1|||
170904295|NCT02786901|617652293|FG001|Overall Study|Disallowed medication|1|||
170904296|NCT02786901|617652294|FG002|Overall Study|Disallowed medication|0|||
170904297|NCT02786901|617652292|FG000|Overall Study|Randomized in error|2|||
170904298|NCT02786901|617652293|FG001|Overall Study|Randomized in error|0|||
170904299|NCT02786901|617652294|FG002|Overall Study|Randomized in error|1|||
170904300|NCT02983604|617652295|FG000|Overall Study|Enrolled but not Treated|0|||
170904301|NCT02983604|617652296|FG001|Overall Study|Enrolled but not Treated|0|||
170904302|NCT02983604|617652297|FG002|Overall Study|Enrolled but not Treated|1|||
170904303|NCT02983604|617652298|FG003|Overall Study|Enrolled but not Treated|0|||
170904304|NCT01486264|617652299|FG000|Overall Study|Death|1|||
170509540|NCT03297021|616208602|FG001|Overall Study|Incomplete/illegible data sheet|2|||
170509541|NCT03297021|616208603|FG002|Overall Study|Incomplete/illegible data sheet|3|||
170509542|NCT03297021|616208601|FG000|Overall Study|Missing Post-Op Data|1|||
170509543|NCT03297021|616208602|FG001|Overall Study|Missing Post-Op Data|2|||
170553251|NCT00185614|616371844|FG000|Inter-treatment Period|Relapse|2|||
170805656|NCT02488408|617297397|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
170904305|NCT01486264|617652300|FG001|Overall Study|Death|1|||
170904306|NCT01486264|617652299|FG000|Overall Study|Adverse Event|3|||
170904307|NCT01486264|617652300|FG001|Overall Study|Adverse Event|3|||
170904308|NCT01486264|617652299|FG000|Overall Study|Lack of Efficacy|6|||
170904309|NCT01486264|617652300|FG001|Overall Study|Lack of Efficacy|10|||
170509544|NCT03297021|616208603|FG002|Overall Study|Missing Post-Op Data|1|||
170509545|NCT02779075|616208604|FG000|Overall Study|Withdrawal by Subject|1|||
170509546|NCT02779075|616208605|FG001|Overall Study|Withdrawal by Subject|3|||
170509547|NCT02779075|616208604|FG000|Overall Study|IV lost during 2nd study|1|||
170509548|NCT02779075|616208605|FG001|Overall Study|IV lost during 2nd study|0|||
170509549|NCT03077607|616208606|FG000|Period 1 (15 Days)|Adverse Event|1|||
170509550|NCT03077607|616208607|FG001|Period 1 (15 Days)|Adverse Event|0|||
170509551|NCT03077607|616208606|FG000|Period 1 (15 Days)|Death|1|||
170509552|NCT03077607|616208607|FG001|Period 1 (15 Days)|Death|0|||
170509553|NCT03077607|616208606|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
170509554|NCT03077607|616208607|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
170509555|NCT03077607|616208606|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
170509556|NCT03077607|616208607|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
170509557|NCT04278924|616208609|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
170509558|NCT04278924|616208610|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
170509559|NCT04278924|616208611|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
170509560|NCT04278924|616208612|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
170509561|NCT04278924|616208613|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
170509562|NCT04278924|616208614|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
170509563|NCT04278924|616208615|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
170509564|NCT04278924|616208609|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
170509565|NCT04278924|616208610|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
170509566|NCT04278924|616208611|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
170509567|NCT04278924|616208612|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
170509568|NCT04278924|616208613|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
170509569|NCT04278924|616208614|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
170509570|NCT04278924|616208615|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
170553252|NCT00185614|616371844|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
170553253|NCT02410200|616371850|FG000|Overall Study|Adverse Event|2|||
170553254|NCT00661687|616371852|FG000|Overall Study|Study related symptoms and complaints|5|||
170553255|NCT00661687|616371852|FG000|Overall Study|Positive slit lamp findings|4|||
170553256|NCT00661687|616371852|FG000|Overall Study|Inability to maintain wearing schedule|3|||
170553257|NCT00661687|616371852|FG000|Overall Study|Physician Decision|1|||
170553258|NCT00661687|616371852|FG000|Overall Study|Adverse Event|2|||
170805657|NCT02488408|617297398|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
170805658|NCT02488408|617297399|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
170805659|NCT02488408|617297400|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
170805660|NCT02488408|617297401|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
170805661|NCT02488408|617297402|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
170805662|NCT02488408|617297403|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
170805663|NCT02488408|617297394|FG000|Part B|Investigator Decision|0|||
170805664|NCT02488408|617297395|FG001|Part B|Investigator Decision|0|||
170805665|NCT02488408|617297396|FG002|Part B|Investigator Decision|0|||
170805666|NCT02488408|617297397|FG003|Part B|Investigator Decision|0|||
170805667|NCT02488408|617297398|FG004|Part B|Investigator Decision|0|||
170805668|NCT02488408|617297399|FG005|Part B|Investigator Decision|0|||
170805669|NCT02488408|617297400|FG006|Part B|Investigator Decision|1|||
170805670|NCT02488408|617297401|FG007|Part B|Investigator Decision|0|||
170805671|NCT02488408|617297402|FG008|Part B|Investigator Decision|2|||
170805672|NCT02488408|617297403|FG009|Part B|Investigator Decision|1|||
170805673|NCT00719888|617297404|FG000|Overall Study|Death|24|||
170805674|NCT00719888|617297405|FG001|Overall Study|Death|9|||
170805675|NCT00719888|617297404|FG000|Overall Study|Relapse|8|||
170805676|NCT00719888|617297405|FG001|Overall Study|Relapse|3|||
170805677|NCT00719888|617297404|FG000|Overall Study|Physician Decision|1|||
170805678|NCT00719888|617297405|FG001|Overall Study|Physician Decision|0|||
170805679|NCT00719888|617297404|FG000|Overall Study|Withdrawal by Subject|1|||
170805680|NCT00719888|617297405|FG001|Overall Study|Withdrawal by Subject|0|||
170805681|NCT03773107|617297406|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
170805682|NCT03773107|617297407|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
170805683|NCT03773107|617297408|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
170805684|NCT03773107|617297409|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
170509571|NCT04767529|616208616|FG000|Overall Study|Adverse Event|0|||
170509572|NCT04767529|616208617|FG001|Overall Study|Adverse Event|4|||
170509573|NCT04767529|616208618|FG002|Overall Study|Adverse Event|3|||
170509574|NCT04767529|616208616|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
170509575|NCT04767529|616208617|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
170553259|NCT01362530|616371854|FG000|Base Study (Cycle 1)|Adverse Event|2|||
170805685|NCT02556918|617299286|FG000|Overall Study|Protocol Violation|5|||
170805686|NCT02556918|617299287|FG001|Overall Study|Protocol Violation|6|||
170805687|NCT02556918|617299286|FG000|Overall Study|Withdrawal by Subject|4|||
170805688|NCT02556918|617299287|FG001|Overall Study|Withdrawal by Subject|4|||
170805689|NCT01276509|617299290|FG000|Overall Study|Adverse Event|9|||
170805690|NCT01276509|617299291|FG001|Overall Study|Adverse Event|8|||
170509576|NCT04767529|616208618|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
170509577|NCT04767529|616208616|FG000|Overall Study|Required use of a prohibited medication|0|||
170509578|NCT04767529|616208617|FG001|Overall Study|Required use of a prohibited medication|1|||
170805691|NCT01276509|617299292|FG002|Overall Study|Adverse Event|4|||
170805692|NCT01276509|617299293|FG003|Overall Study|Adverse Event|3|||
170509579|NCT04767529|616208618|FG002|Overall Study|Required use of a prohibited medication|0|||
170805693|NCT01276509|617299290|FG000|Overall Study|Lack of Efficacy|2|||
170805694|NCT01276509|617299291|FG001|Overall Study|Lack of Efficacy|1|||
170805695|NCT01276509|617299292|FG002|Overall Study|Lack of Efficacy|1|||
170805696|NCT01276509|617299293|FG003|Overall Study|Lack of Efficacy|2|||
170805697|NCT01276509|617299290|FG000|Overall Study|Pregnancy|1|||
170805698|NCT01276509|617299291|FG001|Overall Study|Pregnancy|0|||
170805699|NCT01276509|617299292|FG002|Overall Study|Pregnancy|0|||
170805700|NCT01276509|617299293|FG003|Overall Study|Pregnancy|0|||
170805701|NCT01276509|617299290|FG000|Overall Study|Withdrawal by Subject|1|||
170805702|NCT01276509|617299291|FG001|Overall Study|Withdrawal by Subject|2|||
170805703|NCT01276509|617299292|FG002|Overall Study|Withdrawal by Subject|0|||
170805704|NCT01276509|617299293|FG003|Overall Study|Withdrawal by Subject|0|||
170805705|NCT01276509|617299290|FG000|Overall Study|Other|0|||
170805706|NCT01276509|617299291|FG001|Overall Study|Other|1|||
170805707|NCT01276509|617299292|FG002|Overall Study|Other|0|||
170805708|NCT01276509|617299293|FG003|Overall Study|Other|0|||
170509580|NCT04767529|616208616|FG000|Overall Study|Withdrawal by Subject|7|||
170509581|NCT04767529|616208617|FG001|Overall Study|Withdrawal by Subject|5|||
170509582|NCT04767529|616208618|FG002|Overall Study|Withdrawal by Subject|4|||
170509583|NCT04767529|616208616|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
170509584|NCT04767529|616208617|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
170509585|NCT04767529|616208618|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
170509586|NCT04767529|616208616|FG000|Overall Study|Lost to Follow-up|0|||
170509587|NCT04767529|616208617|FG001|Overall Study|Lost to Follow-up|2|||
170643261|NCT01864005|616708359|FG001|Overall Study|Disease need|1|||
170805709|NCT05349721|617299295|FG000|Part A (24 Weeks)|Adverse Event|9|||
170805710|NCT05349721|617299296|FG001|Part A (24 Weeks)|Adverse Event|2|||
170805711|NCT05349721|617299295|FG000|Part A (24 Weeks)|Death|8|||
170805712|NCT05349721|617299296|FG001|Part A (24 Weeks)|Death|3|||
170805713|NCT05349721|617299295|FG000|Part A (24 Weeks)|Disease Progression|1|||
170805714|NCT05349721|617299296|FG001|Part A (24 Weeks)|Disease Progression|1|||
170805715|NCT05349721|617299295|FG000|Part A (24 Weeks)|Screen Failure|2|||
170805716|NCT05349721|617299296|FG001|Part A (24 Weeks)|Screen Failure|0|||
170805717|NCT05349721|617299295|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
170805718|NCT05349721|617299296|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
170805719|NCT05349721|617299295|FG000|Part A (24 Weeks)|Other Than Specified|5|||
170805720|NCT05349721|617299296|FG001|Part A (24 Weeks)|Other Than Specified|1|||
170805721|NCT05349721|617299295|FG000|Part B (28 Weeks)|Adverse Event|3|||
170805722|NCT05349721|617299296|FG001|Part B (28 Weeks)|Adverse Event|0|||
170805723|NCT05349721|617299295|FG000|Part B (28 Weeks)|Death|21|||
170805724|NCT05349721|617299296|FG001|Part B (28 Weeks)|Death|11|||
170805725|NCT05349721|617299295|FG000|Part B (28 Weeks)|Disease Progression|2|||
170805726|NCT05349721|617299296|FG001|Part B (28 Weeks)|Disease Progression|1|||
170805727|NCT05349721|617299295|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
170805728|NCT05349721|617299296|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
170805729|NCT05349721|617299295|FG000|Part B (28 Weeks)|Physician Decision|1|||
170805730|NCT05349721|617299296|FG001|Part B (28 Weeks)|Physician Decision|0|||
170509588|NCT04767529|616208618|FG002|Overall Study|Lost to Follow-up|3|||
170509589|NCT04847232|616208619|FG000|Overall Study|Death|123|||
170509590|NCT04847232|616208620|FG001|Overall Study|Death|115|||
170509591|NCT04847232|616208619|FG000|Overall Study|Lost to Follow-up|3|||
170509592|NCT04847232|616208620|FG001|Overall Study|Lost to Follow-up|10|||
170509593|NCT04847232|616208619|FG000|Overall Study|Withdrawal by Subject|73|||
170509594|NCT04847232|616208620|FG001|Overall Study|Withdrawal by Subject|101|||
170509595|NCT04847232|616208619|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
170509596|NCT04847232|616208620|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
170509597|NCT04401202|616208621|FG000|Overall Study|Lost to Follow-up|2|||
170509598|NCT04401202|616208622|FG001|Overall Study|Lost to Follow-up|2|||
170509599|NCT04401202|616208621|FG000|Overall Study|Adverse Event|0|||
170509600|NCT04401202|616208622|FG001|Overall Study|Adverse Event|1|||
170509601|NCT04401202|616208621|FG000|Overall Study|Hospitalized|4|||
170509602|NCT04401202|616208622|FG001|Overall Study|Hospitalized|1|||
170509603|NCT05697627|616208625|FG000|Overall Study|Adverse Event|1|||
170509604|NCT04348500|616208626|FG000|Overall Study|Death|2|||
170509605|NCT04348500|616208627|FG001|Overall Study|Death|2|||
170509606|NCT04348500|616208626|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
170509607|NCT04348500|616208627|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
170509608|NCT00624832|616208628|FG000|Overall Study|Adverse Event|0|||
170805731|NCT05349721|617299295|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
170805732|NCT05349721|617299296|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
170805733|NCT05349721|617299295|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
170509609|NCT00624832|616208629|FG001|Overall Study|Adverse Event|1|||
170509610|NCT00624832|616208630|FG002|Overall Study|Adverse Event|0|||
170509611|NCT00624832|616208631|FG003|Overall Study|Adverse Event|1|||
170509612|NCT00624832|616208628|FG000|Overall Study|Abnormal Laboratory Value|2|||
170509613|NCT00624832|616208629|FG001|Overall Study|Abnormal Laboratory Value|0|||
170509614|NCT00624832|616208630|FG002|Overall Study|Abnormal Laboratory Value|0|||
170509615|NCT00624832|616208631|FG003|Overall Study|Abnormal Laboratory Value|0|||
170509616|NCT00703118|616208638|FG000|Overall Study|Adverse Event|1|||
170509617|NCT00703118|616208639|FG001|Overall Study|Adverse Event|2|||
170509618|NCT00703118|616208640|FG002|Overall Study|Adverse Event|2|||
170509619|NCT00703118|616208638|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
170509620|NCT00703118|616208639|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
170509621|NCT00703118|616208640|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
170509622|NCT00703118|616208638|FG000|Overall Study|Lost to Follow-up|6|||
170509623|NCT00703118|616208639|FG001|Overall Study|Lost to Follow-up|4|||
170509624|NCT00703118|616208640|FG002|Overall Study|Lost to Follow-up|4|||
170509625|NCT00703118|616208638|FG000|Overall Study|Withdrawal by Subject|8|||
170509626|NCT00703118|616208639|FG001|Overall Study|Withdrawal by Subject|7|||
170509627|NCT00703118|616208640|FG002|Overall Study|Withdrawal by Subject|13|||
170509628|NCT00703118|616208638|FG000|Overall Study|Other|0|||
170509629|NCT00703118|616208639|FG001|Overall Study|Other|0|||
170509630|NCT00703118|616208640|FG002|Overall Study|Other|1|||
170509631|NCT00530790|616208641|FG000|Overall Study|Adverse Event|2|||
170509632|NCT00530790|616208641|FG000|Overall Study|Withdrawal by Subject|2|||
170509633|NCT00530790|616208641|FG000|Overall Study|Physician Decision|1|||
170509634|NCT00002525|616208645|FG000|Overall Study|Adverse Event|36|||
170509635|NCT00002525|616208646|FG001|Overall Study|Adverse Event|0|||
170509636|NCT00002525|616208645|FG000|Overall Study|Death|5|||
170509637|NCT00002525|616208646|FG001|Overall Study|Death|0|||
170509638|NCT00002525|616208645|FG000|Overall Study|Withdrawal by Subject|11|||
170509639|NCT00002525|616208646|FG001|Overall Study|Withdrawal by Subject|0|||
170509640|NCT00002525|616208645|FG000|Overall Study|Start non-protocol therapy|1|||
170509641|NCT00002525|616208646|FG001|Overall Study|Start non-protocol therapy|0|||
170509642|NCT00002525|616208645|FG000|Overall Study|Other complicating disease|1|||
170509643|NCT00002525|616208646|FG001|Overall Study|Other complicating disease|0|||
170509644|NCT00002525|616208645|FG000|Overall Study|Duke's A, B1, D disease|92|||
170509645|NCT00002525|616208646|FG001|Overall Study|Duke's A, B1, D disease|0|||
170509646|NCT00002525|616208645|FG000|Overall Study|Error|6|||
170509647|NCT00002525|616208646|FG001|Overall Study|Error|0|||
170509648|NCT00002525|616208645|FG000|Overall Study|Other|26|||
170509649|NCT00002525|616208646|FG001|Overall Study|Other|0|||
170509650|NCT00002525|616208645|FG000|Overall Study|Never start protocol therapy|8|||
170509651|NCT00002525|616208646|FG001|Overall Study|Never start protocol therapy|0|||
170509652|NCT03304184|616208647|FG000|Overall Study|Withdrawal by Subject|1|||
170509653|NCT03304184|616208648|FG001|Overall Study|Withdrawal by Subject|2|||
170509654|NCT02334384|616208651|FG000|Overall Study|Lost to Follow-up|1|||
170509655|NCT02334384|616208652|FG001|Overall Study|Lost to Follow-up|1|||
170509656|NCT04527978|616208653|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
170509657|NCT04527978|616208654|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
170509658|NCT00090584|616208657|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
170509659|NCT00090584|616208658|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
170509660|NCT00090584|616208657|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
170509661|NCT00090584|616208658|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
170509662|NCT01578499|616208663|FG000|Overall Study|Reason not Specified|0|||
170509663|NCT01578499|616208664|FG001|Overall Study|Reason not Specified|1|||
170509664|NCT01578499|616208663|FG000|Overall Study|Lost to Follow-up|2|||
170509665|NCT01578499|616208664|FG001|Overall Study|Lost to Follow-up|1|||
170805734|NCT05349721|617299296|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
170805735|NCT05349721|617299295|FG000|Part B (28 Weeks)|Other Than Specified|4|||
170805736|NCT05349721|617299296|FG001|Part B (28 Weeks)|Other Than Specified|2|||
170805737|NCT05349721|617299295|FG000|Part C (108 Weeks)|Death|0|||
170805738|NCT05349721|617299296|FG001|Part C (108 Weeks)|Death|1|||
170805739|NCT05349721|617299295|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
170509666|NCT01578499|616208663|FG000|Overall Study|Withdrawal by Subject|10|||
170509667|NCT01578499|616208664|FG001|Overall Study|Withdrawal by Subject|16|||
170509668|NCT01578499|616208663|FG000|Overall Study|Death|20|||
170509669|NCT01578499|616208664|FG001|Overall Study|Death|25|||
170509670|NCT01578499|616208663|FG000|Overall Study|Died and End of Study Page not Completed|2|||
170509671|NCT01578499|616208664|FG001|Overall Study|Died and End of Study Page not Completed|0|||
170509672|NCT00508157|616208666|FG000|Overall Study|Adverse Event|0|||
170509673|NCT00508157|616208667|FG001|Overall Study|Adverse Event|1|||
170509674|NCT00508157|616208666|FG000|Overall Study|Subject Withdrew Consent|1|||
170509675|NCT00508157|616208667|FG001|Overall Study|Subject Withdrew Consent|0|||
170509676|NCT00508157|616208666|FG000|Overall Study|Lost to Follow-up|1|||
170509677|NCT00508157|616208667|FG001|Overall Study|Lost to Follow-up|0|||
170643262|NCT01864005|616708358|FG000|Overall Study|Need GP IIb/IIIa|1|||
170805740|NCT05349721|617299296|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
170509678|NCT00508157|616208666|FG000|Overall Study|Subject no longer met study criteria|0|||
170509679|NCT00508157|616208667|FG001|Overall Study|Subject no longer met study criteria|1|||
170509680|NCT00508157|616208666|FG000|Overall Study|Other known cause|0|||
170509681|NCT00508157|616208667|FG001|Overall Study|Other known cause|1|||
170509682|NCT01987232|616208670|FG000|Overall Study|Ongoing in Study|0|||
170509683|NCT01987232|616208671|FG001|Overall Study|Ongoing in Study|0|||
170509684|NCT01987232|616208672|FG002|Overall Study|Ongoing in Study|0|||
170509685|NCT01987232|616208673|FG003|Overall Study|Ongoing in Study|1|||
170509686|NCT01987232|616208674|FG004|Overall Study|Ongoing in Study|0|||
170509687|NCT03723070|616208688|FG000|Overall Study|Lost to Follow-up|2|||
170509688|NCT03723070|616208688|FG000|Overall Study|Physician Decision|1|||
170509689|NCT03723070|616208688|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
170509690|NCT00477607|616208689|FG000|Overall Study|Lost to Follow-up|7|||
170509691|NCT00477607|616208690|FG001|Overall Study|Lost to Follow-up|7|||
170509692|NCT00432276|616208691|FG000|Overall Study|Hyperglycemic Rescue|44|||
170509693|NCT00432276|616208692|FG001|Overall Study|Hyperglycemic Rescue|87|||
170509694|NCT00432276|616208691|FG000|Overall Study|Adverse Event|13|||
170509695|NCT00432276|616208692|FG001|Overall Study|Adverse Event|16|||
170509696|NCT00432276|616208691|FG000|Overall Study|Protocol Violation|25|||
170509697|NCT00432276|616208692|FG001|Overall Study|Protocol Violation|20|||
170509698|NCT00432276|616208691|FG000|Overall Study|Lost to Follow-up|6|||
170509699|NCT00432276|616208692|FG001|Overall Study|Lost to Follow-up|2|||
170509700|NCT00432276|616208691|FG000|Overall Study|Withdrawal by Subject|25|||
170509701|NCT00432276|616208692|FG001|Overall Study|Withdrawal by Subject|20|||
170643263|NCT01864005|616708359|FG001|Overall Study|Need GP IIb/IIIa|3|||
170643264|NCT00763698|616708360|FG000|Overall Study|Unsuccessful Implant|5|||
170643265|NCT00763698|616708360|FG000|Overall Study|Death|4|||
170805741|NCT05349721|617299295|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
170805742|NCT05349721|617299296|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
170805743|NCT05349721|617299295|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
170805744|NCT05349721|617299296|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
170805745|NCT02972034|617299298|FG000|Overall Study|Death|11|||
170509702|NCT00432276|616208691|FG000|Overall Study|Physician Decision|6|||
170509703|NCT00432276|616208692|FG001|Overall Study|Physician Decision|8|||
170509704|NCT00432276|616208691|FG000|Overall Study|Other|2|||
170509705|NCT00432276|616208692|FG001|Overall Study|Other|3|||
170805746|NCT02972034|617299299|FG001|Overall Study|Death|1|||
170805747|NCT02972034|617299300|FG002|Overall Study|Death|3|||
170805748|NCT02972034|617299301|FG003|Overall Study|Death|3|||
170805749|NCT02972034|617299302|FG004|Overall Study|Death|2|||
170805750|NCT02972034|617299303|FG005|Overall Study|Death|2|||
170805751|NCT02972034|617299304|FG006|Overall Study|Death|3|||
170805752|NCT02972034|617299305|FG007|Overall Study|Death|4|||
170805753|NCT02972034|617299306|FG008|Overall Study|Death|8|||
170805754|NCT02972034|617299307|FG009|Overall Study|Death|11|||
170805755|NCT02972034|617299308|FG010|Overall Study|Death|3|||
170805756|NCT02972034|617299309|FG011|Overall Study|Death|2|||
170805757|NCT02972034|617299310|FG012|Overall Study|Death|11|||
170509706|NCT00655681|616208693|FG000|Overall Study|Lost to Follow-up|1|||
170509707|NCT00655681|616208694|FG001|Overall Study|Lost to Follow-up|1|||
170509708|NCT00594386|616208695|FG000|Overall Study|Major protocol violation|2|||
170509709|NCT00594386|616208695|FG000|Overall Study|Lack of Efficacy|12|||
170509710|NCT00594386|616208695|FG000|Overall Study|Adverse Event|68|||
170509711|NCT00594386|616208695|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
170509712|NCT00594386|616208695|FG000|Overall Study|Subject withdrew consent|35|||
170509713|NCT00594386|616208695|FG000|Overall Study|Study ended per sponsor|115|||
170509714|NCT00594386|616208695|FG000|Overall Study|Lost to Follow-up|6|||
170509715|NCT00594386|616208695|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
170509716|NCT00594386|616208695|FG000|Overall Study|Other: Subject moved to Seattle|1|||
170509717|NCT00594386|616208695|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
170509718|NCT00594386|616208695|FG000|Overall Study|Other: Study terminated per investigator|2|||
170509719|NCT00594386|616208695|FG000|Overall Study|Other: Sponsor closure of study|1|||
170509720|NCT00594386|616208695|FG000|Overall Study|Other: Site terminated participation|1|||
170509721|NCT00594386|616208695|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
170509722|NCT00594386|616208695|FG000|Overall Study|Other: Loss of drivers license|1|||
170509723|NCT01210144|616208698|FG000|Overall Study|Lack of ovarian response|1|||
170509724|NCT01210144|616208699|FG001|Overall Study|Lack of ovarian response|0|||
170509725|NCT01210144|616208698|FG000|Overall Study|No fertilization|1|||
170509726|NCT01210144|616208699|FG001|Overall Study|No fertilization|0|||
170643266|NCT00763698|616708360|FG000|Overall Study|Withdrawal by Subject|1|||
170805758|NCT02972034|617299311|FG013|Overall Study|Death|10|||
170805759|NCT02972034|617299312|FG014|Overall Study|Death|9|||
170805760|NCT02972034|617299298|FG000|Overall Study|Lost to Follow-up|0|||
170805761|NCT02972034|617299299|FG001|Overall Study|Lost to Follow-up|0|||
170509727|NCT01210144|616208698|FG000|Overall Study|No transfer|1|||
170509728|NCT01210144|616208699|FG001|Overall Study|No transfer|0|||
170509729|NCT01783821|616208705|FG000|Overall Study|Screen Failure|1|||
170509730|NCT01783821|616208706|FG001|Overall Study|Screen Failure|1|||
170509731|NCT00866333|616208707|FG000|Overall Study|Withdrawal of consent|0|||
170509732|NCT00866333|616208708|FG001|Overall Study|Withdrawal of consent|1|||
170509733|NCT00866333|616208709|FG002|Overall Study|Withdrawal of consent|2|||
170509734|NCT00866333|616208707|FG000|Overall Study|Reason not Specified|3|||
170509735|NCT00866333|616208708|FG001|Overall Study|Reason not Specified|1|||
170509736|NCT00866333|616208709|FG002|Overall Study|Reason not Specified|1|||
170509737|NCT00866333|616208707|FG000|Overall Study|Study Terminated by Sponsor|2|||
170509738|NCT00866333|616208708|FG001|Overall Study|Study Terminated by Sponsor|5|||
170509739|NCT00866333|616208709|FG002|Overall Study|Study Terminated by Sponsor|9|||
170643267|NCT02184572|616708361|FG000|Overall Study|Lost to Follow-up|29|||
170509740|NCT00422292|616208710|FG000|Overall Study|Serious adverse events|1|||
170805762|NCT02972034|617299300|FG002|Overall Study|Lost to Follow-up|0|||
170805763|NCT02972034|617299301|FG003|Overall Study|Lost to Follow-up|0|||
170509741|NCT00422292|616208711|FG001|Overall Study|Serious adverse events|4|||
170643268|NCT02184572|616708362|FG001|Overall Study|Lost to Follow-up|21|||
170643269|NCT02184572|616708361|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
170643270|NCT02184572|616708362|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
170643271|NCT02184572|616708361|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
170643272|NCT02184572|616708362|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
170643273|NCT02184572|616708361|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
170643274|NCT02184572|616708362|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
170643275|NCT02184572|616708361|FG000|Overall Study|Traveling Outside The Country|1|||
170643276|NCT02184572|616708362|FG001|Overall Study|Traveling Outside The Country|0|||
170643277|NCT02184572|616708361|FG000|Overall Study|Withdrawal by Subject|14|||
170643278|NCT02184572|616708362|FG001|Overall Study|Withdrawal by Subject|9|||
170643279|NCT00964171|616708365|FG000|Overall Study|Death|5|||
170643280|NCT03091348|616708370|FG000|Overall Study|Lost to Follow-up|2|||
170643281|NCT03091348|616708371|FG001|Overall Study|Lost to Follow-up|1|||
170643282|NCT05334212|616708372|FG000|Overall Study|Study terminated prematurely|7|||
170643283|NCT01324401|616708376|FG000|Overall Study|Withdrawn before any treatment|0|||
170643284|NCT01324401|616708377|FG001|Overall Study|Withdrawn before any treatment|3|||
170643285|NCT01324401|616708376|FG000|Overall Study|Adverse Event|1|||
170643286|NCT01324401|616708377|FG001|Overall Study|Adverse Event|3|||
170643287|NCT01708902|616708380|FG000|Overall Study|Adverse Event|3|||
170643288|NCT01708902|616708381|FG001|Overall Study|Adverse Event|4|||
170643289|NCT01708902|616708382|FG002|Overall Study|Adverse Event|9|||
170643290|NCT01708902|616708383|FG003|Overall Study|Adverse Event|2|||
170643291|NCT01708902|616708384|FG004|Overall Study|Adverse Event|7|||
170643292|NCT01708902|616708385|FG005|Overall Study|Adverse Event|3|||
170643293|NCT01708902|616708386|FG006|Overall Study|Adverse Event|5|||
170643294|NCT01708902|616708380|FG000|Overall Study|Lack of Efficacy|3|||
170643295|NCT01708902|616708381|FG001|Overall Study|Lack of Efficacy|1|||
170643296|NCT01708902|616708382|FG002|Overall Study|Lack of Efficacy|0|||
170643297|NCT01708902|616708383|FG003|Overall Study|Lack of Efficacy|0|||
170643298|NCT01708902|616708384|FG004|Overall Study|Lack of Efficacy|0|||
170643299|NCT01708902|616708385|FG005|Overall Study|Lack of Efficacy|1|||
170643300|NCT01708902|616708386|FG006|Overall Study|Lack of Efficacy|0|||
170643301|NCT01708902|616708380|FG000|Overall Study|Non compliance with protocol|0|||
170643302|NCT01708902|616708381|FG001|Overall Study|Non compliance with protocol|2|||
170643303|NCT01708902|616708382|FG002|Overall Study|Non compliance with protocol|1|||
170643304|NCT01708902|616708383|FG003|Overall Study|Non compliance with protocol|3|||
170643305|NCT01708902|616708384|FG004|Overall Study|Non compliance with protocol|0|||
170643306|NCT01708902|616708385|FG005|Overall Study|Non compliance with protocol|0|||
170643307|NCT01708902|616708386|FG006|Overall Study|Non compliance with protocol|0|||
170643308|NCT01708902|616708380|FG000|Overall Study|Lost to Follow-up|2|||
170643309|NCT01708902|616708381|FG001|Overall Study|Lost to Follow-up|1|||
170643310|NCT01708902|616708382|FG002|Overall Study|Lost to Follow-up|2|||
170643311|NCT01708902|616708383|FG003|Overall Study|Lost to Follow-up|2|||
170643312|NCT01708902|616708384|FG004|Overall Study|Lost to Follow-up|0|||
170643313|NCT01708902|616708385|FG005|Overall Study|Lost to Follow-up|0|||
170643314|NCT01708902|616708386|FG006|Overall Study|Lost to Follow-up|1|||
170643315|NCT01708902|616708380|FG000|Overall Study|Refused to continue trial medication|8|||
170643316|NCT01708902|616708381|FG001|Overall Study|Refused to continue trial medication|0|||
170643317|NCT01708902|616708382|FG002|Overall Study|Refused to continue trial medication|4|||
170643318|NCT01708902|616708383|FG003|Overall Study|Refused to continue trial medication|2|||
170643319|NCT01708902|616708384|FG004|Overall Study|Refused to continue trial medication|8|||
170643320|NCT01708902|616708385|FG005|Overall Study|Refused to continue trial medication|1|||
170643321|NCT01708902|616708386|FG006|Overall Study|Refused to continue trial medication|1|||
170643322|NCT01708902|616708380|FG000|Overall Study|Other Reason|1|||
170643323|NCT01708902|616708381|FG001|Overall Study|Other Reason|0|||
170643324|NCT01708902|616708382|FG002|Overall Study|Other Reason|1|||
170643325|NCT01708902|616708383|FG003|Overall Study|Other Reason|1|||
170643326|NCT01708902|616708384|FG004|Overall Study|Other Reason|1|||
170643327|NCT01708902|616708385|FG005|Overall Study|Other Reason|2|||
170643328|NCT01708902|616708386|FG006|Overall Study|Other Reason|0|||
170805764|NCT02972034|617299302|FG004|Overall Study|Lost to Follow-up|1|||
170805765|NCT02972034|617299303|FG005|Overall Study|Lost to Follow-up|0|||
170805766|NCT02972034|617299304|FG006|Overall Study|Lost to Follow-up|0|||
170805767|NCT02972034|617299305|FG007|Overall Study|Lost to Follow-up|1|||
170805768|NCT02972034|617299306|FG008|Overall Study|Lost to Follow-up|0|||
170643329|NCT01014910|616708387|FG000|Overall Study|Withdrawal by Subject|0|||
170643330|NCT01014910|616708388|FG001|Overall Study|Withdrawal by Subject|2|||
170643331|NCT03753789|616708389|FG000|Overall Study|Withdrawal by Subject|2|||
170643332|NCT00853567|616708393|FG000|Overall Study|Study prematurely terminated|71|||
170643333|NCT02055118|616708394|FG000|Overall Study|Withdrawal by Subject|0|||
170643334|NCT02055118|616708395|FG001|Overall Study|Withdrawal by Subject|2|||
170643335|NCT02055118|616708396|FG002|Overall Study|Withdrawal by Subject|0|||
170643336|NCT01818752|616708397|FG000|Overall Study|Adverse Event|64|||
170643337|NCT01818752|616708398|FG001|Overall Study|Adverse Event|74|||
170805769|NCT02972034|617299307|FG009|Overall Study|Lost to Follow-up|0|||
170509742|NCT00422292|616208712|FG002|Overall Study|Serious adverse events|0|||
170509743|NCT00422292|616208713|FG003|Overall Study|Serious adverse events|0|||
170509744|NCT00422292|616208710|FG000|Overall Study|Adverse Event|1|||
170509745|NCT00422292|616208711|FG001|Overall Study|Adverse Event|0|||
170509746|NCT00422292|616208712|FG002|Overall Study|Adverse Event|1|||
170509747|NCT00422292|616208713|FG003|Overall Study|Adverse Event|0|||
170509748|NCT00422292|616208710|FG000|Overall Study|Protocol Violation|4|||
170509749|NCT00422292|616208711|FG001|Overall Study|Protocol Violation|25|||
170509750|NCT00422292|616208712|FG002|Overall Study|Protocol Violation|8|||
170643338|NCT01818752|616708397|FG000|Overall Study|Death|14|||
170643339|NCT01818752|616708398|FG001|Overall Study|Death|18|||
170643340|NCT01818752|616708397|FG000|Overall Study|Non-compliance|16|||
170643341|NCT01818752|616708398|FG001|Overall Study|Non-compliance|20|||
170643342|NCT01818752|616708397|FG000|Overall Study|Withdrawal by Subject|15|||
170643343|NCT01818752|616708398|FG001|Overall Study|Withdrawal by Subject|14|||
170643344|NCT01818752|616708397|FG000|Overall Study|Physician Decision|9|||
170643345|NCT01818752|616708398|FG001|Overall Study|Physician Decision|8|||
170643346|NCT01818752|616708397|FG000|Overall Study|Disease Progression|54|||
170643347|NCT01818752|616708398|FG001|Overall Study|Disease Progression|48|||
170643348|NCT01818752|616708397|FG000|Overall Study|Other|7|||
170643349|NCT01818752|616708398|FG001|Overall Study|Other|8|||
170643350|NCT01818752|616708397|FG000|Overall Study|Continuing Treatment|1|||
170643351|NCT01818752|616708398|FG001|Overall Study|Continuing Treatment|4|||
170643352|NCT01818752|616708397|FG000|Overall Study|Randomized but not Dosed|7|||
170643353|NCT01818752|616708398|FG001|Overall Study|Randomized but not Dosed|4|||
170643354|NCT01584440|616708399|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
170643355|NCT01584440|616708400|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
170643356|NCT01584440|616708401|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
170643357|NCT01584440|616708402|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
170643358|NCT01584440|616708403|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
170643359|NCT01584440|616708399|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
170643360|NCT01584440|616708400|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
170643361|NCT01584440|616708401|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
170643362|NCT01584440|616708402|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
170643363|NCT01584440|616708403|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
170643364|NCT01584440|616708399|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
170643365|NCT01584440|616708400|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
170643366|NCT01584440|616708401|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
170643367|NCT01584440|616708402|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
170643368|NCT01584440|616708403|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
170643369|NCT01584440|616708399|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
170643370|NCT01584440|616708400|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
170643371|NCT01584440|616708401|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
170643372|NCT01584440|616708402|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
170643373|NCT01584440|616708403|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
170643374|NCT01584440|616708399|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
170643375|NCT01584440|616708400|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
170643376|NCT01584440|616708401|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
170643377|NCT01584440|616708402|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
170643378|NCT01584440|616708403|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
170643379|NCT01584440|616708399|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
170643380|NCT01584440|616708400|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
170643381|NCT01584440|616708401|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
170805770|NCT02972034|617299308|FG010|Overall Study|Lost to Follow-up|0|||
170805771|NCT02972034|617299309|FG011|Overall Study|Lost to Follow-up|0|||
170805772|NCT02972034|617299310|FG012|Overall Study|Lost to Follow-up|0|||
170805773|NCT02972034|617299311|FG013|Overall Study|Lost to Follow-up|0|||
170805774|NCT02972034|617299312|FG014|Overall Study|Lost to Follow-up|1|||
170805775|NCT02972034|617299298|FG000|Overall Study|Physician Decision|0|||
170805776|NCT02972034|617299299|FG001|Overall Study|Physician Decision|0|||
170805777|NCT02972034|617299300|FG002|Overall Study|Physician Decision|0|||
170805778|NCT02972034|617299301|FG003|Overall Study|Physician Decision|0|||
170805779|NCT02972034|617299302|FG004|Overall Study|Physician Decision|0|||
170643382|NCT01584440|616708402|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
170643383|NCT01584440|616708403|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
170643384|NCT01584440|616708399|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
170643385|NCT01584440|616708400|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
170509751|NCT00422292|616208713|FG003|Overall Study|Protocol Violation|5|||
170643386|NCT01584440|616708401|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
170643387|NCT01584440|616708402|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
170643388|NCT01584440|616708403|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
170643389|NCT01584440|616708399|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
170643390|NCT01584440|616708400|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
170643391|NCT01584440|616708401|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
170643392|NCT01584440|616708402|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
170643393|NCT01584440|616708403|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
170805780|NCT02972034|617299303|FG005|Overall Study|Physician Decision|0|||
170643394|NCT01584440|616708399|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
170643395|NCT01584440|616708400|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
170643396|NCT01584440|616708401|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
170643397|NCT01584440|616708402|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
170643398|NCT01584440|616708403|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
170643399|NCT03212144|616708404|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
170643400|NCT03212144|616708405|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
170643401|NCT03212144|616708404|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
170643402|NCT03212144|616708405|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
170643403|NCT01338298|616708409|FG000|Overall Study|Withdrawal by Subject|1|||
170643404|NCT01338298|616708410|FG001|Overall Study|Withdrawal by Subject|1|||
170643405|NCT01338298|616708409|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
170643406|NCT01338298|616708410|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
170643407|NCT01338298|616708409|FG000|Overall Study|Administrative error|0|||
170643408|NCT01338298|616708410|FG001|Overall Study|Administrative error|1|||
170643409|NCT01338298|616708409|FG000|Overall Study|Positive symptom worsening|1|||
170643410|NCT01338298|616708410|FG001|Overall Study|Positive symptom worsening|0|||
170643411|NCT01338298|616708409|FG000|Overall Study|Depressive symptoms and nausea|1|||
170643412|NCT01338298|616708410|FG001|Overall Study|Depressive symptoms and nausea|0|||
170643413|NCT01338298|616708409|FG000|Overall Study|Non-adherence|1|||
170643414|NCT01338298|616708410|FG001|Overall Study|Non-adherence|0|||
170643415|NCT02872285|616708411|FG000|Overall Study|Withdrawal by Subject|2|||
170643416|NCT02872285|616708412|FG001|Overall Study|Withdrawal by Subject|0|||
170643417|NCT02872285|616708411|FG000|Overall Study|Lost to Follow-up|2|||
170643418|NCT02872285|616708412|FG001|Overall Study|Lost to Follow-up|2|||
170643419|NCT02872285|616708411|FG000|Overall Study|Discontinued due to back surgery|1|||
170643420|NCT02872285|616708412|FG001|Overall Study|Discontinued due to back surgery|0|||
170643421|NCT00531427|616708413|FG000|Overall Study|Withdrawal by Subject|7|||
170643422|NCT00531427|616708414|FG001|Overall Study|Withdrawal by Subject|13|||
170643423|NCT00531427|616708413|FG000|Overall Study|Adverse Event|44|||
170643424|NCT00531427|616708414|FG001|Overall Study|Adverse Event|30|||
170643425|NCT00531427|616708413|FG000|Overall Study|Lost to Follow-up|4|||
170643426|NCT00531427|616708414|FG001|Overall Study|Lost to Follow-up|3|||
170643427|NCT00531427|616708413|FG000|Overall Study|Lack of Efficacy|14|||
170643428|NCT00531427|616708414|FG001|Overall Study|Lack of Efficacy|39|||
170643429|NCT00531427|616708413|FG000|Overall Study|Administrative|4|||
170643430|NCT00531427|616708414|FG001|Overall Study|Administrative|9|||
170643431|NCT04189224|616708416|FG000|Period 2|Adverse Event|0|||
170643432|NCT04189224|616708417|FG001|Period 2|Adverse Event|1|||
170643433|NCT05688670|616708418|FG000|Overall Study|Change in surgery plan|1|||
170643434|NCT05688670|616708419|FG001|Overall Study|Change in surgery plan|4|||
170643435|NCT05688670|616708418|FG000|Overall Study|Inability to extubate|1|||
170643436|NCT05688670|616708419|FG001|Overall Study|Inability to extubate|2|||
170643437|NCT05688670|616708418|FG000|Overall Study|Day of surgery cancellation|0|||
170643438|NCT05688670|616708419|FG001|Overall Study|Day of surgery cancellation|1|||
170643439|NCT05688670|616708418|FG000|Overall Study|Reintubated on PCICU arrival|0|||
170643440|NCT05688670|616708419|FG001|Overall Study|Reintubated on PCICU arrival|1|||
170643441|NCT00488683|616708420|FG000|Overall Study|Withdrawal by Subject|1|||
170643442|NCT00488683|616708421|FG001|Overall Study|Withdrawal by Subject|2|||
170643443|NCT00488683|616708422|FG002|Overall Study|Withdrawal by Subject|2|||
170643444|NCT00488683|616708420|FG000|Overall Study|Lost to Follow-up|5|||
170643445|NCT00488683|616708421|FG001|Overall Study|Lost to Follow-up|3|||
170643446|NCT00488683|616708422|FG002|Overall Study|Lost to Follow-up|0|||
170643447|NCT00488683|616708420|FG000|Overall Study|Protocol Violation|5|||
170643448|NCT00488683|616708421|FG001|Overall Study|Protocol Violation|1|||
170643449|NCT00488683|616708422|FG002|Overall Study|Protocol Violation|0|||
170643450|NCT00488683|616708420|FG000|Overall Study|Unable to Classify|1|||
170643451|NCT00488683|616708421|FG001|Overall Study|Unable to Classify|0|||
170643452|NCT00488683|616708422|FG002|Overall Study|Unable to Classify|0|||
170643453|NCT03374202|616708423|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
170643454|NCT03374202|616708424|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
170643455|NCT03374202|616708425|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
170643456|NCT03374202|616708423|FG000|Five Year Long Term Follow Up|Death|0|||
170643457|NCT03374202|616708424|FG001|Five Year Long Term Follow Up|Death|1|||
170643458|NCT03374202|616708425|FG002|Five Year Long Term Follow Up|Death|0|||
170643459|NCT00336856|616710034|FG000|Overall Study|Withdrawal by Subject|3|||
170643460|NCT00336856|616710034|FG000|Overall Study|Found ineligible at time of analysis|1|||
170643461|NCT02151773|616710035|FG000|Overall Study|Protocol Deviation|64|||
170643462|NCT01767142|616710036|FG000|Overall Study|Lost to Follow-up|3|||
170643463|NCT03317405|616710041|FG000|Overall Study|Withdrawal by Subject|1|||
170643464|NCT03317405|616710042|FG001|Overall Study|Withdrawal by Subject|0|||
170643465|NCT03317405|616710043|FG002|Overall Study|Withdrawal by Subject|0|||
170643466|NCT03317405|616710041|FG000|Overall Study|Physician Decision|0|||
170643467|NCT03317405|616710042|FG001|Overall Study|Physician Decision|0|||
170643468|NCT03317405|616710043|FG002|Overall Study|Physician Decision|1|||
170509752|NCT00422292|616208710|FG000|Overall Study|Lost to Follow-up|6|||
170509753|NCT00422292|616208711|FG001|Overall Study|Lost to Follow-up|12|||
170509754|NCT00422292|616208712|FG002|Overall Study|Lost to Follow-up|6|||
170643469|NCT03317405|616710041|FG000|Overall Study|Surgery Rescheduled|0|||
170643470|NCT03317405|616710042|FG001|Overall Study|Surgery Rescheduled|1|||
170643471|NCT03317405|616710043|FG002|Overall Study|Surgery Rescheduled|0|||
170643472|NCT00635219|616710044|FG000|Overall Study|Adverse Event|12|||
170643473|NCT00635219|616710045|FG001|Overall Study|Adverse Event|10|||
170643474|NCT00635219|616710046|FG002|Overall Study|Adverse Event|18|||
170643475|NCT00635219|616710047|FG003|Overall Study|Adverse Event|15|||
170643476|NCT00635219|616710048|FG004|Overall Study|Adverse Event|19|||
170643477|NCT00635219|616710044|FG000|Overall Study|Lack of Efficacy|5|||
170643478|NCT00635219|616710045|FG001|Overall Study|Lack of Efficacy|6|||
170643479|NCT00635219|616710046|FG002|Overall Study|Lack of Efficacy|3|||
170643480|NCT00635219|616710047|FG003|Overall Study|Lack of Efficacy|4|||
170643481|NCT00635219|616710048|FG004|Overall Study|Lack of Efficacy|6|||
170643482|NCT00635219|616710044|FG000|Overall Study|Non-compliance With Study Product|0|||
170643483|NCT00635219|616710045|FG001|Overall Study|Non-compliance With Study Product|0|||
170643484|NCT00635219|616710046|FG002|Overall Study|Non-compliance With Study Product|0|||
170643485|NCT00635219|616710047|FG003|Overall Study|Non-compliance With Study Product|2|||
170643486|NCT00635219|616710048|FG004|Overall Study|Non-compliance With Study Product|1|||
170643487|NCT00635219|616710044|FG000|Overall Study|Protocol Violation|0|||
170643488|NCT00635219|616710045|FG001|Overall Study|Protocol Violation|2|||
170643489|NCT00635219|616710046|FG002|Overall Study|Protocol Violation|3|||
170643490|NCT00635219|616710047|FG003|Overall Study|Protocol Violation|2|||
170643491|NCT00635219|616710048|FG004|Overall Study|Protocol Violation|4|||
170643492|NCT00635219|616710044|FG000|Overall Study|Withdrawal of Consent|8|||
170643493|NCT00635219|616710045|FG001|Overall Study|Withdrawal of Consent|6|||
170643494|NCT00635219|616710046|FG002|Overall Study|Withdrawal of Consent|8|||
170643495|NCT00635219|616710047|FG003|Overall Study|Withdrawal of Consent|11|||
170643496|NCT00635219|616710048|FG004|Overall Study|Withdrawal of Consent|8|||
170643497|NCT00635219|616710044|FG000|Overall Study|Lost to Follow-up|0|||
170643498|NCT00635219|616710045|FG001|Overall Study|Lost to Follow-up|0|||
170643499|NCT00635219|616710046|FG002|Overall Study|Lost to Follow-up|2|||
170643500|NCT00635219|616710047|FG003|Overall Study|Lost to Follow-up|0|||
170643501|NCT00635219|616710048|FG004|Overall Study|Lost to Follow-up|3|||
170643502|NCT00635219|616710044|FG000|Overall Study|Administrative or Other Reasons|0|||
170643503|NCT00635219|616710045|FG001|Overall Study|Administrative or Other Reasons|1|||
170643504|NCT00635219|616710046|FG002|Overall Study|Administrative or Other Reasons|1|||
170643505|NCT00635219|616710047|FG003|Overall Study|Administrative or Other Reasons|0|||
170643506|NCT00635219|616710048|FG004|Overall Study|Administrative or Other Reasons|1|||
170643507|NCT01598129|616710057|FG000|Overall Study|Disease progression|6|||
170643508|NCT01598129|616710057|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
170643509|NCT01598129|616710057|FG000|Overall Study|Withdrawal by Subject|1|||
170643510|NCT00505076|616710058|FG000|Overall Study|Adverse Event|1|||
170643511|NCT00505076|616710059|FG001|Overall Study|Adverse Event|0|||
170643512|NCT00505076|616710060|FG002|Overall Study|Adverse Event|1|||
170643513|NCT00505076|616710058|FG000|Overall Study|Protocol Violation|2|||
170643514|NCT00505076|616710059|FG001|Overall Study|Protocol Violation|1|||
170643515|NCT00505076|616710060|FG002|Overall Study|Protocol Violation|2|||
170643516|NCT00505076|616710058|FG000|Overall Study|Withdrawal by Subject|0|||
170509755|NCT00422292|616208713|FG003|Overall Study|Lost to Follow-up|6|||
170643517|NCT00505076|616710059|FG001|Overall Study|Withdrawal by Subject|1|||
170643518|NCT00505076|616710060|FG002|Overall Study|Withdrawal by Subject|2|||
170643519|NCT04093024|616710061|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
170646063|NCT01628029|616717882|FG003|Overall Study|Incomplete primary outcome assessment|0|||
170509756|NCT00422292|616208710|FG000|Overall Study|Withdrawal by Subject|6|||
170509757|NCT00422292|616208711|FG001|Overall Study|Withdrawal by Subject|25|||
170509758|NCT00422292|616208712|FG002|Overall Study|Withdrawal by Subject|7|||
170509759|NCT00422292|616208713|FG003|Overall Study|Withdrawal by Subject|13|||
170509760|NCT02440854|616208714|FG000|Overall Study|Relocation of patient|1|||
170509761|NCT02440854|616208714|FG000|Overall Study|Death|6|||
170509762|NCT02440854|616208714|FG000|Overall Study|Lost to Follow-up|10|||
170509763|NCT02440854|616208714|FG000|Overall Study|Afatinib discontinuation|46|||
170509764|NCT02440854|616208714|FG000|Overall Study|stopped study at earlier timepoint|14|||
170509765|NCT02440854|616208714|FG000|Overall Study|Study medication not received|1|||
170805781|NCT02972034|617299304|FG006|Overall Study|Physician Decision|0|||
170805782|NCT02972034|617299305|FG007|Overall Study|Physician Decision|1|||
170805783|NCT02972034|617299306|FG008|Overall Study|Physician Decision|0|||
170805784|NCT02972034|617299307|FG009|Overall Study|Physician Decision|0|||
170805785|NCT02972034|617299308|FG010|Overall Study|Physician Decision|1|||
170805786|NCT02972034|617299309|FG011|Overall Study|Physician Decision|0|||
170805787|NCT02972034|617299310|FG012|Overall Study|Physician Decision|0|||
170805788|NCT02972034|617299311|FG013|Overall Study|Physician Decision|0|||
170805789|NCT02972034|617299312|FG014|Overall Study|Physician Decision|0|||
170805790|NCT02972034|617299298|FG000|Overall Study|Sponsor Decision|0|||
170805791|NCT02972034|617299299|FG001|Overall Study|Sponsor Decision|0|||
170805792|NCT02972034|617299300|FG002|Overall Study|Sponsor Decision|0|||
170805793|NCT02972034|617299301|FG003|Overall Study|Sponsor Decision|1|||
170805794|NCT02972034|617299302|FG004|Overall Study|Sponsor Decision|0|||
170805795|NCT02972034|617299303|FG005|Overall Study|Sponsor Decision|0|||
170805796|NCT02972034|617299304|FG006|Overall Study|Sponsor Decision|1|||
170805797|NCT02972034|617299305|FG007|Overall Study|Sponsor Decision|1|||
170805798|NCT02972034|617299306|FG008|Overall Study|Sponsor Decision|1|||
170805799|NCT02972034|617299307|FG009|Overall Study|Sponsor Decision|2|||
170805800|NCT02972034|617299308|FG010|Overall Study|Sponsor Decision|2|||
170805801|NCT02972034|617299309|FG011|Overall Study|Sponsor Decision|0|||
170805802|NCT02972034|617299310|FG012|Overall Study|Sponsor Decision|1|||
170805803|NCT02972034|617299311|FG013|Overall Study|Sponsor Decision|0|||
170904310|NCT01486264|617652299|FG000|Overall Study|Withdrawal by Subject|7|||
170904311|NCT01486264|617652300|FG001|Overall Study|Withdrawal by Subject|18|||
170904312|NCT01486264|617652299|FG000|Overall Study|Physician Decision|1|||
170904313|NCT01486264|617652300|FG001|Overall Study|Physician Decision|1|||
170509766|NCT02440854|616208714|FG000|Overall Study|Violation of inclusion criteria|2|||
170509767|NCT00385827|616210489|FG000|Part 1|Adverse Event|1|||
170509768|NCT00385827|616210490|FG001|Part 1|Adverse Event|0|||
170509769|NCT00385827|616210491|FG002|Part 1|Adverse Event|0|||
170509770|NCT00385827|616210489|FG000|Part 1|Death|2|||
170509771|NCT00385827|616210490|FG001|Part 1|Death|0|||
170509772|NCT00385827|616210491|FG002|Part 1|Death|0|||
170509773|NCT00385827|616210489|FG000|Part 1|Lack of Efficacy|5|||
170509774|NCT00385827|616210490|FG001|Part 1|Lack of Efficacy|0|||
170509775|NCT00385827|616210491|FG002|Part 1|Lack of Efficacy|0|||
170509776|NCT00385827|616210489|FG000|Part 1|Other|1|||
170509777|NCT00385827|616210490|FG001|Part 1|Other|0|||
170509778|NCT00385827|616210491|FG002|Part 1|Other|0|||
170509779|NCT00385827|616210489|FG000|Part 2|Adverse Event|0|||
170509780|NCT00385827|616210490|FG001|Part 2|Adverse Event|6|||
170509781|NCT00385827|616210491|FG002|Part 2|Adverse Event|10|||
170509782|NCT00385827|616210489|FG000|Part 2|Death|0|||
170509783|NCT00385827|616210490|FG001|Part 2|Death|0|||
170509784|NCT00385827|616210491|FG002|Part 2|Death|2|||
170509785|NCT00385827|616210489|FG000|Part 2|Lack of Efficacy|0|||
170509786|NCT00385827|616210490|FG001|Part 2|Lack of Efficacy|14|||
170509787|NCT00385827|616210491|FG002|Part 2|Lack of Efficacy|13|||
170509788|NCT00385827|616210489|FG000|Part 2|Randomized but not treated|0|||
170509789|NCT00385827|616210490|FG001|Part 2|Randomized but not treated|2|||
170509790|NCT00385827|616210491|FG002|Part 2|Randomized but not treated|2|||
170509791|NCT00385827|616210489|FG000|Part 2|Other|0|||
170509792|NCT00385827|616210490|FG001|Part 2|Other|11|||
170509793|NCT00385827|616210491|FG002|Part 2|Other|21|||
170509794|NCT00582426|616210502|FG000|Overall Study|Lost to Follow-up|0|||
170509795|NCT00582426|616210503|FG001|Overall Study|Lost to Follow-up|2|||
170509796|NCT00582426|616210502|FG000|Overall Study|Adverse Event|4|||
170509797|NCT00582426|616210503|FG001|Overall Study|Adverse Event|2|||
170509798|NCT00582426|616210502|FG000|Overall Study|Protocol Violation|6|||
170509799|NCT00582426|616210503|FG001|Overall Study|Protocol Violation|2|||
170509800|NCT00582426|616210502|FG000|Overall Study|Death|4|||
170509801|NCT00582426|616210503|FG001|Overall Study|Death|3|||
170509802|NCT00582426|616210502|FG000|Overall Study|Withdrawal by Subject|3|||
170509803|NCT00582426|616210503|FG001|Overall Study|Withdrawal by Subject|2|||
170509804|NCT00582426|616210502|FG000|Overall Study|Disease Progression|2|||
170509805|NCT00582426|616210503|FG001|Overall Study|Disease Progression|2|||
170509806|NCT00582426|616210502|FG000|Overall Study|Use of illicit drugs|1|||
170509807|NCT00582426|616210503|FG001|Overall Study|Use of illicit drugs|0|||
170509808|NCT02164318|616210506|FG000|Overall Study|Withdrawal by Subject|0|||
170509809|NCT02164318|616210507|FG001|Overall Study|Withdrawal by Subject|1|||
170509810|NCT02164318|616210508|FG002|Overall Study|Withdrawal by Subject|0|||
170643520|NCT04093024|616710062|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
170643521|NCT04093024|616710061|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
170643522|NCT04093024|616710062|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
170643523|NCT04093024|616710061|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
170643524|NCT04093024|616710062|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
170643525|NCT04093024|616710061|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
170643526|NCT04093024|616710062|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
170643527|NCT00591318|616710063|FG000|Overall Study|Lack of Efficacy|2|||
170643528|NCT00591318|616710064|FG001|Overall Study|Lack of Efficacy|0|||
170643529|NCT00591318|616710063|FG000|Overall Study|Adverse Event|2|||
170643530|NCT00591318|616710064|FG001|Overall Study|Adverse Event|0|||
170643531|NCT00647270|616710069|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
170643532|NCT00647270|616710070|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
170643533|NCT00647270|616710071|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
170643534|NCT00647270|616710069|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
170643535|NCT00647270|616710070|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
170643536|NCT00647270|616710071|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
170643537|NCT00647270|616710069|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
170643538|NCT00647270|616710070|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
170643539|NCT00647270|616710071|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
170643540|NCT00647270|616710069|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
170643541|NCT00647270|616710070|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
170643542|NCT00647270|616710071|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
170643543|NCT00647270|616710069|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
170643544|NCT00647270|616710070|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
170643545|NCT00647270|616710071|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
170643546|NCT00647270|616710069|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
170643547|NCT00647270|616710070|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
170643548|NCT00647270|616710071|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
170643549|NCT00647270|616710069|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
170643550|NCT00647270|616710070|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
170643551|NCT00647270|616710071|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
170643552|NCT03615040|616710072|FG000|Overall Study|Withdrawal by Subject|2|||
170643553|NCT03615040|616710073|FG001|Overall Study|Withdrawal by Subject|1|||
170643554|NCT03615040|616710072|FG000|Overall Study|Physician Decision|2|||
170643555|NCT03615040|616710073|FG001|Overall Study|Physician Decision|2|||
170643556|NCT03615040|616710072|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
170643557|NCT03615040|616710073|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
170643558|NCT03615040|616710072|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
170643559|NCT03615040|616710073|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
170643560|NCT03615040|616710072|FG000|Overall Study|Death|0|||
170643561|NCT03615040|616710073|FG001|Overall Study|Death|2|||
170643562|NCT01541397|616710074|FG000|Overall Study|Study ended prior to data collection|4|||
170643563|NCT01541397|616710075|FG001|Overall Study|Study ended prior to data collection|2|||
170643564|NCT01128621|616710078|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
170643565|NCT01128621|616710079|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
170643566|NCT00233454|616710080|FG000|Overall Study|Death|6|||
170643567|NCT04224688|616710081|FG000|Overall Study|Withdrawal by Subject|1|||
170643568|NCT04224688|616710082|FG001|Overall Study|Withdrawal by Subject|3|||
170643569|NCT04224688|616710081|FG000|Overall Study|Lack of Efficacy|1|||
170805804|NCT02972034|617299312|FG014|Overall Study|Sponsor Decision|1|||
170805805|NCT02972034|617299298|FG000|Overall Study|Withdrawal by Subject|3|||
170805806|NCT02972034|617299299|FG001|Overall Study|Withdrawal by Subject|0|||
170805807|NCT02972034|617299300|FG002|Overall Study|Withdrawal by Subject|0|||
170805808|NCT02972034|617299301|FG003|Overall Study|Withdrawal by Subject|0|||
170805809|NCT02972034|617299302|FG004|Overall Study|Withdrawal by Subject|1|||
170805810|NCT02972034|617299303|FG005|Overall Study|Withdrawal by Subject|1|||
170805811|NCT02972034|617299304|FG006|Overall Study|Withdrawal by Subject|0|||
170805812|NCT02972034|617299305|FG007|Overall Study|Withdrawal by Subject|0|||
170805813|NCT02972034|617299306|FG008|Overall Study|Withdrawal by Subject|1|||
170805814|NCT02972034|617299307|FG009|Overall Study|Withdrawal by Subject|1|||
170805815|NCT02972034|617299308|FG010|Overall Study|Withdrawal by Subject|2|||
170805816|NCT02972034|617299309|FG011|Overall Study|Withdrawal by Subject|1|||
170805817|NCT02972034|617299310|FG012|Overall Study|Withdrawal by Subject|1|||
170805818|NCT02972034|617299311|FG013|Overall Study|Withdrawal by Subject|1|||
170805819|NCT02972034|617299312|FG014|Overall Study|Withdrawal by Subject|0|||
170805820|NCT02972034|617299298|FG000|Overall Study|Screen Failure|0|||
170805821|NCT02972034|617299299|FG001|Overall Study|Screen Failure|0|||
170805822|NCT02972034|617299300|FG002|Overall Study|Screen Failure|0|||
170509811|NCT02164318|616210509|FG003|Overall Study|Withdrawal by Subject|1|||
170509812|NCT00662311|616210510|FG000|Overall Study|Respiratory Infection|1|||
170509813|NCT00662311|616210511|FG001|Overall Study|Respiratory Infection|0|||
170509814|NCT00662311|616210512|FG002|Overall Study|Respiratory Infection|0|||
170509815|NCT04727528|616210513|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
170509816|NCT04727528|616210514|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
170509817|NCT04727528|616210513|FG000|Open-label Period|Randomized who did not receive treatment|1|||
170509818|NCT04727528|616210514|FG001|Open-label Period|Randomized who did not receive treatment|0|||
170509819|NCT04727528|616210513|FG000|Double-blind Treatment Phase|Adverse Event|0|||
170509820|NCT04727528|616210514|FG001|Double-blind Treatment Phase|Adverse Event|1|||
170509821|NCT04727528|616210513|FG000|Double-blind Treatment Phase|Death|0|||
170509822|NCT04727528|616210514|FG001|Double-blind Treatment Phase|Death|1|||
170509823|NCT04727528|616210513|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
170509824|NCT04727528|616210514|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
170509825|NCT04727528|616210513|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
170509826|NCT04727528|616210514|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
170509827|NCT04727528|616210513|FG000|Double-blind Treatment Phase|Physician Decision|0|||
170509828|NCT04727528|616210514|FG001|Double-blind Treatment Phase|Physician Decision|1|||
170509829|NCT04727528|616210513|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
170509830|NCT04727528|616210514|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170509831|NCT01467271|616210516|FG000|Overall Study|Death|84|||
170509832|NCT01467271|616210516|FG000|Overall Study|Lost to Follow-up|83|||
170509833|NCT01467271|616210516|FG000|Overall Study|Retraction of patient's consent|21|||
170509834|NCT01467271|616210516|FG000|Overall Study|Other reason|14|||
170509835|NCT02335346|616210517|FG000|Overall Study|Adverse Event|11|||
170509836|NCT02335346|616210517|FG000|Overall Study|Withdrawal by Subject|1|||
170509837|NCT03300050|616210519|FG000|Overall Study|Lost to Follow-up|2|||
170509838|NCT03300050|616210520|FG001|Overall Study|Lost to Follow-up|1|||
170509839|NCT03300050|616210521|FG002|Overall Study|Lost to Follow-up|0|||
170509840|NCT03300050|616210522|FG003|Overall Study|Lost to Follow-up|0|||
170509841|NCT03300050|616210523|FG004|Overall Study|Lost to Follow-up|1|||
170509842|NCT03300050|616210519|FG000|Overall Study|Withdrawal by Subject|1|||
170509843|NCT03300050|616210520|FG001|Overall Study|Withdrawal by Subject|1|||
170509844|NCT03300050|616210521|FG002|Overall Study|Withdrawal by Subject|1|||
170509845|NCT03300050|616210522|FG003|Overall Study|Withdrawal by Subject|0|||
170509846|NCT03300050|616210523|FG004|Overall Study|Withdrawal by Subject|0|||
170509847|NCT03300050|616210519|FG000|Overall Study|Death|0|||
170509848|NCT03300050|616210520|FG001|Overall Study|Death|0|||
170509849|NCT03300050|616210521|FG002|Overall Study|Death|1|||
170509850|NCT03300050|616210522|FG003|Overall Study|Death|0|||
170509851|NCT03300050|616210523|FG004|Overall Study|Death|0|||
170509852|NCT03300050|616210519|FG000|Overall Study|Not Eligible at Randomization|0|||
170509853|NCT03300050|616210520|FG001|Overall Study|Not Eligible at Randomization|0|||
170509854|NCT03300050|616210521|FG002|Overall Study|Not Eligible at Randomization|1|||
170509855|NCT03300050|616210522|FG003|Overall Study|Not Eligible at Randomization|1|||
170509856|NCT03300050|616210523|FG004|Overall Study|Not Eligible at Randomization|0|||
170509857|NCT01411319|616210528|FG000|Overall Study|Lost to Follow-up|1|||
170509858|NCT01964989|616210529|FG000|Overall Study|Protocol Violation|3|||
170509859|NCT01964989|616210530|FG001|Overall Study|Protocol Violation|4|||
170509860|NCT01964989|616210529|FG000|Overall Study|Administrative Reason|103|||
170509861|NCT01964989|616210530|FG001|Overall Study|Administrative Reason|95|||
170509862|NCT01964989|616210529|FG000|Overall Study|Adverse Event|0|||
170509863|NCT01964989|616210530|FG001|Overall Study|Adverse Event|1|||
170509864|NCT01964989|616210529|FG000|Overall Study|Death|1|||
170553260|NCT01362530|616371855|FG001|Base Study (Cycle 1)|Adverse Event|0|||
170553261|NCT01362530|616371854|FG000|Base Study (Cycle 1)|Physician Decision|0|||
170553262|NCT01362530|616371855|FG001|Base Study (Cycle 1)|Physician Decision|1|||
170553263|NCT01362530|616371854|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
170509865|NCT01964989|616210530|FG001|Overall Study|Death|3|||
170509866|NCT01964989|616210529|FG000|Overall Study|Withdrawal by Subject|156|||
170553264|NCT01362530|616371855|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
170509867|NCT01964989|616210530|FG001|Overall Study|Withdrawal by Subject|160|||
170509868|NCT01964989|616210529|FG000|Overall Study|Lost to Follow-up|254|||
170509869|NCT01964989|616210530|FG001|Overall Study|Lost to Follow-up|232|||
170509870|NCT01964989|616210529|FG000|Overall Study|Other|267|||
170509871|NCT01964989|616210530|FG001|Overall Study|Other|252|||
170904314|NCT01486264|617652299|FG000|Overall Study|Protocol Violation|3|||
170904315|NCT01486264|617652300|FG001|Overall Study|Protocol Violation|0|||
170904316|NCT01486264|617652299|FG000|Overall Study|Lost to Follow-up|3|||
170904317|NCT01486264|617652300|FG001|Overall Study|Lost to Follow-up|2|||
170904318|NCT01486264|617652299|FG000|Overall Study|Other|5|||
170904319|NCT01486264|617652300|FG001|Overall Study|Other|11|||
170904320|NCT01486264|617652299|FG000|Overall Study|Not treated|0|||
170904321|NCT01486264|617652300|FG001|Overall Study|Not treated|1|||
170904322|NCT04927312|617652301|FG000|Overall Study|Adverse Event|1|||
170904323|NCT04927312|617652301|FG000|Overall Study|Death|1|||
170904324|NCT04927312|617652301|FG000|Overall Study|Withdrawal by Subject|1|||
170904325|NCT04927312|617652301|FG000|Overall Study|Other|1|||
170904326|NCT03168867|617652302|FG000|Overall Study|Withdrawal by Subject|1|||
170904327|NCT03168867|617652303|FG001|Overall Study|Withdrawal by Subject|5|||
170904328|NCT00509106|617652305|FG000|Overall Study|Adverse Event|3|||
170904329|NCT00509106|617652306|FG001|Overall Study|Adverse Event|2|||
170904330|NCT00509106|617652305|FG000|Overall Study|Noncompliance|0|||
170509872|NCT02769312|616210531|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
170509873|NCT02769312|616210532|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
170509874|NCT02769312|616210531|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
170509875|NCT02769312|616210532|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
170509876|NCT02769312|616210531|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
170509877|NCT02769312|616210532|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
170509878|NCT02769312|616210531|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
170509879|NCT02769312|616210532|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
170509880|NCT02769312|616210531|FG000|Follow-up|Lost to Follow-up|1|||
170509881|NCT02769312|616210532|FG001|Follow-up|Lost to Follow-up|1|||
170509882|NCT02815267|616210533|FG000|Double-Blind Phase|Adverse Event|0|||
170509883|NCT02815267|616210534|FG001|Double-Blind Phase|Adverse Event|3|||
170509884|NCT02815267|616210533|FG000|Double-Blind Phase|Lost to Follow-up|17|||
170553265|NCT01362530|616371854|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
170805823|NCT02972034|617299301|FG003|Overall Study|Screen Failure|0|||
170805824|NCT02972034|617299302|FG004|Overall Study|Screen Failure|0|||
170805825|NCT02972034|617299303|FG005|Overall Study|Screen Failure|0|||
170805826|NCT02972034|617299304|FG006|Overall Study|Screen Failure|0|||
170805827|NCT02972034|617299305|FG007|Overall Study|Screen Failure|0|||
170805828|NCT02972034|617299306|FG008|Overall Study|Screen Failure|0|||
170805829|NCT02972034|617299307|FG009|Overall Study|Screen Failure|0|||
170805830|NCT02972034|617299308|FG010|Overall Study|Screen Failure|0|||
170805831|NCT02972034|617299309|FG011|Overall Study|Screen Failure|0|||
170805832|NCT02972034|617299310|FG012|Overall Study|Screen Failure|1|||
170805833|NCT02972034|617299311|FG013|Overall Study|Screen Failure|0|||
170805834|NCT02972034|617299312|FG014|Overall Study|Screen Failure|0|||
170805835|NCT03861052|617299313|FG000|Overall Study|Adverse Event|1|||
170805836|NCT03861052|617299314|FG001|Overall Study|Adverse Event|1|||
170805837|NCT03861052|617299315|FG002|Overall Study|Adverse Event|2|||
170805838|NCT03861052|617299316|FG003|Overall Study|Adverse Event|4|||
170805839|NCT03861052|617299313|FG000|Overall Study|Lost to Follow-up|0|||
170805840|NCT03861052|617299314|FG001|Overall Study|Lost to Follow-up|0|||
170805841|NCT03861052|617299315|FG002|Overall Study|Lost to Follow-up|0|||
170805842|NCT03861052|617299316|FG003|Overall Study|Lost to Follow-up|1|||
170805843|NCT03861052|617299313|FG000|Overall Study|Physician Decision|0|||
170805844|NCT03861052|617299314|FG001|Overall Study|Physician Decision|1|||
170805845|NCT03861052|617299315|FG002|Overall Study|Physician Decision|0|||
170805846|NCT03861052|617299316|FG003|Overall Study|Physician Decision|0|||
170805847|NCT03861052|617299313|FG000|Overall Study|Withdrawal by Subject|2|||
170805848|NCT03861052|617299314|FG001|Overall Study|Withdrawal by Subject|5|||
170805849|NCT03861052|617299315|FG002|Overall Study|Withdrawal by Subject|3|||
170805850|NCT03861052|617299316|FG003|Overall Study|Withdrawal by Subject|0|||
170805851|NCT03861052|617299313|FG000|Overall Study|Relocation to other city|1|||
170805852|NCT03861052|617299314|FG001|Overall Study|Relocation to other city|0|||
170805853|NCT03861052|617299315|FG002|Overall Study|Relocation to other city|0|||
170805854|NCT03861052|617299316|FG003|Overall Study|Relocation to other city|0|||
170904331|NCT00509106|617652306|FG001|Overall Study|Noncompliance|1|||
170904332|NCT00509106|617652305|FG000|Overall Study|At the request of sponsor/investigator|1|||
170553266|NCT01362530|616371855|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
170805855|NCT03009344|617299317|FG000|Overall Study|Lack of Efficacy|5|||
170805856|NCT03009344|617299317|FG000|Overall Study|Withdrawal by Subject|1|||
170805857|NCT03009344|617299317|FG000|Overall Study|Adverse Event|1|||
170509885|NCT02815267|616210534|FG001|Double-Blind Phase|Lost to Follow-up|9|||
170509886|NCT02815267|616210533|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
170509887|NCT02815267|616210534|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
170509888|NCT02815267|616210533|FG000|Double-Blind Phase|Protocol Violation|3|||
170509889|NCT02815267|616210534|FG001|Double-Blind Phase|Protocol Violation|2|||
170509890|NCT02815267|616210533|FG000|Double-Blind Phase|Site withdrawal|1|||
170509891|NCT02815267|616210534|FG001|Double-Blind Phase|Site withdrawal|6|||
170509892|NCT02815267|616210533|FG000|Double-Blind Phase|Received a disallowed medication|1|||
170509893|NCT02815267|616210534|FG001|Double-Blind Phase|Received a disallowed medication|1|||
170509894|NCT02815267|616210533|FG000|Open-Label Phase|Adverse Event|1|||
170553267|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
170553268|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
170553269|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
170553270|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
170553271|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
170553272|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
170553273|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
170553274|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
170553275|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
170553276|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
170553277|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
170553278|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
170553279|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
170553280|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
170553281|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
170553282|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
170553283|NCT01362530|616371854|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
170553284|NCT01362530|616371855|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
170553285|NCT01034657|616371856|FG000|Core Phase|Withdrawal by Subject|1|||
170553286|NCT01034657|616371857|FG001|Core Phase|Withdrawal by Subject|0|||
170553287|NCT01034657|616371858|FG002|Core Phase|Withdrawal by Subject|0|||
170553288|NCT01034657|616371856|FG000|Core Phase|Lack of Efficacy|2|||
170553289|NCT01034657|616371857|FG001|Core Phase|Lack of Efficacy|0|||
170553290|NCT01034657|616371858|FG002|Core Phase|Lack of Efficacy|0|||
170553291|NCT01034657|616371856|FG000|Core Phase|Abnormal laboratory value|1|||
170553292|NCT01034657|616371857|FG001|Core Phase|Abnormal laboratory value|0|||
170553293|NCT01034657|616371858|FG002|Core Phase|Abnormal laboratory value|0|||
170553294|NCT01034657|616371856|FG000|Core Phase|Adverse Event|8|||
170553295|NCT01034657|616371857|FG001|Core Phase|Adverse Event|0|||
170553296|NCT01034657|616371858|FG002|Core Phase|Adverse Event|0|||
170553297|NCT01034657|616371856|FG000|Core Phase|Protocol Violation|2|||
170553298|NCT01034657|616371857|FG001|Core Phase|Protocol Violation|0|||
170553299|NCT01034657|616371858|FG002|Core Phase|Protocol Violation|0|||
170553300|NCT01034657|616371856|FG000|Randomized Phase|Withdrawal by Subject|0|||
170553301|NCT01034657|616371857|FG001|Randomized Phase|Withdrawal by Subject|2|||
170553302|NCT01034657|616371858|FG002|Randomized Phase|Withdrawal by Subject|0|||
170553303|NCT01034657|616371856|FG000|Randomized Phase|Lack of Efficacy|5|||
170553304|NCT01034657|616371857|FG001|Randomized Phase|Lack of Efficacy|1|||
170553305|NCT01034657|616371858|FG002|Randomized Phase|Lack of Efficacy|0|||
170553306|NCT01034657|616371856|FG000|Randomized Phase|Abnormal laboratory value|0|||
170553307|NCT01034657|616371857|FG001|Randomized Phase|Abnormal laboratory value|1|||
170553308|NCT01034657|616371858|FG002|Randomized Phase|Abnormal laboratory value|0|||
170553309|NCT01034657|616371856|FG000|Randomized Phase|Adverse Event|0|||
170553310|NCT01034657|616371857|FG001|Randomized Phase|Adverse Event|2|||
170553311|NCT01034657|616371858|FG002|Randomized Phase|Adverse Event|1|||
170553312|NCT01772693|616371859|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
170553313|NCT01772693|616371860|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
170553314|NCT01772693|616371859|FG000|Overall Study|Withdrawal by Subject|2|||
170553315|NCT01772693|616371860|FG001|Overall Study|Withdrawal by Subject|0|||
170553316|NCT01772693|616371859|FG000|Overall Study|Alternative Treatment|2|||
170553317|NCT01772693|616371860|FG001|Overall Study|Alternative Treatment|0|||
170553318|NCT01225952|616371873|FG000|Overall Study|Lost to Follow-up|1|||
170553319|NCT01225952|616371874|FG001|Overall Study|Lost to Follow-up|0|||
170553320|NCT01225952|616371875|FG002|Overall Study|Lost to Follow-up|0|||
170553321|NCT01225952|616371873|FG000|Overall Study|Study Eye Explanted|0|||
170553322|NCT01225952|616371874|FG001|Overall Study|Study Eye Explanted|0|||
170553323|NCT01225952|616371875|FG002|Overall Study|Study Eye Explanted|1|||
170553324|NCT01225952|616371873|FG000|Overall Study|Withdrawal by Subject|4|||
170553325|NCT01225952|616371874|FG001|Overall Study|Withdrawal by Subject|4|||
170553326|NCT01225952|616371875|FG002|Overall Study|Withdrawal by Subject|5|||
170553327|NCT01225952|616371873|FG000|Overall Study|Surgical complications|1|||
170553328|NCT01225952|616371874|FG001|Overall Study|Surgical complications|0|||
170643570|NCT04224688|616710082|FG001|Overall Study|Lack of Efficacy|1|||
170643571|NCT04224688|616710081|FG000|Overall Study|Adverse event, not fatal|0|||
170643572|NCT04224688|616710082|FG001|Overall Study|Adverse event, not fatal|2|||
170643573|NCT04224688|616710081|FG000|Overall Study|COVID-19|0|||
170643574|NCT04224688|616710082|FG001|Overall Study|COVID-19|1|||
170643575|NCT04074161|616710083|FG000|Overall Study|Withdrawal by Subject|2|||
170643576|NCT04074161|616710084|FG001|Overall Study|Withdrawal by Subject|4|||
170643577|NCT04074161|616710085|FG002|Overall Study|Withdrawal by Subject|1|||
170643578|NCT04074161|616710083|FG000|Overall Study|Lost to Follow-up|4|||
170553329|NCT01225952|616371875|FG002|Overall Study|Surgical complications|0|||
170553330|NCT00889005|616371876|FG000|Overall Study|Lost to Follow-up|4|||
170553331|NCT00889005|616371877|FG001|Overall Study|Lost to Follow-up|2|||
170553332|NCT00889005|616371876|FG000|Overall Study|Withdrawal by Subject|4|||
170553333|NCT00889005|616371877|FG001|Overall Study|Withdrawal by Subject|0|||
170553334|NCT01347086|616371884|FG000|Overall Study|failed screening visit|0|||
170553335|NCT01347086|616371885|FG001|Overall Study|failed screening visit|0|||
170553336|NCT01347086|616371886|FG002|Overall Study|failed screening visit|1|||
170553337|NCT01347086|616371887|FG003|Overall Study|failed screening visit|0|||
170643579|NCT04074161|616710084|FG001|Overall Study|Lost to Follow-up|5|||
170643580|NCT04074161|616710085|FG002|Overall Study|Lost to Follow-up|3|||
170643581|NCT01024309|616710088|FG000|Overall Study|Physician Decision|4|||
170643582|NCT01024309|616710089|FG001|Overall Study|Physician Decision|0|||
170643583|NCT01024309|616710088|FG000|Overall Study|Withdrawal by Subject|4|||
170643584|NCT01024309|616710089|FG001|Overall Study|Withdrawal by Subject|4|||
170643585|NCT02059291|616710091|FG000|Epoch 2|Lack of Efficacy|0|||
170643586|NCT02059291|616710092|FG001|Epoch 2|Lack of Efficacy|0|||
170643587|NCT02059291|616710093|FG002|Epoch 2|Lack of Efficacy|0|||
170643588|NCT02059291|616710094|FG003|Epoch 2|Lack of Efficacy|1|||
170643589|NCT02059291|616710095|FG004|Epoch 2|Lack of Efficacy|0|||
170643590|NCT02059291|616710096|FG005|Epoch 2|Lack of Efficacy|1|||
170643591|NCT02059291|616710097|FG006|Epoch 2|Lack of Efficacy|0|||
170643592|NCT02059291|616710098|FG007|Epoch 2|Lack of Efficacy|0|||
170643593|NCT02059291|616710099|FG008|Epoch 2|Lack of Efficacy|0|||
170643594|NCT02059291|616710100|FG009|Epoch 2|Lack of Efficacy|0|||
170643595|NCT02059291|616710101|FG010|Epoch 2|Lack of Efficacy|0|||
170643596|NCT02059291|616710102|FG011|Epoch 2|Lack of Efficacy|0|||
170643597|NCT02059291|616710103|FG012|Epoch 2|Lack of Efficacy|0|||
170643598|NCT02059291|616710104|FG013|Epoch 2|Lack of Efficacy|0|||
170643599|NCT02059291|616710105|FG014|Epoch 2|Lack of Efficacy|0|||
170643600|NCT02059291|616710106|FG015|Epoch 2|Lack of Efficacy|0|||
170643601|NCT02059291|616710107|FG016|Epoch 2|Lack of Efficacy|0|||
170643602|NCT02059291|616710108|FG017|Epoch 2|Lack of Efficacy|0|||
170643603|NCT02059291|616710109|FG018|Epoch 2|Lack of Efficacy|0|||
170643604|NCT02059291|616710110|FG019|Epoch 2|Lack of Efficacy|0|||
170643605|NCT02059291|616710111|FG020|Epoch 2|Lack of Efficacy|0|||
170643606|NCT02059291|616710112|FG021|Epoch 2|Lack of Efficacy|0|||
170643607|NCT02059291|616710113|FG022|Epoch 2|Lack of Efficacy|0|||
170643608|NCT02059291|616710114|FG023|Epoch 2|Lack of Efficacy|0|||
170643609|NCT02059291|616710115|FG024|Epoch 2|Lack of Efficacy|0|||
170643610|NCT02059291|616710091|FG000|Epoch 2|Adverse Event|0|||
170643611|NCT02059291|616710092|FG001|Epoch 2|Adverse Event|0|||
170643612|NCT02059291|616710093|FG002|Epoch 2|Adverse Event|1|||
170643613|NCT02059291|616710094|FG003|Epoch 2|Adverse Event|1|||
170643614|NCT02059291|616710095|FG004|Epoch 2|Adverse Event|0|||
170643615|NCT02059291|616710096|FG005|Epoch 2|Adverse Event|0|||
170643616|NCT02059291|616710097|FG006|Epoch 2|Adverse Event|0|||
170643617|NCT02059291|616710098|FG007|Epoch 2|Adverse Event|1|||
170643618|NCT02059291|616710099|FG008|Epoch 2|Adverse Event|1|||
170643619|NCT02059291|616710100|FG009|Epoch 2|Adverse Event|0|||
170643620|NCT02059291|616710101|FG010|Epoch 2|Adverse Event|0|||
170643621|NCT02059291|616710102|FG011|Epoch 2|Adverse Event|0|||
170643622|NCT02059291|616710103|FG012|Epoch 2|Adverse Event|0|||
170643623|NCT02059291|616710104|FG013|Epoch 2|Adverse Event|0|||
170643624|NCT02059291|616710105|FG014|Epoch 2|Adverse Event|0|||
170643625|NCT02059291|616710106|FG015|Epoch 2|Adverse Event|0|||
170643626|NCT02059291|616710107|FG016|Epoch 2|Adverse Event|0|||
170643627|NCT02059291|616710108|FG017|Epoch 2|Adverse Event|0|||
170643628|NCT02059291|616710109|FG018|Epoch 2|Adverse Event|0|||
170643629|NCT02059291|616710110|FG019|Epoch 2|Adverse Event|0|||
170643630|NCT02059291|616710111|FG020|Epoch 2|Adverse Event|0|||
170643631|NCT02059291|616710112|FG021|Epoch 2|Adverse Event|0|||
170643632|NCT02059291|616710113|FG022|Epoch 2|Adverse Event|0|||
170643633|NCT02059291|616710114|FG023|Epoch 2|Adverse Event|0|||
170643634|NCT02059291|616710115|FG024|Epoch 2|Adverse Event|0|||
170643635|NCT02059291|616710091|FG000|Epoch 2|Withdrawal by Subject|0|||
170643636|NCT02059291|616710092|FG001|Epoch 2|Withdrawal by Subject|1|||
170643637|NCT02059291|616710093|FG002|Epoch 2|Withdrawal by Subject|0|||
170643638|NCT02059291|616710094|FG003|Epoch 2|Withdrawal by Subject|0|||
170643639|NCT02059291|616710095|FG004|Epoch 2|Withdrawal by Subject|0|||
170643640|NCT02059291|616710096|FG005|Epoch 2|Withdrawal by Subject|1|||
170643641|NCT02059291|616710097|FG006|Epoch 2|Withdrawal by Subject|0|||
170643642|NCT02059291|616710098|FG007|Epoch 2|Withdrawal by Subject|0|||
170643643|NCT02059291|616710099|FG008|Epoch 2|Withdrawal by Subject|1|||
170643644|NCT02059291|616710100|FG009|Epoch 2|Withdrawal by Subject|0|||
170643645|NCT02059291|616710101|FG010|Epoch 2|Withdrawal by Subject|0|||
170643646|NCT02059291|616710102|FG011|Epoch 2|Withdrawal by Subject|0|||
170643647|NCT02059291|616710103|FG012|Epoch 2|Withdrawal by Subject|0|||
170643648|NCT02059291|616710104|FG013|Epoch 2|Withdrawal by Subject|0|||
170643649|NCT02059291|616710105|FG014|Epoch 2|Withdrawal by Subject|0|||
170643650|NCT02059291|616710106|FG015|Epoch 2|Withdrawal by Subject|0|||
170643651|NCT02059291|616710107|FG016|Epoch 2|Withdrawal by Subject|0|||
170643652|NCT02059291|616710108|FG017|Epoch 2|Withdrawal by Subject|0|||
170643653|NCT02059291|616710109|FG018|Epoch 2|Withdrawal by Subject|0|||
170643654|NCT02059291|616710110|FG019|Epoch 2|Withdrawal by Subject|0|||
170643655|NCT02059291|616710111|FG020|Epoch 2|Withdrawal by Subject|0|||
170643656|NCT02059291|616710112|FG021|Epoch 2|Withdrawal by Subject|0|||
170643657|NCT02059291|616710113|FG022|Epoch 2|Withdrawal by Subject|0|||
170643658|NCT02059291|616710114|FG023|Epoch 2|Withdrawal by Subject|0|||
170643659|NCT02059291|616710115|FG024|Epoch 2|Withdrawal by Subject|0|||
170643660|NCT02059291|616710091|FG000|Epoch 3|Physician Decision|0|||
170643661|NCT02059291|616710092|FG001|Epoch 3|Physician Decision|0|||
170643662|NCT02059291|616710093|FG002|Epoch 3|Physician Decision|0|||
170643663|NCT02059291|616710094|FG003|Epoch 3|Physician Decision|0|||
170643664|NCT02059291|616710095|FG004|Epoch 3|Physician Decision|0|||
170643665|NCT02059291|616710096|FG005|Epoch 3|Physician Decision|0|||
170643666|NCT02059291|616710097|FG006|Epoch 3|Physician Decision|0|||
170509895|NCT02815267|616210534|FG001|Open-Label Phase|Adverse Event|1|||
170509896|NCT02815267|616210533|FG000|Open-Label Phase|Lost to Follow-up|23|||
170509897|NCT02815267|616210534|FG001|Open-Label Phase|Lost to Follow-up|9|||
170553338|NCT01347086|616371888|FG004|Overall Study|failed screening visit|0|||
170553339|NCT01347086|616371889|FG005|Overall Study|failed screening visit|0|||
170553340|NCT01347086|616371890|FG006|Overall Study|failed screening visit|1|||
170553341|NCT01347086|616371891|FG007|Overall Study|failed screening visit|1|||
170553342|NCT01347086|616371892|FG008|Overall Study|failed screening visit|0|||
170553343|NCT01347086|616371893|FG009|Overall Study|failed screening visit|1|||
170553344|NCT03766906|616371894|FG000|Overall Study|Withdrawal by Subject|6|||
170553345|NCT01437189|616371895|FG000|Overall Study|Adverse Event|3|||
170553346|NCT01437189|616371895|FG000|Overall Study|Lack of Efficacy|4|||
170553347|NCT01437189|616371895|FG000|Overall Study|Withdrawal by Subject|8|||
170553348|NCT03032484|616371896|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
170553349|NCT03032484|616371897|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
170553350|NCT03032484|616371896|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
170553351|NCT03032484|616371897|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
170553352|NCT01689649|616371898|FG000|Overall Study|Lack of Efficacy|3|||
170553353|NCT01689649|616371898|FG000|Overall Study|Non-compliance|11|||
170553354|NCT01689649|616371898|FG000|Overall Study|Protocol Violation|3|||
170553355|NCT01689649|616371898|FG000|Overall Study|Lost to Follow-up|5|||
170553356|NCT00835549|616371899|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
170553357|NCT00835549|616371900|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
170553358|NCT04893811|616371901|FG000|Vaccination Phase|Death|1|||
170553359|NCT04893811|616371902|FG001|Vaccination Phase|Death|0|||
170553360|NCT04893811|616371901|FG000|Vaccination Phase|Lost to Follow-up|1|||
170553361|NCT04893811|616371902|FG001|Vaccination Phase|Lost to Follow-up|1|||
170553362|NCT04893811|616371901|FG000|Vaccination Phase|Protocol Violation|2|||
170553363|NCT04893811|616371902|FG001|Vaccination Phase|Protocol Violation|0|||
170553364|NCT04893811|616371901|FG000|Vaccination Phase|Withdrawal by Subject|2|||
170553365|NCT04893811|616371902|FG001|Vaccination Phase|Withdrawal by Subject|1|||
170553366|NCT04893811|616371901|FG000|Vaccination Phase|Other|0|||
170553367|NCT04893811|616371902|FG001|Vaccination Phase|Other|1|||
170553368|NCT04893811|616371901|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
170553369|NCT04893811|616371902|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
170553370|NCT04893811|616371901|FG000|Follow-up Phase|Lost to Follow-up|0|||
170553371|NCT04893811|616371902|FG001|Follow-up Phase|Lost to Follow-up|1|||
170553372|NCT03268499|616371903|FG000|Overall Study|Withdrawal by Subject|2|||
170553373|NCT03268499|616371904|FG001|Overall Study|Withdrawal by Subject|1|||
170553374|NCT05524948|616371911|FG000|Overall Study|Withdrawal by Subject|1|||
170553375|NCT05524948|616371912|FG001|Overall Study|Withdrawal by Subject|0|||
170553376|NCT05524948|616371911|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
170553377|NCT05524948|616371912|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
170553378|NCT00595075|616371915|FG000|Overall Study|Withdrawal by Subject|1|||
170553379|NCT00595075|616371916|FG001|Overall Study|Withdrawal by Subject|0|||
170553380|NCT05261490|616371918|FG000|Overall Study|Other|1|||
170553381|NCT05261490|616371919|FG001|Overall Study|Other|0|||
170553382|NCT05261490|616371920|FG002|Overall Study|Other|0|||
170553383|NCT05261490|616371918|FG000|Overall Study|Study Terminated by Sponsor|1|||
170553384|NCT05261490|616371919|FG001|Overall Study|Study Terminated by Sponsor|1|||
170553385|NCT05261490|616371920|FG002|Overall Study|Study Terminated by Sponsor|4|||
170553386|NCT05261490|616371918|FG000|Overall Study|Death|1|||
170553387|NCT05261490|616371919|FG001|Overall Study|Death|2|||
170553388|NCT05261490|616371920|FG002|Overall Study|Death|0|||
170553389|NCT01260311|616371922|FG000|Overall Study|Adverse Event|11|||
170553390|NCT01260311|616371922|FG000|Overall Study|Lack of Efficacy|4|||
170553391|NCT01260311|616371922|FG000|Overall Study|Lost to Follow-up|25|||
170553392|NCT01260311|616371922|FG000|Overall Study|Withdrawal by Subject|6|||
170553393|NCT01260311|616371922|FG000|Overall Study|Financial Constraints|77|||
170553394|NCT01260311|616371922|FG000|Overall Study|Gone to Province|2|||
170553395|NCT01260311|616371922|FG000|Overall Study|Medication Stopped|1|||
170553396|NCT01260311|616371922|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
170553397|NCT02395627|616371927|FG000|Overall Study|Withdrawal by Subject|0|||
170553398|NCT02395627|616371928|FG001|Overall Study|Withdrawal by Subject|2|||
170553399|NCT02395627|616371929|FG002|Overall Study|Withdrawal by Subject|0|||
170643667|NCT02059291|616710098|FG007|Epoch 3|Physician Decision|0|||
170643668|NCT02059291|616710099|FG008|Epoch 3|Physician Decision|0|||
170553400|NCT02395627|616371927|FG000|Overall Study|Did not receive pembrolizumab|3|||
170553401|NCT02395627|616371928|FG001|Overall Study|Did not receive pembrolizumab|1|||
170643669|NCT02059291|616710100|FG009|Epoch 3|Physician Decision|0|||
170553402|NCT02395627|616371929|FG002|Overall Study|Did not receive pembrolizumab|0|||
170553403|NCT03253627|616371930|FG000|Overall Study|Lost to Follow-up|1|||
170553404|NCT03253627|616371931|FG001|Overall Study|Lost to Follow-up|2|||
170553405|NCT03253627|616371930|FG000|Overall Study|Withdrawal by Subject|0|||
170553406|NCT03253627|616371931|FG001|Overall Study|Withdrawal by Subject|2|||
170553407|NCT03253627|616371930|FG000|Overall Study|Inability to complete MRI|1|||
170553408|NCT03253627|616371931|FG001|Overall Study|Inability to complete MRI|0|||
170553409|NCT02554474|616371934|FG000|Overall Study|Protocol Violation|1|||
170553410|NCT02554474|616371935|FG001|Overall Study|Protocol Violation|1|||
170643670|NCT02059291|616710101|FG010|Epoch 3|Physician Decision|0|||
170643671|NCT02059291|616710102|FG011|Epoch 3|Physician Decision|0|||
170643672|NCT02059291|616710103|FG012|Epoch 3|Physician Decision|0|||
170643673|NCT02059291|616710104|FG013|Epoch 3|Physician Decision|1|||
170643674|NCT02059291|616710105|FG014|Epoch 3|Physician Decision|0|||
170643675|NCT02059291|616710106|FG015|Epoch 3|Physician Decision|1|||
170643676|NCT02059291|616710107|FG016|Epoch 3|Physician Decision|0|||
170643677|NCT02059291|616710108|FG017|Epoch 3|Physician Decision|0|||
170643678|NCT02059291|616710109|FG018|Epoch 3|Physician Decision|0|||
170643679|NCT02059291|616710110|FG019|Epoch 3|Physician Decision|0|||
170643680|NCT02059291|616710111|FG020|Epoch 3|Physician Decision|0|||
170643681|NCT02059291|616710112|FG021|Epoch 3|Physician Decision|0|||
170643682|NCT02059291|616710113|FG022|Epoch 3|Physician Decision|0|||
170643683|NCT02059291|616710114|FG023|Epoch 3|Physician Decision|0|||
170643684|NCT02059291|616710115|FG024|Epoch 3|Physician Decision|0|||
170643685|NCT02059291|616710091|FG000|Epoch 3|Adverse Event|0|||
170643686|NCT02059291|616710092|FG001|Epoch 3|Adverse Event|0|||
170643687|NCT02059291|616710093|FG002|Epoch 3|Adverse Event|0|||
170643688|NCT02059291|616710094|FG003|Epoch 3|Adverse Event|0|||
170643689|NCT02059291|616710095|FG004|Epoch 3|Adverse Event|0|||
170643690|NCT02059291|616710096|FG005|Epoch 3|Adverse Event|0|||
170643691|NCT02059291|616710097|FG006|Epoch 3|Adverse Event|0|||
170643692|NCT02059291|616710098|FG007|Epoch 3|Adverse Event|0|||
170643693|NCT02059291|616710099|FG008|Epoch 3|Adverse Event|0|||
170643694|NCT02059291|616710100|FG009|Epoch 3|Adverse Event|0|||
170643695|NCT02059291|616710101|FG010|Epoch 3|Adverse Event|0|||
170643696|NCT02059291|616710102|FG011|Epoch 3|Adverse Event|0|||
170643697|NCT02059291|616710103|FG012|Epoch 3|Adverse Event|0|||
170643698|NCT02059291|616710104|FG013|Epoch 3|Adverse Event|0|||
170643699|NCT02059291|616710105|FG014|Epoch 3|Adverse Event|0|||
170643700|NCT02059291|616710106|FG015|Epoch 3|Adverse Event|1|||
170643701|NCT02059291|616710107|FG016|Epoch 3|Adverse Event|0|||
170805858|NCT03678688|617299318|FG000|Overall Study|Reason not Specified|0|||
170805859|NCT03678688|617299319|FG001|Overall Study|Reason not Specified|0|||
170805860|NCT03678688|617299320|FG002|Overall Study|Reason not Specified|3|||
170805861|NCT03678688|617299321|FG003|Overall Study|Reason not Specified|0|||
170805862|NCT03678688|617299322|FG004|Overall Study|Reason not Specified|1|||
170643702|NCT02059291|616710108|FG017|Epoch 3|Adverse Event|0|||
170643703|NCT02059291|616710109|FG018|Epoch 3|Adverse Event|0|||
170643704|NCT02059291|616710110|FG019|Epoch 3|Adverse Event|0|||
170643705|NCT02059291|616710111|FG020|Epoch 3|Adverse Event|0|||
170643706|NCT02059291|616710112|FG021|Epoch 3|Adverse Event|0|||
170805863|NCT03678688|617299323|FG005|Overall Study|Reason not Specified|0|||
170643707|NCT02059291|616710113|FG022|Epoch 3|Adverse Event|0|||
170643708|NCT02059291|616710114|FG023|Epoch 3|Adverse Event|0|||
170643709|NCT02059291|616710115|FG024|Epoch 3|Adverse Event|0|||
170805864|NCT03678688|617299324|FG006|Overall Study|Reason not Specified|0|||
170643710|NCT02059291|616710091|FG000|Epoch 3|Lack of Efficacy|0|||
170643711|NCT02059291|616710092|FG001|Epoch 3|Lack of Efficacy|0|||
170805865|NCT03678688|617299325|FG007|Overall Study|Reason not Specified|0|||
170805866|NCT03678688|617299326|FG008|Overall Study|Reason not Specified|0|||
170805867|NCT03678688|617299318|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
170805868|NCT03678688|617299319|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
170805869|NCT03678688|617299320|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
170805870|NCT03678688|617299321|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
170805871|NCT03678688|617299322|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
170805872|NCT03678688|617299323|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
170805873|NCT03678688|617299324|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
170805874|NCT03678688|617299325|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
170805875|NCT03678688|617299326|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
170805876|NCT03678688|617299318|FG000|Overall Study|Covid Related Adverse Event|0|||
170805877|NCT03678688|617299319|FG001|Overall Study|Covid Related Adverse Event|0|||
170805878|NCT03678688|617299320|FG002|Overall Study|Covid Related Adverse Event|0|||
170805879|NCT03678688|617299321|FG003|Overall Study|Covid Related Adverse Event|0|||
170805880|NCT03678688|617299322|FG004|Overall Study|Covid Related Adverse Event|0|||
170805881|NCT03678688|617299323|FG005|Overall Study|Covid Related Adverse Event|3|||
170805882|NCT03678688|617299324|FG006|Overall Study|Covid Related Adverse Event|1|||
170805883|NCT03678688|617299325|FG007|Overall Study|Covid Related Adverse Event|1|||
170805884|NCT03678688|617299326|FG008|Overall Study|Covid Related Adverse Event|0|||
170805885|NCT03678688|617299318|FG000|Overall Study|Physician Decision|0|||
170805886|NCT03678688|617299319|FG001|Overall Study|Physician Decision|0|||
170805887|NCT03678688|617299320|FG002|Overall Study|Physician Decision|0|||
170805888|NCT03678688|617299321|FG003|Overall Study|Physician Decision|0|||
170805889|NCT03678688|617299322|FG004|Overall Study|Physician Decision|0|||
170805890|NCT03678688|617299323|FG005|Overall Study|Physician Decision|1|||
170805891|NCT03678688|617299324|FG006|Overall Study|Physician Decision|0|||
170805892|NCT03678688|617299325|FG007|Overall Study|Physician Decision|0|||
170805893|NCT03678688|617299326|FG008|Overall Study|Physician Decision|0|||
170805894|NCT03678688|617299318|FG000|Overall Study|Withdrawal by Subject|0|||
170805895|NCT03678688|617299319|FG001|Overall Study|Withdrawal by Subject|0|||
170805896|NCT03678688|617299320|FG002|Overall Study|Withdrawal by Subject|0|||
170805897|NCT03678688|617299321|FG003|Overall Study|Withdrawal by Subject|0|||
170805898|NCT03678688|617299322|FG004|Overall Study|Withdrawal by Subject|0|||
170805899|NCT03678688|617299323|FG005|Overall Study|Withdrawal by Subject|0|||
170805900|NCT03678688|617299324|FG006|Overall Study|Withdrawal by Subject|2|||
170805901|NCT03678688|617299325|FG007|Overall Study|Withdrawal by Subject|1|||
170805902|NCT03678688|617299326|FG008|Overall Study|Withdrawal by Subject|0|||
170805903|NCT02534233|617299329|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
170805904|NCT03823703|617299334|FG000|Overall Study|Sponsor request|0|||
170805905|NCT03823703|617299335|FG001|Overall Study|Sponsor request|3|||
170805906|NCT03823703|617299336|FG002|Overall Study|Sponsor request|4|||
170805907|NCT03823703|617299334|FG000|Overall Study|Adverse Event|3|||
170805908|NCT03823703|617299335|FG001|Overall Study|Adverse Event|1|||
170805909|NCT03823703|617299336|FG002|Overall Study|Adverse Event|0|||
170805910|NCT03823703|617299334|FG000|Overall Study|Withdrawal by Subject|0|||
170805911|NCT03823703|617299335|FG001|Overall Study|Withdrawal by Subject|1|||
170805912|NCT03823703|617299336|FG002|Overall Study|Withdrawal by Subject|0|||
170805913|NCT00799409|617299337|FG000|Overall Study|Withdrawal by Subject|1|||
170805914|NCT00799409|617299338|FG001|Overall Study|Withdrawal by Subject|0|||
170805915|NCT00799409|617299339|FG002|Overall Study|Withdrawal by Subject|0|||
170805916|NCT00799409|617299337|FG000|Overall Study|Lost to Follow-up|1|||
170805917|NCT00799409|617299338|FG001|Overall Study|Lost to Follow-up|0|||
170805918|NCT00799409|617299339|FG002|Overall Study|Lost to Follow-up|0|||
170805919|NCT00799409|617299337|FG000|Overall Study|Optimal Dose Not Achieved|2|||
170805920|NCT00799409|617299338|FG001|Overall Study|Optimal Dose Not Achieved|0|||
170805921|NCT00799409|617299339|FG002|Overall Study|Optimal Dose Not Achieved|0|||
170805922|NCT00799409|617299337|FG000|Overall Study|Failure to follow study protocol)|1|||
170805923|NCT00799409|617299338|FG001|Overall Study|Failure to follow study protocol)|0|||
170805924|NCT00799409|617299339|FG002|Overall Study|Failure to follow study protocol)|0|||
170805925|NCT00799409|617299337|FG000|Overall Study|Did not attend lab school day 1|1|||
170805926|NCT00799409|617299338|FG001|Overall Study|Did not attend lab school day 1|0|||
170805927|NCT00799409|617299339|FG002|Overall Study|Did not attend lab school day 1|0|||
170805928|NCT00799409|617299337|FG000|Overall Study|medication compliance|1|||
170805929|NCT00799409|617299338|FG001|Overall Study|medication compliance|0|||
170805930|NCT00799409|617299339|FG002|Overall Study|medication compliance|0|||
170805931|NCT01732757|617299340|FG000|Overall Study|Lost to Follow-up|1|||
170805932|NCT01732757|617299341|FG001|Overall Study|Lost to Follow-up|0|||
170805933|NCT01732757|617299342|FG002|Overall Study|Lost to Follow-up|0|||
170805934|NCT00925548|617299343|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
170805935|NCT00925548|617299344|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
170805936|NCT06571695|617299346|FG000|Overall Study|Lost to Follow-up|1|||
170805937|NCT06571695|617299347|FG001|Overall Study|Lost to Follow-up|6|||
170805938|NCT02278796|617299348|FG000|Overall Study|Death|2|||
170805939|NCT02278796|617299349|FG001|Overall Study|Death|3|||
170805940|NCT04926857|617299350|FG000|Overall Study|Withdrawal by Subject|40|||
170509898|NCT02815267|616210533|FG000|Open-Label Phase|Withdrawal by Subject|24|||
170509899|NCT02815267|616210534|FG001|Open-Label Phase|Withdrawal by Subject|13|||
170509900|NCT02815267|616210533|FG000|Open-Label Phase|Protocol Violation|0|||
170509901|NCT02815267|616210534|FG001|Open-Label Phase|Protocol Violation|1|||
170509902|NCT02815267|616210533|FG000|Open-Label Phase|Administrative|21|||
170509903|NCT02815267|616210534|FG001|Open-Label Phase|Administrative|12|||
170509904|NCT02815267|616210533|FG000|Open-Label Phase|Other|2|||
170904333|NCT00509106|617652306|FG001|Overall Study|At the request of sponsor/investigator|2|||
170904334|NCT00509106|617652305|FG000|Overall Study|Withdrew consent|4|||
170904335|NCT00509106|617652306|FG001|Overall Study|Withdrew consent|8|||
170904336|NCT00509106|617652305|FG000|Overall Study|Lost to Follow-up|16|||
170904337|NCT00509106|617652306|FG001|Overall Study|Lost to Follow-up|10|||
170904338|NCT00509106|617652305|FG000|Overall Study|Other|1|||
170904339|NCT00509106|617652306|FG001|Overall Study|Other|0|||
170904340|NCT00509106|617652305|FG000|Overall Study|Death|6|||
170904341|NCT00509106|617652306|FG001|Overall Study|Death|6|||
170904342|NCT05421754|617652309|FG000|Overall Study|Technical issue with sensor|1|||
170904343|NCT01051739|617652310|FG000|Overall Study|Death|3|||
170904344|NCT01051739|617652311|FG001|Overall Study|Death|3|||
170904345|NCT01051739|617652310|FG000|Overall Study|Withdrawal by Subject|25|||
170904346|NCT01051739|617652311|FG001|Overall Study|Withdrawal by Subject|10|||
170904347|NCT03527043|617652313|FG000|Overall Study|Withdrawal by Subject|1|||
170904348|NCT03527043|617652314|FG001|Overall Study|Withdrawal by Subject|0|||
170904349|NCT01440101|617652315|FG000|Overall Study|Adverse Event|2|||
170904350|NCT01440101|617652316|FG001|Overall Study|Adverse Event|0|||
170904351|NCT01440101|617652317|FG002|Overall Study|Adverse Event|0|||
170904352|NCT01440101|617652315|FG000|Overall Study|Withdrawal by Subject|0|||
170904353|NCT01440101|617652316|FG001|Overall Study|Withdrawal by Subject|3|||
170904354|NCT01440101|617652317|FG002|Overall Study|Withdrawal by Subject|1|||
170904355|NCT01440101|617652315|FG000|Overall Study|Other|0|||
170904356|NCT01440101|617652316|FG001|Overall Study|Other|1|||
170904357|NCT01440101|617652317|FG002|Overall Study|Other|0|||
170904358|NCT00659438|617652318|FG000|Overall Study|Withdrawal by Subject|2|||
170904359|NCT00659438|617652319|FG001|Overall Study|Withdrawal by Subject|2|||
170904360|NCT00659438|617652318|FG000|Overall Study|Death|11|||
170904361|NCT00659438|617652319|FG001|Overall Study|Death|6|||
170904362|NCT00659438|617652318|FG000|Overall Study|Lost to Follow-up|1|||
170904363|NCT00659438|617652319|FG001|Overall Study|Lost to Follow-up|0|||
170904364|NCT02469246|617652320|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
170904365|NCT02469246|617652321|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
170904366|NCT02469246|617652320|FG000|Double-Blind Phase|Adverse Event|12|||
170904367|NCT02469246|617652321|FG001|Double-Blind Phase|Adverse Event|9|||
170904368|NCT02469246|617652320|FG000|Double-Blind Phase|Death|2|||
170904369|NCT02469246|617652321|FG001|Double-Blind Phase|Death|0|||
170904370|NCT02469246|617652320|FG000|Double-Blind Phase|Lack of Efficacy|2|||
170904371|NCT02469246|617652321|FG001|Double-Blind Phase|Lack of Efficacy|1|||
170904372|NCT02469246|617652320|FG000|Double-Blind Phase|Investigator's Discretion|8|||
170904373|NCT02469246|617652321|FG001|Double-Blind Phase|Investigator's Discretion|8|||
170904374|NCT02469246|617652320|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
170904375|NCT02469246|617652321|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
170904376|NCT02469246|617652320|FG000|Double-Blind Phase|Protocol Violation|1|||
170904377|NCT02469246|617652321|FG001|Double-Blind Phase|Protocol Violation|1|||
170904378|NCT02469246|617652320|FG000|Double-Blind Phase|Withdrew Consent|25|||
170904379|NCT02469246|617652321|FG001|Double-Blind Phase|Withdrew Consent|25|||
170904380|NCT02469246|617652320|FG000|Double-Blind Phase|Lost to Follow-up|9|||
170904381|NCT02469246|617652321|FG001|Double-Blind Phase|Lost to Follow-up|5|||
170904382|NCT01275222|617652322|FG000|Phase l by Treatment|Adverse Event|1|||
170904383|NCT01275222|617652323|FG001|Phase l by Treatment|Adverse Event|4|||
170904384|NCT01275222|617652324|FG002|Phase l by Treatment|Adverse Event|2|||
170904385|NCT01275222|617652325|FG003|Phase l by Treatment|Adverse Event|3|||
170904386|NCT01275222|617652326|FG004|Phase l by Treatment|Adverse Event|0|||
170904387|NCT01275222|617652327|FG005|Phase l by Treatment|Adverse Event|0|||
170904388|NCT01275222|617652322|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
170904389|NCT01275222|617652323|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
170904390|NCT01275222|617652324|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
170904391|NCT01275222|617652325|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
170904392|NCT01275222|617652326|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
170904393|NCT01275222|617652327|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
170509905|NCT02815267|616210534|FG001|Open-Label Phase|Other|5|||
170509906|NCT04126317|616210550|FG000|Overall Study|Adverse Event|0|||
170904394|NCT01275222|617652322|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
170904395|NCT01275222|617652323|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
170904396|NCT01275222|617652324|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
170904397|NCT01275222|617652325|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
170904398|NCT01275222|617652326|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
170904399|NCT01275222|617652327|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
170904400|NCT01275222|617652322|FG000|Phase l by Treatment|Disease progression|12|||
170904401|NCT01275222|617652323|FG001|Phase l by Treatment|Disease progression|8|||
170904402|NCT01275222|617652324|FG002|Phase l by Treatment|Disease progression|2|||
170904403|NCT01275222|617652325|FG003|Phase l by Treatment|Disease progression|5|||
170904404|NCT01275222|617652326|FG004|Phase l by Treatment|Disease progression|0|||
170509907|NCT04126317|616210551|FG001|Overall Study|Adverse Event|1|||
170904405|NCT01275222|617652327|FG005|Phase l by Treatment|Disease progression|0|||
170904406|NCT01275222|617652322|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
170904407|NCT01275222|617652323|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
170904408|NCT01275222|617652324|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
170904409|NCT01275222|617652325|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
170904410|NCT01275222|617652326|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
170904411|NCT01275222|617652327|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
170904412|NCT01275222|617652322|FG000|Phase l by Treatment|Death|0|||
170904413|NCT01275222|617652323|FG001|Phase l by Treatment|Death|1|||
170904414|NCT01275222|617652324|FG002|Phase l by Treatment|Death|0|||
170904415|NCT01275222|617652325|FG003|Phase l by Treatment|Death|1|||
170904416|NCT01275222|617652326|FG004|Phase l by Treatment|Death|0|||
170904417|NCT01275222|617652327|FG005|Phase l by Treatment|Death|0|||
170904418|NCT01275222|617652322|FG000|Phase ll by Stratum|Adverse Event|0|||
170904419|NCT01275222|617652323|FG001|Phase ll by Stratum|Adverse Event|0|||
170904420|NCT01275222|617652324|FG002|Phase ll by Stratum|Adverse Event|0|||
170904421|NCT01275222|617652325|FG003|Phase ll by Stratum|Adverse Event|0|||
170904422|NCT01275222|617652326|FG004|Phase ll by Stratum|Adverse Event|2|||
170904423|NCT01275222|617652327|FG005|Phase ll by Stratum|Adverse Event|10|||
170904424|NCT01275222|617652322|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
170904425|NCT01275222|617652323|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
170904426|NCT01275222|617652324|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
170904427|NCT01275222|617652325|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
170904428|NCT01275222|617652326|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
170904429|NCT01275222|617652327|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
170904430|NCT01275222|617652322|FG000|Phase ll by Stratum|Disease progression|0|||
170904431|NCT01275222|617652323|FG001|Phase ll by Stratum|Disease progression|0|||
170904432|NCT01275222|617652324|FG002|Phase ll by Stratum|Disease progression|0|||
170904433|NCT01275222|617652325|FG003|Phase ll by Stratum|Disease progression|0|||
170904434|NCT01275222|617652326|FG004|Phase ll by Stratum|Disease progression|23|||
170904435|NCT01275222|617652327|FG005|Phase ll by Stratum|Disease progression|31|||
170904436|NCT01275222|617652322|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
170904437|NCT01275222|617652323|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
170904438|NCT01275222|617652324|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
170904439|NCT01275222|617652325|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
170904440|NCT01275222|617652326|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
170904441|NCT01275222|617652327|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
170904442|NCT01275222|617652322|FG000|Phase ll by Stratum|Death|0|||
170904443|NCT01275222|617652323|FG001|Phase ll by Stratum|Death|0|||
170904444|NCT01275222|617652324|FG002|Phase ll by Stratum|Death|0|||
170904445|NCT01275222|617652325|FG003|Phase ll by Stratum|Death|0|||
170904446|NCT01275222|617652326|FG004|Phase ll by Stratum|Death|1|||
170904447|NCT01275222|617652327|FG005|Phase ll by Stratum|Death|1|||
170904448|NCT04325503|617652332|FG000|Overall Study|Withdrawal by Subject|1|||
170904449|NCT04325503|617652332|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
170904450|NCT01642212|617652333|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
170904451|NCT01642212|617652334|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
170904452|NCT01642212|617652335|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
170904453|NCT01642212|617652336|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
170904454|NCT01642212|617652337|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
170904455|NCT01642212|617652333|FG000|Double-blind Treatment|Other|0|||
170904456|NCT01642212|617652334|FG001|Double-blind Treatment|Other|2|||
170904457|NCT01642212|617652335|FG002|Double-blind Treatment|Other|1|||
170904458|NCT01642212|617652336|FG003|Double-blind Treatment|Other|0|||
170904459|NCT01642212|617652337|FG004|Double-blind Treatment|Other|0|||
170904460|NCT01642212|617652333|FG000|Double-blind Treatment|Non-compliance|0|||
170904461|NCT01642212|617652334|FG001|Double-blind Treatment|Non-compliance|1|||
170904462|NCT01642212|617652335|FG002|Double-blind Treatment|Non-compliance|0|||
170904463|NCT01642212|617652336|FG003|Double-blind Treatment|Non-compliance|0|||
170904464|NCT01642212|617652337|FG004|Double-blind Treatment|Non-compliance|0|||
170904465|NCT01642212|617652333|FG000|Double-blind Treatment|Adverse Event|0|||
170904466|NCT01642212|617652334|FG001|Double-blind Treatment|Adverse Event|0|||
170904467|NCT01642212|617652335|FG002|Double-blind Treatment|Adverse Event|1|||
170509908|NCT04126317|616210550|FG000|Overall Study|Withdrawal by Subject|4|||
170904468|NCT01642212|617652336|FG003|Double-blind Treatment|Adverse Event|0|||
170904469|NCT01642212|617652337|FG004|Double-blind Treatment|Adverse Event|0|||
170904470|NCT01642212|617652333|FG000|Open-label Extension|Adverse Event|0|||
170509909|NCT04126317|616210551|FG001|Overall Study|Withdrawal by Subject|1|||
170904471|NCT01642212|617652334|FG001|Open-label Extension|Adverse Event|0|||
170904472|NCT01642212|617652335|FG002|Open-label Extension|Adverse Event|0|||
170904473|NCT01642212|617652336|FG003|Open-label Extension|Adverse Event|3|||
170904474|NCT01642212|617652337|FG004|Open-label Extension|Adverse Event|0|||
170904475|NCT01642212|617652333|FG000|Open-label Extension|Sponsor Decision|0|||
170904476|NCT01642212|617652334|FG001|Open-label Extension|Sponsor Decision|0|||
170904477|NCT01642212|617652335|FG002|Open-label Extension|Sponsor Decision|0|||
170643712|NCT02059291|616710093|FG002|Epoch 3|Lack of Efficacy|0|||
170643713|NCT02059291|616710094|FG003|Epoch 3|Lack of Efficacy|0|||
170643714|NCT02059291|616710095|FG004|Epoch 3|Lack of Efficacy|0|||
170643715|NCT02059291|616710096|FG005|Epoch 3|Lack of Efficacy|0|||
170643716|NCT02059291|616710097|FG006|Epoch 3|Lack of Efficacy|0|||
170643717|NCT02059291|616710098|FG007|Epoch 3|Lack of Efficacy|0|||
170643718|NCT02059291|616710099|FG008|Epoch 3|Lack of Efficacy|0|||
170643719|NCT02059291|616710100|FG009|Epoch 3|Lack of Efficacy|0|||
170643720|NCT02059291|616710101|FG010|Epoch 3|Lack of Efficacy|0|||
170643721|NCT02059291|616710102|FG011|Epoch 3|Lack of Efficacy|0|||
170643722|NCT02059291|616710103|FG012|Epoch 3|Lack of Efficacy|0|||
170643723|NCT02059291|616710104|FG013|Epoch 3|Lack of Efficacy|0|||
170643724|NCT02059291|616710105|FG014|Epoch 3|Lack of Efficacy|0|||
170643725|NCT02059291|616710106|FG015|Epoch 3|Lack of Efficacy|3|||
170643726|NCT02059291|616710107|FG016|Epoch 3|Lack of Efficacy|0|||
170643727|NCT02059291|616710108|FG017|Epoch 3|Lack of Efficacy|0|||
170643728|NCT02059291|616710109|FG018|Epoch 3|Lack of Efficacy|0|||
170643729|NCT02059291|616710110|FG019|Epoch 3|Lack of Efficacy|0|||
170643730|NCT02059291|616710111|FG020|Epoch 3|Lack of Efficacy|0|||
170643731|NCT02059291|616710112|FG021|Epoch 3|Lack of Efficacy|0|||
170643732|NCT02059291|616710113|FG022|Epoch 3|Lack of Efficacy|0|||
170643733|NCT02059291|616710114|FG023|Epoch 3|Lack of Efficacy|0|||
170643734|NCT02059291|616710115|FG024|Epoch 3|Lack of Efficacy|0|||
170643735|NCT02059291|616710091|FG000|Epoch 3|Withdrawal by Subject|0|||
170643736|NCT02059291|616710092|FG001|Epoch 3|Withdrawal by Subject|0|||
170643737|NCT02059291|616710093|FG002|Epoch 3|Withdrawal by Subject|0|||
170643738|NCT02059291|616710094|FG003|Epoch 3|Withdrawal by Subject|0|||
170643739|NCT02059291|616710095|FG004|Epoch 3|Withdrawal by Subject|0|||
170643740|NCT02059291|616710096|FG005|Epoch 3|Withdrawal by Subject|0|||
170643741|NCT02059291|616710097|FG006|Epoch 3|Withdrawal by Subject|0|||
170643742|NCT02059291|616710098|FG007|Epoch 3|Withdrawal by Subject|0|||
170643743|NCT02059291|616710099|FG008|Epoch 3|Withdrawal by Subject|0|||
170805941|NCT04926857|617299350|FG000|Overall Study|Death|9|||
170805942|NCT04926857|617299350|FG000|Overall Study|Study product no longer in use|44|||
170805943|NCT04926857|617299350|FG000|Overall Study|Inadequate data to address primary objective|16|||
170805944|NCT00357994|617299353|FG000|Overall Study|Adverse Event|1|||
170805945|NCT00357994|617299354|FG001|Overall Study|Adverse Event|2|||
170805946|NCT00357994|617299353|FG000|Overall Study|Lack of Efficacy|0|||
170805947|NCT00357994|617299354|FG001|Overall Study|Lack of Efficacy|1|||
170805948|NCT00357994|617299353|FG000|Overall Study|Protocol Violation|1|||
170805949|NCT00357994|617299354|FG001|Overall Study|Protocol Violation|0|||
170805950|NCT04652869|617299365|FG000|Overall Study|Withdrawal by Subject|0|||
170509910|NCT01908582|616210554|FG000|Period 2|Physician Decision|1|||
170805951|NCT04652869|617299366|FG001|Overall Study|Withdrawal by Subject|2|||
170805952|NCT04652869|617299367|FG002|Overall Study|Withdrawal by Subject|0|||
170805953|NCT01372085|617299368|FG000|Washout Period 2|Physician Decision|0|||
170805954|NCT01372085|617299369|FG001|Washout Period 2|Physician Decision|0|||
170805955|NCT01372085|617299370|FG002|Washout Period 2|Physician Decision|0|||
170805956|NCT01372085|617299371|FG003|Washout Period 2|Physician Decision|0|||
170805957|NCT01372085|617299372|FG004|Washout Period 2|Physician Decision|1|||
170805958|NCT01372085|617299373|FG005|Washout Period 2|Physician Decision|0|||
170805959|NCT01372085|617299374|FG006|Washout Period 2|Physician Decision|0|||
170805960|NCT01372085|617299375|FG007|Washout Period 2|Physician Decision|0|||
170805961|NCT01372085|617299376|FG008|Washout Period 2|Physician Decision|0|||
170805962|NCT01372085|617299377|FG009|Washout Period 2|Physician Decision|0|||
170805963|NCT01372085|617299368|FG000|Washout Period 3|Withdrawal by Subject|0|||
170805964|NCT01372085|617299369|FG001|Washout Period 3|Withdrawal by Subject|0|||
170805965|NCT01372085|617299370|FG002|Washout Period 3|Withdrawal by Subject|0|||
170904478|NCT01642212|617652336|FG003|Open-label Extension|Sponsor Decision|7|||
170643744|NCT02059291|616710100|FG009|Epoch 3|Withdrawal by Subject|0|||
170643745|NCT02059291|616710101|FG010|Epoch 3|Withdrawal by Subject|0|||
170643746|NCT02059291|616710102|FG011|Epoch 3|Withdrawal by Subject|0|||
170643747|NCT02059291|616710103|FG012|Epoch 3|Withdrawal by Subject|0|||
170643748|NCT02059291|616710104|FG013|Epoch 3|Withdrawal by Subject|0|||
170643749|NCT02059291|616710105|FG014|Epoch 3|Withdrawal by Subject|0|||
170643750|NCT02059291|616710106|FG015|Epoch 3|Withdrawal by Subject|1|||
170643751|NCT02059291|616710107|FG016|Epoch 3|Withdrawal by Subject|0|||
170643752|NCT02059291|616710108|FG017|Epoch 3|Withdrawal by Subject|0|||
170643753|NCT02059291|616710109|FG018|Epoch 3|Withdrawal by Subject|0|||
170643754|NCT02059291|616710110|FG019|Epoch 3|Withdrawal by Subject|0|||
170643755|NCT02059291|616710111|FG020|Epoch 3|Withdrawal by Subject|0|||
170643756|NCT02059291|616710112|FG021|Epoch 3|Withdrawal by Subject|0|||
170805966|NCT01372085|617299371|FG003|Washout Period 3|Withdrawal by Subject|0|||
170805967|NCT01372085|617299372|FG004|Washout Period 3|Withdrawal by Subject|0|||
170509911|NCT01908582|616210554|FG000|Period 2|Withdrawal by Subject|1|||
170643757|NCT02059291|616710113|FG022|Epoch 3|Withdrawal by Subject|0|||
170643758|NCT02059291|616710114|FG023|Epoch 3|Withdrawal by Subject|0|||
170643759|NCT02059291|616710115|FG024|Epoch 3|Withdrawal by Subject|0|||
170643760|NCT02059291|616710091|FG000|Epoch 4|Adverse Event|0|||
170643761|NCT02059291|616710092|FG001|Epoch 4|Adverse Event|0|||
170643762|NCT02059291|616710093|FG002|Epoch 4|Adverse Event|0|||
170553411|NCT02554474|616371934|FG000|Overall Study|Health issue not related to the study|1|||
170643763|NCT02059291|616710094|FG003|Epoch 4|Adverse Event|0|||
170509912|NCT01108237|616210555|FG000|Overall Study|No alignment data|2|||
170643764|NCT02059291|616710095|FG004|Epoch 4|Adverse Event|0|||
170805968|NCT01372085|617299373|FG005|Washout Period 3|Withdrawal by Subject|2|||
170509913|NCT01108237|616210556|FG001|Overall Study|No alignment data|15|||
170509914|NCT01108237|616210555|FG000|Overall Study|Did not meet criteria for analysis|7|||
170509915|NCT01108237|616210556|FG001|Overall Study|Did not meet criteria for analysis|0|||
170509916|NCT00660595|616210557|FG000|Overall Study|Lost to Follow-up|0|||
170509917|NCT00660595|616210558|FG001|Overall Study|Lost to Follow-up|1|||
170509918|NCT00660595|616210557|FG000|Overall Study|Did not consent to participate in study|12|||
170643765|NCT02059291|616710096|FG005|Epoch 4|Adverse Event|0|||
170643766|NCT02059291|616710097|FG006|Epoch 4|Adverse Event|0|||
170509919|NCT00660595|616210558|FG001|Overall Study|Did not consent to participate in study|8|||
170509920|NCT00660595|616210557|FG000|Overall Study|Participant left hospital|1|||
170509921|NCT00660595|616210558|FG001|Overall Study|Participant left hospital|0|||
170509922|NCT00660595|616210557|FG000|Overall Study|Non Specified reasons|5|||
170509923|NCT00660595|616210558|FG001|Overall Study|Non Specified reasons|0|||
170509924|NCT02714036|616210561|FG000|Overall Study|Adverse Event|9|||
170509925|NCT02714036|616210562|FG001|Overall Study|Adverse Event|2|||
170509926|NCT02714036|616210561|FG000|Overall Study|Withdrawal by Subject|3|||
170509927|NCT02714036|616210562|FG001|Overall Study|Withdrawal by Subject|2|||
170509928|NCT00715520|616210563|FG000|Overall Study|Screen failure|8|||
170509929|NCT00715520|616210564|FG001|Overall Study|Screen failure|1|||
170509930|NCT00715520|616210565|FG002|Overall Study|Screen failure|1|||
170509931|NCT00715520|616210563|FG000|Overall Study|Withdrawal by Subject|2|||
170509932|NCT00715520|616210564|FG001|Overall Study|Withdrawal by Subject|0|||
170509933|NCT00715520|616210565|FG002|Overall Study|Withdrawal by Subject|1|||
170509934|NCT04942210|616210566|FG000|Overall Study|Adverse Event|0|||
170509935|NCT04942210|616210567|FG001|Overall Study|Adverse Event|1|||
170509936|NCT04942210|616210566|FG000|Overall Study|Protocol Deviation|4|||
170509937|NCT04942210|616210567|FG001|Overall Study|Protocol Deviation|1|||
170509938|NCT04942210|616210566|FG000|Overall Study|Withdrawal by Subject|5|||
170509939|NCT04942210|616210567|FG001|Overall Study|Withdrawal by Subject|2|||
170509940|NCT04942210|616210566|FG000|Overall Study|Lost to Follow-up|16|||
170509941|NCT04942210|616210567|FG001|Overall Study|Lost to Follow-up|7|||
170509942|NCT04942210|616210566|FG000|Overall Study|Ongoing at the time of DBL date|60|||
170509943|NCT04942210|616210567|FG001|Overall Study|Ongoing at the time of DBL date|25|||
170509944|NCT04942210|616210566|FG000|Overall Study|Randomized but did not receive vaccination|3|||
170509945|NCT04942210|616210567|FG001|Overall Study|Randomized but did not receive vaccination|0|||
170509946|NCT01038752|616210568|FG000|Overall Study|Tumor Progression|2|||
170509947|NCT01038752|616210569|FG001|Overall Study|Tumor Progression|2|||
170509948|NCT01038752|616210568|FG000|Overall Study|Lost to Follow-up|3|||
170509949|NCT01038752|616210569|FG001|Overall Study|Lost to Follow-up|3|||
170509950|NCT04165135|616210572|FG000|Overall Study|Protocol Violation|10|||
170509951|NCT04165135|616210572|FG000|Overall Study|Participants withdrawal of consent|5|||
170509952|NCT05053035|616210575|FG000|Overall Study|Withdrawal by Subject|1|||
170509953|NCT05053035|616210576|FG001|Overall Study|Withdrawal by Subject|0|||
170509954|NCT01618916|616210577|FG000|Overall Study|Adverse Event|1|||
170509955|NCT01618916|616210578|FG001|Overall Study|Adverse Event|0|||
170509956|NCT01618916|616210579|FG002|Overall Study|Adverse Event|0|||
170509957|NCT01618916|616210580|FG003|Overall Study|Adverse Event|0|||
170509958|NCT01618916|616210581|FG004|Overall Study|Adverse Event|0|||
170509959|NCT01618916|616210582|FG005|Overall Study|Adverse Event|0|||
170509960|NCT01618916|616210577|FG000|Overall Study|Withdrawal by Subject|0|||
170509961|NCT01618916|616210578|FG001|Overall Study|Withdrawal by Subject|1|||
170509962|NCT01618916|616210579|FG002|Overall Study|Withdrawal by Subject|1|||
170509963|NCT01618916|616210580|FG003|Overall Study|Withdrawal by Subject|0|||
170509964|NCT01618916|616210581|FG004|Overall Study|Withdrawal by Subject|1|||
170509965|NCT01618916|616210582|FG005|Overall Study|Withdrawal by Subject|0|||
170509966|NCT01618916|616210577|FG000|Overall Study|Lost to Follow-up|1|||
170643767|NCT02059291|616710098|FG007|Epoch 4|Adverse Event|0|||
170509967|NCT01618916|616210578|FG001|Overall Study|Lost to Follow-up|0|||
170509968|NCT01618916|616210579|FG002|Overall Study|Lost to Follow-up|0|||
170509969|NCT01618916|616210580|FG003|Overall Study|Lost to Follow-up|2|||
170509970|NCT01618916|616210581|FG004|Overall Study|Lost to Follow-up|0|||
170643768|NCT02059291|616710099|FG008|Epoch 4|Adverse Event|0|||
170509971|NCT01618916|616210582|FG005|Overall Study|Lost to Follow-up|0|||
170509972|NCT00438256|616210583|FG000|Overall Study|Ineligible for Resection|2|||
170509973|NCT00438256|616210584|FG001|Overall Study|Ineligible for Resection|1|||
170509974|NCT00438256|616210585|FG002|Overall Study|Ineligible for Resection|1|||
170509975|NCT00438256|616210586|FG003|Overall Study|Ineligible for Resection|7|||
170509976|NCT00438256|616210583|FG000|Overall Study|Excluded final Diagnosis|0|||
170509977|NCT00438256|616210584|FG001|Overall Study|Excluded final Diagnosis|0|||
170509978|NCT00438256|616210585|FG002|Overall Study|Excluded final Diagnosis|0|||
170904479|NCT01642212|617652337|FG004|Open-label Extension|Sponsor Decision|4|||
170904480|NCT01642212|617652333|FG000|Open-label Extension|Consent Withdrawn|0|||
170904481|NCT01642212|617652334|FG001|Open-label Extension|Consent Withdrawn|0|||
170904482|NCT01642212|617652335|FG002|Open-label Extension|Consent Withdrawn|0|||
170904483|NCT01642212|617652336|FG003|Open-label Extension|Consent Withdrawn|0|||
170904484|NCT01642212|617652337|FG004|Open-label Extension|Consent Withdrawn|2|||
170904485|NCT01642212|617652333|FG000|Open-label Extension|Lost to Follow-up|0|||
170904486|NCT01642212|617652334|FG001|Open-label Extension|Lost to Follow-up|0|||
170904487|NCT01642212|617652335|FG002|Open-label Extension|Lost to Follow-up|0|||
170904488|NCT01642212|617652336|FG003|Open-label Extension|Lost to Follow-up|0|||
170904489|NCT01642212|617652337|FG004|Open-label Extension|Lost to Follow-up|1|||
170904490|NCT01642212|617652333|FG000|Open-label Extension|Other|0|||
170904491|NCT01642212|617652334|FG001|Open-label Extension|Other|0|||
170904492|NCT01642212|617652335|FG002|Open-label Extension|Other|0|||
170904493|NCT01642212|617652336|FG003|Open-label Extension|Other|0|||
170904494|NCT01642212|617652337|FG004|Open-label Extension|Other|1|||
170904495|NCT00144170|617652338|FG000|Overall Study|Adverse Event|84|||
170904496|NCT00144170|617652339|FG001|Overall Study|Adverse Event|41|||
170904497|NCT00144170|617652338|FG000|Overall Study|Protocol Violation|23|||
170904498|NCT00144170|617652339|FG001|Overall Study|Protocol Violation|16|||
170904499|NCT00144170|617652338|FG000|Overall Study|Lost to Follow-up|5|||
170904500|NCT00144170|617652339|FG001|Overall Study|Lost to Follow-up|10|||
170904501|NCT00144170|617652338|FG000|Overall Study|Withdrawal by Subject|29|||
170904502|NCT00144170|617652339|FG001|Overall Study|Withdrawal by Subject|13|||
170904503|NCT00144170|617652338|FG000|Overall Study|Other reason not defined above|211|||
170904504|NCT00144170|617652339|FG001|Overall Study|Other reason not defined above|316|||
170904505|NCT00981526|617652340|FG000|Overall Study|Withdrawal by Subject|0|||
170904506|NCT00981526|617652341|FG001|Overall Study|Withdrawal by Subject|2|||
170904507|NCT00981526|617652340|FG000|Overall Study|Physician Decision|4|||
170904508|NCT00981526|617652341|FG001|Overall Study|Physician Decision|4|||
170904509|NCT01243268|617652342|FG000|Overall Study|Lost to Follow-up|4|||
170904510|NCT01243268|617652342|FG000|Overall Study|Protocol Violation|51|||
170904511|NCT01243268|617652342|FG000|Overall Study|Deviation with contract date|7|||
170904512|NCT01243268|617652342|FG000|Overall Study|Duplicate subject|2|||
170904513|NCT00332202|617652343|FG000|Overall Study|Adverse Event|72|||
170904514|NCT00332202|617652344|FG001|Overall Study|Adverse Event|28|||
170904515|NCT00332202|617652343|FG000|Overall Study|Lost to Follow-up|2|||
170904516|NCT00332202|617652344|FG001|Overall Study|Lost to Follow-up|1|||
170904517|NCT00332202|617652343|FG000|Overall Study|Physician Decision|6|||
170904518|NCT00332202|617652344|FG001|Overall Study|Physician Decision|8|||
170904519|NCT00332202|617652343|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
170904520|NCT00332202|617652344|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
170904521|NCT00332202|617652343|FG000|Overall Study|Protocol Violation|7|||
170904522|NCT00332202|617652344|FG001|Overall Study|Protocol Violation|2|||
170904523|NCT00332202|617652343|FG000|Overall Study|Sponsor Decision|1|||
170904524|NCT00332202|617652344|FG001|Overall Study|Sponsor Decision|2|||
170904525|NCT00332202|617652343|FG000|Overall Study|Withdrawal by Subject|36|||
170904526|NCT00332202|617652344|FG001|Overall Study|Withdrawal by Subject|17|||
170904527|NCT00332202|617652343|FG000|Overall Study|Progressive Disease|106|||
170904528|NCT00332202|617652344|FG001|Overall Study|Progressive Disease|60|||
170904529|NCT00332202|617652343|FG000|Overall Study|Death|5|||
170904530|NCT00332202|617652344|FG001|Overall Study|Death|2|||
170904531|NCT00957853|617652345|FG000|Overall Study|Withdrawal by Subject|1|||
170904532|NCT00957853|617652346|FG001|Overall Study|Withdrawal by Subject|0|||
170509979|NCT00438256|616210586|FG003|Overall Study|Excluded final Diagnosis|2|||
170509980|NCT00938587|616210596|FG000|Overall Study|Adverse Event|2|||
170509981|NCT00938587|616210597|FG001|Overall Study|Adverse Event|0|||
170904533|NCT00957853|617652347|FG002|Overall Study|Withdrawal by Subject|0|||
170904534|NCT00488631|617652350|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
170904535|NCT00488631|617652351|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
170904536|NCT00488631|617652352|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
170904537|NCT00488631|617652353|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
170509982|NCT00938587|616210598|FG002|Overall Study|Adverse Event|0|||
170509983|NCT00938587|616210599|FG003|Overall Study|Adverse Event|2|||
170904538|NCT00488631|617652354|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
170509984|NCT00938587|616210596|FG000|Overall Study|Did not meet entrance criteria|0|||
170509985|NCT00938587|616210597|FG001|Overall Study|Did not meet entrance criteria|0|||
170904539|NCT00488631|617652355|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
170904540|NCT00488631|617652356|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
170643769|NCT02059291|616710100|FG009|Epoch 4|Adverse Event|0|||
170904541|NCT00488631|617652357|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
170904542|NCT00488631|617652358|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
170904543|NCT00488631|617652359|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
170509986|NCT00938587|616210598|FG002|Overall Study|Did not meet entrance criteria|1|||
170509987|NCT00938587|616210599|FG003|Overall Study|Did not meet entrance criteria|0|||
170509988|NCT00938587|616210596|FG000|Overall Study|Withdrawal by Subject|1|||
170509989|NCT00938587|616210597|FG001|Overall Study|Withdrawal by Subject|1|||
170509990|NCT00938587|616210598|FG002|Overall Study|Withdrawal by Subject|0|||
170509991|NCT00938587|616210599|FG003|Overall Study|Withdrawal by Subject|0|||
170509992|NCT00849290|616210600|FG000|Overall Study|Adverse Event|3|||
170509993|NCT00849290|616210600|FG000|Overall Study|Death|14|||
170509994|NCT00849290|616210600|FG000|Overall Study|Withdrawal by Subject|11|||
170509995|NCT00849290|616210600|FG000|Overall Study|Lost to Follow-up|2|||
170509996|NCT00849290|616210600|FG000|Overall Study|Protocol Violation|5|||
170509997|NCT00849290|616210600|FG000|Overall Study|Disease Progression|20|||
170509998|NCT00750919|616210601|FG000|Overall Study|Adverse Event|9|||
170509999|NCT00750919|616210601|FG000|Overall Study|Withdrawal by Subject|1|||
170510000|NCT00750919|616210601|FG000|Overall Study|Lack of Efficacy|8|||
170510001|NCT00750919|616210601|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
170510002|NCT00750919|616210601|FG000|Overall Study|Other|36|||
170510003|NCT00048997|616210610|FG000|Overall Study|Protocol Violation|7|||
170510004|NCT00048997|616210611|FG001|Overall Study|Protocol Violation|2|||
170510005|NCT00048997|616210610|FG000|Overall Study|Withdrawal by Subject|6|||
170510006|NCT00048997|616210611|FG001|Overall Study|Withdrawal by Subject|1|||
170510007|NCT02819440|616210612|FG000|Overall Study|Adverse Event|3|||
170510008|NCT02819440|616210613|FG001|Overall Study|Adverse Event|1|||
170510009|NCT02819440|616210612|FG000|Overall Study|Lost to Follow-up|1|||
170510010|NCT02819440|616210613|FG001|Overall Study|Lost to Follow-up|3|||
170510011|NCT02819440|616210612|FG000|Overall Study|Withdrawal by Subject|9|||
170510012|NCT02819440|616210613|FG001|Overall Study|Withdrawal by Subject|8|||
170510013|NCT03742258|616210621|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
170510014|NCT03742258|616210622|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
170510015|NCT03742258|616210623|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
170510016|NCT03742258|616210621|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
170510017|NCT03742258|616210622|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
170510018|NCT03742258|616210623|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
170510019|NCT03742258|616210621|FG000|Survival Follow-Up|Still in Follow-up|0|||
170510020|NCT03742258|616210622|FG001|Survival Follow-Up|Still in Follow-up|0|||
170510021|NCT03742258|616210623|FG002|Survival Follow-Up|Still in Follow-up|2|||
170510022|NCT01333956|616210627|FG000|Overall Study|Lost to Follow-up|1|||
170510023|NCT01333956|616210628|FG001|Overall Study|Lost to Follow-up|2|||
170510024|NCT01333956|616210629|FG002|Overall Study|Lost to Follow-up|0|||
170510025|NCT01333956|616210630|FG003|Overall Study|Lost to Follow-up|1|||
170510026|NCT01333956|616210627|FG000|Overall Study|Unable to complete study procedure|1|||
170510027|NCT01333956|616210628|FG001|Overall Study|Unable to complete study procedure|0|||
170510028|NCT01333956|616210629|FG002|Overall Study|Unable to complete study procedure|0|||
170510029|NCT01333956|616210630|FG003|Overall Study|Unable to complete study procedure|1|||
170510030|NCT01333956|616210627|FG000|Overall Study|Withdrawal by Subject|0|||
170510031|NCT01333956|616210628|FG001|Overall Study|Withdrawal by Subject|2|||
170510032|NCT01333956|616210629|FG002|Overall Study|Withdrawal by Subject|1|||
170510033|NCT01333956|616210630|FG003|Overall Study|Withdrawal by Subject|0|||
170510034|NCT00207727|616210631|FG000|Overall Study|Withdrawal by Subject|0|||
170510035|NCT00207727|616210632|FG001|Overall Study|Withdrawal by Subject|0|||
170510036|NCT00207727|616210633|FG002|Overall Study|Withdrawal by Subject|0|||
170510037|NCT00207727|616210634|FG003|Overall Study|Withdrawal by Subject|0|||
170510038|NCT00207727|616210635|FG004|Overall Study|Withdrawal by Subject|1|||
170510039|NCT00207727|616210631|FG000|Overall Study|Lost to Follow-up|0|||
170510040|NCT00207727|616210632|FG001|Overall Study|Lost to Follow-up|1|||
170510041|NCT00207727|616210633|FG002|Overall Study|Lost to Follow-up|0|||
170510042|NCT00207727|616210634|FG003|Overall Study|Lost to Follow-up|0|||
170510043|NCT00207727|616210635|FG004|Overall Study|Lost to Follow-up|0|||
170510044|NCT00207727|616210631|FG000|Overall Study|Other|38|||
170510045|NCT00207727|616210632|FG001|Overall Study|Other|41|||
170510046|NCT00207727|616210633|FG002|Overall Study|Other|41|||
170510047|NCT00207727|616210634|FG003|Overall Study|Other|37|||
170510048|NCT00207727|616210635|FG004|Overall Study|Other|33|||
170510049|NCT03759366|616210636|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
170510050|NCT03759366|616210636|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
170510051|NCT03759366|616210636|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
170510052|NCT03759366|616210636|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
170510053|NCT03759366|616210636|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
170510054|NCT03759366|616210636|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
170510055|NCT03759366|616210636|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
170553412|NCT02554474|616371935|FG001|Overall Study|Health issue not related to the study|0|||
170553413|NCT02554474|616371934|FG000|Overall Study|Withdrawal by Subject|1|||
170510056|NCT00539032|616210642|FG000|Overall Study|Withdrawal by Subject|2|||
170510057|NCT00539032|616210643|FG001|Overall Study|Withdrawal by Subject|1|||
170510058|NCT02333383|616210645|FG000|Overall Study|Adalimumab discontinuation|21|||
170510059|NCT02333383|616210645|FG000|Overall Study|Lost to Follow-up|15|||
170510060|NCT02333383|616210645|FG000|Overall Study|Withdrawal by Subject|3|||
170510061|NCT02333383|616210645|FG000|Overall Study|Transfer to another hospital|2|||
170510062|NCT04459598|616210646|FG000|Overall Study|Adverse Event|1|||
170510063|NCT04459598|616210647|FG001|Overall Study|Adverse Event|1|||
170510064|NCT01653327|616210654|FG000|Overall Study|Withdrawal by Subject|1|||
170510065|NCT01854879|616210655|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
170510066|NCT01854879|616210655|FG000|Overall Study|screen fail|3|||
170510067|NCT01854879|616210655|FG000|Overall Study|incomplete data set|1|||
170510068|NCT04683939|616210656|FG000|Overall Study|Study termination by the sponsor|0|||
170510069|NCT04683939|616210657|FG001|Overall Study|Study termination by the sponsor|1|||
170510070|NCT04683939|616210658|FG002|Overall Study|Study termination by the sponsor|2|||
170510071|NCT04683939|616210659|FG003|Overall Study|Study termination by the sponsor|2|||
170553414|NCT02554474|616371935|FG001|Overall Study|Withdrawal by Subject|1|||
170553415|NCT03186378|616371940|FG000|Overall Study|Lost to Follow-up|1|||
170553416|NCT03186378|616371941|FG001|Overall Study|Lost to Follow-up|0|||
170553417|NCT03511209|616371942|FG000|Overall Study|Withdrawal by Subject|2|||
170553418|NCT03511209|616371943|FG001|Overall Study|Withdrawal by Subject|4|||
170553419|NCT03511209|616371942|FG000|Overall Study|Death|1|||
170553420|NCT03511209|616371943|FG001|Overall Study|Death|0|||
170553421|NCT03511209|616371942|FG000|Overall Study|Lost to Follow-up|0|||
170553422|NCT03511209|616371943|FG001|Overall Study|Lost to Follow-up|2|||
170553423|NCT03247673|616371947|FG000|Overall Study|Withdrawal by Subject|1|||
170553424|NCT03247673|616371948|FG001|Overall Study|Withdrawal by Subject|0|||
170553425|NCT03247673|616371949|FG002|Overall Study|Withdrawal by Subject|3|||
170553426|NCT03247673|616371947|FG000|Overall Study|Lost to Follow-up|0|||
170553427|NCT03247673|616371948|FG001|Overall Study|Lost to Follow-up|0|||
170510072|NCT04683939|616210656|FG000|Overall Study|Death|1|||
170510073|NCT04683939|616210657|FG001|Overall Study|Death|1|||
170510074|NCT04683939|616210658|FG002|Overall Study|Death|2|||
170510075|NCT04683939|616210659|FG003|Overall Study|Death|1|||
170510076|NCT04683939|616210656|FG000|Overall Study|Withdrawal by Subject|1|||
170510077|NCT04683939|616210657|FG001|Overall Study|Withdrawal by Subject|0|||
170510078|NCT04683939|616210658|FG002|Overall Study|Withdrawal by Subject|0|||
170510079|NCT04683939|616210659|FG003|Overall Study|Withdrawal by Subject|0|||
170510080|NCT04683939|616210656|FG000|Overall Study|Physician Decision|1|||
170510081|NCT04683939|616210657|FG001|Overall Study|Physician Decision|0|||
170510082|NCT04683939|616210658|FG002|Overall Study|Physician Decision|0|||
170510083|NCT04683939|616210659|FG003|Overall Study|Physician Decision|0|||
170510084|NCT04683939|616210656|FG000|Overall Study|Lost to Follow-up|0|||
170510085|NCT04683939|616210657|FG001|Overall Study|Lost to Follow-up|1|||
170510086|NCT04683939|616210658|FG002|Overall Study|Lost to Follow-up|0|||
170510087|NCT04683939|616210659|FG003|Overall Study|Lost to Follow-up|0|||
170510088|NCT04985942|616212438|FG000|Overall Study|Adverse Event|14|||
170510089|NCT04985942|616212439|FG001|Overall Study|Adverse Event|2|||
170510090|NCT04985942|616212438|FG000|Overall Study|Lack of Efficacy|0|||
170510091|NCT04985942|616212439|FG001|Overall Study|Lack of Efficacy|3|||
170510092|NCT04985942|616212438|FG000|Overall Study|Lost to Follow-up|1|||
170510093|NCT04985942|616212439|FG001|Overall Study|Lost to Follow-up|1|||
170510094|NCT04985942|616212438|FG000|Overall Study|Protocol Violation|1|||
170510095|NCT04985942|616212439|FG001|Overall Study|Protocol Violation|1|||
170510096|NCT04985942|616212438|FG000|Overall Study|Withdrawal by Subject|5|||
170510097|NCT04985942|616212439|FG001|Overall Study|Withdrawal by Subject|4|||
170510098|NCT02757352|616212442|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
170510099|NCT02757352|616212443|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
170553428|NCT03247673|616371949|FG002|Overall Study|Lost to Follow-up|1|||
170553429|NCT04754399|616371952|FG000|Overall Study|Adverse Event|5|||
170553430|NCT04754399|616371952|FG000|Overall Study|Withdrawal by Subject|6|||
170904544|NCT00488631|617652350|FG000|Double Blind Period (Week 0-54)|Death|0|||
170553431|NCT05259722|616371953|FG000|Overall Study|Adverse Event|2|||
170510100|NCT02757352|616212444|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
170643770|NCT02059291|616710101|FG010|Epoch 4|Adverse Event|0|||
170643771|NCT02059291|616710102|FG011|Epoch 4|Adverse Event|0|||
170904545|NCT00488631|617652351|FG001|Double Blind Period (Week 0-54)|Death|0|||
170510101|NCT02757352|616212445|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
170510102|NCT02757352|616212446|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
170510103|NCT02757352|616212447|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
170510104|NCT02757352|616212448|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
170553432|NCT05259722|616371954|FG001|Overall Study|Adverse Event|24|||
170553433|NCT05259722|616371953|FG000|Overall Study|Lost to Follow-up|5|||
170643772|NCT02059291|616710103|FG012|Epoch 4|Adverse Event|0|||
170553434|NCT05259722|616371954|FG001|Overall Study|Lost to Follow-up|1|||
170510105|NCT02757352|616212449|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
170510106|NCT02757352|616212450|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
170510107|NCT02757352|616212451|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
170510108|NCT02757352|616212442|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510109|NCT02757352|616212443|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510110|NCT02757352|616212444|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
170510111|NCT02757352|616212445|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510112|NCT02757352|616212446|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510113|NCT02757352|616212447|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510114|NCT02757352|616212448|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510115|NCT02757352|616212449|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510116|NCT02757352|616212450|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510117|NCT02757352|616212451|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
170510118|NCT02757352|616212442|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
170510119|NCT02757352|616212443|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
170510120|NCT02757352|616212444|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
170510121|NCT02757352|616212445|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
170510122|NCT02757352|616212446|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
170510123|NCT02757352|616212447|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
170510124|NCT02757352|616212448|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
170510125|NCT02757352|616212449|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
170510126|NCT02757352|616212450|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
170510127|NCT02757352|616212451|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
170510128|NCT02757352|616212442|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510129|NCT02757352|616212443|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
170510130|NCT02757352|616212444|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510131|NCT02757352|616212445|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510132|NCT02757352|616212446|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510133|NCT02757352|616212447|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510134|NCT02757352|616212448|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510135|NCT02757352|616212449|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510136|NCT02757352|616212450|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510137|NCT02757352|616212451|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
170510138|NCT02757352|616212442|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510139|NCT02757352|616212443|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
170510140|NCT02757352|616212444|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510141|NCT02757352|616212445|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510142|NCT02757352|616212446|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510143|NCT02757352|616212447|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510144|NCT02757352|616212448|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510145|NCT02757352|616212449|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510146|NCT02757352|616212450|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510147|NCT02757352|616212451|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510148|NCT02757352|616212442|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
170510149|NCT02757352|616212443|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
170510150|NCT02757352|616212444|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
170510151|NCT02757352|616212445|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510152|NCT02757352|616212446|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510153|NCT02757352|616212447|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510154|NCT02757352|616212448|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510155|NCT02757352|616212449|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510156|NCT02757352|616212450|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510157|NCT02757352|616212451|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510158|NCT02757352|616212442|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
170510159|NCT02757352|616212443|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
170510160|NCT02757352|616212444|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
170510161|NCT02757352|616212445|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
170510162|NCT02757352|616212446|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
170510163|NCT02757352|616212447|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
170510164|NCT02757352|616212448|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
170510165|NCT02757352|616212449|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
170553435|NCT05259722|616371953|FG000|Overall Study|Lack of Efficacy|8|||
170553436|NCT05259722|616371954|FG001|Overall Study|Lack of Efficacy|26|||
170510166|NCT02757352|616212450|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
170510167|NCT02757352|616212451|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
170510168|NCT02757352|616212442|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
170510169|NCT02757352|616212443|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
170510170|NCT02757352|616212444|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
170510171|NCT02757352|616212445|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
170510172|NCT02757352|616212446|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
170510173|NCT02757352|616212447|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
170510174|NCT02757352|616212448|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
170510175|NCT02757352|616212449|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
170510176|NCT02757352|616212450|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
170510177|NCT02757352|616212451|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
170510178|NCT02757352|616212442|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510179|NCT02757352|616212443|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510180|NCT02757352|616212444|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510181|NCT02757352|616212445|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
170510182|NCT02757352|616212446|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
170510183|NCT02757352|616212447|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
170510184|NCT02757352|616212448|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510185|NCT02757352|616212449|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510186|NCT02757352|616212450|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510187|NCT02757352|616212451|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
170510188|NCT02757352|616212442|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510189|NCT02757352|616212443|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510190|NCT02757352|616212444|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510191|NCT02757352|616212445|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510192|NCT02757352|616212446|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
170510193|NCT02757352|616212447|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510194|NCT02757352|616212448|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510195|NCT02757352|616212449|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510196|NCT02757352|616212450|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510197|NCT02757352|616212451|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
170510198|NCT02757352|616212442|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510199|NCT02757352|616212443|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510200|NCT02757352|616212444|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510201|NCT02757352|616212445|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510202|NCT02757352|616212446|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510203|NCT02757352|616212447|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
170510204|NCT02757352|616212448|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510205|NCT02757352|616212449|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510206|NCT02757352|616212450|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510207|NCT02757352|616212451|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
170510208|NCT02757352|616212442|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510209|NCT02757352|616212443|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510210|NCT02757352|616212444|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510211|NCT02757352|616212445|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
170904546|NCT00488631|617652352|FG002|Double Blind Period (Week 0-54)|Death|0|||
170904547|NCT00488631|617652353|FG003|Double Blind Period (Week 0-54)|Death|0|||
170904548|NCT00488631|617652354|FG004|Double Blind Period (Week 0-54)|Death|0|||
170904549|NCT00488631|617652355|FG005|Double Blind Period (Week 0-54)|Death|1|||
170904550|NCT00488631|617652356|FG006|Double Blind Period (Week 0-54)|Death|0|||
170904551|NCT00488631|617652357|FG007|Double Blind Period (Week 0-54)|Death|0|||
170904552|NCT00488631|617652358|FG008|Double Blind Period (Week 0-54)|Death|0|||
170904553|NCT00488631|617652359|FG009|Double Blind Period (Week 0-54)|Death|0|||
170904554|NCT00488631|617652350|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
170904555|NCT00488631|617652351|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
170904556|NCT00488631|617652352|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
170904557|NCT00488631|617652353|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
170904558|NCT00488631|617652354|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
170510212|NCT02757352|616212446|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
170510213|NCT02757352|616212447|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
170510214|NCT02757352|616212448|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170904559|NCT00488631|617652355|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
170904560|NCT00488631|617652356|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
170904561|NCT00488631|617652357|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
170904562|NCT00488631|617652358|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
170904563|NCT00488631|617652359|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
170904564|NCT00488631|617652350|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
170904565|NCT00488631|617652351|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
170904566|NCT00488631|617652352|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
170904567|NCT00488631|617652353|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
170904568|NCT00488631|617652354|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
170904569|NCT00488631|617652355|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
170904570|NCT00488631|617652356|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
170904571|NCT00488631|617652357|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
170904572|NCT00488631|617652358|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
170510215|NCT02757352|616212449|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510216|NCT02757352|616212450|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510217|NCT02757352|616212451|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
170510218|NCT02757352|616212442|FG000|Follow-Up Period|Adverse Event|0|||
170904573|NCT00488631|617652359|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
170904574|NCT00488631|617652350|FG000|Double Blind Period (Week 0-54)|Other|6|||
170510219|NCT02757352|616212443|FG001|Follow-Up Period|Adverse Event|0|||
170510220|NCT02757352|616212444|FG002|Follow-Up Period|Adverse Event|0|||
170510221|NCT02757352|616212445|FG003|Follow-Up Period|Adverse Event|0|||
170510222|NCT02757352|616212446|FG004|Follow-Up Period|Adverse Event|0|||
170510223|NCT02757352|616212447|FG005|Follow-Up Period|Adverse Event|0|||
170510224|NCT02757352|616212448|FG006|Follow-Up Period|Adverse Event|1|||
170510225|NCT02757352|616212449|FG007|Follow-Up Period|Adverse Event|0|||
170510226|NCT02757352|616212450|FG008|Follow-Up Period|Adverse Event|2|||
170510227|NCT02757352|616212451|FG009|Follow-Up Period|Adverse Event|0|||
170510228|NCT02757352|616212442|FG000|Follow-Up Period|Lost to Follow-up|0|||
170510229|NCT02757352|616212443|FG001|Follow-Up Period|Lost to Follow-up|0|||
170510230|NCT02757352|616212444|FG002|Follow-Up Period|Lost to Follow-up|0|||
170510231|NCT02757352|616212445|FG003|Follow-Up Period|Lost to Follow-up|0|||
170510232|NCT02757352|616212446|FG004|Follow-Up Period|Lost to Follow-up|0|||
170510233|NCT02757352|616212447|FG005|Follow-Up Period|Lost to Follow-up|0|||
170510234|NCT02757352|616212448|FG006|Follow-Up Period|Lost to Follow-up|0|||
170510235|NCT02757352|616212449|FG007|Follow-Up Period|Lost to Follow-up|0|||
170510236|NCT02757352|616212450|FG008|Follow-Up Period|Lost to Follow-up|1|||
170510237|NCT02757352|616212451|FG009|Follow-Up Period|Lost to Follow-up|0|||
170510238|NCT02757352|616212442|FG000|Follow-Up Period|Lack of Efficacy|0|||
170510239|NCT02757352|616212443|FG001|Follow-Up Period|Lack of Efficacy|0|||
170510240|NCT02757352|616212444|FG002|Follow-Up Period|Lack of Efficacy|0|||
170510241|NCT02757352|616212445|FG003|Follow-Up Period|Lack of Efficacy|0|||
170510242|NCT02757352|616212446|FG004|Follow-Up Period|Lack of Efficacy|0|||
170510243|NCT02757352|616212447|FG005|Follow-Up Period|Lack of Efficacy|0|||
170510244|NCT02757352|616212448|FG006|Follow-Up Period|Lack of Efficacy|0|||
170510245|NCT02757352|616212449|FG007|Follow-Up Period|Lack of Efficacy|0|||
170510246|NCT02757352|616212450|FG008|Follow-Up Period|Lack of Efficacy|1|||
170510247|NCT02757352|616212451|FG009|Follow-Up Period|Lack of Efficacy|1|||
170510248|NCT02757352|616212442|FG000|Follow-Up Period|Withdrawal by Subject|0|||
170904575|NCT00488631|617652351|FG001|Double Blind Period (Week 0-54)|Other|12|||
170904576|NCT00488631|617652352|FG002|Double Blind Period (Week 0-54)|Other|10|||
170643773|NCT02059291|616710104|FG013|Epoch 4|Adverse Event|0|||
170643774|NCT02059291|616710105|FG014|Epoch 4|Adverse Event|0|||
170643775|NCT02059291|616710106|FG015|Epoch 4|Adverse Event|0|||
170643776|NCT02059291|616710107|FG016|Epoch 4|Adverse Event|1|||
170643777|NCT02059291|616710108|FG017|Epoch 4|Adverse Event|0|||
170643778|NCT02059291|616710109|FG018|Epoch 4|Adverse Event|0|||
170643779|NCT02059291|616710110|FG019|Epoch 4|Adverse Event|0|||
170643780|NCT02059291|616710111|FG020|Epoch 4|Adverse Event|0|||
170643781|NCT02059291|616710112|FG021|Epoch 4|Adverse Event|0|||
170643782|NCT02059291|616710113|FG022|Epoch 4|Adverse Event|1|||
170643783|NCT02059291|616710114|FG023|Epoch 4|Adverse Event|0|||
170643784|NCT02059291|616710115|FG024|Epoch 4|Adverse Event|0|||
170643785|NCT02059291|616710091|FG000|Epoch 4|Pregnancy|0|||
170643786|NCT02059291|616710092|FG001|Epoch 4|Pregnancy|0|||
170643787|NCT02059291|616710093|FG002|Epoch 4|Pregnancy|0|||
170643788|NCT02059291|616710094|FG003|Epoch 4|Pregnancy|0|||
170643789|NCT02059291|616710095|FG004|Epoch 4|Pregnancy|0|||
170643790|NCT02059291|616710096|FG005|Epoch 4|Pregnancy|0|||
170643791|NCT02059291|616710097|FG006|Epoch 4|Pregnancy|0|||
170643792|NCT02059291|616710098|FG007|Epoch 4|Pregnancy|0|||
170643793|NCT02059291|616710099|FG008|Epoch 4|Pregnancy|0|||
170643794|NCT02059291|616710100|FG009|Epoch 4|Pregnancy|0|||
170643795|NCT02059291|616710101|FG010|Epoch 4|Pregnancy|0|||
170643796|NCT02059291|616710102|FG011|Epoch 4|Pregnancy|0|||
170643797|NCT02059291|616710103|FG012|Epoch 4|Pregnancy|0|||
170643798|NCT02059291|616710104|FG013|Epoch 4|Pregnancy|0|||
170643799|NCT02059291|616710105|FG014|Epoch 4|Pregnancy|0|||
170643800|NCT02059291|616710106|FG015|Epoch 4|Pregnancy|0|||
170643801|NCT02059291|616710107|FG016|Epoch 4|Pregnancy|1|||
170643802|NCT02059291|616710108|FG017|Epoch 4|Pregnancy|0|||
170643803|NCT02059291|616710109|FG018|Epoch 4|Pregnancy|0|||
170643804|NCT02059291|616710110|FG019|Epoch 4|Pregnancy|0|||
170643805|NCT02059291|616710111|FG020|Epoch 4|Pregnancy|0|||
170643806|NCT02059291|616710112|FG021|Epoch 4|Pregnancy|0|||
170643807|NCT02059291|616710113|FG022|Epoch 4|Pregnancy|0|||
170643808|NCT02059291|616710114|FG023|Epoch 4|Pregnancy|0|||
170643809|NCT02059291|616710115|FG024|Epoch 4|Pregnancy|0|||
170643810|NCT02059291|616710091|FG000|Epoch 4|Withdrawal by Subject|0|||
170643811|NCT02059291|616710092|FG001|Epoch 4|Withdrawal by Subject|0|||
170643812|NCT02059291|616710093|FG002|Epoch 4|Withdrawal by Subject|0|||
170643813|NCT02059291|616710094|FG003|Epoch 4|Withdrawal by Subject|0|||
170643814|NCT02059291|616710095|FG004|Epoch 4|Withdrawal by Subject|0|||
170643815|NCT02059291|616710096|FG005|Epoch 4|Withdrawal by Subject|0|||
170643816|NCT02059291|616710097|FG006|Epoch 4|Withdrawal by Subject|0|||
170643817|NCT02059291|616710098|FG007|Epoch 4|Withdrawal by Subject|0|||
170643818|NCT02059291|616710099|FG008|Epoch 4|Withdrawal by Subject|0|||
170643819|NCT02059291|616710100|FG009|Epoch 4|Withdrawal by Subject|0|||
170643820|NCT02059291|616710101|FG010|Epoch 4|Withdrawal by Subject|0|||
170643821|NCT02059291|616710102|FG011|Epoch 4|Withdrawal by Subject|0|||
170643822|NCT02059291|616710103|FG012|Epoch 4|Withdrawal by Subject|0|||
170643823|NCT02059291|616710104|FG013|Epoch 4|Withdrawal by Subject|0|||
170643824|NCT02059291|616710105|FG014|Epoch 4|Withdrawal by Subject|0|||
170643825|NCT02059291|616710106|FG015|Epoch 4|Withdrawal by Subject|0|||
170643826|NCT02059291|616710107|FG016|Epoch 4|Withdrawal by Subject|0|||
170643827|NCT02059291|616710108|FG017|Epoch 4|Withdrawal by Subject|0|||
170643828|NCT02059291|616710109|FG018|Epoch 4|Withdrawal by Subject|0|||
170643829|NCT02059291|616710110|FG019|Epoch 4|Withdrawal by Subject|0|||
170643830|NCT02059291|616710111|FG020|Epoch 4|Withdrawal by Subject|1|||
170643831|NCT02059291|616710112|FG021|Epoch 4|Withdrawal by Subject|0|||
170643832|NCT02059291|616710113|FG022|Epoch 4|Withdrawal by Subject|0|||
170643833|NCT02059291|616710114|FG023|Epoch 4|Withdrawal by Subject|0|||
170643834|NCT02059291|616710115|FG024|Epoch 4|Withdrawal by Subject|0|||
170643835|NCT02059291|616710091|FG000|Epoch 4|Lack of Efficacy|0|||
170643836|NCT02059291|616710092|FG001|Epoch 4|Lack of Efficacy|0|||
170643837|NCT02059291|616710093|FG002|Epoch 4|Lack of Efficacy|0|||
170904577|NCT00488631|617652353|FG003|Double Blind Period (Week 0-54)|Other|11|||
170643838|NCT02059291|616710094|FG003|Epoch 4|Lack of Efficacy|0|||
170643839|NCT02059291|616710095|FG004|Epoch 4|Lack of Efficacy|0|||
170643840|NCT02059291|616710096|FG005|Epoch 4|Lack of Efficacy|0|||
170904578|NCT00488631|617652354|FG004|Double Blind Period (Week 0-54)|Other|14|||
170643841|NCT02059291|616710097|FG006|Epoch 4|Lack of Efficacy|0|||
170643842|NCT02059291|616710098|FG007|Epoch 4|Lack of Efficacy|0|||
170643843|NCT02059291|616710099|FG008|Epoch 4|Lack of Efficacy|0|||
170643844|NCT02059291|616710100|FG009|Epoch 4|Lack of Efficacy|0|||
170643845|NCT02059291|616710101|FG010|Epoch 4|Lack of Efficacy|0|||
170643846|NCT02059291|616710102|FG011|Epoch 4|Lack of Efficacy|0|||
170643847|NCT02059291|616710103|FG012|Epoch 4|Lack of Efficacy|0|||
170643848|NCT02059291|616710104|FG013|Epoch 4|Lack of Efficacy|0|||
170643849|NCT02059291|616710105|FG014|Epoch 4|Lack of Efficacy|0|||
170643850|NCT02059291|616710106|FG015|Epoch 4|Lack of Efficacy|0|||
170643851|NCT02059291|616710107|FG016|Epoch 4|Lack of Efficacy|0|||
170643852|NCT02059291|616710108|FG017|Epoch 4|Lack of Efficacy|0|||
170643853|NCT02059291|616710109|FG018|Epoch 4|Lack of Efficacy|0|||
170643854|NCT02059291|616710110|FG019|Epoch 4|Lack of Efficacy|0|||
170643855|NCT02059291|616710111|FG020|Epoch 4|Lack of Efficacy|0|||
170643856|NCT02059291|616710112|FG021|Epoch 4|Lack of Efficacy|0|||
170643857|NCT02059291|616710113|FG022|Epoch 4|Lack of Efficacy|0|||
170643858|NCT02059291|616710114|FG023|Epoch 4|Lack of Efficacy|1|||
170643859|NCT02059291|616710115|FG024|Epoch 4|Lack of Efficacy|0|||
170643860|NCT04975438|616710117|FG000|Overall Study|Lost to Follow-up|1|||
170643861|NCT04975438|616710118|FG001|Overall Study|Lost to Follow-up|0|||
170643862|NCT04975438|616710119|FG002|Overall Study|Lost to Follow-up|1|||
170510249|NCT02757352|616212443|FG001|Follow-Up Period|Withdrawal by Subject|0|||
170510250|NCT02757352|616212444|FG002|Follow-Up Period|Withdrawal by Subject|0|||
170510251|NCT02757352|616212445|FG003|Follow-Up Period|Withdrawal by Subject|0|||
170510252|NCT02757352|616212446|FG004|Follow-Up Period|Withdrawal by Subject|0|||
170510253|NCT02757352|616212447|FG005|Follow-Up Period|Withdrawal by Subject|0|||
170510254|NCT02757352|616212448|FG006|Follow-Up Period|Withdrawal by Subject|0|||
170510255|NCT02757352|616212449|FG007|Follow-Up Period|Withdrawal by Subject|1|||
170510256|NCT02757352|616212450|FG008|Follow-Up Period|Withdrawal by Subject|6|||
170510257|NCT02757352|616212451|FG009|Follow-Up Period|Withdrawal by Subject|2|||
170510258|NCT00904917|616212453|FG000|Overall Study|Lost to Follow-up|2|||
170510259|NCT00904917|616212454|FG001|Overall Study|Lost to Follow-up|2|||
170510260|NCT00904917|616212455|FG002|Overall Study|Lost to Follow-up|2|||
170510261|NCT00904917|616212456|FG003|Overall Study|Lost to Follow-up|2|||
170510262|NCT01299896|616212457|FG000|Overall Study|Withdrawal by Subject|1|||
170510263|NCT01299896|616212458|FG001|Overall Study|Withdrawal by Subject|7|||
170510264|NCT01299896|616212457|FG000|Overall Study|Lost to Follow-up|0|||
170510265|NCT01299896|616212458|FG001|Overall Study|Lost to Follow-up|11|||
170510266|NCT01796301|616212477|FG000|Overall Study|Withdrawal by Subject|15|||
170553437|NCT05259722|616371953|FG000|Overall Study|Withdrawal by Subject|15|||
170553438|NCT05259722|616371954|FG001|Overall Study|Withdrawal by Subject|33|||
170553439|NCT05259722|616371953|FG000|Overall Study|Various reasons|3|||
170553440|NCT05259722|616371954|FG001|Overall Study|Various reasons|9|||
170553441|NCT05259722|616371953|FG000|Overall Study|Not exposed to IMP|1|||
170553442|NCT05259722|616371954|FG001|Overall Study|Not exposed to IMP|12|||
170553443|NCT05259722|616371953|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
170553444|NCT05259722|616371954|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
170553445|NCT05346640|616371956|FG000|Overall Study|Lack of Efficacy|2|||
170553446|NCT05346640|616371956|FG000|Overall Study|Lost to Follow-up|14|||
170553447|NCT05346640|616371956|FG000|Overall Study|Protocol Violation|4|||
170553448|NCT05346640|616371956|FG000|Overall Study|Withdrawal by Subject|2|||
170553449|NCT05346640|616371956|FG000|Overall Study|Physiological Complications|3|||
170553450|NCT05346640|616371956|FG000|Overall Study|Other Reason|3|||
170553451|NCT01412983|616371957|FG000|1st Period|Ineligible|0|||
170553452|NCT01412983|616371958|FG001|1st Period|Ineligible|1|||
170553453|NCT01412983|616371957|FG000|1st Period|Positive slit lamp finding|0|||
170553454|NCT01412983|616371958|FG001|1st Period|Positive slit lamp finding|1|||
170553455|NCT01412983|616371957|FG000|1st Period|Unacceptable lens movement|0|||
170553456|NCT01412983|616371958|FG001|1st Period|Unacceptable lens movement|1|||
170553457|NCT01412983|616371957|FG000|1st Period|Inability to maintain wear|0|||
170553458|NCT01412983|616371958|FG001|1st Period|Inability to maintain wear|1|||
170553459|NCT04495478|616371962|FG000|Overall Study|Withdrawal by Subject|0|||
170553460|NCT04495478|616371963|FG001|Overall Study|Withdrawal by Subject|0|||
170553461|NCT04495478|616371964|FG002|Overall Study|Withdrawal by Subject|0|||
170643863|NCT04975438|616710120|FG003|Overall Study|Lost to Follow-up|0|||
170643864|NCT04975438|616710117|FG000|Overall Study|Withdrawal by Subject|1|||
170510267|NCT01796301|616212478|FG001|Overall Study|Withdrawal by Subject|15|||
170805969|NCT01372085|617299374|FG006|Washout Period 3|Withdrawal by Subject|0|||
170553462|NCT04495478|616371965|FG003|Overall Study|Withdrawal by Subject|1|||
170553463|NCT04495478|616371966|FG004|Overall Study|Withdrawal by Subject|0|||
170553464|NCT04495478|616371967|FG005|Overall Study|Withdrawal by Subject|0|||
170643865|NCT04975438|616710118|FG001|Overall Study|Withdrawal by Subject|0|||
170805970|NCT01372085|617299375|FG007|Washout Period 3|Withdrawal by Subject|0|||
170553465|NCT04495478|616371968|FG006|Overall Study|Withdrawal by Subject|0|||
170553466|NCT04495478|616371962|FG000|Overall Study|Physician Decision|0|||
170553467|NCT04495478|616371963|FG001|Overall Study|Physician Decision|1|||
170553468|NCT04495478|616371964|FG002|Overall Study|Physician Decision|0|||
170553469|NCT04495478|616371965|FG003|Overall Study|Physician Decision|0|||
170553470|NCT04495478|616371966|FG004|Overall Study|Physician Decision|1|||
170553471|NCT04495478|616371967|FG005|Overall Study|Physician Decision|0|||
170553472|NCT04495478|616371968|FG006|Overall Study|Physician Decision|0|||
170553473|NCT00655746|616371971|FG000|Overall Study|Withdrawal by Subject|1|||
170553474|NCT00561821|616371972|FG000|Overall Study|Not treated|0|||
170553475|NCT00561821|616371973|FG001|Overall Study|Not treated|0|||
170553476|NCT00561821|616371974|FG002|Overall Study|Not treated|1|||
170553477|NCT00561821|616371975|FG003|Overall Study|Not treated|0|||
170553478|NCT00561821|616371972|FG000|Overall Study|Withdrawal by Subject|0|||
170553479|NCT00561821|616371973|FG001|Overall Study|Withdrawal by Subject|1|||
170553480|NCT00561821|616371974|FG002|Overall Study|Withdrawal by Subject|0|||
170553481|NCT00561821|616371975|FG003|Overall Study|Withdrawal by Subject|2|||
170553482|NCT00561821|616371972|FG000|Overall Study|Reasons not related to trial|2|||
170553483|NCT00561821|616371973|FG001|Overall Study|Reasons not related to trial|1|||
170553484|NCT00561821|616371974|FG002|Overall Study|Reasons not related to trial|0|||
170553485|NCT00561821|616371975|FG003|Overall Study|Reasons not related to trial|0|||
170553486|NCT00561821|616371972|FG000|Overall Study|Other (reason not specified)|1|||
170553487|NCT00561821|616371973|FG001|Overall Study|Other (reason not specified)|1|||
170553488|NCT00561821|616371974|FG002|Overall Study|Other (reason not specified)|0|||
170553489|NCT00561821|616371975|FG003|Overall Study|Other (reason not specified)|0|||
170553490|NCT00561821|616371972|FG000|Overall Study|Adverse Event|2|||
170553491|NCT00561821|616371973|FG001|Overall Study|Adverse Event|3|||
170553492|NCT00561821|616371974|FG002|Overall Study|Adverse Event|1|||
170553493|NCT00561821|616371975|FG003|Overall Study|Adverse Event|1|||
170553494|NCT03178942|616371976|FG000|Overall Study|Withdrawal by Subject|2|||
170553495|NCT03178942|616371977|FG001|Overall Study|Withdrawal by Subject|0|||
170553496|NCT03178942|616371976|FG000|Overall Study|Lost to Follow-up|1|||
170553497|NCT03178942|616371977|FG001|Overall Study|Lost to Follow-up|2|||
170553498|NCT00581100|616373483|FG000|Overall Study|Death|1|||
170553499|NCT00581100|616373484|FG001|Overall Study|Death|0|||
170553500|NCT00581100|616373483|FG000|Overall Study|Adverse Event|2|||
170553501|NCT00581100|616373484|FG001|Overall Study|Adverse Event|1|||
170553502|NCT00581100|616373483|FG000|Overall Study|Withdrawal by Subject|1|||
170553503|NCT00581100|616373484|FG001|Overall Study|Withdrawal by Subject|4|||
170553504|NCT00581100|616373483|FG000|Overall Study|Other|3|||
170553505|NCT00581100|616373484|FG001|Overall Study|Other|0|||
170553506|NCT02904265|616373490|FG000|Overall Study|Physician Decision|1|||
170553507|NCT02904265|616373491|FG001|Overall Study|Physician Decision|2|||
170553508|NCT05069415|616373496|FG000|Overall Study|Withdrawal by Subject|2|||
170553509|NCT05069415|616373497|FG001|Overall Study|Withdrawal by Subject|0|||
170553510|NCT05069415|616373496|FG000|Overall Study|Adverse Event|2|||
170553511|NCT05069415|616373497|FG001|Overall Study|Adverse Event|0|||
170553512|NCT00101400|616373498|FG000|Survival Follow-Up|Alive|7|||
170553513|NCT01500135|616373504|FG000|Overall Study|Withdrawal of Consent|4|||
170553514|NCT01500135|616373505|FG001|Overall Study|Withdrawal of Consent|0|||
170553515|NCT01500135|616373504|FG000|Overall Study|Lost to Follow-up|6|||
170553516|NCT01500135|616373505|FG001|Overall Study|Lost to Follow-up|4|||
170553517|NCT01500135|616373504|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
170553518|NCT01500135|616373505|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
170553519|NCT01500135|616373504|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
170553520|NCT01500135|616373505|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
170553521|NCT01500135|616373504|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
170553522|NCT01500135|616373505|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
170553523|NCT01500135|616373504|FG000|Overall Study|Participant was a Safety Concern|1|||
170553524|NCT01500135|616373505|FG001|Overall Study|Participant was a Safety Concern|0|||
170553525|NCT01500135|616373504|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
170805971|NCT01372085|617299376|FG008|Washout Period 3|Withdrawal by Subject|0|||
170805972|NCT01372085|617299377|FG009|Washout Period 3|Withdrawal by Subject|0|||
170553526|NCT01500135|616373505|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
170553527|NCT01661595|616373506|FG000|Phase 1: Week 0-4|Adverse Event|1|||
170553528|NCT01661595|616373507|FG001|Phase 1: Week 0-4|Adverse Event|0|||
170553529|NCT01661595|616373508|FG002|Phase 1: Week 0-4|Adverse Event|0|||
170553530|NCT01661595|616373509|FG003|Phase 1: Week 0-4|Adverse Event|0|||
170553531|NCT01661595|616373506|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
170553532|NCT01661595|616373507|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
170553533|NCT01661595|616373508|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
170553534|NCT01661595|616373509|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
170553535|NCT00912509|616373510|FG000|Overall Study|Lost to Follow-up|1|||
170553536|NCT00912509|616373511|FG001|Overall Study|Lost to Follow-up|0|||
170553537|NCT00912509|616373510|FG000|Overall Study|Lack of Efficacy|4|||
170553538|NCT00912509|616373511|FG001|Overall Study|Lack of Efficacy|3|||
170553539|NCT05538728|616373512|FG000|Overall Study|Withdrawal by Subject|1|||
170510268|NCT01796301|616212477|FG000|Overall Study|Lost to Follow-up|3|||
170510269|NCT01796301|616212478|FG001|Overall Study|Lost to Follow-up|3|||
170510270|NCT01796301|616212477|FG000|Overall Study|Death|0|||
170510271|NCT01796301|616212478|FG001|Overall Study|Death|1|||
170510272|NCT01796301|616212477|FG000|Overall Study|Decision by Sponsor|0|||
170510273|NCT01796301|616212478|FG001|Overall Study|Decision by Sponsor|1|||
170510274|NCT01148459|616212479|FG000|Overall Study|Serious Adverse Event|5|||
170510275|NCT01148459|616212480|FG001|Overall Study|Serious Adverse Event|4|||
170510276|NCT01148459|616212479|FG000|Overall Study|Withdrawal by Subject|1|||
170510277|NCT01148459|616212480|FG001|Overall Study|Withdrawal by Subject|0|||
170510278|NCT01148459|616212479|FG000|Overall Study|Migrated/moved from study area|3|||
170510279|NCT01148459|616212480|FG001|Overall Study|Migrated/moved from study area|6|||
170510280|NCT01148459|616212479|FG000|Overall Study|Lost to Follow-up|2|||
170510281|NCT01148459|616212480|FG001|Overall Study|Lost to Follow-up|0|||
170510282|NCT01148459|616212479|FG000|Overall Study|Refusal|1|||
170510283|NCT01148459|616212480|FG001|Overall Study|Refusal|0|||
170510284|NCT01148459|616212479|FG000|Overall Study|Failure to comply with study procedures|0|||
170510285|NCT01148459|616212480|FG001|Overall Study|Failure to comply with study procedures|1|||
170510286|NCT02496039|616212481|FG000|Overall Study|Adverse Event|3|||
170510287|NCT02496039|616212481|FG000|Overall Study|Protocol Violation|1|||
170510288|NCT00948922|616212482|FG000|Overall Study|Did not start study treatment|2|||
170643866|NCT04975438|616710119|FG002|Overall Study|Withdrawal by Subject|0|||
170643867|NCT04975438|616710120|FG003|Overall Study|Withdrawal by Subject|0|||
170643868|NCT01276054|616710126|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
170643869|NCT01276054|616710127|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
170643870|NCT00787267|616710128|FG000|Overall Study|Screen failure/Ineligible|10|||
170643871|NCT00787267|616710128|FG000|Overall Study|No Reason Provided|1|||
170643872|NCT00787267|616710128|FG000|Overall Study|Withdrawal by Subject|1|||
170643873|NCT04343235|616710129|FG000|Overall Study|Lost to Follow-up|3|||
170643874|NCT04343235|616710130|FG001|Overall Study|Lost to Follow-up|2|||
170643875|NCT00865280|616710131|FG000|Overall Study|Withdrawal by Subject|4|||
170643876|NCT00865280|616710132|FG001|Overall Study|Withdrawal by Subject|1|||
170643877|NCT00865280|616710131|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
170643878|NCT00865280|616710132|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
170643879|NCT00865280|616710131|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
170643880|NCT00865280|616710132|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
170643881|NCT00865280|616710131|FG000|Overall Study|Exclusion Condition|1|||
170643882|NCT00865280|616710132|FG001|Overall Study|Exclusion Condition|0|||
170510289|NCT00948922|616212483|FG001|Overall Study|Did not start study treatment|5|||
170510290|NCT00948922|616212484|FG002|Overall Study|Did not start study treatment|0|||
170510291|NCT00948922|616212482|FG000|Overall Study|Withdrawal by Subject|0|||
170510292|NCT00948922|616212483|FG001|Overall Study|Withdrawal by Subject|2|||
170510293|NCT00948922|616212484|FG002|Overall Study|Withdrawal by Subject|1|||
170510294|NCT00948922|616212482|FG000|Overall Study|Death|3|||
170510295|NCT00948922|616212483|FG001|Overall Study|Death|0|||
170510296|NCT00948922|616212484|FG002|Overall Study|Death|0|||
170510297|NCT00948922|616212482|FG000|Overall Study|Disease progression|0|||
170510298|NCT00948922|616212483|FG001|Overall Study|Disease progression|1|||
170510299|NCT00948922|616212484|FG002|Overall Study|Disease progression|0|||
170510300|NCT00948922|616212482|FG000|Overall Study|Insurance issues|1|||
170510301|NCT00948922|616212483|FG001|Overall Study|Insurance issues|0|||
170510302|NCT00948922|616212484|FG002|Overall Study|Insurance issues|0|||
170510303|NCT00948922|616212482|FG000|Overall Study|Transplant eligibility issues|2|||
170510304|NCT00948922|616212483|FG001|Overall Study|Transplant eligibility issues|3|||
170510305|NCT00948922|616212484|FG002|Overall Study|Transplant eligibility issues|0|||
170510306|NCT00948922|616212482|FG000|Overall Study|Not evaluable at time of analysis|0|||
170510307|NCT00948922|616212483|FG001|Overall Study|Not evaluable at time of analysis|3|||
170510308|NCT00948922|616212484|FG002|Overall Study|Not evaluable at time of analysis|0|||
170553540|NCT05538728|616373513|FG001|Overall Study|Withdrawal by Subject|1|||
170553541|NCT01517178|616373514|FG000|Period 1|Adverse Event|1|||
170553542|NCT01517178|616373515|FG001|Period 1|Adverse Event|2|||
170553543|NCT01517178|616373514|FG000|Period 1|Lack of Efficacy|0|||
170553544|NCT01517178|616373515|FG001|Period 1|Lack of Efficacy|1|||
170553545|NCT01517178|616373514|FG000|Period 1|E.g. study termination|3|||
170553546|NCT01517178|616373515|FG001|Period 1|E.g. study termination|1|||
170553547|NCT01517178|616373514|FG000|Period 1|Withdrawal by Subject|0|||
170553548|NCT01517178|616373515|FG001|Period 1|Withdrawal by Subject|1|||
170553549|NCT01517178|616373514|FG000|Period 2|Adverse Event|1|||
170510309|NCT04854057|616212485|FG000|Overall Study|Adverse Event|0|||
170553550|NCT01517178|616373515|FG001|Period 2|Adverse Event|0|||
170553551|NCT01517178|616373514|FG000|Period 2|Withdrawal by Subject|3|||
170643883|NCT00865280|616710131|FG000|Overall Study|Adverse Event|0|||
170643884|NCT00865280|616710132|FG001|Overall Study|Adverse Event|1|||
170510310|NCT04854057|616212486|FG001|Overall Study|Adverse Event|1|||
170510311|NCT02131233|616212487|FG000|Overall Study|Not Treated|2|||
170553552|NCT01517178|616373515|FG001|Period 2|Withdrawal by Subject|0|||
170553553|NCT01517178|616373514|FG000|Period 2|E.g. study termination|2|||
170553554|NCT01517178|616373515|FG001|Period 2|E.g. study termination|2|||
170553555|NCT01557569|616373516|FG000|Overall Study|Adverse Event|2|||
170553556|NCT01557569|616373517|FG001|Overall Study|Adverse Event|0|||
170805973|NCT01833455|617299378|FG000|Overall Study|Withdrawal by Subject|1|||
170805974|NCT01833455|617299379|FG001|Overall Study|Withdrawal by Subject|0|||
170805975|NCT00562094|617299380|FG000|Overall Study|Lost to Follow-up|62|||
170510312|NCT02131233|616212488|FG001|Overall Study|Not Treated|3|||
170510313|NCT02131233|616212487|FG000|Overall Study|Adverse Event|7|||
170510314|NCT02131233|616212488|FG001|Overall Study|Adverse Event|6|||
170510315|NCT02131233|616212487|FG000|Overall Study|Death|0|||
170510316|NCT02131233|616212488|FG001|Overall Study|Death|1|||
170510317|NCT02131233|616212487|FG000|Overall Study|Lack of Efficacy|6|||
170510318|NCT02131233|616212488|FG001|Overall Study|Lack of Efficacy|3|||
170510319|NCT02131233|616212487|FG000|Overall Study|Lost to Follow-up|14|||
170510320|NCT02131233|616212488|FG001|Overall Study|Lost to Follow-up|13|||
170510321|NCT02131233|616212487|FG000|Overall Study|Non-Compliance With Study Drug|8|||
170510322|NCT02131233|616212488|FG001|Overall Study|Non-Compliance With Study Drug|5|||
170805976|NCT03689946|617299383|FG000|Overall Study|Withdrawal by Subject|3|||
170805977|NCT03689946|617299383|FG000|Overall Study|Lost to Follow-up|3|||
170805978|NCT03689946|617299383|FG000|Overall Study|Data corruption|2|||
170805979|NCT01555138|617299384|FG000|Overall Study|Death|0|||
170805980|NCT01555138|617299385|FG001|Overall Study|Death|1|||
170805981|NCT01555138|617299384|FG000|Overall Study|Lost to Follow-up|1|||
170805982|NCT01555138|617299385|FG001|Overall Study|Lost to Follow-up|0|||
170805983|NCT01555138|617299384|FG000|Overall Study|Abnormal Lab reults|1|||
170805984|NCT01555138|617299385|FG001|Overall Study|Abnormal Lab reults|3|||
170805985|NCT01555138|617299384|FG000|Overall Study|Lack of Efficacy|2|||
170805986|NCT01555138|617299385|FG001|Overall Study|Lack of Efficacy|2|||
170805987|NCT01555138|617299384|FG000|Overall Study|Protocol Violation|5|||
170805988|NCT01555138|617299385|FG001|Overall Study|Protocol Violation|3|||
170805989|NCT01555138|617299384|FG000|Overall Study|Administrative problems|8|||
170805990|NCT01555138|617299385|FG001|Overall Study|Administrative problems|0|||
170805991|NCT01555138|617299384|FG000|Overall Study|Withdrawal by Subject|16|||
170805992|NCT01555138|617299385|FG001|Overall Study|Withdrawal by Subject|15|||
170805993|NCT01555138|617299384|FG000|Overall Study|Adverse Event|14|||
170805994|NCT01555138|617299385|FG001|Overall Study|Adverse Event|14|||
170805995|NCT03220724|617299387|FG000|Overall Study|Lost to Follow-up|2|||
170805996|NCT03220724|617299388|FG001|Overall Study|Lost to Follow-up|2|||
170805997|NCT03220724|617299389|FG002|Overall Study|Lost to Follow-up|0|||
170805998|NCT03220724|617299390|FG003|Overall Study|Lost to Follow-up|3|||
170805999|NCT03220724|617299391|FG004|Overall Study|Lost to Follow-up|1|||
170806000|NCT03220724|617299392|FG005|Overall Study|Lost to Follow-up|0|||
170806001|NCT03220724|617299393|FG006|Overall Study|Lost to Follow-up|2|||
170806002|NCT03220724|617299394|FG007|Overall Study|Lost to Follow-up|1|||
170806003|NCT03220724|617299395|FG008|Overall Study|Lost to Follow-up|0|||
170806004|NCT03220724|617299387|FG000|Overall Study|Withdrawal by Subject|1|||
170806005|NCT03220724|617299388|FG001|Overall Study|Withdrawal by Subject|0|||
170806006|NCT03220724|617299389|FG002|Overall Study|Withdrawal by Subject|1|||
170553557|NCT01557569|616373516|FG000|Overall Study|high blood pressure|0|||
170553558|NCT01557569|616373517|FG001|Overall Study|high blood pressure|1|||
170553559|NCT01557569|616373516|FG000|Overall Study|Withdrawal by Subject|3|||
170553560|NCT01557569|616373517|FG001|Overall Study|Withdrawal by Subject|5|||
170806007|NCT03220724|617299390|FG003|Overall Study|Withdrawal by Subject|0|||
170904579|NCT00488631|617652355|FG005|Double Blind Period (Week 0-54)|Other|34|||
170553561|NCT01557569|616373516|FG000|Overall Study|noncompliance with rules of residential|0|||
170553562|NCT01557569|616373517|FG001|Overall Study|noncompliance with rules of residential|1|||
170553563|NCT01050218|616373518|FG000|Overall Study|Adverse Event|37|||
170553564|NCT01050218|616373518|FG000|Overall Study|Lack of Efficacy|8|||
170553565|NCT01050218|616373518|FG000|Overall Study|Protocol Violation|3|||
170553566|NCT01050218|616373518|FG000|Overall Study|Withdrawal by Subject|18|||
170553567|NCT01050218|616373518|FG000|Overall Study|Discontinued by sponsor|18|||
170553568|NCT01050218|616373518|FG000|Overall Study|Compliance|2|||
170806008|NCT03220724|617299391|FG004|Overall Study|Withdrawal by Subject|0|||
170904580|NCT00488631|617652356|FG006|Double Blind Period (Week 0-54)|Other|0|||
170904581|NCT00488631|617652357|FG007|Double Blind Period (Week 0-54)|Other|0|||
170510323|NCT02131233|616212487|FG000|Overall Study|Physician Decision|7|||
170510324|NCT02131233|616212488|FG001|Overall Study|Physician Decision|0|||
170806009|NCT03220724|617299392|FG005|Overall Study|Withdrawal by Subject|0|||
170510325|NCT02131233|616212487|FG000|Overall Study|Pregnancy|4|||
170510326|NCT02131233|616212488|FG001|Overall Study|Pregnancy|0|||
170806010|NCT03220724|617299393|FG006|Overall Study|Withdrawal by Subject|0|||
170806011|NCT03220724|617299394|FG007|Overall Study|Withdrawal by Subject|0|||
170806012|NCT03220724|617299395|FG008|Overall Study|Withdrawal by Subject|0|||
170904582|NCT00488631|617652358|FG008|Double Blind Period (Week 0-54)|Other|0|||
170553569|NCT01050218|616373518|FG000|Overall Study|Failed to return|7|||
170553570|NCT01050218|616373518|FG000|Overall Study|Serious Adverse Event|1|||
170553571|NCT01050218|616373518|FG000|Overall Study|Family emergency|1|||
170553572|NCT02336555|616373519|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170806013|NCT03960645|617299396|FG000|Overall Study|Protocol Violation|1|||
170806014|NCT03960645|617299397|FG001|Overall Study|Protocol Violation|0|||
170510327|NCT02131233|616212487|FG000|Overall Study|Withdrawal by Subject|18|||
170510328|NCT02131233|616212488|FG001|Overall Study|Withdrawal by Subject|11|||
170510329|NCT05114564|616212490|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
170510330|NCT05114564|616212491|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
170510331|NCT05114564|616212490|FG000|First Intervention|Adverse Event|0|||
170510332|NCT05114564|616212491|FG001|First Intervention|Adverse Event|1|||
170510333|NCT00255840|616212498|FG000|Overall Study|Lost to Follow-up|10|||
170510334|NCT00255840|616212499|FG001|Overall Study|Lost to Follow-up|14|||
170510335|NCT00255840|616212498|FG000|Overall Study|Discontinued intervention|53|||
170510336|NCT00255840|616212499|FG001|Overall Study|Discontinued intervention|56|||
170510337|NCT01006590|616212507|FG000|Overall Study|Adverse Event|2|||
170510338|NCT01006590|616212508|FG001|Overall Study|Adverse Event|3|||
170510339|NCT01006590|616212507|FG000|Overall Study|Death|1|||
170510340|NCT01006590|616212508|FG001|Overall Study|Death|1|||
170510341|NCT01006590|616212507|FG000|Overall Study|Lost to Follow-up|1|||
170510342|NCT01006590|616212508|FG001|Overall Study|Lost to Follow-up|1|||
170510343|NCT01006590|616212507|FG000|Overall Study|Protocol Violation|1|||
170806015|NCT03392194|617299400|FG000|Overall Study|Withdrawal by Subject|1|||
170904583|NCT00488631|617652359|FG009|Double Blind Period (Week 0-54)|Other|0|||
170904584|NCT00488631|617652350|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
170904585|NCT00488631|617652351|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
170904586|NCT00488631|617652352|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
170904587|NCT00488631|617652353|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
170904588|NCT00488631|617652354|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
170904589|NCT00488631|617652355|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
170904590|NCT00488631|617652356|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
170904591|NCT00488631|617652357|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
170904592|NCT00488631|617652358|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
170904593|NCT00488631|617652359|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
170904594|NCT00488631|617652350|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
170904595|NCT00488631|617652351|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
170904596|NCT00488631|617652352|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
170904597|NCT00488631|617652353|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
170904598|NCT00488631|617652354|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
170904599|NCT00488631|617652355|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
170904600|NCT00488631|617652356|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
170904601|NCT00488631|617652357|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
170904602|NCT00488631|617652358|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
170904603|NCT00488631|617652359|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
170904604|NCT00488631|617652350|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
170904605|NCT00488631|617652351|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
170904606|NCT00488631|617652352|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
170510344|NCT01006590|616212508|FG001|Overall Study|Protocol Violation|0|||
170510345|NCT01006590|616212507|FG000|Overall Study|Withdrawal by Subject|4|||
170510346|NCT01006590|616212508|FG001|Overall Study|Withdrawal by Subject|2|||
170510347|NCT01006590|616212507|FG000|Overall Study|Study specific discontinuation criteria|16|||
170510348|NCT01006590|616212508|FG001|Overall Study|Study specific discontinuation criteria|23|||
170510349|NCT01006590|616212507|FG000|Overall Study|Other|3|||
170806016|NCT03392194|617299401|FG001|Overall Study|Withdrawal by Subject|2|||
170806017|NCT03392194|617299400|FG000|Overall Study|Conflicts with personal schedule|1|||
170806018|NCT03392194|617299401|FG001|Overall Study|Conflicts with personal schedule|0|||
170806019|NCT00918333|617299402|FG000|Overall Study|Drug not taken per protocol|1|||
170806020|NCT00918333|617299403|FG001|Overall Study|Drug not taken per protocol|0|||
170806021|NCT00918333|617299402|FG000|Overall Study|Inadequate amount of drugs provided|1|||
170806022|NCT00918333|617299403|FG001|Overall Study|Inadequate amount of drugs provided|4|||
170806023|NCT00918333|617299402|FG000|Overall Study|Ineligible|1|||
170806024|NCT00918333|617299403|FG001|Overall Study|Ineligible|0|||
170806025|NCT00918333|617299402|FG000|Overall Study|Withdrawal by Subject|0|||
170806026|NCT00918333|617299403|FG001|Overall Study|Withdrawal by Subject|1|||
170806027|NCT00454194|617299404|FG000|Overall Study|Adverse Event|7|||
170806028|NCT00454194|617299405|FG001|Overall Study|Adverse Event|2|||
170806029|NCT00454194|617299404|FG000|Overall Study|Withdrawal by Subject|12|||
170806030|NCT00454194|617299405|FG001|Overall Study|Withdrawal by Subject|8|||
170806031|NCT00454194|617299404|FG000|Overall Study|Other Medical Problems|1|||
170806032|NCT00454194|617299405|FG001|Overall Study|Other Medical Problems|2|||
170806033|NCT00454194|617299404|FG000|Overall Study|Other Unspecified Reason|2|||
170510350|NCT01006590|616212508|FG001|Overall Study|Other|2|||
170806034|NCT00454194|617299405|FG001|Overall Study|Other Unspecified Reason|2|||
170806035|NCT03345979|617299406|FG000|Overall Study|Withdrawal by Subject|20|||
170806036|NCT03345979|617299407|FG001|Overall Study|Withdrawal by Subject|31|||
170510351|NCT03332095|616212509|FG000|Overall Study|Lost to Follow-up|1|||
170510352|NCT03332095|616212510|FG001|Overall Study|Lost to Follow-up|0|||
170510353|NCT03332095|616212509|FG000|Overall Study|Pregnancy|0|||
170510354|NCT03332095|616212510|FG001|Overall Study|Pregnancy|1|||
170510355|NCT03146741|616212514|FG000|Overall Study|Txp with non-HCV+ heart|4|||
170510356|NCT03146741|616212514|FG000|Overall Study|Listeted for MOT|2|||
170510357|NCT03146741|616212514|FG000|Overall Study|Physician Decision|2|||
170510358|NCT03146741|616212514|FG000|Overall Study|Awaiting txp|2|||
170510359|NCT03224624|616212515|FG000|Overall Study|Lost to Follow-up|9|||
170510360|NCT03224624|616212516|FG001|Overall Study|Lost to Follow-up|4|||
170510361|NCT03224624|616212515|FG000|Overall Study|Death|1|||
170510362|NCT03224624|616212516|FG001|Overall Study|Death|0|||
170510363|NCT03760458|616212517|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
170904607|NCT00488631|617652353|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
170904608|NCT00488631|617652354|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
170904609|NCT00488631|617652355|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
170904610|NCT00488631|617652356|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
170904611|NCT00488631|617652357|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
170904612|NCT00488631|617652358|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
170904613|NCT00488631|617652359|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
170904614|NCT00488631|617652350|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
170904615|NCT00488631|617652351|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
170904616|NCT00488631|617652352|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
170904617|NCT00488631|617652353|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
170904618|NCT00488631|617652354|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
170904619|NCT00488631|617652355|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
170904620|NCT00488631|617652356|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
170904621|NCT00488631|617652357|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
170904622|NCT00488631|617652358|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
170904623|NCT00488631|617652359|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
170904624|NCT00488631|617652350|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
170904625|NCT00488631|617652351|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
170904626|NCT00488631|617652352|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
170904627|NCT00488631|617652353|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
170904628|NCT00488631|617652354|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
170904629|NCT00488631|617652355|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
170904630|NCT00488631|617652356|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
170904631|NCT00488631|617652357|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
170904632|NCT00488631|617652358|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
170904633|NCT00488631|617652359|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
170904634|NCT03871491|617652360|FG000|Overall Study|Withdrawal by Subject|14|||
170904635|NCT03871491|617652361|FG001|Overall Study|Withdrawal by Subject|14|||
170904636|NCT03871491|617652362|FG002|Overall Study|Withdrawal by Subject|14|||
170904637|NCT03871491|617652363|FG003|Overall Study|Withdrawal by Subject|14|||
170510364|NCT03760458|616212518|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
170510365|NCT03760458|616212519|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
170510366|NCT03760458|616212520|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
170510367|NCT03760458|616212521|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
170510368|NCT03913104|616212524|FG000|Overall Study|Lost to Follow-up|20|||
170510369|NCT03913104|616212524|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
170510370|NCT03913104|616212524|FG000|Overall Study|Withdrawal by Subject|2|||
170510371|NCT01119846|616212525|FG000|Overall Study|Adverse Event|1|||
170510372|NCT01119846|616212526|FG001|Overall Study|Adverse Event|0|||
170510373|NCT01119846|616212527|FG002|Overall Study|Adverse Event|6|||
170510374|NCT01119846|616212525|FG000|Overall Study|Physician Decision|1|||
170510375|NCT01119846|616212526|FG001|Overall Study|Physician Decision|0|||
170510376|NCT01119846|616212527|FG002|Overall Study|Physician Decision|0|||
170510377|NCT01119846|616212525|FG000|Overall Study|Protocol Violation|0|||
170510378|NCT01119846|616212526|FG001|Overall Study|Protocol Violation|0|||
170510379|NCT01119846|616212527|FG002|Overall Study|Protocol Violation|1|||
170904638|NCT03871491|617652360|FG000|Overall Study|Physician Decision|0|||
170510380|NCT01119846|616212525|FG000|Overall Study|Withdrawal by Subject|0|||
170510381|NCT01119846|616212526|FG001|Overall Study|Withdrawal by Subject|0|||
170510382|NCT01119846|616212527|FG002|Overall Study|Withdrawal by Subject|4|||
170510383|NCT03420222|616212533|FG000|Overall Study|Withdrawal by Subject|5|||
170510384|NCT03420222|616212534|FG001|Overall Study|Withdrawal by Subject|0|||
170510385|NCT03420222|616212533|FG000|Overall Study|Physician Decision|0|||
170510386|NCT03420222|616212534|FG001|Overall Study|Physician Decision|1|||
170510387|NCT02651688|616212535|FG000|Overall Study|Non-compliance|0|||
170510388|NCT02651688|616212536|FG001|Overall Study|Non-compliance|0|||
170510389|NCT02651688|616212537|FG002|Overall Study|Non-compliance|1|||
170643885|NCT01396057|616710150|FG000|Overall Study|Adverse Event|2|||
170643886|NCT01396057|616710151|FG001|Overall Study|Adverse Event|6|||
170806037|NCT03345979|617299406|FG000|Overall Study|Adverse Event|10|||
170806038|NCT03345979|617299407|FG001|Overall Study|Adverse Event|11|||
170806039|NCT03345979|617299406|FG000|Overall Study|Lost to Follow-up|8|||
170806040|NCT03345979|617299407|FG001|Overall Study|Lost to Follow-up|9|||
170806041|NCT03345979|617299406|FG000|Overall Study|Lack of Efficacy|4|||
170806042|NCT03345979|617299407|FG001|Overall Study|Lack of Efficacy|2|||
170806043|NCT03345979|617299406|FG000|Overall Study|Protocol Violation|1|||
170806044|NCT03345979|617299407|FG001|Overall Study|Protocol Violation|3|||
170806045|NCT03345979|617299406|FG000|Overall Study|Physician Decision|0|||
170806046|NCT03345979|617299407|FG001|Overall Study|Physician Decision|2|||
170806047|NCT00734578|617299410|FG000|Overall Study|Adverse Event|4|||
170806048|NCT00734578|617299411|FG001|Overall Study|Adverse Event|6|||
170806049|NCT00734578|617299412|FG002|Overall Study|Adverse Event|1|||
170806050|NCT00734578|617299410|FG000|Overall Study|Protocol Violation|8|||
170806051|NCT00734578|617299411|FG001|Overall Study|Protocol Violation|6|||
170806052|NCT00734578|617299412|FG002|Overall Study|Protocol Violation|3|||
170806053|NCT00734578|617299410|FG000|Overall Study|Withdrawal by Subject|7|||
170806054|NCT00734578|617299411|FG001|Overall Study|Withdrawal by Subject|8|||
170806055|NCT00734578|617299412|FG002|Overall Study|Withdrawal by Subject|11|||
170806056|NCT00734578|617299410|FG000|Overall Study|Lost to Follow-up|9|||
170806057|NCT00734578|617299411|FG001|Overall Study|Lost to Follow-up|3|||
170806058|NCT00734578|617299412|FG002|Overall Study|Lost to Follow-up|5|||
170806059|NCT00734578|617299410|FG000|Overall Study|Lack of Efficacy|3|||
170806060|NCT00734578|617299411|FG001|Overall Study|Lack of Efficacy|2|||
170806061|NCT00734578|617299412|FG002|Overall Study|Lack of Efficacy|5|||
170806062|NCT00734578|617299410|FG000|Overall Study|Randomized in error|1|||
170806063|NCT00734578|617299411|FG001|Overall Study|Randomized in error|0|||
170806064|NCT00734578|617299412|FG002|Overall Study|Randomized in error|0|||
170806065|NCT00734578|617299410|FG000|Overall Study|Exclusion criteria|1|||
170806066|NCT00734578|617299411|FG001|Overall Study|Exclusion criteria|0|||
170806067|NCT00734578|617299412|FG002|Overall Study|Exclusion criteria|0|||
170806068|NCT02095145|617299413|FG000|Overall Study|Withdrawal by Subject|1|||
170806069|NCT02095145|617299414|FG001|Overall Study|Withdrawal by Subject|0|||
170806070|NCT02085941|617299417|FG000|Overall Study|Lack of Efficacy|1|||
170806071|NCT02085941|617299418|FG001|Overall Study|Lack of Efficacy|0|||
170806072|NCT02085941|617299417|FG000|Overall Study|Death|6|||
170806073|NCT02085941|617299418|FG001|Overall Study|Death|1|||
170806074|NCT02085941|617299417|FG000|Overall Study|Lost to Follow-up|1|||
170806075|NCT02085941|617299418|FG001|Overall Study|Lost to Follow-up|0|||
170806076|NCT02085941|617299417|FG000|Overall Study|Physician Decision|0|||
170806077|NCT02085941|617299418|FG001|Overall Study|Physician Decision|2|||
170806078|NCT00787176|617299422|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
170806079|NCT00787176|617299423|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
170806080|NCT00787176|617299424|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
170806081|NCT00787176|617299425|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
170806082|NCT01124045|617299426|FG000|Overall Study|Lost to Follow-up|0|||
170806083|NCT01124045|617299427|FG001|Overall Study|Lost to Follow-up|1|||
170806084|NCT01124045|617299426|FG000|Overall Study|Physician Decision|0|||
170806085|NCT01124045|617299427|FG001|Overall Study|Physician Decision|2|||
170806086|NCT03184987|617299435|FG000|Overall Study|Withdrawal by Subject|0|||
170806087|NCT03184987|617299436|FG001|Overall Study|Withdrawal by Subject|1|||
170806088|NCT03184987|617299437|FG002|Overall Study|Withdrawal by Subject|2|||
170806089|NCT03184987|617299435|FG000|Overall Study|Physician Decision|0|||
170806090|NCT03184987|617299436|FG001|Overall Study|Physician Decision|0|||
170806091|NCT03184987|617299437|FG002|Overall Study|Physician Decision|1|||
170806092|NCT03184987|617299435|FG000|Overall Study|Adverse Event|1|||
170806093|NCT03184987|617299436|FG001|Overall Study|Adverse Event|0|||
170806094|NCT03184987|617299437|FG002|Overall Study|Adverse Event|1|||
170806095|NCT02517268|617299442|FG000|Overall Study|Withdrawal by Subject|1|||
170510390|NCT02651688|616212535|FG000|Overall Study|Principal Investigator (PI) decision|0|||
170806096|NCT02517268|617299443|FG001|Overall Study|Withdrawal by Subject|0|||
170806097|NCT04686266|617299446|FG000|Overall Study|Withdrawal by Subject|0|||
170806098|NCT04686266|617299447|FG001|Overall Study|Withdrawal by Subject|1|||
170806099|NCT05613907|617299452|FG000|Overall Study|Lost to Follow-up|5|||
170806100|NCT05613907|617299452|FG000|Overall Study|Death|3|||
170806101|NCT05613907|617299452|FG000|Overall Study|Withdrawal by Subject|2|||
170806102|NCT03789656|617299453|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
170806103|NCT03789656|617299454|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
170806104|NCT03789656|617299455|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
170806105|NCT03789656|617299456|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
170806106|NCT03789656|617299457|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
170806107|NCT03789656|617299453|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
170806108|NCT03789656|617299454|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
170904639|NCT03871491|617652361|FG001|Overall Study|Physician Decision|0|||
170510391|NCT02651688|616212536|FG001|Overall Study|Principal Investigator (PI) decision|2|||
170510392|NCT02651688|616212537|FG002|Overall Study|Principal Investigator (PI) decision|0|||
170510393|NCT02651688|616212535|FG000|Overall Study|Lost to Follow-up|1|||
170510394|NCT02651688|616212536|FG001|Overall Study|Lost to Follow-up|3|||
170510395|NCT02651688|616212537|FG002|Overall Study|Lost to Follow-up|0|||
170510396|NCT02651688|616212535|FG000|Overall Study|Withdrawal by Subject|1|||
170510397|NCT02651688|616212536|FG001|Overall Study|Withdrawal by Subject|0|||
170510398|NCT02651688|616212537|FG002|Overall Study|Withdrawal by Subject|2|||
170510399|NCT02112877|616212538|FG000|Overall Study|Withdrawal by Subject|1|||
170510400|NCT02112877|616212539|FG001|Overall Study|Withdrawal by Subject|7|||
170510401|NCT02112877|616212538|FG000|Overall Study|Visit Missed|1|||
170510402|NCT02112877|616212539|FG001|Overall Study|Visit Missed|6|||
170510403|NCT01490697|616212550|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
170510404|NCT01490697|616212551|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
170510405|NCT00379808|616212552|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
170510406|NCT00379808|616212553|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
170510407|NCT01380691|616212556|FG000|Washout (7 Days)|Protocol Violation|0|||
170510408|NCT01380691|616212557|FG001|Washout (7 Days)|Protocol Violation|0|||
170510409|NCT01380691|616212558|FG002|Washout (7 Days)|Protocol Violation|0|||
170510410|NCT01380691|616212559|FG003|Washout (7 Days)|Protocol Violation|1|||
170510411|NCT01380691|616212556|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
170510412|NCT01380691|616212557|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
170510413|NCT01380691|616212558|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
170510414|NCT01380691|616212559|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
170510415|NCT02791438|616212563|FG000|Treatment Period|Adverse Event|1|||
170510416|NCT02791438|616212564|FG001|Treatment Period|Adverse Event|0|||
170643887|NCT01396057|616710150|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170643888|NCT01396057|616710151|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
170643889|NCT01396057|616710150|FG000|Overall Study|Protocol deviation|4|||
170643890|NCT01396057|616710151|FG001|Overall Study|Protocol deviation|4|||
170643891|NCT01396057|616710150|FG000|Overall Study|Consent withdrawn|3|||
170643892|NCT01396057|616710151|FG001|Overall Study|Consent withdrawn|2|||
170643893|NCT00228553|616710154|FG000|Overall Study|Adverse Event|112|||
170643894|NCT00228553|616710154|FG000|Overall Study|Lack of Efficacy|34|||
170643895|NCT00228553|616710154|FG000|Overall Study|Lost to Follow-up|67|||
170643896|NCT00228553|616710154|FG000|Overall Study|Physician Decision|48|||
170643897|NCT00228553|616710154|FG000|Overall Study|Protocol Violation|6|||
170643898|NCT00228553|616710154|FG000|Overall Study|Withdrawal by Subject|115|||
170643899|NCT00228553|616710154|FG000|Overall Study|Pregnancy|2|||
170643900|NCT00228553|616710154|FG000|Overall Study|Miscellaneous|46|||
170643901|NCT04530136|616710155|FG000|Overall Study|Lost to Follow-up|2|||
170510417|NCT02791438|616212563|FG000|Treatment Period|Withdrawal by Subject|0|||
170510418|NCT02791438|616212564|FG001|Treatment Period|Withdrawal by Subject|1|||
170510419|NCT02791438|616212563|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
170510420|NCT02791438|616212564|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
170510421|NCT01952080|616212565|FG000|Overall Study|Withdrawal by Subject|0|||
170510422|NCT01952080|616212566|FG001|Overall Study|Withdrawal by Subject|0|||
170643902|NCT04530136|616710156|FG001|Overall Study|Lost to Follow-up|3|||
170643903|NCT04530136|616710155|FG000|Overall Study|Withdrawal by Subject|1|||
170510423|NCT01952080|616212567|FG002|Overall Study|Withdrawal by Subject|0|||
170510424|NCT01952080|616212568|FG003|Overall Study|Withdrawal by Subject|1|||
170510425|NCT01952080|616212565|FG000|Overall Study|Protocol Non-compliance|0|||
170510426|NCT01952080|616212566|FG001|Overall Study|Protocol Non-compliance|1|||
170510427|NCT01952080|616212567|FG002|Overall Study|Protocol Non-compliance|0|||
170510428|NCT01952080|616212568|FG003|Overall Study|Protocol Non-compliance|0|||
170643904|NCT04530136|616710156|FG001|Overall Study|Withdrawal by Subject|0|||
170643905|NCT04530136|616710155|FG000|Overall Study|Death|0|||
170643906|NCT04530136|616710156|FG001|Overall Study|Death|1|||
170643907|NCT02878798|616710158|FG000|Overall Study|Withdrawal by Subject|5|||
170643908|NCT02878798|616710159|FG001|Overall Study|Withdrawal by Subject|4|||
170643909|NCT02878798|616710158|FG000|Overall Study|Lost to Follow-up|2|||
170643910|NCT02878798|616710159|FG001|Overall Study|Lost to Follow-up|2|||
170643911|NCT02878798|616710158|FG000|Overall Study|Protocol Violation|0|||
170643912|NCT02878798|616710159|FG001|Overall Study|Protocol Violation|1|||
170643913|NCT02720042|616710165|FG000|Overall Study|Death|3|||
170643914|NCT02720042|616710165|FG000|Overall Study|Lost to Follow-up|4|||
170643915|NCT02720042|616710165|FG000|Overall Study|Withdrawal by Subject|1|||
170643916|NCT02720042|616710165|FG000|Overall Study|Physician Decision|3|||
170643917|NCT02720042|616710165|FG000|Overall Study|Phasix Mesh explanted|1|||
170643918|NCT02720042|616710165|FG000|Overall Study|unable due to non-study-related illness|3|||
170643919|NCT03704636|616710166|FG000|Overall Study|Inadequate Venous Flow|3|||
170643920|NCT00884741|616710167|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
170643921|NCT00884741|616710168|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
170643922|NCT00884741|616710169|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
170643923|NCT00884741|616710170|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
170643924|NCT00884741|616710167|FG000|Step 1 Registration: Tissue Screening|Death|3|||
170643925|NCT00884741|616710168|FG001|Step 1 Registration: Tissue Screening|Death|0|||
170643926|NCT00884741|616710169|FG002|Step 1 Registration: Tissue Screening|Death|0|||
170643927|NCT00884741|616710170|FG003|Step 1 Registration: Tissue Screening|Death|0|||
170643928|NCT00884741|616710167|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
170643929|NCT00884741|616710168|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
170643930|NCT00884741|616710169|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
170643931|NCT00884741|616710170|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
170643932|NCT00884741|616710167|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
170643933|NCT00884741|616710168|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
170643934|NCT00884741|616710169|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
170643935|NCT00884741|616710170|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
170643936|NCT00884741|616710167|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
170643937|NCT00884741|616710168|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
170643938|NCT00884741|616710169|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
170643939|NCT00884741|616710170|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
170643940|NCT00884741|616710167|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
170643941|NCT00884741|616710168|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
170643942|NCT00884741|616710169|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
170643943|NCT00884741|616710170|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
170643944|NCT00884741|616710167|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
170643945|NCT00884741|616710168|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
170643946|NCT00884741|616710169|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
170643947|NCT00884741|616710170|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
170643948|NCT00884741|616710167|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
170643949|NCT00884741|616710168|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
170643950|NCT00884741|616710169|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
170643951|NCT00884741|616710170|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
170643952|NCT00884741|616710167|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
170643953|NCT00884741|616710168|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
170643954|NCT00884741|616710169|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
170643955|NCT00884741|616710170|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
170643956|NCT00884741|616710167|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
170643957|NCT00884741|616710168|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
170643958|NCT00884741|616710169|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
170643959|NCT00884741|616710170|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
170510429|NCT02134353|616212570|FG000|Overall Study|Adverse Event|10|||
170643960|NCT00884741|616710167|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
170643961|NCT00884741|616710168|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
170643962|NCT00884741|616710169|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
170510430|NCT02134353|616212571|FG001|Overall Study|Adverse Event|6|||
170643963|NCT00884741|616710170|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
170806109|NCT03789656|617299455|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
170806110|NCT03789656|617299456|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
170510431|NCT02134353|616212570|FG000|Overall Study|Lost to Follow-up|1|||
170510432|NCT02134353|616212571|FG001|Overall Study|Lost to Follow-up|1|||
170510433|NCT02134353|616212570|FG000|Overall Study|Lack of Efficacy|2|||
170510434|NCT02134353|616212571|FG001|Overall Study|Lack of Efficacy|1|||
170510435|NCT02134353|616212570|FG000|Overall Study|Withdrawal by Subject|12|||
170510436|NCT02134353|616212571|FG001|Overall Study|Withdrawal by Subject|13|||
170510437|NCT02134353|616212570|FG000|Overall Study|Death|0|||
170510438|NCT02134353|616212571|FG001|Overall Study|Death|1|||
170510439|NCT02134353|616212570|FG000|Overall Study|Pregnancy|0|||
170510440|NCT02134353|616212571|FG001|Overall Study|Pregnancy|1|||
170510441|NCT02134353|616212570|FG000|Overall Study|Relocation|1|||
170510442|NCT02134353|616212571|FG001|Overall Study|Relocation|0|||
170510443|NCT02134353|616212570|FG000|Overall Study|Other - Patient's Choice|0|||
170510444|NCT02134353|616212571|FG001|Overall Study|Other - Patient's Choice|1|||
170510445|NCT03426436|616212574|FG000|Overall Study|Incorrect lead placement|12|||
170510446|NCT03426436|616212574|FG000|Overall Study|Withdrawal by Subject|2|||
170510447|NCT03426436|616212574|FG000|Overall Study|Consent issue|1|||
170510448|NCT03426436|616212574|FG000|Overall Study|ECGs not saved|4|||
170510449|NCT02243046|616212580|FG000|Overall Study|Lost to Follow-up|1|||
170510450|NCT02243046|616212581|FG001|Overall Study|Lost to Follow-up|1|||
170510451|NCT02243046|616212582|FG002|Overall Study|Lost to Follow-up|4|||
170510452|NCT04607980|616212583|FG000|Overall Study|Adverse Event|3|||
170510453|NCT04607980|616212584|FG001|Overall Study|Adverse Event|4|||
170510454|NCT04607980|616212583|FG000|Overall Study|Death|0|||
170510455|NCT04607980|616212584|FG001|Overall Study|Death|1|||
170510456|NCT04607980|616212583|FG000|Overall Study|Withdrawal by Subject|2|||
170510457|NCT04607980|616212584|FG001|Overall Study|Withdrawal by Subject|5|||
170510458|NCT04607980|616212583|FG000|Overall Study|Lost to Follow-up|4|||
170510459|NCT04607980|616212584|FG001|Overall Study|Lost to Follow-up|8|||
170510460|NCT04607980|616212583|FG000|Overall Study|Protocol Violation|0|||
170510461|NCT04607980|616212584|FG001|Overall Study|Protocol Violation|3|||
170510462|NCT04607980|616212583|FG000|Overall Study|Other|3|||
170510463|NCT04607980|616212584|FG001|Overall Study|Other|0|||
170510464|NCT02669082|616212585|FG000|Overall Study|Adverse Event|1|||
170510465|NCT04918355|616212586|FG000|Overall Study|no qualifying health encounter|497|||
170510466|NCT04918355|616212587|FG001|Overall Study|no qualifying health encounter|192|||
170510467|NCT04918355|616212588|FG002|Overall Study|no qualifying health encounter|438|||
170510468|NCT04918355|616212589|FG003|Overall Study|no qualifying health encounter|424|||
170510469|NCT04852276|616212593|FG000|Overall Study|Death|2|||
170510470|NCT04852276|616212594|FG001|Overall Study|Death|0|||
170510471|NCT04852276|616212593|FG000|Overall Study|Lost to Follow-up|15|||
170510472|NCT04852276|616212594|FG001|Overall Study|Lost to Follow-up|9|||
170510473|NCT04852276|616212593|FG000|Overall Study|Withdrawal by Subject|26|||
170510474|NCT04852276|616212594|FG001|Overall Study|Withdrawal by Subject|6|||
170510475|NCT01128400|616214097|FG000|Overall Study|Lost to Follow-up|1|||
170510476|NCT01128400|616214098|FG001|Overall Study|Lost to Follow-up|0|||
170510477|NCT01128400|616214099|FG002|Overall Study|Lost to Follow-up|1|||
170510478|NCT01128400|616214097|FG000|Overall Study|Screening failure|1|||
170510479|NCT01128400|616214098|FG001|Overall Study|Screening failure|0|||
170510480|NCT01128400|616214099|FG002|Overall Study|Screening failure|0|||
170510481|NCT01128400|616214097|FG000|Overall Study|were not invited to participate on taste|0|||
170510482|NCT01128400|616214098|FG001|Overall Study|were not invited to participate on taste|0|||
170510483|NCT01128400|616214099|FG002|Overall Study|were not invited to participate on taste|15|||
170806111|NCT03789656|617299457|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
170510484|NCT01128400|616214097|FG000|Overall Study|Excluded due to sinus problems|0|||
170510485|NCT01128400|616214098|FG001|Overall Study|Excluded due to sinus problems|1|||
170510486|NCT01128400|616214099|FG002|Overall Study|Excluded due to sinus problems|0|||
170510487|NCT04750278|616214100|FG000|Overall Study|Death|9|||
170510488|NCT04750278|616214101|FG001|Overall Study|Death|10|||
170510489|NCT04750278|616214102|FG002|Overall Study|Death|10|||
170510490|NCT04750278|616214100|FG000|Overall Study|Withdrawal by Subject|4|||
170510491|NCT04750278|616214101|FG001|Overall Study|Withdrawal by Subject|1|||
170510492|NCT04750278|616214102|FG002|Overall Study|Withdrawal by Subject|2|||
170510493|NCT04750278|616214100|FG000|Overall Study|Lost to Follow-up|1|||
170510494|NCT04750278|616214101|FG001|Overall Study|Lost to Follow-up|1|||
170510495|NCT04750278|616214102|FG002|Overall Study|Lost to Follow-up|1|||
170510496|NCT04750278|616214100|FG000|Overall Study|Pregnancy|1|||
170510497|NCT04750278|616214101|FG001|Overall Study|Pregnancy|0|||
170510498|NCT04750278|616214102|FG002|Overall Study|Pregnancy|0|||
170510499|NCT04750278|616214100|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
170510500|NCT04750278|616214101|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
170510501|NCT04750278|616214102|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
170510502|NCT04750278|616214100|FG000|Overall Study|Non-compliance|0|||
170510503|NCT04750278|616214101|FG001|Overall Study|Non-compliance|0|||
170510504|NCT04750278|616214102|FG002|Overall Study|Non-compliance|1|||
170510505|NCT04750278|616214100|FG000|Overall Study|Transfer to Outside Facility|0|||
170510506|NCT04750278|616214101|FG001|Overall Study|Transfer to Outside Facility|2|||
170510507|NCT04750278|616214102|FG002|Overall Study|Transfer to Outside Facility|1|||
170806112|NCT03789656|617299453|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
170806113|NCT03789656|617299454|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
170806114|NCT03789656|617299455|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
170806115|NCT03789656|617299456|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
170510508|NCT04750278|616214100|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
170510509|NCT04750278|616214101|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
170553573|NCT02336555|616373520|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
170510510|NCT04750278|616214102|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
170510511|NCT04750278|616214100|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
170510512|NCT04750278|616214101|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
170510513|NCT04750278|616214102|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
170510514|NCT01212159|616214103|FG000|Overall Study|Withdrawal by Subject|12|||
170510515|NCT01212159|616214104|FG001|Overall Study|Withdrawal by Subject|12|||
170510516|NCT05025332|616214105|FG000|Screening|Screen failure|12|||
170510517|NCT05025332|616214105|FG000|Treatment & Follow Up|Protocol Violation|1|||
170510518|NCT05025332|616214105|FG000|Treatment & Follow Up|Adverse Event|4|||
170510519|NCT02626000|616214121|FG000|Overall Study|Decision by Sponsor|1|||
170510520|NCT02626000|616214121|FG000|Overall Study|Death|29|||
170510521|NCT01005901|616214129|FG000|Overall Study|Withdrawal by Subject|38|||
170510522|NCT01005901|616214130|FG001|Overall Study|Withdrawal by Subject|14|||
170510523|NCT01005901|616214129|FG000|Overall Study|Adverse Event|30|||
170510524|NCT01005901|616214130|FG001|Overall Study|Adverse Event|16|||
170510525|NCT01005901|616214129|FG000|Overall Study|Administrative problems|21|||
170510526|NCT01005901|616214130|FG001|Overall Study|Administrative problems|13|||
170510527|NCT01005901|616214129|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
170510528|NCT01005901|616214130|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
170510529|NCT01005901|616214129|FG000|Overall Study|Protocol Violation|4|||
170510530|NCT01005901|616214130|FG001|Overall Study|Protocol Violation|3|||
170510531|NCT01005901|616214129|FG000|Overall Study|Death|2|||
170510532|NCT01005901|616214130|FG001|Overall Study|Death|3|||
170510533|NCT01005901|616214129|FG000|Overall Study|Lost to Follow-up|1|||
170510534|NCT01005901|616214130|FG001|Overall Study|Lost to Follow-up|2|||
170553574|NCT02336555|616373519|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
170553575|NCT02336555|616373520|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
170553576|NCT02336555|616373519|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
170553577|NCT02336555|616373520|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
170553578|NCT00993473|616373521|FG000|Overall Study|Adverse Event|0|||
170553579|NCT00993473|616373522|FG001|Overall Study|Adverse Event|2|||
170553580|NCT00993473|616373521|FG000|Overall Study|Protocol Violation|1|||
170553581|NCT00993473|616373522|FG001|Overall Study|Protocol Violation|2|||
170553582|NCT00993473|616373521|FG000|Overall Study|Lost to Follow-up|1|||
170553583|NCT00993473|616373522|FG001|Overall Study|Lost to Follow-up|0|||
170553584|NCT00993473|616373521|FG000|Overall Study|Withdrawal by Subject|1|||
170553585|NCT00993473|616373522|FG001|Overall Study|Withdrawal by Subject|5|||
170553586|NCT00993473|616373521|FG000|Overall Study|Technical problem with CGM device|0|||
170553587|NCT00993473|616373522|FG001|Overall Study|Technical problem with CGM device|1|||
170553588|NCT00993473|616373521|FG000|Overall Study|Family event|1|||
170553589|NCT00993473|616373522|FG001|Overall Study|Family event|0|||
170553590|NCT01633112|616373525|FG000|Overall Study|Lack of Efficacy|1|||
170553591|NCT01633112|616373526|FG001|Overall Study|Lack of Efficacy|6|||
170553592|NCT01633112|616373527|FG002|Overall Study|Lack of Efficacy|13|||
170553593|NCT01633112|616373525|FG000|Overall Study|Abnormal laboratory value(s)|3|||
170553594|NCT01633112|616373526|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170553595|NCT01633112|616373527|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170553596|NCT01633112|616373525|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170553597|NCT01633112|616373526|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170553598|NCT01633112|616373527|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170553599|NCT01633112|616373525|FG000|Overall Study|Administrative problems|1|||
170553600|NCT01633112|616373526|FG001|Overall Study|Administrative problems|2|||
170553601|NCT01633112|616373527|FG002|Overall Study|Administrative problems|5|||
170553602|NCT01633112|616373525|FG000|Overall Study|Adverse Event|16|||
170553603|NCT01633112|616373526|FG001|Overall Study|Adverse Event|18|||
170553604|NCT01633112|616373527|FG002|Overall Study|Adverse Event|20|||
170553605|NCT01633112|616373525|FG000|Overall Study|Lost to Follow-up|7|||
170553606|NCT01633112|616373526|FG001|Overall Study|Lost to Follow-up|19|||
170553607|NCT01633112|616373527|FG002|Overall Study|Lost to Follow-up|6|||
170643964|NCT00884741|616710167|FG000|Randomization|Protocol Violation|0|||
170806116|NCT03789656|617299457|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
170553608|NCT01633112|616373525|FG000|Overall Study|Protocol Violation|4|||
170553609|NCT01633112|616373526|FG001|Overall Study|Protocol Violation|0|||
170553610|NCT01633112|616373527|FG002|Overall Study|Protocol Violation|2|||
170553611|NCT01633112|616373525|FG000|Overall Study|Subject no longer requires study drug|0|||
170553612|NCT01633112|616373526|FG001|Overall Study|Subject no longer requires study drug|0|||
170904640|NCT03871491|617652362|FG002|Overall Study|Physician Decision|1|||
170510535|NCT01005901|616214129|FG000|Overall Study|Patient's inability to use the device|1|||
170510536|NCT01005901|616214130|FG001|Overall Study|Patient's inability to use the device|1|||
170510537|NCT01005901|616214129|FG000|Overall Study|No longer requires study drug|0|||
170510538|NCT01005901|616214130|FG001|Overall Study|No longer requires study drug|1|||
170510539|NCT00329745|616214131|FG000|Overall Study|Protocol Violation|1|||
170510540|NCT00329745|616214132|FG001|Overall Study|Protocol Violation|0|||
170510541|NCT00329745|616214131|FG000|Overall Study|Withdrawal by Subject|0|||
170510542|NCT00329745|616214132|FG001|Overall Study|Withdrawal by Subject|1|||
170510543|NCT00329745|616214131|FG000|Overall Study|Lost to Follow-up|86|||
170510544|NCT00329745|616214132|FG001|Overall Study|Lost to Follow-up|101|||
170510545|NCT01597492|616214133|FG000|Overall Study|Withdrawal by Subject|1|||
170510546|NCT01597492|616214134|FG001|Overall Study|Withdrawal by Subject|2|||
170510547|NCT01597492|616214133|FG000|Overall Study|Adverse Event|3|||
170510548|NCT01597492|616214134|FG001|Overall Study|Adverse Event|0|||
170510549|NCT01597492|616214133|FG000|Overall Study|Lost to Follow-up|0|||
170510550|NCT01597492|616214134|FG001|Overall Study|Lost to Follow-up|2|||
170510551|NCT01597492|616214133|FG000|Overall Study|Other Reason|2|||
170510552|NCT01597492|616214134|FG001|Overall Study|Other Reason|0|||
170510553|NCT02570750|616214137|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
170510554|NCT02570750|616214138|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
170510555|NCT02570750|616214137|FG000|Overall Study|Protocol deviation|4|||
170510556|NCT02570750|616214138|FG001|Overall Study|Protocol deviation|2|||
170510557|NCT02570750|616214137|FG000|Overall Study|Withdrawal by Subject|5|||
170510558|NCT02570750|616214138|FG001|Overall Study|Withdrawal by Subject|0|||
170510559|NCT02570750|616214137|FG000|Overall Study|Lost to Follow-up|2|||
170510560|NCT02570750|616214138|FG001|Overall Study|Lost to Follow-up|2|||
170510561|NCT02570750|616214137|FG000|Overall Study|Adverse Event|2|||
170510562|NCT02570750|616214138|FG001|Overall Study|Adverse Event|1|||
170510563|NCT01884545|616214139|FG000|Overall Study|Lost to Follow-up|6|||
170510564|NCT01884545|616214140|FG001|Overall Study|Lost to Follow-up|4|||
170510565|NCT01884545|616214141|FG002|Overall Study|Lost to Follow-up|9|||
170510566|NCT01884545|616214142|FG003|Overall Study|Lost to Follow-up|4|||
170553613|NCT01633112|616373527|FG002|Overall Study|Subject no longer requires study drug|1|||
170553614|NCT01633112|616373525|FG000|Overall Study|Withdrawal by Subject|20|||
170553615|NCT01633112|616373526|FG001|Overall Study|Withdrawal by Subject|12|||
170553616|NCT01633112|616373527|FG002|Overall Study|Withdrawal by Subject|41|||
170553617|NCT01633112|616373525|FG000|Overall Study|missing Study Completion CRF|1|||
170553618|NCT01633112|616373526|FG001|Overall Study|missing Study Completion CRF|1|||
170553619|NCT01633112|616373527|FG002|Overall Study|missing Study Completion CRF|4|||
170553620|NCT01959919|616373528|FG000|Overall Study|Did not meet the eligibility criteria|2|||
170510567|NCT01884545|616214139|FG000|Overall Study|Patient withdrawn|7|||
170510568|NCT01884545|616214140|FG001|Overall Study|Patient withdrawn|12|||
170510569|NCT01884545|616214141|FG002|Overall Study|Patient withdrawn|5|||
170510570|NCT01884545|616214142|FG003|Overall Study|Patient withdrawn|5|||
170510571|NCT01884545|616214139|FG000|Overall Study|Non-adherence|0|||
170510572|NCT01884545|616214140|FG001|Overall Study|Non-adherence|2|||
170553621|NCT01998477|616373529|FG000|Overall Study|Lost to Follow-up|4|||
170553622|NCT01998477|616373530|FG001|Overall Study|Lost to Follow-up|5|||
170904641|NCT03871491|617652363|FG003|Overall Study|Physician Decision|1|||
170904642|NCT03871491|617652360|FG000|Overall Study|Lost to Follow-up|50|||
170904643|NCT03871491|617652361|FG001|Overall Study|Lost to Follow-up|15|||
170904644|NCT03871491|617652362|FG002|Overall Study|Lost to Follow-up|36|||
170904645|NCT03871491|617652363|FG003|Overall Study|Lost to Follow-up|11|||
170904646|NCT05202808|617652364|FG000|Overall Study|Lost to Follow-up|3|||
170904647|NCT05202808|617652365|FG001|Overall Study|Lost to Follow-up|1|||
170904648|NCT02793544|617652366|FG000|Overall Study|Death|10|||
170904649|NCT02793544|617652367|FG001|Overall Study|Death|8|||
170904650|NCT02793544|617652366|FG000|Overall Study|Lost to Follow-up|2|||
170904651|NCT02793544|617652367|FG001|Overall Study|Lost to Follow-up|0|||
170904652|NCT02793544|617652366|FG000|Overall Study|Withdrawal by Subject|1|||
170904653|NCT02793544|617652367|FG001|Overall Study|Withdrawal by Subject|0|||
170904654|NCT01822561|617652371|FG000|Overall Study|Withdrawal by Subject|2|||
170904655|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
170904656|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
170904657|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
170904658|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
170904659|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
170904660|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
170904661|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
170904662|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
170904663|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
170904664|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
170904665|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
170904666|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
170904667|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
170904668|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
170904669|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
170904670|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
170904671|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
170904672|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
170904673|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
170904674|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
170904675|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Death|0|||
170904676|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Death|1|||
170904677|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Death|0|||
170904678|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Death|0|||
170904679|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Death|0|||
170904680|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
170510573|NCT01884545|616214141|FG002|Overall Study|Non-adherence|0|||
170510574|NCT01884545|616214142|FG003|Overall Study|Non-adherence|0|||
170510575|NCT01410240|616214143|FG000|Overall Study|Physician Decision|0|||
170510576|NCT01410240|616214144|FG001|Overall Study|Physician Decision|0|||
170510577|NCT01410240|616214145|FG002|Overall Study|Physician Decision|1|||
170510578|NCT01410240|616214143|FG000|Overall Study|Missed week 6 assessments|1|||
170553623|NCT01998477|616373529|FG000|Overall Study|Withdrawal by Subject|6|||
170553624|NCT01998477|616373530|FG001|Overall Study|Withdrawal by Subject|0|||
170553625|NCT02913326|616373533|FG000|Overall Study|Reason not listed|0|||
170553626|NCT02913326|616373534|FG001|Overall Study|Reason not listed|1|||
170553627|NCT02913326|616373533|FG000|Overall Study|Lost to Follow-up|0|||
170553628|NCT02913326|616373534|FG001|Overall Study|Lost to Follow-up|1|||
170553629|NCT02913326|616373533|FG000|Overall Study|Adverse Event|1|||
170553630|NCT02913326|616373534|FG001|Overall Study|Adverse Event|0|||
170553631|NCT03769467|616373537|FG000|Overall Study|Adverse Event|1|||
170553632|NCT03769467|616373538|FG001|Overall Study|Adverse Event|1|||
170553633|NCT03769467|616373539|FG002|Overall Study|Adverse Event|0|||
170553634|NCT03769467|616373537|FG000|Overall Study|Death|3|||
170553635|NCT03769467|616373538|FG001|Overall Study|Death|3|||
170553636|NCT03769467|616373539|FG002|Overall Study|Death|0|||
170553637|NCT03769467|616373537|FG000|Overall Study|Study Terminated By Sponsor|2|||
170553638|NCT03769467|616373538|FG001|Overall Study|Study Terminated By Sponsor|1|||
170553639|NCT03769467|616373539|FG002|Overall Study|Study Terminated By Sponsor|0|||
170553640|NCT03769467|616373537|FG000|Overall Study|Withdrawal by Subject|0|||
170553641|NCT03769467|616373538|FG001|Overall Study|Withdrawal by Subject|1|||
170553642|NCT03769467|616373539|FG002|Overall Study|Withdrawal by Subject|0|||
170553643|NCT01887600|616373542|FG000|Overall Study|Death|39|||
170553644|NCT01887600|616373543|FG001|Overall Study|Death|16|||
170553645|NCT01887600|616373542|FG000|Overall Study|Lack of Efficacy|3|||
170553646|NCT01887600|616373543|FG001|Overall Study|Lack of Efficacy|26|||
170553647|NCT01887600|616373542|FG000|Overall Study|Lost to Follow-up|5|||
170553648|NCT01887600|616373543|FG001|Overall Study|Lost to Follow-up|1|||
170553649|NCT01887600|616373542|FG000|Overall Study|Physician Decision|7|||
170553650|NCT01887600|616373543|FG001|Overall Study|Physician Decision|8|||
170553651|NCT01887600|616373542|FG000|Overall Study|Protocol Deviation|3|||
170553652|NCT01887600|616373543|FG001|Overall Study|Protocol Deviation|0|||
170553653|NCT01887600|616373542|FG000|Overall Study|Withdrawal by Subject|58|||
170553654|NCT01887600|616373543|FG001|Overall Study|Withdrawal by Subject|52|||
170553655|NCT01887600|616373542|FG000|Overall Study|Adverse Event|21|||
170553656|NCT01887600|616373543|FG001|Overall Study|Adverse Event|9|||
170553657|NCT01887600|616373542|FG000|Overall Study|Non-compliance with study drug|3|||
170553658|NCT01887600|616373543|FG001|Overall Study|Non-compliance with study drug|0|||
170553659|NCT01887600|616373542|FG000|Overall Study|Miscellaneous|6|||
170553660|NCT01887600|616373543|FG001|Overall Study|Miscellaneous|2|||
170553661|NCT01887600|616373542|FG000|Overall Study|Progressive Disease|1|||
170553662|NCT01887600|616373543|FG001|Overall Study|Progressive Disease|0|||
170553663|NCT00962650|616373544|FG000|Overall Study|Transgastric DP was not completed|2|||
170553664|NCT03688139|616373545|FG000|Overall Study|Lost to Follow-up|2|||
170553665|NCT03688139|616373546|FG001|Overall Study|Lost to Follow-up|0|||
170553666|NCT03688139|616373545|FG000|Overall Study|Physician Decision|0|||
170553667|NCT03688139|616373546|FG001|Overall Study|Physician Decision|1|||
170553668|NCT03688139|616373545|FG000|Overall Study|Withdrawal by Subject|2|||
170553669|NCT03688139|616373546|FG001|Overall Study|Withdrawal by Subject|3|||
170510579|NCT01410240|616214144|FG001|Overall Study|Missed week 6 assessments|1|||
170510580|NCT01410240|616214145|FG002|Overall Study|Missed week 6 assessments|1|||
170510581|NCT02776670|616214146|FG000|Overall Study|Adverse Event|0|||
170510582|NCT02776670|616214147|FG001|Overall Study|Adverse Event|2|||
170510583|NCT02776670|616214146|FG000|Overall Study|Protocol Violation|0|||
170510584|NCT02776670|616214147|FG001|Overall Study|Protocol Violation|2|||
170510585|NCT02776670|616214146|FG000|Overall Study|Withdrawal by Subject|0|||
170510586|NCT02776670|616214147|FG001|Overall Study|Withdrawal by Subject|1|||
170510587|NCT02776670|616214146|FG000|Overall Study|Other - Reason not given|0|||
170510588|NCT02776670|616214147|FG001|Overall Study|Other - Reason not given|1|||
170510589|NCT01424241|616214148|FG000|Overall Study|Withdrawal by Subject|1|||
170510590|NCT01424241|616214148|FG000|Overall Study|Time constraints|2|||
170510591|NCT00496587|616214153|FG000|Overall Study|Adverse Event|2|||
170510592|NCT00496587|616214153|FG000|Overall Study|Progressive Disease|24|||
170553670|NCT00231465|616373547|FG000|Overall Study|Completed only one cycle|1|||
170553671|NCT00231465|616373547|FG000|Overall Study|Did not have follow up CT scans|1|||
170553672|NCT00420056|616373548|FG000|Overall Study|Objective progression or relapse|17|||
170553673|NCT03624036|616373549|FG000|Overall Study|Death|2|||
170553674|NCT03624036|616373550|FG001|Overall Study|Death|3|||
170553675|NCT03624036|616373551|FG002|Overall Study|Death|0|||
170553676|NCT03624036|616373552|FG003|Overall Study|Death|1|||
170553677|NCT03624036|616373549|FG000|Overall Study|Withdrawal by Subject|1|||
170553678|NCT03624036|616373550|FG001|Overall Study|Withdrawal by Subject|0|||
170553679|NCT03624036|616373551|FG002|Overall Study|Withdrawal by Subject|1|||
170553680|NCT03624036|616373552|FG003|Overall Study|Withdrawal by Subject|0|||
170510593|NCT00496587|616214153|FG000|Overall Study|Withdrawal by Subject|2|||
170510594|NCT00496587|616214153|FG000|Overall Study|Death|1|||
170510595|NCT00496587|616214153|FG000|Overall Study|Complications unrelated|2|||
170510596|NCT00482170|616214158|FG000|Overall Study|Adverse Event|5|||
170553681|NCT03624036|616373549|FG000|Overall Study|Enrolled but Never Treated|1|||
170553682|NCT03624036|616373550|FG001|Overall Study|Enrolled but Never Treated|0|||
170553683|NCT03624036|616373551|FG002|Overall Study|Enrolled but Never Treated|0|||
170904681|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
170904682|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
170904683|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
170904684|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
170904685|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
170904686|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
170904687|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
170904688|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
170904689|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
170904690|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
170904691|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
170904692|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
170904693|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
170904694|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
170904695|NCT05087030|617652372|FG000|Main Period (Week 0 to Week 52)|Other|1|||
170904696|NCT05087030|617652373|FG001|Main Period (Week 0 to Week 52)|Other|2|||
170904697|NCT05087030|617652374|FG002|Main Period (Week 0 to Week 52)|Other|0|||
170904698|NCT05087030|617652375|FG003|Main Period (Week 0 to Week 52)|Other|0|||
170904699|NCT05087030|617652376|FG004|Main Period (Week 0 to Week 52)|Other|0|||
170904700|NCT05087030|617652372|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
170904701|NCT05087030|617652373|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
170904702|NCT05087030|617652374|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
170904703|NCT05087030|617652375|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
170904704|NCT05087030|617652376|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
170904705|NCT01444300|617652377|FG000|Overall Study|Adverse Event|4|||
170904706|NCT01444300|617652378|FG001|Overall Study|Adverse Event|0|||
170904707|NCT02722044|617652379|FG000|Overall Study|Adverse Event|2|||
170904708|NCT02722044|617652379|FG000|Overall Study|Physician Decision|1|||
170904709|NCT02722044|617652379|FG000|Overall Study|Withdrawal by Subject|1|||
170904710|NCT02722044|617652379|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
170904711|NCT04826900|617652380|FG000|Overall Study|Family factor|1|||
170904712|NCT04826900|617652381|FG001|Overall Study|Family factor|1|||
170904713|NCT01523873|617652386|FG000|Overall Study|Protocol Violation|422|||
170904714|NCT01084252|617653824|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904715|NCT01084252|617653825|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904716|NCT01084252|617653826|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904717|NCT01084252|617653827|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904718|NCT01084252|617653828|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170510597|NCT00482170|616214159|FG001|Overall Study|Adverse Event|14|||
170510598|NCT00482170|616214158|FG000|Overall Study|Withdrawal by Subject|6|||
170510599|NCT00482170|616214159|FG001|Overall Study|Withdrawal by Subject|1|||
170510600|NCT00482170|616214158|FG000|Overall Study|Protocol Violation|2|||
170510601|NCT00482170|616214159|FG001|Overall Study|Protocol Violation|3|||
170510602|NCT00482170|616214158|FG000|Overall Study|Lost to Follow-up|2|||
170510603|NCT00482170|616214159|FG001|Overall Study|Lost to Follow-up|0|||
170510604|NCT00482170|616214158|FG000|Overall Study|Unspecified reason|0|||
170510605|NCT00482170|616214159|FG001|Overall Study|Unspecified reason|2|||
170510606|NCT00592592|616214163|FG000|Overall Study|Patient found ineligible upon chart review|1|||
170510607|NCT01134263|616214164|FG000|Overall Study|Serious adverse event|2|||
170510608|NCT01134263|616214165|FG001|Overall Study|Serious adverse event|1|||
170510609|NCT01134263|616214166|FG002|Overall Study|Serious adverse event|1|||
170510610|NCT01134263|616214167|FG003|Overall Study|Serious adverse event|1|||
170510611|NCT01134263|616214168|FG004|Overall Study|Serious adverse event|1|||
170510612|NCT01134263|616214164|FG000|Overall Study|Other adverse event|1|||
170510613|NCT01134263|616214165|FG001|Overall Study|Other adverse event|2|||
170510614|NCT01134263|616214166|FG002|Overall Study|Other adverse event|5|||
170510615|NCT01134263|616214167|FG003|Overall Study|Other adverse event|3|||
170510616|NCT01134263|616214168|FG004|Overall Study|Other adverse event|0|||
170510617|NCT01134263|616214164|FG000|Overall Study|Protocol Violation|8|||
170510618|NCT01134263|616214165|FG001|Overall Study|Protocol Violation|7|||
170510619|NCT01134263|616214166|FG002|Overall Study|Protocol Violation|2|||
170510620|NCT01134263|616214167|FG003|Overall Study|Protocol Violation|4|||
170510621|NCT01134263|616214168|FG004|Overall Study|Protocol Violation|2|||
170510622|NCT01134263|616214164|FG000|Overall Study|Lost to Follow-up|4|||
170510623|NCT01134263|616214165|FG001|Overall Study|Lost to Follow-up|3|||
170553684|NCT03624036|616373552|FG003|Overall Study|Enrolled but Never Treated|0|||
170510624|NCT01134263|616214166|FG002|Overall Study|Lost to Follow-up|5|||
170510625|NCT01134263|616214167|FG003|Overall Study|Lost to Follow-up|3|||
170510626|NCT01134263|616214168|FG004|Overall Study|Lost to Follow-up|1|||
170510627|NCT01134263|616214164|FG000|Overall Study|Withdrawal by Subject|8|||
170510628|NCT01134263|616214165|FG001|Overall Study|Withdrawal by Subject|6|||
170510629|NCT01134263|616214166|FG002|Overall Study|Withdrawal by Subject|16|||
170553685|NCT03624036|616373549|FG000|Overall Study|Reason not Specified|3|||
170904719|NCT01084252|617653829|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904720|NCT01084252|617653830|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904721|NCT01084252|617653831|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904722|NCT01084252|617653832|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904723|NCT01084252|617653833|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904724|NCT01084252|617653834|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904725|NCT01084252|617653835|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904726|NCT01084252|617653836|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
170904727|NCT01084252|617653837|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
170904728|NCT01024244|617653838|FG000|Overall Study|Adverse Event|1|||
170904729|NCT01024244|617653839|FG001|Overall Study|Adverse Event|2|||
170904730|NCT01024244|617653840|FG002|Overall Study|Adverse Event|0|||
170904731|NCT01024244|617653841|FG003|Overall Study|Adverse Event|1|||
170904732|NCT01024244|617653842|FG004|Overall Study|Adverse Event|2|||
170904733|NCT01024244|617653838|FG000|Overall Study|Entry Criteria Not Met|0|||
170904734|NCT01024244|617653839|FG001|Overall Study|Entry Criteria Not Met|1|||
170904735|NCT01024244|617653840|FG002|Overall Study|Entry Criteria Not Met|0|||
170904736|NCT01024244|617653841|FG003|Overall Study|Entry Criteria Not Met|0|||
170904737|NCT01024244|617653842|FG004|Overall Study|Entry Criteria Not Met|0|||
170904738|NCT01024244|617653838|FG000|Overall Study|Lack of Efficacy|1|||
170904739|NCT01024244|617653839|FG001|Overall Study|Lack of Efficacy|0|||
170904740|NCT01024244|617653840|FG002|Overall Study|Lack of Efficacy|0|||
170904741|NCT01024244|617653841|FG003|Overall Study|Lack of Efficacy|0|||
170904742|NCT01024244|617653842|FG004|Overall Study|Lack of Efficacy|0|||
170904743|NCT01024244|617653838|FG000|Overall Study|Protocol Violation|1|||
170904744|NCT01024244|617653839|FG001|Overall Study|Protocol Violation|0|||
170904745|NCT01024244|617653840|FG002|Overall Study|Protocol Violation|0|||
170904746|NCT01024244|617653841|FG003|Overall Study|Protocol Violation|0|||
170904747|NCT01024244|617653842|FG004|Overall Study|Protocol Violation|2|||
170904748|NCT01024244|617653838|FG000|Overall Study|Sponsor Decision|14|||
170904749|NCT01024244|617653839|FG001|Overall Study|Sponsor Decision|7|||
170904750|NCT01024244|617653840|FG002|Overall Study|Sponsor Decision|14|||
170904751|NCT01024244|617653841|FG003|Overall Study|Sponsor Decision|12|||
170904752|NCT01024244|617653842|FG004|Overall Study|Sponsor Decision|10|||
170904753|NCT01024244|617653838|FG000|Overall Study|Withdrawal by Subject|0|||
170904754|NCT01024244|617653839|FG001|Overall Study|Withdrawal by Subject|1|||
170904755|NCT01024244|617653840|FG002|Overall Study|Withdrawal by Subject|0|||
170904756|NCT01024244|617653841|FG003|Overall Study|Withdrawal by Subject|0|||
170904757|NCT01024244|617653842|FG004|Overall Study|Withdrawal by Subject|0|||
170904758|NCT00914628|617653843|FG000|Overall Study|Death|35|||
170904759|NCT00914628|617653844|FG001|Overall Study|Death|17|||
170904760|NCT00914628|617653843|FG000|Overall Study|Medical decision|4|||
170904761|NCT00914628|617653844|FG001|Overall Study|Medical decision|0|||
170904762|NCT00914628|617653843|FG000|Overall Study|Protocol Violation|1|||
170904763|NCT00914628|617653844|FG001|Overall Study|Protocol Violation|0|||
170904764|NCT00914628|617653843|FG000|Overall Study|Lack of Efficacy|1|||
170904765|NCT00914628|617653844|FG001|Overall Study|Lack of Efficacy|0|||
170904766|NCT00914628|617653843|FG000|Overall Study|non-randomized|1|||
170904767|NCT00914628|617653844|FG001|Overall Study|non-randomized|0|||
170904768|NCT00914628|617653843|FG000|Overall Study|Relapse|1|||
170904769|NCT00914628|617653844|FG001|Overall Study|Relapse|2|||
170904770|NCT00914628|617653843|FG000|Overall Study|Study terminated by Sponsor|14|||
170904771|NCT00914628|617653844|FG001|Overall Study|Study terminated by Sponsor|8|||
170904772|NCT00914628|617653843|FG000|Overall Study|Patients who did not receive a single dose|7|||
170904773|NCT00914628|617653844|FG001|Overall Study|Patients who did not receive a single dose|1|||
170904774|NCT01896232|617653851|FG000|Overall Study|Death|6|||
170904775|NCT01896232|617653852|FG001|Overall Study|Death|10|||
170904776|NCT01896232|617653851|FG000|Overall Study|Withdrawal by Subject|32|||
170904777|NCT01896232|617653852|FG001|Overall Study|Withdrawal by Subject|31|||
170904778|NCT01896232|617653851|FG000|Overall Study|Sponsor Decision|2|||
170904779|NCT01896232|617653852|FG001|Overall Study|Sponsor Decision|0|||
170904780|NCT01896232|617653851|FG000|Overall Study|Lost to Follow-up|9|||
170904781|NCT01896232|617653852|FG001|Overall Study|Lost to Follow-up|12|||
170553686|NCT03624036|616373550|FG001|Overall Study|Reason not Specified|0|||
170553687|NCT03624036|616373551|FG002|Overall Study|Reason not Specified|2|||
170904782|NCT02638012|617653855|FG000|Overall Study|Lost to Follow-up|1|||
170904783|NCT03199911|617653856|FG000|Overall Study|Lost to Follow-up|5|||
170904784|NCT03199911|617653857|FG001|Overall Study|Lost to Follow-up|5|||
170904785|NCT03199911|617653856|FG000|Overall Study|Did not proceed with surgery|2|||
170904786|NCT03199911|617653857|FG001|Overall Study|Did not proceed with surgery|1|||
170643965|NCT00884741|616710168|FG001|Randomization|Protocol Violation|0|||
170904787|NCT02559505|617653858|FG000|Overall Study|Lost to Follow-up|23|||
170904788|NCT02559505|617653859|FG001|Overall Study|Lost to Follow-up|20|||
170904789|NCT02559505|617653858|FG000|Overall Study|Withdrawal by Subject|4|||
170904790|NCT02559505|617653859|FG001|Overall Study|Withdrawal by Subject|2|||
170904791|NCT00686205|617653860|FG000|Overall Study|Protocol Violation|127|||
170553688|NCT03624036|616373552|FG003|Overall Study|Reason not Specified|2|||
170904792|NCT00686205|617653861|FG001|Overall Study|Protocol Violation|0|||
170904793|NCT00686205|617653860|FG000|Overall Study|Withdrawal by Subject|2|||
170904794|NCT00686205|617653861|FG001|Overall Study|Withdrawal by Subject|0|||
170904795|NCT00686205|617653860|FG000|Overall Study|Specimen handling procedure altered|5878|||
170904796|NCT00686205|617653861|FG001|Overall Study|Specimen handling procedure altered|0|||
170904797|NCT00686205|617653860|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
170904798|NCT00686205|617653861|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
170904799|NCT00486902|617653864|FG000|Overall Study|Withdrawal by Subject|1|||
170904800|NCT00486902|617653865|FG001|Overall Study|Withdrawal by Subject|2|||
170904801|NCT00486902|617653864|FG000|Overall Study|decision for postpartum tubal ligation|3|||
170904802|NCT00486902|617653865|FG001|Overall Study|decision for postpartum tubal ligation|1|||
170904803|NCT00486902|617653864|FG000|Overall Study|spinal anesthetic protocal violation|1|||
170904804|NCT00486902|617653865|FG001|Overall Study|spinal anesthetic protocal violation|1|||
170904805|NCT00486902|617653864|FG000|Overall Study|Did not meet inclusion criteria|1|||
170904806|NCT00486902|617653865|FG001|Overall Study|Did not meet inclusion criteria|0|||
170904807|NCT00486902|617653864|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
170904808|NCT00486902|617653865|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
170904809|NCT01217606|617653866|FG000|Initial Treatment Phase|Other Reasons|0|||
170904810|NCT01217606|617653867|FG001|Initial Treatment Phase|Other Reasons|2|||
170904811|NCT01217606|617653866|FG000|Initial Treatment Phase|Protocol Violation|3|||
170904812|NCT01217606|617653867|FG001|Initial Treatment Phase|Protocol Violation|2|||
170904813|NCT01217606|617653866|FG000|Initial Treatment Phase|Personal Reasons|0|||
170904814|NCT01217606|617653867|FG001|Initial Treatment Phase|Personal Reasons|2|||
170904815|NCT01217606|617653866|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
170904816|NCT01217606|617653867|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
170904817|NCT01217606|617653866|FG000|Initial Treatment Phase|Adverse Event|10|||
170904818|NCT01217606|617653867|FG001|Initial Treatment Phase|Adverse Event|6|||
170904819|NCT01217606|617653866|FG000|9-Month Masked Extension|Adverse Event|3|||
170904820|NCT01217606|617653867|FG001|9-Month Masked Extension|Adverse Event|6|||
170904821|NCT01217606|617653866|FG000|9-Month Masked Extension|Other Reasons|4|||
170904822|NCT01217606|617653867|FG001|9-Month Masked Extension|Other Reasons|4|||
170553689|NCT01185366|616373561|FG000|First Line Therapy|Insurance Coverage Denied|1|||
170643966|NCT00884741|616710169|FG002|Randomization|Protocol Violation|8|||
170643967|NCT00884741|616710170|FG003|Randomization|Protocol Violation|8|||
170643968|NCT02762370|616710173|FG000|Overall Study|Protocol Violation|1|||
170643969|NCT02762370|616710174|FG001|Overall Study|Protocol Violation|0|||
170643970|NCT01578850|616710178|FG000|Period 1|Insufficient Clinical Response|1|||
170643971|NCT01578850|616710179|FG001|Period 1|Insufficient Clinical Response|0|||
170643972|NCT01578850|616710180|FG002|Period 1|Insufficient Clinical Response|0|||
170643973|NCT01578850|616710178|FG000|Period 1|Adverse Event|11|||
170643974|NCT01578850|616710179|FG001|Period 1|Adverse Event|0|||
170643975|NCT01578850|616710180|FG002|Period 1|Adverse Event|0|||
170643976|NCT01578850|616710178|FG000|Period 1|Death|1|||
170643977|NCT01578850|616710179|FG001|Period 1|Death|0|||
170643978|NCT01578850|616710180|FG002|Period 1|Death|0|||
170643979|NCT01578850|616710178|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
170643980|NCT01578850|616710179|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
170643981|NCT01578850|616710180|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
170643982|NCT01578850|616710178|FG000|Period 1|Withdrawal by Subject|9|||
170643983|NCT01578850|616710179|FG001|Period 1|Withdrawal by Subject|0|||
170643984|NCT01578850|616710180|FG002|Period 1|Withdrawal by Subject|0|||
170643985|NCT01578850|616710178|FG000|Period 1|Study Terminated by Sponsor|3|||
170643986|NCT01578850|616710179|FG001|Period 1|Study Terminated by Sponsor|0|||
170643987|NCT01578850|616710180|FG002|Period 1|Study Terminated by Sponsor|0|||
170643988|NCT01578850|616710178|FG000|Period 2|Insufficient Clinical Response|0|||
170643989|NCT01578850|616710179|FG001|Period 2|Insufficient Clinical Response|1|||
170643990|NCT01578850|616710180|FG002|Period 2|Insufficient Clinical Response|0|||
170643991|NCT01578850|616710178|FG000|Period 2|Adverse Event|0|||
170643992|NCT01578850|616710179|FG001|Period 2|Adverse Event|3|||
170643993|NCT01578850|616710180|FG002|Period 2|Adverse Event|6|||
170643994|NCT01578850|616710178|FG000|Period 2|Lost to Follow-up|0|||
170643995|NCT01578850|616710179|FG001|Period 2|Lost to Follow-up|1|||
170643996|NCT01578850|616710180|FG002|Period 2|Lost to Follow-up|2|||
170643997|NCT01578850|616710178|FG000|Period 2|Withdrawal by Subject|0|||
170643998|NCT01578850|616710179|FG001|Period 2|Withdrawal by Subject|2|||
170643999|NCT01578850|616710180|FG002|Period 2|Withdrawal by Subject|2|||
170644000|NCT01578850|616710178|FG000|Period 2|Study Terminated by Sponsor|0|||
170644001|NCT01578850|616710179|FG001|Period 2|Study Terminated by Sponsor|5|||
170644002|NCT01578850|616710180|FG002|Period 2|Study Terminated by Sponsor|4|||
170644003|NCT01578850|616710178|FG000|Period 2|Unspecified Reasons|0|||
170644004|NCT01578850|616710179|FG001|Period 2|Unspecified Reasons|1|||
170644005|NCT01578850|616710180|FG002|Period 2|Unspecified Reasons|0|||
170644006|NCT02281383|616710184|FG000|Overall Study|Progressive Disease|1|||
170644007|NCT02281383|616710184|FG000|Overall Study|Withdrawal by Subject|6|||
170644008|NCT02281383|616710184|FG000|Overall Study|Protocol Violation|2|||
170644009|NCT02281383|616710184|FG000|Overall Study|Death|1|||
170644010|NCT02281383|616710184|FG000|Overall Study|Adverse Event|2|||
170644011|NCT01215097|616710185|FG000|Overall Study|Adverse Event|1|||
170644012|NCT01215097|616710186|FG001|Overall Study|Adverse Event|3|||
170644013|NCT01215097|616710185|FG000|Overall Study|Protocol Violation|0|||
170644014|NCT01215097|616710186|FG001|Overall Study|Protocol Violation|2|||
170644015|NCT01215097|616710185|FG000|Overall Study|Lost to Follow-up|2|||
170644016|NCT01215097|616710186|FG001|Overall Study|Lost to Follow-up|0|||
170644017|NCT01215097|616710185|FG000|Overall Study|Withdrawal by Subject|6|||
170644018|NCT01215097|616710186|FG001|Overall Study|Withdrawal by Subject|3|||
170644019|NCT01215097|616710185|FG000|Overall Study|Lack of Efficacy|0|||
170644020|NCT01215097|616710186|FG001|Overall Study|Lack of Efficacy|3|||
170644021|NCT01215097|616710185|FG000|Overall Study|patient's refusal to come|2|||
170644022|NCT01215097|616710186|FG001|Overall Study|patient's refusal to come|2|||
170644023|NCT01215097|616710185|FG000|Overall Study|patient's private reason|1|||
170644024|NCT01215097|616710186|FG001|Overall Study|patient's private reason|1|||
170644025|NCT01711216|616710187|FG000|Overall Study|Adverse Event|4|||
170644026|NCT01711216|616710187|FG000|Overall Study|Pregnancy|56|||
170644027|NCT01711216|616710187|FG000|Overall Study|Withdrawal by Subject|6|||
170644028|NCT01711216|616710187|FG000|Overall Study|Lost to Follow-up|46|||
170644029|NCT01711216|616710187|FG000|Overall Study|variety of other minor reasons|83|||
170806117|NCT03789656|617299453|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
170510630|NCT01134263|616214167|FG003|Overall Study|Withdrawal by Subject|7|||
170510631|NCT01134263|616214168|FG004|Overall Study|Withdrawal by Subject|5|||
170644030|NCT01711216|616710187|FG000|Overall Study|no reason specified|22|||
170644031|NCT01821560|616710188|FG000|Overall Study|Lost to Follow-up|5|||
170644032|NCT01821560|616710189|FG001|Overall Study|Lost to Follow-up|5|||
170644033|NCT01821560|616710188|FG000|Overall Study|Withdrawal by Subject|1|||
170644034|NCT01821560|616710189|FG001|Overall Study|Withdrawal by Subject|1|||
170644035|NCT01821560|616710188|FG000|Overall Study|Protocol Violation|0|||
170644036|NCT01821560|616710189|FG001|Overall Study|Protocol Violation|1|||
170644037|NCT01253577|616710195|FG000|Overall Study|Lost to Follow-up|3|||
170644038|NCT01604278|616711500|FG000|Overall Study|Lack of Efficacy|0|||
170510632|NCT01134263|616214164|FG000|Overall Study|Enrolled, but not treated|1|||
170644039|NCT01604278|616711501|FG001|Overall Study|Lack of Efficacy|1|||
170644040|NCT01604278|616711500|FG000|Overall Study|Lost to Follow-up|1|||
170644041|NCT01604278|616711501|FG001|Overall Study|Lost to Follow-up|0|||
170553690|NCT01185366|616373562|FG001|First Line Therapy|Insurance Coverage Denied|1|||
170553691|NCT01185366|616373561|FG000|First Line Therapy|Withdrawal by Subject|1|||
170510633|NCT01134263|616214165|FG001|Overall Study|Enrolled, but not treated|1|||
170510634|NCT01134263|616214166|FG002|Overall Study|Enrolled, but not treated|0|||
170553692|NCT01185366|616373562|FG001|First Line Therapy|Withdrawal by Subject|0|||
170553693|NCT01185366|616373561|FG000|First Line Therapy|Lack of Metastatic Site|1|||
170553694|NCT01185366|616373562|FG001|First Line Therapy|Lack of Metastatic Site|0|||
170553695|NCT01185366|616373561|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
170553696|NCT01185366|616373562|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
170553697|NCT01185366|616373561|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
170553698|NCT01185366|616373562|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
170553699|NCT01185366|616373561|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
170553700|NCT01185366|616373562|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
170553701|NCT01185366|616373561|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
170553702|NCT01185366|616373562|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
170553703|NCT00401830|616373566|FG000|Overall Study|Adverse Event|10|||
170553704|NCT00401830|616373567|FG001|Overall Study|Adverse Event|18|||
170553705|NCT00401830|616373566|FG000|Overall Study|Lack of Efficacy|11|||
170553706|NCT00401830|616373567|FG001|Overall Study|Lack of Efficacy|5|||
170553707|NCT00401830|616373566|FG000|Overall Study|Withdrawal by Subject|4|||
170553708|NCT00401830|616373567|FG001|Overall Study|Withdrawal by Subject|3|||
170553709|NCT00401830|616373566|FG000|Overall Study|Protocol Violation|3|||
170553710|NCT00401830|616373567|FG001|Overall Study|Protocol Violation|3|||
170553711|NCT00401830|616373566|FG000|Overall Study|Non-compliance with drug study|1|||
170553712|NCT00401830|616373567|FG001|Overall Study|Non-compliance with drug study|0|||
170553713|NCT00401830|616373566|FG000|Overall Study|Lost to Follow-up|1|||
170553714|NCT00401830|616373567|FG001|Overall Study|Lost to Follow-up|3|||
170553715|NCT00401830|616373566|FG000|Overall Study|Other: Personal / Family problems|1|||
170553716|NCT00401830|616373567|FG001|Overall Study|Other: Personal / Family problems|0|||
170553717|NCT01720602|616373568|FG000|Overall Study|Adverse Event|3|||
170553718|NCT01720602|616373568|FG000|Overall Study|Progressive disease on therapy|2|||
170553719|NCT02539394|616373569|FG000|Overall Study|Protocol Violation|1|||
170553720|NCT02539394|616373570|FG001|Overall Study|Protocol Violation|3|||
170553721|NCT02539394|616373569|FG000|Overall Study|Lost to Follow-up|1|||
170553722|NCT02539394|616373570|FG001|Overall Study|Lost to Follow-up|2|||
170553723|NCT02539394|616373569|FG000|Overall Study|Incomplete dataset|6|||
170553724|NCT02539394|616373570|FG001|Overall Study|Incomplete dataset|6|||
170806118|NCT03789656|617299454|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
170806119|NCT03789656|617299455|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
170553725|NCT02184442|616373573|FG000|Overall Study|Death|61|||
170553726|NCT02184442|616373574|FG001|Overall Study|Death|65|||
170553727|NCT02184442|616373573|FG000|Overall Study|Withdrawal by Subject|3|||
170553728|NCT02184442|616373574|FG001|Overall Study|Withdrawal by Subject|11|||
170553729|NCT02691494|616373579|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
170553730|NCT02691494|616373580|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
170553731|NCT02691494|616373581|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
170553732|NCT02691494|616373579|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
170553733|NCT02691494|616373580|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
170553734|NCT02691494|616373581|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
170553735|NCT02691494|616373579|FG000|Post-Treatment Follow-Up Period|Other|2|||
170553736|NCT02691494|616373580|FG001|Post-Treatment Follow-Up Period|Other|1|||
170553737|NCT02691494|616373581|FG002|Post-Treatment Follow-Up Period|Other|1|||
170553738|NCT02691494|616373579|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
170553739|NCT02691494|616373580|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
170553740|NCT02691494|616373581|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
170553741|NCT02691494|616373579|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
170553742|NCT02691494|616373580|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
170553743|NCT02691494|616373581|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
170553744|NCT02916433|616373585|FG000|Overall Study|Withdrawal by Subject|1|||
170553745|NCT02916433|616373586|FG001|Overall Study|Withdrawal by Subject|0|||
170553746|NCT02916433|616373585|FG000|Overall Study|Physician Decision|1|||
170553747|NCT02916433|616373586|FG001|Overall Study|Physician Decision|0|||
170553748|NCT01152385|616373588|FG000|Overall Study|Withdrawal by Subject|3|||
170553749|NCT01152385|616373589|FG001|Overall Study|Withdrawal by Subject|1|||
170553750|NCT01152385|616373590|FG002|Overall Study|Withdrawal by Subject|1|||
170553751|NCT01152385|616373591|FG003|Overall Study|Withdrawal by Subject|1|||
170553752|NCT01152385|616373588|FG000|Overall Study|Protocol Violation|0|||
170553753|NCT01152385|616373589|FG001|Overall Study|Protocol Violation|0|||
170553754|NCT01152385|616373590|FG002|Overall Study|Protocol Violation|0|||
170553755|NCT01152385|616373591|FG003|Overall Study|Protocol Violation|1|||
170553756|NCT01152385|616373588|FG000|Overall Study|Adverse Event|1|||
170553757|NCT01152385|616373589|FG001|Overall Study|Adverse Event|1|||
170553758|NCT01152385|616373590|FG002|Overall Study|Adverse Event|0|||
170553759|NCT01152385|616373591|FG003|Overall Study|Adverse Event|0|||
170553760|NCT01152385|616373588|FG000|Overall Study|Study-specific withdrawal criteria|1|||
170553761|NCT01152385|616373589|FG001|Overall Study|Study-specific withdrawal criteria|1|||
170553762|NCT01152385|616373590|FG002|Overall Study|Study-specific withdrawal criteria|2|||
170553763|NCT01152385|616373591|FG003|Overall Study|Study-specific withdrawal criteria|0|||
170553764|NCT01152385|616373588|FG000|Overall Study|Other|4|||
170553765|NCT01152385|616373589|FG001|Overall Study|Other|3|||
170553766|NCT01152385|616373590|FG002|Overall Study|Other|2|||
170553767|NCT01152385|616373591|FG003|Overall Study|Other|3|||
170553768|NCT03249558|616373592|FG000|Overall Study|Lost to Follow-up|2|||
170553769|NCT03249558|616373593|FG001|Overall Study|Lost to Follow-up|1|||
170553770|NCT03249558|616373594|FG002|Overall Study|Lost to Follow-up|4|||
170553771|NCT03249558|616373592|FG000|Overall Study|Physician Decision|1|||
170553772|NCT03249558|616373593|FG001|Overall Study|Physician Decision|0|||
170553773|NCT03249558|616373594|FG002|Overall Study|Physician Decision|0|||
170553774|NCT03249558|616373592|FG000|Overall Study|Withdrawal by Subject|6|||
170553775|NCT03249558|616373593|FG001|Overall Study|Withdrawal by Subject|5|||
170553776|NCT03249558|616373594|FG002|Overall Study|Withdrawal by Subject|7|||
170553777|NCT03249558|616373592|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
170553778|NCT03249558|616373593|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
170553779|NCT03249558|616373594|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
170553780|NCT03249558|616373592|FG000|Overall Study|Protocol Violation|1|||
170553781|NCT03249558|616373593|FG001|Overall Study|Protocol Violation|1|||
170553782|NCT03249558|616373594|FG002|Overall Study|Protocol Violation|2|||
170553783|NCT03369704|616373595|FG000|Treatment Epoch|technical problems|1|||
170553784|NCT03369704|616373596|FG001|Treatment Epoch|technical problems|0|||
170553785|NCT03369704|616373595|FG000|Treatment Epoch|Protocol Violation|1|||
170553786|NCT03369704|616373596|FG001|Treatment Epoch|Protocol Violation|0|||
170553787|NCT03369704|616373595|FG000|Treatment Epoch|Lost to Follow-up|0|||
170553788|NCT03369704|616373596|FG001|Treatment Epoch|Lost to Follow-up|1|||
170553789|NCT03369704|616373595|FG000|Treatment Epoch|Lack of Efficacy|0|||
170644042|NCT01604278|616711500|FG000|Overall Study|Administrative problems|2|||
170644043|NCT01604278|616711501|FG001|Overall Study|Administrative problems|1|||
170644044|NCT01604278|616711500|FG000|Overall Study|Withdrawal by Subject|3|||
170644045|NCT01604278|616711501|FG001|Overall Study|Withdrawal by Subject|3|||
170644046|NCT01604278|616711500|FG000|Overall Study|Adverse Event|3|||
170644047|NCT01604278|616711501|FG001|Overall Study|Adverse Event|5|||
170644048|NCT01604278|616711500|FG000|Overall Study|Protocol Deviation|5|||
170644049|NCT01604278|616711501|FG001|Overall Study|Protocol Deviation|3|||
170644050|NCT00507728|616711506|FG000|Randomization to Month 3|Lost to Follow-up|15|||
170644051|NCT00507728|616711507|FG001|Randomization to Month 3|Lost to Follow-up|14|||
170644052|NCT00507728|616711508|FG002|Randomization to Month 3|Lost to Follow-up|20|||
170644053|NCT00507728|616711506|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
170644054|NCT00507728|616711507|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
170644055|NCT00507728|616711508|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
170644056|NCT04022733|616711509|FG000|Overall Study|conversion to open surgery|3|||
170644057|NCT04022733|616711510|FG001|Overall Study|conversion to open surgery|2|||
170644058|NCT04022733|616711509|FG000|Overall Study|bradycardia|0|||
170644059|NCT04022733|616711510|FG001|Overall Study|bradycardia|1|||
170644060|NCT00361634|616711518|FG000|Overall Study|Lost to Follow-up|1|||
170644061|NCT00361634|616711518|FG000|Overall Study|Withdrawal by Subject|1|||
170644062|NCT05573386|616711519|FG000|Overall Study|Withdrawal by Subject|3|||
170644063|NCT05573386|616711520|FG001|Overall Study|Withdrawal by Subject|2|||
170644064|NCT02500056|616711523|FG000|Overall Study|Lost to Follow-up|3|||
170644065|NCT02500056|616711524|FG001|Overall Study|Lost to Follow-up|7|||
170644066|NCT02500056|616711523|FG000|Overall Study|Recurrence|1|||
170904823|NCT01217606|617653866|FG000|9-Month Masked Extension|Personal Reasons|2|||
170644067|NCT02500056|616711524|FG001|Overall Study|Recurrence|0|||
170644068|NCT02500056|616711523|FG000|Overall Study|Death|3|||
170644069|NCT02500056|616711524|FG001|Overall Study|Death|1|||
170644070|NCT03595228|616711525|FG000|Overall Study|Death|2|||
170644071|NCT03595228|616711525|FG000|Overall Study|Lack of Efficacy|13|||
170644072|NCT03595228|616711525|FG000|Overall Study|Withdrawal by Subject|3|||
170644073|NCT03595228|616711525|FG000|Overall Study|Withdrawal by Sponsor|1|||
170644074|NCT03232333|616711526|FG000|Overall Study|Infection or Osteomyelitis|9|||
170644075|NCT03232333|616711526|FG000|Overall Study|Lost to Follow-up|4|||
170644076|NCT03232333|616711526|FG000|Overall Study|Withdrawal by Subject|2|||
170644077|NCT01155011|616711529|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
170644078|NCT01155011|616711530|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
170644079|NCT01155011|616711529|FG000|Baseline to 6 Months|investigator decision, moved|4|||
170644080|NCT01155011|616711530|FG001|Baseline to 6 Months|investigator decision, moved|5|||
170644081|NCT01155011|616711529|FG000|Baseline to 6 Months|Death|0|||
170904824|NCT01217606|617653867|FG001|9-Month Masked Extension|Personal Reasons|1|||
170904825|NCT01217606|617653866|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
170904826|NCT01217606|617653867|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
170904827|NCT01217606|617653866|FG000|9-Month Masked Extension|Pregnancy|1|||
170904828|NCT01217606|617653867|FG001|9-Month Masked Extension|Pregnancy|0|||
170904829|NCT01217606|617653866|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
170904830|NCT01217606|617653867|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
170904831|NCT01062399|617653868|FG000|Overall Study|Protocol Violation|0|||
170904832|NCT01062399|617653869|FG001|Overall Study|Protocol Violation|1|||
170904833|NCT01062399|617653870|FG002|Overall Study|Protocol Violation|0|||
170904834|NCT01062399|617653871|FG003|Overall Study|Protocol Violation|6|||
170904835|NCT01062399|617653872|FG004|Overall Study|Protocol Violation|4|||
170904836|NCT00942409|617653873|FG000|Overall Study|Lack of Efficacy|1|||
170904837|NCT00942409|617653873|FG000|Overall Study|study drug unavailable|2|||
170904838|NCT00870688|617653874|FG000|Overall Study|Lost to Follow-up|2|||
170904839|NCT00870688|617653874|FG000|Overall Study|Death, Unrelated|1|||
170904840|NCT00870688|617653874|FG000|Overall Study|Granules in the Stools|1|||
170904841|NCT02015819|617653875|FG000|Overall Study|Rickham catheter was misaligned|0|||
170904842|NCT02015819|617653876|FG001|Overall Study|Rickham catheter was misaligned|0|||
170904843|NCT02015819|617653877|FG002|Overall Study|Rickham catheter was misaligned|0|||
170904844|NCT02015819|617653878|FG003|Overall Study|Rickham catheter was misaligned|1|||
170904845|NCT01697215|617653883|FG000|Overall Study|Physician Decision|5|||
170510635|NCT01134263|616214167|FG003|Overall Study|Enrolled, but not treated|1|||
170644082|NCT01155011|616711530|FG001|Baseline to 6 Months|Death|1|||
170510636|NCT01134263|616214168|FG004|Overall Study|Enrolled, but not treated|0|||
170510637|NCT01557517|616214169|FG000|Overall Study|Death|1|||
170644083|NCT01155011|616711529|FG000|6 to 12 Months|Withdrawal by Subject|8|||
170644084|NCT01155011|616711530|FG001|6 to 12 Months|Withdrawal by Subject|5|||
170644085|NCT01155011|616711529|FG000|6 to 12 Months|Death|1|||
170644086|NCT01155011|616711530|FG001|6 to 12 Months|Death|5|||
170644087|NCT01253811|616711531|FG000|Overall Study|Withdrawal criteria|1|||
170644088|NCT01087736|616711532|FG000|Overall Study|Lost to Follow-up|1|||
170904846|NCT01697215|617653883|FG000|Overall Study|Malfunction|9|||
170904847|NCT01697215|617653883|FG000|Overall Study|CXR not available|9|||
170904848|NCT00828464|617653884|FG000|Overall Study|Withdrawal by Subject|1|||
170510638|NCT01557517|616214170|FG001|Overall Study|Death|0|||
170510639|NCT01557517|616214169|FG000|Overall Study|Refused further treatment|0|||
170510640|NCT01557517|616214170|FG001|Overall Study|Refused further treatment|2|||
170510641|NCT01557517|616214169|FG000|Overall Study|Adverse Event|0|||
170510642|NCT01557517|616214170|FG001|Overall Study|Adverse Event|2|||
170510643|NCT01557517|616214169|FG000|Overall Study|Pt declined before treatment started|1|||
170510644|NCT01557517|616214170|FG001|Overall Study|Pt declined before treatment started|0|||
170510645|NCT02700698|616214171|FG000|Overall Study|Withdrawal by Subject|1|||
170510646|NCT02700698|616214172|FG001|Overall Study|Withdrawal by Subject|0|||
170510647|NCT02005627|616214181|FG000|Overall Study|Lost to Follow-up|1|||
170510648|NCT02005627|616214182|FG001|Overall Study|Lost to Follow-up|2|||
170510649|NCT02005627|616214181|FG000|Overall Study|Withdrawal by Subject|1|||
170510650|NCT02005627|616214182|FG001|Overall Study|Withdrawal by Subject|2|||
170510651|NCT01404949|616214187|FG000|Overall Study|Not Treated|1|||
170510652|NCT03230838|616214188|FG000|Overall Study|Withdrawal by Subject|3|||
170510653|NCT03230838|616214189|FG001|Overall Study|Withdrawal by Subject|0|||
170510654|NCT03230838|616214188|FG000|Overall Study|Temperature excursion|1|||
170510655|NCT03230838|616214189|FG001|Overall Study|Temperature excursion|0|||
170510656|NCT02279745|616214191|FG000|Overall Study|Adverse Event|7|||
170510657|NCT02279745|616214191|FG000|Overall Study|Death|6|||
170510658|NCT02279745|616214191|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
170510659|NCT02279745|616214191|FG000|Overall Study|Withdrawal by Subject|2|||
170510660|NCT02279745|616214191|FG000|Overall Study|Pregnancy|1|||
170510661|NCT02279745|616214191|FG000|Overall Study|Study Non-compliance|1|||
170510662|NCT02279745|616214191|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
170510663|NCT01706575|616214194|FG000|Overall Study|Participant Withdrew Consent|4|||
170510664|NCT01706575|616214194|FG000|Overall Study|Lost to Follow-up|2|||
170510665|NCT01706575|616214194|FG000|Overall Study|Started but not Treated|6|||
170510666|NCT03244618|616214195|FG000|Overall Study|Lost to Follow-up|3|||
170510667|NCT03244618|616214196|FG001|Overall Study|Lost to Follow-up|4|||
170510668|NCT03244618|616214195|FG000|Overall Study|Protocol Violation|4|||
170553790|NCT03369704|616373596|FG001|Treatment Epoch|Lack of Efficacy|2|||
170553791|NCT03369704|616373595|FG000|Treatment Epoch|Adverse Event|2|||
170553792|NCT03369704|616373596|FG001|Treatment Epoch|Adverse Event|0|||
170553793|NCT03369704|616373595|FG000|Follow-up Epoch|Lost to Follow-up|1|||
170553794|NCT03369704|616373596|FG001|Follow-up Epoch|Lost to Follow-up|0|||
170553795|NCT02656173|616373597|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
170553796|NCT02656173|616373598|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
170553797|NCT02656173|616373597|FG000|Overall Study|Adverse Event|7|||
170553798|NCT02656173|616373598|FG001|Overall Study|Adverse Event|5|||
170553799|NCT02656173|616373597|FG000|Overall Study|Withdrawal by Subject|1|||
170553800|NCT02656173|616373598|FG001|Overall Study|Withdrawal by Subject|3|||
170553801|NCT02656173|616373597|FG000|Overall Study|Protocol Violation|0|||
170553802|NCT02656173|616373598|FG001|Overall Study|Protocol Violation|1|||
170553803|NCT02656173|616373597|FG000|Overall Study|Miscellaneous|2|||
170644089|NCT01087736|616711533|FG001|Overall Study|Lost to Follow-up|0|||
170904849|NCT00087438|617653893|FG000|Overall Study|Ineligible / No protocol treatment|4|||
170904850|NCT00811252|617653894|FG000|Overall Study|Adverse Event|6|||
170904851|NCT00811252|617653895|FG001|Overall Study|Adverse Event|10|||
170904852|NCT00811252|617653896|FG002|Overall Study|Adverse Event|15|||
170904853|NCT00811252|617653894|FG000|Overall Study|Lack of Efficacy|7|||
170510669|NCT03244618|616214196|FG001|Overall Study|Protocol Violation|3|||
170510670|NCT03244618|616214195|FG000|Overall Study|Withdrawal by Subject|0|||
170510671|NCT03244618|616214196|FG001|Overall Study|Withdrawal by Subject|2|||
170510672|NCT03469999|616214197|FG000|Overall Study|Lost to Follow-up|2|||
170510673|NCT03084315|616214198|FG000|Overall Study|Lost to Follow-up|8|||
170510674|NCT03084315|616214199|FG001|Overall Study|Lost to Follow-up|7|||
170510675|NCT03084315|616214198|FG000|Overall Study|Withdrawal by Subject|2|||
170510676|NCT03084315|616214199|FG001|Overall Study|Withdrawal by Subject|2|||
170510677|NCT02155322|616214203|FG000|Overall Study|Adverse Event|1|||
170510678|NCT02155322|616214203|FG000|Overall Study|Physician Decision|1|||
170904854|NCT00811252|617653895|FG001|Overall Study|Lack of Efficacy|2|||
170904855|NCT00811252|617653896|FG002|Overall Study|Lack of Efficacy|0|||
170904856|NCT00811252|617653894|FG000|Overall Study|Protocol Violation|3|||
170510679|NCT02155322|616214203|FG000|Overall Study|Relapse/Recurrence|8|||
170510680|NCT02155322|616214203|FG000|Overall Study|Withdrawal by Subject|4|||
170510681|NCT04424914|616214206|FG000|Overall Study|Other|0|||
170510682|NCT04424914|616214207|FG001|Overall Study|Other|0|||
170510683|NCT04424914|616214208|FG002|Overall Study|Other|28|||
170510684|NCT04424914|616214206|FG000|Overall Study|Withdrawal by Subject|3|||
170510685|NCT04424914|616214207|FG001|Overall Study|Withdrawal by Subject|0|||
170510686|NCT04424914|616214208|FG002|Overall Study|Withdrawal by Subject|0|||
170510687|NCT04424914|616214206|FG000|Overall Study|Study terminated by sponsor|23|||
170553804|NCT02656173|616373598|FG001|Overall Study|Miscellaneous|0|||
170553805|NCT03927846|616373602|FG000|Overall Study|Lost to Follow-up|10|||
170644090|NCT01087736|616711532|FG000|Overall Study|Death|0|||
170510688|NCT04424914|616214207|FG001|Overall Study|Study terminated by sponsor|7|||
170904857|NCT00811252|617653895|FG001|Overall Study|Protocol Violation|3|||
170510689|NCT04424914|616214208|FG002|Overall Study|Study terminated by sponsor|0|||
170510690|NCT04424914|616214206|FG000|Overall Study|Lost to Follow-up|0|||
170510691|NCT04424914|616214207|FG001|Overall Study|Lost to Follow-up|0|||
170510692|NCT04424914|616214208|FG002|Overall Study|Lost to Follow-up|1|||
170510693|NCT04424914|616214206|FG000|Overall Study|Death|3|||
170510694|NCT04424914|616214207|FG001|Overall Study|Death|1|||
170510695|NCT04424914|616214208|FG002|Overall Study|Death|0|||
170510696|NCT00460746|616214209|FG000|Overall Study|Adverse Event|1|||
170510697|NCT00460746|616214209|FG000|Overall Study|Lost to Follow-up|1|||
170510698|NCT01603394|616214211|FG000|Overall Study|Adverse Event|1|||
170510699|NCT00394771|616214212|FG000|Overall Study|Did not meet protocol requirements|1|||
170510700|NCT00394771|616214213|FG001|Overall Study|Did not meet protocol requirements|0|||
170510701|NCT00394771|616214214|FG002|Overall Study|Did not meet protocol requirements|2|||
170510702|NCT00394771|616214215|FG003|Overall Study|Did not meet protocol requirements|0|||
170510703|NCT00394771|616214212|FG000|Overall Study|Protocol Violation|2|||
170510704|NCT00394771|616214213|FG001|Overall Study|Protocol Violation|4|||
170510705|NCT00394771|616214214|FG002|Overall Study|Protocol Violation|9|||
170510706|NCT00394771|616214215|FG003|Overall Study|Protocol Violation|7|||
170510707|NCT00394771|616214212|FG000|Overall Study|Withdrawal by Subject|10|||
170510708|NCT00394771|616214213|FG001|Overall Study|Withdrawal by Subject|6|||
170510709|NCT00394771|616214214|FG002|Overall Study|Withdrawal by Subject|8|||
170510710|NCT00394771|616214215|FG003|Overall Study|Withdrawal by Subject|12|||
170510711|NCT00394771|616214212|FG000|Overall Study|Adverse Event|10|||
170510712|NCT00394771|616214213|FG001|Overall Study|Adverse Event|5|||
170510713|NCT00394771|616214214|FG002|Overall Study|Adverse Event|12|||
170510714|NCT00394771|616214215|FG003|Overall Study|Adverse Event|8|||
170806120|NCT03789656|617299456|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
170806121|NCT03789656|617299457|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
170806122|NCT05470114|617299458|FG000|Overall Study|Withdrawal by Subject|1|||
170806123|NCT05470114|617299459|FG001|Overall Study|Withdrawal by Subject|0|||
170806124|NCT05470114|617299458|FG000|Overall Study|Lost to Follow-up|1|||
170806125|NCT05470114|617299459|FG001|Overall Study|Lost to Follow-up|0|||
170806126|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
170806127|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
170806128|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
170806129|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
170806130|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
170806131|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
170806132|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
170806133|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
170806134|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
170806135|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
170806136|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
170806137|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
170806138|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
170806139|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
170806140|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
170806141|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
170806142|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
170806143|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
170806144|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
170806145|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
170806146|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
170806147|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
170806148|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
170806149|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
170806150|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
170510715|NCT00394771|616214212|FG000|Overall Study|Participant pregnant|0|||
170510716|NCT00394771|616214213|FG001|Overall Study|Participant pregnant|1|||
170510717|NCT00394771|616214214|FG002|Overall Study|Participant pregnant|2|||
170510718|NCT00394771|616214215|FG003|Overall Study|Participant pregnant|2|||
170510719|NCT00394771|616214212|FG000|Overall Study|Lost to Follow-up|15|||
170510720|NCT00394771|616214213|FG001|Overall Study|Lost to Follow-up|15|||
170553806|NCT03927846|616373603|FG001|Overall Study|Lost to Follow-up|11|||
170553807|NCT03878069|616373604|FG000|Overall Study|Death|0|||
170553808|NCT03878069|616373605|FG001|Overall Study|Death|1|||
170553809|NCT03878069|616373606|FG002|Overall Study|Death|0|||
170553810|NCT00834587|616373607|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
170553811|NCT00834587|616373608|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
170553812|NCT03810495|616373609|FG000|Overall Study|Lost to Follow-up|2|||
170806151|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
170904858|NCT00811252|617653896|FG002|Overall Study|Protocol Violation|2|||
170510721|NCT00394771|616214214|FG002|Overall Study|Lost to Follow-up|13|||
170510722|NCT00394771|616214215|FG003|Overall Study|Lost to Follow-up|10|||
170553813|NCT03810495|616373609|FG000|Overall Study|Withdrawal by Subject|1|||
170510723|NCT00394771|616214212|FG000|Overall Study|Other|3|||
170510724|NCT00394771|616214213|FG001|Overall Study|Other|3|||
170510725|NCT00394771|616214214|FG002|Overall Study|Other|1|||
170510726|NCT00394771|616214215|FG003|Overall Study|Other|0|||
170510727|NCT03383692|616214216|FG000|Overall Study|Progressive disease as per RECIST|3|||
170510728|NCT03383692|616214217|FG001|Overall Study|Progressive disease as per RECIST|3|||
170510729|NCT03383692|616214216|FG000|Overall Study|Clinical progression|0|||
170510730|NCT03383692|616214217|FG001|Overall Study|Clinical progression|1|||
170510731|NCT03383692|616214216|FG000|Overall Study|Adverse Event|3|||
170510732|NCT03383692|616214217|FG001|Overall Study|Adverse Event|0|||
170510733|NCT03417024|616214220|FG000|Overall Study|Study Termination prior to follow-up|11|||
170510734|NCT03417024|616214220|FG000|Overall Study|Physician Decision|2|||
170510735|NCT03168919|616214221|FG000|Overall Study|Withdrawal by Subject|2|||
170510736|NCT01085136|616214222|FG000|Part A|Other Adverse event|223|||
170510737|NCT01085136|616214223|FG001|Part A|Other Adverse event|0|||
170510738|NCT01085136|616214224|FG002|Part A|Other Adverse event|0|||
170510739|NCT01085136|616214222|FG000|Part A|Protocol Violation|3|||
170510740|NCT01085136|616214223|FG001|Part A|Protocol Violation|0|||
170510741|NCT01085136|616214224|FG002|Part A|Protocol Violation|0|||
170510742|NCT01085136|616214222|FG000|Part A|Lost to Follow-up|3|||
170510743|NCT01085136|616214223|FG001|Part A|Lost to Follow-up|0|||
170510744|NCT01085136|616214224|FG002|Part A|Lost to Follow-up|0|||
170510745|NCT01085136|616214222|FG000|Part A|Refusal to continue trial medication|64|||
170510746|NCT01085136|616214223|FG001|Part A|Refusal to continue trial medication|0|||
170510747|NCT01085136|616214224|FG002|Part A|Refusal to continue trial medication|0|||
170510748|NCT01085136|616214222|FG000|Part A|Other reason not defined above|30|||
170510749|NCT01085136|616214223|FG001|Part A|Other reason not defined above|0|||
170510750|NCT01085136|616214224|FG002|Part A|Other reason not defined above|0|||
170510751|NCT01085136|616214222|FG000|Part B|Other AE|0|||
170510752|NCT01085136|616214223|FG001|Part B|Other AE|29|||
170510753|NCT01085136|616214224|FG002|Part B|Other AE|8|||
170510754|NCT01085136|616214222|FG000|Part B|Refusal to continue trial medication|0|||
170510755|NCT01085136|616214223|FG001|Part B|Refusal to continue trial medication|12|||
170510756|NCT01085136|616214224|FG002|Part B|Refusal to continue trial medication|7|||
170510757|NCT01085136|616214222|FG000|Part B|Not treated|0|||
170510758|NCT01085136|616214223|FG001|Part B|Not treated|4|||
170510759|NCT01085136|616214224|FG002|Part B|Not treated|8|||
170510760|NCT01085136|616214222|FG000|Part B|Other reason not defined above|0|||
170510761|NCT01085136|616214223|FG001|Part B|Other reason not defined above|6|||
170510762|NCT01085136|616214224|FG002|Part B|Other reason not defined above|3|||
170510763|NCT02195427|616214225|FG000|Overall Study|Did not consent to study extension|13|||
170510764|NCT02195427|616214226|FG001|Overall Study|Did not consent to study extension|9|||
170510765|NCT02195427|616214225|FG000|Overall Study|Withdrawal by Subject|4|||
170510766|NCT02195427|616214226|FG001|Overall Study|Withdrawal by Subject|2|||
170510767|NCT02195427|616214225|FG000|Overall Study|Lost to Follow-up|0|||
170510768|NCT02195427|616214226|FG001|Overall Study|Lost to Follow-up|1|||
170510769|NCT02195427|616214225|FG000|Overall Study|Protocol Violation|7|||
170510770|NCT02195427|616214226|FG001|Overall Study|Protocol Violation|14|||
170510771|NCT02195427|616214225|FG000|Overall Study|Conditional re-treatment at W52|2|||
170510772|NCT02195427|616214226|FG001|Overall Study|Conditional re-treatment at W52|1|||
170510773|NCT00386425|616214227|FG000|Overall Study|Physician Decision|3|||
170510774|NCT00386425|616214228|FG001|Overall Study|Physician Decision|0|||
170510775|NCT00386425|616214229|FG002|Overall Study|Physician Decision|0|||
170510776|NCT00386425|616214227|FG000|Overall Study|Withdrawal by Subject|0|||
170510777|NCT00386425|616214228|FG001|Overall Study|Withdrawal by Subject|1|||
170510778|NCT00386425|616214229|FG002|Overall Study|Withdrawal by Subject|0|||
170510779|NCT02655419|616214230|FG000|Overall Study|Enrolled but not treated|1|||
170510780|NCT02655419|616214231|FG001|Overall Study|Enrolled but not treated|5|||
170510781|NCT02655419|616214230|FG000|Overall Study|Withdrawal by Subject|4|||
170510782|NCT02655419|616214231|FG001|Overall Study|Withdrawal by Subject|1|||
170510783|NCT02655419|616214230|FG000|Overall Study|Other|0|||
170510784|NCT02655419|616214231|FG001|Overall Study|Other|1|||
170510785|NCT04226495|616214235|FG000|Overall Study|Withdrawal by Subject|3|||
170510786|NCT04226495|616214236|FG001|Overall Study|Withdrawal by Subject|3|||
170510787|NCT04226495|616214235|FG000|Overall Study|PI discretion|3|||
170510788|NCT04226495|616214236|FG001|Overall Study|PI discretion|4|||
170510789|NCT00448812|616214237|FG000|Year 2|Missed visit but remained in study|4|||
170510790|NCT00448812|616214238|FG001|Year 2|Missed visit but remained in study|1|||
170510791|NCT00448812|616214237|FG000|Year 3|Withdrawal by Subject|1|||
170510792|NCT00448812|616214238|FG001|Year 3|Withdrawal by Subject|3|||
170510793|NCT00448812|616214237|FG000|Year 3|Lost to Follow-up|1|||
170510794|NCT00448812|616214238|FG001|Year 3|Lost to Follow-up|0|||
170510795|NCT00448812|616214237|FG000|Year 3|Missed visit but remained in study|2|||
170510796|NCT00448812|616214238|FG001|Year 3|Missed visit but remained in study|0|||
170510797|NCT00448812|616214237|FG000|Year 5|Missed visit but remained in study|1|||
170510798|NCT00448812|616214238|FG001|Year 5|Missed visit but remained in study|0|||
170510799|NCT02526160|616215836|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
170510800|NCT02526160|616215837|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
170510801|NCT02526160|616215836|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
170510802|NCT02526160|616215837|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
170510803|NCT02526160|616215836|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
170510804|NCT02526160|616215837|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
170510805|NCT02526160|616215836|FG000|Open-Label Treatment Extension Period I|Death|0|||
170510806|NCT02526160|616215837|FG001|Open-Label Treatment Extension Period I|Death|1|||
170510807|NCT02526160|616215836|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
170510808|NCT02526160|616215837|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
170510809|NCT02526160|616215836|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
170510810|NCT02526160|616215837|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
170510811|NCT02526160|616215836|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
170510812|NCT02526160|616215837|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
170510813|NCT02526160|616215836|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
170510814|NCT02526160|616215837|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
170510815|NCT04227405|616215838|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
170510816|NCT04227405|616215839|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
170510817|NCT04227405|616215838|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
170510818|NCT04227405|616215839|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
170510819|NCT04227405|616215838|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
170510820|NCT04227405|616215839|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
170510821|NCT03396822|616215840|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
170510822|NCT03396822|616215840|FG000|Overall Study|Physician Decision|1|||
170510823|NCT03630705|616215843|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
170510824|NCT03630705|616215844|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
170510825|NCT03630705|616215845|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
170510826|NCT03630705|616215846|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170510827|NCT03630705|616215843|FG000|Overall Study|Lost to Follow-up|1|||
170510828|NCT03630705|616215844|FG001|Overall Study|Lost to Follow-up|2|||
170510829|NCT03630705|616215845|FG002|Overall Study|Lost to Follow-up|0|||
170510830|NCT03630705|616215846|FG003|Overall Study|Lost to Follow-up|0|||
170904859|NCT00811252|617653894|FG000|Overall Study|Withdrawal of Consent|1|||
170904860|NCT00811252|617653895|FG001|Overall Study|Withdrawal of Consent|2|||
170904861|NCT00811252|617653896|FG002|Overall Study|Withdrawal of Consent|2|||
170904862|NCT00811252|617653894|FG000|Overall Study|Lost to Follow-up|0|||
170904863|NCT00811252|617653895|FG001|Overall Study|Lost to Follow-up|0|||
170904864|NCT00811252|617653896|FG002|Overall Study|Lost to Follow-up|2|||
170904865|NCT00811252|617653894|FG000|Overall Study|Administrative or Other Reasons|0|||
170904866|NCT00811252|617653895|FG001|Overall Study|Administrative or Other Reasons|3|||
170904867|NCT00811252|617653896|FG002|Overall Study|Administrative or Other Reasons|2|||
170904868|NCT00283387|617653899|FG000|First Intervention|Subject non-compliant|1|||
170904869|NCT00283387|617653900|FG001|First Intervention|Subject non-compliant|1|||
170904870|NCT00283387|617653899|FG000|First Intervention|Withdrawal by Subject|0|||
170904871|NCT00283387|617653900|FG001|First Intervention|Withdrawal by Subject|1|||
170904872|NCT05340504|617653901|FG000|Overall Study|Withdrawal by Subject|1|||
170904873|NCT05340504|617653902|FG001|Overall Study|Withdrawal by Subject|0|||
170904874|NCT00824421|617653907|FG000|Overall Study|Adverse Event|6|||
170904875|NCT00824421|617653908|FG001|Overall Study|Adverse Event|6|||
170904876|NCT00824421|617653909|FG002|Overall Study|Adverse Event|6|||
170904877|NCT00824421|617653907|FG000|Overall Study|Death|0|||
170904878|NCT00824421|617653908|FG001|Overall Study|Death|1|||
170904879|NCT00824421|617653909|FG002|Overall Study|Death|0|||
170904880|NCT00824421|617653907|FG000|Overall Study|Lack of Efficacy|5|||
170904881|NCT00824421|617653908|FG001|Overall Study|Lack of Efficacy|7|||
170904882|NCT00824421|617653909|FG002|Overall Study|Lack of Efficacy|4|||
170904883|NCT00824421|617653907|FG000|Overall Study|Lost to Follow-up|2|||
170904884|NCT00824421|617653908|FG001|Overall Study|Lost to Follow-up|3|||
170904885|NCT00824421|617653909|FG002|Overall Study|Lost to Follow-up|0|||
170904886|NCT00824421|617653907|FG000|Overall Study|Pregnancy|1|||
170904887|NCT00824421|617653908|FG001|Overall Study|Pregnancy|0|||
170904888|NCT00824421|617653909|FG002|Overall Study|Pregnancy|1|||
170904889|NCT00824421|617653907|FG000|Overall Study|Withdrawal by Subject|2|||
170904890|NCT00824421|617653908|FG001|Overall Study|Withdrawal by Subject|3|||
170510831|NCT03536663|616215847|FG000|Endexo|Protocol Violation|1|||
170510832|NCT01775787|616215848|FG000|First 7-10 Days|Adverse Event|0|||
170553814|NCT01691092|616373610|FG000|Overall Study|Lost to Follow-up|10|||
170510833|NCT01775787|616215849|FG001|First 7-10 Days|Adverse Event|1|||
170904891|NCT00824421|617653909|FG002|Overall Study|Withdrawal by Subject|3|||
170904892|NCT00824421|617653907|FG000|Overall Study|Randomized but not Treated|1|||
170904893|NCT00824421|617653908|FG001|Overall Study|Randomized but not Treated|1|||
170904894|NCT00824421|617653909|FG002|Overall Study|Randomized but not Treated|0|||
170510834|NCT01775787|616215848|FG000|First 7-10 Days|family emergency|0|||
170510835|NCT01775787|616215849|FG001|First 7-10 Days|family emergency|1|||
170510836|NCT01775787|616215848|FG000|First 7-10 Days|time commitment|0|||
170510837|NCT01775787|616215849|FG001|First 7-10 Days|time commitment|2|||
170510838|NCT01775787|616215848|FG000|First 7-10 Days|concerns with using IV|1|||
170510839|NCT01775787|616215849|FG001|First 7-10 Days|concerns with using IV|2|||
170510840|NCT01775787|616215848|FG000|Second 7-10 Days|time commitment|0|||
170510841|NCT01775787|616215849|FG001|Second 7-10 Days|time commitment|1|||
170510842|NCT01775787|616215848|FG000|Second 7-10 Days|concerns with using IV|0|||
170510843|NCT01775787|616215849|FG001|Second 7-10 Days|concerns with using IV|1|||
170510844|NCT01502956|616215851|FG000|Overall Study|Death|0|||
170510845|NCT01502956|616215852|FG001|Overall Study|Death|2|||
170510846|NCT01502956|616215851|FG000|Overall Study|Lost to Follow-up|14|||
170510847|NCT01502956|616215852|FG001|Overall Study|Lost to Follow-up|11|||
170510848|NCT01502956|616215851|FG000|Overall Study|Physician Decision|2|||
170510849|NCT01502956|616215852|FG001|Overall Study|Physician Decision|3|||
170510850|NCT01502956|616215851|FG000|Overall Study|Withdrawal by Subject|8|||
170510851|NCT01502956|616215852|FG001|Overall Study|Withdrawal by Subject|10|||
170510852|NCT01616758|616215853|FG000|Overall Study|Adverse Event|1|||
170510853|NCT01616758|616215853|FG000|Overall Study|Withdrawal by Subject|2|||
170510854|NCT01616758|616215853|FG000|Overall Study|Disease progression|18|||
170510855|NCT01616758|616215853|FG000|Overall Study|Study termination by Sponsor|1|||
170510856|NCT04076319|616215858|FG000|Overall Study|Withdrawal by Subject|2|||
170510857|NCT04076319|616215859|FG001|Overall Study|Withdrawal by Subject|0|||
170510858|NCT04076319|616215858|FG000|Overall Study|Death|1|||
170510859|NCT04076319|616215859|FG001|Overall Study|Death|0|||
170510860|NCT01054222|616215860|FG000|Overall Study|Lack of Efficacy|1|||
170510861|NCT01054222|616215860|FG000|Overall Study|Lost to Follow-up|4|||
170510862|NCT01054222|616215860|FG000|Overall Study|Withdrawal by Subject|6|||
170510863|NCT03782571|616215864|FG000|Period 1|Withdrawal by Subject|1|||
170510864|NCT03782571|616215865|FG001|Period 1|Withdrawal by Subject|0|||
170510865|NCT03782571|616215866|FG002|Period 1|Withdrawal by Subject|0|||
170510866|NCT03782571|616215867|FG003|Period 1|Withdrawal by Subject|0|||
170510867|NCT03782571|616215864|FG000|Period 3|Subject Unable to Attend V5|1|||
170510868|NCT03782571|616215865|FG001|Period 3|Subject Unable to Attend V5|0|||
170510869|NCT03782571|616215866|FG002|Period 3|Subject Unable to Attend V5|0|||
170510870|NCT03782571|616215867|FG003|Period 3|Subject Unable to Attend V5|0|||
170510871|NCT03782571|616215864|FG000|Period 3|Adverse Event|1|||
170510872|NCT03782571|616215865|FG001|Period 3|Adverse Event|0|||
170510873|NCT03782571|616215866|FG002|Period 3|Adverse Event|0|||
170510874|NCT03782571|616215867|FG003|Period 3|Adverse Event|0|||
170510875|NCT03504189|616215868|FG000|Overall Study|Withdrawal by Subject|1|||
170510876|NCT03504189|616215868|FG000|Overall Study|Screening Failure|1|||
170510877|NCT03504189|616215868|FG000|Overall Study|Device Failure|2|||
170510878|NCT03488563|616215869|FG000|Overall Study|Lost to Follow-up|7|||
170510879|NCT03488563|616215870|FG001|Overall Study|Lost to Follow-up|6|||
170510880|NCT03488563|616215871|FG002|Overall Study|Lost to Follow-up|7|||
170510881|NCT03488563|616215869|FG000|Overall Study|Withdrawal by Subject|8|||
170510882|NCT03488563|616215870|FG001|Overall Study|Withdrawal by Subject|7|||
170904895|NCT00824421|617653907|FG000|Overall Study|Other|0|||
170904896|NCT00824421|617653908|FG001|Overall Study|Other|1|||
170904897|NCT00824421|617653909|FG002|Overall Study|Other|0|||
170904898|NCT05089708|617653910|FG000|Overall Study|Lost to Follow-up|9|||
170904899|NCT05089708|617653911|FG001|Overall Study|Lost to Follow-up|7|||
170904900|NCT05089708|617653910|FG000|Overall Study|Withdrawal by Subject|3|||
170904901|NCT05089708|617653911|FG001|Overall Study|Withdrawal by Subject|1|||
170510883|NCT03488563|616215871|FG002|Overall Study|Withdrawal by Subject|7|||
170510884|NCT03488563|616215869|FG000|Overall Study|Physician Decision|0|||
170510885|NCT03488563|616215870|FG001|Overall Study|Physician Decision|0|||
170510886|NCT03488563|616215871|FG002|Overall Study|Physician Decision|1|||
170510887|NCT03488563|616215869|FG000|Overall Study|Protocol Violation|3|||
170510888|NCT03488563|616215870|FG001|Overall Study|Protocol Violation|2|||
170510889|NCT03488563|616215871|FG002|Overall Study|Protocol Violation|6|||
170510890|NCT03488563|616215869|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
170510891|NCT03488563|616215870|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
170510892|NCT03488563|616215871|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
170510893|NCT03488563|616215869|FG000|Overall Study|Use of prohibited medication|2|||
170510894|NCT03488563|616215870|FG001|Overall Study|Use of prohibited medication|0|||
170510895|NCT03488563|616215871|FG002|Overall Study|Use of prohibited medication|0|||
170510896|NCT03488563|616215869|FG000|Overall Study|Adverse Event|1|||
170553815|NCT01691092|616373610|FG000|Overall Study|Physician Decision|4|||
170904902|NCT05089708|617653910|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
170904903|NCT05089708|617653911|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
170510897|NCT03488563|616215870|FG001|Overall Study|Adverse Event|0|||
170510898|NCT03488563|616215871|FG002|Overall Study|Adverse Event|1|||
170553816|NCT01691092|616373610|FG000|Overall Study|Withdrawal by Subject|3|||
170904904|NCT05089708|617653910|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
170904905|NCT05089708|617653911|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
170510899|NCT03488563|616215869|FG000|Overall Study|Subject returned for ET visit|0|||
170510900|NCT03488563|616215870|FG001|Overall Study|Subject returned for ET visit|1|||
170510901|NCT03488563|616215871|FG002|Overall Study|Subject returned for ET visit|0|||
170510902|NCT03488563|616215869|FG000|Overall Study|Sponsor's decision|0|||
170510903|NCT03488563|616215870|FG001|Overall Study|Sponsor's decision|0|||
170510904|NCT03488563|616215871|FG002|Overall Study|Sponsor's decision|1|||
170510905|NCT00667563|616215877|FG000|Overall Study|Protocol Violation|24|||
170510906|NCT00339833|616215878|FG000|Overall Study|Withdrawal by Subject|1|||
170510907|NCT00339833|616215879|FG001|Overall Study|Withdrawal by Subject|2|||
170510908|NCT00339833|616215878|FG000|Overall Study|toothache|0|||
170510909|NCT00339833|616215879|FG001|Overall Study|toothache|1|||
170510910|NCT00339833|616215878|FG000|Overall Study|indigestion|0|||
170510911|NCT00339833|616215879|FG001|Overall Study|indigestion|1|||
170510912|NCT00339833|616215878|FG000|Overall Study|Chest pain|0|||
170510913|NCT00339833|616215879|FG001|Overall Study|Chest pain|1|||
170510914|NCT00339833|616215878|FG000|Overall Study|minor infection|0|||
170510915|NCT00339833|616215879|FG001|Overall Study|minor infection|1|||
170510916|NCT00339833|616215878|FG000|Overall Study|Poor venous access|2|||
170510917|NCT00339833|616215879|FG001|Overall Study|Poor venous access|2|||
170510918|NCT00339833|616215878|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
170510919|NCT00339833|616215879|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
170510920|NCT00339833|616215878|FG000|Overall Study|Error in data records|1|||
170510921|NCT00339833|616215879|FG001|Overall Study|Error in data records|0|||
170510922|NCT04399889|616215880|FG000|Overall Study|Death|5|||
170510923|NCT04399889|616215881|FG001|Overall Study|Death|1|||
170510924|NCT04399889|616215882|FG002|Overall Study|Death|1|||
170510925|NCT01535443|616215905|FG000|Overall Study|Physician Decision|3|||
170510926|NCT02260817|616215906|FG000|Overall Study|Lost to Follow-up|0|||
170904906|NCT01772134|617653913|FG000|Overall Study|Adverse Event|6|||
170904907|NCT01772134|617653914|FG001|Overall Study|Adverse Event|5|||
170904908|NCT01772134|617653915|FG002|Overall Study|Adverse Event|10|||
170904909|NCT01772134|617653913|FG000|Overall Study|Withdrew Consent|3|||
170904910|NCT01772134|617653914|FG001|Overall Study|Withdrew Consent|1|||
170904911|NCT01772134|617653915|FG002|Overall Study|Withdrew Consent|5|||
170904912|NCT01772134|617653913|FG000|Overall Study|Lost to Follow-up|2|||
170904913|NCT01772134|617653914|FG001|Overall Study|Lost to Follow-up|0|||
170904914|NCT01772134|617653915|FG002|Overall Study|Lost to Follow-up|0|||
170904915|NCT01772134|617653913|FG000|Overall Study|Protocol Deviation|4|||
170904916|NCT01772134|617653914|FG001|Overall Study|Protocol Deviation|3|||
170904917|NCT01772134|617653915|FG002|Overall Study|Protocol Deviation|3|||
170904918|NCT01772134|617653913|FG000|Overall Study|Lack of Efficacy|11|||
170904919|NCT01772134|617653914|FG001|Overall Study|Lack of Efficacy|5|||
170904920|NCT01772134|617653915|FG002|Overall Study|Lack of Efficacy|3|||
170904921|NCT01772134|617653913|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
170904922|NCT01772134|617653914|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
170904923|NCT01772134|617653915|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
170904924|NCT01772134|617653913|FG000|Overall Study|Randomized Study Medication Not Received|2|||
170904925|NCT01772134|617653914|FG001|Overall Study|Randomized Study Medication Not Received|0|||
170904926|NCT01772134|617653915|FG002|Overall Study|Randomized Study Medication Not Received|1|||
170904927|NCT00594399|617653920|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
170904928|NCT00594399|617653921|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
170904929|NCT00594399|617653922|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
170904930|NCT00594399|617653920|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
170904931|NCT00594399|617653921|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
170904932|NCT00594399|617653922|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
170904933|NCT00594399|617653920|FG000|Initial 3 Month Counseling|Personal issues|2|||
170904934|NCT00594399|617653921|FG001|Initial 3 Month Counseling|Personal issues|0|||
170904935|NCT00594399|617653922|FG002|Initial 3 Month Counseling|Personal issues|0|||
170904936|NCT00594399|617653920|FG000|Initial 3 Month Counseling|Too busy|7|||
170904937|NCT00594399|617653921|FG001|Initial 3 Month Counseling|Too busy|1|||
170904938|NCT00594399|617653922|FG002|Initial 3 Month Counseling|Too busy|0|||
170510927|NCT02260817|616215907|FG001|Overall Study|Lost to Follow-up|14|||
170510928|NCT02260817|616215906|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
170510929|NCT02260817|616215907|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
170510930|NCT02260817|616215906|FG000|Overall Study|Observation, no biopsy|0|||
170510931|NCT02260817|616215907|FG001|Overall Study|Observation, no biopsy|1|||
170510932|NCT02260817|616215906|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
170510933|NCT02260817|616215907|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
170510934|NCT02260817|616215906|FG000|Overall Study|Protocol Violation|0|||
170510935|NCT02260817|616215907|FG001|Overall Study|Protocol Violation|14|||
170510936|NCT00957424|616215908|FG000|Overall Study|Lost to Follow-up|19|||
170510937|NCT00957424|616215908|FG000|Overall Study|Protocol Violation|3|||
170510938|NCT00957424|616215908|FG000|Overall Study|Withdrawal by Subject|1|||
170904939|NCT00594399|617653920|FG000|Initial 3 Month Counseling|Pain|2|||
170904940|NCT00594399|617653921|FG001|Initial 3 Month Counseling|Pain|0|||
170904941|NCT00594399|617653922|FG002|Initial 3 Month Counseling|Pain|0|||
170904942|NCT00594399|617653920|FG000|Initial 3 Month Counseling|Moved|1|||
170510939|NCT00162097|616215909|FG000|Overall Study|Participant no longer met study criteria|0|||
170510940|NCT00162097|616215910|FG001|Overall Study|Participant no longer met study criteria|0|||
170510941|NCT00162097|616215911|FG002|Overall Study|Participant no longer met study criteria|0|||
170510942|NCT00162097|616215912|FG003|Overall Study|Participant no longer met study criteria|1|||
170510943|NCT01204918|616215913|FG000|Overall Study|Withdrawal by Subject|4|||
170510944|NCT01204918|616215914|FG001|Overall Study|Withdrawal by Subject|10|||
170510945|NCT01204918|616215915|FG002|Overall Study|Withdrawal by Subject|5|||
170510946|NCT00770913|616215916|FG000|Overall Study|Adverse Event|1|||
170510947|NCT00770913|616215917|FG001|Overall Study|Adverse Event|3|||
170510948|NCT00770913|616215918|FG002|Overall Study|Adverse Event|6|||
170510949|NCT00770913|616215916|FG000|Overall Study|Refusal to continue participation|6|||
170510950|NCT00770913|616215917|FG001|Overall Study|Refusal to continue participation|4|||
170510951|NCT00770913|616215918|FG002|Overall Study|Refusal to continue participation|5|||
170510952|NCT00770913|616215916|FG000|Overall Study|Physician Decision|0|||
170510953|NCT00770913|616215917|FG001|Overall Study|Physician Decision|1|||
170510954|NCT00770913|616215918|FG002|Overall Study|Physician Decision|1|||
170510955|NCT00770913|616215916|FG000|Overall Study|Protocol Violation|3|||
170510956|NCT00770913|616215917|FG001|Overall Study|Protocol Violation|0|||
170510957|NCT00770913|616215918|FG002|Overall Study|Protocol Violation|1|||
170510958|NCT00770913|616215916|FG000|Overall Study|Incorrect drug was allocated|1|||
170510959|NCT00770913|616215917|FG001|Overall Study|Incorrect drug was allocated|0|||
170510960|NCT00770913|616215918|FG002|Overall Study|Incorrect drug was allocated|0|||
170510961|NCT00269477|616215922|FG000|Overall Study|Protocol Violation|5|||
170510962|NCT00269477|616215923|FG001|Overall Study|Protocol Violation|5|||
170510963|NCT00269477|616215924|FG002|Overall Study|Protocol Violation|1|||
170510964|NCT00269477|616215925|FG003|Overall Study|Protocol Violation|0|||
170510965|NCT00269477|616215922|FG000|Overall Study|Missed post-vaccination blood draw|0|||
170510966|NCT00269477|616215923|FG001|Overall Study|Missed post-vaccination blood draw|1|||
170510967|NCT00269477|616215924|FG002|Overall Study|Missed post-vaccination blood draw|0|||
170510968|NCT00269477|616215925|FG003|Overall Study|Missed post-vaccination blood draw|0|||
170510969|NCT00431067|616215926|FG000|Overall Study|Other Adverse Event|9|||
170510970|NCT00431067|616215926|FG000|Overall Study|Progressive disease|30|||
170510971|NCT00431067|616215926|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
170510972|NCT00548249|616215927|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
170510973|NCT00548249|616215928|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
170510974|NCT00548249|616215929|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
170510975|NCT00548249|616215930|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
170510976|NCT00548249|616215931|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
170510977|NCT00548249|616215927|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
170510978|NCT00548249|616215928|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
170510979|NCT00548249|616215929|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
170510980|NCT00548249|616215930|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
170510981|NCT00548249|616215931|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
170510982|NCT00548249|616215927|FG000|Overall Study|Protocol Violation|1|||
170510983|NCT00548249|616215928|FG001|Overall Study|Protocol Violation|1|||
170510984|NCT00548249|616215929|FG002|Overall Study|Protocol Violation|4|||
170510985|NCT00548249|616215930|FG003|Overall Study|Protocol Violation|0|||
170510986|NCT00548249|616215931|FG004|Overall Study|Protocol Violation|3|||
170510987|NCT00548249|616215927|FG000|Overall Study|Miscellaneous|2|||
170510988|NCT00548249|616215928|FG001|Overall Study|Miscellaneous|3|||
170510989|NCT00548249|616215929|FG002|Overall Study|Miscellaneous|2|||
170510990|NCT00548249|616215930|FG003|Overall Study|Miscellaneous|0|||
170510991|NCT00548249|616215931|FG004|Overall Study|Miscellaneous|2|||
170510992|NCT00548249|616215927|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
170510993|NCT00548249|616215928|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
170510994|NCT00548249|616215929|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
170806152|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
170806153|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
170806154|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
170510995|NCT00548249|616215930|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
170510996|NCT00548249|616215931|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
170510997|NCT00548249|616215927|FG000|Overall Study|Adverse Event|2|||
170510998|NCT00548249|616215928|FG001|Overall Study|Adverse Event|2|||
170510999|NCT00548249|616215929|FG002|Overall Study|Adverse Event|0|||
170511000|NCT00548249|616215930|FG003|Overall Study|Adverse Event|1|||
170511001|NCT00548249|616215931|FG004|Overall Study|Adverse Event|1|||
170511002|NCT00548249|616215927|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
170511003|NCT00548249|616215928|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
170511004|NCT00548249|616215929|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
170511005|NCT00548249|616215930|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
170511006|NCT00548249|616215931|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
170511007|NCT00548249|616215927|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
170511008|NCT00548249|616215928|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
170511009|NCT00548249|616215929|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
170511010|NCT00548249|616215930|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
170511011|NCT00548249|616215931|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
170511012|NCT00548249|616215927|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
170511013|NCT00548249|616215928|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
170511014|NCT00548249|616215929|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
170511015|NCT00548249|616215930|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
170511016|NCT00548249|616215931|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
170511017|NCT00548249|616215927|FG000|Overall Study|Prolonged hospitalization|0|||
170511018|NCT00548249|616215928|FG001|Overall Study|Prolonged hospitalization|0|||
170511019|NCT00548249|616215929|FG002|Overall Study|Prolonged hospitalization|2|||
170511020|NCT00548249|616215930|FG003|Overall Study|Prolonged hospitalization|1|||
170511021|NCT00548249|616215931|FG004|Overall Study|Prolonged hospitalization|0|||
170511022|NCT00548249|616215927|FG000|Overall Study|Withdrawal by Subject|2|||
170511023|NCT00548249|616215928|FG001|Overall Study|Withdrawal by Subject|0|||
170511024|NCT00548249|616215929|FG002|Overall Study|Withdrawal by Subject|0|||
170511025|NCT00548249|616215930|FG003|Overall Study|Withdrawal by Subject|0|||
170511026|NCT00548249|616215931|FG004|Overall Study|Withdrawal by Subject|0|||
170511027|NCT00548249|616215927|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
170511028|NCT00548249|616215928|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
170511029|NCT00548249|616215929|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
170511030|NCT00548249|616215930|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
170511031|NCT00548249|616215931|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
170511032|NCT00548249|616215927|FG000|Overall Study|Sponsor's request|0|||
170511033|NCT00548249|616215928|FG001|Overall Study|Sponsor's request|0|||
170511034|NCT00548249|616215929|FG002|Overall Study|Sponsor's request|0|||
170511035|NCT00548249|616215930|FG003|Overall Study|Sponsor's request|1|||
170511036|NCT00548249|616215931|FG004|Overall Study|Sponsor's request|0|||
170511037|NCT02347072|616215936|FG000|Overall Study|Adverse Event|2|||
170511038|NCT02347072|616215936|FG000|Overall Study|Withdrawal by Subject|6|||
170511039|NCT02347072|616215936|FG000|Overall Study|Physician Decision|1|||
170511040|NCT02347072|616215936|FG000|Overall Study|Lost to Follow-up|2|||
170511041|NCT02347072|616215936|FG000|Overall Study|Protocol Violation|1|||
170511042|NCT02347072|616215936|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
170511043|NCT01134393|616215941|FG000|Overall Study|Adverse Event|18|||
170511044|NCT01134393|616215941|FG000|Overall Study|Lack of Efficacy|2|||
170511045|NCT01134393|616215941|FG000|Overall Study|Protocol Violation|12|||
170511046|NCT01134393|616215941|FG000|Overall Study|Lost to Follow-up|3|||
170511047|NCT01134393|616215941|FG000|Overall Study|Withdrawal by Subject|11|||
170511048|NCT01134393|616215941|FG000|Overall Study|Other|6|||
170511049|NCT00080483|616215944|FG000|Overall Study|Lost to Follow-up|1|||
170511050|NCT00080483|616215945|FG001|Overall Study|Lost to Follow-up|1|||
170511051|NCT00080483|616215944|FG000|Overall Study|Physician Decision|1|||
170511052|NCT00080483|616215945|FG001|Overall Study|Physician Decision|1|||
170511053|NCT02007278|616215948|FG000|Overall Study|Failure to comply with an eligibility|0|||
170511054|NCT02007278|616215949|FG001|Overall Study|Failure to comply with an eligibility|1|||
170511055|NCT02007278|616215948|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
170511056|NCT02007278|616215949|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
170511057|NCT02007278|616215948|FG000|Overall Study|Incorrect medication administration|1|||
170511058|NCT02007278|616215949|FG001|Overall Study|Incorrect medication administration|0|||
170511059|NCT02007278|616215948|FG000|Overall Study|Mis-randomization|1|||
170511060|NCT02007278|616215949|FG001|Overall Study|Mis-randomization|1|||
170511061|NCT01429441|616215950|FG000|Overall Study|Adverse Event|5|||
170511062|NCT01429441|616215951|FG001|Overall Study|Adverse Event|1|||
170511063|NCT01429441|616215950|FG000|Overall Study|Death|0|||
170511064|NCT01429441|616215951|FG001|Overall Study|Death|2|||
170511065|NCT01429441|616215950|FG000|Overall Study|Lost to Follow-up|5|||
170511066|NCT01429441|616215951|FG001|Overall Study|Lost to Follow-up|2|||
170511067|NCT01429441|616215950|FG000|Overall Study|Physician Decision|1|||
170511068|NCT01429441|616215951|FG001|Overall Study|Physician Decision|0|||
170511069|NCT01429441|616215950|FG000|Overall Study|Withdrawal by Subject|27|||
170511070|NCT01429441|616215951|FG001|Overall Study|Withdrawal by Subject|18|||
170511071|NCT01606748|616215952|FG000|Overall Study|Adverse Event|1|||
170511072|NCT01606748|616215953|FG001|Overall Study|Adverse Event|0|||
170511073|NCT01606748|616215952|FG000|Overall Study|Progressive Disease|1|||
170511074|NCT01606748|616215953|FG001|Overall Study|Progressive Disease|0|||
170511075|NCT01606748|616215952|FG000|Overall Study|Withdrawal by Subject|1|||
170511076|NCT01606748|616215953|FG001|Overall Study|Withdrawal by Subject|0|||
170511077|NCT02670382|616215954|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
170511078|NCT02670382|616215955|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
170553817|NCT01691092|616373610|FG000|Overall Study|non-compliance|3|||
170553818|NCT01691092|616373610|FG000|Overall Study|used for different study|2|||
170553819|NCT01691092|616373610|FG000|Overall Study|screen fail|19|||
170553820|NCT03061214|616373613|FG000|Overall Study|Withdrawal by Subject|21|||
170553821|NCT03061214|616373614|FG001|Overall Study|Withdrawal by Subject|26|||
170553822|NCT03061214|616373615|FG002|Overall Study|Withdrawal by Subject|9|||
170904943|NCT00594399|617653921|FG001|Initial 3 Month Counseling|Moved|0|||
170904944|NCT00594399|617653922|FG002|Initial 3 Month Counseling|Moved|0|||
170904945|NCT00594399|617653920|FG000|Initial 3 Month Counseling|Family illness|1|||
170904946|NCT00594399|617653921|FG001|Initial 3 Month Counseling|Family illness|0|||
170904947|NCT00594399|617653922|FG002|Initial 3 Month Counseling|Family illness|0|||
170904948|NCT00594399|617653920|FG000|Rerandomization Arm 1 Only|Death|2|||
170904949|NCT00594399|617653921|FG001|Rerandomization Arm 1 Only|Death|1|||
170904950|NCT00594399|617653922|FG002|Rerandomization Arm 1 Only|Death|0|||
170904951|NCT00594399|617653920|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
170904952|NCT00594399|617653921|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
170904953|NCT00594399|617653922|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
170904954|NCT00201851|617653924|FG000|Overall Study|Lost to Follow-up|2|||
170904955|NCT00201851|617653925|FG001|Overall Study|Lost to Follow-up|1|||
170904956|NCT00201851|617653926|FG002|Overall Study|Lost to Follow-up|0|||
170904957|NCT00201851|617653924|FG000|Overall Study|Ineligible post enrollment|6|||
170904958|NCT00201851|617653925|FG001|Overall Study|Ineligible post enrollment|1|||
170904959|NCT00201851|617653926|FG002|Overall Study|Ineligible post enrollment|1|||
170904960|NCT00636818|617653930|FG000|Overall Study|Adverse Event|1|||
170904961|NCT00636818|617653930|FG000|Overall Study|Lost to Follow-up|2|||
170904962|NCT00636818|617653930|FG000|Overall Study|Entry Criteria Exclusion|3|||
170904963|NCT00636818|617653930|FG000|Overall Study|Protocol Violation|1|||
170904964|NCT00636818|617653930|FG000|Overall Study|Withdrawal by Subject|4|||
170904965|NCT02201940|617653931|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
170904966|NCT02201940|617653932|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
170904967|NCT02201940|617653931|FG000|Overall Study|Lack of Efficacy|2|||
170904968|NCT02201940|617653932|FG001|Overall Study|Lack of Efficacy|113|||
170904969|NCT02201940|617653931|FG000|Overall Study|Lost to Follow-up|5|||
170904970|NCT02201940|617653932|FG001|Overall Study|Lost to Follow-up|0|||
170904971|NCT02201940|617653931|FG000|Overall Study|Withdrew Consent|2|||
170904972|NCT02201940|617653932|FG001|Overall Study|Withdrew Consent|1|||
170904973|NCT02201940|617653931|FG000|Overall Study|Investigator's Discretion|1|||
170904974|NCT02201940|617653932|FG001|Overall Study|Investigator's Discretion|1|||
170904975|NCT02201940|617653931|FG000|Overall Study|Death|1|||
170904976|NCT02201940|617653932|FG001|Overall Study|Death|0|||
170904977|NCT02201940|617653931|FG000|Overall Study|Adverse Event|0|||
170904978|NCT02201940|617653932|FG001|Overall Study|Adverse Event|1|||
170904979|NCT02305563|617653935|FG000|Treatment Period|Disease progression|0|||
170904980|NCT02305563|617653936|FG001|Treatment Period|Disease progression|0|||
170904981|NCT02305563|617653937|FG002|Treatment Period|Disease progression|15|||
170904982|NCT02305563|617653938|FG003|Treatment Period|Disease progression|6|||
170904983|NCT02305563|617653939|FG004|Treatment Period|Disease progression|6|||
170904984|NCT02305563|617653935|FG000|Treatment Period|Study drug toxicity|0|||
170904985|NCT02305563|617653936|FG001|Treatment Period|Study drug toxicity|0|||
170904986|NCT02305563|617653937|FG002|Treatment Period|Study drug toxicity|0|||
170904987|NCT02305563|617653938|FG003|Treatment Period|Study drug toxicity|1|||
170904988|NCT02305563|617653939|FG004|Treatment Period|Study drug toxicity|2|||
170904989|NCT02305563|617653935|FG000|Treatment Period|Death|0|||
170904990|NCT02305563|617653936|FG001|Treatment Period|Death|0|||
170904991|NCT02305563|617653937|FG002|Treatment Period|Death|1|||
170904992|NCT02305563|617653938|FG003|Treatment Period|Death|2|||
170904993|NCT02305563|617653939|FG004|Treatment Period|Death|1|||
170904994|NCT02305563|617653935|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
170904995|NCT02305563|617653936|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
170904996|NCT02305563|617653937|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
170904997|NCT02305563|617653938|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
170511079|NCT01810783|616215956|FG000|Overall Study|Adverse Event|32|||
170511080|NCT01810783|616215956|FG000|Overall Study|Withdrawal by Subject|22|||
170553823|NCT03061214|616373613|FG000|Overall Study|Lost to Follow-up|3|||
170553824|NCT03061214|616373614|FG001|Overall Study|Lost to Follow-up|1|||
170553825|NCT03061214|616373615|FG002|Overall Study|Lost to Follow-up|1|||
170904998|NCT02305563|617653939|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
170904999|NCT02305563|617653935|FG000|Treatment Period|Participant request to stop therapy|0|||
170511081|NCT01810783|616215956|FG000|Overall Study|Lack of Efficacy|12|||
170511082|NCT01810783|616215956|FG000|Overall Study|Lost to Follow-up|10|||
170511083|NCT01810783|616215956|FG000|Overall Study|Protocol Violation|5|||
170511084|NCT01810783|616215956|FG000|Overall Study|Non-compliance with IMP|4|||
170511085|NCT01810783|616215956|FG000|Overall Study|Adminstrative or other reason(s)|23|||
170511086|NCT01810783|616215956|FG000|Overall Study|Enrolled, not treated|1|||
170511087|NCT00358956|616215957|FG000|Overall Study|Adverse Event|3|||
170511088|NCT00358956|616215957|FG000|Overall Study|condition under investigation worsened|4|||
170511089|NCT00358956|616215957|FG000|Overall Study|Withdrawal by Subject|1|||
170511090|NCT04776018|616215958|FG000|Overall Study|Death|0|||
170511091|NCT04776018|616215959|FG001|Overall Study|Death|1|||
170511092|NCT04776018|616215960|FG002|Overall Study|Death|4|||
170511093|NCT04776018|616215961|FG003|Overall Study|Death|1|||
170511094|NCT04776018|616215962|FG004|Overall Study|Death|4|||
170511095|NCT04776018|616215963|FG005|Overall Study|Death|0|||
170511096|NCT04776018|616215964|FG006|Overall Study|Death|0|||
170511097|NCT04776018|616215958|FG000|Overall Study|Study terminated by sponsor|2|||
170511098|NCT04776018|616215959|FG001|Overall Study|Study terminated by sponsor|1|||
170511099|NCT04776018|616215960|FG002|Overall Study|Study terminated by sponsor|4|||
170511100|NCT04776018|616215961|FG003|Overall Study|Study terminated by sponsor|0|||
170511101|NCT04776018|616215962|FG004|Overall Study|Study terminated by sponsor|3|||
170511102|NCT04776018|616215963|FG005|Overall Study|Study terminated by sponsor|0|||
170511103|NCT04776018|616215964|FG006|Overall Study|Study terminated by sponsor|0|||
170511104|NCT04776018|616215958|FG000|Overall Study|Withdrawal by Subject|1|||
170511105|NCT04776018|616215959|FG001|Overall Study|Withdrawal by Subject|0|||
170511106|NCT04776018|616215960|FG002|Overall Study|Withdrawal by Subject|0|||
170511107|NCT04776018|616215961|FG003|Overall Study|Withdrawal by Subject|2|||
170511108|NCT04776018|616215962|FG004|Overall Study|Withdrawal by Subject|1|||
170511109|NCT04776018|616215963|FG005|Overall Study|Withdrawal by Subject|0|||
170511110|NCT04776018|616215964|FG006|Overall Study|Withdrawal by Subject|0|||
170511111|NCT04776018|616215958|FG000|Overall Study|Other|0|||
170511112|NCT04776018|616215959|FG001|Overall Study|Other|1|||
170511113|NCT04776018|616215960|FG002|Overall Study|Other|1|||
170511114|NCT04776018|616215961|FG003|Overall Study|Other|0|||
170511115|NCT04776018|616215962|FG004|Overall Study|Other|0|||
170511116|NCT04776018|616215963|FG005|Overall Study|Other|0|||
170511117|NCT04776018|616215964|FG006|Overall Study|Other|0|||
170511118|NCT04776018|616215958|FG000|Overall Study|Lost to Follow-up|0|||
170511119|NCT04776018|616215959|FG001|Overall Study|Lost to Follow-up|0|||
170511120|NCT04776018|616215960|FG002|Overall Study|Lost to Follow-up|1|||
170511121|NCT04776018|616215961|FG003|Overall Study|Lost to Follow-up|0|||
170511122|NCT04776018|616215962|FG004|Overall Study|Lost to Follow-up|0|||
170511123|NCT04776018|616215963|FG005|Overall Study|Lost to Follow-up|0|||
170511124|NCT04776018|616215964|FG006|Overall Study|Lost to Follow-up|0|||
170511125|NCT00793546|616215965|FG000|Overall Study|Death|3|||
170553826|NCT03061214|616373613|FG000|Overall Study|Death|1|||
170553827|NCT03061214|616373614|FG001|Overall Study|Death|1|||
170553828|NCT03061214|616373615|FG002|Overall Study|Death|0|||
170553829|NCT03727022|616375447|FG000|Phase A|Lost to Follow-up|2|||
170553830|NCT03727022|616375448|FG001|Phase A|Lost to Follow-up|3|||
170511126|NCT00793546|616215966|FG001|Overall Study|Death|0|||
170511127|NCT00793546|616215965|FG000|Overall Study|Lost to Follow-up|1|||
170511128|NCT00793546|616215966|FG001|Overall Study|Lost to Follow-up|0|||
170511129|NCT00793546|616215965|FG000|Overall Study|Withdrawal by Subject|1|||
170511130|NCT00793546|616215966|FG001|Overall Study|Withdrawal by Subject|1|||
170511131|NCT00793546|616215965|FG000|Overall Study|Study Terminated by Sponsor|8|||
170511132|NCT00793546|616215966|FG001|Overall Study|Study Terminated by Sponsor|27|||
170553831|NCT03727022|616375447|FG000|Phase A|Withdrawal by Subject|10|||
170511133|NCT00793546|616215965|FG000|Overall Study|Other|1|||
170511134|NCT00793546|616215966|FG001|Overall Study|Other|0|||
170511135|NCT02620384|616215967|FG000|Overall Study|Adverse Event|2|||
170511136|NCT02620384|616215968|FG001|Overall Study|Adverse Event|1|||
170511137|NCT02620384|616215967|FG000|Overall Study|Discharged prior to 2nd dose|2|||
170511138|NCT02620384|616215968|FG001|Overall Study|Discharged prior to 2nd dose|5|||
170511139|NCT02620384|616215967|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
170553832|NCT03727022|616375448|FG001|Phase A|Withdrawal by Subject|9|||
170511140|NCT02620384|616215968|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
170511141|NCT00094536|616215969|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
170553833|NCT03727022|616375447|FG000|Phase B|Lost to Follow-up|0|||
170553834|NCT03727022|616375448|FG001|Phase B|Lost to Follow-up|1|||
170511142|NCT00094536|616215969|FG000|Treatment and Follow-up|Adverse Event|4|||
170511143|NCT00094536|616215969|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
170511144|NCT00094536|616215969|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
170511145|NCT00094536|616215969|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
170511146|NCT00094536|616215969|FG000|Treatment and Follow-up|Subject non-compliance|9|||
170511147|NCT00094536|616215969|FG000|Treatment and Follow-up|Unable to attend visits|1|||
170511148|NCT03252145|616217853|FG000|Overall Study|Withdrawal by Subject|1|||
170511149|NCT03252145|616217854|FG001|Overall Study|Withdrawal by Subject|0|||
170511150|NCT03252145|616217853|FG000|Overall Study|Complicating Disease|1|||
170511151|NCT03252145|616217854|FG001|Overall Study|Complicating Disease|2|||
170511152|NCT01763827|616217860|FG000|Overall Study|Withdrawal by Subject|1|||
170511153|NCT01763827|616217861|FG001|Overall Study|Withdrawal by Subject|0|||
170511154|NCT01763827|616217862|FG002|Overall Study|Withdrawal by Subject|0|||
170511155|NCT01763827|616217863|FG003|Overall Study|Withdrawal by Subject|0|||
170511156|NCT01763827|616217864|FG004|Overall Study|Withdrawal by Subject|2|||
170511157|NCT01763827|616217865|FG005|Overall Study|Withdrawal by Subject|0|||
170511158|NCT01763827|616217860|FG000|Overall Study|Decision by sponsor|2|||
170511159|NCT01763827|616217861|FG001|Overall Study|Decision by sponsor|0|||
170511160|NCT01763827|616217862|FG002|Overall Study|Decision by sponsor|3|||
170511161|NCT01763827|616217863|FG003|Overall Study|Decision by sponsor|0|||
170511162|NCT01763827|616217864|FG004|Overall Study|Decision by sponsor|2|||
170511163|NCT01763827|616217865|FG005|Overall Study|Decision by sponsor|1|||
170511164|NCT01763827|616217860|FG000|Overall Study|Lost to Follow-up|0|||
170511165|NCT01763827|616217861|FG001|Overall Study|Lost to Follow-up|1|||
170511166|NCT01763827|616217862|FG002|Overall Study|Lost to Follow-up|1|||
170511167|NCT01763827|616217863|FG003|Overall Study|Lost to Follow-up|1|||
170511168|NCT01763827|616217864|FG004|Overall Study|Lost to Follow-up|2|||
170511169|NCT01763827|616217865|FG005|Overall Study|Lost to Follow-up|1|||
170511170|NCT03746405|616217870|FG000|Overall Study|Withdrawal by Subject|3|||
170511171|NCT03746405|616217871|FG001|Overall Study|Withdrawal by Subject|0|||
170511172|NCT03746405|616217870|FG000|Overall Study|technical difficulties|0|||
170511173|NCT03746405|616217871|FG001|Overall Study|technical difficulties|2|||
170511174|NCT03130959|616217874|FG000|Overall Study|Disease progression|19|||
170511175|NCT03130959|616217875|FG001|Overall Study|Disease progression|7|||
170511176|NCT03130959|616217876|FG002|Overall Study|Disease progression|12|||
170511177|NCT03130959|616217877|FG003|Overall Study|Disease progression|7|||
170511178|NCT03130959|616217878|FG004|Overall Study|Disease progression|12|||
170511179|NCT03130959|616217879|FG005|Overall Study|Disease progression|3|||
170511180|NCT03130959|616217880|FG006|Overall Study|Disease progression|6|||
170511181|NCT03130959|616217881|FG007|Overall Study|Disease progression|3|||
170511182|NCT03130959|616217882|FG008|Overall Study|Disease progression|15|||
170511183|NCT03130959|616217883|FG009|Overall Study|Disease progression|8|||
170511184|NCT03130959|616217874|FG000|Overall Study|Study drug toxicity|2|||
170511185|NCT03130959|616217875|FG001|Overall Study|Study drug toxicity|2|||
170511186|NCT03130959|616217876|FG002|Overall Study|Study drug toxicity|1|||
170511187|NCT03130959|616217877|FG003|Overall Study|Study drug toxicity|2|||
170511188|NCT03130959|616217878|FG004|Overall Study|Study drug toxicity|1|||
170511189|NCT03130959|616217879|FG005|Overall Study|Study drug toxicity|1|||
170511190|NCT03130959|616217880|FG006|Overall Study|Study drug toxicity|3|||
170511191|NCT03130959|616217881|FG007|Overall Study|Study drug toxicity|0|||
170511192|NCT03130959|616217882|FG008|Overall Study|Study drug toxicity|3|||
170511193|NCT03130959|616217883|FG009|Overall Study|Study drug toxicity|3|||
170511194|NCT03130959|616217874|FG000|Overall Study|Other reasons|0|||
170511195|NCT03130959|616217875|FG001|Overall Study|Other reasons|0|||
170511196|NCT03130959|616217876|FG002|Overall Study|Other reasons|0|||
170511197|NCT03130959|616217877|FG003|Overall Study|Other reasons|0|||
170511198|NCT03130959|616217878|FG004|Overall Study|Other reasons|0|||
170511199|NCT03130959|616217879|FG005|Overall Study|Other reasons|1|||
170511200|NCT03130959|616217880|FG006|Overall Study|Other reasons|1|||
170511201|NCT03130959|616217881|FG007|Overall Study|Other reasons|0|||
170511202|NCT03130959|616217882|FG008|Overall Study|Other reasons|0|||
170553835|NCT03727022|616375447|FG000|Phase B|Subject Non-Compliance|1|||
170553836|NCT03727022|616375448|FG001|Phase B|Subject Non-Compliance|0|||
170511203|NCT03130959|616217883|FG009|Overall Study|Other reasons|0|||
170511204|NCT03130959|616217874|FG000|Overall Study|Subject request to discontinue therapy|0|||
170511205|NCT03130959|616217875|FG001|Overall Study|Subject request to discontinue therapy|0|||
170511206|NCT03130959|616217876|FG002|Overall Study|Subject request to discontinue therapy|1|||
170511207|NCT03130959|616217877|FG003|Overall Study|Subject request to discontinue therapy|1|||
170511208|NCT03130959|616217878|FG004|Overall Study|Subject request to discontinue therapy|0|||
170511209|NCT03130959|616217879|FG005|Overall Study|Subject request to discontinue therapy|0|||
170511210|NCT03130959|616217880|FG006|Overall Study|Subject request to discontinue therapy|1|||
170553837|NCT03727022|616375447|FG000|Phase B|Withdrawal by Subject|3|||
170511211|NCT03130959|616217881|FG007|Overall Study|Subject request to discontinue therapy|1|||
170511212|NCT03130959|616217882|FG008|Overall Study|Subject request to discontinue therapy|0|||
170511213|NCT03130959|616217883|FG009|Overall Study|Subject request to discontinue therapy|0|||
170511214|NCT03130959|616217874|FG000|Overall Study|Not reported|0|||
170511215|NCT03130959|616217875|FG001|Overall Study|Not reported|0|||
170511216|NCT03130959|616217876|FG002|Overall Study|Not reported|0|||
170511217|NCT03130959|616217877|FG003|Overall Study|Not reported|1|||
170511218|NCT03130959|616217878|FG004|Overall Study|Not reported|0|||
170511219|NCT03130959|616217879|FG005|Overall Study|Not reported|1|||
170511220|NCT03130959|616217880|FG006|Overall Study|Not reported|0|||
170511221|NCT03130959|616217881|FG007|Overall Study|Not reported|0|||
170511222|NCT03130959|616217882|FG008|Overall Study|Not reported|0|||
170511223|NCT03130959|616217883|FG009|Overall Study|Not reported|1|||
170511224|NCT03130959|616217874|FG000|Overall Study|Adverse Event unrelated to drug|0|||
170511225|NCT03130959|616217875|FG001|Overall Study|Adverse Event unrelated to drug|0|||
170511226|NCT03130959|616217876|FG002|Overall Study|Adverse Event unrelated to drug|1|||
170511227|NCT03130959|616217877|FG003|Overall Study|Adverse Event unrelated to drug|1|||
170511228|NCT03130959|616217878|FG004|Overall Study|Adverse Event unrelated to drug|1|||
170511229|NCT03130959|616217879|FG005|Overall Study|Adverse Event unrelated to drug|0|||
170511230|NCT03130959|616217880|FG006|Overall Study|Adverse Event unrelated to drug|1|||
170511231|NCT03130959|616217881|FG007|Overall Study|Adverse Event unrelated to drug|0|||
170511232|NCT03130959|616217882|FG008|Overall Study|Adverse Event unrelated to drug|1|||
170511233|NCT03130959|616217883|FG009|Overall Study|Adverse Event unrelated to drug|1|||
170511234|NCT03130959|616217874|FG000|Overall Study|Participant withdrew consent|0|||
170511235|NCT03130959|616217875|FG001|Overall Study|Participant withdrew consent|1|||
170511236|NCT03130959|616217876|FG002|Overall Study|Participant withdrew consent|0|||
170511237|NCT03130959|616217877|FG003|Overall Study|Participant withdrew consent|2|||
170511238|NCT03130959|616217878|FG004|Overall Study|Participant withdrew consent|1|||
170511239|NCT03130959|616217879|FG005|Overall Study|Participant withdrew consent|0|||
170511240|NCT03130959|616217880|FG006|Overall Study|Participant withdrew consent|0|||
170511241|NCT03130959|616217881|FG007|Overall Study|Participant withdrew consent|0|||
170511242|NCT03130959|616217882|FG008|Overall Study|Participant withdrew consent|0|||
170511243|NCT03130959|616217883|FG009|Overall Study|Participant withdrew consent|2|||
170511244|NCT03130959|616217874|FG000|Overall Study|Administrative reason by sponsor|1|||
170511245|NCT03130959|616217875|FG001|Overall Study|Administrative reason by sponsor|0|||
170511246|NCT03130959|616217876|FG002|Overall Study|Administrative reason by sponsor|1|||
170553838|NCT03727022|616375448|FG001|Phase B|Withdrawal by Subject|3|||
170553839|NCT03727022|616375447|FG000|Phase B|Site Closure|4|||
170553840|NCT03727022|616375448|FG001|Phase B|Site Closure|0|||
170553841|NCT05550818|616375449|FG000|Overall Study|Protocol Violation|1|||
170553842|NCT05550818|616375450|FG001|Overall Study|Protocol Violation|1|||
170553843|NCT05550818|616375449|FG000|Overall Study|Withdrawal by Subject|2|||
170553844|NCT05550818|616375450|FG001|Overall Study|Withdrawal by Subject|1|||
170553845|NCT00590317|616375451|FG000|Overall Study|Lack of Efficacy|1|||
170553846|NCT00590317|616375452|FG001|Overall Study|Lack of Efficacy|5|||
170553847|NCT03031912|616375453|FG000|Overall Study|Lost to Follow-up|1|||
170553848|NCT03031912|616375454|FG001|Overall Study|Lost to Follow-up|1|||
170553849|NCT03031912|616375455|FG002|Overall Study|Lost to Follow-up|0|||
170553850|NCT03031912|616375456|FG003|Overall Study|Lost to Follow-up|1|||
170553851|NCT03031912|616375457|FG004|Overall Study|Lost to Follow-up|0|||
170553852|NCT03031912|616375458|FG005|Overall Study|Lost to Follow-up|0|||
170553853|NCT03031912|616375459|FG006|Overall Study|Lost to Follow-up|0|||
170553854|NCT03031912|616375460|FG007|Overall Study|Lost to Follow-up|0|||
170553855|NCT03031912|616375461|FG008|Overall Study|Lost to Follow-up|0|||
170553856|NCT03031912|616375462|FG009|Overall Study|Lost to Follow-up|0|||
170553857|NCT04097743|616375465|FG000|Overall Study|Non-compliance of the study instruction.|1|||
170553858|NCT04097743|616375466|FG001|Overall Study|Non-compliance of the study instruction.|0|||
170644091|NCT01087736|616711533|FG001|Overall Study|Death|1|||
170644092|NCT01087736|616711532|FG000|Overall Study|Withdrawal by Subject|0|||
170644093|NCT01087736|616711533|FG001|Overall Study|Withdrawal by Subject|1|||
170644094|NCT00759564|616711534|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
170644095|NCT00759564|616711535|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
170644096|NCT00759564|616711536|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
170644097|NCT00759564|616711537|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
170644098|NCT00759564|616711538|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
170511247|NCT03130959|616217877|FG003|Overall Study|Administrative reason by sponsor|0|||
170511248|NCT03130959|616217878|FG004|Overall Study|Administrative reason by sponsor|0|||
170511249|NCT03130959|616217879|FG005|Overall Study|Administrative reason by sponsor|0|||
170644099|NCT01640314|616711542|FG000|Overall Study|Protocol Violation|0|||
170644100|NCT01640314|616711543|FG001|Overall Study|Protocol Violation|1|||
170644101|NCT02343549|616711545|FG000|Overall Study|Death|11|||
170644102|NCT02343549|616711545|FG000|Overall Study|Withdrawal by Subject|2|||
170644103|NCT00006409|616711553|FG000|Baseline|Protocol Violation|48|||
170644104|NCT00006409|616711554|FG001|Baseline|Protocol Violation|70|||
170644105|NCT00006409|616711555|FG002|Baseline|Protocol Violation|0|||
170644106|NCT00006409|616711556|FG003|Baseline|Protocol Violation|0|||
170644107|NCT00006409|616711557|FG004|Baseline|Protocol Violation|0|||
170644108|NCT00006409|616711558|FG005|Baseline|Protocol Violation|0|||
170511250|NCT03130959|616217880|FG006|Overall Study|Administrative reason by sponsor|0|||
170511251|NCT03130959|616217881|FG007|Overall Study|Administrative reason by sponsor|0|||
170511252|NCT03130959|616217882|FG008|Overall Study|Administrative reason by sponsor|0|||
170511253|NCT03130959|616217883|FG009|Overall Study|Administrative reason by sponsor|0|||
170511254|NCT03130959|616217874|FG000|Overall Study|Lost to Follow-up|1|||
170511255|NCT03130959|616217875|FG001|Overall Study|Lost to Follow-up|0|||
170511256|NCT03130959|616217876|FG002|Overall Study|Lost to Follow-up|0|||
170511257|NCT03130959|616217877|FG003|Overall Study|Lost to Follow-up|0|||
170511258|NCT03130959|616217878|FG004|Overall Study|Lost to Follow-up|0|||
170511259|NCT03130959|616217879|FG005|Overall Study|Lost to Follow-up|0|||
170511260|NCT03130959|616217880|FG006|Overall Study|Lost to Follow-up|0|||
170511261|NCT03130959|616217881|FG007|Overall Study|Lost to Follow-up|0|||
170511262|NCT03130959|616217882|FG008|Overall Study|Lost to Follow-up|0|||
170511263|NCT03130959|616217883|FG009|Overall Study|Lost to Follow-up|0|||
170644109|NCT00006409|616711553|FG000|Post-2 Year Intervention|Protocol Violation|0|||
170511264|NCT02384538|616217898|FG000|Overall Study|Adverse Event|1|||
170644110|NCT00006409|616711554|FG001|Post-2 Year Intervention|Protocol Violation|0|||
170511265|NCT02384538|616217899|FG001|Overall Study|Adverse Event|4|||
170511266|NCT02384538|616217898|FG000|Overall Study|Lack of Efficacy|4|||
170511267|NCT02384538|616217899|FG001|Overall Study|Lack of Efficacy|4|||
170511268|NCT02384538|616217898|FG000|Overall Study|Withdrew Consent|0|||
170511269|NCT02384538|616217899|FG001|Overall Study|Withdrew Consent|4|||
170511270|NCT02384538|616217898|FG000|Overall Study|Other|1|||
170511271|NCT02384538|616217899|FG001|Overall Study|Other|3|||
170511272|NCT04446429|616217902|FG000|Overall Study|Lost to Follow-up|6|||
170511273|NCT04446429|616217903|FG001|Overall Study|Lost to Follow-up|0|||
170511274|NCT02187029|616217904|FG000|Overall Study|Adverse Event|0|||
170511275|NCT02187029|616217905|FG001|Overall Study|Adverse Event|1|||
170511276|NCT02187029|616217906|FG002|Overall Study|Adverse Event|1|||
170511277|NCT02187029|616217907|FG003|Overall Study|Adverse Event|0|||
170511278|NCT02187029|616217904|FG000|Overall Study|Study Terminated by Sponsor|0|||
170511279|NCT02187029|616217905|FG001|Overall Study|Study Terminated by Sponsor|0|||
170511280|NCT02187029|616217906|FG002|Overall Study|Study Terminated by Sponsor|10|||
170511281|NCT02187029|616217907|FG003|Overall Study|Study Terminated by Sponsor|3|||
170511282|NCT02187029|616217904|FG000|Overall Study|Withdrawal by Subject|1|||
170511283|NCT02187029|616217905|FG001|Overall Study|Withdrawal by Subject|0|||
170511284|NCT02187029|616217906|FG002|Overall Study|Withdrawal by Subject|0|||
170511285|NCT02187029|616217907|FG003|Overall Study|Withdrawal by Subject|0|||
170511286|NCT03042910|616217908|FG000|Overall Study|Adverse Event|1|||
170511287|NCT03042910|616217908|FG000|Overall Study|Disease Progression|2|||
170511288|NCT03042910|616217908|FG000|Overall Study|Withdrawal by Subject|3|||
170511289|NCT03042910|616217908|FG000|Overall Study|Enrolled but not treated|1|||
170511290|NCT02985021|616217909|FG000|Overall Study|Inability to comply with study procedures|1|||
170511291|NCT02187861|616217910|FG000|Overall Study|Adverse Event|2|||
170511292|NCT02187861|616217911|FG001|Overall Study|Adverse Event|1|||
170511293|NCT02187861|616217912|FG002|Overall Study|Adverse Event|2|||
170511294|NCT02187861|616217913|FG003|Overall Study|Adverse Event|1|||
170511295|NCT02187861|616217910|FG000|Overall Study|Death|0|||
170511296|NCT02187861|616217911|FG001|Overall Study|Death|3|||
170511297|NCT02187861|616217912|FG002|Overall Study|Death|1|||
170511298|NCT02187861|616217913|FG003|Overall Study|Death|2|||
170511299|NCT02187861|616217910|FG000|Overall Study|Physician Decision|0|||
170511300|NCT02187861|616217911|FG001|Overall Study|Physician Decision|1|||
170511301|NCT02187861|616217912|FG002|Overall Study|Physician Decision|0|||
170511302|NCT02187861|616217913|FG003|Overall Study|Physician Decision|3|||
170511303|NCT02187861|616217910|FG000|Overall Study|Progressive Disease|4|||
170511304|NCT02187861|616217911|FG001|Overall Study|Progressive Disease|42|||
170511305|NCT02187861|616217912|FG002|Overall Study|Progressive Disease|19|||
170511306|NCT02187861|616217913|FG003|Overall Study|Progressive Disease|22|||
170511307|NCT02187861|616217910|FG000|Overall Study|Withdrawal by Subject|0|||
170511308|NCT02187861|616217911|FG001|Overall Study|Withdrawal by Subject|0|||
170511309|NCT02187861|616217912|FG002|Overall Study|Withdrawal by Subject|3|||
170511310|NCT02187861|616217913|FG003|Overall Study|Withdrawal by Subject|3|||
170511311|NCT02187861|616217910|FG000|Overall Study|Other|0|||
170511312|NCT02187861|616217911|FG001|Overall Study|Other|1|||
170511313|NCT02187861|616217912|FG002|Overall Study|Other|7|||
170511314|NCT02187861|616217913|FG003|Overall Study|Other|1|||
170511315|NCT01491841|616217915|FG000|Overall Study|Screen Failure|10|||
170511316|NCT01491841|616217915|FG000|Overall Study|Withdrawal by Subject|1|||
170511317|NCT02933528|616217916|FG000|Overall Study|Lost to Follow-up|2|||
170511318|NCT04105842|616217917|FG000|Overall Study|Withdrawal by Subject|2|||
170511319|NCT00587795|616217919|FG000|Overall Study|Withdrawal by Subject|1|||
170511320|NCT00587795|616217920|FG001|Overall Study|Withdrawal by Subject|0|||
170511321|NCT01869777|616217921|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
170511322|NCT01951573|616217922|FG000|Washout Period|Adverse Event|0|||
170511323|NCT01951573|616217923|FG001|Washout Period|Adverse Event|1|||
170511324|NCT00217581|616217924|FG000|Overall Study|Withdrawal by Subject|1|||
170511325|NCT00707980|616217925|FG000|Overall Study|Adverse Event|49|||
170511326|NCT00707980|616217925|FG000|Overall Study|Lack of Efficacy|35|||
170511327|NCT00707980|616217925|FG000|Overall Study|Non-Compliance with Study Drug|28|||
170511328|NCT00707980|616217925|FG000|Overall Study|Protocol Deviations|19|||
170511329|NCT00707980|616217925|FG000|Overall Study|Withdrawal of Consent|81|||
170511330|NCT00707980|616217925|FG000|Overall Study|Lost to Follow-up|59|||
170511331|NCT00707980|616217925|FG000|Overall Study|Other|39|||
170511332|NCT01882803|616217928|FG000|Overall Study|Disease Progression|1|||
170511333|NCT01882803|616217928|FG000|Overall Study|Withdrawal by Subject|9|||
170511334|NCT01882803|616217928|FG000|Overall Study|Death|68|||
170511335|NCT01882803|616217928|FG000|Overall Study|Physician Decision|3|||
170511336|NCT01882803|616217928|FG000|Overall Study|Lost to Follow-up|3|||
170511337|NCT01882803|616217928|FG000|Overall Study|Follow-up Completed|39|||
170511338|NCT01882803|616217928|FG000|Overall Study|Study Terminated by the Sponsor|6|||
170511339|NCT03066778|616217929|FG000|Overall Study|Death|195|||
170511340|NCT03066778|616217930|FG001|Overall Study|Death|205|||
170511341|NCT03066778|616217929|FG000|Overall Study|Withdrawal by Subject|5|||
170511342|NCT03066778|616217930|FG001|Overall Study|Withdrawal by Subject|7|||
170511343|NCT03585712|616217931|FG000|Treatment Period 1|Protocol Violation|1|||
170511344|NCT03585712|616217932|FG001|Treatment Period 1|Protocol Violation|0|||
170511345|NCT03585712|616217933|FG002|Treatment Period 1|Protocol Violation|0|||
170511346|NCT03585712|616217931|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
170511347|NCT03585712|616217932|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
170511348|NCT03585712|616217933|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
170511349|NCT03585712|616217931|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
170511350|NCT03585712|616217932|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
170511351|NCT03585712|616217933|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
170511352|NCT03585712|616217931|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
170511353|NCT03585712|616217932|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
170511354|NCT03585712|616217933|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
170511355|NCT01280682|616217935|FG000|Overall Study|Lost to Follow-up|0|||
170511356|NCT01280682|616217936|FG001|Overall Study|Lost to Follow-up|6|||
170511357|NCT01280682|616217935|FG000|Overall Study|Withdrawal by Subject|0|||
170511358|NCT01280682|616217936|FG001|Overall Study|Withdrawal by Subject|7|||
170511359|NCT02886884|616217941|FG000|Follow-up|Withdrawal by Subject|0|||
170511360|NCT02886884|616217942|FG001|Follow-up|Withdrawal by Subject|0|||
170511361|NCT02886884|616217943|FG002|Follow-up|Withdrawal by Subject|0|||
170511362|NCT02886884|616217944|FG003|Follow-up|Withdrawal by Subject|1|||
170511363|NCT02697734|616217947|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
170511364|NCT02697734|616217948|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
170511365|NCT02697734|616217947|FG000|Core Phase - up to Week 48|Adverse Event|1|||
170511366|NCT02697734|616217948|FG001|Core Phase - up to Week 48|Adverse Event|2|||
170511367|NCT02697734|616217947|FG000|Core Phase - up to Week 48|Physician Decision|1|||
170511368|NCT02697734|616217948|FG001|Core Phase - up to Week 48|Physician Decision|0|||
170511369|NCT02697734|616217947|FG000|Optional Extension Phase|Adverse Event|5|||
170511370|NCT02697734|616217948|FG001|Optional Extension Phase|Adverse Event|1|||
170511371|NCT02697734|616217947|FG000|Optional Extension Phase|Physician Decision|0|||
170511372|NCT02697734|616217948|FG001|Optional Extension Phase|Physician Decision|1|||
170511373|NCT02324699|616217949|FG000|Overall Study|study terminated|1|||
170511374|NCT00625183|616217950|FG000|Overall Study|Disease Progression|1|||
170511375|NCT00380718|616217951|FG000|Overall Study|Adverse Event|1|||
170511376|NCT00380718|616217951|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
170553875|NCT05520333|616375471|FG000|Overall Study|Lost to Follow-up|3|||
170553876|NCT05520333|616375472|FG001|Overall Study|Lost to Follow-up|6|||
170553877|NCT02439957|616375482|FG000|Overall Study|Study Terminated|3|||
170511377|NCT04318132|616217955|FG000|Overall Study|Protocol Violation|0|||
170553878|NCT02439957|616375483|FG001|Overall Study|Study Terminated|3|||
170553879|NCT00770679|616375484|FG000|Overall Study|Lost to Follow-up|3|||
170553880|NCT00770679|616375484|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
170511378|NCT04318132|616217956|FG001|Overall Study|Protocol Violation|0|||
170511379|NCT04318132|616217957|FG002|Overall Study|Protocol Violation|3|||
170553881|NCT05122143|616375490|FG000|Overall Study|Adverse Event|1|||
170511380|NCT04318132|616217958|FG003|Overall Study|Protocol Violation|0|||
170511381|NCT01863732|616217959|FG000|Overall Study|Adverse Event|2|||
170511382|NCT01863732|616217960|FG001|Overall Study|Adverse Event|0|||
170511383|NCT01863732|616217961|FG002|Overall Study|Adverse Event|3|||
170553882|NCT05122143|616375491|FG001|Overall Study|Adverse Event|0|||
170553883|NCT05122143|616375492|FG002|Overall Study|Adverse Event|0|||
170511384|NCT01863732|616217962|FG003|Overall Study|Adverse Event|3|||
170511385|NCT01863732|616217959|FG000|Overall Study|Lack of Efficacy|1|||
170511386|NCT01863732|616217960|FG001|Overall Study|Lack of Efficacy|0|||
170511387|NCT01863732|616217961|FG002|Overall Study|Lack of Efficacy|2|||
170511388|NCT01863732|616217962|FG003|Overall Study|Lack of Efficacy|1|||
170511389|NCT01863732|616217959|FG000|Overall Study|Lost to Follow-up|2|||
170511390|NCT01863732|616217960|FG001|Overall Study|Lost to Follow-up|2|||
170511391|NCT01863732|616217961|FG002|Overall Study|Lost to Follow-up|1|||
170511392|NCT01863732|616217962|FG003|Overall Study|Lost to Follow-up|1|||
170511393|NCT01863732|616217959|FG000|Overall Study|Physician Decision|1|||
170511394|NCT01863732|616217960|FG001|Overall Study|Physician Decision|0|||
170511395|NCT01863732|616217961|FG002|Overall Study|Physician Decision|1|||
170511396|NCT01863732|616217962|FG003|Overall Study|Physician Decision|0|||
170511397|NCT01863732|616217959|FG000|Overall Study|Pregnancy|0|||
170511398|NCT01863732|616217960|FG001|Overall Study|Pregnancy|0|||
170511399|NCT01863732|616217961|FG002|Overall Study|Pregnancy|0|||
170511400|NCT01863732|616217962|FG003|Overall Study|Pregnancy|1|||
170511401|NCT01863732|616217959|FG000|Overall Study|Technical problems|0|||
170511402|NCT01863732|616217960|FG001|Overall Study|Technical problems|1|||
170511403|NCT01863732|616217961|FG002|Overall Study|Technical problems|1|||
170511404|NCT01863732|616217962|FG003|Overall Study|Technical problems|0|||
170511405|NCT01863732|616217959|FG000|Overall Study|Subject/guardian decision|6|||
170511406|NCT01863732|616217960|FG001|Overall Study|Subject/guardian decision|9|||
170511407|NCT01863732|616217961|FG002|Overall Study|Subject/guardian decision|3|||
170511408|NCT01863732|616217962|FG003|Overall Study|Subject/guardian decision|1|||
170511409|NCT01863732|616217959|FG000|Overall Study|Death|1|||
170511410|NCT01863732|616217960|FG001|Overall Study|Death|0|||
170511411|NCT01863732|616217961|FG002|Overall Study|Death|0|||
170511412|NCT01863732|616217962|FG003|Overall Study|Death|1|||
170511413|NCT01215435|616217966|FG000|Overall Study|Adverse Event|1|||
170511414|NCT01215435|616217967|FG001|Overall Study|Adverse Event|0|||
170511415|NCT01215435|616217966|FG000|Overall Study|Protocol Violation|2|||
170511416|NCT01215435|616217967|FG001|Overall Study|Protocol Violation|0|||
170511417|NCT01215435|616217966|FG000|Overall Study|Withdrawal Criteria|8|||
170511418|NCT01215435|616217967|FG001|Overall Study|Withdrawal Criteria|11|||
170511419|NCT01215435|616217966|FG000|Overall Study|Lost to Follow-up|3|||
170511420|NCT01215435|616217967|FG001|Overall Study|Lost to Follow-up|0|||
170511421|NCT01215435|616217966|FG000|Overall Study|Unclassified|5|||
170511422|NCT01215435|616217967|FG001|Overall Study|Unclassified|5|||
170511423|NCT01156051|616217970|FG000|Overall Study|Lost to Follow-up|1|||
170511424|NCT01156051|616217971|FG001|Overall Study|Lost to Follow-up|0|||
170511425|NCT01156051|616217970|FG000|Overall Study|patient not compliant with protocol|0|||
170511426|NCT01156051|616217971|FG001|Overall Study|patient not compliant with protocol|1|||
170511427|NCT02179749|616217975|FG000|Overall Study|Adverse Event|0|||
170511428|NCT02179749|616217976|FG001|Overall Study|Adverse Event|0|||
170511429|NCT02179749|616217977|FG002|Overall Study|Adverse Event|1|||
170511430|NCT02179749|616217975|FG000|Overall Study|Withdrawal by Subject|0|||
170511431|NCT02179749|616217976|FG001|Overall Study|Withdrawal by Subject|0|||
170511432|NCT02179749|616217977|FG002|Overall Study|Withdrawal by Subject|1|||
170511433|NCT00435019|616217980|FG000|Overall Study|Adverse Event|1|||
170511434|NCT00435019|616217981|FG001|Overall Study|Adverse Event|0|||
170511435|NCT00435019|616217980|FG000|Overall Study|Lack of Efficacy|1|||
170511436|NCT00435019|616217981|FG001|Overall Study|Lack of Efficacy|2|||
170511437|NCT00435019|616217980|FG000|Overall Study|Protocol Violation|3|||
170511438|NCT00435019|616217981|FG001|Overall Study|Protocol Violation|1|||
170511439|NCT00435019|616217980|FG000|Overall Study|Personal reasons for withdrawal|8|||
170511440|NCT00435019|616217981|FG001|Overall Study|Personal reasons for withdrawal|7|||
170511441|NCT04503668|616217982|FG000|Overall Study|Incomplete data|4|||
170511442|NCT04503668|616217983|FG001|Overall Study|Incomplete data|3|||
170511443|NCT04503668|616217982|FG000|Overall Study|Withdrawal by Subject|1|||
170806155|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
170806156|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
170806157|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
170806158|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
170806159|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
170511444|NCT04503668|616217983|FG001|Overall Study|Withdrawal by Subject|1|||
170511445|NCT04503668|616217982|FG000|Overall Study|Adverse Event|2|||
170511446|NCT04503668|616217983|FG001|Overall Study|Adverse Event|0|||
170511447|NCT02306694|616217984|FG000|Overall Study|Withdrawal by Subject|3|||
170511448|NCT02306694|616217984|FG000|Overall Study|Lost to Follow-up|1|||
170511449|NCT00603382|616217985|FG000|Overall Study|Adverse Event|0|||
170511450|NCT00603382|616217986|FG001|Overall Study|Adverse Event|1|||
170511451|NCT00603382|616217987|FG002|Overall Study|Adverse Event|1|||
170511452|NCT00603382|616217988|FG003|Overall Study|Adverse Event|2|||
170511453|NCT00603382|616217989|FG004|Overall Study|Adverse Event|1|||
170511454|NCT00603382|616217990|FG005|Overall Study|Adverse Event|2|||
170511455|NCT00603382|616217985|FG000|Overall Study|Lack of Efficacy|14|||
170511456|NCT00603382|616217986|FG001|Overall Study|Lack of Efficacy|9|||
170511457|NCT00603382|616217987|FG002|Overall Study|Lack of Efficacy|3|||
170511458|NCT00603382|616217988|FG003|Overall Study|Lack of Efficacy|6|||
170511459|NCT00603382|616217989|FG004|Overall Study|Lack of Efficacy|6|||
170511460|NCT00603382|616217990|FG005|Overall Study|Lack of Efficacy|11|||
170511461|NCT00603382|616217985|FG000|Overall Study|Protocol Violation|1|||
170511462|NCT00603382|616217986|FG001|Overall Study|Protocol Violation|0|||
170511463|NCT00603382|616217987|FG002|Overall Study|Protocol Violation|1|||
170511464|NCT00603382|616217988|FG003|Overall Study|Protocol Violation|2|||
170511465|NCT00603382|616217989|FG004|Overall Study|Protocol Violation|1|||
170511466|NCT00603382|616217990|FG005|Overall Study|Protocol Violation|0|||
170511467|NCT00603382|616217985|FG000|Overall Study|Lost to Follow-up|0|||
170511468|NCT00603382|616217986|FG001|Overall Study|Lost to Follow-up|1|||
170511469|NCT00603382|616217987|FG002|Overall Study|Lost to Follow-up|1|||
170511470|NCT00603382|616217988|FG003|Overall Study|Lost to Follow-up|1|||
170511471|NCT00603382|616217989|FG004|Overall Study|Lost to Follow-up|0|||
170511472|NCT00603382|616217990|FG005|Overall Study|Lost to Follow-up|1|||
170511473|NCT00603382|616217985|FG000|Overall Study|Physician Decision|0|||
170511474|NCT00603382|616217986|FG001|Overall Study|Physician Decision|0|||
170511475|NCT00603382|616217987|FG002|Overall Study|Physician Decision|2|||
170511476|NCT00603382|616217988|FG003|Overall Study|Physician Decision|0|||
170511477|NCT00603382|616217989|FG004|Overall Study|Physician Decision|1|||
170511478|NCT00603382|616217990|FG005|Overall Study|Physician Decision|3|||
170511479|NCT00603382|616217985|FG000|Overall Study|Withdrawal by Subject|3|||
170511480|NCT00603382|616217986|FG001|Overall Study|Withdrawal by Subject|3|||
170511481|NCT00603382|616217987|FG002|Overall Study|Withdrawal by Subject|1|||
170511482|NCT00603382|616217988|FG003|Overall Study|Withdrawal by Subject|1|||
170511483|NCT00603382|616217989|FG004|Overall Study|Withdrawal by Subject|0|||
170511484|NCT00603382|616217990|FG005|Overall Study|Withdrawal by Subject|1|||
170511485|NCT03782974|616217991|FG000|Overall Study|Withdrawal by Subject|7|||
170511486|NCT03782974|616217992|FG001|Overall Study|Withdrawal by Subject|7|||
170511487|NCT03782974|616217991|FG000|Overall Study|Pregnancy|1|||
170511488|NCT03782974|616217992|FG001|Overall Study|Pregnancy|0|||
170511489|NCT00583102|616217993|FG000|Overall Study|Adverse Event|3|||
170511490|NCT01907217|616217996|FG000|Overall Study|Withdrawal by Subject|0|||
170511491|NCT01907217|616217997|FG001|Overall Study|Withdrawal by Subject|2|||
170511492|NCT01764659|616217998|FG000|Overall Study|Death|1|||
170511493|NCT01764659|616217998|FG000|Overall Study|Physician Decision|1|||
170511494|NCT01210352|616217999|FG000|Overall Study|Adverse Event|0|||
170511495|NCT01210352|616218000|FG001|Overall Study|Adverse Event|0|||
170511496|NCT01210352|616218001|FG002|Overall Study|Adverse Event|0|||
170511497|NCT01210352|616218002|FG003|Overall Study|Adverse Event|0|||
170511498|NCT01210352|616218003|FG004|Overall Study|Adverse Event|0|||
170511499|NCT01210352|616218004|FG005|Overall Study|Adverse Event|0|||
170511500|NCT01210352|616218005|FG006|Overall Study|Adverse Event|0|||
170511501|NCT01210352|616218006|FG007|Overall Study|Adverse Event|2|||
170511502|NCT01210352|616218007|FG008|Overall Study|Adverse Event|1|||
170511503|NCT01210352|616217999|FG000|Overall Study|Lack of Efficacy|0|||
170511504|NCT01210352|616218000|FG001|Overall Study|Lack of Efficacy|0|||
170511505|NCT01210352|616218001|FG002|Overall Study|Lack of Efficacy|0|||
170511506|NCT01210352|616218002|FG003|Overall Study|Lack of Efficacy|0|||
170511507|NCT01210352|616218003|FG004|Overall Study|Lack of Efficacy|0|||
170511508|NCT01210352|616218004|FG005|Overall Study|Lack of Efficacy|0|||
170511509|NCT01210352|616218005|FG006|Overall Study|Lack of Efficacy|1|||
170511510|NCT01210352|616218006|FG007|Overall Study|Lack of Efficacy|0|||
170905000|NCT02305563|617653936|FG001|Treatment Period|Participant request to stop therapy|2|||
170905001|NCT02305563|617653937|FG002|Treatment Period|Participant request to stop therapy|0|||
170905002|NCT02305563|617653938|FG003|Treatment Period|Participant request to stop therapy|1|||
170905003|NCT02305563|617653939|FG004|Treatment Period|Participant request to stop therapy|0|||
170905004|NCT02305563|617653935|FG000|Treatment Period|Participant withdrew consent|0|||
170905005|NCT02305563|617653936|FG001|Treatment Period|Participant withdrew consent|0|||
170905006|NCT02305563|617653937|FG002|Treatment Period|Participant withdrew consent|1|||
170905007|NCT02305563|617653938|FG003|Treatment Period|Participant withdrew consent|1|||
170905008|NCT02305563|617653939|FG004|Treatment Period|Participant withdrew consent|1|||
170905009|NCT02305563|617653935|FG000|Treatment Period|Maximum clinical benefit|0|||
170905010|NCT02305563|617653936|FG001|Treatment Period|Maximum clinical benefit|0|||
170905011|NCT02305563|617653937|FG002|Treatment Period|Maximum clinical benefit|0|||
170511511|NCT01210352|616218007|FG008|Overall Study|Lack of Efficacy|0|||
170511512|NCT01210352|616217999|FG000|Overall Study|Physician Decision|0|||
170511513|NCT01210352|616218000|FG001|Overall Study|Physician Decision|0|||
170511514|NCT01210352|616218001|FG002|Overall Study|Physician Decision|0|||
170511515|NCT01210352|616218002|FG003|Overall Study|Physician Decision|0|||
170511516|NCT01210352|616218003|FG004|Overall Study|Physician Decision|0|||
170511517|NCT01210352|616218004|FG005|Overall Study|Physician Decision|0|||
170511518|NCT01210352|616218005|FG006|Overall Study|Physician Decision|0|||
170511519|NCT01210352|616218006|FG007|Overall Study|Physician Decision|1|||
170511520|NCT01210352|616218007|FG008|Overall Study|Physician Decision|2|||
170511521|NCT01210352|616217999|FG000|Overall Study|Withdrawal by Subject|0|||
170511522|NCT01210352|616218000|FG001|Overall Study|Withdrawal by Subject|0|||
170511523|NCT01210352|616218001|FG002|Overall Study|Withdrawal by Subject|1|||
170511524|NCT01210352|616218002|FG003|Overall Study|Withdrawal by Subject|0|||
170511525|NCT01210352|616218003|FG004|Overall Study|Withdrawal by Subject|0|||
170511526|NCT01210352|616218004|FG005|Overall Study|Withdrawal by Subject|0|||
170511527|NCT01210352|616218005|FG006|Overall Study|Withdrawal by Subject|1|||
170511528|NCT01210352|616218006|FG007|Overall Study|Withdrawal by Subject|0|||
170511529|NCT01210352|616218007|FG008|Overall Study|Withdrawal by Subject|1|||
170644111|NCT00006409|616711555|FG002|Post-2 Year Intervention|Protocol Violation|251|||
170905012|NCT02305563|617653938|FG003|Treatment Period|Maximum clinical benefit|0|||
170511530|NCT01210352|616217999|FG000|Overall Study|Patient Discharged Early|0|||
170511531|NCT01210352|616218000|FG001|Overall Study|Patient Discharged Early|0|||
170511532|NCT01210352|616218001|FG002|Overall Study|Patient Discharged Early|1|||
170511533|NCT01210352|616218002|FG003|Overall Study|Patient Discharged Early|0|||
170511534|NCT01210352|616218003|FG004|Overall Study|Patient Discharged Early|0|||
170511535|NCT01210352|616218004|FG005|Overall Study|Patient Discharged Early|0|||
170511536|NCT01210352|616218005|FG006|Overall Study|Patient Discharged Early|0|||
170511537|NCT01210352|616218006|FG007|Overall Study|Patient Discharged Early|0|||
170511538|NCT01210352|616218007|FG008|Overall Study|Patient Discharged Early|0|||
170511539|NCT01298141|616218011|FG000|Overall Study|Adverse Event|3|||
170511540|NCT01298141|616218011|FG000|Overall Study|Refusal of Required Study Procedures|1|||
170511541|NCT01298141|616218011|FG000|Overall Study|Withdrawal by Subject|6|||
170511542|NCT01298141|616218011|FG000|Overall Study|Termination of Study by the Investigator|5|||
170511543|NCT01298141|616218011|FG000|Overall Study|Other|5|||
170511544|NCT01298141|616218011|FG000|Overall Study|Lost to Follow-up|1|||
170511545|NCT01298141|616218011|FG000|Overall Study|Death|6|||
170511546|NCT01298141|616218011|FG000|Overall Study|Not treated|4|||
170511547|NCT00350779|616218012|FG000|Overall Study|Adverse Event|4|||
170511548|NCT00350779|616218013|FG001|Overall Study|Adverse Event|2|||
170511549|NCT00350779|616218012|FG000|Overall Study|Lack of Efficacy|0|||
170511550|NCT00350779|616218013|FG001|Overall Study|Lack of Efficacy|4|||
170511551|NCT00350779|616218012|FG000|Overall Study|Lost to Follow-up|2|||
170511552|NCT00350779|616218013|FG001|Overall Study|Lost to Follow-up|0|||
170511553|NCT00350779|616218012|FG000|Overall Study|Physician Decision|2|||
170511554|NCT00350779|616218013|FG001|Overall Study|Physician Decision|4|||
170511555|NCT00350779|616218012|FG000|Overall Study|Protocol Violation|3|||
170511556|NCT00350779|616218013|FG001|Overall Study|Protocol Violation|1|||
170511557|NCT00350779|616218012|FG000|Overall Study|Withdrawal by Subject|9|||
170511558|NCT00350779|616218013|FG001|Overall Study|Withdrawal by Subject|8|||
170511559|NCT00350779|616218012|FG000|Overall Study|Patient Moved|2|||
170511560|NCT00350779|616218013|FG001|Overall Study|Patient Moved|1|||
170511561|NCT00350779|616218012|FG000|Overall Study|Non-compliance with study procedures|0|||
170511562|NCT00350779|616218013|FG001|Overall Study|Non-compliance with study procedures|1|||
170511563|NCT02012959|616218014|FG000|Treatment Phase A|Adverse Event|2|||
170511564|NCT02012959|616218015|FG001|Treatment Phase A|Adverse Event|0|||
170905013|NCT02305563|617653939|FG004|Treatment Period|Maximum clinical benefit|1|||
170905014|NCT02305563|617653935|FG000|Treatment Period|Poor/non-compliance|0|||
170511565|NCT02012959|616218016|FG002|Treatment Phase A|Adverse Event|0|||
170511566|NCT02012959|616218017|FG003|Treatment Phase A|Adverse Event|0|||
170511567|NCT02012959|616218018|FG004|Treatment Phase A|Adverse Event|0|||
170511568|NCT00398216|616219843|FG000|Overall Study|Adverse Event|4|||
170511569|NCT00398216|616219844|FG001|Overall Study|Adverse Event|2|||
170511570|NCT00398216|616219845|FG002|Overall Study|Adverse Event|5|||
170511571|NCT00398216|616219846|FG003|Overall Study|Adverse Event|7|||
170511572|NCT00398216|616219847|FG004|Overall Study|Adverse Event|2|||
170511573|NCT00398216|616219843|FG000|Overall Study|Protocol Violation|2|||
170511574|NCT00398216|616219844|FG001|Overall Study|Protocol Violation|4|||
170511575|NCT00398216|616219845|FG002|Overall Study|Protocol Violation|5|||
170511576|NCT00398216|616219846|FG003|Overall Study|Protocol Violation|7|||
170511577|NCT00398216|616219847|FG004|Overall Study|Protocol Violation|5|||
170511578|NCT00398216|616219843|FG000|Overall Study|Lost to Follow-up|1|||
170511579|NCT00398216|616219844|FG001|Overall Study|Lost to Follow-up|6|||
170511580|NCT00398216|616219845|FG002|Overall Study|Lost to Follow-up|4|||
170511581|NCT00398216|616219846|FG003|Overall Study|Lost to Follow-up|4|||
170511582|NCT00398216|616219847|FG004|Overall Study|Lost to Follow-up|1|||
170511583|NCT00398216|616219843|FG000|Overall Study|Death|0|||
170511584|NCT00398216|616219844|FG001|Overall Study|Death|3|||
170511585|NCT00398216|616219845|FG002|Overall Study|Death|0|||
170511586|NCT00398216|616219846|FG003|Overall Study|Death|0|||
170511587|NCT00398216|616219847|FG004|Overall Study|Death|0|||
170511588|NCT00398216|616219843|FG000|Overall Study|Withdrawal by Subject|1|||
170511589|NCT00398216|616219844|FG001|Overall Study|Withdrawal by Subject|0|||
170511590|NCT00398216|616219845|FG002|Overall Study|Withdrawal by Subject|3|||
170511591|NCT00398216|616219846|FG003|Overall Study|Withdrawal by Subject|1|||
170511592|NCT00398216|616219847|FG004|Overall Study|Withdrawal by Subject|2|||
170511593|NCT00398216|616219843|FG000|Overall Study|administrative reasons|3|||
170511594|NCT00398216|616219844|FG001|Overall Study|administrative reasons|4|||
170511595|NCT00398216|616219845|FG002|Overall Study|administrative reasons|4|||
170511596|NCT00398216|616219846|FG003|Overall Study|administrative reasons|3|||
170511597|NCT00398216|616219847|FG004|Overall Study|administrative reasons|3|||
170511598|NCT00398216|616219843|FG000|Overall Study|entrance criteria|0|||
170511599|NCT00398216|616219844|FG001|Overall Study|entrance criteria|0|||
170511600|NCT00398216|616219845|FG002|Overall Study|entrance criteria|0|||
170511601|NCT00398216|616219846|FG003|Overall Study|entrance criteria|0|||
170511602|NCT00398216|616219847|FG004|Overall Study|entrance criteria|2|||
170511603|NCT01048944|616219848|FG000|Overall Study|Protocol Violation|8|||
170511604|NCT01048944|616219849|FG001|Overall Study|Protocol Violation|10|||
170553884|NCT05122143|616375493|FG003|Overall Study|Adverse Event|0|||
170553885|NCT05122143|616375494|FG004|Overall Study|Adverse Event|1|||
170553886|NCT05122143|616375495|FG005|Overall Study|Adverse Event|0|||
170553887|NCT05122143|616375490|FG000|Overall Study|Protocol non-compliance|0|||
170553888|NCT05122143|616375491|FG001|Overall Study|Protocol non-compliance|0|||
170553889|NCT05122143|616375492|FG002|Overall Study|Protocol non-compliance|1|||
170905015|NCT02305563|617653936|FG001|Treatment Period|Poor/non-compliance|0|||
170905016|NCT02305563|617653937|FG002|Treatment Period|Poor/non-compliance|0|||
170905017|NCT02305563|617653938|FG003|Treatment Period|Poor/non-compliance|0|||
170905018|NCT02305563|617653939|FG004|Treatment Period|Poor/non-compliance|1|||
170905019|NCT02305563|617653935|FG000|Treatment Period|Administrative reason by Sponsor|0|||
170905020|NCT02305563|617653936|FG001|Treatment Period|Administrative reason by Sponsor|0|||
170905021|NCT02305563|617653937|FG002|Treatment Period|Administrative reason by Sponsor|0|||
170905022|NCT02305563|617653938|FG003|Treatment Period|Administrative reason by Sponsor|0|||
170905023|NCT02305563|617653939|FG004|Treatment Period|Administrative reason by Sponsor|1|||
170905024|NCT02305563|617653935|FG000|Treatment Period|other reason|2|||
170905025|NCT02305563|617653936|FG001|Treatment Period|other reason|0|||
170905026|NCT02305563|617653937|FG002|Treatment Period|other reason|2|||
170905027|NCT02305563|617653938|FG003|Treatment Period|other reason|2|||
170905028|NCT02305563|617653939|FG004|Treatment Period|other reason|1|||
170905029|NCT02305563|617653935|FG000|Treatment Period|Randomized but not treated|0|||
170905030|NCT02305563|617653936|FG001|Treatment Period|Randomized but not treated|0|||
170905031|NCT02305563|617653937|FG002|Treatment Period|Randomized but not treated|0|||
170905032|NCT02305563|617653938|FG003|Treatment Period|Randomized but not treated|0|||
170905033|NCT02305563|617653939|FG004|Treatment Period|Randomized but not treated|2|||
170905034|NCT02305563|617653935|FG000|Treatment Period|added ULO, then disease progression|0|||
170905035|NCT02305563|617653936|FG001|Treatment Period|added ULO, then disease progression|0|||
170905036|NCT02305563|617653937|FG002|Treatment Period|added ULO, then disease progression|0|||
170905037|NCT02305563|617653938|FG003|Treatment Period|added ULO, then disease progression|0|||
170905038|NCT02305563|617653939|FG004|Treatment Period|added ULO, then disease progression|4|||
170905039|NCT02305563|617653935|FG000|Treatment Period|added ULO; then other reason|0|||
170905040|NCT02305563|617653936|FG001|Treatment Period|added ULO; then other reason|0|||
170905041|NCT02305563|617653937|FG002|Treatment Period|added ULO; then other reason|0|||
170905042|NCT02305563|617653938|FG003|Treatment Period|added ULO; then other reason|0|||
170905043|NCT02305563|617653939|FG004|Treatment Period|added ULO; then other reason|1|||
170905044|NCT02305563|617653935|FG000|Treatment Period|added ULO, then request to stop|0|||
170905045|NCT02305563|617653936|FG001|Treatment Period|added ULO, then request to stop|0|||
170905046|NCT02305563|617653937|FG002|Treatment Period|added ULO, then request to stop|0|||
170905047|NCT02305563|617653938|FG003|Treatment Period|added ULO, then request to stop|0|||
170905048|NCT02305563|617653939|FG004|Treatment Period|added ULO, then request to stop|1|||
170905049|NCT02305563|617653935|FG000|Follow-up Period|Death|0|||
170905050|NCT02305563|617653936|FG001|Follow-up Period|Death|0|||
170905051|NCT02305563|617653937|FG002|Follow-up Period|Death|5|||
170905052|NCT02305563|617653938|FG003|Follow-up Period|Death|4|||
170905053|NCT02305563|617653939|FG004|Follow-up Period|Death|7|||
170905054|NCT02305563|617653935|FG000|Follow-up Period|Participant withdrew consent|0|||
170905055|NCT02305563|617653936|FG001|Follow-up Period|Participant withdrew consent|0|||
170905056|NCT02305563|617653937|FG002|Follow-up Period|Participant withdrew consent|2|||
170905057|NCT02305563|617653938|FG003|Follow-up Period|Participant withdrew consent|1|||
170905058|NCT02305563|617653939|FG004|Follow-up Period|Participant withdrew consent|0|||
170905059|NCT02305563|617653935|FG000|Follow-up Period|other reason|0|||
170905060|NCT02305563|617653936|FG001|Follow-up Period|other reason|0|||
170511605|NCT01048944|616219850|FG002|Overall Study|Protocol Violation|10|||
170511606|NCT01048944|616219851|FG003|Overall Study|Protocol Violation|2|||
170511607|NCT01962948|616219852|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
170511608|NCT01962948|616219853|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
170511609|NCT01962948|616219854|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
170553890|NCT05122143|616375493|FG003|Overall Study|Protocol non-compliance|0|||
170553891|NCT05122143|616375494|FG004|Overall Study|Protocol non-compliance|0|||
170905061|NCT02305563|617653937|FG002|Follow-up Period|other reason|0|||
170905062|NCT02305563|617653938|FG003|Follow-up Period|other reason|0|||
170905063|NCT02305563|617653939|FG004|Follow-up Period|other reason|1|||
170905064|NCT02305563|617653935|FG000|Follow-up Period|Followup no longer required per protocol|3|||
170806160|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
170806161|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
170511610|NCT01962948|616219855|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
170511611|NCT00376532|616219856|FG000|Overall Study|Lack sufficient blood sample|6|||
170511612|NCT00376532|616219857|FG001|Overall Study|Lack sufficient blood sample|6|||
170511613|NCT02207400|616219858|FG000|Overall Study|Adverse Event|1|||
170511614|NCT02207400|616219859|FG001|Overall Study|Adverse Event|1|||
170511615|NCT02207400|616219858|FG000|Overall Study|Lost to Follow-up|6|||
170511616|NCT02207400|616219859|FG001|Overall Study|Lost to Follow-up|7|||
170511617|NCT02207400|616219858|FG000|Overall Study|Protocol Violation|1|||
170511618|NCT02207400|616219859|FG001|Overall Study|Protocol Violation|1|||
170511619|NCT02207400|616219858|FG000|Overall Study|Withdrawal by Subject|8|||
170511620|NCT02207400|616219859|FG001|Overall Study|Withdrawal by Subject|4|||
170511621|NCT02207400|616219858|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
170511622|NCT02207400|616219859|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
170511623|NCT02113007|616219862|FG000|Overall Study|Progressive disease|2|||
170511624|NCT00885378|616219863|FG000|Overall Study|Lack of Efficacy|2|||
170511625|NCT00885378|616219864|FG001|Overall Study|Lack of Efficacy|2|||
170511626|NCT00885378|616219863|FG000|Overall Study|Withdrawal by Subject|1|||
170511627|NCT00885378|616219864|FG001|Overall Study|Withdrawal by Subject|2|||
170511628|NCT00885378|616219863|FG000|Overall Study|Lost to Follow-up|1|||
170511629|NCT00885378|616219864|FG001|Overall Study|Lost to Follow-up|2|||
170511630|NCT00885378|616219863|FG000|Overall Study|Poor/Noncompliance|2|||
170511631|NCT00885378|616219864|FG001|Overall Study|Poor/Noncompliance|2|||
170511632|NCT00885378|616219863|FG000|Overall Study|Protocol Violation|2|||
170511633|NCT00885378|616219864|FG001|Overall Study|Protocol Violation|0|||
170511634|NCT02501161|616219865|FG000|Overall Study|Adverse Event|2|||
170511635|NCT02501161|616219866|FG001|Overall Study|Adverse Event|6|||
170511636|NCT02501161|616219865|FG000|Overall Study|Lost to Follow-up|7|||
170511637|NCT02501161|616219866|FG001|Overall Study|Lost to Follow-up|4|||
170511638|NCT02501161|616219865|FG000|Overall Study|Withdrawal by Subject|10|||
170511639|NCT02501161|616219866|FG001|Overall Study|Withdrawal by Subject|15|||
170511640|NCT02501161|616219865|FG000|Overall Study|Other|3|||
170511641|NCT02501161|616219866|FG001|Overall Study|Other|0|||
170511642|NCT03091738|616219867|FG000|Overall Study|Adverse Event|1|||
170511643|NCT03091738|616219867|FG000|Overall Study|Lost to Follow-up|1|||
170511644|NCT04336475|616219868|FG000|Overall Study|pain|1|||
170511645|NCT04336475|616219869|FG001|Overall Study|pain|0|||
170511646|NCT04336475|616219868|FG000|Overall Study|upper respiratory infection|1|||
170511647|NCT04336475|616219869|FG001|Overall Study|upper respiratory infection|0|||
170511648|NCT04336475|616219868|FG000|Overall Study|Lost to Follow-up|0|||
170511649|NCT04336475|616219869|FG001|Overall Study|Lost to Follow-up|2|||
170511650|NCT05205005|616219873|FG000|Overall Study|Withdrawal by Subject|1|||
170511651|NCT05205005|616219874|FG001|Overall Study|Withdrawal by Subject|0|||
170511652|NCT05205005|616219873|FG000|Overall Study|Adverse Event|1|||
170511653|NCT05205005|616219874|FG001|Overall Study|Adverse Event|0|||
170511654|NCT00313586|616219875|FG000|Overall Study|Disease progression|14|||
170511655|NCT00313586|616219876|FG001|Overall Study|Disease progression|19|||
170511656|NCT00313586|616219877|FG002|Overall Study|Disease progression|10|||
170511657|NCT00313586|616219878|FG003|Overall Study|Disease progression|3|||
170511658|NCT00313586|616219875|FG000|Overall Study|Adverse Event|12|||
170511659|NCT00313586|616219876|FG001|Overall Study|Adverse Event|18|||
170511660|NCT00313586|616219877|FG002|Overall Study|Adverse Event|3|||
170511661|NCT00313586|616219878|FG003|Overall Study|Adverse Event|10|||
170511662|NCT00313586|616219875|FG000|Overall Study|Death|11|||
170511663|NCT00313586|616219876|FG001|Overall Study|Death|8|||
170511664|NCT00313586|616219877|FG002|Overall Study|Death|1|||
170511665|NCT00313586|616219878|FG003|Overall Study|Death|7|||
170511666|NCT00313586|616219875|FG000|Overall Study|Withdrawal by Subject|13|||
170511667|NCT00313586|616219876|FG001|Overall Study|Withdrawal by Subject|6|||
170511668|NCT00313586|616219877|FG002|Overall Study|Withdrawal by Subject|6|||
170511669|NCT00313586|616219878|FG003|Overall Study|Withdrawal by Subject|2|||
170511670|NCT00313586|616219875|FG000|Overall Study|Alternative therapy|3|||
170511671|NCT00313586|616219876|FG001|Overall Study|Alternative therapy|6|||
170511672|NCT00313586|616219877|FG002|Overall Study|Alternative therapy|2|||
170511673|NCT00313586|616219878|FG003|Overall Study|Alternative therapy|0|||
170511674|NCT00313586|616219875|FG000|Overall Study|Other complicating disease|2|||
170511675|NCT00313586|616219876|FG001|Overall Study|Other complicating disease|2|||
170511676|NCT00313586|616219877|FG002|Overall Study|Other complicating disease|0|||
170511677|NCT00313586|616219878|FG003|Overall Study|Other complicating disease|0|||
170806162|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
170806163|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
170511678|NCT00313586|616219875|FG000|Overall Study|Did not achieve HI-major/better response|10|||
170511679|NCT00313586|616219876|FG001|Overall Study|Did not achieve HI-major/better response|7|||
170511680|NCT00313586|616219877|FG002|Overall Study|Did not achieve HI-major/better response|2|||
170511681|NCT00313586|616219878|FG003|Overall Study|Did not achieve HI-major/better response|1|||
170511682|NCT00313586|616219875|FG000|Overall Study|Physician Decision|2|||
170511683|NCT00313586|616219876|FG001|Overall Study|Physician Decision|1|||
170511684|NCT00313586|616219877|FG002|Overall Study|Physician Decision|0|||
170511685|NCT00313586|616219878|FG003|Overall Study|Physician Decision|0|||
170511686|NCT00313586|616219875|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
170511687|NCT00313586|616219876|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
170511688|NCT00313586|616219877|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
170511689|NCT00313586|616219878|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
170511690|NCT00313586|616219875|FG000|Overall Study|Lost insurance|0|||
170511691|NCT00313586|616219876|FG001|Overall Study|Lost insurance|1|||
170511692|NCT00313586|616219877|FG002|Overall Study|Lost insurance|0|||
170511693|NCT00313586|616219878|FG003|Overall Study|Lost insurance|0|||
170511694|NCT00313586|616219875|FG000|Overall Study|Moved|0|||
170511695|NCT00313586|616219876|FG001|Overall Study|Moved|1|||
170511696|NCT00313586|616219877|FG002|Overall Study|Moved|0|||
170511697|NCT00313586|616219878|FG003|Overall Study|Moved|0|||
170511698|NCT00313586|616219875|FG000|Overall Study|Death before starting treatment|1|||
170511699|NCT00313586|616219876|FG001|Overall Study|Death before starting treatment|0|||
170644112|NCT00006409|616711556|FG003|Post-2 Year Intervention|Protocol Violation|168|||
170553892|NCT05122143|616375495|FG005|Overall Study|Protocol non-compliance|0|||
170553893|NCT05122143|616375490|FG000|Overall Study|Covid contact|0|||
170553894|NCT05122143|616375491|FG001|Overall Study|Covid contact|0|||
170553895|NCT05122143|616375492|FG002|Overall Study|Covid contact|0|||
170553896|NCT05122143|616375493|FG003|Overall Study|Covid contact|0|||
170553897|NCT05122143|616375494|FG004|Overall Study|Covid contact|1|||
170553898|NCT05122143|616375495|FG005|Overall Study|Covid contact|0|||
170553899|NCT01550965|616375496|FG000|Overall Study|Adverse Event|26|||
170553900|NCT01550965|616375496|FG000|Overall Study|Withdrawal by Subject|10|||
170553901|NCT01550965|616375496|FG000|Overall Study|Lost to Follow-up|2|||
170553902|NCT01550965|616375496|FG000|Overall Study|Lack of Efficacy|59|||
170553903|NCT01550965|616375496|FG000|Overall Study|Other|13|||
170553904|NCT00692237|616375497|FG000|Overall Study|Withdrawal by Subject|1|||
170553905|NCT00692237|616375498|FG001|Overall Study|Withdrawal by Subject|3|||
170553906|NCT00692237|616375497|FG000|Overall Study|Adverse Event|0|||
170553907|NCT00692237|616375498|FG001|Overall Study|Adverse Event|1|||
170553908|NCT00836901|616375503|FG000|First Intervention|Withdrawal by Subject|1|||
170553909|NCT00836901|616375504|FG001|First Intervention|Withdrawal by Subject|0|||
170553910|NCT05562934|616375507|FG000|Overall Study|Adverse Event|0|||
170553911|NCT05562934|616375508|FG001|Overall Study|Adverse Event|2|||
170553912|NCT05562934|616375509|FG002|Overall Study|Adverse Event|0|||
170553913|NCT05562934|616375510|FG003|Overall Study|Adverse Event|0|||
170553914|NCT05562934|616375511|FG004|Overall Study|Adverse Event|2|||
170553915|NCT05562934|616375507|FG000|Overall Study|Lost to Follow-up|0|||
170553916|NCT05562934|616375508|FG001|Overall Study|Lost to Follow-up|0|||
170553917|NCT05562934|616375509|FG002|Overall Study|Lost to Follow-up|0|||
170553918|NCT05562934|616375510|FG003|Overall Study|Lost to Follow-up|0|||
170553919|NCT05562934|616375511|FG004|Overall Study|Lost to Follow-up|1|||
170553920|NCT05562934|616375507|FG000|Overall Study|Protocol Violation|0|||
170553921|NCT05562934|616375508|FG001|Overall Study|Protocol Violation|0|||
170553922|NCT05562934|616375509|FG002|Overall Study|Protocol Violation|0|||
170553923|NCT05562934|616375510|FG003|Overall Study|Protocol Violation|1|||
170553924|NCT05562934|616375511|FG004|Overall Study|Protocol Violation|1|||
170553925|NCT05562934|616375507|FG000|Overall Study|Withdrawal by Subject|0|||
170553926|NCT05562934|616375508|FG001|Overall Study|Withdrawal by Subject|0|||
170553927|NCT05562934|616375509|FG002|Overall Study|Withdrawal by Subject|1|||
170553928|NCT05562934|616375510|FG003|Overall Study|Withdrawal by Subject|1|||
170553929|NCT05562934|616375511|FG004|Overall Study|Withdrawal by Subject|0|||
170553930|NCT05365217|616375512|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170553931|NCT05365217|616375513|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170553932|NCT06433908|616375514|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
170553933|NCT06433908|616375515|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
170553934|NCT06433908|616375516|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
170553935|NCT06433908|616375517|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
170553936|NCT06433908|616375514|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
170553937|NCT06433908|616375515|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
170553938|NCT06433908|616375516|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
170553939|NCT06433908|616375517|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
170644113|NCT00006409|616711557|FG004|Post-2 Year Intervention|Protocol Violation|0|||
170511700|NCT00313586|616219877|FG002|Overall Study|Death before starting treatment|0|||
170511701|NCT00313586|616219878|FG003|Overall Study|Death before starting treatment|0|||
170511702|NCT00264290|616219879|FG000|Intervention (8 Weeks)|Adverse Event|1|||
170553940|NCT06433908|616375514|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
170553941|NCT06433908|616375515|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
170511703|NCT00264290|616219880|FG001|Intervention (8 Weeks)|Adverse Event|0|||
170511704|NCT04472494|616219881|FG000|Pre-treatment|Other reasons|2|||
170511705|NCT04472494|616219882|FG001|Pre-treatment|Other reasons|0|||
170511706|NCT04472494|616219881|FG000|Treatment|Death|5|||
170511707|NCT04472494|616219882|FG001|Treatment|Death|2|||
170511708|NCT04472494|616219881|FG000|Treatment|Hospital discharge|1|||
170511709|NCT04472494|616219882|FG001|Treatment|Hospital discharge|1|||
170511710|NCT02829047|616219883|FG000|Overall Study|Withdrawal by Subject|1|||
170511711|NCT00760487|616219887|FG000|Overall Study|Unilateral implantation|3|||
170511712|NCT02438280|616219889|FG000|Overall Study|Physician Decision|1|||
170511713|NCT02438280|616219890|FG001|Overall Study|Physician Decision|0|||
170511714|NCT03299101|616219891|FG000|Overall Study|Lost to Follow-up|1|||
170511715|NCT03299101|616219891|FG000|Overall Study|Withdrawal by Subject|5|||
170511716|NCT03299101|616219891|FG000|Overall Study|Surgery was changed|3|||
170511717|NCT03299101|616219891|FG000|Overall Study|Not enough time to complete prehab|1|||
170511718|NCT04217317|616219892|FG000|Overall Study|Lack of Efficacy|4|||
170511719|NCT04217317|616219892|FG000|Overall Study|Physician Decision|1|||
170511720|NCT01690299|616219893|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
170511721|NCT01690299|616219894|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
170511722|NCT01690299|616219895|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
170511723|NCT01690299|616219896|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
170511724|NCT01690299|616219897|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
170511725|NCT01690299|616219898|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
170511726|NCT01690299|616219893|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
170511727|NCT01690299|616219894|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170511728|NCT01690299|616219895|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170511729|NCT01690299|616219896|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170511730|NCT01690299|616219897|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170511731|NCT01690299|616219898|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
170511732|NCT01690299|616219893|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
170511733|NCT01690299|616219894|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
170511734|NCT01690299|616219895|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170511735|NCT01690299|616219896|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170511736|NCT01690299|616219897|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170511737|NCT01690299|616219898|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
170511738|NCT01690299|616219893|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
170511739|NCT01690299|616219894|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
170511740|NCT01690299|616219895|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
170511741|NCT01690299|616219896|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
170511742|NCT01690299|616219897|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
170511743|NCT01690299|616219898|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
170511744|NCT01690299|616219893|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
170511745|NCT01690299|616219894|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
170511746|NCT01690299|616219895|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
170511747|NCT01690299|616219896|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
170511748|NCT01690299|616219897|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
170511749|NCT01690299|616219898|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
170511750|NCT01690299|616219893|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
170511751|NCT01690299|616219894|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
170511752|NCT01690299|616219895|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
170511753|NCT01690299|616219896|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
170511754|NCT01690299|616219897|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
170511755|NCT01690299|616219898|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
170511756|NCT01690299|616219893|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
170511757|NCT01690299|616219894|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
170511758|NCT01690299|616219895|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
170511759|NCT01690299|616219896|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
170511760|NCT01690299|616219897|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
170553942|NCT06433908|616375516|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
170553943|NCT06433908|616375517|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
170553944|NCT05418426|616375518|FG000|Overall Study|Adverse Event|0|||
170553945|NCT05418426|616375519|FG001|Overall Study|Adverse Event|1|||
170511761|NCT01690299|616219898|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
170511762|NCT01690299|616219893|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
170511763|NCT01690299|616219894|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
170511764|NCT01690299|616219895|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
170553946|NCT05418426|616375520|FG002|Overall Study|Adverse Event|0|||
170553947|NCT05418426|616375518|FG000|Overall Study|Withdrawal by Subject|0|||
170806164|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
170806165|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
170511765|NCT01690299|616219896|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
170511766|NCT01690299|616219897|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
170511767|NCT01690299|616219898|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
170511768|NCT01690299|616219893|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
170511769|NCT01690299|616219894|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
170511770|NCT01690299|616219895|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
170511771|NCT01690299|616219896|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
170511772|NCT01690299|616219897|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
170511773|NCT01690299|616219898|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
170511774|NCT01690299|616219893|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
170511775|NCT01690299|616219894|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
170511776|NCT01690299|616219895|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
170511777|NCT01690299|616219896|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
170511778|NCT01690299|616219897|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
170511779|NCT01690299|616219898|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
170511780|NCT02869893|616219901|FG000|Overall Study|participant aversion to IV|5|||
170511781|NCT02869893|616219901|FG000|Overall Study|participant fear of MRI scanner|2|||
170511782|NCT00551525|616219902|FG000|Overall Study|Protocol Violation|5|||
170511783|NCT03970200|616219912|FG000|Overall Study|Death|2|||
170511784|NCT03970200|616219913|FG001|Overall Study|Death|2|||
170511785|NCT03970200|616219914|FG002|Overall Study|Death|1|||
170511786|NCT03970200|616219912|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
170511787|NCT03970200|616219913|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
170511788|NCT03970200|616219914|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
170511789|NCT01607346|616219915|FG000|Overall Study|Adverse Event|3|||
170511790|NCT01098162|616219916|FG000|Overall Study|Adverse Event|37|||
170511791|NCT01098162|616219916|FG000|Overall Study|Lack of Efficacy|4|||
170511792|NCT01098162|616219916|FG000|Overall Study|Wish of Patient|7|||
170511793|NCT01098162|616219916|FG000|Overall Study|Lost to Follow-up|9|||
170511794|NCT01098162|616219916|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
170511795|NCT01098162|616219916|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
170511796|NCT01098162|616219916|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
170511797|NCT01098162|616219916|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
170511798|NCT01098162|616219916|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
170511799|NCT01098162|616219916|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
170511800|NCT01098162|616219916|FG000|Overall Study|Other Reason|1|||
170511801|NCT01098162|616219916|FG000|Overall Study|Reason Unknown|26|||
170511802|NCT01605825|616219917|FG000|Overall Study|Adverse Event|4|||
170511803|NCT01605825|616219918|FG001|Overall Study|Adverse Event|2|||
170511804|NCT01605825|616219917|FG000|Overall Study|Withdrawal by Subject|0|||
170511805|NCT01605825|616219918|FG001|Overall Study|Withdrawal by Subject|1|||
170511806|NCT01605825|616219917|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
170511807|NCT01605825|616219918|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
170511808|NCT01605825|616219917|FG000|Overall Study|Non-Compliance with Protocol|3|||
170511809|NCT01605825|616219918|FG001|Overall Study|Non-Compliance with Protocol|0|||
170511810|NCT01778751|616219927|FG000|Overall Study|Lost to Follow-up|1|||
170511811|NCT01778751|616219928|FG001|Overall Study|Lost to Follow-up|0|||
170511812|NCT01778751|616219927|FG000|Overall Study|Withdrawal by Subject|0|||
170511813|NCT01778751|616219928|FG001|Overall Study|Withdrawal by Subject|2|||
170511814|NCT01778751|616219927|FG000|Overall Study|Transfered care|1|||
170511815|NCT01778751|616219928|FG001|Overall Study|Transfered care|0|||
170511816|NCT03337048|616219929|FG000|Overall Study|Withdrawal by Subject|2|||
170511817|NCT03337048|616219930|FG001|Overall Study|Withdrawal by Subject|0|||
170511818|NCT03337048|616219931|FG002|Overall Study|Withdrawal by Subject|0|||
170511819|NCT02669667|616219932|FG000|Overall Study|Lost to Follow-up|0|||
170511820|NCT02669667|616219933|FG001|Overall Study|Lost to Follow-up|0|||
170511821|NCT02669667|616219934|FG002|Overall Study|Lost to Follow-up|0|||
170511822|NCT02669667|616219935|FG003|Overall Study|Lost to Follow-up|0|||
170511823|NCT02669667|616219936|FG004|Overall Study|Lost to Follow-up|0|||
170511824|NCT02669667|616219937|FG005|Overall Study|Lost to Follow-up|1|||
170511825|NCT02669667|616219938|FG006|Overall Study|Lost to Follow-up|0|||
170511826|NCT00840034|616219940|FG000|Acute Treatment Phase|Adverse Event|6|||
170511827|NCT00840034|616219941|FG001|Acute Treatment Phase|Adverse Event|8|||
170511828|NCT00840034|616219940|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
170553948|NCT05418426|616375519|FG001|Overall Study|Withdrawal by Subject|1|||
170511829|NCT00840034|616219941|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
170511830|NCT00840034|616219940|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
170511831|NCT00840034|616219941|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
170553949|NCT05418426|616375520|FG002|Overall Study|Withdrawal by Subject|0|||
170806166|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
170905065|NCT02305563|617653936|FG001|Follow-up Period|Followup no longer required per protocol|3|||
170905066|NCT02305563|617653937|FG002|Follow-up Period|Followup no longer required per protocol|4|||
170511832|NCT00840034|616219940|FG000|Acute Treatment Phase|Physician Decision|0|||
170511833|NCT00840034|616219941|FG001|Acute Treatment Phase|Physician Decision|1|||
170511834|NCT00840034|616219940|FG000|Acute Treatment Phase|Protocol Violation|2|||
170511835|NCT00840034|616219941|FG001|Acute Treatment Phase|Protocol Violation|4|||
170511836|NCT00840034|616219940|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
170511837|NCT00840034|616219941|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
170511838|NCT00840034|616219940|FG000|Taper Phase|Adverse Event|1|||
170511839|NCT00840034|616219941|FG001|Taper Phase|Adverse Event|0|||
170511840|NCT00840034|616219940|FG000|Taper Phase|Lost to Follow-up|1|||
170511841|NCT00840034|616219941|FG001|Taper Phase|Lost to Follow-up|1|||
170511842|NCT00840034|616219940|FG000|Taper Phase|Withdrawal by Subject|1|||
170511843|NCT00840034|616219941|FG001|Taper Phase|Withdrawal by Subject|1|||
170511844|NCT02839876|616219952|FG000|Overall Study|Protocol Violation|10|||
170511845|NCT02839876|616219953|FG001|Overall Study|Protocol Violation|11|||
170511846|NCT00636961|616219954|FG000|Period 1|Administrative problems|1|||
170511847|NCT00636961|616219955|FG001|Period 1|Administrative problems|1|||
170511848|NCT00636961|616219954|FG000|Period 2|Adverse Event|1|||
170511849|NCT00636961|616219955|FG001|Period 2|Adverse Event|0|||
170511850|NCT03816007|616219960|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
170511851|NCT03816007|616219961|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
170511852|NCT03816007|616219960|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
170511853|NCT03816007|616219961|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
170511854|NCT03816007|616219960|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
170511855|NCT03816007|616219961|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
170511856|NCT03628716|616219962|FG000|Overall Study|Adverse Event|1|||
170511857|NCT03628716|616219963|FG001|Overall Study|Adverse Event|1|||
170511858|NCT03628716|616219962|FG000|Overall Study|Death|1|||
170511859|NCT03628716|616219963|FG001|Overall Study|Death|0|||
170511860|NCT03628716|616219962|FG000|Overall Study|Lack of Efficacy|15|||
170511861|NCT03628716|616219963|FG001|Overall Study|Lack of Efficacy|20|||
170511862|NCT03628716|616219962|FG000|Overall Study|Withdrawal by Subject|1|||
170511863|NCT03628716|616219963|FG001|Overall Study|Withdrawal by Subject|2|||
170511864|NCT03628716|616219962|FG000|Overall Study|Study Terminated by Sponsor|1|||
170511865|NCT03628716|616219963|FG001|Overall Study|Study Terminated by Sponsor|0|||
170511866|NCT00862459|616219964|FG000|Overall Study|Lost to Follow-up|1|||
170511867|NCT00862459|616219965|FG001|Overall Study|Lost to Follow-up|2|||
170511868|NCT00862459|616219966|FG002|Overall Study|Lost to Follow-up|2|||
170511869|NCT00862459|616219964|FG000|Overall Study|Protocol Violation|1|||
170511870|NCT00862459|616219965|FG001|Overall Study|Protocol Violation|0|||
170511871|NCT00862459|616219966|FG002|Overall Study|Protocol Violation|0|||
170511872|NCT00862459|616219964|FG000|Overall Study|Withdrawal by Subject|1|||
170511873|NCT00862459|616219965|FG001|Overall Study|Withdrawal by Subject|1|||
170511874|NCT00862459|616219966|FG002|Overall Study|Withdrawal by Subject|3|||
170511875|NCT00862459|616219964|FG000|Overall Study|Adverse Event|0|||
170511876|NCT00862459|616219965|FG001|Overall Study|Adverse Event|1|||
170511877|NCT00862459|616219966|FG002|Overall Study|Adverse Event|0|||
170511878|NCT00862459|616219964|FG000|Overall Study|Personal reasons|1|||
170511879|NCT00862459|616219965|FG001|Overall Study|Personal reasons|0|||
170511880|NCT00862459|616219966|FG002|Overall Study|Personal reasons|0|||
170511881|NCT00862459|616219964|FG000|Overall Study|Operation|1|||
170511882|NCT00862459|616219965|FG001|Overall Study|Operation|1|||
170511883|NCT00862459|616219966|FG002|Overall Study|Operation|0|||
170511884|NCT00862459|616219964|FG000|Overall Study|Intravenous (IV) site problems|1|||
170511885|NCT00862459|616219965|FG001|Overall Study|Intravenous (IV) site problems|0|||
170511886|NCT00862459|616219966|FG002|Overall Study|Intravenous (IV) site problems|1|||
170511887|NCT00862459|616219964|FG000|Overall Study|Unable to hold still for imaging|0|||
170511888|NCT00862459|616219965|FG001|Overall Study|Unable to hold still for imaging|1|||
170553950|NCT05418426|616375518|FG000|Overall Study|Protocol Violation|0|||
170553951|NCT05418426|616375519|FG001|Overall Study|Protocol Violation|0|||
170553952|NCT05418426|616375520|FG002|Overall Study|Protocol Violation|1|||
170553953|NCT00113373|616375524|FG000|Overall Study|Ineligible: wrong primary|1|||
170553954|NCT00113373|616375524|FG000|Overall Study|Ineligible: second primary|1|||
170553955|NCT00113373|616375524|FG000|Overall Study|Never Treated|1|||
170553956|NCT04629521|616375529|FG000|Overall Study|Death|1|||
170553957|NCT04629521|616375529|FG000|Overall Study|Lost to Follow-up|3|||
170905067|NCT02305563|617653938|FG003|Follow-up Period|Followup no longer required per protocol|1|||
170905068|NCT02305563|617653939|FG004|Follow-up Period|Followup no longer required per protocol|4|||
170905069|NCT05300087|617653944|FG000|Overall Study|Withdrawal by Subject|0|||
170511889|NCT00862459|616219966|FG002|Overall Study|Unable to hold still for imaging|0|||
170905070|NCT05300087|617653945|FG001|Overall Study|Withdrawal by Subject|1|||
170511890|NCT00862459|616219964|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
170511891|NCT00862459|616219965|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
170511892|NCT00862459|616219966|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
170511893|NCT00862459|616219964|FG000|Overall Study|Administrative problems|0|||
170511894|NCT00862459|616219965|FG001|Overall Study|Administrative problems|1|||
170511895|NCT00862459|616219966|FG002|Overall Study|Administrative problems|0|||
170905071|NCT01697345|617653953|FG000|Overall Study|Withdrawal by Subject|1|||
170905072|NCT02370121|617653956|FG000|Overall Study|Lost to Follow-up|1|||
170905073|NCT02370121|617653957|FG001|Overall Study|Lost to Follow-up|1|||
170905074|NCT05262764|617653962|FG000|Overall Study|Case report form not collected|9|||
170905075|NCT05262764|617653962|FG000|Overall Study|No patient visits after entry|23|||
170905076|NCT05262764|617653962|FG000|Overall Study|Registration rule not followed|2|||
170905077|NCT05262764|617653962|FG000|Overall Study|Patient of non-chronic heart failure|1|||
170905078|NCT01769105|617653963|FG000|First Intervention|Protocol Violation|2|||
170905079|NCT01769105|617653964|FG001|First Intervention|Protocol Violation|2|||
170905080|NCT01769105|617653963|FG000|Cross-over|Lost to Follow-up|5|||
170905081|NCT01769105|617653964|FG001|Cross-over|Lost to Follow-up|0|||
170905082|NCT00684177|617653969|FG000|Overall Study|Adverse Event|4|||
170905083|NCT00684177|617653970|FG001|Overall Study|Adverse Event|3|||
170905084|NCT00684177|617653969|FG000|Overall Study|Lack of Efficacy|10|||
170905085|NCT00684177|617653970|FG001|Overall Study|Lack of Efficacy|15|||
170905086|NCT00684177|617653969|FG000|Overall Study|Protocol Violation|1|||
170905087|NCT00684177|617653970|FG001|Overall Study|Protocol Violation|0|||
170905088|NCT00684177|617653969|FG000|Overall Study|Lost to Follow-up|2|||
170905089|NCT00684177|617653970|FG001|Overall Study|Lost to Follow-up|1|||
170905090|NCT00684177|617653969|FG000|Overall Study|Physician Decision|2|||
170905091|NCT00684177|617653970|FG001|Overall Study|Physician Decision|0|||
170905092|NCT00684177|617653969|FG000|Overall Study|Withdrawal by Subject|1|||
170905093|NCT00684177|617653970|FG001|Overall Study|Withdrawal by Subject|2|||
170905094|NCT00684177|617653969|FG000|Overall Study|Other|1|||
170905095|NCT00684177|617653970|FG001|Overall Study|Other|2|||
170905096|NCT02770807|617653971|FG000|Overall Study|Adverse Event|3|||
170905097|NCT02770807|617653972|FG001|Overall Study|Adverse Event|3|||
170905098|NCT02770807|617653973|FG002|Overall Study|Adverse Event|1|||
170905099|NCT02770807|617653971|FG000|Overall Study|Withdrawal by Subject|7|||
170905100|NCT02770807|617653972|FG001|Overall Study|Withdrawal by Subject|3|||
170905101|NCT02770807|617653973|FG002|Overall Study|Withdrawal by Subject|4|||
170905102|NCT02770807|617653971|FG000|Overall Study|Other|0|||
170905103|NCT02770807|617653972|FG001|Overall Study|Other|1|||
170905104|NCT02770807|617653973|FG002|Overall Study|Other|0|||
170511896|NCT02906033|616219967|FG000|Baseline|Protocol Violation|37|||
170511897|NCT02906033|616219968|FG001|Baseline|Protocol Violation|33|||
170511898|NCT02906033|616219967|FG000|Follow-up|Lost to Follow-up|46|||
170511899|NCT02906033|616219968|FG001|Follow-up|Lost to Follow-up|62|||
170511900|NCT00856843|616219969|FG000|Overall Study|Withdrawal by Subject|1|||
170511901|NCT00856843|616219970|FG001|Overall Study|Withdrawal by Subject|5|||
170511902|NCT00856843|616219969|FG000|Overall Study|Lack of Efficacy|1|||
170511903|NCT00856843|616219970|FG001|Overall Study|Lack of Efficacy|0|||
170511904|NCT02071082|616219971|FG000|Overall Study|Enrolled and Never Treated|1|||
170511905|NCT02071082|616219972|FG001|Overall Study|Enrolled and Never Treated|1|||
170511906|NCT02071082|616219971|FG000|Overall Study|Adverse Event|0|||
170511907|NCT02071082|616219972|FG001|Overall Study|Adverse Event|1|||
170511908|NCT02071082|616219971|FG000|Overall Study|Withdrew Consent|0|||
170511909|NCT02071082|616219972|FG001|Overall Study|Withdrew Consent|4|||
170511910|NCT02071082|616219971|FG000|Overall Study|Lost to Follow-up|1|||
170511911|NCT02071082|616219972|FG001|Overall Study|Lost to Follow-up|1|||
170511912|NCT02101359|616219973|FG000|Overall Study|Not included|23|||
170511913|NCT02101359|616219974|FG001|Overall Study|Not included|13|||
170511914|NCT02101359|616219973|FG000|Overall Study|Withdrawal by Subject|5|||
170511915|NCT02101359|616219974|FG001|Overall Study|Withdrawal by Subject|4|||
170511916|NCT02101359|616219973|FG000|Overall Study|Lost to Follow-up|1|||
170511917|NCT02101359|616219974|FG001|Overall Study|Lost to Follow-up|0|||
170511918|NCT02101359|616219973|FG000|Overall Study|Protocol Violation|0|||
170511919|NCT02101359|616219974|FG001|Overall Study|Protocol Violation|2|||
170511920|NCT00494221|616219975|FG000|Overall Study|Death|15|||
170511921|NCT00494221|616219976|FG001|Overall Study|Death|9|||
170511922|NCT00494221|616219977|FG002|Overall Study|Death|14|||
170511923|NCT00494221|616219975|FG000|Overall Study|Withdrawal by Subject|1|||
170511924|NCT00494221|616219976|FG001|Overall Study|Withdrawal by Subject|2|||
170511925|NCT00494221|616219977|FG002|Overall Study|Withdrawal by Subject|0|||
170511926|NCT01900431|616219981|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
170511927|NCT01900431|616219982|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
170905105|NCT02770807|617653971|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
170905106|NCT02770807|617653972|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
170905107|NCT02770807|617653973|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
170905108|NCT02770807|617653971|FG000|Overall Study|Physician Decision|0|||
170905109|NCT02770807|617653972|FG001|Overall Study|Physician Decision|0|||
170905110|NCT02770807|617653973|FG002|Overall Study|Physician Decision|1|||
170905111|NCT01121406|617656018|FG000|Overall Study|Progressive disease RECIST|44|||
170905112|NCT01121406|617656019|FG001|Overall Study|Progressive disease RECIST|28|||
170905113|NCT01121406|617656018|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
170905114|NCT01121406|617656019|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
170905115|NCT01121406|617656018|FG000|Overall Study|Other AE|3|||
170511928|NCT01900431|616219983|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
170511929|NCT01900431|616219981|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
170511930|NCT01900431|616219982|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
170511931|NCT01900431|616219983|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
170511932|NCT01900431|616219981|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
170511933|NCT01900431|616219982|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
170511934|NCT01900431|616219983|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
170511935|NCT01900431|616219981|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
170553958|NCT04629521|616375529|FG000|Overall Study|Subject withdrew consent|3|||
170553959|NCT04629521|616375529|FG000|Overall Study|Enrolled in error|1|||
170553960|NCT01335685|616375532|FG000|Overall Study|Study Terminated by Sponsor|2|||
170553961|NCT01335685|616375533|FG001|Overall Study|Study Terminated by Sponsor|1|||
170553962|NCT01335685|616375534|FG002|Overall Study|Study Terminated by Sponsor|1|||
170553963|NCT01335685|616375535|FG003|Overall Study|Study Terminated by Sponsor|10|||
170553964|NCT01335685|616375536|FG004|Overall Study|Study Terminated by Sponsor|0|||
170553965|NCT01335685|616375537|FG005|Overall Study|Study Terminated by Sponsor|4|||
170553966|NCT01335685|616375538|FG006|Overall Study|Study Terminated by Sponsor|2|||
170553967|NCT01335685|616375539|FG007|Overall Study|Study Terminated by Sponsor|3|||
170553968|NCT01335685|616375532|FG000|Overall Study|Withdrawal by Subject|1|||
170553969|NCT01335685|616375533|FG001|Overall Study|Withdrawal by Subject|0|||
170553970|NCT01335685|616375534|FG002|Overall Study|Withdrawal by Subject|0|||
170553971|NCT01335685|616375535|FG003|Overall Study|Withdrawal by Subject|1|||
170553972|NCT01335685|616375536|FG004|Overall Study|Withdrawal by Subject|0|||
170553973|NCT01335685|616375537|FG005|Overall Study|Withdrawal by Subject|0|||
170553974|NCT01335685|616375538|FG006|Overall Study|Withdrawal by Subject|0|||
170553975|NCT01335685|616375539|FG007|Overall Study|Withdrawal by Subject|0|||
170553976|NCT01335685|616375532|FG000|Overall Study|Reason not Specified|0|||
170553977|NCT01335685|616375533|FG001|Overall Study|Reason not Specified|0|||
170553978|NCT01335685|616375534|FG002|Overall Study|Reason not Specified|1|||
170553979|NCT01335685|616375535|FG003|Overall Study|Reason not Specified|0|||
170553980|NCT01335685|616375536|FG004|Overall Study|Reason not Specified|0|||
170553981|NCT01335685|616375537|FG005|Overall Study|Reason not Specified|1|||
170553982|NCT01335685|616375538|FG006|Overall Study|Reason not Specified|0|||
170553983|NCT01335685|616375539|FG007|Overall Study|Reason not Specified|0|||
170553984|NCT03211832|616375540|FG000|Overall Study|No longer with agency|32|||
170553985|NCT03211832|616375541|FG001|Overall Study|No longer with agency|49|||
170553986|NCT03211832|616375542|FG002|Overall Study|No longer with agency|30|||
170553987|NCT03211832|616375540|FG000|Overall Study|Declined survey|3|||
170553988|NCT03211832|616375541|FG001|Overall Study|Declined survey|3|||
170553989|NCT03211832|616375542|FG002|Overall Study|Declined survey|2|||
170553990|NCT03211832|616375540|FG000|Overall Study|Not available during data collection|1|||
170553991|NCT03211832|616375541|FG001|Overall Study|Not available during data collection|0|||
170553992|NCT03211832|616375542|FG002|Overall Study|Not available during data collection|2|||
170553993|NCT00855166|616375543|FG000|Overall Study|Adverse Event|0|||
170553994|NCT00855166|616375544|FG001|Overall Study|Adverse Event|2|||
170553995|NCT00855166|616375543|FG000|Overall Study|Death|0|||
170553996|NCT00855166|616375544|FG001|Overall Study|Death|1|||
170553997|NCT00855166|616375543|FG000|Overall Study|Withdrawal by Subject|1|||
170553998|NCT00855166|616375544|FG001|Overall Study|Withdrawal by Subject|4|||
170553999|NCT00855166|616375543|FG000|Overall Study|Poor/non-compliance|2|||
170554000|NCT00855166|616375544|FG001|Overall Study|Poor/non-compliance|0|||
170554001|NCT00855166|616375543|FG000|Overall Study|Administrative reasons by sponsor|1|||
170554002|NCT00855166|616375544|FG001|Overall Study|Administrative reasons by sponsor|0|||
170554003|NCT00855166|616375543|FG000|Overall Study|Subject no longer meets study criteria|1|||
170554004|NCT00855166|616375544|FG001|Overall Study|Subject no longer meets study criteria|1|||
170554005|NCT02991859|616375548|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554006|NCT02991859|616375549|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
170554007|NCT02991859|616375550|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554008|NCT02991859|616375551|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554009|NCT02991859|616375552|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
170554010|NCT02991859|616375553|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554011|NCT02991859|616375554|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554012|NCT02991859|616375555|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554013|NCT02991859|616375556|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554014|NCT02991859|616375557|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554015|NCT02991859|616375558|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554016|NCT02991859|616375559|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554017|NCT02991859|616375560|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554018|NCT02991859|616375561|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554019|NCT02991859|616375562|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170905116|NCT01121406|617656019|FG001|Overall Study|Other AE|10|||
170511936|NCT01900431|616219982|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
170511937|NCT01900431|616219983|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
170511938|NCT01900431|616219981|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
170806167|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
170806168|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
170511939|NCT01900431|616219982|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
170511940|NCT01900431|616219983|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
170511941|NCT01900431|616219981|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
170511942|NCT01900431|616219982|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
170511943|NCT01900431|616219983|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
170511944|NCT01900431|616219981|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
170511945|NCT01900431|616219982|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
170511946|NCT01900431|616219983|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
170511947|NCT01900431|616219981|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
170511948|NCT01900431|616219982|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
170511949|NCT01900431|616219983|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
170511950|NCT01900431|616219981|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
170511951|NCT01900431|616219982|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
170511952|NCT01900431|616219983|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
170511953|NCT01841567|616219984|FG000|Overall Study|Adverse Event|3|||
170511954|NCT00659776|616219989|FG000|Overall Study|Withdrawal by Subject|12|||
170511955|NCT00659776|616219990|FG001|Overall Study|Withdrawal by Subject|2|||
170511956|NCT00659776|616219991|FG002|Overall Study|Withdrawal by Subject|0|||
170511957|NCT00742027|616219992|FG000|Overall Study|Disease Progression|76|||
170511958|NCT00742027|616219992|FG000|Overall Study|New Cancer Therapy|19|||
170511959|NCT00742027|616219992|FG000|Overall Study|Withdrawal by Subject|18|||
170511960|NCT00742027|616219992|FG000|Overall Study|Death|7|||
170511961|NCT00742027|616219992|FG000|Overall Study|Lost to Follow-up|4|||
170511962|NCT00742027|616219992|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
170511963|NCT00742027|616219992|FG000|Overall Study|Missing|2|||
170511964|NCT00742027|616219992|FG000|Overall Study|Administrative Problems|1|||
170511965|NCT01180049|616219993|FG000|Overall Study|Other|9|||
170511966|NCT01180049|616219994|FG001|Overall Study|Other|7|||
170511967|NCT01180049|616219993|FG000|Overall Study|Lost to Follow-up|8|||
170511968|NCT01180049|616219994|FG001|Overall Study|Lost to Follow-up|6|||
170511969|NCT01180049|616219993|FG000|Overall Study|Death|36|||
170511970|NCT01180049|616219994|FG001|Overall Study|Death|35|||
170511971|NCT02483572|616219997|FG000|Overall Study|Withdrawal by Subject|1|||
170511972|NCT02483572|616219998|FG001|Overall Study|Withdrawal by Subject|0|||
170511973|NCT02483572|616219997|FG000|Overall Study|Lost to Follow-up|1|||
170511974|NCT02483572|616219998|FG001|Overall Study|Lost to Follow-up|0|||
170511975|NCT02483572|616219997|FG000|Overall Study|Physician Decision|0|||
170511976|NCT02483572|616219998|FG001|Overall Study|Physician Decision|1|||
170511977|NCT03338569|616219999|FG000|Overall Study|Physician Decision|8|||
170511978|NCT03338569|616220000|FG001|Overall Study|Physician Decision|3|||
170511979|NCT03338569|616219999|FG000|Overall Study|Withdrawal by Subject|0|||
170511980|NCT03338569|616220000|FG001|Overall Study|Withdrawal by Subject|1|||
170511981|NCT03338569|616219999|FG000|Overall Study|Lost to Follow-up|0|||
170554020|NCT02991859|616375563|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554021|NCT02991859|616375564|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
170554022|NCT02991859|616375548|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554023|NCT02991859|616375549|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554024|NCT02991859|616375550|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554025|NCT02991859|616375551|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554026|NCT02991859|616375552|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554027|NCT02991859|616375553|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554028|NCT02991859|616375554|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554029|NCT02991859|616375555|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554030|NCT02991859|616375556|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554031|NCT02991859|616375557|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554032|NCT02991859|616375558|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554033|NCT02991859|616375559|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554034|NCT02991859|616375560|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
170554035|NCT02991859|616375561|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
170554036|NCT02991859|616375562|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554037|NCT02991859|616375563|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170806169|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
170806170|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
170554038|NCT02991859|616375564|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
170554039|NCT02991859|616375548|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554040|NCT02991859|616375549|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554041|NCT02991859|616375550|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554042|NCT02991859|616375551|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554043|NCT02991859|616375552|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554044|NCT02991859|616375553|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
170554045|NCT02991859|616375554|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554046|NCT02991859|616375555|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554047|NCT02991859|616375556|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554048|NCT02991859|616375557|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554049|NCT02991859|616375558|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554050|NCT02991859|616375559|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554051|NCT02991859|616375560|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554052|NCT02991859|616375561|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554053|NCT02991859|616375562|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554054|NCT02991859|616375563|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554055|NCT02991859|616375564|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
170554056|NCT02991859|616375548|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554057|NCT02991859|616375549|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554058|NCT02991859|616375550|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554059|NCT02991859|616375551|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554060|NCT02991859|616375552|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554061|NCT02991859|616375553|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554062|NCT02991859|616375554|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554063|NCT02991859|616375555|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554064|NCT02991859|616375556|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554065|NCT02991859|616375557|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
170554066|NCT02991859|616375558|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554067|NCT02991859|616375559|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554068|NCT02991859|616375560|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554069|NCT02991859|616375561|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554070|NCT02991859|616375562|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554071|NCT02991859|616375563|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554072|NCT02991859|616375564|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
170554073|NCT02991859|616375548|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554074|NCT02991859|616375549|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554075|NCT02991859|616375550|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554076|NCT02991859|616375551|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554077|NCT02991859|616375552|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554078|NCT02991859|616375553|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554079|NCT02991859|616375554|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554080|NCT02991859|616375555|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554081|NCT02991859|616375556|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
170554082|NCT02991859|616375557|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554083|NCT02991859|616375558|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554084|NCT02991859|616375559|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554085|NCT02991859|616375560|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554086|NCT02991859|616375561|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554087|NCT02991859|616375562|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554088|NCT02991859|616375563|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554089|NCT02991859|616375564|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
170554090|NCT03777020|616375565|FG000|Overall Study|Withdrawal by Subject|4|||
170554091|NCT03777020|616375566|FG001|Overall Study|Withdrawal by Subject|4|||
170554092|NCT03777020|616375565|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
170554093|NCT03777020|616375566|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
170554094|NCT00489476|616375567|FG000|Overall Study|Lost to Follow-up|0|||
170554095|NCT00489476|616375568|FG001|Overall Study|Lost to Follow-up|1|||
170554096|NCT00489476|616375569|FG002|Overall Study|Lost to Follow-up|0|||
170554097|NCT00489476|616375570|FG003|Overall Study|Lost to Follow-up|0|||
170554098|NCT03460704|616375571|FG000|Overall Study|Withdrawal by Subject|11|||
170554099|NCT03460704|616375572|FG001|Overall Study|Withdrawal by Subject|14|||
170554100|NCT03460704|616375571|FG000|Overall Study|Study terminated by the Sponsor|29|||
170554101|NCT03460704|616375572|FG001|Overall Study|Study terminated by the Sponsor|19|||
170554102|NCT03460704|616375571|FG000|Overall Study|Adverse Event|10|||
170554103|NCT03460704|616375572|FG001|Overall Study|Adverse Event|5|||
170644114|NCT00006409|616711558|FG005|Post-2 Year Intervention|Protocol Violation|0|||
170644115|NCT00006409|616711553|FG000|Post-3 Year Intervention|Protocol Violation|0|||
170644116|NCT00006409|616711554|FG001|Post-3 Year Intervention|Protocol Violation|0|||
170644117|NCT00006409|616711555|FG002|Post-3 Year Intervention|Protocol Violation|0|||
170644118|NCT00006409|616711556|FG003|Post-3 Year Intervention|Protocol Violation|0|||
170644119|NCT00006409|616711557|FG004|Post-3 Year Intervention|Protocol Violation|62|||
170554104|NCT03460704|616375571|FG000|Overall Study|Death|3|||
170644120|NCT00006409|616711558|FG005|Post-3 Year Intervention|Protocol Violation|62|||
170644121|NCT02743611|616711559|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
170644122|NCT02743611|616711560|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
170644123|NCT02743611|616711561|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
170644124|NCT02743611|616711562|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
170644125|NCT01960907|616711569|FG000|Overall Study|Death|4|||
170644126|NCT01960907|616711570|FG001|Overall Study|Death|3|||
170644127|NCT01960907|616711569|FG000|Overall Study|Withdrawal by Subject|32|||
170644128|NCT01960907|616711570|FG001|Overall Study|Withdrawal by Subject|42|||
170644129|NCT01989208|616711571|FG000|200 mg (7 Days)|Protocol Violation|0|||
170644130|NCT01989208|616711572|FG001|200 mg (7 Days)|Protocol Violation|1|||
170644131|NCT05405257|616711573|FG000|Overall Study|Withdrawal by Subject|1|||
170644132|NCT00776919|616711574|FG000|Overall Study|Withdrawal by Subject|16|||
170644133|NCT00776919|616711575|FG001|Overall Study|Withdrawal by Subject|14|||
170644134|NCT00776919|616711576|FG002|Overall Study|Withdrawal by Subject|15|||
170644135|NCT00776919|616711577|FG003|Overall Study|Withdrawal by Subject|26|||
170644136|NCT00776919|616711574|FG000|Overall Study|Lost to Follow-up|8|||
170644137|NCT00776919|616711575|FG001|Overall Study|Lost to Follow-up|12|||
170644138|NCT00776919|616711576|FG002|Overall Study|Lost to Follow-up|11|||
170554105|NCT03460704|616375572|FG001|Overall Study|Death|2|||
170554106|NCT03460704|616375571|FG000|Overall Study|Non-Compliance with Study Drug|3|||
170554107|NCT03460704|616375572|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170554108|NCT03460704|616375571|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170554109|NCT03460704|616375572|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
170554110|NCT03460704|616375571|FG000|Overall Study|Other|2|||
170554111|NCT03460704|616375572|FG001|Overall Study|Other|1|||
170554112|NCT01421459|616375573|FG000|Overall Study|Adverse Event|6|||
170554113|NCT01421459|616375574|FG001|Overall Study|Adverse Event|10|||
170554114|NCT01421459|616375573|FG000|Overall Study|Death|1|||
170554115|NCT01421459|616375574|FG001|Overall Study|Death|1|||
170554116|NCT01421459|616375573|FG000|Overall Study|Lack of Efficacy|1|||
170554117|NCT01421459|616375574|FG001|Overall Study|Lack of Efficacy|2|||
170554118|NCT01421459|616375573|FG000|Overall Study|Lost to Follow-up|8|||
170554119|NCT01421459|616375574|FG001|Overall Study|Lost to Follow-up|9|||
170554120|NCT01421459|616375573|FG000|Overall Study|Physician Decision|9|||
170554121|NCT01421459|616375574|FG001|Overall Study|Physician Decision|9|||
170554122|NCT01421459|616375573|FG000|Overall Study|Protocol Violation|8|||
170554123|NCT01421459|616375574|FG001|Overall Study|Protocol Violation|5|||
170554124|NCT01421459|616375573|FG000|Overall Study|Withdrawal by Subject|12|||
170554125|NCT01421459|616375574|FG001|Overall Study|Withdrawal by Subject|16|||
170554126|NCT01422382|616375577|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
170554127|NCT00967499|616375578|FG000|Overall Study|Adverse Event|0|||
170554128|NCT00967499|616375579|FG001|Overall Study|Adverse Event|1|||
170554129|NCT00967499|616375578|FG000|Overall Study|Protocol Violation|1|||
170554130|NCT00967499|616375579|FG001|Overall Study|Protocol Violation|0|||
170554131|NCT00967499|616375578|FG000|Overall Study|Sponsor Decision|1|||
170554132|NCT00967499|616375579|FG001|Overall Study|Sponsor Decision|0|||
170554133|NCT00967499|616375578|FG000|Overall Study|Randomized but not treated|63|||
170554134|NCT00967499|616375579|FG001|Overall Study|Randomized but not treated|59|||
170554135|NCT04003389|616375580|FG000|Overall Study|Adverse Event|27|||
170554136|NCT04003389|616375581|FG001|Overall Study|Adverse Event|34|||
170554137|NCT04003389|616375582|FG002|Overall Study|Adverse Event|28|||
170644139|NCT00776919|616711577|FG003|Overall Study|Lost to Follow-up|8|||
170554138|NCT04003389|616375580|FG000|Overall Study|Lost to Follow-up|39|||
170644140|NCT00776919|616711574|FG000|Overall Study|Adverse Event|1|||
170644141|NCT00776919|616711575|FG001|Overall Study|Adverse Event|0|||
170644142|NCT00776919|616711576|FG002|Overall Study|Adverse Event|2|||
170644143|NCT00776919|616711577|FG003|Overall Study|Adverse Event|2|||
170644144|NCT00776919|616711574|FG000|Overall Study|Protocol Violation|1|||
170554139|NCT04003389|616375581|FG001|Overall Study|Lost to Follow-up|30|||
170554140|NCT04003389|616375582|FG002|Overall Study|Lost to Follow-up|33|||
170554141|NCT04003389|616375580|FG000|Overall Study|Protocol Violation|1|||
170554142|NCT04003389|616375581|FG001|Overall Study|Protocol Violation|6|||
170644145|NCT00776919|616711575|FG001|Overall Study|Protocol Violation|2|||
170644146|NCT00776919|616711576|FG002|Overall Study|Protocol Violation|0|||
170644147|NCT00776919|616711577|FG003|Overall Study|Protocol Violation|1|||
170644148|NCT00776919|616711574|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
170644149|NCT00776919|616711575|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
170511982|NCT03338569|616220000|FG001|Overall Study|Lost to Follow-up|1|||
170644150|NCT00776919|616711576|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
170644151|NCT00776919|616711577|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
170644152|NCT01788215|616711580|FG000|Overall Study|Withdrawal by Subject|0|||
170644153|NCT01788215|616711581|FG001|Overall Study|Withdrawal by Subject|1|||
170644154|NCT01788215|616711580|FG000|Overall Study|Lost to Follow-up|2|||
170644155|NCT01788215|616711581|FG001|Overall Study|Lost to Follow-up|0|||
170644156|NCT03116152|616711582|FG000|Overall Study|Disease Progression|49|||
170644157|NCT03116152|616711583|FG001|Overall Study|Disease Progression|47|||
170644158|NCT03116152|616711582|FG000|Overall Study|Death|5|||
170644159|NCT03116152|616711583|FG001|Overall Study|Death|2|||
170644160|NCT03116152|616711582|FG000|Overall Study|Adverse Event|21|||
170644161|NCT03116152|616711583|FG001|Overall Study|Adverse Event|7|||
170644162|NCT03116152|616711582|FG000|Overall Study|Protocol Violation|2|||
170644163|NCT03116152|616711583|FG001|Overall Study|Protocol Violation|2|||
170644164|NCT03116152|616711582|FG000|Overall Study|Withdrawal by Subject|0|||
170644165|NCT03116152|616711583|FG001|Overall Study|Withdrawal by Subject|1|||
170644166|NCT03116152|616711582|FG000|Overall Study|Physician Decision|3|||
170644167|NCT03116152|616711583|FG001|Overall Study|Physician Decision|2|||
170644168|NCT03116152|616711582|FG000|Overall Study|other|11|||
170644169|NCT03116152|616711583|FG001|Overall Study|other|34|||
170644170|NCT00275340|616711584|FG000|Overall Study|Lost to Follow-up|2|||
170644171|NCT00275340|616711585|FG001|Overall Study|Lost to Follow-up|4|||
170644172|NCT00862641|616711586|FG000|Overall Study|Randomized, but drug not received|1|||
170644173|NCT00862641|616711587|FG001|Overall Study|Randomized, but drug not received|4|||
170644174|NCT00862641|616711588|FG002|Overall Study|Randomized, but drug not received|1|||
170644175|NCT00862641|616711589|FG003|Overall Study|Randomized, but drug not received|4|||
170644176|NCT02365480|616711590|FG000|Overall Study|Withdrawal by Subject|2|||
170644177|NCT02365480|616711591|FG001|Overall Study|Withdrawal by Subject|0|||
170644178|NCT01419197|616711592|FG000|Overall Study|Death|247|||
170644179|NCT01419197|616711593|FG001|Overall Study|Death|122|||
170644180|NCT01419197|616711592|FG000|Overall Study|Physician Decision|4|||
170644181|NCT01419197|616711593|FG001|Overall Study|Physician Decision|4|||
170644182|NCT01419197|616711592|FG000|Overall Study|Non-compliance|3|||
170644183|NCT01419197|616711593|FG001|Overall Study|Non-compliance|1|||
170644184|NCT01419197|616711592|FG000|Overall Study|Withdrawal by Subject|33|||
170644185|NCT01419197|616711593|FG001|Overall Study|Withdrawal by Subject|32|||
170644186|NCT01419197|616711592|FG000|Overall Study|Study Completed by Sponsor|103|||
170644187|NCT01419197|616711593|FG001|Overall Study|Study Completed by Sponsor|34|||
170644188|NCT01419197|616711592|FG000|Overall Study|Reason Not Specified|0|||
170644189|NCT01419197|616711593|FG001|Overall Study|Reason Not Specified|1|||
170644190|NCT01419197|616711592|FG000|Overall Study|Lost to Follow-up|14|||
170644191|NCT01419197|616711593|FG001|Overall Study|Lost to Follow-up|4|||
170644192|NCT00653939|616711594|FG000|Overall Study|Adverse Event|1|||
170644193|NCT00653939|616711595|FG001|Overall Study|Adverse Event|3|||
170644194|NCT00653939|616711594|FG000|Overall Study|Withdrawal by Subject|3|||
170644195|NCT00653939|616711595|FG001|Overall Study|Withdrawal by Subject|3|||
170644196|NCT00653939|616711594|FG000|Overall Study|Physician Decision|4|||
170644197|NCT00653939|616711595|FG001|Overall Study|Physician Decision|0|||
170644198|NCT00653939|616711594|FG000|Overall Study|Disease Progression|2|||
170644199|NCT00653939|616711595|FG001|Overall Study|Disease Progression|3|||
170644200|NCT00653939|616711594|FG000|Overall Study|Other|2|||
170644201|NCT00653939|616711595|FG001|Overall Study|Other|6|||
170644202|NCT02032238|616711596|FG000|Overall Study|Lost to Follow-up|2|||
170644203|NCT02032238|616711597|FG001|Overall Study|Lost to Follow-up|0|||
170644204|NCT03037580|616711598|FG000|Overall Study|Withdrawal by Subject|3|||
170644205|NCT03037580|616711599|FG001|Overall Study|Withdrawal by Subject|0|||
170644206|NCT03037580|616711598|FG000|Overall Study|Adverse Event|1|||
170644207|NCT03037580|616711599|FG001|Overall Study|Adverse Event|0|||
170644208|NCT03037580|616711598|FG000|Overall Study|Study Terminated by Sponsor|12|||
170905117|NCT01121406|617656018|FG000|Overall Study|Non-compliant with protocol|0|||
170905118|NCT01121406|617656019|FG001|Overall Study|Non-compliant with protocol|2|||
170905119|NCT01121406|617656018|FG000|Overall Study|Lost to Follow-up|0|||
170511983|NCT00528372|616220001|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
170644209|NCT03037580|616711599|FG001|Overall Study|Study Terminated by Sponsor|15|||
170644210|NCT03037580|616711598|FG000|Overall Study|Death|0|||
170905120|NCT01121406|617656019|FG001|Overall Study|Lost to Follow-up|1|||
170644211|NCT03037580|616711599|FG001|Overall Study|Death|1|||
170644212|NCT00029146|616711600|FG000|Overall Study|Lost to Follow-up|2|||
170644213|NCT00029146|616711601|FG001|Overall Study|Lost to Follow-up|1|||
170644214|NCT04556383|616711602|FG000|PCP|Lack of Efficacy|28|||
170644215|NCT04556383|616711603|FG001|PCP|Lack of Efficacy|23|||
170644216|NCT04556383|616711604|FG002|PCP|Lack of Efficacy|23|||
170644217|NCT04556383|616711605|FG003|PCP|Lack of Efficacy|0|||
170644218|NCT04556383|616711602|FG000|PCP|Study terminated by sponsor|15|||
170644219|NCT04556383|616711603|FG001|PCP|Study terminated by sponsor|13|||
170644220|NCT04556383|616711604|FG002|PCP|Study terminated by sponsor|16|||
170644221|NCT04556383|616711605|FG003|PCP|Study terminated by sponsor|0|||
170644222|NCT04556383|616711602|FG000|PCP|Withdrawal by Subject|8|||
170511984|NCT00528372|616220002|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
170511985|NCT00528372|616220003|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
170511986|NCT00528372|616220004|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
170511987|NCT00528372|616220005|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
170511988|NCT00528372|616220006|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
170511989|NCT00528372|616220007|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
170511990|NCT00528372|616220008|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
170511991|NCT00528372|616220009|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
170511992|NCT00528372|616220001|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
170511993|NCT00528372|616220002|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
170511994|NCT00528372|616220003|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
170511995|NCT00528372|616220004|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
170511996|NCT00528372|616220005|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
170511997|NCT00528372|616220006|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
170511998|NCT00528372|616220007|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
170511999|NCT00528372|616220008|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
170512000|NCT00528372|616220009|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
170512001|NCT00528372|616220001|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
170512002|NCT00528372|616220002|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
170512003|NCT00528372|616220003|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
170512004|NCT00528372|616220004|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
170512005|NCT00528372|616220005|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
170512006|NCT00528372|616220006|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
170512007|NCT00528372|616220007|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
170512008|NCT00528372|616220008|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
170512009|NCT00528372|616220009|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
170512010|NCT00528372|616220001|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
170512011|NCT00528372|616220002|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
170512012|NCT00528372|616220003|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
170512013|NCT00528372|616220004|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
170512014|NCT00528372|616220005|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
170512015|NCT00528372|616220006|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
170512016|NCT00528372|616220007|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
170512017|NCT00528372|616220008|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
170512018|NCT00528372|616220009|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
170512019|NCT00528372|616220001|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
170512020|NCT00528372|616220002|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
170512021|NCT00528372|616220003|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
170512022|NCT00528372|616220004|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
170512023|NCT00528372|616220005|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
170512024|NCT00528372|616220006|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
170512025|NCT00528372|616220007|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
170512026|NCT00528372|616220008|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
170512027|NCT00528372|616220009|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
170512028|NCT00528372|616220001|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
170512029|NCT00528372|616220002|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
170512030|NCT00528372|616220003|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
170512031|NCT00528372|616220004|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
170512032|NCT00528372|616220005|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
170512033|NCT00528372|616220006|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
170512034|NCT00528372|616220007|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
170512035|NCT00528372|616220008|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
170512036|NCT00528372|616220009|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
170512037|NCT00528372|616220001|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
170512038|NCT00528372|616220002|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
170554143|NCT04003389|616375582|FG002|Overall Study|Protocol Violation|5|||
170554144|NCT04003389|616375580|FG000|Overall Study|Withdrawal by Subject|119|||
170905121|NCT01121406|617656018|FG000|Overall Study|Refused continuation of study med.|1|||
170905122|NCT01121406|617656019|FG001|Overall Study|Refused continuation of study med.|2|||
170905123|NCT01121406|617656018|FG000|Overall Study|Reason other than specified above|2|||
170905124|NCT01121406|617656019|FG001|Overall Study|Reason other than specified above|6|||
170905125|NCT01121406|617656018|FG000|Overall Study|Not treated|1|||
170905126|NCT01121406|617656019|FG001|Overall Study|Not treated|0|||
170905127|NCT00892437|617656020|FG000|Randomized Phase|Randomized but not treated|6|||
170644223|NCT04556383|616711603|FG001|PCP|Withdrawal by Subject|6|||
170644224|NCT04556383|616711604|FG002|PCP|Withdrawal by Subject|6|||
170644225|NCT04556383|616711605|FG003|PCP|Withdrawal by Subject|0|||
170644226|NCT04556383|616711602|FG000|PCP|Adverse Event|1|||
170644227|NCT04556383|616711603|FG001|PCP|Adverse Event|7|||
170644228|NCT04556383|616711604|FG002|PCP|Adverse Event|7|||
170644229|NCT04556383|616711605|FG003|PCP|Adverse Event|0|||
170644230|NCT04556383|616711602|FG000|PCP|Other, Not Specified|1|||
170644231|NCT04556383|616711603|FG001|PCP|Other, Not Specified|2|||
170644232|NCT04556383|616711604|FG002|PCP|Other, Not Specified|1|||
170644233|NCT04556383|616711605|FG003|PCP|Other, Not Specified|0|||
170644234|NCT04556383|616711602|FG000|PCP|Protocol Violation|1|||
170644235|NCT04556383|616711603|FG001|PCP|Protocol Violation|0|||
170644236|NCT04556383|616711604|FG002|PCP|Protocol Violation|1|||
170905128|NCT00892437|617656021|FG001|Randomized Phase|Randomized but not treated|0|||
170512039|NCT00528372|616220003|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
170512040|NCT00528372|616220004|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
170512041|NCT00528372|616220005|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
170512042|NCT00528372|616220006|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
170512043|NCT00528372|616220007|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
170512044|NCT00528372|616220008|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
170512045|NCT00528372|616220009|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
170512046|NCT00528372|616220001|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
170905129|NCT00892437|617656020|FG000|Randomized Phase|Adverse Event|2|||
170905130|NCT00892437|617656021|FG001|Randomized Phase|Adverse Event|2|||
170905131|NCT00892437|617656020|FG000|Randomized Phase|Lost to Follow-up|1|||
170512047|NCT00528372|616220002|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
170512048|NCT00528372|616220003|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
170512049|NCT00528372|616220004|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
170512050|NCT00528372|616220005|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
170512051|NCT00528372|616220006|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
170512052|NCT00528372|616220007|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
170512053|NCT00528372|616220008|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
170512054|NCT00528372|616220009|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
170512055|NCT00528372|616220001|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
170512056|NCT00528372|616220002|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
170512057|NCT00528372|616220003|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
170512058|NCT00528372|616220004|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
170512059|NCT00528372|616220005|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
170512060|NCT00528372|616220006|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
170554145|NCT04003389|616375581|FG001|Overall Study|Withdrawal by Subject|79|||
170554146|NCT04003389|616375582|FG002|Overall Study|Withdrawal by Subject|85|||
170554147|NCT04003389|616375580|FG000|Overall Study|Miscellaneous|14|||
170554148|NCT04003389|616375581|FG001|Overall Study|Miscellaneous|11|||
170554149|NCT04003389|616375582|FG002|Overall Study|Miscellaneous|14|||
170554150|NCT04003389|616375580|FG000|Overall Study|Participant did not receive study drug|1|||
170554151|NCT04003389|616375581|FG001|Overall Study|Participant did not receive study drug|0|||
170554152|NCT04003389|616375582|FG002|Overall Study|Participant did not receive study drug|0|||
170554153|NCT02899754|616375583|FG000|Overall Study|Lost to Follow-up|7|||
170554154|NCT02899754|616375584|FG001|Overall Study|Lost to Follow-up|9|||
170554155|NCT05032820|616375585|FG000|Overall Study|Lost to Follow-up|1|||
170554156|NCT05032820|616375585|FG000|Overall Study|Withdrawal by Subject|1|||
170554157|NCT04082364|616375586|FG000|Overall Study|Death|23|||
170554158|NCT04082364|616375587|FG001|Overall Study|Death|1|||
170554159|NCT04082364|616375588|FG002|Overall Study|Death|1|||
170905132|NCT00892437|617656021|FG001|Randomized Phase|Lost to Follow-up|3|||
170905133|NCT00892437|617656020|FG000|Randomized Phase|Investigator's Discretion|1|||
170905134|NCT00892437|617656021|FG001|Randomized Phase|Investigator's Discretion|0|||
170512061|NCT00528372|616220007|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
170554160|NCT04082364|616375589|FG003|Overall Study|Death|2|||
170644237|NCT04556383|616711605|FG003|PCP|Protocol Violation|0|||
170644238|NCT04556383|616711602|FG000|PCP|Lost to Follow-up|1|||
170644239|NCT04556383|616711603|FG001|PCP|Lost to Follow-up|0|||
170905135|NCT00892437|617656020|FG000|Randomized Phase|Withdrew Consent|1|||
170905136|NCT00892437|617656021|FG001|Randomized Phase|Withdrew Consent|0|||
170905137|NCT00892437|617656020|FG000|Open-Label Extension Phase|Adverse Event|4|||
170512062|NCT00528372|616220008|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
170554161|NCT04082364|616375590|FG004|Overall Study|Death|1|||
170554162|NCT04082364|616375586|FG000|Overall Study|Lost to Follow-up|1|||
170554163|NCT04082364|616375587|FG001|Overall Study|Lost to Follow-up|0|||
170554164|NCT04082364|616375588|FG002|Overall Study|Lost to Follow-up|0|||
170554165|NCT04082364|616375589|FG003|Overall Study|Lost to Follow-up|0|||
170644240|NCT04556383|616711604|FG002|PCP|Lost to Follow-up|0|||
170644241|NCT04556383|616711605|FG003|PCP|Lost to Follow-up|0|||
170644242|NCT04556383|616711602|FG000|PCP|Physician Decision|0|||
170905138|NCT00892437|617656021|FG001|Open-Label Extension Phase|Adverse Event|2|||
170512063|NCT00528372|616220009|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
170512064|NCT00528372|616220001|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
170512065|NCT00528372|616220002|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
170512066|NCT00528372|616220003|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
170512067|NCT00528372|616220004|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
170512068|NCT00528372|616220005|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
170512069|NCT00528372|616220006|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
170512070|NCT00528372|616220007|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
170512071|NCT00528372|616220008|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
170512072|NCT00528372|616220009|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
170512073|NCT00528372|616220001|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
170512074|NCT00528372|616220002|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
170512075|NCT00528372|616220003|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
170512076|NCT00528372|616220004|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
170512077|NCT00528372|616220005|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
170512078|NCT00528372|616220006|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
170512079|NCT00528372|616220007|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
170512080|NCT00528372|616220008|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
170512081|NCT00528372|616220009|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
170512082|NCT00528372|616220001|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
170512083|NCT00528372|616220002|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
170512084|NCT00528372|616220003|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
170512085|NCT00528372|616220004|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
170512086|NCT00528372|616220005|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
170512087|NCT00528372|616220006|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
170512088|NCT00528372|616220007|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
170512089|NCT00528372|616220008|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
170512090|NCT00528372|616220009|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
170512091|NCT00528372|616220001|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
170512092|NCT00528372|616220002|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
170512093|NCT00528372|616220003|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
170512094|NCT00528372|616220004|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
170512095|NCT00528372|616220005|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
170512096|NCT00528372|616220006|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
170512097|NCT00528372|616220007|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
170512098|NCT00528372|616220008|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
170512099|NCT00528372|616220009|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
170512100|NCT00528372|616220001|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
170512101|NCT00528372|616220002|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
170512102|NCT00528372|616220003|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
170512103|NCT00528372|616220004|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
170512104|NCT00528372|616220005|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
170512105|NCT00528372|616220006|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
170512106|NCT00528372|616220007|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
170512107|NCT00528372|616220008|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
170512108|NCT00528372|616220009|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
170512109|NCT00528372|616220001|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
170512110|NCT00528372|616220002|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
170512111|NCT00528372|616220003|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
170512112|NCT00528372|616220004|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
170512113|NCT00528372|616220005|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
170512114|NCT00528372|616220006|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
170512115|NCT00528372|616220007|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
170512116|NCT00528372|616220008|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
170512117|NCT00528372|616220009|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
170554166|NCT04082364|616375590|FG004|Overall Study|Lost to Follow-up|1|||
170554167|NCT04082364|616375586|FG000|Overall Study|Physician Decision|1|||
170554168|NCT04082364|616375587|FG001|Overall Study|Physician Decision|1|||
170554169|NCT04082364|616375588|FG002|Overall Study|Physician Decision|0|||
170554170|NCT04082364|616375589|FG003|Overall Study|Physician Decision|2|||
170806171|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
170554171|NCT04082364|616375590|FG004|Overall Study|Physician Decision|1|||
170554172|NCT04082364|616375586|FG000|Overall Study|Withdrawal by Subject|1|||
170512118|NCT01289574|616220012|FG000|Overall Study|Lack of Efficacy|4|||
170512119|NCT01289574|616220013|FG001|Overall Study|Lack of Efficacy|0|||
170512120|NCT01289574|616220014|FG002|Overall Study|Lack of Efficacy|1|||
170512121|NCT01289574|616220012|FG000|Overall Study|Lost to Follow-up|2|||
170512122|NCT01289574|616220013|FG001|Overall Study|Lost to Follow-up|0|||
170512123|NCT01289574|616220014|FG002|Overall Study|Lost to Follow-up|1|||
170512124|NCT01289574|616220012|FG000|Overall Study|Withdrawal by Subject|1|||
170512125|NCT01289574|616220013|FG001|Overall Study|Withdrawal by Subject|1|||
170512126|NCT01289574|616220014|FG002|Overall Study|Withdrawal by Subject|1|||
170512127|NCT01289574|616220012|FG000|Overall Study|Adverse Event|0|||
170512128|NCT01289574|616220013|FG001|Overall Study|Adverse Event|1|||
170512129|NCT01289574|616220014|FG002|Overall Study|Adverse Event|0|||
170512130|NCT01289574|616220012|FG000|Overall Study|Subject wanted alternate treatment|0|||
170512131|NCT01289574|616220013|FG001|Overall Study|Subject wanted alternate treatment|1|||
170512132|NCT01289574|616220014|FG002|Overall Study|Subject wanted alternate treatment|0|||
170512133|NCT02432144|616220015|FG000|Overall Study|Participant Non-Compliance|1|||
170512134|NCT00262002|616220016|FG000|Overall Study|Adverse Event|2|||
170512135|NCT00262002|616220017|FG001|Overall Study|Adverse Event|1|||
170512136|NCT00262002|616220018|FG002|Overall Study|Adverse Event|0|||
170512137|NCT00262002|616220019|FG003|Overall Study|Adverse Event|0|||
170512138|NCT00262002|616220020|FG004|Overall Study|Adverse Event|0|||
170512139|NCT00262002|616220021|FG005|Overall Study|Adverse Event|1|||
170512140|NCT00262002|616220022|FG006|Overall Study|Adverse Event|0|||
170512141|NCT00262002|616220016|FG000|Overall Study|Withdrawal by Subject|4|||
170512142|NCT00262002|616220017|FG001|Overall Study|Withdrawal by Subject|2|||
170512143|NCT00262002|616220018|FG002|Overall Study|Withdrawal by Subject|0|||
170512144|NCT00262002|616220019|FG003|Overall Study|Withdrawal by Subject|1|||
170554173|NCT04082364|616375587|FG001|Overall Study|Withdrawal by Subject|1|||
170554174|NCT04082364|616375588|FG002|Overall Study|Withdrawal by Subject|0|||
170554175|NCT04082364|616375589|FG003|Overall Study|Withdrawal by Subject|0|||
170554176|NCT04082364|616375590|FG004|Overall Study|Withdrawal by Subject|1|||
170554177|NCT04082364|616375586|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
170554178|NCT04082364|616375587|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
170554179|NCT04082364|616375588|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
170554180|NCT04082364|616375589|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
170554181|NCT04082364|616375590|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
170554182|NCT04082364|616375586|FG000|Overall Study|Disease progression|0|||
170554183|NCT04082364|616375587|FG001|Overall Study|Disease progression|0|||
170554184|NCT04082364|616375588|FG002|Overall Study|Disease progression|0|||
170554185|NCT04082364|616375589|FG003|Overall Study|Disease progression|1|||
170554186|NCT04082364|616375590|FG004|Overall Study|Disease progression|0|||
170554187|NCT04806373|616375596|FG000|Overall Study|Withdrawal by Subject|1|||
170554188|NCT04806373|616375597|FG001|Overall Study|Withdrawal by Subject|1|||
170554189|NCT01615029|616375598|FG000|Overall Study|Adverse Event|1|||
170554190|NCT01615029|616375599|FG001|Overall Study|Adverse Event|0|||
170554191|NCT01615029|616375600|FG002|Overall Study|Adverse Event|3|||
170554192|NCT01615029|616375601|FG003|Overall Study|Adverse Event|0|||
170554193|NCT01615029|616375602|FG004|Overall Study|Adverse Event|4|||
170554194|NCT01615029|616375598|FG000|Overall Study|Progressive disease|1|||
170554195|NCT01615029|616375599|FG001|Overall Study|Progressive disease|1|||
170554196|NCT01615029|616375600|FG002|Overall Study|Progressive disease|1|||
170554197|NCT01615029|616375601|FG003|Overall Study|Progressive disease|1|||
170554198|NCT01615029|616375602|FG004|Overall Study|Progressive disease|10|||
170554199|NCT01615029|616375598|FG000|Overall Study|Physician Decision|0|||
170554200|NCT01615029|616375599|FG001|Overall Study|Physician Decision|0|||
170554201|NCT01615029|616375600|FG002|Overall Study|Physician Decision|0|||
170554202|NCT01615029|616375601|FG003|Overall Study|Physician Decision|0|||
170554203|NCT01615029|616375602|FG004|Overall Study|Physician Decision|2|||
170554204|NCT01450631|616375603|FG000|Overall Study|Lost to Follow-up|2|||
170554205|NCT01450631|616375604|FG001|Overall Study|Lost to Follow-up|4|||
170554206|NCT01450631|616375603|FG000|Overall Study|Withdrawal by Subject|1|||
170554207|NCT01450631|616375604|FG001|Overall Study|Withdrawal by Subject|0|||
170554208|NCT05213624|616375608|FG000|Overall Study|Adverse Event|0|||
170554209|NCT05213624|616375609|FG001|Overall Study|Adverse Event|3|||
170554210|NCT05213624|616375610|FG002|Overall Study|Adverse Event|0|||
170512145|NCT00262002|616220020|FG004|Overall Study|Withdrawal by Subject|2|||
170512146|NCT00262002|616220021|FG005|Overall Study|Withdrawal by Subject|2|||
170512147|NCT00262002|616220022|FG006|Overall Study|Withdrawal by Subject|2|||
170512148|NCT00262002|616220016|FG000|Overall Study|Lost to Follow-up|2|||
170512149|NCT00262002|616220017|FG001|Overall Study|Lost to Follow-up|0|||
170512150|NCT00262002|616220018|FG002|Overall Study|Lost to Follow-up|0|||
170512151|NCT00262002|616220019|FG003|Overall Study|Lost to Follow-up|2|||
170554211|NCT05213624|616375611|FG003|Overall Study|Adverse Event|0|||
170554212|NCT05213624|616375608|FG000|Overall Study|Protocol deviation|0|||
170554213|NCT05213624|616375609|FG001|Overall Study|Protocol deviation|2|||
170554214|NCT05213624|616375610|FG002|Overall Study|Protocol deviation|0|||
170554215|NCT05213624|616375611|FG003|Overall Study|Protocol deviation|0|||
170554216|NCT05213624|616375608|FG000|Overall Study|Withdrawal by Subject|0|||
170512152|NCT00262002|616220020|FG004|Overall Study|Lost to Follow-up|0|||
170512153|NCT00262002|616220021|FG005|Overall Study|Lost to Follow-up|1|||
170512154|NCT00262002|616220022|FG006|Overall Study|Lost to Follow-up|0|||
170512155|NCT00262002|616220016|FG000|Overall Study|Inapropriate enrollment|0|||
170512156|NCT00262002|616220017|FG001|Overall Study|Inapropriate enrollment|1|||
170512157|NCT00262002|616220018|FG002|Overall Study|Inapropriate enrollment|0|||
170512158|NCT00262002|616220019|FG003|Overall Study|Inapropriate enrollment|0|||
170512159|NCT00262002|616220020|FG004|Overall Study|Inapropriate enrollment|0|||
170512160|NCT00262002|616220021|FG005|Overall Study|Inapropriate enrollment|0|||
170512161|NCT00262002|616220022|FG006|Overall Study|Inapropriate enrollment|0|||
170512162|NCT00262002|616220016|FG000|Overall Study|Protocol Violation|3|||
170512163|NCT00262002|616220017|FG001|Overall Study|Protocol Violation|2|||
170512164|NCT00262002|616220018|FG002|Overall Study|Protocol Violation|0|||
170512165|NCT00262002|616220019|FG003|Overall Study|Protocol Violation|2|||
170512166|NCT00262002|616220020|FG004|Overall Study|Protocol Violation|5|||
170512167|NCT00262002|616220021|FG005|Overall Study|Protocol Violation|3|||
170512168|NCT00262002|616220022|FG006|Overall Study|Protocol Violation|2|||
170512169|NCT00262002|616220016|FG000|Overall Study|Unable to classify|0|||
170512170|NCT00262002|616220017|FG001|Overall Study|Unable to classify|0|||
170512171|NCT00262002|616220018|FG002|Overall Study|Unable to classify|0|||
170512172|NCT00262002|616220019|FG003|Overall Study|Unable to classify|0|||
170512173|NCT00262002|616220020|FG004|Overall Study|Unable to classify|0|||
170512174|NCT00262002|616220021|FG005|Overall Study|Unable to classify|0|||
170512175|NCT00262002|616220022|FG006|Overall Study|Unable to classify|2|||
170512176|NCT02849704|616221875|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
170512177|NCT02849704|616221876|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
170512178|NCT02849704|616221875|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
170512179|NCT02849704|616221876|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
170512180|NCT02849704|616221875|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
170512181|NCT02849704|616221876|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
170512182|NCT02447328|616221879|FG000|Overall Study|Withdrawal by Subject|1|||
170512183|NCT04304508|616221885|FG000|Overall Study|Subject Decision|29|||
170512184|NCT04304508|616221886|FG001|Overall Study|Subject Decision|39|||
170512185|NCT04304508|616221887|FG002|Overall Study|Subject Decision|37|||
170512186|NCT04304508|616221888|FG003|Overall Study|Subject Decision|48|||
170512187|NCT04304508|616221885|FG000|Overall Study|Death|6|||
170512188|NCT04304508|616221886|FG001|Overall Study|Death|1|||
170512189|NCT04304508|616221887|FG002|Overall Study|Death|8|||
170512190|NCT04304508|616221888|FG003|Overall Study|Death|5|||
170512191|NCT04304508|616221885|FG000|Overall Study|Non-compliance With Study Drug|3|||
170512192|NCT04304508|616221886|FG001|Overall Study|Non-compliance With Study Drug|1|||
170512193|NCT04304508|616221887|FG002|Overall Study|Non-compliance With Study Drug|2|||
170512194|NCT04304508|616221888|FG003|Overall Study|Non-compliance With Study Drug|0|||
170512195|NCT04304508|616221885|FG000|Overall Study|Switching To Other Therapy|1|||
170512196|NCT04304508|616221886|FG001|Overall Study|Switching To Other Therapy|1|||
170512197|NCT04304508|616221887|FG002|Overall Study|Switching To Other Therapy|1|||
170512198|NCT04304508|616221888|FG003|Overall Study|Switching To Other Therapy|2|||
170512199|NCT04304508|616221885|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
170512200|NCT04304508|616221886|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
170512201|NCT04304508|616221887|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
170512202|NCT04304508|616221888|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
170512203|NCT04304508|616221885|FG000|Overall Study|Withdrawal by Subject|7|||
170512204|NCT04304508|616221886|FG001|Overall Study|Withdrawal by Subject|5|||
170512205|NCT04304508|616221887|FG002|Overall Study|Withdrawal by Subject|11|||
170512206|NCT04304508|616221888|FG003|Overall Study|Withdrawal by Subject|6|||
170512207|NCT04304508|616221885|FG000|Overall Study|Logistical Difficulties|2|||
170512208|NCT04304508|616221886|FG001|Overall Study|Logistical Difficulties|2|||
170512209|NCT04304508|616221887|FG002|Overall Study|Logistical Difficulties|3|||
170512210|NCT04304508|616221888|FG003|Overall Study|Logistical Difficulties|2|||
170512211|NCT04304508|616221885|FG000|Overall Study|Missing Information|1|||
170512212|NCT04304508|616221886|FG001|Overall Study|Missing Information|2|||
170905139|NCT00892437|617656020|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
170512213|NCT04304508|616221887|FG002|Overall Study|Missing Information|1|||
170512214|NCT04304508|616221888|FG003|Overall Study|Missing Information|3|||
170512215|NCT04304508|616221885|FG000|Overall Study|Other|7|||
170512216|NCT04304508|616221886|FG001|Overall Study|Other|6|||
170512217|NCT04304508|616221887|FG002|Overall Study|Other|5|||
170512218|NCT04304508|616221888|FG003|Overall Study|Other|4|||
170512219|NCT04304508|616221885|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
170512220|NCT04304508|616221886|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
170512221|NCT04304508|616221887|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
170512222|NCT04304508|616221888|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
170512223|NCT04304508|616221885|FG000|Overall Study|Physician Decision|3|||
170512224|NCT04304508|616221886|FG001|Overall Study|Physician Decision|4|||
170905140|NCT00892437|617656021|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
170512225|NCT04304508|616221887|FG002|Overall Study|Physician Decision|9|||
170512226|NCT04304508|616221888|FG003|Overall Study|Physician Decision|7|||
170512227|NCT04304508|616221885|FG000|Overall Study|Study drug never administered|10|||
170512228|NCT04304508|616221886|FG001|Overall Study|Study drug never administered|4|||
170512229|NCT04304508|616221887|FG002|Overall Study|Study drug never administered|4|||
170512230|NCT04304508|616221888|FG003|Overall Study|Study drug never administered|4|||
170512231|NCT04304508|616221885|FG000|Overall Study|Adverse Event|49|||
170512232|NCT04304508|616221886|FG001|Overall Study|Adverse Event|50|||
170512233|NCT04304508|616221887|FG002|Overall Study|Adverse Event|51|||
170512234|NCT04304508|616221888|FG003|Overall Study|Adverse Event|56|||
170512235|NCT04304508|616221885|FG000|Overall Study|Lost to Follow-up|1|||
170512236|NCT04304508|616221886|FG001|Overall Study|Lost to Follow-up|5|||
170512237|NCT04304508|616221887|FG002|Overall Study|Lost to Follow-up|2|||
170512238|NCT04304508|616221888|FG003|Overall Study|Lost to Follow-up|3|||
170512239|NCT00824655|616221895|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
170512240|NCT00824655|616221896|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
170512241|NCT00824655|616221895|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
170512242|NCT00824655|616221896|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
170512243|NCT01826981|616221899|FG000|Overall Study|Lack of Efficacy|0|||
170512244|NCT01826981|616221900|FG001|Overall Study|Lack of Efficacy|1|||
170512245|NCT01826981|616221901|FG002|Overall Study|Lack of Efficacy|0|||
170512246|NCT01826981|616221902|FG003|Overall Study|Lack of Efficacy|0|||
170512247|NCT01826981|616221903|FG004|Overall Study|Lack of Efficacy|5|||
170512248|NCT01826981|616221904|FG005|Overall Study|Lack of Efficacy|0|||
170512249|NCT01826981|616221905|FG006|Overall Study|Lack of Efficacy|0|||
170512250|NCT01826981|616221906|FG007|Overall Study|Lack of Efficacy|8|||
170512251|NCT01826981|616221907|FG008|Overall Study|Lack of Efficacy|7|||
170512252|NCT01826981|616221908|FG009|Overall Study|Lack of Efficacy|0|||
170512253|NCT01826981|616221909|FG010|Overall Study|Lack of Efficacy|1|||
170512254|NCT01826981|616221910|FG011|Overall Study|Lack of Efficacy|0|||
170512255|NCT01826981|616221911|FG012|Overall Study|Lack of Efficacy|0|||
170512256|NCT01826981|616221912|FG013|Overall Study|Lack of Efficacy|3|||
170512257|NCT01826981|616221913|FG014|Overall Study|Lack of Efficacy|0|||
170512258|NCT01826981|616221899|FG000|Overall Study|Lost to Follow-up|0|||
170512259|NCT01826981|616221900|FG001|Overall Study|Lost to Follow-up|0|||
170512260|NCT01826981|616221901|FG002|Overall Study|Lost to Follow-up|0|||
170512261|NCT01826981|616221902|FG003|Overall Study|Lost to Follow-up|0|||
170512262|NCT01826981|616221903|FG004|Overall Study|Lost to Follow-up|1|||
170512263|NCT01826981|616221904|FG005|Overall Study|Lost to Follow-up|1|||
170512264|NCT01826981|616221905|FG006|Overall Study|Lost to Follow-up|0|||
170512265|NCT01826981|616221906|FG007|Overall Study|Lost to Follow-up|1|||
170512266|NCT01826981|616221907|FG008|Overall Study|Lost to Follow-up|0|||
170512267|NCT01826981|616221908|FG009|Overall Study|Lost to Follow-up|1|||
170512268|NCT01826981|616221909|FG010|Overall Study|Lost to Follow-up|1|||
170512269|NCT01826981|616221910|FG011|Overall Study|Lost to Follow-up|1|||
170512270|NCT01826981|616221911|FG012|Overall Study|Lost to Follow-up|1|||
170512271|NCT01826981|616221912|FG013|Overall Study|Lost to Follow-up|0|||
170512272|NCT01826981|616221913|FG014|Overall Study|Lost to Follow-up|0|||
170512273|NCT01826981|616221899|FG000|Overall Study|Withdrew Consent|0|||
170512274|NCT01826981|616221900|FG001|Overall Study|Withdrew Consent|0|||
170512275|NCT01826981|616221901|FG002|Overall Study|Withdrew Consent|0|||
170512276|NCT01826981|616221902|FG003|Overall Study|Withdrew Consent|0|||
170512277|NCT01826981|616221903|FG004|Overall Study|Withdrew Consent|0|||
170512278|NCT01826981|616221904|FG005|Overall Study|Withdrew Consent|0|||
170512279|NCT01826981|616221905|FG006|Overall Study|Withdrew Consent|1|||
170512280|NCT01826981|616221906|FG007|Overall Study|Withdrew Consent|1|||
170512281|NCT01826981|616221907|FG008|Overall Study|Withdrew Consent|0|||
170512282|NCT01826981|616221908|FG009|Overall Study|Withdrew Consent|0|||
170512283|NCT01826981|616221909|FG010|Overall Study|Withdrew Consent|0|||
170512284|NCT01826981|616221910|FG011|Overall Study|Withdrew Consent|1|||
170512285|NCT01826981|616221911|FG012|Overall Study|Withdrew Consent|0|||
170512286|NCT01826981|616221912|FG013|Overall Study|Withdrew Consent|1|||
170512287|NCT01826981|616221913|FG014|Overall Study|Withdrew Consent|0|||
170512288|NCT01826981|616221899|FG000|Overall Study|Adverse Event|0|||
170512289|NCT01826981|616221900|FG001|Overall Study|Adverse Event|0|||
170512290|NCT01826981|616221901|FG002|Overall Study|Adverse Event|0|||
170512291|NCT01826981|616221902|FG003|Overall Study|Adverse Event|0|||
170512292|NCT01826981|616221903|FG004|Overall Study|Adverse Event|1|||
170512293|NCT01826981|616221904|FG005|Overall Study|Adverse Event|0|||
170512294|NCT01826981|616221905|FG006|Overall Study|Adverse Event|0|||
170512295|NCT01826981|616221906|FG007|Overall Study|Adverse Event|0|||
170512296|NCT01826981|616221907|FG008|Overall Study|Adverse Event|0|||
170512297|NCT01826981|616221908|FG009|Overall Study|Adverse Event|0|||
170512298|NCT01826981|616221909|FG010|Overall Study|Adverse Event|0|||
170512299|NCT01826981|616221910|FG011|Overall Study|Adverse Event|0|||
170512300|NCT01826981|616221911|FG012|Overall Study|Adverse Event|0|||
170512301|NCT01826981|616221912|FG013|Overall Study|Adverse Event|0|||
170512302|NCT01826981|616221913|FG014|Overall Study|Adverse Event|0|||
170512303|NCT01826981|616221899|FG000|Overall Study|Upper G-I Haemorrhage|0|||
170644243|NCT04556383|616711603|FG001|PCP|Physician Decision|1|||
170512304|NCT01826981|616221900|FG001|Overall Study|Upper G-I Haemorrhage|0|||
170512305|NCT01826981|616221901|FG002|Overall Study|Upper G-I Haemorrhage|0|||
170512306|NCT01826981|616221902|FG003|Overall Study|Upper G-I Haemorrhage|0|||
170512307|NCT01826981|616221903|FG004|Overall Study|Upper G-I Haemorrhage|0|||
170512308|NCT01826981|616221904|FG005|Overall Study|Upper G-I Haemorrhage|0|||
170512309|NCT01826981|616221905|FG006|Overall Study|Upper G-I Haemorrhage|0|||
170512310|NCT01826981|616221906|FG007|Overall Study|Upper G-I Haemorrhage|0|||
170512311|NCT01826981|616221907|FG008|Overall Study|Upper G-I Haemorrhage|0|||
170512312|NCT01826981|616221908|FG009|Overall Study|Upper G-I Haemorrhage|0|||
170512313|NCT01826981|616221909|FG010|Overall Study|Upper G-I Haemorrhage|0|||
170512314|NCT01826981|616221910|FG011|Overall Study|Upper G-I Haemorrhage|0|||
170512315|NCT01826981|616221911|FG012|Overall Study|Upper G-I Haemorrhage|0|||
170512316|NCT01826981|616221912|FG013|Overall Study|Upper G-I Haemorrhage|1|||
170512317|NCT01826981|616221913|FG014|Overall Study|Upper G-I Haemorrhage|0|||
170512318|NCT01826981|616221899|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512319|NCT01826981|616221900|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512320|NCT01826981|616221901|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512321|NCT01826981|616221902|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512322|NCT01826981|616221903|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512323|NCT01826981|616221904|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512324|NCT01826981|616221905|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512325|NCT01826981|616221906|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
170512326|NCT01826981|616221907|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512327|NCT01826981|616221908|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512328|NCT01826981|616221909|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512329|NCT01826981|616221910|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512330|NCT01826981|616221911|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512331|NCT01826981|616221912|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512332|NCT01826981|616221913|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
170512333|NCT03479008|616221914|FG000|Overall Study|Withdrawal by Subject|3|||
170512334|NCT00412932|616221915|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
170512335|NCT00412932|616221915|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
170512336|NCT00412932|616221915|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
170512337|NCT00412932|616221915|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
170512338|NCT00412932|616221915|FG000|Olmesartan (Olm) 20 mg|Other|1|||
170512339|NCT00412932|616221915|FG000|Olmesartan 40 mg|Adverse Event|4|||
170512340|NCT00412932|616221915|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
170512341|NCT00412932|616221915|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
170512342|NCT00412932|616221915|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
170512343|NCT00412932|616221915|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
170512344|NCT00412932|616221915|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
170512345|NCT00412932|616221915|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
170512346|NCT00929994|616221916|FG000|Overall Study|Withdrawal by Subject|1|||
170512347|NCT00929994|616221916|FG000|Overall Study|medical issue unrelated to intervention|4|||
170512348|NCT00929994|616221916|FG000|Overall Study|employment|1|||
170512349|NCT02061813|616221917|FG000|Overall Study|Withdrawal by Subject|1|||
170512350|NCT02061813|616221917|FG000|Overall Study|Protocol Violation|2|||
170512351|NCT01705080|616221918|FG000|Overall Study|Missed visit|10|||
170512352|NCT01705080|616221919|FG001|Overall Study|Missed visit|4|||
170512353|NCT01705080|616221920|FG002|Overall Study|Missed visit|1|||
170512354|NCT01705080|616221918|FG000|Overall Study|Death|4|||
170512355|NCT01705080|616221919|FG001|Overall Study|Death|4|||
170512356|NCT01705080|616221920|FG002|Overall Study|Death|6|||
170512357|NCT01705080|616221918|FG000|Overall Study|Withdrawal by Subject|61|||
170512358|NCT01705080|616221919|FG001|Overall Study|Withdrawal by Subject|44|||
170512359|NCT01705080|616221920|FG002|Overall Study|Withdrawal by Subject|9|||
170512360|NCT01704755|616221921|FG000|Overall Study|Adverse Event|4|||
170512361|NCT01704755|616221922|FG001|Overall Study|Adverse Event|1|||
170512362|NCT01704755|616221921|FG000|Overall Study|Lost to Follow-up|3|||
170512363|NCT01704755|616221922|FG001|Overall Study|Lost to Follow-up|4|||
170512364|NCT01704755|616221921|FG000|Overall Study|Withdrew consent|1|||
170512365|NCT01704755|616221922|FG001|Overall Study|Withdrew consent|1|||
170512366|NCT01704755|616221921|FG000|Overall Study|Other (not specified)|3|||
170512367|NCT01704755|616221922|FG001|Overall Study|Other (not specified)|1|||
170512368|NCT01704755|616221921|FG000|Overall Study|Withdrew consent and personal issues|1|||
170512369|NCT01704755|616221922|FG001|Overall Study|Withdrew consent and personal issues|0|||
170512370|NCT02821416|616221923|FG000|Overall Study|Adverse Event|0|||
170512371|NCT02821416|616221924|FG001|Overall Study|Adverse Event|1|||
170512372|NCT02821416|616221923|FG000|Overall Study|Withdrawal by Subject|2|||
170512373|NCT02821416|616221924|FG001|Overall Study|Withdrawal by Subject|0|||
170512374|NCT02821416|616221923|FG000|Overall Study|Lost to Follow-up|1|||
170512375|NCT02821416|616221924|FG001|Overall Study|Lost to Follow-up|0|||
170512376|NCT01763203|616221927|FG000|Overall Study|Death|4|||
170512377|NCT01763203|616221928|FG001|Overall Study|Death|7|||
170512378|NCT01763203|616221927|FG000|Overall Study|Lost to Follow-up|12|||
170512379|NCT01763203|616221928|FG001|Overall Study|Lost to Follow-up|12|||
170512380|NCT01763203|616221927|FG000|Overall Study|Withdrawal by Subject|8|||
170512381|NCT01763203|616221928|FG001|Overall Study|Withdrawal by Subject|12|||
170512382|NCT01763203|616221927|FG000|Overall Study|Moved out of study region|7|||
170512383|NCT01763203|616221928|FG001|Overall Study|Moved out of study region|10|||
170512384|NCT01763203|616221927|FG000|Overall Study|Physician Decision|2|||
170512385|NCT01763203|616221928|FG001|Overall Study|Physician Decision|1|||
170512386|NCT02256917|616221929|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
170512387|NCT02256917|616221929|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
170512388|NCT02256917|616221929|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
170512389|NCT02256917|616221929|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
170512390|NCT02256917|616221929|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
170512391|NCT02756819|616221930|FG000|Overall Study|Lost for observation|23|||
170512392|NCT02756819|616221930|FG000|Overall Study|Patient's unwillingness|16|||
170512393|NCT02756819|616221930|FG000|Overall Study|Insufficient efficacy|2|||
170512394|NCT02756819|616221930|FG000|Overall Study|Adverse Event|2|||
170512395|NCT02756819|616221930|FG000|Overall Study|Reason not Specified|9|||
170512396|NCT01301079|616221931|FG000|Overall Study|Lost to Follow-up|2|||
170512397|NCT01301079|616221932|FG001|Overall Study|Lost to Follow-up|2|||
170512398|NCT00943592|616221935|FG000|Overall Study|Death|3|||
170512399|NCT01909973|616221936|FG000|Overall Study|Lost to Follow-up|1|||
170512400|NCT01909973|616221937|FG001|Overall Study|Lost to Follow-up|0|||
170512401|NCT01152996|616221938|FG000|Overall Study|Withdrawal by Subject|142|||
170512402|NCT01152996|616221938|FG000|Overall Study|Adverse Event|115|||
170512403|NCT01152996|616221938|FG000|Overall Study|Lost to Follow-up|112|||
170512404|NCT01152996|616221938|FG000|Overall Study|Lack of Efficacy|68|||
170512405|NCT01152996|616221938|FG000|Overall Study|Noncompliance|41|||
170512406|NCT01152996|616221938|FG000|Overall Study|Other|36|||
170512407|NCT01152996|616221938|FG000|Overall Study|Protocol Violation|22|||
170512408|NCT01152996|616221938|FG000|Overall Study|Elevated liver enzymes|1|||
170512409|NCT05259917|616221945|FG000|Overall Study|Protocol Violation|0|||
170512410|NCT05259917|616221946|FG001|Overall Study|Protocol Violation|0|||
170512411|NCT05259917|616221947|FG002|Overall Study|Protocol Violation|1|||
170512412|NCT05259917|616221948|FG003|Overall Study|Protocol Violation|0|||
170512413|NCT05259917|616221949|FG004|Overall Study|Protocol Violation|0|||
170512414|NCT05259917|616221950|FG005|Overall Study|Protocol Violation|0|||
170512415|NCT05259917|616221945|FG000|Overall Study|Lost to Follow-up|0|||
170512416|NCT05259917|616221946|FG001|Overall Study|Lost to Follow-up|0|||
170512417|NCT05259917|616221947|FG002|Overall Study|Lost to Follow-up|1|||
170512418|NCT05259917|616221948|FG003|Overall Study|Lost to Follow-up|0|||
170512419|NCT05259917|616221949|FG004|Overall Study|Lost to Follow-up|0|||
170512420|NCT05259917|616221950|FG005|Overall Study|Lost to Follow-up|1|||
170512421|NCT05259917|616221945|FG000|Overall Study|Physician Decision|0|||
170512422|NCT05259917|616221946|FG001|Overall Study|Physician Decision|1|||
170512423|NCT05259917|616221947|FG002|Overall Study|Physician Decision|0|||
170512424|NCT05259917|616221948|FG003|Overall Study|Physician Decision|0|||
170512425|NCT05259917|616221949|FG004|Overall Study|Physician Decision|0|||
170512426|NCT05259917|616221950|FG005|Overall Study|Physician Decision|0|||
170512427|NCT05259917|616221945|FG000|Overall Study|Withdrawal by Subject|0|||
170512428|NCT05259917|616221946|FG001|Overall Study|Withdrawal by Subject|1|||
170512429|NCT05259917|616221947|FG002|Overall Study|Withdrawal by Subject|0|||
170512430|NCT05259917|616221948|FG003|Overall Study|Withdrawal by Subject|0|||
170512431|NCT05259917|616221949|FG004|Overall Study|Withdrawal by Subject|1|||
170512432|NCT05259917|616221950|FG005|Overall Study|Withdrawal by Subject|1|||
170512433|NCT05259917|616221945|FG000|Overall Study|Trial Termination by Sponsor|7|||
170512434|NCT05259917|616221946|FG001|Overall Study|Trial Termination by Sponsor|2|||
170512435|NCT05259917|616221947|FG002|Overall Study|Trial Termination by Sponsor|3|||
170512436|NCT05259917|616221948|FG003|Overall Study|Trial Termination by Sponsor|5|||
170512437|NCT05259917|616221949|FG004|Overall Study|Trial Termination by Sponsor|11|||
170512438|NCT05259917|616221950|FG005|Overall Study|Trial Termination by Sponsor|4|||
170512439|NCT05259917|616221945|FG000|Overall Study|Other|1|||
170512440|NCT05259917|616221946|FG001|Overall Study|Other|0|||
170512441|NCT05259917|616221947|FG002|Overall Study|Other|2|||
170512442|NCT05259917|616221948|FG003|Overall Study|Other|0|||
170512443|NCT05259917|616221949|FG004|Overall Study|Other|0|||
170512444|NCT05259917|616221950|FG005|Overall Study|Other|0|||
170512445|NCT00303472|616221951|FG000|Treatment Period|Adverse Event|0|||
170512446|NCT00303472|616221952|FG001|Treatment Period|Adverse Event|0|||
170512447|NCT00303472|616221953|FG002|Treatment Period|Adverse Event|0|||
170512448|NCT00303472|616221954|FG003|Treatment Period|Adverse Event|0|||
170512449|NCT00303472|616221955|FG004|Treatment Period|Adverse Event|1|||
170512450|NCT00303472|616221956|FG005|Treatment Period|Adverse Event|0|||
170512451|NCT00303472|616221957|FG006|Treatment Period|Adverse Event|0|||
170512452|NCT00303472|616221951|FG000|Treatment Period|Death|0|||
170512453|NCT00303472|616221952|FG001|Treatment Period|Death|0|||
170512454|NCT00303472|616221953|FG002|Treatment Period|Death|0|||
170512455|NCT00303472|616221954|FG003|Treatment Period|Death|1|||
170512456|NCT00303472|616221955|FG004|Treatment Period|Death|0|||
170512457|NCT00303472|616221956|FG005|Treatment Period|Death|0|||
170512458|NCT00303472|616221957|FG006|Treatment Period|Death|1|||
170512459|NCT00303472|616221951|FG000|Treatment Period|Withdrawal by Subject|0|||
170512460|NCT00303472|616221952|FG001|Treatment Period|Withdrawal by Subject|0|||
170512461|NCT00303472|616221953|FG002|Treatment Period|Withdrawal by Subject|0|||
170512462|NCT00303472|616221954|FG003|Treatment Period|Withdrawal by Subject|1|||
170512463|NCT00303472|616221955|FG004|Treatment Period|Withdrawal by Subject|0|||
170512464|NCT00303472|616221956|FG005|Treatment Period|Withdrawal by Subject|1|||
170512465|NCT00303472|616221957|FG006|Treatment Period|Withdrawal by Subject|0|||
170512466|NCT00303472|616221951|FG000|Treatment Period|Other|0|||
170512467|NCT00303472|616221952|FG001|Treatment Period|Other|0|||
170512468|NCT00303472|616221953|FG002|Treatment Period|Other|0|||
170512469|NCT00303472|616221954|FG003|Treatment Period|Other|0|||
170512470|NCT00303472|616221955|FG004|Treatment Period|Other|1|||
170512471|NCT00303472|616221956|FG005|Treatment Period|Other|0|||
170512472|NCT00303472|616221957|FG006|Treatment Period|Other|1|||
170512473|NCT00303472|616221951|FG000|Treatment Period|Disease Progression (to AML)|0|||
170512474|NCT00303472|616221952|FG001|Treatment Period|Disease Progression (to AML)|0|||
170512475|NCT00303472|616221953|FG002|Treatment Period|Disease Progression (to AML)|0|||
170512476|NCT00303472|616221954|FG003|Treatment Period|Disease Progression (to AML)|0|||
170512477|NCT00303472|616221955|FG004|Treatment Period|Disease Progression (to AML)|1|||
170512478|NCT00303472|616221956|FG005|Treatment Period|Disease Progression (to AML)|0|||
170512479|NCT00303472|616221957|FG006|Treatment Period|Disease Progression (to AML)|0|||
170512480|NCT00303472|616221951|FG000|Treatment Extension (Optional)|Adverse Event|1|||
170512481|NCT00303472|616221952|FG001|Treatment Extension (Optional)|Adverse Event|0|||
170512482|NCT00303472|616221953|FG002|Treatment Extension (Optional)|Adverse Event|1|||
170512483|NCT00303472|616221954|FG003|Treatment Extension (Optional)|Adverse Event|0|||
170512484|NCT00303472|616221955|FG004|Treatment Extension (Optional)|Adverse Event|0|||
170512485|NCT00303472|616221956|FG005|Treatment Extension (Optional)|Adverse Event|0|||
170512486|NCT00303472|616221957|FG006|Treatment Extension (Optional)|Adverse Event|0|||
170512487|NCT00303472|616221951|FG000|Treatment Extension (Optional)|Death|2|||
170512488|NCT00303472|616221952|FG001|Treatment Extension (Optional)|Death|0|||
170512489|NCT00303472|616221953|FG002|Treatment Extension (Optional)|Death|1|||
170512490|NCT00303472|616221954|FG003|Treatment Extension (Optional)|Death|0|||
170512491|NCT00303472|616221955|FG004|Treatment Extension (Optional)|Death|0|||
170512492|NCT00303472|616221956|FG005|Treatment Extension (Optional)|Death|0|||
170512493|NCT00303472|616221957|FG006|Treatment Extension (Optional)|Death|0|||
170512494|NCT00303472|616221951|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
170512495|NCT00303472|616221952|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
170512496|NCT00303472|616221953|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
170512497|NCT00303472|616221954|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
170512498|NCT00303472|616221955|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
170512499|NCT00303472|616221956|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
170512500|NCT00303472|616221957|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
170512501|NCT00303472|616221951|FG000|Treatment Extension (Optional)|Physician Decision|0|||
170512502|NCT00303472|616221952|FG001|Treatment Extension (Optional)|Physician Decision|4|||
170512503|NCT00303472|616221953|FG002|Treatment Extension (Optional)|Physician Decision|2|||
170512504|NCT00303472|616221954|FG003|Treatment Extension (Optional)|Physician Decision|3|||
170512505|NCT00303472|616221955|FG004|Treatment Extension (Optional)|Physician Decision|2|||
170512506|NCT00303472|616221956|FG005|Treatment Extension (Optional)|Physician Decision|0|||
170554217|NCT05213624|616375609|FG001|Overall Study|Withdrawal by Subject|0|||
170554218|NCT05213624|616375610|FG002|Overall Study|Withdrawal by Subject|0|||
170554219|NCT05213624|616375611|FG003|Overall Study|Withdrawal by Subject|1|||
170554220|NCT05213624|616375608|FG000|Overall Study|Not treated|0|||
170554221|NCT05213624|616375609|FG001|Overall Study|Not treated|1|||
170512507|NCT00303472|616221957|FG006|Treatment Extension (Optional)|Physician Decision|0|||
170512508|NCT00303472|616221951|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
170512509|NCT00303472|616221952|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
170512510|NCT00303472|616221953|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
170512511|NCT00303472|616221954|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
170512512|NCT00303472|616221955|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
170512513|NCT00303472|616221956|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
170512514|NCT00303472|616221957|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
170512515|NCT00303472|616221951|FG000|Treatment Extension (Optional)|Other|0|||
170512516|NCT00303472|616221952|FG001|Treatment Extension (Optional)|Other|2|||
170512517|NCT00303472|616221953|FG002|Treatment Extension (Optional)|Other|4|||
170512518|NCT00303472|616221954|FG003|Treatment Extension (Optional)|Other|2|||
170512519|NCT00303472|616221955|FG004|Treatment Extension (Optional)|Other|1|||
170512520|NCT00303472|616221956|FG005|Treatment Extension (Optional)|Other|0|||
170512521|NCT00303472|616221957|FG006|Treatment Extension (Optional)|Other|0|||
170512522|NCT00303472|616221951|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
170512523|NCT00303472|616221952|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
170512524|NCT00303472|616221953|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
170554222|NCT05213624|616375610|FG002|Overall Study|Not treated|2|||
170512525|NCT00303472|616221954|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
170512526|NCT00303472|616221955|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
170512527|NCT00303472|616221956|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
170512528|NCT00303472|616221957|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
170512529|NCT03517449|616221961|FG000|Overall Study|Death|184|||
170512530|NCT03517449|616221962|FG001|Overall Study|Death|236|||
170512531|NCT03517449|616221961|FG000|Overall Study|Lost to Follow-up|0|||
170512532|NCT03517449|616221962|FG001|Overall Study|Lost to Follow-up|2|||
170512533|NCT03517449|616221961|FG000|Overall Study|Withdrawal by Subject|7|||
170512534|NCT03517449|616221962|FG001|Overall Study|Withdrawal by Subject|26|||
170512535|NCT03517449|616221961|FG000|Overall Study|Participants Ongoing|220|||
170512536|NCT03517449|616221962|FG001|Overall Study|Participants Ongoing|152|||
170512537|NCT01808222|616221965|FG000|Overall Study|mpMR scan was not performed|1|||
170512538|NCT00575510|616221966|FG000|Overall Study|Lost to Follow-up|4|||
170512539|NCT00575510|616221967|FG001|Overall Study|Lost to Follow-up|6|||
170512540|NCT00575510|616221968|FG002|Overall Study|Lost to Follow-up|9|||
170512541|NCT00575510|616221966|FG000|Overall Study|Withdrawal by Subject|1|||
170512542|NCT00575510|616221967|FG001|Overall Study|Withdrawal by Subject|0|||
170512543|NCT00575510|616221968|FG002|Overall Study|Withdrawal by Subject|0|||
170512544|NCT00575510|616221966|FG000|Overall Study|Clinic Called Patient|7|||
170512545|NCT00575510|616221967|FG001|Overall Study|Clinic Called Patient|7|||
170512546|NCT00575510|616221968|FG002|Overall Study|Clinic Called Patient|7|||
170512547|NCT00575510|616221966|FG000|Overall Study|Pregnancy|0|||
170512548|NCT00575510|616221967|FG001|Overall Study|Pregnancy|0|||
170512549|NCT00575510|616221968|FG002|Overall Study|Pregnancy|1|||
170512550|NCT01428115|616221969|FG000|Overall Study|Lack of Efficacy|3|||
170512551|NCT01428115|616221969|FG000|Overall Study|Lost to Follow-up|10|||
170512552|NCT01428115|616221969|FG000|Overall Study|Pregnancy|1|||
170512553|NCT01428115|616221969|FG000|Overall Study|Protocol Violation|3|||
170512554|NCT01428115|616221969|FG000|Overall Study|Withdrawal by Subject|4|||
170512555|NCT03172364|616221970|FG000|Overall Study|Adverse Event|1|||
170512556|NCT03172364|616221971|FG001|Overall Study|Adverse Event|1|||
170512557|NCT03172364|616221970|FG000|Overall Study|Protocol Violation|1|||
170512558|NCT03172364|616221971|FG001|Overall Study|Protocol Violation|0|||
170512559|NCT03755518|616221972|FG000|Overall Study|Lack of Efficacy|10|||
170554223|NCT05213624|616375611|FG003|Overall Study|Not treated|2|||
170554224|NCT01602380|616375623|FG000|Overall Study|Death|147|||
170554225|NCT01602380|616375624|FG001|Overall Study|Death|145|||
170554226|NCT01602380|616375623|FG000|Overall Study|Withdrawal by Subject|39|||
170554227|NCT01602380|616375624|FG001|Overall Study|Withdrawal by Subject|41|||
170512560|NCT03755518|616221972|FG000|Overall Study|Adverse Event|7|||
170512561|NCT03755518|616221972|FG000|Overall Study|Study Terminated by Sponsor|5|||
170512562|NCT03755518|616221972|FG000|Overall Study|Death|1|||
170512563|NCT03755518|616221972|FG000|Overall Study|Withdrawal by Subject|3|||
170512564|NCT03755518|616221972|FG000|Overall Study|Progressive Disease|4|||
170512565|NCT03755518|616221972|FG000|Overall Study|Bone Marrow Transplant|4|||
170512566|NCT03755518|616221972|FG000|Overall Study|Physicians Decision|1|||
170512567|NCT03755518|616221972|FG000|Overall Study|Relapse|1|||
170512568|NCT03755518|616221972|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
170512569|NCT03755518|616221972|FG000|Overall Study|Withdrawal by PI|1|||
170512570|NCT01714609|616221973|FG000|Overall Study|Protocol Violation|1|||
170554228|NCT01602380|616375623|FG000|Overall Study|Lost to Follow-up|15|||
170512571|NCT01714609|616221974|FG001|Overall Study|Protocol Violation|0|||
170512572|NCT00630747|616221975|FG000|Overall Study|Death|1|||
170554229|NCT01602380|616375624|FG001|Overall Study|Lost to Follow-up|12|||
170806172|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
170806173|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
170806174|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
170806175|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
170806176|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
170806177|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
170806178|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
170806179|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
170806180|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806181|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
170806182|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806183|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806184|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806185|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806186|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806187|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806188|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806189|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
170806190|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
170806191|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
170806192|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
170806193|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
170806194|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
170806195|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
170806196|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
170806197|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
170806198|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
170806199|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
170806200|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
170806201|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
170806202|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
170806203|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
170806204|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
170806205|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
170806206|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
170806207|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
170806208|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
170806209|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
170806210|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
170806211|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
170806212|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
170806213|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
170806214|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
170806215|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
170806216|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
170806217|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
170806218|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
170806219|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
170806220|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
170806221|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
170806222|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
170806223|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
170806224|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
170806225|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806226|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
170806227|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
170806228|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170905141|NCT00892437|617656020|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
170905142|NCT00892437|617656021|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
170905143|NCT00892437|617656020|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
170905144|NCT00892437|617656021|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
170905145|NCT00892437|617656020|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
170806229|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806230|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806231|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806232|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806233|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
170806234|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
170806235|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
170512573|NCT00630747|616221975|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
170512574|NCT00630747|616221975|FG000|Overall Study|Returned to country of origin|1|||
170512575|NCT02732327|616221978|FG000|Overall Study|Protocol Violation|0|||
170512576|NCT02732327|616221979|FG001|Overall Study|Protocol Violation|1|||
170512577|NCT03403621|616221980|FG000|Overall Study|Withdrawal by Subject|2|||
170512578|NCT03403621|616221981|FG001|Overall Study|Withdrawal by Subject|2|||
170512579|NCT01078298|616221983|FG000|Overall Study|Lost to Follow-up|12|||
170512580|NCT01078298|616221984|FG001|Overall Study|Lost to Follow-up|13|||
170512581|NCT01078298|616221983|FG000|Overall Study|Withdrawal by Subject|31|||
170512582|NCT01078298|616221984|FG001|Overall Study|Withdrawal by Subject|33|||
170512583|NCT01078298|616221983|FG000|Overall Study|Protocol Violation|6|||
170512584|NCT01078298|616221984|FG001|Overall Study|Protocol Violation|6|||
170512585|NCT01078298|616221983|FG000|Overall Study|Adverse Event|6|||
170512586|NCT01078298|616221984|FG001|Overall Study|Adverse Event|5|||
170512587|NCT01078298|616221983|FG000|Overall Study|Death|2|||
170512588|NCT01078298|616221984|FG001|Overall Study|Death|0|||
170512589|NCT01078298|616221983|FG000|Overall Study|Did not meet entrance criteria|0|||
170512590|NCT01078298|616221984|FG001|Overall Study|Did not meet entrance criteria|1|||
170512591|NCT01078298|616221983|FG000|Overall Study|Other|24|||
170512592|NCT01078298|616221984|FG001|Overall Study|Other|32|||
170512593|NCT00628927|616221988|FG000|Overall Study|Problems performing blood draw|6|||
170512594|NCT00628927|616221989|FG001|Overall Study|Problems performing blood draw|0|||
170512595|NCT00628927|616221988|FG000|Overall Study|Lost to Follow-up|1|||
170512596|NCT00628927|616221989|FG001|Overall Study|Lost to Follow-up|0|||
170512597|NCT00628927|616221988|FG000|Overall Study|Equipment failure|1|||
170512598|NCT00628927|616221989|FG001|Overall Study|Equipment failure|0|||
170512599|NCT01738191|616221990|FG000|Overall Study|Withdrawal by Subject|4|||
170512600|NCT01738191|616221991|FG001|Overall Study|Withdrawal by Subject|1|||
170512601|NCT04811664|616221992|FG000|Overall Study|Lost to Follow-up|78|||
170512602|NCT04811664|616221993|FG001|Overall Study|Lost to Follow-up|125|||
170512603|NCT04811664|616221994|FG002|Overall Study|Lost to Follow-up|46|||
170512604|NCT04811664|616221992|FG000|Overall Study|Withdrawal by Subject|39|||
170512605|NCT04811664|616221993|FG001|Overall Study|Withdrawal by Subject|76|||
170512606|NCT04811664|616221994|FG002|Overall Study|Withdrawal by Subject|12|||
170512607|NCT04811664|616221992|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
170512608|NCT04811664|616221993|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
170512609|NCT04811664|616221994|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
170512610|NCT04811664|616221992|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
170512611|NCT04811664|616221993|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
170512612|NCT04811664|616221994|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
170512613|NCT04811664|616221992|FG000|Overall Study|Protocol Violation|0|||
170512614|NCT04811664|616221993|FG001|Overall Study|Protocol Violation|5|||
170512615|NCT04811664|616221994|FG002|Overall Study|Protocol Violation|11|||
170512616|NCT04811664|616221992|FG000|Overall Study|Study Terminated by Sponsor|4|||
170512617|NCT04811664|616221993|FG001|Overall Study|Study Terminated by Sponsor|3|||
170512618|NCT04811664|616221994|FG002|Overall Study|Study Terminated by Sponsor|34|||
170512619|NCT04811664|616221992|FG000|Overall Study|Early Study Closure|3|||
170512620|NCT04811664|616221993|FG001|Overall Study|Early Study Closure|7|||
170512621|NCT04811664|616221994|FG002|Overall Study|Early Study Closure|79|||
170512622|NCT04811664|616221992|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
170512623|NCT04811664|616221993|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
170512624|NCT04811664|616221994|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
170512625|NCT02717442|616221995|FG000|Overall Study|Study Terminated by Sponsor|31|||
170512626|NCT02717442|616221996|FG001|Overall Study|Study Terminated by Sponsor|29|||
170512627|NCT02717442|616221995|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
170512628|NCT02717442|616221996|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
170512629|NCT02717442|616221995|FG000|Overall Study|Other - Not Specified|2|||
170512630|NCT02717442|616221996|FG001|Overall Study|Other - Not Specified|0|||
170512631|NCT02774005|616221997|FG000|Overall Study|Adverse Event|8|||
170512632|NCT02774005|616221997|FG000|Overall Study|Withdrawal by Subject|23|||
170512633|NCT02774005|616221997|FG000|Overall Study|Lost to Follow-up|7|||
170512634|NCT02774005|616221997|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
170512635|NCT02774005|616221997|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
170806236|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
170512636|NCT02774005|616221997|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
170512637|NCT02774005|616221997|FG000|Overall Study|Death|1|||
170512638|NCT02774005|616221997|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
170512639|NCT02774005|616221997|FG000|Overall Study|Lack of compliance with study medication|4|||
170512640|NCT02774005|616221997|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
170512641|NCT02774005|616221997|FG000|Overall Study|another study|1|||
170512642|NCT02774005|616221997|FG000|Overall Study|cardiologist imposed travel restriction|1|||
170512643|NCT00723697|616221998|FG000|Overall Study|Physician questionnaires not received|2|||
170512644|NCT00723697|616221998|FG000|Overall Study|Missing Informed Consent Form|10|||
170512645|NCT00723697|616221998|FG000|Overall Study|Other exclusion criteria applied|6|||
170512646|NCT01790516|616222000|FG000|Overall Study|Physician Decision|1|||
170512647|NCT01790516|616222001|FG001|Overall Study|Physician Decision|0|||
170512648|NCT01402986|616222002|FG000|Overall Study|Withdrawal by Subject|7|||
170512649|NCT01402986|616222003|FG001|Overall Study|Withdrawal by Subject|10|||
170512650|NCT01402986|616222004|FG002|Overall Study|Withdrawal by Subject|7|||
170512651|NCT01402986|616222005|FG003|Overall Study|Withdrawal by Subject|13|||
170512652|NCT01402986|616222002|FG000|Overall Study|Death|0|||
170512653|NCT01402986|616222003|FG001|Overall Study|Death|0|||
170512654|NCT01402986|616222004|FG002|Overall Study|Death|0|||
170512655|NCT01402986|616222005|FG003|Overall Study|Death|2|||
170512656|NCT01402986|616222002|FG000|Overall Study|Lost to Follow-up|0|||
170512657|NCT01402986|616222003|FG001|Overall Study|Lost to Follow-up|0|||
170512658|NCT01402986|616222004|FG002|Overall Study|Lost to Follow-up|0|||
170512659|NCT01402986|616222005|FG003|Overall Study|Lost to Follow-up|1|||
170512660|NCT01402986|616222002|FG000|Overall Study|Other|2|||
170512661|NCT01402986|616222003|FG001|Overall Study|Other|5|||
170512662|NCT01402986|616222004|FG002|Overall Study|Other|1|||
170512663|NCT01402986|616222005|FG003|Overall Study|Other|6|||
170512664|NCT02070978|616222006|FG000|Overall Study|Adverse Event|6|||
170512665|NCT02070978|616222007|FG001|Overall Study|Adverse Event|2|||
170512666|NCT02070978|616222008|FG002|Overall Study|Adverse Event|0|||
170512667|NCT02070978|616222006|FG000|Overall Study|Lost to Follow-up|1|||
170512668|NCT02070978|616222007|FG001|Overall Study|Lost to Follow-up|3|||
170512669|NCT02070978|616222008|FG002|Overall Study|Lost to Follow-up|4|||
170512670|NCT02070978|616222006|FG000|Overall Study|Withdrawal by Subject|3|||
170512671|NCT02070978|616222007|FG001|Overall Study|Withdrawal by Subject|5|||
170512672|NCT02070978|616222008|FG002|Overall Study|Withdrawal by Subject|3|||
170512673|NCT02070978|616222006|FG000|Overall Study|Protocol Violation|1|||
170512674|NCT02070978|616222007|FG001|Overall Study|Protocol Violation|0|||
170512675|NCT02070978|616222008|FG002|Overall Study|Protocol Violation|3|||
170512676|NCT02070978|616222006|FG000|Overall Study|Lack of Efficacy|0|||
170512677|NCT02070978|616222007|FG001|Overall Study|Lack of Efficacy|1|||
170512678|NCT02070978|616222008|FG002|Overall Study|Lack of Efficacy|0|||
170512679|NCT02070978|616222006|FG000|Overall Study|Death|0|||
170512680|NCT02070978|616222007|FG001|Overall Study|Death|0|||
170512681|NCT02070978|616222008|FG002|Overall Study|Death|2|||
170512682|NCT02070978|616222006|FG000|Overall Study|Un-specified|3|||
170512683|NCT02070978|616222007|FG001|Overall Study|Un-specified|2|||
170512684|NCT02070978|616222008|FG002|Overall Study|Un-specified|2|||
170512685|NCT02070978|616222006|FG000|Overall Study|Terminated by Sponsor|33|||
170512686|NCT02070978|616222007|FG001|Overall Study|Terminated by Sponsor|40|||
170512687|NCT02070978|616222008|FG002|Overall Study|Terminated by Sponsor|39|||
170512688|NCT03749109|616222009|FG000|Overall Study|Adverse Event|2|||
170512689|NCT03749109|616222010|FG001|Overall Study|Adverse Event|0|||
170512690|NCT03951753|616222011|FG000|Overall Study|Adverse Event|1|||
170512691|NCT03951753|616222012|FG001|Overall Study|Adverse Event|0|||
170512692|NCT03951753|616222013|FG002|Overall Study|Adverse Event|3|||
170512693|NCT03951753|616222011|FG000|Overall Study|Withdrawal by Subject|3|||
170512694|NCT03951753|616222012|FG001|Overall Study|Withdrawal by Subject|1|||
170512695|NCT03951753|616222013|FG002|Overall Study|Withdrawal by Subject|0|||
170512696|NCT03951753|616222011|FG000|Overall Study|Lost to Follow-up|0|||
170512697|NCT03951753|616222012|FG001|Overall Study|Lost to Follow-up|0|||
170512698|NCT03951753|616222013|FG002|Overall Study|Lost to Follow-up|1|||
170512699|NCT03178851|616222014|FG000|Overall Study|Death|48|||
170512700|NCT03178851|616222015|FG001|Overall Study|Death|2|||
170512701|NCT03178851|616222016|FG002|Overall Study|Death|25|||
170512702|NCT03178851|616222014|FG000|Overall Study|Withdrawal by Subject|8|||
170512703|NCT03178851|616222015|FG001|Overall Study|Withdrawal by Subject|0|||
170512704|NCT03178851|616222016|FG002|Overall Study|Withdrawal by Subject|0|||
170512705|NCT03178851|616222014|FG000|Overall Study|Lost to Follow-up|5|||
170512706|NCT03178851|616222015|FG001|Overall Study|Lost to Follow-up|2|||
170512707|NCT03178851|616222016|FG002|Overall Study|Lost to Follow-up|0|||
170512708|NCT03178851|616222014|FG000|Overall Study|Adverse Event|0|||
170512709|NCT03178851|616222015|FG001|Overall Study|Adverse Event|0|||
170512710|NCT03178851|616222016|FG002|Overall Study|Adverse Event|1|||
170512711|NCT03178851|616222014|FG000|Overall Study|Study Termination by Sponsor|31|||
170512712|NCT03178851|616222015|FG001|Overall Study|Study Termination by Sponsor|7|||
170512713|NCT03178851|616222016|FG002|Overall Study|Study Termination by Sponsor|26|||
170905146|NCT00892437|617656021|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
170512714|NCT01905592|616222019|FG000|Overall Study|Disease Progression|51|||
170512715|NCT01905592|616222020|FG001|Overall Study|Disease Progression|110|||
170512716|NCT01905592|616222019|FG000|Overall Study|Toxicity|1|||
170512717|NCT01905592|616222020|FG001|Overall Study|Toxicity|16|||
170512718|NCT01905592|616222019|FG000|Overall Study|Physician Decision|0|||
170512719|NCT01905592|616222020|FG001|Overall Study|Physician Decision|2|||
170512720|NCT01905592|616222019|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
170512721|NCT01905592|616222020|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
170512722|NCT01905592|616222019|FG000|Overall Study|Protocol Violation|0|||
170512723|NCT01905592|616222020|FG001|Overall Study|Protocol Violation|1|||
170512724|NCT01905592|616222019|FG000|Overall Study|Sponsor's decision|1|||
170512725|NCT01905592|616222020|FG001|Overall Study|Sponsor's decision|1|||
170512726|NCT01905592|616222019|FG000|Overall Study|Not treated|7|||
170512727|NCT01905592|616222020|FG001|Overall Study|Not treated|3|||
170512728|NCT01905592|616222019|FG000|Overall Study|Withdrawal by Subject|10|||
170512729|NCT01905592|616222020|FG001|Overall Study|Withdrawal by Subject|2|||
170512730|NCT02669043|616222025|FG000|Overall Study|Didn't meet I/E criteria|4|||
170512731|NCT01483599|616222026|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
170512732|NCT01483599|616222027|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512733|NCT01483599|616222028|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512734|NCT01483599|616222029|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
170512735|NCT01483599|616222030|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
170512736|NCT01483599|616222031|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
170512737|NCT01483599|616222032|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
170512738|NCT01483599|616222033|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512739|NCT01483599|616222034|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512740|NCT01483599|616222035|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512741|NCT01483599|616222036|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512742|NCT01483599|616222037|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512743|NCT01483599|616222038|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512744|NCT01483599|616222039|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
170512745|NCT01483599|616222026|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512746|NCT01483599|616222027|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
170512747|NCT01483599|616222028|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512748|NCT01483599|616222029|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
170512749|NCT01483599|616222030|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512750|NCT01483599|616222031|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512751|NCT01483599|616222032|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
170512752|NCT01483599|616222033|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512753|NCT01483599|616222034|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512754|NCT01483599|616222035|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512755|NCT01483599|616222036|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512756|NCT01483599|616222037|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512757|NCT01483599|616222038|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512758|NCT01483599|616222039|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
170512759|NCT01483599|616222026|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
170512760|NCT01483599|616222027|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512761|NCT01483599|616222028|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512762|NCT01483599|616222029|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512763|NCT01483599|616222030|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512764|NCT01483599|616222031|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512765|NCT01483599|616222032|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512766|NCT01483599|616222033|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512767|NCT01483599|616222034|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512768|NCT01483599|616222035|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512769|NCT01483599|616222036|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170554230|NCT01602380|616375623|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
170554231|NCT01602380|616375624|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
170905147|NCT03068715|617656024|FG000|Overall Study|No longer met inclusion criteria|1|||
170554232|NCT01602380|616375623|FG000|Overall Study|Other|2|||
170554233|NCT01602380|616375624|FG001|Overall Study|Other|0|||
170554234|NCT01390584|616375630|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
170644244|NCT04556383|616711604|FG002|PCP|Physician Decision|0|||
170512770|NCT01483599|616222037|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512771|NCT01483599|616222038|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512772|NCT01483599|616222039|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
170512773|NCT01483599|616222026|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
170512774|NCT01483599|616222027|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
170512775|NCT01483599|616222028|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
170806237|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
170806238|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
170512776|NCT01483599|616222029|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
170512777|NCT01483599|616222030|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
170512778|NCT01483599|616222031|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
170512779|NCT01483599|616222032|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
170512780|NCT01483599|616222033|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
170512781|NCT01483599|616222034|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
170512782|NCT01483599|616222035|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
170512783|NCT01483599|616222036|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
170512784|NCT01483599|616222037|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
170512785|NCT01483599|616222038|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
170512786|NCT01483599|616222039|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
170512787|NCT01483599|616222026|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
170512788|NCT01483599|616222027|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
170512789|NCT01483599|616222028|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
170512790|NCT01483599|616222029|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
170512791|NCT01483599|616222030|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
170512792|NCT01483599|616222031|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
170512793|NCT01483599|616222032|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
170512794|NCT01483599|616222033|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
170512795|NCT01483599|616222034|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
170512796|NCT01483599|616222035|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
170512797|NCT01483599|616222036|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
170512798|NCT01483599|616222037|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
170512799|NCT01483599|616222038|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
170512800|NCT01483599|616222039|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
170512801|NCT01483599|616222026|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512802|NCT01483599|616222027|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512803|NCT01483599|616222028|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512804|NCT01483599|616222029|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512805|NCT01483599|616222030|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512806|NCT01483599|616222031|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512807|NCT01483599|616222032|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512808|NCT01483599|616222033|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
170512809|NCT01483599|616222034|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
170512810|NCT01483599|616222035|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512811|NCT01483599|616222036|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512812|NCT01483599|616222037|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
170512813|NCT01483599|616222038|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
170512814|NCT01483599|616222039|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
170512815|NCT01483599|616222026|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512816|NCT01483599|616222027|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512817|NCT01483599|616222028|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512818|NCT01483599|616222029|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512819|NCT01483599|616222030|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512820|NCT01483599|616222031|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512821|NCT01483599|616222032|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512822|NCT01483599|616222033|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512823|NCT01483599|616222034|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
170512824|NCT01483599|616222035|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512825|NCT01483599|616222036|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512826|NCT01483599|616222037|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
170512827|NCT01483599|616222038|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
170512828|NCT01483599|616222039|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
170512829|NCT01483599|616222026|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512830|NCT01483599|616222027|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512831|NCT01483599|616222028|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512832|NCT01483599|616222029|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512833|NCT01483599|616222030|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512834|NCT01483599|616222031|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170644245|NCT04556383|616711605|FG003|PCP|Physician Decision|0|||
170806239|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
170806240|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
170806241|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
170554235|NCT01390584|616375631|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
170554236|NCT01390584|616375632|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
170554237|NCT00787800|616375633|FG000|Overall Study|Withdrawal by Subject|3|||
170554238|NCT00787800|616375634|FG001|Overall Study|Withdrawal by Subject|5|||
170554239|NCT00787800|616375633|FG000|Overall Study|Death|0|||
170554240|NCT00787800|616375634|FG001|Overall Study|Death|2|||
170554241|NCT00461812|616375636|FG000|Overall Study|study terminated|10|||
170554242|NCT00954538|616375641|FG000|Part III|Withdrawal by Subject|0|||
170554243|NCT00954538|616375642|FG001|Part III|Withdrawal by Subject|0|||
170554244|NCT00954538|616375643|FG002|Part III|Withdrawal by Subject|0|||
170554245|NCT00954538|616375644|FG003|Part III|Withdrawal by Subject|0|||
170554246|NCT00954538|616375645|FG004|Part III|Withdrawal by Subject|1|||
170554247|NCT00954538|616375646|FG005|Part III|Withdrawal by Subject|0|||
170554248|NCT00974233|616375647|FG000|Induction Chemoimmunotherapy|Death|2|||
170554249|NCT00974233|616375647|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
170554250|NCT00974233|616375647|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
170554251|NCT00974233|616375647|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
170554252|NCT00974233|616375647|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
170554253|NCT00974233|616375647|FG000|Maintenance Lenalidomide|Adverse Event|8|||
170554254|NCT04153149|616375648|FG000|Double Blind Period|Death|63|||
170554255|NCT04153149|616375649|FG001|Double Blind Period|Death|49|||
170644246|NCT04556383|616711602|FG000|PCP|Site terminated by sponsor|0|||
170644247|NCT04556383|616711603|FG001|PCP|Site terminated by sponsor|1|||
170644248|NCT04556383|616711604|FG002|PCP|Site terminated by sponsor|0|||
170644249|NCT04556383|616711605|FG003|PCP|Site terminated by sponsor|0|||
170644250|NCT04556383|616711602|FG000|OLE|Study terminated by sponsor|0|||
170644251|NCT04556383|616711603|FG001|OLE|Study terminated by sponsor|0|||
170644252|NCT04556383|616711604|FG002|OLE|Study terminated by sponsor|0|||
170644253|NCT04556383|616711605|FG003|OLE|Study terminated by sponsor|68|||
170644254|NCT04556383|616711602|FG000|OLE|Withdrawal by Subject|0|||
170644255|NCT04556383|616711603|FG001|OLE|Withdrawal by Subject|0|||
170644256|NCT04556383|616711604|FG002|OLE|Withdrawal by Subject|0|||
170644257|NCT04556383|616711605|FG003|OLE|Withdrawal by Subject|10|||
170644258|NCT04556383|616711602|FG000|OLE|Lack of Efficacy|0|||
170644259|NCT04556383|616711603|FG001|OLE|Lack of Efficacy|0|||
170644260|NCT04556383|616711604|FG002|OLE|Lack of Efficacy|0|||
170644261|NCT04556383|616711605|FG003|OLE|Lack of Efficacy|7|||
170644262|NCT04556383|616711602|FG000|OLE|Adverse Event|0|||
170644263|NCT04556383|616711603|FG001|OLE|Adverse Event|0|||
170644264|NCT04556383|616711604|FG002|OLE|Adverse Event|0|||
170644265|NCT04556383|616711605|FG003|OLE|Adverse Event|2|||
170644266|NCT04556383|616711602|FG000|OLE|Other, Not Specified|0|||
170644267|NCT04556383|616711603|FG001|OLE|Other, Not Specified|0|||
170644268|NCT04556383|616711604|FG002|OLE|Other, Not Specified|0|||
170644269|NCT04556383|616711605|FG003|OLE|Other, Not Specified|2|||
170644270|NCT04556383|616711602|FG000|OLE|Death|0|||
170644271|NCT04556383|616711603|FG001|OLE|Death|0|||
170644272|NCT04556383|616711604|FG002|OLE|Death|0|||
170644273|NCT04556383|616711605|FG003|OLE|Death|1|||
170644274|NCT04556383|616711602|FG000|OLE|Lost to Follow-up|0|||
170644275|NCT04556383|616711603|FG001|OLE|Lost to Follow-up|0|||
170644276|NCT04556383|616711604|FG002|OLE|Lost to Follow-up|0|||
170644277|NCT04556383|616711605|FG003|OLE|Lost to Follow-up|1|||
170644278|NCT00539188|616711606|FG000|Overall Study|Withdrawal by Subject|1|||
170554256|NCT04153149|616375650|FG002|Double Blind Period|Death|0|||
170554257|NCT04153149|616375651|FG003|Double Blind Period|Death|0|||
170554258|NCT04153149|616375648|FG000|Double Blind Period|Withdrawal by Subject|16|||
170554259|NCT04153149|616375649|FG001|Double Blind Period|Withdrawal by Subject|11|||
170554260|NCT04153149|616375650|FG002|Double Blind Period|Withdrawal by Subject|0|||
170554261|NCT04153149|616375651|FG003|Double Blind Period|Withdrawal by Subject|0|||
170554262|NCT04153149|616375648|FG000|Double Blind Period|Adverse Event|6|||
170554263|NCT04153149|616375649|FG001|Double Blind Period|Adverse Event|2|||
170554264|NCT04153149|616375650|FG002|Double Blind Period|Adverse Event|0|||
170554265|NCT04153149|616375651|FG003|Double Blind Period|Adverse Event|0|||
170554266|NCT04153149|616375648|FG000|Double Blind Period|Lost to Follow-up|2|||
170554267|NCT04153149|616375649|FG001|Double Blind Period|Lost to Follow-up|1|||
170554268|NCT04153149|616375650|FG002|Double Blind Period|Lost to Follow-up|0|||
170554269|NCT04153149|616375651|FG003|Double Blind Period|Lost to Follow-up|0|||
170644279|NCT00539188|616711607|FG001|Overall Study|Withdrawal by Subject|0|||
170644280|NCT00539188|616711606|FG000|Overall Study|Lost to Follow-up|2|||
170644281|NCT00539188|616711607|FG001|Overall Study|Lost to Follow-up|1|||
170644282|NCT03567343|616711608|FG000|Overall Study|Lost to Follow-up|2|||
170644283|NCT03567343|616711609|FG001|Overall Study|Lost to Follow-up|1|||
170554270|NCT04153149|616375648|FG000|Double Blind Period|Withdrawal by guardian|0|||
170554271|NCT04153149|616375649|FG001|Double Blind Period|Withdrawal by guardian|2|||
170644284|NCT03567343|616711608|FG000|Overall Study|No longer eligible|2|||
170644285|NCT03567343|616711609|FG001|Overall Study|No longer eligible|1|||
170644286|NCT03567343|616711608|FG000|Overall Study|Adverse Event|1|||
170644287|NCT03567343|616711609|FG001|Overall Study|Adverse Event|0|||
170644288|NCT03567343|616711608|FG000|Overall Study|Protocol Violation|1|||
170644289|NCT03567343|616711609|FG001|Overall Study|Protocol Violation|1|||
170644290|NCT01994889|616711610|FG000|Overall Study|Adverse Event|5|||
170512835|NCT01483599|616222032|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512836|NCT01483599|616222033|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512837|NCT01483599|616222034|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
170806242|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
170806243|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
170806244|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
170806245|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
170806246|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
170806247|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
170806248|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
170806249|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
170806250|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
170512838|NCT01483599|616222035|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512839|NCT01483599|616222036|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
170512840|NCT01483599|616222037|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512841|NCT01483599|616222038|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
170512842|NCT01483599|616222039|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
170512843|NCT01483599|616222026|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512844|NCT01483599|616222027|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512845|NCT01483599|616222028|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512846|NCT01483599|616222029|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512847|NCT01483599|616222030|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512848|NCT01483599|616222031|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512849|NCT01483599|616222032|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512850|NCT01483599|616222033|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512851|NCT01483599|616222034|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
170512852|NCT01483599|616222035|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512853|NCT01483599|616222036|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512854|NCT01483599|616222037|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
170512855|NCT01483599|616222038|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
170512856|NCT01483599|616222039|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
170512857|NCT01483599|616222026|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
170512858|NCT01483599|616222027|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
170512859|NCT01483599|616222028|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
170512860|NCT01483599|616222029|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
170512861|NCT01483599|616222030|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
170512862|NCT01483599|616222031|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
170512863|NCT01483599|616222032|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
170554272|NCT04153149|616375650|FG002|Double Blind Period|Withdrawal by guardian|0|||
170554273|NCT04153149|616375651|FG003|Double Blind Period|Withdrawal by guardian|0|||
170554274|NCT04153149|616375648|FG000|Double Blind Period|Reason Not Specified|5|||
170554275|NCT04153149|616375649|FG001|Double Blind Period|Reason Not Specified|4|||
170554276|NCT04153149|616375650|FG002|Double Blind Period|Reason Not Specified|0|||
170554277|NCT04153149|616375651|FG003|Double Blind Period|Reason Not Specified|0|||
170554278|NCT04153149|616375648|FG000|Double Blind Period|Physician Decision|2|||
170554279|NCT04153149|616375649|FG001|Double Blind Period|Physician Decision|0|||
170554280|NCT04153149|616375650|FG002|Double Blind Period|Physician Decision|0|||
170554281|NCT04153149|616375651|FG003|Double Blind Period|Physician Decision|0|||
170554282|NCT04153149|616375648|FG000|Open Label Extension Period|Death|0|||
170554283|NCT04153149|616375649|FG001|Open Label Extension Period|Death|0|||
170554284|NCT04153149|616375650|FG002|Open Label Extension Period|Death|7|||
170554285|NCT04153149|616375651|FG003|Open Label Extension Period|Death|3|||
170554286|NCT04153149|616375648|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
170554287|NCT04153149|616375649|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
170554288|NCT04153149|616375650|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
170554289|NCT04153149|616375651|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
170554290|NCT04153149|616375648|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
170554291|NCT04153149|616375649|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
170554292|NCT04153149|616375650|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
170554293|NCT04153149|616375651|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
170554294|NCT04153149|616375648|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
170554295|NCT04153149|616375649|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
170554296|NCT04153149|616375650|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
170554297|NCT04153149|616375651|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
170512864|NCT01483599|616222033|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
170512865|NCT01483599|616222034|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
170512866|NCT01483599|616222035|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
170512867|NCT01483599|616222036|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
170512868|NCT01483599|616222037|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
170512869|NCT01483599|616222038|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
170512870|NCT01483599|616222039|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
170512871|NCT00958412|616222041|FG000|Overall Study|Study prematurely terminated|18|||
170512872|NCT02552888|616222042|FG000|Overall Study|Lost to Follow-up|1|||
170512873|NCT02552888|616222043|FG001|Overall Study|Lost to Follow-up|1|||
170512874|NCT00401193|616224488|FG000|Overall Study|Adverse Event|1|||
170512875|NCT00401193|616224489|FG001|Overall Study|Adverse Event|3|||
170512876|NCT00401193|616224490|FG002|Overall Study|Adverse Event|1|||
170512877|NCT00401193|616224488|FG000|Overall Study|Protocol Violation|3|||
170512878|NCT00401193|616224489|FG001|Overall Study|Protocol Violation|1|||
170512879|NCT00401193|616224490|FG002|Overall Study|Protocol Violation|1|||
170512880|NCT00401193|616224488|FG000|Overall Study|Lost to Follow-up|6|||
170512881|NCT00401193|616224489|FG001|Overall Study|Lost to Follow-up|5|||
170512882|NCT00401193|616224490|FG002|Overall Study|Lost to Follow-up|1|||
170512883|NCT00401193|616224488|FG000|Overall Study|Withdrawal by Subject|2|||
170512884|NCT00401193|616224489|FG001|Overall Study|Withdrawal by Subject|0|||
170512885|NCT00401193|616224490|FG002|Overall Study|Withdrawal by Subject|1|||
170512886|NCT00401193|616224488|FG000|Overall Study|Other Event|3|||
170512887|NCT00401193|616224489|FG001|Overall Study|Other Event|2|||
170512888|NCT00401193|616224490|FG002|Overall Study|Other Event|2|||
170512889|NCT01844817|616224491|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
170512890|NCT01844817|616224492|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
170512891|NCT01844817|616224491|FG000|Treatment|Progressive Disease|27|||
170512892|NCT01844817|616224492|FG001|Treatment|Progressive Disease|36|||
170512893|NCT01844817|616224491|FG000|Treatment|Adverse Event|17|||
170512894|NCT01844817|616224492|FG001|Treatment|Adverse Event|9|||
170512895|NCT01844817|616224491|FG000|Treatment|Withdrawal by Subject|10|||
170554298|NCT01657942|616375652|FG000|Overall Study|Alternative Treatment|7|||
170554299|NCT01657942|616375652|FG000|Overall Study|Lost to Follow-up|1|||
170554300|NCT03283241|616376878|FG000|Overall Study|Adverse Event|4|||
170554301|NCT03283241|616376879|FG001|Overall Study|Adverse Event|1|||
170554302|NCT03283241|616376878|FG000|Overall Study|Withdrawal by Subject|0|||
170554303|NCT03283241|616376879|FG001|Overall Study|Withdrawal by Subject|1|||
170554304|NCT03283241|616376878|FG000|Overall Study|Subject relocated to Finland|0|||
170554305|NCT03283241|616376879|FG001|Overall Study|Subject relocated to Finland|1|||
170554306|NCT00666263|616376880|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
170644291|NCT01994889|616711611|FG001|Overall Study|Adverse Event|12|||
170512896|NCT01844817|616224492|FG001|Treatment|Withdrawal by Subject|6|||
170512897|NCT01844817|616224491|FG000|Treatment|Death|10|||
170512898|NCT01844817|616224492|FG001|Treatment|Death|8|||
170512899|NCT01844817|616224491|FG000|Treatment|Lost to Follow-up|0|||
170512900|NCT01844817|616224492|FG001|Treatment|Lost to Follow-up|1|||
170512901|NCT01844817|616224491|FG000|Treatment|Other|0|||
170644292|NCT01994889|616711612|FG002|Overall Study|Adverse Event|11|||
170512902|NCT01844817|616224492|FG001|Treatment|Other|3|||
170512903|NCT01133704|616224493|FG000|Overall Study|Death|44|||
170512904|NCT01133704|616224494|FG001|Overall Study|Death|26|||
170512905|NCT01133704|616224493|FG000|Overall Study|Patient refused to continue|4|||
170644293|NCT01994889|616711610|FG000|Overall Study|Cardiac Device Implantation|0|||
170512906|NCT01133704|616224494|FG001|Overall Study|Patient refused to continue|0|||
170512907|NCT01133704|616224493|FG000|Overall Study|Study Closure|1|||
170512908|NCT01133704|616224494|FG001|Overall Study|Study Closure|0|||
170512909|NCT03638466|616224495|FG000|Overall Study|Early Termination|0|||
170512910|NCT03638466|616224496|FG001|Overall Study|Early Termination|1|||
170512911|NCT02576977|616224497|FG000|Overall Study|Adverse Event|13|||
170512912|NCT02576977|616224498|FG001|Overall Study|Adverse Event|2|||
170512913|NCT02576977|616224497|FG000|Overall Study|Death|73|||
170512914|NCT02576977|616224498|FG001|Overall Study|Death|60|||
170512915|NCT02576977|616224497|FG000|Overall Study|Screen failure|1|||
170512916|NCT02576977|616224498|FG001|Overall Study|Screen failure|0|||
170512917|NCT02576977|616224497|FG000|Overall Study|Study Terminated at Selected Sites|27|||
170512918|NCT02576977|616224498|FG001|Overall Study|Study Terminated at Selected Sites|50|||
170512919|NCT02576977|616224497|FG000|Overall Study|Withdrawal by Subject|11|||
170512920|NCT02576977|616224498|FG001|Overall Study|Withdrawal by Subject|11|||
170512921|NCT02576977|616224497|FG000|Overall Study|Final Disposition Unknown|0|||
170512922|NCT02576977|616224498|FG001|Overall Study|Final Disposition Unknown|1|||
170554307|NCT00666263|616376881|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
170554308|NCT00666263|616376880|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
170554309|NCT00666263|616376881|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
170554310|NCT00666263|616376880|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
170554311|NCT00666263|616376881|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
170554312|NCT00129974|616376882|FG000|Overall Study|Other|1|||
170554313|NCT00266032|616376883|FG000|Treatment|Adverse Event|42|||
170554314|NCT00266032|616376884|FG001|Treatment|Adverse Event|26|||
170554315|NCT00266032|616376885|FG002|Treatment|Adverse Event|10|||
170554316|NCT00266032|616376883|FG000|Treatment|Lost to Follow-up|19|||
170554317|NCT00266032|616376884|FG001|Treatment|Lost to Follow-up|4|||
170554318|NCT00266032|616376885|FG002|Treatment|Lost to Follow-up|2|||
170554319|NCT00266032|616376883|FG000|Treatment|Pregnancy|3|||
170554320|NCT00266032|616376884|FG001|Treatment|Pregnancy|2|||
170554321|NCT00266032|616376885|FG002|Treatment|Pregnancy|2|||
170554322|NCT00266032|616376883|FG000|Treatment|Protocol Violation|6|||
170554323|NCT00266032|616376884|FG001|Treatment|Protocol Violation|14|||
170554324|NCT00266032|616376885|FG002|Treatment|Protocol Violation|13|||
170554325|NCT00266032|616376883|FG000|Treatment|Withdrawal by Subject|28|||
170554326|NCT00266032|616376884|FG001|Treatment|Withdrawal by Subject|13|||
170554327|NCT00266032|616376885|FG002|Treatment|Withdrawal by Subject|12|||
170554328|NCT00266032|616376883|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
170554329|NCT00266032|616376884|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
170554330|NCT00266032|616376885|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
170554331|NCT00266032|616376883|FG000|Open-label Safety Extension|Adverse Event|5|||
170554332|NCT00266032|616376884|FG001|Open-label Safety Extension|Adverse Event|0|||
170554333|NCT00266032|616376885|FG002|Open-label Safety Extension|Adverse Event|4|||
170554334|NCT00266032|616376883|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
170554335|NCT00266032|616376884|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
170554336|NCT00266032|616376885|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
170554337|NCT00266032|616376883|FG000|Open-label Safety Extension|Pregnancy|4|||
170554338|NCT00266032|616376884|FG001|Open-label Safety Extension|Pregnancy|1|||
170554339|NCT00266032|616376885|FG002|Open-label Safety Extension|Pregnancy|2|||
170554340|NCT00266032|616376883|FG000|Open-label Safety Extension|Protocol Violation|1|||
170554341|NCT00266032|616376884|FG001|Open-label Safety Extension|Protocol Violation|3|||
170554342|NCT00266032|616376885|FG002|Open-label Safety Extension|Protocol Violation|2|||
170554343|NCT00266032|616376883|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
170554344|NCT00266032|616376884|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
170554345|NCT00266032|616376885|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
170554346|NCT00266032|616376883|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
170554347|NCT00266032|616376884|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
170554348|NCT00266032|616376885|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
170554349|NCT00124657|616376887|FG000|Overall Study|Toxicity|0|||
170554350|NCT00124657|616376888|FG001|Overall Study|Toxicity|0|||
170554351|NCT00124657|616376889|FG002|Overall Study|Toxicity|1|||
170554352|NCT00124657|616376887|FG000|Overall Study|Non-compliance|1|||
170554353|NCT00124657|616376888|FG001|Overall Study|Non-compliance|0|||
170554354|NCT00124657|616376889|FG002|Overall Study|Non-compliance|4|||
170554355|NCT00124657|616376887|FG000|Overall Study|Progressive disease|14|||
170554356|NCT00124657|616376888|FG001|Overall Study|Progressive disease|5|||
170512923|NCT02576977|616224497|FG000|Overall Study|Lost to Follow-up|1|||
170512924|NCT02576977|616224498|FG001|Overall Study|Lost to Follow-up|0|||
170512925|NCT02576977|616224497|FG000|Overall Study|Progressive Disease|0|||
170512926|NCT02576977|616224498|FG001|Overall Study|Progressive Disease|1|||
170512927|NCT04530838|616224499|FG000|Overall Study|Other|2|||
170554357|NCT00124657|616376889|FG002|Overall Study|Progressive disease|27|||
170554358|NCT00124657|616376887|FG000|Overall Study|Intercurrent illness|1|||
170554359|NCT00124657|616376888|FG001|Overall Study|Intercurrent illness|0|||
170512928|NCT04530838|616224500|FG001|Overall Study|Other|1|||
170512929|NCT04530838|616224501|FG002|Overall Study|Other|0|||
170512930|NCT04530838|616224499|FG000|Overall Study|Physician Decision|0|||
170512931|NCT04530838|616224500|FG001|Overall Study|Physician Decision|0|||
170512932|NCT04530838|616224501|FG002|Overall Study|Physician Decision|1|||
170512933|NCT04530838|616224499|FG000|Overall Study|Death|0|||
170512934|NCT04530838|616224500|FG001|Overall Study|Death|0|||
170512935|NCT04530838|616224501|FG002|Overall Study|Death|1|||
170512936|NCT04530838|616224499|FG000|Overall Study|Adverse Event|0|||
170512937|NCT04530838|616224500|FG001|Overall Study|Adverse Event|1|||
170512938|NCT04530838|616224501|FG002|Overall Study|Adverse Event|0|||
170512939|NCT04530838|616224499|FG000|Overall Study|No longer meets eligibility criteria|1|||
170512940|NCT04530838|616224500|FG001|Overall Study|No longer meets eligibility criteria|0|||
170512941|NCT04530838|616224501|FG002|Overall Study|No longer meets eligibility criteria|2|||
170512942|NCT04530838|616224499|FG000|Overall Study|Withdrawal by parent/guardian|5|||
170512943|NCT04530838|616224500|FG001|Overall Study|Withdrawal by parent/guardian|2|||
170512944|NCT04530838|616224501|FG002|Overall Study|Withdrawal by parent/guardian|2|||
170512945|NCT00803712|616224502|FG000|Overall Study|Noncompliance|3|||
170512946|NCT00803712|616224503|FG001|Overall Study|Noncompliance|0|||
170512947|NCT00803712|616224502|FG000|Overall Study|Adverse Event|5|||
170512948|NCT00803712|616224503|FG001|Overall Study|Adverse Event|0|||
170512949|NCT00803712|616224502|FG000|Overall Study|Death|8|||
170512950|NCT00803712|616224503|FG001|Overall Study|Death|7|||
170512951|NCT00803712|616224502|FG000|Overall Study|Lost to Follow-up|3|||
170512952|NCT00803712|616224503|FG001|Overall Study|Lost to Follow-up|1|||
170512953|NCT00803712|616224502|FG000|Overall Study|Withdrawal by Subject|2|||
170512954|NCT00803712|616224503|FG001|Overall Study|Withdrawal by Subject|4|||
170512955|NCT00803712|616224502|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
170512956|NCT00803712|616224503|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
170512957|NCT00803712|616224502|FG000|Overall Study|Protocol criteria (other)|0|||
170512958|NCT00803712|616224503|FG001|Overall Study|Protocol criteria (other)|2|||
170512959|NCT00803712|616224502|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
170512960|NCT00803712|616224503|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
170512961|NCT00803712|616224502|FG000|Overall Study|Administrative decision|2|||
170512962|NCT00803712|616224503|FG001|Overall Study|Administrative decision|3|||
170512963|NCT00803712|616224502|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
170512964|NCT00803712|616224503|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
170512965|NCT02362425|616224506|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
170512966|NCT02362425|616224507|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
170512967|NCT02362425|616224508|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
170512968|NCT02362425|616224509|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
170512969|NCT02362425|616224506|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
170512970|NCT02362425|616224507|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
170512971|NCT02362425|616224508|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
170512972|NCT02362425|616224509|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
170512973|NCT02362425|616224506|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
170512974|NCT02362425|616224507|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
170512975|NCT02362425|616224508|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
170512976|NCT02362425|616224509|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
170512977|NCT02362425|616224506|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
170512978|NCT02362425|616224507|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
170512979|NCT02362425|616224508|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
170512980|NCT02362425|616224509|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
170512981|NCT02362425|616224506|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
170512982|NCT02362425|616224507|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
170512983|NCT02362425|616224508|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
170512984|NCT02362425|616224509|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
170512985|NCT02362425|616224506|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
170512986|NCT02362425|616224507|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
170512987|NCT02362425|616224508|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
170512988|NCT02362425|616224509|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
170512989|NCT02362425|616224506|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
170512990|NCT02362425|616224507|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
170512991|NCT02362425|616224508|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
170512992|NCT02362425|616224509|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
170806251|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
170512993|NCT02362425|616224506|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
170806252|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
170512994|NCT02362425|616224507|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
170512995|NCT02362425|616224508|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
170554360|NCT00124657|616376889|FG002|Overall Study|Intercurrent illness|0|||
170512996|NCT02362425|616224509|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
170512997|NCT02155309|616224510|FG000|Overall Study|Protocol Violation|0|||
170512998|NCT02155309|616224511|FG001|Overall Study|Protocol Violation|0|||
170512999|NCT02155309|616224512|FG002|Overall Study|Protocol Violation|1|||
170513000|NCT00314808|616224514|FG000|Overall Study|Disease Progression without AE|4|||
170513001|NCT00314808|616224514|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
170513002|NCT02906579|616224525|FG000|Overall Study|Adverse Event|1|||
170513003|NCT02906579|616224525|FG000|Overall Study|Physician Decision|1|||
170513004|NCT02030119|616224526|FG000|Overall Study|Withdrawal by Subject|3|||
170513005|NCT02030119|616224527|FG001|Overall Study|Withdrawal by Subject|1|||
170513006|NCT02030119|616224528|FG002|Overall Study|Withdrawal by Subject|5|||
170513007|NCT02030119|616224529|FG003|Overall Study|Withdrawal by Subject|3|||
170513008|NCT02030119|616224526|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
170513009|NCT02030119|616224527|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
170513010|NCT02030119|616224528|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
170513011|NCT02030119|616224529|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
170513012|NCT03498313|616224532|FG000|Experimental Period 1|Adverse Event|1|||
170513013|NCT03498313|616224533|FG001|Experimental Period 1|Adverse Event|0|||
170513014|NCT03498313|616224534|FG002|Experimental Period 1|Adverse Event|0|||
170513015|NCT03498313|616224535|FG003|Experimental Period 1|Adverse Event|1|||
170513016|NCT03498313|616224536|FG004|Experimental Period 1|Adverse Event|0|||
170513017|NCT03498313|616224537|FG005|Experimental Period 1|Adverse Event|0|||
170513018|NCT03498313|616224532|FG000|Experimental Period 1|Withdrawal by Subject|0|||
170513019|NCT03498313|616224533|FG001|Experimental Period 1|Withdrawal by Subject|1|||
170513020|NCT03498313|616224534|FG002|Experimental Period 1|Withdrawal by Subject|0|||
170513021|NCT03498313|616224535|FG003|Experimental Period 1|Withdrawal by Subject|0|||
170513022|NCT03498313|616224536|FG004|Experimental Period 1|Withdrawal by Subject|0|||
170513023|NCT03498313|616224537|FG005|Experimental Period 1|Withdrawal by Subject|0|||
170513024|NCT03498313|616224532|FG000|Washout Period 1|Anovulation|1|||
170513025|NCT03498313|616224533|FG001|Washout Period 1|Anovulation|0|||
170513026|NCT03498313|616224534|FG002|Washout Period 1|Anovulation|0|||
170513027|NCT03498313|616224535|FG003|Washout Period 1|Anovulation|0|||
170513028|NCT03498313|616224536|FG004|Washout Period 1|Anovulation|0|||
170513029|NCT03498313|616224537|FG005|Washout Period 1|Anovulation|0|||
170513030|NCT03498313|616224532|FG000|Washout Period 1|Withdrawal by Subject|0|||
170513031|NCT03498313|616224533|FG001|Washout Period 1|Withdrawal by Subject|3|||
170513032|NCT03498313|616224534|FG002|Washout Period 1|Withdrawal by Subject|0|||
170513033|NCT03498313|616224535|FG003|Washout Period 1|Withdrawal by Subject|1|||
170513034|NCT03498313|616224536|FG004|Washout Period 1|Withdrawal by Subject|0|||
170513035|NCT03498313|616224537|FG005|Washout Period 1|Withdrawal by Subject|1|||
170513036|NCT03498313|616224532|FG000|Experimental Period 2|Adverse Event|0|||
170513037|NCT03498313|616224533|FG001|Experimental Period 2|Adverse Event|0|||
170513038|NCT03498313|616224534|FG002|Experimental Period 2|Adverse Event|0|||
170513039|NCT03498313|616224535|FG003|Experimental Period 2|Adverse Event|0|||
170513040|NCT03498313|616224536|FG004|Experimental Period 2|Adverse Event|1|||
170513041|NCT03498313|616224537|FG005|Experimental Period 2|Adverse Event|2|||
170513042|NCT03498313|616224532|FG000|Washout Period 2|Physician Decision|1|||
170513043|NCT03498313|616224533|FG001|Washout Period 2|Physician Decision|0|||
170513044|NCT03498313|616224534|FG002|Washout Period 2|Physician Decision|0|||
170513045|NCT03498313|616224535|FG003|Washout Period 2|Physician Decision|1|||
170513046|NCT03498313|616224536|FG004|Washout Period 2|Physician Decision|0|||
170513047|NCT03498313|616224537|FG005|Washout Period 2|Physician Decision|1|||
170513048|NCT03498313|616224532|FG000|Washout Period 2|Withdrawal by Subject|3|||
170554361|NCT01378195|616376892|FG000|Overall Study|Lost to Follow-up|29|||
170554362|NCT01378195|616376893|FG001|Overall Study|Lost to Follow-up|18|||
170513049|NCT03498313|616224533|FG001|Washout Period 2|Withdrawal by Subject|2|||
170513050|NCT03498313|616224534|FG002|Washout Period 2|Withdrawal by Subject|0|||
170513051|NCT03498313|616224535|FG003|Washout Period 2|Withdrawal by Subject|0|||
170513052|NCT03498313|616224536|FG004|Washout Period 2|Withdrawal by Subject|2|||
170513053|NCT03498313|616224537|FG005|Washout Period 2|Withdrawal by Subject|0|||
170513054|NCT03498313|616224532|FG000|Washout Period 2|Anovulation|0|||
170806253|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
170806254|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
170806255|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
170806256|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
170806257|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
170806258|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
170806259|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
170806260|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
170806261|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
170513055|NCT03498313|616224533|FG001|Washout Period 2|Anovulation|0|||
170513056|NCT03498313|616224534|FG002|Washout Period 2|Anovulation|0|||
170554363|NCT00752219|616376894|FG000|Overall Study|Clinical failure|0|||
170513057|NCT03498313|616224535|FG003|Washout Period 2|Anovulation|0|||
170513058|NCT03498313|616224536|FG004|Washout Period 2|Anovulation|0|||
170513059|NCT03498313|616224537|FG005|Washout Period 2|Anovulation|1|||
170513060|NCT02630563|616224543|FG000|Overall Study|Administrative|1|||
170513061|NCT03519919|616224548|FG000|Overall Study|Withdrawal by Subject|1|||
170513062|NCT03519919|616224548|FG000|Overall Study|Lack of Efficacy|1|||
170513063|NCT03519919|616224548|FG000|Overall Study|Screen Failure|1|||
170513064|NCT03076996|616224549|FG000|Overall Study|Withdrawal by Subject|2|||
170513065|NCT03076996|616224549|FG000|Overall Study|Lost to Follow-up|3|||
170513066|NCT03076996|616224549|FG000|Overall Study|Literacy precluded participation|1|||
170513067|NCT02144077|616224554|FG000|Overall Study|Withdrawal by Subject|3|||
170513068|NCT02144077|616224555|FG001|Overall Study|Withdrawal by Subject|3|||
170513069|NCT02144077|616224554|FG000|Overall Study|Adverse Event|2|||
170513070|NCT02144077|616224555|FG001|Overall Study|Adverse Event|3|||
170513071|NCT02144077|616224554|FG000|Overall Study|Lost to Follow-up|2|||
170513072|NCT02144077|616224555|FG001|Overall Study|Lost to Follow-up|2|||
170513073|NCT02144077|616224554|FG000|Overall Study|Protocol Violation|1|||
170513074|NCT02144077|616224555|FG001|Overall Study|Protocol Violation|2|||
170513075|NCT02144077|616224554|FG000|Overall Study|Death|0|||
170513076|NCT02144077|616224555|FG001|Overall Study|Death|1|||
170513077|NCT02144077|616224554|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
170513078|NCT02144077|616224555|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
170554364|NCT00752219|616376895|FG001|Overall Study|Clinical failure|1|||
170554365|NCT00752219|616376894|FG000|Overall Study|Adverse Event|5|||
170554366|NCT00752219|616376895|FG001|Overall Study|Adverse Event|3|||
170554367|NCT00752219|616376894|FG000|Overall Study|Protocol deviation|1|||
170554368|NCT00752219|616376895|FG001|Overall Study|Protocol deviation|0|||
170554369|NCT00752219|616376894|FG000|Overall Study|Lost to Follow-up|1|||
170554370|NCT00752219|616376895|FG001|Overall Study|Lost to Follow-up|2|||
170554371|NCT00752219|616376894|FG000|Overall Study|Randomized but not treated|1|||
170554372|NCT00752219|616376895|FG001|Overall Study|Randomized but not treated|0|||
170554373|NCT00752219|616376894|FG000|Overall Study|Other|3|||
170513079|NCT00878800|616224556|FG000|Overall Study|Adverse Event|0|||
170513080|NCT00878800|616224557|FG001|Overall Study|Adverse Event|0|||
170513081|NCT00878800|616224558|FG002|Overall Study|Adverse Event|2|||
170554374|NCT00752219|616376895|FG001|Overall Study|Other|0|||
170554375|NCT02853136|616376896|FG000|Wash-out|Adverse Event|0|||
170554376|NCT02853136|616376897|FG001|Wash-out|Adverse Event|0|||
170644294|NCT01994889|616711611|FG001|Overall Study|Cardiac Device Implantation|2|||
170644295|NCT01994889|616711612|FG002|Overall Study|Cardiac Device Implantation|0|||
170644296|NCT01994889|616711610|FG000|Overall Study|Organ Transplantation|1|||
170644297|NCT01994889|616711611|FG001|Overall Study|Organ Transplantation|5|||
170644298|NCT01994889|616711612|FG002|Overall Study|Organ Transplantation|5|||
170513082|NCT00878800|616224559|FG003|Overall Study|Adverse Event|0|||
170513083|NCT00878800|616224560|FG004|Overall Study|Adverse Event|1|||
170513084|NCT00878800|616224556|FG000|Overall Study|Progressive disease|1|||
170513085|NCT00878800|616224557|FG001|Overall Study|Progressive disease|5|||
170513086|NCT00878800|616224558|FG002|Overall Study|Progressive disease|6|||
170644299|NCT01994889|616711610|FG000|Overall Study|No longer willing to participate|8|||
170644300|NCT01994889|616711611|FG001|Overall Study|No longer willing to participate|17|||
170644301|NCT01994889|616711612|FG002|Overall Study|No longer willing to participate|37|||
170644302|NCT01994889|616711610|FG000|Overall Study|Lost to Follow-up|0|||
170644303|NCT01994889|616711611|FG001|Overall Study|Lost to Follow-up|1|||
170644304|NCT01994889|616711612|FG002|Overall Study|Lost to Follow-up|0|||
170644305|NCT01994889|616711610|FG000|Overall Study|Protocol Violation|0|||
170644306|NCT01994889|616711611|FG001|Overall Study|Protocol Violation|1|||
170644307|NCT01994889|616711612|FG002|Overall Study|Protocol Violation|1|||
170644308|NCT01994889|616711610|FG000|Overall Study|Death|14|||
170644309|NCT01994889|616711611|FG001|Overall Study|Death|25|||
170644310|NCT01994889|616711612|FG002|Overall Study|Death|38|||
170644311|NCT01510769|616711613|FG000|Overall Study|Adverse Event|7|||
170644312|NCT01510769|616711614|FG001|Overall Study|Adverse Event|6|||
170644313|NCT01510769|616711615|FG002|Overall Study|Adverse Event|4|||
170644314|NCT01510769|616711613|FG000|Overall Study|Gout Flare|0|||
170644315|NCT01510769|616711614|FG001|Overall Study|Gout Flare|3|||
170644316|NCT01510769|616711615|FG002|Overall Study|Gout Flare|1|||
170644317|NCT01510769|616711613|FG000|Overall Study|Protocol Violation|11|||
170644318|NCT01510769|616711614|FG001|Overall Study|Protocol Violation|10|||
170644319|NCT01510769|616711615|FG002|Overall Study|Protocol Violation|9|||
170644320|NCT01510769|616711613|FG000|Overall Study|Lost to Follow-up|5|||
170644321|NCT01510769|616711614|FG001|Overall Study|Lost to Follow-up|1|||
170644322|NCT01510769|616711615|FG002|Overall Study|Lost to Follow-up|5|||
170644323|NCT01510769|616711613|FG000|Overall Study|Withdrawal by Subject|3|||
170644324|NCT01510769|616711614|FG001|Overall Study|Withdrawal by Subject|4|||
170644325|NCT01510769|616711615|FG002|Overall Study|Withdrawal by Subject|3|||
170644326|NCT01510769|616711613|FG000|Overall Study|Death|1|||
170644327|NCT01510769|616711614|FG001|Overall Study|Death|1|||
170644328|NCT01510769|616711615|FG002|Overall Study|Death|0|||
170644329|NCT02674204|616711616|FG000|Overall Study|Adverse Event|1|||
170644330|NCT02674204|616711617|FG001|Overall Study|Adverse Event|0|||
170644331|NCT02874144|616711618|FG000|Overall Study|Lost to Follow-up|3|||
170644332|NCT02874144|616711619|FG001|Overall Study|Lost to Follow-up|5|||
170644333|NCT00282308|616711624|FG000|Treatment Period|Lost to Follow-up|1|||
170644334|NCT00282308|616711625|FG001|Treatment Period|Lost to Follow-up|0|||
170644335|NCT00282308|616711626|FG002|Treatment Period|Lost to Follow-up|0|||
170644336|NCT00282308|616711624|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
170644337|NCT00282308|616711625|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
170644338|NCT00282308|616711626|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
170644339|NCT00282308|616711624|FG000|Treatment Period|Adverse Event|0|||
170644340|NCT00282308|616711625|FG001|Treatment Period|Adverse Event|2|||
170513087|NCT00878800|616224559|FG003|Overall Study|Progressive disease|5|||
170513088|NCT00878800|616224560|FG004|Overall Study|Progressive disease|13|||
170513089|NCT00878800|616224556|FG000|Overall Study|Withdrew consent|1|||
170513090|NCT00878800|616224557|FG001|Overall Study|Withdrew consent|1|||
170513091|NCT00878800|616224558|FG002|Overall Study|Withdrew consent|0|||
170644341|NCT00282308|616711626|FG002|Treatment Period|Adverse Event|0|||
170644342|NCT00282308|616711624|FG000|Treatment Period|Not Treated with Study Drug|1|||
170644343|NCT00282308|616711625|FG001|Treatment Period|Not Treated with Study Drug|0|||
170513092|NCT00878800|616224559|FG003|Overall Study|Withdrew consent|1|||
170644344|NCT00282308|616711626|FG002|Treatment Period|Not Treated with Study Drug|0|||
170513093|NCT00878800|616224560|FG004|Overall Study|Withdrew consent|1|||
170644345|NCT00282308|616711624|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
170644346|NCT00282308|616711625|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
170644347|NCT00282308|616711626|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
170644348|NCT00282308|616711624|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
170513094|NCT00878800|616224556|FG000|Overall Study|Death|0|||
170644349|NCT00282308|616711625|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
170644350|NCT00282308|616711626|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
170644351|NCT00282308|616711624|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
170644352|NCT00282308|616711625|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
170644353|NCT00282308|616711626|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
170513095|NCT00878800|616224557|FG001|Overall Study|Death|0|||
170513096|NCT00878800|616224558|FG002|Overall Study|Death|1|||
170513097|NCT00878800|616224559|FG003|Overall Study|Death|0|||
170513098|NCT00878800|616224560|FG004|Overall Study|Death|0|||
170513099|NCT00878800|616224556|FG000|Overall Study|Other|1|||
170513100|NCT00878800|616224557|FG001|Overall Study|Other|1|||
170513101|NCT00878800|616224558|FG002|Overall Study|Other|0|||
170513102|NCT00878800|616224559|FG003|Overall Study|Other|0|||
170513103|NCT00878800|616224560|FG004|Overall Study|Other|1|||
170513104|NCT00460239|616224561|FG000|Overall Study|Physician Decision|0|||
170513105|NCT00460239|616224562|FG001|Overall Study|Physician Decision|1|||
170513106|NCT00460239|616224563|FG002|Overall Study|Physician Decision|0|||
170513107|NCT00460239|616224564|FG003|Overall Study|Physician Decision|0|||
170513108|NCT00460239|616224565|FG004|Overall Study|Physician Decision|0|||
170513109|NCT00460239|616224566|FG005|Overall Study|Physician Decision|2|||
170513110|NCT00460239|616224567|FG006|Overall Study|Physician Decision|0|||
170513111|NCT00460239|616224568|FG007|Overall Study|Physician Decision|0|||
170513112|NCT00460239|616224569|FG008|Overall Study|Physician Decision|0|||
170513113|NCT00460239|616224561|FG000|Overall Study|Withdrawal by Subject|0|||
170513114|NCT00460239|616224562|FG001|Overall Study|Withdrawal by Subject|0|||
170513115|NCT00460239|616224563|FG002|Overall Study|Withdrawal by Subject|0|||
170513116|NCT00460239|616224564|FG003|Overall Study|Withdrawal by Subject|0|||
170513117|NCT00460239|616224565|FG004|Overall Study|Withdrawal by Subject|0|||
170513118|NCT00460239|616224566|FG005|Overall Study|Withdrawal by Subject|1|||
170513119|NCT00460239|616224567|FG006|Overall Study|Withdrawal by Subject|0|||
170513120|NCT00460239|616224568|FG007|Overall Study|Withdrawal by Subject|0|||
170513121|NCT00460239|616224569|FG008|Overall Study|Withdrawal by Subject|0|||
170513122|NCT02982863|616224575|FG000|Overall Study|Not eligible patients|809|||
170513123|NCT02982863|616224576|FG001|Overall Study|Not eligible patients|4261|||
170513124|NCT02982863|616224577|FG002|Overall Study|Not eligible patients|1852|||
170513125|NCT02982863|616224578|FG003|Overall Study|Not eligible patients|1400|||
170513126|NCT02982863|616224579|FG004|Overall Study|Not eligible patients|492|||
170513127|NCT02457195|616224580|FG000|Overall Study|Adverse Event|3|||
170513128|NCT02457195|616224580|FG000|Overall Study|Protocol Violation|2|||
170513129|NCT02457195|616224580|FG000|Overall Study|Withdrawal by Subject|4|||
170513130|NCT04313400|616224581|FG000|Overall Study|Withdrawal by Subject|0|||
170513131|NCT04313400|616224582|FG001|Overall Study|Withdrawal by Subject|0|||
170513132|NCT04313400|616224583|FG002|Overall Study|Withdrawal by Subject|0|||
170513133|NCT04313400|616224584|FG003|Overall Study|Withdrawal by Subject|0|||
170513134|NCT04313400|616224585|FG004|Overall Study|Withdrawal by Subject|0|||
170513135|NCT04313400|616224586|FG005|Overall Study|Withdrawal by Subject|4|||
170513136|NCT04313400|616224587|FG006|Overall Study|Withdrawal by Subject|1|||
170513137|NCT04313400|616224581|FG000|Overall Study|Adverse Event|0|||
170513138|NCT04313400|616224582|FG001|Overall Study|Adverse Event|0|||
170513139|NCT04313400|616224583|FG002|Overall Study|Adverse Event|0|||
170513140|NCT04313400|616224584|FG003|Overall Study|Adverse Event|0|||
170513141|NCT04313400|616224585|FG004|Overall Study|Adverse Event|0|||
170513142|NCT04313400|616224586|FG005|Overall Study|Adverse Event|1|||
170513143|NCT04313400|616224587|FG006|Overall Study|Adverse Event|0|||
170513144|NCT04313400|616224581|FG000|Overall Study|Lost to Follow-up|0|||
170513145|NCT04313400|616224582|FG001|Overall Study|Lost to Follow-up|0|||
170513146|NCT04313400|616224583|FG002|Overall Study|Lost to Follow-up|0|||
170513147|NCT04313400|616224584|FG003|Overall Study|Lost to Follow-up|0|||
170513148|NCT04313400|616224585|FG004|Overall Study|Lost to Follow-up|0|||
170513149|NCT04313400|616224586|FG005|Overall Study|Lost to Follow-up|1|||
170513150|NCT04313400|616224587|FG006|Overall Study|Lost to Follow-up|0|||
170513151|NCT01563913|616224592|FG000|Overall Study|Physician Decision|1|||
170513152|NCT01563913|616224593|FG001|Overall Study|Physician Decision|0|||
170513153|NCT01563913|616224592|FG000|Overall Study|Spouse Passed Away|1|||
170513154|NCT01563913|616224593|FG001|Overall Study|Spouse Passed Away|0|||
170513155|NCT02091414|616224594|FG000|Overall Study|Withdrawal by Subject|2|||
170513156|NCT02091414|616224594|FG000|Overall Study|Death|2|||
170513157|NCT02521792|616224600|FG000|Overall Study|Study Terminated|6|||
170513158|NCT01188668|616224601|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
170513159|NCT01188668|616224601|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
170513160|NCT01188668|616224601|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
170513161|NCT00902746|616224602|FG000|Overall Study|Protocol Violation|7|||
170513162|NCT00902746|616224602|FG000|Overall Study|Withdrawal by Subject|16|||
170513163|NCT00902746|616224602|FG000|Overall Study|Adverse Event|8|||
170513164|NCT00902746|616224602|FG000|Overall Study|Lost to Follow-up|3|||
170513165|NCT00902746|616224602|FG000|Overall Study|Physician Decision|2|||
170513166|NCT01737879|616224603|FG000|Overall Study|Death|1|||
170513167|NCT01737879|616224603|FG000|Overall Study|Sponsor decision|40|||
170513168|NCT00359294|616224604|FG000|Overall Study|Progressive disease|1|||
170513169|NCT00359294|616224605|FG001|Overall Study|Progressive disease|1|||
170513170|NCT00359294|616224606|FG002|Overall Study|Progressive disease|2|||
170513171|NCT00359294|616224607|FG003|Overall Study|Progressive disease|3|||
170513172|NCT00359294|616224608|FG004|Overall Study|Progressive disease|2|||
170513173|NCT00359294|616224604|FG000|Overall Study|Withdrawal by Subject|0|||
170513174|NCT00359294|616224605|FG001|Overall Study|Withdrawal by Subject|0|||
170513175|NCT00359294|616224606|FG002|Overall Study|Withdrawal by Subject|0|||
170513176|NCT00359294|616224607|FG003|Overall Study|Withdrawal by Subject|0|||
170513177|NCT00359294|616224608|FG004|Overall Study|Withdrawal by Subject|1|||
170513178|NCT00359294|616224604|FG000|Overall Study|Not treated|0|||
170513179|NCT00359294|616224605|FG001|Overall Study|Not treated|0|||
170513180|NCT00359294|616224606|FG002|Overall Study|Not treated|0|||
170513181|NCT00359294|616224607|FG003|Overall Study|Not treated|1|||
170513182|NCT00359294|616224608|FG004|Overall Study|Not treated|0|||
170513183|NCT00359294|616224604|FG000|Overall Study|Physician Decision|0|||
170513184|NCT00359294|616224605|FG001|Overall Study|Physician Decision|0|||
170513185|NCT00359294|616224606|FG002|Overall Study|Physician Decision|1|||
170513186|NCT00359294|616224607|FG003|Overall Study|Physician Decision|0|||
170513187|NCT00359294|616224608|FG004|Overall Study|Physician Decision|0|||
170513188|NCT03882957|616224609|FG000|Overall Study|Did not complete all three arms|1|||
170513189|NCT03762681|616224612|FG000|Part 1|Withdrawal by Subject|0|||
170513190|NCT03762681|616224613|FG001|Part 1|Withdrawal by Subject|0|||
170513191|NCT03762681|616224614|FG002|Part 1|Withdrawal by Subject|0|||
170513192|NCT03762681|616224615|FG003|Part 1|Withdrawal by Subject|1|||
170513193|NCT03762681|616224616|FG004|Part 1|Withdrawal by Subject|0|||
170513194|NCT03762681|616224617|FG005|Part 1|Withdrawal by Subject|0|||
170513195|NCT03762681|616224618|FG006|Part 1|Withdrawal by Subject|0|||
170513196|NCT03762681|616224619|FG007|Part 1|Withdrawal by Subject|0|||
170513197|NCT03762681|616224612|FG000|Part 2a|Pandemic Travel Restrictions|0|||
170513198|NCT03762681|616224613|FG001|Part 2a|Pandemic Travel Restrictions|0|||
170513199|NCT03762681|616224614|FG002|Part 2a|Pandemic Travel Restrictions|0|||
170513200|NCT03762681|616224615|FG003|Part 2a|Pandemic Travel Restrictions|0|||
170513201|NCT03762681|616224616|FG004|Part 2a|Pandemic Travel Restrictions|0|||
170513202|NCT03762681|616224617|FG005|Part 2a|Pandemic Travel Restrictions|0|||
170513203|NCT03762681|616224618|FG006|Part 2a|Pandemic Travel Restrictions|0|||
170513204|NCT03762681|616224619|FG007|Part 2a|Pandemic Travel Restrictions|1|||
170513205|NCT03148067|616224622|FG000|Overall Study|Lost to Follow-up|3|||
170513206|NCT03148067|616224622|FG000|Overall Study|Death|1|||
170513207|NCT01915771|616224624|FG000|Day 1|Withdrawal by Subject|1|||
170513208|NCT01915771|616224624|FG000|Day 15|Withdrawal by Subject|1|||
170513209|NCT02912455|616224625|FG000|Overall Study|Withdrawal by Subject|0|||
170513210|NCT02912455|616224626|FG001|Overall Study|Withdrawal by Subject|1|||
170513211|NCT02912455|616224625|FG000|Overall Study|Lack of Efficacy|0|||
170513212|NCT02912455|616224626|FG001|Overall Study|Lack of Efficacy|1|||
170513213|NCT02912455|616224625|FG000|Overall Study|Lost to Follow-up|2|||
170513214|NCT02912455|616224626|FG001|Overall Study|Lost to Follow-up|1|||
170513215|NCT00621517|616224627|FG000|Overall Study|Lost to Follow-up|3|||
170513216|NCT00621517|616224628|FG001|Overall Study|Lost to Follow-up|3|||
170513217|NCT00621517|616224627|FG000|Overall Study|Withdrawal by Subject|3|||
170513218|NCT00621517|616224628|FG001|Overall Study|Withdrawal by Subject|4|||
170513219|NCT00621517|616224627|FG000|Overall Study|Adverse Event|1|||
170513220|NCT00621517|616224628|FG001|Overall Study|Adverse Event|0|||
170513221|NCT00073008|616224629|FG000|Overall Study|Missing|6|||
170513222|NCT00073008|616224630|FG001|Overall Study|Missing|6|||
170513223|NCT00073008|616224629|FG000|Overall Study|Withdrawal by Subject|2|||
170513224|NCT00073008|616224630|FG001|Overall Study|Withdrawal by Subject|2|||
170513225|NCT00073008|616224629|FG000|Overall Study|Lost to Follow-up|1|||
170513226|NCT00073008|616224630|FG001|Overall Study|Lost to Follow-up|3|||
170513227|NCT00073008|616224629|FG000|Overall Study|Death|46|||
170513228|NCT00073008|616224630|FG001|Overall Study|Death|47|||
170513229|NCT00073008|616224629|FG000|Overall Study|"Other selected on Case Report Form"|7|||
170513230|NCT00073008|616224630|FG001|Overall Study|"Other selected on Case Report Form"|5|||
170513231|NCT00334295|616224639|FG000|Overall Study|Patients received fewer than 3 injection|5|||
170513232|NCT00492232|616224650|FG000|Placebo Run-in|Adverse Event|0|||
170513233|NCT00492232|616224651|FG001|Placebo Run-in|Adverse Event|2|||
170513234|NCT00492232|616224650|FG000|Placebo Run-in|Protocol Violation|0|||
170513235|NCT00492232|616224651|FG001|Placebo Run-in|Protocol Violation|3|||
170513236|NCT00492232|616224650|FG000|Placebo Run-in|Lost to Follow-up|0|||
170513237|NCT00492232|616224651|FG001|Placebo Run-in|Lost to Follow-up|3|||
170513238|NCT00492232|616224650|FG000|Placebo Run-in|Withdrawal by Subject|0|||
170513239|NCT00492232|616224651|FG001|Placebo Run-in|Withdrawal by Subject|8|||
170513240|NCT00492232|616224650|FG000|Placebo Run-in|Pregnancy|0|||
170513241|NCT00492232|616224651|FG001|Placebo Run-in|Pregnancy|1|||
170513242|NCT00492232|616224650|FG000|Placebo Run-in|Entrance criteria not met|0|||
170513243|NCT00492232|616224651|FG001|Placebo Run-in|Entrance criteria not met|45|||
170513244|NCT00492232|616224650|FG000|Placebo Run-in|Other|0|||
170513245|NCT00492232|616224651|FG001|Placebo Run-in|Other|6|||
170513246|NCT00492232|616224650|FG000|Placebo Run-in|Missing|0|||
170513247|NCT00492232|616224651|FG001|Placebo Run-in|Missing|2|||
170513248|NCT00492232|616224650|FG000|Double-Blind Treatment|Adverse Event|1|||
170513249|NCT00492232|616224651|FG001|Double-Blind Treatment|Adverse Event|2|||
170513250|NCT00492232|616224650|FG000|Double-Blind Treatment|Protocol Violation|3|||
170513251|NCT00492232|616224651|FG001|Double-Blind Treatment|Protocol Violation|7|||
170513252|NCT00492232|616224650|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
170513253|NCT00492232|616224651|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
170513254|NCT00492232|616224650|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
170554377|NCT02853136|616376898|FG002|Wash-out|Adverse Event|0|||
170554378|NCT02853136|616376899|FG003|Wash-out|Adverse Event|1|||
170644354|NCT00282308|616711624|FG000|Safety Follow-up Period|Adverse Event|0|||
170644355|NCT00282308|616711625|FG001|Safety Follow-up Period|Adverse Event|0|||
170513255|NCT00492232|616224651|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
170513256|NCT00492232|616224650|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
170513257|NCT00492232|616224651|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
170513258|NCT00492232|616224650|FG000|Double-Blind Treatment|Other|6|||
170513259|NCT00492232|616224651|FG001|Double-Blind Treatment|Other|5|||
170513260|NCT00492232|616224650|FG000|Double-Blind Treatment|Randomized not treated|1|||
170513261|NCT00492232|616224651|FG001|Double-Blind Treatment|Randomized not treated|0|||
170513262|NCT00492232|616224650|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
170513263|NCT00492232|616224651|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
170513264|NCT00395642|616224652|FG000|Overall Study|Death|4|||
170513265|NCT00395642|616224652|FG000|Overall Study|Lost to Follow-up|1|||
170513266|NCT00395642|616224652|FG000|Overall Study|Physician Decision|7|||
170513267|NCT00395642|616224652|FG000|Overall Study|Withdrawal by Subject|1|||
170513268|NCT03275389|616224654|FG000|Overall Study|Lost to Follow-up|10|||
170513269|NCT03275389|616224655|FG001|Overall Study|Lost to Follow-up|10|||
170513270|NCT03275389|616224656|FG002|Overall Study|Lost to Follow-up|19|||
170513271|NCT03275389|616224657|FG003|Overall Study|Lost to Follow-up|12|||
170513272|NCT03275389|616224658|FG004|Overall Study|Lost to Follow-up|11|||
170513273|NCT03275389|616224659|FG005|Overall Study|Lost to Follow-up|12|||
170513274|NCT03275389|616224660|FG006|Overall Study|Lost to Follow-up|21|||
170513275|NCT03275389|616224661|FG007|Overall Study|Lost to Follow-up|15|||
170513276|NCT03275389|616224662|FG008|Overall Study|Lost to Follow-up|12|||
170513277|NCT03275389|616224663|FG009|Overall Study|Lost to Follow-up|14|||
170513278|NCT03275389|616224654|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
170513279|NCT03275389|616224655|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
170513280|NCT03275389|616224656|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
170513281|NCT03275389|616224657|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
170513282|NCT03275389|616224658|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
170513283|NCT03275389|616224659|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
170513284|NCT03275389|616224660|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
170513285|NCT03275389|616224661|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
170513286|NCT03275389|616224662|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
170513287|NCT03275389|616224663|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
170513288|NCT03275389|616224654|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
170513289|NCT03275389|616224655|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170513290|NCT03275389|616224656|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170513291|NCT03275389|616224657|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
170513292|NCT03275389|616224658|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
170513293|NCT03275389|616224659|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
170513294|NCT03275389|616224660|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
170513295|NCT03275389|616224661|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
170644356|NCT00282308|616711626|FG002|Safety Follow-up Period|Adverse Event|1|||
170644357|NCT00282308|616711624|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
170644358|NCT00282308|616711625|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
170644359|NCT00282308|616711626|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
170644360|NCT00282308|616711624|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
170644361|NCT00282308|616711625|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
170644362|NCT00282308|616711626|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
170644363|NCT00282308|616711624|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
170513296|NCT03275389|616224662|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
170513297|NCT03275389|616224663|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
170513298|NCT03275389|616224654|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170513299|NCT03275389|616224655|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
170513300|NCT03275389|616224656|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170513301|NCT03275389|616224657|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
170513302|NCT03275389|616224658|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170513303|NCT03275389|616224659|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170513304|NCT03275389|616224660|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170644364|NCT00282308|616711625|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
170806262|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
170806263|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
170806264|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
170806265|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
170806266|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
170806267|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
170806268|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
170806269|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
170513305|NCT03275389|616224661|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170513306|NCT03275389|616224662|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170513307|NCT03275389|616224663|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170513308|NCT03275389|616224654|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170513309|NCT03275389|616224655|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170513310|NCT03275389|616224656|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
170513311|NCT03275389|616224657|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170513312|NCT03275389|616224658|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170513313|NCT03275389|616224659|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170513314|NCT03275389|616224660|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170513315|NCT03275389|616224661|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170513316|NCT03275389|616224662|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170513317|NCT03275389|616224663|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
170513318|NCT03275389|616224654|FG000|Overall Study|Other|0|||
170513319|NCT03275389|616224655|FG001|Overall Study|Other|4|||
170513320|NCT03275389|616224656|FG002|Overall Study|Other|3|||
170513321|NCT03275389|616224657|FG003|Overall Study|Other|2|||
170513322|NCT03275389|616224658|FG004|Overall Study|Other|2|||
170513323|NCT03275389|616224659|FG005|Overall Study|Other|2|||
170513324|NCT03275389|616224660|FG006|Overall Study|Other|0|||
170513325|NCT03275389|616224661|FG007|Overall Study|Other|0|||
170513326|NCT03275389|616224662|FG008|Overall Study|Other|1|||
170513327|NCT03275389|616224663|FG009|Overall Study|Other|0|||
170513328|NCT00978341|616224668|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
170513329|NCT00978341|616224669|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
170513330|NCT03035916|616224670|FG000|Overall Study|Puncture failed|0|||
170513331|NCT03035916|616224671|FG001|Overall Study|Puncture failed|2|||
170513332|NCT03035916|616224672|FG002|Overall Study|Puncture failed|0|||
170513333|NCT03885999|616224673|FG000|Overall Study|Adverse Event|1|||
170513334|NCT01451554|616224674|FG000|Overall Study|Withdrawal by Subject|14|||
170513335|NCT01451554|616224675|FG001|Overall Study|Withdrawal by Subject|9|||
170513336|NCT02452554|616224676|FG000|Overall Study|Death|2|||
170513337|NCT02452554|616224677|FG001|Overall Study|Death|1|||
170513338|NCT02452554|616224678|FG002|Overall Study|Death|0|||
170513339|NCT02452554|616224679|FG003|Overall Study|Death|0|||
170513340|NCT02452554|616224680|FG004|Overall Study|Death|0|||
170513341|NCT02452554|616224681|FG005|Overall Study|Death|0|||
170513342|NCT02452554|616224676|FG000|Overall Study|Lack of Efficacy|13|||
170513343|NCT02452554|616224677|FG001|Overall Study|Lack of Efficacy|14|||
170513344|NCT02452554|616224678|FG002|Overall Study|Lack of Efficacy|9|||
170513345|NCT02452554|616224679|FG003|Overall Study|Lack of Efficacy|1|||
170513346|NCT02452554|616224680|FG004|Overall Study|Lack of Efficacy|5|||
170513347|NCT02452554|616224681|FG005|Overall Study|Lack of Efficacy|8|||
170513348|NCT02452554|616224676|FG000|Overall Study|Physician Decision|0|||
170513349|NCT02452554|616224677|FG001|Overall Study|Physician Decision|1|||
170513350|NCT02452554|616224678|FG002|Overall Study|Physician Decision|0|||
170513351|NCT02452554|616224679|FG003|Overall Study|Physician Decision|0|||
170513352|NCT02452554|616224680|FG004|Overall Study|Physician Decision|0|||
170513353|NCT02452554|616224681|FG005|Overall Study|Physician Decision|0|||
170513354|NCT02452554|616224676|FG000|Overall Study|Withdrawal by Subject|1|||
170513355|NCT02452554|616224677|FG001|Overall Study|Withdrawal by Subject|0|||
170513356|NCT02452554|616224678|FG002|Overall Study|Withdrawal by Subject|2|||
170513357|NCT02452554|616224679|FG003|Overall Study|Withdrawal by Subject|0|||
170513358|NCT02452554|616224680|FG004|Overall Study|Withdrawal by Subject|0|||
170513359|NCT02452554|616224681|FG005|Overall Study|Withdrawal by Subject|1|||
170513360|NCT02452554|616224676|FG000|Overall Study|Ineligible|0|||
170513361|NCT02452554|616224677|FG001|Overall Study|Ineligible|1|||
170554379|NCT03997383|616376902|FG000|Double-blind Treatment Period|Adverse Event|4|||
170554380|NCT03997383|616376903|FG001|Double-blind Treatment Period|Adverse Event|3|||
170554381|NCT03997383|616376902|FG000|Double-blind Treatment Period|Death|4|||
170554382|NCT03997383|616376903|FG001|Double-blind Treatment Period|Death|4|||
170554383|NCT03997383|616376902|FG000|Double-blind Treatment Period|Physician Decision|2|||
170554384|NCT03997383|616376903|FG001|Double-blind Treatment Period|Physician Decision|0|||
170554385|NCT03997383|616376902|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
170554386|NCT03997383|616376903|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
170554387|NCT03997383|616376902|FG000|Open-label Extension Period|Ongoing|148|||
170554388|NCT03997383|616376903|FG001|Open-label Extension Period|Ongoing|151|||
170513362|NCT02452554|616224678|FG002|Overall Study|Ineligible|0|||
170554389|NCT03997383|616376902|FG000|Open-label Extension Period|Adverse Event|4|||
170554390|NCT03997383|616376903|FG001|Open-label Extension Period|Adverse Event|1|||
170513363|NCT02452554|616224679|FG003|Overall Study|Ineligible|0|||
170513364|NCT02452554|616224680|FG004|Overall Study|Ineligible|0|||
170513365|NCT02452554|616224681|FG005|Overall Study|Ineligible|0|||
170513366|NCT02452554|616224676|FG000|Overall Study|Never Received Treatment|1|||
170513367|NCT02452554|616224677|FG001|Overall Study|Never Received Treatment|0|||
170513368|NCT02452554|616224678|FG002|Overall Study|Never Received Treatment|0|||
170554391|NCT03997383|616376902|FG000|Open-label Extension Period|Death|8|||
170806270|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
170806271|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
170513369|NCT02452554|616224679|FG003|Overall Study|Never Received Treatment|0|||
170513370|NCT02452554|616224680|FG004|Overall Study|Never Received Treatment|0|||
170513371|NCT02452554|616224681|FG005|Overall Study|Never Received Treatment|0|||
170513372|NCT01085084|616224682|FG000|Overall Study|Withdrawal by Subject|1|||
170513373|NCT01085084|616224683|FG001|Overall Study|Withdrawal by Subject|0|||
170513374|NCT01085084|616224684|FG002|Overall Study|Withdrawal by Subject|0|||
170513375|NCT01085084|616224682|FG000|Overall Study|Lost to Follow-up|2|||
170513376|NCT01085084|616224683|FG001|Overall Study|Lost to Follow-up|1|||
170513377|NCT01085084|616224684|FG002|Overall Study|Lost to Follow-up|1|||
170513378|NCT01085084|616224682|FG000|Overall Study|Adverse Event|4|||
170513379|NCT01085084|616224683|FG001|Overall Study|Adverse Event|3|||
170513380|NCT01085084|616224684|FG002|Overall Study|Adverse Event|6|||
170513381|NCT01085084|616224682|FG000|Overall Study|Treatment Failure|0|||
170513382|NCT01085084|616224683|FG001|Overall Study|Treatment Failure|1|||
170513383|NCT01085084|616224684|FG002|Overall Study|Treatment Failure|2|||
170513384|NCT02749799|616224685|FG000|Overall Study|Adverse Event|2|||
170513385|NCT02749799|616224685|FG000|Overall Study|Lost to Follow-up|4|||
170513386|NCT02749799|616224685|FG000|Overall Study|Protocol Violation|1|||
170513387|NCT02749799|616224685|FG000|Overall Study|Withdrawal by Subject|1|||
170513388|NCT04378569|616226567|FG000|Overall Study|Adverse Event|0|||
170513389|NCT04378569|616226568|FG001|Overall Study|Adverse Event|0|||
170513390|NCT04378569|616226569|FG002|Overall Study|Adverse Event|2|||
170513391|NCT04378569|616226570|FG003|Overall Study|Adverse Event|0|||
170513392|NCT04378569|616226571|FG004|Overall Study|Adverse Event|3|||
170513393|NCT04378569|616226572|FG005|Overall Study|Adverse Event|3|||
170513394|NCT04378569|616226567|FG000|Overall Study|Lost to Follow-up|0|||
170513395|NCT04378569|616226568|FG001|Overall Study|Lost to Follow-up|3|||
170513396|NCT04378569|616226569|FG002|Overall Study|Lost to Follow-up|1|||
170513397|NCT04378569|616226570|FG003|Overall Study|Lost to Follow-up|0|||
170513398|NCT04378569|616226571|FG004|Overall Study|Lost to Follow-up|1|||
170513399|NCT04378569|616226572|FG005|Overall Study|Lost to Follow-up|1|||
170513400|NCT04378569|616226567|FG000|Overall Study|Protocol Violation|0|||
170513401|NCT04378569|616226568|FG001|Overall Study|Protocol Violation|0|||
170513402|NCT04378569|616226569|FG002|Overall Study|Protocol Violation|0|||
170513403|NCT04378569|616226570|FG003|Overall Study|Protocol Violation|0|||
170513404|NCT04378569|616226571|FG004|Overall Study|Protocol Violation|0|||
170513405|NCT04378569|616226572|FG005|Overall Study|Protocol Violation|1|||
170513406|NCT04378569|616226567|FG000|Overall Study|Withdrawal by Subject|0|||
170513407|NCT04378569|616226568|FG001|Overall Study|Withdrawal by Subject|6|||
170513408|NCT04378569|616226569|FG002|Overall Study|Withdrawal by Subject|7|||
170513409|NCT04378569|616226570|FG003|Overall Study|Withdrawal by Subject|4|||
170513410|NCT04378569|616226571|FG004|Overall Study|Withdrawal by Subject|5|||
170513411|NCT04378569|616226572|FG005|Overall Study|Withdrawal by Subject|4|||
170513412|NCT04378569|616226567|FG000|Overall Study|Lack of response|0|||
170513413|NCT04378569|616226568|FG001|Overall Study|Lack of response|0|||
170513414|NCT04378569|616226569|FG002|Overall Study|Lack of response|1|||
170513415|NCT04378569|616226570|FG003|Overall Study|Lack of response|0|||
170513416|NCT04378569|616226571|FG004|Overall Study|Lack of response|1|||
170513417|NCT04378569|616226572|FG005|Overall Study|Lack of response|1|||
170513418|NCT03251482|616226574|FG000|Overall Study|Withdrawal by Subject|0|||
170513419|NCT03251482|616226575|FG001|Overall Study|Withdrawal by Subject|1|||
170513420|NCT03251482|616226576|FG002|Overall Study|Withdrawal by Subject|0|||
170513421|NCT03251482|616226577|FG003|Overall Study|Withdrawal by Subject|0|||
170513422|NCT03251482|616226578|FG004|Overall Study|Withdrawal by Subject|0|||
170513423|NCT02823470|616226581|FG000|Overall Study|Adverse Event|1|||
170806272|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
170806273|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
170513424|NCT02823470|616226582|FG001|Overall Study|Adverse Event|0|||
170513425|NCT02823470|616226581|FG000|Overall Study|Study terminated by sponsor|8|||
170513426|NCT02823470|616226582|FG001|Overall Study|Study terminated by sponsor|15|||
170513427|NCT02688764|616226583|FG000|Overall Study|Adverse Event|3|||
170513428|NCT02688764|616226584|FG001|Overall Study|Adverse Event|3|||
170513429|NCT02688764|616226583|FG000|Overall Study|AE/Kidney transplant|1|||
170513430|NCT02688764|616226584|FG001|Overall Study|AE/Kidney transplant|0|||
170513431|NCT02688764|616226583|FG000|Overall Study|AE/Lack of efficacy|1|||
170513432|NCT02688764|616226584|FG001|Overall Study|AE/Lack of efficacy|0|||
170513433|NCT02688764|616226583|FG000|Overall Study|AE/Non-compl.|1|||
170513434|NCT02688764|616226584|FG001|Overall Study|AE/Non-compl.|0|||
170513435|NCT02688764|616226583|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
170513436|NCT02688764|616226584|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
170513437|NCT02688764|616226583|FG000|Overall Study|AE/Other|0|||
170513438|NCT02688764|616226584|FG001|Overall Study|AE/Other|1|||
170513439|NCT02688764|616226583|FG000|Overall Study|AE/Physician decision|1|||
170513440|NCT02688764|616226584|FG001|Overall Study|AE/Physician decision|0|||
170513441|NCT02688764|616226583|FG000|Overall Study|AE/Withd. parent|3|||
170513442|NCT02688764|616226584|FG001|Overall Study|AE/Withd. parent|0|||
170513443|NCT02688764|616226583|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
170554392|NCT03997383|616376903|FG001|Open-label Extension Period|Death|9|||
170554393|NCT03997383|616376902|FG000|Open-label Extension Period|Physician Decision|1|||
170554394|NCT03997383|616376903|FG001|Open-label Extension Period|Physician Decision|1|||
170554395|NCT03997383|616376902|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
170513444|NCT02688764|616226584|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
170513445|NCT02688764|616226583|FG000|Overall Study|AE/Withd. subject|1|||
170513446|NCT02688764|616226584|FG001|Overall Study|AE/Withd. subject|0|||
170513447|NCT02688764|616226583|FG000|Overall Study|Kidney transplant|10|||
170513448|NCT02688764|616226584|FG001|Overall Study|Kidney transplant|4|||
170513449|NCT02688764|616226583|FG000|Overall Study|Lack of Efficacy|3|||
170513450|NCT02688764|616226584|FG001|Overall Study|Lack of Efficacy|2|||
170513451|NCT02688764|616226583|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
170513452|NCT02688764|616226584|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
170513453|NCT02688764|616226583|FG000|Overall Study|Non-compliance with study drug|4|||
170513454|NCT02688764|616226584|FG001|Overall Study|Non-compliance with study drug|0|||
170513455|NCT02688764|616226583|FG000|Overall Study|Non-compl./Physician decision|2|||
170513456|NCT02688764|616226584|FG001|Overall Study|Non-compl./Physician decision|0|||
170513457|NCT02688764|616226583|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
170513458|NCT02688764|616226584|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
170513459|NCT02688764|616226583|FG000|Overall Study|Non-compl./Withd. subject|0|||
170513460|NCT02688764|616226584|FG001|Overall Study|Non-compl./Withd. subject|2|||
170513461|NCT02688764|616226583|FG000|Overall Study|Phosphorus level outside safe range|0|||
170513462|NCT02688764|616226584|FG001|Overall Study|Phosphorus level outside safe range|1|||
170513463|NCT02688764|616226583|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
170513464|NCT02688764|616226584|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
170513465|NCT02688764|616226583|FG000|Overall Study|Study drug taste/Withd. parent|1|||
170513466|NCT02688764|616226584|FG001|Overall Study|Study drug taste/Withd. parent|0|||
170513467|NCT02688764|616226583|FG000|Overall Study|Subject moving out|2|||
170513468|NCT02688764|616226584|FG001|Overall Study|Subject moving out|0|||
170513469|NCT02688764|616226583|FG000|Overall Study|Subject taken off dialysis|1|||
170513470|NCT02688764|616226584|FG001|Overall Study|Subject taken off dialysis|0|||
170513471|NCT02688764|616226583|FG000|Overall Study|Withdrawal by parent|3|||
170513472|NCT02688764|616226584|FG001|Overall Study|Withdrawal by parent|0|||
170513473|NCT02579382|616226585|FG000|Main Study Phase|Lost to Follow-up|0|||
170554396|NCT03997383|616376903|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
170554397|NCT03997383|616376902|FG000|Open-label Extension Period|Reason Not Specified|2|||
170554398|NCT03997383|616376903|FG001|Open-label Extension Period|Reason Not Specified|0|||
170554399|NCT01856478|616376906|FG000|Overall Study|Not treated|0|||
170554400|NCT01856478|616376907|FG001|Overall Study|Not treated|8|||
170554401|NCT01856478|616376906|FG000|Overall Study|Progressive disease per RECIST|146|||
170554402|NCT01856478|616376907|FG001|Overall Study|Progressive disease per RECIST|49|||
170554403|NCT01856478|616376906|FG000|Overall Study|Worsening of underlying cancer|6|||
170554404|NCT01856478|616376907|FG001|Overall Study|Worsening of underlying cancer|2|||
170554405|NCT01856478|616376906|FG000|Overall Study|Adverse events|57|||
170554406|NCT01856478|616376907|FG001|Overall Study|Adverse events|30|||
170554407|NCT01856478|616376906|FG000|Overall Study|Non-compliant with protocol|1|||
170554408|NCT01856478|616376907|FG001|Overall Study|Non-compliant with protocol|1|||
170554409|NCT01856478|616376906|FG000|Overall Study|Lost to Follow-up|1|||
170554410|NCT01856478|616376907|FG001|Overall Study|Lost to Follow-up|1|||
170554411|NCT01856478|616376906|FG000|Overall Study|Refused to continue trial medication|13|||
170554412|NCT01856478|616376907|FG001|Overall Study|Refused to continue trial medication|11|||
170554413|NCT01856478|616376906|FG000|Overall Study|Other reason than listed|4|||
170554414|NCT01856478|616376907|FG001|Overall Study|Other reason than listed|10|||
170554415|NCT03769116|616376908|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
170554416|NCT03769116|616376909|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
170554417|NCT03769116|616376908|FG000|Part 3 - Open Label|Physician Decision|1|||
170554418|NCT03769116|616376909|FG001|Part 3 - Open Label|Physician Decision|0|||
170554419|NCT03769116|616376908|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
170644365|NCT00282308|616711626|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
170513474|NCT02579382|616226586|FG001|Main Study Phase|Lost to Follow-up|0|||
170513475|NCT02579382|616226587|FG002|Main Study Phase|Lost to Follow-up|2|||
170513476|NCT02579382|616226588|FG003|Main Study Phase|Lost to Follow-up|0|||
170513477|NCT02579382|616226585|FG000|Main Study Phase|Withdrew Consent|0|||
170513478|NCT02579382|616226586|FG001|Main Study Phase|Withdrew Consent|0|||
170513479|NCT02579382|616226587|FG002|Main Study Phase|Withdrew Consent|0|||
170554420|NCT03769116|616376909|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
170554421|NCT02514746|616376910|FG000|Overall Study|Chronically Ill|1|||
170554422|NCT02514746|616376911|FG001|Overall Study|Chronically Ill|2|||
170554423|NCT02514746|616376910|FG000|Overall Study|Physician Decision|4|||
170554424|NCT02514746|616376911|FG001|Overall Study|Physician Decision|2|||
170554425|NCT02514746|616376910|FG000|Overall Study|Withdrawal by Subject|12|||
170513480|NCT02579382|616226588|FG003|Main Study Phase|Withdrew Consent|2|||
170513481|NCT02579382|616226585|FG000|Main Study Phase|Lack of Efficacy|0|||
170513482|NCT02579382|616226586|FG001|Main Study Phase|Lack of Efficacy|0|||
170513483|NCT02579382|616226587|FG002|Main Study Phase|Lack of Efficacy|0|||
170513484|NCT02579382|616226588|FG003|Main Study Phase|Lack of Efficacy|1|||
170513485|NCT02579382|616226585|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
170513486|NCT02579382|616226586|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
170554426|NCT02514746|616376911|FG001|Overall Study|Withdrawal by Subject|10|||
170554427|NCT02514746|616376910|FG000|Overall Study|Other|5|||
170554428|NCT02514746|616376911|FG001|Overall Study|Other|1|||
170513487|NCT02579382|616226587|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
170513488|NCT02579382|616226588|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
170513489|NCT02579382|616226585|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
170554429|NCT03030261|616376912|FG000|Overall Study|Still receiving continuation therapy|5|||
170554430|NCT04003142|616376913|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
170554431|NCT04003142|616376914|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
170513490|NCT02579382|616226586|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
170513491|NCT02579382|616226587|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
170513492|NCT02579382|616226588|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
170513493|NCT02579382|616226585|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
170513494|NCT02579382|616226586|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
170513495|NCT02579382|616226587|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
170513496|NCT02579382|616226588|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
170513497|NCT02579382|616226585|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
170513498|NCT02579382|616226586|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
170513499|NCT02579382|616226587|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
170513500|NCT02579382|616226588|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
170513501|NCT02579382|616226585|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
170513502|NCT02579382|616226586|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
170513503|NCT02579382|616226587|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
170513504|NCT02579382|616226588|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
170513505|NCT02579382|616226585|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
170513506|NCT02579382|616226586|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
170513507|NCT02579382|616226587|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
170513508|NCT02579382|616226588|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
170513509|NCT03026283|616226589|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
170513510|NCT03026283|616226590|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
170513511|NCT03026283|616226591|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
170513512|NCT03026283|616226592|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
170513513|NCT03026283|616226593|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
170513514|NCT03026283|616226594|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
170513515|NCT03026283|616226595|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
170513516|NCT03026283|616226596|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
170513517|NCT03026283|616226589|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
170513518|NCT03026283|616226590|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
170513519|NCT03026283|616226591|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
170513520|NCT03026283|616226592|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
170513521|NCT03026283|616226593|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
170513522|NCT03026283|616226594|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
170513523|NCT03026283|616226595|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
170513524|NCT03026283|616226596|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
170513525|NCT03026283|616226589|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
170513526|NCT03026283|616226590|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
170513527|NCT03026283|616226591|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
170513528|NCT03026283|616226592|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
170513529|NCT03026283|616226593|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
170554432|NCT04003142|616376915|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
170554433|NCT04003142|616376916|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
170554434|NCT04003142|616376917|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
170905148|NCT03068715|617656025|FG001|Overall Study|No longer met inclusion criteria|0|||
170905149|NCT00728416|617656026|FG000|Overall Study|Adverse Event|1|||
170905150|NCT00728416|617656027|FG001|Overall Study|Adverse Event|1|||
170905151|NCT00728416|617656026|FG000|Overall Study|Treatment Failure|0|||
170905152|NCT00728416|617656027|FG001|Overall Study|Treatment Failure|1|||
170905153|NCT00728416|617656026|FG000|Overall Study|Withdrawal by Subject|1|||
170905154|NCT00728416|617656027|FG001|Overall Study|Withdrawal by Subject|0|||
170905155|NCT03584009|617656028|FG000|Overall Study|Death|25|||
170905156|NCT03584009|617656029|FG001|Overall Study|Death|18|||
170905157|NCT03584009|617656028|FG000|Overall Study|Lost to Follow-up|0|||
170905158|NCT03584009|617656029|FG001|Overall Study|Lost to Follow-up|1|||
170905159|NCT03584009|617656028|FG000|Overall Study|Physician Decision|1|||
170905160|NCT03584009|617656029|FG001|Overall Study|Physician Decision|1|||
170905161|NCT03584009|617656028|FG000|Overall Study|Study Terminated by Sponsor|22|||
170905162|NCT03584009|617656029|FG001|Overall Study|Study Terminated by Sponsor|30|||
170905163|NCT03584009|617656028|FG000|Overall Study|Withdrawal by Subject|3|||
170905164|NCT03584009|617656029|FG001|Overall Study|Withdrawal by Subject|2|||
170554435|NCT04003142|616376913|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
170554436|NCT04003142|616376914|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
170554437|NCT04003142|616376915|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
170905165|NCT00768560|617656030|FG000|Intervention Set 1|Adverse Event|0|||
170905166|NCT00768560|617656031|FG001|Intervention Set 1|Adverse Event|1|||
170905167|NCT00768560|617656032|FG002|Intervention Set 1|Adverse Event|0|||
170905168|NCT00768560|617656033|FG003|Intervention Set 1|Adverse Event|0|||
170905169|NCT00768560|617656034|FG004|Intervention Set 1|Adverse Event|0|||
170905170|NCT00768560|617656035|FG005|Intervention Set 1|Adverse Event|0|||
170905171|NCT04433117|617656040|FG000|Overall Study|Withdrawal by Subject|1|||
170644366|NCT01001325|616711627|FG000|Overall Study|Lost to Follow-up|16|||
170644367|NCT01001325|616711628|FG001|Overall Study|Lost to Follow-up|10|||
170644368|NCT01001325|616711627|FG000|Overall Study|Protocol Violation|2|||
170644369|NCT01001325|616711628|FG001|Overall Study|Protocol Violation|0|||
170644370|NCT05477108|616711629|FG000|Overall Study|Participants randomized, not treated|1|||
170644371|NCT05477108|616711630|FG001|Overall Study|Participants randomized, not treated|1|||
170644372|NCT05477108|616711631|FG002|Overall Study|Participants randomized, not treated|1|||
170644373|NCT05477108|616711629|FG000|Overall Study|Physician Decision|0|||
170644374|NCT05477108|616711630|FG001|Overall Study|Physician Decision|0|||
170644375|NCT05477108|616711631|FG002|Overall Study|Physician Decision|1|||
170644376|NCT05477108|616711629|FG000|Overall Study|withdrawn from study|0|||
170644377|NCT05477108|616711630|FG001|Overall Study|withdrawn from study|0|||
170644378|NCT05477108|616711631|FG002|Overall Study|withdrawn from study|1|||
170644379|NCT03255083|616711637|FG000|Overall Study|Clinical progression|1|||
170644380|NCT03255083|616711638|FG001|Overall Study|Clinical progression|0|||
170644381|NCT03255083|616711639|FG002|Overall Study|Clinical progression|0|||
170644382|NCT03255083|616711640|FG003|Overall Study|Clinical progression|0|||
170644383|NCT03255083|616711637|FG000|Overall Study|Adverse Event|0|||
170644384|NCT03255083|616711638|FG001|Overall Study|Adverse Event|1|||
170644385|NCT03255083|616711639|FG002|Overall Study|Adverse Event|0|||
170644386|NCT03255083|616711640|FG003|Overall Study|Adverse Event|0|||
170644387|NCT03255083|616711637|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
170644388|NCT03255083|616711638|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
170644389|NCT03255083|616711639|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
170644390|NCT03255083|616711640|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
170644391|NCT03255083|616711637|FG000|Overall Study|Withdrawal by Subject|1|||
170644392|NCT03255083|616711638|FG001|Overall Study|Withdrawal by Subject|1|||
170644393|NCT03255083|616711639|FG002|Overall Study|Withdrawal by Subject|1|||
170644394|NCT03255083|616711640|FG003|Overall Study|Withdrawal by Subject|0|||
170644395|NCT01330017|616713764|FG000|Overall Study|Adverse Event|0|||
170644396|NCT01330017|616713765|FG001|Overall Study|Adverse Event|1|||
170644397|NCT01330017|616713766|FG002|Overall Study|Adverse Event|1|||
170644398|NCT01330017|616713767|FG003|Overall Study|Adverse Event|4|||
170644399|NCT01330017|616713768|FG004|Overall Study|Adverse Event|0|||
170644400|NCT01330017|616713764|FG000|Overall Study|Withdrawal by Subject|0|||
170644401|NCT01330017|616713765|FG001|Overall Study|Withdrawal by Subject|0|||
170644402|NCT01330017|616713766|FG002|Overall Study|Withdrawal by Subject|1|||
170644403|NCT01330017|616713767|FG003|Overall Study|Withdrawal by Subject|0|||
170644404|NCT01330017|616713768|FG004|Overall Study|Withdrawal by Subject|1|||
170644405|NCT01330017|616713764|FG000|Overall Study|Lost to Follow-up|0|||
170644406|NCT01330017|616713765|FG001|Overall Study|Lost to Follow-up|0|||
170644407|NCT01330017|616713766|FG002|Overall Study|Lost to Follow-up|1|||
170644408|NCT01330017|616713767|FG003|Overall Study|Lost to Follow-up|0|||
170644409|NCT01330017|616713768|FG004|Overall Study|Lost to Follow-up|0|||
170644410|NCT01330017|616713764|FG000|Overall Study|Protocol Violation|0|||
170644411|NCT01330017|616713765|FG001|Overall Study|Protocol Violation|0|||
170644412|NCT01330017|616713766|FG002|Overall Study|Protocol Violation|0|||
170644413|NCT01330017|616713767|FG003|Overall Study|Protocol Violation|1|||
170644414|NCT01330017|616713768|FG004|Overall Study|Protocol Violation|0|||
170644415|NCT01330017|616713764|FG000|Overall Study|Unknown Reason|5|||
170644416|NCT01330017|616713765|FG001|Overall Study|Unknown Reason|3|||
170644417|NCT01330017|616713766|FG002|Overall Study|Unknown Reason|5|||
170644418|NCT01330017|616713767|FG003|Overall Study|Unknown Reason|7|||
170644419|NCT01330017|616713768|FG004|Overall Study|Unknown Reason|2|||
170644420|NCT01325337|616713769|FG000|Overall Study|Adverse Event|0|||
170644421|NCT01325337|616713770|FG001|Overall Study|Adverse Event|2|||
170644422|NCT01325337|616713771|FG002|Overall Study|Adverse Event|2|||
170644423|NCT01325337|616713772|FG003|Overall Study|Adverse Event|1|||
170644424|NCT01325337|616713773|FG004|Overall Study|Adverse Event|2|||
170644425|NCT01325337|616713769|FG000|Overall Study|Lost to Follow-up|2|||
170644426|NCT01325337|616713770|FG001|Overall Study|Lost to Follow-up|2|||
170806274|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
170806275|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
170806276|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
170806277|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
170806278|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
170806279|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
170806280|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
170806281|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
170806282|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
170806283|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
170806284|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
170644427|NCT01325337|616713771|FG002|Overall Study|Lost to Follow-up|2|||
170644428|NCT01325337|616713772|FG003|Overall Study|Lost to Follow-up|1|||
170644429|NCT01325337|616713773|FG004|Overall Study|Lost to Follow-up|2|||
170644430|NCT01325337|616713769|FG000|Overall Study|Personal Reasons|2|||
170644431|NCT01325337|616713770|FG001|Overall Study|Personal Reasons|5|||
170644432|NCT01325337|616713771|FG002|Overall Study|Personal Reasons|4|||
170644433|NCT01325337|616713772|FG003|Overall Study|Personal Reasons|8|||
170644434|NCT01325337|616713773|FG004|Overall Study|Personal Reasons|3|||
170644435|NCT01325337|616713769|FG000|Overall Study|Withdrawal by Subject|1|||
170644436|NCT01325337|616713770|FG001|Overall Study|Withdrawal by Subject|0|||
170644437|NCT01325337|616713771|FG002|Overall Study|Withdrawal by Subject|1|||
170644438|NCT01325337|616713772|FG003|Overall Study|Withdrawal by Subject|0|||
170644439|NCT01325337|616713773|FG004|Overall Study|Withdrawal by Subject|1|||
170644440|NCT00830869|616713774|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
170644441|NCT00830869|616713775|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
170644442|NCT00830869|616713776|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
170644443|NCT00830869|616713777|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
170644444|NCT00830869|616713778|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
170644445|NCT00830869|616713779|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
170644446|NCT00830869|616713780|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
170644447|NCT00830869|616713781|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
170644448|NCT00830869|616713782|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
170644449|NCT00830869|616713783|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
170644450|NCT00830869|616713784|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
170644451|NCT00830869|616713785|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
170644452|NCT00830869|616713774|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
170644453|NCT00830869|616713775|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
170644454|NCT00830869|616713776|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
170644455|NCT00830869|616713777|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
170644456|NCT00830869|616713778|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
170644457|NCT00830869|616713779|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
170644458|NCT00830869|616713780|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
170644459|NCT00830869|616713781|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
170644460|NCT00830869|616713782|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
170644461|NCT00830869|616713783|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
170644462|NCT00830869|616713784|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
170644463|NCT00830869|616713785|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
170644464|NCT00830869|616713774|FG000|Period 1: Part 1|Adverse Event|0|||
170644465|NCT00830869|616713775|FG001|Period 1: Part 1|Adverse Event|0|||
170644466|NCT00830869|616713776|FG002|Period 1: Part 1|Adverse Event|0|||
170644467|NCT00830869|616713777|FG003|Period 1: Part 1|Adverse Event|0|||
170644468|NCT00830869|616713778|FG004|Period 1: Part 1|Adverse Event|0|||
170644469|NCT00830869|616713779|FG005|Period 1: Part 1|Adverse Event|1|||
170644470|NCT00830869|616713780|FG006|Period 1: Part 1|Adverse Event|1|||
170644471|NCT00830869|616713781|FG007|Period 1: Part 1|Adverse Event|0|||
170644472|NCT00830869|616713782|FG008|Period 1: Part 1|Adverse Event|0|||
170644473|NCT00830869|616713783|FG009|Period 1: Part 1|Adverse Event|0|||
170644474|NCT00830869|616713784|FG010|Period 1: Part 1|Adverse Event|0|||
170644475|NCT00830869|616713785|FG011|Period 1: Part 1|Adverse Event|0|||
170644476|NCT00830869|616713774|FG000|Period 1: Part 1|Progressive disease|1|||
170644477|NCT00830869|616713775|FG001|Period 1: Part 1|Progressive disease|0|||
170644478|NCT00830869|616713776|FG002|Period 1: Part 1|Progressive disease|1|||
170644479|NCT00830869|616713777|FG003|Period 1: Part 1|Progressive disease|6|||
170644480|NCT00830869|616713778|FG004|Period 1: Part 1|Progressive disease|4|||
170644481|NCT00830869|616713779|FG005|Period 1: Part 1|Progressive disease|4|||
170644482|NCT00830869|616713780|FG006|Period 1: Part 1|Progressive disease|1|||
170644483|NCT00830869|616713781|FG007|Period 1: Part 1|Progressive disease|0|||
170644484|NCT00830869|616713782|FG008|Period 1: Part 1|Progressive disease|0|||
170644485|NCT00830869|616713783|FG009|Period 1: Part 1|Progressive disease|0|||
170644486|NCT00830869|616713784|FG010|Period 1: Part 1|Progressive disease|0|||
170644487|NCT00830869|616713785|FG011|Period 1: Part 1|Progressive disease|0|||
170644488|NCT00830869|616713774|FG000|Period 2: Part 2|Protocol Violation|0|||
170806285|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
170806286|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
170806287|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
170644489|NCT00830869|616713775|FG001|Period 2: Part 2|Protocol Violation|0|||
170644490|NCT00830869|616713776|FG002|Period 2: Part 2|Protocol Violation|0|||
170644491|NCT00830869|616713777|FG003|Period 2: Part 2|Protocol Violation|0|||
170644492|NCT00830869|616713778|FG004|Period 2: Part 2|Protocol Violation|0|||
170644493|NCT00830869|616713779|FG005|Period 2: Part 2|Protocol Violation|0|||
170644494|NCT00830869|616713780|FG006|Period 2: Part 2|Protocol Violation|0|||
170644495|NCT00830869|616713781|FG007|Period 2: Part 2|Protocol Violation|1|||
170644496|NCT00830869|616713782|FG008|Period 2: Part 2|Protocol Violation|0|||
170644497|NCT00830869|616713783|FG009|Period 2: Part 2|Protocol Violation|1|||
170644498|NCT00830869|616713784|FG010|Period 2: Part 2|Protocol Violation|0|||
170644499|NCT00830869|616713785|FG011|Period 2: Part 2|Protocol Violation|0|||
170644500|NCT00830869|616713774|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
170644501|NCT00830869|616713775|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
170644502|NCT00830869|616713776|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
170644503|NCT00830869|616713777|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
170644504|NCT00830869|616713778|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
170644505|NCT00830869|616713779|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
170644506|NCT00830869|616713780|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
170644507|NCT00830869|616713781|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
170644508|NCT00830869|616713782|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
170644509|NCT00830869|616713783|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
170644510|NCT00830869|616713784|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
170644511|NCT00830869|616713785|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
170644512|NCT00830869|616713774|FG000|Period 2: Part 2|Adverse Event|0|||
170644513|NCT00830869|616713775|FG001|Period 2: Part 2|Adverse Event|0|||
170644514|NCT00830869|616713776|FG002|Period 2: Part 2|Adverse Event|0|||
170513530|NCT03026283|616226594|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
170513531|NCT03026283|616226595|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
170513532|NCT03026283|616226596|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
170513533|NCT03026283|616226589|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
170644515|NCT00830869|616713777|FG003|Period 2: Part 2|Adverse Event|0|||
170644516|NCT00830869|616713778|FG004|Period 2: Part 2|Adverse Event|0|||
170513534|NCT03026283|616226590|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
170513535|NCT03026283|616226591|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
170644517|NCT00830869|616713779|FG005|Period 2: Part 2|Adverse Event|0|||
170644518|NCT00830869|616713780|FG006|Period 2: Part 2|Adverse Event|0|||
170644519|NCT00830869|616713781|FG007|Period 2: Part 2|Adverse Event|4|||
170644520|NCT00830869|616713782|FG008|Period 2: Part 2|Adverse Event|3|||
170644521|NCT00830869|616713783|FG009|Period 2: Part 2|Adverse Event|2|||
170644522|NCT00830869|616713784|FG010|Period 2: Part 2|Adverse Event|2|||
170644523|NCT00830869|616713785|FG011|Period 2: Part 2|Adverse Event|0|||
170644524|NCT00830869|616713774|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
170644525|NCT00830869|616713775|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
170644526|NCT00830869|616713776|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
170644527|NCT00830869|616713777|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
170644528|NCT00830869|616713778|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
170644529|NCT00830869|616713779|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
170644530|NCT00830869|616713780|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
170644531|NCT00830869|616713781|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
170644532|NCT00830869|616713782|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
170644533|NCT00830869|616713783|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
170644534|NCT00830869|616713784|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
170644535|NCT00830869|616713785|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
170644536|NCT00830869|616713774|FG000|Period 2: Part 2|Progressive disease|0|||
170644537|NCT00830869|616713775|FG001|Period 2: Part 2|Progressive disease|0|||
170644538|NCT00830869|616713776|FG002|Period 2: Part 2|Progressive disease|0|||
170644539|NCT00830869|616713777|FG003|Period 2: Part 2|Progressive disease|0|||
170644540|NCT00830869|616713778|FG004|Period 2: Part 2|Progressive disease|0|||
170644541|NCT00830869|616713779|FG005|Period 2: Part 2|Progressive disease|0|||
170644542|NCT00830869|616713780|FG006|Period 2: Part 2|Progressive disease|0|||
170644543|NCT00830869|616713781|FG007|Period 2: Part 2|Progressive disease|14|||
170644544|NCT00830869|616713782|FG008|Period 2: Part 2|Progressive disease|11|||
170644545|NCT00830869|616713783|FG009|Period 2: Part 2|Progressive disease|12|||
170644546|NCT00830869|616713784|FG010|Period 2: Part 2|Progressive disease|8|||
170644547|NCT00830869|616713785|FG011|Period 2: Part 2|Progressive disease|15|||
170644548|NCT00830869|616713774|FG000|Period 2: Part 2|Other|0|||
170644549|NCT00830869|616713775|FG001|Period 2: Part 2|Other|0|||
170644550|NCT00830869|616713776|FG002|Period 2: Part 2|Other|0|||
170644551|NCT00830869|616713777|FG003|Period 2: Part 2|Other|0|||
170644552|NCT00830869|616713778|FG004|Period 2: Part 2|Other|0|||
170644553|NCT00830869|616713779|FG005|Period 2: Part 2|Other|0|||
170806288|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
170513536|NCT03026283|616226592|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
170644554|NCT00830869|616713780|FG006|Period 2: Part 2|Other|0|||
170644555|NCT00830869|616713781|FG007|Period 2: Part 2|Other|0|||
170644556|NCT00830869|616713782|FG008|Period 2: Part 2|Other|0|||
170644557|NCT00830869|616713783|FG009|Period 2: Part 2|Other|1|||
170644558|NCT00830869|616713784|FG010|Period 2: Part 2|Other|0|||
170644559|NCT00830869|616713785|FG011|Period 2: Part 2|Other|0|||
170644560|NCT00281658|616713786|FG000|Randomized Phase|Adverse Event|0|||
170644561|NCT00281658|616713787|FG001|Randomized Phase|Adverse Event|2|||
170644562|NCT00281658|616713788|FG002|Randomized Phase|Adverse Event|0|||
170644563|NCT00281658|616713789|FG003|Randomized Phase|Adverse Event|0|||
170644564|NCT00281658|616713786|FG000|Randomized Phase|Lost to Follow-up|34|||
170644565|NCT00281658|616713787|FG001|Randomized Phase|Lost to Follow-up|27|||
170513537|NCT03026283|616226593|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
170513538|NCT03026283|616226594|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
170513539|NCT03026283|616226595|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
170513540|NCT03026283|616226596|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
170513541|NCT03026283|616226589|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
170513542|NCT03026283|616226590|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
170513543|NCT03026283|616226591|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
170513544|NCT03026283|616226592|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
170513545|NCT03026283|616226593|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
170513546|NCT03026283|616226594|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
170513547|NCT03026283|616226595|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
170513548|NCT03026283|616226596|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
170513549|NCT03026283|616226589|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
170513550|NCT03026283|616226590|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
170513551|NCT03026283|616226591|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
170513552|NCT03026283|616226592|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
170513553|NCT03026283|616226593|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
170513554|NCT03026283|616226594|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
170513555|NCT03026283|616226595|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
170513556|NCT03026283|616226596|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
170513557|NCT03026283|616226589|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
170513558|NCT03026283|616226590|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
170513559|NCT03026283|616226591|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
170513560|NCT03026283|616226592|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
170513561|NCT03026283|616226593|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
170513562|NCT03026283|616226594|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
170513563|NCT03026283|616226595|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
170513564|NCT03026283|616226596|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
170513565|NCT03026283|616226589|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
170513566|NCT03026283|616226590|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
170513567|NCT03026283|616226591|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
170513568|NCT03026283|616226592|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
170513569|NCT03026283|616226593|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
170513570|NCT03026283|616226594|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
170513571|NCT03026283|616226595|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
170513572|NCT03026283|616226596|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
170513573|NCT03026283|616226589|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
170513574|NCT03026283|616226590|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
170513575|NCT03026283|616226591|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
170513576|NCT03026283|616226592|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
170513577|NCT03026283|616226593|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
170513578|NCT03026283|616226594|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
170513579|NCT03026283|616226595|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
170513580|NCT03026283|616226596|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
170513581|NCT03335813|616226604|FG000|Overall Study|Withdrawal by Subject|1|||
170513582|NCT00759655|616226605|FG000|Overall Study|Termination of the study by sponsor|1|||
170513583|NCT02213380|616226613|FG000|Underwent Randomization|Withdrawal by Subject|2|||
170513584|NCT02213380|616226614|FG001|Underwent Randomization|Withdrawal by Subject|0|||
170513585|NCT02213380|616226613|FG000|Underwent Randomization|Not treated|3|||
170513586|NCT02213380|616226614|FG001|Underwent Randomization|Not treated|3|||
170513587|NCT02213380|616226613|FG000|Per-protocol Analysis|Protocol Violation|32|||
170513588|NCT02213380|616226614|FG001|Per-protocol Analysis|Protocol Violation|36|||
170513589|NCT01310127|616226618|FG000|Overall Study|Protocol Violation|1|||
170513590|NCT01310127|616226619|FG001|Overall Study|Protocol Violation|1|||
170513591|NCT01310127|616226618|FG000|Overall Study|advanced psc cataract outlier|1|||
170513592|NCT01310127|616226619|FG001|Overall Study|advanced psc cataract outlier|0|||
170513593|NCT01490840|616226623|FG000|Phase 1|Lost to Follow-up|1|||
170513594|NCT01490840|616226624|FG001|Phase 1|Lost to Follow-up|0|||
170513595|NCT01490840|616226623|FG000|Phase 1|Adverse Event|2|||
170513596|NCT01490840|616226624|FG001|Phase 1|Adverse Event|1|||
170513597|NCT01490840|616226623|FG000|Phase 1|Withdrawal by Subject|6|||
170806289|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
170806290|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
170513598|NCT01490840|616226624|FG001|Phase 1|Withdrawal by Subject|5|||
170513599|NCT01490840|616226623|FG000|Phase 1|Visit 6a omitted|1|||
170513600|NCT01490840|616226624|FG001|Phase 1|Visit 6a omitted|0|||
170513601|NCT01490840|616226623|FG000|Phase 2|Withdrawal by Subject|4|||
170513602|NCT01490840|616226624|FG001|Phase 2|Withdrawal by Subject|3|||
170513603|NCT01490840|616226623|FG000|Phase 2|Permanent interruption of fingolimod|0|||
170513604|NCT01490840|616226624|FG001|Phase 2|Permanent interruption of fingolimod|1|||
170513605|NCT01490840|616226623|FG000|Phase 2|Lost to Follow-up|1|||
170513606|NCT01490840|616226624|FG001|Phase 2|Lost to Follow-up|1|||
170513607|NCT01490840|616226623|FG000|Phase 2|Adverse Event|1|||
170513608|NCT01490840|616226624|FG001|Phase 2|Adverse Event|1|||
170513609|NCT01025284|616226625|FG000|Overall Study|Investigator Decision|0|||
170513610|NCT01025284|616226626|FG001|Overall Study|Investigator Decision|1|||
170513611|NCT01025284|616226627|FG002|Overall Study|Investigator Decision|0|||
170513612|NCT01025284|616226625|FG000|Overall Study|Withdrawal by Subject|0|||
170513613|NCT01025284|616226626|FG001|Overall Study|Withdrawal by Subject|1|||
170513614|NCT01025284|616226627|FG002|Overall Study|Withdrawal by Subject|0|||
170513615|NCT01465230|616226628|FG000|Overall Study|Withdrawal by Subject|2|||
170513616|NCT02753816|616226629|FG000|Overall Study|Protocol Violation|0|||
170513617|NCT02753816|616226630|FG001|Overall Study|Protocol Violation|1|||
170513618|NCT02753816|616226631|FG002|Overall Study|Protocol Violation|0|||
170513619|NCT00905567|616226632|FG000|Washout|Withdrawal by Subject|0|||
170513620|NCT00905567|616226633|FG001|Washout|Withdrawal by Subject|1|||
170513621|NCT01738919|616226638|FG000|Overall Study|Lost to Follow-up|1|||
170513622|NCT01738919|616226639|FG001|Overall Study|Lost to Follow-up|0|||
170513623|NCT01738919|616226638|FG000|Overall Study|Immigrated|0|||
170513624|NCT01738919|616226639|FG001|Overall Study|Immigrated|1|||
170513625|NCT01738919|616226638|FG000|Overall Study|Withdrawal by Subject|0|||
170513626|NCT01738919|616226639|FG001|Overall Study|Withdrawal by Subject|1|||
170513627|NCT01738919|616226638|FG000|Overall Study|Not treated in accordance to guidelines|0|||
170513628|NCT01738919|616226639|FG001|Overall Study|Not treated in accordance to guidelines|1|||
170513629|NCT01473940|616226640|FG000|Induction Therapy|Death|0|||
170513630|NCT01473940|616226641|FG001|Induction Therapy|Death|0|||
170513631|NCT01473940|616226642|FG002|Induction Therapy|Death|1|||
170513632|NCT01473940|616226643|FG003|Induction Therapy|Death|1|||
170513633|NCT01473940|616226640|FG000|Induction Therapy|Progressive Disease|0|||
170513634|NCT01473940|616226641|FG001|Induction Therapy|Progressive Disease|1|||
170513635|NCT01473940|616226642|FG002|Induction Therapy|Progressive Disease|1|||
170513636|NCT01473940|616226643|FG003|Induction Therapy|Progressive Disease|0|||
170513637|NCT01473940|616226640|FG000|Maintenance Therapy|Progressive Disease|1|||
170513638|NCT01473940|616226641|FG001|Maintenance Therapy|Progressive Disease|2|||
170513639|NCT01473940|616226642|FG002|Maintenance Therapy|Progressive Disease|1|||
170513640|NCT01473940|616226643|FG003|Maintenance Therapy|Progressive Disease|4|||
170513641|NCT00621257|616226648|FG000|Overall Study|Lost to Follow-up|4|||
170513642|NCT00621257|616226649|FG001|Overall Study|Lost to Follow-up|0|||
170513643|NCT00621257|616226650|FG002|Overall Study|Lost to Follow-up|2|||
170513644|NCT00621257|616226651|FG003|Overall Study|Lost to Follow-up|4|||
170513645|NCT00621257|616226652|FG004|Overall Study|Lost to Follow-up|7|||
170513646|NCT00621257|616226648|FG000|Overall Study|Adverse Event|0|||
170513647|NCT00621257|616226649|FG001|Overall Study|Adverse Event|1|||
170513648|NCT00621257|616226650|FG002|Overall Study|Adverse Event|1|||
170513649|NCT00621257|616226651|FG003|Overall Study|Adverse Event|0|||
170513650|NCT00621257|616226652|FG004|Overall Study|Adverse Event|0|||
170513651|NCT00621257|616226648|FG000|Overall Study|Physician Decision|0|||
170513652|NCT00621257|616226649|FG001|Overall Study|Physician Decision|2|||
170513653|NCT00621257|616226650|FG002|Overall Study|Physician Decision|0|||
170513654|NCT00621257|616226651|FG003|Overall Study|Physician Decision|1|||
170513655|NCT00621257|616226652|FG004|Overall Study|Physician Decision|1|||
170513656|NCT00621257|616226648|FG000|Overall Study|Withdrawal by Subject|0|||
170513657|NCT00621257|616226649|FG001|Overall Study|Withdrawal by Subject|0|||
170513658|NCT00621257|616226650|FG002|Overall Study|Withdrawal by Subject|0|||
170513659|NCT00621257|616226651|FG003|Overall Study|Withdrawal by Subject|1|||
170513660|NCT00621257|616226652|FG004|Overall Study|Withdrawal by Subject|1|||
170513661|NCT01255904|616226653|FG000|Overall Study|Physician Decision|1|||
170513662|NCT01255904|616226654|FG001|Overall Study|Physician Decision|4|||
170513663|NCT00184002|616226655|FG000|Overall Study|Adverse Event|9|||
170513664|NCT00184002|616226655|FG000|Overall Study|Death|3|||
170513665|NCT00184002|616226655|FG000|Overall Study|Physician Decision|1|||
170513666|NCT00184002|616226655|FG000|Overall Study|Withdrawal by Subject|4|||
170513667|NCT00305227|616226656|FG000|Overall Study|Lost to Follow-up|7|||
170513668|NCT00305227|616226657|FG001|Overall Study|Lost to Follow-up|6|||
170513669|NCT02075008|616226672|FG000|Overall Study|Technical problems|1|||
170513670|NCT02075008|616226672|FG000|Overall Study|Pregnancy|1|||
170513671|NCT02075008|616226672|FG000|Overall Study|Physician Decision|1|||
170513672|NCT02075008|616226672|FG000|Overall Study|Lost to Follow-up|1|||
170513673|NCT02075008|616226672|FG000|Overall Study|Lack of Efficacy|1|||
170513674|NCT02075008|616226672|FG000|Overall Study|Death|1|||
170513675|NCT02075008|616226672|FG000|Overall Study|Adverse Event|5|||
170513676|NCT02075008|616226672|FG000|Overall Study|Withdrawal by Subject|6|||
170513677|NCT02075008|616226672|FG000|Overall Study|Study terminated by Sponsor|159|||
170513678|NCT01042392|616226678|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
170513679|NCT01042392|616226679|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
170513680|NCT01042392|616226680|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
170513681|NCT01042392|616226681|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
170513682|NCT01042392|616226678|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
170513683|NCT01042392|616226679|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
170513684|NCT01042392|616226680|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
170513685|NCT01042392|616226681|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
170513686|NCT01042392|616226678|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
170513687|NCT01042392|616226679|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
170513688|NCT01042392|616226680|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
170513689|NCT01042392|616226681|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
170513690|NCT01042392|616226678|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
170513691|NCT01042392|616226679|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
170513692|NCT01042392|616226680|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
170513693|NCT01042392|616226681|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
170513694|NCT01042392|616226678|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
170513695|NCT01042392|616226679|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
170513696|NCT01042392|616226680|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
170513697|NCT01042392|616226681|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
170644566|NCT00281658|616713788|FG002|Randomized Phase|Lost to Follow-up|0|||
170644567|NCT00281658|616713789|FG003|Randomized Phase|Lost to Follow-up|0|||
170644568|NCT00281658|616713786|FG000|Randomized Phase|Withdrawal by Subject|8|||
170644569|NCT00281658|616713787|FG001|Randomized Phase|Withdrawal by Subject|7|||
170644570|NCT00281658|616713788|FG002|Randomized Phase|Withdrawal by Subject|0|||
170513698|NCT01042392|616226678|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
170513699|NCT01042392|616226679|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
170513700|NCT01042392|616226680|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
170513701|NCT01042392|616226681|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
170513702|NCT01042392|616226678|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
170644571|NCT00281658|616713789|FG003|Randomized Phase|Withdrawal by Subject|0|||
170644572|NCT00281658|616713786|FG000|Randomized Phase|Study closed/terminated|1|||
170644573|NCT00281658|616713787|FG001|Randomized Phase|Study closed/terminated|1|||
170644574|NCT00281658|616713788|FG002|Randomized Phase|Study closed/terminated|0|||
170644575|NCT00281658|616713789|FG003|Randomized Phase|Study closed/terminated|0|||
170644576|NCT00281658|616713786|FG000|Randomized Phase|Disease progression|36|||
170644577|NCT00281658|616713787|FG001|Randomized Phase|Disease progression|27|||
170644578|NCT00281658|616713788|FG002|Randomized Phase|Disease progression|0|||
170644579|NCT00281658|616713789|FG003|Randomized Phase|Disease progression|0|||
170644580|NCT00281658|616713786|FG000|Randomized Phase|Physician Decision|1|||
170644581|NCT00281658|616713787|FG001|Randomized Phase|Physician Decision|1|||
170644582|NCT00281658|616713788|FG002|Randomized Phase|Physician Decision|0|||
170644583|NCT00281658|616713789|FG003|Randomized Phase|Physician Decision|0|||
170644584|NCT00281658|616713786|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
170644585|NCT00281658|616713787|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
170905172|NCT04433117|617656041|FG001|Overall Study|Withdrawal by Subject|0|||
170513703|NCT01042392|616226679|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
170513704|NCT01042392|616226680|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
170513705|NCT01042392|616226681|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
170513706|NCT01042392|616226678|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
170513707|NCT01042392|616226679|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
170513708|NCT01042392|616226680|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
170513709|NCT01042392|616226681|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
170513710|NCT01042392|616226678|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
170513711|NCT01042392|616226679|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
170513712|NCT01042392|616226680|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
170513713|NCT01042392|616226681|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
170644586|NCT00281658|616713788|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
170905173|NCT03830281|617656042|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
170905174|NCT03830281|617656043|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
170905175|NCT03830281|617656042|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
170905176|NCT03830281|617656043|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
170644587|NCT00281658|616713789|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
170644588|NCT00281658|616713786|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
170644589|NCT00281658|616713787|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
170644590|NCT00281658|616713788|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
170513714|NCT03117361|616226682|FG000|Overall Study|Progressive disease|5|||
170513715|NCT03117361|616226682|FG000|Overall Study|Death|1|||
170513716|NCT03117361|616226682|FG000|Overall Study|Physician Decision|2|||
170513717|NCT03117361|616226682|FG000|Overall Study|On study treatment at the end of study|1|||
170513718|NCT03117361|616226682|FG000|Overall Study|Treatment-related adverse event|1|||
170513719|NCT03904420|616226686|FG000|Overall Study|Study terminated|2|||
170513720|NCT03904420|616226687|FG001|Overall Study|Study terminated|2|||
170513721|NCT00614874|616226688|FG000|Overall Study|Protocol Violation|1|||
170513722|NCT00614874|616226688|FG000|Overall Study|Withdrawal by Subject|1|||
170513723|NCT02087943|616226689|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
170513724|NCT02087943|616226690|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
170513725|NCT02087943|616226691|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
170513726|NCT02087943|616226692|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
170513727|NCT02087943|616226693|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
170513728|NCT02087943|616226689|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
170513729|NCT02087943|616226690|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
170513730|NCT02087943|616226691|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
170513731|NCT02087943|616226692|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
170513732|NCT02087943|616226693|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
170513733|NCT02087943|616226689|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
170513734|NCT02087943|616226690|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
170513735|NCT02087943|616226691|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
170513736|NCT02087943|616226692|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
170513737|NCT02087943|616226693|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
170513738|NCT02087943|616226689|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
170513739|NCT02087943|616226690|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
170513740|NCT02087943|616226691|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
170513741|NCT02087943|616226692|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
170513742|NCT02087943|616226693|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
170513743|NCT02087943|616226689|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
170513744|NCT02087943|616226690|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
170513745|NCT02087943|616226691|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
170513746|NCT02087943|616226692|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
170513747|NCT02087943|616226693|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
170513748|NCT02087943|616226689|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
170513749|NCT02087943|616226690|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
170513750|NCT02087943|616226691|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
170513751|NCT02087943|616226692|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
170513752|NCT02087943|616226693|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
170513753|NCT02087943|616226689|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
170513754|NCT02087943|616226690|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
170513755|NCT02087943|616226691|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
170513756|NCT02087943|616226692|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
170513757|NCT02087943|616226693|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
170513758|NCT02087943|616226689|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
170513759|NCT02087943|616226690|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
170513760|NCT02087943|616226691|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
170513761|NCT02087943|616226692|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
170513762|NCT02087943|616226693|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
170513763|NCT02087943|616226689|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
170513764|NCT02087943|616226690|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
170513765|NCT02087943|616226691|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
170513766|NCT02087943|616226692|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
170513767|NCT02087943|616226693|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
170513768|NCT02087943|616226689|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
170513769|NCT02087943|616226690|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
170513770|NCT02087943|616226691|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
170513771|NCT02087943|616226692|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
170554438|NCT04003142|616376916|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
170554439|NCT04003142|616376917|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
170554440|NCT04003142|616376913|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
170554441|NCT04003142|616376914|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
170554442|NCT04003142|616376915|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
170513772|NCT02087943|616226693|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
170513773|NCT04607135|616226695|FG000|Overall Study|Physician Decision|1|||
170513774|NCT04607135|616226695|FG000|Overall Study|Withdrawal by Subject|1|||
170513775|NCT04607135|616226695|FG000|Overall Study|Equipment not working|3|||
170554443|NCT04003142|616376916|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
170554444|NCT04003142|616376917|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
170554445|NCT04003142|616376913|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
170554446|NCT04003142|616376914|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
170554447|NCT04003142|616376915|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
170554448|NCT04003142|616376916|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
170554449|NCT04003142|616376917|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
170554450|NCT04003142|616376913|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
170554451|NCT04003142|616376914|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
170554452|NCT04003142|616376915|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
170554453|NCT04003142|616376916|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
170554454|NCT04003142|616376917|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
170554455|NCT04003142|616376913|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
170554456|NCT04003142|616376914|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
170554457|NCT04003142|616376915|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
170554458|NCT04003142|616376916|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
170554459|NCT04003142|616376917|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
170554460|NCT04003142|616376913|FG000|Extension Period (40 Weeks)|Death|0|||
170554461|NCT04003142|616376914|FG001|Extension Period (40 Weeks)|Death|0|||
170554462|NCT04003142|616376915|FG002|Extension Period (40 Weeks)|Death|0|||
170554463|NCT04003142|616376916|FG003|Extension Period (40 Weeks)|Death|0|||
170554464|NCT04003142|616376917|FG004|Extension Period (40 Weeks)|Death|1|||
170554465|NCT04003142|616376913|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
170554466|NCT04003142|616376914|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
170554467|NCT04003142|616376915|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
170554468|NCT04003142|616376916|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
170554469|NCT04003142|616376917|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
170554470|NCT04003142|616376913|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
170554471|NCT04003142|616376914|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
170554472|NCT04003142|616376915|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
170554473|NCT04003142|616376916|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
170554474|NCT04003142|616376917|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
170554475|NCT04003142|616376913|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
170554476|NCT04003142|616376914|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
170554477|NCT04003142|616376915|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
170554478|NCT04003142|616376916|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
170554479|NCT04003142|616376917|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
170554480|NCT04003142|616376913|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
170554481|NCT04003142|616376914|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
170554482|NCT04003142|616376915|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
170554483|NCT04003142|616376916|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
170554484|NCT04003142|616376917|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
170554485|NCT05810597|616376918|FG000|Period 1|Adverse Event|2|||
170554486|NCT05810597|616376919|FG001|Period 1|Adverse Event|0|||
170554487|NCT05810597|616376918|FG000|Period 1|Physician Decision|1|||
170554488|NCT05810597|616376919|FG001|Period 1|Physician Decision|0|||
170554489|NCT03382873|616376920|FG000|Overall Study|Lost to Follow-up|9|||
170554490|NCT03382873|616376921|FG001|Overall Study|Lost to Follow-up|10|||
170554491|NCT03382873|616376920|FG000|Overall Study|Withdrawal by Subject|6|||
170554492|NCT03382873|616376921|FG001|Overall Study|Withdrawal by Subject|11|||
170554493|NCT03382873|616376920|FG000|Overall Study|Visit not completed due to pandemic|16|||
170554494|NCT03382873|616376921|FG001|Overall Study|Visit not completed due to pandemic|41|||
170554495|NCT05021224|616376924|FG000|Overall Study|Did not complete all survey items|4|||
170554496|NCT05021224|616376925|FG001|Overall Study|Did not complete all survey items|1|||
170554497|NCT05021224|616376926|FG002|Overall Study|Did not complete all survey items|0|||
170554498|NCT05021224|616376927|FG003|Overall Study|Did not complete all survey items|2|||
170554499|NCT04903093|616376930|FG000|Overall Study|Withdrawal by Subject|0|||
170554500|NCT04903093|616376931|FG001|Overall Study|Withdrawal by Subject|0|||
170554501|NCT04903093|616376932|FG002|Overall Study|Withdrawal by Subject|0|||
170554502|NCT04903093|616376933|FG003|Overall Study|Withdrawal by Subject|1|||
170554503|NCT04903093|616376934|FG004|Overall Study|Withdrawal by Subject|0|||
170554504|NCT04903093|616376935|FG005|Overall Study|Withdrawal by Subject|0|||
170554505|NCT05375929|616376936|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
170554506|NCT05375929|616376937|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
170644591|NCT00281658|616713789|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
170807007|NCT00985088|617303643|FG000|Overall Study|Serious Adverse Event|1|||
170554507|NCT05375929|616376938|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
170554508|NCT05375929|616376939|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
170554509|NCT05375929|616376936|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
170554510|NCT05375929|616376937|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
170554511|NCT05375929|616376938|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
170554512|NCT05375929|616376939|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
170554513|NCT05375929|616376936|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
170644592|NCT00281658|616713786|FG000|Randomized Phase|Treatment ongoing|1|||
170644593|NCT00281658|616713787|FG001|Randomized Phase|Treatment ongoing|0|||
170644594|NCT00281658|616713788|FG002|Randomized Phase|Treatment ongoing|0|||
170644595|NCT00281658|616713789|FG003|Randomized Phase|Treatment ongoing|0|||
170644596|NCT00281658|616713786|FG000|Open Label Phase|Adverse Event|0|||
170644597|NCT00281658|616713787|FG001|Open Label Phase|Adverse Event|0|||
170644598|NCT00281658|616713788|FG002|Open Label Phase|Adverse Event|1|||
170644599|NCT00281658|616713789|FG003|Open Label Phase|Adverse Event|0|||
170644600|NCT00281658|616713786|FG000|Open Label Phase|Lost to Follow-up|0|||
170644601|NCT00281658|616713787|FG001|Open Label Phase|Lost to Follow-up|0|||
170644602|NCT00281658|616713788|FG002|Open Label Phase|Lost to Follow-up|16|||
170644603|NCT00281658|616713789|FG003|Open Label Phase|Lost to Follow-up|2|||
170644604|NCT00281658|616713786|FG000|Open Label Phase|Withdrawal by Subject|0|||
170644605|NCT00281658|616713787|FG001|Open Label Phase|Withdrawal by Subject|0|||
170644606|NCT00281658|616713788|FG002|Open Label Phase|Withdrawal by Subject|3|||
170644607|NCT00281658|616713789|FG003|Open Label Phase|Withdrawal by Subject|2|||
170644608|NCT00281658|616713786|FG000|Open Label Phase|Disease progression|0|||
170644609|NCT00281658|616713787|FG001|Open Label Phase|Disease progression|0|||
170644610|NCT00281658|616713788|FG002|Open Label Phase|Disease progression|18|||
170644611|NCT00281658|616713789|FG003|Open Label Phase|Disease progression|0|||
170644612|NCT00281658|616713786|FG000|Open Label Phase|Physician Decision|0|||
170644613|NCT00281658|616713787|FG001|Open Label Phase|Physician Decision|0|||
170644614|NCT00281658|616713788|FG002|Open Label Phase|Physician Decision|1|||
170644615|NCT00281658|616713789|FG003|Open Label Phase|Physician Decision|0|||
170644616|NCT00281658|616713786|FG000|Open Label Phase|Relocation of patient|0|||
170644617|NCT00281658|616713787|FG001|Open Label Phase|Relocation of patient|0|||
170644618|NCT00281658|616713788|FG002|Open Label Phase|Relocation of patient|1|||
170644619|NCT00281658|616713789|FG003|Open Label Phase|Relocation of patient|0|||
170644620|NCT00281658|616713786|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
170644621|NCT00281658|616713787|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
170644622|NCT00281658|616713788|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
170644623|NCT00281658|616713789|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
170644624|NCT00730028|616713790|FG000|Overall Study|Adverse Event|23|||
170644625|NCT00730028|616713791|FG001|Overall Study|Adverse Event|26|||
170644626|NCT00730028|616713792|FG002|Overall Study|Adverse Event|16|||
170644627|NCT00730028|616713793|FG003|Overall Study|Adverse Event|20|||
170644628|NCT00730028|616713794|FG004|Overall Study|Adverse Event|43|||
170644629|NCT00730028|616713790|FG000|Overall Study|Lost to Follow-up|13|||
170644630|NCT00730028|616713791|FG001|Overall Study|Lost to Follow-up|26|||
170644631|NCT00730028|616713792|FG002|Overall Study|Lost to Follow-up|22|||
170644632|NCT00730028|616713793|FG003|Overall Study|Lost to Follow-up|26|||
170644633|NCT00730028|616713794|FG004|Overall Study|Lost to Follow-up|25|||
170644634|NCT00730028|616713790|FG000|Overall Study|Protocol Violation|6|||
170644635|NCT00730028|616713791|FG001|Overall Study|Protocol Violation|1|||
170644636|NCT00730028|616713792|FG002|Overall Study|Protocol Violation|1|||
170644637|NCT00730028|616713793|FG003|Overall Study|Protocol Violation|2|||
170644638|NCT00730028|616713794|FG004|Overall Study|Protocol Violation|0|||
170644639|NCT00730028|616713790|FG000|Overall Study|Withdrawal by Subject|9|||
170644640|NCT00730028|616713791|FG001|Overall Study|Withdrawal by Subject|5|||
170644641|NCT00730028|616713792|FG002|Overall Study|Withdrawal by Subject|4|||
170644642|NCT00730028|616713793|FG003|Overall Study|Withdrawal by Subject|5|||
170644643|NCT00730028|616713794|FG004|Overall Study|Withdrawal by Subject|9|||
170644644|NCT00730028|616713790|FG000|Overall Study|Physician Decision|3|||
170644645|NCT00730028|616713791|FG001|Overall Study|Physician Decision|3|||
170644646|NCT00730028|616713792|FG002|Overall Study|Physician Decision|2|||
170644647|NCT00730028|616713793|FG003|Overall Study|Physician Decision|3|||
170644648|NCT00730028|616713794|FG004|Overall Study|Physician Decision|2|||
170644649|NCT00730028|616713790|FG000|Overall Study|Treatment Failure|5|||
170644650|NCT00730028|616713791|FG001|Overall Study|Treatment Failure|5|||
170644651|NCT00730028|616713792|FG002|Overall Study|Treatment Failure|0|||
170644652|NCT00730028|616713793|FG003|Overall Study|Treatment Failure|0|||
170644653|NCT00730028|616713794|FG004|Overall Study|Treatment Failure|1|||
170644654|NCT00730028|616713790|FG000|Overall Study|Randomization Error|1|||
170644655|NCT00730028|616713791|FG001|Overall Study|Randomization Error|0|||
170644656|NCT00730028|616713792|FG002|Overall Study|Randomization Error|0|||
170644657|NCT00730028|616713793|FG003|Overall Study|Randomization Error|0|||
170644658|NCT00730028|616713794|FG004|Overall Study|Randomization Error|2|||
170644659|NCT01425463|616713795|FG000|Overall Study|Adverse Event|5|||
170644660|NCT01425463|616713796|FG001|Overall Study|Adverse Event|7|||
170644661|NCT01425463|616713795|FG000|Overall Study|Lack of Efficacy|1|||
170644662|NCT01425463|616713796|FG001|Overall Study|Lack of Efficacy|1|||
170644663|NCT01425463|616713795|FG000|Overall Study|Protocol Violation|2|||
170644664|NCT01425463|616713796|FG001|Overall Study|Protocol Violation|2|||
170644665|NCT01425463|616713795|FG000|Overall Study|Lost to Follow-up|5|||
170644666|NCT01425463|616713796|FG001|Overall Study|Lost to Follow-up|2|||
170644667|NCT01425463|616713795|FG000|Overall Study|Withdrawal by Subject|7|||
170644668|NCT01425463|616713796|FG001|Overall Study|Withdrawal by Subject|5|||
170644669|NCT01425463|616713795|FG000|Overall Study|Unknown Reason|4|||
170806291|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
170806292|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
170806293|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
170806294|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
170806295|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
170806296|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
170513776|NCT03465709|616226696|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
170513777|NCT03465709|616226696|FG000|Overall Study|Withdrawal by Subject|3|||
170513778|NCT05359952|616226697|FG000|Overall Study|Lost to Follow-up|1|||
170513779|NCT05359952|616226698|FG001|Overall Study|Lost to Follow-up|0|||
170513780|NCT05980013|616226699|FG000|Overall Study|Withdrawal by Subject|0|||
170513781|NCT05980013|616226700|FG001|Overall Study|Withdrawal by Subject|1|||
170513782|NCT05980013|616226699|FG000|Overall Study|Device Error|0|||
170513783|NCT05980013|616226700|FG001|Overall Study|Device Error|1|||
170513784|NCT03739710|616226701|FG000|Overall Study|Screen Failed|81|||
170513785|NCT01753115|616226702|FG000|Overall Study|Lost to Follow-up|3|||
170513786|NCT01753115|616226703|FG001|Overall Study|Lost to Follow-up|6|||
170513787|NCT01753115|616226704|FG002|Overall Study|Lost to Follow-up|8|||
170513788|NCT01753115|616226702|FG000|Overall Study|Withdrawal by Subject|6|||
170513789|NCT01753115|616226703|FG001|Overall Study|Withdrawal by Subject|5|||
170513790|NCT01753115|616226704|FG002|Overall Study|Withdrawal by Subject|6|||
170513791|NCT01753115|616226702|FG000|Overall Study|Subject non-compliant|3|||
170513792|NCT01753115|616226703|FG001|Overall Study|Subject non-compliant|3|||
170513793|NCT01753115|616226704|FG002|Overall Study|Subject non-compliant|0|||
170513794|NCT01753115|616226702|FG000|Overall Study|Used excluded drug|0|||
170513795|NCT01753115|616226703|FG001|Overall Study|Used excluded drug|1|||
170513796|NCT01753115|616226704|FG002|Overall Study|Used excluded drug|0|||
170513797|NCT00685360|616226713|FG000|Overall Study|Lost to Follow-up|0|||
170513798|NCT00685360|616226714|FG001|Overall Study|Lost to Follow-up|1|||
170513799|NCT00685360|616226715|FG002|Overall Study|Lost to Follow-up|2|||
170513800|NCT00685360|616226713|FG000|Overall Study|Adverse Event|4|||
170513801|NCT00685360|616226714|FG001|Overall Study|Adverse Event|6|||
170513802|NCT00685360|616226715|FG002|Overall Study|Adverse Event|4|||
170513803|NCT00685360|616226713|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
170513804|NCT00685360|616226714|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
170513805|NCT00685360|616226715|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
170513806|NCT00685360|616226713|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
170513807|NCT00685360|616226714|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
170513808|NCT00685360|616226715|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
170513809|NCT00685360|616226713|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
170513810|NCT00685360|616226714|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
170513811|NCT00685360|616226715|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
170513812|NCT00685360|616226713|FG000|Overall Study|Protocol Deviation|0|||
170513813|NCT00685360|616226714|FG001|Overall Study|Protocol Deviation|1|||
170513814|NCT00685360|616226715|FG002|Overall Study|Protocol Deviation|1|||
170513815|NCT04978337|616226718|FG000|Overall Study|Withdrawal by Subject|0|||
170513816|NCT04978337|616226719|FG001|Overall Study|Withdrawal by Subject|1|||
170554514|NCT05375929|616376937|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
170554515|NCT05375929|616376938|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
170554516|NCT05375929|616376939|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
170554517|NCT05375929|616376936|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
170554518|NCT05375929|616376937|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
170554519|NCT05375929|616376938|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
170554520|NCT05375929|616376939|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
170554521|NCT05375929|616376936|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
170554522|NCT05375929|616376937|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
170554523|NCT05375929|616376938|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
170554524|NCT05375929|616376939|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
170554525|NCT05375929|616376936|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
170554526|NCT05375929|616376937|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
170554527|NCT05375929|616376938|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
170554528|NCT05375929|616376939|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
170554529|NCT05375929|616376936|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
170554530|NCT05375929|616376937|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
170554531|NCT05375929|616376938|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
170554532|NCT05375929|616376939|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
170554533|NCT05375929|616376936|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
170554534|NCT05375929|616376937|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
170513817|NCT02937636|616226724|FG000|Overall Study|Other (Not specified)|3|||
170513818|NCT02937636|616226725|FG001|Overall Study|Other (Not specified)|2|||
170513819|NCT04208412|616226726|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
170513820|NCT04208412|616226727|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
170513821|NCT04208412|616226726|FG000|Overall Study|Withdrawal by Subject|1|||
170513822|NCT04208412|616226727|FG001|Overall Study|Withdrawal by Subject|0|||
170513823|NCT04208412|616226726|FG000|Overall Study|Lost to Follow-up|0|||
170513824|NCT04208412|616226727|FG001|Overall Study|Lost to Follow-up|1|||
170513825|NCT02588092|616226730|FG000|Overall Study|Death|4|||
170513826|NCT02588092|616226731|FG001|Overall Study|Death|3|||
170513827|NCT02588092|616226732|FG002|Overall Study|Death|3|||
170513828|NCT02588092|616226733|FG003|Overall Study|Death|3|||
170513829|NCT02588092|616226734|FG004|Overall Study|Death|2|||
170513830|NCT02588092|616226735|FG005|Overall Study|Death|2|||
170513831|NCT02588092|616226736|FG006|Overall Study|Death|2|||
170513832|NCT02588092|616226737|FG007|Overall Study|Death|1|||
170513833|NCT02588092|616226738|FG008|Overall Study|Death|5|||
170513834|NCT02588092|616226739|FG009|Overall Study|Death|2|||
170513835|NCT02588092|616226730|FG000|Overall Study|Withdrawal by Subject|0|||
170513836|NCT02588092|616226731|FG001|Overall Study|Withdrawal by Subject|0|||
170513837|NCT02588092|616226732|FG002|Overall Study|Withdrawal by Subject|0|||
170513838|NCT02588092|616226733|FG003|Overall Study|Withdrawal by Subject|0|||
170513839|NCT02588092|616226734|FG004|Overall Study|Withdrawal by Subject|0|||
170513840|NCT02588092|616226735|FG005|Overall Study|Withdrawal by Subject|1|||
170513841|NCT02588092|616226736|FG006|Overall Study|Withdrawal by Subject|1|||
170513842|NCT02588092|616226737|FG007|Overall Study|Withdrawal by Subject|2|||
170513843|NCT02588092|616226738|FG008|Overall Study|Withdrawal by Subject|0|||
170513844|NCT02588092|616226739|FG009|Overall Study|Withdrawal by Subject|0|||
170513845|NCT02588092|616226730|FG000|Overall Study|Started Another Treatment|0|||
170513846|NCT02588092|616226731|FG001|Overall Study|Started Another Treatment|0|||
170513847|NCT02588092|616226732|FG002|Overall Study|Started Another Treatment|0|||
170513848|NCT02588092|616226733|FG003|Overall Study|Started Another Treatment|0|||
170513849|NCT02588092|616226734|FG004|Overall Study|Started Another Treatment|1|||
170513850|NCT02588092|616226735|FG005|Overall Study|Started Another Treatment|0|||
170513851|NCT02588092|616226736|FG006|Overall Study|Started Another Treatment|0|||
170513852|NCT02588092|616226737|FG007|Overall Study|Started Another Treatment|1|||
170513853|NCT02588092|616226738|FG008|Overall Study|Started Another Treatment|0|||
170513854|NCT02588092|616226739|FG009|Overall Study|Started Another Treatment|0|||
170513855|NCT02588092|616226730|FG000|Overall Study|Sponsor Decision|0|||
170513856|NCT02588092|616226731|FG001|Overall Study|Sponsor Decision|0|||
170513857|NCT02588092|616226732|FG002|Overall Study|Sponsor Decision|0|||
170513858|NCT02588092|616226733|FG003|Overall Study|Sponsor Decision|0|||
170513859|NCT02588092|616226734|FG004|Overall Study|Sponsor Decision|0|||
170513860|NCT02588092|616226735|FG005|Overall Study|Sponsor Decision|0|||
170513861|NCT02588092|616226736|FG006|Overall Study|Sponsor Decision|0|||
170513862|NCT02588092|616226737|FG007|Overall Study|Sponsor Decision|0|||
170513863|NCT02588092|616226738|FG008|Overall Study|Sponsor Decision|1|||
170513864|NCT02588092|616226739|FG009|Overall Study|Sponsor Decision|1|||
170513865|NCT01348100|616226740|FG000|Overall Study|Subject Withdrew Consent|0|||
170513866|NCT01348100|616226741|FG001|Overall Study|Subject Withdrew Consent|0|||
170513867|NCT01348100|616226742|FG002|Overall Study|Subject Withdrew Consent|2|||
170554535|NCT05375929|616376938|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
170554536|NCT05375929|616376939|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
170554537|NCT05375929|616376936|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
170554538|NCT05375929|616376937|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
170554539|NCT05375929|616376938|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
170554540|NCT05375929|616376939|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
170554541|NCT05375929|616376936|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
170554542|NCT05375929|616376937|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
170554543|NCT05375929|616376938|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
170554544|NCT05375929|616376939|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
170554545|NCT00025233|616376946|FG000|Overall Study|Ineligible: wrong cell type|1|||
170554546|NCT00025233|616376946|FG000|Overall Study|Ineligible: wrong primary|1|||
170554547|NCT00025233|616376946|FG000|Overall Study|Ineligible: improper prior treatment|1|||
170554548|NCT00025233|616376946|FG000|Overall Study|Never treated|1|||
170554549|NCT01539525|616376947|FG000|Overall Study|Lost to Follow-up|19|||
170554550|NCT01539525|616376948|FG001|Overall Study|Lost to Follow-up|12|||
170554551|NCT01539525|616376949|FG002|Overall Study|Lost to Follow-up|11|||
170554552|NCT01539525|616376947|FG000|Overall Study|Withdrawal by Subject|0|||
170513868|NCT01348100|616226743|FG003|Overall Study|Subject Withdrew Consent|0|||
170513869|NCT01348100|616226744|FG004|Overall Study|Subject Withdrew Consent|1|||
170513870|NCT01348100|616226745|FG005|Overall Study|Subject Withdrew Consent|0|||
170513871|NCT01348100|616226746|FG006|Overall Study|Subject Withdrew Consent|1|||
170513872|NCT01348100|616226740|FG000|Overall Study|Protocol Deviation|0|||
170513873|NCT01348100|616226741|FG001|Overall Study|Protocol Deviation|0|||
170513874|NCT01348100|616226742|FG002|Overall Study|Protocol Deviation|0|||
170513875|NCT01348100|616226743|FG003|Overall Study|Protocol Deviation|1|||
170513876|NCT01348100|616226744|FG004|Overall Study|Protocol Deviation|0|||
170513877|NCT01348100|616226745|FG005|Overall Study|Protocol Deviation|0|||
170513878|NCT01348100|616226746|FG006|Overall Study|Protocol Deviation|0|||
170513879|NCT01348100|616226740|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170513880|NCT01348100|616226741|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170513881|NCT01348100|616226742|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170513882|NCT01348100|616226743|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170513883|NCT01348100|616226744|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170513884|NCT01348100|616226745|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
170513885|NCT01348100|616226746|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170513886|NCT01348100|616226740|FG000|Overall Study|Lost to Follow-up|0|||
170513887|NCT01348100|616226741|FG001|Overall Study|Lost to Follow-up|0|||
170513888|NCT01348100|616226742|FG002|Overall Study|Lost to Follow-up|0|||
170513889|NCT01348100|616226743|FG003|Overall Study|Lost to Follow-up|0|||
170513890|NCT01348100|616226744|FG004|Overall Study|Lost to Follow-up|0|||
170513891|NCT01348100|616226745|FG005|Overall Study|Lost to Follow-up|0|||
170513892|NCT01348100|616226746|FG006|Overall Study|Lost to Follow-up|1|||
170513893|NCT01348100|616226740|FG000|Overall Study|Administrative Problems|0|||
170513894|NCT01348100|616226741|FG001|Overall Study|Administrative Problems|0|||
170513895|NCT01348100|616226742|FG002|Overall Study|Administrative Problems|0|||
170513896|NCT01348100|616226743|FG003|Overall Study|Administrative Problems|0|||
170513897|NCT01348100|616226744|FG004|Overall Study|Administrative Problems|0|||
170513898|NCT01348100|616226745|FG005|Overall Study|Administrative Problems|1|||
170513899|NCT01348100|616226746|FG006|Overall Study|Administrative Problems|1|||
170513900|NCT00531947|616226749|FG000|Overall Study|Adverse Event|5|||
170513901|NCT00531947|616226750|FG001|Overall Study|Adverse Event|10|||
170513902|NCT00531947|616226749|FG000|Overall Study|Lost to Follow-up|12|||
170513903|NCT00531947|616226750|FG001|Overall Study|Lost to Follow-up|9|||
170513904|NCT00531947|616226749|FG000|Overall Study|Withdrawal by Subject|14|||
170554553|NCT01539525|616376948|FG001|Overall Study|Withdrawal by Subject|3|||
170554554|NCT01539525|616376949|FG002|Overall Study|Withdrawal by Subject|2|||
170554555|NCT01539525|616376947|FG000|Overall Study|Protocol Violation|1|||
170554556|NCT01539525|616376948|FG001|Overall Study|Protocol Violation|1|||
170554557|NCT01539525|616376949|FG002|Overall Study|Protocol Violation|4|||
170554558|NCT02268851|616376950|FG000|Overall Study|Death|0|||
170554559|NCT02268851|616376951|FG001|Overall Study|Death|0|||
170554560|NCT02268851|616376952|FG002|Overall Study|Death|0|||
170554561|NCT02268851|616376953|FG003|Overall Study|Death|1|||
170554562|NCT02268851|616376954|FG004|Overall Study|Death|2|||
170554563|NCT02268851|616376955|FG005|Overall Study|Death|1|||
170554564|NCT02268851|616376950|FG000|Overall Study|Adverse Event|0|||
170554565|NCT02268851|616376951|FG001|Overall Study|Adverse Event|0|||
170554566|NCT02268851|616376952|FG002|Overall Study|Adverse Event|0|||
170554567|NCT02268851|616376953|FG003|Overall Study|Adverse Event|0|||
170554568|NCT02268851|616376954|FG004|Overall Study|Adverse Event|2|||
170554569|NCT02268851|616376955|FG005|Overall Study|Adverse Event|2|||
170554570|NCT02268851|616376950|FG000|Overall Study|Withdrawal by Subject|0|||
170554571|NCT02268851|616376951|FG001|Overall Study|Withdrawal by Subject|0|||
170554572|NCT02268851|616376952|FG002|Overall Study|Withdrawal by Subject|0|||
170554573|NCT02268851|616376953|FG003|Overall Study|Withdrawal by Subject|2|||
170554574|NCT02268851|616376954|FG004|Overall Study|Withdrawal by Subject|0|||
170554575|NCT02268851|616376955|FG005|Overall Study|Withdrawal by Subject|1|||
170554576|NCT02268851|616376950|FG000|Overall Study|Progressive Disease|1|||
170554577|NCT02268851|616376951|FG001|Overall Study|Progressive Disease|3|||
170554578|NCT02268851|616376952|FG002|Overall Study|Progressive Disease|0|||
170554579|NCT02268851|616376953|FG003|Overall Study|Progressive Disease|0|||
170554580|NCT02268851|616376954|FG004|Overall Study|Progressive Disease|1|||
170554581|NCT02268851|616376955|FG005|Overall Study|Progressive Disease|4|||
170554582|NCT02268851|616376950|FG000|Overall Study|Physician Decision|0|||
170644670|NCT01425463|616713796|FG001|Overall Study|Unknown Reason|7|||
170644671|NCT01332799|616713799|FG000|Overall Study|Insufficient funding|10|||
170513905|NCT00531947|616226750|FG001|Overall Study|Withdrawal by Subject|19|||
170513906|NCT00531947|616226749|FG000|Overall Study|Protocol Violation|2|||
170513907|NCT00531947|616226750|FG001|Overall Study|Protocol Violation|1|||
170513908|NCT00531947|616226749|FG000|Overall Study|Non-Compliance|4|||
170513909|NCT00531947|616226750|FG001|Overall Study|Non-Compliance|7|||
170513910|NCT00531947|616226749|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
170554583|NCT02268851|616376951|FG001|Overall Study|Physician Decision|0|||
170554584|NCT02268851|616376952|FG002|Overall Study|Physician Decision|1|||
170554585|NCT02268851|616376953|FG003|Overall Study|Physician Decision|0|||
170554586|NCT02268851|616376954|FG004|Overall Study|Physician Decision|0|||
170554587|NCT02268851|616376955|FG005|Overall Study|Physician Decision|1|||
170554588|NCT02268851|616376950|FG000|Overall Study|Patient Compliance|0|||
170554589|NCT02268851|616376951|FG001|Overall Study|Patient Compliance|0|||
170554590|NCT02268851|616376952|FG002|Overall Study|Patient Compliance|0|||
170554591|NCT02268851|616376953|FG003|Overall Study|Patient Compliance|0|||
170554592|NCT02268851|616376954|FG004|Overall Study|Patient Compliance|1|||
170513911|NCT00531947|616226750|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
170513912|NCT02383355|616226751|FG000|Overall Study|Adverse Event|2|||
170513913|NCT02383355|616226752|FG001|Overall Study|Adverse Event|0|||
170513914|NCT00435188|616226753|FG000|Overall Study|Death|1|||
170513915|NCT00435188|616226754|FG001|Overall Study|Death|6|||
170513916|NCT00435188|616226753|FG000|Overall Study|Withdrawal by Subject|16|||
170513917|NCT00435188|616226754|FG001|Overall Study|Withdrawal by Subject|11|||
170513918|NCT00435188|616226753|FG000|Overall Study|Lost to Follow-up|5|||
170513919|NCT00435188|616226754|FG001|Overall Study|Lost to Follow-up|6|||
170513920|NCT04399538|616226759|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
170513921|NCT04399538|616226760|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
170513922|NCT04399538|616226761|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
170513923|NCT04399538|616226762|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
170513924|NCT04399538|616226763|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
170513925|NCT04399538|616226759|FG000|Double-Blind Treatment|Adverse Event|0|||
170513926|NCT04399538|616226760|FG001|Double-Blind Treatment|Adverse Event|0|||
170513927|NCT04399538|616226761|FG002|Double-Blind Treatment|Adverse Event|0|||
170513928|NCT04399538|616226762|FG003|Double-Blind Treatment|Adverse Event|0|||
170513929|NCT04399538|616226763|FG004|Double-Blind Treatment|Adverse Event|1|||
170513930|NCT04399538|616226759|FG000|Follow-Up|Adverse Event|0|||
170513931|NCT04399538|616226760|FG001|Follow-Up|Adverse Event|0|||
170513932|NCT04399538|616226761|FG002|Follow-Up|Adverse Event|0|||
170513933|NCT04399538|616226762|FG003|Follow-Up|Adverse Event|0|||
170513934|NCT04399538|616226763|FG004|Follow-Up|Adverse Event|1|||
170513935|NCT04399538|616226759|FG000|Follow-Up|Withdrawal by Subject|0|||
170513936|NCT04399538|616226760|FG001|Follow-Up|Withdrawal by Subject|0|||
170513937|NCT04399538|616226761|FG002|Follow-Up|Withdrawal by Subject|0|||
170513938|NCT04399538|616226762|FG003|Follow-Up|Withdrawal by Subject|2|||
170513939|NCT04399538|616226763|FG004|Follow-Up|Withdrawal by Subject|0|||
170513940|NCT02109445|616226764|FG000|Overall Study|Symptomatic deterioration|2|||
170513941|NCT02109445|616226764|FG000|Overall Study|Adverse Event|1|||
170513942|NCT00966355|616226769|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
170513943|NCT00966355|616226770|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
170513944|NCT00966355|616226771|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
170513945|NCT00966355|616226769|FG000|Overall Study|newly diagnosed advanced HCC|11|||
170513946|NCT00966355|616226770|FG001|Overall Study|newly diagnosed advanced HCC|12|||
170513947|NCT00966355|616226771|FG002|Overall Study|newly diagnosed advanced HCC|10|||
170554593|NCT02268851|616376955|FG005|Overall Study|Patient Compliance|1|||
170554594|NCT02268851|616376950|FG000|Overall Study|Co-Morbid Condition|0|||
170554595|NCT02268851|616376951|FG001|Overall Study|Co-Morbid Condition|0|||
170554596|NCT02268851|616376952|FG002|Overall Study|Co-Morbid Condition|0|||
170554597|NCT02268851|616376953|FG003|Overall Study|Co-Morbid Condition|0|||
170554598|NCT02268851|616376954|FG004|Overall Study|Co-Morbid Condition|1|||
170554599|NCT02268851|616376955|FG005|Overall Study|Co-Morbid Condition|1|||
170554600|NCT02528305|616376956|FG000|Overall Study|Withdrawal by Subject|1|||
170554601|NCT02528305|616376956|FG000|Overall Study|Adverse Event|1|||
170554602|NCT02528305|616376956|FG000|Overall Study|Physician Decision|1|||
170554603|NCT03425188|616376958|FG000|Overall Study|Withdrawal by Subject|1|||
170554604|NCT04634331|616376959|FG000|Overall Study|Withdrawal by Subject|2|||
170554605|NCT04634331|616376960|FG001|Overall Study|Withdrawal by Subject|2|||
170554606|NCT01308788|616376961|FG000|2-year Treatment|medication change by treating physician|4|||
170554607|NCT01308788|616376962|FG001|2-year Treatment|medication change by treating physician|11|||
170554608|NCT00322218|616376963|FG000|Overall Study|Death|3|||
170554609|NCT00322218|616376964|FG001|Overall Study|Death|6|||
170554610|NCT00124306|616376965|FG000|Overall Study|Adverse Event|7|||
170554611|NCT00124306|616376966|FG001|Overall Study|Adverse Event|2|||
170554612|NCT00124306|616376965|FG000|Overall Study|Lost to Follow-up|10|||
170554613|NCT00124306|616376966|FG001|Overall Study|Lost to Follow-up|6|||
170554614|NCT00124306|616376965|FG000|Overall Study|Lack of Efficacy|3|||
170554615|NCT00124306|616376966|FG001|Overall Study|Lack of Efficacy|6|||
170554616|NCT00124306|616376965|FG000|Overall Study|Personal constraints|0|||
170554617|NCT00124306|616376966|FG001|Overall Study|Personal constraints|2|||
170554618|NCT00124306|616376965|FG000|Overall Study|Use of unacceptable medication|1|||
170554619|NCT00124306|616376966|FG001|Overall Study|Use of unacceptable medication|0|||
170554620|NCT00124306|616376965|FG000|Overall Study|Abnormal lab result|0|||
170554621|NCT00124306|616376966|FG001|Overall Study|Abnormal lab result|1|||
170554622|NCT00124306|616376965|FG000|Overall Study|Other|2|||
170554623|NCT00124306|616376966|FG001|Overall Study|Other|0|||
170554624|NCT00890097|616376967|FG000|Overall Study|Adverse Event|21|||
170554625|NCT00890097|616376968|FG001|Overall Study|Adverse Event|32|||
170554626|NCT00890097|616376969|FG002|Overall Study|Adverse Event|28|||
170554627|NCT00890097|616376967|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
170554628|NCT00890097|616376968|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
170554629|NCT00890097|616376969|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
170554630|NCT00890097|616376967|FG000|Overall Study|Withdrew Consent|9|||
170554631|NCT00890097|616376968|FG001|Overall Study|Withdrew Consent|6|||
170554632|NCT00890097|616376969|FG002|Overall Study|Withdrew Consent|9|||
170554633|NCT00890097|616376967|FG000|Overall Study|Lost to Follow-up|5|||
170554634|NCT00890097|616376968|FG001|Overall Study|Lost to Follow-up|5|||
170554635|NCT00890097|616376969|FG002|Overall Study|Lost to Follow-up|5|||
170554636|NCT00890097|616376967|FG000|Overall Study|Noncompliance|0|||
170554637|NCT00890097|616376968|FG001|Overall Study|Noncompliance|4|||
170554638|NCT00890097|616376969|FG002|Overall Study|Noncompliance|4|||
170554639|NCT00890097|616376967|FG000|Overall Study|Sponsor Decision|7|||
170554640|NCT00890097|616376968|FG001|Overall Study|Sponsor Decision|11|||
170554641|NCT00890097|616376969|FG002|Overall Study|Sponsor Decision|7|||
170554642|NCT00890097|616376967|FG000|Overall Study|Did not attend final visit|2|||
170644672|NCT01332799|616713800|FG001|Overall Study|Insufficient funding|10|||
170513948|NCT00966355|616226769|FG000|Overall Study|Lost to Follow-up|5|||
170513949|NCT00966355|616226770|FG001|Overall Study|Lost to Follow-up|4|||
170513950|NCT00966355|616226771|FG002|Overall Study|Lost to Follow-up|3|||
170513951|NCT02793947|616228203|FG000|Overall Study|Death|1|||
170513952|NCT02793947|616228204|FG001|Overall Study|Death|0|||
170513953|NCT02793947|616228203|FG000|Overall Study|Physician Decision|1|||
170513954|NCT02793947|616228204|FG001|Overall Study|Physician Decision|5|||
170513955|NCT00547248|616228209|FG000|Overall Study|Protocol Violation|0|||
170513956|NCT00547248|616228210|FG001|Overall Study|Protocol Violation|0|||
170513957|NCT00547248|616228211|FG002|Overall Study|Protocol Violation|1|||
170513958|NCT00547248|616228212|FG003|Overall Study|Protocol Violation|1|||
170513959|NCT00547248|616228209|FG000|Overall Study|Migrated/moved from study area|0|||
170513960|NCT00547248|616228210|FG001|Overall Study|Migrated/moved from study area|0|||
170513961|NCT00547248|616228211|FG002|Overall Study|Migrated/moved from study area|2|||
170513962|NCT00547248|616228212|FG003|Overall Study|Migrated/moved from study area|0|||
170513963|NCT00547248|616228209|FG000|Overall Study|Withdrawal by Subject|0|||
170513964|NCT00547248|616228210|FG001|Overall Study|Withdrawal by Subject|0|||
170513965|NCT00547248|616228211|FG002|Overall Study|Withdrawal by Subject|7|||
170513966|NCT00547248|616228212|FG003|Overall Study|Withdrawal by Subject|1|||
170513967|NCT02849171|616228213|FG000|Overall Study|Withdrawal by Subject|1|||
170513968|NCT02849171|616228213|FG000|Overall Study|Not treated|1|||
170513969|NCT05133323|616228214|FG000|Overall Study|Lack of Efficacy|0|||
170513970|NCT05133323|616228215|FG001|Overall Study|Lack of Efficacy|0|||
170513971|NCT05133323|616228216|FG002|Overall Study|Lack of Efficacy|1|||
170513972|NCT05133323|616228214|FG000|Overall Study|Withdrawal by Subject|2|||
170513973|NCT05133323|616228215|FG001|Overall Study|Withdrawal by Subject|1|||
170513974|NCT05133323|616228216|FG002|Overall Study|Withdrawal by Subject|0|||
170513975|NCT00694356|616228225|FG000|Overall Study|Adverse Event|1|||
170513976|NCT00694356|616228226|FG001|Overall Study|Adverse Event|0|||
170513977|NCT00694356|616228227|FG002|Overall Study|Adverse Event|0|||
170513978|NCT00694356|616228225|FG000|Overall Study|Progressive Disease|2|||
170513979|NCT00694356|616228226|FG001|Overall Study|Progressive Disease|6|||
170513980|NCT00694356|616228227|FG002|Overall Study|Progressive Disease|6|||
170513981|NCT00741598|616228231|FG000|Overall Study|Lost to Follow-up|3|||
170513982|NCT00741598|616228232|FG001|Overall Study|Lost to Follow-up|4|||
170513983|NCT00741598|616228231|FG000|Overall Study|Lack of Efficacy|1|||
170513984|NCT00741598|616228232|FG001|Overall Study|Lack of Efficacy|2|||
170513985|NCT00741598|616228231|FG000|Overall Study|Physician Decision|1|||
170513986|NCT00741598|616228232|FG001|Overall Study|Physician Decision|1|||
170513987|NCT00741598|616228231|FG000|Overall Study|Pregnancy|1|||
170513988|NCT00741598|616228232|FG001|Overall Study|Pregnancy|0|||
170513989|NCT00741598|616228231|FG000|Overall Study|Withdrawal by Subject|3|||
170513990|NCT00741598|616228232|FG001|Overall Study|Withdrawal by Subject|2|||
170513991|NCT04152083|616228233|FG000|Overall Study|Lost to Follow-up|2|||
170513992|NCT04152083|616228234|FG001|Overall Study|Lost to Follow-up|1|||
170554643|NCT00890097|616376968|FG001|Overall Study|Did not attend final visit|3|||
170554644|NCT00890097|616376969|FG002|Overall Study|Did not attend final visit|0|||
170554645|NCT00890097|616376967|FG000|Overall Study|Subject Decision|3|||
170554646|NCT00890097|616376968|FG001|Overall Study|Subject Decision|2|||
170554647|NCT00890097|616376969|FG002|Overall Study|Subject Decision|6|||
170554648|NCT00890097|616376967|FG000|Overall Study|Randomization Error|2|||
170554649|NCT00890097|616376968|FG001|Overall Study|Randomization Error|0|||
170554650|NCT00890097|616376969|FG002|Overall Study|Randomization Error|0|||
170554651|NCT00890097|616376967|FG000|Overall Study|Failed inclusion criteria|3|||
170554652|NCT00890097|616376968|FG001|Overall Study|Failed inclusion criteria|4|||
170554653|NCT00890097|616376969|FG002|Overall Study|Failed inclusion criteria|0|||
170554654|NCT00890097|616376967|FG000|Overall Study|Transportation|0|||
170554655|NCT00890097|616376968|FG001|Overall Study|Transportation|2|||
170554656|NCT00890097|616376969|FG002|Overall Study|Transportation|0|||
170554657|NCT00890097|616376967|FG000|Overall Study|Subject Moved|0|||
170554658|NCT00890097|616376968|FG001|Overall Study|Subject Moved|4|||
170554659|NCT00890097|616376969|FG002|Overall Study|Subject Moved|0|||
170554660|NCT00890097|616376967|FG000|Overall Study|Protocol Deviation|1|||
170554661|NCT00890097|616376968|FG001|Overall Study|Protocol Deviation|1|||
170554662|NCT00890097|616376969|FG002|Overall Study|Protocol Deviation|1|||
170554663|NCT01694771|616376970|FG000|Overall Study|Adverse Event|18|||
170554664|NCT01694771|616376971|FG001|Overall Study|Adverse Event|16|||
170554665|NCT01694771|616376970|FG000|Overall Study|Lack of Efficacy|1|||
170554666|NCT01694771|616376971|FG001|Overall Study|Lack of Efficacy|0|||
170554667|NCT01694771|616376970|FG000|Overall Study|Non compliance protocol|7|||
170554668|NCT01694771|616376971|FG001|Overall Study|Non compliance protocol|6|||
170513993|NCT04152083|616228233|FG000|Overall Study|Adverse Event|1|||
170513994|NCT04152083|616228234|FG001|Overall Study|Adverse Event|0|||
170513995|NCT04152083|616228233|FG000|Overall Study|Randomized but not treated|3|||
170513996|NCT04152083|616228234|FG001|Overall Study|Randomized but not treated|2|||
170513997|NCT02087670|616228235|FG000|Overall Study|Withdrawal by Subject|3|||
170513998|NCT02087670|616228236|FG001|Overall Study|Withdrawal by Subject|2|||
170554669|NCT01694771|616376970|FG000|Overall Study|Lost to Follow-up|2|||
170554670|NCT01694771|616376971|FG001|Overall Study|Lost to Follow-up|3|||
170806297|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
170806298|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
170806299|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
170644673|NCT00945906|616713801|FG000|Overall Study|Withdrawal by Subject|1|||
170644674|NCT00945906|616713801|FG000|Overall Study|Did not want to return for last visit|2|||
170644675|NCT00945906|616713801|FG000|Overall Study|Unable to return for last visit|2|||
170513999|NCT01639703|616228237|FG000|Overall Study|Withdrawal by Subject|5|||
170514000|NCT01639703|616228237|FG000|Overall Study|Other reason|7|||
170514001|NCT03318003|616228238|FG000|Overall Study|Withdrawal by Subject|1|||
170514002|NCT03318003|616228239|FG001|Overall Study|Withdrawal by Subject|1|||
170514003|NCT03318003|616228238|FG000|Overall Study|fetal loss|0|||
170514004|NCT03318003|616228239|FG001|Overall Study|fetal loss|1|||
170514005|NCT02072941|616228240|FG000|Overall Study|Withdrawal by Subject|29|||
170514006|NCT02072941|616228241|FG001|Overall Study|Withdrawal by Subject|21|||
170514007|NCT02072941|616228240|FG000|Overall Study|Lost to Follow-up|4|||
170514008|NCT02072941|616228241|FG001|Overall Study|Lost to Follow-up|4|||
170514009|NCT02072941|616228240|FG000|Overall Study|Death|3|||
170514010|NCT02072941|616228241|FG001|Overall Study|Death|2|||
170514011|NCT02072941|616228240|FG000|Overall Study|Removed by Study Staff|2|||
170514012|NCT02072941|616228241|FG001|Overall Study|Removed by Study Staff|2|||
170514013|NCT01247350|616228244|FG000|Overall Study|Adverse Event|0|||
170514014|NCT01247350|616228245|FG001|Overall Study|Adverse Event|0|||
170514015|NCT01247350|616228246|FG002|Overall Study|Adverse Event|1|||
170514016|NCT01247350|616228247|FG003|Overall Study|Adverse Event|0|||
170514017|NCT01247350|616228248|FG004|Overall Study|Adverse Event|0|||
170514018|NCT01247350|616228244|FG000|Overall Study|Withdrawal by Subject|0|||
170514019|NCT01247350|616228245|FG001|Overall Study|Withdrawal by Subject|0|||
170514020|NCT01247350|616228246|FG002|Overall Study|Withdrawal by Subject|0|||
170514021|NCT01247350|616228247|FG003|Overall Study|Withdrawal by Subject|1|||
170514022|NCT01247350|616228248|FG004|Overall Study|Withdrawal by Subject|0|||
170514023|NCT01247350|616228244|FG000|Overall Study|Entry criteria not met|0|||
170514024|NCT01247350|616228245|FG001|Overall Study|Entry criteria not met|0|||
170514025|NCT01247350|616228246|FG002|Overall Study|Entry criteria not met|0|||
170514026|NCT01247350|616228247|FG003|Overall Study|Entry criteria not met|0|||
170514027|NCT01247350|616228248|FG004|Overall Study|Entry criteria not met|1|||
170514028|NCT00715299|616228249|FG000|Overall Study|Withdrawal by Subject|1|||
170514029|NCT00715299|616228249|FG000|Overall Study|Adverse Event|3|||
170514030|NCT00715299|616228249|FG000|Overall Study|failed the pre-screen exercise test|2|||
170514031|NCT02020889|616228250|FG000|Overall Study|Adverse Event|0|||
170514032|NCT02020889|616228251|FG001|Overall Study|Adverse Event|1|||
170514033|NCT02020889|616228250|FG000|Overall Study|Lack of Efficacy|1|||
170514034|NCT02020889|616228251|FG001|Overall Study|Lack of Efficacy|0|||
170514035|NCT02020889|616228250|FG000|Overall Study|Lost to Follow-up|1|||
170514036|NCT02020889|616228251|FG001|Overall Study|Lost to Follow-up|0|||
170514037|NCT02020889|616228250|FG000|Overall Study|Physician Decision|2|||
170514038|NCT02020889|616228251|FG001|Overall Study|Physician Decision|0|||
170514039|NCT02020889|616228250|FG000|Overall Study|Withdrawal by Subject|3|||
170514040|NCT02020889|616228251|FG001|Overall Study|Withdrawal by Subject|2|||
170514041|NCT00809094|616228252|FG000|Overall Study|Lost to Follow-up|0|||
170644676|NCT00945906|616713801|FG000|Overall Study|Moved to another country|2|||
170644677|NCT03700684|616713802|FG000|Overall Study|COVID-19|0|||
170644678|NCT03700684|616713803|FG001|Overall Study|COVID-19|0|||
170644679|NCT03700684|616713804|FG002|Overall Study|COVID-19|2|||
170644680|NCT00538785|616713814|FG000|Overall Study|Death|9|||
170644681|NCT00538785|616713815|FG001|Overall Study|Death|10|||
170644682|NCT00538785|616713814|FG000|Overall Study|Withdrawal of consent|9|||
170644683|NCT00538785|616713815|FG001|Overall Study|Withdrawal of consent|7|||
170644684|NCT00538785|616713814|FG000|Overall Study|Lost to Follow-up|1|||
170644685|NCT00538785|616713815|FG001|Overall Study|Lost to Follow-up|0|||
170644686|NCT01639729|616713820|FG000|Overall Study|Withdrawal by Subject|1|||
170644687|NCT01639729|616713821|FG001|Overall Study|Withdrawal by Subject|0|||
170644688|NCT01639729|616713822|FG002|Overall Study|Withdrawal by Subject|1|||
170806300|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
170807008|NCT00985088|617303644|FG001|Overall Study|Serious Adverse Event|1|||
170514042|NCT00809094|616228253|FG001|Overall Study|Lost to Follow-up|1|||
170514043|NCT00411450|616228254|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
170514044|NCT00232557|616228255|FG000|Overall Study|Lost to Follow-up|3|||
170514045|NCT00232557|616228256|FG001|Overall Study|Lost to Follow-up|5|||
170514046|NCT04435808|616228257|FG000|Overall Study|Study stopped by DSMB|0|||
170514047|NCT04435808|616228258|FG001|Overall Study|Study stopped by DSMB|1|||
170514048|NCT00807612|616228261|FG000|Overall Study|Death|8|||
170644689|NCT01639729|616713823|FG003|Overall Study|Withdrawal by Subject|1|||
170514049|NCT00807612|616228261|FG000|Overall Study|Study early termination|5|||
170514050|NCT00807612|616228261|FG000|Overall Study|Withdrawal by Subject|1|||
170514051|NCT02768792|616228262|FG000|Overall Study|Adverse Event|1|||
170514052|NCT04819438|616228263|FG000|Overall Study|Withdrawal by Subject|1|||
170514053|NCT04819438|616228264|FG001|Overall Study|Withdrawal by Subject|0|||
170514054|NCT04819438|616228263|FG000|Overall Study|Adverse Event|0|||
170514055|NCT04819438|616228264|FG001|Overall Study|Adverse Event|1|||
170514056|NCT04819438|616228263|FG000|Overall Study|Protocol Violation|0|||
170514057|NCT04819438|616228264|FG001|Overall Study|Protocol Violation|1|||
170514058|NCT03836209|616228265|FG000|Overall Study|Adverse Event|5|||
170514059|NCT03836209|616228266|FG001|Overall Study|Adverse Event|2|||
170514060|NCT03836209|616228265|FG000|Overall Study|Death|4|||
170514061|NCT03836209|616228266|FG001|Overall Study|Death|1|||
170514062|NCT03836209|616228265|FG000|Overall Study|Lack of Efficacy|7|||
170514063|NCT03836209|616228266|FG001|Overall Study|Lack of Efficacy|10|||
170514064|NCT03836209|616228265|FG000|Overall Study|Physician Decision|7|||
170514065|NCT03836209|616228266|FG001|Overall Study|Physician Decision|11|||
170514066|NCT03836209|616228265|FG000|Overall Study|Protocol Violation|0|||
170514067|NCT03836209|616228266|FG001|Overall Study|Protocol Violation|3|||
170514068|NCT03836209|616228265|FG000|Overall Study|Withdrawal by Subject|2|||
170806301|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
170806302|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
170806303|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
170806304|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
170806305|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
170806306|NCT03598790|617301485|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
170806307|NCT03598790|617301486|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
170806308|NCT03598790|617301487|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
170806309|NCT03598790|617301488|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
170806310|NCT03598790|617301489|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
170806311|NCT03598790|617301490|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
170806312|NCT03598790|617301491|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
170806313|NCT03598790|617301492|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
170806314|NCT03598790|617301493|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
170806315|NCT03598790|617301485|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170514069|NCT03836209|616228266|FG001|Overall Study|Withdrawal by Subject|10|||
170806316|NCT03598790|617301486|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170806317|NCT03598790|617301487|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170806318|NCT03598790|617301488|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
170806319|NCT03598790|617301489|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
170806320|NCT03598790|617301490|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
170806321|NCT03598790|617301491|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170514070|NCT03836209|616228265|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
170514071|NCT03836209|616228266|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
170514072|NCT04892446|616228270|FG000|Overall Study|Death|4|||
170514073|NCT04892446|616228271|FG001|Overall Study|Death|4|||
170514074|NCT04892446|616228272|FG002|Overall Study|Death|0|||
170514075|NCT04892446|616228270|FG000|Overall Study|Withdrew consent|3|||
170514076|NCT04892446|616228271|FG001|Overall Study|Withdrew consent|0|||
170514077|NCT04892446|616228272|FG002|Overall Study|Withdrew consent|1|||
170514078|NCT04892446|616228270|FG000|Overall Study|Investigator's discretion|1|||
170514079|NCT04892446|616228271|FG001|Overall Study|Investigator's discretion|1|||
170514080|NCT04892446|616228272|FG002|Overall Study|Investigator's discretion|0|||
170514081|NCT04892446|616228270|FG000|Overall Study|Study terminated by sponsor|0|||
170514082|NCT04892446|616228271|FG001|Overall Study|Study terminated by sponsor|0|||
170514083|NCT04892446|616228272|FG002|Overall Study|Study terminated by sponsor|2|||
170514084|NCT02328937|616228273|FG000|Period 1|Lost to Follow-up|0|||
170514085|NCT02328937|616228274|FG001|Period 1|Lost to Follow-up|0|||
170514086|NCT02328937|616228275|FG002|Period 1|Lost to Follow-up|0|||
170514087|NCT02328937|616228276|FG003|Period 1|Lost to Follow-up|1|||
170514088|NCT02328937|616228277|FG004|Period 1|Lost to Follow-up|0|||
170806322|NCT03598790|617301492|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170806323|NCT03598790|617301493|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
170514089|NCT02328937|616228278|FG005|Period 1|Lost to Follow-up|0|||
170514090|NCT02328937|616228273|FG000|Period 2|Adverse Event|0|||
170514091|NCT02328937|616228274|FG001|Period 2|Adverse Event|0|||
170554671|NCT01694771|616376970|FG000|Overall Study|Consent withdrawn|7|||
170554672|NCT01694771|616376971|FG001|Overall Study|Consent withdrawn|9|||
170514092|NCT02328937|616228275|FG002|Period 2|Adverse Event|1|||
170514093|NCT02328937|616228276|FG003|Period 2|Adverse Event|0|||
170514094|NCT02328937|616228277|FG004|Period 2|Adverse Event|0|||
170514095|NCT02328937|616228278|FG005|Period 2|Adverse Event|0|||
170644690|NCT01639729|616713824|FG004|Overall Study|Withdrawal by Subject|0|||
170644691|NCT01639729|616713825|FG005|Overall Study|Withdrawal by Subject|0|||
170514096|NCT00705341|616228279|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
170514097|NCT00705341|616228280|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
170514098|NCT00705341|616228281|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
170514099|NCT00705341|616228282|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
170514100|NCT00705341|616228279|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
170514101|NCT00705341|616228280|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
170514102|NCT00705341|616228281|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
170514103|NCT00705341|616228282|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
170514104|NCT00435461|616228283|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
170514105|NCT00435461|616228284|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
170514106|NCT00435461|616228285|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
170514107|NCT00435461|616228283|FG000|Overall Study|Protocol Violation|6|||
170514108|NCT00435461|616228284|FG001|Overall Study|Protocol Violation|9|||
170514109|NCT00435461|616228285|FG002|Overall Study|Protocol Violation|10|||
170514110|NCT00435461|616228283|FG000|Overall Study|Participant randomized(inadequate score)|1|||
170514111|NCT00435461|616228284|FG001|Overall Study|Participant randomized(inadequate score)|0|||
170514112|NCT00435461|616228285|FG002|Overall Study|Participant randomized(inadequate score)|0|||
170514113|NCT00435461|616228283|FG000|Overall Study|Compliance less than 80 percent|1|||
170644692|NCT00322621|616713829|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
170644693|NCT00322621|616713830|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
170644694|NCT00322621|616713831|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
170644695|NCT00322621|616713829|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
170644696|NCT00322621|616713830|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
170644697|NCT00322621|616713831|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
170644698|NCT00322621|616713829|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
170644699|NCT00322621|616713830|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
170644700|NCT00322621|616713831|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
170514114|NCT00435461|616228284|FG001|Overall Study|Compliance less than 80 percent|0|||
170644701|NCT00322621|616713829|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
170644702|NCT00322621|616713830|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
170644703|NCT00322621|616713831|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
170644704|NCT00322621|616713829|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
170644705|NCT00322621|616713830|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
170644706|NCT00322621|616713831|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
170644707|NCT00322621|616713829|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
170644708|NCT00322621|616713830|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
170644709|NCT00322621|616713831|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
170644710|NCT00322621|616713829|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
170644711|NCT00322621|616713830|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
170644712|NCT00322621|616713831|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
170644713|NCT00322621|616713829|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
170644714|NCT00322621|616713830|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
170644715|NCT00322621|616713831|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
170644716|NCT00322621|616713829|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
170644717|NCT00322621|616713830|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
170644718|NCT00322621|616713831|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
170644719|NCT00322621|616713829|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
170644720|NCT00322621|616713830|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
170644721|NCT00322621|616713831|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
170514115|NCT00435461|616228285|FG002|Overall Study|Compliance less than 80 percent|0|||
170514116|NCT00435461|616228283|FG000|Overall Study|In error, two study medications switched|1|||
170514117|NCT00435461|616228284|FG001|Overall Study|In error, two study medications switched|0|||
170514118|NCT00435461|616228285|FG002|Overall Study|In error, two study medications switched|0|||
170644722|NCT00322621|616713829|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
170514119|NCT00435461|616228283|FG000|Overall Study|Lack of Efficacy|2|||
170514120|NCT00435461|616228284|FG001|Overall Study|Lack of Efficacy|1|||
170514121|NCT00435461|616228285|FG002|Overall Study|Lack of Efficacy|0|||
170514122|NCT00435461|616228283|FG000|Overall Study|Withdrawal by Subject|1|||
170514123|NCT00435461|616228284|FG001|Overall Study|Withdrawal by Subject|0|||
170514124|NCT00435461|616228285|FG002|Overall Study|Withdrawal by Subject|2|||
170514125|NCT00435461|616228283|FG000|Overall Study|Randomized in error|1|||
170514126|NCT00435461|616228284|FG001|Overall Study|Randomized in error|0|||
170514127|NCT00435461|616228285|FG002|Overall Study|Randomized in error|0|||
170514128|NCT00435461|616228283|FG000|Overall Study|Participant could not tolerate symptoms|0|||
170514129|NCT00435461|616228284|FG001|Overall Study|Participant could not tolerate symptoms|0|||
170514130|NCT00435461|616228285|FG002|Overall Study|Participant could not tolerate symptoms|1|||
170514131|NCT00435461|616228283|FG000|Overall Study|Participant could not swallow capsule|0|||
170514132|NCT00435461|616228284|FG001|Overall Study|Participant could not swallow capsule|0|||
170514133|NCT00435461|616228285|FG002|Overall Study|Participant could not swallow capsule|1|||
170514134|NCT00435461|616228283|FG000|Overall Study|Pregnancy|2|||
170514135|NCT00435461|616228284|FG001|Overall Study|Pregnancy|0|||
170514136|NCT00435461|616228285|FG002|Overall Study|Pregnancy|0|||
170514137|NCT00435461|616228283|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
170514138|NCT00435461|616228284|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
170514139|NCT00435461|616228285|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
170514140|NCT00435461|616228283|FG000|Overall Study|Participant ended study one day early|1|||
170514141|NCT00435461|616228284|FG001|Overall Study|Participant ended study one day early|0|||
170514142|NCT00435461|616228285|FG002|Overall Study|Participant ended study one day early|0|||
170514143|NCT00435461|616228283|FG000|Overall Study|Noncompliance with study requirements|1|||
170514144|NCT00435461|616228284|FG001|Overall Study|Noncompliance with study requirements|1|||
170514145|NCT00435461|616228285|FG002|Overall Study|Noncompliance with study requirements|1|||
170514146|NCT00435461|616228283|FG000|Overall Study|Adverse Event|1|||
170514147|NCT00435461|616228284|FG001|Overall Study|Adverse Event|2|||
170514148|NCT00435461|616228285|FG002|Overall Study|Adverse Event|6|||
170514149|NCT00435461|616228283|FG000|Overall Study|Non-Compliance of diary|2|||
170514150|NCT00435461|616228284|FG001|Overall Study|Non-Compliance of diary|0|||
170514151|NCT00435461|616228285|FG002|Overall Study|Non-Compliance of diary|1|||
170514152|NCT00435461|616228283|FG000|Overall Study|Lost to Follow-up|1|||
170514153|NCT00435461|616228284|FG001|Overall Study|Lost to Follow-up|1|||
170514154|NCT00435461|616228285|FG002|Overall Study|Lost to Follow-up|2|||
170514155|NCT01768559|616228288|FG000|Overall Study|Randomized but not treated|0|||
170514156|NCT01768559|616228289|FG001|Overall Study|Randomized but not treated|0|||
170514157|NCT01768559|616228290|FG002|Overall Study|Randomized but not treated|1|||
170514158|NCT01768559|616228288|FG000|Overall Study|Adverse Event|15|||
170514159|NCT01768559|616228289|FG001|Overall Study|Adverse Event|2|||
170514160|NCT01768559|616228290|FG002|Overall Study|Adverse Event|5|||
170514161|NCT01768559|616228288|FG000|Overall Study|Lack of Efficacy|6|||
170514162|NCT01768559|616228289|FG001|Overall Study|Lack of Efficacy|4|||
170514163|NCT01768559|616228290|FG002|Overall Study|Lack of Efficacy|0|||
170514164|NCT01768559|616228288|FG000|Overall Study|Poor compliance to protocol|0|||
170514165|NCT01768559|616228289|FG001|Overall Study|Poor compliance to protocol|3|||
170514166|NCT01768559|616228290|FG002|Overall Study|Poor compliance to protocol|2|||
170514167|NCT01768559|616228288|FG000|Overall Study|Other than specified|9|||
170514168|NCT01768559|616228289|FG001|Overall Study|Other than specified|8|||
170514169|NCT01768559|616228290|FG002|Overall Study|Other than specified|5|||
170514170|NCT02782377|616228291|FG000|Overall Study|Physician Decision|5|||
170554673|NCT01694771|616376970|FG000|Overall Study|Other reasons|5|||
170554674|NCT01694771|616376971|FG001|Overall Study|Other reasons|6|||
170554675|NCT02797522|616378538|FG000|Overall Study|Study Terminated by Sponsor|0|||
170554676|NCT02797522|616378539|FG001|Overall Study|Study Terminated by Sponsor|0|||
170554677|NCT02797522|616378540|FG002|Overall Study|Study Terminated by Sponsor|0|||
170554678|NCT02797522|616378541|FG003|Overall Study|Study Terminated by Sponsor|0|||
170554679|NCT02797522|616378542|FG004|Overall Study|Study Terminated by Sponsor|0|||
170554680|NCT02797522|616378543|FG005|Overall Study|Study Terminated by Sponsor|0|||
170554681|NCT02797522|616378544|FG006|Overall Study|Study Terminated by Sponsor|0|||
170554682|NCT02797522|616378545|FG007|Overall Study|Study Terminated by Sponsor|4|||
170554683|NCT02797522|616378546|FG008|Overall Study|Study Terminated by Sponsor|2|||
170554684|NCT02797522|616378547|FG009|Overall Study|Study Terminated by Sponsor|4|||
170554685|NCT02797522|616378548|FG010|Overall Study|Study Terminated by Sponsor|1|||
170554686|NCT04129398|616378549|FG000|Overall Study|Physician Decision|2|||
170554687|NCT00866775|616378552|FG000|Overall Study|Adverse Event|5|||
170554688|NCT00866775|616378553|FG001|Overall Study|Adverse Event|19|||
170554689|NCT00866775|616378552|FG000|Overall Study|Death|1|||
170554690|NCT00866775|616378553|FG001|Overall Study|Death|0|||
170554691|NCT00866775|616378552|FG000|Overall Study|Lost to Follow-up|0|||
170554692|NCT00866775|616378553|FG001|Overall Study|Lost to Follow-up|4|||
170554693|NCT00866775|616378552|FG000|Overall Study|Physician Decision|0|||
170554694|NCT00866775|616378553|FG001|Overall Study|Physician Decision|3|||
170554695|NCT00866775|616378552|FG000|Overall Study|Protocol Violation|3|||
170554696|NCT00866775|616378553|FG001|Overall Study|Protocol Violation|4|||
170554697|NCT00866775|616378552|FG000|Overall Study|Withdrawal by Subject|4|||
170554698|NCT00866775|616378553|FG001|Overall Study|Withdrawal by Subject|4|||
170554699|NCT00866775|616378552|FG000|Overall Study|met exit criteria|23|||
170514171|NCT00398047|616228294|FG000|Overall Study|all patient progressed before completion|3|||
170554700|NCT00866775|616378553|FG001|Overall Study|met exit criteria|17|||
170514172|NCT00237692|616228295|FG000|Overall Study|Lost to Follow-up|9|||
170514173|NCT00237692|616228296|FG001|Overall Study|Lost to Follow-up|3|||
170514174|NCT00237692|616228297|FG002|Overall Study|Lost to Follow-up|5|||
170554701|NCT00866775|616378552|FG000|Overall Study|discontinued due to communication error|0|||
170554702|NCT00866775|616378553|FG001|Overall Study|discontinued due to communication error|1|||
170554703|NCT00833703|616378554|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
170554704|NCT00833703|616378555|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
170554705|NCT01904279|616378559|FG000|Overall Study|Lack of Efficacy|2|||
170554706|NCT01904279|616378560|FG001|Overall Study|Lack of Efficacy|3|||
170554707|NCT01904279|616378559|FG000|Overall Study|Withdrawal by Subject|1|||
170554708|NCT01904279|616378560|FG001|Overall Study|Withdrawal by Subject|0|||
170644723|NCT00322621|616713830|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
170644724|NCT00322621|616713831|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
170554709|NCT00841815|616378561|FG000|Washout|Withdrawal by Subject|0|||
170554710|NCT00841815|616378562|FG001|Washout|Withdrawal by Subject|1|||
170554711|NCT04557735|616378563|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
170554712|NCT04557735|616378563|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
170554713|NCT04557735|616378563|FG000|Treatment Period (26 Weeks)|Death|5|||
170554714|NCT04557735|616378563|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
170554715|NCT04557735|616378563|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
170554716|NCT04557735|616378563|FG000|Follow-Up Period (26 Weeks)|Death|4|||
170554717|NCT03533491|616378564|FG000|Overall Study|Lost to Follow-up|2|||
170554718|NCT04403880|616378566|FG000|Overall Study|Death|1|||
170554719|NCT04403880|616378567|FG001|Overall Study|Death|0|||
170554720|NCT04403880|616378568|FG002|Overall Study|Death|2|||
170554721|NCT04403880|616378569|FG003|Overall Study|Death|0|||
170554722|NCT04403880|616378570|FG004|Overall Study|Death|0|||
170554723|NCT04403880|616378571|FG005|Overall Study|Death|0|||
170554724|NCT04403880|616378572|FG006|Overall Study|Death|0|||
170644725|NCT04136444|616713832|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
170644726|NCT04136444|616713833|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
170644727|NCT01853839|616713838|FG000|Overall Study|Violated inclusion criteria|2|||
170644728|NCT01853839|616713838|FG000|Overall Study|Not meet ITT population definition|58|||
170644729|NCT01853839|616713838|FG000|Overall Study|End of treatment visit too early|33|||
170554725|NCT04403880|616378566|FG000|Overall Study|Physician Decision|0|||
170554726|NCT04403880|616378567|FG001|Overall Study|Physician Decision|0|||
170554727|NCT04403880|616378568|FG002|Overall Study|Physician Decision|0|||
170554728|NCT04403880|616378569|FG003|Overall Study|Physician Decision|0|||
170554729|NCT04403880|616378570|FG004|Overall Study|Physician Decision|1|||
170554730|NCT04403880|616378571|FG005|Overall Study|Physician Decision|0|||
170644730|NCT01853839|616713838|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
170806324|NCT03598790|617301485|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
170514175|NCT00237692|616228298|FG003|Overall Study|Lost to Follow-up|3|||
170514176|NCT00237692|616228295|FG000|Overall Study|Death|1|||
170514177|NCT00237692|616228296|FG001|Overall Study|Death|2|||
170514178|NCT00237692|616228297|FG002|Overall Study|Death|2|||
170514179|NCT00237692|616228298|FG003|Overall Study|Death|3|||
170514180|NCT00237692|616228295|FG000|Overall Study|Excluded - did not meet criteria|4|||
170514181|NCT00237692|616228296|FG001|Overall Study|Excluded - did not meet criteria|3|||
170514182|NCT00237692|616228297|FG002|Overall Study|Excluded - did not meet criteria|5|||
170514183|NCT00237692|616228298|FG003|Overall Study|Excluded - did not meet criteria|9|||
170514184|NCT00237692|616228295|FG000|Overall Study|Withdrawal by Subject|4|||
170514185|NCT00237692|616228296|FG001|Overall Study|Withdrawal by Subject|6|||
170514186|NCT00237692|616228297|FG002|Overall Study|Withdrawal by Subject|10|||
170514187|NCT00237692|616228298|FG003|Overall Study|Withdrawal by Subject|4|||
170514188|NCT01408901|616228300|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
170514189|NCT01408901|616228301|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
170514190|NCT01408901|616228302|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
170514191|NCT01408901|616228303|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
170514192|NCT01408901|616228300|FG000|6-Week Follow-Up|Death|1|||
170514193|NCT01408901|616228301|FG001|6-Week Follow-Up|Death|0|||
170514194|NCT01408901|616228302|FG002|6-Week Follow-Up|Death|0|||
170514195|NCT01408901|616228303|FG003|6-Week Follow-Up|Death|0|||
170514196|NCT01408901|616228300|FG000|6-Week Follow-Up|Cancelled visit|0|||
170514197|NCT01408901|616228301|FG001|6-Week Follow-Up|Cancelled visit|1|||
170514198|NCT01408901|616228302|FG002|6-Week Follow-Up|Cancelled visit|0|||
170514199|NCT01408901|616228303|FG003|6-Week Follow-Up|Cancelled visit|2|||
170514200|NCT01408901|616228300|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
170514201|NCT01408901|616228301|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
170514202|NCT01408901|616228302|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
170514203|NCT01408901|616228303|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
170514204|NCT01408901|616228300|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
170514205|NCT01408901|616228301|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
170514206|NCT01408901|616228302|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
170514207|NCT01408901|616228303|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
170514208|NCT01408901|616228300|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
170514209|NCT01408901|616228301|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
170514210|NCT01408901|616228302|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
170554731|NCT04403880|616378572|FG006|Overall Study|Physician Decision|0|||
170554732|NCT04403880|616378566|FG000|Overall Study|Lost to Follow-up|4|||
170554733|NCT04403880|616378567|FG001|Overall Study|Lost to Follow-up|3|||
170554734|NCT04403880|616378568|FG002|Overall Study|Lost to Follow-up|8|||
170554735|NCT04403880|616378569|FG003|Overall Study|Lost to Follow-up|7|||
170554736|NCT04403880|616378570|FG004|Overall Study|Lost to Follow-up|8|||
170514211|NCT01408901|616228303|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
170514212|NCT01408901|616228300|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
170514213|NCT01408901|616228301|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
170514214|NCT01408901|616228302|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
170514215|NCT01408901|616228303|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
170514216|NCT01408901|616228300|FG000|26-Week Follow-Up|Death|0|||
170514217|NCT01408901|616228301|FG001|26-Week Follow-Up|Death|1|||
170514218|NCT01408901|616228302|FG002|26-Week Follow-Up|Death|0|||
170514219|NCT01408901|616228303|FG003|26-Week Follow-Up|Death|0|||
170514220|NCT02081001|616228304|FG000|Overall Study|Adverse Event|0|||
170514221|NCT02081001|616228305|FG001|Overall Study|Adverse Event|0|||
170514222|NCT02081001|616228306|FG002|Overall Study|Adverse Event|0|||
170514223|NCT02081001|616228307|FG003|Overall Study|Adverse Event|0|||
170514224|NCT02081001|616228308|FG004|Overall Study|Adverse Event|1|||
170514225|NCT02081001|616228309|FG005|Overall Study|Adverse Event|0|||
170514226|NCT02081001|616228310|FG006|Overall Study|Adverse Event|0|||
170514227|NCT02081001|616228311|FG007|Overall Study|Adverse Event|0|||
170514228|NCT02081001|616228312|FG008|Overall Study|Adverse Event|0|||
170514229|NCT02081001|616228313|FG009|Overall Study|Adverse Event|0|||
170514230|NCT02081001|616228314|FG010|Overall Study|Adverse Event|0|||
170514231|NCT02081001|616228315|FG011|Overall Study|Adverse Event|0|||
170514232|NCT01436227|616228319|FG000|Overall Study|Adverse Event|7|||
170514233|NCT01436227|616228319|FG000|Overall Study|Death|1|||
170514234|NCT01436227|616228319|FG000|Overall Study|Lack of Efficacy|1|||
170514235|NCT01436227|616228319|FG000|Overall Study|Lost to Follow-up|3|||
170514236|NCT01436227|616228319|FG000|Overall Study|Physician Decision|1|||
170514237|NCT01436227|616228319|FG000|Overall Study|Withdrawal by Subject|7|||
170514238|NCT01436227|616228319|FG000|Overall Study|Disease progression, relapse|6|||
170514239|NCT04865419|616228326|FG000|Overall Study|Other|1|||
170514240|NCT04865419|616228327|FG001|Overall Study|Other|2|||
170806325|NCT03598790|617301486|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
170806326|NCT03598790|617301487|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
170806327|NCT03598790|617301488|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
170806328|NCT03598790|617301489|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
170806329|NCT03598790|617301490|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
170806330|NCT03598790|617301491|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
170806331|NCT03598790|617301492|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
170806332|NCT03598790|617301493|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
170806333|NCT03598790|617301485|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170806334|NCT03598790|617301486|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170806335|NCT03598790|617301487|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170806336|NCT03598790|617301488|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
170806337|NCT03598790|617301489|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170806338|NCT03598790|617301490|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170806339|NCT03598790|617301491|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170806340|NCT03598790|617301492|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170806341|NCT03598790|617301493|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
170806342|NCT03598790|617301485|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
170806343|NCT03598790|617301486|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
170806344|NCT03598790|617301487|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
170554737|NCT04403880|616378571|FG005|Overall Study|Lost to Follow-up|1|||
170554738|NCT04403880|616378572|FG006|Overall Study|Lost to Follow-up|8|||
170554739|NCT04403880|616378566|FG000|Overall Study|Withdrawal by Subject|8|||
170554740|NCT04403880|616378567|FG001|Overall Study|Withdrawal by Subject|9|||
170554741|NCT04403880|616378568|FG002|Overall Study|Withdrawal by Subject|22|||
170554742|NCT04403880|616378569|FG003|Overall Study|Withdrawal by Subject|16|||
170554743|NCT04403880|616378570|FG004|Overall Study|Withdrawal by Subject|16|||
170554744|NCT04403880|616378571|FG005|Overall Study|Withdrawal by Subject|8|||
170554745|NCT04403880|616378572|FG006|Overall Study|Withdrawal by Subject|11|||
170554746|NCT04403880|616378566|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
170554747|NCT04403880|616378567|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
170554748|NCT04403880|616378568|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
170554749|NCT04403880|616378569|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
170554750|NCT04403880|616378570|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
170554751|NCT04403880|616378571|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
170554752|NCT04403880|616378572|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
170554753|NCT04403880|616378566|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
170554754|NCT04403880|616378567|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
170554755|NCT04403880|616378568|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
170554756|NCT04403880|616378569|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
170554757|NCT04403880|616378570|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
170554758|NCT04403880|616378571|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
170554759|NCT04403880|616378572|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
170554760|NCT04403880|616378566|FG000|Overall Study|Pregnancy|2|||
170554761|NCT04403880|616378567|FG001|Overall Study|Pregnancy|0|||
170554762|NCT04403880|616378568|FG002|Overall Study|Pregnancy|5|||
170554763|NCT04403880|616378569|FG003|Overall Study|Pregnancy|0|||
170554764|NCT04403880|616378570|FG004|Overall Study|Pregnancy|1|||
170554765|NCT04403880|616378571|FG005|Overall Study|Pregnancy|0|||
170554766|NCT04403880|616378572|FG006|Overall Study|Pregnancy|1|||
170554767|NCT04403880|616378566|FG000|Overall Study|Sponsor Decision|2|||
170554768|NCT04403880|616378567|FG001|Overall Study|Sponsor Decision|0|||
170554769|NCT04403880|616378568|FG002|Overall Study|Sponsor Decision|14|||
170554770|NCT04403880|616378569|FG003|Overall Study|Sponsor Decision|1|||
170554771|NCT04403880|616378570|FG004|Overall Study|Sponsor Decision|1|||
170554772|NCT04403880|616378571|FG005|Overall Study|Sponsor Decision|0|||
170554773|NCT04403880|616378572|FG006|Overall Study|Sponsor Decision|2|||
170554774|NCT04403880|616378566|FG000|Overall Study|Other|18|||
170554775|NCT04403880|616378567|FG001|Overall Study|Other|9|||
170554776|NCT04403880|616378568|FG002|Overall Study|Other|14|||
170554777|NCT04403880|616378569|FG003|Overall Study|Other|10|||
170554778|NCT04403880|616378570|FG004|Overall Study|Other|11|||
170554779|NCT04403880|616378571|FG005|Overall Study|Other|12|||
170554780|NCT04403880|616378572|FG006|Overall Study|Other|15|||
170806345|NCT03598790|617301488|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
170554781|NCT03768414|616378582|FG000|Overall Study|Adverse Event or side effects|72|||
170554782|NCT03768414|616378583|FG001|Overall Study|Adverse Event or side effects|28|||
170554783|NCT03768414|616378582|FG000|Overall Study|Refusal unrelated to adverse event|33|||
170554784|NCT03768414|616378583|FG001|Overall Study|Refusal unrelated to adverse event|33|||
170554785|NCT03768414|616378582|FG000|Overall Study|Progression/relapse|132|||
170554786|NCT03768414|616378583|FG001|Overall Study|Progression/relapse|60|||
170514241|NCT04865419|616228328|FG002|Overall Study|Other|2|||
170514242|NCT04865419|616228329|FG003|Overall Study|Other|1|||
170514243|NCT04865419|616228330|FG004|Overall Study|Other|3|||
170514244|NCT04865419|616228331|FG005|Overall Study|Other|0|||
170514245|NCT04865419|616228332|FG006|Overall Study|Other|0|||
170514246|NCT04865419|616228333|FG007|Overall Study|Other|1|||
170514247|NCT04865419|616228334|FG008|Overall Study|Other|0|||
170514248|NCT04865419|616228335|FG009|Overall Study|Other|0|||
170514249|NCT04865419|616228336|FG010|Overall Study|Other|0|||
170514250|NCT04865419|616228326|FG000|Overall Study|Withdrawal by Subject|0|||
170514251|NCT04865419|616228327|FG001|Overall Study|Withdrawal by Subject|1|||
170514252|NCT04865419|616228328|FG002|Overall Study|Withdrawal by Subject|1|||
170514253|NCT04865419|616228329|FG003|Overall Study|Withdrawal by Subject|0|||
170514254|NCT04865419|616228330|FG004|Overall Study|Withdrawal by Subject|0|||
170514255|NCT04865419|616228331|FG005|Overall Study|Withdrawal by Subject|0|||
170514256|NCT04865419|616228332|FG006|Overall Study|Withdrawal by Subject|0|||
170554787|NCT03768414|616378582|FG000|Overall Study|Death|9|||
170554788|NCT03768414|616378583|FG001|Overall Study|Death|6|||
170554789|NCT03768414|616378582|FG000|Overall Study|Other - not protocol specified|45|||
170554790|NCT03768414|616378583|FG001|Overall Study|Other - not protocol specified|18|||
170554791|NCT03768414|616378582|FG000|Overall Study|Reason under review|3|||
170554792|NCT03768414|616378583|FG001|Overall Study|Reason under review|2|||
170554793|NCT05451329|616378584|FG000|Overall Study|Adverse Event|1|||
170554794|NCT05451329|616378585|FG001|Overall Study|Adverse Event|1|||
170554795|NCT05451329|616378586|FG002|Overall Study|Adverse Event|0|||
170554796|NCT05451329|616378584|FG000|Overall Study|Withdrawal by Subject|1|||
170554797|NCT05451329|616378585|FG001|Overall Study|Withdrawal by Subject|0|||
170554798|NCT05451329|616378586|FG002|Overall Study|Withdrawal by Subject|0|||
170554799|NCT05451329|616378584|FG000|Overall Study|Investigational Product Lot exchange|1|||
170554800|NCT05451329|616378585|FG001|Overall Study|Investigational Product Lot exchange|1|||
170554801|NCT05451329|616378586|FG002|Overall Study|Investigational Product Lot exchange|0|||
170554802|NCT02556736|616378587|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
170554803|NCT02556736|616378588|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
170554804|NCT02556736|616378589|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
170554805|NCT02556736|616378590|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
170554806|NCT02556736|616378587|FG000|Open Label Treatment Period|Adverse Event|0|||
170554807|NCT02556736|616378588|FG001|Open Label Treatment Period|Adverse Event|0|||
170554808|NCT02556736|616378589|FG002|Open Label Treatment Period|Adverse Event|0|||
170554809|NCT02556736|616378590|FG003|Open Label Treatment Period|Adverse Event|1|||
170554810|NCT02556736|616378587|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
170554811|NCT02556736|616378588|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
170554812|NCT02556736|616378589|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
170554813|NCT02556736|616378590|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
170554814|NCT02940223|616378598|FG000|Overall Study|Failed Requirement|2|||
170554815|NCT02940223|616378599|FG001|Overall Study|Failed Requirement|0|||
170554816|NCT01302834|616378601|FG000|Overall Study|Protocol Violation|17|||
170554817|NCT01302834|616378602|FG001|Overall Study|Protocol Violation|23|||
170554818|NCT01302834|616378601|FG000|Overall Study|HIV positive|1|||
170554819|NCT01302834|616378602|FG001|Overall Study|HIV positive|3|||
170554820|NCT04770272|616378603|FG000|Overall Study|Death|1|||
170554821|NCT04770272|616378604|FG001|Overall Study|Death|0|||
170554822|NCT04770272|616378603|FG000|Overall Study|Withdrawal by Subject|11|||
170554823|NCT04770272|616378604|FG001|Overall Study|Withdrawal by Subject|12|||
170554824|NCT04770272|616378603|FG000|Overall Study|Protocol Violation|0|||
170554825|NCT04770272|616378604|FG001|Overall Study|Protocol Violation|2|||
170554826|NCT04770272|616378603|FG000|Overall Study|Adverse Event|23|||
170554827|NCT04770272|616378604|FG001|Overall Study|Adverse Event|21|||
170554828|NCT04770272|616378603|FG000|Overall Study|Physician Decision|7|||
170554829|NCT04770272|616378604|FG001|Overall Study|Physician Decision|3|||
170554830|NCT04770272|616378603|FG000|Overall Study|Disease progression|4|||
170554831|NCT04770272|616378604|FG001|Overall Study|Disease progression|8|||
170554832|NCT04770272|616378603|FG000|Overall Study|Switched to other therapy.|0|||
170554833|NCT04770272|616378604|FG001|Overall Study|Switched to other therapy.|2|||
170554834|NCT02363946|616378605|FG000|Overall Study|Lost to Follow-up|0|||
170554835|NCT02363946|616378606|FG001|Overall Study|Lost to Follow-up|0|||
170554836|NCT02363946|616378607|FG002|Overall Study|Lost to Follow-up|0|||
170514257|NCT04865419|616228333|FG007|Overall Study|Withdrawal by Subject|1|||
170514258|NCT04865419|616228334|FG008|Overall Study|Withdrawal by Subject|2|||
170554837|NCT02363946|616378608|FG003|Overall Study|Lost to Follow-up|0|||
170554838|NCT02363946|616378609|FG004|Overall Study|Lost to Follow-up|0|||
170554839|NCT02363946|616378610|FG005|Overall Study|Lost to Follow-up|0|||
170554840|NCT02363946|616378611|FG006|Overall Study|Lost to Follow-up|0|||
170554841|NCT02363946|616378612|FG007|Overall Study|Lost to Follow-up|1|||
170554842|NCT02363946|616378613|FG008|Overall Study|Lost to Follow-up|0|||
170554843|NCT02363946|616378614|FG009|Overall Study|Lost to Follow-up|0|||
170514259|NCT04865419|616228335|FG009|Overall Study|Withdrawal by Subject|1|||
170554844|NCT02363946|616378615|FG010|Overall Study|Lost to Follow-up|0|||
170554845|NCT02363946|616378616|FG011|Overall Study|Lost to Follow-up|0|||
170554846|NCT02363946|616378617|FG012|Overall Study|Lost to Follow-up|0|||
170554847|NCT03996395|616378620|FG000|Overall Study|Lost to Follow-up|4|||
170554848|NCT03996395|616378620|FG000|Overall Study|Withdrawal by Subject|1|||
170554849|NCT03996395|616378620|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
170514260|NCT04865419|616228336|FG010|Overall Study|Withdrawal by Subject|0|||
170514261|NCT04865419|616228326|FG000|Overall Study|Study terminated by Sponsor|0|||
170514262|NCT04865419|616228327|FG001|Overall Study|Study terminated by Sponsor|0|||
170514263|NCT04865419|616228328|FG002|Overall Study|Study terminated by Sponsor|0|||
170554850|NCT02097225|616378621|FG000|Dose Level 4|Adverse Event|0|||
170554851|NCT02097225|616378622|FG001|Dose Level 4|Adverse Event|0|||
170554852|NCT02097225|616378623|FG002|Dose Level 4|Adverse Event|0|||
170554853|NCT02097225|616378624|FG003|Dose Level 4|Adverse Event|0|||
170554854|NCT02097225|616378625|FG004|Dose Level 4|Adverse Event|1|||
170554855|NCT02536339|616378631|FG000|Overall Study|Death|20|||
170554856|NCT02536339|616378631|FG000|Overall Study|Withdrawal by Subject|3|||
170554857|NCT02536339|616378631|FG000|Overall Study|Lost to Follow-up|2|||
170554858|NCT02536339|616378631|FG000|Overall Study|Treatment discontinued|2|||
170554859|NCT02536339|616378631|FG000|Overall Study|Physician Decision|1|||
170554860|NCT01905683|616378632|FG000|Overall Study|Protocol Violation|1|||
170554861|NCT01905683|616378632|FG000|Overall Study|Re-injection criteria not met; others|13|||
170554862|NCT01905683|616378632|FG000|Overall Study|Physician Decision|1|||
170554863|NCT01905683|616378632|FG000|Overall Study|Lack of Efficacy|8|||
170554864|NCT01905683|616378632|FG000|Overall Study|Withdrawal by Subject|20|||
170554865|NCT01905683|616378632|FG000|Overall Study|Adverse Event|4|||
170554866|NCT01905683|616378632|FG000|Overall Study|Lost to Follow-up|4|||
170554867|NCT03759379|616379990|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
170554868|NCT03759379|616379991|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
170554869|NCT03759379|616379990|FG000|Treatment Period|Death|2|||
170554870|NCT03759379|616379991|FG001|Treatment Period|Death|3|||
170554871|NCT03759379|616379990|FG000|Treatment Period|Lost to Follow-up|1|||
170554872|NCT03759379|616379991|FG001|Treatment Period|Lost to Follow-up|0|||
170554873|NCT03759379|616379990|FG000|Treatment Period|Physician Decision|0|||
170554874|NCT03759379|616379991|FG001|Treatment Period|Physician Decision|1|||
170554875|NCT04924608|616379992|FG000|Overall Study|Adverse Event|10|||
170554876|NCT04924608|616379993|FG001|Overall Study|Adverse Event|6|||
170554877|NCT04924608|616379992|FG000|Overall Study|Lost to Follow-up|1|||
170554878|NCT04924608|616379993|FG001|Overall Study|Lost to Follow-up|1|||
170806346|NCT03598790|617301489|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
170806347|NCT03598790|617301490|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
170806348|NCT03598790|617301491|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
170806349|NCT03598790|617301492|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
170806350|NCT03598790|617301493|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
170806351|NCT03598790|617301485|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
170806352|NCT03598790|617301486|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
170514264|NCT04865419|616228329|FG003|Overall Study|Study terminated by Sponsor|2|||
170514265|NCT04865419|616228330|FG004|Overall Study|Study terminated by Sponsor|2|||
170514266|NCT04865419|616228331|FG005|Overall Study|Study terminated by Sponsor|0|||
170514267|NCT04865419|616228332|FG006|Overall Study|Study terminated by Sponsor|0|||
170514268|NCT04865419|616228333|FG007|Overall Study|Study terminated by Sponsor|0|||
170514269|NCT04865419|616228334|FG008|Overall Study|Study terminated by Sponsor|0|||
170514270|NCT04865419|616228335|FG009|Overall Study|Study terminated by Sponsor|0|||
170514271|NCT04865419|616228336|FG010|Overall Study|Study terminated by Sponsor|1|||
170806353|NCT03598790|617301487|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
170806354|NCT03598790|617301488|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
170514272|NCT04865419|616228326|FG000|Overall Study|Death|3|||
170514273|NCT04865419|616228327|FG001|Overall Study|Death|1|||
170514274|NCT04865419|616228328|FG002|Overall Study|Death|4|||
170514275|NCT04865419|616228329|FG003|Overall Study|Death|2|||
170514276|NCT04865419|616228330|FG004|Overall Study|Death|5|||
170514277|NCT04865419|616228331|FG005|Overall Study|Death|2|||
170514278|NCT04865419|616228332|FG006|Overall Study|Death|1|||
170514279|NCT04865419|616228333|FG007|Overall Study|Death|1|||
170514280|NCT04865419|616228334|FG008|Overall Study|Death|2|||
170514281|NCT04865419|616228335|FG009|Overall Study|Death|2|||
170514282|NCT04865419|616228336|FG010|Overall Study|Death|1|||
170554879|NCT04924608|616379992|FG000|Overall Study|Ongoing at the data cut-off date|54|||
170554880|NCT04924608|616379993|FG001|Overall Study|Ongoing at the data cut-off date|60|||
170554881|NCT04924608|616379992|FG000|Overall Study|Progressive Disease|2|||
170554882|NCT04924608|616379993|FG001|Overall Study|Progressive Disease|0|||
170554883|NCT04924608|616379992|FG000|Overall Study|Withdrawal by Subject|3|||
170514283|NCT04865419|616228326|FG000|Overall Study|Lost to Follow-up|0|||
170514284|NCT04865419|616228327|FG001|Overall Study|Lost to Follow-up|0|||
170554884|NCT04924608|616379993|FG001|Overall Study|Withdrawal by Subject|6|||
170554885|NCT04924608|616379992|FG000|Overall Study|Other reason|1|||
170554886|NCT04924608|616379993|FG001|Overall Study|Other reason|1|||
170554887|NCT03379870|616379994|FG000|Overall Study|Lost to Follow-up|1|||
170554888|NCT03379870|616379995|FG001|Overall Study|Lost to Follow-up|0|||
170644731|NCT00835211|616713839|FG000|First Intervention|Withdrawal by Subject|0|||
170644732|NCT00835211|616713840|FG001|First Intervention|Withdrawal by Subject|1|||
170644733|NCT00835211|616713839|FG000|Washout: 7 Days|Adverse Event|2|||
170644734|NCT00835211|616713840|FG001|Washout: 7 Days|Adverse Event|1|||
170644735|NCT00835211|616713839|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
170644736|NCT00835211|616713840|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
170644737|NCT04973436|616713842|FG000|Overall Study|Lost to Follow-up|3|||
170644738|NCT04973436|616713842|FG000|Overall Study|Withdrawal by Subject|1|||
170644739|NCT04973436|616713842|FG000|Overall Study|Death|2|||
170644740|NCT02395172|616713844|FG000|Overall Study|Participants randomized but not treated|3|||
170806355|NCT03598790|617301489|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
170644741|NCT02395172|616713845|FG001|Overall Study|Participants randomized but not treated|31|||
170644742|NCT00946985|616713852|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
170644743|NCT00946985|616713852|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
170644744|NCT00946985|616713852|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
170644745|NCT00946985|616713852|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
170644746|NCT00946985|616713852|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
170644747|NCT00946985|616713852|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
170644748|NCT00946985|616713852|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
170806356|NCT03598790|617301490|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
170806357|NCT03598790|617301491|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
170806358|NCT03598790|617301492|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
170806359|NCT03598790|617301493|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
170806360|NCT03896581|617301497|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
170644749|NCT00946985|616713852|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
170644750|NCT00946985|616713852|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
170644751|NCT00271505|616713853|FG000|Overall Study|Screen Failure|3|||
170644752|NCT00271505|616713853|FG000|Overall Study|Adverse Event|1|||
170644753|NCT00271505|616713853|FG000|Overall Study|Death|1|||
170644754|NCT00119678|616713854|FG000|Double-blind Treatment Period|Death|1|||
170644755|NCT00119678|616713855|FG001|Double-blind Treatment Period|Death|0|||
170644756|NCT00119678|616713854|FG000|Double-blind Treatment Period|Adverse Event|7|||
170644757|NCT00119678|616713855|FG001|Double-blind Treatment Period|Adverse Event|1|||
170806361|NCT03896581|617301498|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
170806362|NCT03896581|617301497|FG000|Overall Study|Withdrawal by Subject|4|||
170905177|NCT03830281|617656042|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
170905178|NCT03830281|617656043|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
170905179|NCT03830281|617656042|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
170905180|NCT03830281|617656043|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
170905181|NCT03830281|617656042|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
170905182|NCT03830281|617656043|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
170905183|NCT03830281|617656042|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
170905184|NCT03830281|617656043|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
170905185|NCT03830281|617656042|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
170905186|NCT03830281|617656043|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
170905187|NCT03830281|617656042|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
170905188|NCT03830281|617656043|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
170905189|NCT03830281|617656042|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
170905190|NCT03830281|617656043|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
170905191|NCT02604264|617656044|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
170905192|NCT02604264|617656045|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
170905193|NCT02690701|617656047|FG000|Treatment Period 1|Adverse Event|2|||
170514285|NCT04865419|616228328|FG002|Overall Study|Lost to Follow-up|0|||
170514286|NCT04865419|616228329|FG003|Overall Study|Lost to Follow-up|0|||
170514287|NCT04865419|616228330|FG004|Overall Study|Lost to Follow-up|0|||
170514288|NCT04865419|616228331|FG005|Overall Study|Lost to Follow-up|0|||
170644758|NCT00119678|616713854|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
170905194|NCT02690701|617656048|FG001|Treatment Period 1|Adverse Event|2|||
170905195|NCT02690701|617656047|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170905196|NCT02690701|617656048|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170905197|NCT02690701|617656047|FG000|Treatment Period 2|Adverse Event|2|||
170905198|NCT02690701|617656048|FG001|Treatment Period 2|Adverse Event|0|||
170514289|NCT04865419|616228332|FG006|Overall Study|Lost to Follow-up|0|||
170644759|NCT00119678|616713855|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
170644760|NCT00119678|616713854|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
170644761|NCT00119678|616713855|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
170806363|NCT03896581|617301498|FG001|Overall Study|Withdrawal by Subject|1|||
170905199|NCT02690701|617656047|FG000|Treatment Period 2|Lack of Efficacy|1|||
170905200|NCT02690701|617656048|FG001|Treatment Period 2|Lack of Efficacy|0|||
170905201|NCT02690701|617656047|FG000|Treatment Period 2|Lost to Follow-up|0|||
170514290|NCT04865419|616228333|FG007|Overall Study|Lost to Follow-up|0|||
170644762|NCT00119678|616713854|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
170644763|NCT00119678|616713855|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
170644764|NCT00119678|616713854|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
170644765|NCT00119678|616713855|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
170644766|NCT00119678|616713854|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
170644767|NCT00119678|616713855|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
170644768|NCT00119678|616713854|FG000|Double-blind Treatment Period|Pregnancy|0|||
170644769|NCT00119678|616713855|FG001|Double-blind Treatment Period|Pregnancy|2|||
170644770|NCT00119678|616713854|FG000|Double-blind Treatment Period|Not treated|1|||
170644771|NCT00119678|616713855|FG001|Double-blind Treatment Period|Not treated|2|||
170806364|NCT03896581|617301497|FG000|Overall Study|Lost to Follow-up|1|||
170806365|NCT03896581|617301498|FG001|Overall Study|Lost to Follow-up|0|||
170806366|NCT03896581|617301497|FG000|Overall Study|Lack of Efficacy|2|||
170806367|NCT03896581|617301498|FG001|Overall Study|Lack of Efficacy|1|||
170806368|NCT03896581|617301497|FG000|Overall Study|Adverse event, non-fatal|0|||
170806369|NCT03896581|617301498|FG001|Overall Study|Adverse event, non-fatal|2|||
170806370|NCT03137459|617301515|FG000|2-month Assessment|Withdrawal by Subject|13|||
170806371|NCT03137459|617301516|FG001|2-month Assessment|Withdrawal by Subject|3|||
170806372|NCT03137459|617301515|FG000|2-month Assessment|Unable to reach|42|||
170806373|NCT03137459|617301516|FG001|2-month Assessment|Unable to reach|32|||
170806374|NCT03137459|617301515|FG000|2-month Assessment|Refused assessment|7|||
170806375|NCT03137459|617301516|FG001|2-month Assessment|Refused assessment|5|||
170806376|NCT03137459|617301515|FG000|2-month Assessment|Acutely ill|6|||
170806377|NCT03137459|617301516|FG001|2-month Assessment|Acutely ill|2|||
170806378|NCT03137459|617301515|FG000|4-month Assessment|Death|4|||
170806379|NCT03137459|617301516|FG001|4-month Assessment|Death|2|||
170806380|NCT03137459|617301515|FG000|4-month Assessment|Withdrawal by Subject|4|||
170806381|NCT03137459|617301516|FG001|4-month Assessment|Withdrawal by Subject|2|||
170806382|NCT03137459|617301515|FG000|4-month Assessment|Unable to reach|44|||
170806383|NCT03137459|617301516|FG001|4-month Assessment|Unable to reach|29|||
170806384|NCT03137459|617301515|FG000|4-month Assessment|Refused assessment|24|||
170806385|NCT03137459|617301516|FG001|4-month Assessment|Refused assessment|10|||
170514291|NCT04865419|616228334|FG008|Overall Study|Lost to Follow-up|0|||
170514292|NCT04865419|616228335|FG009|Overall Study|Lost to Follow-up|1|||
170514293|NCT04865419|616228336|FG010|Overall Study|Lost to Follow-up|0|||
170514294|NCT01386944|616228348|FG000|Overall Study|Adverse Event|26|||
170514295|NCT01386944|616228348|FG000|Overall Study|Lack of Efficacy|14|||
170514296|NCT01386944|616228348|FG000|Overall Study|Lost to Follow-up|8|||
170514297|NCT01386944|616228348|FG000|Overall Study|Unspecified reason|8|||
170514298|NCT00972283|616228353|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
170514299|NCT00972283|616228354|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
170514300|NCT00972283|616228353|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
170514301|NCT00972283|616228354|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
170514302|NCT00972283|616228353|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
170514303|NCT00972283|616228354|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
170514304|NCT00972283|616228353|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
170514305|NCT00972283|616228354|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
170514306|NCT00972283|616228353|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
170514307|NCT00972283|616228354|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
170514308|NCT00972283|616228353|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
170514309|NCT00972283|616228354|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
170514310|NCT00972283|616228353|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
170514311|NCT00972283|616228354|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
170514312|NCT00972283|616228353|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
170514313|NCT00972283|616228354|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
170514314|NCT00972283|616228353|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
170514315|NCT00972283|616228354|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
170514316|NCT00972283|616228353|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
170514317|NCT00972283|616228354|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
170806386|NCT03137459|617301515|FG000|4-month Assessment|Acutely ill|2|||
170806387|NCT03137459|617301516|FG001|4-month Assessment|Acutely ill|3|||
170806388|NCT03137459|617301515|FG000|6-months|Lost to Follow-up|14|||
170806389|NCT03137459|617301516|FG001|6-months|Lost to Follow-up|11|||
170806390|NCT03137459|617301515|FG000|6-months|Death|0|||
170806391|NCT03137459|617301516|FG001|6-months|Death|2|||
170806392|NCT03137459|617301515|FG000|6-months|Refused assessment|6|||
170806393|NCT03137459|617301516|FG001|6-months|Refused assessment|3|||
170806394|NCT03137459|617301515|FG000|6-months|Acutely ill|1|||
170806395|NCT03137459|617301516|FG001|6-months|Acutely ill|1|||
170806396|NCT00489554|617301517|FG000|Overall Study|Adverse Event|2|||
170806397|NCT00489554|617301517|FG000|Overall Study|Withdrawal by Subject|1|||
170806398|NCT00489554|617301517|FG000|Overall Study|Lost to Follow-up|1|||
170806399|NCT01737398|617301518|FG000|Overall Study|Adverse event or SAE|16|||
170806400|NCT01737398|617301519|FG001|Overall Study|Adverse event or SAE|1|||
170806401|NCT01737398|617301518|FG000|Overall Study|Stopping rule met|2|||
170806402|NCT01737398|617301519|FG001|Overall Study|Stopping rule met|1|||
170806403|NCT01737398|617301518|FG000|Overall Study|Voluntary withdrawal|2|||
170806404|NCT01737398|617301519|FG001|Overall Study|Voluntary withdrawal|3|||
170806405|NCT01737398|617301518|FG000|Overall Study|Ineligibility|1|||
170806406|NCT01737398|617301519|FG001|Overall Study|Ineligibility|0|||
170806407|NCT01737398|617301518|FG000|Overall Study|Liver transplant|1|||
170806408|NCT01737398|617301519|FG001|Overall Study|Liver transplant|0|||
170806409|NCT01737398|617301518|FG000|Overall Study|Disease progression|2|||
170806410|NCT01737398|617301519|FG001|Overall Study|Disease progression|3|||
170806411|NCT01737398|617301518|FG000|Overall Study|Sponsor's decision|2|||
170806412|NCT01737398|617301519|FG001|Overall Study|Sponsor's decision|0|||
170806413|NCT00108355|617301521|FG000|Overall Study|Peritonitis at index paracentesis|1|||
170806414|NCT00108355|617301522|FG001|Overall Study|Peritonitis at index paracentesis|1|||
170806415|NCT00108355|617301521|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
170806416|NCT00108355|617301522|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
170806417|NCT04921358|617301523|FG000|Overall Study|Withdrawal by Subject|6|||
170806418|NCT04921358|617301524|FG001|Overall Study|Withdrawal by Subject|13|||
170806419|NCT04921358|617301523|FG000|Overall Study|Lost to Follow-up|3|||
170806420|NCT04921358|617301524|FG001|Overall Study|Lost to Follow-up|6|||
170806421|NCT04921358|617301523|FG000|Overall Study|Study Terminated by Sponsor|86|||
170806422|NCT04921358|617301524|FG001|Overall Study|Study Terminated by Sponsor|89|||
170806423|NCT04921358|617301523|FG000|Overall Study|Death|92|||
170806424|NCT04921358|617301524|FG001|Overall Study|Death|82|||
170806425|NCT04992273|617301525|FG000|Overall Study|Lost to Follow-up|0|||
170806426|NCT04992273|617301526|FG001|Overall Study|Lost to Follow-up|1|||
170806427|NCT02824198|617301527|FG000|Overall Study|Non-compliance with the protocol|5|||
170806428|NCT02824198|617301528|FG001|Overall Study|Non-compliance with the protocol|1|||
170806429|NCT02824198|617301527|FG000|Overall Study|Lost to Follow-up|5|||
170806430|NCT02824198|617301528|FG001|Overall Study|Lost to Follow-up|2|||
170806431|NCT02824198|617301527|FG000|Overall Study|Withdrawal by Subject|5|||
170806432|NCT02824198|617301528|FG001|Overall Study|Withdrawal by Subject|0|||
170806433|NCT00887224|617301529|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
170514318|NCT01588405|616228355|FG000|Overall Study|Adverse Event|1|||
170514319|NCT01588405|616228355|FG000|Overall Study|Clinical Worsening|1|||
170514320|NCT01416155|616228356|FG000|Overall Study|Adverse Event|8|||
170514321|NCT01416155|616228356|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
170514322|NCT01416155|616228356|FG000|Overall Study|Withdrawal by Subject|33|||
170514323|NCT01416155|616228356|FG000|Overall Study|Investigator decision|8|||
170514324|NCT01416155|616228356|FG000|Overall Study|Other|7|||
170514325|NCT00382109|616228360|FG000|Overall Study|Adverse Event|3|||
170514326|NCT00382109|616228361|FG001|Overall Study|Adverse Event|0|||
170514327|NCT00382109|616228360|FG000|Overall Study|Physician Decision|6|||
170514328|NCT00382109|616228361|FG001|Overall Study|Physician Decision|1|||
170514329|NCT00382109|616228360|FG000|Overall Study|Withdrawal by Subject|1|||
170514330|NCT00382109|616228361|FG001|Overall Study|Withdrawal by Subject|0|||
170514331|NCT00382109|616228360|FG000|Overall Study|ineligible|2|||
170514332|NCT00382109|616228361|FG001|Overall Study|ineligible|0|||
170514333|NCT00382109|616228360|FG000|Overall Study|Other|0|||
170514334|NCT00382109|616228361|FG001|Overall Study|Other|2|||
170514335|NCT00382109|616228360|FG000|Overall Study|consent withdrawal|0|||
170514336|NCT00382109|616228361|FG001|Overall Study|consent withdrawal|1|||
170514337|NCT02226120|616228365|FG000|Overall Study|Adverse Event|60|||
170514338|NCT02226120|616228365|FG000|Overall Study|Death|172|||
170514339|NCT02226120|616228365|FG000|Overall Study|Study terminated by sponsor|1|||
170514340|NCT02226120|616228365|FG000|Overall Study|Technical problems|4|||
170514341|NCT02226120|616228365|FG000|Overall Study|Lost to Follow-up|13|||
170514342|NCT02226120|616228365|FG000|Overall Study|Physician Decision|21|||
170514343|NCT02226120|616228365|FG000|Overall Study|Withdrawal by parent/guardian|36|||
170514344|NCT02226120|616228365|FG000|Overall Study|Non-compliance with study drug|10|||
170514345|NCT02226120|616228365|FG000|Overall Study|Protocol deviation|1|||
170514346|NCT02226120|616228365|FG000|Overall Study|missing treatment disposition pages|2|||
170554889|NCT03379870|616379994|FG000|Overall Study|Protocol Violation|1|||
170554890|NCT03379870|616379995|FG001|Overall Study|Protocol Violation|1|||
170554891|NCT00003645|616379996|FG000|Overall Study|Death|4|||
170554892|NCT00003645|616379997|FG001|Overall Study|Death|1|||
170554893|NCT00003645|616379996|FG000|Overall Study|Lost to Follow-up|7|||
170554894|NCT00003645|616379997|FG001|Overall Study|Lost to Follow-up|8|||
170554895|NCT00003645|616379996|FG000|Overall Study|Withdrawal by Subject|1|||
170554896|NCT00003645|616379997|FG001|Overall Study|Withdrawal by Subject|3|||
170554897|NCT03058952|616379998|FG000|Overall Study|Adverse Event|1|||
170554898|NCT03058952|616379999|FG001|Overall Study|Adverse Event|0|||
170554899|NCT03058952|616379998|FG000|Overall Study|Lost to Follow-up|15|||
170554900|NCT03058952|616379999|FG001|Overall Study|Lost to Follow-up|15|||
170554901|NCT03058952|616379998|FG000|Overall Study|Withdrawal by Subject|7|||
170554902|NCT03058952|616379999|FG001|Overall Study|Withdrawal by Subject|11|||
170554903|NCT04101331|616380002|FG000|Overall Study|Adverse Event|9|||
170554904|NCT04101331|616380002|FG000|Overall Study|Disease progression|82|||
170554905|NCT04101331|616380002|FG000|Overall Study|Withdrawal by Subject|1|||
170554906|NCT04101331|616380002|FG000|Overall Study|Investigator decision|6|||
170554907|NCT04101331|616380002|FG000|Overall Study|Death|6|||
170554908|NCT04101331|616380002|FG000|Overall Study|Allogenic transplant|1|||
170554909|NCT04616196|616380003|FG000|Overall Study|Progressive Disease|3|||
170554910|NCT04616196|616380004|FG001|Overall Study|Progressive Disease|0|||
170554911|NCT04616196|616380005|FG002|Overall Study|Progressive Disease|4|||
170554912|NCT04616196|616380006|FG003|Overall Study|Progressive Disease|1|||
170554913|NCT04616196|616380003|FG000|Overall Study|Death|2|||
170554914|NCT04616196|616380004|FG001|Overall Study|Death|4|||
170554915|NCT04616196|616380005|FG002|Overall Study|Death|1|||
170554916|NCT04616196|616380006|FG003|Overall Study|Death|0|||
170554917|NCT04616196|616380003|FG000|Overall Study|Withdrawal by Subject|0|||
170554918|NCT04616196|616380004|FG001|Overall Study|Withdrawal by Subject|2|||
170554919|NCT04616196|616380005|FG002|Overall Study|Withdrawal by Subject|0|||
170554920|NCT04616196|616380006|FG003|Overall Study|Withdrawal by Subject|0|||
170554921|NCT04616196|616380003|FG000|Overall Study|Lost to Follow-up|1|||
170806434|NCT00887224|617301530|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
170806435|NCT00887224|617301531|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
170806436|NCT00887224|617301529|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
170806437|NCT00887224|617301530|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
170554922|NCT04616196|616380004|FG001|Overall Study|Lost to Follow-up|0|||
170554923|NCT04616196|616380005|FG002|Overall Study|Lost to Follow-up|0|||
170554924|NCT04616196|616380006|FG003|Overall Study|Lost to Follow-up|0|||
170554925|NCT04616196|616380003|FG000|Overall Study|Sponsor request|2|||
170554926|NCT04616196|616380004|FG001|Overall Study|Sponsor request|1|||
170554927|NCT04616196|616380005|FG002|Overall Study|Sponsor request|1|||
170554928|NCT04616196|616380006|FG003|Overall Study|Sponsor request|2|||
170554929|NCT01373281|616380007|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
170554930|NCT01373281|616380008|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
170554931|NCT01373281|616380007|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
170554932|NCT01373281|616380008|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
170554933|NCT01373281|616380007|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
170554934|NCT01373281|616380008|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
170554935|NCT01373281|616380007|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
170554936|NCT01373281|616380008|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
170554937|NCT01373281|616380007|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
170554938|NCT01373281|616380008|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
170554939|NCT01373281|616380007|FG000|Surveillance Expansion Period|Protocol Violation|9|||
170554940|NCT01373281|616380008|FG001|Surveillance Expansion Period|Protocol Violation|1|||
170554941|NCT01373281|616380007|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
170554942|NCT01373281|616380008|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
170554943|NCT01373281|616380007|FG000|Surveillance Expansion Period|Serious adverse event|3|||
170554944|NCT01373281|616380008|FG001|Surveillance Expansion Period|Serious adverse event|4|||
170554945|NCT02254291|616380013|FG000|Overall Study|Withdrawal by Subject|0|||
170554946|NCT02254291|616380014|FG001|Overall Study|Withdrawal by Subject|3|||
170554947|NCT02254291|616380015|FG002|Overall Study|Withdrawal by Subject|1|||
170554948|NCT02254291|616380013|FG000|Overall Study|Missing follow-up information|0|||
170554949|NCT02254291|616380014|FG001|Overall Study|Missing follow-up information|0|||
170554950|NCT02254291|616380015|FG002|Overall Study|Missing follow-up information|1|||
170554951|NCT06790303|616380016|FG000|Overall Study|Study Terminated by sponsor|4|||
170554952|NCT06790303|616380016|FG000|Overall Study|Death|4|||
170554953|NCT02579759|616380021|FG000|Overall Study|Protocol Violation|2|||
170554954|NCT02579759|616380022|FG001|Overall Study|Protocol Violation|0|||
170554955|NCT02579759|616380023|FG002|Overall Study|Protocol Violation|0|||
170554956|NCT02579759|616380021|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
170554957|NCT02579759|616380022|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
170554958|NCT02579759|616380023|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
170554959|NCT02579759|616380021|FG000|Overall Study|BfArM hold|13|||
170554960|NCT02579759|616380022|FG001|Overall Study|BfArM hold|12|||
170554961|NCT02579759|616380023|FG002|Overall Study|BfArM hold|12|||
170554962|NCT02579759|616380021|FG000|Overall Study|Sponsor stopped Dose 2|0|||
170554963|NCT02579759|616380022|FG001|Overall Study|Sponsor stopped Dose 2|41|||
170554964|NCT02579759|616380023|FG002|Overall Study|Sponsor stopped Dose 2|0|||
170554965|NCT02579759|616380021|FG000|Overall Study|Non compliance|0|||
170554966|NCT02579759|616380022|FG001|Overall Study|Non compliance|1|||
170554967|NCT02579759|616380023|FG002|Overall Study|Non compliance|0|||
170554968|NCT02579759|616380021|FG000|Overall Study|Pregnancy|0|||
170554969|NCT02579759|616380022|FG001|Overall Study|Pregnancy|1|||
170554970|NCT02579759|616380023|FG002|Overall Study|Pregnancy|0|||
170554971|NCT02579759|616380021|FG000|Overall Study|Inclusion/exclusion criteria|0|||
170554972|NCT02579759|616380022|FG001|Overall Study|Inclusion/exclusion criteria|0|||
170554973|NCT02579759|616380023|FG002|Overall Study|Inclusion/exclusion criteria|1|||
170554974|NCT02579759|616380021|FG000|Overall Study|Adverse Event|4|||
170554975|NCT02579759|616380022|FG001|Overall Study|Adverse Event|3|||
170554976|NCT02579759|616380023|FG002|Overall Study|Adverse Event|1|||
170554977|NCT02579759|616380021|FG000|Overall Study|Withdrawal by Subject|3|||
170554978|NCT02579759|616380022|FG001|Overall Study|Withdrawal by Subject|3|||
170554979|NCT02579759|616380023|FG002|Overall Study|Withdrawal by Subject|5|||
170554980|NCT02579759|616380021|FG000|Overall Study|Lost to Follow-up|2|||
170554981|NCT02579759|616380022|FG001|Overall Study|Lost to Follow-up|2|||
170554982|NCT02579759|616380023|FG002|Overall Study|Lost to Follow-up|2|||
170554983|NCT03436732|616380025|FG000|Overall Study|Not treated-enrolled in different study|1|||
170554984|NCT03436732|616380026|FG001|Overall Study|Not treated-enrolled in different study|0|||
170554985|NCT03436732|616380025|FG000|Overall Study|Off study after cycle 1|1|||
170554986|NCT03436732|616380026|FG001|Overall Study|Off study after cycle 1|0|||
170554987|NCT03436732|616380025|FG000|Overall Study|Adverse Event|2|||
170554988|NCT03436732|616380026|FG001|Overall Study|Adverse Event|0|||
170554989|NCT03436732|616380025|FG000|Overall Study|Death|0|||
170554990|NCT03436732|616380026|FG001|Overall Study|Death|1|||
170554991|NCT03345550|616380027|FG000|Overall Study|Withdrawal by Subject|1|||
170554992|NCT03345550|616380028|FG001|Overall Study|Withdrawal by Subject|0|||
170554993|NCT03345550|616380027|FG000|Overall Study|Lost to Follow-up|4|||
170554994|NCT03345550|616380028|FG001|Overall Study|Lost to Follow-up|5|||
170554995|NCT03440411|616380031|FG000|Overall Study|Adverse Event|0|||
170554996|NCT03440411|616380032|FG001|Overall Study|Adverse Event|0|||
170554997|NCT03440411|616380033|FG002|Overall Study|Adverse Event|1|||
170554998|NCT03440411|616380034|FG003|Overall Study|Adverse Event|0|||
170554999|NCT03440411|616380031|FG000|Overall Study|PD|2|||
170555000|NCT03440411|616380032|FG001|Overall Study|PD|1|||
170555001|NCT03440411|616380033|FG002|Overall Study|PD|1|||
170555002|NCT03440411|616380034|FG003|Overall Study|PD|1|||
170555003|NCT03440411|616380031|FG000|Overall Study|Withdrawal by Subject|1|||
170555004|NCT03440411|616380032|FG001|Overall Study|Withdrawal by Subject|0|||
170555005|NCT03440411|616380033|FG002|Overall Study|Withdrawal by Subject|0|||
170555006|NCT03440411|616380034|FG003|Overall Study|Withdrawal by Subject|0|||
170555007|NCT03440411|616380031|FG000|Overall Study|Closed study by sponsor|0|||
170555008|NCT03440411|616380032|FG001|Overall Study|Closed study by sponsor|0|||
170555009|NCT03440411|616380033|FG002|Overall Study|Closed study by sponsor|0|||
170555010|NCT03440411|616380034|FG003|Overall Study|Closed study by sponsor|1|||
170555011|NCT00443456|616380035|FG000|Overall Study|Adverse Event|16|||
170555012|NCT00443456|616380035|FG000|Overall Study|Move|1|||
170555013|NCT00443456|616380035|FG000|Overall Study|Withdrawal by Subject|1|||
170555014|NCT03242434|616380036|FG000|Overall Study|Death|0|||
170555015|NCT03242434|616380037|FG001|Overall Study|Death|2|||
170555016|NCT00414609|616380038|FG000|Core Study|Adverse Event|9|||
170555017|NCT00414609|616380039|FG001|Core Study|Adverse Event|11|||
170555018|NCT00414609|616380040|FG002|Core Study|Adverse Event|0|||
170555019|NCT00414609|616380038|FG000|Core Study|Abnormal laboratory values|0|||
170555020|NCT00414609|616380039|FG001|Core Study|Abnormal laboratory values|1|||
170555021|NCT00414609|616380040|FG002|Core Study|Abnormal laboratory values|0|||
170555022|NCT00414609|616380038|FG000|Core Study|Abnormal test procedure results|1|||
170555023|NCT00414609|616380039|FG001|Core Study|Abnormal test procedure results|1|||
170555024|NCT00414609|616380040|FG002|Core Study|Abnormal test procedure results|0|||
170555025|NCT00414609|616380038|FG000|Core Study|Protocol deviation|0|||
170555026|NCT00414609|616380039|FG001|Core Study|Protocol deviation|1|||
170555027|NCT00414609|616380040|FG002|Core Study|Protocol deviation|0|||
170555028|NCT00414609|616380038|FG000|Core Study|Patient withdrew consent|10|||
170555029|NCT00414609|616380039|FG001|Core Study|Patient withdrew consent|11|||
170555030|NCT00414609|616380040|FG002|Core Study|Patient withdrew consent|0|||
170555031|NCT00414609|616380038|FG000|Core Study|Lost to Follow-up|7|||
170555032|NCT00414609|616380039|FG001|Core Study|Lost to Follow-up|4|||
170555033|NCT00414609|616380040|FG002|Core Study|Lost to Follow-up|0|||
170555034|NCT00414609|616380038|FG000|Core Study|Administrative problems|0|||
170555035|NCT00414609|616380039|FG001|Core Study|Administrative problems|2|||
170555036|NCT00414609|616380040|FG002|Core Study|Administrative problems|0|||
170555037|NCT00414609|616380038|FG000|Core Study|Death|7|||
170555038|NCT00414609|616380039|FG001|Core Study|Death|14|||
170555039|NCT00414609|616380040|FG002|Core Study|Death|0|||
170555040|NCT00414609|616380038|FG000|Extension Study|Adverse Event|0|||
170555041|NCT00414609|616380039|FG001|Extension Study|Adverse Event|0|||
170555042|NCT00414609|616380040|FG002|Extension Study|Adverse Event|14|||
170555043|NCT00414609|616380038|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
170555044|NCT00414609|616380039|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
170555045|NCT00414609|616380040|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
170555046|NCT00414609|616380038|FG000|Extension Study|Withdrawal by Subject|0|||
170555047|NCT00414609|616380039|FG001|Extension Study|Withdrawal by Subject|0|||
170555048|NCT00414609|616380040|FG002|Extension Study|Withdrawal by Subject|13|||
170555049|NCT00414609|616380038|FG000|Extension Study|Lost to Follow-up|0|||
170555050|NCT00414609|616380039|FG001|Extension Study|Lost to Follow-up|0|||
170555051|NCT00414609|616380040|FG002|Extension Study|Lost to Follow-up|10|||
170555052|NCT00414609|616380038|FG000|Extension Study|Administrative problems|0|||
170555053|NCT00414609|616380039|FG001|Extension Study|Administrative problems|0|||
170555054|NCT00414609|616380040|FG002|Extension Study|Administrative problems|1|||
170555055|NCT00414609|616380038|FG000|Extension Study|Death|0|||
170555056|NCT00414609|616380039|FG001|Extension Study|Death|0|||
170555057|NCT00414609|616380040|FG002|Extension Study|Death|17|||
170555058|NCT02367885|616380052|FG000|Overall Study|Lost to Follow-up|1|||
170555059|NCT02367885|616380053|FG001|Overall Study|Lost to Follow-up|0|||
170555060|NCT02367885|616380054|FG002|Overall Study|Lost to Follow-up|0|||
170555061|NCT02367885|616380052|FG000|Overall Study|Withdrawal by Subject|1|||
170555062|NCT02367885|616380053|FG001|Overall Study|Withdrawal by Subject|0|||
170555063|NCT02367885|616380054|FG002|Overall Study|Withdrawal by Subject|0|||
170555064|NCT04693715|616380055|FG000|Overall Study|Adverse Events Leading to Death|2|||
170555065|NCT04693715|616380056|FG001|Overall Study|Adverse Events Leading to Death|2|||
170555066|NCT04693715|616380057|FG002|Overall Study|Adverse Events Leading to Death|4|||
170555067|NCT04693715|616380055|FG000|Overall Study|Lost to Follow-up|0|||
170555068|NCT04693715|616380056|FG001|Overall Study|Lost to Follow-up|2|||
170555069|NCT04693715|616380057|FG002|Overall Study|Lost to Follow-up|2|||
170555070|NCT04693715|616380055|FG000|Overall Study|Physician Decision|0|||
170555071|NCT04693715|616380056|FG001|Overall Study|Physician Decision|1|||
170555072|NCT04693715|616380057|FG002|Overall Study|Physician Decision|0|||
170555073|NCT04693715|616380055|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
170555074|NCT04693715|616380056|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
170555075|NCT04693715|616380057|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
170555076|NCT04693715|616380055|FG000|Overall Study|Withdrawal by Subject|0|||
170555077|NCT04693715|616380056|FG001|Overall Study|Withdrawal by Subject|0|||
170806438|NCT00887224|617301531|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
170555078|NCT04693715|616380057|FG002|Overall Study|Withdrawal by Subject|1|||
170555079|NCT01682720|616380066|FG000|Overall Study|Randomized but Not Treated|0|||
170555080|NCT01682720|616380067|FG001|Overall Study|Randomized but Not Treated|1|||
170555081|NCT01682720|616380068|FG002|Overall Study|Randomized but Not Treated|1|||
170555082|NCT01682720|616380069|FG003|Overall Study|Randomized but Not Treated|0|||
170806439|NCT00887224|617301529|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
170644772|NCT00119678|616713854|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
170644773|NCT00119678|616713855|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
170644774|NCT00119678|616713854|FG000|Open-label Treatment Period|Death|1|||
170644775|NCT00119678|616713855|FG001|Open-label Treatment Period|Death|0|||
170644776|NCT00119678|616713854|FG000|Open-label Treatment Period|Adverse Event|3|||
170644777|NCT00119678|616713855|FG001|Open-label Treatment Period|Adverse Event|0|||
170644778|NCT00119678|616713854|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
170644779|NCT00119678|616713855|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
170644780|NCT00119678|616713854|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
170644781|NCT00119678|616713855|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
170644782|NCT00119678|616713854|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
170644783|NCT00119678|616713855|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
170644784|NCT00119678|616713854|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
170644785|NCT00119678|616713855|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
170644786|NCT00119678|616713854|FG000|Open-label Treatment Period|Pregnancy|1|||
170644787|NCT00119678|616713855|FG001|Open-label Treatment Period|Pregnancy|0|||
170644788|NCT00119678|616713854|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
170644789|NCT00119678|616713855|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
170644790|NCT00509145|616713856|FG000|Overall Study|Death|0|||
170644791|NCT00509145|616713857|FG001|Overall Study|Death|2|||
170644792|NCT00509145|616713856|FG000|Overall Study|Adverse Event|42|||
170644793|NCT00509145|616713857|FG001|Overall Study|Adverse Event|28|||
170644794|NCT00509145|616713856|FG000|Overall Study|Withdrawal by Subject|32|||
170644795|NCT00509145|616713857|FG001|Overall Study|Withdrawal by Subject|38|||
170644796|NCT00509145|616713856|FG000|Overall Study|Physician Decision|11|||
170644797|NCT00509145|616713857|FG001|Overall Study|Physician Decision|14|||
170644798|NCT00509145|616713856|FG000|Overall Study|Protocol Violation|1|||
170644799|NCT00509145|616713857|FG001|Overall Study|Protocol Violation|6|||
170644800|NCT00509145|616713856|FG000|Overall Study|Pregnancy|3|||
170644801|NCT00509145|616713857|FG001|Overall Study|Pregnancy|8|||
170644802|NCT00509145|616713856|FG000|Overall Study|Lost to Follow-up|6|||
170644803|NCT00509145|616713857|FG001|Overall Study|Lost to Follow-up|5|||
170644804|NCT00509145|616713856|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
170644805|NCT00509145|616713857|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
170644806|NCT00509145|616713856|FG000|Overall Study|Other|6|||
170644807|NCT00509145|616713857|FG001|Overall Study|Other|6|||
170644808|NCT00246740|616713858|FG000|Initial Enrollment|Death|1|||
170644809|NCT00246740|616713859|FG001|Initial Enrollment|Death|0|||
170644810|NCT00246740|616713858|FG000|Initial Enrollment|Additional surgery scheduled|0|||
170644811|NCT00246740|616713859|FG001|Initial Enrollment|Additional surgery scheduled|2|||
170644812|NCT00246740|616713858|FG000|Initial Enrollment|Surgery schedule change|4|||
170806440|NCT00887224|617301530|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
170806441|NCT00887224|617301531|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
170806442|NCT00887224|617301529|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
170806443|NCT00887224|617301530|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
170806444|NCT00887224|617301531|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
170806445|NCT00887224|617301529|FG000|Open-label Response (OLR) Phase|Other|1|||
170806446|NCT00887224|617301530|FG001|Open-label Response (OLR) Phase|Other|0|||
170806447|NCT00887224|617301531|FG002|Open-label Response (OLR) Phase|Other|0|||
170806448|NCT00887224|617301529|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
170806449|NCT00887224|617301530|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
170806450|NCT00887224|617301531|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
170806451|NCT00887224|617301529|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
170806452|NCT00887224|617301530|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
170806453|NCT00887224|617301531|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
170806454|NCT00887224|617301529|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
170806455|NCT00887224|617301530|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
170806456|NCT00887224|617301531|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
170806457|NCT00887224|617301529|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
170806458|NCT00887224|617301530|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
170806459|NCT00887224|617301531|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
170806460|NCT00887224|617301529|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
170806461|NCT00887224|617301530|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
170644813|NCT00246740|616713859|FG001|Initial Enrollment|Surgery schedule change|4|||
170644814|NCT00246740|616713858|FG000|Initial Enrollment|Other|1|||
170644815|NCT00246740|616713859|FG001|Initial Enrollment|Other|2|||
170644816|NCT00335764|616713860|FG000|Overall Study|wrong histology|1|||
170644817|NCT00335764|616713861|FG001|Overall Study|wrong histology|0|||
170644818|NCT00335764|616713862|FG002|Overall Study|wrong histology|0|||
170644819|NCT00335764|616713863|FG003|Overall Study|wrong histology|0|||
170644820|NCT00335764|616713864|FG004|Overall Study|wrong histology|1|||
170806462|NCT00887224|617301531|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
170806463|NCT00887224|617301529|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
170806464|NCT00887224|617301530|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
170806465|NCT00887224|617301531|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
170555083|NCT01682720|616380066|FG000|Overall Study|Terminated by Sponsor|83|||
170806466|NCT00887224|617301529|FG000|Open-label Stability (OLS) Phase|Other|1|||
170806467|NCT00887224|617301530|FG001|Open-label Stability (OLS) Phase|Other|0|||
170806468|NCT00887224|617301531|FG002|Open-label Stability (OLS) Phase|Other|0|||
170806469|NCT00887224|617301529|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
170806470|NCT00887224|617301530|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
170806471|NCT00887224|617301531|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
170806472|NCT00887224|617301529|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
170806473|NCT00887224|617301530|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
170806474|NCT00887224|617301531|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
170806475|NCT00887224|617301529|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
170806476|NCT00887224|617301530|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
170806477|NCT00887224|617301531|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
170806478|NCT00887224|617301529|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
170806479|NCT00887224|617301530|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
170806480|NCT00887224|617301531|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
170806481|NCT00887224|617301529|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
170806482|NCT00887224|617301530|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
170806483|NCT00887224|617301531|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
170806484|NCT00887224|617301529|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
170806485|NCT00887224|617301530|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
170806486|NCT00887224|617301531|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
170555084|NCT01682720|616380067|FG001|Overall Study|Terminated by Sponsor|0|||
170555085|NCT01682720|616380068|FG002|Overall Study|Terminated by Sponsor|0|||
170555086|NCT01682720|616380069|FG003|Overall Study|Terminated by Sponsor|0|||
170555087|NCT01682720|616380066|FG000|Overall Study|Efficacy Failure|0|||
170555088|NCT01682720|616380067|FG001|Overall Study|Efficacy Failure|3|||
170555089|NCT01682720|616380068|FG002|Overall Study|Efficacy Failure|3|||
170555090|NCT01682720|616380069|FG003|Overall Study|Efficacy Failure|30|||
170555091|NCT01682720|616380066|FG000|Overall Study|Lost to Follow-up|1|||
170555092|NCT01682720|616380067|FG001|Overall Study|Lost to Follow-up|1|||
170555093|NCT01682720|616380068|FG002|Overall Study|Lost to Follow-up|0|||
170555094|NCT01682720|616380069|FG003|Overall Study|Lost to Follow-up|6|||
170555095|NCT01682720|616380066|FG000|Overall Study|Subject Withdrew Consent|0|||
170555096|NCT01682720|616380067|FG001|Overall Study|Subject Withdrew Consent|0|||
170806487|NCT00887224|617301529|FG000|OL Taper Phase / OL Follow Up|Other|30|||
170806488|NCT00887224|617301530|FG001|OL Taper Phase / OL Follow Up|Other|0|||
170806489|NCT00887224|617301531|FG002|OL Taper Phase / OL Follow Up|Other|0|||
170806490|NCT00887224|617301529|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
170806491|NCT00887224|617301530|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
170806492|NCT00887224|617301531|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
170806493|NCT00887224|617301529|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
170806494|NCT00887224|617301530|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
170806495|NCT00887224|617301531|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
170806496|NCT00887224|617301529|FG000|Double-blind (DB) Phase|Adverse Event|0|||
170806497|NCT00887224|617301530|FG001|Double-blind (DB) Phase|Adverse Event|7|||
170806498|NCT00887224|617301531|FG002|Double-blind (DB) Phase|Adverse Event|2|||
170806499|NCT00887224|617301529|FG000|Double-blind (DB) Phase|Failed to return|0|||
170806500|NCT00887224|617301530|FG001|Double-blind (DB) Phase|Failed to return|2|||
170806501|NCT00887224|617301531|FG002|Double-blind (DB) Phase|Failed to return|2|||
170806502|NCT00887224|617301529|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
170806503|NCT00887224|617301530|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
170806504|NCT00887224|617301531|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
170806505|NCT00887224|617301529|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
170806506|NCT00887224|617301530|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
170806507|NCT00887224|617301531|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
170806508|NCT00887224|617301529|FG000|Double-blind (DB) Phase|Other|0|||
170806509|NCT00887224|617301530|FG001|Double-blind (DB) Phase|Other|2|||
170806510|NCT00887224|617301531|FG002|Double-blind (DB) Phase|Other|0|||
170806511|NCT00887224|617301529|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
170806512|NCT00887224|617301530|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
170806513|NCT00887224|617301531|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
170806514|NCT00887224|617301529|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
170806515|NCT00887224|617301530|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
170806516|NCT00887224|617301531|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
170806517|NCT00887224|617301529|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
170555097|NCT01682720|616380068|FG002|Overall Study|Subject Withdrew Consent|2|||
170555098|NCT01682720|616380069|FG003|Overall Study|Subject Withdrew Consent|2|||
170806518|NCT00887224|617301530|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
170806519|NCT00887224|617301531|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
170806520|NCT00887224|617301529|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
170806521|NCT00887224|617301530|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
170806522|NCT00887224|617301531|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
170806523|NCT00887224|617301529|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
170806524|NCT00887224|617301530|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
170806525|NCT00887224|617301531|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
170806526|NCT00887224|617301529|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
170806527|NCT00887224|617301530|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
170905202|NCT02690701|617656048|FG001|Treatment Period 2|Lost to Follow-up|2|||
170905203|NCT02690701|617656047|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170905204|NCT02690701|617656048|FG001|Treatment Period 2|Withdrawal by Subject|2|||
170555099|NCT01682720|616380066|FG000|Overall Study|Adverse Event|1|||
170905205|NCT02690701|617656047|FG000|Treatment Period 2|Protocol Violation|0|||
170555100|NCT01682720|616380067|FG001|Overall Study|Adverse Event|0|||
170555101|NCT01682720|616380068|FG002|Overall Study|Adverse Event|1|||
170555102|NCT01682720|616380069|FG003|Overall Study|Adverse Event|1|||
170555103|NCT01687595|616380070|FG000|Overall Study|Withdrawal by Subject|8|||
170555104|NCT01687595|616380071|FG001|Overall Study|Withdrawal by Subject|0|||
170555105|NCT01687595|616380070|FG000|Overall Study|Lost to Follow-up|3|||
170555106|NCT01687595|616380071|FG001|Overall Study|Lost to Follow-up|1|||
170555107|NCT01687595|616380070|FG000|Overall Study|Investigator's decision|1|||
170555108|NCT01687595|616380071|FG001|Overall Study|Investigator's decision|0|||
170555109|NCT01687595|616380070|FG000|Overall Study|Sponsor's decision|1|||
170555110|NCT01687595|616380071|FG001|Overall Study|Sponsor's decision|0|||
170555111|NCT01687595|616380070|FG000|Overall Study|Noncompliance|1|||
170555112|NCT01687595|616380071|FG001|Overall Study|Noncompliance|2|||
170555113|NCT01687595|616380070|FG000|Overall Study|Other than specified|56|||
170555114|NCT01687595|616380071|FG001|Overall Study|Other than specified|7|||
170555115|NCT04204902|616380072|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
170555116|NCT04204902|616380073|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
170555117|NCT00456365|616380079|FG000|Overall Study|Lost to Follow-up|1|||
170555118|NCT00456365|616380080|FG001|Overall Study|Lost to Follow-up|3|||
170555119|NCT00456365|616380079|FG000|Overall Study|Withdrawal by Subject|4|||
170555120|NCT00456365|616380080|FG001|Overall Study|Withdrawal by Subject|7|||
170555121|NCT00456365|616380079|FG000|Overall Study|Pregnancy|1|||
170555122|NCT00456365|616380080|FG001|Overall Study|Pregnancy|1|||
170555123|NCT00456365|616380079|FG000|Overall Study|oncologic diagnosis|1|||
170555124|NCT00456365|616380080|FG001|Overall Study|oncologic diagnosis|1|||
170555125|NCT02096354|616380084|FG000|Overall Study|Physician Decision|4|||
170555126|NCT02096354|616380085|FG001|Overall Study|Physician Decision|5|||
170555127|NCT02096354|616380086|FG002|Overall Study|Physician Decision|0|||
170555128|NCT02096354|616380084|FG000|Overall Study|Withdrawal by Subject|3|||
170555129|NCT02096354|616380085|FG001|Overall Study|Withdrawal by Subject|1|||
170555130|NCT02096354|616380086|FG002|Overall Study|Withdrawal by Subject|0|||
170555131|NCT02096354|616380084|FG000|Overall Study|Adverse Event|7|||
170555132|NCT02096354|616380085|FG001|Overall Study|Adverse Event|4|||
170555133|NCT02096354|616380086|FG002|Overall Study|Adverse Event|0|||
170555134|NCT02096354|616380084|FG000|Overall Study|Ineligible|0|||
170555135|NCT02096354|616380085|FG001|Overall Study|Ineligible|0|||
170555136|NCT02096354|616380086|FG002|Overall Study|Ineligible|11|||
170555137|NCT03715829|616380087|FG000|Dose Ranging Period|Adverse Event|2|||
170555138|NCT03715829|616380088|FG001|Dose Ranging Period|Adverse Event|4|||
170555139|NCT03715829|616380089|FG002|Dose Ranging Period|Adverse Event|5|||
170555140|NCT03715829|616380090|FG003|Dose Ranging Period|Adverse Event|2|||
170555141|NCT03715829|616380091|FG004|Dose Ranging Period|Adverse Event|3|||
170555142|NCT03715829|616380092|FG005|Dose Ranging Period|Adverse Event|3|||
170555143|NCT03715829|616380093|FG006|Dose Ranging Period|Adverse Event|0|||
170555144|NCT03715829|616380094|FG007|Dose Ranging Period|Adverse Event|0|||
170555145|NCT03715829|616380095|FG008|Dose Ranging Period|Adverse Event|0|||
170905206|NCT02690701|617656048|FG001|Treatment Period 2|Protocol Violation|1|||
170905207|NCT02700451|617656049|FG000|Overall Study|Protocol Violation|2|||
170905208|NCT02700451|617656050|FG001|Overall Study|Protocol Violation|2|||
170555146|NCT03715829|616380096|FG009|Dose Ranging Period|Adverse Event|0|||
170555147|NCT03715829|616380097|FG010|Dose Ranging Period|Adverse Event|0|||
170555148|NCT03715829|616380087|FG000|Dose Ranging Period|Lack of Efficacy|0|||
170555149|NCT03715829|616380088|FG001|Dose Ranging Period|Lack of Efficacy|1|||
170555150|NCT03715829|616380089|FG002|Dose Ranging Period|Lack of Efficacy|0|||
170555151|NCT03715829|616380090|FG003|Dose Ranging Period|Lack of Efficacy|1|||
170806528|NCT00887224|617301531|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
170905209|NCT02700451|617656051|FG002|Overall Study|Protocol Violation|3|||
170555152|NCT03715829|616380091|FG004|Dose Ranging Period|Lack of Efficacy|0|||
170555153|NCT03715829|616380092|FG005|Dose Ranging Period|Lack of Efficacy|0|||
170555154|NCT03715829|616380093|FG006|Dose Ranging Period|Lack of Efficacy|0|||
170555155|NCT03715829|616380094|FG007|Dose Ranging Period|Lack of Efficacy|0|||
170644821|NCT02466659|616713865|FG000|Overall Study|Lost to Follow-up|5|||
170806529|NCT00887224|617301529|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
170806530|NCT00887224|617301530|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
170806531|NCT00887224|617301531|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
170806532|NCT00887224|617301529|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
170806533|NCT00887224|617301530|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
170806534|NCT00887224|617301531|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
170555156|NCT03715829|616380095|FG008|Dose Ranging Period|Lack of Efficacy|0|||
170555157|NCT03715829|616380096|FG009|Dose Ranging Period|Lack of Efficacy|0|||
170555158|NCT03715829|616380097|FG010|Dose Ranging Period|Lack of Efficacy|0|||
170555159|NCT03715829|616380087|FG000|Dose Ranging Period|Lost to Follow-up|2|||
170555160|NCT03715829|616380088|FG001|Dose Ranging Period|Lost to Follow-up|0|||
170555161|NCT03715829|616380089|FG002|Dose Ranging Period|Lost to Follow-up|1|||
170555162|NCT03715829|616380090|FG003|Dose Ranging Period|Lost to Follow-up|1|||
170555163|NCT03715829|616380091|FG004|Dose Ranging Period|Lost to Follow-up|1|||
170555164|NCT03715829|616380092|FG005|Dose Ranging Period|Lost to Follow-up|2|||
170555165|NCT03715829|616380093|FG006|Dose Ranging Period|Lost to Follow-up|0|||
170555166|NCT03715829|616380094|FG007|Dose Ranging Period|Lost to Follow-up|0|||
170555167|NCT03715829|616380095|FG008|Dose Ranging Period|Lost to Follow-up|0|||
170555168|NCT03715829|616380096|FG009|Dose Ranging Period|Lost to Follow-up|0|||
170555169|NCT03715829|616380097|FG010|Dose Ranging Period|Lost to Follow-up|0|||
170555170|NCT03715829|616380087|FG000|Dose Ranging Period|Protocol Violation|0|||
170555171|NCT03715829|616380088|FG001|Dose Ranging Period|Protocol Violation|0|||
170555172|NCT03715829|616380089|FG002|Dose Ranging Period|Protocol Violation|0|||
170555173|NCT03715829|616380090|FG003|Dose Ranging Period|Protocol Violation|1|||
170555174|NCT03715829|616380091|FG004|Dose Ranging Period|Protocol Violation|0|||
170555175|NCT03715829|616380092|FG005|Dose Ranging Period|Protocol Violation|0|||
170555176|NCT03715829|616380093|FG006|Dose Ranging Period|Protocol Violation|0|||
170555177|NCT03715829|616380094|FG007|Dose Ranging Period|Protocol Violation|0|||
170555178|NCT03715829|616380095|FG008|Dose Ranging Period|Protocol Violation|0|||
170555179|NCT03715829|616380096|FG009|Dose Ranging Period|Protocol Violation|0|||
170555180|NCT03715829|616380097|FG010|Dose Ranging Period|Protocol Violation|0|||
170555181|NCT03715829|616380087|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
170555182|NCT03715829|616380088|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
170555183|NCT03715829|616380089|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
170555184|NCT03715829|616380090|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
170555185|NCT03715829|616380091|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
170555186|NCT03715829|616380092|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
170555187|NCT03715829|616380093|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
170555188|NCT03715829|616380094|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
170555189|NCT03715829|616380095|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
170555190|NCT03715829|616380096|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
170555191|NCT03715829|616380097|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
170555192|NCT03715829|616380087|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555193|NCT03715829|616380088|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555194|NCT03715829|616380089|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
170555195|NCT03715829|616380090|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555196|NCT03715829|616380091|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555197|NCT03715829|616380092|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555198|NCT03715829|616380093|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555199|NCT03715829|616380094|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555200|NCT03715829|616380095|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555201|NCT03715829|616380096|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555202|NCT03715829|616380097|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
170555203|NCT03715829|616380087|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555204|NCT03715829|616380088|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555205|NCT03715829|616380089|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
170555206|NCT03715829|616380090|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555207|NCT03715829|616380091|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
170555208|NCT03715829|616380092|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555209|NCT03715829|616380093|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555210|NCT03715829|616380094|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555211|NCT03715829|616380095|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555212|NCT03715829|616380096|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555213|NCT03715829|616380097|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
170555214|NCT03715829|616380087|FG000|Dose Ranging Period|Other|0|||
170555215|NCT03715829|616380088|FG001|Dose Ranging Period|Other|0|||
170806535|NCT00887224|617301529|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
170806536|NCT00887224|617301530|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
170555216|NCT03715829|616380089|FG002|Dose Ranging Period|Other|2|||
170905210|NCT02700451|617656049|FG000|Overall Study|Discontinued intervention|14|||
170905211|NCT02700451|617656050|FG001|Overall Study|Discontinued intervention|15|||
170905212|NCT02700451|617656051|FG002|Overall Study|Discontinued intervention|14|||
170905213|NCT01309737|617656053|FG000|Week 0 to 16|Death|1|||
170905214|NCT01309737|617656054|FG001|Week 0 to 16|Death|0|||
170905215|NCT01309737|617656055|FG002|Week 0 to 16|Death|1|||
170905216|NCT01309737|617656056|FG003|Week 0 to 16|Death|0|||
170905217|NCT01309737|617656057|FG004|Week 0 to 16|Death|0|||
170905218|NCT01309737|617656053|FG000|Week 0 to 16|Adverse Event|11|||
170905219|NCT01309737|617656054|FG001|Week 0 to 16|Adverse Event|10|||
170905220|NCT01309737|617656055|FG002|Week 0 to 16|Adverse Event|5|||
170905221|NCT01309737|617656056|FG003|Week 0 to 16|Adverse Event|0|||
170905222|NCT01309737|617656057|FG004|Week 0 to 16|Adverse Event|0|||
170905223|NCT01309737|617656053|FG000|Week 0 to 16|Lack of Efficacy|15|||
170905224|NCT01309737|617656054|FG001|Week 0 to 16|Lack of Efficacy|2|||
170905225|NCT01309737|617656055|FG002|Week 0 to 16|Lack of Efficacy|24|||
170905226|NCT01309737|617656056|FG003|Week 0 to 16|Lack of Efficacy|0|||
170905227|NCT01309737|617656057|FG004|Week 0 to 16|Lack of Efficacy|0|||
170905228|NCT01309737|617656053|FG000|Week 0 to 16|Lost to Follow-up|7|||
170905229|NCT01309737|617656054|FG001|Week 0 to 16|Lost to Follow-up|8|||
170905230|NCT01309737|617656055|FG002|Week 0 to 16|Lost to Follow-up|3|||
170905231|NCT01309737|617656056|FG003|Week 0 to 16|Lost to Follow-up|0|||
170905232|NCT01309737|617656057|FG004|Week 0 to 16|Lost to Follow-up|0|||
170905233|NCT01309737|617656053|FG000|Week 0 to 16|Withdrawal by Subject|7|||
170905234|NCT01309737|617656054|FG001|Week 0 to 16|Withdrawal by Subject|6|||
170555217|NCT03715829|616380090|FG003|Dose Ranging Period|Other|0|||
170555218|NCT03715829|616380091|FG004|Dose Ranging Period|Other|0|||
170905235|NCT01309737|617656055|FG002|Week 0 to 16|Withdrawal by Subject|7|||
170905236|NCT01309737|617656056|FG003|Week 0 to 16|Withdrawal by Subject|0|||
170905237|NCT01309737|617656057|FG004|Week 0 to 16|Withdrawal by Subject|0|||
170905238|NCT01309737|617656053|FG000|Week 0 to 16|Other|10|||
170905239|NCT01309737|617656054|FG001|Week 0 to 16|Other|14|||
170905240|NCT01309737|617656055|FG002|Week 0 to 16|Other|4|||
170905241|NCT01309737|617656056|FG003|Week 0 to 16|Other|0|||
170905242|NCT01309737|617656057|FG004|Week 0 to 16|Other|0|||
170905243|NCT01309737|617656053|FG000|Week 0 to 16|Randomized, but not treated|1|||
170555219|NCT03715829|616380092|FG005|Dose Ranging Period|Other|3|||
170555220|NCT03715829|616380093|FG006|Dose Ranging Period|Other|0|||
170555221|NCT03715829|616380094|FG007|Dose Ranging Period|Other|0|||
170555222|NCT03715829|616380095|FG008|Dose Ranging Period|Other|0|||
170555223|NCT03715829|616380096|FG009|Dose Ranging Period|Other|0|||
170555224|NCT03715829|616380097|FG010|Dose Ranging Period|Other|0|||
170555225|NCT03715829|616380087|FG000|Extension Period|Adverse Event|0|||
170555226|NCT03715829|616380088|FG001|Extension Period|Adverse Event|0|||
170555227|NCT03715829|616380089|FG002|Extension Period|Adverse Event|0|||
170555228|NCT03715829|616380090|FG003|Extension Period|Adverse Event|0|||
170555229|NCT03715829|616380091|FG004|Extension Period|Adverse Event|0|||
170555230|NCT03715829|616380092|FG005|Extension Period|Adverse Event|0|||
170555231|NCT03715829|616380093|FG006|Extension Period|Adverse Event|3|||
170555232|NCT03715829|616380094|FG007|Extension Period|Adverse Event|1|||
170555233|NCT03715829|616380095|FG008|Extension Period|Adverse Event|6|||
170555234|NCT03715829|616380096|FG009|Extension Period|Adverse Event|0|||
170555235|NCT03715829|616380097|FG010|Extension Period|Adverse Event|0|||
170555236|NCT03715829|616380087|FG000|Extension Period|Lack of Efficacy|0|||
170555237|NCT03715829|616380088|FG001|Extension Period|Lack of Efficacy|0|||
170555238|NCT03715829|616380089|FG002|Extension Period|Lack of Efficacy|0|||
170555239|NCT03715829|616380090|FG003|Extension Period|Lack of Efficacy|0|||
170555240|NCT03715829|616380091|FG004|Extension Period|Lack of Efficacy|0|||
170555241|NCT03715829|616380092|FG005|Extension Period|Lack of Efficacy|0|||
170555242|NCT03715829|616380093|FG006|Extension Period|Lack of Efficacy|1|||
170555243|NCT03715829|616380094|FG007|Extension Period|Lack of Efficacy|9|||
170555244|NCT03715829|616380095|FG008|Extension Period|Lack of Efficacy|2|||
170555245|NCT03715829|616380096|FG009|Extension Period|Lack of Efficacy|0|||
170555246|NCT03715829|616380097|FG010|Extension Period|Lack of Efficacy|0|||
170555247|NCT03715829|616380087|FG000|Extension Period|Lost to Follow-up|0|||
170555248|NCT03715829|616380088|FG001|Extension Period|Lost to Follow-up|0|||
170555249|NCT03715829|616380089|FG002|Extension Period|Lost to Follow-up|0|||
170555250|NCT03715829|616380090|FG003|Extension Period|Lost to Follow-up|0|||
170555251|NCT03715829|616380091|FG004|Extension Period|Lost to Follow-up|0|||
170555252|NCT03715829|616380092|FG005|Extension Period|Lost to Follow-up|0|||
170555253|NCT03715829|616380093|FG006|Extension Period|Lost to Follow-up|0|||
170555254|NCT03715829|616380094|FG007|Extension Period|Lost to Follow-up|0|||
170555255|NCT03715829|616380095|FG008|Extension Period|Lost to Follow-up|2|||
170555256|NCT03715829|616380096|FG009|Extension Period|Lost to Follow-up|0|||
170555257|NCT03715829|616380097|FG010|Extension Period|Lost to Follow-up|0|||
170555258|NCT03715829|616380087|FG000|Extension Period|Protocol Violation|0|||
170555259|NCT03715829|616380088|FG001|Extension Period|Protocol Violation|0|||
170905244|NCT01309737|617656054|FG001|Week 0 to 16|Randomized, but not treated|0|||
170905245|NCT01309737|617656055|FG002|Week 0 to 16|Randomized, but not treated|0|||
170555260|NCT03715829|616380089|FG002|Extension Period|Protocol Violation|0|||
170806537|NCT00887224|617301531|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
170555261|NCT03715829|616380090|FG003|Extension Period|Protocol Violation|0|||
170555262|NCT03715829|616380091|FG004|Extension Period|Protocol Violation|0|||
170555263|NCT03715829|616380092|FG005|Extension Period|Protocol Violation|0|||
170555264|NCT03715829|616380093|FG006|Extension Period|Protocol Violation|0|||
170555265|NCT03715829|616380094|FG007|Extension Period|Protocol Violation|0|||
170555266|NCT03715829|616380095|FG008|Extension Period|Protocol Violation|1|||
170555267|NCT03715829|616380096|FG009|Extension Period|Protocol Violation|0|||
170555268|NCT03715829|616380097|FG010|Extension Period|Protocol Violation|0|||
170555269|NCT03715829|616380087|FG000|Extension Period|Withdrawal by Subject|0|||
170555270|NCT03715829|616380088|FG001|Extension Period|Withdrawal by Subject|0|||
170555271|NCT03715829|616380089|FG002|Extension Period|Withdrawal by Subject|0|||
170555272|NCT03715829|616380090|FG003|Extension Period|Withdrawal by Subject|0|||
170555273|NCT03715829|616380091|FG004|Extension Period|Withdrawal by Subject|0|||
170555274|NCT03715829|616380092|FG005|Extension Period|Withdrawal by Subject|0|||
170555275|NCT03715829|616380093|FG006|Extension Period|Withdrawal by Subject|3|||
170555276|NCT03715829|616380094|FG007|Extension Period|Withdrawal by Subject|3|||
170555277|NCT03715829|616380095|FG008|Extension Period|Withdrawal by Subject|12|||
170555278|NCT03715829|616380096|FG009|Extension Period|Withdrawal by Subject|3|||
170555279|NCT03715829|616380097|FG010|Extension Period|Withdrawal by Subject|0|||
170555280|NCT03715829|616380087|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555281|NCT03715829|616380088|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555282|NCT03715829|616380089|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555283|NCT03715829|616380090|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555284|NCT03715829|616380091|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555285|NCT03715829|616380092|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555286|NCT03715829|616380093|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555287|NCT03715829|616380094|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
170555288|NCT03715829|616380095|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
170555289|NCT03715829|616380096|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555290|NCT03715829|616380097|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
170555291|NCT03715829|616380087|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555292|NCT03715829|616380088|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555293|NCT03715829|616380089|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555294|NCT03715829|616380090|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555295|NCT03715829|616380091|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555296|NCT03715829|616380092|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555297|NCT03715829|616380093|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555298|NCT03715829|616380094|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555299|NCT03715829|616380095|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
170644822|NCT02466659|616713866|FG001|Overall Study|Lost to Follow-up|2|||
170644823|NCT00929643|616713869|FG000|Overall Study|Protocol Violation|2|||
170644824|NCT01536392|616713870|FG000|Overall Study|Adverse Event|2|||
170644825|NCT01536392|616713871|FG001|Overall Study|Adverse Event|2|||
170644826|NCT01536392|616713870|FG000|Overall Study|Physician Decision|2|||
170644827|NCT01536392|616713871|FG001|Overall Study|Physician Decision|3|||
170644828|NCT01536392|616713870|FG000|Overall Study|Withdrawal by Subject|3|||
170644829|NCT01536392|616713871|FG001|Overall Study|Withdrawal by Subject|6|||
170644830|NCT01536392|616713870|FG000|Overall Study|Non Compliance|3|||
170644831|NCT01536392|616713871|FG001|Overall Study|Non Compliance|4|||
170806538|NCT03883828|617301532|FG000|Overall Study|Did not start radiotherapy|1|||
170806539|NCT03883828|617301533|FG001|Overall Study|Did not start radiotherapy|2|||
170806540|NCT03732807|617301536|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
170806541|NCT03732807|617301537|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
170806542|NCT03732807|617301538|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
170806543|NCT03732807|617301539|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
170806544|NCT03732807|617301540|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
170806545|NCT03732807|617301541|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
170806546|NCT03732807|617301542|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
170806547|NCT03732807|617301536|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
170806548|NCT03732807|617301537|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
170806549|NCT03732807|617301538|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
170806550|NCT03732807|617301539|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
170555300|NCT03715829|616380096|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555301|NCT03715829|616380097|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
170555302|NCT03715829|616380087|FG000|Extension Period|Other|0|||
170555303|NCT03715829|616380088|FG001|Extension Period|Other|0|||
170555304|NCT03715829|616380089|FG002|Extension Period|Other|0|||
170644832|NCT01536392|616713870|FG000|Overall Study|Completed therapy early|3|||
170644833|NCT01536392|616713871|FG001|Overall Study|Completed therapy early|0|||
170905246|NCT01309737|617656056|FG003|Week 0 to 16|Randomized, but not treated|0|||
170905247|NCT01309737|617656057|FG004|Week 0 to 16|Randomized, but not treated|0|||
170555305|NCT03715829|616380090|FG003|Extension Period|Other|0|||
170555306|NCT03715829|616380091|FG004|Extension Period|Other|0|||
170555307|NCT03715829|616380092|FG005|Extension Period|Other|0|||
170555308|NCT03715829|616380093|FG006|Extension Period|Other|1|||
170555309|NCT03715829|616380094|FG007|Extension Period|Other|2|||
170555310|NCT03715829|616380095|FG008|Extension Period|Other|4|||
170555311|NCT03715829|616380096|FG009|Extension Period|Other|0|||
170555312|NCT03715829|616380097|FG010|Extension Period|Other|0|||
170555313|NCT03647137|616380099|FG000|Overall Study|Scan Limitation|2|||
170555314|NCT03647137|616380100|FG001|Overall Study|Scan Limitation|1|||
170555315|NCT03647137|616380101|FG002|Overall Study|Scan Limitation|1|||
170555316|NCT03647137|616380102|FG003|Overall Study|Scan Limitation|2|||
170555317|NCT00069953|616380104|FG000|Overall Study|Protocol Violation|2|||
170555318|NCT03900650|616380105|FG000|Overall Study|Withdrawal by Subject|1|||
170555319|NCT03900650|616380106|FG001|Overall Study|Withdrawal by Subject|1|||
170555320|NCT03900650|616380107|FG002|Overall Study|Withdrawal by Subject|0|||
170555321|NCT03900650|616380108|FG003|Overall Study|Withdrawal by Subject|0|||
170555322|NCT03900650|616380105|FG000|Overall Study|Withdrawn by staff|1|||
170555323|NCT03900650|616380106|FG001|Overall Study|Withdrawn by staff|0|||
170555324|NCT03900650|616380107|FG002|Overall Study|Withdrawn by staff|0|||
170555325|NCT03900650|616380108|FG003|Overall Study|Withdrawn by staff|0|||
170555326|NCT00829868|616380113|FG000|Washout|Physician Decision|1|||
170555327|NCT00829868|616380114|FG001|Washout|Physician Decision|0|||
170555328|NCT03163667|616380116|FG000|Overall Study|Death|15|||
170555329|NCT03163667|616380117|FG001|Overall Study|Death|27|||
170555330|NCT03163667|616380116|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
170555331|NCT03163667|616380117|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
170555332|NCT05305651|616380118|FG000|Overall Study|Death|1|||
170555333|NCT05305651|616380118|FG000|Overall Study|Withdrawal by Subject|4|||
170555334|NCT05305651|616380118|FG000|Overall Study|Lost to Follow-up|4|||
170555335|NCT02296476|616381253|FG000|Overall Study|Disease Progression|6|||
170555336|NCT02296476|616381254|FG001|Overall Study|Disease Progression|4|||
170555337|NCT02296476|616381255|FG002|Overall Study|Disease Progression|2|||
170555338|NCT03502681|616381256|FG000|Overall Study|Adverse Event|1|||
170555339|NCT03502681|616381257|FG001|Overall Study|Adverse Event|1|||
170555340|NCT03502681|616381256|FG000|Overall Study|Disease Progression|2|||
170555341|NCT03502681|616381257|FG001|Overall Study|Disease Progression|1|||
170555342|NCT00003907|616381263|FG000|Overall Study|Adverse Event|2|||
170555343|NCT00003907|616381264|FG001|Overall Study|Adverse Event|11|||
170555344|NCT00003907|616381263|FG000|Overall Study|Death|2|||
170555345|NCT00003907|616381264|FG001|Overall Study|Death|0|||
170555346|NCT00003907|616381263|FG000|Overall Study|Withdrawal by Subject|1|||
170555347|NCT00003907|616381264|FG001|Overall Study|Withdrawal by Subject|3|||
170555348|NCT00003907|616381263|FG000|Overall Study|Progressive disease|4|||
170555349|NCT00003907|616381264|FG001|Overall Study|Progressive disease|4|||
170555350|NCT00003907|616381263|FG000|Overall Study|Complicating disease|1|||
170555351|NCT00003907|616381264|FG001|Overall Study|Complicating disease|0|||
170555352|NCT00003907|616381263|FG000|Overall Study|Other|1|||
170555353|NCT00003907|616381264|FG001|Overall Study|Other|3|||
170555354|NCT00003907|616381263|FG000|Overall Study|ineligible or not treated|2|||
170555355|NCT00003907|616381264|FG001|Overall Study|ineligible or not treated|2|||
170555356|NCT02489279|616381269|FG000|Overall Study|Lost to Follow-up|12|||
170555357|NCT02489279|616381270|FG001|Overall Study|Lost to Follow-up|10|||
170555358|NCT00505687|616381271|FG000|Overall Study|Important protocol violation|2|||
170555359|NCT00505687|616381271|FG000|Overall Study|Lack of Efficacy|15|||
170555360|NCT00505687|616381271|FG000|Overall Study|Adverse Event|48|||
170555361|NCT00505687|616381271|FG000|Overall Study|Subject withdrew consent|15|||
170555362|NCT00505687|616381271|FG000|Overall Study|Lost to Follow-up|1|||
170555363|NCT00505687|616381271|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
170555364|NCT00505687|616381271|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
170555365|NCT00505687|616381271|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
170555366|NCT00505687|616381271|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
170555367|NCT00505687|616381271|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
170555368|NCT00505687|616381271|FG000|Overall Study|Other: Disease Progression|1|||
170555369|NCT00505687|616381271|FG000|Overall Study|Other: As Per Sponsor|8|||
170555370|NCT03707821|616381272|FG000|Overall Study|Protocol Violation|0|||
170555371|NCT03707821|616381273|FG001|Overall Study|Protocol Violation|1|||
170555372|NCT03707821|616381272|FG000|Overall Study|Unsatisfactory Visual Response|1|||
170555373|NCT03707821|616381273|FG001|Overall Study|Unsatisfactory Visual Response|0|||
170555374|NCT03707821|616381272|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
170905248|NCT01309737|617656053|FG000|Week 16 to 52|Death|0|||
170555375|NCT03707821|616381273|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
170555376|NCT03673176|616381274|FG000|Overall Study|Death prior to intervention|1|||
170555377|NCT03673176|616381274|FG000|Overall Study|Death following intervention|3|||
170555378|NCT03673176|616381274|FG000|Overall Study|Withdrawal by Subject|1|||
170555379|NCT00586157|616381275|FG000|First Intervention|Worsening behavior|1|||
170555380|NCT00586157|616381276|FG001|First Intervention|Worsening behavior|0|||
170555381|NCT00586157|616381275|FG000|Second Intervention|Withdrawal by Subject|1|||
170555382|NCT00586157|616381276|FG001|Second Intervention|Withdrawal by Subject|0|||
170555383|NCT00586157|616381275|FG000|Second Intervention|Worsening behavior|1|||
170555384|NCT00586157|616381276|FG001|Second Intervention|Worsening behavior|0|||
170555385|NCT00586157|616381275|FG000|Second Intervention|Adverse Event|0|||
170555386|NCT00586157|616381276|FG001|Second Intervention|Adverse Event|1|||
170555387|NCT02378480|616381277|FG000|Overall Study|Physician Decision|1|||
170555388|NCT02378480|616381278|FG001|Overall Study|Physician Decision|1|||
170555389|NCT02378480|616381277|FG000|Overall Study|Death|1|||
170555390|NCT02378480|616381278|FG001|Overall Study|Death|2|||
170555391|NCT02378480|616381277|FG000|Overall Study|Randomized, but Not Treated|6|||
170555392|NCT02378480|616381278|FG001|Overall Study|Randomized, but Not Treated|4|||
170555393|NCT02378480|616381277|FG000|Overall Study|Adverse Event|0|||
170555394|NCT02378480|616381278|FG001|Overall Study|Adverse Event|1|||
170555395|NCT02378480|616381277|FG000|Overall Study|Missed EOT/PTE Visit|1|||
170555396|NCT02378480|616381278|FG001|Overall Study|Missed EOT/PTE Visit|2|||
170555397|NCT02378480|616381277|FG000|Overall Study|Withdrawal by Subject|9|||
170555398|NCT02378480|616381278|FG001|Overall Study|Withdrawal by Subject|4|||
170555399|NCT02378480|616381277|FG000|Overall Study|Lost to Follow-up|10|||
170555400|NCT02378480|616381278|FG001|Overall Study|Lost to Follow-up|18|||
170555401|NCT01230060|616381282|FG000|Overall Study|Withdrawal by Subject|1|||
170555402|NCT01217892|616381284|FG000|Overall Study|Adverse Event|1|||
170555403|NCT01217892|616381285|FG001|Overall Study|Adverse Event|1|||
170555404|NCT01217892|616381286|FG002|Overall Study|Adverse Event|1|||
170555405|NCT01217892|616381287|FG003|Overall Study|Adverse Event|0|||
170555406|NCT01217892|616381284|FG000|Overall Study|Withdrawal by Subject|0|||
170555407|NCT01217892|616381285|FG001|Overall Study|Withdrawal by Subject|2|||
170555408|NCT01217892|616381286|FG002|Overall Study|Withdrawal by Subject|1|||
170555409|NCT01217892|616381287|FG003|Overall Study|Withdrawal by Subject|0|||
170555410|NCT01217892|616381284|FG000|Overall Study|Lab value|1|||
170555411|NCT01217892|616381285|FG001|Overall Study|Lab value|0|||
170555412|NCT01217892|616381286|FG002|Overall Study|Lab value|1|||
170555413|NCT01217892|616381287|FG003|Overall Study|Lab value|0|||
170555414|NCT01217892|616381284|FG000|Overall Study|Subject no longer meets study criteria|5|||
170555415|NCT01217892|616381285|FG001|Overall Study|Subject no longer meets study criteria|2|||
170555416|NCT01217892|616381286|FG002|Overall Study|Subject no longer meets study criteria|4|||
170555417|NCT01217892|616381287|FG003|Overall Study|Subject no longer meets study criteria|8|||
170555418|NCT01217892|616381284|FG000|Overall Study|Incorrect enrollment|0|||
170555419|NCT01217892|616381285|FG001|Overall Study|Incorrect enrollment|1|||
170555420|NCT01217892|616381286|FG002|Overall Study|Incorrect enrollment|1|||
170555421|NCT01217892|616381287|FG003|Overall Study|Incorrect enrollment|0|||
170555422|NCT01217892|616381284|FG000|Overall Study|Poor/Non-Compliance|0|||
170555423|NCT01217892|616381285|FG001|Overall Study|Poor/Non-Compliance|0|||
170555424|NCT01217892|616381286|FG002|Overall Study|Poor/Non-Compliance|1|||
170644834|NCT02703337|616713878|FG000|Period One (Part A)|Withdrawal by Subject|0|||
170644835|NCT02703337|616713879|FG001|Period One (Part A)|Withdrawal by Subject|0|||
170644836|NCT02703337|616713880|FG002|Period One (Part A)|Withdrawal by Subject|0|||
170644837|NCT02703337|616713881|FG003|Period One (Part A)|Withdrawal by Subject|0|||
170644838|NCT02703337|616713882|FG004|Period One (Part A)|Withdrawal by Subject|1|||
170644839|NCT02703337|616713883|FG005|Period One (Part A)|Withdrawal by Subject|0|||
170644840|NCT02703337|616713884|FG006|Period One (Part A)|Withdrawal by Subject|0|||
170644841|NCT02703337|616713885|FG007|Period One (Part A)|Withdrawal by Subject|0|||
170644842|NCT01144299|616713890|FG000|Overall Study|Lost to Follow-up|1|||
170555425|NCT01217892|616381287|FG003|Overall Study|Poor/Non-Compliance|0|||
170555426|NCT03802916|616381289|FG000|Overall Study|Adverse Event|0|||
170555427|NCT03802916|616381290|FG001|Overall Study|Adverse Event|1|||
170555428|NCT03802916|616381289|FG000|Overall Study|Withdrawal by Subject|0|||
170806551|NCT03732807|617301540|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
170806552|NCT03732807|617301541|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
170806553|NCT03732807|617301542|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
170806554|NCT03732807|617301536|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
170806555|NCT03732807|617301537|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
170806556|NCT03732807|617301538|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
170806557|NCT03732807|617301539|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
170806558|NCT03732807|617301540|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
170806559|NCT03732807|617301541|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
170806560|NCT03732807|617301542|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
170905249|NCT01309737|617656054|FG001|Week 16 to 52|Death|0|||
170555429|NCT03802916|616381290|FG001|Overall Study|Withdrawal by Subject|1|||
170555430|NCT00831389|616381291|FG000|Overall Study|Withdrawal by Subject|0|||
170555431|NCT00831389|616381292|FG001|Overall Study|Withdrawal by Subject|1|||
170555432|NCT00278161|616381293|FG000|Overall Study|Death|11|||
170555433|NCT01817777|616381294|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
170644843|NCT01144299|616713891|FG001|Overall Study|Lost to Follow-up|0|||
170644844|NCT01144299|616713890|FG000|Overall Study|Withdrawal by Subject|1|||
170555434|NCT01817777|616381295|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
170555435|NCT01817777|616381296|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
170555436|NCT01817777|616381294|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
170555437|NCT01817777|616381295|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
170555438|NCT01817777|616381296|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
170555439|NCT01817777|616381294|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
170555440|NCT01817777|616381295|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
170555441|NCT01817777|616381296|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
170555442|NCT01817777|616381294|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
170555443|NCT01817777|616381295|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
170555444|NCT01817777|616381296|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
170555445|NCT01817777|616381294|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
170555446|NCT01817777|616381295|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
170555447|NCT01817777|616381296|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
170555448|NCT04102514|616381297|FG000|Overall Study|Death|3|||
170555449|NCT04102514|616381298|FG001|Overall Study|Death|0|||
170555450|NCT04102514|616381299|FG002|Overall Study|Death|0|||
170555451|NCT04102514|616381300|FG003|Overall Study|Death|0|||
170555452|NCT04102514|616381297|FG000|Overall Study|Lost to Follow-up|0|||
170555453|NCT04102514|616381298|FG001|Overall Study|Lost to Follow-up|0|||
170555454|NCT04102514|616381299|FG002|Overall Study|Lost to Follow-up|3|||
170555455|NCT04102514|616381300|FG003|Overall Study|Lost to Follow-up|0|||
170555456|NCT04102514|616381297|FG000|Overall Study|Physician Decision|0|||
170555457|NCT04102514|616381298|FG001|Overall Study|Physician Decision|0|||
170555458|NCT04102514|616381299|FG002|Overall Study|Physician Decision|1|||
170555459|NCT04102514|616381300|FG003|Overall Study|Physician Decision|0|||
170555460|NCT04102514|616381297|FG000|Overall Study|Withdrawal by Subject|7|||
170555461|NCT04102514|616381298|FG001|Overall Study|Withdrawal by Subject|13|||
170555462|NCT04102514|616381299|FG002|Overall Study|Withdrawal by Subject|7|||
170555463|NCT04102514|616381300|FG003|Overall Study|Withdrawal by Subject|14|||
170555464|NCT04102514|616381297|FG000|Overall Study|Moved to longterm care facility|6|||
170555465|NCT04102514|616381298|FG001|Overall Study|Moved to longterm care facility|0|||
170555466|NCT04102514|616381299|FG002|Overall Study|Moved to longterm care facility|4|||
170555467|NCT04102514|616381300|FG003|Overall Study|Moved to longterm care facility|0|||
170555468|NCT00619918|616381301|FG000|Overall Study|Withdrawal by Subject|4|||
170555469|NCT00619918|616381302|FG001|Overall Study|Withdrawal by Subject|3|||
170555470|NCT00619918|616381301|FG000|Overall Study|Physician Decision|2|||
170555471|NCT00619918|616381302|FG001|Overall Study|Physician Decision|4|||
170555472|NCT00619918|616381301|FG000|Overall Study|Transfer to outside facility|3|||
170555473|NCT00619918|616381302|FG001|Overall Study|Transfer to outside facility|3|||
170555474|NCT00619918|616381301|FG000|Overall Study|Left before receiving first dose|7|||
170555475|NCT00619918|616381302|FG001|Overall Study|Left before receiving first dose|6|||
170555476|NCT00619918|616381301|FG000|Overall Study|ICU admission|4|||
170555477|NCT00619918|616381302|FG001|Overall Study|ICU admission|6|||
170555478|NCT02758626|616381309|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
170555479|NCT02758626|616381310|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
170555480|NCT02758626|616381309|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
170555481|NCT02758626|616381310|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
170806561|NCT03732807|617301536|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
170806562|NCT03732807|617301537|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
170806563|NCT03732807|617301538|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
170806564|NCT03732807|617301539|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
170806565|NCT03732807|617301540|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
170806566|NCT03732807|617301541|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
170806567|NCT03732807|617301542|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
170806568|NCT03732807|617301536|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
170806569|NCT03732807|617301537|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
170806570|NCT03732807|617301538|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
170806571|NCT03732807|617301539|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
170806572|NCT03732807|617301540|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
170555482|NCT02758626|616381309|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
170555483|NCT02758626|616381310|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
170806573|NCT03732807|617301541|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
170806574|NCT03732807|617301542|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
170806575|NCT03732807|617301536|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
170555484|NCT02758626|616381309|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
170555485|NCT02758626|616381310|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
170555486|NCT03579719|616381311|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
170555487|NCT01443026|616381312|FG000|Overall Study|Physician Decision|1|||
170555488|NCT01443026|616381313|FG001|Overall Study|Physician Decision|0|||
170555489|NCT01443026|616381312|FG000|Overall Study|Death|0|||
170644845|NCT01144299|616713891|FG001|Overall Study|Withdrawal by Subject|0|||
170644846|NCT04237116|616713892|FG000|Overall Study|Adverse Event|0|||
170644847|NCT04237116|616713893|FG001|Overall Study|Adverse Event|1|||
170644848|NCT04237116|616713892|FG000|Overall Study|Study terminated by Sponsor|4|||
170644849|NCT04237116|616713893|FG001|Overall Study|Study terminated by Sponsor|1|||
170644850|NCT00899431|616713894|FG000|Overall Study|Physician Decision|1|||
170644851|NCT00899431|616713895|FG001|Overall Study|Physician Decision|0|||
170644852|NCT00899431|616713896|FG002|Overall Study|Physician Decision|0|||
170555490|NCT01443026|616381313|FG001|Overall Study|Death|1|||
170555491|NCT01443026|616381312|FG000|Overall Study|Withdrawal by Subject|0|||
170555492|NCT01443026|616381313|FG001|Overall Study|Withdrawal by Subject|3|||
170555493|NCT01443026|616381312|FG000|Overall Study|Lost to Follow-up|2|||
170555494|NCT01443026|616381313|FG001|Overall Study|Lost to Follow-up|1|||
170555495|NCT00721110|616381316|FG000|Overall Study|Ultram use|1|||
170555496|NCT00721110|616381317|FG001|Overall Study|Ultram use|0|||
170555497|NCT00721110|616381318|FG002|Overall Study|Ultram use|0|||
170555498|NCT00721110|616381319|FG003|Overall Study|Ultram use|0|||
170555499|NCT00721110|616381316|FG000|Overall Study|vertical incision|0|||
170555500|NCT00721110|616381317|FG001|Overall Study|vertical incision|0|||
170644853|NCT03698591|616713897|FG000|Overall Study|Withdrawal by Subject|2|||
170644854|NCT03698591|616713898|FG001|Overall Study|Withdrawal by Subject|2|||
170644855|NCT03698591|616713897|FG000|Overall Study|Failed drug screen|1|||
170806576|NCT03732807|617301537|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
170806577|NCT03732807|617301538|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
170555501|NCT00721110|616381318|FG002|Overall Study|vertical incision|1|||
170555502|NCT00721110|616381319|FG003|Overall Study|vertical incision|0|||
170555503|NCT02799043|616381323|FG000|Overall Study|Adverse Event|0|||
170555504|NCT02799043|616381324|FG001|Overall Study|Adverse Event|1|||
170555505|NCT02799043|616381323|FG000|Overall Study|Death|1|||
170555506|NCT02799043|616381324|FG001|Overall Study|Death|1|||
170555507|NCT02799043|616381323|FG000|Overall Study|Lost to Follow-up|3|||
170555508|NCT02799043|616381324|FG001|Overall Study|Lost to Follow-up|6|||
170555509|NCT02799043|616381323|FG000|Overall Study|Withdrawal by Subject|4|||
170555510|NCT02799043|616381324|FG001|Overall Study|Withdrawal by Subject|4|||
170555511|NCT02799043|616381323|FG000|Overall Study|Moved to different country|0|||
170555512|NCT02799043|616381324|FG001|Overall Study|Moved to different country|1|||
170555513|NCT02799043|616381323|FG000|Overall Study|Trial Screen Failure|1|||
170555514|NCT02799043|616381324|FG001|Overall Study|Trial Screen Failure|0|||
170555515|NCT02799043|616381323|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
170555516|NCT02799043|616381324|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
170555517|NCT01554904|616381325|FG000|Overall Study|Withdrawal by Subject|3|||
170555518|NCT01554904|616381325|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
170555519|NCT03829683|616381330|FG000|Overall Study|Lost to Follow-up|1|||
170555520|NCT03829683|616381331|FG001|Overall Study|Lost to Follow-up|0|||
170555521|NCT03829683|616381330|FG000|Overall Study|Physician Decision|3|||
170555522|NCT03829683|616381331|FG001|Overall Study|Physician Decision|1|||
170555523|NCT03829683|616381330|FG000|Overall Study|Withdrawal by Subject|0|||
170555524|NCT03829683|616381331|FG001|Overall Study|Withdrawal by Subject|1|||
170555525|NCT03829683|616381330|FG000|Overall Study|Discharge from hospital|1|||
170555526|NCT03829683|616381331|FG001|Overall Study|Discharge from hospital|0|||
170555527|NCT01051661|616381334|FG000|Overall Study|Adverse Event|1|||
170555528|NCT01051661|616381335|FG001|Overall Study|Adverse Event|1|||
170555529|NCT01051661|616381336|FG002|Overall Study|Adverse Event|1|||
170555530|NCT01051661|616381337|FG003|Overall Study|Adverse Event|1|||
170555531|NCT01051661|616381338|FG004|Overall Study|Adverse Event|0|||
170555532|NCT01051661|616381339|FG005|Overall Study|Adverse Event|0|||
170555533|NCT01051661|616381334|FG000|Overall Study|Lost to Follow-up|13|||
170555534|NCT01051661|616381335|FG001|Overall Study|Lost to Follow-up|22|||
170555535|NCT01051661|616381336|FG002|Overall Study|Lost to Follow-up|15|||
170555536|NCT01051661|616381337|FG003|Overall Study|Lost to Follow-up|17|||
170555537|NCT01051661|616381338|FG004|Overall Study|Lost to Follow-up|10|||
170555538|NCT01051661|616381339|FG005|Overall Study|Lost to Follow-up|24|||
170555539|NCT01051661|616381334|FG000|Overall Study|Migrated/moved from study area|1|||
170555540|NCT01051661|616381335|FG001|Overall Study|Migrated/moved from study area|6|||
170555541|NCT01051661|616381336|FG002|Overall Study|Migrated/moved from study area|6|||
170555542|NCT01051661|616381337|FG003|Overall Study|Migrated/moved from study area|8|||
170555543|NCT01051661|616381338|FG004|Overall Study|Migrated/moved from study area|7|||
170555544|NCT01051661|616381339|FG005|Overall Study|Migrated/moved from study area|3|||
170555545|NCT01051661|616381334|FG000|Overall Study|Refused blood sampling|0|||
170555546|NCT01051661|616381335|FG001|Overall Study|Refused blood sampling|0|||
170555547|NCT01051661|616381336|FG002|Overall Study|Refused blood sampling|0|||
170555548|NCT01051661|616381337|FG003|Overall Study|Refused blood sampling|0|||
170555549|NCT01051661|616381338|FG004|Overall Study|Refused blood sampling|0|||
170555550|NCT01051661|616381339|FG005|Overall Study|Refused blood sampling|1|||
170555551|NCT01051661|616381334|FG000|Overall Study|Data not reliable|1|||
170644856|NCT03698591|616713898|FG001|Overall Study|Failed drug screen|1|||
170644857|NCT03698591|616713897|FG000|Overall Study|Failed health screen|0|||
170644858|NCT03698591|616713898|FG001|Overall Study|Failed health screen|1|||
170555552|NCT01051661|616381335|FG001|Overall Study|Data not reliable|0|||
170555553|NCT01051661|616381336|FG002|Overall Study|Data not reliable|0|||
170555554|NCT01051661|616381337|FG003|Overall Study|Data not reliable|0|||
170555555|NCT01051661|616381338|FG004|Overall Study|Data not reliable|0|||
170555556|NCT01051661|616381339|FG005|Overall Study|Data not reliable|1|||
170555557|NCT01051661|616381334|FG000|Overall Study|Unable to attend visit(s)|2|||
170555558|NCT01051661|616381335|FG001|Overall Study|Unable to attend visit(s)|4|||
170555559|NCT01051661|616381336|FG002|Overall Study|Unable to attend visit(s)|2|||
170555560|NCT01051661|616381337|FG003|Overall Study|Unable to attend visit(s)|1|||
170555561|NCT01051661|616381338|FG004|Overall Study|Unable to attend visit(s)|3|||
170555562|NCT01051661|616381339|FG005|Overall Study|Unable to attend visit(s)|2|||
170555563|NCT01051661|616381334|FG000|Overall Study|Consent not received from both parents|0|||
170555564|NCT01051661|616381335|FG001|Overall Study|Consent not received from both parents|0|||
170555565|NCT01051661|616381336|FG002|Overall Study|Consent not received from both parents|0|||
170555566|NCT01051661|616381337|FG003|Overall Study|Consent not received from both parents|0|||
170555567|NCT01051661|616381338|FG004|Overall Study|Consent not received from both parents|0|||
170555568|NCT01051661|616381339|FG005|Overall Study|Consent not received from both parents|1|||
170555569|NCT01051661|616381334|FG000|Overall Study|Failure to comply with protocol|0|||
170555570|NCT01051661|616381335|FG001|Overall Study|Failure to comply with protocol|0|||
170555571|NCT01051661|616381336|FG002|Overall Study|Failure to comply with protocol|2|||
170555572|NCT01051661|616381337|FG003|Overall Study|Failure to comply with protocol|0|||
170555573|NCT01051661|616381338|FG004|Overall Study|Failure to comply with protocol|0|||
170555574|NCT01051661|616381339|FG005|Overall Study|Failure to comply with protocol|0|||
170555575|NCT01051661|616381334|FG000|Overall Study|Subject lost legal representation|0|||
170555576|NCT01051661|616381335|FG001|Overall Study|Subject lost legal representation|0|||
170555577|NCT01051661|616381336|FG002|Overall Study|Subject lost legal representation|0|||
170555578|NCT01051661|616381337|FG003|Overall Study|Subject lost legal representation|0|||
170555579|NCT01051661|616381338|FG004|Overall Study|Subject lost legal representation|1|||
170555580|NCT01051661|616381339|FG005|Overall Study|Subject lost legal representation|0|||
170555581|NCT01051661|616381334|FG000|Overall Study|Protocol Violation|0|||
170555582|NCT01051661|616381335|FG001|Overall Study|Protocol Violation|0|||
170555583|NCT01051661|616381336|FG002|Overall Study|Protocol Violation|0|||
170555584|NCT01051661|616381337|FG003|Overall Study|Protocol Violation|1|||
170555585|NCT01051661|616381338|FG004|Overall Study|Protocol Violation|2|||
170555586|NCT01051661|616381339|FG005|Overall Study|Protocol Violation|1|||
170555587|NCT01051661|616381334|FG000|Overall Study|Withdrawal by Subject|16|||
170555588|NCT01051661|616381335|FG001|Overall Study|Withdrawal by Subject|30|||
170555589|NCT01051661|616381336|FG002|Overall Study|Withdrawal by Subject|13|||
170555590|NCT01051661|616381337|FG003|Overall Study|Withdrawal by Subject|28|||
170555591|NCT01051661|616381338|FG004|Overall Study|Withdrawal by Subject|12|||
170555592|NCT01051661|616381339|FG005|Overall Study|Withdrawal by Subject|34|||
170555593|NCT01681849|616381340|FG000|Overall Study|Protocol Violation|2|||
170555594|NCT01681849|616381341|FG001|Overall Study|Protocol Violation|0|||
170555595|NCT01681849|616381342|FG002|Overall Study|Protocol Violation|0|||
170555596|NCT01681849|616381340|FG000|Overall Study|Withdrawal by Subject|3|||
170555597|NCT01681849|616381341|FG001|Overall Study|Withdrawal by Subject|5|||
170555598|NCT01681849|616381342|FG002|Overall Study|Withdrawal by Subject|33|||
170555599|NCT01681849|616381340|FG000|Overall Study|Lost to Follow-up|3|||
170555600|NCT01681849|616381341|FG001|Overall Study|Lost to Follow-up|2|||
170555601|NCT01681849|616381342|FG002|Overall Study|Lost to Follow-up|6|||
170555602|NCT02852005|616381346|FG000|Overall Study|Lost to Follow-up|0|||
170555603|NCT02852005|616381347|FG001|Overall Study|Lost to Follow-up|0|||
170555604|NCT02852005|616381348|FG002|Overall Study|Lost to Follow-up|0|||
170555605|NCT02852005|616381349|FG003|Overall Study|Lost to Follow-up|0|||
170555606|NCT02852005|616381350|FG004|Overall Study|Lost to Follow-up|1|||
170555607|NCT02852005|616381346|FG000|Overall Study|Withdrawal by Subject|1|||
170555608|NCT02852005|616381347|FG001|Overall Study|Withdrawal by Subject|0|||
170555609|NCT02852005|616381348|FG002|Overall Study|Withdrawal by Subject|0|||
170555610|NCT02852005|616381349|FG003|Overall Study|Withdrawal by Subject|0|||
170555611|NCT02852005|616381350|FG004|Overall Study|Withdrawal by Subject|0|||
170555612|NCT04525183|616381351|FG000|Overall Study|Withdrawal by Subject|0|||
170555613|NCT04525183|616381352|FG001|Overall Study|Withdrawal by Subject|0|||
170555614|NCT04525183|616381353|FG002|Overall Study|Withdrawal by Subject|3|||
170555615|NCT04525183|616381351|FG000|Overall Study|Study non-compliance|0|||
170555616|NCT04525183|616381352|FG001|Overall Study|Study non-compliance|0|||
170555617|NCT04525183|616381353|FG002|Overall Study|Study non-compliance|1|||
170555618|NCT04525183|616381351|FG000|Overall Study|Recurrent disease before starting on study|0|||
170555619|NCT04525183|616381352|FG001|Overall Study|Recurrent disease before starting on study|0|||
170555620|NCT04525183|616381353|FG002|Overall Study|Recurrent disease before starting on study|1|||
170555621|NCT01044459|616381354|FG000|Overall Study|Withdrawal by Subject|21|||
170555622|NCT01044459|616381355|FG001|Overall Study|Withdrawal by Subject|28|||
170555623|NCT01044459|616381354|FG000|Overall Study|Terminated by Sponsor|22|||
170555624|NCT01044459|616381355|FG001|Overall Study|Terminated by Sponsor|21|||
170555625|NCT01044459|616381354|FG000|Overall Study|Adverse Event|22|||
170555626|NCT01044459|616381355|FG001|Overall Study|Adverse Event|20|||
170555627|NCT01044459|616381354|FG000|Overall Study|Lack of Efficacy|23|||
170555628|NCT01044459|616381355|FG001|Overall Study|Lack of Efficacy|12|||
170555629|NCT01044459|616381354|FG000|Overall Study|Protocol Violation|11|||
170555630|NCT01044459|616381355|FG001|Overall Study|Protocol Violation|16|||
170555631|NCT01044459|616381354|FG000|Overall Study|Other Reason|7|||
170555632|NCT01044459|616381355|FG001|Overall Study|Other Reason|14|||
170555633|NCT01044459|616381354|FG000|Overall Study|COPD exacerbation|9|||
170555634|NCT01044459|616381355|FG001|Overall Study|COPD exacerbation|8|||
170555635|NCT01044459|616381354|FG000|Overall Study|Lost to Follow-up|18|||
170555636|NCT01044459|616381355|FG001|Overall Study|Lost to Follow-up|12|||
170555637|NCT01149460|616383005|FG000|Overall Study|Withdrawal by Subject|0|||
170555638|NCT01149460|616383006|FG001|Overall Study|Withdrawal by Subject|2|||
170555639|NCT00321932|616383007|FG000|Overall Study|Death|3|||
170555640|NCT00321932|616383008|FG001|Overall Study|Death|6|||
170555641|NCT00321932|616383007|FG000|Overall Study|Withdrawal by Subject|3|||
170555642|NCT00321932|616383008|FG001|Overall Study|Withdrawal by Subject|6|||
170555643|NCT00321932|616383007|FG000|Overall Study|Early relapse|2|||
170555644|NCT00321932|616383008|FG001|Overall Study|Early relapse|8|||
170555645|NCT00321932|616383007|FG000|Overall Study|Missing data|2|||
170555646|NCT00321932|616383008|FG001|Overall Study|Missing data|1|||
170555647|NCT00668642|616383009|FG000|First Off-cycle|Cancer progression|1|||
170555648|NCT00668642|616383010|FG001|First Off-cycle|Cancer progression|0|||
170555649|NCT00668642|616383009|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
170555650|NCT00668642|616383010|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
170555651|NCT02014467|616383011|FG000|Overall Study|Adverse Event|4|||
170555652|NCT02014467|616383012|FG001|Overall Study|Adverse Event|0|||
170555653|NCT02014467|616383011|FG000|Overall Study|Protocol Violation|3|||
170555654|NCT02014467|616383012|FG001|Overall Study|Protocol Violation|0|||
170555655|NCT02014467|616383011|FG000|Overall Study|Physician Decision|2|||
170555656|NCT02014467|616383012|FG001|Overall Study|Physician Decision|3|||
170555657|NCT02014467|616383011|FG000|Overall Study|Withdrawal by Subject|16|||
170555658|NCT02014467|616383012|FG001|Overall Study|Withdrawal by Subject|4|||
170555659|NCT03663582|616383013|FG000|Overall Study|Physician Decision|1|||
170555660|NCT00480532|616383016|FG000|Overall Study|Withdrawal by Subject|2|||
170555661|NCT00480532|616383017|FG001|Overall Study|Withdrawal by Subject|4|||
170555662|NCT00480532|616383018|FG002|Overall Study|Withdrawal by Subject|3|||
170555663|NCT00480532|616383019|FG003|Overall Study|Withdrawal by Subject|1|||
170555664|NCT00480532|616383016|FG000|Overall Study|Protocol Violation|0|||
170555665|NCT00480532|616383017|FG001|Overall Study|Protocol Violation|0|||
170555666|NCT00480532|616383018|FG002|Overall Study|Protocol Violation|1|||
170555667|NCT00480532|616383019|FG003|Overall Study|Protocol Violation|0|||
170555668|NCT01285102|616383020|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
170555669|NCT01358734|616383031|FG000|Overall Study|Adverse Event|4|||
170555670|NCT01358734|616383032|FG001|Overall Study|Adverse Event|7|||
170555671|NCT01358734|616383033|FG002|Overall Study|Adverse Event|3|||
170555672|NCT01358734|616383031|FG000|Overall Study|Lack of Efficacy|0|||
170555673|NCT01358734|616383032|FG001|Overall Study|Lack of Efficacy|1|||
170555674|NCT01358734|616383033|FG002|Overall Study|Lack of Efficacy|3|||
170555675|NCT01358734|616383031|FG000|Overall Study|Withdrawal by Subject|1|||
170555676|NCT01358734|616383032|FG001|Overall Study|Withdrawal by Subject|6|||
170555677|NCT01358734|616383033|FG002|Overall Study|Withdrawal by Subject|3|||
170555678|NCT01358734|616383031|FG000|Overall Study|Death|3|||
170555679|NCT01358734|616383032|FG001|Overall Study|Death|7|||
170555680|NCT01358734|616383033|FG002|Overall Study|Death|2|||
170555681|NCT01358734|616383031|FG000|Overall Study|Progressive Disease|5|||
170555682|NCT01358734|616383032|FG001|Overall Study|Progressive Disease|13|||
170555683|NCT01358734|616383033|FG002|Overall Study|Progressive Disease|16|||
170555684|NCT01358734|616383031|FG000|Overall Study|Non-compliance with study drug|0|||
170555685|NCT01358734|616383032|FG001|Overall Study|Non-compliance with study drug|0|||
170555686|NCT01358734|616383033|FG002|Overall Study|Non-compliance with study drug|1|||
170555687|NCT01358734|616383031|FG000|Overall Study|Other|2|||
170555688|NCT01358734|616383032|FG001|Overall Study|Other|5|||
170555689|NCT01358734|616383033|FG002|Overall Study|Other|4|||
170555690|NCT01358734|616383031|FG000|Overall Study|Protocol Violation|0|||
170555691|NCT01358734|616383032|FG001|Overall Study|Protocol Violation|0|||
170644859|NCT03698591|616713897|FG000|Overall Study|Ineligible for financial compensation|1|||
170555692|NCT01358734|616383033|FG002|Overall Study|Protocol Violation|2|||
170555693|NCT02157610|616383036|FG000|Overall Study|Death|4|||
170555694|NCT02157610|616383037|FG001|Overall Study|Death|4|||
170555695|NCT01592747|616383038|FG000|Overall Study|Loss of Therapeutic Response|107|||
170555696|NCT01592747|616383039|FG001|Overall Study|Loss of Therapeutic Response|108|||
170555697|NCT01592747|616383040|FG002|Overall Study|Loss of Therapeutic Response|100|||
170555698|NCT01592747|616383038|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
170555699|NCT01592747|616383039|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
170555700|NCT01592747|616383040|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
170555701|NCT01592747|616383038|FG000|Overall Study|Adverse Event|1|||
170555702|NCT01592747|616383039|FG001|Overall Study|Adverse Event|0|||
170555703|NCT01592747|616383040|FG002|Overall Study|Adverse Event|0|||
170555704|NCT01592747|616383038|FG000|Overall Study|Protocol Violation|4|||
170555705|NCT01592747|616383039|FG001|Overall Study|Protocol Violation|0|||
170555706|NCT01592747|616383040|FG002|Overall Study|Protocol Violation|4|||
170555707|NCT01592747|616383038|FG000|Overall Study|Lack of Efficacy|0|||
170555708|NCT01592747|616383039|FG001|Overall Study|Lack of Efficacy|1|||
170555709|NCT01592747|616383040|FG002|Overall Study|Lack of Efficacy|0|||
170555710|NCT01592747|616383038|FG000|Overall Study|Withdrawal by Subject|2|||
170555711|NCT01592747|616383039|FG001|Overall Study|Withdrawal by Subject|0|||
170555712|NCT01592747|616383040|FG002|Overall Study|Withdrawal by Subject|2|||
170555713|NCT01592747|616383038|FG000|Overall Study|Lost to Follow-up|1|||
170555714|NCT01592747|616383039|FG001|Overall Study|Lost to Follow-up|0|||
170555715|NCT01592747|616383040|FG002|Overall Study|Lost to Follow-up|1|||
170555716|NCT01592747|616383038|FG000|Overall Study|Other Reasons|1|||
170555717|NCT01592747|616383039|FG001|Overall Study|Other Reasons|1|||
170555718|NCT01592747|616383040|FG002|Overall Study|Other Reasons|0|||
170555719|NCT01935947|616383041|FG000|Overall Study|Adverse Event|0|||
170555720|NCT01935947|616383042|FG001|Overall Study|Adverse Event|2|||
170555721|NCT01935947|616383043|FG002|Overall Study|Adverse Event|0|||
170555722|NCT01935947|616383041|FG000|Overall Study|Diease Progression|2|||
170555723|NCT01935947|616383042|FG001|Overall Study|Diease Progression|2|||
170555724|NCT01935947|616383043|FG002|Overall Study|Diease Progression|2|||
170555725|NCT01935947|616383041|FG000|Overall Study|Death|1|||
170555726|NCT01935947|616383042|FG001|Overall Study|Death|0|||
170555727|NCT01935947|616383043|FG002|Overall Study|Death|0|||
170555728|NCT03322566|616383044|FG000|Overall Study|Death|34|||
170555729|NCT03322566|616383045|FG001|Overall Study|Death|35|||
170555730|NCT03322566|616383046|FG002|Overall Study|Death|23|||
170555731|NCT03322566|616383044|FG000|Overall Study|Physician Decision|6|||
170555732|NCT03322566|616383045|FG001|Overall Study|Physician Decision|7|||
170555733|NCT03322566|616383046|FG002|Overall Study|Physician Decision|2|||
170555734|NCT03322566|616383044|FG000|Overall Study|Withdrawal by Subject|4|||
170555735|NCT03322566|616383045|FG001|Overall Study|Withdrawal by Subject|3|||
170555736|NCT03322566|616383046|FG002|Overall Study|Withdrawal by Subject|6|||
170555737|NCT03322566|616383044|FG000|Overall Study|Lost to Follow-up|0|||
170555738|NCT03322566|616383045|FG001|Overall Study|Lost to Follow-up|0|||
170555739|NCT03322566|616383046|FG002|Overall Study|Lost to Follow-up|1|||
170555740|NCT03322566|616383044|FG000|Overall Study|Study terminated by sponsor|1|||
170555741|NCT03322566|616383045|FG001|Overall Study|Study terminated by sponsor|0|||
170555742|NCT03322566|616383046|FG002|Overall Study|Study terminated by sponsor|1|||
170555743|NCT01602484|616383047|FG000|Overall Study|Airway issues unrelated to study|0|||
170555744|NCT01602484|616383048|FG001|Overall Study|Airway issues unrelated to study|1|||
170555745|NCT05763381|616383051|FG000|Overall Study|Lost to Follow-up|2|||
170555746|NCT05763381|616383052|FG001|Overall Study|Lost to Follow-up|3|||
170555747|NCT05763381|616383051|FG000|Overall Study|Withdrawal by Subject|1|||
170555748|NCT05763381|616383052|FG001|Overall Study|Withdrawal by Subject|2|||
170555749|NCT01916226|616383053|FG000|Overall Study|Adverse Event|1|||
170555750|NCT01916226|616383054|FG001|Overall Study|Adverse Event|0|||
170555751|NCT01916226|616383055|FG002|Overall Study|Adverse Event|1|||
170555752|NCT01916226|616383056|FG003|Overall Study|Adverse Event|1|||
170555753|NCT01916226|616383053|FG000|Overall Study|Lack of Efficacy|0|||
170555754|NCT01916226|616383054|FG001|Overall Study|Lack of Efficacy|0|||
170555755|NCT01916226|616383055|FG002|Overall Study|Lack of Efficacy|2|||
170555756|NCT01916226|616383056|FG003|Overall Study|Lack of Efficacy|1|||
170555757|NCT01916226|616383053|FG000|Overall Study|Protocol Violation|0|||
170555758|NCT01916226|616383054|FG001|Overall Study|Protocol Violation|1|||
170555759|NCT01916226|616383055|FG002|Overall Study|Protocol Violation|0|||
170555760|NCT01916226|616383056|FG003|Overall Study|Protocol Violation|1|||
170555761|NCT01916226|616383053|FG000|Overall Study|Physician Decision|0|||
170555762|NCT01916226|616383054|FG001|Overall Study|Physician Decision|0|||
170555763|NCT01916226|616383055|FG002|Overall Study|Physician Decision|0|||
170555764|NCT01916226|616383056|FG003|Overall Study|Physician Decision|1|||
170555765|NCT00759395|616383057|FG000|Overall Study|Adverse Event|1|||
170555766|NCT00759395|616383058|FG001|Overall Study|Adverse Event|0|||
170555767|NCT00759395|616383057|FG000|Overall Study|Withdrawal by Subject|1|||
170555768|NCT00759395|616383058|FG001|Overall Study|Withdrawal by Subject|0|||
170555769|NCT00759395|616383057|FG000|Overall Study|Lack of Efficacy|0|||
170555770|NCT00759395|616383058|FG001|Overall Study|Lack of Efficacy|2|||
170555771|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
170555772|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
170555773|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
170555774|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
170555775|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
170555776|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
170555777|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
170555778|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
170555779|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
170555780|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
170555781|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
170806578|NCT03732807|617301539|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
170806579|NCT03732807|617301540|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
170806580|NCT03732807|617301541|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
170806581|NCT03732807|617301542|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
170806582|NCT03732807|617301536|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
170806583|NCT03732807|617301537|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
170806584|NCT03732807|617301538|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
170806585|NCT03732807|617301539|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
170806586|NCT03732807|617301540|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
170806587|NCT03732807|617301541|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
170806588|NCT03732807|617301542|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
170806589|NCT03732807|617301536|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
170806590|NCT03732807|617301537|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
170806591|NCT03732807|617301538|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
170806592|NCT03732807|617301539|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
170806593|NCT03732807|617301540|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
170806594|NCT03732807|617301541|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
170806595|NCT03732807|617301542|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
170806596|NCT03732807|617301536|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
170806597|NCT03732807|617301537|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
170806598|NCT03732807|617301538|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
170806599|NCT03732807|617301539|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
170806600|NCT03732807|617301540|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
170806601|NCT03732807|617301541|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
170806602|NCT03732807|617301542|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
170806603|NCT03732807|617301536|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
170806604|NCT03732807|617301537|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
170644860|NCT03698591|616713898|FG001|Overall Study|Ineligible for financial compensation|0|||
170644861|NCT03698591|616713897|FG000|Overall Study|Equipment Error|1|||
170644862|NCT03698591|616713898|FG001|Overall Study|Equipment Error|0|||
170644863|NCT03698591|616713897|FG000|Overall Study|Could not establish TMS dosage|0|||
170644864|NCT03698591|616713898|FG001|Overall Study|Could not establish TMS dosage|1|||
170644865|NCT00661427|616713899|FG000|Overall Study|Adverse Event|5|||
170644866|NCT00661427|616713900|FG001|Overall Study|Adverse Event|5|||
170644867|NCT00661427|616713899|FG000|Overall Study|Patient not treated|0|||
170644868|NCT00661427|616713900|FG001|Overall Study|Patient not treated|2|||
170644869|NCT02660983|616713901|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
170806605|NCT03732807|617301538|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
170806606|NCT03732807|617301539|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
170806607|NCT03732807|617301540|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
170806608|NCT03732807|617301541|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
170806609|NCT03732807|617301542|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
170806610|NCT03732807|617301536|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
170806611|NCT03732807|617301537|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
170806612|NCT03732807|617301538|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
170806613|NCT03732807|617301539|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
170806614|NCT03732807|617301540|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
170806615|NCT03732807|617301541|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
170806616|NCT03732807|617301542|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
170806617|NCT03732807|617301536|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
170555782|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
170555783|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
170555784|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
170555785|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
170555786|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
170555787|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
170555788|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
170644870|NCT02660983|616713902|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
170644871|NCT02660983|616713901|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
170644872|NCT02660983|616713902|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
170806618|NCT03732807|617301537|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
170806619|NCT03732807|617301538|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
170555789|NCT00086515|616383059|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
170555790|NCT00086515|616383060|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
170644873|NCT02660983|616713901|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
170644874|NCT02660983|616713902|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
170644875|NCT02660983|616713901|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
170555791|NCT00086515|616383059|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
170555792|NCT00086515|616383060|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
170555793|NCT00086515|616383059|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
170555794|NCT00086515|616383060|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
170555795|NCT00086515|616383059|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
170555796|NCT00086515|616383060|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
170555797|NCT00086515|616383059|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
170555798|NCT00086515|616383060|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
170555799|NCT00086515|616383059|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
170555800|NCT00086515|616383060|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
170555801|NCT00086515|616383059|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
170555802|NCT00086515|616383060|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
170555803|NCT00086515|616383059|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
170555804|NCT00086515|616383060|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
170555805|NCT00086515|616383059|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
170555806|NCT00086515|616383060|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
170555807|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
170555808|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
170555809|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
170555810|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
170555811|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
170555812|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
170555813|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
170555814|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
170555815|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
170555816|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
170555817|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
170555818|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
170555819|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
170555820|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
170555821|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
170555822|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
170555823|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
170555824|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
170555825|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
170555826|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
170555827|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
170555828|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
170555829|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
170555830|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
170555831|NCT00086515|616383059|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
170555832|NCT00086515|616383060|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
170555833|NCT01166646|616383066|FG000|Overall Study|Protocol Violation|0|||
170555834|NCT01166646|616383067|FG001|Overall Study|Protocol Violation|1|||
170555835|NCT01166646|616383066|FG000|Overall Study|Adverse Event|1|||
170555836|NCT01166646|616383067|FG001|Overall Study|Adverse Event|0|||
170555837|NCT05142306|616383068|FG000|Overall Study|Withdrawal by Subject|0|||
170555838|NCT05142306|616383069|FG001|Overall Study|Withdrawal by Subject|0|||
170555839|NCT05142306|616383070|FG002|Overall Study|Withdrawal by Subject|1|||
170555840|NCT02251041|616383071|FG000|Overall Study|Did not receive intervention|15|||
170555841|NCT02251041|616383072|FG001|Overall Study|Did not receive intervention|4|||
170555842|NCT00803049|616383073|FG000|Overall Study|Adverse Event|21|||
170555843|NCT00803049|616383074|FG001|Overall Study|Adverse Event|33|||
170555844|NCT00803049|616383075|FG002|Overall Study|Adverse Event|13|||
170555845|NCT00803049|616383076|FG003|Overall Study|Adverse Event|27|||
170555846|NCT00803049|616383073|FG000|Overall Study|Lack of Efficacy|10|||
170555847|NCT00803049|616383074|FG001|Overall Study|Lack of Efficacy|19|||
170555848|NCT00803049|616383075|FG002|Overall Study|Lack of Efficacy|6|||
170555849|NCT00803049|616383076|FG003|Overall Study|Lack of Efficacy|13|||
170806620|NCT03732807|617301539|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
170806621|NCT03732807|617301540|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
170555850|NCT00803049|616383073|FG000|Overall Study|Lost to Follow-up|0|||
170555851|NCT00803049|616383074|FG001|Overall Study|Lost to Follow-up|2|||
170555852|NCT00803049|616383075|FG002|Overall Study|Lost to Follow-up|0|||
170555853|NCT00803049|616383076|FG003|Overall Study|Lost to Follow-up|3|||
170555854|NCT00803049|616383073|FG000|Overall Study|Death|2|||
170555855|NCT00803049|616383074|FG001|Overall Study|Death|1|||
170555856|NCT00803049|616383075|FG002|Overall Study|Death|0|||
170555857|NCT00803049|616383076|FG003|Overall Study|Death|2|||
170555858|NCT00803049|616383073|FG000|Overall Study|Progressive Disease|6|||
170555859|NCT00803049|616383074|FG001|Overall Study|Progressive Disease|10|||
170905250|NCT01309737|617656055|FG002|Week 16 to 52|Death|0|||
170806622|NCT03732807|617301541|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
170806623|NCT03732807|617301542|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
170555860|NCT00803049|616383075|FG002|Overall Study|Progressive Disease|6|||
170555861|NCT00803049|616383076|FG003|Overall Study|Progressive Disease|6|||
170555862|NCT00803049|616383073|FG000|Overall Study|Withdrawal by Subject|19|||
170555863|NCT00803049|616383074|FG001|Overall Study|Withdrawal by Subject|43|||
170555864|NCT00803049|616383075|FG002|Overall Study|Withdrawal by Subject|16|||
170555865|NCT00803049|616383076|FG003|Overall Study|Withdrawal by Subject|44|||
170555866|NCT00803049|616383073|FG000|Overall Study|Protocol Violation|0|||
170555867|NCT00803049|616383074|FG001|Overall Study|Protocol Violation|1|||
170555868|NCT00803049|616383075|FG002|Overall Study|Protocol Violation|1|||
170555869|NCT00803049|616383076|FG003|Overall Study|Protocol Violation|0|||
170555870|NCT00803049|616383073|FG000|Overall Study|Randomized and Not Treated|0|||
170555871|NCT00803049|616383074|FG001|Overall Study|Randomized and Not Treated|0|||
170555872|NCT00803049|616383075|FG002|Overall Study|Randomized and Not Treated|0|||
170555873|NCT00803049|616383076|FG003|Overall Study|Randomized and Not Treated|2|||
170555874|NCT00803049|616383073|FG000|Overall Study|Other than Specified Above|3|||
170555875|NCT00803049|616383074|FG001|Overall Study|Other than Specified Above|9|||
170555876|NCT00803049|616383075|FG002|Overall Study|Other than Specified Above|2|||
170555877|NCT00803049|616383076|FG003|Overall Study|Other than Specified Above|5|||
170555878|NCT04126174|616383079|FG000|Overall Study|Lost to Follow-up|3|||
170555879|NCT04126174|616383080|FG001|Overall Study|Lost to Follow-up|3|||
170555880|NCT03773562|616383091|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
170555881|NCT03773562|616383091|FG000|Overall Study|Lost to Follow-up|10|||
170555882|NCT03773562|616383091|FG000|Overall Study|Withdrawal by Subject|1|||
170555883|NCT03131479|616383092|FG000|Overall Study|Adverse Event|0|||
170555884|NCT03131479|616383093|FG001|Overall Study|Adverse Event|0|||
170555885|NCT03131479|616383094|FG002|Overall Study|Adverse Event|1|||
170555886|NCT03131479|616383095|FG003|Overall Study|Adverse Event|1|||
170555887|NCT03131479|616383096|FG004|Overall Study|Adverse Event|0|||
170555888|NCT03131479|616383092|FG000|Overall Study|Subject/Guardian Decision|0|||
170555889|NCT03131479|616383093|FG001|Overall Study|Subject/Guardian Decision|0|||
170555890|NCT03131479|616383094|FG002|Overall Study|Subject/Guardian Decision|0|||
170555891|NCT03131479|616383095|FG003|Overall Study|Subject/Guardian Decision|1|||
170555892|NCT03131479|616383096|FG004|Overall Study|Subject/Guardian Decision|0|||
170555893|NCT01272219|616383097|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
170555894|NCT01272219|616383098|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
170555895|NCT01272219|616383099|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
170555896|NCT01272219|616383100|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
170555897|NCT01272219|616383101|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
170555898|NCT01272219|616383102|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
170555899|NCT01272219|616383097|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
170555900|NCT01272219|616383098|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
170555901|NCT01272219|616383099|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
170555902|NCT01272219|616383100|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
170555903|NCT01272219|616383101|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
170555904|NCT01272219|616383102|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
170555905|NCT01272219|616383097|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
170555906|NCT01272219|616383098|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
170555907|NCT01272219|616383099|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
170555908|NCT01272219|616383100|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
170555909|NCT01272219|616383101|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
170555910|NCT01272219|616383102|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
170555911|NCT01272219|616383097|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
170555912|NCT01272219|616383098|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
170555913|NCT01272219|616383099|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
170555914|NCT01272219|616383100|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
170555915|NCT01272219|616383101|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
170555916|NCT01272219|616383102|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
170555917|NCT01272219|616383097|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
170555918|NCT01272219|616383098|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
170555919|NCT01272219|616383099|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
170555920|NCT01272219|616383100|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
170555921|NCT01272219|616383101|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
170555922|NCT01272219|616383102|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
170555923|NCT01272219|616383097|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
170555924|NCT01272219|616383098|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
170555925|NCT01272219|616383099|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
170555926|NCT01272219|616383100|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
170555927|NCT01272219|616383101|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
170555928|NCT01272219|616383102|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
170555929|NCT01272219|616383097|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
170806624|NCT03732807|617301536|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
170806625|NCT03732807|617301537|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
170806626|NCT03732807|617301538|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
170806627|NCT03732807|617301539|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
170806628|NCT03732807|617301540|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
170806629|NCT03732807|617301541|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
170806630|NCT03732807|617301542|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
170806631|NCT03732807|617301536|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
170806632|NCT03732807|617301537|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
170806633|NCT03732807|617301538|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
170806634|NCT03732807|617301539|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
170806635|NCT03732807|617301540|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
170806636|NCT03732807|617301541|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
170806637|NCT03732807|617301542|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
170806638|NCT00999596|617301546|FG000|Overall Study|Statistical population not required|101|||
170806639|NCT04693637|617301548|FG000|Overall Study|Death|4|||
170806640|NCT04693637|617301548|FG000|Overall Study|Withdrawal by Subject|3|||
170806641|NCT04693637|617301548|FG000|Overall Study|Physician Decision|2|||
170806642|NCT04693637|617301548|FG000|Overall Study|Lost to Follow-up|1|||
170806643|NCT04885998|617301551|FG000|Overall Study|Withdrawal by Subject|0|||
170806644|NCT04885998|617301552|FG001|Overall Study|Withdrawal by Subject|2|||
170806645|NCT04885998|617301553|FG002|Overall Study|Withdrawal by Subject|0|||
170806646|NCT04885998|617301554|FG003|Overall Study|Withdrawal by Subject|3|||
170806647|NCT04885998|617301551|FG000|Overall Study|Lost to Follow-up|1|||
170806648|NCT04885998|617301552|FG001|Overall Study|Lost to Follow-up|1|||
170806649|NCT04885998|617301553|FG002|Overall Study|Lost to Follow-up|0|||
170806650|NCT04885998|617301554|FG003|Overall Study|Lost to Follow-up|0|||
170806651|NCT04885998|617301551|FG000|Overall Study|Death|2|||
170806652|NCT04885998|617301552|FG001|Overall Study|Death|1|||
170806653|NCT04885998|617301553|FG002|Overall Study|Death|2|||
170806654|NCT04885998|617301554|FG003|Overall Study|Death|2|||
170806655|NCT04885998|617301551|FG000|Overall Study|Decision by sponsor|1|||
170806656|NCT04885998|617301552|FG001|Overall Study|Decision by sponsor|1|||
170806657|NCT04885998|617301553|FG002|Overall Study|Decision by sponsor|0|||
170806658|NCT04885998|617301554|FG003|Overall Study|Decision by sponsor|0|||
170806659|NCT05260437|617301555|FG000|Overall Study|Lost to Follow-up|5|||
170806660|NCT05260437|617301556|FG001|Overall Study|Lost to Follow-up|2|||
170806661|NCT05260437|617301557|FG002|Overall Study|Lost to Follow-up|1|||
170806662|NCT05260437|617301558|FG003|Overall Study|Lost to Follow-up|2|||
170806663|NCT05260437|617301559|FG004|Overall Study|Lost to Follow-up|2|||
170806664|NCT05260437|617301555|FG000|Overall Study|Withdrawal by Subject|3|||
170806665|NCT05260437|617301556|FG001|Overall Study|Withdrawal by Subject|0|||
170806666|NCT05260437|617301557|FG002|Overall Study|Withdrawal by Subject|4|||
170806667|NCT05260437|617301558|FG003|Overall Study|Withdrawal by Subject|5|||
170806668|NCT05260437|617301559|FG004|Overall Study|Withdrawal by Subject|0|||
170806669|NCT05260437|617301555|FG000|Overall Study|Vaccine Not Administered|0|||
170806670|NCT05260437|617301556|FG001|Overall Study|Vaccine Not Administered|1|||
170806671|NCT05260437|617301557|FG002|Overall Study|Vaccine Not Administered|0|||
170806672|NCT05260437|617301558|FG003|Overall Study|Vaccine Not Administered|0|||
170806673|NCT05260437|617301559|FG004|Overall Study|Vaccine Not Administered|0|||
170806674|NCT00195819|617301560|FG000|Double-Blind|Withdrawal by Subject|1|||
170806675|NCT00195819|617301561|FG001|Double-Blind|Withdrawal by Subject|0|||
170806676|NCT00195819|617301560|FG000|Double-Blind|Moved|1|||
170644876|NCT02660983|616713902|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
170644877|NCT02660983|616713901|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
170644878|NCT02660983|616713902|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
170644879|NCT02660983|616713901|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
170644880|NCT02660983|616713902|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
170644881|NCT02660983|616713901|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
170644882|NCT02660983|616713902|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
170644883|NCT00334113|616713904|FG000|Overall Study|Lost to Follow-up|2|||
170644884|NCT00334113|616713905|FG001|Overall Study|Lost to Follow-up|2|||
170806677|NCT00195819|617301561|FG001|Double-Blind|Moved|0|||
170806678|NCT00195819|617301560|FG000|Open-label|Adverse Event|0|||
170806679|NCT00195819|617301561|FG001|Open-label|Adverse Event|9|||
170806680|NCT00195819|617301560|FG000|Open-label|Lack of Efficacy|0|||
170806681|NCT00195819|617301561|FG001|Open-label|Lack of Efficacy|2|||
170806682|NCT00195819|617301560|FG000|Open-label|Pregnancy|0|||
170806683|NCT00195819|617301561|FG001|Open-label|Pregnancy|1|||
170806684|NCT00195819|617301560|FG000|Open-label|Protocol Violation|0|||
170806685|NCT00195819|617301561|FG001|Open-label|Protocol Violation|2|||
170806686|NCT00195819|617301560|FG000|Open-label|Moved|0|||
170644885|NCT00334113|616713904|FG000|Overall Study|Withdrawal by Subject|0|||
170555930|NCT01272219|616383098|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
170555931|NCT01272219|616383099|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
170555932|NCT01272219|616383100|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
170555933|NCT01272219|616383101|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
170555934|NCT01272219|616383102|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
170555935|NCT01272219|616383097|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
170555936|NCT01272219|616383098|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
170555937|NCT01272219|616383099|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
170555938|NCT01272219|616383100|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
170555939|NCT01272219|616383101|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
170555940|NCT01272219|616383102|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
170555941|NCT01272219|616383097|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
170555942|NCT01272219|616383098|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
170555943|NCT01272219|616383099|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
170555944|NCT01272219|616383100|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
170555945|NCT01272219|616383101|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
170555946|NCT01272219|616383102|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
170555947|NCT01272219|616383097|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
170555948|NCT01272219|616383098|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
170555949|NCT01272219|616383099|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
170555950|NCT01272219|616383100|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
170555951|NCT01272219|616383101|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
170555952|NCT01272219|616383102|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
170555953|NCT01272219|616383097|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
170555954|NCT01272219|616383098|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
170555955|NCT01272219|616383099|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
170555956|NCT01272219|616383100|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
170555957|NCT01272219|616383101|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
170555958|NCT01272219|616383102|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
170555959|NCT01272219|616383097|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
170555960|NCT01272219|616383098|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
170555961|NCT01272219|616383099|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
170555962|NCT01272219|616383100|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
170555963|NCT01272219|616383101|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
170555964|NCT01272219|616383102|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
170555965|NCT01272219|616383097|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
170555966|NCT01272219|616383098|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
170555967|NCT01272219|616383099|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
170555968|NCT01272219|616383100|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
170555969|NCT01272219|616383101|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
170555970|NCT01272219|616383102|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
170555971|NCT01272219|616383097|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
170555972|NCT01272219|616383098|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
170555973|NCT01272219|616383099|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
170555974|NCT01272219|616383100|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
170555975|NCT01272219|616383101|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
170555976|NCT01272219|616383102|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
170555977|NCT01272219|616383097|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
170555978|NCT01272219|616383098|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
170555979|NCT01272219|616383099|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
170555980|NCT01272219|616383100|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
170555981|NCT01272219|616383101|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
170555982|NCT01272219|616383102|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
170555983|NCT01272219|616383097|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
170555984|NCT01272219|616383098|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
170555985|NCT01272219|616383099|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
170555986|NCT01272219|616383100|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
170555987|NCT01272219|616383101|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
170555988|NCT01272219|616383102|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
170555989|NCT04439903|616383103|FG000|Overall Study|Withdrawal by Subject|2|||
170555990|NCT04439903|616383103|FG000|Overall Study|Screen Failure|1|||
170555991|NCT02181413|616383104|FG000|Overall Study|Withdrawal by Subject|45|||
170555992|NCT02181413|616383105|FG001|Overall Study|Withdrawal by Subject|61|||
170555993|NCT02181413|616383104|FG000|Overall Study|Reason Not Specified|2|||
170555994|NCT02181413|616383105|FG001|Overall Study|Reason Not Specified|5|||
170555995|NCT02181413|616383104|FG000|Overall Study|Lost to Follow-up|8|||
170555996|NCT02181413|616383105|FG001|Overall Study|Lost to Follow-up|7|||
170555997|NCT02298946|616383107|FG000|Overall Study|Did not receive treatment|2|||
170555998|NCT02298946|616383108|FG001|Overall Study|Did not receive treatment|0|||
170555999|NCT02298946|616383107|FG000|Overall Study|Unevaluable|2|||
170556000|NCT02298946|616383108|FG001|Overall Study|Unevaluable|1|||
170556001|NCT03204812|616383109|FG000|Overall Study|Adverse Event|3|||
170556002|NCT03973489|616383110|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
170556003|NCT03973489|616383111|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
170556004|NCT03973489|616383112|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
170556005|NCT03973489|616383113|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
170556006|NCT03973489|616383114|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
170556007|NCT03973489|616383115|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
170556008|NCT03973489|616383116|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
170556009|NCT03973489|616383117|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
170556010|NCT03973489|616383110|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
170556011|NCT03973489|616383111|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
170556012|NCT03973489|616383112|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
170556013|NCT03973489|616383113|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
170556014|NCT03973489|616383114|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
170556015|NCT03973489|616383115|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
170556016|NCT03973489|616383116|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
170556017|NCT03973489|616383117|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
170556018|NCT03973489|616383110|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
170556019|NCT03973489|616383111|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
170556020|NCT03973489|616383112|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
170556021|NCT03973489|616383113|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
170556022|NCT03973489|616383114|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
170556023|NCT03973489|616383115|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
170556024|NCT03973489|616383116|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
170556025|NCT03973489|616383117|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
170556026|NCT03973489|616383110|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
170556027|NCT03973489|616383111|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
170556028|NCT03973489|616383112|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
170556029|NCT03973489|616383113|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
170556030|NCT03973489|616383114|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
170556031|NCT03973489|616383115|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
170556032|NCT03973489|616383116|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
170556033|NCT03973489|616383117|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
170556034|NCT03973489|616383110|FG000|Second Intervention (1 Day)|Adverse Event|0|||
170556035|NCT03973489|616383111|FG001|Second Intervention (1 Day)|Adverse Event|0|||
170556036|NCT03973489|616383112|FG002|Second Intervention (1 Day)|Adverse Event|0|||
170556037|NCT03973489|616383113|FG003|Second Intervention (1 Day)|Adverse Event|1|||
170556038|NCT03973489|616383114|FG004|Second Intervention (1 Day)|Adverse Event|0|||
170556039|NCT03973489|616383115|FG005|Second Intervention (1 Day)|Adverse Event|0|||
170556040|NCT03973489|616383116|FG006|Second Intervention (1 Day)|Adverse Event|0|||
170556041|NCT03973489|616383117|FG007|Second Intervention (1 Day)|Adverse Event|0|||
170556042|NCT03301415|616383118|FG000|Overall Study|Lost to Follow-up|2|||
170556043|NCT03301415|616383118|FG000|Overall Study|Unable to comply with visit schedule|2|||
170556044|NCT00392288|616383119|FG000|Overall Study|Adverse Event|17|||
170556045|NCT00392288|616383120|FG001|Overall Study|Adverse Event|7|||
170556046|NCT00392288|616383121|FG002|Overall Study|Adverse Event|8|||
170556047|NCT00392288|616383119|FG000|Overall Study|Lack of Efficacy|8|||
170556048|NCT00392288|616383120|FG001|Overall Study|Lack of Efficacy|5|||
170556049|NCT00392288|616383121|FG002|Overall Study|Lack of Efficacy|3|||
170556050|NCT00392288|616383119|FG000|Overall Study|Protocol Violation|1|||
170556051|NCT00392288|616383120|FG001|Overall Study|Protocol Violation|3|||
170556052|NCT00392288|616383121|FG002|Overall Study|Protocol Violation|1|||
170556053|NCT00392288|616383119|FG000|Overall Study|Lost to Follow-up|1|||
170556054|NCT00392288|616383120|FG001|Overall Study|Lost to Follow-up|1|||
170556055|NCT00392288|616383121|FG002|Overall Study|Lost to Follow-up|1|||
170556056|NCT00392288|616383119|FG000|Overall Study|Withdrawal by Subject|1|||
170556057|NCT00392288|616383120|FG001|Overall Study|Withdrawal by Subject|0|||
170556058|NCT00392288|616383121|FG002|Overall Study|Withdrawal by Subject|2|||
170556059|NCT00392288|616383119|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
170556060|NCT00392288|616383120|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
170556061|NCT00392288|616383121|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
170556062|NCT00392288|616383119|FG000|Overall Study|Other|3|||
170556063|NCT00392288|616383120|FG001|Overall Study|Other|4|||
170556064|NCT00392288|616383121|FG002|Overall Study|Other|1|||
170556065|NCT02544763|616383122|FG000|Overall Study|Adverse Event|8|||
170556066|NCT02544763|616383123|FG001|Overall Study|Adverse Event|8|||
170556067|NCT02544763|616383124|FG002|Overall Study|Adverse Event|0|||
170556068|NCT02544763|616383122|FG000|Overall Study|Withdrawn by parent/guardian|1|||
170556069|NCT02544763|616383123|FG001|Overall Study|Withdrawn by parent/guardian|1|||
170556070|NCT02544763|616383124|FG002|Overall Study|Withdrawn by parent/guardian|1|||
170556071|NCT02544763|616383122|FG000|Overall Study|Met withdrawal criteria|0|||
170556072|NCT02544763|616383123|FG001|Overall Study|Met withdrawal criteria|2|||
170556073|NCT02544763|616383124|FG002|Overall Study|Met withdrawal criteria|0|||
170556074|NCT02544763|616383122|FG000|Overall Study|Physician Decision|0|||
170556075|NCT02544763|616383123|FG001|Overall Study|Physician Decision|1|||
170556076|NCT02544763|616383124|FG002|Overall Study|Physician Decision|0|||
170556077|NCT02544763|616383122|FG000|Overall Study|Difficulties taking IMP|1|||
170556078|NCT02544763|616383123|FG001|Overall Study|Difficulties taking IMP|0|||
170556079|NCT02544763|616383124|FG002|Overall Study|Difficulties taking IMP|0|||
170556080|NCT01111552|616383125|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
170556081|NCT01111552|616383126|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
170556082|NCT01111552|616383127|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
170556083|NCT01111552|616383128|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
170556084|NCT01111552|616383129|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
170556085|NCT01111552|616383125|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
170556086|NCT01111552|616383126|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
170556087|NCT01111552|616383127|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
170556088|NCT01111552|616383128|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
170556089|NCT01111552|616383129|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
170556090|NCT01111552|616383125|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
170556091|NCT01111552|616383126|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
170556092|NCT01111552|616383127|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
170556093|NCT01111552|616383128|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
170556094|NCT01111552|616383129|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
170556095|NCT01111552|616383125|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
170556096|NCT01111552|616383126|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
170556097|NCT01111552|616383127|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
170556098|NCT01111552|616383128|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
170556099|NCT01111552|616383129|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
170556100|NCT01111552|616383125|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
170556101|NCT01111552|616383126|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
170556102|NCT01111552|616383127|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
170556103|NCT01111552|616383128|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
170556104|NCT01111552|616383129|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
170556105|NCT01111552|616383125|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
170556106|NCT01111552|616383126|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
170556107|NCT01111552|616383127|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
170556108|NCT01111552|616383128|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
170556109|NCT01111552|616383129|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
170556110|NCT01111552|616383125|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
170556111|NCT01111552|616383126|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
170556112|NCT01111552|616383127|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
170556113|NCT01111552|616383128|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
170556114|NCT01111552|616383129|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
170556115|NCT01111552|616383125|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
170556116|NCT01111552|616383126|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
170556117|NCT01111552|616383127|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
170556118|NCT01111552|616383128|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
170556119|NCT01111552|616383129|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
170556120|NCT01111552|616383125|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170556121|NCT01111552|616383126|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170556122|NCT01111552|616383127|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170806687|NCT00195819|617301561|FG001|Open-label|Moved|1|||
170806688|NCT00195819|617301560|FG000|Open-label|Withdrawal by Subject|0|||
170806689|NCT00195819|617301561|FG001|Open-label|Withdrawal by Subject|5|||
170806690|NCT03298087|617301567|FG000|Overall Study|Withdrawal by Subject|4|||
170806691|NCT00229658|617301576|FG000|Overall Study|Administrative|2|||
170556123|NCT01111552|616383128|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
170556124|NCT01111552|616383129|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170556125|NCT01111552|616383125|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
170556126|NCT01111552|616383126|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
170556127|NCT01111552|616383127|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
170806692|NCT00229658|617301577|FG001|Overall Study|Administrative|1|||
170806693|NCT00229658|617301576|FG000|Overall Study|Investigator decision|13|||
170806694|NCT00229658|617301577|FG001|Overall Study|Investigator decision|10|||
170806695|NCT00229658|617301576|FG000|Overall Study|Other|80|||
170806696|NCT00229658|617301577|FG001|Overall Study|Other|60|||
170806697|NCT00229658|617301576|FG000|Overall Study|Lost to Follow-up|82|||
170806698|NCT00229658|617301577|FG001|Overall Study|Lost to Follow-up|55|||
170806699|NCT00229658|617301576|FG000|Overall Study|Serious Adverse Event|2|||
170806700|NCT00229658|617301577|FG001|Overall Study|Serious Adverse Event|2|||
170806701|NCT00229658|617301576|FG000|Overall Study|Withdrawal of consent|46|||
170806702|NCT00229658|617301577|FG001|Overall Study|Withdrawal of consent|39|||
170806703|NCT00093496|617301578|FG000|Overall Study|Protocol Violation|1|||
170556128|NCT01111552|616383128|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
170556129|NCT01111552|616383129|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
170556130|NCT01111552|616383125|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
170556131|NCT01111552|616383126|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
170556132|NCT01111552|616383127|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
170556133|NCT01111552|616383128|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
170556134|NCT01111552|616383129|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
170556135|NCT01111552|616383125|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
170556136|NCT01111552|616383126|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
170556137|NCT01111552|616383127|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
170556138|NCT01111552|616383128|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
170556139|NCT01111552|616383129|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
170556140|NCT01111552|616383125|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
170556141|NCT01111552|616383126|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
170556142|NCT01111552|616383127|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
170556143|NCT01111552|616383128|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
170556144|NCT01111552|616383129|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
170556145|NCT01111552|616383125|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
170556146|NCT01111552|616383126|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
170556147|NCT01111552|616383127|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
170556148|NCT01111552|616383128|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
170556149|NCT01111552|616383129|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
170644886|NCT00334113|616713905|FG001|Overall Study|Withdrawal by Subject|1|||
170644887|NCT02509026|616713906|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
170644888|NCT02509026|616713906|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
170644889|NCT02509026|616713906|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
170644890|NCT02509026|616713906|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
170644891|NCT02509026|616713906|FG000|Induction Period (24 Weeks)|Other|2|||
170644892|NCT02509026|616713906|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
170806704|NCT00093496|617301579|FG001|Overall Study|Protocol Violation|3|||
170806705|NCT01953224|617301583|FG000|Overall Study|Lost to Follow-up|1|||
170556150|NCT01852214|616383130|FG000|Period 1|Adverse Event|1|||
170556151|NCT01852214|616383131|FG001|Period 1|Adverse Event|2|||
170556152|NCT01852214|616383130|FG000|Period 1|Withdrawal by Subject|0|||
170556153|NCT01852214|616383131|FG001|Period 1|Withdrawal by Subject|1|||
170556154|NCT01852214|616383130|FG000|Washout Period|Withdrawal by Subject|0|||
170556155|NCT01852214|616383131|FG001|Washout Period|Withdrawal by Subject|1|||
170556156|NCT00421408|616383132|FG000|Overall Study|Lost to Follow-up|30|||
170556157|NCT00421408|616383133|FG001|Overall Study|Lost to Follow-up|20|||
170556158|NCT00421408|616383132|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
170556159|NCT00421408|616383133|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
170556160|NCT04091438|616383134|FG000|Treatment Period 1 (1 Day)|Other|1|||
170556161|NCT04091438|616383135|FG001|Treatment Period 1 (1 Day)|Other|0|||
170556162|NCT04091438|616383134|FG000|Washout Period (1 Day)|Protocol deviation|0|||
170556163|NCT04091438|616383135|FG001|Washout Period (1 Day)|Protocol deviation|1|||
170556164|NCT04091438|616383134|FG000|Washout Period (1 Day)|Other|0|||
170556165|NCT04091438|616383135|FG001|Washout Period (1 Day)|Other|1|||
170556166|NCT04105725|616383136|FG000|Primary Intervention|Lost to Follow-up|0|||
170556167|NCT04105725|616383137|FG001|Primary Intervention|Lost to Follow-up|2|||
170556168|NCT04105725|616383136|FG000|Primary Intervention|Withdrawal by Subject|0|||
170556169|NCT04105725|616383137|FG001|Primary Intervention|Withdrawal by Subject|1|||
170556170|NCT04309500|616383143|FG000|Overall Study|Lost to Follow-up|1|||
170556171|NCT04309500|616383144|FG001|Overall Study|Lost to Follow-up|0|||
170806706|NCT01953224|617301584|FG001|Overall Study|Lost to Follow-up|1|||
170806707|NCT01953224|617301583|FG000|Overall Study|Withdrawal by Subject|1|||
170556172|NCT04309500|616383145|FG002|Overall Study|Lost to Follow-up|0|||
170556173|NCT04309500|616383146|FG003|Overall Study|Lost to Follow-up|0|||
170556174|NCT00553475|616383147|FG000|Overall Study|Adverse Event|7|||
170556175|NCT00553475|616383148|FG001|Overall Study|Adverse Event|17|||
170644893|NCT02509026|616713906|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
170556176|NCT00553475|616383149|FG002|Overall Study|Adverse Event|13|||
170556177|NCT00553475|616383147|FG000|Overall Study|Lack of Efficacy|7|||
170556178|NCT00553475|616383148|FG001|Overall Study|Lack of Efficacy|1|||
170556179|NCT00553475|616383149|FG002|Overall Study|Lack of Efficacy|0|||
170556180|NCT00553475|616383147|FG000|Overall Study|Withdrawal by Subject|1|||
170556181|NCT00553475|616383148|FG001|Overall Study|Withdrawal by Subject|1|||
170556182|NCT00553475|616383149|FG002|Overall Study|Withdrawal by Subject|0|||
170556183|NCT00553475|616383147|FG000|Overall Study|Physician Decision|1|||
170556184|NCT00553475|616383148|FG001|Overall Study|Physician Decision|0|||
170556185|NCT00553475|616383149|FG002|Overall Study|Physician Decision|0|||
170556186|NCT00553475|616383147|FG000|Overall Study|Due to moving|0|||
170556187|NCT00553475|616383148|FG001|Overall Study|Due to moving|1|||
170556188|NCT00553475|616383149|FG002|Overall Study|Due to moving|0|||
170556189|NCT00913835|616383150|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
170556190|NCT00913835|616383151|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
170556191|NCT00913835|616383150|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
170556192|NCT00913835|616383151|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
170556193|NCT00913835|616383150|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
170556194|NCT00913835|616383151|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
170556195|NCT00913835|616383150|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
170556196|NCT00913835|616383151|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
170556197|NCT00913835|616383150|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
170556198|NCT00913835|616383151|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
170556199|NCT00773461|616383152|FG000|Overall Study|Adverse Event|1|||
170556200|NCT00773461|616383153|FG001|Overall Study|Adverse Event|3|||
170556201|NCT00773461|616383152|FG000|Overall Study|Withdrawal by Subject|4|||
170556202|NCT00773461|616383153|FG001|Overall Study|Withdrawal by Subject|1|||
170556203|NCT00637156|616383154|FG000|Overall Study|Withdrawal by Subject|0|||
170556204|NCT00637156|616383155|FG001|Overall Study|Withdrawal by Subject|7|||
170556205|NCT00637156|616383154|FG000|Overall Study|Death|0|||
170556206|NCT00637156|616383155|FG001|Overall Study|Death|1|||
170556207|NCT00637156|616383154|FG000|Overall Study|Lost to Follow-up|10|||
170556208|NCT00637156|616383155|FG001|Overall Study|Lost to Follow-up|16|||
170556209|NCT02679274|616383156|FG000|Overall Study|Withdrawal by Subject|1|||
170556210|NCT02679274|616383157|FG001|Overall Study|Withdrawal by Subject|0|||
170556211|NCT03193437|616383164|FG000|Overall Study|Adverse Event|4|||
170556212|NCT03193437|616383164|FG000|Overall Study|Withdrawal by Subject|2|||
170556213|NCT03193437|616383164|FG000|Overall Study|Disease Progression|2|||
170556214|NCT04976855|616383165|FG000|Part I|Withdrawal by Subject|0|||
170556215|NCT04976855|616383166|FG001|Part I|Withdrawal by Subject|1|||
170556216|NCT04976855|616383167|FG002|Part I|Withdrawal by Subject|0|||
170556217|NCT04976855|616383168|FG003|Part I|Withdrawal by Subject|0|||
170556218|NCT04976855|616383169|FG004|Part I|Withdrawal by Subject|0|||
170556219|NCT04976855|616383170|FG005|Part I|Withdrawal by Subject|0|||
170556220|NCT04976855|616383171|FG006|Part I|Withdrawal by Subject|0|||
170556221|NCT04976855|616383165|FG000|Part II|Adverse Event|0|||
170556222|NCT04976855|616383166|FG001|Part II|Adverse Event|0|||
170556223|NCT04976855|616383167|FG002|Part II|Adverse Event|0|||
170556224|NCT04976855|616383168|FG003|Part II|Adverse Event|1|||
170556225|NCT04976855|616383169|FG004|Part II|Adverse Event|0|||
170556226|NCT04976855|616383170|FG005|Part II|Adverse Event|0|||
170556227|NCT04976855|616383171|FG006|Part II|Adverse Event|0|||
170556228|NCT04976855|616383165|FG000|Part II|Withdrawal by Subject|0|||
170556229|NCT04976855|616383166|FG001|Part II|Withdrawal by Subject|0|||
170556230|NCT04976855|616383167|FG002|Part II|Withdrawal by Subject|0|||
170556231|NCT04976855|616383168|FG003|Part II|Withdrawal by Subject|0|||
170556232|NCT04976855|616383169|FG004|Part II|Withdrawal by Subject|1|||
170644894|NCT02509026|616713906|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
170644895|NCT02509026|616713906|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
170644896|NCT02509026|616713906|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
170556233|NCT04976855|616383170|FG005|Part II|Withdrawal by Subject|0|||
170556234|NCT04976855|616383171|FG006|Part II|Withdrawal by Subject|0|||
170556235|NCT04976855|616383165|FG000|Part II|Lost to Follow-up|0|||
170556236|NCT04976855|616383166|FG001|Part II|Lost to Follow-up|0|||
170644897|NCT02509026|616713906|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
170644898|NCT02509026|616713906|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
170644899|NCT02509026|616713906|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
170556237|NCT04976855|616383167|FG002|Part II|Lost to Follow-up|0|||
170556238|NCT04976855|616383168|FG003|Part II|Lost to Follow-up|0|||
170556239|NCT04976855|616383169|FG004|Part II|Lost to Follow-up|0|||
170556240|NCT04976855|616383170|FG005|Part II|Lost to Follow-up|1|||
170556241|NCT04976855|616383171|FG006|Part II|Lost to Follow-up|0|||
170556242|NCT02038036|616383172|FG000|Core Study|Adverse Event|7|||
170556243|NCT02038036|616383173|FG001|Core Study|Adverse Event|7|||
170556244|NCT02038036|616383172|FG000|Core Study|Death|1|||
170556245|NCT02038036|616383173|FG001|Core Study|Death|1|||
170556246|NCT02038036|616383172|FG000|Core Study|Disease progression|2|||
170556247|NCT02038036|616383173|FG001|Core Study|Disease progression|2|||
170644900|NCT00243841|616713908|FG000|Overall Study|Physician Decision|0|||
170556248|NCT02038036|616383172|FG000|Core Study|Lost to Follow-up|0|||
170556249|NCT02038036|616383173|FG001|Core Study|Lost to Follow-up|1|||
170556250|NCT02038036|616383172|FG000|Core Study|Physician Decision|2|||
170556251|NCT02038036|616383173|FG001|Core Study|Physician Decision|1|||
170556252|NCT02038036|616383172|FG000|Core Study|Subject/guardian decision|0|||
170556253|NCT02038036|616383173|FG001|Core Study|Subject/guardian decision|1|||
170556254|NCT02038036|616383172|FG000|Core Study|Withdrawal by Subject|3|||
170556255|NCT02038036|616383173|FG001|Core Study|Withdrawal by Subject|1|||
170556256|NCT02038036|616383172|FG000|Crossover Period|Withdrawal by Subject|0|||
170556257|NCT02038036|616383173|FG001|Crossover Period|Withdrawal by Subject|3|||
170556258|NCT02038036|616383172|FG000|Crossover Period|Adverse Event|0|||
170556259|NCT02038036|616383173|FG001|Crossover Period|Adverse Event|9|||
170556260|NCT02038036|616383172|FG000|Crossover Period|Death|0|||
170556261|NCT02038036|616383173|FG001|Crossover Period|Death|2|||
170556262|NCT02038036|616383172|FG000|Crossover Period|Disease progression|0|||
170556263|NCT02038036|616383173|FG001|Crossover Period|Disease progression|3|||
170556264|NCT02038036|616383172|FG000|Crossover Period|Lost to Follow-up|0|||
170556265|NCT02038036|616383173|FG001|Crossover Period|Lost to Follow-up|1|||
170556266|NCT02038036|616383172|FG000|Crossover Period|Physician Decision|0|||
170556267|NCT02038036|616383173|FG001|Crossover Period|Physician Decision|2|||
170556268|NCT00908141|616383176|FG000|Overall Study|Withdrawal by Subject|0|||
170556269|NCT00908141|616383177|FG001|Overall Study|Withdrawal by Subject|1|||
170806708|NCT01953224|617301584|FG001|Overall Study|Withdrawal by Subject|2|||
170806709|NCT00586313|617301585|FG000|Overall Study|Lack of Efficacy|2|||
170806710|NCT03205566|617301592|FG000|Phase 1|Protocol Violation|1|||
170806711|NCT03205566|617301593|FG001|Phase 1|Protocol Violation|1|||
170806712|NCT03739866|617301595|FG000|Overall Study|Lost to Follow-up|0|||
170806713|NCT03739866|617301596|FG001|Overall Study|Lost to Follow-up|0|||
170806714|NCT03739866|617301597|FG002|Overall Study|Lost to Follow-up|0|||
170806715|NCT03739866|617301598|FG003|Overall Study|Lost to Follow-up|1|||
170806716|NCT03739866|617301599|FG004|Overall Study|Lost to Follow-up|0|||
170806717|NCT03739866|617301600|FG005|Overall Study|Lost to Follow-up|0|||
170806718|NCT03739866|617301601|FG006|Overall Study|Lost to Follow-up|0|||
170806719|NCT03739866|617301602|FG007|Overall Study|Lost to Follow-up|0|||
170806720|NCT03739866|617301595|FG000|Overall Study|Enrolled but not treated|0|||
170806721|NCT03739866|617301596|FG001|Overall Study|Enrolled but not treated|0|||
170806722|NCT03739866|617301597|FG002|Overall Study|Enrolled but not treated|1|||
170806723|NCT03739866|617301598|FG003|Overall Study|Enrolled but not treated|0|||
170806724|NCT03739866|617301599|FG004|Overall Study|Enrolled but not treated|1|||
170806725|NCT03739866|617301600|FG005|Overall Study|Enrolled but not treated|0|||
170806726|NCT03739866|617301601|FG006|Overall Study|Enrolled but not treated|0|||
170806727|NCT03739866|617301602|FG007|Overall Study|Enrolled but not treated|0|||
170806728|NCT00853580|617301603|FG000|Overall Study|Lost to Follow-up|3|||
170806729|NCT00853580|617301604|FG001|Overall Study|Lost to Follow-up|5|||
170806730|NCT00853580|617301603|FG000|Overall Study|Protocol Violation|2|||
170806731|NCT00853580|617301604|FG001|Overall Study|Protocol Violation|1|||
170806732|NCT00853580|617301603|FG000|Overall Study|Withdrawal by Subject|2|||
170806733|NCT00853580|617301604|FG001|Overall Study|Withdrawal by Subject|8|||
170806734|NCT00853580|617301603|FG000|Overall Study|Commenced contraindicated therapy|0|||
170806735|NCT00853580|617301604|FG001|Overall Study|Commenced contraindicated therapy|2|||
170806736|NCT01034306|617301605|FG000|Overall Study|Adverse Event|1|||
170806737|NCT01034306|617301606|FG001|Overall Study|Adverse Event|0|||
170806738|NCT01034306|617301605|FG000|Overall Study|Lost to Follow-up|0|||
170806739|NCT01034306|617301606|FG001|Overall Study|Lost to Follow-up|1|||
170806740|NCT01034306|617301605|FG000|Overall Study|Withdrawal by Subject|2|||
170806741|NCT01034306|617301606|FG001|Overall Study|Withdrawal by Subject|2|||
170806742|NCT01034306|617301605|FG000|Overall Study|hospitalized and decided to stop|1|||
170806743|NCT01034306|617301606|FG001|Overall Study|hospitalized and decided to stop|0|||
170806744|NCT01034306|617301605|FG000|Overall Study|Noncomplience|1|||
170806745|NCT01034306|617301606|FG001|Overall Study|Noncomplience|0|||
170806746|NCT03057600|617301607|FG000|Overall Study|Adverse Event|0|||
170806747|NCT03057600|617301608|FG001|Overall Study|Adverse Event|0|||
170806748|NCT03057600|617301609|FG002|Overall Study|Adverse Event|4|||
170806749|NCT03057600|617301610|FG003|Overall Study|Adverse Event|0|||
170806750|NCT03057600|617301607|FG000|Overall Study|Radiologic Disease Progression|8|||
170806751|NCT03057600|617301608|FG001|Overall Study|Radiologic Disease Progression|7|||
170806752|NCT03057600|617301609|FG002|Overall Study|Radiologic Disease Progression|13|||
170806753|NCT03057600|617301610|FG003|Overall Study|Radiologic Disease Progression|10|||
170806754|NCT03057600|617301607|FG000|Overall Study|Symptomatic Deterioration|0|||
170806755|NCT03057600|617301608|FG001|Overall Study|Symptomatic Deterioration|1|||
170806756|NCT03057600|617301609|FG002|Overall Study|Symptomatic Deterioration|1|||
170806757|NCT03057600|617301610|FG003|Overall Study|Symptomatic Deterioration|0|||
170806758|NCT03057600|617301607|FG000|Overall Study|Investigator Decision|0|||
170806759|NCT03057600|617301608|FG001|Overall Study|Investigator Decision|0|||
170806760|NCT03057600|617301609|FG002|Overall Study|Investigator Decision|1|||
170806761|NCT03057600|617301610|FG003|Overall Study|Investigator Decision|0|||
170806762|NCT03057600|617301607|FG000|Overall Study|Study Termination by Sponsor|0|||
170806763|NCT03057600|617301608|FG001|Overall Study|Study Termination by Sponsor|0|||
170806764|NCT03057600|617301609|FG002|Overall Study|Study Termination by Sponsor|0|||
170806765|NCT03057600|617301610|FG003|Overall Study|Study Termination by Sponsor|2|||
170806766|NCT03057600|617301607|FG000|Overall Study|Withdrawal by Subject|0|||
170806767|NCT03057600|617301608|FG001|Overall Study|Withdrawal by Subject|1|||
170806768|NCT03057600|617301609|FG002|Overall Study|Withdrawal by Subject|0|||
170806769|NCT03057600|617301610|FG003|Overall Study|Withdrawal by Subject|0|||
170806770|NCT03057600|617301607|FG000|Overall Study|Other, Not Specified|1|||
170806771|NCT03057600|617301608|FG001|Overall Study|Other, Not Specified|1|||
170806772|NCT03057600|617301609|FG002|Overall Study|Other, Not Specified|1|||
170806773|NCT03057600|617301610|FG003|Overall Study|Other, Not Specified|1|||
170806774|NCT02384382|617301611|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
170806775|NCT02384382|617301611|FG000|Overall Study|Death|1|||
170806776|NCT02384382|617301611|FG000|Overall Study|Adverse Event|1|||
170806777|NCT02384382|617301611|FG000|Overall Study|Disease progression|16|||
170806778|NCT01953692|617301612|FG000|Overall Study|Adverse Event|5|||
170806779|NCT01953692|617301613|FG001|Overall Study|Adverse Event|2|||
170806780|NCT01953692|617301614|FG002|Overall Study|Adverse Event|4|||
170806781|NCT01953692|617301615|FG003|Overall Study|Adverse Event|2|||
170806782|NCT01953692|617301616|FG004|Overall Study|Adverse Event|1|||
170806783|NCT01953692|617301617|FG005|Overall Study|Adverse Event|2|||
170806784|NCT01953692|617301618|FG006|Overall Study|Adverse Event|0|||
170806785|NCT01953692|617301619|FG007|Overall Study|Adverse Event|0|||
170644901|NCT00243841|616713909|FG001|Overall Study|Physician Decision|0|||
170644902|NCT00243841|616713910|FG002|Overall Study|Physician Decision|1|||
170644903|NCT00243841|616713911|FG003|Overall Study|Physician Decision|0|||
170644904|NCT00243841|616713912|FG004|Overall Study|Physician Decision|0|||
170644905|NCT00243841|616713913|FG005|Overall Study|Physician Decision|2|||
170644906|NCT00363545|616713914|FG000|Overall Study|Serious Adverse Event|0|||
170644907|NCT00363545|616713915|FG001|Overall Study|Serious Adverse Event|1|||
170644908|NCT00363545|616713914|FG000|Overall Study|Withdrawal by Subject|12|||
170644909|NCT00363545|616713915|FG001|Overall Study|Withdrawal by Subject|15|||
170644910|NCT00363545|616713914|FG000|Overall Study|Migrated/moved from study area|3|||
170644911|NCT00363545|616713915|FG001|Overall Study|Migrated/moved from study area|6|||
170644912|NCT00363545|616713914|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
170644913|NCT00363545|616713915|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
170644914|NCT00363545|616713914|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
170644915|NCT00363545|616713915|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
170644916|NCT00363545|616713914|FG000|Overall Study|Others|1|||
170644917|NCT00363545|616713915|FG001|Overall Study|Others|0|||
170644918|NCT00721968|616713916|FG000|Overall Study|Lost to Follow-up|2|||
170644919|NCT00721968|616713917|FG001|Overall Study|Lost to Follow-up|0|||
170644920|NCT04303195|616713918|FG000|Overall Study|Adverse Event|1|||
170644921|NCT04303195|616713919|FG001|Overall Study|Adverse Event|3|||
170644922|NCT04303195|616713920|FG002|Overall Study|Adverse Event|7|||
170644923|NCT04303195|616713921|FG003|Overall Study|Adverse Event|0|||
170644924|NCT04303195|616713918|FG000|Overall Study|Lost to Follow-up|1|||
170644925|NCT04303195|616713919|FG001|Overall Study|Lost to Follow-up|0|||
170644926|NCT04303195|616713920|FG002|Overall Study|Lost to Follow-up|1|||
170644927|NCT04303195|616713921|FG003|Overall Study|Lost to Follow-up|4|||
170644928|NCT04303195|616713918|FG000|Overall Study|Withdrawal by Subject|3|||
170644929|NCT04303195|616713919|FG001|Overall Study|Withdrawal by Subject|1|||
170644930|NCT04303195|616713920|FG002|Overall Study|Withdrawal by Subject|1|||
170644931|NCT04303195|616713921|FG003|Overall Study|Withdrawal by Subject|1|||
170644932|NCT04303195|616713918|FG000|Overall Study|No study drug administered or protocol deviation|0|||
170806786|NCT01953692|617301620|FG008|Overall Study|Adverse Event|0|||
170806787|NCT01953692|617301612|FG000|Overall Study|Clinical Progression|0|||
170806788|NCT01953692|617301613|FG001|Overall Study|Clinical Progression|15|||
170806789|NCT01953692|617301614|FG002|Overall Study|Clinical Progression|7|||
170806790|NCT01953692|617301615|FG003|Overall Study|Clinical Progression|5|||
170806791|NCT01953692|617301616|FG004|Overall Study|Clinical Progression|0|||
170806792|NCT01953692|617301617|FG005|Overall Study|Clinical Progression|7|||
170806793|NCT01953692|617301618|FG006|Overall Study|Clinical Progression|20|||
170806794|NCT01953692|617301619|FG007|Overall Study|Clinical Progression|3|||
170806795|NCT01953692|617301620|FG008|Overall Study|Clinical Progression|3|||
170806796|NCT01953692|617301612|FG000|Overall Study|Death|5|||
170806797|NCT01953692|617301613|FG001|Overall Study|Death|0|||
170806798|NCT01953692|617301614|FG002|Overall Study|Death|2|||
170806799|NCT01953692|617301615|FG003|Overall Study|Death|2|||
170806800|NCT01953692|617301616|FG004|Overall Study|Death|1|||
170806801|NCT01953692|617301617|FG005|Overall Study|Death|3|||
170806802|NCT01953692|617301618|FG006|Overall Study|Death|6|||
170806803|NCT01953692|617301619|FG007|Overall Study|Death|2|||
170806804|NCT01953692|617301620|FG008|Overall Study|Death|1|||
170806805|NCT01953692|617301612|FG000|Overall Study|Excluded Medication|1|||
170806806|NCT01953692|617301613|FG001|Overall Study|Excluded Medication|0|||
170644933|NCT04303195|616713919|FG001|Overall Study|No study drug administered or protocol deviation|2|||
170644934|NCT04303195|616713920|FG002|Overall Study|No study drug administered or protocol deviation|0|||
170644935|NCT04303195|616713921|FG003|Overall Study|No study drug administered or protocol deviation|2|||
170644936|NCT01064947|616713922|FG000|Overall Study|negative culture|41|||
170644937|NCT02970942|616713923|FG000|Overall Study|Death|0|||
170806807|NCT01953692|617301614|FG002|Overall Study|Excluded Medication|0|||
170806808|NCT01953692|617301615|FG003|Overall Study|Excluded Medication|0|||
170806809|NCT01953692|617301616|FG004|Overall Study|Excluded Medication|0|||
170806810|NCT01953692|617301617|FG005|Overall Study|Excluded Medication|0|||
170644938|NCT02970942|616713924|FG001|Overall Study|Death|1|||
170644939|NCT02970942|616713925|FG002|Overall Study|Death|0|||
170644940|NCT02970942|616713926|FG003|Overall Study|Death|0|||
170644941|NCT02970942|616713923|FG000|Overall Study|Lost to Follow-up|1|||
170644942|NCT02970942|616713924|FG001|Overall Study|Lost to Follow-up|0|||
170644943|NCT02970942|616713925|FG002|Overall Study|Lost to Follow-up|2|||
170644944|NCT02970942|616713926|FG003|Overall Study|Lost to Follow-up|1|||
170644945|NCT02970942|616713923|FG000|Overall Study|Withdrawal by Subject|3|||
170644946|NCT02970942|616713924|FG001|Overall Study|Withdrawal by Subject|5|||
170905251|NCT01309737|617656056|FG003|Week 16 to 52|Death|0|||
170905252|NCT01309737|617656057|FG004|Week 16 to 52|Death|1|||
170905253|NCT01309737|617656053|FG000|Week 16 to 52|Adverse Event|7|||
170905254|NCT01309737|617656054|FG001|Week 16 to 52|Adverse Event|7|||
170806811|NCT01953692|617301618|FG006|Overall Study|Excluded Medication|0|||
170806812|NCT01953692|617301619|FG007|Overall Study|Excluded Medication|0|||
170806813|NCT01953692|617301620|FG008|Overall Study|Excluded Medication|0|||
170806814|NCT01953692|617301612|FG000|Overall Study|Lost to Follow-up|1|||
170806815|NCT01953692|617301613|FG001|Overall Study|Lost to Follow-up|0|||
170806816|NCT01953692|617301614|FG002|Overall Study|Lost to Follow-up|3|||
170806817|NCT01953692|617301615|FG003|Overall Study|Lost to Follow-up|1|||
170556585|NCT05551117|616385208|FG000|Overall Study|Death|23|||
170556586|NCT05551117|616385209|FG001|Overall Study|Death|20|||
170556587|NCT05551117|616385210|FG002|Overall Study|Death|0|||
170556588|NCT05551117|616385211|FG003|Overall Study|Death|2|||
170556589|NCT05551117|616385208|FG000|Overall Study|Lost to Follow-up|1|||
170556590|NCT05551117|616385209|FG001|Overall Study|Lost to Follow-up|1|||
170556591|NCT05551117|616385210|FG002|Overall Study|Lost to Follow-up|0|||
170556592|NCT05551117|616385211|FG003|Overall Study|Lost to Follow-up|0|||
170556593|NCT05551117|616385208|FG000|Overall Study|Withdrawal by Subject|9|||
170556594|NCT05551117|616385209|FG001|Overall Study|Withdrawal by Subject|13|||
170556595|NCT05551117|616385210|FG002|Overall Study|Withdrawal by Subject|4|||
170556596|NCT05551117|616385211|FG003|Overall Study|Withdrawal by Subject|0|||
170556597|NCT05551117|616385208|FG000|Overall Study|Elected to receive vobramitamab duocarmazine after protocol amendment 2.|0|||
170556598|NCT05551117|616385209|FG001|Overall Study|Elected to receive vobramitamab duocarmazine after protocol amendment 2.|0|||
170556599|NCT05551117|616385210|FG002|Overall Study|Elected to receive vobramitamab duocarmazine after protocol amendment 2.|1|||
170556600|NCT05551117|616385211|FG003|Overall Study|Elected to receive vobramitamab duocarmazine after protocol amendment 2.|0|||
170806818|NCT01953692|617301616|FG004|Overall Study|Lost to Follow-up|0|||
170806819|NCT01953692|617301617|FG005|Overall Study|Lost to Follow-up|1|||
170644947|NCT02970942|616713925|FG002|Overall Study|Withdrawal by Subject|3|||
170644948|NCT02970942|616713926|FG003|Overall Study|Withdrawal by Subject|2|||
170556615|NCT04175106|616385222|FG000|Overall Study|Discontinued intervention (COVID-19)|2|||
170556616|NCT04175106|616385222|FG000|Overall Study|Non-compliance|3|||
170556617|NCT04175106|616385222|FG000|Overall Study|Lost to Follow-up|1|||
170556618|NCT04175106|616385222|FG000|Overall Study|Lack of Availability|3|||
170556619|NCT04175106|616385222|FG000|Overall Study|Discomfort|2|||
170644949|NCT01065454|616713929|FG000|Treatment|Adverse Event|7|||
170644950|NCT01065454|616713930|FG001|Treatment|Adverse Event|4|||
170644951|NCT01065454|616713931|FG002|Treatment|Adverse Event|3|||
170644952|NCT01065454|616713932|FG003|Treatment|Adverse Event|6|||
170644953|NCT01065454|616713929|FG000|Treatment|Death|1|||
170644954|NCT01065454|616713930|FG001|Treatment|Death|0|||
170644955|NCT01065454|616713931|FG002|Treatment|Death|0|||
170556720|NCT03393975|616385257|FG000|Urgent Treatment Period|Physician Decision|0|||
170556721|NCT03393975|616385258|FG001|Urgent Treatment Period|Physician Decision|0|||
170556722|NCT03393975|616385259|FG002|Urgent Treatment Period|Physician Decision|0|||
170556723|NCT03393975|616385260|FG003|Urgent Treatment Period|Physician Decision|1|||
170556724|NCT03393975|616385257|FG000|Prophylaxis Period 1|Reason not Specified|0|||
170556725|NCT03393975|616385258|FG001|Prophylaxis Period 1|Reason not Specified|1|||
170556726|NCT03393975|616385259|FG002|Prophylaxis Period 1|Reason not Specified|0|||
170556727|NCT03393975|616385260|FG003|Prophylaxis Period 1|Reason not Specified|0|||
170556728|NCT03393975|616385257|FG000|Prophylaxis Period 2|Reason not Specified|0|||
170556729|NCT03393975|616385258|FG001|Prophylaxis Period 2|Reason not Specified|1|||
170556730|NCT03393975|616385259|FG002|Prophylaxis Period 2|Reason not Specified|0|||
170556731|NCT03393975|616385260|FG003|Prophylaxis Period 2|Reason not Specified|0|||
170556734|NCT04850846|616385264|FG000|Overall Study|Withdrawal by Subject|1|||
170556735|NCT04850846|616385265|FG001|Overall Study|Withdrawal by Subject|2|||
170556736|NCT04850846|616385264|FG000|Overall Study|Adverse Event|3|||
170556737|NCT04850846|616385265|FG001|Overall Study|Adverse Event|1|||
170556738|NCT04850846|616385264|FG000|Overall Study|Subject stopped taking medication|2|||
170644956|NCT01065454|616713932|FG003|Treatment|Death|0|||
170644957|NCT01065454|616713929|FG000|Treatment|Non-compliance|1|||
170556739|NCT04850846|616385265|FG001|Overall Study|Subject stopped taking medication|4|||
170556740|NCT04850846|616385264|FG000|Overall Study|Other|2|||
170556741|NCT04850846|616385265|FG001|Overall Study|Other|0|||
170644958|NCT01065454|616713930|FG001|Treatment|Non-compliance|0|||
170556761|NCT06060977|616385277|FG000|Overall Study|Withdrawal by Subject|1|||
170556762|NCT06060977|616385278|FG001|Overall Study|Withdrawal by Subject|0|||
170644959|NCT01065454|616713931|FG002|Treatment|Non-compliance|0|||
170644960|NCT01065454|616713932|FG003|Treatment|Non-compliance|1|||
170644961|NCT01065454|616713929|FG000|Treatment|Protocol Decision|0|||
170644962|NCT01065454|616713930|FG001|Treatment|Protocol Decision|0|||
170644963|NCT01065454|616713931|FG002|Treatment|Protocol Decision|3|||
170644964|NCT01065454|616713932|FG003|Treatment|Protocol Decision|2|||
170644965|NCT01065454|616713929|FG000|Treatment|Protocol Violation|1|||
170644966|NCT01065454|616713930|FG001|Treatment|Protocol Violation|0|||
170644967|NCT01065454|616713931|FG002|Treatment|Protocol Violation|1|||
170644968|NCT01065454|616713932|FG003|Treatment|Protocol Violation|0|||
170806820|NCT01953692|617301618|FG006|Overall Study|Lost to Follow-up|0|||
170556777|NCT00183625|616385286|FG000|Overall Study|Withdrawal by Subject|18|||
170556778|NCT00183625|616385287|FG001|Overall Study|Withdrawal by Subject|18|||
170556779|NCT00183625|616385288|FG002|Overall Study|Withdrawal by Subject|19|||
170556780|NCT00183625|616385289|FG003|Overall Study|Withdrawal by Subject|14|||
170644969|NCT01065454|616713929|FG000|Treatment|Withdrawal by Subject|3|||
170644970|NCT01065454|616713930|FG001|Treatment|Withdrawal by Subject|1|||
170644971|NCT01065454|616713931|FG002|Treatment|Withdrawal by Subject|2|||
170644972|NCT01065454|616713932|FG003|Treatment|Withdrawal by Subject|3|||
170556802|NCT02357966|616385297|FG000|Overall Study|Death|0|||
170556803|NCT02357966|616385298|FG001|Overall Study|Death|0|||
170556804|NCT02357966|616385299|FG002|Overall Study|Death|1|||
170556805|NCT02357966|616385300|FG003|Overall Study|Death|0|||
170556806|NCT02357966|616385301|FG004|Overall Study|Death|2|||
170556807|NCT02357966|616385302|FG005|Overall Study|Death|0|||
170556808|NCT02357966|616385297|FG000|Overall Study|Physician Decision|1|||
170556809|NCT02357966|616385298|FG001|Overall Study|Physician Decision|0|||
170556810|NCT02357966|616385299|FG002|Overall Study|Physician Decision|0|||
170556811|NCT02357966|616385300|FG003|Overall Study|Physician Decision|0|||
170556812|NCT02357966|616385301|FG004|Overall Study|Physician Decision|1|||
170556813|NCT02357966|616385302|FG005|Overall Study|Physician Decision|0|||
170556829|NCT03349996|616385309|FG000|Overall Study|Adverse Event|5|||
170556830|NCT03349996|616385309|FG000|Overall Study|Death|12|||
170556831|NCT03349996|616385309|FG000|Overall Study|Lost to Follow-up|1|||
170556832|NCT03349996|616385309|FG000|Overall Study|Withdrawal by Subject|9|||
170556833|NCT04432831|616385310|FG000|Overall Study|Withdrawal by Subject|24|||
170556834|NCT04432831|616385311|FG001|Overall Study|Withdrawal by Subject|28|||
170556835|NCT04432831|616385312|FG002|Overall Study|Withdrawal by Subject|21|||
170556836|NCT04432831|616385310|FG000|Overall Study|Death|23|||
170556837|NCT04432831|616385311|FG001|Overall Study|Death|23|||
170556838|NCT04432831|616385312|FG002|Overall Study|Death|17|||
170556839|NCT04432831|616385310|FG000|Overall Study|Lost to Follow-up|15|||
170556840|NCT04432831|616385311|FG001|Overall Study|Lost to Follow-up|15|||
170556841|NCT04432831|616385312|FG002|Overall Study|Lost to Follow-up|12|||
170556842|NCT04432831|616385310|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
170556843|NCT04432831|616385311|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
170556844|NCT04432831|616385312|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
170556845|NCT04432831|616385310|FG000|Overall Study|Reason Not Specified|7|||
170556846|NCT04432831|616385311|FG001|Overall Study|Reason Not Specified|11|||
170556847|NCT04432831|616385312|FG002|Overall Study|Reason Not Specified|9|||
170556848|NCT04432831|616385310|FG000|Overall Study|Adverse Event|7|||
170556849|NCT04432831|616385311|FG001|Overall Study|Adverse Event|7|||
170556850|NCT04432831|616385312|FG002|Overall Study|Adverse Event|7|||
170556851|NCT04432831|616385310|FG000|Overall Study|Physician Decision|1|||
170556852|NCT04432831|616385311|FG001|Overall Study|Physician Decision|3|||
170556853|NCT04432831|616385312|FG002|Overall Study|Physician Decision|6|||
170556854|NCT04432831|616385310|FG000|Overall Study|Protocol Violation|1|||
170556855|NCT04432831|616385311|FG001|Overall Study|Protocol Violation|0|||
170556856|NCT04432831|616385312|FG002|Overall Study|Protocol Violation|2|||
170556857|NCT04432831|616385310|FG000|Overall Study|Pregnancy|0|||
170556858|NCT04432831|616385311|FG001|Overall Study|Pregnancy|1|||
170556859|NCT04432831|616385312|FG002|Overall Study|Pregnancy|0|||
170556860|NCT04432831|616385310|FG000|Overall Study|Lack of Efficacy|0|||
170556861|NCT04432831|616385311|FG001|Overall Study|Lack of Efficacy|0|||
170556862|NCT04432831|616385312|FG002|Overall Study|Lack of Efficacy|2|||
170905255|NCT01309737|617656055|FG002|Week 16 to 52|Adverse Event|0|||
170905256|NCT01309737|617656056|FG003|Week 16 to 52|Adverse Event|6|||
170905257|NCT01309737|617656057|FG004|Week 16 to 52|Adverse Event|5|||
170905258|NCT01309737|617656053|FG000|Week 16 to 52|Lack of Efficacy|107|||
170905259|NCT01309737|617656054|FG001|Week 16 to 52|Lack of Efficacy|76|||
170905260|NCT01309737|617656055|FG002|Week 16 to 52|Lack of Efficacy|0|||
170644973|NCT01065454|616713929|FG000|Follow up|Adverse Event|1|||
170644974|NCT01065454|616713930|FG001|Follow up|Adverse Event|0|||
170644975|NCT01065454|616713931|FG002|Follow up|Adverse Event|0|||
170644976|NCT01065454|616713932|FG003|Follow up|Adverse Event|1|||
170644977|NCT01065454|616713929|FG000|Follow up|Death|0|||
170644978|NCT01065454|616713930|FG001|Follow up|Death|1|||
170644979|NCT01065454|616713931|FG002|Follow up|Death|1|||
170644980|NCT01065454|616713932|FG003|Follow up|Death|0|||
170644981|NCT01065454|616713929|FG000|Follow up|Lost to Follow-up|0|||
170644982|NCT01065454|616713930|FG001|Follow up|Lost to Follow-up|0|||
170644983|NCT01065454|616713931|FG002|Follow up|Lost to Follow-up|0|||
170644984|NCT01065454|616713932|FG003|Follow up|Lost to Follow-up|1|||
170644985|NCT01065454|616713929|FG000|Follow up|Progressive disease|0|||
170644986|NCT01065454|616713930|FG001|Follow up|Progressive disease|0|||
170644987|NCT01065454|616713931|FG002|Follow up|Progressive disease|0|||
170644988|NCT01065454|616713932|FG003|Follow up|Progressive disease|1|||
170644989|NCT01065454|616713929|FG000|Follow up|Withdrawal by Subject|1|||
170644990|NCT01065454|616713930|FG001|Follow up|Withdrawal by Subject|1|||
170644991|NCT01065454|616713931|FG002|Follow up|Withdrawal by Subject|1|||
170644992|NCT01065454|616713932|FG003|Follow up|Withdrawal by Subject|0|||
170644993|NCT01065454|616713929|FG000|Follow up|study ongoing|37|||
170644994|NCT01065454|616713930|FG001|Follow up|study ongoing|22|||
170644995|NCT01065454|616713931|FG002|Follow up|study ongoing|15|||
170644996|NCT01065454|616713932|FG003|Follow up|study ongoing|41|||
170644997|NCT04614324|616713933|FG000|Overall Study|Lost to Follow-up|3|||
170644998|NCT04614324|616713933|FG000|Overall Study|Physician Decision|1|||
170644999|NCT04614324|616713933|FG000|Overall Study|Withdrawal by Subject|2|||
170645000|NCT04614324|616713933|FG000|Overall Study|Remaining in Follow up|123|||
170645001|NCT03137069|616715825|FG000|Overall Study|Withdrawal by Subject|1|||
170645002|NCT03137069|616715826|FG001|Overall Study|Withdrawal by Subject|2|||
170645003|NCT03137069|616715827|FG002|Overall Study|Withdrawal by Subject|2|||
170645004|NCT03137069|616715828|FG003|Overall Study|Withdrawal by Subject|2|||
170645005|NCT03137069|616715829|FG004|Overall Study|Withdrawal by Subject|0|||
170645006|NCT03137069|616715830|FG005|Overall Study|Withdrawal by Subject|0|||
170645007|NCT03137069|616715825|FG000|Overall Study|Adverse Event|0|||
170645008|NCT03137069|616715826|FG001|Overall Study|Adverse Event|3|||
170645009|NCT03137069|616715827|FG002|Overall Study|Adverse Event|1|||
170645010|NCT03137069|616715828|FG003|Overall Study|Adverse Event|1|||
170645011|NCT03137069|616715829|FG004|Overall Study|Adverse Event|0|||
170645012|NCT03137069|616715830|FG005|Overall Study|Adverse Event|1|||
170645013|NCT03137069|616715825|FG000|Overall Study|Protocol Violation|0|||
170645014|NCT03137069|616715826|FG001|Overall Study|Protocol Violation|1|||
170645015|NCT03137069|616715827|FG002|Overall Study|Protocol Violation|0|||
170645016|NCT03137069|616715828|FG003|Overall Study|Protocol Violation|1|||
170645017|NCT03137069|616715829|FG004|Overall Study|Protocol Violation|1|||
170645018|NCT03137069|616715830|FG005|Overall Study|Protocol Violation|1|||
170645019|NCT03137069|616715825|FG000|Overall Study|Physician Decision|0|||
170645020|NCT03137069|616715826|FG001|Overall Study|Physician Decision|0|||
170645021|NCT03137069|616715827|FG002|Overall Study|Physician Decision|0|||
170645022|NCT03137069|616715828|FG003|Overall Study|Physician Decision|1|||
170905261|NCT01309737|617656056|FG003|Week 16 to 52|Lack of Efficacy|25|||
170645023|NCT03137069|616715829|FG004|Overall Study|Physician Decision|0|||
170645024|NCT03137069|616715830|FG005|Overall Study|Physician Decision|0|||
170645025|NCT03137069|616715825|FG000|Overall Study|Study Terminated by Sponsor|0|||
170645026|NCT03137069|616715826|FG001|Overall Study|Study Terminated by Sponsor|0|||
170645027|NCT03137069|616715827|FG002|Overall Study|Study Terminated by Sponsor|0|||
170556965|NCT05936099|616385343|FG000|Overall Study|Lost to Follow-up|10|||
170556966|NCT05936099|616385344|FG001|Overall Study|Lost to Follow-up|38|||
170645028|NCT03137069|616715828|FG003|Overall Study|Study Terminated by Sponsor|0|||
170806821|NCT01953692|617301619|FG007|Overall Study|Lost to Follow-up|0|||
170645029|NCT03137069|616715829|FG004|Overall Study|Study Terminated by Sponsor|1|||
170645030|NCT03137069|616715830|FG005|Overall Study|Study Terminated by Sponsor|0|||
170645031|NCT03137069|616715825|FG000|Overall Study|Data Entry Error|0|||
170645032|NCT03137069|616715826|FG001|Overall Study|Data Entry Error|0|||
170645033|NCT03137069|616715827|FG002|Overall Study|Data Entry Error|0|||
170645034|NCT03137069|616715828|FG003|Overall Study|Data Entry Error|1|||
170645035|NCT03137069|616715829|FG004|Overall Study|Data Entry Error|0|||
170645036|NCT03137069|616715830|FG005|Overall Study|Data Entry Error|0|||
170645037|NCT02043899|616715831|FG000|Overall Study|Adverse Event|3|||
170645038|NCT02043899|616715831|FG000|Overall Study|Physician Decision|1|||
170645039|NCT02043899|616715831|FG000|Overall Study|Withdrawal by Subject|2|||
170645040|NCT02043899|616715831|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
170645041|NCT02043899|616715831|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
170645042|NCT02043899|616715831|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
170645043|NCT02043899|616715831|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
170645044|NCT02043899|616715831|FG000|Overall Study|Treatment delayed|1|||
170645045|NCT00362180|616715832|FG000|Treated Period|Withdrawal by Subject|1|||
170645046|NCT00362180|616715833|FG001|Treated Period|Withdrawal by Subject|0|||
170645047|NCT00362180|616715834|FG002|Treated Period|Withdrawal by Subject|0|||
170645048|NCT00362180|616715835|FG003|Treated Period|Withdrawal by Subject|0|||
170645049|NCT00362180|616715836|FG004|Treated Period|Withdrawal by Subject|0|||
170645050|NCT00362180|616715837|FG005|Treated Period|Withdrawal by Subject|0|||
170645051|NCT00362180|616715838|FG006|Treated Period|Withdrawal by Subject|0|||
170645052|NCT00362180|616715839|FG007|Treated Period|Withdrawal by Subject|0|||
170645053|NCT00362180|616715840|FG008|Treated Period|Withdrawal by Subject|0|||
170645054|NCT00362180|616715832|FG000|Treated Period|Adverse Event|0|||
170645055|NCT00362180|616715833|FG001|Treated Period|Adverse Event|0|||
170645056|NCT00362180|616715834|FG002|Treated Period|Adverse Event|0|||
170645057|NCT00362180|616715835|FG003|Treated Period|Adverse Event|0|||
170645058|NCT00362180|616715836|FG004|Treated Period|Adverse Event|0|||
170645059|NCT00362180|616715837|FG005|Treated Period|Adverse Event|1|||
170645060|NCT00362180|616715838|FG006|Treated Period|Adverse Event|0|||
170645061|NCT00362180|616715839|FG007|Treated Period|Adverse Event|1|||
170645062|NCT00362180|616715840|FG008|Treated Period|Adverse Event|0|||
170645063|NCT00877773|616715843|FG000|Overall Study|Disease Progression|44|||
170645064|NCT00422513|616715846|FG000|Overall Study|Lack of Efficacy|4|||
170645065|NCT00422513|616715847|FG001|Overall Study|Lack of Efficacy|5|||
170645066|NCT00422513|616715846|FG000|Overall Study|Protocol Violation|23|||
170645067|NCT00422513|616715847|FG001|Overall Study|Protocol Violation|7|||
170645068|NCT00422513|616715846|FG000|Overall Study|Refused Treatment|4|||
170645069|NCT00422513|616715847|FG001|Overall Study|Refused Treatment|2|||
170645070|NCT00422513|616715846|FG000|Overall Study|Withdrawal by Subject|2|||
170645071|NCT00422513|616715847|FG001|Overall Study|Withdrawal by Subject|1|||
170645072|NCT00422513|616715846|FG000|Overall Study|early termination of the study|67|||
170645073|NCT00422513|616715847|FG001|Overall Study|early termination of the study|80|||
170645074|NCT00422513|616715846|FG000|Overall Study|Adverse Event|4|||
170645075|NCT00422513|616715847|FG001|Overall Study|Adverse Event|4|||
170645076|NCT00422513|616715846|FG000|Overall Study|Death|3|||
170645077|NCT00422513|616715847|FG001|Overall Study|Death|7|||
170645078|NCT02267317|616715853|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
170806822|NCT01953692|617301620|FG008|Overall Study|Lost to Follow-up|0|||
170557502|NCT05577702|616387504|FG000|Overall Study|Study Ended by Sponsor|19|||
170557503|NCT05577702|616387505|FG001|Overall Study|Study Ended by Sponsor|17|||
170557504|NCT05577702|616387506|FG002|Overall Study|Study Ended by Sponsor|19|||
170557505|NCT05577702|616387507|FG003|Overall Study|Study Ended by Sponsor|16|||
170557506|NCT05577702|616387508|FG004|Overall Study|Study Ended by Sponsor|38|||
170557507|NCT05577702|616387504|FG000|Overall Study|Death|1|||
170557508|NCT05577702|616387505|FG001|Overall Study|Death|2|||
170557509|NCT05577702|616387506|FG002|Overall Study|Death|1|||
170557510|NCT05577702|616387507|FG003|Overall Study|Death|3|||
170557511|NCT05577702|616387508|FG004|Overall Study|Death|2|||
170557512|NCT05577702|616387504|FG000|Overall Study|Withdrawal by Subject|0|||
170557513|NCT05577702|616387505|FG001|Overall Study|Withdrawal by Subject|1|||
170557514|NCT05577702|616387506|FG002|Overall Study|Withdrawal by Subject|0|||
170557515|NCT05577702|616387507|FG003|Overall Study|Withdrawal by Subject|1|||
170557516|NCT05577702|616387508|FG004|Overall Study|Withdrawal by Subject|1|||
170557517|NCT03375047|616387515|FG000|Overall Study|Pregnancy|0|||
170557518|NCT03375047|616387516|FG001|Overall Study|Pregnancy|0|||
170557519|NCT03375047|616387517|FG002|Overall Study|Pregnancy|1|||
170557520|NCT03375047|616387518|FG003|Overall Study|Pregnancy|0|||
170557521|NCT03375047|616387519|FG004|Overall Study|Pregnancy|0|||
170557522|NCT03375047|616387520|FG005|Overall Study|Pregnancy|0|||
170557523|NCT03375047|616387521|FG006|Overall Study|Pregnancy|0|||
170557524|NCT03375047|616387522|FG007|Overall Study|Pregnancy|0|||
170557525|NCT03375047|616387523|FG008|Overall Study|Pregnancy|0|||
170557526|NCT03375047|616387524|FG009|Overall Study|Pregnancy|0|||
170557527|NCT03375047|616387525|FG010|Overall Study|Pregnancy|0|||
170557528|NCT03375047|616387526|FG011|Overall Study|Pregnancy|0|||
170557529|NCT03375047|616387515|FG000|Overall Study|Adverse Event|0|||
170557530|NCT03375047|616387516|FG001|Overall Study|Adverse Event|0|||
170557531|NCT03375047|616387517|FG002|Overall Study|Adverse Event|0|||
170557532|NCT03375047|616387518|FG003|Overall Study|Adverse Event|0|||
170557533|NCT03375047|616387519|FG004|Overall Study|Adverse Event|0|||
170557534|NCT03375047|616387520|FG005|Overall Study|Adverse Event|0|||
170557535|NCT03375047|616387521|FG006|Overall Study|Adverse Event|0|||
170557536|NCT03375047|616387522|FG007|Overall Study|Adverse Event|1|||
170557537|NCT03375047|616387523|FG008|Overall Study|Adverse Event|0|||
170557538|NCT03375047|616387524|FG009|Overall Study|Adverse Event|0|||
170557539|NCT03375047|616387525|FG010|Overall Study|Adverse Event|0|||
170557540|NCT03375047|616387526|FG011|Overall Study|Adverse Event|0|||
170557541|NCT03375047|616387515|FG000|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557542|NCT03375047|616387516|FG001|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557543|NCT03375047|616387517|FG002|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170806823|NCT01953692|617301612|FG000|Overall Study|Physician Decision|11|||
170806824|NCT01953692|617301613|FG001|Overall Study|Physician Decision|4|||
170557544|NCT03375047|616387518|FG003|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557545|NCT03375047|616387519|FG004|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557546|NCT03375047|616387520|FG005|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557547|NCT03375047|616387521|FG006|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557548|NCT03375047|616387522|FG007|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557549|NCT03375047|616387523|FG008|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557550|NCT03375047|616387524|FG009|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|1|||
170557551|NCT03375047|616387525|FG010|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557552|NCT03375047|616387526|FG011|Overall Study|Site closure due to Coronavirus disease 2019 pandemic|0|||
170557576|NCT04332653|616387536|FG000|Phase 1b|Death|1|||
170557577|NCT04332653|616387537|FG001|Phase 1b|Death|1|||
170557578|NCT04332653|616387538|FG002|Phase 1b|Death|1|||
170557579|NCT04332653|616387539|FG003|Phase 1b|Death|0|||
170557580|NCT04332653|616387540|FG004|Phase 1b|Death|0|||
170557581|NCT04332653|616387541|FG005|Phase 1b|Death|0|||
170557582|NCT04332653|616387542|FG006|Phase 1b|Death|0|||
170557583|NCT04332653|616387543|FG007|Phase 1b|Death|0|||
170557584|NCT04332653|616387544|FG008|Phase 1b|Death|0|||
170557585|NCT04332653|616387545|FG009|Phase 1b|Death|0|||
170557586|NCT04332653|616387546|FG010|Phase 1b|Death|0|||
170557587|NCT04332653|616387536|FG000|Phase 1b|Lost to Follow-up|0|||
170557588|NCT04332653|616387537|FG001|Phase 1b|Lost to Follow-up|0|||
170557589|NCT04332653|616387538|FG002|Phase 1b|Lost to Follow-up|1|||
170557590|NCT04332653|616387539|FG003|Phase 1b|Lost to Follow-up|0|||
170557591|NCT04332653|616387540|FG004|Phase 1b|Lost to Follow-up|0|||
170557592|NCT04332653|616387541|FG005|Phase 1b|Lost to Follow-up|0|||
170557593|NCT04332653|616387542|FG006|Phase 1b|Lost to Follow-up|0|||
170557594|NCT04332653|616387543|FG007|Phase 1b|Lost to Follow-up|0|||
170557595|NCT04332653|616387544|FG008|Phase 1b|Lost to Follow-up|0|||
170557596|NCT04332653|616387545|FG009|Phase 1b|Lost to Follow-up|0|||
170557597|NCT04332653|616387546|FG010|Phase 1b|Lost to Follow-up|0|||
170557598|NCT04332653|616387536|FG000|Phase 1b|Progressive Disease|0|||
170557599|NCT04332653|616387537|FG001|Phase 1b|Progressive Disease|2|||
170557600|NCT04332653|616387538|FG002|Phase 1b|Progressive Disease|0|||
170557601|NCT04332653|616387539|FG003|Phase 1b|Progressive Disease|0|||
170557602|NCT04332653|616387540|FG004|Phase 1b|Progressive Disease|0|||
170557603|NCT04332653|616387541|FG005|Phase 1b|Progressive Disease|0|||
170557604|NCT04332653|616387542|FG006|Phase 1b|Progressive Disease|0|||
170557605|NCT04332653|616387543|FG007|Phase 1b|Progressive Disease|0|||
170557606|NCT04332653|616387544|FG008|Phase 1b|Progressive Disease|0|||
170557607|NCT04332653|616387545|FG009|Phase 1b|Progressive Disease|0|||
170557608|NCT04332653|616387546|FG010|Phase 1b|Progressive Disease|0|||
170557609|NCT04332653|616387536|FG000|Phase 1b|Withdrawal by Subject|1|||
170557610|NCT04332653|616387537|FG001|Phase 1b|Withdrawal by Subject|0|||
170557611|NCT04332653|616387538|FG002|Phase 1b|Withdrawal by Subject|4|||
170557612|NCT04332653|616387539|FG003|Phase 1b|Withdrawal by Subject|0|||
170557613|NCT04332653|616387540|FG004|Phase 1b|Withdrawal by Subject|0|||
170557614|NCT04332653|616387541|FG005|Phase 1b|Withdrawal by Subject|0|||
170645079|NCT02267317|616715854|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
170557615|NCT04332653|616387542|FG006|Phase 1b|Withdrawal by Subject|0|||
170557616|NCT04332653|616387543|FG007|Phase 1b|Withdrawal by Subject|0|||
170557617|NCT04332653|616387544|FG008|Phase 1b|Withdrawal by Subject|0|||
170557618|NCT04332653|616387545|FG009|Phase 1b|Withdrawal by Subject|0|||
170557619|NCT04332653|616387546|FG010|Phase 1b|Withdrawal by Subject|0|||
170557620|NCT04332653|616387536|FG000|Phase 2a|Adverse Event|0|||
170557621|NCT04332653|616387537|FG001|Phase 2a|Adverse Event|0|||
170557622|NCT04332653|616387538|FG002|Phase 2a|Adverse Event|0|||
170557623|NCT04332653|616387539|FG003|Phase 2a|Adverse Event|1|||
170557624|NCT04332653|616387540|FG004|Phase 2a|Adverse Event|0|||
170557625|NCT04332653|616387541|FG005|Phase 2a|Adverse Event|0|||
170557626|NCT04332653|616387542|FG006|Phase 2a|Adverse Event|0|||
170557627|NCT04332653|616387543|FG007|Phase 2a|Adverse Event|0|||
170557628|NCT04332653|616387544|FG008|Phase 2a|Adverse Event|0|||
170557629|NCT04332653|616387545|FG009|Phase 2a|Adverse Event|0|||
170557630|NCT04332653|616387546|FG010|Phase 2a|Adverse Event|0|||
170557631|NCT04332653|616387536|FG000|Phase 2a|Death|0|||
170557632|NCT04332653|616387537|FG001|Phase 2a|Death|0|||
170557633|NCT04332653|616387538|FG002|Phase 2a|Death|0|||
170557634|NCT04332653|616387539|FG003|Phase 2a|Death|9|||
170557635|NCT04332653|616387540|FG004|Phase 2a|Death|20|||
170557636|NCT04332653|616387541|FG005|Phase 2a|Death|12|||
170557637|NCT04332653|616387542|FG006|Phase 2a|Death|18|||
170557638|NCT04332653|616387543|FG007|Phase 2a|Death|16|||
170557639|NCT04332653|616387544|FG008|Phase 2a|Death|18|||
170557640|NCT04332653|616387545|FG009|Phase 2a|Death|24|||
170557641|NCT04332653|616387546|FG010|Phase 2a|Death|8|||
170557642|NCT04332653|616387536|FG000|Phase 2a|Lost to Follow-up|0|||
170557643|NCT04332653|616387537|FG001|Phase 2a|Lost to Follow-up|0|||
170557644|NCT04332653|616387538|FG002|Phase 2a|Lost to Follow-up|0|||
170557645|NCT04332653|616387539|FG003|Phase 2a|Lost to Follow-up|1|||
170557646|NCT04332653|616387540|FG004|Phase 2a|Lost to Follow-up|2|||
170557647|NCT04332653|616387541|FG005|Phase 2a|Lost to Follow-up|0|||
170557648|NCT04332653|616387542|FG006|Phase 2a|Lost to Follow-up|0|||
170557649|NCT04332653|616387543|FG007|Phase 2a|Lost to Follow-up|0|||
170557650|NCT04332653|616387544|FG008|Phase 2a|Lost to Follow-up|1|||
170557651|NCT04332653|616387545|FG009|Phase 2a|Lost to Follow-up|1|||
170557652|NCT04332653|616387546|FG010|Phase 2a|Lost to Follow-up|1|||
170557653|NCT04332653|616387536|FG000|Phase 2a|Physician Decision|0|||
170557654|NCT04332653|616387537|FG001|Phase 2a|Physician Decision|0|||
170557655|NCT04332653|616387538|FG002|Phase 2a|Physician Decision|0|||
170557656|NCT04332653|616387539|FG003|Phase 2a|Physician Decision|0|||
170557657|NCT04332653|616387540|FG004|Phase 2a|Physician Decision|0|||
170557658|NCT04332653|616387541|FG005|Phase 2a|Physician Decision|0|||
170557659|NCT04332653|616387542|FG006|Phase 2a|Physician Decision|0|||
170557660|NCT04332653|616387543|FG007|Phase 2a|Physician Decision|0|||
170557661|NCT04332653|616387544|FG008|Phase 2a|Physician Decision|1|||
170557662|NCT04332653|616387545|FG009|Phase 2a|Physician Decision|0|||
170557663|NCT04332653|616387546|FG010|Phase 2a|Physician Decision|0|||
170557664|NCT04332653|616387536|FG000|Phase 2a|Progressive Disease|0|||
170557665|NCT04332653|616387537|FG001|Phase 2a|Progressive Disease|0|||
170557666|NCT04332653|616387538|FG002|Phase 2a|Progressive Disease|0|||
170557667|NCT04332653|616387539|FG003|Phase 2a|Progressive Disease|0|||
170557668|NCT04332653|616387540|FG004|Phase 2a|Progressive Disease|0|||
170557669|NCT04332653|616387541|FG005|Phase 2a|Progressive Disease|0|||
170557670|NCT04332653|616387542|FG006|Phase 2a|Progressive Disease|0|||
170557671|NCT04332653|616387543|FG007|Phase 2a|Progressive Disease|3|||
170557672|NCT04332653|616387544|FG008|Phase 2a|Progressive Disease|0|||
170557673|NCT04332653|616387545|FG009|Phase 2a|Progressive Disease|3|||
170557674|NCT04332653|616387546|FG010|Phase 2a|Progressive Disease|0|||
170557675|NCT04332653|616387536|FG000|Phase 2a|Study Terminated by Sponsor|0|||
170557676|NCT04332653|616387537|FG001|Phase 2a|Study Terminated by Sponsor|0|||
170557677|NCT04332653|616387538|FG002|Phase 2a|Study Terminated by Sponsor|0|||
170557678|NCT04332653|616387539|FG003|Phase 2a|Study Terminated by Sponsor|0|||
170557679|NCT04332653|616387540|FG004|Phase 2a|Study Terminated by Sponsor|1|||
170557680|NCT04332653|616387541|FG005|Phase 2a|Study Terminated by Sponsor|0|||
170557681|NCT04332653|616387542|FG006|Phase 2a|Study Terminated by Sponsor|1|||
170557682|NCT04332653|616387543|FG007|Phase 2a|Study Terminated by Sponsor|3|||
170557683|NCT04332653|616387544|FG008|Phase 2a|Study Terminated by Sponsor|1|||
170557684|NCT04332653|616387545|FG009|Phase 2a|Study Terminated by Sponsor|2|||
170557685|NCT04332653|616387546|FG010|Phase 2a|Study Terminated by Sponsor|0|||
170557686|NCT04332653|616387536|FG000|Phase 2a|Withdrawal by Subject|0|||
170557687|NCT04332653|616387537|FG001|Phase 2a|Withdrawal by Subject|0|||
170557688|NCT04332653|616387538|FG002|Phase 2a|Withdrawal by Subject|0|||
170557689|NCT04332653|616387539|FG003|Phase 2a|Withdrawal by Subject|4|||
170557690|NCT04332653|616387540|FG004|Phase 2a|Withdrawal by Subject|11|||
170557691|NCT04332653|616387541|FG005|Phase 2a|Withdrawal by Subject|5|||
170557692|NCT04332653|616387542|FG006|Phase 2a|Withdrawal by Subject|9|||
170557693|NCT04332653|616387543|FG007|Phase 2a|Withdrawal by Subject|5|||
170557694|NCT04332653|616387544|FG008|Phase 2a|Withdrawal by Subject|11|||
170557695|NCT04332653|616387545|FG009|Phase 2a|Withdrawal by Subject|4|||
170557696|NCT04332653|616387546|FG010|Phase 2a|Withdrawal by Subject|3|||
170557697|NCT04332653|616387536|FG000|Phase 2a|Miscellaneous|0|||
170557698|NCT04332653|616387537|FG001|Phase 2a|Miscellaneous|0|||
170557699|NCT04332653|616387538|FG002|Phase 2a|Miscellaneous|0|||
170557700|NCT04332653|616387539|FG003|Phase 2a|Miscellaneous|1|||
170557701|NCT04332653|616387540|FG004|Phase 2a|Miscellaneous|0|||
170557702|NCT04332653|616387541|FG005|Phase 2a|Miscellaneous|0|||
170557703|NCT04332653|616387542|FG006|Phase 2a|Miscellaneous|1|||
170557704|NCT04332653|616387543|FG007|Phase 2a|Miscellaneous|1|||
170557705|NCT04332653|616387544|FG008|Phase 2a|Miscellaneous|0|||
170557706|NCT04332653|616387545|FG009|Phase 2a|Miscellaneous|0|||
170557707|NCT04332653|616387546|FG010|Phase 2a|Miscellaneous|0|||
170645080|NCT02267317|616715855|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
170565508|NCT02286895|616418550|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
170565509|NCT02286895|616418551|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
170565510|NCT02286895|616418550|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
170565511|NCT02286895|616418551|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
170558043|NCT06545500|616387662|FG000|Overall Study|Adverse Event|0|||
170558044|NCT06545500|616387663|FG001|Overall Study|Adverse Event|0|||
170558045|NCT06545500|616387664|FG002|Overall Study|Adverse Event|0|||
170558046|NCT06545500|616387665|FG003|Overall Study|Adverse Event|1|||
170558047|NCT06545500|616387662|FG000|Overall Study|Lost to Follow-up|0|||
170558048|NCT06545500|616387663|FG001|Overall Study|Lost to Follow-up|0|||
170558049|NCT06545500|616387664|FG002|Overall Study|Lost to Follow-up|0|||
170558050|NCT06545500|616387665|FG003|Overall Study|Lost to Follow-up|1|||
170558051|NCT06545500|616387662|FG000|Overall Study|Not Wanting Further Contact|1|||
170558052|NCT06545500|616387663|FG001|Overall Study|Not Wanting Further Contact|0|||
170558053|NCT06545500|616387664|FG002|Overall Study|Not Wanting Further Contact|0|||
170558054|NCT06545500|616387665|FG003|Overall Study|Not Wanting Further Contact|0|||
170558055|NCT06545500|616387662|FG000|Overall Study|Withdrawal of Consent|1|||
170558056|NCT06545500|616387663|FG001|Overall Study|Withdrawal of Consent|0|||
170558057|NCT06545500|616387664|FG002|Overall Study|Withdrawal of Consent|0|||
170558058|NCT06545500|616387665|FG003|Overall Study|Withdrawal of Consent|0|||
170558059|NCT06545500|616387662|FG000|Overall Study|Withdrawal Due to Hurricane|0|||
170558060|NCT06545500|616387663|FG001|Overall Study|Withdrawal Due to Hurricane|0|||
170558061|NCT06545500|616387664|FG002|Overall Study|Withdrawal Due to Hurricane|1|||
170558062|NCT06545500|616387665|FG003|Overall Study|Withdrawal Due to Hurricane|0|||
170558110|NCT06593587|616388925|FG000|Overall Study|Protocol Violation|1|||
170558111|NCT06593587|616388926|FG001|Overall Study|Protocol Violation|0|||
170558112|NCT06593587|616388925|FG000|Overall Study|Randomized, not vaccinated|1|||
170558113|NCT06593587|616388926|FG001|Overall Study|Randomized, not vaccinated|0|||
170558114|NCT03947684|616388927|FG000|Overall Study|Lost to Follow-up|13|||
170558115|NCT03947684|616388928|FG001|Overall Study|Lost to Follow-up|5|||
170558116|NCT03947684|616388929|FG002|Overall Study|Lost to Follow-up|1|||
170558117|NCT03947684|616388927|FG000|Overall Study|Withdrawal by Subject|11|||
170558118|NCT03947684|616388928|FG001|Overall Study|Withdrawal by Subject|4|||
170558119|NCT03947684|616388929|FG002|Overall Study|Withdrawal by Subject|0|||
170558120|NCT03947684|616388927|FG000|Overall Study|Physician Decision|1|||
170558121|NCT03947684|616388928|FG001|Overall Study|Physician Decision|0|||
170558122|NCT03947684|616388929|FG002|Overall Study|Physician Decision|0|||
170558123|NCT03947684|616388927|FG000|Overall Study|Lack of adherence to study protocol|2|||
170558124|NCT03947684|616388928|FG001|Overall Study|Lack of adherence to study protocol|0|||
170558125|NCT03947684|616388929|FG002|Overall Study|Lack of adherence to study protocol|0|||
170806825|NCT01953692|617301614|FG002|Overall Study|Physician Decision|2|||
170905262|NCT01309737|617656057|FG004|Week 16 to 52|Lack of Efficacy|21|||
170905263|NCT01309737|617656053|FG000|Week 16 to 52|Lost to Follow-up|4|||
170645081|NCT02267317|616715856|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
170558291|NCT00458536|616388973|FG000|Overall Study|Disease progression prior to treatment|7|||
170558292|NCT00458536|616388973|FG000|Overall Study|Unable to make vaccine|3|||
170558293|NCT00458536|616388973|FG000|Overall Study|No measurable disease after surgery|2|||
170558294|NCT00458536|616388973|FG000|Overall Study|Did not have renal cell carcinoma|2|||
170558295|NCT00458536|616388973|FG000|Overall Study|Patient did not have surgery|1|||
170558296|NCT00458536|616388973|FG000|Overall Study|Ineligible due to toxicity|1|||
170558297|NCT00458536|616388973|FG000|Overall Study|Withdrawal by Subject|1|||
170558298|NCT00458536|616388973|FG000|Overall Study|Progressive disease during treatment|2|||
170558311|NCT03820986|616388979|FG000|Overall Study|Death|201|||
170558312|NCT03820986|616388980|FG001|Overall Study|Death|175|||
170558313|NCT03820986|616388979|FG000|Overall Study|Lost to Follow-up|1|||
170558314|NCT03820986|616388980|FG001|Overall Study|Lost to Follow-up|1|||
170558315|NCT03820986|616388979|FG000|Overall Study|Physician Decision|1|||
170558316|NCT03820986|616388980|FG001|Overall Study|Physician Decision|0|||
170558317|NCT03820986|616388979|FG000|Overall Study|Sponsor Decision|122|||
170558318|NCT03820986|616388980|FG001|Overall Study|Sponsor Decision|160|||
170558319|NCT03820986|616388979|FG000|Overall Study|Withdrawal by Subject|9|||
170558320|NCT03820986|616388980|FG001|Overall Study|Withdrawal by Subject|4|||
170558321|NCT05165888|616388988|FG000|Overall Study|Withdrawal by Subject|0|||
170558322|NCT05165888|616388989|FG001|Overall Study|Withdrawal by Subject|1|||
170558353|NCT03567174|616389003|FG000|Overall Study|Death|24|||
170558354|NCT03567174|616389004|FG001|Overall Study|Death|31|||
170558355|NCT03567174|616389003|FG000|Overall Study|Lost to Follow-up|165|||
170558356|NCT03567174|616389004|FG001|Overall Study|Lost to Follow-up|174|||
170905264|NCT01309737|617656054|FG001|Week 16 to 52|Lost to Follow-up|2|||
170905265|NCT01309737|617656055|FG002|Week 16 to 52|Lost to Follow-up|0|||
170905266|NCT01309737|617656056|FG003|Week 16 to 52|Lost to Follow-up|1|||
170558434|NCT03275285|616389829|FG000|Overall Study|Adverse Event|24|||
170558435|NCT03275285|616389830|FG001|Overall Study|Adverse Event|29|||
170558436|NCT03275285|616389829|FG000|Overall Study|Progressive disease|68|||
170558437|NCT03275285|616389830|FG001|Overall Study|Progressive disease|86|||
170558438|NCT03275285|616389829|FG000|Overall Study|Withdrawal by Subject|18|||
170558439|NCT03275285|616389830|FG001|Overall Study|Withdrawal by Subject|21|||
170558440|NCT03275285|616389829|FG000|Overall Study|Treatment extension study|1|||
170558441|NCT03275285|616389830|FG001|Overall Study|Treatment extension study|24|||
170558442|NCT03275285|616389829|FG000|Overall Study|Randomized and not treated|1|||
170558443|NCT03275285|616389830|FG001|Overall Study|Randomized and not treated|2|||
170558444|NCT03275285|616389829|FG000|Overall Study|Study discontinuation|1|||
170558445|NCT03275285|616389830|FG001|Overall Study|Study discontinuation|5|||
170558446|NCT03275285|616389829|FG000|Overall Study|Others|10|||
170558447|NCT03275285|616389830|FG001|Overall Study|Others|12|||
170645082|NCT02267317|616715857|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
170645083|NCT02267317|616715858|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
170645084|NCT02267317|616715853|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
170645085|NCT02267317|616715854|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
170645086|NCT02267317|616715855|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
170645087|NCT02267317|616715856|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
170645088|NCT02267317|616715857|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
170645089|NCT02267317|616715858|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
170645090|NCT02208063|616715862|FG000|Overall Study|Death|3|||
170645091|NCT02208063|616715863|FG001|Overall Study|Death|5|||
170645092|NCT02208063|616715862|FG000|Overall Study|Not Specified in report|3|||
170645093|NCT02208063|616715863|FG001|Overall Study|Not Specified in report|4|||
170645094|NCT02208063|616715862|FG000|Overall Study|Withdrawal by Subject|5|||
170645095|NCT02208063|616715863|FG001|Overall Study|Withdrawal by Subject|2|||
170645096|NCT02208063|616715862|FG000|Overall Study|Lost to Follow-up|1|||
170645097|NCT02208063|616715863|FG001|Overall Study|Lost to Follow-up|0|||
170645098|NCT03595618|616715864|FG000|Overall Study|Adverse Event|16|||
170645099|NCT03595618|616715865|FG001|Overall Study|Adverse Event|17|||
170645100|NCT03595618|616715866|FG002|Overall Study|Adverse Event|20|||
170645101|NCT03595618|616715867|FG003|Overall Study|Adverse Event|8|||
170645102|NCT03595618|616715864|FG000|Overall Study|Withdrawal by Subject|12|||
170645103|NCT03595618|616715865|FG001|Overall Study|Withdrawal by Subject|14|||
170645104|NCT03595618|616715866|FG002|Overall Study|Withdrawal by Subject|14|||
170645105|NCT03595618|616715867|FG003|Overall Study|Withdrawal by Subject|10|||
170645106|NCT03595618|616715864|FG000|Overall Study|Lost to Follow-up|6|||
170645107|NCT03595618|616715865|FG001|Overall Study|Lost to Follow-up|4|||
170645108|NCT03595618|616715866|FG002|Overall Study|Lost to Follow-up|5|||
170645109|NCT03595618|616715867|FG003|Overall Study|Lost to Follow-up|6|||
170645110|NCT03595618|616715864|FG000|Overall Study|Protocol Violation|2|||
170645111|NCT03595618|616715865|FG001|Overall Study|Protocol Violation|0|||
170645112|NCT03595618|616715866|FG002|Overall Study|Protocol Violation|6|||
170645113|NCT03595618|616715867|FG003|Overall Study|Protocol Violation|2|||
170645114|NCT03595618|616715864|FG000|Overall Study|Physician Decision|0|||
170905267|NCT01309737|617656057|FG004|Week 16 to 52|Lost to Follow-up|4|||
170905268|NCT01309737|617656053|FG000|Week 16 to 52|Withdrawal by Subject|5|||
170905269|NCT01309737|617656054|FG001|Week 16 to 52|Withdrawal by Subject|6|||
170905270|NCT01309737|617656055|FG002|Week 16 to 52|Withdrawal by Subject|0|||
170905271|NCT01309737|617656056|FG003|Week 16 to 52|Withdrawal by Subject|0|||
170558493|NCT06648291|616389840|FG000|Overall Study|Lost to Follow-up|0|||
170558494|NCT06648291|616389841|FG001|Overall Study|Lost to Follow-up|1|||
170558495|NCT06648291|616389840|FG000|Overall Study|Death|0|||
170558496|NCT06648291|616389841|FG001|Overall Study|Death|1|||
170558497|NCT06648291|616389840|FG000|Overall Study|Physician Decision|0|||
170905272|NCT01309737|617656057|FG004|Week 16 to 52|Withdrawal by Subject|2|||
170558498|NCT06648291|616389841|FG001|Overall Study|Physician Decision|2|||
170558499|NCT06648291|616389840|FG000|Overall Study|difficulty using the equipment|2|||
170645115|NCT03595618|616715865|FG001|Overall Study|Physician Decision|0|||
170645116|NCT03595618|616715866|FG002|Overall Study|Physician Decision|1|||
170645117|NCT03595618|616715867|FG003|Overall Study|Physician Decision|2|||
170645118|NCT03595618|616715864|FG000|Overall Study|Miscellaneous|7|||
170645119|NCT03595618|616715865|FG001|Overall Study|Miscellaneous|5|||
170905273|NCT01309737|617656053|FG000|Week 16 to 52|Other|10|||
170558500|NCT06648291|616389841|FG001|Overall Study|difficulty using the equipment|0|||
170558588|NCT07116759|616389855|FG000|Overall Study|Incompatibility with the RHMC device|2|||
170558597|NCT04701203|616389863|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
170558598|NCT04701203|616389864|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
170558599|NCT04701203|616389865|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
170558600|NCT04701203|616389863|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
170558601|NCT04701203|616389864|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
170558602|NCT04701203|616389865|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
170558603|NCT04701203|616389863|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
170558604|NCT04701203|616389864|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
170558605|NCT04701203|616389865|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
170558606|NCT04701203|616389863|FG000|Open-Label Period (Weeks 26 to 182)|Withdrawal by Subject|0|||
170558607|NCT04701203|616389864|FG001|Open-Label Period (Weeks 26 to 182)|Withdrawal by Subject|0|||
170558608|NCT04701203|616389865|FG002|Open-Label Period (Weeks 26 to 182)|Withdrawal by Subject|5|||
170558609|NCT04701203|616389863|FG000|Open-Label Period (Weeks 26 to 182)|Pregnancy|0|||
170558610|NCT04701203|616389864|FG001|Open-Label Period (Weeks 26 to 182)|Pregnancy|0|||
170558611|NCT04701203|616389865|FG002|Open-Label Period (Weeks 26 to 182)|Pregnancy|1|||
170905274|NCT01309737|617656054|FG001|Week 16 to 52|Other|12|||
170905275|NCT01309737|617656055|FG002|Week 16 to 52|Other|0|||
170905276|NCT01309737|617656056|FG003|Week 16 to 52|Other|2|||
170905277|NCT01309737|617656057|FG004|Week 16 to 52|Other|0|||
170905278|NCT00404092|617656064|FG000|Overall Study|Death|1|||
170905279|NCT00404092|617656065|FG001|Overall Study|Death|0|||
170905280|NCT00404092|617656066|FG002|Overall Study|Death|0|||
170905281|NCT00404092|617656067|FG003|Overall Study|Death|0|||
170905282|NCT00404092|617656064|FG000|Overall Study|Adverse Event|0|||
170905283|NCT00404092|617656065|FG001|Overall Study|Adverse Event|0|||
170565512|NCT03036852|616418552|FG000|Overall Study|Death|2|||
170905284|NCT00404092|617656066|FG002|Overall Study|Adverse Event|1|||
170905285|NCT00404092|617656067|FG003|Overall Study|Adverse Event|0|||
170565513|NCT03036852|616418552|FG000|Overall Study|Lack of Efficacy|2|||
170905286|NCT00749203|617656068|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
170905287|NCT00749203|617656069|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
170905288|NCT00749203|617656068|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
170558630|NCT02657356|616391555|FG000|Overall Study|Death|1|||
170558631|NCT02657356|616391556|FG001|Overall Study|Death|0|||
170558632|NCT02657356|616391555|FG000|Overall Study|Withdrawal by Subject|5|||
170558633|NCT02657356|616391556|FG001|Overall Study|Withdrawal by Subject|6|||
170558634|NCT02657356|616391555|FG000|Overall Study|Terminated by Sponsor|8|||
170558635|NCT02657356|616391556|FG001|Overall Study|Terminated by Sponsor|5|||
170558636|NCT02657356|616391555|FG000|Overall Study|Rolled over to EAP study|6|||
170558637|NCT02657356|616391556|FG001|Overall Study|Rolled over to EAP study|4|||
170558638|NCT03514134|616391557|FG000|Overall Study|Lost to Follow-up|0|||
170558639|NCT03514134|616391558|FG001|Overall Study|Lost to Follow-up|1|||
170558640|NCT02471144|616391559|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
170558641|NCT02471144|616391560|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
170558642|NCT02471144|616391561|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
170558643|NCT02471144|616391562|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
170558644|NCT02471144|616391563|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
170558645|NCT02471144|616391564|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
170558646|NCT02471144|616391565|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
170558647|NCT02471144|616391566|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
170558648|NCT02471144|616391567|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
170558649|NCT02471144|616391568|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
170558650|NCT02471144|616391569|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
170558651|NCT02471144|616391559|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558652|NCT02471144|616391560|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558653|NCT02471144|616391561|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558654|NCT02471144|616391562|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
170558655|NCT02471144|616391563|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558656|NCT02471144|616391564|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558657|NCT02471144|616391565|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558658|NCT02471144|616391566|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558659|NCT02471144|616391567|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558660|NCT02471144|616391568|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558661|NCT02471144|616391569|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
170558662|NCT02471144|616391559|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558663|NCT02471144|616391560|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558664|NCT02471144|616391561|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
170558665|NCT02471144|616391562|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558666|NCT02471144|616391563|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558667|NCT02471144|616391564|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558668|NCT02471144|616391565|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558669|NCT02471144|616391566|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558670|NCT02471144|616391567|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558671|NCT02471144|616391568|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558672|NCT02471144|616391569|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
170558673|NCT02471144|616391559|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
170558674|NCT02471144|616391560|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
170558675|NCT02471144|616391561|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558676|NCT02471144|616391562|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558677|NCT02471144|616391563|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558678|NCT02471144|616391564|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558679|NCT02471144|616391565|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558680|NCT02471144|616391566|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558681|NCT02471144|616391567|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558682|NCT02471144|616391568|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558683|NCT02471144|616391569|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
170558684|NCT02471144|616391559|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
170558685|NCT02471144|616391560|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
170558686|NCT02471144|616391561|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
170558687|NCT02471144|616391562|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
170558688|NCT02471144|616391563|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
170558689|NCT02471144|616391564|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
170558690|NCT02471144|616391565|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
170558691|NCT02471144|616391566|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
170558692|NCT02471144|616391567|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
170558693|NCT02471144|616391568|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
170558694|NCT02471144|616391569|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
170558695|NCT02471144|616391559|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170558696|NCT02471144|616391560|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170645120|NCT03595618|616715866|FG002|Overall Study|Miscellaneous|10|||
170645121|NCT03595618|616715867|FG003|Overall Study|Miscellaneous|6|||
170645122|NCT02338232|616715868|FG000|Overall Study|Screen Failure|3|||
170645123|NCT02338232|616715868|FG000|Overall Study|Withdrawal by Subject|6|||
170645124|NCT02338232|616715868|FG000|Overall Study|Adverse Event|2|||
170645125|NCT03890666|616715869|FG000|Overall Study|Withdrawal by Subject|0|||
170645126|NCT03890666|616715870|FG001|Overall Study|Withdrawal by Subject|1|||
170645127|NCT03890666|616715869|FG000|Overall Study|Protocol deviation|1|||
170645128|NCT03890666|616715870|FG001|Overall Study|Protocol deviation|4|||
170645129|NCT03890666|616715869|FG000|Overall Study|Lost to Follow-up|2|||
170645130|NCT03890666|616715870|FG001|Overall Study|Lost to Follow-up|5|||
170645131|NCT03890666|616715869|FG000|Overall Study|Other than specified|1|||
170645132|NCT03890666|616715870|FG001|Overall Study|Other than specified|8|||
170645133|NCT01105065|616715871|FG000|Overall Study|Adverse Event|5|||
170645134|NCT01105065|616715871|FG000|Overall Study|Technical Problems|1|||
170645135|NCT03996369|616715872|FG000|Overall Study|Protocol deviation|1|||
170645136|NCT03996369|616715873|FG001|Overall Study|Protocol deviation|1|||
170645137|NCT03996369|616715872|FG000|Overall Study|Physician Decision|4|||
170645138|NCT03996369|616715873|FG001|Overall Study|Physician Decision|2|||
170645139|NCT03996369|616715872|FG000|Overall Study|Participant decision|0|||
170645140|NCT03996369|616715873|FG001|Overall Study|Participant decision|1|||
170645141|NCT03996369|616715872|FG000|Overall Study|Lack of Efficacy|4|||
170645142|NCT03996369|616715873|FG001|Overall Study|Lack of Efficacy|0|||
170645143|NCT03996369|616715872|FG000|Overall Study|Adverse Event|9|||
170645144|NCT03996369|616715873|FG001|Overall Study|Adverse Event|0|||
170645145|NCT03996369|616715872|FG000|Overall Study|Withdrawal by Subject|6|||
170645146|NCT03996369|616715873|FG001|Overall Study|Withdrawal by Subject|8|||
170645147|NCT03996369|616715872|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
170645148|NCT03996369|616715873|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
170645149|NCT03996369|616715872|FG000|Overall Study|Lost to Follow-up|0|||
170645150|NCT03996369|616715873|FG001|Overall Study|Lost to Follow-up|1|||
170645151|NCT02238067|616715874|FG000|Overall Study|Not completed survey at Month 6|45|||
170645152|NCT01565343|616715875|FG000|Overall Study|Administrative decision/technical issues|1|||
170645153|NCT01565343|616715876|FG001|Overall Study|Administrative decision/technical issues|0|||
170558697|NCT02471144|616391561|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170558698|NCT02471144|616391562|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170558699|NCT02471144|616391563|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170558700|NCT02471144|616391564|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
170558701|NCT02471144|616391565|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170558702|NCT02471144|616391566|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170558703|NCT02471144|616391567|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
170558704|NCT02471144|616391568|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170558705|NCT02471144|616391569|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
170558706|NCT02471144|616391559|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558707|NCT02471144|616391560|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558708|NCT02471144|616391561|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558709|NCT02471144|616391562|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558710|NCT02471144|616391563|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558711|NCT02471144|616391564|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558712|NCT02471144|616391565|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558713|NCT02471144|616391566|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558714|NCT02471144|616391567|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
170558715|NCT02471144|616391568|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558716|NCT02471144|616391569|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
170558717|NCT02471144|616391559|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170558718|NCT02471144|616391560|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170558719|NCT02471144|616391561|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170558720|NCT02471144|616391562|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170645154|NCT01565343|616715877|FG002|Overall Study|Administrative decision/technical issues|0|||
170645155|NCT02213133|616715879|FG000|Overall Study|Participant discontinued study therapy|2|||
170645156|NCT02213133|616715880|FG001|Overall Study|Participant discontinued study therapy|0|||
170645157|NCT02213133|616715881|FG002|Overall Study|Participant discontinued study therapy|0|||
170645158|NCT02213133|616715879|FG000|Overall Study|Participant withdrew informed consent|2|||
170645159|NCT02213133|616715880|FG001|Overall Study|Participant withdrew informed consent|1|||
170558721|NCT02471144|616391563|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170558722|NCT02471144|616391564|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170558723|NCT02471144|616391565|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170558724|NCT02471144|616391566|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
170558725|NCT02471144|616391567|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
170558726|NCT02471144|616391568|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170645160|NCT02213133|616715881|FG002|Overall Study|Participant withdrew informed consent|2|||
170645161|NCT02213133|616715879|FG000|Overall Study|Disease progression|11|||
170558727|NCT02471144|616391569|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
170558728|NCT02471144|616391559|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558729|NCT02471144|616391560|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558730|NCT02471144|616391561|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558731|NCT02471144|616391562|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558732|NCT02471144|616391563|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558733|NCT02471144|616391564|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558734|NCT02471144|616391565|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558735|NCT02471144|616391566|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558736|NCT02471144|616391567|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
170558737|NCT02471144|616391568|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
170558738|NCT02471144|616391569|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
170558739|NCT02471144|616391559|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558740|NCT02471144|616391560|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558741|NCT02471144|616391561|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558742|NCT02471144|616391562|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558743|NCT02471144|616391563|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558744|NCT02471144|616391564|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558745|NCT02471144|616391565|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558746|NCT02471144|616391566|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558747|NCT02471144|616391567|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558748|NCT02471144|616391568|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
170558749|NCT02471144|616391569|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
170558750|NCT02471144|616391559|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558751|NCT02471144|616391560|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558752|NCT02471144|616391561|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558753|NCT02471144|616391562|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558754|NCT02471144|616391563|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558755|NCT02471144|616391564|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558756|NCT02471144|616391565|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558757|NCT02471144|616391566|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558758|NCT02471144|616391567|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558759|NCT02471144|616391568|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
170558760|NCT02471144|616391569|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
170558761|NCT02471144|616391559|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558762|NCT02471144|616391560|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558763|NCT02471144|616391561|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558764|NCT02471144|616391562|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558765|NCT02471144|616391563|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558766|NCT02471144|616391564|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558767|NCT02471144|616391565|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558768|NCT02471144|616391566|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558769|NCT02471144|616391567|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
170558770|NCT02471144|616391568|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
170558771|NCT02471144|616391569|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
170558772|NCT02471144|616391559|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558773|NCT02471144|616391560|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558774|NCT02471144|616391561|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558775|NCT02471144|616391562|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558776|NCT02471144|616391563|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558777|NCT02471144|616391564|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558778|NCT02471144|616391565|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558779|NCT02471144|616391566|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558780|NCT02471144|616391567|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558781|NCT02471144|616391568|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
170558782|NCT02471144|616391569|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
170558783|NCT02471144|616391559|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170558784|NCT02471144|616391560|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170558785|NCT02471144|616391561|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170558786|NCT02471144|616391562|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170558787|NCT02471144|616391563|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170558788|NCT02471144|616391564|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170558789|NCT02471144|616391565|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170558790|NCT02471144|616391566|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170558791|NCT02471144|616391567|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
170565514|NCT03036852|616418552|FG000|Overall Study|Adverse Event|1|||
170558792|NCT02471144|616391568|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
170558793|NCT02471144|616391569|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
170558794|NCT04976777|616391571|FG000|Overall Study|COVID-19 Infection|1|||
170558795|NCT04976777|616391572|FG001|Overall Study|COVID-19 Infection|0|||
170558796|NCT00462826|616391573|FG000|Overall Study|Ineligible - second primary|1|||
170558797|NCT00462826|616391573|FG000|Overall Study|Ineligible - wrong cell type|1|||
170558798|NCT00462826|616391573|FG000|Overall Study|Ineligible - wrong primary|2|||
170558799|NCT00462826|616391573|FG000|Overall Study|Never treated|1|||
170558800|NCT03768336|616391574|FG000|Overall Study|Lost to Follow-up|3|||
170558801|NCT03768336|616391575|FG001|Overall Study|Lost to Follow-up|2|||
170558802|NCT03768336|616391574|FG000|Overall Study|Became Ineligible|2|||
170558803|NCT03768336|616391575|FG001|Overall Study|Became Ineligible|0|||
170558804|NCT03768336|616391574|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
170558805|NCT03768336|616391575|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
170558806|NCT03768336|616391574|FG000|Overall Study|Missed final survey (post-treatment|0|||
170558807|NCT03768336|616391575|FG001|Overall Study|Missed final survey (post-treatment|1|||
170558808|NCT05654181|616391576|FG000|Overall Study|Adverse Event|1|||
170558809|NCT05654181|616391577|FG001|Overall Study|Adverse Event|0|||
170558810|NCT05654181|616391578|FG002|Overall Study|Adverse Event|0|||
170558811|NCT05654181|616391579|FG003|Overall Study|Adverse Event|0|||
170558812|NCT05654181|616391580|FG004|Overall Study|Adverse Event|0|||
170558813|NCT05654181|616391581|FG005|Overall Study|Adverse Event|0|||
170558814|NCT05654181|616391582|FG006|Overall Study|Adverse Event|0|||
170558815|NCT05654181|616391583|FG007|Overall Study|Adverse Event|1|||
170558816|NCT05654181|616391584|FG008|Overall Study|Adverse Event|0|||
170558817|NCT05654181|616391585|FG009|Overall Study|Adverse Event|0|||
170558818|NCT05654181|616391576|FG000|Overall Study|Withdrawal by Subject|0|||
170558819|NCT05654181|616391577|FG001|Overall Study|Withdrawal by Subject|0|||
170558820|NCT05654181|616391578|FG002|Overall Study|Withdrawal by Subject|0|||
170558821|NCT05654181|616391579|FG003|Overall Study|Withdrawal by Subject|0|||
170558822|NCT05654181|616391580|FG004|Overall Study|Withdrawal by Subject|0|||
170558823|NCT05654181|616391581|FG005|Overall Study|Withdrawal by Subject|0|||
170558824|NCT05654181|616391582|FG006|Overall Study|Withdrawal by Subject|0|||
170558825|NCT05654181|616391583|FG007|Overall Study|Withdrawal by Subject|1|||
170558826|NCT05654181|616391584|FG008|Overall Study|Withdrawal by Subject|0|||
170558827|NCT05654181|616391585|FG009|Overall Study|Withdrawal by Subject|0|||
170558828|NCT05654181|616391576|FG000|Overall Study|Other|0|||
170558829|NCT05654181|616391577|FG001|Overall Study|Other|0|||
170645162|NCT02213133|616715880|FG001|Overall Study|Disease progression|2|||
170558830|NCT05654181|616391578|FG002|Overall Study|Other|0|||
170558831|NCT05654181|616391579|FG003|Overall Study|Other|0|||
170558832|NCT05654181|616391580|FG004|Overall Study|Other|1|||
170558833|NCT05654181|616391581|FG005|Overall Study|Other|1|||
170558834|NCT05654181|616391582|FG006|Overall Study|Other|0|||
170558835|NCT05654181|616391583|FG007|Overall Study|Other|0|||
170558836|NCT05654181|616391584|FG008|Overall Study|Other|0|||
170558837|NCT05654181|616391585|FG009|Overall Study|Other|0|||
170558838|NCT03977155|616391586|FG000|Overall Study|Adverse Event|3|||
170558839|NCT03977155|616391587|FG001|Overall Study|Adverse Event|0|||
170558840|NCT03977155|616391588|FG002|Overall Study|Adverse Event|0|||
170558841|NCT03977155|616391586|FG000|Overall Study|Lost to Follow-up|0|||
170558842|NCT03977155|616391587|FG001|Overall Study|Lost to Follow-up|1|||
170558843|NCT03977155|616391588|FG002|Overall Study|Lost to Follow-up|0|||
170558844|NCT03977155|616391586|FG000|Overall Study|Withdrawal by Subject|1|||
170558845|NCT03977155|616391587|FG001|Overall Study|Withdrawal by Subject|1|||
170558846|NCT03977155|616391588|FG002|Overall Study|Withdrawal by Subject|2|||
170558847|NCT03977155|616391586|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
170558848|NCT03977155|616391587|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
170558849|NCT03977155|616391588|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
170558850|NCT00936936|616391589|FG000|Overall Study|Adverse Event|7|||
170558851|NCT00936936|616391590|FG001|Overall Study|Adverse Event|1|||
170558852|NCT00936936|616391589|FG000|Overall Study|Disease Progression|2|||
170558853|NCT00936936|616391590|FG001|Overall Study|Disease Progression|2|||
170558854|NCT00936936|616391589|FG000|Overall Study|Unrelated|3|||
170558855|NCT00936936|616391590|FG001|Overall Study|Unrelated|1|||
170558856|NCT02278003|616391592|FG000|Overall Study|Withdrawal by Subject|11|||
170558857|NCT02278003|616391593|FG001|Overall Study|Withdrawal by Subject|0|||
170558858|NCT02278003|616391592|FG000|Overall Study|Not Treated|1|||
170558859|NCT02278003|616391593|FG001|Overall Study|Not Treated|0|||
170558860|NCT02278003|616391592|FG000|Overall Study|Recognition task improperly completed|7|||
170558861|NCT02278003|616391593|FG001|Overall Study|Recognition task improperly completed|0|||
170558862|NCT01397253|616391594|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
170558863|NCT01397253|616391595|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
170558864|NCT00980044|616391596|FG000|Overall Study|Withdrawal by Subject|5|||
170558865|NCT00980044|616391597|FG001|Overall Study|Withdrawal by Subject|7|||
170558866|NCT00980044|616391598|FG002|Overall Study|Withdrawal by Subject|3|||
170645163|NCT02213133|616715881|FG002|Overall Study|Disease progression|0|||
170558867|NCT00980044|616391596|FG000|Overall Study|Protocol Violation|0|||
170558868|NCT00980044|616391597|FG001|Overall Study|Protocol Violation|0|||
170558869|NCT00980044|616391598|FG002|Overall Study|Protocol Violation|2|||
170558870|NCT00442702|616391601|FG000|Titration Period|Adverse Event|2|||
170558871|NCT00442702|616391602|FG001|Titration Period|Adverse Event|0|||
170558872|NCT00442702|616391601|FG000|Titration Period|Death|3|||
170558873|NCT00442702|616391602|FG001|Titration Period|Death|2|||
170558874|NCT00442702|616391601|FG000|Titration Period|Insufficient Therapeutic Response|1|||
170558875|NCT00442702|616391602|FG001|Titration Period|Insufficient Therapeutic Response|0|||
170558876|NCT00442702|616391601|FG000|Titration Period|Refused Treatment|4|||
170558877|NCT00442702|616391602|FG001|Titration Period|Refused Treatment|1|||
170558878|NCT00442702|616391601|FG000|Titration Period|Failure to return|1|||
170558879|NCT00442702|616391602|FG001|Titration Period|Failure to return|0|||
170558880|NCT00442702|616391601|FG000|Titration Period|Hospitalized in another hospital|1|||
170558881|NCT00442702|616391602|FG001|Titration Period|Hospitalized in another hospital|0|||
170558882|NCT00442702|616391601|FG000|Evaluation Period|Adverse Event|1|||
170558883|NCT00442702|616391602|FG001|Evaluation Period|Adverse Event|0|||
170558884|NCT00442702|616391601|FG000|Evaluation Period|Death|1|||
170558885|NCT00442702|616391602|FG001|Evaluation Period|Death|1|||
170558886|NCT00442702|616391601|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
170558887|NCT00442702|616391602|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
170558888|NCT00442702|616391601|FG000|Evaluation Period|Refused treatment|1|||
170558889|NCT00442702|616391602|FG001|Evaluation Period|Refused treatment|1|||
170558890|NCT00442702|616391601|FG000|Evaluation Period|Renal transplant|0|||
170558891|NCT00442702|616391602|FG001|Evaluation Period|Renal transplant|1|||
170558892|NCT00442702|616391601|FG000|Evaluation Period|Failure to return|1|||
170558893|NCT00442702|616391602|FG001|Evaluation Period|Failure to return|0|||
170558894|NCT00442702|616391601|FG000|Evaluation Period|Site closure|0|||
170558895|NCT00442702|616391602|FG001|Evaluation Period|Site closure|1|||
170558896|NCT01444781|616391603|FG000|Overall Study|Lost to Follow-up|0|||
170558897|NCT01444781|616391604|FG001|Overall Study|Lost to Follow-up|3|||
170558898|NCT01444781|616391605|FG002|Overall Study|Lost to Follow-up|1|||
170558899|NCT01444781|616391603|FG000|Overall Study|Withdrawal by Subject|3|||
170558900|NCT01444781|616391604|FG001|Overall Study|Withdrawal by Subject|1|||
170558901|NCT01444781|616391605|FG002|Overall Study|Withdrawal by Subject|2|||
170558902|NCT03396445|616391609|FG000|Treatment Period|Death|2|||
170558903|NCT03396445|616391610|FG001|Treatment Period|Death|2|||
170558904|NCT03396445|616391611|FG002|Treatment Period|Death|1|||
170558905|NCT03396445|616391612|FG003|Treatment Period|Death|1|||
170558906|NCT03396445|616391613|FG004|Treatment Period|Death|3|||
170558907|NCT03396445|616391614|FG005|Treatment Period|Death|2|||
170558908|NCT03396445|616391615|FG006|Treatment Period|Death|5|||
170558909|NCT03396445|616391616|FG007|Treatment Period|Death|3|||
170558910|NCT03396445|616391617|FG008|Treatment Period|Death|3|||
170558911|NCT03396445|616391618|FG009|Treatment Period|Death|3|||
170558912|NCT03396445|616391619|FG010|Treatment Period|Death|7|||
170558913|NCT03396445|616391620|FG011|Treatment Period|Death|12|||
170558914|NCT03396445|616391621|FG012|Treatment Period|Death|28|||
170558915|NCT03396445|616391622|FG013|Treatment Period|Death|14|||
170558916|NCT03396445|616391623|FG014|Treatment Period|Death|10|||
170558917|NCT03396445|616391624|FG015|Treatment Period|Death|8|||
170558918|NCT03396445|616391625|FG016|Treatment Period|Death|18|||
170558919|NCT03396445|616391626|FG017|Treatment Period|Death|0|||
170558920|NCT03396445|616391627|FG018|Treatment Period|Death|0|||
170558921|NCT03396445|616391628|FG019|Treatment Period|Death|0|||
170558922|NCT03396445|616391629|FG020|Treatment Period|Death|0|||
170558923|NCT03396445|616391630|FG021|Treatment Period|Death|0|||
170558924|NCT03396445|616391631|FG022|Treatment Period|Death|0|||
170558925|NCT03396445|616391632|FG023|Treatment Period|Death|0|||
170558926|NCT03396445|616391633|FG024|Treatment Period|Death|0|||
170558927|NCT03396445|616391634|FG025|Treatment Period|Death|0|||
170558928|NCT03396445|616391609|FG000|Treatment Period|Lost to Follow-up|0|||
170558929|NCT03396445|616391610|FG001|Treatment Period|Lost to Follow-up|0|||
170558930|NCT03396445|616391611|FG002|Treatment Period|Lost to Follow-up|0|||
170558931|NCT03396445|616391612|FG003|Treatment Period|Lost to Follow-up|0|||
170558932|NCT03396445|616391613|FG004|Treatment Period|Lost to Follow-up|0|||
170558933|NCT03396445|616391614|FG005|Treatment Period|Lost to Follow-up|0|||
170558934|NCT03396445|616391615|FG006|Treatment Period|Lost to Follow-up|0|||
170558935|NCT03396445|616391616|FG007|Treatment Period|Lost to Follow-up|0|||
170558936|NCT03396445|616391617|FG008|Treatment Period|Lost to Follow-up|0|||
170558937|NCT03396445|616391618|FG009|Treatment Period|Lost to Follow-up|0|||
170558938|NCT03396445|616391619|FG010|Treatment Period|Lost to Follow-up|0|||
170558939|NCT03396445|616391620|FG011|Treatment Period|Lost to Follow-up|0|||
170558940|NCT03396445|616391621|FG012|Treatment Period|Lost to Follow-up|1|||
170558941|NCT03396445|616391622|FG013|Treatment Period|Lost to Follow-up|0|||
170558942|NCT03396445|616391623|FG014|Treatment Period|Lost to Follow-up|1|||
170558943|NCT03396445|616391624|FG015|Treatment Period|Lost to Follow-up|0|||
170558944|NCT03396445|616391625|FG016|Treatment Period|Lost to Follow-up|0|||
170558945|NCT03396445|616391626|FG017|Treatment Period|Lost to Follow-up|0|||
170558946|NCT03396445|616391627|FG018|Treatment Period|Lost to Follow-up|0|||
170558947|NCT03396445|616391628|FG019|Treatment Period|Lost to Follow-up|0|||
170558948|NCT03396445|616391629|FG020|Treatment Period|Lost to Follow-up|0|||
170558949|NCT03396445|616391630|FG021|Treatment Period|Lost to Follow-up|0|||
170558950|NCT03396445|616391631|FG022|Treatment Period|Lost to Follow-up|0|||
170558951|NCT03396445|616391632|FG023|Treatment Period|Lost to Follow-up|0|||
170558952|NCT03396445|616391633|FG024|Treatment Period|Lost to Follow-up|0|||
170558953|NCT03396445|616391634|FG025|Treatment Period|Lost to Follow-up|0|||
170558954|NCT03396445|616391609|FG000|Treatment Period|Physician Decision|0|||
170558955|NCT03396445|616391610|FG001|Treatment Period|Physician Decision|0|||
170558956|NCT03396445|616391611|FG002|Treatment Period|Physician Decision|0|||
170558957|NCT03396445|616391612|FG003|Treatment Period|Physician Decision|0|||
170558958|NCT03396445|616391613|FG004|Treatment Period|Physician Decision|1|||
170558959|NCT03396445|616391614|FG005|Treatment Period|Physician Decision|0|||
170558960|NCT03396445|616391615|FG006|Treatment Period|Physician Decision|0|||
170558961|NCT03396445|616391616|FG007|Treatment Period|Physician Decision|0|||
170558962|NCT03396445|616391617|FG008|Treatment Period|Physician Decision|0|||
170558963|NCT03396445|616391618|FG009|Treatment Period|Physician Decision|1|||
170558964|NCT03396445|616391619|FG010|Treatment Period|Physician Decision|0|||
170558965|NCT03396445|616391620|FG011|Treatment Period|Physician Decision|0|||
170558966|NCT03396445|616391621|FG012|Treatment Period|Physician Decision|0|||
170558967|NCT03396445|616391622|FG013|Treatment Period|Physician Decision|0|||
170558968|NCT03396445|616391623|FG014|Treatment Period|Physician Decision|0|||
170558969|NCT03396445|616391624|FG015|Treatment Period|Physician Decision|0|||
170558970|NCT03396445|616391625|FG016|Treatment Period|Physician Decision|0|||
170558971|NCT03396445|616391626|FG017|Treatment Period|Physician Decision|0|||
170558972|NCT03396445|616391627|FG018|Treatment Period|Physician Decision|0|||
170558973|NCT03396445|616391628|FG019|Treatment Period|Physician Decision|0|||
170558974|NCT03396445|616391629|FG020|Treatment Period|Physician Decision|0|||
170558975|NCT03396445|616391630|FG021|Treatment Period|Physician Decision|0|||
170558976|NCT03396445|616391631|FG022|Treatment Period|Physician Decision|0|||
170558977|NCT03396445|616391632|FG023|Treatment Period|Physician Decision|0|||
170558978|NCT03396445|616391633|FG024|Treatment Period|Physician Decision|0|||
170558979|NCT03396445|616391634|FG025|Treatment Period|Physician Decision|0|||
170558980|NCT03396445|616391609|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558981|NCT03396445|616391610|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558982|NCT03396445|616391611|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558983|NCT03396445|616391612|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558984|NCT03396445|616391613|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558985|NCT03396445|616391614|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558986|NCT03396445|616391615|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558987|NCT03396445|616391616|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558988|NCT03396445|616391617|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558989|NCT03396445|616391618|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558990|NCT03396445|616391619|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558991|NCT03396445|616391620|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558992|NCT03396445|616391621|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
170558993|NCT03396445|616391622|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558994|NCT03396445|616391623|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
170558995|NCT03396445|616391624|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558996|NCT03396445|616391625|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558997|NCT03396445|616391626|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558998|NCT03396445|616391627|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170558999|NCT03396445|616391628|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170559000|NCT03396445|616391629|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170559001|NCT03396445|616391630|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170559002|NCT03396445|616391631|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170559003|NCT03396445|616391632|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170559004|NCT03396445|616391633|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170559005|NCT03396445|616391634|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
170559006|NCT03396445|616391609|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
170559007|NCT03396445|616391610|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
170559008|NCT03396445|616391611|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
170559009|NCT03396445|616391612|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
170645164|NCT02213133|616715879|FG000|Overall Study|Adverse Event (AE)|1|||
170559010|NCT03396445|616391613|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
170559011|NCT03396445|616391614|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559012|NCT03396445|616391615|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
170559013|NCT03396445|616391616|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559014|NCT03396445|616391617|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559015|NCT03396445|616391618|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559016|NCT03396445|616391619|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559017|NCT03396445|616391620|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559018|NCT03396445|616391621|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559019|NCT03396445|616391622|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559020|NCT03396445|616391623|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559021|NCT03396445|616391624|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559022|NCT03396445|616391625|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559023|NCT03396445|616391626|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559024|NCT03396445|616391627|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559025|NCT03396445|616391628|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559026|NCT03396445|616391629|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559027|NCT03396445|616391630|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559028|NCT03396445|616391631|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559029|NCT03396445|616391632|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559030|NCT03396445|616391633|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559031|NCT03396445|616391634|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
170559032|NCT03396445|616391609|FG000|Treatment Period|Withdrawal by Subject|0|||
170559033|NCT03396445|616391610|FG001|Treatment Period|Withdrawal by Subject|0|||
170559034|NCT03396445|616391611|FG002|Treatment Period|Withdrawal by Subject|0|||
170559035|NCT03396445|616391612|FG003|Treatment Period|Withdrawal by Subject|0|||
170559036|NCT03396445|616391613|FG004|Treatment Period|Withdrawal by Subject|0|||
170559037|NCT03396445|616391614|FG005|Treatment Period|Withdrawal by Subject|0|||
170559038|NCT03396445|616391615|FG006|Treatment Period|Withdrawal by Subject|0|||
170559039|NCT03396445|616391616|FG007|Treatment Period|Withdrawal by Subject|0|||
170559040|NCT03396445|616391617|FG008|Treatment Period|Withdrawal by Subject|0|||
170559041|NCT03396445|616391618|FG009|Treatment Period|Withdrawal by Subject|0|||
170559042|NCT03396445|616391619|FG010|Treatment Period|Withdrawal by Subject|0|||
170559043|NCT03396445|616391620|FG011|Treatment Period|Withdrawal by Subject|0|||
170559044|NCT03396445|616391621|FG012|Treatment Period|Withdrawal by Subject|0|||
170559045|NCT03396445|616391622|FG013|Treatment Period|Withdrawal by Subject|0|||
170559046|NCT03396445|616391623|FG014|Treatment Period|Withdrawal by Subject|1|||
170559047|NCT03396445|616391624|FG015|Treatment Period|Withdrawal by Subject|0|||
170559048|NCT03396445|616391625|FG016|Treatment Period|Withdrawal by Subject|1|||
170559049|NCT03396445|616391626|FG017|Treatment Period|Withdrawal by Subject|0|||
170559050|NCT03396445|616391627|FG018|Treatment Period|Withdrawal by Subject|0|||
170559051|NCT03396445|616391628|FG019|Treatment Period|Withdrawal by Subject|0|||
170559052|NCT03396445|616391629|FG020|Treatment Period|Withdrawal by Subject|0|||
170559053|NCT03396445|616391630|FG021|Treatment Period|Withdrawal by Subject|0|||
170559054|NCT03396445|616391631|FG022|Treatment Period|Withdrawal by Subject|0|||
170559055|NCT03396445|616391632|FG023|Treatment Period|Withdrawal by Subject|0|||
170559056|NCT03396445|616391633|FG024|Treatment Period|Withdrawal by Subject|0|||
170559057|NCT03396445|616391634|FG025|Treatment Period|Withdrawal by Subject|0|||
170559058|NCT03396445|616391609|FG000|Switch-over Period|Death|0|||
170645165|NCT02213133|616715880|FG001|Overall Study|Adverse Event (AE)|0|||
170645166|NCT02213133|616715881|FG002|Overall Study|Adverse Event (AE)|0|||
170645167|NCT02213133|616715879|FG000|Overall Study|Death|16|||
170645168|NCT02213133|616715880|FG001|Overall Study|Death|2|||
170645169|NCT02213133|616715881|FG002|Overall Study|Death|1|||
170645170|NCT02213133|616715879|FG000|Overall Study|Other|5|||
170645171|NCT02213133|616715880|FG001|Overall Study|Other|0|||
170645172|NCT02213133|616715881|FG002|Overall Study|Other|0|||
170645173|NCT00638183|616715882|FG000|Overall Study|Adverse Event|23|||
170645174|NCT00638183|616715882|FG000|Overall Study|Lack of Efficacy|14|||
170645175|NCT00638183|616715882|FG000|Overall Study|Physician Decision|9|||
170645176|NCT00638183|616715882|FG000|Overall Study|Lost to Follow-up|46|||
170645177|NCT00638183|616715882|FG000|Overall Study|Other reason not defined above|27|||
170559059|NCT03396445|616391610|FG001|Switch-over Period|Death|0|||
170645178|NCT01433289|616715883|FG000|Overall Study|Pregnancy|0|||
170645179|NCT01433289|616715884|FG001|Overall Study|Pregnancy|1|||
170645180|NCT01433289|616715885|FG002|Overall Study|Pregnancy|0|||
170645181|NCT01433289|616715886|FG003|Overall Study|Pregnancy|0|||
170645182|NCT00600119|616715887|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
170559060|NCT03396445|616391611|FG002|Switch-over Period|Death|0|||
170559061|NCT03396445|616391612|FG003|Switch-over Period|Death|0|||
170559062|NCT03396445|616391613|FG004|Switch-over Period|Death|0|||
170559063|NCT03396445|616391614|FG005|Switch-over Period|Death|0|||
170559064|NCT03396445|616391615|FG006|Switch-over Period|Death|0|||
170559065|NCT03396445|616391616|FG007|Switch-over Period|Death|0|||
170559066|NCT03396445|616391617|FG008|Switch-over Period|Death|0|||
170559067|NCT03396445|616391618|FG009|Switch-over Period|Death|0|||
170559068|NCT03396445|616391619|FG010|Switch-over Period|Death|0|||
170559069|NCT03396445|616391620|FG011|Switch-over Period|Death|0|||
170559070|NCT03396445|616391621|FG012|Switch-over Period|Death|0|||
170559071|NCT03396445|616391622|FG013|Switch-over Period|Death|0|||
170559072|NCT03396445|616391623|FG014|Switch-over Period|Death|0|||
170559073|NCT03396445|616391624|FG015|Switch-over Period|Death|0|||
170559074|NCT03396445|616391625|FG016|Switch-over Period|Death|0|||
170559075|NCT03396445|616391626|FG017|Switch-over Period|Death|0|||
170559076|NCT03396445|616391627|FG018|Switch-over Period|Death|1|||
170559077|NCT03396445|616391628|FG019|Switch-over Period|Death|2|||
170559078|NCT03396445|616391629|FG020|Switch-over Period|Death|2|||
170559079|NCT03396445|616391630|FG021|Switch-over Period|Death|1|||
170559080|NCT03396445|616391631|FG022|Switch-over Period|Death|2|||
170559081|NCT03396445|616391632|FG023|Switch-over Period|Death|0|||
170559082|NCT03396445|616391633|FG024|Switch-over Period|Death|1|||
170559083|NCT03396445|616391634|FG025|Switch-over Period|Death|6|||
170559084|NCT03396445|616391609|FG000|Switch-over Period|Lost to Follow-up|0|||
170559085|NCT03396445|616391610|FG001|Switch-over Period|Lost to Follow-up|0|||
170559086|NCT03396445|616391611|FG002|Switch-over Period|Lost to Follow-up|0|||
170559087|NCT03396445|616391612|FG003|Switch-over Period|Lost to Follow-up|0|||
170559088|NCT03396445|616391613|FG004|Switch-over Period|Lost to Follow-up|0|||
170559089|NCT03396445|616391614|FG005|Switch-over Period|Lost to Follow-up|0|||
170559090|NCT03396445|616391615|FG006|Switch-over Period|Lost to Follow-up|0|||
170559091|NCT03396445|616391616|FG007|Switch-over Period|Lost to Follow-up|0|||
170559092|NCT03396445|616391617|FG008|Switch-over Period|Lost to Follow-up|0|||
170559093|NCT03396445|616391618|FG009|Switch-over Period|Lost to Follow-up|0|||
170559094|NCT03396445|616391619|FG010|Switch-over Period|Lost to Follow-up|0|||
170559095|NCT03396445|616391620|FG011|Switch-over Period|Lost to Follow-up|0|||
170559096|NCT03396445|616391621|FG012|Switch-over Period|Lost to Follow-up|0|||
170559097|NCT03396445|616391622|FG013|Switch-over Period|Lost to Follow-up|0|||
170559098|NCT03396445|616391623|FG014|Switch-over Period|Lost to Follow-up|0|||
170559099|NCT03396445|616391624|FG015|Switch-over Period|Lost to Follow-up|0|||
170559100|NCT03396445|616391625|FG016|Switch-over Period|Lost to Follow-up|0|||
170559101|NCT03396445|616391626|FG017|Switch-over Period|Lost to Follow-up|0|||
170559102|NCT03396445|616391627|FG018|Switch-over Period|Lost to Follow-up|0|||
170559103|NCT03396445|616391628|FG019|Switch-over Period|Lost to Follow-up|0|||
170559104|NCT03396445|616391629|FG020|Switch-over Period|Lost to Follow-up|0|||
170559105|NCT03396445|616391630|FG021|Switch-over Period|Lost to Follow-up|0|||
170559106|NCT03396445|616391631|FG022|Switch-over Period|Lost to Follow-up|0|||
170559107|NCT03396445|616391632|FG023|Switch-over Period|Lost to Follow-up|1|||
170559108|NCT03396445|616391633|FG024|Switch-over Period|Lost to Follow-up|0|||
170559109|NCT03396445|616391634|FG025|Switch-over Period|Lost to Follow-up|0|||
170559110|NCT03440385|616391635|FG000|Overall Study|Other Reason|4|||
170559111|NCT03440385|616391636|FG001|Overall Study|Other Reason|1|||
170559112|NCT03440385|616391635|FG000|Overall Study|Site Closed|1|||
170559113|NCT03440385|616391636|FG001|Overall Study|Site Closed|0|||
170645183|NCT00600119|616715888|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
170645184|NCT00600119|616715889|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
170905289|NCT00749203|617656069|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
170905290|NCT00749203|617656068|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
170559114|NCT03440385|616391635|FG000|Overall Study|Lost to Follow-up|2|||
170559115|NCT03440385|616391636|FG001|Overall Study|Lost to Follow-up|0|||
170645185|NCT00600119|616715890|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
170559116|NCT03440385|616391635|FG000|Overall Study|Withdrawal by Subject|12|||
170559117|NCT03440385|616391636|FG001|Overall Study|Withdrawal by Subject|6|||
170559118|NCT03440385|616391635|FG000|Overall Study|Lack of Efficacy|9|||
170559119|NCT03440385|616391636|FG001|Overall Study|Lack of Efficacy|2|||
170559120|NCT03440385|616391635|FG000|Overall Study|Adverse Event|15|||
170559121|NCT03440385|616391636|FG001|Overall Study|Adverse Event|11|||
170559122|NCT03014089|616391638|FG000|Overall Study|Withdrawal by Subject|0|||
170559123|NCT03014089|616391639|FG001|Overall Study|Withdrawal by Subject|1|||
170559124|NCT03014089|616391640|FG002|Overall Study|Withdrawal by Subject|1|||
170645186|NCT00600119|616715891|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
170559125|NCT03014089|616391641|FG003|Overall Study|Withdrawal by Subject|1|||
170559126|NCT03014089|616391638|FG000|Overall Study|Lost to Follow-up|1|||
170559127|NCT03014089|616391639|FG001|Overall Study|Lost to Follow-up|0|||
170559128|NCT03014089|616391640|FG002|Overall Study|Lost to Follow-up|0|||
170559129|NCT03014089|616391641|FG003|Overall Study|Lost to Follow-up|0|||
170559130|NCT03014089|616391638|FG000|Overall Study|Adverse Event|1|||
170559131|NCT03014089|616391639|FG001|Overall Study|Adverse Event|0|||
170559132|NCT03014089|616391640|FG002|Overall Study|Adverse Event|1|||
170559133|NCT03014089|616391641|FG003|Overall Study|Adverse Event|0|||
170559134|NCT03257657|616391642|FG000|Overall Study|Lost to Follow-up|0|||
170559135|NCT03257657|616391643|FG001|Overall Study|Lost to Follow-up|3|||
170559136|NCT03257657|616391642|FG000|Overall Study|Withdrawn|0|||
170559137|NCT03257657|616391643|FG001|Overall Study|Withdrawn|1|||
170559138|NCT03257657|616391642|FG000|Overall Study|Noted not eligible right after enrolled|0|||
170559139|NCT03257657|616391643|FG001|Overall Study|Noted not eligible right after enrolled|1|||
170559140|NCT02272985|616391644|FG000|Overall Study|Withdrawal by Subject|1|||
170559141|NCT02272985|616391644|FG000|Overall Study|hip fracture|1|||
170559142|NCT02272985|616391644|FG000|Overall Study|kidney transplantation|1|||
170559143|NCT02263547|616391645|FG000|Overall Study|Adverse Event|1|||
170559144|NCT02263547|616391645|FG000|Overall Study|Lost to Follow-up|2|||
170559145|NCT01432444|616391648|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
170559146|NCT01432444|616391649|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
170559147|NCT01432444|616391650|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
170559148|NCT01432444|616391648|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
170559149|NCT01432444|616391649|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
170559150|NCT01432444|616391650|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
170559151|NCT01432444|616391648|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
170559152|NCT01432444|616391649|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
170559153|NCT01432444|616391650|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
170559154|NCT01432444|616391648|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
170559155|NCT01432444|616391649|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
170559156|NCT01432444|616391650|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
170559157|NCT01432444|616391648|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
170559158|NCT01432444|616391649|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
170559159|NCT01432444|616391650|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
170559160|NCT01432444|616391648|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
170559161|NCT01432444|616391649|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
170559162|NCT01432444|616391650|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
170559163|NCT01432444|616391648|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
170559164|NCT01432444|616391649|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
170559165|NCT01432444|616391650|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
170559166|NCT01432444|616391648|FG000|Treatment Phase|Lost to Follow-up|0|||
170559167|NCT01432444|616391649|FG001|Treatment Phase|Lost to Follow-up|33|||
170559168|NCT01432444|616391650|FG002|Treatment Phase|Lost to Follow-up|0|||
170559169|NCT01432444|616391648|FG000|Treatment Phase|Adverse Event|0|||
170559170|NCT01432444|616391649|FG001|Treatment Phase|Adverse Event|37|||
170559171|NCT01432444|616391650|FG002|Treatment Phase|Adverse Event|0|||
170559172|NCT01432444|616391648|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
170559173|NCT01432444|616391649|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
170559174|NCT01432444|616391650|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
170559175|NCT01432444|616391648|FG000|Treatment Phase|Physician Decision|0|||
170559176|NCT01432444|616391649|FG001|Treatment Phase|Physician Decision|5|||
170559177|NCT01432444|616391650|FG002|Treatment Phase|Physician Decision|0|||
170559178|NCT01432444|616391648|FG000|Treatment Phase|Withdrawal by Subject|0|||
170559179|NCT01432444|616391649|FG001|Treatment Phase|Withdrawal by Subject|41|||
170559180|NCT01432444|616391650|FG002|Treatment Phase|Withdrawal by Subject|0|||
170559181|NCT01432444|616391648|FG000|Treatment Phase|Protocol Deviation|0|||
170559182|NCT01432444|616391649|FG001|Treatment Phase|Protocol Deviation|3|||
170559183|NCT01432444|616391650|FG002|Treatment Phase|Protocol Deviation|0|||
170559184|NCT01432444|616391648|FG000|Treatment Phase|Lack of Efficacy|0|||
170559185|NCT01432444|616391649|FG001|Treatment Phase|Lack of Efficacy|10|||
170559186|NCT01432444|616391650|FG002|Treatment Phase|Lack of Efficacy|0|||
170559187|NCT01432444|616391648|FG000|Extension Phase|Lost to Follow-up|0|||
170559188|NCT01432444|616391649|FG001|Extension Phase|Lost to Follow-up|0|||
170559189|NCT01432444|616391650|FG002|Extension Phase|Lost to Follow-up|17|||
170559190|NCT01432444|616391648|FG000|Extension Phase|Adverse Event|0|||
170559191|NCT01432444|616391649|FG001|Extension Phase|Adverse Event|0|||
170559192|NCT01432444|616391650|FG002|Extension Phase|Adverse Event|10|||
170559193|NCT01432444|616391648|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
170559194|NCT01432444|616391649|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
170559195|NCT01432444|616391650|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
170559196|NCT01432444|616391648|FG000|Extension Phase|Met Withdrawal Criteria|0|||
170559197|NCT01432444|616391649|FG001|Extension Phase|Met Withdrawal Criteria|0|||
170559198|NCT01432444|616391650|FG002|Extension Phase|Met Withdrawal Criteria|144|||
170559199|NCT01432444|616391648|FG000|Extension Phase|Physician Decision|0|||
170559200|NCT01432444|616391649|FG001|Extension Phase|Physician Decision|0|||
170559201|NCT01432444|616391650|FG002|Extension Phase|Physician Decision|1|||
170559202|NCT01432444|616391648|FG000|Extension Phase|Withdrawal by Subject|0|||
170559203|NCT01432444|616391649|FG001|Extension Phase|Withdrawal by Subject|0|||
170559204|NCT01432444|616391650|FG002|Extension Phase|Withdrawal by Subject|13|||
170559205|NCT02301897|616391651|FG000|Treatment Course 1|Non-Compliance|0|||
170559206|NCT02301897|616391652|FG001|Treatment Course 1|Non-Compliance|0|||
170559207|NCT02301897|616391653|FG002|Treatment Course 1|Non-Compliance|1|||
170559208|NCT02301897|616391651|FG000|Treatment Course 1|Adverse Event|1|||
170559209|NCT02301897|616391652|FG001|Treatment Course 1|Adverse Event|1|||
170559210|NCT02301897|616391653|FG002|Treatment Course 1|Adverse Event|0|||
170559211|NCT02301897|616391651|FG000|Treatment Course 1|Lost to Follow-up|1|||
170559212|NCT02301897|616391652|FG001|Treatment Course 1|Lost to Follow-up|2|||
170559213|NCT02301897|616391653|FG002|Treatment Course 1|Lost to Follow-up|1|||
170559214|NCT02301897|616391651|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
170559215|NCT02301897|616391652|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
170559216|NCT02301897|616391653|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
170559217|NCT02301897|616391651|FG000|Treatment Course 1|Withdrawal by Subject|0|||
170559218|NCT02301897|616391652|FG001|Treatment Course 1|Withdrawal by Subject|0|||
170559219|NCT02301897|616391653|FG002|Treatment Course 1|Withdrawal by Subject|2|||
170559220|NCT02301897|616391651|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
170559221|NCT02301897|616391652|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
170559222|NCT02301897|616391653|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
170559223|NCT02301897|616391651|FG000|Treatment Course 2|Lost to Follow-up|0|||
170559224|NCT02301897|616391652|FG001|Treatment Course 2|Lost to Follow-up|2|||
170559225|NCT02301897|616391653|FG002|Treatment Course 2|Lost to Follow-up|0|||
170559226|NCT02301897|616391651|FG000|Treatment Course 2|Pregnancy|0|||
170559227|NCT02301897|616391652|FG001|Treatment Course 2|Pregnancy|1|||
170559228|NCT02301897|616391653|FG002|Treatment Course 2|Pregnancy|1|||
170559229|NCT02301897|616391651|FG000|Treatment Course 2|Withdrawal by Subject|0|||
170559230|NCT02301897|616391652|FG001|Treatment Course 2|Withdrawal by Subject|2|||
170559231|NCT02301897|616391653|FG002|Treatment Course 2|Withdrawal by Subject|0|||
170559232|NCT02301897|616391651|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
170559233|NCT02301897|616391652|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
170559234|NCT02301897|616391653|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
170559235|NCT00337168|616391654|FG000|Overall Study|Death|5|||
170559236|NCT00337168|616391654|FG000|Overall Study|Not protocol specified|2|||
170559237|NCT00337168|616391654|FG000|Overall Study|Did not start therapy|1|||
170559238|NCT03787615|616391655|FG000|Overall Study|Withdrawal by Subject|2|||
170559239|NCT03787615|616391655|FG000|Overall Study|Lost to Follow-up|2|||
170559240|NCT06582732|616391656|FG000|Initial Study Period|Adverse Event|0|||
170559241|NCT06582732|616391657|FG001|Initial Study Period|Adverse Event|0|||
170559242|NCT06582732|616391658|FG002|Initial Study Period|Adverse Event|0|||
170559243|NCT06582732|616391659|FG003|Initial Study Period|Adverse Event|2|||
170559244|NCT06582732|616391660|FG004|Initial Study Period|Adverse Event|0|||
170559245|NCT06582732|616391661|FG005|Initial Study Period|Adverse Event|0|||
170559246|NCT06582732|616391662|FG006|Initial Study Period|Adverse Event|0|||
170559247|NCT06582732|616391656|FG000|Initial Study Period|Death|1|||
170559248|NCT06582732|616391657|FG001|Initial Study Period|Death|0|||
170559249|NCT06582732|616391658|FG002|Initial Study Period|Death|0|||
170559250|NCT06582732|616391659|FG003|Initial Study Period|Death|0|||
170559251|NCT06582732|616391660|FG004|Initial Study Period|Death|1|||
170559252|NCT06582732|616391661|FG005|Initial Study Period|Death|0|||
170559253|NCT06582732|616391662|FG006|Initial Study Period|Death|0|||
170559254|NCT06582732|616391656|FG000|Initial Study Period|Lost to Follow-up|0|||
170559255|NCT06582732|616391657|FG001|Initial Study Period|Lost to Follow-up|0|||
170559256|NCT06582732|616391658|FG002|Initial Study Period|Lost to Follow-up|2|||
170559257|NCT06582732|616391659|FG003|Initial Study Period|Lost to Follow-up|0|||
170559258|NCT06582732|616391660|FG004|Initial Study Period|Lost to Follow-up|0|||
170645187|NCT00600119|616715892|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
170645188|NCT00600119|616715887|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
170806826|NCT01953692|617301615|FG003|Overall Study|Physician Decision|2|||
170559259|NCT06582732|616391661|FG005|Initial Study Period|Lost to Follow-up|0|||
170559260|NCT06582732|616391662|FG006|Initial Study Period|Lost to Follow-up|0|||
170559261|NCT06582732|616391656|FG000|Initial Study Period|Withdrawal by Subject|0|||
170559262|NCT06582732|616391657|FG001|Initial Study Period|Withdrawal by Subject|1|||
170559263|NCT06582732|616391658|FG002|Initial Study Period|Withdrawal by Subject|0|||
170559264|NCT06582732|616391659|FG003|Initial Study Period|Withdrawal by Subject|1|||
170559265|NCT06582732|616391660|FG004|Initial Study Period|Withdrawal by Subject|3|||
170559266|NCT06582732|616391661|FG005|Initial Study Period|Withdrawal by Subject|1|||
170559267|NCT06582732|616391662|FG006|Initial Study Period|Withdrawal by Subject|2|||
170559268|NCT06582732|616391656|FG000|Initial Study Period|Moved Away|0|||
170559269|NCT06582732|616391657|FG001|Initial Study Period|Moved Away|0|||
170559270|NCT06582732|616391658|FG002|Initial Study Period|Moved Away|0|||
170559271|NCT06582732|616391659|FG003|Initial Study Period|Moved Away|0|||
170559272|NCT06582732|616391660|FG004|Initial Study Period|Moved Away|1|||
170559273|NCT06582732|616391661|FG005|Initial Study Period|Moved Away|0|||
170559274|NCT06582732|616391662|FG006|Initial Study Period|Moved Away|0|||
170559275|NCT03931330|616391663|FG000|Overall Study|Physician Decision|1|||
170559276|NCT03412929|616391664|FG000|Overall Study|Protocol Violation|3|||
170559277|NCT01229111|616391665|FG000|Overall Study|Death|1|||
170559278|NCT01381679|616391670|FG000|Overall Study|Adverse Event|3|||
170559279|NCT01381679|616391670|FG000|Overall Study|Lost to Follow-up|885|||
170559280|NCT02697448|616391673|FG000|Overall Study|Protocol Violation|2|||
170559281|NCT02697448|616391674|FG001|Overall Study|Protocol Violation|4|||
170559282|NCT02697448|616391673|FG000|Overall Study|Clinical concerns during ablation|1|||
170559283|NCT02697448|616391674|FG001|Overall Study|Clinical concerns during ablation|1|||
170559284|NCT02697448|616391673|FG000|Overall Study|No data collected|2|||
170559285|NCT02697448|616391674|FG001|Overall Study|No data collected|0|||
170559286|NCT05473715|616391675|FG000|Overall Study|Trial terminate|2|||
170559287|NCT05473715|616391676|FG001|Overall Study|Trial terminate|1|||
170559288|NCT01946880|616391677|FG000|Overall Study|Lost to Follow-up|1|||
170559289|NCT01946880|616391678|FG001|Overall Study|Lost to Follow-up|0|||
170559290|NCT01946880|616391677|FG000|Overall Study|Physician Decision|1|||
170559291|NCT01946880|616391678|FG001|Overall Study|Physician Decision|1|||
170559292|NCT01946880|616391677|FG000|Overall Study|Withdrawal by Subject|3|||
170559293|NCT01946880|616391678|FG001|Overall Study|Withdrawal by Subject|2|||
170559294|NCT01946880|616391677|FG000|Overall Study|Met Primary Endpoint|1|||
170559295|NCT01946880|616391678|FG001|Overall Study|Met Primary Endpoint|0|||
170559296|NCT01946880|616391677|FG000|Overall Study|Personal and Family Issues|1|||
170559297|NCT01946880|616391678|FG001|Overall Study|Personal and Family Issues|0|||
170559298|NCT02609503|616391679|FG000|Overall Study|Adverse Event|1|||
170559299|NCT02609503|616391679|FG000|Overall Study|Death|1|||
170559300|NCT02609503|616391679|FG000|Overall Study|Withdrawal by Subject|1|||
170559301|NCT02609503|616391679|FG000|Overall Study|Disease progression|1|||
170559302|NCT02951819|616391680|FG000|Overall Study|Death|9|||
170559303|NCT02951819|616391681|FG001|Overall Study|Death|7|||
170559304|NCT02951819|616391680|FG000|Overall Study|Withdrawal by Subject|3|||
170559305|NCT02951819|616391681|FG001|Overall Study|Withdrawal by Subject|0|||
170559306|NCT02951819|616391680|FG000|Overall Study|Adverse Event|1|||
170559307|NCT02951819|616391681|FG001|Overall Study|Adverse Event|0|||
170559308|NCT02951819|616391680|FG000|Overall Study|Lack of Efficacy|4|||
170559309|NCT02951819|616391681|FG001|Overall Study|Lack of Efficacy|0|||
170559310|NCT02951819|616391680|FG000|Overall Study|Lost to Follow-up|1|||
170559311|NCT02951819|616391681|FG001|Overall Study|Lost to Follow-up|0|||
170559312|NCT02951819|616391680|FG000|Overall Study|Progressive Disease|1|||
170559313|NCT02951819|616391681|FG001|Overall Study|Progressive Disease|0|||
170559314|NCT02951819|616391680|FG000|Overall Study|Other|9|||
170559315|NCT02951819|616391681|FG001|Overall Study|Other|0|||
170559316|NCT00581919|616391685|FG000|Overall Study|Adverse Event|8|||
170559317|NCT00581919|616391685|FG000|Overall Study|Death|1|||
170559318|NCT00581919|616391685|FG000|Overall Study|Disease Progression|10|||
170559319|NCT00581919|616391685|FG000|Overall Study|Physician Decision|1|||
170559320|NCT00581919|616391685|FG000|Overall Study|Other Complicating Disease|1|||
170559321|NCT00581919|616391685|FG000|Overall Study|Started Non-Protocol Therapy|2|||
170559322|NCT00581919|616391685|FG000|Overall Study|Withdrawal by Subject|1|||
170559323|NCT04642079|616391686|FG000|Overall Study|Lost to Follow-up|2|||
170559324|NCT04642079|616391687|FG001|Overall Study|Lost to Follow-up|5|||
170559325|NCT04642079|616391688|FG002|Overall Study|Lost to Follow-up|2|||
170559326|NCT04642079|616391689|FG003|Overall Study|Lost to Follow-up|0|||
170559327|NCT04642079|616391686|FG000|Overall Study|Withdrawal by Subject|0|||
170559328|NCT04642079|616391687|FG001|Overall Study|Withdrawal by Subject|4|||
170559329|NCT04642079|616391688|FG002|Overall Study|Withdrawal by Subject|1|||
170559330|NCT04642079|616391689|FG003|Overall Study|Withdrawal by Subject|2|||
170559331|NCT04642079|616391686|FG000|Overall Study|Other|0|||
170559332|NCT04642079|616391687|FG001|Overall Study|Other|0|||
170559333|NCT04642079|616391688|FG002|Overall Study|Other|0|||
170559334|NCT04642079|616391689|FG003|Overall Study|Other|1|||
170559335|NCT04642079|616391686|FG000|Overall Study|No longer met eligibility criteria|1|||
170559336|NCT04642079|616391687|FG001|Overall Study|No longer met eligibility criteria|0|||
170559337|NCT04642079|616391688|FG002|Overall Study|No longer met eligibility criteria|1|||
170806827|NCT01953692|617301616|FG004|Overall Study|Physician Decision|1|||
170559338|NCT04642079|616391689|FG003|Overall Study|No longer met eligibility criteria|1|||
170559339|NCT02420314|616391691|FG000|Overall Study|Withdrawal by Subject|1|||
170559340|NCT02420314|616391691|FG000|Overall Study|Protocol Violation|1|||
170559341|NCT04079920|616391692|FG000|Overall Study|Adverse event, not related to study drug|2|||
170559342|NCT04079920|616391692|FG000|Overall Study|Adverse event related to study drug|10|||
170559343|NCT04079920|616391692|FG000|Overall Study|Death|2|||
170559344|NCT04079920|616391692|FG000|Overall Study|Lost to Follow-up|22|||
170559345|NCT04079920|616391692|FG000|Overall Study|Physician Decision|1|||
170559346|NCT04079920|616391692|FG000|Overall Study|Withdrawal by Subject|11|||
170559347|NCT03760068|616391693|FG000|Overall Study|Withdrawal by Subject|7|||
170559348|NCT03760068|616391694|FG001|Overall Study|Withdrawal by Subject|8|||
170559349|NCT03760068|616391693|FG000|Overall Study|Adverse Event|1|||
170559350|NCT03760068|616391694|FG001|Overall Study|Adverse Event|2|||
170559351|NCT03760068|616391693|FG000|Overall Study|Administrative Decision by Sponsor|0|||
170559352|NCT03760068|616391694|FG001|Overall Study|Administrative Decision by Sponsor|2|||
170559353|NCT03760068|616391693|FG000|Overall Study|Physician Decision|1|||
170559354|NCT03760068|616391694|FG001|Overall Study|Physician Decision|2|||
170559355|NCT03760068|616391693|FG000|Overall Study|Lost to Follow-up|4|||
170559356|NCT03760068|616391694|FG001|Overall Study|Lost to Follow-up|9|||
170559357|NCT03760068|616391693|FG000|Overall Study|Subject Moved Out of State|1|||
170559358|NCT03760068|616391694|FG001|Overall Study|Subject Moved Out of State|0|||
170559359|NCT05430919|616391695|FG000|Overall Study|Protocol Violation|0|||
170559360|NCT05430919|616391696|FG001|Overall Study|Protocol Violation|0|||
170559361|NCT05430919|616391697|FG002|Overall Study|Protocol Violation|1|||
170559362|NCT05430919|616391698|FG003|Overall Study|Protocol Violation|0|||
170559363|NCT05430919|616391695|FG000|Overall Study|Lost to Follow-up|0|||
170559364|NCT05430919|616391696|FG001|Overall Study|Lost to Follow-up|1|||
170559365|NCT05430919|616391697|FG002|Overall Study|Lost to Follow-up|0|||
170559366|NCT05430919|616391698|FG003|Overall Study|Lost to Follow-up|0|||
170559367|NCT05430919|616391695|FG000|Overall Study|Withdrawal by Subject|3|||
170559368|NCT05430919|616391696|FG001|Overall Study|Withdrawal by Subject|0|||
170559369|NCT05430919|616391697|FG002|Overall Study|Withdrawal by Subject|0|||
170559370|NCT05430919|616391698|FG003|Overall Study|Withdrawal by Subject|1|||
170559371|NCT01618708|616391701|FG000|Overall Study|Adverse Event|10|||
170559372|NCT01618708|616391702|FG001|Overall Study|Adverse Event|10|||
170559373|NCT01618708|616391701|FG000|Overall Study|Lost to Follow-up|3|||
170559374|NCT01618708|616391702|FG001|Overall Study|Lost to Follow-up|3|||
170559375|NCT01618708|616391701|FG000|Overall Study|Withdrawal by Subject|17|||
170559376|NCT01618708|616391702|FG001|Overall Study|Withdrawal by Subject|22|||
170559377|NCT01618708|616391701|FG000|Overall Study|Lack of Efficacy|8|||
170559378|NCT01618708|616391702|FG001|Overall Study|Lack of Efficacy|8|||
170559379|NCT01618708|616391701|FG000|Overall Study|Technical problems|2|||
170559380|NCT01618708|616391702|FG001|Overall Study|Technical problems|0|||
170559381|NCT01618708|616391701|FG000|Overall Study|Other than specified above|1|||
170559382|NCT01618708|616391702|FG001|Overall Study|Other than specified above|1|||
170559383|NCT01618708|616391701|FG000|Overall Study|Randomized but not treated|3|||
170559384|NCT01618708|616391702|FG001|Overall Study|Randomized but not treated|2|||
170559385|NCT00050011|616391710|FG000|Overall Study|Adverse Event|41|||
170559386|NCT00050011|616391711|FG001|Overall Study|Adverse Event|46|||
170559387|NCT00050011|616391710|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170559388|NCT00050011|616391711|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170559389|NCT00050011|616391710|FG000|Overall Study|Abnormal test procedure results|0|||
170559390|NCT00050011|616391711|FG001|Overall Study|Abnormal test procedure results|1|||
170559391|NCT00050011|616391710|FG000|Overall Study|Lack of Efficacy|16|||
170559392|NCT00050011|616391711|FG001|Overall Study|Lack of Efficacy|21|||
170559393|NCT00050011|616391710|FG000|Overall Study|Participant condition no longer required|1|||
170559394|NCT00050011|616391711|FG001|Overall Study|Participant condition no longer required|0|||
170559395|NCT00050011|616391710|FG000|Overall Study|Protocol Violation|4|||
170559396|NCT00050011|616391711|FG001|Overall Study|Protocol Violation|10|||
170559397|NCT00050011|616391710|FG000|Overall Study|Withdrawal by Subject|34|||
170559398|NCT00050011|616391711|FG001|Overall Study|Withdrawal by Subject|26|||
170559399|NCT00050011|616391710|FG000|Overall Study|Lost to Follow-up|7|||
170559400|NCT00050011|616391711|FG001|Overall Study|Lost to Follow-up|9|||
170559401|NCT00050011|616391710|FG000|Overall Study|Administrative problems|10|||
170559402|NCT00050011|616391711|FG001|Overall Study|Administrative problems|6|||
170559403|NCT00050011|616391710|FG000|Overall Study|Death|7|||
170559404|NCT00050011|616391711|FG001|Overall Study|Death|4|||
170559405|NCT00050011|616391710|FG000|Overall Study|Unknown - Reason is missing|0|||
170559406|NCT00050011|616391711|FG001|Overall Study|Unknown - Reason is missing|2|||
170559407|NCT00323622|616391713|FG000|Overall Study|Other|30|||
170559408|NCT00323622|616391714|FG001|Overall Study|Other|91|||
170559409|NCT00323622|616391715|FG002|Overall Study|Other|4|||
170559410|NCT00323622|616391716|FG003|Overall Study|Other|12|||
170559411|NCT00323622|616391717|FG004|Overall Study|Other|32|||
170559412|NCT00323622|616391718|FG005|Overall Study|Other|74|||
170559413|NCT00323622|616391719|FG006|Overall Study|Other|5|||
170559414|NCT00323622|616391720|FG007|Overall Study|Other|13|||
170559415|NCT00323622|616391713|FG000|Overall Study|Death|1|||
170559416|NCT00323622|616391714|FG001|Overall Study|Death|1|||
170559417|NCT00323622|616391715|FG002|Overall Study|Death|0|||
170559418|NCT00323622|616391716|FG003|Overall Study|Death|0|||
170559419|NCT00323622|616391717|FG004|Overall Study|Death|7|||
170559420|NCT00323622|616391718|FG005|Overall Study|Death|0|||
170559421|NCT00323622|616391719|FG006|Overall Study|Death|0|||
170559422|NCT00323622|616391720|FG007|Overall Study|Death|2|||
170559423|NCT02412436|616391721|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
170559424|NCT02412436|616391721|FG000|Overall Study|Lost to Follow-up|6|||
170559425|NCT02412436|616391721|FG000|Overall Study|Unable to get to clinic|3|||
170559426|NCT02412436|616391721|FG000|Overall Study|Death|1|||
170559427|NCT02412436|616391721|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
170559428|NCT00911157|616391724|FG000|Overall Study|Adverse Event|4|||
170559429|NCT00911157|616391725|FG001|Overall Study|Adverse Event|1|||
170559430|NCT00911157|616391724|FG000|Overall Study|Withdrawal by Subject|1|||
170559431|NCT00911157|616391725|FG001|Overall Study|Withdrawal by Subject|1|||
170565515|NCT03036852|616418552|FG000|Overall Study|Lost to Follow-up|1|||
170565516|NCT00163189|616418558|FG000|Overall Study|Other|6|||
170559432|NCT00911157|616391724|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
170559433|NCT00911157|616391725|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
170559434|NCT00911157|616391724|FG000|Overall Study|Need to treat for lung cancer|1|||
170559435|NCT00911157|616391725|FG001|Overall Study|Need to treat for lung cancer|0|||
170559436|NCT04650893|616391726|FG000|Overall Study|Lost to Follow-up|11|||
170559437|NCT04650893|616391727|FG001|Overall Study|Lost to Follow-up|10|||
170559438|NCT04650893|616391728|FG002|Overall Study|Lost to Follow-up|11|||
170559439|NCT04573881|616391729|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
170559440|NCT00488293|616393194|FG000|Overall Study|Lost to Follow-up|28|||
170559441|NCT00488293|616393195|FG001|Overall Study|Lost to Follow-up|25|||
170559442|NCT00488293|616393194|FG000|Overall Study|Withdrawal by Subject|5|||
170559443|NCT00488293|616393195|FG001|Overall Study|Withdrawal by Subject|3|||
170559444|NCT00488293|616393194|FG000|Overall Study|Death|2|||
170559445|NCT00488293|616393195|FG001|Overall Study|Death|1|||
170559446|NCT00488293|616393194|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
170559447|NCT00488293|616393195|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
170559448|NCT00500331|616393196|FG000|Overall Study|Adverse Event|0|||
170559449|NCT00500331|616393197|FG001|Overall Study|Adverse Event|2|||
170559450|NCT00500331|616393198|FG002|Overall Study|Adverse Event|0|||
170559451|NCT00500331|616393199|FG003|Overall Study|Adverse Event|1|||
170559452|NCT00500331|616393200|FG004|Overall Study|Adverse Event|2|||
170559453|NCT00500331|616393201|FG005|Overall Study|Adverse Event|2|||
170559454|NCT00500331|616393202|FG006|Overall Study|Adverse Event|0|||
170559455|NCT00500331|616393196|FG000|Overall Study|Lost to Follow-up|1|||
170559456|NCT00500331|616393197|FG001|Overall Study|Lost to Follow-up|1|||
170559457|NCT00500331|616393198|FG002|Overall Study|Lost to Follow-up|1|||
170559458|NCT00500331|616393199|FG003|Overall Study|Lost to Follow-up|2|||
170559459|NCT00500331|616393200|FG004|Overall Study|Lost to Follow-up|1|||
170559460|NCT00500331|616393201|FG005|Overall Study|Lost to Follow-up|0|||
170559461|NCT00500331|616393202|FG006|Overall Study|Lost to Follow-up|0|||
170559462|NCT00500331|616393196|FG000|Overall Study|Protocol Violation|3|||
170559463|NCT00500331|616393197|FG001|Overall Study|Protocol Violation|1|||
170559464|NCT00500331|616393198|FG002|Overall Study|Protocol Violation|1|||
170559465|NCT00500331|616393199|FG003|Overall Study|Protocol Violation|0|||
170559466|NCT00500331|616393200|FG004|Overall Study|Protocol Violation|1|||
170559467|NCT00500331|616393201|FG005|Overall Study|Protocol Violation|1|||
170559468|NCT00500331|616393202|FG006|Overall Study|Protocol Violation|1|||
170559469|NCT00500331|616393196|FG000|Overall Study|Withdrawal by Subject|4|||
170559470|NCT00500331|616393197|FG001|Overall Study|Withdrawal by Subject|0|||
170559471|NCT00500331|616393198|FG002|Overall Study|Withdrawal by Subject|1|||
170559472|NCT00500331|616393199|FG003|Overall Study|Withdrawal by Subject|5|||
170559473|NCT00500331|616393200|FG004|Overall Study|Withdrawal by Subject|0|||
170559474|NCT00500331|616393201|FG005|Overall Study|Withdrawal by Subject|1|||
170559475|NCT00500331|616393202|FG006|Overall Study|Withdrawal by Subject|1|||
170559476|NCT00500331|616393196|FG000|Overall Study|Lack of Efficacy|3|||
170559477|NCT00500331|616393197|FG001|Overall Study|Lack of Efficacy|1|||
170559478|NCT00500331|616393198|FG002|Overall Study|Lack of Efficacy|0|||
170559479|NCT00500331|616393199|FG003|Overall Study|Lack of Efficacy|0|||
170559480|NCT00500331|616393200|FG004|Overall Study|Lack of Efficacy|0|||
170559481|NCT00500331|616393201|FG005|Overall Study|Lack of Efficacy|0|||
170559482|NCT00500331|616393202|FG006|Overall Study|Lack of Efficacy|0|||
170559483|NCT00500331|616393196|FG000|Overall Study|Liver function test abnormality|0|||
170559484|NCT00500331|616393197|FG001|Overall Study|Liver function test abnormality|0|||
170559485|NCT00500331|616393198|FG002|Overall Study|Liver function test abnormality|1|||
170645189|NCT00600119|616715888|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
170645190|NCT00600119|616715889|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
170559486|NCT00500331|616393199|FG003|Overall Study|Liver function test abnormality|0|||
170559487|NCT00500331|616393200|FG004|Overall Study|Liver function test abnormality|0|||
170559488|NCT00500331|616393201|FG005|Overall Study|Liver function test abnormality|0|||
170559489|NCT00500331|616393202|FG006|Overall Study|Liver function test abnormality|0|||
170559490|NCT00500331|616393196|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
170559491|NCT00500331|616393197|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
170559492|NCT00500331|616393198|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
170559493|NCT00500331|616393199|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
170559494|NCT00500331|616393200|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
170559495|NCT00500331|616393201|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
170559496|NCT00500331|616393202|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
170645191|NCT00600119|616715890|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
170559497|NCT00500331|616393196|FG000|Overall Study|Didn't return for continuation of study|1|||
170559498|NCT00500331|616393197|FG001|Overall Study|Didn't return for continuation of study|0|||
170559499|NCT00500331|616393198|FG002|Overall Study|Didn't return for continuation of study|0|||
170559500|NCT00500331|616393199|FG003|Overall Study|Didn't return for continuation of study|0|||
170559501|NCT00500331|616393200|FG004|Overall Study|Didn't return for continuation of study|0|||
170559502|NCT00500331|616393201|FG005|Overall Study|Didn't return for continuation of study|0|||
170559503|NCT00500331|616393202|FG006|Overall Study|Didn't return for continuation of study|0|||
170559504|NCT00500331|616393196|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
170559505|NCT00500331|616393197|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
170559506|NCT00500331|616393198|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
170559507|NCT00500331|616393199|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
170559508|NCT00500331|616393200|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
170559509|NCT00500331|616393201|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
170559510|NCT00500331|616393202|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
170559511|NCT00500331|616393196|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
170559512|NCT00500331|616393197|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
170559513|NCT00500331|616393198|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
170559514|NCT00500331|616393199|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
170559515|NCT00500331|616393200|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
170559516|NCT00500331|616393201|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
170559517|NCT00500331|616393202|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
170559518|NCT00500331|616393196|FG000|Overall Study|Participant was randomized by mistake|1|||
170559519|NCT00500331|616393197|FG001|Overall Study|Participant was randomized by mistake|0|||
170559520|NCT00500331|616393198|FG002|Overall Study|Participant was randomized by mistake|0|||
170559521|NCT00500331|616393199|FG003|Overall Study|Participant was randomized by mistake|0|||
170559522|NCT00500331|616393200|FG004|Overall Study|Participant was randomized by mistake|0|||
170559523|NCT00500331|616393201|FG005|Overall Study|Participant was randomized by mistake|0|||
170559524|NCT00500331|616393202|FG006|Overall Study|Participant was randomized by mistake|0|||
170559525|NCT00500331|616393196|FG000|Overall Study|Diabetologist nurse in the study|0|||
170559526|NCT00500331|616393197|FG001|Overall Study|Diabetologist nurse in the study|0|||
170559527|NCT00500331|616393198|FG002|Overall Study|Diabetologist nurse in the study|1|||
170559528|NCT00500331|616393199|FG003|Overall Study|Diabetologist nurse in the study|0|||
170559529|NCT00500331|616393200|FG004|Overall Study|Diabetologist nurse in the study|0|||
170559530|NCT00500331|616393201|FG005|Overall Study|Diabetologist nurse in the study|0|||
170559531|NCT00500331|616393202|FG006|Overall Study|Diabetologist nurse in the study|0|||
170559532|NCT00500331|616393196|FG000|Overall Study|State ban of biological samples export|0|||
170559533|NCT00500331|616393197|FG001|Overall Study|State ban of biological samples export|0|||
170559534|NCT00500331|616393198|FG002|Overall Study|State ban of biological samples export|0|||
170559535|NCT00500331|616393199|FG003|Overall Study|State ban of biological samples export|1|||
170559536|NCT00500331|616393200|FG004|Overall Study|State ban of biological samples export|0|||
170559537|NCT00500331|616393201|FG005|Overall Study|State ban of biological samples export|0|||
170559538|NCT00500331|616393202|FG006|Overall Study|State ban of biological samples export|0|||
170559539|NCT00500331|616393196|FG000|Overall Study|Protocol violated|0|||
170559540|NCT00500331|616393197|FG001|Overall Study|Protocol violated|0|||
170559541|NCT00500331|616393198|FG002|Overall Study|Protocol violated|0|||
170559542|NCT00500331|616393199|FG003|Overall Study|Protocol violated|1|||
170559543|NCT00500331|616393200|FG004|Overall Study|Protocol violated|0|||
170559544|NCT00500331|616393201|FG005|Overall Study|Protocol violated|0|||
170559545|NCT00500331|616393202|FG006|Overall Study|Protocol violated|0|||
170559546|NCT00939185|616393205|FG000|Overall Study|Adverse Event|3|||
170559547|NCT00939185|616393205|FG000|Overall Study|Lack of Efficacy|1|||
170559548|NCT00939185|616393205|FG000|Overall Study|Lost to Follow-up|6|||
170559549|NCT00939185|616393205|FG000|Overall Study|Other|3|||
170559550|NCT00939185|616393205|FG000|Overall Study|Withdrawal by Subject|2|||
170559551|NCT00939185|616393205|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
170559552|NCT00363298|616393206|FG000|First Study Week|Lack of Efficacy|6|||
170559553|NCT00363298|616393207|FG001|First Study Week|Lack of Efficacy|5|||
170559554|NCT00363298|616393206|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
170559555|NCT00363298|616393207|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
170559556|NCT03468998|616393210|FG000|Overall Study|Withdrawal by Subject|1|||
170559557|NCT03468998|616393211|FG001|Overall Study|Withdrawal by Subject|1|||
170559558|NCT03468998|616393212|FG002|Overall Study|Withdrawal by Subject|0|||
170559559|NCT03468998|616393213|FG003|Overall Study|Withdrawal by Subject|4|||
170559560|NCT03468998|616393214|FG004|Overall Study|Withdrawal by Subject|1|||
170559561|NCT03468998|616393215|FG005|Overall Study|Withdrawal by Subject|0|||
170559562|NCT00959049|616393216|FG000|Overall Study|Adverse Event|1|||
170559563|NCT00959049|616393217|FG001|Overall Study|Adverse Event|0|||
170559564|NCT00959049|616393218|FG002|Overall Study|Adverse Event|0|||
170559565|NCT00959049|616393219|FG003|Overall Study|Adverse Event|0|||
170559566|NCT00959049|616393220|FG004|Overall Study|Adverse Event|0|||
170559567|NCT00959049|616393221|FG005|Overall Study|Adverse Event|0|||
170559568|NCT00959049|616393216|FG000|Overall Study|Lost to Follow-up|17|||
170559569|NCT00959049|616393217|FG001|Overall Study|Lost to Follow-up|5|||
170559570|NCT00959049|616393218|FG002|Overall Study|Lost to Follow-up|1|||
170559571|NCT00959049|616393219|FG003|Overall Study|Lost to Follow-up|10|||
170559572|NCT00959049|616393220|FG004|Overall Study|Lost to Follow-up|9|||
170559573|NCT00959049|616393221|FG005|Overall Study|Lost to Follow-up|1|||
170559574|NCT00959049|616393216|FG000|Overall Study|Contraindicated medication|0|||
170559575|NCT00959049|616393217|FG001|Overall Study|Contraindicated medication|0|||
170559576|NCT00959049|616393218|FG002|Overall Study|Contraindicated medication|0|||
170559577|NCT00959049|616393219|FG003|Overall Study|Contraindicated medication|1|||
170559578|NCT00959049|616393220|FG004|Overall Study|Contraindicated medication|0|||
170559579|NCT00959049|616393221|FG005|Overall Study|Contraindicated medication|0|||
170559580|NCT00959049|616393216|FG000|Overall Study|Withdrawal by Subject|0|||
170559581|NCT00959049|616393217|FG001|Overall Study|Withdrawal by Subject|2|||
170559582|NCT00959049|616393218|FG002|Overall Study|Withdrawal by Subject|0|||
170559583|NCT00959049|616393219|FG003|Overall Study|Withdrawal by Subject|0|||
170559584|NCT00959049|616393220|FG004|Overall Study|Withdrawal by Subject|0|||
170559585|NCT00959049|616393221|FG005|Overall Study|Withdrawal by Subject|0|||
170559586|NCT02801578|616393222|FG000|Overall Study|Adverse Event|2|||
170559587|NCT00137449|616393223|FG000|Overall Study|Disease Progression|8|||
170559588|NCT00137449|616393224|FG001|Overall Study|Disease Progression|13|||
170559589|NCT00137449|616393223|FG000|Overall Study|Death|4|||
170559590|NCT00137449|616393224|FG001|Overall Study|Death|3|||
170559591|NCT00137449|616393223|FG000|Overall Study|Adverse Event|3|||
170559592|NCT00137449|616393224|FG001|Overall Study|Adverse Event|1|||
170559593|NCT00137449|616393223|FG000|Overall Study|Withdrawal by Subject|1|||
170559594|NCT00137449|616393224|FG001|Overall Study|Withdrawal by Subject|1|||
170559595|NCT01356940|616393227|FG000|First Intervention (28 Days)|Adverse Event|1|||
170559596|NCT01356940|616393228|FG001|First Intervention (28 Days)|Adverse Event|0|||
170559597|NCT01356940|616393227|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
170559598|NCT01356940|616393228|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
170559599|NCT03412591|616393231|FG000|Overall Study|Withdrawal by Subject|1|||
170559600|NCT03412591|616393232|FG001|Overall Study|Withdrawal by Subject|8|||
170559601|NCT03412591|616393231|FG000|Overall Study|Adverse Event|0|||
170559602|NCT03412591|616393232|FG001|Overall Study|Adverse Event|1|||
170559603|NCT01892189|616393233|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
170559604|NCT01892189|616393234|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
170559605|NCT01892189|616393235|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
170559606|NCT01892189|616393236|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
170559607|NCT01892189|616393237|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
170559608|NCT01892189|616393238|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
170559609|NCT01892189|616393239|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
170559610|NCT01892189|616393240|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
170559611|NCT01892189|616393241|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
170559612|NCT01892189|616393233|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170559613|NCT01892189|616393234|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170645192|NCT00600119|616715891|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
170645193|NCT00600119|616715892|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
170645194|NCT00600119|616715887|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
170645195|NCT00600119|616715888|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
170559614|NCT01892189|616393235|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
170559615|NCT01892189|616393236|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
170559616|NCT01892189|616393237|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170559617|NCT01892189|616393238|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170559618|NCT01892189|616393239|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
170559619|NCT01892189|616393240|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170559620|NCT01892189|616393241|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
170559621|NCT01892189|616393233|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
170559622|NCT01892189|616393234|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
170559623|NCT01892189|616393235|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
170559624|NCT01892189|616393236|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
170559625|NCT01892189|616393237|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
170559626|NCT01892189|616393238|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
170559627|NCT01892189|616393239|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
170559628|NCT01892189|616393240|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
170559629|NCT01892189|616393241|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
170559630|NCT00856557|616393248|FG000|Overall Study|No patients with contextual flags|12|||
170559631|NCT00856557|616393249|FG001|Overall Study|No patients with contextual flags|16|||
170559632|NCT01052779|616393252|FG000|Overall Study|Adverse Event|1|||
170559633|NCT01052779|616393253|FG001|Overall Study|Adverse Event|4|||
170559634|NCT01052779|616393252|FG000|Overall Study|Withdrawal by Subject|1|||
170559635|NCT01052779|616393253|FG001|Overall Study|Withdrawal by Subject|2|||
170559636|NCT01052779|616393252|FG000|Overall Study|Other-Protocol Violation|1|||
170559637|NCT01052779|616393253|FG001|Overall Study|Other-Protocol Violation|1|||
170559638|NCT01052779|616393252|FG000|Overall Study|Other-Surgery|0|||
170559639|NCT01052779|616393253|FG001|Overall Study|Other-Surgery|2|||
170559640|NCT01052779|616393252|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
170559641|NCT01052779|616393253|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
170559642|NCT02684461|616393254|FG000|Overall Study|Adverse Event|1|||
170559643|NCT02684461|616393255|FG001|Overall Study|Adverse Event|0|||
170559644|NCT02684461|616393256|FG002|Overall Study|Adverse Event|0|||
170559645|NCT02684461|616393254|FG000|Overall Study|Lack of Efficacy|1|||
170559646|NCT02684461|616393255|FG001|Overall Study|Lack of Efficacy|2|||
170559647|NCT02684461|616393256|FG002|Overall Study|Lack of Efficacy|0|||
170559648|NCT04507204|616393257|FG000|Overall Study|Adverse Event|8|||
170559649|NCT04507204|616393258|FG001|Overall Study|Adverse Event|13|||
170559650|NCT04507204|616393257|FG000|Overall Study|Death|0|||
170559651|NCT04507204|616393258|FG001|Overall Study|Death|1|||
170559652|NCT04507204|616393257|FG000|Overall Study|Lost to Follow-up|15|||
170559653|NCT04507204|616393258|FG001|Overall Study|Lost to Follow-up|14|||
170559654|NCT04507204|616393257|FG000|Overall Study|Poor Compliance with Protocol|2|||
170559655|NCT04507204|616393258|FG001|Overall Study|Poor Compliance with Protocol|4|||
170559656|NCT04507204|616393257|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
170559657|NCT04507204|616393258|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
170559658|NCT04507204|616393257|FG000|Overall Study|Withdrawal of Patient Consent|21|||
170559659|NCT04507204|616393258|FG001|Overall Study|Withdrawal of Patient Consent|13|||
170559660|NCT00557440|616393259|FG000|Treatment Period 1|Adverse Event|0|||
170559661|NCT00557440|616393260|FG001|Treatment Period 1|Adverse Event|0|||
170559662|NCT00557440|616393261|FG002|Treatment Period 1|Adverse Event|1|||
170559663|NCT00814983|616393264|FG000|Overall Study|Screen failure|1|||
170559664|NCT00814983|616393265|FG001|Overall Study|Screen failure|0|||
170559665|NCT00814983|616393264|FG000|Overall Study|Withdrawal by Subject|1|||
170559666|NCT00814983|616393265|FG001|Overall Study|Withdrawal by Subject|0|||
170559667|NCT00814983|616393264|FG000|Overall Study|Graft failure|1|||
170559668|NCT00814983|616393265|FG001|Overall Study|Graft failure|0|||
170559669|NCT00425555|616393266|FG000|Overall Study|Withdrawal by Subject|11|||
170559670|NCT00425555|616393267|FG001|Overall Study|Withdrawal by Subject|8|||
170559671|NCT00425555|616393266|FG000|Overall Study|Lost to Follow-up|0|||
170559672|NCT00425555|616393267|FG001|Overall Study|Lost to Follow-up|1|||
170559673|NCT00425555|616393266|FG000|Overall Study|Administrative problems|3|||
170559674|NCT00425555|616393267|FG001|Overall Study|Administrative problems|0|||
170559675|NCT00425555|616393266|FG000|Overall Study|Death|1|||
170905291|NCT00749203|617656069|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
170905292|NCT00749203|617656068|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
170905293|NCT00749203|617656069|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
170559676|NCT00425555|616393267|FG001|Overall Study|Death|2|||
170559677|NCT00425555|616393266|FG000|Overall Study|New cancer therapy|2|||
170559678|NCT00425555|616393267|FG001|Overall Study|New cancer therapy|1|||
170559679|NCT00425555|616393266|FG000|Overall Study|Disease progression|36|||
170559680|NCT00425555|616393267|FG001|Overall Study|Disease progression|33|||
170559681|NCT00425555|616393266|FG000|Overall Study|Adverse Event|25|||
170559682|NCT00425555|616393267|FG001|Overall Study|Adverse Event|15|||
170559683|NCT00425555|616393266|FG000|Overall Study|Protocol Violation|1|||
170559684|NCT00425555|616393267|FG001|Overall Study|Protocol Violation|0|||
170559685|NCT02327169|616393269|FG000|Overall Study|Progressive Disease|1|||
170559686|NCT02327169|616393270|FG001|Overall Study|Progressive Disease|3|||
170559687|NCT02327169|616393271|FG002|Overall Study|Progressive Disease|4|||
170559688|NCT02327169|616393272|FG003|Overall Study|Progressive Disease|3|||
170559689|NCT02327169|616393273|FG004|Overall Study|Progressive Disease|4|||
170559690|NCT02327169|616393274|FG005|Overall Study|Progressive Disease|3|||
170559691|NCT02327169|616393275|FG006|Overall Study|Progressive Disease|3|||
170559692|NCT02327169|616393276|FG007|Overall Study|Progressive Disease|3|||
170559693|NCT02327169|616393277|FG008|Overall Study|Progressive Disease|4|||
170559694|NCT02327169|616393278|FG009|Overall Study|Progressive Disease|4|||
170559695|NCT02327169|616393279|FG010|Overall Study|Progressive Disease|4|||
170559696|NCT02327169|616393280|FG011|Overall Study|Progressive Disease|3|||
170559697|NCT02327169|616393281|FG012|Overall Study|Progressive Disease|1|||
170559698|NCT02327169|616393282|FG013|Overall Study|Progressive Disease|3|||
170559699|NCT02327169|616393283|FG014|Overall Study|Progressive Disease|3|||
170559700|NCT02327169|616393269|FG000|Overall Study|Adverse Event|2|||
170559701|NCT02327169|616393270|FG001|Overall Study|Adverse Event|0|||
170559702|NCT02327169|616393271|FG002|Overall Study|Adverse Event|1|||
170559703|NCT02327169|616393272|FG003|Overall Study|Adverse Event|0|||
170559704|NCT02327169|616393273|FG004|Overall Study|Adverse Event|1|||
170559705|NCT02327169|616393274|FG005|Overall Study|Adverse Event|0|||
170559706|NCT02327169|616393275|FG006|Overall Study|Adverse Event|0|||
170559707|NCT02327169|616393276|FG007|Overall Study|Adverse Event|0|||
170559708|NCT02327169|616393277|FG008|Overall Study|Adverse Event|0|||
170559709|NCT02327169|616393278|FG009|Overall Study|Adverse Event|2|||
170559710|NCT02327169|616393279|FG010|Overall Study|Adverse Event|0|||
170905294|NCT00749203|617656068|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
170559711|NCT02327169|616393280|FG011|Overall Study|Adverse Event|3|||
170559712|NCT02327169|616393281|FG012|Overall Study|Adverse Event|0|||
170559713|NCT02327169|616393282|FG013|Overall Study|Adverse Event|2|||
170559714|NCT02327169|616393283|FG014|Overall Study|Adverse Event|1|||
170559715|NCT02327169|616393269|FG000|Overall Study|Symptomatic Deterioration|0|||
170559716|NCT02327169|616393270|FG001|Overall Study|Symptomatic Deterioration|0|||
170559717|NCT02327169|616393271|FG002|Overall Study|Symptomatic Deterioration|1|||
170565517|NCT00163189|616418558|FG000|Overall Study|Lost to Follow-up|1|||
170559718|NCT02327169|616393272|FG003|Overall Study|Symptomatic Deterioration|0|||
170559719|NCT02327169|616393273|FG004|Overall Study|Symptomatic Deterioration|1|||
170559720|NCT02327169|616393274|FG005|Overall Study|Symptomatic Deterioration|1|||
170559721|NCT02327169|616393275|FG006|Overall Study|Symptomatic Deterioration|0|||
170559722|NCT02327169|616393276|FG007|Overall Study|Symptomatic Deterioration|0|||
170559723|NCT02327169|616393277|FG008|Overall Study|Symptomatic Deterioration|2|||
170559724|NCT02327169|616393278|FG009|Overall Study|Symptomatic Deterioration|1|||
170559725|NCT02327169|616393279|FG010|Overall Study|Symptomatic Deterioration|0|||
170559726|NCT02327169|616393280|FG011|Overall Study|Symptomatic Deterioration|0|||
170559727|NCT02327169|616393281|FG012|Overall Study|Symptomatic Deterioration|0|||
170559728|NCT02327169|616393282|FG013|Overall Study|Symptomatic Deterioration|2|||
170559729|NCT02327169|616393283|FG014|Overall Study|Symptomatic Deterioration|1|||
170559730|NCT02327169|616393269|FG000|Overall Study|Reason Not Specified|0|||
170559731|NCT02327169|616393270|FG001|Overall Study|Reason Not Specified|0|||
170559732|NCT02327169|616393271|FG002|Overall Study|Reason Not Specified|1|||
170559733|NCT02327169|616393272|FG003|Overall Study|Reason Not Specified|0|||
170559734|NCT02327169|616393273|FG004|Overall Study|Reason Not Specified|0|||
170559735|NCT02327169|616393274|FG005|Overall Study|Reason Not Specified|0|||
170559736|NCT02327169|616393275|FG006|Overall Study|Reason Not Specified|0|||
170559737|NCT02327169|616393276|FG007|Overall Study|Reason Not Specified|0|||
170559738|NCT02327169|616393277|FG008|Overall Study|Reason Not Specified|0|||
170559739|NCT02327169|616393278|FG009|Overall Study|Reason Not Specified|1|||
170559740|NCT02327169|616393279|FG010|Overall Study|Reason Not Specified|2|||
170559741|NCT02327169|616393280|FG011|Overall Study|Reason Not Specified|1|||
170559742|NCT02327169|616393281|FG012|Overall Study|Reason Not Specified|0|||
170559743|NCT02327169|616393282|FG013|Overall Study|Reason Not Specified|0|||
170559744|NCT02327169|616393283|FG014|Overall Study|Reason Not Specified|2|||
170559745|NCT02327169|616393269|FG000|Overall Study|Withdrawal by Subject|1|||
170559746|NCT02327169|616393270|FG001|Overall Study|Withdrawal by Subject|0|||
170559747|NCT02327169|616393271|FG002|Overall Study|Withdrawal by Subject|0|||
170559748|NCT02327169|616393272|FG003|Overall Study|Withdrawal by Subject|0|||
170559749|NCT02327169|616393273|FG004|Overall Study|Withdrawal by Subject|1|||
170559750|NCT02327169|616393274|FG005|Overall Study|Withdrawal by Subject|0|||
170559751|NCT02327169|616393275|FG006|Overall Study|Withdrawal by Subject|0|||
170559752|NCT02327169|616393276|FG007|Overall Study|Withdrawal by Subject|1|||
170559753|NCT02327169|616393277|FG008|Overall Study|Withdrawal by Subject|0|||
170559754|NCT02327169|616393278|FG009|Overall Study|Withdrawal by Subject|0|||
170559755|NCT02327169|616393279|FG010|Overall Study|Withdrawal by Subject|0|||
170559756|NCT02327169|616393280|FG011|Overall Study|Withdrawal by Subject|0|||
170559757|NCT02327169|616393281|FG012|Overall Study|Withdrawal by Subject|0|||
170559758|NCT02327169|616393282|FG013|Overall Study|Withdrawal by Subject|0|||
170559759|NCT02327169|616393283|FG014|Overall Study|Withdrawal by Subject|3|||
170559760|NCT02327169|616393269|FG000|Overall Study|Lost to Follow-up|0|||
170559761|NCT02327169|616393270|FG001|Overall Study|Lost to Follow-up|0|||
170559762|NCT02327169|616393271|FG002|Overall Study|Lost to Follow-up|0|||
170559763|NCT02327169|616393272|FG003|Overall Study|Lost to Follow-up|0|||
170559764|NCT02327169|616393273|FG004|Overall Study|Lost to Follow-up|1|||
170559765|NCT02327169|616393274|FG005|Overall Study|Lost to Follow-up|0|||
170559766|NCT02327169|616393275|FG006|Overall Study|Lost to Follow-up|0|||
170559767|NCT02327169|616393276|FG007|Overall Study|Lost to Follow-up|0|||
170559768|NCT02327169|616393277|FG008|Overall Study|Lost to Follow-up|0|||
170559769|NCT02327169|616393278|FG009|Overall Study|Lost to Follow-up|0|||
170559770|NCT02327169|616393279|FG010|Overall Study|Lost to Follow-up|0|||
170559771|NCT02327169|616393280|FG011|Overall Study|Lost to Follow-up|0|||
170559772|NCT02327169|616393281|FG012|Overall Study|Lost to Follow-up|0|||
170559773|NCT02327169|616393282|FG013|Overall Study|Lost to Follow-up|0|||
170559774|NCT02327169|616393283|FG014|Overall Study|Lost to Follow-up|0|||
170559775|NCT03528902|616393286|FG000|Overall Study|Adverse Event|1|||
170559776|NCT03528902|616393287|FG001|Overall Study|Adverse Event|0|||
170559777|NCT03411044|616393288|FG000|Overall Study|Death|30|||
170559778|NCT03411044|616393288|FG000|Overall Study|Withdrawal by Subject|48|||
170559779|NCT03411044|616393288|FG000|Overall Study|Lost to Follow-up|78|||
170559780|NCT03411044|616393288|FG000|Overall Study|Adverse Event|30|||
170905295|NCT00749203|617656069|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
170905296|NCT00749203|617656068|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
170559781|NCT03411044|616393288|FG000|Overall Study|Missing status|4|||
170559782|NCT02034565|616393289|FG000|Overall Study|Adverse Event|1|||
170559783|NCT02034565|616393290|FG001|Overall Study|Adverse Event|0|||
170559784|NCT05837481|616393291|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
170559785|NCT05837481|616393292|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
170559786|NCT05014919|616393295|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
170559787|NCT05014919|616393296|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
170559788|NCT05014919|616393297|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
170559789|NCT05014919|616393295|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
170559790|NCT05014919|616393296|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
170559791|NCT05014919|616393297|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
170559792|NCT05014919|616393295|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
170559793|NCT05014919|616393296|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
170559794|NCT05014919|616393297|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
170559795|NCT05014919|616393295|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
170559796|NCT05014919|616393296|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
170559797|NCT05014919|616393297|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
170559798|NCT05014919|616393295|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
170559799|NCT05014919|616393296|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
170559800|NCT05014919|616393297|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
170559801|NCT05014919|616393295|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
170559802|NCT05014919|616393296|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
170559803|NCT05014919|616393297|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
170559804|NCT05014919|616393295|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
170559805|NCT05014919|616393296|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
170559806|NCT05014919|616393297|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
170559807|NCT05014919|616393295|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
170559808|NCT05014919|616393296|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
170559809|NCT05014919|616393297|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
170559810|NCT00680914|616393300|FG000|Overall Study|Consent withdrawal|6|||
170559811|NCT00680914|616393301|FG001|Overall Study|Consent withdrawal|3|||
170559812|NCT00680914|616393300|FG000|Overall Study|Lost to Follow-up|4|||
170559813|NCT00680914|616393301|FG001|Overall Study|Lost to Follow-up|0|||
170559814|NCT00680914|616393300|FG000|Overall Study|serious adverse event (SAE)|0|||
170559815|NCT00680914|616393301|FG001|Overall Study|serious adverse event (SAE)|1|||
170559816|NCT01848457|616393305|FG000|Overall Study|Death|1|||
170559817|NCT01848457|616393306|FG001|Overall Study|Death|0|||
170559818|NCT01848457|616393307|FG002|Overall Study|Death|0|||
170559819|NCT01848457|616393308|FG003|Overall Study|Death|0|||
170559820|NCT01491919|616393309|FG000|Overall Study|Insufficient PK sampling|1|||
170559821|NCT01491919|616393310|FG001|Overall Study|Insufficient PK sampling|2|||
170559822|NCT01491919|616393311|FG002|Overall Study|Insufficient PK sampling|1|||
170559823|NCT02135133|616393312|FG000|Overall Study|Adverse Event|10|||
170559824|NCT02135133|616393312|FG000|Overall Study|regulatory mandate|5|||
170559825|NCT03034044|616393315|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
170559826|NCT01877278|616393318|FG000|Overall Study|Lost to Follow-up|3|||
170559827|NCT01877278|616393319|FG001|Overall Study|Lost to Follow-up|3|||
170559828|NCT01027351|616393321|FG000|Overall Study|Withdrawal by Subject|1|||
170559829|NCT01027351|616393322|FG001|Overall Study|Withdrawal by Subject|0|||
170559830|NCT01027351|616393323|FG002|Overall Study|Withdrawal by Subject|1|||
170559831|NCT01027351|616393324|FG003|Overall Study|Withdrawal by Subject|0|||
170559832|NCT01027351|616393325|FG004|Overall Study|Withdrawal by Subject|3|||
170559833|NCT01027351|616393326|FG005|Overall Study|Withdrawal by Subject|5|||
170559834|NCT01027351|616393321|FG000|Overall Study|Lost to Follow-up|1|||
170559835|NCT01027351|616393322|FG001|Overall Study|Lost to Follow-up|1|||
170559836|NCT01027351|616393323|FG002|Overall Study|Lost to Follow-up|0|||
170559837|NCT01027351|616393324|FG003|Overall Study|Lost to Follow-up|1|||
170559838|NCT01027351|616393325|FG004|Overall Study|Lost to Follow-up|6|||
170559839|NCT01027351|616393326|FG005|Overall Study|Lost to Follow-up|0|||
170559840|NCT01027351|616393321|FG000|Overall Study|Inappropriate enrollment|0|||
170559841|NCT01027351|616393322|FG001|Overall Study|Inappropriate enrollment|0|||
170559842|NCT01027351|616393323|FG002|Overall Study|Inappropriate enrollment|0|||
170559843|NCT01027351|616393324|FG003|Overall Study|Inappropriate enrollment|0|||
170559844|NCT01027351|616393325|FG004|Overall Study|Inappropriate enrollment|1|||
170559845|NCT01027351|616393326|FG005|Overall Study|Inappropriate enrollment|0|||
170559846|NCT01027351|616393321|FG000|Overall Study|Protocol Violation|1|||
170559847|NCT01027351|616393322|FG001|Overall Study|Protocol Violation|0|||
170559848|NCT01027351|616393323|FG002|Overall Study|Protocol Violation|0|||
170559849|NCT01027351|616393324|FG003|Overall Study|Protocol Violation|1|||
170559850|NCT01027351|616393325|FG004|Overall Study|Protocol Violation|1|||
170559851|NCT01027351|616393326|FG005|Overall Study|Protocol Violation|0|||
170559852|NCT00112385|616393336|FG000|Overall Study|Lost to Follow-up|1|||
170559853|NCT00112385|616393337|FG001|Overall Study|Lost to Follow-up|0|||
170559854|NCT00112385|616393336|FG000|Overall Study|Withdrawal by Subject|0|||
170559855|NCT00112385|616393337|FG001|Overall Study|Withdrawal by Subject|1|||
170559856|NCT04123704|616394986|FG000|Overall Study|Disease progression|2|||
170559857|NCT03033784|616394991|FG000|Overall Study|Anxiety related to MRI scanner|0|||
170559858|NCT03033784|616394992|FG001|Overall Study|Anxiety related to MRI scanner|1|||
170559859|NCT03033784|616394993|FG002|Overall Study|Anxiety related to MRI scanner|0|||
170559860|NCT03033784|616394994|FG003|Overall Study|Anxiety related to MRI scanner|0|||
170559861|NCT03033784|616394995|FG004|Overall Study|Anxiety related to MRI scanner|0|||
170559862|NCT03033784|616394996|FG005|Overall Study|Anxiety related to MRI scanner|0|||
170559863|NCT03033784|616394997|FG006|Overall Study|Anxiety related to MRI scanner|0|||
170559864|NCT03033784|616394998|FG007|Overall Study|Anxiety related to MRI scanner|0|||
170559865|NCT03033784|616394999|FG008|Overall Study|Anxiety related to MRI scanner|0|||
170559866|NCT03033784|616395000|FG009|Overall Study|Anxiety related to MRI scanner|0|||
170559867|NCT03033784|616395001|FG010|Overall Study|Anxiety related to MRI scanner|0|||
170559868|NCT03033784|616395002|FG011|Overall Study|Anxiety related to MRI scanner|0|||
170559869|NCT03033784|616395003|FG012|Overall Study|Anxiety related to MRI scanner|0|||
170559870|NCT03033784|616394991|FG000|Overall Study|Withdrawal by Subject|0|||
170559871|NCT03033784|616394992|FG001|Overall Study|Withdrawal by Subject|0|||
170559872|NCT03033784|616394993|FG002|Overall Study|Withdrawal by Subject|0|||
170559873|NCT03033784|616394994|FG003|Overall Study|Withdrawal by Subject|0|||
170559874|NCT03033784|616394995|FG004|Overall Study|Withdrawal by Subject|0|||
170559875|NCT03033784|616394996|FG005|Overall Study|Withdrawal by Subject|0|||
170559876|NCT03033784|616394997|FG006|Overall Study|Withdrawal by Subject|0|||
170559877|NCT03033784|616394998|FG007|Overall Study|Withdrawal by Subject|0|||
170559878|NCT03033784|616394999|FG008|Overall Study|Withdrawal by Subject|0|||
170559879|NCT03033784|616395000|FG009|Overall Study|Withdrawal by Subject|0|||
170559880|NCT03033784|616395001|FG010|Overall Study|Withdrawal by Subject|0|||
170559881|NCT03033784|616395002|FG011|Overall Study|Withdrawal by Subject|0|||
170559882|NCT03033784|616395003|FG012|Overall Study|Withdrawal by Subject|2|||
170559883|NCT00267488|616395006|FG000|Overall Study|Sponsor Terminated Study|9|||
170559884|NCT00267488|616395006|FG000|Overall Study|Protocol Violation|1|||
170559885|NCT00267488|616395006|FG000|Overall Study|Other (Disease Progression)|1|||
170559886|NCT03332056|616395007|FG000|Overall Study|Incomplete questionnaires|8|||
170559887|NCT03332056|616395008|FG001|Overall Study|Incomplete questionnaires|9|||
170559888|NCT03332056|616395007|FG000|Overall Study|Passed stone prior to surgery date|1|||
170559889|NCT03332056|616395008|FG001|Overall Study|Passed stone prior to surgery date|0|||
170559890|NCT03332056|616395007|FG000|Overall Study|Did not require a ureteral stent|0|||
170559891|NCT03332056|616395008|FG001|Overall Study|Did not require a ureteral stent|1|||
170559892|NCT02374255|616395009|FG000|Overall Study|Withdrawal by Subject|2|||
170559893|NCT02374255|616395010|FG001|Overall Study|Withdrawal by Subject|0|||
170559894|NCT02374255|616395011|FG002|Overall Study|Withdrawal by Subject|0|||
170559895|NCT02374255|616395012|FG003|Overall Study|Withdrawal by Subject|0|||
170559896|NCT02093520|616395017|FG000|Overall Study|Not treated|6|||
170559897|NCT02093520|616395018|FG001|Overall Study|Not treated|22|||
170559898|NCT00851084|616395019|FG000|Overall Study|Randomized but not treated|1|||
170559899|NCT00851084|616395020|FG001|Overall Study|Randomized but not treated|0|||
170559900|NCT00851084|616395019|FG000|Overall Study|Adverse Event|26|||
170559901|NCT00851084|616395020|FG001|Overall Study|Adverse Event|36|||
170559902|NCT00851084|616395019|FG000|Overall Study|Disease progression|52|||
170559903|NCT00851084|616395020|FG001|Overall Study|Disease progression|47|||
170559904|NCT00851084|616395019|FG000|Overall Study|Poor compliance to protocol|1|||
170559905|NCT00851084|616395020|FG001|Overall Study|Poor compliance to protocol|1|||
170559906|NCT00851084|616395019|FG000|Overall Study|Physician Decision|13|||
170559907|NCT00851084|616395020|FG001|Overall Study|Physician Decision|14|||
170559908|NCT00851084|616395019|FG000|Overall Study|Consent withdrawn|0|||
170559909|NCT00851084|616395020|FG001|Overall Study|Consent withdrawn|2|||
170559910|NCT00851084|616395019|FG000|Overall Study|Withdrawal by Subject|11|||
170559911|NCT00851084|616395020|FG001|Overall Study|Withdrawal by Subject|12|||
170559912|NCT00851084|616395019|FG000|Overall Study|Metastatic surgery|6|||
170559913|NCT00851084|616395020|FG001|Overall Study|Metastatic surgery|6|||
170559914|NCT00851084|616395019|FG000|Overall Study|Other|7|||
170559915|NCT00851084|616395020|FG001|Overall Study|Other|1|||
170559916|NCT00734032|616395021|FG000|Overall Study|Adverse Event|0|||
170559917|NCT00734032|616395022|FG001|Overall Study|Adverse Event|1|||
170559918|NCT00734032|616395023|FG002|Overall Study|Adverse Event|0|||
170559919|NCT00734032|616395024|FG003|Overall Study|Adverse Event|0|||
170559920|NCT00730327|616395025|FG000|Overall Study|Lost to Follow-up|14|||
170559921|NCT00730327|616395026|FG001|Overall Study|Lost to Follow-up|16|||
170559922|NCT00730327|616395025|FG000|Overall Study|Adverse Event|8|||
170559923|NCT00730327|616395026|FG001|Overall Study|Adverse Event|1|||
170559924|NCT00730327|616395025|FG000|Overall Study|Withdrawal by Subject|3|||
170559925|NCT00730327|616395026|FG001|Overall Study|Withdrawal by Subject|13|||
170559926|NCT00730327|616395025|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
170559927|NCT00730327|616395026|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
170559928|NCT03360344|616395027|FG000|Overall Study|Withdrawal by Subject|0|||
170559929|NCT03360344|616395028|FG001|Overall Study|Withdrawal by Subject|1|||
170559930|NCT03360344|616395029|FG002|Overall Study|Withdrawal by Subject|1|||
170559931|NCT02989857|616395032|FG000|Randomization Phase|Not Treated|3|||
170559932|NCT02989857|616395033|FG001|Randomization Phase|Not Treated|2|||
170559933|NCT02989857|616395034|FG002|Randomization Phase|Not Treated|0|||
170559934|NCT00095576|616395035|FG000|Overall Study|Adverse Event|5|||
170559935|NCT00095576|616395036|FG001|Overall Study|Adverse Event|3|||
170559936|NCT00095576|616395035|FG000|Overall Study|Lost to Follow-up|233|||
170559937|NCT00095576|616395036|FG001|Overall Study|Lost to Follow-up|229|||
170559938|NCT00095576|616395035|FG000|Overall Study|Protocol Violation|1|||
170559939|NCT00095576|616395036|FG001|Overall Study|Protocol Violation|0|||
170559940|NCT00095576|616395035|FG000|Overall Study|Withdrawal by Subject|34|||
170559941|NCT00095576|616395036|FG001|Overall Study|Withdrawal by Subject|47|||
170559942|NCT00095576|616395035|FG000|Overall Study|Option to switch to a rollover study|1097|||
170559943|NCT00095576|616395036|FG001|Overall Study|Option to switch to a rollover study|1099|||
170559944|NCT00095576|616395035|FG000|Overall Study|Site terminated|75|||
170559945|NCT00095576|616395036|FG001|Overall Study|Site terminated|67|||
170559946|NCT00095576|616395035|FG000|Overall Study|Subject moved|30|||
170559947|NCT00095576|616395036|FG001|Overall Study|Subject moved|36|||
170559948|NCT04490278|616395039|FG000|Overall Study|Lost to Follow-up|6|||
170559949|NCT00366457|616395040|FG000|Overall Study|never began study therapy|2|||
170559950|NCT02332928|616395041|FG000|Overall Study|Withdrawal by Subject|0|||
170559951|NCT02332928|616395042|FG001|Overall Study|Withdrawal by Subject|2|||
170559952|NCT02332928|616395041|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
170559953|NCT02332928|616395042|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
170559954|NCT01425814|616395045|FG000|Period 1|Stability criteria not fulfilled|0|||
170559955|NCT01425814|616395046|FG001|Period 1|Stability criteria not fulfilled|1|||
170559956|NCT01425814|616395047|FG002|Period 1|Stability criteria not fulfilled|0|||
170559957|NCT01425814|616395048|FG003|Period 1|Stability criteria not fulfilled|0|||
170559958|NCT01425814|616395049|FG004|Period 1|Stability criteria not fulfilled|0|||
170559959|NCT01425814|616395050|FG005|Period 1|Stability criteria not fulfilled|0|||
170559960|NCT01425814|616395045|FG000|Period 2|Stability criteria not fulfilled|0|||
170559961|NCT01425814|616395046|FG001|Period 2|Stability criteria not fulfilled|1|||
170559962|NCT01425814|616395047|FG002|Period 2|Stability criteria not fulfilled|0|||
170559963|NCT01425814|616395048|FG003|Period 2|Stability criteria not fulfilled|0|||
170559964|NCT01425814|616395049|FG004|Period 2|Stability criteria not fulfilled|0|||
170559965|NCT01425814|616395050|FG005|Period 2|Stability criteria not fulfilled|0|||
170559966|NCT01425814|616395045|FG000|Period 3|Adverse Event|0|||
170559967|NCT01425814|616395046|FG001|Period 3|Adverse Event|0|||
170559968|NCT01425814|616395047|FG002|Period 3|Adverse Event|0|||
170559969|NCT01425814|616395048|FG003|Period 3|Adverse Event|0|||
170559970|NCT01425814|616395049|FG004|Period 3|Adverse Event|0|||
170559971|NCT01425814|616395050|FG005|Period 3|Adverse Event|1|||
170559972|NCT01425814|616395045|FG000|Period 4|Adverse Event|1|||
170559973|NCT01425814|616395046|FG001|Period 4|Adverse Event|0|||
170559974|NCT01425814|616395047|FG002|Period 4|Adverse Event|1|||
170559975|NCT01425814|616395048|FG003|Period 4|Adverse Event|0|||
170559976|NCT01425814|616395049|FG004|Period 4|Adverse Event|0|||
170559977|NCT01425814|616395050|FG005|Period 4|Adverse Event|0|||
170559978|NCT01425814|616395045|FG000|Period 5|Stability criteria not fulfilled|0|||
170559979|NCT01425814|616395046|FG001|Period 5|Stability criteria not fulfilled|0|||
170559980|NCT01425814|616395047|FG002|Period 5|Stability criteria not fulfilled|1|||
170559981|NCT01425814|616395048|FG003|Period 5|Stability criteria not fulfilled|0|||
170559982|NCT01425814|616395049|FG004|Period 5|Stability criteria not fulfilled|0|||
170559983|NCT01425814|616395050|FG005|Period 5|Stability criteria not fulfilled|1|||
170559984|NCT00565747|616395051|FG000|Overall Study|No embryo transfer|67|||
170559985|NCT00565747|616395052|FG001|Overall Study|No embryo transfer|73|||
170559986|NCT03309202|616395053|FG000|Overall Study|Lost to Follow-up|1|||
170559987|NCT03309202|616395054|FG001|Overall Study|Lost to Follow-up|0|||
170559988|NCT03309202|616395055|FG002|Overall Study|Lost to Follow-up|0|||
170559989|NCT03309202|616395056|FG003|Overall Study|Lost to Follow-up|0|||
170559990|NCT01905540|616395057|FG000|Period 3|Other|1|||
170559991|NCT01905540|616395058|FG001|Period 3|Other|0|||
170559992|NCT01905540|616395059|FG002|Period 3|Other|1|||
170559993|NCT01905540|616395060|FG003|Period 3|Other|1|||
170559994|NCT02743962|616395063|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
170559995|NCT02743962|616395064|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
170559996|NCT03232567|616395071|FG000|Overall Study|Withdrawal by Subject|0|||
170559997|NCT03232567|616395072|FG001|Overall Study|Withdrawal by Subject|1|||
170559998|NCT03232567|616395073|FG002|Overall Study|Withdrawal by Subject|0|||
170559999|NCT03232567|616395074|FG003|Overall Study|Withdrawal by Subject|0|||
170560000|NCT02655601|616395075|FG000|Overall Study|Adverse Event|0|||
170560001|NCT02655601|616395076|FG001|Overall Study|Adverse Event|0|||
170560002|NCT02655601|616395077|FG002|Overall Study|Adverse Event|0|||
170560003|NCT02655601|616395078|FG003|Overall Study|Adverse Event|1|||
170560004|NCT02655601|616395079|FG004|Overall Study|Adverse Event|1|||
170560005|NCT02655601|616395080|FG005|Overall Study|Adverse Event|0|||
170560006|NCT02655601|616395075|FG000|Overall Study|Physician Decision|0|||
170560007|NCT02655601|616395076|FG001|Overall Study|Physician Decision|0|||
170560008|NCT02655601|616395077|FG002|Overall Study|Physician Decision|0|||
170560009|NCT02655601|616395078|FG003|Overall Study|Physician Decision|0|||
170560010|NCT02655601|616395079|FG004|Overall Study|Physician Decision|1|||
170560011|NCT02655601|616395080|FG005|Overall Study|Physician Decision|1|||
170560012|NCT02655601|616395075|FG000|Overall Study|Withdrawal by Subject|0|||
170560013|NCT02655601|616395076|FG001|Overall Study|Withdrawal by Subject|0|||
170560014|NCT02655601|616395077|FG002|Overall Study|Withdrawal by Subject|0|||
170560015|NCT02655601|616395078|FG003|Overall Study|Withdrawal by Subject|0|||
170560016|NCT02655601|616395079|FG004|Overall Study|Withdrawal by Subject|4|||
170560017|NCT02655601|616395080|FG005|Overall Study|Withdrawal by Subject|8|||
170560018|NCT02655601|616395075|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
170560019|NCT02655601|616395076|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
170560020|NCT02655601|616395077|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
170560021|NCT02655601|616395078|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
170560022|NCT02655601|616395079|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
170560023|NCT02655601|616395080|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
170560024|NCT00427700|616395081|FG000|Overall Study|Lost to Follow-up|2|||
170560025|NCT00427700|616395082|FG001|Overall Study|Lost to Follow-up|5|||
170560026|NCT00427700|616395081|FG000|Overall Study|no induction of menses|1|||
170560027|NCT00427700|616395082|FG001|Overall Study|no induction of menses|4|||
170560028|NCT00427700|616395081|FG000|Overall Study|Pregnancy|0|||
170560029|NCT00427700|616395082|FG001|Overall Study|Pregnancy|2|||
170560030|NCT02014376|616395083|FG000|Overall Study|Adverse Event|1|||
170560031|NCT02014376|616395084|FG001|Overall Study|Adverse Event|1|||
170560032|NCT02014376|616395085|FG002|Overall Study|Adverse Event|0|||
170560033|NCT02014376|616395083|FG000|Overall Study|Lost to Follow-up|2|||
170560034|NCT02014376|616395084|FG001|Overall Study|Lost to Follow-up|0|||
170560035|NCT02014376|616395085|FG002|Overall Study|Lost to Follow-up|0|||
170560036|NCT01969409|616395086|FG000|Overall Study|Death|2|||
170560037|NCT01969409|616395087|FG001|Overall Study|Death|2|||
170560038|NCT01969409|616395086|FG000|Overall Study|Transplant|1|||
170560039|NCT01969409|616395087|FG001|Overall Study|Transplant|1|||
170560040|NCT01969409|616395086|FG000|Overall Study|Withdrawal by Subject|0|||
170560041|NCT01969409|616395087|FG001|Overall Study|Withdrawal by Subject|1|||
170560042|NCT00815633|616395088|FG000|Overall Study|study terminated|1|||
170560043|NCT02457065|616395089|FG000|Overall Study|Lost to Follow-up|9|||
170560044|NCT02457065|616395090|FG001|Overall Study|Lost to Follow-up|11|||
170560045|NCT03038087|616395091|FG000|Overall Study|lost data|1|||
170560046|NCT00654355|616395092|FG000|Overall Study|Lost to Follow-up|2|||
170645196|NCT00600119|616715889|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
170645197|NCT00600119|616715890|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
170645198|NCT00600119|616715891|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
170645199|NCT00600119|616715892|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
170645200|NCT00600119|616715887|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
170645201|NCT00600119|616715888|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
170645202|NCT00600119|616715889|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
170645203|NCT00600119|616715890|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
170645204|NCT00600119|616715891|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
170645205|NCT00600119|616715892|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
170645206|NCT00600119|616715887|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
170645207|NCT00600119|616715888|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
170645208|NCT00600119|616715889|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
170645209|NCT00600119|616715890|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
170645210|NCT00600119|616715891|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
170645211|NCT00600119|616715892|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
170645212|NCT00600119|616715887|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
170645213|NCT00600119|616715888|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
170645214|NCT00600119|616715889|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
170560047|NCT00654355|616395093|FG001|Overall Study|Lost to Follow-up|2|||
170560048|NCT02226653|616395097|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
170560049|NCT02226653|616395098|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
170645215|NCT00600119|616715890|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
170645216|NCT00600119|616715891|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
170645217|NCT00600119|616715892|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
170560050|NCT02226653|616395097|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
170560051|NCT02226653|616395098|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
170645218|NCT00600119|616715887|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
170645219|NCT00600119|616715888|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
170645220|NCT00600119|616715889|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170645221|NCT00600119|616715890|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
170645222|NCT00600119|616715891|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
170645223|NCT00600119|616715892|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
170806828|NCT01953692|617301617|FG005|Overall Study|Physician Decision|2|||
170560052|NCT00635050|616395099|FG000|Overall Study|Withdrawal by Subject|1|||
170560053|NCT03038620|616395100|FG000|Overall Study|Lost to Follow-up|18|||
170560054|NCT03038620|616395101|FG001|Overall Study|Lost to Follow-up|23|||
170560055|NCT03038620|616395100|FG000|Overall Study|Withdrawal by Subject|0|||
170560056|NCT03038620|616395101|FG001|Overall Study|Withdrawal by Subject|15|||
170560057|NCT03038620|616395100|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
170560058|NCT03038620|616395101|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
170560059|NCT01922895|616395103|FG000|Overall Study|Death|0|||
170560060|NCT01922895|616395104|FG001|Overall Study|Death|1|||
170560061|NCT01922895|616395103|FG000|Overall Study|Withdrawal by Subject|1|||
170560062|NCT01922895|616395104|FG001|Overall Study|Withdrawal by Subject|2|||
170560063|NCT01922895|616395103|FG000|Overall Study|Lost to Follow-up|5|||
170560064|NCT01922895|616395104|FG001|Overall Study|Lost to Follow-up|11|||
170560065|NCT01435356|616395109|FG000|Overall Study|Adverse Event|2|||
170560066|NCT01435356|616395110|FG001|Overall Study|Adverse Event|0|||
170560067|NCT01435356|616395109|FG000|Overall Study|Disease progression/recurrence|17|||
170560068|NCT01435356|616395110|FG001|Overall Study|Disease progression/recurrence|10|||
170560069|NCT01435356|616395109|FG000|Overall Study|Protocol Violation|0|||
170560070|NCT01435356|616395110|FG001|Overall Study|Protocol Violation|1|||
170560071|NCT01435356|616395109|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
170560072|NCT01435356|616395110|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
170560073|NCT01435356|616395109|FG000|Overall Study|Withdrawal by Subject|1|||
170560074|NCT01435356|616395110|FG001|Overall Study|Withdrawal by Subject|1|||
170560075|NCT01435356|616395109|FG000|Overall Study|Facial palsy|1|||
170560076|NCT01435356|616395110|FG001|Overall Study|Facial palsy|0|||
170560077|NCT01435356|616395109|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
170560078|NCT01435356|616395110|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
170560079|NCT01435356|616395109|FG000|Overall Study|Physician Decision|1|||
170560080|NCT01435356|616395110|FG001|Overall Study|Physician Decision|0|||
170560081|NCT01435356|616395109|FG000|Overall Study|Patient decision|3|||
170560082|NCT01435356|616395110|FG001|Overall Study|Patient decision|0|||
170560083|NCT01435356|616395109|FG000|Overall Study|Patient moved to another city|1|||
170560084|NCT01435356|616395110|FG001|Overall Study|Patient moved to another city|1|||
170560085|NCT03312543|616395114|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
170560086|NCT03312543|616395115|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
170560087|NCT03312543|616395114|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
170560088|NCT03312543|616395115|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
170560089|NCT03312543|616395114|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
170560090|NCT03312543|616395115|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
170560091|NCT03312543|616395114|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
170560092|NCT03312543|616395115|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
170560093|NCT03312543|616395114|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
170560094|NCT03312543|616395115|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
170560095|NCT03312543|616395114|FG000|Regression (Week 12 to Week 24)|Death|0|||
170560096|NCT03312543|616395115|FG001|Regression (Week 12 to Week 24)|Death|1|||
170560097|NCT04507269|616395116|FG000|Overall Study|Withdrawal by Subject|1|||
170560098|NCT04507269|616395117|FG001|Overall Study|Withdrawal by Subject|1|||
170560099|NCT04507269|616395118|FG002|Overall Study|Withdrawal by Subject|0|||
170560100|NCT04507269|616395119|FG003|Overall Study|Withdrawal by Subject|0|||
170560101|NCT04507269|616395120|FG004|Overall Study|Withdrawal by Subject|0|||
170560102|NCT04507269|616395121|FG005|Overall Study|Withdrawal by Subject|0|||
170560103|NCT04507269|616395116|FG000|Overall Study|Lost to Follow-up|0|||
170560104|NCT04507269|616395117|FG001|Overall Study|Lost to Follow-up|0|||
170560105|NCT04507269|616395118|FG002|Overall Study|Lost to Follow-up|0|||
170560106|NCT04507269|616395119|FG003|Overall Study|Lost to Follow-up|0|||
170560107|NCT04507269|616395120|FG004|Overall Study|Lost to Follow-up|1|||
170560108|NCT04507269|616395121|FG005|Overall Study|Lost to Follow-up|0|||
170560109|NCT05852340|616395122|FG000|Period 5|Not completing the meal|0|||
170560110|NCT05852340|616395123|FG001|Period 5|Not completing the meal|1|||
170560111|NCT05852340|616395124|FG002|Period 5|Not completing the meal|0|||
170560112|NCT05852340|616395125|FG003|Period 5|Not completing the meal|0|||
170560113|NCT05852340|616395122|FG000|Period 5|Adverse Event|0|||
170560114|NCT05852340|616395123|FG001|Period 5|Adverse Event|0|||
170560115|NCT05852340|616395124|FG002|Period 5|Adverse Event|0|||
170560116|NCT05852340|616395125|FG003|Period 5|Adverse Event|1|||
170560117|NCT00071032|616395128|FG000|Overall Study|Lost to Follow-up|1|||
170560118|NCT00071032|616395129|FG001|Overall Study|Lost to Follow-up|1|||
170560119|NCT00071032|616395128|FG000|Overall Study|Withdrawal by Subject|8|||
170560120|NCT00071032|616395129|FG001|Overall Study|Withdrawal by Subject|6|||
170560121|NCT00071032|616395128|FG000|Overall Study|Missing Primary Outcome|0|||
170560122|NCT00071032|616395129|FG001|Overall Study|Missing Primary Outcome|1|||
170560123|NCT04042311|616395133|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
170560124|NCT04042311|616395133|FG000|Overall Study|Unable to tolerate|4|||
170560125|NCT04042311|616395133|FG000|Overall Study|Concurrent illness|2|||
170560126|NCT04042311|616395133|FG000|Overall Study|Adverse Event|2|||
170560127|NCT04042311|616395133|FG000|Overall Study|No longer meeting inclusion criteria|2|||
170560128|NCT04042311|616395133|FG000|Overall Study|No reason given|1|||
170560129|NCT04042311|616395133|FG000|Overall Study|Withdrawal by Subject|4|||
170645224|NCT00600119|616715887|FG000|Double-blind Treatment Period|Other|0|||
170645225|NCT00600119|616715888|FG001|Double-blind Treatment Period|Other|0|||
170645226|NCT00600119|616715889|FG002|Double-blind Treatment Period|Other|0|||
170645227|NCT00600119|616715890|FG003|Double-blind Treatment Period|Other|0|||
170645228|NCT00600119|616715891|FG004|Double-blind Treatment Period|Other|2|||
170645229|NCT00600119|616715892|FG005|Double-blind Treatment Period|Other|1|||
170645230|NCT00600119|616715887|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
170645231|NCT00600119|616715888|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
170645232|NCT00600119|616715889|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
170646064|NCT01628029|616717883|FG004|Overall Study|Incomplete primary outcome assessment|0|||
170560130|NCT04134936|616395134|FG000|Overall Study|Adverse Event|3|||
170560131|NCT04134936|616395135|FG001|Overall Study|Adverse Event|2|||
170560132|NCT04134936|616395134|FG000|Overall Study|Withdrawal by Subject|2|||
170560133|NCT04134936|616395135|FG001|Overall Study|Withdrawal by Subject|3|||
170560134|NCT04134936|616395134|FG000|Overall Study|Physician Decision|0|||
170560135|NCT04134936|616395135|FG001|Overall Study|Physician Decision|1|||
170560136|NCT04134936|616395134|FG000|Overall Study|Progressive disease, joined another trial|1|||
170560137|NCT04134936|616395135|FG001|Overall Study|Progressive disease, joined another trial|0|||
170560138|NCT04134936|616395134|FG000|Overall Study|Progressive disease|1|||
170560139|NCT04134936|616395135|FG001|Overall Study|Progressive disease|0|||
170560140|NCT03518060|616395136|FG000|Overall Study|Death|1|||
170560141|NCT03518060|616395136|FG000|Overall Study|Poor adherence|1|||
170560142|NCT03518060|616395136|FG000|Overall Study|Withdrawal of informed consent|2|||
170560143|NCT03518060|616395136|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
170560144|NCT03518060|616395136|FG000|Overall Study|Physician Decision|7|||
170560145|NCT03518060|616395136|FG000|Overall Study|Adverse drug reactions|23|||
170560146|NCT03518060|616395136|FG000|Overall Study|Withdrawal by Subject|25|||
170560147|NCT03518060|616395136|FG000|Overall Study|Lost to Follow-up|13|||
170560148|NCT02061085|616395137|FG000|Overall Study|Adverse Event|8|||
170560149|NCT01107496|616395145|FG000|Overall Study|Adverse Event|1|||
170560150|NCT01107496|616395146|FG001|Overall Study|Adverse Event|0|||
170560151|NCT01107496|616395145|FG000|Overall Study|Lack of Efficacy|1|||
170560152|NCT01107496|616395146|FG001|Overall Study|Lack of Efficacy|0|||
170560153|NCT01107496|616395145|FG000|Overall Study|Protocol Violation|0|||
170560154|NCT01107496|616395146|FG001|Overall Study|Protocol Violation|1|||
170560155|NCT01107496|616395145|FG000|Overall Study|Lost to Follow-up|0|||
170560156|NCT01107496|616395146|FG001|Overall Study|Lost to Follow-up|1|||
170560157|NCT03709472|616395147|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
170560158|NCT03709472|616395148|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
170560159|NCT03709472|616395147|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
170560160|NCT03709472|616395148|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
170560161|NCT03448393|616395150|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
170560162|NCT03448393|616395151|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
170560163|NCT03448393|616395152|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
170560164|NCT03448393|616395153|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
170560165|NCT03448393|616395154|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
170560166|NCT03448393|616395155|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
170560167|NCT03448393|616395156|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
170560168|NCT03448393|616395157|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
170560169|NCT03448393|616395158|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
170560170|NCT03448393|616395150|FG000|Dose Expansion|Not treated - screen failure|0|||
170560171|NCT03448393|616395151|FG001|Dose Expansion|Not treated - screen failure|0|||
170560172|NCT03448393|616395152|FG002|Dose Expansion|Not treated - screen failure|0|||
170560173|NCT03448393|616395153|FG003|Dose Expansion|Not treated - screen failure|0|||
170560174|NCT03448393|616395154|FG004|Dose Expansion|Not treated - screen failure|0|||
170560175|NCT03448393|616395155|FG005|Dose Expansion|Not treated - screen failure|0|||
170560176|NCT03448393|616395156|FG006|Dose Expansion|Not treated - screen failure|0|||
170560177|NCT03448393|616395157|FG007|Dose Expansion|Not treated - screen failure|0|||
170560178|NCT03448393|616395158|FG008|Dose Expansion|Not treated - screen failure|7|||
170560179|NCT00642759|616395159|FG000|Overall Study|Protocol Violation|1|||
170560180|NCT03537508|616395161|FG000|Overall Study|Adverse Event|2|||
170560181|NCT03537508|616395162|FG001|Overall Study|Adverse Event|1|||
170560182|NCT03537508|616395161|FG000|Overall Study|Protocol Violation|65|||
170560183|NCT03537508|616395162|FG001|Overall Study|Protocol Violation|48|||
170560184|NCT03537508|616395161|FG000|Overall Study|Lost to Follow-up|86|||
170560185|NCT03537508|616395162|FG001|Overall Study|Lost to Follow-up|60|||
170560186|NCT03537508|616395161|FG000|Overall Study|Withdrawal by parent/guardian|263|||
170560187|NCT03537508|616395162|FG001|Overall Study|Withdrawal by parent/guardian|149|||
170560188|NCT01992757|616396689|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
170560189|NCT01497197|616396691|FG000|Overall Study|Lost to Follow-up|1|||
170560190|NCT01497197|616396692|FG001|Overall Study|Lost to Follow-up|0|||
170560191|NCT01497197|616396691|FG000|Overall Study|Protocol Violation|0|||
170560192|NCT01497197|616396692|FG001|Overall Study|Protocol Violation|2|||
170560193|NCT01497197|616396691|FG000|Overall Study|Withdrawal by Subject|2|||
170560194|NCT01497197|616396692|FG001|Overall Study|Withdrawal by Subject|1|||
170560195|NCT01497197|616396691|FG000|Overall Study|Excessive/lack of response to treatment|1|||
170560196|NCT01497197|616396692|FG001|Overall Study|Excessive/lack of response to treatment|0|||
170560197|NCT01497197|616396691|FG000|Overall Study|Risk of OHSS|1|||
170560198|NCT01497197|616396692|FG001|Overall Study|Risk of OHSS|0|||
170560199|NCT01497197|616396691|FG000|Overall Study|No oocytes retrieved|3|||
170560200|NCT01497197|616396692|FG001|Overall Study|No oocytes retrieved|2|||
170560201|NCT01497197|616396691|FG000|Overall Study|No fertilisation|6|||
170560202|NCT01497197|616396692|FG001|Overall Study|No fertilisation|5|||
170560203|NCT01497197|616396691|FG000|Overall Study|Intention to freeze all embryos|0|||
170560204|NCT01497197|616396692|FG001|Overall Study|Intention to freeze all embryos|1|||
170560205|NCT01497197|616396691|FG000|Overall Study|All embryos discarded|0|||
170560206|NCT01497197|616396692|FG001|Overall Study|All embryos discarded|3|||
170560207|NCT01497197|616396691|FG000|Overall Study|Other|3|||
170560208|NCT01497197|616396692|FG001|Overall Study|Other|1|||
170560209|NCT04484857|616396693|FG000|Overall Study|Adverse Event|2|||
170560210|NCT04484857|616396693|FG000|Overall Study|Death|10|||
170560211|NCT04484857|616396693|FG000|Overall Study|Withdrawal by Subject|3|||
170560212|NCT04484857|616396693|FG000|Overall Study|Transferred/Relocation|5|||
170560213|NCT04484857|616396693|FG000|Overall Study|Kidney Transplant|7|||
170560214|NCT04484857|616396693|FG000|Overall Study|Other than specified|4|||
170560215|NCT04484857|616396693|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
170560216|NCT00183248|616396702|FG000|Overall Study|Lost to Follow-up|0|||
170560217|NCT00183248|616396703|FG001|Overall Study|Lost to Follow-up|1|||
170560218|NCT00183248|616396702|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
170560219|NCT00183248|616396703|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
170560220|NCT04734210|616396706|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
170560221|NCT04734210|616396707|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
170560222|NCT04734210|616396708|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
170560223|NCT04734210|616396706|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
170560224|NCT04734210|616396707|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
170560225|NCT04734210|616396708|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
170560226|NCT04734210|616396706|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
170560227|NCT04734210|616396707|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
170560228|NCT04734210|616396708|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
170560229|NCT04734210|616396706|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
170560230|NCT04734210|616396707|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
170560231|NCT04734210|616396708|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
170560232|NCT03580044|616396709|FG000|Overall Study|Death|2|||
170560233|NCT03580044|616396710|FG001|Overall Study|Death|1|||
170560234|NCT03580044|616396709|FG000|Overall Study|Withdrawal by Subject|1|||
170560235|NCT03580044|616396710|FG001|Overall Study|Withdrawal by Subject|1|||
170560236|NCT03524157|616396711|FG000|Overall Study|cytology not readable|0|||
170560237|NCT03524157|616396712|FG001|Overall Study|cytology not readable|0|||
170560238|NCT03524157|616396713|FG002|Overall Study|cytology not readable|1|||
170560239|NCT04507763|616396714|FG000|Overall Study|Participants did not meet entrance criteria|201|||
170560240|NCT00573768|616396715|FG000|Overall Study|Adverse Event|1|||
170560241|NCT00573768|616396716|FG001|Overall Study|Adverse Event|1|||
170560242|NCT00573768|616396717|FG002|Overall Study|Adverse Event|2|||
170560243|NCT00573768|616396715|FG000|Overall Study|Protocol Violation|1|||
170560244|NCT00573768|616396716|FG001|Overall Study|Protocol Violation|0|||
170560245|NCT00573768|616396717|FG002|Overall Study|Protocol Violation|1|||
170560246|NCT00573768|616396715|FG000|Overall Study|Withdrawal by Subject|0|||
170560247|NCT00573768|616396716|FG001|Overall Study|Withdrawal by Subject|1|||
170560248|NCT00573768|616396717|FG002|Overall Study|Withdrawal by Subject|0|||
170560249|NCT00573768|616396715|FG000|Overall Study|Lost to Follow-up|0|||
170560250|NCT00573768|616396716|FG001|Overall Study|Lost to Follow-up|0|||
170905297|NCT00749203|617656069|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
170905298|NCT02034123|617656070|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905299|NCT02034123|617656071|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905300|NCT02034123|617656072|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905301|NCT02034123|617656073|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170560251|NCT00573768|616396717|FG002|Overall Study|Lost to Follow-up|1|||
170560252|NCT03427619|616396718|FG000|Overall Study|Physician Decision|3|||
170560253|NCT03427619|616396718|FG000|Overall Study|Withdrawal by Subject|4|||
170560254|NCT03427619|616396718|FG000|Overall Study|Lost to Follow-up|5|||
170560255|NCT03427619|616396718|FG000|Overall Study|Administrative|4|||
170560256|NCT03427619|616396718|FG000|Overall Study|Other|2|||
170560257|NCT03427619|616396718|FG000|Overall Study|Unknown or Missing Completion Status|48|||
170560258|NCT02095106|616396723|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
170560259|NCT02095106|616396724|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
170560260|NCT03729609|616396727|FG000|Overall Study|Protocol Violation|1|||
170560261|NCT01055028|616396729|FG000|Screening|Screen Failure|1|||
170560262|NCT01055028|616396730|FG001|Screening|Screen Failure|1|||
170560263|NCT01055028|616396729|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
170560264|NCT01055028|616396730|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
170560265|NCT01055028|616396729|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
170560266|NCT01055028|616396730|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
170560267|NCT01055028|616396729|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
170560268|NCT01055028|616396730|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
170560269|NCT02919618|616396732|FG000|Overall Study|Death|1|||
170560270|NCT02592863|616396733|FG000|Overall Study|Withdrawal by Subject|2|||
170560271|NCT02592863|616396734|FG001|Overall Study|Withdrawal by Subject|2|||
170560272|NCT02592863|616396733|FG000|Overall Study|Lost to Follow-up|1|||
170560273|NCT02592863|616396734|FG001|Overall Study|Lost to Follow-up|1|||
170560274|NCT02743221|616396735|FG000|Overall Study|Progressive disease|29|||
170560275|NCT02743221|616396736|FG001|Overall Study|Progressive disease|38|||
170560276|NCT02743221|616396735|FG000|Overall Study|Adverse Event|17|||
170560277|NCT02743221|616396736|FG001|Overall Study|Adverse Event|14|||
170560278|NCT02743221|616396735|FG000|Overall Study|non medical reason|8|||
170560279|NCT02743221|616396736|FG001|Overall Study|non medical reason|2|||
170560280|NCT02743221|616396735|FG000|Overall Study|Physician Decision|2|||
170560281|NCT02743221|616396736|FG001|Overall Study|Physician Decision|5|||
170560282|NCT02743221|616396735|FG000|Overall Study|Patient not eligible, not treated|0|||
170560283|NCT02743221|616396736|FG001|Overall Study|Patient not eligible, not treated|1|||
170560284|NCT04770285|616396739|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
170560285|NCT04770285|616396740|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
170560286|NCT04770285|616396739|FG000|Overall Study|Lack of Efficacy|0|||
170560287|NCT04770285|616396740|FG001|Overall Study|Lack of Efficacy|1|||
170560288|NCT04770285|616396739|FG000|Overall Study|Lost to Follow-up|11|||
170560289|NCT04770285|616396740|FG001|Overall Study|Lost to Follow-up|8|||
170560290|NCT04770285|616396739|FG000|Overall Study|Protocol Deviation|6|||
170560291|NCT04770285|616396740|FG001|Overall Study|Protocol Deviation|6|||
170560292|NCT04770285|616396739|FG000|Overall Study|Technical Problem|0|||
170560293|NCT04770285|616396740|FG001|Overall Study|Technical Problem|1|||
170560294|NCT04770285|616396739|FG000|Overall Study|Withdrawal by Subject|9|||
170560295|NCT04770285|616396740|FG001|Overall Study|Withdrawal by Subject|8|||
170560296|NCT04770285|616396739|FG000|Overall Study|Reason Not Specified|0|||
170560297|NCT04770285|616396740|FG001|Overall Study|Reason Not Specified|1|||
170560298|NCT00645658|616396741|FG000|Overall Study|Withdrawal by Subject|1|||
170560299|NCT00645658|616396742|FG001|Overall Study|Withdrawal by Subject|0|||
170560300|NCT00645658|616396741|FG000|Overall Study|Did not complete all assesments|0|||
170560301|NCT00645658|616396742|FG001|Overall Study|Did not complete all assesments|2|||
170560302|NCT01674062|616396750|FG000|Overall Study|Insufficient Therapeutic Response|56|||
170560303|NCT01674062|616396751|FG001|Overall Study|Insufficient Therapeutic Response|26|||
170560304|NCT01674062|616396750|FG000|Overall Study|Other|8|||
170560305|NCT01674062|616396751|FG001|Overall Study|Other|1|||
170560306|NCT01674062|616396750|FG000|Overall Study|Adverse Event|1|||
170560307|NCT01674062|616396751|FG001|Overall Study|Adverse Event|1|||
170560308|NCT01674062|616396750|FG000|Overall Study|Death|0|||
170560309|NCT01674062|616396751|FG001|Overall Study|Death|1|||
170560310|NCT01674062|616396750|FG000|Overall Study|Programming Error|1|||
170560311|NCT01674062|616396751|FG001|Overall Study|Programming Error|0|||
170560312|NCT04620668|616396752|FG000|Overall Study|Withdrawal by Subject|2|||
170560313|NCT04620668|616396753|FG001|Overall Study|Withdrawal by Subject|0|||
170560314|NCT04620668|616396752|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
170560315|NCT04620668|616396753|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
170560316|NCT04620668|616396752|FG000|Overall Study|Removed before analysis: missing data|2|||
170560317|NCT04620668|616396753|FG001|Overall Study|Removed before analysis: missing data|0|||
170560318|NCT04620668|616396752|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
170560319|NCT04620668|616396753|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
170560320|NCT04620668|616396752|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
170560321|NCT04620668|616396753|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
170560322|NCT03895372|616396756|FG000|Investigational Treatment Period|Adverse Event|1|||
170560323|NCT03895372|616396757|FG001|Investigational Treatment Period|Adverse Event|0|||
170399320|NCT03193190|615799945|FG008|Stage 1|Progressive Disease|0|||
170560324|NCT03895372|616396758|FG002|Investigational Treatment Period|Adverse Event|0|||
170560325|NCT03895372|616396759|FG003|Investigational Treatment Period|Adverse Event|0|||
170560326|NCT03895372|616396760|FG004|Investigational Treatment Period|Adverse Event|0|||
170560327|NCT03895372|616396761|FG005|Investigational Treatment Period|Adverse Event|0|||
170560328|NCT03895372|616396762|FG006|Investigational Treatment Period|Adverse Event|4|||
170560329|NCT03895372|616396763|FG007|Investigational Treatment Period|Adverse Event|3|||
170560330|NCT03895372|616396756|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
170560331|NCT03895372|616396757|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
170560332|NCT03895372|616396758|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
170560333|NCT03895372|616396759|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
170560334|NCT03895372|616396760|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
170560335|NCT03895372|616396761|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
170560336|NCT03895372|616396762|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
170560337|NCT03895372|616396763|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
170560338|NCT03895372|616396756|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
170560339|NCT03895372|616396757|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
170560340|NCT03895372|616396758|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
170565518|NCT00163189|616418558|FG000|Overall Study|Protocol Violation|2|||
170565519|NCT00163189|616418558|FG000|Overall Study|Death|3|||
170565520|NCT00163189|616418558|FG000|Overall Study|Adverse Event|6|||
170565521|NCT00163189|616418558|FG000|Overall Study|Lack of Efficacy|7|||
170565522|NCT00163189|616418558|FG000|Overall Study|Study terminated by sponsor|11|||
170565523|NCT00163189|616418558|FG000|Overall Study|Withdrawal by Subject|11|||
170565524|NCT00163189|616418558|FG000|Overall Study|Did not meet continuation criterion|16|||
170565525|NCT02154061|616418559|FG000|Overall Study|Pregnancy|1|||
170565526|NCT02154061|616418560|FG001|Overall Study|Pregnancy|0|||
170565527|NCT02154061|616418559|FG000|Overall Study|enrolled but not vaccinated|1|||
170565528|NCT02154061|616418560|FG001|Overall Study|enrolled but not vaccinated|0|||
170565529|NCT01936831|616418561|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
170565530|NCT01936831|616418562|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
170565531|NCT01936831|616418563|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
170565532|NCT01936831|616418564|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
170565533|NCT01936831|616418565|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
170565534|NCT01936831|616418566|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
170565535|NCT01936831|616418567|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
170565536|NCT01936831|616418568|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
170565537|NCT01936831|616418569|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
170565538|NCT00186628|616418570|FG000|Overall Study|Death|2|||
170565539|NCT00186628|616418570|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
170565540|NCT01331681|616418572|FG000|Overall Study|Adverse Event|10|||
170565541|NCT01331681|616418573|FG001|Overall Study|Adverse Event|13|||
170565542|NCT01331681|616418574|FG002|Overall Study|Adverse Event|10|||
170565543|NCT01331681|616418572|FG000|Overall Study|Death|6|||
170565544|NCT01331681|616418573|FG001|Overall Study|Death|6|||
170565545|NCT01331681|616418574|FG002|Overall Study|Death|2|||
170565546|NCT01331681|616418572|FG000|Overall Study|Lack of Efficacy|0|||
170565547|NCT01331681|616418573|FG001|Overall Study|Lack of Efficacy|1|||
170565548|NCT01331681|616418574|FG002|Overall Study|Lack of Efficacy|0|||
170565549|NCT01331681|616418572|FG000|Overall Study|Withdrawal by Subject|12|||
170565550|NCT01331681|616418573|FG001|Overall Study|Withdrawal by Subject|8|||
170565551|NCT01331681|616418574|FG002|Overall Study|Withdrawal by Subject|15|||
170565552|NCT01331681|616418572|FG000|Overall Study|Protocol Violation|1|||
170565553|NCT01331681|616418573|FG001|Overall Study|Protocol Violation|1|||
170565554|NCT01331681|616418574|FG002|Overall Study|Protocol Violation|0|||
170565555|NCT01331681|616418572|FG000|Overall Study|Lost to Follow-up|2|||
170565556|NCT01331681|616418573|FG001|Overall Study|Lost to Follow-up|4|||
170565557|NCT01331681|616418574|FG002|Overall Study|Lost to Follow-up|1|||
170565558|NCT01331681|616418572|FG000|Overall Study|Physician Decision|2|||
170565559|NCT01331681|616418573|FG001|Overall Study|Physician Decision|0|||
170565560|NCT01331681|616418574|FG002|Overall Study|Physician Decision|4|||
170565561|NCT01331681|616418572|FG000|Overall Study|Therapeutic procedure required|1|||
170565562|NCT01331681|616418573|FG001|Overall Study|Therapeutic procedure required|0|||
170565563|NCT01331681|616418574|FG002|Overall Study|Therapeutic procedure required|0|||
170565564|NCT01331681|616418572|FG000|Overall Study|Sponsor decision|1|||
170565565|NCT01331681|616418573|FG001|Overall Study|Sponsor decision|1|||
170565566|NCT01331681|616418574|FG002|Overall Study|Sponsor decision|0|||
170565567|NCT01331681|616418572|FG000|Overall Study|Switching to other therapy|0|||
170565568|NCT01331681|616418573|FG001|Overall Study|Switching to other therapy|0|||
170565569|NCT01331681|616418574|FG002|Overall Study|Switching to other therapy|1|||
170565570|NCT01331681|616418572|FG000|Overall Study|Not Received Study Treatment|0|||
170565571|NCT01331681|616418573|FG001|Overall Study|Not Received Study Treatment|0|||
170560341|NCT03895372|616396759|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
170560342|NCT03895372|616396760|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
170560343|NCT03895372|616396761|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
170560344|NCT03895372|616396762|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
170560345|NCT03895372|616396763|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
170560346|NCT03895372|616396756|FG000|Investigational Treatment Period|Other|0|||
170560347|NCT03895372|616396757|FG001|Investigational Treatment Period|Other|0|||
170560348|NCT03895372|616396758|FG002|Investigational Treatment Period|Other|0|||
170560349|NCT03895372|616396759|FG003|Investigational Treatment Period|Other|0|||
170560350|NCT03895372|616396760|FG004|Investigational Treatment Period|Other|0|||
170560351|NCT03895372|616396761|FG005|Investigational Treatment Period|Other|1|||
170560352|NCT03895372|616396762|FG006|Investigational Treatment Period|Other|0|||
170560353|NCT03895372|616396763|FG007|Investigational Treatment Period|Other|2|||
170560354|NCT03895372|616396756|FG000|Investigational Treatment Period|Protocol Violation|0|||
170560355|NCT03895372|616396757|FG001|Investigational Treatment Period|Protocol Violation|0|||
170560356|NCT03895372|616396758|FG002|Investigational Treatment Period|Protocol Violation|0|||
170560357|NCT03895372|616396759|FG003|Investigational Treatment Period|Protocol Violation|1|||
170560358|NCT03895372|616396760|FG004|Investigational Treatment Period|Protocol Violation|0|||
170560359|NCT03895372|616396761|FG005|Investigational Treatment Period|Protocol Violation|0|||
170560360|NCT03895372|616396762|FG006|Investigational Treatment Period|Protocol Violation|0|||
170560361|NCT03895372|616396763|FG007|Investigational Treatment Period|Protocol Violation|0|||
170560362|NCT03895372|616396756|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
170560363|NCT03895372|616396757|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
170560364|NCT03895372|616396758|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
170560365|NCT03895372|616396759|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
170560366|NCT03895372|616396760|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
170560367|NCT03895372|616396761|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
170560368|NCT03895372|616396762|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
170560369|NCT03895372|616396763|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
170560370|NCT03895372|616396756|FG000|Extension Treatment Period|Adverse Event|0|||
170560371|NCT03895372|616396757|FG001|Extension Treatment Period|Adverse Event|1|||
170560372|NCT03895372|616396758|FG002|Extension Treatment Period|Adverse Event|0|||
170560373|NCT03895372|616396759|FG003|Extension Treatment Period|Adverse Event|1|||
170560374|NCT03895372|616396760|FG004|Extension Treatment Period|Adverse Event|0|||
170560375|NCT03895372|616396761|FG005|Extension Treatment Period|Adverse Event|0|||
170560376|NCT03895372|616396762|FG006|Extension Treatment Period|Adverse Event|3|||
170560377|NCT03895372|616396763|FG007|Extension Treatment Period|Adverse Event|3|||
170560378|NCT03895372|616396756|FG000|Extension Treatment Period|Other|1|||
170560379|NCT03895372|616396757|FG001|Extension Treatment Period|Other|3|||
170560380|NCT03895372|616396758|FG002|Extension Treatment Period|Other|0|||
170560381|NCT03895372|616396759|FG003|Extension Treatment Period|Other|0|||
170560382|NCT03895372|616396760|FG004|Extension Treatment Period|Other|1|||
170560383|NCT03895372|616396761|FG005|Extension Treatment Period|Other|0|||
170560384|NCT03895372|616396762|FG006|Extension Treatment Period|Other|0|||
170560385|NCT03895372|616396763|FG007|Extension Treatment Period|Other|2|||
170560386|NCT03895372|616396756|FG000|Extension Treatment Period|Pregnancy|0|||
170560387|NCT03895372|616396757|FG001|Extension Treatment Period|Pregnancy|0|||
170560388|NCT03895372|616396758|FG002|Extension Treatment Period|Pregnancy|0|||
170560389|NCT03895372|616396759|FG003|Extension Treatment Period|Pregnancy|0|||
170560390|NCT03895372|616396760|FG004|Extension Treatment Period|Pregnancy|1|||
170560391|NCT03895372|616396761|FG005|Extension Treatment Period|Pregnancy|0|||
170560392|NCT03895372|616396762|FG006|Extension Treatment Period|Pregnancy|0|||
170560393|NCT03895372|616396763|FG007|Extension Treatment Period|Pregnancy|0|||
170560394|NCT03895372|616396756|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
170560395|NCT03895372|616396757|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
170560396|NCT03895372|616396758|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
170560397|NCT03895372|616396759|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
170560398|NCT03895372|616396760|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
170560399|NCT03895372|616396761|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
170560400|NCT03895372|616396762|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
170560401|NCT03895372|616396763|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
170560402|NCT03685149|616396764|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
170560403|NCT03685149|616396765|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
170560404|NCT03685149|616396764|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170560405|NCT03685149|616396765|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
170560406|NCT03685149|616396764|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
170560407|NCT03685149|616396765|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
170560408|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
170560409|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
170560410|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
170646065|NCT01628029|616717884|FG005|Overall Study|Incomplete primary outcome assessment|0|||
170560411|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
170560412|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
170560413|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
170560414|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
170560415|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
170560416|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
170560417|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
170560418|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
170560419|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
170560420|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
170560421|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
170560422|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
170560423|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
170560424|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
170560425|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
170560426|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
170560427|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
170560428|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
170560429|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
170560430|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
170560431|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
170560432|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
170560433|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
170560434|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
170560435|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
170560436|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
170560437|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
170560438|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
170560439|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
170560440|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
170560441|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
170560442|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
170560443|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
170560444|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
170560445|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
170560446|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
170560447|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
170560448|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
170560449|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
170560450|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
170560451|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
170560452|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
170560453|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
170560454|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
170560455|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
170560456|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
170560457|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
170560458|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
170560459|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
170560460|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
170560461|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
170560462|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
170560463|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
170560464|NCT01362790|616396779|FG000|Pilot Phase & Phase 2|Death on study|0|||
170560465|NCT01362790|616396780|FG001|Pilot Phase & Phase 2|Death on study|0|||
170560466|NCT01362790|616396781|FG002|Pilot Phase & Phase 2|Death on study|0|||
170560467|NCT01362790|616396782|FG003|Pilot Phase & Phase 2|Death on study|1|||
170560468|NCT01362790|616396783|FG004|Pilot Phase & Phase 2|Death on study|0|||
170560469|NCT01362790|616396784|FG005|Pilot Phase & Phase 2|Death on study|0|||
170560470|NCT01362790|616396785|FG006|Pilot Phase & Phase 2|Death on study|0|||
170560471|NCT01362790|616396779|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
170905302|NCT02034123|617656074|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
170560472|NCT01362790|616396780|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
170560473|NCT01362790|616396781|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
170560474|NCT01362790|616396782|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
170560475|NCT01362790|616396783|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
170560476|NCT01362790|616396784|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
170560477|NCT01362790|616396785|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
170560478|NCT01362790|616396779|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
170560479|NCT01362790|616396780|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
170560480|NCT01362790|616396781|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
170560481|NCT01362790|616396782|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
170560482|NCT01362790|616396783|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
170560483|NCT01362790|616396784|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
170560484|NCT01362790|616396785|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
170560485|NCT01362790|616396779|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
170560486|NCT01362790|616396780|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
170560487|NCT01362790|616396781|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
170560488|NCT01362790|616396782|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
170560489|NCT01362790|616396783|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
170560490|NCT01362790|616396784|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
170560491|NCT01362790|616396785|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
170560492|NCT04347538|616396788|FG000|Overall Study|Lost to Follow-up|4|||
170560493|NCT04347538|616396789|FG001|Overall Study|Lost to Follow-up|5|||
170560494|NCT04347538|616396790|FG002|Overall Study|Lost to Follow-up|7|||
170560495|NCT05081843|616396791|FG000|Overall Study|Lost to Follow-up|135|||
170560496|NCT05081843|616396792|FG001|Overall Study|Lost to Follow-up|145|||
170560497|NCT04197583|616396801|FG000|Overall Study|Study Stent Replacement|34|||
170560498|NCT04197583|616396802|FG001|Overall Study|Study Stent Replacement|8|||
170560499|NCT04197583|616396801|FG000|Overall Study|Lost to Follow-up|14|||
170560500|NCT04197583|616396802|FG001|Overall Study|Lost to Follow-up|3|||
170560501|NCT04197583|616396801|FG000|Overall Study|Death|3|||
170560502|NCT04197583|616396802|FG001|Overall Study|Death|0|||
170560503|NCT04197583|616396801|FG000|Overall Study|Physician Decision|1|||
170560504|NCT04197583|616396802|FG001|Overall Study|Physician Decision|0|||
170560505|NCT04197583|616396801|FG000|Overall Study|Withdrawal by Subject|1|||
170560506|NCT04197583|616396802|FG001|Overall Study|Withdrawal by Subject|1|||
170560507|NCT04197583|616396801|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
170560508|NCT04197583|616396802|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
170560509|NCT04197583|616396801|FG000|Overall Study|Screen Failure|0|||
170560510|NCT04197583|616396802|FG001|Overall Study|Screen Failure|20|||
170560511|NCT05487378|616396811|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
170560512|NCT05487378|616396812|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
170560513|NCT05487378|616396811|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
170560514|NCT05487378|616396812|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
170560515|NCT02414841|616396818|FG000|Overall Study|Withdrawal by Subject|7|||
170560516|NCT02414841|616396819|FG001|Overall Study|Withdrawal by Subject|5|||
170560517|NCT02414841|616396818|FG000|Overall Study|Lost to Follow-up|13|||
170560518|NCT02414841|616396819|FG001|Overall Study|Lost to Follow-up|6|||
170560519|NCT02414841|616396818|FG000|Overall Study|Death|17|||
170560520|NCT02414841|616396819|FG001|Overall Study|Death|14|||
170560521|NCT02414841|616396818|FG000|Overall Study|Received a Kidney Transplant|13|||
170560522|NCT02414841|616396819|FG001|Overall Study|Received a Kidney Transplant|4|||
170560523|NCT02414841|616396818|FG000|Overall Study|Randomized But Not Treated|6|||
170560524|NCT02414841|616396819|FG001|Overall Study|Randomized But Not Treated|4|||
170560525|NCT05185453|616396820|FG000|Overall Study|Lost to Follow-up|13|||
170560526|NCT05185453|616396821|FG001|Overall Study|Lost to Follow-up|3|||
170560527|NCT00133705|616398743|FG000|Overall Study|Withdrawal by Subject|2|||
170560528|NCT00133705|616398744|FG001|Overall Study|Withdrawal by Subject|3|||
170560529|NCT00836706|616398747|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
170560530|NCT00836706|616398748|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
170560531|NCT00688740|616398753|FG000|Overall Study|Adverse Event|45|||
170560532|NCT00688740|616398754|FG001|Overall Study|Adverse Event|8|||
170560533|NCT00688740|616398753|FG000|Overall Study|Death|2|||
170560534|NCT00688740|616398754|FG001|Overall Study|Death|2|||
170560535|NCT00688740|616398753|FG000|Overall Study|Lost to Follow-up|0|||
170560536|NCT00688740|616398754|FG001|Overall Study|Lost to Follow-up|1|||
170560537|NCT00688740|616398753|FG000|Overall Study|Consent Withdrawn|17|||
170560538|NCT00688740|616398754|FG001|Overall Study|Consent Withdrawn|17|||
170560539|NCT00688740|616398753|FG000|Overall Study|Breast Cancer Relapse|1|||
170560540|NCT00688740|616398754|FG001|Overall Study|Breast Cancer Relapse|4|||
170560541|NCT00688740|616398753|FG000|Overall Study|Violation of Inclusion Criteria|1|||
170560542|NCT00688740|616398754|FG001|Overall Study|Violation of Inclusion Criteria|3|||
170560543|NCT02829996|616398762|FG000|Overall Study|Withdrawal by Subject|1|||
170560544|NCT02829996|616398763|FG001|Overall Study|Withdrawal by Subject|0|||
170560545|NCT02829996|616398764|FG002|Overall Study|Withdrawal by Subject|0|||
170560546|NCT02829996|616398765|FG003|Overall Study|Withdrawal by Subject|0|||
170560547|NCT02829996|616398766|FG004|Overall Study|Withdrawal by Subject|0|||
170560548|NCT03801525|616398772|FG000|Overall Study|Adverse Event|17|||
170560549|NCT03801525|616398773|FG001|Overall Study|Adverse Event|1|||
170560550|NCT03801525|616398774|FG002|Overall Study|Adverse Event|0|||
170905303|NCT02034123|617656075|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170560551|NCT03801525|616398772|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
170560552|NCT03801525|616398773|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
170560553|NCT03801525|616398774|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
170560554|NCT03801525|616398772|FG000|Overall Study|Death|29|||
170560555|NCT03801525|616398773|FG001|Overall Study|Death|1|||
170560556|NCT03801525|616398774|FG002|Overall Study|Death|4|||
170560557|NCT03801525|616398772|FG000|Overall Study|Disease Progression|6|||
170560558|NCT03801525|616398773|FG001|Overall Study|Disease Progression|0|||
170560559|NCT03801525|616398774|FG002|Overall Study|Disease Progression|1|||
170560560|NCT03801525|616398772|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
170560561|NCT03801525|616398773|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
170560562|NCT03801525|616398774|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
170560563|NCT03801525|616398772|FG000|Overall Study|Investigator Decision|18|||
170560564|NCT03801525|616398773|FG001|Overall Study|Investigator Decision|1|||
170560565|NCT03801525|616398774|FG002|Overall Study|Investigator Decision|0|||
170560566|NCT03801525|616398772|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
170560567|NCT03801525|616398773|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
170560568|NCT03801525|616398774|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
170560569|NCT03801525|616398772|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
170560570|NCT03801525|616398773|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
170560571|NCT03801525|616398774|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
170560572|NCT03801525|616398772|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
170560573|NCT03801525|616398773|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
170560574|NCT03801525|616398774|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
170560575|NCT03801525|616398772|FG000|Overall Study|Withdrawal of Subject Consent|38|||
170560576|NCT03801525|616398773|FG001|Overall Study|Withdrawal of Subject Consent|2|||
170560577|NCT03801525|616398774|FG002|Overall Study|Withdrawal of Subject Consent|1|||
170560578|NCT03801525|616398772|FG000|Overall Study|Reason not Specified|4|||
170560579|NCT03801525|616398773|FG001|Overall Study|Reason not Specified|0|||
170560580|NCT03801525|616398774|FG002|Overall Study|Reason not Specified|4|||
170560581|NCT01206517|616398775|FG000|Overall Study|Withdrawal by Subject|0|||
170560582|NCT01206517|616398776|FG001|Overall Study|Withdrawal by Subject|0|||
170560583|NCT01206517|616398777|FG002|Overall Study|Withdrawal by Subject|2|||
170560584|NCT01206517|616398778|FG003|Overall Study|Withdrawal by Subject|0|||
170560585|NCT01206517|616398779|FG004|Overall Study|Withdrawal by Subject|1|||
170560586|NCT01206517|616398780|FG005|Overall Study|Withdrawal by Subject|0|||
170560587|NCT00725985|616398783|FG000|ITP- Treatment Disposition|Adverse Event|20|||
170560588|NCT00725985|616398784|FG001|ITP- Treatment Disposition|Adverse Event|10|||
170560589|NCT00725985|616398785|FG002|ITP- Treatment Disposition|Adverse Event|5|||
170560590|NCT00725985|616398786|FG003|ITP- Treatment Disposition|Adverse Event|0|||
170560591|NCT00725985|616398787|FG004|ITP- Treatment Disposition|Adverse Event|0|||
170560592|NCT00725985|616398788|FG005|ITP- Treatment Disposition|Adverse Event|0|||
170560593|NCT00725985|616398789|FG006|ITP- Treatment Disposition|Adverse Event|0|||
170560594|NCT00725985|616398790|FG007|ITP- Treatment Disposition|Adverse Event|0|||
170560595|NCT00725985|616398791|FG008|ITP- Treatment Disposition|Adverse Event|0|||
170560596|NCT00725985|616398792|FG009|ITP- Treatment Disposition|Adverse Event|0|||
170560597|NCT00725985|616398793|FG010|ITP- Treatment Disposition|Adverse Event|0|||
170560598|NCT00725985|616398794|FG011|ITP- Treatment Disposition|Adverse Event|0|||
170560599|NCT00725985|616398783|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560600|NCT00725985|616398784|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560601|NCT00725985|616398785|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
170560602|NCT00725985|616398786|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560603|NCT00725985|616398787|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560604|NCT00725985|616398788|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560605|NCT00725985|616398789|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560606|NCT00725985|616398790|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560607|NCT00725985|616398791|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560608|NCT00725985|616398792|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560609|NCT00725985|616398793|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560610|NCT00725985|616398794|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
170560611|NCT00725985|616398783|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
170560612|NCT00725985|616398784|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
170560613|NCT00725985|616398785|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
170560614|NCT00725985|616398786|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
170560615|NCT00725985|616398787|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
170560616|NCT00725985|616398788|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
170560617|NCT00725985|616398789|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
170560618|NCT00725985|616398790|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
170560619|NCT00725985|616398791|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
170560620|NCT00725985|616398792|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
170560621|NCT00725985|616398793|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
170645233|NCT00600119|616715890|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
170645234|NCT00600119|616715891|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
170645235|NCT00600119|616715892|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
170560622|NCT00725985|616398794|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
170560623|NCT00725985|616398783|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
170560624|NCT00725985|616398784|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
170560625|NCT00725985|616398785|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
170645236|NCT00600119|616715887|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
170645237|NCT00600119|616715888|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
170645238|NCT00600119|616715889|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
170645239|NCT00600119|616715890|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
170645240|NCT00600119|616715891|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
170645241|NCT00600119|616715892|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
170645242|NCT00600119|616715887|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
170645243|NCT00600119|616715888|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
170645244|NCT00600119|616715889|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
170645245|NCT00600119|616715890|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
170645246|NCT00600119|616715891|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
170645247|NCT00600119|616715892|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
170645248|NCT00600119|616715887|FG000|Double-blind Treatment Period|Physician Decision|2|||
170645249|NCT00600119|616715888|FG001|Double-blind Treatment Period|Physician Decision|0|||
170645250|NCT00600119|616715889|FG002|Double-blind Treatment Period|Physician Decision|0|||
170645251|NCT00600119|616715890|FG003|Double-blind Treatment Period|Physician Decision|0|||
170645252|NCT00600119|616715891|FG004|Double-blind Treatment Period|Physician Decision|0|||
170645253|NCT00600119|616715892|FG005|Double-blind Treatment Period|Physician Decision|0|||
170645254|NCT00600119|616715887|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
170645255|NCT00600119|616715888|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
170645256|NCT00600119|616715889|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
170645257|NCT00600119|616715890|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
170645258|NCT00600119|616715891|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
170560626|NCT00725985|616398786|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
170560627|NCT00725985|616398787|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
170560628|NCT00725985|616398788|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
170560629|NCT00725985|616398789|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
170560630|NCT00725985|616398790|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
170560631|NCT00725985|616398791|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
170560632|NCT00725985|616398792|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
170560633|NCT00725985|616398793|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
170560634|NCT00725985|616398794|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
170560635|NCT00725985|616398783|FG000|ITP- Treatment Disposition|Other|50|||
170560636|NCT00725985|616398784|FG001|ITP- Treatment Disposition|Other|38|||
170560637|NCT00725985|616398785|FG002|ITP- Treatment Disposition|Other|24|||
170560638|NCT00725985|616398786|FG003|ITP- Treatment Disposition|Other|0|||
170560639|NCT00725985|616398787|FG004|ITP- Treatment Disposition|Other|0|||
170560640|NCT00725985|616398788|FG005|ITP- Treatment Disposition|Other|0|||
170560641|NCT00725985|616398789|FG006|ITP- Treatment Disposition|Other|0|||
170560642|NCT00725985|616398790|FG007|ITP- Treatment Disposition|Other|0|||
170560643|NCT00725985|616398791|FG008|ITP- Treatment Disposition|Other|0|||
170560644|NCT00725985|616398792|FG009|ITP- Treatment Disposition|Other|0|||
170560645|NCT00725985|616398793|FG010|ITP- Treatment Disposition|Other|0|||
170560646|NCT00725985|616398794|FG011|ITP- Treatment Disposition|Other|0|||
170560647|NCT00725985|616398783|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170560648|NCT00725985|616398784|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170560649|NCT00725985|616398785|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170560650|NCT00725985|616398786|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
170560651|NCT00725985|616398787|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
170645259|NCT00600119|616715892|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
170560652|NCT00725985|616398788|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
170560653|NCT00725985|616398789|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170645260|NCT00600119|616715887|FG000|Double-blind Treatment Period|Adverse Event|1|||
170645261|NCT00600119|616715888|FG001|Double-blind Treatment Period|Adverse Event|1|||
170645262|NCT00600119|616715889|FG002|Double-blind Treatment Period|Adverse Event|0|||
170645263|NCT00600119|616715890|FG003|Double-blind Treatment Period|Adverse Event|1|||
170645264|NCT00600119|616715891|FG004|Double-blind Treatment Period|Adverse Event|2|||
170645265|NCT00600119|616715892|FG005|Double-blind Treatment Period|Adverse Event|10|||
170560654|NCT00725985|616398790|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170560655|NCT00725985|616398791|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170560656|NCT00725985|616398792|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170560657|NCT00725985|616398793|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170560658|NCT00725985|616398794|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
170560659|NCT00725985|616398783|FG000|OLMP (Up to 96 Weeks)|Death|0|||
170560660|NCT00725985|616398784|FG001|OLMP (Up to 96 Weeks)|Death|0|||
170560661|NCT00725985|616398785|FG002|OLMP (Up to 96 Weeks)|Death|0|||
170560662|NCT00725985|616398786|FG003|OLMP (Up to 96 Weeks)|Death|0|||
170560663|NCT00725985|616398787|FG004|OLMP (Up to 96 Weeks)|Death|1|||
170560664|NCT00725985|616398788|FG005|OLMP (Up to 96 Weeks)|Death|0|||
170560665|NCT00725985|616398789|FG006|OLMP (Up to 96 Weeks)|Death|0|||
170560666|NCT00725985|616398790|FG007|OLMP (Up to 96 Weeks)|Death|0|||
170560667|NCT00725985|616398791|FG008|OLMP (Up to 96 Weeks)|Death|0|||
170560668|NCT00725985|616398792|FG009|OLMP (Up to 96 Weeks)|Death|0|||
170560669|NCT00725985|616398793|FG010|OLMP (Up to 96 Weeks)|Death|0|||
170560670|NCT00725985|616398794|FG011|OLMP (Up to 96 Weeks)|Death|0|||
170560671|NCT00725985|616398783|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560672|NCT00725985|616398784|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560673|NCT00725985|616398785|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560674|NCT00725985|616398786|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
170560675|NCT00725985|616398787|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560676|NCT00725985|616398788|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560677|NCT00725985|616398789|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560678|NCT00725985|616398790|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560679|NCT00725985|616398791|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560680|NCT00725985|616398792|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560681|NCT00725985|616398793|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560682|NCT00725985|616398794|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
170560683|NCT00725985|616398783|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560684|NCT00725985|616398784|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560685|NCT00725985|616398785|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560686|NCT00725985|616398786|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560687|NCT00725985|616398787|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560688|NCT00725985|616398788|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
170560689|NCT00725985|616398789|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560690|NCT00725985|616398790|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560691|NCT00725985|616398791|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560692|NCT00725985|616398792|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560693|NCT00725985|616398793|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560694|NCT00725985|616398794|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
170560695|NCT00725985|616398783|FG000|OLMP (Up to 96 Weeks)|Other|0|||
170560696|NCT00725985|616398784|FG001|OLMP (Up to 96 Weeks)|Other|0|||
170560697|NCT00725985|616398785|FG002|OLMP (Up to 96 Weeks)|Other|0|||
170560698|NCT00725985|616398786|FG003|OLMP (Up to 96 Weeks)|Other|15|||
170560699|NCT00725985|616398787|FG004|OLMP (Up to 96 Weeks)|Other|20|||
170560700|NCT00725985|616398788|FG005|OLMP (Up to 96 Weeks)|Other|44|||
170560701|NCT00725985|616398789|FG006|OLMP (Up to 96 Weeks)|Other|0|||
170560702|NCT00725985|616398790|FG007|OLMP (Up to 96 Weeks)|Other|0|||
170560703|NCT00725985|616398791|FG008|OLMP (Up to 96 Weeks)|Other|0|||
170560704|NCT00725985|616398792|FG009|OLMP (Up to 96 Weeks)|Other|0|||
170560705|NCT00725985|616398793|FG010|OLMP (Up to 96 Weeks)|Other|0|||
170560706|NCT00725985|616398794|FG011|OLMP (Up to 96 Weeks)|Other|0|||
170560707|NCT00725985|616398783|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560708|NCT00725985|616398784|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560709|NCT00725985|616398785|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560710|NCT00725985|616398786|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560711|NCT00725985|616398787|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560712|NCT00725985|616398788|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560713|NCT00725985|616398789|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560714|NCT00725985|616398790|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
170560715|NCT00725985|616398791|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560716|NCT00725985|616398792|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560717|NCT00725985|616398793|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560718|NCT00725985|616398794|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
170560719|NCT00725985|616398783|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560720|NCT00725985|616398784|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560721|NCT00725985|616398785|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560722|NCT00725985|616398786|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560723|NCT00725985|616398787|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560724|NCT00725985|616398788|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560725|NCT00725985|616398789|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560726|NCT00725985|616398790|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560727|NCT00725985|616398791|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
170560728|NCT00725985|616398792|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560729|NCT00725985|616398793|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560730|NCT00725985|616398794|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
170560731|NCT00725985|616398783|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560732|NCT00725985|616398784|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560733|NCT00725985|616398785|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560734|NCT00725985|616398786|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560735|NCT00725985|616398787|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560736|NCT00725985|616398788|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560737|NCT00725985|616398789|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
170560738|NCT00725985|616398790|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
170560739|NCT00725985|616398791|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
170560740|NCT00725985|616398792|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560741|NCT00725985|616398793|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560742|NCT00725985|616398794|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
170560743|NCT00725985|616398783|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560744|NCT00725985|616398784|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560745|NCT00725985|616398785|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560746|NCT00725985|616398786|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560747|NCT00725985|616398787|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560748|NCT00725985|616398788|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560749|NCT00725985|616398789|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560750|NCT00725985|616398790|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560751|NCT00725985|616398791|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
170560752|NCT00725985|616398792|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
170560753|NCT00725985|616398793|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
170560754|NCT00725985|616398794|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
170560755|NCT02546323|616398795|FG000|Overall Study|Withdrawal by Subject|36|||
170560756|NCT02546323|616398796|FG001|Overall Study|Withdrawal by Subject|33|||
170560757|NCT02546323|616398795|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
170560758|NCT02546323|616398796|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
170560759|NCT02546323|616398795|FG000|Overall Study|Adverse Event|17|||
170560760|NCT02546323|616398796|FG001|Overall Study|Adverse Event|11|||
170560761|NCT02546323|616398795|FG000|Overall Study|Patient Specific Reasons|1|||
170560762|NCT02546323|616398796|FG001|Overall Study|Patient Specific Reasons|2|||
170560763|NCT02546323|616398795|FG000|Overall Study|Lost to Follow-up|2|||
170560764|NCT02546323|616398796|FG001|Overall Study|Lost to Follow-up|3|||
170560765|NCT02546323|616398795|FG000|Overall Study|Non-compliance with Study Drug|2|||
170560766|NCT02546323|616398796|FG001|Overall Study|Non-compliance with Study Drug|2|||
170560767|NCT02546323|616398795|FG000|Overall Study|Met Withdrawal Criteria|2|||
170560768|NCT02546323|616398796|FG001|Overall Study|Met Withdrawal Criteria|14|||
170560769|NCT04476784|616398797|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
170560770|NCT04476784|616398798|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
170560771|NCT00976456|616398804|FG000|Overall Study|Adverse Event|17|||
170560772|NCT00976456|616398805|FG001|Overall Study|Adverse Event|22|||
170560773|NCT00976456|616398804|FG000|Overall Study|Death|7|||
170560774|NCT00976456|616398805|FG001|Overall Study|Death|9|||
170560775|NCT00976456|616398804|FG000|Overall Study|Lack of Efficacy|5|||
170560776|NCT00976456|616398805|FG001|Overall Study|Lack of Efficacy|2|||
170560777|NCT00976456|616398804|FG000|Overall Study|Withdrawal by Subject|3|||
170560778|NCT00976456|616398805|FG001|Overall Study|Withdrawal by Subject|1|||
170560779|NCT00976456|616398804|FG000|Overall Study|screening failure, unknown|11|||
170560780|NCT00976456|616398805|FG001|Overall Study|screening failure, unknown|4|||
170560781|NCT00863304|616398809|FG000|Overall Study|Adverse Event|10|||
170560782|NCT00863304|616398810|FG001|Overall Study|Adverse Event|4|||
170560783|NCT00863304|616398811|FG002|Overall Study|Adverse Event|14|||
170560784|NCT00863304|616398812|FG003|Overall Study|Adverse Event|16|||
170560785|NCT00863304|616398809|FG000|Overall Study|Lost to Follow-up|1|||
170560786|NCT00863304|616398810|FG001|Overall Study|Lost to Follow-up|5|||
170560787|NCT00863304|616398811|FG002|Overall Study|Lost to Follow-up|4|||
170560788|NCT00863304|616398812|FG003|Overall Study|Lost to Follow-up|2|||
170560789|NCT00863304|616398809|FG000|Overall Study|Lack of Efficacy|57|||
170560790|NCT00863304|616398810|FG001|Overall Study|Lack of Efficacy|26|||
170560791|NCT00863304|616398811|FG002|Overall Study|Lack of Efficacy|30|||
170560792|NCT00863304|616398812|FG003|Overall Study|Lack of Efficacy|28|||
170645266|NCT00600119|616715887|FG000|Follow-up Period|Adverse Event|0|||
170560793|NCT00863304|616398809|FG000|Overall Study|Withdrawal by Subject|19|||
170560794|NCT00863304|616398810|FG001|Overall Study|Withdrawal by Subject|14|||
170560795|NCT00863304|616398811|FG002|Overall Study|Withdrawal by Subject|20|||
170560796|NCT00863304|616398812|FG003|Overall Study|Withdrawal by Subject|18|||
170560797|NCT00863304|616398809|FG000|Overall Study|Other|1|||
170645267|NCT00600119|616715888|FG001|Follow-up Period|Adverse Event|0|||
170560798|NCT00863304|616398810|FG001|Overall Study|Other|0|||
170560799|NCT00863304|616398811|FG002|Overall Study|Other|0|||
170560800|NCT00863304|616398812|FG003|Overall Study|Other|1|||
170560801|NCT00863304|616398809|FG000|Overall Study|Protocol Violation|2|||
170560802|NCT00863304|616398810|FG001|Overall Study|Protocol Violation|6|||
170560803|NCT00863304|616398811|FG002|Overall Study|Protocol Violation|2|||
170560804|NCT00863304|616398812|FG003|Overall Study|Protocol Violation|0|||
170560805|NCT00863304|616398809|FG000|Overall Study|Randomized, but not Treated|3|||
170560806|NCT00863304|616398810|FG001|Overall Study|Randomized, but not Treated|1|||
170645268|NCT00600119|616715889|FG002|Follow-up Period|Adverse Event|0|||
170560807|NCT00863304|616398811|FG002|Overall Study|Randomized, but not Treated|4|||
170560808|NCT00863304|616398812|FG003|Overall Study|Randomized, but not Treated|1|||
170560809|NCT00863304|616398809|FG000|Overall Study|Entered extension study|101|||
170560810|NCT00863304|616398810|FG001|Overall Study|Entered extension study|129|||
170560811|NCT00863304|616398811|FG002|Overall Study|Entered extension study|113|||
170560812|NCT00863304|616398812|FG003|Overall Study|Entered extension study|125|||
170560813|NCT00478257|616398814|FG000|Overall Study|Withdrawal by Subject|8|||
170560814|NCT00478257|616398815|FG001|Overall Study|Withdrawal by Subject|3|||
170560815|NCT00806585|616398816|FG000|Overall Study|Study terminated by Sponsor|0|||
170560816|NCT00806585|616398817|FG001|Overall Study|Study terminated by Sponsor|0|||
170560817|NCT00806585|616398818|FG002|Overall Study|Study terminated by Sponsor|1|||
170560818|NCT00806585|616398819|FG003|Overall Study|Study terminated by Sponsor|2|||
170560819|NCT00806585|616398820|FG004|Overall Study|Study terminated by Sponsor|0|||
170560820|NCT00806585|616398816|FG000|Overall Study|Protocol Violation|3|||
170560821|NCT00806585|616398817|FG001|Overall Study|Protocol Violation|1|||
170560822|NCT00806585|616398818|FG002|Overall Study|Protocol Violation|2|||
170560823|NCT00806585|616398819|FG003|Overall Study|Protocol Violation|0|||
170560824|NCT00806585|616398820|FG004|Overall Study|Protocol Violation|0|||
170560825|NCT00806585|616398816|FG000|Overall Study|Physician Decision|0|||
170560826|NCT00806585|616398817|FG001|Overall Study|Physician Decision|2|||
170560827|NCT00806585|616398818|FG002|Overall Study|Physician Decision|3|||
170560828|NCT00806585|616398819|FG003|Overall Study|Physician Decision|0|||
170560829|NCT00806585|616398820|FG004|Overall Study|Physician Decision|1|||
170560830|NCT00806585|616398816|FG000|Overall Study|Lost to Follow-up|2|||
170560831|NCT00806585|616398817|FG001|Overall Study|Lost to Follow-up|1|||
170560832|NCT00806585|616398818|FG002|Overall Study|Lost to Follow-up|2|||
170560833|NCT00806585|616398819|FG003|Overall Study|Lost to Follow-up|2|||
170560834|NCT00806585|616398820|FG004|Overall Study|Lost to Follow-up|5|||
170560835|NCT00806585|616398816|FG000|Overall Study|Lack of Efficacy|1|||
170560836|NCT00806585|616398817|FG001|Overall Study|Lack of Efficacy|0|||
170560837|NCT00806585|616398818|FG002|Overall Study|Lack of Efficacy|0|||
170560838|NCT00806585|616398819|FG003|Overall Study|Lack of Efficacy|0|||
170560839|NCT00806585|616398820|FG004|Overall Study|Lack of Efficacy|0|||
170560840|NCT00806585|616398816|FG000|Overall Study|Adverse Event|1|||
170560841|NCT00806585|616398817|FG001|Overall Study|Adverse Event|5|||
170560842|NCT00806585|616398818|FG002|Overall Study|Adverse Event|3|||
170560843|NCT00806585|616398819|FG003|Overall Study|Adverse Event|4|||
170560844|NCT00806585|616398820|FG004|Overall Study|Adverse Event|2|||
170560845|NCT00806585|616398816|FG000|Overall Study|Withdrawal by Subject|10|||
170560846|NCT00806585|616398817|FG001|Overall Study|Withdrawal by Subject|8|||
170560847|NCT00806585|616398818|FG002|Overall Study|Withdrawal by Subject|9|||
170560848|NCT00806585|616398819|FG003|Overall Study|Withdrawal by Subject|3|||
170560849|NCT00806585|616398820|FG004|Overall Study|Withdrawal by Subject|11|||
170560850|NCT00806585|616398816|FG000|Overall Study|Completion status unknown|15|||
170560851|NCT00806585|616398817|FG001|Overall Study|Completion status unknown|14|||
170560852|NCT00806585|616398818|FG002|Overall Study|Completion status unknown|12|||
170560853|NCT00806585|616398819|FG003|Overall Study|Completion status unknown|4|||
170560854|NCT00806585|616398820|FG004|Overall Study|Completion status unknown|12|||
170560855|NCT05030766|616398823|FG000|Phase 1 Participants|Lost to Follow-up|12|||
170560856|NCT05030766|616398824|FG001|Phase 1 Participants|Lost to Follow-up|22|||
170560857|NCT05030766|616398825|FG002|Phase 1 Participants|Lost to Follow-up|0|||
170560858|NCT05030766|616398826|FG003|Phase 1 Participants|Lost to Follow-up|0|||
170560859|NCT05030766|616398823|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
170560860|NCT05030766|616398824|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
170560861|NCT05030766|616398825|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
170560862|NCT05030766|616398826|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
170560863|NCT05030766|616398823|FG000|Phase 2 Participants|Lost to Follow-up|0|||
170560864|NCT05030766|616398824|FG001|Phase 2 Participants|Lost to Follow-up|0|||
170560865|NCT05030766|616398825|FG002|Phase 2 Participants|Lost to Follow-up|6|||
170560866|NCT05030766|616398826|FG003|Phase 2 Participants|Lost to Follow-up|2|||
170560867|NCT01472185|616398831|FG000|Overall Study|Randomized but Not Treated|0|||
170560868|NCT01472185|616398832|FG001|Overall Study|Randomized but Not Treated|1|||
170560869|NCT01472185|616398831|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
170560870|NCT01472185|616398832|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
170645269|NCT00600119|616715890|FG003|Follow-up Period|Adverse Event|0|||
170560871|NCT01472185|616398831|FG000|Overall Study|Hyperglycemia|5|||
170560872|NCT01472185|616398832|FG001|Overall Study|Hyperglycemia|2|||
170560873|NCT01472185|616398831|FG000|Overall Study|Investigator's Discretion|3|||
170560874|NCT01472185|616398832|FG001|Overall Study|Investigator's Discretion|1|||
170560875|NCT01472185|616398831|FG000|Overall Study|Lost to Follow-up|4|||
170560876|NCT01472185|616398832|FG001|Overall Study|Lost to Follow-up|1|||
170560877|NCT01472185|616398831|FG000|Overall Study|Protocol Violation|5|||
170560878|NCT01472185|616398832|FG001|Overall Study|Protocol Violation|1|||
170560879|NCT01472185|616398831|FG000|Overall Study|Subject Noncompliance|8|||
170560880|NCT01472185|616398832|FG001|Overall Study|Subject Noncompliance|15|||
170560881|NCT01472185|616398831|FG000|Overall Study|Subject Withdrew Consent|6|||
170560882|NCT01472185|616398832|FG001|Overall Study|Subject Withdrew Consent|3|||
170560883|NCT01309230|616398833|FG000|Overall Study|Withdrawal by Subject|0|||
170560884|NCT01309230|616398834|FG001|Overall Study|Withdrawal by Subject|2|||
170560885|NCT01309230|616398833|FG000|Overall Study|Observation arm closed|0|||
170560886|NCT01309230|616398834|FG001|Overall Study|Observation arm closed|2|||
170560887|NCT04581395|616398835|FG000|Overall Study|Protocol Violation|4|||
170560888|NCT04581395|616398836|FG001|Overall Study|Protocol Violation|3|||
170560889|NCT04581395|616398837|FG002|Overall Study|Protocol Violation|2|||
170560890|NCT04581395|616398835|FG000|Overall Study|Physician Decision|0|||
170560891|NCT04581395|616398836|FG001|Overall Study|Physician Decision|1|||
170560892|NCT04581395|616398837|FG002|Overall Study|Physician Decision|0|||
170560893|NCT02284893|616398843|FG000|26 Week (Short Term)|Adverse Event|1|||
170560894|NCT02284893|616398844|FG001|26 Week (Short Term)|Adverse Event|9|||
170560895|NCT02284893|616398843|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
170560896|NCT02284893|616398844|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
170560897|NCT02284893|616398843|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
170560898|NCT02284893|616398844|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
170560899|NCT02284893|616398843|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
170560900|NCT02284893|616398844|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
170560901|NCT02284893|616398843|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
170560902|NCT02284893|616398844|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
170560903|NCT02284893|616398843|FG000|26 Week (Short Term)|Other|1|||
170560904|NCT02284893|616398844|FG001|26 Week (Short Term)|Other|1|||
170560905|NCT02284893|616398843|FG000|52 Week (Long Term)|Adverse Event|3|||
170560906|NCT02284893|616398844|FG001|52 Week (Long Term)|Adverse Event|1|||
170560907|NCT02284893|616398843|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
170560908|NCT02284893|616398844|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
170560909|NCT02284893|616398843|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
170560910|NCT02284893|616398844|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
170560911|NCT02284893|616398843|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
170560912|NCT02284893|616398844|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
170560913|NCT02284893|616398843|FG000|52 Week (Long Term)|Non-Compliance|2|||
170560914|NCT02284893|616398844|FG001|52 Week (Long Term)|Non-Compliance|3|||
170560915|NCT03078868|616398847|FG000|Overall Study|Physician Decision|3|||
170560916|NCT05360784|616398850|FG000|Overall Study|Discontinued|25|||
170560917|NCT05360784|616398851|FG001|Overall Study|Discontinued|11|||
170560918|NCT04875533|616398855|FG000|Overall Study|Adverse Event|6|||
170560919|NCT04875533|616398856|FG001|Overall Study|Adverse Event|4|||
170560920|NCT04875533|616398855|FG000|Overall Study|Protocol Violation|4|||
170560921|NCT04875533|616398856|FG001|Overall Study|Protocol Violation|0|||
170560922|NCT04875533|616398855|FG000|Overall Study|Withdrawal by Subject|8|||
170560923|NCT04875533|616398856|FG001|Overall Study|Withdrawal by Subject|5|||
170560924|NCT04875533|616398855|FG000|Overall Study|No longer meets eligibility criteria|1|||
170560925|NCT04875533|616398856|FG001|Overall Study|No longer meets eligibility criteria|0|||
170560926|NCT04875533|616398855|FG000|Overall Study|Other|0|||
170560927|NCT04875533|616398856|FG001|Overall Study|Other|2|||
170645270|NCT00600119|616715891|FG004|Follow-up Period|Adverse Event|0|||
170645271|NCT00600119|616715892|FG005|Follow-up Period|Adverse Event|1|||
170645272|NCT00600119|616715887|FG000|Follow-up Period|Other|1|||
170645273|NCT00600119|616715888|FG001|Follow-up Period|Other|0|||
170645274|NCT00600119|616715889|FG002|Follow-up Period|Other|0|||
170645275|NCT00600119|616715890|FG003|Follow-up Period|Other|0|||
170645276|NCT00600119|616715891|FG004|Follow-up Period|Other|0|||
170645277|NCT00600119|616715892|FG005|Follow-up Period|Other|0|||
170645278|NCT00729469|616715893|FG000|Overall Study|Adverse Event|14|||
170645279|NCT00729469|616715894|FG001|Overall Study|Adverse Event|25|||
170645280|NCT00729469|616715893|FG000|Overall Study|Lost to Follow-up|9|||
170645281|NCT00729469|616715894|FG001|Overall Study|Lost to Follow-up|9|||
170645282|NCT00729469|616715893|FG000|Overall Study|Protocol Violation|2|||
170645283|NCT00729469|616715894|FG001|Overall Study|Protocol Violation|1|||
170645284|NCT00729469|616715893|FG000|Overall Study|Withdrawal by Subject|19|||
170645285|NCT00729469|616715894|FG001|Overall Study|Withdrawal by Subject|8|||
170645286|NCT00729469|616715893|FG000|Overall Study|Other-Not mentioned|9|||
170645287|NCT00729469|616715894|FG001|Overall Study|Other-Not mentioned|4|||
170399321|NCT03193190|615799946|FG009|Stage 1|Progressive Disease|0|||
170560928|NCT04918771|616398857|FG000|Overall Study|Withdrawal by Subject|4|||
170560929|NCT04918771|616398858|FG001|Overall Study|Withdrawal by Subject|5|||
170560930|NCT04918771|616398857|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
170560931|NCT04918771|616398858|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
170560932|NCT02971163|616398859|FG000|Overall Study|Lost to Follow-up|4|||
170645288|NCT02412488|616715897|FG000|Overall Study|Lost to Follow-up|10|||
170645289|NCT02412488|616715897|FG000|Overall Study|Withdrawal by Subject|5|||
170560933|NCT02971163|616398860|FG001|Overall Study|Lost to Follow-up|2|||
170645290|NCT02412488|616715897|FG000|Overall Study|Physician Decision|1|||
170645291|NCT02412488|616715897|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
170560934|NCT02657343|616398861|FG000|Overall Study|Death|0|||
170560935|NCT02657343|616398862|FG001|Overall Study|Death|2|||
170645292|NCT02412488|616715897|FG000|Overall Study|Reveal LINQ explant|1|||
170645293|NCT00674154|616715898|FG000|Overall Study|Withdrawal by Subject|3|||
170645294|NCT00674154|616715899|FG001|Overall Study|Withdrawal by Subject|1|||
170645295|NCT00674154|616715898|FG000|Overall Study|Did not want parathyroidectomy|0|||
170645296|NCT00674154|616715899|FG001|Overall Study|Did not want parathyroidectomy|2|||
170645297|NCT00816023|616715900|FG000|Overall Study|Lost to Follow-up|1|||
170560936|NCT02657343|616398863|FG002|Overall Study|Death|0|||
170560937|NCT02657343|616398864|FG003|Overall Study|Death|0|||
170560938|NCT02657343|616398865|FG004|Overall Study|Death|0|||
170560939|NCT02657343|616398866|FG005|Overall Study|Death|0|||
170560940|NCT02657343|616398861|FG000|Overall Study|Patient went to hospice|1|||
170560941|NCT02657343|616398862|FG001|Overall Study|Patient went to hospice|0|||
170560942|NCT02657343|616398863|FG002|Overall Study|Patient went to hospice|0|||
170560943|NCT02657343|616398864|FG003|Overall Study|Patient went to hospice|0|||
170560944|NCT02657343|616398865|FG004|Overall Study|Patient went to hospice|0|||
170560945|NCT02657343|616398866|FG005|Overall Study|Patient went to hospice|0|||
170560946|NCT02657343|616398861|FG000|Overall Study|Withdrawal by Subject|0|||
170560947|NCT02657343|616398862|FG001|Overall Study|Withdrawal by Subject|0|||
170560948|NCT02657343|616398863|FG002|Overall Study|Withdrawal by Subject|0|||
170560949|NCT02657343|616398864|FG003|Overall Study|Withdrawal by Subject|0|||
170560950|NCT02657343|616398865|FG004|Overall Study|Withdrawal by Subject|1|||
170560951|NCT02657343|616398866|FG005|Overall Study|Withdrawal by Subject|0|||
170560952|NCT02904096|616398869|FG000|Overall Study|Adverse Event|1|||
170560953|NCT02904096|616398870|FG001|Overall Study|Adverse Event|0|||
170560954|NCT02904096|616398869|FG000|Overall Study|Withdrawal by Subject|4|||
170560955|NCT02904096|616398870|FG001|Overall Study|Withdrawal by Subject|3|||
170560956|NCT02904096|616398869|FG000|Overall Study|Lost to Follow-up|10|||
170560957|NCT02904096|616398870|FG001|Overall Study|Lost to Follow-up|17|||
170560958|NCT02904096|616398869|FG000|Overall Study|Non-compliant|3|||
170560959|NCT02904096|616398870|FG001|Overall Study|Non-compliant|1|||
170560960|NCT02904096|616398869|FG000|Overall Study|Sponsor instructed|1|||
170560961|NCT02904096|616398870|FG001|Overall Study|Sponsor instructed|0|||
170560962|NCT01813357|616398871|FG000|Overall Study|Lost to Follow-up|5|||
170560963|NCT01813357|616398872|FG001|Overall Study|Lost to Follow-up|6|||
170560964|NCT02607722|616398881|FG000|Overall Study|No data reliability|1|||
170560965|NCT02607722|616398881|FG000|Overall Study|no patient visit|18|||
170560966|NCT02607722|616398881|FG000|Overall Study|missing info in CRF|13|||
170560967|NCT02607722|616398881|FG000|Overall Study|Withdrawal by Subject|616|||
170560968|NCT02607722|616398881|FG000|Overall Study|Lost to Follow-up|312|||
170560969|NCT02607722|616398881|FG000|Overall Study|Improved|22|||
170560970|NCT02607722|616398881|FG000|Overall Study|Lack of Efficacy|316|||
170560971|NCT02607722|616398881|FG000|Overall Study|Adverse Event|2553|||
170560972|NCT02607722|616398881|FG000|Overall Study|Not treated|1|||
170560973|NCT02607722|616398881|FG000|Overall Study|No CRF collected|138|||
170560974|NCT02607722|616398881|FG000|Overall Study|without CRF|4225|||
170560975|NCT02607722|616398881|FG000|Overall Study|Physician Decision|367|||
170560976|NCT03238196|616398882|FG000|Overall Study|Adverse Event|3|||
170560977|NCT03238196|616398883|FG001|Overall Study|Adverse Event|0|||
170560978|NCT03238196|616398884|FG002|Overall Study|Adverse Event|2|||
170560979|NCT03238196|616398885|FG003|Overall Study|Adverse Event|2|||
170560980|NCT03238196|616398882|FG000|Overall Study|Withdrawal by Subject|4|||
170560981|NCT03238196|616398883|FG001|Overall Study|Withdrawal by Subject|1|||
170560982|NCT03238196|616398884|FG002|Overall Study|Withdrawal by Subject|1|||
170560983|NCT03238196|616398885|FG003|Overall Study|Withdrawal by Subject|0|||
170560984|NCT03238196|616398882|FG000|Overall Study|Disease progression|14|||
170560985|NCT03238196|616398883|FG001|Overall Study|Disease progression|2|||
170560986|NCT03238196|616398884|FG002|Overall Study|Disease progression|3|||
170560987|NCT03238196|616398885|FG003|Overall Study|Disease progression|2|||
170560988|NCT03238196|616398882|FG000|Overall Study|Still on treatment|1|||
170560989|NCT03238196|616398883|FG001|Overall Study|Still on treatment|0|||
170560990|NCT03238196|616398884|FG002|Overall Study|Still on treatment|0|||
170560991|NCT03238196|616398885|FG003|Overall Study|Still on treatment|0|||
170560992|NCT00847730|616398886|FG000|Overall Study|Multiple interruptions in therapy|8|||
170560993|NCT04938427|616398887|FG000|Overall Study|Adverse Event|5|||
170560994|NCT04938427|616398888|FG001|Overall Study|Adverse Event|19|||
170560995|NCT04938427|616398887|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
170560996|NCT04938427|616398888|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170560997|NCT04938427|616398887|FG000|Overall Study|Withdrawal by Subject|1|||
170560998|NCT04938427|616398888|FG001|Overall Study|Withdrawal by Subject|0|||
170560999|NCT04938427|616398887|FG000|Overall Study|Reason Not Specified|2|||
170645298|NCT00816023|616715901|FG001|Overall Study|Lost to Follow-up|1|||
170645299|NCT00816023|616715902|FG002|Overall Study|Lost to Follow-up|0|||
170561000|NCT04938427|616398888|FG001|Overall Study|Reason Not Specified|1|||
170561001|NCT02496000|616398889|FG000|Overall Study|Withdrawal by Subject|1|||
170561002|NCT02496000|616398890|FG001|Overall Study|Withdrawal by Subject|2|||
170561003|NCT02496000|616398891|FG002|Overall Study|Withdrawal by Subject|0|||
170561004|NCT02496000|616398889|FG000|Overall Study|Lost to Follow-up|1|||
170561005|NCT02496000|616398890|FG001|Overall Study|Lost to Follow-up|0|||
170561006|NCT02496000|616398891|FG002|Overall Study|Lost to Follow-up|1|||
170561007|NCT02496000|616398889|FG000|Overall Study|Protocol Violation|0|||
170561008|NCT02496000|616398890|FG001|Overall Study|Protocol Violation|0|||
170561009|NCT02496000|616398891|FG002|Overall Study|Protocol Violation|1|||
170561010|NCT02496000|616398889|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
170561011|NCT02496000|616398890|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
170561012|NCT02496000|616398891|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
170561013|NCT02496000|616398889|FG000|Overall Study|undetermined|0|||
170561014|NCT02496000|616398890|FG001|Overall Study|undetermined|1|||
170561015|NCT02496000|616398891|FG002|Overall Study|undetermined|0|||
170561016|NCT01969058|616398892|FG000|Overall Study|Withdrawal by Subject|2|||
170561017|NCT01969058|616398893|FG001|Overall Study|Withdrawal by Subject|0|||
170561018|NCT01969058|616398892|FG000|Overall Study|Adverse Event|1|||
170561019|NCT01969058|616398893|FG001|Overall Study|Adverse Event|0|||
170561020|NCT04090749|616398894|FG000|Open Label Pilot|Lost to Follow-up|1|||
170561021|NCT04090749|616398895|FG001|Open Label Pilot|Lost to Follow-up|0|||
170561022|NCT04090749|616398896|FG002|Open Label Pilot|Lost to Follow-up|0|||
170561023|NCT04090749|616398894|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
170561024|NCT04090749|616398895|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
170561025|NCT04090749|616398896|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
170561026|NCT04090749|616398894|FG000|Pilot Trial|Lost to Follow-up|0|||
170561027|NCT04090749|616398895|FG001|Pilot Trial|Lost to Follow-up|1|||
170561028|NCT04090749|616398896|FG002|Pilot Trial|Lost to Follow-up|1|||
170561029|NCT03510715|616398897|FG000|Overall Study|Adverse Event|1|||
170561030|NCT03510715|616398898|FG001|Overall Study|Adverse Event|0|||
170561031|NCT05318287|616398899|FG000|Overall Study|Lost to Follow-up|8|||
170561032|NCT01972659|616398900|FG000|Overall Study|Protocol Violation|2|||
170561033|NCT01972659|616398901|FG001|Overall Study|Protocol Violation|2|||
170561034|NCT01972659|616398900|FG000|Overall Study|problems realted to acceleromyograph|2|||
170561035|NCT01972659|616398901|FG001|Overall Study|problems realted to acceleromyograph|1|||
170561036|NCT02613507|616398904|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
170561037|NCT02613507|616398905|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
170561038|NCT02613507|616398904|FG000|Pre-Treamtent|Participant withdrew consent|0|||
170561039|NCT02613507|616398905|FG001|Pre-Treamtent|Participant withdrew consent|4|||
170561040|NCT02613507|616398904|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
170561041|NCT02613507|616398905|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
170561042|NCT02613507|616398904|FG000|Treatment|Not reported|3|||
170561043|NCT02613507|616398905|FG001|Treatment|Not reported|0|||
170561044|NCT02613507|616398904|FG000|Treatment|Other reasons|8|||
170561045|NCT02613507|616398905|FG001|Treatment|Other reasons|0|||
170561046|NCT02613507|616398904|FG000|Treatment|Participant no longer meets criteria|3|||
170561047|NCT02613507|616398905|FG001|Treatment|Participant no longer meets criteria|0|||
170561048|NCT02613507|616398904|FG000|Treatment|Maximum clinical benefit|5|||
170561049|NCT02613507|616398905|FG001|Treatment|Maximum clinical benefit|10|||
170561050|NCT02613507|616398904|FG000|Treatment|Lost to Follow-up|1|||
170561051|NCT02613507|616398905|FG001|Treatment|Lost to Follow-up|0|||
170561052|NCT02613507|616398904|FG000|Treatment|Participant withdrew consent|0|||
170561053|NCT02613507|616398905|FG001|Treatment|Participant withdrew consent|2|||
170561054|NCT02613507|616398904|FG000|Treatment|Participant request to discontinue study treatment|13|||
170561055|NCT02613507|616398905|FG001|Treatment|Participant request to discontinue study treatment|17|||
170561056|NCT02613507|616398904|FG000|Treatment|Adverse event unrelated to study drug|20|||
170561057|NCT02613507|616398905|FG001|Treatment|Adverse event unrelated to study drug|3|||
170561058|NCT02613507|616398904|FG000|Treatment|Death|2|||
170561059|NCT02613507|616398905|FG001|Treatment|Death|0|||
170561060|NCT02613507|616398904|FG000|Treatment|Study drug toxicity|19|||
170561061|NCT02613507|616398905|FG001|Treatment|Study drug toxicity|14|||
170561062|NCT02613507|616398904|FG000|Treatment|Disease progression|263|||
170561063|NCT02613507|616398905|FG001|Treatment|Disease progression|110|||
170561064|NCT00791648|616401257|FG000|Overall Study|Physician Decision|0|||
170561065|NCT00791648|616401258|FG001|Overall Study|Physician Decision|1|||
170561066|NCT00791648|616401257|FG000|Overall Study|Withdrawal by Subject|0|||
170561067|NCT00791648|616401258|FG001|Overall Study|Withdrawal by Subject|1|||
170561068|NCT03552029|616401259|FG000|Overall Study|Death|3|||
170561069|NCT03552029|616401260|FG001|Overall Study|Death|0|||
170561070|NCT03552029|616401259|FG000|Overall Study|Adverse Event|1|||
170561071|NCT03552029|616401260|FG001|Overall Study|Adverse Event|0|||
170561072|NCT03552029|616401259|FG000|Overall Study|Lack of Efficacy|0|||
170561073|NCT03552029|616401260|FG001|Overall Study|Lack of Efficacy|2|||
170561074|NCT03552029|616401259|FG000|Overall Study|Physician Decision|0|||
170561075|NCT03552029|616401260|FG001|Overall Study|Physician Decision|1|||
170561076|NCT03552029|616401259|FG000|Overall Study|Study terminated by Sponsor|0|||
170561077|NCT03552029|616401260|FG001|Overall Study|Study terminated by Sponsor|1|||
170561078|NCT03552029|616401259|FG000|Overall Study|Other|0|||
170561079|NCT03552029|616401260|FG001|Overall Study|Other|2|||
170561080|NCT01344356|616401264|FG000|Overall Study|Physician Decision|0|||
170561081|NCT01344356|616401265|FG001|Overall Study|Physician Decision|3|||
170561082|NCT01344356|616401264|FG000|Overall Study|Lost to Follow-up|0|||
170561083|NCT01344356|616401265|FG001|Overall Study|Lost to Follow-up|6|||
170561084|NCT01441960|616401266|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
170561085|NCT01441960|616401267|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
170561086|NCT01441960|616401266|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
170561087|NCT01441960|616401267|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
170561088|NCT01441960|616401266|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
170561089|NCT01441960|616401267|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
170561090|NCT01182350|616401268|FG000|Overall Study|Adverse Event|5|||
170561091|NCT01182350|616401269|FG001|Overall Study|Adverse Event|0|||
170561092|NCT01182350|616401270|FG002|Overall Study|Adverse Event|0|||
170561093|NCT01182350|616401271|FG003|Overall Study|Adverse Event|0|||
170561094|NCT01182350|616401272|FG004|Overall Study|Adverse Event|0|||
170561095|NCT01182350|616401268|FG000|Overall Study|Disease Progression|15|||
170561096|NCT01182350|616401269|FG001|Overall Study|Disease Progression|12|||
170561097|NCT01182350|616401270|FG002|Overall Study|Disease Progression|0|||
170561098|NCT01182350|616401271|FG003|Overall Study|Disease Progression|1|||
170561099|NCT01182350|616401272|FG004|Overall Study|Disease Progression|0|||
170561100|NCT01182350|616401268|FG000|Overall Study|Death|0|||
170561101|NCT01182350|616401269|FG001|Overall Study|Death|1|||
170561102|NCT01182350|616401270|FG002|Overall Study|Death|1|||
170561103|NCT01182350|616401271|FG003|Overall Study|Death|0|||
170561104|NCT01182350|616401272|FG004|Overall Study|Death|0|||
170561105|NCT01182350|616401268|FG000|Overall Study|Withdrawal by Subject|3|||
170561106|NCT01182350|616401269|FG001|Overall Study|Withdrawal by Subject|1|||
170561107|NCT01182350|616401270|FG002|Overall Study|Withdrawal by Subject|0|||
170561108|NCT01182350|616401271|FG003|Overall Study|Withdrawal by Subject|1|||
170561109|NCT01182350|616401272|FG004|Overall Study|Withdrawal by Subject|0|||
170561110|NCT01182350|616401268|FG000|Overall Study|Alternative Therapy|2|||
170561111|NCT01182350|616401269|FG001|Overall Study|Alternative Therapy|0|||
170561112|NCT01182350|616401270|FG002|Overall Study|Alternative Therapy|1|||
170561113|NCT01182350|616401271|FG003|Overall Study|Alternative Therapy|0|||
170561114|NCT01182350|616401272|FG004|Overall Study|Alternative Therapy|0|||
170561115|NCT01182350|616401268|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
170561116|NCT01182350|616401269|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
170561117|NCT01182350|616401270|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
170561118|NCT01182350|616401271|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
170561119|NCT01182350|616401272|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
170561120|NCT01182350|616401268|FG000|Overall Study|Unevaluable for Biopsy|0|||
170561121|NCT01182350|616401269|FG001|Overall Study|Unevaluable for Biopsy|0|||
170561122|NCT01182350|616401270|FG002|Overall Study|Unevaluable for Biopsy|0|||
170561123|NCT01182350|616401271|FG003|Overall Study|Unevaluable for Biopsy|0|||
170561124|NCT01182350|616401272|FG004|Overall Study|Unevaluable for Biopsy|3|||
170561125|NCT04023487|616401273|FG000|Overall Study|Lost to Follow-up|5|||
170561126|NCT04023487|616401274|FG001|Overall Study|Lost to Follow-up|4|||
170561127|NCT04023487|616401273|FG000|Overall Study|Pregnancy|1|||
170561128|NCT04023487|616401274|FG001|Overall Study|Pregnancy|2|||
170561129|NCT04023487|616401273|FG000|Overall Study|Withdrawal by Subject|4|||
170561130|NCT04023487|616401274|FG001|Overall Study|Withdrawal by Subject|5|||
170561131|NCT04023487|616401273|FG000|Overall Study|Partially completed testing|8|||
170561132|NCT04023487|616401274|FG001|Overall Study|Partially completed testing|4|||
170561133|NCT00605189|616401275|FG000|Overall Study|Adverse Event|1|||
170561134|NCT00605189|616401276|FG001|Overall Study|Adverse Event|0|||
170561135|NCT00605189|616401277|FG002|Overall Study|Adverse Event|0|||
170561136|NCT00605189|616401275|FG000|Overall Study|Other|2|||
170561137|NCT00605189|616401276|FG001|Overall Study|Other|2|||
170561138|NCT00605189|616401277|FG002|Overall Study|Other|0|||
170561139|NCT04403919|616401278|FG000|Overall Study|Lost to Follow-up|0|||
170561140|NCT04403919|616401279|FG001|Overall Study|Lost to Follow-up|0|||
170561141|NCT04403919|616401280|FG002|Overall Study|Lost to Follow-up|0|||
170561142|NCT04403919|616401281|FG003|Overall Study|Lost to Follow-up|1|||
170561143|NCT02507934|616401282|FG000|Overall Study|Lost to Follow-up|2|||
170561144|NCT02507934|616401283|FG001|Overall Study|Lost to Follow-up|0|||
170561145|NCT02507934|616401282|FG000|Overall Study|Withdrawal by Subject|2|||
170561146|NCT02507934|616401283|FG001|Overall Study|Withdrawal by Subject|0|||
170561147|NCT03766399|616401285|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561148|NCT03766399|616401286|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561149|NCT03766399|616401287|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561150|NCT03766399|616401288|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561151|NCT03766399|616401289|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561152|NCT03766399|616401290|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561153|NCT03766399|616401291|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561154|NCT03766399|616401292|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561155|NCT03766399|616401293|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561156|NCT03766399|616401294|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561157|NCT03766399|616401295|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561158|NCT03766399|616401296|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561159|NCT03766399|616401297|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561160|NCT03766399|616401298|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
170561161|NCT03766399|616401299|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561162|NCT03766399|616401300|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561163|NCT03766399|616401301|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561164|NCT03766399|616401302|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
170561165|NCT04661839|616401303|FG000|Overall Study|Not Treated|0|||
170561166|NCT04661839|616401304|FG001|Overall Study|Not Treated|0|||
170561167|NCT04661839|616401305|FG002|Overall Study|Not Treated|1|||
170561168|NCT04661839|616401306|FG003|Overall Study|Not Treated|0|||
170561169|NCT04661839|616401303|FG000|Overall Study|Lost to Follow-up|1|||
170561170|NCT04661839|616401304|FG001|Overall Study|Lost to Follow-up|0|||
170561171|NCT04661839|616401305|FG002|Overall Study|Lost to Follow-up|0|||
170561172|NCT04661839|616401306|FG003|Overall Study|Lost to Follow-up|1|||
170561173|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
170561174|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
170561175|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
170561176|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
170561177|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
170561178|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
170561179|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
170561180|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
170561181|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
170561182|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
170561183|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
170561184|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
170561185|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
170561186|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
170561187|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
170561188|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
170561189|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
170561190|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
170561191|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
170561192|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
170561193|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
170561194|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
170561195|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
170561196|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
170561197|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
170561198|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
170561199|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
170561200|NCT03093415|616401307|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
170561201|NCT03093415|616401308|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
170561202|NCT03093415|616401309|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
170561203|NCT03093415|616401307|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
170561204|NCT03093415|616401308|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
170561205|NCT03093415|616401309|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
170561206|NCT03559530|616401310|FG000|Overall Study|non-location of medical records|44|||
170561207|NCT03559530|616401311|FG001|Overall Study|non-location of medical records|0|||
170561208|NCT03559530|616401310|FG000|Overall Study|culture results not considered for treat|29|||
170561209|NCT03559530|616401311|FG001|Overall Study|culture results not considered for treat|0|||
170561210|NCT03559530|616401310|FG000|Overall Study|duplicate cases|8|||
170561211|NCT03559530|616401311|FG001|Overall Study|duplicate cases|0|||
170561212|NCT03559530|616401310|FG000|Overall Study|other species of Acinetobacte|7|||
170561213|NCT03559530|616401311|FG001|Overall Study|other species of Acinetobacte|0|||
170561214|NCT03559530|616401310|FG000|Overall Study|contamination / colonization|3|||
170561215|NCT03559530|616401311|FG001|Overall Study|contamination / colonization|0|||
170561216|NCT01559935|616401312|FG000|Car Phase|Toxicity|4|||
170561217|NCT01559935|616401312|FG000|Car Phase|Death|1|||
170561218|NCT01559935|616401312|FG000|Car Phase|Lack of Efficacy|2|||
170561219|NCT01559935|616401312|FG000|Car Phase|Lost to Follow-up|1|||
170561220|NCT01559935|616401312|FG000|Car Phase|Physician Decision|1|||
170561221|NCT01559935|616401312|FG000|Car Phase|Withdrawal by Subject|2|||
170561222|NCT01559935|616401312|FG000|Car Phase|Per protocol|1|||
170561223|NCT01559935|616401312|FG000|Car Phase|Insurance|1|||
170561224|NCT01559935|616401312|FG000|Car Phase|non-compliance|1|||
170561225|NCT01559935|616401312|FG000|BiRD Phase|Toxicity|1|||
170561226|NCT01559935|616401312|FG000|BiRD Phase|Lack of Efficacy|1|||
170645300|NCT00816023|616715903|FG003|Overall Study|Lost to Follow-up|0|||
170645301|NCT00816023|616715900|FG000|Overall Study|Withdrawal by Subject|1|||
170645302|NCT00816023|616715901|FG001|Overall Study|Withdrawal by Subject|0|||
170645303|NCT00816023|616715902|FG002|Overall Study|Withdrawal by Subject|0|||
170645304|NCT00816023|616715903|FG003|Overall Study|Withdrawal by Subject|0|||
170645305|NCT00816023|616715900|FG000|Overall Study|Physician Decision|0|||
170645306|NCT00816023|616715901|FG001|Overall Study|Physician Decision|0|||
170645307|NCT00816023|616715902|FG002|Overall Study|Physician Decision|1|||
170645308|NCT00816023|616715903|FG003|Overall Study|Physician Decision|0|||
170645309|NCT00816023|616715900|FG000|Overall Study|assessments complete prior to window|1|||
170645310|NCT00816023|616715901|FG001|Overall Study|assessments complete prior to window|1|||
170645311|NCT00816023|616715902|FG002|Overall Study|assessments complete prior to window|2|||
170645312|NCT00816023|616715903|FG003|Overall Study|assessments complete prior to window|1|||
170645313|NCT00816023|616715900|FG000|Overall Study|Randomized Not Treated|6|||
170645314|NCT00816023|616715901|FG001|Overall Study|Randomized Not Treated|4|||
170645315|NCT00816023|616715902|FG002|Overall Study|Randomized Not Treated|6|||
170645316|NCT00816023|616715903|FG003|Overall Study|Randomized Not Treated|11|||
170645317|NCT01224782|616715904|FG000|Overall Study|Lost to Follow-up|177|||
170645318|NCT01224782|616715904|FG000|Overall Study|Withdrawal by Subject|16|||
170645319|NCT01224782|616715904|FG000|Overall Study|Death|14|||
170905304|NCT02034123|617656076|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905305|NCT02034123|617656077|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
170905306|NCT02034123|617656078|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
170905307|NCT02034123|617656079|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170561227|NCT01559935|616401312|FG000|BiRD Phase|Withdrawal by Subject|2|||
170561228|NCT01559935|616401312|FG000|Maintenance Phase|Remains on study|28|||
170561229|NCT01559935|616401312|FG000|Maintenance Phase|Toxicity|1|||
170561230|NCT01559935|616401312|FG000|Maintenance Phase|Lack of Efficacy|18|||
170561231|NCT01559935|616401312|FG000|Maintenance Phase|Withdrawal by Subject|5|||
170561232|NCT01559935|616401312|FG000|Maintenance Phase|Non-compliance|2|||
170561233|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561234|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
170561235|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561236|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
170561237|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
170561238|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
170561239|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
170561240|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561241|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561242|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561243|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561244|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561245|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561246|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561247|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561248|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
170561249|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
170561250|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
170561251|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
170561252|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
170561253|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
170561254|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
170561255|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
170561256|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
170561257|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
170561258|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
170561259|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
170561260|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
170645320|NCT01224782|616715904|FG000|Overall Study|Improvement|13|||
170561261|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
170561262|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
170905308|NCT02034123|617656080|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170561263|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
170561264|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
170645321|NCT01224782|616715904|FG000|Overall Study|Adverse Event|12|||
170645322|NCT01224782|616715904|FG000|Overall Study|Adverse Reaction|11|||
170561265|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
170561266|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
170561267|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561268|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561269|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561270|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561271|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561272|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561273|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561274|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561275|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561276|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561277|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561278|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561279|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561280|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
170561281|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
170561282|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561283|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
170561284|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
170645323|NCT01224782|616715904|FG000|Overall Study|Noncompliance|10|||
170645324|NCT01224782|616715904|FG000|Overall Study|Other|4|||
170645325|NCT01224782|616715904|FG000|Overall Study|Start of Dialysis|3|||
170645326|NCT01224782|616715904|FG000|Overall Study|Change of Treatment|1|||
170645327|NCT01224782|616715904|FG000|Overall Study|Financial Reasons|1|||
170645328|NCT01224782|616715904|FG000|Overall Study|Deterioration|1|||
170645329|NCT01224782|616715904|FG000|Overall Study|Transplantation|1|||
170645330|NCT00566696|616715905|FG000|Overall Study|Met Exclusion Criteria|2|||
170645331|NCT00566696|616715905|FG000|Overall Study|Muromonab not available|1|||
170645332|NCT00566696|616715905|FG000|Overall Study|Health Status Change|1|||
170561285|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
170561286|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
170561287|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
170561288|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561289|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561290|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170645333|NCT00566696|616715905|FG000|Overall Study|Physician Decision|1|||
170645334|NCT00566696|616715905|FG000|Overall Study|Non-Patient Donors|37|||
170645335|NCT00706342|616715910|FG000|Overall Study|Adverse Event|3|||
170645336|NCT00706342|616715910|FG000|Overall Study|Not responding to treatment|2|||
170645337|NCT00706342|616715910|FG000|Overall Study|Withdrawn due to failure to respond|1|||
170645338|NCT00706342|616715910|FG000|Overall Study|Death|1|||
170645339|NCT00706342|616715910|FG000|Overall Study|Withdrew from the study on his own.|1|||
170645340|NCT00706342|616715910|FG000|Overall Study|Investigator discretion|2|||
170645341|NCT00706342|616715910|FG000|Overall Study|Non-responder Week 12|1|||
170645342|NCT00706342|616715910|FG000|Overall Study|Ongoing|6|||
170645343|NCT00706342|616715910|FG000|Overall Study|WIthdrawal of consent|1|||
170645344|NCT01798849|616715914|FG000|Overall Study|Physician Decision|0|||
170645345|NCT01798849|616715915|FG001|Overall Study|Physician Decision|0|||
170561291|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561292|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561293|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561294|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561295|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561296|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170561297|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561298|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561299|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561300|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
170645346|NCT01798849|616715916|FG002|Overall Study|Physician Decision|1|||
170645347|NCT03500224|616715917|FG000|Overall Study|Withdrawal by Subject|2|||
170645348|NCT00101452|616715920|FG000|Overall Study|Adverse Event|2|||
170645349|NCT00101452|616715921|FG001|Overall Study|Adverse Event|0|||
170645350|NCT00101452|616715922|FG002|Overall Study|Adverse Event|1|||
170645351|NCT00101452|616715920|FG000|Overall Study|Lost to Follow-up|13|||
170645352|NCT00101452|616715921|FG001|Overall Study|Lost to Follow-up|8|||
170561301|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561302|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561303|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
170561304|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561305|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561306|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561307|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561308|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561309|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561310|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561311|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561312|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
170561313|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561314|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561315|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
170561316|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561317|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561318|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561319|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561320|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561321|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561322|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561323|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561324|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561325|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561326|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561327|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561328|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
170561329|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
170561330|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
170561331|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
170561332|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561333|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561334|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561335|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561336|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561337|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561338|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561339|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561340|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561341|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561342|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561343|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561344|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170561345|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
170561346|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
170561347|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
170561348|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
170561349|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
170561350|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
170561351|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
170561352|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
170561353|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
170561354|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
170561355|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
170561356|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
170561357|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
170561358|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
170561359|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
170561360|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
170561361|NCT02958865|616401313|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561362|NCT02958865|616401314|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561363|NCT02958865|616401315|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561364|NCT02958865|616401316|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561365|NCT02958865|616401317|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
170561366|NCT02958865|616401318|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561367|NCT02958865|616401319|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561368|NCT02958865|616401320|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561369|NCT02958865|616401321|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561370|NCT02958865|616401322|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561371|NCT02958865|616401323|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561372|NCT02958865|616401324|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561373|NCT02958865|616401325|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561374|NCT02958865|616401326|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561375|NCT02958865|616401327|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561376|NCT02958865|616401328|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170561377|NCT02958865|616401313|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
170561378|NCT02958865|616401314|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
170561379|NCT02958865|616401315|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
170561380|NCT02958865|616401316|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
170561381|NCT02958865|616401317|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
170561382|NCT02958865|616401318|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
170561383|NCT02958865|616401319|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
170561384|NCT02958865|616401320|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
170561385|NCT02958865|616401321|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
170561386|NCT02958865|616401322|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
170561387|NCT02958865|616401323|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
170561388|NCT02958865|616401324|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
170561389|NCT02958865|616401325|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
170561390|NCT02958865|616401326|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
170561391|NCT02958865|616401327|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
170561392|NCT02958865|616401328|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
170561393|NCT02958865|616401313|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561394|NCT02958865|616401314|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561395|NCT02958865|616401315|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561396|NCT02958865|616401316|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561397|NCT02958865|616401317|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561398|NCT02958865|616401318|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561399|NCT02958865|616401319|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561400|NCT02958865|616401320|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561401|NCT02958865|616401321|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
170561402|NCT02958865|616401322|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
170561403|NCT02958865|616401323|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561404|NCT02958865|616401324|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
170561405|NCT02958865|616401325|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561406|NCT02958865|616401326|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
170561407|NCT02958865|616401327|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
170561408|NCT02958865|616401328|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
170561409|NCT02958865|616401313|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561410|NCT02958865|616401314|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561411|NCT02958865|616401315|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561412|NCT02958865|616401316|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561413|NCT02958865|616401317|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561414|NCT02958865|616401318|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561415|NCT02958865|616401319|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561416|NCT02958865|616401320|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561417|NCT02958865|616401321|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561418|NCT02958865|616401322|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
170561419|NCT02958865|616401323|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561420|NCT02958865|616401324|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561421|NCT02958865|616401325|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561422|NCT02958865|616401326|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561423|NCT02958865|616401327|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
170561424|NCT02958865|616401328|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
170561425|NCT02958865|616401313|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561426|NCT02958865|616401314|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561427|NCT02958865|616401315|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561428|NCT02958865|616401316|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561429|NCT02958865|616401317|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561430|NCT02958865|616401318|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561431|NCT02958865|616401319|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561432|NCT02958865|616401320|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170645353|NCT00101452|616715922|FG002|Overall Study|Lost to Follow-up|14|||
170561433|NCT02958865|616401321|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561434|NCT02958865|616401322|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561435|NCT02958865|616401323|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
170561436|NCT02958865|616401324|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
170561437|NCT02958865|616401325|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
170561438|NCT02958865|616401326|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
170561439|NCT02958865|616401327|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
170561440|NCT02958865|616401328|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
170561441|NCT02958865|616401313|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
170561442|NCT02958865|616401314|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
170561443|NCT02958865|616401315|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
170561444|NCT02958865|616401316|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
170561445|NCT02958865|616401317|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
170561446|NCT02958865|616401318|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
170561447|NCT02958865|616401319|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
170561448|NCT02958865|616401320|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
170561449|NCT02958865|616401321|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
170561450|NCT02958865|616401322|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
170561451|NCT02958865|616401323|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
170561452|NCT02958865|616401324|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
170561453|NCT02958865|616401325|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
170561454|NCT02958865|616401326|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
170561455|NCT02958865|616401327|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
170561456|NCT02958865|616401328|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
170561457|NCT02958865|616401313|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561458|NCT02958865|616401314|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561459|NCT02958865|616401315|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561460|NCT02958865|616401316|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561461|NCT02958865|616401317|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561462|NCT02958865|616401318|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561463|NCT02958865|616401319|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561464|NCT02958865|616401320|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561465|NCT02958865|616401321|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561466|NCT02958865|616401322|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561467|NCT02958865|616401323|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561468|NCT02958865|616401324|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561469|NCT02958865|616401325|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561470|NCT02958865|616401326|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
170561471|NCT02958865|616401327|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561472|NCT02958865|616401328|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
170561473|NCT02958865|616401313|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561474|NCT02958865|616401314|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561475|NCT02958865|616401315|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561476|NCT02958865|616401316|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561477|NCT02958865|616401317|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561478|NCT02958865|616401318|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561479|NCT02958865|616401319|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561480|NCT02958865|616401320|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561481|NCT02958865|616401321|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561482|NCT02958865|616401322|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561483|NCT02958865|616401323|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561484|NCT02958865|616401324|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561485|NCT02958865|616401325|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561486|NCT02958865|616401326|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
170561487|NCT02958865|616401327|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561488|NCT02958865|616401328|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
170561489|NCT02958865|616401313|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561490|NCT02958865|616401314|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561491|NCT02958865|616401315|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561492|NCT02958865|616401316|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561493|NCT02958865|616401317|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170806829|NCT01953692|617301618|FG006|Overall Study|Physician Decision|4|||
170561494|NCT02958865|616401318|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561495|NCT02958865|616401319|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561496|NCT02958865|616401320|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561497|NCT02958865|616401321|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561498|NCT02958865|616401322|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
170561499|NCT02958865|616401323|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561500|NCT02958865|616401324|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561501|NCT02958865|616401325|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561502|NCT02958865|616401326|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561503|NCT02958865|616401327|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561504|NCT02958865|616401328|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
170561505|NCT02661815|616401331|FG000|Overall Study|Withdrawal by Subject|1|||
170561506|NCT02661815|616401332|FG001|Overall Study|Withdrawal by Subject|0|||
170561507|NCT02661815|616401333|FG002|Overall Study|Withdrawal by Subject|0|||
170561508|NCT02661815|616401334|FG003|Overall Study|Withdrawal by Subject|0|||
170561509|NCT01605097|616401338|FG000|Overall Study|Protocol Violation|1|||
170561510|NCT04380142|616401341|FG000|LD/CD Stabilization Period|Adverse Event|3|||
170561511|NCT04380142|616401342|FG001|LD/CD Stabilization Period|Adverse Event|0|||
170561512|NCT04380142|616401343|FG002|LD/CD Stabilization Period|Adverse Event|0|||
170561513|NCT04380142|616401341|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
170561514|NCT04380142|616401342|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
170561515|NCT04380142|616401343|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
170561516|NCT04380142|616401341|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
170561517|NCT04380142|616401342|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
170561518|NCT04380142|616401343|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
170561519|NCT04380142|616401341|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
170561520|NCT04380142|616401342|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
170561521|NCT04380142|616401343|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
170561522|NCT04380142|616401341|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
170561523|NCT04380142|616401342|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
170561524|NCT04380142|616401343|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
170561525|NCT04380142|616401341|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
170561526|NCT04380142|616401342|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
170561527|NCT04380142|616401343|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
170561528|NCT04380142|616401341|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170561529|NCT04380142|616401342|FG001|Double-Blind Treatment Period|Adverse Event|1|||
170561530|NCT04380142|616401343|FG002|Double-Blind Treatment Period|Adverse Event|14|||
170561531|NCT04380142|616401341|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
170561532|NCT04380142|616401342|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
170561533|NCT04380142|616401343|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
170561534|NCT04380142|616401341|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
170561535|NCT04380142|616401342|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
170561536|NCT04380142|616401343|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
170561537|NCT04380142|616401341|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
170561538|NCT04380142|616401342|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
170561539|NCT04380142|616401343|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
170561540|NCT04380142|616401341|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
170561541|NCT04380142|616401342|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
170561542|NCT04380142|616401343|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
170561543|NCT04380142|616401341|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
170561544|NCT04380142|616401342|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
170561545|NCT04380142|616401343|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
170561546|NCT00209131|616401348|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
170561547|NCT00209131|616401349|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
170561548|NCT02796651|616401352|FG000|Overall Study|Adverse Event|6|||
170561549|NCT02796651|616401352|FG000|Overall Study|Lost to Follow-up|1|||
170561550|NCT02796651|616401352|FG000|Overall Study|Withdrawal by Subject|4|||
170561551|NCT02796651|616401352|FG000|Overall Study|Protocol Violation|4|||
170561552|NCT02796651|616401352|FG000|Overall Study|Lack of Efficacy|1|||
170561553|NCT02796651|616401352|FG000|Overall Study|Other|10|||
170561554|NCT00437073|616401353|FG000|Overall Study|Sponsor Terminated Study|1|||
170561555|NCT00437073|616401354|FG001|Overall Study|Sponsor Terminated Study|0|||
170561556|NCT00437073|616401353|FG000|Overall Study|Physician Decision|0|||
170561557|NCT00437073|616401354|FG001|Overall Study|Physician Decision|1|||
170561558|NCT03485157|616401355|FG000|Double Blind Phase|Lost to Follow-up|4|||
170561559|NCT03485157|616401356|FG001|Double Blind Phase|Lost to Follow-up|4|||
170561560|NCT03485157|616401355|FG000|Double Blind Phase|Adverse Event|2|||
170561561|NCT03485157|616401356|FG001|Double Blind Phase|Adverse Event|1|||
170561562|NCT03485157|616401355|FG000|Double Blind Phase|Withdrawal by Subject|6|||
170561563|NCT03485157|616401356|FG001|Double Blind Phase|Withdrawal by Subject|9|||
170561564|NCT03485157|616401355|FG000|Double Blind Phase|Removal by PI|3|||
170561565|NCT03485157|616401356|FG001|Double Blind Phase|Removal by PI|7|||
170561566|NCT03485157|616401355|FG000|Open Label Phase|Lost to Follow-up|1|||
170561567|NCT03485157|616401356|FG001|Open Label Phase|Lost to Follow-up|2|||
170561568|NCT03485157|616401355|FG000|Open Label Phase|Adverse Event|0|||
170561569|NCT03485157|616401356|FG001|Open Label Phase|Adverse Event|1|||
170561570|NCT03485157|616401355|FG000|Open Label Phase|Withdrawal by Subject|1|||
170561571|NCT03485157|616401356|FG001|Open Label Phase|Withdrawal by Subject|2|||
170561572|NCT03485157|616401355|FG000|Open Label Phase|Removal by PI|2|||
170561573|NCT03485157|616401356|FG001|Open Label Phase|Removal by PI|0|||
170561574|NCT00787150|616401362|FG000|Overall Study|Adverse Event|4|||
170561575|NCT00787150|616401363|FG001|Overall Study|Adverse Event|4|||
170561576|NCT00787150|616401364|FG002|Overall Study|Adverse Event|4|||
170561577|NCT00787150|616401362|FG000|Overall Study|Physician Decision|1|||
170561578|NCT00787150|616401363|FG001|Overall Study|Physician Decision|2|||
170561579|NCT00787150|616401364|FG002|Overall Study|Physician Decision|1|||
170561580|NCT00787150|616401362|FG000|Overall Study|Withdrawal by Subject|2|||
170561581|NCT00787150|616401363|FG001|Overall Study|Withdrawal by Subject|1|||
170561582|NCT00787150|616401364|FG002|Overall Study|Withdrawal by Subject|0|||
170561583|NCT00787150|616401362|FG000|Overall Study|Dosing incorrect study durg|2|||
170561584|NCT00787150|616401363|FG001|Overall Study|Dosing incorrect study durg|0|||
170561585|NCT00787150|616401364|FG002|Overall Study|Dosing incorrect study durg|0|||
170561586|NCT01849276|616401365|FG000|Followed for Survival for 5 Years|Death|1|||
170561587|NCT01849276|616401365|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
170561588|NCT02011542|616401370|FG000|Overall Study|Physician Decision|1|||
170561589|NCT03261505|616401371|FG000|Overall Study|Withdrawal by Subject|2|||
170561590|NCT03261505|616401372|FG001|Overall Study|Withdrawal by Subject|3|||
170561591|NCT03261505|616401373|FG002|Overall Study|Withdrawal by Subject|4|||
170561592|NCT03261505|616401374|FG003|Overall Study|Withdrawal by Subject|3|||
170561593|NCT03261505|616401371|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
170561594|NCT03261505|616401372|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
170561595|NCT03261505|616401373|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
170561596|NCT03261505|616401374|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
170561597|NCT03261505|616401371|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
170561598|NCT03261505|616401372|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
170561599|NCT03261505|616401373|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
170561600|NCT03261505|616401374|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
170561601|NCT03261505|616401371|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
170561602|NCT03261505|616401372|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
170561603|NCT03261505|616401373|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
170561604|NCT03261505|616401374|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
170561605|NCT01299961|616401375|FG000|Overall Study|Adverse Event|3|||
170561606|NCT01299961|616401375|FG000|Overall Study|Lack of Efficacy|2|||
170561607|NCT01299961|616401375|FG000|Overall Study|Lost to Follow-up|1|||
170561608|NCT00663260|616401377|FG000|Overall Study|Lack of Efficacy|2|||
170561609|NCT00663260|616401378|FG001|Overall Study|Lack of Efficacy|0|||
170561610|NCT00663260|616401379|FG002|Overall Study|Lack of Efficacy|0|||
170561611|NCT00663260|616401377|FG000|Overall Study|Adverse Event|12|||
170561612|NCT00663260|616401378|FG001|Overall Study|Adverse Event|7|||
170561613|NCT00663260|616401379|FG002|Overall Study|Adverse Event|6|||
170561614|NCT00663260|616401377|FG000|Overall Study|Withdrawal by Subject|3|||
170561615|NCT00663260|616401378|FG001|Overall Study|Withdrawal by Subject|1|||
170561616|NCT00663260|616401379|FG002|Overall Study|Withdrawal by Subject|6|||
170561617|NCT00663260|616401377|FG000|Overall Study|Death|1|||
170561618|NCT00663260|616401378|FG001|Overall Study|Death|0|||
170561619|NCT00663260|616401379|FG002|Overall Study|Death|1|||
170561620|NCT00663260|616401377|FG000|Overall Study|Lost to Follow-up|0|||
170561621|NCT00663260|616401378|FG001|Overall Study|Lost to Follow-up|1|||
170561622|NCT00663260|616401379|FG002|Overall Study|Lost to Follow-up|0|||
170561623|NCT00663260|616401377|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
170561624|NCT00663260|616401378|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
170561625|NCT00663260|616401379|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
170561626|NCT01506726|616401383|FG000|Overall Study|Adverse Event|1|||
170561627|NCT01506726|616401384|FG001|Overall Study|Adverse Event|2|||
170561628|NCT00526799|616401385|FG000|Overall Study|Withdrawal by Subject|1|||
170561629|NCT00526799|616401386|FG001|Overall Study|Withdrawal by Subject|0|||
170561630|NCT00526799|616401385|FG000|Overall Study|Intercurrent Complicating Disease|0|||
170561631|NCT00526799|616401386|FG001|Overall Study|Intercurrent Complicating Disease|1|||
170561632|NCT02871219|616401387|FG000|Overall Study|Adverse Event|15|||
170561633|NCT02871219|616401387|FG000|Overall Study|Death|3|||
170561634|NCT02871219|616401387|FG000|Overall Study|Progression|3|||
170561635|NCT02871219|616401387|FG000|Overall Study|Infections|7|||
170561636|NCT02871219|616401387|FG000|Overall Study|Infusion Related|4|||
170561637|NCT02303821|616401388|FG000|Overall Study|Withdrawal by Subject|0|||
170561638|NCT02303821|616401389|FG001|Overall Study|Withdrawal by Subject|0|||
170561639|NCT02303821|616401390|FG002|Overall Study|Withdrawal by Subject|0|||
170561640|NCT02303821|616401391|FG003|Overall Study|Withdrawal by Subject|0|||
170561641|NCT02303821|616401392|FG004|Overall Study|Withdrawal by Subject|0|||
170561642|NCT02303821|616401393|FG005|Overall Study|Withdrawal by Subject|0|||
170561643|NCT02303821|616401394|FG006|Overall Study|Withdrawal by Subject|0|||
170561644|NCT02303821|616401395|FG007|Overall Study|Withdrawal by Subject|2|||
170561645|NCT02303821|616401388|FG000|Overall Study|Death|0|||
170561646|NCT02303821|616401389|FG001|Overall Study|Death|2|||
170561647|NCT02303821|616401390|FG002|Overall Study|Death|0|||
170561648|NCT02303821|616401391|FG003|Overall Study|Death|0|||
170561649|NCT02303821|616401392|FG004|Overall Study|Death|0|||
170561650|NCT02303821|616401393|FG005|Overall Study|Death|3|||
170561651|NCT02303821|616401394|FG006|Overall Study|Death|41|||
170561652|NCT02303821|616401395|FG007|Overall Study|Death|29|||
170561653|NCT02303821|616401388|FG000|Overall Study|Lost to Follow-up|0|||
170561654|NCT02303821|616401389|FG001|Overall Study|Lost to Follow-up|0|||
170561655|NCT02303821|616401390|FG002|Overall Study|Lost to Follow-up|0|||
170561656|NCT02303821|616401391|FG003|Overall Study|Lost to Follow-up|0|||
170561657|NCT02303821|616401392|FG004|Overall Study|Lost to Follow-up|0|||
170561658|NCT02303821|616401393|FG005|Overall Study|Lost to Follow-up|0|||
170561659|NCT02303821|616401394|FG006|Overall Study|Lost to Follow-up|1|||
170561660|NCT02303821|616401395|FG007|Overall Study|Lost to Follow-up|0|||
170561661|NCT02303821|616401388|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
170561662|NCT02303821|616401389|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
170561663|NCT02303821|616401390|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
170561664|NCT02303821|616401391|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
170561665|NCT02303821|616401392|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
170561666|NCT02303821|616401393|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
170561667|NCT02303821|616401394|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
170561668|NCT02303821|616401395|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
170561669|NCT02303821|616401388|FG000|Overall Study|Decision by sponsor|0|||
170561670|NCT02303821|616401389|FG001|Overall Study|Decision by sponsor|0|||
170561671|NCT02303821|616401390|FG002|Overall Study|Decision by sponsor|0|||
170561672|NCT02303821|616401391|FG003|Overall Study|Decision by sponsor|0|||
170561673|NCT02303821|616401392|FG004|Overall Study|Decision by sponsor|0|||
170561674|NCT02303821|616401393|FG005|Overall Study|Decision by sponsor|1|||
170561675|NCT02303821|616401394|FG006|Overall Study|Decision by sponsor|0|||
170561676|NCT02303821|616401395|FG007|Overall Study|Decision by sponsor|0|||
170561677|NCT02303821|616401388|FG000|Overall Study|Protocol-specified criteria|0|||
170561678|NCT02303821|616401389|FG001|Overall Study|Protocol-specified criteria|1|||
170561679|NCT02303821|616401390|FG002|Overall Study|Protocol-specified criteria|0|||
170561680|NCT02303821|616401391|FG003|Overall Study|Protocol-specified criteria|0|||
170561681|NCT02303821|616401392|FG004|Overall Study|Protocol-specified criteria|0|||
170561682|NCT02303821|616401393|FG005|Overall Study|Protocol-specified criteria|1|||
170561683|NCT02303821|616401394|FG006|Overall Study|Protocol-specified criteria|0|||
170561684|NCT02303821|616401395|FG007|Overall Study|Protocol-specified criteria|0|||
170561685|NCT01903863|616401399|FG000|Overall Study|Physician Decision|2|||
170561686|NCT01903863|616401400|FG001|Overall Study|Physician Decision|0|||
170561687|NCT03909971|616401405|FG000|Overall Study|Participant transition to rollover study|26|||
170561688|NCT03909971|616401406|FG001|Overall Study|Participant transition to rollover study|9|||
170561689|NCT03909971|616401405|FG000|Overall Study|Global Deterioration of Health Status|2|||
170561690|NCT03909971|616401406|FG001|Overall Study|Global Deterioration of Health Status|2|||
170561691|NCT03909971|616401405|FG000|Overall Study|Progressive Disease|28|||
170561692|NCT03909971|616401406|FG001|Overall Study|Progressive Disease|21|||
170561693|NCT03909971|616401405|FG000|Overall Study|Death|6|||
170561694|NCT03909971|616401406|FG001|Overall Study|Death|6|||
170561695|NCT03909971|616401405|FG000|Overall Study|Adverse Event|1|||
170561696|NCT03909971|616401406|FG001|Overall Study|Adverse Event|2|||
170561697|NCT03909971|616401405|FG000|Overall Study|Withdrawal by Subject|2|||
170561698|NCT03909971|616401406|FG001|Overall Study|Withdrawal by Subject|1|||
170561699|NCT03909971|616401405|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
170561700|NCT03909971|616401406|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
170561701|NCT03909971|616401405|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
170561702|NCT03909971|616401406|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
170561703|NCT03734536|616401407|FG000|Overall Study|Withdrew Consent|1|||
170561704|NCT03734536|616401408|FG001|Overall Study|Withdrew Consent|5|||
170561705|NCT03734536|616401407|FG000|Overall Study|Lost to Follow-up|10|||
170561706|NCT03734536|616401408|FG001|Overall Study|Lost to Follow-up|7|||
170561707|NCT06028464|616401409|FG000|Washout|Positive drug test.|1|||
170561708|NCT01385995|616401410|FG000|Period 1, 2 Months|Physician Decision|1|||
170561709|NCT01385995|616401411|FG001|Period 1, 2 Months|Physician Decision|0|||
170561710|NCT02457793|616401415|FG000|Overall Study|Reason not specified|0|||
170806830|NCT01953692|617301619|FG007|Overall Study|Physician Decision|1|||
170561711|NCT02457793|616401416|FG001|Overall Study|Reason not specified|0|||
170561712|NCT02457793|616401417|FG002|Overall Study|Reason not specified|0|||
170561713|NCT02457793|616401418|FG003|Overall Study|Reason not specified|1|||
170561714|NCT02457793|616401419|FG004|Overall Study|Reason not specified|1|||
170561715|NCT02457793|616401420|FG005|Overall Study|Reason not specified|1|||
170561716|NCT02457793|616401415|FG000|Overall Study|Withdrawal by Subject|0|||
170561717|NCT02457793|616401416|FG001|Overall Study|Withdrawal by Subject|4|||
170561718|NCT02457793|616401417|FG002|Overall Study|Withdrawal by Subject|2|||
170645354|NCT00101452|616715920|FG000|Overall Study|Withdrawal by Subject|10|||
170645355|NCT00101452|616715921|FG001|Overall Study|Withdrawal by Subject|14|||
170645356|NCT00101452|616715922|FG002|Overall Study|Withdrawal by Subject|9|||
170645357|NCT00101452|616715920|FG000|Overall Study|Baseline Fail|2|||
170645358|NCT00101452|616715921|FG001|Overall Study|Baseline Fail|1|||
170645359|NCT00101452|616715922|FG002|Overall Study|Baseline Fail|2|||
170645360|NCT00101452|616715920|FG000|Overall Study|Physician Decision|0|||
170645361|NCT00101452|616715921|FG001|Overall Study|Physician Decision|3|||
170645362|NCT00101452|616715922|FG002|Overall Study|Physician Decision|2|||
170645363|NCT00101452|616715920|FG000|Overall Study|Protocol Violation|2|||
170645364|NCT00101452|616715921|FG001|Overall Study|Protocol Violation|1|||
170645365|NCT00101452|616715922|FG002|Overall Study|Protocol Violation|3|||
170645366|NCT00101452|616715920|FG000|Overall Study|Other|15|||
170561719|NCT02457793|616401418|FG003|Overall Study|Withdrawal by Subject|2|||
170561720|NCT02457793|616401419|FG004|Overall Study|Withdrawal by Subject|2|||
170561721|NCT02457793|616401420|FG005|Overall Study|Withdrawal by Subject|2|||
170561722|NCT02457793|616401415|FG000|Overall Study|Adverse Event|0|||
170645367|NCT00101452|616715921|FG001|Overall Study|Other|16|||
170561723|NCT02457793|616401416|FG001|Overall Study|Adverse Event|0|||
170561724|NCT02457793|616401417|FG002|Overall Study|Adverse Event|0|||
170561725|NCT02457793|616401418|FG003|Overall Study|Adverse Event|1|||
170561726|NCT02457793|616401419|FG004|Overall Study|Adverse Event|0|||
170561727|NCT02457793|616401420|FG005|Overall Study|Adverse Event|0|||
170561728|NCT02457793|616401415|FG000|Overall Study|Physician Decision|1|||
170561729|NCT02457793|616401416|FG001|Overall Study|Physician Decision|0|||
170561730|NCT02457793|616401417|FG002|Overall Study|Physician Decision|1|||
170561731|NCT02457793|616401418|FG003|Overall Study|Physician Decision|1|||
170561732|NCT02457793|616401419|FG004|Overall Study|Physician Decision|1|||
170561733|NCT02457793|616401420|FG005|Overall Study|Physician Decision|3|||
170561734|NCT03814044|616401425|FG000|Overall Study|Protocol deviation|1|||
170561735|NCT03941093|616401426|FG000|Overall Study|Protocol Violation|0|||
170561736|NCT03941093|616401427|FG001|Overall Study|Protocol Violation|1|||
170561737|NCT03941093|616401426|FG000|Overall Study|Withdrawal by Subject|9|||
170561738|NCT03941093|616401427|FG001|Overall Study|Withdrawal by Subject|6|||
170561739|NCT03164356|616401430|FG000|Overall Study|Lost to Follow-up|1|||
170561740|NCT03164356|616401431|FG001|Overall Study|Lost to Follow-up|1|||
170561741|NCT03164356|616401432|FG002|Overall Study|Lost to Follow-up|2|||
170561742|NCT03164356|616401433|FG003|Overall Study|Lost to Follow-up|1|||
170561743|NCT03164356|616401430|FG000|Overall Study|Physician Decision|0|||
170561744|NCT03164356|616401431|FG001|Overall Study|Physician Decision|0|||
170561745|NCT03164356|616401432|FG002|Overall Study|Physician Decision|3|||
170561746|NCT03164356|616401433|FG003|Overall Study|Physician Decision|0|||
170561747|NCT03164356|616401430|FG000|Overall Study|Protocol Violation|2|||
170561748|NCT03164356|616401431|FG001|Overall Study|Protocol Violation|1|||
170561749|NCT03164356|616401432|FG002|Overall Study|Protocol Violation|0|||
170561750|NCT03164356|616401433|FG003|Overall Study|Protocol Violation|0|||
170561751|NCT03164356|616401430|FG000|Overall Study|Withdrawal by Subject|1|||
170561752|NCT03164356|616401431|FG001|Overall Study|Withdrawal by Subject|0|||
170561753|NCT03164356|616401432|FG002|Overall Study|Withdrawal by Subject|0|||
170561754|NCT03164356|616401433|FG003|Overall Study|Withdrawal by Subject|0|||
170561755|NCT03164356|616401430|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
170561756|NCT03164356|616401431|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
170561757|NCT03164356|616401432|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
170561758|NCT03164356|616401433|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
170645368|NCT00101452|616715922|FG002|Overall Study|Other|12|||
170645369|NCT00486811|616715923|FG000|Overall Study|Adverse Event|28|||
170561759|NCT03164356|616401430|FG000|Overall Study|Subject Incarcerated|0|||
170561760|NCT03164356|616401431|FG001|Overall Study|Subject Incarcerated|1|||
170561761|NCT03164356|616401432|FG002|Overall Study|Subject Incarcerated|0|||
170561762|NCT03164356|616401433|FG003|Overall Study|Subject Incarcerated|0|||
170561763|NCT03164356|616401430|FG000|Overall Study|Prosthetist unable to participate|0|||
170561764|NCT03164356|616401431|FG001|Overall Study|Prosthetist unable to participate|2|||
170561765|NCT03164356|616401432|FG002|Overall Study|Prosthetist unable to participate|1|||
170561766|NCT03164356|616401433|FG003|Overall Study|Prosthetist unable to participate|0|||
170645370|NCT00486811|616715924|FG001|Overall Study|Adverse Event|60|||
170645371|NCT00486811|616715925|FG002|Overall Study|Adverse Event|135|||
170645372|NCT00486811|616715923|FG000|Overall Study|Lack of Efficacy|34|||
170645373|NCT00486811|616715924|FG001|Overall Study|Lack of Efficacy|14|||
170645374|NCT00486811|616715925|FG002|Overall Study|Lack of Efficacy|7|||
170561767|NCT03648372|616401434|FG000|Overall Study|Withdrawal by Subject|2|||
170561768|NCT03648372|616401435|FG001|Overall Study|Withdrawal by Subject|0|||
170561769|NCT03648372|616401436|FG002|Overall Study|Withdrawal by Subject|0|||
170561770|NCT03648372|616401437|FG003|Overall Study|Withdrawal by Subject|0|||
170561771|NCT03648372|616401438|FG004|Overall Study|Withdrawal by Subject|0|||
170561772|NCT03648372|616401439|FG005|Overall Study|Withdrawal by Subject|1|||
170561773|NCT03648372|616401440|FG006|Overall Study|Withdrawal by Subject|2|||
170561774|NCT03648372|616401441|FG007|Overall Study|Withdrawal by Subject|0|||
170561775|NCT03648372|616401442|FG008|Overall Study|Withdrawal by Subject|0|||
170561776|NCT03648372|616401443|FG009|Overall Study|Withdrawal by Subject|0|||
170561777|NCT03648372|616401444|FG010|Overall Study|Withdrawal by Subject|2|||
170561778|NCT03648372|616401445|FG011|Overall Study|Withdrawal by Subject|0|||
170561779|NCT03648372|616401446|FG012|Overall Study|Withdrawal by Subject|2|||
170561780|NCT03648372|616401447|FG013|Overall Study|Withdrawal by Subject|0|||
170561781|NCT03648372|616401448|FG014|Overall Study|Withdrawal by Subject|0|||
170561782|NCT03648372|616401449|FG015|Overall Study|Withdrawal by Subject|0|||
170561783|NCT03648372|616401450|FG016|Overall Study|Withdrawal by Subject|1|||
170561784|NCT03648372|616401451|FG017|Overall Study|Withdrawal by Subject|0|||
170561785|NCT03648372|616401452|FG018|Overall Study|Withdrawal by Subject|0|||
170561786|NCT03648372|616401453|FG019|Overall Study|Withdrawal by Subject|0|||
170561787|NCT03648372|616401454|FG020|Overall Study|Withdrawal by Subject|0|||
170561788|NCT03648372|616401434|FG000|Overall Study|Progressive Disease|2|||
170561789|NCT03648372|616401435|FG001|Overall Study|Progressive Disease|3|||
170561790|NCT03648372|616401436|FG002|Overall Study|Progressive Disease|4|||
170561791|NCT03648372|616401437|FG003|Overall Study|Progressive Disease|3|||
170561792|NCT03648372|616401438|FG004|Overall Study|Progressive Disease|2|||
170561793|NCT03648372|616401439|FG005|Overall Study|Progressive Disease|2|||
170561794|NCT03648372|616401440|FG006|Overall Study|Progressive Disease|3|||
170561795|NCT03648372|616401441|FG007|Overall Study|Progressive Disease|3|||
170561796|NCT03648372|616401442|FG008|Overall Study|Progressive Disease|5|||
170561797|NCT03648372|616401443|FG009|Overall Study|Progressive Disease|5|||
170561798|NCT03648372|616401444|FG010|Overall Study|Progressive Disease|2|||
170561799|NCT03648372|616401445|FG011|Overall Study|Progressive Disease|3|||
170561800|NCT03648372|616401446|FG012|Overall Study|Progressive Disease|3|||
170561801|NCT03648372|616401447|FG013|Overall Study|Progressive Disease|3|||
170561802|NCT03648372|616401448|FG014|Overall Study|Progressive Disease|6|||
170561803|NCT03648372|616401449|FG015|Overall Study|Progressive Disease|0|||
170561804|NCT03648372|616401450|FG016|Overall Study|Progressive Disease|0|||
170561805|NCT03648372|616401451|FG017|Overall Study|Progressive Disease|0|||
170561806|NCT03648372|616401452|FG018|Overall Study|Progressive Disease|0|||
170561807|NCT03648372|616401453|FG019|Overall Study|Progressive Disease|0|||
170561808|NCT03648372|616401454|FG020|Overall Study|Progressive Disease|0|||
170561809|NCT03648372|616401434|FG000|Overall Study|Other|0|||
170561810|NCT03648372|616401435|FG001|Overall Study|Other|0|||
170561811|NCT03648372|616401436|FG002|Overall Study|Other|0|||
170561812|NCT03648372|616401437|FG003|Overall Study|Other|0|||
170561813|NCT03648372|616401438|FG004|Overall Study|Other|1|||
170561814|NCT03648372|616401439|FG005|Overall Study|Other|0|||
170561815|NCT03648372|616401440|FG006|Overall Study|Other|0|||
170561816|NCT03648372|616401441|FG007|Overall Study|Other|0|||
170561817|NCT03648372|616401442|FG008|Overall Study|Other|0|||
170561818|NCT03648372|616401443|FG009|Overall Study|Other|0|||
170561819|NCT03648372|616401444|FG010|Overall Study|Other|1|||
170561820|NCT03648372|616401445|FG011|Overall Study|Other|2|||
170561821|NCT03648372|616401446|FG012|Overall Study|Other|1|||
170561822|NCT03648372|616401447|FG013|Overall Study|Other|3|||
170561823|NCT03648372|616401448|FG014|Overall Study|Other|0|||
170561824|NCT03648372|616401449|FG015|Overall Study|Other|5|||
170561825|NCT03648372|616401450|FG016|Overall Study|Other|1|||
170561826|NCT03648372|616401451|FG017|Overall Study|Other|5|||
170561827|NCT03648372|616401452|FG018|Overall Study|Other|0|||
170561828|NCT03648372|616401453|FG019|Overall Study|Other|1|||
170561829|NCT03648372|616401454|FG020|Overall Study|Other|0|||
170561830|NCT03648372|616401434|FG000|Overall Study|Lost to Follow-up|0|||
170561831|NCT03648372|616401435|FG001|Overall Study|Lost to Follow-up|0|||
170561832|NCT03648372|616401436|FG002|Overall Study|Lost to Follow-up|0|||
170561833|NCT03648372|616401437|FG003|Overall Study|Lost to Follow-up|0|||
170561834|NCT03648372|616401438|FG004|Overall Study|Lost to Follow-up|0|||
170561835|NCT03648372|616401439|FG005|Overall Study|Lost to Follow-up|0|||
170561836|NCT03648372|616401440|FG006|Overall Study|Lost to Follow-up|0|||
170561837|NCT03648372|616401441|FG007|Overall Study|Lost to Follow-up|0|||
170561838|NCT03648372|616401442|FG008|Overall Study|Lost to Follow-up|0|||
170561839|NCT03648372|616401443|FG009|Overall Study|Lost to Follow-up|0|||
170561840|NCT03648372|616401444|FG010|Overall Study|Lost to Follow-up|0|||
170561841|NCT03648372|616401445|FG011|Overall Study|Lost to Follow-up|0|||
170561842|NCT03648372|616401446|FG012|Overall Study|Lost to Follow-up|0|||
170561843|NCT03648372|616401447|FG013|Overall Study|Lost to Follow-up|1|||
170561844|NCT03648372|616401448|FG014|Overall Study|Lost to Follow-up|0|||
170561845|NCT03648372|616401449|FG015|Overall Study|Lost to Follow-up|1|||
170561846|NCT03648372|616401450|FG016|Overall Study|Lost to Follow-up|0|||
170561847|NCT03648372|616401451|FG017|Overall Study|Lost to Follow-up|1|||
170561848|NCT03648372|616401452|FG018|Overall Study|Lost to Follow-up|0|||
170561849|NCT03648372|616401453|FG019|Overall Study|Lost to Follow-up|0|||
170561850|NCT03648372|616401454|FG020|Overall Study|Lost to Follow-up|0|||
170561851|NCT03648372|616401434|FG000|Overall Study|Start of a New Systemic Treatment|0|||
170561852|NCT03648372|616401435|FG001|Overall Study|Start of a New Systemic Treatment|0|||
170561853|NCT03648372|616401436|FG002|Overall Study|Start of a New Systemic Treatment|0|||
170561854|NCT03648372|616401437|FG003|Overall Study|Start of a New Systemic Treatment|0|||
170561855|NCT03648372|616401438|FG004|Overall Study|Start of a New Systemic Treatment|0|||
170561856|NCT03648372|616401439|FG005|Overall Study|Start of a New Systemic Treatment|0|||
170561857|NCT03648372|616401440|FG006|Overall Study|Start of a New Systemic Treatment|0|||
170561858|NCT03648372|616401441|FG007|Overall Study|Start of a New Systemic Treatment|2|||
170561859|NCT03648372|616401442|FG008|Overall Study|Start of a New Systemic Treatment|0|||
170561860|NCT03648372|616401443|FG009|Overall Study|Start of a New Systemic Treatment|0|||
170561861|NCT03648372|616401444|FG010|Overall Study|Start of a New Systemic Treatment|1|||
170561862|NCT03648372|616401445|FG011|Overall Study|Start of a New Systemic Treatment|0|||
170561863|NCT03648372|616401446|FG012|Overall Study|Start of a New Systemic Treatment|0|||
170561864|NCT03648372|616401447|FG013|Overall Study|Start of a New Systemic Treatment|0|||
170561865|NCT03648372|616401448|FG014|Overall Study|Start of a New Systemic Treatment|0|||
170561866|NCT03648372|616401449|FG015|Overall Study|Start of a New Systemic Treatment|0|||
170561867|NCT03648372|616401450|FG016|Overall Study|Start of a New Systemic Treatment|0|||
170561868|NCT03648372|616401451|FG017|Overall Study|Start of a New Systemic Treatment|0|||
170561869|NCT03648372|616401452|FG018|Overall Study|Start of a New Systemic Treatment|0|||
170561870|NCT03648372|616401453|FG019|Overall Study|Start of a New Systemic Treatment|0|||
170561871|NCT03648372|616401454|FG020|Overall Study|Start of a New Systemic Treatment|0|||
170561872|NCT04795531|616402642|FG000|Overall Study|Withdrawal by Subject|4|||
170561873|NCT04795531|616402643|FG001|Overall Study|Withdrawal by Subject|4|||
170561874|NCT04795531|616402642|FG000|Overall Study|Lost to Follow-up|0|||
170561875|NCT04795531|616402643|FG001|Overall Study|Lost to Follow-up|1|||
170561876|NCT04795531|616402642|FG000|Overall Study|Physician Decision|0|||
170561877|NCT04795531|616402643|FG001|Overall Study|Physician Decision|2|||
170561878|NCT04795531|616402642|FG000|Overall Study|Death|2|||
170561879|NCT04795531|616402643|FG001|Overall Study|Death|1|||
170561880|NCT04887831|616402644|FG000|Overall Study|Death|26|||
170561881|NCT04887831|616402645|FG001|Overall Study|Death|26|||
170561882|NCT04887831|616402644|FG000|Overall Study|Lost to Follow-up|0|||
170561883|NCT04887831|616402645|FG001|Overall Study|Lost to Follow-up|1|||
170561884|NCT04887831|616402644|FG000|Overall Study|Withdrawal by Subject|2|||
170561885|NCT04887831|616402645|FG001|Overall Study|Withdrawal by Subject|1|||
170561886|NCT04887831|616402644|FG000|Overall Study|Study Terminated by Sponsor|18|||
170561887|NCT04887831|616402645|FG001|Overall Study|Study Terminated by Sponsor|17|||
170561888|NCT04887831|616402644|FG000|Overall Study|Other|1|||
170561889|NCT04887831|616402645|FG001|Overall Study|Other|0|||
170561890|NCT00633126|616402646|FG000|Overall Study|Did not receive full dose|1|||
170561891|NCT01168596|616402647|FG000|Overall Study|Withdrawal by Subject|3|||
170561892|NCT01168596|616402648|FG001|Overall Study|Withdrawal by Subject|1|||
170561893|NCT01276704|616402649|FG000|Overall Study|Lost to Follow-up|2|||
170561894|NCT01276704|616402650|FG001|Overall Study|Lost to Follow-up|3|||
170561895|NCT01276704|616402649|FG000|Overall Study|Non-compliant|2|||
170561896|NCT01276704|616402650|FG001|Overall Study|Non-compliant|2|||
170561897|NCT01276704|616402649|FG000|Overall Study|Withdrawal by Subject|7|||
170561898|NCT01276704|616402650|FG001|Overall Study|Withdrawal by Subject|1|||
170561899|NCT01276704|616402649|FG000|Overall Study|Physician Decision|3|||
170561900|NCT01276704|616402650|FG001|Overall Study|Physician Decision|5|||
170561901|NCT02390076|616402656|FG000|Overall Study|Lost to Follow-up|2|||
170561902|NCT02390076|616402657|FG001|Overall Study|Lost to Follow-up|1|||
170561903|NCT02390076|616402658|FG002|Overall Study|Lost to Follow-up|4|||
170561904|NCT03243084|616402660|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
170561905|NCT03243084|616402661|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
170561906|NCT00553254|616402662|FG000|Overall Study|Death|3|||
170561907|NCT00553254|616402663|FG001|Overall Study|Death|6|||
170561908|NCT00553254|616402664|FG002|Overall Study|Death|25|||
170561909|NCT00553254|616402662|FG000|Overall Study|Lost to Follow-up|0|||
170561910|NCT00553254|616402663|FG001|Overall Study|Lost to Follow-up|0|||
170561911|NCT00553254|616402664|FG002|Overall Study|Lost to Follow-up|2|||
170561912|NCT00553254|616402662|FG000|Overall Study|Withdrawal by Subject|2|||
170561913|NCT00553254|616402663|FG001|Overall Study|Withdrawal by Subject|0|||
170561914|NCT00553254|616402664|FG002|Overall Study|Withdrawal by Subject|2|||
170561915|NCT00553254|616402662|FG000|Overall Study|Study terminated by Sponsor|0|||
170806831|NCT01953692|617301620|FG008|Overall Study|Physician Decision|0|||
170561916|NCT00553254|616402663|FG001|Overall Study|Study terminated by Sponsor|0|||
170561917|NCT00553254|616402664|FG002|Overall Study|Study terminated by Sponsor|1|||
170561918|NCT00553254|616402662|FG000|Overall Study|Other|1|||
170645375|NCT00486811|616715923|FG000|Overall Study|Lost to Follow-up|4|||
170645376|NCT00486811|616715924|FG001|Overall Study|Lost to Follow-up|6|||
170645377|NCT00486811|616715925|FG002|Overall Study|Lost to Follow-up|4|||
170645378|NCT00486811|616715923|FG000|Overall Study|Withdrawal by Subject|33|||
170645379|NCT00486811|616715924|FG001|Overall Study|Withdrawal by Subject|44|||
170645380|NCT00486811|616715925|FG002|Overall Study|Withdrawal by Subject|58|||
170645381|NCT00486811|616715923|FG000|Overall Study|Study drug non-compliant|5|||
170645382|NCT00486811|616715924|FG001|Overall Study|Study drug non-compliant|6|||
170645383|NCT00486811|616715925|FG002|Overall Study|Study drug non-compliant|3|||
170645384|NCT00486811|616715923|FG000|Overall Study|All other|18|||
170645385|NCT00486811|616715924|FG001|Overall Study|All other|11|||
170645386|NCT00486811|616715925|FG002|Overall Study|All other|7|||
170645387|NCT00145977|616715933|FG000|Overall Study|Lack of Efficacy|0|||
170645388|NCT00145977|616715934|FG001|Overall Study|Lack of Efficacy|4|||
170645389|NCT00145977|616715933|FG000|Overall Study|Lost to Follow-up|1|||
170645390|NCT00145977|616715934|FG001|Overall Study|Lost to Follow-up|0|||
170645391|NCT00145977|616715933|FG000|Overall Study|Withdrawal by Subject|1|||
170645392|NCT00145977|616715934|FG001|Overall Study|Withdrawal by Subject|0|||
170645393|NCT00852371|616715935|FG000|Overall Study|Lost to Follow-up|2|||
170645394|NCT00852371|616715936|FG001|Overall Study|Lost to Follow-up|3|||
170645395|NCT00852371|616715937|FG002|Overall Study|Lost to Follow-up|4|||
170645396|NCT00852371|616715938|FG003|Overall Study|Lost to Follow-up|2|||
170645397|NCT02717832|616715949|FG000|Overall Study|Inability to place IV|3|||
170645398|NCT02259088|616715950|FG000|Overall Study|Adverse Event|6|||
170645399|NCT02259088|616715951|FG001|Overall Study|Adverse Event|4|||
170645400|NCT02259088|616715950|FG000|Overall Study|Lost to Follow-up|2|||
170645401|NCT02259088|616715951|FG001|Overall Study|Lost to Follow-up|0|||
170645402|NCT02259088|616715950|FG000|Overall Study|Death|2|||
170645403|NCT02259088|616715951|FG001|Overall Study|Death|0|||
170645404|NCT02259088|616715950|FG000|Overall Study|Physician Decision|5|||
170645405|NCT02259088|616715951|FG001|Overall Study|Physician Decision|2|||
170645406|NCT02259088|616715950|FG000|Overall Study|Protocol deviation|5|||
170645407|NCT02259088|616715951|FG001|Overall Study|Protocol deviation|0|||
170645408|NCT02259088|616715950|FG000|Overall Study|Subject/guardian decision|8|||
170645409|NCT02259088|616715951|FG001|Overall Study|Subject/guardian decision|8|||
170645410|NCT02228980|616715952|FG000|Overall Study|Adverse Event|14|||
170645411|NCT02228980|616715953|FG001|Overall Study|Adverse Event|0|||
170645412|NCT02228980|616715954|FG002|Overall Study|Adverse Event|0|||
170645413|NCT02228980|616715955|FG003|Overall Study|Adverse Event|0|||
170645414|NCT02228980|616715952|FG000|Overall Study|Protocol Violation|7|||
170645415|NCT02228980|616715953|FG001|Overall Study|Protocol Violation|0|||
170645416|NCT02228980|616715954|FG002|Overall Study|Protocol Violation|0|||
170645417|NCT02228980|616715955|FG003|Overall Study|Protocol Violation|0|||
170645418|NCT02228980|616715952|FG000|Overall Study|Withdrawal by Subject|3|||
170645419|NCT02228980|616715953|FG001|Overall Study|Withdrawal by Subject|3|||
170645420|NCT02228980|616715954|FG002|Overall Study|Withdrawal by Subject|2|||
170645421|NCT02228980|616715955|FG003|Overall Study|Withdrawal by Subject|3|||
170645422|NCT03060551|616715956|FG000|Overall Study|Withdrawal by Subject|1|||
170645423|NCT03060551|616715956|FG000|Overall Study|Adverse Event|1|||
170645424|NCT00978757|616715961|FG000|Overall Study|Physician Decision|1|||
170645425|NCT00978757|616715962|FG001|Overall Study|Physician Decision|3|||
170645426|NCT01214395|616715965|FG000|Overall Study|All patients had infection|5|||
170645427|NCT00715910|616715966|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
170645428|NCT00715910|616715967|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
170645429|NCT00715910|616715968|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
170645430|NCT00715910|616715969|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
170645431|NCT00715910|616715970|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
170645432|NCT00715910|616715971|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
170645433|NCT00715910|616715966|FG000|Booster and ESFU Phase|Other|0|||
170645434|NCT00715910|616715967|FG001|Booster and ESFU Phase|Other|0|||
170645435|NCT00715910|616715968|FG002|Booster and ESFU Phase|Other|0|||
170645436|NCT00715910|616715969|FG003|Booster and ESFU Phase|Other|5|||
170645437|NCT00715910|616715970|FG004|Booster and ESFU Phase|Other|1|||
170645438|NCT00715910|616715971|FG005|Booster and ESFU Phase|Other|0|||
170645439|NCT01185353|616715972|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
170645440|NCT01185353|616715973|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
170645441|NCT01185353|616715974|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
170645442|NCT01185353|616715975|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
170645443|NCT01185353|616715976|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
170645444|NCT01185353|616715977|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
170645445|NCT01185353|616715978|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
170645446|NCT01185353|616715979|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
170645447|NCT01185353|616715980|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
170645448|NCT01185353|616715981|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
170645449|NCT01185353|616715972|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170645450|NCT01185353|616715973|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170645451|NCT01185353|616715974|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170645452|NCT01185353|616715975|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170561919|NCT00553254|616402663|FG001|Overall Study|Other|0|||
170561920|NCT00553254|616402664|FG002|Overall Study|Other|13|||
170561921|NCT02314923|616402665|FG000|Overall Study|Death|0|||
170561922|NCT02314923|616402666|FG001|Overall Study|Death|0|||
170561923|NCT02314923|616402667|FG002|Overall Study|Death|0|||
170561924|NCT02314923|616402668|FG003|Overall Study|Death|1|||
170561925|NCT02314923|616402669|FG004|Overall Study|Death|0|||
170561926|NCT02314923|616402670|FG005|Overall Study|Death|0|||
170561927|NCT02314923|616402671|FG006|Overall Study|Death|0|||
170561928|NCT02314923|616402672|FG007|Overall Study|Death|0|||
170561929|NCT02314923|616402673|FG008|Overall Study|Death|0|||
170561930|NCT02314923|616402674|FG009|Overall Study|Death|0|||
170561931|NCT02314923|616402665|FG000|Overall Study|Lost to Follow-up|2|||
170561932|NCT02314923|616402666|FG001|Overall Study|Lost to Follow-up|3|||
170561933|NCT02314923|616402667|FG002|Overall Study|Lost to Follow-up|1|||
170561934|NCT02314923|616402668|FG003|Overall Study|Lost to Follow-up|0|||
170561935|NCT02314923|616402669|FG004|Overall Study|Lost to Follow-up|0|||
170561936|NCT02314923|616402670|FG005|Overall Study|Lost to Follow-up|0|||
170561937|NCT02314923|616402671|FG006|Overall Study|Lost to Follow-up|3|||
170561938|NCT02314923|616402672|FG007|Overall Study|Lost to Follow-up|4|||
170561939|NCT02314923|616402673|FG008|Overall Study|Lost to Follow-up|2|||
170561940|NCT02314923|616402674|FG009|Overall Study|Lost to Follow-up|0|||
170561941|NCT02314923|616402665|FG000|Overall Study|Withdrawal by Subject|0|||
170561942|NCT02314923|616402666|FG001|Overall Study|Withdrawal by Subject|0|||
170561943|NCT02314923|616402667|FG002|Overall Study|Withdrawal by Subject|1|||
170561944|NCT02314923|616402668|FG003|Overall Study|Withdrawal by Subject|0|||
170561945|NCT02314923|616402669|FG004|Overall Study|Withdrawal by Subject|1|||
170561946|NCT02314923|616402670|FG005|Overall Study|Withdrawal by Subject|0|||
170561947|NCT02314923|616402671|FG006|Overall Study|Withdrawal by Subject|1|||
170561948|NCT02314923|616402672|FG007|Overall Study|Withdrawal by Subject|0|||
170561949|NCT02314923|616402673|FG008|Overall Study|Withdrawal by Subject|0|||
170561950|NCT02314923|616402674|FG009|Overall Study|Withdrawal by Subject|0|||
170561951|NCT02314923|616402665|FG000|Overall Study|Physician Decision|0|||
170561952|NCT02314923|616402666|FG001|Overall Study|Physician Decision|1|||
170561953|NCT02314923|616402667|FG002|Overall Study|Physician Decision|0|||
170561954|NCT02314923|616402668|FG003|Overall Study|Physician Decision|0|||
170561955|NCT02314923|616402669|FG004|Overall Study|Physician Decision|0|||
170561956|NCT02314923|616402670|FG005|Overall Study|Physician Decision|0|||
170561957|NCT02314923|616402671|FG006|Overall Study|Physician Decision|0|||
170561958|NCT02314923|616402672|FG007|Overall Study|Physician Decision|0|||
170561959|NCT02314923|616402673|FG008|Overall Study|Physician Decision|0|||
170561960|NCT02314923|616402674|FG009|Overall Study|Physician Decision|0|||
170561961|NCT02314923|616402665|FG000|Overall Study|Participant unavailable|0|||
170561962|NCT02314923|616402666|FG001|Overall Study|Participant unavailable|0|||
170561963|NCT02314923|616402667|FG002|Overall Study|Participant unavailable|0|||
170561964|NCT02314923|616402668|FG003|Overall Study|Participant unavailable|0|||
170561965|NCT02314923|616402669|FG004|Overall Study|Participant unavailable|0|||
170561966|NCT02314923|616402670|FG005|Overall Study|Participant unavailable|1|||
170561967|NCT02314923|616402671|FG006|Overall Study|Participant unavailable|0|||
170561968|NCT02314923|616402672|FG007|Overall Study|Participant unavailable|0|||
170561969|NCT02314923|616402673|FG008|Overall Study|Participant unavailable|0|||
170561970|NCT02314923|616402674|FG009|Overall Study|Participant unavailable|0|||
170561971|NCT02314923|616402665|FG000|Overall Study|Screen failure|0|||
170561972|NCT02314923|616402666|FG001|Overall Study|Screen failure|0|||
170561973|NCT02314923|616402667|FG002|Overall Study|Screen failure|0|||
170561974|NCT02314923|616402668|FG003|Overall Study|Screen failure|0|||
170561975|NCT02314923|616402669|FG004|Overall Study|Screen failure|0|||
170561976|NCT02314923|616402670|FG005|Overall Study|Screen failure|0|||
170561977|NCT02314923|616402671|FG006|Overall Study|Screen failure|1|||
170561978|NCT02314923|616402672|FG007|Overall Study|Screen failure|0|||
170561979|NCT02314923|616402673|FG008|Overall Study|Screen failure|0|||
170561980|NCT02314923|616402674|FG009|Overall Study|Screen failure|0|||
170561981|NCT02314923|616402665|FG000|Overall Study|Participant relocation|1|||
170561982|NCT02314923|616402666|FG001|Overall Study|Participant relocation|0|||
170561983|NCT02314923|616402667|FG002|Overall Study|Participant relocation|0|||
170561984|NCT02314923|616402668|FG003|Overall Study|Participant relocation|0|||
170561985|NCT02314923|616402669|FG004|Overall Study|Participant relocation|0|||
170561986|NCT02314923|616402670|FG005|Overall Study|Participant relocation|0|||
170561987|NCT02314923|616402671|FG006|Overall Study|Participant relocation|0|||
170561988|NCT02314923|616402672|FG007|Overall Study|Participant relocation|1|||
170561989|NCT02314923|616402673|FG008|Overall Study|Participant relocation|0|||
170561990|NCT02314923|616402674|FG009|Overall Study|Participant relocation|0|||
170561991|NCT01500317|616402677|FG000|Overall Study|Withdrawal by Subject|3|||
170561992|NCT01500317|616402678|FG001|Overall Study|Withdrawal by Subject|2|||
170561993|NCT01500317|616402679|FG002|Overall Study|Withdrawal by Subject|0|||
170561994|NCT02090764|616402680|FG000|Overall Study|Adverse Event|1|||
170561995|NCT02090764|616402681|FG001|Overall Study|Adverse Event|3|||
170561996|NCT02090764|616402680|FG000|Overall Study|Lack of Efficacy|0|||
170561997|NCT02090764|616402681|FG001|Overall Study|Lack of Efficacy|13|||
170806832|NCT01953692|617301612|FG000|Overall Study|Protocol Violation|0|||
170645453|NCT01185353|616715976|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
170645454|NCT01185353|616715977|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170645455|NCT01185353|616715978|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170645456|NCT01185353|616715979|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170645457|NCT01185353|616715980|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170645458|NCT01185353|616715981|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
170645459|NCT01185353|616715972|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
170645460|NCT01185353|616715973|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
170645461|NCT01185353|616715974|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
170645462|NCT01185353|616715975|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
170645463|NCT01185353|616715976|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
170645464|NCT01185353|616715977|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
170645465|NCT01185353|616715978|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
170645466|NCT01185353|616715979|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
170645467|NCT01185353|616715980|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
170645468|NCT01185353|616715981|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
170645469|NCT01185353|616715972|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
170561998|NCT02090764|616402680|FG000|Overall Study|Withdrawal by Subject|2|||
170561999|NCT02090764|616402681|FG001|Overall Study|Withdrawal by Subject|1|||
170562000|NCT02090764|616402680|FG000|Overall Study|Intercurrent illness and other|1|||
170562001|NCT02090764|616402681|FG001|Overall Study|Intercurrent illness and other|1|||
170645470|NCT01185353|616715973|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
170562002|NCT02090764|616402680|FG000|Overall Study|Lost to Follow-up|2|||
170562003|NCT02090764|616402681|FG001|Overall Study|Lost to Follow-up|2|||
170562004|NCT02300233|616402684|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
170562005|NCT02300233|616402685|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
170562006|NCT02300233|616402686|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
170562007|NCT02300233|616402684|FG000|Overall Study|Withdrawal by Subject|1|||
170562008|NCT02300233|616402685|FG001|Overall Study|Withdrawal by Subject|0|||
170562009|NCT02300233|616402686|FG002|Overall Study|Withdrawal by Subject|3|||
170562010|NCT02300233|616402684|FG000|Overall Study|Investigator Judgement|0|||
170562011|NCT02300233|616402685|FG001|Overall Study|Investigator Judgement|0|||
170562012|NCT02300233|616402686|FG002|Overall Study|Investigator Judgement|1|||
170645471|NCT01185353|616715974|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
170645472|NCT01185353|616715975|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
170645473|NCT01185353|616715976|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
170645474|NCT01185353|616715977|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
170645475|NCT01185353|616715978|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
170645476|NCT01185353|616715979|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
170645477|NCT01185353|616715980|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
170645478|NCT01185353|616715981|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
170645479|NCT01185353|616715972|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645480|NCT01185353|616715973|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645481|NCT01185353|616715974|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645482|NCT01185353|616715975|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645483|NCT01185353|616715976|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
170645484|NCT01185353|616715977|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645485|NCT01185353|616715978|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645486|NCT01185353|616715979|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645487|NCT01185353|616715980|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645488|NCT01185353|616715981|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
170645489|NCT01185353|616715972|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
170645490|NCT01185353|616715973|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
170645491|NCT01185353|616715974|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
170645492|NCT01185353|616715975|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
170645493|NCT01185353|616715976|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
170645494|NCT01185353|616715977|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
170645495|NCT01185353|616715978|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
170645496|NCT01185353|616715979|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
170645497|NCT01185353|616715980|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
170562013|NCT02300233|616402684|FG000|Overall Study|Reason Not Specified|0|||
170562014|NCT02300233|616402685|FG001|Overall Study|Reason Not Specified|0|||
170562015|NCT02300233|616402686|FG002|Overall Study|Reason Not Specified|5|||
170562016|NCT00833690|616402687|FG000|Overall Study|Withdrawal by Subject|1|||
170645498|NCT01185353|616715981|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
170645499|NCT01185353|616715972|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
170645500|NCT01185353|616715973|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
170645501|NCT01185353|616715974|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
170562017|NCT00833690|616402688|FG001|Overall Study|Withdrawal by Subject|0|||
170562018|NCT00833690|616402689|FG002|Overall Study|Withdrawal by Subject|0|||
170562019|NCT00833690|616402687|FG000|Overall Study|Discontinued study drug|3|||
170562020|NCT00833690|616402688|FG001|Overall Study|Discontinued study drug|2|||
170562021|NCT00833690|616402689|FG002|Overall Study|Discontinued study drug|0|||
170562022|NCT02115321|616402690|FG000|Overall Study|Death|1|||
170562023|NCT02115321|616402691|FG001|Overall Study|Death|0|||
170562024|NCT03331354|616402696|FG000|Overall Study|Withdrawal by Subject|1|||
170562025|NCT03331354|616402697|FG001|Overall Study|Withdrawal by Subject|3|||
170905309|NCT02034123|617656081|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905310|NCT02034123|617656082|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905311|NCT02034123|617656083|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170562026|NCT03331354|616402696|FG000|Overall Study|Lost to Follow-up|3|||
170562027|NCT03331354|616402697|FG001|Overall Study|Lost to Follow-up|3|||
170562028|NCT03331354|616402696|FG000|Overall Study|Found employment before initiated active intervention|0|||
170562029|NCT03331354|616402697|FG001|Overall Study|Found employment before initiated active intervention|4|||
170562030|NCT05889468|616402698|FG000|Overall Study|Lost to Follow-up|9|||
170562031|NCT05889468|616402699|FG001|Overall Study|Lost to Follow-up|2|||
170562032|NCT05889468|616402698|FG000|Overall Study|Withdrawal by Subject|2|||
170562033|NCT05889468|616402699|FG001|Overall Study|Withdrawal by Subject|2|||
170562034|NCT01767987|616402700|FG000|Overall Study|Physician Decision|4|||
170562035|NCT01767987|616402701|FG001|Overall Study|Physician Decision|1|||
170562036|NCT01153516|616402702|FG000|Overall Study|Both subjects refused surgery|2|||
170562037|NCT01153516|616402703|FG001|Overall Study|Both subjects refused surgery|0|||
170562038|NCT01983111|616402712|FG000|Overall Study|Withdrawal by Subject|8|||
170562039|NCT01983111|616402713|FG001|Overall Study|Withdrawal by Subject|6|||
170562040|NCT01983111|616402712|FG000|Overall Study|Adverse Event|4|||
170562041|NCT01983111|616402713|FG001|Overall Study|Adverse Event|0|||
170562042|NCT01983111|616402712|FG000|Overall Study|Protocol Violation|0|||
170562043|NCT01983111|616402713|FG001|Overall Study|Protocol Violation|1|||
170562044|NCT00105066|616402717|FG000|Overall Study|Adverse Event|2|||
170562045|NCT00105066|616402718|FG001|Overall Study|Adverse Event|5|||
170562046|NCT00539500|616402719|FG000|Overall Study|Disease Progression|1|||
170562047|NCT00539500|616402719|FG000|Overall Study|Lost to Follow-up|2|||
170562048|NCT01979185|616402721|FG000|Period 2|Other|0|||
170562049|NCT01979185|616402722|FG001|Period 2|Other|1|||
170562050|NCT00980798|616402723|FG000|Overall Study|Adverse Event|7|||
170562051|NCT00980798|616402724|FG001|Overall Study|Adverse Event|36|||
170562052|NCT00980798|616402723|FG000|Overall Study|Lack of Efficacy|16|||
170562053|NCT00980798|616402724|FG001|Overall Study|Lack of Efficacy|5|||
170562054|NCT00980798|616402723|FG000|Overall Study|Lost to Follow-up|0|||
170562055|NCT00980798|616402724|FG001|Overall Study|Lost to Follow-up|1|||
170562056|NCT00980798|616402723|FG000|Overall Study|Physician Decision|2|||
170562057|NCT00980798|616402724|FG001|Overall Study|Physician Decision|1|||
170562058|NCT00980798|616402723|FG000|Overall Study|Withdrawal by Subject|8|||
170562059|NCT00980798|616402724|FG001|Overall Study|Withdrawal by Subject|11|||
170562060|NCT00980798|616402723|FG000|Overall Study|Other|0|||
170562061|NCT00980798|616402724|FG001|Overall Study|Other|1|||
170562062|NCT04079738|616402731|FG000|Study Treatment|Death|1|||
170562063|NCT04079738|616402732|FG001|Study Treatment|Death|0|||
170562064|NCT04079738|616402733|FG002|Study Treatment|Death|0|||
170562065|NCT04079738|616402734|FG003|Study Treatment|Death|0|||
170562066|NCT04079738|616402731|FG000|Study Treatment|Adverse Event|2|||
170562067|NCT04079738|616402732|FG001|Study Treatment|Adverse Event|0|||
170562068|NCT04079738|616402733|FG002|Study Treatment|Adverse Event|0|||
170562069|NCT04079738|616402734|FG003|Study Treatment|Adverse Event|0|||
170562070|NCT04079738|616402731|FG000|Study Treatment|withdrawal before treatment|1|||
170562071|NCT04079738|616402732|FG001|Study Treatment|withdrawal before treatment|0|||
170562072|NCT04079738|616402733|FG002|Study Treatment|withdrawal before treatment|0|||
170562073|NCT04079738|616402734|FG003|Study Treatment|withdrawal before treatment|0|||
170562074|NCT04079738|616402731|FG000|Study Treatment|symptomatic deterioration|2|||
170562075|NCT04079738|616402732|FG001|Study Treatment|symptomatic deterioration|0|||
170562076|NCT04079738|616402733|FG002|Study Treatment|symptomatic deterioration|0|||
170562077|NCT04079738|616402734|FG003|Study Treatment|symptomatic deterioration|0|||
170562078|NCT04079738|616402731|FG000|Study Treatment|Disease Progression|1|||
170562079|NCT04079738|616402732|FG001|Study Treatment|Disease Progression|0|||
170562080|NCT04079738|616402733|FG002|Study Treatment|Disease Progression|0|||
170905312|NCT02034123|617656084|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905313|NCT02034123|617656085|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170562081|NCT04079738|616402734|FG003|Study Treatment|Disease Progression|0|||
170562082|NCT04079738|616402731|FG000|Study Treatment|withdrawal after treatment|1|||
170562083|NCT04079738|616402732|FG001|Study Treatment|withdrawal after treatment|0|||
170562084|NCT04079738|616402733|FG002|Study Treatment|withdrawal after treatment|0|||
170562085|NCT04079738|616402734|FG003|Study Treatment|withdrawal after treatment|0|||
170562086|NCT04079738|616402731|FG000|Follow up|Withdrawal by Subject|3|||
170562087|NCT04079738|616402732|FG001|Follow up|Withdrawal by Subject|0|||
170562088|NCT04079738|616402733|FG002|Follow up|Withdrawal by Subject|0|||
170562089|NCT04079738|616402734|FG003|Follow up|Withdrawal by Subject|0|||
170562090|NCT04079738|616402731|FG000|Follow up|Death|5|||
170645502|NCT01185353|616715975|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
170645503|NCT01185353|616715976|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
170645504|NCT01185353|616715977|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
170645505|NCT01185353|616715978|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
170645506|NCT01185353|616715979|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
170645507|NCT01185353|616715980|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
170645508|NCT01185353|616715981|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
170645509|NCT01185353|616715972|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
170645510|NCT01185353|616715973|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
170645511|NCT01185353|616715974|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
170645512|NCT01185353|616715975|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
170645513|NCT01185353|616715976|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
170645514|NCT01185353|616715977|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
170645515|NCT01185353|616715978|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
170645516|NCT01185353|616715979|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
170645517|NCT01185353|616715980|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
170645518|NCT01185353|616715981|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
170645519|NCT01185353|616715972|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
170645520|NCT01185353|616715973|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
170645521|NCT01185353|616715974|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
170645522|NCT01185353|616715975|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
170645523|NCT01185353|616715976|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
170645524|NCT01185353|616715977|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
170645525|NCT01185353|616715978|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
170645526|NCT01185353|616715979|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
170645527|NCT01185353|616715980|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
170645528|NCT01185353|616715981|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
170645529|NCT01185353|616715972|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
170645530|NCT01185353|616715973|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
170645531|NCT01185353|616715974|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
170645532|NCT01185353|616715975|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
170645533|NCT01185353|616715976|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
170645534|NCT01185353|616715977|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
170645535|NCT01185353|616715978|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
170645536|NCT01185353|616715979|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
170645537|NCT01185353|616715980|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
170645538|NCT01185353|616715981|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
170562091|NCT04079738|616402732|FG001|Follow up|Death|0|||
170562092|NCT04079738|616402733|FG002|Follow up|Death|0|||
170562093|NCT04079738|616402734|FG003|Follow up|Death|0|||
170645539|NCT01185353|616715972|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170645540|NCT01185353|616715973|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170562094|NCT02259231|616402737|FG000|Overall Study|Adverse Event|1|||
170562095|NCT02259231|616402738|FG001|Overall Study|Adverse Event|1|||
170645541|NCT01185353|616715974|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170645542|NCT01185353|616715975|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170645543|NCT01185353|616715976|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170645544|NCT01185353|616715977|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170645545|NCT01185353|616715978|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
170645546|NCT01185353|616715979|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170645547|NCT01185353|616715980|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170645548|NCT01185353|616715981|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
170645549|NCT01185353|616715972|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
170645550|NCT01185353|616715973|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
170645551|NCT01185353|616715974|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
170645552|NCT01185353|616715975|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
170645553|NCT01185353|616715976|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
170645554|NCT01185353|616715977|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
170645555|NCT01185353|616715978|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
170645556|NCT01185353|616715979|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
170645557|NCT01185353|616715980|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
170645558|NCT01185353|616715981|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
170645559|NCT01185353|616715972|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
170562096|NCT02259231|616402739|FG002|Overall Study|Adverse Event|2|||
170562097|NCT02259231|616402740|FG003|Overall Study|Adverse Event|0|||
170562098|NCT02259231|616402741|FG004|Overall Study|Adverse Event|0|||
170562099|NCT02259231|616402742|FG005|Overall Study|Adverse Event|0|||
170562100|NCT02259231|616402743|FG006|Overall Study|Adverse Event|0|||
170645560|NCT01185353|616715973|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
170645561|NCT01185353|616715974|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
170562101|NCT02259231|616402737|FG000|Overall Study|Progressive Disease|4|||
170645562|NCT01185353|616715975|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
170645563|NCT01185353|616715976|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
170645564|NCT01185353|616715977|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
170645565|NCT01185353|616715978|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
170645566|NCT01185353|616715979|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
170645567|NCT01185353|616715980|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
170645568|NCT01185353|616715981|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
170645569|NCT01185353|616715972|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
170562102|NCT02259231|616402738|FG001|Overall Study|Progressive Disease|5|||
170562103|NCT02259231|616402739|FG002|Overall Study|Progressive Disease|4|||
170562104|NCT02259231|616402740|FG003|Overall Study|Progressive Disease|5|||
170562105|NCT02259231|616402741|FG004|Overall Study|Progressive Disease|4|||
170562106|NCT02259231|616402742|FG005|Overall Study|Progressive Disease|5|||
170562107|NCT02259231|616402743|FG006|Overall Study|Progressive Disease|4|||
170562108|NCT02259231|616402737|FG000|Overall Study|Sponsor termination of study|1|||
170562109|NCT02259231|616402738|FG001|Overall Study|Sponsor termination of study|0|||
170562110|NCT02259231|616402739|FG002|Overall Study|Sponsor termination of study|0|||
170562111|NCT02259231|616402740|FG003|Overall Study|Sponsor termination of study|1|||
170562112|NCT02259231|616402741|FG004|Overall Study|Sponsor termination of study|2|||
170562113|NCT02259231|616402742|FG005|Overall Study|Sponsor termination of study|1|||
170562114|NCT02259231|616402743|FG006|Overall Study|Sponsor termination of study|1|||
170562115|NCT04562090|616402746|FG000|Overall Study|Withdrawal by Subject|3|||
170562116|NCT04562090|616402747|FG001|Overall Study|Withdrawal by Subject|4|||
170562117|NCT04562090|616402746|FG000|Overall Study|Protocol Violation|2|||
170562118|NCT04562090|616402747|FG001|Overall Study|Protocol Violation|0|||
170562119|NCT04562090|616402746|FG000|Overall Study|Lack of Efficacy|0|||
170562120|NCT04562090|616402747|FG001|Overall Study|Lack of Efficacy|1|||
170562121|NCT04562090|616402746|FG000|Overall Study|Adverse Event|1|||
170562122|NCT04562090|616402747|FG001|Overall Study|Adverse Event|4|||
170562123|NCT04562090|616402746|FG000|Overall Study|Miscellaneous|0|||
170562124|NCT04562090|616402747|FG001|Overall Study|Miscellaneous|3|||
170562125|NCT03633058|616402748|FG000|Overall Study|Adverse Event|0|||
170562126|NCT03633058|616402749|FG001|Overall Study|Adverse Event|0|||
170562127|NCT03633058|616402750|FG002|Overall Study|Adverse Event|1|||
170562128|NCT03633058|616402751|FG003|Overall Study|Adverse Event|0|||
170562129|NCT00432965|616402752|FG000|Overall Study|Lost to Follow-up|22|||
170562130|NCT00432965|616402753|FG001|Overall Study|Lost to Follow-up|19|||
170562131|NCT00432965|616402752|FG000|Overall Study|Withdrawal by Subject|13|||
170562132|NCT00432965|616402753|FG001|Overall Study|Withdrawal by Subject|13|||
170562133|NCT00432965|616402752|FG000|Overall Study|Physician Decision|14|||
170562134|NCT00432965|616402753|FG001|Overall Study|Physician Decision|13|||
170562135|NCT00432965|616402752|FG000|Overall Study|Lack of Efficacy|8|||
170562136|NCT00432965|616402753|FG001|Overall Study|Lack of Efficacy|13|||
170562137|NCT00432965|616402752|FG000|Overall Study|Non-compliance|7|||
170562138|NCT00432965|616402753|FG001|Overall Study|Non-compliance|0|||
170562139|NCT00432965|616402752|FG000|Overall Study|Adverse Event|22|||
170562140|NCT00432965|616402753|FG001|Overall Study|Adverse Event|19|||
170562141|NCT00432965|616402752|FG000|Overall Study|Death|3|||
170562142|NCT00432965|616402753|FG001|Overall Study|Death|4|||
170562143|NCT00432965|616402752|FG000|Overall Study|Exclusionary Methods|1|||
170562144|NCT00432965|616402753|FG001|Overall Study|Exclusionary Methods|2|||
170562145|NCT00432965|616402752|FG000|Overall Study|Incomplete Data|4|||
170562146|NCT00432965|616402753|FG001|Overall Study|Incomplete Data|3|||
170562147|NCT04629196|616402754|FG000|Overall Study|Subject discontinued study drug|1|||
170562148|NCT04629196|616402755|FG001|Overall Study|Subject discontinued study drug|0|||
170562149|NCT04629196|616402754|FG000|Overall Study|Subject study drug dosing increased|1|||
170562150|NCT04629196|616402755|FG001|Overall Study|Subject study drug dosing increased|1|||
170562151|NCT04629196|616402754|FG000|Overall Study|Withdrawal by Subject|1|||
170562152|NCT04629196|616402755|FG001|Overall Study|Withdrawal by Subject|2|||
170562153|NCT00835354|616402758|FG000|First Intervention|Adverse Event|0|||
170562154|NCT00835354|616402759|FG001|First Intervention|Adverse Event|1|||
170562155|NCT03559556|616402764|FG000|Overall Study|Withdrawal by Subject|1|||
170562156|NCT04727151|616402768|FG000|Overall Study|Death|0|||
170562157|NCT04727151|616402769|FG001|Overall Study|Death|0|||
170562158|NCT04727151|616402770|FG002|Overall Study|Death|0|||
170562159|NCT04727151|616402771|FG003|Overall Study|Death|0|||
170562160|NCT04727151|616402772|FG004|Overall Study|Death|3|||
170562161|NCT04727151|616402768|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
170562162|NCT04727151|616402769|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
170562163|NCT04727151|616402770|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
170562164|NCT04727151|616402771|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
170562165|NCT04727151|616402772|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
170562166|NCT01587196|616402773|FG000|Overall Study|Lost to Follow-up|50|||
170562167|NCT01587196|616402773|FG000|Overall Study|Withdrawal by Subject|4|||
170562168|NCT04846868|616402778|FG000|Overall Study|Adverse Event|12|||
170562169|NCT04846868|616402779|FG001|Overall Study|Adverse Event|11|||
170562170|NCT04846868|616402778|FG000|Overall Study|Protocol deviation|6|||
170562171|NCT04846868|616402779|FG001|Overall Study|Protocol deviation|2|||
170562172|NCT04846868|616402778|FG000|Overall Study|Perceived lack of efficacy|3|||
170562173|NCT04846868|616402779|FG001|Overall Study|Perceived lack of efficacy|2|||
170562174|NCT04846868|616402778|FG000|Overall Study|Change of residence|2|||
170562175|NCT04846868|616402779|FG001|Overall Study|Change of residence|3|||
170562176|NCT04846868|616402778|FG000|Overall Study|Burden of study procedures|1|||
170562177|NCT04846868|616402779|FG001|Overall Study|Burden of study procedures|1|||
170562178|NCT04846868|616402778|FG000|Overall Study|No reason available|2|||
170562179|NCT04846868|616402779|FG001|Overall Study|No reason available|5|||
170562180|NCT04846868|616402778|FG000|Overall Study|Other reason listed|20|||
170562181|NCT04846868|616402779|FG001|Overall Study|Other reason listed|10|||
170562182|NCT04846868|616402778|FG000|Overall Study|Not treated|0|||
170562183|NCT04846868|616402779|FG001|Overall Study|Not treated|1|||
170562184|NCT03557502|616402780|FG000|Protocol 2|Withdrawal by Subject|1|||
170562185|NCT03557502|616402781|FG001|Protocol 2|Withdrawal by Subject|1|||
170562186|NCT03557502|616402780|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
170562187|NCT03557502|616402781|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
170562188|NCT01323192|616405133|FG000|Overall Study|Adverse Event|6|||
170562189|NCT01323192|616405134|FG001|Overall Study|Adverse Event|1|||
170562190|NCT01323192|616405133|FG000|Overall Study|Withdrawal by Subject|3|||
170562191|NCT01323192|616405134|FG001|Overall Study|Withdrawal by Subject|1|||
170562192|NCT01323192|616405133|FG000|Overall Study|Noncompliance with study medication|0|||
170562193|NCT01323192|616405134|FG001|Overall Study|Noncompliance with study medication|3|||
170562194|NCT01323192|616405133|FG000|Overall Study|Nonmedical reasons|0|||
170562195|NCT01323192|616405134|FG001|Overall Study|Nonmedical reasons|1|||
170562196|NCT00189423|616405135|FG000|Overall Study|Death|746|||
170562197|NCT00189423|616405136|FG001|Overall Study|Death|747|||
170562198|NCT00189423|616405135|FG000|Overall Study|Withdrawal by Subject|9|||
170562199|NCT00189423|616405136|FG001|Overall Study|Withdrawal by Subject|9|||
170562200|NCT00189423|616405135|FG000|Overall Study|Lost to Follow-up|10|||
170562201|NCT00189423|616405136|FG001|Overall Study|Lost to Follow-up|10|||
170562202|NCT04622592|616405137|FG000|Overall Study|Death|0|||
170562203|NCT04622592|616405138|FG001|Overall Study|Death|0|||
170562204|NCT04622592|616405139|FG002|Overall Study|Death|1|||
170562205|NCT04622592|616405140|FG003|Overall Study|Death|0|||
170562206|NCT04622592|616405141|FG004|Overall Study|Death|0|||
170562207|NCT04622592|616405142|FG005|Overall Study|Death|0|||
170562208|NCT04622592|616405143|FG006|Overall Study|Death|0|||
170562209|NCT04622592|616405144|FG007|Overall Study|Death|1|||
170562210|NCT04622592|616405137|FG000|Overall Study|Lost to Follow-up|0|||
170562211|NCT04622592|616405138|FG001|Overall Study|Lost to Follow-up|0|||
170562212|NCT04622592|616405139|FG002|Overall Study|Lost to Follow-up|0|||
170562213|NCT04622592|616405140|FG003|Overall Study|Lost to Follow-up|3|||
170562214|NCT04622592|616405141|FG004|Overall Study|Lost to Follow-up|1|||
170562215|NCT04622592|616405142|FG005|Overall Study|Lost to Follow-up|0|||
170905314|NCT02034123|617656086|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905315|NCT02034123|617656087|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
170905316|NCT02034123|617656070|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905317|NCT02034123|617656071|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905318|NCT02034123|617656072|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905319|NCT02034123|617656073|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
170905320|NCT02034123|617656074|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905321|NCT02034123|617656075|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905322|NCT02034123|617656076|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905323|NCT02034123|617656077|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905324|NCT02034123|617656078|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905325|NCT02034123|617656079|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905326|NCT02034123|617656080|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905327|NCT02034123|617656081|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905328|NCT02034123|617656082|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170562216|NCT04622592|616405143|FG006|Overall Study|Lost to Follow-up|2|||
170562217|NCT04622592|616405144|FG007|Overall Study|Lost to Follow-up|2|||
170562218|NCT04622592|616405137|FG000|Overall Study|Physician Decision|0|||
170562219|NCT04622592|616405138|FG001|Overall Study|Physician Decision|0|||
170562220|NCT04622592|616405139|FG002|Overall Study|Physician Decision|0|||
170562221|NCT04622592|616405140|FG003|Overall Study|Physician Decision|0|||
170562222|NCT04622592|616405141|FG004|Overall Study|Physician Decision|1|||
170562223|NCT04622592|616405142|FG005|Overall Study|Physician Decision|0|||
170562224|NCT04622592|616405143|FG006|Overall Study|Physician Decision|0|||
170562225|NCT04622592|616405144|FG007|Overall Study|Physician Decision|0|||
170562226|NCT04622592|616405137|FG000|Overall Study|Withdrawal by Subject|1|||
170562227|NCT04622592|616405138|FG001|Overall Study|Withdrawal by Subject|0|||
170562228|NCT04622592|616405139|FG002|Overall Study|Withdrawal by Subject|2|||
170562229|NCT04622592|616405140|FG003|Overall Study|Withdrawal by Subject|0|||
170905329|NCT02034123|617656083|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905330|NCT02034123|617656084|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905331|NCT02034123|617656085|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905332|NCT02034123|617656086|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905333|NCT02034123|617656087|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
170905334|NCT02034123|617656070|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905335|NCT02034123|617656071|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905336|NCT02034123|617656072|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905337|NCT02034123|617656073|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905338|NCT02034123|617656074|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905339|NCT02034123|617656075|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905340|NCT02034123|617656076|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905341|NCT02034123|617656077|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905342|NCT02034123|617656078|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
170905343|NCT02034123|617656079|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905344|NCT02034123|617656080|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905345|NCT02034123|617656081|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905346|NCT02034123|617656082|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905347|NCT02034123|617656083|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905348|NCT02034123|617656084|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905349|NCT02034123|617656085|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905350|NCT02034123|617656086|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905351|NCT02034123|617656087|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
170905352|NCT02034123|617656070|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905353|NCT02034123|617656071|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905354|NCT02034123|617656072|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905355|NCT02034123|617656073|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
170562230|NCT04622592|616405141|FG004|Overall Study|Withdrawal by Subject|0|||
170562231|NCT04622592|616405142|FG005|Overall Study|Withdrawal by Subject|0|||
170562232|NCT04622592|616405143|FG006|Overall Study|Withdrawal by Subject|1|||
170562233|NCT04622592|616405144|FG007|Overall Study|Withdrawal by Subject|4|||
170562234|NCT04622592|616405137|FG000|Overall Study|Other than specified above|0|||
170562235|NCT04622592|616405138|FG001|Overall Study|Other than specified above|0|||
170562236|NCT04622592|616405139|FG002|Overall Study|Other than specified above|1|||
170562237|NCT04622592|616405140|FG003|Overall Study|Other than specified above|0|||
170562238|NCT04622592|616405141|FG004|Overall Study|Other than specified above|0|||
170562239|NCT04622592|616405142|FG005|Overall Study|Other than specified above|0|||
170562240|NCT04622592|616405143|FG006|Overall Study|Other than specified above|0|||
170562241|NCT04622592|616405144|FG007|Overall Study|Other than specified above|0|||
170562242|NCT01702298|616405145|FG000|Overall Study|Withdrawal by Subject|1|||
170562243|NCT03847519|616405151|FG000|Overall Study|Death|5|||
170562244|NCT03847519|616405152|FG001|Overall Study|Death|8|||
170562245|NCT03847519|616405153|FG002|Overall Study|Death|1|||
170562246|NCT03847519|616405151|FG000|Overall Study|Lost to Follow-up|1|||
170562247|NCT03847519|616405152|FG001|Overall Study|Lost to Follow-up|2|||
170562248|NCT03847519|616405153|FG002|Overall Study|Lost to Follow-up|0|||
170562249|NCT03847519|616405151|FG000|Overall Study|Study Terminated by Sponsor|0|||
170562250|NCT03847519|616405152|FG001|Overall Study|Study Terminated by Sponsor|3|||
170562251|NCT03847519|616405153|FG002|Overall Study|Study Terminated by Sponsor|2|||
170562252|NCT01668004|616405154|FG000|Overall Study|Adverse Event|7|||
170562253|NCT01668004|616405154|FG000|Overall Study|Withdrawal by Subject|2|||
170562254|NCT01668004|616405154|FG000|Overall Study|Lost to Follow-up|5|||
170562255|NCT01668004|616405154|FG000|Overall Study|Lack of Efficacy|9|||
170562256|NCT01668004|616405154|FG000|Overall Study|Non-compliance with treatment|2|||
170562257|NCT02448381|616405164|FG000|Overall Study|Adverse Event|2|||
170562258|NCT02448381|616405165|FG001|Overall Study|Adverse Event|0|||
170562259|NCT02448381|616405164|FG000|Overall Study|Lost to Follow-up|16|||
170562260|NCT02448381|616405165|FG001|Overall Study|Lost to Follow-up|9|||
170562261|NCT02448381|616405164|FG000|Overall Study|Physician Decision|1|||
170562262|NCT02448381|616405165|FG001|Overall Study|Physician Decision|1|||
170562263|NCT02448381|616405164|FG000|Overall Study|Pregnancy|1|||
170562264|NCT02448381|616405165|FG001|Overall Study|Pregnancy|0|||
170562265|NCT02448381|616405164|FG000|Overall Study|Withdrawal by Subject|13|||
170562266|NCT02448381|616405165|FG001|Overall Study|Withdrawal by Subject|9|||
170562267|NCT02448381|616405164|FG000|Overall Study|Noncompliance with Study Procedures|2|||
170562268|NCT02448381|616405165|FG001|Overall Study|Noncompliance with Study Procedures|0|||
170562269|NCT00335829|616405166|FG000|Overall Study|Withdrawal by Subject|1|||
170562270|NCT00335829|616405166|FG000|Overall Study|Lost to Follow-up|1|||
170562271|NCT00335829|616405166|FG000|Overall Study|Adverse Event|1|||
170645570|NCT01185353|616715973|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
170645571|NCT01185353|616715974|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
170645572|NCT01185353|616715975|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
170645573|NCT01185353|616715976|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
170645574|NCT01185353|616715977|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
170645575|NCT01185353|616715978|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
170645576|NCT01185353|616715979|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
170645577|NCT01185353|616715980|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
170645578|NCT01185353|616715981|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
170645579|NCT01185353|616715972|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645580|NCT01185353|616715973|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645581|NCT01185353|616715974|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645582|NCT01185353|616715975|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645583|NCT01185353|616715976|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645584|NCT01185353|616715977|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645585|NCT01185353|616715978|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645586|NCT01185353|616715979|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645587|NCT01185353|616715980|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
170399322|NCT03193190|615799947|FG010|Stage 1|Progressive Disease|0|||
170562272|NCT00744861|616405174|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
170562273|NCT00744861|616405175|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
170562274|NCT00744861|616405176|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
170562275|NCT00744861|616405177|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
170562276|NCT00744861|616405174|FG000|Feasibility Stage 1|Pregnancy|0|||
170562277|NCT00744861|616405175|FG001|Feasibility Stage 1|Pregnancy|1|||
170562278|NCT00744861|616405176|FG002|Feasibility Stage 1|Pregnancy|0|||
170562279|NCT00744861|616405177|FG003|Feasibility Stage 1|Pregnancy|0|||
170562280|NCT00744861|616405174|FG000|Pivotal Stage 2|Adverse Event|0|||
170562281|NCT00744861|616405175|FG001|Pivotal Stage 2|Adverse Event|0|||
170562282|NCT00744861|616405176|FG002|Pivotal Stage 2|Adverse Event|6|||
170562283|NCT00744861|616405177|FG003|Pivotal Stage 2|Adverse Event|11|||
170562284|NCT00744861|616405174|FG000|Pivotal Stage 2|Death|0|||
170562285|NCT00744861|616405175|FG001|Pivotal Stage 2|Death|0|||
170562286|NCT00744861|616405176|FG002|Pivotal Stage 2|Death|0|||
170562287|NCT00744861|616405177|FG003|Pivotal Stage 2|Death|1|||
170562288|NCT00744861|616405174|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
170562289|NCT00744861|616405175|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
170562290|NCT00744861|616405176|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
170562291|NCT00744861|616405177|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
170562292|NCT00744861|616405174|FG000|Pivotal Stage 2|Physician Decision|0|||
170562293|NCT00744861|616405175|FG001|Pivotal Stage 2|Physician Decision|0|||
170562294|NCT00744861|616405176|FG002|Pivotal Stage 2|Physician Decision|3|||
170562295|NCT00744861|616405177|FG003|Pivotal Stage 2|Physician Decision|1|||
170562296|NCT00744861|616405174|FG000|Pivotal Stage 2|Protocol Violation|0|||
170562297|NCT00744861|616405175|FG001|Pivotal Stage 2|Protocol Violation|0|||
170562298|NCT00744861|616405176|FG002|Pivotal Stage 2|Protocol Violation|0|||
170562299|NCT00744861|616405177|FG003|Pivotal Stage 2|Protocol Violation|1|||
170562300|NCT00744861|616405174|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
170562301|NCT00744861|616405175|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
170562302|NCT00744861|616405176|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
170562303|NCT00744861|616405177|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
170562304|NCT00744861|616405174|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
170562305|NCT00744861|616405175|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
170562306|NCT00744861|616405176|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
170562307|NCT00744861|616405177|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
170562308|NCT04856527|616405178|FG000|Overall Study|Unable to complete experimental task|2|||
170562309|NCT04856527|616405179|FG001|Overall Study|Unable to complete experimental task|0|||
170562310|NCT03605693|616405180|FG000|Overall Study|Lost to Follow-up|4|||
170562311|NCT03605693|616405181|FG001|Overall Study|Lost to Follow-up|0|||
170562312|NCT03605693|616405180|FG000|Overall Study|Physician Decision|1|||
170562313|NCT03605693|616405181|FG001|Overall Study|Physician Decision|0|||
170562314|NCT04752566|616405182|FG000|Overall Study|Protocol Violation|0|||
170562315|NCT04752566|616405183|FG001|Overall Study|Protocol Violation|1|||
170562316|NCT04752566|616405182|FG000|Overall Study|Death|1|||
170562317|NCT04752566|616405183|FG001|Overall Study|Death|0|||
170562318|NCT04752566|616405182|FG000|Overall Study|Adverse Event|1|||
170562319|NCT04752566|616405183|FG001|Overall Study|Adverse Event|0|||
170562320|NCT04752566|616405182|FG000|Overall Study|Withdrawal by Subject|2|||
170562321|NCT04752566|616405183|FG001|Overall Study|Withdrawal by Subject|0|||
170562322|NCT04752566|616405182|FG000|Overall Study|Physician Decision|1|||
170562323|NCT04752566|616405183|FG001|Overall Study|Physician Decision|1|||
170562324|NCT02038647|616405184|FG000|Overall Study|Progressive Disease|50|||
170562325|NCT02038647|616405185|FG001|Overall Study|Progressive Disease|59|||
170562326|NCT02038647|616405184|FG000|Overall Study|Adverse Event|18|||
170645588|NCT01185353|616715981|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
170645589|NCT01185353|616715972|FG000|Part C (Weeks 24 Through 76)|Death|0|||
170562327|NCT02038647|616405185|FG001|Overall Study|Adverse Event|10|||
170562328|NCT02038647|616405184|FG000|Overall Study|Symptomatic Deterioration|7|||
170562329|NCT02038647|616405185|FG001|Overall Study|Symptomatic Deterioration|7|||
170562330|NCT02038647|616405184|FG000|Overall Study|Withdrawal by Subject|5|||
170562331|NCT02038647|616405185|FG001|Overall Study|Withdrawal by Subject|2|||
170562332|NCT02038647|616405184|FG000|Overall Study|Not Reported|0|||
170562333|NCT02038647|616405185|FG001|Overall Study|Not Reported|1|||
170562334|NCT02038647|616405184|FG000|Overall Study|Ongoing at Datacut|9|||
170562335|NCT02038647|616405185|FG001|Overall Study|Ongoing at Datacut|10|||
170562336|NCT02757430|616405186|FG000|Overall Study|Physician Decision|6|||
170562337|NCT02757430|616405186|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
170562338|NCT02757430|616405186|FG000|Overall Study|No informed consent|1|||
170562339|NCT02757430|616405186|FG000|Overall Study|No procedure performed|2|||
170562340|NCT03502200|616405189|FG000|Overall Study|Adverse Event|1|||
170562341|NCT03502200|616405190|FG001|Overall Study|Adverse Event|0|||
170562342|NCT03502200|616405189|FG000|Overall Study|Lost to Follow-up|36|||
170562343|NCT03502200|616405190|FG001|Overall Study|Lost to Follow-up|38|||
170562344|NCT03502200|616405189|FG000|Overall Study|Study Team Decision|1|||
170562345|NCT03502200|616405190|FG001|Overall Study|Study Team Decision|1|||
170562346|NCT03502200|616405189|FG000|Overall Study|Withdrawal by Subject|5|||
170562347|NCT03502200|616405190|FG001|Overall Study|Withdrawal by Subject|7|||
170562348|NCT03502200|616405189|FG000|Overall Study|Death|0|||
170562349|NCT03502200|616405190|FG001|Overall Study|Death|2|||
170905356|NCT02034123|617656074|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
170905357|NCT02034123|617656075|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905358|NCT02034123|617656076|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905359|NCT02034123|617656077|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905360|NCT02034123|617656078|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905361|NCT02034123|617656079|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905362|NCT02034123|617656080|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905363|NCT02034123|617656081|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905364|NCT02034123|617656082|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905365|NCT02034123|617656083|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905366|NCT02034123|617656084|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905367|NCT02034123|617656085|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905368|NCT02034123|617656086|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905369|NCT02034123|617656087|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
170905370|NCT01511445|617656088|FG000|Overall Study|Lost to Follow-up|3|||
170905371|NCT01511445|617656089|FG001|Overall Study|Lost to Follow-up|1|||
170905372|NCT01511445|617656088|FG000|Overall Study|Protocol Violation|1|||
170905373|NCT01511445|617656089|FG001|Overall Study|Protocol Violation|3|||
170905374|NCT01511445|617656088|FG000|Overall Study|Protocol Violation|1|||
170905375|NCT01511445|617656089|FG001|Overall Study|Protocol Violation|0|||
170905376|NCT00709202|617656090|FG000|Overall Study|Withdrawal by Subject|6|||
170905377|NCT00709202|617656091|FG001|Overall Study|Withdrawal by Subject|6|||
170905378|NCT02344576|617656092|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
170905379|NCT02344576|617656093|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
170905380|NCT02344576|617656094|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
170905381|NCT02344576|617656095|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
170905382|NCT02344576|617656092|FG000|1-Month Follow-Up|Death|13|||
170905383|NCT02344576|617656093|FG001|1-Month Follow-Up|Death|8|||
170905384|NCT02344576|617656094|FG002|1-Month Follow-Up|Death|0|||
170905385|NCT02344576|617656095|FG003|1-Month Follow-Up|Death|0|||
170905386|NCT02344576|617656092|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
170905387|NCT02344576|617656093|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
170905388|NCT02344576|617656094|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
170905389|NCT02344576|617656095|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
170905390|NCT02344576|617656092|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
170905391|NCT02344576|617656093|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
170905392|NCT02344576|617656094|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
170905393|NCT02344576|617656095|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
170905394|NCT02344576|617656092|FG000|6-Month Follow-Up|Death|14|||
170905395|NCT02344576|617656093|FG001|6-Month Follow-Up|Death|14|||
170905396|NCT02344576|617656094|FG002|6-Month Follow-Up|Death|0|||
170905397|NCT02344576|617656095|FG003|6-Month Follow-Up|Death|0|||
170905398|NCT02344576|617656092|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
170562350|NCT00855335|616405191|FG000|Overall Study|Lost to Follow-up|0|||
170562351|NCT00855335|616405192|FG001|Overall Study|Lost to Follow-up|0|||
170562352|NCT00855335|616405193|FG002|Overall Study|Lost to Follow-up|3|||
170562353|NCT00855335|616405194|FG003|Overall Study|Lost to Follow-up|1|||
170562354|NCT00855335|616405195|FG004|Overall Study|Lost to Follow-up|0|||
170562355|NCT00855335|616405191|FG000|Overall Study|Withdrawal by Subject|0|||
170562356|NCT00855335|616405192|FG001|Overall Study|Withdrawal by Subject|0|||
170905399|NCT02344576|617656093|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
170905400|NCT02344576|617656094|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
170562357|NCT00855335|616405193|FG002|Overall Study|Withdrawal by Subject|0|||
170562358|NCT00855335|616405194|FG003|Overall Study|Withdrawal by Subject|1|||
170562359|NCT00855335|616405195|FG004|Overall Study|Withdrawal by Subject|0|||
170562360|NCT00855335|616405191|FG000|Overall Study|Adverse Event|2|||
170562361|NCT00855335|616405192|FG001|Overall Study|Adverse Event|0|||
170562362|NCT00855335|616405193|FG002|Overall Study|Adverse Event|0|||
170562363|NCT00855335|616405194|FG003|Overall Study|Adverse Event|0|||
170562364|NCT00855335|616405195|FG004|Overall Study|Adverse Event|0|||
170562365|NCT00855335|616405191|FG000|Overall Study|Physician Decision|1|||
170562366|NCT00855335|616405192|FG001|Overall Study|Physician Decision|1|||
170562367|NCT00855335|616405193|FG002|Overall Study|Physician Decision|0|||
170562368|NCT00855335|616405194|FG003|Overall Study|Physician Decision|0|||
170562369|NCT00855335|616405195|FG004|Overall Study|Physician Decision|0|||
170562370|NCT00855335|616405191|FG000|Overall Study|Other|2|||
170562371|NCT00855335|616405192|FG001|Overall Study|Other|1|||
170562372|NCT00855335|616405193|FG002|Overall Study|Other|2|||
170562373|NCT00855335|616405194|FG003|Overall Study|Other|5|||
170562374|NCT00855335|616405195|FG004|Overall Study|Other|1|||
170562375|NCT03097289|616405197|FG000|Overall Study|Adverse Event|1|||
170562376|NCT03097289|616405197|FG000|Overall Study|Equipment failure|2|||
170562377|NCT03097289|616405197|FG000|Overall Study|Collected platelet product unusable|3|||
170562378|NCT02526290|616405200|FG000|Overall Study|Adverse Event|3|||
170562379|NCT02526290|616405200|FG000|Overall Study|Withdrawal by Subject|4|||
170562380|NCT02526290|616405200|FG000|Overall Study|Physician Decision|1|||
170562381|NCT02082977|616405201|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
170905401|NCT02344576|617656095|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
170905402|NCT02344576|617656092|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
170905403|NCT02344576|617656093|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
170905404|NCT02344576|617656094|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
170905405|NCT02344576|617656095|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
170905406|NCT02698189|617656096|FG000|Overall Study|Physician Decision|3|||
170905407|NCT02698189|617656097|FG001|Overall Study|Physician Decision|0|||
170905408|NCT02698189|617656096|FG000|Overall Study|Progressive disease|0|||
170905409|NCT02698189|617656097|FG001|Overall Study|Progressive disease|5|||
170905410|NCT02698189|617656096|FG000|Overall Study|Study terminated by sponsor|0|||
170905411|NCT02698189|617656097|FG001|Overall Study|Study terminated by sponsor|1|||
170905412|NCT02240706|617656098|FG000|Overall Study|Lack of Efficacy|2|||
170905413|NCT02240706|617656099|FG001|Overall Study|Lack of Efficacy|2|||
170905414|NCT02240706|617656100|FG002|Overall Study|Lack of Efficacy|2|||
170905415|NCT02240706|617656101|FG003|Overall Study|Lack of Efficacy|2|||
170905416|NCT02240706|617656102|FG004|Overall Study|Lack of Efficacy|5|||
170905417|NCT02240706|617656103|FG005|Overall Study|Lack of Efficacy|0|||
170905418|NCT02240706|617656104|FG006|Overall Study|Lack of Efficacy|0|||
170905419|NCT02240706|617656098|FG000|Overall Study|Adverse Event|1|||
170905420|NCT02240706|617656099|FG001|Overall Study|Adverse Event|0|||
170905421|NCT02240706|617656100|FG002|Overall Study|Adverse Event|1|||
170905422|NCT02240706|617656101|FG003|Overall Study|Adverse Event|0|||
170905423|NCT02240706|617656102|FG004|Overall Study|Adverse Event|2|||
170905424|NCT02240706|617656103|FG005|Overall Study|Adverse Event|0|||
170905425|NCT02240706|617656104|FG006|Overall Study|Adverse Event|0|||
170905426|NCT02240706|617656098|FG000|Overall Study|Progressive disease|0|||
170905427|NCT02240706|617656099|FG001|Overall Study|Progressive disease|0|||
170905428|NCT02240706|617656100|FG002|Overall Study|Progressive disease|0|||
170905429|NCT02240706|617656101|FG003|Overall Study|Progressive disease|0|||
170905430|NCT02240706|617656102|FG004|Overall Study|Progressive disease|1|||
170905431|NCT02240706|617656103|FG005|Overall Study|Progressive disease|0|||
170905432|NCT02240706|617656104|FG006|Overall Study|Progressive disease|0|||
170562382|NCT02082977|616405202|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
170562383|NCT02082977|616405203|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
170562384|NCT02082977|616405204|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
170562385|NCT02082977|616405205|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
170562386|NCT02082977|616405206|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
170562387|NCT02082977|616405207|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
170562388|NCT02082977|616405208|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
170562389|NCT02082977|616405209|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
170562390|NCT02082977|616405210|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
170562391|NCT02082977|616405201|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170399323|NCT03193190|615799948|FG011|Stage 1|Progressive Disease|0|||
170562392|NCT02082977|616405202|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170562393|NCT02082977|616405203|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170562394|NCT02082977|616405204|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170562395|NCT02082977|616405205|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170562396|NCT02082977|616405206|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170562397|NCT02082977|616405207|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170905433|NCT02240706|617656098|FG000|Overall Study|Dose limiting toxicity|0|||
170905434|NCT02240706|617656099|FG001|Overall Study|Dose limiting toxicity|0|||
170905435|NCT02240706|617656100|FG002|Overall Study|Dose limiting toxicity|0|||
170905436|NCT02240706|617656101|FG003|Overall Study|Dose limiting toxicity|0|||
170905437|NCT02240706|617656102|FG004|Overall Study|Dose limiting toxicity|1|||
170905438|NCT02240706|617656103|FG005|Overall Study|Dose limiting toxicity|0|||
170905439|NCT02240706|617656104|FG006|Overall Study|Dose limiting toxicity|0|||
170905440|NCT02240706|617656098|FG000|Overall Study|Refused to continue taking medication|0|||
170905441|NCT02240706|617656099|FG001|Overall Study|Refused to continue taking medication|1|||
170905442|NCT02240706|617656100|FG002|Overall Study|Refused to continue taking medication|3|||
170905443|NCT02240706|617656101|FG003|Overall Study|Refused to continue taking medication|1|||
170905444|NCT02240706|617656102|FG004|Overall Study|Refused to continue taking medication|2|||
170562398|NCT02082977|616405208|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
170562399|NCT02082977|616405209|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170562400|NCT02082977|616405210|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
170562401|NCT02082977|616405201|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562402|NCT02082977|616405202|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562403|NCT02082977|616405203|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562404|NCT02082977|616405204|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562405|NCT02082977|616405205|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562406|NCT02082977|616405206|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
170562407|NCT02082977|616405207|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562408|NCT02082977|616405208|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562409|NCT02082977|616405209|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562410|NCT02082977|616405210|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
170562411|NCT02082977|616405201|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
170562412|NCT02082977|616405202|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
170562413|NCT02082977|616405203|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
170562414|NCT02082977|616405204|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
170562415|NCT02082977|616405205|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
170562416|NCT02082977|616405206|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
170562417|NCT02082977|616405207|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
170562418|NCT02082977|616405208|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
170562419|NCT02082977|616405209|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
170562420|NCT02082977|616405210|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
170562421|NCT02082977|616405201|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562422|NCT02082977|616405202|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562423|NCT02082977|616405203|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562424|NCT02082977|616405204|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562425|NCT02082977|616405205|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562426|NCT02082977|616405206|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562427|NCT02082977|616405207|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562428|NCT02082977|616405208|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
170562429|NCT02082977|616405209|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562430|NCT02082977|616405210|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
170562431|NCT00049543|616405211|FG000|Overall Study|still on treatment|2|||
170562432|NCT00049543|616405212|FG001|Overall Study|still on treatment|9|||
170562433|NCT02106832|616405213|FG000|Overall Study|Adverse Event|1|||
170562434|NCT02106832|616405214|FG001|Overall Study|Adverse Event|2|||
170562435|NCT02106832|616405215|FG002|Overall Study|Adverse Event|3|||
170562436|NCT02106832|616405216|FG003|Overall Study|Adverse Event|0|||
170562437|NCT02106832|616405213|FG000|Overall Study|Death|4|||
170905445|NCT02240706|617656103|FG005|Overall Study|Refused to continue taking medication|0|||
170905446|NCT02240706|617656104|FG006|Overall Study|Refused to continue taking medication|0|||
170905447|NCT02240706|617656098|FG000|Overall Study|Insurance billing concerns|0|||
170905448|NCT02240706|617656099|FG001|Overall Study|Insurance billing concerns|0|||
170905449|NCT02240706|617656100|FG002|Overall Study|Insurance billing concerns|0|||
170905450|NCT02240706|617656101|FG003|Overall Study|Insurance billing concerns|1|||
170905451|NCT02240706|617656102|FG004|Overall Study|Insurance billing concerns|0|||
170905452|NCT02240706|617656103|FG005|Overall Study|Insurance billing concerns|0|||
170905453|NCT02240706|617656104|FG006|Overall Study|Insurance billing concerns|0|||
170905454|NCT03301857|617656105|FG000|Overall Study|Death|0|||
170905455|NCT03301857|617656106|FG001|Overall Study|Death|2|||
170905456|NCT03301857|617656105|FG000|Overall Study|Lost to Follow-up|4|||
170905457|NCT03301857|617656106|FG001|Overall Study|Lost to Follow-up|2|||
170905458|NCT03301857|617656105|FG000|Overall Study|Decision by Sponsor|6|||
170905459|NCT03301857|617656106|FG001|Overall Study|Decision by Sponsor|0|||
170905460|NCT03301857|617656105|FG000|Overall Study|Withdrawal by Subject|12|||
170905461|NCT03301857|617656106|FG001|Overall Study|Withdrawal by Subject|4|||
170905462|NCT00702143|617656124|FG000|Overall Study|Lost to Follow-up|0|||
170905463|NCT00702143|617656125|FG001|Overall Study|Lost to Follow-up|0|||
170562438|NCT02106832|616405214|FG001|Overall Study|Death|4|||
170562439|NCT02106832|616405215|FG002|Overall Study|Death|1|||
170562440|NCT02106832|616405216|FG003|Overall Study|Death|4|||
170905464|NCT00702143|617656126|FG002|Overall Study|Lost to Follow-up|1|||
170562441|NCT02106832|616405213|FG000|Overall Study|Deterioration of general conditions|0|||
170562442|NCT02106832|616405214|FG001|Overall Study|Deterioration of general conditions|0|||
170905465|NCT04091217|617656127|FG000|Overall Study|Lost to Follow-up|2|||
170905466|NCT02495948|617656128|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
170905467|NCT02495948|617656129|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
170905468|NCT02495948|617656128|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
170905469|NCT02495948|617656129|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
170905470|NCT00100048|617656130|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
170905471|NCT00100048|617656131|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
170905472|NCT00100048|617656132|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
170905473|NCT00100048|617656133|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
170905474|NCT00100048|617656134|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
170905475|NCT00100048|617656135|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
170905476|NCT00100048|617656130|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
170905477|NCT00100048|617656131|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
170905478|NCT00100048|617656132|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
170905479|NCT00100048|617656133|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
170905480|NCT00100048|617656134|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
170905481|NCT00100048|617656135|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
170905482|NCT00100048|617656130|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
170905483|NCT00100048|617656131|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
170905484|NCT00100048|617656132|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
170905485|NCT00100048|617656133|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
170905486|NCT00100048|617656134|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
170905487|NCT00100048|617656135|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
170905488|NCT00100048|617656130|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
170905489|NCT00100048|617656131|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
170905490|NCT00100048|617656132|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
170905491|NCT00100048|617656133|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
170905492|NCT00100048|617656134|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
170905493|NCT00100048|617656135|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
170905494|NCT00100048|617656130|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
170905495|NCT00100048|617656131|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
170905496|NCT00100048|617656132|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
170905497|NCT00100048|617656133|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
170905498|NCT00100048|617656134|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
170905499|NCT00100048|617656135|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
170905500|NCT00100048|617656130|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
170905501|NCT00100048|617656131|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
170905502|NCT00100048|617656132|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
170905503|NCT00100048|617656133|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
170905504|NCT00100048|617656134|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
170905505|NCT00100048|617656135|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
170905506|NCT00100048|617656130|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
170905507|NCT00100048|617656131|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
170905508|NCT00100048|617656132|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
170905509|NCT00100048|617656133|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
170905510|NCT00100048|617656134|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
170905511|NCT00100048|617656135|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
170905512|NCT00100048|617656130|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
170905513|NCT00100048|617656131|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
170562443|NCT02106832|616405215|FG002|Overall Study|Deterioration of general conditions|1|||
170562444|NCT02106832|616405216|FG003|Overall Study|Deterioration of general conditions|0|||
170562445|NCT02106832|616405213|FG000|Overall Study|Lost to Follow-up|0|||
170905514|NCT00100048|617656132|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
170905515|NCT00100048|617656133|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
170905516|NCT00100048|617656134|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
170905517|NCT00100048|617656135|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
170905518|NCT00667277|617656136|FG000|Overall Study|Withdrawal by Subject|2|||
170905519|NCT04885257|617656143|FG000|Overall Study|Withdrawal by Subject|1|||
170905520|NCT04885257|617656144|FG001|Overall Study|Withdrawal by Subject|0|||
170905521|NCT00686543|617656145|FG000|Overall Study|Adverse Event|9|||
170905522|NCT00686543|617656146|FG001|Overall Study|Adverse Event|1|||
170905523|NCT00686543|617656147|FG002|Overall Study|Adverse Event|3|||
170905524|NCT00686543|617656148|FG003|Overall Study|Adverse Event|2|||
170905525|NCT00686543|617656145|FG000|Overall Study|Withdrawal by Subject|2|||
170905526|NCT00686543|617656146|FG001|Overall Study|Withdrawal by Subject|0|||
170905527|NCT00686543|617656147|FG002|Overall Study|Withdrawal by Subject|0|||
170905528|NCT00686543|617656148|FG003|Overall Study|Withdrawal by Subject|0|||
170905529|NCT00686543|617656145|FG000|Overall Study|Protocol Violation|3|||
170905530|NCT00686543|617656146|FG001|Overall Study|Protocol Violation|0|||
170905531|NCT00686543|617656147|FG002|Overall Study|Protocol Violation|2|||
170562446|NCT02106832|616405214|FG001|Overall Study|Lost to Follow-up|1|||
170562447|NCT02106832|616405215|FG002|Overall Study|Lost to Follow-up|1|||
170562448|NCT02106832|616405216|FG003|Overall Study|Lost to Follow-up|3|||
170562449|NCT02106832|616405213|FG000|Overall Study|Physician Decision|1|||
170562450|NCT02106832|616405214|FG001|Overall Study|Physician Decision|0|||
170562451|NCT02106832|616405215|FG002|Overall Study|Physician Decision|0|||
170562452|NCT02106832|616405216|FG003|Overall Study|Physician Decision|0|||
170562453|NCT02106832|616405213|FG000|Overall Study|Protocol Violation|0|||
170562454|NCT02106832|616405214|FG001|Overall Study|Protocol Violation|0|||
170562455|NCT02106832|616405215|FG002|Overall Study|Protocol Violation|0|||
170562456|NCT02106832|616405216|FG003|Overall Study|Protocol Violation|1|||
170562457|NCT02106832|616405213|FG000|Overall Study|Withdrawal by Subject|17|||
170562458|NCT02106832|616405214|FG001|Overall Study|Withdrawal by Subject|17|||
170562459|NCT02106832|616405215|FG002|Overall Study|Withdrawal by Subject|10|||
170562460|NCT02106832|616405216|FG003|Overall Study|Withdrawal by Subject|7|||
170562461|NCT02106832|616405213|FG000|Overall Study|Technical problems|0|||
170562462|NCT02106832|616405214|FG001|Overall Study|Technical problems|1|||
170562463|NCT02106832|616405215|FG002|Overall Study|Technical problems|0|||
170562464|NCT02106832|616405216|FG003|Overall Study|Technical problems|0|||
170562465|NCT04716894|616405241|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
170562466|NCT04716894|616405241|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
170562467|NCT04724837|616405244|FG000|Overall Study|Other|4|||
170562468|NCT04724837|616405245|FG001|Overall Study|Other|16|||
170562469|NCT04724837|616405246|FG002|Overall Study|Other|0|||
170562470|NCT04724837|616405244|FG000|Overall Study|Withdrawal by Subject|2|||
170562471|NCT04724837|616405245|FG001|Overall Study|Withdrawal by Subject|9|||
170562472|NCT04724837|616405246|FG002|Overall Study|Withdrawal by Subject|9|||
170562473|NCT04724837|616405244|FG000|Overall Study|Adverse Event|2|||
170562474|NCT04724837|616405245|FG001|Overall Study|Adverse Event|7|||
170562475|NCT04724837|616405246|FG002|Overall Study|Adverse Event|4|||
170562476|NCT04724837|616405244|FG000|Overall Study|Lost to Follow-up|0|||
170562477|NCT04724837|616405245|FG001|Overall Study|Lost to Follow-up|1|||
170905532|NCT00686543|617656148|FG003|Overall Study|Protocol Violation|1|||
170905533|NCT01053429|617656149|FG000|Overall Study|Adverse Event|64|||
170905534|NCT01053429|617656149|FG000|Overall Study|Other|309|||
170562478|NCT04724837|616405246|FG002|Overall Study|Lost to Follow-up|3|||
170562479|NCT04724837|616405244|FG000|Overall Study|Physician Decision|1|||
170562480|NCT04724837|616405245|FG001|Overall Study|Physician Decision|2|||
170562481|NCT04724837|616405246|FG002|Overall Study|Physician Decision|0|||
170562482|NCT04724837|616405244|FG000|Overall Study|Death|0|||
170905535|NCT00538681|617656150|FG000|Overall Study|Progressive Disease|7|||
170905536|NCT00538681|617656151|FG001|Overall Study|Progressive Disease|0|||
170562483|NCT04724837|616405245|FG001|Overall Study|Death|0|||
170562484|NCT04724837|616405246|FG002|Overall Study|Death|1|||
170562485|NCT04724837|616405244|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
170562486|NCT04724837|616405245|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
170562487|NCT04724837|616405246|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
170562488|NCT04724837|616405244|FG000|Overall Study|Study Terminated by Sponsor|0|||
170562489|NCT04724837|616405245|FG001|Overall Study|Study Terminated by Sponsor|1|||
170562490|NCT04724837|616405246|FG002|Overall Study|Study Terminated by Sponsor|0|||
170562491|NCT00522379|616405247|FG000|Overall Study|Adverse Event|12|||
170562492|NCT00522379|616405248|FG001|Overall Study|Adverse Event|15|||
170562493|NCT00522379|616405249|FG002|Overall Study|Adverse Event|12|||
170562494|NCT00522379|616405250|FG003|Overall Study|Adverse Event|5|||
170562495|NCT00522379|616405251|FG004|Overall Study|Adverse Event|17|||
170562496|NCT00522379|616405247|FG000|Overall Study|Lack of Efficacy|3|||
170562497|NCT00522379|616405248|FG001|Overall Study|Lack of Efficacy|0|||
170562498|NCT00522379|616405249|FG002|Overall Study|Lack of Efficacy|2|||
170562499|NCT00522379|616405250|FG003|Overall Study|Lack of Efficacy|2|||
170562500|NCT00522379|616405251|FG004|Overall Study|Lack of Efficacy|7|||
170562501|NCT00522379|616405247|FG000|Overall Study|Withdrawal by Subject|2|||
170562502|NCT00522379|616405248|FG001|Overall Study|Withdrawal by Subject|3|||
170562503|NCT00522379|616405249|FG002|Overall Study|Withdrawal by Subject|1|||
170562504|NCT00522379|616405250|FG003|Overall Study|Withdrawal by Subject|2|||
170562505|NCT00522379|616405251|FG004|Overall Study|Withdrawal by Subject|0|||
170562506|NCT00522379|616405247|FG000|Overall Study|Protocol Violation|1|||
170562507|NCT00522379|616405248|FG001|Overall Study|Protocol Violation|1|||
170562508|NCT00522379|616405249|FG002|Overall Study|Protocol Violation|2|||
170562509|NCT00522379|616405250|FG003|Overall Study|Protocol Violation|0|||
170562510|NCT00522379|616405251|FG004|Overall Study|Protocol Violation|0|||
170562511|NCT00522379|616405247|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
170562512|NCT00522379|616405248|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
170905537|NCT00538681|617656152|FG002|Overall Study|Progressive Disease|1|||
170905538|NCT00538681|617656153|FG003|Overall Study|Progressive Disease|0|||
170905539|NCT00538681|617656150|FG000|Overall Study|Sponsor Decision|1|||
170905540|NCT00538681|617656151|FG001|Overall Study|Sponsor Decision|3|||
170905541|NCT00538681|617656152|FG002|Overall Study|Sponsor Decision|8|||
170905542|NCT00538681|617656153|FG003|Overall Study|Sponsor Decision|9|||
170905543|NCT00538681|617656150|FG000|Overall Study|Adverse Event|1|||
170905544|NCT00538681|617656151|FG001|Overall Study|Adverse Event|1|||
170905545|NCT00538681|617656152|FG002|Overall Study|Adverse Event|1|||
170905546|NCT00538681|617656153|FG003|Overall Study|Adverse Event|0|||
170905547|NCT00538681|617656150|FG000|Overall Study|Death|0|||
170905548|NCT00538681|617656151|FG001|Overall Study|Death|0|||
170905549|NCT00538681|617656152|FG002|Overall Study|Death|1|||
170905550|NCT00538681|617656153|FG003|Overall Study|Death|1|||
170905551|NCT00538681|617656150|FG000|Overall Study|Investigator Decision|0|||
170905552|NCT00538681|617656151|FG001|Overall Study|Investigator Decision|0|||
170905553|NCT00538681|617656152|FG002|Overall Study|Investigator Decision|0|||
170905554|NCT00538681|617656153|FG003|Overall Study|Investigator Decision|1|||
170905555|NCT02382133|617656156|FG000|Overall Study|Death|22|||
170905556|NCT02382133|617656156|FG000|Overall Study|transfer out of ICU|4|||
170905557|NCT02382133|617656156|FG000|Overall Study|Physician Decision|2|||
170905558|NCT02382133|617656156|FG000|Overall Study|arterial catheter loss|4|||
170905559|NCT02382133|617656156|FG000|Overall Study|pressure injury both sites|1|||
170562513|NCT00522379|616405249|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
170562514|NCT00522379|616405250|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
170562515|NCT00522379|616405251|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
170562516|NCT00522379|616405247|FG000|Overall Study|Lost to Follow-up|1|||
170562517|NCT00522379|616405248|FG001|Overall Study|Lost to Follow-up|0|||
170562518|NCT00522379|616405249|FG002|Overall Study|Lost to Follow-up|4|||
170562519|NCT00522379|616405250|FG003|Overall Study|Lost to Follow-up|2|||
170562520|NCT00522379|616405251|FG004|Overall Study|Lost to Follow-up|2|||
170562521|NCT00522379|616405247|FG000|Overall Study|Randomization error|0|||
170562522|NCT00522379|616405248|FG001|Overall Study|Randomization error|0|||
170562523|NCT00522379|616405249|FG002|Overall Study|Randomization error|0|||
170562524|NCT00522379|616405250|FG003|Overall Study|Randomization error|0|||
170562525|NCT00522379|616405251|FG004|Overall Study|Randomization error|1|||
170562526|NCT00522379|616405247|FG000|Overall Study|Dispensing error|1|||
170905560|NCT01976806|617656158|FG000|Overall Study|Lost to Follow-up|1|||
170905561|NCT01976806|617656159|FG001|Overall Study|Lost to Follow-up|4|||
170905562|NCT01976806|617656158|FG000|Overall Study|Adverse Event|1|||
170905563|NCT01976806|617656159|FG001|Overall Study|Adverse Event|1|||
170905564|NCT01976806|617656158|FG000|Overall Study|Withdrawal by Subject|1|||
170905565|NCT01976806|617656159|FG001|Overall Study|Withdrawal by Subject|1|||
170399324|NCT03193190|615799949|FG012|Stage 1|Progressive Disease|0|||
170562527|NCT00522379|616405248|FG001|Overall Study|Dispensing error|0|||
170562528|NCT00522379|616405249|FG002|Overall Study|Dispensing error|0|||
170562529|NCT00522379|616405250|FG003|Overall Study|Dispensing error|1|||
170562530|NCT00522379|616405251|FG004|Overall Study|Dispensing error|0|||
170905566|NCT04429022|617656166|FG000|Overall Study|Protocol Violation|18|||
170905567|NCT04429022|617656167|FG001|Overall Study|Protocol Violation|1|||
170905568|NCT04321343|617656168|FG000|Overall Study|Adverse Event|0|||
170905569|NCT04321343|617656169|FG001|Overall Study|Adverse Event|0|||
170905570|NCT04321343|617656170|FG002|Overall Study|Adverse Event|1|||
170905571|NCT04321343|617656171|FG003|Overall Study|Adverse Event|0|||
170905572|NCT04321343|617656168|FG000|Overall Study|Death|0|||
170905573|NCT04321343|617656169|FG001|Overall Study|Death|0|||
170905574|NCT04321343|617656170|FG002|Overall Study|Death|0|||
170905575|NCT04321343|617656171|FG003|Overall Study|Death|1|||
170905576|NCT04321343|617656168|FG000|Overall Study|Pregnancy|1|||
170905577|NCT04321343|617656169|FG001|Overall Study|Pregnancy|0|||
170905578|NCT04321343|617656170|FG002|Overall Study|Pregnancy|0|||
170905579|NCT04321343|617656171|FG003|Overall Study|Pregnancy|0|||
170905580|NCT04321343|617656168|FG000|Overall Study|Protocol Violation|1|||
170905581|NCT04321343|617656169|FG001|Overall Study|Protocol Violation|1|||
170905582|NCT04321343|617656170|FG002|Overall Study|Protocol Violation|1|||
170905583|NCT04321343|617656171|FG003|Overall Study|Protocol Violation|1|||
170905584|NCT04321343|617656168|FG000|Overall Study|Withdrawal by Subject|0|||
170562531|NCT00522379|616405247|FG000|Overall Study|Subject Moved|1|||
170562532|NCT00522379|616405248|FG001|Overall Study|Subject Moved|1|||
170562533|NCT00522379|616405249|FG002|Overall Study|Subject Moved|0|||
170562534|NCT00522379|616405250|FG003|Overall Study|Subject Moved|0|||
170562535|NCT00522379|616405251|FG004|Overall Study|Subject Moved|0|||
170562536|NCT00522379|616405247|FG000|Overall Study|Sponsor Request|0|||
170562537|NCT00522379|616405248|FG001|Overall Study|Sponsor Request|1|||
170562538|NCT00522379|616405249|FG002|Overall Study|Sponsor Request|0|||
170562539|NCT00522379|616405250|FG003|Overall Study|Sponsor Request|0|||
170562540|NCT00522379|616405251|FG004|Overall Study|Sponsor Request|0|||
170562541|NCT00522379|616405247|FG000|Overall Study|Family Problem|0|||
170562542|NCT00522379|616405248|FG001|Overall Study|Family Problem|0|||
170562543|NCT00522379|616405249|FG002|Overall Study|Family Problem|1|||
170562544|NCT00522379|616405250|FG003|Overall Study|Family Problem|0|||
170562545|NCT00522379|616405251|FG004|Overall Study|Family Problem|0|||
170562546|NCT00522379|616405247|FG000|Overall Study|Site Closed|0|||
170562547|NCT00522379|616405248|FG001|Overall Study|Site Closed|0|||
170562548|NCT00522379|616405249|FG002|Overall Study|Site Closed|0|||
170562549|NCT00522379|616405250|FG003|Overall Study|Site Closed|1|||
170562550|NCT00522379|616405251|FG004|Overall Study|Site Closed|0|||
170562551|NCT00522379|616405247|FG000|Overall Study|Subject Withdrawal|0|||
170562552|NCT00522379|616405248|FG001|Overall Study|Subject Withdrawal|0|||
170562553|NCT00522379|616405249|FG002|Overall Study|Subject Withdrawal|0|||
170562554|NCT00522379|616405250|FG003|Overall Study|Subject Withdrawal|1|||
170562555|NCT00522379|616405251|FG004|Overall Study|Subject Withdrawal|0|||
170562556|NCT04222673|616405252|FG000|Overall Study|Lost to Follow-up|5|||
170562557|NCT03213509|616405264|FG000|Overall Study|Did not consent for verbal autopsy|4|||
170562558|NCT03213509|616405265|FG001|Overall Study|Did not consent for verbal autopsy|5|||
170562559|NCT03620981|616405266|FG000|Overall Study|Adverse Event|14|||
170562560|NCT03620981|616405267|FG001|Overall Study|Adverse Event|38|||
170562561|NCT03620981|616405268|FG002|Overall Study|Adverse Event|25|||
170562562|NCT03620981|616405266|FG000|Overall Study|Lack of Efficacy|2|||
170562563|NCT03620981|616405267|FG001|Overall Study|Lack of Efficacy|1|||
170562564|NCT03620981|616405268|FG002|Overall Study|Lack of Efficacy|1|||
170562565|NCT03620981|616405266|FG000|Overall Study|Physician Decision|7|||
170562566|NCT03620981|616405267|FG001|Overall Study|Physician Decision|4|||
170562567|NCT03620981|616405268|FG002|Overall Study|Physician Decision|4|||
170562568|NCT03620981|616405266|FG000|Overall Study|Protocol Violation|1|||
170562569|NCT03620981|616405267|FG001|Overall Study|Protocol Violation|2|||
170562570|NCT03620981|616405268|FG002|Overall Study|Protocol Violation|1|||
170562571|NCT03620981|616405266|FG000|Overall Study|Withdrawal by Legal Representative|2|||
170562572|NCT03620981|616405267|FG001|Overall Study|Withdrawal by Legal Representative|1|||
170562573|NCT03620981|616405268|FG002|Overall Study|Withdrawal by Legal Representative|1|||
170562574|NCT03620981|616405266|FG000|Overall Study|Withdrawal by Care Giver|2|||
170562575|NCT03620981|616405267|FG001|Overall Study|Withdrawal by Care Giver|0|||
170562576|NCT03620981|616405268|FG002|Overall Study|Withdrawal by Care Giver|1|||
170562577|NCT03620981|616405266|FG000|Overall Study|Non-compliance with Study Drug|1|||
170562578|NCT03620981|616405267|FG001|Overall Study|Non-compliance with Study Drug|1|||
170562579|NCT03620981|616405268|FG002|Overall Study|Non-compliance with Study Drug|0|||
170562580|NCT05552859|616405275|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
170905585|NCT04321343|617656169|FG001|Overall Study|Withdrawal by Subject|6|||
170399325|NCT03193190|615799950|FG013|Stage 1|Progressive Disease|0|||
170562581|NCT05552859|616405276|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
170562582|NCT01380080|616405277|FG000|Overall Study|Death|36|||
170562583|NCT01380080|616405278|FG001|Overall Study|Death|44|||
170562584|NCT01380080|616405277|FG000|Overall Study|Site is closing|28|||
170645590|NCT01185353|616715973|FG001|Part C (Weeks 24 Through 76)|Death|0|||
170562585|NCT01380080|616405278|FG001|Overall Study|Site is closing|31|||
170905586|NCT04321343|617656170|FG002|Overall Study|Withdrawal by Subject|0|||
170905587|NCT04321343|617656171|FG003|Overall Study|Withdrawal by Subject|2|||
170905588|NCT04321343|617656168|FG000|Overall Study|Lost to Follow-up|2|||
170562586|NCT01380080|616405277|FG000|Overall Study|Not able to get to clinic|7|||
170562587|NCT01380080|616405278|FG001|Overall Study|Not able to get to clinic|1|||
170562588|NCT01380080|616405277|FG000|Overall Study|Not willing to adhere to requirements|6|||
170562589|NCT01380080|616405278|FG001|Overall Study|Not willing to adhere to requirements|2|||
170562590|NCT01380080|616405277|FG000|Overall Study|Withdrawal by Subject|5|||
170562591|NCT01380080|616405278|FG001|Overall Study|Withdrawal by Subject|2|||
170562592|NCT01380080|616405277|FG000|Overall Study|Lost to Follow-up|3|||
170562593|NCT01380080|616405278|FG001|Overall Study|Lost to Follow-up|3|||
170562594|NCT00210132|616405279|FG000|Overall Study|Protocol Violation|1|||
170562595|NCT00210132|616405280|FG001|Overall Study|Protocol Violation|4|||
170562596|NCT02711202|616405281|FG000|Overall Study|Adverse Event|3|||
170562597|NCT02711202|616405282|FG001|Overall Study|Adverse Event|0|||
170562598|NCT02711202|616405281|FG000|Overall Study|graft loss|1|||
170562599|NCT02711202|616405282|FG001|Overall Study|graft loss|0|||
170562600|NCT02402647|616405283|FG000|Overall Study|Lost to Follow-up|13|||
170562601|NCT02402647|616405284|FG001|Overall Study|Lost to Follow-up|7|||
170562602|NCT02402647|616405283|FG000|Overall Study|Protocol Violation|1|||
170562603|NCT02402647|616405284|FG001|Overall Study|Protocol Violation|1|||
170562604|NCT02402647|616405283|FG000|Overall Study|scheduled and timed out|2|||
170562605|NCT02402647|616405284|FG001|Overall Study|scheduled and timed out|1|||
170562606|NCT02402647|616405283|FG000|Overall Study|medical illness|2|||
170562607|NCT02402647|616405284|FG001|Overall Study|medical illness|4|||
170562608|NCT02402647|616405283|FG000|Overall Study|Moved|2|||
170562609|NCT02402647|616405284|FG001|Overall Study|Moved|0|||
170562610|NCT02402647|616405283|FG000|Overall Study|loved one illness|1|||
170562611|NCT02402647|616405284|FG001|Overall Study|loved one illness|0|||
170562612|NCT02402647|616405283|FG000|Overall Study|deceased preexisting condition|2|||
170562613|NCT02402647|616405284|FG001|Overall Study|deceased preexisting condition|0|||
170562614|NCT02402647|616405283|FG000|Overall Study|Other|2|||
170562615|NCT02402647|616405284|FG001|Overall Study|Other|1|||
170562616|NCT01889251|616405285|FG000|Overall Study|Adverse Event|1|||
170562617|NCT01889251|616405286|FG001|Overall Study|Adverse Event|0|||
170562618|NCT01344226|616405287|FG000|Overall Study|Protocol Violation|2|||
170562619|NCT01344226|616405287|FG000|Overall Study|Withdrawal by Subject|3|||
170562620|NCT01344226|616405287|FG000|Overall Study|Lack of Efficacy|3|||
170562621|NCT02255656|616405290|FG000|Overall Study|Adverse Event|11|||
170562622|NCT02255656|616405290|FG000|Overall Study|Poor compliance to protocol|3|||
170562623|NCT02255656|616405290|FG000|Overall Study|Lost to Follow-up|30|||
170562624|NCT02255656|616405290|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
170562625|NCT02255656|616405290|FG000|Overall Study|Other|126|||
170562626|NCT03612570|616405294|FG000|Overall Study|Lost to Follow-up|1|||
170562627|NCT04144517|616405297|FG000|Overall Study|Physician Decision|0|||
170562628|NCT04144517|616405298|FG001|Overall Study|Physician Decision|1|||
170562629|NCT04144517|616405297|FG000|Overall Study|Other|2|||
170562630|NCT04144517|616405298|FG001|Overall Study|Other|2|||
170905589|NCT04321343|617656169|FG001|Overall Study|Lost to Follow-up|2|||
170905590|NCT04321343|617656170|FG002|Overall Study|Lost to Follow-up|1|||
170905591|NCT04321343|617656171|FG003|Overall Study|Lost to Follow-up|3|||
170905592|NCT00045032|617656176|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
170905593|NCT00045032|617656177|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
170399326|NCT03193190|615799951|FG014|Stage 1|Progressive Disease|0|||
170562631|NCT04144517|616405297|FG000|Overall Study|Death|6|||
170562632|NCT04144517|616405298|FG001|Overall Study|Death|3|||
170562633|NCT02757768|616405300|FG000|Overall Study|Randomized Never Received Study Drug|3|||
170562634|NCT02757768|616405301|FG001|Overall Study|Randomized Never Received Study Drug|4|||
170562635|NCT02757768|616405300|FG000|Overall Study|Adverse Event|5|||
170562636|NCT02757768|616405301|FG001|Overall Study|Adverse Event|3|||
170562637|NCT02757768|616405300|FG000|Overall Study|Lack of Efficacy|2|||
170562638|NCT02757768|616405301|FG001|Overall Study|Lack of Efficacy|1|||
170562639|NCT02757768|616405300|FG000|Overall Study|Lost to Follow-up|1|||
170562640|NCT02757768|616405301|FG001|Overall Study|Lost to Follow-up|0|||
170562641|NCT02757768|616405300|FG000|Overall Study|Protocol Deviation|2|||
170562642|NCT02757768|616405301|FG001|Overall Study|Protocol Deviation|9|||
170562643|NCT02757768|616405300|FG000|Overall Study|Withdrawal by Subject|16|||
170562644|NCT02757768|616405301|FG001|Overall Study|Withdrawal by Subject|9|||
170562645|NCT02757768|616405300|FG000|Overall Study|Miscellaneous|4|||
170562646|NCT02757768|616405301|FG001|Overall Study|Miscellaneous|2|||
170562647|NCT00835367|616405313|FG000|Washout|Adverse Event|2|||
170562648|NCT00835367|616405314|FG001|Washout|Adverse Event|0|||
170562649|NCT00835367|616405313|FG000|Washout|Withdrawal by Subject|1|||
170562650|NCT00835367|616405314|FG001|Washout|Withdrawal by Subject|0|||
170562651|NCT00835367|616405313|FG000|Second Intervention|Adverse Event|1|||
170562652|NCT00835367|616405314|FG001|Second Intervention|Adverse Event|1|||
170562653|NCT05929326|616405315|FG000|Overall Study|unqualified sample|2|||
170562654|NCT05929326|616405316|FG001|Overall Study|unqualified sample|3|||
170562655|NCT05929326|616405317|FG002|Overall Study|unqualified sample|7|||
170562656|NCT00835172|616405318|FG000|Washout|Protocol Violation|0|||
170562657|NCT00835172|616405319|FG001|Washout|Protocol Violation|1|||
170562658|NCT05212168|616405329|FG000|Overall Study|Lost to Follow-up|0|||
170562659|NCT05212168|616405330|FG001|Overall Study|Lost to Follow-up|3|||
170562660|NCT05212168|616405329|FG000|Overall Study|Study terminated by sponsor|30|||
170562661|NCT05212168|616405330|FG001|Overall Study|Study terminated by sponsor|27|||
170562662|NCT05212168|616405329|FG000|Overall Study|Other|4|||
170562663|NCT05212168|616405330|FG001|Overall Study|Other|7|||
170562664|NCT02333799|616406939|FG000|Treatment Period|Withdrawal by Subject|1|||
170562665|NCT02333799|616406939|FG000|Treatment Period|Death|6|||
170562666|NCT02333799|616406939|FG000|6 Month Follow Up Period|Physician Decision|1|||
170562667|NCT02333799|616406939|FG000|6 Month Follow Up Period|Death|1|||
170562668|NCT02333799|616406939|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
170562669|NCT02333799|616406939|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
170562670|NCT05847686|616406940|FG000|Overall Study|Withdrawal by Subject|3|||
170562671|NCT03716830|616406941|FG000|Overall Study|Withdrawal by Subject|2|||
170562672|NCT03716830|616406942|FG001|Overall Study|Withdrawal by Subject|2|||
170562673|NCT03716830|616406943|FG002|Overall Study|Withdrawal by Subject|6|||
170562674|NCT03716830|616406944|FG003|Overall Study|Withdrawal by Subject|5|||
170562675|NCT03716830|616406941|FG000|Overall Study|Adverse Event|1|||
170562676|NCT03716830|616406942|FG001|Overall Study|Adverse Event|2|||
170562677|NCT03716830|616406943|FG002|Overall Study|Adverse Event|0|||
170562678|NCT03716830|616406944|FG003|Overall Study|Adverse Event|1|||
170562679|NCT03716830|616406941|FG000|Overall Study|Lost to Follow-up|1|||
170562680|NCT03716830|616406942|FG001|Overall Study|Lost to Follow-up|1|||
170562681|NCT03716830|616406943|FG002|Overall Study|Lost to Follow-up|0|||
170562682|NCT03716830|616406944|FG003|Overall Study|Lost to Follow-up|0|||
170562683|NCT04696146|616406945|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
170562684|NCT04696146|616406946|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
170562685|NCT04696146|616406945|FG000|Overall Study|Off hours issue with product|1|||
170562686|NCT04696146|616406946|FG001|Overall Study|Off hours issue with product|0|||
170562687|NCT04043286|616406950|FG000|Overall Study|Withdrawal by Subject|2|||
170562688|NCT04043286|616406951|FG001|Overall Study|Withdrawal by Subject|2|||
170562689|NCT01732536|616406952|FG000|Overall Study|Withdrawal by Subject|1|||
170562690|NCT01732536|616406953|FG001|Overall Study|Withdrawal by Subject|1|||
170562691|NCT02552225|616406954|FG000|Overall Study|Withdrawal by Subject|1|||
170562692|NCT02552225|616406955|FG001|Overall Study|Withdrawal by Subject|0|||
170562693|NCT03376516|616406960|FG000|Overall Study|Not treated|1|||
170562694|NCT03376516|616406960|FG000|Overall Study|Consent withdrawn|1|||
170562695|NCT02276040|616406961|FG000|Overall Study|Physician Decision|15|||
170562696|NCT00876447|616406962|FG000|Overall Study|Other miscellaneous reasons|3|||
170562697|NCT00876447|616406963|FG001|Overall Study|Other miscellaneous reasons|8|||
170562698|NCT00876447|616406962|FG000|Overall Study|Site closure|19|||
170562699|NCT00876447|616406963|FG001|Overall Study|Site closure|14|||
170562700|NCT00876447|616406962|FG000|Overall Study|Protocol Violation|9|||
170562701|NCT00876447|616406963|FG001|Overall Study|Protocol Violation|3|||
170562702|NCT00876447|616406962|FG000|Overall Study|Personal reasons|30|||
170562703|NCT00876447|616406963|FG001|Overall Study|Personal reasons|28|||
170562704|NCT00876447|616406962|FG000|Overall Study|Lost to Follow-up|6|||
170562705|NCT00876447|616406963|FG001|Overall Study|Lost to Follow-up|15|||
170562706|NCT00876447|616406962|FG000|Overall Study|Pregnancy|4|||
170562707|NCT00876447|616406963|FG001|Overall Study|Pregnancy|2|||
170562708|NCT00876447|616406962|FG000|Overall Study|Lack of Efficacy|5|||
170562709|NCT00876447|616406963|FG001|Overall Study|Lack of Efficacy|3|||
170562710|NCT00876447|616406962|FG000|Overall Study|Adverse Event|4|||
170562711|NCT00876447|616406963|FG001|Overall Study|Adverse Event|8|||
170562712|NCT00567502|616406964|FG000|Overall Study|Lost to Follow-up|91|||
170562713|NCT00567502|616406965|FG001|Overall Study|Lost to Follow-up|14|||
170562714|NCT00567502|616406966|FG002|Overall Study|Lost to Follow-up|351|||
170562715|NCT00567502|616406967|FG003|Overall Study|Lost to Follow-up|2|||
170562716|NCT00567502|616406964|FG000|Overall Study|Death|65|||
170562717|NCT00567502|616406965|FG001|Overall Study|Death|16|||
170562718|NCT00567502|616406966|FG002|Overall Study|Death|360|||
170562719|NCT00567502|616406967|FG003|Overall Study|Death|5|||
170562720|NCT00567502|616406964|FG000|Overall Study|Other|64|||
170562721|NCT00567502|616406965|FG001|Overall Study|Other|2|||
170562722|NCT00567502|616406966|FG002|Overall Study|Other|134|||
170562723|NCT00567502|616406967|FG003|Overall Study|Other|6|||
170562724|NCT00567502|616406964|FG000|Overall Study|Participant request|12|||
170562725|NCT00567502|616406965|FG001|Overall Study|Participant request|1|||
170562726|NCT00567502|616406966|FG002|Overall Study|Participant request|33|||
170562727|NCT00567502|616406967|FG003|Overall Study|Participant request|1|||
170562728|NCT00567502|616406964|FG000|Overall Study|Sponsor request|9|||
170562729|NCT00567502|616406965|FG001|Overall Study|Sponsor request|0|||
170562730|NCT00567502|616406966|FG002|Overall Study|Sponsor request|30|||
170562731|NCT00567502|616406967|FG003|Overall Study|Sponsor request|1|||
170562732|NCT00567502|616406964|FG000|Overall Study|Never Initiated Treatment|0|||
170562733|NCT00567502|616406965|FG001|Overall Study|Never Initiated Treatment|0|||
170562734|NCT00567502|616406966|FG002|Overall Study|Never Initiated Treatment|0|||
170562735|NCT00567502|616406967|FG003|Overall Study|Never Initiated Treatment|72|||
170562736|NCT01581684|616406968|FG000|Overall Study|Other reason not defined|0|||
170562737|NCT01581684|616406969|FG001|Overall Study|Other reason not defined|0|||
170562738|NCT01581684|616406970|FG002|Overall Study|Other reason not defined|0|||
170562739|NCT01581684|616406971|FG003|Overall Study|Other reason not defined|0|||
170562740|NCT01581684|616406972|FG004|Overall Study|Other reason not defined|0|||
170562741|NCT01581684|616406973|FG005|Overall Study|Other reason not defined|0|||
170562742|NCT01581684|616406974|FG006|Overall Study|Other reason not defined|0|||
170562743|NCT01581684|616406975|FG007|Overall Study|Other reason not defined|0|||
170562744|NCT01581684|616406976|FG008|Overall Study|Other reason not defined|1|||
170562745|NCT01581684|616406977|FG009|Overall Study|Other reason not defined|0|||
170562746|NCT01359956|616406978|FG000|Overall Study|Death|58|||
170562747|NCT01359956|616406979|FG001|Overall Study|Death|60|||
170562748|NCT01359956|616406980|FG002|Overall Study|Death|66|||
170562749|NCT01359956|616406981|FG003|Overall Study|Death|57|||
170562750|NCT01359956|616406978|FG000|Overall Study|Lost to Follow-up|3|||
170562751|NCT01359956|616406979|FG001|Overall Study|Lost to Follow-up|4|||
170562752|NCT01359956|616406980|FG002|Overall Study|Lost to Follow-up|1|||
170562753|NCT01359956|616406981|FG003|Overall Study|Lost to Follow-up|1|||
170562754|NCT02835690|616406982|FG000|Overall Study|Death|12|||
170562755|NCT02835690|616406983|FG001|Overall Study|Death|11|||
170562756|NCT02835690|616406984|FG002|Overall Study|Death|13|||
170562757|NCT02835690|616406982|FG000|Overall Study|Transferred to Extension Study|2|||
170562758|NCT02835690|616406983|FG001|Overall Study|Transferred to Extension Study|2|||
170562759|NCT02835690|616406984|FG002|Overall Study|Transferred to Extension Study|1|||
170562760|NCT02835690|616406982|FG000|Overall Study|Did Not Continue on Extension Study|0|||
170562761|NCT02835690|616406983|FG001|Overall Study|Did Not Continue on Extension Study|0|||
170562762|NCT02835690|616406984|FG002|Overall Study|Did Not Continue on Extension Study|1|||
170562763|NCT02835690|616406982|FG000|Overall Study|Not Treated|0|||
170562764|NCT02835690|616406983|FG001|Overall Study|Not Treated|2|||
170562765|NCT02835690|616406984|FG002|Overall Study|Not Treated|0|||
170562766|NCT03728933|616406985|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
170562767|NCT03728933|616406986|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170562768|NCT03728933|616406987|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170562769|NCT03728933|616406985|FG000|Overall Study|Withdrawal by Subject|0|||
170562770|NCT03728933|616406986|FG001|Overall Study|Withdrawal by Subject|0|||
170562771|NCT03728933|616406987|FG002|Overall Study|Withdrawal by Subject|1|||
170562772|NCT03728933|616406985|FG000|Overall Study|Lost to Follow-up|0|||
170562773|NCT03728933|616406986|FG001|Overall Study|Lost to Follow-up|1|||
170562774|NCT03728933|616406987|FG002|Overall Study|Lost to Follow-up|0|||
170562775|NCT03728933|616406985|FG000|Overall Study|Adverse Event|1|||
170562776|NCT03728933|616406986|FG001|Overall Study|Adverse Event|0|||
170562777|NCT03728933|616406987|FG002|Overall Study|Adverse Event|0|||
170562778|NCT02297516|616406988|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
170562779|NCT02297516|616406989|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
170562780|NCT02297516|616406988|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
170562781|NCT02297516|616406989|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
170562782|NCT02297516|616406988|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
170562783|NCT02297516|616406989|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
170562784|NCT03674281|616406990|FG000|Overall Study|screen failure|2|||
170562785|NCT03674281|616406991|FG001|Overall Study|screen failure|0|||
170562786|NCT03674281|616406992|FG002|Overall Study|screen failure|0|||
170562787|NCT03674281|616406990|FG000|Overall Study|Withdrawal by Subject|1|||
170562788|NCT03674281|616406991|FG001|Overall Study|Withdrawal by Subject|3|||
170562789|NCT03674281|616406992|FG002|Overall Study|Withdrawal by Subject|3|||
170562790|NCT00710593|616406993|FG000|Overall Study|Incarceration|1|||
170562791|NCT00710593|616406994|FG001|Overall Study|Incarceration|0|||
170562792|NCT00710593|616406993|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
170562793|NCT00710593|616406994|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
170562794|NCT00710593|616406993|FG000|Overall Study|Lost to Follow-up|3|||
170562795|NCT00710593|616406994|FG001|Overall Study|Lost to Follow-up|1|||
170562796|NCT00710593|616406993|FG000|Overall Study|Moved out of area|1|||
170562797|NCT00710593|616406994|FG001|Overall Study|Moved out of area|0|||
170562798|NCT00710593|616406993|FG000|Overall Study|Failure to adhere or complete study eval|1|||
170562799|NCT00710593|616406994|FG001|Overall Study|Failure to adhere or complete study eval|1|||
170562800|NCT00710593|616406993|FG000|Overall Study|Protocol Violation|1|||
170562801|NCT00710593|616406994|FG001|Overall Study|Protocol Violation|1|||
170562802|NCT00710593|616406993|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
170562803|NCT00710593|616406994|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
170562804|NCT02538614|616406997|FG000|Overall Study|Progressive Disease|2|||
170562805|NCT00582907|616406998|FG000|1st Course|Withdrawal by Subject|1|||
170562806|NCT00582907|616406999|FG001|1st Course|Withdrawal by Subject|0|||
170562807|NCT00582907|616407000|FG002|1st Course|Withdrawal by Subject|0|||
170562808|NCT00582907|616407001|FG003|1st Course|Withdrawal by Subject|0|||
170562809|NCT00582907|616406998|FG000|1st Course|Lost to Follow-up|0|||
170562810|NCT00582907|616406999|FG001|1st Course|Lost to Follow-up|0|||
170562811|NCT00582907|616407000|FG002|1st Course|Lost to Follow-up|0|||
170562812|NCT00582907|616407001|FG003|1st Course|Lost to Follow-up|1|||
170562813|NCT00582907|616406998|FG000|2nd Course|Lack of Efficacy|1|||
170562814|NCT00582907|616406999|FG001|2nd Course|Lack of Efficacy|0|||
170562815|NCT00582907|616407000|FG002|2nd Course|Lack of Efficacy|0|||
170562816|NCT00582907|616407001|FG003|2nd Course|Lack of Efficacy|0|||
170562817|NCT00276419|616407005|FG000|First Intervention|Adverse Event|1|||
170562818|NCT00276419|616407006|FG001|First Intervention|Adverse Event|0|||
170562819|NCT00276419|616407005|FG000|First Intervention|Withdrawal by Subject|0|||
170562820|NCT00276419|616407006|FG001|First Intervention|Withdrawal by Subject|2|||
170562821|NCT04099277|616407007|FG000|Overall Study|Physician Decision|1|||
170562822|NCT04099277|616407007|FG000|Overall Study|Withdrawal by Subject|1|||
170562823|NCT00415636|616407008|FG000|Overall Study|Symptomatic deterioration|1|||
170562824|NCT00415636|616407009|FG001|Overall Study|Symptomatic deterioration|0|||
170562825|NCT00415636|616407010|FG002|Overall Study|Symptomatic deterioration|1|||
170562826|NCT00415636|616407011|FG003|Overall Study|Symptomatic deterioration|2|||
170562827|NCT00415636|616407012|FG004|Overall Study|Symptomatic deterioration|0|||
170562828|NCT00415636|616407013|FG005|Overall Study|Symptomatic deterioration|1|||
170562829|NCT00415636|616407008|FG000|Overall Study|Adverse Event|0|||
170562830|NCT00415636|616407009|FG001|Overall Study|Adverse Event|0|||
170562831|NCT00415636|616407010|FG002|Overall Study|Adverse Event|0|||
170562832|NCT00415636|616407011|FG003|Overall Study|Adverse Event|1|||
170562833|NCT00415636|616407012|FG004|Overall Study|Adverse Event|1|||
170562834|NCT00415636|616407013|FG005|Overall Study|Adverse Event|0|||
170562835|NCT00415636|616407008|FG000|Overall Study|Withdrawal by Subject|0|||
170562836|NCT00415636|616407009|FG001|Overall Study|Withdrawal by Subject|0|||
170562837|NCT00415636|616407010|FG002|Overall Study|Withdrawal by Subject|0|||
170562838|NCT00415636|616407011|FG003|Overall Study|Withdrawal by Subject|0|||
170562839|NCT00415636|616407012|FG004|Overall Study|Withdrawal by Subject|1|||
170562840|NCT00415636|616407013|FG005|Overall Study|Withdrawal by Subject|0|||
170562841|NCT00415636|616407008|FG000|Overall Study|Disease progression|0|||
170562842|NCT00415636|616407009|FG001|Overall Study|Disease progression|0|||
170562843|NCT00415636|616407010|FG002|Overall Study|Disease progression|0|||
170562844|NCT00415636|616407011|FG003|Overall Study|Disease progression|3|||
170562845|NCT00415636|616407012|FG004|Overall Study|Disease progression|0|||
170562846|NCT00415636|616407013|FG005|Overall Study|Disease progression|1|||
170562847|NCT01263119|616407014|FG000|Period 1|Protocol Violation|2|||
170562848|NCT01263119|616407014|FG000|Period 2|Adverse Event|2|||
170562849|NCT02138825|616407015|FG000|Main Study Treatment|Adverse Event|11|||
170562850|NCT02138825|616407016|FG001|Main Study Treatment|Adverse Event|3|||
170562851|NCT02138825|616407015|FG000|Main Study Treatment|Death|1|||
170562852|NCT02138825|616407016|FG001|Main Study Treatment|Death|2|||
170562853|NCT02138825|616407015|FG000|Main Study Treatment|Protocol Violation|2|||
170562854|NCT02138825|616407016|FG001|Main Study Treatment|Protocol Violation|2|||
170562855|NCT02138825|616407015|FG000|Main Study Treatment|Sponsor decision|12|||
170562856|NCT02138825|616407016|FG001|Main Study Treatment|Sponsor decision|18|||
170562857|NCT02138825|616407015|FG000|Main Study Treatment|Study terminated by sponsor|10|||
170562858|NCT02138825|616407016|FG001|Main Study Treatment|Study terminated by sponsor|9|||
170562859|NCT02138825|616407015|FG000|Main Study Treatment|Withdrawal by Subject|3|||
170562860|NCT02138825|616407016|FG001|Main Study Treatment|Withdrawal by Subject|1|||
170562861|NCT02138825|616407015|FG000|Main Study Treatment|Medical decision|1|||
170562862|NCT02138825|616407016|FG001|Main Study Treatment|Medical decision|0|||
170562863|NCT02138825|616407015|FG000|Long-term Extension|Study termination by sponsor|32|||
170562864|NCT02138825|616407016|FG001|Long-term Extension|Study termination by sponsor|38|||
170562865|NCT02138825|616407015|FG000|Safety Follow-up|Adverse Event|4|||
170562866|NCT02138825|616407016|FG001|Safety Follow-up|Adverse Event|3|||
170562867|NCT02138825|616407015|FG000|Safety Follow-up|Death|11|||
170562868|NCT02138825|616407016|FG001|Safety Follow-up|Death|5|||
170905594|NCT00045032|617656178|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
170905595|NCT00045032|617656176|FG000|Overall Study|Death|22|||
170562869|NCT02138825|616407015|FG000|Safety Follow-up|Withdrawal by Subject|5|||
170562870|NCT02138825|616407016|FG001|Safety Follow-up|Withdrawal by Subject|3|||
170562871|NCT02138825|616407015|FG000|Safety Follow-up|clinic worsening|1|||
170562872|NCT02138825|616407016|FG001|Safety Follow-up|clinic worsening|0|||
170562873|NCT02138825|616407015|FG000|Safety Follow-up|withdrawal by PI|1|||
170562874|NCT02138825|616407016|FG001|Safety Follow-up|withdrawal by PI|0|||
170562875|NCT02138825|616407015|FG000|Safety Follow-up|logistical difficulties|0|||
170562876|NCT02138825|616407016|FG001|Safety Follow-up|logistical difficulties|1|||
170562877|NCT02138825|616407015|FG000|Safety Follow-up|progressive disease|0|||
170562878|NCT02138825|616407016|FG001|Safety Follow-up|progressive disease|2|||
170562879|NCT02138825|616407015|FG000|Safety Follow-up|too unwell to attend the visit|0|||
170562880|NCT02138825|616407016|FG001|Safety Follow-up|too unwell to attend the visit|1|||
170562881|NCT02138825|616407015|FG000|Safety Follow-up|treatment unblinded|0|||
170562882|NCT02138825|616407016|FG001|Safety Follow-up|treatment unblinded|1|||
170562883|NCT02138825|616407015|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
170562884|NCT02138825|616407016|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
170562885|NCT00560508|616407025|FG000|12 Week Double-blind Period|Adverse Event|3|||
170562886|NCT00560508|616407026|FG001|12 Week Double-blind Period|Adverse Event|2|||
170562887|NCT00560508|616407025|FG000|12 Week Double-blind Period|Protocol Violation|1|||
170562888|NCT00560508|616407026|FG001|12 Week Double-blind Period|Protocol Violation|0|||
170562889|NCT00560508|616407025|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
170562890|NCT00560508|616407026|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
170562891|NCT00560508|616407025|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
170562892|NCT00560508|616407026|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
170562893|NCT00560508|616407025|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
170562894|NCT00560508|616407026|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
170562895|NCT00560508|616407025|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
170562896|NCT00560508|616407026|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
170562897|NCT00560508|616407025|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
170562898|NCT00560508|616407026|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
170562899|NCT03493958|616407027|FG000|Overall Study|Withdrawal by Subject|6|||
170562900|NCT03493958|616407027|FG000|Overall Study|Lost to Follow-up|7|||
170562901|NCT03493958|616407027|FG000|Overall Study|Did not complete all required study procedures|2|||
170562902|NCT01822925|616407032|FG000|Overall Study|Adverse Event|1|||
170562903|NCT01822925|616407033|FG001|Overall Study|Adverse Event|1|||
170562904|NCT01822925|616407034|FG002|Overall Study|Adverse Event|1|||
170562905|NCT01822925|616407035|FG003|Overall Study|Adverse Event|1|||
170562906|NCT01822925|616407032|FG000|Overall Study|Lost to Follow-up|0|||
170562907|NCT01822925|616407033|FG001|Overall Study|Lost to Follow-up|1|||
170562908|NCT01822925|616407034|FG002|Overall Study|Lost to Follow-up|0|||
170562909|NCT01822925|616407035|FG003|Overall Study|Lost to Follow-up|0|||
170562910|NCT01822925|616407032|FG000|Overall Study|Protocol Violation|1|||
170562911|NCT01822925|616407033|FG001|Overall Study|Protocol Violation|0|||
170562912|NCT01822925|616407034|FG002|Overall Study|Protocol Violation|0|||
170562913|NCT01822925|616407035|FG003|Overall Study|Protocol Violation|1|||
170562914|NCT01822925|616407032|FG000|Overall Study|Withdrawal by Subject|2|||
170562915|NCT01822925|616407033|FG001|Overall Study|Withdrawal by Subject|0|||
170562916|NCT01822925|616407034|FG002|Overall Study|Withdrawal by Subject|2|||
170562917|NCT01822925|616407035|FG003|Overall Study|Withdrawal by Subject|2|||
170562918|NCT01822925|616407032|FG000|Overall Study|Taking prohibited medication|2|||
170562919|NCT01822925|616407033|FG001|Overall Study|Taking prohibited medication|0|||
170562920|NCT01822925|616407034|FG002|Overall Study|Taking prohibited medication|0|||
170562921|NCT01822925|616407035|FG003|Overall Study|Taking prohibited medication|1|||
170562922|NCT04562116|616407037|FG000|Overall Study|Lost to Follow-up|1|||
170562923|NCT04562116|616407037|FG000|Overall Study|Withdrawal by Subject|3|||
170562924|NCT05134649|616407038|FG000|Overall Study|Lost to Follow-up|12|||
170562925|NCT05134649|616407038|FG000|Overall Study|Withdrawal by Subject|14|||
170562926|NCT05134649|616407038|FG000|Overall Study|Pregnancy|1|||
170562927|NCT05134649|616407038|FG000|Overall Study|Other, not specified|3|||
170562928|NCT03510273|616407044|FG000|Overall Study|Withdrawal by Subject|2|||
170562929|NCT03510273|616407044|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
170562930|NCT03510273|616407044|FG000|Overall Study|Moved away from study area|4|||
170562931|NCT00265122|616407048|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
170562932|NCT00265122|616407049|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
170562933|NCT00265122|616407050|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
170562934|NCT00265122|616407051|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
170562935|NCT00265122|616407052|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
170562936|NCT00265122|616407053|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
170905596|NCT00045032|617656177|FG001|Overall Study|Death|24|||
170905597|NCT00045032|617656178|FG002|Overall Study|Death|17|||
170905598|NCT00045032|617656176|FG000|Overall Study|Insufficient Therapeutic Response|542|||
170905599|NCT00045032|617656177|FG001|Overall Study|Insufficient Therapeutic Response|437|||
170905600|NCT00045032|617656178|FG002|Overall Study|Insufficient Therapeutic Response|445|||
170905601|NCT00045032|617656176|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
170905602|NCT00045032|617656177|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
170905603|NCT00045032|617656178|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
170905604|NCT00045032|617656176|FG000|Overall Study|Other Protocol Violation|2|||
170905605|NCT00045032|617656177|FG001|Overall Study|Other Protocol Violation|0|||
170905606|NCT00045032|617656178|FG002|Overall Study|Other Protocol Violation|1|||
170905607|NCT00045032|617656176|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
170905608|NCT00045032|617656177|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
170905609|NCT00045032|617656178|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
170905610|NCT00045032|617656176|FG000|Overall Study|Failure to Return|57|||
170905611|NCT00045032|617656177|FG001|Overall Study|Failure to Return|62|||
170905612|NCT00045032|617656178|FG002|Overall Study|Failure to Return|61|||
170905613|NCT00045032|617656176|FG000|Overall Study|Other|93|||
170905614|NCT00045032|617656177|FG001|Overall Study|Other|84|||
170905615|NCT00045032|617656178|FG002|Overall Study|Other|105|||
170905616|NCT02582658|617656179|FG000|Overall Study|Failure to Return|10|||
170905617|NCT02582658|617656179|FG000|Overall Study|Insufficient Virological Response|2|||
170905618|NCT02582658|617656179|FG000|Overall Study|Withdrawn Consent|1|||
170905619|NCT02582658|617656179|FG000|Overall Study|Death|1|||
170905620|NCT02582658|617656179|FG000|Overall Study|Not further specified|11|||
170905621|NCT02017444|617658448|FG000|Overall Study|Physician Decision|1|||
170905622|NCT02017444|617658449|FG001|Overall Study|Physician Decision|0|||
170905623|NCT02017444|617658448|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
170905624|NCT02017444|617658449|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
170905625|NCT01614457|617658450|FG000|Overall Study|Non-Compliance|1|||
170905626|NCT01614457|617658451|FG001|Overall Study|Non-Compliance|0|||
170905627|NCT01614457|617658450|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
170905628|NCT01614457|617658451|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
170905629|NCT02342171|617658452|FG000|Overall Study|Death|4|||
170905630|NCT02342171|617658453|FG001|Overall Study|Death|87|||
170905631|NCT02342171|617658452|FG000|Overall Study|Received favipiravir|10|||
170905632|NCT02342171|617658453|FG001|Overall Study|Received favipiravir|0|||
170905633|NCT02342171|617658452|FG000|Overall Study|Missing cycle treshold value|1|||
170905634|NCT02342171|617658453|FG001|Overall Study|Missing cycle treshold value|0|||
170905635|NCT02342171|617658452|FG000|Overall Study|Unknown outcome|0|||
170905636|NCT02342171|617658453|FG001|Overall Study|Unknown outcome|1|||
170905637|NCT02342171|617658452|FG000|Overall Study|Missing age data|0|||
170905638|NCT02342171|617658453|FG001|Overall Study|Missing age data|1|||
170905639|NCT03518840|617658456|FG000|Overall Study|Lost to Follow-up|6|||
170905640|NCT00875420|617658459|FG000|Overall Study|Adverse Event|0|||
170905641|NCT00875420|617658460|FG001|Overall Study|Adverse Event|1|||
170905642|NCT00875420|617658461|FG002|Overall Study|Adverse Event|1|||
170905643|NCT00875420|617658462|FG003|Overall Study|Adverse Event|0|||
170905644|NCT00875420|617658463|FG004|Overall Study|Adverse Event|0|||
170905645|NCT00875420|617658459|FG000|Overall Study|Inability to complete study procedures|1|||
170905646|NCT00875420|617658460|FG001|Overall Study|Inability to complete study procedures|0|||
170905647|NCT00875420|617658461|FG002|Overall Study|Inability to complete study procedures|1|||
170905648|NCT00875420|617658462|FG003|Overall Study|Inability to complete study procedures|1|||
170905649|NCT00875420|617658463|FG004|Overall Study|Inability to complete study procedures|1|||
170905650|NCT00875420|617658459|FG000|Overall Study|Lost to Follow-up|1|||
170905651|NCT00875420|617658460|FG001|Overall Study|Lost to Follow-up|0|||
170905652|NCT00875420|617658461|FG002|Overall Study|Lost to Follow-up|0|||
170562937|NCT00265122|616407048|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
170562938|NCT00265122|616407049|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
170562939|NCT00265122|616407050|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
170905653|NCT00875420|617658462|FG003|Overall Study|Lost to Follow-up|0|||
170905654|NCT00875420|617658463|FG004|Overall Study|Lost to Follow-up|0|||
170562940|NCT00265122|616407051|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
170562941|NCT00265122|616407052|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
170905655|NCT00875420|617658459|FG000|Overall Study|Personal reason|0|||
170905656|NCT00875420|617658460|FG001|Overall Study|Personal reason|0|||
170905657|NCT00875420|617658461|FG002|Overall Study|Personal reason|0|||
170905658|NCT00875420|617658462|FG003|Overall Study|Personal reason|0|||
170905659|NCT00875420|617658463|FG004|Overall Study|Personal reason|1|||
170905660|NCT00875420|617658459|FG000|Overall Study|Prohibited medication|0|||
170905661|NCT00875420|617658460|FG001|Overall Study|Prohibited medication|0|||
170905662|NCT00875420|617658461|FG002|Overall Study|Prohibited medication|0|||
170905663|NCT00875420|617658462|FG003|Overall Study|Prohibited medication|1|||
170905664|NCT00875420|617658463|FG004|Overall Study|Prohibited medication|0|||
170905665|NCT00875420|617658459|FG000|Overall Study|Sponsor decision|0|||
170562942|NCT00265122|616407053|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
170562943|NCT00265122|616407048|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
170562944|NCT00265122|616407049|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
170562945|NCT00265122|616407050|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
170562946|NCT00265122|616407051|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
170562947|NCT00265122|616407052|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
170562948|NCT00265122|616407053|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
170562949|NCT00265122|616407048|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
170562950|NCT00265122|616407049|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
170562951|NCT00265122|616407050|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
170562952|NCT00265122|616407051|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
170562953|NCT00265122|616407052|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
170562954|NCT00265122|616407053|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
170562955|NCT00265122|616407048|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
170562956|NCT00265122|616407049|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
170562957|NCT00265122|616407050|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
170562958|NCT00265122|616407051|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
170562959|NCT00265122|616407052|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
170562960|NCT00265122|616407053|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
170562961|NCT00265122|616407048|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
170562962|NCT00265122|616407049|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
170562963|NCT00265122|616407050|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
170562964|NCT00265122|616407051|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
170562965|NCT00265122|616407052|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
170562966|NCT00265122|616407053|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
170562967|NCT02589938|616407054|FG000|Overall Study|Withdrawal by Subject|11|||
170562968|NCT02589938|616407055|FG001|Overall Study|Withdrawal by Subject|5|||
170562969|NCT02589938|616407056|FG002|Overall Study|Withdrawal by Subject|6|||
170562970|NCT02589938|616407054|FG000|Overall Study|Lost to Follow-up|3|||
170562971|NCT02589938|616407055|FG001|Overall Study|Lost to Follow-up|3|||
170562972|NCT02589938|616407056|FG002|Overall Study|Lost to Follow-up|3|||
170562973|NCT02589938|616407054|FG000|Overall Study|Death|1|||
170562974|NCT02589938|616407055|FG001|Overall Study|Death|0|||
170562975|NCT02589938|616407056|FG002|Overall Study|Death|1|||
170562976|NCT02589938|616407054|FG000|Overall Study|Protocol Violation|6|||
170562977|NCT02589938|616407055|FG001|Overall Study|Protocol Violation|2|||
170562978|NCT02589938|616407056|FG002|Overall Study|Protocol Violation|3|||
170562979|NCT02589938|616407054|FG000|Overall Study|Physician Decision|1|||
170562980|NCT02589938|616407055|FG001|Overall Study|Physician Decision|0|||
170562981|NCT02589938|616407056|FG002|Overall Study|Physician Decision|0|||
170562982|NCT02589938|616407054|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
170562983|NCT02589938|616407055|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
170562984|NCT02589938|616407056|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
170562985|NCT01467466|616407057|FG000|Overall Study|Withdrawal by Subject|15|||
170562986|NCT01467466|616407058|FG001|Overall Study|Withdrawal by Subject|18|||
170562987|NCT01467466|616407059|FG002|Overall Study|Withdrawal by Subject|13|||
170562988|NCT01467466|616407060|FG003|Overall Study|Withdrawal by Subject|11|||
170562989|NCT01467466|616407057|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
170562990|NCT01467466|616407058|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
170562991|NCT01467466|616407059|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
170562992|NCT01467466|616407060|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
170562993|NCT01467466|616407057|FG000|Overall Study|Procedure Cancelled|46|||
170562994|NCT01467466|616407058|FG001|Overall Study|Procedure Cancelled|45|||
170562995|NCT01467466|616407059|FG002|Overall Study|Procedure Cancelled|25|||
170562996|NCT01467466|616407060|FG003|Overall Study|Procedure Cancelled|29|||
170562997|NCT01467466|616407057|FG000|Overall Study|No Endpoint Blood Draw|38|||
170562998|NCT01467466|616407058|FG001|Overall Study|No Endpoint Blood Draw|32|||
170562999|NCT01467466|616407059|FG002|Overall Study|No Endpoint Blood Draw|51|||
170563000|NCT01467466|616407060|FG003|Overall Study|No Endpoint Blood Draw|43|||
170563001|NCT02231580|616407070|FG000|Overall Study|Adverse Event|5|||
170563002|NCT02231580|616407071|FG001|Overall Study|Adverse Event|0|||
170563003|NCT01121757|616407072|FG000|First Drug|Death|1|||
170563004|NCT01121757|616407073|FG001|First Drug|Death|0|||
170563005|NCT01121757|616407072|FG000|First Drug|Disease Progression|0|||
170563006|NCT01121757|616407073|FG001|First Drug|Disease Progression|2|||
170563007|NCT01121757|616407072|FG000|Combination|Physician Decision|0|||
170563008|NCT01121757|616407073|FG001|Combination|Physician Decision|1|||
170563009|NCT01121757|616407072|FG000|Combination|Disease Progression|2|||
170563010|NCT01121757|616407073|FG001|Combination|Disease Progression|0|||
170563011|NCT04890509|616407078|FG000|Overall Study|Death|4|||
170563012|NCT04890509|616407079|FG001|Overall Study|Death|4|||
170563013|NCT02495883|616407083|FG000|Overall Study|Excessive head motion|1|||
170563014|NCT02495883|616407084|FG001|Overall Study|Excessive head motion|0|||
170905666|NCT00875420|617658460|FG001|Overall Study|Sponsor decision|1|||
170905667|NCT00875420|617658461|FG002|Overall Study|Sponsor decision|0|||
170905668|NCT00875420|617658462|FG003|Overall Study|Sponsor decision|0|||
170905669|NCT00875420|617658463|FG004|Overall Study|Sponsor decision|0|||
170905670|NCT00875420|617658459|FG000|Overall Study|Withdrawal by Subject|0|||
170905671|NCT00875420|617658460|FG001|Overall Study|Withdrawal by Subject|0|||
170905672|NCT00875420|617658461|FG002|Overall Study|Withdrawal by Subject|1|||
170905673|NCT00875420|617658462|FG003|Overall Study|Withdrawal by Subject|0|||
170905674|NCT00875420|617658463|FG004|Overall Study|Withdrawal by Subject|0|||
170905675|NCT02579603|617658466|FG000|Overall Study|Not treated|1|||
170905676|NCT02579603|617658467|FG001|Overall Study|Not treated|0|||
170905677|NCT02579603|617658466|FG000|Overall Study|Adverse Event|2|||
170905678|NCT02579603|617658467|FG001|Overall Study|Adverse Event|2|||
170905679|NCT02579603|617658466|FG000|Overall Study|Other than stated|1|||
170905680|NCT02579603|617658467|FG001|Overall Study|Other than stated|0|||
170905681|NCT00469079|617658468|FG000|Overall Study|Lack of Efficacy|3|||
170905682|NCT00469079|617658469|FG001|Overall Study|Lack of Efficacy|8|||
170905683|NCT00469079|617658470|FG002|Overall Study|Lack of Efficacy|5|||
170905684|NCT00469079|617658468|FG000|Overall Study|Adverse Event|1|||
170905685|NCT00469079|617658469|FG001|Overall Study|Adverse Event|3|||
170905686|NCT00469079|617658470|FG002|Overall Study|Adverse Event|2|||
170905687|NCT00469079|617658468|FG000|Overall Study|Lost to Follow-up|4|||
170905688|NCT00469079|617658469|FG001|Overall Study|Lost to Follow-up|8|||
170905689|NCT00469079|617658470|FG002|Overall Study|Lost to Follow-up|10|||
170905690|NCT00469079|617658468|FG000|Overall Study|Withdrawal by Subject|1|||
170905691|NCT00469079|617658469|FG001|Overall Study|Withdrawal by Subject|2|||
170905692|NCT00469079|617658470|FG002|Overall Study|Withdrawal by Subject|2|||
170905693|NCT00469079|617658468|FG000|Overall Study|Ineligible|0|||
170905694|NCT00469079|617658469|FG001|Overall Study|Ineligible|1|||
170905695|NCT00469079|617658470|FG002|Overall Study|Ineligible|0|||
170905696|NCT00942162|617658471|FG000|Overall Study|Death|45|||
170905697|NCT00942162|617658472|FG001|Overall Study|Death|35|||
170905698|NCT00942162|617658473|FG002|Overall Study|Death|0|||
170905699|NCT00942162|617658471|FG000|Overall Study|Withdrawal by Subject|7|||
170905700|NCT00942162|617658472|FG001|Overall Study|Withdrawal by Subject|2|||
170905701|NCT00942162|617658473|FG002|Overall Study|Withdrawal by Subject|0|||
170905702|NCT00942162|617658471|FG000|Overall Study|Lost to Follow-up|4|||
170905703|NCT00942162|617658472|FG001|Overall Study|Lost to Follow-up|0|||
170905704|NCT00942162|617658473|FG002|Overall Study|Lost to Follow-up|0|||
170905705|NCT00942162|617658471|FG000|Overall Study|Other|14|||
170905706|NCT00942162|617658472|FG001|Overall Study|Other|13|||
170905707|NCT00942162|617658473|FG002|Overall Study|Other|2|||
170905708|NCT01756157|617658474|FG000|First Intervention Period|Withdrawal by Subject|1|||
170905709|NCT01756157|617658475|FG001|First Intervention Period|Withdrawal by Subject|0|||
170905710|NCT01756157|617658474|FG000|First Intervention Period|Lost to Follow-up|0|||
170905711|NCT01756157|617658475|FG001|First Intervention Period|Lost to Follow-up|2|||
170905712|NCT03368859|617658476|FG000|Overall Study|Withdrew Consent|5|||
170905713|NCT03368859|617658477|FG001|Overall Study|Withdrew Consent|4|||
170905714|NCT03368859|617658476|FG000|Overall Study|Death|12|||
170905715|NCT03368859|617658477|FG001|Overall Study|Death|6|||
170905716|NCT03368859|617658476|FG000|Overall Study|Study terminated by Sponsor|18|||
170905717|NCT03368859|617658477|FG001|Overall Study|Study terminated by Sponsor|23|||
170905718|NCT03368859|617658476|FG000|Overall Study|Other|1|||
170905719|NCT03368859|617658477|FG001|Overall Study|Other|1|||
170905720|NCT02698410|617658478|FG000|Overall Study|Adverse Event|2|||
170905721|NCT02698410|617658478|FG000|Overall Study|Withdrawal by Subject|1|||
170905722|NCT02698410|617658478|FG000|Overall Study|Other|1|||
170905723|NCT04331899|617658479|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
170905724|NCT04331899|617658480|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
170905725|NCT02424539|617658483|FG000|Overall Study|Adverse Event|0|||
170905726|NCT02424539|617658484|FG001|Overall Study|Adverse Event|0|||
170563015|NCT00964678|616407085|FG000|Overall Study|Physician Decision|4|||
170563016|NCT02520154|616407086|FG000|Overall Study|Death|1|||
170905727|NCT02424539|617658485|FG002|Overall Study|Adverse Event|1|||
170905728|NCT02424539|617658483|FG000|Overall Study|Physician Decision|0|||
170905729|NCT02424539|617658484|FG001|Overall Study|Physician Decision|0|||
170905730|NCT02424539|617658485|FG002|Overall Study|Physician Decision|1|||
170905731|NCT02424539|617658483|FG000|Overall Study|Withdrawal by Subject|3|||
170563017|NCT02520154|616407086|FG000|Overall Study|Withdrawal by Subject|2|||
170905732|NCT02424539|617658484|FG001|Overall Study|Withdrawal by Subject|1|||
170905733|NCT02424539|617658485|FG002|Overall Study|Withdrawal by Subject|0|||
170905734|NCT02424539|617658483|FG000|Overall Study|Other: Reached stopping criteria|11|||
170905735|NCT02424539|617658484|FG001|Overall Study|Other: Reached stopping criteria|7|||
170905736|NCT02424539|617658485|FG002|Overall Study|Other: Reached stopping criteria|6|||
170905737|NCT01485614|617658486|FG000|Randomization|Not Treated|1|||
170905738|NCT01485614|617658487|FG001|Randomization|Not Treated|0|||
170905739|NCT01485614|617658488|FG002|Randomization|Not Treated|0|||
170905740|NCT01485614|617658489|FG003|Randomization|Not Treated|0|||
170905741|NCT01485614|617658486|FG000|Weeks 0-20|Lost to Follow-up|2|||
170905742|NCT01485614|617658487|FG001|Weeks 0-20|Lost to Follow-up|0|||
170563018|NCT02520154|616407086|FG000|Overall Study|Physician Decision|2|||
170563019|NCT06022107|616407087|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
170563020|NCT06022107|616407087|FG000|Overall Study|Dropped out of study for higher level of care|1|||
170563021|NCT06022107|616407087|FG000|Overall Study|Lost to Follow-up|2|||
170563022|NCT05943990|616407095|FG000|Overall Study|Study Terminated by Sponsor|0|||
170563023|NCT05943990|616407096|FG001|Overall Study|Study Terminated by Sponsor|0|||
170905743|NCT01485614|617658488|FG002|Weeks 0-20|Lost to Follow-up|0|||
170905744|NCT01485614|617658489|FG003|Weeks 0-20|Lost to Follow-up|0|||
170905745|NCT01485614|617658486|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
170905746|NCT01485614|617658487|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
170905747|NCT01485614|617658488|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
170905748|NCT01485614|617658489|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
170905749|NCT01485614|617658486|FG000|Weeks 0-20|Withdrawal by Subject|3|||
170905750|NCT01485614|617658487|FG001|Weeks 0-20|Withdrawal by Subject|2|||
170905751|NCT01485614|617658488|FG002|Weeks 0-20|Withdrawal by Subject|1|||
170905752|NCT01485614|617658489|FG003|Weeks 0-20|Withdrawal by Subject|0|||
170905753|NCT01485614|617658486|FG000|Weeks 20-54|Lost to Follow-up|4|||
170905754|NCT01485614|617658487|FG001|Weeks 20-54|Lost to Follow-up|3|||
170905755|NCT01485614|617658488|FG002|Weeks 20-54|Lost to Follow-up|1|||
170905756|NCT01485614|617658489|FG003|Weeks 20-54|Lost to Follow-up|0|||
170905757|NCT01485614|617658486|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
170905758|NCT01485614|617658487|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
170905759|NCT01485614|617658488|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
170905760|NCT01485614|617658489|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
170905761|NCT01485614|617658486|FG000|Weeks 20-54|Withdrawal by Subject|5|||
170905762|NCT01485614|617658487|FG001|Weeks 20-54|Withdrawal by Subject|3|||
170905763|NCT01485614|617658488|FG002|Weeks 20-54|Withdrawal by Subject|0|||
170905764|NCT01485614|617658489|FG003|Weeks 20-54|Withdrawal by Subject|0|||
170905765|NCT03941548|617658491|FG000|Overall Study|Adverse Event|0|||
170905766|NCT03941548|617658492|FG001|Overall Study|Adverse Event|1|||
170905767|NCT03941548|617658491|FG000|Overall Study|Lost to Follow-up|0|||
170905768|NCT03941548|617658492|FG001|Overall Study|Lost to Follow-up|1|||
170905769|NCT03941548|617658491|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
170905770|NCT03941548|617658492|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
170905771|NCT02599402|617658493|FG000|Overall Study|Disease progression|153|||
170905772|NCT02599402|617658493|FG000|Overall Study|Study drug toxicity|201|||
170905773|NCT02599402|617658493|FG000|Overall Study|Death|26|||
170905774|NCT02599402|617658493|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
170905775|NCT02599402|617658493|FG000|Overall Study|Participant request to discontinue study treatment|13|||
170905776|NCT02599402|617658493|FG000|Overall Study|Participant withdrew consent|5|||
170905777|NCT02599402|617658493|FG000|Overall Study|Lost to Follow-up|1|||
170905778|NCT02599402|617658493|FG000|Overall Study|Maximum Clinical Benefit|7|||
170905779|NCT02599402|617658493|FG000|Overall Study|Poor/non-compliance|1|||
170905780|NCT02599402|617658493|FG000|Overall Study|Pregnancy|1|||
170905781|NCT02599402|617658493|FG000|Overall Study|Participant no longer met study criteria|7|||
170905782|NCT02599402|617658493|FG000|Overall Study|Other Reasons|95|||
170905783|NCT02586805|617658494|FG000|Overall Study|Withdrawal by Subject|3|||
170905784|NCT02586805|617658495|FG001|Overall Study|Withdrawal by Subject|1|||
170905785|NCT02586805|617658496|FG002|Overall Study|Withdrawal by Subject|1|||
170905786|NCT02586805|617658497|FG003|Overall Study|Withdrawal by Subject|2|||
170905787|NCT02586805|617658494|FG000|Overall Study|Adverse Event|2|||
170905788|NCT02586805|617658495|FG001|Overall Study|Adverse Event|0|||
170905789|NCT02586805|617658496|FG002|Overall Study|Adverse Event|1|||
170905790|NCT02586805|617658497|FG003|Overall Study|Adverse Event|0|||
170905791|NCT02586805|617658494|FG000|Overall Study|Lost to Follow-up|0|||
170905792|NCT02586805|617658495|FG001|Overall Study|Lost to Follow-up|0|||
170905793|NCT02586805|617658496|FG002|Overall Study|Lost to Follow-up|1|||
170905794|NCT02586805|617658497|FG003|Overall Study|Lost to Follow-up|0|||
170905795|NCT02586805|617658494|FG000|Overall Study|Physician Decision|1|||
170905796|NCT02586805|617658495|FG001|Overall Study|Physician Decision|0|||
170563024|NCT05943990|616407097|FG002|Overall Study|Study Terminated by Sponsor|1|||
170905797|NCT02586805|617658496|FG002|Overall Study|Physician Decision|0|||
170905798|NCT02586805|617658497|FG003|Overall Study|Physician Decision|0|||
170563025|NCT02581930|616407098|FG000|Overall Study|Withdrawal by Subject|1|||
170905799|NCT01859403|617658498|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
170905800|NCT01859403|617658499|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
170905801|NCT01859403|617658498|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
170905802|NCT01859403|617658499|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
170905803|NCT01859403|617658498|FG000|Primary Endpoint Measure|Physician Decision|0|||
170905804|NCT01859403|617658499|FG001|Primary Endpoint Measure|Physician Decision|1|||
170905805|NCT01859403|617658498|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
170563026|NCT02581930|616407098|FG000|Overall Study|patient declined further treatment|1|||
170905806|NCT01859403|617658499|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
170905807|NCT01157117|617658500|FG000|Overall Study|Dosing Symptoms|0|||
170905808|NCT01157117|617658501|FG001|Overall Study|Dosing Symptoms|4|||
170905809|NCT01157117|617658502|FG002|Overall Study|Dosing Symptoms|0|||
170563027|NCT01334918|616409018|FG000|Overall Study|Did not receive study drug|6|||
170563028|NCT01334918|616409019|FG001|Overall Study|Did not receive study drug|0|||
170563029|NCT01334918|616409018|FG000|Overall Study|Adverse Event|2|||
170563030|NCT01334918|616409019|FG001|Overall Study|Adverse Event|0|||
170563031|NCT01334918|616409018|FG000|Overall Study|Withdrawal by Subject|0|||
170563032|NCT01334918|616409019|FG001|Overall Study|Withdrawal by Subject|1|||
170563033|NCT01576783|616409023|FG000|Overall Study|Change in Medical Care|1|||
170563034|NCT01576783|616409024|FG001|Overall Study|Change in Medical Care|0|||
170563035|NCT01576783|616409023|FG000|Overall Study|Lost to Follow-up|14|||
170563036|NCT01576783|616409024|FG001|Overall Study|Lost to Follow-up|16|||
170563037|NCT01576783|616409023|FG000|Overall Study|Withdrawal by Subject|5|||
170563038|NCT01576783|616409024|FG001|Overall Study|Withdrawal by Subject|1|||
170563039|NCT05489328|616409025|FG000|Overall Study|Lost to Follow-up|0|||
170563040|NCT05489328|616409026|FG001|Overall Study|Lost to Follow-up|0|||
170563041|NCT05489328|616409027|FG002|Overall Study|Lost to Follow-up|1|||
170563042|NCT05489328|616409028|FG003|Overall Study|Lost to Follow-up|0|||
170563043|NCT05489328|616409029|FG004|Overall Study|Lost to Follow-up|2|||
170563044|NCT05489328|616409030|FG005|Overall Study|Lost to Follow-up|0|||
170563045|NCT05489328|616409031|FG006|Overall Study|Lost to Follow-up|0|||
170563046|NCT05489328|616409032|FG007|Overall Study|Lost to Follow-up|1|||
170563047|NCT05489328|616409033|FG008|Overall Study|Lost to Follow-up|0|||
170563048|NCT05489328|616409025|FG000|Overall Study|Withdrawal by Subject|0|||
170563049|NCT05489328|616409026|FG001|Overall Study|Withdrawal by Subject|0|||
170563050|NCT05489328|616409027|FG002|Overall Study|Withdrawal by Subject|0|||
170563051|NCT05489328|616409028|FG003|Overall Study|Withdrawal by Subject|0|||
170563052|NCT05489328|616409029|FG004|Overall Study|Withdrawal by Subject|0|||
170563053|NCT05489328|616409030|FG005|Overall Study|Withdrawal by Subject|0|||
170563054|NCT05489328|616409031|FG006|Overall Study|Withdrawal by Subject|1|||
170563055|NCT05489328|616409032|FG007|Overall Study|Withdrawal by Subject|1|||
170563056|NCT05489328|616409033|FG008|Overall Study|Withdrawal by Subject|0|||
170563057|NCT05489328|616409025|FG000|Overall Study|Other|0|||
170563058|NCT05489328|616409026|FG001|Overall Study|Other|0|||
170563059|NCT05489328|616409027|FG002|Overall Study|Other|0|||
170563060|NCT05489328|616409028|FG003|Overall Study|Other|0|||
170563061|NCT05489328|616409029|FG004|Overall Study|Other|0|||
170563062|NCT05489328|616409030|FG005|Overall Study|Other|0|||
170563063|NCT05489328|616409031|FG006|Overall Study|Other|0|||
170563064|NCT05489328|616409032|FG007|Overall Study|Other|1|||
170563065|NCT05489328|616409033|FG008|Overall Study|Other|1|||
170563066|NCT01083602|616409034|FG000|Overall Study|Adverse Event|11|||
170563067|NCT01083602|616409034|FG000|Overall Study|New Cancer Therapy|2|||
170563068|NCT01083602|616409034|FG000|Overall Study|Death|1|||
170563069|NCT01083602|616409034|FG000|Overall Study|Withdrawal by Subject|5|||
170563070|NCT01083602|616409034|FG000|Overall Study|Lack of Efficacy|36|||
170563071|NCT01657370|616409036|FG000|Overall Study|Withdrawal by Subject|0|||
170563072|NCT01657370|616409037|FG001|Overall Study|Withdrawal by Subject|0|||
170563073|NCT01657370|616409038|FG002|Overall Study|Withdrawal by Subject|1|||
170563074|NCT01657370|616409039|FG003|Overall Study|Withdrawal by Subject|0|||
170563075|NCT01657370|616409040|FG004|Overall Study|Withdrawal by Subject|0|||
170563076|NCT01657370|616409041|FG005|Overall Study|Withdrawal by Subject|1|||
170563077|NCT01657370|616409036|FG000|Overall Study|Physician Decision|2|||
170563078|NCT01657370|616409037|FG001|Overall Study|Physician Decision|3|||
170563079|NCT01657370|616409038|FG002|Overall Study|Physician Decision|1|||
170563080|NCT01657370|616409039|FG003|Overall Study|Physician Decision|2|||
170563081|NCT01657370|616409040|FG004|Overall Study|Physician Decision|5|||
170563082|NCT01657370|616409041|FG005|Overall Study|Physician Decision|0|||
170563083|NCT01657370|616409036|FG000|Overall Study|Lack of Qualifying Event|1|||
170563084|NCT01657370|616409037|FG001|Overall Study|Lack of Qualifying Event|0|||
170563085|NCT01657370|616409038|FG002|Overall Study|Lack of Qualifying Event|3|||
170563086|NCT01657370|616409039|FG003|Overall Study|Lack of Qualifying Event|2|||
170563087|NCT01657370|616409040|FG004|Overall Study|Lack of Qualifying Event|1|||
170563088|NCT01657370|616409041|FG005|Overall Study|Lack of Qualifying Event|2|||
170563089|NCT01657370|616409036|FG000|Overall Study|Adverse Event|0|||
170563090|NCT01657370|616409037|FG001|Overall Study|Adverse Event|0|||
170563091|NCT01657370|616409038|FG002|Overall Study|Adverse Event|0|||
170563092|NCT01657370|616409039|FG003|Overall Study|Adverse Event|0|||
170563093|NCT01657370|616409040|FG004|Overall Study|Adverse Event|1|||
170563094|NCT01657370|616409041|FG005|Overall Study|Adverse Event|0|||
170563095|NCT01657370|616409036|FG000|Overall Study|Protocol Violation|1|||
170563096|NCT01657370|616409037|FG001|Overall Study|Protocol Violation|1|||
170563097|NCT01657370|616409038|FG002|Overall Study|Protocol Violation|1|||
170563098|NCT01657370|616409039|FG003|Overall Study|Protocol Violation|1|||
170563099|NCT01657370|616409040|FG004|Overall Study|Protocol Violation|0|||
170563100|NCT01657370|616409041|FG005|Overall Study|Protocol Violation|0|||
170563101|NCT01657370|616409036|FG000|Overall Study|Lost to Follow-up|2|||
170563102|NCT01657370|616409037|FG001|Overall Study|Lost to Follow-up|0|||
170563103|NCT01657370|616409038|FG002|Overall Study|Lost to Follow-up|1|||
170563104|NCT01657370|616409039|FG003|Overall Study|Lost to Follow-up|0|||
170563105|NCT01657370|616409040|FG004|Overall Study|Lost to Follow-up|0|||
170563106|NCT01657370|616409041|FG005|Overall Study|Lost to Follow-up|1|||
170563107|NCT01819272|616409042|FG000|Overall Study|Adverse Event|1|||
170563108|NCT01819272|616409043|FG001|Overall Study|Adverse Event|0|||
170563109|NCT01819272|616409044|FG002|Overall Study|Adverse Event|0|||
170563110|NCT01819272|616409045|FG003|Overall Study|Adverse Event|2|||
170563111|NCT01819272|616409046|FG004|Overall Study|Adverse Event|0|||
170563112|NCT01819272|616409047|FG005|Overall Study|Adverse Event|0|||
170563113|NCT01819272|616409042|FG000|Overall Study|Lost to Follow-up|3|||
170563114|NCT01819272|616409043|FG001|Overall Study|Lost to Follow-up|0|||
170563115|NCT01819272|616409044|FG002|Overall Study|Lost to Follow-up|1|||
170563116|NCT01819272|616409045|FG003|Overall Study|Lost to Follow-up|0|||
170563117|NCT01819272|616409046|FG004|Overall Study|Lost to Follow-up|0|||
170563118|NCT01819272|616409047|FG005|Overall Study|Lost to Follow-up|3|||
170563119|NCT01819272|616409042|FG000|Overall Study|Protocol Violation|0|||
170563120|NCT01819272|616409043|FG001|Overall Study|Protocol Violation|0|||
170563121|NCT01819272|616409044|FG002|Overall Study|Protocol Violation|0|||
170563122|NCT01819272|616409045|FG003|Overall Study|Protocol Violation|1|||
170563123|NCT01819272|616409046|FG004|Overall Study|Protocol Violation|2|||
170563124|NCT01819272|616409047|FG005|Overall Study|Protocol Violation|3|||
170563125|NCT01819272|616409042|FG000|Overall Study|Physician Decision|0|||
170563126|NCT01819272|616409043|FG001|Overall Study|Physician Decision|1|||
170563127|NCT01819272|616409044|FG002|Overall Study|Physician Decision|0|||
170563128|NCT01819272|616409045|FG003|Overall Study|Physician Decision|0|||
170563129|NCT01819272|616409046|FG004|Overall Study|Physician Decision|0|||
170563130|NCT01819272|616409047|FG005|Overall Study|Physician Decision|0|||
170563131|NCT01819272|616409042|FG000|Overall Study|Withdrawal of Consent|0|||
170563132|NCT01819272|616409043|FG001|Overall Study|Withdrawal of Consent|1|||
170563133|NCT01819272|616409044|FG002|Overall Study|Withdrawal of Consent|2|||
170563134|NCT01819272|616409045|FG003|Overall Study|Withdrawal of Consent|1|||
170563135|NCT01819272|616409046|FG004|Overall Study|Withdrawal of Consent|0|||
170563136|NCT01819272|616409047|FG005|Overall Study|Withdrawal of Consent|1|||
170563137|NCT01819272|616409042|FG000|Overall Study|Loss of Glucose Control|2|||
170563138|NCT01819272|616409043|FG001|Overall Study|Loss of Glucose Control|1|||
170563139|NCT01819272|616409044|FG002|Overall Study|Loss of Glucose Control|0|||
170563140|NCT01819272|616409045|FG003|Overall Study|Loss of Glucose Control|1|||
170563141|NCT01819272|616409046|FG004|Overall Study|Loss of Glucose Control|2|||
170563142|NCT01819272|616409047|FG005|Overall Study|Loss of Glucose Control|0|||
170563143|NCT05484895|616409048|FG000|Overall Study|Lost to Follow-up|63|||
170563144|NCT05484895|616409049|FG001|Overall Study|Lost to Follow-up|64|||
170563145|NCT00805389|616409050|FG000|Overall Study|Adverse Event|0|||
170563146|NCT00805389|616409051|FG001|Overall Study|Adverse Event|0|||
170563147|NCT00805389|616409052|FG002|Overall Study|Adverse Event|1|||
170563148|NCT00805389|616409053|FG003|Overall Study|Adverse Event|2|||
170563149|NCT00805389|616409054|FG004|Overall Study|Adverse Event|0|||
170563150|NCT00805389|616409050|FG000|Overall Study|Lost to Follow-up|4|||
170563151|NCT00805389|616409051|FG001|Overall Study|Lost to Follow-up|3|||
170563152|NCT00805389|616409052|FG002|Overall Study|Lost to Follow-up|6|||
170563153|NCT00805389|616409053|FG003|Overall Study|Lost to Follow-up|10|||
170563154|NCT00805389|616409054|FG004|Overall Study|Lost to Follow-up|9|||
170563155|NCT00805389|616409050|FG000|Overall Study|Protocol Violation|0|||
170563156|NCT00805389|616409051|FG001|Overall Study|Protocol Violation|0|||
170563157|NCT00805389|616409052|FG002|Overall Study|Protocol Violation|1|||
170563158|NCT00805389|616409053|FG003|Overall Study|Protocol Violation|0|||
170563159|NCT00805389|616409054|FG004|Overall Study|Protocol Violation|0|||
170563160|NCT00805389|616409050|FG000|Overall Study|Withdrawal by Subject|3|||
170563161|NCT00805389|616409051|FG001|Overall Study|Withdrawal by Subject|2|||
170563162|NCT00805389|616409052|FG002|Overall Study|Withdrawal by Subject|4|||
170563163|NCT00805389|616409053|FG003|Overall Study|Withdrawal by Subject|5|||
170563164|NCT00805389|616409054|FG004|Overall Study|Withdrawal by Subject|4|||
170563165|NCT03698279|616409057|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170563166|NCT03698279|616409058|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170563167|NCT03698279|616409059|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170563168|NCT03698279|616409060|FG003|Overall Study|Withdrawal by parent/guardian|1|||
170563169|NCT03698279|616409061|FG004|Overall Study|Withdrawal by parent/guardian|0|||
170563170|NCT03698279|616409062|FG005|Overall Study|Withdrawal by parent/guardian|0|||
170563171|NCT03698279|616409057|FG000|Overall Study|Protocol deviation|1|||
170563172|NCT03698279|616409058|FG001|Overall Study|Protocol deviation|0|||
170563173|NCT03698279|616409059|FG002|Overall Study|Protocol deviation|1|||
170563174|NCT03698279|616409060|FG003|Overall Study|Protocol deviation|0|||
170563175|NCT03698279|616409061|FG004|Overall Study|Protocol deviation|0|||
170563176|NCT03698279|616409062|FG005|Overall Study|Protocol deviation|0|||
170563177|NCT03698279|616409057|FG000|Overall Study|Withdrawal by Subject|0|||
170563178|NCT03698279|616409058|FG001|Overall Study|Withdrawal by Subject|0|||
170563179|NCT03698279|616409059|FG002|Overall Study|Withdrawal by Subject|1|||
170563180|NCT03698279|616409060|FG003|Overall Study|Withdrawal by Subject|0|||
170563181|NCT03698279|616409061|FG004|Overall Study|Withdrawal by Subject|0|||
170563182|NCT03698279|616409062|FG005|Overall Study|Withdrawal by Subject|0|||
170563183|NCT03698279|616409057|FG000|Overall Study|Lost to Follow-up|3|||
170563184|NCT03698279|616409058|FG001|Overall Study|Lost to Follow-up|1|||
170563185|NCT03698279|616409059|FG002|Overall Study|Lost to Follow-up|4|||
170563186|NCT03698279|616409060|FG003|Overall Study|Lost to Follow-up|5|||
170563187|NCT03698279|616409061|FG004|Overall Study|Lost to Follow-up|0|||
170563188|NCT03698279|616409062|FG005|Overall Study|Lost to Follow-up|0|||
170563189|NCT03122184|616409068|FG000|Overall Study|Lost to Follow-up|4|||
170563190|NCT03122184|616409069|FG001|Overall Study|Lost to Follow-up|6|||
170563191|NCT03122184|616409068|FG000|Overall Study|Withdrawal by Subject|3|||
170563192|NCT03122184|616409069|FG001|Overall Study|Withdrawal by Subject|0|||
170563193|NCT03122184|616409068|FG000|Overall Study|Terminated due to cognitive problem|1|||
170563194|NCT03122184|616409069|FG001|Overall Study|Terminated due to cognitive problem|0|||
170563195|NCT02986074|616409072|FG000|First Trial Period|Adverse Event|1|||
170563196|NCT02986074|616409073|FG001|First Trial Period|Adverse Event|0|||
170563197|NCT02986074|616409074|FG002|First Trial Period|Adverse Event|0|||
170563198|NCT02986074|616409075|FG003|First Trial Period|Adverse Event|0|||
170563199|NCT02986074|616409072|FG000|Follow up Period|system explant|0|||
170563200|NCT02986074|616409073|FG001|Follow up Period|system explant|0|||
170563201|NCT02986074|616409074|FG002|Follow up Period|system explant|1|||
170563202|NCT02986074|616409075|FG003|Follow up Period|system explant|2|||
170563203|NCT02986074|616409072|FG000|Follow up Period|Physician Decision|0|||
170563204|NCT02986074|616409073|FG001|Follow up Period|Physician Decision|0|||
170563205|NCT02986074|616409074|FG002|Follow up Period|Physician Decision|0|||
170563206|NCT02986074|616409075|FG003|Follow up Period|Physician Decision|1|||
170563207|NCT02239926|616409078|FG000|Overall Study|Withdrawal by Subject|0|||
170563208|NCT02239926|616409079|FG001|Overall Study|Withdrawal by Subject|1|||
170563209|NCT01628913|616409080|FG000|Overall Study|Adverse Event|12|||
170563210|NCT01628913|616409081|FG001|Overall Study|Adverse Event|5|||
170563211|NCT01628913|616409080|FG000|Overall Study|Disease Progression|11|||
170563212|NCT01628913|616409081|FG001|Overall Study|Disease Progression|14|||
170563213|NCT01628913|616409080|FG000|Overall Study|Protocol Violation|1|||
170563214|NCT01628913|616409081|FG001|Overall Study|Protocol Violation|0|||
170563215|NCT01628913|616409080|FG000|Overall Study|Death|1|||
170563216|NCT01628913|616409081|FG001|Overall Study|Death|0|||
170563217|NCT01628913|616409080|FG000|Overall Study|study terminated by Sponsor|4|||
170563218|NCT01628913|616409081|FG001|Overall Study|study terminated by Sponsor|9|||
170563219|NCT01628913|616409080|FG000|Overall Study|Withdrawal by Subject|1|||
170563220|NCT01628913|616409081|FG001|Overall Study|Withdrawal by Subject|0|||
170563221|NCT01628913|616409080|FG000|Overall Study|Physician Decision|1|||
170563222|NCT01628913|616409081|FG001|Overall Study|Physician Decision|3|||
170563223|NCT02415556|616409082|FG000|Overall Study|Adverse Event|3|||
170563224|NCT02415556|616409083|FG001|Overall Study|Adverse Event|4|||
170563225|NCT02415556|616409084|FG002|Overall Study|Adverse Event|2|||
170563226|NCT02415556|616409085|FG003|Overall Study|Adverse Event|4|||
170905810|NCT01157117|617658500|FG000|Overall Study|Withdrawal by Subject|4|||
170905811|NCT01157117|617658501|FG001|Overall Study|Withdrawal by Subject|1|||
170905812|NCT01157117|617658502|FG002|Overall Study|Withdrawal by Subject|1|||
170905813|NCT01157117|617658500|FG000|Overall Study|Lack of Efficacy|1|||
170905814|NCT01157117|617658501|FG001|Overall Study|Lack of Efficacy|1|||
170905815|NCT01157117|617658502|FG002|Overall Study|Lack of Efficacy|0|||
170905816|NCT01157117|617658500|FG000|Overall Study|Lost to Follow-up|0|||
170905817|NCT01157117|617658501|FG001|Overall Study|Lost to Follow-up|0|||
170905818|NCT01157117|617658502|FG002|Overall Study|Lost to Follow-up|1|||
170905819|NCT01157117|617658500|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
170905820|NCT01157117|617658501|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
170905821|NCT01157117|617658502|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
170905822|NCT00813748|617658503|FG000|Skin Test Substudy|Physician Decision|0|||
170905823|NCT00813748|617658504|FG001|Skin Test Substudy|Physician Decision|1|||
170905824|NCT00504257|617658505|FG000|Overall Study|Withdrawal by Subject|2|||
170905825|NCT00504257|617658505|FG000|Overall Study|ineligible histology|2|||
170905826|NCT03185130|617658506|FG000|Overall Study|Withdrawal by Subject|0|||
170905827|NCT03185130|617658507|FG001|Overall Study|Withdrawal by Subject|2|||
170905828|NCT02286960|617658508|FG000|Overall Study|Lost to Follow-up|3|||
170905829|NCT02286960|617658509|FG001|Overall Study|Lost to Follow-up|3|||
170905830|NCT00472303|617658510|FG000|Titration Phase|Adverse Event|22|||
170905831|NCT00472303|617658511|FG001|Titration Phase|Adverse Event|12|||
170905832|NCT00472303|617658512|FG002|Titration Phase|Adverse Event|0|||
170905833|NCT00472303|617658510|FG000|Titration Phase|Death|4|||
170905834|NCT00472303|617658511|FG001|Titration Phase|Death|2|||
170905835|NCT00472303|617658512|FG002|Titration Phase|Death|0|||
170905836|NCT00472303|617658510|FG000|Titration Phase|Lack of Efficacy|10|||
170905837|NCT00472303|617658511|FG001|Titration Phase|Lack of Efficacy|0|||
170905838|NCT00472303|617658512|FG002|Titration Phase|Lack of Efficacy|0|||
170563227|NCT02415556|616409082|FG000|Overall Study|Lost to Follow-up|4|||
170563228|NCT02415556|616409083|FG001|Overall Study|Lost to Follow-up|5|||
170563229|NCT02415556|616409084|FG002|Overall Study|Lost to Follow-up|4|||
170563230|NCT02415556|616409085|FG003|Overall Study|Lost to Follow-up|1|||
170563231|NCT02415556|616409082|FG000|Overall Study|Withdrawal by Subject|13|||
170563232|NCT02415556|616409083|FG001|Overall Study|Withdrawal by Subject|4|||
170563233|NCT02415556|616409084|FG002|Overall Study|Withdrawal by Subject|14|||
170563234|NCT02415556|616409085|FG003|Overall Study|Withdrawal by Subject|12|||
170563235|NCT02415556|616409082|FG000|Overall Study|Physician Decision|1|||
170563236|NCT02415556|616409083|FG001|Overall Study|Physician Decision|3|||
170563237|NCT02415556|616409084|FG002|Overall Study|Physician Decision|1|||
170563238|NCT02415556|616409085|FG003|Overall Study|Physician Decision|2|||
170645591|NCT01185353|616715974|FG002|Part C (Weeks 24 Through 76)|Death|0|||
170645592|NCT01185353|616715975|FG003|Part C (Weeks 24 Through 76)|Death|0|||
170645593|NCT01185353|616715976|FG004|Part C (Weeks 24 Through 76)|Death|0|||
170645594|NCT01185353|616715977|FG005|Part C (Weeks 24 Through 76)|Death|0|||
170645595|NCT01185353|616715978|FG006|Part C (Weeks 24 Through 76)|Death|0|||
170645596|NCT01185353|616715979|FG007|Part C (Weeks 24 Through 76)|Death|0|||
170645597|NCT01185353|616715980|FG008|Part C (Weeks 24 Through 76)|Death|0|||
170645598|NCT01185353|616715981|FG009|Part C (Weeks 24 Through 76)|Death|1|||
170645599|NCT01185353|616715972|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170645600|NCT01185353|616715973|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170645601|NCT01185353|616715974|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170645602|NCT01185353|616715975|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170645603|NCT01185353|616715976|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170563239|NCT02415556|616409082|FG000|Overall Study|Censored - study completion|4|||
170563240|NCT02415556|616409083|FG001|Overall Study|Censored - study completion|5|||
170563241|NCT02415556|616409084|FG002|Overall Study|Censored - study completion|1|||
170563242|NCT02415556|616409085|FG003|Overall Study|Censored - study completion|0|||
170563243|NCT02415556|616409082|FG000|Overall Study|Family-related issues|0|||
170563244|NCT02415556|616409083|FG001|Overall Study|Family-related issues|0|||
170563245|NCT02415556|616409084|FG002|Overall Study|Family-related issues|0|||
170563246|NCT02415556|616409085|FG003|Overall Study|Family-related issues|1|||
170645604|NCT01185353|616715977|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170645605|NCT01185353|616715978|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170645606|NCT01185353|616715979|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170645607|NCT01185353|616715980|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
170645608|NCT01185353|616715981|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
170645609|NCT01185353|616715972|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170645610|NCT01185353|616715973|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170645611|NCT01185353|616715974|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170645612|NCT01185353|616715975|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170645613|NCT01185353|616715976|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170645614|NCT01185353|616715977|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170645615|NCT01185353|616715978|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170645616|NCT01185353|616715979|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170905839|NCT00472303|617658510|FG000|Titration Phase|Withdrawal by Subject|16|||
170563247|NCT02569853|616409088|FG000|Overall Study|Adverse Event|2|||
170563248|NCT02569853|616409089|FG001|Overall Study|Adverse Event|0|||
170563249|NCT02569853|616409088|FG000|Overall Study|Withdrawal by Subject|3|||
170563250|NCT02569853|616409089|FG001|Overall Study|Withdrawal by Subject|2|||
170563251|NCT02569853|616409088|FG000|Overall Study|Lost to Follow-up|3|||
170905840|NCT00472303|617658511|FG001|Titration Phase|Withdrawal by Subject|13|||
170563252|NCT02569853|616409089|FG001|Overall Study|Lost to Follow-up|3|||
170563253|NCT02569853|616409088|FG000|Overall Study|Protocol Violation|1|||
170563254|NCT02569853|616409089|FG001|Overall Study|Protocol Violation|1|||
170563255|NCT02569853|616409088|FG000|Overall Study|Did not experience migraine attack|10|||
170563256|NCT02569853|616409089|FG001|Overall Study|Did not experience migraine attack|7|||
170563257|NCT02569853|616409088|FG000|Overall Study|Physician Decision|1|||
170563258|NCT02569853|616409089|FG001|Overall Study|Physician Decision|1|||
170563259|NCT00419744|616409092|FG000|Overall Study|Adverse Event|39|||
170563260|NCT00419744|616409093|FG001|Overall Study|Adverse Event|40|||
170563261|NCT00419744|616409094|FG002|Overall Study|Adverse Event|50|||
170563262|NCT00419744|616409092|FG000|Overall Study|Withdrawal by Subject|45|||
170563263|NCT00419744|616409093|FG001|Overall Study|Withdrawal by Subject|49|||
170563264|NCT00419744|616409094|FG002|Overall Study|Withdrawal by Subject|52|||
170563265|NCT00419744|616409092|FG000|Overall Study|Lost to Follow-up|8|||
170563266|NCT00419744|616409093|FG001|Overall Study|Lost to Follow-up|10|||
170563267|NCT00419744|616409094|FG002|Overall Study|Lost to Follow-up|6|||
170563268|NCT00419744|616409092|FG000|Overall Study|Protocol Violation|4|||
170563269|NCT00419744|616409093|FG001|Overall Study|Protocol Violation|7|||
170563270|NCT00419744|616409094|FG002|Overall Study|Protocol Violation|8|||
170563271|NCT00419744|616409092|FG000|Overall Study|Randomized in error|9|||
170563272|NCT00419744|616409093|FG001|Overall Study|Randomized in error|6|||
170563273|NCT00419744|616409094|FG002|Overall Study|Randomized in error|7|||
170563274|NCT00419744|616409092|FG000|Overall Study|Moving out of state|2|||
170905841|NCT00472303|617658512|FG002|Titration Phase|Withdrawal by Subject|0|||
170905842|NCT00472303|617658510|FG000|Titration Phase|Trial Medication non-compliant|4|||
170905843|NCT00472303|617658511|FG001|Titration Phase|Trial Medication non-compliant|1|||
170905844|NCT00472303|617658512|FG002|Titration Phase|Trial Medication non-compliant|0|||
170905845|NCT00472303|617658510|FG000|Titration Phase|Other|3|||
170905846|NCT00472303|617658511|FG001|Titration Phase|Other|1|||
170905847|NCT00472303|617658512|FG002|Titration Phase|Other|0|||
170905848|NCT00472303|617658510|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
170905849|NCT00472303|617658511|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
170905850|NCT00472303|617658512|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
170905851|NCT00472303|617658510|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
170905852|NCT00472303|617658511|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
170645617|NCT01185353|616715980|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
170563275|NCT00419744|616409093|FG001|Overall Study|Moving out of state|0|||
170563276|NCT00419744|616409094|FG002|Overall Study|Moving out of state|1|||
170563277|NCT00419744|616409092|FG000|Overall Study|Physician Decision|10|||
170563278|NCT00419744|616409093|FG001|Overall Study|Physician Decision|5|||
170563279|NCT00419744|616409094|FG002|Overall Study|Physician Decision|6|||
170563280|NCT00419744|616409092|FG000|Overall Study|Spirometry mouthpiece issues|0|||
170563281|NCT00419744|616409093|FG001|Overall Study|Spirometry mouthpiece issues|1|||
170563282|NCT00419744|616409094|FG002|Overall Study|Spirometry mouthpiece issues|2|||
170563283|NCT00419744|616409092|FG000|Overall Study|Incorrect medication kit dispensed|0|||
170563284|NCT00419744|616409093|FG001|Overall Study|Incorrect medication kit dispensed|0|||
170563285|NCT00419744|616409094|FG002|Overall Study|Incorrect medication kit dispensed|1|||
170563286|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
170905853|NCT00472303|617658512|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
170905854|NCT00472303|617658510|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
170905855|NCT00472303|617658511|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
170563287|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
170645618|NCT01185353|616715981|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
170563288|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
170563289|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
170563290|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
170563291|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
170645619|NCT01185353|616715972|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
170645620|NCT01185353|616715973|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
170645621|NCT01185353|616715974|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
170563292|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
170563293|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
170563294|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
170563295|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
170563296|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
170563297|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
170563298|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
170563299|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
170563300|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
170563301|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
170563302|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
170563303|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
170563304|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
170563305|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
170563306|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
170563307|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
170563308|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
170563309|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
170563310|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
170563311|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
170563312|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
170563313|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
170563314|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
170563315|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
170563316|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
170563317|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
170563318|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
170563319|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
170563320|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
170563321|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
170563322|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
170563323|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
170563324|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
170563325|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
170563326|NCT04392154|616409095|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
170563327|NCT04392154|616409096|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
170563328|NCT04392154|616409097|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
170563329|NCT04392154|616409098|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
170563330|NCT04392154|616409095|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
170563331|NCT04392154|616409096|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
170563332|NCT04392154|616409097|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
170563333|NCT04392154|616409098|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
170563334|NCT04392154|616409095|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
170563335|NCT04392154|616409096|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
170563336|NCT04392154|616409097|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
170563337|NCT04392154|616409098|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
170563338|NCT04392154|616409095|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
170563339|NCT04392154|616409096|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
170563340|NCT04392154|616409097|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
170563341|NCT04392154|616409098|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
170563342|NCT00023595|616409099|FG000|5 Year Follow up|Lost to Follow-up|2|||
170563343|NCT00023595|616409100|FG001|5 Year Follow up|Lost to Follow-up|2|||
170563344|NCT00023595|616409101|FG002|5 Year Follow up|Lost to Follow-up|1|||
170563345|NCT00023595|616409102|FG003|5 Year Follow up|Lost to Follow-up|7|||
170563346|NCT00023595|616409103|FG004|5 Year Follow up|Lost to Follow-up|3|||
170563347|NCT00023595|616409099|FG000|10 Year Follow up|Lost to Follow-up|12|||
170563348|NCT00023595|616409100|FG001|10 Year Follow up|Lost to Follow-up|10|||
170563349|NCT00023595|616409101|FG002|10 Year Follow up|Lost to Follow-up|3|||
170563350|NCT00023595|616409102|FG003|10 Year Follow up|Lost to Follow-up|0|||
170563351|NCT00023595|616409103|FG004|10 Year Follow up|Lost to Follow-up|0|||
170563352|NCT00879398|616409104|FG000|Overall Study|Visit Stop|399|||
170563353|NCT00879398|616409104|FG000|Overall Study|Lack of Efficacy|64|||
170563354|NCT00879398|616409104|FG000|Overall Study|Adverse Event|41|||
170563355|NCT00879398|616409104|FG000|Overall Study|Other Reasons|171|||
170905856|NCT00472303|617658512|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
170905857|NCT00472303|617658510|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
170563356|NCT04583618|616409110|FG000|Overall Study|Adverse Event|0|||
170563357|NCT04583618|616409111|FG001|Overall Study|Adverse Event|0|||
170563358|NCT04583618|616409112|FG002|Overall Study|Adverse Event|1|||
170563359|NCT04583618|616409113|FG003|Overall Study|Adverse Event|0|||
170563360|NCT04583618|616409114|FG004|Overall Study|Adverse Event|0|||
170563361|NCT04583618|616409110|FG000|Overall Study|Protocol deviation|1|||
170563362|NCT04583618|616409111|FG001|Overall Study|Protocol deviation|1|||
170563363|NCT04583618|616409112|FG002|Overall Study|Protocol deviation|1|||
170563364|NCT04583618|616409113|FG003|Overall Study|Protocol deviation|0|||
170563365|NCT04583618|616409114|FG004|Overall Study|Protocol deviation|0|||
170563366|NCT04583618|616409110|FG000|Overall Study|Withdrawal by Subject|2|||
170563367|NCT04583618|616409111|FG001|Overall Study|Withdrawal by Subject|1|||
170563368|NCT04583618|616409112|FG002|Overall Study|Withdrawal by Subject|3|||
170563369|NCT04583618|616409113|FG003|Overall Study|Withdrawal by Subject|1|||
170563370|NCT04583618|616409114|FG004|Overall Study|Withdrawal by Subject|1|||
170563371|NCT04583618|616409110|FG000|Overall Study|Lost to Follow-up|0|||
170563372|NCT04583618|616409111|FG001|Overall Study|Lost to Follow-up|1|||
170563373|NCT04583618|616409112|FG002|Overall Study|Lost to Follow-up|3|||
170563374|NCT04583618|616409113|FG003|Overall Study|Lost to Follow-up|1|||
170645622|NCT01185353|616715975|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
170645623|NCT01185353|616715976|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
170645624|NCT01185353|616715977|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
170645625|NCT01185353|616715978|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
170563375|NCT04583618|616409114|FG004|Overall Study|Lost to Follow-up|1|||
170563376|NCT05852470|616409117|FG000|Overall Study|Withdrawal by Subject|0|||
170563377|NCT05852470|616409118|FG001|Overall Study|Withdrawal by Subject|1|||
170563378|NCT06071104|616409119|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
170806833|NCT01953692|617301613|FG001|Overall Study|Protocol Violation|2|||
170806834|NCT01953692|617301614|FG002|Overall Study|Protocol Violation|1|||
170806835|NCT01953692|617301615|FG003|Overall Study|Protocol Violation|0|||
170806836|NCT01953692|617301616|FG004|Overall Study|Protocol Violation|0|||
170806837|NCT01953692|617301617|FG005|Overall Study|Protocol Violation|0|||
170806838|NCT01953692|617301618|FG006|Overall Study|Protocol Violation|0|||
170806839|NCT01953692|617301619|FG007|Overall Study|Protocol Violation|1|||
170806840|NCT01953692|617301620|FG008|Overall Study|Protocol Violation|0|||
170806841|NCT01953692|617301612|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
170806842|NCT01953692|617301613|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
170806843|NCT01953692|617301614|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
170806844|NCT01953692|617301615|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
170806845|NCT01953692|617301616|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
170806846|NCT01953692|617301617|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
170806847|NCT01953692|617301618|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
170806848|NCT01953692|617301619|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
170806849|NCT01953692|617301620|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
170806850|NCT01953692|617301612|FG000|Overall Study|Withdrawal by Subject|4|||
170806851|NCT01953692|617301613|FG001|Overall Study|Withdrawal by Subject|2|||
170806852|NCT01953692|617301614|FG002|Overall Study|Withdrawal by Subject|1|||
170806853|NCT01953692|617301615|FG003|Overall Study|Withdrawal by Subject|2|||
170806854|NCT01953692|617301616|FG004|Overall Study|Withdrawal by Subject|0|||
170806855|NCT01953692|617301617|FG005|Overall Study|Withdrawal by Subject|3|||
170806856|NCT01953692|617301618|FG006|Overall Study|Withdrawal by Subject|2|||
170806857|NCT01953692|617301619|FG007|Overall Study|Withdrawal by Subject|1|||
170806858|NCT01953692|617301620|FG008|Overall Study|Withdrawal by Subject|1|||
170806859|NCT02113449|617301621|FG000|Overall Study|Adverse Event|4|||
170806860|NCT02091752|617301622|FG000|Overall Study|Study terminated by Sponsor|2|||
170806861|NCT02091752|617301622|FG000|Overall Study|Adverse Event|1|||
170806862|NCT01065779|617301623|FG000|Overall Study|Duplicate Investigation|1|||
170806863|NCT01065779|617301623|FG000|Overall Study|Investigation Before Contract Date|37|||
170806864|NCT01065779|617301623|FG000|Overall Study|Non-enrollment Period Administration|10|||
170806865|NCT01065779|617301623|FG000|Overall Study|Not Administered With Study Drug|17|||
170806866|NCT01065779|617301623|FG000|Overall Study|Failed to Follow-up|10|||
170806867|NCT01065779|617301623|FG000|Overall Study|Inclusion Criteria Violation|7|||
170806868|NCT02157948|617301624|FG000|Overall Study|Withdrawal by Subject|4|||
170806869|NCT02157948|617301625|FG001|Overall Study|Withdrawal by Subject|5|||
170806870|NCT02157948|617301624|FG000|Overall Study|Lost to Follow-up|3|||
170806871|NCT02157948|617301625|FG001|Overall Study|Lost to Follow-up|2|||
170806872|NCT02157948|617301624|FG000|Overall Study|Protocol Specified Criteria|2|||
170806873|NCT02157948|617301625|FG001|Overall Study|Protocol Specified Criteria|1|||
170806874|NCT02157948|617301624|FG000|Overall Study|Decision by Sponsor|0|||
170806875|NCT02157948|617301625|FG001|Overall Study|Decision by Sponsor|1|||
170806876|NCT03389802|617301649|FG000|Overall Study|Lack of Efficacy|3|||
170806877|NCT03389802|617301650|FG001|Overall Study|Lack of Efficacy|3|||
170806878|NCT03389802|617301651|FG002|Overall Study|Lack of Efficacy|13|||
170563379|NCT01722669|616409124|FG000|Overall Study|Withdrawal by Subject|0|||
170563380|NCT01722669|616409125|FG001|Overall Study|Withdrawal by Subject|0|||
170563381|NCT01722669|616409126|FG002|Overall Study|Withdrawal by Subject|0|||
170563382|NCT01722669|616409127|FG003|Overall Study|Withdrawal by Subject|0|||
170563383|NCT01722669|616409128|FG004|Overall Study|Withdrawal by Subject|0|||
170563384|NCT01722669|616409129|FG005|Overall Study|Withdrawal by Subject|2|||
170563385|NCT02302222|616409133|FG000|Overall Study|Physician Decision|0|||
170563386|NCT02302222|616409134|FG001|Overall Study|Physician Decision|4|||
170563387|NCT02302222|616409133|FG000|Overall Study|Lost to Follow-up|1|||
170563388|NCT02302222|616409134|FG001|Overall Study|Lost to Follow-up|0|||
170563389|NCT02302222|616409133|FG000|Overall Study|Treatment discontinued before day 5|0|||
170563390|NCT02302222|616409134|FG001|Overall Study|Treatment discontinued before day 5|1|||
170563391|NCT02302222|616409133|FG000|Overall Study|Withdrawn prior to any treatment|0|||
170563392|NCT02302222|616409134|FG001|Overall Study|Withdrawn prior to any treatment|1|||
170563393|NCT02420717|616409137|FG000|Overall Study|Did not receive all study medication|2|||
170563394|NCT02420717|616409138|FG001|Overall Study|Did not receive all study medication|0|||
170563395|NCT02420717|616409139|FG002|Overall Study|Did not receive all study medication|0|||
170563396|NCT04116489|616409140|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
170563397|NCT04116489|616409140|FG000|Overall Study|Withdrawal by Subject|1|||
170563398|NCT00016354|616409141|FG000|Overall Study|Lack of Efficacy|0|||
170563399|NCT00016354|616409142|FG001|Overall Study|Lack of Efficacy|0|||
170563400|NCT00016354|616409143|FG002|Overall Study|Lack of Efficacy|0|||
170563401|NCT00016354|616409144|FG003|Overall Study|Lack of Efficacy|0|||
170563402|NCT00016354|616409145|FG004|Overall Study|Lack of Efficacy|0|||
170563403|NCT00016354|616409146|FG005|Overall Study|Lack of Efficacy|0|||
170563404|NCT00016354|616409147|FG006|Overall Study|Lack of Efficacy|0|||
170563405|NCT00016354|616409148|FG007|Overall Study|Lack of Efficacy|1|||
170563406|NCT03781570|616409149|FG000|Overall Study|Technical Issues (equipment failure)|31|||
170563407|NCT03781570|616409149|FG000|Overall Study|Withdrawal by Subject|7|||
170563408|NCT03781570|616409149|FG000|Overall Study|Physical Constraints|11|||
170563409|NCT03138564|616409150|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
170563410|NCT03138564|616409151|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
170563411|NCT03138564|616409150|FG000|Overall Study|Lost to Follow-up|16|||
170563412|NCT03138564|616409151|FG001|Overall Study|Lost to Follow-up|2|||
170563413|NCT03138564|616409150|FG000|Overall Study|Withdrawal by Subject|48|||
170563414|NCT03138564|616409151|FG001|Overall Study|Withdrawal by Subject|4|||
170563415|NCT03138564|616409150|FG000|Overall Study|No longer met eligibility criteria|2|||
170563416|NCT03138564|616409151|FG001|Overall Study|No longer met eligibility criteria|0|||
170563417|NCT03138564|616409150|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
170563418|NCT03138564|616409151|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
170563419|NCT03138564|616409150|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
170563420|NCT03138564|616409151|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
170563421|NCT03138564|616409150|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
170563422|NCT03138564|616409151|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
170563423|NCT03138564|616409150|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
170563424|NCT03138564|616409151|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
170563425|NCT02769481|616409158|FG000|Overall Study|Protocol Violation|1|||
170563426|NCT02769481|616409159|FG001|Overall Study|Protocol Violation|0|||
170905858|NCT00472303|617658511|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
170905859|NCT00472303|617658512|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
170905860|NCT00472303|617658510|FG000|Discontinuations After Titration Phase|Other|5|||
170905861|NCT00472303|617658511|FG001|Discontinuations After Titration Phase|Other|0|||
170905862|NCT00472303|617658512|FG002|Discontinuations After Titration Phase|Other|0|||
170905863|NCT00472303|617658510|FG000|Maintenance Phase|Adverse Event|5|||
170905864|NCT00472303|617658511|FG001|Maintenance Phase|Adverse Event|6|||
170905865|NCT00472303|617658512|FG002|Maintenance Phase|Adverse Event|6|||
170905866|NCT00472303|617658510|FG000|Maintenance Phase|Death|3|||
170905867|NCT00472303|617658511|FG001|Maintenance Phase|Death|0|||
170563427|NCT02769481|616409158|FG000|Overall Study|Adverse Event|3|||
170563428|NCT02769481|616409159|FG001|Overall Study|Adverse Event|6|||
170563429|NCT02769481|616409158|FG000|Overall Study|Entry Criteria Not Met|1|||
170563430|NCT02769481|616409159|FG001|Overall Study|Entry Criteria Not Met|2|||
170563431|NCT02769481|616409158|FG000|Overall Study|Withdrawal by Subject|14|||
170563432|NCT02769481|616409159|FG001|Overall Study|Withdrawal by Subject|16|||
170563433|NCT02769481|616409158|FG000|Overall Study|Lost to Follow-up|9|||
170563434|NCT02769481|616409159|FG001|Overall Study|Lost to Follow-up|9|||
170563435|NCT02769481|616409158|FG000|Overall Study|Physician Decision|0|||
170563436|NCT02769481|616409159|FG001|Overall Study|Physician Decision|1|||
170563437|NCT02769481|616409158|FG000|Overall Study|Terminated by Sponsor|1|||
170905868|NCT00472303|617658512|FG002|Maintenance Phase|Death|2|||
170905869|NCT00472303|617658510|FG000|Maintenance Phase|Lack of Efficacy|2|||
170905870|NCT00472303|617658511|FG001|Maintenance Phase|Lack of Efficacy|2|||
170563438|NCT02769481|616409159|FG001|Overall Study|Terminated by Sponsor|0|||
170563439|NCT02769481|616409158|FG000|Overall Study|Death|0|||
170563440|NCT02769481|616409159|FG001|Overall Study|Death|1|||
170563441|NCT02769481|616409158|FG000|Overall Study|Undefined|4|||
170563442|NCT02769481|616409159|FG001|Overall Study|Undefined|1|||
170563443|NCT06272383|616409163|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
170563444|NCT06272383|616409164|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
170563445|NCT05715827|616409169|FG000|Overall Study|Physician Decision|0|||
170563446|NCT05715827|616409170|FG001|Overall Study|Physician Decision|1|||
170563447|NCT05715827|616409169|FG000|Overall Study|console communication error|0|||
170563448|NCT05715827|616409170|FG001|Overall Study|console communication error|1|||
170563449|NCT04116853|616409171|FG000|Overall Study|Adverse Event|1|||
170563450|NCT04116853|616409172|FG001|Overall Study|Adverse Event|3|||
170563451|NCT04116853|616409171|FG000|Overall Study|Lost to Follow-up|2|||
170563452|NCT04116853|616409172|FG001|Overall Study|Lost to Follow-up|0|||
170563453|NCT04116853|616409171|FG000|Overall Study|Incarceration|0|||
170563454|NCT04116853|616409172|FG001|Overall Study|Incarceration|1|||
170563455|NCT04116853|616409171|FG000|Overall Study|Pregnancy|1|||
170563456|NCT04116853|616409172|FG001|Overall Study|Pregnancy|1|||
170563457|NCT04116853|616409171|FG000|Overall Study|Began Other Weight Loss program|4|||
170563458|NCT04116853|616409172|FG001|Overall Study|Began Other Weight Loss program|8|||
170563459|NCT04116853|616409171|FG000|Overall Study|Began Anti-Obesity Medication|3|||
170563460|NCT04116853|616409172|FG001|Overall Study|Began Anti-Obesity Medication|3|||
170563461|NCT04116853|616409171|FG000|Overall Study|Protocol Violation|0|||
170563462|NCT04116853|616409172|FG001|Overall Study|Protocol Violation|1|||
170563463|NCT03359395|616409173|FG000|First Intervention A / B|Withdrawal by Subject|1|||
170563464|NCT03359395|616409174|FG001|First Intervention A / B|Withdrawal by Subject|0|||
170563465|NCT03359395|616409173|FG000|First Intervention A / B|Lost to Follow-up|2|||
170563466|NCT03359395|616409174|FG001|First Intervention A / B|Lost to Follow-up|3|||
170563467|NCT03359395|616409173|FG000|Second Intervention B/A|Exclusion criteria|0|||
170563468|NCT03359395|616409174|FG001|Second Intervention B/A|Exclusion criteria|1|||
170563469|NCT03359395|616409173|FG000|Second Intervention B/A|Lost to Follow-up|3|||
170563470|NCT03359395|616409174|FG001|Second Intervention B/A|Lost to Follow-up|2|||
170563471|NCT00618787|616409177|FG000|Overall Study|Adverse Event|0|||
170563472|NCT00618787|616409178|FG001|Overall Study|Adverse Event|1|||
170563473|NCT00618787|616409177|FG000|Overall Study|Withdrawal by Subject|2|||
170563474|NCT00618787|616409178|FG001|Overall Study|Withdrawal by Subject|1|||
170563475|NCT00618787|616409177|FG000|Overall Study|Lost to Follow-up|1|||
170563476|NCT00618787|616409178|FG001|Overall Study|Lost to Follow-up|0|||
170563477|NCT01994876|616409179|FG000|Test Period 1|Withdrawal by Subject|0|||
170563478|NCT01994876|616409180|FG001|Test Period 1|Withdrawal by Subject|1|||
170563479|NCT01994876|616409179|FG000|Test Period 1|Adverse Event|0|||
170563480|NCT01994876|616409180|FG001|Test Period 1|Adverse Event|1|||
170563481|NCT01994876|616409179|FG000|Test Period 2|Adverse Event|1|||
170563482|NCT01994876|616409180|FG001|Test Period 2|Adverse Event|0|||
170563483|NCT01994876|616409179|FG000|Test Period 2|Protocol Violation|0|||
170563484|NCT01994876|616409180|FG001|Test Period 2|Protocol Violation|1|||
170563485|NCT02776735|616409181|FG000|Overall Study|Adverse Event|0|||
170563486|NCT02776735|616409182|FG001|Overall Study|Adverse Event|0|||
170563487|NCT02776735|616409183|FG002|Overall Study|Adverse Event|0|||
170563488|NCT02776735|616409184|FG003|Overall Study|Adverse Event|1|||
170563489|NCT02776735|616409185|FG004|Overall Study|Adverse Event|0|||
170563490|NCT02776735|616409186|FG005|Overall Study|Adverse Event|1|||
170563491|NCT02776735|616409181|FG000|Overall Study|Lost to Follow-up|0|||
170563492|NCT02776735|616409182|FG001|Overall Study|Lost to Follow-up|0|||
170563493|NCT02776735|616409183|FG002|Overall Study|Lost to Follow-up|0|||
170563494|NCT02776735|616409184|FG003|Overall Study|Lost to Follow-up|1|||
170563495|NCT02776735|616409185|FG004|Overall Study|Lost to Follow-up|0|||
170563496|NCT02776735|616409186|FG005|Overall Study|Lost to Follow-up|0|||
170563497|NCT02776735|616409181|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170563498|NCT02776735|616409182|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170563499|NCT02776735|616409183|FG002|Overall Study|Withdrawal by parent/guardian|2|||
170563500|NCT02776735|616409184|FG003|Overall Study|Withdrawal by parent/guardian|2|||
170563501|NCT02776735|616409185|FG004|Overall Study|Withdrawal by parent/guardian|0|||
170563502|NCT02776735|616409186|FG005|Overall Study|Withdrawal by parent/guardian|0|||
170563503|NCT02776735|616409181|FG000|Overall Study|Withdrawal by Subject|1|||
170563504|NCT02776735|616409182|FG001|Overall Study|Withdrawal by Subject|0|||
170563505|NCT02776735|616409183|FG002|Overall Study|Withdrawal by Subject|0|||
170563506|NCT02776735|616409184|FG003|Overall Study|Withdrawal by Subject|0|||
170563507|NCT02776735|616409185|FG004|Overall Study|Withdrawal by Subject|0|||
170563508|NCT02776735|616409186|FG005|Overall Study|Withdrawal by Subject|1|||
170563509|NCT02776735|616409181|FG000|Overall Study|Other|0|||
170563510|NCT02776735|616409182|FG001|Overall Study|Other|0|||
170563511|NCT02776735|616409183|FG002|Overall Study|Other|3|||
170563512|NCT02776735|616409184|FG003|Overall Study|Other|0|||
170563513|NCT02776735|616409185|FG004|Overall Study|Other|0|||
170563514|NCT02776735|616409186|FG005|Overall Study|Other|0|||
170645626|NCT01185353|616715979|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
170645627|NCT01185353|616715980|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
170645628|NCT01185353|616715981|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
170645629|NCT01185353|616715972|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
170645630|NCT01185353|616715973|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
170645631|NCT01185353|616715974|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
170645632|NCT01185353|616715975|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
170645633|NCT01185353|616715976|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
170645634|NCT01185353|616715977|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
170645635|NCT01185353|616715978|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
170645636|NCT01185353|616715979|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
170645637|NCT01185353|616715980|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
170645638|NCT01185353|616715981|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
170645639|NCT01185353|616715972|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
170645640|NCT01185353|616715973|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
170905871|NCT00472303|617658512|FG002|Maintenance Phase|Lack of Efficacy|4|||
170905872|NCT00472303|617658510|FG000|Maintenance Phase|Withdrawal by Subject|6|||
170905873|NCT00472303|617658511|FG001|Maintenance Phase|Withdrawal by Subject|7|||
170905874|NCT00472303|617658512|FG002|Maintenance Phase|Withdrawal by Subject|3|||
170563515|NCT01133665|616410984|FG000|Overall Study|Physician Decision|2|||
170563516|NCT03021486|616410985|FG000|Overall Study|Withdrawal by Subject|1|||
170563517|NCT03021486|616410986|FG001|Overall Study|Withdrawal by Subject|1|||
170563518|NCT03021486|616410987|FG002|Overall Study|Withdrawal by Subject|3|||
170563519|NCT03021486|616410985|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
170563520|NCT03021486|616410986|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
170563521|NCT03021486|616410987|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
170563522|NCT01246960|616410988|FG000|Overall Study|Lost to Follow-up|3|||
170563523|NCT01246960|616410989|FG001|Overall Study|Lost to Follow-up|1|||
170563524|NCT01246960|616410988|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
170563525|NCT01246960|616410989|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
170563526|NCT05111145|616410990|FG000|Overall Study|Commercial drug is available for participant|76|||
170563527|NCT05111145|616410990|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
170563528|NCT02336815|616410991|FG000|Overall Study|Disease Progression|45|||
170563529|NCT02336815|616410992|FG001|Overall Study|Disease Progression|70|||
170563530|NCT02336815|616410991|FG000|Overall Study|Adverse Event|18|||
170563531|NCT02336815|616410992|FG001|Overall Study|Adverse Event|39|||
170563532|NCT02336815|616410991|FG000|Overall Study|Physician Decision|11|||
170563533|NCT02336815|616410992|FG001|Overall Study|Physician Decision|4|||
170563534|NCT02336815|616410991|FG000|Overall Study|Withdrawal by Subject|3|||
170563535|NCT02336815|616410992|FG001|Overall Study|Withdrawal by Subject|2|||
170563536|NCT02336815|616410991|FG000|Overall Study|Lost to Follow-up|1|||
170563537|NCT02336815|616410992|FG001|Overall Study|Lost to Follow-up|3|||
170563538|NCT02336815|616410991|FG000|Overall Study|Other|1|||
170563539|NCT02336815|616410992|FG001|Overall Study|Other|5|||
170563540|NCT01784029|616410993|FG000|Overall Study|Lost to Follow-up|19|||
170563541|NCT01784029|616410994|FG001|Overall Study|Lost to Follow-up|20|||
170563542|NCT01784029|616410995|FG002|Overall Study|Lost to Follow-up|22|||
170563543|NCT03235050|616410996|FG000|Overall Study|Adverse Event|0|||
170563544|NCT03235050|616410997|FG001|Overall Study|Adverse Event|0|||
170563545|NCT03235050|616410998|FG002|Overall Study|Adverse Event|1|||
170563546|NCT03235050|616410999|FG003|Overall Study|Adverse Event|4|||
170563547|NCT03235050|616411000|FG004|Overall Study|Adverse Event|1|||
170563548|NCT03235050|616410996|FG000|Overall Study|Death|0|||
170563549|NCT03235050|616410997|FG001|Overall Study|Death|0|||
170563550|NCT03235050|616410998|FG002|Overall Study|Death|0|||
170563551|NCT03235050|616410999|FG003|Overall Study|Death|2|||
170563552|NCT03235050|616411000|FG004|Overall Study|Death|1|||
170563553|NCT03235050|616410996|FG000|Overall Study|Lost to Follow-up|1|||
170563554|NCT03235050|616410997|FG001|Overall Study|Lost to Follow-up|2|||
170563555|NCT03235050|616410998|FG002|Overall Study|Lost to Follow-up|1|||
170645641|NCT01185353|616715974|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
170645642|NCT01185353|616715975|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
170905875|NCT00472303|617658510|FG000|Maintenance Phase|Trial medication non-compliant|0|||
170563556|NCT03235050|616410999|FG003|Overall Study|Lost to Follow-up|2|||
170563557|NCT03235050|616411000|FG004|Overall Study|Lost to Follow-up|0|||
170563558|NCT03235050|616410996|FG000|Overall Study|Withdrawal by Subject|3|||
170563559|NCT03235050|616410997|FG001|Overall Study|Withdrawal by Subject|2|||
170563560|NCT03235050|616410998|FG002|Overall Study|Withdrawal by Subject|2|||
170563561|NCT03235050|616410999|FG003|Overall Study|Withdrawal by Subject|5|||
170563562|NCT03235050|616411000|FG004|Overall Study|Withdrawal by Subject|7|||
170563563|NCT03235050|616410996|FG000|Overall Study|Other reasons|0|||
170563564|NCT03235050|616410997|FG001|Overall Study|Other reasons|1|||
170563565|NCT03235050|616410998|FG002|Overall Study|Other reasons|0|||
170563566|NCT03235050|616410999|FG003|Overall Study|Other reasons|1|||
170645643|NCT01185353|616715976|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
170563567|NCT03235050|616411000|FG004|Overall Study|Other reasons|2|||
170563568|NCT00370292|616411001|FG000|Overall Study|Disease Progression|4|||
170563569|NCT00370292|616411001|FG000|Overall Study|Adverse Event|7|||
170563570|NCT00370292|616411001|FG000|Overall Study|Physician Decision|2|||
170563571|NCT03186638|616411002|FG000|Overall Study|Withdrawal by Subject|4|||
170563572|NCT03186638|616411003|FG001|Overall Study|Withdrawal by Subject|4|||
170563573|NCT03186638|616411002|FG000|Overall Study|Withdrawn due to medical problem|3|||
170563574|NCT03186638|616411003|FG001|Overall Study|Withdrawn due to medical problem|2|||
170563575|NCT03186638|616411002|FG000|Overall Study|Lost to Follow-up|1|||
170563576|NCT03186638|616411003|FG001|Overall Study|Lost to Follow-up|0|||
170563577|NCT02704208|616411004|FG000|Overall Study|Lost to Follow-up|42|||
170563578|NCT02704208|616411005|FG001|Overall Study|Lost to Follow-up|37|||
170563579|NCT00598650|616411008|FG000|Overall Study|Withdrawal by Subject|3|||
170563580|NCT00598650|616411008|FG000|Overall Study|Adverse Event|18|||
170563581|NCT00598650|616411008|FG000|Overall Study|No treatment for 3 weeks|1|||
170563582|NCT00598650|616411008|FG000|Overall Study|Not eligible|1|||
170563583|NCT00598650|616411008|FG000|Overall Study|Prohibited Concomitant Medication|2|||
170563584|NCT00598650|616411008|FG000|Overall Study|Physician Decision|2|||
170563585|NCT05201807|616411012|FG000|Overall Study|Adverse Event|1|||
170563586|NCT05201807|616411012|FG000|Overall Study|COVID-19 Related|1|||
170563587|NCT01209767|616411013|FG000|Overall Study|Withdrawal by Subject|1|||
170563588|NCT01209767|616411013|FG000|Overall Study|Lost to Follow-up|3|||
170563589|NCT01621178|616411014|FG000|Overall Study|Adverse Event|5|||
170563590|NCT01621178|616411015|FG001|Overall Study|Adverse Event|2|||
170563591|NCT01621178|616411016|FG002|Overall Study|Adverse Event|8|||
170563592|NCT01621178|616411014|FG000|Overall Study|Death|6|||
170563593|NCT01621178|616411015|FG001|Overall Study|Death|7|||
170563594|NCT01621178|616411016|FG002|Overall Study|Death|2|||
170563595|NCT01621178|616411014|FG000|Overall Study|Lost to Follow-up|1|||
170563596|NCT01621178|616411015|FG001|Overall Study|Lost to Follow-up|2|||
170563597|NCT01621178|616411016|FG002|Overall Study|Lost to Follow-up|1|||
170563598|NCT01621178|616411014|FG000|Overall Study|Withdrawal by Subject|14|||
170563599|NCT01621178|616411015|FG001|Overall Study|Withdrawal by Subject|17|||
170563600|NCT01621178|616411016|FG002|Overall Study|Withdrawal by Subject|18|||
170563601|NCT01621178|616411014|FG000|Overall Study|Physician Decision|5|||
170563602|NCT01621178|616411015|FG001|Overall Study|Physician Decision|2|||
170563603|NCT01621178|616411016|FG002|Overall Study|Physician Decision|7|||
170563604|NCT00105534|616411017|FG000|Overall Study|Adverse Event|2|||
170563605|NCT00105534|616411018|FG001|Overall Study|Adverse Event|5|||
170563606|NCT00105534|616411017|FG000|Overall Study|Protocol Violation|1|||
170563607|NCT00105534|616411018|FG001|Overall Study|Protocol Violation|4|||
170563608|NCT00105534|616411017|FG000|Overall Study|Withdrawal by Subject|6|||
170563609|NCT00105534|616411018|FG001|Overall Study|Withdrawal by Subject|6|||
170563610|NCT00105534|616411017|FG000|Overall Study|Lost to Follow-up|5|||
170563611|NCT00105534|616411018|FG001|Overall Study|Lost to Follow-up|1|||
170563612|NCT00105534|616411017|FG000|Overall Study|Lack of Efficacy|7|||
170563613|NCT00105534|616411018|FG001|Overall Study|Lack of Efficacy|15|||
170563614|NCT00105534|616411017|FG000|Overall Study|Treatment unmasked|1|||
170563615|NCT00105534|616411018|FG001|Overall Study|Treatment unmasked|0|||
170563616|NCT00105534|616411017|FG000|Overall Study|Other Reason|0|||
170563617|NCT00105534|616411018|FG001|Overall Study|Other Reason|2|||
170563618|NCT02935192|616411019|FG000|Overall Study|Withdrawal by Subject|8|||
170563619|NCT02935192|616411020|FG001|Overall Study|Withdrawal by Subject|4|||
170563620|NCT02465931|616411022|FG000|Overall Study|Lost to Follow-up|9|||
170563621|NCT02465931|616411023|FG001|Overall Study|Lost to Follow-up|11|||
170563622|NCT02465931|616411022|FG000|Overall Study|Protocol Violation|1|||
170563623|NCT02465931|616411023|FG001|Overall Study|Protocol Violation|0|||
170563624|NCT02465931|616411022|FG000|Overall Study|Withdrawal by Subject|1|||
170563625|NCT02465931|616411023|FG001|Overall Study|Withdrawal by Subject|0|||
170563626|NCT00492557|616411024|FG000|Overall Study|Subject request|12|||
170563627|NCT00492557|616411025|FG001|Overall Study|Subject request|11|||
170563628|NCT00492557|616411024|FG000|Overall Study|Protocol Violation|7|||
170563629|NCT00492557|616411025|FG001|Overall Study|Protocol Violation|8|||
170563630|NCT00492557|616411024|FG000|Overall Study|Other|2|||
170563631|NCT00492557|616411025|FG001|Overall Study|Other|2|||
170563632|NCT00492557|616411024|FG000|Overall Study|Death|1|||
170563633|NCT00492557|616411025|FG001|Overall Study|Death|1|||
170563634|NCT00492557|616411024|FG000|Overall Study|Adverse Event|1|||
170563635|NCT00492557|616411025|FG001|Overall Study|Adverse Event|0|||
170563636|NCT00492557|616411024|FG000|Overall Study|Failed to return|1|||
170563637|NCT00492557|616411025|FG001|Overall Study|Failed to return|0|||
170563638|NCT00492557|616411024|FG000|Overall Study|Lost to Follow-up|0|||
170563639|NCT00492557|616411025|FG001|Overall Study|Lost to Follow-up|1|||
170563640|NCT01645176|616411032|FG000|Overall Study|Lack of Efficacy|4|||
170563641|NCT01645176|616411032|FG000|Overall Study|did not complete final MRI|1|||
170563642|NCT02164864|616411035|FG000|Overall Study|Trial disease worsening|7|||
170563643|NCT02164864|616411036|FG001|Overall Study|Trial disease worsening|5|||
170563644|NCT02164864|616411037|FG002|Overall Study|Trial disease worsening|1|||
170563645|NCT02164864|616411035|FG000|Overall Study|Other pre-existing disease worsening|6|||
170806879|NCT03389802|617301652|FG003|Overall Study|Lack of Efficacy|6|||
170563646|NCT02164864|616411036|FG001|Overall Study|Other pre-existing disease worsening|4|||
170563647|NCT02164864|616411037|FG002|Overall Study|Other pre-existing disease worsening|9|||
170905876|NCT00472303|617658511|FG001|Maintenance Phase|Trial medication non-compliant|0|||
170905877|NCT00472303|617658512|FG002|Maintenance Phase|Trial medication non-compliant|1|||
170905878|NCT00472303|617658510|FG000|Maintenance Phase|Resolution of pain|0|||
170905879|NCT00472303|617658511|FG001|Maintenance Phase|Resolution of pain|0|||
170905880|NCT00472303|617658512|FG002|Maintenance Phase|Resolution of pain|1|||
170905881|NCT00472303|617658510|FG000|Maintenance Phase|Other|1|||
170563648|NCT02164864|616411035|FG000|Overall Study|Other Adverse Event (AE)|52|||
170563649|NCT02164864|616411036|FG001|Overall Study|Other Adverse Event (AE)|32|||
170563650|NCT02164864|616411037|FG002|Overall Study|Other Adverse Event (AE)|49|||
170563651|NCT02164864|616411035|FG000|Overall Study|Protocol Violation|2|||
170563652|NCT02164864|616411036|FG001|Overall Study|Protocol Violation|4|||
170563653|NCT02164864|616411037|FG002|Overall Study|Protocol Violation|1|||
170563654|NCT02164864|616411035|FG000|Overall Study|Lost to Follow-up|4|||
170563655|NCT02164864|616411036|FG001|Overall Study|Lost to Follow-up|3|||
170563656|NCT02164864|616411037|FG002|Overall Study|Lost to Follow-up|2|||
170563657|NCT02164864|616411035|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
170563658|NCT02164864|616411036|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
170563659|NCT02164864|616411037|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
170563660|NCT02164864|616411035|FG000|Overall Study|Other than stated|3|||
170563661|NCT02164864|616411036|FG001|Overall Study|Other than stated|4|||
170563662|NCT02164864|616411037|FG002|Overall Study|Other than stated|14|||
170563663|NCT00904371|616411038|FG000|Overall Study|Adverse Event|2|||
170563664|NCT00904371|616411038|FG000|Overall Study|Lost to Follow-up|4|||
170563665|NCT00904371|616411038|FG000|Overall Study|Discontinued at target blood pressure|2|||
170563666|NCT00904371|616411038|FG000|Overall Study|Continued with Tritace|1|||
170563667|NCT00261833|616411039|FG000|Overall Study|Death|1|||
170563668|NCT00261833|616411040|FG001|Overall Study|Death|3|||
170563669|NCT00261833|616411039|FG000|Overall Study|Adverse Event|1|||
170563670|NCT00261833|616411040|FG001|Overall Study|Adverse Event|4|||
170563671|NCT00261833|616411039|FG000|Overall Study|Withdrawal by Subject|5|||
170563672|NCT00261833|616411040|FG001|Overall Study|Withdrawal by Subject|7|||
170563673|NCT00261833|616411039|FG000|Overall Study|Protocol Violation|0|||
170563674|NCT00261833|616411040|FG001|Overall Study|Protocol Violation|1|||
170563675|NCT00261833|616411039|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
170563676|NCT00261833|616411040|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
170563677|NCT00261833|616411039|FG000|Overall Study|Lung transplantation|1|||
170563678|NCT00261833|616411040|FG001|Overall Study|Lung transplantation|1|||
170645644|NCT01185353|616715977|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
170645645|NCT01185353|616715978|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
170645646|NCT01185353|616715979|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
170645647|NCT01185353|616715980|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
170645648|NCT01185353|616715981|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
170645649|NCT01185353|616715972|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
170645650|NCT01185353|616715973|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
170645651|NCT01185353|616715974|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
170905882|NCT00472303|617658511|FG001|Maintenance Phase|Other|1|||
170905883|NCT00472303|617658512|FG002|Maintenance Phase|Other|0|||
170905884|NCT03293680|617658517|FG000|Overall Study|Death|1|||
170905885|NCT03293680|617658517|FG000|Overall Study|Did not meet inclusion criteria|8|||
170905886|NCT00922935|617658518|FG000|Overall Study|Protocol Violation|0|||
170645652|NCT01185353|616715975|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
170563679|NCT00261833|616411039|FG000|Overall Study|Missing reason|1|||
170563680|NCT00261833|616411040|FG001|Overall Study|Missing reason|0|||
170563681|NCT00261833|616411039|FG000|Overall Study|Not interested in being participant|0|||
170563682|NCT00261833|616411040|FG001|Overall Study|Not interested in being participant|1|||
170563683|NCT01948427|616411041|FG000|Overall Study|Serious Adverse Event|3|||
170563684|NCT01948427|616411042|FG001|Overall Study|Serious Adverse Event|0|||
170563685|NCT01948427|616411043|FG002|Overall Study|Serious Adverse Event|0|||
170645653|NCT01185353|616715976|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
170563686|NCT01948427|616411044|FG003|Overall Study|Serious Adverse Event|0|||
170645654|NCT01185353|616715977|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
170645655|NCT01185353|616715978|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
170905887|NCT00922935|617658519|FG001|Overall Study|Protocol Violation|3|||
170905888|NCT00922935|617658520|FG002|Overall Study|Protocol Violation|0|||
170563687|NCT01948427|616411045|FG004|Overall Study|Serious Adverse Event|1|||
170563688|NCT01948427|616411041|FG000|Overall Study|Investigator Request|0|||
170563689|NCT01948427|616411042|FG001|Overall Study|Investigator Request|8|||
170563690|NCT01948427|616411043|FG002|Overall Study|Investigator Request|0|||
170563691|NCT01948427|616411044|FG003|Overall Study|Investigator Request|0|||
170563692|NCT01948427|616411045|FG004|Overall Study|Investigator Request|6|||
170905889|NCT00922935|617658518|FG000|Overall Study|Physician Decision|1|||
170905890|NCT00922935|617658519|FG001|Overall Study|Physician Decision|1|||
170645656|NCT01185353|616715979|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
170563693|NCT01948427|616411041|FG000|Overall Study|Lost to Follow-up|1|||
170563694|NCT01948427|616411042|FG001|Overall Study|Lost to Follow-up|0|||
170563695|NCT01948427|616411043|FG002|Overall Study|Lost to Follow-up|0|||
170563696|NCT01948427|616411044|FG003|Overall Study|Lost to Follow-up|0|||
170563697|NCT01948427|616411045|FG004|Overall Study|Lost to Follow-up|4|||
170563698|NCT01948427|616411041|FG000|Overall Study|Withdrawal by Subject|2|||
170563699|NCT01948427|616411042|FG001|Overall Study|Withdrawal by Subject|0|||
170563700|NCT01948427|616411043|FG002|Overall Study|Withdrawal by Subject|0|||
170563701|NCT01948427|616411044|FG003|Overall Study|Withdrawal by Subject|0|||
170563702|NCT01948427|616411045|FG004|Overall Study|Withdrawal by Subject|1|||
170563703|NCT01948427|616411041|FG000|Overall Study|Other, Not Specified|1|||
170563704|NCT01948427|616411042|FG001|Overall Study|Other, Not Specified|9|||
170563705|NCT01948427|616411043|FG002|Overall Study|Other, Not Specified|0|||
170563706|NCT01948427|616411044|FG003|Overall Study|Other, Not Specified|0|||
170563707|NCT01948427|616411045|FG004|Overall Study|Other, Not Specified|2|||
170563708|NCT00402987|616411046|FG000|Overall Study|Lack of Efficacy|0|||
170563709|NCT00402987|616411047|FG001|Overall Study|Lack of Efficacy|0|||
170563710|NCT00402987|616411048|FG002|Overall Study|Lack of Efficacy|1|||
170563711|NCT00402987|616411049|FG003|Overall Study|Lack of Efficacy|0|||
170563712|NCT00256126|616411050|FG000|Overall Study|Adverse Event|1|||
170563713|NCT00256126|616411051|FG001|Overall Study|Adverse Event|0|||
170563714|NCT00256126|616411050|FG000|Overall Study|Other|1|||
170563715|NCT00256126|616411051|FG001|Overall Study|Other|2|||
170563716|NCT02434081|616411052|FG000|Overall Study|Death (never started treatment)|2|||
170563717|NCT02434081|616411052|FG000|Overall Study|Death|2|||
170563718|NCT02434081|616411052|FG000|Overall Study|Progression|20|||
170563719|NCT02434081|616411052|FG000|Overall Study|Adverse Event|20|||
170563720|NCT02434081|616411052|FG000|Overall Study|Physician Decision|2|||
170563721|NCT02434081|616411052|FG000|Overall Study|Withdrawal by Subject|1|||
170563722|NCT02434081|616411052|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
170563723|NCT00583219|616411059|FG000|Phase 2|Withdrawal by Subject|1|||
170563724|NCT02131766|616411060|FG000|Overall Study|Withdrawal by Subject|4|||
170563725|NCT02706392|616411067|FG000|Overall Study|Death|1|||
170563726|NCT02706392|616411068|FG001|Overall Study|Death|0|||
170563727|NCT02706392|616411069|FG002|Overall Study|Death|2|||
170563728|NCT02706392|616411070|FG003|Overall Study|Death|2|||
170563729|NCT02706392|616411071|FG004|Overall Study|Death|5|||
170563730|NCT02706392|616411072|FG005|Overall Study|Death|2|||
170563731|NCT00619866|616411073|FG000|Weeks 1 - 12|Adverse Event|0|||
170563732|NCT00619866|616411074|FG001|Weeks 1 - 12|Adverse Event|1|||
170645657|NCT01185353|616715980|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
170645658|NCT01185353|616715981|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
170645659|NCT01030666|616715983|FG000|Overall Study|Lost to Follow-up|3|||
170563733|NCT00619866|616411075|FG002|Weeks 1 - 12|Adverse Event|2|||
170563734|NCT00619866|616411076|FG003|Weeks 1 - 12|Adverse Event|0|||
170563735|NCT00619866|616411077|FG004|Weeks 1 - 12|Adverse Event|0|||
170563736|NCT00619866|616411073|FG000|Weeks 1 - 12|Non-compliance|0|||
170563737|NCT00619866|616411074|FG001|Weeks 1 - 12|Non-compliance|0|||
170563738|NCT00619866|616411075|FG002|Weeks 1 - 12|Non-compliance|1|||
170563739|NCT00619866|616411076|FG003|Weeks 1 - 12|Non-compliance|0|||
170563740|NCT00619866|616411077|FG004|Weeks 1 - 12|Non-compliance|0|||
170563741|NCT00619866|616411073|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
170563742|NCT00619866|616411074|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
170563743|NCT00619866|616411075|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
170563744|NCT00619866|616411076|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
170563745|NCT00619866|616411077|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
170563746|NCT00619866|616411073|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
170563747|NCT00619866|616411074|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
170563748|NCT00619866|616411075|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
170563749|NCT00619866|616411076|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
170563750|NCT00619866|616411077|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
170563751|NCT00619866|616411073|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
170563752|NCT00619866|616411074|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
170563753|NCT00619866|616411075|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
170563754|NCT00619866|616411076|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
170563755|NCT00619866|616411077|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
170563756|NCT00619866|616411073|FG000|Weeks 1 - 12|Sponsor Decision|0|||
170563757|NCT00619866|616411074|FG001|Weeks 1 - 12|Sponsor Decision|1|||
170563758|NCT00619866|616411075|FG002|Weeks 1 - 12|Sponsor Decision|0|||
170563759|NCT00619866|616411076|FG003|Weeks 1 - 12|Sponsor Decision|0|||
170563760|NCT00619866|616411077|FG004|Weeks 1 - 12|Sponsor Decision|0|||
170563761|NCT00619866|616411073|FG000|Weeks 13 - 24|Adverse Event|0|||
170563762|NCT00619866|616411074|FG001|Weeks 13 - 24|Adverse Event|0|||
170563763|NCT00619866|616411075|FG002|Weeks 13 - 24|Adverse Event|2|||
170563764|NCT00619866|616411076|FG003|Weeks 13 - 24|Adverse Event|1|||
170563765|NCT00619866|616411077|FG004|Weeks 13 - 24|Adverse Event|0|||
170563766|NCT00619866|616411073|FG000|Weeks 13 - 24|Protocol Deviation|0|||
170563767|NCT00619866|616411074|FG001|Weeks 13 - 24|Protocol Deviation|0|||
170563768|NCT00619866|616411075|FG002|Weeks 13 - 24|Protocol Deviation|0|||
170645660|NCT01030666|616715984|FG001|Overall Study|Lost to Follow-up|2|||
170563769|NCT00619866|616411076|FG003|Weeks 13 - 24|Protocol Deviation|1|||
170563770|NCT00619866|616411077|FG004|Weeks 13 - 24|Protocol Deviation|0|||
170563771|NCT00619866|616411073|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
170563772|NCT00619866|616411074|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
170563773|NCT00619866|616411075|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
170563774|NCT00619866|616411076|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
170563775|NCT00619866|616411077|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
170563776|NCT00619866|616411073|FG000|Weeks 13 - 24|Non-compliance|0|||
170563777|NCT00619866|616411074|FG001|Weeks 13 - 24|Non-compliance|1|||
170563778|NCT00619866|616411075|FG002|Weeks 13 - 24|Non-compliance|1|||
170563779|NCT00619866|616411076|FG003|Weeks 13 - 24|Non-compliance|0|||
170563780|NCT00619866|616411077|FG004|Weeks 13 - 24|Non-compliance|0|||
170563781|NCT00619866|616411073|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
170563782|NCT00619866|616411074|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
170563783|NCT00619866|616411075|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
170563784|NCT00619866|616411076|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
170563785|NCT00619866|616411077|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
170563786|NCT01656161|616411078|FG000|Overall Study|Death|3|||
170563787|NCT01656161|616411078|FG000|Overall Study|Adverse Event|2|||
170563788|NCT01656161|616411078|FG000|Overall Study|Protocol Violation|1|||
170563789|NCT01656161|616411078|FG000|Overall Study|Withdrawal by Subject|1|||
170563790|NCT05205616|616411092|FG000|Overall Study|Lost to Follow-up|4|||
170563791|NCT05205616|616411093|FG001|Overall Study|Lost to Follow-up|4|||
170563792|NCT00982280|616411101|FG000|Observation Period|Not eligible to be dosed|19|||
170563793|NCT00982280|616411101|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
170563794|NCT00982280|616411101|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
170563795|NCT00982280|616411101|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
170563796|NCT00982280|616411101|FG000|Maintenance Period|Adverse Event|1|||
170563797|NCT03773484|616411102|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
170563798|NCT05177354|616411103|FG000|Implant to 30-day Visit|Physician Decision|1|||
170563799|NCT05177354|616411103|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
170563800|NCT05177354|616411103|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
170563801|NCT05177354|616411103|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
170563802|NCT03636022|616411104|FG000|Overall Study|Withdrawal by Subject|1|||
170563803|NCT03636022|616411105|FG001|Overall Study|Withdrawal by Subject|3|||
170563804|NCT03330847|616411108|FG000|Overall Study|Patients ongoing study|62|||
170563805|NCT03330847|616411109|FG001|Overall Study|Patients ongoing study|65|||
170563806|NCT03330847|616411110|FG002|Overall Study|Patients ongoing study|15|||
170563807|NCT02936323|616411111|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
170563808|NCT02936323|616411112|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
170563809|NCT02936323|616411113|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
170563810|NCT02936323|616411114|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
170563811|NCT02936323|616411115|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
170563812|NCT02936323|616411116|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
170563813|NCT02936323|616411117|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
170563814|NCT02936323|616411118|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
170563815|NCT02936323|616411119|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
170563816|NCT02936323|616411120|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
170563817|NCT02936323|616411111|FG000|Phase 1 Dose Escalation|Death|2|||
170563818|NCT02936323|616411112|FG001|Phase 1 Dose Escalation|Death|1|||
170563819|NCT02936323|616411113|FG002|Phase 1 Dose Escalation|Death|3|||
170563820|NCT02936323|616411114|FG003|Phase 1 Dose Escalation|Death|1|||
170563821|NCT02936323|616411115|FG004|Phase 1 Dose Escalation|Death|2|||
170563822|NCT02936323|616411116|FG005|Phase 1 Dose Escalation|Death|3|||
170563823|NCT02936323|616411117|FG006|Phase 1 Dose Escalation|Death|3|||
170563824|NCT02936323|616411118|FG007|Phase 1 Dose Escalation|Death|0|||
170563825|NCT02936323|616411119|FG008|Phase 1 Dose Escalation|Death|0|||
170563826|NCT02936323|616411120|FG009|Phase 1 Dose Escalation|Death|0|||
170563827|NCT02936323|616411111|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170563828|NCT02936323|616411112|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170563829|NCT02936323|616411113|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170563830|NCT02936323|616411114|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170645661|NCT00599339|616715989|FG000|Overall Study|Adverse Event|79|||
170645662|NCT00599339|616715989|FG000|Overall Study|Withdrawal by Subject|137|||
170645663|NCT00599339|616715989|FG000|Overall Study|Other Reason|179|||
170563831|NCT02936323|616411115|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170563832|NCT02936323|616411116|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
170563833|NCT02936323|616411117|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170563834|NCT02936323|616411118|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170563835|NCT02936323|616411119|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170563836|NCT02936323|616411120|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
170563837|NCT02936323|616411111|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
170645664|NCT00599339|616715989|FG000|Overall Study|Lost to Follow-up|221|||
170905891|NCT00922935|617658520|FG002|Overall Study|Physician Decision|0|||
170905892|NCT00922935|617658518|FG000|Overall Study|Lost to Follow-up|0|||
170905893|NCT00922935|617658519|FG001|Overall Study|Lost to Follow-up|1|||
170905894|NCT00922935|617658520|FG002|Overall Study|Lost to Follow-up|0|||
170905895|NCT01491945|617658521|FG000|Overall Study|Death|30|||
170905896|NCT01491945|617658521|FG000|Overall Study|Withdrwan/LTF|16|||
170905897|NCT01491945|617658521|FG000|Overall Study|Conversion|4|||
170905898|NCT01491945|617658521|FG000|Overall Study|Missed Visit|1|||
170905899|NCT04283461|617658522|FG000|Overall Study|Enrolled in separate trial|0|||
170905900|NCT04283461|617658523|FG001|Overall Study|Enrolled in separate trial|0|||
170905901|NCT04283461|617658524|FG002|Overall Study|Enrolled in separate trial|8|||
170905902|NCT04283461|617658525|FG003|Overall Study|Enrolled in separate trial|13|||
170905903|NCT04283461|617658526|FG004|Overall Study|Enrolled in separate trial|12|||
170905904|NCT04283461|617658527|FG005|Overall Study|Enrolled in separate trial|0|||
170905905|NCT04283461|617658528|FG006|Overall Study|Enrolled in separate trial|0|||
170905906|NCT04283461|617658529|FG007|Overall Study|Enrolled in separate trial|8|||
170905907|NCT04283461|617658530|FG008|Overall Study|Enrolled in separate trial|0|||
170905908|NCT04283461|617658531|FG009|Overall Study|Enrolled in separate trial|0|||
170905909|NCT04283461|617658532|FG010|Overall Study|Enrolled in separate trial|0|||
170905910|NCT04283461|617658533|FG011|Overall Study|Enrolled in separate trial|7|||
170905911|NCT04283461|617658534|FG012|Overall Study|Enrolled in separate trial|0|||
170905912|NCT00074958|617658536|FG000|Overall Study|Adverse Event|1|||
170905913|NCT03192904|617658541|FG000|Overall Study|Physician Decision|3|||
170905914|NCT03192904|617658542|FG001|Overall Study|Physician Decision|1|||
170905915|NCT03192904|617658541|FG000|Overall Study|Lost to Follow-up|0|||
170905916|NCT03192904|617658542|FG001|Overall Study|Lost to Follow-up|1|||
170905917|NCT03133767|617658552|FG000|Overall Study|Lost to Follow-up|38|||
170905918|NCT03133767|617658553|FG001|Overall Study|Lost to Follow-up|24|||
170905919|NCT03133767|617658552|FG000|Overall Study|Protocol Violation|0|||
170905920|NCT03133767|617658553|FG001|Overall Study|Protocol Violation|1|||
170905921|NCT01856114|617658554|FG000|Overall Study|Withdrawal by Subject|1|||
170905922|NCT01856114|617658555|FG001|Overall Study|Withdrawal by Subject|0|||
170905923|NCT01856114|617658554|FG000|Overall Study|Adverse Event|1|||
170905924|NCT01856114|617658555|FG001|Overall Study|Adverse Event|0|||
170905925|NCT02853760|617658556|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
170905926|NCT02853760|617658557|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
170905927|NCT02853760|617658558|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
170905928|NCT02853760|617658559|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
170905929|NCT02853760|617658560|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
170905930|NCT02853760|617658561|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
170905931|NCT02333227|617658566|FG000|Overall Study|Lost to Follow-up|137|||
170905932|NCT02333227|617658567|FG001|Overall Study|Lost to Follow-up|106|||
170905933|NCT02333227|617658566|FG000|Overall Study|Pregnancy Interrupted|42|||
170563838|NCT02936323|616411112|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
170563839|NCT02936323|616411113|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
170563840|NCT02936323|616411114|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
170563841|NCT02936323|616411115|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
170563842|NCT02936323|616411116|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
170563843|NCT02936323|616411117|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
170563844|NCT02936323|616411118|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
170563845|NCT02936323|616411119|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
170563846|NCT02936323|616411120|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
170563847|NCT02936323|616411111|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
170563848|NCT02936323|616411112|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
170563849|NCT02936323|616411113|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
170563850|NCT02936323|616411114|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
170563851|NCT02936323|616411115|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
170563852|NCT02936323|616411116|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
170563853|NCT02936323|616411117|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
170563854|NCT02936323|616411118|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
170563855|NCT02936323|616411119|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
170905934|NCT02333227|617658567|FG001|Overall Study|Pregnancy Interrupted|89|||
170905935|NCT02333227|617658566|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
170905936|NCT02333227|617658567|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
170905937|NCT00818259|617658570|FG000|Part I|Withdrawal by Subject|1|||
170905938|NCT00818259|617658571|FG001|Part I|Withdrawal by Subject|0|||
170905939|NCT00818259|617658572|FG002|Part I|Withdrawal by Subject|0|||
170905940|NCT00818259|617658573|FG003|Part I|Withdrawal by Subject|0|||
170905941|NCT00818259|617658574|FG004|Part I|Withdrawal by Subject|0|||
170905942|NCT00818259|617658575|FG005|Part I|Withdrawal by Subject|0|||
170905943|NCT00818259|617658576|FG006|Part I|Withdrawal by Subject|0|||
170905944|NCT00818259|617658577|FG007|Part I|Withdrawal by Subject|0|||
170905945|NCT00818259|617658578|FG008|Part I|Withdrawal by Subject|0|||
170905946|NCT00818259|617658570|FG000|Part II|Physician Decision|0|||
170563856|NCT02936323|616411120|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
170563857|NCT02936323|616411111|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
170563858|NCT02936323|616411112|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
170563859|NCT02936323|616411113|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
170563860|NCT02936323|616411114|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
170563861|NCT02936323|616411115|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
170563862|NCT02936323|616411116|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
170563863|NCT02936323|616411117|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
170563864|NCT02936323|616411118|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
170563865|NCT02936323|616411119|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
170563866|NCT02936323|616411120|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
170563867|NCT02936323|616411111|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563868|NCT02936323|616411112|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563869|NCT02936323|616411113|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563870|NCT02936323|616411114|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563871|NCT02936323|616411115|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563872|NCT02936323|616411116|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563873|NCT02936323|616411117|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563874|NCT02936323|616411118|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563875|NCT02936323|616411119|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
170563876|NCT02936323|616411120|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
170563877|NCT02936323|616411111|FG000|Phase 2a Dose Expansion|Death|0|||
170563878|NCT02936323|616411112|FG001|Phase 2a Dose Expansion|Death|0|||
170563879|NCT02936323|616411113|FG002|Phase 2a Dose Expansion|Death|0|||
170563880|NCT02936323|616411114|FG003|Phase 2a Dose Expansion|Death|0|||
170563881|NCT02936323|616411115|FG004|Phase 2a Dose Expansion|Death|0|||
170563882|NCT02936323|616411116|FG005|Phase 2a Dose Expansion|Death|0|||
170563883|NCT02936323|616411117|FG006|Phase 2a Dose Expansion|Death|0|||
170563884|NCT02936323|616411118|FG007|Phase 2a Dose Expansion|Death|4|||
170563885|NCT02936323|616411119|FG008|Phase 2a Dose Expansion|Death|8|||
170563886|NCT02936323|616411120|FG009|Phase 2a Dose Expansion|Death|10|||
170563887|NCT01346592|616411121|FG000|Overall Study|Lost to Follow-up|62|||
170563888|NCT01346592|616411122|FG001|Overall Study|Lost to Follow-up|29|||
170563889|NCT01346592|616411123|FG002|Overall Study|Lost to Follow-up|29|||
170563890|NCT01346592|616411121|FG000|Overall Study|Protocol Violation|2|||
170563891|NCT01346592|616411122|FG001|Overall Study|Protocol Violation|1|||
170563892|NCT01346592|616411123|FG002|Overall Study|Protocol Violation|0|||
170563893|NCT01346592|616411121|FG000|Overall Study|Death|1|||
170563894|NCT01346592|616411122|FG001|Overall Study|Death|3|||
170563895|NCT01346592|616411123|FG002|Overall Study|Death|4|||
170563896|NCT01346592|616411121|FG000|Overall Study|Adverse Event|0|||
170563897|NCT01346592|616411122|FG001|Overall Study|Adverse Event|1|||
170563898|NCT01346592|616411123|FG002|Overall Study|Adverse Event|0|||
170563899|NCT01346592|616411121|FG000|Overall Study|Withdrawal by Subject|77|||
170563900|NCT01346592|616411122|FG001|Overall Study|Withdrawal by Subject|51|||
170563901|NCT01346592|616411123|FG002|Overall Study|Withdrawal by Subject|38|||
170563902|NCT01346592|616411121|FG000|Overall Study|Inappropriate enrollment|3|||
170563903|NCT01346592|616411122|FG001|Overall Study|Inappropriate enrollment|1|||
170563904|NCT01346592|616411123|FG002|Overall Study|Inappropriate enrollment|1|||
170563905|NCT01346592|616411121|FG000|Overall Study|Administrative reason|1|||
170563906|NCT01346592|616411122|FG001|Overall Study|Administrative reason|0|||
170563907|NCT01346592|616411123|FG002|Overall Study|Administrative reason|0|||
170563908|NCT01346592|616411121|FG000|Overall Study|Unable to Classify|7|||
170563909|NCT01346592|616411122|FG001|Overall Study|Unable to Classify|3|||
170563910|NCT01346592|616411123|FG002|Overall Study|Unable to Classify|6|||
170563911|NCT02781558|616411124|FG000|Overall Study|Lost to Follow-up|2|||
170563912|NCT02781558|616411125|FG001|Overall Study|Lost to Follow-up|2|||
170563913|NCT02781558|616411124|FG000|Overall Study|Adverse Event|1|||
170563914|NCT02781558|616411125|FG001|Overall Study|Adverse Event|0|||
170563915|NCT00643279|616411132|FG000|Overall Study|Death|13|||
170563916|NCT00643279|616411133|FG001|Overall Study|Death|11|||
170563917|NCT00643279|616411132|FG000|Overall Study|Withdrawal by Subject|3|||
170563918|NCT00643279|616411133|FG001|Overall Study|Withdrawal by Subject|0|||
170563919|NCT00643279|616411132|FG000|Overall Study|Lost to Follow-up|0|||
170563920|NCT00643279|616411133|FG001|Overall Study|Lost to Follow-up|1|||
170563921|NCT00643279|616411132|FG000|Overall Study|Physician Decision|0|||
170563922|NCT00643279|616411133|FG001|Overall Study|Physician Decision|1|||
170563923|NCT04398706|616411134|FG000|Overall Study|Adverse Event|0|||
170563924|NCT04398706|616411135|FG001|Overall Study|Adverse Event|0|||
170563925|NCT04398706|616411136|FG002|Overall Study|Adverse Event|0|||
170563926|NCT04398706|616411137|FG003|Overall Study|Adverse Event|0|||
170563927|NCT04398706|616411138|FG004|Overall Study|Adverse Event|0|||
170563928|NCT04398706|616411139|FG005|Overall Study|Adverse Event|1|||
170563929|NCT04398706|616411140|FG006|Overall Study|Adverse Event|1|||
170563930|NCT04398706|616411141|FG007|Overall Study|Adverse Event|0|||
170563931|NCT04398706|616411134|FG000|Overall Study|Lost to Follow-up|0|||
170563932|NCT04398706|616411135|FG001|Overall Study|Lost to Follow-up|1|||
170563933|NCT04398706|616411136|FG002|Overall Study|Lost to Follow-up|2|||
170563934|NCT04398706|616411137|FG003|Overall Study|Lost to Follow-up|1|||
170563935|NCT04398706|616411138|FG004|Overall Study|Lost to Follow-up|6|||
170563936|NCT04398706|616411139|FG005|Overall Study|Lost to Follow-up|3|||
170563937|NCT04398706|616411140|FG006|Overall Study|Lost to Follow-up|8|||
170563938|NCT04398706|616411141|FG007|Overall Study|Lost to Follow-up|2|||
170563939|NCT04398706|616411134|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170563940|NCT04398706|616411135|FG001|Overall Study|Withdrawal by parent/guardian|2|||
170563941|NCT04398706|616411136|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170563942|NCT04398706|616411137|FG003|Overall Study|Withdrawal by parent/guardian|2|||
170563943|NCT04398706|616411138|FG004|Overall Study|Withdrawal by parent/guardian|19|||
170563944|NCT04398706|616411139|FG005|Overall Study|Withdrawal by parent/guardian|23|||
170563945|NCT04398706|616411140|FG006|Overall Study|Withdrawal by parent/guardian|13|||
170563946|NCT04398706|616411141|FG007|Overall Study|Withdrawal by parent/guardian|11|||
170563947|NCT04398706|616411134|FG000|Overall Study|Protocol deviation|0|||
170563948|NCT04398706|616411135|FG001|Overall Study|Protocol deviation|1|||
170563949|NCT04398706|616411136|FG002|Overall Study|Protocol deviation|0|||
170563950|NCT04398706|616411137|FG003|Overall Study|Protocol deviation|0|||
170563951|NCT04398706|616411138|FG004|Overall Study|Protocol deviation|6|||
170563952|NCT04398706|616411139|FG005|Overall Study|Protocol deviation|4|||
170563953|NCT04398706|616411140|FG006|Overall Study|Protocol deviation|6|||
170563954|NCT04398706|616411141|FG007|Overall Study|Protocol deviation|3|||
170563955|NCT05819398|616411143|FG000|Overall Study|Withdrawal by Subject|11|||
170563956|NCT05819398|616411144|FG001|Overall Study|Withdrawal by Subject|7|||
170563957|NCT05819398|616411145|FG002|Overall Study|Withdrawal by Subject|6|||
170563958|NCT05819398|616411146|FG003|Overall Study|Withdrawal by Subject|6|||
170563959|NCT05819398|616411143|FG000|Overall Study|Lost to Follow-up|0|||
170563960|NCT05819398|616411144|FG001|Overall Study|Lost to Follow-up|2|||
170563961|NCT05819398|616411145|FG002|Overall Study|Lost to Follow-up|0|||
170563962|NCT05819398|616411146|FG003|Overall Study|Lost to Follow-up|1|||
170563963|NCT05819398|616411143|FG000|Overall Study|Adverse Event|1|||
170563964|NCT05819398|616411144|FG001|Overall Study|Adverse Event|3|||
170563965|NCT05819398|616411145|FG002|Overall Study|Adverse Event|4|||
170563966|NCT05819398|616411146|FG003|Overall Study|Adverse Event|5|||
170563967|NCT05819398|616411143|FG000|Overall Study|Other than listed|0|||
170563968|NCT05819398|616411144|FG001|Overall Study|Other than listed|2|||
170563969|NCT05819398|616411145|FG002|Overall Study|Other than listed|2|||
170563970|NCT05819398|616411146|FG003|Overall Study|Other than listed|0|||
170563971|NCT05819398|616411143|FG000|Overall Study|Lack of Efficacy|0|||
170563972|NCT05819398|616411144|FG001|Overall Study|Lack of Efficacy|1|||
170563973|NCT05819398|616411145|FG002|Overall Study|Lack of Efficacy|0|||
170563974|NCT05819398|616411146|FG003|Overall Study|Lack of Efficacy|0|||
170563975|NCT05819398|616411143|FG000|Overall Study|Study terminated by sponsor|20|||
170563976|NCT05819398|616411144|FG001|Overall Study|Study terminated by sponsor|18|||
170563977|NCT05819398|616411145|FG002|Overall Study|Study terminated by sponsor|20|||
170563978|NCT05819398|616411146|FG003|Overall Study|Study terminated by sponsor|22|||
170563979|NCT02114177|616412585|FG000|Overall Study|Lost to Follow-up|1|||
170563980|NCT02114177|616412586|FG001|Overall Study|Lost to Follow-up|2|||
170563981|NCT02114177|616412585|FG000|Overall Study|Withdrawal by Subject|6|||
170563982|NCT02114177|616412586|FG001|Overall Study|Withdrawal by Subject|1|||
170563983|NCT02114177|616412585|FG000|Overall Study|Other|2|||
170563984|NCT02114177|616412586|FG001|Overall Study|Other|1|||
170563985|NCT01897493|616412587|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
170563986|NCT02777086|616412588|FG000|Overall Study|Lost to Follow-up|96|||
170563987|NCT02777086|616412589|FG001|Overall Study|Lost to Follow-up|99|||
170563988|NCT04388826|616412590|FG000|Overall Study|Lost to Follow-up|3|||
170563989|NCT04388826|616412591|FG001|Overall Study|Lost to Follow-up|2|||
170563990|NCT04388826|616412590|FG000|Overall Study|Adverse Event|1|||
170563991|NCT04388826|616412591|FG001|Overall Study|Adverse Event|0|||
170563992|NCT01840943|616412592|FG000|Overall Study|Withdrawal by Subject|5|||
170563993|NCT01840943|616412593|FG001|Overall Study|Withdrawal by Subject|6|||
170645665|NCT00599339|616715989|FG000|Overall Study|No valid data consent|36|||
170645666|NCT00599339|616715989|FG000|Overall Study|Study Termination Status Unknown|12|||
170563994|NCT01840943|616412592|FG000|Overall Study|Physician Decision|4|||
170563995|NCT01840943|616412593|FG001|Overall Study|Physician Decision|2|||
170563996|NCT01840943|616412592|FG000|Overall Study|Lost to Follow-up|4|||
170563997|NCT01840943|616412593|FG001|Overall Study|Lost to Follow-up|4|||
170563998|NCT02367456|616412594|FG000|Overall Study|Death|8|||
170563999|NCT02367456|616412595|FG001|Overall Study|Death|24|||
170564000|NCT02367456|616412596|FG002|Overall Study|Death|17|||
170564001|NCT02367456|616412594|FG000|Overall Study|Lost to Follow-up|1|||
170564002|NCT02367456|616412595|FG001|Overall Study|Lost to Follow-up|3|||
170564003|NCT02367456|616412596|FG002|Overall Study|Lost to Follow-up|1|||
170564004|NCT02367456|616412594|FG000|Overall Study|Other reason|3|||
170564005|NCT02367456|616412595|FG001|Overall Study|Other reason|3|||
170564006|NCT02367456|616412596|FG002|Overall Study|Other reason|9|||
170564007|NCT02367456|616412594|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
170564008|NCT02367456|616412595|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
170905947|NCT00818259|617658571|FG001|Part II|Physician Decision|0|||
170905948|NCT00818259|617658572|FG002|Part II|Physician Decision|1|||
170905949|NCT00818259|617658573|FG003|Part II|Physician Decision|0|||
170905950|NCT00818259|617658574|FG004|Part II|Physician Decision|0|||
170905951|NCT00818259|617658575|FG005|Part II|Physician Decision|0|||
170905952|NCT00818259|617658576|FG006|Part II|Physician Decision|0|||
170905953|NCT00818259|617658577|FG007|Part II|Physician Decision|0|||
170905954|NCT00818259|617658578|FG008|Part II|Physician Decision|0|||
170905955|NCT00818259|617658570|FG000|Part II|Lack of Efficacy|0|||
170905956|NCT00818259|617658571|FG001|Part II|Lack of Efficacy|0|||
170905957|NCT00818259|617658572|FG002|Part II|Lack of Efficacy|0|||
170905958|NCT00818259|617658573|FG003|Part II|Lack of Efficacy|1|||
170905959|NCT00818259|617658574|FG004|Part II|Lack of Efficacy|0|||
170905960|NCT00818259|617658575|FG005|Part II|Lack of Efficacy|0|||
170905961|NCT00818259|617658576|FG006|Part II|Lack of Efficacy|0|||
170905962|NCT00818259|617658577|FG007|Part II|Lack of Efficacy|0|||
170905963|NCT00818259|617658578|FG008|Part II|Lack of Efficacy|0|||
170905964|NCT00818259|617658570|FG000|Part II|Not Treated|0|||
170905965|NCT00818259|617658571|FG001|Part II|Not Treated|0|||
170905966|NCT00818259|617658572|FG002|Part II|Not Treated|0|||
170905967|NCT00818259|617658573|FG003|Part II|Not Treated|1|||
170905968|NCT00818259|617658574|FG004|Part II|Not Treated|0|||
170905969|NCT00818259|617658575|FG005|Part II|Not Treated|0|||
170905970|NCT00818259|617658576|FG006|Part II|Not Treated|0|||
170905971|NCT00818259|617658577|FG007|Part II|Not Treated|0|||
170905972|NCT00818259|617658578|FG008|Part II|Not Treated|0|||
170905973|NCT00818259|617658570|FG000|Part IV|Physician Decision|0|||
170564009|NCT02367456|616412596|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
170564010|NCT05067335|616412597|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
170564011|NCT05067335|616412598|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
170564012|NCT05067335|616412599|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
170564013|NCT05067335|616412600|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
170564014|NCT05067335|616412597|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
170564015|NCT05067335|616412598|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
170564016|NCT05067335|616412599|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
170564017|NCT05067335|616412600|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
170564018|NCT05067335|616412597|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
170564019|NCT05067335|616412598|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
170564020|NCT05067335|616412599|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
170564021|NCT05067335|616412600|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
170564022|NCT05067335|616412597|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
170564023|NCT05067335|616412598|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
170564024|NCT05067335|616412599|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
170564025|NCT05067335|616412600|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
170564026|NCT05067335|616412597|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
170564027|NCT05067335|616412598|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
170564028|NCT05067335|616412599|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
170564029|NCT05067335|616412600|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
170564030|NCT05067335|616412597|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
170564031|NCT05067335|616412598|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
170564032|NCT05067335|616412599|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
170564033|NCT05067335|616412600|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
170564034|NCT05067335|616412597|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
170564035|NCT05067335|616412598|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
170564036|NCT05067335|616412599|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
170564037|NCT05067335|616412600|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
170564038|NCT05067335|616412597|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
170564039|NCT05067335|616412598|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
170564040|NCT05067335|616412599|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
170564041|NCT05067335|616412600|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
170564042|NCT05067335|616412597|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
170565572|NCT01331681|616418574|FG002|Overall Study|Not Received Study Treatment|2|||
170905974|NCT00818259|617658571|FG001|Part IV|Physician Decision|0|||
170905975|NCT00818259|617658572|FG002|Part IV|Physician Decision|0|||
170905976|NCT00818259|617658573|FG003|Part IV|Physician Decision|0|||
170905977|NCT00818259|617658574|FG004|Part IV|Physician Decision|0|||
170905978|NCT00818259|617658575|FG005|Part IV|Physician Decision|1|||
170905979|NCT00818259|617658576|FG006|Part IV|Physician Decision|0|||
170905980|NCT00818259|617658577|FG007|Part IV|Physician Decision|0|||
170905981|NCT00818259|617658578|FG008|Part IV|Physician Decision|0|||
170905982|NCT00818259|617658570|FG000|Part V|Adverse Event|0|||
170905983|NCT00818259|617658571|FG001|Part V|Adverse Event|0|||
170905984|NCT00818259|617658572|FG002|Part V|Adverse Event|0|||
170564043|NCT05067335|616412598|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
170564044|NCT05067335|616412599|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
170564045|NCT05067335|616412600|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
170564046|NCT05067335|616412597|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
170564047|NCT05067335|616412598|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
170564048|NCT05067335|616412599|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
170905985|NCT00818259|617658573|FG003|Part V|Adverse Event|0|||
170905986|NCT00818259|617658574|FG004|Part V|Adverse Event|0|||
170905987|NCT00818259|617658575|FG005|Part V|Adverse Event|0|||
170905988|NCT00818259|617658576|FG006|Part V|Adverse Event|0|||
170905989|NCT00818259|617658577|FG007|Part V|Adverse Event|1|||
170564049|NCT05067335|616412600|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
170564050|NCT03610048|616412601|FG000|Overall Study|Study terminated by sponsor|84|||
170564051|NCT03610048|616412601|FG000|Overall Study|Adverse Event|32|||
170564052|NCT03610048|616412601|FG000|Overall Study|Withdrawal by Subject|31|||
170564053|NCT03610048|616412601|FG000|Overall Study|Lost to Follow-up|8|||
170564054|NCT03610048|616412601|FG000|Overall Study|Other|4|||
170564055|NCT03610048|616412601|FG000|Overall Study|Physician Decision|1|||
170564056|NCT03610048|616412601|FG000|Overall Study|Pregnancy|1|||
170564057|NCT00754572|616412603|FG000|Overall Study|Adverse Event|19|||
170564058|NCT00754572|616412603|FG000|Overall Study|Other|39|||
170564059|NCT00754572|616412603|FG000|Overall Study|Protocol Violation|3|||
170564060|NCT00754572|616412603|FG000|Overall Study|Withdrawal by Subject|3|||
170564061|NCT00754572|616412603|FG000|Overall Study|Lack of Efficacy|2|||
170564062|NCT00754572|616412603|FG000|Overall Study|Death|1|||
170564063|NCT00754572|616412603|FG000|Overall Study|Administrative Reason|3|||
170564064|NCT00754572|616412603|FG000|Overall Study|Lost to Follow-up|1|||
170564065|NCT04617860|616412604|FG000|Overall Study|Adverse Event|0|||
170564066|NCT04617860|616412605|FG001|Overall Study|Adverse Event|2|||
170564067|NCT04617860|616412606|FG002|Overall Study|Adverse Event|2|||
170564068|NCT04617860|616412604|FG000|Overall Study|Withdrawal by Subject|0|||
170564069|NCT04617860|616412605|FG001|Overall Study|Withdrawal by Subject|0|||
170564070|NCT04617860|616412606|FG002|Overall Study|Withdrawal by Subject|2|||
170564071|NCT04617860|616412604|FG000|Overall Study|Physician Decision|0|||
170564072|NCT04617860|616412605|FG001|Overall Study|Physician Decision|1|||
170564073|NCT04617860|616412606|FG002|Overall Study|Physician Decision|0|||
170564074|NCT04617860|616412604|FG000|Overall Study|Sponsor Decision|0|||
170564075|NCT04617860|616412605|FG001|Overall Study|Sponsor Decision|3|||
170564076|NCT04617860|616412606|FG002|Overall Study|Sponsor Decision|1|||
170564077|NCT04617860|616412604|FG000|Overall Study|Termination of Study by Sponsor|8|||
170564078|NCT04617860|616412605|FG001|Overall Study|Termination of Study by Sponsor|4|||
170564079|NCT04617860|616412606|FG002|Overall Study|Termination of Study by Sponsor|13|||
170564080|NCT00474903|616412609|FG000|Overall Study|Protocol Violation|1|||
170564081|NCT00474903|616412610|FG001|Overall Study|Protocol Violation|5|||
170564082|NCT00474903|616412611|FG002|Overall Study|Protocol Violation|2|||
170564083|NCT02735200|616412614|FG000|Overall Study|Lost to Follow-up|0|||
170564084|NCT02735200|616412615|FG001|Overall Study|Lost to Follow-up|5|||
170564085|NCT02735200|616412614|FG000|Overall Study|Withdrawal by Subject|8|||
170564086|NCT02735200|616412615|FG001|Overall Study|Withdrawal by Subject|0|||
170564087|NCT02493764|616412619|FG000|Overall Study|Adverse Event|2|||
170564088|NCT02493764|616412620|FG001|Overall Study|Adverse Event|2|||
170564089|NCT02493764|616412619|FG000|Overall Study|Death|44|||
170564090|NCT02493764|616412620|FG001|Overall Study|Death|58|||
170564091|NCT02493764|616412619|FG000|Overall Study|Lost to Follow-up|2|||
170564092|NCT02493764|616412620|FG001|Overall Study|Lost to Follow-up|1|||
170564093|NCT02493764|616412619|FG000|Overall Study|Protocol Violation|6|||
170564094|NCT02493764|616412620|FG001|Overall Study|Protocol Violation|7|||
170564095|NCT02493764|616412619|FG000|Overall Study|Physician Decision|1|||
170564096|NCT02493764|616412620|FG001|Overall Study|Physician Decision|1|||
170564097|NCT02493764|616412619|FG000|Overall Study|Participant moved|17|||
170564098|NCT02493764|616412620|FG001|Overall Study|Participant moved|5|||
170564099|NCT02493764|616412619|FG000|Overall Study|Withdrawal parent/guardian|0|||
170564100|NCT02493764|616412620|FG001|Overall Study|Withdrawal parent/guardian|1|||
170564101|NCT02493764|616412619|FG000|Overall Study|Withdrawal by Subject|11|||
170564102|NCT02493764|616412620|FG001|Overall Study|Withdrawal by Subject|7|||
170564103|NCT01561976|616412623|FG000|Period 1|Adverse Event|0|||
170564104|NCT01561976|616412624|FG001|Period 1|Adverse Event|0|||
170564105|NCT01561976|616412625|FG002|Period 1|Adverse Event|1|||
170564106|NCT01561976|616412626|FG003|Period 1|Adverse Event|0|||
170564107|NCT01561976|616412627|FG004|Period 1|Adverse Event|0|||
170564108|NCT01561976|616412628|FG005|Period 1|Adverse Event|0|||
170564109|NCT01561976|616412623|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
170905990|NCT00818259|617658578|FG008|Part V|Adverse Event|0|||
170905991|NCT04640766|617658579|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
170905992|NCT02597062|617658580|FG000|Overall Study|Ineligible|1|||
170564110|NCT01561976|616412624|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
170564111|NCT01561976|616412625|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
170564112|NCT01561976|616412626|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
170564113|NCT01561976|616412627|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
170564114|NCT01561976|616412628|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
170564115|NCT01561976|616412623|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170564116|NCT01561976|616412624|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170564117|NCT01561976|616412625|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170564118|NCT01561976|616412626|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170564119|NCT01561976|616412627|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170564120|NCT01561976|616412628|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
170564121|NCT01561976|616412623|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
170564122|NCT01561976|616412624|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
170564123|NCT01561976|616412625|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
170564124|NCT01561976|616412626|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
170564125|NCT01561976|616412627|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
170564126|NCT01561976|616412628|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
170564127|NCT01493414|616412629|FG000|Overall Study|Adverse Event|405|||
170564128|NCT01493414|616412629|FG000|Overall Study|Disease progression|204|||
170564129|NCT01493414|616412629|FG000|Overall Study|Death|101|||
170564130|NCT01493414|616412629|FG000|Overall Study|Physician Decision|93|||
170564131|NCT01493414|616412629|FG000|Overall Study|Withdrawal by Subject|79|||
170564132|NCT01493414|616412629|FG000|Overall Study|Protocol deviation|27|||
170564133|NCT01493414|616412629|FG000|Overall Study|Administrative problems|25|||
170564134|NCT01493414|616412629|FG000|Overall Study|Lost to Follow-up|16|||
170564135|NCT01977222|616412634|FG000|Overall Study|Withdrawal by Subject|1|||
170564136|NCT04846231|616412643|FG000|Overall Study|Lost to Follow-up|1|||
170564137|NCT04846231|616412644|FG001|Overall Study|Lost to Follow-up|0|||
170564138|NCT04846231|616412645|FG002|Overall Study|Lost to Follow-up|0|||
170564139|NCT04846231|616412646|FG003|Overall Study|Lost to Follow-up|0|||
170564140|NCT04846231|616412647|FG004|Overall Study|Lost to Follow-up|0|||
170564141|NCT04846231|616412648|FG005|Overall Study|Lost to Follow-up|0|||
170564142|NCT04846231|616412649|FG006|Overall Study|Lost to Follow-up|0|||
170564143|NCT04846231|616412650|FG007|Overall Study|Lost to Follow-up|1|||
170564144|NCT04846231|616412643|FG000|Overall Study|Withdrawal by Subject|0|||
170564145|NCT04846231|616412644|FG001|Overall Study|Withdrawal by Subject|1|||
170564146|NCT04846231|616412645|FG002|Overall Study|Withdrawal by Subject|2|||
170564147|NCT04846231|616412646|FG003|Overall Study|Withdrawal by Subject|1|||
170564148|NCT04846231|616412647|FG004|Overall Study|Withdrawal by Subject|0|||
170564149|NCT04846231|616412648|FG005|Overall Study|Withdrawal by Subject|0|||
170564150|NCT04846231|616412649|FG006|Overall Study|Withdrawal by Subject|0|||
170564151|NCT04846231|616412650|FG007|Overall Study|Withdrawal by Subject|0|||
170564152|NCT04846231|616412643|FG000|Overall Study|Protocol Violation|0|||
170564153|NCT04846231|616412644|FG001|Overall Study|Protocol Violation|1|||
170564154|NCT04846231|616412645|FG002|Overall Study|Protocol Violation|0|||
170564155|NCT04846231|616412646|FG003|Overall Study|Protocol Violation|0|||
170564156|NCT04846231|616412647|FG004|Overall Study|Protocol Violation|0|||
170564157|NCT04846231|616412648|FG005|Overall Study|Protocol Violation|0|||
170564158|NCT04846231|616412649|FG006|Overall Study|Protocol Violation|0|||
170564159|NCT04846231|616412650|FG007|Overall Study|Protocol Violation|0|||
170564160|NCT04846231|616412643|FG000|Overall Study|Adverse Event|0|||
170564161|NCT04846231|616412644|FG001|Overall Study|Adverse Event|0|||
170564162|NCT04846231|616412645|FG002|Overall Study|Adverse Event|0|||
170564163|NCT04846231|616412646|FG003|Overall Study|Adverse Event|0|||
170564164|NCT04846231|616412647|FG004|Overall Study|Adverse Event|0|||
170564165|NCT04846231|616412648|FG005|Overall Study|Adverse Event|0|||
170564166|NCT04846231|616412649|FG006|Overall Study|Adverse Event|1|||
170564167|NCT04846231|616412650|FG007|Overall Study|Adverse Event|1|||
170564168|NCT05448950|616412653|FG000|Overall Study|Death|2|||
170564169|NCT05448950|616412653|FG000|Overall Study|Withdrawal by Subject|1|||
170564170|NCT05448950|616412653|FG000|Overall Study|AVG abandoned|4|||
170564171|NCT01646827|616412654|FG000|Overall Study|Lost to Follow-up|0|||
170564172|NCT01646827|616412655|FG001|Overall Study|Lost to Follow-up|3|||
170564173|NCT01646827|616412654|FG000|Overall Study|Physician Decision|1|||
170564174|NCT01646827|616412655|FG001|Overall Study|Physician Decision|2|||
170564175|NCT01646827|616412654|FG000|Overall Study|Withdrawal by Subject|1|||
170564176|NCT01646827|616412655|FG001|Overall Study|Withdrawal by Subject|0|||
170564177|NCT01143402|616412665|FG000|Overall Study|Rapid clinical decline|1|||
170564178|NCT01143402|616412666|FG001|Overall Study|Rapid clinical decline|1|||
170564179|NCT01143402|616412667|FG002|Overall Study|Rapid clinical decline|0|||
170564180|NCT01143402|616412665|FG000|Overall Study|Not Treated|0|||
170564181|NCT01143402|616412666|FG001|Overall Study|Not Treated|0|||
170564182|NCT01143402|616412667|FG002|Overall Study|Not Treated|1|||
170564183|NCT04462471|616412668|FG000|Overall Study|Adverse Event|0|||
170564184|NCT04462471|616412669|FG001|Overall Study|Adverse Event|1|||
170564185|NCT04462471|616412670|FG002|Overall Study|Adverse Event|0|||
170564186|NCT04462471|616412671|FG003|Overall Study|Adverse Event|0|||
170564187|NCT04462471|616412668|FG000|Overall Study|Disease progression|1|||
170564188|NCT04462471|616412669|FG001|Overall Study|Disease progression|0|||
170564189|NCT04462471|616412670|FG002|Overall Study|Disease progression|0|||
170564190|NCT04462471|616412671|FG003|Overall Study|Disease progression|0|||
170564191|NCT05805150|616412672|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
170564192|NCT05805150|616412673|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
170564193|NCT00485173|616412679|FG000|Overall Study|Death|4|||
170564194|NCT00485173|616412680|FG001|Overall Study|Death|3|||
170564195|NCT00485173|616412679|FG000|Overall Study|Lost to Follow-up|32|||
170564196|NCT00485173|616412680|FG001|Overall Study|Lost to Follow-up|61|||
170564197|NCT03193801|616412696|FG000|Overall Study|Physician Decision|2|||
170564198|NCT03193801|616412696|FG000|Overall Study|Withdrawal by Subject|1|||
170564199|NCT03110562|616412697|FG000|Initial Treatment Period|Disease Progression|1|||
170564200|NCT03110562|616412698|FG001|Initial Treatment Period|Disease Progression|1|||
170564201|NCT03110562|616412699|FG002|Initial Treatment Period|Disease Progression|0|||
170564202|NCT03110562|616412700|FG003|Initial Treatment Period|Disease Progression|0|||
170564203|NCT03110562|616412697|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
170564204|NCT03110562|616412698|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
170564205|NCT03110562|616412699|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
170564206|NCT03110562|616412700|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
170564207|NCT03110562|616412697|FG000|Initial Treatment Period|Adverse Event|1|||
170564208|NCT03110562|616412698|FG001|Initial Treatment Period|Adverse Event|0|||
170564209|NCT03110562|616412699|FG002|Initial Treatment Period|Adverse Event|0|||
170564210|NCT03110562|616412700|FG003|Initial Treatment Period|Adverse Event|0|||
170564211|NCT03110562|616412697|FG000|Initial Treatment Period|Death|74|||
170564212|NCT03110562|616412698|FG001|Initial Treatment Period|Death|82|||
170564213|NCT03110562|616412699|FG002|Initial Treatment Period|Death|0|||
170564214|NCT03110562|616412700|FG003|Initial Treatment Period|Death|0|||
170564215|NCT03110562|616412697|FG000|Initial Treatment Period|Lost to Follow-up|13|||
170564216|NCT03110562|616412698|FG001|Initial Treatment Period|Lost to Follow-up|8|||
170564217|NCT03110562|616412699|FG002|Initial Treatment Period|Lost to Follow-up|0|||
170564218|NCT03110562|616412700|FG003|Initial Treatment Period|Lost to Follow-up|0|||
170564219|NCT03110562|616412697|FG000|Initial Treatment Period|Protocol Deviation|1|||
170564220|NCT03110562|616412698|FG001|Initial Treatment Period|Protocol Deviation|0|||
170564221|NCT03110562|616412699|FG002|Initial Treatment Period|Protocol Deviation|0|||
170564222|NCT03110562|616412700|FG003|Initial Treatment Period|Protocol Deviation|0|||
170564223|NCT03110562|616412697|FG000|Initial Treatment Period|Physician Decision|2|||
170564224|NCT03110562|616412698|FG001|Initial Treatment Period|Physician Decision|1|||
170564225|NCT03110562|616412699|FG002|Initial Treatment Period|Physician Decision|0|||
170564226|NCT03110562|616412700|FG003|Initial Treatment Period|Physician Decision|0|||
170564227|NCT03110562|616412697|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
170564228|NCT03110562|616412698|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
170564229|NCT03110562|616412699|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
170564230|NCT03110562|616412700|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
170564231|NCT03110562|616412697|FG000|Initial Treatment Period|Other|5|||
170564232|NCT03110562|616412698|FG001|Initial Treatment Period|Other|4|||
170564233|NCT03110562|616412699|FG002|Initial Treatment Period|Other|0|||
170564234|NCT03110562|616412700|FG003|Initial Treatment Period|Other|0|||
170564235|NCT03110562|616412697|FG000|Initial Treatment Period|Randomized but never treated|0|||
170564236|NCT03110562|616412698|FG001|Initial Treatment Period|Randomized but never treated|3|||
170564237|NCT03110562|616412699|FG002|Initial Treatment Period|Randomized but never treated|0|||
170564238|NCT03110562|616412700|FG003|Initial Treatment Period|Randomized but never treated|0|||
170564239|NCT03110562|616412697|FG000|Crossover Period|Disease Progression|0|||
170564240|NCT03110562|616412698|FG001|Crossover Period|Disease Progression|0|||
170564241|NCT03110562|616412699|FG002|Crossover Period|Disease Progression|1|||
170564242|NCT03110562|616412700|FG003|Crossover Period|Disease Progression|0|||
170564243|NCT03110562|616412697|FG000|Crossover Period|Withdrawal by Subject|0|||
170564244|NCT03110562|616412698|FG001|Crossover Period|Withdrawal by Subject|0|||
170564245|NCT03110562|616412699|FG002|Crossover Period|Withdrawal by Subject|8|||
170399327|NCT03193190|615799952|FG015|Stage 1|Progressive Disease|0|||
170564246|NCT03110562|616412700|FG003|Crossover Period|Withdrawal by Subject|6|||
170564247|NCT03110562|616412697|FG000|Crossover Period|Death|0|||
170564248|NCT03110562|616412698|FG001|Crossover Period|Death|0|||
170564249|NCT03110562|616412699|FG002|Crossover Period|Death|37|||
170564250|NCT03110562|616412700|FG003|Crossover Period|Death|3|||
170564251|NCT03110562|616412697|FG000|Crossover Period|Lost to Follow-up|0|||
170564252|NCT03110562|616412698|FG001|Crossover Period|Lost to Follow-up|0|||
170564253|NCT03110562|616412699|FG002|Crossover Period|Lost to Follow-up|0|||
170564254|NCT03110562|616412700|FG003|Crossover Period|Lost to Follow-up|1|||
170564255|NCT03110562|616412697|FG000|Crossover Period|Other|0|||
170564256|NCT03110562|616412698|FG001|Crossover Period|Other|0|||
170564257|NCT03110562|616412699|FG002|Crossover Period|Other|1|||
170564258|NCT03110562|616412700|FG003|Crossover Period|Other|1|||
170564259|NCT03110562|616412697|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
170564260|NCT03110562|616412698|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
170564261|NCT03110562|616412699|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
170564262|NCT03110562|616412700|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
170564263|NCT03189719|616412706|FG000|Overall Study|Death|325|||
170564264|NCT03189719|616412707|FG001|Overall Study|Death|361|||
170564265|NCT03189719|616412706|FG000|Overall Study|Physician Decision|1|||
170564266|NCT03189719|616412707|FG001|Overall Study|Physician Decision|0|||
170564267|NCT03189719|616412706|FG000|Overall Study|Sponsor Decision|40|||
170564268|NCT03189719|616412707|FG001|Overall Study|Sponsor Decision|12|||
170564269|NCT03189719|616412706|FG000|Overall Study|Withdrawal by Subject|7|||
170564270|NCT03189719|616412707|FG001|Overall Study|Withdrawal by Subject|3|||
170564271|NCT05211596|616412708|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
170564272|NCT05211596|616412708|FG000|Baseline to 6 Months|Death|1|||
170564273|NCT05211596|616412708|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
170564274|NCT05211596|616412708|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
170564275|NCT02293551|616412709|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
170564276|NCT02293551|616412710|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
170564277|NCT02293551|616412711|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
170564278|NCT02293551|616412712|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
170564279|NCT02293551|616412713|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
170564280|NCT02293551|616412714|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
170564281|NCT02293551|616412709|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
170564282|NCT02293551|616412710|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
170564283|NCT02293551|616412711|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
170564284|NCT02293551|616412712|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
170564285|NCT02293551|616412713|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
170564286|NCT02293551|616412714|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
170564287|NCT02293551|616412709|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
170564288|NCT02293551|616412710|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
170564289|NCT02293551|616412711|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
170564290|NCT02293551|616412712|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
170564291|NCT02293551|616412713|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
170564292|NCT02293551|616412714|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
170564293|NCT04532749|616412715|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
170564294|NCT04532749|616412716|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
170564295|NCT04532749|616412715|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
170564296|NCT04532749|616412716|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
170564297|NCT04532749|616412715|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
170564298|NCT04532749|616412716|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
170564299|NCT04532749|616412715|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
170564300|NCT04532749|616412716|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
170564301|NCT04532749|616412715|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
170564302|NCT04532749|616412716|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
170564303|NCT04532749|616412715|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
170564304|NCT04532749|616412716|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
170564305|NCT04532749|616412715|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
170564306|NCT04532749|616412716|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
170564307|NCT04532749|616412715|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
170564308|NCT04532749|616412716|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
170564309|NCT04532749|616412715|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
170564310|NCT04532749|616412716|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
170564311|NCT04532749|616412715|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
170564312|NCT04532749|616412716|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
170564313|NCT01107886|616412722|FG000|Overall Study|Lost to Follow-up|15|||
170564314|NCT01107886|616412723|FG001|Overall Study|Lost to Follow-up|13|||
170564315|NCT01107886|616412722|FG000|Overall Study|Withdrawal by Subject|180|||
170564316|NCT01107886|616412723|FG001|Overall Study|Withdrawal by Subject|196|||
170564317|NCT01107886|616412722|FG000|Overall Study|Administrative withdrawal of consent|7|||
170564318|NCT01107886|616412723|FG001|Overall Study|Administrative withdrawal of consent|5|||
170564319|NCT00529633|616414399|FG000|Overall Study|Withdrawal by Subject|1|||
170564320|NCT00529633|616414400|FG001|Overall Study|Withdrawal by Subject|1|||
170564321|NCT00140140|616414404|FG000|Overall Study|Unacceptable toxicity|1|||
170564322|NCT00140140|616414405|FG001|Overall Study|Unacceptable toxicity|1|||
170564323|NCT00140140|616414406|FG002|Overall Study|Unacceptable toxicity|2|||
170564324|NCT00140140|616414404|FG000|Overall Study|Physician Decision|1|||
170564325|NCT00140140|616414405|FG001|Overall Study|Physician Decision|1|||
170564326|NCT00140140|616414406|FG002|Overall Study|Physician Decision|0|||
170564327|NCT00069641|616414407|FG000|Overall Study|Death|1|||
170564328|NCT00069641|616414408|FG001|Overall Study|Death|0|||
170564329|NCT00069641|616414409|FG002|Overall Study|Death|1|||
170564330|NCT01664624|616414410|FG000|Overall Study|Adverse Event|0|||
170564331|NCT01664624|616414411|FG001|Overall Study|Adverse Event|1|||
170905993|NCT03372941|617658581|FG000|Overall Study|Lost to Follow-up|2|||
170905994|NCT03372941|617658582|FG001|Overall Study|Lost to Follow-up|4|||
170905995|NCT00741819|617658583|FG000|Overall Study|Adverse Event|3|||
170905996|NCT00741819|617658583|FG000|Overall Study|Withdrawal by Subject|3|||
170905997|NCT00741819|617658583|FG000|Overall Study|Death|1|||
170905998|NCT00741819|617658583|FG000|Overall Study|Disease progression|1|||
170905999|NCT01126580|617658584|FG000|Overall Study|Adverse Event|14|||
170906000|NCT01126580|617658585|FG001|Overall Study|Adverse Event|8|||
170564332|NCT01664624|616414412|FG002|Overall Study|Adverse Event|0|||
170564333|NCT01664624|616414413|FG003|Overall Study|Adverse Event|0|||
170564334|NCT04778592|616414414|FG000|Overall Study|Adverse Event|1|||
170564335|NCT04778592|616414415|FG001|Overall Study|Adverse Event|2|||
170564336|NCT04778592|616414414|FG000|Overall Study|Withdrawal by Subject|1|||
170564337|NCT04778592|616414415|FG001|Overall Study|Withdrawal by Subject|2|||
170564338|NCT03423121|616414416|FG000|Overall Study|Lost to Follow-up|2|||
170564339|NCT03423121|616414417|FG001|Overall Study|Lost to Follow-up|6|||
170564340|NCT03423121|616414416|FG000|Overall Study|Adverse Event|1|||
170564341|NCT03423121|616414417|FG001|Overall Study|Adverse Event|0|||
170564342|NCT01029535|616414424|FG000|Overall Study|Lost to Follow-up|24|||
170564343|NCT01029535|616414424|FG000|Overall Study|Protocol Violation|2|||
170564344|NCT01029535|616414424|FG000|Overall Study|Participant Withdrew Consent|2|||
170564345|NCT01029535|616414424|FG000|Overall Study|Adverse Event|1|||
170564346|NCT01029535|616414424|FG000|Overall Study|Use of Another Treatment|1|||
170564347|NCT01029535|616414424|FG000|Overall Study|Death|1|||
170564348|NCT03289143|616414425|FG000|Overall Study|Caregiver Unavailability|1|||
170564349|NCT03289143|616414426|FG001|Overall Study|Caregiver Unavailability|1|||
170564350|NCT03289143|616414427|FG002|Overall Study|Caregiver Unavailability|0|||
170564351|NCT03289143|616414428|FG003|Overall Study|Caregiver Unavailability|0|||
170564352|NCT03289143|616414425|FG000|Overall Study|Research Department Closure|0|||
170564353|NCT03289143|616414426|FG001|Overall Study|Research Department Closure|0|||
170564354|NCT03289143|616414427|FG002|Overall Study|Research Department Closure|1|||
170564355|NCT03289143|616414428|FG003|Overall Study|Research Department Closure|0|||
170564356|NCT03289143|616414425|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
170564357|NCT03289143|616414426|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
170564358|NCT03289143|616414427|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
170564359|NCT03289143|616414428|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
170564360|NCT03289143|616414425|FG000|Overall Study|Medical Monitor Decision|1|||
170564361|NCT03289143|616414426|FG001|Overall Study|Medical Monitor Decision|0|||
170564362|NCT03289143|616414427|FG002|Overall Study|Medical Monitor Decision|0|||
170564363|NCT03289143|616414428|FG003|Overall Study|Medical Monitor Decision|0|||
170564364|NCT03289143|616414425|FG000|Overall Study|Participant Non-Compliance|0|||
170564365|NCT03289143|616414426|FG001|Overall Study|Participant Non-Compliance|0|||
170906001|NCT01126580|617658586|FG002|Overall Study|Adverse Event|12|||
170906002|NCT01126580|617658584|FG000|Overall Study|Withdrawal by Subject|11|||
170906003|NCT01126580|617658585|FG001|Overall Study|Withdrawal by Subject|19|||
170906004|NCT01126580|617658586|FG002|Overall Study|Withdrawal by Subject|14|||
170906005|NCT01126580|617658584|FG000|Overall Study|Sponsor Decision|5|||
170906006|NCT01126580|617658585|FG001|Overall Study|Sponsor Decision|4|||
170564366|NCT03289143|616414427|FG002|Overall Study|Participant Non-Compliance|1|||
170564367|NCT03289143|616414428|FG003|Overall Study|Participant Non-Compliance|0|||
170564368|NCT03289143|616414425|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
170564369|NCT03289143|616414426|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
170564370|NCT03289143|616414427|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
170564371|NCT03289143|616414428|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
170564372|NCT03289143|616414425|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
170564373|NCT03289143|616414426|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
170564374|NCT03289143|616414427|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
170564375|NCT03289143|616414428|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
170564376|NCT03289143|616414425|FG000|Overall Study|Caregiver Passed Away|1|||
170564377|NCT03289143|616414426|FG001|Overall Study|Caregiver Passed Away|0|||
170564378|NCT03289143|616414427|FG002|Overall Study|Caregiver Passed Away|0|||
170564379|NCT03289143|616414428|FG003|Overall Study|Caregiver Passed Away|0|||
170564380|NCT03289143|616414425|FG000|Overall Study|Physician Decision|0|||
170564381|NCT03289143|616414426|FG001|Overall Study|Physician Decision|2|||
170564382|NCT03289143|616414427|FG002|Overall Study|Physician Decision|2|||
170564383|NCT03289143|616414428|FG003|Overall Study|Physician Decision|2|||
170564384|NCT03289143|616414425|FG000|Overall Study|Protocol Deviation|2|||
170564385|NCT03289143|616414426|FG001|Overall Study|Protocol Deviation|1|||
170564386|NCT03289143|616414427|FG002|Overall Study|Protocol Deviation|3|||
170564387|NCT03289143|616414428|FG003|Overall Study|Protocol Deviation|1|||
170564388|NCT03289143|616414425|FG000|Overall Study|Study Terminated By Sponsor|101|||
170564389|NCT03289143|616414426|FG001|Overall Study|Study Terminated By Sponsor|75|||
170906007|NCT01126580|617658586|FG002|Overall Study|Sponsor Decision|7|||
170906008|NCT01126580|617658584|FG000|Overall Study|Physician Decision|1|||
170906009|NCT01126580|617658585|FG001|Overall Study|Physician Decision|1|||
170564390|NCT03289143|616414427|FG002|Overall Study|Study Terminated By Sponsor|100|||
170564391|NCT03289143|616414428|FG003|Overall Study|Study Terminated By Sponsor|69|||
170564392|NCT03289143|616414425|FG000|Overall Study|Withdrawal by Subject|14|||
170564393|NCT03289143|616414426|FG001|Overall Study|Withdrawal by Subject|6|||
170564394|NCT03289143|616414427|FG002|Overall Study|Withdrawal by Subject|14|||
170564395|NCT03289143|616414428|FG003|Overall Study|Withdrawal by Subject|12|||
170564396|NCT03289143|616414425|FG000|Overall Study|Adverse Event|10|||
170564397|NCT03289143|616414426|FG001|Overall Study|Adverse Event|7|||
170564398|NCT03289143|616414427|FG002|Overall Study|Adverse Event|6|||
170564399|NCT03289143|616414428|FG003|Overall Study|Adverse Event|5|||
170564400|NCT03289143|616414425|FG000|Overall Study|Death|2|||
170564401|NCT03289143|616414426|FG001|Overall Study|Death|0|||
170564402|NCT03289143|616414427|FG002|Overall Study|Death|2|||
170564403|NCT03289143|616414428|FG003|Overall Study|Death|1|||
170564404|NCT03289143|616414425|FG000|Overall Study|Lost to Follow-up|2|||
170564405|NCT03289143|616414426|FG001|Overall Study|Lost to Follow-up|1|||
170564406|NCT03289143|616414427|FG002|Overall Study|Lost to Follow-up|1|||
170564407|NCT03289143|616414428|FG003|Overall Study|Lost to Follow-up|0|||
170564408|NCT03289143|616414425|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
170564409|NCT03289143|616414426|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
170564410|NCT03289143|616414427|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
170564411|NCT03289143|616414428|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
170564412|NCT03289143|616414425|FG000|Overall Study|Withdrawal by Caregiver|0|||
170564413|NCT03289143|616414426|FG001|Overall Study|Withdrawal by Caregiver|1|||
170564414|NCT03289143|616414427|FG002|Overall Study|Withdrawal by Caregiver|0|||
170564415|NCT03289143|616414428|FG003|Overall Study|Withdrawal by Caregiver|0|||
170564416|NCT03289143|616414425|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
170564417|NCT03289143|616414426|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
170564418|NCT03289143|616414427|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
170564419|NCT03289143|616414428|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
170564420|NCT03289143|616414425|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
170564421|NCT03289143|616414426|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
170564422|NCT03289143|616414427|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
170564423|NCT03289143|616414428|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
170564424|NCT00730756|616414429|FG000|Overall Study|Adverse Event|2|||
170564425|NCT00730756|616414430|FG001|Overall Study|Adverse Event|0|||
170564426|NCT00730756|616414429|FG000|Overall Study|Lack of Efficacy|1|||
170564427|NCT00730756|616414430|FG001|Overall Study|Lack of Efficacy|1|||
170564428|NCT00730756|616414429|FG000|Overall Study|Protocol Deviation|1|||
170564429|NCT00730756|616414430|FG001|Overall Study|Protocol Deviation|2|||
170564430|NCT00730756|616414429|FG000|Overall Study|Lost to Follow-up|0|||
170564431|NCT00730756|616414430|FG001|Overall Study|Lost to Follow-up|1|||
170564432|NCT00730756|616414429|FG000|Overall Study|Withdrew Consent|0|||
170564433|NCT00730756|616414430|FG001|Overall Study|Withdrew Consent|1|||
170564434|NCT01126190|616414433|FG000|Double-Blind Phase|Death|0|||
170564435|NCT01126190|616414434|FG001|Double-Blind Phase|Death|1|||
170564436|NCT01126190|616414435|FG002|Double-Blind Phase|Death|0|||
170564437|NCT01126190|616414433|FG000|Double-Blind Phase|Adverse Event|1|||
170564438|NCT01126190|616414434|FG001|Double-Blind Phase|Adverse Event|2|||
170564439|NCT01126190|616414435|FG002|Double-Blind Phase|Adverse Event|0|||
170564440|NCT01126190|616414433|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
170564441|NCT01126190|616414434|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
170564442|NCT01126190|616414435|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
170564443|NCT01126190|616414433|FG000|Double-Blind Phase|Request of Investigator|1|||
170564444|NCT01126190|616414434|FG001|Double-Blind Phase|Request of Investigator|0|||
170564445|NCT01126190|616414435|FG002|Double-Blind Phase|Request of Investigator|0|||
170564446|NCT01126190|616414433|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
170564447|NCT01126190|616414434|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
170564448|NCT01126190|616414435|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
170564449|NCT01126190|616414433|FG000|Double-Blind Phase|Non-compliance|1|||
170564450|NCT01126190|616414434|FG001|Double-Blind Phase|Non-compliance|0|||
170564451|NCT01126190|616414435|FG002|Double-Blind Phase|Non-compliance|0|||
170564452|NCT01126190|616414433|FG000|Double-Blind Phase|Lost to Follow-up|1|||
170564453|NCT01126190|616414434|FG001|Double-Blind Phase|Lost to Follow-up|3|||
170564454|NCT01126190|616414435|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170564455|NCT01126190|616414433|FG000|Open-Label Phase|Death|0|||
170564456|NCT01126190|616414434|FG001|Open-Label Phase|Death|0|||
170564457|NCT01126190|616414435|FG002|Open-Label Phase|Death|1|||
170564458|NCT01126190|616414433|FG000|Open-Label Phase|Adverse Event|0|||
170906010|NCT01126580|617658586|FG002|Overall Study|Physician Decision|2|||
170564459|NCT01126190|616414434|FG001|Open-Label Phase|Adverse Event|0|||
170564460|NCT01126190|616414435|FG002|Open-Label Phase|Adverse Event|4|||
170564461|NCT01126190|616414433|FG000|Open-Label Phase|Withdrawal by Subject|0|||
170564462|NCT01126190|616414434|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170564463|NCT01126190|616414435|FG002|Open-Label Phase|Withdrawal by Subject|6|||
170564464|NCT00524121|616414436|FG000|Overall Study|Disease progression|6|||
170564465|NCT00524121|616414436|FG000|Overall Study|Adverse Event|4|||
170564466|NCT00524121|616414436|FG000|Overall Study|Patient refused|2|||
170564467|NCT00524121|616414436|FG000|Overall Study|Other|1|||
170906011|NCT01126580|617658584|FG000|Overall Study|Entry Criteria Not Met|1|||
170564468|NCT00524121|616414436|FG000|Overall Study|Death|1|||
170564469|NCT00524121|616414436|FG000|Overall Study|Not treated (became ineligible)|4|||
170564470|NCT00524121|616414436|FG000|Overall Study|Not treated (changed mind)|1|||
170564471|NCT04047446|616414437|FG000|Overall Study|Physician Decision|1|||
170564472|NCT04047446|616414438|FG001|Overall Study|Physician Decision|0|||
170564473|NCT00329420|616414439|FG000|Re-induction Phase|Lack of Efficacy|0|||
170564474|NCT00329420|616414440|FG001|Re-induction Phase|Lack of Efficacy|1|||
170564475|NCT00329420|616414441|FG002|Re-induction Phase|Lack of Efficacy|0|||
170564476|NCT00329420|616414439|FG000|Re-induction Phase|Withdrawal of Consent|0|||
170564477|NCT00329420|616414440|FG001|Re-induction Phase|Withdrawal of Consent|0|||
170564478|NCT00329420|616414441|FG002|Re-induction Phase|Withdrawal of Consent|1|||
170564479|NCT00329420|616414439|FG000|Re-induction Phase|Did not respond to re-induction|6|||
170564480|NCT00329420|616414440|FG001|Re-induction Phase|Did not respond to re-induction|5|||
170564481|NCT00329420|616414441|FG002|Re-induction Phase|Did not respond to re-induction|7|||
170564482|NCT00329420|616414439|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
170564483|NCT00329420|616414440|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
170564484|NCT00329420|616414441|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
170564485|NCT00329420|616414439|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
170564486|NCT00329420|616414440|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
170564487|NCT00329420|616414441|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
170564488|NCT00329420|616414439|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
170564489|NCT00329420|616414440|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
170564490|NCT00329420|616414441|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
170564491|NCT02862574|616414442|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170564492|NCT02862574|616414443|FG001|Double-Blind Treatment Period|Adverse Event|1|||
170564493|NCT02862574|616414444|FG002|Double-Blind Treatment Period|Adverse Event|0|||
170564494|NCT02862574|616414442|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
170564495|NCT02862574|616414443|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
170564496|NCT02862574|616414444|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
170564497|NCT02862574|616414442|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
170564498|NCT02862574|616414443|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
170564499|NCT02862574|616414444|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
170564500|NCT01446874|616414445|FG000|Overall Study|Not eligible|1|||
170564501|NCT01446874|616414446|FG001|Overall Study|Not eligible|0|||
170564502|NCT01446874|616414447|FG002|Overall Study|Not eligible|0|||
170564503|NCT01446874|616414445|FG000|Overall Study|No surgery/No qualifying surgery|1|||
170564504|NCT01446874|616414446|FG001|Overall Study|No surgery/No qualifying surgery|0|||
170564505|NCT01446874|616414447|FG002|Overall Study|No surgery/No qualifying surgery|12|||
170564506|NCT01446874|616414445|FG000|Overall Study|Non-compliance|0|||
170564507|NCT01446874|616414446|FG001|Overall Study|Non-compliance|4|||
170564508|NCT01446874|616414447|FG002|Overall Study|Non-compliance|0|||
170564509|NCT01446874|616414445|FG000|Overall Study|Antibiotics for pre-op infection|0|||
170564510|NCT01446874|616414446|FG001|Overall Study|Antibiotics for pre-op infection|0|||
170564511|NCT01446874|616414447|FG002|Overall Study|Antibiotics for pre-op infection|2|||
170564512|NCT01446874|616414445|FG000|Overall Study|Withdrawal by Subject|0|||
170564513|NCT01446874|616414446|FG001|Overall Study|Withdrawal by Subject|0|||
170564514|NCT01446874|616414447|FG002|Overall Study|Withdrawal by Subject|4|||
170564515|NCT01135992|616414448|FG000|Overall Study|Adverse Event|1|||
170564516|NCT01135992|616414448|FG000|Overall Study|Lack of Efficacy|1|||
170564517|NCT01135992|616414448|FG000|Overall Study|Protocol Violation|2|||
170564518|NCT01135992|616414448|FG000|Overall Study|Withdrawal criteria|10|||
170564519|NCT01135992|616414448|FG000|Overall Study|Unclassified|7|||
170564520|NCT01977898|616414449|FG000|Overall Study|Non functioning catheter|1|||
170564521|NCT01977898|616414450|FG001|Overall Study|Non functioning catheter|1|||
170564522|NCT03639610|616414455|FG000|Overall Study|Adverse Event|7|||
170564523|NCT03639610|616414456|FG001|Overall Study|Adverse Event|1|||
170564524|NCT03639610|616414457|FG002|Overall Study|Adverse Event|0|||
170564525|NCT03639610|616414455|FG000|Overall Study|Physician Decision|3|||
170564526|NCT03639610|616414456|FG001|Overall Study|Physician Decision|1|||
170564527|NCT03639610|616414457|FG002|Overall Study|Physician Decision|0|||
170906012|NCT01126580|617658585|FG001|Overall Study|Entry Criteria Not Met|1|||
170564528|NCT03639610|616414455|FG000|Overall Study|Disease progression|8|||
170564529|NCT03639610|616414456|FG001|Overall Study|Disease progression|5|||
170564530|NCT03639610|616414457|FG002|Overall Study|Disease progression|3|||
170564531|NCT03639610|616414455|FG000|Overall Study|Study terminated by sponsor|2|||
170564532|NCT03639610|616414456|FG001|Overall Study|Study terminated by sponsor|1|||
170564533|NCT03639610|616414457|FG002|Overall Study|Study terminated by sponsor|1|||
170645667|NCT01165216|616715994|FG000|Overall Study|Adverse Event|6|||
170906013|NCT01126580|617658586|FG002|Overall Study|Entry Criteria Not Met|2|||
170906014|NCT01126580|617658584|FG000|Overall Study|Lack of Efficacy|2|||
170645668|NCT01165216|616715995|FG001|Overall Study|Adverse Event|3|||
170645669|NCT01165216|616715994|FG000|Overall Study|Withdrawal by Subject|1|||
170645670|NCT01165216|616715995|FG001|Overall Study|Withdrawal by Subject|1|||
170645671|NCT01165216|616715994|FG000|Overall Study|Disease progression|1|||
170645672|NCT01165216|616715995|FG001|Overall Study|Disease progression|3|||
170645673|NCT01601652|616715996|FG000|Overall Study|Death|1|||
170645674|NCT02537015|616716003|FG000|Overall Study|Adverse Event|3|||
170564534|NCT03639610|616414455|FG000|Overall Study|Patient request to stop treatment|1|||
170564535|NCT03639610|616414456|FG001|Overall Study|Patient request to stop treatment|2|||
170564536|NCT03639610|616414457|FG002|Overall Study|Patient request to stop treatment|0|||
170564537|NCT02660229|616414458|FG000|Overall Study|Adverse Event|2|||
170564538|NCT02660229|616414459|FG001|Overall Study|Adverse Event|0|||
170564539|NCT02660229|616414458|FG000|Overall Study|Withdrawal by Subject|0|||
170564540|NCT02660229|616414459|FG001|Overall Study|Withdrawal by Subject|1|||
170564541|NCT02727322|616414465|FG000|Overall Study|Withdrawal by Subject|1|||
170564542|NCT02727322|616414466|FG001|Overall Study|Withdrawal by Subject|1|||
170564543|NCT02727322|616414465|FG000|Overall Study|Protocol Violation|1|||
170564544|NCT02727322|616414466|FG001|Overall Study|Protocol Violation|0|||
170564545|NCT02410772|616414471|FG000|Overall Study|Death|3|||
170564546|NCT02410772|616414472|FG001|Overall Study|Death|4|||
170564547|NCT02410772|616414473|FG002|Overall Study|Death|8|||
170564548|NCT02410772|616414471|FG000|Overall Study|Lost to Follow-up|31|||
170564549|NCT02410772|616414472|FG001|Overall Study|Lost to Follow-up|23|||
170564550|NCT02410772|616414473|FG002|Overall Study|Lost to Follow-up|22|||
170564551|NCT02410772|616414471|FG000|Overall Study|Pregnancy|8|||
170564552|NCT02410772|616414472|FG001|Overall Study|Pregnancy|4|||
170564553|NCT02410772|616414473|FG002|Overall Study|Pregnancy|5|||
170564554|NCT02410772|616414471|FG000|Overall Study|Protocol Violation|8|||
170564555|NCT02410772|616414472|FG001|Overall Study|Protocol Violation|8|||
170564556|NCT02410772|616414473|FG002|Overall Study|Protocol Violation|4|||
170564557|NCT02410772|616414471|FG000|Overall Study|Baseline Drug Resistance|49|||
170564558|NCT02410772|616414472|FG001|Overall Study|Baseline Drug Resistance|40|||
170564559|NCT02410772|616414473|FG002|Overall Study|Baseline Drug Resistance|51|||
170564560|NCT02410772|616414471|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
170564561|NCT02410772|616414472|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
170564562|NCT02410772|616414473|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
170564563|NCT02410772|616414471|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
170564564|NCT02410772|616414472|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
170564565|NCT02410772|616414473|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
170564566|NCT01146613|616414474|FG000|Overall Study|Lost to Follow-up|3|||
170564567|NCT01146613|616414475|FG001|Overall Study|Lost to Follow-up|8|||
170564568|NCT01146613|616414474|FG000|Overall Study|Lack of Efficacy|0|||
170564569|NCT01146613|616414475|FG001|Overall Study|Lack of Efficacy|1|||
170564570|NCT01146613|616414474|FG000|Overall Study|Death|1|||
170564571|NCT01146613|616414475|FG001|Overall Study|Death|0|||
170564572|NCT01146613|616414474|FG000|Overall Study|Physician Decision|1|||
170564573|NCT01146613|616414475|FG001|Overall Study|Physician Decision|0|||
170564574|NCT01146613|616414474|FG000|Overall Study|Withdrawal by Subject|0|||
170564575|NCT01146613|616414475|FG001|Overall Study|Withdrawal by Subject|3|||
170564576|NCT01146613|616414474|FG000|Overall Study|schedule conflict|1|||
170564577|NCT01146613|616414475|FG001|Overall Study|schedule conflict|0|||
170564578|NCT01146613|616414474|FG000|Overall Study|Outpatient detox|1|||
170564579|NCT01146613|616414475|FG001|Overall Study|Outpatient detox|0|||
170564580|NCT05878067|616414476|FG000|Overall Study|Lost to Follow-up|2|||
170564581|NCT00329030|616414477|FG000|Overall Study|Withdrawal by Subject|1|||
170564582|NCT00329030|616414478|FG001|Overall Study|Withdrawal by Subject|3|||
170564583|NCT00329030|616414477|FG000|Overall Study|Progressive Disease|6|||
170564584|NCT00329030|616414478|FG001|Overall Study|Progressive Disease|2|||
170564585|NCT00329030|616414477|FG000|Overall Study|Ineligible Pathology|1|||
170564586|NCT00329030|616414478|FG001|Overall Study|Ineligible Pathology|1|||
170564587|NCT02006927|616414482|FG000|Overall Study|Adverse Event|2|||
170564588|NCT02006927|616414482|FG000|Overall Study|Withdrawal by Subject|1|||
170564589|NCT01164007|616414483|FG000|Overall Study|Adverse Event|5|||
170564590|NCT01164007|616414483|FG000|Overall Study|Progression of Disease|30|||
170564591|NCT01164007|616414483|FG000|Overall Study|Protocol Violation|1|||
170564592|NCT01164007|616414483|FG000|Overall Study|Withdrawal by Subject|1|||
170564593|NCT01164007|616414483|FG000|Overall Study|Medical Decision|3|||
170564594|NCT03218917|616414486|FG000|Overall Study|Adverse Event|3|||
170645675|NCT02537015|616716003|FG000|Overall Study|Withdrawal by Subject|2|||
170564595|NCT03218917|616414487|FG001|Overall Study|Adverse Event|3|||
170564596|NCT03218917|616414488|FG002|Overall Study|Adverse Event|2|||
170564597|NCT03218917|616414486|FG000|Overall Study|Subject withdrew consent|2|||
170564598|NCT03218917|616414487|FG001|Overall Study|Subject withdrew consent|4|||
170564599|NCT03218917|616414488|FG002|Overall Study|Subject withdrew consent|10|||
170564600|NCT03218917|616414486|FG000|Overall Study|Physician Decision|0|||
170564601|NCT03218917|616414487|FG001|Overall Study|Physician Decision|1|||
170564602|NCT03218917|616414488|FG002|Overall Study|Physician Decision|1|||
170564603|NCT03218917|616414486|FG000|Overall Study|Lost to Follow-up|1|||
170564604|NCT03218917|616414487|FG001|Overall Study|Lost to Follow-up|0|||
170564605|NCT03218917|616414488|FG002|Overall Study|Lost to Follow-up|0|||
170564606|NCT03218917|616414486|FG000|Overall Study|Reason Missing|0|||
170564607|NCT03218917|616414487|FG001|Overall Study|Reason Missing|2|||
170564608|NCT03218917|616414488|FG002|Overall Study|Reason Missing|0|||
170564609|NCT03218917|616414486|FG000|Overall Study|Death|0|||
170564610|NCT03218917|616414487|FG001|Overall Study|Death|1|||
170564611|NCT03218917|616414488|FG002|Overall Study|Death|0|||
170564612|NCT03218917|616414486|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170564613|NCT03218917|616414487|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170564614|NCT03218917|616414488|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170564615|NCT01307449|616414489|FG000|Overall Study|Adverse Event|1|||
170564616|NCT01307449|616414490|FG001|Overall Study|Adverse Event|0|||
170564617|NCT01307449|616414491|FG002|Overall Study|Adverse Event|0|||
170564618|NCT01307449|616414492|FG003|Overall Study|Adverse Event|0|||
170564619|NCT02639390|616414493|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
170564620|NCT02639390|616414494|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
170564621|NCT01531998|616414495|FG000|Overall Study|Withdrawal by Subject|3|||
170564622|NCT02927795|616414496|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
170564623|NCT02927795|616414496|FG000|Overall Study|Not Treated|4|||
170564624|NCT02581891|616414497|FG000|Overall Study|Adverse Event|4|||
170564625|NCT02581891|616414498|FG001|Overall Study|Adverse Event|6|||
170564626|NCT02581891|616414497|FG000|Overall Study|Death|3|||
170564627|NCT02581891|616414498|FG001|Overall Study|Death|4|||
170564628|NCT02581891|616414497|FG000|Overall Study|Lost to Follow-up|1|||
170564629|NCT02581891|616414498|FG001|Overall Study|Lost to Follow-up|2|||
170564630|NCT02581891|616414497|FG000|Overall Study|Physician Decision|0|||
170564631|NCT02581891|616414498|FG001|Overall Study|Physician Decision|1|||
170564632|NCT02581891|616414497|FG000|Overall Study|Withdrawal by Subject|4|||
170564633|NCT02581891|616414498|FG001|Overall Study|Withdrawal by Subject|5|||
170564634|NCT02581891|616414497|FG000|Overall Study|Other Reasons|3|||
170564635|NCT02581891|616414498|FG001|Overall Study|Other Reasons|1|||
170564636|NCT02581891|616414497|FG000|Overall Study|Discontinued during followup|1|||
170564637|NCT02581891|616414498|FG001|Overall Study|Discontinued during followup|0|||
170564638|NCT04067011|616414500|FG000|Overall Study|Not Treated|8|||
170564639|NCT04067011|616414501|FG001|Overall Study|Not Treated|7|||
170564640|NCT04067011|616414502|FG002|Overall Study|Not Treated|5|||
170564641|NCT04067011|616414500|FG000|Overall Study|Adverse Event|2|||
170564642|NCT04067011|616414501|FG001|Overall Study|Adverse Event|1|||
170564643|NCT04067011|616414502|FG002|Overall Study|Adverse Event|0|||
170564644|NCT04067011|616414500|FG000|Overall Study|Withdrawal by Subject|6|||
170564645|NCT04067011|616414501|FG001|Overall Study|Withdrawal by Subject|2|||
170564646|NCT04067011|616414502|FG002|Overall Study|Withdrawal by Subject|1|||
170564647|NCT04067011|616414500|FG000|Overall Study|Lost to Follow-up|0|||
170564648|NCT04067011|616414501|FG001|Overall Study|Lost to Follow-up|0|||
170564649|NCT04067011|616414502|FG002|Overall Study|Lost to Follow-up|1|||
170564650|NCT04067011|616414500|FG000|Overall Study|Physician Decision|1|||
170564651|NCT04067011|616414501|FG001|Overall Study|Physician Decision|1|||
170564652|NCT04067011|616414502|FG002|Overall Study|Physician Decision|0|||
170564653|NCT04067011|616414500|FG000|Overall Study|Other Reasons|2|||
170564654|NCT04067011|616414501|FG001|Overall Study|Other Reasons|0|||
170564655|NCT04067011|616414502|FG002|Overall Study|Other Reasons|1|||
170564656|NCT04067011|616414500|FG000|Overall Study|Missing|0|||
170564657|NCT04067011|616414501|FG001|Overall Study|Missing|2|||
170564658|NCT04067011|616414502|FG002|Overall Study|Missing|0|||
170564659|NCT00431964|616414505|FG000|Overall Study|Adverse Event|1|||
170564660|NCT00431964|616414506|FG001|Overall Study|Adverse Event|0|||
170564661|NCT00431964|616414505|FG000|Overall Study|Lost to Follow-up|1|||
170564662|NCT00431964|616414506|FG001|Overall Study|Lost to Follow-up|2|||
170564663|NCT00431964|616414505|FG000|Overall Study|Physician Decision|2|||
170564664|NCT00431964|616414506|FG001|Overall Study|Physician Decision|2|||
170564665|NCT00431964|616414505|FG000|Overall Study|Withdrawal by Subject|2|||
170564666|NCT00431964|616414506|FG001|Overall Study|Withdrawal by Subject|1|||
170564667|NCT00431964|616414505|FG000|Overall Study|Parental Consent Withdrawn|0|||
170564668|NCT00431964|616414506|FG001|Overall Study|Parental Consent Withdrawn|2|||
170564669|NCT00431964|616414505|FG000|Overall Study|Due to Unstable Health|0|||
170564670|NCT00431964|616414506|FG001|Overall Study|Due to Unstable Health|1|||
170564671|NCT01215851|616414508|FG000|Treatment Period|Adverse Event|1|||
170564672|NCT01215851|616414509|FG001|Treatment Period|Adverse Event|1|||
170564673|NCT01215851|616414510|FG002|Treatment Period|Adverse Event|1|||
170645676|NCT02537015|616716003|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170645677|NCT01808092|616716005|FG000|Overall Study|Death|39|||
170645678|NCT01808092|616716006|FG001|Overall Study|Death|29|||
170645679|NCT01808092|616716005|FG000|Overall Study|Lost to Follow-up|3|||
170645680|NCT01808092|616716006|FG001|Overall Study|Lost to Follow-up|7|||
170645681|NCT01808092|616716005|FG000|Overall Study|Withdrawal by Subject|9|||
170645682|NCT01808092|616716006|FG001|Overall Study|Withdrawal by Subject|4|||
170645683|NCT01808092|616716005|FG000|Overall Study|Other Eligibility criteria|3|||
170645684|NCT01808092|616716006|FG001|Overall Study|Other Eligibility criteria|5|||
170645685|NCT03425253|616716014|FG000|Overall Study|Adverse Event|2|||
170645686|NCT03425253|616716014|FG000|Overall Study|Lost to Follow-up|3|||
170645687|NCT03425253|616716014|FG000|Overall Study|Withdrew Consent|6|||
170645688|NCT03425253|616716014|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
170645689|NCT04174365|616716017|FG000|Overall Study|Lost to Follow-up|1|||
170645690|NCT04174365|616716018|FG001|Overall Study|Lost to Follow-up|2|||
170645691|NCT04174365|616716017|FG000|Overall Study|Adverse Event|2|||
170645692|NCT04174365|616716018|FG001|Overall Study|Adverse Event|1|||
170564674|NCT01215851|616414511|FG003|Treatment Period|Adverse Event|3|||
170564675|NCT01215851|616414512|FG004|Treatment Period|Adverse Event|0|||
170564676|NCT01215851|616414513|FG005|Treatment Period|Adverse Event|1|||
170564677|NCT01215851|616414508|FG000|Follow up Period|Lost to Follow-up|0|||
170564678|NCT01215851|616414509|FG001|Follow up Period|Lost to Follow-up|0|||
170564679|NCT01215851|616414510|FG002|Follow up Period|Lost to Follow-up|0|||
170564680|NCT01215851|616414511|FG003|Follow up Period|Lost to Follow-up|0|||
170564681|NCT01215851|616414512|FG004|Follow up Period|Lost to Follow-up|0|||
170564682|NCT01215851|616414513|FG005|Follow up Period|Lost to Follow-up|1|||
170564683|NCT01276106|616414514|FG000|Overall Study|Adverse Event|3|||
170564684|NCT01276106|616414515|FG001|Overall Study|Adverse Event|3|||
170564685|NCT01276106|616414516|FG002|Overall Study|Adverse Event|11|||
170564686|NCT01276106|616414517|FG003|Overall Study|Adverse Event|3|||
170564687|NCT01276106|616414514|FG000|Overall Study|Withdrawal by Subject|6|||
170564688|NCT01276106|616414515|FG001|Overall Study|Withdrawal by Subject|3|||
170564689|NCT01276106|616414516|FG002|Overall Study|Withdrawal by Subject|1|||
170564690|NCT01276106|616414517|FG003|Overall Study|Withdrawal by Subject|6|||
170564691|NCT01276106|616414514|FG000|Overall Study|Lack of Efficacy|0|||
170564692|NCT01276106|616414515|FG001|Overall Study|Lack of Efficacy|1|||
170564693|NCT01276106|616414516|FG002|Overall Study|Lack of Efficacy|0|||
170564694|NCT01276106|616414517|FG003|Overall Study|Lack of Efficacy|1|||
170564695|NCT01276106|616414514|FG000|Overall Study|Lost to Follow-up|2|||
170564696|NCT01276106|616414515|FG001|Overall Study|Lost to Follow-up|1|||
170564697|NCT01276106|616414516|FG002|Overall Study|Lost to Follow-up|1|||
170564698|NCT01276106|616414517|FG003|Overall Study|Lost to Follow-up|0|||
170564699|NCT01276106|616414514|FG000|Overall Study|Physician Decision|0|||
170564700|NCT01276106|616414515|FG001|Overall Study|Physician Decision|0|||
170564701|NCT01276106|616414516|FG002|Overall Study|Physician Decision|1|||
170564702|NCT01276106|616414517|FG003|Overall Study|Physician Decision|1|||
170564703|NCT01276106|616414514|FG000|Overall Study|Protocol Violation|1|||
170564704|NCT01276106|616414515|FG001|Overall Study|Protocol Violation|1|||
170564705|NCT01276106|616414516|FG002|Overall Study|Protocol Violation|0|||
170564706|NCT01276106|616414517|FG003|Overall Study|Protocol Violation|2|||
170564707|NCT01276106|616414514|FG000|Overall Study|Insufficient therapeutic effects|0|||
170564708|NCT01276106|616414515|FG001|Overall Study|Insufficient therapeutic effects|0|||
170564709|NCT01276106|616414516|FG002|Overall Study|Insufficient therapeutic effects|2|||
170564710|NCT01276106|616414517|FG003|Overall Study|Insufficient therapeutic effects|0|||
170564711|NCT01242514|616414518|FG000|Overall Study|e.g., project closure|1042|||
170564712|NCT01242514|616414519|FG001|Overall Study|e.g., project closure|305|||
170564713|NCT01242514|616414520|FG002|Overall Study|e.g., project closure|171|||
170564714|NCT01242514|616414518|FG000|Overall Study|Subject decision|33|||
170645693|NCT04174365|616716017|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
170564715|NCT01242514|616414519|FG001|Overall Study|Subject decision|8|||
170564716|NCT01242514|616414520|FG002|Overall Study|Subject decision|2|||
170564717|NCT01242514|616414518|FG000|Overall Study|Severe non-compliance to protocol|5|||
170564718|NCT01242514|616414519|FG001|Overall Study|Severe non-compliance to protocol|2|||
170564719|NCT01242514|616414520|FG002|Overall Study|Severe non-compliance to protocol|1|||
170645694|NCT04174365|616716018|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
170564720|NCT01242514|616414518|FG000|Overall Study|Lack of therapeutic response|99|||
170564721|NCT01242514|616414519|FG001|Overall Study|Lack of therapeutic response|16|||
170564722|NCT01242514|616414520|FG002|Overall Study|Lack of therapeutic response|10|||
170564723|NCT01242514|616414518|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
170645695|NCT04174365|616716017|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
170564724|NCT01242514|616414519|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
170564725|NCT01242514|616414520|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
170564726|NCT01242514|616414518|FG000|Overall Study|Lost to Follow-up|14|||
170564727|NCT01242514|616414519|FG001|Overall Study|Lost to Follow-up|5|||
170645696|NCT04174365|616716018|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
170645697|NCT04174365|616716017|FG000|Overall Study|Protocol Deviation|1|||
170564728|NCT01242514|616414520|FG002|Overall Study|Lost to Follow-up|4|||
170564729|NCT01242514|616414518|FG000|Overall Study|Adverse Event|129|||
170564730|NCT01242514|616414519|FG001|Overall Study|Adverse Event|18|||
170564731|NCT01242514|616414520|FG002|Overall Study|Adverse Event|19|||
170564732|NCT00862940|616414524|FG000|Overall Study|Adverse Event|15|||
170564733|NCT00862940|616414525|FG001|Overall Study|Adverse Event|12|||
170564734|NCT00862940|616414524|FG000|Overall Study|Lack of Efficacy|1|||
170564735|NCT00862940|616414525|FG001|Overall Study|Lack of Efficacy|3|||
170564736|NCT00862940|616414524|FG000|Overall Study|Protocol Violation|2|||
170564737|NCT00862940|616414525|FG001|Overall Study|Protocol Violation|5|||
170564738|NCT00862940|616414524|FG000|Overall Study|Withdrawal by Subject|4|||
170564739|NCT00862940|616414525|FG001|Overall Study|Withdrawal by Subject|6|||
170564740|NCT00862940|616414524|FG000|Overall Study|Non-compliance|4|||
170564741|NCT00862940|616414525|FG001|Overall Study|Non-compliance|0|||
170564742|NCT00862940|616414524|FG000|Overall Study|Lost to Follow-up|0|||
170564743|NCT00862940|616414525|FG001|Overall Study|Lost to Follow-up|1|||
170564744|NCT00862940|616414524|FG000|Overall Study|Administrative or other reason(s)|4|||
170564745|NCT00862940|616414525|FG001|Overall Study|Administrative or other reason(s)|3|||
170564746|NCT00829244|616414531|FG000|Overall Study|Adverse Event|1|||
170564747|NCT00829244|616414532|FG001|Overall Study|Adverse Event|3|||
170564748|NCT00829244|616414531|FG000|Overall Study|Protocol Violation|1|||
170564749|NCT00829244|616414532|FG001|Overall Study|Protocol Violation|0|||
170564750|NCT00829244|616414531|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
170564751|NCT00829244|616414532|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
170564752|NCT00829244|616414531|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
170564753|NCT00829244|616414532|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
170564754|NCT00829244|616414531|FG000|Overall Study|No fertilization|2|||
170564755|NCT00829244|616414532|FG001|Overall Study|No fertilization|2|||
170564756|NCT00829244|616414531|FG000|Overall Study|All embryos discarded|0|||
170564757|NCT00829244|616414532|FG001|Overall Study|All embryos discarded|3|||
170564758|NCT00829244|616414531|FG000|Overall Study|No embryo cleavage|0|||
170564759|NCT00829244|616414532|FG001|Overall Study|No embryo cleavage|2|||
170564760|NCT01542788|616414535|FG000|Overall Study|Randomized but Not Treated|2|||
170564761|NCT01542788|616414536|FG001|Overall Study|Randomized but Not Treated|0|||
170564762|NCT01542788|616414535|FG000|Overall Study|Lack of Efficacy|41|||
170564763|NCT01542788|616414536|FG001|Overall Study|Lack of Efficacy|71|||
170564764|NCT01542788|616414535|FG000|Overall Study|Lost to Follow-up|5|||
170564765|NCT01542788|616414536|FG001|Overall Study|Lost to Follow-up|0|||
170564766|NCT01542788|616414535|FG000|Overall Study|Death|3|||
170564767|NCT01542788|616414536|FG001|Overall Study|Death|0|||
170564768|NCT01542788|616414535|FG000|Overall Study|Protocol Violation|2|||
170564769|NCT01542788|616414536|FG001|Overall Study|Protocol Violation|0|||
170564770|NCT01542788|616414535|FG000|Overall Study|Physician Decision|1|||
170564771|NCT01542788|616414536|FG001|Overall Study|Physician Decision|0|||
170564772|NCT01542788|616414535|FG000|Overall Study|Withdrawal by Subject|1|||
170564773|NCT01542788|616414536|FG001|Overall Study|Withdrawal by Subject|0|||
170564774|NCT01346176|616414538|FG000|Recruited|Protocol Violation|1|||
170564775|NCT01346176|616414539|FG001|Recruited|Protocol Violation|0|||
170564776|NCT01346176|616414540|FG002|Recruited|Protocol Violation|0|||
170564777|NCT01346176|616414538|FG000|Completed Advance Directive|Death|3|||
170564778|NCT01346176|616414539|FG001|Completed Advance Directive|Death|2|||
170564779|NCT01346176|616414540|FG002|Completed Advance Directive|Death|2|||
170564780|NCT01346176|616414538|FG000|Completed Advance Directive|Became Ineligible|3|||
170564781|NCT01346176|616414539|FG001|Completed Advance Directive|Became Ineligible|0|||
170564782|NCT01346176|616414540|FG002|Completed Advance Directive|Became Ineligible|1|||
170564783|NCT01346176|616414538|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
170564784|NCT01346176|616414539|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
170564785|NCT01346176|616414540|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
170564786|NCT01346176|616414538|FG000|Completed Satisfaction Survey|Death|3|||
170564787|NCT01346176|616414539|FG001|Completed Satisfaction Survey|Death|0|||
170564788|NCT01346176|616414540|FG002|Completed Satisfaction Survey|Death|2|||
170564789|NCT01346176|616414538|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
170564790|NCT01346176|616414539|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
170564791|NCT01346176|616414540|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
170564792|NCT05239221|616414541|FG000|Overall Study|Adverse Event|0|||
170564793|NCT05239221|616414542|FG001|Overall Study|Adverse Event|0|||
170564794|NCT05239221|616414543|FG002|Overall Study|Adverse Event|0|||
170564795|NCT05239221|616414544|FG003|Overall Study|Adverse Event|0|||
170564796|NCT05239221|616414545|FG004|Overall Study|Adverse Event|0|||
170564797|NCT05239221|616414546|FG005|Overall Study|Adverse Event|0|||
170564798|NCT05239221|616414547|FG006|Overall Study|Adverse Event|1|||
170564799|NCT05239221|616414548|FG007|Overall Study|Adverse Event|0|||
170564800|NCT05239221|616414549|FG008|Overall Study|Adverse Event|0|||
170564801|NCT05239221|616414550|FG009|Overall Study|Adverse Event|0|||
170564802|NCT05239221|616414551|FG010|Overall Study|Adverse Event|1|||
170564803|NCT05239221|616414552|FG011|Overall Study|Adverse Event|1|||
170564804|NCT05239221|616414553|FG012|Overall Study|Adverse Event|0|||
170564805|NCT05239221|616414554|FG013|Overall Study|Adverse Event|0|||
170564806|NCT05239221|616414555|FG014|Overall Study|Adverse Event|0|||
170564807|NCT05239221|616414556|FG015|Overall Study|Adverse Event|0|||
170564808|NCT05239221|616414541|FG000|Overall Study|Withdrawal by Subject|0|||
170564809|NCT05239221|616414542|FG001|Overall Study|Withdrawal by Subject|0|||
170564810|NCT05239221|616414543|FG002|Overall Study|Withdrawal by Subject|0|||
170564811|NCT05239221|616414544|FG003|Overall Study|Withdrawal by Subject|0|||
170564812|NCT05239221|616414545|FG004|Overall Study|Withdrawal by Subject|0|||
170564813|NCT05239221|616414546|FG005|Overall Study|Withdrawal by Subject|0|||
170564814|NCT05239221|616414547|FG006|Overall Study|Withdrawal by Subject|0|||
170564815|NCT05239221|616414548|FG007|Overall Study|Withdrawal by Subject|0|||
170564816|NCT05239221|616414549|FG008|Overall Study|Withdrawal by Subject|0|||
170564817|NCT05239221|616414550|FG009|Overall Study|Withdrawal by Subject|0|||
170564818|NCT05239221|616414551|FG010|Overall Study|Withdrawal by Subject|1|||
170564819|NCT05239221|616414552|FG011|Overall Study|Withdrawal by Subject|0|||
170564820|NCT05239221|616414553|FG012|Overall Study|Withdrawal by Subject|0|||
170564821|NCT05239221|616414554|FG013|Overall Study|Withdrawal by Subject|0|||
170564822|NCT05239221|616414555|FG014|Overall Study|Withdrawal by Subject|0|||
170564823|NCT05239221|616414556|FG015|Overall Study|Withdrawal by Subject|1|||
170564824|NCT00639457|616416980|FG000|Overall Study|Withdrawal by Subject|2|||
170564825|NCT00639457|616416981|FG001|Overall Study|Withdrawal by Subject|3|||
170564826|NCT01354223|616416985|FG000|Overall Study|Withdrawal by Subject|3|||
170564827|NCT01354223|616416986|FG001|Overall Study|Withdrawal by Subject|1|||
170564828|NCT04102007|616416991|FG000|Overall Study|Adverse Event|4|||
170564829|NCT04102007|616416991|FG000|Overall Study|Lost to Follow-up|3|||
170564830|NCT04102007|616416991|FG000|Overall Study|Withdrawal by Subject|12|||
170564831|NCT04102007|616416991|FG000|Overall Study|Eligibility Violation|5|||
170564832|NCT04102007|616416991|FG000|Overall Study|Lack of Efficacy|6|||
170564833|NCT04102007|616416991|FG000|Overall Study|Protocol Deviation|5|||
170564834|NCT04102007|616416991|FG000|Overall Study|Protocol Compliance|1|||
170564835|NCT04102007|616416991|FG000|Overall Study|Withdrew Treatment|2|||
170564836|NCT04102007|616416991|FG000|Overall Study|Pregnancy|1|||
170564837|NCT05173974|616416992|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
170564838|NCT05173974|616416993|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
170564839|NCT05173974|616416994|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
170564840|NCT05173974|616416995|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
170564841|NCT05173974|616416992|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
170564842|NCT05173974|616416993|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
170564843|NCT05173974|616416994|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
170564844|NCT05173974|616416995|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
170564845|NCT00948688|616416996|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
170564846|NCT00948688|616416997|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
170564847|NCT00948688|616416996|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
170564848|NCT00948688|616416997|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
170564849|NCT00948688|616416996|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
170564850|NCT00948688|616416997|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
170564851|NCT03983421|616416998|FG000|Overall Study|Lost to Follow-up|1|||
170564852|NCT00355030|616416999|FG000|Study Period 1 Treatment|Adverse Event|1|||
170564853|NCT00355030|616417000|FG001|Study Period 1 Treatment|Adverse Event|1|||
170564854|NCT00355030|616416999|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
170564855|NCT00355030|616417000|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
170564856|NCT00355030|616416999|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
170564857|NCT00355030|616417000|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
170564858|NCT00355030|616416999|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
170564859|NCT00355030|616417000|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
170645698|NCT04174365|616716018|FG001|Overall Study|Protocol Deviation|0|||
170645699|NCT04174365|616716017|FG000|Overall Study|Lack of Efficacy|0|||
170645700|NCT04174365|616716018|FG001|Overall Study|Lack of Efficacy|2|||
170564860|NCT00355030|616416999|FG000|Study Period 1 Treatment|Physician Decision|0|||
170564861|NCT00355030|616417000|FG001|Study Period 1 Treatment|Physician Decision|1|||
170564862|NCT00355030|616416999|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
170564863|NCT00355030|616417000|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
170564864|NCT00355030|616416999|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
170564865|NCT00355030|616417000|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
170564866|NCT00355030|616416999|FG000|Study Period 1 Treatment|Other|2|||
170564867|NCT00355030|616417000|FG001|Study Period 1 Treatment|Other|6|||
170564868|NCT00355030|616416999|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
170564869|NCT00355030|616417000|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
170564870|NCT00355030|616416999|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
170645701|NCT04174365|616716017|FG000|Overall Study|Disease Relapse|1|||
170564871|NCT00355030|616417000|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
170564872|NCT02136914|616417001|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
170564873|NCT02136914|616417002|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
170564874|NCT02136914|616417001|FG000|Overall Study|Withdrawal by Subject|3|||
170564875|NCT02136914|616417002|FG001|Overall Study|Withdrawal by Subject|10|||
170564876|NCT02136914|616417001|FG000|Overall Study|Subject Unwilling to Proceed|7|||
170564877|NCT02136914|616417002|FG001|Overall Study|Subject Unwilling to Proceed|2|||
170564878|NCT02136914|616417001|FG000|Overall Study|Lost to Follow-up|1|||
170564879|NCT02136914|616417002|FG001|Overall Study|Lost to Follow-up|1|||
170564880|NCT02136914|616417001|FG000|Overall Study|Did Not Receive Study Drug|2|||
170564881|NCT02136914|616417002|FG001|Overall Study|Did Not Receive Study Drug|0|||
170564882|NCT02136914|616417001|FG000|Overall Study|Lack of Efficacy|1|||
170564883|NCT02136914|616417002|FG001|Overall Study|Lack of Efficacy|0|||
170564884|NCT02136914|616417001|FG000|Overall Study|Death|0|||
170564885|NCT02136914|616417002|FG001|Overall Study|Death|1|||
170564886|NCT00949533|616417005|FG000|Overall Study|Lost to Follow-up|0|||
170564887|NCT00949533|616417006|FG001|Overall Study|Lost to Follow-up|1|||
170564888|NCT01493089|616417007|FG000|Overall Study|Protocol Violation|2|||
170564889|NCT01493089|616417008|FG001|Overall Study|Protocol Violation|2|||
170564890|NCT01493089|616417007|FG000|Overall Study|Withdrawal by Subject|1|||
170564891|NCT01493089|616417008|FG001|Overall Study|Withdrawal by Subject|0|||
170564892|NCT01493089|616417007|FG000|Overall Study|Physician Decision|0|||
170564893|NCT01493089|616417008|FG001|Overall Study|Physician Decision|1|||
170564894|NCT02234362|616417009|FG000|Overall Study|Not eligible after first screening visit|17|||
170564895|NCT02234362|616417009|FG000|Overall Study|Lost to Follow-up|6|||
170564896|NCT02234362|616417009|FG000|Overall Study|Withdrawal by Subject|3|||
170564897|NCT00560417|616417010|FG000|Overall Study|Adverse Event|3|||
170564898|NCT00560417|616417011|FG001|Overall Study|Adverse Event|2|||
170564899|NCT00560417|616417010|FG000|Overall Study|Entry Criteria Not Met|1|||
170564900|NCT00560417|616417011|FG001|Overall Study|Entry Criteria Not Met|0|||
170564901|NCT00560417|616417010|FG000|Overall Study|Lost to Follow-up|0|||
170564902|NCT00560417|616417011|FG001|Overall Study|Lost to Follow-up|1|||
170564903|NCT00560417|616417010|FG000|Overall Study|Physician Decision|2|||
170564904|NCT00560417|616417011|FG001|Overall Study|Physician Decision|6|||
170564905|NCT00560417|616417010|FG000|Overall Study|Protocol Violation|6|||
170564906|NCT00560417|616417011|FG001|Overall Study|Protocol Violation|5|||
170564907|NCT00560417|616417010|FG000|Overall Study|Sponsor Decision|2|||
170564908|NCT00560417|616417011|FG001|Overall Study|Sponsor Decision|0|||
170564909|NCT00560417|616417010|FG000|Overall Study|Withdrawal by Subject|3|||
170564910|NCT00560417|616417011|FG001|Overall Study|Withdrawal by Subject|3|||
170564911|NCT01870869|616417012|FG000|Overall Study|Implanted with nonstudy device|1|||
170564912|NCT01870869|616417013|FG001|Overall Study|Implanted with nonstudy device|3|||
170564913|NCT01870869|616417014|FG002|Overall Study|Implanted with nonstudy device|14|||
170564914|NCT01870869|616417015|FG003|Overall Study|Implanted with nonstudy device|4|||
170564915|NCT01870869|616417012|FG000|Overall Study|Death|0|||
170564916|NCT01870869|616417013|FG001|Overall Study|Death|0|||
170564917|NCT01870869|616417014|FG002|Overall Study|Death|7|||
170564918|NCT01870869|616417015|FG003|Overall Study|Death|1|||
170564919|NCT01870869|616417012|FG000|Overall Study|Subject choice|6|||
170564920|NCT01870869|616417013|FG001|Overall Study|Subject choice|2|||
170564921|NCT01870869|616417014|FG002|Overall Study|Subject choice|22|||
170564922|NCT01870869|616417015|FG003|Overall Study|Subject choice|8|||
170564923|NCT01870869|616417012|FG000|Overall Study|Lost to Follow-up|10|||
170564924|NCT01870869|616417013|FG001|Overall Study|Lost to Follow-up|2|||
170564925|NCT01870869|616417014|FG002|Overall Study|Lost to Follow-up|25|||
170564926|NCT01870869|616417015|FG003|Overall Study|Lost to Follow-up|3|||
170564927|NCT01870869|616417012|FG000|Overall Study|Reason not Specified|1|||
170564928|NCT01870869|616417013|FG001|Overall Study|Reason not Specified|2|||
170564929|NCT01870869|616417014|FG002|Overall Study|Reason not Specified|20|||
170564930|NCT01870869|616417015|FG003|Overall Study|Reason not Specified|4|||
170645702|NCT04174365|616716018|FG001|Overall Study|Disease Relapse|0|||
170564931|NCT01870869|616417012|FG000|Overall Study|Not evaluable|10|||
170564932|NCT01870869|616417013|FG001|Overall Study|Not evaluable|5|||
170564933|NCT01870869|616417014|FG002|Overall Study|Not evaluable|42|||
170564934|NCT01870869|616417015|FG003|Overall Study|Not evaluable|10|||
170564935|NCT00652834|616417016|FG000|Overall Study|Withdrawal by Subject|3|||
170564936|NCT00652834|616417016|FG000|Overall Study|Lost to Follow-up|2|||
170564937|NCT00320606|616417019|FG000|Overall Study|Adverse Event|1|||
170564938|NCT00320606|616417019|FG000|Overall Study|Protocol Violation|1|||
170564939|NCT00320606|616417019|FG000|Overall Study|Withdrawal by Subject|1|||
170564940|NCT03984825|616417020|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
170564941|NCT03984825|616417020|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
170564942|NCT03984825|616417020|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
170564943|NCT00622726|616417021|FG000|March, 2008 to August, 2010|Death|5|||
170564944|NCT00622726|616417022|FG001|March, 2008 to August, 2010|Death|2|||
170564945|NCT00622726|616417021|FG000|August, 2010 to April, 2013|Death|1|||
170564946|NCT00622726|616417022|FG001|August, 2010 to April, 2013|Death|5|||
170564947|NCT00854360|616417027|FG000|Overall Study|Adverse Event|0|||
170645703|NCT04174365|616716017|FG000|Overall Study|Reason Not Specified|0|||
170645704|NCT04174365|616716018|FG001|Overall Study|Reason Not Specified|1|||
170645705|NCT03472547|616716019|FG000|Overall Study|Withdrawal by Subject|30|||
170645706|NCT03865316|616717794|FG000|Overall Study|Procedure Cancelled|4|||
170645707|NCT03865316|616717794|FG000|Overall Study|Equipment failure|4|||
170645708|NCT03658876|616717795|FG000|Overall Study|Protocol Violation|3|||
170645709|NCT03658876|616717796|FG001|Overall Study|Protocol Violation|2|||
170645710|NCT03658876|616717795|FG000|Overall Study|Withdrawal by Subject|2|||
170645711|NCT03658876|616717796|FG001|Overall Study|Withdrawal by Subject|0|||
170645712|NCT03658876|616717795|FG000|Overall Study|Death|0|||
170645713|NCT03658876|616717796|FG001|Overall Study|Death|1|||
170645714|NCT03658876|616717795|FG000|Overall Study|Intercurrent illness|6|||
170645715|NCT03658876|616717796|FG001|Overall Study|Intercurrent illness|4|||
170645716|NCT03658876|616717795|FG000|Overall Study|Transplantation/other operation|1|||
170645717|NCT03658876|616717796|FG001|Overall Study|Transplantation/other operation|5|||
170645718|NCT01948193|616717797|FG000|Overall Study|Serious event|2|||
170645719|NCT01948193|616717797|FG000|Overall Study|Lost to Follow-up|7|||
170645720|NCT05746429|616717798|FG000|Feasibility Study|Lost to Follow-up|0|||
170645721|NCT05746429|616717799|FG001|Feasibility Study|Lost to Follow-up|1|||
170645722|NCT05746429|616717800|FG002|Feasibility Study|Lost to Follow-up|2|||
170645723|NCT02434471|616717801|FG000|Overall Study|Physician Decision|9|||
170645724|NCT02979977|616717802|FG000|Overall Study|Death|5|||
170564948|NCT00854360|616417028|FG001|Overall Study|Adverse Event|1|||
170564949|NCT00854360|616417029|FG002|Overall Study|Adverse Event|2|||
170564950|NCT00854360|616417030|FG003|Overall Study|Adverse Event|6|||
170564951|NCT00854360|616417027|FG000|Overall Study|Withdrawal by Subject|0|||
170564952|NCT00854360|616417028|FG001|Overall Study|Withdrawal by Subject|0|||
170564953|NCT00854360|616417029|FG002|Overall Study|Withdrawal by Subject|0|||
170564954|NCT00854360|616417030|FG003|Overall Study|Withdrawal by Subject|1|||
170564955|NCT00854360|616417027|FG000|Overall Study|Pregnancy|0|||
170564956|NCT00854360|616417028|FG001|Overall Study|Pregnancy|1|||
170564957|NCT00854360|616417029|FG002|Overall Study|Pregnancy|0|||
170564958|NCT00854360|616417030|FG003|Overall Study|Pregnancy|0|||
170564959|NCT00854360|616417027|FG000|Overall Study|Lack of Efficacy|2|||
170564960|NCT00854360|616417028|FG001|Overall Study|Lack of Efficacy|1|||
170564961|NCT00854360|616417029|FG002|Overall Study|Lack of Efficacy|0|||
170564962|NCT00854360|616417030|FG003|Overall Study|Lack of Efficacy|0|||
170564963|NCT00854360|616417027|FG000|Overall Study|Other|0|||
170645725|NCT02979977|616717802|FG000|Overall Study|Disease Progression|2|||
170645726|NCT02979977|616717802|FG000|Overall Study|Withdrawal by Subject|1|||
170645727|NCT02979977|616717802|FG000|Overall Study|Adverse Event|1|||
170645728|NCT04562480|616717803|FG000|Overall Study|Withdrawal by Subject|1|||
170645729|NCT03040999|616717804|FG000|Overall Study|Lost to Follow-up|2|||
170645730|NCT03040999|616717805|FG001|Overall Study|Lost to Follow-up|2|||
170645731|NCT03040999|616717804|FG000|Overall Study|Withdrawal by Subject|12|||
170645732|NCT03040999|616717805|FG001|Overall Study|Withdrawal by Subject|13|||
170645733|NCT03040999|616717804|FG000|Overall Study|Death|155|||
170645734|NCT03040999|616717805|FG001|Overall Study|Death|171|||
170645735|NCT03040999|616717804|FG000|Overall Study|Physician Decision|0|||
170645736|NCT03040999|616717805|FG001|Overall Study|Physician Decision|3|||
170645737|NCT00003472|616717806|FG000|Overall Study|Not evaluable|3|||
170645738|NCT01964755|616717807|FG000|Overall Study|Death|2|||
170645739|NCT00668733|616717809|FG000|Overall Study|Lost to Follow-up|2|||
170645740|NCT00668733|616717810|FG001|Overall Study|Lost to Follow-up|3|||
170645741|NCT00668733|616717809|FG000|Overall Study|Withdrawal by Subject|0|||
170645742|NCT00668733|616717810|FG001|Overall Study|Withdrawal by Subject|4|||
170645743|NCT01659554|616717813|FG000|Overall Study|Study Termination|4|||
170645744|NCT00603590|616717817|FG000|Overall Study|Did not attend study clinic|39|||
170645745|NCT00603590|616717818|FG001|Overall Study|Did not attend study clinic|30|||
170645746|NCT00603590|616717817|FG000|Overall Study|Refused blood test|5|||
170645747|NCT00603590|616717818|FG001|Overall Study|Refused blood test|1|||
170564964|NCT00854360|616417028|FG001|Overall Study|Other|0|||
170564965|NCT00854360|616417029|FG002|Overall Study|Other|0|||
170564966|NCT00854360|616417030|FG003|Overall Study|Other|3|||
170564967|NCT02037529|616417031|FG000|Overall Study|Withdrawal by Subject|1|||
170564968|NCT02037529|616417032|FG001|Overall Study|Withdrawal by Subject|3|||
170564969|NCT02037529|616417031|FG000|Overall Study|Adverse Event|0|||
170564970|NCT02037529|616417032|FG001|Overall Study|Adverse Event|1|||
170564971|NCT00718315|616417033|FG000|Overall Study|Adverse Event|1|||
170564972|NCT00718315|616417034|FG001|Overall Study|Adverse Event|2|||
170645748|NCT00603590|616717817|FG000|Overall Study|Patient discontinued study drug|22|||
170645749|NCT00603590|616717818|FG001|Overall Study|Patient discontinued study drug|15|||
170645750|NCT00603590|616717817|FG000|Overall Study|Adverse Event|2|||
170645751|NCT00603590|616717818|FG001|Overall Study|Adverse Event|0|||
170645752|NCT00603590|616717817|FG000|Overall Study|Lost to Follow-up|8|||
170645753|NCT00603590|616717818|FG001|Overall Study|Lost to Follow-up|4|||
170645754|NCT00603590|616717817|FG000|Overall Study|Cardiovascular event|0|||
170645755|NCT00603590|616717818|FG001|Overall Study|Cardiovascular event|1|||
170645756|NCT00910624|616717819|FG000|Treatment Phase|Adverse Event|2|||
170645757|NCT00910624|616717820|FG001|Treatment Phase|Adverse Event|6|||
170645758|NCT00910624|616717821|FG002|Treatment Phase|Adverse Event|6|||
170645759|NCT00910624|616717822|FG003|Treatment Phase|Adverse Event|0|||
170645760|NCT00910624|616717819|FG000|Treatment Phase|Treatment Failure|23|||
170645761|NCT00910624|616717820|FG001|Treatment Phase|Treatment Failure|10|||
170645762|NCT00910624|616717821|FG002|Treatment Phase|Treatment Failure|0|||
170645763|NCT00910624|616717822|FG003|Treatment Phase|Treatment Failure|0|||
170645764|NCT00910624|616717819|FG000|Treatment Phase|Lost to Follow-up|0|||
170645765|NCT00910624|616717820|FG001|Treatment Phase|Lost to Follow-up|0|||
170645766|NCT00910624|616717821|FG002|Treatment Phase|Lost to Follow-up|1|||
170645767|NCT00910624|616717822|FG003|Treatment Phase|Lost to Follow-up|0|||
170645768|NCT00910624|616717819|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
170645769|NCT00910624|616717820|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
170645770|NCT00910624|616717821|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
170645771|NCT00910624|616717822|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
170645772|NCT00910624|616717819|FG000|Treatment Phase|Withdrawal by Subject|2|||
170645773|NCT00910624|616717820|FG001|Treatment Phase|Withdrawal by Subject|1|||
170645774|NCT00910624|616717821|FG002|Treatment Phase|Withdrawal by Subject|0|||
170645775|NCT00910624|616717822|FG003|Treatment Phase|Withdrawal by Subject|0|||
170645776|NCT00910624|616717819|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
170645777|NCT00910624|616717820|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
170645778|NCT00910624|616717821|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
170645779|NCT00910624|616717822|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
170645780|NCT00910624|616717819|FG000|Follow-Up Phase|Adverse Event|0|||
170645781|NCT00910624|616717820|FG001|Follow-Up Phase|Adverse Event|0|||
170645782|NCT00910624|616717821|FG002|Follow-Up Phase|Adverse Event|1|||
170645783|NCT00910624|616717822|FG003|Follow-Up Phase|Adverse Event|0|||
170645784|NCT00910624|616717819|FG000|Follow-Up Phase|Lost to Follow-up|3|||
170645785|NCT00910624|616717820|FG001|Follow-Up Phase|Lost to Follow-up|1|||
170645786|NCT00910624|616717821|FG002|Follow-Up Phase|Lost to Follow-up|2|||
170645787|NCT00910624|616717822|FG003|Follow-Up Phase|Lost to Follow-up|0|||
170645788|NCT00910624|616717819|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
170645789|NCT00910624|616717820|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
170645790|NCT00910624|616717821|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
170645791|NCT00910624|616717822|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
170645792|NCT00910624|616717819|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
170645793|NCT00910624|616717820|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
170645794|NCT00910624|616717821|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
170645795|NCT00910624|616717822|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
170645796|NCT00910624|616717819|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
170645797|NCT00910624|616717820|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
170645798|NCT00910624|616717821|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
170645799|NCT00910624|616717822|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
170645800|NCT00910624|616717819|FG000|Follow-Up Phase|Administrative|0|||
170645801|NCT00910624|616717820|FG001|Follow-Up Phase|Administrative|1|||
170645802|NCT00910624|616717821|FG002|Follow-Up Phase|Administrative|1|||
170645803|NCT00910624|616717822|FG003|Follow-Up Phase|Administrative|0|||
170645804|NCT01122264|616717826|FG000|Overall Study|Adverse Event|6|||
170645805|NCT01122264|616717827|FG001|Overall Study|Adverse Event|5|||
170645806|NCT01122264|616717828|FG002|Overall Study|Adverse Event|7|||
170645807|NCT01122264|616717826|FG000|Overall Study|Death|1|||
170645808|NCT01122264|616717827|FG001|Overall Study|Death|0|||
170645809|NCT01122264|616717828|FG002|Overall Study|Death|0|||
170645810|NCT01122264|616717826|FG000|Overall Study|Lost to Follow-up|5|||
170564973|NCT00718315|616417035|FG002|Overall Study|Adverse Event|3|||
170564974|NCT00718315|616417033|FG000|Overall Study|Death|6|||
170564975|NCT00718315|616417034|FG001|Overall Study|Death|6|||
170564976|NCT00718315|616417035|FG002|Overall Study|Death|5|||
170564977|NCT00718315|616417033|FG000|Overall Study|Lost to Follow-up|2|||
170564978|NCT00718315|616417034|FG001|Overall Study|Lost to Follow-up|3|||
170564979|NCT00718315|616417035|FG002|Overall Study|Lost to Follow-up|4|||
170564980|NCT00718315|616417033|FG000|Overall Study|Protocol Violation|5|||
170564981|NCT00718315|616417034|FG001|Overall Study|Protocol Violation|5|||
170564982|NCT00718315|616417035|FG002|Overall Study|Protocol Violation|3|||
170564983|NCT00718315|616417033|FG000|Overall Study|Erlotinib dose decreased|4|||
170564984|NCT00718315|616417034|FG001|Overall Study|Erlotinib dose decreased|3|||
170645811|NCT01122264|616717827|FG001|Overall Study|Lost to Follow-up|9|||
170645812|NCT01122264|616717828|FG002|Overall Study|Lost to Follow-up|13|||
170399412|NCT04644237|615799955|FG000|Overall Study|Adverse Event|18|||
170564985|NCT00718315|616417035|FG002|Overall Study|Erlotinib dose decreased|1|||
170564986|NCT00718315|616417033|FG000|Overall Study|Use of Minocyclin|1|||
170645813|NCT01122264|616717826|FG000|Overall Study|Entry Criteria Not Met|1|||
170645814|NCT01122264|616717827|FG001|Overall Study|Entry Criteria Not Met|0|||
170645815|NCT01122264|616717828|FG002|Overall Study|Entry Criteria Not Met|0|||
170645816|NCT01122264|616717826|FG000|Overall Study|Protocol Violation|7|||
170645817|NCT01122264|616717827|FG001|Overall Study|Protocol Violation|7|||
170645818|NCT01122264|616717828|FG002|Overall Study|Protocol Violation|9|||
170645819|NCT01122264|616717826|FG000|Overall Study|Withdrawal by Subject|6|||
170645820|NCT01122264|616717827|FG001|Overall Study|Withdrawal by Subject|6|||
170645821|NCT01122264|616717828|FG002|Overall Study|Withdrawal by Subject|16|||
170645822|NCT01122264|616717826|FG000|Overall Study|Physician Decision|3|||
170645823|NCT01122264|616717827|FG001|Overall Study|Physician Decision|1|||
170645824|NCT01122264|616717828|FG002|Overall Study|Physician Decision|1|||
170645825|NCT01122264|616717826|FG000|Overall Study|Lack of Efficacy|3|||
170645826|NCT01122264|616717827|FG001|Overall Study|Lack of Efficacy|1|||
170645827|NCT01122264|616717828|FG002|Overall Study|Lack of Efficacy|1|||
170645828|NCT03005873|616717829|FG000|Overall Study|Prohibited medication use post radnomization|1|||
170645829|NCT03005873|616717830|FG001|Overall Study|Prohibited medication use post radnomization|1|||
170645830|NCT03005873|616717831|FG002|Overall Study|Prohibited medication use post radnomization|1|||
170399413|NCT04644237|615799956|FG001|Overall Study|Adverse Event|19|||
170645831|NCT03005873|616717829|FG000|Overall Study|Withdrew consent|0|||
170645832|NCT03005873|616717830|FG001|Overall Study|Withdrew consent|1|||
170645833|NCT03005873|616717831|FG002|Overall Study|Withdrew consent|2|||
170645834|NCT03005873|616717829|FG000|Overall Study|Lost to Follow-up|0|||
170645835|NCT03005873|616717830|FG001|Overall Study|Lost to Follow-up|1|||
170645836|NCT03005873|616717831|FG002|Overall Study|Lost to Follow-up|0|||
170645837|NCT03005873|616717829|FG000|Overall Study|Ineligible post randomization|0|||
170645838|NCT03005873|616717830|FG001|Overall Study|Ineligible post randomization|0|||
170645839|NCT03005873|616717831|FG002|Overall Study|Ineligible post randomization|1|||
170645840|NCT04585009|616717832|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
170645841|NCT04585009|616717833|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645842|NCT04585009|616717834|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645843|NCT04585009|616717835|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645844|NCT04585009|616717836|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645845|NCT04585009|616717837|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645846|NCT04585009|616717838|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645847|NCT04585009|616717839|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645848|NCT04585009|616717840|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645849|NCT04585009|616717841|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645850|NCT04585009|616717842|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645851|NCT04585009|616717843|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
170645852|NCT04585009|616717832|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
170645853|NCT04585009|616717833|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645854|NCT04585009|616717834|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645855|NCT04585009|616717835|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170806880|NCT03389802|617301653|FG004|Overall Study|Lack of Efficacy|1|||
170564987|NCT00718315|616417034|FG001|Overall Study|Use of Minocyclin|1|||
170564988|NCT00718315|616417035|FG002|Overall Study|Use of Minocyclin|1|||
170564989|NCT00718315|616417033|FG000|Overall Study|Disease progression|0|||
170564990|NCT00718315|616417034|FG001|Overall Study|Disease progression|1|||
170645856|NCT04585009|616717836|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645857|NCT04585009|616717837|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645858|NCT04585009|616717838|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645859|NCT04585009|616717839|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645860|NCT04585009|616717840|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645861|NCT04585009|616717841|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645862|NCT04585009|616717842|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645863|NCT04585009|616717843|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
170645864|NCT04585009|616717832|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645865|NCT04585009|616717833|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645866|NCT04585009|616717834|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645867|NCT04585009|616717835|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645868|NCT04585009|616717836|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645869|NCT04585009|616717837|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645870|NCT04585009|616717838|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645871|NCT04585009|616717839|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
170645872|NCT04585009|616717840|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645873|NCT04585009|616717841|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645874|NCT04585009|616717842|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170645875|NCT04585009|616717843|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
170806881|NCT03389802|617301649|FG000|Overall Study|Adverse Event|0|||
170564991|NCT00718315|616417035|FG002|Overall Study|Disease progression|1|||
170564992|NCT00718315|616417033|FG000|Overall Study|Other|0|||
170564993|NCT00718315|616417034|FG001|Overall Study|Other|0|||
170564994|NCT00718315|616417035|FG002|Overall Study|Other|1|||
170564995|NCT00718315|616417033|FG000|Overall Study|Use of ATB and Corticoids|0|||
170564996|NCT00718315|616417034|FG001|Overall Study|Use of ATB and Corticoids|1|||
170564997|NCT00718315|616417035|FG002|Overall Study|Use of ATB and Corticoids|2|||
170564998|NCT02271880|616417036|FG000|Overall Study|Premature discontinuation of study|3|||
170564999|NCT02271880|616417037|FG001|Overall Study|Premature discontinuation of study|4|||
170565000|NCT00399529|616417038|FG000|Overall Study|Off Study Prior to Treatment|2|||
170565001|NCT00673920|616417041|FG000|Baseline up to Week 48|Withdrew consent|1|||
170565002|NCT00673920|616417042|FG001|Baseline up to Week 48|Withdrew consent|0|||
170565003|NCT00673920|616417043|FG002|Baseline up to Week 48|Withdrew consent|2|||
170565004|NCT00673920|616417044|FG003|Baseline up to Week 48|Withdrew consent|0|||
170565005|NCT00673920|616417045|FG004|Baseline up to Week 48|Withdrew consent|0|||
170565006|NCT00673920|616417046|FG005|Baseline up to Week 48|Withdrew consent|0|||
170565007|NCT00673920|616417047|FG006|Baseline up to Week 48|Withdrew consent|0|||
170565008|NCT00673920|616417048|FG007|Baseline up to Week 48|Withdrew consent|0|||
170565009|NCT00673920|616417041|FG000|Baseline up to Week 48|Refused treatment|1|||
170565010|NCT00673920|616417042|FG001|Baseline up to Week 48|Refused treatment|0|||
170565011|NCT00673920|616417043|FG002|Baseline up to Week 48|Refused treatment|0|||
170399414|NCT04644237|615799955|FG000|Overall Study|Progressive Disease|61|||
170565012|NCT00673920|616417044|FG003|Baseline up to Week 48|Refused treatment|0|||
170565013|NCT00673920|616417045|FG004|Baseline up to Week 48|Refused treatment|0|||
170565014|NCT00673920|616417046|FG005|Baseline up to Week 48|Refused treatment|0|||
170565015|NCT00673920|616417047|FG006|Baseline up to Week 48|Refused treatment|0|||
170565016|NCT00673920|616417048|FG007|Baseline up to Week 48|Refused treatment|0|||
170565017|NCT00673920|616417041|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
170565018|NCT00673920|616417042|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
170565019|NCT00673920|616417043|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
170565020|NCT00673920|616417044|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
170565021|NCT00673920|616417045|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
170565022|NCT00673920|616417046|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
170565023|NCT00673920|616417047|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
170565024|NCT00673920|616417048|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
170565025|NCT00673920|616417041|FG000|Baseline up to Week 48|Protocol Violation|0|||
170565026|NCT00673920|616417042|FG001|Baseline up to Week 48|Protocol Violation|0|||
170565027|NCT00673920|616417043|FG002|Baseline up to Week 48|Protocol Violation|1|||
170565028|NCT00673920|616417044|FG003|Baseline up to Week 48|Protocol Violation|0|||
170565029|NCT00673920|616417045|FG004|Baseline up to Week 48|Protocol Violation|0|||
170565030|NCT00673920|616417046|FG005|Baseline up to Week 48|Protocol Violation|0|||
170565031|NCT00673920|616417047|FG006|Baseline up to Week 48|Protocol Violation|0|||
170565032|NCT00673920|616417048|FG007|Baseline up to Week 48|Protocol Violation|0|||
170565033|NCT00673920|616417041|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
170565034|NCT00673920|616417042|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
170565035|NCT00673920|616417043|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
170565036|NCT00673920|616417044|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
170565037|NCT00673920|616417045|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
170565038|NCT00673920|616417046|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
170565039|NCT00673920|616417047|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
170565040|NCT00673920|616417048|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
170565041|NCT00673920|616417041|FG000|Baseline up to Week 48|Administrative/Other|0|||
170565042|NCT00673920|616417042|FG001|Baseline up to Week 48|Administrative/Other|1|||
170565043|NCT00673920|616417043|FG002|Baseline up to Week 48|Administrative/Other|2|||
170565044|NCT00673920|616417044|FG003|Baseline up to Week 48|Administrative/Other|0|||
170565045|NCT00673920|616417045|FG004|Baseline up to Week 48|Administrative/Other|0|||
170565046|NCT00673920|616417046|FG005|Baseline up to Week 48|Administrative/Other|0|||
170565047|NCT00673920|616417047|FG006|Baseline up to Week 48|Administrative/Other|0|||
170565048|NCT00673920|616417048|FG007|Baseline up to Week 48|Administrative/Other|0|||
170565049|NCT00673920|616417041|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
170565050|NCT00673920|616417042|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
170565051|NCT00673920|616417043|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
170565052|NCT00673920|616417044|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
170565053|NCT00673920|616417045|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
170565054|NCT00673920|616417046|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
170565055|NCT00673920|616417047|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
170565056|NCT00673920|616417048|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
170565057|NCT00673920|616417041|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
170565058|NCT00673920|616417042|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
170565059|NCT00673920|616417043|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
170565060|NCT00673920|616417044|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
170565061|NCT00673920|616417045|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
170565062|NCT00673920|616417046|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
170565063|NCT00673920|616417047|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
170565064|NCT00673920|616417048|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
170565065|NCT00673920|616417041|FG000|Week 24 to Week 48|Failure to return|0|||
170565066|NCT00673920|616417042|FG001|Week 24 to Week 48|Failure to return|0|||
170565067|NCT00673920|616417043|FG002|Week 24 to Week 48|Failure to return|0|||
170565068|NCT00673920|616417044|FG003|Week 24 to Week 48|Failure to return|0|||
170565069|NCT00673920|616417045|FG004|Week 24 to Week 48|Failure to return|0|||
170565070|NCT00673920|616417046|FG005|Week 24 to Week 48|Failure to return|1|||
170565071|NCT00673920|616417047|FG006|Week 24 to Week 48|Failure to return|0|||
170565072|NCT00673920|616417048|FG007|Week 24 to Week 48|Failure to return|0|||
170565073|NCT00673920|616417041|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
170565074|NCT00673920|616417042|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
170565075|NCT00673920|616417043|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
170565076|NCT00673920|616417044|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
170565077|NCT00673920|616417045|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
170565078|NCT00673920|616417046|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
170565079|NCT00673920|616417047|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
170565080|NCT00673920|616417048|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
170565081|NCT00673920|616417041|FG000|Week 24 to Week 48|Death|0|||
170565082|NCT00673920|616417042|FG001|Week 24 to Week 48|Death|0|||
170565083|NCT00673920|616417043|FG002|Week 24 to Week 48|Death|0|||
170565084|NCT00673920|616417044|FG003|Week 24 to Week 48|Death|0|||
170565085|NCT00673920|616417045|FG004|Week 24 to Week 48|Death|0|||
170565086|NCT00673920|616417046|FG005|Week 24 to Week 48|Death|1|||
170906015|NCT01126580|617658585|FG001|Overall Study|Lack of Efficacy|3|||
170906016|NCT01126580|617658586|FG002|Overall Study|Lack of Efficacy|4|||
170906017|NCT01126580|617658584|FG000|Overall Study|Protocol Violation|0|||
170906018|NCT01126580|617658585|FG001|Overall Study|Protocol Violation|1|||
170906019|NCT01126580|617658586|FG002|Overall Study|Protocol Violation|2|||
170906020|NCT01126580|617658584|FG000|Overall Study|Lost to Follow-up|15|||
170906021|NCT01126580|617658585|FG001|Overall Study|Lost to Follow-up|13|||
170906022|NCT01126580|617658586|FG002|Overall Study|Lost to Follow-up|9|||
170906023|NCT01126580|617658584|FG000|Overall Study|Treatment Non-compliance|0|||
170906024|NCT01126580|617658585|FG001|Overall Study|Treatment Non-compliance|2|||
170906025|NCT01126580|617658586|FG002|Overall Study|Treatment Non-compliance|3|||
170906026|NCT01731002|617658596|FG000|Overall Study|Adverse Event|0|||
170906027|NCT01731002|617658597|FG001|Overall Study|Adverse Event|2|||
170906028|NCT01731002|617658598|FG002|Overall Study|Adverse Event|2|||
170906029|NCT01731002|617658596|FG000|Overall Study|Non-Compliant|0|||
170565087|NCT00673920|616417047|FG006|Week 24 to Week 48|Death|0|||
170565088|NCT00673920|616417048|FG007|Week 24 to Week 48|Death|0|||
170565089|NCT00673920|616417041|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
170565090|NCT00673920|616417042|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
170565091|NCT00673920|616417043|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
170565092|NCT00673920|616417044|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
170565093|NCT00673920|616417045|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
170565094|NCT00673920|616417046|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
170565095|NCT00673920|616417047|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
170565096|NCT00673920|616417048|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
170565097|NCT02519842|616417049|FG000|Base Study: Cycle 1|Screening Failure|1|||
170565098|NCT02519842|616417050|FG001|Base Study: Cycle 1|Screening Failure|1|||
170565099|NCT02519842|616417051|FG002|Base Study: Cycle 1|Screening Failure|0|||
170565100|NCT02519842|616417049|FG000|Base Study: Cycle 1|Adverse Event|1|||
170565101|NCT02519842|616417050|FG001|Base Study: Cycle 1|Adverse Event|0|||
170565102|NCT02519842|616417051|FG002|Base Study: Cycle 1|Adverse Event|0|||
170565103|NCT02519842|616417049|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
170565104|NCT02519842|616417050|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
170565105|NCT02519842|616417051|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
170565106|NCT02519842|616417049|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
170565107|NCT02519842|616417050|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
170565108|NCT02519842|616417051|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
170565109|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
170565110|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
170565111|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
170565112|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
170565113|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
170565114|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
170565115|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
170565116|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
170565117|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
170565118|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
170565119|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
170565120|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
170565121|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Death|0|||
170565122|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Death|0|||
170565123|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Death|1|||
170565124|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
170565125|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
170565126|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
170565127|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
170565128|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
170565129|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
170565130|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
170565131|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
170565132|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
170565133|NCT02519842|616417049|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
170565134|NCT02519842|616417050|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
170565135|NCT02519842|616417051|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
170565136|NCT01463527|616417053|FG000|Overall Study|Protocol Violation|1|||
170565137|NCT01463527|616417054|FG001|Overall Study|Protocol Violation|1|||
170565138|NCT01463527|616417053|FG000|Overall Study|Crying >20% of sedation|5|||
170906030|NCT01731002|617658597|FG001|Overall Study|Non-Compliant|1|||
170906031|NCT01731002|617658598|FG002|Overall Study|Non-Compliant|0|||
170906032|NCT01731002|617658596|FG000|Overall Study|Lost to Follow-up|1|||
170906033|NCT01731002|617658597|FG001|Overall Study|Lost to Follow-up|0|||
170906034|NCT01731002|617658598|FG002|Overall Study|Lost to Follow-up|0|||
170565139|NCT01463527|616417054|FG001|Overall Study|Crying >20% of sedation|6|||
170565140|NCT01076010|616417057|FG000|Overall Study|Death|15|||
170565141|NCT01076010|616417058|FG001|Overall Study|Death|1|||
170565142|NCT01076010|616417059|FG002|Overall Study|Death|0|||
170565143|NCT01076010|616417057|FG000|Overall Study|Adverse Event|7|||
170565144|NCT01076010|616417058|FG001|Overall Study|Adverse Event|2|||
170565145|NCT01076010|616417059|FG002|Overall Study|Adverse Event|0|||
170565146|NCT01076010|616417057|FG000|Overall Study|Progressive disease|90|||
170565147|NCT01076010|616417058|FG001|Overall Study|Progressive disease|30|||
170565148|NCT01076010|616417059|FG002|Overall Study|Progressive disease|1|||
170565149|NCT01076010|616417057|FG000|Overall Study|Lack of Efficacy|4|||
170565150|NCT01076010|616417058|FG001|Overall Study|Lack of Efficacy|0|||
170565151|NCT01076010|616417059|FG002|Overall Study|Lack of Efficacy|0|||
170565152|NCT01076010|616417057|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
170565153|NCT01076010|616417058|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
170565154|NCT01076010|616417059|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
170565155|NCT01076010|616417057|FG000|Overall Study|Significant Surgical Procedure|0|||
170565156|NCT01076010|616417058|FG001|Overall Study|Significant Surgical Procedure|1|||
170565157|NCT01076010|616417059|FG002|Overall Study|Significant Surgical Procedure|0|||
170565158|NCT01076010|616417057|FG000|Overall Study|Protocol Violation|0|||
170565159|NCT01076010|616417058|FG001|Overall Study|Protocol Violation|1|||
170565160|NCT01076010|616417059|FG002|Overall Study|Protocol Violation|0|||
170565161|NCT01076010|616417057|FG000|Overall Study|Noncompliance|1|||
170565162|NCT01076010|616417058|FG001|Overall Study|Noncompliance|1|||
170565163|NCT01076010|616417059|FG002|Overall Study|Noncompliance|0|||
170565164|NCT01076010|616417057|FG000|Overall Study|Withdrawal by Subject|3|||
170565165|NCT01076010|616417058|FG001|Overall Study|Withdrawal by Subject|0|||
170565166|NCT01076010|616417059|FG002|Overall Study|Withdrawal by Subject|1|||
170565167|NCT01076010|616417057|FG000|Overall Study|Other|5|||
170565168|NCT01076010|616417058|FG001|Overall Study|Other|2|||
170565169|NCT01076010|616417059|FG002|Overall Study|Other|0|||
170565170|NCT01612676|616417060|FG000|Overall Study|Adverse Event|2|||
170565171|NCT01612676|616417061|FG001|Overall Study|Adverse Event|3|||
170565172|NCT01612676|616417062|FG002|Overall Study|Adverse Event|1|||
170565173|NCT01612676|616417063|FG003|Overall Study|Adverse Event|3|||
170645876|NCT04585009|616717832|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645877|NCT04585009|616717833|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645878|NCT04585009|616717834|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645879|NCT04585009|616717835|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645880|NCT04585009|616717836|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
170645881|NCT04585009|616717837|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645882|NCT04585009|616717838|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645883|NCT04585009|616717839|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645884|NCT04585009|616717840|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645885|NCT04585009|616717841|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645886|NCT04585009|616717842|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645887|NCT04585009|616717843|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
170645888|NCT04585009|616717832|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645889|NCT04585009|616717833|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645890|NCT04585009|616717834|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645891|NCT04585009|616717835|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645892|NCT04585009|616717836|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645893|NCT04585009|616717837|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645894|NCT04585009|616717838|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170565174|NCT01612676|616417060|FG000|Overall Study|Protocol Violation|0|||
170645895|NCT04585009|616717839|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645896|NCT04585009|616717840|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645897|NCT04585009|616717841|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
170645898|NCT04585009|616717842|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645899|NCT04585009|616717843|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
170645900|NCT04585009|616717832|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645901|NCT04585009|616717833|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645902|NCT04585009|616717834|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645903|NCT04585009|616717835|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645904|NCT04585009|616717836|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645905|NCT04585009|616717837|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645906|NCT04585009|616717838|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645907|NCT04585009|616717839|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645908|NCT04585009|616717840|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645909|NCT04585009|616717841|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645910|NCT04585009|616717842|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
170645911|NCT04585009|616717843|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
170645912|NCT03699475|616717844|FG000|Overall Study|Death|1|||
170645913|NCT00097981|616717845|FG000|Overall Study|Adverse Event|31|||
170645914|NCT00097981|616717846|FG001|Overall Study|Adverse Event|44|||
170645915|NCT00097981|616717845|FG000|Overall Study|Withdrawal by Subject|10|||
170645916|NCT00097981|616717846|FG001|Overall Study|Withdrawal by Subject|8|||
170645917|NCT00097981|616717845|FG000|Overall Study|Protocol Violation|1|||
170645918|NCT00097981|616717846|FG001|Overall Study|Protocol Violation|1|||
170645919|NCT00097981|616717845|FG000|Overall Study|Death|2|||
170645920|NCT00097981|616717846|FG001|Overall Study|Death|4|||
170565175|NCT01612676|616417061|FG001|Overall Study|Protocol Violation|1|||
170565176|NCT01612676|616417062|FG002|Overall Study|Protocol Violation|0|||
170565177|NCT01612676|616417063|FG003|Overall Study|Protocol Violation|0|||
170565178|NCT01156844|616417066|FG000|Overall Study|Adverse Event|0|||
170565179|NCT01156844|616417067|FG001|Overall Study|Adverse Event|0|||
170565180|NCT01156844|616417068|FG002|Overall Study|Adverse Event|1|||
170565181|NCT01156844|616417069|FG003|Overall Study|Adverse Event|1|||
170565182|NCT01156844|616417066|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170565183|NCT01156844|616417067|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170565184|NCT01156844|616417068|FG002|Overall Study|Abnormal test procedure result(s)|2|||
170565185|NCT01156844|616417069|FG003|Overall Study|Abnormal test procedure result(s)|2|||
170565186|NCT01156844|616417066|FG000|Overall Study|Withdrawal by Subject|0|||
170565187|NCT01156844|616417067|FG001|Overall Study|Withdrawal by Subject|0|||
170565188|NCT01156844|616417068|FG002|Overall Study|Withdrawal by Subject|2|||
170565189|NCT01156844|616417069|FG003|Overall Study|Withdrawal by Subject|2|||
170565190|NCT01156844|616417066|FG000|Overall Study|Lost to Follow-up|0|||
170565191|NCT01156844|616417067|FG001|Overall Study|Lost to Follow-up|0|||
170565192|NCT01156844|616417068|FG002|Overall Study|Lost to Follow-up|1|||
170565193|NCT01156844|616417069|FG003|Overall Study|Lost to Follow-up|0|||
170565194|NCT01156844|616417066|FG000|Overall Study|Administrative problems|0|||
170565195|NCT01156844|616417067|FG001|Overall Study|Administrative problems|1|||
170399415|NCT04644237|615799956|FG001|Overall Study|Progressive Disease|23|||
170565196|NCT01156844|616417068|FG002|Overall Study|Administrative problems|0|||
170565197|NCT01156844|616417069|FG003|Overall Study|Administrative problems|1|||
170565198|NCT01156844|616417066|FG000|Overall Study|Protocol deviation|2|||
170645921|NCT00097981|616717845|FG000|Overall Study|Physician Decision|7|||
170645922|NCT00097981|616717846|FG001|Overall Study|Physician Decision|1|||
170645923|NCT00097981|616717845|FG000|Overall Study|Disease Progression|8|||
170645924|NCT00097981|616717846|FG001|Overall Study|Disease Progression|2|||
170645925|NCT00097981|616717845|FG000|Overall Study|Transplant planned|28|||
170645926|NCT00097981|616717846|FG001|Overall Study|Transplant planned|27|||
170645927|NCT00097981|616717845|FG000|Overall Study|Other|19|||
170645928|NCT00097981|616717846|FG001|Overall Study|Other|13|||
170645929|NCT00412373|616717849|FG000|Overall Study|Adverse Event|8|||
170645930|NCT00412373|616717850|FG001|Overall Study|Adverse Event|13|||
170645931|NCT00412373|616717849|FG000|Overall Study|Lack of Efficacy|16|||
170645932|NCT00412373|616717850|FG001|Overall Study|Lack of Efficacy|22|||
170645933|NCT00412373|616717849|FG000|Overall Study|Lost to Follow-up|7|||
170645934|NCT00412373|616717850|FG001|Overall Study|Lost to Follow-up|13|||
170645935|NCT00412373|616717849|FG000|Overall Study|Withdrawal by Subject|8|||
170645936|NCT00412373|616717850|FG001|Overall Study|Withdrawal by Subject|27|||
170645937|NCT00412373|616717849|FG000|Overall Study|Other|2|||
170645938|NCT00412373|616717850|FG001|Overall Study|Other|2|||
170645939|NCT05111886|616717853|FG000|Overall Study|Lost to Follow-up|0|||
170645940|NCT05111886|616717854|FG001|Overall Study|Lost to Follow-up|0|||
170645941|NCT05111886|616717855|FG002|Overall Study|Lost to Follow-up|0|||
170645942|NCT05111886|616717856|FG003|Overall Study|Lost to Follow-up|4|||
170645943|NCT05111886|616717857|FG004|Overall Study|Lost to Follow-up|0|||
170645944|NCT04644029|616717858|FG000|Overall Study|Death|1|||
170645945|NCT04644029|616717859|FG001|Overall Study|Death|0|||
170645946|NCT04644029|616717858|FG000|Overall Study|Physician Decision|1|||
170645947|NCT04644029|616717859|FG001|Overall Study|Physician Decision|2|||
170645948|NCT04644029|616717858|FG000|Overall Study|Withdrawal by Subject|21|||
170645949|NCT04644029|616717859|FG001|Overall Study|Withdrawal by Subject|19|||
170645950|NCT04644029|616717858|FG000|Overall Study|Lost to Follow-up|31|||
170645951|NCT04644029|616717859|FG001|Overall Study|Lost to Follow-up|34|||
170645952|NCT04644029|616717858|FG000|Overall Study|Study Terminated by Sponsor|308|||
170645953|NCT04644029|616717859|FG001|Overall Study|Study Terminated by Sponsor|309|||
170645954|NCT04644029|616717858|FG000|Overall Study|Randomized in Error|2|||
170645955|NCT04644029|616717859|FG001|Overall Study|Randomized in Error|1|||
170645956|NCT04644029|616717858|FG000|Overall Study|Other|0|||
170645957|NCT04644029|616717859|FG001|Overall Study|Other|1|||
170645958|NCT05051644|616717860|FG000|Overall Study|Withdrawal by Subject|0|||
170645959|NCT05051644|616717861|FG001|Overall Study|Withdrawal by Subject|1|||
170645960|NCT03135119|616717862|FG000|Overall Study|Lost to Follow-up|2|||
170645961|NCT03135119|616717863|FG001|Overall Study|Lost to Follow-up|0|||
170645962|NCT03135119|616717862|FG000|Overall Study|Physician Decision|1|||
170645963|NCT03135119|616717863|FG001|Overall Study|Physician Decision|1|||
170645964|NCT03135119|616717862|FG000|Overall Study|COVID-19 Shutdown|2|||
170645965|NCT03135119|616717863|FG001|Overall Study|COVID-19 Shutdown|2|||
170645966|NCT01478048|616717864|FG000|Overall Study|Disease Progression|52|||
170645967|NCT01478048|616717865|FG001|Overall Study|Disease Progression|35|||
170645968|NCT01478048|616717864|FG000|Overall Study|study drug toxicity|11|||
170645969|NCT01478048|616717865|FG001|Overall Study|study drug toxicity|14|||
170645970|NCT01478048|616717864|FG000|Overall Study|Adverse Event|2|||
170645971|NCT01478048|616717865|FG001|Overall Study|Adverse Event|11|||
170645972|NCT01478048|616717864|FG000|Overall Study|subject request to discontinue treatment|3|||
170645973|NCT01478048|616717865|FG001|Overall Study|subject request to discontinue treatment|5|||
170645974|NCT01478048|616717864|FG000|Overall Study|Withdrawal by Subject|2|||
170645975|NCT01478048|616717865|FG001|Overall Study|Withdrawal by Subject|5|||
170645976|NCT01478048|616717864|FG000|Overall Study|non-specified|6|||
170645977|NCT01478048|616717865|FG001|Overall Study|non-specified|4|||
170645978|NCT01478048|616717864|FG000|Overall Study|poor/non-compliance|0|||
170645979|NCT01478048|616717865|FG001|Overall Study|poor/non-compliance|1|||
170645980|NCT01478048|616717864|FG000|Overall Study|no longer meets study criteria|1|||
170645981|NCT01478048|616717865|FG001|Overall Study|no longer meets study criteria|0|||
170645982|NCT01369329|616717869|FG000|Overall Study|Withdrawal by Subject|8|||
170645983|NCT01369329|616717870|FG001|Overall Study|Withdrawal by Subject|6|||
170645984|NCT01369329|616717871|FG002|Overall Study|Withdrawal by Subject|10|||
170645985|NCT01369329|616717869|FG000|Overall Study|Lost to Follow-up|2|||
170645986|NCT01369329|616717870|FG001|Overall Study|Lost to Follow-up|2|||
170645987|NCT01369329|616717871|FG002|Overall Study|Lost to Follow-up|2|||
170645988|NCT01369329|616717869|FG000|Overall Study|Other|2|||
170645989|NCT01369329|616717870|FG001|Overall Study|Other|3|||
170645990|NCT01369329|616717871|FG002|Overall Study|Other|2|||
170645991|NCT01836276|616717872|FG000|Overall Study|Lost to Follow-up|28|||
170645992|NCT01836276|616717873|FG001|Overall Study|Lost to Follow-up|51|||
170645993|NCT04809467|616717874|FG000|Overall Study|Death|9|||
170645994|NCT04809467|616717875|FG001|Overall Study|Death|7|||
170645995|NCT04809467|616717876|FG002|Overall Study|Death|4|||
170645996|NCT04809467|616717877|FG003|Overall Study|Death|0|||
170645997|NCT04809467|616717878|FG004|Overall Study|Death|1|||
170645998|NCT04809467|616717874|FG000|Overall Study|Lost to Follow-up|0|||
170645999|NCT04809467|616717875|FG001|Overall Study|Lost to Follow-up|0|||
170646000|NCT04809467|616717876|FG002|Overall Study|Lost to Follow-up|1|||
170646001|NCT04809467|616717877|FG003|Overall Study|Lost to Follow-up|1|||
170646002|NCT04809467|616717878|FG004|Overall Study|Lost to Follow-up|0|||
170646003|NCT04809467|616717874|FG000|Overall Study|Withdrawal by Subject|2|||
170646004|NCT04809467|616717875|FG001|Overall Study|Withdrawal by Subject|1|||
170646005|NCT04809467|616717876|FG002|Overall Study|Withdrawal by Subject|3|||
170646006|NCT04809467|616717877|FG003|Overall Study|Withdrawal by Subject|1|||
170646007|NCT04809467|616717878|FG004|Overall Study|Withdrawal by Subject|0|||
170906035|NCT01731002|617658596|FG000|Overall Study|Test Agent Discontinuation|0|||
170646008|NCT04809467|616717874|FG000|Overall Study|Sponsor Terminated Collection of Follow-up Data|3|||
170646009|NCT04809467|616717875|FG001|Overall Study|Sponsor Terminated Collection of Follow-up Data|2|||
170646010|NCT04809467|616717876|FG002|Overall Study|Sponsor Terminated Collection of Follow-up Data|10|||
170646011|NCT04809467|616717877|FG003|Overall Study|Sponsor Terminated Collection of Follow-up Data|1|||
170646012|NCT04809467|616717878|FG004|Overall Study|Sponsor Terminated Collection of Follow-up Data|2|||
170646013|NCT04809467|616717874|FG000|Overall Study|Medical Decision Due to Worsening Clinical Condition|1|||
170646014|NCT04809467|616717875|FG001|Overall Study|Medical Decision Due to Worsening Clinical Condition|0|||
170646015|NCT04809467|616717876|FG002|Overall Study|Medical Decision Due to Worsening Clinical Condition|0|||
170646016|NCT04809467|616717877|FG003|Overall Study|Medical Decision Due to Worsening Clinical Condition|0|||
170646017|NCT04809467|616717878|FG004|Overall Study|Medical Decision Due to Worsening Clinical Condition|0|||
170646018|NCT04809467|616717874|FG000|Overall Study|Transitioned to Rollover Protocol|0|||
170646019|NCT04809467|616717875|FG001|Overall Study|Transitioned to Rollover Protocol|1|||
170646020|NCT04809467|616717876|FG002|Overall Study|Transitioned to Rollover Protocol|2|||
170646021|NCT04809467|616717877|FG003|Overall Study|Transitioned to Rollover Protocol|0|||
170646022|NCT04809467|616717878|FG004|Overall Study|Transitioned to Rollover Protocol|1|||
170646023|NCT04809467|616717874|FG000|Overall Study|Withdrawal per Principal Investigator; New Treatment|0|||
170646024|NCT04809467|616717875|FG001|Overall Study|Withdrawal per Principal Investigator; New Treatment|0|||
170646025|NCT04809467|616717876|FG002|Overall Study|Withdrawal per Principal Investigator; New Treatment|1|||
170646026|NCT04809467|616717877|FG003|Overall Study|Withdrawal per Principal Investigator; New Treatment|0|||
170646027|NCT04809467|616717878|FG004|Overall Study|Withdrawal per Principal Investigator; New Treatment|0|||
170646028|NCT01628029|616717879|FG000|Overall Study|Symptom burden|1|||
170646029|NCT01628029|616717880|FG001|Overall Study|Symptom burden|0|||
170646030|NCT01628029|616717881|FG002|Overall Study|Symptom burden|1|||
170646031|NCT01628029|616717882|FG003|Overall Study|Symptom burden|0|||
170646032|NCT01628029|616717883|FG004|Overall Study|Symptom burden|1|||
170646033|NCT01628029|616717884|FG005|Overall Study|Symptom burden|1|||
170646034|NCT01628029|616717885|FG006|Overall Study|Symptom burden|2|||
170646035|NCT01628029|616717886|FG007|Overall Study|Symptom burden|2|||
170646036|NCT01628029|616717879|FG000|Overall Study|Withdrew due to lack of benefit|0|||
170646037|NCT01628029|616717880|FG001|Overall Study|Withdrew due to lack of benefit|1|||
170646038|NCT01628029|616717881|FG002|Overall Study|Withdrew due to lack of benefit|0|||
170565199|NCT01156844|616417067|FG001|Overall Study|Protocol deviation|0|||
170565200|NCT01156844|616417068|FG002|Overall Study|Protocol deviation|0|||
170565201|NCT01156844|616417069|FG003|Overall Study|Protocol deviation|0|||
170565202|NCT05525910|616417073|FG000|Period 4|Per sponsor due to study timelines|0|||
170565203|NCT05525910|616417074|FG001|Period 4|Per sponsor due to study timelines|0|||
170565204|NCT05525910|616417075|FG002|Period 4|Per sponsor due to study timelines|1|||
170565205|NCT05525910|616417076|FG003|Period 4|Per sponsor due to study timelines|1|||
170565206|NCT05525910|616417077|FG004|Period 4|Per sponsor due to study timelines|1|||
170565207|NCT03886493|616417078|FG000|Overall Study|Adverse Event|1|||
170565208|NCT00181844|616417080|FG000|Signed Consent|Withdrawal by Subject|5|||
170565209|NCT00181844|616417080|FG000|Signed Consent|Did not meet entrance criteria|7|||
170565210|NCT00181844|616417080|FG000|Exposed to Study Medication|Adverse Event|10|||
170565211|NCT00181844|616417080|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
170565212|NCT00181844|616417080|FG000|Exposed to Study Medication|Non-compliance|2|||
170565213|NCT00181844|616417080|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
170565214|NCT00181844|616417080|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
170565215|NCT00107276|616417081|FG000|Overall Study|Progression|46|||
170565216|NCT00107276|616417081|FG000|Overall Study|Adverse Event|6|||
170565217|NCT00107276|616417081|FG000|Overall Study|M.D. decision|2|||
170565218|NCT00107276|616417081|FG000|Overall Study|Patient refusal|1|||
170565219|NCT00107276|616417081|FG000|Overall Study|Death|1|||
170565220|NCT00107276|616417081|FG000|Overall Study|Ineligible|16|||
170565221|NCT03746015|616417082|FG000|Overall Study|Withdrawal of Consent|1|||
170565222|NCT03746015|616417083|FG001|Overall Study|Withdrawal of Consent|0|||
170565223|NCT03746015|616417084|FG002|Overall Study|Withdrawal of Consent|0|||
170565224|NCT05209386|616417085|FG000|Overall Study|Withdrawal by Subject|8|||
170565225|NCT05209386|616417085|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
170565226|NCT02836249|616417086|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
170565227|NCT02836249|616417087|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
170565228|NCT02836249|616417088|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
170565229|NCT02836249|616417089|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
170565230|NCT02836249|616417086|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
170646039|NCT01628029|616717882|FG003|Overall Study|Withdrew due to lack of benefit|1|||
170646040|NCT01628029|616717883|FG004|Overall Study|Withdrew due to lack of benefit|0|||
170646041|NCT01628029|616717884|FG005|Overall Study|Withdrew due to lack of benefit|0|||
170565231|NCT02836249|616417087|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
170565232|NCT02836249|616417088|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
170565233|NCT02836249|616417089|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
170565234|NCT02836249|616417086|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
170565235|NCT02836249|616417087|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
170565236|NCT02836249|616417088|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
170565237|NCT02836249|616417089|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
170565238|NCT02836249|616417086|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170565239|NCT02836249|616417087|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
170565240|NCT02836249|616417088|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170565241|NCT02836249|616417089|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170565242|NCT02836249|616417086|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
170565243|NCT02836249|616417087|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
170565244|NCT02836249|616417088|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
170565245|NCT02836249|616417089|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
170565246|NCT02836249|616417086|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
170565247|NCT02836249|616417087|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
170565248|NCT02836249|616417088|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
170565249|NCT02836249|616417089|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
170565250|NCT02836249|616417086|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
170565251|NCT02836249|616417087|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
170565252|NCT02836249|616417088|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
170565253|NCT02836249|616417089|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
170565254|NCT02836249|616417086|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
170565255|NCT02836249|616417087|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
170565256|NCT02836249|616417088|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
170565257|NCT02836249|616417089|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
170565258|NCT02836249|616417086|FG000|Open-Label TAF Treatment Phase|Death|0|||
170565259|NCT02836249|616417087|FG001|Open-Label TAF Treatment Phase|Death|0|||
170565260|NCT02836249|616417088|FG002|Open-Label TAF Treatment Phase|Death|1|||
170565261|NCT02836249|616417089|FG003|Open-Label TAF Treatment Phase|Death|0|||
170565262|NCT02836249|616417086|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
170565263|NCT02836249|616417087|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
170565264|NCT02836249|616417088|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
170565265|NCT02836249|616417089|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
170565266|NCT02836249|616417086|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
170565267|NCT02836249|616417087|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
170565268|NCT02836249|616417088|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
170565269|NCT02836249|616417089|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
170565270|NCT05200845|616417092|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
170565271|NCT05200845|616417093|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
170565272|NCT05200845|616417094|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
170565273|NCT05200845|616417095|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
170565274|NCT05200845|616417092|FG000|Overall Study|Withdrawal by Subject|0|||
170565275|NCT05200845|616417093|FG001|Overall Study|Withdrawal by Subject|1|||
170565276|NCT05200845|616417094|FG002|Overall Study|Withdrawal by Subject|1|||
170565277|NCT05200845|616417095|FG003|Overall Study|Withdrawal by Subject|0|||
170565278|NCT00928668|616417098|FG000|Overall Study|Adverse Event|1|||
170565279|NCT00928668|616417099|FG001|Overall Study|Adverse Event|0|||
170565280|NCT00928668|616417100|FG002|Overall Study|Adverse Event|0|||
170565281|NCT00928668|616417101|FG003|Overall Study|Adverse Event|0|||
170565282|NCT00928668|616417102|FG004|Overall Study|Adverse Event|0|||
170565283|NCT00928668|616417098|FG000|Overall Study|Protocol Violation|0|||
170565284|NCT00928668|616417099|FG001|Overall Study|Protocol Violation|0|||
170565285|NCT00928668|616417100|FG002|Overall Study|Protocol Violation|0|||
170565286|NCT00928668|616417101|FG003|Overall Study|Protocol Violation|0|||
170565287|NCT00928668|616417102|FG004|Overall Study|Protocol Violation|1|||
170565288|NCT00928668|616417098|FG000|Overall Study|Withdrawal by Subject|0|||
170565289|NCT00928668|616417099|FG001|Overall Study|Withdrawal by Subject|1|||
170565290|NCT00928668|616417100|FG002|Overall Study|Withdrawal by Subject|1|||
170565291|NCT00928668|616417101|FG003|Overall Study|Withdrawal by Subject|0|||
170565292|NCT00928668|616417102|FG004|Overall Study|Withdrawal by Subject|0|||
170565293|NCT00928668|616417098|FG000|Overall Study|Other reasons not listed above|0|||
170565294|NCT00928668|616417099|FG001|Overall Study|Other reasons not listed above|0|||
170565295|NCT00928668|616417100|FG002|Overall Study|Other reasons not listed above|0|||
170565296|NCT00928668|616417101|FG003|Overall Study|Other reasons not listed above|1|||
170646042|NCT01628029|616717885|FG006|Overall Study|Withdrew due to lack of benefit|0|||
170565297|NCT00928668|616417102|FG004|Overall Study|Other reasons not listed above|0|||
170646043|NCT01628029|616717886|FG007|Overall Study|Withdrew due to lack of benefit|0|||
170565298|NCT02303262|616417103|FG000|Overall Study|Withdrawal by Subject|2|||
170565299|NCT02943473|616417109|FG000|Overall Study|enrolled but not dosed|1|||
170565300|NCT02943473|616417109|FG000|Overall Study|screen failure|1|||
170646044|NCT01628029|616717879|FG000|Overall Study|Non compliant|0|||
170646045|NCT01628029|616717880|FG001|Overall Study|Non compliant|0|||
170646046|NCT01628029|616717881|FG002|Overall Study|Non compliant|1|||
170646047|NCT01628029|616717882|FG003|Overall Study|Non compliant|0|||
170646048|NCT01628029|616717883|FG004|Overall Study|Non compliant|0|||
170646049|NCT01628029|616717884|FG005|Overall Study|Non compliant|0|||
170646050|NCT01628029|616717885|FG006|Overall Study|Non compliant|0|||
170646051|NCT01628029|616717886|FG007|Overall Study|Non compliant|0|||
170646052|NCT01628029|616717879|FG000|Overall Study|started different cancer treatment clinical trial|0|||
170646053|NCT01628029|616717880|FG001|Overall Study|started different cancer treatment clinical trial|0|||
170646054|NCT01628029|616717881|FG002|Overall Study|started different cancer treatment clinical trial|1|||
170565301|NCT02943473|616417109|FG000|Overall Study|Physician Decision|4|||
170565302|NCT01728246|616417110|FG000|Overall Study|Participant needed rescue medication|1|||
170565303|NCT01728246|616417111|FG001|Overall Study|Participant needed rescue medication|5|||
170565304|NCT01728246|616417110|FG000|Overall Study|Protocol Violation|1|||
170565305|NCT01728246|616417111|FG001|Overall Study|Protocol Violation|0|||
170565306|NCT01728246|616417110|FG000|Overall Study|Withdrawal by Subject|2|||
170565307|NCT01728246|616417111|FG001|Overall Study|Withdrawal by Subject|3|||
170565308|NCT01728246|616417110|FG000|Overall Study|Lost to Follow-up|23|||
170565309|NCT01728246|616417111|FG001|Overall Study|Lost to Follow-up|22|||
170565310|NCT01728246|616417110|FG000|Overall Study|Lack of Efficacy|1|||
170565311|NCT01728246|616417111|FG001|Overall Study|Lack of Efficacy|1|||
170565312|NCT01728246|616417110|FG000|Overall Study|Adverse Event|8|||
170565313|NCT01728246|616417111|FG001|Overall Study|Adverse Event|5|||
170565314|NCT04138056|616417117|FG000|Primary Study|Lost to Follow-up|3|||
170565315|NCT04138056|616417118|FG001|Primary Study|Lost to Follow-up|4|||
170565316|NCT04138056|616417119|FG002|Primary Study|Lost to Follow-up|1|||
170565317|NCT04138056|616417120|FG003|Primary Study|Lost to Follow-up|1|||
170565318|NCT04138056|616417121|FG004|Primary Study|Lost to Follow-up|4|||
170565319|NCT04138056|616417117|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
170565320|NCT04138056|616417118|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
170565321|NCT04138056|616417119|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
170565322|NCT04138056|616417120|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
170565323|NCT04138056|616417121|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
170565324|NCT04138056|616417117|FG000|Extension Study|Lost to Follow-up|1|||
170565325|NCT04138056|616417118|FG001|Extension Study|Lost to Follow-up|2|||
170565326|NCT04138056|616417119|FG002|Extension Study|Lost to Follow-up|1|||
170565327|NCT04138056|616417120|FG003|Extension Study|Lost to Follow-up|0|||
170565328|NCT04138056|616417121|FG004|Extension Study|Lost to Follow-up|1|||
170565329|NCT00060944|616417125|FG000|Overall Study|Adverse Event|12|||
170565330|NCT00060944|616417126|FG001|Overall Study|Adverse Event|10|||
170565331|NCT00060944|616417125|FG000|Overall Study|Death|2|||
170565332|NCT00060944|616417126|FG001|Overall Study|Death|3|||
170565333|NCT00060944|616417125|FG000|Overall Study|Withdrawal by Subject|18|||
170565334|NCT00060944|616417126|FG001|Overall Study|Withdrawal by Subject|5|||
170565335|NCT00060944|616417125|FG000|Overall Study|Disease Progression|93|||
170565336|NCT00060944|616417126|FG001|Overall Study|Disease Progression|94|||
170565337|NCT00060944|616417125|FG000|Overall Study|Lost to Follow-up|1|||
170565338|NCT00060944|616417126|FG001|Overall Study|Lost to Follow-up|0|||
170565339|NCT00060944|616417125|FG000|Overall Study|Subject Ineligible To Continue|2|||
170565340|NCT00060944|616417126|FG001|Overall Study|Subject Ineligible To Continue|1|||
170565341|NCT00060944|616417125|FG000|Overall Study|Treatment Switch|0|||
170565342|NCT00060944|616417126|FG001|Overall Study|Treatment Switch|13|||
170565343|NCT00060944|616417125|FG000|Overall Study|Other|2|||
170565344|NCT00060944|616417126|FG001|Overall Study|Other|4|||
170565345|NCT00060944|616417125|FG000|Overall Study|randomized but not treated|6|||
170565346|NCT00060944|616417126|FG001|Overall Study|randomized but not treated|4|||
170565347|NCT01968980|616417127|FG000|Overall Study|Death|0|||
170565348|NCT01968980|616417128|FG001|Overall Study|Death|1|||
170565349|NCT01968980|616417127|FG000|Overall Study|Adverse Event|1|||
170565350|NCT01968980|616417128|FG001|Overall Study|Adverse Event|3|||
170565351|NCT01968980|616417127|FG000|Overall Study|Does not meet entry criteria|1|||
170565352|NCT01968980|616417128|FG001|Overall Study|Does not meet entry criteria|3|||
170565353|NCT01968980|616417127|FG000|Overall Study|Withdrawal by Subject|13|||
170565354|NCT01968980|616417128|FG001|Overall Study|Withdrawal by Subject|5|||
170565355|NCT01968980|616417127|FG000|Overall Study|Other unspecified|1|||
170565356|NCT01968980|616417128|FG001|Overall Study|Other unspecified|2|||
170565357|NCT03961308|616417130|FG000|Overall Study|Withdrawal by Subject|1|||
170565358|NCT03961308|616417131|FG001|Overall Study|Withdrawal by Subject|0|||
170565359|NCT03961308|616417130|FG000|Overall Study|Other|1|||
170565360|NCT03961308|616417131|FG001|Overall Study|Other|0|||
170565361|NCT03961308|616417130|FG000|Overall Study|Lost to Follow-up|0|||
170565362|NCT03961308|616417131|FG001|Overall Study|Lost to Follow-up|1|||
170565363|NCT03961308|616417130|FG000|Overall Study|Adverse Event|0|||
170565364|NCT03961308|616417131|FG001|Overall Study|Adverse Event|1|||
170565365|NCT05901636|616417137|FG000|Overall Study|Lost to Follow-up|0|||
170565366|NCT05901636|616417138|FG001|Overall Study|Lost to Follow-up|1|||
170565367|NCT05901636|616417139|FG002|Overall Study|Lost to Follow-up|0|||
170565368|NCT05901636|616417140|FG003|Overall Study|Lost to Follow-up|1|||
170565369|NCT05901636|616417141|FG004|Overall Study|Lost to Follow-up|1|||
170565370|NCT05901636|616417142|FG005|Overall Study|Lost to Follow-up|3|||
170565371|NCT05901636|616417143|FG006|Overall Study|Lost to Follow-up|1|||
170565372|NCT05901636|616417137|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
170565373|NCT05901636|616417138|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
170565374|NCT05901636|616417139|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
170565375|NCT05901636|616417140|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
170565376|NCT05901636|616417141|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
170565377|NCT05901636|616417142|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
170565378|NCT05901636|616417143|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
170565379|NCT05901636|616417137|FG000|Overall Study|Withdrawal by Subject|1|||
170565380|NCT05901636|616417138|FG001|Overall Study|Withdrawal by Subject|1|||
170565381|NCT05901636|616417139|FG002|Overall Study|Withdrawal by Subject|0|||
170565382|NCT05901636|616417140|FG003|Overall Study|Withdrawal by Subject|0|||
170565383|NCT05901636|616417141|FG004|Overall Study|Withdrawal by Subject|1|||
170565384|NCT05901636|616417142|FG005|Overall Study|Withdrawal by Subject|1|||
170565385|NCT05901636|616417143|FG006|Overall Study|Withdrawal by Subject|0|||
170565386|NCT05901636|616417137|FG000|Overall Study|Other|0|||
170565387|NCT05901636|616417138|FG001|Overall Study|Other|0|||
170565388|NCT05901636|616417139|FG002|Overall Study|Other|1|||
170565389|NCT05901636|616417140|FG003|Overall Study|Other|1|||
170565390|NCT05901636|616417141|FG004|Overall Study|Other|0|||
170565391|NCT05901636|616417142|FG005|Overall Study|Other|0|||
170565392|NCT05901636|616417143|FG006|Overall Study|Other|0|||
170565393|NCT04549454|616417144|FG000|T1 to T2|Lost to Follow-up|22|||
170565394|NCT04549454|616417145|FG001|T1 to T2|Lost to Follow-up|26|||
170565395|NCT04549454|616417144|FG000|T1 to T3|Lost to Follow-up|31|||
170565396|NCT04549454|616417145|FG001|T1 to T3|Lost to Follow-up|36|||
170565397|NCT03012880|616417146|FG000|Overall Study|Withdrawal by Subject|1|||
170565398|NCT03012880|616417147|FG001|Overall Study|Withdrawal by Subject|0|||
170565399|NCT03012880|616417146|FG000|Overall Study|Ineligible|1|||
170565400|NCT03012880|616417147|FG001|Overall Study|Ineligible|0|||
170565401|NCT01405196|616417148|FG000|Overall Study|Study Terminated by Sponsor|0|||
170565402|NCT01405196|616417149|FG001|Overall Study|Study Terminated by Sponsor|0|||
170565403|NCT01405196|616417150|FG002|Overall Study|Study Terminated by Sponsor|9|||
170565404|NCT01405196|616417151|FG003|Overall Study|Study Terminated by Sponsor|0|||
170565405|NCT01405196|616417148|FG000|Overall Study|Other|2|||
170565406|NCT01405196|616417149|FG001|Overall Study|Other|2|||
170565407|NCT01405196|616417150|FG002|Overall Study|Other|5|||
170646055|NCT01628029|616717882|FG003|Overall Study|started different cancer treatment clinical trial|0|||
170565408|NCT01405196|616417151|FG003|Overall Study|Other|0|||
170565409|NCT01405196|616417148|FG000|Overall Study|Withdrawal by Subject|4|||
170565410|NCT01405196|616417149|FG001|Overall Study|Withdrawal by Subject|6|||
170565411|NCT01405196|616417150|FG002|Overall Study|Withdrawal by Subject|3|||
170565412|NCT01405196|616417151|FG003|Overall Study|Withdrawal by Subject|6|||
170565413|NCT01405196|616417148|FG000|Overall Study|Adverse Event|2|||
170565414|NCT01405196|616417149|FG001|Overall Study|Adverse Event|2|||
170646066|NCT01628029|616717885|FG006|Overall Study|Incomplete primary outcome assessment|0|||
170646067|NCT01628029|616717886|FG007|Overall Study|Incomplete primary outcome assessment|0|||
170646068|NCT06015945|616717889|FG000|Overall Study|Withdrawal by Subject|1|||
170646069|NCT04083976|616717890|FG000|Overall Study|Lost to Follow-up|3|||
170646070|NCT04083976|616717891|FG001|Overall Study|Lost to Follow-up|0|||
170646071|NCT04083976|616717892|FG002|Overall Study|Lost to Follow-up|0|||
170646072|NCT04083976|616717893|FG003|Overall Study|Lost to Follow-up|1|||
170646073|NCT04083976|616717890|FG000|Overall Study|Withdrawal by Subject|16|||
170646074|NCT04083976|616717891|FG001|Overall Study|Withdrawal by Subject|1|||
170646075|NCT04083976|616717892|FG002|Overall Study|Withdrawal by Subject|9|||
170646076|NCT04083976|616717893|FG003|Overall Study|Withdrawal by Subject|0|||
170646077|NCT04083976|616717890|FG000|Overall Study|Sponsor Decision|14|||
170646078|NCT04083976|616717891|FG001|Overall Study|Sponsor Decision|0|||
170646079|NCT04083976|616717892|FG002|Overall Study|Sponsor Decision|0|||
170646080|NCT04083976|616717893|FG003|Overall Study|Sponsor Decision|7|||
170646081|NCT04083976|616717890|FG000|Overall Study|Other|1|||
170646082|NCT04083976|616717891|FG001|Overall Study|Other|0|||
170646083|NCT04083976|616717892|FG002|Overall Study|Other|1|||
170646084|NCT04083976|616717893|FG003|Overall Study|Other|0|||
170646085|NCT03635567|616717894|FG000|Overall Study|Lost to Follow-up|4|||
170646086|NCT03635567|616717895|FG001|Overall Study|Lost to Follow-up|1|||
170646087|NCT03635567|616717894|FG000|Overall Study|Withdrawal by Subject|11|||
170646088|NCT03635567|616717895|FG001|Overall Study|Withdrawal by Subject|16|||
170646089|NCT03635567|616717894|FG000|Overall Study|Sponsor Decision|99|||
170646090|NCT03635567|616717895|FG001|Overall Study|Sponsor Decision|57|||
170646091|NCT03635567|616717894|FG000|Overall Study|Death|194|||
170646092|NCT03635567|616717895|FG001|Overall Study|Death|235|||
170646093|NCT04913220|616717896|FG000|Overall Study|Not Related to Coronavirus Disease 2019 (COVID-19)|0|||
170646094|NCT04913220|616717897|FG001|Overall Study|Not Related to Coronavirus Disease 2019 (COVID-19)|0|||
170646095|NCT04913220|616717898|FG002|Overall Study|Not Related to Coronavirus Disease 2019 (COVID-19)|1|||
170646096|NCT04913220|616717899|FG003|Overall Study|Not Related to Coronavirus Disease 2019 (COVID-19)|0|||
170646097|NCT04913220|616717896|FG000|Overall Study|Withdrawal by Subject|1|||
170646098|NCT04913220|616717897|FG001|Overall Study|Withdrawal by Subject|0|||
170646099|NCT04913220|616717898|FG002|Overall Study|Withdrawal by Subject|3|||
170646100|NCT04913220|616717899|FG003|Overall Study|Withdrawal by Subject|0|||
170646101|NCT04913220|616717896|FG000|Overall Study|Poor Compliance to Protocol|0|||
170646102|NCT04913220|616717897|FG001|Overall Study|Poor Compliance to Protocol|0|||
170646103|NCT04913220|616717898|FG002|Overall Study|Poor Compliance to Protocol|1|||
170646104|NCT04913220|616717899|FG003|Overall Study|Poor Compliance to Protocol|0|||
170646105|NCT04913220|616717896|FG000|Overall Study|Progressive Disease|8|||
170646106|NCT04913220|616717897|FG001|Overall Study|Progressive Disease|4|||
170646107|NCT04913220|616717898|FG002|Overall Study|Progressive Disease|3|||
170646108|NCT04913220|616717899|FG003|Overall Study|Progressive Disease|2|||
170646109|NCT04913220|616717896|FG000|Overall Study|Adverse event: Not related to COVID-19|7|||
170646110|NCT04913220|616717897|FG001|Overall Study|Adverse event: Not related to COVID-19|1|||
170646111|NCT04913220|616717898|FG002|Overall Study|Adverse event: Not related to COVID-19|4|||
170646112|NCT04913220|616717899|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
170646113|NCT01883453|616717902|FG000|Overall Study|No episode of common cold|25|||
170646114|NCT01883453|616717903|FG001|Overall Study|No episode of common cold|23|||
170646115|NCT00796445|616717906|FG000|Overall Study|Protocol Violation|5|||
170646116|NCT00796445|616717907|FG001|Overall Study|Protocol Violation|3|||
170646117|NCT00796445|616717906|FG000|Overall Study|Adverse event, serious fatal|10|||
170646118|NCT00796445|616717907|FG001|Overall Study|Adverse event, serious fatal|5|||
170646119|NCT00796445|616717906|FG000|Overall Study|Adverse event, non-fatal|4|||
170646120|NCT00796445|616717907|FG001|Overall Study|Adverse event, non-fatal|0|||
170646121|NCT00796445|616717906|FG000|Overall Study|Disease progression/recurrence|537|||
170646122|NCT00796445|616717907|FG001|Overall Study|Disease progression/recurrence|268|||
170646123|NCT00796445|616717906|FG000|Overall Study|Other|10|||
170646124|NCT00796445|616717907|FG001|Overall Study|Other|7|||
170646125|NCT00796445|616717906|FG000|Overall Study|Withdrawal by Subject|18|||
170646126|NCT00796445|616717907|FG001|Overall Study|Withdrawal by Subject|9|||
170646127|NCT00796445|616717906|FG000|Overall Study|Invalid Informed Consent Form|1|||
170646128|NCT00796445|616717907|FG001|Overall Study|Invalid Informed Consent Form|0|||
170646129|NCT00388583|616717908|FG000|Overall Study|Protocol Violation|1|||
170646130|NCT00388583|616717909|FG001|Overall Study|Protocol Violation|0|||
170646131|NCT00388583|616717908|FG000|Overall Study|Withdrawal by Subject|3|||
170646132|NCT00388583|616717909|FG001|Overall Study|Withdrawal by Subject|3|||
170565573|NCT01130337|616418575|FG000|Overall Study|Withdrawal by Subject|3|||
170565574|NCT01130337|616418575|FG000|Overall Study|Principal investigator decision|1|||
170565575|NCT01130337|616418575|FG000|Overall Study|Death|1|||
170565576|NCT01130337|616418575|FG000|Overall Study|Disease progression|1|||
170565577|NCT01130337|616418575|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
170565578|NCT01130337|616418575|FG000|Overall Study|Surgical resection (R2)|1|||
170565579|NCT00658541|616418579|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
170565580|NCT00658541|616418580|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
170565581|NCT00658541|616418579|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
170565582|NCT00658541|616418580|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
170565583|NCT04661033|616418581|FG000|Overall Study|Adverse Event|0|||
170565584|NCT04661033|616418582|FG001|Overall Study|Adverse Event|0|||
170646133|NCT00388583|616717908|FG000|Overall Study|Serious Adverse Event|2|||
170565585|NCT04661033|616418583|FG002|Overall Study|Adverse Event|1|||
170646134|NCT00388583|616717909|FG001|Overall Study|Serious Adverse Event|0|||
170646135|NCT00388583|616717908|FG000|Overall Study|Did not receive vaccine|0|||
170646136|NCT00388583|616717909|FG001|Overall Study|Did not receive vaccine|1|||
170646137|NCT00913458|616717910|FG000|Phase 1|Non-Responder|54|||
170646138|NCT00913458|616717911|FG001|Phase 1|Non-Responder|0|||
170646139|NCT00913458|616717912|FG002|Phase 1|Non-Responder|0|||
170646140|NCT00913458|616717913|FG003|Phase 1|Non-Responder|0|||
170646141|NCT00913458|616717914|FG004|Phase 1|Non-Responder|0|||
170646142|NCT00913458|616717915|FG005|Phase 1|Non-Responder|0|||
170646143|NCT00913458|616717916|FG006|Phase 1|Non-Responder|0|||
170646144|NCT00913458|616717910|FG000|Phase 1|Subject Request|17|||
170646145|NCT00913458|616717911|FG001|Phase 1|Subject Request|0|||
170646146|NCT00913458|616717912|FG002|Phase 1|Subject Request|0|||
170646147|NCT00913458|616717913|FG003|Phase 1|Subject Request|0|||
170646148|NCT00913458|616717914|FG004|Phase 1|Subject Request|0|||
170646149|NCT00913458|616717915|FG005|Phase 1|Subject Request|0|||
170646150|NCT00913458|616717916|FG006|Phase 1|Subject Request|0|||
170646151|NCT00913458|616717910|FG000|Phase 1|Adverse Event|20|||
170646152|NCT00913458|616717911|FG001|Phase 1|Adverse Event|0|||
170646153|NCT00913458|616717912|FG002|Phase 1|Adverse Event|0|||
170646154|NCT00913458|616717913|FG003|Phase 1|Adverse Event|0|||
170646155|NCT00913458|616717914|FG004|Phase 1|Adverse Event|0|||
170646156|NCT00913458|616717915|FG005|Phase 1|Adverse Event|0|||
170646157|NCT00913458|616717916|FG006|Phase 1|Adverse Event|0|||
170646158|NCT00913458|616717910|FG000|Phase 1|Lost to Follow-up|2|||
170646159|NCT00913458|616717911|FG001|Phase 1|Lost to Follow-up|0|||
170646160|NCT00913458|616717912|FG002|Phase 1|Lost to Follow-up|0|||
170646161|NCT00913458|616717913|FG003|Phase 1|Lost to Follow-up|0|||
170646162|NCT00913458|616717914|FG004|Phase 1|Lost to Follow-up|0|||
170646163|NCT00913458|616717915|FG005|Phase 1|Lost to Follow-up|0|||
170646164|NCT00913458|616717916|FG006|Phase 1|Lost to Follow-up|0|||
170646165|NCT00913458|616717910|FG000|Phase 1|Protocol Violation|10|||
170646166|NCT00913458|616717911|FG001|Phase 1|Protocol Violation|0|||
170646167|NCT00913458|616717912|FG002|Phase 1|Protocol Violation|0|||
170646168|NCT00913458|616717913|FG003|Phase 1|Protocol Violation|0|||
170646169|NCT00913458|616717914|FG004|Phase 1|Protocol Violation|0|||
170646170|NCT00913458|616717915|FG005|Phase 1|Protocol Violation|0|||
170646171|NCT00913458|616717916|FG006|Phase 1|Protocol Violation|0|||
170646172|NCT00913458|616717910|FG000|Phase 1|Sponsor|2|||
170646173|NCT00913458|616717911|FG001|Phase 1|Sponsor|0|||
170646174|NCT00913458|616717912|FG002|Phase 1|Sponsor|0|||
170646175|NCT00913458|616717913|FG003|Phase 1|Sponsor|0|||
170646176|NCT00913458|616717914|FG004|Phase 1|Sponsor|0|||
170646177|NCT00913458|616717915|FG005|Phase 1|Sponsor|0|||
170646178|NCT00913458|616717916|FG006|Phase 1|Sponsor|0|||
170646179|NCT00913458|616717910|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
170646180|NCT00913458|616717911|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
170646181|NCT00913458|616717912|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
170646182|NCT00913458|616717913|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
170646183|NCT00913458|616717914|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
170646184|NCT00913458|616717915|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
170646185|NCT00913458|616717916|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
170646186|NCT00913458|616717910|FG000|Phase 2|Non-Responder|0|||
170646187|NCT00913458|616717911|FG001|Phase 2|Non-Responder|5|||
170646188|NCT00913458|616717912|FG002|Phase 2|Non-Responder|7|||
170646189|NCT00913458|616717913|FG003|Phase 2|Non-Responder|12|||
170646190|NCT00913458|616717914|FG004|Phase 2|Non-Responder|0|||
170646191|NCT00913458|616717915|FG005|Phase 2|Non-Responder|0|||
170646192|NCT00913458|616717916|FG006|Phase 2|Non-Responder|0|||
170646193|NCT00913458|616717910|FG000|Phase 2|Subject Request|0|||
170646194|NCT00913458|616717911|FG001|Phase 2|Subject Request|0|||
170646195|NCT00913458|616717912|FG002|Phase 2|Subject Request|1|||
170646196|NCT00913458|616717913|FG003|Phase 2|Subject Request|2|||
170646197|NCT00913458|616717914|FG004|Phase 2|Subject Request|0|||
170646198|NCT00913458|616717915|FG005|Phase 2|Subject Request|0|||
170646199|NCT00913458|616717916|FG006|Phase 2|Subject Request|0|||
170646200|NCT00913458|616717910|FG000|Phase 2|Adverse Event|0|||
170646201|NCT00913458|616717911|FG001|Phase 2|Adverse Event|3|||
170646202|NCT00913458|616717912|FG002|Phase 2|Adverse Event|0|||
170646203|NCT00913458|616717913|FG003|Phase 2|Adverse Event|1|||
170646204|NCT00913458|616717914|FG004|Phase 2|Adverse Event|0|||
170646205|NCT00913458|616717915|FG005|Phase 2|Adverse Event|0|||
170646206|NCT00913458|616717916|FG006|Phase 2|Adverse Event|0|||
170646207|NCT00913458|616717910|FG000|Phase 2|Lost to Follow-up|0|||
170565586|NCT04661033|616418584|FG003|Overall Study|Adverse Event|0|||
170565587|NCT04661033|616418581|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
170565588|NCT04661033|616418582|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
170906175|NCT05738486|617660808|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
170906176|NCT05738486|617660809|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
170906177|NCT05738486|617660810|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
170906178|NCT03395210|617660811|FG000|Overall Study|Other|0|||
170906179|NCT03395210|617660812|FG001|Overall Study|Other|0|||
170906180|NCT03395210|617660813|FG002|Overall Study|Other|0|||
170906181|NCT03395210|617660814|FG003|Overall Study|Other|0|||
170906182|NCT03395210|617660815|FG004|Overall Study|Other|1|||
170906183|NCT03395210|617660811|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
170906184|NCT03395210|617660812|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
170906185|NCT03395210|617660813|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
170906186|NCT03395210|617660814|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
170906187|NCT03395210|617660815|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
170906188|NCT03395210|617660811|FG000|Overall Study|Adverse Event|1|||
170906189|NCT03395210|617660812|FG001|Overall Study|Adverse Event|0|||
170906190|NCT03395210|617660813|FG002|Overall Study|Adverse Event|2|||
170906191|NCT03395210|617660814|FG003|Overall Study|Adverse Event|4|||
170906192|NCT03395210|617660815|FG004|Overall Study|Adverse Event|3|||
170906193|NCT03395210|617660811|FG000|Overall Study|Need of Rescue Medication|1|||
170906194|NCT03395210|617660812|FG001|Overall Study|Need of Rescue Medication|0|||
170906195|NCT03395210|617660813|FG002|Overall Study|Need of Rescue Medication|1|||
170906196|NCT03395210|617660814|FG003|Overall Study|Need of Rescue Medication|4|||
170906197|NCT03395210|617660815|FG004|Overall Study|Need of Rescue Medication|0|||
170906198|NCT03395210|617660811|FG000|Overall Study|Lack of Response|0|||
170906199|NCT03395210|617660812|FG001|Overall Study|Lack of Response|0|||
170906200|NCT03395210|617660813|FG002|Overall Study|Lack of Response|0|||
170906201|NCT03395210|617660814|FG003|Overall Study|Lack of Response|5|||
170906202|NCT03395210|617660815|FG004|Overall Study|Lack of Response|5|||
170906203|NCT03395210|617660811|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
170906204|NCT03395210|617660812|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
170906205|NCT03395210|617660813|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
170906206|NCT03395210|617660814|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
170906207|NCT03395210|617660815|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
170906208|NCT03395210|617660811|FG000|Overall Study|Participant Decision|1|||
170906209|NCT03395210|617660812|FG001|Overall Study|Participant Decision|1|||
170906210|NCT03395210|617660813|FG002|Overall Study|Participant Decision|0|||
170906211|NCT03395210|617660814|FG003|Overall Study|Participant Decision|4|||
170906212|NCT03395210|617660815|FG004|Overall Study|Participant Decision|0|||
170906213|NCT03395210|617660811|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
170906214|NCT03395210|617660812|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
170906215|NCT03395210|617660813|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
170906216|NCT03395210|617660814|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
170906217|NCT03395210|617660815|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
170906218|NCT04909463|617660816|FG000|Overall Study|Withdrawal by Subject|0|||
170906219|NCT04909463|617660817|FG001|Overall Study|Withdrawal by Subject|1|||
170906220|NCT04909463|617660818|FG002|Overall Study|Withdrawal by Subject|0|||
170906221|NCT04909463|617660819|FG003|Overall Study|Withdrawal by Subject|0|||
170906222|NCT04909463|617660816|FG000|Overall Study|Lost to Follow-up|2|||
170906223|NCT04909463|617660817|FG001|Overall Study|Lost to Follow-up|1|||
170906224|NCT04909463|617660818|FG002|Overall Study|Lost to Follow-up|1|||
170906225|NCT04909463|617660819|FG003|Overall Study|Lost to Follow-up|0|||
170906226|NCT00853632|617660820|FG000|Overall Study|Death|88|||
170906227|NCT00853632|617660820|FG000|Overall Study|Withdrawal by Subject|45|||
170906228|NCT00853632|617660820|FG000|Overall Study|Lost to Follow-up|30|||
170906229|NCT00853632|617660820|FG000|Overall Study|Reoperation/Explant|17|||
170906230|NCT00853632|617660820|FG000|Overall Study|Exit with other reason|22|||
170906231|NCT04364854|617660821|FG000|Overall Study|Withdrawal by Subject|1|||
170906232|NCT04364854|617660822|FG001|Overall Study|Withdrawal by Subject|0|||
170906233|NCT04364854|617660823|FG002|Overall Study|Withdrawal by Subject|1|||
170906234|NCT04364854|617660824|FG003|Overall Study|Withdrawal by Subject|3|||
170906235|NCT04364854|617660821|FG000|Overall Study|Death|1|||
170906236|NCT04364854|617660822|FG001|Overall Study|Death|0|||
170906237|NCT04364854|617660823|FG002|Overall Study|Death|0|||
170906238|NCT04364854|617660824|FG003|Overall Study|Death|0|||
170906239|NCT04364854|617660821|FG000|Overall Study|Lost to Follow-up|0|||
170906240|NCT04364854|617660822|FG001|Overall Study|Lost to Follow-up|0|||
170906241|NCT04364854|617660823|FG002|Overall Study|Lost to Follow-up|0|||
170906242|NCT04364854|617660824|FG003|Overall Study|Lost to Follow-up|1|||
170906243|NCT04493619|617660826|FG000|Overall Study|Death|4|||
170906244|NCT04493619|617660827|FG001|Overall Study|Death|3|||
170906245|NCT04493619|617660828|FG002|Overall Study|Death|3|||
170646208|NCT00913458|616717911|FG001|Phase 2|Lost to Follow-up|0|||
170565589|NCT04661033|616418583|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
170565590|NCT04661033|616418584|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
170565591|NCT04661033|616418581|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
170565592|NCT04661033|616418582|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
170565593|NCT04661033|616418583|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
170565594|NCT04661033|616418584|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
170565595|NCT04661033|616418581|FG000|Overall Study|Early discontinuation as per PI|1|||
170565596|NCT04661033|616418582|FG001|Overall Study|Early discontinuation as per PI|0|||
170565597|NCT04661033|616418583|FG002|Overall Study|Early discontinuation as per PI|0|||
170565598|NCT04661033|616418584|FG003|Overall Study|Early discontinuation as per PI|0|||
170565599|NCT01987557|616418587|FG000|Overall Study|Protocol Violation|1|||
170565600|NCT01987557|616418588|FG001|Overall Study|Protocol Violation|0|||
170565601|NCT01987557|616418589|FG002|Overall Study|Protocol Violation|1|||
170646209|NCT00913458|616717912|FG002|Phase 2|Lost to Follow-up|0|||
170646210|NCT00913458|616717913|FG003|Phase 2|Lost to Follow-up|1|||
170646211|NCT00913458|616717914|FG004|Phase 2|Lost to Follow-up|0|||
170646212|NCT00913458|616717915|FG005|Phase 2|Lost to Follow-up|0|||
170646213|NCT00913458|616717916|FG006|Phase 2|Lost to Follow-up|0|||
170646214|NCT00913458|616717910|FG000|Phase 2|Protocol Violation|0|||
170646215|NCT00913458|616717911|FG001|Phase 2|Protocol Violation|2|||
170646216|NCT00913458|616717912|FG002|Phase 2|Protocol Violation|0|||
170646217|NCT00913458|616717913|FG003|Phase 2|Protocol Violation|0|||
170646218|NCT00913458|616717914|FG004|Phase 2|Protocol Violation|0|||
170646219|NCT00913458|616717915|FG005|Phase 2|Protocol Violation|0|||
170646220|NCT00913458|616717916|FG006|Phase 2|Protocol Violation|0|||
170646221|NCT00913458|616717910|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
170646222|NCT00913458|616717911|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
170646223|NCT00913458|616717912|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
170646224|NCT00913458|616717913|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
170646225|NCT00913458|616717914|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
170646226|NCT00913458|616717915|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
170646227|NCT00913458|616717916|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
170646228|NCT00913458|616717910|FG000|Phase 3|Adverse Event|0|||
170646229|NCT00913458|616717911|FG001|Phase 3|Adverse Event|0|||
170646230|NCT00913458|616717912|FG002|Phase 3|Adverse Event|0|||
170646231|NCT00913458|616717913|FG003|Phase 3|Adverse Event|0|||
170646232|NCT00913458|616717914|FG004|Phase 3|Adverse Event|5|||
170646233|NCT00913458|616717915|FG005|Phase 3|Adverse Event|4|||
170646234|NCT00913458|616717916|FG006|Phase 3|Adverse Event|1|||
170565602|NCT01987557|616418587|FG000|Overall Study|Withdrawal by Subject|2|||
170565603|NCT01987557|616418588|FG001|Overall Study|Withdrawal by Subject|1|||
170646235|NCT00913458|616717910|FG000|Phase 3|Lost to Follow-up|0|||
170646236|NCT00913458|616717911|FG001|Phase 3|Lost to Follow-up|0|||
170646237|NCT00913458|616717912|FG002|Phase 3|Lost to Follow-up|0|||
170646238|NCT00913458|616717913|FG003|Phase 3|Lost to Follow-up|0|||
170646239|NCT00913458|616717914|FG004|Phase 3|Lost to Follow-up|2|||
170646240|NCT00913458|616717915|FG005|Phase 3|Lost to Follow-up|0|||
170646241|NCT00913458|616717916|FG006|Phase 3|Lost to Follow-up|0|||
170646242|NCT00913458|616717910|FG000|Phase 3|Non-Responder|0|||
170646243|NCT00913458|616717911|FG001|Phase 3|Non-Responder|0|||
170646244|NCT00913458|616717912|FG002|Phase 3|Non-Responder|0|||
170646245|NCT00913458|616717913|FG003|Phase 3|Non-Responder|0|||
170646246|NCT00913458|616717914|FG004|Phase 3|Non-Responder|0|||
170565604|NCT01987557|616418589|FG002|Overall Study|Withdrawal by Subject|2|||
170565605|NCT01987557|616418587|FG000|Overall Study|Adverse Event|0|||
170565606|NCT01987557|616418588|FG001|Overall Study|Adverse Event|2|||
170565607|NCT01987557|616418589|FG002|Overall Study|Adverse Event|0|||
170565608|NCT01959932|616418593|FG000|Overall Study|Withdrawal by Subject|1|||
170565609|NCT01959932|616418594|FG001|Overall Study|Withdrawal by Subject|0|||
170565610|NCT01959932|616418595|FG002|Overall Study|Withdrawal by Subject|0|||
170565611|NCT00397540|616418596|FG000|Overall Study|short follow-up duration < 12 months|1|||
170565612|NCT00397540|616418597|FG001|Overall Study|short follow-up duration < 12 months|0|||
170565613|NCT01463033|616418598|FG000|Overall Study|Lost to Follow-up|4|||
170565614|NCT01463033|616418599|FG001|Overall Study|Lost to Follow-up|4|||
170565615|NCT01463033|616418598|FG000|Overall Study|Death|3|||
170565616|NCT01463033|616418599|FG001|Overall Study|Death|2|||
170565617|NCT00776230|616418603|FG000|Overall Study|Lost to Follow-up|2|||
170565618|NCT00776230|616418604|FG001|Overall Study|Lost to Follow-up|1|||
170565619|NCT00776230|616418605|FG002|Overall Study|Lost to Follow-up|5|||
170565620|NCT00776230|616418603|FG000|Overall Study|Not vaccinated at Day 0|1|||
170646247|NCT00913458|616717915|FG005|Phase 3|Non-Responder|1|||
170646248|NCT00913458|616717916|FG006|Phase 3|Non-Responder|3|||
170646249|NCT00913458|616717910|FG000|Phase 3|Withdrawal by Subject|0|||
170646250|NCT00913458|616717911|FG001|Phase 3|Withdrawal by Subject|0|||
170646251|NCT00913458|616717912|FG002|Phase 3|Withdrawal by Subject|0|||
170646252|NCT00913458|616717913|FG003|Phase 3|Withdrawal by Subject|0|||
170646253|NCT00913458|616717914|FG004|Phase 3|Withdrawal by Subject|1|||
170646254|NCT00913458|616717915|FG005|Phase 3|Withdrawal by Subject|2|||
170646255|NCT00913458|616717916|FG006|Phase 3|Withdrawal by Subject|0|||
170646256|NCT00913458|616717910|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
170646257|NCT00913458|616717911|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
170646258|NCT00913458|616717912|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
170646259|NCT00913458|616717913|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
170646260|NCT00913458|616717914|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
170646261|NCT00913458|616717915|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
170646262|NCT00913458|616717916|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
170646263|NCT02366091|616717917|FG000|Overall Study|Withdrawal by Subject|3|||
170646264|NCT02366091|616717918|FG001|Overall Study|Withdrawal by Subject|7|||
170646265|NCT02366091|616717919|FG002|Overall Study|Withdrawal by Subject|3|||
170646266|NCT02366091|616717920|FG003|Overall Study|Withdrawal by Subject|1|||
170646267|NCT05194579|616717921|FG000|Overall Study|Lost to Follow-up|2|||
170646268|NCT05194579|616717922|FG001|Overall Study|Lost to Follow-up|3|||
170646269|NCT05194579|616717921|FG000|Overall Study|Withdrawal by Subject|3|||
170646270|NCT05194579|616717922|FG001|Overall Study|Withdrawal by Subject|4|||
170565621|NCT00776230|616418604|FG001|Overall Study|Not vaccinated at Day 0|0|||
170565622|NCT00776230|616418605|FG002|Overall Study|Not vaccinated at Day 0|0|||
170565623|NCT00776230|616418603|FG000|Overall Study|Withdrawal by Subject|0|||
170565624|NCT00776230|616418604|FG001|Overall Study|Withdrawal by Subject|1|||
170565625|NCT00776230|616418605|FG002|Overall Study|Withdrawal by Subject|0|||
170565626|NCT00776230|616418603|FG000|Overall Study|Subject missed Visit 4|0|||
170565627|NCT00776230|616418604|FG001|Overall Study|Subject missed Visit 4|1|||
170565628|NCT00776230|616418605|FG002|Overall Study|Subject missed Visit 4|0|||
170565629|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
170565630|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
170646271|NCT05194579|616717921|FG000|Overall Study|Refused further study procedures|0|||
170565631|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
170565632|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Death|0|||
170565633|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Death|0|||
170565634|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Death|1|||
170565635|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
170565636|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
170565637|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
170565638|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
170565639|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
170565640|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
170565641|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
170565642|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
170565643|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
170565644|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Graft loss|0|||
170565645|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Graft loss|0|||
170565646|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Graft loss|7|||
170565647|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
170565648|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
170565649|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
170565650|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
170565651|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
170565652|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
170565653|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
170565654|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
170565655|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
170565656|NCT00956293|616418606|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
170565657|NCT00956293|616418607|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
170565658|NCT00956293|616418608|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
170565659|NCT00956293|616418606|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
170565660|NCT00956293|616418607|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
170565661|NCT00956293|616418608|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
170565662|NCT00956293|616418606|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
170565663|NCT00956293|616418607|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
170565664|NCT00956293|616418608|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
170565665|NCT00956293|616418606|FG000|Main Period (Randomization)|Adverse Event|0|||
170565666|NCT00956293|616418607|FG001|Main Period (Randomization)|Adverse Event|15|||
170646272|NCT05194579|616717922|FG001|Overall Study|Refused further study procedures|1|||
170646273|NCT05194579|616717921|FG000|Overall Study|Protocol deviation|1|||
170646274|NCT05194579|616717922|FG001|Overall Study|Protocol deviation|0|||
170646275|NCT02279407|616717923|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
170646276|NCT02279407|616717924|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
170646277|NCT02279407|616717925|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
170646278|NCT02279407|616717926|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
170646279|NCT02279407|616717923|FG000|Overall Study|Withdrawal by Subject|1|||
170646280|NCT02279407|616717924|FG001|Overall Study|Withdrawal by Subject|0|||
170646281|NCT02279407|616717925|FG002|Overall Study|Withdrawal by Subject|1|||
170565667|NCT00956293|616418608|FG002|Main Period (Randomization)|Adverse Event|0|||
170646282|NCT02279407|616717926|FG003|Overall Study|Withdrawal by Subject|1|||
170646283|NCT02279407|616717923|FG000|Overall Study|Adverse Event|1|||
170646284|NCT02279407|616717924|FG001|Overall Study|Adverse Event|1|||
170646285|NCT02279407|616717925|FG002|Overall Study|Adverse Event|2|||
170646286|NCT02279407|616717926|FG003|Overall Study|Adverse Event|0|||
170646287|NCT01579812|616717930|FG000|Overall Study|Ineligible after treatment start|40|||
170646288|NCT01579812|616717930|FG000|Overall Study|Patient choice|3|||
170646289|NCT01579812|616717930|FG000|Overall Study|Noncompliance|3|||
170646290|NCT01579812|616717930|FG000|Overall Study|Withdrawal by Subject|6|||
170646291|NCT01782469|616717931|FG000|Overall Study|Lost to Follow-up|1|||
170646292|NCT01038869|616717932|FG000|Overall Study|Withdrawal by Subject|1|||
170646293|NCT01038869|616717932|FG000|Overall Study|Lost to Follow-up|6|||
170646294|NCT02350764|616717933|FG000|Overall Study|Adverse Event|4|||
170646295|NCT02350764|616717933|FG000|Overall Study|Death|3|||
170646296|NCT02350764|616717933|FG000|Overall Study|Physician Decision|2|||
170646297|NCT02350764|616717933|FG000|Overall Study|Withdrawal by Subject|2|||
170646298|NCT03180619|616717934|FG000|Overall Study|Withdrew Consent|5|||
170646299|NCT03180619|616717935|FG001|Overall Study|Withdrew Consent|0|||
170646300|NCT03180619|616717936|FG002|Overall Study|Withdrew Consent|2|||
170646301|NCT03180619|616717934|FG000|Overall Study|Death|2|||
170646302|NCT03180619|616717935|FG001|Overall Study|Death|1|||
170646303|NCT03180619|616717936|FG002|Overall Study|Death|2|||
170646304|NCT03180619|616717934|FG000|Overall Study|Adverse Event|2|||
170565668|NCT00956293|616418606|FG000|Follow-up Period|Follow-up period was terminated.|20|||
170565669|NCT00956293|616418607|FG001|Follow-up Period|Follow-up period was terminated.|32|||
170565670|NCT00956293|616418608|FG002|Follow-up Period|Follow-up period was terminated.|0|||
170565671|NCT02536664|616418609|FG000|Overall Study|Inadequate completion of documentation|2|||
170565672|NCT02536664|616418610|FG001|Overall Study|Inadequate completion of documentation|4|||
170565673|NCT02536664|616418609|FG000|Overall Study|Progression|13|||
170565674|NCT02536664|616418610|FG001|Overall Study|Progression|18|||
170565675|NCT02536664|616418609|FG000|Overall Study|Death due to lymphoma|2|||
170565676|NCT02536664|616418610|FG001|Overall Study|Death due to lymphoma|1|||
170565677|NCT02536664|616418609|FG000|Overall Study|Death due to other reason|3|||
170565678|NCT02536664|616418610|FG001|Overall Study|Death due to other reason|2|||
170565679|NCT02536664|616418609|FG000|Overall Study|Intolerability|8|||
170646305|NCT03180619|616717935|FG001|Overall Study|Adverse Event|0|||
170565680|NCT02536664|616418610|FG001|Overall Study|Intolerability|6|||
170565681|NCT02536664|616418609|FG000|Overall Study|Withdrawal by Subject|8|||
170646306|NCT03180619|616717936|FG002|Overall Study|Adverse Event|1|||
170646307|NCT03180619|616717934|FG000|Overall Study|Investigator's discretion|2|||
170646308|NCT03180619|616717935|FG001|Overall Study|Investigator's discretion|0|||
170646309|NCT03180619|616717936|FG002|Overall Study|Investigator's discretion|1|||
170646310|NCT04854122|616717937|FG000|Overall Study|Lost to Follow-up|1|||
170646311|NCT04854122|616717938|FG001|Overall Study|Lost to Follow-up|1|||
170646312|NCT04854122|616717939|FG002|Overall Study|Lost to Follow-up|0|||
170646313|NCT00612105|616717940|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
170565682|NCT02536664|616418610|FG001|Overall Study|Withdrawal by Subject|5|||
170565683|NCT02536664|616418609|FG000|Overall Study|Other|18|||
170565684|NCT02536664|616418610|FG001|Overall Study|Other|24|||
170565685|NCT02536664|616418609|FG000|Overall Study|Missing|53|||
170565686|NCT02536664|616418610|FG001|Overall Study|Missing|20|||
170565687|NCT03507127|616418613|FG000|Overall Study|Withdrawal by Subject|1|||
170565688|NCT03507127|616418614|FG001|Overall Study|Withdrawal by Subject|0|||
170565689|NCT03507127|616418613|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
170565690|NCT03507127|616418614|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
170565691|NCT03770286|616418617|FG000|Overall Study|Lost to Follow-up|6|||
170646314|NCT00612105|616717941|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
170646315|NCT00612105|616717940|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
170646316|NCT00612105|616717941|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
170646317|NCT00612105|616717940|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
170646318|NCT00612105|616717941|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
170646319|NCT00612105|616717940|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
170646320|NCT00612105|616717941|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
170646321|NCT00612105|616717940|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
170646322|NCT00612105|616717941|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
170646323|NCT00612105|616717940|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
170646324|NCT00612105|616717941|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
170646325|NCT00612105|616717940|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
170646326|NCT00612105|616717941|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
170646327|NCT00612105|616717940|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
170646328|NCT00612105|616717941|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
170646329|NCT00612105|616717940|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
170646330|NCT00612105|616717941|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
170646331|NCT00612105|616717940|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
170646332|NCT00612105|616717941|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
170646333|NCT00612105|616717940|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
170646334|NCT00612105|616717941|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
170646335|NCT00612105|616717940|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
170646336|NCT00612105|616717941|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
170646337|NCT00717236|616717942|FG000|Double-Blind Period|Adverse Event|33|||
170646338|NCT00717236|616717943|FG001|Double-Blind Period|Adverse Event|6|||
170646339|NCT00717236|616717942|FG000|Double-Blind Period|Lack of Efficacy|6|||
170646340|NCT00717236|616717943|FG001|Double-Blind Period|Lack of Efficacy|6|||
170646341|NCT00717236|616717942|FG000|Double-Blind Period|Lost to Follow-up|3|||
170646342|NCT00717236|616717943|FG001|Double-Blind Period|Lost to Follow-up|5|||
170646343|NCT00717236|616717942|FG000|Double-Blind Period|Withdrawal by Subject|10|||
170646344|NCT00717236|616717943|FG001|Double-Blind Period|Withdrawal by Subject|2|||
170646345|NCT00717236|616717942|FG000|Double-Blind Period|Loss of efficacy|3|||
170646346|NCT00717236|616717943|FG001|Double-Blind Period|Loss of efficacy|0|||
170646347|NCT00717236|616717942|FG000|Double-Blind Period|Other: Death|1|||
170646348|NCT00717236|616717943|FG001|Double-Blind Period|Other: Death|0|||
170646349|NCT00717236|616717942|FG000|Double-Blind Period|Other: Pregnancy|1|||
170646350|NCT00717236|616717943|FG001|Double-Blind Period|Other: Pregnancy|0|||
170646351|NCT00717236|616717942|FG000|Double-Blind Period|Other: Protocol Violation|2|||
170646352|NCT00717236|616717943|FG001|Double-Blind Period|Other: Protocol Violation|0|||
170646353|NCT00717236|616717942|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
170646354|NCT00717236|616717943|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
170646355|NCT00717236|616717942|FG000|Double-Blind Period|Other: Site withdrew|2|||
170646356|NCT00717236|616717943|FG001|Double-Blind Period|Other: Site withdrew|0|||
170565692|NCT03770286|616418618|FG001|Overall Study|Lost to Follow-up|4|||
170565693|NCT03770286|616418619|FG002|Overall Study|Lost to Follow-up|3|||
170646357|NCT00717236|616717942|FG000|Double-Blind Period|Other: Screening failure|1|||
170646358|NCT00717236|616717943|FG001|Double-Blind Period|Other: Screening failure|0|||
170646359|NCT00717236|616717942|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
170646360|NCT00717236|616717943|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
170646361|NCT00717236|616717942|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
170646362|NCT00717236|616717943|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
170646363|NCT00717236|616717942|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
170646364|NCT00717236|616717943|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
170646365|NCT00717236|616717942|FG000|Double-Blind Period|Other: History of cancer|1|||
170646366|NCT00717236|616717943|FG001|Double-Blind Period|Other: History of cancer|0|||
170646367|NCT00717236|616717942|FG000|Double-Blind Period|Other: Sponsor request|1|||
170646368|NCT00717236|616717943|FG001|Double-Blind Period|Other: Sponsor request|0|||
170646369|NCT00717236|616717942|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
170646370|NCT00717236|616717943|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
170646371|NCT00717236|616717942|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
170646372|NCT00717236|616717943|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
170646373|NCT00717236|616717942|FG000|Double-Blind Period|Other: Subject moved|1|||
170646374|NCT00717236|616717943|FG001|Double-Blind Period|Other: Subject moved|1|||
170646375|NCT00717236|616717942|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
170646376|NCT00717236|616717943|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
170646377|NCT00717236|616717942|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
170646378|NCT00717236|616717943|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
170646379|NCT00717236|616717942|FG000|Double-Blind Period|Other: Transportation problems|0|||
170646380|NCT00717236|616717943|FG001|Double-Blind Period|Other: Transportation problems|1|||
170646381|NCT00717236|616717942|FG000|Double-Blind Period|Other: Investigator Decision|0|||
170646382|NCT00717236|616717943|FG001|Double-Blind Period|Other: Investigator Decision|1|||
170646383|NCT00717236|616717942|FG000|Open-Label Period|Adverse Event|29|||
170646384|NCT00717236|616717943|FG001|Open-Label Period|Adverse Event|4|||
170646385|NCT00717236|616717942|FG000|Open-Label Period|Lack of Efficacy|30|||
170646386|NCT00717236|616717943|FG001|Open-Label Period|Lack of Efficacy|8|||
170646387|NCT00717236|616717942|FG000|Open-Label Period|Lost to Follow-up|28|||
170646388|NCT00717236|616717943|FG001|Open-Label Period|Lost to Follow-up|4|||
170646389|NCT00717236|616717942|FG000|Open-Label Period|Withdrawal by Subject|20|||
170646390|NCT00717236|616717943|FG001|Open-Label Period|Withdrawal by Subject|2|||
170646391|NCT00717236|616717942|FG000|Open-Label Period|Loss of Efficacy|6|||
170646392|NCT00717236|616717943|FG001|Open-Label Period|Loss of Efficacy|1|||
170646393|NCT00717236|616717942|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
170646394|NCT00717236|616717943|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
170646395|NCT00717236|616717942|FG000|Open-Label Period|Other: Lack of Compliance|1|||
170646396|NCT00717236|616717943|FG001|Open-Label Period|Other: Lack of Compliance|1|||
170646397|NCT00717236|616717942|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
170646398|NCT00717236|616717943|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
170646399|NCT00717236|616717942|FG000|Open-Label Period|Other: Moved|1|||
170565694|NCT03770286|616418617|FG000|Overall Study|Protocol Violation|1|||
170565695|NCT03770286|616418618|FG001|Overall Study|Protocol Violation|0|||
170565696|NCT03770286|616418619|FG002|Overall Study|Protocol Violation|2|||
170565697|NCT02505425|616418620|FG000|Overall Study|Lost to Follow-up|41|||
170565698|NCT02505425|616418621|FG001|Overall Study|Lost to Follow-up|61|||
170565699|NCT02505425|616418622|FG002|Overall Study|Lost to Follow-up|31|||
170565700|NCT02505425|616418623|FG003|Overall Study|Lost to Follow-up|19|||
170565701|NCT02505425|616418620|FG000|Overall Study|Withdrawal by Subject|39|||
170565702|NCT02505425|616418621|FG001|Overall Study|Withdrawal by Subject|9|||
170565703|NCT02505425|616418622|FG002|Overall Study|Withdrawal by Subject|19|||
170565704|NCT02505425|616418623|FG003|Overall Study|Withdrawal by Subject|7|||
170565705|NCT02505425|616418620|FG000|Overall Study|Death|8|||
170565706|NCT02505425|616418621|FG001|Overall Study|Death|12|||
170565707|NCT02505425|616418622|FG002|Overall Study|Death|0|||
170565708|NCT02505425|616418623|FG003|Overall Study|Death|0|||
170565709|NCT00545779|616418624|FG000|Overall Study|Violation of selection criteria at entry|8|||
170565710|NCT00545779|616418624|FG000|Overall Study|Other protocol violation|1|||
170565711|NCT00545779|616418624|FG000|Overall Study|Did not cooperate|7|||
170565712|NCT00545779|616418624|FG000|Overall Study|Withdrawal by Subject|20|||
170565713|NCT00545779|616418624|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
170565714|NCT00545779|616418624|FG000|Overall Study|Failure to return|3|||
170565715|NCT02257528|616418625|FG000|Overall Study|Never received study treatment|1|||
170565716|NCT03274466|616418628|FG000|Overall Study|Withdrawal by Subject|7|||
170565717|NCT03274466|616418629|FG001|Overall Study|Withdrawal by Subject|3|||
170565718|NCT03274466|616418628|FG000|Overall Study|Protocol Specified Withdrawal|5|||
170565719|NCT03274466|616418629|FG001|Overall Study|Protocol Specified Withdrawal|11|||
170565720|NCT03274466|616418628|FG000|Overall Study|Lost to Follow-up|5|||
170565721|NCT03274466|616418629|FG001|Overall Study|Lost to Follow-up|7|||
170565722|NCT03274466|616418628|FG000|Overall Study|Subject Non-compliance|0|||
170565723|NCT03274466|616418629|FG001|Overall Study|Subject Non-compliance|1|||
170565724|NCT03274466|616418628|FG000|Overall Study|Adverse Event|3|||
170565725|NCT03274466|616418629|FG001|Overall Study|Adverse Event|3|||
170565726|NCT03274466|616418628|FG000|Overall Study|Physician Decision|0|||
170565727|NCT03274466|616418629|FG001|Overall Study|Physician Decision|1|||
170565728|NCT03274466|616418628|FG000|Overall Study|Protocol Violation|3|||
170565729|NCT03274466|616418629|FG001|Overall Study|Protocol Violation|3|||
170565730|NCT04712669|616418630|FG000|Double Blind Phase|Adverse Event|4|||
170565731|NCT04712669|616418631|FG001|Double Blind Phase|Adverse Event|4|||
170565732|NCT04712669|616418632|FG002|Double Blind Phase|Adverse Event|3|||
170565733|NCT04712669|616418633|FG003|Double Blind Phase|Adverse Event|0|||
170565734|NCT04712669|616418634|FG004|Double Blind Phase|Adverse Event|0|||
170565735|NCT04712669|616418635|FG005|Double Blind Phase|Adverse Event|0|||
170565736|NCT04712669|616418636|FG006|Double Blind Phase|Adverse Event|0|||
170565737|NCT04712669|616418637|FG007|Double Blind Phase|Adverse Event|0|||
170565738|NCT04712669|616418630|FG000|Double Blind Phase|Physician Decision|1|||
170565739|NCT04712669|616418631|FG001|Double Blind Phase|Physician Decision|0|||
170565740|NCT04712669|616418632|FG002|Double Blind Phase|Physician Decision|0|||
170565741|NCT04712669|616418633|FG003|Double Blind Phase|Physician Decision|0|||
170565742|NCT04712669|616418634|FG004|Double Blind Phase|Physician Decision|0|||
170565743|NCT04712669|616418635|FG005|Double Blind Phase|Physician Decision|0|||
170565744|NCT04712669|616418636|FG006|Double Blind Phase|Physician Decision|0|||
170565745|NCT04712669|616418637|FG007|Double Blind Phase|Physician Decision|0|||
170565746|NCT04712669|616418630|FG000|Double Blind Phase|Withdrawal by Subject|3|||
170565747|NCT04712669|616418631|FG001|Double Blind Phase|Withdrawal by Subject|6|||
170565748|NCT04712669|616418632|FG002|Double Blind Phase|Withdrawal by Subject|0|||
170565749|NCT04712669|616418633|FG003|Double Blind Phase|Withdrawal by Subject|0|||
170565750|NCT04712669|616418634|FG004|Double Blind Phase|Withdrawal by Subject|0|||
170565751|NCT04712669|616418635|FG005|Double Blind Phase|Withdrawal by Subject|0|||
170565752|NCT04712669|616418636|FG006|Double Blind Phase|Withdrawal by Subject|0|||
170646400|NCT00717236|616717943|FG001|Open-Label Period|Other: Moved|0|||
170565753|NCT04712669|616418637|FG007|Double Blind Phase|Withdrawal by Subject|0|||
170565754|NCT04712669|616418630|FG000|Double Blind Phase|Termination by Sponsor|0|||
170565755|NCT04712669|616418631|FG001|Double Blind Phase|Termination by Sponsor|0|||
170565756|NCT04712669|616418632|FG002|Double Blind Phase|Termination by Sponsor|1|||
170565757|NCT04712669|616418633|FG003|Double Blind Phase|Termination by Sponsor|0|||
170565758|NCT04712669|616418634|FG004|Double Blind Phase|Termination by Sponsor|0|||
170565759|NCT04712669|616418635|FG005|Double Blind Phase|Termination by Sponsor|0|||
170565760|NCT04712669|616418636|FG006|Double Blind Phase|Termination by Sponsor|0|||
170565761|NCT04712669|616418637|FG007|Double Blind Phase|Termination by Sponsor|0|||
170565762|NCT04712669|616418630|FG000|Open Label Phase|Adverse Event|0|||
170565763|NCT04712669|616418631|FG001|Open Label Phase|Adverse Event|0|||
170565764|NCT04712669|616418632|FG002|Open Label Phase|Adverse Event|0|||
170565765|NCT04712669|616418633|FG003|Open Label Phase|Adverse Event|1|||
170565766|NCT04712669|616418634|FG004|Open Label Phase|Adverse Event|1|||
170565767|NCT04712669|616418635|FG005|Open Label Phase|Adverse Event|3|||
170565768|NCT04712669|616418636|FG006|Open Label Phase|Adverse Event|1|||
170565769|NCT04712669|616418637|FG007|Open Label Phase|Adverse Event|2|||
170565770|NCT04712669|616418630|FG000|Open Label Phase|Death|0|||
170565771|NCT04712669|616418631|FG001|Open Label Phase|Death|0|||
170565772|NCT04712669|616418632|FG002|Open Label Phase|Death|0|||
170565773|NCT04712669|616418633|FG003|Open Label Phase|Death|1|||
170565774|NCT04712669|616418634|FG004|Open Label Phase|Death|0|||
170565775|NCT04712669|616418635|FG005|Open Label Phase|Death|0|||
170565776|NCT04712669|616418636|FG006|Open Label Phase|Death|0|||
170565777|NCT04712669|616418637|FG007|Open Label Phase|Death|0|||
170565778|NCT04712669|616418630|FG000|Open Label Phase|Lack of Efficacy|0|||
170565779|NCT04712669|616418631|FG001|Open Label Phase|Lack of Efficacy|0|||
170565780|NCT04712669|616418632|FG002|Open Label Phase|Lack of Efficacy|0|||
170565781|NCT04712669|616418633|FG003|Open Label Phase|Lack of Efficacy|0|||
170565782|NCT04712669|616418634|FG004|Open Label Phase|Lack of Efficacy|1|||
170565783|NCT04712669|616418635|FG005|Open Label Phase|Lack of Efficacy|0|||
170565784|NCT04712669|616418636|FG006|Open Label Phase|Lack of Efficacy|0|||
170565785|NCT04712669|616418637|FG007|Open Label Phase|Lack of Efficacy|0|||
170565786|NCT04712669|616418630|FG000|Open Label Phase|Lost to Follow-up|0|||
170565787|NCT04712669|616418631|FG001|Open Label Phase|Lost to Follow-up|0|||
170565788|NCT04712669|616418632|FG002|Open Label Phase|Lost to Follow-up|0|||
170565789|NCT04712669|616418633|FG003|Open Label Phase|Lost to Follow-up|0|||
170565790|NCT04712669|616418634|FG004|Open Label Phase|Lost to Follow-up|0|||
170565791|NCT04712669|616418635|FG005|Open Label Phase|Lost to Follow-up|0|||
170565792|NCT04712669|616418636|FG006|Open Label Phase|Lost to Follow-up|1|||
170565793|NCT04712669|616418637|FG007|Open Label Phase|Lost to Follow-up|1|||
170565794|NCT04712669|616418630|FG000|Open Label Phase|Physician Decision|0|||
170565795|NCT04712669|616418631|FG001|Open Label Phase|Physician Decision|0|||
170565796|NCT04712669|616418632|FG002|Open Label Phase|Physician Decision|0|||
170565797|NCT04712669|616418633|FG003|Open Label Phase|Physician Decision|1|||
170565798|NCT04712669|616418634|FG004|Open Label Phase|Physician Decision|0|||
170565799|NCT04712669|616418635|FG005|Open Label Phase|Physician Decision|0|||
170565800|NCT04712669|616418636|FG006|Open Label Phase|Physician Decision|0|||
170565801|NCT04712669|616418637|FG007|Open Label Phase|Physician Decision|0|||
170565802|NCT04712669|616418630|FG000|Open Label Phase|Withdrawal by Subject|0|||
170565803|NCT04712669|616418631|FG001|Open Label Phase|Withdrawal by Subject|0|||
170565804|NCT04712669|616418632|FG002|Open Label Phase|Withdrawal by Subject|0|||
170807009|NCT00985088|617303645|FG002|Overall Study|Serious Adverse Event|0|||
170807010|NCT00985088|617303646|FG003|Overall Study|Serious Adverse Event|0|||
170807011|NCT00985088|617303647|FG004|Overall Study|Serious Adverse Event|0|||
170807012|NCT00985088|617303648|FG005|Overall Study|Serious Adverse Event|0|||
170807013|NCT00985088|617303649|FG006|Overall Study|Serious Adverse Event|0|||
170807014|NCT00985088|617303650|FG007|Overall Study|Serious Adverse Event|1|||
170807015|NCT00985088|617303643|FG000|Overall Study|Adverse Event|0|||
170807016|NCT00985088|617303644|FG001|Overall Study|Adverse Event|0|||
170807017|NCT00985088|617303645|FG002|Overall Study|Adverse Event|1|||
170807018|NCT00985088|617303646|FG003|Overall Study|Adverse Event|0|||
170807019|NCT00985088|617303647|FG004|Overall Study|Adverse Event|0|||
170807020|NCT00985088|617303648|FG005|Overall Study|Adverse Event|0|||
170807021|NCT00985088|617303649|FG006|Overall Study|Adverse Event|0|||
170807022|NCT00985088|617303650|FG007|Overall Study|Adverse Event|0|||
170807023|NCT00985088|617303643|FG000|Overall Study|Withdrawal by Subject|4|||
170807024|NCT00985088|617303644|FG001|Overall Study|Withdrawal by Subject|0|||
170807025|NCT00985088|617303645|FG002|Overall Study|Withdrawal by Subject|0|||
170807026|NCT00985088|617303646|FG003|Overall Study|Withdrawal by Subject|1|||
170807027|NCT00985088|617303647|FG004|Overall Study|Withdrawal by Subject|3|||
170807028|NCT00985088|617303648|FG005|Overall Study|Withdrawal by Subject|2|||
170807029|NCT00985088|617303649|FG006|Overall Study|Withdrawal by Subject|1|||
170807030|NCT00985088|617303650|FG007|Overall Study|Withdrawal by Subject|2|||
170807031|NCT00985088|617303643|FG000|Overall Study|Migrated/moved from study area|0|||
170807032|NCT00985088|617303644|FG001|Overall Study|Migrated/moved from study area|0|||
170807033|NCT00985088|617303645|FG002|Overall Study|Migrated/moved from study area|1|||
170807034|NCT00985088|617303646|FG003|Overall Study|Migrated/moved from study area|0|||
170807035|NCT00985088|617303647|FG004|Overall Study|Migrated/moved from study area|0|||
170807036|NCT00985088|617303648|FG005|Overall Study|Migrated/moved from study area|0|||
170807037|NCT00985088|617303649|FG006|Overall Study|Migrated/moved from study area|0|||
170807038|NCT00985088|617303650|FG007|Overall Study|Migrated/moved from study area|1|||
170807039|NCT00985088|617303643|FG000|Overall Study|Lost to Follow-up|6|||
170807040|NCT00985088|617303644|FG001|Overall Study|Lost to Follow-up|1|||
170807041|NCT00985088|617303645|FG002|Overall Study|Lost to Follow-up|2|||
170807042|NCT00985088|617303646|FG003|Overall Study|Lost to Follow-up|6|||
170807043|NCT00985088|617303647|FG004|Overall Study|Lost to Follow-up|6|||
170807044|NCT00985088|617303648|FG005|Overall Study|Lost to Follow-up|5|||
170807045|NCT00985088|617303649|FG006|Overall Study|Lost to Follow-up|3|||
170807046|NCT00985088|617303650|FG007|Overall Study|Lost to Follow-up|2|||
170565805|NCT04712669|616418633|FG003|Open Label Phase|Withdrawal by Subject|1|||
170565806|NCT04712669|616418634|FG004|Open Label Phase|Withdrawal by Subject|5|||
170807047|NCT03964974|617303652|FG000|Overall Study|Lost to Follow-up|3|||
170807048|NCT03964974|617303653|FG001|Overall Study|Lost to Follow-up|2|||
170906246|NCT04493619|617660829|FG003|Overall Study|Death|4|||
170565807|NCT04712669|616418635|FG005|Open Label Phase|Withdrawal by Subject|5|||
170646401|NCT00717236|616717942|FG000|Open-Label Period|Other: Investigator Decision|1|||
170646402|NCT00717236|616717943|FG001|Open-Label Period|Other: Investigator Decision|0|||
170646403|NCT00717236|616717942|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
170646404|NCT00717236|616717943|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
170646405|NCT00717236|616717942|FG000|Open-Label Period|Other: Sponsor Request|3|||
170565808|NCT04712669|616418636|FG006|Open Label Phase|Withdrawal by Subject|0|||
170565809|NCT04712669|616418637|FG007|Open Label Phase|Withdrawal by Subject|4|||
170565810|NCT04712669|616418630|FG000|Open Label Phase|Termination by Sponsor|0|||
170565811|NCT04712669|616418631|FG001|Open Label Phase|Termination by Sponsor|0|||
170565812|NCT04712669|616418632|FG002|Open Label Phase|Termination by Sponsor|0|||
170565813|NCT04712669|616418633|FG003|Open Label Phase|Termination by Sponsor|11|||
170565814|NCT04712669|616418634|FG004|Open Label Phase|Termination by Sponsor|9|||
170565815|NCT04712669|616418635|FG005|Open Label Phase|Termination by Sponsor|14|||
170565816|NCT04712669|616418636|FG006|Open Label Phase|Termination by Sponsor|0|||
170565817|NCT04712669|616418637|FG007|Open Label Phase|Termination by Sponsor|14|||
170565818|NCT04237584|616418644|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
170565819|NCT04237584|616418645|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
170565820|NCT04237584|616418646|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
170565821|NCT04237584|616418647|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
170565822|NCT04237584|616418644|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
170565823|NCT04237584|616418645|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
170565824|NCT04237584|616418646|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
170565825|NCT04237584|616418647|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
170565826|NCT04237584|616418644|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
170565827|NCT04237584|616418645|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
170565828|NCT04237584|616418646|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
170565829|NCT04237584|616418647|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
170565830|NCT04237584|616418644|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
170565831|NCT04237584|616418645|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
170565832|NCT04237584|616418646|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
170565833|NCT04237584|616418647|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
170565834|NCT04237584|616418644|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
170565835|NCT04237584|616418645|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
170565836|NCT04237584|616418646|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
170565837|NCT04237584|616418647|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
170565838|NCT01400412|616418650|FG000|Overall Study|Lost to Follow-up|4|||
170565839|NCT01400412|616418651|FG001|Overall Study|Lost to Follow-up|7|||
170565840|NCT01400412|616418650|FG000|Overall Study|Withdrawal by Subject|3|||
170565841|NCT01400412|616418651|FG001|Overall Study|Withdrawal by Subject|4|||
170565842|NCT01400412|616418650|FG000|Overall Study|Unable to complete|3|||
170565843|NCT01400412|616418651|FG001|Overall Study|Unable to complete|3|||
170565844|NCT01400412|616418650|FG000|Overall Study|Never started study treatment|0|||
170565845|NCT01400412|616418651|FG001|Overall Study|Never started study treatment|3|||
170565846|NCT01649869|616418652|FG000|Overall Study|Family member illness|1|||
170565847|NCT01649869|616418653|FG001|Overall Study|Family member illness|0|||
170565848|NCT01649869|616418652|FG000|Overall Study|Required treatment outside protocol|1|||
170565849|NCT01649869|616418653|FG001|Overall Study|Required treatment outside protocol|0|||
170565850|NCT01649869|616418652|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
170565851|NCT01649869|616418653|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
170565852|NCT03549338|616420327|FG000|Overall Study|Progressive Disease|1|||
170565853|NCT03549338|616420328|FG001|Overall Study|Progressive Disease|0|||
170565854|NCT03549338|616420329|FG002|Overall Study|Progressive Disease|0|||
170565855|NCT03549338|616420327|FG000|Overall Study|Clinical Progression|0|||
170565856|NCT03549338|616420328|FG001|Overall Study|Clinical Progression|1|||
170565857|NCT03549338|616420329|FG002|Overall Study|Clinical Progression|0|||
170565858|NCT00269113|616420330|FG000|Overall Study|Adverse Event|14|||
170565859|NCT00269113|616420331|FG001|Overall Study|Adverse Event|7|||
170565860|NCT00269113|616420330|FG000|Overall Study|Lack of Efficacy|35|||
170565861|NCT00269113|616420331|FG001|Overall Study|Lack of Efficacy|18|||
170565862|NCT00269113|616420330|FG000|Overall Study|Early Improvement|2|||
170565863|NCT00269113|616420331|FG001|Overall Study|Early Improvement|0|||
170646406|NCT00717236|616717943|FG001|Open-Label Period|Other: Sponsor Request|0|||
170646407|NCT00717236|616717942|FG000|Open-Label Period|Other: Cataract Surgery|1|||
170646408|NCT00717236|616717943|FG001|Open-Label Period|Other: Cataract Surgery|0|||
170565864|NCT00269113|616420330|FG000|Overall Study|Withdrawal by Subject|0|||
170565865|NCT00269113|616420331|FG001|Overall Study|Withdrawal by Subject|2|||
170565866|NCT00269113|616420330|FG000|Overall Study|Death|6|||
170565867|NCT00269113|616420331|FG001|Overall Study|Death|2|||
170646409|NCT00717236|616717942|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
170646410|NCT00717236|616717943|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
170646411|NCT00717236|616717942|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
170906247|NCT04493619|617660826|FG000|Overall Study|Study discontinued early|10|||
170906248|NCT04493619|617660827|FG001|Overall Study|Study discontinued early|0|||
170906249|NCT04493619|617660828|FG002|Overall Study|Study discontinued early|4|||
170906250|NCT04493619|617660829|FG003|Overall Study|Study discontinued early|8|||
170906251|NCT04493619|617660826|FG000|Overall Study|Lost to Follow-up|0|||
170906252|NCT04493619|617660827|FG001|Overall Study|Lost to Follow-up|0|||
170906253|NCT04493619|617660828|FG002|Overall Study|Lost to Follow-up|0|||
170906254|NCT04493619|617660829|FG003|Overall Study|Lost to Follow-up|1|||
170906255|NCT01672892|617660830|FG000|Overall Study|Protocol Violation|7|||
170906256|NCT01672892|617660831|FG001|Overall Study|Protocol Violation|3|||
170906257|NCT03528681|617660839|FG000|Open-Label Phase|Physician Decision|2|||
170906258|NCT03528681|617660840|FG001|Open-Label Phase|Physician Decision|0|||
170906259|NCT03528681|617660841|FG002|Open-Label Phase|Physician Decision|0|||
170906260|NCT03528681|617660842|FG003|Open-Label Phase|Physician Decision|0|||
170906261|NCT03528681|617660839|FG000|Open-Label Phase|Withdrawal by Subject|8|||
170906262|NCT03528681|617660840|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170906263|NCT03528681|617660841|FG002|Open-Label Phase|Withdrawal by Subject|0|||
170906264|NCT03528681|617660842|FG003|Open-Label Phase|Withdrawal by Subject|0|||
170906265|NCT03528681|617660839|FG000|Open-Label Phase|(Not collected)|4|||
170906266|NCT03528681|617660840|FG001|Open-Label Phase|(Not collected)|0|||
170906267|NCT03528681|617660841|FG002|Open-Label Phase|(Not collected)|0|||
170906268|NCT03528681|617660842|FG003|Open-Label Phase|(Not collected)|0|||
170906269|NCT03528681|617660839|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
170906270|NCT03528681|617660840|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
170906271|NCT03528681|617660841|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
170906272|NCT03528681|617660842|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
170906273|NCT03528681|617660839|FG000|Randomized Treatment Phase|Physician Decision|0|||
170906274|NCT03528681|617660840|FG001|Randomized Treatment Phase|Physician Decision|5|||
170906275|NCT03528681|617660841|FG002|Randomized Treatment Phase|Physician Decision|1|||
170906276|NCT03528681|617660842|FG003|Randomized Treatment Phase|Physician Decision|2|||
170906277|NCT03528681|617660839|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
170906278|NCT03528681|617660840|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
170906279|NCT03528681|617660841|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
170906280|NCT03528681|617660842|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
170906281|NCT03528681|617660839|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
170906282|NCT03528681|617660840|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
170906283|NCT03528681|617660841|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
170906284|NCT03528681|617660842|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
170906285|NCT03528681|617660839|FG000|Randomized Treatment Phase|(Not collected)|0|||
170906286|NCT03528681|617660840|FG001|Randomized Treatment Phase|(Not collected)|4|||
170906287|NCT03528681|617660841|FG002|Randomized Treatment Phase|(Not collected)|6|||
170646412|NCT00717236|616717943|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
170906288|NCT03528681|617660842|FG003|Randomized Treatment Phase|(Not collected)|5|||
170906289|NCT00374556|617660852|FG000|Overall Study|Lost to Follow-up|1|||
170906290|NCT00374556|617660853|FG001|Overall Study|Lost to Follow-up|0|||
170906291|NCT00374556|617660852|FG000|Overall Study|Removed at baseline due to medical cond|0|||
170906292|NCT00374556|617660853|FG001|Overall Study|Removed at baseline due to medical cond|1|||
170906293|NCT00473694|617660854|FG000|Overall Study|Adverse Event|0|||
170906294|NCT00473694|617660855|FG001|Overall Study|Adverse Event|1|||
170906295|NCT00473694|617660856|FG002|Overall Study|Adverse Event|0|||
170906296|NCT00473694|617660857|FG003|Overall Study|Adverse Event|0|||
170906297|NCT00473694|617660854|FG000|Overall Study|Participants did not receive treatment|11|||
170906298|NCT00473694|617660855|FG001|Overall Study|Participants did not receive treatment|3|||
170906299|NCT00473694|617660856|FG002|Overall Study|Participants did not receive treatment|5|||
170906300|NCT00473694|617660857|FG003|Overall Study|Participants did not receive treatment|6|||
170906301|NCT00473694|617660854|FG000|Overall Study|Lost to Follow-up|0|||
170906302|NCT00473694|617660855|FG001|Overall Study|Lost to Follow-up|0|||
170906303|NCT00473694|617660856|FG002|Overall Study|Lost to Follow-up|0|||
170906304|NCT00473694|617660857|FG003|Overall Study|Lost to Follow-up|1|||
170906305|NCT01006356|617660858|FG000|Overall Study|Adverse Event|6|||
170906306|NCT01006356|617660858|FG000|Overall Study|Physician Decision|1|||
170906307|NCT01006356|617660858|FG000|Overall Study|Paticipants did not cooperate|6|||
170906308|NCT01006356|617660858|FG000|Overall Study|Withdrawal by Subject|1|||
170906309|NCT01006356|617660858|FG000|Overall Study|Choice by participants|2|||
170906310|NCT01006356|617660858|FG000|Overall Study|Protocol Violation|3|||
170906311|NCT01006356|617660858|FG000|Overall Study|Other|23|||
170906312|NCT02468193|617660859|FG000|Overall Study|Adverse Event|4|||
170906313|NCT02468193|617660859|FG000|Overall Study|Subject/ Guardian decision|2|||
170906314|NCT00742781|617660860|FG000|Overall Study|Withdrawal by Subject|3|||
170906315|NCT01416181|617660861|FG000|Part 1|Other|10|||
170565868|NCT00269113|616420330|FG000|Overall Study|Lost to Follow-up|2|||
170565869|NCT00269113|616420331|FG001|Overall Study|Lost to Follow-up|1|||
170565870|NCT00269113|616420330|FG000|Overall Study|Protocol Violation|15|||
170565871|NCT00269113|616420331|FG001|Overall Study|Protocol Violation|5|||
170565872|NCT00269113|616420330|FG000|Overall Study|Other|0|||
170565873|NCT00269113|616420331|FG001|Overall Study|Other|2|||
170565874|NCT03386773|616420332|FG000|Overall Study|Lost to Follow-up|24|||
170565875|NCT03386773|616420333|FG001|Overall Study|Lost to Follow-up|33|||
170565876|NCT03386773|616420332|FG000|Overall Study|Withdrawal by Subject|3|||
170565877|NCT03386773|616420333|FG001|Overall Study|Withdrawal by Subject|2|||
170565878|NCT01517984|616420334|FG000|Overall Study|Lost to Follow-up|0|||
170565879|NCT01517984|616420335|FG001|Overall Study|Lost to Follow-up|1|||
170565880|NCT01517984|616420336|FG002|Overall Study|Lost to Follow-up|0|||
170565881|NCT01517984|616420337|FG003|Overall Study|Lost to Follow-up|0|||
170565882|NCT01517984|616420334|FG000|Overall Study|Withdrawal by Subject|1|||
170565883|NCT01517984|616420335|FG001|Overall Study|Withdrawal by Subject|8|||
170565884|NCT01517984|616420336|FG002|Overall Study|Withdrawal by Subject|4|||
170565885|NCT01517984|616420337|FG003|Overall Study|Withdrawal by Subject|1|||
170565886|NCT01517984|616420334|FG000|Overall Study|Screen Failure|4|||
170565887|NCT01517984|616420335|FG001|Overall Study|Screen Failure|0|||
170565888|NCT01517984|616420336|FG002|Overall Study|Screen Failure|0|||
170565889|NCT01517984|616420337|FG003|Overall Study|Screen Failure|0|||
170565890|NCT01517984|616420334|FG000|Overall Study|Ineligible for randomization|0|||
170565891|NCT01517984|616420335|FG001|Overall Study|Ineligible for randomization|14|||
170565892|NCT01517984|616420336|FG002|Overall Study|Ineligible for randomization|0|||
170565893|NCT01517984|616420337|FG003|Overall Study|Ineligible for randomization|0|||
170565894|NCT02724839|616420340|FG000|Overall Study|Withdrawal by Subject|1|||
170565895|NCT02724839|616420341|FG001|Overall Study|Withdrawal by Subject|1|||
170565896|NCT02724839|616420342|FG002|Overall Study|Withdrawal by Subject|0|||
170565897|NCT02724839|616420340|FG000|Overall Study|Lost to Follow-up|0|||
170565898|NCT02724839|616420341|FG001|Overall Study|Lost to Follow-up|3|||
170565899|NCT02724839|616420342|FG002|Overall Study|Lost to Follow-up|2|||
170565900|NCT02724839|616420340|FG000|Overall Study|Physician Decision|0|||
170565901|NCT02724839|616420341|FG001|Overall Study|Physician Decision|0|||
170565902|NCT02724839|616420342|FG002|Overall Study|Physician Decision|3|||
170565903|NCT01693367|616420343|FG000|Overall Study|Withdrawal by Subject|1|||
170565904|NCT01693367|616420344|FG001|Overall Study|Withdrawal by Subject|1|||
170565905|NCT01693367|616420343|FG000|Overall Study|Physician Decision|0|||
170565906|NCT01693367|616420344|FG001|Overall Study|Physician Decision|1|||
170565907|NCT01155050|616420345|FG000|Overall Study|Lost to Follow-up|15|||
170565908|NCT01155050|616420346|FG001|Overall Study|Lost to Follow-up|20|||
170565909|NCT01155050|616420347|FG002|Overall Study|Lost to Follow-up|19|||
170565910|NCT01155050|616420348|FG003|Overall Study|Lost to Follow-up|22|||
170565911|NCT01198587|616420351|FG000|Overall Study|Lost to Follow-up|8|||
170565912|NCT01198587|616420352|FG001|Overall Study|Lost to Follow-up|0|||
170565913|NCT01198587|616420353|FG002|Overall Study|Lost to Follow-up|9|||
170565914|NCT01198587|616420354|FG003|Overall Study|Lost to Follow-up|0|||
170565915|NCT00690794|616420355|FG000|Overall Study|Adverse Event|12|||
170565916|NCT00690794|616420356|FG001|Overall Study|Adverse Event|10|||
170565917|NCT00690794|616420355|FG000|Overall Study|Lost to Follow-up|1|||
170565918|NCT00690794|616420356|FG001|Overall Study|Lost to Follow-up|4|||
170565919|NCT00690794|616420355|FG000|Overall Study|Withdrawal by Subject|0|||
170565920|NCT00690794|616420356|FG001|Overall Study|Withdrawal by Subject|9|||
170565921|NCT00690794|616420355|FG000|Overall Study|Protocol Violation|6|||
170565922|NCT00690794|616420356|FG001|Overall Study|Protocol Violation|7|||
170565923|NCT00690794|616420355|FG000|Overall Study|Noncompliance|1|||
170565924|NCT00690794|616420356|FG001|Overall Study|Noncompliance|2|||
170565925|NCT00690794|616420355|FG000|Overall Study|Other not specified|1|||
170565926|NCT00690794|616420356|FG001|Overall Study|Other not specified|3|||
170565927|NCT00557193|616420357|FG000|Induction|Adverse Event|2|||
170565928|NCT00557193|616420358|FG001|Induction|Adverse Event|0|||
170565929|NCT00557193|616420359|FG002|Induction|Adverse Event|0|||
170565930|NCT00557193|616420360|FG003|Induction|Adverse Event|0|||
170565931|NCT00557193|616420361|FG004|Induction|Adverse Event|0|||
170565932|NCT00557193|616420362|FG005|Induction|Adverse Event|0|||
170565933|NCT00557193|616420357|FG000|Induction|Death|6|||
170565934|NCT00557193|616420358|FG001|Induction|Death|0|||
170565935|NCT00557193|616420359|FG002|Induction|Death|0|||
170565936|NCT00557193|616420360|FG003|Induction|Death|0|||
170565937|NCT00557193|616420361|FG004|Induction|Death|0|||
170565938|NCT00557193|616420362|FG005|Induction|Death|0|||
170565939|NCT00557193|616420357|FG000|Induction|Physician Decision|3|||
170565940|NCT00557193|616420358|FG001|Induction|Physician Decision|0|||
170565941|NCT00557193|616420359|FG002|Induction|Physician Decision|0|||
170565942|NCT00557193|616420360|FG003|Induction|Physician Decision|0|||
170565943|NCT00557193|616420361|FG004|Induction|Physician Decision|0|||
170565944|NCT00557193|616420362|FG005|Induction|Physician Decision|0|||
170565945|NCT00557193|616420357|FG000|Induction|Withdrawal by Subject|1|||
170565946|NCT00557193|616420358|FG001|Induction|Withdrawal by Subject|0|||
170565947|NCT00557193|616420359|FG002|Induction|Withdrawal by Subject|0|||
170565948|NCT00557193|616420360|FG003|Induction|Withdrawal by Subject|0|||
170906316|NCT01416181|617660862|FG001|Part 1|Other|24|||
170906317|NCT01416181|617660861|FG000|Part 1|Death|0|||
170906318|NCT01416181|617660862|FG001|Part 1|Death|1|||
170565949|NCT00557193|616420361|FG004|Induction|Withdrawal by Subject|0|||
170565950|NCT00557193|616420362|FG005|Induction|Withdrawal by Subject|0|||
170565951|NCT00557193|616420357|FG000|Induction|Refusal of Further Protocol Therapy|2|||
170565952|NCT00557193|616420358|FG001|Induction|Refusal of Further Protocol Therapy|0|||
170565953|NCT00557193|616420359|FG002|Induction|Refusal of Further Protocol Therapy|0|||
170906319|NCT01416181|617660861|FG000|Part 1|Investigator Decision|7|||
170906320|NCT01416181|617660862|FG001|Part 1|Investigator Decision|6|||
170906321|NCT01416181|617660861|FG000|Part 1|Withdrawal by Subject|74|||
170906322|NCT01416181|617660862|FG001|Part 1|Withdrawal by Subject|48|||
170906323|NCT01416181|617660861|FG000|Part 1|Lack of Efficacy|16|||
170906324|NCT01416181|617660862|FG001|Part 1|Lack of Efficacy|8|||
170906325|NCT01416181|617660861|FG000|Part 1|Lost to Follow-up|1|||
170906326|NCT01416181|617660862|FG001|Part 1|Lost to Follow-up|1|||
170906327|NCT01416181|617660861|FG000|Part 1|Adverse Event|15|||
170906328|NCT01416181|617660862|FG001|Part 1|Adverse Event|18|||
170906329|NCT01416181|617660861|FG000|Part 1|Ongoing in Follow-Up|14|||
170906330|NCT01416181|617660862|FG001|Part 1|Ongoing in Follow-Up|8|||
170906331|NCT01416181|617660861|FG000|Part 2|Adverse Event|11|||
170906332|NCT01416181|617660862|FG001|Part 2|Adverse Event|4|||
170906333|NCT01416181|617660861|FG000|Part 2|Other|234|||
170906334|NCT01416181|617660862|FG001|Part 2|Other|267|||
170906335|NCT01416181|617660861|FG000|Part 2|Investigator Decision|6|||
170906336|NCT01416181|617660862|FG001|Part 2|Investigator Decision|7|||
170906337|NCT01416181|617660861|FG000|Part 2|Withdrawal by Subject|14|||
170906338|NCT01416181|617660862|FG001|Part 2|Withdrawal by Subject|5|||
170906339|NCT01416181|617660861|FG000|Part 2|Lack of Efficacy|4|||
170906340|NCT01416181|617660862|FG001|Part 2|Lack of Efficacy|1|||
170906341|NCT01416181|617660861|FG000|Part 2|Lost to Follow-up|2|||
170906342|NCT01416181|617660862|FG001|Part 2|Lost to Follow-up|2|||
170906343|NCT02981472|617660863|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
170906344|NCT02981472|617660864|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
170906345|NCT02981472|617660863|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
170906346|NCT02981472|617660864|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170906347|NCT02981472|617660863|FG000|Treatment Period|Adverse Event|6|||
170906348|NCT02981472|617660864|FG001|Treatment Period|Adverse Event|1|||
170906349|NCT02981472|617660863|FG000|Treatment Period|Participant withdrew consent|1|||
170906350|NCT02981472|617660864|FG001|Treatment Period|Participant withdrew consent|0|||
170906351|NCT02981472|617660863|FG000|Treatment Period|Lost to Follow-up|0|||
170906352|NCT02981472|617660864|FG001|Treatment Period|Lost to Follow-up|1|||
170906353|NCT02799381|617660869|FG000|Overall Study|Withdrew consent|3|||
170906354|NCT02799381|617660870|FG001|Overall Study|Withdrew consent|2|||
170906355|NCT02799381|617660869|FG000|Overall Study|Adverse Event|0|||
170906356|NCT02799381|617660870|FG001|Overall Study|Adverse Event|1|||
170565954|NCT00557193|616420360|FG003|Induction|Refusal of Further Protocol Therapy|0|||
170565955|NCT00557193|616420361|FG004|Induction|Refusal of Further Protocol Therapy|0|||
170565956|NCT00557193|616420362|FG005|Induction|Refusal of Further Protocol Therapy|0|||
170565957|NCT00557193|616420357|FG000|Induction|Ineligible|8|||
170565958|NCT00557193|616420358|FG001|Induction|Ineligible|0|||
170565959|NCT00557193|616420359|FG002|Induction|Ineligible|0|||
170565960|NCT00557193|616420360|FG003|Induction|Ineligible|0|||
170565961|NCT00557193|616420361|FG004|Induction|Ineligible|0|||
170565962|NCT00557193|616420362|FG005|Induction|Ineligible|0|||
170565963|NCT00557193|616420357|FG000|Induction|Inevaluable for post Induction|2|||
170565964|NCT00557193|616420358|FG001|Induction|Inevaluable for post Induction|0|||
170565965|NCT00557193|616420359|FG002|Induction|Inevaluable for post Induction|0|||
170565966|NCT00557193|616420360|FG003|Induction|Inevaluable for post Induction|0|||
170565967|NCT00557193|616420361|FG004|Induction|Inevaluable for post Induction|0|||
170565968|NCT00557193|616420362|FG005|Induction|Inevaluable for post Induction|0|||
170565969|NCT00557193|616420357|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
170565970|NCT00557193|616420358|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
170565971|NCT00557193|616420359|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
170565972|NCT00557193|616420360|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
170565973|NCT00557193|616420361|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
170565974|NCT00557193|616420362|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
170906357|NCT02799381|617660869|FG000|Overall Study|Participant did not take any study drug|1|||
170906358|NCT02799381|617660870|FG001|Overall Study|Participant did not take any study drug|0|||
170906359|NCT03952130|617660871|FG000|Overall Study|Adverse Event|0|||
170906360|NCT03952130|617660872|FG001|Overall Study|Adverse Event|1|||
170906361|NCT03952130|617660871|FG000|Overall Study|Lost to Follow-up|1|||
170906362|NCT03952130|617660872|FG001|Overall Study|Lost to Follow-up|0|||
170906363|NCT03952130|617660871|FG000|Overall Study|Withdrawal by Subject|1|||
170906364|NCT03952130|617660872|FG001|Overall Study|Withdrawal by Subject|5|||
170906365|NCT01713348|617660873|FG000|Overall Study|Withdrawal by Subject|3|||
170906366|NCT01713348|617660874|FG001|Overall Study|Withdrawal by Subject|2|||
170906367|NCT01713348|617660875|FG002|Overall Study|Withdrawal by Subject|2|||
170565975|NCT00557193|616420357|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
170565976|NCT00557193|616420358|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
170565977|NCT00557193|616420359|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
170565978|NCT00557193|616420360|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
170565979|NCT00557193|616420361|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
170565980|NCT00557193|616420362|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
170565981|NCT00557193|616420357|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
170565982|NCT00557193|616420358|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
170565983|NCT00557193|616420359|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
170565984|NCT00557193|616420360|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
170565985|NCT00557193|616420361|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
170565986|NCT00557193|616420362|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
170565987|NCT00557193|616420357|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
170565988|NCT00557193|616420358|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
170565989|NCT00557193|616420359|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
170565990|NCT00557193|616420360|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
170565991|NCT00557193|616420361|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
170565992|NCT00557193|616420362|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
170565993|NCT00557193|616420357|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
170565994|NCT00557193|616420358|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
170565995|NCT00557193|616420359|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
170565996|NCT00557193|616420360|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
170565997|NCT00557193|616420361|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
170565998|NCT00557193|616420362|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
170565999|NCT00557193|616420357|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
170566000|NCT00557193|616420358|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
170566001|NCT00557193|616420359|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
170566002|NCT00557193|616420360|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
170566003|NCT00557193|616420361|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
170566004|NCT00557193|616420362|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
170566005|NCT00557193|616420357|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
170566006|NCT00557193|616420358|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
170566007|NCT00557193|616420359|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
170566008|NCT00557193|616420360|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
170566009|NCT00557193|616420361|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
170566010|NCT00557193|616420362|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
170566011|NCT00557193|616420357|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
170566012|NCT00557193|616420358|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
170566013|NCT00557193|616420359|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
170566014|NCT00557193|616420360|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
170566015|NCT00557193|616420361|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
170566016|NCT00557193|616420362|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
170566017|NCT00557193|616420357|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
170566018|NCT00557193|616420358|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
170566019|NCT00557193|616420359|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
170566020|NCT00557193|616420360|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
170566021|NCT00557193|616420361|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
170566022|NCT00557193|616420362|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
170566023|NCT00305448|616420363|FG000|Overall Study|Protocol Violation|0|||
170566024|NCT00305448|616420364|FG001|Overall Study|Protocol Violation|1|||
170566025|NCT00305448|616420365|FG002|Overall Study|Protocol Violation|0|||
170566026|NCT00305448|616420363|FG000|Overall Study|Withdrawal by Subject|2|||
170566027|NCT00305448|616420364|FG001|Overall Study|Withdrawal by Subject|0|||
170566028|NCT00305448|616420365|FG002|Overall Study|Withdrawal by Subject|1|||
170566029|NCT00305448|616420363|FG000|Overall Study|Adverse Event|1|||
170566030|NCT00305448|616420364|FG001|Overall Study|Adverse Event|0|||
170566031|NCT00305448|616420365|FG002|Overall Study|Adverse Event|1|||
170566032|NCT00305448|616420363|FG000|Overall Study|Disease Progression|27|||
170566033|NCT00305448|616420364|FG001|Overall Study|Disease Progression|31|||
170566034|NCT00305448|616420365|FG002|Overall Study|Disease Progression|28|||
170566035|NCT00305448|616420363|FG000|Overall Study|Subjective Disease Progression|1|||
170566036|NCT00305448|616420364|FG001|Overall Study|Subjective Disease Progression|2|||
170566037|NCT00305448|616420365|FG002|Overall Study|Subjective Disease Progression|2|||
170566038|NCT00305448|616420363|FG000|Overall Study|Tumor Marker Elevation|0|||
170566039|NCT00305448|616420364|FG001|Overall Study|Tumor Marker Elevation|0|||
170566040|NCT00305448|616420365|FG002|Overall Study|Tumor Marker Elevation|1|||
170566041|NCT00387088|616420366|FG000|Overall Study|Adverse Event|143|||
170566042|NCT00387088|616420367|FG001|Overall Study|Adverse Event|156|||
170566043|NCT00387088|616420366|FG000|Overall Study|Protocol Violation|47|||
170566044|NCT00387088|616420367|FG001|Overall Study|Protocol Violation|35|||
170566045|NCT00387088|616420366|FG000|Overall Study|Withdrawal by Subject|20|||
170566046|NCT00387088|616420367|FG001|Overall Study|Withdrawal by Subject|35|||
170566047|NCT00387088|616420366|FG000|Overall Study|Lack of Efficacy|28|||
170566048|NCT00387088|616420367|FG001|Overall Study|Lack of Efficacy|67|||
170566049|NCT00387088|616420366|FG000|Overall Study|Lost to Follow-up|22|||
170566050|NCT00387088|616420367|FG001|Overall Study|Lost to Follow-up|28|||
170566051|NCT00387088|616420366|FG000|Overall Study|Other|58|||
170807049|NCT03964974|617303652|FG000|Overall Study|Withdrawal by Subject|0|||
170566052|NCT00387088|616420367|FG001|Overall Study|Other|52|||
170566053|NCT03435380|616420368|FG000|Overall Study|Death|1|||
170566054|NCT03435380|616420369|FG001|Overall Study|Death|2|||
170566055|NCT03435380|616420370|FG002|Overall Study|Death|1|||
170566056|NCT03435380|616420368|FG000|Overall Study|Lost to Follow-up|12|||
170566057|NCT03435380|616420369|FG001|Overall Study|Lost to Follow-up|8|||
170566058|NCT03435380|616420370|FG002|Overall Study|Lost to Follow-up|6|||
170566059|NCT03435380|616420368|FG000|Overall Study|Physician Decision|1|||
170566060|NCT03435380|616420369|FG001|Overall Study|Physician Decision|0|||
170566061|NCT03435380|616420370|FG002|Overall Study|Physician Decision|0|||
170566062|NCT03435380|616420368|FG000|Overall Study|Withdrawal by Subject|0|||
170807050|NCT03964974|617303653|FG001|Overall Study|Withdrawal by Subject|3|||
170807051|NCT01256359|617303660|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
170807052|NCT01256359|617303661|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
170807053|NCT01256359|617303660|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
170807054|NCT01256359|617303661|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
170807055|NCT03176407|617303666|FG000|Overall Study|Protocol Violation|1|||
170807056|NCT03176407|617303666|FG000|Overall Study|human failure|1|||
170807057|NCT03176407|617303666|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
170807058|NCT03842189|617303667|FG000|Overall Study|Lost to Follow-up|0|||
170807059|NCT03842189|617303668|FG001|Overall Study|Lost to Follow-up|0|||
170807060|NCT03842189|617303669|FG002|Overall Study|Lost to Follow-up|0|||
170807061|NCT03842189|617303670|FG003|Overall Study|Lost to Follow-up|0|||
170807062|NCT03842189|617303671|FG004|Overall Study|Lost to Follow-up|0|||
170807063|NCT03842189|617303672|FG005|Overall Study|Lost to Follow-up|0|||
170807064|NCT03842189|617303673|FG006|Overall Study|Lost to Follow-up|1|||
170807065|NCT03842189|617303674|FG007|Overall Study|Lost to Follow-up|0|||
170807066|NCT01428583|617303677|FG000|Overall Study|Adverse Event|75|||
170807067|NCT01428583|617303677|FG000|Overall Study|Withdrawal by Subject|51|||
170807068|NCT01428583|617303677|FG000|Overall Study|Lack of Efficacy|37|||
170807069|NCT01428583|617303677|FG000|Overall Study|Lost to Follow-up|17|||
170807070|NCT01428583|617303677|FG000|Overall Study|Death|1|||
170807071|NCT01428583|617303677|FG000|Overall Study|Pregnancy|1|||
170807072|NCT01428583|617303677|FG000|Overall Study|Protocol Violation|1|||
170807073|NCT01428583|617303677|FG000|Overall Study|Physician Decision|12|||
170807074|NCT01428583|617303677|FG000|Overall Study|Non-compliant|25|||
170807075|NCT01428583|617303677|FG000|Overall Study|Confirmed positive urine drug test|8|||
170807076|NCT01428583|617303677|FG000|Overall Study|Sponsor's request|3|||
170807077|NCT01428583|617303677|FG000|Overall Study|Other|6|||
170807078|NCT00670488|617303680|FG000|Overall Study|Adverse Event|0|||
170807079|NCT00670488|617303681|FG001|Overall Study|Adverse Event|7|||
170807080|NCT00670488|617303682|FG002|Overall Study|Adverse Event|0|||
170807081|NCT00670488|617303683|FG003|Overall Study|Adverse Event|3|||
170807082|NCT00670488|617303684|FG004|Overall Study|Adverse Event|1|||
170807083|NCT00670488|617303685|FG005|Overall Study|Adverse Event|1|||
170807084|NCT00670488|617303686|FG006|Overall Study|Adverse Event|5|||
170807085|NCT00670488|617303687|FG007|Overall Study|Adverse Event|1|||
170807086|NCT00670488|617303688|FG008|Overall Study|Adverse Event|0|||
170566063|NCT03435380|616420369|FG001|Overall Study|Withdrawal by Subject|1|||
170566064|NCT03435380|616420370|FG002|Overall Study|Withdrawal by Subject|1|||
170566065|NCT03435380|616420368|FG000|Overall Study|Ineligible|0|||
170566066|NCT03435380|616420369|FG001|Overall Study|Ineligible|1|||
170566067|NCT03435380|616420370|FG002|Overall Study|Ineligible|1|||
170566068|NCT02431325|616420373|FG000|Overall Study|Adverse Event|3|||
170566069|NCT02431325|616420374|FG001|Overall Study|Adverse Event|0|||
170566070|NCT02431325|616420373|FG000|Overall Study|Lost to Follow-up|0|||
170566071|NCT02431325|616420374|FG001|Overall Study|Lost to Follow-up|1|||
170566072|NCT02431325|616420373|FG000|Overall Study|Withdrawal by Subject|1|||
170566073|NCT02431325|616420374|FG001|Overall Study|Withdrawal by Subject|2|||
170566074|NCT02431325|616420373|FG000|Overall Study|Declined to take study medication|1|||
170566075|NCT02431325|616420374|FG001|Overall Study|Declined to take study medication|0|||
170566076|NCT02431325|616420373|FG000|Overall Study|Withdrew before starting study medication|1|||
170566077|NCT02431325|616420374|FG001|Overall Study|Withdrew before starting study medication|0|||
170566078|NCT02431325|616420373|FG000|Overall Study|Placebo shortage|2|||
170566079|NCT02431325|616420374|FG001|Overall Study|Placebo shortage|0|||
170566080|NCT03500211|616420375|FG000|Overall Study|Withdrawal by Subject|1|||
170566081|NCT03500211|616420376|FG001|Overall Study|Withdrawal by Subject|1|||
170566082|NCT01917318|616420377|FG000|First Treatment|Withdrawal by Subject|0|||
170566083|NCT01917318|616420378|FG001|First Treatment|Withdrawal by Subject|1|||
170566084|NCT00742625|616420379|FG000|Remission Induction|Progression|6|||
170566085|NCT00742625|616420379|FG000|Remission Induction|Failed induction|8|||
170566086|NCT00742625|616420379|FG000|Remission Induction|Adverse Event|3|||
170566087|NCT00742625|616420379|FG000|Remission Induction|Death|10|||
170566088|NCT00742625|616420379|FG000|Remission Induction|Refusal|5|||
170566089|NCT00742625|616420379|FG000|Remission Induction|Non protocol treatment|17|||
170566090|NCT00742625|616420379|FG000|Remission Induction|Other, not specified|5|||
170566091|NCT00742625|616420379|FG000|Consolidation|Progression|5|||
170566092|NCT00742625|616420379|FG000|Consolidation|Adverse Event|1|||
170566093|NCT00742625|616420379|FG000|Consolidation|Death|1|||
170566094|NCT00742625|616420379|FG000|Consolidation|Refused|1|||
170566095|NCT00742625|616420379|FG000|Consolidation|Non protocol therapy|13|||
170566096|NCT04460183|616420380|FG000|Overall Study|Lost to Follow-up|3|||
170566097|NCT04460183|616420381|FG001|Overall Study|Lost to Follow-up|1|||
170566098|NCT04460183|616420380|FG000|Overall Study|Withdrawal by Subject|1|||
170566099|NCT04460183|616420381|FG001|Overall Study|Withdrawal by Subject|0|||
170566100|NCT01128569|616420385|FG000|Washout Period 1|Adverse Event|0|||
170566101|NCT01128569|616420386|FG001|Washout Period 1|Adverse Event|0|||
170566102|NCT01128569|616420387|FG002|Washout Period 1|Adverse Event|1|||
170566103|NCT01128569|616420388|FG003|Washout Period 1|Adverse Event|0|||
170566104|NCT01128569|616420389|FG004|Washout Period 1|Adverse Event|0|||
170566105|NCT01128569|616420390|FG005|Washout Period 1|Adverse Event|0|||
170566106|NCT01128569|616420385|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170566107|NCT01128569|616420386|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170566108|NCT01128569|616420387|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170566109|NCT01128569|616420388|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170566110|NCT01128569|616420389|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170566111|NCT01128569|616420390|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170566112|NCT03338400|616420391|FG000|Overall Study|Lost to Follow-up|1|||
170566113|NCT03338400|616420392|FG001|Overall Study|Lost to Follow-up|2|||
170566114|NCT01865487|616420393|FG000|Overall Study|Lost to Follow-up|0|||
170566115|NCT01865487|616420394|FG001|Overall Study|Lost to Follow-up|0|||
170566116|NCT01865487|616420395|FG002|Overall Study|Lost to Follow-up|0|||
170566117|NCT01865487|616420396|FG003|Overall Study|Lost to Follow-up|1|||
170566118|NCT01865487|616420397|FG004|Overall Study|Lost to Follow-up|0|||
170566119|NCT01865487|616420398|FG005|Overall Study|Lost to Follow-up|0|||
170566120|NCT01865487|616420399|FG006|Overall Study|Lost to Follow-up|1|||
170566121|NCT01865487|616420400|FG007|Overall Study|Lost to Follow-up|0|||
170566122|NCT01865487|616420401|FG008|Overall Study|Lost to Follow-up|0|||
170566123|NCT01865487|616420402|FG009|Overall Study|Lost to Follow-up|0|||
170566124|NCT01865487|616420393|FG000|Overall Study|Withdrawal by Subject|0|||
170566125|NCT01865487|616420394|FG001|Overall Study|Withdrawal by Subject|0|||
170646413|NCT00717236|616717942|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
170566126|NCT01865487|616420395|FG002|Overall Study|Withdrawal by Subject|0|||
170566127|NCT01865487|616420396|FG003|Overall Study|Withdrawal by Subject|0|||
170566128|NCT01865487|616420397|FG004|Overall Study|Withdrawal by Subject|1|||
170566129|NCT01865487|616420398|FG005|Overall Study|Withdrawal by Subject|0|||
170566130|NCT01865487|616420399|FG006|Overall Study|Withdrawal by Subject|0|||
170566131|NCT01865487|616420400|FG007|Overall Study|Withdrawal by Subject|0|||
170566132|NCT01865487|616420401|FG008|Overall Study|Withdrawal by Subject|0|||
170566133|NCT01865487|616420402|FG009|Overall Study|Withdrawal by Subject|0|||
170566134|NCT01627691|616420406|FG000|Overall Study|Death|11|||
170566135|NCT01627691|616420406|FG000|Overall Study|Lost to Follow-up|3|||
170566136|NCT01627691|616420406|FG000|Overall Study|Withdrawal by Subject|1|||
170566137|NCT01627691|616420406|FG000|Overall Study|Missed the visit|3|||
170566138|NCT01908140|616420407|FG000|Overall Study|Other or Progressive Disease|5|||
170566139|NCT01908140|616420408|FG001|Overall Study|Other or Progressive Disease|12|||
170566140|NCT01908140|616420407|FG000|Overall Study|Lack of Efficacy|7|||
170566141|NCT01908140|616420408|FG001|Overall Study|Lack of Efficacy|5|||
170566142|NCT01908140|616420407|FG000|Overall Study|Withdrawal by Subject|23|||
170566143|NCT01908140|616420408|FG001|Overall Study|Withdrawal by Subject|24|||
170906368|NCT01713348|617660876|FG003|Overall Study|Withdrawal by Subject|0|||
170906369|NCT01713348|617660873|FG000|Overall Study|Lost to Follow-up|1|||
170906370|NCT01713348|617660874|FG001|Overall Study|Lost to Follow-up|0|||
170906371|NCT01713348|617660875|FG002|Overall Study|Lost to Follow-up|0|||
170906372|NCT01713348|617660876|FG003|Overall Study|Lost to Follow-up|0|||
170906373|NCT00621023|617660877|FG000|Overall Study|Death|5|||
170906374|NCT00621023|617660877|FG000|Overall Study|Follow up discontinued|1|||
170906375|NCT04178590|617660888|FG000|Overall Study|Pregnancy|1|||
170906376|NCT04178590|617660888|FG000|Overall Study|Lost to Follow-up|1|||
170906377|NCT04723537|617660889|FG000|Overall Study|Withdrawal by Subject|3|||
170906378|NCT04723537|617660890|FG001|Overall Study|Withdrawal by Subject|0|||
170906379|NCT04723537|617660891|FG002|Overall Study|Withdrawal by Subject|0|||
170906380|NCT04723537|617660889|FG000|Overall Study|Physician Decision|0|||
170906381|NCT04723537|617660890|FG001|Overall Study|Physician Decision|0|||
170906382|NCT04723537|617660891|FG002|Overall Study|Physician Decision|1|||
170906383|NCT04723537|617660889|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
170906384|NCT04723537|617660890|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
170906385|NCT04723537|617660891|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
170906386|NCT04419506|617660892|FG000|Overall Study|Adverse Event|0|||
170906387|NCT04419506|617660893|FG001|Overall Study|Adverse Event|10|||
170906388|NCT04419506|617660894|FG002|Overall Study|Adverse Event|0|||
170906389|NCT04419506|617660895|FG003|Overall Study|Adverse Event|3|||
170906390|NCT04419506|617660892|FG000|Overall Study|Withdrawal by Subject|0|||
170906391|NCT04419506|617660893|FG001|Overall Study|Withdrawal by Subject|0|||
170906392|NCT04419506|617660894|FG002|Overall Study|Withdrawal by Subject|0|||
170906393|NCT04419506|617660895|FG003|Overall Study|Withdrawal by Subject|1|||
170906394|NCT04419506|617660892|FG000|Overall Study|poor-compliance|0|||
170906395|NCT04419506|617660893|FG001|Overall Study|poor-compliance|0|||
170906396|NCT04419506|617660894|FG002|Overall Study|poor-compliance|0|||
170906397|NCT04419506|617660895|FG003|Overall Study|poor-compliance|1|||
170906398|NCT00817414|617660896|FG000|Overall Study|Adverse Event|1|||
170906399|NCT00817414|617660897|FG001|Overall Study|Adverse Event|1|||
170906400|NCT00817414|617660898|FG002|Overall Study|Adverse Event|1|||
170906401|NCT00817414|617660899|FG003|Overall Study|Adverse Event|0|||
170906402|NCT00817414|617660900|FG004|Overall Study|Adverse Event|0|||
170906403|NCT00817414|617660896|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
170906404|NCT00817414|617660897|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
170906405|NCT00817414|617660898|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
170906406|NCT00817414|617660899|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
170906407|NCT00817414|617660900|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
170906408|NCT00817414|617660896|FG000|Overall Study|Withdrawal by Subject|1|||
170906409|NCT00817414|617660897|FG001|Overall Study|Withdrawal by Subject|1|||
170906410|NCT00817414|617660898|FG002|Overall Study|Withdrawal by Subject|0|||
170906411|NCT00817414|617660899|FG003|Overall Study|Withdrawal by Subject|0|||
170906412|NCT00817414|617660900|FG004|Overall Study|Withdrawal by Subject|0|||
170906413|NCT00817414|617660896|FG000|Overall Study|Lost to Follow-up|0|||
170906414|NCT00817414|617660897|FG001|Overall Study|Lost to Follow-up|0|||
170906415|NCT00817414|617660898|FG002|Overall Study|Lost to Follow-up|1|||
170906416|NCT00817414|617660899|FG003|Overall Study|Lost to Follow-up|1|||
170906417|NCT00817414|617660900|FG004|Overall Study|Lost to Follow-up|1|||
170906418|NCT00817414|617660896|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
170906419|NCT00817414|617660897|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
170906420|NCT00817414|617660898|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
170906421|NCT00817414|617660899|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
170906422|NCT00817414|617660900|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
170906423|NCT00817414|617660896|FG000|Overall Study|Protocol Violation|0|||
170906424|NCT00817414|617660897|FG001|Overall Study|Protocol Violation|0|||
170906425|NCT00817414|617660898|FG002|Overall Study|Protocol Violation|0|||
170566144|NCT01908140|616420407|FG000|Overall Study|Lost to Follow-up|1|||
170566145|NCT01908140|616420408|FG001|Overall Study|Lost to Follow-up|6|||
170906426|NCT00817414|617660899|FG003|Overall Study|Protocol Violation|0|||
170906427|NCT00817414|617660900|FG004|Overall Study|Protocol Violation|1|||
170906428|NCT03717922|617660905|FG000|Overall Study|Lost to Follow-up|2|||
170906429|NCT03717922|617660906|FG001|Overall Study|Lost to Follow-up|2|||
170906430|NCT01242111|617660907|FG000|Overall Study|Adverse Event|1|||
170906431|NCT01242111|617660907|FG000|Overall Study|Withdrawal by Subject|1|||
170566146|NCT01908140|616420407|FG000|Overall Study|Protocol Violation|8|||
170566147|NCT01908140|616420408|FG001|Overall Study|Protocol Violation|9|||
170566148|NCT01908140|616420407|FG000|Overall Study|Adverse Event|22|||
170566149|NCT01908140|616420408|FG001|Overall Study|Adverse Event|23|||
170566150|NCT00698828|616420415|FG000|Overall Study|Adverse Event|3|||
170566151|NCT00698828|616420416|FG001|Overall Study|Adverse Event|4|||
170566152|NCT00698828|616420417|FG002|Overall Study|Adverse Event|4|||
170566153|NCT00698828|616420415|FG000|Overall Study|Death|0|||
170566154|NCT00698828|616420416|FG001|Overall Study|Death|0|||
170566155|NCT00698828|616420417|FG002|Overall Study|Death|1|||
170566156|NCT00698828|616420415|FG000|Overall Study|Exacerbation of COPD|1|||
170566157|NCT00698828|616420416|FG001|Overall Study|Exacerbation of COPD|3|||
170566158|NCT00698828|616420417|FG002|Overall Study|Exacerbation of COPD|0|||
170566159|NCT00698828|616420415|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
170566160|NCT00698828|616420416|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
170566161|NCT00698828|616420417|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
170566162|NCT00698828|616420415|FG000|Overall Study|Investigator/Sponsor decision|1|||
170566163|NCT00698828|616420416|FG001|Overall Study|Investigator/Sponsor decision|0|||
170566164|NCT00698828|616420417|FG002|Overall Study|Investigator/Sponsor decision|2|||
170646414|NCT00717236|616717943|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
170646415|NCT04525885|616717944|FG000|Overall Study|Screen Failure|1|||
170646416|NCT04525885|616717945|FG001|Overall Study|Screen Failure|0|||
170646417|NCT04525885|616717946|FG002|Overall Study|Screen Failure|0|||
170646418|NCT04525885|616717944|FG000|Overall Study|Withdrawal by Subject|14|||
170646419|NCT04525885|616717945|FG001|Overall Study|Withdrawal by Subject|6|||
170646420|NCT04525885|616717946|FG002|Overall Study|Withdrawal by Subject|20|||
170646421|NCT04525885|616717944|FG000|Overall Study|Physician Decision|1|||
170646422|NCT04525885|616717945|FG001|Overall Study|Physician Decision|0|||
170646423|NCT04525885|616717946|FG002|Overall Study|Physician Decision|1|||
170646424|NCT04948333|616717949|FG000|Overall Study|Adverse Event|6|||
170566165|NCT00698828|616420415|FG000|Overall Study|Lost to Follow-up|1|||
170566166|NCT00698828|616420416|FG001|Overall Study|Lost to Follow-up|1|||
170646425|NCT04948333|616717950|FG001|Overall Study|Adverse Event|4|||
170646426|NCT04948333|616717951|FG002|Overall Study|Adverse Event|0|||
170646427|NCT04948333|616717952|FG003|Overall Study|Adverse Event|2|||
170646428|NCT04948333|616717949|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
170646429|NCT04948333|616717950|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170646430|NCT04948333|616717951|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170646431|NCT04948333|616717952|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170646432|NCT04948333|616717949|FG000|Overall Study|Progressive Disease|1|||
170646433|NCT04948333|616717950|FG001|Overall Study|Progressive Disease|5|||
170646434|NCT04948333|616717951|FG002|Overall Study|Progressive Disease|0|||
170646435|NCT04948333|616717952|FG003|Overall Study|Progressive Disease|0|||
170646436|NCT04948333|616717949|FG000|Overall Study|Physician Decision|2|||
170646437|NCT04948333|616717950|FG001|Overall Study|Physician Decision|2|||
170646438|NCT04948333|616717951|FG002|Overall Study|Physician Decision|0|||
170646439|NCT04948333|616717952|FG003|Overall Study|Physician Decision|0|||
170646440|NCT04948333|616717949|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
170646441|NCT04948333|616717950|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
170646442|NCT04948333|616717951|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
170646443|NCT04948333|616717952|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
170646444|NCT04948333|616717949|FG000|Overall Study|Withdrawal by Subject|2|||
170646445|NCT04948333|616717950|FG001|Overall Study|Withdrawal by Subject|0|||
170646446|NCT04948333|616717951|FG002|Overall Study|Withdrawal by Subject|0|||
170646447|NCT04948333|616717952|FG003|Overall Study|Withdrawal by Subject|1|||
170646448|NCT04948333|616717949|FG000|Overall Study|Protocol Violation|0|||
170646449|NCT04948333|616717950|FG001|Overall Study|Protocol Violation|1|||
170646450|NCT04948333|616717951|FG002|Overall Study|Protocol Violation|0|||
170646451|NCT04948333|616717952|FG003|Overall Study|Protocol Violation|0|||
170646452|NCT04948333|616717949|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
170646453|NCT04948333|616717950|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
170646454|NCT04948333|616717951|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
170646455|NCT04948333|616717952|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
170646456|NCT01181986|616717953|FG000|Phase 1|Lost to Follow-up|0|||
170646457|NCT01181986|616717954|FG001|Phase 1|Lost to Follow-up|1|||
170646458|NCT01181986|616717955|FG002|Phase 1|Lost to Follow-up|1|||
170646459|NCT01181986|616717953|FG000|Phase 1|Adverse Event|0|||
170646460|NCT01181986|616717954|FG001|Phase 1|Adverse Event|0|||
170646461|NCT01181986|616717955|FG002|Phase 1|Adverse Event|1|||
170566167|NCT00698828|616420417|FG002|Overall Study|Lost to Follow-up|0|||
170646462|NCT01181986|616717953|FG000|Phase 1|Protocol Violation|1|||
170646463|NCT01181986|616717954|FG001|Phase 1|Protocol Violation|0|||
170646464|NCT01181986|616717955|FG002|Phase 1|Protocol Violation|0|||
170566168|NCT00698828|616420415|FG000|Overall Study|Withdrew consent|0|||
170566169|NCT00698828|616420416|FG001|Overall Study|Withdrew consent|7|||
170566170|NCT00698828|616420417|FG002|Overall Study|Withdrew consent|4|||
170646465|NCT01181986|616717953|FG000|Phase 2|Adverse Event|0|||
170906432|NCT01242111|617660907|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
170566171|NCT00698828|616420415|FG000|Overall Study|Withdrew consent (not treated)|2|||
170566172|NCT00698828|616420416|FG001|Overall Study|Withdrew consent (not treated)|0|||
170566173|NCT00698828|616420417|FG002|Overall Study|Withdrew consent (not treated)|0|||
170566174|NCT02013609|616420418|FG000|Overall Study|Withdrawal by Subject|9|||
170566175|NCT02013609|616420418|FG000|Overall Study|Lost to Follow-up|3|||
170566176|NCT02013609|616420418|FG000|Overall Study|Adverse Event|3|||
170566177|NCT02013609|616420418|FG000|Overall Study|Met Withdrawal Criteria|3|||
170566178|NCT01119287|616420419|FG000|Overall Study|Patient Decision, not related to AE|0|||
170566179|NCT01119287|616420420|FG001|Overall Study|Patient Decision, not related to AE|0|||
170566180|NCT01119287|616420421|FG002|Overall Study|Patient Decision, not related to AE|2|||
170566181|NCT01119287|616420422|FG003|Overall Study|Patient Decision, not related to AE|2|||
170566182|NCT01119287|616420423|FG004|Overall Study|Patient Decision, not related to AE|1|||
170566183|NCT01119287|616420424|FG005|Overall Study|Patient Decision, not related to AE|0|||
170646466|NCT01181986|616717954|FG001|Phase 2|Adverse Event|3|||
170646467|NCT01181986|616717955|FG002|Phase 2|Adverse Event|0|||
170646468|NCT01181986|616717953|FG000|Phase 2|Medical condition|0|||
170646469|NCT01181986|616717954|FG001|Phase 2|Medical condition|1|||
170646470|NCT01181986|616717955|FG002|Phase 2|Medical condition|0|||
170646471|NCT00530504|616717958|FG000|Overall Study|Death|54|||
170646472|NCT00530504|616717958|FG000|Overall Study|Lost to Follow-up|26|||
170646473|NCT00530504|616717958|FG000|Overall Study|Withdrawal by Subject|39|||
170646474|NCT00530504|616717958|FG000|Overall Study|Exited study due to other reasons|33|||
170646475|NCT02122783|616718931|FG000|Overall Study|Adverse Event|0|||
170646476|NCT02122783|616718932|FG001|Overall Study|Adverse Event|1|||
170646477|NCT04378907|616718934|FG000|Overall Study|Withdrawal by Subject|1|||
170646478|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Adverse Event|0|||
170646479|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Adverse Event|4|||
170646480|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Adverse Event|2|||
170566184|NCT03604497|616420426|FG000|Overall Study|Protocol Violation|52|||
170566185|NCT02980107|616420430|FG000|Overall Study|Withdrawal by Subject|51|||
170566186|NCT02980107|616420431|FG001|Overall Study|Withdrawal by Subject|62|||
170566187|NCT02412670|616420432|FG000|Overall Study|Adverse Event|4|||
170566188|NCT02412670|616420433|FG001|Overall Study|Adverse Event|1|||
170566189|NCT02412670|616420432|FG000|Overall Study|Physician Decision|1|||
170566190|NCT02412670|616420433|FG001|Overall Study|Physician Decision|0|||
170566191|NCT02412670|616420432|FG000|Overall Study|Withdrawal by Subject|1|||
170566192|NCT02412670|616420433|FG001|Overall Study|Withdrawal by Subject|0|||
170566193|NCT02412670|616420432|FG000|Overall Study|Ineligible|1|||
170566194|NCT02412670|616420433|FG001|Overall Study|Ineligible|0|||
170566195|NCT03440008|616420436|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
170566196|NCT03440008|616420437|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
170566197|NCT03440008|616420436|FG000|Overall Study|Withdrawal by Subject|1|||
170566198|NCT03440008|616420437|FG001|Overall Study|Withdrawal by Subject|0|||
170566199|NCT02284191|616420446|FG000|Overall Study|Withdrawal by Subject|1|||
170566200|NCT02284191|616420447|FG001|Overall Study|Withdrawal by Subject|3|||
170566201|NCT02284191|616420446|FG000|Overall Study|Lost to Follow-up|1|||
170566202|NCT02284191|616420447|FG001|Overall Study|Lost to Follow-up|0|||
170566203|NCT04064905|616420448|FG000|Overall Study|Lost to Follow-up|0|||
170566204|NCT04064905|616420449|FG001|Overall Study|Lost to Follow-up|3|||
170566205|NCT04064905|616420450|FG002|Overall Study|Lost to Follow-up|1|||
170566206|NCT04064905|616420451|FG003|Overall Study|Lost to Follow-up|4|||
170566207|NCT04064905|616420452|FG004|Overall Study|Lost to Follow-up|2|||
170566208|NCT03139448|616420453|FG000|Overall Study|Lack of Efficacy|6|||
170566209|NCT03139448|616420454|FG001|Overall Study|Lack of Efficacy|7|||
170566210|NCT03139448|616420453|FG000|Overall Study|Location of procedure changed|2|||
170566211|NCT03139448|616420454|FG001|Overall Study|Location of procedure changed|8|||
170566212|NCT03139448|616420453|FG000|Overall Study|Withdrawal by Subject|3|||
170566213|NCT03139448|616420454|FG001|Overall Study|Withdrawal by Subject|6|||
170566214|NCT03139448|616420453|FG000|Overall Study|Screen fail|1|||
170566215|NCT03139448|616420454|FG001|Overall Study|Screen fail|3|||
170566216|NCT03139448|616420453|FG000|Overall Study|Physician Decision|0|||
170566217|NCT03139448|616420454|FG001|Overall Study|Physician Decision|2|||
170566218|NCT00760552|616420455|FG000|Overall Study|Death|2|||
170566219|NCT00760552|616420456|FG001|Overall Study|Death|0|||
170566220|NCT00760552|616420455|FG000|Overall Study|Lost to Follow-up|11|||
170646481|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Adverse Event|3|||
170646482|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Adverse Event|0|||
170906433|NCT01126619|617660910|FG000|Overall Study|Not eligible for the study|2|||
170566221|NCT00760552|616420456|FG001|Overall Study|Lost to Follow-up|10|||
170646483|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Lack of Efficacy|0|||
170566222|NCT01038323|616420457|FG000|Overall Study|Withdrawal by Subject|3|||
170566223|NCT01038323|616420458|FG001|Overall Study|Withdrawal by Subject|2|||
170566224|NCT01038323|616420459|FG002|Overall Study|Withdrawal by Subject|4|||
170566225|NCT01832727|616420467|FG000|Overall Study|Adverse Event|4|||
170566226|NCT01832727|616420468|FG001|Overall Study|Adverse Event|6|||
170646484|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Lack of Efficacy|4|||
170566227|NCT01832727|616420469|FG002|Overall Study|Adverse Event|1|||
170566228|NCT01832727|616420470|FG003|Overall Study|Adverse Event|0|||
170566229|NCT01832727|616420471|FG004|Overall Study|Adverse Event|1|||
170566230|NCT01832727|616420472|FG005|Overall Study|Adverse Event|1|||
170566231|NCT01832727|616420473|FG006|Overall Study|Adverse Event|2|||
170566232|NCT01832727|616420474|FG007|Overall Study|Adverse Event|1|||
170566233|NCT01832727|616420475|FG008|Overall Study|Adverse Event|9|||
170566234|NCT01832727|616420467|FG000|Overall Study|Disease progression|3|||
170566235|NCT01832727|616420468|FG001|Overall Study|Disease progression|0|||
170566236|NCT01832727|616420469|FG002|Overall Study|Disease progression|2|||
170566237|NCT01832727|616420470|FG003|Overall Study|Disease progression|1|||
170566238|NCT01832727|616420471|FG004|Overall Study|Disease progression|3|||
170566239|NCT01832727|616420472|FG005|Overall Study|Disease progression|3|||
170566240|NCT01832727|616420473|FG006|Overall Study|Disease progression|6|||
170566241|NCT01832727|616420474|FG007|Overall Study|Disease progression|2|||
170906434|NCT01126619|617660910|FG000|Overall Study|Investigator decision|4|||
170906435|NCT01126619|617660910|FG000|Overall Study|Serious adverse event|1|||
170906436|NCT01126619|617660910|FG000|Overall Study|Withdrawal by Subject|9|||
170906437|NCT01126619|617660910|FG000|Overall Study|Non-compliance|1|||
170906438|NCT04876391|617660913|FG000|Overall Study|Withdrawal by Subject|1|||
170906439|NCT04876391|617660914|FG001|Overall Study|Withdrawal by Subject|10|||
170906440|NCT04876391|617660913|FG000|Overall Study|Lost to Follow-up|2|||
170906441|NCT04876391|617660914|FG001|Overall Study|Lost to Follow-up|4|||
170906442|NCT04876391|617660913|FG000|Overall Study|Lack of Efficacy|0|||
170906443|NCT04876391|617660914|FG001|Overall Study|Lack of Efficacy|2|||
170906444|NCT04876391|617660913|FG000|Overall Study|Adverse Event|3|||
170906445|NCT04876391|617660914|FG001|Overall Study|Adverse Event|1|||
170906446|NCT04876391|617660913|FG000|Overall Study|Patient non-compliance|0|||
170906447|NCT04876391|617660914|FG001|Overall Study|Patient non-compliance|1|||
170906448|NCT04876391|617660913|FG000|Overall Study|Personal reasons|0|||
170906449|NCT04876391|617660914|FG001|Overall Study|Personal reasons|1|||
170906450|NCT04876391|617660913|FG000|Overall Study|Withdrawn as per protocol|2|||
170906451|NCT04876391|617660914|FG001|Overall Study|Withdrawn as per protocol|2|||
170906452|NCT01929083|617660915|FG000|Intervention 1|Lost to Follow-up|2|||
170906453|NCT01929083|617660916|FG001|Intervention 1|Lost to Follow-up|0|||
170906454|NCT01929083|617660915|FG000|Intervention 1|Nonadherent to study medications|1|||
170906455|NCT01929083|617660916|FG001|Intervention 1|Nonadherent to study medications|0|||
170906456|NCT01929083|617660915|FG000|Intervention 2|Adverse Event|0|||
170906457|NCT01929083|617660916|FG001|Intervention 2|Adverse Event|1|||
170906458|NCT01931865|617660919|FG000|Overall Study|Lost to Follow-up|2|||
170906459|NCT01931865|617660919|FG000|Overall Study|Withdrawal by Subject|2|||
170906460|NCT01829048|617660920|FG000|Overall Study|Withdrawal by Subject|0|||
170906461|NCT01829048|617660921|FG001|Overall Study|Withdrawal by Subject|0|||
170906462|NCT01829048|617660922|FG002|Overall Study|Withdrawal by Subject|0|||
170906463|NCT01829048|617660923|FG003|Overall Study|Withdrawal by Subject|2|||
170906464|NCT01829048|617660924|FG004|Overall Study|Withdrawal by Subject|0|||
170906465|NCT01122927|617660929|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
170906466|NCT01122927|617660930|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
170906467|NCT01122927|617660929|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
170906468|NCT01122927|617660930|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
170906469|NCT01122927|617660929|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
170906470|NCT01122927|617660930|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
170906471|NCT01122927|617660929|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
170906472|NCT01122927|617660930|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
170906473|NCT01122927|617660929|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
170906474|NCT01122927|617660930|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
170906475|NCT01122927|617660929|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
170906476|NCT01122927|617660930|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
170906477|NCT01122927|617660929|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
170906478|NCT01122927|617660930|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
170906479|NCT01122927|617660929|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
170906480|NCT01122927|617660930|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
170906481|NCT01122927|617660929|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
170906482|NCT01122927|617660930|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
170906483|NCT01122927|617660929|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
170566242|NCT01832727|616420475|FG008|Overall Study|Disease progression|7|||
170566243|NCT01832727|616420467|FG000|Overall Study|Lost to Follow-up|0|||
170906484|NCT01122927|617660930|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
170906485|NCT01122927|617660929|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
170906486|NCT01122927|617660930|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
170566244|NCT01832727|616420468|FG001|Overall Study|Lost to Follow-up|0|||
170566245|NCT01832727|616420469|FG002|Overall Study|Lost to Follow-up|0|||
170566246|NCT01832727|616420470|FG003|Overall Study|Lost to Follow-up|1|||
170566247|NCT01832727|616420471|FG004|Overall Study|Lost to Follow-up|0|||
170566248|NCT01832727|616420472|FG005|Overall Study|Lost to Follow-up|0|||
170566249|NCT01832727|616420473|FG006|Overall Study|Lost to Follow-up|0|||
170566250|NCT01832727|616420474|FG007|Overall Study|Lost to Follow-up|0|||
170566251|NCT01832727|616420475|FG008|Overall Study|Lost to Follow-up|0|||
170566252|NCT01832727|616420467|FG000|Overall Study|Physician Decision|1|||
170566253|NCT01832727|616420468|FG001|Overall Study|Physician Decision|0|||
170566254|NCT01832727|616420469|FG002|Overall Study|Physician Decision|0|||
170566255|NCT01832727|616420470|FG003|Overall Study|Physician Decision|1|||
170566256|NCT01832727|616420471|FG004|Overall Study|Physician Decision|0|||
170566257|NCT01832727|616420472|FG005|Overall Study|Physician Decision|1|||
170566258|NCT01832727|616420473|FG006|Overall Study|Physician Decision|0|||
170566259|NCT01832727|616420474|FG007|Overall Study|Physician Decision|0|||
170906487|NCT01122927|617660929|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
170906488|NCT01122927|617660930|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
170906489|NCT03427073|617660931|FG000|Overall Study|Disease Progression|1|||
170906490|NCT03427073|617660932|FG001|Overall Study|Disease Progression|1|||
170906491|NCT03427073|617660933|FG002|Overall Study|Disease Progression|1|||
170906492|NCT03427073|617660934|FG003|Overall Study|Disease Progression|3|||
170906493|NCT03427073|617660935|FG004|Overall Study|Disease Progression|3|||
170906494|NCT03427073|617660936|FG005|Overall Study|Disease Progression|4|||
170906495|NCT03427073|617660937|FG006|Overall Study|Disease Progression|2|||
170906496|NCT03427073|617660938|FG007|Overall Study|Disease Progression|3|||
170906497|NCT03427073|617660931|FG000|Overall Study|Physician Decision|0|||
170906498|NCT03427073|617660932|FG001|Overall Study|Physician Decision|0|||
170906499|NCT03427073|617660933|FG002|Overall Study|Physician Decision|0|||
170906500|NCT03427073|617660934|FG003|Overall Study|Physician Decision|0|||
170906501|NCT03427073|617660935|FG004|Overall Study|Physician Decision|0|||
170906502|NCT03427073|617660936|FG005|Overall Study|Physician Decision|0|||
170906503|NCT03427073|617660937|FG006|Overall Study|Physician Decision|1|||
170906504|NCT03427073|617660938|FG007|Overall Study|Physician Decision|1|||
170906505|NCT01985321|617660939|FG000|Overall Study|Protocol Violation|4|||
170906506|NCT01985321|617660940|FG001|Overall Study|Protocol Violation|3|||
170906507|NCT01985321|617660939|FG000|Overall Study|Withdrawal by Subject|1|||
170906508|NCT01985321|617660940|FG001|Overall Study|Withdrawal by Subject|0|||
170906509|NCT01985321|617660939|FG000|Overall Study|Lost to Follow-up|5|||
170906510|NCT01985321|617660940|FG001|Overall Study|Lost to Follow-up|2|||
170906511|NCT01985321|617660939|FG000|Overall Study|Subject treated wrong type of sore|1|||
170906512|NCT01985321|617660940|FG001|Overall Study|Subject treated wrong type of sore|0|||
170906513|NCT01023789|617660941|FG000|3 - Year Visit|Death|29|||
170906514|NCT01023789|617660941|FG000|3 - Year Visit|Withdrawal of consent|1|||
170906515|NCT01023789|617660941|FG000|3 - Year Visit|Lost to Follow-up|13|||
170906516|NCT02115308|617660943|FG000|Overall Study|Safety Screening|2|||
170906517|NCT02115308|617660944|FG001|Overall Study|Safety Screening|2|||
170906518|NCT02272790|617660951|FG000|Overall Study|Physician Decision|0|||
170906519|NCT02272790|617660952|FG001|Overall Study|Physician Decision|1|||
170906520|NCT02272790|617660953|FG002|Overall Study|Physician Decision|0|||
170906521|NCT02272790|617660954|FG003|Overall Study|Physician Decision|0|||
170906522|NCT02272790|617660955|FG004|Overall Study|Physician Decision|0|||
170906523|NCT02272790|617660956|FG005|Overall Study|Physician Decision|0|||
170906524|NCT03022461|617660957|FG000|Overall Study|Death|3|||
170906525|NCT01982630|617660958|FG000|Overall Study|Adverse Event|2|||
170906526|NCT01982630|617660959|FG001|Overall Study|Adverse Event|0|||
170906527|NCT01982630|617660960|FG002|Overall Study|Adverse Event|1|||
170906528|NCT01982630|617660961|FG003|Overall Study|Adverse Event|0|||
170906529|NCT01982630|617660962|FG004|Overall Study|Adverse Event|1|||
170906530|NCT01982630|617660963|FG005|Overall Study|Adverse Event|2|||
170906531|NCT01982630|617660964|FG006|Overall Study|Adverse Event|1|||
170906532|NCT01982630|617660965|FG007|Overall Study|Adverse Event|0|||
170906533|NCT01982630|617660958|FG000|Overall Study|Physician Decision|1|||
170906534|NCT01982630|617660959|FG001|Overall Study|Physician Decision|0|||
170906535|NCT01982630|617660960|FG002|Overall Study|Physician Decision|2|||
170906536|NCT01982630|617660961|FG003|Overall Study|Physician Decision|1|||
170906537|NCT01982630|617660962|FG004|Overall Study|Physician Decision|2|||
170906538|NCT01982630|617660963|FG005|Overall Study|Physician Decision|0|||
170906539|NCT01982630|617660964|FG006|Overall Study|Physician Decision|0|||
170906540|NCT01982630|617660965|FG007|Overall Study|Physician Decision|0|||
170906541|NCT01982630|617660958|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
170906542|NCT01982630|617660959|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
170906543|NCT01982630|617660960|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
170906544|NCT01982630|617660961|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
170566260|NCT01832727|616420475|FG008|Overall Study|Physician Decision|0|||
170906545|NCT01982630|617660962|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
170566261|NCT01832727|616420467|FG000|Overall Study|Withdrawal by Subject|1|||
170906546|NCT01982630|617660963|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
170906547|NCT01982630|617660964|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
170906548|NCT01982630|617660965|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
170566262|NCT01832727|616420468|FG001|Overall Study|Withdrawal by Subject|1|||
170566263|NCT01832727|616420469|FG002|Overall Study|Withdrawal by Subject|0|||
170646485|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Lack of Efficacy|2|||
170646486|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Lack of Efficacy|1|||
170646487|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Lack of Efficacy|0|||
170646488|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Lost to Follow-up|0|||
170646489|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Lost to Follow-up|5|||
170646490|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Lost to Follow-up|6|||
170646491|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Lost to Follow-up|3|||
170646492|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Lost to Follow-up|3|||
170646493|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Non-Compliance With Study Drug|0|||
170566264|NCT01832727|616420470|FG003|Overall Study|Withdrawal by Subject|1|||
170906549|NCT01982630|617660958|FG000|Overall Study|Withdrawal by Subject|0|||
170906550|NCT01982630|617660959|FG001|Overall Study|Withdrawal by Subject|0|||
170906551|NCT01982630|617660960|FG002|Overall Study|Withdrawal by Subject|0|||
170906552|NCT01982630|617660961|FG003|Overall Study|Withdrawal by Subject|0|||
170906553|NCT01982630|617660962|FG004|Overall Study|Withdrawal by Subject|0|||
170906554|NCT01982630|617660963|FG005|Overall Study|Withdrawal by Subject|1|||
170906555|NCT01982630|617660964|FG006|Overall Study|Withdrawal by Subject|0|||
170906556|NCT01982630|617660965|FG007|Overall Study|Withdrawal by Subject|0|||
170906557|NCT03248128|617660966|FG000|Overall Study|Lost to Follow-up|1|||
170906558|NCT03248128|617660967|FG001|Overall Study|Lost to Follow-up|0|||
170906559|NCT03248128|617660966|FG000|Overall Study|Withdrawal by Subject|16|||
170906560|NCT03248128|617660967|FG001|Overall Study|Withdrawal by Subject|14|||
170906561|NCT03248128|617660966|FG000|Overall Study|Site Closed|4|||
170906562|NCT03248128|617660967|FG001|Overall Study|Site Closed|3|||
170906563|NCT03248128|617660966|FG000|Overall Study|Randomized, but did not receive treatment|1|||
170906564|NCT03248128|617660967|FG001|Overall Study|Randomized, but did not receive treatment|3|||
170906565|NCT01914679|617660968|FG000|Overall Study|Lack of Efficacy|1|||
170906566|NCT01914679|617660968|FG000|Overall Study|Sponsor terminated study|4|||
170906567|NCT00256295|617660969|FG000|Overall Study|Withdrawal by Subject|3|||
170906568|NCT00256295|617660969|FG000|Overall Study|Death|1|||
170906569|NCT03929250|617660972|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
170906570|NCT03929250|617660973|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
170906571|NCT02452359|617660976|FG000|Overall Study|Adverse Event|1|||
170906572|NCT02452359|617660976|FG000|Overall Study|Lost to Follow-up|15|||
170906573|NCT02452359|617660976|FG000|Overall Study|Pregnancy|1|||
170906574|NCT02452359|617660976|FG000|Overall Study|Withdrawal by Subject|4|||
170906575|NCT01826214|617662405|FG000|Overall Study|Adverse Event|7|||
170906576|NCT01826214|617662406|FG001|Overall Study|Adverse Event|6|||
170906577|NCT01826214|617662405|FG000|Overall Study|Death|3|||
170906578|NCT01826214|617662406|FG001|Overall Study|Death|1|||
170906579|NCT01826214|617662405|FG000|Overall Study|Lost to Follow-up|1|||
170906580|NCT01826214|617662406|FG001|Overall Study|Lost to Follow-up|0|||
170906581|NCT01826214|617662405|FG000|Overall Study|Physician Decision|0|||
170906582|NCT01826214|617662406|FG001|Overall Study|Physician Decision|2|||
170906583|NCT01826214|617662405|FG000|Overall Study|Progressive disease|22|||
170906584|NCT01826214|617662406|FG001|Overall Study|Progressive disease|21|||
170906585|NCT01826214|617662405|FG000|Overall Study|Study terminated by Sponsor|0|||
170906586|NCT01826214|617662406|FG001|Overall Study|Study terminated by Sponsor|1|||
170906587|NCT01826214|617662405|FG000|Overall Study|Subject/guardian decision|2|||
170906588|NCT01826214|617662406|FG001|Overall Study|Subject/guardian decision|3|||
170906589|NCT00955110|617662414|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
170906590|NCT00955110|617662414|FG000|Treatment Phase|Adverse Event|2|||
170906591|NCT00955110|617662414|FG000|Treatment Phase|Administrative reasons|2|||
170906592|NCT00955110|617662414|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
170906593|NCT00955110|617662414|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
170566265|NCT01832727|616420471|FG004|Overall Study|Withdrawal by Subject|0|||
170566266|NCT01832727|616420472|FG005|Overall Study|Withdrawal by Subject|1|||
170566267|NCT01832727|616420473|FG006|Overall Study|Withdrawal by Subject|0|||
170566268|NCT01832727|616420474|FG007|Overall Study|Withdrawal by Subject|2|||
170566269|NCT01832727|616420475|FG008|Overall Study|Withdrawal by Subject|1|||
170566270|NCT01832727|616420467|FG000|Overall Study|Study terminated by sponsor|0|||
170566271|NCT01832727|616420468|FG001|Overall Study|Study terminated by sponsor|0|||
170566272|NCT01832727|616420469|FG002|Overall Study|Study terminated by sponsor|0|||
170566273|NCT01832727|616420470|FG003|Overall Study|Study terminated by sponsor|0|||
170566274|NCT01832727|616420471|FG004|Overall Study|Study terminated by sponsor|0|||
170566275|NCT01832727|616420472|FG005|Overall Study|Study terminated by sponsor|0|||
170566276|NCT01832727|616420473|FG006|Overall Study|Study terminated by sponsor|0|||
170566277|NCT01832727|616420474|FG007|Overall Study|Study terminated by sponsor|1|||
170566278|NCT01832727|616420475|FG008|Overall Study|Study terminated by sponsor|1|||
170646494|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Non-Compliance With Study Drug|1|||
170646495|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Non-Compliance With Study Drug|1|||
170906594|NCT02128490|617662415|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
170906595|NCT02128490|617662416|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
170906596|NCT02128490|617662417|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
170646496|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Non-Compliance With Study Drug|1|||
170646497|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Non-Compliance With Study Drug|0|||
170646498|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Pregnancy|0|||
170646499|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Pregnancy|1|||
170646500|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Pregnancy|1|||
170646501|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Pregnancy|0|||
170646502|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Pregnancy|0|||
170646503|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Protocol Violation|0|||
170646504|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Protocol Violation|0|||
170646505|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Protocol Violation|0|||
170646506|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Protocol Violation|3|||
170646507|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Protocol Violation|0|||
170646508|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Withdrawal by Participant|0|||
170646509|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Withdrawal by Participant|14|||
170566279|NCT00461708|616420478|FG000|Overall Study|Adverse Event|17|||
170566280|NCT00461708|616420479|FG001|Overall Study|Adverse Event|7|||
170566281|NCT00461708|616420478|FG000|Overall Study|Lack of Efficacy|68|||
170566282|NCT00461708|616420479|FG001|Overall Study|Lack of Efficacy|20|||
170566283|NCT00461708|616420478|FG000|Overall Study|Physician Decision|10|||
170566284|NCT00461708|616420479|FG001|Overall Study|Physician Decision|4|||
170566285|NCT00461708|616420478|FG000|Overall Study|Withdrawal by Subject|8|||
170566286|NCT00461708|616420479|FG001|Overall Study|Withdrawal by Subject|2|||
170566287|NCT00461708|616420478|FG000|Overall Study|Other|4|||
170566288|NCT00461708|616420479|FG001|Overall Study|Other|4|||
170566289|NCT00461708|616420478|FG000|Overall Study|Death|8|||
170566290|NCT00461708|616420479|FG001|Overall Study|Death|1|||
170566291|NCT02394561|616420480|FG000|CORE Phase|Adverse Event|7|||
170566292|NCT02394561|616420481|FG001|CORE Phase|Adverse Event|9|||
170566293|NCT02394561|616420480|FG000|CORE Phase|Death|0|||
170566294|NCT02394561|616420481|FG001|CORE Phase|Death|1|||
170566295|NCT02394561|616420480|FG000|CORE Phase|Pregnancy|1|||
170566296|NCT02394561|616420481|FG001|CORE Phase|Pregnancy|0|||
170566297|NCT02394561|616420480|FG000|CORE Phase|Lost to Follow-up|1|||
170566298|NCT02394561|616420481|FG001|CORE Phase|Lost to Follow-up|0|||
170566299|NCT02394561|616420480|FG000|CORE Phase|Physician Decision|1|||
170566300|NCT02394561|616420481|FG001|CORE Phase|Physician Decision|1|||
170566301|NCT02394561|616420480|FG000|CORE Phase|Withdrawal by Subject|2|||
170566302|NCT02394561|616420481|FG001|CORE Phase|Withdrawal by Subject|2|||
170566303|NCT02394561|616420480|FG000|CORE Phase|Lack of Efficacy|1|||
170566304|NCT02394561|616420481|FG001|CORE Phase|Lack of Efficacy|6|||
170566305|NCT02394561|616420480|FG000|Extension Phase|Adverse Event|6|||
170566306|NCT02394561|616420481|FG001|Extension Phase|Adverse Event|1|||
170566307|NCT02394561|616420480|FG000|Extension Phase|Death|0|||
170566308|NCT02394561|616420481|FG001|Extension Phase|Death|1|||
170566309|NCT02394561|616420480|FG000|Extension Phase|Protocol Violation|1|||
170566310|NCT02394561|616420481|FG001|Extension Phase|Protocol Violation|0|||
170566311|NCT02394561|616420480|FG000|Extension Phase|Lost to Follow-up|1|||
170566312|NCT02394561|616420481|FG001|Extension Phase|Lost to Follow-up|0|||
170566313|NCT02394561|616420480|FG000|Extension Phase|Physician Decision|0|||
170566314|NCT02394561|616420481|FG001|Extension Phase|Physician Decision|2|||
170566315|NCT02394561|616420480|FG000|Extension Phase|Withdrawal by Subject|0|||
170566316|NCT02394561|616420481|FG001|Extension Phase|Withdrawal by Subject|5|||
170566317|NCT02394561|616420480|FG000|Extension Phase|Lack of Efficacy|3|||
170906597|NCT02128490|617662418|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
170906598|NCT02128490|617662419|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
170906599|NCT02128490|617662415|FG000|Overall Study|Major Protocol Deviation|1|||
170906600|NCT02128490|617662416|FG001|Overall Study|Major Protocol Deviation|2|||
170906601|NCT02128490|617662417|FG002|Overall Study|Major Protocol Deviation|0|||
170906602|NCT02128490|617662418|FG003|Overall Study|Major Protocol Deviation|2|||
170906603|NCT02128490|617662419|FG004|Overall Study|Major Protocol Deviation|2|||
170906604|NCT02128490|617662415|FG000|Overall Study|Lost to Follow-up|0|||
170906605|NCT02128490|617662416|FG001|Overall Study|Lost to Follow-up|0|||
170906606|NCT02128490|617662417|FG002|Overall Study|Lost to Follow-up|1|||
170906607|NCT02128490|617662418|FG003|Overall Study|Lost to Follow-up|1|||
170906608|NCT02128490|617662419|FG004|Overall Study|Lost to Follow-up|1|||
170906609|NCT02128490|617662415|FG000|Overall Study|Voluntary Withdrawal|3|||
170906610|NCT02128490|617662416|FG001|Overall Study|Voluntary Withdrawal|3|||
170906611|NCT02128490|617662417|FG002|Overall Study|Voluntary Withdrawal|1|||
170906612|NCT02128490|617662418|FG003|Overall Study|Voluntary Withdrawal|1|||
170906613|NCT02128490|617662419|FG004|Overall Study|Voluntary Withdrawal|2|||
170906614|NCT02128490|617662415|FG000|Overall Study|Lack of Efficacy|0|||
170566318|NCT02394561|616420481|FG001|Extension Phase|Lack of Efficacy|3|||
170906615|NCT02128490|617662416|FG001|Overall Study|Lack of Efficacy|1|||
170566319|NCT00501644|616420482|FG000|Overall Study|Adverse Event|4|||
170566320|NCT00501644|616420482|FG000|Overall Study|Withdrawal by Subject|1|||
170566321|NCT02553629|616420483|FG000|Overall Study|Logistic reasons|3|||
170906616|NCT02128490|617662417|FG002|Overall Study|Lack of Efficacy|0|||
170906617|NCT02128490|617662418|FG003|Overall Study|Lack of Efficacy|0|||
170906618|NCT02128490|617662419|FG004|Overall Study|Lack of Efficacy|0|||
170906619|NCT02128490|617662415|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
170906620|NCT02128490|617662416|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
170906621|NCT02128490|617662417|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
170906622|NCT02128490|617662418|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
170906623|NCT02128490|617662419|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
170906624|NCT02128490|617662415|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170906625|NCT02128490|617662416|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170906626|NCT02128490|617662417|FG002|Overall Study|Other Miscellaneous Reasons|2|||
170906627|NCT02128490|617662418|FG003|Overall Study|Other Miscellaneous Reasons|1|||
170906628|NCT02128490|617662419|FG004|Overall Study|Other Miscellaneous Reasons|1|||
170906629|NCT02243176|617662420|FG000|Overall Study|Other reason|1|||
170906630|NCT02243176|617662421|FG001|Overall Study|Other reason|2|||
170906631|NCT02243176|617662420|FG000|Overall Study|protocol specified withdrawal critera|1|||
170906632|NCT02243176|617662421|FG001|Overall Study|protocol specified withdrawal critera|3|||
170906633|NCT02243176|617662420|FG000|Overall Study|Protocol Violation|2|||
170906634|NCT02243176|617662421|FG001|Overall Study|Protocol Violation|1|||
170906635|NCT02243176|617662420|FG000|Overall Study|Withdrawal by Subject|8|||
170906636|NCT02243176|617662421|FG001|Overall Study|Withdrawal by Subject|7|||
170906637|NCT02243176|617662420|FG000|Overall Study|Adverse Event|2|||
170906638|NCT02243176|617662421|FG001|Overall Study|Adverse Event|2|||
170906639|NCT03311126|617662425|FG000|Induction|Death|1|||
170906640|NCT03311126|617662425|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
170906641|NCT03716726|617662426|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
170906642|NCT03716726|617662427|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
170906643|NCT03716726|617662426|FG000|12 Months Followup|Lost to Follow-up|10|||
170906644|NCT03716726|617662427|FG001|12 Months Followup|Lost to Follow-up|17|||
170906645|NCT03523585|617662429|FG000|Overall Study|Progressive Disease|174|||
170906646|NCT03523585|617662430|FG001|Overall Study|Progressive Disease|64|||
170906647|NCT03523585|617662431|FG002|Overall Study|Progressive Disease|77|||
170906648|NCT03523585|617662429|FG000|Overall Study|Adverse Event|74|||
170906649|NCT03523585|617662430|FG001|Overall Study|Adverse Event|5|||
170906650|NCT03523585|617662431|FG002|Overall Study|Adverse Event|9|||
170906651|NCT03523585|617662429|FG000|Overall Study|Withdrawal by Subject|30|||
170906652|NCT03523585|617662430|FG001|Overall Study|Withdrawal by Subject|11|||
170906653|NCT03523585|617662431|FG002|Overall Study|Withdrawal by Subject|6|||
170906654|NCT03523585|617662429|FG000|Overall Study|Clinical Progression|23|||
170906655|NCT03523585|617662430|FG001|Overall Study|Clinical Progression|5|||
170906656|NCT03523585|617662431|FG002|Overall Study|Clinical Progression|10|||
170906657|NCT03523585|617662429|FG000|Overall Study|Death|4|||
170906658|NCT03523585|617662430|FG001|Overall Study|Death|0|||
170906659|NCT03523585|617662431|FG002|Overall Study|Death|1|||
170906660|NCT03523585|617662429|FG000|Overall Study|Physician Decision|2|||
170906661|NCT03523585|617662430|FG001|Overall Study|Physician Decision|1|||
170906662|NCT03523585|617662431|FG002|Overall Study|Physician Decision|0|||
170906663|NCT03523585|617662429|FG000|Overall Study|Lost to Follow-up|1|||
170906664|NCT03523585|617662430|FG001|Overall Study|Lost to Follow-up|0|||
170906665|NCT03523585|617662431|FG002|Overall Study|Lost to Follow-up|0|||
170906666|NCT03523585|617662429|FG000|Overall Study|Miscellaneous|1|||
170906667|NCT03523585|617662430|FG001|Overall Study|Miscellaneous|0|||
170906668|NCT03523585|617662431|FG002|Overall Study|Miscellaneous|0|||
170906669|NCT03523585|617662429|FG000|Overall Study|Protocol Deviation|1|||
170906670|NCT03523585|617662430|FG001|Overall Study|Protocol Deviation|0|||
170906671|NCT03523585|617662431|FG002|Overall Study|Protocol Deviation|1|||
170906672|NCT03523585|617662429|FG000|Overall Study|Randomized But Not Treated|2|||
170906673|NCT03523585|617662430|FG001|Overall Study|Randomized But Not Treated|4|||
170906674|NCT03523585|617662431|FG002|Overall Study|Randomized But Not Treated|3|||
170906675|NCT01473004|617662432|FG000|Overall Study|Incomplete Lobar Treatment|1|||
170906676|NCT01473004|617662433|FG001|Overall Study|Incomplete Lobar Treatment|0|||
170906677|NCT00698516|617662434|FG000|Overall Study|Study Termination|2|||
170906678|NCT00698516|617662434|FG000|Overall Study|Withdrawal by Subject|3|||
170906679|NCT05882890|617662435|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
170566322|NCT02553629|616420484|FG001|Overall Study|Logistic reasons|6|||
170566323|NCT04436744|616420489|FG000|Overall Study|Adverse Event|1|||
170906680|NCT00541307|617662439|FG000|Overall Study|Death|5|||
170906681|NCT00541307|617662439|FG000|Overall Study|Physician Decision|3|||
170906682|NCT00541307|617662439|FG000|Overall Study|Withdrawal by Subject|6|||
170906683|NCT00541307|617662439|FG000|Overall Study|Lost to Follow-up|4|||
170566324|NCT04436744|616420490|FG001|Overall Study|Adverse Event|1|||
170566325|NCT04436744|616420489|FG000|Overall Study|Death|1|||
170906684|NCT00541307|617662439|FG000|Overall Study|Subject returned early (outside window)|1|||
170566326|NCT04436744|616420490|FG001|Overall Study|Death|0|||
170906685|NCT00541307|617662439|FG000|Overall Study|Surgical Bypass|5|||
170906686|NCT04329949|617662442|FG000|Overall Study|Death|36|||
170906687|NCT04329949|617662442|FG000|Overall Study|Withdrawal by Subject|4|||
170646510|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Withdrawal by Participant|8|||
170646511|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Withdrawal by Participant|11|||
170646512|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Withdrawal by Participant|4|||
170646513|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Withdrawal by Caregiver|0|||
170566327|NCT04436744|616420489|FG000|Overall Study|Lost to Follow-up|0|||
170566328|NCT04436744|616420490|FG001|Overall Study|Lost to Follow-up|2|||
170566329|NCT04436744|616420489|FG000|Overall Study|Physician Decision|0|||
170566330|NCT04436744|616420490|FG001|Overall Study|Physician Decision|1|||
170566331|NCT04436744|616420489|FG000|Overall Study|Progressive Disease|0|||
170566332|NCT04436744|616420490|FG001|Overall Study|Progressive Disease|4|||
170566333|NCT04436744|616420489|FG000|Overall Study|Protocol Deviation|1|||
170566334|NCT04436744|616420490|FG001|Overall Study|Protocol Deviation|1|||
170566335|NCT04436744|616420489|FG000|Overall Study|Withdrawal by Subject|1|||
170566336|NCT04436744|616420490|FG001|Overall Study|Withdrawal by Subject|2|||
170566337|NCT01378117|616420491|FG000|Overall Study|withdrawal|2|||
170566338|NCT01378117|616420492|FG001|Overall Study|withdrawal|1|||
170566339|NCT01378117|616420493|FG002|Overall Study|withdrawal|2|||
170566340|NCT01378117|616420491|FG000|Overall Study|discharged before med given|2|||
170566341|NCT01378117|616420492|FG001|Overall Study|discharged before med given|0|||
170566342|NCT01378117|616420493|FG002|Overall Study|discharged before med given|1|||
170566343|NCT02961244|616420494|FG000|Overall Study|Protocol Violation|0|||
170566344|NCT02961244|616420495|FG001|Overall Study|Protocol Violation|1|||
170566345|NCT02961244|616420494|FG000|Overall Study|Withdrawal by Subject|1|||
170566346|NCT02961244|616420495|FG001|Overall Study|Withdrawal by Subject|2|||
170566347|NCT02961244|616420494|FG000|Overall Study|Surgery plan change after study approval|0|||
170566348|NCT02961244|616420495|FG001|Overall Study|Surgery plan change after study approval|2|||
170566349|NCT02961244|616420494|FG000|Overall Study|Lost to Follow-up|0|||
170566350|NCT02961244|616420495|FG001|Overall Study|Lost to Follow-up|2|||
170566351|NCT02961244|616420494|FG000|Overall Study|İnadequate data|0|||
170566352|NCT02961244|616420495|FG001|Overall Study|İnadequate data|2|||
170566353|NCT03383666|616420499|FG000|Overall Study|Withdrawal by Subject|2|||
170566354|NCT03383666|616420499|FG000|Overall Study|Lost to Follow-up|2|||
170566355|NCT01240863|616420505|FG000|Open-label Titration Period|Adverse Event|47|||
170566356|NCT01240863|616420506|FG001|Open-label Titration Period|Adverse Event|0|||
170566357|NCT01240863|616420507|FG002|Open-label Titration Period|Adverse Event|0|||
170566358|NCT01240863|616420505|FG000|Open-label Titration Period|Lack of Efficacy|19|||
170566359|NCT01240863|616420506|FG001|Open-label Titration Period|Lack of Efficacy|0|||
170566360|NCT01240863|616420507|FG002|Open-label Titration Period|Lack of Efficacy|0|||
170566361|NCT01240863|616420505|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
170566362|NCT01240863|616420506|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
170566363|NCT01240863|616420507|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
170566364|NCT01240863|616420505|FG000|Open-label Titration Period|Protocol Violation|7|||
170566365|NCT01240863|616420506|FG001|Open-label Titration Period|Protocol Violation|0|||
170566366|NCT01240863|616420507|FG002|Open-label Titration Period|Protocol Violation|0|||
170566367|NCT01240863|616420505|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
170566368|NCT01240863|616420506|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
170566369|NCT01240863|616420507|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
170566370|NCT01240863|616420505|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
170566371|NCT01240863|616420506|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
170566372|NCT01240863|616420507|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
170566373|NCT01240863|616420505|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
170566374|NCT01240863|616420506|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
170566375|NCT01240863|616420507|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
170566376|NCT01240863|616420505|FG000|Open-label Titration Period|Other|7|||
170566377|NCT01240863|616420506|FG001|Open-label Titration Period|Other|0|||
170566378|NCT01240863|616420507|FG002|Open-label Titration Period|Other|0|||
170566379|NCT01240863|616420505|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
170566380|NCT01240863|616420506|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
170566381|NCT01240863|616420507|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
170566382|NCT01240863|616420505|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
170566383|NCT01240863|616420506|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
170566384|NCT01240863|616420507|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
170566385|NCT01240863|616420505|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170566386|NCT01240863|616420506|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
170566387|NCT01240863|616420507|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
170566388|NCT01240863|616420505|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
170646514|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Withdrawal by Caregiver|10|||
170807087|NCT00670488|617303689|FG009|Overall Study|Adverse Event|1|||
170566389|NCT01240863|616420506|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
170566390|NCT01240863|616420507|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
170566391|NCT01240863|616420505|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
170646515|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Withdrawal by Caregiver|5|||
170646516|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Withdrawal by Caregiver|11|||
170646517|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Withdrawal by Caregiver|1|||
170646518|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Physician Decision|0|||
170646519|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Physician Decision|0|||
170646520|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Physician Decision|2|||
170646521|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Physician Decision|0|||
170646522|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Physician Decision|0|||
170646523|NCT03238326|616718935|FG000|Open-label Period (About 25 Months)|Reason Not Specified|0|||
170646524|NCT03238326|616718936|FG001|Open-label Period (About 25 Months)|Reason Not Specified|2|||
170646525|NCT03238326|616718937|FG002|Open-label Period (About 25 Months)|Reason Not Specified|3|||
170646526|NCT03238326|616718938|FG003|Open-label Period (About 25 Months)|Reason Not Specified|4|||
170646527|NCT03238326|616718939|FG004|Open-label Period (About 25 Months)|Reason Not Specified|1|||
170646528|NCT04166734|616718940|FG000|Overall Study|Lack of Efficacy|2|||
170646529|NCT04166734|616718941|FG001|Overall Study|Lack of Efficacy|0|||
170646530|NCT04166734|616718940|FG000|Overall Study|Adverse Event|1|||
170646531|NCT04166734|616718941|FG001|Overall Study|Adverse Event|0|||
170646532|NCT04166734|616718940|FG000|Overall Study|Intercurrent illness|1|||
170646533|NCT04166734|616718941|FG001|Overall Study|Intercurrent illness|0|||
170646534|NCT04166734|616718940|FG000|Overall Study|Other|1|||
170646535|NCT04166734|616718941|FG001|Overall Study|Other|0|||
170646536|NCT06634797|616718942|FG000|Overall Study|Other Than Specified|1|||
170646537|NCT06634797|616718943|FG001|Overall Study|Other Than Specified|1|||
170646538|NCT06634797|616718942|FG000|Overall Study|Withdrawal by Subject|12|||
170646539|NCT06634797|616718943|FG001|Overall Study|Withdrawal by Subject|21|||
170646540|NCT06634797|616718942|FG000|Overall Study|Physician Decision|3|||
170646541|NCT06634797|616718943|FG001|Overall Study|Physician Decision|3|||
170646542|NCT06634797|616718942|FG000|Overall Study|Lost to Follow-up|46|||
170646543|NCT06634797|616718943|FG001|Overall Study|Lost to Follow-up|48|||
170646544|NCT06634797|616718942|FG000|Overall Study|Adverse Event|0|||
170646545|NCT06634797|616718943|FG001|Overall Study|Adverse Event|1|||
170646546|NCT06634797|616718942|FG000|Overall Study|Screen Failure|0|||
170646547|NCT06634797|616718943|FG001|Overall Study|Screen Failure|2|||
170646548|NCT05052996|616718946|FG000|Overall Study|Still on study|0|||
170646549|NCT05052996|616718947|FG001|Overall Study|Still on study|0|||
170646550|NCT05052996|616718948|FG002|Overall Study|Still on study|47|||
170646551|NCT05052996|616718949|FG003|Overall Study|Still on study|44|||
170646552|NCT05052996|616718946|FG000|Overall Study|Cohort terminated by sponsor|21|||
170646553|NCT05052996|616718947|FG001|Overall Study|Cohort terminated by sponsor|12|||
170646554|NCT05052996|616718948|FG002|Overall Study|Cohort terminated by sponsor|0|||
170646555|NCT05052996|616718949|FG003|Overall Study|Cohort terminated by sponsor|0|||
170646556|NCT05052996|616718946|FG000|Overall Study|Withdrew consent|1|||
170646557|NCT05052996|616718947|FG001|Overall Study|Withdrew consent|0|||
170646558|NCT05052996|616718948|FG002|Overall Study|Withdrew consent|1|||
170646559|NCT05052996|616718949|FG003|Overall Study|Withdrew consent|2|||
170646560|NCT05052996|616718946|FG000|Overall Study|Lost to Follow-up|1|||
170646561|NCT05052996|616718947|FG001|Overall Study|Lost to Follow-up|0|||
170646562|NCT05052996|616718948|FG002|Overall Study|Lost to Follow-up|0|||
170646563|NCT05052996|616718949|FG003|Overall Study|Lost to Follow-up|2|||
170646564|NCT05052996|616718946|FG000|Overall Study|Adverse Event|0|||
170646565|NCT05052996|616718947|FG001|Overall Study|Adverse Event|0|||
170646566|NCT05052996|616718948|FG002|Overall Study|Adverse Event|2|||
170646567|NCT05052996|616718949|FG003|Overall Study|Adverse Event|0|||
170646568|NCT05052996|616718946|FG000|Overall Study|Randomized but never treated|0|||
170646569|NCT05052996|616718947|FG001|Overall Study|Randomized but never treated|0|||
170646570|NCT05052996|616718948|FG002|Overall Study|Randomized but never treated|1|||
170646571|NCT05052996|616718949|FG003|Overall Study|Randomized but never treated|1|||
170646572|NCT05052996|616718946|FG000|Overall Study|Protocol Violation|1|||
170646573|NCT05052996|616718947|FG001|Overall Study|Protocol Violation|0|||
170646574|NCT05052996|616718948|FG002|Overall Study|Protocol Violation|0|||
170646575|NCT05052996|616718949|FG003|Overall Study|Protocol Violation|0|||
170646576|NCT04385303|616718950|FG000|Overall Study|Adverse Event|1|||
170646577|NCT04385303|616718951|FG001|Overall Study|Adverse Event|1|||
170646578|NCT04385303|616718950|FG000|Overall Study|Death|1|||
170646579|NCT04385303|616718951|FG001|Overall Study|Death|0|||
170646580|NCT04385303|616718950|FG000|Overall Study|Lack of Efficacy|3|||
170646581|NCT04385303|616718951|FG001|Overall Study|Lack of Efficacy|6|||
170646582|NCT04385303|616718950|FG000|Overall Study|Lost to Follow-up|3|||
170646583|NCT04385303|616718951|FG001|Overall Study|Lost to Follow-up|5|||
170646584|NCT04385303|616718950|FG000|Overall Study|Subject Non-Compliance|1|||
170646585|NCT04385303|616718951|FG001|Overall Study|Subject Non-Compliance|1|||
170646586|NCT04385303|616718950|FG000|Overall Study|Withdrawal by Subject|9|||
170646587|NCT04385303|616718951|FG001|Overall Study|Withdrawal by Subject|8|||
170646588|NCT04385303|616718950|FG000|Overall Study|Duplicate Subject|2|||
170646589|NCT04385303|616718951|FG001|Overall Study|Duplicate Subject|1|||
170646590|NCT01781299|616718952|FG000|Overall Study|Withdrawal by Subject|0|||
170646591|NCT01781299|616718953|FG001|Overall Study|Withdrawal by Subject|1|||
170646592|NCT00146848|616718954|FG000|Pre-randomization|Death|19|||
170646593|NCT00146848|616718955|FG001|Pre-randomization|Death|0|||
170646594|NCT00146848|616718956|FG002|Pre-randomization|Death|0|||
170646595|NCT00146848|616718954|FG000|Pre-randomization|Lost to Follow-up|70|||
170646596|NCT00146848|616718955|FG001|Pre-randomization|Lost to Follow-up|0|||
170646597|NCT00146848|616718956|FG002|Pre-randomization|Lost to Follow-up|0|||
170646598|NCT00146848|616718954|FG000|Pre-randomization|Physician Decision|8|||
170646599|NCT00146848|616718955|FG001|Pre-randomization|Physician Decision|0|||
170646600|NCT00146848|616718956|FG002|Pre-randomization|Physician Decision|0|||
170906688|NCT04329949|617662442|FG000|Overall Study|Termination of study by sponsor|3|||
170906689|NCT01845025|617662449|FG000|Overall Study|Adverse Event|6|||
170906690|NCT01845025|617662450|FG001|Overall Study|Adverse Event|3|||
170906691|NCT01845025|617662449|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170906692|NCT01845025|617662450|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170906693|NCT01845025|617662449|FG000|Overall Study|Withdrawal by Subject|48|||
170906694|NCT01845025|617662450|FG001|Overall Study|Withdrawal by Subject|44|||
170906695|NCT01845025|617662449|FG000|Overall Study|Lost to Follow-up|13|||
170906696|NCT01845025|617662450|FG001|Overall Study|Lost to Follow-up|13|||
170906697|NCT01845025|617662449|FG000|Overall Study|Administrative problems|8|||
170906698|NCT01845025|617662450|FG001|Overall Study|Administrative problems|8|||
170906699|NCT01845025|617662449|FG000|Overall Study|Death|2|||
170906700|NCT01845025|617662450|FG001|Overall Study|Death|0|||
170906701|NCT01845025|617662449|FG000|Overall Study|Protocol deviation|3|||
170906702|NCT01845025|617662450|FG001|Overall Study|Protocol deviation|6|||
170906703|NCT01845025|617662449|FG000|Overall Study|Missing|1|||
170906704|NCT01845025|617662450|FG001|Overall Study|Missing|1|||
170906705|NCT04645797|617662451|FG000|Overall Study|Disease Progression|3|||
170906706|NCT04645797|617662452|FG001|Overall Study|Disease Progression|3|||
170906707|NCT04645797|617662453|FG002|Overall Study|Disease Progression|1|||
170906708|NCT04645797|617662454|FG003|Overall Study|Disease Progression|0|||
170906709|NCT04645797|617662455|FG004|Overall Study|Disease Progression|0|||
170906710|NCT04645797|617662456|FG005|Overall Study|Disease Progression|0|||
170906711|NCT04645797|617662457|FG006|Overall Study|Disease Progression|0|||
170906712|NCT04645797|617662451|FG000|Overall Study|Death|3|||
170906713|NCT04645797|617662452|FG001|Overall Study|Death|1|||
170906714|NCT04645797|617662453|FG002|Overall Study|Death|0|||
170906715|NCT04645797|617662454|FG003|Overall Study|Death|0|||
170906716|NCT04645797|617662455|FG004|Overall Study|Death|0|||
170906717|NCT04645797|617662456|FG005|Overall Study|Death|0|||
170906718|NCT04645797|617662457|FG006|Overall Study|Death|0|||
170906719|NCT00345605|617662460|FG000|Arm 1|Adverse Event|0|||
170906720|NCT00345605|617662461|FG001|Arm 1|Adverse Event|1|||
170906721|NCT00345605|617662460|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
170906722|NCT00345605|617662461|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
170906723|NCT00500071|617662474|FG000|Screening and Washout Phase|Protocol Violation|1|||
170906724|NCT00500071|617662474|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
170906725|NCT00500071|617662474|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
170906726|NCT00500071|617662474|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
170906727|NCT00500071|617662474|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
170906728|NCT00500071|617662474|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
170906729|NCT00500071|617662474|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
170906730|NCT03596164|617662475|FG000|Overall Study|Adverse Event|0|||
170906731|NCT03596164|617662476|FG001|Overall Study|Adverse Event|1|||
170906732|NCT03596164|617662475|FG000|Overall Study|Death|1|||
170906733|NCT03596164|617662476|FG001|Overall Study|Death|0|||
170906734|NCT04112914|617662477|FG000|Overall Study|Lost to Follow-up|13|||
170906735|NCT04112914|617662478|FG001|Overall Study|Lost to Follow-up|9|||
170646601|NCT00146848|616718954|FG000|Pre-randomization|Protocol Violation|172|||
170646602|NCT00146848|616718955|FG001|Pre-randomization|Protocol Violation|0|||
170646603|NCT00146848|616718956|FG002|Pre-randomization|Protocol Violation|0|||
170646604|NCT00146848|616718954|FG000|Pre-randomization|Withdrawal by Subject|40|||
170906736|NCT04112914|617662477|FG000|Overall Study|Withdrawal by Subject|1|||
170906737|NCT04112914|617662478|FG001|Overall Study|Withdrawal by Subject|0|||
170646605|NCT00146848|616718955|FG001|Pre-randomization|Withdrawal by Subject|0|||
170646606|NCT00146848|616718956|FG002|Pre-randomization|Withdrawal by Subject|0|||
170906738|NCT02635204|617662486|FG000|Overall Study|Adverse Event|1|||
170906739|NCT02635204|617662487|FG001|Overall Study|Adverse Event|0|||
170906740|NCT02635204|617662486|FG000|Overall Study|Lost to Follow-up|1|||
170906741|NCT02635204|617662487|FG001|Overall Study|Lost to Follow-up|1|||
170906742|NCT01244737|617662488|FG000|Overall Study|Physician Decision|2|||
170906743|NCT01244737|617662489|FG001|Overall Study|Physician Decision|18|||
170906744|NCT01244737|617662490|FG002|Overall Study|Physician Decision|5|||
170906745|NCT01244737|617662488|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
170646607|NCT00146848|616718954|FG000|Post-randomization|Lost to Follow-up|12|||
170646608|NCT00146848|616718955|FG001|Post-randomization|Lost to Follow-up|15|||
170646609|NCT00146848|616718956|FG002|Post-randomization|Lost to Follow-up|12|||
170646610|NCT00146848|616718954|FG000|Post-randomization|Withdrawn|26|||
170646611|NCT00146848|616718955|FG001|Post-randomization|Withdrawn|32|||
170646612|NCT00146848|616718956|FG002|Post-randomization|Withdrawn|27|||
170646613|NCT00475982|616718957|FG000|Overall Study|surgery rescheduled|7|||
170646614|NCT00475982|616718958|FG001|Overall Study|surgery rescheduled|3|||
170646615|NCT01105767|616718959|FG000|Overall Study|Lost to Follow-up|1160|||
170646616|NCT01105767|616718960|FG001|Overall Study|Lost to Follow-up|1614|||
170646617|NCT01105767|616718961|FG002|Overall Study|Lost to Follow-up|1184|||
170646618|NCT00743106|616718962|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
170646619|NCT00743106|616718963|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
170646620|NCT02410343|616718968|FG000|Core Period (24 Weeks)|Adverse Event|1|||
170646621|NCT02410343|616718969|FG001|Core Period (24 Weeks)|Adverse Event|0|||
170646622|NCT02410343|616718968|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
170646623|NCT02410343|616718969|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
170646624|NCT02410343|616718968|FG000|Extension Period (12 Months)|Adverse Event|1|||
170646625|NCT02410343|616718969|FG001|Extension Period (12 Months)|Adverse Event|0|||
170646626|NCT02410343|616718968|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
170646627|NCT02410343|616718969|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
170646628|NCT00783198|616718970|FG000|Overall Study|Adverse Event|15|||
170646629|NCT00783198|616718971|FG001|Overall Study|Adverse Event|19|||
170807088|NCT00670488|617303680|FG000|Overall Study|Physician Decision|1|||
170807089|NCT00670488|617303681|FG001|Overall Study|Physician Decision|9|||
170566392|NCT01240863|616420506|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
170566393|NCT01240863|616420507|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
170566394|NCT01240863|616420505|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
170566395|NCT01240863|616420506|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
170566396|NCT01240863|616420507|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
170566397|NCT01240863|616420505|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
170566398|NCT01240863|616420506|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
170566399|NCT01240863|616420507|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
170566400|NCT01240863|616420505|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
170566401|NCT01240863|616420506|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
170566402|NCT01240863|616420507|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
170566403|NCT02297412|616420508|FG000|Overall Study|Canceled|1|||
170566404|NCT02297412|616420509|FG001|Overall Study|Canceled|1|||
170566405|NCT01355627|616420510|FG000|Overall Study|Request By the Patient to Discontinue|5|||
170566406|NCT01355627|616420511|FG001|Overall Study|Request By the Patient to Discontinue|7|||
170566407|NCT01355627|616420510|FG000|Overall Study|Lost to Follow-up|8|||
170566408|NCT01355627|616420511|FG001|Overall Study|Lost to Follow-up|7|||
170566409|NCT01355627|616420510|FG000|Overall Study|Fatal Adverse Event|19|||
170566410|NCT01355627|616420511|FG001|Overall Study|Fatal Adverse Event|23|||
170566411|NCT01355627|616420510|FG000|Overall Study|Other|1|||
170566412|NCT01355627|616420511|FG001|Overall Study|Other|1|||
170566413|NCT01729039|616420516|FG000|Overall Study|disqualified|2|||
170566414|NCT01729039|616420517|FG001|Overall Study|disqualified|5|||
170566415|NCT01729039|616420516|FG000|Overall Study|Withdrawal by Subject|8|||
170566416|NCT01729039|616420517|FG001|Overall Study|Withdrawal by Subject|7|||
170566417|NCT04646005|616420518|FG000|Overall Study|Adverse Event|1|||
170566418|NCT04646005|616420518|FG000|Overall Study|Progressive Disease|71|||
170566419|NCT04646005|616420518|FG000|Overall Study|Death|20|||
170566420|NCT04646005|616420518|FG000|Overall Study|Withdrawal by Subject|12|||
170566421|NCT04646005|616420518|FG000|Overall Study|Sponsor Request|9|||
170566422|NCT01492426|616422017|FG000|Treatment|Death|0|||
170566423|NCT01492426|616422018|FG001|Treatment|Death|1|||
170566424|NCT01492426|616422017|FG000|Treatment|Other|1|||
170566425|NCT01492426|616422018|FG001|Treatment|Other|0|||
170566426|NCT01492426|616422017|FG000|Treatment|Adverse Event|25|||
170566427|NCT01492426|616422018|FG001|Treatment|Adverse Event|25|||
170566428|NCT01492426|616422017|FG000|Treatment|Lack of Efficacy|38|||
170566429|NCT01492426|616422018|FG001|Treatment|Lack of Efficacy|5|||
170566430|NCT01492426|616422017|FG000|Treatment|Participant withdrew consent|1|||
170566431|NCT01492426|616422018|FG001|Treatment|Participant withdrew consent|2|||
170566432|NCT01492426|616422017|FG000|Treatment|Poor compliance/noncompliance|1|||
170566433|NCT01492426|616422018|FG001|Treatment|Poor compliance/noncompliance|0|||
170566434|NCT01492426|616422017|FG000|Treatment|Subject requested discontinue study drug|7|||
170807090|NCT00670488|617303682|FG002|Overall Study|Physician Decision|0|||
170566435|NCT01492426|616422018|FG001|Treatment|Subject requested discontinue study drug|3|||
170646630|NCT00783198|616718972|FG002|Overall Study|Adverse Event|3|||
170807091|NCT00670488|617303683|FG003|Overall Study|Physician Decision|1|||
170807092|NCT00670488|617303684|FG004|Overall Study|Physician Decision|0|||
170646631|NCT00783198|616718970|FG000|Overall Study|Lost to Follow-up|11|||
170566436|NCT01492426|616422017|FG000|Treatment|Lost to Follow-up|9|||
170646632|NCT00783198|616718971|FG001|Overall Study|Lost to Follow-up|1|||
170646633|NCT00783198|616718972|FG002|Overall Study|Lost to Follow-up|7|||
170807093|NCT00670488|617303685|FG005|Overall Study|Physician Decision|0|||
170906746|NCT01244737|617662489|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
170906747|NCT01244737|617662490|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
170906748|NCT01244737|617662488|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
170646634|NCT00783198|616718970|FG000|Overall Study|Withdrawal by Subject|22|||
170646635|NCT00783198|616718971|FG001|Overall Study|Withdrawal by Subject|14|||
170646636|NCT00783198|616718972|FG002|Overall Study|Withdrawal by Subject|20|||
170646637|NCT00783198|616718970|FG000|Overall Study|Noncompliance with protocol|7|||
170906749|NCT01244737|617662489|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
170906750|NCT01244737|617662490|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
170906751|NCT01244737|617662488|FG000|Overall Study|MIB immunopathology results not available|3|||
170906752|NCT01244737|617662489|FG001|Overall Study|MIB immunopathology results not available|2|||
170906753|NCT01244737|617662490|FG002|Overall Study|MIB immunopathology results not available|0|||
170906754|NCT01244737|617662488|FG000|Overall Study|PET data failure|0|||
170906755|NCT01244737|617662489|FG001|Overall Study|PET data failure|1|||
170906756|NCT01244737|617662490|FG002|Overall Study|PET data failure|0|||
170906757|NCT01244737|617662488|FG000|Overall Study|Withdrawal by Subject|0|||
170906758|NCT01244737|617662489|FG001|Overall Study|Withdrawal by Subject|0|||
170906759|NCT01244737|617662490|FG002|Overall Study|Withdrawal by Subject|1|||
170906760|NCT00389207|617662491|FG000|Overall Study|Adverse Event|26|||
170906761|NCT00389207|617662492|FG001|Overall Study|Adverse Event|32|||
170906762|NCT00389207|617662493|FG002|Overall Study|Adverse Event|10|||
170906763|NCT00389207|617662491|FG000|Overall Study|Protocol Violation|3|||
170906764|NCT00389207|617662492|FG001|Overall Study|Protocol Violation|1|||
170906765|NCT00389207|617662493|FG002|Overall Study|Protocol Violation|4|||
170906766|NCT00389207|617662491|FG000|Overall Study|Lost to Follow-up|12|||
170906767|NCT00389207|617662492|FG001|Overall Study|Lost to Follow-up|9|||
170646638|NCT00783198|616718971|FG001|Overall Study|Noncompliance with protocol|7|||
170906768|NCT00389207|617662493|FG002|Overall Study|Lost to Follow-up|7|||
170906769|NCT00389207|617662491|FG000|Overall Study|Withdrawal by Subject|5|||
170906770|NCT00389207|617662492|FG001|Overall Study|Withdrawal by Subject|7|||
170906771|NCT00389207|617662493|FG002|Overall Study|Withdrawal by Subject|11|||
170906772|NCT00389207|617662491|FG000|Overall Study|Other|17|||
170906773|NCT00389207|617662492|FG001|Overall Study|Other|23|||
170906774|NCT00389207|617662493|FG002|Overall Study|Other|9|||
170906775|NCT02580058|617662496|FG000|Overall Study|Adverse Event|16|||
170906776|NCT02580058|617662497|FG001|Overall Study|Adverse Event|30|||
170906777|NCT02580058|617662498|FG002|Overall Study|Adverse Event|20|||
170906778|NCT02580058|617662496|FG000|Overall Study|Death|4|||
170906779|NCT02580058|617662497|FG001|Overall Study|Death|4|||
170906780|NCT02580058|617662498|FG002|Overall Study|Death|5|||
170906781|NCT02580058|617662496|FG000|Overall Study|Physician Decision|1|||
170906782|NCT02580058|617662497|FG001|Overall Study|Physician Decision|3|||
170906783|NCT02580058|617662498|FG002|Overall Study|Physician Decision|11|||
170906784|NCT02580058|617662496|FG000|Overall Study|Other|5|||
170906785|NCT02580058|617662497|FG001|Overall Study|Other|1|||
170906786|NCT02580058|617662498|FG002|Overall Study|Other|3|||
170906787|NCT02580058|617662496|FG000|Overall Study|Withdrawal by Subject|4|||
170906788|NCT02580058|617662497|FG001|Overall Study|Withdrawal by Subject|7|||
170906789|NCT02580058|617662498|FG002|Overall Study|Withdrawal by Subject|31|||
170906790|NCT02580058|617662496|FG000|Overall Study|Global Deterioration of Health Status|19|||
170906791|NCT02580058|617662497|FG001|Overall Study|Global Deterioration of Health Status|18|||
170906792|NCT02580058|617662498|FG002|Overall Study|Global Deterioration of Health Status|24|||
170906793|NCT02580058|617662496|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
170906794|NCT02580058|617662497|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170906795|NCT02580058|617662498|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
170906796|NCT02580058|617662496|FG000|Overall Study|Progressive Disease|137|||
170906797|NCT02580058|617662497|FG001|Overall Study|Progressive Disease|125|||
170646639|NCT00783198|616718972|FG002|Overall Study|Noncompliance with protocol|10|||
170646640|NCT00783198|616718970|FG000|Overall Study|Did not meet protocol eligibility|0|||
170906798|NCT02580058|617662498|FG002|Overall Study|Progressive Disease|94|||
170906799|NCT02580058|617662496|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170906800|NCT02580058|617662497|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170906801|NCT02580058|617662498|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170906802|NCT03486314|617662500|FG000|Part A|Adverse Event|1|||
170906803|NCT03486314|617662501|FG001|Part A|Adverse Event|0|||
170906804|NCT03486314|617662502|FG002|Part A|Adverse Event|0|||
170906805|NCT03486314|617662500|FG000|Part A|Symptomatic Deterioration|2|||
170906806|NCT03486314|617662501|FG001|Part A|Symptomatic Deterioration|0|||
170906807|NCT03486314|617662502|FG002|Part A|Symptomatic Deterioration|0|||
170906808|NCT01364467|617662503|FG000|Overall Study|Lost to Follow-up|1|||
170906809|NCT01364467|617662504|FG001|Overall Study|Lost to Follow-up|2|||
170906810|NCT03953118|617662507|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
170906811|NCT03953118|617662508|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
170906812|NCT05490771|617662509|FG000|Overall Study|Disease progression|18|||
170906813|NCT05490771|617662509|FG000|Overall Study|Adverse Event|3|||
170906814|NCT05490771|617662509|FG000|Overall Study|Other complicating disease|1|||
170906815|NCT05490771|617662509|FG000|Overall Study|Withdrawal by Subject|3|||
170906816|NCT05490771|617662509|FG000|Overall Study|Physician Decision|1|||
170906817|NCT05490771|617662509|FG000|Overall Study|Still on treatment|2|||
170906818|NCT05490771|617662509|FG000|Overall Study|Never start protocol therapy|5|||
170906819|NCT05490771|617662509|FG000|Overall Study|Ineligible|2|||
170906820|NCT00424398|617662513|FG000|Overall Study|Withdrawal by Subject|2|||
170906821|NCT00424398|617662514|FG001|Overall Study|Withdrawal by Subject|1|||
170906822|NCT00424398|617662515|FG002|Overall Study|Withdrawal by Subject|0|||
170906823|NCT00424398|617662513|FG000|Overall Study|Subject met exclusion criteria|1|||
170906824|NCT00424398|617662514|FG001|Overall Study|Subject met exclusion criteria|0|||
170906825|NCT00424398|617662515|FG002|Overall Study|Subject met exclusion criteria|0|||
170906826|NCT01442181|617662518|FG000|Overall Study|patient refused surgery|1|||
170906827|NCT01442181|617662519|FG001|Overall Study|patient refused surgery|0|||
170906828|NCT01442181|617662518|FG000|Overall Study|no insurance for surgery|1|||
170906829|NCT01442181|617662519|FG001|Overall Study|no insurance for surgery|0|||
170906830|NCT01442181|617662518|FG000|Overall Study|low ejection factor|0|||
170906831|NCT01442181|617662519|FG001|Overall Study|low ejection factor|1|||
170906832|NCT01442181|617662518|FG000|Overall Study|Lost to Follow-up|1|||
170906833|NCT01442181|617662519|FG001|Overall Study|Lost to Follow-up|1|||
170906834|NCT01442181|617662518|FG000|Overall Study|patient in an additional study|1|||
170906835|NCT01442181|617662519|FG001|Overall Study|patient in an additional study|0|||
170906836|NCT01442181|617662518|FG000|Overall Study|atrial fibrillation not noted|0|||
170906837|NCT01442181|617662519|FG001|Overall Study|atrial fibrillation not noted|1|||
170906838|NCT00246259|617662520|FG000|Overall Study|Other|3|||
170906839|NCT00246259|617662521|FG001|Overall Study|Other|3|||
170906840|NCT00246259|617662520|FG000|Overall Study|Not stable by Week 18|2|||
170906841|NCT00246259|617662521|FG001|Overall Study|Not stable by Week 18|1|||
170906842|NCT00246259|617662520|FG000|Overall Study|Participant non-compliant|4|||
170906843|NCT00246259|617662521|FG001|Overall Study|Participant non-compliant|9|||
170906844|NCT00246259|617662520|FG000|Overall Study|Lack of Efficacy|2|||
170906845|NCT00246259|617662521|FG001|Overall Study|Lack of Efficacy|2|||
170906846|NCT00246259|617662520|FG000|Overall Study|Investigator withdrew participant|2|||
170906847|NCT00246259|617662521|FG001|Overall Study|Investigator withdrew participant|0|||
170906848|NCT00246259|617662520|FG000|Overall Study|Adverse Event|5|||
170906849|NCT00246259|617662521|FG001|Overall Study|Adverse Event|0|||
170906850|NCT00246259|617662520|FG000|Overall Study|Lost to Follow-up|3|||
170906851|NCT00246259|617662521|FG001|Overall Study|Lost to Follow-up|4|||
170906852|NCT00246259|617662520|FG000|Overall Study|Withdrawal by Subject|5|||
170906853|NCT00246259|617662521|FG001|Overall Study|Withdrawal by Subject|1|||
170906854|NCT00246259|617662520|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
170906855|NCT00246259|617662521|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
170906856|NCT00855439|617662522|FG000|Overall Study|Withdrawal by Subject|2|||
170906857|NCT00855439|617662523|FG001|Overall Study|Withdrawal by Subject|0|||
170906858|NCT00855439|617662522|FG000|Overall Study|Pregnancy|1|||
170906859|NCT00855439|617662523|FG001|Overall Study|Pregnancy|0|||
170906860|NCT05502289|617662524|FG000|Period 1|Out Of Window|1|||
170906861|NCT05502289|617662525|FG001|Period 1|Out Of Window|0|||
170906862|NCT01564784|617662526|FG000|Overall Study|Other|1|||
170906863|NCT01564784|617662527|FG001|Overall Study|Other|0|||
170906864|NCT01564784|617662526|FG000|Overall Study|Subject refused further follow-up|1|||
170906865|NCT01564784|617662527|FG001|Overall Study|Subject refused further follow-up|6|||
170906866|NCT01564784|617662526|FG000|Overall Study|Lost to Follow-up|1|||
170906867|NCT01564784|617662527|FG001|Overall Study|Lost to Follow-up|1|||
170906868|NCT01564784|617662526|FG000|Overall Study|Death|131|||
170906869|NCT01564784|617662527|FG001|Overall Study|Death|126|||
170646641|NCT00783198|616718971|FG001|Overall Study|Did not meet protocol eligibility|1|||
170646642|NCT00783198|616718972|FG002|Overall Study|Did not meet protocol eligibility|0|||
170646643|NCT00783198|616718970|FG000|Overall Study|Administrative|2|||
170646644|NCT00783198|616718971|FG001|Overall Study|Administrative|1|||
170646645|NCT00783198|616718972|FG002|Overall Study|Administrative|2|||
170646646|NCT01134705|616718973|FG000|Overall Study|Adverse Event|1|||
170906870|NCT01076179|617662528|FG000|Overall Study|Withdrawal by Subject|1|||
170906871|NCT01273818|617662529|FG000|Overall Study|Physician Decision|13|||
170906872|NCT01273818|617662530|FG001|Overall Study|Physician Decision|2|||
170906873|NCT01273818|617662531|FG002|Overall Study|Physician Decision|9|||
170906874|NCT00820040|617662536|FG000|Overall Study|Death|1|||
170906875|NCT00820040|617662536|FG000|Overall Study|Sponsor terminated study|1|||
170906876|NCT00820040|617662536|FG000|Overall Study|Screen failure|1|||
170906877|NCT03934684|617662537|FG000|Overall Study|Participants continuing in study|11|||
170906878|NCT03934684|617662538|FG001|Overall Study|Participants continuing in study|4|||
170906879|NCT03934684|617662537|FG000|Overall Study|Discontinuation of carfilzomib|20|||
170906880|NCT03934684|617662538|FG001|Overall Study|Discontinuation of carfilzomib|30|||
170906881|NCT03934684|617662537|FG000|Overall Study|Death|2|||
170646647|NCT01134705|616718974|FG001|Overall Study|Adverse Event|7|||
170906882|NCT03934684|617662538|FG001|Overall Study|Death|2|||
170906883|NCT03934684|617662537|FG000|Overall Study|Lost to Follow-up|2|||
170906884|NCT03934684|617662538|FG001|Overall Study|Lost to Follow-up|5|||
170906885|NCT03934684|617662537|FG000|Overall Study|Withdrawal by Subject|7|||
170906886|NCT03934684|617662538|FG001|Overall Study|Withdrawal by Subject|8|||
170906887|NCT01073943|617662540|FG000|Overall Study|Withdrawal by Subject|8|||
170906888|NCT01073943|617662541|FG001|Overall Study|Withdrawal by Subject|2|||
170807094|NCT00670488|617303686|FG006|Overall Study|Physician Decision|0|||
170807095|NCT00670488|617303687|FG007|Overall Study|Physician Decision|0|||
170807096|NCT00670488|617303688|FG008|Overall Study|Physician Decision|0|||
170807097|NCT00670488|617303689|FG009|Overall Study|Physician Decision|0|||
170807098|NCT00670488|617303680|FG000|Overall Study|Progressive Disease|2|||
170906889|NCT01073943|617662540|FG000|Overall Study|Protocol Violation|2|||
170906890|NCT01073943|617662541|FG001|Overall Study|Protocol Violation|1|||
170906891|NCT01073943|617662540|FG000|Overall Study|Adverse Event|1|||
170906892|NCT01073943|617662541|FG001|Overall Study|Adverse Event|1|||
170906893|NCT01073943|617662540|FG000|Overall Study|Lost to Follow-up|0|||
170906894|NCT01073943|617662541|FG001|Overall Study|Lost to Follow-up|2|||
170906895|NCT01073943|617662540|FG000|Overall Study|Power outage; colonoscopy not done|1|||
170906896|NCT01073943|617662541|FG001|Overall Study|Power outage; colonoscopy not done|0|||
170906897|NCT01073943|617662540|FG000|Overall Study|Subject forgot|0|||
170906898|NCT01073943|617662541|FG001|Overall Study|Subject forgot|1|||
170646648|NCT01134705|616718973|FG000|Overall Study|Withdrawal by Subject|6|||
170807099|NCT00670488|617303681|FG001|Overall Study|Progressive Disease|41|||
170807100|NCT00670488|617303682|FG002|Overall Study|Progressive Disease|3|||
170807101|NCT00670488|617303683|FG003|Overall Study|Progressive Disease|2|||
170807102|NCT00670488|617303684|FG004|Overall Study|Progressive Disease|2|||
170807103|NCT00670488|617303685|FG005|Overall Study|Progressive Disease|4|||
170807104|NCT00670488|617303686|FG006|Overall Study|Progressive Disease|11|||
170807105|NCT00670488|617303687|FG007|Overall Study|Progressive Disease|2|||
170807106|NCT00670488|617303688|FG008|Overall Study|Progressive Disease|2|||
170807107|NCT00670488|617303689|FG009|Overall Study|Progressive Disease|1|||
170807108|NCT00670488|617303680|FG000|Overall Study|Withdrawal by Subject|0|||
170807109|NCT00670488|617303681|FG001|Overall Study|Withdrawal by Subject|1|||
170807110|NCT00670488|617303682|FG002|Overall Study|Withdrawal by Subject|0|||
170807111|NCT00670488|617303683|FG003|Overall Study|Withdrawal by Subject|1|||
170807112|NCT00670488|617303684|FG004|Overall Study|Withdrawal by Subject|0|||
170807113|NCT00670488|617303685|FG005|Overall Study|Withdrawal by Subject|0|||
170906899|NCT01073943|617662540|FG000|Overall Study|Unable to return for follow-up|0|||
170906900|NCT01073943|617662541|FG001|Overall Study|Unable to return for follow-up|1|||
170906901|NCT01073943|617662540|FG000|Overall Study|Could not tolerate prep|1|||
170646649|NCT01134705|616718974|FG001|Overall Study|Withdrawal by Subject|6|||
170646650|NCT01134705|616718973|FG000|Overall Study|Pregnancy|1|||
170646651|NCT01134705|616718974|FG001|Overall Study|Pregnancy|0|||
170646652|NCT01134705|616718973|FG000|Overall Study|Lost to Follow-up|5|||
170646653|NCT01134705|616718974|FG001|Overall Study|Lost to Follow-up|2|||
170646654|NCT01134705|616718973|FG000|Overall Study|Protocol Violation|1|||
170646655|NCT01134705|616718974|FG001|Overall Study|Protocol Violation|1|||
170646656|NCT01134705|616718973|FG000|Overall Study|Other|1|||
170646657|NCT01134705|616718974|FG001|Overall Study|Other|6|||
170646658|NCT04784442|616718975|FG000|Overall Study|Adverse Event|1|||
170646659|NCT04784442|616718976|FG001|Overall Study|Adverse Event|0|||
170646660|NCT04784442|616718977|FG002|Overall Study|Adverse Event|2|||
170646661|NCT04784442|616718978|FG003|Overall Study|Adverse Event|1|||
170646662|NCT04784442|616718975|FG000|Overall Study|Protocol Violation|1|||
170646663|NCT04784442|616718976|FG001|Overall Study|Protocol Violation|0|||
170646664|NCT04784442|616718977|FG002|Overall Study|Protocol Violation|0|||
170646665|NCT04784442|616718978|FG003|Overall Study|Protocol Violation|0|||
170646666|NCT04784442|616718975|FG000|Overall Study|Non-compliance with study drug|1|||
170646667|NCT04784442|616718976|FG001|Overall Study|Non-compliance with study drug|0|||
170646668|NCT04784442|616718977|FG002|Overall Study|Non-compliance with study drug|0|||
170646669|NCT04784442|616718978|FG003|Overall Study|Non-compliance with study drug|0|||
170646670|NCT04619225|616718980|FG000|Overall Study|Physician Decision|2|||
170646671|NCT05119569|616718982|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
170646672|NCT05119569|616718983|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
170646673|NCT05119569|616718984|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
170906902|NCT01073943|617662541|FG001|Overall Study|Could not tolerate prep|0|||
170906903|NCT02192359|617662542|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
170646674|NCT05119569|616718985|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
170906904|NCT02192359|617662543|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
170646675|NCT05119569|616718982|FG000|Double Blind Treatment Phase|Adverse Event|6|||
170646676|NCT05119569|616718983|FG001|Double Blind Treatment Phase|Adverse Event|0|||
170646677|NCT05119569|616718984|FG002|Double Blind Treatment Phase|Adverse Event|0|||
170646678|NCT05119569|616718985|FG003|Double Blind Treatment Phase|Adverse Event|0|||
170807114|NCT00670488|617303686|FG006|Overall Study|Withdrawal by Subject|1|||
170807115|NCT00670488|617303687|FG007|Overall Study|Withdrawal by Subject|0|||
170807116|NCT00670488|617303688|FG008|Overall Study|Withdrawal by Subject|1|||
170906905|NCT02192359|617662544|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
170906906|NCT02192359|617662545|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
170906907|NCT02192359|617662542|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
170906908|NCT02192359|617662543|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
170906909|NCT02192359|617662544|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
170906910|NCT02192359|617662545|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
170807117|NCT00670488|617303689|FG009|Overall Study|Withdrawal by Subject|0|||
170807118|NCT00109031|617303699|FG000|Overall Study|Adverse Event|0|||
170807119|NCT00109031|617303700|FG001|Overall Study|Adverse Event|0|||
170807120|NCT00109031|617303701|FG002|Overall Study|Adverse Event|1|||
170807121|NCT00109031|617303702|FG003|Overall Study|Adverse Event|0|||
170807122|NCT00109031|617303699|FG000|Overall Study|Withdrawal by Subject|0|||
170807123|NCT00109031|617303700|FG001|Overall Study|Withdrawal by Subject|1|||
170807124|NCT00109031|617303701|FG002|Overall Study|Withdrawal by Subject|0|||
170807125|NCT00109031|617303702|FG003|Overall Study|Withdrawal by Subject|0|||
170807126|NCT00109031|617303699|FG000|Overall Study|Physician Decision|0|||
170807127|NCT00109031|617303700|FG001|Overall Study|Physician Decision|1|||
170906911|NCT02192359|617662542|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
170906912|NCT02192359|617662543|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
170906913|NCT02192359|617662544|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
170906914|NCT02192359|617662545|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
170906915|NCT00658333|617662546|FG000|Overall Study|Adverse Event|2|||
170906916|NCT00658333|617662547|FG001|Overall Study|Adverse Event|1|||
170906917|NCT03414359|617662557|FG000|Overall Study|Lack of Efficacy|1|||
170906918|NCT03414359|617662558|FG001|Overall Study|Lack of Efficacy|1|||
170906919|NCT03414359|617662557|FG000|Overall Study|Protocol Violation|0|||
170906920|NCT03414359|617662558|FG001|Overall Study|Protocol Violation|1|||
170906921|NCT00886821|617664588|FG000|Stage 2|Adverse Event|0|||
170906922|NCT00886821|617664589|FG001|Stage 2|Adverse Event|0|||
170906923|NCT00886821|617664590|FG002|Stage 2|Adverse Event|0|||
170906924|NCT00886821|617664591|FG003|Stage 2|Adverse Event|0|||
170906925|NCT00886821|617664592|FG004|Stage 2|Adverse Event|0|||
170906926|NCT00886821|617664593|FG005|Stage 2|Adverse Event|0|||
170906927|NCT00886821|617664594|FG006|Stage 2|Adverse Event|0|||
170906928|NCT00886821|617664595|FG007|Stage 2|Adverse Event|0|||
170906929|NCT00886821|617664596|FG008|Stage 2|Adverse Event|0|||
170906930|NCT00886821|617664597|FG009|Stage 2|Adverse Event|0|||
170906931|NCT00886821|617664598|FG010|Stage 2|Adverse Event|0|||
170807128|NCT00109031|617303701|FG002|Overall Study|Physician Decision|0|||
170807129|NCT00109031|617303702|FG003|Overall Study|Physician Decision|0|||
170807130|NCT00109031|617303699|FG000|Overall Study|Protocol Violation|0|||
170807131|NCT00109031|617303700|FG001|Overall Study|Protocol Violation|0|||
170807132|NCT00109031|617303701|FG002|Overall Study|Protocol Violation|1|||
170807133|NCT00109031|617303702|FG003|Overall Study|Protocol Violation|0|||
170807134|NCT01822756|617303703|FG000|Overall Study|Adverse Event|0|||
170807135|NCT01822756|617303704|FG001|Overall Study|Adverse Event|0|||
170807136|NCT01822756|617303705|FG002|Overall Study|Adverse Event|0|||
170807137|NCT01822756|617303706|FG003|Overall Study|Adverse Event|2|||
170807138|NCT01822756|617303707|FG004|Overall Study|Adverse Event|0|||
170807139|NCT01822756|617303703|FG000|Overall Study|Disease progression|11|||
170807140|NCT01822756|617303704|FG001|Overall Study|Disease progression|1|||
170807141|NCT01822756|617303705|FG002|Overall Study|Disease progression|7|||
170906932|NCT00886821|617664599|FG011|Stage 2|Adverse Event|1|||
170906933|NCT00886821|617664600|FG012|Stage 2|Adverse Event|3|||
170906934|NCT00886821|617664601|FG013|Stage 2|Adverse Event|0|||
170566437|NCT01492426|616422018|FG001|Treatment|Lost to Follow-up|4|||
170566438|NCT01492426|616422017|FG000|Treatment|Participant does not meet study criteria|1|||
170566439|NCT01492426|616422018|FG001|Treatment|Participant does not meet study criteria|0|||
170566440|NCT01492426|616422017|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
170566441|NCT01492426|616422018|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
170566442|NCT01492426|616422017|FG000|Follow-Up|Death|1|||
170807142|NCT01822756|617303706|FG003|Overall Study|Disease progression|2|||
170906935|NCT00886821|617664588|FG000|Stage 2|Lost to Follow-up|0|||
170906936|NCT00886821|617664589|FG001|Stage 2|Lost to Follow-up|0|||
170906937|NCT00886821|617664590|FG002|Stage 2|Lost to Follow-up|0|||
170906938|NCT00886821|617664591|FG003|Stage 2|Lost to Follow-up|0|||
170906939|NCT00886821|617664592|FG004|Stage 2|Lost to Follow-up|0|||
170906940|NCT00886821|617664593|FG005|Stage 2|Lost to Follow-up|0|||
170906941|NCT00886821|617664594|FG006|Stage 2|Lost to Follow-up|0|||
170906942|NCT00886821|617664595|FG007|Stage 2|Lost to Follow-up|0|||
170566443|NCT01492426|616422018|FG001|Follow-Up|Death|0|||
170807143|NCT01822756|617303707|FG004|Overall Study|Disease progression|6|||
170807144|NCT01822756|617303703|FG000|Overall Study|Death|2|||
170807145|NCT01822756|617303704|FG001|Overall Study|Death|2|||
170807146|NCT01822756|617303705|FG002|Overall Study|Death|1|||
170807147|NCT01822756|617303706|FG003|Overall Study|Death|0|||
170807148|NCT01822756|617303707|FG004|Overall Study|Death|0|||
170566444|NCT01492426|616422017|FG000|Follow-Up|Other|4|||
170566445|NCT01492426|616422018|FG001|Follow-Up|Other|2|||
170906943|NCT00886821|617664596|FG008|Stage 2|Lost to Follow-up|0|||
170906944|NCT00886821|617664597|FG009|Stage 2|Lost to Follow-up|0|||
170906945|NCT00886821|617664598|FG010|Stage 2|Lost to Follow-up|0|||
170906946|NCT00886821|617664599|FG011|Stage 2|Lost to Follow-up|0|||
170906947|NCT00886821|617664600|FG012|Stage 2|Lost to Follow-up|2|||
170906948|NCT00886821|617664601|FG013|Stage 2|Lost to Follow-up|1|||
170906949|NCT03816995|617664606|FG000|Overall Study|Withdrawal by Subject|3|||
170906950|NCT03816995|617664607|FG001|Overall Study|Withdrawal by Subject|1|||
170906951|NCT03816995|617664606|FG000|Overall Study|Cancelled Surgery|8|||
170906952|NCT03816995|617664607|FG001|Overall Study|Cancelled Surgery|12|||
170906953|NCT03816995|617664606|FG000|Overall Study|No wound protector used|11|||
170906954|NCT03816995|617664607|FG001|Overall Study|No wound protector used|17|||
170906955|NCT03816995|617664606|FG000|Overall Study|Protocol Violation|2|||
170906956|NCT03816995|617664607|FG001|Overall Study|Protocol Violation|3|||
170906957|NCT02874794|617664610|FG000|Overall Study|Physician Decision|3|||
170906958|NCT02874794|617664611|FG001|Overall Study|Physician Decision|2|||
170906959|NCT02874794|617664610|FG000|Overall Study|Withdrawal by Subject|2|||
170906960|NCT02874794|617664611|FG001|Overall Study|Withdrawal by Subject|8|||
170906961|NCT02874794|617664610|FG000|Overall Study|Death|2|||
170906962|NCT02874794|617664611|FG001|Overall Study|Death|1|||
170906963|NCT01584024|617664612|FG000|Overall Study|Lost to Follow-up|10|||
170906964|NCT01584024|617664612|FG000|Overall Study|Withdrawal by Subject|3|||
170906965|NCT00613314|617664613|FG000|Overall Study|Adverse Event|5|||
170906966|NCT00613314|617664613|FG000|Overall Study|Protocol Violation|14|||
170906967|NCT00613314|617664613|FG000|Overall Study|Lost to Follow-up|46|||
170906968|NCT00613314|617664613|FG000|Overall Study|Other reason not defined above|90|||
170906969|NCT05408858|617664615|FG000|Overall Study|no longer met eligibility criteria|1|||
170906970|NCT01324830|617664616|FG000|Overall Study|Progressive Disease|3|||
170906971|NCT01324830|617664617|FG001|Overall Study|Progressive Disease|2|||
170906972|NCT01324830|617664618|FG002|Overall Study|Progressive Disease|3|||
170906973|NCT01324830|617664619|FG003|Overall Study|Progressive Disease|3|||
170906974|NCT01324830|617664620|FG004|Overall Study|Progressive Disease|6|||
170906975|NCT01324830|617664621|FG005|Overall Study|Progressive Disease|6|||
170906976|NCT01324830|617664622|FG006|Overall Study|Progressive Disease|3|||
170906977|NCT01324830|617664623|FG007|Overall Study|Progressive Disease|3|||
170906978|NCT01324830|617664624|FG008|Overall Study|Progressive Disease|3|||
170906979|NCT01324830|617664625|FG009|Overall Study|Progressive Disease|6|||
170906980|NCT01324830|617664626|FG010|Overall Study|Progressive Disease|2|||
170906981|NCT01324830|617664627|FG011|Overall Study|Progressive Disease|1|||
170906982|NCT01324830|617664628|FG012|Overall Study|Progressive Disease|1|||
170906983|NCT01324830|617664629|FG013|Overall Study|Progressive Disease|1|||
170906984|NCT01324830|617664630|FG014|Overall Study|Progressive Disease|1|||
170906985|NCT01324830|617664631|FG015|Overall Study|Progressive Disease|3|||
170906986|NCT01324830|617664632|FG016|Overall Study|Progressive Disease|2|||
170906987|NCT01324830|617664633|FG017|Overall Study|Progressive Disease|3|||
170906988|NCT01324830|617664634|FG018|Overall Study|Progressive Disease|4|||
170906989|NCT01324830|617664616|FG000|Overall Study|Dose limiting toxicity|0|||
170906990|NCT01324830|617664617|FG001|Overall Study|Dose limiting toxicity|0|||
170906991|NCT01324830|617664618|FG002|Overall Study|Dose limiting toxicity|0|||
170906992|NCT01324830|617664619|FG003|Overall Study|Dose limiting toxicity|0|||
170906993|NCT01324830|617664620|FG004|Overall Study|Dose limiting toxicity|1|||
170906994|NCT01324830|617664621|FG005|Overall Study|Dose limiting toxicity|0|||
170906995|NCT01324830|617664622|FG006|Overall Study|Dose limiting toxicity|0|||
170906996|NCT01324830|617664623|FG007|Overall Study|Dose limiting toxicity|0|||
170906997|NCT01324830|617664624|FG008|Overall Study|Dose limiting toxicity|0|||
170906998|NCT01324830|617664625|FG009|Overall Study|Dose limiting toxicity|0|||
170906999|NCT01324830|617664626|FG010|Overall Study|Dose limiting toxicity|0|||
170907000|NCT01324830|617664627|FG011|Overall Study|Dose limiting toxicity|0|||
170907001|NCT01324830|617664628|FG012|Overall Study|Dose limiting toxicity|0|||
170907002|NCT01324830|617664629|FG013|Overall Study|Dose limiting toxicity|0|||
170907003|NCT01324830|617664630|FG014|Overall Study|Dose limiting toxicity|0|||
170907004|NCT01324830|617664631|FG015|Overall Study|Dose limiting toxicity|0|||
170907005|NCT01324830|617664632|FG016|Overall Study|Dose limiting toxicity|1|||
170566446|NCT01492426|616422017|FG000|Follow-Up|Participant Withdrew Consent|6|||
170907006|NCT01324830|617664633|FG017|Overall Study|Dose limiting toxicity|1|||
170907007|NCT01324830|617664634|FG018|Overall Study|Dose limiting toxicity|1|||
170907008|NCT01324830|617664616|FG000|Overall Study|Reason not mentioned above|0|||
170907009|NCT01324830|617664617|FG001|Overall Study|Reason not mentioned above|0|||
170566447|NCT01492426|616422018|FG001|Follow-Up|Participant Withdrew Consent|1|||
170566448|NCT01492426|616422017|FG000|Follow-Up|Lost to Follow-up|12|||
170907010|NCT01324830|617664618|FG002|Overall Study|Reason not mentioned above|0|||
170907011|NCT01324830|617664619|FG003|Overall Study|Reason not mentioned above|0|||
170566449|NCT01492426|616422018|FG001|Follow-Up|Lost to Follow-up|6|||
170907012|NCT01324830|617664620|FG004|Overall Study|Reason not mentioned above|0|||
170907013|NCT01324830|617664621|FG005|Overall Study|Reason not mentioned above|0|||
170907014|NCT01324830|617664622|FG006|Overall Study|Reason not mentioned above|0|||
170907015|NCT01324830|617664623|FG007|Overall Study|Reason not mentioned above|0|||
170566450|NCT00652743|616422019|FG000|Months 12-18|Lost to Follow-up|1|||
170566451|NCT00652743|616422020|FG001|Months 12-18|Lost to Follow-up|2|||
170566452|NCT00652743|616422021|FG002|Months 12-18|Lost to Follow-up|7|||
170566453|NCT00652743|616422019|FG000|Months 24-30|Other|5|||
170566454|NCT00652743|616422020|FG001|Months 24-30|Other|1|||
170566455|NCT00652743|616422021|FG002|Months 24-30|Other|11|||
170566456|NCT00652743|616422019|FG000|Months 36-42|Serious Adverse Events|0|||
170566457|NCT00652743|616422020|FG001|Months 36-42|Serious Adverse Events|1|||
170566458|NCT00652743|616422021|FG002|Months 36-42|Serious Adverse Events|1|||
170566459|NCT00652743|616422019|FG000|Months 36-42|Withdrawal by Subject|1|||
170566460|NCT00652743|616422020|FG001|Months 36-42|Withdrawal by Subject|1|||
170566461|NCT00652743|616422021|FG002|Months 36-42|Withdrawal by Subject|0|||
170566462|NCT00652743|616422019|FG000|Months 36-42|Lost to Follow-up|0|||
170566463|NCT00652743|616422020|FG001|Months 36-42|Lost to Follow-up|1|||
170566464|NCT00652743|616422021|FG002|Months 36-42|Lost to Follow-up|0|||
170566465|NCT00652743|616422019|FG000|Months 36-42|Migrated/moved from study area|1|||
170566466|NCT00652743|616422020|FG001|Months 36-42|Migrated/moved from study area|0|||
170566467|NCT00652743|616422021|FG002|Months 36-42|Migrated/moved from study area|0|||
170566468|NCT00652743|616422019|FG000|Months 36-42|Other|4|||
170566469|NCT00652743|616422020|FG001|Months 36-42|Other|2|||
170566470|NCT00652743|616422021|FG002|Months 36-42|Other|8|||
170566471|NCT01123148|616422022|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
170566472|NCT01123148|616422022|FG000|Overall Study|Didn't meet milestone criteria|1|||
170566473|NCT00688467|616422023|FG000|Treatment Period 1|Adverse Event|2|||
170566474|NCT00688467|616422024|FG001|Treatment Period 1|Adverse Event|1|||
170566475|NCT00688467|616422023|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
170566476|NCT00688467|616422024|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
170566477|NCT00688467|616422023|FG000|Treatment Period 2|Protocol Violation|0|||
170566478|NCT00688467|616422024|FG001|Treatment Period 2|Protocol Violation|1|||
170566479|NCT00688467|616422023|FG000|Treatment Period 2|Adverse Event|0|||
170566480|NCT00688467|616422024|FG001|Treatment Period 2|Adverse Event|1|||
170566481|NCT00399568|616422025|FG000|Overall Study|Adverse Event|1|||
170566482|NCT00399568|616422026|FG001|Overall Study|Adverse Event|2|||
170566483|NCT00399568|616422025|FG000|Overall Study|Withdrawal by Subject|7|||
170566484|NCT00399568|616422026|FG001|Overall Study|Withdrawal by Subject|3|||
170566485|NCT00399568|616422025|FG000|Overall Study|Protocol non-compliance|2|||
170566486|NCT00399568|616422026|FG001|Overall Study|Protocol non-compliance|2|||
170566487|NCT00399568|616422025|FG000|Overall Study|Lost to Follow-up|2|||
170566488|NCT00399568|616422026|FG001|Overall Study|Lost to Follow-up|2|||
170566489|NCT00925002|616422027|FG000|Overall Study|Other|1|||
170566490|NCT00925002|616422028|FG001|Overall Study|Other|4|||
170566491|NCT00925002|616422029|FG002|Overall Study|Other|0|||
170566492|NCT00925002|616422027|FG000|Overall Study|Death|1|||
170566493|NCT00925002|616422028|FG001|Overall Study|Death|1|||
170566494|NCT00925002|616422029|FG002|Overall Study|Death|5|||
170566495|NCT00925002|616422027|FG000|Overall Study|Adverse Event|3|||
170566496|NCT00925002|616422028|FG001|Overall Study|Adverse Event|1|||
170566497|NCT00925002|616422029|FG002|Overall Study|Adverse Event|2|||
170566498|NCT00925002|616422027|FG000|Overall Study|Participant withdrew consent|1|||
170566499|NCT00925002|616422028|FG001|Overall Study|Participant withdrew consent|3|||
170646679|NCT05119569|616718982|FG000|Open Label Extension Phase|Ongoing in the study|0|||
170807149|NCT01822756|617303703|FG000|Overall Study|Lost to Follow-up|1|||
170807150|NCT01822756|617303704|FG001|Overall Study|Lost to Follow-up|0|||
170807151|NCT01822756|617303705|FG002|Overall Study|Lost to Follow-up|1|||
170807152|NCT01822756|617303706|FG003|Overall Study|Lost to Follow-up|0|||
170566500|NCT00925002|616422029|FG002|Overall Study|Participant withdrew consent|3|||
170807153|NCT01822756|617303707|FG004|Overall Study|Lost to Follow-up|1|||
170807154|NCT01822756|617303703|FG000|Overall Study|Physician Decision|0|||
170807155|NCT01822756|617303704|FG001|Overall Study|Physician Decision|1|||
170807156|NCT01822756|617303705|FG002|Overall Study|Physician Decision|0|||
170807157|NCT01822756|617303706|FG003|Overall Study|Physician Decision|0|||
170807158|NCT01822756|617303707|FG004|Overall Study|Physician Decision|0|||
170807159|NCT01822756|617303703|FG000|Overall Study|disease progression & patient preference|2|||
170807160|NCT01822756|617303704|FG001|Overall Study|disease progression & patient preference|0|||
170807161|NCT01822756|617303705|FG002|Overall Study|disease progression & patient preference|1|||
170907016|NCT01324830|617664624|FG008|Overall Study|Reason not mentioned above|0|||
170907017|NCT01324830|617664625|FG009|Overall Study|Reason not mentioned above|0|||
170566501|NCT00399035|616422037|FG000|Overall Study|Death|289|||
170566502|NCT00399035|616422038|FG001|Overall Study|Death|141|||
170566503|NCT00399035|616422039|FG002|Overall Study|Death|234|||
170566504|NCT00399035|616422037|FG000|Overall Study|Lost to Follow-up|2|||
170566505|NCT00399035|616422038|FG001|Overall Study|Lost to Follow-up|1|||
170566506|NCT00399035|616422039|FG002|Overall Study|Lost to Follow-up|5|||
170646680|NCT05119569|616718983|FG001|Open Label Extension Phase|Ongoing in the study|0|||
170807162|NCT01822756|617303706|FG003|Overall Study|disease progression & patient preference|0|||
170807163|NCT01822756|617303707|FG004|Overall Study|disease progression & patient preference|0|||
170566507|NCT00399035|616422037|FG000|Overall Study|Withdrawal by Subject|19|||
170807164|NCT02208843|617303708|FG000|Overall Study|Clinical symptoms of progression|2|||
170566508|NCT00399035|616422038|FG001|Overall Study|Withdrawal by Subject|15|||
170566509|NCT00399035|616422039|FG002|Overall Study|Withdrawal by Subject|12|||
170566510|NCT00399035|616422037|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
170566511|NCT00399035|616422038|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
170566512|NCT00399035|616422039|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
170566513|NCT00399035|616422037|FG000|Overall Study|Severe non-compliance with protocol|2|||
170566514|NCT00399035|616422038|FG001|Overall Study|Severe non-compliance with protocol|1|||
170566515|NCT00399035|616422039|FG002|Overall Study|Severe non-compliance with protocol|0|||
170646681|NCT05119569|616718984|FG002|Open Label Extension Phase|Ongoing in the study|65|||
170646682|NCT05119569|616718985|FG003|Open Label Extension Phase|Ongoing in the study|34|||
170646683|NCT05104866|616718986|FG000|Overall Study|Reason unknown|1|||
170646684|NCT05104866|616718987|FG001|Overall Study|Reason unknown|1|||
170646685|NCT05104866|616718986|FG000|Overall Study|Ongoing in study at data cut-off date|120|||
170646686|NCT05104866|616718987|FG001|Overall Study|Ongoing in study at data cut-off date|131|||
170646687|NCT05104866|616718986|FG000|Overall Study|Withdrawal by Subject|25|||
170646688|NCT05104866|616718987|FG001|Overall Study|Withdrawal by Subject|29|||
170646689|NCT05104866|616718986|FG000|Overall Study|Lost to Follow-up|5|||
170646690|NCT05104866|616718987|FG001|Overall Study|Lost to Follow-up|2|||
170646691|NCT05104866|616718986|FG000|Overall Study|Death|214|||
170646692|NCT05104866|616718987|FG001|Overall Study|Death|204|||
170646693|NCT05663866|616718989|FG000|Overall Study|Adverse Event|0|||
170646694|NCT05663866|616718990|FG001|Overall Study|Adverse Event|0|||
170566516|NCT02949011|616422040|FG000|Overall Study|Adverse Event|6|||
170566517|NCT02949011|616422041|FG001|Overall Study|Adverse Event|7|||
170566518|NCT02949011|616422042|FG002|Overall Study|Adverse Event|3|||
170646695|NCT05663866|616718991|FG002|Overall Study|Adverse Event|1|||
170646696|NCT05663866|616718992|FG003|Overall Study|Adverse Event|0|||
170646697|NCT05663866|616718989|FG000|Overall Study|Physician Decision|0|||
170646698|NCT05663866|616718990|FG001|Overall Study|Physician Decision|0|||
170646699|NCT05663866|616718991|FG002|Overall Study|Physician Decision|0|||
170646700|NCT05663866|616718992|FG003|Overall Study|Physician Decision|1|||
170646701|NCT05663866|616718989|FG000|Overall Study|Withdrawal by Subject|0|||
170646702|NCT05663866|616718990|FG001|Overall Study|Withdrawal by Subject|2|||
170646703|NCT05663866|616718991|FG002|Overall Study|Withdrawal by Subject|1|||
170646704|NCT05663866|616718992|FG003|Overall Study|Withdrawal by Subject|2|||
170646705|NCT05663866|616718989|FG000|Overall Study|Progressive disease|4|||
170646706|NCT05663866|616718990|FG001|Overall Study|Progressive disease|8|||
170646707|NCT05663866|616718991|FG002|Overall Study|Progressive disease|5|||
170646708|NCT05663866|616718992|FG003|Overall Study|Progressive disease|2|||
170646709|NCT05663866|616718989|FG000|Overall Study|Other|1|||
170566519|NCT02949011|616422040|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
170566520|NCT02949011|616422041|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
170566521|NCT02949011|616422042|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
170566522|NCT02949011|616422040|FG000|Overall Study|Protocol Deviation|5|||
170566523|NCT02949011|616422041|FG001|Overall Study|Protocol Deviation|3|||
170566524|NCT02949011|616422042|FG002|Overall Study|Protocol Deviation|3|||
170566525|NCT02949011|616422040|FG000|Overall Study|Lack of Efficacy|0|||
170566526|NCT02949011|616422041|FG001|Overall Study|Lack of Efficacy|2|||
170566527|NCT02949011|616422042|FG002|Overall Study|Lack of Efficacy|0|||
170566528|NCT02949011|616422040|FG000|Overall Study|Withdrawal by Subject|13|||
170566529|NCT02949011|616422041|FG001|Overall Study|Withdrawal by Subject|13|||
170566530|NCT02949011|616422042|FG002|Overall Study|Withdrawal by Subject|21|||
170566531|NCT02949011|616422040|FG000|Overall Study|Lost to Follow-up|7|||
170566532|NCT02949011|616422041|FG001|Overall Study|Lost to Follow-up|5|||
170566533|NCT02949011|616422042|FG002|Overall Study|Lost to Follow-up|5|||
170566534|NCT02949011|616422040|FG000|Overall Study|Death|0|||
170566535|NCT02949011|616422041|FG001|Overall Study|Death|0|||
170566536|NCT02949011|616422042|FG002|Overall Study|Death|1|||
170566537|NCT02949011|616422040|FG000|Overall Study|Miscellaneous|2|||
170566538|NCT02949011|616422041|FG001|Overall Study|Miscellaneous|4|||
170566539|NCT02949011|616422042|FG002|Overall Study|Miscellaneous|6|||
170566540|NCT04108273|616422043|FG000|Overall Study|COVID Pandemic|1|||
170566541|NCT04108273|616422044|FG001|Overall Study|COVID Pandemic|0|||
170566542|NCT01541371|616422045|FG000|Overall Study|Withdrawal by Subject|14|||
170646710|NCT05663866|616718990|FG001|Overall Study|Other|0|||
170646711|NCT05663866|616718991|FG002|Overall Study|Other|0|||
170646712|NCT05663866|616718992|FG003|Overall Study|Other|0|||
170566543|NCT01541371|616422045|FG000|Overall Study|Lost to Follow-up|21|||
170566544|NCT01541371|616422045|FG000|Overall Study|Adverse Event|15|||
170566545|NCT01541371|616422045|FG000|Overall Study|Lack of Efficacy|12|||
170566546|NCT01541371|616422045|FG000|Overall Study|Protocol Violation|6|||
170566547|NCT01541371|616422045|FG000|Overall Study|Study medication non-compliance|3|||
170566548|NCT01541371|616422045|FG000|Overall Study|Other|6|||
170646713|NCT05663866|616718989|FG000|Overall Study|Ongoing|1|||
170646714|NCT05663866|616718990|FG001|Overall Study|Ongoing|27|||
170566549|NCT01170663|616422046|FG000|Overall Study|Lost to Follow-up|3|||
170646715|NCT05663866|616718991|FG002|Overall Study|Ongoing|6|||
170646716|NCT05663866|616718992|FG003|Overall Study|Ongoing|1|||
170566550|NCT01170663|616422047|FG001|Overall Study|Lost to Follow-up|9|||
170566551|NCT01170663|616422046|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
170566552|NCT01170663|616422047|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
170566553|NCT02746809|616422048|FG000|Enrollment|Inclusion Exclusion not met|9|||
170566554|NCT02746809|616422048|FG000|Enrollment|Withdrawal by Subject|1|||
170566555|NCT02746809|616422048|FG000|Enrollment|Expected Enrollment Met|2|||
170566556|NCT02746809|616422048|FG000|Procedure|Death|1|||
170566557|NCT02746809|616422048|FG000|1-Month|Death|5|||
170566558|NCT02746809|616422048|FG000|6-Month|Death|2|||
170566559|NCT02746809|616422048|FG000|6-Month|Withdrawal by Subject|1|||
170566560|NCT02746809|616422048|FG000|12-Month|Death|3|||
170907018|NCT01324830|617664626|FG010|Overall Study|Reason not mentioned above|0|||
170907019|NCT01324830|617664627|FG011|Overall Study|Reason not mentioned above|0|||
170907020|NCT01324830|617664628|FG012|Overall Study|Reason not mentioned above|0|||
170907021|NCT01324830|617664629|FG013|Overall Study|Reason not mentioned above|0|||
170907022|NCT01324830|617664630|FG014|Overall Study|Reason not mentioned above|0|||
170907023|NCT01324830|617664631|FG015|Overall Study|Reason not mentioned above|0|||
170907024|NCT01324830|617664632|FG016|Overall Study|Reason not mentioned above|0|||
170907025|NCT01324830|617664633|FG017|Overall Study|Reason not mentioned above|1|||
170907026|NCT01324830|617664634|FG018|Overall Study|Reason not mentioned above|0|||
170907027|NCT01324830|617664616|FG000|Overall Study|Adverse Event, serious fatal|0|||
170907028|NCT01324830|617664617|FG001|Overall Study|Adverse Event, serious fatal|1|||
170907029|NCT01324830|617664618|FG002|Overall Study|Adverse Event, serious fatal|0|||
170907030|NCT01324830|617664619|FG003|Overall Study|Adverse Event, serious fatal|0|||
170907031|NCT01324830|617664620|FG004|Overall Study|Adverse Event, serious fatal|0|||
170907032|NCT01324830|617664621|FG005|Overall Study|Adverse Event, serious fatal|0|||
170907033|NCT01324830|617664622|FG006|Overall Study|Adverse Event, serious fatal|0|||
170907034|NCT01324830|617664623|FG007|Overall Study|Adverse Event, serious fatal|0|||
170907035|NCT01324830|617664624|FG008|Overall Study|Adverse Event, serious fatal|0|||
170907036|NCT01324830|617664625|FG009|Overall Study|Adverse Event, serious fatal|0|||
170907037|NCT01324830|617664626|FG010|Overall Study|Adverse Event, serious fatal|0|||
170907038|NCT01324830|617664627|FG011|Overall Study|Adverse Event, serious fatal|0|||
170907039|NCT01324830|617664628|FG012|Overall Study|Adverse Event, serious fatal|0|||
170907040|NCT01324830|617664629|FG013|Overall Study|Adverse Event, serious fatal|0|||
170907041|NCT01324830|617664630|FG014|Overall Study|Adverse Event, serious fatal|0|||
170907042|NCT01324830|617664631|FG015|Overall Study|Adverse Event, serious fatal|0|||
170907043|NCT01324830|617664632|FG016|Overall Study|Adverse Event, serious fatal|0|||
170907044|NCT01324830|617664633|FG017|Overall Study|Adverse Event, serious fatal|0|||
170907045|NCT01324830|617664634|FG018|Overall Study|Adverse Event, serious fatal|0|||
170907046|NCT01324830|617664616|FG000|Overall Study|Adverse Event, non-fatal|0|||
170907047|NCT01324830|617664617|FG001|Overall Study|Adverse Event, non-fatal|0|||
170907048|NCT01324830|617664618|FG002|Overall Study|Adverse Event, non-fatal|0|||
170907049|NCT01324830|617664619|FG003|Overall Study|Adverse Event, non-fatal|0|||
170907050|NCT01324830|617664620|FG004|Overall Study|Adverse Event, non-fatal|0|||
170907051|NCT01324830|617664621|FG005|Overall Study|Adverse Event, non-fatal|0|||
170907052|NCT01324830|617664622|FG006|Overall Study|Adverse Event, non-fatal|0|||
170907053|NCT01324830|617664623|FG007|Overall Study|Adverse Event, non-fatal|0|||
170907054|NCT01324830|617664624|FG008|Overall Study|Adverse Event, non-fatal|2|||
170907055|NCT01324830|617664625|FG009|Overall Study|Adverse Event, non-fatal|0|||
170907056|NCT01324830|617664626|FG010|Overall Study|Adverse Event, non-fatal|1|||
170907057|NCT01324830|617664627|FG011|Overall Study|Adverse Event, non-fatal|0|||
170907058|NCT01324830|617664628|FG012|Overall Study|Adverse Event, non-fatal|0|||
170907059|NCT01324830|617664629|FG013|Overall Study|Adverse Event, non-fatal|0|||
170907060|NCT01324830|617664630|FG014|Overall Study|Adverse Event, non-fatal|0|||
170907061|NCT01324830|617664631|FG015|Overall Study|Adverse Event, non-fatal|0|||
170907062|NCT01324830|617664632|FG016|Overall Study|Adverse Event, non-fatal|0|||
170907063|NCT01324830|617664633|FG017|Overall Study|Adverse Event, non-fatal|1|||
170907064|NCT01324830|617664634|FG018|Overall Study|Adverse Event, non-fatal|0|||
170566561|NCT02746809|616422048|FG000|12-Month|Withdrawal by Subject|2|||
170566562|NCT02746809|616422048|FG000|24-Month|Death|1|||
170566563|NCT02746809|616422048|FG000|24-Month|Withdrawal by Subject|1|||
170566564|NCT02746809|616422048|FG000|36-Month|Death|8|||
170907065|NCT01324830|617664616|FG000|Overall Study|Withdrawal by Subject|0|||
170907066|NCT01324830|617664617|FG001|Overall Study|Withdrawal by Subject|0|||
170907067|NCT01324830|617664618|FG002|Overall Study|Withdrawal by Subject|0|||
170907068|NCT01324830|617664619|FG003|Overall Study|Withdrawal by Subject|0|||
170907069|NCT01324830|617664620|FG004|Overall Study|Withdrawal by Subject|0|||
170907070|NCT01324830|617664621|FG005|Overall Study|Withdrawal by Subject|1|||
170907071|NCT01324830|617664622|FG006|Overall Study|Withdrawal by Subject|0|||
170907072|NCT01324830|617664623|FG007|Overall Study|Withdrawal by Subject|0|||
170566565|NCT02746809|616422048|FG000|36-Month|Withdrawal by Subject|1|||
170566566|NCT02746809|616422048|FG000|48-Month|Death|7|||
170566567|NCT02746809|616422048|FG000|48-Month|Withdrawal by Subject|1|||
170566568|NCT02746809|616422048|FG000|60-Month|Death|1|||
170566569|NCT02746809|616422048|FG000|60-Month|Lost to Follow-up|2|||
170566570|NCT04828707|616422049|FG000|Overall Study|Lost to Follow-up|3|||
170566571|NCT04828707|616422050|FG001|Overall Study|Lost to Follow-up|2|||
170566572|NCT04828707|616422049|FG000|Overall Study|Withdrawal by Subject|2|||
170566573|NCT04828707|616422050|FG001|Overall Study|Withdrawal by Subject|1|||
170566574|NCT03498716|616422058|FG000|Overall Study|Withdrawal by Subject|88|||
170566575|NCT03498716|616422059|FG001|Overall Study|Withdrawal by Subject|73|||
170566576|NCT03498716|616422058|FG000|Overall Study|Study Terminated By Sponsor|933|||
170566577|NCT03498716|616422059|FG001|Overall Study|Study Terminated By Sponsor|927|||
170566578|NCT03498716|616422058|FG000|Overall Study|Lost to Follow-up|15|||
170566579|NCT03498716|616422059|FG001|Overall Study|Lost to Follow-up|26|||
170566580|NCT03498716|616422058|FG000|Overall Study|Disease Relapse|0|||
170566581|NCT03498716|616422059|FG001|Overall Study|Disease Relapse|1|||
170566582|NCT03498716|616422058|FG000|Overall Study|Death|58|||
170566583|NCT03498716|616422059|FG001|Overall Study|Death|72|||
170566584|NCT03498716|616422058|FG000|Overall Study|Physician Decision|4|||
170566585|NCT03498716|616422059|FG001|Overall Study|Physician Decision|2|||
170566586|NCT02257684|616422060|FG000|Overall Study|Adverse Event|2|||
170566587|NCT02257684|616422060|FG000|Overall Study|Lack of Efficacy|1|||
170566588|NCT02257684|616422060|FG000|Overall Study|Sponsor's Decision|1|||
170566589|NCT01570387|616422061|FG000|Overall Study|Adverse Event|1|||
170566590|NCT01570387|616422062|FG001|Overall Study|Adverse Event|0|||
170566591|NCT01570387|616422063|FG002|Overall Study|Adverse Event|0|||
170566592|NCT01570387|616422064|FG003|Overall Study|Adverse Event|0|||
170566593|NCT01570387|616422061|FG000|Overall Study|Death|0|||
170566594|NCT01570387|616422062|FG001|Overall Study|Death|0|||
170566595|NCT01570387|616422063|FG002|Overall Study|Death|0|||
170566596|NCT01570387|616422064|FG003|Overall Study|Death|1|||
170566597|NCT01570387|616422061|FG000|Overall Study|Withdrawal by Subject|0|||
170566598|NCT01570387|616422062|FG001|Overall Study|Withdrawal by Subject|0|||
170566599|NCT01570387|616422063|FG002|Overall Study|Withdrawal by Subject|0|||
170566600|NCT01570387|616422064|FG003|Overall Study|Withdrawal by Subject|1|||
170566601|NCT01876381|616422065|FG000|Overall Study|Lack of Efficacy|5|||
170566602|NCT01876381|616422065|FG000|Overall Study|Physician Decision|1|||
170566603|NCT01876381|616422065|FG000|Overall Study|Withdrawal by Subject|1|||
170566604|NCT03323164|616422068|FG000|Overall Study|Poor quality imaging/scans|2|||
170566605|NCT03323164|616422069|FG001|Overall Study|Poor quality imaging/scans|2|||
170566606|NCT00654732|616422070|FG000|Overall Study|Adverse Event|4|||
170566607|NCT00654732|616422071|FG001|Overall Study|Adverse Event|6|||
170566608|NCT01734902|616422074|FG000|Overall Study|Other than listed|0|||
170566609|NCT01734902|616422075|FG001|Overall Study|Other than listed|2|||
170807165|NCT02208843|617303708|FG000|Overall Study|Progression disease according to RECIST|24|||
170807166|NCT02208843|617303708|FG000|Overall Study|Adverse Event|12|||
170807167|NCT02208843|617303708|FG000|Overall Study|Protocol Violation|1|||
170807168|NCT02208843|617303708|FG000|Overall Study|Withdrawal by Subject|1|||
170807169|NCT02208843|617303708|FG000|Overall Study|Switched to commercial afatinib|20|||
170807170|NCT01604824|617303709|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
170807171|NCT01604824|617303710|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
170807172|NCT01604824|617303711|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
170807173|NCT01604824|617303712|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
170807174|NCT01604824|617303713|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
170807175|NCT01604824|617303714|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
170807176|NCT01604824|617303709|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
170807177|NCT01604824|617303710|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
170807178|NCT01604824|617303711|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
170807179|NCT01604824|617303712|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
170807180|NCT01604824|617303713|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
170807181|NCT01604824|617303714|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
170807182|NCT02630966|617303715|FG000|Overall Study|Adverse Event|1|||
170807183|NCT02630966|617303716|FG001|Overall Study|Adverse Event|3|||
170807184|NCT02630966|617303715|FG000|Overall Study|Significant Protocol Deviation|0|||
170807185|NCT02630966|617303716|FG001|Overall Study|Significant Protocol Deviation|2|||
170807186|NCT02630966|617303715|FG000|Overall Study|Voluntary Withdrawal|1|||
170807187|NCT02630966|617303716|FG001|Overall Study|Voluntary Withdrawal|1|||
170807188|NCT02630966|617303715|FG000|Overall Study|Lack of Efficacy|0|||
170807189|NCT02630966|617303716|FG001|Overall Study|Lack of Efficacy|2|||
170807190|NCT01801007|617303717|FG000|Overall Study|Adverse Event|2|||
170807191|NCT01801007|617303717|FG000|Overall Study|Lost to Follow-up|4|||
170807192|NCT01801007|617303717|FG000|Overall Study|Withdrawal by Subject|5|||
170807193|NCT02743819|617303719|FG000|Overall Study|Lack of Efficacy|5|||
170807194|NCT02743819|617303719|FG000|Overall Study|Death|2|||
170566610|NCT01133847|616422076|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
170566611|NCT01133847|616422077|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
170566612|NCT01133847|616422078|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
170566613|NCT01133847|616422076|FG000|Follow-Up Phase|Lost to Follow-up|1|||
170566614|NCT01133847|616422077|FG001|Follow-Up Phase|Lost to Follow-up|3|||
170566615|NCT01133847|616422078|FG002|Follow-Up Phase|Lost to Follow-up|7|||
170907073|NCT01324830|617664624|FG008|Overall Study|Withdrawal by Subject|0|||
170907074|NCT01324830|617664625|FG009|Overall Study|Withdrawal by Subject|0|||
170907075|NCT01324830|617664626|FG010|Overall Study|Withdrawal by Subject|1|||
170907076|NCT01324830|617664627|FG011|Overall Study|Withdrawal by Subject|0|||
170907077|NCT01324830|617664628|FG012|Overall Study|Withdrawal by Subject|0|||
170907078|NCT01324830|617664629|FG013|Overall Study|Withdrawal by Subject|0|||
170907079|NCT01324830|617664630|FG014|Overall Study|Withdrawal by Subject|0|||
170907080|NCT01324830|617664631|FG015|Overall Study|Withdrawal by Subject|0|||
170907081|NCT01324830|617664632|FG016|Overall Study|Withdrawal by Subject|0|||
170907082|NCT01324830|617664633|FG017|Overall Study|Withdrawal by Subject|0|||
170907083|NCT01324830|617664634|FG018|Overall Study|Withdrawal by Subject|1|||
170907084|NCT01973283|617664635|FG000|Overall Study|Lost to Follow-up|4|||
170907085|NCT00886938|617664636|FG000|Overall Study|Adverse Event|1|||
170907086|NCT00886938|617664636|FG000|Overall Study|Withdrawal by Subject|1|||
170907087|NCT00917384|617664637|FG000|Overall Study|Lost to Follow-up|4|||
170907088|NCT00917384|617664638|FG001|Overall Study|Lost to Follow-up|2|||
170907089|NCT00917384|617664637|FG000|Overall Study|Withdrawal by Subject|10|||
170907090|NCT00917384|617664638|FG001|Overall Study|Withdrawal by Subject|2|||
170907091|NCT03126227|617664639|FG000|Overall Study|Adverse Event|43|||
170907092|NCT03126227|617664640|FG001|Overall Study|Adverse Event|4|||
170907093|NCT03126227|617664639|FG000|Overall Study|Death|0|||
170907094|NCT03126227|617664640|FG001|Overall Study|Death|1|||
170907095|NCT03126227|617664639|FG000|Overall Study|Lost to Follow-up|0|||
170907096|NCT03126227|617664640|FG001|Overall Study|Lost to Follow-up|1|||
170907097|NCT03126227|617664639|FG000|Overall Study|Physician Decision|2|||
170907098|NCT03126227|617664640|FG001|Overall Study|Physician Decision|0|||
170907099|NCT03126227|617664639|FG000|Overall Study|Protocol Violation|1|||
170907100|NCT03126227|617664640|FG001|Overall Study|Protocol Violation|0|||
170907101|NCT03126227|617664639|FG000|Overall Study|Withdrawal by Subject|19|||
170907102|NCT03126227|617664640|FG001|Overall Study|Withdrawal by Subject|3|||
170907103|NCT03126227|617664639|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
170907104|NCT03126227|617664640|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
170907105|NCT03126227|617664639|FG000|Overall Study|Lack of dosing compliance|2|||
170907106|NCT03126227|617664640|FG001|Overall Study|Lack of dosing compliance|0|||
170907107|NCT03126227|617664639|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
170907108|NCT03126227|617664640|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
170907109|NCT03126227|617664639|FG000|Overall Study|Scheduling conflict|1|||
170907110|NCT03126227|617664640|FG001|Overall Study|Scheduling conflict|0|||
170907111|NCT01575548|617664641|FG000|Overall Study|Adverse Event|15|||
170907112|NCT01575548|617664642|FG001|Overall Study|Adverse Event|2|||
170907113|NCT01575548|617664641|FG000|Overall Study|Disease progression|12|||
170907114|NCT01575548|617664642|FG001|Overall Study|Disease progression|25|||
170907115|NCT01575548|617664641|FG000|Overall Study|Death|1|||
170907116|NCT01575548|617664642|FG001|Overall Study|Death|0|||
170907117|NCT01575548|617664641|FG000|Overall Study|Other complicating disease|1|||
170907118|NCT01575548|617664642|FG001|Overall Study|Other complicating disease|0|||
170907119|NCT01575548|617664641|FG000|Overall Study|Withdrawal by Subject|7|||
170907120|NCT01575548|617664642|FG001|Overall Study|Withdrawal by Subject|3|||
170907121|NCT01575548|617664641|FG000|Overall Study|Noncompliance|1|||
170907122|NCT01575548|617664642|FG001|Overall Study|Noncompliance|0|||
170907123|NCT01575548|617664641|FG000|Overall Study|Anticipated surgery|0|||
170907124|NCT01575548|617664642|FG001|Overall Study|Anticipated surgery|1|||
170907125|NCT01575548|617664641|FG000|Overall Study|Never started protocol therapy|3|||
170907126|NCT01575548|617664642|FG001|Overall Study|Never started protocol therapy|2|||
170907127|NCT03872180|617664643|FG000|Overall Study|Adverse Event|4|||
170566616|NCT01854528|616422079|FG000|Overall Study|Adverse Event|0|||
170566617|NCT01854528|616422080|FG001|Overall Study|Adverse Event|4|||
170566618|NCT01854528|616422079|FG000|Overall Study|Withdrawal by Subject|0|||
170566619|NCT01854528|616422080|FG001|Overall Study|Withdrawal by Subject|2|||
170566620|NCT01854528|616422079|FG000|Overall Study|Virologic Failure|0|||
170566621|NCT01854528|616422080|FG001|Overall Study|Virologic Failure|9|||
170907128|NCT03872180|617664643|FG000|Overall Study|Lack of Efficacy|2|||
170907129|NCT02835495|617664648|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
170907130|NCT02835495|617664649|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
170907131|NCT02835495|617664648|FG000|Overall Study|Declined in-person follow-up visit|4|||
170907132|NCT02835495|617664649|FG001|Overall Study|Declined in-person follow-up visit|2|||
170907133|NCT00356915|617664650|FG000|Overall Study|Non compliance|1|||
170907134|NCT00356915|617664651|FG001|Overall Study|Non compliance|2|||
170907135|NCT00356915|617664652|FG002|Overall Study|Non compliance|1|||
170907136|NCT00356915|617664650|FG000|Overall Study|Protocol Violation|2|||
170907137|NCT00356915|617664651|FG001|Overall Study|Protocol Violation|3|||
170907138|NCT00356915|617664652|FG002|Overall Study|Protocol Violation|2|||
170566622|NCT00518180|616422082|FG000|Overall Study|Withdrawal by Subject|29|||
170907139|NCT00356915|617664650|FG000|Overall Study|Withdrawal by Subject|14|||
170907140|NCT00356915|617664651|FG001|Overall Study|Withdrawal by Subject|14|||
170566623|NCT00518180|616422083|FG001|Overall Study|Withdrawal by Subject|30|||
170907141|NCT00356915|617664652|FG002|Overall Study|Withdrawal by Subject|10|||
170907142|NCT00356915|617664650|FG000|Overall Study|Lack of Efficacy|0|||
170907143|NCT00356915|617664651|FG001|Overall Study|Lack of Efficacy|0|||
170907144|NCT00356915|617664652|FG002|Overall Study|Lack of Efficacy|3|||
170907145|NCT00356915|617664650|FG000|Overall Study|Lost to Follow-up|27|||
170907146|NCT00356915|617664651|FG001|Overall Study|Lost to Follow-up|34|||
170907147|NCT00356915|617664652|FG002|Overall Study|Lost to Follow-up|14|||
170907148|NCT00356915|617664650|FG000|Overall Study|Administrative Decision|0|||
170907149|NCT00356915|617664651|FG001|Overall Study|Administrative Decision|0|||
170907150|NCT00356915|617664652|FG002|Overall Study|Administrative Decision|1|||
170907151|NCT00356915|617664650|FG000|Overall Study|Physician Decision|0|||
170907152|NCT00356915|617664651|FG001|Overall Study|Physician Decision|2|||
170907153|NCT00356915|617664652|FG002|Overall Study|Physician Decision|0|||
170907154|NCT00356915|617664650|FG000|Overall Study|Adverse Event|21|||
170907155|NCT00356915|617664651|FG001|Overall Study|Adverse Event|31|||
170907156|NCT00356915|617664652|FG002|Overall Study|Adverse Event|8|||
170907157|NCT00356915|617664650|FG000|Overall Study|Miscellaneous reasons|11|||
170907158|NCT00356915|617664651|FG001|Overall Study|Miscellaneous reasons|8|||
170907159|NCT00356915|617664652|FG002|Overall Study|Miscellaneous reasons|3|||
170907160|NCT02371629|617664653|FG000|Overall Study|Patient decision|14|||
170907161|NCT02371629|617664654|FG001|Overall Study|Patient decision|10|||
170907162|NCT02371629|617664653|FG000|Overall Study|Adverse Event|8|||
170907163|NCT02371629|617664654|FG001|Overall Study|Adverse Event|8|||
170907164|NCT02371629|617664653|FG000|Overall Study|Physician Decision|2|||
170907165|NCT02371629|617664654|FG001|Overall Study|Physician Decision|3|||
170907166|NCT02371629|617664653|FG000|Overall Study|Death|1|||
170907167|NCT02371629|617664654|FG001|Overall Study|Death|1|||
170907168|NCT02371629|617664653|FG000|Overall Study|Noncompliance with study treatment|1|||
170907169|NCT02371629|617664654|FG001|Overall Study|Noncompliance with study treatment|0|||
170907170|NCT02371629|617664653|FG000|Overall Study|Lack of Efficacy|0|||
170907171|NCT02371629|617664654|FG001|Overall Study|Lack of Efficacy|2|||
170907172|NCT02371629|617664653|FG000|Overall Study|Protocol deviation|0|||
170907173|NCT02371629|617664654|FG001|Overall Study|Protocol deviation|1|||
170907174|NCT01193335|617664655|FG000|After Infant Series|Lost to Follow-up|1|||
170907175|NCT01193335|617664656|FG001|After Infant Series|Lost to Follow-up|2|||
170907176|NCT01193335|617664655|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
170907177|NCT01193335|617664656|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
170907178|NCT01193335|617664655|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
170907179|NCT01193335|617664656|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
170907180|NCT01193335|617664655|FG000|1-Year Follow-up|Lost to Follow-up|4|||
170907181|NCT01193335|617664656|FG001|1-Year Follow-up|Lost to Follow-up|0|||
170907182|NCT01193335|617664655|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
170907183|NCT01193335|617664656|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
170907184|NCT01193335|617664655|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
170907185|NCT01193335|617664656|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
170907186|NCT06129487|617664659|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
170907187|NCT06129487|617664660|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
170907188|NCT00258154|617664661|FG000|Overall Study|Adverse Event|1|||
170907189|NCT00258154|617664662|FG001|Overall Study|Adverse Event|0|||
170907190|NCT00258154|617664661|FG000|Overall Study|Lost to Follow-up|0|||
170907191|NCT00258154|617664662|FG001|Overall Study|Lost to Follow-up|1|||
170907192|NCT00258154|617664661|FG000|Overall Study|Protocol Violation|2|||
170907193|NCT00258154|617664662|FG001|Overall Study|Protocol Violation|1|||
170907194|NCT00258154|617664661|FG000|Overall Study|Withdrawal by Subject|3|||
170907195|NCT00258154|617664662|FG001|Overall Study|Withdrawal by Subject|4|||
170907196|NCT00258154|617664661|FG000|Overall Study|Patient Moved|3|||
170907197|NCT00258154|617664662|FG001|Overall Study|Patient Moved|1|||
170907198|NCT00816036|617664665|FG000|Overall Study|Death|47|||
170907199|NCT00816036|617664666|FG001|Overall Study|Death|28|||
170907200|NCT00816036|617664665|FG000|Overall Study|Lost to Follow-up|75|||
170907201|NCT00816036|617664666|FG001|Overall Study|Lost to Follow-up|57|||
170907202|NCT00816036|617664665|FG000|Overall Study|Withdrawal by Subject|54|||
170907203|NCT00816036|617664666|FG001|Overall Study|Withdrawal by Subject|23|||
170907204|NCT00004980|617664667|FG000|Overall Study|Withdrawal by Subject|1|||
170907205|NCT00004980|617664668|FG001|Overall Study|Withdrawal by Subject|0|||
170907206|NCT00004980|617664667|FG000|Overall Study|memory difficulties|1|||
170907207|NCT00004980|617664668|FG001|Overall Study|memory difficulties|1|||
170907208|NCT00004980|617664667|FG000|Overall Study|Physician Decision|0|||
170907209|NCT00004980|617664668|FG001|Overall Study|Physician Decision|1|||
170907210|NCT01624194|617664669|FG000|Overall Study|Lost to Follow-up|1|||
170907211|NCT01624194|617664670|FG001|Overall Study|Lost to Follow-up|0|||
170907212|NCT01624194|617664669|FG000|Overall Study|Withdrawal by Subject|1|||
170907213|NCT01624194|617664670|FG001|Overall Study|Withdrawal by Subject|0|||
170907214|NCT03459040|617664677|FG000|Overall Study|Death|8|||
170907215|NCT03459040|617664677|FG000|Overall Study|Withdrawal by Subject|1|||
170907216|NCT00986349|617664678|FG000|Overall Study|Unsuccessful implant procedure|3|||
170907217|NCT00986349|617664678|FG000|Overall Study|Adverse Event|2|||
170907218|NCT00986349|617664678|FG000|Overall Study|Physician Decision|1|||
170907219|NCT00986349|617664678|FG000|Overall Study|device migration|1|||
170907220|NCT02299934|617664679|FG000|Overall Study|Termination of study|13|||
170907221|NCT00561353|617664680|FG000|Overall Study|Subject reached a virologic endpoint|2|||
170907222|NCT00561353|617664681|FG001|Overall Study|Subject reached a virologic endpoint|1|||
170907223|NCT00561353|617664682|FG002|Overall Study|Subject reached a virologic endpoint|1|||
170907224|NCT00561353|617664683|FG003|Overall Study|Subject reached a virologic endpoint|4|||
170907225|NCT00561353|617664684|FG004|Overall Study|Subject reached a virologic endpoint|1|||
170907226|NCT00561353|617664685|FG005|Overall Study|Subject reached a virologic endpoint|3|||
170907227|NCT00561353|617664686|FG006|Overall Study|Subject reached a virologic endpoint|4|||
170907228|NCT00561353|617664687|FG007|Overall Study|Subject reached a virologic endpoint|4|||
170907229|NCT00561353|617664688|FG008|Overall Study|Subject reached a virologic endpoint|5|||
170907230|NCT00561353|617664689|FG009|Overall Study|Subject reached a virologic endpoint|0|||
170907231|NCT00561353|617664680|FG000|Overall Study|Subject ineligible to continue the trial|0|||
170907232|NCT00561353|617664681|FG001|Overall Study|Subject ineligible to continue the trial|0|||
170566624|NCT00518180|616422084|FG002|Overall Study|Withdrawal by Subject|42|||
170566625|NCT00518180|616422082|FG000|Overall Study|Lost to Follow-up|30|||
170566626|NCT00518180|616422083|FG001|Overall Study|Lost to Follow-up|28|||
170566627|NCT00518180|616422084|FG002|Overall Study|Lost to Follow-up|34|||
170566628|NCT00518180|616422082|FG000|Overall Study|Administrative reason|0|||
170566629|NCT00518180|616422083|FG001|Overall Study|Administrative reason|2|||
170566630|NCT00518180|616422084|FG002|Overall Study|Administrative reason|2|||
170566631|NCT00518180|616422082|FG000|Overall Study|Protocol Violation|5|||
170566632|NCT00518180|616422083|FG001|Overall Study|Protocol Violation|7|||
170566633|NCT00518180|616422084|FG002|Overall Study|Protocol Violation|4|||
170646717|NCT03120624|616718996|FG000|Overall Study|Withdrawal by Subject|0|||
170646718|NCT03120624|616718997|FG001|Overall Study|Withdrawal by Subject|1|||
170646719|NCT03120624|616718998|FG002|Overall Study|Withdrawal by Subject|0|||
170566634|NCT00518180|616422082|FG000|Overall Study|Unable to classify|0|||
170566635|NCT00518180|616422083|FG001|Overall Study|Unable to classify|2|||
170566636|NCT00518180|616422084|FG002|Overall Study|Unable to classify|0|||
170566637|NCT00518180|616422082|FG000|Overall Study|Adverse Event|1|||
170566638|NCT00518180|616422083|FG001|Overall Study|Adverse Event|0|||
170566639|NCT00518180|616422084|FG002|Overall Study|Adverse Event|0|||
170566640|NCT01368614|616422085|FG000|Screening Period|Screen Failure|58|||
170566641|NCT01368614|616422086|FG001|Screening Period|Screen Failure|0|||
170566642|NCT01368614|616422087|FG002|Screening Period|Screen Failure|0|||
170566643|NCT01368614|616422088|FG003|Screening Period|Screen Failure|0|||
170566644|NCT01368614|616422085|FG000|Study Period|Withdrawal by Subject|0|||
170566645|NCT01368614|616422086|FG001|Study Period|Withdrawal by Subject|1|||
170566646|NCT01368614|616422087|FG002|Study Period|Withdrawal by Subject|1|||
170566647|NCT01368614|616422088|FG003|Study Period|Withdrawal by Subject|3|||
170566648|NCT01368614|616422085|FG000|Study Period|Lost to Follow-up|0|||
170566649|NCT01368614|616422086|FG001|Study Period|Lost to Follow-up|0|||
170566650|NCT01368614|616422087|FG002|Study Period|Lost to Follow-up|1|||
170566651|NCT01368614|616422088|FG003|Study Period|Lost to Follow-up|0|||
170566652|NCT00746811|616422092|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
170566653|NCT00746811|616422093|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
170566654|NCT01538199|616422094|FG000|Overall Study|Lost to Follow-up|1|||
170566655|NCT01538199|616422095|FG001|Overall Study|Lost to Follow-up|2|||
170566656|NCT01538199|616422096|FG002|Overall Study|Lost to Follow-up|1|||
170566657|NCT01538199|616422097|FG003|Overall Study|Lost to Follow-up|0|||
170566658|NCT01538199|616422094|FG000|Overall Study|participant did not have time|1|||
170566659|NCT01538199|616422095|FG001|Overall Study|participant did not have time|0|||
170566660|NCT01538199|616422096|FG002|Overall Study|participant did not have time|0|||
170566661|NCT01538199|616422097|FG003|Overall Study|participant did not have time|2|||
170566662|NCT01538199|616422094|FG000|Overall Study|Lack of Efficacy|0|||
170566663|NCT01538199|616422095|FG001|Overall Study|Lack of Efficacy|1|||
170566664|NCT01538199|616422096|FG002|Overall Study|Lack of Efficacy|0|||
170566665|NCT01538199|616422097|FG003|Overall Study|Lack of Efficacy|0|||
170566666|NCT02081586|616422098|FG000|Overall Study|Lost to Follow-up|0|||
170566667|NCT02081586|616422099|FG001|Overall Study|Lost to Follow-up|1|||
170566668|NCT02081586|616422100|FG002|Overall Study|Lost to Follow-up|0|||
170566669|NCT02081586|616422101|FG003|Overall Study|Lost to Follow-up|1|||
170566670|NCT02081586|616422098|FG000|Overall Study|Head injury not related to study|0|||
170566671|NCT02081586|616422099|FG001|Overall Study|Head injury not related to study|0|||
170566672|NCT02081586|616422100|FG002|Overall Study|Head injury not related to study|1|||
170566673|NCT02081586|616422101|FG003|Overall Study|Head injury not related to study|0|||
170566674|NCT03358030|616422104|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
170566675|NCT03358030|616422105|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
170566676|NCT03358030|616422106|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
170566677|NCT03358030|616422107|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
170566678|NCT03358030|616422104|FG000|Overall Study|Ineligibility|0|||
170566679|NCT03358030|616422105|FG001|Overall Study|Ineligibility|0|||
170566680|NCT03358030|616422106|FG002|Overall Study|Ineligibility|0|||
170566681|NCT03358030|616422107|FG003|Overall Study|Ineligibility|2|||
170566682|NCT03358030|616422104|FG000|Overall Study|Voluntary Withdrawal|1|||
170566683|NCT03358030|616422105|FG001|Overall Study|Voluntary Withdrawal|1|||
170566684|NCT03358030|616422106|FG002|Overall Study|Voluntary Withdrawal|3|||
170566685|NCT03358030|616422107|FG003|Overall Study|Voluntary Withdrawal|1|||
170566686|NCT03358030|616422104|FG000|Overall Study|Other|0|||
170566687|NCT03358030|616422105|FG001|Overall Study|Other|0|||
170566688|NCT03358030|616422106|FG002|Overall Study|Other|1|||
170566689|NCT03358030|616422107|FG003|Overall Study|Other|0|||
170566690|NCT02604511|616422108|FG000|Overall Study|Adverse Event|3|||
170566691|NCT02604511|616422108|FG000|Overall Study|Disease Progression|4|||
170566692|NCT02604511|616422108|FG000|Overall Study|Withdrawal by Subject|3|||
170566693|NCT02604511|616422108|FG000|Overall Study|Participant ineligible|1|||
170646720|NCT03120624|616718999|FG003|Overall Study|Withdrawal by Subject|0|||
170646721|NCT03120624|616719000|FG004|Overall Study|Withdrawal by Subject|0|||
170646722|NCT03120624|616719001|FG005|Overall Study|Withdrawal by Subject|0|||
170646723|NCT03120624|616719002|FG006|Overall Study|Withdrawal by Subject|0|||
170646724|NCT03120624|616719003|FG007|Overall Study|Withdrawal by Subject|0|||
170807195|NCT02743819|617303719|FG000|Overall Study|Adverse Event|1|||
170566694|NCT02604511|616422108|FG000|Overall Study|Intercurrent illness|1|||
170566695|NCT00789555|616422121|FG000|Overall Study|Protocol Amendment|78|||
170566696|NCT00789555|616422122|FG001|Overall Study|Protocol Amendment|76|||
170566697|NCT00789555|616422123|FG002|Overall Study|Protocol Amendment|80|||
170566698|NCT00789555|616422121|FG000|Overall Study|Adverse Event|17|||
170566699|NCT00789555|616422122|FG001|Overall Study|Adverse Event|7|||
170566700|NCT00789555|616422123|FG002|Overall Study|Adverse Event|10|||
170566701|NCT00789555|616422121|FG000|Overall Study|Lost to Follow-up|9|||
170907233|NCT00561353|617664682|FG002|Overall Study|Subject ineligible to continue the trial|0|||
170907234|NCT00561353|617664683|FG003|Overall Study|Subject ineligible to continue the trial|0|||
170907235|NCT00561353|617664684|FG004|Overall Study|Subject ineligible to continue the trial|0|||
170907236|NCT00561353|617664685|FG005|Overall Study|Subject ineligible to continue the trial|1|||
170907237|NCT00561353|617664686|FG006|Overall Study|Subject ineligible to continue the trial|1|||
170907238|NCT00561353|617664687|FG007|Overall Study|Subject ineligible to continue the trial|0|||
170907239|NCT00561353|617664688|FG008|Overall Study|Subject ineligible to continue the trial|2|||
170907240|NCT00561353|617664689|FG009|Overall Study|Subject ineligible to continue the trial|1|||
170907241|NCT00561353|617664680|FG000|Overall Study|Other|1|||
170907242|NCT00561353|617664681|FG001|Overall Study|Other|0|||
170907243|NCT00561353|617664682|FG002|Overall Study|Other|1|||
170907244|NCT00561353|617664683|FG003|Overall Study|Other|0|||
170907245|NCT00561353|617664684|FG004|Overall Study|Other|0|||
170907246|NCT00561353|617664685|FG005|Overall Study|Other|2|||
170907247|NCT00561353|617664686|FG006|Overall Study|Other|0|||
170907248|NCT00561353|617664687|FG007|Overall Study|Other|0|||
170907249|NCT00561353|617664688|FG008|Overall Study|Other|0|||
170907250|NCT00561353|617664689|FG009|Overall Study|Other|0|||
170907251|NCT00561353|617664680|FG000|Overall Study|Adverse Event|0|||
170907252|NCT00561353|617664681|FG001|Overall Study|Adverse Event|0|||
170907253|NCT00561353|617664682|FG002|Overall Study|Adverse Event|0|||
170907254|NCT00561353|617664683|FG003|Overall Study|Adverse Event|2|||
170907255|NCT00561353|617664684|FG004|Overall Study|Adverse Event|0|||
170907256|NCT00561353|617664685|FG005|Overall Study|Adverse Event|0|||
170907257|NCT00561353|617664686|FG006|Overall Study|Adverse Event|1|||
170907258|NCT00561353|617664687|FG007|Overall Study|Adverse Event|0|||
170907259|NCT00561353|617664688|FG008|Overall Study|Adverse Event|0|||
170907260|NCT00561353|617664689|FG009|Overall Study|Adverse Event|1|||
170907261|NCT00561353|617664680|FG000|Overall Study|Lost to Follow-up|2|||
170907262|NCT00561353|617664681|FG001|Overall Study|Lost to Follow-up|0|||
170907263|NCT00561353|617664682|FG002|Overall Study|Lost to Follow-up|1|||
170907264|NCT00561353|617664683|FG003|Overall Study|Lost to Follow-up|0|||
170907265|NCT00561353|617664684|FG004|Overall Study|Lost to Follow-up|0|||
170907266|NCT00561353|617664685|FG005|Overall Study|Lost to Follow-up|0|||
170907267|NCT00561353|617664686|FG006|Overall Study|Lost to Follow-up|0|||
170907268|NCT00561353|617664687|FG007|Overall Study|Lost to Follow-up|0|||
170907269|NCT00561353|617664688|FG008|Overall Study|Lost to Follow-up|0|||
170907270|NCT00561353|617664689|FG009|Overall Study|Lost to Follow-up|0|||
170907271|NCT00561353|617664680|FG000|Overall Study|Withdrawal by Subject|0|||
170907272|NCT00561353|617664681|FG001|Overall Study|Withdrawal by Subject|2|||
170907273|NCT00561353|617664682|FG002|Overall Study|Withdrawal by Subject|0|||
170907274|NCT00561353|617664683|FG003|Overall Study|Withdrawal by Subject|0|||
170907275|NCT00561353|617664684|FG004|Overall Study|Withdrawal by Subject|0|||
170907276|NCT00561353|617664685|FG005|Overall Study|Withdrawal by Subject|0|||
170907277|NCT00561353|617664686|FG006|Overall Study|Withdrawal by Subject|0|||
170907278|NCT00561353|617664687|FG007|Overall Study|Withdrawal by Subject|0|||
170907279|NCT00561353|617664688|FG008|Overall Study|Withdrawal by Subject|0|||
170907280|NCT00561353|617664689|FG009|Overall Study|Withdrawal by Subject|0|||
170907281|NCT03577990|617664690|FG000|Overall Study|Lost to Follow-up|4|||
170907282|NCT03577990|617664691|FG001|Overall Study|Lost to Follow-up|6|||
170907283|NCT03577990|617664690|FG000|Overall Study|Withdrawal by Subject|4|||
170907284|NCT03577990|617664691|FG001|Overall Study|Withdrawal by Subject|7|||
170907285|NCT02493751|617664699|FG000|Overall Study|Withdrawal by Subject|2|||
170907286|NCT02493751|617664700|FG001|Overall Study|Withdrawal by Subject|8|||
170907287|NCT02493751|617664699|FG000|Overall Study|Death|6|||
170907288|NCT02493751|617664700|FG001|Overall Study|Death|13|||
170907289|NCT02493751|617664699|FG000|Overall Study|Lost to Follow-up|2|||
170907290|NCT02493751|617664700|FG001|Overall Study|Lost to Follow-up|3|||
170907291|NCT02493751|617664699|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
170907292|NCT02493751|617664700|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
170907293|NCT01259466|617664701|FG000|Overall Study|Withdrawal by Subject|1|||
170646725|NCT07152808|616719011|FG000|Overall Study|screening failure|10|||
170646726|NCT02907892|616719580|FG000|Overall Study|Lost to Follow-up|27|||
170646727|NCT02907892|616719581|FG001|Overall Study|Lost to Follow-up|40|||
170646728|NCT01974765|616719582|FG000|Overall Study|Withdrawal by Subject|1|||
170907294|NCT01259466|617664702|FG001|Overall Study|Withdrawal by Subject|9|||
170907295|NCT00761215|617664708|FG000|Overall Study|Randomized but didn't receive drug|1|||
170907296|NCT00761215|617664709|FG001|Overall Study|Randomized but didn't receive drug|1|||
170907297|NCT00761215|617664710|FG002|Overall Study|Randomized but didn't receive drug|2|||
170907298|NCT00761215|617664708|FG000|Overall Study|Lost to Follow-up|6|||
170907299|NCT00761215|617664709|FG001|Overall Study|Lost to Follow-up|3|||
170907300|NCT00761215|617664710|FG002|Overall Study|Lost to Follow-up|6|||
170907301|NCT00761215|617664708|FG000|Overall Study|Withdrawal by Subject|1|||
170907302|NCT00761215|617664709|FG001|Overall Study|Withdrawal by Subject|0|||
170907303|NCT00761215|617664710|FG002|Overall Study|Withdrawal by Subject|0|||
170907304|NCT00761215|617664708|FG000|Overall Study|Bacteremia|1|||
170907305|NCT00761215|617664709|FG001|Overall Study|Bacteremia|0|||
170566702|NCT00789555|616422122|FG001|Overall Study|Lost to Follow-up|10|||
170566703|NCT00789555|616422123|FG002|Overall Study|Lost to Follow-up|18|||
170566704|NCT00789555|616422121|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
170566705|NCT00789555|616422122|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
170566706|NCT00789555|616422123|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
170566707|NCT00789555|616422121|FG000|Overall Study|Treatment failure|11|||
170566708|NCT00789555|616422122|FG001|Overall Study|Treatment failure|8|||
170566709|NCT00789555|616422123|FG002|Overall Study|Treatment failure|12|||
170566710|NCT00789555|616422121|FG000|Overall Study|Protocol Violation|6|||
170566711|NCT00789555|616422122|FG001|Overall Study|Protocol Violation|9|||
170566712|NCT00789555|616422123|FG002|Overall Study|Protocol Violation|13|||
170566713|NCT00698841|616422124|FG000|Overall Study|Withdrawal by Subject|2|||
170566714|NCT00698841|616422124|FG000|Overall Study|Adverse Event|3|||
170566715|NCT00698841|616422124|FG000|Overall Study|Disease progression|7|||
170566716|NCT00698841|616422124|FG000|Overall Study|Failure to meet eligibility criteria|2|||
170566717|NCT00698841|616422124|FG000|Overall Study|Study drug toxicity|2|||
170566718|NCT00698841|616422124|FG000|Overall Study|Other|2|||
170566719|NCT00404248|616422125|FG000|Overall Study|pts declining status|0|||
170566720|NCT00404248|616422126|FG001|Overall Study|pts declining status|1|||
170566721|NCT00404248|616422127|FG002|Overall Study|pts declining status|0|||
170566722|NCT00404248|616422128|FG003|Overall Study|pts declining status|0|||
170566723|NCT00404248|616422129|FG004|Overall Study|pts declining status|0|||
170566724|NCT00404248|616422130|FG005|Overall Study|pts declining status|0|||
170566725|NCT00404248|616422131|FG006|Overall Study|pts declining status|0|||
170566726|NCT00404248|616422132|FG007|Overall Study|pts declining status|0|||
170566727|NCT00404248|616422133|FG008|Overall Study|pts declining status|0|||
170566728|NCT05788991|616422137|FG000|Overall Study|Not treated with study medication|1|||
170566729|NCT05788991|616422138|FG001|Overall Study|Not treated with study medication|3|||
170566730|NCT05788991|616422137|FG000|Overall Study|Withdrawal by Subject|1|||
170566731|NCT05788991|616422138|FG001|Overall Study|Withdrawal by Subject|0|||
170566732|NCT05788991|616422137|FG000|Overall Study|Lack of Efficacy|0|||
170566733|NCT05788991|616422138|FG001|Overall Study|Lack of Efficacy|1|||
170566734|NCT05788991|616422137|FG000|Overall Study|Protocol Violation|1|||
170566735|NCT05788991|616422138|FG001|Overall Study|Protocol Violation|2|||
170566736|NCT03802396|616422139|FG000|Overall Study|Withdrawal by Subject|2|||
170566737|NCT03802396|616422140|FG001|Overall Study|Withdrawal by Subject|0|||
170566738|NCT03802396|616422139|FG000|Overall Study|Surgery Cancelled|1|||
170566739|NCT03802396|616422140|FG001|Overall Study|Surgery Cancelled|0|||
170566740|NCT01150357|616422148|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
170566741|NCT01150357|616422149|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
170566742|NCT01150357|616422150|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
170566743|NCT01150357|616422148|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
170566744|NCT01150357|616422149|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
170566745|NCT01150357|616422150|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
170566746|NCT01150357|616422148|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
170566747|NCT01150357|616422149|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
170566748|NCT01150357|616422150|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
170566749|NCT01150357|616422148|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
170566750|NCT01150357|616422149|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
170566751|NCT01150357|616422150|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
170566752|NCT01150357|616422148|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
170566753|NCT01150357|616422149|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
170566754|NCT01150357|616422150|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
170566755|NCT01150357|616422148|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
170566756|NCT01150357|616422149|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
170566757|NCT01150357|616422150|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
170566758|NCT01150357|616422148|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
170566759|NCT01150357|616422149|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
170566760|NCT01150357|616422150|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
170566761|NCT02661672|616422151|FG000|Overall Study|Lost to Follow-up|1|||
170566762|NCT02661672|616422151|FG000|Overall Study|Death|4|||
170566763|NCT02391311|616423689|FG000|Overall Study|Lost to Follow-up|2|||
170566764|NCT02391311|616423690|FG001|Overall Study|Lost to Follow-up|1|||
170566765|NCT02391311|616423689|FG000|Overall Study|deemed ineligible after baseline|1|||
170646729|NCT01974765|616719582|FG000|Overall Study|Death|1|||
170807196|NCT00243867|617303720|FG000|Overall Study|Adverse Event|24|||
170566766|NCT02391311|616423690|FG001|Overall Study|deemed ineligible after baseline|1|||
170566767|NCT02808897|616423693|FG000|Overall Study|Lost to Follow-up|9|||
170566768|NCT02808897|616423694|FG001|Overall Study|Lost to Follow-up|11|||
170566769|NCT01343888|616423695|FG000|Overall Study|Adverse Event|12|||
170566770|NCT01343888|616423696|FG001|Overall Study|Adverse Event|22|||
170566771|NCT01343888|616423697|FG002|Overall Study|Adverse Event|5|||
170566772|NCT01343888|616423695|FG000|Overall Study|Lack of Efficacy|9|||
170807197|NCT00243867|617303721|FG001|Overall Study|Adverse Event|34|||
170907306|NCT00761215|617664710|FG002|Overall Study|Bacteremia|0|||
170907307|NCT05662332|617664711|FG000|Overall Study|Death|3|||
170907308|NCT05662332|617664712|FG001|Overall Study|Death|3|||
170907309|NCT05662332|617664711|FG000|Overall Study|Lost to Follow-up|3|||
170907310|NCT05662332|617664712|FG001|Overall Study|Lost to Follow-up|8|||
170907311|NCT05662332|617664711|FG000|Overall Study|Physician Decision|1|||
170907312|NCT05662332|617664712|FG001|Overall Study|Physician Decision|2|||
170907313|NCT05662332|617664711|FG000|Overall Study|Protocol Deviation|2|||
170907314|NCT05662332|617664712|FG001|Overall Study|Protocol Deviation|1|||
170907315|NCT05662332|617664711|FG000|Overall Study|Withdrawal by Subject|14|||
170907316|NCT05662332|617664712|FG001|Overall Study|Withdrawal by Subject|14|||
170907317|NCT05662332|617664711|FG000|Overall Study|Assigned Treatment by Mistake|5|||
170907318|NCT05662332|617664712|FG001|Overall Study|Assigned Treatment by Mistake|7|||
170907319|NCT05662332|617664711|FG000|Overall Study|Non-compliance with study drug|4|||
170907320|NCT05662332|617664712|FG001|Overall Study|Non-compliance with study drug|1|||
170907321|NCT05662332|617664711|FG000|Overall Study|Due to Bariatric surgery|1|||
170907322|NCT05662332|617664712|FG001|Overall Study|Due to Bariatric surgery|0|||
170907323|NCT05662332|617664711|FG000|Overall Study|Subject Moving out of State|0|||
170907324|NCT05662332|617664712|FG001|Overall Study|Subject Moving out of State|1|||
170907325|NCT05662332|617664711|FG000|Overall Study|Subject Missed the Schedule|1|||
170907326|NCT05662332|617664712|FG001|Overall Study|Subject Missed the Schedule|0|||
170907327|NCT05662332|617664711|FG000|Overall Study|The Patient Moved to Another City|1|||
170907328|NCT05662332|617664712|FG001|Overall Study|The Patient Moved to Another City|0|||
170907329|NCT02827877|617664713|FG000|Overall Study|Withdrawal by Subject|1|||
170907330|NCT00519532|617664716|FG000|Overall Study|Adverse Event|11|||
170907331|NCT00519532|617664716|FG000|Overall Study|Withdrawal by Subject|5|||
170907332|NCT00519532|617664716|FG000|Overall Study|Lost to Follow-up|2|||
170907333|NCT03914300|617664717|FG000|Overall Study|Adverse Event|1|||
170566773|NCT01343888|616423696|FG001|Overall Study|Lack of Efficacy|9|||
170566774|NCT01343888|616423697|FG002|Overall Study|Lack of Efficacy|13|||
170566775|NCT01343888|616423695|FG000|Overall Study|Lost to Follow-up|0|||
170566776|NCT01343888|616423696|FG001|Overall Study|Lost to Follow-up|2|||
170907334|NCT00814710|617664718|FG000|Overall Study|Adverse Event|1|||
170566777|NCT01343888|616423697|FG002|Overall Study|Lost to Follow-up|1|||
170566778|NCT01343888|616423695|FG000|Overall Study|Protocol Violation|0|||
170907335|NCT00814710|617664719|FG001|Overall Study|Adverse Event|0|||
170907336|NCT00814710|617664718|FG000|Overall Study|Lost to Follow-up|7|||
170907337|NCT00814710|617664719|FG001|Overall Study|Lost to Follow-up|3|||
170907338|NCT00457639|617664725|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
170907339|NCT00457639|617664726|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
170907340|NCT00457639|617664725|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
170907341|NCT00457639|617664726|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
170907342|NCT00457639|617664725|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
170907343|NCT00457639|617664726|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
170907344|NCT03885284|617664727|FG000|Overall Study|Disease Progression|1|||
170907345|NCT03885284|617664728|FG001|Overall Study|Disease Progression|3|||
170907346|NCT03885284|617664727|FG000|Overall Study|Physician Decision|0|||
170907347|NCT03885284|617664728|FG001|Overall Study|Physician Decision|1|||
170907348|NCT00002850|617664729|FG000|Overall Study|Death|4|||
170907349|NCT00002850|617664730|FG001|Overall Study|Death|1|||
170907350|NCT00002850|617664731|FG002|Overall Study|Death|3|||
170907351|NCT00002850|617664729|FG000|Overall Study|Protocol Violation|1|||
170907352|NCT00002850|617664730|FG001|Overall Study|Protocol Violation|0|||
170907353|NCT00002850|617664731|FG002|Overall Study|Protocol Violation|1|||
170566779|NCT01343888|616423696|FG001|Overall Study|Protocol Violation|2|||
170566780|NCT01343888|616423697|FG002|Overall Study|Protocol Violation|0|||
170566781|NCT01343888|616423695|FG000|Overall Study|Withdrawal by Subject|4|||
170566782|NCT01343888|616423696|FG001|Overall Study|Withdrawal by Subject|4|||
170566783|NCT01343888|616423697|FG002|Overall Study|Withdrawal by Subject|2|||
170566784|NCT01343888|616423695|FG000|Overall Study|other than stated above|0|||
170566785|NCT01343888|616423696|FG001|Overall Study|other than stated above|0|||
170566786|NCT01343888|616423697|FG002|Overall Study|other than stated above|1|||
170566787|NCT02133573|616423698|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
170646730|NCT01974765|616719582|FG000|Overall Study|Adverse Event|2|||
170907354|NCT00002850|617664729|FG000|Overall Study|Withdrawal by Subject|0|||
170907355|NCT00002850|617664730|FG001|Overall Study|Withdrawal by Subject|1|||
170907356|NCT00002850|617664731|FG002|Overall Study|Withdrawal by Subject|0|||
170907357|NCT03542682|617664735|FG000|Overall Study|COVID-19 Protocol|0|||
170907358|NCT03542682|617664736|FG001|Overall Study|COVID-19 Protocol|1|||
170907359|NCT03598777|617664737|FG000|Overall Study|Study Terminated by Sponsor|3|||
170907360|NCT03598777|617664738|FG001|Overall Study|Study Terminated by Sponsor|0|||
170907361|NCT03598777|617664739|FG002|Overall Study|Study Terminated by Sponsor|0|||
170907362|NCT03598777|617664740|FG003|Overall Study|Study Terminated by Sponsor|0|||
170907363|NCT03598777|617664741|FG004|Overall Study|Study Terminated by Sponsor|15|||
170907364|NCT03598777|617664737|FG000|Overall Study|Withdrawal by Subject|1|||
170566788|NCT02133573|616423699|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
170566789|NCT02133573|616423698|FG000|Overall Study|Child Deaths|3|||
170807198|NCT00243867|617303720|FG000|Overall Study|Lack of Efficacy|115|||
170807199|NCT00243867|617303721|FG001|Overall Study|Lack of Efficacy|78|||
170807200|NCT00243867|617303720|FG000|Overall Study|Withdrawal by Subject|11|||
170807201|NCT00243867|617303721|FG001|Overall Study|Withdrawal by Subject|23|||
170807202|NCT00243867|617303720|FG000|Overall Study|Lost to Follow-up|2|||
170807203|NCT00243867|617303721|FG001|Overall Study|Lost to Follow-up|1|||
170807204|NCT00243867|617303720|FG000|Overall Study|Physician Decision|2|||
170807205|NCT00243867|617303721|FG001|Overall Study|Physician Decision|7|||
170807206|NCT00243867|617303720|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
170807207|NCT00243867|617303721|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
170807208|NCT05787496|617303724|FG000|Overall Study|Adverse Event|0|||
170807209|NCT05787496|617303725|FG001|Overall Study|Adverse Event|0|||
170807210|NCT05787496|617303726|FG002|Overall Study|Adverse Event|0|||
170807211|NCT05787496|617303727|FG003|Overall Study|Adverse Event|1|||
170807212|NCT05787496|617303728|FG004|Overall Study|Adverse Event|0|||
170807213|NCT05787496|617303729|FG005|Overall Study|Adverse Event|0|||
170807214|NCT05787496|617303724|FG000|Overall Study|Study Terminated by sponsor|0|||
170807215|NCT05787496|617303725|FG001|Overall Study|Study Terminated by sponsor|0|||
170807216|NCT05787496|617303726|FG002|Overall Study|Study Terminated by sponsor|0|||
170807217|NCT05787496|617303727|FG003|Overall Study|Study Terminated by sponsor|1|||
170807218|NCT05787496|617303728|FG004|Overall Study|Study Terminated by sponsor|0|||
170807219|NCT05787496|617303729|FG005|Overall Study|Study Terminated by sponsor|0|||
170807220|NCT05787496|617303724|FG000|Overall Study|Death|2|||
170807221|NCT05787496|617303725|FG001|Overall Study|Death|1|||
170807222|NCT05787496|617303726|FG002|Overall Study|Death|1|||
170807223|NCT05787496|617303727|FG003|Overall Study|Death|4|||
170807224|NCT05787496|617303728|FG004|Overall Study|Death|1|||
170807225|NCT05787496|617303729|FG005|Overall Study|Death|2|||
170807226|NCT00467272|617303730|FG000|Overall Study|Pneumonia|2|||
170807227|NCT00467272|617303730|FG000|Overall Study|Thrombophlebitis|1|||
170807228|NCT02542943|617303731|FG000|Overall Study|Lost to Follow-up|1|||
170646731|NCT00348933|616719583|FG000|Overall Study|Withdrawal by Subject|10|||
170566790|NCT02133573|616423699|FG001|Overall Study|Child Deaths|5|||
170566791|NCT02133573|616423698|FG000|Overall Study|Child Declined Follow Ups|2|||
170566792|NCT02133573|616423699|FG001|Overall Study|Child Declined Follow Ups|1|||
170566793|NCT02133573|616423698|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
170566794|NCT02133573|616423699|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
170566795|NCT01008618|616423702|FG000|Period 1 (Titration Period)|Physician Decision|2|||
170566796|NCT01008618|616423703|FG001|Period 1 (Titration Period)|Physician Decision|0|||
170566797|NCT01008618|616423704|FG002|Period 1 (Titration Period)|Physician Decision|0|||
170566798|NCT01008618|616423702|FG000|Period 1 (Titration Period)|Adverse Event|33|||
170566799|NCT01008618|616423703|FG001|Period 1 (Titration Period)|Adverse Event|0|||
170566800|NCT01008618|616423704|FG002|Period 1 (Titration Period)|Adverse Event|0|||
170566801|NCT01008618|616423702|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
170566802|NCT01008618|616423703|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
170566803|NCT01008618|616423704|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
170566804|NCT01008618|616423702|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
170566805|NCT01008618|616423703|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
170566806|NCT01008618|616423704|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
170566807|NCT01008618|616423702|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
170566808|NCT01008618|616423703|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
170566809|NCT01008618|616423704|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
170566810|NCT01008618|616423702|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
170566811|NCT01008618|616423703|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
170566812|NCT01008618|616423704|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
170566813|NCT01008618|616423702|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
170566814|NCT01008618|616423703|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
170566815|NCT01008618|616423704|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
170566816|NCT01008618|616423702|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
170566817|NCT01008618|616423703|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
170566818|NCT01008618|616423704|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
170566819|NCT01008618|616423702|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
170566820|NCT01008618|616423703|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
170566821|NCT01008618|616423704|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
170566822|NCT01008618|616423702|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
170566823|NCT01008618|616423703|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
170646732|NCT00348933|616719583|FG000|Overall Study|Lost to Follow-up|6|||
170807229|NCT02542943|617303732|FG001|Overall Study|Lost to Follow-up|0|||
170807230|NCT02542943|617303733|FG002|Overall Study|Lost to Follow-up|0|||
170807231|NCT02542943|617303731|FG000|Overall Study|Withdrawal by Subject|0|||
170807232|NCT02542943|617303732|FG001|Overall Study|Withdrawal by Subject|1|||
170807233|NCT02542943|617303733|FG002|Overall Study|Withdrawal by Subject|0|||
170566824|NCT01008618|616423704|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
170566825|NCT01008618|616423702|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
170566826|NCT01008618|616423703|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
170566827|NCT01008618|616423704|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
170566828|NCT01008618|616423702|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
170566829|NCT01008618|616423703|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
170566830|NCT01008618|616423704|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
170566831|NCT00894387|616423705|FG000|Overall Study|Adverse Event|44|||
170566832|NCT00894387|616423706|FG001|Overall Study|Adverse Event|45|||
170566833|NCT00894387|616423705|FG000|Overall Study|Abnormal Laboratory values|2|||
170566834|NCT00894387|616423706|FG001|Overall Study|Abnormal Laboratory values|2|||
170566835|NCT00894387|616423705|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170566836|NCT00894387|616423706|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170566837|NCT00894387|616423705|FG000|Overall Study|Lost to Follow-up|3|||
170566838|NCT00894387|616423706|FG001|Overall Study|Lost to Follow-up|5|||
170566839|NCT00894387|616423705|FG000|Overall Study|Administrative problems|2|||
170566840|NCT00894387|616423706|FG001|Overall Study|Administrative problems|2|||
170566841|NCT00894387|616423705|FG000|Overall Study|Death|77|||
170566842|NCT00894387|616423706|FG001|Overall Study|Death|76|||
170566843|NCT00894387|616423705|FG000|Overall Study|Protocol Deviation|4|||
170566844|NCT00894387|616423706|FG001|Overall Study|Protocol Deviation|0|||
170566845|NCT00894387|616423705|FG000|Overall Study|Patient's request|25|||
170566846|NCT00894387|616423706|FG001|Overall Study|Patient's request|30|||
170566847|NCT00894387|616423705|FG000|Overall Study|Other (Missing)|5|||
170566848|NCT00894387|616423706|FG001|Overall Study|Other (Missing)|3|||
170566849|NCT00894387|616423705|FG000|Overall Study|Mis-randomized|13|||
170566850|NCT00894387|616423706|FG001|Overall Study|Mis-randomized|9|||
170566851|NCT00894387|616423705|FG000|Overall Study|GCP non-compliance|0|||
170566852|NCT00894387|616423706|FG001|Overall Study|GCP non-compliance|2|||
170566853|NCT00487981|616423709|FG000|Overall Study|Hypothyroidism diagnosis|1|||
170566854|NCT01213082|616423710|FG000|Overall Study|Lost to Follow-up|6|||
170566855|NCT01213082|616423711|FG001|Overall Study|Lost to Follow-up|7|||
170566856|NCT01213082|616423712|FG002|Overall Study|Lost to Follow-up|4|||
170566857|NCT01213082|616423710|FG000|Overall Study|Physician Decision|0|||
170807234|NCT02409680|617303736|FG000|Overall Study|Lost to Follow-up|15|||
170807235|NCT02409680|617303737|FG001|Overall Study|Lost to Follow-up|30|||
170807236|NCT01690624|617303740|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
170807237|NCT01690624|617303741|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
170807238|NCT01690624|617303742|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
170807239|NCT01690624|617303743|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
170807240|NCT01690624|617303740|FG000|Overall Study|Adverse event (other than DLT)|3|||
170807241|NCT01690624|617303741|FG001|Overall Study|Adverse event (other than DLT)|1|||
170807242|NCT01690624|617303742|FG002|Overall Study|Adverse event (other than DLT)|1|||
170807243|NCT01690624|617303743|FG003|Overall Study|Adverse event (other than DLT)|1|||
170807244|NCT01690624|617303740|FG000|Overall Study|Withdrawal by Subject|0|||
170807245|NCT01690624|617303741|FG001|Overall Study|Withdrawal by Subject|0|||
170807246|NCT01690624|617303742|FG002|Overall Study|Withdrawal by Subject|1|||
170807247|NCT01690624|617303743|FG003|Overall Study|Withdrawal by Subject|0|||
170807248|NCT01690624|617303740|FG000|Overall Study|Sponsor is ending trial|0|||
170807249|NCT01690624|617303741|FG001|Overall Study|Sponsor is ending trial|0|||
170807250|NCT01690624|617303742|FG002|Overall Study|Sponsor is ending trial|0|||
170807251|NCT01690624|617303743|FG003|Overall Study|Sponsor is ending trial|1|||
170807252|NCT01690624|617303740|FG000|Overall Study|Physician Decision|0|||
170807253|NCT01690624|617303741|FG001|Overall Study|Physician Decision|0|||
170807254|NCT01690624|617303742|FG002|Overall Study|Physician Decision|0|||
170807255|NCT01690624|617303743|FG003|Overall Study|Physician Decision|1|||
170807256|NCT01690624|617303740|FG000|Overall Study|Withdrawal by Subject|0|||
170807257|NCT01690624|617303741|FG001|Overall Study|Withdrawal by Subject|1|||
170807258|NCT01690624|617303742|FG002|Overall Study|Withdrawal by Subject|0|||
170807259|NCT01690624|617303743|FG003|Overall Study|Withdrawal by Subject|0|||
170807260|NCT01690624|617303740|FG000|Overall Study|Lack of Efficacy|1|||
170807261|NCT01690624|617303741|FG001|Overall Study|Lack of Efficacy|1|||
170807262|NCT01690624|617303742|FG002|Overall Study|Lack of Efficacy|3|||
170807263|NCT01690624|617303743|FG003|Overall Study|Lack of Efficacy|0|||
170807264|NCT01563185|617303750|FG000|Overall Study|Withdrawal by Subject|1|||
170807265|NCT01563185|617303750|FG000|Overall Study|Non-Compliance with study drug|1|||
170807266|NCT04577651|617303751|FG000|Overall Study|Screen Failure|7|||
170807267|NCT04577651|617303751|FG000|Overall Study|Adverse Event|1|||
170807268|NCT04577651|617303751|FG000|Overall Study|Death|1|||
170807269|NCT04577651|617303751|FG000|Overall Study|Physician Decision|1|||
170807270|NCT04577651|617303751|FG000|Overall Study|Withdrawal by Subject|3|||
170566858|NCT01213082|616423711|FG001|Overall Study|Physician Decision|0|||
170566859|NCT01213082|616423712|FG002|Overall Study|Physician Decision|1|||
170807271|NCT00647387|617303754|FG000|Overall Study|Lost to Follow-up|6|||
170807272|NCT00647387|617303754|FG000|Overall Study|Unsuccessful implant|5|||
170566860|NCT00856609|616423722|FG000|Overall Study|Adverse Event|1|||
170566861|NCT00856609|616423723|FG001|Overall Study|Adverse Event|0|||
170566862|NCT01788943|616423724|FG000|Overall Study|Withdrawal by Subject|1|||
170566863|NCT01788943|616423725|FG001|Overall Study|Withdrawal by Subject|0|||
170566864|NCT01816295|616423726|FG000|Double Blind Phase|Adverse Event|11|||
170566865|NCT01816295|616423727|FG001|Double Blind Phase|Adverse Event|8|||
170566866|NCT01816295|616423726|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
170566867|NCT01816295|616423727|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
170566868|NCT01816295|616423726|FG000|Double Blind Phase|Lost to Follow-up|3|||
170566869|NCT01816295|616423727|FG001|Double Blind Phase|Lost to Follow-up|5|||
170566870|NCT01816295|616423726|FG000|Double Blind Phase|Physician Decision|2|||
170566871|NCT01816295|616423727|FG001|Double Blind Phase|Physician Decision|2|||
170566872|NCT01816295|616423726|FG000|Double Blind Phase|Protocol Violation|17|||
170566873|NCT01816295|616423727|FG001|Double Blind Phase|Protocol Violation|11|||
170566874|NCT01816295|616423726|FG000|Double Blind Phase|Sponsor Decision|8|||
170566875|NCT01816295|616423727|FG001|Double Blind Phase|Sponsor Decision|8|||
170566876|NCT01816295|616423726|FG000|Double Blind Phase|Withdrawal by Subject|22|||
170566877|NCT01816295|616423727|FG001|Double Blind Phase|Withdrawal by Subject|20|||
170566878|NCT01816295|616423726|FG000|OLE Phase|Adverse Event|17|||
170566879|NCT01816295|616423727|FG001|OLE Phase|Adverse Event|15|||
170566880|NCT01816295|616423726|FG000|OLE Phase|Death|1|||
170566881|NCT01816295|616423727|FG001|OLE Phase|Death|0|||
170566882|NCT01816295|616423726|FG000|OLE Phase|Entry Criteria Not Met|3|||
170566883|NCT01816295|616423727|FG001|OLE Phase|Entry Criteria Not Met|5|||
170566884|NCT01816295|616423726|FG000|OLE Phase|Lost to Follow-up|5|||
170566885|NCT01816295|616423727|FG001|OLE Phase|Lost to Follow-up|5|||
170566886|NCT01816295|616423726|FG000|OLE Phase|Physician Decision|3|||
170566887|NCT01816295|616423727|FG001|OLE Phase|Physician Decision|1|||
170646733|NCT00348933|616719583|FG000|Overall Study|Protocol Violation|2|||
170566888|NCT01816295|616423726|FG000|OLE Phase|Protocol Violation|4|||
170566889|NCT01816295|616423727|FG001|OLE Phase|Protocol Violation|4|||
170566890|NCT01816295|616423726|FG000|OLE Phase|Sponsor Decision|7|||
170646734|NCT00348933|616719583|FG000|Overall Study|Adverse Event|7|||
170646735|NCT02929498|616719590|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
170646736|NCT02929498|616719591|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
170646737|NCT02929498|616719592|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
170646738|NCT02929498|616719590|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
170646739|NCT02929498|616719591|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
170646740|NCT02929498|616719592|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
170646741|NCT02744040|616719593|FG000|Overall Study|Withdrawal by Subject|3|||
170646742|NCT02744040|616719594|FG001|Overall Study|Withdrawal by Subject|2|||
170646743|NCT02744040|616719595|FG002|Overall Study|Withdrawal by Subject|2|||
170646744|NCT02744040|616719593|FG000|Overall Study|Physician Decision|0|||
170646745|NCT02744040|616719594|FG001|Overall Study|Physician Decision|8|||
170646746|NCT02744040|616719595|FG002|Overall Study|Physician Decision|13|||
170646747|NCT02744040|616719593|FG000|Overall Study|Lost to Follow-up|3|||
170646748|NCT02744040|616719594|FG001|Overall Study|Lost to Follow-up|1|||
170646749|NCT02744040|616719595|FG002|Overall Study|Lost to Follow-up|7|||
170646750|NCT01028300|616719596|FG000|Overall Study|Study Terminated|4|||
170646751|NCT00946153|616719599|FG000|Phase 2|Adverse Event|0|||
170646752|NCT00946153|616719600|FG001|Phase 2|Adverse Event|0|||
170646753|NCT00946153|616719601|FG002|Phase 2|Adverse Event|0|||
170646754|NCT00946153|616719602|FG003|Phase 2|Adverse Event|0|||
170646755|NCT00946153|616719603|FG004|Phase 2|Adverse Event|6|||
170646756|NCT00946153|616719599|FG000|Phase 2|Need more reduction of dose|0|||
170807273|NCT00647387|617303754|FG000|Overall Study|Device explanted|3|||
170807274|NCT00647387|617303754|FG000|Overall Study|Other Reason|3|||
170807275|NCT00647387|617303754|FG000|Overall Study|Death|2|||
170807276|NCT05293717|617303756|FG000|Overall Study|Physician Decision|1|||
170807277|NCT03147287|617303757|FG000|Overall Study|Randomized Not Treated|2|||
170807278|NCT03147287|617303758|FG001|Overall Study|Randomized Not Treated|1|||
170807279|NCT03147287|617303759|FG002|Overall Study|Randomized Not Treated|1|||
170807280|NCT03147287|617303757|FG000|Overall Study|Progressive Disease RECIST|31|||
170807281|NCT03147287|617303758|FG001|Overall Study|Progressive Disease RECIST|72|||
170807282|NCT03147287|617303759|FG002|Overall Study|Progressive Disease RECIST|32|||
170807283|NCT03147287|617303757|FG000|Overall Study|Progressive Disease not RECIST|13|||
170807284|NCT03147287|617303758|FG001|Overall Study|Progressive Disease not RECIST|21|||
170807285|NCT03147287|617303759|FG002|Overall Study|Progressive Disease not RECIST|13|||
170807286|NCT03147287|617303757|FG000|Overall Study|Physician Decision|1|||
170807287|NCT03147287|617303758|FG001|Overall Study|Physician Decision|2|||
170807288|NCT03147287|617303759|FG002|Overall Study|Physician Decision|1|||
170807289|NCT03147287|617303757|FG000|Overall Study|Intercurrent illness|0|||
170807290|NCT03147287|617303758|FG001|Overall Study|Intercurrent illness|1|||
170807291|NCT03147287|617303759|FG002|Overall Study|Intercurrent illness|0|||
170566891|NCT01816295|616423727|FG001|OLE Phase|Sponsor Decision|9|||
170807292|NCT03147287|617303757|FG000|Overall Study|Withdrawal by Subject|2|||
170807293|NCT03147287|617303758|FG001|Overall Study|Withdrawal by Subject|3|||
170646757|NCT00946153|616719600|FG001|Phase 2|Need more reduction of dose|0|||
170566892|NCT01816295|616423726|FG000|OLE Phase|Withdrawal by Subject|10|||
170566893|NCT01816295|616423727|FG001|OLE Phase|Withdrawal by Subject|10|||
170566894|NCT01816295|616423726|FG000|OLE Phase|Lack of Efficacy|3|||
170566895|NCT01816295|616423727|FG001|OLE Phase|Lack of Efficacy|7|||
170566896|NCT01847092|616423728|FG000|Overall Study|Adverse Event|12|||
170566897|NCT01847092|616423729|FG001|Overall Study|Adverse Event|3|||
170566898|NCT01847092|616423728|FG000|Overall Study|Withdrawal by Subject|5|||
170566899|NCT01847092|616423729|FG001|Overall Study|Withdrawal by Subject|5|||
170566900|NCT01847092|616423728|FG000|Overall Study|Protocol Specified|8|||
170566901|NCT01847092|616423729|FG001|Overall Study|Protocol Specified|0|||
170566902|NCT01847092|616423728|FG000|Overall Study|Physician Decision|1|||
170566903|NCT01847092|616423729|FG001|Overall Study|Physician Decision|1|||
170566904|NCT01847092|616423728|FG000|Overall Study|Protocol Violation|0|||
170566905|NCT01847092|616423729|FG001|Overall Study|Protocol Violation|2|||
170566906|NCT01534481|616423731|FG000|Overall Study|Lost to Follow-up|29|||
170566907|NCT01534481|616423732|FG001|Overall Study|Lost to Follow-up|24|||
170566908|NCT01534481|616423731|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
170566909|NCT01534481|616423732|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
170566910|NCT01664247|616423734|FG000|Overall Study|Adverse Event|5|||
170566911|NCT01664247|616423735|FG001|Overall Study|Adverse Event|3|||
170807294|NCT03147287|617303759|FG002|Overall Study|Withdrawal by Subject|2|||
170807295|NCT03147287|617303757|FG000|Overall Study|Patient Non-Compliance|0|||
170807296|NCT03147287|617303758|FG001|Overall Study|Patient Non-Compliance|2|||
170807297|NCT03147287|617303759|FG002|Overall Study|Patient Non-Compliance|0|||
170807298|NCT03147287|617303757|FG000|Overall Study|Patient moved|0|||
170807299|NCT03147287|617303758|FG001|Overall Study|Patient moved|1|||
170807300|NCT03147287|617303759|FG002|Overall Study|Patient moved|0|||
170807301|NCT03147287|617303757|FG000|Overall Study|Arm A crossover without PD|1|||
170807302|NCT03147287|617303758|FG001|Overall Study|Arm A crossover without PD|0|||
170807303|NCT03147287|617303759|FG002|Overall Study|Arm A crossover without PD|0|||
170807304|NCT03147287|617303757|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
170807305|NCT03147287|617303758|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
170807306|NCT03147287|617303759|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
170807307|NCT00302211|617303760|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
170807308|NCT00302211|617303761|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
170807309|NCT00302211|617303762|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
170807310|NCT00302211|617303763|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
170807311|NCT00302211|617303764|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
170807312|NCT00302211|617303760|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
170807313|NCT00302211|617303761|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
170807314|NCT00302211|617303762|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
170807315|NCT00302211|617303763|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
170807316|NCT00302211|617303764|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
170807317|NCT00302211|617303760|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
170807318|NCT00302211|617303761|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
170807319|NCT00302211|617303762|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
170807320|NCT00302211|617303763|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
170807321|NCT00302211|617303764|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
170807322|NCT00302211|617303760|FG000|Double Blind Period (New Patients)|Disease progression|0|||
170807323|NCT00302211|617303761|FG001|Double Blind Period (New Patients)|Disease progression|1|||
170807324|NCT00302211|617303762|FG002|Double Blind Period (New Patients)|Disease progression|1|||
170807325|NCT00302211|617303763|FG003|Double Blind Period (New Patients)|Disease progression|0|||
170807326|NCT00302211|617303764|FG004|Double Blind Period (New Patients)|Disease progression|0|||
170807327|NCT00302211|617303760|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
170807328|NCT00302211|617303761|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
170807329|NCT00302211|617303762|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
170807330|NCT00302211|617303763|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
170807331|NCT00302211|617303764|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
170807332|NCT00302211|617303760|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
170807333|NCT00302211|617303761|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
170807334|NCT00302211|617303762|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
170807335|NCT00302211|617303763|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
170807336|NCT00302211|617303764|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
170807337|NCT00302211|617303760|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
170807338|NCT00302211|617303761|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
170807339|NCT00302211|617303762|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
170807340|NCT00302211|617303763|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
170566912|NCT01664247|616423734|FG000|Overall Study|Protocol Violation|3|||
170566913|NCT01664247|616423735|FG001|Overall Study|Protocol Violation|5|||
170566914|NCT01664247|616423734|FG000|Overall Study|Withdrawal Criteria|1|||
170566915|NCT01664247|616423735|FG001|Overall Study|Withdrawal Criteria|4|||
170566916|NCT01664247|616423734|FG000|Overall Study|Unclassified|5|||
170566917|NCT01664247|616423735|FG001|Overall Study|Unclassified|29|||
170566918|NCT03064074|616423736|FG000|Overall Study|Physician Decision|0|||
170566919|NCT03064074|616423737|FG001|Overall Study|Physician Decision|0|||
170566920|NCT03064074|616423738|FG002|Overall Study|Physician Decision|0|||
170566921|NCT03064074|616423739|FG003|Overall Study|Physician Decision|1|||
170566922|NCT00945659|616423740|FG000|Overall Study|Lost to Follow-up|7|||
170566923|NCT00945659|616423741|FG001|Overall Study|Lost to Follow-up|20|||
170566924|NCT00945659|616423742|FG002|Overall Study|Lost to Follow-up|17|||
170566925|NCT00269087|616423743|FG000|Overall Study|Adverse Event|20|||
170566926|NCT00269087|616423743|FG000|Overall Study|Withdrawal by Subject|1|||
170807341|NCT00302211|617303764|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
170807342|NCT00302211|617303760|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
170807343|NCT00302211|617303761|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
170807344|NCT00302211|617303762|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
170807345|NCT00302211|617303763|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
170807346|NCT00302211|617303764|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
170807347|NCT00302211|617303760|FG000|Open Label-Patients From Double-Blind|Death|0|||
170807348|NCT00302211|617303761|FG001|Open Label-Patients From Double-Blind|Death|0|||
170807349|NCT00302211|617303762|FG002|Open Label-Patients From Double-Blind|Death|0|||
170807350|NCT00302211|617303763|FG003|Open Label-Patients From Double-Blind|Death|1|||
170807351|NCT00302211|617303764|FG004|Open Label-Patients From Double-Blind|Death|1|||
170807352|NCT00302211|617303760|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
170807353|NCT00302211|617303761|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
170807354|NCT00302211|617303762|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
170807355|NCT00302211|617303763|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
170807356|NCT00302211|617303764|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
170807357|NCT00302211|617303760|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
170807358|NCT00302211|617303761|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
170807359|NCT00302211|617303762|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
170807360|NCT00302211|617303763|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
170807361|NCT00302211|617303764|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
170807362|NCT00302211|617303760|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
170807363|NCT00302211|617303761|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
170807364|NCT00302211|617303762|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
170807365|NCT00302211|617303763|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
170807366|NCT00302211|617303764|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
170807367|NCT04634669|617305314|FG000|Overall Study|Study Terminated by Sponsor|95|||
170807368|NCT04634669|617305314|FG000|Overall Study|Withdrawal by Subject|20|||
170807369|NCT04634669|617305314|FG000|Overall Study|All Other Reasons|55|||
170807370|NCT00878189|617305317|FG000|Overall Study|Death|0|||
170807371|NCT00878189|617305318|FG001|Overall Study|Death|1|||
170807372|NCT00878189|617305319|FG002|Overall Study|Death|0|||
170807373|NCT00878189|617305320|FG003|Overall Study|Death|1|||
170807374|NCT00878189|617305321|FG004|Overall Study|Death|0|||
170807375|NCT00878189|617305322|FG005|Overall Study|Death|0|||
170807376|NCT00878189|617305323|FG006|Overall Study|Death|0|||
170807377|NCT00878189|617305324|FG007|Overall Study|Death|0|||
170807378|NCT00878189|617305325|FG008|Overall Study|Death|1|||
170807379|NCT00878189|617305317|FG000|Overall Study|Participant Refused to Follow-up|0|||
170807380|NCT00878189|617305318|FG001|Overall Study|Participant Refused to Follow-up|0|||
170807381|NCT00878189|617305319|FG002|Overall Study|Participant Refused to Follow-up|0|||
170807382|NCT00878189|617305320|FG003|Overall Study|Participant Refused to Follow-up|0|||
170807383|NCT00878189|617305321|FG004|Overall Study|Participant Refused to Follow-up|0|||
170807384|NCT00878189|617305322|FG005|Overall Study|Participant Refused to Follow-up|4|||
170807385|NCT00878189|617305323|FG006|Overall Study|Participant Refused to Follow-up|0|||
170807386|NCT00878189|617305324|FG007|Overall Study|Participant Refused to Follow-up|0|||
170807387|NCT00878189|617305325|FG008|Overall Study|Participant Refused to Follow-up|0|||
170807388|NCT00878189|617305317|FG000|Overall Study|Other|3|||
170807389|NCT00878189|617305318|FG001|Overall Study|Other|2|||
170807390|NCT00878189|617305319|FG002|Overall Study|Other|4|||
170807391|NCT00878189|617305320|FG003|Overall Study|Other|7|||
170807392|NCT00878189|617305321|FG004|Overall Study|Other|4|||
170807393|NCT00878189|617305322|FG005|Overall Study|Other|18|||
170807394|NCT00878189|617305323|FG006|Overall Study|Other|15|||
170807395|NCT00878189|617305324|FG007|Overall Study|Other|3|||
170807396|NCT00878189|617305325|FG008|Overall Study|Other|4|||
170807397|NCT00878189|617305317|FG000|Overall Study|Lost to Follow-up|0|||
170566927|NCT00269087|616423743|FG000|Overall Study|Exacerbation of COPD|13|||
170566928|NCT03179761|616423746|FG000|Overall Study|Death|2|||
170566929|NCT03179761|616423747|FG001|Overall Study|Death|5|||
170566930|NCT03179761|616423746|FG000|Overall Study|Lost to Follow-up|2|||
170566931|NCT03179761|616423747|FG001|Overall Study|Lost to Follow-up|2|||
170566932|NCT03179761|616423746|FG000|Overall Study|Protocol Violation|1|||
170566933|NCT03179761|616423747|FG001|Overall Study|Protocol Violation|0|||
170566934|NCT03179761|616423746|FG000|Overall Study|Withdrawal by Subject|1|||
170566935|NCT03179761|616423747|FG001|Overall Study|Withdrawal by Subject|4|||
170566936|NCT03179761|616423746|FG000|Overall Study|Investigator Request|0|||
170566937|NCT03179761|616423747|FG001|Overall Study|Investigator Request|2|||
170566938|NCT00565409|616423748|FG000|Period 1 Open Label|Adverse Event|17|||
170566939|NCT00565409|616423749|FG001|Period 1 Open Label|Adverse Event|0|||
170566940|NCT00565409|616423750|FG002|Period 1 Open Label|Adverse Event|0|||
170566941|NCT00565409|616423751|FG003|Period 1 Open Label|Adverse Event|0|||
170566942|NCT00565409|616423748|FG000|Period 1 Open Label|Death|2|||
170566943|NCT00565409|616423749|FG001|Period 1 Open Label|Death|0|||
170566944|NCT00565409|616423750|FG002|Period 1 Open Label|Death|0|||
170566945|NCT00565409|616423751|FG003|Period 1 Open Label|Death|0|||
170566946|NCT00565409|616423748|FG000|Period 1 Open Label|Lost to Follow-up|1|||
170646758|NCT00946153|616719601|FG002|Phase 2|Need more reduction of dose|0|||
170646759|NCT00946153|616719602|FG003|Phase 2|Need more reduction of dose|0|||
170646760|NCT00946153|616719603|FG004|Phase 2|Need more reduction of dose|2|||
170646761|NCT00946153|616719599|FG000|Phase 2|Physician Decision|0|||
170646762|NCT00946153|616719600|FG001|Phase 2|Physician Decision|0|||
170646763|NCT00946153|616719601|FG002|Phase 2|Physician Decision|0|||
170646764|NCT00946153|616719602|FG003|Phase 2|Physician Decision|0|||
170646765|NCT00946153|616719603|FG004|Phase 2|Physician Decision|1|||
170646766|NCT00946153|616719599|FG000|Phase 2|14 days washout for recovery due to AE|0|||
170646767|NCT00946153|616719600|FG001|Phase 2|14 days washout for recovery due to AE|0|||
170646768|NCT00946153|616719601|FG002|Phase 2|14 days washout for recovery due to AE|0|||
170646769|NCT00946153|616719602|FG003|Phase 2|14 days washout for recovery due to AE|0|||
170646770|NCT00946153|616719603|FG004|Phase 2|14 days washout for recovery due to AE|4|||
170646771|NCT04002908|616719612|FG000|Overall Study|Death|41|||
170646772|NCT04002908|616719613|FG001|Overall Study|Death|0|||
170646773|NCT04002908|616719614|FG002|Overall Study|Death|0|||
170646774|NCT04002908|616719615|FG003|Overall Study|Death|0|||
170646775|NCT04002908|616719612|FG000|Overall Study|Withdrawal by Subject|112|||
170646776|NCT04002908|616719613|FG001|Overall Study|Withdrawal by Subject|0|||
170646777|NCT04002908|616719614|FG002|Overall Study|Withdrawal by Subject|0|||
170646778|NCT04002908|616719615|FG003|Overall Study|Withdrawal by Subject|0|||
170646779|NCT04002908|616719612|FG000|Overall Study|Lost to Follow-up|72|||
170646780|NCT04002908|616719613|FG001|Overall Study|Lost to Follow-up|0|||
170646781|NCT04002908|616719614|FG002|Overall Study|Lost to Follow-up|0|||
170646782|NCT04002908|616719615|FG003|Overall Study|Lost to Follow-up|0|||
170646783|NCT04002908|616719612|FG000|Overall Study|Infant died, so mother withdrawn|34|||
170646784|NCT04002908|616719613|FG001|Overall Study|Infant died, so mother withdrawn|0|||
170646785|NCT04002908|616719614|FG002|Overall Study|Infant died, so mother withdrawn|0|||
170646786|NCT04002908|616719615|FG003|Overall Study|Infant died, so mother withdrawn|0|||
170646787|NCT00006289|616719618|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
170646788|NCT00006289|616719619|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
170646789|NCT00006289|616719618|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
170646790|NCT00006289|616719619|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
170646791|NCT05089084|616719620|FG000|Overall Study|Due to acute pancreatitis|3|||
170646792|NCT05089084|616719621|FG001|Overall Study|Due to acute pancreatitis|0|||
170646793|NCT05089084|616719622|FG002|Overall Study|Due to acute pancreatitis|0|||
170646794|NCT05089084|616719620|FG000|Overall Study|Due to other adverse event|0|||
170646795|NCT05089084|616719621|FG001|Overall Study|Due to other adverse event|2|||
170646796|NCT05089084|616719622|FG002|Overall Study|Due to other adverse event|1|||
170646797|NCT05089084|616719620|FG000|Overall Study|Withdrawal by Subject|3|||
170646798|NCT05089084|616719621|FG001|Overall Study|Withdrawal by Subject|0|||
170566947|NCT00565409|616423749|FG001|Period 1 Open Label|Lost to Follow-up|0|||
170566948|NCT00565409|616423750|FG002|Period 1 Open Label|Lost to Follow-up|0|||
170566949|NCT00565409|616423751|FG003|Period 1 Open Label|Lost to Follow-up|0|||
170646799|NCT05089084|616719622|FG002|Overall Study|Withdrawal by Subject|0|||
170646800|NCT05089084|616719620|FG000|Overall Study|Pregnancy|0|||
170646801|NCT05089084|616719621|FG001|Overall Study|Pregnancy|1|||
170646802|NCT05089084|616719622|FG002|Overall Study|Pregnancy|0|||
170646803|NCT05089084|616719620|FG000|Overall Study|Other, not specified|0|||
170646804|NCT05089084|616719621|FG001|Overall Study|Other, not specified|0|||
170646805|NCT05089084|616719622|FG002|Overall Study|Other, not specified|1|||
170566950|NCT00565409|616423748|FG000|Period 1 Open Label|Other|21|||
170566951|NCT00565409|616423749|FG001|Period 1 Open Label|Other|0|||
170566952|NCT00565409|616423750|FG002|Period 1 Open Label|Other|0|||
170566953|NCT00565409|616423751|FG003|Period 1 Open Label|Other|0|||
170566954|NCT00565409|616423748|FG000|Period 1 Open Label|Protocol Violation|14|||
170566955|NCT00565409|616423749|FG001|Period 1 Open Label|Protocol Violation|0|||
170646806|NCT04538664|616719625|FG000|Overall Study|Withdrawal by Subject|5|||
170646807|NCT04538664|616719626|FG001|Overall Study|Withdrawal by Subject|9|||
170646808|NCT04538664|616719625|FG000|Overall Study|Lost to Follow-up|2|||
170566956|NCT00565409|616423750|FG002|Period 1 Open Label|Protocol Violation|0|||
170566957|NCT00565409|616423751|FG003|Period 1 Open Label|Protocol Violation|0|||
170566958|NCT00565409|616423748|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
170566959|NCT00565409|616423749|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
170566960|NCT00565409|616423750|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
170566961|NCT00565409|616423751|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
170566962|NCT00565409|616423748|FG000|Period 1 Open Label|no conclusion of participation record|1|||
170566963|NCT00565409|616423749|FG001|Period 1 Open Label|no conclusion of participation record|0|||
170566964|NCT00565409|616423750|FG002|Period 1 Open Label|no conclusion of participation record|0|||
170566965|NCT00565409|616423751|FG003|Period 1 Open Label|no conclusion of participation record|0|||
170566966|NCT00565409|616423748|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
170566967|NCT00565409|616423749|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
170566968|NCT00565409|616423750|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
170566969|NCT00565409|616423751|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
170566970|NCT00565409|616423748|FG000|Period 2 Double-Blind|Adverse Event|0|||
170566971|NCT00565409|616423749|FG001|Period 2 Double-Blind|Adverse Event|7|||
170566972|NCT00565409|616423750|FG002|Period 2 Double-Blind|Adverse Event|4|||
170566973|NCT00565409|616423751|FG003|Period 2 Double-Blind|Adverse Event|5|||
170907365|NCT03598777|617664738|FG001|Overall Study|Withdrawal by Subject|1|||
170907366|NCT03598777|617664739|FG002|Overall Study|Withdrawal by Subject|0|||
170907367|NCT03598777|617664740|FG003|Overall Study|Withdrawal by Subject|0|||
170566974|NCT00565409|616423748|FG000|Period 2 Double-Blind|Death|0|||
170566975|NCT00565409|616423749|FG001|Period 2 Double-Blind|Death|2|||
170566976|NCT00565409|616423750|FG002|Period 2 Double-Blind|Death|0|||
170907368|NCT03598777|617664741|FG004|Overall Study|Withdrawal by Subject|0|||
170907369|NCT03598777|617664737|FG000|Overall Study|Adverse Event|1|||
170907370|NCT03598777|617664738|FG001|Overall Study|Adverse Event|0|||
170907371|NCT03598777|617664739|FG002|Overall Study|Adverse Event|0|||
170907372|NCT03598777|617664740|FG003|Overall Study|Adverse Event|0|||
170907373|NCT03598777|617664741|FG004|Overall Study|Adverse Event|0|||
170907374|NCT03598777|617664737|FG000|Overall Study|Lost to Follow-up|1|||
170907375|NCT03598777|617664738|FG001|Overall Study|Lost to Follow-up|0|||
170907376|NCT03598777|617664739|FG002|Overall Study|Lost to Follow-up|0|||
170907377|NCT03598777|617664740|FG003|Overall Study|Lost to Follow-up|0|||
170907378|NCT03598777|617664741|FG004|Overall Study|Lost to Follow-up|0|||
170907379|NCT02006576|617664745|FG000|Overall Study|Withdrawal by Subject|4|||
170907380|NCT02006576|617664746|FG001|Overall Study|Withdrawal by Subject|6|||
170907381|NCT02006576|617664747|FG002|Overall Study|Withdrawal by Subject|2|||
170907382|NCT02006576|617664745|FG000|Overall Study|Death|0|||
170907383|NCT02006576|617664746|FG001|Overall Study|Death|0|||
170907384|NCT02006576|617664747|FG002|Overall Study|Death|1|||
170907385|NCT02006576|617664745|FG000|Overall Study|Lost to Follow-up|1|||
170907386|NCT02006576|617664746|FG001|Overall Study|Lost to Follow-up|0|||
170907387|NCT02006576|617664747|FG002|Overall Study|Lost to Follow-up|1|||
170907388|NCT02006576|617664745|FG000|Overall Study|Screen Failure, too sick, other|13|||
170907389|NCT02006576|617664746|FG001|Overall Study|Screen Failure, too sick, other|1|||
170907390|NCT02006576|617664747|FG002|Overall Study|Screen Failure, too sick, other|13|||
170907391|NCT00785577|617664748|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
170907392|NCT00785577|617664749|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
170907393|NCT00785577|617664750|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
170907394|NCT00785577|617664751|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
170907395|NCT00785577|617664752|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
170907396|NCT00785577|617664748|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
170907397|NCT00785577|617664749|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
170907398|NCT00785577|617664750|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
170907399|NCT00785577|617664751|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
170907400|NCT00785577|617664752|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
170907401|NCT00785577|617664748|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
170907402|NCT00785577|617664749|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
170907403|NCT00785577|617664750|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
170907404|NCT00785577|617664751|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
170907405|NCT00785577|617664752|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
170907406|NCT00785577|617664748|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
170907407|NCT00785577|617664749|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
170907408|NCT00785577|617664750|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
170907409|NCT00785577|617664751|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
170907410|NCT00785577|617664752|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
170907411|NCT00785577|617664748|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
170907412|NCT00785577|617664749|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
170907413|NCT00785577|617664750|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
170907414|NCT00785577|617664751|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
170907415|NCT00785577|617664752|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
170907416|NCT00785577|617664748|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
170566977|NCT00565409|616423751|FG003|Period 2 Double-Blind|Death|0|||
170566978|NCT00565409|616423748|FG000|Period 2 Double-Blind|Protocol Violation|0|||
170566979|NCT00565409|616423749|FG001|Period 2 Double-Blind|Protocol Violation|4|||
170566980|NCT00565409|616423750|FG002|Period 2 Double-Blind|Protocol Violation|6|||
170566981|NCT00565409|616423751|FG003|Period 2 Double-Blind|Protocol Violation|2|||
170566982|NCT00565409|616423748|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
170566983|NCT00565409|616423749|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
170566984|NCT00565409|616423750|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
170566985|NCT00565409|616423751|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
170566986|NCT00565409|616423748|FG000|Period 2 Double-Blind|Other|0|||
170566987|NCT00565409|616423749|FG001|Period 2 Double-Blind|Other|4|||
170566988|NCT00565409|616423750|FG002|Period 2 Double-Blind|Other|5|||
170566989|NCT00565409|616423751|FG003|Period 2 Double-Blind|Other|9|||
170566990|NCT00565409|616423748|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
170566991|NCT00565409|616423749|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
170566992|NCT00565409|616423750|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
170566993|NCT00565409|616423751|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
170566994|NCT02170064|616423754|FG000|Overall Study|Withdrawal by Subject|5|||
170566995|NCT02170064|616423755|FG001|Overall Study|Withdrawal by Subject|1|||
170566996|NCT02170064|616423756|FG002|Overall Study|Withdrawal by Subject|1|||
170566997|NCT02170064|616423754|FG000|Overall Study|Physician Decision|1|||
170566998|NCT02170064|616423755|FG001|Overall Study|Physician Decision|1|||
170566999|NCT02170064|616423756|FG002|Overall Study|Physician Decision|0|||
170567000|NCT04211363|616423757|FG000|Overall Study|Adverse Event|5|||
170567001|NCT04211363|616423758|FG001|Overall Study|Adverse Event|2|||
170567002|NCT04211363|616423757|FG000|Overall Study|Physician Decision|0|||
170567003|NCT04211363|616423758|FG001|Overall Study|Physician Decision|1|||
170567004|NCT04211363|616423757|FG000|Overall Study|Protocol Violation|1|||
170567005|NCT04211363|616423758|FG001|Overall Study|Protocol Violation|0|||
170567006|NCT04211363|616423757|FG000|Overall Study|Pregnancy|1|||
170567007|NCT04211363|616423758|FG001|Overall Study|Pregnancy|0|||
170567008|NCT04211363|616423757|FG000|Overall Study|Lost to Follow-up|12|||
170567009|NCT04211363|616423758|FG001|Overall Study|Lost to Follow-up|4|||
170567010|NCT04211363|616423757|FG000|Overall Study|Withdrawal by Subject|11|||
170567011|NCT04211363|616423758|FG001|Overall Study|Withdrawal by Subject|11|||
170567012|NCT04211363|616423757|FG000|Overall Study|Other|1|||
170567013|NCT04211363|616423758|FG001|Overall Study|Other|2|||
170567014|NCT03434834|616423759|FG000|Overall Study|unable to swallow OCT probe|16|||
170567015|NCT01823289|616423760|FG000|Overall Study|Lost to Follow-up|5|||
170567016|NCT01823289|616423760|FG000|Overall Study|Adverse Event|5|||
170567017|NCT01823289|616423760|FG000|Overall Study|Lack of Efficacy|1|||
170567018|NCT01823289|616423760|FG000|Overall Study|Physician Decision|9|||
170567019|NCT01823289|616423760|FG000|Overall Study|Administered contraindicated medicine|1|||
170567020|NCT01823289|616423760|FG000|Overall Study|Transaminase increased more than 3 times|1|||
170567021|NCT01823289|616423760|FG000|Overall Study|Drug affected efficacy and safety|1|||
170567022|NCT01823289|616423760|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
170567023|NCT01812057|616423768|FG000|Overall Study|Protocol Violation|1|||
170567024|NCT01812057|616423769|FG001|Overall Study|Protocol Violation|0|||
170567025|NCT01812057|616423768|FG000|Overall Study|Physician Decision|1|||
170567026|NCT01812057|616423769|FG001|Overall Study|Physician Decision|0|||
170567027|NCT03937479|616423775|FG000|Overall Study|Adverse Event|2|||
170567028|NCT03937479|616423776|FG001|Overall Study|Adverse Event|3|||
170567029|NCT03937479|616423777|FG002|Overall Study|Adverse Event|0|||
170567030|NCT03937479|616423778|FG003|Overall Study|Adverse Event|0|||
170567031|NCT03937479|616423779|FG004|Overall Study|Adverse Event|1|||
170567032|NCT03937479|616423775|FG000|Overall Study|Withdrawal by Subject|3|||
170567033|NCT03937479|616423776|FG001|Overall Study|Withdrawal by Subject|5|||
170567034|NCT03937479|616423777|FG002|Overall Study|Withdrawal by Subject|2|||
170567035|NCT03937479|616423778|FG003|Overall Study|Withdrawal by Subject|2|||
170567036|NCT03937479|616423779|FG004|Overall Study|Withdrawal by Subject|1|||
170567037|NCT03937479|616423775|FG000|Overall Study|Protocol Violation|5|||
170567038|NCT03937479|616423776|FG001|Overall Study|Protocol Violation|6|||
170807398|NCT00878189|617305318|FG001|Overall Study|Lost to Follow-up|0|||
170807399|NCT00878189|617305319|FG002|Overall Study|Lost to Follow-up|0|||
170807400|NCT00878189|617305320|FG003|Overall Study|Lost to Follow-up|0|||
170807401|NCT00878189|617305321|FG004|Overall Study|Lost to Follow-up|0|||
170807402|NCT00878189|617305322|FG005|Overall Study|Lost to Follow-up|1|||
170807403|NCT00878189|617305323|FG006|Overall Study|Lost to Follow-up|1|||
170807404|NCT00878189|617305324|FG007|Overall Study|Lost to Follow-up|0|||
170567039|NCT03937479|616423777|FG002|Overall Study|Protocol Violation|4|||
170567040|NCT03937479|616423778|FG003|Overall Study|Protocol Violation|3|||
170567041|NCT03937479|616423779|FG004|Overall Study|Protocol Violation|2|||
170567042|NCT03937479|616423775|FG000|Overall Study|Lost to Follow-up|0|||
170567043|NCT03937479|616423776|FG001|Overall Study|Lost to Follow-up|1|||
170567044|NCT03937479|616423777|FG002|Overall Study|Lost to Follow-up|0|||
170567045|NCT03937479|616423778|FG003|Overall Study|Lost to Follow-up|1|||
170807405|NCT00878189|617305325|FG008|Overall Study|Lost to Follow-up|0|||
170807406|NCT00878189|617305317|FG000|Overall Study|Objection Progression or Relapse|0|||
170567046|NCT03937479|616423779|FG004|Overall Study|Lost to Follow-up|0|||
170567047|NCT03937479|616423775|FG000|Overall Study|Physician Decision|0|||
170567048|NCT03937479|616423776|FG001|Overall Study|Physician Decision|0|||
170567049|NCT03937479|616423777|FG002|Overall Study|Physician Decision|1|||
170567050|NCT03937479|616423778|FG003|Overall Study|Physician Decision|0|||
170567051|NCT03937479|616423779|FG004|Overall Study|Physician Decision|1|||
170567052|NCT00940602|616423784|FG000|Overall Study|Administrative problems|1|||
170567053|NCT00940602|616423785|FG001|Overall Study|Administrative problems|1|||
170567054|NCT00940602|616423784|FG000|Overall Study|Patient/guardian decision|13|||
170567055|NCT00940602|616423785|FG001|Overall Study|Patient/guardian decision|28|||
170567056|NCT00940602|616423784|FG000|Overall Study|Physician Decision|8|||
170567057|NCT00940602|616423785|FG001|Overall Study|Physician Decision|5|||
170567058|NCT00940602|616423784|FG000|Overall Study|Pregnancy|1|||
170567059|NCT00940602|616423785|FG001|Overall Study|Pregnancy|0|||
170567060|NCT00940602|616423784|FG000|Overall Study|Protocol Deviation (untreated)|1|||
170807407|NCT00878189|617305318|FG001|Overall Study|Objection Progression or Relapse|0|||
170807408|NCT00878189|617305319|FG002|Overall Study|Objection Progression or Relapse|0|||
170807409|NCT00878189|617305320|FG003|Overall Study|Objection Progression or Relapse|0|||
170567061|NCT00940602|616423785|FG001|Overall Study|Protocol Deviation (untreated)|0|||
170567062|NCT00940602|616423784|FG000|Overall Study|Disease progression|8|||
170567063|NCT00940602|616423785|FG001|Overall Study|Disease progression|2|||
170567064|NCT00940602|616423784|FG000|Overall Study|Death|38|||
170567065|NCT00940602|616423785|FG001|Overall Study|Death|19|||
170567066|NCT00940602|616423784|FG000|Overall Study|Lost to Follow-up|3|||
170567067|NCT00940602|616423785|FG001|Overall Study|Lost to Follow-up|1|||
170567068|NCT00940602|616423784|FG000|Overall Study|Patient withdrew consent|26|||
170567069|NCT00940602|616423785|FG001|Overall Study|Patient withdrew consent|13|||
170567070|NCT00940602|616423784|FG000|Overall Study|Adverse Event|7|||
170567071|NCT00940602|616423785|FG001|Overall Study|Adverse Event|2|||
170567072|NCT00940602|616423784|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
170567073|NCT00940602|616423785|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
170567074|NCT01880957|616423786|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
170567075|NCT01880957|616423787|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
170567076|NCT01880957|616423786|FG000|Overall Study|Lost to Follow-up|11|||
170567077|NCT01880957|616423787|FG001|Overall Study|Lost to Follow-up|0|||
170567078|NCT01880957|616423786|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
170567079|NCT01880957|616423787|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
170567080|NCT02230189|616423789|FG000|Overall Study|Withdrawal by Subject|3|||
170567081|NCT02230189|616423790|FG001|Overall Study|Withdrawal by Subject|0|||
170567082|NCT02230189|616423791|FG002|Overall Study|Withdrawal by Subject|1|||
170567083|NCT02230189|616423789|FG000|Overall Study|Lost to Follow-up|1|||
170567084|NCT02230189|616423790|FG001|Overall Study|Lost to Follow-up|0|||
170567085|NCT02230189|616423791|FG002|Overall Study|Lost to Follow-up|0|||
170567086|NCT02230189|616423789|FG000|Overall Study|Physician Decision|1|||
170567087|NCT02230189|616423790|FG001|Overall Study|Physician Decision|0|||
170567088|NCT02230189|616423791|FG002|Overall Study|Physician Decision|0|||
170567089|NCT01696643|616423792|FG000|Overall Study|Adverse Event|15|||
170567090|NCT01696643|616423793|FG001|Overall Study|Adverse Event|7|||
170567091|NCT01696643|616423792|FG000|Overall Study|Death|1|||
170567092|NCT01696643|616423793|FG001|Overall Study|Death|2|||
170567093|NCT01696643|616423792|FG000|Overall Study|Lack of Efficacy|3|||
170567094|NCT01696643|616423793|FG001|Overall Study|Lack of Efficacy|0|||
170567095|NCT01696643|616423792|FG000|Overall Study|Lost to Follow-up|67|||
170567096|NCT01696643|616423793|FG001|Overall Study|Lost to Follow-up|67|||
170567097|NCT01696643|616423792|FG000|Overall Study|Physician Decision|3|||
170567098|NCT01696643|616423793|FG001|Overall Study|Physician Decision|2|||
170567099|NCT01696643|616423792|FG000|Overall Study|Pregnancy|0|||
170567100|NCT01696643|616423793|FG001|Overall Study|Pregnancy|1|||
170567101|NCT01696643|616423792|FG000|Overall Study|Protocol Violation|7|||
170567102|NCT01696643|616423793|FG001|Overall Study|Protocol Violation|7|||
170567103|NCT01696643|616423792|FG000|Overall Study|Study Terminated by Sponsor|286|||
170567104|NCT01696643|616423793|FG001|Overall Study|Study Terminated by Sponsor|294|||
170567105|NCT01696643|616423792|FG000|Overall Study|Withdrawal by Subject|142|||
170567106|NCT01696643|616423793|FG001|Overall Study|Withdrawal by Subject|149|||
170567107|NCT01696643|616423792|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
170567108|NCT01696643|616423793|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
170567109|NCT01696643|616423792|FG000|Overall Study|Site Error|2|||
170567110|NCT01696643|616423793|FG001|Overall Study|Site Error|1|||
170567111|NCT01696643|616423792|FG000|Overall Study|Participant Incarcerated|0|||
170567112|NCT01696643|616423793|FG001|Overall Study|Participant Incarcerated|1|||
170567113|NCT01696643|616423792|FG000|Overall Study|Medical Monitor Decision|0|||
170567114|NCT01696643|616423793|FG001|Overall Study|Medical Monitor Decision|2|||
170567115|NCT01696643|616423792|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
170567116|NCT01696643|616423793|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
170567117|NCT02359903|616423795|FG000|Overall Study|Adverse Event|0|||
170907417|NCT00785577|617664749|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
170907418|NCT00785577|617664750|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
170907419|NCT00785577|617664751|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
170907420|NCT00785577|617664752|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
170907421|NCT00785577|617664748|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
170907422|NCT00785577|617664749|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
170907423|NCT00785577|617664750|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
170567118|NCT02359903|616423796|FG001|Overall Study|Adverse Event|2|||
170567119|NCT00546481|616423797|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
170567120|NCT00546481|616423798|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
170567121|NCT00546481|616423799|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
170567122|NCT00546481|616423797|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
170567123|NCT00546481|616423798|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
170567124|NCT00546481|616423799|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
170567125|NCT00546481|616423797|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
170567126|NCT00546481|616423798|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
170567127|NCT00546481|616423799|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
170567128|NCT00546481|616423797|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
170567129|NCT00546481|616423798|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
170567130|NCT00546481|616423799|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
170567131|NCT00546481|616423797|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
170567132|NCT00546481|616423798|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
170567133|NCT00546481|616423799|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
170567134|NCT00546481|616423797|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
170567135|NCT00546481|616423798|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
170567136|NCT00546481|616423799|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
170567137|NCT00546481|616423797|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
170567138|NCT00546481|616423798|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
170567139|NCT00546481|616423799|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
170567140|NCT00546481|616423797|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
170567141|NCT00546481|616423798|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
170567142|NCT00546481|616423799|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
170567143|NCT00546481|616423797|FG000|Maintenance Phase (CERA)|Other Reason|0|||
170567144|NCT00546481|616423798|FG001|Maintenance Phase (CERA)|Other Reason|0|||
170567145|NCT00546481|616423799|FG002|Maintenance Phase (CERA)|Other Reason|1|||
170567146|NCT00244621|616423800|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
170567147|NCT00244621|616423801|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
170567148|NCT00244621|616423802|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
170567149|NCT00244621|616423800|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
170567150|NCT00244621|616423801|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
170567151|NCT00244621|616423802|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170567152|NCT00244621|616423800|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
170567153|NCT00244621|616423801|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
170567154|NCT00244621|616423802|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
170567155|NCT00244621|616423800|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
170567156|NCT00244621|616423801|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
170567157|NCT00244621|616423802|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
170567158|NCT00244621|616423800|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
170567159|NCT00244621|616423801|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
170567160|NCT00244621|616423802|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
170567161|NCT00244621|616423800|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
170567162|NCT00244621|616423801|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
170567163|NCT00244621|616423802|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
170567164|NCT00244621|616423800|FG000|Open-label Treatment Period|Adverse Event|0|||
170567165|NCT00244621|616423801|FG001|Open-label Treatment Period|Adverse Event|0|||
170567166|NCT00244621|616423802|FG002|Open-label Treatment Period|Adverse Event|1|||
170907424|NCT00785577|617664751|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
170907425|NCT00785577|617664752|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
170567167|NCT00244621|616423800|FG000|Open-label Treatment Period|Moved abroad|0|||
170567168|NCT00244621|616423801|FG001|Open-label Treatment Period|Moved abroad|0|||
170567169|NCT00244621|616423802|FG002|Open-label Treatment Period|Moved abroad|1|||
170567170|NCT01193101|616423808|FG000|Overall Study|Adverse Event|0|||
170567171|NCT01193101|616423809|FG001|Overall Study|Adverse Event|1|||
170567172|NCT01193101|616423810|FG002|Overall Study|Adverse Event|1|||
170646809|NCT04538664|616719626|FG001|Overall Study|Lost to Follow-up|1|||
170646810|NCT04538664|616719625|FG000|Overall Study|Ongoing|106|||
170646811|NCT04538664|616719626|FG001|Overall Study|Ongoing|115|||
170646812|NCT04593875|616719627|FG000|Washout / Follow-Up (2 weeks)|Withdrawn by investigator after completing first intervention follow-up|0|||
170567173|NCT01193101|616423811|FG003|Overall Study|Adverse Event|3|||
170567174|NCT01193101|616423808|FG000|Overall Study|Lack of Efficacy|3|||
170567175|NCT01193101|616423809|FG001|Overall Study|Lack of Efficacy|1|||
170567176|NCT01193101|616423810|FG002|Overall Study|Lack of Efficacy|0|||
170567177|NCT01193101|616423811|FG003|Overall Study|Lack of Efficacy|8|||
170567178|NCT01193101|616423808|FG000|Overall Study|Withdrawal by Subject|2|||
170907426|NCT00785577|617664748|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
170907427|NCT00785577|617664749|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
170907428|NCT00785577|617664750|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
170907429|NCT00785577|617664751|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
170907430|NCT00785577|617664752|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
170907431|NCT00785577|617664748|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
170907432|NCT00785577|617664749|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
170907433|NCT00785577|617664750|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
170907434|NCT00785577|617664751|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
170907435|NCT00785577|617664752|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
170907436|NCT00785577|617664748|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
170907437|NCT00785577|617664749|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
170907438|NCT00785577|617664750|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
170907439|NCT00785577|617664751|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
170907440|NCT00785577|617664752|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
170907441|NCT01919411|617664753|FG000|Overall Study|Lost to Follow-up|2|||
170907442|NCT01919411|617664754|FG001|Overall Study|Lost to Follow-up|4|||
170907443|NCT01919411|617664753|FG000|Overall Study|Physician Decision|1|||
170907444|NCT01919411|617664754|FG001|Overall Study|Physician Decision|0|||
170907445|NCT01919411|617664753|FG000|Overall Study|Protocol Violation|2|||
170907446|NCT01919411|617664754|FG001|Overall Study|Protocol Violation|1|||
170907447|NCT04090164|617664760|FG000|Overall Study|incomplete data on file|245|||
170907448|NCT04090164|617664761|FG001|Overall Study|incomplete data on file|0|||
170907449|NCT00840463|617664762|FG000|Overall Study|Adverse Event|1|||
170907450|NCT00840463|617664763|FG001|Overall Study|Adverse Event|0|||
170907451|NCT01887210|617664767|FG000|Overall Study|Withdrawal by Subject|1|||
170907452|NCT01887210|617664768|FG001|Overall Study|Withdrawal by Subject|3|||
170907453|NCT01887210|617664767|FG000|Overall Study|Lost to Follow-up|0|||
170907454|NCT01887210|617664768|FG001|Overall Study|Lost to Follow-up|1|||
170907455|NCT00957372|617664775|FG000|PART I|Lost to Follow-up|0|||
170907456|NCT00957372|617664776|FG001|PART I|Lost to Follow-up|0|||
170907457|NCT00957372|617664777|FG002|PART I|Lost to Follow-up|1|||
170907458|NCT00957372|617664778|FG003|PART I|Lost to Follow-up|0|||
170907459|NCT00957372|617664775|FG000|PART II|Withdrawal by Subject|0|||
170646813|NCT04593875|616719628|FG001|Washout / Follow-Up (2 weeks)|Withdrawn by investigator after completing first intervention follow-up|1|||
170646814|NCT06457204|616719629|FG000|Washout|Adverse Event|0|||
170567179|NCT01193101|616423809|FG001|Overall Study|Withdrawal by Subject|4|||
170567180|NCT01193101|616423810|FG002|Overall Study|Withdrawal by Subject|1|||
170567181|NCT01193101|616423811|FG003|Overall Study|Withdrawal by Subject|1|||
170567182|NCT01193101|616423808|FG000|Overall Study|Administrative problems|0|||
170567183|NCT01193101|616423809|FG001|Overall Study|Administrative problems|0|||
170567184|NCT01193101|616423810|FG002|Overall Study|Administrative problems|1|||
170567185|NCT01193101|616423811|FG003|Overall Study|Administrative problems|0|||
170567186|NCT01193101|616423808|FG000|Overall Study|Abnormal test procedure results|0|||
170567187|NCT01193101|616423809|FG001|Overall Study|Abnormal test procedure results|1|||
170567188|NCT01193101|616423810|FG002|Overall Study|Abnormal test procedure results|0|||
170567189|NCT01193101|616423811|FG003|Overall Study|Abnormal test procedure results|0|||
170567190|NCT02347085|616423812|FG000|Overall Study|Adverse Event|2|||
170567191|NCT02347085|616423812|FG000|Overall Study|Lack of Efficacy|1|||
170567192|NCT02347085|616423812|FG000|Overall Study|Withdrawal by Subject|4|||
170567193|NCT02347085|616423812|FG000|Overall Study|Lost to Follow-up|1|||
170567194|NCT02347085|616423812|FG000|Overall Study|Protocol Criteria|2|||
170567195|NCT02271529|616423813|FG000|Overall Study|Withdrawal by Subject|1|||
170567196|NCT01957865|616423814|FG000|Overall Study|Found HIV negative|0|||
170567197|NCT01957865|616423815|FG001|Overall Study|Found HIV negative|0|||
170567198|NCT01957865|616423816|FG002|Overall Study|Found HIV negative|1|||
170567199|NCT01957865|616423814|FG000|Overall Study|Lost to Follow-up|0|||
170567200|NCT01957865|616423815|FG001|Overall Study|Lost to Follow-up|2|||
170567201|NCT01957865|616423816|FG002|Overall Study|Lost to Follow-up|2|||
170567202|NCT01082614|616423817|FG000|Overall Study|Adverse Event|1|||
170567203|NCT01082614|616423818|FG001|Overall Study|Adverse Event|4|||
170907460|NCT00957372|617664776|FG001|PART II|Withdrawal by Subject|0|||
170567204|NCT01082614|616423817|FG000|Overall Study|Equipment Malfunction|0|||
170907461|NCT00957372|617664777|FG002|PART II|Withdrawal by Subject|0|||
170907462|NCT00957372|617664778|FG003|PART II|Withdrawal by Subject|8|||
170907463|NCT00957372|617664775|FG000|PART II|Physician Decision|0|||
170907464|NCT00957372|617664776|FG001|PART II|Physician Decision|0|||
170907465|NCT00957372|617664777|FG002|PART II|Physician Decision|0|||
170907466|NCT00957372|617664778|FG003|PART II|Physician Decision|1|||
170907467|NCT00957372|617664775|FG000|PART II|Pregnancy|0|||
170907468|NCT00957372|617664776|FG001|PART II|Pregnancy|0|||
170567205|NCT01082614|616423818|FG001|Overall Study|Equipment Malfunction|1|||
170567206|NCT01082614|616423817|FG000|Overall Study|Physician Decision|2|||
170567207|NCT01082614|616423818|FG001|Overall Study|Physician Decision|0|||
170567208|NCT00950651|616423822|FG000|Overall Study|Adverse Event|17|||
170567209|NCT00950651|616423823|FG001|Overall Study|Adverse Event|20|||
170567210|NCT00950651|616423822|FG000|Overall Study|Death|1|||
170567211|NCT00950651|616423823|FG001|Overall Study|Death|0|||
170567212|NCT00950651|616423822|FG000|Overall Study|Lack of Efficacy|2|||
170567213|NCT00950651|616423823|FG001|Overall Study|Lack of Efficacy|2|||
170567214|NCT00950651|616423822|FG000|Overall Study|Protocol Violation|3|||
170567215|NCT00950651|616423823|FG001|Overall Study|Protocol Violation|4|||
170567216|NCT00950651|616423822|FG000|Overall Study|Withdrawal by Subject|8|||
170567217|NCT00950651|616423823|FG001|Overall Study|Withdrawal by Subject|9|||
170567218|NCT03783780|616423828|FG000|Overall Study|Withdrawn prior to completion|1|||
170567219|NCT03768427|616423829|FG000|Overall Study|Death|0|||
170567220|NCT03768427|616423830|FG001|Overall Study|Death|0|||
170567221|NCT03768427|616423831|FG002|Overall Study|Death|1|||
170567222|NCT03768427|616423832|FG003|Overall Study|Death|0|||
170567223|NCT03768427|616423829|FG000|Overall Study|Lost to Follow-up|2|||
170567224|NCT03768427|616423830|FG001|Overall Study|Lost to Follow-up|0|||
170907469|NCT00957372|617664777|FG002|PART II|Pregnancy|0|||
170907470|NCT00957372|617664778|FG003|PART II|Pregnancy|1|||
170907471|NCT00957372|617664775|FG000|PART II|Not Know|0|||
170907472|NCT00957372|617664776|FG001|PART II|Not Know|0|||
170907473|NCT00957372|617664777|FG002|PART II|Not Know|0|||
170907474|NCT00957372|617664778|FG003|PART II|Not Know|20|||
170907475|NCT00957372|617664775|FG000|PART II|Adverse Event|0|||
170907476|NCT00957372|617664776|FG001|PART II|Adverse Event|0|||
170907477|NCT00957372|617664777|FG002|PART II|Adverse Event|0|||
170907478|NCT00957372|617664778|FG003|PART II|Adverse Event|10|||
170907479|NCT00957372|617664775|FG000|PART II|Patient non-compliance|0|||
170907480|NCT00957372|617664776|FG001|PART II|Patient non-compliance|0|||
170907481|NCT00957372|617664777|FG002|PART II|Patient non-compliance|0|||
170907482|NCT00957372|617664778|FG003|PART II|Patient non-compliance|4|||
170907483|NCT03113500|617666320|FG000|Overall Study|Withdrawal by Subject|1|||
170907484|NCT04893265|617666329|FG000|Overall Study|Withdrawal by Subject|2|||
170907485|NCT04893265|617666330|FG001|Overall Study|Withdrawal by Subject|5|||
170907486|NCT04893265|617666329|FG000|Overall Study|Lost to Follow-up|0|||
170907487|NCT04893265|617666330|FG001|Overall Study|Lost to Follow-up|4|||
170907488|NCT02401256|617666333|FG000|Overall Study|Adverse Event|5|||
170907489|NCT02401256|617666333|FG000|Overall Study|Withdrawal by Subject|12|||
170907490|NCT03090191|617666334|FG000|Overall Study|Adverse Event|90|||
170907491|NCT03090191|617666335|FG001|Overall Study|Adverse Event|72|||
170907492|NCT03090191|617666334|FG000|Overall Study|Death|365|||
170907493|NCT03090191|617666335|FG001|Overall Study|Death|358|||
170907494|NCT03090191|617666334|FG000|Overall Study|Lost to Follow-up|382|||
170907495|NCT03090191|617666335|FG001|Overall Study|Lost to Follow-up|394|||
170907496|NCT03090191|617666334|FG000|Overall Study|Physician Decision|77|||
170907497|NCT03090191|617666335|FG001|Overall Study|Physician Decision|66|||
170907498|NCT03090191|617666334|FG000|Overall Study|Protocol Violation|43|||
170907499|NCT03090191|617666335|FG001|Overall Study|Protocol Violation|52|||
170907500|NCT03090191|617666334|FG000|Overall Study|Withdrawal by Subject|2160|||
170907501|NCT03090191|617666335|FG001|Overall Study|Withdrawal by Subject|2133|||
170907502|NCT03090191|617666334|FG000|Overall Study|Site terminated|7|||
170907503|NCT03090191|617666335|FG001|Overall Study|Site terminated|8|||
170907504|NCT03090191|617666334|FG000|Overall Study|Other|66|||
170567225|NCT03768427|616423831|FG002|Overall Study|Lost to Follow-up|0|||
170567226|NCT03768427|616423832|FG003|Overall Study|Lost to Follow-up|0|||
170567227|NCT03768427|616423829|FG000|Overall Study|Physician Decision|3|||
170567228|NCT03768427|616423830|FG001|Overall Study|Physician Decision|2|||
170567229|NCT03768427|616423831|FG002|Overall Study|Physician Decision|4|||
170646815|NCT06457204|616719630|FG001|Washout|Adverse Event|2|||
170646816|NCT01097005|616719632|FG000|Overall Study|Case Report Form not collected|18|||
170907505|NCT03090191|617666335|FG001|Overall Study|Other|60|||
170907506|NCT03090191|617666334|FG000|Overall Study|Withdrawn before any study vaccination|43|||
170907507|NCT03090191|617666335|FG001|Overall Study|Withdrawn before any study vaccination|52|||
170907508|NCT02037919|617666339|FG000|Overall Study|Lost to Follow-up|30|||
170567230|NCT03768427|616423832|FG003|Overall Study|Physician Decision|4|||
170567231|NCT03768427|616423829|FG000|Overall Study|Withdrawal by Subject|7|||
170567232|NCT03768427|616423830|FG001|Overall Study|Withdrawal by Subject|2|||
170567233|NCT03768427|616423831|FG002|Overall Study|Withdrawal by Subject|6|||
170567234|NCT03768427|616423832|FG003|Overall Study|Withdrawal by Subject|7|||
170567235|NCT03710889|616423835|FG000|Overall Study|Adverse Event|2|||
170907509|NCT02037919|617666340|FG001|Overall Study|Lost to Follow-up|45|||
170907510|NCT00733902|617666343|FG000|Overall Study|Death|0|||
170907511|NCT00733902|617666344|FG001|Overall Study|Death|0|||
170907512|NCT00733902|617666345|FG002|Overall Study|Death|0|||
170907513|NCT00733902|617666346|FG003|Overall Study|Death|1|||
170567236|NCT03710889|616423835|FG000|Overall Study|Protocol Deviation|1|||
170907514|NCT00733902|617666343|FG000|Overall Study|Adverse Event|3|||
170907515|NCT00733902|617666344|FG001|Overall Study|Adverse Event|4|||
170907516|NCT00733902|617666345|FG002|Overall Study|Adverse Event|7|||
170567237|NCT01816984|616423836|FG000|Overall Study|declining health status|1|||
170567238|NCT00542178|616423837|FG000|Overall Study|did not complete year 4 follow-up|75|||
170567239|NCT00542178|616423838|FG001|Overall Study|did not complete year 4 follow-up|80|||
170567240|NCT00542178|616423839|FG002|Overall Study|did not complete year 4 follow-up|74|||
170567241|NCT00542178|616423840|FG003|Overall Study|did not complete year 4 follow-up|62|||
170907517|NCT00733902|617666346|FG003|Overall Study|Adverse Event|11|||
170907518|NCT00733902|617666343|FG000|Overall Study|Lack of Efficacy|56|||
170907519|NCT00733902|617666344|FG001|Overall Study|Lack of Efficacy|21|||
170907520|NCT00733902|617666345|FG002|Overall Study|Lack of Efficacy|34|||
170907521|NCT00733902|617666346|FG003|Overall Study|Lack of Efficacy|23|||
170907522|NCT00733902|617666343|FG000|Overall Study|Protocol Violation|4|||
170907523|NCT00733902|617666344|FG001|Overall Study|Protocol Violation|6|||
170907524|NCT00733902|617666345|FG002|Overall Study|Protocol Violation|3|||
170907525|NCT00733902|617666346|FG003|Overall Study|Protocol Violation|3|||
170907526|NCT00733902|617666343|FG000|Overall Study|Withdrawal by Subject|10|||
170907527|NCT00733902|617666344|FG001|Overall Study|Withdrawal by Subject|5|||
170907528|NCT00733902|617666345|FG002|Overall Study|Withdrawal by Subject|4|||
170907529|NCT00733902|617666346|FG003|Overall Study|Withdrawal by Subject|16|||
170907530|NCT00733902|617666343|FG000|Overall Study|Entered extension study|89|||
170907531|NCT00733902|617666344|FG001|Overall Study|Entered extension study|124|||
170907532|NCT00733902|617666345|FG002|Overall Study|Entered extension study|111|||
170907533|NCT00733902|617666346|FG003|Overall Study|Entered extension study|109|||
170907534|NCT00733902|617666343|FG000|Overall Study|Randomized but not treated|2|||
170907535|NCT00733902|617666344|FG001|Overall Study|Randomized but not treated|2|||
170907536|NCT00733902|617666345|FG002|Overall Study|Randomized but not treated|2|||
170907537|NCT00733902|617666346|FG003|Overall Study|Randomized but not treated|1|||
170907538|NCT01458340|617666351|FG000|Overall Study|Adverse Event|5|||
170907539|NCT01458340|617666352|FG001|Overall Study|Adverse Event|4|||
170907540|NCT01458340|617666353|FG002|Overall Study|Adverse Event|2|||
170907541|NCT01458340|617666351|FG000|Overall Study|Lost to Follow-up|3|||
170907542|NCT01458340|617666352|FG001|Overall Study|Lost to Follow-up|3|||
170907543|NCT01458340|617666353|FG002|Overall Study|Lost to Follow-up|10|||
170907544|NCT01458340|617666351|FG000|Overall Study|Miscellaneous|0|||
170907545|NCT01458340|617666352|FG001|Overall Study|Miscellaneous|1|||
170907546|NCT01458340|617666353|FG002|Overall Study|Miscellaneous|0|||
170907547|NCT01458340|617666351|FG000|Overall Study|Physician Decision|1|||
170907548|NCT01458340|617666352|FG001|Overall Study|Physician Decision|1|||
170907549|NCT01458340|617666353|FG002|Overall Study|Physician Decision|2|||
170907550|NCT01458340|617666351|FG000|Overall Study|Protocol Violation|6|||
170907551|NCT01458340|617666352|FG001|Overall Study|Protocol Violation|6|||
170907552|NCT01458340|617666353|FG002|Overall Study|Protocol Violation|5|||
170907553|NCT01458340|617666351|FG000|Overall Study|Withdrawal by Subject|12|||
170907554|NCT01458340|617666352|FG001|Overall Study|Withdrawal by Subject|6|||
170907555|NCT01458340|617666353|FG002|Overall Study|Withdrawal by Subject|4|||
170907556|NCT04899271|617666356|FG000|Overall Study|Lost to Follow-up|1|||
170907557|NCT04899271|617666357|FG001|Overall Study|Lost to Follow-up|0|||
170907558|NCT04899271|617666356|FG000|Overall Study|Subject request/consent withdrawal|2|||
170907559|NCT04899271|617666357|FG001|Overall Study|Subject request/consent withdrawal|0|||
170907560|NCT01925703|617666358|FG000|Overall Study|Physician Decision|1|||
170907561|NCT01925703|617666358|FG000|Overall Study|Lost to Follow-up|2|||
170907562|NCT01925703|617666358|FG000|Overall Study|Discharge prior to full iron repletion|1|||
170907563|NCT02088034|617666359|FG000|Overall Study|Lost to Follow-up|1|||
170907564|NCT02088034|617666360|FG001|Overall Study|Lost to Follow-up|1|||
170907565|NCT02088034|617666361|FG002|Overall Study|Lost to Follow-up|0|||
170907566|NCT02088034|617666359|FG000|Overall Study|Pregnancy|2|||
170907567|NCT02088034|617666360|FG001|Overall Study|Pregnancy|1|||
170907568|NCT02088034|617666361|FG002|Overall Study|Pregnancy|2|||
170907569|NCT01733329|617666380|FG000|Overall Study|Protocol Violation|1|||
170907570|NCT01733329|617666381|FG001|Overall Study|Protocol Violation|1|||
170907571|NCT01733329|617666380|FG000|Overall Study|Uterine artery injury|1|||
170907572|NCT01733329|617666381|FG001|Overall Study|Uterine artery injury|0|||
170907573|NCT01508676|617666383|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
170907574|NCT01508676|617666384|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
170907575|NCT01508676|617666383|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
170907576|NCT01508676|617666384|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
170907577|NCT01508676|617666383|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
170567242|NCT00542178|616423841|FG004|Overall Study|did not complete year 4 follow-up|64|||
170567243|NCT00542178|616423842|FG005|Overall Study|did not complete year 4 follow-up|89|||
170907578|NCT01508676|617666384|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
170907579|NCT01508676|617666383|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
170907580|NCT01508676|617666384|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
170907581|NCT01508676|617666383|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
170907582|NCT01508676|617666384|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
170907583|NCT03228186|617666388|FG000|Overall Study|Patient never started treatment|1|||
170907584|NCT01634243|617666389|FG000|Overall Study|Adverse Event|5|||
170907585|NCT01634243|617666390|FG001|Overall Study|Adverse Event|5|||
170907586|NCT01634243|617666389|FG000|Overall Study|Lack of Efficacy|1|||
170907587|NCT01634243|617666390|FG001|Overall Study|Lack of Efficacy|0|||
170567244|NCT00542178|616423843|FG006|Overall Study|did not complete year 4 follow-up|87|||
170567245|NCT00542178|616423844|FG007|Overall Study|did not complete year 4 follow-up|85|||
170567246|NCT04464473|616423845|FG000|Overall Study|New piercing could not be removed for scanning|0|||
170567247|NCT04464473|616423846|FG001|Overall Study|New piercing could not be removed for scanning|0|||
170567248|NCT04464473|616423847|FG002|Overall Study|New piercing could not be removed for scanning|0|||
170567249|NCT04464473|616423848|FG003|Overall Study|New piercing could not be removed for scanning|1|||
170567250|NCT04464473|616423849|FG004|Overall Study|New piercing could not be removed for scanning|0|||
170567251|NCT04464473|616423850|FG005|Overall Study|New piercing could not be removed for scanning|0|||
170567252|NCT04464473|616423845|FG000|Overall Study|Adverse Event|0|||
170567253|NCT04464473|616423846|FG001|Overall Study|Adverse Event|0|||
170567254|NCT04464473|616423847|FG002|Overall Study|Adverse Event|0|||
170567255|NCT04464473|616423848|FG003|Overall Study|Adverse Event|1|||
170567256|NCT04464473|616423849|FG004|Overall Study|Adverse Event|0|||
170567257|NCT04464473|616423850|FG005|Overall Study|Adverse Event|0|||
170567258|NCT04464473|616423845|FG000|Overall Study|Lost to Follow-up|0|||
170567259|NCT04464473|616423846|FG001|Overall Study|Lost to Follow-up|0|||
170567260|NCT04464473|616423847|FG002|Overall Study|Lost to Follow-up|0|||
170567261|NCT04464473|616423848|FG003|Overall Study|Lost to Follow-up|1|||
170567262|NCT04464473|616423849|FG004|Overall Study|Lost to Follow-up|0|||
170567263|NCT04464473|616423850|FG005|Overall Study|Lost to Follow-up|0|||
170567264|NCT02561962|616423851|FG000|Overall Study|Withdrawal by Subject|1|||
170567265|NCT02561962|616423852|FG001|Overall Study|Withdrawal by Subject|0|||
170567266|NCT02561962|616423853|FG002|Overall Study|Withdrawal by Subject|0|||
170567267|NCT02561962|616423854|FG003|Overall Study|Withdrawal by Subject|0|||
170567268|NCT02561962|616423855|FG004|Overall Study|Withdrawal by Subject|1|||
170567269|NCT02561962|616423856|FG005|Overall Study|Withdrawal by Subject|1|||
170567270|NCT02561962|616423857|FG006|Overall Study|Withdrawal by Subject|2|||
170567271|NCT02561962|616423858|FG007|Overall Study|Withdrawal by Subject|1|||
170567272|NCT02561962|616423859|FG008|Overall Study|Withdrawal by Subject|0|||
170567273|NCT02561962|616423851|FG000|Overall Study|Decision by sponsor|0|||
170567274|NCT02561962|616423852|FG001|Overall Study|Decision by sponsor|0|||
170567275|NCT02561962|616423853|FG002|Overall Study|Decision by sponsor|0|||
170567276|NCT02561962|616423854|FG003|Overall Study|Decision by sponsor|0|||
170567277|NCT02561962|616423855|FG004|Overall Study|Decision by sponsor|1|||
170567278|NCT02561962|616423856|FG005|Overall Study|Decision by sponsor|1|||
170567279|NCT02561962|616423857|FG006|Overall Study|Decision by sponsor|0|||
170567280|NCT02561962|616423858|FG007|Overall Study|Decision by sponsor|3|||
170567281|NCT02561962|616423859|FG008|Overall Study|Decision by sponsor|0|||
170567282|NCT02561962|616423851|FG000|Overall Study|Lost to Follow-up|0|||
170567283|NCT02561962|616423852|FG001|Overall Study|Lost to Follow-up|0|||
170567284|NCT02561962|616423853|FG002|Overall Study|Lost to Follow-up|0|||
170567285|NCT02561962|616423854|FG003|Overall Study|Lost to Follow-up|0|||
170567286|NCT02561962|616423855|FG004|Overall Study|Lost to Follow-up|0|||
170567287|NCT02561962|616423856|FG005|Overall Study|Lost to Follow-up|1|||
170567288|NCT02561962|616423857|FG006|Overall Study|Lost to Follow-up|0|||
170567289|NCT02561962|616423858|FG007|Overall Study|Lost to Follow-up|0|||
170567290|NCT02561962|616423859|FG008|Overall Study|Lost to Follow-up|0|||
170567291|NCT03586973|616423860|FG000|Overall Study|Death|15|||
170567292|NCT03586973|616423861|FG001|Overall Study|Death|8|||
170567293|NCT03586973|616423860|FG000|Overall Study|Site Terminated by Sponsor|3|||
170567294|NCT03586973|616423861|FG001|Overall Study|Site Terminated by Sponsor|6|||
170567295|NCT03586973|616423860|FG000|Overall Study|Withdrawal by Subject|1|||
170567296|NCT03586973|616423861|FG001|Overall Study|Withdrawal by Subject|0|||
170567297|NCT03586973|616423860|FG000|Overall Study|Lost to Follow-up|1|||
170567298|NCT03586973|616423861|FG001|Overall Study|Lost to Follow-up|0|||
170567299|NCT05010070|616425204|FG000|Overall Study|Lost to Follow-up|1|||
170567300|NCT05010070|616425204|FG000|Overall Study|Withdrawal by Subject|1|||
170567301|NCT00503984|616425210|FG000|Overall Study|Protocol Violation|0|||
170567302|NCT00503984|616425211|FG001|Overall Study|Protocol Violation|1|||
170567303|NCT00503984|616425212|FG002|Overall Study|Protocol Violation|0|||
170567304|NCT00503984|616425213|FG003|Overall Study|Protocol Violation|0|||
170567305|NCT00503984|616425214|FG004|Overall Study|Protocol Violation|0|||
170567306|NCT00503984|616425215|FG005|Overall Study|Protocol Violation|0|||
170567307|NCT00503984|616425210|FG000|Overall Study|Adverse Event|0|||
170567308|NCT00503984|616425211|FG001|Overall Study|Adverse Event|1|||
170567309|NCT00503984|616425212|FG002|Overall Study|Adverse Event|0|||
170567310|NCT00503984|616425213|FG003|Overall Study|Adverse Event|0|||
170567311|NCT00503984|616425214|FG004|Overall Study|Adverse Event|0|||
170567312|NCT00503984|616425215|FG005|Overall Study|Adverse Event|0|||
170567313|NCT00503984|616425210|FG000|Overall Study|Death|0|||
170567314|NCT00503984|616425211|FG001|Overall Study|Death|0|||
170567315|NCT00503984|616425212|FG002|Overall Study|Death|0|||
170567316|NCT00503984|616425213|FG003|Overall Study|Death|0|||
170567317|NCT00503984|616425214|FG004|Overall Study|Death|1|||
170567318|NCT00503984|616425215|FG005|Overall Study|Death|0|||
170567319|NCT00552071|616425216|FG000|Overall Study|Adverse Event|1|||
170567320|NCT00552071|616425217|FG001|Overall Study|Adverse Event|0|||
170907588|NCT00184054|617666394|FG000|Overall Study|Adverse Event|1|||
170567321|NCT00552071|616425216|FG000|Overall Study|Lack of Efficacy|1|||
170567322|NCT00552071|616425217|FG001|Overall Study|Lack of Efficacy|0|||
170567323|NCT00552071|616425216|FG000|Overall Study|Physician Decision|1|||
170567324|NCT00552071|616425217|FG001|Overall Study|Physician Decision|0|||
170567325|NCT00552071|616425216|FG000|Overall Study|Pregnancy|1|||
170567326|NCT00552071|616425217|FG001|Overall Study|Pregnancy|0|||
170567327|NCT00552071|616425216|FG000|Overall Study|Death|0|||
170567328|NCT00552071|616425217|FG001|Overall Study|Death|1|||
170567329|NCT00552071|616425216|FG000|Overall Study|Withdrawal by Subject|0|||
170567330|NCT00552071|616425217|FG001|Overall Study|Withdrawal by Subject|1|||
170567331|NCT00952705|616425218|FG000|Overall Study|Lost to Follow-up|24|||
170567332|NCT00952705|616425219|FG001|Overall Study|Lost to Follow-up|8|||
170567333|NCT00952705|616425220|FG002|Overall Study|Lost to Follow-up|9|||
170567334|NCT00952705|616425218|FG000|Overall Study|Withdrawal by Subject|2|||
170567335|NCT00952705|616425219|FG001|Overall Study|Withdrawal by Subject|1|||
170567336|NCT00952705|616425220|FG002|Overall Study|Withdrawal by Subject|1|||
170567337|NCT00952705|616425218|FG000|Overall Study|Death|2|||
170567338|NCT00952705|616425219|FG001|Overall Study|Death|0|||
170567339|NCT00952705|616425220|FG002|Overall Study|Death|0|||
170567340|NCT00952705|616425218|FG000|Overall Study|Incarcerated post dose|5|||
170567341|NCT00952705|616425219|FG001|Overall Study|Incarcerated post dose|0|||
170567342|NCT00952705|616425220|FG002|Overall Study|Incarcerated post dose|0|||
170567343|NCT00952705|616425218|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
170567344|NCT00952705|616425219|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
170567345|NCT00952705|616425220|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
170567346|NCT01944020|616425223|FG000|Overall Study|Withdrawal by Subject|5|||
170567347|NCT01944020|616425224|FG001|Overall Study|Withdrawal by Subject|0|||
170567348|NCT00692003|616425225|FG000|Overall Study|Sponsor Decision|5|||
170567349|NCT00692003|616425226|FG001|Overall Study|Sponsor Decision|1|||
170567350|NCT01669902|616425227|FG000|Overall Study|Adverse Event|11|||
170567351|NCT01669902|616425227|FG000|Overall Study|Lack of Efficacy|10|||
170567352|NCT01669902|616425227|FG000|Overall Study|Other|8|||
170567353|NCT01248793|616425230|FG000|Overall Study|Lost to Follow-up|0|||
170567354|NCT01248793|616425231|FG001|Overall Study|Lost to Follow-up|1|||
170567355|NCT01248793|616425230|FG000|Overall Study|Adverse Event|1|||
170567356|NCT01248793|616425231|FG001|Overall Study|Adverse Event|1|||
170567357|NCT01248793|616425230|FG000|Overall Study|Protocol Violation|0|||
170567358|NCT01248793|616425231|FG001|Overall Study|Protocol Violation|1|||
170567359|NCT01248793|616425230|FG000|Overall Study|Withdrawal by Subject|3|||
170567360|NCT01248793|616425231|FG001|Overall Study|Withdrawal by Subject|3|||
170567361|NCT00517699|616425232|FG000|Overall Study|Withdrawal by Subject|1|||
170567362|NCT00517699|616425232|FG000|Overall Study|Lack of Efficacy|1|||
170567363|NCT00517699|616425232|FG000|Overall Study|Administrative error|1|||
170567364|NCT00517699|616425232|FG000|Overall Study|Study terminated by Sponsor|2|||
170567365|NCT01114737|616425233|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
170567366|NCT01114737|616425234|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
170567367|NCT01114737|616425233|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
170567368|NCT01114737|616425234|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
170567369|NCT01114737|616425233|FG000|Randomized Treatment Period|Pregnancy|1|||
170567370|NCT01114737|616425234|FG001|Randomized Treatment Period|Pregnancy|0|||
170646817|NCT01097005|616719632|FG000|Overall Study|Subjects cannot visit the hospital|1|||
170646818|NCT01097005|616719632|FG000|Overall Study|Poor medication compliance|1|||
170646819|NCT01097005|616719632|FG000|Overall Study|No examination data available|244|||
170646820|NCT01097005|616719632|FG000|Overall Study|Deviation from exclusion criteria|37|||
170646821|NCT01097005|616719632|FG000|Overall Study|Adverse Event|14|||
170646822|NCT01097005|616719632|FG000|Overall Study|Discontinuance by complication|50|||
170907589|NCT02296840|617666395|FG000|Overall Study|Adverse Event|1|||
170907590|NCT02296840|617666396|FG001|Overall Study|Adverse Event|1|||
170907591|NCT02296840|617666395|FG000|Overall Study|Protocol Violation|2|||
170907592|NCT02296840|617666396|FG001|Overall Study|Protocol Violation|1|||
170907593|NCT02296840|617666395|FG000|Overall Study|Lost to Follow-up|6|||
170567371|NCT01114737|616425233|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
170567372|NCT01114737|616425234|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
170567373|NCT01114737|616425233|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
170567374|NCT01114737|616425234|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
170567375|NCT01114737|616425233|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
170567376|NCT01114737|616425234|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
170646823|NCT05009979|616719633|FG000|Overall Study|Withdrawal by Subject|1|||
170646824|NCT06924281|616719634|FG000|Overall Study|Lost to Follow-up|1|||
170646825|NCT06924281|616719635|FG001|Overall Study|Lost to Follow-up|1|||
170907594|NCT02296840|617666396|FG001|Overall Study|Lost to Follow-up|17|||
170907595|NCT03819140|617666397|FG000|Overall Study|Lost to Follow-up|1|||
170567377|NCT02580877|616425237|FG000|Overall Study|Withdrawal by Subject|1|||
170567378|NCT02580877|616425238|FG001|Overall Study|Withdrawal by Subject|3|||
170567379|NCT02580877|616425237|FG000|Overall Study|Adverse Event|0|||
170567380|NCT02580877|616425238|FG001|Overall Study|Adverse Event|1|||
170567381|NCT01466491|616425239|FG000|Overall Study|Protocol Violation|0|||
170567382|NCT01466491|616425240|FG001|Overall Study|Protocol Violation|3|||
170567383|NCT01466491|616425241|FG002|Overall Study|Protocol Violation|2|||
170567384|NCT01466491|616425242|FG003|Overall Study|Protocol Violation|0|||
170567385|NCT01466491|616425239|FG000|Overall Study|Missing Data|0|||
170567386|NCT01466491|616425240|FG001|Overall Study|Missing Data|0|||
170567387|NCT01466491|616425241|FG002|Overall Study|Missing Data|1|||
170567388|NCT01466491|616425242|FG003|Overall Study|Missing Data|0|||
170567389|NCT01462929|616425243|FG000|Overall Study|Adverse Event|3|||
170567390|NCT01462929|616425244|FG001|Overall Study|Adverse Event|3|||
170567391|NCT01462929|616425245|FG002|Overall Study|Adverse Event|4|||
170567392|NCT01462929|616425243|FG000|Overall Study|Withdrawal by Subject|2|||
170567393|NCT01462929|616425244|FG001|Overall Study|Withdrawal by Subject|1|||
170567394|NCT01462929|616425245|FG002|Overall Study|Withdrawal by Subject|0|||
170567395|NCT01462929|616425243|FG000|Overall Study|Lack of Efficacy|0|||
170567396|NCT01462929|616425244|FG001|Overall Study|Lack of Efficacy|0|||
170567397|NCT01462929|616425245|FG002|Overall Study|Lack of Efficacy|1|||
170567398|NCT00887159|616425248|FG000|Overall Study|Disease progression|6|||
170567399|NCT00887159|616425249|FG001|Overall Study|Disease progression|39|||
170567400|NCT00887159|616425250|FG002|Overall Study|Disease progression|33|||
170567401|NCT00887159|616425248|FG000|Overall Study|Adverse Event|3|||
170567402|NCT00887159|616425249|FG001|Overall Study|Adverse Event|4|||
170567403|NCT00887159|616425250|FG002|Overall Study|Adverse Event|17|||
170567404|NCT00887159|616425248|FG000|Overall Study|Death|2|||
170567405|NCT00887159|616425249|FG001|Overall Study|Death|2|||
170567406|NCT00887159|616425250|FG002|Overall Study|Death|0|||
170567407|NCT00887159|616425248|FG000|Overall Study|Withdrawal by Subject|4|||
170567408|NCT00887159|616425249|FG001|Overall Study|Withdrawal by Subject|4|||
170567409|NCT00887159|616425250|FG002|Overall Study|Withdrawal by Subject|2|||
170567410|NCT00887159|616425248|FG000|Overall Study|Alternative therapy|2|||
170567411|NCT00887159|616425249|FG001|Overall Study|Alternative therapy|0|||
170567412|NCT00887159|616425250|FG002|Overall Study|Alternative therapy|0|||
170567413|NCT00887159|616425248|FG000|Overall Study|Physician Decision|1|||
170567414|NCT00887159|616425249|FG001|Overall Study|Physician Decision|1|||
170567415|NCT00887159|616425250|FG002|Overall Study|Physician Decision|0|||
170567416|NCT00887159|616425248|FG000|Overall Study|Sympomatic deterioration|1|||
170567417|NCT00887159|616425249|FG001|Overall Study|Sympomatic deterioration|0|||
170567418|NCT00887159|616425250|FG002|Overall Study|Sympomatic deterioration|0|||
170567419|NCT00887159|616425248|FG000|Overall Study|Treatment delayed|1|||
170567420|NCT00887159|616425249|FG001|Overall Study|Treatment delayed|1|||
170567421|NCT00887159|616425250|FG002|Overall Study|Treatment delayed|0|||
170567422|NCT00887159|616425248|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
170567423|NCT00887159|616425249|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
170567424|NCT00887159|616425250|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
170567425|NCT00887159|616425248|FG000|Overall Study|Received more tx instead of observation|1|||
170567426|NCT00887159|616425249|FG001|Overall Study|Received more tx instead of observation|0|||
170567427|NCT00887159|616425250|FG002|Overall Study|Received more tx instead of observation|0|||
170567428|NCT00887159|616425248|FG000|Overall Study|Ineligible|5|||
170807410|NCT00878189|617305321|FG004|Overall Study|Objection Progression or Relapse|0|||
170567429|NCT00887159|616425249|FG001|Overall Study|Ineligible|1|||
170567430|NCT00887159|616425250|FG002|Overall Study|Ineligible|0|||
170567431|NCT00887159|616425248|FG000|Overall Study|Never started assigned therapy|3|||
170807411|NCT00878189|617305322|FG005|Overall Study|Objection Progression or Relapse|0|||
170807412|NCT00878189|617305323|FG006|Overall Study|Objection Progression or Relapse|0|||
170807413|NCT00878189|617305324|FG007|Overall Study|Objection Progression or Relapse|0|||
170807414|NCT00878189|617305325|FG008|Overall Study|Objection Progression or Relapse|3|||
170807415|NCT02708498|617305326|FG000|Overall Study|Death|20|||
170807416|NCT02708498|617305327|FG001|Overall Study|Death|19|||
170807417|NCT02708498|617305328|FG002|Overall Study|Death|0|||
170807418|NCT02708498|617305329|FG003|Overall Study|Death|0|||
170807419|NCT02708498|617305330|FG004|Overall Study|Death|1|||
170807420|NCT02708498|617305331|FG005|Overall Study|Death|0|||
170807421|NCT02708498|617305332|FG006|Overall Study|Death|0|||
170807422|NCT02708498|617305333|FG007|Overall Study|Death|0|||
170807423|NCT02708498|617305326|FG000|Overall Study|Unknown reason, missing data|0|||
170807424|NCT02708498|617305327|FG001|Overall Study|Unknown reason, missing data|0|||
170807425|NCT02708498|617305328|FG002|Overall Study|Unknown reason, missing data|62|||
170567432|NCT00887159|616425249|FG001|Overall Study|Never started assigned therapy|3|||
170567433|NCT00887159|616425250|FG002|Overall Study|Never started assigned therapy|4|||
170567434|NCT00812955|616425251|FG000|Overall Study|Adverse Event|7|||
170567435|NCT00812955|616425252|FG001|Overall Study|Adverse Event|6|||
170646826|NCT04627285|616719636|FG000|Overall Study|Adverse Event|0|||
170807426|NCT02708498|617305329|FG003|Overall Study|Unknown reason, missing data|51|||
170807427|NCT02708498|617305330|FG004|Overall Study|Unknown reason, missing data|195|||
170807428|NCT02708498|617305331|FG005|Overall Study|Unknown reason, missing data|132|||
170567436|NCT00812955|616425253|FG002|Overall Study|Adverse Event|3|||
170567437|NCT00812955|616425254|FG003|Overall Study|Adverse Event|4|||
170567438|NCT00812955|616425251|FG000|Overall Study|Lost to Follow-up|2|||
170646827|NCT04627285|616719637|FG001|Overall Study|Adverse Event|2|||
170567439|NCT00812955|616425252|FG001|Overall Study|Lost to Follow-up|1|||
170567440|NCT00812955|616425253|FG002|Overall Study|Lost to Follow-up|1|||
170567441|NCT00812955|616425254|FG003|Overall Study|Lost to Follow-up|2|||
170567442|NCT00812955|616425251|FG000|Overall Study|Withdrawal by Subject|1|||
170567443|NCT00812955|616425252|FG001|Overall Study|Withdrawal by Subject|0|||
170567444|NCT00812955|616425253|FG002|Overall Study|Withdrawal by Subject|1|||
170567445|NCT00812955|616425254|FG003|Overall Study|Withdrawal by Subject|2|||
170567446|NCT00812955|616425251|FG000|Overall Study|randomized in error|0|||
170567447|NCT00812955|616425252|FG001|Overall Study|randomized in error|0|||
170567448|NCT00812955|616425253|FG002|Overall Study|randomized in error|1|||
170567449|NCT00812955|616425254|FG003|Overall Study|randomized in error|0|||
170567450|NCT01990742|616425262|FG000|Overall Study|Withdrawal by facility|407|||
170567451|NCT01990742|616425263|FG001|Overall Study|Withdrawal by facility|1083|||
170567452|NCT01990742|616425262|FG000|Overall Study|Facility closed|0|||
170567453|NCT01990742|616425263|FG001|Overall Study|Facility closed|270|||
170567454|NCT02441218|616425264|FG000|Overall Study|Death|503|||
170567455|NCT02441218|616425265|FG001|Overall Study|Death|553|||
170567456|NCT02441218|616425264|FG000|Overall Study|Withdrawal by Subject|73|||
170567457|NCT02441218|616425265|FG001|Overall Study|Withdrawal by Subject|58|||
170567458|NCT02441218|616425264|FG000|Overall Study|Lost to Follow-up|2|||
170567459|NCT02441218|616425265|FG001|Overall Study|Lost to Follow-up|1|||
170567460|NCT00506142|616425268|FG000|Overall Study|Adverse Event|8|||
170567461|NCT00506142|616425269|FG001|Overall Study|Adverse Event|7|||
170567462|NCT00506142|616425268|FG000|Overall Study|Lack of Efficacy|21|||
170567463|NCT00506142|616425269|FG001|Overall Study|Lack of Efficacy|7|||
170567464|NCT00506142|616425268|FG000|Overall Study|Withdrawal by Subject|4|||
170567465|NCT00506142|616425269|FG001|Overall Study|Withdrawal by Subject|5|||
170567466|NCT00506142|616425268|FG000|Overall Study|Physician Decision|1|||
170567467|NCT00506142|616425269|FG001|Overall Study|Physician Decision|0|||
170567468|NCT00506142|616425268|FG000|Overall Study|New health condition|1|||
170567469|NCT00506142|616425269|FG001|Overall Study|New health condition|0|||
170567470|NCT00454116|616425275|FG000|Overall Study|Adverse Event|5|||
170567471|NCT00454116|616425276|FG001|Overall Study|Adverse Event|11|||
170567472|NCT00454116|616425277|FG002|Overall Study|Adverse Event|9|||
170567473|NCT00454116|616425275|FG000|Overall Study|Condition under investigation worsened|17|||
170567474|NCT00454116|616425276|FG001|Overall Study|Condition under investigation worsened|13|||
170567475|NCT00454116|616425277|FG002|Overall Study|Condition under investigation worsened|18|||
170567476|NCT00454116|616425275|FG000|Overall Study|Withdrawal by Subject|3|||
170567477|NCT00454116|616425276|FG001|Overall Study|Withdrawal by Subject|3|||
170567478|NCT00454116|616425277|FG002|Overall Study|Withdrawal by Subject|1|||
170567479|NCT00454116|616425275|FG000|Overall Study|Other|2|||
170567480|NCT00454116|616425276|FG001|Overall Study|Other|2|||
170567481|NCT00454116|616425277|FG002|Overall Study|Other|0|||
170567482|NCT02071771|616425284|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
170567483|NCT02071771|616425285|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
170567484|NCT02071771|616425284|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
170567485|NCT02071771|616425285|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
170567486|NCT00783432|616425286|FG000|Overall Study|Adverse Event|22|||
170567487|NCT00783432|616425287|FG001|Overall Study|Adverse Event|17|||
170567488|NCT00783432|616425286|FG000|Overall Study|Lack of Efficacy|20|||
170567489|NCT00783432|616425287|FG001|Overall Study|Lack of Efficacy|21|||
170567490|NCT00783432|616425286|FG000|Overall Study|Lost to Follow-up|11|||
170567491|NCT00783432|616425287|FG001|Overall Study|Lost to Follow-up|6|||
170567492|NCT00783432|616425286|FG000|Overall Study|Withdrawal by Subject|23|||
170567493|NCT00783432|616425287|FG001|Overall Study|Withdrawal by Subject|20|||
170567494|NCT00783432|616425286|FG000|Overall Study|subject moved|3|||
170567495|NCT00783432|616425287|FG001|Overall Study|subject moved|5|||
170567496|NCT00783432|616425286|FG000|Overall Study|Protocol Violation|6|||
170567497|NCT00783432|616425287|FG001|Overall Study|Protocol Violation|9|||
170567498|NCT00110214|616425293|FG000|Overall Study|Never started treatment|21|||
170567499|NCT00110214|616425294|FG001|Overall Study|Never started treatment|20|||
170567500|NCT00110214|616425293|FG000|Overall Study|Disease progression or death|260|||
170567501|NCT00110214|616425294|FG001|Overall Study|Disease progression or death|151|||
170567502|NCT00110214|616425293|FG000|Overall Study|Adverse Event|115|||
170567503|NCT00110214|616425294|FG001|Overall Study|Adverse Event|192|||
170567504|NCT00110214|616425293|FG000|Overall Study|Refused further treatment|52|||
170567505|NCT00110214|616425294|FG001|Overall Study|Refused further treatment|65|||
170567506|NCT00110214|616425293|FG000|Overall Study|Other (not specified)|61|||
170567507|NCT00110214|616425294|FG001|Overall Study|Other (not specified)|75|||
170567508|NCT01088503|616425295|FG000|Overall Study|Withdrawal by Subject|118|||
170567509|NCT01088503|616425296|FG001|Overall Study|Withdrawal by Subject|327|||
170567510|NCT01088503|616425297|FG002|Overall Study|Withdrawal by Subject|10|||
170567511|NCT01088503|616425295|FG000|Overall Study|Death|64|||
170567512|NCT01088503|616425296|FG001|Overall Study|Death|358|||
170646828|NCT04627285|616719636|FG000|Overall Study|Lost to Follow-up|1|||
170646829|NCT04627285|616719637|FG001|Overall Study|Lost to Follow-up|0|||
170646830|NCT04627285|616719636|FG000|Overall Study|Withdrawal by Subject|1|||
170646831|NCT04627285|616719637|FG001|Overall Study|Withdrawal by Subject|1|||
170646832|NCT04627285|616719636|FG000|Overall Study|Sponsor decision|5|||
170646833|NCT04627285|616719637|FG001|Overall Study|Sponsor decision|0|||
170646834|NCT04627285|616719636|FG000|Overall Study|Participant left country; aunt informed the site|0|||
170646835|NCT04627285|616719637|FG001|Overall Study|Participant left country; aunt informed the site|1|||
170646836|NCT04917042|616719638|FG000|Overall Study|Subject is still on long-term follow-up|1|||
170646837|NCT02616146|616721482|FG000|Overall Study|Adverse Event|64|||
170646838|NCT02616146|616721483|FG001|Overall Study|Adverse Event|24|||
170646839|NCT02616146|616721482|FG000|Overall Study|Lost to Follow-up|23|||
170646840|NCT02616146|616721483|FG001|Overall Study|Lost to Follow-up|13|||
170646841|NCT02616146|616721482|FG000|Overall Study|Non-compliance with study protocol|2|||
170646842|NCT02616146|616721483|FG001|Overall Study|Non-compliance with study protocol|0|||
170646843|NCT02616146|616721482|FG000|Overall Study|Non-compliance with study drug|4|||
170646844|NCT02616146|616721483|FG001|Overall Study|Non-compliance with study drug|2|||
170646845|NCT02616146|616721482|FG000|Overall Study|Pregnancy|2|||
170567513|NCT01088503|616425297|FG002|Overall Study|Death|7|||
170567514|NCT00811954|616425298|FG000|Overall Study|Death|10|||
170567515|NCT00811954|616425299|FG001|Overall Study|Death|6|||
170567516|NCT00811954|616425300|FG002|Overall Study|Death|13|||
170567517|NCT00811954|616425298|FG000|Overall Study|Lost to Follow-up|29|||
170567518|NCT00811954|616425299|FG001|Overall Study|Lost to Follow-up|23|||
170567519|NCT00811954|616425300|FG002|Overall Study|Lost to Follow-up|34|||
170567520|NCT00811954|616425298|FG000|Overall Study|Not able to get to clinic|28|||
170567521|NCT00811954|616425299|FG001|Overall Study|Not able to get to clinic|35|||
170567522|NCT00811954|616425300|FG002|Overall Study|Not able to get to clinic|30|||
170567523|NCT00811954|616425298|FG000|Overall Study|Not willing to adhere to requirements|12|||
170567524|NCT00811954|616425299|FG001|Overall Study|Not willing to adhere to requirements|2|||
170567525|NCT00811954|616425300|FG002|Overall Study|Not willing to adhere to requirements|16|||
170567526|NCT00811954|616425298|FG000|Overall Study|Withdraw consent prior study completion|4|||
170567527|NCT00811954|616425299|FG001|Overall Study|Withdraw consent prior study completion|6|||
170567528|NCT00811954|616425300|FG002|Overall Study|Withdraw consent prior study completion|5|||
170567529|NCT00811954|616425298|FG000|Overall Study|Site Closure|4|||
170567530|NCT00811954|616425299|FG001|Overall Study|Site Closure|0|||
170567531|NCT00811954|616425300|FG002|Overall Study|Site Closure|1|||
170567532|NCT00811954|616425298|FG000|Overall Study|Severe Debilitation|2|||
170567533|NCT00811954|616425299|FG001|Overall Study|Severe Debilitation|0|||
170567534|NCT00811954|616425300|FG002|Overall Study|Severe Debilitation|1|||
170567535|NCT00811954|616425298|FG000|Overall Study|Complete Protocol: No follow-up|0|||
170646846|NCT02616146|616721483|FG001|Overall Study|Pregnancy|2|||
170646847|NCT02616146|616721482|FG000|Overall Study|Pregnancy wish|3|||
170646848|NCT02616146|616721483|FG001|Overall Study|Pregnancy wish|0|||
170646849|NCT02616146|616721482|FG000|Overall Study|Protocol Violation|6|||
170646850|NCT02616146|616721483|FG001|Overall Study|Protocol Violation|3|||
170646851|NCT02616146|616721482|FG000|Overall Study|Study terminated by sponsor|1372|||
170646852|NCT02616146|616721483|FG001|Overall Study|Study terminated by sponsor|432|||
170646853|NCT02616146|616721482|FG000|Overall Study|Participant moved|4|||
170646854|NCT02616146|616721483|FG001|Overall Study|Participant moved|3|||
170646855|NCT02616146|616721482|FG000|Overall Study|Withdrawal by Subject|30|||
170646856|NCT02616146|616721483|FG001|Overall Study|Withdrawal by Subject|24|||
170646857|NCT02616146|616721482|FG000|Overall Study|Physician Decision|2|||
170646858|NCT02616146|616721483|FG001|Overall Study|Physician Decision|1|||
170646859|NCT01221272|616721485|FG000|Period 1|Adverse Event|2|||
170646860|NCT01221272|616721486|FG001|Period 1|Adverse Event|0|||
170567536|NCT00811954|616425299|FG001|Overall Study|Complete Protocol: No follow-up|0|||
170567537|NCT00811954|616425300|FG002|Overall Study|Complete Protocol: No follow-up|1|||
170567538|NCT00592631|616425305|FG000|Overall Study|Lost to Follow-up|0|||
170646861|NCT01221272|616721485|FG000|Period 1|Consent Withdrawal|0|||
170646862|NCT01221272|616721486|FG001|Period 1|Consent Withdrawal|1|||
170646863|NCT01221272|616721485|FG000|Period 1|Significant Dosing Noncompliance|0|||
170646864|NCT01221272|616721486|FG001|Period 1|Significant Dosing Noncompliance|1|||
170646865|NCT01221272|616721485|FG000|Period 2|Adverse Event|0|||
170646866|NCT01221272|616721486|FG001|Period 2|Adverse Event|2|||
170646867|NCT02522624|616721489|FG000|Overall Study|Technical failure|1|||
170646868|NCT02522624|616721490|FG001|Overall Study|Technical failure|0|||
170646869|NCT03254108|616721491|FG000|Overall Study|Adverse Event|0|||
170646870|NCT03254108|616721492|FG001|Overall Study|Adverse Event|2|||
170646871|NCT03254108|616721493|FG002|Overall Study|Adverse Event|0|||
170567539|NCT00592631|616425306|FG001|Overall Study|Lost to Follow-up|2|||
170567540|NCT01023217|616425307|FG000|Overall Study|Withdrawal by Subject|1|||
170567541|NCT01023217|616425308|FG001|Overall Study|Withdrawal by Subject|0|||
170567542|NCT00523978|616425316|FG000|Overall Study|Withdrawal by Subject|3|||
170567543|NCT00523978|616425317|FG001|Overall Study|Withdrawal by Subject|7|||
170646872|NCT03254108|616721494|FG003|Overall Study|Adverse Event|1|||
170646873|NCT03254108|616721495|FG004|Overall Study|Adverse Event|1|||
170567544|NCT00523978|616425316|FG000|Overall Study|Screen Failures|5|||
170567545|NCT00523978|616425317|FG001|Overall Study|Screen Failures|1|||
170567546|NCT00523978|616425316|FG000|Overall Study|Death|1|||
170567547|NCT00523978|616425317|FG001|Overall Study|Death|0|||
170567548|NCT04881760|616425322|FG000|Overall Study|Adverse Event|0|||
170567549|NCT04881760|616425323|FG001|Overall Study|Adverse Event|1|||
170567550|NCT04881760|616425324|FG002|Overall Study|Adverse Event|1|||
170567551|NCT04881760|616425325|FG003|Overall Study|Adverse Event|0|||
170567552|NCT04881760|616425326|FG004|Overall Study|Adverse Event|1|||
170567553|NCT04881760|616425327|FG005|Overall Study|Adverse Event|1|||
170567554|NCT04881760|616425328|FG006|Overall Study|Adverse Event|2|||
170567555|NCT04881760|616425322|FG000|Overall Study|Death|0|||
170567556|NCT04881760|616425323|FG001|Overall Study|Death|0|||
170567557|NCT04881760|616425324|FG002|Overall Study|Death|0|||
170567558|NCT04881760|616425325|FG003|Overall Study|Death|1|||
170567559|NCT04881760|616425326|FG004|Overall Study|Death|0|||
170567560|NCT04881760|616425327|FG005|Overall Study|Death|0|||
170567561|NCT04881760|616425328|FG006|Overall Study|Death|0|||
170567562|NCT04881760|616425322|FG000|Overall Study|Lost to Follow-up|5|||
170567563|NCT04881760|616425323|FG001|Overall Study|Lost to Follow-up|7|||
170567564|NCT04881760|616425324|FG002|Overall Study|Lost to Follow-up|5|||
170567565|NCT04881760|616425325|FG003|Overall Study|Lost to Follow-up|1|||
170567566|NCT04881760|616425326|FG004|Overall Study|Lost to Follow-up|2|||
170567567|NCT04881760|616425327|FG005|Overall Study|Lost to Follow-up|4|||
170567568|NCT04881760|616425328|FG006|Overall Study|Lost to Follow-up|4|||
170567569|NCT04881760|616425322|FG000|Overall Study|Withdrawal by Subject|13|||
170567570|NCT04881760|616425323|FG001|Overall Study|Withdrawal by Subject|1|||
170567571|NCT04881760|616425324|FG002|Overall Study|Withdrawal by Subject|1|||
170567572|NCT04881760|616425325|FG003|Overall Study|Withdrawal by Subject|4|||
170567573|NCT04881760|616425326|FG004|Overall Study|Withdrawal by Subject|2|||
170567574|NCT04881760|616425327|FG005|Overall Study|Withdrawal by Subject|1|||
170567575|NCT04881760|616425328|FG006|Overall Study|Withdrawal by Subject|2|||
170567576|NCT04881760|616425322|FG000|Overall Study|Randomized but Never Treated|0|||
170567577|NCT04881760|616425323|FG001|Overall Study|Randomized but Never Treated|0|||
170567578|NCT04881760|616425324|FG002|Overall Study|Randomized but Never Treated|0|||
170567579|NCT04881760|616425325|FG003|Overall Study|Randomized but Never Treated|1|||
170567580|NCT04881760|616425326|FG004|Overall Study|Randomized but Never Treated|0|||
170567581|NCT04881760|616425327|FG005|Overall Study|Randomized but Never Treated|0|||
170567582|NCT04881760|616425328|FG006|Overall Study|Randomized but Never Treated|0|||
170567583|NCT04881760|616425322|FG000|Overall Study|Inadvertent Enrollment|2|||
170567584|NCT04881760|616425323|FG001|Overall Study|Inadvertent Enrollment|0|||
170567585|NCT04881760|616425324|FG002|Overall Study|Inadvertent Enrollment|0|||
170567586|NCT04881760|616425325|FG003|Overall Study|Inadvertent Enrollment|0|||
170567587|NCT04881760|616425326|FG004|Overall Study|Inadvertent Enrollment|0|||
170567588|NCT04881760|616425327|FG005|Overall Study|Inadvertent Enrollment|0|||
170567589|NCT04881760|616425328|FG006|Overall Study|Inadvertent Enrollment|0|||
170567590|NCT04881760|616425322|FG000|Overall Study|Site Closure|0|||
170567591|NCT04881760|616425323|FG001|Overall Study|Site Closure|0|||
170567592|NCT04881760|616425324|FG002|Overall Study|Site Closure|0|||
170567593|NCT04881760|616425325|FG003|Overall Study|Site Closure|1|||
170567594|NCT04881760|616425326|FG004|Overall Study|Site Closure|0|||
170567595|NCT04881760|616425327|FG005|Overall Study|Site Closure|0|||
170567596|NCT04881760|616425328|FG006|Overall Study|Site Closure|0|||
170567597|NCT01182298|616425329|FG000|Overall Study|Lack of Efficacy|4|||
170567598|NCT01182298|616425329|FG000|Overall Study|Withdrawal by Subject|2|||
170567599|NCT01822665|616425330|FG000|Overall Study|Adverse Event|3|||
170567600|NCT01822665|616425330|FG000|Overall Study|Other Reason|5|||
170567601|NCT00271544|616425331|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
170567602|NCT00271544|616425331|FG000|Overall Study|Model 4196 lead not attempted|9|||
170567603|NCT00271544|616425331|FG000|Overall Study|Implant not attempted|4|||
170567604|NCT03342560|616425332|FG000|Overall Study|Lost to Follow-up|2|||
170567605|NCT03571971|616425333|FG000|Overall Study|Lost to Follow-up|2|||
170567606|NCT03571971|616425334|FG001|Overall Study|Lost to Follow-up|2|||
170567607|NCT03571971|616425333|FG000|Overall Study|Protocol Violation|2|||
170567608|NCT03571971|616425334|FG001|Overall Study|Protocol Violation|3|||
170567609|NCT03571971|616425333|FG000|Overall Study|Withdrawal by Subject|2|||
170567610|NCT03571971|616425334|FG001|Overall Study|Withdrawal by Subject|0|||
170567611|NCT03571971|616425333|FG000|Overall Study|Incomplete primary outcome data|2|||
170567612|NCT03571971|616425334|FG001|Overall Study|Incomplete primary outcome data|0|||
170567613|NCT03950856|616425338|FG000|Overall Study|Death|1|||
170567614|NCT03950856|616425339|FG001|Overall Study|Death|2|||
170567615|NCT03950856|616425340|FG002|Overall Study|Death|0|||
170567616|NCT03950856|616425341|FG003|Overall Study|Death|0|||
170567617|NCT03950856|616425338|FG000|Overall Study|Lost to Follow-up|5|||
170567618|NCT03950856|616425339|FG001|Overall Study|Lost to Follow-up|6|||
170567619|NCT03950856|616425340|FG002|Overall Study|Lost to Follow-up|8|||
170567620|NCT03950856|616425341|FG003|Overall Study|Lost to Follow-up|2|||
170567621|NCT03950856|616425338|FG000|Overall Study|Protocol Violation|2|||
170567622|NCT03950856|616425339|FG001|Overall Study|Protocol Violation|0|||
170567623|NCT03950856|616425340|FG002|Overall Study|Protocol Violation|0|||
170567624|NCT03950856|616425341|FG003|Overall Study|Protocol Violation|1|||
170567625|NCT03950856|616425338|FG000|Overall Study|Withdrawal by Subject|4|||
170567626|NCT03950856|616425339|FG001|Overall Study|Withdrawal by Subject|1|||
170567627|NCT03950856|616425340|FG002|Overall Study|Withdrawal by Subject|3|||
170567628|NCT03950856|616425341|FG003|Overall Study|Withdrawal by Subject|1|||
170567629|NCT03950856|616425338|FG000|Overall Study|Unable to phone|7|||
170567630|NCT03950856|616425339|FG001|Overall Study|Unable to phone|6|||
170567631|NCT03950856|616425340|FG002|Overall Study|Unable to phone|7|||
170567632|NCT03950856|616425341|FG003|Overall Study|Unable to phone|2|||
170567633|NCT02121509|616425342|FG000|Washout Period (35 Days)|Adverse Event|1|||
170567634|NCT02121509|616425343|FG001|Washout Period (35 Days)|Adverse Event|1|||
170567635|NCT02121509|616425344|FG002|Washout Period (35 Days)|Adverse Event|0|||
170567636|NCT02121509|616425345|FG003|Washout Period (35 Days)|Adverse Event|0|||
170567637|NCT02121509|616425342|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
170567638|NCT02121509|616425343|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
170567639|NCT02121509|616425344|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
170567640|NCT02121509|616425345|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
170567641|NCT02121509|616425342|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
170567642|NCT02121509|616425343|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
170567643|NCT02121509|616425344|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
170567644|NCT02121509|616425345|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
170567645|NCT00636181|616425348|FG000|Overall Study|Withdrawal by Subject|8|||
170567646|NCT00636181|616425349|FG001|Overall Study|Withdrawal by Subject|6|||
170567647|NCT00636181|616425350|FG002|Overall Study|Withdrawal by Subject|10|||
170567648|NCT00867035|616425351|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
170567649|NCT00867035|616425352|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
170567650|NCT00867035|616425351|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
170567651|NCT00867035|616425352|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
170567652|NCT04422431|616425355|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
170567653|NCT04422431|616425355|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
170567654|NCT04422431|616425355|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
170567655|NCT04422431|616425355|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
170567656|NCT04422431|616425355|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
170567657|NCT04422431|616425355|FG000|Extension Period (48 Weeks)|Other than specified|2|||
170567658|NCT02993263|616425356|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
170567659|NCT04046939|616425357|FG000|Primary Assessment Period|Adverse Event|1|||
170567660|NCT04046939|616425358|FG001|Primary Assessment Period|Adverse Event|0|||
170567661|NCT04046939|616425359|FG002|Primary Assessment Period|Adverse Event|0|||
170567662|NCT04046939|616425360|FG003|Primary Assessment Period|Adverse Event|0|||
170567663|NCT04046939|616425357|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
170567664|NCT04046939|616425358|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
170567665|NCT04046939|616425359|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
170567666|NCT04046939|616425360|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
170567667|NCT04046939|616425357|FG000|Primary Assessment Period|Physician Decision|0|||
170567668|NCT04046939|616425358|FG001|Primary Assessment Period|Physician Decision|0|||
170567669|NCT04046939|616425359|FG002|Primary Assessment Period|Physician Decision|1|||
170567670|NCT04046939|616425360|FG003|Primary Assessment Period|Physician Decision|0|||
170567671|NCT04046939|616425357|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
170567672|NCT04046939|616425358|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
170567673|NCT04046939|616425359|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
170567674|NCT04046939|616425360|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
170567675|NCT04704193|616425361|FG000|Overall Study|Withdrawal by Subject|1|||
170567676|NCT00829998|616425362|FG000|Washout|Adverse Event|0|||
170567677|NCT00829998|616425363|FG001|Washout|Adverse Event|1|||
170567678|NCT03984188|616425364|FG000|Overall Study|Death|2|||
170567679|NCT03984188|616425365|FG001|Overall Study|Death|4|||
170567680|NCT03984188|616425364|FG000|Overall Study|Physician Decision|0|||
170567681|NCT03984188|616425365|FG001|Overall Study|Physician Decision|2|||
170567682|NCT03984188|616425364|FG000|Overall Study|Lost to Follow-up|3|||
170567683|NCT03984188|616425365|FG001|Overall Study|Lost to Follow-up|2|||
170567684|NCT03984188|616425364|FG000|Overall Study|Withdrawal by Subject|6|||
170567685|NCT03984188|616425365|FG001|Overall Study|Withdrawal by Subject|0|||
170907596|NCT03819140|617666398|FG001|Overall Study|Lost to Follow-up|2|||
170907597|NCT03819140|617666397|FG000|Overall Study|Withdrawal by Subject|3|||
170567686|NCT01770743|616427351|FG000|Overall Study|Adverse Event|1|||
170567687|NCT01770743|616427352|FG001|Overall Study|Adverse Event|0|||
170567688|NCT01770743|616427353|FG002|Overall Study|Adverse Event|0|||
170567689|NCT01770743|616427354|FG003|Overall Study|Adverse Event|0|||
170567690|NCT01770743|616427355|FG004|Overall Study|Adverse Event|0|||
170567691|NCT01770743|616427351|FG000|Overall Study|Withdrawal by Subject|0|||
170567692|NCT01770743|616427352|FG001|Overall Study|Withdrawal by Subject|0|||
170567693|NCT01770743|616427353|FG002|Overall Study|Withdrawal by Subject|1|||
170567694|NCT01770743|616427354|FG003|Overall Study|Withdrawal by Subject|1|||
170567695|NCT01770743|616427355|FG004|Overall Study|Withdrawal by Subject|1|||
170567696|NCT01770743|616427351|FG000|Overall Study|Lost to Follow-up|0|||
170567697|NCT01770743|616427352|FG001|Overall Study|Lost to Follow-up|2|||
170567698|NCT01770743|616427353|FG002|Overall Study|Lost to Follow-up|0|||
170567699|NCT01770743|616427354|FG003|Overall Study|Lost to Follow-up|0|||
170567700|NCT01770743|616427355|FG004|Overall Study|Lost to Follow-up|1|||
170567701|NCT01770743|616427351|FG000|Overall Study|Sponsor Terminated Subject|1|||
170567702|NCT01770743|616427352|FG001|Overall Study|Sponsor Terminated Subject|0|||
170567703|NCT01770743|616427353|FG002|Overall Study|Sponsor Terminated Subject|0|||
170567704|NCT01770743|616427354|FG003|Overall Study|Sponsor Terminated Subject|1|||
170567705|NCT01770743|616427355|FG004|Overall Study|Sponsor Terminated Subject|0|||
170567706|NCT01770743|616427351|FG000|Overall Study|Moving Out of State|0|||
170567707|NCT01770743|616427352|FG001|Overall Study|Moving Out of State|1|||
170646874|NCT03254108|616721491|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
170646875|NCT03254108|616721492|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
170807429|NCT02708498|617305332|FG006|Overall Study|Unknown reason, missing data|0|||
170807430|NCT02708498|617305333|FG007|Overall Study|Unknown reason, missing data|0|||
170907598|NCT03819140|617666398|FG001|Overall Study|Withdrawal by Subject|2|||
170907599|NCT03819140|617666397|FG000|Overall Study|Adverse Event|0|||
170907600|NCT03819140|617666398|FG001|Overall Study|Adverse Event|1|||
170907601|NCT03819140|617666397|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
170907602|NCT03819140|617666398|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
170907603|NCT03819140|617666397|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
170807431|NCT00910962|617305336|FG000|Overall Study|Adverse Event|5|||
170807432|NCT00910962|617305337|FG001|Overall Study|Adverse Event|20|||
170807433|NCT00910962|617305338|FG002|Overall Study|Adverse Event|17|||
170807434|NCT00910962|617305336|FG000|Overall Study|Protocol Violation|1|||
170807435|NCT00910962|617305337|FG001|Overall Study|Protocol Violation|3|||
170807436|NCT00910962|617305338|FG002|Overall Study|Protocol Violation|3|||
170807437|NCT00910962|617305336|FG000|Overall Study|Lost to Follow-up|0|||
170807438|NCT00910962|617305337|FG001|Overall Study|Lost to Follow-up|3|||
170807439|NCT00910962|617305338|FG002|Overall Study|Lost to Follow-up|1|||
170807440|NCT00910962|617305336|FG000|Overall Study|Physician Decision|0|||
170807441|NCT00910962|617305337|FG001|Overall Study|Physician Decision|6|||
170807442|NCT00910962|617305338|FG002|Overall Study|Physician Decision|6|||
170807443|NCT00910962|617305336|FG000|Overall Study|Withdrawal by Subject|25|||
170807444|NCT00910962|617305337|FG001|Overall Study|Withdrawal by Subject|32|||
170807445|NCT00910962|617305338|FG002|Overall Study|Withdrawal by Subject|32|||
170807446|NCT00910962|617305336|FG000|Overall Study|Reached defined stopping criteria|12|||
170807447|NCT00910962|617305337|FG001|Overall Study|Reached defined stopping criteria|14|||
170807448|NCT00910962|617305338|FG002|Overall Study|Reached defined stopping criteria|17|||
170907604|NCT03819140|617666398|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
170907605|NCT02485717|617666401|FG000|Overall Study|Lost to Follow-up|6|||
170907606|NCT02485717|617666402|FG001|Overall Study|Lost to Follow-up|0|||
170907607|NCT02485717|617666403|FG002|Overall Study|Lost to Follow-up|0|||
170907608|NCT02485717|617666401|FG000|Overall Study|Withdrawal by Subject|0|||
170907609|NCT02485717|617666402|FG001|Overall Study|Withdrawal by Subject|0|||
170907610|NCT02485717|617666403|FG002|Overall Study|Withdrawal by Subject|1|||
170907611|NCT02485717|617666401|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
170907612|NCT02485717|617666402|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
170907613|NCT02485717|617666403|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
170907614|NCT02485717|617666401|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
170907615|NCT02485717|617666402|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
170907616|NCT02485717|617666403|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
170907617|NCT00828451|617666404|FG000|Overall Study|Death|2|||
170907618|NCT00828451|617666404|FG000|Overall Study|Lack of intravenous line|7|||
170907619|NCT00828451|617666404|FG000|Overall Study|Withdrawal by Subject|1|||
170907620|NCT00828451|617666404|FG000|Overall Study|Deterioration in clinical status|1|||
170907621|NCT01450540|617666410|FG000|Overall Study|Withdrawal by Subject|19|||
170907622|NCT01450540|617666411|FG001|Overall Study|Withdrawal by Subject|13|||
170907623|NCT01450540|617666410|FG000|Overall Study|protocol deviation|3|||
170907624|NCT01450540|617666411|FG001|Overall Study|protocol deviation|23|||
170907625|NCT00140855|617666412|FG000|Overall Study|Progressive disease|2|||
170907626|NCT02932267|617666413|FG000|Overall Study|Withdrawal by Subject|3|||
170567708|NCT01770743|616427353|FG002|Overall Study|Moving Out of State|0|||
170567709|NCT01770743|616427354|FG003|Overall Study|Moving Out of State|0|||
170907627|NCT02932267|617666413|FG000|Overall Study|Lost to Follow-up|4|||
170907628|NCT02932267|617666413|FG000|Overall Study|Pregnancy|1|||
170907629|NCT03476239|617666417|FG000|Overall Study|Withdrawal by Subject|10|||
170567710|NCT01770743|616427355|FG004|Overall Study|Moving Out of State|0|||
170567711|NCT04472650|616427364|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
170567712|NCT04472650|616427365|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
170807449|NCT02788981|617305341|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
170907630|NCT03476239|617666417|FG000|Overall Study|Death|80|||
170567713|NCT00272792|616427369|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
170567714|NCT00272792|616427370|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
170567715|NCT00272792|616427369|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
170567716|NCT00272792|616427370|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
170567717|NCT00272792|616427369|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
170567718|NCT00272792|616427370|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
170567719|NCT00272792|616427369|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
170567720|NCT00272792|616427370|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
170567721|NCT00443703|616427371|FG000|Overall Study|Never Treated|3|||
170567722|NCT00443703|616427372|FG001|Overall Study|Never Treated|1|||
170567723|NCT00443703|616427371|FG000|Overall Study|Adverse Event|7|||
170567724|NCT00443703|616427372|FG001|Overall Study|Adverse Event|3|||
170567725|NCT00443703|616427371|FG000|Overall Study|Lack of Efficacy|3|||
170567726|NCT00443703|616427372|FG001|Overall Study|Lack of Efficacy|1|||
170567727|NCT00443703|616427371|FG000|Overall Study|Lost to Follow-up|0|||
170567728|NCT00443703|616427372|FG001|Overall Study|Lost to Follow-up|4|||
170567729|NCT00443703|616427371|FG000|Overall Study|Physician Decision|4|||
170567730|NCT00443703|616427372|FG001|Overall Study|Physician Decision|2|||
170567731|NCT00443703|616427371|FG000|Overall Study|Protocol Violation|1|||
170567732|NCT00443703|616427372|FG001|Overall Study|Protocol Violation|1|||
170567733|NCT00443703|616427371|FG000|Overall Study|Withdrawal by Subject|9|||
170567734|NCT00443703|616427372|FG001|Overall Study|Withdrawal by Subject|6|||
170567735|NCT00443703|616427371|FG000|Overall Study|Progressive Disease|1|||
170567736|NCT00443703|616427372|FG001|Overall Study|Progressive Disease|0|||
170567737|NCT02921789|616427376|FG000|Overall Study|Adverse Event|0|||
170567738|NCT02921789|616427377|FG001|Overall Study|Adverse Event|1|||
170567739|NCT02921789|616427376|FG000|Overall Study|Lost to Follow-up|1|||
170567740|NCT02921789|616427377|FG001|Overall Study|Lost to Follow-up|0|||
170567741|NCT02921789|616427376|FG000|Overall Study|Protocol Deviation|2|||
170567742|NCT02921789|616427377|FG001|Overall Study|Protocol Deviation|0|||
170567743|NCT02921789|616427376|FG000|Overall Study|Withdrawal by Subject|2|||
170567744|NCT02921789|616427377|FG001|Overall Study|Withdrawal by Subject|1|||
170567745|NCT02921789|616427376|FG000|Overall Study|Miscellaneous|3|||
170567746|NCT02921789|616427377|FG001|Overall Study|Miscellaneous|2|||
170907631|NCT03476239|617666417|FG000|Overall Study|Lost to Follow-up|8|||
170907632|NCT01650805|617666420|FG000|Overall Study|Withdrawal by Subject|1|||
170907633|NCT01650805|617666421|FG001|Overall Study|Withdrawal by Subject|0|||
170907634|NCT02515669|617666424|FG000|228 Week Open-Label Phase|Other|0|||
170907635|NCT02515669|617666425|FG001|228 Week Open-Label Phase|Other|0|||
170907636|NCT02515669|617666426|FG002|228 Week Open-Label Phase|Other|1|||
170907637|NCT02515669|617666427|FG003|228 Week Open-Label Phase|Other|4|||
170907638|NCT02515669|617666424|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
170907639|NCT02515669|617666425|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
170907640|NCT02515669|617666426|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
170907641|NCT02515669|617666427|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
170907642|NCT02515669|617666424|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
170907643|NCT02515669|617666425|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
170907644|NCT02515669|617666426|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
170567747|NCT04592341|616427378|FG000|Overall Study|Physician Decision|5|||
170567748|NCT04592341|616427378|FG000|Overall Study|Study Terminated by Sponsor|5|||
170567749|NCT04592341|616427378|FG000|Overall Study|Withdrawal by Subject|53|||
170567750|NCT04592341|616427378|FG000|Overall Study|Lost to Follow-up|3|||
170567751|NCT04592341|616427378|FG000|Overall Study|Death|1|||
170567752|NCT04592341|616427378|FG000|Overall Study|Adverse Event|5|||
170567753|NCT04592341|616427378|FG000|Overall Study|other|4|||
170567754|NCT02808429|616427379|FG000|Overall Study|Lost to Follow-up|1|||
170567755|NCT02808429|616427380|FG001|Overall Study|Lost to Follow-up|0|||
170567756|NCT02808429|616427381|FG002|Overall Study|Lost to Follow-up|0|||
170567757|NCT02808429|616427379|FG000|Overall Study|Protocol Violation|0|||
170567758|NCT02808429|616427380|FG001|Overall Study|Protocol Violation|1|||
170567759|NCT02808429|616427381|FG002|Overall Study|Protocol Violation|0|||
170567760|NCT02808429|616427379|FG000|Overall Study|Premature study termination by sponsor|2|||
170567761|NCT02808429|616427380|FG001|Overall Study|Premature study termination by sponsor|0|||
170567762|NCT02808429|616427381|FG002|Overall Study|Premature study termination by sponsor|1|||
170567763|NCT02808429|616427379|FG000|Overall Study|Relocation|0|||
170907645|NCT02515669|617666427|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
170907646|NCT02515669|617666424|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
170907647|NCT02515669|617666425|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
170907648|NCT02515669|617666426|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
170567764|NCT02808429|616427380|FG001|Overall Study|Relocation|0|||
170567765|NCT02808429|616427381|FG002|Overall Study|Relocation|1|||
170567766|NCT01436110|616427382|FG000|Overall Study|Lack of Efficacy|23|||
170567767|NCT01436110|616427383|FG001|Overall Study|Lack of Efficacy|14|||
170567768|NCT01436110|616427384|FG002|Overall Study|Lack of Efficacy|9|||
170567769|NCT01436110|616427382|FG000|Overall Study|Withdrawal by Subject|6|||
170907649|NCT02515669|617666427|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
170907650|NCT02515669|617666424|FG000|228 Week Open-Label Phase|Missing|0|||
170907651|NCT02515669|617666425|FG001|228 Week Open-Label Phase|Missing|2|||
170907652|NCT02515669|617666426|FG002|228 Week Open-Label Phase|Missing|2|||
170907653|NCT02515669|617666427|FG003|228 Week Open-Label Phase|Missing|2|||
170907654|NCT03750838|617666430|FG000|Overall Study|Lost to Follow-up|10|||
170907655|NCT03750838|617666431|FG001|Overall Study|Lost to Follow-up|6|||
170907656|NCT01444391|617666432|FG000|Overall Study|Death|1|||
170907657|NCT04865731|617666440|FG000|Overall Study|Physician Decision|2|||
170907658|NCT04865731|617666441|FG001|Overall Study|Physician Decision|1|||
170907659|NCT04865731|617666440|FG000|Overall Study|Adverse Event|1|||
170907660|NCT04865731|617666441|FG001|Overall Study|Adverse Event|0|||
170907661|NCT04865731|617666440|FG000|Overall Study|Withdrawal by Subject|0|||
170907662|NCT04865731|617666441|FG001|Overall Study|Withdrawal by Subject|1|||
170907663|NCT05847881|617666446|FG000|Overall Study|Principal Investigator Decision|8|||
170907664|NCT05847881|617666446|FG000|Overall Study|Withdrawal by Subject|2|||
170907665|NCT00222105|617666451|FG000|Overall Study|Removed due to wrong diagnosis|1|||
170907666|NCT00222105|617666451|FG000|Overall Study|Withdrawal by Subject|1|||
170907667|NCT00222105|617666451|FG000|Overall Study|Adverse Event|8|||
170907668|NCT00222105|617666451|FG000|Overall Study|Treatment delays|2|||
170907669|NCT00222105|617666451|FG000|Overall Study|Death|2|||
170907670|NCT03277196|617666454|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
170907671|NCT03277196|617666454|FG000|Overall Study|Lost to Follow-up|3|||
170907672|NCT03277196|617666454|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
170907673|NCT03277196|617666454|FG000|Overall Study|Other|2|||
170907674|NCT03439345|617667902|FG000|Overall Study|Lost to Follow-up|0|||
170907675|NCT03439345|617667903|FG001|Overall Study|Lost to Follow-up|1|||
170907676|NCT03439345|617667902|FG000|Overall Study|Consent withdrawn|0|||
170907677|NCT03439345|617667903|FG001|Overall Study|Consent withdrawn|1|||
170907678|NCT01386385|617667906|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
170907679|NCT01386385|617667907|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
170907680|NCT01386385|617667908|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
170907681|NCT01386385|617667909|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
170907682|NCT01386385|617667910|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
170907683|NCT01386385|617667911|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
170907684|NCT01386385|617667912|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
170907685|NCT01386385|617667913|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
170907686|NCT01386385|617667906|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
170907687|NCT01386385|617667907|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
170907688|NCT01386385|617667908|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
170907689|NCT01386385|617667909|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
170907690|NCT01386385|617667910|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
170907691|NCT01386385|617667911|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
170907692|NCT01386385|617667912|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
170907693|NCT01386385|617667913|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
170907694|NCT01386385|617667906|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
170907695|NCT01386385|617667907|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
170907696|NCT01386385|617667908|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
170907697|NCT01386385|617667909|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
170907698|NCT01386385|617667910|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
170567770|NCT01436110|616427383|FG001|Overall Study|Withdrawal by Subject|8|||
170567771|NCT01436110|616427384|FG002|Overall Study|Withdrawal by Subject|4|||
170567772|NCT01436110|616427382|FG000|Overall Study|Adverse Event|2|||
170567773|NCT01436110|616427383|FG001|Overall Study|Adverse Event|1|||
170567774|NCT01436110|616427384|FG002|Overall Study|Adverse Event|2|||
170567775|NCT01436110|616427382|FG000|Overall Study|Physician Decision|3|||
170567776|NCT01436110|616427383|FG001|Overall Study|Physician Decision|1|||
170567777|NCT01436110|616427384|FG002|Overall Study|Physician Decision|1|||
170567778|NCT01436110|616427382|FG000|Overall Study|Lost to Follow-up|1|||
170567779|NCT01436110|616427383|FG001|Overall Study|Lost to Follow-up|1|||
170907699|NCT01386385|617667911|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
170907700|NCT01386385|617667912|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
170907701|NCT01386385|617667913|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
170907702|NCT01386385|617667906|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
170907703|NCT01386385|617667907|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
170907704|NCT01386385|617667908|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
170907705|NCT01386385|617667909|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
170907706|NCT01386385|617667910|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
170907707|NCT01386385|617667911|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
170907708|NCT01386385|617667912|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
170567780|NCT01436110|616427384|FG002|Overall Study|Lost to Follow-up|3|||
170567781|NCT01436110|616427382|FG000|Overall Study|Protocol Violation|3|||
170567782|NCT01436110|616427383|FG001|Overall Study|Protocol Violation|1|||
170567783|NCT01436110|616427384|FG002|Overall Study|Protocol Violation|1|||
170567784|NCT01436110|616427382|FG000|Overall Study|Did Not Receive Trial Medication|1|||
170567785|NCT01436110|616427383|FG001|Overall Study|Did Not Receive Trial Medication|0|||
170567786|NCT01436110|616427384|FG002|Overall Study|Did Not Receive Trial Medication|3|||
170567787|NCT01016067|616427385|FG000|Overall Study|Lost to Follow-up|1|||
170567788|NCT01016067|616427386|FG001|Overall Study|Lost to Follow-up|2|||
170567789|NCT01016067|616427385|FG000|Overall Study|Physician Decision|1|||
170567790|NCT01016067|616427386|FG001|Overall Study|Physician Decision|1|||
170567791|NCT01016067|616427385|FG000|Overall Study|Withdrew due to Relocation|0|||
170567792|NCT01016067|616427386|FG001|Overall Study|Withdrew due to Relocation|1|||
170567793|NCT01673646|616427389|FG000|Overall Study|Adverse Event|2|||
170567794|NCT01673646|616427390|FG001|Overall Study|Adverse Event|1|||
170567795|NCT01673646|616427391|FG002|Overall Study|Adverse Event|1|||
170567796|NCT01673646|616427389|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170567797|NCT01673646|616427390|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170567798|NCT01673646|616427391|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170567799|NCT01673646|616427389|FG000|Overall Study|Condition no longer requires study drug|0|||
170567800|NCT01673646|616427390|FG001|Overall Study|Condition no longer requires study drug|1|||
170567801|NCT01673646|616427391|FG002|Overall Study|Condition no longer requires study drug|0|||
170567802|NCT01673646|616427389|FG000|Overall Study|Withdrawal by Subject|0|||
170567803|NCT01673646|616427390|FG001|Overall Study|Withdrawal by Subject|2|||
170567804|NCT01673646|616427391|FG002|Overall Study|Withdrawal by Subject|2|||
170567805|NCT01673646|616427389|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
170567806|NCT01673646|616427390|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
170567807|NCT01673646|616427391|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
170567808|NCT01448616|616427393|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
170567809|NCT01448616|616427394|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
170567810|NCT01448616|616427395|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
170567811|NCT01448616|616427396|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
170567812|NCT01448616|616427393|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
170567813|NCT01448616|616427394|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
170567814|NCT01448616|616427395|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
170567815|NCT01448616|616427396|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
170567816|NCT01448616|616427393|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
170567817|NCT01448616|616427394|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
170567818|NCT01448616|616427395|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
170567819|NCT01448616|616427396|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
170567820|NCT01448616|616427393|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
170567821|NCT01448616|616427394|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
170567822|NCT01448616|616427395|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
170567823|NCT01448616|616427396|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
170567824|NCT01448616|616427393|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
170567825|NCT01448616|616427394|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
170567826|NCT01448616|616427395|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
170567827|NCT01448616|616427396|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
170567828|NCT01567722|616427397|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
170567829|NCT01567722|616427398|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
170567830|NCT01567722|616427399|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
170567831|NCT01567722|616427397|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
170567832|NCT01567722|616427398|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
170567833|NCT01567722|616427399|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
170567834|NCT01567722|616427397|FG000|Overall Study|Protocol closure by the OCG|2|||
170567835|NCT01567722|616427398|FG001|Overall Study|Protocol closure by the OCG|0|||
170567836|NCT01567722|616427399|FG002|Overall Study|Protocol closure by the OCG|0|||
170567837|NCT01567722|616427397|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
170567838|NCT01567722|616427398|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
170567839|NCT01567722|616427399|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
170567840|NCT04577781|616427400|FG000|Overall Study|Adverse Event|2|||
170567841|NCT04577781|616427401|FG001|Overall Study|Adverse Event|2|||
170567842|NCT04577781|616427400|FG000|Overall Study|Physician Decision|1|||
170567843|NCT04577781|616427401|FG001|Overall Study|Physician Decision|0|||
170567844|NCT01464879|616427402|FG000|Overall Study|Physician Decision|1|||
170567845|NCT01464879|616427402|FG000|Overall Study|Non-compliance|1|||
170567846|NCT01911260|616427405|FG000|Supplementation Period|transference or evasion of school|7|||
170567847|NCT01911260|616427406|FG001|Supplementation Period|transference or evasion of school|9|||
170646876|NCT03254108|616721493|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
170567848|NCT01911260|616427407|FG002|Supplementation Period|transference or evasion of school|7|||
170567849|NCT01911260|616427408|FG003|Supplementation Period|transference or evasion of school|6|||
170567850|NCT01911260|616427405|FG000|Supplementation Period|Adverse Event|2|||
170567851|NCT01911260|616427406|FG001|Supplementation Period|Adverse Event|0|||
170567852|NCT01911260|616427407|FG002|Supplementation Period|Adverse Event|1|||
170567853|NCT01911260|616427408|FG003|Supplementation Period|Adverse Event|0|||
170567854|NCT01911260|616427405|FG000|Supplementation Period|refused to receive supplement|1|||
170567855|NCT01911260|616427406|FG001|Supplementation Period|refused to receive supplement|0|||
170567856|NCT01911260|616427407|FG002|Supplementation Period|refused to receive supplement|1|||
170567857|NCT01911260|616427408|FG003|Supplementation Period|refused to receive supplement|0|||
170567858|NCT01911260|616427405|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
170567859|NCT01911260|616427406|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
170567860|NCT01911260|616427407|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
170567861|NCT01911260|616427408|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
170567862|NCT01911260|616427405|FG000|Follow-up Period|transference or evasion of school|13|||
170567863|NCT01911260|616427406|FG001|Follow-up Period|transference or evasion of school|20|||
170567864|NCT01911260|616427407|FG002|Follow-up Period|transference or evasion of school|15|||
170567865|NCT01911260|616427408|FG003|Follow-up Period|transference or evasion of school|12|||
170567866|NCT02712788|616427411|FG000|Overall Study|Physician Decision|1|||
170567867|NCT02712788|616427412|FG001|Overall Study|Physician Decision|0|||
170567868|NCT02712788|616427411|FG000|Overall Study|Protocol Violation|1|||
170567869|NCT02712788|616427412|FG001|Overall Study|Protocol Violation|0|||
170567870|NCT00575666|616427415|FG000|Overall Study|Withdrawal by Subject|3|||
170567871|NCT00575666|616427416|FG001|Overall Study|Withdrawal by Subject|2|||
170567872|NCT00575666|616427415|FG000|Overall Study|Physician Decision|1|||
170567873|NCT00575666|616427416|FG001|Overall Study|Physician Decision|1|||
170567874|NCT00508482|616427417|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
170567875|NCT00508482|616427418|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
170567876|NCT00508482|616427419|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
170567877|NCT00508482|616427417|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
170567878|NCT00508482|616427418|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
170567879|NCT00508482|616427419|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
170567880|NCT00508482|616427417|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
170567881|NCT00508482|616427418|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
170567882|NCT00508482|616427419|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
170567883|NCT01847755|616427420|FG000|Overall Study|Adverse Event|2|||
170567884|NCT01847755|616427420|FG000|Overall Study|Withdrawal by Subject|2|||
170567885|NCT01847755|616427420|FG000|Overall Study|Physician Decision|1|||
170567886|NCT03508050|616427423|FG000|Overall Study|Pleural adhesions|1|||
170567887|NCT03508050|616427424|FG001|Overall Study|Pleural adhesions|0|||
170567888|NCT03508050|616427423|FG000|Overall Study|Mucus plug|1|||
170567889|NCT03508050|616427424|FG001|Overall Study|Mucus plug|0|||
170567890|NCT03508050|616427423|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
170567891|NCT03508050|616427424|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
170567892|NCT03508050|616427423|FG000|Overall Study|Sustained desaturation|0|||
170567893|NCT03508050|616427424|FG001|Overall Study|Sustained desaturation|1|||
170567894|NCT00811720|616427428|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
170567895|NCT00811720|616427429|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
170567896|NCT00811720|616427428|FG000|All Treated Patients|Adverse Event|20|||
170567897|NCT00811720|616427429|FG001|All Treated Patients|Adverse Event|62|||
170567898|NCT00811720|616427428|FG000|All Treated Patients|Lack of Efficacy|22|||
170567899|NCT00811720|616427429|FG001|All Treated Patients|Lack of Efficacy|18|||
170567900|NCT00811720|616427428|FG000|All Treated Patients|Non-compliance|0|||
170907709|NCT01386385|617667913|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
170907710|NCT01386385|617667906|FG000|Phase II Concurrent CRT|Adverse Event|0|||
170907711|NCT01386385|617667907|FG001|Phase II Concurrent CRT|Adverse Event|0|||
170907712|NCT01386385|617667908|FG002|Phase II Concurrent CRT|Adverse Event|0|||
170646877|NCT03254108|616721494|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
170646878|NCT03254108|616721495|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
170907713|NCT01386385|617667909|FG003|Phase II Concurrent CRT|Adverse Event|0|||
170907714|NCT01386385|617667910|FG004|Phase II Concurrent CRT|Adverse Event|0|||
170567901|NCT00811720|616427429|FG001|All Treated Patients|Non-compliance|14|||
170567902|NCT00811720|616427428|FG000|All Treated Patients|Protocol Violation|9|||
170567903|NCT00811720|616427429|FG001|All Treated Patients|Protocol Violation|16|||
170567904|NCT00811720|616427428|FG000|All Treated Patients|Withdrawal by Subject|28|||
170567905|NCT00811720|616427429|FG001|All Treated Patients|Withdrawal by Subject|34|||
170567906|NCT00811720|616427428|FG000|All Treated Patients|Lost to Follow-up|10|||
170567907|NCT00811720|616427429|FG001|All Treated Patients|Lost to Follow-up|16|||
170567908|NCT00811720|616427428|FG000|All Treated Patients|Other Reason|7|||
170907715|NCT01386385|617667911|FG005|Phase II Concurrent CRT|Adverse Event|0|||
170907716|NCT01386385|617667912|FG006|Phase II Concurrent CRT|Adverse Event|3|||
170567909|NCT00811720|616427429|FG001|All Treated Patients|Other Reason|4|||
170567910|NCT03894891|616427430|FG000|Overall Study|Withdrawal by Subject|1|||
170567911|NCT03894891|616427430|FG000|Overall Study|Completed protocol treatment per protocol|5|||
170567912|NCT02750930|616427432|FG000|Overall Study|Study closed/terminated|8|||
170567913|NCT04389866|616427436|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
170567914|NCT04389866|616427437|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
170567915|NCT00776789|616427442|FG000|Overall Study|Consent refusal|2|||
170567916|NCT00776789|616427443|FG001|Overall Study|Consent refusal|2|||
170567917|NCT00776789|616427442|FG000|Overall Study|Poor quality video|1|||
170567918|NCT00776789|616427443|FG001|Overall Study|Poor quality video|1|||
170567919|NCT02850978|616427446|FG000|Overall Study|Uncollectable CRF|27|||
170567920|NCT02850978|616427446|FG000|Overall Study|No visit since the first visit|35|||
170567921|NCT02850978|616427446|FG000|Overall Study|Adverse Event|81|||
170567922|NCT02850978|616427446|FG000|Overall Study|Lack of Efficacy|40|||
170567923|NCT02850978|616427446|FG000|Overall Study|Improvement in condition|34|||
170567924|NCT02850978|616427446|FG000|Overall Study|Lost to Follow-up|121|||
170567925|NCT02850978|616427446|FG000|Overall Study|Reason not listed|88|||
170567926|NCT00699413|616427447|FG000|Overall Study|Withdrawal by Subject|0|||
170567927|NCT00699413|616427448|FG001|Overall Study|Withdrawal by Subject|2|||
170567928|NCT00699413|616427447|FG000|Overall Study|Study terminated by sponsor|4|||
170567929|NCT00699413|616427448|FG001|Overall Study|Study terminated by sponsor|2|||
170567930|NCT02779777|616427449|FG000|Overall Study|Disease Progression|1|||
170567931|NCT02779777|616427450|FG001|Overall Study|Disease Progression|0|||
170567932|NCT02779777|616427451|FG002|Overall Study|Disease Progression|0|||
170567933|NCT02779777|616427449|FG000|Overall Study|Adverse Event|3|||
170567934|NCT02779777|616427450|FG001|Overall Study|Adverse Event|1|||
170567935|NCT02779777|616427451|FG002|Overall Study|Adverse Event|0|||
170567936|NCT02779777|616427449|FG000|Overall Study|Physician Decision|9|||
170567937|NCT02779777|616427450|FG001|Overall Study|Physician Decision|0|||
170567938|NCT02779777|616427451|FG002|Overall Study|Physician Decision|1|||
170567939|NCT02779777|616427449|FG000|Overall Study|Withdrawal by Subject|1|||
170567940|NCT02779777|616427450|FG001|Overall Study|Withdrawal by Subject|0|||
170567941|NCT02779777|616427451|FG002|Overall Study|Withdrawal by Subject|0|||
170567942|NCT00251693|616427452|FG000|Overall Study|Adverse Event|17|||
170567943|NCT00251693|616427453|FG001|Overall Study|Adverse Event|9|||
170567944|NCT00251693|616427454|FG002|Overall Study|Adverse Event|9|||
170567945|NCT00251693|616427452|FG000|Overall Study|Protocol Violation|2|||
170567946|NCT00251693|616427453|FG001|Overall Study|Protocol Violation|0|||
170567947|NCT00251693|616427454|FG002|Overall Study|Protocol Violation|2|||
170567948|NCT00251693|616427452|FG000|Overall Study|Lost to Follow-up|12|||
170567949|NCT00251693|616427453|FG001|Overall Study|Lost to Follow-up|7|||
170567950|NCT00251693|616427454|FG002|Overall Study|Lost to Follow-up|8|||
170567951|NCT00251693|616427452|FG000|Overall Study|Withdrawal by Subject|11|||
170567952|NCT00251693|616427453|FG001|Overall Study|Withdrawal by Subject|17|||
170567953|NCT00251693|616427454|FG002|Overall Study|Withdrawal by Subject|14|||
170567954|NCT00251693|616427452|FG000|Overall Study|Lack of Efficacy|0|||
170567955|NCT00251693|616427453|FG001|Overall Study|Lack of Efficacy|1|||
170567956|NCT00251693|616427454|FG002|Overall Study|Lack of Efficacy|0|||
170567957|NCT00251693|616427452|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
170567958|NCT00251693|616427453|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
170567959|NCT00251693|616427454|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
170567960|NCT00251693|616427452|FG000|Overall Study|Noncompliant|0|||
170567961|NCT00251693|616427453|FG001|Overall Study|Noncompliant|0|||
170567962|NCT00251693|616427454|FG002|Overall Study|Noncompliant|2|||
170567963|NCT00251693|616427452|FG000|Overall Study|Possible Barrett's esophagus|3|||
170567964|NCT00251693|616427453|FG001|Overall Study|Possible Barrett's esophagus|5|||
170567965|NCT00251693|616427454|FG002|Overall Study|Possible Barrett's esophagus|2|||
170567966|NCT00251693|616427452|FG000|Overall Study|Subject request/subject unavailable|1|||
170567967|NCT00251693|616427453|FG001|Overall Study|Subject request/subject unavailable|2|||
170567968|NCT00251693|616427454|FG002|Overall Study|Subject request/subject unavailable|0|||
170646879|NCT00369629|616721496|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
170646880|NCT00369629|616721497|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
170907717|NCT01386385|617667913|FG007|Phase II Concurrent CRT|Adverse Event|3|||
170907718|NCT01386385|617667906|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
170907719|NCT01386385|617667907|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
170907720|NCT01386385|617667908|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
170907721|NCT01386385|617667909|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
170567969|NCT00251693|616427452|FG000|Overall Study|Abnormal laboratory findings|0|||
170567970|NCT00251693|616427453|FG001|Overall Study|Abnormal laboratory findings|0|||
170567971|NCT00251693|616427454|FG002|Overall Study|Abnormal laboratory findings|1|||
170567972|NCT00421148|616427455|FG000|Overall Study|Lost to Follow-up|0|||
170567973|NCT00421148|616427456|FG001|Overall Study|Lost to Follow-up|0|||
170567974|NCT00421148|616427457|FG002|Overall Study|Lost to Follow-up|0|||
170907722|NCT01386385|617667910|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
170567975|NCT00421148|616427458|FG003|Overall Study|Lost to Follow-up|0|||
170907723|NCT01386385|617667911|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
170907724|NCT01386385|617667912|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
170567976|NCT00421148|616427459|FG004|Overall Study|Lost to Follow-up|0|||
170567977|NCT00421148|616427460|FG005|Overall Study|Lost to Follow-up|0|||
170567978|NCT00421148|616427461|FG006|Overall Study|Lost to Follow-up|0|||
170567979|NCT00421148|616427462|FG007|Overall Study|Lost to Follow-up|0|||
170567980|NCT00421148|616427463|FG008|Overall Study|Lost to Follow-up|0|||
170567981|NCT00421148|616427464|FG009|Overall Study|Lost to Follow-up|0|||
170567982|NCT00421148|616427465|FG010|Overall Study|Lost to Follow-up|0|||
170567983|NCT00421148|616427466|FG011|Overall Study|Lost to Follow-up|0|||
170567984|NCT00421148|616427467|FG012|Overall Study|Lost to Follow-up|0|||
170567985|NCT00421148|616427468|FG013|Overall Study|Lost to Follow-up|0|||
170567986|NCT00421148|616427469|FG014|Overall Study|Lost to Follow-up|0|||
170567987|NCT00421148|616427470|FG015|Overall Study|Lost to Follow-up|0|||
170567988|NCT00421148|616427471|FG016|Overall Study|Lost to Follow-up|0|||
170567989|NCT00421148|616427472|FG017|Overall Study|Lost to Follow-up|1|||
170567990|NCT00421148|616427473|FG018|Overall Study|Lost to Follow-up|0|||
170567991|NCT00421148|616427474|FG019|Overall Study|Lost to Follow-up|0|||
170567992|NCT00421148|616427455|FG000|Overall Study|Withdrawal by Subject|0|||
170567993|NCT00421148|616427456|FG001|Overall Study|Withdrawal by Subject|0|||
170567994|NCT00421148|616427457|FG002|Overall Study|Withdrawal by Subject|0|||
170567995|NCT00421148|616427458|FG003|Overall Study|Withdrawal by Subject|0|||
170567996|NCT00421148|616427459|FG004|Overall Study|Withdrawal by Subject|0|||
170567997|NCT00421148|616427460|FG005|Overall Study|Withdrawal by Subject|0|||
170567998|NCT00421148|616427461|FG006|Overall Study|Withdrawal by Subject|0|||
170567999|NCT00421148|616427462|FG007|Overall Study|Withdrawal by Subject|0|||
170568000|NCT00421148|616427463|FG008|Overall Study|Withdrawal by Subject|0|||
170568001|NCT00421148|616427464|FG009|Overall Study|Withdrawal by Subject|0|||
170568002|NCT00421148|616427465|FG010|Overall Study|Withdrawal by Subject|0|||
170568003|NCT00421148|616427466|FG011|Overall Study|Withdrawal by Subject|0|||
170568004|NCT00421148|616427467|FG012|Overall Study|Withdrawal by Subject|0|||
170568005|NCT00421148|616427468|FG013|Overall Study|Withdrawal by Subject|0|||
170568006|NCT00421148|616427469|FG014|Overall Study|Withdrawal by Subject|0|||
170568007|NCT00421148|616427470|FG015|Overall Study|Withdrawal by Subject|0|||
170568008|NCT00421148|616427471|FG016|Overall Study|Withdrawal by Subject|0|||
170568009|NCT00421148|616427472|FG017|Overall Study|Withdrawal by Subject|1|||
170568010|NCT00421148|616427473|FG018|Overall Study|Withdrawal by Subject|0|||
170568011|NCT00421148|616427474|FG019|Overall Study|Withdrawal by Subject|0|||
170568012|NCT00421148|616427455|FG000|Overall Study|Protocol Violation|0|||
170568013|NCT00421148|616427456|FG001|Overall Study|Protocol Violation|0|||
170568014|NCT00421148|616427457|FG002|Overall Study|Protocol Violation|0|||
170568015|NCT00421148|616427458|FG003|Overall Study|Protocol Violation|0|||
170568016|NCT00421148|616427459|FG004|Overall Study|Protocol Violation|0|||
170568017|NCT00421148|616427460|FG005|Overall Study|Protocol Violation|1|||
170568018|NCT00421148|616427461|FG006|Overall Study|Protocol Violation|0|||
170568019|NCT00421148|616427462|FG007|Overall Study|Protocol Violation|0|||
170568020|NCT00421148|616427463|FG008|Overall Study|Protocol Violation|0|||
170568021|NCT00421148|616427464|FG009|Overall Study|Protocol Violation|0|||
170568022|NCT00421148|616427465|FG010|Overall Study|Protocol Violation|0|||
170568023|NCT00421148|616427466|FG011|Overall Study|Protocol Violation|0|||
170568024|NCT00421148|616427467|FG012|Overall Study|Protocol Violation|0|||
170568025|NCT00421148|616427468|FG013|Overall Study|Protocol Violation|0|||
170568026|NCT00421148|616427469|FG014|Overall Study|Protocol Violation|0|||
170568027|NCT00421148|616427470|FG015|Overall Study|Protocol Violation|0|||
170568028|NCT00421148|616427471|FG016|Overall Study|Protocol Violation|0|||
170568029|NCT00421148|616427472|FG017|Overall Study|Protocol Violation|0|||
170907725|NCT01386385|617667913|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
170907726|NCT01386385|617667906|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
170907727|NCT01386385|617667907|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
170568030|NCT00421148|616427473|FG018|Overall Study|Protocol Violation|1|||
170568031|NCT00421148|616427474|FG019|Overall Study|Protocol Violation|0|||
170568032|NCT00570713|616427475|FG000|Overall Study|Adverse Event|16|||
170568033|NCT00570713|616427476|FG001|Overall Study|Adverse Event|9|||
170568034|NCT00570713|616427475|FG000|Overall Study|Death|7|||
170568035|NCT00570713|616427476|FG001|Overall Study|Death|7|||
170568036|NCT00570713|616427475|FG000|Overall Study|Lack of Efficacy|40|||
170568037|NCT00570713|616427476|FG001|Overall Study|Lack of Efficacy|49|||
170568038|NCT00570713|616427475|FG000|Overall Study|Physician Decision|2|||
170568039|NCT00570713|616427476|FG001|Overall Study|Physician Decision|2|||
170568040|NCT00570713|616427475|FG000|Overall Study|Withdrawal by Subject|3|||
170568041|NCT00570713|616427476|FG001|Overall Study|Withdrawal by Subject|3|||
170568042|NCT00570713|616427475|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
170568043|NCT00570713|616427476|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
170568044|NCT00469833|616427478|FG000|Overall Study|No IV access|2|||
170568045|NCT03289533|616427479|FG000|Overall Study|Death|12|||
170568046|NCT03289533|616427479|FG000|Overall Study|Terminated from study by sponsor|10|||
170568047|NCT01030822|616427480|FG000|Overall Study|Moved/migrated from study area|6|||
170568048|NCT01030822|616427481|FG001|Overall Study|Moved/migrated from study area|7|||
170568049|NCT01030822|616427482|FG002|Overall Study|Moved/migrated from study area|3|||
170568050|NCT01030822|616427480|FG000|Overall Study|Withdrawal by Subject|16|||
170568051|NCT01030822|616427481|FG001|Overall Study|Withdrawal by Subject|13|||
170568052|NCT01030822|616427482|FG002|Overall Study|Withdrawal by Subject|16|||
170568053|NCT01030822|616427480|FG000|Overall Study|Lost to Follow-up|9|||
170568054|NCT01030822|616427481|FG001|Overall Study|Lost to Follow-up|4|||
170568055|NCT01030822|616427482|FG002|Overall Study|Lost to Follow-up|7|||
170568056|NCT01284959|616427483|FG000|Overall Study|Withdrawal by Subject|1|||
170568057|NCT01284959|616427484|FG001|Overall Study|Withdrawal by Subject|0|||
170568058|NCT01284959|616427485|FG002|Overall Study|Withdrawal by Subject|0|||
170568059|NCT01284959|616427483|FG000|Overall Study|Adverse Event|0|||
170568060|NCT01284959|616427484|FG001|Overall Study|Adverse Event|0|||
170568061|NCT01284959|616427485|FG002|Overall Study|Adverse Event|1|||
170568062|NCT01055613|616427486|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
170568063|NCT01055613|616427487|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170568064|NCT01055613|616427486|FG000|Overall Study|Unacceptable lens fit|1|||
170568065|NCT01055613|616427487|FG001|Overall Study|Unacceptable lens fit|0|||
170568066|NCT01055613|616427486|FG000|Overall Study|Discomfort|2|||
170568067|NCT01055613|616427487|FG001|Overall Study|Discomfort|1|||
170568068|NCT01055613|616427486|FG000|Overall Study|Lost to Follow-up|1|||
170568069|NCT01055613|616427487|FG001|Overall Study|Lost to Follow-up|1|||
170568070|NCT01055613|616427486|FG000|Overall Study|Protocol Violation|1|||
170568071|NCT01055613|616427487|FG001|Overall Study|Protocol Violation|1|||
170568072|NCT01055613|616427486|FG000|Overall Study|Subject Disinterest|1|||
170568073|NCT01055613|616427487|FG001|Overall Study|Subject Disinterest|1|||
170568074|NCT00363311|616427494|FG000|Overall Study|Adverse Event|6|||
170568075|NCT00363311|616427495|FG001|Overall Study|Adverse Event|4|||
170568076|NCT00363311|616427494|FG000|Overall Study|Lost to Follow-up|3|||
170568077|NCT00363311|616427495|FG001|Overall Study|Lost to Follow-up|0|||
170568078|NCT00363311|616427494|FG000|Overall Study|Protocol Violation|1|||
170568079|NCT00363311|616427495|FG001|Overall Study|Protocol Violation|2|||
170568080|NCT00363311|616427494|FG000|Overall Study|Withdrawal by Subject|12|||
170568081|NCT00363311|616427495|FG001|Overall Study|Withdrawal by Subject|6|||
170568082|NCT00363311|616427494|FG000|Overall Study|Physician Decision|1|||
170568083|NCT00363311|616427495|FG001|Overall Study|Physician Decision|1|||
170568084|NCT00363311|616427494|FG000|Overall Study|Sponsor Terminated Study|2|||
170568085|NCT00363311|616427495|FG001|Overall Study|Sponsor Terminated Study|2|||
170568086|NCT00363311|616427494|FG000|Overall Study|Disease Progression|46|||
170568087|NCT00363311|616427495|FG001|Overall Study|Disease Progression|26|||
170568088|NCT00363311|616427494|FG000|Overall Study|Non-Compliance|1|||
170568089|NCT00363311|616427495|FG001|Overall Study|Non-Compliance|1|||
170568090|NCT00363311|616427494|FG000|Overall Study|Participant Refused Biopsy|1|||
170568091|NCT00363311|616427495|FG001|Overall Study|Participant Refused Biopsy|0|||
170568092|NCT00363311|616427494|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
170568093|NCT00363311|616427495|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
170568094|NCT00363311|616427494|FG000|Overall Study|Participant Opted for Treatment|1|||
170568095|NCT00363311|616427495|FG001|Overall Study|Participant Opted for Treatment|0|||
170568096|NCT00363311|616427494|FG000|Overall Study|Participant Moved to Another Country|1|||
170568097|NCT00363311|616427495|FG001|Overall Study|Participant Moved to Another Country|0|||
170568098|NCT00363311|616427494|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
170568099|NCT00363311|616427495|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
170568100|NCT00363311|616427494|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
170568101|NCT00363311|616427495|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
170568102|NCT00363311|616427494|FG000|Overall Study|Participant Moved to Louisiana|0|||
170568103|NCT00363311|616427495|FG001|Overall Study|Participant Moved to Louisiana|1|||
170568104|NCT00401843|616427496|FG000|Overall Study|Achieved Complete Response|1|||
170568105|NCT00401843|616427497|FG001|Overall Study|Achieved Complete Response|5|||
170568106|NCT00401843|616427498|FG002|Overall Study|Achieved Complete Response|11|||
170568107|NCT00401843|616427496|FG000|Overall Study|Adverse Event|7|||
170568108|NCT00401843|616427497|FG001|Overall Study|Adverse Event|26|||
170568109|NCT00401843|616427498|FG002|Overall Study|Adverse Event|27|||
170646881|NCT00369629|616721498|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
170646882|NCT00369629|616721499|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
170907728|NCT01386385|617667908|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
170907729|NCT01386385|617667909|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
170907730|NCT01386385|617667910|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
170907731|NCT01386385|617667911|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
170907732|NCT01386385|617667912|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
170907733|NCT01386385|617667913|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
170568110|NCT00401843|616427496|FG000|Overall Study|Death|0|||
170568111|NCT00401843|616427497|FG001|Overall Study|Death|8|||
170568112|NCT00401843|616427498|FG002|Overall Study|Death|10|||
170568113|NCT00401843|616427496|FG000|Overall Study|Disease progression|10|||
170568114|NCT00401843|616427497|FG001|Overall Study|Disease progression|60|||
170568115|NCT00401843|616427498|FG002|Overall Study|Disease progression|49|||
170568116|NCT00401843|616427496|FG000|Overall Study|End of Study|1|||
170568117|NCT00401843|616427497|FG001|Overall Study|End of Study|1|||
170568118|NCT00401843|616427498|FG002|Overall Study|End of Study|2|||
170568119|NCT00401843|616427496|FG000|Overall Study|Lost to Follow-up|0|||
170568120|NCT00401843|616427497|FG001|Overall Study|Lost to Follow-up|0|||
170568121|NCT00401843|616427498|FG002|Overall Study|Lost to Follow-up|2|||
170568122|NCT00401843|616427496|FG000|Overall Study|Other Unspecified|0|||
170568123|NCT00401843|616427497|FG001|Overall Study|Other Unspecified|3|||
170568124|NCT00401843|616427498|FG002|Overall Study|Other Unspecified|5|||
170568125|NCT00401843|616427496|FG000|Overall Study|Physician Decision|0|||
170568126|NCT00401843|616427497|FG001|Overall Study|Physician Decision|16|||
170568127|NCT00401843|616427498|FG002|Overall Study|Physician Decision|10|||
170568128|NCT00401843|616427496|FG000|Overall Study|Protocol Violation|0|||
170568129|NCT00401843|616427497|FG001|Overall Study|Protocol Violation|0|||
170568130|NCT00401843|616427498|FG002|Overall Study|Protocol Violation|1|||
170568131|NCT00401843|616427496|FG000|Overall Study|Withdrawal by Subject|1|||
170568132|NCT00401843|616427497|FG001|Overall Study|Withdrawal by Subject|5|||
170568133|NCT00401843|616427498|FG002|Overall Study|Withdrawal by Subject|5|||
170568134|NCT00401843|616427496|FG000|Overall Study|Withdrawal of consent to study agent|1|||
170568135|NCT00401843|616427497|FG001|Overall Study|Withdrawal of consent to study agent|15|||
170568136|NCT00401843|616427498|FG002|Overall Study|Withdrawal of consent to study agent|17|||
170568137|NCT00401843|616427496|FG000|Overall Study|Randomized but not Treated|0|||
170568138|NCT00401843|616427497|FG001|Overall Study|Randomized but not Treated|2|||
170568139|NCT00401843|616427498|FG002|Overall Study|Randomized but not Treated|3|||
170568140|NCT00401843|616427496|FG000|Overall Study|Received incorrect treatment|0|||
170568141|NCT00401843|616427497|FG001|Overall Study|Received incorrect treatment|3|||
170568142|NCT00401843|616427498|FG002|Overall Study|Received incorrect treatment|0|||
170568143|NCT00120627|616427501|FG000|Overall Study|Withdrawal by Subject|5|||
170568144|NCT00120627|616427502|FG001|Overall Study|Withdrawal by Subject|5|||
170568145|NCT01508910|616427503|FG000|Treatment|Death|2|||
170568146|NCT01508910|616427504|FG001|Treatment|Death|3|||
170568147|NCT01508910|616427505|FG002|Treatment|Death|2|||
170568148|NCT01508910|616427506|FG003|Treatment|Death|0|||
170568149|NCT01508910|616427503|FG000|Treatment|Lost to Follow-up|0|||
170568150|NCT01508910|616427504|FG001|Treatment|Lost to Follow-up|0|||
170568151|NCT01508910|616427505|FG002|Treatment|Lost to Follow-up|2|||
170568152|NCT01508910|616427506|FG003|Treatment|Lost to Follow-up|1|||
170568153|NCT01508910|616427503|FG000|Treatment|Withdrawal by Subject|0|||
170568154|NCT01508910|616427504|FG001|Treatment|Withdrawal by Subject|1|||
170568155|NCT01508910|616427505|FG002|Treatment|Withdrawal by Subject|6|||
170568156|NCT01508910|616427506|FG003|Treatment|Withdrawal by Subject|1|||
170568157|NCT01508910|616427503|FG000|Treatment|Sponsor Decision|0|||
170568158|NCT01508910|616427504|FG001|Treatment|Sponsor Decision|0|||
170568159|NCT01508910|616427505|FG002|Treatment|Sponsor Decision|0|||
170568160|NCT01508910|616427506|FG003|Treatment|Sponsor Decision|1|||
170568161|NCT01595529|616427507|FG000|Overall Study|Adverse Event|2|||
170568162|NCT01595529|616427508|FG001|Overall Study|Adverse Event|0|||
170568163|NCT01595529|616427507|FG000|Overall Study|Subject Non-Compliant|2|||
170568164|NCT01595529|616427508|FG001|Overall Study|Subject Non-Compliant|0|||
170568165|NCT01595529|616427507|FG000|Overall Study|Lost to Follow-up|8|||
170807450|NCT02788981|617305342|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
170807451|NCT05553366|617305343|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
170568166|NCT01595529|616427508|FG001|Overall Study|Lost to Follow-up|14|||
170568167|NCT01595529|616427507|FG000|Overall Study|Protocol Violation|1|||
170568168|NCT01595529|616427508|FG001|Overall Study|Protocol Violation|2|||
170568169|NCT01595529|616427507|FG000|Overall Study|Physician Decision|1|||
170568170|NCT01595529|616427508|FG001|Overall Study|Physician Decision|0|||
170568171|NCT01595529|616427507|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
170568172|NCT01595529|616427508|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
170568173|NCT01595529|616427507|FG000|Overall Study|Administrative Decision|1|||
170568174|NCT01595529|616427508|FG001|Overall Study|Administrative Decision|0|||
170568175|NCT01595529|616427507|FG000|Overall Study|Entry Failure/Screening Failure|6|||
170568176|NCT01595529|616427508|FG001|Overall Study|Entry Failure/Screening Failure|1|||
170568177|NCT04016714|616427509|FG000|Overall Study|Death|1|||
170568178|NCT04016714|616427510|FG001|Overall Study|Death|0|||
170568179|NCT04016714|616427509|FG000|Overall Study|Lost to Follow-up|3|||
170568180|NCT04016714|616427510|FG001|Overall Study|Lost to Follow-up|1|||
170568181|NCT04016714|616427509|FG000|Overall Study|Physician Decision|3|||
170568182|NCT04016714|616427510|FG001|Overall Study|Physician Decision|3|||
170568183|NCT04016714|616427509|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
170568184|NCT04016714|616427510|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
170568185|NCT01677988|616427516|FG000|Overall Study|Lack of Efficacy|2|||
170568186|NCT02629861|616427521|FG000|Overall Study|Adverse Event|7|||
170568187|NCT02629861|616427522|FG001|Overall Study|Adverse Event|5|||
170568188|NCT02629861|616427523|FG002|Overall Study|Adverse Event|4|||
170568189|NCT02629861|616427521|FG000|Overall Study|Withdrawal by Subject|5|||
170568190|NCT02629861|616427522|FG001|Overall Study|Withdrawal by Subject|8|||
170568191|NCT02629861|616427523|FG002|Overall Study|Withdrawal by Subject|13|||
170568192|NCT02629861|616427521|FG000|Overall Study|Protocol Violation|2|||
170568193|NCT02629861|616427522|FG001|Overall Study|Protocol Violation|3|||
170568194|NCT02629861|616427523|FG002|Overall Study|Protocol Violation|7|||
170568195|NCT02629861|616427521|FG000|Overall Study|Lost to Follow-up|12|||
170568196|NCT02629861|616427522|FG001|Overall Study|Lost to Follow-up|9|||
170568197|NCT02629861|616427523|FG002|Overall Study|Lost to Follow-up|4|||
170568198|NCT02629861|616427521|FG000|Overall Study|Other|1|||
170568199|NCT02629861|616427522|FG001|Overall Study|Other|1|||
170568200|NCT02629861|616427523|FG002|Overall Study|Other|0|||
170568201|NCT02629861|616427521|FG000|Overall Study|Pregnancy|2|||
170568202|NCT02629861|616427522|FG001|Overall Study|Pregnancy|1|||
170568203|NCT02629861|616427523|FG002|Overall Study|Pregnancy|0|||
170568204|NCT00659425|616427524|FG000|Overall Study|Disease progression|1|||
170568205|NCT00659425|616427525|FG001|Overall Study|Disease progression|0|||
170568206|NCT00659425|616427526|FG002|Overall Study|Disease progression|0|||
170568207|NCT00659425|616427527|FG003|Overall Study|Disease progression|1|||
170568208|NCT00659425|616427528|FG004|Overall Study|Disease progression|0|||
170568209|NCT00659425|616427529|FG005|Overall Study|Disease progression|2|||
170568210|NCT00659425|616427530|FG006|Overall Study|Disease progression|4|||
170568211|NCT00659425|616427531|FG007|Overall Study|Disease progression|3|||
170568212|NCT00659425|616427532|FG008|Overall Study|Disease progression|5|||
170568213|NCT00659425|616427533|FG009|Overall Study|Disease progression|3|||
170568214|NCT00659425|616427524|FG000|Overall Study|Death|0|||
170568215|NCT00659425|616427525|FG001|Overall Study|Death|0|||
170568216|NCT00659425|616427526|FG002|Overall Study|Death|0|||
170568217|NCT00659425|616427527|FG003|Overall Study|Death|1|||
170568218|NCT00659425|616427528|FG004|Overall Study|Death|0|||
170568219|NCT00659425|616427529|FG005|Overall Study|Death|0|||
170568220|NCT00659425|616427530|FG006|Overall Study|Death|1|||
170568221|NCT00659425|616427531|FG007|Overall Study|Death|0|||
170568222|NCT00659425|616427532|FG008|Overall Study|Death|0|||
170568223|NCT00659425|616427533|FG009|Overall Study|Death|0|||
170568224|NCT00659425|616427524|FG000|Overall Study|Adverse Event|0|||
170568225|NCT00659425|616427525|FG001|Overall Study|Adverse Event|0|||
170568226|NCT00659425|616427526|FG002|Overall Study|Adverse Event|0|||
170568227|NCT00659425|616427527|FG003|Overall Study|Adverse Event|0|||
170568228|NCT00659425|616427528|FG004|Overall Study|Adverse Event|0|||
170568229|NCT00659425|616427529|FG005|Overall Study|Adverse Event|1|||
170568230|NCT00659425|616427530|FG006|Overall Study|Adverse Event|0|||
170568231|NCT00659425|616427531|FG007|Overall Study|Adverse Event|3|||
170568232|NCT00659425|616427532|FG008|Overall Study|Adverse Event|1|||
170568233|NCT00659425|616427533|FG009|Overall Study|Adverse Event|4|||
170568234|NCT00659425|616427524|FG000|Overall Study|Investigator Discretion|0|||
170568235|NCT00659425|616427525|FG001|Overall Study|Investigator Discretion|0|||
170568236|NCT00659425|616427526|FG002|Overall Study|Investigator Discretion|0|||
170568237|NCT00659425|616427527|FG003|Overall Study|Investigator Discretion|0|||
170568238|NCT00659425|616427528|FG004|Overall Study|Investigator Discretion|0|||
170568239|NCT00659425|616427529|FG005|Overall Study|Investigator Discretion|1|||
170568240|NCT00659425|616427530|FG006|Overall Study|Investigator Discretion|0|||
170568241|NCT00659425|616427531|FG007|Overall Study|Investigator Discretion|3|||
170568242|NCT00659425|616427532|FG008|Overall Study|Investigator Discretion|0|||
170568243|NCT00659425|616427533|FG009|Overall Study|Investigator Discretion|0|||
170568244|NCT00659425|616427524|FG000|Overall Study|Other|0|||
170568245|NCT00659425|616427525|FG001|Overall Study|Other|1|||
170568246|NCT00659425|616427526|FG002|Overall Study|Other|1|||
170568247|NCT00659425|616427527|FG003|Overall Study|Other|2|||
170568248|NCT00659425|616427528|FG004|Overall Study|Other|4|||
170568249|NCT00659425|616427529|FG005|Overall Study|Other|0|||
170568250|NCT00659425|616427530|FG006|Overall Study|Other|3|||
170568251|NCT00659425|616427531|FG007|Overall Study|Other|2|||
170568252|NCT00659425|616427532|FG008|Overall Study|Other|0|||
170568253|NCT00659425|616427533|FG009|Overall Study|Other|6|||
170568254|NCT00902330|616427553|FG000|Overall Study|Too overwhelmed by treatment|2|||
170568255|NCT00902330|616427554|FG001|Overall Study|Too overwhelmed by treatment|5|||
170568256|NCT00902330|616427553|FG000|Overall Study|Adverse Event|1|||
170568257|NCT00902330|616427554|FG001|Overall Study|Adverse Event|0|||
170568258|NCT00902330|616427553|FG000|Overall Study|No post baseline data|1|||
170568259|NCT00902330|616427554|FG001|Overall Study|No post baseline data|0|||
170568260|NCT00165789|616427555|FG000|Overall Study|Adverse Event|0|||
170568261|NCT00165789|616427556|FG001|Overall Study|Adverse Event|3|||
170568262|NCT00165789|616427557|FG002|Overall Study|Adverse Event|0|||
170568263|NCT00165789|616427558|FG003|Overall Study|Adverse Event|12|||
170568264|NCT00165789|616427555|FG000|Overall Study|Withdrawal by Subject|0|||
170568265|NCT00165789|616427556|FG001|Overall Study|Withdrawal by Subject|1|||
170568266|NCT00165789|616427557|FG002|Overall Study|Withdrawal by Subject|1|||
170568267|NCT00165789|616427558|FG003|Overall Study|Withdrawal by Subject|2|||
170568268|NCT01174563|616427560|FG000|Overall Study|Progressive Disease|45|||
170568269|NCT01174563|616427560|FG000|Overall Study|Death|5|||
170568270|NCT01174563|616427560|FG000|Overall Study|Investigator's Discretion|5|||
170568271|NCT01174563|616427560|FG000|Overall Study|Participant Withdrew Consent|3|||
170568272|NCT01174563|616427560|FG000|Overall Study|Rash Adverse Event|1|||
170568273|NCT01174563|616427560|FG000|Overall Study|Sponsor's decision|1|||
170568274|NCT02735421|616429647|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
170568275|NCT02735421|616429647|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
170568276|NCT02735421|616429647|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
170568277|NCT02735421|616429647|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
170568278|NCT02735421|616429647|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
170568279|NCT02735421|616429647|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
170568280|NCT02735421|616429647|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
170568281|NCT01978145|616429649|FG000|Treatment Period 1|Adverse Event|1|||
170568282|NCT01978145|616429650|FG001|Treatment Period 1|Adverse Event|9|||
170568283|NCT01978145|616429649|FG000|Treatment Period 1|Physician Decision|1|||
170568284|NCT01978145|616429650|FG001|Treatment Period 1|Physician Decision|0|||
170568285|NCT01978145|616429649|FG000|Treatment Period 1|Withdrawal by Subject|5|||
170568286|NCT01978145|616429650|FG001|Treatment Period 1|Withdrawal by Subject|4|||
170568287|NCT01978145|616429649|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
170568288|NCT01978145|616429650|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
170568289|NCT01978145|616429649|FG000|Washout Period 1|Adverse Event|0|||
170568290|NCT01978145|616429650|FG001|Washout Period 1|Adverse Event|1|||
170568291|NCT01978145|616429649|FG000|Washout Period 1|Withdrawal by Subject|1|||
170568292|NCT01978145|616429650|FG001|Washout Period 1|Withdrawal by Subject|1|||
170568293|NCT01978145|616429649|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
170568294|NCT01978145|616429650|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
170568295|NCT01978145|616429649|FG000|Treatment Period 2|Adverse Event|3|||
170568296|NCT01978145|616429650|FG001|Treatment Period 2|Adverse Event|3|||
170568297|NCT01978145|616429649|FG000|Treatment Period 2|Protocol Violation|0|||
170568298|NCT01978145|616429650|FG001|Treatment Period 2|Protocol Violation|1|||
170568299|NCT01978145|616429649|FG000|Treatment Period 2|Lost to Follow-up|1|||
170568300|NCT01978145|616429650|FG001|Treatment Period 2|Lost to Follow-up|1|||
170568301|NCT01978145|616429649|FG000|Treatment Period 2|Withdrawal by Subject|7|||
170568302|NCT01978145|616429650|FG001|Treatment Period 2|Withdrawal by Subject|4|||
170568303|NCT01978145|616429649|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
170568304|NCT01978145|616429650|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
170568305|NCT00322049|616429651|FG000|Overall Study|Moved out of area|0|||
170568306|NCT00322049|616429652|FG001|Overall Study|Moved out of area|0|||
170568307|NCT00322049|616429653|FG002|Overall Study|Moved out of area|0|||
170568308|NCT00322049|616429654|FG003|Overall Study|Moved out of area|1|||
170568309|NCT00322049|616429651|FG000|Overall Study|Infected with Dengue during study|0|||
170568310|NCT00322049|616429652|FG001|Overall Study|Infected with Dengue during study|1|||
170568311|NCT00322049|616429653|FG002|Overall Study|Infected with Dengue during study|0|||
170568312|NCT00322049|616429654|FG003|Overall Study|Infected with Dengue during study|0|||
170568313|NCT00810277|616429666|FG000|Overall Study|Adverse Event|1|||
170568314|NCT01173679|616429667|FG000|Overall Study|Death|1|||
170568315|NCT01250054|616429668|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
170568316|NCT01250054|616429669|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
170568317|NCT02026011|616429670|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
170568318|NCT02026011|616429671|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
170568319|NCT02026011|616429670|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
170568320|NCT02026011|616429671|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
170568321|NCT02026011|616429670|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
170568322|NCT02026011|616429671|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
170568323|NCT02026011|616429670|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
170568324|NCT02026011|616429671|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
170568325|NCT00755807|616429674|FG000|Acute Phase|Adverse Event|16|||
170568326|NCT00755807|616429675|FG001|Acute Phase|Adverse Event|5|||
170568327|NCT00755807|616429674|FG000|Acute Phase|Protocol Violation|1|||
170568328|NCT00755807|616429675|FG001|Acute Phase|Protocol Violation|3|||
170568329|NCT00755807|616429674|FG000|Acute Phase|Withdrawal by Subject|1|||
170646883|NCT00369629|616721496|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
170646884|NCT00369629|616721497|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
170568330|NCT00755807|616429675|FG001|Acute Phase|Withdrawal by Subject|2|||
170568331|NCT00755807|616429674|FG000|Acute Phase|Lack of Efficacy|0|||
170568332|NCT00755807|616429675|FG001|Acute Phase|Lack of Efficacy|1|||
170568333|NCT00755807|616429674|FG000|Acute Phase|Physician Decision|0|||
170646885|NCT00369629|616721498|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
170807452|NCT05553366|617305344|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
170807453|NCT05553366|617305345|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
170568334|NCT00755807|616429675|FG001|Acute Phase|Physician Decision|1|||
170568335|NCT00755807|616429674|FG000|Open-label Extension Phase|Adverse Event|7|||
170568336|NCT00755807|616429675|FG001|Open-label Extension Phase|Adverse Event|7|||
170568337|NCT00755807|616429674|FG000|Open-label Extension Phase|Protocol Violation|5|||
170568338|NCT00755807|616429675|FG001|Open-label Extension Phase|Protocol Violation|2|||
170568339|NCT00755807|616429674|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
170568340|NCT00755807|616429675|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
170568341|NCT00755807|616429674|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
170568342|NCT00755807|616429675|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
170568343|NCT00755807|616429674|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
170568344|NCT00755807|616429675|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
170568345|NCT00755807|616429674|FG000|Open-label Extension Phase|Sponsor Decision|0|||
170568346|NCT00755807|616429675|FG001|Open-label Extension Phase|Sponsor Decision|1|||
170568347|NCT00939107|616429676|FG000|Overall Study|Lost to Follow-up|14|||
170568348|NCT00939107|616429677|FG001|Overall Study|Lost to Follow-up|12|||
170568349|NCT00529243|616429678|FG000|Overall Study|Adverse Event|1|||
170568350|NCT00529243|616429678|FG000|Overall Study|Death|1|||
170568351|NCT00529243|616429678|FG000|Overall Study|Relocated|1|||
170568352|NCT01585025|616429685|FG000|Overall Study|Withdrawal by Subject|0|||
170568353|NCT01585025|616429686|FG001|Overall Study|Withdrawal by Subject|3|||
170568354|NCT01585025|616429687|FG002|Overall Study|Withdrawal by Subject|4|||
170568355|NCT02122380|616429688|FG000|First Intervention (30 Days)|Adverse Event|1|||
170568356|NCT02122380|616429689|FG001|First Intervention (30 Days)|Adverse Event|0|||
170568357|NCT02122380|616429688|FG000|First Intervention (30 Days)|Physician Decision|0|||
170568358|NCT02122380|616429689|FG001|First Intervention (30 Days)|Physician Decision|1|||
170568359|NCT02122380|616429688|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
170568360|NCT02122380|616429689|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
170568361|NCT02122380|616429688|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
170568362|NCT02122380|616429689|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
170568363|NCT02122380|616429688|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
170568364|NCT02122380|616429689|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
170568365|NCT01783444|616429690|FG000|Treatment Phase|Adverse Event|9|||
170568366|NCT01783444|616429691|FG001|Treatment Phase|Adverse Event|20|||
170568367|NCT01783444|616429692|FG002|Treatment Phase|Adverse Event|19|||
170568368|NCT01783444|616429690|FG000|Treatment Phase|Disease Progression|76|||
170568369|NCT01783444|616429691|FG001|Treatment Phase|Disease Progression|66|||
170568370|NCT01783444|616429692|FG002|Treatment Phase|Disease Progression|64|||
170568371|NCT01783444|616429690|FG000|Treatment Phase|Death|2|||
170568372|NCT01783444|616429691|FG001|Treatment Phase|Death|2|||
170568373|NCT01783444|616429692|FG002|Treatment Phase|Death|2|||
170568374|NCT01783444|616429690|FG000|Treatment Phase|Protocol Violation|1|||
170568375|NCT01783444|616429691|FG001|Treatment Phase|Protocol Violation|1|||
170568376|NCT01783444|616429692|FG002|Treatment Phase|Protocol Violation|2|||
170568377|NCT01783444|616429690|FG000|Treatment Phase|Withdrawal by Subject|6|||
170568378|NCT01783444|616429691|FG001|Treatment Phase|Withdrawal by Subject|8|||
170568379|NCT01783444|616429692|FG002|Treatment Phase|Withdrawal by Subject|9|||
170568380|NCT01783444|616429690|FG000|Treatment Phase|Administrative problems|2|||
170568381|NCT01783444|616429691|FG001|Treatment Phase|Administrative problems|0|||
170568382|NCT01783444|616429692|FG002|Treatment Phase|Administrative problems|1|||
170568383|NCT01783444|616429690|FG000|Treatment Phase|Physician Decision|8|||
170568384|NCT01783444|616429691|FG001|Treatment Phase|Physician Decision|6|||
170568385|NCT01783444|616429692|FG002|Treatment Phase|Physician Decision|5|||
170568386|NCT01783444|616429690|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
170568387|NCT01783444|616429691|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
170568388|NCT01783444|616429692|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
170568389|NCT01783444|616429690|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
170568390|NCT01783444|616429691|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
170568391|NCT01783444|616429692|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
170568392|NCT01783444|616429690|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
170568393|NCT01783444|616429691|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
170568394|NCT01783444|616429692|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
170568395|NCT01783444|616429690|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
170568396|NCT01783444|616429691|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
170568397|NCT01783444|616429692|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
170568398|NCT01783444|616429690|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
170568399|NCT01783444|616429691|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
170568400|NCT01783444|616429692|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
170568401|NCT01783444|616429690|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
170568402|NCT01783444|616429691|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
170807454|NCT05553366|617305343|FG000|Overall Study|Lost to Follow-up|3|||
170807455|NCT05553366|617305344|FG001|Overall Study|Lost to Follow-up|3|||
170807456|NCT05553366|617305345|FG002|Overall Study|Lost to Follow-up|3|||
170807457|NCT05553366|617305343|FG000|Overall Study|Other non-compliance|1|||
170807458|NCT05553366|617305344|FG001|Overall Study|Other non-compliance|1|||
170807459|NCT05553366|617305345|FG002|Overall Study|Other non-compliance|0|||
170807460|NCT05553366|617305343|FG000|Overall Study|Randomized but not dosed|0|||
170568403|NCT01783444|616429692|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
170807461|NCT05553366|617305344|FG001|Overall Study|Randomized but not dosed|0|||
170568404|NCT00937495|616429699|FG000|Overall Study|Protocol Violation|2|||
170568405|NCT00441272|616429700|FG000|Overall Study|Study terminated prior to enrollment|25|||
170568406|NCT00441272|616429701|FG001|Overall Study|Study terminated prior to enrollment|25|||
170907734|NCT01386385|617667906|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
170568407|NCT02549989|616429702|FG000|Overall Study|Adverse Event|4|||
170568408|NCT02549989|616429702|FG000|Overall Study|Death|1|||
170568409|NCT02549989|616429702|FG000|Overall Study|Lack of Efficacy|19|||
170568410|NCT02549989|616429702|FG000|Overall Study|Withdrawal by Subject|3|||
170568411|NCT00427011|616429703|FG000|Overall Study|Adverse Event|10|||
170568412|NCT00427011|616429703|FG000|Overall Study|Withdrawal by Subject|1|||
170568413|NCT00427011|616429703|FG000|Overall Study|Lack of Efficacy|2|||
170568414|NCT00427011|616429703|FG000|Overall Study|Other|12|||
170568415|NCT02628444|616429707|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
170568416|NCT02628444|616429708|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
170568417|NCT02628444|616429709|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
170568418|NCT02628444|616429710|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
170568419|NCT02628444|616429711|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
170568420|NCT02628444|616429712|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
170568421|NCT02628444|616429713|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
170568422|NCT02628444|616429714|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
170568423|NCT02628444|616429715|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
170568424|NCT02628444|616429707|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
170568425|NCT02628444|616429708|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
170568426|NCT02628444|616429709|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
170568427|NCT02628444|616429710|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
170568428|NCT02628444|616429711|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
170568429|NCT02628444|616429712|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
170568430|NCT02628444|616429713|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
170568431|NCT02628444|616429714|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
170568432|NCT02628444|616429715|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
170568433|NCT02628444|616429707|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
170568434|NCT02628444|616429708|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
170568435|NCT02628444|616429709|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
170568436|NCT02628444|616429710|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568437|NCT02628444|616429711|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568438|NCT02628444|616429712|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568439|NCT02628444|616429713|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568440|NCT02628444|616429714|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568441|NCT02628444|616429715|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568442|NCT02628444|616429707|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
170568443|NCT02628444|616429708|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
170568444|NCT02628444|616429709|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
170568445|NCT02628444|616429710|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
170568446|NCT02628444|616429711|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
170568447|NCT02628444|616429712|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
170568448|NCT02628444|616429713|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
170646886|NCT00369629|616721499|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
170907735|NCT01386385|617667907|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
170907736|NCT01386385|617667908|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
170907737|NCT01386385|617667909|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
170907738|NCT01386385|617667910|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
170907739|NCT01386385|617667911|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
170907740|NCT01386385|617667912|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
170907741|NCT01386385|617667913|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
170907742|NCT01386385|617667906|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
170907743|NCT01386385|617667907|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
170907744|NCT01386385|617667908|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
170907745|NCT01386385|617667909|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
170907746|NCT01386385|617667910|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
170907747|NCT01386385|617667911|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
170907748|NCT01386385|617667912|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
170907749|NCT01386385|617667913|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
170907750|NCT01843374|617667914|FG000|Overall Study|Death|155|||
170907751|NCT01843374|617667915|FG001|Overall Study|Death|313|||
170568449|NCT02628444|616429714|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
170568450|NCT02628444|616429715|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
170568451|NCT02628444|616429707|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
170568452|NCT02628444|616429708|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
170568453|NCT02628444|616429709|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
170568454|NCT02628444|616429710|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
170568455|NCT02628444|616429711|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
170568456|NCT02628444|616429712|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
170568457|NCT02628444|616429713|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
170568458|NCT02628444|616429714|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
170568459|NCT02628444|616429715|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
170568460|NCT02628444|616429707|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
170568461|NCT02628444|616429708|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
170568462|NCT02628444|616429709|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
170568463|NCT02628444|616429710|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
170568464|NCT02628444|616429711|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
170568465|NCT02628444|616429712|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
170568466|NCT02628444|616429713|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
170568467|NCT02628444|616429714|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
170568468|NCT02628444|616429715|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
170568469|NCT02628444|616429707|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
170568470|NCT02628444|616429708|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
170568471|NCT02628444|616429709|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
170568472|NCT02628444|616429710|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
170568473|NCT02628444|616429711|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
170568474|NCT02628444|616429712|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
170568475|NCT02628444|616429713|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
170568476|NCT02628444|616429714|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
170568477|NCT02628444|616429715|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
170568478|NCT02628444|616429707|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568479|NCT02628444|616429708|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568480|NCT02628444|616429709|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
170568481|NCT02628444|616429710|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
170568482|NCT02628444|616429711|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
170568483|NCT02628444|616429712|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
170568484|NCT02628444|616429713|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
170568485|NCT02628444|616429714|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
170568486|NCT02628444|616429715|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
170568487|NCT02628444|616429707|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
170568488|NCT02628444|616429708|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
170568489|NCT02628444|616429709|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
170568490|NCT02628444|616429710|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
170568491|NCT02628444|616429711|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
170568492|NCT02628444|616429712|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
170568493|NCT02628444|616429713|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
170568494|NCT02628444|616429714|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
170568495|NCT02628444|616429715|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
170568496|NCT02628444|616429707|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
170568497|NCT02628444|616429708|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
170568498|NCT02628444|616429709|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
170568499|NCT02628444|616429710|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
170907752|NCT01843374|617667914|FG000|Overall Study|Withdrawal by Subject|14|||
170907753|NCT01843374|617667915|FG001|Overall Study|Withdrawal by Subject|20|||
170907754|NCT01843374|617667914|FG000|Overall Study|Withdrawing due to Other reason|20|||
170907755|NCT01843374|617667915|FG001|Overall Study|Withdrawing due to Other reason|46|||
170907756|NCT03704051|617667920|FG000|Overall Study|Withdrawal by Subject|4|||
170907757|NCT03704051|617667921|FG001|Overall Study|Withdrawal by Subject|0|||
170907758|NCT01348919|617667931|FG000|Overall Study|Adverse Event|3|||
170907759|NCT01348919|617667932|FG001|Overall Study|Adverse Event|1|||
170568500|NCT02628444|616429711|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
170907760|NCT01348919|617667933|FG002|Overall Study|Adverse Event|0|||
170907761|NCT01348919|617667931|FG000|Overall Study|Withdrawal by Subject|0|||
170568501|NCT02628444|616429712|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
170568502|NCT02628444|616429713|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
170568503|NCT02628444|616429714|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
170568504|NCT02628444|616429715|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
170568505|NCT02079909|616429716|FG000|Overall Study|Adverse Event|23|||
170568506|NCT02079909|616429717|FG001|Overall Study|Adverse Event|23|||
170568507|NCT02079909|616429718|FG002|Overall Study|Adverse Event|7|||
170568508|NCT02079909|616429716|FG000|Overall Study|Withdrawal by Subject|9|||
170568509|NCT02079909|616429717|FG001|Overall Study|Withdrawal by Subject|17|||
170568510|NCT02079909|616429718|FG002|Overall Study|Withdrawal by Subject|4|||
170568511|NCT02079909|616429716|FG000|Overall Study|Lost to Follow-up|2|||
170568512|NCT02079909|616429717|FG001|Overall Study|Lost to Follow-up|3|||
170568513|NCT02079909|616429718|FG002|Overall Study|Lost to Follow-up|1|||
170568514|NCT02079909|616429716|FG000|Overall Study|Death|2|||
170568515|NCT02079909|616429717|FG001|Overall Study|Death|2|||
170568516|NCT02079909|616429718|FG002|Overall Study|Death|0|||
170568517|NCT02079909|616429716|FG000|Overall Study|Lack of Efficacy|0|||
170568518|NCT02079909|616429717|FG001|Overall Study|Lack of Efficacy|0|||
170568519|NCT02079909|616429718|FG002|Overall Study|Lack of Efficacy|1|||
170568520|NCT02079909|616429716|FG000|Overall Study|Protocol Violation|0|||
170568521|NCT02079909|616429717|FG001|Overall Study|Protocol Violation|1|||
170568522|NCT02079909|616429718|FG002|Overall Study|Protocol Violation|1|||
170568523|NCT02079909|616429716|FG000|Overall Study|Physician Decision|0|||
170568524|NCT02079909|616429717|FG001|Overall Study|Physician Decision|1|||
170568525|NCT02079909|616429718|FG002|Overall Study|Physician Decision|1|||
170568526|NCT02079909|616429716|FG000|Overall Study|Relocation etc.|2|||
170568527|NCT02079909|616429717|FG001|Overall Study|Relocation etc.|2|||
170568528|NCT02079909|616429718|FG002|Overall Study|Relocation etc.|3|||
170568529|NCT03423602|616429723|FG000|Overall Study|Death|1|||
170568530|NCT03423602|616429723|FG000|Overall Study|Lost to Follow-up|6|||
170568531|NCT03423602|616429723|FG000|Overall Study|Protocol Violation|1|||
170568532|NCT03423602|616429723|FG000|Overall Study|Withdrawal by Subject|4|||
170568533|NCT01192126|616429724|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
170907762|NCT01348919|617667932|FG001|Overall Study|Withdrawal by Subject|1|||
170907763|NCT01348919|617667933|FG002|Overall Study|Withdrawal by Subject|0|||
170907764|NCT01348919|617667931|FG000|Overall Study|Disease progression|0|||
170907765|NCT01348919|617667932|FG001|Overall Study|Disease progression|1|||
170907766|NCT01348919|617667933|FG002|Overall Study|Disease progression|1|||
170907767|NCT02517515|617667934|FG000|Overall Study|Adverse Event|0|||
170568534|NCT01192126|616429725|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
170568535|NCT01192126|616429724|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
170568536|NCT01192126|616429725|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
170568537|NCT06164691|616429726|FG000|Overall Study|Withdrawal by Subject|2|||
170568538|NCT06164691|616429727|FG001|Overall Study|Withdrawal by Subject|0|||
170568539|NCT06164691|616429728|FG002|Overall Study|Withdrawal by Subject|0|||
170568540|NCT00002766|616429729|FG000|Overall Study|Withdrawal by Subject|0|||
170568541|NCT00002766|616429730|FG001|Overall Study|Withdrawal by Subject|1|||
170568542|NCT00002766|616429729|FG000|Overall Study|Patient Not Treated|1|||
170568543|NCT00002766|616429730|FG001|Overall Study|Patient Not Treated|2|||
170568544|NCT00002766|616429729|FG000|Overall Study|Adverse Event|1|||
170568545|NCT00002766|616429730|FG001|Overall Study|Adverse Event|1|||
170568546|NCT00002766|616429729|FG000|Overall Study|Protocol Violation|1|||
170568547|NCT00002766|616429730|FG001|Overall Study|Protocol Violation|0|||
170568548|NCT00800735|616429732|FG000|Overall Study|Administrative/Other|2|||
170568549|NCT00800735|616429732|FG000|Overall Study|Insufficient Therapeutic Response|2|||
170568550|NCT00800735|616429732|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
170568551|NCT00800735|616429732|FG000|Overall Study|Withdrew Consent|3|||
170568552|NCT02078752|616429733|FG000|Overall Study|Death|0|||
170568553|NCT02078752|616429734|FG001|Overall Study|Death|3|||
170568554|NCT02078752|616429735|FG002|Overall Study|Death|0|||
170568555|NCT02078752|616429736|FG003|Overall Study|Death|0|||
170568556|NCT02078752|616429737|FG004|Overall Study|Death|0|||
170568557|NCT02078752|616429738|FG005|Overall Study|Death|1|||
170568558|NCT02078752|616429739|FG006|Overall Study|Death|0|||
170568559|NCT02078752|616429740|FG007|Overall Study|Death|1|||
170568560|NCT02078752|616429741|FG008|Overall Study|Death|0|||
170568561|NCT02078752|616429742|FG009|Overall Study|Death|4|||
170907768|NCT02517515|617667935|FG001|Overall Study|Adverse Event|1|||
170907769|NCT02517515|617667934|FG000|Overall Study|Withdrew Consent|0|||
170568562|NCT02078752|616429733|FG000|Overall Study|Lost to Follow-up|1|||
170568563|NCT02078752|616429734|FG001|Overall Study|Lost to Follow-up|0|||
170568564|NCT02078752|616429735|FG002|Overall Study|Lost to Follow-up|0|||
170568565|NCT02078752|616429736|FG003|Overall Study|Lost to Follow-up|1|||
170568566|NCT02078752|616429737|FG004|Overall Study|Lost to Follow-up|0|||
170568567|NCT02078752|616429738|FG005|Overall Study|Lost to Follow-up|0|||
170568568|NCT02078752|616429739|FG006|Overall Study|Lost to Follow-up|0|||
170568569|NCT02078752|616429740|FG007|Overall Study|Lost to Follow-up|0|||
170568570|NCT02078752|616429741|FG008|Overall Study|Lost to Follow-up|0|||
170907770|NCT02517515|617667935|FG001|Overall Study|Withdrew Consent|1|||
170907771|NCT02517515|617667934|FG000|Overall Study|Lost to Follow-up|1|||
170907772|NCT02517515|617667935|FG001|Overall Study|Lost to Follow-up|0|||
170907773|NCT02517515|617667934|FG000|Overall Study|Other|1|||
170568571|NCT02078752|616429742|FG009|Overall Study|Lost to Follow-up|0|||
170568572|NCT02078752|616429733|FG000|Overall Study|Withdrawal by Subject|1|||
170568573|NCT02078752|616429734|FG001|Overall Study|Withdrawal by Subject|1|||
170568574|NCT02078752|616429735|FG002|Overall Study|Withdrawal by Subject|1|||
170568575|NCT02078752|616429736|FG003|Overall Study|Withdrawal by Subject|1|||
170568576|NCT02078752|616429737|FG004|Overall Study|Withdrawal by Subject|0|||
170568577|NCT02078752|616429738|FG005|Overall Study|Withdrawal by Subject|3|||
170568578|NCT02078752|616429739|FG006|Overall Study|Withdrawal by Subject|2|||
170568579|NCT02078752|616429740|FG007|Overall Study|Withdrawal by Subject|1|||
170568580|NCT02078752|616429741|FG008|Overall Study|Withdrawal by Subject|0|||
170568581|NCT02078752|616429742|FG009|Overall Study|Withdrawal by Subject|1|||
170568582|NCT02078752|616429733|FG000|Overall Study|Other|0|||
170568583|NCT02078752|616429734|FG001|Overall Study|Other|3|||
170568584|NCT02078752|616429735|FG002|Overall Study|Other|0|||
170568585|NCT02078752|616429736|FG003|Overall Study|Other|0|||
170568586|NCT02078752|616429737|FG004|Overall Study|Other|1|||
170568587|NCT02078752|616429738|FG005|Overall Study|Other|0|||
170568588|NCT02078752|616429739|FG006|Overall Study|Other|0|||
170568589|NCT02078752|616429740|FG007|Overall Study|Other|1|||
170568590|NCT02078752|616429741|FG008|Overall Study|Other|0|||
170568591|NCT02078752|616429742|FG009|Overall Study|Other|0|||
170568592|NCT02078752|616429733|FG000|Overall Study|Study terminated by sponsor|0|||
170568593|NCT02078752|616429734|FG001|Overall Study|Study terminated by sponsor|0|||
170568594|NCT02078752|616429735|FG002|Overall Study|Study terminated by sponsor|0|||
170568595|NCT02078752|616429736|FG003|Overall Study|Study terminated by sponsor|0|||
170568596|NCT02078752|616429737|FG004|Overall Study|Study terminated by sponsor|0|||
170568597|NCT02078752|616429738|FG005|Overall Study|Study terminated by sponsor|0|||
170568598|NCT02078752|616429739|FG006|Overall Study|Study terminated by sponsor|0|||
170568599|NCT02078752|616429740|FG007|Overall Study|Study terminated by sponsor|0|||
170568600|NCT02078752|616429741|FG008|Overall Study|Study terminated by sponsor|0|||
170568601|NCT02078752|616429742|FG009|Overall Study|Study terminated by sponsor|5|||
170568602|NCT01000506|616429747|FG000|Overall Study|Adverse Event|6|||
170568603|NCT01000506|616429748|FG001|Overall Study|Adverse Event|5|||
170568604|NCT01000506|616429749|FG002|Overall Study|Adverse Event|8|||
170568605|NCT01000506|616429750|FG003|Overall Study|Adverse Event|9|||
170568606|NCT01000506|616429747|FG000|Overall Study|Lack of Efficacy|8|||
170568607|NCT01000506|616429748|FG001|Overall Study|Lack of Efficacy|6|||
170568608|NCT01000506|616429749|FG002|Overall Study|Lack of Efficacy|4|||
170568609|NCT01000506|616429750|FG003|Overall Study|Lack of Efficacy|4|||
170568610|NCT01000506|616429747|FG000|Overall Study|Protocol Violation|1|||
170568611|NCT01000506|616429748|FG001|Overall Study|Protocol Violation|1|||
170568612|NCT01000506|616429749|FG002|Overall Study|Protocol Violation|0|||
170568613|NCT01000506|616429750|FG003|Overall Study|Protocol Violation|0|||
170568614|NCT01000506|616429747|FG000|Overall Study|Lost to Follow-up|1|||
170568615|NCT01000506|616429748|FG001|Overall Study|Lost to Follow-up|1|||
170568616|NCT01000506|616429749|FG002|Overall Study|Lost to Follow-up|4|||
170568617|NCT01000506|616429750|FG003|Overall Study|Lost to Follow-up|0|||
170568618|NCT01000506|616429747|FG000|Overall Study|Physician Decision|1|||
170568619|NCT01000506|616429748|FG001|Overall Study|Physician Decision|3|||
170568620|NCT01000506|616429749|FG002|Overall Study|Physician Decision|3|||
170568621|NCT01000506|616429750|FG003|Overall Study|Physician Decision|3|||
170568622|NCT01000506|616429747|FG000|Overall Study|Withdrawal by Subject|11|||
170568623|NCT01000506|616429748|FG001|Overall Study|Withdrawal by Subject|8|||
170568624|NCT01000506|616429749|FG002|Overall Study|Withdrawal by Subject|2|||
170907774|NCT02517515|617667935|FG001|Overall Study|Other|0|||
170907775|NCT01009463|617667936|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
170907776|NCT01009463|617667937|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
170907777|NCT01009463|617667938|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
170907778|NCT01009463|617667939|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
170907779|NCT01009463|617667940|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
170907780|NCT01009463|617667936|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
170568625|NCT01000506|616429750|FG003|Overall Study|Withdrawal by Subject|7|||
170568626|NCT01188967|616429752|FG000|Overall Study|Withdrawal by Subject|1|||
170568627|NCT01188967|616429753|FG001|Overall Study|Withdrawal by Subject|1|||
170568628|NCT01188967|616429752|FG000|Overall Study|Physician Decision|1|||
170568629|NCT01188967|616429753|FG001|Overall Study|Physician Decision|1|||
170568630|NCT01188967|616429752|FG000|Overall Study|Lost to Follow-up|3|||
170568631|NCT01188967|616429753|FG001|Overall Study|Lost to Follow-up|2|||
170568632|NCT00332696|616429760|FG000|Overall Study|Death|24|||
170568633|NCT00332696|616429761|FG001|Overall Study|Death|14|||
170568634|NCT00332696|616429760|FG000|Overall Study|Insufficient therapeutic effect|4|||
170568635|NCT00332696|616429761|FG001|Overall Study|Insufficient therapeutic effect|11|||
170568636|NCT00332696|616429760|FG000|Overall Study|Adverse Event|1|||
170568637|NCT00332696|616429761|FG001|Overall Study|Adverse Event|2|||
170907781|NCT01009463|617667937|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
170907782|NCT01009463|617667938|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
170907783|NCT01009463|617667939|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
170907784|NCT01009463|617667940|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
170907785|NCT01009463|617667936|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
170907786|NCT01009463|617667937|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
170907787|NCT01009463|617667938|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
170907788|NCT01009463|617667939|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
170907789|NCT01009463|617667940|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
170907790|NCT01009463|617667936|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
170907791|NCT01009463|617667937|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
170907792|NCT01009463|617667938|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
170907793|NCT01009463|617667939|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
170907794|NCT01009463|617667940|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
170907795|NCT01009463|617667936|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
170907796|NCT01009463|617667937|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
170907797|NCT01009463|617667938|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
170907798|NCT01009463|617667939|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
170907799|NCT01009463|617667940|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
170907800|NCT01009463|617667936|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
170907801|NCT01009463|617667937|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
170568638|NCT00332696|616429760|FG000|Overall Study|Condition does not justify treatment|0|||
170568639|NCT00332696|616429761|FG001|Overall Study|Condition does not justify treatment|2|||
170568640|NCT00332696|616429760|FG000|Overall Study|Lost to Follow-up|0|||
170568641|NCT00332696|616429761|FG001|Overall Study|Lost to Follow-up|1|||
170568642|NCT00332696|616429760|FG000|Overall Study|Withdrawal by Subject|1|||
170568643|NCT00332696|616429761|FG001|Overall Study|Withdrawal by Subject|0|||
170568644|NCT00382174|616429762|FG000|Overall Study|Lost to Follow-up|1|||
170568645|NCT00382174|616429763|FG001|Overall Study|Lost to Follow-up|4|||
170568646|NCT00382174|616429764|FG002|Overall Study|Lost to Follow-up|5|||
170568647|NCT00382174|616429762|FG000|Overall Study|Adverse Event|1|||
170568648|NCT00382174|616429763|FG001|Overall Study|Adverse Event|4|||
170568649|NCT00382174|616429764|FG002|Overall Study|Adverse Event|5|||
170568650|NCT00382174|616429762|FG000|Overall Study|Withdrawal by Subject|1|||
170568651|NCT00382174|616429763|FG001|Overall Study|Withdrawal by Subject|4|||
170568652|NCT00382174|616429764|FG002|Overall Study|Withdrawal by Subject|5|||
170568653|NCT00382174|616429762|FG000|Overall Study|Non compliance|1|||
170568654|NCT00382174|616429763|FG001|Overall Study|Non compliance|0|||
170568655|NCT00382174|616429764|FG002|Overall Study|Non compliance|1|||
170568656|NCT00382174|616429762|FG000|Overall Study|Physician Decision|0|||
170568657|NCT00382174|616429763|FG001|Overall Study|Physician Decision|2|||
170568658|NCT00382174|616429764|FG002|Overall Study|Physician Decision|2|||
170568659|NCT00382174|616429762|FG000|Overall Study|Failed to meet criteria|0|||
170568660|NCT00382174|616429763|FG001|Overall Study|Failed to meet criteria|1|||
170568661|NCT00382174|616429764|FG002|Overall Study|Failed to meet criteria|1|||
170568662|NCT00382174|616429762|FG000|Overall Study|Wounds merged|0|||
170568663|NCT00382174|616429763|FG001|Overall Study|Wounds merged|2|||
170568664|NCT00382174|616429764|FG002|Overall Study|Wounds merged|2|||
170568665|NCT02216526|616429765|FG000|Overall Study|Adverse Event|1|||
170568666|NCT02216526|616429766|FG001|Overall Study|Adverse Event|1|||
170568667|NCT02216526|616429767|FG002|Overall Study|Adverse Event|0|||
170568668|NCT02216526|616429765|FG000|Overall Study|Death|0|||
170568669|NCT02216526|616429766|FG001|Overall Study|Death|1|||
170568670|NCT02216526|616429767|FG002|Overall Study|Death|3|||
170568671|NCT02216526|616429765|FG000|Overall Study|Protocol Violation|2|||
170568672|NCT02216526|616429766|FG001|Overall Study|Protocol Violation|0|||
170568673|NCT02216526|616429767|FG002|Overall Study|Protocol Violation|2|||
170568674|NCT02216526|616429765|FG000|Overall Study|Hospitalization|2|||
170568675|NCT02216526|616429766|FG001|Overall Study|Hospitalization|1|||
170907802|NCT01009463|617667938|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
170907803|NCT01009463|617667939|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
170907804|NCT01009463|617667940|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
170907805|NCT01009463|617667936|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
170907806|NCT01009463|617667937|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
170907807|NCT01009463|617667938|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
170907808|NCT01009463|617667939|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
170907809|NCT01009463|617667940|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
170568676|NCT02216526|616429767|FG002|Overall Study|Hospitalization|3|||
170568677|NCT01736917|616429770|FG000|Overall Study|Adverse Event|1|||
170568678|NCT01736917|616429770|FG000|Overall Study|Protocol Violation|10|||
170568679|NCT01657305|616429772|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
170568680|NCT01657305|616429772|FG000|Overall Study|Withdrawal by Subject|4|||
170907810|NCT01009463|617667936|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
170568681|NCT01657305|616429772|FG000|Overall Study|Adverse Event|1|||
170907811|NCT01009463|617667937|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
170568682|NCT01657305|616429772|FG000|Overall Study|Lost to Follow-up|1|||
170568683|NCT01657305|616429772|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
170568684|NCT04103450|616429775|FG000|Overall Study|Adverse Event|4|||
170568685|NCT04103450|616429776|FG001|Overall Study|Adverse Event|2|||
170568686|NCT04103450|616429775|FG000|Overall Study|Lack of Efficacy|3|||
170568687|NCT04103450|616429776|FG001|Overall Study|Lack of Efficacy|0|||
170568688|NCT04103450|616429775|FG000|Overall Study|Withdrawal by Subject|5|||
170568689|NCT04103450|616429776|FG001|Overall Study|Withdrawal by Subject|3|||
170907812|NCT01009463|617667938|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
170907813|NCT01009463|617667939|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
170568690|NCT04103450|616429775|FG000|Overall Study|Lost to Follow-up|1|||
170568691|NCT04103450|616429776|FG001|Overall Study|Lost to Follow-up|2|||
170568692|NCT04103450|616429775|FG000|Overall Study|Physician Decision|1|||
170568693|NCT04103450|616429776|FG001|Overall Study|Physician Decision|2|||
170568694|NCT04103450|616429775|FG000|Overall Study|Protocol Violation|1|||
170568695|NCT04103450|616429776|FG001|Overall Study|Protocol Violation|0|||
170568696|NCT04103450|616429775|FG000|Overall Study|Other|1|||
170568697|NCT04103450|616429776|FG001|Overall Study|Other|1|||
170568698|NCT02259114|616429777|FG000|Overall Study|Progressive Disease|14|||
170568699|NCT02259114|616429778|FG001|Overall Study|Progressive Disease|2|||
170568700|NCT02259114|616429779|FG002|Overall Study|Progressive Disease|10|||
170568701|NCT02259114|616429780|FG003|Overall Study|Progressive Disease|2|||
170568702|NCT02259114|616429781|FG004|Overall Study|Progressive Disease|5|||
170568703|NCT02259114|616429777|FG000|Overall Study|Adverse Event|2|||
170568704|NCT02259114|616429778|FG001|Overall Study|Adverse Event|1|||
170568705|NCT02259114|616429779|FG002|Overall Study|Adverse Event|0|||
170568706|NCT02259114|616429780|FG003|Overall Study|Adverse Event|0|||
170568707|NCT02259114|616429781|FG004|Overall Study|Adverse Event|1|||
170568708|NCT02259114|616429777|FG000|Overall Study|Death|3|||
170568709|NCT02259114|616429778|FG001|Overall Study|Death|0|||
170568710|NCT02259114|616429779|FG002|Overall Study|Death|1|||
170568711|NCT02259114|616429780|FG003|Overall Study|Death|0|||
170568712|NCT02259114|616429781|FG004|Overall Study|Death|0|||
170568713|NCT02259114|616429777|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
170568714|NCT02259114|616429778|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
170568715|NCT02259114|616429779|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
170568716|NCT02259114|616429780|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
170568717|NCT02259114|616429781|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
170568718|NCT02259114|616429777|FG000|Overall Study|Withdrawal by Subject|0|||
170568719|NCT02259114|616429778|FG001|Overall Study|Withdrawal by Subject|0|||
170568720|NCT02259114|616429779|FG002|Overall Study|Withdrawal by Subject|1|||
170568721|NCT02259114|616429780|FG003|Overall Study|Withdrawal by Subject|1|||
170568722|NCT02259114|616429781|FG004|Overall Study|Withdrawal by Subject|0|||
170568723|NCT02259114|616429777|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
170568724|NCT02259114|616429778|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
170568725|NCT02259114|616429779|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
170568726|NCT02259114|616429780|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
170568727|NCT02259114|616429781|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
170568728|NCT02259114|616429777|FG000|Overall Study|Not Treated|1|||
170568729|NCT02259114|616429778|FG001|Overall Study|Not Treated|0|||
170568730|NCT02259114|616429779|FG002|Overall Study|Not Treated|0|||
170568731|NCT02259114|616429780|FG003|Overall Study|Not Treated|0|||
170568732|NCT02259114|616429781|FG004|Overall Study|Not Treated|0|||
170568733|NCT03824392|616429784|FG000|Overall Study|Adverse Event|1|||
170568734|NCT03824392|616429785|FG001|Overall Study|Adverse Event|0|||
170568735|NCT03824392|616429786|FG002|Overall Study|Adverse Event|0|||
170568736|NCT03824392|616429787|FG003|Overall Study|Adverse Event|0|||
170568737|NCT03824392|616429784|FG000|Overall Study|Investigator Decision|0|||
170568738|NCT03824392|616429785|FG001|Overall Study|Investigator Decision|1|||
170568739|NCT03824392|616429786|FG002|Overall Study|Investigator Decision|0|||
170568740|NCT03824392|616429787|FG003|Overall Study|Investigator Decision|0|||
170568741|NCT03824392|616429784|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
170907814|NCT01009463|617667940|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
170568742|NCT03824392|616429785|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
170568743|NCT03824392|616429786|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
170568744|NCT03824392|616429787|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
170568745|NCT00967616|616429788|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
170568746|NCT00967616|616429789|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
170568747|NCT00967616|616429788|FG000|Overall Study|Death|0|||
170568748|NCT00967616|616429789|FG001|Overall Study|Death|3|||
170568749|NCT00967616|616429788|FG000|Overall Study|Withdrawal by Subject|8|||
170568750|NCT00967616|616429789|FG001|Overall Study|Withdrawal by Subject|4|||
170568751|NCT00967616|616429788|FG000|Overall Study|Progressive Disease|31|||
170907815|NCT01009463|617667936|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
170568752|NCT00967616|616429789|FG001|Overall Study|Progressive Disease|18|||
170568753|NCT00967616|616429788|FG000|Overall Study|Other|8|||
170568754|NCT00967616|616429789|FG001|Overall Study|Other|8|||
170568755|NCT00967616|616429788|FG000|Overall Study|Protocol Violation|1|||
170568756|NCT00967616|616429789|FG001|Overall Study|Protocol Violation|0|||
170568757|NCT02951780|616429793|FG000|Period 1|Adverse Event|0|||
170568758|NCT02951780|616429794|FG001|Period 1|Adverse Event|0|||
170568759|NCT02951780|616429795|FG002|Period 1|Adverse Event|0|||
170568760|NCT02951780|616429796|FG003|Period 1|Adverse Event|1|||
170568761|NCT02951780|616429797|FG004|Period 1|Adverse Event|0|||
170568762|NCT02951780|616429798|FG005|Period 1|Adverse Event|0|||
170568763|NCT02951780|616429799|FG006|Period 1|Adverse Event|0|||
170568764|NCT02951780|616429800|FG007|Period 1|Adverse Event|0|||
170568765|NCT02951780|616429801|FG008|Period 1|Adverse Event|0|||
170568766|NCT02951780|616429793|FG000|Period 1|Scheduling Conflicts|0|||
170568767|NCT02951780|616429794|FG001|Period 1|Scheduling Conflicts|0|||
170568768|NCT02951780|616429795|FG002|Period 1|Scheduling Conflicts|0|||
170568769|NCT02951780|616429796|FG003|Period 1|Scheduling Conflicts|0|||
170568770|NCT02951780|616429797|FG004|Period 1|Scheduling Conflicts|0|||
170568771|NCT02951780|616429798|FG005|Period 1|Scheduling Conflicts|0|||
170568772|NCT02951780|616429799|FG006|Period 1|Scheduling Conflicts|0|||
170568773|NCT02951780|616429800|FG007|Period 1|Scheduling Conflicts|1|||
170568774|NCT02951780|616429801|FG008|Period 1|Scheduling Conflicts|0|||
170568775|NCT02951780|616429793|FG000|Period 2|Scheduling Conflicts|0|||
170568776|NCT02951780|616429794|FG001|Period 2|Scheduling Conflicts|0|||
170568777|NCT02951780|616429795|FG002|Period 2|Scheduling Conflicts|0|||
170568778|NCT02951780|616429796|FG003|Period 2|Scheduling Conflicts|0|||
170568779|NCT02951780|616429797|FG004|Period 2|Scheduling Conflicts|0|||
170568780|NCT02951780|616429798|FG005|Period 2|Scheduling Conflicts|0|||
170568781|NCT02951780|616429799|FG006|Period 2|Scheduling Conflicts|0|||
170568782|NCT02951780|616429800|FG007|Period 2|Scheduling Conflicts|1|||
170568783|NCT02951780|616429801|FG008|Period 2|Scheduling Conflicts|0|||
170568784|NCT02289469|616429802|FG000|Overall Study|Unable to match a control|6|||
170568785|NCT02289469|616429803|FG001|Overall Study|Unable to match a control|0|||
170568786|NCT01644643|616429804|FG000|Overall Study|Death|1|||
170568787|NCT01644643|616429805|FG001|Overall Study|Death|0|||
170568788|NCT01644643|616429806|FG002|Overall Study|Death|3|||
170568789|NCT01644643|616429807|FG003|Overall Study|Death|3|||
170568790|NCT01644643|616429804|FG000|Overall Study|Lost to Follow-up|0|||
170568791|NCT01644643|616429805|FG001|Overall Study|Lost to Follow-up|0|||
170568792|NCT01644643|616429806|FG002|Overall Study|Lost to Follow-up|0|||
170568793|NCT01644643|616429807|FG003|Overall Study|Lost to Follow-up|4|||
170568794|NCT01644643|616429804|FG000|Overall Study|Withdrawal by Subject|1|||
170568795|NCT01644643|616429805|FG001|Overall Study|Withdrawal by Subject|0|||
170568796|NCT01644643|616429806|FG002|Overall Study|Withdrawal by Subject|2|||
170568797|NCT01644643|616429807|FG003|Overall Study|Withdrawal by Subject|1|||
170568798|NCT01644643|616429804|FG000|Overall Study|Other Eligibility criteria|0|||
170568799|NCT01644643|616429805|FG001|Overall Study|Other Eligibility criteria|0|||
170568800|NCT01644643|616429806|FG002|Overall Study|Other Eligibility criteria|0|||
170568801|NCT01644643|616429807|FG003|Overall Study|Other Eligibility criteria|2|||
170568802|NCT04940130|616429808|FG000|Overall Study|Travel|1|||
170646887|NCT00369629|616721496|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
170646888|NCT00369629|616721497|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
170646889|NCT00369629|616721498|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
170646890|NCT00369629|616721499|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
170907816|NCT01009463|617667937|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
170907817|NCT01009463|617667938|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
170907818|NCT01009463|617667939|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
170907819|NCT01009463|617667940|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
170568803|NCT04940130|616429809|FG001|Overall Study|Travel|0|||
170568804|NCT04940130|616429810|FG002|Overall Study|Travel|2|||
170568805|NCT04940130|616429808|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
170568806|NCT04940130|616429809|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
170646891|NCT00369629|616721496|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
170646892|NCT00369629|616721497|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
170646893|NCT00369629|616721498|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
170568807|NCT04940130|616429810|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
170568808|NCT04940130|616429808|FG000|Overall Study|Adverse Event|0|||
170568809|NCT04940130|616429809|FG001|Overall Study|Adverse Event|0|||
170568810|NCT04940130|616429810|FG002|Overall Study|Adverse Event|2|||
170568811|NCT04940130|616429808|FG000|Overall Study|Disease progression/treatment failure|0|||
170568812|NCT04940130|616429809|FG001|Overall Study|Disease progression/treatment failure|0|||
170568813|NCT04940130|616429810|FG002|Overall Study|Disease progression/treatment failure|1|||
170568814|NCT04940130|616429808|FG000|Overall Study|Participant refusal|0|||
170568815|NCT04940130|616429809|FG001|Overall Study|Participant refusal|0|||
170568816|NCT04940130|616429810|FG002|Overall Study|Participant refusal|1|||
170568817|NCT00539240|616429811|FG000|Overall Study|Withdrawal by Subject|0|||
170907820|NCT01009463|617667936|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
170907821|NCT01009463|617667937|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
170907822|NCT01009463|617667938|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
170907823|NCT01009463|617667939|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
170907824|NCT01009463|617667940|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
170907825|NCT01009463|617667936|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
170907826|NCT01009463|617667937|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
170907827|NCT01009463|617667938|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
170907828|NCT01009463|617667939|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
170907829|NCT01009463|617667940|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
170907830|NCT01009463|617667936|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170907831|NCT01009463|617667937|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
170907832|NCT01009463|617667938|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
170907833|NCT01009463|617667939|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
170907834|NCT01009463|617667940|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
170907835|NCT01009463|617667936|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
170907836|NCT01009463|617667937|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
170907837|NCT01009463|617667938|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
170907838|NCT01009463|617667939|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
170907839|NCT01009463|617667940|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
170907840|NCT04430348|617667943|FG000|Overall Study|Death|3|||
170907841|NCT04430348|617667944|FG001|Overall Study|Death|2|||
170907842|NCT04430348|617667945|FG002|Overall Study|Death|2|||
170907843|NCT04430348|617667946|FG003|Overall Study|Death|2|||
170907844|NCT04430348|617667947|FG004|Overall Study|Death|2|||
170907845|NCT04430348|617667948|FG005|Overall Study|Death|3|||
170907846|NCT04430348|617667943|FG000|Overall Study|Lost to Follow-up|0|||
170907847|NCT04430348|617667944|FG001|Overall Study|Lost to Follow-up|0|||
170907848|NCT04430348|617667945|FG002|Overall Study|Lost to Follow-up|0|||
170907849|NCT04430348|617667946|FG003|Overall Study|Lost to Follow-up|1|||
170907850|NCT04430348|617667947|FG004|Overall Study|Lost to Follow-up|0|||
170907851|NCT04430348|617667948|FG005|Overall Study|Lost to Follow-up|0|||
170907852|NCT04430348|617667943|FG000|Overall Study|Adverse Event|0|||
170907853|NCT04430348|617667944|FG001|Overall Study|Adverse Event|0|||
170907854|NCT04430348|617667945|FG002|Overall Study|Adverse Event|0|||
170907855|NCT04430348|617667946|FG003|Overall Study|Adverse Event|0|||
170907856|NCT04430348|617667947|FG004|Overall Study|Adverse Event|0|||
170907857|NCT04430348|617667948|FG005|Overall Study|Adverse Event|1|||
170907858|NCT04430348|617667943|FG000|Overall Study|Withdrawal by Subject|0|||
170907859|NCT04430348|617667944|FG001|Overall Study|Withdrawal by Subject|1|||
170907860|NCT04430348|617667945|FG002|Overall Study|Withdrawal by Subject|0|||
170907861|NCT04430348|617667946|FG003|Overall Study|Withdrawal by Subject|0|||
170907862|NCT04430348|617667947|FG004|Overall Study|Withdrawal by Subject|0|||
170907863|NCT04430348|617667948|FG005|Overall Study|Withdrawal by Subject|1|||
170907864|NCT04430348|617667943|FG000|Overall Study|Study Terminated by Sponsor|0|||
170907865|NCT04430348|617667944|FG001|Overall Study|Study Terminated by Sponsor|0|||
170907866|NCT04430348|617667945|FG002|Overall Study|Study Terminated by Sponsor|2|||
170907867|NCT04430348|617667946|FG003|Overall Study|Study Terminated by Sponsor|0|||
170907868|NCT04430348|617667947|FG004|Overall Study|Study Terminated by Sponsor|1|||
170907869|NCT04430348|617667948|FG005|Overall Study|Study Terminated by Sponsor|1|||
170907870|NCT02413398|617667951|FG000|Overall Study|Lost to Follow-up|2|||
170907871|NCT02413398|617667952|FG001|Overall Study|Lost to Follow-up|4|||
170907872|NCT02413398|617667951|FG000|Overall Study|Withdrawal by Subject|1|||
170907873|NCT02413398|617667952|FG001|Overall Study|Withdrawal by Subject|1|||
170907874|NCT02413398|617667951|FG000|Overall Study|Other Eligibility criteria|1|||
170907875|NCT02413398|617667952|FG001|Overall Study|Other Eligibility criteria|2|||
170568818|NCT00539240|616429812|FG001|Overall Study|Withdrawal by Subject|2|||
170568819|NCT00539240|616429813|FG002|Overall Study|Withdrawal by Subject|0|||
170568820|NCT00539240|616429811|FG000|Overall Study|Protocol Violation|1|||
170568821|NCT00539240|616429812|FG001|Overall Study|Protocol Violation|1|||
170568822|NCT00539240|616429813|FG002|Overall Study|Protocol Violation|4|||
170907876|NCT03839524|617667956|FG000|Overall Study|Adverse Event|1|||
170907877|NCT03715465|617667958|FG000|Overall Study|Withdrawal by Subject|1|||
170907878|NCT03715465|617667959|FG001|Overall Study|Withdrawal by Subject|2|||
170907879|NCT00719810|617667967|FG000|Overall Study|Adverse Event|0|||
170907880|NCT00719810|617667968|FG001|Overall Study|Adverse Event|2|||
170907881|NCT00719810|617667969|FG002|Overall Study|Adverse Event|3|||
170568823|NCT00539240|616429811|FG000|Overall Study|Lost to Follow-up|2|||
170907882|NCT00719810|617667967|FG000|Overall Study|Lost to Follow-up|2|||
170568824|NCT00539240|616429812|FG001|Overall Study|Lost to Follow-up|3|||
170907883|NCT00719810|617667968|FG001|Overall Study|Lost to Follow-up|0|||
170907884|NCT00719810|617667969|FG002|Overall Study|Lost to Follow-up|3|||
170907885|NCT00719810|617667967|FG000|Overall Study|Physician Decision|0|||
170907886|NCT00719810|617667968|FG001|Overall Study|Physician Decision|1|||
170907887|NCT00719810|617667969|FG002|Overall Study|Physician Decision|0|||
170907888|NCT00719810|617667967|FG000|Overall Study|Withdrawal by Subject|1|||
170907889|NCT00719810|617667968|FG001|Overall Study|Withdrawal by Subject|1|||
170907890|NCT00719810|617667969|FG002|Overall Study|Withdrawal by Subject|2|||
170907891|NCT02465034|617667987|FG000|Overall Study|Withdrawal by Subject|1|||
170907892|NCT02465034|617667988|FG001|Overall Study|Withdrawal by Subject|1|||
170907893|NCT02465034|617667987|FG000|Overall Study|Screen fail|2|||
170907894|NCT02465034|617667988|FG001|Overall Study|Screen fail|0|||
170907895|NCT02465034|617667987|FG000|Overall Study|Could not be scheduled for study visit|0|||
170907896|NCT02465034|617667988|FG001|Overall Study|Could not be scheduled for study visit|5|||
170907897|NCT00573131|617667989|FG000|Overall Study|Withdrawal by Subject|10|||
170907898|NCT00573131|617667990|FG001|Overall Study|Withdrawal by Subject|8|||
170907899|NCT00893789|617667995|FG000|Overall Study|Withdrawal by Subject|3|||
170907900|NCT00893789|617667996|FG001|Overall Study|Withdrawal by Subject|1|||
170907901|NCT00893789|617667997|FG002|Overall Study|Withdrawal by Subject|3|||
170907902|NCT00893789|617667998|FG003|Overall Study|Withdrawal by Subject|1|||
170907903|NCT00893789|617667995|FG000|Overall Study|Noncompliance With Study Drug|1|||
170907904|NCT00893789|617667996|FG001|Overall Study|Noncompliance With Study Drug|0|||
170907905|NCT00893789|617667997|FG002|Overall Study|Noncompliance With Study Drug|1|||
170907906|NCT00893789|617667998|FG003|Overall Study|Noncompliance With Study Drug|2|||
170907907|NCT00893789|617667995|FG000|Overall Study|Noncompliance With Study Procedures|1|||
170907908|NCT00893789|617667996|FG001|Overall Study|Noncompliance With Study Procedures|0|||
170907909|NCT00893789|617667997|FG002|Overall Study|Noncompliance With Study Procedures|0|||
170907910|NCT00893789|617667998|FG003|Overall Study|Noncompliance With Study Procedures|0|||
170907911|NCT00893789|617667995|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
170907912|NCT00893789|617667996|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
170907913|NCT00893789|617667997|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
170907914|NCT00893789|617667998|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
170907915|NCT00893789|617667995|FG000|Overall Study|Adverse Event|0|||
170907916|NCT00893789|617667996|FG001|Overall Study|Adverse Event|2|||
170907917|NCT00893789|617667997|FG002|Overall Study|Adverse Event|1|||
170907918|NCT00893789|617667998|FG003|Overall Study|Adverse Event|5|||
170907919|NCT00893789|617667995|FG000|Overall Study|Protocol Violation|0|||
170907920|NCT00893789|617667996|FG001|Overall Study|Protocol Violation|1|||
170907921|NCT00893789|617667997|FG002|Overall Study|Protocol Violation|1|||
170907922|NCT00893789|617667998|FG003|Overall Study|Protocol Violation|4|||
170907923|NCT00893789|617667995|FG000|Overall Study|Lost to Follow-up|0|||
170907924|NCT00893789|617667996|FG001|Overall Study|Lost to Follow-up|0|||
170907925|NCT00893789|617667997|FG002|Overall Study|Lost to Follow-up|0|||
170907926|NCT00893789|617667998|FG003|Overall Study|Lost to Follow-up|1|||
170907927|NCT02024464|617667999|FG000|Overall Study|Discontinued|5|||
170907928|NCT02024464|617668000|FG001|Overall Study|Discontinued|4|||
170907929|NCT02024464|617667999|FG000|Overall Study|Missed Visits|1|||
170907930|NCT02024464|617668000|FG001|Overall Study|Missed Visits|0|||
170907931|NCT02024464|617667999|FG000|Overall Study|Lost to Follow-up|4|||
170907932|NCT02024464|617668000|FG001|Overall Study|Lost to Follow-up|7|||
170907933|NCT00384956|617668001|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
170907934|NCT00947154|617668004|FG000|Overall Study|Lost to Follow-up|1|||
170907935|NCT03293030|617668007|FG000|Overall Study|Withdrawal by Subject|3|||
170907936|NCT02504541|617668008|FG000|Overall Study|Adverse Event|4|||
170907937|NCT02504541|617668008|FG000|Overall Study|Withdrawal by Subject|4|||
170907938|NCT02504541|617668008|FG000|Overall Study|Lost to Follow-up|1|||
170907939|NCT02504541|617668008|FG000|Overall Study|Met Stopping Criteria|1|||
170907940|NCT02504541|617668008|FG000|Overall Study|Protocol Violation|2|||
170907941|NCT02504541|617668008|FG000|Overall Study|Termination by Sponsor|1|||
170907942|NCT02504541|617668008|FG000|Overall Study|Other|2|||
170907943|NCT02504541|617668008|FG000|Overall Study|Multiple|5|||
170907944|NCT00091793|617668009|FG000|Overall Study|Adverse Event|1|||
170907945|NCT00091793|617668010|FG001|Overall Study|Adverse Event|2|||
170907946|NCT00091793|617668009|FG000|Overall Study|Withdrawal by Subject|10|||
170907947|NCT00091793|617668010|FG001|Overall Study|Withdrawal by Subject|15|||
170907948|NCT00091793|617668009|FG000|Overall Study|Ineligibility determined|2|||
170907949|NCT00091793|617668010|FG001|Overall Study|Ineligibility determined|0|||
170907950|NCT00091793|617668009|FG000|Overall Study|Lost to Follow-up|7|||
170907951|NCT00091793|617668010|FG001|Overall Study|Lost to Follow-up|5|||
170907952|NCT00091793|617668009|FG000|Overall Study|Noncompliance|2|||
170568825|NCT00539240|616429813|FG002|Overall Study|Lost to Follow-up|1|||
170907953|NCT00091793|617668010|FG001|Overall Study|Noncompliance|0|||
170907954|NCT00091793|617668009|FG000|Overall Study|Other|2|||
170907955|NCT00091793|617668010|FG001|Overall Study|Other|0|||
170907956|NCT02424149|617668011|FG000|Overall Study|surgery cancelled|2|||
170907957|NCT02424149|617668012|FG001|Overall Study|surgery cancelled|0|||
170907958|NCT02424149|617668011|FG000|Overall Study|Withdrawal by Subject|0|||
170907959|NCT02424149|617668012|FG001|Overall Study|Withdrawal by Subject|1|||
170907960|NCT03794986|617668013|FG000|Overall Study|0 Sessions Attended|34|||
170907961|NCT03794986|617668014|FG001|Overall Study|0 Sessions Attended|37|||
170568826|NCT00539240|616429811|FG000|Overall Study|Adverse Event|3|||
170568827|NCT00539240|616429812|FG001|Overall Study|Adverse Event|1|||
170568828|NCT00539240|616429813|FG002|Overall Study|Adverse Event|10|||
170568829|NCT03386435|616429814|FG000|Overall Study|Protocol Violation|5|||
170568830|NCT03386435|616429815|FG001|Overall Study|Protocol Violation|7|||
170568831|NCT04540367|616429816|FG000|Overall Study|Withdrawal by Subject|0|||
170568832|NCT04540367|616429817|FG001|Overall Study|Withdrawal by Subject|0|||
170568833|NCT04540367|616429818|FG002|Overall Study|Withdrawal by Subject|0|||
170568834|NCT04540367|616429819|FG003|Overall Study|Withdrawal by Subject|2|||
170568835|NCT04540367|616429816|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
170568836|NCT04540367|616429817|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
170568837|NCT04540367|616429818|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
170568838|NCT04540367|616429819|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
170568839|NCT04540367|616429816|FG000|Overall Study|Adverse Event|0|||
170568840|NCT04540367|616429817|FG001|Overall Study|Adverse Event|0|||
170568841|NCT04540367|616429818|FG002|Overall Study|Adverse Event|1|||
170568842|NCT04540367|616429819|FG003|Overall Study|Adverse Event|1|||
170568843|NCT03092479|616429822|FG000|Overall Study|Lost to Follow-up|3|||
170568844|NCT03092479|616429823|FG001|Overall Study|Lost to Follow-up|2|||
170568845|NCT03092479|616429822|FG000|Overall Study|Withdrawal by Subject|4|||
170568846|NCT03092479|616429823|FG001|Overall Study|Withdrawal by Subject|0|||
170568847|NCT03913130|616429824|FG000|Overall Study|Sponsor Decision|1|||
170568848|NCT03402841|616429831|FG000|Overall Study|Withdrawal by Subject|3|||
170568849|NCT03402841|616429831|FG000|Overall Study|Lost to Follow-up|2|||
170568850|NCT03402841|616429831|FG000|Overall Study|Death|146|||
170568851|NCT00444106|616429834|FG000|Overall Study|Lost to Follow-up|2|||
170568852|NCT00444106|616429835|FG001|Overall Study|Lost to Follow-up|1|||
170568853|NCT00444106|616429836|FG002|Overall Study|Lost to Follow-up|0|||
170568854|NCT00444106|616429834|FG000|Overall Study|Abnormal Test Procedure Results|0|||
170568855|NCT00444106|616429835|FG001|Overall Study|Abnormal Test Procedure Results|0|||
170568856|NCT00444106|616429836|FG002|Overall Study|Abnormal Test Procedure Results|1|||
170568857|NCT02317627|616429845|FG000|Overall Study|Withdrawal by Subject|0|||
170568858|NCT02317627|616429846|FG001|Overall Study|Withdrawal by Subject|1|||
170568859|NCT02317627|616429847|FG002|Overall Study|Withdrawal by Subject|1|||
170568860|NCT02317627|616429845|FG000|Overall Study|Lost to Follow-up|2|||
170568861|NCT02317627|616429846|FG001|Overall Study|Lost to Follow-up|0|||
170568862|NCT02317627|616429847|FG002|Overall Study|Lost to Follow-up|0|||
170568863|NCT02317627|616429845|FG000|Overall Study|Stopped by Investigator|0|||
170568864|NCT02317627|616429846|FG001|Overall Study|Stopped by Investigator|1|||
170568865|NCT02317627|616429847|FG002|Overall Study|Stopped by Investigator|0|||
170568866|NCT02317627|616429845|FG000|Overall Study|Adverse Event|0|||
170568867|NCT02317627|616429846|FG001|Overall Study|Adverse Event|2|||
170568868|NCT02317627|616429847|FG002|Overall Study|Adverse Event|3|||
170568869|NCT02317627|616429845|FG000|Overall Study|Non-compliance with study drug|0|||
170568870|NCT02317627|616429846|FG001|Overall Study|Non-compliance with study drug|1|||
170568871|NCT02317627|616429847|FG002|Overall Study|Non-compliance with study drug|0|||
170568872|NCT04749914|616429848|FG000|Period 1|Adverse Event|1|||
170568873|NCT04749914|616429849|FG001|Period 1|Adverse Event|0|||
170568874|NCT04749914|616429850|FG002|Period 1|Adverse Event|0|||
170568875|NCT04749914|616429851|FG003|Period 1|Adverse Event|0|||
170568876|NCT04749914|616429848|FG000|Period 1|Withdrawal by Subject|1|||
170568877|NCT04749914|616429849|FG001|Period 1|Withdrawal by Subject|0|||
170568878|NCT04749914|616429850|FG002|Period 1|Withdrawal by Subject|1|||
170568879|NCT04749914|616429851|FG003|Period 1|Withdrawal by Subject|0|||
170568880|NCT00403130|616429852|FG000|2 Years From Start of Treatment|Not Eligible|3|||
170568881|NCT00403130|616429852|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
170568882|NCT00403130|616429852|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
170568883|NCT00403130|616429852|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
170568884|NCT01280968|616429853|FG000|Overall Study|Lost to Follow-up|8|||
170568885|NCT01280968|616429854|FG001|Overall Study|Lost to Follow-up|2|||
170568886|NCT01280968|616429853|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
170568887|NCT01280968|616429854|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
170568888|NCT01280968|616429853|FG000|Overall Study|Commuting Problems|2|||
170646894|NCT00369629|616721499|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
170568889|NCT01280968|616429854|FG001|Overall Study|Commuting Problems|0|||
170568890|NCT01280968|616429853|FG000|Overall Study|Anxiety|2|||
170568891|NCT01280968|616429854|FG001|Overall Study|Anxiety|0|||
170568892|NCT01280968|616429853|FG000|Overall Study|Adverse Event|1|||
170568893|NCT01280968|616429854|FG001|Overall Study|Adverse Event|0|||
170568894|NCT01280968|616429853|FG000|Overall Study|Scheduling Conflicts|1|||
170568895|NCT01280968|616429854|FG001|Overall Study|Scheduling Conflicts|1|||
170568896|NCT01280968|616429853|FG000|Overall Study|Pre-existing Neurological Condition|1|||
170568897|NCT01280968|616429854|FG001|Overall Study|Pre-existing Neurological Condition|0|||
170568898|NCT01280968|616429853|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
170568899|NCT01280968|616429854|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
170646895|NCT00369629|616721496|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
170907962|NCT03794986|617668013|FG000|Overall Study|Withdrawal by Subject|4|||
170907963|NCT03794986|617668014|FG001|Overall Study|Withdrawal by Subject|6|||
170907964|NCT03794986|617668013|FG000|Overall Study|Protocol Violation|1|||
170907965|NCT03794986|617668014|FG001|Overall Study|Protocol Violation|0|||
170907966|NCT02317510|617668015|FG000|Overall Study|Adverse Event|0|||
170907967|NCT02317510|617668016|FG001|Overall Study|Adverse Event|1|||
170907968|NCT00542828|617668019|FG000|Overall Study|Physician Decision|1|||
170907969|NCT00542828|617668019|FG000|Overall Study|Need for Prohibited Treatment|3|||
170907970|NCT00542828|617668019|FG000|Overall Study|Study Prematurely Discontinued|7|||
170907971|NCT00542828|617668019|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
170907972|NCT00095303|617668020|FG000|Main Study|Lost to Follow-up|91|||
170907973|NCT00095303|617668021|FG001|Main Study|Lost to Follow-up|87|||
170907974|NCT00095303|617668020|FG000|Follow Up Study|Lost to Follow-up|59|||
170907975|NCT00095303|617668021|FG001|Follow Up Study|Lost to Follow-up|58|||
170907976|NCT05139030|617668027|FG000|Overall Study|Withdrawal by Subject|1|||
170907977|NCT05139030|617668028|FG001|Overall Study|Withdrawal by Subject|3|||
170907978|NCT05139030|617668027|FG000|Overall Study|Adverse Event|0|||
170907979|NCT05139030|617668028|FG001|Overall Study|Adverse Event|1|||
170907980|NCT05139030|617668027|FG000|Overall Study|Failure to meet continuation criteria|0|||
170907981|NCT05139030|617668028|FG001|Overall Study|Failure to meet continuation criteria|1|||
170907982|NCT02502864|617668033|FG000|Overall Study|Withdrawal by Subject|1|||
170907983|NCT00613626|617668038|FG000|Overall Study|Ineligible|0|||
170907984|NCT00613626|617668039|FG001|Overall Study|Ineligible|1|||
170907985|NCT00613626|617668040|FG002|Overall Study|Ineligible|0|||
170907986|NCT04375878|617668041|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
170907987|NCT04375878|617668042|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
170907988|NCT04375878|617668043|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
170907989|NCT04375878|617668044|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
170907990|NCT04375878|617668045|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
170907991|NCT04375878|617668046|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
170907992|NCT04375878|617668041|FG000|Crossover First and Second Interventions|Adverse Event|0|||
170907993|NCT04375878|617668042|FG001|Crossover First and Second Interventions|Adverse Event|0|||
170907994|NCT04375878|617668043|FG002|Crossover First and Second Interventions|Adverse Event|1|||
170907995|NCT04375878|617668044|FG003|Crossover First and Second Interventions|Adverse Event|0|||
170907996|NCT04375878|617668045|FG004|Crossover First and Second Interventions|Adverse Event|0|||
170907997|NCT04375878|617668046|FG005|Crossover First and Second Interventions|Adverse Event|0|||
170907998|NCT04375878|617668041|FG000|Extension Phase|Withdrawal by Subject|0|||
170907999|NCT04375878|617668042|FG001|Extension Phase|Withdrawal by Subject|0|||
170908000|NCT04375878|617668043|FG002|Extension Phase|Withdrawal by Subject|0|||
170908001|NCT04375878|617668044|FG003|Extension Phase|Withdrawal by Subject|0|||
170908002|NCT04375878|617668045|FG004|Extension Phase|Withdrawal by Subject|1|||
170908003|NCT04375878|617668046|FG005|Extension Phase|Withdrawal by Subject|0|||
170908004|NCT01299025|617668049|FG000|Overall Study|Withdrawal by Subject|2|||
170908005|NCT01299025|617668050|FG001|Overall Study|Withdrawal by Subject|1|||
170908006|NCT01299025|617668049|FG000|Overall Study|Lost to Follow-up|1|||
170908007|NCT01299025|617668050|FG001|Overall Study|Lost to Follow-up|0|||
170568900|NCT00038948|616429855|FG000|Overall Study|Adverse Event|131|||
170568901|NCT00038948|616429856|FG001|Overall Study|Adverse Event|43|||
170568902|NCT00038948|616429855|FG000|Overall Study|Lost to Follow-up|4|||
170807462|NCT05553366|617305345|FG002|Overall Study|Randomized but not dosed|2|||
170807463|NCT02022657|617305346|FG000|Overall Study|Withdrawal by Subject|2|||
170807464|NCT02022657|617305347|FG001|Overall Study|Withdrawal by Subject|0|||
170807465|NCT02022657|617305348|FG002|Overall Study|Withdrawal by Subject|1|||
170807466|NCT02022657|617305349|FG003|Overall Study|Withdrawal by Subject|0|||
170807467|NCT02022657|617305350|FG004|Overall Study|Withdrawal by Subject|0|||
170807468|NCT02022657|617305351|FG005|Overall Study|Withdrawal by Subject|0|||
170807469|NCT02022657|617305346|FG000|Overall Study|Physician Decision|0|||
170807470|NCT02022657|617305347|FG001|Overall Study|Physician Decision|0|||
170807471|NCT02022657|617305348|FG002|Overall Study|Physician Decision|0|||
170807472|NCT02022657|617305349|FG003|Overall Study|Physician Decision|0|||
170807473|NCT02022657|617305350|FG004|Overall Study|Physician Decision|0|||
170807474|NCT02022657|617305351|FG005|Overall Study|Physician Decision|1|||
170807475|NCT03274076|617305352|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
170807476|NCT03274076|617305353|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
170807477|NCT03274076|617305354|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
170807478|NCT03274076|617305355|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
170908008|NCT03212261|617668051|FG000|Overall Study|Became ineligible d/t tech|2|||
170908009|NCT03212261|617668051|FG000|Overall Study|Tech Trouble- No first study visit|1|||
170908010|NCT03212261|617668051|FG000|Overall Study|Lost to Follow-up|7|||
170807479|NCT03274076|617305352|FG000|24 Weeks Open Label|Adverse Event|0|||
170807480|NCT03274076|617305353|FG001|24 Weeks Open Label|Adverse Event|0|||
170807481|NCT03274076|617305354|FG002|24 Weeks Open Label|Adverse Event|2|||
170908011|NCT03212261|617668051|FG000|Overall Study|Family Emergency|1|||
170908012|NCT03212261|617668051|FG000|Overall Study|Too busy/ No time|5|||
170908013|NCT05480514|617668052|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
170908014|NCT05480514|617668053|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
170908015|NCT05480514|617668052|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
170908016|NCT05480514|617668053|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
170908017|NCT05480514|617668052|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
170908018|NCT05480514|617668053|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
170908019|NCT05480514|617668052|FG000|Period 1|Covid-19 Related|1|||
170908020|NCT05480514|617668053|FG001|Period 1|Covid-19 Related|0|||
170908021|NCT05480514|617668052|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
170908022|NCT05480514|617668053|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
170908023|NCT00195351|617668056|FG000|Overall Study|Lost to Follow-up|9|||
170908024|NCT00195351|617668057|FG001|Overall Study|Lost to Follow-up|9|||
170908025|NCT00195351|617668056|FG000|Overall Study|Withdrawal by Subject|6|||
170908026|NCT00195351|617668057|FG001|Overall Study|Withdrawal by Subject|3|||
170908027|NCT00195351|617668056|FG000|Overall Study|Protocol Deviation|3|||
170908028|NCT00195351|617668057|FG001|Overall Study|Protocol Deviation|2|||
170908029|NCT00195351|617668056|FG000|Overall Study|Death|3|||
170908030|NCT00195351|617668057|FG001|Overall Study|Death|1|||
170908031|NCT00195351|617668056|FG000|Overall Study|Lack of Efficacy|0|||
170908032|NCT00195351|617668057|FG001|Overall Study|Lack of Efficacy|1|||
170908033|NCT03815175|617668058|FG000|Overall Study|Subject Lost to Follow-up|6|||
170908034|NCT03815175|617668058|FG000|Overall Study|Subject Withdrew Consent|48|||
170908035|NCT03815175|617668058|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
170908036|NCT03815175|617668058|FG000|Overall Study|Death|86|||
170908037|NCT03815175|617668058|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
170908038|NCT03815175|617668058|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
170908039|NCT03815175|617668058|FG000|Overall Study|Other Status Change Reason|1|||
170908040|NCT03815175|617668058|FG000|Overall Study|Missed Visit|12|||
170908041|NCT04332419|617668059|FG000|Overall Study|Withdrawal by Subject|1|||
170908042|NCT01480180|617668060|FG000|Main Phase|Withdrawal criteria|12|||
170908043|NCT01480180|617668061|FG001|Main Phase|Withdrawal criteria|1|||
170908044|NCT01480180|617668062|FG002|Main Phase|Withdrawal criteria|0|||
170908045|NCT01480180|617668063|FG003|Main Phase|Withdrawal criteria|0|||
170908046|NCT01480180|617668064|FG004|Main Phase|Withdrawal criteria|0|||
170908047|NCT01480180|617668065|FG005|Main Phase|Withdrawal criteria|0|||
170908048|NCT01480180|617668060|FG000|Main Phase|Lack of Efficacy|1|||
170908049|NCT01480180|617668061|FG001|Main Phase|Lack of Efficacy|0|||
170908050|NCT01480180|617668062|FG002|Main Phase|Lack of Efficacy|0|||
170908051|NCT01480180|617668063|FG003|Main Phase|Lack of Efficacy|0|||
170908052|NCT01480180|617668064|FG004|Main Phase|Lack of Efficacy|0|||
170908053|NCT01480180|617668065|FG005|Main Phase|Lack of Efficacy|0|||
170908054|NCT01480180|617668060|FG000|Main Phase|Non-compliance|3|||
170908055|NCT01480180|617668061|FG001|Main Phase|Non-compliance|0|||
170908056|NCT01480180|617668062|FG002|Main Phase|Non-compliance|0|||
170908057|NCT01480180|617668063|FG003|Main Phase|Non-compliance|0|||
170908058|NCT01480180|617668064|FG004|Main Phase|Non-compliance|0|||
170908059|NCT01480180|617668065|FG005|Main Phase|Non-compliance|0|||
170908060|NCT01480180|617668060|FG000|Main Phase|Unclassified|3|||
170908061|NCT01480180|617668061|FG001|Main Phase|Unclassified|0|||
170908062|NCT01480180|617668062|FG002|Main Phase|Unclassified|0|||
170908063|NCT01480180|617668063|FG003|Main Phase|Unclassified|0|||
170908064|NCT01480180|617668064|FG004|Main Phase|Unclassified|0|||
170908065|NCT01480180|617668065|FG005|Main Phase|Unclassified|0|||
170908066|NCT01480180|617668060|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
170807482|NCT03274076|617305355|FG003|24 Weeks Open Label|Adverse Event|0|||
170807483|NCT03274076|617305352|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
170807484|NCT03274076|617305353|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
170807485|NCT03274076|617305354|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
170807486|NCT03274076|617305355|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
170807487|NCT01629589|617305357|FG000|Overall Study|Protocol Violation|4|||
170807488|NCT01629589|617305358|FG001|Overall Study|Protocol Violation|2|||
170807489|NCT01629589|617305357|FG000|Overall Study|Lost to Follow-up|2|||
170807490|NCT01629589|617305358|FG001|Overall Study|Lost to Follow-up|1|||
170807491|NCT01629589|617305357|FG000|Overall Study|Withdrawal by Subject|2|||
170807492|NCT01629589|617305358|FG001|Overall Study|Withdrawal by Subject|3|||
170908067|NCT01480180|617668061|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
170908068|NCT01480180|617668062|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
170908069|NCT01480180|617668063|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
170908070|NCT01480180|617668064|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
170908071|NCT01480180|617668065|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
170908072|NCT01480180|617668060|FG000|Extension Phase, Part 1|Unclassified|0|||
170908073|NCT01480180|617668061|FG001|Extension Phase, Part 1|Unclassified|0|||
170908074|NCT01480180|617668062|FG002|Extension Phase, Part 1|Unclassified|1|||
170908075|NCT01480180|617668063|FG003|Extension Phase, Part 1|Unclassified|0|||
170908076|NCT01480180|617668064|FG004|Extension Phase, Part 1|Unclassified|0|||
170908077|NCT01480180|617668065|FG005|Extension Phase, Part 1|Unclassified|0|||
170908078|NCT01480180|617668060|FG000|Extension Phase, Part 1|Adverse Event|0|||
170908079|NCT01480180|617668061|FG001|Extension Phase, Part 1|Adverse Event|0|||
170908080|NCT01480180|617668062|FG002|Extension Phase, Part 1|Adverse Event|4|||
170908081|NCT01480180|617668063|FG003|Extension Phase, Part 1|Adverse Event|1|||
170908082|NCT01480180|617668064|FG004|Extension Phase, Part 1|Adverse Event|0|||
170908083|NCT01480180|617668065|FG005|Extension Phase, Part 1|Adverse Event|0|||
170908084|NCT01480180|617668060|FG000|Extension Phase, Part 1|Change of treatment|0|||
170908085|NCT01480180|617668061|FG001|Extension Phase, Part 1|Change of treatment|0|||
170908086|NCT01480180|617668062|FG002|Extension Phase, Part 1|Change of treatment|0|||
170908087|NCT01480180|617668063|FG003|Extension Phase, Part 1|Change of treatment|9|||
170908088|NCT01480180|617668064|FG004|Extension Phase, Part 1|Change of treatment|0|||
170908089|NCT01480180|617668065|FG005|Extension Phase, Part 1|Change of treatment|0|||
170908090|NCT01480180|617668060|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
170908091|NCT01480180|617668061|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
170908092|NCT01480180|617668062|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
170908093|NCT01480180|617668063|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
170908094|NCT01480180|617668064|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
170908095|NCT01480180|617668065|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
170908096|NCT01480180|617668060|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
170908097|NCT01480180|617668061|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
170908098|NCT01480180|617668062|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
170908099|NCT01480180|617668063|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
170908100|NCT01480180|617668064|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
170908101|NCT01480180|617668065|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
170908102|NCT01480180|617668060|FG000|Extension Phase, Part 2|Unclassified|0|||
170908103|NCT01480180|617668061|FG001|Extension Phase, Part 2|Unclassified|0|||
170908104|NCT01480180|617668062|FG002|Extension Phase, Part 2|Unclassified|3|||
170908105|NCT01480180|617668063|FG003|Extension Phase, Part 2|Unclassified|1|||
170908106|NCT01480180|617668064|FG004|Extension Phase, Part 2|Unclassified|1|||
170908107|NCT01480180|617668065|FG005|Extension Phase, Part 2|Unclassified|0|||
170908108|NCT00519623|617668068|FG000|Overall Study|Adverse Event|1|||
170908109|NCT01824602|617668070|FG000|Overall Study|Withdrawal by Subject|0|||
170908110|NCT01824602|617668071|FG001|Overall Study|Withdrawal by Subject|0|||
170908111|NCT01824602|617668072|FG002|Overall Study|Withdrawal by Subject|1|||
170908112|NCT01824602|617668073|FG003|Overall Study|Withdrawal by Subject|2|||
170908113|NCT01824602|617668070|FG000|Overall Study|Patient non-compliance|0|||
170908114|NCT01824602|617668071|FG001|Overall Study|Patient non-compliance|0|||
170908115|NCT01824602|617668072|FG002|Overall Study|Patient non-compliance|1|||
170908116|NCT01824602|617668073|FG003|Overall Study|Patient non-compliance|0|||
170908117|NCT01824602|617668070|FG000|Overall Study|Adverse Event|1|||
170908118|NCT01824602|617668071|FG001|Overall Study|Adverse Event|0|||
170908119|NCT01824602|617668072|FG002|Overall Study|Adverse Event|2|||
170908120|NCT01824602|617668073|FG003|Overall Study|Adverse Event|2|||
170908121|NCT01824602|617668070|FG000|Overall Study|Treatment failure|0|||
170908122|NCT01824602|617668071|FG001|Overall Study|Treatment failure|0|||
170908123|NCT01824602|617668072|FG002|Overall Study|Treatment failure|0|||
170908124|NCT01824602|617668073|FG003|Overall Study|Treatment failure|1|||
170908125|NCT04222725|617668076|FG000|Overall Study|Adverse Event|0|||
170908126|NCT04222725|617668077|FG001|Overall Study|Adverse Event|1|||
170908127|NCT04222725|617668078|FG002|Overall Study|Adverse Event|0|||
170908128|NCT04222725|617668079|FG003|Overall Study|Adverse Event|0|||
170908129|NCT00104871|617668080|FG000|Overall Study|Not evaluable|1|||
170908130|NCT02332915|617668084|FG000|Overall Study|Moved out of region|3|||
170908131|NCT02332915|617668085|FG001|Overall Study|Moved out of region|0|||
170908132|NCT02332915|617668084|FG000|Overall Study|Unrelated illness|1|||
170908133|NCT02332915|617668085|FG001|Overall Study|Unrelated illness|1|||
170908134|NCT02332915|617668084|FG000|Overall Study|Travel distance prohibitive|0|||
170908135|NCT02332915|617668085|FG001|Overall Study|Travel distance prohibitive|1|||
170908136|NCT02332915|617668084|FG000|Overall Study|did not meet inclusion criteria|2|||
170908137|NCT02332915|617668085|FG001|Overall Study|did not meet inclusion criteria|4|||
170908138|NCT03191786|617668086|FG000|Overall Study|Death|236|||
170908139|NCT03191786|617668087|FG001|Overall Study|Death|127|||
170908140|NCT03191786|617668086|FG000|Overall Study|Lost to Follow-up|9|||
170908141|NCT03191786|617668087|FG001|Overall Study|Lost to Follow-up|3|||
170908142|NCT03191786|617668086|FG000|Overall Study|Physician Decision|1|||
170908143|NCT03191786|617668087|FG001|Overall Study|Physician Decision|0|||
170908144|NCT03191786|617668086|FG000|Overall Study|Moved to Post Trial Access Program|30|||
170908145|NCT03191786|617668087|FG001|Overall Study|Moved to Post Trial Access Program|5|||
170908146|NCT03191786|617668086|FG000|Overall Study|Withdrawal by Subject|26|||
170908147|NCT03191786|617668087|FG001|Overall Study|Withdrawal by Subject|16|||
170908148|NCT05405166|617669572|FG000|Overall Study|Death|49|||
170908149|NCT05405166|617669573|FG001|Overall Study|Death|50|||
170908150|NCT05405166|617669572|FG000|Overall Study|Withdrawal by Subject|10|||
170908151|NCT05405166|617669573|FG001|Overall Study|Withdrawal by Subject|3|||
170908152|NCT05405166|617669572|FG000|Overall Study|Ongoing at the time of PCD|209|||
170908153|NCT05405166|617669573|FG001|Overall Study|Ongoing at the time of PCD|210|||
170908154|NCT03746080|617669575|FG000|Overall Study|In follow up|2|||
170908155|NCT03746080|617669575|FG000|Overall Study|Death|15|||
170908156|NCT03167619|617669578|FG000|Overall Study|Death|11|||
170908157|NCT03167619|617669579|FG001|Overall Study|Death|8|||
170908158|NCT03167619|617669578|FG000|Overall Study|Withdrawal by Subject|1|||
170908159|NCT03167619|617669579|FG001|Overall Study|Withdrawal by Subject|2|||
170908160|NCT03167619|617669578|FG000|Overall Study|Physician Decision|0|||
170908161|NCT03167619|617669579|FG001|Overall Study|Physician Decision|1|||
170908162|NCT01021007|617669587|FG000|Overall Study|Lost to Follow-up|1|||
170908163|NCT01021007|617669588|FG001|Overall Study|Lost to Follow-up|1|||
170908164|NCT01021007|617669587|FG000|Overall Study|Adverse Event|1|||
170908165|NCT01021007|617669588|FG001|Overall Study|Adverse Event|3|||
170908166|NCT03230097|617669589|FG000|Overall Study|Adverse Event|2|||
170908167|NCT03230097|617669590|FG001|Overall Study|Adverse Event|1|||
170908168|NCT03230097|617669589|FG000|Overall Study|non-compliance|0|||
170568903|NCT00038948|616429856|FG001|Overall Study|Lost to Follow-up|4|||
170568904|NCT00038948|616429855|FG000|Overall Study|Nonmedical event|5|||
170568905|NCT00038948|616429856|FG001|Overall Study|Nonmedical event|7|||
170568906|NCT00038948|616429855|FG000|Overall Study|Withdrawal by Subject|23|||
170568907|NCT00038948|616429856|FG001|Overall Study|Withdrawal by Subject|10|||
170568908|NCT00038948|616429855|FG000|Overall Study|Protocol Violation|3|||
170568909|NCT00038948|616429856|FG001|Overall Study|Protocol Violation|7|||
170568910|NCT00038948|616429855|FG000|Overall Study|Lack of Efficacy|3|||
170568911|NCT00038948|616429856|FG001|Overall Study|Lack of Efficacy|6|||
170568912|NCT05270863|616429857|FG000|Visit 2 First Intervention|Randomization error|0|||
170568913|NCT05270863|616429858|FG001|Visit 2 First Intervention|Randomization error|0|||
170568914|NCT05270863|616429859|FG002|Visit 2 First Intervention|Randomization error|0|||
170568915|NCT05270863|616429860|FG003|Visit 2 First Intervention|Randomization error|1|||
170568916|NCT05270863|616429861|FG004|Visit 2 First Intervention|Randomization error|0|||
170568917|NCT05270863|616429862|FG005|Visit 2 First Intervention|Randomization error|0|||
170807493|NCT01629589|617305357|FG000|Overall Study|Did not receive study vaccine|0|||
170807494|NCT01629589|617305358|FG001|Overall Study|Did not receive study vaccine|1|||
170807495|NCT03781375|617305359|FG000|Double-blind Phase|Adverse Event|0|||
170807496|NCT03781375|617305360|FG001|Double-blind Phase|Adverse Event|1|||
170807497|NCT03781375|617305359|FG000|Double-blind Phase|Lack of Response|6|||
170807498|NCT03781375|617305360|FG001|Double-blind Phase|Lack of Response|2|||
170807499|NCT03781375|617305359|FG000|Double-blind Phase|Other|1|||
170807500|NCT03781375|617305360|FG001|Double-blind Phase|Other|3|||
170807501|NCT03781375|617305359|FG000|Open-label Phase|Protocol Issues|0|||
170807502|NCT03781375|617305360|FG001|Open-label Phase|Protocol Issues|1|||
170807503|NCT03781375|617305359|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
170807504|NCT03781375|617305360|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
170807505|NCT03781375|617305359|FG000|Open-label Phase|Other|2|||
170807506|NCT03781375|617305360|FG001|Open-label Phase|Other|2|||
170807507|NCT02079649|617305362|FG000|Overall Study|Lost to Follow-up|0|||
170807508|NCT02079649|617305363|FG001|Overall Study|Lost to Follow-up|0|||
170807509|NCT02079649|617305364|FG002|Overall Study|Lost to Follow-up|0|||
170807510|NCT02079649|617305365|FG003|Overall Study|Lost to Follow-up|1|||
170807511|NCT02079649|617305362|FG000|Overall Study|Withdrawal by Subject|0|||
170807512|NCT02079649|617305363|FG001|Overall Study|Withdrawal by Subject|0|||
170807513|NCT02079649|617305364|FG002|Overall Study|Withdrawal by Subject|0|||
170807514|NCT02079649|617305365|FG003|Overall Study|Withdrawal by Subject|1|||
170807515|NCT02079649|617305362|FG000|Overall Study|Randomization error (prior to treatment)|1|||
170807516|NCT02079649|617305363|FG001|Overall Study|Randomization error (prior to treatment)|0|||
170807517|NCT02079649|617305364|FG002|Overall Study|Randomization error (prior to treatment)|1|||
170807518|NCT02079649|617305365|FG003|Overall Study|Randomization error (prior to treatment)|0|||
170807519|NCT01932970|617305387|FG000|Overall Study|Withdrawal by Subject|5|||
170807520|NCT01932970|617305387|FG000|Overall Study|Death|1|||
170807521|NCT01932970|617305387|FG000|Overall Study|Lost to Follow-up|2|||
170807522|NCT01932970|617305387|FG000|Overall Study|Protocol Specified Criteria|10|||
170807523|NCT03412747|617305388|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
170807524|NCT03412747|617305389|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
170807525|NCT03412747|617305390|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
170807526|NCT03412747|617305388|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
170807527|NCT03412747|617305389|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
170807528|NCT03412747|617305390|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
170807529|NCT03412747|617305388|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
170568918|NCT05270863|616429857|FG000|First Washout|Withdrawal by Subject|0|||
170807530|NCT03412747|617305389|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
170807531|NCT03412747|617305390|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
170807532|NCT03412747|617305388|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
170807533|NCT03412747|617305389|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
170807534|NCT03412747|617305390|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
170807535|NCT03412747|617305388|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
170908169|NCT03230097|617669590|FG001|Overall Study|non-compliance|1|||
170908170|NCT03230097|617669589|FG000|Overall Study|Lost to Follow-up|2|||
170908171|NCT03230097|617669590|FG001|Overall Study|Lost to Follow-up|4|||
170646896|NCT00369629|616721497|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
170646897|NCT00369629|616721498|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
170646898|NCT00369629|616721499|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
170646899|NCT00369629|616721496|FG000|Completed 4 More Cycles|Progressive disease|2|||
170646900|NCT00369629|616721497|FG001|Completed 4 More Cycles|Progressive disease|1|||
170646901|NCT00369629|616721498|FG002|Completed 4 More Cycles|Progressive disease|2|||
170646902|NCT00369629|616721499|FG003|Completed 4 More Cycles|Progressive disease|0|||
170646903|NCT00369629|616721496|FG000|Follow up for 1 Year|Death|2|||
170646904|NCT00369629|616721497|FG001|Follow up for 1 Year|Death|1|||
170646905|NCT00369629|616721498|FG002|Follow up for 1 Year|Death|1|||
170646906|NCT00369629|616721499|FG003|Follow up for 1 Year|Death|0|||
170646907|NCT00369629|616721496|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
170646908|NCT00369629|616721497|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
170646909|NCT00369629|616721498|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
170646910|NCT00369629|616721499|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
170646911|NCT00369629|616721496|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
170646912|NCT00369629|616721497|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
170646913|NCT00369629|616721498|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
170646914|NCT00369629|616721499|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
170646915|NCT02600871|616721500|FG000|Overall Study|Lost to Follow-up|13|||
170646916|NCT02600871|616721501|FG001|Overall Study|Lost to Follow-up|10|||
170646917|NCT01142089|616721504|FG000|Overall Study|Physician Decision|1|||
170646918|NCT01142089|616721505|FG001|Overall Study|Physician Decision|0|||
170646919|NCT01142089|616721504|FG000|Overall Study|Withdrawal by Subject|1|||
170646920|NCT01142089|616721505|FG001|Overall Study|Withdrawal by Subject|2|||
170646921|NCT01142089|616721504|FG000|Overall Study|Use of prohibited medications|0|||
170646922|NCT01142089|616721505|FG001|Overall Study|Use of prohibited medications|1|||
170646923|NCT01142089|616721504|FG000|Overall Study|Noncompliance with study procedures|2|||
170646924|NCT01142089|616721505|FG001|Overall Study|Noncompliance with study procedures|1|||
170646925|NCT01142089|616721504|FG000|Overall Study|Patient required rescue medication|8|||
170646926|NCT01142089|616721505|FG001|Overall Study|Patient required rescue medication|17|||
170646927|NCT01489111|616721506|FG000|Overall Study|Withdrawal criterion|1|||
170646928|NCT01347580|616721509|FG000|Overall Study|Withdrawal by Subject|13|||
170646929|NCT01347580|616721510|FG001|Overall Study|Withdrawal by Subject|23|||
170646930|NCT01347580|616721509|FG000|Overall Study|Death|30|||
170646931|NCT01347580|616721510|FG001|Overall Study|Death|19|||
170646932|NCT01347580|616721509|FG000|Overall Study|Protocol Violation|10|||
170646933|NCT01347580|616721510|FG001|Overall Study|Protocol Violation|7|||
170646934|NCT01347580|616721509|FG000|Overall Study|Lost to Follow-up|3|||
170646935|NCT01347580|616721510|FG001|Overall Study|Lost to Follow-up|1|||
170646936|NCT01347580|616721509|FG000|Overall Study|Had other reason|9|||
170646937|NCT01347580|616721510|FG001|Overall Study|Had other reason|6|||
170646938|NCT00874939|616721511|FG000|Overall Study|Study terminated|4|||
170646939|NCT02168387|616721512|FG000|Overall Study|Planned exubation|6|||
170646940|NCT02168387|616721513|FG001|Overall Study|Planned exubation|3|||
170646941|NCT02168387|616721512|FG000|Overall Study|Death|1|||
170646942|NCT02168387|616721513|FG001|Overall Study|Death|0|||
170646943|NCT01444092|616721515|FG000|Overall Study|Adverse Event|8|||
170646944|NCT01444092|616721515|FG000|Overall Study|Protocol Violation|1|||
170646945|NCT01444092|616721515|FG000|Overall Study|Withdrawal by Subject|1|||
170646946|NCT01444092|616721515|FG000|Overall Study|Other Eligibility criteria|7|||
170646947|NCT00528970|616721516|FG000|Overall Study|Adverse Event|6|||
170646948|NCT00528970|616721517|FG001|Overall Study|Adverse Event|8|||
170646949|NCT00528970|616721518|FG002|Overall Study|Adverse Event|5|||
170646950|NCT00528970|616721516|FG000|Overall Study|Lost to Follow-up|0|||
170646951|NCT00528970|616721517|FG001|Overall Study|Lost to Follow-up|0|||
170646952|NCT00528970|616721518|FG002|Overall Study|Lost to Follow-up|1|||
170646953|NCT00528970|616721516|FG000|Overall Study|Other than specified|2|||
170646954|NCT00528970|616721517|FG001|Overall Study|Other than specified|3|||
170646955|NCT00528970|616721518|FG002|Overall Study|Other than specified|3|||
170646956|NCT00528970|616721516|FG000|Overall Study|Protocol Violation|2|||
170646957|NCT00528970|616721517|FG001|Overall Study|Protocol Violation|1|||
170646958|NCT00528970|616721518|FG002|Overall Study|Protocol Violation|4|||
170646959|NCT00528970|616721516|FG000|Overall Study|Lack of Efficacy|0|||
170646960|NCT00528970|616721517|FG001|Overall Study|Lack of Efficacy|0|||
170646961|NCT00528970|616721518|FG002|Overall Study|Lack of Efficacy|1|||
170646962|NCT00528970|616721516|FG000|Overall Study|Withdrawal by Subject|4|||
170646963|NCT00528970|616721517|FG001|Overall Study|Withdrawal by Subject|3|||
170646964|NCT00528970|616721518|FG002|Overall Study|Withdrawal by Subject|5|||
170646965|NCT00528970|616721516|FG000|Overall Study|Randomized but not treated|0|||
170646966|NCT00528970|616721517|FG001|Overall Study|Randomized but not treated|0|||
170646967|NCT00528970|616721518|FG002|Overall Study|Randomized but not treated|1|||
170646968|NCT01104376|616721519|FG000|Overall Study|Withdrawal by Subject|15|||
170646969|NCT01104376|616721519|FG000|Overall Study|Consented but excluded after labs|13|||
170646970|NCT00797966|616721520|FG000|Phase A|Lost to Follow-up|0|||
170646971|NCT00797966|616721521|FG001|Phase A|Lost to Follow-up|0|||
170646972|NCT00797966|616721522|FG002|Phase A|Lost to Follow-up|0|||
170646973|NCT00797966|616721523|FG003|Phase A|Lost to Follow-up|0|||
170646974|NCT00797966|616721524|FG004|Phase A|Lost to Follow-up|33|||
170646975|NCT00797966|616721525|FG005|Phase A|Lost to Follow-up|0|||
170646976|NCT00797966|616721520|FG000|Phase A|Adverse Event|0|||
170646977|NCT00797966|616721521|FG001|Phase A|Adverse Event|0|||
170646978|NCT00797966|616721522|FG002|Phase A|Adverse Event|0|||
170646979|NCT00797966|616721523|FG003|Phase A|Adverse Event|0|||
170807536|NCT03412747|617305389|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
170807537|NCT03412747|617305390|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
170807538|NCT03412747|617305388|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
170807539|NCT03412747|617305389|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
170807540|NCT03412747|617305390|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
170807541|NCT03412747|617305388|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
170807542|NCT03412747|617305389|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
170568919|NCT05270863|616429858|FG001|First Washout|Withdrawal by Subject|0|||
170568920|NCT05270863|616429859|FG002|First Washout|Withdrawal by Subject|0|||
170807543|NCT03412747|617305390|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
170807544|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
170908172|NCT03230097|617669589|FG000|Overall Study|Withdrawal by Subject|7|||
170908173|NCT03230097|617669590|FG001|Overall Study|Withdrawal by Subject|3|||
170908174|NCT03230097|617669589|FG000|Overall Study|Trial termination|4|||
170908175|NCT03230097|617669590|FG001|Overall Study|Trial termination|5|||
170908176|NCT03230097|617669589|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
170908177|NCT03230097|617669590|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
170908178|NCT03230097|617669589|FG000|Overall Study|outcome event|0|||
170908179|NCT03230097|617669590|FG001|Overall Study|outcome event|1|||
170908180|NCT03056287|617669597|FG000|Overall Study|Withdrawal by Subject|0|||
170908181|NCT03056287|617669598|FG001|Overall Study|Withdrawal by Subject|1|||
170908182|NCT03056287|617669599|FG002|Overall Study|Withdrawal by Subject|0|||
170908183|NCT03056287|617669600|FG003|Overall Study|Withdrawal by Subject|0|||
170908184|NCT03056287|617669597|FG000|Overall Study|move out of area|0|||
170807545|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
170568921|NCT05270863|616429860|FG003|First Washout|Withdrawal by Subject|0|||
170568922|NCT05270863|616429861|FG004|First Washout|Withdrawal by Subject|1|||
170568923|NCT05270863|616429862|FG005|First Washout|Withdrawal by Subject|1|||
170807546|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
170807547|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
170807548|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
170807549|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
170807550|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
170807551|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
170807552|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
170807553|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
170807554|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
170807555|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
170807556|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
170807557|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
170807558|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
170807559|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
170807560|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
170807561|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
170807562|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
170807563|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
170807564|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
170807565|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
170807566|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
170908185|NCT03056287|617669598|FG001|Overall Study|move out of area|0|||
170908186|NCT03056287|617669599|FG002|Overall Study|move out of area|1|||
170568924|NCT05270863|616429857|FG000|First Washout|Lost to Follow-up|0|||
170568925|NCT05270863|616429858|FG001|First Washout|Lost to Follow-up|0|||
170568926|NCT05270863|616429859|FG002|First Washout|Lost to Follow-up|0|||
170568927|NCT05270863|616429860|FG003|First Washout|Lost to Follow-up|0|||
170568928|NCT05270863|616429861|FG004|First Washout|Lost to Follow-up|0|||
170568929|NCT05270863|616429862|FG005|First Washout|Lost to Follow-up|1|||
170568930|NCT05270863|616429857|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
170568931|NCT05270863|616429858|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
170568932|NCT05270863|616429859|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
170568933|NCT05270863|616429860|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
170568934|NCT05270863|616429861|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
170568935|NCT05270863|616429862|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
170568936|NCT05270863|616429857|FG000|Second Washout|Withdrawal by Subject|1|||
170908187|NCT03056287|617669600|FG003|Overall Study|move out of area|1|||
170908188|NCT00900796|617669608|FG000|Phase 1|Lacked sufficient information|4|||
170908189|NCT00900796|617669608|FG000|Phase 1|Missing information at Week 16|7|||
170908190|NCT00900796|617669608|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
170908191|NCT00900796|617669608|FG000|Phase 2|Lost to Follow-up|5|||
170908192|NCT00635102|617669616|FG000|Overall Study|Withdrawal by Subject|7|||
170908193|NCT00635102|617669617|FG001|Overall Study|Withdrawal by Subject|8|||
170908194|NCT00440401|617669620|FG000|Overall Study|Adverse Event|2|||
170568937|NCT05270863|616429858|FG001|Second Washout|Withdrawal by Subject|1|||
170568938|NCT05270863|616429859|FG002|Second Washout|Withdrawal by Subject|0|||
170568939|NCT05270863|616429860|FG003|Second Washout|Withdrawal by Subject|0|||
170568940|NCT05270863|616429861|FG004|Second Washout|Withdrawal by Subject|0|||
170568941|NCT05270863|616429862|FG005|Second Washout|Withdrawal by Subject|0|||
170568942|NCT05270863|616429857|FG000|Second Washout|Lost to Follow-up|0|||
170568943|NCT05270863|616429858|FG001|Second Washout|Lost to Follow-up|0|||
170568944|NCT05270863|616429859|FG002|Second Washout|Lost to Follow-up|0|||
170568945|NCT05270863|616429860|FG003|Second Washout|Lost to Follow-up|1|||
170568946|NCT05270863|616429861|FG004|Second Washout|Lost to Follow-up|0|||
170568947|NCT05270863|616429862|FG005|Second Washout|Lost to Follow-up|0|||
170568948|NCT04790279|616431837|FG000|Overall Study|Did not meet medication start criteria|27|||
170568949|NCT04790279|616431838|FG001|Overall Study|Did not meet medication start criteria|15|||
170568950|NCT04790279|616431837|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
170568951|NCT04790279|616431838|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
170568952|NCT04790279|616431837|FG000|Overall Study|Protocol Violation|8|||
170568953|NCT04790279|616431838|FG001|Overall Study|Protocol Violation|3|||
170568954|NCT04790279|616431837|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
170568955|NCT04790279|616431838|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
170568956|NCT03247829|616431850|FG000|Overall Study|Death|3|||
170568957|NCT03247829|616431851|FG001|Overall Study|Death|4|||
170568958|NCT03247829|616431850|FG000|Overall Study|Enter Hospice Care|1|||
170568959|NCT03247829|616431851|FG001|Overall Study|Enter Hospice Care|0|||
170568960|NCT03247829|616431850|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
170568961|NCT03247829|616431851|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
170568962|NCT03247829|616431850|FG000|Overall Study|LVAD Explant|1|||
170568963|NCT03247829|616431851|FG001|Overall Study|LVAD Explant|1|||
170568964|NCT03247829|616431850|FG000|Overall Study|Transplant|1|||
170568965|NCT03247829|616431851|FG001|Overall Study|Transplant|1|||
170568966|NCT01856322|616431853|FG000|Overall Study|off study due to lack of accrual|0|||
170568967|NCT01856322|616431854|FG001|Overall Study|off study due to lack of accrual|0|||
170568968|NCT01856322|616431855|FG002|Overall Study|off study due to lack of accrual|3|||
170568969|NCT00288015|616431856|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
170568970|NCT00288015|616431856|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
170568971|NCT00288015|616431856|FG000|First Response Assessment|Withdrawal by Subject|1|||
170568972|NCT00288015|616431856|FG000|First Response Assessment|Death|1|||
170568973|NCT00288015|616431856|FG000|First Response Assessment|Physician Decision|2|||
170568974|NCT00288015|616431856|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
170568975|NCT00288015|616431856|FG000|Follow up for Survival x 2 Years|Death|13|||
170568976|NCT00288015|616431856|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
170568977|NCT00288015|616431856|FG000|Follow up for Survival x 2 Years|Other|9|||
170568978|NCT01333722|616431859|FG000|Overall Study|Lack of Efficacy|0|||
170568979|NCT01333722|616431860|FG001|Overall Study|Lack of Efficacy|2|||
170568980|NCT01333722|616431859|FG000|Overall Study|Withdrawal by Subject|0|||
170568981|NCT01333722|616431860|FG001|Overall Study|Withdrawal by Subject|1|||
170568982|NCT00784368|616431861|FG000|Overall Study|Physician Decision|0|||
170568983|NCT00784368|616431862|FG001|Overall Study|Physician Decision|0|||
170568984|NCT00784368|616431863|FG002|Overall Study|Physician Decision|6|||
170568985|NCT00784368|616431861|FG000|Overall Study|Lack of Efficacy|2|||
170568986|NCT00784368|616431862|FG001|Overall Study|Lack of Efficacy|0|||
170908195|NCT00440401|617669621|FG001|Overall Study|Adverse Event|1|||
170908196|NCT00440401|617669620|FG000|Overall Study|Other|2|||
170568987|NCT00784368|616431863|FG002|Overall Study|Lack of Efficacy|1|||
170568988|NCT00784368|616431861|FG000|Overall Study|Adverse Event|6|||
170568989|NCT00784368|616431862|FG001|Overall Study|Adverse Event|9|||
170568990|NCT00784368|616431863|FG002|Overall Study|Adverse Event|2|||
170568991|NCT00784368|616431861|FG000|Overall Study|Diagnosis of fever|0|||
170568992|NCT00784368|616431862|FG001|Overall Study|Diagnosis of fever|0|||
170908197|NCT00440401|617669621|FG001|Overall Study|Other|5|||
170908198|NCT01938625|617669622|FG000|Overall Study|Withdrawal by Subject|0|||
170568993|NCT00784368|616431863|FG002|Overall Study|Diagnosis of fever|1|||
170568994|NCT00784368|616431861|FG000|Overall Study|Worsening of complications|0|||
170568995|NCT00784368|616431862|FG001|Overall Study|Worsening of complications|0|||
170568996|NCT00784368|616431863|FG002|Overall Study|Worsening of complications|1|||
170646980|NCT00797966|616721524|FG004|Phase A|Adverse Event|46|||
170908199|NCT01938625|617669623|FG001|Overall Study|Withdrawal by Subject|1|||
170646981|NCT00797966|616721525|FG005|Phase A|Adverse Event|0|||
170646982|NCT00797966|616721520|FG000|Phase A|Met withdrawal criteria|0|||
170646983|NCT00797966|616721521|FG001|Phase A|Met withdrawal criteria|0|||
170646984|NCT00797966|616721522|FG002|Phase A|Met withdrawal criteria|0|||
170646985|NCT00797966|616721523|FG003|Phase A|Met withdrawal criteria|0|||
170908200|NCT01938625|617669622|FG000|Overall Study|Adverse Event|0|||
170908201|NCT01938625|617669623|FG001|Overall Study|Adverse Event|1|||
170908202|NCT02750410|617669625|FG000|Double-Blind Treatment Period|Adverse Event|2|||
170908203|NCT02750410|617669626|FG001|Double-Blind Treatment Period|Adverse Event|2|||
170908204|NCT02750410|617669625|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170908205|NCT02750410|617669626|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170908206|NCT02750410|617669625|FG000|Open-Label Extension Period|Adverse Event|5|||
170908207|NCT02750410|617669626|FG001|Open-Label Extension Period|Adverse Event|3|||
170908208|NCT02750410|617669625|FG000|Open-Label Extension Period|Protocol Violation|0|||
170908209|NCT02750410|617669626|FG001|Open-Label Extension Period|Protocol Violation|1|||
170908210|NCT02750410|617669625|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
170908211|NCT02750410|617669626|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
170908212|NCT01937312|617669627|FG000|Overall Study|Adverse Event|10|||
170908213|NCT01937312|617669628|FG001|Overall Study|Adverse Event|1|||
170908214|NCT01937312|617669627|FG000|Overall Study|Lack of Efficacy|0|||
170908215|NCT01937312|617669628|FG001|Overall Study|Lack of Efficacy|1|||
170908216|NCT01937312|617669627|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
170908217|NCT01937312|617669628|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
170908218|NCT00308620|617669629|FG000|Overall Study|Death|1|||
170908219|NCT00308620|617669630|FG001|Overall Study|Death|1|||
170908220|NCT00308620|617669631|FG002|Overall Study|Death|0|||
170908221|NCT00308620|617669629|FG000|Overall Study|Lost to Follow-up|0|||
170807567|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
170807568|NCT03412747|617305388|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
170807569|NCT03412747|617305389|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
170807570|NCT03412747|617305390|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
170807571|NCT06065176|617305397|FG000|Overall Study|Lost to Follow-up|11|||
170807572|NCT06065176|617305398|FG001|Overall Study|Lost to Follow-up|11|||
170807573|NCT06065176|617305399|FG002|Overall Study|Lost to Follow-up|10|||
170807574|NCT06065176|617305397|FG000|Overall Study|Withdrawal by Subject|1|||
170807575|NCT06065176|617305398|FG001|Overall Study|Withdrawal by Subject|1|||
170807576|NCT06065176|617305399|FG002|Overall Study|Withdrawal by Subject|2|||
170807577|NCT06065176|617305397|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
170807578|NCT06065176|617305398|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
170807579|NCT06065176|617305399|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
170807580|NCT03683030|617305402|FG000|Overall Study|Enrolled but screen failures|12|||
170807581|NCT03683030|617305403|FG001|Overall Study|Enrolled but screen failures|7|||
170807582|NCT03683030|617305402|FG000|Overall Study|Enrolled but no catheter inserted|11|||
170807583|NCT03683030|617305403|FG001|Overall Study|Enrolled but no catheter inserted|13|||
170807584|NCT03683030|617305402|FG000|Overall Study|Withdrawal by Subject|0|||
170807585|NCT03683030|617305403|FG001|Overall Study|Withdrawal by Subject|2|||
170807586|NCT03683030|617305402|FG000|Overall Study|Early termination by subject|1|||
170807587|NCT03683030|617305403|FG001|Overall Study|Early termination by subject|0|||
170807588|NCT03683030|617305402|FG000|Overall Study|Lost to Follow-up|0|||
170807589|NCT03683030|617305403|FG001|Overall Study|Lost to Follow-up|6|||
170807590|NCT03683030|617305402|FG000|Overall Study|Death|0|||
170807591|NCT03683030|617305403|FG001|Overall Study|Death|2|||
170807592|NCT03683030|617305402|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
170807593|NCT03683030|617305403|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
170807594|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
170807595|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
170807596|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
170807597|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
170807598|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
170807599|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
170807600|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
170807601|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
170807602|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
170807603|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
170807604|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
170807605|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
170908222|NCT00308620|617669630|FG001|Overall Study|Lost to Follow-up|0|||
170646986|NCT00797966|616721524|FG004|Phase A|Met withdrawal criteria|4|||
170646987|NCT00797966|616721525|FG005|Phase A|Met withdrawal criteria|0|||
170908223|NCT00308620|617669631|FG002|Overall Study|Lost to Follow-up|1|||
170908224|NCT01531725|617669634|FG000|Overall Study|Protocol Violation|5|||
170807606|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
170807607|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
170807608|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
170807609|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
170807610|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
170807611|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
170807612|NCT02222493|617305406|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
170807613|NCT02222493|617305407|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
170807614|NCT02222493|617305406|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
170807615|NCT02222493|617305407|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
170807616|NCT02222493|617305406|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
170807617|NCT02222493|617305407|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
170807618|NCT02222493|617305406|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
170807619|NCT02222493|617305407|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
170807620|NCT02222493|617305406|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
170646988|NCT00797966|616721520|FG000|Phase A|Physician Decision|0|||
170646989|NCT00797966|616721521|FG001|Phase A|Physician Decision|0|||
170646990|NCT00797966|616721522|FG002|Phase A|Physician Decision|0|||
170646991|NCT00797966|616721523|FG003|Phase A|Physician Decision|0|||
170646992|NCT00797966|616721524|FG004|Phase A|Physician Decision|13|||
170646993|NCT00797966|616721525|FG005|Phase A|Physician Decision|0|||
170646994|NCT00797966|616721520|FG000|Phase A|Withdrawal by Subject|0|||
170646995|NCT00797966|616721521|FG001|Phase A|Withdrawal by Subject|0|||
170646996|NCT00797966|616721522|FG002|Phase A|Withdrawal by Subject|0|||
170646997|NCT00797966|616721523|FG003|Phase A|Withdrawal by Subject|0|||
170646998|NCT00797966|616721524|FG004|Phase A|Withdrawal by Subject|33|||
170646999|NCT00797966|616721525|FG005|Phase A|Withdrawal by Subject|0|||
170647000|NCT00797966|616721520|FG000|Phase A|Protocol deviation|0|||
170647001|NCT00797966|616721521|FG001|Phase A|Protocol deviation|0|||
170647002|NCT00797966|616721522|FG002|Phase A|Protocol deviation|0|||
170647003|NCT00797966|616721523|FG003|Phase A|Protocol deviation|0|||
170647004|NCT00797966|616721524|FG004|Phase A|Protocol deviation|56|||
170647005|NCT00797966|616721525|FG005|Phase A|Protocol deviation|0|||
170647006|NCT00797966|616721520|FG000|Phase B|Lost to Follow-up|0|||
170647007|NCT00797966|616721521|FG001|Phase B|Lost to Follow-up|1|||
170647008|NCT00797966|616721522|FG002|Phase B|Lost to Follow-up|3|||
170647009|NCT00797966|616721523|FG003|Phase B|Lost to Follow-up|0|||
170647010|NCT00797966|616721524|FG004|Phase B|Lost to Follow-up|0|||
170568997|NCT00784368|616431861|FG000|Overall Study|Worsening of symptoms|0|||
170568998|NCT00784368|616431862|FG001|Overall Study|Worsening of symptoms|1|||
170568999|NCT00784368|616431863|FG002|Overall Study|Worsening of symptoms|0|||
170569000|NCT00784368|616431861|FG000|Overall Study|Withdrawal of informed consent|0|||
170569001|NCT00784368|616431862|FG001|Overall Study|Withdrawal of informed consent|1|||
170569002|NCT00784368|616431863|FG002|Overall Study|Withdrawal of informed consent|0|||
170569003|NCT00720356|616431866|FG000|Registration to Study|Determined to have methylated MGMT|67|||
170569004|NCT00720356|616431866|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
170569005|NCT00720356|616431866|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
170569006|NCT00720356|616431866|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
170569007|NCT00720356|616431866|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
170569008|NCT00720356|616431866|FG000|Follow up Until Death|Withdrawal by Subject|1|||
170569009|NCT00720356|616431866|FG000|Follow up Until Death|Alive at last data collection|4|||
170569010|NCT02237001|616431869|FG000|Overall Study|Lost to Follow-up|2|||
170569011|NCT02237001|616431869|FG000|Overall Study|Withdrawal by Subject|1|||
170807621|NCT02222493|617305407|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
170807622|NCT02222493|617305406|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
170807623|NCT02222493|617305407|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
170807624|NCT02222493|617305406|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
170807625|NCT02222493|617305407|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
170908225|NCT03215277|617669636|FG000|Overall Study|Adverse Event|2|||
170908226|NCT03215277|617669637|FG001|Overall Study|Adverse Event|3|||
170908227|NCT03215277|617669636|FG000|Overall Study|Death|1|||
170908228|NCT03215277|617669637|FG001|Overall Study|Death|0|||
170908229|NCT03215277|617669636|FG000|Overall Study|Lost to Follow-up|0|||
170908230|NCT03215277|617669637|FG001|Overall Study|Lost to Follow-up|1|||
170908231|NCT03215277|617669636|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
170908232|NCT03215277|617669637|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
170908233|NCT00693706|617669641|FG000|Overall Study|Protocol Violation|0|||
170647011|NCT00797966|616721525|FG005|Phase B|Lost to Follow-up|0|||
170647012|NCT00797966|616721520|FG000|Phase B|Adverse Event|2|||
170647013|NCT00797966|616721521|FG001|Phase B|Adverse Event|1|||
170647014|NCT00797966|616721522|FG002|Phase B|Adverse Event|3|||
170908234|NCT00693706|617669642|FG001|Overall Study|Protocol Violation|1|||
170647015|NCT00797966|616721523|FG003|Phase B|Adverse Event|1|||
170647016|NCT00797966|616721524|FG004|Phase B|Adverse Event|0|||
170569012|NCT02237001|616431869|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
170908235|NCT02498652|617669645|FG000|Overall Study|Protocol Violation|0|||
170908236|NCT02498652|617669646|FG001|Overall Study|Protocol Violation|1|||
170908237|NCT00730236|617669648|FG000|Overall Study|Adverse Event|4|||
170908238|NCT00730236|617669648|FG000|Overall Study|Withdrawal by Subject|1|||
170908239|NCT00730236|617669648|FG000|Overall Study|Non-compliance|1|||
170908240|NCT00465569|617669653|FG000|Overall Study|persistent eczema during dose escalation|1|||
170908241|NCT00465569|617669654|FG001|Overall Study|persistent eczema during dose escalation|0|||
170908242|NCT00482001|617669656|FG000|Overall Study|Protocol Violation|1|||
170908243|NCT00482001|617669657|FG001|Overall Study|Protocol Violation|1|||
170908244|NCT02388776|617669658|FG000|Overall Study|Death|1|||
170908245|NCT02388776|617669658|FG000|Overall Study|Lost to Follow-up|1|||
170908246|NCT04786210|617669659|FG000|Overall Study|Lost to Follow-up|2|||
170908247|NCT04786210|617669659|FG000|Overall Study|Withdrawal by Subject|4|||
170908248|NCT03826914|617669660|FG000|Overall Study|Withdrawal by Subject|1|||
170908249|NCT03826914|617669661|FG001|Overall Study|Withdrawal by Subject|1|||
170908250|NCT04334148|617669663|FG000|Overall Study|positive nasal swab at baseline|0|||
170908251|NCT04334148|617669664|FG001|Overall Study|positive nasal swab at baseline|1|||
170908252|NCT05370157|617669667|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
170908253|NCT05370157|617669668|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
170908254|NCT05370157|617669667|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
170908255|NCT05370157|617669668|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
170908256|NCT00498173|617669669|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
170908257|NCT00498173|617669670|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
170908258|NCT00498173|617669671|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
170908259|NCT01548638|617669673|FG000|Overall Study|Protocol Violation|3|||
170908260|NCT01548638|617669673|FG000|Overall Study|Withdrawal by Subject|1|||
170908261|NCT02117687|617669677|FG000|Overall Study|Lost to Follow-up|0|||
170908262|NCT02117687|617669678|FG001|Overall Study|Lost to Follow-up|1|||
170908263|NCT02117687|617669677|FG000|Overall Study|Adverse Event|0|||
170908264|NCT02117687|617669678|FG001|Overall Study|Adverse Event|2|||
170908265|NCT02117687|617669677|FG000|Overall Study|Other Reasons|1|||
170908266|NCT02117687|617669678|FG001|Overall Study|Other Reasons|1|||
170908267|NCT01687673|617669683|FG000|Overall Study|Physician Decision|1|||
170908268|NCT02234622|617669684|FG000|Overall Study|Withdrawal by Subject|16|||
170908269|NCT02234622|617669685|FG001|Overall Study|Withdrawal by Subject|22|||
170908270|NCT02234622|617669684|FG000|Overall Study|Lost to Follow-up|27|||
170908271|NCT02234622|617669685|FG001|Overall Study|Lost to Follow-up|14|||
170908272|NCT00618956|617669686|FG000|Overall Study|Adverse Event|10|||
170908273|NCT00618956|617669687|FG001|Overall Study|Adverse Event|34|||
170908274|NCT00618956|617669686|FG000|Overall Study|Lack of Efficacy|2|||
170908275|NCT00618956|617669687|FG001|Overall Study|Lack of Efficacy|1|||
170908276|NCT00618956|617669686|FG000|Overall Study|Withdrawal by Subject|5|||
170908277|NCT00618956|617669687|FG001|Overall Study|Withdrawal by Subject|7|||
170908278|NCT00618956|617669686|FG000|Overall Study|Lost to Follow-up|4|||
170908279|NCT00618956|617669687|FG001|Overall Study|Lost to Follow-up|5|||
170908280|NCT00618956|617669686|FG000|Overall Study|Protocol Violation|2|||
170569013|NCT02237001|616431869|FG000|Overall Study|Re-operation|4|||
170569014|NCT02237001|616431869|FG000|Overall Study|Incarceration|1|||
170569015|NCT01713582|616431870|FG000|Overall Study|Disease progression|3|||
170569016|NCT01713582|616431871|FG001|Overall Study|Disease progression|3|||
170569017|NCT01713582|616431872|FG002|Overall Study|Disease progression|3|||
170569018|NCT01713582|616431873|FG003|Overall Study|Disease progression|2|||
170569019|NCT01713582|616431874|FG004|Overall Study|Disease progression|3|||
170569020|NCT01713582|616431875|FG005|Overall Study|Disease progression|3|||
170569021|NCT01713582|616431876|FG006|Overall Study|Disease progression|3|||
170569022|NCT01713582|616431877|FG007|Overall Study|Disease progression|3|||
170569023|NCT01713582|616431878|FG008|Overall Study|Disease progression|3|||
170569024|NCT01713582|616431879|FG009|Overall Study|Disease progression|11|||
170569025|NCT01713582|616431880|FG010|Overall Study|Disease progression|10|||
170569026|NCT01713582|616431881|FG011|Overall Study|Disease progression|5|||
170647017|NCT00797966|616721525|FG005|Phase B|Adverse Event|0|||
170647018|NCT00797966|616721520|FG000|Phase B|Met Withdrawal Criteria|3|||
170908281|NCT00618956|617669687|FG001|Overall Study|Protocol Violation|2|||
170908282|NCT00618956|617669686|FG000|Overall Study|did not meet criteria, non-compliance|2|||
170908283|NCT00618956|617669687|FG001|Overall Study|did not meet criteria, non-compliance|1|||
170908284|NCT00072189|617669688|FG000|Overall Study|Withdrawal by Subject|1|||
170569027|NCT01713582|616431882|FG012|Overall Study|Disease progression|3|||
170569028|NCT01713582|616431883|FG013|Overall Study|Disease progression|3|||
170569029|NCT01713582|616431884|FG014|Overall Study|Disease progression|6|||
170569030|NCT01713582|616431885|FG015|Overall Study|Disease progression|6|||
170908285|NCT00144300|617669689|FG000|Overall Study|Adverse Event|18|||
170908286|NCT00144300|617669690|FG001|Overall Study|Adverse Event|16|||
170908287|NCT00144300|617669689|FG000|Overall Study|Protocol Violation|1|||
170908288|NCT00144300|617669690|FG001|Overall Study|Protocol Violation|3|||
170908289|NCT00144300|617669689|FG000|Overall Study|Lost to Follow-up|3|||
170647019|NCT00797966|616721521|FG001|Phase B|Met Withdrawal Criteria|3|||
170647020|NCT00797966|616721522|FG002|Phase B|Met Withdrawal Criteria|6|||
170647021|NCT00797966|616721523|FG003|Phase B|Met Withdrawal Criteria|1|||
170647022|NCT00797966|616721524|FG004|Phase B|Met Withdrawal Criteria|0|||
170647023|NCT00797966|616721525|FG005|Phase B|Met Withdrawal Criteria|0|||
170647024|NCT00797966|616721520|FG000|Phase B|Physician Decision|1|||
170647025|NCT00797966|616721521|FG001|Phase B|Physician Decision|0|||
170647026|NCT00797966|616721522|FG002|Phase B|Physician Decision|3|||
170807626|NCT02222493|617305406|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
170807627|NCT02222493|617305407|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
170807628|NCT02222493|617305406|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
170807629|NCT02222493|617305407|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
170908290|NCT00144300|617669690|FG001|Overall Study|Lost to Follow-up|0|||
170908291|NCT00144300|617669689|FG000|Overall Study|Withdrawal by Subject|6|||
170908292|NCT00144300|617669690|FG001|Overall Study|Withdrawal by Subject|6|||
170807630|NCT02222493|617305406|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
170807631|NCT02222493|617305407|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
170807632|NCT02222493|617305406|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
170807633|NCT02222493|617305407|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
170807634|NCT02222493|617305406|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
170807635|NCT02222493|617305407|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
170807636|NCT02222493|617305406|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
170807637|NCT02222493|617305407|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
170807638|NCT00145470|617305408|FG000|Overall Study|Adverse Event|19|||
170807639|NCT00145470|617305409|FG001|Overall Study|Adverse Event|25|||
170807640|NCT00145470|617305408|FG000|Overall Study|Lack of Efficacy|27|||
170807641|NCT00145470|617305409|FG001|Overall Study|Lack of Efficacy|13|||
170807642|NCT00145470|617305408|FG000|Overall Study|Withdrawal by Subject|36|||
170807643|NCT00145470|617305409|FG001|Overall Study|Withdrawal by Subject|34|||
170807644|NCT00145470|617305408|FG000|Overall Study|Lost to Follow-up|21|||
170807645|NCT00145470|617305409|FG001|Overall Study|Lost to Follow-up|17|||
170807646|NCT00145470|617305408|FG000|Overall Study|Reason Not Reported|9|||
170807647|NCT00145470|617305409|FG001|Overall Study|Reason Not Reported|9|||
170807648|NCT01701401|617305412|FG000|Overall Study|Randomized But Not Treated|3|||
170807649|NCT01701401|617305413|FG001|Overall Study|Randomized But Not Treated|1|||
170807650|NCT01701401|617305414|FG002|Overall Study|Randomized But Not Treated|0|||
170807651|NCT01701401|617305415|FG003|Overall Study|Randomized But Not Treated|1|||
170807652|NCT01701401|617305412|FG000|Overall Study|Lost to Follow-up|5|||
170807653|NCT01701401|617305413|FG001|Overall Study|Lost to Follow-up|5|||
170807654|NCT01701401|617305414|FG002|Overall Study|Lost to Follow-up|1|||
170807655|NCT01701401|617305415|FG003|Overall Study|Lost to Follow-up|3|||
170807656|NCT01701401|617305412|FG000|Overall Study|Withdrew Consent|0|||
170807657|NCT01701401|617305413|FG001|Overall Study|Withdrew Consent|3|||
170807658|NCT01701401|617305414|FG002|Overall Study|Withdrew Consent|1|||
170807659|NCT01701401|617305415|FG003|Overall Study|Withdrew Consent|2|||
170807660|NCT01701401|617305412|FG000|Overall Study|Lack of Efficacy|1|||
170807661|NCT01701401|617305413|FG001|Overall Study|Lack of Efficacy|0|||
170807662|NCT01701401|617305414|FG002|Overall Study|Lack of Efficacy|2|||
170807663|NCT01701401|617305415|FG003|Overall Study|Lack of Efficacy|0|||
170807664|NCT01701401|617305412|FG000|Overall Study|Adverse Event|1|||
170807665|NCT01701401|617305413|FG001|Overall Study|Adverse Event|0|||
170807666|NCT01701401|617305414|FG002|Overall Study|Adverse Event|0|||
170807667|NCT01701401|617305415|FG003|Overall Study|Adverse Event|0|||
170807668|NCT01701401|617305412|FG000|Overall Study|Protocol Violation|0|||
170807669|NCT01701401|617305413|FG001|Overall Study|Protocol Violation|0|||
170807670|NCT01701401|617305414|FG002|Overall Study|Protocol Violation|1|||
170807671|NCT01701401|617305415|FG003|Overall Study|Protocol Violation|0|||
170807672|NCT00914966|617305416|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
170807673|NCT00914966|617305416|FG000|Step 1: 1500 Units|Physician Decision|1|||
170807674|NCT00914966|617305416|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
170807675|NCT00933270|617305417|FG000|Overall Study|Withdrawal by Subject|26|||
170647027|NCT00797966|616721523|FG003|Phase B|Physician Decision|1|||
170647028|NCT00797966|616721524|FG004|Phase B|Physician Decision|0|||
170647029|NCT00797966|616721525|FG005|Phase B|Physician Decision|0|||
170647030|NCT00797966|616721520|FG000|Phase B|Withdrawal by Subject|1|||
170647031|NCT00797966|616721521|FG001|Phase B|Withdrawal by Subject|4|||
170807676|NCT00933270|617305417|FG000|Overall Study|Insufficient Follow-up|10|||
170807677|NCT00933270|617305417|FG000|Overall Study|Lost to Follow-up|14|||
170807678|NCT00933270|617305417|FG000|Overall Study|Adverse Event|1|||
170807679|NCT00933270|617305417|FG000|Overall Study|Missed Visit|2|||
170807680|NCT00933270|617305417|FG000|Overall Study|Death|24|||
170807681|NCT00933270|617305417|FG000|Overall Study|Moved or would not return|10|||
170807682|NCT05824559|617305418|FG000|Overall Study|Adverse Event|2|||
170807683|NCT05824559|617305418|FG000|Overall Study|Physician Decision|2|||
170807684|NCT05824559|617305418|FG000|Overall Study|Progressive Disease|16|||
170908293|NCT00144300|617669689|FG000|Overall Study|Other reason (not specified)|1|||
170569031|NCT01713582|616431886|FG016|Overall Study|Disease progression|5|||
170569032|NCT01713582|616431887|FG017|Overall Study|Disease progression|2|||
170569033|NCT01713582|616431888|FG018|Overall Study|Disease progression|3|||
170569034|NCT01713582|616431889|FG019|Overall Study|Disease progression|5|||
170569035|NCT01713582|616431890|FG020|Overall Study|Disease progression|15|||
170569036|NCT01713582|616431870|FG000|Overall Study|Death|0|||
170569037|NCT01713582|616431871|FG001|Overall Study|Death|0|||
170569038|NCT01713582|616431872|FG002|Overall Study|Death|0|||
170569039|NCT01713582|616431873|FG003|Overall Study|Death|1|||
170569040|NCT01713582|616431874|FG004|Overall Study|Death|1|||
170569041|NCT01713582|616431875|FG005|Overall Study|Death|3|||
170569042|NCT01713582|616431876|FG006|Overall Study|Death|3|||
170569043|NCT01713582|616431877|FG007|Overall Study|Death|2|||
170569044|NCT01713582|616431878|FG008|Overall Study|Death|3|||
170569045|NCT01713582|616431879|FG009|Overall Study|Death|4|||
170569046|NCT01713582|616431880|FG010|Overall Study|Death|3|||
170569047|NCT01713582|616431881|FG011|Overall Study|Death|0|||
170569048|NCT01713582|616431882|FG012|Overall Study|Death|0|||
170569049|NCT01713582|616431883|FG013|Overall Study|Death|0|||
170569050|NCT01713582|616431884|FG014|Overall Study|Death|0|||
170569051|NCT01713582|616431885|FG015|Overall Study|Death|0|||
170569052|NCT01713582|616431886|FG016|Overall Study|Death|0|||
170569053|NCT01713582|616431887|FG017|Overall Study|Death|0|||
170569054|NCT01713582|616431888|FG018|Overall Study|Death|0|||
170569055|NCT01713582|616431889|FG019|Overall Study|Death|0|||
170569056|NCT01713582|616431890|FG020|Overall Study|Death|0|||
170569057|NCT01713582|616431870|FG000|Overall Study|Adverse event-related|0|||
170569058|NCT01713582|616431871|FG001|Overall Study|Adverse event-related|0|||
170569059|NCT01713582|616431872|FG002|Overall Study|Adverse event-related|0|||
170569060|NCT01713582|616431873|FG003|Overall Study|Adverse event-related|0|||
170569061|NCT01713582|616431874|FG004|Overall Study|Adverse event-related|0|||
170569062|NCT01713582|616431875|FG005|Overall Study|Adverse event-related|0|||
170569063|NCT01713582|616431876|FG006|Overall Study|Adverse event-related|0|||
170569064|NCT01713582|616431877|FG007|Overall Study|Adverse event-related|0|||
170569065|NCT01713582|616431878|FG008|Overall Study|Adverse event-related|0|||
170569066|NCT01713582|616431879|FG009|Overall Study|Adverse event-related|1|||
170569067|NCT01713582|616431880|FG010|Overall Study|Adverse event-related|1|||
170569068|NCT01713582|616431881|FG011|Overall Study|Adverse event-related|0|||
170569069|NCT01713582|616431882|FG012|Overall Study|Adverse event-related|0|||
170807685|NCT05824559|617305418|FG000|Overall Study|Study Terminated by Sponsor|1|||
170807686|NCT05824559|617305418|FG000|Overall Study|Withdrawal by Subject|2|||
170807687|NCT04827732|617305419|FG000|Overall Study|Did not start treatment|0|||
170807688|NCT04827732|617305420|FG001|Overall Study|Did not start treatment|1|||
170807689|NCT04827732|617305421|FG002|Overall Study|Did not start treatment|0|||
170807690|NCT04827732|617305422|FG003|Overall Study|Did not start treatment|1|||
170807691|NCT05366751|617305424|FG000|Overall Study|Adverse Event|25|||
170807692|NCT05366751|617305424|FG000|Overall Study|Physician Decision|3|||
170807693|NCT05366751|617305424|FG000|Overall Study|Lost to Follow-up|2|||
170807694|NCT05366751|617305424|FG000|Overall Study|Withdrawal by Subject|14|||
170807695|NCT05366751|617305424|FG000|Overall Study|Study Terminated by Sponsor|50|||
170807696|NCT05366751|617305424|FG000|Overall Study|Site Terminated by Sponsor|3|||
170807697|NCT04256421|617305429|FG000|Overall Study|Death|171|||
170807698|NCT04256421|617305430|FG001|Overall Study|Death|180|||
170807699|NCT04256421|617305429|FG000|Overall Study|Lost to Follow-up|1|||
170807700|NCT04256421|617305430|FG001|Overall Study|Lost to Follow-up|1|||
170807701|NCT04256421|617305429|FG000|Overall Study|Withdrawal by Subject|9|||
170807702|NCT04256421|617305430|FG001|Overall Study|Withdrawal by Subject|10|||
170807703|NCT04256421|617305429|FG000|Overall Study|Ongoing in Study|66|||
170807704|NCT04256421|617305430|FG001|Overall Study|Ongoing in Study|52|||
170807705|NCT05432986|617305431|FG000|Overall Study|Withdrawal by Subject|2|||
170807706|NCT05432986|617305431|FG000|Overall Study|incomplete measurement|7|||
170569070|NCT01713582|616431883|FG013|Overall Study|Adverse event-related|0|||
170569071|NCT01713582|616431884|FG014|Overall Study|Adverse event-related|0|||
170807707|NCT04493424|617307169|FG000|Overall Study|Termination of the trial by the sponsor|89|||
170807708|NCT04493424|617307169|FG000|Overall Study|Withdrawal by Subject|9|||
170807709|NCT04493424|617307169|FG000|Overall Study|Lost to Follow-up|2|||
170569072|NCT01713582|616431885|FG015|Overall Study|Adverse event-related|0|||
170647032|NCT00797966|616721522|FG002|Phase B|Withdrawal by Subject|3|||
170807710|NCT04493424|617307169|FG000|Overall Study|Lack of Efficacy|3|||
170807711|NCT04493424|617307169|FG000|Overall Study|Adverse Event|5|||
170807712|NCT03410992|617307170|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807713|NCT03410992|617307171|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
170807714|NCT03410992|617307172|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807715|NCT03410992|617307173|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807716|NCT03410992|617307174|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807717|NCT03410992|617307175|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807718|NCT03410992|617307176|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807719|NCT03410992|617307177|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170647033|NCT00797966|616721523|FG003|Phase B|Withdrawal by Subject|3|||
170647034|NCT00797966|616721524|FG004|Phase B|Withdrawal by Subject|0|||
170647035|NCT00797966|616721525|FG005|Phase B|Withdrawal by Subject|0|||
170647036|NCT00797966|616721520|FG000|Phase B|Protocol Deviation|4|||
170647037|NCT00797966|616721521|FG001|Phase B|Protocol Deviation|8|||
170647038|NCT00797966|616721522|FG002|Phase B|Protocol Deviation|2|||
170647039|NCT00797966|616721523|FG003|Phase B|Protocol Deviation|6|||
170647040|NCT00797966|616721524|FG004|Phase B|Protocol Deviation|0|||
170647041|NCT00797966|616721525|FG005|Phase B|Protocol Deviation|0|||
170647042|NCT00797966|616721520|FG000|Phase B|Lack of Efficacy|0|||
170647043|NCT00797966|616721521|FG001|Phase B|Lack of Efficacy|1|||
170647044|NCT00797966|616721522|FG002|Phase B|Lack of Efficacy|1|||
170647045|NCT00797966|616721523|FG003|Phase B|Lack of Efficacy|4|||
170647046|NCT00797966|616721524|FG004|Phase B|Lack of Efficacy|0|||
170647047|NCT00797966|616721525|FG005|Phase B|Lack of Efficacy|0|||
170647048|NCT00797966|616721520|FG000|Phase A+|Lost to Follow-up|0|||
170647049|NCT00797966|616721521|FG001|Phase A+|Lost to Follow-up|0|||
170647050|NCT00797966|616721522|FG002|Phase A+|Lost to Follow-up|0|||
170647051|NCT00797966|616721523|FG003|Phase A+|Lost to Follow-up|0|||
170647052|NCT00797966|616721524|FG004|Phase A+|Lost to Follow-up|0|||
170647053|NCT00797966|616721525|FG005|Phase A+|Lost to Follow-up|9|||
170647054|NCT00797966|616721520|FG000|Phase A+|Met withdrawal criteria|0|||
170647055|NCT00797966|616721521|FG001|Phase A+|Met withdrawal criteria|0|||
170647056|NCT00797966|616721522|FG002|Phase A+|Met withdrawal criteria|0|||
170647057|NCT00797966|616721523|FG003|Phase A+|Met withdrawal criteria|0|||
170647058|NCT00797966|616721524|FG004|Phase A+|Met withdrawal criteria|0|||
170647059|NCT00797966|616721525|FG005|Phase A+|Met withdrawal criteria|5|||
170647060|NCT00797966|616721520|FG000|Phase A+|Withdrawal by Subject|0|||
170647061|NCT00797966|616721521|FG001|Phase A+|Withdrawal by Subject|0|||
170647062|NCT00797966|616721522|FG002|Phase A+|Withdrawal by Subject|0|||
170647063|NCT00797966|616721523|FG003|Phase A+|Withdrawal by Subject|0|||
170647064|NCT00797966|616721524|FG004|Phase A+|Withdrawal by Subject|0|||
170647065|NCT00797966|616721525|FG005|Phase A+|Withdrawal by Subject|6|||
170647066|NCT00797966|616721520|FG000|Phase A+|Adverse Event|0|||
170647067|NCT00797966|616721521|FG001|Phase A+|Adverse Event|0|||
170647068|NCT00797966|616721522|FG002|Phase A+|Adverse Event|0|||
170647069|NCT00797966|616721523|FG003|Phase A+|Adverse Event|0|||
170647070|NCT00797966|616721524|FG004|Phase A+|Adverse Event|0|||
170647071|NCT00797966|616721525|FG005|Phase A+|Adverse Event|4|||
170647072|NCT00797966|616721520|FG000|Phase A+|Protocol deviation|0|||
170647073|NCT00797966|616721521|FG001|Phase A+|Protocol deviation|0|||
170647074|NCT00797966|616721522|FG002|Phase A+|Protocol deviation|0|||
170647075|NCT00797966|616721523|FG003|Phase A+|Protocol deviation|0|||
170647076|NCT00797966|616721524|FG004|Phase A+|Protocol deviation|0|||
170647077|NCT00797966|616721525|FG005|Phase A+|Protocol deviation|4|||
170647078|NCT01002820|616721526|FG000|Overall Study|Adverse Event|1|||
170647079|NCT01002820|616721526|FG000|Overall Study|Withdrawal by Subject|2|||
170647080|NCT01002820|616721526|FG000|Overall Study|Lack of Efficacy|1|||
170647081|NCT01673347|616721527|FG000|Overall Study|failure of allograft|7|||
170647082|NCT02855541|616721532|FG000|Overall Study|Change in health status|2|||
170647083|NCT02855541|616721532|FG000|Overall Study|Withdrawal by Subject|2|||
170647084|NCT00640224|616721533|FG000|Overall Study|Lost to Follow-up|5|||
170647085|NCT00640224|616721534|FG001|Overall Study|Lost to Follow-up|2|||
170647086|NCT00640224|616721535|FG002|Overall Study|Lost to Follow-up|0|||
170647087|NCT00640224|616721536|FG003|Overall Study|Lost to Follow-up|0|||
170647088|NCT00640224|616721533|FG000|Overall Study|Withdrawal by Subject|1|||
170807720|NCT03410992|617307178|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807721|NCT03410992|617307179|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807722|NCT03410992|617307180|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
170807723|NCT03410992|617307170|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
170807724|NCT03410992|617307171|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
170807725|NCT03410992|617307172|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170807726|NCT03410992|617307173|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170807727|NCT03410992|617307174|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170807728|NCT03410992|617307175|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170807729|NCT03410992|617307176|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170807730|NCT03410992|617307177|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170908294|NCT00144300|617669690|FG001|Overall Study|Other reason (not specified)|3|||
170647089|NCT00640224|616721534|FG001|Overall Study|Withdrawal by Subject|0|||
170647090|NCT00640224|616721535|FG002|Overall Study|Withdrawal by Subject|0|||
170647091|NCT00640224|616721536|FG003|Overall Study|Withdrawal by Subject|0|||
170647092|NCT00640224|616721533|FG000|Overall Study|Headaches|0|||
170647093|NCT00640224|616721534|FG001|Overall Study|Headaches|1|||
170647094|NCT00640224|616721535|FG002|Overall Study|Headaches|0|||
170647095|NCT00640224|616721536|FG003|Overall Study|Headaches|0|||
170647096|NCT01252667|616721537|FG000|Overall Study|Transplant aborted post-conditioning|0|||
170647097|NCT01252667|616721538|FG001|Overall Study|Transplant aborted post-conditioning|0|||
170647098|NCT01252667|616721539|FG002|Overall Study|Transplant aborted post-conditioning|0|||
170908295|NCT02403206|617669695|FG000|Overall Study|Lost to Follow-up|4|||
170908296|NCT02403206|617669696|FG001|Overall Study|Lost to Follow-up|3|||
170908297|NCT02403206|617669695|FG000|Overall Study|Physician Decision|2|||
170908298|NCT02403206|617669696|FG001|Overall Study|Physician Decision|0|||
170908299|NCT02403206|617669695|FG000|Overall Study|Withdrawal by Subject|3|||
170908300|NCT02403206|617669696|FG001|Overall Study|Withdrawal by Subject|3|||
170908301|NCT02403206|617669695|FG000|Overall Study|Reason not given|2|||
170908302|NCT02403206|617669696|FG001|Overall Study|Reason not given|4|||
170908303|NCT00630032|617669697|FG000|Overall Study|Death|55|||
170908304|NCT00630032|617669698|FG001|Overall Study|Death|49|||
170908305|NCT00630032|617669697|FG000|Overall Study|Withdrawal by Subject|3|||
170908306|NCT00630032|617669698|FG001|Overall Study|Withdrawal by Subject|2|||
170908307|NCT00630032|617669697|FG000|Overall Study|Lost to Follow-up|18|||
170908308|NCT00630032|617669698|FG001|Overall Study|Lost to Follow-up|31|||
170908309|NCT00630032|617669697|FG000|Overall Study|Protocol Violation|1|||
170908310|NCT00630032|617669698|FG001|Overall Study|Protocol Violation|0|||
170908311|NCT00630032|617669697|FG000|Overall Study|Patient has moved|1|||
170908312|NCT00630032|617669698|FG001|Overall Study|Patient has moved|1|||
170908313|NCT00630032|617669697|FG000|Overall Study|Disease progression|1|||
170908314|NCT00630032|617669698|FG001|Overall Study|Disease progression|1|||
170908315|NCT00630032|617669697|FG000|Overall Study|End of monitoring in US centers|11|||
170908316|NCT00630032|617669698|FG001|Overall Study|End of monitoring in US centers|11|||
170908317|NCT04070378|617669702|FG000|Overall Study|Withdrawal by Subject|2|||
170908318|NCT04070378|617669702|FG000|Overall Study|Screen Failure|6|||
170908319|NCT04070378|617669702|FG000|Overall Study|Physician Decision|1|||
170908320|NCT04070378|617669702|FG000|Overall Study|Adverse Event|1|||
170908321|NCT03232073|617669705|FG000|Overall Study|Death|1|||
170908322|NCT03232073|617669706|FG001|Overall Study|Death|0|||
170908323|NCT03232073|617669705|FG000|Overall Study|Adverse Event|7|||
170908324|NCT03232073|617669706|FG001|Overall Study|Adverse Event|12|||
170908325|NCT03232073|617669705|FG000|Overall Study|Lost to Follow-up|6|||
170908326|NCT03232073|617669706|FG001|Overall Study|Lost to Follow-up|6|||
170908327|NCT03232073|617669705|FG000|Overall Study|Lack of Efficacy|10|||
170908328|NCT03232073|617669706|FG001|Overall Study|Lack of Efficacy|8|||
170908329|NCT03232073|617669705|FG000|Overall Study|Physician Decision|9|||
170908330|NCT03232073|617669706|FG001|Overall Study|Physician Decision|2|||
170908331|NCT03232073|617669705|FG000|Overall Study|Withdrawal by Subject|54|||
170908332|NCT03232073|617669706|FG001|Overall Study|Withdrawal by Subject|39|||
170908333|NCT05781542|617671019|FG000|Overall Study|Lost to Follow-up|1|||
170908334|NCT05781542|617671020|FG001|Overall Study|Lost to Follow-up|0|||
170908335|NCT05781542|617671021|FG002|Overall Study|Lost to Follow-up|1|||
170908336|NCT03705494|617671025|FG000|Overall Study|Lost to Follow-up|2|||
170908337|NCT03705494|617671026|FG001|Overall Study|Lost to Follow-up|1|||
170908338|NCT03705494|617671025|FG000|Overall Study|Withdrawal by Subject|5|||
170908339|NCT03705494|617671026|FG001|Overall Study|Withdrawal by Subject|2|||
170908340|NCT02495077|617671027|FG000|Overall Study|Adverse Event|0|||
170908341|NCT02495077|617671028|FG001|Overall Study|Adverse Event|1|||
170908342|NCT02495077|617671029|FG002|Overall Study|Adverse Event|1|||
170908343|NCT02495077|617671030|FG003|Overall Study|Adverse Event|0|||
170908344|NCT02495077|617671027|FG000|Overall Study|Death|3|||
170908345|NCT02495077|617671028|FG001|Overall Study|Death|5|||
170908346|NCT02495077|617671029|FG002|Overall Study|Death|0|||
170908347|NCT02495077|617671030|FG003|Overall Study|Death|0|||
170908348|NCT02495077|617671027|FG000|Overall Study|Lost to Follow-up|6|||
170908349|NCT02495077|617671028|FG001|Overall Study|Lost to Follow-up|4|||
170908350|NCT02495077|617671029|FG002|Overall Study|Lost to Follow-up|0|||
170569073|NCT01713582|616431886|FG016|Overall Study|Adverse event-related|0|||
170569074|NCT01713582|616431887|FG017|Overall Study|Adverse event-related|0|||
170569075|NCT01713582|616431888|FG018|Overall Study|Adverse event-related|1|||
170569076|NCT01713582|616431889|FG019|Overall Study|Adverse event-related|0|||
170569077|NCT01713582|616431890|FG020|Overall Study|Adverse event-related|0|||
170908351|NCT02495077|617671030|FG003|Overall Study|Lost to Follow-up|0|||
170908352|NCT02495077|617671027|FG000|Overall Study|Physician Decision|2|||
170908353|NCT02495077|617671028|FG001|Overall Study|Physician Decision|1|||
170908354|NCT02495077|617671029|FG002|Overall Study|Physician Decision|4|||
170908355|NCT02495077|617671030|FG003|Overall Study|Physician Decision|0|||
170908356|NCT02495077|617671027|FG000|Overall Study|Protocol Violation|0|||
170908357|NCT02495077|617671028|FG001|Overall Study|Protocol Violation|1|||
170908358|NCT02495077|617671029|FG002|Overall Study|Protocol Violation|0|||
170569078|NCT01713582|616431870|FG000|Overall Study|Adverse event-unrelated|0|||
170908359|NCT02495077|617671030|FG003|Overall Study|Protocol Violation|0|||
170908360|NCT02495077|617671027|FG000|Overall Study|Screen Failure|0|||
170908361|NCT02495077|617671028|FG001|Overall Study|Screen Failure|0|||
170908362|NCT02495077|617671029|FG002|Overall Study|Screen Failure|0|||
170908363|NCT02495077|617671030|FG003|Overall Study|Screen Failure|48|||
170908364|NCT02495077|617671027|FG000|Overall Study|Withdrawal by Subject|7|||
170908365|NCT02495077|617671028|FG001|Overall Study|Withdrawal by Subject|7|||
170908366|NCT02495077|617671029|FG002|Overall Study|Withdrawal by Subject|7|||
170908367|NCT02495077|617671030|FG003|Overall Study|Withdrawal by Subject|0|||
170908368|NCT02495077|617671027|FG000|Overall Study|Covid-19 research restrictions|1|||
170908369|NCT02495077|617671028|FG001|Overall Study|Covid-19 research restrictions|0|||
170908370|NCT02495077|617671029|FG002|Overall Study|Covid-19 research restrictions|0|||
170908371|NCT02495077|617671030|FG003|Overall Study|Covid-19 research restrictions|0|||
170647099|NCT01252667|616721540|FG003|Overall Study|Transplant aborted post-conditioning|0|||
170647100|NCT01252667|616721541|FG004|Overall Study|Transplant aborted post-conditioning|0|||
170647101|NCT01252667|616721542|FG005|Overall Study|Transplant aborted post-conditioning|1|||
170647102|NCT03032380|616721543|FG000|Overall Study|Adverse Event|0|||
170647103|NCT03032380|616721544|FG001|Overall Study|Adverse Event|1|||
170647104|NCT03032380|616721543|FG000|Overall Study|Lack of Efficacy|1|||
170647105|NCT03032380|616721544|FG001|Overall Study|Lack of Efficacy|0|||
170647106|NCT03032380|616721543|FG000|Overall Study|Withdrawal by Subject|2|||
170647107|NCT03032380|616721544|FG001|Overall Study|Withdrawal by Subject|3|||
170647108|NCT03032380|616721543|FG000|Overall Study|Recovery|0|||
170647109|NCT03032380|616721544|FG001|Overall Study|Recovery|1|||
170647110|NCT03032380|616721543|FG000|Overall Study|Death|39|||
170647111|NCT03032380|616721544|FG001|Overall Study|Death|34|||
170647112|NCT03032380|616721543|FG000|Overall Study|Other - Miscellaneous|0|||
170647113|NCT03032380|616721544|FG001|Overall Study|Other - Miscellaneous|1|||
170647114|NCT00331552|616721545|FG000|Period 3: Phase II|Neurological Symptoms|1|||
170647115|NCT00331552|616721546|FG001|Period 3: Phase II|Neurological Symptoms|0|||
170647116|NCT00331552|616721545|FG000|Period 3: Phase II|Severe Nausea|1|||
170647117|NCT00331552|616721546|FG001|Period 3: Phase II|Severe Nausea|0|||
170647118|NCT02937584|616721547|FG000|Period 1|Adverse Event|1|||
170647119|NCT02937584|616721548|FG001|Period 1|Adverse Event|2|||
170647120|NCT02937584|616721547|FG000|Washout|Adverse Event|0|||
170647121|NCT02937584|616721548|FG001|Washout|Adverse Event|1|||
170647122|NCT00701662|616721549|FG000|Overall Study|Lack of Efficacy|1|||
170647123|NCT00422084|616721552|FG000|Overall Study|Adverse Event|21|||
170647124|NCT00422084|616721553|FG001|Overall Study|Adverse Event|7|||
170647125|NCT00422084|616721552|FG000|Overall Study|Withdrawal by Subject|12|||
170647126|NCT00422084|616721553|FG001|Overall Study|Withdrawal by Subject|9|||
170647127|NCT00422084|616721552|FG000|Overall Study|Lost to Follow-up|14|||
170647128|NCT00422084|616721553|FG001|Overall Study|Lost to Follow-up|9|||
170647129|NCT00422084|616721552|FG000|Overall Study|Protocol Violation|4|||
170647130|NCT00422084|616721553|FG001|Overall Study|Protocol Violation|1|||
170647131|NCT00422084|616721552|FG000|Overall Study|Lack of Efficacy|40|||
170647132|NCT00422084|616721553|FG001|Overall Study|Lack of Efficacy|42|||
170647133|NCT00422084|616721552|FG000|Overall Study|P. vivax infection|3|||
170647134|NCT00422084|616721553|FG001|Overall Study|P. vivax infection|6|||
170647135|NCT00422084|616721552|FG000|Overall Study|Cyesis|1|||
170647136|NCT00422084|616721553|FG001|Overall Study|Cyesis|0|||
170647137|NCT00422084|616721552|FG000|Overall Study|Withdrawn from study accidentally|1|||
170647138|NCT00422084|616721553|FG001|Overall Study|Withdrawn from study accidentally|0|||
170647139|NCT00422084|616721552|FG000|Overall Study|Non-compliance|1|||
170647140|NCT00422084|616721553|FG001|Overall Study|Non-compliance|0|||
170647141|NCT00422084|616721552|FG000|Overall Study|Re-location|0|||
170647142|NCT00422084|616721553|FG001|Overall Study|Re-location|1|||
170647143|NCT00422084|616721552|FG000|Overall Study|Not defined|1|||
170647144|NCT00422084|616721553|FG001|Overall Study|Not defined|1|||
170647145|NCT00653432|616721554|FG000|Overall Study|Adverse Event|4|||
170647146|NCT00653432|616721555|FG001|Overall Study|Adverse Event|1|||
170647147|NCT00653432|616721554|FG000|Overall Study|Withdrawal by Subject|4|||
170647148|NCT00653432|616721555|FG001|Overall Study|Withdrawal by Subject|5|||
170647149|NCT00653432|616721554|FG000|Overall Study|Lost to Follow-up|7|||
170647150|NCT00653432|616721555|FG001|Overall Study|Lost to Follow-up|6|||
170647151|NCT00653432|616721554|FG000|Overall Study|Use/Need of Con Therapy|2|||
170647152|NCT00653432|616721555|FG001|Overall Study|Use/Need of Con Therapy|1|||
170647153|NCT00653432|616721554|FG000|Overall Study|Other - Reason Not Provided|5|||
170647154|NCT00653432|616721555|FG001|Overall Study|Other - Reason Not Provided|3|||
170647155|NCT02353143|616721556|FG000|Overall Study|Withdrawal by Subject|1|||
170647156|NCT02353143|616721557|FG001|Overall Study|Withdrawal by Subject|0|||
170647157|NCT02353143|616721558|FG002|Overall Study|Withdrawal by Subject|0|||
170647158|NCT02353143|616721559|FG003|Overall Study|Withdrawal by Subject|0|||
170647159|NCT02353143|616721560|FG004|Overall Study|Withdrawal by Subject|1|||
170647160|NCT02353143|616721561|FG005|Overall Study|Withdrawal by Subject|0|||
170647161|NCT02353143|616721562|FG006|Overall Study|Withdrawal by Subject|0|||
170647162|NCT02353143|616721563|FG007|Overall Study|Withdrawal by Subject|1|||
170647163|NCT02353143|616721564|FG008|Overall Study|Withdrawal by Subject|1|||
170647164|NCT02353143|616721556|FG000|Overall Study|Lack of Efficacy|2|||
170647165|NCT02353143|616721557|FG001|Overall Study|Lack of Efficacy|1|||
170647166|NCT02353143|616721558|FG002|Overall Study|Lack of Efficacy|2|||
170647167|NCT02353143|616721559|FG003|Overall Study|Lack of Efficacy|4|||
170647168|NCT02353143|616721560|FG004|Overall Study|Lack of Efficacy|13|||
170647169|NCT02353143|616721561|FG005|Overall Study|Lack of Efficacy|2|||
170647170|NCT02353143|616721562|FG006|Overall Study|Lack of Efficacy|2|||
170647171|NCT02353143|616721563|FG007|Overall Study|Lack of Efficacy|2|||
170647172|NCT02353143|616721564|FG008|Overall Study|Lack of Efficacy|1|||
170647173|NCT02353143|616721556|FG000|Overall Study|reason not specified|1|||
170647174|NCT02353143|616721557|FG001|Overall Study|reason not specified|2|||
170647175|NCT02353143|616721558|FG002|Overall Study|reason not specified|0|||
170647176|NCT02353143|616721559|FG003|Overall Study|reason not specified|0|||
170647177|NCT02353143|616721560|FG004|Overall Study|reason not specified|6|||
170647178|NCT02353143|616721561|FG005|Overall Study|reason not specified|1|||
170647179|NCT02353143|616721562|FG006|Overall Study|reason not specified|0|||
170647180|NCT02353143|616721563|FG007|Overall Study|reason not specified|3|||
170647181|NCT02353143|616721564|FG008|Overall Study|reason not specified|1|||
170647182|NCT02353143|616721556|FG000|Overall Study|Physician Decision|0|||
170647183|NCT02353143|616721557|FG001|Overall Study|Physician Decision|4|||
170647184|NCT02353143|616721558|FG002|Overall Study|Physician Decision|2|||
170647185|NCT02353143|616721559|FG003|Overall Study|Physician Decision|3|||
170647186|NCT02353143|616721560|FG004|Overall Study|Physician Decision|4|||
170647187|NCT02353143|616721561|FG005|Overall Study|Physician Decision|0|||
170647188|NCT02353143|616721562|FG006|Overall Study|Physician Decision|1|||
170807731|NCT03410992|617307178|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170807732|NCT03410992|617307179|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170807733|NCT03410992|617307180|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
170807734|NCT03410992|617307170|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
170807735|NCT03410992|617307171|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
170647189|NCT02353143|616721563|FG007|Overall Study|Physician Decision|2|||
170647190|NCT02353143|616721564|FG008|Overall Study|Physician Decision|0|||
170647191|NCT02353143|616721556|FG000|Overall Study|Adverse Event|0|||
170647192|NCT02353143|616721557|FG001|Overall Study|Adverse Event|0|||
170647193|NCT02353143|616721558|FG002|Overall Study|Adverse Event|1|||
170647194|NCT02353143|616721559|FG003|Overall Study|Adverse Event|0|||
170807736|NCT03410992|617307172|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807737|NCT03410992|617307173|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807738|NCT03410992|617307174|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807739|NCT03410992|617307175|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807740|NCT03410992|617307176|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807741|NCT03410992|617307177|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807742|NCT03410992|617307178|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807743|NCT03410992|617307179|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807744|NCT03410992|617307180|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
170807745|NCT03410992|617307170|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
170807746|NCT03410992|617307171|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807747|NCT03410992|617307172|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807748|NCT03410992|617307173|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807749|NCT03410992|617307174|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807750|NCT03410992|617307175|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807751|NCT03410992|617307176|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807752|NCT03410992|617307177|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807753|NCT03410992|617307178|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807754|NCT03410992|617307179|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807755|NCT03410992|617307180|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
170807756|NCT03410992|617307170|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
170807757|NCT03410992|617307171|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
170807758|NCT03410992|617307172|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807759|NCT03410992|617307173|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807760|NCT03410992|617307174|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807761|NCT03410992|617307175|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807762|NCT03410992|617307176|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807763|NCT03410992|617307177|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807764|NCT03410992|617307178|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807765|NCT03410992|617307179|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807766|NCT03410992|617307180|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
170807767|NCT03410992|617307170|FG000|Week 16 Assessment|Incorrect escapers|0|||
170807768|NCT03410992|617307171|FG001|Week 16 Assessment|Incorrect escapers|6|||
170807769|NCT03410992|617307172|FG002|Week 16 Assessment|Incorrect escapers|0|||
170647195|NCT02353143|616721560|FG004|Overall Study|Adverse Event|1|||
170807770|NCT03410992|617307173|FG003|Week 16 Assessment|Incorrect escapers|0|||
170807771|NCT03410992|617307174|FG004|Week 16 Assessment|Incorrect escapers|0|||
170807772|NCT03410992|617307175|FG005|Week 16 Assessment|Incorrect escapers|0|||
170807773|NCT03410992|617307176|FG006|Week 16 Assessment|Incorrect escapers|0|||
170807774|NCT03410992|617307177|FG007|Week 16 Assessment|Incorrect escapers|0|||
170807775|NCT03410992|617307178|FG008|Week 16 Assessment|Incorrect escapers|0|||
170647196|NCT02353143|616721561|FG005|Overall Study|Adverse Event|1|||
170647197|NCT02353143|616721562|FG006|Overall Study|Adverse Event|0|||
170647198|NCT02353143|616721563|FG007|Overall Study|Adverse Event|0|||
170647199|NCT02353143|616721564|FG008|Overall Study|Adverse Event|0|||
170647200|NCT02353143|616721556|FG000|Overall Study|patient receiving other treatment for AML|0|||
170647201|NCT02353143|616721557|FG001|Overall Study|patient receiving other treatment for AML|0|||
170647202|NCT02353143|616721558|FG002|Overall Study|patient receiving other treatment for AML|1|||
170647203|NCT02353143|616721559|FG003|Overall Study|patient receiving other treatment for AML|0|||
170647204|NCT02353143|616721560|FG004|Overall Study|patient receiving other treatment for AML|0|||
170647205|NCT02353143|616721561|FG005|Overall Study|patient receiving other treatment for AML|0|||
170647206|NCT02353143|616721562|FG006|Overall Study|patient receiving other treatment for AML|0|||
170647207|NCT02353143|616721563|FG007|Overall Study|patient receiving other treatment for AML|0|||
170647208|NCT02353143|616721564|FG008|Overall Study|patient receiving other treatment for AML|0|||
170647209|NCT02353143|616721556|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
170647210|NCT02353143|616721557|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
170647211|NCT02353143|616721558|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
170647212|NCT02353143|616721559|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
170647213|NCT02353143|616721560|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
170647214|NCT02353143|616721561|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
170647215|NCT02353143|616721562|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
170647216|NCT02353143|616721563|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
170647217|NCT02353143|616721564|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
170647218|NCT04740905|616721565|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
170647219|NCT04740905|616721566|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
170647220|NCT04740905|616721565|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
170647221|NCT04740905|616721566|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
170647222|NCT04740905|616721565|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
170647223|NCT04740905|616721566|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
170647224|NCT04740905|616721565|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
170647225|NCT04740905|616721566|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
170647226|NCT04740905|616721565|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
170647227|NCT04740905|616721566|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
170647228|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
170647229|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
170647230|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
170647231|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
170647232|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
170647233|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
170647234|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
170807776|NCT03410992|617307179|FG009|Week 16 Assessment|Incorrect escapers|0|||
170807777|NCT03410992|617307180|FG010|Week 16 Assessment|Incorrect escapers|0|||
170807778|NCT03410992|617307170|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170569079|NCT01713582|616431871|FG001|Overall Study|Adverse event-unrelated|0|||
170569080|NCT01713582|616431872|FG002|Overall Study|Adverse event-unrelated|0|||
170569081|NCT01713582|616431873|FG003|Overall Study|Adverse event-unrelated|0|||
170569082|NCT01713582|616431874|FG004|Overall Study|Adverse event-unrelated|0|||
170569083|NCT01713582|616431875|FG005|Overall Study|Adverse event-unrelated|1|||
170569084|NCT01713582|616431876|FG006|Overall Study|Adverse event-unrelated|1|||
170569085|NCT01713582|616431877|FG007|Overall Study|Adverse event-unrelated|1|||
170569086|NCT01713582|616431878|FG008|Overall Study|Adverse event-unrelated|0|||
170569087|NCT01713582|616431879|FG009|Overall Study|Adverse event-unrelated|0|||
170569088|NCT01713582|616431880|FG010|Overall Study|Adverse event-unrelated|0|||
170569089|NCT01713582|616431881|FG011|Overall Study|Adverse event-unrelated|0|||
170569090|NCT01713582|616431882|FG012|Overall Study|Adverse event-unrelated|0|||
170569091|NCT01713582|616431883|FG013|Overall Study|Adverse event-unrelated|1|||
170569092|NCT01713582|616431884|FG014|Overall Study|Adverse event-unrelated|1|||
170569093|NCT01713582|616431885|FG015|Overall Study|Adverse event-unrelated|0|||
170569094|NCT01713582|616431886|FG016|Overall Study|Adverse event-unrelated|0|||
170569095|NCT01713582|616431887|FG017|Overall Study|Adverse event-unrelated|0|||
170647235|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
170807779|NCT03410992|617307171|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170807780|NCT03410992|617307172|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170807781|NCT03410992|617307173|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
170807782|NCT03410992|617307174|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
170807783|NCT03410992|617307175|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170807784|NCT03410992|617307176|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170807785|NCT03410992|617307177|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170807786|NCT03410992|617307178|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170807787|NCT03410992|617307179|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170569096|NCT01713582|616431888|FG018|Overall Study|Adverse event-unrelated|0|||
170569097|NCT01713582|616431889|FG019|Overall Study|Adverse event-unrelated|0|||
170569098|NCT01713582|616431890|FG020|Overall Study|Adverse event-unrelated|0|||
170569099|NCT01713582|616431870|FG000|Overall Study|Withdrawal of consent|0|||
170569100|NCT01713582|616431871|FG001|Overall Study|Withdrawal of consent|0|||
170647236|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
170647237|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
170647238|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
170647239|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
170807788|NCT03410992|617307180|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
170807789|NCT03410992|617307170|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
170807790|NCT03410992|617307171|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
170807791|NCT03410992|617307172|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
170807792|NCT03410992|617307173|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
170807793|NCT03410992|617307174|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
170807794|NCT03410992|617307175|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
170807795|NCT03410992|617307176|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
170807796|NCT03410992|617307177|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
170807797|NCT03410992|617307178|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
170807798|NCT03410992|617307179|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
170807799|NCT03410992|617307180|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
170807800|NCT03410992|617307170|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807801|NCT03410992|617307171|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807802|NCT03410992|617307172|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807803|NCT03410992|617307173|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807804|NCT03410992|617307174|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807805|NCT03410992|617307175|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
170807806|NCT03410992|617307176|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807807|NCT03410992|617307177|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807808|NCT03410992|617307178|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807809|NCT03410992|617307179|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807810|NCT03410992|617307180|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
170807811|NCT03410992|617307170|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
170807812|NCT03410992|617307171|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
170807813|NCT03410992|617307172|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
170807814|NCT03410992|617307173|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
170807815|NCT03410992|617307174|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
170807816|NCT03410992|617307175|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
170807817|NCT03410992|617307176|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
170807818|NCT03410992|617307177|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
170807819|NCT03410992|617307178|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
170807820|NCT03410992|617307179|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
170807821|NCT03410992|617307180|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
170807822|NCT03410992|617307170|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807823|NCT03410992|617307171|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807824|NCT03410992|617307172|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807825|NCT03410992|617307173|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807826|NCT03410992|617307174|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807827|NCT03410992|617307175|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807828|NCT03410992|617307176|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807829|NCT03410992|617307177|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
170647240|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
170647241|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
170647242|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
170647243|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
170647244|NCT04740905|616721565|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
170647245|NCT04740905|616721566|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
170647246|NCT00065429|616721567|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
170647247|NCT00065429|616721568|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
170647248|NCT00065429|616721569|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
170647249|NCT00065429|616721570|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
170647250|NCT00065429|616721571|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
170647251|NCT00065429|616721572|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
170647252|NCT00065429|616721573|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
170647253|NCT00065429|616721567|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
170647254|NCT00065429|616721568|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
170647255|NCT00065429|616721569|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
170647256|NCT00065429|616721570|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
170647257|NCT00065429|616721571|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
170647258|NCT00065429|616721572|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
170647259|NCT00065429|616721573|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
170647260|NCT00065429|616721567|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
170647261|NCT00065429|616721568|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
170647262|NCT00065429|616721569|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
170647263|NCT00065429|616721570|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
170647264|NCT00065429|616721571|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
170647265|NCT00065429|616721572|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
170647266|NCT00065429|616721573|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
170647267|NCT00065429|616721567|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
170647268|NCT00065429|616721568|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
170647269|NCT00065429|616721569|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
170647270|NCT00065429|616721570|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
170647271|NCT00065429|616721571|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
170647272|NCT00065429|616721572|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
170647273|NCT00065429|616721573|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
170647274|NCT00065429|616721567|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
170647275|NCT00065429|616721568|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
170647276|NCT00065429|616721569|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
170647277|NCT00065429|616721570|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
170647278|NCT00065429|616721571|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
170647279|NCT00065429|616721572|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
170647280|NCT00065429|616721573|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
170647281|NCT00065429|616721567|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
170647282|NCT00065429|616721568|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
170647283|NCT00065429|616721569|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
170647284|NCT00065429|616721570|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
170647285|NCT00065429|616721571|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
170647286|NCT00065429|616721572|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
170647287|NCT00065429|616721573|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
170647288|NCT00065429|616721567|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
170647289|NCT00065429|616721568|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
170647290|NCT00065429|616721569|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
170647291|NCT00065429|616721570|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
170647292|NCT00065429|616721571|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
170647293|NCT00065429|616721572|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
170647294|NCT00065429|616721573|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
170647295|NCT00441116|616721575|FG000|Overall Study|Adverse Event|1|||
170647296|NCT00441116|616721576|FG001|Overall Study|Adverse Event|1|||
170647297|NCT00441116|616721575|FG000|Overall Study|Withdrawal by Subject|1|||
170647298|NCT00441116|616721576|FG001|Overall Study|Withdrawal by Subject|0|||
170647299|NCT00441116|616721575|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
170647300|NCT00441116|616721576|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
170647301|NCT01590758|616721579|FG000|Overall Study|Withdrawal by Subject|0|||
170647302|NCT01590758|616721580|FG001|Overall Study|Withdrawal by Subject|3|||
170647303|NCT01590758|616721579|FG000|Overall Study|Physician Decision|1|||
170647304|NCT01590758|616721580|FG001|Overall Study|Physician Decision|2|||
170647305|NCT01590758|616721579|FG000|Overall Study|Lost to Follow-up|4|||
170647306|NCT01590758|616721580|FG001|Overall Study|Lost to Follow-up|2|||
170647307|NCT02756806|616721581|FG000|Overall Study|Study terminated early|5|||
170647308|NCT03158285|616721582|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
170647309|NCT03158285|616721583|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
170647310|NCT03158285|616721584|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
170647311|NCT03158285|616721582|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
170647312|NCT03158285|616721583|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
170647313|NCT03158285|616721584|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
170647314|NCT03158285|616721582|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
170647315|NCT03158285|616721583|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
170647316|NCT03158285|616721584|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
170647317|NCT03158285|616721582|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
170647318|NCT03158285|616721583|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
170647319|NCT03158285|616721584|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
170647320|NCT03158285|616721582|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
170647321|NCT03158285|616721583|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
170647322|NCT03158285|616721584|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
170647323|NCT03158285|616721582|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
170647324|NCT03158285|616721583|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
170647325|NCT03158285|616721584|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
170647326|NCT03158285|616721582|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
170807830|NCT03410992|617307178|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807831|NCT03410992|617307179|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807832|NCT03410992|617307180|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
170807833|NCT03410992|617307170|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807834|NCT03410992|617307171|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807835|NCT03410992|617307172|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807836|NCT03410992|617307173|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807837|NCT03410992|617307174|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807838|NCT03410992|617307175|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807839|NCT03410992|617307176|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807840|NCT03410992|617307177|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807841|NCT03410992|617307178|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
170807842|NCT03410992|617307179|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807843|NCT03410992|617307180|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
170807844|NCT00597376|617307181|FG000|Overall Study|Withdrawal by Subject|4|||
170807845|NCT00597376|617307182|FG001|Overall Study|Withdrawal by Subject|3|||
170807846|NCT00597376|617307181|FG000|Overall Study|Adverse Event|4|||
170807847|NCT00597376|617307182|FG001|Overall Study|Adverse Event|1|||
170807848|NCT01380145|617307183|FG000|Overall Study|Progressive disease|4|||
170807849|NCT02634307|617307184|FG000|Overall Study|Adverse Event|50|||
170807850|NCT02634307|617307185|FG001|Overall Study|Adverse Event|24|||
170807851|NCT02634307|617307186|FG002|Overall Study|Adverse Event|14|||
170807852|NCT02634307|617307184|FG000|Overall Study|Lost to Follow-up|21|||
170807853|NCT02634307|617307185|FG001|Overall Study|Lost to Follow-up|5|||
170807854|NCT02634307|617307186|FG002|Overall Study|Lost to Follow-up|6|||
170807855|NCT02634307|617307184|FG000|Overall Study|Pregnancy|5|||
170807856|NCT02634307|617307185|FG001|Overall Study|Pregnancy|1|||
170807857|NCT02634307|617307186|FG002|Overall Study|Pregnancy|3|||
170807858|NCT02634307|617307184|FG000|Overall Study|Withdrawal by Subject|38|||
170807859|NCT02634307|617307185|FG001|Overall Study|Withdrawal by Subject|24|||
170807860|NCT02634307|617307186|FG002|Overall Study|Withdrawal by Subject|18|||
170807861|NCT02634307|617307184|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170807862|NCT02634307|617307185|FG001|Overall Study|Non-Compliance with Study Drug|2|||
170807863|NCT02634307|617307186|FG002|Overall Study|Non-Compliance with Study Drug|2|||
170807864|NCT02634307|617307184|FG000|Overall Study|Lack of Efficacy|1|||
170807865|NCT02634307|617307185|FG001|Overall Study|Lack of Efficacy|5|||
170807866|NCT02634307|617307186|FG002|Overall Study|Lack of Efficacy|3|||
170807867|NCT02634307|617307184|FG000|Overall Study|Physician Decision|7|||
170807868|NCT02634307|617307185|FG001|Overall Study|Physician Decision|5|||
170807869|NCT02634307|617307186|FG002|Overall Study|Physician Decision|5|||
170807870|NCT02634307|617307184|FG000|Overall Study|Reason not Specified|3|||
170807871|NCT02634307|617307185|FG001|Overall Study|Reason not Specified|5|||
170807872|NCT02634307|617307186|FG002|Overall Study|Reason not Specified|10|||
170807873|NCT00413283|617307187|FG000|Overall Study|Withdrawal by Subject|1|||
170807874|NCT00413283|617307188|FG001|Overall Study|Withdrawal by Subject|0|||
170807875|NCT00413283|617307189|FG002|Overall Study|Withdrawal by Subject|0|||
170807876|NCT00413283|617307190|FG003|Overall Study|Withdrawal by Subject|1|||
170807877|NCT00413283|617307187|FG000|Overall Study|Death|0|||
170807878|NCT00413283|617307188|FG001|Overall Study|Death|0|||
170807879|NCT00413283|617307189|FG002|Overall Study|Death|1|||
170807880|NCT00413283|617307190|FG003|Overall Study|Death|1|||
170807881|NCT00413283|617307187|FG000|Overall Study|Adverse Event|0|||
170807882|NCT00413283|617307188|FG001|Overall Study|Adverse Event|0|||
170807883|NCT00413283|617307189|FG002|Overall Study|Adverse Event|0|||
170807884|NCT00413283|617307190|FG003|Overall Study|Adverse Event|1|||
170807885|NCT00413283|617307187|FG000|Overall Study|Ineligibility determined|0|||
170807886|NCT00413283|617307188|FG001|Overall Study|Ineligibility determined|0|||
170807887|NCT00413283|617307189|FG002|Overall Study|Ineligibility determined|0|||
170807888|NCT00413283|617307190|FG003|Overall Study|Ineligibility determined|1|||
170807889|NCT00413283|617307187|FG000|Overall Study|Protocol deviation|0|||
170807890|NCT00413283|617307188|FG001|Overall Study|Protocol deviation|1|||
170807891|NCT00413283|617307189|FG002|Overall Study|Protocol deviation|0|||
170807892|NCT00413283|617307190|FG003|Overall Study|Protocol deviation|0|||
170647327|NCT03158285|616721583|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
170647328|NCT03158285|616721584|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
170647329|NCT03158285|616721582|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
170647330|NCT03158285|616721583|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
170807893|NCT00413283|617307187|FG000|Overall Study|Requirement for alternative therapy|0|||
170807894|NCT00413283|617307188|FG001|Overall Study|Requirement for alternative therapy|2|||
170807895|NCT00413283|617307189|FG002|Overall Study|Requirement for alternative therapy|0|||
170807896|NCT00413283|617307190|FG003|Overall Study|Requirement for alternative therapy|0|||
170807897|NCT00413283|617307187|FG000|Overall Study|Other|0|||
170807898|NCT00413283|617307188|FG001|Overall Study|Other|0|||
170807899|NCT00413283|617307189|FG002|Overall Study|Other|1|||
170807900|NCT00413283|617307190|FG003|Overall Study|Other|0|||
170807901|NCT02132949|617307191|FG000|Overall Study|Death|7|||
170807902|NCT02132949|617307192|FG001|Overall Study|Death|13|||
170647331|NCT03158285|616721584|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
170647332|NCT03158285|616721582|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
170647333|NCT03158285|616721583|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
170647334|NCT03158285|616721584|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
170647335|NCT03158285|616721582|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
170647336|NCT03158285|616721583|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
170647337|NCT03158285|616721584|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
170647338|NCT03158285|616721582|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
170647339|NCT03158285|616721583|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
170647340|NCT03158285|616721584|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
170647341|NCT03158285|616721582|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
170647342|NCT03158285|616721583|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
170647343|NCT03158285|616721584|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
170647344|NCT03158285|616721582|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
170647345|NCT03158285|616721583|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
170647346|NCT03158285|616721584|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
170647347|NCT03158285|616721582|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
170647348|NCT03158285|616721583|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
170647349|NCT03158285|616721584|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
170647350|NCT03158285|616721582|FG000|Active Treatment Period: Week 52-100|Death|1|||
170647351|NCT03158285|616721583|FG001|Active Treatment Period: Week 52-100|Death|0|||
170647352|NCT03158285|616721584|FG002|Active Treatment Period: Week 52-100|Death|0|||
170647353|NCT03158285|616721582|FG000|Active Treatment Period: Week 52-100|Other|4|||
170647354|NCT03158285|616721583|FG001|Active Treatment Period: Week 52-100|Other|1|||
170647355|NCT03158285|616721584|FG002|Active Treatment Period: Week 52-100|Other|0|||
170647356|NCT01642615|616721585|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
170647357|NCT01642615|616721586|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
170647358|NCT01642615|616721587|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
170647359|NCT01642615|616721585|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
170647360|NCT01642615|616721586|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
170569101|NCT01713582|616431872|FG002|Overall Study|Withdrawal of consent|1|||
170569102|NCT01713582|616431873|FG003|Overall Study|Withdrawal of consent|0|||
170569103|NCT01713582|616431874|FG004|Overall Study|Withdrawal of consent|0|||
170569104|NCT01713582|616431875|FG005|Overall Study|Withdrawal of consent|1|||
170569105|NCT01713582|616431876|FG006|Overall Study|Withdrawal of consent|0|||
170569106|NCT01713582|616431877|FG007|Overall Study|Withdrawal of consent|0|||
170569107|NCT01713582|616431878|FG008|Overall Study|Withdrawal of consent|0|||
170569108|NCT01713582|616431879|FG009|Overall Study|Withdrawal of consent|1|||
170569109|NCT01713582|616431880|FG010|Overall Study|Withdrawal of consent|0|||
170569110|NCT01713582|616431881|FG011|Overall Study|Withdrawal of consent|0|||
170569111|NCT01713582|616431882|FG012|Overall Study|Withdrawal of consent|0|||
170569112|NCT01713582|616431883|FG013|Overall Study|Withdrawal of consent|0|||
170569113|NCT01713582|616431884|FG014|Overall Study|Withdrawal of consent|0|||
170569114|NCT01713582|616431885|FG015|Overall Study|Withdrawal of consent|0|||
170569115|NCT01713582|616431886|FG016|Overall Study|Withdrawal of consent|0|||
170569116|NCT01713582|616431887|FG017|Overall Study|Withdrawal of consent|0|||
170569117|NCT01713582|616431888|FG018|Overall Study|Withdrawal of consent|1|||
170569118|NCT01713582|616431889|FG019|Overall Study|Withdrawal of consent|0|||
170569119|NCT01713582|616431890|FG020|Overall Study|Withdrawal of consent|0|||
170569120|NCT01713582|616431870|FG000|Overall Study|Lack of Efficacy|0|||
170569121|NCT01713582|616431871|FG001|Overall Study|Lack of Efficacy|0|||
170569122|NCT01713582|616431872|FG002|Overall Study|Lack of Efficacy|0|||
170569123|NCT01713582|616431873|FG003|Overall Study|Lack of Efficacy|0|||
170569124|NCT01713582|616431874|FG004|Overall Study|Lack of Efficacy|0|||
170569125|NCT01713582|616431875|FG005|Overall Study|Lack of Efficacy|0|||
170569126|NCT01713582|616431876|FG006|Overall Study|Lack of Efficacy|0|||
170647361|NCT01642615|616721587|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
170647362|NCT01642615|616721585|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
170569127|NCT01713582|616431877|FG007|Overall Study|Lack of Efficacy|0|||
170569128|NCT01713582|616431878|FG008|Overall Study|Lack of Efficacy|0|||
170569129|NCT01713582|616431879|FG009|Overall Study|Lack of Efficacy|1|||
170569130|NCT01713582|616431880|FG010|Overall Study|Lack of Efficacy|2|||
170569131|NCT01713582|616431881|FG011|Overall Study|Lack of Efficacy|0|||
170569132|NCT01713582|616431882|FG012|Overall Study|Lack of Efficacy|0|||
170569133|NCT01713582|616431883|FG013|Overall Study|Lack of Efficacy|0|||
170647363|NCT01642615|616721586|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
170647364|NCT01642615|616721587|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
170647365|NCT01642615|616721585|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
170647366|NCT01642615|616721586|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
170647367|NCT01642615|616721587|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
170647368|NCT01642615|616721585|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
170569134|NCT01713582|616431884|FG014|Overall Study|Lack of Efficacy|0|||
170807903|NCT02132949|617307191|FG000|Overall Study|Lost to Follow-up|14|||
170807904|NCT02132949|617307192|FG001|Overall Study|Lost to Follow-up|4|||
170569135|NCT01713582|616431885|FG015|Overall Study|Lack of Efficacy|0|||
170569136|NCT01713582|616431886|FG016|Overall Study|Lack of Efficacy|0|||
170569137|NCT01713582|616431887|FG017|Overall Study|Lack of Efficacy|0|||
170569138|NCT01713582|616431888|FG018|Overall Study|Lack of Efficacy|0|||
170569139|NCT01713582|616431889|FG019|Overall Study|Lack of Efficacy|0|||
170569140|NCT01713582|616431890|FG020|Overall Study|Lack of Efficacy|0|||
170569141|NCT01713582|616431870|FG000|Overall Study|Withdrawal by Subject|0|||
170569142|NCT01713582|616431871|FG001|Overall Study|Withdrawal by Subject|0|||
170569143|NCT01713582|616431872|FG002|Overall Study|Withdrawal by Subject|0|||
170569144|NCT01713582|616431873|FG003|Overall Study|Withdrawal by Subject|0|||
170569145|NCT01713582|616431874|FG004|Overall Study|Withdrawal by Subject|0|||
170569146|NCT01713582|616431875|FG005|Overall Study|Withdrawal by Subject|0|||
170569147|NCT01713582|616431876|FG006|Overall Study|Withdrawal by Subject|0|||
170569148|NCT01713582|616431877|FG007|Overall Study|Withdrawal by Subject|0|||
170569149|NCT01713582|616431878|FG008|Overall Study|Withdrawal by Subject|0|||
170569150|NCT01713582|616431879|FG009|Overall Study|Withdrawal by Subject|0|||
170569151|NCT01713582|616431880|FG010|Overall Study|Withdrawal by Subject|0|||
170569152|NCT01713582|616431881|FG011|Overall Study|Withdrawal by Subject|0|||
170569153|NCT01713582|616431882|FG012|Overall Study|Withdrawal by Subject|0|||
170569154|NCT01713582|616431883|FG013|Overall Study|Withdrawal by Subject|0|||
170569155|NCT01713582|616431884|FG014|Overall Study|Withdrawal by Subject|0|||
170569156|NCT01713582|616431885|FG015|Overall Study|Withdrawal by Subject|0|||
170569157|NCT01713582|616431886|FG016|Overall Study|Withdrawal by Subject|0|||
170569158|NCT01713582|616431887|FG017|Overall Study|Withdrawal by Subject|1|||
170569159|NCT01713582|616431888|FG018|Overall Study|Withdrawal by Subject|0|||
170569160|NCT01713582|616431889|FG019|Overall Study|Withdrawal by Subject|0|||
170569161|NCT01713582|616431890|FG020|Overall Study|Withdrawal by Subject|0|||
170569162|NCT01713582|616431870|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
170569163|NCT01713582|616431871|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
170569164|NCT01713582|616431872|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
170569165|NCT01713582|616431873|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
170569166|NCT01713582|616431874|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
170569167|NCT01713582|616431875|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
170647369|NCT01642615|616721586|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
170807905|NCT02132949|617307191|FG000|Overall Study|Withdrawal by Subject|6|||
170807906|NCT02132949|617307192|FG001|Overall Study|Withdrawal by Subject|5|||
170807907|NCT02132949|617307191|FG000|Overall Study|Noncompliance|5|||
170807908|NCT02132949|617307192|FG001|Overall Study|Noncompliance|1|||
170807909|NCT02132949|617307191|FG000|Overall Study|Physician Decision|3|||
170807910|NCT02132949|617307192|FG001|Overall Study|Physician Decision|1|||
170807911|NCT02132949|617307191|FG000|Overall Study|Disease Progression|3|||
170807912|NCT02132949|617307192|FG001|Overall Study|Disease Progression|0|||
170807913|NCT02132949|617307191|FG000|Overall Study|Adverse Event|2|||
170807914|NCT02132949|617307192|FG001|Overall Study|Adverse Event|1|||
170807915|NCT02132949|617307191|FG000|Overall Study|Withdrew Prior to Treatment|1|||
170807916|NCT02132949|617307192|FG001|Overall Study|Withdrew Prior to Treatment|2|||
170807917|NCT02132949|617307191|FG000|Overall Study|Reason Unspecified|0|||
170807918|NCT02132949|617307192|FG001|Overall Study|Reason Unspecified|1|||
170807919|NCT05755906|617307193|FG000|Overall Study|Failure to meet randomization criteria|1|||
170807920|NCT05755906|617307194|FG001|Overall Study|Failure to meet randomization criteria|1|||
170807921|NCT05755906|617307193|FG000|Overall Study|Lost to Follow-up|0|||
170807922|NCT05755906|617307194|FG001|Overall Study|Lost to Follow-up|1|||
170807923|NCT05755906|617307193|FG000|Overall Study|Physician Decision|0|||
170807924|NCT05755906|617307194|FG001|Overall Study|Physician Decision|1|||
170807925|NCT05755906|617307193|FG000|Overall Study|Withdrawal by Subject|2|||
170807926|NCT05755906|617307194|FG001|Overall Study|Withdrawal by Subject|6|||
170807927|NCT00667017|617307195|FG000|Overall Study|Withdrawal by Subject|1|||
170807928|NCT01823224|617307196|FG000|Overall Study|Lost to Follow-up|5|||
170807929|NCT01823224|617307197|FG001|Overall Study|Lost to Follow-up|6|||
170807930|NCT01823224|617307196|FG000|Overall Study|didn't qualify|1|||
170807931|NCT01823224|617307197|FG001|Overall Study|didn't qualify|2|||
170807932|NCT01823224|617307196|FG000|Overall Study|pharmacy error|0|||
170807933|NCT01823224|617307197|FG001|Overall Study|pharmacy error|1|||
170807934|NCT01823224|617307196|FG000|Overall Study|missed med dose|0|||
170807935|NCT01823224|617307197|FG001|Overall Study|missed med dose|1|||
170807936|NCT01823224|617307196|FG000|Overall Study|Withdrawal by Subject|0|||
170807937|NCT01823224|617307197|FG001|Overall Study|Withdrawal by Subject|1|||
170569168|NCT01713582|616431876|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
170807938|NCT00745875|617307203|FG000|Overall Study|Continuing study treatment|4|||
170569169|NCT01713582|616431877|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
170807939|NCT00745875|617307204|FG001|Overall Study|Continuing study treatment|4|||
170807940|NCT01532648|617307205|FG000|Overall Study|Lost to Follow-up|3|||
170807941|NCT01532648|617307206|FG001|Overall Study|Lost to Follow-up|4|||
170807942|NCT01532648|617307205|FG000|Overall Study|Lack of Efficacy|4|||
170807943|NCT01532648|617307206|FG001|Overall Study|Lack of Efficacy|1|||
170807944|NCT01532648|617307205|FG000|Overall Study|Protocol Violation|1|||
170807945|NCT01532648|617307206|FG001|Overall Study|Protocol Violation|1|||
170807946|NCT01532648|617307205|FG000|Overall Study|Adverse Event|12|||
170807947|NCT01532648|617307206|FG001|Overall Study|Adverse Event|9|||
170807948|NCT01532648|617307205|FG000|Overall Study|Withdrawal by Subject|16|||
170807949|NCT01532648|617307206|FG001|Overall Study|Withdrawal by Subject|2|||
170807950|NCT02148705|617307207|FG000|Overall Study|Death|2|||
170807951|NCT02148705|617307208|FG001|Overall Study|Death|0|||
170807952|NCT02148705|617307209|FG002|Overall Study|Death|0|||
170807953|NCT02148705|617307207|FG000|Overall Study|Lost to Follow-up|13|||
170807954|NCT02148705|617307208|FG001|Overall Study|Lost to Follow-up|4|||
170807955|NCT02148705|617307209|FG002|Overall Study|Lost to Follow-up|10|||
170807956|NCT02148705|617307207|FG000|Overall Study|Withdrawal by Subject|3|||
170807957|NCT02148705|617307208|FG001|Overall Study|Withdrawal by Subject|0|||
170807958|NCT02148705|617307209|FG002|Overall Study|Withdrawal by Subject|2|||
170807959|NCT02148705|617307207|FG000|Overall Study|Not Treated|0|||
170569170|NCT01713582|616431878|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
170569171|NCT01713582|616431879|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
170569172|NCT01713582|616431880|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
170569173|NCT01713582|616431881|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
170569174|NCT01713582|616431882|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
170569175|NCT01713582|616431883|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
170569176|NCT01713582|616431884|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
170569177|NCT01713582|616431885|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
170807960|NCT02148705|617307208|FG001|Overall Study|Not Treated|1|||
170807961|NCT02148705|617307209|FG002|Overall Study|Not Treated|5|||
170807962|NCT01583166|617307210|FG000|Overall Study|Withdrawal by Subject|4|||
170807963|NCT01583166|617307211|FG001|Overall Study|Withdrawal by Subject|6|||
170807964|NCT01737021|617307214|FG000|Overall Study|Lost to Follow-up|5|||
170807965|NCT01737021|617307215|FG001|Overall Study|Lost to Follow-up|3|||
170807966|NCT03737110|617307217|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
170807967|NCT03737110|617307218|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
170807968|NCT03737110|617307219|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
170807969|NCT03737110|617307220|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
170807970|NCT03737110|617307221|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
170807971|NCT03737110|617307222|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
170807972|NCT03737110|617307217|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
170807973|NCT03737110|617307218|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
170807974|NCT03737110|617307219|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
170807975|NCT03737110|617307220|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
170807976|NCT03737110|617307221|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
170807977|NCT03737110|617307222|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
170807978|NCT03737110|617307217|FG000|Run-in (RI) Period|Adverse Event|4|||
170807979|NCT03737110|617307218|FG001|Run-in (RI) Period|Adverse Event|0|||
170807980|NCT03737110|617307219|FG002|Run-in (RI) Period|Adverse Event|0|||
170807981|NCT03737110|617307220|FG003|Run-in (RI) Period|Adverse Event|0|||
170807982|NCT03737110|617307221|FG004|Run-in (RI) Period|Adverse Event|0|||
170807983|NCT03737110|617307222|FG005|Run-in (RI) Period|Adverse Event|0|||
170807984|NCT03737110|617307217|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
170807985|NCT03737110|617307218|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
170807986|NCT03737110|617307219|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
170807987|NCT03737110|617307220|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
170807988|NCT03737110|617307221|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
170807989|NCT03737110|617307222|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
170807990|NCT03737110|617307217|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
170647370|NCT01642615|616721587|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
170647371|NCT01642615|616721585|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
170647372|NCT01642615|616721586|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
170647373|NCT01642615|616721587|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
170569178|NCT01713582|616431886|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
170569179|NCT01713582|616431887|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
170569180|NCT01713582|616431888|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
170569181|NCT01713582|616431889|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
170569182|NCT01713582|616431890|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
170569183|NCT01713582|616431870|FG000|Overall Study|Disease progression and adverse event|0|||
170807991|NCT03737110|617307218|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
170807992|NCT03737110|617307219|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
170807993|NCT03737110|617307220|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
170807994|NCT03737110|617307221|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
170807995|NCT03737110|617307222|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
170647374|NCT01642615|616721585|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
170647375|NCT01642615|616721586|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
170647376|NCT01642615|616721587|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
170647377|NCT01642615|616721585|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
170647378|NCT01642615|616721586|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
170647379|NCT01642615|616721587|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
170647380|NCT01642615|616721585|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
170647381|NCT01642615|616721586|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
170647382|NCT01642615|616721587|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
170647383|NCT00402740|616721588|FG000|Overall Study|Withdrawal by Subject|18|||
170647384|NCT00402740|616721588|FG000|Overall Study|Death|50|||
170647385|NCT00402740|616721588|FG000|Overall Study|Lost to Follow-up|6|||
170647386|NCT00402740|616721588|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
170647387|NCT00402740|616721588|FG000|Overall Study|Subject disposition unknown.|1|||
170647388|NCT01011309|616721589|FG000|Overall Study|Adverse Event|2|||
170647389|NCT01011309|616721590|FG001|Overall Study|Adverse Event|1|||
170647390|NCT01011309|616721591|FG002|Overall Study|Adverse Event|2|||
170647391|NCT01011309|616721589|FG000|Overall Study|Lack of Efficacy|0|||
170647392|NCT01011309|616721590|FG001|Overall Study|Lack of Efficacy|1|||
170647393|NCT01011309|616721591|FG002|Overall Study|Lack of Efficacy|0|||
170647394|NCT01011309|616721589|FG000|Overall Study|Protocol Violation|0|||
170647395|NCT01011309|616721590|FG001|Overall Study|Protocol Violation|1|||
170647396|NCT01011309|616721591|FG002|Overall Study|Protocol Violation|3|||
170647397|NCT04359901|616721594|FG000|Overall Study|Withdrawal by Subject|0|||
170647398|NCT04359901|616721595|FG001|Overall Study|Withdrawal by Subject|1|||
170647399|NCT04359901|616721594|FG000|Overall Study|Death|6|||
170647400|NCT04359901|616721595|FG001|Overall Study|Death|2|||
170647401|NCT05092360|616721596|FG000|Overall Study|Withdrawal by Subject|21|||
170647402|NCT05092360|616721597|FG001|Overall Study|Withdrawal by Subject|4|||
170647403|NCT05092360|616721598|FG002|Overall Study|Withdrawal by Subject|9|||
170647404|NCT05092360|616721599|FG003|Overall Study|Withdrawal by Subject|26|||
170647405|NCT05092360|616721596|FG000|Overall Study|Death|97|||
170647406|NCT05092360|616721597|FG001|Overall Study|Death|14|||
170647407|NCT05092360|616721598|FG002|Overall Study|Death|31|||
170647408|NCT05092360|616721599|FG003|Overall Study|Death|101|||
170647409|NCT05092360|616721596|FG000|Overall Study|Lost to Follow-up|1|||
170647410|NCT05092360|616721597|FG001|Overall Study|Lost to Follow-up|2|||
170647411|NCT05092360|616721598|FG002|Overall Study|Lost to Follow-up|2|||
170647412|NCT05092360|616721599|FG003|Overall Study|Lost to Follow-up|2|||
170647413|NCT05092360|616721596|FG000|Overall Study|Study terminated by sponsor|65|||
170647414|NCT05092360|616721597|FG001|Overall Study|Study terminated by sponsor|7|||
170647415|NCT05092360|616721598|FG002|Overall Study|Study terminated by sponsor|13|||
170647416|NCT05092360|616721599|FG003|Overall Study|Study terminated by sponsor|61|||
170647417|NCT01675167|616721600|FG000|Open-label Titration Phase|Adverse Event|81|||
170647418|NCT01675167|616721601|FG001|Open-label Titration Phase|Adverse Event|0|||
170647419|NCT01675167|616721602|FG002|Open-label Titration Phase|Adverse Event|0|||
170647420|NCT01675167|616721600|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
170647421|NCT01675167|616721601|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
170647422|NCT01675167|616721602|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
170647423|NCT01675167|616721600|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
170647424|NCT01675167|616721601|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
170647425|NCT01675167|616721602|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
170647426|NCT01675167|616721600|FG000|Open-label Titration Phase|Protocol Violation|43|||
170647427|NCT01675167|616721601|FG001|Open-label Titration Phase|Protocol Violation|0|||
170647428|NCT01675167|616721602|FG002|Open-label Titration Phase|Protocol Violation|0|||
170647429|NCT01675167|616721600|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
170647430|NCT01675167|616721601|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
170647431|NCT01675167|616721602|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
170647432|NCT01675167|616721600|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
170647433|NCT01675167|616721601|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
170647434|NCT01675167|616721602|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
170647435|NCT01675167|616721600|FG000|Open-label Titration Phase|Other|55|||
170647436|NCT01675167|616721601|FG001|Open-label Titration Phase|Other|0|||
170647437|NCT01675167|616721602|FG002|Open-label Titration Phase|Other|0|||
170647438|NCT01675167|616721600|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
170647439|NCT01675167|616721601|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
170647440|NCT01675167|616721602|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
170647441|NCT01675167|616721600|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170647442|NCT01675167|616721601|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
170647443|NCT01675167|616721602|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
170647444|NCT01675167|616721600|FG000|Double-blind Treatment Phase|Adverse Event|0|||
170647445|NCT01675167|616721601|FG001|Double-blind Treatment Phase|Adverse Event|5|||
170647446|NCT01675167|616721602|FG002|Double-blind Treatment Phase|Adverse Event|13|||
170647447|NCT01675167|616721600|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
170647448|NCT01675167|616721601|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
170647449|NCT01675167|616721602|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
170647450|NCT01675167|616721600|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
170647451|NCT01675167|616721601|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
170647452|NCT01675167|616721602|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
170647453|NCT01675167|616721600|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
170647454|NCT01675167|616721601|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
170647455|NCT01675167|616721602|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
170647456|NCT01675167|616721600|FG000|Double-blind Treatment Phase|Other|0|||
170647457|NCT01675167|616721601|FG001|Double-blind Treatment Phase|Other|7|||
170647458|NCT01675167|616721602|FG002|Double-blind Treatment Phase|Other|5|||
170647459|NCT05601544|616721603|FG000|Phase 2 Period 1|Adverse Event|0|||
170647460|NCT05601544|616721604|FG001|Phase 2 Period 1|Adverse Event|1|||
170647461|NCT05601544|616721605|FG002|Phase 2 Period 1|Adverse Event|0|||
170647462|NCT05601544|616721606|FG003|Phase 2 Period 1|Adverse Event|0|||
170647463|NCT05601544|616721607|FG004|Phase 2 Period 1|Adverse Event|0|||
170647464|NCT05601544|616721608|FG005|Phase 2 Period 1|Adverse Event|0|||
170647465|NCT01457352|616721611|FG000|Period 1|Adverse Event|2|||
170647466|NCT01457352|616721612|FG001|Period 1|Adverse Event|0|||
170647467|NCT01457352|616721611|FG000|Period 1|Withdrawal by Subject|2|||
170647468|NCT01457352|616721612|FG001|Period 1|Withdrawal by Subject|0|||
170647469|NCT01457352|616721611|FG000|Period 1|Physician Decision|2|||
170807996|NCT03737110|617307217|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
170807997|NCT03737110|617307218|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
170807998|NCT03737110|617307219|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
170807999|NCT03737110|617307220|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
170808000|NCT03737110|617307221|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
170808001|NCT03737110|617307222|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
170808002|NCT03737110|617307217|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
170808003|NCT03737110|617307218|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
170808004|NCT03737110|617307219|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
170808005|NCT03737110|617307220|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
170808006|NCT03737110|617307221|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
170808007|NCT03737110|617307222|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
170808008|NCT03737110|617307217|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
170808009|NCT03737110|617307218|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
170808010|NCT03737110|617307219|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
170808011|NCT03737110|617307220|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
170808012|NCT03737110|617307221|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
170808013|NCT03737110|617307222|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
170808014|NCT05462990|617307225|FG000|Overall Study|Adverse Event|3|||
170808015|NCT05462990|617307226|FG001|Overall Study|Adverse Event|3|||
170808016|NCT05462990|617307225|FG000|Overall Study|Lost to Follow-up|1|||
170808017|NCT05462990|617307226|FG001|Overall Study|Lost to Follow-up|1|||
170808018|NCT05462990|617307225|FG000|Overall Study|Physician Decision|1|||
170808019|NCT05462990|617307226|FG001|Overall Study|Physician Decision|1|||
170808020|NCT05462990|617307225|FG000|Overall Study|Protocol Deviation|3|||
170808021|NCT05462990|617307226|FG001|Overall Study|Protocol Deviation|1|||
170808022|NCT05462990|617307225|FG000|Overall Study|Study Terminated By Sponsor|14|||
170808023|NCT05462990|617307226|FG001|Overall Study|Study Terminated By Sponsor|18|||
170808024|NCT05462990|617307225|FG000|Overall Study|Withdrawal by Subject|2|||
170808025|NCT05462990|617307226|FG001|Overall Study|Withdrawal by Subject|1|||
170808026|NCT02736188|617307227|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
170808027|NCT02736188|617307227|FG000|Overall Study|Adverse Event|1|||
170808028|NCT02736188|617307227|FG000|Overall Study|Withdrawal by Subject|1|||
170808029|NCT02736188|617307227|FG000|Overall Study|Other|6|||
170808030|NCT01698918|617307228|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
170808031|NCT01698918|617307228|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
170808032|NCT01698918|617307228|FG000|First Line Treatment (Core+Extension)|Death|2|||
170808033|NCT01698918|617307228|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
170647470|NCT01457352|616721612|FG001|Period 1|Physician Decision|0|||
170808034|NCT01698918|617307228|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
170808035|NCT01698918|617307228|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
170808036|NCT01698918|617307228|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
170808037|NCT01698918|617307228|FG000|Second Line Treatment (Core+Extension)|Death|1|||
170647471|NCT01457352|616721611|FG000|Period 1|MS related disease progression|1|||
170647472|NCT01457352|616721612|FG001|Period 1|MS related disease progression|0|||
170647473|NCT01457352|616721611|FG000|Period 1|Withdrawn|1|||
170647474|NCT01457352|616721612|FG001|Period 1|Withdrawn|0|||
170647475|NCT01457352|616721611|FG000|Period 1|withdrew per sponsor|1|||
170647476|NCT01457352|616721612|FG001|Period 1|withdrew per sponsor|0|||
170647477|NCT01457352|616721611|FG000|Period 1|Protocol Violation|4|||
170647478|NCT01457352|616721612|FG001|Period 1|Protocol Violation|0|||
170647479|NCT01457352|616721611|FG000|Period 1|Did not meet eligibility criteria|3|||
170647480|NCT01457352|616721612|FG001|Period 1|Did not meet eligibility criteria|0|||
170647481|NCT01457352|616721611|FG000|Period 2|Withdrawal by Subject|23|||
170647482|NCT01457352|616721612|FG001|Period 2|Withdrawal by Subject|0|||
170647483|NCT01457352|616721611|FG000|Period 2|Adverse Event|22|||
170647484|NCT01457352|616721612|FG001|Period 2|Adverse Event|0|||
170647485|NCT01457352|616721611|FG000|Period 2|no analysis|10|||
170647486|NCT01457352|616721612|FG001|Period 2|no analysis|0|||
170647487|NCT01457352|616721611|FG000|Period 2|Lack of Efficacy|8|||
170647488|NCT01457352|616721612|FG001|Period 2|Lack of Efficacy|0|||
170647489|NCT01457352|616721611|FG000|Period 2|Protocol Violation|4|||
170647490|NCT01457352|616721612|FG001|Period 2|Protocol Violation|0|||
170647491|NCT01457352|616721611|FG000|Period 2|Sponsor's withdrawal|7|||
170647492|NCT01457352|616721612|FG001|Period 2|Sponsor's withdrawal|0|||
170647493|NCT01457352|616721611|FG000|Period 2|Lost to Follow-up|1|||
170647494|NCT01457352|616721612|FG001|Period 2|Lost to Follow-up|0|||
170647495|NCT01457352|616721611|FG000|Period 2|dose change|1|||
170647496|NCT01457352|616721612|FG001|Period 2|dose change|0|||
170647497|NCT01457352|616721611|FG000|Period 2|Physician Decision|1|||
170647498|NCT01457352|616721612|FG001|Period 2|Physician Decision|0|||
170647499|NCT01457352|616721611|FG000|Period 2|Did not meet eligibility criteria|3|||
170647500|NCT01457352|616721612|FG001|Period 2|Did not meet eligibility criteria|0|||
170647501|NCT01457352|616721611|FG000|Period 3|Adverse Event|1|||
170647502|NCT01457352|616721612|FG001|Period 3|Adverse Event|1|||
170647503|NCT01457352|616721611|FG000|Period 3|Withdrawal by Subject|0|||
170647504|NCT01457352|616721612|FG001|Period 3|Withdrawal by Subject|2|||
170647505|NCT01457352|616721611|FG000|Period 3|incorrect treatment|0|||
170569184|NCT01713582|616431871|FG001|Overall Study|Disease progression and adverse event|0|||
170569185|NCT01713582|616431872|FG002|Overall Study|Disease progression and adverse event|0|||
170569186|NCT01713582|616431873|FG003|Overall Study|Disease progression and adverse event|0|||
170569187|NCT01713582|616431874|FG004|Overall Study|Disease progression and adverse event|0|||
170569188|NCT01713582|616431875|FG005|Overall Study|Disease progression and adverse event|0|||
170569189|NCT01713582|616431876|FG006|Overall Study|Disease progression and adverse event|0|||
170569190|NCT01713582|616431877|FG007|Overall Study|Disease progression and adverse event|0|||
170569191|NCT01713582|616431878|FG008|Overall Study|Disease progression and adverse event|0|||
170569192|NCT01713582|616431879|FG009|Overall Study|Disease progression and adverse event|0|||
170569193|NCT01713582|616431880|FG010|Overall Study|Disease progression and adverse event|0|||
170569194|NCT01713582|616431881|FG011|Overall Study|Disease progression and adverse event|0|||
170569195|NCT01713582|616431882|FG012|Overall Study|Disease progression and adverse event|0|||
170569196|NCT01713582|616431883|FG013|Overall Study|Disease progression and adverse event|0|||
170569197|NCT01713582|616431884|FG014|Overall Study|Disease progression and adverse event|0|||
170569198|NCT01713582|616431885|FG015|Overall Study|Disease progression and adverse event|0|||
170569199|NCT01713582|616431886|FG016|Overall Study|Disease progression and adverse event|1|||
170569200|NCT01713582|616431887|FG017|Overall Study|Disease progression and adverse event|0|||
170569201|NCT01713582|616431888|FG018|Overall Study|Disease progression and adverse event|0|||
170569202|NCT01713582|616431889|FG019|Overall Study|Disease progression and adverse event|0|||
170569203|NCT01713582|616431890|FG020|Overall Study|Disease progression and adverse event|0|||
170569204|NCT01047007|616431891|FG000|Overall Study|Adverse Event|0|||
170569205|NCT01047007|616431892|FG001|Overall Study|Adverse Event|2|||
170569206|NCT01047007|616431893|FG002|Overall Study|Adverse Event|1|||
170569207|NCT01047007|616431894|FG003|Overall Study|Adverse Event|0|||
170569208|NCT01047007|616431891|FG000|Overall Study|Progressive Disease|2|||
170569209|NCT01047007|616431892|FG001|Overall Study|Progressive Disease|4|||
170569210|NCT01047007|616431893|FG002|Overall Study|Progressive Disease|1|||
170569211|NCT01047007|616431894|FG003|Overall Study|Progressive Disease|0|||
170569212|NCT03846427|616431895|FG000|Overall Study|Death|13|||
170569213|NCT03846427|616431895|FG000|Overall Study|Withdrawal by Subject|3|||
170569214|NCT03846427|616431895|FG000|Overall Study|Physician Decision|1|||
170569215|NCT03257358|616431896|FG000|Overall Study|Adverse Event|25|||
170569216|NCT03257358|616431897|FG001|Overall Study|Adverse Event|12|||
170569217|NCT03257358|616431896|FG000|Overall Study|Lack of Efficacy|1|||
170647506|NCT01457352|616721612|FG001|Period 3|incorrect treatment|1|||
170647507|NCT01457352|616721611|FG000|Period 3|Sponsor's withdrawal|0|||
170647508|NCT01457352|616721612|FG001|Period 3|Sponsor's withdrawal|1|||
170647509|NCT03952039|616721613|FG000|Overall Study|Adverse Event|22|||
170647510|NCT03952039|616721614|FG001|Overall Study|Adverse Event|8|||
170647511|NCT03952039|616721613|FG000|Overall Study|Withdrawal by Participant|17|||
170647512|NCT03952039|616721614|FG001|Overall Study|Withdrawal by Participant|12|||
170647513|NCT03952039|616721613|FG000|Overall Study|Death|13|||
170647514|NCT03952039|616721614|FG001|Overall Study|Death|6|||
170647515|NCT03952039|616721613|FG000|Overall Study|Lack of Efficacy|12|||
170647516|NCT03952039|616721614|FG001|Overall Study|Lack of Efficacy|2|||
170647517|NCT03952039|616721613|FG000|Overall Study|Physician Decision|9|||
170647518|NCT03952039|616721614|FG001|Overall Study|Physician Decision|3|||
170647519|NCT03952039|616721613|FG000|Overall Study|Progressive Disease|6|||
170647520|NCT03952039|616721614|FG001|Overall Study|Progressive Disease|4|||
170647521|NCT03952039|616721613|FG000|Overall Study|Other Reasons|12|||
170647522|NCT03952039|616721614|FG001|Overall Study|Other Reasons|4|||
170647523|NCT02626624|616721615|FG000|Overall Study|Adverse Event|1|||
170647524|NCT02626624|616721615|FG000|Overall Study|Lost to Follow-up|3|||
170647525|NCT02626624|616721615|FG000|Overall Study|Protocol Violation|4|||
170647526|NCT02626624|616721615|FG000|Overall Study|Death|2|||
170647527|NCT04487080|616721616|FG000|Overall Study|Withdrawal by Subject|19|||
170647528|NCT04487080|616721617|FG001|Overall Study|Withdrawal by Subject|18|||
170647529|NCT04487080|616721618|FG002|Overall Study|Withdrawal by Subject|13|||
170647530|NCT04487080|616721616|FG000|Overall Study|Lost to Follow-up|3|||
170647531|NCT04487080|616721617|FG001|Overall Study|Lost to Follow-up|1|||
170647532|NCT04487080|616721618|FG002|Overall Study|Lost to Follow-up|0|||
170647533|NCT04487080|616721616|FG000|Overall Study|Ongoing|313|||
170647534|NCT04487080|616721617|FG001|Overall Study|Ongoing|297|||
170647535|NCT04487080|616721618|FG002|Overall Study|Ongoing|149|||
170647536|NCT05141448|616721619|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
170647537|NCT05141448|616721620|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
170647538|NCT05141448|616721621|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
170647539|NCT05141448|616721622|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
170647540|NCT05141448|616721623|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
170647541|NCT05141448|616721624|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
170647542|NCT05141448|616721619|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
170647543|NCT05141448|616721620|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
170647544|NCT05141448|616721621|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
170647545|NCT05141448|616721622|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
170647546|NCT05141448|616721623|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
170647547|NCT05141448|616721624|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
170647548|NCT05141448|616721619|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
170647549|NCT05141448|616721620|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
170647550|NCT05141448|616721621|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
170647551|NCT05141448|616721622|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
170647552|NCT05141448|616721623|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
170647553|NCT05141448|616721624|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
170647554|NCT05141448|616721619|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
170647555|NCT05141448|616721620|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
170647556|NCT05141448|616721621|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
170647557|NCT05141448|616721622|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
170647558|NCT05141448|616721623|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
170647559|NCT05141448|616721624|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
170647560|NCT05141448|616721619|FG000|Period 2|COVID-19 Related|0|||
170647561|NCT05141448|616721620|FG001|Period 2|COVID-19 Related|0|||
170647562|NCT05141448|616721621|FG002|Period 2|COVID-19 Related|0|||
170647563|NCT05141448|616721622|FG003|Period 2|COVID-19 Related|1|||
170569218|NCT03257358|616431897|FG001|Overall Study|Lack of Efficacy|1|||
170569219|NCT03257358|616431896|FG000|Overall Study|Lost to Follow-up|12|||
170569220|NCT03257358|616431897|FG001|Overall Study|Lost to Follow-up|4|||
170569221|NCT03257358|616431896|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
170569222|NCT03257358|616431897|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
170569223|NCT03257358|616431896|FG000|Overall Study|Physician Decision|2|||
170569224|NCT03257358|616431897|FG001|Overall Study|Physician Decision|2|||
170569225|NCT03257358|616431896|FG000|Overall Study|Protocol Violation|5|||
170569226|NCT03257358|616431897|FG001|Overall Study|Protocol Violation|3|||
170569227|NCT03257358|616431896|FG000|Overall Study|Technical problems|4|||
170569228|NCT03257358|616431897|FG001|Overall Study|Technical problems|1|||
170569229|NCT03257358|616431896|FG000|Overall Study|Withdrawal by Subject|8|||
170569230|NCT03257358|616431897|FG001|Overall Study|Withdrawal by Subject|3|||
170569231|NCT03257358|616431896|FG000|Overall Study|Withdrawal of informed consent|9|||
170647564|NCT05141448|616721623|FG004|Period 2|COVID-19 Related|0|||
170647565|NCT05141448|616721624|FG005|Period 2|COVID-19 Related|1|||
170647566|NCT05141448|616721619|FG000|3|Covid-19 related|2|||
170569232|NCT03257358|616431897|FG001|Overall Study|Withdrawal of informed consent|5|||
170569233|NCT03257358|616431896|FG000|Overall Study|New therapy for study indication|1|||
170647567|NCT05141448|616721620|FG001|3|Covid-19 related|0|||
170647568|NCT05141448|616721621|FG002|3|Covid-19 related|0|||
170569234|NCT03257358|616431897|FG001|Overall Study|New therapy for study indication|0|||
170569235|NCT03257358|616431896|FG000|Overall Study|No longer requires treatment|0|||
170808038|NCT01698918|617307228|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
170647569|NCT05141448|616721622|FG003|3|Covid-19 related|0|||
170647570|NCT05141448|616721623|FG004|3|Covid-19 related|0|||
170647571|NCT05141448|616721624|FG005|3|Covid-19 related|1|||
170647572|NCT05141448|616721619|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
170647573|NCT05141448|616721620|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
170647574|NCT05141448|616721621|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
170647575|NCT05141448|616721622|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
170647576|NCT05141448|616721623|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
170647577|NCT05141448|616721624|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
170647578|NCT00576420|616723349|FG000|Overall Study|Death|0|||
170647579|NCT00576420|616723350|FG001|Overall Study|Death|0|||
170647580|NCT00576420|616723351|FG002|Overall Study|Death|1|||
170647581|NCT03039621|616723356|FG000|Overall Study|Violation of inclusion criteria|3|||
170647582|NCT03039621|616723357|FG001|Overall Study|Violation of inclusion criteria|2|||
170647583|NCT03039621|616723356|FG000|Overall Study|Non-compliance with protocol requirement|4|||
170647584|NCT03039621|616723357|FG001|Overall Study|Non-compliance with protocol requirement|5|||
170647585|NCT03039621|616723356|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
170647586|NCT03039621|616723357|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
170647587|NCT03039621|616723356|FG000|Overall Study|Violation of non-inclusion criteria|1|||
170647588|NCT03039621|616723357|FG001|Overall Study|Violation of non-inclusion criteria|2|||
170647589|NCT01771809|616723358|FG000|Overall Study|Adverse Event|4|||
170647590|NCT01771809|616723359|FG001|Overall Study|Adverse Event|12|||
170647591|NCT01771809|616723358|FG000|Overall Study|Protocol Violation|0|||
170647592|NCT01771809|616723359|FG001|Overall Study|Protocol Violation|1|||
170647593|NCT01771809|616723358|FG000|Overall Study|Withdrawal by Subject|34|||
170647594|NCT01771809|616723359|FG001|Overall Study|Withdrawal by Subject|42|||
170808039|NCT01698918|617307228|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
170808040|NCT00836498|617307229|FG000|Overall Study|Adverse Event|1|||
170647595|NCT01771809|616723358|FG000|Overall Study|Lost to Follow-up|1|||
170808041|NCT00836498|617307230|FG001|Overall Study|Adverse Event|0|||
170808042|NCT00836498|617307229|FG000|Overall Study|Lost to Follow-up|1|||
170808043|NCT00836498|617307230|FG001|Overall Study|Lost to Follow-up|0|||
170808044|NCT00836498|617307229|FG000|Overall Study|Withdrawal by Subject|2|||
170808045|NCT00836498|617307230|FG001|Overall Study|Withdrawal by Subject|1|||
170808046|NCT03489369|617307231|FG000|Overall Study|Documented Progressive Disease|3|||
170808047|NCT03489369|617307232|FG001|Overall Study|Documented Progressive Disease|2|||
170808048|NCT03489369|617307233|FG002|Overall Study|Documented Progressive Disease|3|||
170808049|NCT03489369|617307234|FG003|Overall Study|Documented Progressive Disease|6|||
170808050|NCT03489369|617307231|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
170808051|NCT03489369|617307232|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
170808052|NCT03489369|617307233|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
170808053|NCT03489369|617307234|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
170808054|NCT01968967|617307235|FG000|Treatment Period|Other|22|||
170808055|NCT01968967|617307236|FG001|Treatment Period|Other|22|||
170647596|NCT01771809|616723359|FG001|Overall Study|Lost to Follow-up|3|||
170647597|NCT01771809|616723358|FG000|Overall Study|Other (Insufficient clinical response)|22|||
170647598|NCT01771809|616723359|FG001|Overall Study|Other (Insufficient clinical response)|20|||
170647599|NCT01771809|616723358|FG000|Overall Study|Death|1|||
170647600|NCT01771809|616723359|FG001|Overall Study|Death|0|||
170647601|NCT01771809|616723358|FG000|Overall Study|Other (other)|9|||
170647602|NCT01771809|616723359|FG001|Overall Study|Other (other)|5|||
170647603|NCT01106092|616723360|FG000|Overall Study|Withdrawal by Subject|0|||
170647604|NCT01106092|616723361|FG001|Overall Study|Withdrawal by Subject|0|||
170647605|NCT01106092|616723362|FG002|Overall Study|Withdrawal by Subject|0|||
170647606|NCT01106092|616723363|FG003|Overall Study|Withdrawal by Subject|1|||
170647607|NCT04839562|616723370|FG000|Overall Study|Withdrawal by Subject|0|||
170647608|NCT04839562|616723371|FG001|Overall Study|Withdrawal by Subject|1|||
170647609|NCT04839562|616723370|FG000|Overall Study|Physician Decision|0|||
170647610|NCT04839562|616723371|FG001|Overall Study|Physician Decision|1|||
170647611|NCT04966910|616723372|FG000|Baseline|Participant did not complete measure|0|||
170647612|NCT04966910|616723373|FG001|Baseline|Participant did not complete measure|0|||
170647613|NCT04966910|616723374|FG002|Baseline|Participant did not complete measure|1|||
170647614|NCT04966910|616723375|FG003|Baseline|Participant did not complete measure|0|||
170647615|NCT04966910|616723372|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
170647616|NCT04966910|616723373|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
170647617|NCT04966910|616723374|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
170647618|NCT04966910|616723375|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
170647619|NCT04966910|616723372|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
170647620|NCT04966910|616723373|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
170647621|NCT04966910|616723374|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
170647622|NCT04966910|616723375|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
170647623|NCT04966910|616723372|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
170647624|NCT04966910|616723373|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
170647625|NCT04966910|616723374|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
170647626|NCT04966910|616723375|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
170647627|NCT00002931|616723377|FG000|Overall Study|rapidly progressing disease during|2|||
170647628|NCT01246466|616723382|FG000|Overall Study|Death|1|||
170647629|NCT01246466|616723382|FG000|Overall Study|Withdrawal by Subject|1|||
170647630|NCT02870933|616723389|FG000|Overall Study|Death|2|||
170569236|NCT03257358|616431897|FG001|Overall Study|No longer requires treatment|1|||
170569237|NCT00488514|616431898|FG000|Overall Study|Adverse Event|41|||
170569238|NCT00488514|616431898|FG000|Overall Study|Lost to Follow-up|44|||
170569239|NCT00488514|616431898|FG000|Overall Study|Protocol Violation|32|||
170569240|NCT00488514|616431898|FG000|Overall Study|Withdrawal by Subject|106|||
170569241|NCT00488514|616431898|FG000|Overall Study|Lack of Efficacy|28|||
170569242|NCT00488514|616431898|FG000|Overall Study|Did not meet criteria for treatment|30|||
170569243|NCT00488514|616431898|FG000|Overall Study|Postive drug screen|1|||
170569244|NCT00488514|616431898|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
170569245|NCT00488514|616431898|FG000|Overall Study|Investigator decision|1|||
170569246|NCT00488514|616431898|FG000|Overall Study|Participant had too few migraines|5|||
170569247|NCT00488514|616431898|FG000|Overall Study|Increase in number of migraines|2|||
170569248|NCT00488514|616431898|FG000|Overall Study|Increased use of concomitant medication|1|||
170569249|NCT02332187|616431901|FG000|Overall Study|Withdrawal by Subject|2|||
170569250|NCT02332187|616431902|FG001|Overall Study|Withdrawal by Subject|2|||
170569251|NCT02332187|616431901|FG000|Overall Study|Adverse Event|0|||
170569252|NCT02332187|616431902|FG001|Overall Study|Adverse Event|1|||
170569253|NCT00980148|616431903|FG000|Overall Study|Discharged from facility|89|||
170569254|NCT00980148|616431904|FG001|Overall Study|Discharged from facility|96|||
170569255|NCT00980148|616431903|FG000|Overall Study|Received other antichlamydia treatment|20|||
170569256|NCT00980148|616431904|FG001|Overall Study|Received other antichlamydia treatment|14|||
170569257|NCT00980148|616431903|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
170569258|NCT00980148|616431904|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
170569259|NCT00980148|616431903|FG000|Overall Study|Various other reasons|8|||
170569260|NCT00980148|616431904|FG001|Overall Study|Various other reasons|9|||
170569261|NCT02852967|616431905|FG000|Overall Study|Adverse Event|3|||
170569262|NCT02852967|616431906|FG001|Overall Study|Adverse Event|1|||
170569263|NCT02852967|616431907|FG002|Overall Study|Adverse Event|0|||
170569264|NCT02852967|616431908|FG003|Overall Study|Adverse Event|1|||
170569265|NCT02852967|616431909|FG004|Overall Study|Adverse Event|0|||
170569266|NCT02852967|616431905|FG000|Overall Study|Death|1|||
170569267|NCT02852967|616431906|FG001|Overall Study|Death|0|||
170569268|NCT02852967|616431907|FG002|Overall Study|Death|0|||
170569269|NCT02852967|616431908|FG003|Overall Study|Death|0|||
170647631|NCT02870933|616723390|FG001|Overall Study|Death|1|||
170569270|NCT02852967|616431909|FG004|Overall Study|Death|0|||
170569271|NCT02852967|616431905|FG000|Overall Study|Lost to Follow-up|1|||
170569272|NCT02852967|616431906|FG001|Overall Study|Lost to Follow-up|2|||
170569273|NCT02852967|616431907|FG002|Overall Study|Lost to Follow-up|3|||
170569274|NCT02852967|616431908|FG003|Overall Study|Lost to Follow-up|4|||
170569275|NCT02852967|616431909|FG004|Overall Study|Lost to Follow-up|4|||
170647632|NCT02870933|616723389|FG000|Overall Study|Withdrawal by Subject|0|||
170647633|NCT02870933|616723390|FG001|Overall Study|Withdrawal by Subject|1|||
170569276|NCT02852967|616431905|FG000|Overall Study|Withdrawal by Subject|6|||
170569277|NCT02852967|616431906|FG001|Overall Study|Withdrawal by Subject|12|||
170569278|NCT02852967|616431907|FG002|Overall Study|Withdrawal by Subject|7|||
170569279|NCT02852967|616431908|FG003|Overall Study|Withdrawal by Subject|10|||
170569280|NCT02852967|616431909|FG004|Overall Study|Withdrawal by Subject|10|||
170569281|NCT02852967|616431905|FG000|Overall Study|SAE|0|||
170569282|NCT02852967|616431906|FG001|Overall Study|SAE|0|||
170569283|NCT02852967|616431907|FG002|Overall Study|SAE|0|||
170569284|NCT02852967|616431908|FG003|Overall Study|SAE|3|||
170569285|NCT02852967|616431909|FG004|Overall Study|SAE|0|||
170569286|NCT02852967|616431905|FG000|Overall Study|Elevated Liver Enzymes|2|||
170569287|NCT02852967|616431906|FG001|Overall Study|Elevated Liver Enzymes|0|||
170569288|NCT02852967|616431907|FG002|Overall Study|Elevated Liver Enzymes|0|||
170569289|NCT02852967|616431908|FG003|Overall Study|Elevated Liver Enzymes|2|||
170569290|NCT02852967|616431909|FG004|Overall Study|Elevated Liver Enzymes|2|||
170569291|NCT02852967|616431905|FG000|Overall Study|Physician Decision|0|||
170569292|NCT02852967|616431906|FG001|Overall Study|Physician Decision|0|||
170569293|NCT02852967|616431907|FG002|Overall Study|Physician Decision|0|||
170569294|NCT02852967|616431908|FG003|Overall Study|Physician Decision|1|||
170569295|NCT02852967|616431909|FG004|Overall Study|Physician Decision|0|||
170569296|NCT02852967|616431905|FG000|Overall Study|Lack of Efficacy|0|||
170569297|NCT02852967|616431906|FG001|Overall Study|Lack of Efficacy|1|||
170569298|NCT02852967|616431907|FG002|Overall Study|Lack of Efficacy|0|||
170569299|NCT02852967|616431908|FG003|Overall Study|Lack of Efficacy|0|||
170569300|NCT02852967|616431909|FG004|Overall Study|Lack of Efficacy|0|||
170569301|NCT02852967|616431905|FG000|Overall Study|Non-compliance|0|||
170569302|NCT02852967|616431906|FG001|Overall Study|Non-compliance|0|||
170569303|NCT02852967|616431907|FG002|Overall Study|Non-compliance|1|||
170569304|NCT02852967|616431908|FG003|Overall Study|Non-compliance|1|||
170569305|NCT02852967|616431909|FG004|Overall Study|Non-compliance|0|||
170569306|NCT02852967|616431905|FG000|Overall Study|Dispensing Drug Violation|0|||
170569307|NCT02852967|616431906|FG001|Overall Study|Dispensing Drug Violation|0|||
170569308|NCT02852967|616431907|FG002|Overall Study|Dispensing Drug Violation|1|||
170569309|NCT02852967|616431908|FG003|Overall Study|Dispensing Drug Violation|0|||
170569310|NCT02852967|616431909|FG004|Overall Study|Dispensing Drug Violation|0|||
170569311|NCT02852967|616431905|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
170569312|NCT02852967|616431906|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
170569313|NCT02852967|616431907|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
170569314|NCT02852967|616431908|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
170569315|NCT02852967|616431909|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
170569316|NCT02903823|616431910|FG000|Overall Study|Physician Decision|5|||
170569317|NCT02903823|616431910|FG000|Overall Study|Could not advance catheter|1|||
170569318|NCT02903823|616431910|FG000|Overall Study|Catheter dislodgement|1|||
170569319|NCT00339040|616431919|FG000|Stage I|Not able to attend clinic|1|||
170569320|NCT00339040|616431920|FG001|Stage I|Not able to attend clinic|0|||
170569321|NCT00339040|616431919|FG000|Stage I|Protocol Violation|1|||
170569322|NCT00339040|616431920|FG001|Stage I|Protocol Violation|1|||
170569323|NCT00339040|616431919|FG000|Stage II|Lost to Follow-up|3|||
170647634|NCT01350544|616723391|FG000|Overall Study|Administrative Withdrawal|0|||
170647635|NCT01350544|616723392|FG001|Overall Study|Administrative Withdrawal|1|||
170647636|NCT01350544|616723391|FG000|Overall Study|Death|1|||
170647637|NCT01350544|616723392|FG001|Overall Study|Death|2|||
170647638|NCT01350544|616723391|FG000|Overall Study|Moved out of LA County|2|||
170647639|NCT01350544|616723392|FG001|Overall Study|Moved out of LA County|2|||
170647640|NCT01350544|616723391|FG000|Overall Study|Medical Issues|1|||
170647641|NCT01350544|616723392|FG001|Overall Study|Medical Issues|1|||
170647642|NCT01350544|616723391|FG000|Overall Study|Withdrawal by Subject|0|||
170647643|NCT01350544|616723392|FG001|Overall Study|Withdrawal by Subject|1|||
170569324|NCT00339040|616431920|FG001|Stage II|Lost to Follow-up|0|||
170569325|NCT00339040|616431919|FG000|Stage II|Withdrawal by Subject|1|||
170647644|NCT01350544|616723391|FG000|Overall Study|Incarceration|1|||
170647645|NCT01350544|616723392|FG001|Overall Study|Incarceration|0|||
170569326|NCT00339040|616431920|FG001|Stage II|Withdrawal by Subject|2|||
170569327|NCT00339040|616431919|FG000|Stage II|Protocol Violation|3|||
170569328|NCT00339040|616431920|FG001|Stage II|Protocol Violation|0|||
170569329|NCT00339040|616431919|FG000|Stage II|Not able to attend clinic|1|||
170569330|NCT00339040|616431920|FG001|Stage II|Not able to attend clinic|0|||
170569331|NCT00339040|616431919|FG000|Stage II|Site closing|2|||
170569332|NCT00339040|616431920|FG001|Stage II|Site closing|0|||
170569333|NCT00682929|616431921|FG000|Overall Study|Adverse Event|4|||
170569334|NCT00682929|616431922|FG001|Overall Study|Adverse Event|1|||
170569335|NCT00682929|616431923|FG002|Overall Study|Adverse Event|1|||
170569336|NCT00682929|616431921|FG000|Overall Study|Withdrawal by Subject|1|||
170569337|NCT00682929|616431922|FG001|Overall Study|Withdrawal by Subject|2|||
170647646|NCT01350544|616723391|FG000|Overall Study|Lost to Follow-up|18|||
170647647|NCT01350544|616723392|FG001|Overall Study|Lost to Follow-up|15|||
170647648|NCT01430754|616723393|FG000|Run-In Phase|Circadian Period Ineligible|24|||
170647649|NCT01430754|616723394|FG001|Run-In Phase|Circadian Period Ineligible|0|||
170569338|NCT00682929|616431923|FG002|Overall Study|Withdrawal by Subject|1|||
170569339|NCT00682929|616431921|FG000|Overall Study|dosing compliance < 80%|0|||
170569340|NCT00682929|616431922|FG001|Overall Study|dosing compliance < 80%|2|||
170569341|NCT00682929|616431923|FG002|Overall Study|dosing compliance < 80%|0|||
170569342|NCT00682929|616431921|FG000|Overall Study|lag in DEA renewal|1|||
170569343|NCT00682929|616431922|FG001|Overall Study|lag in DEA renewal|0|||
170569344|NCT00682929|616431923|FG002|Overall Study|lag in DEA renewal|0|||
170569345|NCT01747915|616431924|FG000|Overall Study|Other|1|||
170569346|NCT01747915|616431925|FG001|Overall Study|Other|1|||
170647650|NCT01430754|616723393|FG000|Run-In Phase|Protocol Violation|6|||
170647651|NCT01430754|616723394|FG001|Run-In Phase|Protocol Violation|0|||
170647652|NCT01430754|616723393|FG000|Run-In Phase|Adverse Event|2|||
170647653|NCT01430754|616723394|FG001|Run-In Phase|Adverse Event|0|||
170647654|NCT01430754|616723393|FG000|Run-In Phase|Other|2|||
170647655|NCT01430754|616723394|FG001|Run-In Phase|Other|0|||
170647656|NCT01430754|616723393|FG000|Run-In Phase|Withdrawal by Subject|2|||
170647657|NCT01430754|616723394|FG001|Run-In Phase|Withdrawal by Subject|0|||
170647658|NCT01430754|616723393|FG000|Run-In Phase|Lost to Follow-up|1|||
170647659|NCT01430754|616723394|FG001|Run-In Phase|Lost to Follow-up|0|||
170647660|NCT01437995|616723395|FG000|Overall Study|Lost to Follow-up|11|||
170647661|NCT01437995|616723396|FG001|Overall Study|Lost to Follow-up|18|||
170647662|NCT01437995|616723397|FG002|Overall Study|Lost to Follow-up|20|||
170647663|NCT04618770|616723398|FG000|Overall Study|Censored from Analysis|12|||
170647664|NCT04618770|616723398|FG000|Overall Study|Early Termination|25|||
170647665|NCT05338671|616723399|FG000|Overall Study|Lost to Follow-up|2|||
170647666|NCT05338671|616723400|FG001|Overall Study|Lost to Follow-up|2|||
170647667|NCT05338671|616723399|FG000|Overall Study|Root canal completed in a single visit|1|||
170647668|NCT05338671|616723400|FG001|Overall Study|Root canal completed in a single visit|0|||
170647669|NCT03859973|616723401|FG000|Overall Study|Other reason than listed|3|||
170647670|NCT03859973|616723402|FG001|Overall Study|Other reason than listed|2|||
170647671|NCT03859973|616723401|FG000|Overall Study|COVID-19 related, not due to AE|3|||
170647672|NCT03859973|616723402|FG001|Overall Study|COVID-19 related, not due to AE|4|||
170647673|NCT03859973|616723401|FG000|Overall Study|Withdrawal by Subject|8|||
170647674|NCT03859973|616723402|FG001|Overall Study|Withdrawal by Subject|9|||
170647675|NCT03859973|616723401|FG000|Overall Study|Lost to Follow-up|2|||
170647676|NCT03859973|616723402|FG001|Overall Study|Lost to Follow-up|3|||
170647677|NCT03859973|616723401|FG000|Overall Study|Protocol Violation|1|||
170647678|NCT03859973|616723402|FG001|Overall Study|Protocol Violation|3|||
170647679|NCT03859973|616723401|FG000|Overall Study|Adverse Event|3|||
170647680|NCT03859973|616723402|FG001|Overall Study|Adverse Event|5|||
170647681|NCT03085914|616723403|FG000|Overall Study|Death|6|||
170647682|NCT03085914|616723404|FG001|Overall Study|Death|6|||
170647683|NCT03085914|616723405|FG002|Overall Study|Death|4|||
170647684|NCT03085914|616723406|FG003|Overall Study|Death|1|||
170647685|NCT03085914|616723407|FG004|Overall Study|Death|5|||
170647686|NCT03085914|616723408|FG005|Overall Study|Death|2|||
170647687|NCT03085914|616723409|FG006|Overall Study|Death|2|||
170647688|NCT03085914|616723403|FG000|Overall Study|Withdrawal by Subject|1|||
170647689|NCT03085914|616723404|FG001|Overall Study|Withdrawal by Subject|1|||
170647690|NCT03085914|616723405|FG002|Overall Study|Withdrawal by Subject|2|||
170647691|NCT03085914|616723406|FG003|Overall Study|Withdrawal by Subject|2|||
170647692|NCT03085914|616723407|FG004|Overall Study|Withdrawal by Subject|2|||
170647693|NCT03085914|616723408|FG005|Overall Study|Withdrawal by Subject|0|||
170647694|NCT03085914|616723409|FG006|Overall Study|Withdrawal by Subject|1|||
170647695|NCT03085914|616723403|FG000|Overall Study|Lost to Follow-up|0|||
170647696|NCT03085914|616723404|FG001|Overall Study|Lost to Follow-up|0|||
170647697|NCT03085914|616723405|FG002|Overall Study|Lost to Follow-up|1|||
170647698|NCT03085914|616723406|FG003|Overall Study|Lost to Follow-up|0|||
170647699|NCT03085914|616723407|FG004|Overall Study|Lost to Follow-up|0|||
170647700|NCT03085914|616723408|FG005|Overall Study|Lost to Follow-up|1|||
170647701|NCT03085914|616723409|FG006|Overall Study|Lost to Follow-up|1|||
170647702|NCT03085914|616723403|FG000|Overall Study|Reason was not specified,|2|||
170647703|NCT03085914|616723404|FG001|Overall Study|Reason was not specified,|2|||
170647704|NCT03085914|616723405|FG002|Overall Study|Reason was not specified,|2|||
170647705|NCT03085914|616723406|FG003|Overall Study|Reason was not specified,|3|||
170647706|NCT03085914|616723407|FG004|Overall Study|Reason was not specified,|3|||
170647707|NCT03085914|616723408|FG005|Overall Study|Reason was not specified,|3|||
170647708|NCT03085914|616723409|FG006|Overall Study|Reason was not specified,|6|||
170647709|NCT03085914|616723403|FG000|Overall Study|Progressive Disease|0|||
170808056|NCT01968967|617307237|FG002|Treatment Period|Other|0|||
170808057|NCT01968967|617307238|FG003|Treatment Period|Other|0|||
170647710|NCT03085914|616723404|FG001|Overall Study|Progressive Disease|0|||
170647711|NCT03085914|616723405|FG002|Overall Study|Progressive Disease|2|||
170647712|NCT03085914|616723406|FG003|Overall Study|Progressive Disease|2|||
170647713|NCT03085914|616723407|FG004|Overall Study|Progressive Disease|1|||
170647714|NCT03085914|616723408|FG005|Overall Study|Progressive Disease|1|||
170647715|NCT03085914|616723409|FG006|Overall Study|Progressive Disease|1|||
170808058|NCT01968967|617307239|FG004|Treatment Period|Other|0|||
170569347|NCT01747915|616431926|FG002|Overall Study|Other|1|||
170569348|NCT01747915|616431924|FG000|Overall Study|Adverse Event|8|||
170569349|NCT01747915|616431925|FG001|Overall Study|Adverse Event|5|||
170569350|NCT01747915|616431926|FG002|Overall Study|Adverse Event|2|||
170569351|NCT01747915|616431924|FG000|Overall Study|Death|0|||
170569352|NCT01747915|616431925|FG001|Overall Study|Death|0|||
170569353|NCT01747915|616431926|FG002|Overall Study|Death|1|||
170569354|NCT01747915|616431924|FG000|Overall Study|Lack of Efficacy|0|||
170569355|NCT01747915|616431925|FG001|Overall Study|Lack of Efficacy|1|||
170569356|NCT01747915|616431926|FG002|Overall Study|Lack of Efficacy|0|||
170569357|NCT01747915|616431924|FG000|Overall Study|Lost to Follow-up|1|||
170569358|NCT01747915|616431925|FG001|Overall Study|Lost to Follow-up|0|||
170569359|NCT01747915|616431926|FG002|Overall Study|Lost to Follow-up|0|||
170569360|NCT01747915|616431924|FG000|Overall Study|Withdrawal by Subject|4|||
170569361|NCT01747915|616431925|FG001|Overall Study|Withdrawal by Subject|4|||
170569362|NCT01747915|616431926|FG002|Overall Study|Withdrawal by Subject|1|||
170569363|NCT01747915|616431924|FG000|Overall Study|Protocol Violation|1|||
170569364|NCT01747915|616431925|FG001|Overall Study|Protocol Violation|0|||
170569365|NCT01747915|616431926|FG002|Overall Study|Protocol Violation|0|||
170569366|NCT01747915|616431924|FG000|Overall Study|Pregnancy|0|||
170569367|NCT01747915|616431925|FG001|Overall Study|Pregnancy|0|||
170569368|NCT01747915|616431926|FG002|Overall Study|Pregnancy|1|||
170569369|NCT00938912|616431927|FG000|Overall Study|Withdrawal by Subject|28|||
170569370|NCT00938912|616431927|FG000|Overall Study|Lost to Follow-up|4|||
170569371|NCT00938912|616431927|FG000|Overall Study|Lack of Efficacy|43|||
170569372|NCT00938912|616431927|FG000|Overall Study|Adverse event, non-fatal|24|||
170569373|NCT00938912|616431927|FG000|Overall Study|Adverse event, fatal|1|||
170569374|NCT00938912|616431927|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
170569375|NCT00938912|616431927|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
170569376|NCT00938912|616431927|FG000|Overall Study|Participant needed prohibit medication|1|||
170569377|NCT00938912|616431927|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
170569378|NCT00938912|616431927|FG000|Overall Study|Did not meet Eligibility criteria|1|||
170569379|NCT00938912|616431927|FG000|Overall Study|Participant relocated not related to AE|1|||
170569380|NCT00938912|616431927|FG000|Overall Study|Participant moved to another city|1|||
170569381|NCT00938912|616431927|FG000|Overall Study|Participant experienced break through seizures|1|||
170569382|NCT00938912|616431927|FG000|Overall Study|No longer wished to participate in the study|1|||
170569383|NCT00938912|616431927|FG000|Overall Study|Protocol Deviation|2|||
170569384|NCT03341637|616431928|FG000|Overall Study|Lost to Follow-up|1|||
170569385|NCT03341637|616431929|FG001|Overall Study|Lost to Follow-up|0|||
170569386|NCT03341637|616431928|FG000|Overall Study|Withdrawal by Subject|3|||
170569387|NCT03341637|616431929|FG001|Overall Study|Withdrawal by Subject|3|||
170569388|NCT03341637|616431928|FG000|Overall Study|Reason not Specified|1|||
170569389|NCT03341637|616431929|FG001|Overall Study|Reason not Specified|1|||
170569390|NCT00803738|616431943|FG000|Overall Study|Adverse Event|3|||
170569391|NCT00803738|616431944|FG001|Overall Study|Adverse Event|5|||
170569392|NCT00803738|616431943|FG000|Overall Study|Lost to Follow-up|4|||
170569393|NCT00803738|616431944|FG001|Overall Study|Lost to Follow-up|4|||
170569394|NCT00803738|616431943|FG000|Overall Study|Protocol Violation|18|||
170569395|NCT00803738|616431944|FG001|Overall Study|Protocol Violation|10|||
170569396|NCT00803738|616431943|FG000|Overall Study|Withdrawal by Subject|1|||
170569397|NCT00803738|616431944|FG001|Overall Study|Withdrawal by Subject|4|||
170569398|NCT00803738|616431943|FG000|Overall Study|Lack of Efficacy|10|||
170569399|NCT00803738|616431944|FG001|Overall Study|Lack of Efficacy|16|||
170569400|NCT00803738|616431943|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
170569401|NCT00803738|616431944|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
170569402|NCT00803738|616431943|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
170569403|NCT00803738|616431944|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
170569404|NCT02964273|616431945|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
170569405|NCT02964273|616431946|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
170569406|NCT02964273|616431947|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
170569407|NCT02964273|616431948|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
170569408|NCT02964273|616431945|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
170569409|NCT02964273|616431946|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
170569410|NCT02964273|616431947|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
170569411|NCT02964273|616431948|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
170569412|NCT02964273|616431945|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
170569413|NCT02964273|616431946|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
170569414|NCT02964273|616431947|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
170569415|NCT02964273|616431948|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
170569416|NCT02964273|616431945|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
170569417|NCT02964273|616431946|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
170569418|NCT02964273|616431947|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
170569419|NCT02964273|616431948|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
170569420|NCT02964273|616431945|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
170569421|NCT02964273|616431946|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
170569422|NCT02964273|616431947|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
170569423|NCT02964273|616431948|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
170569424|NCT02964273|616431945|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
170569425|NCT02964273|616431946|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
170569426|NCT02964273|616431947|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
170569427|NCT02964273|616431948|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
170569428|NCT03046446|616431949|FG000|Overall Study|Lack of Efficacy|7|||
170569429|NCT03046446|616431949|FG000|Overall Study|Adverse Event|6|||
170569430|NCT03046446|616431949|FG000|Overall Study|Lost to Follow-up|3|||
170569431|NCT03046446|616431949|FG000|Overall Study|Withdrawal by Subject|14|||
170569432|NCT03046446|616431949|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
170569433|NCT03046446|616431949|FG000|Overall Study|Disease Progression (see caveats)|25|||
170569434|NCT03046446|616431949|FG000|Overall Study|Non OA related knee surgery|1|||
170569435|NCT03183063|616431950|FG000|Overall Study|Withdrawal by Subject|2|||
170569436|NCT03183063|616431951|FG001|Overall Study|Withdrawal by Subject|0|||
170569437|NCT03183063|616431952|FG002|Overall Study|Withdrawal by Subject|0|||
170569438|NCT03183063|616431950|FG000|Overall Study|Physician Decision|3|||
170569439|NCT03183063|616431951|FG001|Overall Study|Physician Decision|4|||
170569440|NCT03183063|616431952|FG002|Overall Study|Physician Decision|4|||
170569441|NCT00558636|616431957|FG000|Treatment|Adverse Event|9|||
170569442|NCT00558636|616431958|FG001|Treatment|Adverse Event|2|||
170569443|NCT00558636|616431957|FG000|Treatment|Withdrawal by Subject|2|||
170569444|NCT00558636|616431958|FG001|Treatment|Withdrawal by Subject|0|||
170569445|NCT00558636|616431957|FG000|Treatment|Premature termination of the study|35|||
170569446|NCT00558636|616431958|FG001|Treatment|Premature termination of the study|37|||
170569447|NCT00558636|616431957|FG000|Treatment|Disease progression|1|||
170569448|NCT00558636|616431958|FG001|Treatment|Disease progression|5|||
170569449|NCT00558636|616431957|FG000|Follow-up|Premature termination of the study|12|||
170569450|NCT00558636|616431958|FG001|Follow-up|Premature termination of the study|7|||
170569451|NCT03443687|616431959|FG000|Overall Study|Lost to Follow-up|3|||
170569452|NCT03443687|616431960|FG001|Overall Study|Lost to Follow-up|5|||
170569453|NCT03443687|616431959|FG000|Overall Study|Withdrawal by Subject|1|||
170569454|NCT03443687|616431960|FG001|Overall Study|Withdrawal by Subject|0|||
170569455|NCT03443687|616431959|FG000|Overall Study|Discontinued intervention|1|||
170569456|NCT03443687|616431960|FG001|Overall Study|Discontinued intervention|1|||
170569457|NCT02805790|616431961|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
170569458|NCT02805790|616431962|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
170569459|NCT02897115|616431966|FG000|Overall Study|Early termination of study by sponsor|11|||
170569460|NCT02897115|616431967|FG001|Overall Study|Early termination of study by sponsor|8|||
170569461|NCT03848416|616431969|FG000|Overall Study|Withdrawal by Subject|1|||
170569462|NCT03848416|616431970|FG001|Overall Study|Withdrawal by Subject|0|||
170569463|NCT03848416|616431971|FG002|Overall Study|Withdrawal by Subject|0|||
170569464|NCT03848416|616431969|FG000|Overall Study|Death|0|||
170569465|NCT03848416|616431970|FG001|Overall Study|Death|0|||
170569466|NCT03848416|616431971|FG002|Overall Study|Death|1|||
170569467|NCT03273907|616431973|FG000|Overall Study|Death|1|||
170569468|NCT03273907|616431973|FG000|Overall Study|Lost to Follow-up|4|||
170569469|NCT03273907|616431973|FG000|Overall Study|Withdrawal by Subject|2|||
170569470|NCT03273907|616431973|FG000|Overall Study|COVID 19|2|||
170569471|NCT01244035|616431975|FG000|Part 1: Period 1|Adverse Event|0|||
170569472|NCT01244035|616431976|FG001|Part 1: Period 1|Adverse Event|0|||
170569473|NCT01244035|616431977|FG002|Part 1: Period 1|Adverse Event|0|||
170569474|NCT01244035|616431978|FG003|Part 1: Period 1|Adverse Event|0|||
170569475|NCT01244035|616431979|FG004|Part 1: Period 1|Adverse Event|0|||
170569476|NCT01244035|616431980|FG005|Part 1: Period 1|Adverse Event|1|||
170569477|NCT01244035|616431975|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
170569478|NCT01244035|616431976|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
170569479|NCT01244035|616431977|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
170569480|NCT01244035|616431978|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
170569481|NCT01244035|616431979|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
170569482|NCT01244035|616431980|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
170569483|NCT01244035|616431975|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
170569484|NCT01244035|616431976|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
170569485|NCT01244035|616431977|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
170569486|NCT01244035|616431978|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
170569487|NCT01244035|616431979|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
170569488|NCT01244035|616431980|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
170569489|NCT01244035|616431975|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
170569490|NCT01244035|616431976|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
170569491|NCT01244035|616431977|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
170569492|NCT01244035|616431978|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
170569493|NCT01244035|616431979|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
170569494|NCT01244035|616431980|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
170569495|NCT01244035|616431975|FG000|Part 1: Period 3|Adverse Event|0|||
170569496|NCT01244035|616431976|FG001|Part 1: Period 3|Adverse Event|0|||
170569497|NCT01244035|616431977|FG002|Part 1: Period 3|Adverse Event|0|||
170569498|NCT01244035|616431978|FG003|Part 1: Period 3|Adverse Event|0|||
170569499|NCT01244035|616431979|FG004|Part 1: Period 3|Adverse Event|0|||
170569500|NCT01244035|616431980|FG005|Part 1: Period 3|Adverse Event|1|||
170569501|NCT01244035|616431975|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
170569502|NCT01244035|616431976|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
170569503|NCT01244035|616431977|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
170569504|NCT01244035|616431978|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
170569505|NCT01244035|616431979|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
170569506|NCT01244035|616431980|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
170569507|NCT01244035|616431975|FG000|Part 1: Period 3|Protocol Deviation|0|||
170569508|NCT01244035|616431976|FG001|Part 1: Period 3|Protocol Deviation|1|||
170569509|NCT01244035|616431977|FG002|Part 1: Period 3|Protocol Deviation|0|||
170569510|NCT01244035|616431978|FG003|Part 1: Period 3|Protocol Deviation|0|||
170569511|NCT01244035|616431979|FG004|Part 1: Period 3|Protocol Deviation|0|||
170569512|NCT01244035|616431980|FG005|Part 1: Period 3|Protocol Deviation|0|||
170569513|NCT02776683|616431982|FG000|Pre-switch Period|Protocol Violation|1|||
170569514|NCT02776683|616431983|FG001|Pre-switch Period|Protocol Violation|0|||
170569515|NCT02776683|616431982|FG000|Pre-switch Period|Adverse Event|21|||
170569516|NCT02776683|616431983|FG001|Pre-switch Period|Adverse Event|0|||
170569517|NCT02776683|616431982|FG000|Pre-switch Period|Withdrawal by Subject|9|||
170569518|NCT02776683|616431983|FG001|Pre-switch Period|Withdrawal by Subject|0|||
170569519|NCT02776683|616431982|FG000|Pre-switch Period|Physician Decision|7|||
170569520|NCT02776683|616431983|FG001|Pre-switch Period|Physician Decision|0|||
170569521|NCT02776683|616431982|FG000|Pre-switch Period|Progressive disease|39|||
170569522|NCT02776683|616431983|FG001|Pre-switch Period|Progressive disease|0|||
170569523|NCT02776683|616431982|FG000|Pre-switch Period|Other than listed|3|||
170569524|NCT02776683|616431983|FG001|Pre-switch Period|Other than listed|0|||
170569525|NCT02776683|616431982|FG000|Post-switch Period|Adverse Event|0|||
170569526|NCT02776683|616431983|FG001|Post-switch Period|Adverse Event|3|||
170569527|NCT02776683|616431982|FG000|Post-switch Period|Withdrawal by Subject|0|||
170569528|NCT02776683|616431983|FG001|Post-switch Period|Withdrawal by Subject|2|||
170569529|NCT02776683|616431982|FG000|Post-switch Period|Physician Decision|0|||
170569530|NCT02776683|616431983|FG001|Post-switch Period|Physician Decision|3|||
170569531|NCT02776683|616431982|FG000|Post-switch Period|Progressive disease|0|||
170569532|NCT02776683|616431983|FG001|Post-switch Period|Progressive disease|20|||
170569533|NCT02776683|616431982|FG000|Post-switch Period|Other than listed|0|||
170569534|NCT02776683|616431983|FG001|Post-switch Period|Other than listed|15|||
170569535|NCT00616642|616431985|FG000|Overall Study|Withdrawal by Subject|0|||
170569536|NCT00616642|616431986|FG001|Overall Study|Withdrawal by Subject|1|||
170569537|NCT00570323|616431987|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
170569538|NCT00570323|616431988|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
170569539|NCT00570323|616431987|FG000|Started Treatment After Randomization|Protocol Violation|1|||
170569540|NCT00570323|616431988|FG001|Started Treatment After Randomization|Protocol Violation|0|||
170569541|NCT00570323|616431987|FG000|Started Treatment After Randomization|Physician Decision|1|||
170569542|NCT00570323|616431988|FG001|Started Treatment After Randomization|Physician Decision|0|||
170569543|NCT00570323|616431987|FG000|Complete Study After Start|Lost to Follow-up|0|||
170569544|NCT00570323|616431988|FG001|Complete Study After Start|Lost to Follow-up|1|||
170569545|NCT00570323|616431987|FG000|Complete Study After Start|Withdrawal by Subject|2|||
170569546|NCT00570323|616431988|FG001|Complete Study After Start|Withdrawal by Subject|0|||
170569547|NCT00570323|616431987|FG000|Complete Study After Start|Physician Decision|1|||
170569548|NCT00570323|616431988|FG001|Complete Study After Start|Physician Decision|0|||
170569549|NCT02266147|616431991|FG000|PART 1: Dose Escalation|Physician Decision|0|||
170569550|NCT02266147|616431992|FG001|PART 1: Dose Escalation|Physician Decision|0|||
170569551|NCT02266147|616431993|FG002|PART 1: Dose Escalation|Physician Decision|1|||
170569552|NCT02266147|616431994|FG003|PART 1: Dose Escalation|Physician Decision|0|||
170569553|NCT02266147|616431991|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
170569554|NCT02266147|616431992|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
170569555|NCT02266147|616431993|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
170569556|NCT02266147|616431994|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
170569557|NCT02266147|616431991|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
170569558|NCT02266147|616431992|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
170569559|NCT02266147|616431993|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
170569560|NCT02266147|616431994|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
170569561|NCT02266147|616431991|FG000|PART 1: Dose Escalation|Other|1|||
170569562|NCT02266147|616431992|FG001|PART 1: Dose Escalation|Other|1|||
170569563|NCT02266147|616431993|FG002|PART 1: Dose Escalation|Other|0|||
170569564|NCT02266147|616431994|FG003|PART 1: Dose Escalation|Other|0|||
170569565|NCT02266147|616431991|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
170569566|NCT02266147|616431992|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
170647716|NCT03085914|616723403|FG000|Overall Study|Study Terminated by the Sponsor|0|||
170647717|NCT03085914|616723404|FG001|Overall Study|Study Terminated by the Sponsor|0|||
170647718|NCT03085914|616723405|FG002|Overall Study|Study Terminated by the Sponsor|0|||
170647719|NCT03085914|616723406|FG003|Overall Study|Study Terminated by the Sponsor|1|||
170647720|NCT03085914|616723407|FG004|Overall Study|Study Terminated by the Sponsor|2|||
170647721|NCT03085914|616723408|FG005|Overall Study|Study Terminated by the Sponsor|1|||
170647722|NCT03085914|616723409|FG006|Overall Study|Study Terminated by the Sponsor|0|||
170647723|NCT00294762|616723411|FG000|Overall Study|Did not receive study treatment|3|||
170647724|NCT00294762|616723412|FG001|Overall Study|Did not receive study treatment|3|||
170647725|NCT03560518|616723413|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
170647726|NCT03560518|616723414|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
170647727|NCT03560518|616723415|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
170647728|NCT03560518|616723413|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
170647729|NCT03560518|616723414|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
170647730|NCT03560518|616723415|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
170647731|NCT03560518|616723413|FG000|Double Blind Treatment Period|Protocol Violation|1|||
170647732|NCT03560518|616723414|FG001|Double Blind Treatment Period|Protocol Violation|2|||
170647733|NCT03560518|616723415|FG002|Double Blind Treatment Period|Protocol Violation|0|||
170647734|NCT03560518|616723413|FG000|Double Blind Treatment Period|Pregnancy|0|||
170647735|NCT03560518|616723414|FG001|Double Blind Treatment Period|Pregnancy|2|||
170569567|NCT02266147|616431993|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
170569568|NCT02266147|616431994|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
170647736|NCT03560518|616723415|FG002|Double Blind Treatment Period|Pregnancy|0|||
170569569|NCT02266147|616431991|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
170569570|NCT02266147|616431992|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
170569571|NCT02266147|616431993|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
170569572|NCT02266147|616431994|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
170569573|NCT01063348|616431999|FG000|Overall Study|Lost to Follow-up|3|||
170569574|NCT01063348|616432000|FG001|Overall Study|Lost to Follow-up|10|||
170569575|NCT01882465|616432004|FG000|Period 1|Lens Discomfort|0|||
170569576|NCT01882465|616432005|FG001|Period 1|Lens Discomfort|0|||
170569577|NCT01882465|616432006|FG002|Period 1|Lens Discomfort|0|||
170569578|NCT01882465|616432007|FG003|Period 1|Lens Discomfort|1|||
170569579|NCT01882465|616432008|FG004|Period 1|Lens Discomfort|0|||
170569580|NCT01882465|616432009|FG005|Period 1|Lens Discomfort|0|||
170569581|NCT01882465|616432010|FG006|Period 1|Lens Discomfort|0|||
170569582|NCT01882465|616432004|FG000|Period 1|Withdrawal by Subject|0|||
170569583|NCT01882465|616432005|FG001|Period 1|Withdrawal by Subject|0|||
170569584|NCT01882465|616432006|FG002|Period 1|Withdrawal by Subject|0|||
170569585|NCT01882465|616432007|FG003|Period 1|Withdrawal by Subject|0|||
170569586|NCT01882465|616432008|FG004|Period 1|Withdrawal by Subject|0|||
170569587|NCT01882465|616432009|FG005|Period 1|Withdrawal by Subject|0|||
170569588|NCT01882465|616432010|FG006|Period 1|Withdrawal by Subject|1|||
170569589|NCT01882465|616432004|FG000|Period 2|Protocol Violation|0|||
170569590|NCT01882465|616432005|FG001|Period 2|Protocol Violation|0|||
170569591|NCT01882465|616432006|FG002|Period 2|Protocol Violation|0|||
170569592|NCT01882465|616432007|FG003|Period 2|Protocol Violation|0|||
170569593|NCT01882465|616432008|FG004|Period 2|Protocol Violation|1|||
170569594|NCT01882465|616432009|FG005|Period 2|Protocol Violation|0|||
170569595|NCT01882465|616432010|FG006|Period 2|Protocol Violation|0|||
170569596|NCT00696878|616432011|FG000|Overall Study|Adverse Event|8|||
170569597|NCT00696878|616432011|FG000|Overall Study|Withdrawal by Subject|87|||
170647737|NCT03560518|616723413|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
170647738|NCT03560518|616723414|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
170647739|NCT03560518|616723415|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
170647740|NCT03560518|616723413|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
170647741|NCT03560518|616723414|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
170569598|NCT00696878|616432011|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
170569599|NCT00696878|616432011|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
170647742|NCT03560518|616723415|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
170647743|NCT03560518|616723413|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
170647744|NCT03560518|616723414|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
170647745|NCT03560518|616723415|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
170647746|NCT03560518|616723413|FG000|Double Blind Treatment Period|Adverse Event|0|||
170647747|NCT03560518|616723414|FG001|Double Blind Treatment Period|Adverse Event|3|||
170647748|NCT03560518|616723415|FG002|Double Blind Treatment Period|Adverse Event|1|||
170647749|NCT00917644|616723416|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
170569600|NCT00696878|616432011|FG000|Overall Study|Trial stopped|32|||
170569601|NCT00696878|616432011|FG000|Overall Study|Other reason (not specified)|55|||
170569602|NCT03789292|616432015|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
170569603|NCT03789292|616432016|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
170569604|NCT03789292|616432017|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
170569605|NCT03789292|616432015|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
170569606|NCT03789292|616432016|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
170569607|NCT03789292|616432017|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
170569608|NCT03789292|616432015|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
170569609|NCT03789292|616432016|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
170569610|NCT03789292|616432017|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
170569611|NCT03789292|616432015|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
170569612|NCT03789292|616432016|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
170569613|NCT03789292|616432017|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
170569614|NCT03789292|616432015|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
170569615|NCT03789292|616432016|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
170569616|NCT03789292|616432017|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
170569617|NCT03789292|616432015|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
170569618|NCT03789292|616432016|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
170569619|NCT03789292|616432017|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
170569620|NCT03789292|616432015|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
170569621|NCT03789292|616432016|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
170569622|NCT03789292|616432017|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
170569623|NCT03789292|616432015|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
170569624|NCT03789292|616432016|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
170569625|NCT03789292|616432017|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
170569626|NCT03789292|616432015|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
170569627|NCT03789292|616432016|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
170569628|NCT03789292|616432017|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
170569629|NCT03789292|616432015|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
170569630|NCT03789292|616432016|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
170569631|NCT03789292|616432017|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
170569632|NCT03789292|616432015|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
170569633|NCT03789292|616432016|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
170569634|NCT03789292|616432017|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
170569635|NCT03789292|616432015|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
170569636|NCT03789292|616432016|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
170569637|NCT03789292|616432017|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
170569638|NCT03789292|616432015|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
170569639|NCT03789292|616432016|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
170569640|NCT03789292|616432017|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
170569641|NCT01904721|616432021|FG000|Overall Study|Other Reasons|0|||
170569642|NCT01904721|616432022|FG001|Overall Study|Other Reasons|0|||
170569643|NCT01904721|616432023|FG002|Overall Study|Other Reasons|1|||
170569644|NCT01904721|616432024|FG003|Overall Study|Other Reasons|1|||
170569645|NCT01904721|616432025|FG004|Overall Study|Other Reasons|2|||
170569646|NCT01904721|616432026|FG005|Overall Study|Other Reasons|2|||
170569647|NCT01904721|616432027|FG006|Overall Study|Other Reasons|2|||
170569648|NCT01904721|616432021|FG000|Overall Study|Personal Reasons|0|||
170569649|NCT01904721|616432022|FG001|Overall Study|Personal Reasons|0|||
170569650|NCT01904721|616432023|FG002|Overall Study|Personal Reasons|0|||
170569651|NCT01904721|616432024|FG003|Overall Study|Personal Reasons|0|||
170569652|NCT01904721|616432025|FG004|Overall Study|Personal Reasons|2|||
170569653|NCT01904721|616432026|FG005|Overall Study|Personal Reasons|3|||
170569654|NCT01904721|616432027|FG006|Overall Study|Personal Reasons|3|||
170569655|NCT01904721|616432021|FG000|Overall Study|Lost to Follow-up|0|||
170569656|NCT01904721|616432022|FG001|Overall Study|Lost to Follow-up|0|||
170569657|NCT01904721|616432023|FG002|Overall Study|Lost to Follow-up|0|||
170569658|NCT01904721|616432024|FG003|Overall Study|Lost to Follow-up|0|||
170569659|NCT01904721|616432025|FG004|Overall Study|Lost to Follow-up|1|||
170569660|NCT01904721|616432026|FG005|Overall Study|Lost to Follow-up|3|||
170569661|NCT01904721|616432027|FG006|Overall Study|Lost to Follow-up|1|||
170569662|NCT01904721|616432021|FG000|Overall Study|Lack of Efficacy|0|||
170569663|NCT01904721|616432022|FG001|Overall Study|Lack of Efficacy|0|||
170569664|NCT01904721|616432023|FG002|Overall Study|Lack of Efficacy|0|||
170569665|NCT01904721|616432024|FG003|Overall Study|Lack of Efficacy|0|||
170569666|NCT01904721|616432025|FG004|Overall Study|Lack of Efficacy|0|||
170808059|NCT01968967|617307235|FG000|Treatment Period|Withdrawal by Subject|71|||
170808060|NCT01968967|617307236|FG001|Treatment Period|Withdrawal by Subject|61|||
170808061|NCT01968967|617307237|FG002|Treatment Period|Withdrawal by Subject|0|||
170808062|NCT01968967|617307238|FG003|Treatment Period|Withdrawal by Subject|0|||
170808063|NCT01968967|617307239|FG004|Treatment Period|Withdrawal by Subject|0|||
170808064|NCT01968967|617307235|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
170808065|NCT01968967|617307236|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
170808066|NCT01968967|617307237|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
170569667|NCT01904721|616432026|FG005|Overall Study|Lack of Efficacy|0|||
170569668|NCT01904721|616432027|FG006|Overall Study|Lack of Efficacy|1|||
170569669|NCT01904721|616432021|FG000|Overall Study|Adverse Event|0|||
170569670|NCT01904721|616432022|FG001|Overall Study|Adverse Event|0|||
170569671|NCT01904721|616432023|FG002|Overall Study|Adverse Event|0|||
170569672|NCT01904721|616432024|FG003|Overall Study|Adverse Event|0|||
170569673|NCT01904721|616432025|FG004|Overall Study|Adverse Event|3|||
170569674|NCT01904721|616432026|FG005|Overall Study|Adverse Event|1|||
170569675|NCT01904721|616432027|FG006|Overall Study|Adverse Event|0|||
170569676|NCT00114127|616432038|FG000|Overall Study|Adverse Event|2|||
170569677|NCT00114127|616432039|FG001|Overall Study|Adverse Event|1|||
170569678|NCT00114127|616432038|FG000|Overall Study|Lost to Follow-up|1|||
170569679|NCT00114127|616432039|FG001|Overall Study|Lost to Follow-up|0|||
170569680|NCT00114127|616432038|FG000|Overall Study|Withdrawal by Subject|1|||
170569681|NCT00114127|616432039|FG001|Overall Study|Withdrawal by Subject|3|||
170569682|NCT03188263|616432040|FG000|Overall Study|Withdrawal by Subject|3|||
170569683|NCT03188263|616432041|FG001|Overall Study|Withdrawal by Subject|0|||
170569684|NCT03188263|616432040|FG000|Overall Study|Physician Decision|1|||
170569685|NCT03188263|616432041|FG001|Overall Study|Physician Decision|0|||
170569686|NCT02103062|616432046|FG000|Overall Study|Adverse Event|1|||
170569687|NCT02103062|616432047|FG001|Overall Study|Adverse Event|2|||
170569688|NCT02103062|616432046|FG000|Overall Study|Progressive Disease|17|||
170569689|NCT02103062|616432047|FG001|Overall Study|Progressive Disease|20|||
170569690|NCT02103062|616432046|FG000|Overall Study|Death|0|||
170569691|NCT02103062|616432047|FG001|Overall Study|Death|1|||
170569692|NCT04068922|616432048|FG000|Overall Study|Lost to Follow-up|5|||
170569693|NCT04068922|616432048|FG000|Overall Study|Withdrawal by Subject|7|||
170569694|NCT04068922|616432048|FG000|Overall Study|Adverse Event|1|||
170569695|NCT04551898|616433831|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
170569696|NCT04551898|616433832|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
170569697|NCT04551898|616433833|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
170569698|NCT04551898|616433834|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
170569699|NCT04551898|616433831|FG000|Overall Study|Withdrawal by Subject|5|||
170569700|NCT04551898|616433832|FG001|Overall Study|Withdrawal by Subject|1|||
170569701|NCT04551898|616433833|FG002|Overall Study|Withdrawal by Subject|2|||
170569702|NCT04551898|616433834|FG003|Overall Study|Withdrawal by Subject|2|||
170569703|NCT04551898|616433831|FG000|Overall Study|Lost to Follow-up|2|||
170569704|NCT04551898|616433832|FG001|Overall Study|Lost to Follow-up|1|||
170569705|NCT04551898|616433833|FG002|Overall Study|Lost to Follow-up|2|||
170569706|NCT04551898|616433834|FG003|Overall Study|Lost to Follow-up|2|||
170569707|NCT04551898|616433831|FG000|Overall Study|Death|1|||
170569708|NCT04551898|616433832|FG001|Overall Study|Death|0|||
170569709|NCT04551898|616433833|FG002|Overall Study|Death|0|||
170569710|NCT04551898|616433834|FG003|Overall Study|Death|0|||
170569711|NCT04551898|616433831|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
170569712|NCT04551898|616433832|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
170569713|NCT04551898|616433833|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
170569714|NCT04551898|616433834|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
170569715|NCT03427814|616433835|FG000|Overall Study|Withdrawal by Subject|4|||
170569716|NCT03427814|616433836|FG001|Overall Study|Withdrawal by Subject|4|||
170569717|NCT03427814|616433835|FG000|Overall Study|Lost to Follow-up|0|||
170569718|NCT03427814|616433836|FG001|Overall Study|Lost to Follow-up|2|||
170569719|NCT03427814|616433835|FG000|Overall Study|Death|42|||
170569720|NCT03427814|616433836|FG001|Overall Study|Death|31|||
170569721|NCT03427814|616433835|FG000|Overall Study|Sponsor's Decision|1|||
170569722|NCT03427814|616433836|FG001|Overall Study|Sponsor's Decision|0|||
170569723|NCT03427814|616433835|FG000|Overall Study|Investigator's Decision|1|||
170569724|NCT03427814|616433836|FG001|Overall Study|Investigator's Decision|2|||
170569725|NCT03427814|616433835|FG000|Overall Study|Disease progression|1|||
170647750|NCT00917644|616723417|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
170808067|NCT01968967|617307238|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
170808068|NCT01968967|617307239|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
170808069|NCT01968967|617307235|FG000|Treatment Period|Lost to Follow-up|26|||
170808070|NCT01968967|617307236|FG001|Treatment Period|Lost to Follow-up|31|||
170808071|NCT01968967|617307237|FG002|Treatment Period|Lost to Follow-up|0|||
170808072|NCT01968967|617307238|FG003|Treatment Period|Lost to Follow-up|0|||
170808073|NCT01968967|617307239|FG004|Treatment Period|Lost to Follow-up|0|||
170808074|NCT01968967|617307235|FG000|Treatment Period|Protocol Violation|1|||
170569726|NCT03427814|616433836|FG001|Overall Study|Disease progression|0|||
170569727|NCT03427814|616433835|FG000|Overall Study|Treatment Completed|0|||
170569728|NCT03427814|616433836|FG001|Overall Study|Treatment Completed|1|||
170569729|NCT03427814|616433835|FG000|Overall Study|Sponsor's Decision to End study|21|||
170569730|NCT03427814|616433836|FG001|Overall Study|Sponsor's Decision to End study|25|||
170569731|NCT03427814|616433835|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
170569732|NCT03427814|616433836|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
170647751|NCT00917644|616723416|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
170647752|NCT00917644|616723417|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
170647753|NCT00917644|616723416|FG000|Period 2: Second Intervention|family emergency|1|||
170647754|NCT00917644|616723417|FG001|Period 2: Second Intervention|family emergency|0|||
170647755|NCT01215916|616723420|FG000|Overall Study|Progressive Disease|0|||
170647756|NCT01215916|616723421|FG001|Overall Study|Progressive Disease|2|||
170647757|NCT01215916|616723422|FG002|Overall Study|Progressive Disease|1|||
170647758|NCT01215916|616723423|FG003|Overall Study|Progressive Disease|2|||
170647759|NCT01215916|616723424|FG004|Overall Study|Progressive Disease|5|||
170647760|NCT01215916|616723425|FG005|Overall Study|Progressive Disease|4|||
170647761|NCT01215916|616723426|FG006|Overall Study|Progressive Disease|5|||
170647762|NCT01215916|616723427|FG007|Overall Study|Progressive Disease|3|||
170647763|NCT01215916|616723428|FG008|Overall Study|Progressive Disease|1|||
170647764|NCT01215916|616723420|FG000|Overall Study|Adverse Event|1|||
170647765|NCT01215916|616723421|FG001|Overall Study|Adverse Event|1|||
170647766|NCT01215916|616723422|FG002|Overall Study|Adverse Event|0|||
170647767|NCT01215916|616723423|FG003|Overall Study|Adverse Event|1|||
170647768|NCT01215916|616723424|FG004|Overall Study|Adverse Event|0|||
170647769|NCT01215916|616723425|FG005|Overall Study|Adverse Event|0|||
170647770|NCT01215916|616723426|FG006|Overall Study|Adverse Event|3|||
170647771|NCT01215916|616723427|FG007|Overall Study|Adverse Event|0|||
170647772|NCT01215916|616723428|FG008|Overall Study|Adverse Event|0|||
170647773|NCT01215916|616723420|FG000|Overall Study|Withdrawal by Subject|0|||
170647774|NCT01215916|616723421|FG001|Overall Study|Withdrawal by Subject|1|||
170647775|NCT01215916|616723422|FG002|Overall Study|Withdrawal by Subject|1|||
170647776|NCT01215916|616723423|FG003|Overall Study|Withdrawal by Subject|2|||
170647777|NCT01215916|616723424|FG004|Overall Study|Withdrawal by Subject|0|||
170647778|NCT01215916|616723425|FG005|Overall Study|Withdrawal by Subject|0|||
170647779|NCT01215916|616723426|FG006|Overall Study|Withdrawal by Subject|1|||
170647780|NCT01215916|616723427|FG007|Overall Study|Withdrawal by Subject|0|||
170647781|NCT01215916|616723428|FG008|Overall Study|Withdrawal by Subject|0|||
170647782|NCT01215916|616723420|FG000|Overall Study|Death|0|||
170647783|NCT01215916|616723421|FG001|Overall Study|Death|1|||
170647784|NCT01215916|616723422|FG002|Overall Study|Death|0|||
170647785|NCT01215916|616723423|FG003|Overall Study|Death|0|||
170569733|NCT02393859|616433838|FG000|Overall Study|Decision by Sponsor|2|||
170569734|NCT02393859|616433839|FG001|Overall Study|Decision by Sponsor|4|||
170569735|NCT02393859|616433838|FG000|Overall Study|Withdrawal by Subject|11|||
170569736|NCT02393859|616433839|FG001|Overall Study|Withdrawal by Subject|6|||
170569737|NCT02393859|616433838|FG000|Overall Study|Death|27|||
170569738|NCT02393859|616433839|FG001|Overall Study|Death|10|||
170569739|NCT02393859|616433838|FG000|Overall Study|Lost to Follow-up|1|||
170569740|NCT02393859|616433839|FG001|Overall Study|Lost to Follow-up|1|||
170569741|NCT00954447|616433840|FG000|Overall Study|Adverse Event|33|||
170569742|NCT00954447|616433841|FG001|Overall Study|Adverse Event|25|||
170569743|NCT00954447|616433840|FG000|Overall Study|Lack of Efficacy|17|||
170569744|NCT00954447|616433841|FG001|Overall Study|Lack of Efficacy|3|||
170569745|NCT00954447|616433840|FG000|Overall Study|Protocol Violation|5|||
170569746|NCT00954447|616433841|FG001|Overall Study|Protocol Violation|7|||
170569747|NCT00954447|616433840|FG000|Overall Study|Lost to Follow-up|8|||
170569748|NCT00954447|616433841|FG001|Overall Study|Lost to Follow-up|14|||
170569749|NCT00954447|616433840|FG000|Overall Study|Withdrawal by Subject|26|||
170569750|NCT00954447|616433841|FG001|Overall Study|Withdrawal by Subject|21|||
170569751|NCT00954447|616433840|FG000|Overall Study|Other|21|||
170569752|NCT00954447|616433841|FG001|Overall Study|Other|18|||
170569753|NCT01979614|616433842|FG000|Overall Study|Adverse Event|1|||
170569754|NCT01979614|616433843|FG001|Overall Study|Adverse Event|1|||
170569755|NCT00305877|616433844|FG000|Overall Study|Lack of Efficacy|6|||
170569756|NCT00305877|616433845|FG001|Overall Study|Lack of Efficacy|9|||
170569757|NCT00305877|616433844|FG000|Overall Study|Adverse Event|9|||
170569758|NCT00305877|616433845|FG001|Overall Study|Adverse Event|14|||
170647786|NCT01215916|616723424|FG004|Overall Study|Death|1|||
170808075|NCT01968967|617307236|FG001|Treatment Period|Protocol Violation|2|||
170569759|NCT00305877|616433844|FG000|Overall Study|Death|0|||
170569760|NCT00305877|616433845|FG001|Overall Study|Death|1|||
170569761|NCT00305877|616433844|FG000|Overall Study|Withdrawal by Subject|4|||
170569762|NCT00305877|616433845|FG001|Overall Study|Withdrawal by Subject|2|||
170569763|NCT00305877|616433844|FG000|Overall Study|Physician Decision|1|||
170647787|NCT01215916|616723425|FG005|Overall Study|Death|0|||
170647788|NCT01215916|616723426|FG006|Overall Study|Death|0|||
170569764|NCT00305877|616433845|FG001|Overall Study|Physician Decision|1|||
170647789|NCT01215916|616723427|FG007|Overall Study|Death|0|||
170647790|NCT01215916|616723428|FG008|Overall Study|Death|1|||
170647791|NCT01215916|616723420|FG000|Overall Study|Physician Decision|0|||
170808076|NCT01968967|617307237|FG002|Treatment Period|Protocol Violation|0|||
170569765|NCT00305877|616433844|FG000|Overall Study|Never start treatment|2|||
170569766|NCT00305877|616433845|FG001|Overall Study|Never start treatment|5|||
170569767|NCT00305877|616433844|FG000|Overall Study|Ineligible|2|||
170647792|NCT01215916|616723421|FG001|Overall Study|Physician Decision|0|||
170647793|NCT01215916|616723422|FG002|Overall Study|Physician Decision|1|||
170647794|NCT01215916|616723423|FG003|Overall Study|Physician Decision|1|||
170647795|NCT01215916|616723424|FG004|Overall Study|Physician Decision|0|||
170647796|NCT01215916|616723425|FG005|Overall Study|Physician Decision|0|||
170647797|NCT01215916|616723426|FG006|Overall Study|Physician Decision|0|||
170647798|NCT01215916|616723427|FG007|Overall Study|Physician Decision|0|||
170647799|NCT01215916|616723428|FG008|Overall Study|Physician Decision|0|||
170647800|NCT00357760|616723432|FG000|Overall Study|Disease progression|44|||
170647801|NCT00357760|616723433|FG001|Overall Study|Disease progression|17|||
170647802|NCT00357760|616723432|FG000|Overall Study|Adverse Event|10|||
170647803|NCT00357760|616723433|FG001|Overall Study|Adverse Event|7|||
170647804|NCT00357760|616723432|FG000|Overall Study|Death|0|||
170647805|NCT00357760|616723433|FG001|Overall Study|Death|3|||
170647806|NCT00357760|616723432|FG000|Overall Study|Alternative therapy|1|||
170647807|NCT00357760|616723433|FG001|Overall Study|Alternative therapy|0|||
170647808|NCT00357760|616723432|FG000|Overall Study|Withdrawal by Subject|0|||
170647809|NCT00357760|616723433|FG001|Overall Study|Withdrawal by Subject|2|||
170647810|NCT00357760|616723432|FG000|Overall Study|Never started treatment|2|||
170647811|NCT00357760|616723433|FG001|Overall Study|Never started treatment|1|||
170647812|NCT00357760|616723432|FG000|Overall Study|Ineligible|0|||
170647813|NCT00357760|616723433|FG001|Overall Study|Ineligible|2|||
170647814|NCT00357760|616723432|FG000|Overall Study|Physician Decision|2|||
170647815|NCT00357760|616723433|FG001|Overall Study|Physician Decision|1|||
170647816|NCT00357760|616723432|FG000|Overall Study|Protocol Violation|0|||
170569768|NCT00305877|616433845|FG001|Overall Study|Ineligible|1|||
170647817|NCT00357760|616723433|FG001|Overall Study|Protocol Violation|1|||
170647818|NCT00357760|616723432|FG000|Overall Study|To receive hospice care|0|||
170647819|NCT00357760|616723433|FG001|Overall Study|To receive hospice care|1|||
170647820|NCT02946931|616723434|FG000|Overall Study|Did not require collection of CRFs|588|||
170647821|NCT02946931|616723434|FG000|Overall Study|Other than listed|37|||
170647822|NCT02946931|616723434|FG000|Overall Study|Discharge from hospital|118|||
170647823|NCT02946931|616723434|FG000|Overall Study|Adverse Event|81|||
170647824|NCT02946931|616723434|FG000|Overall Study|CRFs not valid|1|||
170647825|NCT02946931|616723434|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
170647826|NCT00869778|616723438|FG000|Overall Study|Adverse Event|2|||
170647827|NCT00869778|616723439|FG001|Overall Study|Adverse Event|0|||
170647828|NCT00869778|616723440|FG002|Overall Study|Adverse Event|0|||
170647829|NCT00869778|616723438|FG000|Overall Study|Withdrawal by Subject|3|||
170647830|NCT00869778|616723439|FG001|Overall Study|Withdrawal by Subject|4|||
170647831|NCT00869778|616723440|FG002|Overall Study|Withdrawal by Subject|5|||
170569769|NCT00305877|616433844|FG000|Overall Study|Transportation issue with daily RT|0|||
170569770|NCT00305877|616433845|FG001|Overall Study|Transportation issue with daily RT|1|||
170569771|NCT00457392|616433846|FG000|Overall Study|Objective Progression or Relapse|229|||
170569772|NCT00457392|616433847|FG001|Overall Study|Objective Progression or Relapse|296|||
170569773|NCT00457392|616433846|FG000|Overall Study|Death|106|||
170569774|NCT00457392|616433847|FG001|Overall Study|Death|106|||
170569775|NCT00457392|616433846|FG000|Overall Study|Adverse Event|84|||
170569776|NCT00457392|616433847|FG001|Overall Study|Adverse Event|41|||
170569777|NCT00457392|616433846|FG000|Overall Study|Global Deterioration of Health Status|22|||
170647832|NCT00869778|616723438|FG000|Overall Study|Pregnancy|1|||
170647833|NCT00869778|616723439|FG001|Overall Study|Pregnancy|0|||
170647834|NCT00869778|616723440|FG002|Overall Study|Pregnancy|0|||
170647835|NCT00869778|616723438|FG000|Overall Study|Protocol Violation|5|||
170647836|NCT00869778|616723439|FG001|Overall Study|Protocol Violation|3|||
170647837|NCT00869778|616723440|FG002|Overall Study|Protocol Violation|5|||
170647838|NCT00869778|616723438|FG000|Overall Study|Unblinding|1|||
170647839|NCT00869778|616723439|FG001|Overall Study|Unblinding|0|||
170647840|NCT00869778|616723440|FG002|Overall Study|Unblinding|0|||
170647841|NCT03531632|616723445|FG000|Overall Study|Adverse Event|0|||
170647842|NCT03531632|616723446|FG001|Overall Study|Adverse Event|0|||
170647843|NCT03531632|616723447|FG002|Overall Study|Adverse Event|1|||
170647844|NCT03531632|616723445|FG000|Overall Study|Death|4|||
170647845|NCT03531632|616723446|FG001|Overall Study|Death|0|||
170647846|NCT03531632|616723447|FG002|Overall Study|Death|14|||
170647847|NCT03531632|616723445|FG000|Overall Study|Study Terminated|1|||
170647848|NCT03531632|616723446|FG001|Overall Study|Study Terminated|3|||
170569778|NCT00457392|616433847|FG001|Overall Study|Global Deterioration of Health Status|8|||
170647849|NCT03531632|616723447|FG002|Overall Study|Study Terminated|11|||
170647850|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
170647851|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
170569779|NCT00457392|616433846|FG000|Overall Study|Withdrawal by Subject|14|||
170647852|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Adverse Event|7|||
170647853|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Adverse Event|6|||
170647854|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
170647855|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
170647856|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Physician Decision|4|||
170647857|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Physician Decision|4|||
170647858|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
170647859|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
170647860|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
170647861|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
170647862|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
170808077|NCT01968967|617307238|FG003|Treatment Period|Protocol Violation|0|||
170808078|NCT01968967|617307239|FG004|Treatment Period|Protocol Violation|0|||
170808079|NCT01968967|617307235|FG000|Treatment Period|Adverse Event|9|||
170808080|NCT01968967|617307236|FG001|Treatment Period|Adverse Event|8|||
170808081|NCT01968967|617307237|FG002|Treatment Period|Adverse Event|0|||
170808082|NCT01968967|617307238|FG003|Treatment Period|Adverse Event|0|||
170808083|NCT01968967|617307239|FG004|Treatment Period|Adverse Event|0|||
170808084|NCT01968967|617307235|FG000|Treatment Period|Death|9|||
170808085|NCT01968967|617307236|FG001|Treatment Period|Death|2|||
170808086|NCT01968967|617307237|FG002|Treatment Period|Death|0|||
170808087|NCT01968967|617307238|FG003|Treatment Period|Death|0|||
170808088|NCT01968967|617307239|FG004|Treatment Period|Death|0|||
170808089|NCT01968967|617307235|FG000|Treatment Period|Randomized Not Treated|6|||
170808090|NCT01968967|617307236|FG001|Treatment Period|Randomized Not Treated|5|||
170808091|NCT01968967|617307237|FG002|Treatment Period|Randomized Not Treated|0|||
170808092|NCT01968967|617307238|FG003|Treatment Period|Randomized Not Treated|0|||
170808093|NCT01968967|617307239|FG004|Treatment Period|Randomized Not Treated|0|||
170808094|NCT01968967|617307235|FG000|Extension Period|Withdrew Consent|0|||
170808095|NCT01968967|617307236|FG001|Extension Period|Withdrew Consent|0|||
170808096|NCT01968967|617307237|FG002|Extension Period|Withdrew Consent|2|||
170808097|NCT01968967|617307238|FG003|Extension Period|Withdrew Consent|0|||
170808098|NCT01968967|617307239|FG004|Extension Period|Withdrew Consent|5|||
170808099|NCT00701415|617307242|FG000|Overall Study|Adverse Event|0|||
170808100|NCT00701415|617307243|FG001|Overall Study|Adverse Event|1|||
170808101|NCT00701415|617307242|FG000|Overall Study|Social/family issues and needle phobia|1|||
170808102|NCT00701415|617307243|FG001|Overall Study|Social/family issues and needle phobia|0|||
170808103|NCT02106884|617307254|FG000|Overall Study|Change of diagnosis/exclusion|0|||
170808104|NCT02106884|617307255|FG001|Overall Study|Change of diagnosis/exclusion|1|||
170808105|NCT06263673|617307260|FG000|Overall Study|Withdrawal by Subject|0|||
170808106|NCT06263673|617307261|FG001|Overall Study|Withdrawal by Subject|0|||
170808107|NCT06263673|617307262|FG002|Overall Study|Withdrawal by Subject|1|||
170808108|NCT02022670|617307264|FG000|Overall Study|Adverse Event|1|||
170808109|NCT02022670|617307265|FG001|Overall Study|Adverse Event|0|||
170808110|NCT02022670|617307266|FG002|Overall Study|Adverse Event|1|||
170808111|NCT00659373|617307267|FG000|Overall Study|Withdrawal by Subject|3|||
170808112|NCT00659373|617307268|FG001|Overall Study|Withdrawal by Subject|5|||
170808113|NCT00659373|617307267|FG000|Overall Study|Assessment Missed|2|||
170808114|NCT00659373|617307268|FG001|Overall Study|Assessment Missed|2|||
170808115|NCT04138277|617307272|FG000|Pretreatment|Withdrawal by Subject|1|||
170808116|NCT04138277|617307273|FG001|Pretreatment|Withdrawal by Subject|0|||
170808117|NCT04138277|617307272|FG000|Treatment|Adverse Event|6|||
170808118|NCT04138277|617307273|FG001|Treatment|Adverse Event|2|||
170808119|NCT04138277|617307272|FG000|Treatment|Lost to Follow-up|1|||
170808120|NCT04138277|617307273|FG001|Treatment|Lost to Follow-up|0|||
170808121|NCT04138277|617307272|FG000|Treatment|Pregnancy|3|||
170808122|NCT04138277|617307273|FG001|Treatment|Pregnancy|0|||
170808123|NCT04138277|617307272|FG000|Treatment|COVID-19 pandemic|1|||
170808124|NCT04138277|617307273|FG001|Treatment|COVID-19 pandemic|0|||
170808125|NCT04138277|617307272|FG000|Treatment|Withdrawal by Subject|9|||
170808126|NCT04138277|617307273|FG001|Treatment|Withdrawal by Subject|3|||
170808127|NCT04138277|617307272|FG000|Treatment|Sponsor decision|1|||
170808128|NCT04138277|617307273|FG001|Treatment|Sponsor decision|0|||
170808129|NCT04138277|617307272|FG000|Treatment|Physician Decision|1|||
170808130|NCT04138277|617307273|FG001|Treatment|Physician Decision|0|||
170808131|NCT04138277|617307272|FG000|Treatment|Worsening of condition|1|||
170808132|NCT04138277|617307273|FG001|Treatment|Worsening of condition|2|||
170808133|NCT04650581|617307279|FG000|Overall Study|No treated|1|||
170808134|NCT04650581|617307280|FG001|Overall Study|No treated|1|||
170808135|NCT04221451|617307288|FG000|PAP: Baseline (Day 1) up to 104 Weeks|Withdrawal by Subject|2|||
170808136|NCT04221451|617307289|FG001|PAP: Baseline (Day 1) up to 104 Weeks|Withdrawal by Subject|5|||
170808137|NCT04221451|617307290|FG002|PAP: Baseline (Day 1) up to 104 Weeks|Withdrawal by Subject|1|||
170808138|NCT04221451|617307291|FG003|PAP: Baseline (Day 1) up to 104 Weeks|Withdrawal by Subject|0|||
170808139|NCT04221451|617307292|FG004|PAP: Baseline (Day 1) up to 104 Weeks|Withdrawal by Subject|0|||
170808140|NCT04221451|617307293|FG005|PAP: Baseline (Day 1) up to 104 Weeks|Withdrawal by Subject|0|||
170808141|NCT04221451|617307288|FG000|PAP: Baseline (Day 1) up to 104 Weeks|Other|0|||
170808142|NCT04221451|617307289|FG001|PAP: Baseline (Day 1) up to 104 Weeks|Other|0|||
170808143|NCT04221451|617307290|FG002|PAP: Baseline (Day 1) up to 104 Weeks|Other|1|||
170808144|NCT04221451|617307291|FG003|PAP: Baseline (Day 1) up to 104 Weeks|Other|0|||
170808145|NCT04221451|617307292|FG004|PAP: Baseline (Day 1) up to 104 Weeks|Other|0|||
170808146|NCT04221451|617307293|FG005|PAP: Baseline (Day 1) up to 104 Weeks|Other|0|||
170808147|NCT04221451|617307288|FG000|OLE (104 Weeks): From 104 to 208 Weeks|Withdrawal by Subject|0|||
170808148|NCT04221451|617307289|FG001|OLE (104 Weeks): From 104 to 208 Weeks|Withdrawal by Subject|0|||
170647863|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
170647864|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Non-compliance|1|||
170647865|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Non-compliance|0|||
170647866|NCT00470834|616723448|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
170647867|NCT00470834|616723449|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
170647868|NCT00470834|616723448|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
170647869|NCT00470834|616723449|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
170647870|NCT00470834|616723448|FG000|Extension Period (24 Months)|Adverse Event|3|||
170647871|NCT00470834|616723449|FG001|Extension Period (24 Months)|Adverse Event|4|||
170647872|NCT00470834|616723448|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
170647873|NCT00470834|616723449|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
170647874|NCT00470834|616723448|FG000|Extension Period (24 Months)|Physician Decision|4|||
170647875|NCT00470834|616723449|FG001|Extension Period (24 Months)|Physician Decision|3|||
170647876|NCT00470834|616723448|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
170647877|NCT00470834|616723449|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
170647878|NCT00470834|616723448|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
170647879|NCT00470834|616723449|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
170647880|NCT00470834|616723448|FG000|Extension Period (24 Months)|Non-compliance|0|||
170647881|NCT00470834|616723449|FG001|Extension Period (24 Months)|Non-compliance|1|||
170647882|NCT00470834|616723448|FG000|Extension Period (24 Months)|Disease Progression|0|||
170647883|NCT00470834|616723449|FG001|Extension Period (24 Months)|Disease Progression|1|||
170647884|NCT03051620|616723450|FG000|Overall Study|Lost to Follow-up|6|||
170647885|NCT03051620|616723450|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
170647886|NCT00561977|616723451|FG000|Overall Study|Withdrawal by Subject|0|||
170647887|NCT00561977|616723452|FG001|Overall Study|Withdrawal by Subject|2|||
170647888|NCT00561977|616723453|FG002|Overall Study|Withdrawal by Subject|1|||
170647889|NCT00561977|616723451|FG000|Overall Study|Pregnancy|0|||
170647890|NCT00561977|616723452|FG001|Overall Study|Pregnancy|1|||
170647891|NCT00561977|616723453|FG002|Overall Study|Pregnancy|1|||
170647892|NCT00393510|616723454|FG000|Overall Study|Physician Decision|3|||
170647893|NCT00393510|616723455|FG001|Overall Study|Physician Decision|9|||
170647894|NCT01534182|616723456|FG000|Overall Study|Administrative problems|1|||
170647895|NCT01534182|616723457|FG001|Overall Study|Administrative problems|0|||
170647896|NCT01534182|616723456|FG000|Overall Study|Withdrawal by Subject|4|||
170647897|NCT01534182|616723457|FG001|Overall Study|Withdrawal by Subject|7|||
170647898|NCT01534182|616723456|FG000|Overall Study|Adverse Event|7|||
170647899|NCT01534182|616723457|FG001|Overall Study|Adverse Event|3|||
170647900|NCT03077087|616723458|FG000|Overall Study|Physician Decision|2|||
170647901|NCT01989468|616723459|FG000|Overall Study|Adverse Event|10|||
170647902|NCT01989468|616723460|FG001|Overall Study|Adverse Event|15|||
170647903|NCT01989468|616723461|FG002|Overall Study|Adverse Event|4|||
170647904|NCT01989468|616723462|FG003|Overall Study|Adverse Event|5|||
170647905|NCT01989468|616723463|FG004|Overall Study|Adverse Event|4|||
170647906|NCT01989468|616723459|FG000|Overall Study|Lack of Efficacy|11|||
170647907|NCT01989468|616723460|FG001|Overall Study|Lack of Efficacy|11|||
170647908|NCT01989468|616723461|FG002|Overall Study|Lack of Efficacy|7|||
170647909|NCT01989468|616723462|FG003|Overall Study|Lack of Efficacy|4|||
170647910|NCT01989468|616723463|FG004|Overall Study|Lack of Efficacy|2|||
170647911|NCT01989468|616723459|FG000|Overall Study|Lost to Follow-up|5|||
170647912|NCT01989468|616723460|FG001|Overall Study|Lost to Follow-up|2|||
170647913|NCT01989468|616723461|FG002|Overall Study|Lost to Follow-up|0|||
170647914|NCT01989468|616723462|FG003|Overall Study|Lost to Follow-up|1|||
170647915|NCT01989468|616723463|FG004|Overall Study|Lost to Follow-up|1|||
170647916|NCT01989468|616723459|FG000|Overall Study|Physician Decision|4|||
170647917|NCT01989468|616723460|FG001|Overall Study|Physician Decision|1|||
170808149|NCT04221451|617307290|FG002|OLE (104 Weeks): From 104 to 208 Weeks|Withdrawal by Subject|0|||
170808150|NCT04221451|617307291|FG003|OLE (104 Weeks): From 104 to 208 Weeks|Withdrawal by Subject|2|||
170808151|NCT04221451|617307292|FG004|OLE (104 Weeks): From 104 to 208 Weeks|Withdrawal by Subject|1|||
170808152|NCT04221451|617307293|FG005|OLE (104 Weeks): From 104 to 208 Weeks|Withdrawal by Subject|2|||
170808153|NCT04221451|617307288|FG000|OLE (104 Weeks): From 104 to 208 Weeks|Study terminated by sponsor|0|||
170808154|NCT04221451|617307289|FG001|OLE (104 Weeks): From 104 to 208 Weeks|Study terminated by sponsor|0|||
170808155|NCT04221451|617307290|FG002|OLE (104 Weeks): From 104 to 208 Weeks|Study terminated by sponsor|0|||
170808156|NCT04221451|617307291|FG003|OLE (104 Weeks): From 104 to 208 Weeks|Study terminated by sponsor|13|||
170808157|NCT04221451|617307292|FG004|OLE (104 Weeks): From 104 to 208 Weeks|Study terminated by sponsor|33|||
170808158|NCT04221451|617307293|FG005|OLE (104 Weeks): From 104 to 208 Weeks|Study terminated by sponsor|12|||
170808159|NCT04221451|617307288|FG000|OLE (104 Weeks): From 104 to 208 Weeks|Adverse Event|0|||
170808160|NCT04221451|617307289|FG001|OLE (104 Weeks): From 104 to 208 Weeks|Adverse Event|0|||
170808161|NCT04221451|617307290|FG002|OLE (104 Weeks): From 104 to 208 Weeks|Adverse Event|0|||
170808162|NCT04221451|617307291|FG003|OLE (104 Weeks): From 104 to 208 Weeks|Adverse Event|1|||
170808163|NCT04221451|617307292|FG004|OLE (104 Weeks): From 104 to 208 Weeks|Adverse Event|0|||
170808164|NCT04221451|617307293|FG005|OLE (104 Weeks): From 104 to 208 Weeks|Adverse Event|0|||
170808165|NCT03497676|617307294|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
170808166|NCT03497676|617307295|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
170808167|NCT03497676|617307296|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
170808168|NCT03497676|617307297|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
170808169|NCT03497676|617307294|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
170808170|NCT03497676|617307295|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
170808171|NCT03497676|617307296|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
170808172|NCT03497676|617307297|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
170808173|NCT03497676|617307294|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
170808174|NCT03497676|617307295|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
170808175|NCT03497676|617307296|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
170808176|NCT03497676|617307297|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
170808177|NCT03497676|617307294|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
170808178|NCT03497676|617307295|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
170808179|NCT03497676|617307296|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
170808180|NCT03497676|617307297|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
170808181|NCT03497676|617307294|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
170808182|NCT03497676|617307295|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
170808183|NCT03497676|617307296|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
170808184|NCT03497676|617307297|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
170808185|NCT03497676|617307294|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
170808186|NCT03497676|617307295|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
170808187|NCT03497676|617307296|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
170808188|NCT03497676|617307297|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
170808189|NCT03497676|617307294|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
170808190|NCT03497676|617307295|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
170808191|NCT03497676|617307296|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
170808192|NCT03497676|617307297|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
170808193|NCT03497676|617307294|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
170808194|NCT03497676|617307295|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
170808195|NCT03497676|617307296|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
170808196|NCT03497676|617307297|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
170808197|NCT03497676|617307294|FG000|Cohort 2 Week 48 to Week 96|Pregnancy|0|||
170808198|NCT03497676|617307295|FG001|Cohort 2 Week 48 to Week 96|Pregnancy|0|||
170569780|NCT00457392|616433847|FG001|Overall Study|Withdrawal by Subject|8|||
170569781|NCT00457392|616433846|FG000|Overall Study|Lost to Follow-up|6|||
170569782|NCT00457392|616433847|FG001|Overall Study|Lost to Follow-up|7|||
170569783|NCT00457392|616433846|FG000|Overall Study|Protocol Violation|4|||
170569784|NCT00457392|616433847|FG001|Overall Study|Protocol Violation|3|||
170569785|NCT00457392|616433846|FG000|Overall Study|Other|7|||
170569786|NCT00457392|616433847|FG001|Overall Study|Other|4|||
170569787|NCT00457392|616433846|FG000|Overall Study|Study Terminated by Sponsor|1|||
170569788|NCT00457392|616433847|FG001|Overall Study|Study Terminated by Sponsor|4|||
170569789|NCT00457392|616433846|FG000|Overall Study|Randomized, Not Treated|7|||
170569790|NCT00457392|616433847|FG001|Overall Study|Randomized, Not Treated|3|||
170569791|NCT00756275|616433848|FG000|Overall Study|Lost to Follow-up|25|||
170569792|NCT00756275|616433849|FG001|Overall Study|Lost to Follow-up|21|||
170569793|NCT00756275|616433848|FG000|Overall Study|Withdrawal by Subject|4|||
170569794|NCT00756275|616433849|FG001|Overall Study|Withdrawal by Subject|7|||
170647918|NCT01989468|616723461|FG002|Overall Study|Physician Decision|0|||
170647919|NCT01989468|616723462|FG003|Overall Study|Physician Decision|1|||
170647920|NCT01989468|616723463|FG004|Overall Study|Physician Decision|0|||
170647921|NCT01989468|616723459|FG000|Overall Study|Pregnancy|0|||
170647922|NCT01989468|616723460|FG001|Overall Study|Pregnancy|1|||
170647923|NCT01989468|616723461|FG002|Overall Study|Pregnancy|0|||
170647924|NCT01989468|616723462|FG003|Overall Study|Pregnancy|0|||
170647925|NCT01989468|616723463|FG004|Overall Study|Pregnancy|0|||
170647926|NCT01989468|616723459|FG000|Overall Study|Technical Problems|3|||
170647927|NCT01989468|616723460|FG001|Overall Study|Technical Problems|1|||
170647928|NCT01989468|616723461|FG002|Overall Study|Technical Problems|3|||
170647929|NCT01989468|616723462|FG003|Overall Study|Technical Problems|1|||
170647930|NCT01989468|616723463|FG004|Overall Study|Technical Problems|0|||
170647931|NCT01989468|616723459|FG000|Overall Study|Subject Guardian Decision|11|||
170647932|NCT01989468|616723460|FG001|Overall Study|Subject Guardian Decision|6|||
170647933|NCT01989468|616723461|FG002|Overall Study|Subject Guardian Decision|4|||
170647934|NCT01989468|616723462|FG003|Overall Study|Subject Guardian Decision|4|||
170647935|NCT01989468|616723463|FG004|Overall Study|Subject Guardian Decision|1|||
170647936|NCT01989468|616723459|FG000|Overall Study|Death|3|||
170647937|NCT01989468|616723460|FG001|Overall Study|Death|0|||
170647938|NCT01989468|616723461|FG002|Overall Study|Death|1|||
170647939|NCT01989468|616723462|FG003|Overall Study|Death|0|||
170647940|NCT01989468|616723463|FG004|Overall Study|Death|0|||
170647941|NCT00977080|616723466|FG000|Overall Study|Adverse Event|2|||
170647942|NCT00977080|616723467|FG001|Overall Study|Adverse Event|7|||
170647943|NCT00977080|616723468|FG002|Overall Study|Adverse Event|7|||
170647944|NCT00977080|616723469|FG003|Overall Study|Adverse Event|7|||
170647945|NCT00977080|616723466|FG000|Overall Study|Withdrawal by Subject|1|||
170647946|NCT00977080|616723467|FG001|Overall Study|Withdrawal by Subject|5|||
170647947|NCT00977080|616723468|FG002|Overall Study|Withdrawal by Subject|1|||
170647948|NCT00977080|616723469|FG003|Overall Study|Withdrawal by Subject|5|||
170647949|NCT00977080|616723466|FG000|Overall Study|Protocol Violation|7|||
170647950|NCT00977080|616723467|FG001|Overall Study|Protocol Violation|3|||
170647951|NCT00977080|616723468|FG002|Overall Study|Protocol Violation|4|||
170647952|NCT00977080|616723469|FG003|Overall Study|Protocol Violation|3|||
170647953|NCT00977080|616723466|FG000|Overall Study|Noncompliance|0|||
170647954|NCT00977080|616723467|FG001|Overall Study|Noncompliance|2|||
170647955|NCT00977080|616723468|FG002|Overall Study|Noncompliance|1|||
170647956|NCT00977080|616723469|FG003|Overall Study|Noncompliance|0|||
170647957|NCT00977080|616723466|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
170647958|NCT00977080|616723467|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
170647959|NCT00977080|616723468|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
170647960|NCT00977080|616723469|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
170647961|NCT00977080|616723466|FG000|Overall Study|Required kidney transplantation|1|||
170647962|NCT00977080|616723467|FG001|Overall Study|Required kidney transplantation|3|||
170808199|NCT03497676|617307296|FG002|Cohort 2 Week 48 to Week 96|Pregnancy|2|||
170808200|NCT03497676|617307297|FG003|Cohort 2 Week 48 to Week 96|Pregnancy|0|||
170808201|NCT03497676|617307294|FG000|Cohort 2 Week 48 to Week 96|Adverse Event|0|||
170808202|NCT03497676|617307295|FG001|Cohort 2 Week 48 to Week 96|Adverse Event|0|||
170808203|NCT03497676|617307296|FG002|Cohort 2 Week 48 to Week 96|Adverse Event|1|||
170808204|NCT03497676|617307297|FG003|Cohort 2 Week 48 to Week 96|Adverse Event|0|||
170808205|NCT03497676|617307294|FG000|Cohort 2 Safety Extension|Lost to Follow-up|0|||
170808206|NCT03497676|617307295|FG001|Cohort 2 Safety Extension|Lost to Follow-up|0|||
170808207|NCT03497676|617307296|FG002|Cohort 2 Safety Extension|Lost to Follow-up|1|||
170808208|NCT03497676|617307297|FG003|Cohort 2 Safety Extension|Lost to Follow-up|0|||
170808209|NCT02516241|617307300|FG000|Overall Study|Death|255|||
170808210|NCT02516241|617307301|FG001|Overall Study|Death|262|||
170808211|NCT02516241|617307302|FG002|Overall Study|Death|270|||
170808212|NCT02516241|617307300|FG000|Overall Study|Lost to Follow-up|1|||
170808213|NCT02516241|617307301|FG001|Overall Study|Lost to Follow-up|1|||
170808214|NCT02516241|617307302|FG002|Overall Study|Lost to Follow-up|3|||
170808215|NCT02516241|617307300|FG000|Overall Study|Withdrawal by Subject|2|||
170808216|NCT02516241|617307301|FG001|Overall Study|Withdrawal by Subject|7|||
170808217|NCT02516241|617307302|FG002|Overall Study|Withdrawal by Subject|12|||
170647963|NCT00977080|616723468|FG002|Overall Study|Required kidney transplantation|3|||
170647964|NCT00977080|616723469|FG003|Overall Study|Required kidney transplantation|1|||
170647965|NCT00977080|616723466|FG000|Overall Study|Travel for family reasons|1|||
170808218|NCT02516241|617307300|FG000|Overall Study|participants ongoing at data cut-off|84|||
170808219|NCT02516241|617307301|FG001|Overall Study|participants ongoing at data cut-off|76|||
170647966|NCT00977080|616723467|FG001|Overall Study|Travel for family reasons|0|||
170647967|NCT00977080|616723468|FG002|Overall Study|Travel for family reasons|0|||
170647968|NCT00977080|616723469|FG003|Overall Study|Travel for family reasons|0|||
170647969|NCT01950013|616723472|FG000|Overall Study|Withdrawal by Subject|0|||
170647970|NCT01950013|616723473|FG001|Overall Study|Withdrawal by Subject|2|||
170647971|NCT01950013|616723474|FG002|Overall Study|Withdrawal by Subject|0|||
170647972|NCT02925338|616723475|FG000|Overall Study|Death|0|||
170647973|NCT02925338|616723476|FG001|Overall Study|Death|2|||
170647974|NCT02925338|616723477|FG002|Overall Study|Death|1|||
170647975|NCT02925338|616723478|FG003|Overall Study|Death|0|||
170647976|NCT02925338|616723479|FG004|Overall Study|Death|0|||
170647977|NCT02925338|616723475|FG000|Overall Study|Lost to Follow-up|30|||
170647978|NCT02925338|616723476|FG001|Overall Study|Lost to Follow-up|10|||
170647979|NCT02925338|616723477|FG002|Overall Study|Lost to Follow-up|1|||
170647980|NCT02925338|616723478|FG003|Overall Study|Lost to Follow-up|16|||
170647981|NCT02925338|616723479|FG004|Overall Study|Lost to Follow-up|3|||
170647982|NCT02925338|616723475|FG000|Overall Study|Withdrawal by Subject|3|||
170647983|NCT02925338|616723476|FG001|Overall Study|Withdrawal by Subject|0|||
170647984|NCT02925338|616723477|FG002|Overall Study|Withdrawal by Subject|3|||
170647985|NCT02925338|616723478|FG003|Overall Study|Withdrawal by Subject|2|||
170647986|NCT02925338|616723479|FG004|Overall Study|Withdrawal by Subject|2|||
170647987|NCT02925338|616723475|FG000|Overall Study|Missing|38|||
170647988|NCT02925338|616723476|FG001|Overall Study|Missing|27|||
170647989|NCT02925338|616723477|FG002|Overall Study|Missing|0|||
170647990|NCT02925338|616723478|FG003|Overall Study|Missing|3|||
170647991|NCT02925338|616723479|FG004|Overall Study|Missing|2|||
170647992|NCT02925338|616723475|FG000|Overall Study|Participant's Decision|11|||
170647993|NCT02925338|616723476|FG001|Overall Study|Participant's Decision|7|||
170647994|NCT02925338|616723477|FG002|Overall Study|Participant's Decision|3|||
170647995|NCT02925338|616723478|FG003|Overall Study|Participant's Decision|8|||
170647996|NCT02925338|616723479|FG004|Overall Study|Participant's Decision|1|||
170647997|NCT02925338|616723475|FG000|Overall Study|Treatment Discontinuation|144|||
170647998|NCT02925338|616723476|FG001|Overall Study|Treatment Discontinuation|65|||
170647999|NCT02925338|616723477|FG002|Overall Study|Treatment Discontinuation|56|||
170648000|NCT02925338|616723478|FG003|Overall Study|Treatment Discontinuation|131|||
170648001|NCT02925338|616723479|FG004|Overall Study|Treatment Discontinuation|22|||
170648002|NCT00636363|616723483|FG000|Overall Study|Conjunctivitis|0|||
170648003|NCT00636363|616723484|FG001|Overall Study|Conjunctivitis|0|||
170648004|NCT00636363|616723485|FG002|Overall Study|Conjunctivitis|1|||
170648005|NCT00636363|616723483|FG000|Overall Study|Adverse Event|0|||
170648006|NCT00636363|616723484|FG001|Overall Study|Adverse Event|0|||
170648007|NCT00636363|616723485|FG002|Overall Study|Adverse Event|1|||
170648008|NCT00636363|616723483|FG000|Overall Study|Positive slit lamp finding|0|||
170648009|NCT00636363|616723484|FG001|Overall Study|Positive slit lamp finding|2|||
170648010|NCT00636363|616723485|FG002|Overall Study|Positive slit lamp finding|1|||
170648011|NCT00636363|616723483|FG000|Overall Study|Study related symptoms/complaints|8|||
170648012|NCT00636363|616723484|FG001|Overall Study|Study related symptoms/complaints|7|||
170648013|NCT00636363|616723485|FG002|Overall Study|Study related symptoms/complaints|4|||
170648014|NCT00636363|616723483|FG000|Overall Study|Met ineligibility criteria|0|||
170648015|NCT00636363|616723484|FG001|Overall Study|Met ineligibility criteria|0|||
170648016|NCT00636363|616723485|FG002|Overall Study|Met ineligibility criteria|3|||
170648017|NCT00636363|616723483|FG000|Overall Study|Missed > 1 visit|0|||
170648018|NCT00636363|616723484|FG001|Overall Study|Missed > 1 visit|1|||
170648019|NCT00636363|616723485|FG002|Overall Study|Missed > 1 visit|3|||
170648020|NCT00636363|616723483|FG000|Overall Study|Lack of motivation|1|||
170648021|NCT00636363|616723484|FG001|Overall Study|Lack of motivation|0|||
170648022|NCT00636363|616723485|FG002|Overall Study|Lack of motivation|1|||
170648023|NCT00636363|616723483|FG000|Overall Study|Protocol Violation|0|||
170648024|NCT00636363|616723484|FG001|Overall Study|Protocol Violation|3|||
170648025|NCT00636363|616723485|FG002|Overall Study|Protocol Violation|0|||
170648026|NCT00636363|616723483|FG000|Overall Study|Lost to Follow-up|3|||
170648027|NCT00636363|616723484|FG001|Overall Study|Lost to Follow-up|4|||
170648028|NCT00636363|616723485|FG002|Overall Study|Lost to Follow-up|2|||
170648029|NCT00636363|616723483|FG000|Overall Study|Withdrawal by Subject|1|||
170648030|NCT00636363|616723484|FG001|Overall Study|Withdrawal by Subject|3|||
170648031|NCT00636363|616723485|FG002|Overall Study|Withdrawal by Subject|2|||
170648032|NCT01765218|616723488|FG000|Overall Study|Protocol Violation|1|||
170648033|NCT01765218|616723489|FG001|Overall Study|Protocol Violation|2|||
170648034|NCT00313781|616723490|FG000|Before Crossover|Death|22|||
170648035|NCT00313781|616723491|FG001|Before Crossover|Death|8|||
170648036|NCT00313781|616723492|FG002|Before Crossover|Death|0|||
170648037|NCT00313781|616723490|FG000|Before Crossover|Lost to Follow-up|0|||
170648038|NCT00313781|616723491|FG001|Before Crossover|Lost to Follow-up|3|||
170648039|NCT00313781|616723492|FG002|Before Crossover|Lost to Follow-up|0|||
170648040|NCT00313781|616723490|FG000|Before Crossover|Withdrawal by Subject|3|||
170648041|NCT00313781|616723491|FG001|Before Crossover|Withdrawal by Subject|1|||
170648042|NCT00313781|616723492|FG002|Before Crossover|Withdrawal by Subject|0|||
170648043|NCT00313781|616723490|FG000|Before Crossover|Other|45|||
170648044|NCT00313781|616723491|FG001|Before Crossover|Other|30|||
170648045|NCT00313781|616723492|FG002|Before Crossover|Other|0|||
170648046|NCT00313781|616723490|FG000|Before Crossover|Crossover|0|||
170648047|NCT00313781|616723491|FG001|Before Crossover|Crossover|37|||
170648048|NCT00313781|616723492|FG002|Before Crossover|Crossover|0|||
170648049|NCT00313781|616723490|FG000|Before Crossover|Randomized, not treated|5|||
170648050|NCT00313781|616723491|FG001|Before Crossover|Randomized, not treated|0|||
170648051|NCT00313781|616723492|FG002|Before Crossover|Randomized, not treated|0|||
170648052|NCT00313781|616723490|FG000|After Crossover|Death|0|||
170808220|NCT02516241|617307302|FG002|Overall Study|participants ongoing at data cut-off|59|||
170808221|NCT02060487|617307305|FG000|Overall Study|Other|1|||
170808222|NCT02060487|617307306|FG001|Overall Study|Other|2|||
170808223|NCT02060487|617307307|FG002|Overall Study|Other|1|||
170808224|NCT02060487|617307305|FG000|Overall Study|Lack of Efficacy|0|||
170808225|NCT02060487|617307306|FG001|Overall Study|Lack of Efficacy|1|||
170808226|NCT02060487|617307307|FG002|Overall Study|Lack of Efficacy|0|||
170808227|NCT02060487|617307305|FG000|Overall Study|Withdrawal by Subject|3|||
170808228|NCT02060487|617307306|FG001|Overall Study|Withdrawal by Subject|10|||
170808229|NCT02060487|617307307|FG002|Overall Study|Withdrawal by Subject|4|||
170808230|NCT02060487|617307305|FG000|Overall Study|Study Terminated By Sponsor|87|||
170808231|NCT02060487|617307306|FG001|Overall Study|Study Terminated By Sponsor|89|||
170808232|NCT02060487|617307307|FG002|Overall Study|Study Terminated By Sponsor|100|||
170808233|NCT02060487|617307305|FG000|Overall Study|Randomized in error|1|||
170808234|NCT02060487|617307306|FG001|Overall Study|Randomized in error|0|||
170808235|NCT02060487|617307307|FG002|Overall Study|Randomized in error|0|||
170808236|NCT02060487|617307305|FG000|Overall Study|Protocol Violation|0|||
170808237|NCT02060487|617307306|FG001|Overall Study|Protocol Violation|1|||
170808238|NCT02060487|617307307|FG002|Overall Study|Protocol Violation|1|||
170808239|NCT02060487|617307305|FG000|Overall Study|Lost to Follow-up|3|||
170808240|NCT02060487|617307306|FG001|Overall Study|Lost to Follow-up|0|||
170808241|NCT02060487|617307307|FG002|Overall Study|Lost to Follow-up|2|||
170808242|NCT02060487|617307305|FG000|Overall Study|Death|34|||
170808243|NCT02060487|617307306|FG001|Overall Study|Death|25|||
170808244|NCT02060487|617307307|FG002|Overall Study|Death|19|||
170808245|NCT02060487|617307305|FG000|Overall Study|Adverse Event|0|||
170808246|NCT02060487|617307306|FG001|Overall Study|Adverse Event|0|||
170808247|NCT02060487|617307307|FG002|Overall Study|Adverse Event|1|||
170808248|NCT04677738|617307308|FG000|Overall Study|Withdrawal by Subject|4|||
170808249|NCT04677738|617307309|FG001|Overall Study|Withdrawal by Subject|2|||
170808250|NCT05202262|617307310|FG000|Overall Study|Adverse Event|0|||
170808251|NCT05202262|617307311|FG001|Overall Study|Adverse Event|1|||
170808252|NCT05202262|617307312|FG002|Overall Study|Adverse Event|0|||
170808253|NCT05202262|617307313|FG003|Overall Study|Adverse Event|0|||
170808254|NCT05202262|617307310|FG000|Overall Study|Lost to Follow-up|0|||
170808255|NCT05202262|617307311|FG001|Overall Study|Lost to Follow-up|0|||
170808256|NCT05202262|617307312|FG002|Overall Study|Lost to Follow-up|4|||
170808257|NCT05202262|617307313|FG003|Overall Study|Lost to Follow-up|0|||
170808258|NCT05202262|617307310|FG000|Overall Study|Physician Decision|3|||
170808259|NCT05202262|617307311|FG001|Overall Study|Physician Decision|3|||
170808260|NCT05202262|617307312|FG002|Overall Study|Physician Decision|0|||
170808261|NCT05202262|617307313|FG003|Overall Study|Physician Decision|0|||
170808262|NCT05202262|617307310|FG000|Overall Study|Pregnancy|0|||
170808263|NCT05202262|617307311|FG001|Overall Study|Pregnancy|0|||
170808264|NCT05202262|617307312|FG002|Overall Study|Pregnancy|0|||
170808265|NCT05202262|617307313|FG003|Overall Study|Pregnancy|1|||
170808266|NCT05202262|617307310|FG000|Overall Study|Development of withdrawal Criteria|0|||
170808267|NCT05202262|617307311|FG001|Overall Study|Development of withdrawal Criteria|0|||
170808268|NCT05202262|617307312|FG002|Overall Study|Development of withdrawal Criteria|1|||
170808269|NCT05202262|617307313|FG003|Overall Study|Development of withdrawal Criteria|1|||
170808270|NCT05202262|617307310|FG000|Overall Study|Withdrawal by Subject|2|||
170808271|NCT05202262|617307311|FG001|Overall Study|Withdrawal by Subject|3|||
170808272|NCT05202262|617307312|FG002|Overall Study|Withdrawal by Subject|5|||
170808273|NCT05202262|617307313|FG003|Overall Study|Withdrawal by Subject|4|||
170808274|NCT05202262|617307310|FG000|Overall Study|Various Reasons|2|||
170808275|NCT05202262|617307311|FG001|Overall Study|Various Reasons|5|||
170808276|NCT05202262|617307312|FG002|Overall Study|Various Reasons|3|||
170808277|NCT05202262|617307313|FG003|Overall Study|Various Reasons|4|||
170808278|NCT05202262|617307310|FG000|Overall Study|Failure to meet randomization criteria|0|||
170808279|NCT05202262|617307311|FG001|Overall Study|Failure to meet randomization criteria|1|||
170808280|NCT05202262|617307312|FG002|Overall Study|Failure to meet randomization criteria|0|||
170808281|NCT05202262|617307313|FG003|Overall Study|Failure to meet randomization criteria|1|||
170808282|NCT03191266|617307314|FG000|Overall Study|Space occupying lesion on MRI; PI removed participant after randomization, but before TMS initiation|0|||
170808283|NCT03191266|617307315|FG001|Overall Study|Space occupying lesion on MRI; PI removed participant after randomization, but before TMS initiation|1|||
170808284|NCT03191266|617307314|FG000|Overall Study|Withdrawal by Subject|3|||
170808285|NCT03191266|617307315|FG001|Overall Study|Withdrawal by Subject|1|||
170808286|NCT03370133|617307318|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
170808287|NCT03370133|617307319|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
170808288|NCT03370133|617307320|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
170808289|NCT03370133|617307321|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
170808290|NCT03370133|617307322|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
170808291|NCT03370133|617307323|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
170808292|NCT03370133|617307318|FG000|Initial Treatment Period (WK 16)|Death|1|||
170808293|NCT03370133|617307319|FG001|Initial Treatment Period (WK 16)|Death|1|||
170808294|NCT03370133|617307320|FG002|Initial Treatment Period (WK 16)|Death|1|||
170808295|NCT03370133|617307321|FG003|Initial Treatment Period (WK 16)|Death|0|||
170808296|NCT03370133|617307322|FG004|Initial Treatment Period (WK 16)|Death|0|||
170808297|NCT03370133|617307323|FG005|Initial Treatment Period (WK 16)|Death|0|||
170808298|NCT03370133|617307318|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
170808299|NCT03370133|617307319|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
170808300|NCT03370133|617307320|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
170808301|NCT03370133|617307321|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
170808302|NCT03370133|617307322|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
170808303|NCT03370133|617307323|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
170808304|NCT03370133|617307318|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
170808305|NCT03370133|617307319|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
170808306|NCT03370133|617307320|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
170808307|NCT03370133|617307321|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
170808308|NCT03370133|617307322|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
170808309|NCT03370133|617307323|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
170808310|NCT03370133|617307318|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
170808311|NCT03370133|617307319|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
170808312|NCT03370133|617307320|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
170808313|NCT03370133|617307321|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
170808314|NCT03370133|617307322|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
170808315|NCT03370133|617307323|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
170808316|NCT03370133|617307318|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
170808317|NCT03370133|617307319|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
170808318|NCT03370133|617307320|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
170808319|NCT03370133|617307321|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
170808320|NCT03370133|617307322|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
170808321|NCT03370133|617307323|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
170808322|NCT03370133|617307318|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
170808323|NCT03370133|617307319|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
170808324|NCT03370133|617307320|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
170808325|NCT03370133|617307321|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
170808326|NCT03370133|617307322|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
170808327|NCT03370133|617307323|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
170808328|NCT03370133|617307318|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
170808329|NCT03370133|617307319|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
170808330|NCT03370133|617307320|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
170808331|NCT03370133|617307321|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
170808332|NCT03370133|617307322|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
170808333|NCT03370133|617307323|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
170808334|NCT03370133|617307318|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
170808335|NCT03370133|617307319|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
170808336|NCT03370133|617307320|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
170808337|NCT03370133|617307321|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
170808338|NCT03370133|617307322|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
170808339|NCT03370133|617307323|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
170808340|NCT03370133|617307318|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
170808341|NCT03370133|617307319|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
170808342|NCT03370133|617307320|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
170808343|NCT03370133|617307321|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
170808344|NCT03370133|617307322|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
170808345|NCT03370133|617307323|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
170808346|NCT03370133|617307318|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
170808347|NCT03370133|617307319|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
170808348|NCT03370133|617307320|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
170808349|NCT03370133|617307321|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
170808350|NCT03370133|617307322|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
170808351|NCT03370133|617307323|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
170808352|NCT03370133|617307318|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
170808353|NCT03370133|617307319|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
170808354|NCT03370133|617307320|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
170808355|NCT03370133|617307321|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
170808356|NCT03370133|617307322|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
170808357|NCT03370133|617307323|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
170808358|NCT03370133|617307318|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
170808359|NCT03370133|617307319|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
170808360|NCT03370133|617307320|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
170808361|NCT03370133|617307321|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
170648053|NCT00313781|616723491|FG001|After Crossover|Death|0|||
170648054|NCT00313781|616723492|FG002|After Crossover|Death|6|||
170648055|NCT00313781|616723490|FG000|After Crossover|Withdrawal by Subject|0|||
170648056|NCT00313781|616723491|FG001|After Crossover|Withdrawal by Subject|0|||
170648057|NCT00313781|616723492|FG002|After Crossover|Withdrawal by Subject|3|||
170648058|NCT00313781|616723490|FG000|After Crossover|Other|0|||
170648059|NCT00313781|616723491|FG001|After Crossover|Other|0|||
170648060|NCT00313781|616723492|FG002|After Crossover|Other|18|||
170648061|NCT01546623|616723493|FG000|Overall Study|Adverse Event|2|||
170648062|NCT01546623|616723494|FG001|Overall Study|Adverse Event|3|||
170648063|NCT01546623|616723493|FG000|Overall Study|Major Protocol Deviation|1|||
170648064|NCT01546623|616723494|FG001|Overall Study|Major Protocol Deviation|1|||
170648065|NCT01546623|616723493|FG000|Overall Study|High Prostate specific antigen|2|||
170648066|NCT01546623|616723494|FG001|Overall Study|High Prostate specific antigen|1|||
170648067|NCT01546623|616723493|FG000|Overall Study|Did Not Receive Study Drug|1|||
170808362|NCT03370133|617307322|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
170648068|NCT01546623|616723494|FG001|Overall Study|Did Not Receive Study Drug|1|||
170648069|NCT03148691|616723495|FG000|Overall Study|Protocol Violation|1|||
170648070|NCT03148691|616723496|FG001|Overall Study|Protocol Violation|2|||
170648071|NCT03148691|616723497|FG002|Overall Study|Protocol Violation|7|||
170648072|NCT03148691|616723495|FG000|Overall Study|Lost to Follow-up|0|||
170648073|NCT03148691|616723496|FG001|Overall Study|Lost to Follow-up|0|||
170648074|NCT03148691|616723497|FG002|Overall Study|Lost to Follow-up|1|||
170648075|NCT03148691|616723495|FG000|Overall Study|Other|1|||
170648076|NCT03148691|616723496|FG001|Overall Study|Other|0|||
170648077|NCT03148691|616723497|FG002|Overall Study|Other|0|||
170648078|NCT03148691|616723495|FG000|Overall Study|Withdrawal by Subject|1|||
170648079|NCT03148691|616723496|FG001|Overall Study|Withdrawal by Subject|0|||
170648080|NCT03148691|616723497|FG002|Overall Study|Withdrawal by Subject|0|||
170648081|NCT00750152|616723498|FG000|Overall Study|Adverse Event|2|||
170648082|NCT00750152|616723499|FG001|Overall Study|Adverse Event|1|||
170648083|NCT00750152|616723498|FG000|Overall Study|Lost to Follow-up|8|||
170648084|NCT00750152|616723499|FG001|Overall Study|Lost to Follow-up|13|||
170648085|NCT00750152|616723498|FG000|Overall Study|Withdrawal by Subject|3|||
170648086|NCT00750152|616723499|FG001|Overall Study|Withdrawal by Subject|3|||
170648087|NCT00750152|616723498|FG000|Overall Study|Physician Decision|1|||
170648088|NCT00750152|616723499|FG001|Overall Study|Physician Decision|1|||
170648089|NCT00750152|616723498|FG000|Overall Study|Non-compliance|0|||
170648090|NCT00750152|616723499|FG001|Overall Study|Non-compliance|1|||
170648091|NCT00750152|616723498|FG000|Overall Study|Termination by sponsor|1|||
170648092|NCT00750152|616723499|FG001|Overall Study|Termination by sponsor|0|||
170648093|NCT00750152|616723498|FG000|Overall Study|Other|7|||
170648094|NCT00750152|616723499|FG001|Overall Study|Other|8|||
170648095|NCT00096356|616723502|FG000|Overall Study|Adverse Event|11|||
170648096|NCT00096356|616723503|FG001|Overall Study|Adverse Event|9|||
170648097|NCT00096356|616723502|FG000|Overall Study|Physician Decision|5|||
170648098|NCT00096356|616723503|FG001|Overall Study|Physician Decision|3|||
170648099|NCT00096356|616723502|FG000|Overall Study|Withdrawal by Subject|17|||
170648100|NCT00096356|616723503|FG001|Overall Study|Withdrawal by Subject|23|||
170648101|NCT00096356|616723502|FG000|Overall Study|Lack of Efficacy|1|||
170808363|NCT03370133|617307323|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
170808364|NCT03370133|617307318|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
170808365|NCT03370133|617307319|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
170808366|NCT03370133|617307320|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
170808367|NCT03370133|617307321|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
170808368|NCT03370133|617307322|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
170808369|NCT03370133|617307323|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
170808370|NCT03370133|617307318|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
170808371|NCT03370133|617307319|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
170808372|NCT03370133|617307320|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
170808373|NCT03370133|617307321|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
170808374|NCT03370133|617307322|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
170808375|NCT03370133|617307323|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
170808376|NCT05124301|617308869|FG000|Overall Study|Withdrawal by Subject|8|||
170808377|NCT02710669|617308871|FG000|Overall Study|Physician Decision|2|||
170648102|NCT00096356|616723503|FG001|Overall Study|Lack of Efficacy|0|||
170648103|NCT00096356|616723502|FG000|Overall Study|multiple reasons|10|||
170648104|NCT00096356|616723503|FG001|Overall Study|multiple reasons|18|||
170648105|NCT01008423|616723504|FG000|Overall Study|Adverse Event|13|||
170648106|NCT01008423|616723505|FG001|Overall Study|Adverse Event|6|||
170648107|NCT01008423|616723504|FG000|Overall Study|Withdrawal by Subject|4|||
170648108|NCT01008423|616723505|FG001|Overall Study|Withdrawal by Subject|7|||
170648109|NCT01008423|616723504|FG000|Overall Study|Lost to Follow-up|0|||
170648110|NCT01008423|616723505|FG001|Overall Study|Lost to Follow-up|2|||
170648111|NCT01008423|616723504|FG000|Overall Study|Low Cortisol|0|||
170648112|NCT01008423|616723505|FG001|Overall Study|Low Cortisol|1|||
170569795|NCT01309204|616433852|FG000|Overall Study|Adverse Event|48|||
170569796|NCT01309204|616433853|FG001|Overall Study|Adverse Event|58|||
170569797|NCT01309204|616433852|FG000|Overall Study|Lost to Follow-up|2|||
170569798|NCT01309204|616433853|FG001|Overall Study|Lost to Follow-up|2|||
170569799|NCT01309204|616433852|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
170569800|NCT01309204|616433853|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
170569801|NCT01309204|616433852|FG000|Overall Study|Inadequate control of IOP|4|||
170569802|NCT01309204|616433853|FG001|Overall Study|Inadequate control of IOP|4|||
170569803|NCT01309204|616433852|FG000|Overall Study|Other|4|||
170569804|NCT01309204|616433853|FG001|Overall Study|Other|1|||
170569805|NCT03374358|616433854|FG000|Overall Study|Withdrawal by Subject|0|||
170569806|NCT03374358|616433855|FG001|Overall Study|Withdrawal by Subject|2|||
170569807|NCT03012334|616433856|FG000|Period 1|Withdrawal by Subject|0|||
170569808|NCT03012334|616433857|FG001|Period 1|Withdrawal by Subject|0|||
170569809|NCT03012334|616433858|FG002|Period 1|Withdrawal by Subject|0|||
170569810|NCT03012334|616433859|FG003|Period 1|Withdrawal by Subject|0|||
170569811|NCT03012334|616433860|FG004|Period 1|Withdrawal by Subject|0|||
170569812|NCT03012334|616433861|FG005|Period 1|Withdrawal by Subject|0|||
170569813|NCT03012334|616433862|FG006|Period 1|Withdrawal by Subject|0|||
170569814|NCT03012334|616433863|FG007|Period 1|Withdrawal by Subject|0|||
170569815|NCT03012334|616433864|FG008|Period 1|Withdrawal by Subject|0|||
170569816|NCT03012334|616433865|FG009|Period 1|Withdrawal by Subject|1|||
170569817|NCT03012334|616433856|FG000|Period 2|Withdrawal by Subject|0|||
170569818|NCT03012334|616433857|FG001|Period 2|Withdrawal by Subject|1|||
170569819|NCT03012334|616433858|FG002|Period 2|Withdrawal by Subject|0|||
170569820|NCT03012334|616433859|FG003|Period 2|Withdrawal by Subject|0|||
170569821|NCT03012334|616433860|FG004|Period 2|Withdrawal by Subject|0|||
170569822|NCT03012334|616433861|FG005|Period 2|Withdrawal by Subject|0|||
170569823|NCT03012334|616433862|FG006|Period 2|Withdrawal by Subject|0|||
170569824|NCT03012334|616433863|FG007|Period 2|Withdrawal by Subject|0|||
170569825|NCT03012334|616433864|FG008|Period 2|Withdrawal by Subject|0|||
170569826|NCT03012334|616433865|FG009|Period 2|Withdrawal by Subject|0|||
170569827|NCT03012334|616433856|FG000|Period 2|Protocol Violation|0|||
170569828|NCT03012334|616433857|FG001|Period 2|Protocol Violation|0|||
170569829|NCT03012334|616433858|FG002|Period 2|Protocol Violation|1|||
170569830|NCT03012334|616433859|FG003|Period 2|Protocol Violation|0|||
170569831|NCT03012334|616433860|FG004|Period 2|Protocol Violation|0|||
170569832|NCT03012334|616433861|FG005|Period 2|Protocol Violation|0|||
170569833|NCT03012334|616433862|FG006|Period 2|Protocol Violation|0|||
170569834|NCT03012334|616433863|FG007|Period 2|Protocol Violation|1|||
170569835|NCT03012334|616433864|FG008|Period 2|Protocol Violation|0|||
170569836|NCT03012334|616433865|FG009|Period 2|Protocol Violation|0|||
170569837|NCT03012334|616433856|FG000|Period 4|Non-Compliance|0|||
170569838|NCT03012334|616433857|FG001|Period 4|Non-Compliance|0|||
170569839|NCT03012334|616433858|FG002|Period 4|Non-Compliance|0|||
170569840|NCT03012334|616433859|FG003|Period 4|Non-Compliance|0|||
170569841|NCT03012334|616433860|FG004|Period 4|Non-Compliance|0|||
170569842|NCT03012334|616433861|FG005|Period 4|Non-Compliance|0|||
170569843|NCT03012334|616433862|FG006|Period 4|Non-Compliance|1|||
170569844|NCT03012334|616433863|FG007|Period 4|Non-Compliance|0|||
170569845|NCT03012334|616433864|FG008|Period 4|Non-Compliance|0|||
170569846|NCT03012334|616433865|FG009|Period 4|Non-Compliance|0|||
170569847|NCT03012334|616433856|FG000|Period 4|Adverse Event|0|||
170569848|NCT03012334|616433857|FG001|Period 4|Adverse Event|0|||
170569849|NCT03012334|616433858|FG002|Period 4|Adverse Event|0|||
170569850|NCT03012334|616433859|FG003|Period 4|Adverse Event|0|||
170569851|NCT03012334|616433860|FG004|Period 4|Adverse Event|0|||
170569852|NCT03012334|616433861|FG005|Period 4|Adverse Event|0|||
170569853|NCT03012334|616433862|FG006|Period 4|Adverse Event|0|||
170569854|NCT03012334|616433863|FG007|Period 4|Adverse Event|0|||
170569855|NCT03012334|616433864|FG008|Period 4|Adverse Event|1|||
170569856|NCT03012334|616433865|FG009|Period 4|Adverse Event|0|||
170569857|NCT01073293|616433866|FG000|Overall Study|Lost to Follow-up|0|||
170569858|NCT01073293|616433867|FG001|Overall Study|Lost to Follow-up|1|||
170569859|NCT01073293|616433866|FG000|Overall Study|Withdrawal by Subject|5|||
170569860|NCT01073293|616433867|FG001|Overall Study|Withdrawal by Subject|10|||
170569861|NCT03389308|616433868|FG000|Overall Study|Withdrawal by Subject|5|||
170569862|NCT03389308|616433868|FG000|Overall Study|Lost to Follow-up|3|||
170569863|NCT03389308|616433868|FG000|Overall Study|Adverse Event|2|||
170569864|NCT03389308|616433868|FG000|Overall Study|Sponsor Request|2|||
170569865|NCT00573391|616433872|FG000|Overall Study|study stopped|2|||
170569866|NCT00573391|616433873|FG001|Overall Study|study stopped|2|||
170569867|NCT00573391|616433872|FG000|Overall Study|Death|1|||
170648113|NCT01008423|616723504|FG000|Overall Study|Lack of Efficacy|0|||
170648114|NCT01008423|616723505|FG001|Overall Study|Lack of Efficacy|5|||
170648115|NCT01008423|616723504|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
170648116|NCT01008423|616723505|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
170648117|NCT01008423|616723504|FG000|Overall Study|Personal Conflict|1|||
170648118|NCT01008423|616723505|FG001|Overall Study|Personal Conflict|0|||
170648119|NCT01008423|616723504|FG000|Overall Study|Other|0|||
170648120|NCT01008423|616723505|FG001|Overall Study|Other|1|||
170648121|NCT00348881|616723510|FG000|Overall Study|Lost to Follow-up|12|||
170648122|NCT00348881|616723511|FG001|Overall Study|Lost to Follow-up|6|||
170648123|NCT00348881|616723510|FG000|Overall Study|Withdrawal by Subject|3|||
170648124|NCT00348881|616723511|FG001|Overall Study|Withdrawal by Subject|4|||
170648125|NCT00348881|616723510|FG000|Overall Study|Adverse Event|2|||
170648126|NCT00348881|616723511|FG001|Overall Study|Adverse Event|0|||
170648127|NCT00348881|616723510|FG000|Overall Study|Serious Adverse Event|0|||
170648128|NCT00348881|616723511|FG001|Overall Study|Serious Adverse Event|2|||
170648129|NCT00129311|616723517|FG000|Overall Study|Withdrawal by Subject|12|||
170648130|NCT00129311|616723518|FG001|Overall Study|Withdrawal by Subject|19|||
170648131|NCT00557856|616723521|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
170648132|NCT00557856|616723522|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
170648133|NCT00557856|616723523|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
170648134|NCT00557856|616723524|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
170648135|NCT00557856|616723525|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
170648136|NCT00557856|616723526|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
170648137|NCT00557856|616723527|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
170648138|NCT00557856|616723528|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
170648139|NCT00557856|616723529|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
170648140|NCT00557856|616723521|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
170648141|NCT00557856|616723522|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
170648142|NCT00557856|616723523|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
170648143|NCT00557856|616723524|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
170648144|NCT00557856|616723525|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
170648145|NCT00557856|616723526|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
170648146|NCT00557856|616723527|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
170648147|NCT00557856|616723528|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
170648148|NCT00557856|616723529|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
170648149|NCT00557856|616723521|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
170648150|NCT00557856|616723522|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
170648151|NCT00557856|616723523|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
170648152|NCT00557856|616723524|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
170648153|NCT00557856|616723525|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
170648154|NCT00557856|616723526|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
170648155|NCT00557856|616723527|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
170648156|NCT00557856|616723528|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
170648157|NCT00557856|616723529|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
170648158|NCT00557856|616723521|FG000|Part 1: Dose Escalation Phase|Other|0|||
170648159|NCT00557856|616723522|FG001|Part 1: Dose Escalation Phase|Other|0|||
170648160|NCT00557856|616723523|FG002|Part 1: Dose Escalation Phase|Other|1|||
170648161|NCT00557856|616723524|FG003|Part 1: Dose Escalation Phase|Other|1|||
170648162|NCT00557856|616723525|FG004|Part 1: Dose Escalation Phase|Other|0|||
170648163|NCT00557856|616723526|FG005|Part 1: Dose Escalation Phase|Other|0|||
170648164|NCT00557856|616723527|FG006|Part 1: Dose Escalation Phase|Other|0|||
170648165|NCT00557856|616723528|FG007|Part 1: Dose Escalation Phase|Other|1|||
170648166|NCT00557856|616723529|FG008|Part 1: Dose Escalation Phase|Other|0|||
170648167|NCT00557856|616723521|FG000|Part 1: Dose Escalation Phase|Death|0|||
170648168|NCT00557856|616723522|FG001|Part 1: Dose Escalation Phase|Death|0|||
170648169|NCT00557856|616723523|FG002|Part 1: Dose Escalation Phase|Death|0|||
170648170|NCT00557856|616723524|FG003|Part 1: Dose Escalation Phase|Death|0|||
170648171|NCT00557856|616723525|FG004|Part 1: Dose Escalation Phase|Death|0|||
170648172|NCT00557856|616723526|FG005|Part 1: Dose Escalation Phase|Death|1|||
170648173|NCT00557856|616723527|FG006|Part 1: Dose Escalation Phase|Death|0|||
170648174|NCT00557856|616723528|FG007|Part 1: Dose Escalation Phase|Death|0|||
170648175|NCT00557856|616723529|FG008|Part 1: Dose Escalation Phase|Death|0|||
170648176|NCT00557856|616723521|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
170648177|NCT00557856|616723522|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
170648178|NCT00557856|616723523|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
170648179|NCT00557856|616723524|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
170648180|NCT00557856|616723525|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
170648181|NCT00557856|616723526|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
170648182|NCT00557856|616723527|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
170648183|NCT00557856|616723528|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
170648184|NCT00557856|616723529|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
170648185|NCT00557856|616723521|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
170648186|NCT00557856|616723522|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
170648187|NCT00557856|616723523|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
170648188|NCT00557856|616723524|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
170648189|NCT00557856|616723525|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
170648190|NCT00557856|616723526|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
170648191|NCT00557856|616723527|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
170648192|NCT00557856|616723528|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
170648193|NCT00557856|616723529|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
170648194|NCT00557856|616723521|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
170648195|NCT00557856|616723522|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
170648196|NCT00557856|616723523|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
170648197|NCT00557856|616723524|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
170648198|NCT00557856|616723525|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
170648199|NCT00557856|616723526|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
170648200|NCT00557856|616723527|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
170648201|NCT00557856|616723528|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
170648202|NCT00557856|616723529|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
170648203|NCT00557856|616723521|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
170648204|NCT00557856|616723522|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
170648205|NCT00557856|616723523|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
170648206|NCT00557856|616723524|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
170648207|NCT00557856|616723525|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
170648208|NCT00557856|616723526|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
170648209|NCT00557856|616723527|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
170648210|NCT00557856|616723528|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
170648211|NCT00557856|616723529|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
170648212|NCT00557856|616723521|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
170648213|NCT00557856|616723522|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
170648214|NCT00557856|616723523|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
170648215|NCT00557856|616723524|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
170648216|NCT00557856|616723525|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
170648217|NCT00557856|616723526|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
170648218|NCT00557856|616723527|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
170648219|NCT00557856|616723528|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
170648220|NCT00557856|616723529|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
170648221|NCT00557856|616723521|FG000|Part 2: Exploratory Phase|Other|0|||
170648222|NCT00557856|616723522|FG001|Part 2: Exploratory Phase|Other|0|||
170648223|NCT00557856|616723523|FG002|Part 2: Exploratory Phase|Other|0|||
170648224|NCT00557856|616723524|FG003|Part 2: Exploratory Phase|Other|0|||
170648225|NCT00557856|616723525|FG004|Part 2: Exploratory Phase|Other|0|||
170648226|NCT00557856|616723526|FG005|Part 2: Exploratory Phase|Other|0|||
170648227|NCT00557856|616723527|FG006|Part 2: Exploratory Phase|Other|0|||
170648228|NCT00557856|616723528|FG007|Part 2: Exploratory Phase|Other|0|||
170648229|NCT00557856|616723529|FG008|Part 2: Exploratory Phase|Other|1|||
170648230|NCT00557856|616723521|FG000|Part 2: Exploratory Phase|Death|0|||
170648231|NCT00557856|616723522|FG001|Part 2: Exploratory Phase|Death|0|||
170648232|NCT00557856|616723523|FG002|Part 2: Exploratory Phase|Death|0|||
170648233|NCT00557856|616723524|FG003|Part 2: Exploratory Phase|Death|0|||
170648234|NCT00557856|616723525|FG004|Part 2: Exploratory Phase|Death|0|||
170648235|NCT00557856|616723526|FG005|Part 2: Exploratory Phase|Death|0|||
170648236|NCT00557856|616723527|FG006|Part 2: Exploratory Phase|Death|0|||
170648237|NCT00557856|616723528|FG007|Part 2: Exploratory Phase|Death|0|||
170648238|NCT00557856|616723529|FG008|Part 2: Exploratory Phase|Death|2|||
170648239|NCT00557856|616723521|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
170648240|NCT00557856|616723522|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
170648241|NCT00557856|616723523|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
170648242|NCT00557856|616723524|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
170648243|NCT00557856|616723525|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
170648244|NCT00557856|616723526|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
170648245|NCT00557856|616723527|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
170648246|NCT00557856|616723528|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
170648247|NCT00557856|616723529|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
170648248|NCT01182844|616723530|FG000|Overall Study|Withdrawal by Subject|0|||
170648249|NCT01182844|616723531|FG001|Overall Study|Withdrawal by Subject|2|||
170648250|NCT01340872|616725112|FG000|Double-blind Phase|Adverse Event|6|||
170648251|NCT01340872|616725113|FG001|Double-blind Phase|Adverse Event|4|||
170648252|NCT01340872|616725114|FG002|Double-blind Phase|Adverse Event|0|||
170569868|NCT00573391|616433873|FG001|Overall Study|Death|0|||
170569869|NCT00400517|616433874|FG000|Overall Study|Withdrawal by Subject|1|||
170569870|NCT00400517|616433874|FG000|Overall Study|Physician Decision|1|||
170569871|NCT01106157|616433875|FG000|Overall Study|Withdrawal by Subject|1|||
170569872|NCT01106157|616433876|FG001|Overall Study|Withdrawal by Subject|0|||
170569873|NCT02298868|616433877|FG000|Overall Study|Adverse Event|1|||
170569874|NCT02298868|616433877|FG000|Overall Study|Death|1|||
170569875|NCT02298868|616433877|FG000|Overall Study|Patient underwent transplant|1|||
170569876|NCT01118780|616433878|FG000|Overall Study|Adverse Event|15|||
170569877|NCT01118780|616433879|FG001|Overall Study|Adverse Event|15|||
170569878|NCT01118780|616433878|FG000|Overall Study|Death|1|||
170569879|NCT01118780|616433879|FG001|Overall Study|Death|0|||
170569880|NCT01118780|616433878|FG000|Overall Study|Lack of Efficacy|2|||
170569881|NCT01118780|616433879|FG001|Overall Study|Lack of Efficacy|6|||
170569882|NCT01118780|616433878|FG000|Overall Study|Physician Decision|2|||
170569883|NCT01118780|616433879|FG001|Overall Study|Physician Decision|0|||
170569884|NCT01118780|616433878|FG000|Overall Study|Protocol Violation|3|||
170569885|NCT01118780|616433879|FG001|Overall Study|Protocol Violation|6|||
170569886|NCT01118780|616433878|FG000|Overall Study|Withdrawal by Subject|13|||
170569887|NCT01118780|616433879|FG001|Overall Study|Withdrawal by Subject|8|||
170569888|NCT05518461|616433880|FG000|Overall Study|Lost to Follow-up|25|||
170569889|NCT02457247|616433881|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
170569890|NCT02457247|616433882|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
170569891|NCT02457247|616433883|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
170569892|NCT02457247|616433884|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
170569893|NCT02457247|616433881|FG000|Period 1|Significant Protocol Deviation|1|||
170569894|NCT02457247|616433882|FG001|Period 1|Significant Protocol Deviation|1|||
170569895|NCT02457247|616433883|FG002|Period 1|Significant Protocol Deviation|0|||
170569896|NCT02457247|616433884|FG003|Period 1|Significant Protocol Deviation|0|||
170569897|NCT02457247|616433881|FG000|Period 1|Voluntary Withdrawal|1|||
170569898|NCT02457247|616433882|FG001|Period 1|Voluntary Withdrawal|0|||
170569899|NCT02457247|616433883|FG002|Period 1|Voluntary Withdrawal|0|||
170569900|NCT02457247|616433884|FG003|Period 1|Voluntary Withdrawal|0|||
170569901|NCT02457247|616433881|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
170569902|NCT02457247|616433882|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
170569903|NCT02457247|616433883|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
170569904|NCT02457247|616433884|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
170569905|NCT02457247|616433881|FG000|Period 2|Significant Protocol Deviation|1|||
170569906|NCT02457247|616433882|FG001|Period 2|Significant Protocol Deviation|0|||
170569907|NCT02457247|616433883|FG002|Period 2|Significant Protocol Deviation|0|||
170569908|NCT02457247|616433884|FG003|Period 2|Significant Protocol Deviation|0|||
170569909|NCT02457247|616433881|FG000|Period 2|Lost to Follow-up|0|||
170569910|NCT02457247|616433882|FG001|Period 2|Lost to Follow-up|1|||
170569911|NCT02457247|616433883|FG002|Period 2|Lost to Follow-up|0|||
170648253|NCT01340872|616725115|FG003|Double-blind Phase|Adverse Event|0|||
170648254|NCT01340872|616725112|FG000|Double-blind Phase|Withdrawal by Subject|3|||
170648255|NCT01340872|616725113|FG001|Double-blind Phase|Withdrawal by Subject|5|||
170648256|NCT01340872|616725114|FG002|Double-blind Phase|Withdrawal by Subject|0|||
170648257|NCT01340872|616725115|FG003|Double-blind Phase|Withdrawal by Subject|0|||
170648258|NCT01340872|616725112|FG000|Double-blind Phase|Lost to Follow-up|0|||
170648259|NCT01340872|616725113|FG001|Double-blind Phase|Lost to Follow-up|1|||
170648260|NCT01340872|616725114|FG002|Double-blind Phase|Lost to Follow-up|0|||
170648261|NCT01340872|616725115|FG003|Double-blind Phase|Lost to Follow-up|0|||
170648262|NCT01340872|616725112|FG000|Double-blind Phase|Protocol Violation|0|||
170648263|NCT01340872|616725113|FG001|Double-blind Phase|Protocol Violation|1|||
170648264|NCT01340872|616725114|FG002|Double-blind Phase|Protocol Violation|0|||
170648265|NCT01340872|616725115|FG003|Double-blind Phase|Protocol Violation|0|||
170648266|NCT01340872|616725112|FG000|Open-label Phase|Physician Decision|0|||
170648267|NCT01340872|616725113|FG001|Open-label Phase|Physician Decision|0|||
170648268|NCT01340872|616725114|FG002|Open-label Phase|Physician Decision|2|||
170648269|NCT01340872|616725115|FG003|Open-label Phase|Physician Decision|1|||
170648270|NCT01340872|616725112|FG000|Open-label Phase|Pregnancy|0|||
170569912|NCT02457247|616433884|FG003|Period 2|Lost to Follow-up|0|||
170569913|NCT02457247|616433881|FG000|Period 2|Voluntary Withdrawal|1|||
170569914|NCT02457247|616433882|FG001|Period 2|Voluntary Withdrawal|1|||
170569915|NCT02457247|616433883|FG002|Period 2|Voluntary Withdrawal|0|||
170569916|NCT02457247|616433884|FG003|Period 2|Voluntary Withdrawal|0|||
170569917|NCT00739310|616433885|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
170569918|NCT00739310|616433885|FG000|Overall Study|Withdrawal by Subject|1|||
170569919|NCT00739310|616433885|FG000|Overall Study|Lost to Follow-up|2|||
170569920|NCT02954887|616433886|FG000|Overall Study|Withdrawal by Subject|3|||
170569921|NCT02954887|616433886|FG000|Overall Study|Lack of Efficacy|3|||
170569922|NCT02954887|616433886|FG000|Overall Study|Other|1|||
170569923|NCT01374425|616433887|FG000|Overall Study|Radiographic Disease Progression|86|||
170648271|NCT01340872|616725113|FG001|Open-label Phase|Pregnancy|0|||
170648272|NCT01340872|616725114|FG002|Open-label Phase|Pregnancy|1|||
170648273|NCT01340872|616725115|FG003|Open-label Phase|Pregnancy|0|||
170648274|NCT01340872|616725112|FG000|Open-label Phase|Adverse Event|0|||
170569924|NCT01374425|616433888|FG001|Overall Study|Radiographic Disease Progression|81|||
170569925|NCT01374425|616433887|FG000|Overall Study|Clinical Disease Progression|9|||
170569926|NCT01374425|616433888|FG001|Overall Study|Clinical Disease Progression|6|||
170569927|NCT01374425|616433887|FG000|Overall Study|Adverse Event|29|||
170569928|NCT01374425|616433888|FG001|Overall Study|Adverse Event|18|||
170569929|NCT01374425|616433887|FG000|Overall Study|Death (Progression of Disease)|1|||
170569930|NCT01374425|616433888|FG001|Overall Study|Death (Progression of Disease)|0|||
170569931|NCT01374425|616433887|FG000|Overall Study|Death (Adverse Event)|2|||
170569932|NCT01374425|616433888|FG001|Overall Study|Death (Adverse Event)|4|||
170569933|NCT01374425|616433887|FG000|Overall Study|Withdrawal by Subject|6|||
170569934|NCT01374425|616433888|FG001|Overall Study|Withdrawal by Subject|7|||
170569935|NCT01374425|616433887|FG000|Overall Study|Refused Treatment|10|||
170648275|NCT01340872|616725113|FG001|Open-label Phase|Adverse Event|0|||
170648276|NCT01340872|616725114|FG002|Open-label Phase|Adverse Event|8|||
170648277|NCT01340872|616725115|FG003|Open-label Phase|Adverse Event|4|||
170648278|NCT01340872|616725112|FG000|Open-label Phase|Withdrawal by Subject|0|||
170569936|NCT01374425|616433888|FG001|Overall Study|Refused Treatment|24|||
170569937|NCT01374425|616433887|FG000|Overall Study|Protocol Violation|2|||
170569938|NCT01374425|616433888|FG001|Overall Study|Protocol Violation|3|||
170569939|NCT01374425|616433887|FG000|Overall Study|Sponsor Decision|0|||
170569940|NCT01374425|616433888|FG001|Overall Study|Sponsor Decision|1|||
170569941|NCT01374425|616433887|FG000|Overall Study|Lost to Follow-up|2|||
170569942|NCT01374425|616433888|FG001|Overall Study|Lost to Follow-up|1|||
170569943|NCT01374425|616433887|FG000|Overall Study|Other|41|||
170569944|NCT01374425|616433888|FG001|Overall Study|Other|43|||
170569945|NCT00532844|616433891|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
170569946|NCT00532844|616433892|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
170569947|NCT00532844|616433891|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
170569948|NCT00532844|616433892|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
170569949|NCT00532844|616433891|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
170569950|NCT00532844|616433892|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
170569951|NCT00532844|616433891|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
170569952|NCT00532844|616433892|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
170569953|NCT00532844|616433891|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
170569954|NCT00532844|616433892|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
170569955|NCT01077063|616433894|FG000|Overall Study|Adverse Event|3|||
170569956|NCT01077063|616433895|FG001|Overall Study|Adverse Event|0|||
170569957|NCT01077063|616433894|FG000|Overall Study|Death|1|||
170569958|NCT01077063|616433895|FG001|Overall Study|Death|1|||
170569959|NCT01077063|616433894|FG000|Overall Study|Withdrawal by Subject|0|||
170569960|NCT01077063|616433895|FG001|Overall Study|Withdrawal by Subject|2|||
170569961|NCT00553631|616433896|FG000|Overall Study|Withdrawal by Subject|0|||
170569962|NCT00553631|616433897|FG001|Overall Study|Withdrawal by Subject|1|||
170569963|NCT00553631|616433896|FG000|Overall Study|Lost to Follow-up|1|||
170569964|NCT00553631|616433897|FG001|Overall Study|Lost to Follow-up|0|||
170569965|NCT02761642|616433898|FG000|Overall Study|Did not Receive Study Treatment|3|||
170569966|NCT02761642|616433898|FG000|Overall Study|Adverse Event|13|||
170569967|NCT02761642|616433898|FG000|Overall Study|Withdrawal by Subject|2|||
170569968|NCT02761642|616433898|FG000|Overall Study|Non-compliant|7|||
170569969|NCT02761642|616433898|FG000|Overall Study|Death|3|||
170569970|NCT02761642|616433898|FG000|Overall Study|Lack of Efficacy|20|||
170569971|NCT02761642|616433898|FG000|Overall Study|Physician Decision|1|||
170569972|NCT02761642|616433898|FG000|Overall Study|Reason Unspecified|21|||
170569973|NCT00800982|616433899|FG000|Overall Study|Lost to Follow-up|1|||
170569974|NCT00800982|616433900|FG001|Overall Study|Lost to Follow-up|2|||
170569975|NCT00800982|616433899|FG000|Overall Study|Withdrawal by Subject|0|||
170569976|NCT00800982|616433900|FG001|Overall Study|Withdrawal by Subject|1|||
170569977|NCT00800982|616433899|FG000|Overall Study|Patient moved out of state|1|||
170569978|NCT00800982|616433900|FG001|Overall Study|Patient moved out of state|0|||
170569979|NCT02240121|616433903|FG000|Overall Study|Protocol Violation|1|||
170569980|NCT02240121|616433904|FG001|Overall Study|Protocol Violation|2|||
170569981|NCT02240121|616433903|FG000|Overall Study|Physician Decision|0|||
170569982|NCT02240121|616433904|FG001|Overall Study|Physician Decision|1|||
170569983|NCT02240121|616433903|FG000|Overall Study|Change in protocol interpretation|1|||
170569984|NCT02240121|616433904|FG001|Overall Study|Change in protocol interpretation|0|||
170569985|NCT02240121|616433903|FG000|Overall Study|Lack of Efficacy|2|||
170569986|NCT02240121|616433904|FG001|Overall Study|Lack of Efficacy|3|||
170648279|NCT01340872|616725113|FG001|Open-label Phase|Withdrawal by Subject|0|||
170648280|NCT01340872|616725114|FG002|Open-label Phase|Withdrawal by Subject|1|||
170648281|NCT01340872|616725115|FG003|Open-label Phase|Withdrawal by Subject|6|||
170569987|NCT02240121|616433903|FG000|Overall Study|Site closed|1|||
170569988|NCT02240121|616433904|FG001|Overall Study|Site closed|1|||
170648282|NCT01340872|616725112|FG000|Open-label Phase|Worsening of IBD|0|||
170569989|NCT02240121|616433903|FG000|Overall Study|Pregnancy|1|||
170569990|NCT02240121|616433904|FG001|Overall Study|Pregnancy|0|||
170569991|NCT02240121|616433903|FG000|Overall Study|Adverse Event|2|||
170569992|NCT02240121|616433904|FG001|Overall Study|Adverse Event|4|||
170808378|NCT02710669|617308872|FG001|Overall Study|Physician Decision|1|||
170808379|NCT02710669|617308873|FG002|Overall Study|Physician Decision|0|||
170648283|NCT01340872|616725113|FG001|Open-label Phase|Worsening of IBD|0|||
170648284|NCT01340872|616725114|FG002|Open-label Phase|Worsening of IBD|1|||
170808380|NCT02710669|617308871|FG000|Overall Study|Institutional delays (including COVID)|2|||
170808381|NCT02710669|617308872|FG001|Overall Study|Institutional delays (including COVID)|2|||
170808382|NCT02710669|617308873|FG002|Overall Study|Institutional delays (including COVID)|0|||
170808383|NCT02710669|617308871|FG000|Overall Study|arrived in afib/aflutter|10|||
170648285|NCT01340872|616725115|FG003|Open-label Phase|Worsening of IBD|0|||
170648286|NCT04531462|616725116|FG000|Overall Study|Withdrawal by Subject|3|||
170648287|NCT04531462|616725117|FG001|Overall Study|Withdrawal by Subject|1|||
170569993|NCT02240121|616433903|FG000|Overall Study|Withdrawal by Subject|6|||
170569994|NCT02240121|616433904|FG001|Overall Study|Withdrawal by Subject|2|||
170569995|NCT02240121|616433903|FG000|Overall Study|Lost to Follow-up|3|||
170569996|NCT02240121|616433904|FG001|Overall Study|Lost to Follow-up|4|||
170569997|NCT02240121|616433903|FG000|Overall Study|Other than specified|1|||
170569998|NCT02240121|616433904|FG001|Overall Study|Other than specified|3|||
170569999|NCT00003631|616433905|FG000|Overall Study|Patient not treated|1|||
170570000|NCT00003631|616433906|FG001|Overall Study|Patient not treated|0|||
170570001|NCT00003631|616433907|FG002|Overall Study|Patient not treated|1|||
170570002|NCT00003631|616433905|FG000|Overall Study|Protocol Violation|1|||
170570003|NCT00003631|616433906|FG001|Overall Study|Protocol Violation|0|||
170570004|NCT00003631|616433907|FG002|Overall Study|Protocol Violation|0|||
170570005|NCT00003631|616433905|FG000|Overall Study|Adverse Event|1|||
170570006|NCT00003631|616433906|FG001|Overall Study|Adverse Event|1|||
170570007|NCT00003631|616433907|FG002|Overall Study|Adverse Event|5|||
170570008|NCT00003631|616433905|FG000|Overall Study|Death|0|||
170570009|NCT00003631|616433906|FG001|Overall Study|Death|0|||
170570010|NCT00003631|616433907|FG002|Overall Study|Death|1|||
170570011|NCT00003631|616433905|FG000|Overall Study|Evaluable for toxicity only|0|||
170570012|NCT00003631|616433906|FG001|Overall Study|Evaluable for toxicity only|0|||
170570013|NCT00003631|616433907|FG002|Overall Study|Evaluable for toxicity only|2|||
170570014|NCT03943290|616433911|FG000|Overall Study|Sponsor Terminated Study|6|||
170570015|NCT03943290|616433912|FG001|Overall Study|Sponsor Terminated Study|1|||
170570016|NCT03943290|616433913|FG002|Overall Study|Sponsor Terminated Study|11|||
170570017|NCT03943290|616433914|FG003|Overall Study|Sponsor Terminated Study|6|||
170570018|NCT03943290|616433915|FG004|Overall Study|Sponsor Terminated Study|7|||
170570019|NCT03943290|616433916|FG005|Overall Study|Sponsor Terminated Study|6|||
170570020|NCT03943290|616433917|FG006|Overall Study|Sponsor Terminated Study|6|||
170570021|NCT03943290|616433918|FG007|Overall Study|Sponsor Terminated Study|7|||
170570022|NCT03943290|616433919|FG008|Overall Study|Sponsor Terminated Study|8|||
170570023|NCT03943290|616433911|FG000|Overall Study|Lost to Follow-up|1|||
170570024|NCT03943290|616433912|FG001|Overall Study|Lost to Follow-up|0|||
170570025|NCT03943290|616433913|FG002|Overall Study|Lost to Follow-up|1|||
170570026|NCT03943290|616433914|FG003|Overall Study|Lost to Follow-up|0|||
170570027|NCT03943290|616433915|FG004|Overall Study|Lost to Follow-up|0|||
170570028|NCT03943290|616433916|FG005|Overall Study|Lost to Follow-up|0|||
170570029|NCT03943290|616433917|FG006|Overall Study|Lost to Follow-up|0|||
170570030|NCT03943290|616433918|FG007|Overall Study|Lost to Follow-up|1|||
170570031|NCT03943290|616433919|FG008|Overall Study|Lost to Follow-up|0|||
170570032|NCT03943290|616433911|FG000|Overall Study|Withdrawal by Subject|0|||
170570033|NCT03943290|616433912|FG001|Overall Study|Withdrawal by Subject|0|||
170570034|NCT03943290|616433913|FG002|Overall Study|Withdrawal by Subject|1|||
170570035|NCT03943290|616433914|FG003|Overall Study|Withdrawal by Subject|0|||
170570036|NCT03943290|616433915|FG004|Overall Study|Withdrawal by Subject|0|||
170570037|NCT03943290|616433916|FG005|Overall Study|Withdrawal by Subject|0|||
170570038|NCT03943290|616433917|FG006|Overall Study|Withdrawal by Subject|0|||
170808384|NCT02710669|617308872|FG001|Overall Study|arrived in afib/aflutter|8|||
170808385|NCT02710669|617308873|FG002|Overall Study|arrived in afib/aflutter|2|||
170808386|NCT04323800|617308874|FG000|Overall Study|Withdrawal by Subject|4|||
170808387|NCT04323800|617308875|FG001|Overall Study|Withdrawal by Subject|4|||
170808388|NCT04323800|617308874|FG000|Overall Study|Incomplete transfusion|1|||
170808389|NCT04323800|617308875|FG001|Overall Study|Incomplete transfusion|0|||
170808390|NCT04323800|617308874|FG000|Overall Study|Other|0|||
170570039|NCT03943290|616433918|FG007|Overall Study|Withdrawal by Subject|0|||
170570040|NCT03943290|616433919|FG008|Overall Study|Withdrawal by Subject|0|||
170570041|NCT02765399|616433920|FG000|Overall Study|Nausea|1|||
170570042|NCT02765399|616433921|FG001|Overall Study|Nausea|0|||
170570043|NCT00907621|616433923|FG000|Overall Study|Lost to Follow-up|6|||
170570044|NCT00907621|616433924|FG001|Overall Study|Lost to Follow-up|3|||
170570045|NCT00907621|616433923|FG000|Overall Study|intercurrent febrile illness|1|||
170570046|NCT00907621|616433924|FG001|Overall Study|intercurrent febrile illness|1|||
170570047|NCT00959907|616433925|FG000|Overall Study|Protocol Violation|0|||
170570048|NCT00959907|616433926|FG001|Overall Study|Protocol Violation|1|||
170570049|NCT00959907|616433925|FG000|Overall Study|Adverse Event|1|||
170648288|NCT04531462|616725116|FG000|Overall Study|Adverse Event|3|||
170648289|NCT04531462|616725117|FG001|Overall Study|Adverse Event|3|||
170570050|NCT00959907|616433926|FG001|Overall Study|Adverse Event|0|||
170808391|NCT04323800|617308875|FG001|Overall Study|Other|1|||
170570051|NCT00959907|616433925|FG000|Overall Study|Withdrawal by Subject|2|||
170570052|NCT00959907|616433926|FG001|Overall Study|Withdrawal by Subject|0|||
170570053|NCT00730886|616433927|FG000|Overall Study|Lost to Follow-up|1|||
170570054|NCT00730886|616433928|FG001|Overall Study|Lost to Follow-up|0|||
170570055|NCT00730886|616433927|FG000|Overall Study|Physician Decision|1|||
170570056|NCT00730886|616433928|FG001|Overall Study|Physician Decision|0|||
170570057|NCT02030821|616433931|FG000|Overall Study|Physician Decision|2|||
170808392|NCT04323800|617308874|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
170808393|NCT04323800|617308875|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
170808394|NCT02014402|617308879|FG000|Overall Study|Adverse Event|1|||
170808395|NCT02014402|617308880|FG001|Overall Study|Adverse Event|0|||
170808396|NCT02014402|617308881|FG002|Overall Study|Adverse Event|0|||
170808397|NCT02014402|617308882|FG003|Overall Study|Adverse Event|0|||
170808398|NCT02014402|617308879|FG000|Overall Study|Withdrawal by Subject|1|||
170570058|NCT02030821|616433932|FG001|Overall Study|Physician Decision|2|||
170570059|NCT02030821|616433933|FG002|Overall Study|Physician Decision|5|||
170570060|NCT02030821|616433934|FG003|Overall Study|Physician Decision|2|||
170570061|NCT01816048|616433935|FG000|Overall Study|Adverse Event|1|||
170570062|NCT01816048|616433935|FG000|Overall Study|Death|1|||
170570063|NCT01816048|616433935|FG000|Overall Study|Withdrawal by Subject|1|||
170570064|NCT01816048|616433935|FG000|Overall Study|Disease Progression|3|||
170570065|NCT01261975|616433940|FG000|Overall Study|Surgical complication|1|||
170570066|NCT00716274|616433941|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
170570067|NCT00716274|616433942|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
170570068|NCT00716274|616433943|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
170570069|NCT00716274|616433944|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
170570070|NCT00716274|616433945|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
170570071|NCT00716274|616433946|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
170570072|NCT00716274|616433941|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
170570073|NCT00716274|616433942|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
170570074|NCT00716274|616433943|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
170570075|NCT00716274|616433944|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
170570076|NCT00716274|616433945|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
170570077|NCT00716274|616433946|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
170570078|NCT00716274|616433941|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
170570079|NCT00716274|616433942|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
170570080|NCT00716274|616433943|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
170570081|NCT00716274|616433944|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
170570082|NCT00716274|616433945|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
170570083|NCT00716274|616433946|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
170570084|NCT00716274|616433941|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
170570085|NCT00716274|616433942|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
170570086|NCT00716274|616433943|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
170570087|NCT00716274|616433944|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
170570088|NCT00716274|616433945|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
170570089|NCT00716274|616433946|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
170570090|NCT00716274|616433941|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
170570091|NCT00716274|616433942|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
170570092|NCT00716274|616433943|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
170570093|NCT00716274|616433944|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
170570094|NCT00716274|616433945|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
170570095|NCT00716274|616433946|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
170570096|NCT00716274|616433941|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
170570097|NCT00716274|616433942|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
170570098|NCT00716274|616433943|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
170570099|NCT00716274|616433944|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
170570100|NCT00716274|616433945|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
170570101|NCT00716274|616433946|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
170570102|NCT00716274|616433941|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
170570103|NCT00716274|616433942|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
170808399|NCT02014402|617308880|FG001|Overall Study|Withdrawal by Subject|2|||
170808400|NCT02014402|617308881|FG002|Overall Study|Withdrawal by Subject|2|||
170808401|NCT02014402|617308882|FG003|Overall Study|Withdrawal by Subject|1|||
170808402|NCT02014402|617308879|FG000|Overall Study|Subject did not have transportation|0|||
170808403|NCT02014402|617308880|FG001|Overall Study|Subject did not have transportation|1|||
170808404|NCT02014402|617308881|FG002|Overall Study|Subject did not have transportation|0|||
170808405|NCT02014402|617308882|FG003|Overall Study|Subject did not have transportation|0|||
170808406|NCT02014402|617308879|FG000|Overall Study|Lost to Follow-up|0|||
170808407|NCT02014402|617308880|FG001|Overall Study|Lost to Follow-up|0|||
170570104|NCT00716274|616433943|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
170570105|NCT00716274|616433944|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
170570106|NCT00716274|616433945|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
170570107|NCT00716274|616433946|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
170570108|NCT00716274|616433941|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
170570109|NCT00716274|616433942|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
170570110|NCT00716274|616433943|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
170570111|NCT00716274|616433944|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
170570112|NCT00716274|616433945|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
170570113|NCT00716274|616433946|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
170570114|NCT00716274|616433941|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
170570115|NCT00716274|616433942|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
170570116|NCT00716274|616433943|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
170570117|NCT00716274|616433944|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
170570118|NCT00716274|616433945|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
170570119|NCT00716274|616433946|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
170570120|NCT00716274|616433941|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
170570121|NCT00716274|616433942|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
170570122|NCT00716274|616433943|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
170570123|NCT00716274|616433944|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
170570124|NCT00716274|616433945|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
170570125|NCT00716274|616433946|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
170570126|NCT01932788|616433947|FG000|Overall Study|Protocol Violation|18|||
170570127|NCT01932788|616433948|FG001|Overall Study|Protocol Violation|0|||
170570128|NCT01932788|616433947|FG000|Overall Study|Lost to Follow-up|18|||
170570129|NCT01932788|616433948|FG001|Overall Study|Lost to Follow-up|46|||
170570130|NCT01932788|616433947|FG000|Overall Study|Lack of Efficacy|2|||
170570131|NCT01932788|616433948|FG001|Overall Study|Lack of Efficacy|0|||
170570132|NCT01932788|616433947|FG000|Overall Study|Withdrawal by Subject|0|||
170570133|NCT01932788|616433948|FG001|Overall Study|Withdrawal by Subject|5|||
170570134|NCT04290624|616433949|FG000|Overall Study|Adverse Event|1|||
170570135|NCT04290624|616433950|FG001|Overall Study|Adverse Event|0|||
170570136|NCT01171677|616433951|FG000|Overall Study|Withdrawal by Subject|0|||
170570137|NCT01171677|616433952|FG001|Overall Study|Withdrawal by Subject|3|||
170570138|NCT01171677|616433951|FG000|Overall Study|Adverse Event|1|||
170570139|NCT01171677|616433952|FG001|Overall Study|Adverse Event|0|||
170570140|NCT01171677|616433951|FG000|Overall Study|completed <70% IntenSati classes|5|||
170570141|NCT01171677|616433952|FG001|Overall Study|completed <70% IntenSati classes|0|||
170570142|NCT01342094|616433955|FG000|Overall Study|Adverse Event|5|||
170570143|NCT01342094|616433956|FG001|Overall Study|Adverse Event|0|||
170570144|NCT01342094|616433955|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
170570145|NCT01342094|616433956|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
170570146|NCT01342094|616433955|FG000|Overall Study|Withdrawal by Subject|0|||
170570147|NCT01342094|616433956|FG001|Overall Study|Withdrawal by Subject|2|||
170570148|NCT05899829|616433957|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
170570149|NCT05899829|616433958|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
170570150|NCT05899829|616433957|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
170570151|NCT05899829|616433958|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
170570152|NCT02806414|616433963|FG000|Overall Study|Lost to Follow-up|2|||
170570153|NCT04021290|616433968|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
170570154|NCT04021290|616433969|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
170570155|NCT04021290|616433970|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
170570156|NCT04021290|616433968|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
170570157|NCT04021290|616433969|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
170570158|NCT04021290|616433970|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
170570159|NCT04021290|616433968|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
170570160|NCT04021290|616433969|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
170570161|NCT04021290|616433970|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
170570162|NCT04021290|616433968|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
170570163|NCT04021290|616433969|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
170648290|NCT00039871|616725123|FG000|Overall Study|Adverse Event|165|||
170648291|NCT00039871|616725123|FG000|Overall Study|Lost to Follow-up|18|||
170648292|NCT00039871|616725123|FG000|Overall Study|Protocol Violation|24|||
170648293|NCT00039871|616725123|FG000|Overall Study|Withdrawal by Subject|97|||
170648294|NCT00039871|616725123|FG000|Overall Study|Did not meet eligibility criteria|11|||
170808408|NCT02014402|617308881|FG002|Overall Study|Lost to Follow-up|1|||
170808409|NCT02014402|617308882|FG003|Overall Study|Lost to Follow-up|2|||
170808410|NCT05987033|617308886|FG000|Enrollment|Withdrawal by Subject|1|||
170808411|NCT05987033|617308886|FG000|Implantd with NVDX3|Withdrawal by Subject|1|||
170808412|NCT04233879|617308887|FG000|Base Study (Day 1 to Week 144)|Death|3|||
170808413|NCT04233879|617308888|FG001|Base Study (Day 1 to Week 144)|Death|0|||
170808414|NCT04233879|617308887|FG000|Base Study (Day 1 to Week 144)|Lost to Follow-up|16|||
170808415|NCT04233879|617308888|FG001|Base Study (Day 1 to Week 144)|Lost to Follow-up|17|||
170808416|NCT04233879|617308887|FG000|Base Study (Day 1 to Week 144)|Physician Decision|11|||
170570164|NCT04021290|616433970|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
170570165|NCT04021290|616433968|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
170570166|NCT04021290|616433969|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
170570167|NCT04021290|616433970|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
170570168|NCT04021290|616433968|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
170570169|NCT04021290|616433969|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
170570170|NCT04021290|616433970|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
170570171|NCT04021290|616433968|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
170570172|NCT04021290|616433969|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
170570173|NCT04021290|616433970|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
170570174|NCT04021290|616433968|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
170570175|NCT04021290|616433969|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
170570176|NCT04021290|616433970|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
170570177|NCT04021290|616433968|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
170570178|NCT04021290|616433969|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
170570179|NCT04021290|616433970|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
170570180|NCT04021290|616433968|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
170570181|NCT04021290|616433969|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
170570182|NCT04021290|616433970|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
170570183|NCT04021290|616433968|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
170570184|NCT04021290|616433969|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
170570185|NCT04021290|616433970|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
170570186|NCT04021290|616433968|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
170570187|NCT04021290|616433969|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
170570188|NCT04021290|616433970|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
170570189|NCT05076045|616433973|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
170570190|NCT05076045|616433974|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
170570191|NCT03391882|616433975|FG000|Study Overall|Adverse Event|3|||
170570192|NCT03391882|616433976|FG001|Study Overall|Adverse Event|6|||
170570193|NCT03391882|616433977|FG002|Study Overall|Adverse Event|1|||
170570194|NCT03391882|616433978|FG003|Study Overall|Adverse Event|1|||
170570195|NCT03391882|616433979|FG004|Study Overall|Adverse Event|3|||
170570196|NCT03391882|616433980|FG005|Study Overall|Adverse Event|1|||
170570197|NCT03391882|616433975|FG000|Study Overall|Lack of Efficacy|13|||
170570198|NCT03391882|616433976|FG001|Study Overall|Lack of Efficacy|9|||
170570199|NCT03391882|616433977|FG002|Study Overall|Lack of Efficacy|0|||
170570200|NCT03391882|616433978|FG003|Study Overall|Lack of Efficacy|0|||
170570201|NCT03391882|616433979|FG004|Study Overall|Lack of Efficacy|0|||
170570202|NCT03391882|616433980|FG005|Study Overall|Lack of Efficacy|0|||
170570203|NCT03391882|616433975|FG000|Study Overall|Withdrawal by Subject|3|||
170570204|NCT03391882|616433976|FG001|Study Overall|Withdrawal by Subject|3|||
170570205|NCT03391882|616433977|FG002|Study Overall|Withdrawal by Subject|2|||
170570206|NCT03391882|616433978|FG003|Study Overall|Withdrawal by Subject|2|||
170570207|NCT03391882|616433979|FG004|Study Overall|Withdrawal by Subject|1|||
170570208|NCT03391882|616433980|FG005|Study Overall|Withdrawal by Subject|3|||
170570209|NCT03391882|616433975|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
170570210|NCT03391882|616433976|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
170570211|NCT03391882|616433977|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
170570212|NCT03391882|616433978|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
170570213|NCT03391882|616433979|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
170570214|NCT03391882|616433980|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
170570215|NCT03391882|616433975|FG000|Study Overall|Protocol Violation|1|||
170570216|NCT03391882|616433976|FG001|Study Overall|Protocol Violation|0|||
170570217|NCT03391882|616433977|FG002|Study Overall|Protocol Violation|0|||
170570218|NCT03391882|616433978|FG003|Study Overall|Protocol Violation|0|||
170570219|NCT03391882|616433979|FG004|Study Overall|Protocol Violation|0|||
170570220|NCT03391882|616433980|FG005|Study Overall|Protocol Violation|0|||
170570221|NCT03391882|616433975|FG000|Part A - Titration Phase|Adverse Event|3|||
170570222|NCT03391882|616433976|FG001|Part A - Titration Phase|Adverse Event|6|||
170570223|NCT03391882|616433977|FG002|Part A - Titration Phase|Adverse Event|0|||
170808417|NCT04233879|617308888|FG001|Base Study (Day 1 to Week 144)|Physician Decision|7|||
170570224|NCT03391882|616433978|FG003|Part A - Titration Phase|Adverse Event|0|||
170570225|NCT03391882|616433979|FG004|Part A - Titration Phase|Adverse Event|0|||
170570226|NCT03391882|616433980|FG005|Part A - Titration Phase|Adverse Event|0|||
170570227|NCT03391882|616433975|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
170570228|NCT03391882|616433976|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
170570229|NCT03391882|616433977|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
170570230|NCT03391882|616433978|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
170570231|NCT03391882|616433979|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
170570232|NCT03391882|616433980|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
170570233|NCT03391882|616433975|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
170570234|NCT03391882|616433976|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
170648295|NCT00039871|616725123|FG000|Overall Study|Administrative|1|||
170648296|NCT00039871|616725123|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
170648297|NCT00039871|616725123|FG000|Overall Study|Never entered follow-up|7|||
170570235|NCT03391882|616433977|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
170570236|NCT03391882|616433978|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
170570237|NCT03391882|616433979|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
170570238|NCT03391882|616433980|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
170570239|NCT03391882|616433975|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
170570240|NCT03391882|616433976|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
170570241|NCT03391882|616433977|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
170570242|NCT03391882|616433978|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
170570243|NCT03391882|616433979|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
170570244|NCT03391882|616433980|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
170570245|NCT03391882|616433975|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
170570246|NCT03391882|616433976|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
170570247|NCT03391882|616433977|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
170570248|NCT03391882|616433978|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
170570249|NCT03391882|616433979|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
170570250|NCT03391882|616433980|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
170570251|NCT03391882|616433975|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
170570252|NCT03391882|616433976|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
170570253|NCT03391882|616433977|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
170570254|NCT03391882|616433978|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
170570255|NCT03391882|616433979|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
170570256|NCT03391882|616433980|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
170570257|NCT03391882|616433975|FG000|Part B - Treatment Phase|Adverse Event|0|||
170570258|NCT03391882|616433976|FG001|Part B - Treatment Phase|Adverse Event|0|||
170570259|NCT03391882|616433977|FG002|Part B - Treatment Phase|Adverse Event|1|||
170570260|NCT03391882|616433978|FG003|Part B - Treatment Phase|Adverse Event|1|||
170570261|NCT03391882|616433979|FG004|Part B - Treatment Phase|Adverse Event|3|||
170648298|NCT02661178|616725125|FG000|Part 1|Protocol Violation|1|||
170648299|NCT02661178|616725126|FG001|Part 1|Protocol Violation|0|||
170648300|NCT02661178|616725127|FG002|Part 1|Protocol Violation|0|||
170648301|NCT02661178|616725128|FG003|Part 1|Protocol Violation|0|||
170648302|NCT02661178|616725129|FG004|Part 1|Protocol Violation|0|||
170648303|NCT02661178|616725130|FG005|Part 1|Protocol Violation|0|||
170648304|NCT02661178|616725131|FG006|Part 1|Protocol Violation|0|||
170648305|NCT02661178|616725132|FG007|Part 1|Protocol Violation|0|||
170648306|NCT02661178|616725133|FG008|Part 1|Protocol Violation|0|||
170648307|NCT02661178|616725134|FG009|Part 1|Protocol Violation|0|||
170570262|NCT03391882|616433980|FG005|Part B - Treatment Phase|Adverse Event|1|||
170648308|NCT02661178|616725135|FG010|Part 1|Protocol Violation|0|||
170648309|NCT02661178|616725136|FG011|Part 1|Protocol Violation|0|||
170648310|NCT02661178|616725137|FG012|Part 1|Protocol Violation|0|||
170648311|NCT02661178|616725138|FG013|Part 1|Protocol Violation|0|||
170648312|NCT02661178|616725139|FG014|Part 1|Protocol Violation|0|||
170648313|NCT01205581|616725143|FG000|Overall Study|Withdrawal by Subject|1|||
170570263|NCT03391882|616433975|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
170570264|NCT03391882|616433976|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
170648314|NCT01205581|616725144|FG001|Overall Study|Withdrawal by Subject|0|||
170648315|NCT01205581|616725145|FG002|Overall Study|Withdrawal by Subject|0|||
170648316|NCT01205581|616725146|FG003|Overall Study|Withdrawal by Subject|0|||
170648317|NCT01205581|616725147|FG004|Overall Study|Withdrawal by Subject|0|||
170648318|NCT01205581|616725148|FG005|Overall Study|Withdrawal by Subject|0|||
170648319|NCT02278471|616725149|FG000|Overall Study|Lost to Follow-up|6|||
170648320|NCT02278471|616725150|FG001|Overall Study|Lost to Follow-up|15|||
170648321|NCT02278471|616725149|FG000|Overall Study|Death|2|||
170648322|NCT02278471|616725150|FG001|Overall Study|Death|2|||
170648323|NCT02278471|616725149|FG000|Overall Study|Withdrawal by Subject|0|||
170648324|NCT02278471|616725150|FG001|Overall Study|Withdrawal by Subject|3|||
170570265|NCT03391882|616433977|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
170570266|NCT03391882|616433978|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
170570267|NCT03391882|616433979|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
170570268|NCT03391882|616433980|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
170570269|NCT02670473|616433983|FG000|Overall Study|Withdrawal by Subject|1|||
170648325|NCT04456673|616725153|FG000|Overall Study|Adverse Event|7|||
170648326|NCT04456673|616725154|FG001|Overall Study|Adverse Event|14|||
170648327|NCT04456673|616725153|FG000|Overall Study|Poor compliance to protocol|1|||
170648328|NCT04456673|616725154|FG001|Overall Study|Poor compliance to protocol|0|||
170648329|NCT04456673|616725153|FG000|Overall Study|Withdrawal by Subject|31|||
170648330|NCT04456673|616725154|FG001|Overall Study|Withdrawal by Subject|23|||
170648331|NCT04456673|616725153|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
170648332|NCT04456673|616725154|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
170648333|NCT01242813|616725155|FG000|Overall Study|Lost to Follow-up|2|||
170648334|NCT04644315|616725156|FG000|Overall Study|Subject withdrawal of consent|1|||
170648335|NCT02238080|616725158|FG000|Overall Study|Death|13|||
170570270|NCT00027560|616433986|FG000|Overall Study|Withdrawal by Subject|1|||
170570271|NCT03384875|616433987|FG000|Overall Study|Death|1|||
170570272|NCT03384875|616433988|FG001|Overall Study|Death|1|||
170570273|NCT03384875|616433989|FG002|Overall Study|Death|0|||
170570274|NCT03384875|616433987|FG000|Overall Study|Reason not provided|1|||
170570275|NCT03384875|616433988|FG001|Overall Study|Reason not provided|0|||
170570276|NCT03384875|616433989|FG002|Overall Study|Reason not provided|0|||
170570277|NCT00678288|616435445|FG000|Overall Study|Adverse Event|0|||
170570278|NCT00678288|616435446|FG001|Overall Study|Adverse Event|2|||
170570279|NCT00678288|616435445|FG000|Overall Study|Withdrawal by Subject|1|||
170570280|NCT00678288|616435446|FG001|Overall Study|Withdrawal by Subject|1|||
170570281|NCT00678288|616435445|FG000|Overall Study|Study terminated by the sponsor|2|||
170570282|NCT00678288|616435446|FG001|Overall Study|Study terminated by the sponsor|0|||
170570283|NCT00678288|616435445|FG000|Overall Study|Not compliant with study medication|0|||
170570284|NCT00678288|616435446|FG001|Overall Study|Not compliant with study medication|1|||
170570285|NCT00678288|616435445|FG000|Overall Study|Switch to commercial drug|0|||
170570286|NCT00678288|616435446|FG001|Overall Study|Switch to commercial drug|1|||
170570287|NCT00678288|616435445|FG000|Overall Study|Reason not reported|1|||
170570288|NCT00678288|616435446|FG001|Overall Study|Reason not reported|0|||
170570289|NCT00678288|616435445|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
170570290|NCT00678288|616435446|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
170570291|NCT04776161|616435449|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
170570292|NCT04776161|616435450|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
170570293|NCT04776161|616435451|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
170570294|NCT04776161|616435449|FG000|Overall Study|Withdrawal by Subject|1|||
170570295|NCT04776161|616435450|FG001|Overall Study|Withdrawal by Subject|0|||
170570296|NCT04776161|616435451|FG002|Overall Study|Withdrawal by Subject|1|||
170570297|NCT04776161|616435449|FG000|Overall Study|Adverse Event|0|||
170570298|NCT04776161|616435450|FG001|Overall Study|Adverse Event|1|||
170570299|NCT04776161|616435451|FG002|Overall Study|Adverse Event|1|||
170570300|NCT01334554|616435452|FG000|Overall Study|Adverse Event|4|||
170570301|NCT01334554|616435453|FG001|Overall Study|Adverse Event|2|||
170570302|NCT02896257|616435454|FG000|Providers|Without eligible patients|21|||
170570303|NCT02896257|616435455|FG001|Providers|Without eligible patients|28|||
170570304|NCT02896257|616435454|FG000|Patients|PFT entry criteria not met|43|||
170570305|NCT02896257|616435455|FG001|Patients|PFT entry criteria not met|50|||
170570306|NCT02896257|616435454|FG000|Patients|No capacity to review|8|||
170570307|NCT02896257|616435455|FG001|Patients|No capacity to review|11|||
170570308|NCT02896257|616435454|FG000|Patients|Appointment rescheduled/cancelled|5|||
170570309|NCT02896257|616435455|FG001|Patients|Appointment rescheduled/cancelled|7|||
170570310|NCT02896257|616435454|FG000|Patients|PCP not assigned a clinic|4|||
170570311|NCT02896257|616435455|FG001|Patients|PCP not assigned a clinic|0|||
170570312|NCT02896257|616435454|FG000|Patients|No history of COPD|0|||
170570313|NCT02896257|616435455|FG001|Patients|No history of COPD|1|||
170570314|NCT02896257|616435454|FG000|Patients|Deceased between review and index date|0|||
170570315|NCT02896257|616435455|FG001|Patients|Deceased between review and index date|1|||
170570316|NCT02896257|616435454|FG000|Patients|No ICS Rx upon review|1|||
170570317|NCT02896257|616435455|FG001|Patients|No ICS Rx upon review|1|||
170570318|NCT02896257|616435454|FG000|Patients|Protocol Violation|2|||
170570319|NCT02896257|616435455|FG001|Patients|Protocol Violation|1|||
170570320|NCT02896257|616435454|FG000|Patients|Hospice care|0|||
170570321|NCT02896257|616435455|FG001|Patients|Hospice care|1|||
170570322|NCT01535287|616435457|FG000|Overall Study|drug not prepared in time|5|||
170570323|NCT01535287|616435458|FG001|Overall Study|drug not prepared in time|6|||
170570324|NCT00628446|616435459|FG000|Overall Study|Lost to Follow-up|3|||
170570325|NCT00628446|616435459|FG000|Overall Study|Withdrawal by Subject|1|||
170570326|NCT00628446|616435459|FG000|Overall Study|Protocol Violation|3|||
170570327|NCT04723355|616435462|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
170570328|NCT04723355|616435462|FG000|Overall Study|Errors in the informed consent form|2|||
170648336|NCT02238080|616725158|FG000|Overall Study|Treatment interrupted|6|||
170648337|NCT02238080|616725158|FG000|Overall Study|Withdrawal by Subject|2|||
170570329|NCT01823107|616435464|FG000|Overall Study|Withdrawal by Subject|1|||
170570330|NCT00328172|616435469|FG000|Overall Study|Adverse Event|3|||
170570331|NCT00328172|616435470|FG001|Overall Study|Adverse Event|2|||
170648338|NCT02238080|616725158|FG000|Overall Study|Other|4|||
170648339|NCT01738646|616725159|FG000|Overall Study|Still Receiving Treatment|2|||
170570332|NCT00328172|616435471|FG002|Overall Study|Adverse Event|1|||
170570333|NCT00328172|616435472|FG003|Overall Study|Adverse Event|2|||
170570334|NCT00328172|616435473|FG004|Overall Study|Adverse Event|1|||
170570335|NCT00328172|616435469|FG000|Overall Study|Protocol Violation|0|||
170570336|NCT00328172|616435470|FG001|Overall Study|Protocol Violation|1|||
170570337|NCT00328172|616435471|FG002|Overall Study|Protocol Violation|1|||
170570338|NCT00328172|616435472|FG003|Overall Study|Protocol Violation|0|||
170570339|NCT00328172|616435473|FG004|Overall Study|Protocol Violation|0|||
170570340|NCT00328172|616435469|FG000|Overall Study|Lost to Follow-up|1|||
170570341|NCT00328172|616435470|FG001|Overall Study|Lost to Follow-up|1|||
170570342|NCT00328172|616435471|FG002|Overall Study|Lost to Follow-up|2|||
170570343|NCT00328172|616435472|FG003|Overall Study|Lost to Follow-up|1|||
170570344|NCT00328172|616435473|FG004|Overall Study|Lost to Follow-up|1|||
170570345|NCT00328172|616435469|FG000|Overall Study|Withdrawal by Subject|1|||
170570346|NCT00328172|616435470|FG001|Overall Study|Withdrawal by Subject|1|||
170570347|NCT00328172|616435471|FG002|Overall Study|Withdrawal by Subject|1|||
170808418|NCT04233879|617308887|FG000|Base Study (Day 1 to Week 144)|Sponsor Decision|168|||
170808419|NCT04233879|617308888|FG001|Base Study (Day 1 to Week 144)|Sponsor Decision|179|||
170808420|NCT04233879|617308887|FG000|Base Study (Day 1 to Week 144)|Withdrawal by Subject|35|||
170808421|NCT04233879|617308888|FG001|Base Study (Day 1 to Week 144)|Withdrawal by Subject|34|||
170808422|NCT04233879|617308887|FG000|Base Study (Day 1 to Week 144)|Other|6|||
170808423|NCT04233879|617308888|FG001|Base Study (Day 1 to Week 144)|Other|30|||
170808424|NCT04233879|617308887|FG000|Extension Study (Week 144 to 168)|Lost to Follow-up|0|||
170808425|NCT04233879|617308888|FG001|Extension Study (Week 144 to 168)|Lost to Follow-up|1|||
170808426|NCT04233879|617308887|FG000|Extension Study (Week 144 to 168)|Sponsor Decision|20|||
170808427|NCT04233879|617308888|FG001|Extension Study (Week 144 to 168)|Sponsor Decision|25|||
170648340|NCT03642132|616725161|FG000|Chemotherapy Period|Adverse Event|1|||
170648341|NCT03642132|616725162|FG001|Chemotherapy Period|Adverse Event|1|||
170648342|NCT03642132|616725163|FG002|Chemotherapy Period|Adverse Event|0|||
170648343|NCT03642132|616725161|FG000|Chemotherapy Period|Physician's decision|4|||
170648344|NCT03642132|616725162|FG001|Chemotherapy Period|Physician's decision|1|||
170648345|NCT03642132|616725163|FG002|Chemotherapy Period|Physician's decision|0|||
170648346|NCT03642132|616725161|FG000|Chemotherapy Period|Progressive disease|0|||
170570348|NCT00328172|616435472|FG003|Overall Study|Withdrawal by Subject|6|||
170570349|NCT00328172|616435473|FG004|Overall Study|Withdrawal by Subject|0|||
170570350|NCT00328172|616435469|FG000|Overall Study|Lack of Efficacy|14|||
170570351|NCT00328172|616435470|FG001|Overall Study|Lack of Efficacy|9|||
170570352|NCT00328172|616435471|FG002|Overall Study|Lack of Efficacy|4|||
170570353|NCT00328172|616435472|FG003|Overall Study|Lack of Efficacy|4|||
170570354|NCT00328172|616435473|FG004|Overall Study|Lack of Efficacy|3|||
170570355|NCT00328172|616435469|FG000|Overall Study|Other reason (not specified)|3|||
170570356|NCT00328172|616435470|FG001|Overall Study|Other reason (not specified)|0|||
170570357|NCT00328172|616435471|FG002|Overall Study|Other reason (not specified)|1|||
170570358|NCT00328172|616435472|FG003|Overall Study|Other reason (not specified)|0|||
170570359|NCT00328172|616435473|FG004|Overall Study|Other reason (not specified)|0|||
170570360|NCT00077974|616435474|FG000|Overall Study|Adverse Event|22|||
170570361|NCT00077974|616435474|FG000|Overall Study|Protocol Violation|1|||
170570362|NCT00077974|616435474|FG000|Overall Study|Withdrawal by Subject|3|||
170570363|NCT00077974|616435474|FG000|Overall Study|Lack of Efficacy|76|||
170570364|NCT00077974|616435474|FG000|Overall Study|Decision of Sponsor|2|||
170570365|NCT04567524|616435477|FG000|Overall Study|Adverse Event|1|||
170570366|NCT04567524|616435478|FG001|Overall Study|Adverse Event|1|||
170570367|NCT04567524|616435479|FG002|Overall Study|Adverse Event|0|||
170570368|NCT04567524|616435480|FG003|Overall Study|Adverse Event|0|||
170570369|NCT04567524|616435477|FG000|Overall Study|Withdrawal by Subject|2|||
170570370|NCT04567524|616435478|FG001|Overall Study|Withdrawal by Subject|0|||
170570371|NCT04567524|616435479|FG002|Overall Study|Withdrawal by Subject|0|||
170570372|NCT04567524|616435480|FG003|Overall Study|Withdrawal by Subject|1|||
170570373|NCT02848092|616435481|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
170570374|NCT02848092|616435482|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
170570375|NCT02848092|616435481|FG000|1-month Post-training Follow-up|Adverse Event|2|||
170570376|NCT02848092|616435482|FG001|1-month Post-training Follow-up|Adverse Event|1|||
170570377|NCT02848092|616435481|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
170570378|NCT02848092|616435482|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
170570379|NCT02848092|616435481|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
170570380|NCT02848092|616435482|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
170570381|NCT02848092|616435481|FG000|1-month Post-training Follow-up|fatigue|0|||
170570382|NCT02848092|616435482|FG001|1-month Post-training Follow-up|fatigue|1|||
170570383|NCT02848092|616435481|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
170570384|NCT02848092|616435482|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
170570385|NCT02848092|616435481|FG000|6-month Post-training Follow-up|Adverse Event|1|||
170570386|NCT02848092|616435482|FG001|6-month Post-training Follow-up|Adverse Event|1|||
170570387|NCT02848092|616435481|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
170570388|NCT02848092|616435482|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
170570389|NCT02848092|616435481|FG000|6-month Post-training Follow-up|frustrated with task|1|||
170570390|NCT02848092|616435482|FG001|6-month Post-training Follow-up|frustrated with task|0|||
170570391|NCT02848092|616435481|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
170570392|NCT02848092|616435482|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
170570393|NCT02848092|616435481|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
170648347|NCT03642132|616725162|FG001|Chemotherapy Period|Progressive disease|0|||
170648348|NCT03642132|616725163|FG002|Chemotherapy Period|Progressive disease|1|||
170648349|NCT03642132|616725161|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
170648350|NCT03642132|616725162|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
170648351|NCT03642132|616725163|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
170648352|NCT03642132|616725161|FG000|Chemotherapy Period|Other|1|||
170648353|NCT03642132|616725162|FG001|Chemotherapy Period|Other|0|||
170648354|NCT03642132|616725163|FG002|Chemotherapy Period|Other|2|||
170648355|NCT03642132|616725161|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
170648356|NCT03642132|616725162|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
170648357|NCT03642132|616725163|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
170648358|NCT03642132|616725161|FG000|Maintenance Period|Adverse Event|1|||
170648359|NCT03642132|616725162|FG001|Maintenance Period|Adverse Event|2|||
170648360|NCT03642132|616725163|FG002|Maintenance Period|Adverse Event|0|||
170648361|NCT03642132|616725161|FG000|Maintenance Period|Non-compliance with study drug|0|||
170648362|NCT03642132|616725162|FG001|Maintenance Period|Non-compliance with study drug|0|||
170648363|NCT03642132|616725163|FG002|Maintenance Period|Non-compliance with study drug|1|||
170648364|NCT03642132|616725161|FG000|Maintenance Period|Physician's decision|2|||
170648365|NCT03642132|616725162|FG001|Maintenance Period|Physician's decision|2|||
170648366|NCT03642132|616725163|FG002|Maintenance Period|Physician's decision|2|||
170648367|NCT03642132|616725161|FG000|Maintenance Period|Progressive disease|9|||
170648368|NCT03642132|616725162|FG001|Maintenance Period|Progressive disease|3|||
170648369|NCT03642132|616725163|FG002|Maintenance Period|Progressive disease|6|||
170648370|NCT03642132|616725161|FG000|Maintenance Period|Other|0|||
170648371|NCT03642132|616725162|FG001|Maintenance Period|Other|0|||
170648372|NCT03642132|616725163|FG002|Maintenance Period|Other|3|||
170648373|NCT03642132|616725161|FG000|Maintenance Period|Withdrawal by Subject|1|||
170648374|NCT03642132|616725162|FG001|Maintenance Period|Withdrawal by Subject|1|||
170648375|NCT03642132|616725163|FG002|Maintenance Period|Withdrawal by Subject|2|||
170648376|NCT03642132|616725161|FG000|Follow-up Period|Other|0|||
170648377|NCT03642132|616725162|FG001|Follow-up Period|Other|0|||
170648378|NCT03642132|616725163|FG002|Follow-up Period|Other|1|||
170648379|NCT03642132|616725161|FG000|Follow-up Period|Withdrawal by Subject|1|||
170648380|NCT03642132|616725162|FG001|Follow-up Period|Withdrawal by Subject|2|||
170648381|NCT03642132|616725163|FG002|Follow-up Period|Withdrawal by Subject|0|||
170648382|NCT03642132|616725161|FG000|Follow-up Period|Study terminated by sponsor|1|||
170648383|NCT03642132|616725162|FG001|Follow-up Period|Study terminated by sponsor|0|||
170648384|NCT03642132|616725163|FG002|Follow-up Period|Study terminated by sponsor|1|||
170648385|NCT03642132|616725161|FG000|Follow-up Period|Lack of Efficacy|1|||
170648386|NCT03642132|616725162|FG001|Follow-up Period|Lack of Efficacy|0|||
170648387|NCT03642132|616725163|FG002|Follow-up Period|Lack of Efficacy|0|||
170648388|NCT03642132|616725161|FG000|Follow-up Period|Death|1|||
170648389|NCT03642132|616725162|FG001|Follow-up Period|Death|0|||
170648390|NCT03642132|616725163|FG002|Follow-up Period|Death|2|||
170648391|NCT03642132|616725161|FG000|Follow-up Period|Adverse Event|1|||
170648392|NCT03642132|616725162|FG001|Follow-up Period|Adverse Event|0|||
170648393|NCT03642132|616725163|FG002|Follow-up Period|Adverse Event|0|||
170570394|NCT02848092|616435482|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
170570395|NCT00420381|616435487|FG000|Overall Study|Protocol Violation|1|||
170570396|NCT01147393|616435488|FG000|Dose Level 1|Dose limiting Toxicity|2|||
170570397|NCT01147393|616435488|FG000|Dose Level -1|Dose Limited Toxicity|1|||
170570398|NCT03432494|616435506|FG000|Overall Study|Death|1|||
170570399|NCT03432494|616435506|FG000|Overall Study|Noncompliance|1|||
170570400|NCT00775268|616435507|FG000|Baseline|Drug not synthesize dose|1|||
170570401|NCT00775268|616435508|FG001|Baseline|Drug not synthesize dose|0|||
170570402|NCT00775268|616435507|FG000|Baseline|Not treated-ineligible per CT|0|||
170570403|NCT00775268|616435508|FG001|Baseline|Not treated-ineligible per CT|1|||
170570404|NCT00775268|616435507|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
170570405|NCT00775268|616435508|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
170570406|NCT00775268|616435507|FG000|After Completion|Participant missed scan appointment|1|||
170570407|NCT00775268|616435508|FG001|After Completion|Participant missed scan appointment|0|||
170570408|NCT00825994|616435509|FG000|Overall Study|Withdrawal by Subject|2|||
170648394|NCT03337490|616725169|FG000|Overall Study|Withdrawal by Subject|1|||
170648395|NCT03337490|616725170|FG001|Overall Study|Withdrawal by Subject|0|||
170648396|NCT03337490|616725171|FG002|Overall Study|Withdrawal by Subject|0|||
170648397|NCT03337490|616725169|FG000|Overall Study|Lack of Efficacy|10|||
170648398|NCT03337490|616725170|FG001|Overall Study|Lack of Efficacy|12|||
170570409|NCT00825994|616435509|FG000|Overall Study|Lost to Follow-up|1|||
170648399|NCT03337490|616725171|FG002|Overall Study|Lack of Efficacy|35|||
170648400|NCT03337490|616725169|FG000|Overall Study|Physician Decision|0|||
170648401|NCT03337490|616725170|FG001|Overall Study|Physician Decision|1|||
170648402|NCT03337490|616725171|FG002|Overall Study|Physician Decision|0|||
170648403|NCT03337490|616725169|FG000|Overall Study|Lost to Follow-up|0|||
170648404|NCT03337490|616725170|FG001|Overall Study|Lost to Follow-up|1|||
170648405|NCT03337490|616725171|FG002|Overall Study|Lost to Follow-up|0|||
170648406|NCT04493892|616725172|FG000|Overall Study|Withdrawal by Subject|15|||
170648407|NCT02577887|616725173|FG000|Overall Study|Death|93|||
170648408|NCT02577887|616725173|FG000|Overall Study|Protocol Violation|125|||
170570410|NCT00825994|616435509|FG000|Overall Study|Protocol Violation|1|||
170570411|NCT00825994|616435509|FG000|Overall Study|Placebo Responder at V2|1|||
170570412|NCT03745768|616435512|FG000|Overall Study|discontinued study|2|||
170648409|NCT02577887|616725173|FG000|Overall Study|Withdrawal by Subject|80|||
170648410|NCT00159822|616725174|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
170648411|NCT00159822|616725174|FG000|Voriconazole Treatment Period|Adverse Event|9|||
170648412|NCT00159822|616725174|FG000|Voriconazole Treatment Period|Death|4|||
170648413|NCT00159822|616725174|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
170648414|NCT00159822|616725174|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
170648415|NCT00159822|616725174|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
170648416|NCT00159822|616725174|FG000|Post-treatment Follow-up Period|Death|1|||
170648417|NCT00159822|616725174|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
170648418|NCT00159822|616725174|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
170648419|NCT00864916|616725178|FG000|Overall Study|Lost to Follow-up|4|||
170648420|NCT00864916|616725179|FG001|Overall Study|Lost to Follow-up|4|||
170648421|NCT00864916|616725178|FG000|Overall Study|Protocol Violation|1|||
170648422|NCT00864916|616725179|FG001|Overall Study|Protocol Violation|0|||
170648423|NCT00864916|616725178|FG000|Overall Study|Withdrawal by Subject|1|||
170648424|NCT00864916|616725179|FG001|Overall Study|Withdrawal by Subject|0|||
170648425|NCT03774823|616725180|FG000|Overall Study|Withdrawal by Subject|1|||
170648426|NCT03774823|616725181|FG001|Overall Study|Withdrawal by Subject|1|||
170648427|NCT02788279|616725184|FG000|Overall Study|Death|62|||
170648428|NCT02788279|616725185|FG001|Overall Study|Death|136|||
170648429|NCT02788279|616725186|FG002|Overall Study|Death|72|||
170648430|NCT02788279|616725184|FG000|Overall Study|Withdrawal by Subject|10|||
170648431|NCT02788279|616725185|FG001|Overall Study|Withdrawal by Subject|15|||
170648432|NCT02788279|616725186|FG002|Overall Study|Withdrawal by Subject|5|||
170648433|NCT02788279|616725184|FG000|Overall Study|Lost to Follow-up|0|||
170648434|NCT02788279|616725185|FG001|Overall Study|Lost to Follow-up|3|||
170648435|NCT02788279|616725186|FG002|Overall Study|Lost to Follow-up|2|||
170648436|NCT02788279|616725184|FG000|Overall Study|Sponsor decision|18|||
170648437|NCT02788279|616725185|FG001|Overall Study|Sponsor decision|29|||
170648438|NCT02788279|616725186|FG002|Overall Study|Sponsor decision|11|||
170648439|NCT01133990|616725188|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
170648440|NCT01133990|616725189|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170648441|NCT01133990|616725190|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170570413|NCT03745768|616435513|FG001|Overall Study|discontinued study|0|||
170570414|NCT01194245|616435518|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
170570415|NCT01194245|616435519|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
170570416|NCT01194245|616435520|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
170570417|NCT01194245|616435521|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
170570418|NCT01194245|616435522|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
170570419|NCT01194245|616435518|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
170570420|NCT01194245|616435519|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
170570421|NCT01194245|616435520|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
170570422|NCT01194245|616435521|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
170570423|NCT01194245|616435522|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
170570424|NCT01194245|616435518|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
170570425|NCT01194245|616435519|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
170570426|NCT01194245|616435520|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
170570427|NCT01194245|616435521|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
170570428|NCT01194245|616435522|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
170570429|NCT01194245|616435518|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
170570430|NCT01194245|616435519|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
170570431|NCT01194245|616435520|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
170570432|NCT01194245|616435521|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
170570433|NCT01194245|616435522|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
170570434|NCT01194245|616435518|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170570435|NCT01194245|616435519|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170570436|NCT01194245|616435520|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170570437|NCT01194245|616435521|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170570438|NCT01194245|616435522|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
170648442|NCT01133990|616725191|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170648443|NCT01133990|616725192|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170648444|NCT01133990|616725193|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170648445|NCT01133990|616725188|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
170648446|NCT01133990|616725189|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
170570439|NCT01194245|616435518|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170648447|NCT01133990|616725190|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
170648448|NCT01133990|616725191|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
170648449|NCT01133990|616725192|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
170648450|NCT01133990|616725193|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
170648451|NCT01133990|616725188|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
170808428|NCT04233879|617308887|FG000|Extension Study (Week 144 to 168)|Withdrawal by Subject|1|||
170808429|NCT04233879|617308888|FG001|Extension Study (Week 144 to 168)|Withdrawal by Subject|0|||
170570440|NCT01194245|616435519|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170570441|NCT01194245|616435520|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
170570442|NCT01194245|616435521|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
170570443|NCT01194245|616435522|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
170570444|NCT02031302|616435538|FG000|Overall Study|Death|115|||
170570445|NCT02031302|616435539|FG001|Overall Study|Death|0|||
170570446|NCT02031302|616435538|FG000|Overall Study|Not treated with study valve system|18|||
170570447|NCT02031302|616435539|FG001|Overall Study|Not treated with study valve system|0|||
170570448|NCT02031302|616435538|FG000|Overall Study|Missed Follow Up|27|||
170570449|NCT02031302|616435539|FG001|Overall Study|Missed Follow Up|0|||
170570450|NCT02031302|616435538|FG000|Overall Study|Lost to Follow-up|4|||
170570451|NCT02031302|616435539|FG001|Overall Study|Lost to Follow-up|0|||
170570452|NCT01847443|616435540|FG000|Study Period 1|Withdrawal by Subject|0|||
170570453|NCT01847443|616435541|FG001|Study Period 1|Withdrawal by Subject|1|||
170570454|NCT01847443|616435542|FG002|Study Period 1|Withdrawal by Subject|0|||
170570455|NCT01847443|616435543|FG003|Study Period 1|Withdrawal by Subject|0|||
170570456|NCT01847443|616435540|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
170570457|NCT01847443|616435541|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
170570458|NCT01847443|616435542|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
170570459|NCT01847443|616435543|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
170570460|NCT01847443|616435540|FG000|Washout Period Before Study Period 2|Other reason|1|||
170570461|NCT01847443|616435541|FG001|Washout Period Before Study Period 2|Other reason|0|||
170570462|NCT01847443|616435542|FG002|Washout Period Before Study Period 2|Other reason|0|||
170570463|NCT01847443|616435543|FG003|Washout Period Before Study Period 2|Other reason|0|||
170570464|NCT01847443|616435540|FG000|Washout Period Before Study Period 3|Other reason|1|||
170570465|NCT01847443|616435541|FG001|Washout Period Before Study Period 3|Other reason|0|||
170570466|NCT01847443|616435542|FG002|Washout Period Before Study Period 3|Other reason|0|||
170570467|NCT01847443|616435543|FG003|Washout Period Before Study Period 3|Other reason|0|||
170570468|NCT01847443|616435540|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
170570469|NCT01847443|616435541|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
170570470|NCT01847443|616435542|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
170570471|NCT01847443|616435543|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
170570472|NCT01847443|616435540|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
170570473|NCT01847443|616435541|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
170570474|NCT01847443|616435542|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
170570475|NCT01847443|616435543|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
170570476|NCT04067492|616435544|FG000|Overall Study|Lost to Follow-up|0|||
170570477|NCT04067492|616435545|FG001|Overall Study|Lost to Follow-up|0|||
170570478|NCT04067492|616435546|FG002|Overall Study|Lost to Follow-up|0|||
170570479|NCT04067492|616435547|FG003|Overall Study|Lost to Follow-up|0|||
170570480|NCT04067492|616435548|FG004|Overall Study|Lost to Follow-up|0|||
170570481|NCT04067492|616435549|FG005|Overall Study|Lost to Follow-up|1|||
170570482|NCT04067492|616435544|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
170570483|NCT04067492|616435545|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
170570484|NCT04067492|616435546|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
170570485|NCT04067492|616435547|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
170570486|NCT04067492|616435548|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
170570487|NCT04067492|616435549|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
170570488|NCT04067492|616435544|FG000|Overall Study|COVID-19 epidemiological situation|0|||
170570489|NCT04067492|616435545|FG001|Overall Study|COVID-19 epidemiological situation|0|||
170570490|NCT04067492|616435546|FG002|Overall Study|COVID-19 epidemiological situation|0|||
170570491|NCT04067492|616435547|FG003|Overall Study|COVID-19 epidemiological situation|1|||
170570492|NCT04067492|616435548|FG004|Overall Study|COVID-19 epidemiological situation|0|||
170570493|NCT04067492|616435549|FG005|Overall Study|COVID-19 epidemiological situation|0|||
170570494|NCT05653700|616435561|FG000|Overall Study|Non Responders|9|||
170808430|NCT02962284|617308889|FG000|Overall Study|Death|2|||
170808431|NCT02962284|617308890|FG001|Overall Study|Death|0|||
170808432|NCT02962284|617308889|FG000|Overall Study|Progressive disease|2|||
170808433|NCT02962284|617308890|FG001|Overall Study|Progressive disease|3|||
170570495|NCT05653700|616435562|FG001|Overall Study|Non Responders|0|||
170570496|NCT01634152|616435563|FG000|Overall Study|Adverse Event|2|||
170570497|NCT01634152|616435564|FG001|Overall Study|Adverse Event|0|||
170570498|NCT01634152|616435565|FG002|Overall Study|Adverse Event|2|||
170570499|NCT01634152|616435563|FG000|Overall Study|Consent withdrawn not due to AE|1|||
170570500|NCT01634152|616435564|FG001|Overall Study|Consent withdrawn not due to AE|0|||
170570501|NCT01634152|616435565|FG002|Overall Study|Consent withdrawn not due to AE|1|||
170570502|NCT01634152|616435563|FG000|Overall Study|Not treated|0|||
170570503|NCT01634152|616435564|FG001|Overall Study|Not treated|1|||
170570504|NCT01634152|616435565|FG002|Overall Study|Not treated|0|||
170570505|NCT01634152|616435563|FG000|Overall Study|Other reason not defined above|1|||
170570506|NCT01634152|616435564|FG001|Overall Study|Other reason not defined above|0|||
170570507|NCT01634152|616435565|FG002|Overall Study|Other reason not defined above|1|||
170570508|NCT01900665|616435567|FG000|Placebo Controlled Period|Death|9|||
170570509|NCT01900665|616435568|FG001|Placebo Controlled Period|Death|16|||
170570510|NCT01900665|616435567|FG000|Placebo Controlled Period|Adverse Event|48|||
170570511|NCT01900665|616435568|FG001|Placebo Controlled Period|Adverse Event|39|||
170808434|NCT02962284|617308889|FG000|Overall Study|Withdrawal by Subject|1|||
170808435|NCT02962284|617308890|FG001|Overall Study|Withdrawal by Subject|0|||
170808436|NCT02591407|617308891|FG000|Randomization|Cancelled surgery|5|||
170808437|NCT02591407|617308892|FG001|Randomization|Cancelled surgery|3|||
170570512|NCT01900665|616435567|FG000|Placebo Controlled Period|Protocol Violation|1|||
170570513|NCT01900665|616435568|FG001|Placebo Controlled Period|Protocol Violation|7|||
170570514|NCT01900665|616435567|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
170570515|NCT01900665|616435568|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
170570516|NCT01900665|616435567|FG000|Placebo Controlled Period|Physician Decision|11|||
170570517|NCT01900665|616435568|FG001|Placebo Controlled Period|Physician Decision|7|||
170570518|NCT01900665|616435567|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
170570519|NCT01900665|616435568|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
170570520|NCT01900665|616435567|FG000|Placebo Controlled Period|Caregiver Decision|33|||
170570521|NCT01900665|616435568|FG001|Placebo Controlled Period|Caregiver Decision|41|||
170570522|NCT01900665|616435567|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
170570523|NCT01900665|616435568|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
170570524|NCT01900665|616435567|FG000|Open Label Period|Adverse Event|16|||
170570525|NCT01900665|616435568|FG001|Open Label Period|Adverse Event|20|||
170570526|NCT01900665|616435567|FG000|Open Label Period|Death|5|||
170570527|NCT01900665|616435568|FG001|Open Label Period|Death|6|||
170570528|NCT01900665|616435567|FG000|Open Label Period|Lost to Follow-up|1|||
170570529|NCT01900665|616435568|FG001|Open Label Period|Lost to Follow-up|1|||
170570530|NCT01900665|616435567|FG000|Open Label Period|Parent/Caregiver Decision|33|||
170570531|NCT01900665|616435568|FG001|Open Label Period|Parent/Caregiver Decision|34|||
170570532|NCT01900665|616435567|FG000|Open Label Period|Physician Decision|4|||
170570533|NCT01900665|616435568|FG001|Open Label Period|Physician Decision|4|||
170570534|NCT01900665|616435567|FG000|Open Label Period|Protocol Violation|0|||
170570535|NCT01900665|616435568|FG001|Open Label Period|Protocol Violation|1|||
170570536|NCT01900665|616435567|FG000|Open Label Period|Sponsor Decision|802|||
170570537|NCT01900665|616435568|FG001|Open Label Period|Sponsor Decision|765|||
170570538|NCT01900665|616435567|FG000|Open Label Period|Withdrawal by Subject|20|||
170570539|NCT01900665|616435568|FG001|Open Label Period|Withdrawal by Subject|28|||
170570540|NCT00953706|616435571|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
170570541|NCT00953706|616435572|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
170570542|NCT00953706|616435573|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
170570543|NCT00953706|616435574|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
170570544|NCT00953706|616435571|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
170570545|NCT00953706|616435572|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
170570546|NCT00953706|616435573|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
170570547|NCT00953706|616435574|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
170570548|NCT00953706|616435571|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
170570549|NCT00953706|616435572|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
170570550|NCT00953706|616435573|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
170570551|NCT00953706|616435574|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
170570552|NCT00953706|616435571|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
170570553|NCT00953706|616435572|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
170570554|NCT00953706|616435573|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
170570555|NCT00953706|616435574|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
170570556|NCT00953706|616435571|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
170570557|NCT00953706|616435572|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
170570558|NCT00953706|616435573|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
170570559|NCT00953706|616435574|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
170570560|NCT00953706|616435571|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
170570561|NCT00953706|616435572|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
170570562|NCT00953706|616435573|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
170570563|NCT00953706|616435574|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
170570564|NCT00953706|616435571|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
170570565|NCT00953706|616435572|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
170570566|NCT00953706|616435573|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
170808438|NCT02591407|617308891|FG000|Randomization|Withdrawal by Subject|7|||
170648452|NCT01133990|616725189|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
170570567|NCT00953706|616435574|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
170570568|NCT00953706|616435571|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
170570569|NCT00953706|616435572|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
170570570|NCT00953706|616435573|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
170570571|NCT00953706|616435574|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
170570572|NCT00953706|616435571|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
170570573|NCT00953706|616435572|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
170570574|NCT00953706|616435573|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
170570575|NCT00953706|616435574|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
170570576|NCT00953706|616435571|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
170570577|NCT00953706|616435572|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
170570578|NCT00953706|616435573|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
170570579|NCT00953706|616435574|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
170570580|NCT00953706|616435571|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
170570581|NCT00953706|616435572|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
170570582|NCT00953706|616435573|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
170570583|NCT00953706|616435574|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
170570584|NCT01404234|616435575|FG000|Overall Study|Withdrawal by Subject|2|||
170570585|NCT01214837|616435576|FG000|Overall Study|Death|0|||
170570586|NCT01214837|616435577|FG001|Overall Study|Death|0|||
170570587|NCT01214837|616435578|FG002|Overall Study|Death|1|||
170570588|NCT01214837|616435576|FG000|Overall Study|Adverse Event|1|||
170570589|NCT01214837|616435577|FG001|Overall Study|Adverse Event|2|||
170570590|NCT01214837|616435578|FG002|Overall Study|Adverse Event|1|||
170570591|NCT01214837|616435576|FG000|Overall Study|Withdrawal by Subject|27|||
170570592|NCT01214837|616435577|FG001|Overall Study|Withdrawal by Subject|36|||
170570593|NCT01214837|616435578|FG002|Overall Study|Withdrawal by Subject|28|||
170570594|NCT01214837|616435576|FG000|Overall Study|Lost to Follow-up|20|||
170570595|NCT01214837|616435577|FG001|Overall Study|Lost to Follow-up|15|||
170570596|NCT01214837|616435578|FG002|Overall Study|Lost to Follow-up|21|||
170570597|NCT01214837|616435576|FG000|Overall Study|Inappropriate Enrolment|0|||
170570598|NCT01214837|616435577|FG001|Overall Study|Inappropriate Enrolment|1|||
170570599|NCT01214837|616435578|FG002|Overall Study|Inappropriate Enrolment|2|||
170570600|NCT01214837|616435576|FG000|Overall Study|Administrative Reason|2|||
170570601|NCT01214837|616435577|FG001|Overall Study|Administrative Reason|6|||
170570602|NCT01214837|616435578|FG002|Overall Study|Administrative Reason|4|||
170570603|NCT01214837|616435576|FG000|Overall Study|Protocol Violation|3|||
170570604|NCT01214837|616435577|FG001|Overall Study|Protocol Violation|1|||
170570605|NCT01214837|616435578|FG002|Overall Study|Protocol Violation|5|||
170570606|NCT01214837|616435576|FG000|Overall Study|Unable to Classify|1|||
170570607|NCT01214837|616435577|FG001|Overall Study|Unable to Classify|3|||
170570608|NCT01214837|616435578|FG002|Overall Study|Unable to Classify|0|||
170570609|NCT03559270|616435582|FG000|Overall Study|Adverse Event|6|||
170570610|NCT03559270|616435583|FG001|Overall Study|Adverse Event|5|||
170570611|NCT03559270|616435584|FG002|Overall Study|Adverse Event|3|||
170648453|NCT01133990|616725190|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
170648454|NCT01133990|616725191|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
170648455|NCT01133990|616725192|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
170648456|NCT01133990|616725193|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
170648457|NCT01133990|616725188|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
170648458|NCT01133990|616725189|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
170648459|NCT01133990|616725190|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
170648460|NCT01133990|616725191|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
170648461|NCT01133990|616725192|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
170648462|NCT01133990|616725193|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
170648463|NCT05277337|616725194|FG000|Overall Study|Lost to Follow-up|2|||
170648464|NCT05277337|616725195|FG001|Overall Study|Lost to Follow-up|0|||
170648465|NCT05277337|616725194|FG000|Overall Study|Withdrawal by Subject|1|||
170648466|NCT05277337|616725195|FG001|Overall Study|Withdrawal by Subject|0|||
170648467|NCT01185301|616725199|FG000|Overall Study|Adverse Event|3|||
170648468|NCT01185301|616725200|FG001|Overall Study|Adverse Event|0|||
170648469|NCT01185301|616725201|FG002|Overall Study|Adverse Event|2|||
170648470|NCT01185301|616725202|FG003|Overall Study|Adverse Event|3|||
170570612|NCT03559270|616435585|FG003|Overall Study|Adverse Event|0|||
170648471|NCT01185301|616725199|FG000|Overall Study|Withdrawal by Subject|7|||
170648472|NCT01185301|616725200|FG001|Overall Study|Withdrawal by Subject|5|||
170648473|NCT01185301|616725201|FG002|Overall Study|Withdrawal by Subject|2|||
170648474|NCT01185301|616725202|FG003|Overall Study|Withdrawal by Subject|3|||
170570613|NCT03559270|616435582|FG000|Overall Study|Lack of Efficacy|34|||
170570614|NCT03559270|616435583|FG001|Overall Study|Lack of Efficacy|52|||
170570615|NCT03559270|616435584|FG002|Overall Study|Lack of Efficacy|37|||
170570616|NCT03559270|616435585|FG003|Overall Study|Lack of Efficacy|2|||
170570617|NCT03559270|616435582|FG000|Overall Study|Death|0|||
170570618|NCT03559270|616435583|FG001|Overall Study|Death|2|||
170570619|NCT03559270|616435584|FG002|Overall Study|Death|0|||
170570620|NCT03559270|616435585|FG003|Overall Study|Death|0|||
170570621|NCT03559270|616435582|FG000|Overall Study|Lost to Follow-up|16|||
170570622|NCT03559270|616435583|FG001|Overall Study|Lost to Follow-up|4|||
170570623|NCT03559270|616435584|FG002|Overall Study|Lost to Follow-up|12|||
170570624|NCT03559270|616435585|FG003|Overall Study|Lost to Follow-up|3|||
170648475|NCT01185301|616725199|FG000|Overall Study|Lost to Follow-up|2|||
170648476|NCT01185301|616725200|FG001|Overall Study|Lost to Follow-up|0|||
170648477|NCT01185301|616725201|FG002|Overall Study|Lost to Follow-up|0|||
170570625|NCT03559270|616435582|FG000|Overall Study|Sponsor Decision|38|||
170570626|NCT03559270|616435583|FG001|Overall Study|Sponsor Decision|31|||
170570627|NCT03559270|616435584|FG002|Overall Study|Sponsor Decision|35|||
170570628|NCT03559270|616435585|FG003|Overall Study|Sponsor Decision|18|||
170570629|NCT03559270|616435582|FG000|Overall Study|Withdrawal by Subject|19|||
170570630|NCT03559270|616435583|FG001|Overall Study|Withdrawal by Subject|21|||
170570631|NCT03559270|616435584|FG002|Overall Study|Withdrawal by Subject|18|||
170570632|NCT03559270|616435585|FG003|Overall Study|Withdrawal by Subject|7|||
170570633|NCT03559270|616435582|FG000|Overall Study|Physician Decision|3|||
170570634|NCT03559270|616435583|FG001|Overall Study|Physician Decision|2|||
170570635|NCT03559270|616435584|FG002|Overall Study|Physician Decision|1|||
170570636|NCT03559270|616435585|FG003|Overall Study|Physician Decision|0|||
170570637|NCT03559270|616435582|FG000|Overall Study|Pregnancy|0|||
170570638|NCT03559270|616435583|FG001|Overall Study|Pregnancy|1|||
170570639|NCT03559270|616435584|FG002|Overall Study|Pregnancy|0|||
170570640|NCT03559270|616435585|FG003|Overall Study|Pregnancy|0|||
170570641|NCT03559270|616435582|FG000|Overall Study|Protocol Violation|1|||
170570642|NCT03559270|616435583|FG001|Overall Study|Protocol Violation|0|||
170570643|NCT03559270|616435584|FG002|Overall Study|Protocol Violation|2|||
170570644|NCT03559270|616435585|FG003|Overall Study|Protocol Violation|0|||
170570645|NCT03965403|616435586|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
170570646|NCT00342628|616436945|FG000|Overall Study|Withdrawal by Subject|19|||
170570647|NCT00342628|616436946|FG001|Overall Study|Withdrawal by Subject|19|||
170570648|NCT00342628|616436947|FG002|Overall Study|Withdrawal by Subject|18|||
170570649|NCT00342628|616436945|FG000|Overall Study|Death|1|||
170570650|NCT00342628|616436946|FG001|Overall Study|Death|1|||
170570651|NCT00342628|616436947|FG002|Overall Study|Death|0|||
170570652|NCT00342628|616436945|FG000|Overall Study|moved residence|0|||
170570653|NCT00342628|616436946|FG001|Overall Study|moved residence|1|||
170570654|NCT00342628|616436947|FG002|Overall Study|moved residence|1|||
170570655|NCT03759600|616436948|FG000|Overall Study|Adverse Event|2|||
170570656|NCT03759600|616436948|FG000|Overall Study|Progressive Disease|15|||
170570657|NCT03759600|616436948|FG000|Overall Study|Site Terminated by Sponsor|3|||
170570658|NCT04971967|616436949|FG000|Overall Study|Lost to Follow-up|6|||
170570659|NCT04971967|616436950|FG001|Overall Study|Lost to Follow-up|7|||
170570660|NCT00456755|616436956|FG000|Overall Study|Lost to Follow-up|2|||
170570661|NCT00456755|616436957|FG001|Overall Study|Lost to Follow-up|1|||
170570662|NCT01772550|616436958|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
170570663|NCT01772550|616436959|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
170570664|NCT01772550|616436960|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
170570665|NCT01772550|616436958|FG000|Overall Study|Adverse Event|0|||
170570666|NCT01772550|616436959|FG001|Overall Study|Adverse Event|0|||
170570667|NCT01772550|616436960|FG002|Overall Study|Adverse Event|1|||
170570668|NCT01453036|616436961|FG000|Overall Study|Lost to Follow-up|26|||
170570669|NCT01453036|616436962|FG001|Overall Study|Lost to Follow-up|115|||
170570670|NCT01453036|616436963|FG002|Overall Study|Lost to Follow-up|31|||
170570671|NCT00559104|616436964|FG000|Overall Study|Lack of Efficacy|9|||
170570672|NCT00559104|616436965|FG001|Overall Study|Lack of Efficacy|0|||
170570673|NCT01815424|616436966|FG000|Week 0 to 16|Adverse Event|1|||
170570674|NCT01815424|616436967|FG001|Week 0 to 16|Adverse Event|3|||
170648478|NCT01185301|616725202|FG003|Overall Study|Lost to Follow-up|1|||
170570675|NCT01815424|616436968|FG002|Week 0 to 16|Adverse Event|3|||
170570676|NCT01815424|616436969|FG003|Week 0 to 16|Adverse Event|0|||
170570677|NCT01815424|616436970|FG004|Week 0 to 16|Adverse Event|0|||
170570678|NCT01815424|616436966|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
170570679|NCT01815424|616436967|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
170570680|NCT01815424|616436968|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
170570681|NCT01815424|616436969|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
170570682|NCT01815424|616436970|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
170570683|NCT01815424|616436966|FG000|Week 0 to 16|Lost to Follow-up|0|||
170570684|NCT01815424|616436967|FG001|Week 0 to 16|Lost to Follow-up|1|||
170570685|NCT01815424|616436968|FG002|Week 0 to 16|Lost to Follow-up|0|||
170570686|NCT01815424|616436969|FG003|Week 0 to 16|Lost to Follow-up|0|||
170570687|NCT01815424|616436970|FG004|Week 0 to 16|Lost to Follow-up|0|||
170570688|NCT01815424|616436966|FG000|Week 0 to 16|Withdrawal by Subject|0|||
170570689|NCT01815424|616436967|FG001|Week 0 to 16|Withdrawal by Subject|0|||
170570690|NCT01815424|616436968|FG002|Week 0 to 16|Withdrawal by Subject|1|||
170648479|NCT01185301|616725199|FG000|Overall Study|Other Reason|3|||
170570691|NCT01815424|616436969|FG003|Week 0 to 16|Withdrawal by Subject|0|||
170570692|NCT01815424|616436970|FG004|Week 0 to 16|Withdrawal by Subject|0|||
170570693|NCT01815424|616436966|FG000|Week 0 to 16|Other|1|||
170570694|NCT01815424|616436967|FG001|Week 0 to 16|Other|0|||
170570695|NCT01815424|616436968|FG002|Week 0 to 16|Other|3|||
170570696|NCT01815424|616436969|FG003|Week 0 to 16|Other|0|||
170570697|NCT01815424|616436970|FG004|Week 0 to 16|Other|0|||
170570698|NCT01815424|616436966|FG000|Week 0 to 16|Protocol Violation|1|||
170570699|NCT01815424|616436967|FG001|Week 0 to 16|Protocol Violation|0|||
170570700|NCT01815424|616436968|FG002|Week 0 to 16|Protocol Violation|0|||
170570701|NCT01815424|616436969|FG003|Week 0 to 16|Protocol Violation|0|||
170570702|NCT01815424|616436970|FG004|Week 0 to 16|Protocol Violation|0|||
170570703|NCT01815424|616436966|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
170570704|NCT01815424|616436967|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
170570705|NCT01815424|616436968|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
170570706|NCT01815424|616436969|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
170570707|NCT01815424|616436970|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
170570708|NCT01815424|616436966|FG000|Week 16 to 52|Other|0|||
170570709|NCT01815424|616436967|FG001|Week 16 to 52|Other|1|||
170570710|NCT01815424|616436968|FG002|Week 16 to 52|Other|0|||
170570711|NCT01815424|616436969|FG003|Week 16 to 52|Other|0|||
170570712|NCT01815424|616436970|FG004|Week 16 to 52|Other|0|||
170570713|NCT01815424|616436966|FG000|Week 16 to 52|Adverse Event|0|||
170570714|NCT01815424|616436967|FG001|Week 16 to 52|Adverse Event|0|||
170570715|NCT01815424|616436968|FG002|Week 16 to 52|Adverse Event|0|||
170570716|NCT01815424|616436969|FG003|Week 16 to 52|Adverse Event|0|||
170570717|NCT01815424|616436970|FG004|Week 16 to 52|Adverse Event|1|||
170570718|NCT01815424|616436966|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
170570719|NCT01815424|616436967|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
170570720|NCT01815424|616436968|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
170570721|NCT01815424|616436969|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
170570722|NCT01815424|616436970|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
170570723|NCT01815424|616436966|FG000|Week 16 to 52|Lost to Follow-up|0|||
170570724|NCT01815424|616436967|FG001|Week 16 to 52|Lost to Follow-up|2|||
170570725|NCT01815424|616436968|FG002|Week 16 to 52|Lost to Follow-up|0|||
170570726|NCT01815424|616436969|FG003|Week 16 to 52|Lost to Follow-up|2|||
170570727|NCT01815424|616436970|FG004|Week 16 to 52|Lost to Follow-up|1|||
170570728|NCT01815424|616436966|FG000|Week 16 to 52|Withdrawal by Subject|1|||
170570729|NCT01815424|616436967|FG001|Week 16 to 52|Withdrawal by Subject|2|||
170570730|NCT01815424|616436968|FG002|Week 16 to 52|Withdrawal by Subject|0|||
170808439|NCT02591407|617308892|FG001|Randomization|Withdrawal by Subject|1|||
170808440|NCT02591407|617308891|FG000|Randomization|Emergency surgery|0|||
170808441|NCT02591407|617308892|FG001|Randomization|Emergency surgery|1|||
170808442|NCT02591407|617308891|FG000|Follow-up|Lost to Follow-up|1|||
170570731|NCT01815424|616436969|FG003|Week 16 to 52|Withdrawal by Subject|0|||
170570732|NCT01815424|616436970|FG004|Week 16 to 52|Withdrawal by Subject|0|||
170570733|NCT04072835|616436971|FG000|Overall Study|Overall trial ended|603|||
170570734|NCT04072835|616436971|FG000|Overall Study|Ablation|97|||
170570735|NCT04072835|616436971|FG000|Overall Study|Withdrawal of consent|66|||
170570736|NCT04072835|616436971|FG000|Overall Study|Physician Decision|50|||
170570737|NCT04072835|616436971|FG000|Overall Study|Lost to Follow-up|39|||
170570738|NCT04072835|616436971|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
170570739|NCT04072835|616436971|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
170570740|NCT04072835|616436971|FG000|Overall Study|Adverse Event|25|||
170570741|NCT04072835|616436971|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
170570742|NCT04072835|616436971|FG000|Overall Study|Death|11|||
170570743|NCT04072835|616436971|FG000|Overall Study|Participant felt the drug did not work|8|||
170570744|NCT04072835|616436971|FG000|Overall Study|Participant tolerability|5|||
170570745|NCT04072835|616436971|FG000|Overall Study|Missing|5|||
170570746|NCT04072835|616436971|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
170570747|NCT04072835|616436971|FG000|Overall Study|Pregnancy|3|||
170570748|NCT01127633|616436972|FG000|Overall Study|Adverse Event|74|||
170570749|NCT01127633|616436973|FG001|Overall Study|Adverse Event|73|||
170570750|NCT01127633|616436972|FG000|Overall Study|Death|40|||
170570751|NCT01127633|616436973|FG001|Overall Study|Death|43|||
170570752|NCT01127633|616436972|FG000|Overall Study|Lost to Follow-up|4|||
170570753|NCT01127633|616436973|FG001|Overall Study|Lost to Follow-up|0|||
170570754|NCT01127633|616436972|FG000|Overall Study|Parent/Caregiver Decision|246|||
170570755|NCT01127633|616436973|FG001|Overall Study|Parent/Caregiver Decision|228|||
170570756|NCT01127633|616436972|FG000|Overall Study|Physician Decision|60|||
170570757|NCT01127633|616436973|FG001|Overall Study|Physician Decision|45|||
170570758|NCT01127633|616436972|FG000|Overall Study|Withdrawal by Subject|57|||
170570759|NCT01127633|616436973|FG001|Overall Study|Withdrawal by Subject|72|||
170570760|NCT01127633|616436972|FG000|Overall Study|Sponsor Decision|163|||
170570761|NCT01127633|616436973|FG001|Overall Study|Sponsor Decision|195|||
170808443|NCT02591407|617308892|FG001|Follow-up|Lost to Follow-up|0|||
170570762|NCT01127633|616436972|FG000|Overall Study|Protocol Violation|8|||
170570763|NCT01127633|616436973|FG001|Overall Study|Protocol Violation|16|||
170648480|NCT01185301|616725200|FG001|Overall Study|Other Reason|2|||
170648481|NCT01185301|616725201|FG002|Overall Study|Other Reason|2|||
170648482|NCT01185301|616725202|FG003|Overall Study|Other Reason|2|||
170648483|NCT02683746|616725203|FG000|Overall Study|Adverse Event|3|||
170570764|NCT01127633|616436972|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
170570765|NCT01127633|616436973|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
170570766|NCT01127633|616436972|FG000|Overall Study|Not treated|1|||
170570767|NCT01127633|616436973|FG001|Overall Study|Not treated|0|||
170570768|NCT00841776|616436975|FG000|Overall Study|Lack of Efficacy|0|||
170570769|NCT00841776|616436976|FG001|Overall Study|Lack of Efficacy|1|||
170570770|NCT00841776|616436975|FG000|Overall Study|Lost to Follow-up|2|||
170570771|NCT00841776|616436976|FG001|Overall Study|Lost to Follow-up|1|||
170570772|NCT00841776|616436975|FG000|Overall Study|Withdrawal by Subject|0|||
170570773|NCT00841776|616436976|FG001|Overall Study|Withdrawal by Subject|1|||
170570774|NCT01833494|616436982|FG000|Overall Study|Adverse Event|24|||
170570775|NCT01833494|616436982|FG000|Overall Study|Physician Decision|6|||
170570776|NCT01833494|616436982|FG000|Overall Study|Withdrawal by Subject|6|||
170570777|NCT01833494|616436982|FG000|Overall Study|Decrease in serum phosphorus|4|||
170570778|NCT01833494|616436982|FG000|Overall Study|Decrease in serum calcium|4|||
170570779|NCT01833494|616436982|FG000|Overall Study|Increase in serum ferritin|1|||
170570780|NCT01694433|616436983|FG000|Overall Study|Adverse Event|7|||
170570781|NCT01694433|616436984|FG001|Overall Study|Adverse Event|0|||
170570782|NCT01694433|616436983|FG000|Overall Study|Physician Decision|1|||
170570783|NCT01694433|616436984|FG001|Overall Study|Physician Decision|0|||
170570784|NCT01694433|616436983|FG000|Overall Study|Withdrawal by Subject|3|||
170570785|NCT01694433|616436984|FG001|Overall Study|Withdrawal by Subject|4|||
170570786|NCT00443118|616436986|FG000|Overall Study|unknown primary outcome|3|||
170570787|NCT00443118|616436987|FG001|Overall Study|unknown primary outcome|1|||
170570788|NCT00443118|616436988|FG002|Overall Study|unknown primary outcome|0|||
170570789|NCT00443118|616436986|FG000|Overall Study|Withdrawal by Subject|1|||
170570790|NCT00443118|616436987|FG001|Overall Study|Withdrawal by Subject|0|||
170570791|NCT00443118|616436988|FG002|Overall Study|Withdrawal by Subject|0|||
170570792|NCT01665911|616436989|FG000|Overall Study|Protocol Violation|4|||
170570793|NCT01665911|616436989|FG000|Overall Study|Withdrawal by Subject|1|||
170570794|NCT01665911|616436989|FG000|Overall Study|Adverse Event|1|||
170570795|NCT04512001|616436992|FG000|Week 0 to Week 24|Adverse Event|14|||
170570796|NCT04512001|616436993|FG001|Week 0 to Week 24|Adverse Event|10|||
170570797|NCT04512001|616436994|FG002|Week 0 to Week 24|Adverse Event|0|||
170570798|NCT04512001|616436995|FG003|Week 0 to Week 24|Adverse Event|0|||
170570799|NCT04512001|616436996|FG004|Week 0 to Week 24|Adverse Event|0|||
170570800|NCT04512001|616436992|FG000|Week 0 to Week 24|Death|0|||
170570801|NCT04512001|616436993|FG001|Week 0 to Week 24|Death|2|||
170570802|NCT04512001|616436994|FG002|Week 0 to Week 24|Death|0|||
170570803|NCT04512001|616436995|FG003|Week 0 to Week 24|Death|0|||
170570804|NCT04512001|616436996|FG004|Week 0 to Week 24|Death|0|||
170570805|NCT04512001|616436992|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
170570806|NCT04512001|616436993|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
170570807|NCT04512001|616436994|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
170570808|NCT04512001|616436995|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
170570809|NCT04512001|616436996|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
170570810|NCT04512001|616436992|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
170570811|NCT04512001|616436993|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
170570812|NCT04512001|616436994|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
170570813|NCT04512001|616436995|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
170570814|NCT04512001|616436996|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
170648484|NCT02683746|616725204|FG001|Overall Study|Adverse Event|2|||
170648485|NCT02683746|616725203|FG000|Overall Study|Lost to Follow-up|5|||
170648486|NCT02683746|616725204|FG001|Overall Study|Lost to Follow-up|6|||
170648487|NCT02683746|616725203|FG000|Overall Study|Withdrawal by Subject|6|||
170648488|NCT02683746|616725204|FG001|Overall Study|Withdrawal by Subject|5|||
170648489|NCT02683746|616725203|FG000|Overall Study|Physician Decision|2|||
170648490|NCT02683746|616725204|FG001|Overall Study|Physician Decision|1|||
170648491|NCT04987944|616725209|FG000|Overall Study|Adverse Event|0|||
170648492|NCT04987944|616725210|FG001|Overall Study|Adverse Event|1|||
170570815|NCT04512001|616436992|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
170570816|NCT04512001|616436993|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
170570817|NCT04512001|616436994|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
170570818|NCT04512001|616436995|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
170648493|NCT04987944|616725209|FG000|Overall Study|Withdrawal by Subject|0|||
170648494|NCT04987944|616725210|FG001|Overall Study|Withdrawal by Subject|1|||
170570819|NCT04512001|616436996|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
170648495|NCT03222492|616725215|FG000|Overall Study|Withdrawal by Subject|0|||
170570820|NCT04512001|616436992|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
170570821|NCT04512001|616436993|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
170570822|NCT04512001|616436994|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
170648496|NCT03222492|616725216|FG001|Overall Study|Withdrawal by Subject|0|||
170648497|NCT03222492|616725217|FG002|Overall Study|Withdrawal by Subject|1|||
170648498|NCT03222492|616725218|FG003|Overall Study|Withdrawal by Subject|0|||
170648499|NCT03222492|616725215|FG000|Overall Study|COVID-19 related|0|||
170648500|NCT03222492|616725216|FG001|Overall Study|COVID-19 related|0|||
170648501|NCT03222492|616725217|FG002|Overall Study|COVID-19 related|1|||
170648502|NCT03222492|616725218|FG003|Overall Study|COVID-19 related|0|||
170648503|NCT05395091|616725219|FG000|Baseline to Month 12|Adverse Event|7|||
170648504|NCT05395091|616725220|FG001|Baseline to Month 12|Adverse Event|2|||
170648505|NCT05395091|616725221|FG002|Baseline to Month 12|Adverse Event|0|||
170648506|NCT05395091|616725219|FG000|Baseline to Month 12|Death|3|||
170648507|NCT05395091|616725220|FG001|Baseline to Month 12|Death|1|||
170648508|NCT05395091|616725221|FG002|Baseline to Month 12|Death|0|||
170648509|NCT05395091|616725219|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
170648510|NCT05395091|616725220|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
170648511|NCT05395091|616725221|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
170648512|NCT05395091|616725219|FG000|Baseline to Month 12|Protocol Violation|2|||
170648513|NCT05395091|616725220|FG001|Baseline to Month 12|Protocol Violation|3|||
170648514|NCT05395091|616725221|FG002|Baseline to Month 12|Protocol Violation|0|||
170648515|NCT05395091|616725219|FG000|Baseline to Month 12|Physician Decision|1|||
170648516|NCT05395091|616725220|FG001|Baseline to Month 12|Physician Decision|0|||
170570823|NCT04512001|616436995|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
170808444|NCT02591407|617308891|FG000|Follow-up|Protocol Violation|1|||
170808445|NCT02591407|617308892|FG001|Follow-up|Protocol Violation|2|||
170808446|NCT00587171|617308893|FG000|Overall Study|Lost to Follow-up|1|||
170808447|NCT00587171|617308894|FG001|Overall Study|Lost to Follow-up|1|||
170808448|NCT03469258|617308898|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
170808449|NCT00403494|617308902|FG000|Overall Study|Adverse Event|10|||
170808450|NCT00403494|617308903|FG001|Overall Study|Adverse Event|8|||
170648517|NCT05395091|616725221|FG002|Baseline to Month 12|Physician Decision|0|||
170570824|NCT04512001|616436996|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
170570825|NCT04512001|616436992|FG000|Week 24 to Week 63|Adverse Event|0|||
170570826|NCT04512001|616436993|FG001|Week 24 to Week 63|Adverse Event|0|||
170570827|NCT04512001|616436994|FG002|Week 24 to Week 63|Adverse Event|13|||
170570828|NCT04512001|616436995|FG003|Week 24 to Week 63|Adverse Event|8|||
170570829|NCT04512001|616436996|FG004|Week 24 to Week 63|Adverse Event|6|||
170570830|NCT04512001|616436992|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
170570831|NCT04512001|616436993|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
170570832|NCT04512001|616436994|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
170570833|NCT04512001|616436995|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
170570834|NCT04512001|616436996|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
170570835|NCT04512001|616436992|FG000|Week 24 to Week 63|Death|0|||
170570836|NCT04512001|616436993|FG001|Week 24 to Week 63|Death|0|||
170570837|NCT04512001|616436994|FG002|Week 24 to Week 63|Death|0|||
170570838|NCT04512001|616436995|FG003|Week 24 to Week 63|Death|1|||
170570839|NCT04512001|616436996|FG004|Week 24 to Week 63|Death|1|||
170570840|NCT04512001|616436992|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
170570841|NCT04512001|616436993|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
170570842|NCT04512001|616436994|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
170570843|NCT04512001|616436995|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
170570844|NCT04512001|616436996|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
170570845|NCT04512001|616436992|FG000|Week 24 to Week 63|Miscellaneous|0|||
170570846|NCT04512001|616436993|FG001|Week 24 to Week 63|Miscellaneous|0|||
170570847|NCT04512001|616436994|FG002|Week 24 to Week 63|Miscellaneous|3|||
170570848|NCT04512001|616436995|FG003|Week 24 to Week 63|Miscellaneous|2|||
170570849|NCT04512001|616436996|FG004|Week 24 to Week 63|Miscellaneous|1|||
170570850|NCT00506779|616436999|FG000|Overall Study|Withdrawal by Subject|1|||
170570851|NCT00506779|616437000|FG001|Overall Study|Withdrawal by Subject|0|||
170570852|NCT00506779|616437001|FG002|Overall Study|Withdrawal by Subject|1|||
170808451|NCT00403494|617308902|FG000|Overall Study|Withdrew Consent|3|||
170648518|NCT05395091|616725219|FG000|Month 12 to Month 18|Death|1|||
170648519|NCT05395091|616725220|FG001|Month 12 to Month 18|Death|0|||
170648520|NCT05395091|616725221|FG002|Month 12 to Month 18|Death|0|||
170648521|NCT05395091|616725219|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
170648522|NCT05395091|616725220|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
170648523|NCT05395091|616725221|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
170648524|NCT05395091|616725219|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
170808452|NCT00403494|617308903|FG001|Overall Study|Withdrew Consent|2|||
170648525|NCT05395091|616725220|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
170648526|NCT05395091|616725221|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
170570853|NCT00506779|616437002|FG003|Overall Study|Withdrawal by Subject|0|||
170570854|NCT00506779|616436999|FG000|Overall Study|Adverse Event|0|||
170570855|NCT00506779|616437000|FG001|Overall Study|Adverse Event|1|||
170570856|NCT00506779|616437001|FG002|Overall Study|Adverse Event|1|||
170648527|NCT05395091|616725219|FG000|Month 12 to Month 18|Other reasons|0|||
170648528|NCT05395091|616725220|FG001|Month 12 to Month 18|Other reasons|0|||
170808453|NCT00403494|617308902|FG000|Overall Study|Inappropriately enrolled|0|||
170570857|NCT00506779|616437002|FG003|Overall Study|Adverse Event|1|||
170570858|NCT04263766|616437003|FG000|Overall Study|Withdrawal by Subject|6|||
170570859|NCT04263766|616437004|FG001|Overall Study|Withdrawal by Subject|4|||
170570860|NCT04263766|616437003|FG000|Overall Study|Lack of Efficacy|1|||
170570861|NCT04263766|616437004|FG001|Overall Study|Lack of Efficacy|3|||
170570862|NCT04232943|616437005|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
170570863|NCT04232943|616437006|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
170570864|NCT04232943|616437007|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
170570865|NCT04232943|616437005|FG000|Overall Study|Withdrawal by Subject|1|||
170570866|NCT04232943|616437006|FG001|Overall Study|Withdrawal by Subject|1|||
170570867|NCT04232943|616437007|FG002|Overall Study|Withdrawal by Subject|0|||
170570868|NCT02639247|616437008|FG000|Overall Study|Lost to Follow-up|2|||
170570869|NCT02639247|616437009|FG001|Overall Study|Lost to Follow-up|1|||
170570870|NCT02639247|616437008|FG000|Overall Study|Death|2|||
170570871|NCT02639247|616437009|FG001|Overall Study|Death|0|||
170570872|NCT02639247|616437008|FG000|Overall Study|Withdrew Consent|0|||
170570873|NCT02639247|616437009|FG001|Overall Study|Withdrew Consent|1|||
170570874|NCT02639247|616437008|FG000|Overall Study|Protocol Violation|1|||
170570875|NCT02639247|616437009|FG001|Overall Study|Protocol Violation|0|||
170570876|NCT01891396|616437011|FG000|Overall Study|Withdrawal by Subject|4|||
170570877|NCT01891396|616437012|FG001|Overall Study|Withdrawal by Subject|4|||
170570878|NCT01891396|616437013|FG002|Overall Study|Withdrawal by Subject|3|||
170570879|NCT01891396|616437011|FG000|Overall Study|Lost to Follow-up|0|||
170570880|NCT01891396|616437012|FG001|Overall Study|Lost to Follow-up|1|||
170570881|NCT01891396|616437013|FG002|Overall Study|Lost to Follow-up|0|||
170570882|NCT03896477|616437017|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
170570883|NCT03896477|616437018|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
170570884|NCT03896477|616437019|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
170570885|NCT03896477|616437017|FG000|Overall Study|Parent Requested Withdrawal|8|||
170570886|NCT03896477|616437018|FG001|Overall Study|Parent Requested Withdrawal|12|||
170570887|NCT03896477|616437019|FG002|Overall Study|Parent Requested Withdrawal|9|||
170570888|NCT03896477|616437017|FG000|Overall Study|Adverse Event|0|||
170570889|NCT03896477|616437018|FG001|Overall Study|Adverse Event|0|||
170570890|NCT03896477|616437019|FG002|Overall Study|Adverse Event|1|||
170570891|NCT03896477|616437017|FG000|Overall Study|Death|1|||
170570892|NCT03896477|616437018|FG001|Overall Study|Death|0|||
170570893|NCT03896477|616437019|FG002|Overall Study|Death|0|||
170570894|NCT03896477|616437017|FG000|Overall Study|Other|5|||
170570895|NCT03896477|616437018|FG001|Overall Study|Other|6|||
170570896|NCT03896477|616437019|FG002|Overall Study|Other|7|||
170570897|NCT03896477|616437017|FG000|Overall Study|Lost to Follow-up|2|||
170570898|NCT03896477|616437018|FG001|Overall Study|Lost to Follow-up|1|||
170570899|NCT03896477|616437019|FG002|Overall Study|Lost to Follow-up|1|||
170570900|NCT02168101|616437021|FG000|Overall Study|Death|2|||
170570901|NCT02168101|616437022|FG001|Overall Study|Death|2|||
170570902|NCT02168101|616437023|FG002|Overall Study|Death|1|||
170570903|NCT03326063|616437025|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
170570904|NCT03326063|616437026|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
170570905|NCT00590967|616437027|FG000|Overall Study|Withdrawal by Subject|1|||
170570906|NCT00590967|616437028|FG001|Overall Study|Withdrawal by Subject|1|||
170570907|NCT00590967|616437027|FG000|Overall Study|Ineligible|1|||
170570908|NCT00590967|616437028|FG001|Overall Study|Ineligible|0|||
170570909|NCT00590967|616437027|FG000|Overall Study|Poor performance status|0|||
170570910|NCT00590967|616437028|FG001|Overall Study|Poor performance status|1|||
170570911|NCT00590967|616437027|FG000|Overall Study|Non-compliant|0|||
170570912|NCT00590967|616437028|FG001|Overall Study|Non-compliant|2|||
170570913|NCT00590967|616437027|FG000|Overall Study|Did not sign consent form|0|||
170570914|NCT00590967|616437028|FG001|Overall Study|Did not sign consent form|1|||
170570915|NCT00590967|616437027|FG000|Overall Study|Did not receive chemo per protocol|1|||
170570916|NCT00590967|616437028|FG001|Overall Study|Did not receive chemo per protocol|0|||
170570917|NCT01881789|616437029|FG000|Overall Study|Withdrawal by Subject|0|||
170570918|NCT01881789|616437030|FG001|Overall Study|Withdrawal by Subject|2|||
170570919|NCT01881789|616437031|FG002|Overall Study|Withdrawal by Subject|1|||
170648529|NCT05395091|616725221|FG002|Month 12 to Month 18|Other reasons|1|||
170648530|NCT04463069|616725229|FG000|Overall Study|Withdrawal by Subject|2|||
170648531|NCT04463069|616725230|FG001|Overall Study|Withdrawal by Subject|10|||
170570920|NCT01881789|616437032|FG003|Overall Study|Withdrawal by Subject|0|||
170570921|NCT01881789|616437033|FG004|Overall Study|Withdrawal by Subject|1|||
170570922|NCT01881789|616437034|FG005|Overall Study|Withdrawal by Subject|1|||
170570923|NCT01881789|616437029|FG000|Overall Study|Study Terminated by Sponsor|0|||
170570924|NCT01881789|616437030|FG001|Overall Study|Study Terminated by Sponsor|0|||
170570925|NCT01881789|616437031|FG002|Overall Study|Study Terminated by Sponsor|0|||
170570926|NCT01881789|616437032|FG003|Overall Study|Study Terminated by Sponsor|0|||
170570927|NCT01881789|616437033|FG004|Overall Study|Study Terminated by Sponsor|0|||
170570928|NCT01881789|616437034|FG005|Overall Study|Study Terminated by Sponsor|1|||
170570929|NCT01881789|616437029|FG000|Overall Study|Other|3|||
170570930|NCT01881789|616437030|FG001|Overall Study|Other|5|||
170570931|NCT01881789|616437031|FG002|Overall Study|Other|2|||
170570932|NCT01881789|616437032|FG003|Overall Study|Other|3|||
170570933|NCT01881789|616437033|FG004|Overall Study|Other|1|||
170570934|NCT01881789|616437034|FG005|Overall Study|Other|1|||
170570935|NCT00920556|616437035|FG000|Overall Study|Adverse Event|16|||
170570936|NCT00920556|616437035|FG000|Overall Study|Physician Decision|7|||
170570937|NCT00920556|616437035|FG000|Overall Study|Withdrawal by Subject|1|||
170570938|NCT01299389|616437036|FG000|Double-blind|Adverse Event|45|||
170570939|NCT01299389|616437037|FG001|Double-blind|Adverse Event|27|||
170570940|NCT01299389|616437038|FG002|Double-blind|Adverse Event|0|||
170570941|NCT01299389|616437039|FG003|Double-blind|Adverse Event|0|||
170570942|NCT01299389|616437036|FG000|Double-blind|Lack of Efficacy|45|||
170570943|NCT01299389|616437037|FG001|Double-blind|Lack of Efficacy|21|||
170570944|NCT01299389|616437038|FG002|Double-blind|Lack of Efficacy|0|||
170570945|NCT01299389|616437039|FG003|Double-blind|Lack of Efficacy|0|||
170570946|NCT01299389|616437036|FG000|Double-blind|Lost to Follow-up|2|||
170570947|NCT01299389|616437037|FG001|Double-blind|Lost to Follow-up|1|||
170570948|NCT01299389|616437038|FG002|Double-blind|Lost to Follow-up|0|||
170570949|NCT01299389|616437039|FG003|Double-blind|Lost to Follow-up|0|||
170570950|NCT01299389|616437036|FG000|Double-blind|Withdrawal by Subject|16|||
170570951|NCT01299389|616437037|FG001|Double-blind|Withdrawal by Subject|13|||
170570952|NCT01299389|616437038|FG002|Double-blind|Withdrawal by Subject|0|||
170570953|NCT01299389|616437039|FG003|Double-blind|Withdrawal by Subject|0|||
170570954|NCT01299389|616437036|FG000|Double-blind|Other|1|||
170570955|NCT01299389|616437037|FG001|Double-blind|Other|1|||
170570956|NCT01299389|616437038|FG002|Double-blind|Other|0|||
170570957|NCT01299389|616437039|FG003|Double-blind|Other|0|||
170570958|NCT01299389|616437036|FG000|Double-blind|"fail to meet study population criteria"|0|||
170570959|NCT01299389|616437037|FG001|Double-blind|"fail to meet study population criteria"|1|||
170570960|NCT01299389|616437038|FG002|Double-blind|"fail to meet study population criteria"|0|||
170570961|NCT01299389|616437039|FG003|Double-blind|"fail to meet study population criteria"|0|||
170570962|NCT01299389|616437036|FG000|Post-observational|Other|0|||
170570963|NCT01299389|616437037|FG001|Post-observational|Other|0|||
170570964|NCT01299389|616437038|FG002|Post-observational|Other|12|||
170570965|NCT01299389|616437039|FG003|Post-observational|Other|6|||
170570966|NCT03637491|616437040|FG000|Overall Study|Death|9|||
170570967|NCT03637491|616437041|FG001|Overall Study|Death|9|||
170570968|NCT03637491|616437042|FG002|Overall Study|Death|5|||
170570969|NCT03637491|616437043|FG003|Overall Study|Death|3|||
170570970|NCT03637491|616437040|FG000|Overall Study|Lost to Follow-up|0|||
170570971|NCT03637491|616437041|FG001|Overall Study|Lost to Follow-up|1|||
170570972|NCT03637491|616437042|FG002|Overall Study|Lost to Follow-up|0|||
170570973|NCT03637491|616437043|FG003|Overall Study|Lost to Follow-up|1|||
170570974|NCT03637491|616437040|FG000|Overall Study|Study Terminated By Sponsor|0|||
170570975|NCT03637491|616437041|FG001|Overall Study|Study Terminated By Sponsor|2|||
170570976|NCT03637491|616437042|FG002|Overall Study|Study Terminated By Sponsor|1|||
170570977|NCT03637491|616437043|FG003|Overall Study|Study Terminated By Sponsor|0|||
170570978|NCT03637491|616437040|FG000|Overall Study|Withdrawal by Subject|1|||
170570979|NCT03637491|616437041|FG001|Overall Study|Withdrawal by Subject|0|||
170570980|NCT03637491|616437042|FG002|Overall Study|Withdrawal by Subject|1|||
170570981|NCT03637491|616437043|FG003|Overall Study|Withdrawal by Subject|2|||
170570982|NCT01824290|616437045|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
170570983|NCT01824290|616437046|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
170570984|NCT01824290|616437047|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
170570985|NCT01824290|616437048|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
170570986|NCT01824290|616437045|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
170570987|NCT01824290|616437046|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
170570988|NCT01824290|616437047|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
170570989|NCT01824290|616437048|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
170570990|NCT01824290|616437045|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
170570991|NCT01824290|616437046|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
170648532|NCT04463069|616725229|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
170570992|NCT01824290|616437047|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
170570993|NCT01824290|616437048|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
170570994|NCT01824290|616437045|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
170570995|NCT01824290|616437046|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
170570996|NCT01824290|616437047|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
170570997|NCT01824290|616437048|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
170570998|NCT01824290|616437045|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
170570999|NCT01824290|616437046|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
170571000|NCT01824290|616437047|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
170571001|NCT01824290|616437048|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
170571002|NCT01824290|616437045|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
170571003|NCT01824290|616437046|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
170571004|NCT01824290|616437047|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
170571005|NCT01824290|616437048|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
170571006|NCT01490918|616437049|FG000|Overall Study|Lost to Follow-up|2|||
170571007|NCT01490918|616437050|FG001|Overall Study|Lost to Follow-up|1|||
170571008|NCT01490918|616437051|FG002|Overall Study|Lost to Follow-up|0|||
170571009|NCT01490918|616437049|FG000|Overall Study|Withdrawal by Subject|7|||
170571010|NCT01490918|616437050|FG001|Overall Study|Withdrawal by Subject|8|||
170571011|NCT01490918|616437051|FG002|Overall Study|Withdrawal by Subject|3|||
170571012|NCT01490918|616437049|FG000|Overall Study|Adverse Event|0|||
170571013|NCT01490918|616437050|FG001|Overall Study|Adverse Event|0|||
170571014|NCT01490918|616437051|FG002|Overall Study|Adverse Event|1|||
170571015|NCT01490918|616437049|FG000|Overall Study|other cause|4|||
170571016|NCT01490918|616437050|FG001|Overall Study|other cause|5|||
170571017|NCT01490918|616437051|FG002|Overall Study|other cause|8|||
170571018|NCT04419467|616437052|FG000|Overall Study|Not treated with IP|0|||
170571019|NCT04419467|616437053|FG001|Overall Study|Not treated with IP|0|||
170571020|NCT04419467|616437054|FG002|Overall Study|Not treated with IP|2|||
170571021|NCT04419467|616437052|FG000|Overall Study|Adverse Event|0|||
170571022|NCT04419467|616437053|FG001|Overall Study|Adverse Event|2|||
170571023|NCT04419467|616437054|FG002|Overall Study|Adverse Event|0|||
170571024|NCT04419467|616437052|FG000|Overall Study|Death|1|||
170571025|NCT04419467|616437053|FG001|Overall Study|Death|0|||
170571026|NCT04419467|616437054|FG002|Overall Study|Death|0|||
170571027|NCT04419467|616437052|FG000|Overall Study|Lost to Follow-up|0|||
170571028|NCT04419467|616437053|FG001|Overall Study|Lost to Follow-up|1|||
170571029|NCT04419467|616437054|FG002|Overall Study|Lost to Follow-up|2|||
170571030|NCT04419467|616437052|FG000|Overall Study|Withdrawal by Subject|0|||
170571031|NCT04419467|616437053|FG001|Overall Study|Withdrawal by Subject|0|||
170571032|NCT04419467|616437054|FG002|Overall Study|Withdrawal by Subject|4|||
170571033|NCT04419467|616437052|FG000|Overall Study|Pandemic related|0|||
170571034|NCT04419467|616437053|FG001|Overall Study|Pandemic related|0|||
170571035|NCT04419467|616437054|FG002|Overall Study|Pandemic related|1|||
170571036|NCT04419467|616437052|FG000|Overall Study|Reason not known|1|||
170571037|NCT04419467|616437053|FG001|Overall Study|Reason not known|0|||
170571038|NCT04419467|616437054|FG002|Overall Study|Reason not known|0|||
170571039|NCT02967679|616437058|FG000|Overall Study|Adverse Event|1|||
170571040|NCT00543985|616437063|FG000|Overall Study|Withdrawal by Subject|4|||
170571041|NCT00279214|616437064|FG000|Overall Study|Physician Decision|3|||
170571042|NCT00279214|616437065|FG001|Overall Study|Physician Decision|2|||
170571043|NCT00457626|616437066|FG000|Overall Study|Adverse Event|3|||
170571044|NCT00457626|616437066|FG000|Overall Study|Administrative Problems|2|||
170571045|NCT00457626|616437066|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
170571046|NCT01048242|616438310|FG000|Overall Study|See study flow chart|4|||
170571047|NCT01048242|616438311|FG001|Overall Study|See study flow chart|2|||
170571048|NCT02364037|616438312|FG000|Overall Study|Withdrawal by Subject|7|||
170571049|NCT02364037|616438313|FG001|Overall Study|Withdrawal by Subject|4|||
170571050|NCT02364037|616438312|FG000|Overall Study|Lost to Follow-up|37|||
170571051|NCT02364037|616438313|FG001|Overall Study|Lost to Follow-up|49|||
170571052|NCT01119443|616438314|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
170571053|NCT01119443|616438315|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
170571054|NCT01428219|616438316|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
170571055|NCT00355368|616438317|FG000|Overall Study|Protocol Violation|8|||
170571056|NCT00355368|616438318|FG001|Overall Study|Protocol Violation|7|||
170571057|NCT00355368|616438317|FG000|Overall Study|cardiac arrest prior to intubation|2|||
170571058|NCT00355368|616438318|FG001|Overall Study|cardiac arrest prior to intubation|2|||
170571059|NCT01791517|616438319|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
170571060|NCT01791517|616438320|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
170571061|NCT01791517|616438321|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
170571062|NCT01791517|616438322|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
170571063|NCT01791517|616438323|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
170571064|NCT01791517|616438324|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
170571065|NCT01791517|616438325|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
170571066|NCT01791517|616438326|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
170571067|NCT01791517|616438327|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
170571068|NCT01791517|616438328|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
170571069|NCT01791517|616438329|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
170571070|NCT01791517|616438330|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
170571071|NCT01791517|616438319|FG000|Phase I: Period 1|Adverse Event|0|||
170571072|NCT01791517|616438320|FG001|Phase I: Period 1|Adverse Event|0|||
170571073|NCT01791517|616438321|FG002|Phase I: Period 1|Adverse Event|1|||
170571074|NCT01791517|616438322|FG003|Phase I: Period 1|Adverse Event|1|||
170571075|NCT01791517|616438323|FG004|Phase I: Period 1|Adverse Event|0|||
170571076|NCT01791517|616438324|FG005|Phase I: Period 1|Adverse Event|0|||
170571077|NCT01791517|616438325|FG006|Phase I: Period 1|Adverse Event|0|||
170571078|NCT01791517|616438326|FG007|Phase I: Period 1|Adverse Event|0|||
170571079|NCT01791517|616438327|FG008|Phase I: Period 1|Adverse Event|0|||
170571080|NCT01791517|616438328|FG009|Phase I: Period 1|Adverse Event|0|||
170571081|NCT01791517|616438329|FG010|Phase I: Period 1|Adverse Event|0|||
170571082|NCT01791517|616438330|FG011|Phase I: Period 1|Adverse Event|0|||
170571083|NCT01791517|616438319|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
170571084|NCT01791517|616438320|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571085|NCT01791517|616438321|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571086|NCT01791517|616438322|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571087|NCT01791517|616438323|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571088|NCT01791517|616438324|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571089|NCT01791517|616438325|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571090|NCT01791517|616438326|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571091|NCT01791517|616438327|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571092|NCT01791517|616438328|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571093|NCT01791517|616438329|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571094|NCT01791517|616438330|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
170571095|NCT01791517|616438319|FG000|Phase I: Period 1|Protocol Violation|0|||
170571096|NCT01791517|616438320|FG001|Phase I: Period 1|Protocol Violation|1|||
170571097|NCT01791517|616438321|FG002|Phase I: Period 1|Protocol Violation|0|||
170571098|NCT01791517|616438322|FG003|Phase I: Period 1|Protocol Violation|0|||
170571099|NCT01791517|616438323|FG004|Phase I: Period 1|Protocol Violation|0|||
170571100|NCT01791517|616438324|FG005|Phase I: Period 1|Protocol Violation|0|||
170571101|NCT01791517|616438325|FG006|Phase I: Period 1|Protocol Violation|0|||
170571102|NCT01791517|616438326|FG007|Phase I: Period 1|Protocol Violation|0|||
170571103|NCT01791517|616438327|FG008|Phase I: Period 1|Protocol Violation|0|||
170571104|NCT01791517|616438328|FG009|Phase I: Period 1|Protocol Violation|0|||
170571105|NCT01791517|616438329|FG010|Phase I: Period 1|Protocol Violation|0|||
170571106|NCT01791517|616438330|FG011|Phase I: Period 1|Protocol Violation|0|||
170571107|NCT01791517|616438319|FG000|Phase I: Period 1|Lost to Follow-up|0|||
170571108|NCT01791517|616438320|FG001|Phase I: Period 1|Lost to Follow-up|0|||
170571109|NCT01791517|616438321|FG002|Phase I: Period 1|Lost to Follow-up|0|||
170571110|NCT01791517|616438322|FG003|Phase I: Period 1|Lost to Follow-up|1|||
170571111|NCT01791517|616438323|FG004|Phase I: Period 1|Lost to Follow-up|0|||
170571112|NCT01791517|616438324|FG005|Phase I: Period 1|Lost to Follow-up|0|||
170571113|NCT01791517|616438325|FG006|Phase I: Period 1|Lost to Follow-up|1|||
170571114|NCT01791517|616438326|FG007|Phase I: Period 1|Lost to Follow-up|0|||
170571115|NCT01791517|616438327|FG008|Phase I: Period 1|Lost to Follow-up|1|||
170571116|NCT01791517|616438328|FG009|Phase I: Period 1|Lost to Follow-up|1|||
170571117|NCT01791517|616438329|FG010|Phase I: Period 1|Lost to Follow-up|0|||
170571118|NCT01791517|616438330|FG011|Phase I: Period 1|Lost to Follow-up|0|||
170571119|NCT01791517|616438319|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571120|NCT01791517|616438320|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571121|NCT01791517|616438321|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571122|NCT01791517|616438322|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571123|NCT01791517|616438323|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571124|NCT01791517|616438324|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571125|NCT01791517|616438325|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571126|NCT01791517|616438326|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571127|NCT01791517|616438327|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571128|NCT01791517|616438328|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571129|NCT01791517|616438329|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
170571130|NCT01791517|616438330|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
170571131|NCT01791517|616438319|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
170571132|NCT01791517|616438320|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571133|NCT01791517|616438321|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571134|NCT01791517|616438322|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571135|NCT01791517|616438323|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571136|NCT01791517|616438324|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571137|NCT01791517|616438325|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571138|NCT01791517|616438326|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571139|NCT01791517|616438327|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571140|NCT01791517|616438328|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571141|NCT01791517|616438329|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170571142|NCT01791517|616438330|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
170808454|NCT00403494|617308903|FG001|Overall Study|Inappropriately enrolled|1|||
170808455|NCT00403494|617308902|FG000|Overall Study|Lost to Follow-up|0|||
170808456|NCT00403494|617308903|FG001|Overall Study|Lost to Follow-up|2|||
170808457|NCT00403494|617308902|FG000|Overall Study|Protocol noncompliance|0|||
170808458|NCT00403494|617308903|FG001|Overall Study|Protocol noncompliance|1|||
170808459|NCT00403494|617308902|FG000|Overall Study|Death|1|||
170808460|NCT00403494|617308903|FG001|Overall Study|Death|0|||
170808461|NCT00403494|617308902|FG000|Overall Study|Sponsor Request|1|||
170808462|NCT00403494|617308903|FG001|Overall Study|Sponsor Request|0|||
170808463|NCT00768755|617308910|FG000|Phase 1|Death|6|||
170571143|NCT01791517|616438319|FG000|Phase I: Period 2|Protocol Violation|0|||
170571144|NCT01791517|616438320|FG001|Phase I: Period 2|Protocol Violation|0|||
170571145|NCT01791517|616438321|FG002|Phase I: Period 2|Protocol Violation|0|||
170571146|NCT01791517|616438322|FG003|Phase I: Period 2|Protocol Violation|1|||
170571147|NCT01791517|616438323|FG004|Phase I: Period 2|Protocol Violation|0|||
170571148|NCT01791517|616438324|FG005|Phase I: Period 2|Protocol Violation|0|||
170571149|NCT01791517|616438325|FG006|Phase I: Period 2|Protocol Violation|0|||
170571150|NCT01791517|616438326|FG007|Phase I: Period 2|Protocol Violation|0|||
170571151|NCT01791517|616438327|FG008|Phase I: Period 2|Protocol Violation|0|||
170571152|NCT01791517|616438328|FG009|Phase I: Period 2|Protocol Violation|0|||
170571153|NCT01791517|616438329|FG010|Phase I: Period 2|Protocol Violation|0|||
170571154|NCT01791517|616438330|FG011|Phase I: Period 2|Protocol Violation|0|||
170571155|NCT01791517|616438319|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
170571156|NCT01791517|616438320|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
170571157|NCT01791517|616438321|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
170571158|NCT01791517|616438322|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
170571159|NCT01791517|616438323|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
170571160|NCT01791517|616438324|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
170571161|NCT01791517|616438325|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
170571162|NCT01791517|616438326|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
170571163|NCT01791517|616438327|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
170571164|NCT01791517|616438328|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
170571165|NCT01791517|616438329|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
170571166|NCT01791517|616438330|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
170571167|NCT01791517|616438319|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571168|NCT01791517|616438320|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571169|NCT01791517|616438321|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571170|NCT01791517|616438322|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571171|NCT01791517|616438323|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571172|NCT01791517|616438324|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571173|NCT01791517|616438325|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571174|NCT01791517|616438326|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571175|NCT01791517|616438327|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571176|NCT01791517|616438328|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571177|NCT01791517|616438329|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
170571178|NCT01791517|616438330|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
170571179|NCT01791517|616438319|FG000|Phase I: Period 2|Lens Discomfort|0|||
170571180|NCT01791517|616438320|FG001|Phase I: Period 2|Lens Discomfort|0|||
170571181|NCT01791517|616438321|FG002|Phase I: Period 2|Lens Discomfort|0|||
170571182|NCT01791517|616438322|FG003|Phase I: Period 2|Lens Discomfort|0|||
170571183|NCT01791517|616438323|FG004|Phase I: Period 2|Lens Discomfort|0|||
170571184|NCT01791517|616438324|FG005|Phase I: Period 2|Lens Discomfort|1|||
170571185|NCT01791517|616438325|FG006|Phase I: Period 2|Lens Discomfort|0|||
170571186|NCT01791517|616438326|FG007|Phase I: Period 2|Lens Discomfort|0|||
170571187|NCT01791517|616438327|FG008|Phase I: Period 2|Lens Discomfort|0|||
170571188|NCT01791517|616438328|FG009|Phase I: Period 2|Lens Discomfort|0|||
170571189|NCT01791517|616438329|FG010|Phase I: Period 2|Lens Discomfort|0|||
170571190|NCT01791517|616438330|FG011|Phase I: Period 2|Lens Discomfort|0|||
170571191|NCT01791517|616438319|FG000|Phase I: Period 2|Lost to Follow-up|0|||
170571192|NCT01791517|616438320|FG001|Phase I: Period 2|Lost to Follow-up|3|||
170571193|NCT01791517|616438321|FG002|Phase I: Period 2|Lost to Follow-up|2|||
170571194|NCT01791517|616438322|FG003|Phase I: Period 2|Lost to Follow-up|0|||
170571195|NCT01791517|616438323|FG004|Phase I: Period 2|Lost to Follow-up|0|||
170571196|NCT01791517|616438324|FG005|Phase I: Period 2|Lost to Follow-up|0|||
170571197|NCT01791517|616438325|FG006|Phase I: Period 2|Lost to Follow-up|0|||
170571198|NCT01791517|616438326|FG007|Phase I: Period 2|Lost to Follow-up|0|||
170571199|NCT01791517|616438327|FG008|Phase I: Period 2|Lost to Follow-up|0|||
170571200|NCT01791517|616438328|FG009|Phase I: Period 2|Lost to Follow-up|0|||
170571201|NCT01791517|616438329|FG010|Phase I: Period 2|Lost to Follow-up|0|||
170571202|NCT01791517|616438330|FG011|Phase I: Period 2|Lost to Follow-up|0|||
170571203|NCT01791517|616438319|FG000|Phase I: Period 3|Lens Discomfort|0|||
170571204|NCT01791517|616438320|FG001|Phase I: Period 3|Lens Discomfort|0|||
170571205|NCT01791517|616438321|FG002|Phase I: Period 3|Lens Discomfort|0|||
170571206|NCT01791517|616438322|FG003|Phase I: Period 3|Lens Discomfort|0|||
170571207|NCT01791517|616438323|FG004|Phase I: Period 3|Lens Discomfort|0|||
170571208|NCT01791517|616438324|FG005|Phase I: Period 3|Lens Discomfort|0|||
170571209|NCT01791517|616438325|FG006|Phase I: Period 3|Lens Discomfort|0|||
170571210|NCT01791517|616438326|FG007|Phase I: Period 3|Lens Discomfort|0|||
170571211|NCT01791517|616438327|FG008|Phase I: Period 3|Lens Discomfort|0|||
170571212|NCT01791517|616438328|FG009|Phase I: Period 3|Lens Discomfort|0|||
170571213|NCT01791517|616438329|FG010|Phase I: Period 3|Lens Discomfort|0|||
170571214|NCT01791517|616438330|FG011|Phase I: Period 3|Lens Discomfort|1|||
170571215|NCT01791517|616438319|FG000|Phase I: Period 3|Lost to Follow-up|0|||
170571216|NCT01791517|616438320|FG001|Phase I: Period 3|Lost to Follow-up|1|||
170571217|NCT01791517|616438321|FG002|Phase I: Period 3|Lost to Follow-up|0|||
170571218|NCT01791517|616438322|FG003|Phase I: Period 3|Lost to Follow-up|0|||
170571219|NCT01791517|616438323|FG004|Phase I: Period 3|Lost to Follow-up|1|||
170571220|NCT01791517|616438324|FG005|Phase I: Period 3|Lost to Follow-up|0|||
170571221|NCT01791517|616438325|FG006|Phase I: Period 3|Lost to Follow-up|0|||
170571222|NCT01791517|616438326|FG007|Phase I: Period 3|Lost to Follow-up|0|||
170571223|NCT01791517|616438327|FG008|Phase I: Period 3|Lost to Follow-up|0|||
170571224|NCT01791517|616438328|FG009|Phase I: Period 3|Lost to Follow-up|0|||
170571225|NCT01791517|616438329|FG010|Phase I: Period 3|Lost to Follow-up|0|||
170571226|NCT01791517|616438330|FG011|Phase I: Period 3|Lost to Follow-up|0|||
170571227|NCT01791517|616438319|FG000|Phase I: Period 3|Adverse Event|0|||
170571228|NCT01791517|616438320|FG001|Phase I: Period 3|Adverse Event|0|||
170571229|NCT01791517|616438321|FG002|Phase I: Period 3|Adverse Event|0|||
170571230|NCT01791517|616438322|FG003|Phase I: Period 3|Adverse Event|1|||
170571231|NCT01791517|616438323|FG004|Phase I: Period 3|Adverse Event|0|||
170571232|NCT01791517|616438324|FG005|Phase I: Period 3|Adverse Event|0|||
170571233|NCT01791517|616438325|FG006|Phase I: Period 3|Adverse Event|0|||
170571234|NCT01791517|616438326|FG007|Phase I: Period 3|Adverse Event|0|||
170571235|NCT01791517|616438327|FG008|Phase I: Period 3|Adverse Event|0|||
170571236|NCT01791517|616438328|FG009|Phase I: Period 3|Adverse Event|0|||
170571237|NCT01791517|616438329|FG010|Phase I: Period 3|Adverse Event|0|||
170571238|NCT01791517|616438330|FG011|Phase I: Period 3|Adverse Event|0|||
170571239|NCT01791517|616438319|FG000|Phase II|Lost to Follow-up|1|||
170571240|NCT01791517|616438320|FG001|Phase II|Lost to Follow-up|0|||
170571241|NCT01791517|616438321|FG002|Phase II|Lost to Follow-up|1|||
170571242|NCT01791517|616438322|FG003|Phase II|Lost to Follow-up|0|||
170571243|NCT01791517|616438323|FG004|Phase II|Lost to Follow-up|1|||
170571244|NCT01791517|616438324|FG005|Phase II|Lost to Follow-up|2|||
170571245|NCT01791517|616438325|FG006|Phase II|Lost to Follow-up|0|||
170571246|NCT01791517|616438326|FG007|Phase II|Lost to Follow-up|1|||
170571247|NCT01791517|616438327|FG008|Phase II|Lost to Follow-up|1|||
170571248|NCT01791517|616438328|FG009|Phase II|Lost to Follow-up|1|||
170571249|NCT01791517|616438329|FG010|Phase II|Lost to Follow-up|0|||
170571250|NCT01791517|616438330|FG011|Phase II|Lost to Follow-up|0|||
170571251|NCT01791517|616438319|FG000|Phase II|Withdrawal by Subject|1|||
170571252|NCT01791517|616438320|FG001|Phase II|Withdrawal by Subject|0|||
170571253|NCT01791517|616438321|FG002|Phase II|Withdrawal by Subject|0|||
170571254|NCT01791517|616438322|FG003|Phase II|Withdrawal by Subject|0|||
170571255|NCT01791517|616438323|FG004|Phase II|Withdrawal by Subject|0|||
170571256|NCT01791517|616438324|FG005|Phase II|Withdrawal by Subject|2|||
170571257|NCT01791517|616438325|FG006|Phase II|Withdrawal by Subject|0|||
170571258|NCT01791517|616438326|FG007|Phase II|Withdrawal by Subject|1|||
170571259|NCT01791517|616438327|FG008|Phase II|Withdrawal by Subject|0|||
170571260|NCT01791517|616438328|FG009|Phase II|Withdrawal by Subject|0|||
170571261|NCT01791517|616438329|FG010|Phase II|Withdrawal by Subject|1|||
170571262|NCT01791517|616438330|FG011|Phase II|Withdrawal by Subject|0|||
170571263|NCT01791517|616438319|FG000|Phase II|Lack of Efficacy|0|||
170571264|NCT01791517|616438320|FG001|Phase II|Lack of Efficacy|0|||
170571265|NCT01791517|616438321|FG002|Phase II|Lack of Efficacy|0|||
170571266|NCT01791517|616438322|FG003|Phase II|Lack of Efficacy|0|||
170571267|NCT01791517|616438323|FG004|Phase II|Lack of Efficacy|1|||
170571268|NCT01791517|616438324|FG005|Phase II|Lack of Efficacy|0|||
170571269|NCT01791517|616438325|FG006|Phase II|Lack of Efficacy|0|||
170571270|NCT01791517|616438326|FG007|Phase II|Lack of Efficacy|0|||
170571271|NCT01791517|616438327|FG008|Phase II|Lack of Efficacy|0|||
170571272|NCT01791517|616438328|FG009|Phase II|Lack of Efficacy|0|||
170571273|NCT01791517|616438329|FG010|Phase II|Lack of Efficacy|0|||
170571274|NCT01791517|616438330|FG011|Phase II|Lack of Efficacy|0|||
170571275|NCT01791517|616438319|FG000|Phase II|Adverse Event|0|||
170571276|NCT01791517|616438320|FG001|Phase II|Adverse Event|0|||
170571277|NCT01791517|616438321|FG002|Phase II|Adverse Event|0|||
170571278|NCT01791517|616438322|FG003|Phase II|Adverse Event|0|||
170571279|NCT01791517|616438323|FG004|Phase II|Adverse Event|0|||
170571280|NCT01791517|616438324|FG005|Phase II|Adverse Event|0|||
170571281|NCT01791517|616438325|FG006|Phase II|Adverse Event|2|||
170571282|NCT01791517|616438326|FG007|Phase II|Adverse Event|1|||
170571283|NCT01791517|616438327|FG008|Phase II|Adverse Event|0|||
170571284|NCT01791517|616438328|FG009|Phase II|Adverse Event|1|||
170571285|NCT01791517|616438329|FG010|Phase II|Adverse Event|0|||
170808464|NCT00768755|617308911|FG001|Phase 1|Death|0|||
170808465|NCT00768755|617308912|FG002|Phase 1|Death|0|||
170808466|NCT00768755|617308913|FG003|Phase 1|Death|0|||
170808467|NCT00768755|617308910|FG000|Phase 1|Other|4|||
170808468|NCT00768755|617308911|FG001|Phase 1|Other|0|||
170571286|NCT01791517|616438330|FG011|Phase II|Adverse Event|0|||
170571287|NCT01791517|616438319|FG000|Phase II|Lens Handling Difficulties|0|||
170571288|NCT01791517|616438320|FG001|Phase II|Lens Handling Difficulties|0|||
170571289|NCT01791517|616438321|FG002|Phase II|Lens Handling Difficulties|0|||
170571290|NCT01791517|616438322|FG003|Phase II|Lens Handling Difficulties|0|||
170571291|NCT01791517|616438323|FG004|Phase II|Lens Handling Difficulties|0|||
170571292|NCT01791517|616438324|FG005|Phase II|Lens Handling Difficulties|0|||
170571293|NCT01791517|616438325|FG006|Phase II|Lens Handling Difficulties|0|||
170571294|NCT01791517|616438326|FG007|Phase II|Lens Handling Difficulties|0|||
170571295|NCT01791517|616438327|FG008|Phase II|Lens Handling Difficulties|1|||
170571296|NCT01791517|616438328|FG009|Phase II|Lens Handling Difficulties|0|||
170571297|NCT01791517|616438329|FG010|Phase II|Lens Handling Difficulties|0|||
170808469|NCT00768755|617308912|FG002|Phase 1|Other|0|||
170571298|NCT01791517|616438330|FG011|Phase II|Lens Handling Difficulties|0|||
170571299|NCT01791517|616438319|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
170571300|NCT01791517|616438320|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
170571301|NCT01791517|616438321|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
170571302|NCT01791517|616438322|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
170571303|NCT01791517|616438323|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
170571304|NCT01791517|616438324|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
170571305|NCT01791517|616438325|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
170571306|NCT01791517|616438326|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
170571307|NCT01791517|616438327|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
170571308|NCT01791517|616438328|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
170571309|NCT01791517|616438329|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
170571310|NCT01791517|616438330|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
170571311|NCT01791517|616438319|FG000|Phase II|Pre-Existing Ocular Issue|0|||
170571312|NCT01791517|616438320|FG001|Phase II|Pre-Existing Ocular Issue|0|||
170571313|NCT01791517|616438321|FG002|Phase II|Pre-Existing Ocular Issue|0|||
170571314|NCT01791517|616438322|FG003|Phase II|Pre-Existing Ocular Issue|0|||
170571315|NCT01791517|616438323|FG004|Phase II|Pre-Existing Ocular Issue|0|||
170571316|NCT01791517|616438324|FG005|Phase II|Pre-Existing Ocular Issue|0|||
170571317|NCT01791517|616438325|FG006|Phase II|Pre-Existing Ocular Issue|0|||
170571318|NCT01791517|616438326|FG007|Phase II|Pre-Existing Ocular Issue|0|||
170571319|NCT01791517|616438327|FG008|Phase II|Pre-Existing Ocular Issue|0|||
170571320|NCT01791517|616438328|FG009|Phase II|Pre-Existing Ocular Issue|0|||
170571321|NCT01791517|616438329|FG010|Phase II|Pre-Existing Ocular Issue|0|||
170571322|NCT01791517|616438330|FG011|Phase II|Pre-Existing Ocular Issue|1|||
170571323|NCT02185534|616438332|FG000|First Period|Withdrawal by Subject|0|||
170571324|NCT02185534|616438333|FG001|First Period|Withdrawal by Subject|0|||
170571325|NCT02185534|616438334|FG002|First Period|Withdrawal by Subject|0|||
170571326|NCT02185534|616438335|FG003|First Period|Withdrawal by Subject|1|||
170571327|NCT02185534|616438336|FG004|First Period|Withdrawal by Subject|0|||
170571328|NCT02185534|616438337|FG005|First Period|Withdrawal by Subject|0|||
170571329|NCT02185534|616438332|FG000|First Washout Period|Withdrawal by Subject|1|||
170571330|NCT02185534|616438333|FG001|First Washout Period|Withdrawal by Subject|0|||
170571331|NCT02185534|616438334|FG002|First Washout Period|Withdrawal by Subject|0|||
170571332|NCT02185534|616438335|FG003|First Washout Period|Withdrawal by Subject|0|||
170571333|NCT02185534|616438336|FG004|First Washout Period|Withdrawal by Subject|1|||
170571334|NCT02185534|616438337|FG005|First Washout Period|Withdrawal by Subject|0|||
170571335|NCT02185534|616438332|FG000|First Washout Period|Protocol Violation|0|||
170571336|NCT02185534|616438333|FG001|First Washout Period|Protocol Violation|0|||
170571337|NCT02185534|616438334|FG002|First Washout Period|Protocol Violation|0|||
170571338|NCT02185534|616438335|FG003|First Washout Period|Protocol Violation|0|||
170571339|NCT02185534|616438336|FG004|First Washout Period|Protocol Violation|0|||
170571340|NCT02185534|616438337|FG005|First Washout Period|Protocol Violation|1|||
170571341|NCT02756403|616438338|FG000|Overall Study|Unable to swallow medication|0|||
170571342|NCT02756403|616438339|FG001|Overall Study|Unable to swallow medication|1|||
170571343|NCT02756403|616438340|FG002|Overall Study|Unable to swallow medication|1|||
170571344|NCT02756403|616438341|FG003|Overall Study|Unable to swallow medication|1|||
170571345|NCT02756403|616438338|FG000|Overall Study|Did not complete Procedure|0|||
170571346|NCT02756403|616438339|FG001|Overall Study|Did not complete Procedure|1|||
170571347|NCT02756403|616438340|FG002|Overall Study|Did not complete Procedure|0|||
170571348|NCT02756403|616438341|FG003|Overall Study|Did not complete Procedure|0|||
170571349|NCT02756403|616438338|FG000|Overall Study|Changed Mind About Procedure|0|||
170571350|NCT02756403|616438339|FG001|Overall Study|Changed Mind About Procedure|0|||
170571351|NCT02756403|616438340|FG002|Overall Study|Changed Mind About Procedure|1|||
170571352|NCT02756403|616438341|FG003|Overall Study|Changed Mind About Procedure|0|||
170571353|NCT02756403|616438338|FG000|Overall Study|Protocol Violation|0|||
170571354|NCT02756403|616438339|FG001|Overall Study|Protocol Violation|1|||
170571355|NCT02756403|616438340|FG002|Overall Study|Protocol Violation|0|||
170571356|NCT02756403|616438341|FG003|Overall Study|Protocol Violation|1|||
170571357|NCT00527618|616438342|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
170571358|NCT00527618|616438343|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
170571359|NCT00527618|616438342|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
170571360|NCT00527618|616438343|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
170571361|NCT00527618|616438342|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
170571362|NCT00527618|616438343|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
170571363|NCT00527618|616438342|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
170571364|NCT00527618|616438343|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
170571365|NCT00527618|616438342|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
170571366|NCT00527618|616438343|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
170571367|NCT00527618|616438342|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
170571368|NCT00527618|616438343|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
170571369|NCT01151020|616438344|FG000|Overall Study|Death|25|||
170571370|NCT01151020|616438344|FG000|Overall Study|Conversion to open repair|1|||
170648533|NCT04463069|616725230|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
170571371|NCT01151020|616438344|FG000|Overall Study|Lost to Follow-up|4|||
170571372|NCT01151020|616438344|FG000|Overall Study|Withdrawal by Subject|22|||
170571373|NCT01151020|616438344|FG000|Overall Study|Patients did not receive the device|2|||
170571374|NCT00648037|616438345|FG000|Overall Study|Not Treated|1|||
170571375|NCT00648037|616438345|FG000|Overall Study|Withdrawal by Subject|1|||
170571376|NCT00648037|616438345|FG000|Overall Study|Adverse Event|11|||
170571377|NCT00648037|616438345|FG000|Overall Study|Relapse|2|||
170571378|NCT00648037|616438345|FG000|Overall Study|Other|1|||
170571379|NCT01635998|616438346|FG000|Overall Study|Death|1|||
170648534|NCT03073733|616725231|FG000|Overall Study|Lost to Follow-up|1|||
170648535|NCT03073733|616725232|FG001|Overall Study|Lost to Follow-up|0|||
170648536|NCT03073733|616725233|FG002|Overall Study|Lost to Follow-up|0|||
170648537|NCT03073733|616725231|FG000|Overall Study|Physician Decision|0|||
170648538|NCT03073733|616725232|FG001|Overall Study|Physician Decision|1|||
170648539|NCT03073733|616725233|FG002|Overall Study|Physician Decision|0|||
170648540|NCT03073733|616725231|FG000|Overall Study|Withdrawal by Subject|0|||
170648541|NCT03073733|616725232|FG001|Overall Study|Withdrawal by Subject|0|||
170648542|NCT03073733|616725233|FG002|Overall Study|Withdrawal by Subject|1|||
170571380|NCT01635998|616438347|FG001|Overall Study|Death|1|||
170571381|NCT01635998|616438346|FG000|Overall Study|Lost to Follow-up|2|||
170571382|NCT01635998|616438347|FG001|Overall Study|Lost to Follow-up|1|||
170571383|NCT01635998|616438346|FG000|Overall Study|Withdrawal by Subject|1|||
170571384|NCT01635998|616438347|FG001|Overall Study|Withdrawal by Subject|5|||
170571385|NCT00846846|616438348|FG000|Overall Study|Death|56|||
170571386|NCT00846846|616438348|FG000|Overall Study|Withdrawal by Subject|19|||
170571387|NCT00600067|616438351|FG000|Overall Study|Adverse Event|0|||
170571388|NCT00600067|616438352|FG001|Overall Study|Adverse Event|1|||
170571389|NCT00600067|616438351|FG000|Overall Study|Lost to Follow-up|2|||
170571390|NCT00600067|616438352|FG001|Overall Study|Lost to Follow-up|3|||
170571391|NCT00600067|616438351|FG000|Overall Study|protocol non-compliance|0|||
170571392|NCT00600067|616438352|FG001|Overall Study|protocol non-compliance|3|||
170571393|NCT00600067|616438351|FG000|Overall Study|Lack of Efficacy|1|||
170571394|NCT00600067|616438352|FG001|Overall Study|Lack of Efficacy|0|||
170571395|NCT00881894|616438353|FG000|Overall Study|Consent withdrawn|0|||
170571396|NCT00881894|616438354|FG001|Overall Study|Consent withdrawn|1|||
170571397|NCT00881894|616438353|FG000|Overall Study|Other reasons for premature termination|1|||
170571398|NCT00881894|616438354|FG001|Overall Study|Other reasons for premature termination|2|||
170571399|NCT04571060|616438357|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
170571400|NCT04571060|616438358|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
170571401|NCT04571060|616438357|FG000|Overall Study|Never treated migraine|47|||
170571402|NCT04571060|616438358|FG001|Overall Study|Never treated migraine|36|||
170571403|NCT04571060|616438357|FG000|Overall Study|Protocol Violation|4|||
170571404|NCT04571060|616438358|FG001|Overall Study|Protocol Violation|2|||
170571405|NCT04571060|616438357|FG000|Overall Study|Withdrawal by Subject|6|||
170571406|NCT04571060|616438358|FG001|Overall Study|Withdrawal by Subject|2|||
170571407|NCT04571060|616438357|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
170571408|NCT04571060|616438358|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
170571409|NCT01253369|616438359|FG000|Overall Study|Adverse Event|4|||
170571410|NCT01253369|616438359|FG000|Overall Study|Withdrawal by Subject|2|||
170571411|NCT01253369|616438359|FG000|Overall Study|Death|1|||
170571412|NCT01253369|616438359|FG000|Overall Study|Progressive disease|23|||
170571413|NCT01253369|616438359|FG000|Overall Study|Not Evaluable|3|||
170571414|NCT01220401|616438365|FG000|Overall Study|Withdrawal by Subject|2|||
170571415|NCT01220401|616438365|FG000|Overall Study|Protocol Violation|1|||
170571416|NCT00087698|616438366|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
170571417|NCT00087698|616438366|FG000|Overall Study|Death from Other Causes|3|||
170571418|NCT00087698|616438366|FG000|Overall Study|Adverse Event|4|||
170571419|NCT00087698|616438366|FG000|Overall Study|Withdrawal by Subject|4|||
170648543|NCT00835731|616725234|FG000|Overall Study|Withdrawal by Subject|1|||
170648544|NCT00835731|616725235|FG001|Overall Study|Withdrawal by Subject|0|||
170648545|NCT00835731|616725234|FG000|Overall Study|Physician Decision|1|||
170648546|NCT00835731|616725235|FG001|Overall Study|Physician Decision|1|||
170571420|NCT00087698|616438366|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
170571421|NCT00087698|616438366|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
170571422|NCT00087698|616438366|FG000|Overall Study|Clinical Relapse|1|||
170571423|NCT00087698|616438366|FG000|Overall Study|Death from Study Disease|2|||
170571424|NCT00087698|616438366|FG000|Overall Study|Death from Study Drug Toxicity|2|||
170571425|NCT00087698|616438366|FG000|Overall Study|Protocol Violation|1|||
170571426|NCT01853462|616438369|FG000|Overall Study|Withdrawal by Subject|1|||
170648547|NCT01727700|616726755|FG000|Overall Study|Adverse Event|0|||
170571427|NCT01853462|616438370|FG001|Overall Study|Withdrawal by Subject|1|||
170571428|NCT01737762|616438373|FG000|Overall Study|Adverse Event|2|||
170571429|NCT01737762|616438374|FG001|Overall Study|Adverse Event|2|||
170571430|NCT01737762|616438373|FG000|Overall Study|Lost to Follow-up|1|||
170648548|NCT01727700|616726756|FG001|Overall Study|Adverse Event|7|||
170648549|NCT01727700|616726757|FG002|Overall Study|Adverse Event|1|||
170571431|NCT01737762|616438374|FG001|Overall Study|Lost to Follow-up|0|||
170571432|NCT01737762|616438373|FG000|Overall Study|Withdrawal by Subject|2|||
170571433|NCT01737762|616438374|FG001|Overall Study|Withdrawal by Subject|2|||
170571434|NCT01737762|616438373|FG000|Overall Study|Progressive disease|1|||
170571435|NCT01737762|616438374|FG001|Overall Study|Progressive disease|2|||
170571436|NCT01737762|616438373|FG000|Overall Study|Physician Decision|1|||
170571437|NCT01737762|616438374|FG001|Overall Study|Physician Decision|1|||
170571438|NCT01737762|616438373|FG000|Overall Study|Moved from area|2|||
170571439|NCT01737762|616438374|FG001|Overall Study|Moved from area|1|||
170571440|NCT01737762|616438373|FG000|Overall Study|Trial termination|11|||
170571441|NCT01737762|616438374|FG001|Overall Study|Trial termination|9|||
170571442|NCT00326599|616438375|FG000|Overall Study|Withdrawal by Subject|1|||
170571443|NCT00326599|616438376|FG001|Overall Study|Withdrawal by Subject|0|||
170571444|NCT00326599|616438377|FG002|Overall Study|Withdrawal by Subject|5|||
170571445|NCT00326599|616438378|FG003|Overall Study|Withdrawal by Subject|2|||
170571446|NCT00326599|616438375|FG000|Overall Study|Adverse Event|1|||
170571447|NCT00326599|616438376|FG001|Overall Study|Adverse Event|0|||
170571448|NCT00326599|616438377|FG002|Overall Study|Adverse Event|32|||
170571449|NCT00326599|616438378|FG003|Overall Study|Adverse Event|3|||
170571450|NCT00326599|616438375|FG000|Overall Study|Disease Progression|3|||
170571451|NCT00326599|616438376|FG001|Overall Study|Disease Progression|1|||
170571452|NCT00326599|616438377|FG002|Overall Study|Disease Progression|13|||
170571453|NCT00326599|616438378|FG003|Overall Study|Disease Progression|11|||
170571454|NCT00326599|616438375|FG000|Overall Study|Alternate Treatment|1|||
170571455|NCT00326599|616438376|FG001|Overall Study|Alternate Treatment|0|||
170571456|NCT00326599|616438377|FG002|Overall Study|Alternate Treatment|0|||
170571457|NCT00326599|616438378|FG003|Overall Study|Alternate Treatment|0|||
170571458|NCT00326599|616438375|FG000|Overall Study|Death|0|||
170571459|NCT00326599|616438376|FG001|Overall Study|Death|0|||
170571460|NCT00326599|616438377|FG002|Overall Study|Death|1|||
170571461|NCT00326599|616438378|FG003|Overall Study|Death|2|||
170571462|NCT00326599|616438375|FG000|Overall Study|Other Unspecified Reason|0|||
170571463|NCT00326599|616438376|FG001|Overall Study|Other Unspecified Reason|0|||
170571464|NCT00326599|616438377|FG002|Overall Study|Other Unspecified Reason|2|||
170571465|NCT00326599|616438378|FG003|Overall Study|Other Unspecified Reason|1|||
170571466|NCT00625586|616438379|FG000|Overall Study|Adverse Event|1|||
170571467|NCT00625586|616438379|FG000|Overall Study|Progressive disease|1|||
170571468|NCT04721158|616438384|FG000|Overall Study|Lost to Follow-up|4|||
170571469|NCT04721158|616438384|FG000|Overall Study|Device did not connect|1|||
170571470|NCT03958331|616438385|FG000|Overall Study|Withdrawal by Subject|3|||
170571471|NCT03958331|616438386|FG001|Overall Study|Withdrawal by Subject|1|||
170571472|NCT03958331|616438387|FG002|Overall Study|Withdrawal by Subject|5|||
170571473|NCT03958331|616438385|FG000|Overall Study|Weaned from medicine|2|||
170571474|NCT03958331|616438386|FG001|Overall Study|Weaned from medicine|0|||
170571475|NCT03958331|616438387|FG002|Overall Study|Weaned from medicine|0|||
170571476|NCT03958331|616438385|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
170571477|NCT03958331|616438386|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
170648550|NCT01727700|616726755|FG000|Overall Study|Particpant withdrew consent|0|||
170648551|NCT01727700|616726756|FG001|Overall Study|Particpant withdrew consent|3|||
170648552|NCT01727700|616726757|FG002|Overall Study|Particpant withdrew consent|1|||
170648553|NCT01727700|616726755|FG000|Overall Study|Protocol Violation|2|||
170648554|NCT01727700|616726756|FG001|Overall Study|Protocol Violation|0|||
170648555|NCT01727700|616726757|FG002|Overall Study|Protocol Violation|0|||
170648556|NCT01757691|616726760|FG000|Overall Study|Administrative problems|2|||
170648557|NCT01757691|616726761|FG001|Overall Study|Administrative problems|0|||
170808470|NCT00768755|617308913|FG003|Phase 1|Other|0|||
170808471|NCT00768755|617308910|FG000|Phase 2|Death|0|||
170808472|NCT00768755|617308911|FG001|Phase 2|Death|37|||
170808473|NCT00768755|617308912|FG002|Phase 2|Death|48|||
170808474|NCT00768755|617308913|FG003|Phase 2|Death|31|||
170808475|NCT00768755|617308910|FG000|Phase 2|Protocol Violation|0|||
170808476|NCT00768755|617308911|FG001|Phase 2|Protocol Violation|2|||
170808477|NCT00768755|617308912|FG002|Phase 2|Protocol Violation|0|||
170808478|NCT00768755|617308913|FG003|Phase 2|Protocol Violation|1|||
170808479|NCT00768755|617308910|FG000|Phase 2|Lost to Follow-up|0|||
170571478|NCT03958331|616438387|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
170571479|NCT01991483|616438388|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
170571480|NCT01991483|616438389|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
170648558|NCT00773383|616726762|FG000|Overall Study|Adverse Event|4|||
170648559|NCT00773383|616726762|FG000|Overall Study|Death|1|||
170571481|NCT01991483|616438390|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
170571482|NCT01991483|616438391|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
170571483|NCT01991483|616438388|FG000|Dose Level 600 mg|Physician Decision|0|||
170571484|NCT01991483|616438389|FG001|Dose Level 600 mg|Physician Decision|0|||
170571485|NCT01991483|616438390|FG002|Dose Level 600 mg|Physician Decision|1|||
170648560|NCT00773383|616726762|FG000|Overall Study|Progression of Disease|23|||
170808480|NCT00768755|617308911|FG001|Phase 2|Lost to Follow-up|1|||
170808481|NCT00768755|617308912|FG002|Phase 2|Lost to Follow-up|1|||
170808482|NCT00768755|617308913|FG003|Phase 2|Lost to Follow-up|4|||
170648561|NCT00773383|616726762|FG000|Overall Study|Other|2|||
170648562|NCT00773383|616726762|FG000|Overall Study|No study dose received|1|||
170648563|NCT03811093|616726765|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
170648564|NCT03811093|616726766|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
170648565|NCT03811093|616726765|FG000|Overall Study|Unable to measure body fat percentage|2|||
170648566|NCT03811093|616726766|FG001|Overall Study|Unable to measure body fat percentage|0|||
170648567|NCT01909791|616726767|FG000|Overall Study|Death|9|||
170648568|NCT01909791|616726768|FG001|Overall Study|Death|8|||
170648569|NCT01909791|616726769|FG002|Overall Study|Death|4|||
170571486|NCT01991483|616438391|FG003|Dose Level 600 mg|Physician Decision|0|||
170571487|NCT01991483|616438388|FG000|Dose Level 1000 mg|Protocol Violation|0|||
170571488|NCT01991483|616438389|FG001|Dose Level 1000 mg|Protocol Violation|0|||
170571489|NCT01991483|616438390|FG002|Dose Level 1000 mg|Protocol Violation|0|||
170571490|NCT01991483|616438391|FG003|Dose Level 1000 mg|Protocol Violation|1|||
170571491|NCT03192137|616438392|FG000|Overall Study|Adverse Event|10|||
170571492|NCT03192137|616438393|FG001|Overall Study|Adverse Event|11|||
170571493|NCT03192137|616438392|FG000|Overall Study|Physician Decision|1|||
170571494|NCT03192137|616438393|FG001|Overall Study|Physician Decision|0|||
170571495|NCT03192137|616438392|FG000|Overall Study|Lack of Efficacy|20|||
170571496|NCT03192137|616438393|FG001|Overall Study|Lack of Efficacy|37|||
170571497|NCT03192137|616438392|FG000|Overall Study|Withdrawal by Subject|3|||
170571498|NCT03192137|616438393|FG001|Overall Study|Withdrawal by Subject|3|||
170571499|NCT03192137|616438392|FG000|Overall Study|Protocol Violation|4|||
170571500|NCT03192137|616438393|FG001|Overall Study|Protocol Violation|3|||
170571501|NCT03192137|616438392|FG000|Overall Study|Surgery Cancelled|4|||
170571502|NCT03192137|616438393|FG001|Overall Study|Surgery Cancelled|1|||
170571503|NCT03192137|616438392|FG000|Overall Study|Other - Various Administrative Reasons|8|||
170571504|NCT03192137|616438393|FG001|Overall Study|Other - Various Administrative Reasons|3|||
170571505|NCT00657267|616438395|FG000|Overall Study|Progressive disease|45|||
170571506|NCT00657267|616438395|FG000|Overall Study|Adverse Event|9|||
170571507|NCT02737501|616438396|FG000|Randomized Phase|Died|41|||
170571508|NCT02737501|616438397|FG001|Randomized Phase|Died|29|||
170571509|NCT02737501|616438398|FG002|Randomized Phase|Died|0|||
170571510|NCT02737501|616438396|FG000|Randomized Phase|Withdrawal by Subject|16|||
170571511|NCT02737501|616438397|FG001|Randomized Phase|Withdrawal by Subject|6|||
170571512|NCT02737501|616438398|FG002|Randomized Phase|Withdrawal by Subject|0|||
170571513|NCT02737501|616438396|FG000|Randomized Phase|Lost to Follow-up|0|||
170571514|NCT02737501|616438397|FG001|Randomized Phase|Lost to Follow-up|1|||
170571515|NCT02737501|616438398|FG002|Randomized Phase|Lost to Follow-up|0|||
170571516|NCT02737501|616438396|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
170571517|NCT02737501|616438397|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
170571518|NCT02737501|616438398|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
170571519|NCT02737501|616438396|FG000|Randomized Phase|Reason not Specified|1|||
170571520|NCT02737501|616438397|FG001|Randomized Phase|Reason not Specified|1|||
170571521|NCT02737501|616438398|FG002|Randomized Phase|Reason not Specified|0|||
170571522|NCT02737501|616438396|FG000|Randomized Phase|Never Treated|1|||
170571523|NCT02737501|616438397|FG001|Randomized Phase|Never Treated|1|||
170571524|NCT02737501|616438398|FG002|Randomized Phase|Never Treated|0|||
170571525|NCT02737501|616438396|FG000|Crossover Phase|Died|0|||
170571526|NCT02737501|616438397|FG001|Crossover Phase|Died|0|||
170571527|NCT02737501|616438398|FG002|Crossover Phase|Died|22|||
170571528|NCT02737501|616438396|FG000|Crossover Phase|Withdrew Consent|0|||
170571529|NCT02737501|616438397|FG001|Crossover Phase|Withdrew Consent|0|||
170571530|NCT02737501|616438398|FG002|Crossover Phase|Withdrew Consent|9|||
170571531|NCT02737501|616438396|FG000|Crossover Phase|Physician Decision|0|||
170571532|NCT02737501|616438397|FG001|Crossover Phase|Physician Decision|0|||
170571533|NCT02737501|616438398|FG002|Crossover Phase|Physician Decision|1|||
170571534|NCT02737501|616438396|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
170571535|NCT02737501|616438397|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
170571536|NCT02737501|616438398|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
170571537|NCT02012218|616438402|FG000|Overall Study|Withdrawal by Subject|1|||
170571538|NCT02012218|616438403|FG001|Overall Study|Withdrawal by Subject|0|||
170571539|NCT02012218|616438404|FG002|Overall Study|Withdrawal by Subject|1|||
170571540|NCT02012218|616438405|FG003|Overall Study|Withdrawal by Subject|1|||
170571541|NCT02012218|616438406|FG004|Overall Study|Withdrawal by Subject|1|||
170571542|NCT02012218|616438402|FG000|Overall Study|Adverse Event|1|||
170648570|NCT01909791|616726767|FG000|Overall Study|Withdrawal by Subject|5|||
170808483|NCT00768755|617308910|FG000|Phase 2|Withdrawal by Subject|0|||
170571543|NCT02012218|616438403|FG001|Overall Study|Adverse Event|0|||
170571544|NCT02012218|616438404|FG002|Overall Study|Adverse Event|0|||
170571545|NCT02012218|616438405|FG003|Overall Study|Adverse Event|1|||
170571546|NCT02012218|616438406|FG004|Overall Study|Adverse Event|0|||
170571547|NCT02012218|616438402|FG000|Overall Study|Lost to Follow-up|0|||
170571548|NCT02012218|616438403|FG001|Overall Study|Lost to Follow-up|1|||
170571549|NCT02012218|616438404|FG002|Overall Study|Lost to Follow-up|1|||
170808484|NCT00768755|617308911|FG001|Phase 2|Withdrawal by Subject|1|||
170808485|NCT00768755|617308912|FG002|Phase 2|Withdrawal by Subject|0|||
170808486|NCT00768755|617308913|FG003|Phase 2|Withdrawal by Subject|1|||
170648571|NCT01909791|616726768|FG001|Overall Study|Withdrawal by Subject|9|||
170648572|NCT01909791|616726769|FG002|Overall Study|Withdrawal by Subject|13|||
170648573|NCT01909791|616726767|FG000|Overall Study|Lost to Follow-up|5|||
170648574|NCT01909791|616726768|FG001|Overall Study|Lost to Follow-up|11|||
170648575|NCT01909791|616726769|FG002|Overall Study|Lost to Follow-up|10|||
170648576|NCT01909791|616726767|FG000|Overall Study|Missed Visit|2|||
170648577|NCT01909791|616726768|FG001|Overall Study|Missed Visit|0|||
170648578|NCT01909791|616726769|FG002|Overall Study|Missed Visit|1|||
170648579|NCT01713933|616726770|FG000|Overall Study|Lost to Follow-up|2|||
170571550|NCT02012218|616438405|FG003|Overall Study|Lost to Follow-up|0|||
170571551|NCT02012218|616438406|FG004|Overall Study|Lost to Follow-up|0|||
170571552|NCT02012218|616438402|FG000|Overall Study|Protocol Specified|1|||
170571553|NCT02012218|616438403|FG001|Overall Study|Protocol Specified|0|||
170571554|NCT02012218|616438404|FG002|Overall Study|Protocol Specified|0|||
170571555|NCT02012218|616438405|FG003|Overall Study|Protocol Specified|0|||
170571556|NCT02012218|616438406|FG004|Overall Study|Protocol Specified|0|||
170571557|NCT02012218|616438402|FG000|Overall Study|Protocol Deviation|1|||
170571558|NCT02012218|616438403|FG001|Overall Study|Protocol Deviation|0|||
170571559|NCT02012218|616438404|FG002|Overall Study|Protocol Deviation|0|||
170571560|NCT02012218|616438405|FG003|Overall Study|Protocol Deviation|0|||
170571561|NCT02012218|616438406|FG004|Overall Study|Protocol Deviation|0|||
170571562|NCT01070979|616438407|FG000|Overall Study|Adverse Event|2|||
170571563|NCT01070979|616438408|FG001|Overall Study|Adverse Event|3|||
170571564|NCT01070979|616438409|FG002|Overall Study|Adverse Event|3|||
170571565|NCT01070979|616438407|FG000|Overall Study|Lost to Follow-up|2|||
170571566|NCT01070979|616438408|FG001|Overall Study|Lost to Follow-up|1|||
170571567|NCT01070979|616438409|FG002|Overall Study|Lost to Follow-up|1|||
170571568|NCT01070979|616438407|FG000|Overall Study|Protocol Violation|0|||
170571569|NCT01070979|616438408|FG001|Overall Study|Protocol Violation|2|||
170571570|NCT01070979|616438409|FG002|Overall Study|Protocol Violation|6|||
170571571|NCT01070979|616438407|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
170571572|NCT01070979|616438408|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
170571573|NCT01070979|616438409|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
170571574|NCT01070979|616438407|FG000|Overall Study|Withdrawal by Subject|3|||
170571575|NCT01070979|616438408|FG001|Overall Study|Withdrawal by Subject|1|||
170571576|NCT01070979|616438409|FG002|Overall Study|Withdrawal by Subject|1|||
170571577|NCT01070979|616438407|FG000|Overall Study|No study drug taken|0|||
170571578|NCT01070979|616438408|FG001|Overall Study|No study drug taken|1|||
170571579|NCT01070979|616438409|FG002|Overall Study|No study drug taken|0|||
170571580|NCT00142792|616438410|FG000|Overall Study|Death|0|||
170571581|NCT00142792|616438411|FG001|Overall Study|Death|0|||
170571582|NCT00142792|616438412|FG002|Overall Study|Death|1|||
170571583|NCT00142792|616438410|FG000|Overall Study|Withdrawal by Subject|3|||
170571584|NCT00142792|616438411|FG001|Overall Study|Withdrawal by Subject|2|||
170571585|NCT00142792|616438412|FG002|Overall Study|Withdrawal by Subject|3|||
170571586|NCT00142792|616438410|FG000|Overall Study|Lost to Follow-up|8|||
170571587|NCT00142792|616438411|FG001|Overall Study|Lost to Follow-up|11|||
170571588|NCT00142792|616438412|FG002|Overall Study|Lost to Follow-up|7|||
170571589|NCT00142792|616438410|FG000|Overall Study|No category|1|||
170571590|NCT00142792|616438411|FG001|Overall Study|No category|2|||
170571591|NCT00142792|616438412|FG002|Overall Study|No category|1|||
170571592|NCT04819113|616438413|FG000|Overall Study|Withdrawal by parent/guardian|3|||
170571593|NCT04819113|616438413|FG000|Overall Study|Lost to Follow-up|1|||
170648580|NCT01713933|616726770|FG000|Overall Study|Withdrawal by Subject|3|||
170648581|NCT01713933|616726770|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
170648582|NCT02882152|616726771|FG000|Overall Study|Lost to Follow-up|1|||
170648583|NCT02882152|616726772|FG001|Overall Study|Lost to Follow-up|0|||
170648584|NCT01009840|616726773|FG000|Overall Study|Lost to Follow-up|1|||
170648585|NCT01009840|616726773|FG000|Overall Study|Adverse Event|4|||
170648586|NCT01009840|616726773|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
170648587|NCT01009840|616726773|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
170648588|NCT01009840|616726773|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
170648589|NCT03086967|616726779|FG000|Overall Study|Screen Failure|2|||
170648590|NCT03086967|616726780|FG001|Overall Study|Screen Failure|2|||
170648591|NCT03361176|616726781|FG000|Overall Study|Lost to Follow-up|1|||
170648592|NCT03361176|616726782|FG001|Overall Study|Lost to Follow-up|2|||
170648593|NCT03361176|616726781|FG000|Overall Study|Adverse Event|0|||
170648594|NCT03361176|616726782|FG001|Overall Study|Adverse Event|2|||
170648595|NCT03361176|616726781|FG000|Overall Study|Withdrawal by Subject|0|||
170571594|NCT04819113|616438413|FG000|Overall Study|Withdrawn before vaccination|2|||
170571595|NCT00437268|616438414|FG000|Overall Study|Adverse Event|1|||
170571596|NCT00437268|616438415|FG001|Overall Study|Adverse Event|1|||
170571597|NCT00437268|616438414|FG000|Overall Study|Withdrawal by Subject|2|||
170648596|NCT03361176|616726782|FG001|Overall Study|Withdrawal by Subject|1|||
170571598|NCT00437268|616438415|FG001|Overall Study|Withdrawal by Subject|2|||
170571599|NCT00437268|616438414|FG000|Overall Study|Progressive disease|9|||
170648597|NCT02478398|616726783|FG000|Overall Study|Adverse Event|20|||
170648598|NCT02478398|616726784|FG001|Overall Study|Adverse Event|5|||
170571600|NCT00437268|616438415|FG001|Overall Study|Progressive disease|9|||
170571601|NCT00437268|616438414|FG000|Overall Study|Physician Decision|1|||
170571602|NCT00437268|616438415|FG001|Overall Study|Physician Decision|0|||
170571603|NCT00437268|616438414|FG000|Overall Study|Death|0|||
170571604|NCT00437268|616438415|FG001|Overall Study|Death|1|||
170571605|NCT04872569|616438420|FG000|Overall Study|Withdrawal by Subject|2|||
170571606|NCT00444925|616438425|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
170571607|NCT00444925|616438426|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
170571608|NCT00444925|616438427|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
170571609|NCT00444925|616438425|FG000|Double-blind Treatment Period|Death|2|||
170571610|NCT00444925|616438426|FG001|Double-blind Treatment Period|Death|0|||
170571611|NCT00444925|616438427|FG002|Double-blind Treatment Period|Death|0|||
170571612|NCT00444925|616438425|FG000|Double-blind Treatment Period|Adverse Event|6|||
170571613|NCT00444925|616438426|FG001|Double-blind Treatment Period|Adverse Event|28|||
170571614|NCT00444925|616438427|FG002|Double-blind Treatment Period|Adverse Event|44|||
170571615|NCT00444925|616438425|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
170571616|NCT00444925|616438426|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
170571617|NCT00444925|616438427|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
170648599|NCT02478398|616726783|FG000|Overall Study|Lost to Follow-up|5|||
170648600|NCT02478398|616726784|FG001|Overall Study|Lost to Follow-up|4|||
170648601|NCT02478398|616726783|FG000|Overall Study|Non-Compliance With Study Drug|5|||
170648602|NCT02478398|616726784|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170648603|NCT02478398|616726783|FG000|Overall Study|Protocol Violation|3|||
170648604|NCT02478398|616726784|FG001|Overall Study|Protocol Violation|1|||
170648605|NCT02478398|616726783|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
170571618|NCT00444925|616438425|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
170571619|NCT00444925|616438426|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
170648606|NCT02478398|616726784|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
170648607|NCT02478398|616726783|FG000|Overall Study|Withdrawal By Participant|10|||
170648608|NCT02478398|616726784|FG001|Overall Study|Withdrawal By Participant|4|||
170648609|NCT00895011|616726788|FG000|Overall Study|Withdrawal by Subject|14|||
170648610|NCT00895011|616726789|FG001|Overall Study|Withdrawal by Subject|7|||
170648611|NCT00895011|616726790|FG002|Overall Study|Withdrawal by Subject|2|||
170648612|NCT00895011|616726788|FG000|Overall Study|Lost to Follow-up|5|||
170648613|NCT00895011|616726789|FG001|Overall Study|Lost to Follow-up|4|||
170648614|NCT00895011|616726790|FG002|Overall Study|Lost to Follow-up|1|||
170648615|NCT00895011|616726788|FG000|Overall Study|Protocol Violation|3|||
170648616|NCT00895011|616726789|FG001|Overall Study|Protocol Violation|1|||
170648617|NCT00895011|616726790|FG002|Overall Study|Protocol Violation|3|||
170648618|NCT00895011|616726788|FG000|Overall Study|Adverse Event|1|||
170648619|NCT00895011|616726789|FG001|Overall Study|Adverse Event|2|||
170648620|NCT00895011|616726790|FG002|Overall Study|Adverse Event|2|||
170648621|NCT00895011|616726788|FG000|Overall Study|schedule conflict|1|||
170648622|NCT00895011|616726789|FG001|Overall Study|schedule conflict|0|||
170648623|NCT00895011|616726790|FG002|Overall Study|schedule conflict|0|||
170648624|NCT01475071|616726797|FG000|Overall Study|Physician Decision|1|||
170648625|NCT01475071|616726797|FG000|Overall Study|Withdrawal by Subject|6|||
170648626|NCT01475071|616726797|FG000|Overall Study|Lost to Follow-up|1|||
170648627|NCT01752036|616726804|FG000|Overall Study|Death|2|||
170648628|NCT02230527|616726805|FG000|Overall Study|Withdrawal by Subject|1|||
170648629|NCT02230527|616726806|FG001|Overall Study|Withdrawal by Subject|1|||
170648630|NCT02230527|616726805|FG000|Overall Study|Death|1|||
170648631|NCT02230527|616726806|FG001|Overall Study|Death|0|||
170648632|NCT02230527|616726805|FG000|Overall Study|Lost to Follow-up|2|||
170648633|NCT02230527|616726806|FG001|Overall Study|Lost to Follow-up|1|||
170648634|NCT02230527|616726805|FG000|Overall Study|Other|1|||
170648635|NCT02230527|616726806|FG001|Overall Study|Other|0|||
170648636|NCT01011478|616726807|FG000|Overall Study|No follow up data|12|||
170648637|NCT01011478|616726808|FG001|Overall Study|No follow up data|7|||
170648638|NCT04461600|616726809|FG000|Overall Study|Death|6|||
170648639|NCT04461600|616726810|FG001|Overall Study|Death|5|||
170648640|NCT04461600|616726809|FG000|Overall Study|Withdrawal by Subject|0|||
170648641|NCT04461600|616726810|FG001|Overall Study|Withdrawal by Subject|1|||
170648642|NCT03874429|616726811|FG000|Overall Study|Adverse Event|2|||
170571620|NCT00444925|616438427|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
170571621|NCT00444925|616438425|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
170648643|NCT03874429|616726812|FG001|Overall Study|Adverse Event|2|||
170648644|NCT03874429|616726811|FG000|Overall Study|Lack of Efficacy|0|||
170648645|NCT03874429|616726812|FG001|Overall Study|Lack of Efficacy|1|||
170648646|NCT03874429|616726811|FG000|Overall Study|Covid-19 pandemic|4|||
170648647|NCT03874429|616726812|FG001|Overall Study|Covid-19 pandemic|2|||
170648648|NCT01561898|616726815|FG000|Overall Study|Withdrawal by Subject|0|||
170648649|NCT01561898|616726816|FG001|Overall Study|Withdrawal by Subject|8|||
170648650|NCT01561898|616726817|FG002|Overall Study|Withdrawal by Subject|12|||
170648651|NCT01561898|616726818|FG003|Overall Study|Withdrawal by Subject|5|||
170648652|NCT01561898|616726815|FG000|Overall Study|Lack of Efficacy|0|||
170648653|NCT01561898|616726816|FG001|Overall Study|Lack of Efficacy|8|||
170648654|NCT01561898|616726817|FG002|Overall Study|Lack of Efficacy|10|||
170648655|NCT01561898|616726818|FG003|Overall Study|Lack of Efficacy|5|||
170648656|NCT01561898|616726815|FG000|Overall Study|Worsening of complications|0|||
170648657|NCT01561898|616726816|FG001|Overall Study|Worsening of complications|1|||
170648658|NCT01561898|616726817|FG002|Overall Study|Worsening of complications|0|||
170648659|NCT01561898|616726818|FG003|Overall Study|Worsening of complications|0|||
170648660|NCT01561898|616726815|FG000|Overall Study|Lost to Follow-up|0|||
170648661|NCT01561898|616726816|FG001|Overall Study|Lost to Follow-up|0|||
170648662|NCT01561898|616726817|FG002|Overall Study|Lost to Follow-up|1|||
170648663|NCT01561898|616726818|FG003|Overall Study|Lost to Follow-up|0|||
170648664|NCT01561898|616726815|FG000|Overall Study|Adverse Event|1|||
170648665|NCT01561898|616726816|FG001|Overall Study|Adverse Event|19|||
170648666|NCT01561898|616726817|FG002|Overall Study|Adverse Event|14|||
170648667|NCT01561898|616726818|FG003|Overall Study|Adverse Event|9|||
170648668|NCT01561898|616726815|FG000|Overall Study|Physician Decision|1|||
170648669|NCT01561898|616726816|FG001|Overall Study|Physician Decision|5|||
170648670|NCT01561898|616726817|FG002|Overall Study|Physician Decision|7|||
170648671|NCT01561898|616726818|FG003|Overall Study|Physician Decision|1|||
170648672|NCT02160002|616726819|FG000|Overall Study|Withdrawal by Subject|2|||
170648673|NCT02160002|616726820|FG001|Overall Study|Withdrawal by Subject|1|||
170648674|NCT01445548|616726821|FG000|Overall Study|Adverse Event|1|||
170648675|NCT04418661|616726822|FG000|Overall Study|Adverse Event|0|||
170648676|NCT04418661|616726823|FG001|Overall Study|Adverse Event|1|||
170648677|NCT04418661|616726824|FG002|Overall Study|Adverse Event|5|||
170648678|NCT04418661|616726825|FG003|Overall Study|Adverse Event|3|||
170648679|NCT04418661|616726826|FG004|Overall Study|Adverse Event|0|||
170648680|NCT04418661|616726827|FG005|Overall Study|Adverse Event|2|||
170648681|NCT04418661|616726822|FG000|Overall Study|Progressive disease|4|||
170648682|NCT04418661|616726823|FG001|Overall Study|Progressive disease|11|||
170648683|NCT04418661|616726824|FG002|Overall Study|Progressive disease|6|||
170648684|NCT04418661|616726825|FG003|Overall Study|Progressive disease|11|||
170648685|NCT04418661|616726826|FG004|Overall Study|Progressive disease|1|||
170648686|NCT04418661|616726827|FG005|Overall Study|Progressive disease|12|||
170648687|NCT04418661|616726822|FG000|Overall Study|Withdrawal by Subject|0|||
170648688|NCT04418661|616726823|FG001|Overall Study|Withdrawal by Subject|1|||
170648689|NCT04418661|616726824|FG002|Overall Study|Withdrawal by Subject|0|||
170648690|NCT04418661|616726825|FG003|Overall Study|Withdrawal by Subject|1|||
170648691|NCT04418661|616726826|FG004|Overall Study|Withdrawal by Subject|0|||
170648692|NCT04418661|616726827|FG005|Overall Study|Withdrawal by Subject|0|||
170648693|NCT04418661|616726822|FG000|Overall Study|Other|0|||
170648694|NCT04418661|616726823|FG001|Overall Study|Other|0|||
170648695|NCT04418661|616726824|FG002|Overall Study|Other|1|||
170648696|NCT04418661|616726825|FG003|Overall Study|Other|3|||
170648697|NCT04418661|616726826|FG004|Overall Study|Other|0|||
170648698|NCT04418661|616726827|FG005|Overall Study|Other|1|||
170648699|NCT01689532|616726828|FG000|Overall Study|Adverse Event|9|||
170648700|NCT01689532|616726829|FG001|Overall Study|Adverse Event|5|||
170648701|NCT01689532|616726828|FG000|Overall Study|Lack of Efficacy|2|||
170648702|NCT01689532|616726829|FG001|Overall Study|Lack of Efficacy|2|||
170648703|NCT01689532|616726828|FG000|Overall Study|Withdrawal by Subject|1|||
170648704|NCT01689532|616726829|FG001|Overall Study|Withdrawal by Subject|2|||
170648705|NCT01689532|616726828|FG000|Overall Study|Physician Decision|2|||
170648706|NCT01689532|616726829|FG001|Overall Study|Physician Decision|0|||
170648707|NCT00275821|616726830|FG000|Overall Study|Adverse Event|4|||
170648708|NCT00275821|616726831|FG001|Overall Study|Adverse Event|12|||
170648709|NCT00275821|616726832|FG002|Overall Study|Adverse Event|5|||
170648710|NCT00275821|616726830|FG000|Overall Study|Administrative problems|3|||
170648711|NCT00275821|616726831|FG001|Overall Study|Administrative problems|4|||
170648712|NCT00275821|616726832|FG002|Overall Study|Administrative problems|4|||
170648713|NCT00275821|616726830|FG000|Overall Study|Withdrawal by Subject|0|||
170648714|NCT00275821|616726831|FG001|Overall Study|Withdrawal by Subject|2|||
170648715|NCT00275821|616726832|FG002|Overall Study|Withdrawal by Subject|1|||
170648716|NCT00275821|616726830|FG000|Overall Study|Lost to Follow-up|0|||
170648717|NCT00275821|616726831|FG001|Overall Study|Lost to Follow-up|1|||
170648718|NCT00275821|616726832|FG002|Overall Study|Lost to Follow-up|1|||
170648719|NCT00275821|616726830|FG000|Overall Study|Death|0|||
170648720|NCT00275821|616726831|FG001|Overall Study|Death|2|||
170648721|NCT00275821|616726832|FG002|Overall Study|Death|1|||
170648722|NCT00275821|616726830|FG000|Overall Study|Lack of Efficacy|2|||
170648723|NCT00275821|616726831|FG001|Overall Study|Lack of Efficacy|1|||
170648724|NCT00275821|616726832|FG002|Overall Study|Lack of Efficacy|0|||
170648725|NCT00275821|616726830|FG000|Overall Study|Protocol Violation|5|||
170648726|NCT00275821|616726831|FG001|Overall Study|Protocol Violation|1|||
170648727|NCT00275821|616726832|FG002|Overall Study|Protocol Violation|0|||
170648728|NCT00992589|616726833|FG000|Open-Label Phase|Adverse Event|4|||
170648729|NCT00992589|616726834|FG001|Open-Label Phase|Adverse Event|0|||
170648730|NCT00992589|616726835|FG002|Open-Label Phase|Adverse Event|0|||
170648731|NCT00992589|616726836|FG003|Open-Label Phase|Adverse Event|0|||
170648732|NCT00992589|616726833|FG000|Open-Label Phase|Withdrawal by Subject|20|||
170648733|NCT00992589|616726834|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170571622|NCT00444925|616438426|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
170571623|NCT00444925|616438427|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
170571624|NCT00444925|616438425|FG000|Double-blind Treatment Period|Other|7|||
170571625|NCT00444925|616438426|FG001|Double-blind Treatment Period|Other|7|||
170571626|NCT00444925|616438427|FG002|Double-blind Treatment Period|Other|12|||
170571627|NCT00833027|616438428|FG000|Overall Study|Adverse Event|33|||
170571628|NCT00833027|616438428|FG000|Overall Study|Death|1|||
170571629|NCT00833027|616438428|FG000|Overall Study|Lack of Efficacy|12|||
170648734|NCT00992589|616726835|FG002|Open-Label Phase|Withdrawal by Subject|0|||
170648735|NCT00992589|616726836|FG003|Open-Label Phase|Withdrawal by Subject|0|||
170648736|NCT00992589|616726833|FG000|Open-Label Phase|Lost to Follow-up|1|||
170648737|NCT00992589|616726834|FG001|Open-Label Phase|Lost to Follow-up|0|||
170648738|NCT00992589|616726835|FG002|Open-Label Phase|Lost to Follow-up|0|||
170648739|NCT00992589|616726836|FG003|Open-Label Phase|Lost to Follow-up|0|||
170648740|NCT00992589|616726833|FG000|Open-Label Phase|Protocol Violation|3|||
170648741|NCT00992589|616726834|FG001|Open-Label Phase|Protocol Violation|0|||
170648742|NCT00992589|616726835|FG002|Open-Label Phase|Protocol Violation|0|||
170648743|NCT00992589|616726836|FG003|Open-Label Phase|Protocol Violation|0|||
170648744|NCT00992589|616726833|FG000|Open-Label Phase|Physician Decision|4|||
170648745|NCT00992589|616726834|FG001|Open-Label Phase|Physician Decision|0|||
170648746|NCT00992589|616726835|FG002|Open-Label Phase|Physician Decision|0|||
170648747|NCT00992589|616726836|FG003|Open-Label Phase|Physician Decision|0|||
170648748|NCT00992589|616726833|FG000|Open-Label Phase|Other|45|||
170648749|NCT00992589|616726834|FG001|Open-Label Phase|Other|0|||
170648750|NCT00992589|616726835|FG002|Open-Label Phase|Other|0|||
170648751|NCT00992589|616726836|FG003|Open-Label Phase|Other|0|||
170648752|NCT00992589|616726833|FG000|Double-Blind Phase|Adverse Event|0|||
170648753|NCT00992589|616726834|FG001|Double-Blind Phase|Adverse Event|6|||
170648754|NCT00992589|616726835|FG002|Double-Blind Phase|Adverse Event|2|||
170648755|NCT00992589|616726836|FG003|Double-Blind Phase|Adverse Event|3|||
170648756|NCT00992589|616726833|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
170648757|NCT00992589|616726834|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
170648758|NCT00992589|616726835|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
170648759|NCT00992589|616726836|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
170648760|NCT00992589|616726833|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170648761|NCT00992589|616726834|FG001|Double-Blind Phase|Lost to Follow-up|0|||
170648762|NCT00992589|616726835|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170808487|NCT00768755|617308910|FG000|Phase 2|Other|0|||
170808488|NCT00768755|617308911|FG001|Phase 2|Other|1|||
170808489|NCT00768755|617308912|FG002|Phase 2|Other|2|||
170808490|NCT00768755|617308913|FG003|Phase 2|Other|4|||
170808491|NCT00768755|617308910|FG000|Phase 2|Study Terminated by Sponsor|0|||
170808492|NCT00768755|617308911|FG001|Phase 2|Study Terminated by Sponsor|13|||
170808493|NCT00768755|617308912|FG002|Phase 2|Study Terminated by Sponsor|7|||
170808494|NCT00768755|617308913|FG003|Phase 2|Study Terminated by Sponsor|14|||
170808495|NCT00768755|617308910|FG000|Phase 2|Randomized but not treated|0|||
170808496|NCT00768755|617308911|FG001|Phase 2|Randomized but not treated|0|||
170808497|NCT00768755|617308912|FG002|Phase 2|Randomized but not treated|0|||
170808498|NCT00768755|617308913|FG003|Phase 2|Randomized but not treated|2|||
170808499|NCT03436290|617308914|FG000|Overall Study|Post-randomization Exclusion|1|||
170808500|NCT03436290|617308915|FG001|Overall Study|Post-randomization Exclusion|0|||
170808501|NCT03436290|617308914|FG000|Overall Study|Death|6|||
170808502|NCT03436290|617308915|FG001|Overall Study|Death|0|||
170808503|NCT03436290|617308914|FG000|Overall Study|Withdrawal by Subject|4|||
170808504|NCT03436290|617308915|FG001|Overall Study|Withdrawal by Subject|0|||
170808505|NCT03436290|617308914|FG000|Overall Study|Protocol Violation|30|||
170808506|NCT03436290|617308915|FG001|Overall Study|Protocol Violation|0|||
170808507|NCT01079806|617308916|FG000|Day 1 to Week 96|Adverse Event|0|||
170808508|NCT01079806|617308917|FG001|Day 1 to Week 96|Adverse Event|3|||
170808509|NCT01079806|617308916|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
170808510|NCT01079806|617308917|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
170808511|NCT01079806|617308916|FG000|Day 1 to Week 96|Pregnancy|0|||
170808512|NCT01079806|617308917|FG001|Day 1 to Week 96|Pregnancy|1|||
170808513|NCT01079806|617308916|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
170808514|NCT01079806|617308917|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
170808515|NCT01079806|617308916|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
170808516|NCT01079806|617308917|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
170808517|NCT01079806|617308916|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
170808518|NCT01079806|617308917|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
170808519|NCT01079806|617308916|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
170808520|NCT01079806|617308917|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
170808521|NCT01079806|617308916|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
170808522|NCT01079806|617308917|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
170648763|NCT00992589|616726836|FG003|Double-Blind Phase|Lost to Follow-up|2|||
170648764|NCT00992589|616726833|FG000|Double-Blind Phase|Other|0|||
170648765|NCT00992589|616726834|FG001|Double-Blind Phase|Other|1|||
170908372|NCT02495077|617671027|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
170571630|NCT00833027|616438428|FG000|Overall Study|Lost to Follow-up|24|||
170571631|NCT00833027|616438428|FG000|Overall Study|Protocol Violation|115|||
170571632|NCT00833027|616438428|FG000|Overall Study|Withdrawal by Subject|16|||
170571633|NCT00833027|616438428|FG000|Overall Study|Missing|10|||
170571634|NCT04417257|616438429|FG000|Pilot Phase 2|Adverse Event|2|||
170571635|NCT04417257|616438430|FG001|Pilot Phase 2|Adverse Event|0|||
170571636|NCT04417257|616438429|FG000|Pilot Phase 2|Death|14|||
170571637|NCT04417257|616438430|FG001|Pilot Phase 2|Death|11|||
170571638|NCT04417257|616438429|FG000|Pilot Phase 2|Lost to Follow-up|3|||
170571639|NCT04417257|616438430|FG001|Pilot Phase 2|Lost to Follow-up|5|||
170571640|NCT04417257|616438429|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
170571641|NCT04417257|616438430|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
170571642|NCT04417257|616438429|FG000|Pilot Phase 2|Hepatic impairment|1|||
170571643|NCT04417257|616438430|FG001|Pilot Phase 2|Hepatic impairment|0|||
170571644|NCT04417257|616438429|FG000|Pilot Phase 2|Unblinding|1|||
170571645|NCT04417257|616438430|FG001|Pilot Phase 2|Unblinding|0|||
170571646|NCT04417257|616438429|FG000|Pilot Phase 2|All other|0|||
170571647|NCT04417257|616438430|FG001|Pilot Phase 2|All other|2|||
170571648|NCT04417257|616438429|FG000|Phase 3 Extension|Death|3|||
170571649|NCT04417257|616438430|FG001|Phase 3 Extension|Death|1|||
170571650|NCT04417257|616438429|FG000|Phase 3 Extension|Lost to Follow-up|4|||
170571651|NCT04417257|616438430|FG001|Phase 3 Extension|Lost to Follow-up|2|||
170571652|NCT04417257|616438429|FG000|Phase 3 Extension|Patient withdrawal|2|||
170571653|NCT04417257|616438430|FG001|Phase 3 Extension|Patient withdrawal|2|||
170571654|NCT04417257|616438429|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
170571655|NCT04417257|616438430|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
170571656|NCT00656370|616438431|FG000|Overall Study|Screen Failures|7|||
170571657|NCT00656370|616438431|FG000|Overall Study|Alternates|3|||
170571658|NCT00326001|616438438|FG000|Overall Study|Adverse Event|4|||
170571659|NCT00326001|616438439|FG001|Overall Study|Adverse Event|5|||
170571660|NCT00326001|616438438|FG000|Overall Study|Physician Decision|3|||
170571661|NCT00326001|616438439|FG001|Overall Study|Physician Decision|3|||
170571662|NCT01074931|616438440|FG000|Overall Study|Economic reasons|1|||
170571663|NCT01074931|616438440|FG000|Overall Study|Death|5|||
170571664|NCT03132467|616438441|FG000|Overall Study|Adverse Event|2|||
170571665|NCT03132467|616438441|FG000|Overall Study|Withdrawal by Subject|2|||
170571666|NCT01088906|616438442|FG000|Overall Study|Inclusion error|1|||
170571667|NCT01088906|616438442|FG000|Overall Study|Did not receive study treatment|3|||
170571668|NCT01088906|616438442|FG000|Overall Study|Missing data|1|||
170571669|NCT04267926|616439586|FG000|Overall Study|abnormal labs. No longer eligible|0|||
170571670|NCT04267926|616439587|FG001|Overall Study|abnormal labs. No longer eligible|0|||
170571671|NCT04267926|616439588|FG002|Overall Study|abnormal labs. No longer eligible|1|||
170571672|NCT04267926|616439586|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
170571673|NCT04267926|616439587|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
170571674|NCT04267926|616439588|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
170571675|NCT00972023|616439596|FG000|Overall Study|Withdrawal by Subject|1|||
170571676|NCT00532129|616439597|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
170571677|NCT00532129|616439597|FG000|Treatment Period|Physician Decision|15|||
170571678|NCT00532129|616439597|FG000|Treatment Period|Disease progression|3|||
170571679|NCT00532129|616439597|FG000|Treatment Period|Protocol Violation|1|||
170571680|NCT00532129|616439597|FG000|Treatment Period|Other|5|||
170571681|NCT00532129|616439597|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
170571682|NCT00532129|616439597|FG000|Follow-up Period|Disease progression|57|||
170571683|NCT00532129|616439597|FG000|Follow-up Period|Lost to Follow-up|1|||
170571684|NCT00532129|616439597|FG000|Follow-up Period|Other|6|||
170571685|NCT01234480|616439598|FG000|Overall Study|Pregnancy|88|||
170571686|NCT01234480|616439598|FG000|Overall Study|>36/Normal History|50|||
170571687|NCT01234480|616439598|FG000|Overall Study|Age|3|||
170571688|NCT01234480|616439598|FG000|Overall Study|HPV Vaccine History|28|||
170571689|NCT01234480|616439598|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
170571690|NCT01234480|616439598|FG000|Overall Study|Hysterectomy|2|||
170648766|NCT00992589|616726835|FG002|Double-Blind Phase|Other|6|||
170648767|NCT00992589|616726836|FG003|Double-Blind Phase|Other|3|||
170571691|NCT01234480|616439598|FG000|Overall Study|Hysterectomy post enrollment|1|||
170648768|NCT00958438|616726837|FG000|Overall Study|Protocol Violation|3|||
170648769|NCT00958438|616726838|FG001|Overall Study|Protocol Violation|2|||
170648770|NCT00958438|616726839|FG002|Overall Study|Protocol Violation|2|||
170571692|NCT01234480|616439598|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
170571693|NCT01234480|616439598|FG000|Overall Study|Informed Consent Form Violation|30|||
170571694|NCT01234480|616439598|FG000|Overall Study|Incorrect Visit|3|||
170808523|NCT01079806|617308916|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
170808524|NCT01079806|617308917|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
170808525|NCT01079806|617308916|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
170808526|NCT01079806|617308917|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
170808527|NCT03626662|617308920|FG000|Overall Study|Withdrawal of Consent from Study|2|||
170808528|NCT03626662|617308921|FG001|Overall Study|Withdrawal of Consent from Study|0|||
170571695|NCT01234480|616439598|FG000|Overall Study|No Florida Lab License|20|||
170571696|NCT01234480|616439598|FG000|Overall Study|Out of Window|42|||
170571697|NCT01234480|616439598|FG000|Overall Study|Sample Processing/Storage|92|||
170571698|NCT01234480|616439598|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
170571699|NCT01234480|616439598|FG000|Overall Study|Site/Subject non-compliance|44|||
170571700|NCT01234480|616439598|FG000|Overall Study|Missing Sample|9|||
170571701|NCT03370419|616439599|FG000|Overall Study|Lost to Follow-up|16|||
170571702|NCT03052608|616439600|FG000|Treatment Phase|Adverse Event|10|||
170571703|NCT03052608|616439601|FG001|Treatment Phase|Adverse Event|12|||
170571704|NCT03052608|616439600|FG000|Treatment Phase|Death|6|||
170571705|NCT03052608|616439601|FG001|Treatment Phase|Death|4|||
170571706|NCT03052608|616439600|FG000|Treatment Phase|Withdrawal by Subject|4|||
170571707|NCT03052608|616439601|FG001|Treatment Phase|Withdrawal by Subject|12|||
170648771|NCT00958438|616726837|FG000|Overall Study|Withdrawal by Subject|4|||
170571708|NCT03052608|616439600|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
170571709|NCT03052608|616439601|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
170571710|NCT03052608|616439600|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
170571711|NCT03052608|616439601|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
170571712|NCT03052608|616439600|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
170571713|NCT03052608|616439601|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
170571714|NCT03052608|616439600|FG000|Treatment Phase|Ongoing|103|||
170571715|NCT03052608|616439601|FG001|Treatment Phase|Ongoing|31|||
170571716|NCT03052608|616439600|FG000|Long-Term Follow-up Phase|Death|23|||
170571717|NCT03052608|616439601|FG001|Long-Term Follow-up Phase|Death|28|||
170571718|NCT03052608|616439600|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
170571719|NCT03052608|616439601|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
170571720|NCT03052608|616439600|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
170571721|NCT03052608|616439601|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
170571722|NCT03052608|616439600|FG000|Long-Term Follow-up Phase|Ongoing|122|||
170571723|NCT03052608|616439601|FG001|Long-Term Follow-up Phase|Ongoing|99|||
170571724|NCT03145064|616439602|FG000|Overall Study|Death|24|||
170571725|NCT03145064|616439602|FG000|Overall Study|Lost to Follow-up|3|||
170571726|NCT03145064|616439602|FG000|Overall Study|Withdrawal by Subject|6|||
170571727|NCT03145064|616439602|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
170571728|NCT03145064|616439602|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
170648772|NCT00958438|616726838|FG001|Overall Study|Withdrawal by Subject|2|||
170648773|NCT00958438|616726839|FG002|Overall Study|Withdrawal by Subject|1|||
170648774|NCT00958438|616726837|FG000|Overall Study|Adverse Event|0|||
170648775|NCT00958438|616726838|FG001|Overall Study|Adverse Event|3|||
170648776|NCT00958438|616726839|FG002|Overall Study|Adverse Event|0|||
170648777|NCT00958438|616726837|FG000|Overall Study|Physician Decision|1|||
170648778|NCT00958438|616726838|FG001|Overall Study|Physician Decision|0|||
170648779|NCT00958438|616726839|FG002|Overall Study|Physician Decision|1|||
170648780|NCT00958438|616726837|FG000|Overall Study|Other than specified above|2|||
170648781|NCT00958438|616726838|FG001|Overall Study|Other than specified above|3|||
170648782|NCT00958438|616726839|FG002|Overall Study|Other than specified above|2|||
170648783|NCT02108262|616726848|FG000|Overall Study|Non-compliance|0|||
170648784|NCT02108262|616726849|FG001|Overall Study|Non-compliance|2|||
170648785|NCT02108262|616726850|FG002|Overall Study|Non-compliance|1|||
170648786|NCT02108262|616726851|FG003|Overall Study|Non-compliance|1|||
170648787|NCT02108262|616726848|FG000|Overall Study|Randomized by error/screen failure|0|||
170648788|NCT02108262|616726849|FG001|Overall Study|Randomized by error/screen failure|0|||
170648789|NCT02108262|616726850|FG002|Overall Study|Randomized by error/screen failure|1|||
170648790|NCT02108262|616726851|FG003|Overall Study|Randomized by error/screen failure|0|||
170648791|NCT02108262|616726848|FG000|Overall Study|Distance to center|0|||
170571729|NCT00661830|616439603|FG000|Overall Study|Death|37|||
170571730|NCT00661830|616439604|FG001|Overall Study|Death|33|||
170571731|NCT00661830|616439603|FG000|Overall Study|Lost to Follow-up|1|||
170571732|NCT00661830|616439604|FG001|Overall Study|Lost to Follow-up|3|||
170571733|NCT00661830|616439603|FG000|Overall Study|Withdrawal by Subject|1|||
170571734|NCT00661830|616439604|FG001|Overall Study|Withdrawal by Subject|1|||
170571735|NCT00661830|616439603|FG000|Overall Study|Other reason|1|||
170648792|NCT02108262|616726849|FG001|Overall Study|Distance to center|1|||
170648793|NCT02108262|616726850|FG002|Overall Study|Distance to center|1|||
170571736|NCT00661830|616439604|FG001|Overall Study|Other reason|5|||
170648794|NCT02108262|616726851|FG003|Overall Study|Distance to center|0|||
170648795|NCT02108262|616726848|FG000|Overall Study|Adverse Event|0|||
170648796|NCT02108262|616726849|FG001|Overall Study|Adverse Event|11|||
170648797|NCT02108262|616726850|FG002|Overall Study|Adverse Event|6|||
170571737|NCT01475721|616439607|FG000|Overall Study|Death|3|||
170571738|NCT01475721|616439608|FG001|Overall Study|Death|6|||
170648798|NCT02108262|616726851|FG003|Overall Study|Adverse Event|12|||
170648799|NCT02108262|616726848|FG000|Overall Study|Death|0|||
170648800|NCT02108262|616726849|FG001|Overall Study|Death|2|||
170648801|NCT02108262|616726850|FG002|Overall Study|Death|2|||
170648802|NCT02108262|616726851|FG003|Overall Study|Death|1|||
170648803|NCT02108262|616726848|FG000|Overall Study|Lost to Follow-up|0|||
170571739|NCT01475721|616439607|FG000|Overall Study|Withdrawal by Subject|8|||
170571740|NCT01475721|616439608|FG001|Overall Study|Withdrawal by Subject|8|||
170571741|NCT02477527|616439611|FG000|Overall Study|Lost to Follow-up|2|||
170571742|NCT02477527|616439611|FG000|Overall Study|Withdrawal by Subject|1|||
170571743|NCT02477527|616439611|FG000|Overall Study|Screen Failure|3|||
170571744|NCT01639469|616439612|FG000|Overall Study|Death|4|||
170571745|NCT01639469|616439613|FG001|Overall Study|Death|2|||
170571746|NCT01639469|616439612|FG000|Overall Study|Lost to Follow-up|1|||
170571747|NCT01639469|616439613|FG001|Overall Study|Lost to Follow-up|1|||
170571748|NCT02329743|616439616|FG000|Overall Study|Adverse Event|1|||
170571749|NCT02329743|616439617|FG001|Overall Study|Adverse Event|1|||
170571750|NCT02329743|616439618|FG002|Overall Study|Adverse Event|3|||
170571751|NCT02329743|616439616|FG000|Overall Study|Lost to Follow-up|1|||
170571752|NCT02329743|616439617|FG001|Overall Study|Lost to Follow-up|0|||
170571753|NCT02329743|616439618|FG002|Overall Study|Lost to Follow-up|1|||
170571754|NCT02329743|616439616|FG000|Overall Study|Withdrawal by Subject|4|||
170571755|NCT02329743|616439617|FG001|Overall Study|Withdrawal by Subject|4|||
170571756|NCT02329743|616439618|FG002|Overall Study|Withdrawal by Subject|1|||
170571757|NCT02329743|616439616|FG000|Overall Study|Other|0|||
170571758|NCT02329743|616439617|FG001|Overall Study|Other|2|||
170571759|NCT02329743|616439618|FG002|Overall Study|Other|3|||
170571760|NCT02479880|616439627|FG000|Overall Study|Study Terminated by Sponsor|13|||
170571761|NCT02479880|616439628|FG001|Overall Study|Study Terminated by Sponsor|12|||
170571762|NCT02479880|616439627|FG000|Overall Study|Pregnancy|0|||
170571763|NCT02479880|616439628|FG001|Overall Study|Pregnancy|1|||
170571764|NCT00856635|616439633|FG000|Overall Study|Lost to Follow-up|2|||
170571765|NCT00856635|616439634|FG001|Overall Study|Lost to Follow-up|5|||
170571766|NCT00856635|616439633|FG000|Overall Study|Pregnancy|1|||
170571767|NCT00856635|616439634|FG001|Overall Study|Pregnancy|0|||
170571768|NCT00856635|616439633|FG000|Overall Study|Withdrawal by Subject|3|||
170571769|NCT00856635|616439634|FG001|Overall Study|Withdrawal by Subject|1|||
170571770|NCT00856635|616439633|FG000|Overall Study|Serious Adverse Event|1|||
170571771|NCT00856635|616439634|FG001|Overall Study|Serious Adverse Event|0|||
170571772|NCT00856635|616439633|FG000|Overall Study|Other|1|||
170571773|NCT00856635|616439634|FG001|Overall Study|Other|0|||
170571774|NCT00856635|616439633|FG000|Overall Study|Discontinued at Randomization|2|||
170571775|NCT00856635|616439634|FG001|Overall Study|Discontinued at Randomization|2|||
170571776|NCT00374595|616439641|FG000|Overall Study|Death|23|||
170571777|NCT00374595|616439641|FG000|Overall Study|Withdrawal by Subject|39|||
170571778|NCT00374595|616439641|FG000|Overall Study|Lost to Follow-up|3|||
170571779|NCT00374595|616439641|FG000|Overall Study|too much time commitment|1|||
170571780|NCT00374595|616439641|FG000|Overall Study|transfer care to other clinical site|1|||
170571781|NCT00374595|616439641|FG000|Overall Study|relocation|3|||
170571782|NCT00347932|616439644|FG000|Overall Study|Adverse Event|4|||
170571783|NCT00347932|616439645|FG001|Overall Study|Adverse Event|5|||
170571784|NCT00347932|616439644|FG000|Overall Study|Lack of Efficacy|3|||
170571785|NCT00347932|616439645|FG001|Overall Study|Lack of Efficacy|14|||
170571786|NCT00347932|616439644|FG000|Overall Study|Lost to Follow-up|10|||
170571787|NCT00347932|616439645|FG001|Overall Study|Lost to Follow-up|9|||
170571788|NCT00347932|616439644|FG000|Overall Study|Withdrawal by Subject|10|||
170571789|NCT00347932|616439645|FG001|Overall Study|Withdrawal by Subject|16|||
170571790|NCT00347932|616439644|FG000|Overall Study|Did not meet inclusion criteria|4|||
170571791|NCT00347932|616439645|FG001|Overall Study|Did not meet inclusion criteria|8|||
170648804|NCT02108262|616726849|FG001|Overall Study|Lost to Follow-up|0|||
170648805|NCT02108262|616726850|FG002|Overall Study|Lost to Follow-up|1|||
170648806|NCT02108262|616726851|FG003|Overall Study|Lost to Follow-up|0|||
170648807|NCT02108262|616726848|FG000|Overall Study|Physician Decision|0|||
170571792|NCT00175916|616439646|FG000|Overall Study|Death|19|||
170571793|NCT00175916|616439646|FG000|Overall Study|Adverse Event|81|||
170571794|NCT00175916|616439646|FG000|Overall Study|Lack of Efficacy|354|||
170571795|NCT00175916|616439646|FG000|Overall Study|Lost to Follow-up|17|||
170571796|NCT00175916|616439646|FG000|Overall Study|Subject Choice|98|||
170571797|NCT00175916|616439646|FG000|Overall Study|Lack of compliance|8|||
170648808|NCT02108262|616726849|FG001|Overall Study|Physician Decision|0|||
170648809|NCT02108262|616726850|FG002|Overall Study|Physician Decision|2|||
170571798|NCT00175916|616439646|FG000|Overall Study|Patient cannot record seizures|1|||
170571799|NCT00175916|616439646|FG000|Overall Study|Sponsor decision|17|||
170571800|NCT00175916|616439646|FG000|Overall Study|Vigabatrin intake|1|||
170571801|NCT00175916|616439646|FG000|Overall Study|Suicidal behaviour|1|||
170571802|NCT00175916|616439646|FG000|Overall Study|Withdrawal by Subject|1|||
170571803|NCT00175916|616439646|FG000|Overall Study|Seizure - free|4|||
170648810|NCT02108262|616726851|FG003|Overall Study|Physician Decision|0|||
170571804|NCT00175916|616439646|FG000|Overall Study|Administrative reason|1|||
170571805|NCT00175916|616439646|FG000|Overall Study|Pregnancy|1|||
170571806|NCT00175916|616439646|FG000|Overall Study|Patient's request|2|||
170571807|NCT00175916|616439646|FG000|Overall Study|Treating physiciant's choice|1|||
170571808|NCT00175916|616439646|FG000|Overall Study|Moved overseas|1|||
170571809|NCT00175916|616439646|FG000|Overall Study|Loss of job and economic burden|1|||
170571810|NCT00175916|616439646|FG000|Overall Study|Site was closed|9|||
170648811|NCT02108262|616726848|FG000|Overall Study|Withdrawal by Subject|0|||
170648812|NCT02108262|616726849|FG001|Overall Study|Withdrawal by Subject|7|||
170571811|NCT00175916|616439646|FG000|Overall Study|Patient went to prison|1|||
170571812|NCT01484496|616439649|FG000|Period 1|Protocol Violation|3|||
170571813|NCT01484496|616439650|FG001|Period 1|Protocol Violation|4|||
170571814|NCT01484496|616439651|FG002|Period 1|Protocol Violation|0|||
170571815|NCT01484496|616439652|FG003|Period 1|Protocol Violation|0|||
170571816|NCT01484496|616439649|FG000|Period 1|Physician Decision|5|||
170571817|NCT01484496|616439650|FG001|Period 1|Physician Decision|1|||
170571818|NCT01484496|616439651|FG002|Period 1|Physician Decision|0|||
170571819|NCT01484496|616439652|FG003|Period 1|Physician Decision|0|||
170571820|NCT01484496|616439649|FG000|Period 1|Lack of Efficacy|10|||
170571821|NCT01484496|616439650|FG001|Period 1|Lack of Efficacy|15|||
170571822|NCT01484496|616439651|FG002|Period 1|Lack of Efficacy|0|||
170571823|NCT01484496|616439652|FG003|Period 1|Lack of Efficacy|0|||
170571824|NCT01484496|616439649|FG000|Period 1|Adverse Event|25|||
170571825|NCT01484496|616439650|FG001|Period 1|Adverse Event|40|||
170571826|NCT01484496|616439651|FG002|Period 1|Adverse Event|0|||
170571827|NCT01484496|616439652|FG003|Period 1|Adverse Event|0|||
170571828|NCT01484496|616439649|FG000|Period 1|Withdrawal by Subject|15|||
170571829|NCT01484496|616439650|FG001|Period 1|Withdrawal by Subject|12|||
170571830|NCT01484496|616439651|FG002|Period 1|Withdrawal by Subject|0|||
170571831|NCT01484496|616439652|FG003|Period 1|Withdrawal by Subject|0|||
170571832|NCT01484496|616439649|FG000|Period 1|Lost to Follow-up|2|||
170571833|NCT01484496|616439650|FG001|Period 1|Lost to Follow-up|6|||
170571834|NCT01484496|616439651|FG002|Period 1|Lost to Follow-up|0|||
170571835|NCT01484496|616439652|FG003|Period 1|Lost to Follow-up|0|||
170571836|NCT01484496|616439649|FG000|Period 1|Positive Pregnancy|1|||
170571837|NCT01484496|616439650|FG001|Period 1|Positive Pregnancy|6|||
170571838|NCT01484496|616439651|FG002|Period 1|Positive Pregnancy|0|||
170571839|NCT01484496|616439652|FG003|Period 1|Positive Pregnancy|0|||
170571840|NCT01484496|616439649|FG000|Period 1|Treatment Failure|3|||
170571841|NCT01484496|616439650|FG001|Period 1|Treatment Failure|6|||
170571842|NCT01484496|616439651|FG002|Period 1|Treatment Failure|0|||
170571843|NCT01484496|616439652|FG003|Period 1|Treatment Failure|0|||
170571844|NCT01484496|616439649|FG000|Period 1|Lack of Compliance|2|||
170571845|NCT01484496|616439650|FG001|Period 1|Lack of Compliance|1|||
170571846|NCT01484496|616439651|FG002|Period 1|Lack of Compliance|0|||
170571847|NCT01484496|616439652|FG003|Period 1|Lack of Compliance|0|||
170571848|NCT01484496|616439649|FG000|Period 1|Unable to Visit Site|0|||
170571849|NCT01484496|616439650|FG001|Period 1|Unable to Visit Site|2|||
170571850|NCT01484496|616439651|FG002|Period 1|Unable to Visit Site|0|||
170571851|NCT01484496|616439652|FG003|Period 1|Unable to Visit Site|0|||
170571852|NCT01484496|616439649|FG000|Period 2|Lack of Efficacy|0|||
170571853|NCT01484496|616439650|FG001|Period 2|Lack of Efficacy|0|||
170571854|NCT01484496|616439651|FG002|Period 2|Lack of Efficacy|1|||
170571855|NCT01484496|616439652|FG003|Period 2|Lack of Efficacy|3|||
170648813|NCT02108262|616726850|FG002|Overall Study|Withdrawal by Subject|3|||
170648814|NCT02108262|616726851|FG003|Overall Study|Withdrawal by Subject|4|||
170648815|NCT02108262|616726848|FG000|Overall Study|Due to key hepatic values|0|||
170571856|NCT01484496|616439649|FG000|Period 2|Adverse Event|0|||
170571857|NCT01484496|616439650|FG001|Period 2|Adverse Event|0|||
170571858|NCT01484496|616439651|FG002|Period 2|Adverse Event|5|||
170571859|NCT01484496|616439652|FG003|Period 2|Adverse Event|13|||
170571860|NCT01484496|616439649|FG000|Period 2|Other|0|||
170571861|NCT01484496|616439650|FG001|Period 2|Other|0|||
170571862|NCT01484496|616439651|FG002|Period 2|Other|9|||
170571863|NCT01484496|616439652|FG003|Period 2|Other|6|||
170648816|NCT02108262|616726849|FG001|Overall Study|Due to key hepatic values|1|||
170571864|NCT01645735|616439653|FG000|Overall Study|Physician Decision|2|||
170571865|NCT01645735|616439654|FG001|Overall Study|Physician Decision|0|||
170571866|NCT01645735|616439653|FG000|Overall Study|Withdrawal by Subject|1|||
170571867|NCT01645735|616439654|FG001|Overall Study|Withdrawal by Subject|0|||
170571868|NCT01645735|616439653|FG000|Overall Study|Protocol Violation|1|||
170571869|NCT01645735|616439654|FG001|Overall Study|Protocol Violation|0|||
170571870|NCT01645735|616439653|FG000|Overall Study|Adverse Event|0|||
170571871|NCT01645735|616439654|FG001|Overall Study|Adverse Event|1|||
170571872|NCT03198767|616439655|FG000|Overall Study|Protocol Violation|0|||
170571873|NCT03198767|616439656|FG001|Overall Study|Protocol Violation|0|||
170571874|NCT03198767|616439657|FG002|Overall Study|Protocol Violation|0|||
170571875|NCT03198767|616439658|FG003|Overall Study|Protocol Violation|6|||
170571876|NCT03198767|616439659|FG004|Overall Study|Protocol Violation|0|||
170571877|NCT03198767|616439660|FG005|Overall Study|Protocol Violation|0|||
170571878|NCT03198767|616439661|FG006|Overall Study|Protocol Violation|0|||
170571879|NCT00589797|616439664|FG000|Overall Study|Death|1|||
170571880|NCT00589797|616439665|FG001|Overall Study|Death|0|||
170571881|NCT00589797|616439664|FG000|Overall Study|Lost to Follow-up|12|||
170571882|NCT00589797|616439665|FG001|Overall Study|Lost to Follow-up|9|||
170571883|NCT00589797|616439664|FG000|Overall Study|Physician Decision|8|||
170571884|NCT00589797|616439665|FG001|Overall Study|Physician Decision|3|||
170571885|NCT00589797|616439664|FG000|Overall Study|Withdrawal by Subject|6|||
170571886|NCT00589797|616439665|FG001|Overall Study|Withdrawal by Subject|5|||
170571887|NCT00589797|616439664|FG000|Overall Study|Non-Randomized Training Subjects|46|||
170571888|NCT00589797|616439665|FG001|Overall Study|Non-Randomized Training Subjects|6|||
170571889|NCT01881009|616439666|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
170571890|NCT01881009|616439667|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
170571891|NCT04011735|616439668|FG000|Overall Study|Withdrawal by Subject|1|||
170571892|NCT04011735|616439669|FG001|Overall Study|Withdrawal by Subject|0|||
170571893|NCT04011735|616439670|FG002|Overall Study|Withdrawal by Subject|1|||
170571894|NCT04011735|616439668|FG000|Overall Study|Met exclusion criteria after study entry|0|||
170571895|NCT04011735|616439669|FG001|Overall Study|Met exclusion criteria after study entry|1|||
170571896|NCT04011735|616439670|FG002|Overall Study|Met exclusion criteria after study entry|0|||
170571897|NCT02831855|616439671|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
170571898|NCT02831855|616439672|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
170571899|NCT02831855|616439673|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
170571900|NCT02831855|616439671|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
170648817|NCT02108262|616726850|FG002|Overall Study|Due to key hepatic values|0|||
170648818|NCT02108262|616726851|FG003|Overall Study|Due to key hepatic values|0|||
170648819|NCT02108262|616726848|FG000|Overall Study|Unable to contact patient|0|||
170648820|NCT02108262|616726849|FG001|Overall Study|Unable to contact patient|3|||
170648821|NCT02108262|616726850|FG002|Overall Study|Unable to contact patient|1|||
170648822|NCT02108262|616726851|FG003|Overall Study|Unable to contact patient|2|||
170648823|NCT02108262|616726848|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
170648824|NCT02108262|616726849|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
170648825|NCT02108262|616726850|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
170648826|NCT02108262|616726851|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
170648827|NCT02108262|616726848|FG000|Overall Study|Patient did not want another infusion|0|||
170648828|NCT02108262|616726849|FG001|Overall Study|Patient did not want another infusion|3|||
170648829|NCT02108262|616726850|FG002|Overall Study|Patient did not want another infusion|3|||
170648830|NCT02108262|616726851|FG003|Overall Study|Patient did not want another infusion|2|||
170648831|NCT02108262|616726848|FG000|Overall Study|Vacation|0|||
170648832|NCT02108262|616726849|FG001|Overall Study|Vacation|1|||
170648833|NCT02108262|616726850|FG002|Overall Study|Vacation|0|||
170648834|NCT02108262|616726851|FG003|Overall Study|Vacation|0|||
170648835|NCT02108262|616726848|FG000|Overall Study|Patient decision|0|||
170648836|NCT02108262|616726849|FG001|Overall Study|Patient decision|7|||
170648837|NCT02108262|616726850|FG002|Overall Study|Patient decision|9|||
170648838|NCT02108262|616726851|FG003|Overall Study|Patient decision|14|||
170648839|NCT02108262|616726848|FG000|Overall Study|Missed IV due to pharmacy error|0|||
170648840|NCT02108262|616726849|FG001|Overall Study|Missed IV due to pharmacy error|0|||
170648841|NCT02108262|616726850|FG002|Overall Study|Missed IV due to pharmacy error|1|||
170648842|NCT02108262|616726851|FG003|Overall Study|Missed IV due to pharmacy error|0|||
170648843|NCT03339297|616726852|FG000|Overall Study|Relapse of Hematologic Disease|1|||
170648844|NCT03339297|616726853|FG001|Overall Study|Relapse of Hematologic Disease|0|||
170648845|NCT03339297|616726852|FG000|Overall Study|Death|10|||
170648846|NCT03339297|616726853|FG001|Overall Study|Death|7|||
170648847|NCT03339297|616726852|FG000|Overall Study|Hepatic Candidosis|1|||
170648848|NCT03339297|616726853|FG001|Overall Study|Hepatic Candidosis|0|||
170648849|NCT03339297|616726852|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
170648850|NCT03339297|616726853|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
170648851|NCT03339297|616726852|FG000|Overall Study|Consent Withdrawn by Participant|3|||
170648852|NCT03339297|616726853|FG001|Overall Study|Consent Withdrawn by Participant|3|||
170648853|NCT03339297|616726852|FG000|Overall Study|Disease Relapse|2|||
170648854|NCT03339297|616726853|FG001|Overall Study|Disease Relapse|0|||
170571901|NCT02831855|616439672|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
170571902|NCT02831855|616439673|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
170571903|NCT02831855|616439671|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
170571904|NCT02831855|616439672|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
170571905|NCT02831855|616439673|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
170571906|NCT02831855|616439671|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
170571907|NCT02831855|616439672|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
170648855|NCT03339297|616726852|FG000|Overall Study|Physician Decision|1|||
170648856|NCT03339297|616726853|FG001|Overall Study|Physician Decision|1|||
170648857|NCT03339297|616726852|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
170648858|NCT03339297|616726853|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
170648859|NCT03339297|616726852|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
170648860|NCT03339297|616726853|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
170571908|NCT02831855|616439673|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
170571909|NCT02831855|616439671|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
170571910|NCT02831855|616439672|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
170571911|NCT02831855|616439673|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
170571912|NCT02831855|616439671|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
170571913|NCT02831855|616439672|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
170571914|NCT02831855|616439673|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
170571915|NCT02831855|616439671|FG000|Open Label Phase (24 Weeks)|Other|4|||
170571916|NCT02831855|616439672|FG001|Open Label Phase (24 Weeks)|Other|0|||
170571917|NCT02831855|616439673|FG002|Open Label Phase (24 Weeks)|Other|0|||
170571918|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
170571919|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
170571920|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
170571921|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Death|0|||
170571922|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Death|0|||
170571923|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Death|2|||
170571924|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
170571925|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
170571926|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
170571927|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
170571928|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
170571929|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
170571930|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
170571931|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
170571932|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
170571933|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Other|0|||
170571934|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Other|2|||
170571935|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Other|5|||
170571936|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
170571937|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
170571938|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
170571939|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
170571940|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
170571941|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
170571942|NCT02831855|616439671|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
170571943|NCT02831855|616439672|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
170571944|NCT02831855|616439673|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
170648861|NCT03339297|616726852|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
170648862|NCT03339297|616726853|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
170648863|NCT03339297|616726852|FG000|Overall Study|Adverse Event, Non-fatal|1|||
170648864|NCT03339297|616726853|FG001|Overall Study|Adverse Event, Non-fatal|0|||
170648865|NCT03339297|616726852|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
170648866|NCT03339297|616726853|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
170648867|NCT03339297|616726852|FG000|Overall Study|Patient Was Not Eligible|1|||
170648868|NCT03339297|616726853|FG001|Overall Study|Patient Was Not Eligible|0|||
170648869|NCT03726996|616726856|FG000|Overall Study|Parent's decision|2|||
170648870|NCT03726996|616726856|FG000|Overall Study|Study early termination|2|||
170648871|NCT01566214|616726857|FG000|Overall Study|Lost to Follow-up|3|||
170648872|NCT01566214|616726858|FG001|Overall Study|Lost to Follow-up|0|||
170648873|NCT02112045|616726863|FG000|Overall Study|Withdrawal by Subject|1|||
170648874|NCT02112045|616726864|FG001|Overall Study|Withdrawal by Subject|0|||
170648875|NCT00627445|616726865|FG000|Overall Study|Adverse Event|3|||
170648876|NCT00627445|616726866|FG001|Overall Study|Adverse Event|3|||
170648877|NCT00627445|616726865|FG000|Overall Study|Lack of Efficacy|0|||
170648878|NCT00627445|616726866|FG001|Overall Study|Lack of Efficacy|1|||
170648879|NCT00627445|616726865|FG000|Overall Study|Other|6|||
170648880|NCT00627445|616726866|FG001|Overall Study|Other|8|||
170648881|NCT03554486|616726870|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
170648882|NCT03554486|616726871|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
170648883|NCT03554486|616726872|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
170571945|NCT03962855|616439681|FG000|Overall Study|Death|0|||
170648884|NCT03554486|616726870|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
170648885|NCT03554486|616726871|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
170648886|NCT03554486|616726872|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
170648887|NCT03554486|616726870|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
170648888|NCT03554486|616726871|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
170648889|NCT03554486|616726872|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
170571946|NCT03962855|616439682|FG001|Overall Study|Death|1|||
170571947|NCT03962855|616439681|FG000|Overall Study|Lost to Follow-up|0|||
170571948|NCT03962855|616439682|FG001|Overall Study|Lost to Follow-up|1|||
170571949|NCT03962855|616439681|FG000|Overall Study|Adverse Event|0|||
170648890|NCT01616693|616726873|FG000|Evaluated for Safety|Physician Decision|1|||
170571950|NCT03962855|616439682|FG001|Overall Study|Adverse Event|1|||
170571951|NCT03962855|616439681|FG000|Overall Study|Physician Decision|0|||
170571952|NCT03962855|616439682|FG001|Overall Study|Physician Decision|2|||
170571953|NCT04860869|616439683|FG000|Overall Study|Withdrawal by Subject|1|||
170571954|NCT04860869|616439684|FG001|Overall Study|Withdrawal by Subject|0|||
170571955|NCT02834819|616439692|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
170571956|NCT02834819|616439693|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
170571957|NCT04179305|616439695|FG000|Overall Study|Death|1|||
170571958|NCT04179305|616439696|FG001|Overall Study|Death|1|||
170571959|NCT04179305|616439697|FG002|Overall Study|Death|0|||
170571960|NCT04179305|616439698|FG003|Overall Study|Death|0|||
170571961|NCT04179305|616439695|FG000|Overall Study|Lost to Follow-up|1|||
170571962|NCT04179305|616439696|FG001|Overall Study|Lost to Follow-up|1|||
170571963|NCT04179305|616439697|FG002|Overall Study|Lost to Follow-up|0|||
170571964|NCT04179305|616439698|FG003|Overall Study|Lost to Follow-up|0|||
170571965|NCT04179305|616439695|FG000|Overall Study|Withdrawal by Subject|0|||
170571966|NCT04179305|616439696|FG001|Overall Study|Withdrawal by Subject|1|||
170571967|NCT04179305|616439697|FG002|Overall Study|Withdrawal by Subject|0|||
170571968|NCT04179305|616439698|FG003|Overall Study|Withdrawal by Subject|0|||
170571969|NCT04179305|616439695|FG000|Overall Study|Did not have scan|1|||
170571970|NCT04179305|616439696|FG001|Overall Study|Did not have scan|0|||
170571971|NCT04179305|616439697|FG002|Overall Study|Did not have scan|0|||
170808529|NCT03626662|617308922|FG002|Overall Study|Withdrawal of Consent from Study|0|||
170571972|NCT04179305|616439698|FG003|Overall Study|Did not have scan|0|||
170571973|NCT04179305|616439695|FG000|Overall Study|In hospice care|3|||
170571974|NCT04179305|616439696|FG001|Overall Study|In hospice care|0|||
170571975|NCT04179305|616439697|FG002|Overall Study|In hospice care|0|||
170571976|NCT04179305|616439698|FG003|Overall Study|In hospice care|0|||
170571977|NCT03542266|616439701|FG000|Treatment Phase|Withdrawal by Subject|1|||
170571978|NCT03542266|616439701|FG000|Treatment Phase|Adverse Event|1|||
170571979|NCT03542266|616439701|FG000|Treatment Phase|PD|1|||
170571980|NCT00786422|616439712|FG000|Rivaroxaban Treatment|Death|2|||
170571981|NCT00786422|616439712|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
170571982|NCT00786422|616439712|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
170571983|NCT00786422|616439712|FG000|Rivaroxaban Treatment|Physician Decision|1|||
170571984|NCT00786422|616439712|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
170571985|NCT00786422|616439712|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
170571986|NCT00786422|616439712|FG000|Rivaroxaban Treatment|Adverse Event|2|||
170571987|NCT00786422|616439712|FG000|Follow-up Period|Death|1|||
170571988|NCT00786422|616439712|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
170571989|NCT03484429|616439713|FG000|Overall Study|Withdrawal by Subject|1|||
170571990|NCT03484429|616439714|FG001|Overall Study|Withdrawal by Subject|0|||
170808530|NCT03626662|617308923|FG003|Overall Study|Withdrawal of Consent from Study|0|||
170808531|NCT03626662|617308924|FG004|Overall Study|Withdrawal of Consent from Study|4|||
170808532|NCT03626662|617308925|FG005|Overall Study|Withdrawal of Consent from Study|3|||
170808533|NCT03626662|617308926|FG006|Overall Study|Withdrawal of Consent from Study|0|||
170808534|NCT03626662|617308927|FG007|Overall Study|Withdrawal of Consent from Study|0|||
170808535|NCT03626662|617308928|FG008|Overall Study|Withdrawal of Consent from Study|0|||
170808536|NCT03626662|617308929|FG009|Overall Study|Withdrawal of Consent from Study|1|||
170808537|NCT03626662|617308920|FG000|Overall Study|Decision by Sponsor|0|||
170808538|NCT03626662|617308921|FG001|Overall Study|Decision by Sponsor|0|||
170808539|NCT03626662|617308922|FG002|Overall Study|Decision by Sponsor|0|||
170808540|NCT03626662|617308923|FG003|Overall Study|Decision by Sponsor|0|||
170808541|NCT03626662|617308924|FG004|Overall Study|Decision by Sponsor|0|||
170808542|NCT03626662|617308925|FG005|Overall Study|Decision by Sponsor|0|||
170808543|NCT03626662|617308926|FG006|Overall Study|Decision by Sponsor|1|||
170808544|NCT03626662|617308927|FG007|Overall Study|Decision by Sponsor|3|||
170808545|NCT03626662|617308928|FG008|Overall Study|Decision by Sponsor|0|||
170808546|NCT03626662|617308929|FG009|Overall Study|Decision by Sponsor|0|||
170808547|NCT03626662|617308920|FG000|Overall Study|Lost to Follow-up|1|||
170808548|NCT03626662|617308921|FG001|Overall Study|Lost to Follow-up|0|||
170808549|NCT03626662|617308922|FG002|Overall Study|Lost to Follow-up|2|||
170808550|NCT03626662|617308923|FG003|Overall Study|Lost to Follow-up|0|||
170808551|NCT03626662|617308924|FG004|Overall Study|Lost to Follow-up|0|||
170808552|NCT03626662|617308925|FG005|Overall Study|Lost to Follow-up|0|||
170648891|NCT01616693|616726874|FG001|Evaluated for Safety|Physician Decision|0|||
170648892|NCT01616693|616726875|FG002|Evaluated for Safety|Physician Decision|1|||
170648893|NCT01616693|616726876|FG003|Evaluated for Safety|Physician Decision|0|||
170648894|NCT01616693|616726873|FG000|Received Both Vaccines|Adverse Event|2|||
170648895|NCT01616693|616726874|FG001|Received Both Vaccines|Adverse Event|0|||
170648896|NCT01616693|616726875|FG002|Received Both Vaccines|Adverse Event|0|||
170571991|NCT03484429|616439713|FG000|Overall Study|Adverse Event|2|||
170648897|NCT01616693|616726876|FG003|Received Both Vaccines|Adverse Event|0|||
170808553|NCT03626662|617308926|FG006|Overall Study|Lost to Follow-up|0|||
170808554|NCT03626662|617308927|FG007|Overall Study|Lost to Follow-up|0|||
170571992|NCT03484429|616439714|FG001|Overall Study|Adverse Event|0|||
170571993|NCT04466384|616439715|FG000|First Phase|Protocol Violation|1|||
170571994|NCT04466384|616439716|FG001|First Phase|Protocol Violation|0|||
170571995|NCT04466384|616439715|FG000|First Phase|Missing data|1|||
170571996|NCT04466384|616439716|FG001|First Phase|Missing data|0|||
170571997|NCT04466384|616439715|FG000|Cross Over Phase|Physician Decision|1|||
170571998|NCT04466384|616439716|FG001|Cross Over Phase|Physician Decision|0|||
170571999|NCT04466384|616439715|FG000|Cross Over Phase|Withdrawal by Subject|0|||
170572000|NCT04466384|616439716|FG001|Cross Over Phase|Withdrawal by Subject|1|||
170572001|NCT03069716|616439719|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
170572002|NCT03069716|616439720|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
170572003|NCT03069716|616439721|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
170572004|NCT03069716|616439719|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
170572005|NCT03069716|616439720|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
170572006|NCT03069716|616439721|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
170572007|NCT03069716|616439719|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
170572008|NCT03069716|616439720|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
170572009|NCT03069716|616439721|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
170572010|NCT03069716|616439719|FG000|Randomized Treatment|Withdrawal by Subject|0|||
170572011|NCT03069716|616439720|FG001|Randomized Treatment|Withdrawal by Subject|2|||
170572012|NCT03069716|616439721|FG002|Randomized Treatment|Withdrawal by Subject|0|||
170572013|NCT00806260|616439724|FG000|Period 1 (1 Day)|Adverse Event|0|||
170572014|NCT00806260|616439725|FG001|Period 1 (1 Day)|Adverse Event|0|||
170572015|NCT00806260|616439726|FG002|Period 1 (1 Day)|Adverse Event|0|||
170572016|NCT00806260|616439727|FG003|Period 1 (1 Day)|Adverse Event|0|||
170572017|NCT00806260|616439728|FG004|Period 1 (1 Day)|Adverse Event|3|||
170648898|NCT01616693|616726873|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
170648899|NCT01616693|616726874|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
170648900|NCT01616693|616726875|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
170648901|NCT01616693|616726876|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
170648902|NCT01616693|616726873|FG000|Received Both Vaccines|Lost to Follow-up|4|||
170648903|NCT01616693|616726874|FG001|Received Both Vaccines|Lost to Follow-up|3|||
170648904|NCT01616693|616726875|FG002|Received Both Vaccines|Lost to Follow-up|4|||
170648905|NCT01616693|616726876|FG003|Received Both Vaccines|Lost to Follow-up|4|||
170648906|NCT01616693|616726873|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
170648907|NCT01616693|616726874|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
170648908|NCT01616693|616726875|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
170648909|NCT01616693|616726876|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
170648910|NCT00832624|616726877|FG000|Overall Study|Study Terminated|10|||
170648911|NCT00796523|616726878|FG000|Overall Study|Lost to Follow-up|9|||
170648912|NCT00796523|616726879|FG001|Overall Study|Lost to Follow-up|7|||
170648913|NCT00321646|616726881|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
170648914|NCT00321646|616726881|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
170648915|NCT00321646|616726881|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
170648916|NCT02034409|616726884|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
170648917|NCT02034409|616726885|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
170648918|NCT02034409|616726884|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
170648919|NCT02034409|616726885|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
170648920|NCT02034409|616726884|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
170648921|NCT02034409|616726885|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
170648922|NCT02034409|616726884|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
170648923|NCT02034409|616726885|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
170648924|NCT02034409|616726884|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
170648925|NCT02034409|616726885|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
170648926|NCT02034409|616726884|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
170648927|NCT02034409|616726885|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
170648928|NCT02270944|616726886|FG000|Overall Study|Lost to Follow-up|9|||
170648929|NCT02270944|616726887|FG001|Overall Study|Lost to Follow-up|4|||
170648930|NCT02270944|616726886|FG000|Overall Study|Withdrawal by Subject|2|||
170648931|NCT02270944|616726887|FG001|Overall Study|Withdrawal by Subject|1|||
170648932|NCT01375075|616726890|FG000|Overall Study|Adverse Event|0|||
170648933|NCT01375075|616726891|FG001|Overall Study|Adverse Event|0|||
170648934|NCT01375075|616726892|FG002|Overall Study|Adverse Event|3|||
170648935|NCT01375075|616726893|FG003|Overall Study|Adverse Event|1|||
170572018|NCT00806260|616439729|FG005|Period 1 (1 Day)|Adverse Event|0|||
170572019|NCT00806260|616439724|FG000|Period 2|Adverse Event|0|||
170648936|NCT01375075|616726894|FG004|Overall Study|Adverse Event|0|||
170648937|NCT01375075|616726895|FG005|Overall Study|Adverse Event|1|||
170648938|NCT01375075|616726890|FG000|Overall Study|Entry Criterion Not Met|1|||
170648939|NCT01375075|616726891|FG001|Overall Study|Entry Criterion Not Met|0|||
170648940|NCT01375075|616726892|FG002|Overall Study|Entry Criterion Not Met|0|||
170572020|NCT00806260|616439725|FG001|Period 2|Adverse Event|0|||
170572021|NCT00806260|616439726|FG002|Period 2|Adverse Event|0|||
170572022|NCT00806260|616439727|FG003|Period 2|Adverse Event|1|||
170572023|NCT00806260|616439728|FG004|Period 2|Adverse Event|0|||
170572024|NCT00806260|616439729|FG005|Period 2|Adverse Event|0|||
170572025|NCT00806260|616439724|FG000|Period 2|Protocol Violation|1|||
170572026|NCT00806260|616439725|FG001|Period 2|Protocol Violation|0|||
170572027|NCT00806260|616439726|FG002|Period 2|Protocol Violation|1|||
170572028|NCT00806260|616439727|FG003|Period 2|Protocol Violation|0|||
170572029|NCT00806260|616439728|FG004|Period 2|Protocol Violation|0|||
170572030|NCT00806260|616439729|FG005|Period 2|Protocol Violation|0|||
170572031|NCT00806260|616439724|FG000|Period 2|Need to take concomitant medication|1|||
170572032|NCT00806260|616439725|FG001|Period 2|Need to take concomitant medication|0|||
170572033|NCT00806260|616439726|FG002|Period 2|Need to take concomitant medication|0|||
170572034|NCT00806260|616439727|FG003|Period 2|Need to take concomitant medication|0|||
170572035|NCT00806260|616439728|FG004|Period 2|Need to take concomitant medication|0|||
170572036|NCT00806260|616439729|FG005|Period 2|Need to take concomitant medication|0|||
170572037|NCT00806260|616439724|FG000|Period 2|sponsor request|0|||
170572038|NCT00806260|616439725|FG001|Period 2|sponsor request|0|||
170572039|NCT00806260|616439726|FG002|Period 2|sponsor request|1|||
170572040|NCT00806260|616439727|FG003|Period 2|sponsor request|1|||
170572041|NCT00806260|616439728|FG004|Period 2|sponsor request|0|||
170572042|NCT00806260|616439729|FG005|Period 2|sponsor request|0|||
170572043|NCT00806260|616439724|FG000|Period 3|Protocol Violation|0|||
170572044|NCT00806260|616439725|FG001|Period 3|Protocol Violation|1|||
170572045|NCT00806260|616439726|FG002|Period 3|Protocol Violation|1|||
170572046|NCT00806260|616439727|FG003|Period 3|Protocol Violation|0|||
170572047|NCT00806260|616439728|FG004|Period 3|Protocol Violation|0|||
170572048|NCT00806260|616439729|FG005|Period 3|Protocol Violation|0|||
170572049|NCT00806260|616439724|FG000|Period 3|Pregnancy|1|||
170572050|NCT00806260|616439725|FG001|Period 3|Pregnancy|0|||
170572051|NCT00806260|616439726|FG002|Period 3|Pregnancy|0|||
170572052|NCT00806260|616439727|FG003|Period 3|Pregnancy|0|||
170572053|NCT00806260|616439728|FG004|Period 3|Pregnancy|0|||
170572054|NCT00806260|616439729|FG005|Period 3|Pregnancy|0|||
170648941|NCT01375075|616726893|FG003|Overall Study|Entry Criterion Not Met|0|||
170648942|NCT01375075|616726894|FG004|Overall Study|Entry Criterion Not Met|0|||
170648943|NCT01375075|616726895|FG005|Overall Study|Entry Criterion Not Met|1|||
170648944|NCT01375075|616726890|FG000|Overall Study|Withdrawal by Subject|0|||
170648945|NCT01375075|616726891|FG001|Overall Study|Withdrawal by Subject|1|||
170648946|NCT01375075|616726892|FG002|Overall Study|Withdrawal by Subject|0|||
170648947|NCT01375075|616726893|FG003|Overall Study|Withdrawal by Subject|0|||
170648948|NCT01375075|616726894|FG004|Overall Study|Withdrawal by Subject|0|||
170648949|NCT01375075|616726895|FG005|Overall Study|Withdrawal by Subject|1|||
170648950|NCT00831493|616726896|FG000|Overall Study|Intractable nausea and vomiting|1|||
170648951|NCT01379508|616726897|FG000|Treatment to Week 104|Adverse Event|2|||
170648952|NCT01379508|616726898|FG001|Treatment to Week 104|Adverse Event|0|||
170648953|NCT01379508|616726899|FG002|Treatment to Week 104|Adverse Event|5|||
170648954|NCT01379508|616726900|FG003|Treatment to Week 104|Adverse Event|0|||
170648955|NCT01379508|616726897|FG000|Treatment to Week 104|Abnormal lab value|1|||
170648956|NCT01379508|616726898|FG001|Treatment to Week 104|Abnormal lab value|0|||
170648957|NCT01379508|616726899|FG002|Treatment to Week 104|Abnormal lab value|0|||
170648958|NCT01379508|616726900|FG003|Treatment to Week 104|Abnormal lab value|0|||
170648959|NCT01379508|616726897|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
170648960|NCT01379508|616726898|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
170648961|NCT01379508|616726899|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
170648962|NCT01379508|616726900|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
170648963|NCT01379508|616726897|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
170648964|NCT01379508|616726898|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
170648965|NCT01379508|616726899|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
170648966|NCT01379508|616726900|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
170648967|NCT01379508|616726897|FG000|Treatment to Week 104|Lost to Follow-up|5|||
170648968|NCT01379508|616726898|FG001|Treatment to Week 104|Lost to Follow-up|0|||
170648969|NCT01379508|616726899|FG002|Treatment to Week 104|Lost to Follow-up|3|||
170648970|NCT01379508|616726900|FG003|Treatment to Week 104|Lost to Follow-up|0|||
170648971|NCT01379508|616726897|FG000|Treatment to Week 104|Administrative problems|3|||
170648972|NCT01379508|616726898|FG001|Treatment to Week 104|Administrative problems|1|||
170648973|NCT01379508|616726899|FG002|Treatment to Week 104|Administrative problems|0|||
170648974|NCT01379508|616726900|FG003|Treatment to Week 104|Administrative problems|0|||
170648975|NCT01379508|616726897|FG000|Treatment to Week 104|Protocol Violation|1|||
170572055|NCT01897532|616439730|FG000|Discontinuation From Treatment|Not Treated|7|||
170572056|NCT01897532|616439731|FG001|Discontinuation From Treatment|Not Treated|5|||
170572057|NCT01897532|616439730|FG000|Discontinuation From Treatment|Other reason than specified|196|||
170572058|NCT01897532|616439731|FG001|Discontinuation From Treatment|Other reason than specified|176|||
170648976|NCT01379508|616726898|FG001|Treatment to Week 104|Protocol Violation|1|||
170572059|NCT01897532|616439730|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
170648977|NCT01379508|616726899|FG002|Treatment to Week 104|Protocol Violation|1|||
170572060|NCT01897532|616439731|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
170572061|NCT01897532|616439730|FG000|Discontinuation From Treatment|Non compliance|24|||
170572062|NCT01897532|616439731|FG001|Discontinuation From Treatment|Non compliance|15|||
170572063|NCT01897532|616439730|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
170572064|NCT01897532|616439731|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
170572065|NCT01897532|616439730|FG000|Discontinuation From Trial|Not Treated|7|||
170572066|NCT01897532|616439731|FG001|Discontinuation From Trial|Not Treated|5|||
170572067|NCT01897532|616439730|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
170572068|NCT01897532|616439731|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
170572069|NCT02112656|616439736|FG000|Overall Study|Death|78|||
170572070|NCT02112656|616439737|FG001|Overall Study|Death|82|||
170572071|NCT02112656|616439736|FG000|Overall Study|Withdrawal by Subject|9|||
170572072|NCT02112656|616439737|FG001|Overall Study|Withdrawal by Subject|11|||
170572073|NCT02112656|616439736|FG000|Overall Study|Lost to Follow-up|2|||
170572074|NCT02112656|616439737|FG001|Overall Study|Lost to Follow-up|4|||
170572075|NCT02112656|616439736|FG000|Overall Study|Noncompliance|1|||
170572076|NCT02112656|616439737|FG001|Overall Study|Noncompliance|2|||
170572077|NCT02595879|616440791|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
170572078|NCT02595879|616440792|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
170572079|NCT01396187|616440793|FG000|Overall Study|Adverse Event|0|||
170572080|NCT01396187|616440794|FG001|Overall Study|Adverse Event|1|||
170648978|NCT01379508|616726900|FG003|Treatment to Week 104|Protocol Violation|0|||
170648979|NCT01379508|616726897|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
170648980|NCT01379508|616726898|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
170648981|NCT01379508|616726899|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
170648982|NCT01379508|616726900|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
170572081|NCT01396187|616440795|FG002|Overall Study|Adverse Event|0|||
170572082|NCT01396187|616440796|FG003|Overall Study|Adverse Event|0|||
170572083|NCT01396187|616440797|FG004|Overall Study|Adverse Event|0|||
170572084|NCT01396187|616440793|FG000|Overall Study|Withdrawal by Subject|0|||
170572085|NCT01396187|616440794|FG001|Overall Study|Withdrawal by Subject|1|||
170572086|NCT01396187|616440795|FG002|Overall Study|Withdrawal by Subject|1|||
170572087|NCT01396187|616440796|FG003|Overall Study|Withdrawal by Subject|0|||
170572088|NCT01396187|616440797|FG004|Overall Study|Withdrawal by Subject|0|||
170572089|NCT01396187|616440793|FG000|Overall Study|Other|1|||
170572090|NCT01396187|616440794|FG001|Overall Study|Other|1|||
170572091|NCT01396187|616440795|FG002|Overall Study|Other|0|||
170572092|NCT01396187|616440796|FG003|Overall Study|Other|0|||
170648983|NCT01379508|616726897|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
170648984|NCT01379508|616726898|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
170648985|NCT01379508|616726899|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
170648986|NCT01379508|616726900|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
170648987|NCT01379508|616726897|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
170648988|NCT01379508|616726898|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
170648989|NCT01379508|616726899|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
170648990|NCT01379508|616726900|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
170648991|NCT01379508|616726897|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
170648992|NCT01379508|616726898|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
170648993|NCT01379508|616726899|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
170648994|NCT01379508|616726900|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
170648995|NCT02055365|616728985|FG000|Overall Study|Prematurely Withdrawn|1|||
170648996|NCT03603509|616728986|FG000|Overall Study|Lost to Follow-up|3|||
170648997|NCT03603509|616728987|FG001|Overall Study|Lost to Follow-up|4|||
170648998|NCT01258998|616728990|FG000|Overall Study|Ineligible|1|||
170648999|NCT01143389|616728991|FG000|Overall Study|Lost to Follow-up|26|||
170649000|NCT01143389|616728992|FG001|Overall Study|Lost to Follow-up|25|||
170649001|NCT02276027|616728997|FG000|Overall Study|Death|1|||
170649002|NCT02276027|616728998|FG001|Overall Study|Death|0|||
170649003|NCT02276027|616728999|FG002|Overall Study|Death|0|||
170649004|NCT02276027|616729000|FG003|Overall Study|Death|2|||
170649005|NCT02276027|616728997|FG000|Overall Study|Physician Decision|0|||
170649006|NCT02276027|616728998|FG001|Overall Study|Physician Decision|0|||
170649007|NCT02276027|616728999|FG002|Overall Study|Physician Decision|0|||
170572093|NCT01396187|616440797|FG004|Overall Study|Other|1|||
170572094|NCT01898286|616440798|FG000|Overall Study|Withdrawal by Subject|1|||
170572095|NCT01898286|616440798|FG000|Overall Study|Protocol Violation|1|||
170572096|NCT01898286|616440798|FG000|Overall Study|Lost to Follow-up|1|||
170572097|NCT00551031|616440799|FG000|Overall Study|Adverse Event|0|||
170572098|NCT00551031|616440800|FG001|Overall Study|Adverse Event|1|||
170572099|NCT00551031|616440801|FG002|Overall Study|Adverse Event|0|||
170572100|NCT00551031|616440802|FG003|Overall Study|Adverse Event|0|||
170572101|NCT00551031|616440803|FG004|Overall Study|Adverse Event|0|||
170572102|NCT00551031|616440799|FG000|Overall Study|Protocol Violation|1|||
170649008|NCT02276027|616729000|FG003|Overall Study|Physician Decision|1|||
170649009|NCT02276027|616728997|FG000|Overall Study|Progressive disease|1|||
170649010|NCT02276027|616728998|FG001|Overall Study|Progressive disease|13|||
170649011|NCT02276027|616728999|FG002|Overall Study|Progressive disease|12|||
170572103|NCT00551031|616440800|FG001|Overall Study|Protocol Violation|1|||
170572104|NCT00551031|616440801|FG002|Overall Study|Protocol Violation|0|||
170572105|NCT00551031|616440802|FG003|Overall Study|Protocol Violation|0|||
170572106|NCT00551031|616440803|FG004|Overall Study|Protocol Violation|0|||
170572107|NCT00551031|616440799|FG000|Overall Study|Lost to Follow-up|0|||
170572108|NCT00551031|616440800|FG001|Overall Study|Lost to Follow-up|1|||
170572109|NCT00551031|616440801|FG002|Overall Study|Lost to Follow-up|0|||
170572110|NCT00551031|616440802|FG003|Overall Study|Lost to Follow-up|1|||
170572111|NCT00551031|616440803|FG004|Overall Study|Lost to Follow-up|1|||
170572112|NCT00551031|616440799|FG000|Overall Study|Withdrawal by Subject|0|||
170572113|NCT00551031|616440800|FG001|Overall Study|Withdrawal by Subject|4|||
170572114|NCT00551031|616440801|FG002|Overall Study|Withdrawal by Subject|1|||
170572115|NCT00551031|616440802|FG003|Overall Study|Withdrawal by Subject|2|||
170572116|NCT00551031|616440803|FG004|Overall Study|Withdrawal by Subject|0|||
170572117|NCT00551031|616440799|FG000|Overall Study|Serious Adverse Event|0|||
170572118|NCT00551031|616440800|FG001|Overall Study|Serious Adverse Event|2|||
170572119|NCT00551031|616440801|FG002|Overall Study|Serious Adverse Event|1|||
170572120|NCT00551031|616440802|FG003|Overall Study|Serious Adverse Event|0|||
170572121|NCT00551031|616440803|FG004|Overall Study|Serious Adverse Event|0|||
170572122|NCT00551031|616440799|FG000|Overall Study|Did not receive vaccine|1|||
170572123|NCT00551031|616440800|FG001|Overall Study|Did not receive vaccine|2|||
170572124|NCT00551031|616440801|FG002|Overall Study|Did not receive vaccine|0|||
170572125|NCT00551031|616440802|FG003|Overall Study|Did not receive vaccine|0|||
170572126|NCT00551031|616440803|FG004|Overall Study|Did not receive vaccine|0|||
170572127|NCT01650831|616440806|FG000|Overall Study|Screen failure|1|||
170572128|NCT05554146|616440809|FG000|Overall Study|Adverse Event|0|||
170572129|NCT05554146|616440810|FG001|Overall Study|Adverse Event|1|||
170572130|NCT05554146|616440811|FG002|Overall Study|Adverse Event|0|||
170572131|NCT05554146|616440812|FG003|Overall Study|Adverse Event|0|||
170572132|NCT05554146|616440809|FG000|Overall Study|Protocol Violation|0|||
170572133|NCT05554146|616440810|FG001|Overall Study|Protocol Violation|1|||
170572134|NCT05554146|616440811|FG002|Overall Study|Protocol Violation|0|||
170572135|NCT05554146|616440812|FG003|Overall Study|Protocol Violation|0|||
170572136|NCT05554146|616440809|FG000|Overall Study|No longer interested in participating|0|||
170572137|NCT05554146|616440810|FG001|Overall Study|No longer interested in participating|0|||
170572138|NCT05554146|616440811|FG002|Overall Study|No longer interested in participating|1|||
170572139|NCT05554146|616440812|FG003|Overall Study|No longer interested in participating|0|||
170572140|NCT05554146|616440809|FG000|Overall Study|Lost to Follow-up|1|||
170572141|NCT05554146|616440810|FG001|Overall Study|Lost to Follow-up|0|||
170572142|NCT05554146|616440811|FG002|Overall Study|Lost to Follow-up|0|||
170572143|NCT05554146|616440812|FG003|Overall Study|Lost to Follow-up|0|||
170572144|NCT01336712|616440813|FG000|Overall Study|Death|2|||
170572145|NCT01336712|616440813|FG000|Overall Study|Lack of Efficacy|1|||
170572146|NCT00620373|616440814|FG000|Overall Study|Unverified cancer status|33|||
170572147|NCT01897727|616440815|FG000|Overall Study|Exclusion: central sleep apnea|0|||
170572148|NCT01897727|616440816|FG001|Overall Study|Exclusion: central sleep apnea|1|||
170649012|NCT02276027|616729000|FG003|Overall Study|Progressive disease|14|||
170649013|NCT02276027|616728997|FG000|Overall Study|Subject/guardian decision|0|||
170649014|NCT02276027|616728998|FG001|Overall Study|Subject/guardian decision|1|||
170649015|NCT02276027|616728999|FG002|Overall Study|Subject/guardian decision|0|||
170649016|NCT02276027|616729000|FG003|Overall Study|Subject/guardian decision|3|||
170649017|NCT02276027|616728997|FG000|Overall Study|Adverse Event|0|||
170649018|NCT02276027|616728998|FG001|Overall Study|Adverse Event|2|||
170649019|NCT02276027|616728999|FG002|Overall Study|Adverse Event|8|||
170649020|NCT02276027|616729000|FG003|Overall Study|Adverse Event|2|||
170649021|NCT03224598|616729001|FG000|Overall Study|Lost to Follow-up|0|||
170649022|NCT03224598|616729002|FG001|Overall Study|Lost to Follow-up|2|||
170649023|NCT03224598|616729003|FG002|Overall Study|Lost to Follow-up|0|||
170649024|NCT03224598|616729001|FG000|Overall Study|Other|0|||
170649025|NCT03224598|616729002|FG001|Overall Study|Other|1|||
170649026|NCT03224598|616729003|FG002|Overall Study|Other|0|||
170649027|NCT02446171|616729011|FG000|Overall Study|Withdrawal by Subject|0|||
170649028|NCT02446171|616729012|FG001|Overall Study|Withdrawal by Subject|0|||
170572149|NCT04245449|616440817|FG000|Overall Study|COVID shutdown|7|||
170572150|NCT03073525|616440818|FG000|Overall Study|Withdrawal by Subject|0|||
170572151|NCT03073525|616440819|FG001|Overall Study|Withdrawal by Subject|0|||
170572152|NCT03073525|616440820|FG002|Overall Study|Withdrawal by Subject|3|||
170572153|NCT01273038|616440821|FG000|Second Intervention (14 Days)|Adverse Event|0|||
170572154|NCT01273038|616440822|FG001|Second Intervention (14 Days)|Adverse Event|1|||
170649029|NCT02446171|616729013|FG002|Overall Study|Withdrawal by Subject|2|||
170649030|NCT02446171|616729014|FG003|Overall Study|Withdrawal by Subject|0|||
170572155|NCT01273038|616440821|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
170572156|NCT01273038|616440822|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
170649031|NCT03328182|616729015|FG000|Overall Study|Withdrawal by Subject|1|||
170649032|NCT03328182|616729015|FG000|Overall Study|Protocol Violation|2|||
170649033|NCT03328182|616729015|FG000|Overall Study|No Product Evaluated|1|||
170572157|NCT01976299|616440823|FG000|Overall Study|Withdrawal by Subject|3|||
170572158|NCT01976299|616440824|FG001|Overall Study|Withdrawal by Subject|1|||
170572159|NCT01976299|616440823|FG000|Overall Study|Death|4|||
170572160|NCT01976299|616440824|FG001|Overall Study|Death|2|||
170572161|NCT01976299|616440823|FG000|Overall Study|Lost to Follow-up|7|||
170572162|NCT01976299|616440824|FG001|Overall Study|Lost to Follow-up|1|||
170572163|NCT01976299|616440823|FG000|Overall Study|See clarification above in comments|9|||
170572164|NCT01976299|616440824|FG001|Overall Study|See clarification above in comments|2|||
170572165|NCT01349673|616440826|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
170572166|NCT01349673|616440826|FG000|Overall Study|No Longer Qualified For Study|1|||
170572167|NCT01349673|616440826|FG000|Overall Study|Site Closure|10|||
170572168|NCT01349673|616440826|FG000|Overall Study|Withdrawal by Subject|21|||
170572169|NCT01349673|616440826|FG000|Overall Study|Lost to Follow-up|6|||
170572170|NCT01349673|616440826|FG000|Overall Study|Adverse Event|17|||
170572171|NCT01349673|616440826|FG000|Overall Study|Study Terminated By Sponsor|50|||
170572172|NCT01349673|616440826|FG000|Overall Study|Lack of Efficacy|8|||
170572173|NCT03688919|616440827|FG000|Overall Study|Lost to Follow-up|2|||
170572174|NCT03688919|616440828|FG001|Overall Study|Lost to Follow-up|1|||
170572175|NCT03688919|616440827|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
170572176|NCT03688919|616440828|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
170572177|NCT01773967|616440835|FG000|Overall Study|Lost to Follow-up|15|||
170572178|NCT01773967|616440836|FG001|Overall Study|Lost to Follow-up|13|||
170572179|NCT02413996|616440837|FG000|Overall Study|not comfortable with the intervention|9|||
170572180|NCT02413996|616440838|FG001|Overall Study|not comfortable with the intervention|2|||
170572181|NCT00579553|616440839|FG000|Overall Study|Lost to Follow-up|16|||
170572182|NCT00579553|616440840|FG001|Overall Study|Lost to Follow-up|13|||
170572183|NCT00090779|616440841|FG000|Step 1|Withdrawal by Subject|4|||
170572184|NCT00090779|616440842|FG001|Step 1|Withdrawal by Subject|2|||
170572185|NCT00090779|616440841|FG000|Step 1|Lost to Follow-up|3|||
170572186|NCT00090779|616440842|FG001|Step 1|Lost to Follow-up|2|||
170572187|NCT00090779|616440841|FG000|Step 1|Death|0|||
170572188|NCT00090779|616440842|FG001|Step 1|Death|2|||
170572189|NCT00090779|616440841|FG000|Step 1|Physician Decision|1|||
170572190|NCT00090779|616440842|FG001|Step 1|Physician Decision|0|||
170572191|NCT00090779|616440841|FG000|Step 1|Pregnancy|1|||
170572192|NCT00090779|616440842|FG001|Step 1|Pregnancy|0|||
170572193|NCT00090779|616440841|FG000|Step 1|Non-compliance to study requirements|0|||
170572194|NCT00090779|616440842|FG001|Step 1|Non-compliance to study requirements|1|||
170572195|NCT00090779|616440841|FG000|Step 1|Subject relocated|2|||
170572196|NCT00090779|616440842|FG001|Step 1|Subject relocated|8|||
170572197|NCT00090779|616440841|FG000|Step 2|Off study per study closure|6|||
170572198|NCT00090779|616440842|FG001|Step 2|Off study per study closure|16|||
170572199|NCT00090779|616440841|FG000|Step 2|Subject relocated|0|||
170572200|NCT00090779|616440842|FG001|Step 2|Subject relocated|1|||
170572201|NCT00090779|616440841|FG000|Step 2|Non-compliance to study requirements|0|||
170572202|NCT00090779|616440842|FG001|Step 2|Non-compliance to study requirements|1|||
170572203|NCT00090779|616440841|FG000|Step 3|Initiation of ART and off extended study|3|||
170572204|NCT00090779|616440842|FG001|Step 3|Initiation of ART and off extended study|2|||
170572205|NCT00090779|616440841|FG000|Step 3|Off extended study due to study closure|4|||
170572206|NCT00090779|616440842|FG001|Step 3|Off extended study due to study closure|3|||
170572207|NCT01925768|616440847|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
170572208|NCT01925768|616440848|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170572209|NCT01925768|616440847|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
170572210|NCT01925768|616440848|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
170572211|NCT01925768|616440847|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
170572212|NCT01925768|616440848|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
170572213|NCT01925768|616440847|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
170572214|NCT01925768|616440848|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
170572215|NCT01925768|616440847|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
170808555|NCT03626662|617308928|FG008|Overall Study|Lost to Follow-up|0|||
170808556|NCT03626662|617308929|FG009|Overall Study|Lost to Follow-up|0|||
170808557|NCT02919683|617308931|FG000|Post-Surgery Follow-Up|Death|2|||
170808558|NCT02919683|617308932|FG001|Post-Surgery Follow-Up|Death|2|||
170808559|NCT02919683|617308931|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
170808560|NCT02919683|617308932|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
170572216|NCT01925768|616440848|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
170572217|NCT01925768|616440847|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
170572218|NCT01925768|616440848|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
170572219|NCT01925768|616440847|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
170572220|NCT01925768|616440848|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
170572221|NCT01925768|616440847|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
170572222|NCT01925768|616440848|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
170572223|NCT01925768|616440847|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
170808561|NCT00249769|617308933|FG000|Overall Study|Withdrawal by Subject|1|||
170572224|NCT01925768|616440848|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
170572225|NCT01925768|616440847|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
170572226|NCT01925768|616440848|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
170572227|NCT01925768|616440847|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
170572228|NCT01925768|616440848|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
170572229|NCT00714948|616440851|FG000|Overall Study|Adverse Event|2|||
170572230|NCT02891226|616440852|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
170572231|NCT02891226|616440853|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
170572232|NCT02891226|616440854|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
170572233|NCT02891226|616440855|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572234|NCT02891226|616440856|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572235|NCT02891226|616440857|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572236|NCT02891226|616440858|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572237|NCT02891226|616440859|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572238|NCT02891226|616440860|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572239|NCT02891226|616440861|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572240|NCT02891226|616440862|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572241|NCT02891226|616440863|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572242|NCT02891226|616440864|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572243|NCT02891226|616440865|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572244|NCT02891226|616440866|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572245|NCT02891226|616440867|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
170572246|NCT02891226|616440852|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
170572247|NCT02891226|616440853|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
170572248|NCT02891226|616440854|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572249|NCT02891226|616440855|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572250|NCT02891226|616440856|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572251|NCT02891226|616440857|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572252|NCT02891226|616440858|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572253|NCT02891226|616440859|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572254|NCT02891226|616440860|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572255|NCT02891226|616440861|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572256|NCT02891226|616440862|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572257|NCT02891226|616440863|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572258|NCT02891226|616440864|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572259|NCT02891226|616440865|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572260|NCT02891226|616440866|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572261|NCT02891226|616440867|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
170572262|NCT02891226|616440852|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572263|NCT02891226|616440853|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572264|NCT02891226|616440854|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572265|NCT02891226|616440855|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
170572266|NCT02891226|616440856|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572267|NCT02891226|616440857|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572268|NCT02891226|616440858|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572269|NCT02891226|616440859|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572270|NCT02891226|616440860|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572271|NCT02891226|616440861|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572272|NCT02891226|616440862|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572273|NCT02891226|616440863|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572274|NCT02891226|616440864|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572275|NCT02891226|616440865|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572276|NCT02891226|616440866|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572277|NCT02891226|616440867|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
170572278|NCT02891226|616440852|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572279|NCT02891226|616440853|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572280|NCT02891226|616440854|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
170572281|NCT02891226|616440855|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572282|NCT02891226|616440856|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572283|NCT02891226|616440857|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572284|NCT02891226|616440858|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572285|NCT02891226|616440859|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572286|NCT02891226|616440860|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572287|NCT02891226|616440861|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572288|NCT02891226|616440862|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572289|NCT02891226|616440863|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572290|NCT02891226|616440864|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572291|NCT02891226|616440865|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572292|NCT02891226|616440866|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170649034|NCT00504582|616729016|FG000|Overall Study|Lost to Follow-up|1|||
170649035|NCT00504582|616729017|FG001|Overall Study|Lost to Follow-up|0|||
170572293|NCT02891226|616440867|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
170572294|NCT02891226|616440852|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572295|NCT02891226|616440853|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572296|NCT02891226|616440854|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572297|NCT02891226|616440855|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
170572298|NCT02891226|616440856|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572299|NCT02891226|616440857|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572300|NCT02891226|616440858|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572301|NCT02891226|616440859|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572302|NCT02891226|616440860|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572303|NCT02891226|616440861|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572304|NCT02891226|616440862|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572305|NCT02891226|616440863|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572306|NCT02891226|616440864|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572307|NCT02891226|616440865|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572308|NCT02891226|616440866|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572309|NCT02891226|616440867|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
170572310|NCT02891226|616440852|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572311|NCT02891226|616440853|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572312|NCT02891226|616440854|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572313|NCT02891226|616440855|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
170572314|NCT02891226|616440856|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572315|NCT02891226|616440857|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572316|NCT02891226|616440858|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572317|NCT02891226|616440859|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572318|NCT02891226|616440860|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572319|NCT02891226|616440861|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572320|NCT02891226|616440862|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572321|NCT02891226|616440863|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572322|NCT02891226|616440864|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572323|NCT02891226|616440865|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572324|NCT02891226|616440866|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572325|NCT02891226|616440867|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
170572326|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572327|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572328|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572329|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572330|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572331|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572332|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
170572333|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
170572334|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
170572335|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
170572336|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572337|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572338|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572339|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572340|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572341|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
170572342|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572343|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572344|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572345|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572346|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572347|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
170572348|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572349|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572350|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572351|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
170572352|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572353|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170649036|NCT00504582|616729018|FG002|Overall Study|Lost to Follow-up|0|||
170572354|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572355|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572356|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572357|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
170572358|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572359|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170649037|NCT01264081|616729019|FG000|Participants Screened|Screening failures|30|||
170572360|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572361|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572362|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572363|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170649038|NCT01264081|616729019|FG000|Started Treatment|Withdrawal by Subject|1|||
170572364|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
170572365|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
170572366|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
170572367|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
170572368|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572369|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572370|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572371|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572372|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572373|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
170572374|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572375|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572376|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572377|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572378|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
170572379|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572380|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572381|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572382|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572383|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572384|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572385|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572386|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572387|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572388|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572389|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
170572390|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572391|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572392|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572393|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572394|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572395|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572396|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
170572397|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572398|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572399|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572400|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572401|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572402|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572403|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572404|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572405|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
170572406|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572407|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572408|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572409|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572410|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572411|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572412|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572413|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
170572414|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
170572415|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
170572416|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572417|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572418|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572419|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572420|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572421|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
170572422|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170649039|NCT01264081|616729019|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
170649040|NCT02716896|616729020|FG000|Overall Study|Physician Decision|0|||
170649041|NCT02716896|616729021|FG001|Overall Study|Physician Decision|1|||
170649042|NCT02054481|616729024|FG000|Overall Study|Adverse Event|1|||
170649043|NCT02054481|616729025|FG001|Overall Study|Adverse Event|1|||
170649044|NCT02054481|616729026|FG002|Overall Study|Adverse Event|0|||
170572423|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572424|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572425|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572426|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572427|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572428|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572429|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
170572430|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572431|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572432|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572433|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572434|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572435|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572436|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572437|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
170572438|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572439|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572440|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572441|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572442|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572443|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572444|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572445|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572446|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
170572447|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572448|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572449|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572450|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572451|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572452|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572453|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
170572454|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572455|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572456|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572457|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572458|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572459|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572460|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572461|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572462|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572463|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
170572464|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572465|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170649045|NCT02054481|616729027|FG003|Overall Study|Adverse Event|1|||
170649046|NCT02054481|616729024|FG000|Overall Study|Lost to Follow-up|1|||
170572466|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572467|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572468|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572469|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
170572470|NCT02891226|616440852|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572471|NCT02891226|616440853|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572472|NCT02891226|616440854|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572473|NCT02891226|616440855|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572474|NCT02891226|616440856|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572475|NCT02891226|616440857|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170649047|NCT02054481|616729025|FG001|Overall Study|Lost to Follow-up|0|||
170649048|NCT02054481|616729026|FG002|Overall Study|Lost to Follow-up|0|||
170649049|NCT02054481|616729027|FG003|Overall Study|Lost to Follow-up|0|||
170649050|NCT02054481|616729024|FG000|Overall Study|Other reason|2|||
170649051|NCT02054481|616729025|FG001|Overall Study|Other reason|1|||
170649052|NCT02054481|616729026|FG002|Overall Study|Other reason|2|||
170649053|NCT02054481|616729027|FG003|Overall Study|Other reason|0|||
170649054|NCT02320903|616729028|FG000|Overall Study|Withdrawal by Subject|0|||
170649055|NCT02320903|616729029|FG001|Overall Study|Withdrawal by Subject|9|||
170572476|NCT02891226|616440858|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572477|NCT02891226|616440859|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572478|NCT02891226|616440860|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572479|NCT02891226|616440861|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
170572480|NCT02891226|616440862|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572481|NCT02891226|616440863|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572482|NCT02891226|616440864|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572483|NCT02891226|616440865|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572484|NCT02891226|616440866|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572485|NCT02891226|616440867|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
170572486|NCT02891226|616440852|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572487|NCT02891226|616440853|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572488|NCT02891226|616440854|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572489|NCT02891226|616440855|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572490|NCT02891226|616440856|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572491|NCT02891226|616440857|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572492|NCT02891226|616440858|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572493|NCT02891226|616440859|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572494|NCT02891226|616440860|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572495|NCT02891226|616440861|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572496|NCT02891226|616440862|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
170572497|NCT02891226|616440863|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572498|NCT02891226|616440864|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572499|NCT02891226|616440865|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572500|NCT02891226|616440866|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572501|NCT02891226|616440867|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
170572502|NCT02891226|616440852|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572503|NCT02891226|616440853|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572504|NCT02891226|616440854|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572505|NCT02891226|616440855|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572506|NCT02891226|616440856|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572507|NCT02891226|616440857|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572508|NCT02891226|616440858|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572509|NCT02891226|616440859|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572510|NCT02891226|616440860|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572511|NCT02891226|616440861|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572512|NCT02891226|616440862|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
170572513|NCT02891226|616440863|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572514|NCT02891226|616440864|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572515|NCT02891226|616440865|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572516|NCT02891226|616440866|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572517|NCT02891226|616440867|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
170572518|NCT02891226|616440852|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572519|NCT02891226|616440853|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572520|NCT02891226|616440854|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572521|NCT02891226|616440855|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572522|NCT02891226|616440856|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572523|NCT02891226|616440857|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572524|NCT02891226|616440858|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572525|NCT02891226|616440859|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170649056|NCT02320903|616729030|FG002|Overall Study|Withdrawal by Subject|9|||
170649057|NCT02320903|616729028|FG000|Overall Study|Exited therapy; no longer eligible|8|||
170649058|NCT02320903|616729029|FG001|Overall Study|Exited therapy; no longer eligible|2|||
170649059|NCT02320903|616729030|FG002|Overall Study|Exited therapy; no longer eligible|2|||
170649060|NCT02320903|616729028|FG000|Overall Study|Lost to Follow-up|0|||
170649061|NCT02320903|616729029|FG001|Overall Study|Lost to Follow-up|5|||
170649062|NCT02320903|616729030|FG002|Overall Study|Lost to Follow-up|5|||
170649063|NCT01012219|616729031|FG000|Period 1|Withdrawal by Subject|1|||
170649064|NCT01012219|616729031|FG000|Period 2|Withdrawal by Subject|1|||
170649065|NCT03188042|616729048|FG000|Overall Study|Withdrawal by Subject|1|||
170649066|NCT03188042|616729049|FG001|Overall Study|Withdrawal by Subject|1|||
170649067|NCT01328366|616729053|FG000|Overall Study|Death|1|||
170649068|NCT01328366|616729053|FG000|Overall Study|Withdrawal by Subject|2|||
170649069|NCT01328366|616729053|FG000|Overall Study|Lost to Follow-up|7|||
170572526|NCT02891226|616440860|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572527|NCT02891226|616440861|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572528|NCT02891226|616440862|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
170572529|NCT02891226|616440863|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572530|NCT02891226|616440864|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572531|NCT02891226|616440865|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170649070|NCT00137839|616729057|FG000|Overall Study|Adverse Event|7|||
170649071|NCT00137839|616729057|FG000|Overall Study|Physician Decision|7|||
170649072|NCT00137839|616729057|FG000|Overall Study|Death|8|||
170572532|NCT02891226|616440866|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572533|NCT02891226|616440867|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
170572534|NCT02891226|616440852|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572535|NCT02891226|616440853|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572536|NCT02891226|616440854|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572537|NCT02891226|616440855|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572538|NCT02891226|616440856|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572539|NCT02891226|616440857|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572540|NCT02891226|616440858|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572541|NCT02891226|616440859|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572542|NCT02891226|616440860|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572543|NCT02891226|616440861|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572544|NCT02891226|616440862|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
170572545|NCT02891226|616440863|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572546|NCT02891226|616440864|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572547|NCT02891226|616440865|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572548|NCT02891226|616440866|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572549|NCT02891226|616440867|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
170572550|NCT02891226|616440852|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572551|NCT02891226|616440853|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572552|NCT02891226|616440854|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572553|NCT02891226|616440855|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572554|NCT02891226|616440856|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572555|NCT02891226|616440857|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572556|NCT02891226|616440858|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572557|NCT02891226|616440859|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572558|NCT02891226|616440860|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572559|NCT02891226|616440861|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572560|NCT02891226|616440862|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
170572561|NCT02891226|616440863|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572562|NCT02891226|616440864|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572563|NCT02891226|616440865|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572564|NCT02891226|616440866|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572565|NCT02891226|616440867|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
170572566|NCT02891226|616440852|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572567|NCT02891226|616440853|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572568|NCT02891226|616440854|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572569|NCT02891226|616440855|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572570|NCT02891226|616440856|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572571|NCT02891226|616440857|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572572|NCT02891226|616440858|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572573|NCT02891226|616440859|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572574|NCT02891226|616440860|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572575|NCT02891226|616440861|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572576|NCT02891226|616440862|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
170572577|NCT02891226|616440863|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572578|NCT02891226|616440864|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572579|NCT02891226|616440865|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572580|NCT02891226|616440866|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572581|NCT02891226|616440867|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
170572582|NCT02891226|616440852|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572583|NCT02891226|616440853|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572584|NCT02891226|616440854|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170649073|NCT00137839|616729057|FG000|Overall Study|Disease Progression|60|||
170808562|NCT00249769|617308934|FG001|Overall Study|Withdrawal by Subject|10|||
170808563|NCT00249769|617308935|FG002|Overall Study|Withdrawal by Subject|6|||
170808564|NCT00249769|617308933|FG000|Overall Study|Migration from Study Area|1|||
170808565|NCT00249769|617308934|FG001|Overall Study|Migration from Study Area|3|||
170808566|NCT00249769|617308935|FG002|Overall Study|Migration from Study Area|14|||
170808567|NCT00249769|617308933|FG000|Overall Study|Miscellaneous|0|||
170808568|NCT00249769|617308934|FG001|Overall Study|Miscellaneous|2|||
170808569|NCT00249769|617308935|FG002|Overall Study|Miscellaneous|2|||
170808570|NCT00249769|617308933|FG000|Overall Study|Adverse Event|0|||
170808571|NCT00249769|617308934|FG001|Overall Study|Adverse Event|0|||
170649074|NCT00137839|616729057|FG000|Overall Study|Not Start Treatment|1|||
170649075|NCT00137839|616729057|FG000|Overall Study|Prolonged Treatment Delay|1|||
170649076|NCT03860935|616729064|FG000|Overall Study|Withdrawal of Consent|15|||
170572585|NCT02891226|616440855|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572586|NCT02891226|616440856|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572587|NCT02891226|616440857|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572588|NCT02891226|616440858|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572589|NCT02891226|616440859|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572590|NCT02891226|616440860|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572591|NCT02891226|616440861|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572592|NCT02891226|616440862|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
170572593|NCT02891226|616440863|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572594|NCT02891226|616440864|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572595|NCT02891226|616440865|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572596|NCT02891226|616440866|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572597|NCT02891226|616440867|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
170572598|NCT02891226|616440852|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572599|NCT02891226|616440853|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572600|NCT02891226|616440854|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572601|NCT02891226|616440855|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572602|NCT02891226|616440856|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572603|NCT02891226|616440857|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572604|NCT02891226|616440858|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572605|NCT02891226|616440859|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572606|NCT02891226|616440860|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572607|NCT02891226|616440861|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572608|NCT02891226|616440862|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
170572609|NCT02891226|616440863|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572610|NCT02891226|616440864|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572611|NCT02891226|616440865|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572612|NCT02891226|616440866|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572613|NCT02891226|616440867|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
170572614|NCT02891226|616440852|FG000|Follow-up Period|Withdrawal by Subject|0|||
170572615|NCT02891226|616440853|FG001|Follow-up Period|Withdrawal by Subject|0|||
170572616|NCT02891226|616440854|FG002|Follow-up Period|Withdrawal by Subject|0|||
170572617|NCT02891226|616440855|FG003|Follow-up Period|Withdrawal by Subject|0|||
170572618|NCT02891226|616440856|FG004|Follow-up Period|Withdrawal by Subject|0|||
170572619|NCT02891226|616440857|FG005|Follow-up Period|Withdrawal by Subject|0|||
170572620|NCT02891226|616440858|FG006|Follow-up Period|Withdrawal by Subject|0|||
170572621|NCT02891226|616440859|FG007|Follow-up Period|Withdrawal by Subject|0|||
170572622|NCT02891226|616440860|FG008|Follow-up Period|Withdrawal by Subject|0|||
170572623|NCT02891226|616440861|FG009|Follow-up Period|Withdrawal by Subject|0|||
170572624|NCT02891226|616440862|FG010|Follow-up Period|Withdrawal by Subject|0|||
170572625|NCT02891226|616440863|FG011|Follow-up Period|Withdrawal by Subject|1|||
170572626|NCT02891226|616440864|FG012|Follow-up Period|Withdrawal by Subject|0|||
170572627|NCT02891226|616440865|FG013|Follow-up Period|Withdrawal by Subject|0|||
170572628|NCT02891226|616440866|FG014|Follow-up Period|Withdrawal by Subject|1|||
170572629|NCT02891226|616440867|FG015|Follow-up Period|Withdrawal by Subject|1|||
170572630|NCT01085214|616440868|FG000|Overall Study|Alternate treatment required|1|||
170572631|NCT01152437|616440882|FG000|Overall Study|Other Adverse Event|8|||
170572632|NCT01152437|616440883|FG001|Overall Study|Other Adverse Event|1|||
170572633|NCT01152437|616440884|FG002|Overall Study|Other Adverse Event|7|||
170572634|NCT01152437|616440882|FG000|Overall Study|Not treated|0|||
170572635|NCT01152437|616440883|FG001|Overall Study|Not treated|1|||
170572636|NCT01152437|616440884|FG002|Overall Study|Not treated|2|||
170572637|NCT01152437|616440882|FG000|Overall Study|Progressive disease|27|||
170572638|NCT01152437|616440883|FG001|Overall Study|Progressive disease|13|||
170572639|NCT01152437|616440884|FG002|Overall Study|Progressive disease|32|||
170649077|NCT03860935|616729065|FG001|Overall Study|Withdrawal of Consent|6|||
170649078|NCT03860935|616729064|FG000|Overall Study|Death|75|||
170572640|NCT01152437|616440882|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
170649079|NCT03860935|616729065|FG001|Overall Study|Death|51|||
170649080|NCT03739242|616729071|FG000|Overall Study|Withdrawal by Subject|1|||
170649081|NCT03739242|616729072|FG001|Overall Study|Withdrawal by Subject|1|||
170649082|NCT03739242|616729071|FG000|Overall Study|Protocol Violation|0|||
170649083|NCT03739242|616729072|FG001|Overall Study|Protocol Violation|1|||
170649084|NCT01122394|616729073|FG000|Overall Study|Withdrawal by Subject|1|||
170572641|NCT01152437|616440883|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
170572642|NCT01152437|616440884|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
170572643|NCT01985022|616440885|FG000|Overall Study|Lost to Follow-up|0|||
170572644|NCT01985022|616440886|FG001|Overall Study|Lost to Follow-up|1|||
170572645|NCT01985022|616440885|FG000|Overall Study|Protocol Violation|0|||
170572646|NCT01985022|616440886|FG001|Overall Study|Protocol Violation|1|||
170572647|NCT01985022|616440885|FG000|Overall Study|Withdrawal by Subject|4|||
170572648|NCT01985022|616440886|FG001|Overall Study|Withdrawal by Subject|1|||
170572649|NCT02015039|616440887|FG000|Overall Study|Not eligible|0|||
170572650|NCT02015039|616440888|FG001|Overall Study|Not eligible|1|||
170572651|NCT04570384|616440889|FG000|Overall Study|Adverse Event|2|||
170572652|NCT04570384|616440890|FG001|Overall Study|Adverse Event|1|||
170572653|NCT04570384|616440889|FG000|Overall Study|Death|2|||
170572654|NCT04570384|616440890|FG001|Overall Study|Death|5|||
170572655|NCT04570384|616440889|FG000|Overall Study|Lost to Follow-up|1|||
170572656|NCT04570384|616440890|FG001|Overall Study|Lost to Follow-up|0|||
170572657|NCT04570384|616440889|FG000|Overall Study|Other|1|||
170572658|NCT04570384|616440890|FG001|Overall Study|Other|0|||
170572659|NCT04570384|616440889|FG000|Overall Study|Protocol Violation|0|||
170572660|NCT04570384|616440890|FG001|Overall Study|Protocol Violation|1|||
170572661|NCT04570384|616440889|FG000|Overall Study|Sponsor Decision|1|||
170572662|NCT04570384|616440890|FG001|Overall Study|Sponsor Decision|0|||
170572663|NCT04570384|616440889|FG000|Overall Study|Withdrawal by Subject|4|||
170572664|NCT04570384|616440890|FG001|Overall Study|Withdrawal by Subject|2|||
170572665|NCT01673126|616440891|FG000|Overall Study|change of diagnosis|4|||
170572666|NCT01673126|616440892|FG001|Overall Study|change of diagnosis|3|||
170572667|NCT00237042|616440895|FG000|Treatment|Became ineligible post-randomization|0|||
170572668|NCT00237042|616440896|FG001|Treatment|Became ineligible post-randomization|1|||
170649085|NCT01122394|616729074|FG001|Overall Study|Withdrawal by Subject|1|||
170649086|NCT01122394|616729073|FG000|Overall Study|Lost to Follow-up|2|||
170808572|NCT00249769|617308935|FG002|Overall Study|Adverse Event|1|||
170808573|NCT00249769|617308933|FG000|Overall Study|Physician Decision|0|||
170808574|NCT00249769|617308934|FG001|Overall Study|Physician Decision|0|||
170808575|NCT00249769|617308935|FG002|Overall Study|Physician Decision|2|||
170808576|NCT00249769|617308933|FG000|Overall Study|Lost to Follow-up|0|||
170808577|NCT00249769|617308934|FG001|Overall Study|Lost to Follow-up|0|||
170808578|NCT00249769|617308935|FG002|Overall Study|Lost to Follow-up|3|||
170808579|NCT00795184|617308938|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
170808580|NCT00795184|617308939|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
170808581|NCT01530334|617308940|FG000|Overall Study|Adverse Event|3|||
170808582|NCT01530334|617308940|FG000|Overall Study|unknown reason|1|||
170808583|NCT01530334|617308940|FG000|Overall Study|Progressive disease|47|||
170808584|NCT01303510|617308941|FG000|Overall Study|Lost to Follow-up|1|||
170808585|NCT01303510|617308942|FG001|Overall Study|Lost to Follow-up|0|||
170808586|NCT00822900|617308945|FG000|Overall Study|Withdrawal by Subject|14|||
170808587|NCT00822900|617308946|FG001|Overall Study|Withdrawal by Subject|14|||
170808588|NCT00822900|617308945|FG000|Overall Study|Lost to Follow-up|9|||
170808589|NCT00822900|617308946|FG001|Overall Study|Lost to Follow-up|9|||
170808590|NCT00822900|617308945|FG000|Overall Study|Death|83|||
170808591|NCT00822900|617308946|FG001|Overall Study|Death|69|||
170808592|NCT00822900|617308945|FG000|Overall Study|Became a ward of the state|2|||
170808593|NCT00822900|617308946|FG001|Overall Study|Became a ward of the state|1|||
170808594|NCT01638000|617308947|FG000|Overall Study|Randomized but Never Received Drug|7|||
170808595|NCT01638000|617308948|FG001|Overall Study|Randomized but Never Received Drug|10|||
170808596|NCT01638000|617308947|FG000|Overall Study|Adverse Event|14|||
170808597|NCT01638000|617308948|FG001|Overall Study|Adverse Event|16|||
170808598|NCT01638000|617308947|FG000|Overall Study|Lack of Efficacy|5|||
170808599|NCT01638000|617308948|FG001|Overall Study|Lack of Efficacy|6|||
170808600|NCT01638000|617308947|FG000|Overall Study|Protocol Violation|11|||
170808601|NCT01638000|617308948|FG001|Overall Study|Protocol Violation|13|||
170808602|NCT01638000|617308947|FG000|Overall Study|Withdrawal by Subject|21|||
170808603|NCT01638000|617308948|FG001|Overall Study|Withdrawal by Subject|24|||
170808604|NCT01638000|617308947|FG000|Overall Study|Miscellaneous|2|||
170808605|NCT01638000|617308948|FG001|Overall Study|Miscellaneous|2|||
170808606|NCT04566445|617308949|FG000|Overall Study|Death|4|||
170808607|NCT04566445|617308950|FG001|Overall Study|Death|1|||
170808608|NCT04566445|617308951|FG002|Overall Study|Death|1|||
170572669|NCT00237042|616440897|FG002|Treatment|Became ineligible post-randomization|16|||
170572670|NCT00237042|616440895|FG000|Treatment|Moved out of state|1|||
170572671|NCT00237042|616440896|FG001|Treatment|Moved out of state|1|||
170572672|NCT00237042|616440897|FG002|Treatment|Moved out of state|1|||
170572673|NCT00237042|616440895|FG000|Treatment|Completed no treatment|5|||
170808609|NCT04566445|617308949|FG000|Overall Study|Lost to Follow-up|3|||
170808610|NCT04566445|617308950|FG001|Overall Study|Lost to Follow-up|1|||
170572674|NCT00237042|616440896|FG001|Treatment|Completed no treatment|5|||
170572675|NCT00237042|616440897|FG002|Treatment|Completed no treatment|21|||
170808611|NCT04566445|617308951|FG002|Overall Study|Lost to Follow-up|1|||
170808612|NCT04566445|617308949|FG000|Overall Study|Study terminated by sponsor|11|||
170808613|NCT04566445|617308950|FG001|Overall Study|Study terminated by sponsor|17|||
170572676|NCT00237042|616440895|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
170572677|NCT00237042|616440896|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
170572678|NCT00237042|616440897|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
170572679|NCT00237042|616440895|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
170572680|NCT00237042|616440896|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
170572681|NCT00237042|616440897|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
170572682|NCT01913327|616440904|FG000|Overall Study|Withdrawal by Subject|0|||
170572683|NCT01913327|616440905|FG001|Overall Study|Withdrawal by Subject|1|||
170572684|NCT02151786|616440907|FG000|Overall Study|Unavailability of Case Report Form|26|||
170572685|NCT02151786|616440907|FG000|Overall Study|Outside the Contract Period|1|||
170572686|NCT02151786|616440907|FG000|Overall Study|Randomized, not Treated|1|||
170572687|NCT02151786|616440907|FG000|Overall Study|Unavailability of Information|8|||
170572688|NCT03761056|616440911|FG000|Overall Study|Death|8|||
170572689|NCT03761056|616440911|FG000|Overall Study|Enrolled but never treated|2|||
170572690|NCT03761056|616440911|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
170572691|NCT03761056|616440911|FG000|Overall Study|Investigator decision|1|||
170572692|NCT00996658|616440912|FG000|Overall Study|Adverse Event|2|||
170572693|NCT00996658|616440913|FG001|Overall Study|Adverse Event|5|||
170572694|NCT00996658|616440912|FG000|Overall Study|Protocol Violation|0|||
170572695|NCT00996658|616440913|FG001|Overall Study|Protocol Violation|1|||
170572696|NCT00996658|616440912|FG000|Overall Study|Lost to Follow-up|2|||
170572697|NCT00996658|616440913|FG001|Overall Study|Lost to Follow-up|5|||
170572698|NCT00996658|616440912|FG000|Overall Study|Non-compliance issues|3|||
170572699|NCT00996658|616440913|FG001|Overall Study|Non-compliance issues|3|||
170572700|NCT00996658|616440912|FG000|Overall Study|Other|9|||
170572701|NCT00996658|616440913|FG001|Overall Study|Other|7|||
170649087|NCT01122394|616729074|FG001|Overall Study|Lost to Follow-up|2|||
170649088|NCT01122394|616729073|FG000|Overall Study|Adverse Event|0|||
170649089|NCT01122394|616729074|FG001|Overall Study|Adverse Event|1|||
170649090|NCT02446743|616729075|FG000|Overall Study|Withdrawal by Subject|1|||
170649091|NCT02446743|616729076|FG001|Overall Study|Withdrawal by Subject|1|||
170649092|NCT02446743|616729075|FG000|Overall Study|Lost to Follow-up|1|||
170649093|NCT02446743|616729076|FG001|Overall Study|Lost to Follow-up|0|||
170649094|NCT02446743|616729075|FG000|Overall Study|Adverse Event|1|||
170649095|NCT02446743|616729076|FG001|Overall Study|Adverse Event|1|||
170649096|NCT02446743|616729075|FG000|Overall Study|Other|2|||
170649097|NCT02446743|616729076|FG001|Overall Study|Other|3|||
170649098|NCT01363349|616729077|FG000|Overall Study|Adverse Event|6|||
170649099|NCT01363349|616729078|FG001|Overall Study|Adverse Event|7|||
170649100|NCT01363349|616729077|FG000|Overall Study|Lack of Efficacy|3|||
170649101|NCT01363349|616729078|FG001|Overall Study|Lack of Efficacy|10|||
170649102|NCT01363349|616729077|FG000|Overall Study|Non compliance/Protocol deviations|2|||
170649103|NCT01363349|616729078|FG001|Overall Study|Non compliance/Protocol deviations|2|||
170649104|NCT01363349|616729077|FG000|Overall Study|Withdrawal by Subject|14|||
170649105|NCT01363349|616729078|FG001|Overall Study|Withdrawal by Subject|6|||
170649106|NCT01363349|616729077|FG000|Overall Study|Lost to Follow-up|5|||
170649107|NCT01363349|616729078|FG001|Overall Study|Lost to Follow-up|6|||
170649108|NCT01363349|616729077|FG000|Overall Study|Not reported|36|||
170649109|NCT01363349|616729078|FG001|Overall Study|Not reported|37|||
170649110|NCT01363349|616729077|FG000|Overall Study|missing|1|||
170649111|NCT01363349|616729078|FG001|Overall Study|missing|2|||
170649112|NCT00045942|616729079|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
170649113|NCT00045942|616729080|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
170649114|NCT00045942|616729081|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
170649115|NCT00045942|616729082|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
170649116|NCT00045942|616729083|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
170649117|NCT00045942|616729084|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
170649118|NCT00045942|616729085|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
170649119|NCT00045942|616729086|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
170649120|NCT00045942|616729087|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
170649121|NCT00045942|616729079|FG000|PKC412A2104 (Core)|Adverse Event|5|||
170649122|NCT00045942|616729080|FG001|PKC412A2104 (Core)|Adverse Event|0|||
170649123|NCT00045942|616729081|FG002|PKC412A2104 (Core)|Adverse Event|0|||
170649124|NCT00045942|616729082|FG003|PKC412A2104 (Core)|Adverse Event|0|||
170649125|NCT00045942|616729083|FG004|PKC412A2104 (Core)|Adverse Event|0|||
170649126|NCT00045942|616729084|FG005|PKC412A2104 (Core)|Adverse Event|0|||
170649127|NCT00045942|616729085|FG006|PKC412A2104 (Core)|Adverse Event|0|||
170649128|NCT00045942|616729086|FG007|PKC412A2104 (Core)|Adverse Event|0|||
170649129|NCT00045942|616729087|FG008|PKC412A2104 (Core)|Adverse Event|0|||
170649130|NCT00045942|616729079|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
170649131|NCT00045942|616729080|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
170649132|NCT00045942|616729081|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
170649133|NCT00045942|616729082|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
170649134|NCT00045942|616729083|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
170649135|NCT00045942|616729084|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
170649136|NCT00045942|616729085|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
170649137|NCT00045942|616729086|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
170572702|NCT01142388|616443269|FG000|Overall Study|Lack of Efficacy|21|||
170572703|NCT01142388|616443270|FG001|Overall Study|Lack of Efficacy|31|||
170572704|NCT01142388|616443269|FG000|Overall Study|Adverse Event|9|||
170572705|NCT01142388|616443270|FG001|Overall Study|Adverse Event|5|||
170572706|NCT01142388|616443269|FG000|Overall Study|Death|3|||
170572707|NCT01142388|616443270|FG001|Overall Study|Death|2|||
170572708|NCT01142388|616443269|FG000|Overall Study|Withdrawal by Subject|5|||
170572709|NCT01142388|616443270|FG001|Overall Study|Withdrawal by Subject|3|||
170572710|NCT01142388|616443269|FG000|Overall Study|Alternative therapy|1|||
170572711|NCT01142388|616443270|FG001|Overall Study|Alternative therapy|0|||
170572712|NCT01142388|616443269|FG000|Overall Study|Other complications|0|||
170572713|NCT01142388|616443270|FG001|Overall Study|Other complications|2|||
170572714|NCT01142388|616443269|FG000|Overall Study|Other|1|||
170572715|NCT01142388|616443270|FG001|Overall Study|Other|1|||
170572716|NCT01142388|616443269|FG000|Overall Study|Never started therapy|7|||
170572717|NCT01142388|616443270|FG001|Overall Study|Never started therapy|3|||
170572718|NCT03493451|616443276|FG000|Overall Study|Death|11|||
170572719|NCT03493451|616443277|FG001|Overall Study|Death|26|||
170572720|NCT03493451|616443278|FG002|Overall Study|Death|3|||
170572721|NCT03493451|616443276|FG000|Overall Study|Lost to Follow-up|1|||
170572722|NCT03493451|616443277|FG001|Overall Study|Lost to Follow-up|4|||
170572723|NCT03493451|616443278|FG002|Overall Study|Lost to Follow-up|1|||
170572724|NCT03493451|616443276|FG000|Overall Study|Withdrawal by Subject|1|||
170572725|NCT03493451|616443277|FG001|Overall Study|Withdrawal by Subject|1|||
170572726|NCT03493451|616443278|FG002|Overall Study|Withdrawal by Subject|2|||
170572727|NCT03493451|616443276|FG000|Overall Study|Progressive Disease|1|||
170572728|NCT03493451|616443277|FG001|Overall Study|Progressive Disease|0|||
170572729|NCT03493451|616443278|FG002|Overall Study|Progressive Disease|0|||
170572730|NCT03493451|616443276|FG000|Overall Study|Transferred to long term extension study|8|||
170572731|NCT03493451|616443277|FG001|Overall Study|Transferred to long term extension study|13|||
170572732|NCT03493451|616443278|FG002|Overall Study|Transferred to long term extension study|5|||
170572733|NCT01133756|616443279|FG000|Overall Study|Adverse Event|1|||
170572734|NCT01133756|616443280|FG001|Overall Study|Adverse Event|2|||
170572735|NCT01133756|616443281|FG002|Overall Study|Adverse Event|1|||
170572736|NCT01133756|616443279|FG000|Overall Study|Investigator Decision|1|||
170649138|NCT00045942|616729087|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
170649139|NCT00045942|616729079|FG000|PKC412A2104 (Core)|Death|1|||
170649140|NCT00045942|616729080|FG001|PKC412A2104 (Core)|Death|0|||
170649141|NCT00045942|616729081|FG002|PKC412A2104 (Core)|Death|0|||
170649142|NCT00045942|616729082|FG003|PKC412A2104 (Core)|Death|0|||
170649143|NCT00045942|616729083|FG004|PKC412A2104 (Core)|Death|0|||
170649144|NCT00045942|616729084|FG005|PKC412A2104 (Core)|Death|0|||
170649145|NCT00045942|616729085|FG006|PKC412A2104 (Core)|Death|0|||
170649146|NCT00045942|616729086|FG007|PKC412A2104 (Core)|Death|0|||
170649147|NCT00045942|616729087|FG008|PKC412A2104 (Core)|Death|0|||
170649148|NCT00045942|616729079|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
170649149|NCT00045942|616729080|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
170649150|NCT00045942|616729081|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
170649151|NCT00045942|616729082|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
170649152|NCT00045942|616729083|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
170649153|NCT00045942|616729084|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
170649154|NCT00045942|616729085|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
170649155|NCT00045942|616729086|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
170649156|NCT00045942|616729087|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
170649157|NCT00045942|616729079|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
170649158|NCT00045942|616729080|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
170649159|NCT00045942|616729081|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
170649160|NCT00045942|616729082|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
170649161|NCT00045942|616729083|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
170649162|NCT00045942|616729084|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
170649163|NCT00045942|616729085|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
170649164|NCT00045942|616729086|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
170649165|NCT00045942|616729087|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
170649166|NCT00045942|616729079|FG000|PKC412A2104E1|Lack of Efficacy|0|||
170649167|NCT00045942|616729080|FG001|PKC412A2104E1|Lack of Efficacy|11|||
170649168|NCT00045942|616729081|FG002|PKC412A2104E1|Lack of Efficacy|11|||
170649169|NCT00045942|616729082|FG003|PKC412A2104E1|Lack of Efficacy|23|||
170572737|NCT01133756|616443280|FG001|Overall Study|Investigator Decision|0|||
170572738|NCT01133756|616443281|FG002|Overall Study|Investigator Decision|0|||
170649170|NCT00045942|616729083|FG004|PKC412A2104E1|Lack of Efficacy|17|||
170572739|NCT01133756|616443279|FG000|Overall Study|Withdrawal by Subject|0|||
170572740|NCT01133756|616443280|FG001|Overall Study|Withdrawal by Subject|1|||
170572741|NCT01133756|616443281|FG002|Overall Study|Withdrawal by Subject|0|||
170572742|NCT01133756|616443279|FG000|Overall Study|Progression of Disease|0|||
170572743|NCT01133756|616443280|FG001|Overall Study|Progression of Disease|0|||
170572744|NCT01133756|616443281|FG002|Overall Study|Progression of Disease|1|||
170572745|NCT03718325|616443285|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
170572746|NCT03718325|616443286|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
170572747|NCT03718325|616443287|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
170572748|NCT03718325|616443285|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
170572749|NCT03718325|616443286|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
170572750|NCT03718325|616443287|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
170572751|NCT03687957|616443288|FG000|Overall Study|Withdrawal by Subject|0|||
170572752|NCT03687957|616443289|FG001|Overall Study|Withdrawal by Subject|0|||
170572753|NCT03687957|616443290|FG002|Overall Study|Withdrawal by Subject|0|||
170572754|NCT03687957|616443291|FG003|Overall Study|Withdrawal by Subject|2|||
170572755|NCT03687957|616443292|FG004|Overall Study|Withdrawal by Subject|0|||
170572756|NCT03687957|616443293|FG005|Overall Study|Withdrawal by Subject|0|||
170572757|NCT03687957|616443294|FG006|Overall Study|Withdrawal by Subject|3|||
170572758|NCT03687957|616443295|FG007|Overall Study|Withdrawal by Subject|1|||
170572759|NCT03687957|616443296|FG008|Overall Study|Withdrawal by Subject|1|||
170572760|NCT03687957|616443297|FG009|Overall Study|Withdrawal by Subject|0|||
170572761|NCT03687957|616443288|FG000|Overall Study|Disease progression|0|||
170572762|NCT03687957|616443289|FG001|Overall Study|Disease progression|1|||
170572763|NCT03687957|616443290|FG002|Overall Study|Disease progression|1|||
170572764|NCT03687957|616443291|FG003|Overall Study|Disease progression|2|||
170572765|NCT03687957|616443292|FG004|Overall Study|Disease progression|2|||
170572766|NCT03687957|616443293|FG005|Overall Study|Disease progression|0|||
170572767|NCT03687957|616443294|FG006|Overall Study|Disease progression|2|||
170572768|NCT03687957|616443295|FG007|Overall Study|Disease progression|1|||
170572769|NCT03687957|616443296|FG008|Overall Study|Disease progression|0|||
170572770|NCT03687957|616443297|FG009|Overall Study|Disease progression|0|||
170572771|NCT03687957|616443288|FG000|Overall Study|Physician Decision|0|||
170572772|NCT03687957|616443289|FG001|Overall Study|Physician Decision|0|||
170572773|NCT03687957|616443290|FG002|Overall Study|Physician Decision|0|||
170572774|NCT03687957|616443291|FG003|Overall Study|Physician Decision|2|||
170572775|NCT03687957|616443292|FG004|Overall Study|Physician Decision|1|||
170572776|NCT03687957|616443293|FG005|Overall Study|Physician Decision|0|||
170572777|NCT03687957|616443294|FG006|Overall Study|Physician Decision|1|||
170572778|NCT03687957|616443295|FG007|Overall Study|Physician Decision|0|||
170572779|NCT03687957|616443296|FG008|Overall Study|Physician Decision|0|||
170572780|NCT03687957|616443297|FG009|Overall Study|Physician Decision|0|||
170572781|NCT03687957|616443288|FG000|Overall Study|New malignancy|0|||
170572782|NCT03687957|616443289|FG001|Overall Study|New malignancy|0|||
170572783|NCT03687957|616443290|FG002|Overall Study|New malignancy|0|||
170572784|NCT03687957|616443291|FG003|Overall Study|New malignancy|0|||
170572785|NCT03687957|616443292|FG004|Overall Study|New malignancy|1|||
170572786|NCT03687957|616443293|FG005|Overall Study|New malignancy|0|||
170572787|NCT03687957|616443294|FG006|Overall Study|New malignancy|0|||
170649171|NCT00045942|616729084|FG005|PKC412A2104E1|Lack of Efficacy|0|||
170649172|NCT00045942|616729085|FG006|PKC412A2104E1|Lack of Efficacy|0|||
170649173|NCT00045942|616729086|FG007|PKC412A2104E1|Lack of Efficacy|0|||
170649174|NCT00045942|616729087|FG008|PKC412A2104E1|Lack of Efficacy|0|||
170649175|NCT00045942|616729079|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
170649176|NCT00045942|616729080|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
170649177|NCT00045942|616729081|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
170649178|NCT00045942|616729082|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
170649179|NCT00045942|616729083|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
170649180|NCT00045942|616729084|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
170649181|NCT00045942|616729085|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
170649182|NCT00045942|616729086|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
170649183|NCT00045942|616729087|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
170649184|NCT00045942|616729079|FG000|PKC412A2104E1|Adverse Event|0|||
170649185|NCT00045942|616729080|FG001|PKC412A2104E1|Adverse Event|1|||
170649186|NCT00045942|616729081|FG002|PKC412A2104E1|Adverse Event|1|||
170649187|NCT00045942|616729082|FG003|PKC412A2104E1|Adverse Event|3|||
170649188|NCT00045942|616729083|FG004|PKC412A2104E1|Adverse Event|6|||
170649189|NCT00045942|616729084|FG005|PKC412A2104E1|Adverse Event|0|||
170572788|NCT03687957|616443295|FG007|Overall Study|New malignancy|0|||
170572789|NCT03687957|616443296|FG008|Overall Study|New malignancy|0|||
170572790|NCT03687957|616443297|FG009|Overall Study|New malignancy|0|||
170572791|NCT03687957|616443288|FG000|Overall Study|Adverse Event|0|||
170572792|NCT03687957|616443289|FG001|Overall Study|Adverse Event|0|||
170572793|NCT03687957|616443290|FG002|Overall Study|Adverse Event|0|||
170572794|NCT03687957|616443291|FG003|Overall Study|Adverse Event|0|||
170649190|NCT00045942|616729085|FG006|PKC412A2104E1|Adverse Event|0|||
170649191|NCT00045942|616729086|FG007|PKC412A2104E1|Adverse Event|0|||
170649192|NCT00045942|616729087|FG008|PKC412A2104E1|Adverse Event|0|||
170572795|NCT03687957|616443292|FG004|Overall Study|Adverse Event|0|||
170572796|NCT03687957|616443293|FG005|Overall Study|Adverse Event|2|||
170649193|NCT00045942|616729079|FG000|PKC412A2104E1|Death|0|||
170649194|NCT00045942|616729080|FG001|PKC412A2104E1|Death|4|||
170649195|NCT00045942|616729081|FG002|PKC412A2104E1|Death|1|||
170572797|NCT03687957|616443294|FG006|Overall Study|Adverse Event|0|||
170572798|NCT03687957|616443295|FG007|Overall Study|Adverse Event|3|||
170572799|NCT03687957|616443296|FG008|Overall Study|Adverse Event|0|||
170572800|NCT03687957|616443297|FG009|Overall Study|Adverse Event|0|||
170572801|NCT03687957|616443288|FG000|Overall Study|Patient went on hospice|0|||
170572802|NCT03687957|616443289|FG001|Overall Study|Patient went on hospice|0|||
170572803|NCT03687957|616443290|FG002|Overall Study|Patient went on hospice|0|||
170572804|NCT03687957|616443291|FG003|Overall Study|Patient went on hospice|0|||
170572805|NCT03687957|616443292|FG004|Overall Study|Patient went on hospice|0|||
170572806|NCT03687957|616443293|FG005|Overall Study|Patient went on hospice|0|||
170572807|NCT03687957|616443294|FG006|Overall Study|Patient went on hospice|1|||
170572808|NCT03687957|616443295|FG007|Overall Study|Patient went on hospice|0|||
170572809|NCT03687957|616443296|FG008|Overall Study|Patient went on hospice|0|||
170572810|NCT03687957|616443297|FG009|Overall Study|Patient went on hospice|0|||
170572811|NCT03687957|616443288|FG000|Overall Study|Death|0|||
170572812|NCT03687957|616443289|FG001|Overall Study|Death|0|||
170572813|NCT03687957|616443290|FG002|Overall Study|Death|0|||
170572814|NCT03687957|616443291|FG003|Overall Study|Death|0|||
170572815|NCT03687957|616443292|FG004|Overall Study|Death|0|||
170572816|NCT03687957|616443293|FG005|Overall Study|Death|0|||
170572817|NCT03687957|616443294|FG006|Overall Study|Death|0|||
170572818|NCT03687957|616443295|FG007|Overall Study|Death|1|||
170572819|NCT03687957|616443296|FG008|Overall Study|Death|0|||
170572820|NCT03687957|616443297|FG009|Overall Study|Death|0|||
170572821|NCT03941873|616443298|FG000|Overall Study|Death|0|||
170572822|NCT03941873|616443299|FG001|Overall Study|Death|12|||
170572823|NCT03941873|616443300|FG002|Overall Study|Death|2|||
170572824|NCT03941873|616443301|FG003|Overall Study|Death|53|||
170572825|NCT03941873|616443298|FG000|Overall Study|Withdrawal by Subject|1|||
170572826|NCT03941873|616443299|FG001|Overall Study|Withdrawal by Subject|1|||
170572827|NCT03941873|616443300|FG002|Overall Study|Withdrawal by Subject|0|||
170572828|NCT03941873|616443301|FG003|Overall Study|Withdrawal by Subject|5|||
170572829|NCT03941873|616443298|FG000|Overall Study|Lost to Follow-up|1|||
170572830|NCT03941873|616443299|FG001|Overall Study|Lost to Follow-up|2|||
170572831|NCT03941873|616443300|FG002|Overall Study|Lost to Follow-up|0|||
170572832|NCT03941873|616443301|FG003|Overall Study|Lost to Follow-up|0|||
170572833|NCT03941873|616443298|FG000|Overall Study|Sponsor Decision|0|||
170572834|NCT03941873|616443299|FG001|Overall Study|Sponsor Decision|6|||
170572835|NCT03941873|616443300|FG002|Overall Study|Sponsor Decision|0|||
170572836|NCT03941873|616443301|FG003|Overall Study|Sponsor Decision|15|||
170572837|NCT03276728|616443306|FG000|Overall Study|Lost to Follow-up|0|||
170572838|NCT03276728|616443307|FG001|Overall Study|Lost to Follow-up|0|||
170572839|NCT03276728|616443308|FG002|Overall Study|Lost to Follow-up|2|||
170572840|NCT03276728|616443309|FG003|Overall Study|Lost to Follow-up|2|||
170572841|NCT03276728|616443310|FG004|Overall Study|Lost to Follow-up|0|||
170572842|NCT03276728|616443311|FG005|Overall Study|Lost to Follow-up|0|||
170572843|NCT03276728|616443312|FG006|Overall Study|Lost to Follow-up|0|||
170572844|NCT03276728|616443313|FG007|Overall Study|Lost to Follow-up|0|||
170572845|NCT03276728|616443306|FG000|Overall Study|Withdrawal by Subject|0|||
170572846|NCT03276728|616443307|FG001|Overall Study|Withdrawal by Subject|0|||
170572847|NCT03276728|616443308|FG002|Overall Study|Withdrawal by Subject|0|||
170572848|NCT03276728|616443309|FG003|Overall Study|Withdrawal by Subject|3|||
170572849|NCT03276728|616443310|FG004|Overall Study|Withdrawal by Subject|0|||
170572850|NCT03276728|616443311|FG005|Overall Study|Withdrawal by Subject|0|||
170572851|NCT03276728|616443312|FG006|Overall Study|Withdrawal by Subject|0|||
170572852|NCT03276728|616443313|FG007|Overall Study|Withdrawal by Subject|0|||
170572853|NCT03276728|616443306|FG000|Overall Study|Decision by sponsor|0|||
170572854|NCT03276728|616443307|FG001|Overall Study|Decision by sponsor|0|||
170572855|NCT03276728|616443308|FG002|Overall Study|Decision by sponsor|0|||
170572856|NCT03276728|616443309|FG003|Overall Study|Decision by sponsor|0|||
170572857|NCT03276728|616443310|FG004|Overall Study|Decision by sponsor|1|||
170572858|NCT03276728|616443311|FG005|Overall Study|Decision by sponsor|0|||
170572859|NCT03276728|616443312|FG006|Overall Study|Decision by sponsor|2|||
170572860|NCT03276728|616443313|FG007|Overall Study|Decision by sponsor|1|||
170572861|NCT01693250|616443319|FG000|Overall Study|Lost to Follow-up|2|||
170572862|NCT01693250|616443320|FG001|Overall Study|Lost to Follow-up|2|||
170572863|NCT03692403|616443321|FG000|Overall Study|Withdrawal by Subject|1|||
170572864|NCT03692403|616443322|FG001|Overall Study|Withdrawal by Subject|0|||
170572865|NCT03692403|616443323|FG002|Overall Study|Withdrawal by Subject|1|||
170572866|NCT03692403|616443324|FG003|Overall Study|Withdrawal by Subject|0|||
170572867|NCT03692403|616443321|FG000|Overall Study|Adverse Event|0|||
170808614|NCT04566445|617308951|FG002|Overall Study|Study terminated by sponsor|32|||
170808615|NCT04566445|617308949|FG000|Overall Study|Withdrawal by Subject|12|||
170808616|NCT04566445|617308950|FG001|Overall Study|Withdrawal by Subject|14|||
170808617|NCT04566445|617308951|FG002|Overall Study|Withdrawal by Subject|13|||
170808618|NCT04566445|617308949|FG000|Overall Study|Randomized but not treated due to AE|2|||
170808619|NCT04566445|617308950|FG001|Overall Study|Randomized but not treated due to AE|1|||
170808620|NCT04566445|617308951|FG002|Overall Study|Randomized but not treated due to AE|0|||
170808621|NCT04566445|617308949|FG000|Overall Study|Adverse Event|1|||
170572868|NCT03692403|616443322|FG001|Overall Study|Adverse Event|0|||
170572869|NCT03692403|616443323|FG002|Overall Study|Adverse Event|0|||
170572870|NCT03692403|616443324|FG003|Overall Study|Adverse Event|1|||
170572871|NCT03692403|616443321|FG000|Overall Study|Pregnancy|0|||
170572872|NCT03692403|616443322|FG001|Overall Study|Pregnancy|1|||
170572873|NCT03692403|616443323|FG002|Overall Study|Pregnancy|0|||
170572874|NCT03692403|616443324|FG003|Overall Study|Pregnancy|0|||
170572875|NCT03692403|616443321|FG000|Overall Study|Other|0|||
170572876|NCT03692403|616443322|FG001|Overall Study|Other|0|||
170572877|NCT03692403|616443323|FG002|Overall Study|Other|1|||
170572878|NCT03692403|616443324|FG003|Overall Study|Other|0|||
170572879|NCT02197572|616443325|FG000|Overall Study|Progressive Disease|28|||
170572880|NCT02197572|616443325|FG000|Overall Study|Withdrawal by Subject|9|||
170572881|NCT02197572|616443325|FG000|Overall Study|Adverse Event|3|||
170572882|NCT02197572|616443325|FG000|Overall Study|Reason Not Specified|4|||
170572883|NCT00856323|616443326|FG000|Overall Study|Withdrawal by Subject|2|||
170572884|NCT01465386|616443327|FG000|Overall Study|Lack of Efficacy|3|||
170572885|NCT01465386|616443327|FG000|Overall Study|Adverse Event|1|||
170572886|NCT01408277|616443332|FG000|Overall Study|Adverse Event|3|||
170572887|NCT01408277|616443333|FG001|Overall Study|Adverse Event|4|||
170572888|NCT01408277|616443332|FG000|Overall Study|Lost to Follow-up|1|||
170572889|NCT01408277|616443333|FG001|Overall Study|Lost to Follow-up|0|||
170572890|NCT01408277|616443332|FG000|Overall Study|Withdrawal by Subject|2|||
170572891|NCT01408277|616443333|FG001|Overall Study|Withdrawal by Subject|0|||
170572892|NCT01408277|616443332|FG000|Overall Study|Protocol Violation|2|||
170572893|NCT01408277|616443333|FG001|Overall Study|Protocol Violation|0|||
170572894|NCT02840253|616443334|FG000|Overall Study|Unsuccessful block|4|||
170572895|NCT02383862|616443335|FG000|3 Month Follow up|Lost to Follow-up|23|||
170572896|NCT02383862|616443336|FG001|3 Month Follow up|Lost to Follow-up|21|||
170572897|NCT02630693|616443339|FG000|Overall Study|No receive treatment|0|||
170572898|NCT02630693|616443340|FG001|Overall Study|No receive treatment|1|||
170572899|NCT03462758|616443341|FG000|Overall Study|Chose no or other method of contraception|20|||
170572900|NCT03462758|616443342|FG001|Overall Study|Chose no or other method of contraception|23|||
170572901|NCT03462758|616443341|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
170572902|NCT03462758|616443342|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
170572903|NCT03462758|616443341|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
170572904|NCT03462758|616443342|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
170572905|NCT03462758|616443341|FG000|Overall Study|Medical contraindication|2|||
170572906|NCT03462758|616443342|FG001|Overall Study|Medical contraindication|2|||
170572907|NCT03462758|616443341|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
170572908|NCT03462758|616443342|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
170572909|NCT02820844|616443343|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
170572910|NCT02820844|616443344|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
170572911|NCT02820844|616443345|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
170572912|NCT02820844|616443346|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
170572913|NCT02820844|616443347|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
170572914|NCT02820844|616443348|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
170572915|NCT02820844|616443343|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
170572916|NCT02820844|616443344|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
170572917|NCT02820844|616443345|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
170572918|NCT02820844|616443346|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
170572919|NCT02820844|616443347|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
170572920|NCT02820844|616443348|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
170572921|NCT02820844|616443343|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
170572922|NCT02820844|616443344|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
170572923|NCT02820844|616443345|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
170572924|NCT02820844|616443346|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
170572925|NCT02820844|616443347|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
170572926|NCT02820844|616443348|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
170572927|NCT02820844|616443343|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
170572928|NCT02820844|616443344|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
170572929|NCT02820844|616443345|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
170572930|NCT02820844|616443346|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
170572931|NCT02820844|616443347|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
170572932|NCT02820844|616443348|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
170572933|NCT02820844|616443343|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
170572934|NCT02820844|616443344|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
170572935|NCT02820844|616443345|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
170572936|NCT02820844|616443346|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
170572937|NCT02820844|616443347|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
170572938|NCT02820844|616443348|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
170649196|NCT00045942|616729082|FG003|PKC412A2104E1|Death|1|||
170649197|NCT00045942|616729083|FG004|PKC412A2104E1|Death|1|||
170572939|NCT02820844|616443343|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
170572940|NCT02820844|616443344|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
170572941|NCT02820844|616443345|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
170572942|NCT02820844|616443346|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
170572943|NCT02820844|616443347|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
170572944|NCT02820844|616443348|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
170572945|NCT02820844|616443343|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
170572946|NCT02820844|616443344|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
170572947|NCT02820844|616443345|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
170572948|NCT02820844|616443346|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
170572949|NCT02820844|616443347|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
170572950|NCT02820844|616443348|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
170572951|NCT02820844|616443343|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572952|NCT02820844|616443344|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572953|NCT02820844|616443345|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
170572954|NCT02820844|616443346|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
170572955|NCT02820844|616443347|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572956|NCT02820844|616443348|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572957|NCT02820844|616443343|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
170572958|NCT02820844|616443344|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
170649198|NCT00045942|616729084|FG005|PKC412A2104E1|Death|0|||
170572959|NCT02820844|616443345|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
170572960|NCT02820844|616443346|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
170572961|NCT02820844|616443347|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
170572962|NCT02820844|616443348|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
170572963|NCT02820844|616443343|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572964|NCT02820844|616443344|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572965|NCT02820844|616443345|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572966|NCT02820844|616443346|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572967|NCT02820844|616443347|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
170572968|NCT02820844|616443348|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
170572969|NCT04423939|616443349|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
170572970|NCT04423939|616443350|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
170572971|NCT04423939|616443349|FG000|Overall Study|Death|3|||
170572972|NCT04423939|616443350|FG001|Overall Study|Death|0|||
170572973|NCT04423939|616443349|FG000|Overall Study|Withdrawal by Subject|3|||
170572974|NCT04423939|616443350|FG001|Overall Study|Withdrawal by Subject|0|||
170572975|NCT04423939|616443349|FG000|Overall Study|Caregiver to patient who died|0|||
170572976|NCT04423939|616443350|FG001|Overall Study|Caregiver to patient who died|3|||
170572977|NCT04423939|616443349|FG000|Overall Study|Caregiver to patient who withdrew|0|||
170649199|NCT00045942|616729085|FG006|PKC412A2104E1|Death|0|||
170649200|NCT00045942|616729086|FG007|PKC412A2104E1|Death|0|||
170649201|NCT00045942|616729087|FG008|PKC412A2104E1|Death|0|||
170649202|NCT00045942|616729079|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
170649203|NCT00045942|616729080|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
170649204|NCT00045942|616729081|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
170649205|NCT00045942|616729082|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
170649206|NCT00045942|616729083|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
170649207|NCT00045942|616729084|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
170649208|NCT00045942|616729085|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
170649209|NCT00045942|616729086|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
170649210|NCT00045942|616729087|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
170649211|NCT00045942|616729079|FG000|PKC412A2104E2|Lost to Follow-up|0|||
170649212|NCT00045942|616729080|FG001|PKC412A2104E2|Lost to Follow-up|0|||
170649213|NCT00045942|616729081|FG002|PKC412A2104E2|Lost to Follow-up|0|||
170649214|NCT00045942|616729082|FG003|PKC412A2104E2|Lost to Follow-up|0|||
170649215|NCT00045942|616729083|FG004|PKC412A2104E2|Lost to Follow-up|0|||
170649216|NCT00045942|616729084|FG005|PKC412A2104E2|Lost to Follow-up|0|||
170649217|NCT00045942|616729085|FG006|PKC412A2104E2|Lost to Follow-up|0|||
170649218|NCT00045942|616729086|FG007|PKC412A2104E2|Lost to Follow-up|3|||
170649219|NCT00045942|616729087|FG008|PKC412A2104E2|Lost to Follow-up|0|||
170649220|NCT00045942|616729079|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
170649221|NCT00045942|616729080|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
170649222|NCT00045942|616729081|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
170649223|NCT00045942|616729082|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
170649224|NCT00045942|616729083|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
170649225|NCT00045942|616729084|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
170649226|NCT00045942|616729085|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
170649227|NCT00045942|616729086|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
170572978|NCT04423939|616443350|FG001|Overall Study|Caregiver to patient who withdrew|3|||
170572979|NCT00413660|616443352|FG000|Up To Week 12|Adverse Event|1|||
170572980|NCT00413660|616443353|FG001|Up To Week 12|Adverse Event|3|||
170572981|NCT00413660|616443354|FG002|Up To Week 12|Adverse Event|1|||
170572982|NCT00413660|616443355|FG003|Up To Week 12|Adverse Event|4|||
170572983|NCT00413660|616443356|FG004|Up To Week 12|Adverse Event|6|||
170572984|NCT00413660|616443357|FG005|Up To Week 12|Adverse Event|4|||
170572985|NCT00413660|616443358|FG006|Up To Week 12|Adverse Event|1|||
170572986|NCT00413660|616443359|FG007|Up To Week 12|Adverse Event|0|||
170649228|NCT00045942|616729087|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
170649229|NCT00045942|616729079|FG000|PKC412A2104E2|Lack of Efficacy|0|||
170649230|NCT00045942|616729080|FG001|PKC412A2104E2|Lack of Efficacy|0|||
170649231|NCT00045942|616729081|FG002|PKC412A2104E2|Lack of Efficacy|0|||
170572987|NCT00413660|616443360|FG008|Up To Week 12|Adverse Event|0|||
170572988|NCT00413660|616443361|FG009|Up To Week 12|Adverse Event|0|||
170572989|NCT00413660|616443362|FG010|Up To Week 12|Adverse Event|0|||
170649232|NCT00045942|616729082|FG003|PKC412A2104E2|Lack of Efficacy|0|||
170649233|NCT00045942|616729083|FG004|PKC412A2104E2|Lack of Efficacy|0|||
170649234|NCT00045942|616729084|FG005|PKC412A2104E2|Lack of Efficacy|3|||
170649235|NCT00045942|616729085|FG006|PKC412A2104E2|Lack of Efficacy|2|||
170649236|NCT00045942|616729086|FG007|PKC412A2104E2|Lack of Efficacy|2|||
170649237|NCT00045942|616729087|FG008|PKC412A2104E2|Lack of Efficacy|6|||
170649238|NCT00045942|616729079|FG000|PKC412A2104E2|Adverse Event|0|||
170649239|NCT00045942|616729080|FG001|PKC412A2104E2|Adverse Event|0|||
170649240|NCT00045942|616729081|FG002|PKC412A2104E2|Adverse Event|0|||
170649241|NCT00045942|616729082|FG003|PKC412A2104E2|Adverse Event|0|||
170649242|NCT00045942|616729083|FG004|PKC412A2104E2|Adverse Event|0|||
170649243|NCT00045942|616729084|FG005|PKC412A2104E2|Adverse Event|4|||
170649244|NCT00045942|616729085|FG006|PKC412A2104E2|Adverse Event|3|||
170649245|NCT00045942|616729086|FG007|PKC412A2104E2|Adverse Event|1|||
170649246|NCT00045942|616729087|FG008|PKC412A2104E2|Adverse Event|0|||
170649247|NCT00045942|616729079|FG000|PKC412A2104E2|Death|0|||
170649248|NCT00045942|616729080|FG001|PKC412A2104E2|Death|0|||
170649249|NCT00045942|616729081|FG002|PKC412A2104E2|Death|0|||
170649250|NCT00045942|616729082|FG003|PKC412A2104E2|Death|0|||
170649251|NCT00045942|616729083|FG004|PKC412A2104E2|Death|0|||
170649252|NCT00045942|616729084|FG005|PKC412A2104E2|Death|1|||
170649253|NCT00045942|616729085|FG006|PKC412A2104E2|Death|2|||
170649254|NCT00045942|616729086|FG007|PKC412A2104E2|Death|0|||
170649255|NCT00045942|616729087|FG008|PKC412A2104E2|Death|0|||
170649256|NCT05508074|616729088|FG000|Overall Study|Death|2|||
170649257|NCT05508074|616729089|FG001|Overall Study|Death|5|||
170649258|NCT05508074|616729088|FG000|Overall Study|Withdrawal by Subject|1|||
170649259|NCT05508074|616729089|FG001|Overall Study|Withdrawal by Subject|2|||
170649260|NCT05508074|616729088|FG000|Overall Study|Adverse Event|0|||
170649261|NCT05508074|616729089|FG001|Overall Study|Adverse Event|1|||
170649262|NCT05508074|616729088|FG000|Overall Study|Physician Decision|0|||
170649263|NCT05508074|616729089|FG001|Overall Study|Physician Decision|1|||
170649264|NCT05508074|616729088|FG000|Overall Study|wrongly randomized|0|||
170649265|NCT05508074|616729089|FG001|Overall Study|wrongly randomized|1|||
170649266|NCT05508074|616729088|FG000|Overall Study|non-compliance|0|||
170649267|NCT05508074|616729089|FG001|Overall Study|non-compliance|1|||
170908373|NCT02495077|617671028|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
170908374|NCT02495077|617671029|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
170908375|NCT02495077|617671030|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
170908376|NCT02495077|617671027|FG000|Overall Study|Incarcerated|0|||
170908377|NCT02495077|617671028|FG001|Overall Study|Incarcerated|1|||
170908378|NCT02495077|617671029|FG002|Overall Study|Incarcerated|0|||
170908379|NCT02495077|617671030|FG003|Overall Study|Incarcerated|0|||
170908380|NCT02495077|617671027|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
170908381|NCT02495077|617671028|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
170908382|NCT02495077|617671029|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
170908383|NCT02495077|617671030|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
170908384|NCT02495077|617671027|FG000|Overall Study|Timing of transplant and randomization|0|||
170908385|NCT02495077|617671028|FG001|Overall Study|Timing of transplant and randomization|0|||
170908386|NCT02495077|617671029|FG002|Overall Study|Timing of transplant and randomization|5|||
170908387|NCT02495077|617671030|FG003|Overall Study|Timing of transplant and randomization|0|||
170908388|NCT02742649|617671031|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
170908389|NCT02742649|617671032|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
170572990|NCT00413660|616443352|FG000|Up To Week 12|Lack of Efficacy|2|||
170572991|NCT00413660|616443353|FG001|Up To Week 12|Lack of Efficacy|0|||
170649268|NCT00329849|616729090|FG000|Overall Study|Withdrawal by Subject|6|||
170649269|NCT00329849|616729091|FG001|Overall Study|Withdrawal by Subject|4|||
170649270|NCT01101308|616729094|FG000|Period 1|Adverse Event|2|||
170649271|NCT01101308|616729095|FG001|Period 1|Adverse Event|1|||
170649272|NCT01101308|616729094|FG000|Period 1|Positive for cotinine|1|||
170572992|NCT00413660|616443354|FG002|Up To Week 12|Lack of Efficacy|0|||
170572993|NCT00413660|616443355|FG003|Up To Week 12|Lack of Efficacy|0|||
170572994|NCT00413660|616443356|FG004|Up To Week 12|Lack of Efficacy|0|||
170572995|NCT00413660|616443357|FG005|Up To Week 12|Lack of Efficacy|0|||
170572996|NCT00413660|616443358|FG006|Up To Week 12|Lack of Efficacy|5|||
170572997|NCT00413660|616443359|FG007|Up To Week 12|Lack of Efficacy|0|||
170572998|NCT00413660|616443360|FG008|Up To Week 12|Lack of Efficacy|0|||
170572999|NCT00413660|616443361|FG009|Up To Week 12|Lack of Efficacy|0|||
170573000|NCT00413660|616443362|FG010|Up To Week 12|Lack of Efficacy|0|||
170573001|NCT00413660|616443352|FG000|Up To Week 12|Lost to Follow-up|0|||
170573002|NCT00413660|616443353|FG001|Up To Week 12|Lost to Follow-up|1|||
170573003|NCT00413660|616443354|FG002|Up To Week 12|Lost to Follow-up|0|||
170573004|NCT00413660|616443355|FG003|Up To Week 12|Lost to Follow-up|0|||
170573005|NCT00413660|616443356|FG004|Up To Week 12|Lost to Follow-up|1|||
170573006|NCT00413660|616443357|FG005|Up To Week 12|Lost to Follow-up|0|||
170573007|NCT00413660|616443358|FG006|Up To Week 12|Lost to Follow-up|0|||
170573008|NCT00413660|616443359|FG007|Up To Week 12|Lost to Follow-up|0|||
170573009|NCT00413660|616443360|FG008|Up To Week 12|Lost to Follow-up|0|||
170573010|NCT00413660|616443361|FG009|Up To Week 12|Lost to Follow-up|0|||
170573011|NCT00413660|616443362|FG010|Up To Week 12|Lost to Follow-up|0|||
170573012|NCT00413660|616443352|FG000|Up To Week 12|Withdrawal by Subject|0|||
170573013|NCT00413660|616443353|FG001|Up To Week 12|Withdrawal by Subject|2|||
170573014|NCT00413660|616443354|FG002|Up To Week 12|Withdrawal by Subject|0|||
170573015|NCT00413660|616443355|FG003|Up To Week 12|Withdrawal by Subject|2|||
170573016|NCT00413660|616443356|FG004|Up To Week 12|Withdrawal by Subject|0|||
170573017|NCT00413660|616443357|FG005|Up To Week 12|Withdrawal by Subject|2|||
170573018|NCT00413660|616443358|FG006|Up To Week 12|Withdrawal by Subject|2|||
170573019|NCT00413660|616443359|FG007|Up To Week 12|Withdrawal by Subject|0|||
170573020|NCT00413660|616443360|FG008|Up To Week 12|Withdrawal by Subject|0|||
170573021|NCT00413660|616443361|FG009|Up To Week 12|Withdrawal by Subject|0|||
170649273|NCT01101308|616729095|FG001|Period 1|Positive for cotinine|0|||
170649274|NCT04575597|616729097|FG000|Overall Study|Death|0|||
170649275|NCT04575597|616729098|FG001|Overall Study|Death|0|||
170908390|NCT02742649|617671033|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
170908391|NCT02742649|617671034|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
170908392|NCT02742649|617671035|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
170908393|NCT02742649|617671031|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170908394|NCT02742649|617671032|FG001|Double-Blind Treatment Period|Adverse Event|1|||
170908395|NCT02742649|617671033|FG002|Double-Blind Treatment Period|Adverse Event|0|||
170908396|NCT02742649|617671034|FG003|Double-Blind Treatment Period|Adverse Event|0|||
170908397|NCT02742649|617671035|FG004|Double-Blind Treatment Period|Adverse Event|0|||
170908398|NCT02742649|617671031|FG000|Open-Label Period|Lost to Follow-up|0|||
170908399|NCT02742649|617671032|FG001|Open-Label Period|Lost to Follow-up|0|||
170908400|NCT02742649|617671033|FG002|Open-Label Period|Lost to Follow-up|0|||
170908401|NCT02742649|617671034|FG003|Open-Label Period|Lost to Follow-up|0|||
170908402|NCT02742649|617671035|FG004|Open-Label Period|Lost to Follow-up|1|||
170908403|NCT03937986|617671036|FG000|Overall Study|COVID-19 Pandemic|1|||
170908404|NCT02839746|617671039|FG000|Overall Study|Not met selection criteria|12|||
170908405|NCT02089737|617671040|FG000|Overall Study|Survey form not completed|5|||
170908406|NCT02089737|617671040|FG000|Overall Study|Not treated|1|||
170908407|NCT06400238|617671041|FG000|Overall Study|Started Protocol Therapy|2|||
170649276|NCT04575597|616729099|FG002|Overall Study|Death|0|||
170908408|NCT06400238|617671041|FG000|Overall Study|Adverse Event|1|||
170573022|NCT00413660|616443362|FG010|Up To Week 12|Withdrawal by Subject|0|||
170573023|NCT00413660|616443352|FG000|Up To Week 12|Randomized, Not Treated|1|||
170573024|NCT00413660|616443353|FG001|Up To Week 12|Randomized, Not Treated|0|||
170573025|NCT00413660|616443354|FG002|Up To Week 12|Randomized, Not Treated|0|||
170573026|NCT00413660|616443355|FG003|Up To Week 12|Randomized, Not Treated|1|||
170573027|NCT00413660|616443356|FG004|Up To Week 12|Randomized, Not Treated|0|||
170908409|NCT06400238|617671041|FG000|Overall Study|Death|1|||
170573028|NCT00413660|616443357|FG005|Up To Week 12|Randomized, Not Treated|0|||
170908410|NCT06400238|617671041|FG000|Overall Study|Disease Progression|27|||
170908411|NCT06400238|617671041|FG000|Overall Study|Withdrawal by Subject|2|||
170908412|NCT06400238|617671041|FG000|Overall Study|Physician Decision|2|||
170573029|NCT00413660|616443358|FG006|Up To Week 12|Randomized, Not Treated|0|||
170649277|NCT04575597|616729100|FG003|Overall Study|Death|1|||
170573030|NCT00413660|616443359|FG007|Up To Week 12|Randomized, Not Treated|0|||
170573031|NCT00413660|616443360|FG008|Up To Week 12|Randomized, Not Treated|0|||
170573032|NCT00413660|616443361|FG009|Up To Week 12|Randomized, Not Treated|0|||
170573033|NCT00413660|616443362|FG010|Up To Week 12|Randomized, Not Treated|0|||
170573034|NCT00413660|616443352|FG000|Up To Week 12|Other|3|||
170573035|NCT00413660|616443353|FG001|Up To Week 12|Other|1|||
170573036|NCT00413660|616443354|FG002|Up To Week 12|Other|6|||
170573037|NCT00413660|616443355|FG003|Up To Week 12|Other|1|||
170573038|NCT00413660|616443356|FG004|Up To Week 12|Other|2|||
170573039|NCT00413660|616443357|FG005|Up To Week 12|Other|4|||
170573040|NCT00413660|616443358|FG006|Up To Week 12|Other|3|||
170573041|NCT00413660|616443359|FG007|Up To Week 12|Other|0|||
170573042|NCT00413660|616443360|FG008|Up To Week 12|Other|0|||
170573043|NCT00413660|616443361|FG009|Up To Week 12|Other|0|||
170573044|NCT00413660|616443362|FG010|Up To Week 12|Other|0|||
170573045|NCT00413660|616443352|FG000|Post Week 12|Adverse Event|2|||
170573046|NCT00413660|616443353|FG001|Post Week 12|Adverse Event|0|||
170573047|NCT00413660|616443354|FG002|Post Week 12|Adverse Event|2|||
170573048|NCT00413660|616443355|FG003|Post Week 12|Adverse Event|1|||
170573049|NCT00413660|616443356|FG004|Post Week 12|Adverse Event|4|||
170573050|NCT00413660|616443357|FG005|Post Week 12|Adverse Event|2|||
170573051|NCT00413660|616443358|FG006|Post Week 12|Adverse Event|2|||
170573052|NCT00413660|616443359|FG007|Post Week 12|Adverse Event|0|||
170573053|NCT00413660|616443360|FG008|Post Week 12|Adverse Event|0|||
170573054|NCT00413660|616443361|FG009|Post Week 12|Adverse Event|0|||
170573055|NCT00413660|616443362|FG010|Post Week 12|Adverse Event|0|||
170573056|NCT00413660|616443352|FG000|Post Week 12|Lack of Efficacy|0|||
170573057|NCT00413660|616443353|FG001|Post Week 12|Lack of Efficacy|0|||
170573058|NCT00413660|616443354|FG002|Post Week 12|Lack of Efficacy|1|||
170573059|NCT00413660|616443355|FG003|Post Week 12|Lack of Efficacy|0|||
170573060|NCT00413660|616443356|FG004|Post Week 12|Lack of Efficacy|0|||
170573061|NCT00413660|616443357|FG005|Post Week 12|Lack of Efficacy|0|||
170573062|NCT00413660|616443358|FG006|Post Week 12|Lack of Efficacy|0|||
170573063|NCT00413660|616443359|FG007|Post Week 12|Lack of Efficacy|0|||
170573064|NCT00413660|616443360|FG008|Post Week 12|Lack of Efficacy|0|||
170573065|NCT00413660|616443361|FG009|Post Week 12|Lack of Efficacy|1|||
170649278|NCT04575597|616729101|FG004|Overall Study|Death|3|||
170649279|NCT04575597|616729102|FG005|Overall Study|Death|14|||
170649280|NCT04575597|616729097|FG000|Overall Study|Lost to Follow-up|2|||
170649281|NCT04575597|616729098|FG001|Overall Study|Lost to Follow-up|1|||
170649282|NCT04575597|616729099|FG002|Overall Study|Lost to Follow-up|1|||
170649283|NCT04575597|616729100|FG003|Overall Study|Lost to Follow-up|2|||
170649284|NCT04575597|616729101|FG004|Overall Study|Lost to Follow-up|10|||
170649285|NCT04575597|616729102|FG005|Overall Study|Lost to Follow-up|8|||
170649286|NCT04575597|616729097|FG000|Overall Study|Withdrawal by Subject|2|||
170649287|NCT04575597|616729098|FG001|Overall Study|Withdrawal by Subject|2|||
170908413|NCT01981187|617671042|FG000|Overall Study|Participant/guardian decision|2|||
170908414|NCT01981187|617671042|FG000|Overall Study|Physician Decision|1|||
170908415|NCT01981187|617671042|FG000|Overall Study|Disease progression|2|||
170908416|NCT01981187|617671042|FG000|Overall Study|Adverse Event|7|||
170908417|NCT00443560|617671047|FG000|Overall Study|No intrathecal dose|58|||
170908418|NCT00443560|617671048|FG001|Overall Study|No intrathecal dose|26|||
170908419|NCT00443560|617671047|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
170908420|NCT00443560|617671048|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
170908421|NCT02082184|617671049|FG000|Overall Study|Adverse Event|1|||
170908422|NCT02082184|617671050|FG001|Overall Study|Adverse Event|0|||
170908423|NCT02082184|617671049|FG000|Overall Study|Medical diagnosis|1|||
170908424|NCT02082184|617671050|FG001|Overall Study|Medical diagnosis|2|||
170908425|NCT02082184|617671049|FG000|Overall Study|Device associated symptoms|5|||
170908426|NCT02082184|617671050|FG001|Overall Study|Device associated symptoms|0|||
170908427|NCT02082184|617671049|FG000|Overall Study|Withdrawal by Subject|3|||
170908428|NCT02082184|617671050|FG001|Overall Study|Withdrawal by Subject|2|||
170908429|NCT02082184|617671049|FG000|Overall Study|Protocol Violation|0|||
170908430|NCT02082184|617671050|FG001|Overall Study|Protocol Violation|6|||
170908431|NCT02082184|617671049|FG000|Overall Study|Lost to Follow-up|0|||
170908432|NCT02082184|617671050|FG001|Overall Study|Lost to Follow-up|2|||
170573066|NCT00413660|616443362|FG010|Post Week 12|Lack of Efficacy|0|||
170573067|NCT00413660|616443352|FG000|Post Week 12|Lost to Follow-up|0|||
170573068|NCT00413660|616443353|FG001|Post Week 12|Lost to Follow-up|1|||
170573069|NCT00413660|616443354|FG002|Post Week 12|Lost to Follow-up|1|||
170573070|NCT00413660|616443355|FG003|Post Week 12|Lost to Follow-up|0|||
170649288|NCT04575597|616729099|FG002|Overall Study|Withdrawal by Subject|4|||
170573071|NCT00413660|616443356|FG004|Post Week 12|Lost to Follow-up|0|||
170573072|NCT00413660|616443357|FG005|Post Week 12|Lost to Follow-up|0|||
170573073|NCT00413660|616443358|FG006|Post Week 12|Lost to Follow-up|0|||
170649289|NCT04575597|616729100|FG003|Overall Study|Withdrawal by Subject|2|||
170649290|NCT04575597|616729101|FG004|Overall Study|Withdrawal by Subject|25|||
170573074|NCT00413660|616443359|FG007|Post Week 12|Lost to Follow-up|0|||
170573075|NCT00413660|616443360|FG008|Post Week 12|Lost to Follow-up|0|||
170573076|NCT00413660|616443361|FG009|Post Week 12|Lost to Follow-up|0|||
170573077|NCT00413660|616443362|FG010|Post Week 12|Lost to Follow-up|0|||
170573078|NCT00413660|616443352|FG000|Post Week 12|Withdrawal by Subject|0|||
170908433|NCT02082184|617671049|FG000|Overall Study|Subject non-compliance|0|||
170908434|NCT02082184|617671050|FG001|Overall Study|Subject non-compliance|1|||
170908435|NCT01362322|617671057|FG000|Overall Study|Withdrawal by Subject|3|||
170573079|NCT00413660|616443353|FG001|Post Week 12|Withdrawal by Subject|1|||
170573080|NCT00413660|616443354|FG002|Post Week 12|Withdrawal by Subject|1|||
170573081|NCT00413660|616443355|FG003|Post Week 12|Withdrawal by Subject|0|||
170573082|NCT00413660|616443356|FG004|Post Week 12|Withdrawal by Subject|1|||
170573083|NCT00413660|616443357|FG005|Post Week 12|Withdrawal by Subject|0|||
170573084|NCT00413660|616443358|FG006|Post Week 12|Withdrawal by Subject|0|||
170573085|NCT00413660|616443359|FG007|Post Week 12|Withdrawal by Subject|0|||
170573086|NCT00413660|616443360|FG008|Post Week 12|Withdrawal by Subject|0|||
170573087|NCT00413660|616443361|FG009|Post Week 12|Withdrawal by Subject|0|||
170573088|NCT00413660|616443362|FG010|Post Week 12|Withdrawal by Subject|1|||
170573089|NCT00413660|616443352|FG000|Post Week 12|Other|1|||
170573090|NCT00413660|616443353|FG001|Post Week 12|Other|2|||
170573091|NCT00413660|616443354|FG002|Post Week 12|Other|3|||
170573092|NCT00413660|616443355|FG003|Post Week 12|Other|0|||
170573093|NCT00413660|616443356|FG004|Post Week 12|Other|1|||
170573094|NCT00413660|616443357|FG005|Post Week 12|Other|1|||
170573095|NCT00413660|616443358|FG006|Post Week 12|Other|1|||
170573096|NCT00413660|616443359|FG007|Post Week 12|Other|0|||
170573097|NCT00413660|616443360|FG008|Post Week 12|Other|0|||
170573098|NCT00413660|616443361|FG009|Post Week 12|Other|0|||
170573099|NCT00413660|616443362|FG010|Post Week 12|Other|0|||
170573100|NCT03230318|616443363|FG000|Overall Study|Radiographic disease progression|72|||
170573101|NCT03230318|616443364|FG001|Overall Study|Radiographic disease progression|19|||
170573102|NCT03230318|616443363|FG000|Overall Study|Clinical progression|17|||
170808622|NCT04566445|617308950|FG001|Overall Study|Adverse Event|1|||
170808623|NCT04566445|617308951|FG002|Overall Study|Adverse Event|0|||
170808624|NCT04399837|617308952|FG000|Overall Study|Other than listed|0|||
170808625|NCT04399837|617308953|FG001|Overall Study|Other than listed|2|||
170808626|NCT04399837|617308954|FG002|Overall Study|Other than listed|2|||
170808627|NCT04399837|617308955|FG003|Overall Study|Other than listed|3|||
170808628|NCT04399837|617308952|FG000|Overall Study|Withdrawal by Subject|1|||
170808629|NCT04399837|617308953|FG001|Overall Study|Withdrawal by Subject|2|||
170808630|NCT04399837|617308954|FG002|Overall Study|Withdrawal by Subject|1|||
170808631|NCT04399837|617308955|FG003|Overall Study|Withdrawal by Subject|1|||
170808632|NCT01730937|617308967|FG000|Overall Study|Protocol Violation|5|||
170808633|NCT01730937|617308968|FG001|Overall Study|Protocol Violation|11|||
170808634|NCT03846193|617308972|FG000|Overall Study|Physician Decision|0|||
170808635|NCT03846193|617308973|FG001|Overall Study|Physician Decision|0|||
170808636|NCT03846193|617308974|FG002|Overall Study|Physician Decision|1|||
170808637|NCT03846193|617308975|FG003|Overall Study|Physician Decision|0|||
170808638|NCT03846193|617308976|FG004|Overall Study|Physician Decision|0|||
170808639|NCT03846193|617308972|FG000|Overall Study|Lost to Follow-up|0|||
170808640|NCT03846193|617308973|FG001|Overall Study|Lost to Follow-up|0|||
170808641|NCT03846193|617308974|FG002|Overall Study|Lost to Follow-up|0|||
170808642|NCT03846193|617308975|FG003|Overall Study|Lost to Follow-up|0|||
170808643|NCT03846193|617308976|FG004|Overall Study|Lost to Follow-up|1|||
170808644|NCT03846193|617308972|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
170808645|NCT03846193|617308973|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
170808646|NCT03846193|617308974|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
170808647|NCT03846193|617308975|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
170808648|NCT03846193|617308976|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
170808649|NCT04224272|617308989|FG000|Part 1 - Dose Finding|Death|4|||
170808650|NCT04224272|617308989|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
170808651|NCT04224272|617308989|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
170808652|NCT04224272|617308989|FG000|Part 2 - Dose Expansion|Death|10|||
170808653|NCT04224272|617308989|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
170808654|NCT04886258|617308990|FG000|Overall Study|Adverse Event|1|||
170808655|NCT04886258|617308991|FG001|Overall Study|Adverse Event|0|||
170808656|NCT04886258|617308990|FG000|Overall Study|Withdrawal by Subject|5|||
170808657|NCT04886258|617308991|FG001|Overall Study|Withdrawal by Subject|3|||
170808658|NCT02609048|617308992|FG000|Overall Study|Adverse Event|3|||
170808659|NCT02609048|617308993|FG001|Overall Study|Adverse Event|0|||
170808660|NCT02609048|617308994|FG002|Overall Study|Adverse Event|0|||
170808661|NCT02609048|617308992|FG000|Overall Study|Randomized but never treated|1|||
170808662|NCT02609048|617308993|FG001|Overall Study|Randomized but never treated|1|||
170808663|NCT02609048|617308994|FG002|Overall Study|Randomized but never treated|1|||
170808664|NCT02609048|617308992|FG000|Overall Study|Withdrawal of informed consent|1|||
170808665|NCT02609048|617308993|FG001|Overall Study|Withdrawal of informed consent|0|||
170808666|NCT02609048|617308994|FG002|Overall Study|Withdrawal of informed consent|0|||
170808667|NCT02609048|617308992|FG000|Overall Study|Reason not specified|6|||
170808668|NCT02609048|617308993|FG001|Overall Study|Reason not specified|9|||
170808669|NCT02609048|617308994|FG002|Overall Study|Reason not specified|9|||
170808670|NCT01959698|617308995|FG000|Overall Study|Adverse Event|0|||
170808671|NCT01959698|617308996|FG001|Overall Study|Adverse Event|0|||
170808672|NCT01959698|617308997|FG002|Overall Study|Adverse Event|0|||
170808673|NCT01959698|617308998|FG003|Overall Study|Adverse Event|0|||
170573103|NCT03230318|616443364|FG001|Overall Study|Clinical progression|7|||
170573104|NCT03230318|616443363|FG000|Overall Study|Adverse Event|5|||
170573105|NCT03230318|616443364|FG001|Overall Study|Adverse Event|3|||
170573106|NCT03230318|616443363|FG000|Overall Study|Physician Decision|2|||
170573107|NCT03230318|616443364|FG001|Overall Study|Physician Decision|3|||
170573108|NCT03230318|616443363|FG000|Overall Study|Death|3|||
170573109|NCT03230318|616443364|FG001|Overall Study|Death|2|||
170573110|NCT03230318|616443363|FG000|Overall Study|Lost to Follow-up|1|||
170573111|NCT03230318|616443364|FG001|Overall Study|Lost to Follow-up|0|||
170573112|NCT03230318|616443363|FG000|Overall Study|Withdrawal by Subject|1|||
170573113|NCT03230318|616443364|FG001|Overall Study|Withdrawal by Subject|3|||
170573114|NCT03230318|616443363|FG000|Overall Study|Other|3|||
170573115|NCT03230318|616443364|FG001|Overall Study|Other|7|||
170573116|NCT01722994|616443366|FG000|Overall Study|Missing data|25|||
170573117|NCT01722994|616443367|FG001|Overall Study|Missing data|17|||
170573118|NCT01206140|616443372|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
170573119|NCT01206140|616443373|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
170573120|NCT02141672|616443374|FG000|Overall Study|Adverse Event|0|||
170573121|NCT02141672|616443375|FG001|Overall Study|Adverse Event|1|||
170573122|NCT02141672|616443376|FG002|Overall Study|Adverse Event|0|||
170573123|NCT02141672|616443374|FG000|Overall Study|Death|10|||
170573124|NCT02141672|616443375|FG001|Overall Study|Death|2|||
170573125|NCT02141672|616443376|FG002|Overall Study|Death|1|||
170573126|NCT02141672|616443374|FG000|Overall Study|Lack of Efficacy|0|||
170573127|NCT02141672|616443375|FG001|Overall Study|Lack of Efficacy|0|||
170573128|NCT02141672|616443376|FG002|Overall Study|Lack of Efficacy|2|||
170573129|NCT02141672|616443374|FG000|Overall Study|Lost to Follow-up|1|||
170573130|NCT02141672|616443375|FG001|Overall Study|Lost to Follow-up|1|||
170573131|NCT02141672|616443376|FG002|Overall Study|Lost to Follow-up|3|||
170573132|NCT02141672|616443374|FG000|Overall Study|Physician Decision|1|||
170573133|NCT02141672|616443375|FG001|Overall Study|Physician Decision|2|||
170573134|NCT02141672|616443376|FG002|Overall Study|Physician Decision|5|||
170573135|NCT02141672|616443374|FG000|Overall Study|Protocol Violation|0|||
170573136|NCT02141672|616443375|FG001|Overall Study|Protocol Violation|0|||
170573137|NCT02141672|616443376|FG002|Overall Study|Protocol Violation|1|||
170573138|NCT02141672|616443374|FG000|Overall Study|Withdrawal by Subject|3|||
170573139|NCT02141672|616443375|FG001|Overall Study|Withdrawal by Subject|2|||
170573140|NCT02141672|616443376|FG002|Overall Study|Withdrawal by Subject|5|||
170573141|NCT02141672|616443374|FG000|Overall Study|refused to follow-up|1|||
170573142|NCT02141672|616443375|FG001|Overall Study|refused to follow-up|0|||
170573143|NCT02141672|616443376|FG002|Overall Study|refused to follow-up|1|||
170573144|NCT00075764|616443377|FG000|Overall Study|Adverse Event|5|||
170573145|NCT00075764|616443378|FG001|Overall Study|Adverse Event|12|||
170573146|NCT00075764|616443377|FG000|Overall Study|Death|4|||
170573147|NCT00075764|616443378|FG001|Overall Study|Death|8|||
170573148|NCT00075764|616443377|FG000|Overall Study|Withdrawal by Subject|28|||
170573149|NCT00075764|616443378|FG001|Overall Study|Withdrawal by Subject|18|||
170573150|NCT00075764|616443377|FG000|Overall Study|Progression|269|||
170573151|NCT00075764|616443378|FG001|Overall Study|Progression|274|||
170573152|NCT00075764|616443377|FG000|Overall Study|Still on treatment|8|||
170573153|NCT00075764|616443378|FG001|Overall Study|Still on treatment|15|||
170573154|NCT00075764|616443377|FG000|Overall Study|Delinquent|4|||
170573155|NCT00075764|616443378|FG001|Overall Study|Delinquent|2|||
170573156|NCT00075764|616443377|FG000|Overall Study|Not protocol specified|27|||
170573157|NCT00075764|616443378|FG001|Overall Study|Not protocol specified|19|||
170573158|NCT00075764|616443377|FG000|Overall Study|Under review|0|||
170573159|NCT00075764|616443378|FG001|Overall Study|Under review|1|||
170573160|NCT02817594|616443382|FG000|Overall Study|Withdrawal by Subject|1|||
170573161|NCT02817594|616443382|FG000|Overall Study|Other|1|||
170573162|NCT02817594|616443382|FG000|Overall Study|Did Not Receive Treatment|1|||
170573163|NCT02010593|616443383|FG000|Overall Study|Lost to Follow-up|1|||
170573164|NCT02010593|616443384|FG001|Overall Study|Lost to Follow-up|0|||
170573165|NCT02010593|616443383|FG000|Overall Study|Physician Decision|1|||
170573166|NCT02010593|616443384|FG001|Overall Study|Physician Decision|0|||
170573167|NCT02010593|616443383|FG000|Overall Study|Unable to adhere to visit schedule|0|||
170573168|NCT02010593|616443384|FG001|Overall Study|Unable to adhere to visit schedule|2|||
170573169|NCT01135459|616443385|FG000|Overall Study|Adverse Event|8|||
170573170|NCT01135459|616443386|FG001|Overall Study|Adverse Event|10|||
170573171|NCT01135459|616443385|FG000|Overall Study|Lack of Efficacy|3|||
170573172|NCT01135459|616443386|FG001|Overall Study|Lack of Efficacy|1|||
170573173|NCT01135459|616443385|FG000|Overall Study|Withdrawal by Subject|2|||
170573174|NCT01135459|616443386|FG001|Overall Study|Withdrawal by Subject|3|||
170573175|NCT01135459|616443385|FG000|Overall Study|Protocol Violation|5|||
170573176|NCT01135459|616443386|FG001|Overall Study|Protocol Violation|3|||
170573177|NCT01135459|616443385|FG000|Overall Study|Lost to Follow-up|2|||
170573178|NCT01135459|616443386|FG001|Overall Study|Lost to Follow-up|1|||
170573179|NCT01135459|616443385|FG000|Overall Study|Non-compliance to study procedures|0|||
170573180|NCT01135459|616443386|FG001|Overall Study|Non-compliance to study procedures|1|||
170573181|NCT01135459|616443385|FG000|Overall Study|Other than specified|1|||
170573182|NCT01135459|616443386|FG001|Overall Study|Other than specified|1|||
170908436|NCT01362322|617671058|FG001|Overall Study|Withdrawal by Subject|1|||
170908437|NCT01362322|617671057|FG000|Overall Study|Lost to Follow-up|2|||
170908438|NCT01362322|617671058|FG001|Overall Study|Lost to Follow-up|6|||
170908439|NCT01943539|617671059|FG000|Overall Study|Non-compliance with at-home intervention|4|||
170908440|NCT01943539|617671060|FG001|Overall Study|Non-compliance with at-home intervention|0|||
170573183|NCT01803880|616443387|FG000|Overall Study|Adverse Event|1|||
170573184|NCT01803880|616443388|FG001|Overall Study|Adverse Event|0|||
170573185|NCT01803880|616443389|FG002|Overall Study|Adverse Event|0|||
170573186|NCT01803880|616443387|FG000|Overall Study|Withdrawal by Subject|1|||
170573187|NCT01803880|616443388|FG001|Overall Study|Withdrawal by Subject|1|||
170573188|NCT01803880|616443389|FG002|Overall Study|Withdrawal by Subject|4|||
170573189|NCT01803880|616443387|FG000|Overall Study|Physician Decision|0|||
170573190|NCT01803880|616443388|FG001|Overall Study|Physician Decision|0|||
170573191|NCT01803880|616443389|FG002|Overall Study|Physician Decision|1|||
170573192|NCT01803880|616443387|FG000|Overall Study|Unable to return for follow-up visits|0|||
170573193|NCT01803880|616443388|FG001|Overall Study|Unable to return for follow-up visits|1|||
170573194|NCT01803880|616443389|FG002|Overall Study|Unable to return for follow-up visits|2|||
170573195|NCT01803880|616443387|FG000|Overall Study|Lost to Follow-up|1|||
170573196|NCT01803880|616443388|FG001|Overall Study|Lost to Follow-up|2|||
170573197|NCT01803880|616443389|FG002|Overall Study|Lost to Follow-up|3|||
170573198|NCT01803880|616443387|FG000|Overall Study|Protocol Violation|1|||
170573199|NCT01803880|616443388|FG001|Overall Study|Protocol Violation|0|||
170573200|NCT01803880|616443389|FG002|Overall Study|Protocol Violation|0|||
170573201|NCT01803880|616443387|FG000|Overall Study|Early study termination|0|||
170908441|NCT02333331|617671061|FG000|Overall Study|Adverse Event|1|||
170908442|NCT02333331|617671062|FG001|Overall Study|Adverse Event|0|||
170908443|NCT02333331|617671063|FG002|Overall Study|Adverse Event|4|||
170908444|NCT02333331|617671064|FG003|Overall Study|Adverse Event|1|||
170908445|NCT02333331|617671061|FG000|Overall Study|Death|0|||
170908446|NCT02333331|617671062|FG001|Overall Study|Death|0|||
170573202|NCT01803880|616443388|FG001|Overall Study|Early study termination|6|||
170573203|NCT01803880|616443389|FG002|Overall Study|Early study termination|5|||
170573204|NCT01803880|616443387|FG000|Overall Study|Incomplete data entry by sites|2|||
170573205|NCT01803880|616443388|FG001|Overall Study|Incomplete data entry by sites|0|||
170573206|NCT01803880|616443389|FG002|Overall Study|Incomplete data entry by sites|0|||
170573207|NCT01057693|616443394|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
170908447|NCT02333331|617671063|FG002|Overall Study|Death|2|||
170908448|NCT02333331|617671064|FG003|Overall Study|Death|0|||
170908449|NCT02333331|617671061|FG000|Overall Study|Lost to Follow-up|0|||
170908450|NCT02333331|617671062|FG001|Overall Study|Lost to Follow-up|0|||
170908451|NCT02333331|617671063|FG002|Overall Study|Lost to Follow-up|1|||
170908452|NCT02333331|617671064|FG003|Overall Study|Lost to Follow-up|0|||
170908453|NCT02333331|617671061|FG000|Overall Study|Physician Decision|0|||
170908454|NCT02333331|617671062|FG001|Overall Study|Physician Decision|1|||
170908455|NCT02333331|617671063|FG002|Overall Study|Physician Decision|0|||
170908456|NCT02333331|617671064|FG003|Overall Study|Physician Decision|0|||
170908457|NCT02333331|617671061|FG000|Overall Study|Protocol Deviation|0|||
170908458|NCT02333331|617671062|FG001|Overall Study|Protocol Deviation|3|||
170908459|NCT02333331|617671063|FG002|Overall Study|Protocol Deviation|2|||
170908460|NCT02333331|617671064|FG003|Overall Study|Protocol Deviation|1|||
170908461|NCT02333331|617671061|FG000|Overall Study|Patient/Guardian Decision|1|||
170908462|NCT02333331|617671062|FG001|Overall Study|Patient/Guardian Decision|2|||
170908463|NCT02333331|617671063|FG002|Overall Study|Patient/Guardian Decision|9|||
170908464|NCT02333331|617671064|FG003|Overall Study|Patient/Guardian Decision|1|||
170908465|NCT00537940|617671065|FG000|Overall Study|Adverse Event|20|||
170908466|NCT00537940|617671066|FG001|Overall Study|Adverse Event|19|||
170908467|NCT00537940|617671065|FG000|Overall Study|Lack of Efficacy|8|||
170908468|NCT00537940|617671066|FG001|Overall Study|Lack of Efficacy|16|||
170908469|NCT00537940|617671065|FG000|Overall Study|Lost to Follow-up|23|||
170908470|NCT00537940|617671066|FG001|Overall Study|Lost to Follow-up|29|||
170908471|NCT00537940|617671065|FG000|Overall Study|Withdrawal by Subject|113|||
170908472|NCT00537940|617671066|FG001|Overall Study|Withdrawal by Subject|95|||
170908473|NCT00537940|617671065|FG000|Overall Study|Protocol Violation|6|||
170573208|NCT01057693|616443395|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
170573209|NCT01057693|616443396|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
170573210|NCT01057693|616443394|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
170908474|NCT00537940|617671066|FG001|Overall Study|Protocol Violation|4|||
170908475|NCT00537940|617671065|FG000|Overall Study|Pregnancy|1|||
170908476|NCT00537940|617671066|FG001|Overall Study|Pregnancy|1|||
170908477|NCT00537940|617671065|FG000|Overall Study|Study terminated by sponsor|2|||
170908478|NCT00537940|617671066|FG001|Overall Study|Study terminated by sponsor|3|||
170573211|NCT01057693|616443395|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
170908479|NCT00537940|617671065|FG000|Overall Study|Other|10|||
170908480|NCT00537940|617671066|FG001|Overall Study|Other|12|||
170908481|NCT00685178|617671070|FG000|Overall Study|Adverse Event|1|||
170908482|NCT00685178|617671071|FG001|Overall Study|Adverse Event|5|||
170908483|NCT00685178|617671072|FG002|Overall Study|Adverse Event|2|||
170573212|NCT01057693|616443396|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
170573213|NCT01057693|616443394|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
170573214|NCT01057693|616443395|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
170573215|NCT01057693|616443396|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
170573216|NCT01057693|616443394|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
170573217|NCT01057693|616443395|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
170573218|NCT01057693|616443396|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
170573219|NCT01057693|616443394|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
170573220|NCT01057693|616443395|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
170573221|NCT01057693|616443396|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
170573222|NCT01057693|616443394|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
170573223|NCT01057693|616443395|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
170573224|NCT01057693|616443396|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
170573225|NCT01057693|616443394|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
170573226|NCT01057693|616443395|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
170573227|NCT01057693|616443396|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
170573228|NCT01057693|616443394|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
170573229|NCT01057693|616443395|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
170573230|NCT01057693|616443396|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
170573231|NCT01057693|616443394|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
170573232|NCT01057693|616443395|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
170573233|NCT01057693|616443396|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
170573234|NCT01057693|616443394|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
170573235|NCT01057693|616443395|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
170573236|NCT01057693|616443396|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
170573237|NCT01057693|616443394|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
170573238|NCT01057693|616443395|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
170573239|NCT01057693|616443396|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
170573240|NCT01057693|616443394|FG000|Between Single-Blind and Double-Blind|Other|6|||
170573241|NCT01057693|616443395|FG001|Between Single-Blind and Double-Blind|Other|0|||
170573242|NCT01057693|616443396|FG002|Between Single-Blind and Double-Blind|Other|0|||
170573243|NCT01057693|616443394|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
170573244|NCT01057693|616443395|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
170573245|NCT01057693|616443396|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
170573246|NCT01057693|616443394|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
170573247|NCT01057693|616443395|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
170573248|NCT01057693|616443396|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
170573249|NCT01057693|616443394|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
170573250|NCT01057693|616443395|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
170573251|NCT01057693|616443396|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
170573252|NCT01057693|616443394|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
170573253|NCT01057693|616443395|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
170573254|NCT01057693|616443396|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
170573255|NCT01057693|616443394|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
170573256|NCT01057693|616443395|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
170573257|NCT01057693|616443396|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
170573258|NCT01057693|616443394|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
170573259|NCT01057693|616443395|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
170573260|NCT01057693|616443396|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
170573261|NCT01057693|616443394|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
170573262|NCT01057693|616443395|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
170573263|NCT01057693|616443396|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
170573264|NCT02959463|616443397|FG000|Overall Study|Adverse Event|1|||
170573265|NCT02959463|616443398|FG001|Overall Study|Adverse Event|1|||
170573266|NCT02959463|616443397|FG000|Overall Study|Death|1|||
170573267|NCT02959463|616443398|FG001|Overall Study|Death|0|||
170573268|NCT02959463|616443397|FG000|Overall Study|Withdrawal by Subject|1|||
170573269|NCT02959463|616443398|FG001|Overall Study|Withdrawal by Subject|0|||
170573270|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
170573271|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
170573272|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
170573273|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
170573274|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
170573275|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
170573276|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
170908484|NCT00685178|617671073|FG003|Overall Study|Adverse Event|4|||
170573277|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
170573278|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
170573279|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
170573280|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
170573281|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
170573282|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
170573283|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
170573284|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
170573285|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
170573286|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
170573287|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
170573288|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
170573289|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
170573290|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
170573291|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
170573292|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
170573293|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
170573294|NCT01672879|616443401|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
170573295|NCT01672879|616443402|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
170573296|NCT01672879|616443403|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
170573297|NCT01672879|616443401|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
170573298|NCT01672879|616443402|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
170573299|NCT01672879|616443403|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
170573300|NCT01672879|616443401|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
170908485|NCT00685178|617671070|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
170908486|NCT00685178|617671071|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
170908487|NCT00685178|617671072|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
170908488|NCT00685178|617671073|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
170908489|NCT00685178|617671070|FG000|Overall Study|voluntary study discharge|4|||
170908490|NCT00685178|617671071|FG001|Overall Study|voluntary study discharge|5|||
170908491|NCT00685178|617671072|FG002|Overall Study|voluntary study discharge|1|||
170908492|NCT00685178|617671073|FG003|Overall Study|voluntary study discharge|1|||
170908493|NCT00685178|617671070|FG000|Overall Study|incarcerated|1|||
170908494|NCT00685178|617671071|FG001|Overall Study|incarcerated|3|||
170908495|NCT00685178|617671072|FG002|Overall Study|incarcerated|7|||
170908496|NCT00685178|617671073|FG003|Overall Study|incarcerated|0|||
170908497|NCT00685178|617671070|FG000|Overall Study|administrative (disciplinary) discharge|0|||
170908498|NCT00685178|617671071|FG001|Overall Study|administrative (disciplinary) discharge|1|||
170908499|NCT00685178|617671072|FG002|Overall Study|administrative (disciplinary) discharge|0|||
170908500|NCT00685178|617671073|FG003|Overall Study|administrative (disciplinary) discharge|2|||
170908501|NCT00685178|617671070|FG000|Overall Study|Pregnancy|0|||
170908502|NCT00685178|617671071|FG001|Overall Study|Pregnancy|0|||
170908503|NCT00685178|617671072|FG002|Overall Study|Pregnancy|0|||
170908504|NCT00685178|617671073|FG003|Overall Study|Pregnancy|1|||
170908505|NCT01389128|617671078|FG000|Overall Study|Fetal distress|1|||
170908506|NCT01389128|617671079|FG001|Overall Study|Fetal distress|0|||
170908507|NCT01389128|617671078|FG000|Overall Study|Cervix dilation stop|1|||
170908508|NCT01389128|617671079|FG001|Overall Study|Cervix dilation stop|2|||
170908509|NCT01389128|617671078|FG000|Overall Study|Rapid labor evolution|3|||
170908510|NCT01389128|617671079|FG001|Overall Study|Rapid labor evolution|2|||
170908511|NCT01389128|617671078|FG000|Overall Study|Intolerance to procedure|0|||
170908512|NCT01389128|617671079|FG001|Overall Study|Intolerance to procedure|2|||
170908513|NCT00174941|617671080|FG000|Overall Study|Adverse Event|1|||
170908514|NCT00174941|617671081|FG001|Overall Study|Adverse Event|10|||
170908515|NCT00174941|617671082|FG002|Overall Study|Adverse Event|2|||
170908516|NCT00174941|617671083|FG003|Overall Study|Adverse Event|13|||
170908517|NCT00174941|617671080|FG000|Overall Study|Protocol Violation|0|||
170908518|NCT00174941|617671081|FG001|Overall Study|Protocol Violation|1|||
170908519|NCT00174941|617671082|FG002|Overall Study|Protocol Violation|0|||
170908520|NCT00174941|617671083|FG003|Overall Study|Protocol Violation|1|||
170573301|NCT01672879|616443402|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
170908521|NCT00174941|617671080|FG000|Overall Study|Lost to Follow-up|0|||
170908522|NCT00174941|617671081|FG001|Overall Study|Lost to Follow-up|3|||
170908523|NCT00174941|617671082|FG002|Overall Study|Lost to Follow-up|2|||
170573302|NCT01672879|616443403|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
170573303|NCT01672879|616443401|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
170908524|NCT00174941|617671083|FG003|Overall Study|Lost to Follow-up|5|||
170908525|NCT00174941|617671080|FG000|Overall Study|Personal Reason(s)|0|||
170908526|NCT00174941|617671081|FG001|Overall Study|Personal Reason(s)|14|||
170908527|NCT00174941|617671082|FG002|Overall Study|Personal Reason(s)|8|||
170908528|NCT00174941|617671083|FG003|Overall Study|Personal Reason(s)|22|||
170908529|NCT00174941|617671080|FG000|Overall Study|Gout Flare|0|||
170908530|NCT00174941|617671081|FG001|Overall Study|Gout Flare|4|||
170908531|NCT00174941|617671082|FG002|Overall Study|Gout Flare|4|||
170908532|NCT00174941|617671083|FG003|Overall Study|Gout Flare|8|||
170573304|NCT01672879|616443402|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
170573305|NCT01672879|616443403|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
170573306|NCT01672879|616443401|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
170573307|NCT01672879|616443402|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
170573308|NCT01672879|616443403|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
170573309|NCT02651116|616443412|FG000|Overall Study|Adverse Event|0|||
170573310|NCT02651116|616443413|FG001|Overall Study|Adverse Event|1|||
170573311|NCT02651116|616443412|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
170573312|NCT02651116|616443413|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
170573313|NCT01775553|616443414|FG000|Overall Study|Adverse Event|1|||
170573314|NCT01775553|616443414|FG000|Overall Study|Disease Progression|12|||
170573315|NCT03951766|616443415|FG000|Treatment Phase|Lost to Follow-up|1|||
170573316|NCT03951766|616443415|FG000|Follow-up Phase|Lost to Follow-up|10|||
170573317|NCT00041470|616443416|FG000|Overall Study|Loss of Funding|38|||
170573318|NCT02750514|616443419|FG000|Track 1|Disease progression|20|||
170573319|NCT02750514|616443420|FG001|Track 1|Disease progression|1|||
170573320|NCT02750514|616443421|FG002|Track 1|Disease progression|0|||
170573321|NCT02750514|616443422|FG003|Track 1|Disease progression|1|||
170573322|NCT02750514|616443423|FG004|Track 1|Disease progression|0|||
170573323|NCT02750514|616443419|FG000|Track 1|Adverse event unrelated to study drug|1|||
170573324|NCT02750514|616443420|FG001|Track 1|Adverse event unrelated to study drug|0|||
170573325|NCT02750514|616443421|FG002|Track 1|Adverse event unrelated to study drug|0|||
170573326|NCT02750514|616443422|FG003|Track 1|Adverse event unrelated to study drug|0|||
170573327|NCT02750514|616443423|FG004|Track 1|Adverse event unrelated to study drug|0|||
170573328|NCT02750514|616443419|FG000|Track 1|Study drug toxicity|4|||
170573329|NCT02750514|616443420|FG001|Track 1|Study drug toxicity|1|||
170908533|NCT00174941|617671080|FG000|Overall Study|Reason Not Specified|1|||
170573330|NCT02750514|616443421|FG002|Track 1|Study drug toxicity|0|||
170573331|NCT02750514|616443422|FG003|Track 1|Study drug toxicity|1|||
170573332|NCT02750514|616443423|FG004|Track 1|Study drug toxicity|0|||
170573333|NCT02750514|616443419|FG000|Track 1|Participant request to discontinue|1|||
170573334|NCT02750514|616443420|FG001|Track 1|Participant request to discontinue|0|||
170573335|NCT02750514|616443421|FG002|Track 1|Participant request to discontinue|0|||
170573336|NCT02750514|616443422|FG003|Track 1|Participant request to discontinue|0|||
170573337|NCT02750514|616443423|FG004|Track 1|Participant request to discontinue|0|||
170573338|NCT02750514|616443419|FG000|Track 1|Other reasons|1|||
170573339|NCT02750514|616443420|FG001|Track 1|Other reasons|0|||
170573340|NCT02750514|616443421|FG002|Track 1|Other reasons|0|||
170573341|NCT02750514|616443422|FG003|Track 1|Other reasons|0|||
170573342|NCT02750514|616443423|FG004|Track 1|Other reasons|0|||
170573343|NCT02750514|616443419|FG000|Track 2|Disease progression|4|||
170573344|NCT02750514|616443420|FG001|Track 2|Disease progression|5|||
170649291|NCT04575597|616729102|FG005|Overall Study|Withdrawal by Subject|28|||
170908534|NCT00174941|617671081|FG001|Overall Study|Reason Not Specified|6|||
170908535|NCT00174941|617671082|FG002|Overall Study|Reason Not Specified|2|||
170908536|NCT00174941|617671083|FG003|Overall Study|Reason Not Specified|9|||
170908537|NCT01702805|617671084|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
170908538|NCT01702805|617671085|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
170908539|NCT01702805|617671084|FG000|Overall Study|Incomplete Follow-up|18|||
170908540|NCT01702805|617671085|FG001|Overall Study|Incomplete Follow-up|15|||
170908541|NCT01702805|617671084|FG000|Overall Study|Vital Status Assessment Only|40|||
170908542|NCT01702805|617671085|FG001|Overall Study|Vital Status Assessment Only|39|||
170908543|NCT01702805|617671084|FG000|Overall Study|Lost to Follow-up|5|||
170908544|NCT01702805|617671085|FG001|Overall Study|Lost to Follow-up|5|||
170908545|NCT03556904|617671089|FG000|Overall Study|Disease Progression after treatment started|3|||
170908546|NCT03556904|617671090|FG001|Overall Study|Disease Progression after treatment started|3|||
170908547|NCT03556904|617671089|FG000|Overall Study|Sponsor Termination|2|||
170908548|NCT03556904|617671090|FG001|Overall Study|Sponsor Termination|2|||
170908549|NCT03556904|617671089|FG000|Overall Study|Physician Decision|2|||
170908550|NCT03556904|617671090|FG001|Overall Study|Physician Decision|0|||
170908551|NCT03556904|617671089|FG000|Overall Study|Withdrawal by Subject|1|||
170908552|NCT03556904|617671090|FG001|Overall Study|Withdrawal by Subject|0|||
170649292|NCT04575597|616729097|FG000|Overall Study|Not Recorded|0|||
170908553|NCT05309083|617671093|FG000|Overall Study|Withdrawal by Subject|2|||
170908554|NCT01238120|617671094|FG000|Overall Study|Withdrawal by Subject|4|||
170908555|NCT01238120|617671095|FG001|Overall Study|Withdrawal by Subject|1|||
170908556|NCT01238120|617671096|FG002|Overall Study|Withdrawal by Subject|2|||
170573345|NCT02750514|616443421|FG002|Track 2|Disease progression|2|||
170573346|NCT02750514|616443422|FG003|Track 2|Disease progression|5|||
170573347|NCT02750514|616443423|FG004|Track 2|Disease progression|0|||
170908557|NCT01238120|617671097|FG003|Overall Study|Withdrawal by Subject|5|||
170908558|NCT01238120|617671094|FG000|Overall Study|Lost to Follow-up|2|||
170908559|NCT01238120|617671095|FG001|Overall Study|Lost to Follow-up|0|||
170908560|NCT01238120|617671096|FG002|Overall Study|Lost to Follow-up|1|||
170908561|NCT01238120|617671097|FG003|Overall Study|Lost to Follow-up|1|||
170908562|NCT01238120|617671094|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
170908563|NCT01238120|617671095|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
170908564|NCT01238120|617671096|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
170908565|NCT01238120|617671097|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
170908566|NCT00881205|617671098|FG000|Overall Study|Adverse Event|8|||
170908567|NCT00881205|617671099|FG001|Overall Study|Adverse Event|3|||
170908568|NCT00881205|617671098|FG000|Overall Study|Withdrawal by Subject|1|||
170908569|NCT00881205|617671099|FG001|Overall Study|Withdrawal by Subject|2|||
170908570|NCT00881205|617671098|FG000|Overall Study|Lost to Follow-up|0|||
170908571|NCT00881205|617671099|FG001|Overall Study|Lost to Follow-up|1|||
170908572|NCT00881205|617671098|FG000|Overall Study|Administrative problems|1|||
170908573|NCT00881205|617671099|FG001|Overall Study|Administrative problems|1|||
170908574|NCT00881205|617671098|FG000|Overall Study|Condition no longer requires drug|1|||
170908575|NCT00881205|617671099|FG001|Overall Study|Condition no longer requires drug|0|||
170908576|NCT02318602|617671100|FG000|Overall Study|Adverse Event|0|||
170908577|NCT02318602|617671101|FG001|Overall Study|Adverse Event|1|||
170908578|NCT02318602|617671102|FG002|Overall Study|Adverse Event|1|||
170908579|NCT02318602|617671100|FG000|Overall Study|Withdrawal by Subject|0|||
170908580|NCT02318602|617671101|FG001|Overall Study|Withdrawal by Subject|3|||
170908581|NCT02318602|617671102|FG002|Overall Study|Withdrawal by Subject|0|||
170908582|NCT02318602|617671100|FG000|Overall Study|Death|1|||
170908583|NCT02318602|617671101|FG001|Overall Study|Death|0|||
170908584|NCT02318602|617671102|FG002|Overall Study|Death|0|||
170908585|NCT02318602|617671100|FG000|Overall Study|Guardian decision to withdraw|0|||
170908586|NCT02318602|617671101|FG001|Overall Study|Guardian decision to withdraw|0|||
170908587|NCT02318602|617671102|FG002|Overall Study|Guardian decision to withdraw|1|||
170908588|NCT01184989|617671103|FG000|Overall Study|Adverse Event|11|||
170908589|NCT01184989|617671103|FG000|Overall Study|Withdrawal by Subject|1|||
170908590|NCT00849212|617671106|FG000|Overall Study|Lack of Efficacy|1|||
170908591|NCT00849212|617671106|FG000|Overall Study|Withdrawal by Subject|3|||
170908592|NCT00849212|617671106|FG000|Overall Study|Adverse Event|2|||
170908593|NCT00849212|617671106|FG000|Overall Study|Miscellaneous|1|||
170908594|NCT03472534|617671107|FG000|Overall Study|Withdrawal by Subject|9|||
170908595|NCT03472534|617671107|FG000|Overall Study|Adverse Event|2|||
170908596|NCT00923091|617671109|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
170908597|NCT00923091|617671110|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
170908598|NCT00923091|617671111|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
170908599|NCT00923091|617671112|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
170908600|NCT00923091|617671113|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
170908601|NCT00923091|617671114|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
170908602|NCT00923091|617671115|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
170908603|NCT00923091|617671116|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
170908604|NCT00923091|617671117|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
170908605|NCT00923091|617671118|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
170908606|NCT00923091|617671119|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
170908607|NCT00923091|617671120|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
170908608|NCT00923091|617671121|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
170908609|NCT00923091|617671109|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
170908610|NCT00923091|617671110|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
170908611|NCT00923091|617671111|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
170908612|NCT00923091|617671112|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
170908613|NCT00923091|617671113|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
170908614|NCT00923091|617671114|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
170908615|NCT00923091|617671115|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
170908616|NCT00923091|617671116|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
170908617|NCT00923091|617671117|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
170908618|NCT00923091|617671118|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
170908619|NCT00923091|617671119|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
170908620|NCT00923091|617671120|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
170908621|NCT00923091|617671121|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
170908622|NCT00923091|617671109|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
170908623|NCT00923091|617671110|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
170908624|NCT00923091|617671111|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
170908625|NCT00923091|617671112|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
170908626|NCT00923091|617671113|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
170908627|NCT00923091|617671114|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
170573348|NCT02750514|616443419|FG000|Track 2|Adverse event unrelated to study drug|1|||
170573349|NCT02750514|616443420|FG001|Track 2|Adverse event unrelated to study drug|0|||
170573350|NCT02750514|616443421|FG002|Track 2|Adverse event unrelated to study drug|0|||
170573351|NCT02750514|616443422|FG003|Track 2|Adverse event unrelated to study drug|0|||
170573352|NCT02750514|616443423|FG004|Track 2|Adverse event unrelated to study drug|0|||
170573353|NCT02750514|616443419|FG000|Track 2|Study drug toxicity|1|||
170573354|NCT02750514|616443420|FG001|Track 2|Study drug toxicity|2|||
170573355|NCT02750514|616443421|FG002|Track 2|Study drug toxicity|0|||
170573356|NCT02750514|616443422|FG003|Track 2|Study drug toxicity|2|||
170573357|NCT02750514|616443423|FG004|Track 2|Study drug toxicity|0|||
170573358|NCT02750514|616443419|FG000|Track 2|Participant withdrew consent|0|||
170908628|NCT00923091|617671115|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
170908629|NCT00923091|617671116|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
170908630|NCT00923091|617671117|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
170908631|NCT00923091|617671118|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
170908632|NCT00923091|617671119|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
170908633|NCT00923091|617671120|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
170908634|NCT00923091|617671121|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
170908635|NCT00923091|617671109|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908636|NCT00923091|617671110|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908637|NCT00923091|617671111|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908638|NCT00923091|617671112|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908639|NCT00923091|617671113|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908640|NCT00923091|617671114|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
170908641|NCT00923091|617671115|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908642|NCT00923091|617671116|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908643|NCT00923091|617671117|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908644|NCT00923091|617671118|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908645|NCT00923091|617671119|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908646|NCT00923091|617671120|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908647|NCT00923091|617671121|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
170908648|NCT00923091|617671109|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908649|NCT00923091|617671110|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
170908650|NCT00923091|617671111|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908651|NCT00923091|617671112|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
170908652|NCT00923091|617671113|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908653|NCT00923091|617671114|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
170908654|NCT00923091|617671115|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908655|NCT00923091|617671116|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908656|NCT00923091|617671117|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908657|NCT00923091|617671118|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908658|NCT00923091|617671119|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908659|NCT00923091|617671120|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170908660|NCT00923091|617671121|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
170573359|NCT02750514|616443420|FG001|Track 2|Participant withdrew consent|1|||
170573360|NCT02750514|616443421|FG002|Track 2|Participant withdrew consent|0|||
170573361|NCT02750514|616443422|FG003|Track 2|Participant withdrew consent|0|||
170573362|NCT02750514|616443423|FG004|Track 2|Participant withdrew consent|0|||
170573363|NCT02750514|616443419|FG000|Track 3|Disease progression|0|||
170573364|NCT02750514|616443420|FG001|Track 3|Disease progression|24|||
170573365|NCT02750514|616443421|FG002|Track 3|Disease progression|13|||
170573366|NCT02750514|616443422|FG003|Track 3|Disease progression|14|||
170573367|NCT02750514|616443423|FG004|Track 3|Disease progression|0|||
170573368|NCT02750514|616443419|FG000|Track 3|Adverse event unrelated to study drug|0|||
170908661|NCT00923091|617671109|FG000|Period III (Single-Blind)|Adverse Event|5|||
170908662|NCT00923091|617671110|FG001|Period III (Single-Blind)|Adverse Event|0|||
170908663|NCT00923091|617671111|FG002|Period III (Single-Blind)|Adverse Event|0|||
170908664|NCT00923091|617671112|FG003|Period III (Single-Blind)|Adverse Event|0|||
170908665|NCT00923091|617671113|FG004|Period III (Single-Blind)|Adverse Event|0|||
170908666|NCT00923091|617671114|FG005|Period III (Single-Blind)|Adverse Event|0|||
170908667|NCT00923091|617671115|FG006|Period III (Single-Blind)|Adverse Event|0|||
170908668|NCT00923091|617671116|FG007|Period III (Single-Blind)|Adverse Event|0|||
170908669|NCT00923091|617671117|FG008|Period III (Single-Blind)|Adverse Event|0|||
170908670|NCT00923091|617671118|FG009|Period III (Single-Blind)|Adverse Event|0|||
170573369|NCT02750514|616443420|FG001|Track 3|Adverse event unrelated to study drug|1|||
170573370|NCT02750514|616443421|FG002|Track 3|Adverse event unrelated to study drug|1|||
170908671|NCT00923091|617671119|FG010|Period III (Single-Blind)|Adverse Event|0|||
170908672|NCT00923091|617671120|FG011|Period III (Single-Blind)|Adverse Event|0|||
170649293|NCT04575597|616729098|FG001|Overall Study|Not Recorded|0|||
170908673|NCT00923091|617671121|FG012|Period III (Single-Blind)|Adverse Event|0|||
170908674|NCT00923091|617671109|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
170908675|NCT00923091|617671110|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908676|NCT00923091|617671111|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908677|NCT00923091|617671112|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908678|NCT00923091|617671113|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908679|NCT00923091|617671114|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908680|NCT00923091|617671115|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908681|NCT00923091|617671116|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908682|NCT00923091|617671117|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908683|NCT00923091|617671118|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908684|NCT00923091|617671119|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908685|NCT00923091|617671120|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908686|NCT00923091|617671121|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
170908687|NCT00923091|617671109|FG000|Period III (Single-Blind)|Protocol Violation|3|||
170573371|NCT02750514|616443422|FG003|Track 3|Adverse event unrelated to study drug|1|||
170573372|NCT02750514|616443423|FG004|Track 3|Adverse event unrelated to study drug|0|||
170573373|NCT02750514|616443419|FG000|Track 3|Study drug toxicity|0|||
170908688|NCT00923091|617671110|FG001|Period III (Single-Blind)|Protocol Violation|0|||
170573374|NCT02750514|616443420|FG001|Track 3|Study drug toxicity|3|||
170908689|NCT00923091|617671111|FG002|Period III (Single-Blind)|Protocol Violation|0|||
170908690|NCT00923091|617671112|FG003|Period III (Single-Blind)|Protocol Violation|0|||
170908691|NCT00923091|617671113|FG004|Period III (Single-Blind)|Protocol Violation|0|||
170908692|NCT00923091|617671114|FG005|Period III (Single-Blind)|Protocol Violation|0|||
170908693|NCT00923091|617671115|FG006|Period III (Single-Blind)|Protocol Violation|0|||
170908694|NCT00923091|617671116|FG007|Period III (Single-Blind)|Protocol Violation|0|||
170908695|NCT00923091|617671117|FG008|Period III (Single-Blind)|Protocol Violation|0|||
170908696|NCT00923091|617671118|FG009|Period III (Single-Blind)|Protocol Violation|0|||
170908697|NCT00923091|617671119|FG010|Period III (Single-Blind)|Protocol Violation|0|||
170908698|NCT00923091|617671120|FG011|Period III (Single-Blind)|Protocol Violation|0|||
170908699|NCT00923091|617671121|FG012|Period III (Single-Blind)|Protocol Violation|0|||
170908700|NCT00923091|617671109|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
170908701|NCT00923091|617671110|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
170908702|NCT00923091|617671111|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
170908703|NCT00923091|617671112|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
170908704|NCT00923091|617671113|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
170908705|NCT00923091|617671114|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
170908706|NCT00923091|617671115|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
170908707|NCT00923091|617671116|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
170908708|NCT00923091|617671117|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
170908709|NCT00923091|617671118|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
170908710|NCT00923091|617671119|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
170573375|NCT02750514|616443421|FG002|Track 3|Study drug toxicity|0|||
170573376|NCT02750514|616443422|FG003|Track 3|Study drug toxicity|1|||
170573377|NCT02750514|616443423|FG004|Track 3|Study drug toxicity|0|||
170908711|NCT00923091|617671120|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
170908712|NCT00923091|617671121|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
170908713|NCT00923091|617671109|FG000|Period IV (Double-Blind)|Adverse Event|2|||
170908714|NCT00923091|617671110|FG001|Period IV (Double-Blind)|Adverse Event|0|||
170908715|NCT00923091|617671111|FG002|Period IV (Double-Blind)|Adverse Event|0|||
170908716|NCT00923091|617671112|FG003|Period IV (Double-Blind)|Adverse Event|0|||
170908717|NCT00923091|617671113|FG004|Period IV (Double-Blind)|Adverse Event|0|||
170908718|NCT00923091|617671114|FG005|Period IV (Double-Blind)|Adverse Event|0|||
170908719|NCT00923091|617671115|FG006|Period IV (Double-Blind)|Adverse Event|0|||
170908720|NCT00923091|617671116|FG007|Period IV (Double-Blind)|Adverse Event|0|||
170908721|NCT00923091|617671117|FG008|Period IV (Double-Blind)|Adverse Event|0|||
170908722|NCT00923091|617671118|FG009|Period IV (Double-Blind)|Adverse Event|0|||
170908723|NCT00923091|617671119|FG010|Period IV (Double-Blind)|Adverse Event|0|||
170908724|NCT00923091|617671120|FG011|Period IV (Double-Blind)|Adverse Event|0|||
170908725|NCT00923091|617671121|FG012|Period IV (Double-Blind)|Adverse Event|0|||
170908726|NCT00923091|617671109|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908727|NCT00923091|617671110|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
170908728|NCT00923091|617671111|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908729|NCT00923091|617671112|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908730|NCT00923091|617671113|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908731|NCT00923091|617671114|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908732|NCT00923091|617671115|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908733|NCT00923091|617671116|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908734|NCT00923091|617671117|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908735|NCT00923091|617671118|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908736|NCT00923091|617671119|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908737|NCT00923091|617671120|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908738|NCT00923091|617671121|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
170908739|NCT00923091|617671109|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
170908740|NCT00923091|617671110|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
170908741|NCT00923091|617671111|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
170908742|NCT00923091|617671112|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
170908743|NCT00923091|617671113|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
170908744|NCT00923091|617671114|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
170908745|NCT00923091|617671115|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
170908746|NCT00923091|617671116|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
170908747|NCT00923091|617671117|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
170908748|NCT00923091|617671118|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
170908749|NCT00923091|617671119|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
170908750|NCT00923091|617671120|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
170908751|NCT00923091|617671121|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
170908752|NCT00923091|617671109|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908753|NCT00923091|617671110|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908754|NCT00923091|617671111|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908755|NCT00923091|617671112|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908756|NCT00923091|617671113|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908757|NCT00923091|617671114|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908758|NCT00923091|617671115|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908759|NCT00923091|617671116|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908760|NCT00923091|617671117|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
170908761|NCT00923091|617671118|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908762|NCT00923091|617671119|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908763|NCT00923091|617671120|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
170908764|NCT00923091|617671121|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
170908765|NCT00923091|617671109|FG000|Period V (Double -Blind)|Protocol Violation|0|||
170908766|NCT00923091|617671110|FG001|Period V (Double -Blind)|Protocol Violation|0|||
170908767|NCT00923091|617671111|FG002|Period V (Double -Blind)|Protocol Violation|0|||
170908768|NCT00923091|617671112|FG003|Period V (Double -Blind)|Protocol Violation|0|||
170908769|NCT00923091|617671113|FG004|Period V (Double -Blind)|Protocol Violation|0|||
170908770|NCT00923091|617671114|FG005|Period V (Double -Blind)|Protocol Violation|0|||
170908771|NCT00923091|617671115|FG006|Period V (Double -Blind)|Protocol Violation|0|||
170908772|NCT00923091|617671116|FG007|Period V (Double -Blind)|Protocol Violation|0|||
170908773|NCT00923091|617671117|FG008|Period V (Double -Blind)|Protocol Violation|0|||
170908774|NCT00923091|617671118|FG009|Period V (Double -Blind)|Protocol Violation|0|||
170908775|NCT00923091|617671119|FG010|Period V (Double -Blind)|Protocol Violation|0|||
170908776|NCT00923091|617671120|FG011|Period V (Double -Blind)|Protocol Violation|0|||
170908777|NCT00923091|617671121|FG012|Period V (Double -Blind)|Protocol Violation|1|||
170908778|NCT00923091|617671109|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
170908779|NCT00923091|617671110|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
170908780|NCT00923091|617671111|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
170908781|NCT00923091|617671112|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
170908782|NCT00923091|617671113|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
170908783|NCT00923091|617671114|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
170908784|NCT00923091|617671115|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
170908785|NCT00923091|617671116|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
170908786|NCT00923091|617671117|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
170573378|NCT02750514|616443419|FG000|Track 3|Participant request to discontinue|0|||
170573379|NCT02750514|616443420|FG001|Track 3|Participant request to discontinue|2|||
170573380|NCT02750514|616443421|FG002|Track 3|Participant request to discontinue|0|||
170573381|NCT02750514|616443422|FG003|Track 3|Participant request to discontinue|0|||
170573382|NCT02750514|616443423|FG004|Track 3|Participant request to discontinue|0|||
170573383|NCT02750514|616443419|FG000|Track 3|Participant withdrew consent|0|||
170573384|NCT02750514|616443420|FG001|Track 3|Participant withdrew consent|3|||
170573385|NCT02750514|616443421|FG002|Track 3|Participant withdrew consent|1|||
170573386|NCT02750514|616443422|FG003|Track 3|Participant withdrew consent|0|||
170573387|NCT02750514|616443423|FG004|Track 3|Participant withdrew consent|0|||
170573388|NCT02750514|616443419|FG000|Track 3|Other reasons|0|||
170573389|NCT02750514|616443420|FG001|Track 3|Other reasons|3|||
170573390|NCT02750514|616443421|FG002|Track 3|Other reasons|0|||
170573391|NCT02750514|616443422|FG003|Track 3|Other reasons|0|||
170573392|NCT02750514|616443423|FG004|Track 3|Other reasons|0|||
170573393|NCT02750514|616443419|FG000|Track 4|Study drug toxicity|0|||
170573394|NCT02750514|616443420|FG001|Track 4|Study drug toxicity|6|||
170573395|NCT02750514|616443421|FG002|Track 4|Study drug toxicity|0|||
170573396|NCT02750514|616443422|FG003|Track 4|Study drug toxicity|5|||
170573397|NCT02750514|616443423|FG004|Track 4|Study drug toxicity|0|||
170573398|NCT02750514|616443419|FG000|Track 4|Participant request to discontinue|0|||
170573399|NCT02750514|616443420|FG001|Track 4|Participant request to discontinue|1|||
170573400|NCT02750514|616443421|FG002|Track 4|Participant request to discontinue|0|||
170573401|NCT02750514|616443422|FG003|Track 4|Participant request to discontinue|1|||
170573402|NCT02750514|616443423|FG004|Track 4|Participant request to discontinue|0|||
170573403|NCT02750514|616443419|FG000|Track 4|Participant withdrew consent|0|||
170573404|NCT02750514|616443420|FG001|Track 4|Participant withdrew consent|1|||
170573405|NCT02750514|616443421|FG002|Track 4|Participant withdrew consent|0|||
170573406|NCT02750514|616443422|FG003|Track 4|Participant withdrew consent|0|||
170573407|NCT02750514|616443423|FG004|Track 4|Participant withdrew consent|0|||
170573408|NCT02750514|616443419|FG000|Track 4|Other reasons|0|||
170573409|NCT02750514|616443420|FG001|Track 4|Other reasons|5|||
170573410|NCT02750514|616443421|FG002|Track 4|Other reasons|0|||
170573411|NCT02750514|616443422|FG003|Track 4|Other reasons|3|||
170573412|NCT02750514|616443423|FG004|Track 4|Other reasons|0|||
170573413|NCT02750514|616443419|FG000|Track 4|Disease progression|0|||
170573414|NCT02750514|616443420|FG001|Track 4|Disease progression|33|||
170649294|NCT04575597|616729099|FG002|Overall Study|Not Recorded|0|||
170649295|NCT04575597|616729100|FG003|Overall Study|Not Recorded|0|||
170649296|NCT04575597|616729101|FG004|Overall Study|Not Recorded|0|||
170649297|NCT04575597|616729102|FG005|Overall Study|Not Recorded|2|||
170649298|NCT04575597|616729097|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170649299|NCT04575597|616729098|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170649300|NCT04575597|616729099|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170649301|NCT04575597|616729100|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170649302|NCT04575597|616729101|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
170649303|NCT04575597|616729102|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
170649304|NCT00409175|616729104|FG000|Overall Study|Adverse Event|4|||
170649305|NCT00409175|616729105|FG001|Overall Study|Adverse Event|3|||
170649306|NCT00409175|616729104|FG000|Overall Study|Withdrawal by Subject|1|||
170649307|NCT00409175|616729105|FG001|Overall Study|Withdrawal by Subject|2|||
170649308|NCT00409175|616729104|FG000|Overall Study|Negative genotype|0|||
170649309|NCT00409175|616729105|FG001|Overall Study|Negative genotype|1|||
170649310|NCT00409175|616729104|FG000|Overall Study|Liver transplantation|13|||
170649311|NCT00409175|616729105|FG001|Overall Study|Liver transplantation|13|||
170649312|NCT03316911|616729113|FG000|Overall Study|Lost to Follow-up|33|||
170649313|NCT03316911|616729114|FG001|Overall Study|Lost to Follow-up|29|||
170649314|NCT01119937|616729115|FG000|Overall Study|Adverse Event|11|||
170649315|NCT01119937|616729116|FG001|Overall Study|Adverse Event|5|||
170649316|NCT01119937|616729115|FG000|Overall Study|Protocol deviation|3|||
170649317|NCT01119937|616729116|FG001|Overall Study|Protocol deviation|1|||
170649318|NCT01119937|616729115|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
170649319|NCT01119937|616729116|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170649320|NCT01119937|616729115|FG000|Overall Study|Withdrawal by Subject|2|||
170649321|NCT01119937|616729116|FG001|Overall Study|Withdrawal by Subject|1|||
170649322|NCT00548184|616729127|FG000|Overall Study|Adverse Event|3|||
170649323|NCT00548184|616729127|FG000|Overall Study|took other drug|1|||
170649324|NCT00548184|616729127|FG000|Overall Study|Found Her2 negative|1|||
170649325|NCT02431260|616729133|FG000|Overall Study|Subject Decision|0|||
170649326|NCT02431260|616729134|FG001|Overall Study|Subject Decision|1|||
170649327|NCT02431260|616729135|FG002|Overall Study|Subject Decision|1|||
170649328|NCT02431260|616729136|FG003|Overall Study|Subject Decision|0|||
170649329|NCT02431260|616729137|FG004|Overall Study|Subject Decision|0|||
170573415|NCT02750514|616443421|FG002|Track 4|Disease progression|0|||
170573416|NCT02750514|616443422|FG003|Track 4|Disease progression|32|||
170573417|NCT02750514|616443423|FG004|Track 4|Disease progression|0|||
170573418|NCT02750514|616443419|FG000|Track 4|Adverse event unrelated to study drug|0|||
170573419|NCT02750514|616443420|FG001|Track 4|Adverse event unrelated to study drug|5|||
170573420|NCT02750514|616443421|FG002|Track 4|Adverse event unrelated to study drug|0|||
170573421|NCT02750514|616443422|FG003|Track 4|Adverse event unrelated to study drug|0|||
170573422|NCT02750514|616443423|FG004|Track 4|Adverse event unrelated to study drug|0|||
170573423|NCT02750514|616443419|FG000|Track 4|Death|0|||
170573424|NCT02750514|616443420|FG001|Track 4|Death|0|||
170573425|NCT02750514|616443421|FG002|Track 4|Death|0|||
170573426|NCT02750514|616443422|FG003|Track 4|Death|1|||
170573427|NCT02750514|616443423|FG004|Track 4|Death|0|||
170573428|NCT02750514|616443419|FG000|Track 5|Disease progression|0|||
170573429|NCT02750514|616443420|FG001|Track 5|Disease progression|0|||
170573430|NCT02750514|616443421|FG002|Track 5|Disease progression|0|||
170573431|NCT02750514|616443422|FG003|Track 5|Disease progression|0|||
170573432|NCT02750514|616443423|FG004|Track 5|Disease progression|34|||
170573433|NCT02750514|616443419|FG000|Track 5|Adverse event unrelated to study drug|0|||
170573434|NCT02750514|616443420|FG001|Track 5|Adverse event unrelated to study drug|0|||
170573435|NCT02750514|616443421|FG002|Track 5|Adverse event unrelated to study drug|0|||
170573436|NCT02750514|616443422|FG003|Track 5|Adverse event unrelated to study drug|0|||
170573437|NCT02750514|616443423|FG004|Track 5|Adverse event unrelated to study drug|2|||
170573438|NCT02750514|616443419|FG000|Track 5|Study drug toxicity|0|||
170573439|NCT02750514|616443420|FG001|Track 5|Study drug toxicity|0|||
170573440|NCT02750514|616443421|FG002|Track 5|Study drug toxicity|0|||
170573441|NCT02750514|616443422|FG003|Track 5|Study drug toxicity|0|||
170573442|NCT02750514|616443423|FG004|Track 5|Study drug toxicity|2|||
170573443|NCT02750514|616443419|FG000|Track 5|Participant request to discontinue|0|||
170573444|NCT02750514|616443420|FG001|Track 5|Participant request to discontinue|0|||
170908787|NCT00923091|617671118|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
170908788|NCT00923091|617671119|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
170908789|NCT00923091|617671120|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
170908790|NCT00923091|617671121|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
170908791|NCT00923091|617671109|FG000|Period VI (Open-Label)|Adverse Event|17|||
170908792|NCT00923091|617671110|FG001|Period VI (Open-Label)|Adverse Event|0|||
170908793|NCT00923091|617671111|FG002|Period VI (Open-Label)|Adverse Event|4|||
170908794|NCT00923091|617671112|FG003|Period VI (Open-Label)|Adverse Event|1|||
170908795|NCT00923091|617671113|FG004|Period VI (Open-Label)|Adverse Event|1|||
170908796|NCT00923091|617671114|FG005|Period VI (Open-Label)|Adverse Event|0|||
170908797|NCT00923091|617671115|FG006|Period VI (Open-Label)|Adverse Event|0|||
170908798|NCT00923091|617671116|FG007|Period VI (Open-Label)|Adverse Event|0|||
170908799|NCT00923091|617671117|FG008|Period VI (Open-Label)|Adverse Event|0|||
170908800|NCT00923091|617671118|FG009|Period VI (Open-Label)|Adverse Event|0|||
170908801|NCT00923091|617671119|FG010|Period VI (Open-Label)|Adverse Event|0|||
170573445|NCT02750514|616443421|FG002|Track 5|Participant request to discontinue|0|||
170573446|NCT02750514|616443422|FG003|Track 5|Participant request to discontinue|0|||
170573447|NCT02750514|616443423|FG004|Track 5|Participant request to discontinue|3|||
170908802|NCT00923091|617671120|FG011|Period VI (Open-Label)|Adverse Event|0|||
170908803|NCT00923091|617671121|FG012|Period VI (Open-Label)|Adverse Event|0|||
170908804|NCT00923091|617671109|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
170908805|NCT00923091|617671110|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
170908806|NCT00923091|617671111|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
170573448|NCT02750514|616443419|FG000|Track 5|Other reasons|0|||
170573449|NCT02750514|616443420|FG001|Track 5|Other reasons|0|||
170573450|NCT02750514|616443421|FG002|Track 5|Other reasons|0|||
170573451|NCT02750514|616443422|FG003|Track 5|Other reasons|0|||
170573452|NCT02750514|616443423|FG004|Track 5|Other reasons|2|||
170573453|NCT01492088|616443424|FG000|Overall Study|Withdrawal by Patient|0|||
170573454|NCT01492088|616443425|FG001|Overall Study|Withdrawal by Patient|2|||
170573455|NCT01492088|616443426|FG002|Overall Study|Withdrawal by Patient|0|||
170573456|NCT01492088|616443424|FG000|Overall Study|Death|1|||
170573457|NCT01492088|616443425|FG001|Overall Study|Death|6|||
170573458|NCT01492088|616443426|FG002|Overall Study|Death|2|||
170573459|NCT01492088|616443424|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
170908807|NCT00923091|617671112|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
170908808|NCT00923091|617671113|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
170908809|NCT00923091|617671114|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
170908810|NCT00923091|617671115|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
170573460|NCT01492088|616443425|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
170573461|NCT01492088|616443426|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
170573462|NCT01492088|616443424|FG000|Overall Study|Alive at Last Follow-up|0|||
170573463|NCT01492088|616443425|FG001|Overall Study|Alive at Last Follow-up|6|||
170573464|NCT01492088|616443426|FG002|Overall Study|Alive at Last Follow-up|11|||
170573465|NCT00889707|616443433|FG000|Overall Study|Adverse Event|1|||
170649330|NCT02431260|616729138|FG005|Overall Study|Subject Decision|0|||
170908811|NCT00923091|617671116|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
170573466|NCT00889707|616443434|FG001|Overall Study|Adverse Event|0|||
170573467|NCT00889707|616443433|FG000|Overall Study|Withdrawal by Subject|4|||
170573468|NCT00889707|616443434|FG001|Overall Study|Withdrawal by Subject|3|||
170573469|NCT00889707|616443433|FG000|Overall Study|Lost to Follow-up|0|||
170573470|NCT00889707|616443434|FG001|Overall Study|Lost to Follow-up|2|||
170573471|NCT00889707|616443433|FG000|Overall Study|Lack of Efficacy|2|||
170573472|NCT00889707|616443434|FG001|Overall Study|Lack of Efficacy|5|||
170573473|NCT02041299|616443435|FG000|Overall Study|Adverse Event|9|||
170573474|NCT02041299|616443436|FG001|Overall Study|Adverse Event|3|||
170573475|NCT02041299|616443435|FG000|Overall Study|Lost to Follow-up|4|||
170573476|NCT02041299|616443436|FG001|Overall Study|Lost to Follow-up|1|||
170573477|NCT02041299|616443435|FG000|Overall Study|Physician Decision|1|||
170573478|NCT02041299|616443436|FG001|Overall Study|Physician Decision|1|||
170573479|NCT02041299|616443435|FG000|Overall Study|Withdrawal by Subject|13|||
170573480|NCT02041299|616443436|FG001|Overall Study|Withdrawal by Subject|7|||
170573481|NCT02041299|616443435|FG000|Overall Study|Protocol Violation|11|||
170573482|NCT02041299|616443436|FG001|Overall Study|Protocol Violation|4|||
170573483|NCT02041299|616443435|FG000|Overall Study|Termination of the study|7|||
170573484|NCT02041299|616443436|FG001|Overall Study|Termination of the study|3|||
170573485|NCT02041299|616443435|FG000|Overall Study|Required bone marrow transplant|0|||
170573486|NCT02041299|616443436|FG001|Overall Study|Required bone marrow transplant|1|||
170573487|NCT02041299|616443435|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
170573488|NCT02041299|616443436|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
170573489|NCT01964378|616443441|FG000|Overall Study|Disc. due to death before first dosing|0|||
170573490|NCT01964378|616443442|FG001|Overall Study|Disc. due to death before first dosing|1|||
170573491|NCT01964378|616443441|FG000|Overall Study|Disc. due to AE before first dosing|1|||
170908812|NCT00923091|617671117|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
170908813|NCT00923091|617671118|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
170908814|NCT00923091|617671119|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
170908815|NCT00923091|617671120|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
170908816|NCT00923091|617671121|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
170573492|NCT01964378|616443442|FG001|Overall Study|Disc. due to AE before first dosing|0|||
170573493|NCT01964378|616443441|FG000|Overall Study|Death|3|||
170573494|NCT01964378|616443442|FG001|Overall Study|Death|2|||
170573495|NCT01964378|616443441|FG000|Overall Study|Adverse Event|12|||
170573496|NCT01964378|616443442|FG001|Overall Study|Adverse Event|5|||
170573497|NCT01964378|616443441|FG000|Overall Study|Lack of Efficacy|0|||
170573498|NCT01964378|616443442|FG001|Overall Study|Lack of Efficacy|1|||
170573499|NCT01964378|616443441|FG000|Overall Study|Protocol Violation|0|||
170573500|NCT01964378|616443442|FG001|Overall Study|Protocol Violation|1|||
170573501|NCT01964378|616443441|FG000|Overall Study|Lost to Follow-up|0|||
170908817|NCT00923091|617671109|FG000|Period VI (Open-Label)|Protocol Violation|6|||
170573502|NCT01964378|616443442|FG001|Overall Study|Lost to Follow-up|1|||
170573503|NCT01964378|616443441|FG000|Overall Study|Withdrawal by Subject|7|||
170573504|NCT01964378|616443442|FG001|Overall Study|Withdrawal by Subject|5|||
170573505|NCT01964378|616443441|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
170573506|NCT01964378|616443442|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
170908818|NCT00923091|617671110|FG001|Period VI (Open-Label)|Protocol Violation|1|||
170573507|NCT01964378|616443441|FG000|Overall Study|Other|1|||
170908819|NCT00923091|617671111|FG002|Period VI (Open-Label)|Protocol Violation|3|||
170908820|NCT00923091|617671112|FG003|Period VI (Open-Label)|Protocol Violation|1|||
170573508|NCT01964378|616443442|FG001|Overall Study|Other|2|||
170908821|NCT00923091|617671113|FG004|Period VI (Open-Label)|Protocol Violation|4|||
170908822|NCT00923091|617671114|FG005|Period VI (Open-Label)|Protocol Violation|0|||
170908823|NCT00923091|617671115|FG006|Period VI (Open-Label)|Protocol Violation|0|||
170908824|NCT00923091|617671116|FG007|Period VI (Open-Label)|Protocol Violation|0|||
170908825|NCT00923091|617671117|FG008|Period VI (Open-Label)|Protocol Violation|0|||
170908826|NCT00923091|617671118|FG009|Period VI (Open-Label)|Protocol Violation|0|||
170908827|NCT00923091|617671119|FG010|Period VI (Open-Label)|Protocol Violation|0|||
170908828|NCT00923091|617671120|FG011|Period VI (Open-Label)|Protocol Violation|0|||
170908829|NCT00923091|617671121|FG012|Period VI (Open-Label)|Protocol Violation|0|||
170908830|NCT00923091|617671109|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
170908831|NCT00923091|617671110|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
170908832|NCT00923091|617671111|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
170908833|NCT00923091|617671112|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
170908834|NCT00923091|617671113|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
170908835|NCT00923091|617671114|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
170908836|NCT00923091|617671115|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
170908837|NCT00923091|617671116|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
170908838|NCT00923091|617671117|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
170908839|NCT00923091|617671118|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
170908840|NCT00923091|617671119|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
170908841|NCT00923091|617671120|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
170908842|NCT00923091|617671121|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
170908843|NCT00923091|617671109|FG000|Period VI (Open-Label)|Other Reason|0|||
170908844|NCT00923091|617671110|FG001|Period VI (Open-Label)|Other Reason|0|||
170573509|NCT04749745|616443448|FG000|Overall Study|Withdrawal by Subject|1|||
170573510|NCT04749745|616443449|FG001|Overall Study|Withdrawal by Subject|0|||
170573511|NCT01365455|616443453|FG000|Induction Period|Adverse Event|5|||
170573512|NCT01365455|616443454|FG001|Induction Period|Adverse Event|3|||
170908845|NCT00923091|617671111|FG002|Period VI (Open-Label)|Other Reason|0|||
170908846|NCT00923091|617671112|FG003|Period VI (Open-Label)|Other Reason|1|||
170908847|NCT00923091|617671113|FG004|Period VI (Open-Label)|Other Reason|1|||
170573513|NCT01365455|616443455|FG002|Induction Period|Adverse Event|4|||
170573514|NCT01365455|616443456|FG003|Induction Period|Adverse Event|0|||
170573515|NCT01365455|616443457|FG004|Induction Period|Adverse Event|0|||
170573516|NCT01365455|616443453|FG000|Induction Period|Lack of Efficacy|1|||
170573517|NCT01365455|616443454|FG001|Induction Period|Lack of Efficacy|1|||
170573518|NCT01365455|616443455|FG002|Induction Period|Lack of Efficacy|0|||
170573519|NCT01365455|616443456|FG003|Induction Period|Lack of Efficacy|0|||
170573520|NCT01365455|616443457|FG004|Induction Period|Lack of Efficacy|0|||
170573521|NCT01365455|616443453|FG000|Induction Period|Pregnancy|0|||
170573522|NCT01365455|616443454|FG001|Induction Period|Pregnancy|1|||
170573523|NCT01365455|616443455|FG002|Induction Period|Pregnancy|0|||
170573524|NCT01365455|616443456|FG003|Induction Period|Pregnancy|0|||
170573525|NCT01365455|616443457|FG004|Induction Period|Pregnancy|0|||
170573526|NCT01365455|616443453|FG000|Induction Period|Protocol deviation|0|||
170573527|NCT01365455|616443454|FG001|Induction Period|Protocol deviation|1|||
170573528|NCT01365455|616443455|FG002|Induction Period|Protocol deviation|1|||
170573529|NCT01365455|616443456|FG003|Induction Period|Protocol deviation|0|||
170573530|NCT01365455|616443457|FG004|Induction Period|Protocol deviation|0|||
170573531|NCT01365455|616443453|FG000|Induction Period|Subject/guardian decision|9|||
170573532|NCT01365455|616443454|FG001|Induction Period|Subject/guardian decision|1|||
170573533|NCT01365455|616443455|FG002|Induction Period|Subject/guardian decision|8|||
170573534|NCT01365455|616443456|FG003|Induction Period|Subject/guardian decision|0|||
170573535|NCT01365455|616443457|FG004|Induction Period|Subject/guardian decision|0|||
170573536|NCT01365455|616443453|FG000|Induction Period|Lost to Follow-up|0|||
170573537|NCT01365455|616443454|FG001|Induction Period|Lost to Follow-up|0|||
170573538|NCT01365455|616443455|FG002|Induction Period|Lost to Follow-up|3|||
170573539|NCT01365455|616443456|FG003|Induction Period|Lost to Follow-up|0|||
170573540|NCT01365455|616443457|FG004|Induction Period|Lost to Follow-up|0|||
170573541|NCT01365455|616443453|FG000|Maintenance Period|Adverse Event|12|||
170573542|NCT01365455|616443454|FG001|Maintenance Period|Adverse Event|5|||
170573543|NCT01365455|616443455|FG002|Maintenance Period|Adverse Event|1|||
170573544|NCT01365455|616443456|FG003|Maintenance Period|Adverse Event|2|||
170573545|NCT01365455|616443457|FG004|Maintenance Period|Adverse Event|4|||
170573546|NCT01365455|616443453|FG000|Maintenance Period|Lack of Efficacy|10|||
170573547|NCT01365455|616443454|FG001|Maintenance Period|Lack of Efficacy|2|||
170573548|NCT01365455|616443455|FG002|Maintenance Period|Lack of Efficacy|0|||
170573549|NCT01365455|616443456|FG003|Maintenance Period|Lack of Efficacy|2|||
170573550|NCT01365455|616443457|FG004|Maintenance Period|Lack of Efficacy|2|||
170573551|NCT01365455|616443453|FG000|Maintenance Period|Lost to Follow-up|2|||
170908848|NCT00923091|617671114|FG005|Period VI (Open-Label)|Other Reason|0|||
170908849|NCT00923091|617671115|FG006|Period VI (Open-Label)|Other Reason|0|||
170908850|NCT00923091|617671116|FG007|Period VI (Open-Label)|Other Reason|0|||
170908851|NCT00923091|617671117|FG008|Period VI (Open-Label)|Other Reason|0|||
170908852|NCT00923091|617671118|FG009|Period VI (Open-Label)|Other Reason|0|||
170908853|NCT00923091|617671119|FG010|Period VI (Open-Label)|Other Reason|0|||
170908854|NCT00923091|617671120|FG011|Period VI (Open-Label)|Other Reason|0|||
170573552|NCT01365455|616443454|FG001|Maintenance Period|Lost to Follow-up|4|||
170573553|NCT01365455|616443455|FG002|Maintenance Period|Lost to Follow-up|0|||
170573554|NCT01365455|616443456|FG003|Maintenance Period|Lost to Follow-up|0|||
170573555|NCT01365455|616443457|FG004|Maintenance Period|Lost to Follow-up|3|||
170573556|NCT01365455|616443453|FG000|Maintenance Period|Non-compliance with study treatment|0|||
170573557|NCT01365455|616443454|FG001|Maintenance Period|Non-compliance with study treatment|0|||
170573558|NCT01365455|616443455|FG002|Maintenance Period|Non-compliance with study treatment|0|||
170573559|NCT01365455|616443456|FG003|Maintenance Period|Non-compliance with study treatment|1|||
170573560|NCT01365455|616443457|FG004|Maintenance Period|Non-compliance with study treatment|0|||
170573561|NCT01365455|616443453|FG000|Maintenance Period|Physician Decision|0|||
170573562|NCT01365455|616443454|FG001|Maintenance Period|Physician Decision|1|||
170573563|NCT01365455|616443455|FG002|Maintenance Period|Physician Decision|0|||
170573564|NCT01365455|616443456|FG003|Maintenance Period|Physician Decision|0|||
170573565|NCT01365455|616443457|FG004|Maintenance Period|Physician Decision|1|||
170573566|NCT01365455|616443453|FG000|Maintenance Period|Pregnancy|0|||
170573567|NCT01365455|616443454|FG001|Maintenance Period|Pregnancy|4|||
170573568|NCT01365455|616443455|FG002|Maintenance Period|Pregnancy|0|||
170573569|NCT01365455|616443456|FG003|Maintenance Period|Pregnancy|0|||
170573570|NCT01365455|616443457|FG004|Maintenance Period|Pregnancy|2|||
170573571|NCT01365455|616443453|FG000|Maintenance Period|Protocol deviation|1|||
170573572|NCT01365455|616443454|FG001|Maintenance Period|Protocol deviation|1|||
170573573|NCT01365455|616443455|FG002|Maintenance Period|Protocol deviation|0|||
170573574|NCT01365455|616443456|FG003|Maintenance Period|Protocol deviation|0|||
170573575|NCT01365455|616443457|FG004|Maintenance Period|Protocol deviation|0|||
170573576|NCT01365455|616443453|FG000|Maintenance Period|Subject/guardian decision|4|||
170573577|NCT01365455|616443454|FG001|Maintenance Period|Subject/guardian decision|6|||
170573578|NCT01365455|616443455|FG002|Maintenance Period|Subject/guardian decision|2|||
170573579|NCT01365455|616443456|FG003|Maintenance Period|Subject/guardian decision|4|||
170573580|NCT01365455|616443457|FG004|Maintenance Period|Subject/guardian decision|1|||
170573581|NCT03640325|616444932|FG000|Overall Study|Withdrawal by Subject|4|||
170573582|NCT03640325|616444933|FG001|Overall Study|Withdrawal by Subject|1|||
170573583|NCT03640325|616444934|FG002|Overall Study|Withdrawal by Subject|0|||
170573584|NCT03640325|616444932|FG000|Overall Study|Lost to Follow-up|4|||
170573585|NCT03640325|616444933|FG001|Overall Study|Lost to Follow-up|5|||
170573586|NCT03640325|616444934|FG002|Overall Study|Lost to Follow-up|21|||
170573587|NCT03640325|616444932|FG000|Overall Study|Death|5|||
170573588|NCT03640325|616444933|FG001|Overall Study|Death|5|||
170573589|NCT03640325|616444934|FG002|Overall Study|Death|0|||
170573590|NCT05265728|616444935|FG000|Overall Study|Adverse Event|1|||
170573591|NCT05265728|616444935|FG000|Overall Study|Study Terminated by Sponsor|5|||
170573592|NCT05265728|616444935|FG000|Overall Study|Withdrawal by Subject|2|||
170573593|NCT01566149|616444937|FG000|Overall Study|Adverse Event|0|||
170573594|NCT01566149|616444938|FG001|Overall Study|Adverse Event|1|||
170573595|NCT01566149|616444937|FG000|Overall Study|Non-compliance with study medication|2|||
170573596|NCT01566149|616444938|FG001|Overall Study|Non-compliance with study medication|0|||
170573597|NCT01566149|616444937|FG000|Overall Study|Protocol Violation|0|||
170573598|NCT01566149|616444938|FG001|Overall Study|Protocol Violation|1|||
170573599|NCT01566149|616444937|FG000|Overall Study|Withdrawal by Subject|1|||
170573600|NCT01566149|616444938|FG001|Overall Study|Withdrawal by Subject|0|||
170573601|NCT00662831|616444941|FG000|Overall Study|Death|4|||
170573602|NCT00662831|616444942|FG001|Overall Study|Death|1|||
170573603|NCT00662831|616444941|FG000|Overall Study|Lack of Efficacy|6|||
170573604|NCT00662831|616444942|FG001|Overall Study|Lack of Efficacy|6|||
170573605|NCT00662831|616444941|FG000|Overall Study|Lost to Follow-up|1|||
170573606|NCT00662831|616444942|FG001|Overall Study|Lost to Follow-up|0|||
170573607|NCT00662831|616444941|FG000|Overall Study|Withdrawal by Subject|2|||
170573608|NCT00662831|616444942|FG001|Overall Study|Withdrawal by Subject|1|||
170573609|NCT00662831|616444941|FG000|Overall Study|Other|62|||
170573610|NCT00662831|616444942|FG001|Overall Study|Other|31|||
170573611|NCT00662831|616444941|FG000|Overall Study|Protocol Violation|8|||
170573612|NCT00662831|616444942|FG001|Overall Study|Protocol Violation|4|||
170573613|NCT00662831|616444941|FG000|Overall Study|Adverse Event|23|||
170573614|NCT00662831|616444942|FG001|Overall Study|Adverse Event|16|||
170573615|NCT01724216|616444948|FG000|Overall Study|Scan was not completed|1|||
170573616|NCT00564733|616444949|FG000|Overall Study|Withdrawal by Subject|4|||
170573617|NCT00564733|616444949|FG000|Overall Study|Ineligible|5|||
170908855|NCT00923091|617671121|FG012|Period VI (Open-Label)|Other Reason|0|||
170573618|NCT01169337|616444952|FG000|Overall Study|Lack of Efficacy|5|||
170573619|NCT01169337|616444953|FG001|Overall Study|Lack of Efficacy|7|||
170573620|NCT01169337|616444954|FG002|Overall Study|Lack of Efficacy|0|||
170908856|NCT04246047|617671127|FG000|Overall Study|Death|50|||
170573621|NCT01169337|616444952|FG000|Overall Study|Adverse Event|12|||
170573622|NCT01169337|616444953|FG001|Overall Study|Adverse Event|18|||
170573623|NCT01169337|616444954|FG002|Overall Study|Adverse Event|0|||
170573624|NCT01169337|616444952|FG000|Overall Study|Death|2|||
170573625|NCT01169337|616444953|FG001|Overall Study|Death|0|||
170573626|NCT01169337|616444954|FG002|Overall Study|Death|0|||
170573627|NCT01169337|616444952|FG000|Overall Study|Withdrawal by Subject|11|||
170573628|NCT01169337|616444953|FG001|Overall Study|Withdrawal by Subject|11|||
170573629|NCT01169337|616444954|FG002|Overall Study|Withdrawal by Subject|6|||
170908857|NCT04246047|617671128|FG001|Overall Study|Death|77|||
170808674|NCT01959698|617308999|FG004|Overall Study|Adverse Event|0|||
170808675|NCT01959698|617309000|FG005|Overall Study|Adverse Event|0|||
170808676|NCT01959698|617309001|FG006|Overall Study|Adverse Event|1|||
170808677|NCT01959698|617308995|FG000|Overall Study|Physician Decision|1|||
170808678|NCT01959698|617308996|FG001|Overall Study|Physician Decision|0|||
170808679|NCT01959698|617308997|FG002|Overall Study|Physician Decision|1|||
170808680|NCT01959698|617308998|FG003|Overall Study|Physician Decision|2|||
170808681|NCT01959698|617308999|FG004|Overall Study|Physician Decision|0|||
170808682|NCT01959698|617309000|FG005|Overall Study|Physician Decision|3|||
170808683|NCT01959698|617309001|FG006|Overall Study|Physician Decision|3|||
170808684|NCT03769090|617310388|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
170808685|NCT03769090|617310389|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
170808686|NCT03769090|617310390|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
170573630|NCT01169337|616444952|FG000|Overall Study|Noncompliance|2|||
170908858|NCT04246047|617671127|FG000|Overall Study|Lost to Follow-up|1|||
170908859|NCT04246047|617671128|FG001|Overall Study|Lost to Follow-up|3|||
170908860|NCT04246047|617671127|FG000|Overall Study|Physician Decision|4|||
170908861|NCT04246047|617671128|FG001|Overall Study|Physician Decision|10|||
170573631|NCT01169337|616444953|FG001|Overall Study|Noncompliance|0|||
170573632|NCT01169337|616444954|FG002|Overall Study|Noncompliance|0|||
170573633|NCT01169337|616444952|FG000|Overall Study|Other complicating disease|1|||
170573634|NCT01169337|616444953|FG001|Overall Study|Other complicating disease|1|||
170573635|NCT01169337|616444954|FG002|Overall Study|Other complicating disease|0|||
170573636|NCT01169337|616444952|FG000|Overall Study|Physician Decision|1|||
170573637|NCT01169337|616444953|FG001|Overall Study|Physician Decision|5|||
170573638|NCT01169337|616444954|FG002|Overall Study|Physician Decision|0|||
170573639|NCT01169337|616444952|FG000|Overall Study|Alternative therapy|0|||
170573640|NCT01169337|616444953|FG001|Overall Study|Alternative therapy|2|||
170573641|NCT01169337|616444954|FG002|Overall Study|Alternative therapy|0|||
170573642|NCT01169337|616444952|FG000|Overall Study|Changed hospital|0|||
170573643|NCT01169337|616444953|FG001|Overall Study|Changed hospital|1|||
170573644|NCT01169337|616444954|FG002|Overall Study|Changed hospital|0|||
170573645|NCT01169337|616444952|FG000|Overall Study|Never started treatment|0|||
170573646|NCT01169337|616444953|FG001|Overall Study|Never started treatment|2|||
170573647|NCT01169337|616444954|FG002|Overall Study|Never started treatment|0|||
170573648|NCT01169337|616444952|FG000|Overall Study|Reason not reported|1|||
170573649|NCT01169337|616444953|FG001|Overall Study|Reason not reported|0|||
170573650|NCT01169337|616444954|FG002|Overall Study|Reason not reported|0|||
170573651|NCT01169337|616444952|FG000|Overall Study|Continuing lenalidomide|9|||
170573652|NCT01169337|616444953|FG001|Overall Study|Continuing lenalidomide|43|||
170573653|NCT01169337|616444954|FG002|Overall Study|Continuing lenalidomide|0|||
170573654|NCT01134614|616444955|FG000|Overall Study|Still on treatment as of March 2013|21|||
170573655|NCT01134614|616444956|FG001|Overall Study|Still on treatment as of March 2013|13|||
170573656|NCT01134614|616444955|FG000|Overall Study|Progressive disease|60|||
170573657|NCT01134614|616444956|FG001|Overall Study|Progressive disease|54|||
170573658|NCT01134614|616444955|FG000|Overall Study|Adverse Event|26|||
170573659|NCT01134614|616444956|FG001|Overall Study|Adverse Event|39|||
170573660|NCT01134614|616444955|FG000|Overall Study|Death|5|||
170573661|NCT01134614|616444956|FG001|Overall Study|Death|8|||
170573662|NCT01134614|616444955|FG000|Overall Study|Withdrawal by Subject|3|||
170573663|NCT01134614|616444956|FG001|Overall Study|Withdrawal by Subject|2|||
170573664|NCT01134614|616444955|FG000|Overall Study|Alternative therapy|2|||
170573665|NCT01134614|616444956|FG001|Overall Study|Alternative therapy|0|||
170573666|NCT01134614|616444955|FG000|Overall Study|Complicating disease|2|||
170573667|NCT01134614|616444956|FG001|Overall Study|Complicating disease|1|||
170573668|NCT01134614|616444955|FG000|Overall Study|Physician's decision|0|||
170573669|NCT01134614|616444956|FG001|Overall Study|Physician's decision|1|||
170573670|NCT01134614|616444955|FG000|Overall Study|Never started treatment|4|||
170573671|NCT01134614|616444956|FG001|Overall Study|Never started treatment|1|||
170908862|NCT04246047|617671127|FG000|Overall Study|Withdrawal by Subject|19|||
170908863|NCT04246047|617671128|FG001|Overall Study|Withdrawal by Subject|26|||
170908864|NCT04246047|617671127|FG000|Overall Study|Ongoing|169|||
170573672|NCT01134614|616444955|FG000|Overall Study|Pt received tx not allowed on study|0|||
170573673|NCT01134614|616444956|FG001|Overall Study|Pt received tx not allowed on study|1|||
170808687|NCT03769090|617310388|FG000|Overall Study|Withdrawal by Subject|52|||
170808688|NCT03769090|617310389|FG001|Overall Study|Withdrawal by Subject|62|||
170808689|NCT03769090|617310390|FG002|Overall Study|Withdrawal by Subject|74|||
170808690|NCT03769090|617310388|FG000|Overall Study|Death|4|||
170808691|NCT03769090|617310389|FG001|Overall Study|Death|2|||
170908865|NCT04246047|617671128|FG001|Overall Study|Ongoing|135|||
170573674|NCT01134614|616444955|FG000|Overall Study|Symptomatic deterioration|0|||
170649331|NCT02431260|616729139|FG006|Overall Study|Subject Decision|0|||
170573675|NCT01134614|616444956|FG001|Overall Study|Symptomatic deterioration|1|||
170573676|NCT01134614|616444955|FG000|Overall Study|Patient in hospice care|0|||
170573677|NCT01134614|616444956|FG001|Overall Study|Patient in hospice care|1|||
170573678|NCT01456130|616444958|FG000|Overall Study|Adverse Event|4|||
170908866|NCT03772327|617671131|FG000|Overall Study|Lost to Follow-up|3|||
170908867|NCT03772327|617671132|FG001|Overall Study|Lost to Follow-up|4|||
170908868|NCT03772327|617671131|FG000|Overall Study|Withdrawal by Subject|2|||
170908869|NCT03772327|617671132|FG001|Overall Study|Withdrawal by Subject|3|||
170908870|NCT00845429|617671134|FG000|Overall Study|Protocol Violation|5|||
170573679|NCT01456130|616444958|FG000|Overall Study|Voluntary Withdrawal|1|||
170573680|NCT01456130|616444958|FG000|Overall Study|Lack of Efficacy|4|||
170573681|NCT01456130|616444958|FG000|Overall Study|Other|1|||
170573682|NCT03369665|616444961|FG000|Overall Study|Adverse Event|3|||
170573683|NCT03369665|616444961|FG000|Overall Study|Lost to Follow-up|7|||
170573684|NCT03369665|616444961|FG000|Overall Study|Withdrawal by Subject|15|||
170573685|NCT03369665|616444961|FG000|Overall Study|Progression Disease|2|||
170573686|NCT03369665|616444961|FG000|Overall Study|Not classified|3|||
170573687|NCT02688192|616444965|FG000|Overall Study|Lost to Follow-up|11|||
170573688|NCT02688192|616444966|FG001|Overall Study|Lost to Follow-up|5|||
170573689|NCT02688192|616444965|FG000|Overall Study|Physician Decision|1|||
170573690|NCT02688192|616444966|FG001|Overall Study|Physician Decision|0|||
170573691|NCT04188509|616444969|FG000|Overall Study|Adverse Event|2|||
170573692|NCT04188509|616444969|FG000|Overall Study|Lost to Follow-up|1|||
170573693|NCT04188509|616444969|FG000|Overall Study|Withdrawal of Consent|1|||
170573694|NCT04188509|616444969|FG000|Overall Study|Discretion of Investigator|1|||
170573695|NCT04188509|616444969|FG000|Overall Study|Noncompliance|3|||
170573696|NCT04188509|616444969|FG000|Overall Study|Sponsor Decision|127|||
170573697|NCT04188509|616444969|FG000|Overall Study|Other|2|||
170573698|NCT04847843|616444970|FG000|Overall Study|Scheduling Conflicts|6|||
170573699|NCT04847843|616444971|FG001|Overall Study|Scheduling Conflicts|9|||
170573700|NCT04847843|616444970|FG000|Overall Study|Withdrawal by Subject|1|||
170573701|NCT04847843|616444971|FG001|Overall Study|Withdrawal by Subject|0|||
170573702|NCT04847843|616444970|FG000|Overall Study|Lost to Follow-up|1|||
170573703|NCT04847843|616444971|FG001|Overall Study|Lost to Follow-up|1|||
170573704|NCT04847843|616444970|FG000|Overall Study|Pregnancy|0|||
170573705|NCT04847843|616444971|FG001|Overall Study|Pregnancy|2|||
170573706|NCT04847843|616444970|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
170573707|NCT04847843|616444971|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
170573708|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
170573709|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
170573710|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
170573711|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
170573712|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
170573713|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
170573714|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
170573715|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
170573716|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
170573717|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
170573718|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
170573719|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
170573720|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
170573721|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
170573722|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
170573723|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
170573724|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
170573725|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
170573726|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
170573727|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
170573728|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
170573729|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
170573730|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
170573731|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
170573732|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Other|6|||
170573733|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Other|0|||
170573734|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Other|0|||
170573735|NCT05615220|616444972|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
170573736|NCT05615220|616444973|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
170908871|NCT00845429|617671135|FG001|Overall Study|Protocol Violation|4|||
170908872|NCT00845429|617671136|FG002|Overall Study|Protocol Violation|7|||
170573737|NCT05615220|616444974|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
170573738|NCT05615220|616444972|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
170573739|NCT05615220|616444973|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
170573740|NCT05615220|616444974|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
170573741|NCT05615220|616444972|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
170908873|NCT00845429|617671134|FG000|Overall Study|Lost to Follow-up|7|||
170908874|NCT00845429|617671135|FG001|Overall Study|Lost to Follow-up|9|||
170573742|NCT05615220|616444973|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
170573743|NCT05615220|616444974|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
170573744|NCT05615220|616444972|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
170573745|NCT05615220|616444973|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
170573746|NCT05615220|616444974|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
170573747|NCT05615220|616444972|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
170573748|NCT05615220|616444973|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
170573749|NCT05615220|616444974|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
170573750|NCT05615220|616444972|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
170573751|NCT05615220|616444973|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
170573752|NCT05615220|616444974|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
170573753|NCT01459666|616444976|FG000|Overall Study|PI left institution|5|||
170573754|NCT01459666|616444977|FG001|Overall Study|PI left institution|4|||
170573755|NCT01061385|616444978|FG000|Overall Study|Lost to Follow-up|1|||
170573756|NCT01061385|616444979|FG001|Overall Study|Lost to Follow-up|0|||
170573757|NCT01061385|616444978|FG000|Overall Study|subject decision not related to AE|0|||
170573758|NCT01061385|616444979|FG001|Overall Study|subject decision not related to AE|1|||
170808692|NCT03769090|617310390|FG002|Overall Study|Death|2|||
170573759|NCT02803203|616444981|FG000|Overall Study|Adverse Event|4|||
170573760|NCT02803203|616444981|FG000|Overall Study|Death|4|||
170573761|NCT02803203|616444981|FG000|Overall Study|Progressive disease|29|||
170573762|NCT02803203|616444981|FG000|Overall Study|Withdrawal by Subject|8|||
170573763|NCT02803203|616444981|FG000|Overall Study|Complete resection of target disease|2|||
170573764|NCT02803203|616444981|FG000|Overall Study|Switched to commercial Osi|1|||
170573765|NCT02803203|616444981|FG000|Overall Study|Participant moved away|1|||
170573766|NCT00533429|616444982|FG000|Overall Study|Adverse Event|3|||
170573767|NCT00533429|616444983|FG001|Overall Study|Adverse Event|1|||
170573768|NCT00533429|616444982|FG000|Overall Study|Death|1|||
170573769|NCT00533429|616444983|FG001|Overall Study|Death|0|||
170573770|NCT00533429|616444982|FG000|Overall Study|Withdrawal by Subject|2|||
170573771|NCT00533429|616444983|FG001|Overall Study|Withdrawal by Subject|0|||
170573772|NCT00533429|616444982|FG000|Overall Study|Progressive Disease|12|||
170573773|NCT00533429|616444983|FG001|Overall Study|Progressive Disease|13|||
170573774|NCT00533429|616444982|FG000|Overall Study|Symptomatic deterioration|1|||
170573775|NCT00533429|616444983|FG001|Overall Study|Symptomatic deterioration|2|||
170573776|NCT02379052|616444990|FG000|Overall Study|Protocol Violation|0|||
170573777|NCT02379052|616444991|FG001|Overall Study|Protocol Violation|1|||
170573778|NCT02379052|616444990|FG000|Overall Study|Adverse Event|0|||
170573779|NCT02379052|616444991|FG001|Overall Study|Adverse Event|1|||
170573780|NCT02379052|616444990|FG000|Overall Study|Physician Decision|1|||
170573781|NCT02379052|616444991|FG001|Overall Study|Physician Decision|1|||
170573782|NCT02379052|616444990|FG000|Overall Study|Withdrawal by Subject|2|||
170808693|NCT03769090|617310388|FG000|Overall Study|Adverse Event|7|||
170573783|NCT02379052|616444991|FG001|Overall Study|Withdrawal by Subject|0|||
170573784|NCT02379052|616444990|FG000|Overall Study|Lost to Follow-up|2|||
170573785|NCT02379052|616444991|FG001|Overall Study|Lost to Follow-up|1|||
170573786|NCT02379052|616444990|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
170573787|NCT02379052|616444991|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
170573788|NCT02379052|616444990|FG000|Overall Study|Subject was Incarcerated|0|||
170573789|NCT02379052|616444991|FG001|Overall Study|Subject was Incarcerated|1|||
170573790|NCT00127855|616444992|FG000|Primary Vaccination Course|Adverse Event|0|||
170573791|NCT00127855|616444993|FG001|Primary Vaccination Course|Adverse Event|0|||
170808694|NCT03769090|617310389|FG001|Overall Study|Adverse Event|7|||
170808695|NCT03769090|617310390|FG002|Overall Study|Adverse Event|8|||
170808696|NCT03769090|617310388|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
170573792|NCT00127855|616444994|FG002|Primary Vaccination Course|Adverse Event|1|||
170573793|NCT00127855|616444995|FG003|Primary Vaccination Course|Adverse Event|0|||
170573794|NCT00127855|616444996|FG004|Primary Vaccination Course|Adverse Event|0|||
170573795|NCT00127855|616444992|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
170573796|NCT00127855|616444993|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
170573797|NCT00127855|616444994|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
170573798|NCT00127855|616444995|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
170573799|NCT00127855|616444996|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
170573800|NCT00127855|616444992|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
170808697|NCT03769090|617310389|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
170808698|NCT03769090|617310390|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
170808699|NCT03769090|617310388|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
170808700|NCT03769090|617310389|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
170808701|NCT03769090|617310390|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
170808702|NCT03769090|617310388|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
170808703|NCT03769090|617310389|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
170808704|NCT03769090|617310390|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
170573801|NCT00127855|616444993|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
170573802|NCT00127855|616444994|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
170573803|NCT00127855|616444995|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
170573804|NCT00127855|616444996|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
170573805|NCT00127855|616444992|FG000|Primary Vaccination Course|Other|0|||
170808705|NCT03769090|617310388|FG000|Overall Study|Protocol Violation|5|||
170808706|NCT03769090|617310389|FG001|Overall Study|Protocol Violation|6|||
170808707|NCT03769090|617310390|FG002|Overall Study|Protocol Violation|8|||
170808708|NCT03769090|617310388|FG000|Overall Study|Pregnancy|1|||
170808709|NCT03769090|617310389|FG001|Overall Study|Pregnancy|0|||
170808710|NCT03769090|617310390|FG002|Overall Study|Pregnancy|3|||
170808711|NCT03769090|617310388|FG000|Overall Study|Lost to Follow-up|19|||
170808712|NCT03769090|617310389|FG001|Overall Study|Lost to Follow-up|25|||
170808713|NCT03769090|617310390|FG002|Overall Study|Lost to Follow-up|21|||
170808714|NCT03769090|617310388|FG000|Overall Study|Condition under investigation worsened|2|||
170808715|NCT03769090|617310389|FG001|Overall Study|Condition under investigation worsened|0|||
170808716|NCT03769090|617310390|FG002|Overall Study|Condition under investigation worsened|1|||
170808717|NCT03769090|617310388|FG000|Overall Study|Lack of Efficacy|1|||
170808718|NCT03769090|617310389|FG001|Overall Study|Lack of Efficacy|2|||
170908875|NCT00845429|617671136|FG002|Overall Study|Lost to Follow-up|10|||
170908876|NCT00845429|617671134|FG000|Overall Study|Withdrawal by Subject|2|||
170908877|NCT00845429|617671135|FG001|Overall Study|Withdrawal by Subject|2|||
170908878|NCT00845429|617671136|FG002|Overall Study|Withdrawal by Subject|2|||
170908879|NCT00845429|617671134|FG000|Overall Study|Serious adverse event|0|||
170573806|NCT00127855|616444993|FG001|Primary Vaccination Course|Other|0|||
170573807|NCT00127855|616444994|FG002|Primary Vaccination Course|Other|0|||
170573808|NCT00127855|616444995|FG003|Primary Vaccination Course|Other|0|||
170573809|NCT00127855|616444996|FG004|Primary Vaccination Course|Other|1|||
170573810|NCT02343302|616444997|FG000|Overall Study|Physician Decision|1|||
170573811|NCT02343302|616444998|FG001|Overall Study|Physician Decision|1|||
170573812|NCT01887717|616444999|FG000|Overall Study|Withdrawal by Subject|1|||
170573813|NCT01887717|616445000|FG001|Overall Study|Withdrawal by Subject|7|||
170573814|NCT01887717|616444999|FG000|Overall Study|Physician Decision|0|||
170573815|NCT01887717|616445000|FG001|Overall Study|Physician Decision|2|||
170573816|NCT01887717|616444999|FG000|Overall Study|Administrative reasons|5|||
170573817|NCT01887717|616445000|FG001|Overall Study|Administrative reasons|2|||
170573818|NCT01282866|616445005|FG000|Overall Study|Adverse Event|1|||
170573819|NCT02655887|616445006|FG000|Overall Study|Lost to Follow-up|3|||
170573820|NCT02655887|616445006|FG000|Overall Study|Death|4|||
170573821|NCT02655887|616445006|FG000|Overall Study|Withdrawal by Subject|3|||
170573822|NCT02655887|616445006|FG000|Overall Study|Missed 12-month follow-up visit|4|||
170573823|NCT04834726|616445007|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
170573824|NCT04834726|616445008|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
170573825|NCT04834726|616445009|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
170573826|NCT04834726|616445010|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
170573827|NCT04834726|616445011|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
170573828|NCT04834726|616445012|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
170573829|NCT04834726|616445013|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
170573830|NCT04834726|616445014|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
170573831|NCT04834726|616445015|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
170573832|NCT04245709|616445018|FG000|Overall Study|Adverse Event|13|||
170573833|NCT04245709|616445018|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
170573834|NCT01541865|616445024|FG000|Overall Study|Lost to Follow-up|11|||
170573835|NCT01541865|616445024|FG000|Overall Study|Withdrawal by Subject|9|||
170573836|NCT01541865|616445024|FG000|Overall Study|Adverse Event|1|||
170573837|NCT01541865|616445024|FG000|Overall Study|Protocol Violation|1|||
170573838|NCT02948582|616445030|FG000|Washout Period 1|Adverse Event|0|||
170573839|NCT02948582|616445031|FG001|Washout Period 1|Adverse Event|2|||
170573840|NCT02948582|616445032|FG002|Washout Period 1|Adverse Event|0|||
170573841|NCT02948582|616445033|FG003|Washout Period 1|Adverse Event|0|||
170573842|NCT02948582|616445034|FG004|Washout Period 1|Adverse Event|0|||
170573843|NCT02948582|616445035|FG005|Washout Period 1|Adverse Event|0|||
170573844|NCT02948582|616445030|FG000|Washout Period 1|Protocol Violation|0|||
170573845|NCT02948582|616445031|FG001|Washout Period 1|Protocol Violation|0|||
170573846|NCT02948582|616445032|FG002|Washout Period 1|Protocol Violation|0|||
170573847|NCT02948582|616445033|FG003|Washout Period 1|Protocol Violation|0|||
170573848|NCT02948582|616445034|FG004|Washout Period 1|Protocol Violation|0|||
170573849|NCT02948582|616445035|FG005|Washout Period 1|Protocol Violation|1|||
170573850|NCT02948582|616445030|FG000|Washout Period 2|Adverse Event|0|||
170573851|NCT02948582|616445031|FG001|Washout Period 2|Adverse Event|1|||
170573852|NCT02948582|616445032|FG002|Washout Period 2|Adverse Event|0|||
170573853|NCT02948582|616445033|FG003|Washout Period 2|Adverse Event|0|||
170573854|NCT02948582|616445034|FG004|Washout Period 2|Adverse Event|0|||
170573855|NCT02948582|616445035|FG005|Washout Period 2|Adverse Event|0|||
170573856|NCT02948582|616445030|FG000|Washout Period 2|personal reasons|0|||
170573857|NCT02948582|616445031|FG001|Washout Period 2|personal reasons|0|||
170573858|NCT02948582|616445032|FG002|Washout Period 2|personal reasons|0|||
170573859|NCT02948582|616445033|FG003|Washout Period 2|personal reasons|1|||
170573860|NCT02948582|616445034|FG004|Washout Period 2|personal reasons|0|||
170573861|NCT02948582|616445035|FG005|Washout Period 2|personal reasons|0|||
170573862|NCT02948582|616445030|FG000|Washout Period 4|Adverse Event|1|||
170573863|NCT02948582|616445031|FG001|Washout Period 4|Adverse Event|0|||
170573864|NCT02948582|616445032|FG002|Washout Period 4|Adverse Event|1|||
170573865|NCT02948582|616445033|FG003|Washout Period 4|Adverse Event|0|||
170573866|NCT02948582|616445034|FG004|Washout Period 4|Adverse Event|0|||
170573867|NCT02948582|616445035|FG005|Washout Period 4|Adverse Event|0|||
170573868|NCT03810014|616445039|FG000|Overall Study|Pregnancy|2|||
170573869|NCT03810014|616445040|FG001|Overall Study|Pregnancy|2|||
170573870|NCT03810014|616445041|FG002|Overall Study|Pregnancy|0|||
170573871|NCT03810014|616445042|FG003|Overall Study|Pregnancy|2|||
170573872|NCT02389465|616445043|FG000|Overall Study|Lost to Follow-up|1|||
170573873|NCT02389465|616445044|FG001|Overall Study|Lost to Follow-up|3|||
170573874|NCT02389465|616445045|FG002|Overall Study|Lost to Follow-up|3|||
170573875|NCT02389465|616445046|FG003|Overall Study|Lost to Follow-up|0|||
170573876|NCT02389465|616445043|FG000|Overall Study|Physician Decision|0|||
170573877|NCT02389465|616445044|FG001|Overall Study|Physician Decision|0|||
170573878|NCT02389465|616445045|FG002|Overall Study|Physician Decision|0|||
170573879|NCT02389465|616445046|FG003|Overall Study|Physician Decision|1|||
170573880|NCT02389465|616445043|FG000|Overall Study|Withdrawal by Subject|0|||
170573881|NCT02389465|616445044|FG001|Overall Study|Withdrawal by Subject|1|||
170573882|NCT02389465|616445045|FG002|Overall Study|Withdrawal by Subject|2|||
170573883|NCT02389465|616445046|FG003|Overall Study|Withdrawal by Subject|2|||
170573884|NCT03606486|616445049|FG000|Overall Study|Unable to collect sample|5|||
170573885|NCT04339413|616445050|FG000|Overall Study|Reason Not Specified|2|||
170573886|NCT04339413|616445051|FG001|Overall Study|Reason Not Specified|7|||
170573887|NCT04339413|616445050|FG000|Overall Study|Study Terminated by Sponsor|30|||
170573888|NCT04339413|616445051|FG001|Overall Study|Study Terminated by Sponsor|33|||
170573889|NCT04339413|616445050|FG000|Overall Study|Progressive Disease|9|||
170573890|NCT04339413|616445051|FG001|Overall Study|Progressive Disease|6|||
170573891|NCT04339413|616445050|FG000|Overall Study|Withdrawal by Subject|9|||
170573892|NCT04339413|616445051|FG001|Overall Study|Withdrawal by Subject|10|||
170908880|NCT00845429|617671135|FG001|Overall Study|Serious adverse event|0|||
170908881|NCT00845429|617671136|FG002|Overall Study|Serious adverse event|1|||
170908882|NCT03256539|617671139|FG000|Overall Study|Withdrawal by Subject|0|||
170908883|NCT03256539|617671140|FG001|Overall Study|Withdrawal by Subject|3|||
170908884|NCT03256539|617671139|FG000|Overall Study|Unexpected closure of study components|8|||
170908885|NCT03256539|617671140|FG001|Overall Study|Unexpected closure of study components|4|||
170908886|NCT05755438|617671143|FG000|12-week DBVC Period|Adverse Event|4|||
170908887|NCT05755438|617671144|FG001|12-week DBVC Period|Adverse Event|1|||
170908888|NCT05755438|617671143|FG000|12-week DBVC Period|Physician Decision|1|||
170908889|NCT05755438|617671144|FG001|12-week DBVC Period|Physician Decision|1|||
170908890|NCT05755438|617671143|FG000|12-week DBVC Period|Protocol Violation|4|||
170908891|NCT05755438|617671144|FG001|12-week DBVC Period|Protocol Violation|2|||
170908892|NCT05755438|617671143|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
170908893|NCT05755438|617671144|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
170908894|NCT05755438|617671143|FG000|12-week DBVC Period|Sponsor Decision|1|||
170908895|NCT05755438|617671144|FG001|12-week DBVC Period|Sponsor Decision|0|||
170908896|NCT05755438|617671143|FG000|40-week OLE Period|Adverse Event|0|||
170908897|NCT05755438|617671144|FG001|40-week OLE Period|Adverse Event|2|||
170908898|NCT05755438|617671143|FG000|40-week OLE Period|Lack of Efficacy|1|||
170908899|NCT05755438|617671144|FG001|40-week OLE Period|Lack of Efficacy|1|||
170908900|NCT05755438|617671143|FG000|40-week OLE Period|Lost to Follow-up|1|||
170908901|NCT05755438|617671144|FG001|40-week OLE Period|Lost to Follow-up|0|||
170908902|NCT05755438|617671143|FG000|40-week OLE Period|Physician Decision|1|||
170908903|NCT05755438|617671144|FG001|40-week OLE Period|Physician Decision|1|||
170908904|NCT05755438|617671143|FG000|40-week OLE Period|Protocol Violation|1|||
170908905|NCT05755438|617671144|FG001|40-week OLE Period|Protocol Violation|1|||
170908906|NCT05755438|617671143|FG000|40-week OLE Period|Withdrawal by Subject|6|||
170573893|NCT04339413|616445050|FG000|Overall Study|Physician Decision|3|||
170573894|NCT04339413|616445051|FG001|Overall Study|Physician Decision|1|||
170573895|NCT04339413|616445050|FG000|Overall Study|Death|2|||
170573896|NCT04339413|616445051|FG001|Overall Study|Death|0|||
170573897|NCT04339413|616445050|FG000|Overall Study|Adverse Event|3|||
170573898|NCT04339413|616445051|FG001|Overall Study|Adverse Event|0|||
170573899|NCT00049322|616445056|FG000|Overall Study|disease burden|0|||
170573900|NCT00049322|616445057|FG001|Overall Study|disease burden|3|||
170573901|NCT00049322|616445056|FG000|Overall Study|Adverse Event|1|||
170573902|NCT00049322|616445057|FG001|Overall Study|Adverse Event|0|||
170573903|NCT00049322|616445056|FG000|Overall Study|refused angio|0|||
170573904|NCT00049322|616445057|FG001|Overall Study|refused angio|3|||
170908907|NCT05755438|617671144|FG001|40-week OLE Period|Withdrawal by Subject|6|||
170908908|NCT05755438|617671143|FG000|40-week OLE Period|Sponsor Decision|3|||
170908909|NCT05755438|617671144|FG001|40-week OLE Period|Sponsor Decision|0|||
170908910|NCT05755438|617671143|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
170908911|NCT05755438|617671144|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
170908912|NCT05755438|617671143|FG000|40-week OLE Period|Ongoing|46|||
170908913|NCT05755438|617671144|FG001|40-week OLE Period|Ongoing|58|||
170908914|NCT01901328|617671158|FG000|Overall Study|Lost to Follow-up|1|||
170908915|NCT01901328|617671159|FG001|Overall Study|Lost to Follow-up|0|||
170908916|NCT01901328|617671158|FG000|Overall Study|Physician Decision|0|||
170908917|NCT01901328|617671159|FG001|Overall Study|Physician Decision|1|||
170908918|NCT01901328|617671158|FG000|Overall Study|Protocol Violation|1|||
170573905|NCT03994211|616445060|FG000|Core Phase|Adverse Event|0|||
170573906|NCT03994211|616445061|FG001|Core Phase|Adverse Event|1|||
170573907|NCT03994211|616445062|FG002|Core Phase|Adverse Event|0|||
170573908|NCT03994211|616445060|FG000|Extension Phase|Adverse Event|0|||
170573909|NCT03994211|616445061|FG001|Extension Phase|Adverse Event|0|||
170573910|NCT03994211|616445062|FG002|Extension Phase|Adverse Event|1|||
170573911|NCT03994211|616445060|FG000|Extension Phase|Physician Decision|0|||
170573912|NCT03994211|616445061|FG001|Extension Phase|Physician Decision|0|||
170573913|NCT03994211|616445062|FG002|Extension Phase|Physician Decision|1|||
170573914|NCT03994211|616445060|FG000|Extension Phase|Progressive Disease|0|||
170573915|NCT03994211|616445061|FG001|Extension Phase|Progressive Disease|0|||
170573916|NCT03994211|616445062|FG002|Extension Phase|Progressive Disease|20|||
170573917|NCT03994211|616445060|FG000|Extension Phase|Withdrawal by Subject|0|||
170573918|NCT03994211|616445061|FG001|Extension Phase|Withdrawal by Subject|0|||
170573919|NCT03994211|616445062|FG002|Extension Phase|Withdrawal by Subject|2|||
170573920|NCT01140867|616445065|FG000|Overall Study|Adverse Event|22|||
170573921|NCT01140867|616445065|FG000|Overall Study|Lack of Efficacy|3|||
170573922|NCT01140867|616445065|FG000|Overall Study|Lost to Follow-up|2|||
170573923|NCT01140867|616445065|FG000|Overall Study|Withdrawal by Subject|1|||
170908919|NCT01901328|617671159|FG001|Overall Study|Protocol Violation|1|||
170908920|NCT01901328|617671158|FG000|Overall Study|Study Terminated by Sponsor|19|||
170908921|NCT01901328|617671159|FG001|Overall Study|Study Terminated by Sponsor|16|||
170908922|NCT01901328|617671158|FG000|Overall Study|Withdrawal by Subject|1|||
170908923|NCT01901328|617671159|FG001|Overall Study|Withdrawal by Subject|2|||
170908924|NCT01901328|617671158|FG000|Overall Study|Lack of Efficacy|0|||
170908925|NCT01901328|617671159|FG001|Overall Study|Lack of Efficacy|1|||
170908926|NCT02032875|617671160|FG000|Treatment Period|Adverse Event|1|||
170908927|NCT02032875|617671161|FG001|Treatment Period|Adverse Event|0|||
170908928|NCT02032875|617671160|FG000|Treatment Period|Liver transplant, No extension needed|0|||
170908929|NCT02032875|617671161|FG001|Treatment Period|Liver transplant, No extension needed|1|||
170908930|NCT02032875|617671160|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
170908931|NCT02032875|617671161|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
170908932|NCT02032875|617671160|FG000|Follow-up Period|Death|0|||
170908933|NCT02032875|617671161|FG001|Follow-up Period|Death|1|||
170908934|NCT02032875|617671160|FG000|Follow-up Period|Virologic Relapse|3|||
170908935|NCT02032875|617671161|FG001|Follow-up Period|Virologic Relapse|10|||
170908936|NCT05165394|617673449|FG000|Overall Study|Withdrawal by Subject|5|||
170908937|NCT05165394|617673450|FG001|Overall Study|Withdrawal by Subject|1|||
170908938|NCT05165394|617673449|FG000|Overall Study|Lost to Follow-up|1|||
170908939|NCT05165394|617673450|FG001|Overall Study|Lost to Follow-up|2|||
170908940|NCT05165394|617673449|FG000|Overall Study|Other Than Specified|0|||
170908941|NCT05165394|617673450|FG001|Overall Study|Other Than Specified|1|||
170908942|NCT00001259|617673453|FG000|Study 2|Adverse Event|0|||
170908943|NCT00001259|617673454|FG001|Study 2|Adverse Event|0|||
170908944|NCT00001259|617673455|FG002|Study 2|Adverse Event|0|||
170908945|NCT00001259|617673456|FG003|Study 2|Adverse Event|0|||
170908946|NCT00001259|617673457|FG004|Study 2|Adverse Event|2|||
170908947|NCT00001259|617673458|FG005|Study 2|Adverse Event|0|||
170908948|NCT00001259|617673459|FG006|Study 2|Adverse Event|0|||
170908949|NCT01582282|617673460|FG000|Overall Study|Adverse Event|1|||
170908950|NCT01582282|617673461|FG001|Overall Study|Adverse Event|1|||
170908951|NCT01582282|617673462|FG002|Overall Study|Adverse Event|0|||
170908952|NCT01582282|617673460|FG000|Overall Study|Lost to Follow-up|1|||
170573924|NCT01140867|616445065|FG000|Overall Study|Protocol Violation|1|||
170573925|NCT01140867|616445065|FG000|Overall Study|Uncooperative patient|2|||
170573926|NCT01140867|616445065|FG000|Overall Study|Medication Noncompliance|2|||
170573927|NCT02382991|616445071|FG000|Overall Study|Adverse Event|1|||
170573928|NCT02382991|616445072|FG001|Overall Study|Adverse Event|2|||
170573929|NCT02382991|616445071|FG000|Overall Study|Lost to Follow-up|1|||
170573930|NCT02382991|616445072|FG001|Overall Study|Lost to Follow-up|0|||
170908953|NCT01582282|617673461|FG001|Overall Study|Lost to Follow-up|0|||
170908954|NCT01582282|617673462|FG002|Overall Study|Lost to Follow-up|0|||
170908955|NCT01582282|617673460|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
170908956|NCT01582282|617673461|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
170908957|NCT01582282|617673462|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
170908958|NCT05098015|617673463|FG000|Overall Study|Death|1|||
170908959|NCT05098015|617673464|FG001|Overall Study|Death|1|||
170573931|NCT02382991|616445071|FG000|Overall Study|Withdrawal by Subject|0|||
170573932|NCT02382991|616445072|FG001|Overall Study|Withdrawal by Subject|1|||
170573933|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
170573934|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
170573935|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
170573936|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
170573937|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
170573938|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
170573939|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
170573940|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
170573941|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
170573942|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
170573943|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
170908960|NCT05098015|617673465|FG002|Overall Study|Death|3|||
170908961|NCT05098015|617673466|FG003|Overall Study|Death|0|||
170908962|NCT05098015|617673463|FG000|Overall Study|Lost to Follow-up|1|||
170908963|NCT05098015|617673464|FG001|Overall Study|Lost to Follow-up|1|||
170908964|NCT05098015|617673465|FG002|Overall Study|Lost to Follow-up|3|||
170908965|NCT05098015|617673466|FG003|Overall Study|Lost to Follow-up|3|||
170908966|NCT05098015|617673463|FG000|Overall Study|Withdrawal by Subject|0|||
170908967|NCT05098015|617673464|FG001|Overall Study|Withdrawal by Subject|1|||
170908968|NCT05098015|617673465|FG002|Overall Study|Withdrawal by Subject|0|||
170908969|NCT05098015|617673466|FG003|Overall Study|Withdrawal by Subject|2|||
170908970|NCT02158533|617673467|FG000|Stage 1|Adverse Event|6|||
170908971|NCT02158533|617673468|FG001|Stage 1|Adverse Event|4|||
170908972|NCT02158533|617673469|FG002|Stage 1|Adverse Event|7|||
170908973|NCT02158533|617673470|FG003|Stage 1|Adverse Event|0|||
170908974|NCT02158533|617673471|FG004|Stage 1|Adverse Event|0|||
170908975|NCT02158533|617673472|FG005|Stage 1|Adverse Event|0|||
170908976|NCT02158533|617673467|FG000|Stage 1|Withdrawal by Subject|3|||
170908977|NCT02158533|617673468|FG001|Stage 1|Withdrawal by Subject|2|||
170908978|NCT02158533|617673469|FG002|Stage 1|Withdrawal by Subject|1|||
170908979|NCT02158533|617673470|FG003|Stage 1|Withdrawal by Subject|0|||
170908980|NCT02158533|617673471|FG004|Stage 1|Withdrawal by Subject|0|||
170908981|NCT02158533|617673472|FG005|Stage 1|Withdrawal by Subject|0|||
170908982|NCT02158533|617673467|FG000|Stage 1|Lack of Efficacy|1|||
170908983|NCT02158533|617673468|FG001|Stage 1|Lack of Efficacy|0|||
170908984|NCT02158533|617673469|FG002|Stage 1|Lack of Efficacy|0|||
170908985|NCT02158533|617673470|FG003|Stage 1|Lack of Efficacy|0|||
170908986|NCT02158533|617673471|FG004|Stage 1|Lack of Efficacy|0|||
170908987|NCT02158533|617673472|FG005|Stage 1|Lack of Efficacy|0|||
170908988|NCT02158533|617673467|FG000|Stage 1|Lost to Follow-up|3|||
170908989|NCT02158533|617673468|FG001|Stage 1|Lost to Follow-up|1|||
170908990|NCT02158533|617673469|FG002|Stage 1|Lost to Follow-up|0|||
170908991|NCT02158533|617673470|FG003|Stage 1|Lost to Follow-up|0|||
170908992|NCT02158533|617673471|FG004|Stage 1|Lost to Follow-up|0|||
170908993|NCT02158533|617673472|FG005|Stage 1|Lost to Follow-up|0|||
170908994|NCT02158533|617673467|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
170908995|NCT02158533|617673468|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
170908996|NCT02158533|617673469|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
170908997|NCT02158533|617673470|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
170908998|NCT02158533|617673471|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
170908999|NCT02158533|617673472|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
170909000|NCT02158533|617673467|FG000|Stage 1|Non-compliance with study visits|1|||
170909001|NCT02158533|617673468|FG001|Stage 1|Non-compliance with study visits|0|||
170909002|NCT02158533|617673469|FG002|Stage 1|Non-compliance with study visits|0|||
170909003|NCT02158533|617673470|FG003|Stage 1|Non-compliance with study visits|0|||
170909004|NCT02158533|617673471|FG004|Stage 1|Non-compliance with study visits|0|||
170909005|NCT02158533|617673472|FG005|Stage 1|Non-compliance with study visits|0|||
170909006|NCT02158533|617673467|FG000|Stage 2|Adverse Event|0|||
170909007|NCT02158533|617673468|FG001|Stage 2|Adverse Event|0|||
170909008|NCT02158533|617673469|FG002|Stage 2|Adverse Event|0|||
170909009|NCT02158533|617673470|FG003|Stage 2|Adverse Event|0|||
170909010|NCT02158533|617673471|FG004|Stage 2|Adverse Event|0|||
170909011|NCT02158533|617673472|FG005|Stage 2|Adverse Event|1|||
170909012|NCT02158533|617673467|FG000|Stage 2|Lack of Efficacy|0|||
170909013|NCT02158533|617673468|FG001|Stage 2|Lack of Efficacy|0|||
170909014|NCT02158533|617673469|FG002|Stage 2|Lack of Efficacy|0|||
170573944|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
170909015|NCT02158533|617673470|FG003|Stage 2|Lack of Efficacy|0|||
170909016|NCT02158533|617673471|FG004|Stage 2|Lack of Efficacy|1|||
170909017|NCT02158533|617673472|FG005|Stage 2|Lack of Efficacy|0|||
170909018|NCT02158533|617673467|FG000|Stage 2|Lost to Follow-up|0|||
170573945|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
170649332|NCT02431260|616729140|FG007|Overall Study|Subject Decision|0|||
170909019|NCT02158533|617673468|FG001|Stage 2|Lost to Follow-up|0|||
170909020|NCT02158533|617673469|FG002|Stage 2|Lost to Follow-up|0|||
170909021|NCT02158533|617673470|FG003|Stage 2|Lost to Follow-up|1|||
170909022|NCT02158533|617673471|FG004|Stage 2|Lost to Follow-up|1|||
170909023|NCT02158533|617673472|FG005|Stage 2|Lost to Follow-up|2|||
170573946|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
170573947|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
170573948|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
170573949|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
170573950|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
170573951|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
170573952|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
170573953|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
170573954|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
170573955|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
170573956|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
170573957|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
170573958|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
170573959|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
170573960|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
170573961|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
170649333|NCT02431260|616729141|FG008|Overall Study|Subject Decision|1|||
170649334|NCT02431260|616729142|FG009|Overall Study|Subject Decision|1|||
170649335|NCT02431260|616729143|FG010|Overall Study|Subject Decision|0|||
170649336|NCT02431260|616729144|FG011|Overall Study|Subject Decision|1|||
170649337|NCT02431260|616729145|FG012|Overall Study|Subject Decision|0|||
170649338|NCT02431260|616729146|FG013|Overall Study|Subject Decision|0|||
170649339|NCT02431260|616729133|FG000|Overall Study|Death|4|||
170649340|NCT02431260|616729134|FG001|Overall Study|Death|4|||
170649341|NCT02431260|616729135|FG002|Overall Study|Death|3|||
170649342|NCT02431260|616729136|FG003|Overall Study|Death|4|||
170649343|NCT02431260|616729137|FG004|Overall Study|Death|2|||
170649344|NCT02431260|616729138|FG005|Overall Study|Death|2|||
170649345|NCT02431260|616729139|FG006|Overall Study|Death|3|||
170649346|NCT02431260|616729140|FG007|Overall Study|Death|1|||
170649347|NCT02431260|616729141|FG008|Overall Study|Death|6|||
170649348|NCT02431260|616729142|FG009|Overall Study|Death|6|||
170649349|NCT02431260|616729143|FG010|Overall Study|Death|3|||
170649350|NCT02431260|616729144|FG011|Overall Study|Death|2|||
170649351|NCT02431260|616729145|FG012|Overall Study|Death|5|||
170649352|NCT02431260|616729146|FG013|Overall Study|Death|1|||
170649353|NCT02431260|616729133|FG000|Overall Study|Lost to Follow-up|0|||
170649354|NCT02431260|616729134|FG001|Overall Study|Lost to Follow-up|0|||
170649355|NCT02431260|616729135|FG002|Overall Study|Lost to Follow-up|0|||
170649356|NCT02431260|616729136|FG003|Overall Study|Lost to Follow-up|0|||
170649357|NCT02431260|616729137|FG004|Overall Study|Lost to Follow-up|0|||
170649358|NCT02431260|616729138|FG005|Overall Study|Lost to Follow-up|1|||
170649359|NCT02431260|616729139|FG006|Overall Study|Lost to Follow-up|0|||
170649360|NCT02431260|616729140|FG007|Overall Study|Lost to Follow-up|0|||
170649361|NCT02431260|616729141|FG008|Overall Study|Lost to Follow-up|0|||
170649362|NCT02431260|616729142|FG009|Overall Study|Lost to Follow-up|0|||
170649363|NCT02431260|616729143|FG010|Overall Study|Lost to Follow-up|0|||
170649364|NCT02431260|616729144|FG011|Overall Study|Lost to Follow-up|0|||
170909024|NCT02158533|617673467|FG000|Stage 2|Withdrawal by Subject|0|||
170909025|NCT02158533|617673468|FG001|Stage 2|Withdrawal by Subject|0|||
170909026|NCT02158533|617673469|FG002|Stage 2|Withdrawal by Subject|0|||
170909027|NCT02158533|617673470|FG003|Stage 2|Withdrawal by Subject|0|||
170909028|NCT02158533|617673471|FG004|Stage 2|Withdrawal by Subject|1|||
170909029|NCT02158533|617673472|FG005|Stage 2|Withdrawal by Subject|2|||
170649365|NCT02431260|616729145|FG012|Overall Study|Lost to Follow-up|0|||
170649366|NCT02431260|616729146|FG013|Overall Study|Lost to Follow-up|0|||
170649367|NCT02431260|616729133|FG000|Overall Study|Study Terminated by the Sponsor|0|||
170649368|NCT02431260|616729134|FG001|Overall Study|Study Terminated by the Sponsor|0|||
170649369|NCT02431260|616729135|FG002|Overall Study|Study Terminated by the Sponsor|2|||
170649370|NCT02431260|616729136|FG003|Overall Study|Study Terminated by the Sponsor|1|||
170649371|NCT02431260|616729137|FG004|Overall Study|Study Terminated by the Sponsor|1|||
170649372|NCT02431260|616729138|FG005|Overall Study|Study Terminated by the Sponsor|0|||
170909030|NCT02158533|617673467|FG000|Stage 2|Physician Decision|0|||
170909031|NCT02158533|617673468|FG001|Stage 2|Physician Decision|0|||
170909032|NCT02158533|617673469|FG002|Stage 2|Physician Decision|0|||
170909033|NCT02158533|617673470|FG003|Stage 2|Physician Decision|0|||
170909034|NCT02158533|617673471|FG004|Stage 2|Physician Decision|1|||
170909035|NCT02158533|617673472|FG005|Stage 2|Physician Decision|0|||
170909036|NCT02158533|617673467|FG000|Stage 2|Pregnancy|0|||
170909037|NCT02158533|617673468|FG001|Stage 2|Pregnancy|0|||
170909038|NCT02158533|617673469|FG002|Stage 2|Pregnancy|0|||
170909039|NCT02158533|617673470|FG003|Stage 2|Pregnancy|1|||
170909040|NCT02158533|617673471|FG004|Stage 2|Pregnancy|0|||
170909041|NCT02158533|617673472|FG005|Stage 2|Pregnancy|0|||
170909042|NCT02158533|617673467|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
170909043|NCT02158533|617673468|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
170909044|NCT02158533|617673469|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
170909045|NCT02158533|617673470|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
170573962|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
170573963|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
170573964|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
170573965|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
170573966|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
170573967|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
170573968|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
170573969|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
170573970|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
170573971|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
170573972|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
170573973|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
170573974|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
170573975|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
170573976|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
170573977|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
170573978|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
170573979|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
170573980|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
170573981|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
170573982|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
170573983|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
170573984|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
170573985|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
170573986|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
170573987|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
170573988|NCT04951622|616445073|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
170573989|NCT04951622|616445074|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
170573990|NCT04951622|616445075|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
170573991|NCT04951622|616445076|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
170573992|NCT04951622|616445077|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
170573993|NCT04951622|616445073|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
170573994|NCT04951622|616445074|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
170573995|NCT04951622|616445075|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
170573996|NCT04951622|616445076|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
170573997|NCT04951622|616445077|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
170649373|NCT02431260|616729139|FG006|Overall Study|Study Terminated by the Sponsor|1|||
170649374|NCT02431260|616729140|FG007|Overall Study|Study Terminated by the Sponsor|2|||
170649375|NCT02431260|616729141|FG008|Overall Study|Study Terminated by the Sponsor|1|||
170649376|NCT02431260|616729142|FG009|Overall Study|Study Terminated by the Sponsor|1|||
170649377|NCT02431260|616729143|FG010|Overall Study|Study Terminated by the Sponsor|1|||
170649378|NCT02431260|616729144|FG011|Overall Study|Study Terminated by the Sponsor|0|||
170649379|NCT02431260|616729145|FG012|Overall Study|Study Terminated by the Sponsor|4|||
170649380|NCT02431260|616729146|FG013|Overall Study|Study Terminated by the Sponsor|0|||
170649381|NCT02431260|616729133|FG000|Overall Study|Physician Decision|0|||
170649382|NCT02431260|616729134|FG001|Overall Study|Physician Decision|0|||
170649383|NCT02431260|616729135|FG002|Overall Study|Physician Decision|0|||
170649384|NCT02431260|616729136|FG003|Overall Study|Physician Decision|0|||
170649385|NCT02431260|616729137|FG004|Overall Study|Physician Decision|0|||
170649386|NCT02431260|616729138|FG005|Overall Study|Physician Decision|1|||
170649387|NCT02431260|616729139|FG006|Overall Study|Physician Decision|0|||
170649388|NCT02431260|616729140|FG007|Overall Study|Physician Decision|0|||
170649389|NCT02431260|616729141|FG008|Overall Study|Physician Decision|0|||
170649390|NCT02431260|616729142|FG009|Overall Study|Physician Decision|0|||
170649391|NCT02431260|616729143|FG010|Overall Study|Physician Decision|0|||
170649392|NCT02431260|616729144|FG011|Overall Study|Physician Decision|0|||
170649393|NCT02431260|616729145|FG012|Overall Study|Physician Decision|0|||
170649394|NCT02431260|616729146|FG013|Overall Study|Physician Decision|0|||
170909046|NCT02158533|617673471|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
170909047|NCT02158533|617673472|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
170909048|NCT02158533|617673467|FG000|Stage 2|Non-adherence with study visits|0|||
170909049|NCT02158533|617673468|FG001|Stage 2|Non-adherence with study visits|0|||
170909050|NCT02158533|617673469|FG002|Stage 2|Non-adherence with study visits|0|||
170909051|NCT02158533|617673470|FG003|Stage 2|Non-adherence with study visits|0|||
170909052|NCT02158533|617673471|FG004|Stage 2|Non-adherence with study visits|0|||
170649395|NCT02431260|616729133|FG000|Overall Study|Other Unspecified|0|||
170649396|NCT02431260|616729134|FG001|Overall Study|Other Unspecified|0|||
170649397|NCT02431260|616729135|FG002|Overall Study|Other Unspecified|0|||
170649398|NCT02431260|616729136|FG003|Overall Study|Other Unspecified|0|||
170573998|NCT04951622|616445073|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
170573999|NCT04951622|616445074|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
170574000|NCT04951622|616445075|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
170574001|NCT04951622|616445076|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
170574002|NCT04951622|616445077|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
170574003|NCT04951622|616445073|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
170574004|NCT04951622|616445074|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
170574005|NCT04951622|616445075|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
170574006|NCT04951622|616445076|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
170574007|NCT04951622|616445077|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
170574008|NCT04951622|616445073|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
170574009|NCT04951622|616445074|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
170574010|NCT04951622|616445075|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
170574011|NCT04951622|616445076|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
170574012|NCT04951622|616445077|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
170574013|NCT04951622|616445073|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
170574014|NCT04951622|616445074|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
170574015|NCT04951622|616445075|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
170574016|NCT04951622|616445076|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
170574017|NCT04951622|616445077|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
170574018|NCT04951622|616445073|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
170574019|NCT04951622|616445074|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
170574020|NCT04951622|616445075|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
170574021|NCT04951622|616445076|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
170574022|NCT04951622|616445077|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
170574023|NCT04951622|616445073|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
170574024|NCT04951622|616445074|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
170574025|NCT04951622|616445075|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
170574026|NCT04951622|616445076|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
170574027|NCT04951622|616445077|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
170574028|NCT04951622|616445073|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
170574029|NCT04951622|616445074|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
170574030|NCT04951622|616445075|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
170574031|NCT04951622|616445076|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
170574032|NCT04951622|616445077|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
170574033|NCT01445847|616445089|FG000|Overall Study|Protocol Violation|13|||
170574034|NCT01445847|616445090|FG001|Overall Study|Protocol Violation|14|||
170574035|NCT01445847|616445089|FG000|Overall Study|Missed Data|1|||
170574036|NCT01445847|616445090|FG001|Overall Study|Missed Data|0|||
170574037|NCT05223673|616445091|FG000|Overall Study|Protocol Violation|1|||
170574038|NCT05223673|616445091|FG000|Overall Study|Study termination|6|||
170574039|NCT03154476|616445092|FG000|Overall Study|Lost to Follow-up|4|||
170808719|NCT03769090|617310390|FG002|Overall Study|Lack of Efficacy|2|||
170808720|NCT03769090|617310388|FG000|Overall Study|Other reasons|8|||
170808721|NCT03769090|617310389|FG001|Overall Study|Other reasons|12|||
170808722|NCT03769090|617310390|FG002|Overall Study|Other reasons|15|||
170808723|NCT01970878|617310397|FG000|Overall Study|Withdrawal by Subject|11|||
170808724|NCT01970878|617310398|FG001|Overall Study|Withdrawal by Subject|10|||
170574040|NCT03154476|616445093|FG001|Overall Study|Lost to Follow-up|4|||
170574041|NCT02982772|616446797|FG000|Intervention|Lost to Follow-up|19|||
170574042|NCT02982772|616446798|FG001|Intervention|Lost to Follow-up|13|||
170574043|NCT02982772|616446797|FG000|1M Follow-Up|Lost to Follow-up|21|||
170574044|NCT02982772|616446798|FG001|1M Follow-Up|Lost to Follow-up|18|||
170574045|NCT02982772|616446797|FG000|3M Follow-Up|Lost to Follow-up|17|||
170574046|NCT02982772|616446798|FG001|3M Follow-Up|Lost to Follow-up|11|||
170574047|NCT02982772|616446797|FG000|6M Follow-Up|Lost to Follow-up|11|||
170574048|NCT02982772|616446798|FG001|6M Follow-Up|Lost to Follow-up|9|||
170574049|NCT02982772|616446797|FG000|12M Follow-Up|Lost to Follow-up|11|||
170574050|NCT02982772|616446798|FG001|12M Follow-Up|Lost to Follow-up|5|||
170574051|NCT01147965|616446799|FG000|Overall Study|Progressive Disease|3|||
170574052|NCT01147965|616446800|FG001|Overall Study|Progressive Disease|3|||
170574053|NCT01147965|616446801|FG002|Overall Study|Progressive Disease|5|||
170574054|NCT01147965|616446802|FG003|Overall Study|Progressive Disease|9|||
170574055|NCT01147965|616446803|FG004|Overall Study|Progressive Disease|5|||
170574056|NCT01147965|616446804|FG005|Overall Study|Progressive Disease|5|||
170574057|NCT01147965|616446799|FG000|Overall Study|Death|0|||
170574058|NCT01147965|616446800|FG001|Overall Study|Death|0|||
170574059|NCT01147965|616446801|FG002|Overall Study|Death|1|||
170808725|NCT01970878|617310399|FG002|Overall Study|Withdrawal by Subject|14|||
170808726|NCT01970878|617310400|FG003|Overall Study|Withdrawal by Subject|7|||
170649399|NCT02431260|616729137|FG004|Overall Study|Other Unspecified|0|||
170649400|NCT02431260|616729138|FG005|Overall Study|Other Unspecified|0|||
170649401|NCT02431260|616729139|FG006|Overall Study|Other Unspecified|0|||
170649402|NCT02431260|616729140|FG007|Overall Study|Other Unspecified|0|||
170574060|NCT01147965|616446802|FG003|Overall Study|Death|1|||
170574061|NCT01147965|616446803|FG004|Overall Study|Death|0|||
170574062|NCT01147965|616446804|FG005|Overall Study|Death|2|||
170574063|NCT01147965|616446799|FG000|Overall Study|Withdrawal by Subject|0|||
170574064|NCT01147965|616446800|FG001|Overall Study|Withdrawal by Subject|0|||
170574065|NCT01147965|616446801|FG002|Overall Study|Withdrawal by Subject|1|||
170574066|NCT01147965|616446802|FG003|Overall Study|Withdrawal by Subject|1|||
170574067|NCT01147965|616446803|FG004|Overall Study|Withdrawal by Subject|0|||
170574068|NCT01147965|616446804|FG005|Overall Study|Withdrawal by Subject|0|||
170574069|NCT01147965|616446799|FG000|Overall Study|Administration Of Alternative Therapy|0|||
170574070|NCT01147965|616446800|FG001|Overall Study|Administration Of Alternative Therapy|0|||
170574071|NCT01147965|616446801|FG002|Overall Study|Administration Of Alternative Therapy|0|||
170574072|NCT01147965|616446802|FG003|Overall Study|Administration Of Alternative Therapy|0|||
170574073|NCT01147965|616446803|FG004|Overall Study|Administration Of Alternative Therapy|0|||
170574074|NCT01147965|616446804|FG005|Overall Study|Administration Of Alternative Therapy|1|||
170574075|NCT01147965|616446799|FG000|Overall Study|Other|0|||
170574076|NCT01147965|616446800|FG001|Overall Study|Other|0|||
170574077|NCT01147965|616446801|FG002|Overall Study|Other|0|||
170574078|NCT01147965|616446802|FG003|Overall Study|Other|3|||
170574079|NCT01147965|616446803|FG004|Overall Study|Other|1|||
170574080|NCT01147965|616446804|FG005|Overall Study|Other|0|||
170574081|NCT02257242|616446805|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
170574082|NCT02257242|616446806|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
170574083|NCT02257242|616446807|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
170574084|NCT02257242|616446808|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
170574085|NCT02257242|616446809|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
170574086|NCT02257242|616446810|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
170574087|NCT02257242|616446811|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
170574088|NCT02257242|616446812|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
170574089|NCT02257242|616446813|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
170574090|NCT02297815|616446817|FG000|Overall Study|Lost to Follow-up|236|||
170574091|NCT02297815|616446818|FG001|Overall Study|Lost to Follow-up|140|||
170574092|NCT00600106|616446822|FG000|Overall Study|Withdrawal by Subject|1|||
170574093|NCT00600106|616446823|FG001|Overall Study|Withdrawal by Subject|1|||
170574094|NCT01279044|616446834|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
170574095|NCT01279044|616446835|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
170574096|NCT01279044|616446836|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
170574097|NCT01279044|616446834|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
170574098|NCT01279044|616446835|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
170574099|NCT01279044|616446836|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
170574100|NCT01279044|616446834|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
170574101|NCT01279044|616446835|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
170574102|NCT01279044|616446836|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
170574103|NCT00391053|616446839|FG000|Overall Study|Serious Adverse Events|1|||
170574104|NCT00391053|616446840|FG001|Overall Study|Serious Adverse Events|0|||
170574105|NCT00391053|616446841|FG002|Overall Study|Serious Adverse Events|1|||
170574106|NCT00391053|616446842|FG003|Overall Study|Serious Adverse Events|4|||
170574107|NCT00391053|616446839|FG000|Overall Study|Protocol Violation|2|||
170649403|NCT02431260|616729141|FG008|Overall Study|Other Unspecified|0|||
170649404|NCT02431260|616729142|FG009|Overall Study|Other Unspecified|0|||
170649405|NCT02431260|616729143|FG010|Overall Study|Other Unspecified|0|||
170649406|NCT02431260|616729144|FG011|Overall Study|Other Unspecified|1|||
170649407|NCT02431260|616729145|FG012|Overall Study|Other Unspecified|1|||
170649408|NCT02431260|616729146|FG013|Overall Study|Other Unspecified|0|||
170808727|NCT01970878|617310397|FG000|Overall Study|Lost to Follow-up|1|||
170649409|NCT03288142|616729147|FG000|Overall Study|Lost to Follow-up|22|||
170649410|NCT03288142|616729148|FG001|Overall Study|Lost to Follow-up|15|||
170649411|NCT01699867|616729149|FG000|Overall Study|Screening Failure|3|||
170649412|NCT02342418|616729150|FG000|Overall Study|Adverse Event|0|||
170649413|NCT02342418|616729151|FG001|Overall Study|Adverse Event|1|||
170649414|NCT04255394|616729152|FG000|Overall Study|Death|35|||
170808728|NCT01970878|617310398|FG001|Overall Study|Lost to Follow-up|3|||
170808729|NCT01970878|617310399|FG002|Overall Study|Lost to Follow-up|2|||
170808730|NCT01970878|617310400|FG003|Overall Study|Lost to Follow-up|4|||
170808731|NCT01970878|617310397|FG000|Overall Study|Administrative Reasons|1|||
170808732|NCT01970878|617310398|FG001|Overall Study|Administrative Reasons|0|||
170574108|NCT00391053|616446840|FG001|Overall Study|Protocol Violation|0|||
170574109|NCT00391053|616446841|FG002|Overall Study|Protocol Violation|0|||
170574110|NCT00391053|616446842|FG003|Overall Study|Protocol Violation|0|||
170574111|NCT00391053|616446839|FG000|Overall Study|Lost to Follow-up|1|||
170574112|NCT00391053|616446840|FG001|Overall Study|Lost to Follow-up|0|||
170574113|NCT00391053|616446841|FG002|Overall Study|Lost to Follow-up|0|||
170574114|NCT00391053|616446842|FG003|Overall Study|Lost to Follow-up|5|||
170574115|NCT00391053|616446839|FG000|Overall Study|Withdrawal by Subject|5|||
170574116|NCT00391053|616446840|FG001|Overall Study|Withdrawal by Subject|1|||
170574117|NCT00391053|616446841|FG002|Overall Study|Withdrawal by Subject|1|||
170574118|NCT00391053|616446842|FG003|Overall Study|Withdrawal by Subject|1|||
170574119|NCT03783962|616446843|FG000|Overall Study|Lost to Follow-up|3|||
170574120|NCT03783962|616446844|FG001|Overall Study|Lost to Follow-up|6|||
170574121|NCT03783962|616446843|FG000|Overall Study|Protocol Violation|0|||
170574122|NCT03783962|616446844|FG001|Overall Study|Protocol Violation|1|||
170574123|NCT03458325|616446845|FG000|Overall Study|Withdrawal by Subject|1|||
170574124|NCT03801928|616446846|FG000|Overall Study|Adverse Event|1|||
170574125|NCT03801928|616446847|FG001|Overall Study|Adverse Event|0|||
170574126|NCT03801928|616446848|FG002|Overall Study|Adverse Event|1|||
170574127|NCT03801928|616446849|FG003|Overall Study|Adverse Event|2|||
170574128|NCT03801928|616446850|FG004|Overall Study|Adverse Event|0|||
170574129|NCT03801928|616446851|FG005|Overall Study|Adverse Event|2|||
170574130|NCT03801928|616446846|FG000|Overall Study|Lack of Efficacy|0|||
170574131|NCT03801928|616446847|FG001|Overall Study|Lack of Efficacy|0|||
170574132|NCT03801928|616446848|FG002|Overall Study|Lack of Efficacy|1|||
170574133|NCT03801928|616446849|FG003|Overall Study|Lack of Efficacy|0|||
170574134|NCT03801928|616446850|FG004|Overall Study|Lack of Efficacy|0|||
170574135|NCT03801928|616446851|FG005|Overall Study|Lack of Efficacy|0|||
170574136|NCT03801928|616446846|FG000|Overall Study|Lost to Follow-up|5|||
170574137|NCT03801928|616446847|FG001|Overall Study|Lost to Follow-up|1|||
170574138|NCT03801928|616446848|FG002|Overall Study|Lost to Follow-up|1|||
170574139|NCT03801928|616446849|FG003|Overall Study|Lost to Follow-up|4|||
170574140|NCT03801928|616446850|FG004|Overall Study|Lost to Follow-up|4|||
170574141|NCT03801928|616446851|FG005|Overall Study|Lost to Follow-up|2|||
170574142|NCT03801928|616446846|FG000|Overall Study|Withdrawal by Subject|0|||
170574143|NCT03801928|616446847|FG001|Overall Study|Withdrawal by Subject|0|||
170574144|NCT03801928|616446848|FG002|Overall Study|Withdrawal by Subject|2|||
170574145|NCT03801928|616446849|FG003|Overall Study|Withdrawal by Subject|1|||
170574146|NCT03801928|616446850|FG004|Overall Study|Withdrawal by Subject|0|||
170574147|NCT03801928|616446851|FG005|Overall Study|Withdrawal by Subject|0|||
170574148|NCT03801928|616446846|FG000|Overall Study|Other|0|||
170574149|NCT03801928|616446847|FG001|Overall Study|Other|2|||
170574150|NCT03801928|616446848|FG002|Overall Study|Other|0|||
170574151|NCT03801928|616446849|FG003|Overall Study|Other|1|||
170574152|NCT03801928|616446850|FG004|Overall Study|Other|0|||
170574153|NCT03801928|616446851|FG005|Overall Study|Other|1|||
170574154|NCT02763059|616446852|FG000|Overall Study|Lost to Follow-up|4|||
170574155|NCT02763059|616446853|FG001|Overall Study|Lost to Follow-up|1|||
170574156|NCT02763059|616446854|FG002|Overall Study|Lost to Follow-up|6|||
170574157|NCT02763059|616446852|FG000|Overall Study|Withdrawal by Subject|1|||
170574158|NCT02763059|616446853|FG001|Overall Study|Withdrawal by Subject|0|||
170574159|NCT02763059|616446854|FG002|Overall Study|Withdrawal by Subject|3|||
170574160|NCT02370368|616446855|FG000|Overall Study|Adverse Event|1|||
170574161|NCT02370368|616446856|FG001|Overall Study|Adverse Event|2|||
170574162|NCT02370368|616446855|FG000|Overall Study|Withdrawal by Subject|5|||
170574163|NCT02370368|616446856|FG001|Overall Study|Withdrawal by Subject|4|||
170574164|NCT05069597|616446857|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
170574165|NCT05069597|616446858|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
170574166|NCT03650413|616446859|FG000|Overall Study|Adverse Event|1|||
170574167|NCT03650413|616446859|FG000|Overall Study|Lack of Efficacy|17|||
170574168|NCT03650413|616446859|FG000|Overall Study|Other|9|||
170574169|NCT03650413|616446859|FG000|Overall Study|Physician Decision|2|||
170574170|NCT03650413|616446859|FG000|Overall Study|Study Terminated By Sponsor|16|||
170574171|NCT03650413|616446859|FG000|Overall Study|Withdrawal by Subject|16|||
170574172|NCT00131352|616446864|FG000|Initial Treatment Period|Adverse Event|1|||
170574173|NCT00131352|616446865|FG001|Initial Treatment Period|Adverse Event|3|||
170574174|NCT00131352|616446864|FG000|Initial Treatment Period|Non-compliant|1|||
170574175|NCT00131352|616446865|FG001|Initial Treatment Period|Non-compliant|2|||
170574176|NCT00131352|616446864|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
170574177|NCT00131352|616446865|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
170574178|NCT00131352|616446864|FG000|Initial Treatment Period|Lack of Efficacy|6|||
170574179|NCT00131352|616446865|FG001|Initial Treatment Period|Lack of Efficacy|4|||
170574180|NCT00131352|616446864|FG000|Initial Treatment Period|Other|0|||
170574181|NCT00131352|616446865|FG001|Initial Treatment Period|Other|2|||
170574182|NCT00131352|616446864|FG000|Repeat Treatment Period|Adverse Event|1|||
170574183|NCT00131352|616446865|FG001|Repeat Treatment Period|Adverse Event|0|||
170574184|NCT00131352|616446864|FG000|Repeat Treatment Period|Other|1|||
170574185|NCT00131352|616446865|FG001|Repeat Treatment Period|Other|0|||
170574186|NCT00383331|616446866|FG000|Overall Study|Protocol Violation|0|||
170574187|NCT00383331|616446867|FG001|Overall Study|Protocol Violation|1|||
170574188|NCT01766037|616446869|FG000|Overall Study|Adverse Event|1|||
170574189|NCT01766037|616446870|FG001|Overall Study|Adverse Event|0|||
170574190|NCT01766037|616446869|FG000|Overall Study|Lack of Efficacy|1|||
170574191|NCT01766037|616446870|FG001|Overall Study|Lack of Efficacy|0|||
170574192|NCT01766037|616446869|FG000|Overall Study|Lost to Follow-up|0|||
170574193|NCT01766037|616446870|FG001|Overall Study|Lost to Follow-up|10|||
170574194|NCT01766037|616446869|FG000|Overall Study|Physician Decision|0|||
170574195|NCT01766037|616446870|FG001|Overall Study|Physician Decision|1|||
170574196|NCT01766037|616446869|FG000|Overall Study|Withdrawal by Subject|18|||
170574197|NCT01766037|616446870|FG001|Overall Study|Withdrawal by Subject|16|||
170574198|NCT01766037|616446869|FG000|Overall Study|Moved from area|5|||
170574199|NCT01766037|616446870|FG001|Overall Study|Moved from area|0|||
170574200|NCT01766037|616446869|FG000|Overall Study|medical - unrelated|1|||
170574201|NCT01766037|616446870|FG001|Overall Study|medical - unrelated|2|||
170574202|NCT01766037|616446869|FG000|Overall Study|nausea / discomfort|3|||
170574203|NCT01766037|616446870|FG001|Overall Study|nausea / discomfort|0|||
170574204|NCT01643408|616446874|FG000|Overall Study|Adverse Event|12|||
170574205|NCT01643408|616446874|FG000|Overall Study|Other|2|||
170574206|NCT00292045|616446880|FG000|Core Study (Through Week 13)|Adverse Event|1|||
170574207|NCT00292045|616446880|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
170574208|NCT00709319|616446881|FG000|Overall Study|Death|4|||
170574209|NCT00709319|616446881|FG000|Overall Study|Withdrawal by Subject|2|||
170574210|NCT03726658|616446882|FG000|Overall Study|Lost to Follow-up|0|||
170574211|NCT03726658|616446883|FG001|Overall Study|Lost to Follow-up|0|||
170574212|NCT03726658|616446884|FG002|Overall Study|Lost to Follow-up|2|||
170574213|NCT03726658|616446885|FG003|Overall Study|Lost to Follow-up|0|||
170574214|NCT03726658|616446886|FG004|Overall Study|Lost to Follow-up|0|||
170574215|NCT03726658|616446887|FG005|Overall Study|Lost to Follow-up|1|||
170574216|NCT03726658|616446888|FG006|Overall Study|Lost to Follow-up|1|||
170574217|NCT03726658|616446882|FG000|Overall Study|Withdrawal by Subject|1|||
170574218|NCT03726658|616446883|FG001|Overall Study|Withdrawal by Subject|0|||
170574219|NCT03726658|616446884|FG002|Overall Study|Withdrawal by Subject|0|||
170574220|NCT03726658|616446885|FG003|Overall Study|Withdrawal by Subject|0|||
170574221|NCT03726658|616446886|FG004|Overall Study|Withdrawal by Subject|6|||
170574222|NCT03726658|616446887|FG005|Overall Study|Withdrawal by Subject|4|||
170574223|NCT03726658|616446888|FG006|Overall Study|Withdrawal by Subject|2|||
170574224|NCT03726658|616446882|FG000|Overall Study|Pregnancy|0|||
170574225|NCT03726658|616446883|FG001|Overall Study|Pregnancy|0|||
170574226|NCT03726658|616446884|FG002|Overall Study|Pregnancy|0|||
170574227|NCT03726658|616446885|FG003|Overall Study|Pregnancy|0|||
170574228|NCT03726658|616446886|FG004|Overall Study|Pregnancy|0|||
170574229|NCT03726658|616446887|FG005|Overall Study|Pregnancy|0|||
170574230|NCT03726658|616446888|FG006|Overall Study|Pregnancy|1|||
170574231|NCT03726658|616446882|FG000|Overall Study|Not Reported|0|||
170574232|NCT03726658|616446883|FG001|Overall Study|Not Reported|0|||
170574233|NCT03726658|616446884|FG002|Overall Study|Not Reported|0|||
170574234|NCT03726658|616446885|FG003|Overall Study|Not Reported|0|||
170574235|NCT03726658|616446886|FG004|Overall Study|Not Reported|0|||
170574236|NCT03726658|616446887|FG005|Overall Study|Not Reported|0|||
170574237|NCT03726658|616446888|FG006|Overall Study|Not Reported|1|||
170574238|NCT00412958|616446889|FG000|Overall Study|Withdrawal by Subject|3|||
170574239|NCT00412958|616446890|FG001|Overall Study|Withdrawal by Subject|0|||
170574240|NCT00412958|616446891|FG002|Overall Study|Withdrawal by Subject|0|||
170574241|NCT00412958|616446892|FG003|Overall Study|Withdrawal by Subject|1|||
170909053|NCT02158533|617673472|FG005|Stage 2|Non-adherence with study visits|1|||
170909054|NCT00756002|617673482|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
170909055|NCT00756002|617673483|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
170909056|NCT00756002|617673482|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170909057|NCT00756002|617673483|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
170909058|NCT00756002|617673482|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
170909059|NCT00756002|617673483|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
170574242|NCT00412958|616446889|FG000|Overall Study|Adverse Event|0|||
170574243|NCT00412958|616446890|FG001|Overall Study|Adverse Event|1|||
170574244|NCT00412958|616446891|FG002|Overall Study|Adverse Event|0|||
170574245|NCT00412958|616446892|FG003|Overall Study|Adverse Event|0|||
170574246|NCT00412958|616446889|FG000|Overall Study|Lost to Follow-up|0|||
170574247|NCT00412958|616446890|FG001|Overall Study|Lost to Follow-up|1|||
170574248|NCT00412958|616446891|FG002|Overall Study|Lost to Follow-up|0|||
170574249|NCT00412958|616446892|FG003|Overall Study|Lost to Follow-up|0|||
170574250|NCT00412958|616446889|FG000|Overall Study|Death|0|||
170574251|NCT00412958|616446890|FG001|Overall Study|Death|1|||
170574252|NCT00412958|616446891|FG002|Overall Study|Death|0|||
170574253|NCT00412958|616446892|FG003|Overall Study|Death|0|||
170574254|NCT00412958|616446889|FG000|Overall Study|Transport issue|0|||
170574255|NCT00412958|616446890|FG001|Overall Study|Transport issue|1|||
170574256|NCT00412958|616446891|FG002|Overall Study|Transport issue|0|||
170574257|NCT00412958|616446892|FG003|Overall Study|Transport issue|0|||
170649415|NCT04255394|616729153|FG001|Overall Study|Death|25|||
170574258|NCT01318135|616446893|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
170574259|NCT01318135|616446894|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170574260|NCT01318135|616446895|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170574261|NCT01318135|616446896|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170574262|NCT01318135|616446897|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170574263|NCT01318135|616446898|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170574264|NCT01318135|616446899|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170574265|NCT01318135|616446900|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170574266|NCT01318135|616446893|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
170574267|NCT01318135|616446894|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
170574268|NCT01318135|616446895|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
170574269|NCT01318135|616446896|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
170574270|NCT01318135|616446897|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
170574271|NCT01318135|616446898|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
170574272|NCT01318135|616446899|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
170574273|NCT01318135|616446900|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
170574274|NCT01318135|616446893|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
170574275|NCT01318135|616446894|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
170574276|NCT01318135|616446895|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
170574277|NCT01318135|616446896|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
170574278|NCT01318135|616446897|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
170574279|NCT01318135|616446898|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
170574280|NCT01318135|616446899|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
170574281|NCT01318135|616446900|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
170574282|NCT01318135|616446893|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
170574283|NCT01318135|616446894|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
170574284|NCT01318135|616446895|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
170574285|NCT01318135|616446896|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
170574286|NCT01318135|616446897|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
170574287|NCT01318135|616446898|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
170574288|NCT01318135|616446899|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
170574289|NCT01318135|616446900|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
170574290|NCT01318135|616446893|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
170574291|NCT01318135|616446894|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
170574292|NCT01318135|616446895|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
170574293|NCT01318135|616446896|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
170574294|NCT01318135|616446897|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
170574295|NCT01318135|616446898|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
170574296|NCT01318135|616446899|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
170574297|NCT01318135|616446900|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
170574298|NCT01318135|616446893|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
170574299|NCT01318135|616446894|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
170574300|NCT01318135|616446895|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
170574301|NCT01318135|616446896|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
170574302|NCT01318135|616446897|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
170574303|NCT01318135|616446898|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
170574304|NCT01318135|616446899|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
170574305|NCT01318135|616446900|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
170574306|NCT01318135|616446893|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
170574307|NCT01318135|616446894|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
170574308|NCT01318135|616446895|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
170574309|NCT01318135|616446896|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
170574310|NCT01318135|616446897|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
170574311|NCT01318135|616446898|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
170574312|NCT01318135|616446899|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
170574313|NCT01318135|616446900|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
170574314|NCT05710640|616446904|FG000|Overall Study|Physician Decision|0|||
170649416|NCT04255394|616729152|FG000|Overall Study|Device removed|2|||
170574315|NCT05710640|616446905|FG001|Overall Study|Physician Decision|1|||
170574316|NCT05710640|616446904|FG000|Overall Study|Withdrawal by Subject|1|||
170574317|NCT05710640|616446905|FG001|Overall Study|Withdrawal by Subject|0|||
170574318|NCT05710640|616446904|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
170808733|NCT01970878|617310399|FG002|Overall Study|Administrative Reasons|0|||
170808734|NCT01970878|617310400|FG003|Overall Study|Administrative Reasons|4|||
170808735|NCT01970878|617310397|FG000|Overall Study|Lack of Efficacy|2|||
170808736|NCT01970878|617310398|FG001|Overall Study|Lack of Efficacy|1|||
170574319|NCT05710640|616446905|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
170574320|NCT04158375|616446906|FG000|Overall Study|Withdrawal by Subject|0|||
170574321|NCT04158375|616446907|FG001|Overall Study|Withdrawal by Subject|3|||
170574322|NCT04158375|616446908|FG002|Overall Study|Withdrawal by Subject|0|||
170574323|NCT03465722|616446910|FG000|Overall Study|Withdrawal by Subject|21|||
170574324|NCT03465722|616446911|FG001|Overall Study|Withdrawal by Subject|14|||
170574325|NCT03465722|616446910|FG000|Overall Study|Death|89|||
170574326|NCT03465722|616446911|FG001|Overall Study|Death|87|||
170574327|NCT03465722|616446910|FG000|Overall Study|Lost to Follow-up|5|||
170574328|NCT03465722|616446911|FG001|Overall Study|Lost to Follow-up|3|||
170574329|NCT03465722|616446910|FG000|Overall Study|Administrative/Other|33|||
170574330|NCT03465722|616446911|FG001|Overall Study|Administrative/Other|32|||
170574331|NCT03465722|616446910|FG000|Overall Study|Not treated|1|||
170574332|NCT03465722|616446911|FG001|Overall Study|Not treated|2|||
170574333|NCT03465722|616446910|FG000|Overall Study|Sponsor decision|91|||
170574334|NCT03465722|616446911|FG001|Overall Study|Sponsor decision|98|||
170574335|NCT00703963|616446914|FG000|Overall Study|Withdrawal by Subject|7|||
170574336|NCT00703963|616446915|FG001|Overall Study|Withdrawal by Subject|13|||
170574337|NCT00703963|616446914|FG000|Overall Study|Physician Decision|0|||
170574338|NCT00703963|616446915|FG001|Overall Study|Physician Decision|1|||
170574339|NCT00442416|616446923|FG000|Overall Study|Adverse Event|4|||
170574340|NCT00442416|616446924|FG001|Overall Study|Adverse Event|1|||
170574341|NCT00442416|616446923|FG000|Overall Study|Death|1|||
170574342|NCT00442416|616446924|FG001|Overall Study|Death|0|||
170574343|NCT00442416|616446923|FG000|Overall Study|Lack of Efficacy|2|||
170574344|NCT00442416|616446924|FG001|Overall Study|Lack of Efficacy|0|||
170574345|NCT00442416|616446923|FG000|Overall Study|Protocol Violation|2|||
170574346|NCT00442416|616446924|FG001|Overall Study|Protocol Violation|3|||
170574347|NCT00442416|616446923|FG000|Overall Study|Withdrew consent|1|||
170574348|NCT00442416|616446924|FG001|Overall Study|Withdrew consent|2|||
170574349|NCT00442416|616446923|FG000|Overall Study|Administrative/Other|27|||
170574350|NCT00442416|616446924|FG001|Overall Study|Administrative/Other|33|||
170574351|NCT02243371|616446936|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
170574352|NCT02243371|616446937|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
170574353|NCT02243371|616446936|FG000|Overall Study|Death (unrelated)|2|||
170574354|NCT02243371|616446937|FG001|Overall Study|Death (unrelated)|4|||
170574355|NCT02243371|616446936|FG000|Overall Study|Adverse Event (unrelated)|0|||
170574356|NCT02243371|616446937|FG001|Overall Study|Adverse Event (unrelated)|1|||
170574357|NCT02243371|616446936|FG000|Overall Study|Lack of Clinical Benefit|0|||
170574358|NCT02243371|616446937|FG001|Overall Study|Lack of Clinical Benefit|1|||
170574359|NCT02243371|616446936|FG000|Overall Study|Withdrawal by Subject|0|||
170574360|NCT02243371|616446937|FG001|Overall Study|Withdrawal by Subject|2|||
170574361|NCT00955474|616446938|FG000|Overall Study|Physician Decision|7|||
170574362|NCT00955474|616446939|FG001|Overall Study|Physician Decision|5|||
170574363|NCT02528942|616446940|FG000|Overall Study|Did not meet imaging criteria|9|||
170574364|NCT02528942|616446940|FG000|Overall Study|Lost to Follow-up|25|||
170574365|NCT00271856|616446941|FG000|Overall Study|Withdrawal by Subject|1|||
170574366|NCT00271856|616446942|FG001|Overall Study|Withdrawal by Subject|7|||
170574367|NCT00271856|616446941|FG000|Overall Study|Lost to Follow-up|10|||
170574368|NCT00271856|616446942|FG001|Overall Study|Lost to Follow-up|11|||
170574369|NCT00503425|616446943|FG000|Overall Study|Participant files lost|6|||
170574370|NCT00503425|616446943|FG000|Overall Study|Adverse Event|5|||
170574371|NCT00503425|616446943|FG000|Overall Study|Lack of Efficacy|25|||
170808737|NCT01970878|617310399|FG002|Overall Study|Lack of Efficacy|2|||
170574372|NCT00503425|616446943|FG000|Overall Study|Withdrawal by Subject|8|||
170574373|NCT00503425|616446943|FG000|Overall Study|Lost to Follow-up|3|||
170574374|NCT00503425|616446943|FG000|Overall Study|Death|3|||
170574375|NCT00503425|616446943|FG000|Overall Study|Missing Data/Unknown|4|||
170808738|NCT01970878|617310400|FG003|Overall Study|Lack of Efficacy|0|||
170808739|NCT01970878|617310397|FG000|Overall Study|Adverse Event|12|||
170808740|NCT01970878|617310398|FG001|Overall Study|Adverse Event|7|||
170574376|NCT02148263|616446944|FG000|Overall Study|Withdrawal by Subject|3|||
170574377|NCT02148263|616446945|FG001|Overall Study|Withdrawal by Subject|2|||
170574378|NCT03900728|616446946|FG000|Overall Study|No text responses|0|||
170574379|NCT03900728|616446947|FG001|Overall Study|No text responses|0|||
170574380|NCT03900728|616446948|FG002|Overall Study|No text responses|4|||
170574381|NCT01162473|616446955|FG000|Overall Study|Adverse Event|2|||
170574382|NCT01162473|616446956|FG001|Overall Study|Adverse Event|1|||
170574383|NCT01162473|616446955|FG000|Overall Study|Withdrawal by Subject|0|||
170574384|NCT01162473|616446956|FG001|Overall Study|Withdrawal by Subject|4|||
170574385|NCT01144416|616446957|FG000|Intervention Period|Adverse Event|5|||
170574386|NCT01144416|616446958|FG001|Intervention Period|Adverse Event|6|||
170574387|NCT01144416|616446957|FG000|Intervention Period|Insufficient ovarian response|11|||
170574388|NCT01144416|616446958|FG001|Intervention Period|Insufficient ovarian response|17|||
170574389|NCT01144416|616446957|FG000|Intervention Period|Risk of OHSS|0|||
170574390|NCT01144416|616446958|FG001|Intervention Period|Risk of OHSS|1|||
170574391|NCT01144416|616446957|FG000|Intervention Period|Too high ovarian response|4|||
170574392|NCT01144416|616446958|FG001|Intervention Period|Too high ovarian response|2|||
170574393|NCT01144416|616446957|FG000|Intervention Period|No/too few/bad oocytes|7|||
170574394|NCT01144416|616446958|FG001|Intervention Period|No/too few/bad oocytes|5|||
170574395|NCT01144416|616446957|FG000|Intervention Period|No or abnormal fertilization|25|||
170574396|NCT01144416|616446958|FG001|Intervention Period|No or abnormal fertilization|10|||
170574397|NCT01144416|616446957|FG000|Intervention Period|No/too few/bad quality embryos|3|||
170574398|NCT01144416|616446958|FG001|Intervention Period|No/too few/bad quality embryos|3|||
170574399|NCT01144416|616446957|FG000|Intervention Period|Other|7|||
170574400|NCT01144416|616446958|FG001|Intervention Period|Other|5|||
170574401|NCT00886769|616446960|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
170574402|NCT00886769|616446961|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
170574403|NCT00049257|616446962|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
170574404|NCT00049257|616446962|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
170574405|NCT00049257|616446962|FG000|Carboplatin, Paclitaxel|Death|2|||
170574406|NCT00049257|616446962|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
170574407|NCT03670355|616446964|FG000|Overall Study|Adverse Event|1|||
170574408|NCT03670355|616446965|FG001|Overall Study|Adverse Event|0|||
170574409|NCT03670355|616446964|FG000|Overall Study|Unable to comply with study procedures|0|||
170574410|NCT03670355|616446965|FG001|Overall Study|Unable to comply with study procedures|1|||
170574411|NCT03670355|616446964|FG000|Overall Study|Participant refused|0|||
170574412|NCT03670355|616446965|FG001|Overall Study|Participant refused|1|||
170574413|NCT03517436|616446966|FG000|Overall Study|Death|3|||
170574414|NCT03517436|616446966|FG000|Overall Study|Withdrawal by Subject|4|||
170574415|NCT03517436|616446966|FG000|Overall Study|Did not receive study valve.|1|||
170574416|NCT04271540|616446967|FG000|Overall Study|Lost to Follow-up|1|||
170574417|NCT04271540|616446967|FG000|Overall Study|Screen Fail|5|||
170574418|NCT03146663|616446968|FG000|Overall Study|Did not receive study treatment|1|||
170574419|NCT03146663|616446969|FG001|Overall Study|Did not receive study treatment|1|||
170574420|NCT03666988|616446970|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
170574421|NCT03666988|616446971|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
170574422|NCT03666988|616446972|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
170574423|NCT03666988|616446973|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
170574424|NCT03666988|616446974|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
170574425|NCT03666988|616446975|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
170574426|NCT03666988|616446970|FG000|Part 1 (Up to 28 Months)|Other|0|||
170574427|NCT03666988|616446971|FG001|Part 1 (Up to 28 Months)|Other|1|||
170574428|NCT03666988|616446972|FG002|Part 1 (Up to 28 Months)|Other|1|||
170574429|NCT03666988|616446973|FG003|Part 1 (Up to 28 Months)|Other|0|||
170574430|NCT03666988|616446974|FG004|Part 1 (Up to 28 Months)|Other|0|||
170574431|NCT03666988|616446975|FG005|Part 1 (Up to 28 Months)|Other|0|||
170574432|NCT03666988|616446970|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
170574433|NCT03666988|616446971|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
170574434|NCT03666988|616446972|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
170574435|NCT03666988|616446973|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
170574436|NCT03666988|616446974|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
170574437|NCT03666988|616446975|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
170574438|NCT03666988|616446970|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
170574439|NCT03666988|616446971|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
170574440|NCT03666988|616446972|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
170574441|NCT03666988|616446973|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
170574442|NCT03666988|616446974|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
170574443|NCT03666988|616446975|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
170808741|NCT01970878|617310399|FG002|Overall Study|Adverse Event|4|||
170808742|NCT01970878|617310400|FG003|Overall Study|Adverse Event|3|||
170808743|NCT01970878|617310397|FG000|Overall Study|Protocol Specified Criteria|10|||
170808744|NCT01970878|617310398|FG001|Overall Study|Protocol Specified Criteria|4|||
170808745|NCT01970878|617310399|FG002|Overall Study|Protocol Specified Criteria|3|||
170808746|NCT01970878|617310400|FG003|Overall Study|Protocol Specified Criteria|6|||
170574444|NCT03666988|616446970|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
170574445|NCT03666988|616446971|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
170574446|NCT03666988|616446972|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
170574447|NCT03666988|616446973|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
170574448|NCT03666988|616446974|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
170574449|NCT03666988|616446975|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
170808747|NCT01970878|617310397|FG000|Overall Study|Physician Decision|0|||
170808748|NCT01970878|617310398|FG001|Overall Study|Physician Decision|1|||
170574450|NCT02454530|616446976|FG000|Overall Study|Other|8|||
170808749|NCT01970878|617310399|FG002|Overall Study|Physician Decision|1|||
170574451|NCT02454530|616446977|FG001|Overall Study|Other|13|||
170574452|NCT02454530|616446976|FG000|Overall Study|Missing information|56|||
170808750|NCT01970878|617310400|FG003|Overall Study|Physician Decision|0|||
170808751|NCT01970878|617310397|FG000|Overall Study|No Completion Status|0|||
170574453|NCT02454530|616446977|FG001|Overall Study|Missing information|69|||
170574454|NCT02454530|616446976|FG000|Overall Study|Death|2|||
170574455|NCT02454530|616446977|FG001|Overall Study|Death|41|||
170574456|NCT02454530|616446976|FG000|Overall Study|Lost to Follow-up|4|||
170574457|NCT02454530|616446977|FG001|Overall Study|Lost to Follow-up|4|||
170574458|NCT03265145|616446978|FG000|Overall Study|Protocol Violation|2|||
170574459|NCT03265145|616446979|FG001|Overall Study|Protocol Violation|0|||
170574460|NCT03265145|616446978|FG000|Overall Study|Adverse Event|1|||
170574461|NCT03265145|616446979|FG001|Overall Study|Adverse Event|0|||
170574462|NCT03265145|616446978|FG000|Overall Study|Withdrawal by Subject|23|||
170574463|NCT03265145|616446979|FG001|Overall Study|Withdrawal by Subject|19|||
170574464|NCT03265145|616446978|FG000|Overall Study|Death|12|||
170574465|NCT03265145|616446979|FG001|Overall Study|Death|12|||
170574466|NCT03265145|616446978|FG000|Overall Study|Lost to Follow-up|13|||
170574467|NCT03265145|616446979|FG001|Overall Study|Lost to Follow-up|9|||
170574468|NCT03265145|616446978|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
170574469|NCT03265145|616446979|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
170574470|NCT03265145|616446978|FG000|Overall Study|Switched back to previous medication|1|||
170574471|NCT03265145|616446979|FG001|Overall Study|Switched back to previous medication|0|||
170574472|NCT03265145|616446978|FG000|Overall Study|Did not want to take medication|1|||
170574473|NCT03265145|616446979|FG001|Overall Study|Did not want to take medication|0|||
170574474|NCT03265145|616446978|FG000|Overall Study|Subject could not afford medication|0|||
170574475|NCT03265145|616446979|FG001|Overall Study|Subject could not afford medication|1|||
170574476|NCT03265145|616446978|FG000|Overall Study|Site closed|2|||
170574477|NCT03265145|616446979|FG001|Overall Study|Site closed|3|||
170574478|NCT03265145|616446978|FG000|Overall Study|Incorrectly randomized|16|||
170574479|NCT03265145|616446979|FG001|Overall Study|Incorrectly randomized|6|||
170574480|NCT03265145|616446978|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
170574481|NCT03265145|616446979|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
170574482|NCT03265145|616446978|FG000|Overall Study|Physician Decision|0|||
170574483|NCT03265145|616446979|FG001|Overall Study|Physician Decision|3|||
170574484|NCT03265145|616446978|FG000|Overall Study|Subject transferred to another facility|0|||
170574485|NCT03265145|616446979|FG001|Overall Study|Subject transferred to another facility|1|||
170574486|NCT02137070|616446980|FG000|Overall Study|Adverse Event|12|||
170574487|NCT02137070|616446981|FG001|Overall Study|Adverse Event|3|||
170574488|NCT02137070|616446980|FG000|Overall Study|Death|2|||
170574489|NCT02137070|616446981|FG001|Overall Study|Death|0|||
170574490|NCT02137070|616446980|FG000|Overall Study|Lost to Follow-up|24|||
170574491|NCT02137070|616446981|FG001|Overall Study|Lost to Follow-up|9|||
170574492|NCT02137070|616446980|FG000|Overall Study|Physician Decision|0|||
170574493|NCT02137070|616446981|FG001|Overall Study|Physician Decision|1|||
170574494|NCT02137070|616446980|FG000|Overall Study|Protocol Violation|18|||
170574495|NCT02137070|616446981|FG001|Overall Study|Protocol Violation|4|||
170574496|NCT02137070|616446980|FG000|Overall Study|Withdrawal by Subject|18|||
170574497|NCT02137070|616446981|FG001|Overall Study|Withdrawal by Subject|1|||
170574498|NCT05823974|616449250|FG000|Overall Study|Lost to Follow-up|0|||
170574499|NCT05823974|616449251|FG001|Overall Study|Lost to Follow-up|3|||
170574500|NCT05823974|616449252|FG002|Overall Study|Lost to Follow-up|1|||
170574501|NCT05823974|616449253|FG003|Overall Study|Lost to Follow-up|0|||
170574502|NCT05823974|616449254|FG004|Overall Study|Lost to Follow-up|1|||
170574503|NCT05823974|616449255|FG005|Overall Study|Lost to Follow-up|0|||
170574504|NCT05823974|616449256|FG006|Overall Study|Lost to Follow-up|1|||
170574505|NCT05823974|616449257|FG007|Overall Study|Lost to Follow-up|0|||
170574506|NCT05823974|616449258|FG008|Overall Study|Lost to Follow-up|0|||
170574507|NCT05823974|616449259|FG009|Overall Study|Lost to Follow-up|1|||
170574508|NCT05823974|616449260|FG010|Overall Study|Lost to Follow-up|1|||
170649417|NCT04255394|616729153|FG001|Overall Study|Device removed|10|||
170649418|NCT04255394|616729152|FG000|Overall Study|Withdrawal by Subject|9|||
170649419|NCT04255394|616729153|FG001|Overall Study|Withdrawal by Subject|8|||
170574509|NCT05823974|616449261|FG011|Overall Study|Lost to Follow-up|0|||
170574510|NCT05823974|616449262|FG012|Overall Study|Lost to Follow-up|1|||
170574511|NCT05823974|616449263|FG013|Overall Study|Lost to Follow-up|2|||
170574512|NCT05823974|616449264|FG014|Overall Study|Lost to Follow-up|1|||
170574513|NCT05823974|616449265|FG015|Overall Study|Lost to Follow-up|1|||
170574514|NCT05823974|616449266|FG016|Overall Study|Lost to Follow-up|1|||
170649420|NCT04255394|616729152|FG000|Overall Study|Screen Failure/Not treated|12|||
170649421|NCT04255394|616729153|FG001|Overall Study|Screen Failure/Not treated|8|||
170649422|NCT04255394|616729152|FG000|Overall Study|Lost to Follow-up|123|||
170649423|NCT04255394|616729153|FG001|Overall Study|Lost to Follow-up|265|||
170574515|NCT05823974|616449267|FG017|Overall Study|Lost to Follow-up|0|||
170574516|NCT05823974|616449268|FG018|Overall Study|Lost to Follow-up|0|||
170574517|NCT05823974|616449269|FG019|Overall Study|Lost to Follow-up|2|||
170574518|NCT05823974|616449270|FG020|Overall Study|Lost to Follow-up|0|||
170574519|NCT05823974|616449250|FG000|Overall Study|Physician Decision|0|||
170574520|NCT05823974|616449251|FG001|Overall Study|Physician Decision|0|||
170574521|NCT05823974|616449252|FG002|Overall Study|Physician Decision|0|||
170574522|NCT05823974|616449253|FG003|Overall Study|Physician Decision|0|||
170574523|NCT05823974|616449254|FG004|Overall Study|Physician Decision|0|||
170574524|NCT05823974|616449255|FG005|Overall Study|Physician Decision|0|||
170574525|NCT05823974|616449256|FG006|Overall Study|Physician Decision|0|||
170574526|NCT05823974|616449257|FG007|Overall Study|Physician Decision|0|||
170574527|NCT05823974|616449258|FG008|Overall Study|Physician Decision|0|||
170574528|NCT05823974|616449259|FG009|Overall Study|Physician Decision|0|||
170574529|NCT05823974|616449260|FG010|Overall Study|Physician Decision|0|||
170574530|NCT05823974|616449261|FG011|Overall Study|Physician Decision|0|||
170574531|NCT05823974|616449262|FG012|Overall Study|Physician Decision|0|||
170574532|NCT05823974|616449263|FG013|Overall Study|Physician Decision|0|||
170574533|NCT05823974|616449264|FG014|Overall Study|Physician Decision|0|||
170574534|NCT05823974|616449265|FG015|Overall Study|Physician Decision|1|||
170574535|NCT05823974|616449266|FG016|Overall Study|Physician Decision|0|||
170574536|NCT05823974|616449267|FG017|Overall Study|Physician Decision|1|||
170574537|NCT05823974|616449268|FG018|Overall Study|Physician Decision|1|||
170574538|NCT05823974|616449269|FG019|Overall Study|Physician Decision|0|||
170574539|NCT05823974|616449270|FG020|Overall Study|Physician Decision|0|||
170574540|NCT05823974|616449250|FG000|Overall Study|Withdrawal by Subject|1|||
170574541|NCT05823974|616449251|FG001|Overall Study|Withdrawal by Subject|1|||
170574542|NCT05823974|616449252|FG002|Overall Study|Withdrawal by Subject|2|||
170574543|NCT05823974|616449253|FG003|Overall Study|Withdrawal by Subject|0|||
170574544|NCT05823974|616449254|FG004|Overall Study|Withdrawal by Subject|2|||
170574545|NCT05823974|616449255|FG005|Overall Study|Withdrawal by Subject|3|||
170574546|NCT05823974|616449256|FG006|Overall Study|Withdrawal by Subject|1|||
170574547|NCT05823974|616449257|FG007|Overall Study|Withdrawal by Subject|1|||
170574548|NCT05823974|616449258|FG008|Overall Study|Withdrawal by Subject|2|||
170574549|NCT05823974|616449259|FG009|Overall Study|Withdrawal by Subject|1|||
170574550|NCT05823974|616449260|FG010|Overall Study|Withdrawal by Subject|1|||
170574551|NCT05823974|616449261|FG011|Overall Study|Withdrawal by Subject|0|||
170574552|NCT05823974|616449262|FG012|Overall Study|Withdrawal by Subject|0|||
170574553|NCT05823974|616449263|FG013|Overall Study|Withdrawal by Subject|1|||
170574554|NCT05823974|616449264|FG014|Overall Study|Withdrawal by Subject|1|||
170574555|NCT05823974|616449265|FG015|Overall Study|Withdrawal by Subject|3|||
170574556|NCT05823974|616449266|FG016|Overall Study|Withdrawal by Subject|0|||
170574557|NCT05823974|616449267|FG017|Overall Study|Withdrawal by Subject|2|||
170574558|NCT05823974|616449268|FG018|Overall Study|Withdrawal by Subject|2|||
170574559|NCT05823974|616449269|FG019|Overall Study|Withdrawal by Subject|0|||
170574560|NCT05823974|616449270|FG020|Overall Study|Withdrawal by Subject|1|||
170574561|NCT05823974|616449250|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574562|NCT05823974|616449251|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574563|NCT05823974|616449252|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170574564|NCT05823974|616449253|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574565|NCT05823974|616449254|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574566|NCT05823974|616449255|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574567|NCT05823974|616449256|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574568|NCT05823974|616449257|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574569|NCT05823974|616449258|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574570|NCT05823974|616449259|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574571|NCT05823974|616449260|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574572|NCT05823974|616449261|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170909060|NCT00756002|617673482|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
170909061|NCT00756002|617673483|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
170909062|NCT00756002|617673482|FG000|Double-Blind Treatment Period|Other|2|||
170909063|NCT00756002|617673483|FG001|Double-Blind Treatment Period|Other|2|||
170909064|NCT03334214|617673486|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
170909065|NCT03334214|617673487|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
170909066|NCT03334214|617673486|FG000|Overall Study|Withdrawal by Subject|0|||
170909067|NCT03334214|617673487|FG001|Overall Study|Withdrawal by Subject|1|||
170909068|NCT03334214|617673486|FG000|Overall Study|Other|1|||
170909069|NCT03334214|617673487|FG001|Overall Study|Other|0|||
170909070|NCT05655832|617673493|FG000|Overall Study|Not mentioned|0|||
170574573|NCT05823974|616449262|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574574|NCT05823974|616449263|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574575|NCT05823974|616449264|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170574576|NCT05823974|616449265|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574577|NCT05823974|616449266|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574578|NCT05823974|616449267|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574579|NCT05823974|616449268|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170574580|NCT05823974|616449269|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170909071|NCT05655832|617673494|FG001|Overall Study|Not mentioned|1|||
170909072|NCT05655832|617673493|FG000|Overall Study|Withdrawal by Subject|0|||
170574581|NCT05823974|616449270|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170909073|NCT05655832|617673494|FG001|Overall Study|Withdrawal by Subject|1|||
170909074|NCT05655832|617673493|FG000|Overall Study|Protocol non-compliance|0|||
170909075|NCT05655832|617673494|FG001|Overall Study|Protocol non-compliance|1|||
170909076|NCT04516967|617673495|FG000|Core Phase|Adverse Event|2|||
170909077|NCT04516967|617673496|FG001|Core Phase|Adverse Event|1|||
170909078|NCT04516967|617673497|FG002|Core Phase|Adverse Event|0|||
170909079|NCT04516967|617673495|FG000|Core Phase|Physician Decision|1|||
170909080|NCT04516967|617673496|FG001|Core Phase|Physician Decision|1|||
170909081|NCT04516967|617673497|FG002|Core Phase|Physician Decision|0|||
170909082|NCT04516967|617673495|FG000|Core Phase|Lack of Efficacy|7|||
170574582|NCT05823974|616449250|FG000|Overall Study|Other|0|||
170574583|NCT05823974|616449251|FG001|Overall Study|Other|1|||
170574584|NCT05823974|616449252|FG002|Overall Study|Other|1|||
170574585|NCT05823974|616449253|FG003|Overall Study|Other|1|||
170574586|NCT05823974|616449254|FG004|Overall Study|Other|0|||
170574587|NCT05823974|616449255|FG005|Overall Study|Other|1|||
170574588|NCT05823974|616449256|FG006|Overall Study|Other|1|||
170574589|NCT05823974|616449257|FG007|Overall Study|Other|1|||
170574590|NCT05823974|616449258|FG008|Overall Study|Other|1|||
170574591|NCT05823974|616449259|FG009|Overall Study|Other|0|||
170574592|NCT05823974|616449260|FG010|Overall Study|Other|0|||
170574593|NCT05823974|616449261|FG011|Overall Study|Other|0|||
170574594|NCT05823974|616449262|FG012|Overall Study|Other|2|||
170574595|NCT05823974|616449263|FG013|Overall Study|Other|1|||
170574596|NCT05823974|616449264|FG014|Overall Study|Other|0|||
170574597|NCT05823974|616449265|FG015|Overall Study|Other|1|||
170574598|NCT05823974|616449266|FG016|Overall Study|Other|0|||
170574599|NCT05823974|616449267|FG017|Overall Study|Other|0|||
170574600|NCT05823974|616449268|FG018|Overall Study|Other|0|||
170574601|NCT05823974|616449269|FG019|Overall Study|Other|0|||
170574602|NCT05823974|616449270|FG020|Overall Study|Other|0|||
170574603|NCT00316706|616449271|FG000|Overall Study|Lost to Follow-up|38|||
170574604|NCT00316706|616449272|FG001|Overall Study|Lost to Follow-up|48|||
170574605|NCT01945216|616449278|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
170574606|NCT01945216|616449278|FG000|Overall Study|Protocol Violation|42|||
170574607|NCT01945216|616449278|FG000|Overall Study|CRF not assured by investigators|5|||
170574608|NCT02574078|616449284|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574609|NCT02574078|616449285|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574610|NCT02574078|616449286|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574611|NCT02574078|616449287|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574612|NCT02574078|616449288|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170808752|NCT01970878|617310398|FG001|Overall Study|No Completion Status|1|||
170808753|NCT01970878|617310399|FG002|Overall Study|No Completion Status|0|||
170808754|NCT01970878|617310400|FG003|Overall Study|No Completion Status|0|||
170574613|NCT02574078|616449289|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
170574614|NCT02574078|616449290|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
170574615|NCT02574078|616449291|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574616|NCT02574078|616449292|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
170574617|NCT02574078|616449293|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574618|NCT02574078|616449294|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574619|NCT02574078|616449295|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574620|NCT02574078|616449296|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
170574621|NCT02574078|616449284|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
170574622|NCT02574078|616449285|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
170574623|NCT02574078|616449286|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
170574624|NCT02574078|616449287|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
170808755|NCT02830893|617310401|FG000|Overall Study|Relocation to out of the country|1|||
170808756|NCT02830893|617310402|FG001|Overall Study|Relocation to out of the country|0|||
170574625|NCT02574078|616449288|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
170808757|NCT02830893|617310401|FG000|Overall Study|Lost to Follow-up|0|||
170808758|NCT02830893|617310402|FG001|Overall Study|Lost to Follow-up|2|||
170808759|NCT02830893|617310401|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
170574626|NCT02574078|616449289|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
170574627|NCT02574078|616449290|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
170574628|NCT02574078|616449291|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
170574629|NCT02574078|616449292|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
170909083|NCT04516967|617673496|FG001|Core Phase|Lack of Efficacy|18|||
170574630|NCT02574078|616449293|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
170574631|NCT02574078|616449294|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
170574632|NCT02574078|616449295|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
170808760|NCT02830893|617310402|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
170808761|NCT01277302|617310403|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
170909084|NCT04516967|617673497|FG002|Core Phase|Lack of Efficacy|0|||
170909085|NCT04576949|617673498|FG000|Overall Study|Adverse Event|1|||
170574633|NCT02574078|616449296|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
170574634|NCT02574078|616449284|FG000|Pre-Treatment Period|Other reasons|0|||
170574635|NCT02574078|616449285|FG001|Pre-Treatment Period|Other reasons|0|||
170574636|NCT02574078|616449286|FG002|Pre-Treatment Period|Other reasons|0|||
170574637|NCT02574078|616449287|FG003|Pre-Treatment Period|Other reasons|0|||
170574638|NCT02574078|616449288|FG004|Pre-Treatment Period|Other reasons|0|||
170574639|NCT02574078|616449289|FG005|Pre-Treatment Period|Other reasons|0|||
170574640|NCT02574078|616449290|FG006|Pre-Treatment Period|Other reasons|2|||
170574641|NCT02574078|616449291|FG007|Pre-Treatment Period|Other reasons|0|||
170574642|NCT02574078|616449292|FG008|Pre-Treatment Period|Other reasons|0|||
170574643|NCT02574078|616449293|FG009|Pre-Treatment Period|Other reasons|0|||
170574644|NCT02574078|616449294|FG010|Pre-Treatment Period|Other reasons|2|||
170574645|NCT02574078|616449295|FG011|Pre-Treatment Period|Other reasons|0|||
170574646|NCT02574078|616449296|FG012|Pre-Treatment Period|Other reasons|0|||
170574647|NCT02574078|616449284|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
170574648|NCT02574078|616449285|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
170574649|NCT02574078|616449286|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
170574650|NCT02574078|616449287|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
170574651|NCT02574078|616449288|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
170574652|NCT02574078|616449289|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
170574653|NCT02574078|616449290|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
170574654|NCT02574078|616449291|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
170574655|NCT02574078|616449292|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
170574656|NCT02574078|616449293|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
170574657|NCT02574078|616449294|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
170574658|NCT02574078|616449295|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
170574659|NCT02574078|616449296|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
170574660|NCT02574078|616449284|FG000|Treatment Period|Disease progression|6|||
170574661|NCT02574078|616449285|FG001|Treatment Period|Disease progression|4|||
170574662|NCT02574078|616449286|FG002|Treatment Period|Disease progression|7|||
170574663|NCT02574078|616449287|FG003|Treatment Period|Disease progression|18|||
170574664|NCT02574078|616449288|FG004|Treatment Period|Disease progression|16|||
170574665|NCT02574078|616449289|FG005|Treatment Period|Disease progression|26|||
170574666|NCT02574078|616449290|FG006|Treatment Period|Disease progression|5|||
170574667|NCT02574078|616449291|FG007|Treatment Period|Disease progression|9|||
170574668|NCT02574078|616449292|FG008|Treatment Period|Disease progression|8|||
170574669|NCT02574078|616449293|FG009|Treatment Period|Disease progression|5|||
170574670|NCT02574078|616449294|FG010|Treatment Period|Disease progression|20|||
170574671|NCT02574078|616449295|FG011|Treatment Period|Disease progression|29|||
170574672|NCT02574078|616449296|FG012|Treatment Period|Disease progression|2|||
170574673|NCT02574078|616449284|FG000|Treatment Period|Study drug toxicity|1|||
170574674|NCT02574078|616449285|FG001|Treatment Period|Study drug toxicity|1|||
170574675|NCT02574078|616449286|FG002|Treatment Period|Study drug toxicity|0|||
170574676|NCT02574078|616449287|FG003|Treatment Period|Study drug toxicity|5|||
170574677|NCT02574078|616449288|FG004|Treatment Period|Study drug toxicity|3|||
170574678|NCT02574078|616449289|FG005|Treatment Period|Study drug toxicity|1|||
170574679|NCT02574078|616449290|FG006|Treatment Period|Study drug toxicity|2|||
170574680|NCT02574078|616449291|FG007|Treatment Period|Study drug toxicity|0|||
170574681|NCT02574078|616449292|FG008|Treatment Period|Study drug toxicity|2|||
170574682|NCT02574078|616449293|FG009|Treatment Period|Study drug toxicity|1|||
170574683|NCT02574078|616449294|FG010|Treatment Period|Study drug toxicity|16|||
170574684|NCT02574078|616449295|FG011|Treatment Period|Study drug toxicity|2|||
170574685|NCT02574078|616449296|FG012|Treatment Period|Study drug toxicity|4|||
170574686|NCT02574078|616449284|FG000|Treatment Period|Death|2|||
170574687|NCT02574078|616449285|FG001|Treatment Period|Death|0|||
170574688|NCT02574078|616449286|FG002|Treatment Period|Death|0|||
170574689|NCT02574078|616449287|FG003|Treatment Period|Death|0|||
170574690|NCT02574078|616449288|FG004|Treatment Period|Death|1|||
170574691|NCT02574078|616449289|FG005|Treatment Period|Death|1|||
170574692|NCT02574078|616449290|FG006|Treatment Period|Death|1|||
170574693|NCT02574078|616449291|FG007|Treatment Period|Death|1|||
170574694|NCT02574078|616449292|FG008|Treatment Period|Death|7|||
170574695|NCT02574078|616449293|FG009|Treatment Period|Death|1|||
170574696|NCT02574078|616449294|FG010|Treatment Period|Death|0|||
170574697|NCT02574078|616449295|FG011|Treatment Period|Death|2|||
170574698|NCT02574078|616449296|FG012|Treatment Period|Death|1|||
170574699|NCT02574078|616449284|FG000|Treatment Period|Adverse event unrelated to drug|0|||
170574700|NCT02574078|616449285|FG001|Treatment Period|Adverse event unrelated to drug|0|||
170574701|NCT02574078|616449286|FG002|Treatment Period|Adverse event unrelated to drug|1|||
170574702|NCT02574078|616449287|FG003|Treatment Period|Adverse event unrelated to drug|0|||
170574703|NCT02574078|616449288|FG004|Treatment Period|Adverse event unrelated to drug|2|||
170574704|NCT02574078|616449289|FG005|Treatment Period|Adverse event unrelated to drug|3|||
170574705|NCT02574078|616449290|FG006|Treatment Period|Adverse event unrelated to drug|0|||
170574706|NCT02574078|616449291|FG007|Treatment Period|Adverse event unrelated to drug|0|||
170574707|NCT02574078|616449292|FG008|Treatment Period|Adverse event unrelated to drug|1|||
170574708|NCT02574078|616449293|FG009|Treatment Period|Adverse event unrelated to drug|2|||
170574709|NCT02574078|616449294|FG010|Treatment Period|Adverse event unrelated to drug|4|||
170574710|NCT02574078|616449295|FG011|Treatment Period|Adverse event unrelated to drug|1|||
170574711|NCT02574078|616449296|FG012|Treatment Period|Adverse event unrelated to drug|0|||
170574712|NCT02574078|616449284|FG000|Treatment Period|Administrative reason by Sponsor|0|||
170574713|NCT02574078|616449285|FG001|Treatment Period|Administrative reason by Sponsor|1|||
170574714|NCT02574078|616449286|FG002|Treatment Period|Administrative reason by Sponsor|0|||
170574715|NCT02574078|616449287|FG003|Treatment Period|Administrative reason by Sponsor|0|||
170574716|NCT02574078|616449288|FG004|Treatment Period|Administrative reason by Sponsor|0|||
170574717|NCT02574078|616449289|FG005|Treatment Period|Administrative reason by Sponsor|0|||
170574718|NCT02574078|616449290|FG006|Treatment Period|Administrative reason by Sponsor|1|||
170574719|NCT02574078|616449291|FG007|Treatment Period|Administrative reason by Sponsor|0|||
170574720|NCT02574078|616449292|FG008|Treatment Period|Administrative reason by Sponsor|0|||
170574721|NCT02574078|616449293|FG009|Treatment Period|Administrative reason by Sponsor|0|||
170574722|NCT02574078|616449294|FG010|Treatment Period|Administrative reason by Sponsor|0|||
170574723|NCT02574078|616449295|FG011|Treatment Period|Administrative reason by Sponsor|0|||
170574724|NCT02574078|616449296|FG012|Treatment Period|Administrative reason by Sponsor|3|||
170574725|NCT02574078|616449284|FG000|Treatment Period|Other reasons|1|||
170574726|NCT02574078|616449285|FG001|Treatment Period|Other reasons|0|||
170574727|NCT02574078|616449286|FG002|Treatment Period|Other reasons|1|||
170574728|NCT02574078|616449287|FG003|Treatment Period|Other reasons|3|||
170574729|NCT02574078|616449288|FG004|Treatment Period|Other reasons|3|||
170574730|NCT02574078|616449289|FG005|Treatment Period|Other reasons|1|||
170574731|NCT02574078|616449290|FG006|Treatment Period|Other reasons|2|||
170574732|NCT02574078|616449291|FG007|Treatment Period|Other reasons|1|||
170574733|NCT02574078|616449292|FG008|Treatment Period|Other reasons|3|||
170574734|NCT02574078|616449293|FG009|Treatment Period|Other reasons|1|||
170574735|NCT02574078|616449294|FG010|Treatment Period|Other reasons|1|||
170574736|NCT02574078|616449295|FG011|Treatment Period|Other reasons|3|||
170574737|NCT02574078|616449296|FG012|Treatment Period|Other reasons|1|||
170574738|NCT02574078|616449284|FG000|Treatment Period|Participant request to stop drug|0|||
170574739|NCT02574078|616449285|FG001|Treatment Period|Participant request to stop drug|0|||
170574740|NCT02574078|616449286|FG002|Treatment Period|Participant request to stop drug|0|||
170574741|NCT02574078|616449287|FG003|Treatment Period|Participant request to stop drug|2|||
170574742|NCT02574078|616449288|FG004|Treatment Period|Participant request to stop drug|4|||
170574743|NCT02574078|616449289|FG005|Treatment Period|Participant request to stop drug|0|||
170574744|NCT02574078|616449290|FG006|Treatment Period|Participant request to stop drug|1|||
170574745|NCT02574078|616449291|FG007|Treatment Period|Participant request to stop drug|0|||
170574746|NCT02574078|616449292|FG008|Treatment Period|Participant request to stop drug|3|||
170574747|NCT02574078|616449293|FG009|Treatment Period|Participant request to stop drug|2|||
170574748|NCT02574078|616449294|FG010|Treatment Period|Participant request to stop drug|2|||
170574749|NCT02574078|616449295|FG011|Treatment Period|Participant request to stop drug|4|||
170574750|NCT02574078|616449296|FG012|Treatment Period|Participant request to stop drug|1|||
170574751|NCT02574078|616449284|FG000|Treatment Period|Participant withdrew consent|0|||
170574752|NCT02574078|616449285|FG001|Treatment Period|Participant withdrew consent|0|||
170574753|NCT02574078|616449286|FG002|Treatment Period|Participant withdrew consent|0|||
170574754|NCT02574078|616449287|FG003|Treatment Period|Participant withdrew consent|0|||
170574755|NCT02574078|616449288|FG004|Treatment Period|Participant withdrew consent|1|||
170574756|NCT02574078|616449289|FG005|Treatment Period|Participant withdrew consent|1|||
170574757|NCT02574078|616449290|FG006|Treatment Period|Participant withdrew consent|0|||
170574758|NCT02574078|616449291|FG007|Treatment Period|Participant withdrew consent|1|||
170574759|NCT02574078|616449292|FG008|Treatment Period|Participant withdrew consent|0|||
170574760|NCT02574078|616449293|FG009|Treatment Period|Participant withdrew consent|2|||
170574761|NCT02574078|616449294|FG010|Treatment Period|Participant withdrew consent|1|||
170574762|NCT02574078|616449295|FG011|Treatment Period|Participant withdrew consent|4|||
170574763|NCT02574078|616449296|FG012|Treatment Period|Participant withdrew consent|1|||
170574764|NCT02574078|616449284|FG000|Treatment Period|Participant no longer meets criteria|0|||
170574765|NCT02574078|616449285|FG001|Treatment Period|Participant no longer meets criteria|0|||
170574766|NCT02574078|616449286|FG002|Treatment Period|Participant no longer meets criteria|0|||
170574767|NCT02574078|616449287|FG003|Treatment Period|Participant no longer meets criteria|0|||
170574768|NCT02574078|616449288|FG004|Treatment Period|Participant no longer meets criteria|1|||
170574769|NCT02574078|616449289|FG005|Treatment Period|Participant no longer meets criteria|0|||
170574770|NCT02574078|616449290|FG006|Treatment Period|Participant no longer meets criteria|0|||
170574771|NCT02574078|616449291|FG007|Treatment Period|Participant no longer meets criteria|0|||
170808762|NCT01277302|617310404|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
170574772|NCT02574078|616449292|FG008|Treatment Period|Participant no longer meets criteria|0|||
170574773|NCT02574078|616449293|FG009|Treatment Period|Participant no longer meets criteria|1|||
170574774|NCT02574078|616449294|FG010|Treatment Period|Participant no longer meets criteria|1|||
170574775|NCT02574078|616449295|FG011|Treatment Period|Participant no longer meets criteria|1|||
170574776|NCT02574078|616449296|FG012|Treatment Period|Participant no longer meets criteria|0|||
170574777|NCT02574078|616449284|FG000|Treatment Period|Lost to Follow-up|0|||
170574778|NCT02574078|616449285|FG001|Treatment Period|Lost to Follow-up|0|||
170574779|NCT02574078|616449286|FG002|Treatment Period|Lost to Follow-up|0|||
170574780|NCT02574078|616449287|FG003|Treatment Period|Lost to Follow-up|0|||
170574781|NCT02574078|616449288|FG004|Treatment Period|Lost to Follow-up|0|||
170574782|NCT02574078|616449289|FG005|Treatment Period|Lost to Follow-up|0|||
170574783|NCT02574078|616449290|FG006|Treatment Period|Lost to Follow-up|0|||
170574784|NCT02574078|616449291|FG007|Treatment Period|Lost to Follow-up|0|||
170574785|NCT02574078|616449292|FG008|Treatment Period|Lost to Follow-up|0|||
170574786|NCT02574078|616449293|FG009|Treatment Period|Lost to Follow-up|1|||
170574787|NCT02574078|616449294|FG010|Treatment Period|Lost to Follow-up|0|||
170574788|NCT02574078|616449295|FG011|Treatment Period|Lost to Follow-up|1|||
170574789|NCT02574078|616449296|FG012|Treatment Period|Lost to Follow-up|0|||
170574790|NCT02574078|616449284|FG000|Treatment Period|Maximum clinical benefit|0|||
170574791|NCT02574078|616449285|FG001|Treatment Period|Maximum clinical benefit|0|||
170574792|NCT02574078|616449286|FG002|Treatment Period|Maximum clinical benefit|0|||
170574793|NCT02574078|616449287|FG003|Treatment Period|Maximum clinical benefit|0|||
170574794|NCT02574078|616449288|FG004|Treatment Period|Maximum clinical benefit|0|||
170574795|NCT02574078|616449289|FG005|Treatment Period|Maximum clinical benefit|0|||
170574796|NCT02574078|616449290|FG006|Treatment Period|Maximum clinical benefit|0|||
170574797|NCT02574078|616449291|FG007|Treatment Period|Maximum clinical benefit|0|||
170574798|NCT02574078|616449292|FG008|Treatment Period|Maximum clinical benefit|0|||
170574799|NCT02574078|616449293|FG009|Treatment Period|Maximum clinical benefit|1|||
170574800|NCT02574078|616449294|FG010|Treatment Period|Maximum clinical benefit|0|||
170574801|NCT02574078|616449295|FG011|Treatment Period|Maximum clinical benefit|0|||
170574802|NCT02574078|616449296|FG012|Treatment Period|Maximum clinical benefit|0|||
170574803|NCT05935878|616449305|FG000|Overall Study|Death|1|||
170574804|NCT05935878|616449306|FG001|Overall Study|Death|2|||
170574805|NCT05935878|616449305|FG000|Overall Study|Withdrawal by Subject|5|||
170574806|NCT05935878|616449306|FG001|Overall Study|Withdrawal by Subject|5|||
170574807|NCT05935878|616449305|FG000|Overall Study|Revision of implant|1|||
170574808|NCT05935878|616449306|FG001|Overall Study|Revision of implant|1|||
170574809|NCT05935878|616449305|FG000|Overall Study|Mobile bearing dislocation|0|||
170574810|NCT05935878|616449306|FG001|Overall Study|Mobile bearing dislocation|1|||
170574811|NCT03015363|616449315|FG000|Overall Study|Physician Decision|14|||
170574812|NCT03015363|616449315|FG000|Overall Study|Withdrawal by Subject|3|||
170574813|NCT03107052|616449316|FG000|Overall Study|Adverse Event|6|||
170574814|NCT03107052|616449317|FG001|Overall Study|Adverse Event|1|||
170574815|NCT03107052|616449318|FG002|Overall Study|Adverse Event|2|||
170574816|NCT03107052|616449316|FG000|Overall Study|Withdrawal by Subject|9|||
170574817|NCT03107052|616449317|FG001|Overall Study|Withdrawal by Subject|5|||
170574818|NCT03107052|616449318|FG002|Overall Study|Withdrawal by Subject|8|||
170574819|NCT03107052|616449316|FG000|Overall Study|Protocol Violation|6|||
170574820|NCT03107052|616449317|FG001|Overall Study|Protocol Violation|0|||
170574821|NCT03107052|616449318|FG002|Overall Study|Protocol Violation|3|||
170574822|NCT03107052|616449316|FG000|Overall Study|Lost to Follow-up|4|||
170574823|NCT03107052|616449317|FG001|Overall Study|Lost to Follow-up|0|||
170574824|NCT03107052|616449318|FG002|Overall Study|Lost to Follow-up|1|||
170574825|NCT03107052|616449316|FG000|Overall Study|Lack of Efficacy|23|||
170574826|NCT03107052|616449317|FG001|Overall Study|Lack of Efficacy|7|||
170574827|NCT03107052|616449318|FG002|Overall Study|Lack of Efficacy|4|||
170574828|NCT03107052|616449316|FG000|Overall Study|Other than specified|4|||
170574829|NCT03107052|616449317|FG001|Overall Study|Other than specified|2|||
170574830|NCT03107052|616449318|FG002|Overall Study|Other than specified|0|||
170574831|NCT03107052|616449316|FG000|Overall Study|Study terminated due to futility|67|||
170574832|NCT03107052|616449317|FG001|Overall Study|Study terminated due to futility|31|||
170574833|NCT03107052|616449318|FG002|Overall Study|Study terminated due to futility|23|||
170574834|NCT03292874|616449319|FG000|Overall Study|Due to pandemic|5|||
170574835|NCT02482298|616449320|FG000|Overall Study|Withdrawal by Subject|2|||
170574836|NCT02482298|616449321|FG001|Overall Study|Withdrawal by Subject|1|||
170574837|NCT02482298|616449322|FG002|Overall Study|Withdrawal by Subject|2|||
170574838|NCT02482298|616449320|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
170574839|NCT02482298|616449321|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
170574840|NCT02482298|616449322|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
170808763|NCT01277302|617310405|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
170574841|NCT02482298|616449320|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
170574842|NCT02482298|616449321|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
170574843|NCT02482298|616449322|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
170574844|NCT02482298|616449320|FG000|Overall Study|Lost to Follow-up|0|||
170574845|NCT02482298|616449321|FG001|Overall Study|Lost to Follow-up|1|||
170574846|NCT02482298|616449322|FG002|Overall Study|Lost to Follow-up|0|||
170574847|NCT03053440|616449325|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
170574848|NCT03053440|616449326|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
170574849|NCT03053440|616449325|FG000|Overall Study|Death|18|||
170574850|NCT03053440|616449326|FG001|Overall Study|Death|14|||
170574851|NCT03053440|616449325|FG000|Overall Study|Withdrawal by Subject|9|||
170574852|NCT03053440|616449326|FG001|Overall Study|Withdrawal by Subject|8|||
170574853|NCT03053440|616449325|FG000|Overall Study|Lost to Follow-up|1|||
170574854|NCT03053440|616449326|FG001|Overall Study|Lost to Follow-up|0|||
170574855|NCT03053440|616449325|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
170574856|NCT03053440|616449326|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
170574857|NCT03053440|616449325|FG000|Overall Study|Physician Decision|2|||
170574858|NCT03053440|616449326|FG001|Overall Study|Physician Decision|1|||
170574859|NCT03053440|616449325|FG000|Overall Study|Participant Randomized but died before dosing|1|||
170574860|NCT03053440|616449326|FG001|Overall Study|Participant Randomized but died before dosing|0|||
170574861|NCT01188551|616449327|FG000|Overall Study|Pharmacy issues|1|||
170574862|NCT01188551|616449328|FG001|Overall Study|Pharmacy issues|0|||
170574863|NCT01188551|616449329|FG002|Overall Study|Pharmacy issues|0|||
170574864|NCT01188551|616449330|FG003|Overall Study|Pharmacy issues|0|||
170574865|NCT01306643|616449335|FG000|Overall Study|Adverse Event|5|||
170574866|NCT01306643|616449335|FG000|Overall Study|Disease Progression|7|||
170574867|NCT01306643|616449335|FG000|Overall Study|Other: Change in Eligibility Status|1|||
170574868|NCT01582009|616449340|FG000|Overall Study|Withdrawal by Subject|1|||
170574869|NCT01582009|616449340|FG000|Overall Study|Physician Decision|1|||
170574870|NCT00473889|616449342|FG000|Overall Study|Did not receive study medication|1|||
170574871|NCT00473889|616449343|FG001|Overall Study|Did not receive study medication|4|||
170574872|NCT00473889|616449342|FG000|Overall Study|Adverse Event|30|||
170574873|NCT00473889|616449343|FG001|Overall Study|Adverse Event|17|||
170574874|NCT00473889|616449342|FG000|Overall Study|Protocol Violation|4|||
170574875|NCT00473889|616449343|FG001|Overall Study|Protocol Violation|2|||
170574876|NCT00473889|616449342|FG000|Overall Study|Lack of Efficacy|28|||
170574877|NCT00473889|616449343|FG001|Overall Study|Lack of Efficacy|29|||
170574878|NCT00473889|616449342|FG000|Overall Study|Lost to Follow-up|2|||
170574879|NCT00473889|616449343|FG001|Overall Study|Lost to Follow-up|1|||
170574880|NCT00473889|616449342|FG000|Overall Study|Physician Decision|10|||
170574881|NCT00473889|616449343|FG001|Overall Study|Physician Decision|5|||
170574882|NCT00473889|616449342|FG000|Overall Study|Trial Terminated|3|||
170574883|NCT00473889|616449343|FG001|Overall Study|Trial Terminated|6|||
170574884|NCT00473889|616449342|FG000|Overall Study|Withdrawal by Subject|5|||
170574885|NCT00473889|616449343|FG001|Overall Study|Withdrawal by Subject|0|||
170574886|NCT00460655|616449347|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
170574887|NCT00460655|616449348|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170574888|NCT00460655|616449349|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170574889|NCT00460655|616449350|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170574890|NCT00460655|616449347|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
170574891|NCT00460655|616449348|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170574892|NCT00460655|616449349|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170574893|NCT00460655|616449350|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170574894|NCT00460655|616449347|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
170574895|NCT00460655|616449348|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
170574896|NCT00460655|616449349|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
170574897|NCT00460655|616449350|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
170574898|NCT00460655|616449347|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
170574899|NCT00460655|616449348|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
170574900|NCT00460655|616449349|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
170574901|NCT00460655|616449350|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
170574902|NCT00460655|616449347|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
170574903|NCT00460655|616449348|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
170574904|NCT00460655|616449349|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
170574905|NCT00460655|616449350|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
170574906|NCT00460655|616449347|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
170649424|NCT04255394|616729152|FG000|Overall Study|Adverse Event|1|||
170649425|NCT04255394|616729153|FG001|Overall Study|Adverse Event|3|||
170649426|NCT00384111|616729154|FG000|Overall Study|Disease Progression|3|||
170649427|NCT00384111|616729154|FG000|Overall Study|Adverse Event|1|||
170649428|NCT00384111|616729154|FG000|Overall Study|Investigator Decision|3|||
170574907|NCT00460655|616449348|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
170574908|NCT00460655|616449349|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
170574909|NCT00460655|616449350|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
170574910|NCT03050450|616449351|FG000|Overall Study|Physician Decision|1|||
170574911|NCT03050450|616449352|FG001|Overall Study|Physician Decision|0|||
170574912|NCT03050450|616449353|FG002|Overall Study|Physician Decision|0|||
170574913|NCT03050450|616449354|FG003|Overall Study|Physician Decision|0|||
170574914|NCT03050450|616449355|FG004|Overall Study|Physician Decision|0|||
170574915|NCT02553928|616449356|FG000|Overall Study|Adverse Event|2|||
170909086|NCT04576949|617673499|FG001|Overall Study|Adverse Event|3|||
170909087|NCT04576949|617673500|FG002|Overall Study|Adverse Event|2|||
170909088|NCT04576949|617673498|FG000|Overall Study|Withdrawal by Subject|41|||
170574916|NCT02553928|616449357|FG001|Overall Study|Adverse Event|1|||
170574917|NCT02553928|616449356|FG000|Overall Study|Lost to Follow-up|0|||
170574918|NCT02553928|616449357|FG001|Overall Study|Lost to Follow-up|1|||
170574919|NCT02553928|616449356|FG000|Overall Study|Administrative reason(s)|0|||
170574920|NCT02553928|616449357|FG001|Overall Study|Administrative reason(s)|1|||
170574921|NCT02236572|616449358|FG000|Overall Study|Withdrawal by Subject|1|||
170574922|NCT02236572|616449358|FG000|Overall Study|Protocol Violation|1|||
170574923|NCT02236572|616449358|FG000|Overall Study|Lost to Follow-up|1|||
170909089|NCT04576949|617673499|FG001|Overall Study|Withdrawal by Subject|26|||
170909090|NCT04576949|617673500|FG002|Overall Study|Withdrawal by Subject|18|||
170909091|NCT04576949|617673498|FG000|Overall Study|Physician Decision|3|||
170909092|NCT04576949|617673499|FG001|Overall Study|Physician Decision|0|||
170909093|NCT04576949|617673500|FG002|Overall Study|Physician Decision|0|||
170909094|NCT04576949|617673498|FG000|Overall Study|Death|0|||
170909095|NCT04576949|617673499|FG001|Overall Study|Death|1|||
170909096|NCT04576949|617673500|FG002|Overall Study|Death|0|||
170909097|NCT04576949|617673498|FG000|Overall Study|Lost to Follow-up|29|||
170909098|NCT04576949|617673499|FG001|Overall Study|Lost to Follow-up|37|||
170909099|NCT04576949|617673500|FG002|Overall Study|Lost to Follow-up|24|||
170909100|NCT04576949|617673498|FG000|Overall Study|Other, Not Specified|2|||
170909101|NCT04576949|617673499|FG001|Overall Study|Other, Not Specified|3|||
170909102|NCT04576949|617673500|FG002|Overall Study|Other, Not Specified|1|||
170909103|NCT04576949|617673498|FG000|Overall Study|Other|1|||
170909104|NCT04576949|617673499|FG001|Overall Study|Other|0|||
170909105|NCT04576949|617673500|FG002|Overall Study|Other|0|||
170909106|NCT01588197|617673503|FG000|Overall Study|Lack of Efficacy|0|||
170909107|NCT01588197|617673504|FG001|Overall Study|Lack of Efficacy|1|||
170909108|NCT01588197|617673503|FG000|Overall Study|No MRI|1|||
170909109|NCT01588197|617673504|FG001|Overall Study|No MRI|0|||
170909110|NCT05243680|617673505|FG000|Overall Study|Adverse Event|1|||
170909111|NCT05243680|617673506|FG001|Overall Study|Adverse Event|1|||
170909112|NCT05243680|617673505|FG000|Overall Study|Lack of Efficacy|1|||
170909113|NCT05243680|617673506|FG001|Overall Study|Lack of Efficacy|1|||
170909114|NCT05243680|617673505|FG000|Overall Study|Lost to Follow-up|5|||
170909115|NCT05243680|617673506|FG001|Overall Study|Lost to Follow-up|4|||
170909116|NCT05243680|617673505|FG000|Overall Study|Physician Decision|1|||
170909117|NCT05243680|617673506|FG001|Overall Study|Physician Decision|0|||
170909118|NCT05243680|617673505|FG000|Overall Study|Withdrawal by Subject|3|||
170909119|NCT05243680|617673506|FG001|Overall Study|Withdrawal by Subject|10|||
170909120|NCT05243680|617673505|FG000|Overall Study|Data integrity and GCP violations|4|||
170909121|NCT05243680|617673506|FG001|Overall Study|Data integrity and GCP violations|8|||
170909122|NCT05642442|617673507|FG000|Overall Study|Adverse Event|0|||
170909123|NCT05642442|617673508|FG001|Overall Study|Adverse Event|1|||
170909124|NCT05642442|617673507|FG000|Overall Study|Lack of Efficacy|0|||
170909125|NCT05642442|617673508|FG001|Overall Study|Lack of Efficacy|1|||
170909126|NCT05642442|617673507|FG000|Overall Study|Withdrawal by Subject|13|||
170909127|NCT05642442|617673508|FG001|Overall Study|Withdrawal by Subject|9|||
170909128|NCT05642442|617673507|FG000|Overall Study|Other|5|||
170909129|NCT05642442|617673508|FG001|Overall Study|Other|2|||
170909130|NCT05642442|617673507|FG000|Overall Study|Lost to Follow-up|0|||
170909131|NCT05642442|617673508|FG001|Overall Study|Lost to Follow-up|1|||
170909132|NCT01844076|617673515|FG000|Overall Study|Adverse Event|1|||
170909133|NCT01844076|617673516|FG001|Overall Study|Adverse Event|0|||
170909134|NCT01844076|617673517|FG002|Overall Study|Adverse Event|0|||
170909135|NCT01844076|617673518|FG003|Overall Study|Adverse Event|0|||
170909136|NCT01844076|617673515|FG000|Overall Study|Withdrawal by Subject|1|||
170909137|NCT01844076|617673516|FG001|Overall Study|Withdrawal by Subject|0|||
170909138|NCT01844076|617673517|FG002|Overall Study|Withdrawal by Subject|0|||
170909139|NCT01844076|617673518|FG003|Overall Study|Withdrawal by Subject|0|||
170909140|NCT01025336|617673523|FG000|Overall Study|Protocol Violation|0|||
170909141|NCT01025336|617673524|FG001|Overall Study|Protocol Violation|0|||
170909142|NCT01025336|617673525|FG002|Overall Study|Protocol Violation|0|||
170909143|NCT01025336|617673526|FG003|Overall Study|Protocol Violation|2|||
170909144|NCT01025336|617673527|FG004|Overall Study|Protocol Violation|0|||
170909145|NCT00550238|617673533|FG000|Overall Study|Adverse Event|88|||
170909146|NCT00550238|617673533|FG000|Overall Study|Death|34|||
170909147|NCT00550238|617673533|FG000|Overall Study|Disease progression|46|||
170909148|NCT00550238|617673533|FG000|Overall Study|Withdrawal by Subject|167|||
170909149|NCT00550238|617673533|FG000|Overall Study|Physician Decision|31|||
170574924|NCT00606411|616449359|FG000|Overall Study|Adverse Event|1|||
170909150|NCT00550238|617673533|FG000|Overall Study|Patient noncompliance|25|||
170909151|NCT00550238|617673533|FG000|Overall Study|Lost to Follow-up|13|||
170909152|NCT00550238|617673533|FG000|Overall Study|Sponsor decision|55|||
170909153|NCT01486238|617673540|FG000|Overall Study|Death|0|||
170574925|NCT00606411|616449360|FG001|Overall Study|Adverse Event|2|||
170909154|NCT01486238|617673541|FG001|Overall Study|Death|2|||
170574926|NCT00606411|616449359|FG000|Overall Study|Lack of Adherence|1|||
170909155|NCT01486238|617673540|FG000|Overall Study|Withdrawal by Subject|2|||
170909156|NCT01486238|617673541|FG001|Overall Study|Withdrawal by Subject|1|||
170909157|NCT01486238|617673540|FG000|Overall Study|Lost to Follow-up|0|||
170909158|NCT01486238|617673541|FG001|Overall Study|Lost to Follow-up|3|||
170909159|NCT01050062|617673542|FG000|Overall Study|Adverse Event|75|||
170909160|NCT01050062|617673543|FG001|Overall Study|Adverse Event|22|||
170909161|NCT01050062|617673542|FG000|Overall Study|Lost to Follow-up|83|||
170909162|NCT01050062|617673543|FG001|Overall Study|Lost to Follow-up|35|||
170909163|NCT01050062|617673542|FG000|Overall Study|Lack of Efficacy|22|||
170909164|NCT01050062|617673543|FG001|Overall Study|Lack of Efficacy|35|||
170909165|NCT01050062|617673542|FG000|Overall Study|Physician Decision|74|||
170909166|NCT01050062|617673543|FG001|Overall Study|Physician Decision|9|||
170909167|NCT01050062|617673542|FG000|Overall Study|Others|17|||
170909168|NCT01050062|617673543|FG001|Overall Study|Others|11|||
170909169|NCT03894540|617673544|FG000|Overall Study|Adverse Event|0|||
170909170|NCT03894540|617673545|FG001|Overall Study|Adverse Event|0|||
170909171|NCT03894540|617673546|FG002|Overall Study|Adverse Event|0|||
170909172|NCT03894540|617673547|FG003|Overall Study|Adverse Event|0|||
170909173|NCT03894540|617673548|FG004|Overall Study|Adverse Event|1|||
170909174|NCT03894540|617673549|FG005|Overall Study|Adverse Event|0|||
170909175|NCT03894540|617673544|FG000|Overall Study|Withdrawal by Subject|0|||
170909176|NCT03894540|617673545|FG001|Overall Study|Withdrawal by Subject|0|||
170909177|NCT03894540|617673546|FG002|Overall Study|Withdrawal by Subject|0|||
170909178|NCT03894540|617673547|FG003|Overall Study|Withdrawal by Subject|0|||
170909179|NCT03894540|617673548|FG004|Overall Study|Withdrawal by Subject|1|||
170909180|NCT03894540|617673549|FG005|Overall Study|Withdrawal by Subject|0|||
170909181|NCT03894540|617673544|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
170909182|NCT03894540|617673545|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
170909183|NCT03894540|617673546|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
170909184|NCT03894540|617673547|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
170909185|NCT03894540|617673548|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
170909186|NCT03894540|617673549|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
170909187|NCT03894540|617673544|FG000|Overall Study|Progressive Disease Clinical|1|||
170909188|NCT03894540|617673545|FG001|Overall Study|Progressive Disease Clinical|1|||
170909189|NCT03894540|617673546|FG002|Overall Study|Progressive Disease Clinical|0|||
170909190|NCT03894540|617673547|FG003|Overall Study|Progressive Disease Clinical|1|||
170909191|NCT03894540|617673548|FG004|Overall Study|Progressive Disease Clinical|5|||
170909192|NCT03894540|617673549|FG005|Overall Study|Progressive Disease Clinical|1|||
170909193|NCT03894540|617673544|FG000|Overall Study|Study termination by sponsor|0|||
170909194|NCT03894540|617673545|FG001|Overall Study|Study termination by sponsor|0|||
170909195|NCT03894540|617673546|FG002|Overall Study|Study termination by sponsor|0|||
170909196|NCT03894540|617673547|FG003|Overall Study|Study termination by sponsor|0|||
170909197|NCT03894540|617673548|FG004|Overall Study|Study termination by sponsor|2|||
170909198|NCT03894540|617673549|FG005|Overall Study|Study termination by sponsor|0|||
170909199|NCT03043365|617673550|FG000|Weeks 0 to Week 8|Adverse Event|1|||
170909200|NCT03043365|617673551|FG001|Weeks 0 to Week 8|Adverse Event|3|||
170909201|NCT03043365|617673550|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
170909202|NCT03043365|617673551|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
170909203|NCT03043365|617673550|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
170909204|NCT03043365|617673551|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
170909205|NCT02723630|617673552|FG000|Intervention Period 1|Adverse Event|1|||
170909206|NCT02723630|617673553|FG001|Intervention Period 1|Adverse Event|0|||
170909207|NCT02723630|617673554|FG002|Intervention Period 1|Adverse Event|0|||
170909208|NCT02723630|617673555|FG003|Intervention Period 1|Adverse Event|0|||
170909209|NCT02723630|617673556|FG004|Intervention Period 1|Adverse Event|0|||
170909210|NCT02723630|617673557|FG005|Intervention Period 1|Adverse Event|0|||
170909211|NCT02723630|617673552|FG000|Intervention Period 3|consumption of restricted item|0|||
170909212|NCT02723630|617673553|FG001|Intervention Period 3|consumption of restricted item|1|||
170909213|NCT02723630|617673554|FG002|Intervention Period 3|consumption of restricted item|0|||
170909214|NCT02723630|617673555|FG003|Intervention Period 3|consumption of restricted item|0|||
170909215|NCT02723630|617673556|FG004|Intervention Period 3|consumption of restricted item|0|||
170909216|NCT02723630|617673557|FG005|Intervention Period 3|consumption of restricted item|0|||
170909217|NCT00847613|617673570|FG000|Overall Study|Ongoing at cut-off date|250|||
170909218|NCT00847613|617673571|FG001|Overall Study|Ongoing at cut-off date|265|||
170909219|NCT00847613|617673572|FG002|Overall Study|Ongoing at cut-off date|64|||
170909220|NCT00847613|617673573|FG003|Overall Study|Ongoing at cut-off date|64|||
170909221|NCT00847613|617673570|FG000|Overall Study|Death|1|||
170909222|NCT00847613|617673571|FG001|Overall Study|Death|1|||
170909223|NCT00847613|617673572|FG002|Overall Study|Death|0|||
170909224|NCT00847613|617673573|FG003|Overall Study|Death|0|||
170909225|NCT00847613|617673570|FG000|Overall Study|Adverse Event|36|||
170909226|NCT00847613|617673571|FG001|Overall Study|Adverse Event|26|||
170909227|NCT00847613|617673572|FG002|Overall Study|Adverse Event|5|||
170808764|NCT01277302|617310403|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
170808765|NCT01277302|617310404|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
170808766|NCT01277302|617310405|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
170808767|NCT01277302|617310403|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
170808768|NCT01277302|617310404|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
170808769|NCT01277302|617310405|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
170808770|NCT01277302|617310403|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
170808771|NCT01277302|617310404|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
170808772|NCT01277302|617310405|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
170808773|NCT01277302|617310403|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
170808774|NCT01277302|617310404|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
170808775|NCT01277302|617310405|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
170808776|NCT01277302|617310403|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
170808777|NCT01277302|617310404|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
170808778|NCT01277302|617310405|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
170808779|NCT01277302|617310403|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
170808780|NCT01277302|617310404|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
170808781|NCT01277302|617310405|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
170808782|NCT01277302|617310403|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
170808783|NCT01277302|617310404|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
170808784|NCT01277302|617310405|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
170808785|NCT01277302|617310403|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
170808786|NCT01277302|617310404|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
170808787|NCT01277302|617310405|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
170808788|NCT01567852|617310408|FG000|Overall Study|Withdrawal by Subject|3|||
170808789|NCT01567852|617310409|FG001|Overall Study|Withdrawal by Subject|6|||
170808790|NCT01567852|617310408|FG000|Overall Study|ECT discontinued|1|||
170808791|NCT01567852|617310409|FG001|Overall Study|ECT discontinued|1|||
170808792|NCT03332589|617310410|FG000|Overall Study|Lack of Efficacy|2|||
170808793|NCT03332589|617310411|FG001|Overall Study|Lack of Efficacy|0|||
170808794|NCT03332589|617310412|FG002|Overall Study|Lack of Efficacy|0|||
170808795|NCT03332589|617310410|FG000|Overall Study|Adverse Event|1|||
170808796|NCT03332589|617310411|FG001|Overall Study|Adverse Event|0|||
170808797|NCT03332589|617310412|FG002|Overall Study|Adverse Event|0|||
170808798|NCT03332589|617310410|FG000|Overall Study|Death|1|||
170808799|NCT03332589|617310411|FG001|Overall Study|Death|0|||
170808800|NCT03332589|617310412|FG002|Overall Study|Death|0|||
170808801|NCT01364597|617310416|FG000|Overall Study|Adverse Event|4|||
170808802|NCT01364597|617310417|FG001|Overall Study|Adverse Event|5|||
170808803|NCT01364597|617310418|FG002|Overall Study|Adverse Event|16|||
170808804|NCT01364597|617310419|FG003|Overall Study|Adverse Event|7|||
170808805|NCT01364597|617310416|FG000|Overall Study|Lack of Efficacy|4|||
170808806|NCT01364597|617310417|FG001|Overall Study|Lack of Efficacy|4|||
170808807|NCT01364597|617310418|FG002|Overall Study|Lack of Efficacy|23|||
170808808|NCT01364597|617310419|FG003|Overall Study|Lack of Efficacy|8|||
170808809|NCT01364597|617310416|FG000|Overall Study|Protocol Violation|0|||
170808810|NCT01364597|617310417|FG001|Overall Study|Protocol Violation|0|||
170808811|NCT01364597|617310418|FG002|Overall Study|Protocol Violation|2|||
170808812|NCT01364597|617310419|FG003|Overall Study|Protocol Violation|0|||
170808813|NCT01364597|617310416|FG000|Overall Study|Lost to Follow-up|0|||
170808814|NCT01364597|617310417|FG001|Overall Study|Lost to Follow-up|0|||
170808815|NCT01364597|617310418|FG002|Overall Study|Lost to Follow-up|5|||
170808816|NCT01364597|617310419|FG003|Overall Study|Lost to Follow-up|3|||
170808817|NCT01364597|617310416|FG000|Overall Study|Withdrawal by Subject|4|||
170808818|NCT01364597|617310417|FG001|Overall Study|Withdrawal by Subject|1|||
170808819|NCT01364597|617310418|FG002|Overall Study|Withdrawal by Subject|18|||
170808820|NCT01364597|617310419|FG003|Overall Study|Withdrawal by Subject|6|||
170808821|NCT01364597|617310416|FG000|Overall Study|Non compliance|1|||
170808822|NCT01364597|617310417|FG001|Overall Study|Non compliance|0|||
170808823|NCT01364597|617310418|FG002|Overall Study|Non compliance|1|||
170808824|NCT01364597|617310419|FG003|Overall Study|Non compliance|0|||
170808825|NCT01364597|617310416|FG000|Overall Study|Lack of compliance|1|||
170909228|NCT00847613|617673573|FG003|Overall Study|Adverse Event|6|||
170909229|NCT00847613|617673570|FG000|Overall Study|Lack of Efficacy|7|||
170808826|NCT01364597|617310417|FG001|Overall Study|Lack of compliance|0|||
170808827|NCT01364597|617310418|FG002|Overall Study|Lack of compliance|0|||
170808828|NCT01364597|617310419|FG003|Overall Study|Lack of compliance|0|||
170808829|NCT01364597|617310416|FG000|Overall Study|End of treatment epilepsy|1|||
170808830|NCT01364597|617310417|FG001|Overall Study|End of treatment epilepsy|0|||
170808831|NCT01364597|617310418|FG002|Overall Study|End of treatment epilepsy|0|||
170808832|NCT01364597|617310419|FG003|Overall Study|End of treatment epilepsy|0|||
170808833|NCT01364597|617310416|FG000|Overall Study|No Seizures|1|||
170808834|NCT01364597|617310417|FG001|Overall Study|No Seizures|0|||
170909230|NCT00847613|617673571|FG001|Overall Study|Lack of Efficacy|3|||
170909231|NCT00847613|617673572|FG002|Overall Study|Lack of Efficacy|3|||
170649429|NCT00384111|616729154|FG000|Overall Study|Study Terminated by the Sponsor|19|||
170649430|NCT01551420|616729155|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
170649431|NCT01551420|616729156|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
170909232|NCT00847613|617673573|FG003|Overall Study|Lack of Efficacy|1|||
170909233|NCT00847613|617673570|FG000|Overall Study|Study terminated by Sponsor|1|||
170909234|NCT00847613|617673571|FG001|Overall Study|Study terminated by Sponsor|0|||
170909235|NCT00847613|617673572|FG002|Overall Study|Study terminated by Sponsor|2|||
170909236|NCT00847613|617673573|FG003|Overall Study|Study terminated by Sponsor|1|||
170909237|NCT00847613|617673570|FG000|Overall Study|Lost to Follow-up|5|||
170909238|NCT00847613|617673571|FG001|Overall Study|Lost to Follow-up|0|||
170909239|NCT00847613|617673572|FG002|Overall Study|Lost to Follow-up|0|||
170909240|NCT00847613|617673573|FG003|Overall Study|Lost to Follow-up|3|||
170909241|NCT00847613|617673570|FG000|Overall Study|Protocol Violation|6|||
170909242|NCT00847613|617673571|FG001|Overall Study|Protocol Violation|6|||
170909243|NCT00847613|617673572|FG002|Overall Study|Protocol Violation|3|||
170909244|NCT00847613|617673573|FG003|Overall Study|Protocol Violation|1|||
170909245|NCT00847613|617673570|FG000|Overall Study|Pregnancy|1|||
170909246|NCT00847613|617673571|FG001|Overall Study|Pregnancy|1|||
170909247|NCT00847613|617673572|FG002|Overall Study|Pregnancy|0|||
170909248|NCT00847613|617673573|FG003|Overall Study|Pregnancy|0|||
170909249|NCT00847613|617673570|FG000|Overall Study|Site closure|1|||
170909250|NCT00847613|617673571|FG001|Overall Study|Site closure|0|||
170909251|NCT00847613|617673572|FG002|Overall Study|Site closure|0|||
170909252|NCT00847613|617673573|FG003|Overall Study|Site closure|1|||
170909253|NCT00847613|617673570|FG000|Overall Study|Withdrawal by Subject|8|||
170909254|NCT00847613|617673571|FG001|Overall Study|Withdrawal by Subject|11|||
170909255|NCT00847613|617673572|FG002|Overall Study|Withdrawal by Subject|2|||
170909256|NCT00847613|617673573|FG003|Overall Study|Withdrawal by Subject|2|||
170909257|NCT00847613|617673570|FG000|Overall Study|Participant moved|4|||
170909258|NCT00847613|617673571|FG001|Overall Study|Participant moved|1|||
170909259|NCT00847613|617673572|FG002|Overall Study|Participant moved|0|||
170909260|NCT00847613|617673573|FG003|Overall Study|Participant moved|0|||
170909261|NCT00847613|617673570|FG000|Overall Study|Sponsor request|0|||
170909262|NCT00847613|617673571|FG001|Overall Study|Sponsor request|1|||
170909263|NCT00847613|617673572|FG002|Overall Study|Sponsor request|0|||
170909264|NCT00847613|617673573|FG003|Overall Study|Sponsor request|0|||
170909265|NCT00847613|617673570|FG000|Overall Study|Randomized, but not treated|0|||
170909266|NCT00847613|617673571|FG001|Overall Study|Randomized, but not treated|3|||
170909267|NCT00847613|617673572|FG002|Overall Study|Randomized, but not treated|0|||
170909268|NCT00847613|617673573|FG003|Overall Study|Randomized, but not treated|0|||
170909269|NCT00847613|617673570|FG000|Overall Study|Other|1|||
170909270|NCT00847613|617673571|FG001|Overall Study|Other|1|||
170909271|NCT00847613|617673572|FG002|Overall Study|Other|2|||
170909272|NCT00847613|617673573|FG003|Overall Study|Other|0|||
170909273|NCT00754390|617673574|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
170909274|NCT00754390|617673574|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
170909275|NCT00754390|617673574|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
170909276|NCT00754390|617673574|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
170909277|NCT00587223|617673575|FG000|Overall Study|Adverse Event|1|||
170909278|NCT02111369|617673576|FG000|Overall Study|Lost to Follow-up|2|||
170909279|NCT02111369|617673576|FG000|Overall Study|Withdrawal by Subject|1|||
170909280|NCT03519178|617673577|FG000|PF-06873600 Treatment|Adverse Event|0|||
170909281|NCT03519178|617673578|FG001|PF-06873600 Treatment|Adverse Event|0|||
170909282|NCT03519178|617673579|FG002|PF-06873600 Treatment|Adverse Event|0|||
170909283|NCT03519178|617673580|FG003|PF-06873600 Treatment|Adverse Event|0|||
170909284|NCT03519178|617673581|FG004|PF-06873600 Treatment|Adverse Event|0|||
170909285|NCT03519178|617673582|FG005|PF-06873600 Treatment|Adverse Event|0|||
170909286|NCT03519178|617673583|FG006|PF-06873600 Treatment|Adverse Event|0|||
170909287|NCT03519178|617673584|FG007|PF-06873600 Treatment|Adverse Event|2|||
170909288|NCT03519178|617673585|FG008|PF-06873600 Treatment|Adverse Event|1|||
170909289|NCT03519178|617673586|FG009|PF-06873600 Treatment|Adverse Event|0|||
170909290|NCT03519178|617673587|FG010|PF-06873600 Treatment|Adverse Event|0|||
170909291|NCT03519178|617673588|FG011|PF-06873600 Treatment|Adverse Event|0|||
170909292|NCT03519178|617673589|FG012|PF-06873600 Treatment|Adverse Event|1|||
170909293|NCT03519178|617673590|FG013|PF-06873600 Treatment|Adverse Event|3|||
170909294|NCT03519178|617673591|FG014|PF-06873600 Treatment|Adverse Event|2|||
170909295|NCT03519178|617673577|FG000|PF-06873600 Treatment|Death|0|||
170909296|NCT03519178|617673578|FG001|PF-06873600 Treatment|Death|0|||
170909297|NCT03519178|617673579|FG002|PF-06873600 Treatment|Death|0|||
170909298|NCT03519178|617673580|FG003|PF-06873600 Treatment|Death|0|||
170909299|NCT03519178|617673581|FG004|PF-06873600 Treatment|Death|0|||
170909300|NCT03519178|617673582|FG005|PF-06873600 Treatment|Death|0|||
170574927|NCT00606411|616449360|FG001|Overall Study|Lack of Adherence|1|||
170909301|NCT03519178|617673583|FG006|PF-06873600 Treatment|Death|0|||
170909302|NCT03519178|617673584|FG007|PF-06873600 Treatment|Death|0|||
170909303|NCT03519178|617673585|FG008|PF-06873600 Treatment|Death|1|||
170909304|NCT03519178|617673586|FG009|PF-06873600 Treatment|Death|1|||
170574928|NCT00606411|616449359|FG000|Overall Study|Lack of Efficacy|1|||
170574929|NCT00606411|616449360|FG001|Overall Study|Lack of Efficacy|1|||
170909305|NCT03519178|617673587|FG010|PF-06873600 Treatment|Death|0|||
170909306|NCT03519178|617673588|FG011|PF-06873600 Treatment|Death|0|||
170909307|NCT03519178|617673589|FG012|PF-06873600 Treatment|Death|0|||
170808835|NCT01364597|617310418|FG002|Overall Study|No Seizures|0|||
170808836|NCT01364597|617310419|FG003|Overall Study|No Seizures|0|||
170808837|NCT01364597|617310416|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
170808838|NCT01364597|617310417|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
170808839|NCT01364597|617310418|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
170808840|NCT01364597|617310419|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
170808841|NCT01364597|617310416|FG000|Overall Study|Cure|1|||
170909308|NCT03519178|617673590|FG013|PF-06873600 Treatment|Death|0|||
170909309|NCT03519178|617673591|FG014|PF-06873600 Treatment|Death|1|||
170909310|NCT03519178|617673577|FG000|PF-06873600 Treatment|Physician Decision|0|||
170909311|NCT03519178|617673578|FG001|PF-06873600 Treatment|Physician Decision|0|||
170909312|NCT03519178|617673579|FG002|PF-06873600 Treatment|Physician Decision|0|||
170909313|NCT03519178|617673580|FG003|PF-06873600 Treatment|Physician Decision|0|||
170909314|NCT03519178|617673581|FG004|PF-06873600 Treatment|Physician Decision|0|||
170909315|NCT03519178|617673582|FG005|PF-06873600 Treatment|Physician Decision|0|||
170909316|NCT03519178|617673583|FG006|PF-06873600 Treatment|Physician Decision|0|||
170909317|NCT03519178|617673584|FG007|PF-06873600 Treatment|Physician Decision|1|||
170909318|NCT03519178|617673585|FG008|PF-06873600 Treatment|Physician Decision|0|||
170909319|NCT03519178|617673586|FG009|PF-06873600 Treatment|Physician Decision|0|||
170909320|NCT03519178|617673587|FG010|PF-06873600 Treatment|Physician Decision|1|||
170909321|NCT03519178|617673588|FG011|PF-06873600 Treatment|Physician Decision|0|||
170909322|NCT03519178|617673589|FG012|PF-06873600 Treatment|Physician Decision|0|||
170909323|NCT03519178|617673590|FG013|PF-06873600 Treatment|Physician Decision|4|||
170909324|NCT03519178|617673591|FG014|PF-06873600 Treatment|Physician Decision|1|||
170909325|NCT03519178|617673577|FG000|PF-06873600 Treatment|Progressive disease|1|||
170909326|NCT03519178|617673578|FG001|PF-06873600 Treatment|Progressive disease|1|||
170909327|NCT03519178|617673579|FG002|PF-06873600 Treatment|Progressive disease|1|||
170909328|NCT03519178|617673580|FG003|PF-06873600 Treatment|Progressive disease|1|||
170909329|NCT03519178|617673581|FG004|PF-06873600 Treatment|Progressive disease|6|||
170909330|NCT03519178|617673582|FG005|PF-06873600 Treatment|Progressive disease|7|||
170909331|NCT03519178|617673583|FG006|PF-06873600 Treatment|Progressive disease|3|||
170909332|NCT03519178|617673584|FG007|PF-06873600 Treatment|Progressive disease|7|||
170909333|NCT03519178|617673585|FG008|PF-06873600 Treatment|Progressive disease|3|||
170909334|NCT03519178|617673586|FG009|PF-06873600 Treatment|Progressive disease|5|||
170909335|NCT03519178|617673587|FG010|PF-06873600 Treatment|Progressive disease|4|||
170909336|NCT03519178|617673588|FG011|PF-06873600 Treatment|Progressive disease|3|||
170909337|NCT03519178|617673589|FG012|PF-06873600 Treatment|Progressive disease|4|||
170909338|NCT03519178|617673590|FG013|PF-06873600 Treatment|Progressive disease|28|||
170909339|NCT03519178|617673591|FG014|PF-06873600 Treatment|Progressive disease|8|||
170909340|NCT03519178|617673577|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
170909341|NCT03519178|617673578|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
170909342|NCT03519178|617673579|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
170909343|NCT03519178|617673580|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
170909344|NCT03519178|617673581|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
170909345|NCT03519178|617673582|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
170909346|NCT03519178|617673583|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
170909347|NCT03519178|617673584|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
170909348|NCT03519178|617673585|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
170909349|NCT03519178|617673586|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
170909350|NCT03519178|617673587|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
170909351|NCT03519178|617673588|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
170909352|NCT03519178|617673589|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
170909353|NCT03519178|617673590|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
170909354|NCT03519178|617673591|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
170909355|NCT03519178|617673577|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
170909356|NCT03519178|617673578|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
170909357|NCT03519178|617673579|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
170909358|NCT03519178|617673580|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
170909359|NCT03519178|617673581|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
170909360|NCT03519178|617673582|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
170909361|NCT03519178|617673583|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
170909362|NCT03519178|617673584|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
170909363|NCT03519178|617673585|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
170909364|NCT03519178|617673586|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
170909365|NCT03519178|617673587|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
170909366|NCT03519178|617673588|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
170909367|NCT03519178|617673589|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
170909368|NCT03519178|617673590|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
170909369|NCT03519178|617673591|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
170909370|NCT03519178|617673577|FG000|PF-06873600 Treatment|Refused further treatment|0|||
170909371|NCT03519178|617673578|FG001|PF-06873600 Treatment|Refused further treatment|1|||
170909372|NCT03519178|617673579|FG002|PF-06873600 Treatment|Refused further treatment|0|||
170909373|NCT03519178|617673580|FG003|PF-06873600 Treatment|Refused further treatment|0|||
170909374|NCT03519178|617673581|FG004|PF-06873600 Treatment|Refused further treatment|1|||
170909375|NCT03519178|617673582|FG005|PF-06873600 Treatment|Refused further treatment|0|||
170909376|NCT03519178|617673583|FG006|PF-06873600 Treatment|Refused further treatment|0|||
170909377|NCT03519178|617673584|FG007|PF-06873600 Treatment|Refused further treatment|0|||
170909378|NCT03519178|617673585|FG008|PF-06873600 Treatment|Refused further treatment|0|||
170909379|NCT03519178|617673586|FG009|PF-06873600 Treatment|Refused further treatment|0|||
170909380|NCT03519178|617673587|FG010|PF-06873600 Treatment|Refused further treatment|0|||
170909381|NCT03519178|617673588|FG011|PF-06873600 Treatment|Refused further treatment|0|||
170909382|NCT03519178|617673589|FG012|PF-06873600 Treatment|Refused further treatment|0|||
170909383|NCT03519178|617673590|FG013|PF-06873600 Treatment|Refused further treatment|0|||
170909384|NCT03519178|617673591|FG014|PF-06873600 Treatment|Refused further treatment|1|||
170909385|NCT03519178|617673577|FG000|PF-06873600 Treatment|Other|0|||
170909386|NCT03519178|617673578|FG001|PF-06873600 Treatment|Other|0|||
170909387|NCT03519178|617673579|FG002|PF-06873600 Treatment|Other|0|||
170909388|NCT03519178|617673580|FG003|PF-06873600 Treatment|Other|0|||
170909389|NCT03519178|617673581|FG004|PF-06873600 Treatment|Other|0|||
170909390|NCT03519178|617673582|FG005|PF-06873600 Treatment|Other|0|||
170909391|NCT03519178|617673583|FG006|PF-06873600 Treatment|Other|0|||
170909392|NCT03519178|617673584|FG007|PF-06873600 Treatment|Other|0|||
170909393|NCT03519178|617673585|FG008|PF-06873600 Treatment|Other|1|||
170909394|NCT03519178|617673586|FG009|PF-06873600 Treatment|Other|0|||
170909395|NCT03519178|617673587|FG010|PF-06873600 Treatment|Other|0|||
170909396|NCT03519178|617673588|FG011|PF-06873600 Treatment|Other|0|||
170909397|NCT03519178|617673589|FG012|PF-06873600 Treatment|Other|0|||
170909398|NCT03519178|617673590|FG013|PF-06873600 Treatment|Other|1|||
170909399|NCT03519178|617673591|FG014|PF-06873600 Treatment|Other|3|||
170909400|NCT03519178|617673577|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
170909401|NCT03519178|617673578|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
170909402|NCT03519178|617673579|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
170909403|NCT03519178|617673580|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
170909404|NCT03519178|617673581|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
170909405|NCT03519178|617673582|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
170909406|NCT03519178|617673583|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
170909407|NCT03519178|617673584|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
170909408|NCT03519178|617673585|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
170909409|NCT03519178|617673586|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
170909410|NCT03519178|617673587|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
170909411|NCT03519178|617673588|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
170909412|NCT03519178|617673589|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
170909413|NCT03519178|617673590|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
170909414|NCT03519178|617673591|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
170909415|NCT03519178|617673577|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909416|NCT03519178|617673578|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909417|NCT03519178|617673579|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909418|NCT03519178|617673580|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909419|NCT03519178|617673581|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909420|NCT03519178|617673582|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909421|NCT03519178|617673583|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909422|NCT03519178|617673584|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909423|NCT03519178|617673585|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909424|NCT03519178|617673586|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909425|NCT03519178|617673587|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909426|NCT03519178|617673588|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909427|NCT03519178|617673589|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
170909428|NCT03519178|617673590|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
170909429|NCT03519178|617673591|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
170909430|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Adverse Event|0|||
170909431|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Adverse Event|0|||
170909432|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Adverse Event|0|||
170909433|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Adverse Event|0|||
170909434|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Adverse Event|0|||
170909435|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Adverse Event|0|||
170909436|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Adverse Event|0|||
170909437|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Adverse Event|0|||
170909438|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Adverse Event|0|||
170909439|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Adverse Event|0|||
170909440|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Adverse Event|0|||
170909441|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Adverse Event|0|||
170909442|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Adverse Event|0|||
170909443|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Adverse Event|1|||
170909444|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Adverse Event|0|||
170909445|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Death|0|||
170574930|NCT00606411|616449359|FG000|Overall Study|Withdrawal by Subject|2|||
170909446|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Death|0|||
170909447|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Death|0|||
170909448|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Death|0|||
170909449|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Death|0|||
170909450|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Death|0|||
170909451|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Death|0|||
170909452|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Death|0|||
170909453|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Death|0|||
170909454|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Death|1|||
170909455|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Death|0|||
170909456|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Death|0|||
170909457|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Death|0|||
170909458|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Death|0|||
170909459|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Death|1|||
170909460|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909461|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909462|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909463|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909464|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909465|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909466|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909467|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909468|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909469|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909470|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909471|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909472|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909473|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
170909474|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
170909475|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Physician Decision|0|||
170909476|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Physician Decision|0|||
170909477|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Physician Decision|0|||
170909478|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Physician Decision|0|||
170909479|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Physician Decision|0|||
170909480|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Physician Decision|0|||
170909481|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Physician Decision|0|||
170909482|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Physician Decision|0|||
170909483|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Physician Decision|0|||
170909484|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Physician Decision|0|||
170909485|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Physician Decision|0|||
170909486|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Physician Decision|0|||
170909487|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Physician Decision|0|||
170909488|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Physician Decision|4|||
170909489|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Physician Decision|2|||
170909490|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Progressive disease|0|||
170909491|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Progressive disease|0|||
170909492|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Progressive disease|0|||
170909493|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Progressive disease|0|||
170909494|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Progressive disease|0|||
170909495|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Progressive disease|0|||
170909496|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Progressive disease|0|||
170909497|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Progressive disease|0|||
170909498|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Progressive disease|0|||
170909499|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Progressive disease|5|||
170909500|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Progressive disease|0|||
170909501|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Progressive disease|0|||
170909502|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Progressive disease|0|||
170909503|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Progressive disease|30|||
170909504|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Progressive disease|8|||
170909505|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909506|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909507|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909508|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909509|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909510|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909511|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909512|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909513|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909514|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909515|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909516|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909517|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
170909518|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
170909519|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
170909520|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909521|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909522|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909523|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170649432|NCT01551420|616729155|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
170909524|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909525|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909526|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909527|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909528|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909529|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
170909530|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909531|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909532|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
170909533|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
170909534|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
170909535|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909536|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909537|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909538|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909539|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909540|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909541|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909542|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909543|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909544|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
170909545|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909546|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909547|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909548|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
170909549|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
170909550|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
170909551|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
170909552|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
170909553|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
170909554|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
170909555|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
170909556|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
170909557|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
170909558|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
170909559|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
170909560|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
170909561|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
170909562|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
170909563|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
170909564|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
170909565|NCT03519178|617673577|FG000|Fulvestrant. Treatment|Other|0|||
170909566|NCT03519178|617673578|FG001|Fulvestrant. Treatment|Other|0|||
170909567|NCT03519178|617673579|FG002|Fulvestrant. Treatment|Other|0|||
170909568|NCT03519178|617673580|FG003|Fulvestrant. Treatment|Other|0|||
170909569|NCT03519178|617673581|FG004|Fulvestrant. Treatment|Other|0|||
170909570|NCT03519178|617673582|FG005|Fulvestrant. Treatment|Other|0|||
170909571|NCT03519178|617673583|FG006|Fulvestrant. Treatment|Other|0|||
170909572|NCT03519178|617673584|FG007|Fulvestrant. Treatment|Other|0|||
170909573|NCT03519178|617673585|FG008|Fulvestrant. Treatment|Other|0|||
170909574|NCT03519178|617673586|FG009|Fulvestrant. Treatment|Other|0|||
170909575|NCT03519178|617673587|FG010|Fulvestrant. Treatment|Other|0|||
170909576|NCT03519178|617673588|FG011|Fulvestrant. Treatment|Other|0|||
170909577|NCT03519178|617673589|FG012|Fulvestrant. Treatment|Other|0|||
170909578|NCT03519178|617673590|FG013|Fulvestrant. Treatment|Other|1|||
170909579|NCT03519178|617673591|FG014|Fulvestrant. Treatment|Other|3|||
170909580|NCT03519178|617673577|FG000|Letrozole Treatment|Physician Decision|0|||
170909581|NCT03519178|617673578|FG001|Letrozole Treatment|Physician Decision|0|||
170909582|NCT03519178|617673579|FG002|Letrozole Treatment|Physician Decision|0|||
170909583|NCT03519178|617673580|FG003|Letrozole Treatment|Physician Decision|0|||
170909584|NCT03519178|617673581|FG004|Letrozole Treatment|Physician Decision|0|||
170909585|NCT03519178|617673582|FG005|Letrozole Treatment|Physician Decision|0|||
170909586|NCT03519178|617673583|FG006|Letrozole Treatment|Physician Decision|0|||
170909587|NCT03519178|617673584|FG007|Letrozole Treatment|Physician Decision|0|||
170909588|NCT03519178|617673585|FG008|Letrozole Treatment|Physician Decision|0|||
170909589|NCT03519178|617673586|FG009|Letrozole Treatment|Physician Decision|0|||
170909590|NCT03519178|617673587|FG010|Letrozole Treatment|Physician Decision|1|||
170909591|NCT03519178|617673588|FG011|Letrozole Treatment|Physician Decision|0|||
170909592|NCT03519178|617673589|FG012|Letrozole Treatment|Physician Decision|0|||
170574931|NCT00606411|616449360|FG001|Overall Study|Withdrawal by Subject|0|||
170574932|NCT00606411|616449359|FG000|Overall Study|Lost to Follow-up|1|||
170574933|NCT00606411|616449360|FG001|Overall Study|Lost to Follow-up|2|||
170574934|NCT00606411|616449359|FG000|Overall Study|Move out of state|0|||
170808842|NCT01364597|617310417|FG001|Overall Study|Cure|0|||
170808843|NCT01364597|617310418|FG002|Overall Study|Cure|0|||
170808844|NCT01364597|617310419|FG003|Overall Study|Cure|0|||
170808845|NCT01364597|617310416|FG000|Overall Study|Patient was moving|0|||
170808846|NCT01364597|617310417|FG001|Overall Study|Patient was moving|1|||
170808847|NCT01364597|617310418|FG002|Overall Study|Patient was moving|0|||
170808848|NCT01364597|617310419|FG003|Overall Study|Patient was moving|0|||
170808849|NCT01364597|617310416|FG000|Overall Study|Seizures resolved|0|||
170808850|NCT01364597|617310417|FG001|Overall Study|Seizures resolved|0|||
170808851|NCT01364597|617310418|FG002|Overall Study|Seizures resolved|1|||
170808852|NCT01364597|617310419|FG003|Overall Study|Seizures resolved|0|||
170808853|NCT01364597|617310416|FG000|Overall Study|Patient became seizure-free after surgery|0|||
170808854|NCT01364597|617310417|FG001|Overall Study|Patient became seizure-free after surgery|0|||
170808855|NCT01364597|617310418|FG002|Overall Study|Patient became seizure-free after surgery|1|||
170808856|NCT01364597|617310419|FG003|Overall Study|Patient became seizure-free after surgery|0|||
170808857|NCT01364597|617310416|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
170808858|NCT01364597|617310417|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
170808859|NCT01364597|617310418|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
170909593|NCT03519178|617673590|FG013|Letrozole Treatment|Physician Decision|0|||
170909594|NCT03519178|617673591|FG014|Letrozole Treatment|Physician Decision|0|||
170909595|NCT03519178|617673577|FG000|Letrozole Treatment|Progressive disease|0|||
170909596|NCT03519178|617673578|FG001|Letrozole Treatment|Progressive disease|0|||
170909597|NCT03519178|617673579|FG002|Letrozole Treatment|Progressive disease|0|||
170909598|NCT03519178|617673580|FG003|Letrozole Treatment|Progressive disease|0|||
170909599|NCT03519178|617673581|FG004|Letrozole Treatment|Progressive disease|0|||
170909600|NCT03519178|617673582|FG005|Letrozole Treatment|Progressive disease|0|||
170909601|NCT03519178|617673583|FG006|Letrozole Treatment|Progressive disease|0|||
170909602|NCT03519178|617673584|FG007|Letrozole Treatment|Progressive disease|0|||
170909603|NCT03519178|617673585|FG008|Letrozole Treatment|Progressive disease|0|||
170909604|NCT03519178|617673586|FG009|Letrozole Treatment|Progressive disease|0|||
170909605|NCT03519178|617673587|FG010|Letrozole Treatment|Progressive disease|4|||
170909606|NCT03519178|617673588|FG011|Letrozole Treatment|Progressive disease|0|||
170909607|NCT03519178|617673589|FG012|Letrozole Treatment|Progressive disease|0|||
170909608|NCT03519178|617673590|FG013|Letrozole Treatment|Progressive disease|0|||
170909609|NCT03519178|617673591|FG014|Letrozole Treatment|Progressive disease|0|||
170909610|NCT03519178|617673577|FG000|Letrozole Treatment|Global deterioration of health status|0|||
170909611|NCT03519178|617673578|FG001|Letrozole Treatment|Global deterioration of health status|0|||
170909612|NCT03519178|617673579|FG002|Letrozole Treatment|Global deterioration of health status|0|||
170909613|NCT03519178|617673580|FG003|Letrozole Treatment|Global deterioration of health status|0|||
170909614|NCT03519178|617673581|FG004|Letrozole Treatment|Global deterioration of health status|0|||
170909615|NCT03519178|617673582|FG005|Letrozole Treatment|Global deterioration of health status|0|||
170909616|NCT03519178|617673583|FG006|Letrozole Treatment|Global deterioration of health status|0|||
170909617|NCT03519178|617673584|FG007|Letrozole Treatment|Global deterioration of health status|0|||
170909618|NCT03519178|617673585|FG008|Letrozole Treatment|Global deterioration of health status|0|||
170909619|NCT03519178|617673586|FG009|Letrozole Treatment|Global deterioration of health status|0|||
170909620|NCT03519178|617673587|FG010|Letrozole Treatment|Global deterioration of health status|2|||
170909621|NCT03519178|617673588|FG011|Letrozole Treatment|Global deterioration of health status|0|||
170909622|NCT03519178|617673589|FG012|Letrozole Treatment|Global deterioration of health status|0|||
170909623|NCT03519178|617673590|FG013|Letrozole Treatment|Global deterioration of health status|0|||
170909624|NCT03519178|617673591|FG014|Letrozole Treatment|Global deterioration of health status|0|||
170909625|NCT03519178|617673577|FG000|Follow-Up|Death|0|||
170909626|NCT03519178|617673578|FG001|Follow-Up|Death|0|||
170909627|NCT03519178|617673579|FG002|Follow-Up|Death|0|||
170909628|NCT03519178|617673580|FG003|Follow-Up|Death|0|||
170909629|NCT03519178|617673581|FG004|Follow-Up|Death|0|||
170909630|NCT03519178|617673582|FG005|Follow-Up|Death|0|||
170909631|NCT03519178|617673583|FG006|Follow-Up|Death|0|||
170909632|NCT03519178|617673584|FG007|Follow-Up|Death|0|||
170909633|NCT03519178|617673585|FG008|Follow-Up|Death|3|||
170909634|NCT03519178|617673586|FG009|Follow-Up|Death|1|||
170909635|NCT03519178|617673587|FG010|Follow-Up|Death|0|||
170909636|NCT03519178|617673588|FG011|Follow-Up|Death|0|||
170909637|NCT03519178|617673589|FG012|Follow-Up|Death|2|||
170909638|NCT03519178|617673590|FG013|Follow-Up|Death|0|||
170909639|NCT03519178|617673591|FG014|Follow-Up|Death|0|||
170909640|NCT03519178|617673577|FG000|Follow-Up|Lost to Follow-up|0|||
170649433|NCT01551420|616729156|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
170808860|NCT01364597|617310419|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
170909641|NCT03519178|617673578|FG001|Follow-Up|Lost to Follow-up|0|||
170909642|NCT03519178|617673579|FG002|Follow-Up|Lost to Follow-up|0|||
170909643|NCT03519178|617673580|FG003|Follow-Up|Lost to Follow-up|0|||
170909644|NCT03519178|617673581|FG004|Follow-Up|Lost to Follow-up|0|||
170909645|NCT03519178|617673582|FG005|Follow-Up|Lost to Follow-up|3|||
170909646|NCT03519178|617673583|FG006|Follow-Up|Lost to Follow-up|1|||
170909647|NCT03519178|617673584|FG007|Follow-Up|Lost to Follow-up|4|||
170909648|NCT03519178|617673585|FG008|Follow-Up|Lost to Follow-up|1|||
170808861|NCT01364597|617310416|FG000|Overall Study|Patient cured from Epilepsy|0|||
170808862|NCT01364597|617310417|FG001|Overall Study|Patient cured from Epilepsy|0|||
170808863|NCT01364597|617310418|FG002|Overall Study|Patient cured from Epilepsy|1|||
170808864|NCT01364597|617310419|FG003|Overall Study|Patient cured from Epilepsy|0|||
170808865|NCT01364597|617310416|FG000|Overall Study|Investigator decision|0|||
170808866|NCT01364597|617310417|FG001|Overall Study|Investigator decision|0|||
170574935|NCT00606411|616449360|FG001|Overall Study|Move out of state|1|||
170808867|NCT01364597|617310418|FG002|Overall Study|Investigator decision|1|||
170808868|NCT01364597|617310419|FG003|Overall Study|Investigator decision|0|||
170808869|NCT01364597|617310416|FG000|Overall Study|Sponsor recommended discontinuation|0|||
170808870|NCT01364597|617310417|FG001|Overall Study|Sponsor recommended discontinuation|0|||
170808871|NCT01364597|617310418|FG002|Overall Study|Sponsor recommended discontinuation|0|||
170808872|NCT01364597|617310419|FG003|Overall Study|Sponsor recommended discontinuation|1|||
170808873|NCT01364597|617310416|FG000|Overall Study|Parents went abroad with the patient|0|||
170808874|NCT01364597|617310417|FG001|Overall Study|Parents went abroad with the patient|0|||
170574936|NCT00763256|616449365|FG000|Overall Study|Didn't return for appointments|7|||
170574937|NCT00763256|616449366|FG001|Overall Study|Didn't return for appointments|10|||
170574938|NCT04677543|616449370|FG000|Overall Study|Withdrawal by Subject|4|||
170574939|NCT04677543|616449371|FG001|Overall Study|Withdrawal by Subject|1|||
170574940|NCT04677543|616449370|FG000|Overall Study|Physician Decision|0|||
170574941|NCT04677543|616449371|FG001|Overall Study|Physician Decision|1|||
170574942|NCT04677543|616449370|FG000|Overall Study|Adverse Event|0|||
170574943|NCT04677543|616449371|FG001|Overall Study|Adverse Event|1|||
170574944|NCT01272037|616449373|FG000|Overall Study|Death|25|||
170574945|NCT01272037|616449374|FG001|Overall Study|Death|28|||
170574946|NCT01272037|616449373|FG000|Overall Study|Adverse Event|12|||
170574947|NCT01272037|616449374|FG001|Overall Study|Adverse Event|7|||
170574948|NCT01272037|616449373|FG000|Overall Study|Withdrawal by Subject|175|||
170574949|NCT01272037|616449374|FG001|Overall Study|Withdrawal by Subject|93|||
170574950|NCT01272037|616449373|FG000|Overall Study|Disease progression|70|||
170574951|NCT01272037|616449374|FG001|Overall Study|Disease progression|111|||
170574952|NCT01272037|616449373|FG000|Overall Study|Other reason|42|||
170574953|NCT01272037|616449374|FG001|Overall Study|Other reason|41|||
170574954|NCT01272037|616449373|FG000|Overall Study|Delinquent data|24|||
170574955|NCT01272037|616449374|FG001|Overall Study|Delinquent data|19|||
170649434|NCT01551420|616729155|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
170808875|NCT01364597|617310418|FG002|Overall Study|Parents went abroad with the patient|1|||
170808876|NCT01364597|617310419|FG003|Overall Study|Parents went abroad with the patient|0|||
170574956|NCT01272037|616449373|FG000|Overall Study|Reason under review|33|||
170574957|NCT01272037|616449374|FG001|Overall Study|Reason under review|29|||
170574958|NCT01272037|616449373|FG000|Overall Study|On treatment|626|||
170574959|NCT01272037|616449374|FG001|Overall Study|On treatment|632|||
170574960|NCT01393899|616449375|FG000|Overall Study|Study terminated by sponsor|1|||
170574961|NCT01393899|616449376|FG001|Overall Study|Study terminated by sponsor|0|||
170574962|NCT01393899|616449377|FG002|Overall Study|Study terminated by sponsor|1|||
170909649|NCT03519178|617673586|FG009|Follow-Up|Lost to Follow-up|0|||
170909650|NCT03519178|617673587|FG010|Follow-Up|Lost to Follow-up|0|||
170909651|NCT03519178|617673588|FG011|Follow-Up|Lost to Follow-up|0|||
170909652|NCT03519178|617673589|FG012|Follow-Up|Lost to Follow-up|0|||
170909653|NCT03519178|617673590|FG013|Follow-Up|Lost to Follow-up|0|||
170909654|NCT03519178|617673591|FG014|Follow-Up|Lost to Follow-up|0|||
170909655|NCT03519178|617673577|FG000|Follow-Up|Withdrawal by Subject|1|||
170909656|NCT03519178|617673578|FG001|Follow-Up|Withdrawal by Subject|2|||
170909657|NCT03519178|617673579|FG002|Follow-Up|Withdrawal by Subject|2|||
170909658|NCT03519178|617673580|FG003|Follow-Up|Withdrawal by Subject|3|||
170909659|NCT03519178|617673581|FG004|Follow-Up|Withdrawal by Subject|5|||
170909660|NCT03519178|617673582|FG005|Follow-Up|Withdrawal by Subject|1|||
170909661|NCT03519178|617673583|FG006|Follow-Up|Withdrawal by Subject|2|||
170909662|NCT03519178|617673584|FG007|Follow-Up|Withdrawal by Subject|6|||
170909663|NCT03519178|617673585|FG008|Follow-Up|Withdrawal by Subject|5|||
170909664|NCT03519178|617673586|FG009|Follow-Up|Withdrawal by Subject|2|||
170909665|NCT03519178|617673587|FG010|Follow-Up|Withdrawal by Subject|3|||
170909666|NCT03519178|617673588|FG011|Follow-Up|Withdrawal by Subject|5|||
170909667|NCT03519178|617673589|FG012|Follow-Up|Withdrawal by Subject|2|||
170909668|NCT03519178|617673590|FG013|Follow-Up|Withdrawal by Subject|0|||
170909669|NCT03519178|617673591|FG014|Follow-Up|Withdrawal by Subject|0|||
170909670|NCT03519178|617673577|FG000|Follow-Up|Other|0|||
170909671|NCT03519178|617673578|FG001|Follow-Up|Other|0|||
170909672|NCT03519178|617673579|FG002|Follow-Up|Other|0|||
170909673|NCT03519178|617673580|FG003|Follow-Up|Other|0|||
170909674|NCT03519178|617673581|FG004|Follow-Up|Other|0|||
170909675|NCT03519178|617673582|FG005|Follow-Up|Other|0|||
170909676|NCT03519178|617673583|FG006|Follow-Up|Other|0|||
170909677|NCT03519178|617673584|FG007|Follow-Up|Other|1|||
170909678|NCT03519178|617673585|FG008|Follow-Up|Other|0|||
170909679|NCT03519178|617673586|FG009|Follow-Up|Other|0|||
170909680|NCT03519178|617673587|FG010|Follow-Up|Other|0|||
170909681|NCT03519178|617673588|FG011|Follow-Up|Other|0|||
170909682|NCT03519178|617673589|FG012|Follow-Up|Other|0|||
170909683|NCT03519178|617673590|FG013|Follow-Up|Other|0|||
170909684|NCT03519178|617673591|FG014|Follow-Up|Other|0|||
170909685|NCT03519178|617673577|FG000|Long-term Follow-up|Death|0|||
170909686|NCT03519178|617673578|FG001|Long-term Follow-up|Death|0|||
170909687|NCT03519178|617673579|FG002|Long-term Follow-up|Death|0|||
170909688|NCT03519178|617673580|FG003|Long-term Follow-up|Death|0|||
170909689|NCT03519178|617673581|FG004|Long-term Follow-up|Death|0|||
170909690|NCT03519178|617673582|FG005|Long-term Follow-up|Death|0|||
170909691|NCT03519178|617673583|FG006|Long-term Follow-up|Death|0|||
170909692|NCT03519178|617673584|FG007|Long-term Follow-up|Death|0|||
170909693|NCT03519178|617673585|FG008|Long-term Follow-up|Death|0|||
170909694|NCT03519178|617673586|FG009|Long-term Follow-up|Death|0|||
170909695|NCT03519178|617673587|FG010|Long-term Follow-up|Death|0|||
170909696|NCT03519178|617673588|FG011|Long-term Follow-up|Death|0|||
170909697|NCT03519178|617673589|FG012|Long-term Follow-up|Death|0|||
170909698|NCT03519178|617673590|FG013|Long-term Follow-up|Death|4|||
170909699|NCT03519178|617673591|FG014|Long-term Follow-up|Death|4|||
170909700|NCT03519178|617673577|FG000|Long-term Follow-up|Lost to Follow-up|0|||
170909701|NCT03519178|617673578|FG001|Long-term Follow-up|Lost to Follow-up|0|||
170909702|NCT03519178|617673579|FG002|Long-term Follow-up|Lost to Follow-up|0|||
170574963|NCT01393899|616449375|FG000|Overall Study|Other|1|||
170574964|NCT01393899|616449376|FG001|Overall Study|Other|0|||
170574965|NCT01393899|616449377|FG002|Overall Study|Other|0|||
170574966|NCT01393899|616449375|FG000|Overall Study|Withdrawal by Subject|2|||
170574967|NCT01393899|616449376|FG001|Overall Study|Withdrawal by Subject|2|||
170574968|NCT01393899|616449377|FG002|Overall Study|Withdrawal by Subject|1|||
170574969|NCT01393899|616449375|FG000|Overall Study|Lost to Follow-up|0|||
170574970|NCT01393899|616449376|FG001|Overall Study|Lost to Follow-up|0|||
170574971|NCT01393899|616449377|FG002|Overall Study|Lost to Follow-up|1|||
170574972|NCT01393899|616449375|FG000|Overall Study|Does not meet entrance criteria|1|||
170574973|NCT01393899|616449376|FG001|Overall Study|Does not meet entrance criteria|0|||
170574974|NCT01393899|616449377|FG002|Overall Study|Does not meet entrance criteria|1|||
170574975|NCT01393899|616449375|FG000|Overall Study|Lack of Efficacy|26|||
170574976|NCT01393899|616449376|FG001|Overall Study|Lack of Efficacy|21|||
170574977|NCT01393899|616449377|FG002|Overall Study|Lack of Efficacy|16|||
170574978|NCT01393899|616449375|FG000|Overall Study|Adverse Event|1|||
170574979|NCT01393899|616449376|FG001|Overall Study|Adverse Event|5|||
170574980|NCT01393899|616449377|FG002|Overall Study|Adverse Event|3|||
170574981|NCT02503085|616449378|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
170574982|NCT02503085|616449379|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
170574983|NCT02503085|616449380|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
170574984|NCT02503085|616449381|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
170574985|NCT02534883|616449382|FG000|Overall Study|Early Termination|8|||
170574986|NCT02534883|616449383|FG001|Overall Study|Early Termination|3|||
170574987|NCT03328832|616449384|FG000|Overall Study|Lost to Follow-up|0|||
170574988|NCT03328832|616449385|FG001|Overall Study|Lost to Follow-up|1|||
170574989|NCT00132301|616449386|FG000|Overall Study|Death|7|||
170574990|NCT00132301|616449387|FG001|Overall Study|Death|6|||
170574991|NCT00132301|616449386|FG000|Overall Study|Withdrawal by Subject|5|||
170574992|NCT00132301|616449387|FG001|Overall Study|Withdrawal by Subject|2|||
170574993|NCT00132301|616449386|FG000|Overall Study|Physician Decision|1|||
170574994|NCT00132301|616449387|FG001|Overall Study|Physician Decision|1|||
170574995|NCT00132301|616449386|FG000|Overall Study|Lost to Follow-up|5|||
170574996|NCT00132301|616449387|FG001|Overall Study|Lost to Follow-up|3|||
170574997|NCT00132301|616449386|FG000|Overall Study|Other|1|||
170574998|NCT00132301|616449387|FG001|Overall Study|Other|1|||
170574999|NCT00132301|616449386|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
170575000|NCT00132301|616449387|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
170575001|NCT02720523|616449388|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
170575002|NCT02720523|616449389|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
170575003|NCT02720523|616449390|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
170575004|NCT02720523|616449391|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
170575005|NCT02720523|616449392|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
170575006|NCT02720523|616449393|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
170575007|NCT02720523|616449394|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
170575008|NCT02720523|616449388|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
170575009|NCT02720523|616449389|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
170575010|NCT02720523|616449390|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
170575011|NCT02720523|616449391|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
170575012|NCT02720523|616449392|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
170575013|NCT02720523|616449393|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
170575014|NCT02720523|616449394|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
170575015|NCT02720523|616449388|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
170575016|NCT02720523|616449389|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
170575017|NCT02720523|616449390|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
170575018|NCT02720523|616449391|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
170575019|NCT02720523|616449392|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
170575020|NCT02720523|616449393|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
170575021|NCT02720523|616449394|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
170575022|NCT02720523|616449388|FG000|Period 1: Placebo-controlled Period|Other|0|||
170575023|NCT02720523|616449389|FG001|Period 1: Placebo-controlled Period|Other|0|||
170575024|NCT02720523|616449390|FG002|Period 1: Placebo-controlled Period|Other|1|||
170575025|NCT02720523|616449391|FG003|Period 1: Placebo-controlled Period|Other|1|||
170575026|NCT02720523|616449392|FG004|Period 1: Placebo-controlled Period|Other|0|||
170575027|NCT02720523|616449393|FG005|Period 1: Placebo-controlled Period|Other|0|||
170808877|NCT01364597|617310416|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
170575028|NCT02720523|616449394|FG006|Period 1: Placebo-controlled Period|Other|0|||
170575029|NCT02720523|616449388|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
170575030|NCT02720523|616449389|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
170575031|NCT02720523|616449390|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
170808878|NCT01364597|617310417|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
170808879|NCT01364597|617310418|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
170808880|NCT01364597|617310419|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
170575032|NCT02720523|616449391|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
170575033|NCT02720523|616449392|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
170575034|NCT02720523|616449393|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
170575035|NCT02720523|616449394|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
170575036|NCT02720523|616449388|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
170575037|NCT02720523|616449389|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
170575038|NCT02720523|616449390|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
170575039|NCT02720523|616449391|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
170575040|NCT02720523|616449392|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
170575041|NCT02720523|616449393|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
170575042|NCT02720523|616449394|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
170575043|NCT02720523|616449388|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
170575044|NCT02720523|616449389|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
170575045|NCT02720523|616449390|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
170575046|NCT02720523|616449391|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
170575047|NCT02720523|616449392|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
170575048|NCT02720523|616449393|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
170575049|NCT02720523|616449394|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
170575050|NCT02720523|616449388|FG000|Period 2: Long-term Extension Period|Other|0|||
170575051|NCT02720523|616449389|FG001|Period 2: Long-term Extension Period|Other|0|||
170575052|NCT02720523|616449390|FG002|Period 2: Long-term Extension Period|Other|0|||
170575053|NCT02720523|616449391|FG003|Period 2: Long-term Extension Period|Other|0|||
170575054|NCT02720523|616449392|FG004|Period 2: Long-term Extension Period|Other|2|||
170575055|NCT02720523|616449393|FG005|Period 2: Long-term Extension Period|Other|0|||
170575056|NCT02720523|616449394|FG006|Period 2: Long-term Extension Period|Other|3|||
170575057|NCT01890265|616449395|FG000|Overall Study|Other (Unspecified reason)|0|||
170575058|NCT01890265|616449396|FG001|Overall Study|Other (Unspecified reason)|1|||
170575059|NCT01890265|616449397|FG002|Overall Study|Other (Unspecified reason)|0|||
170575060|NCT01890265|616449398|FG003|Overall Study|Other (Unspecified reason)|0|||
170575061|NCT01890265|616449399|FG004|Overall Study|Other (Unspecified reason)|0|||
170575062|NCT01890265|616449400|FG005|Overall Study|Other (Unspecified reason)|0|||
170575063|NCT01890265|616449395|FG000|Overall Study|Progressive disease|6|||
170575064|NCT01890265|616449396|FG001|Overall Study|Progressive disease|6|||
170575065|NCT01890265|616449397|FG002|Overall Study|Progressive disease|0|||
170575066|NCT01890265|616449398|FG003|Overall Study|Progressive disease|0|||
170575067|NCT01890265|616449399|FG004|Overall Study|Progressive disease|0|||
170575068|NCT01890265|616449400|FG005|Overall Study|Progressive disease|0|||
170575069|NCT01890265|616449395|FG000|Overall Study|Adverse Event|2|||
170575070|NCT01890265|616449396|FG001|Overall Study|Adverse Event|1|||
170575071|NCT01890265|616449397|FG002|Overall Study|Adverse Event|0|||
170575072|NCT01890265|616449398|FG003|Overall Study|Adverse Event|0|||
170575073|NCT01890265|616449399|FG004|Overall Study|Adverse Event|0|||
170575074|NCT01890265|616449400|FG005|Overall Study|Adverse Event|0|||
170575075|NCT01890265|616449395|FG000|Overall Study|Death|2|||
170575076|NCT01890265|616449396|FG001|Overall Study|Death|3|||
170575077|NCT01890265|616449397|FG002|Overall Study|Death|1|||
170575078|NCT01890265|616449398|FG003|Overall Study|Death|0|||
170575079|NCT01890265|616449399|FG004|Overall Study|Death|0|||
170575080|NCT01890265|616449400|FG005|Overall Study|Death|0|||
170575081|NCT01890265|616449395|FG000|Overall Study|Withdrawal by Subject|0|||
170808881|NCT01364597|617310416|FG000|Overall Study|BRV administration dropout|0|||
170808882|NCT01364597|617310417|FG001|Overall Study|BRV administration dropout|0|||
170808883|NCT01364597|617310418|FG002|Overall Study|BRV administration dropout|1|||
170808884|NCT01364597|617310419|FG003|Overall Study|BRV administration dropout|0|||
170808885|NCT01364597|617310416|FG000|Overall Study|Dropout|0|||
170808886|NCT01364597|617310417|FG001|Overall Study|Dropout|0|||
170808887|NCT01364597|617310418|FG002|Overall Study|Dropout|3|||
170808888|NCT01364597|617310419|FG003|Overall Study|Dropout|1|||
170808889|NCT01364597|617310416|FG000|Overall Study|Unreliable subject|0|||
170808890|NCT01364597|617310417|FG001|Overall Study|Unreliable subject|0|||
170808891|NCT01364597|617310418|FG002|Overall Study|Unreliable subject|0|||
170808892|NCT01364597|617310419|FG003|Overall Study|Unreliable subject|1|||
170808893|NCT01364597|617310416|FG000|Overall Study|Other|0|||
170808894|NCT01364597|617310417|FG001|Overall Study|Other|0|||
170808895|NCT01364597|617310418|FG002|Overall Study|Other|0|||
170808896|NCT01364597|617310419|FG003|Overall Study|Other|1|||
170808897|NCT03214081|617310420|FG000|Overall Study|Case Report Forms Uncollected|9|||
170808898|NCT03214081|617310420|FG000|Overall Study|Protocol Deviation|54|||
170808899|NCT03493282|617310421|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
170808900|NCT03493282|617310422|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
170808901|NCT03493282|617310423|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
170808902|NCT03493282|617310421|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
170808903|NCT03493282|617310422|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
170808904|NCT03493282|617310423|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
170575082|NCT01890265|616449396|FG001|Overall Study|Withdrawal by Subject|2|||
170575083|NCT01890265|616449397|FG002|Overall Study|Withdrawal by Subject|3|||
170575084|NCT01890265|616449398|FG003|Overall Study|Withdrawal by Subject|0|||
170575085|NCT01890265|616449399|FG004|Overall Study|Withdrawal by Subject|2|||
170575086|NCT01890265|616449400|FG005|Overall Study|Withdrawal by Subject|0|||
170575087|NCT02517398|616449404|FG000|Overall Study|Death|2|||
170575088|NCT02517398|616449405|FG001|Overall Study|Death|3|||
170575089|NCT02517398|616449406|FG002|Overall Study|Death|4|||
170575090|NCT02517398|616449407|FG003|Overall Study|Death|2|||
170575091|NCT02517398|616449408|FG004|Overall Study|Death|3|||
170575092|NCT02517398|616449409|FG005|Overall Study|Death|8|||
170575093|NCT02517398|616449410|FG006|Overall Study|Death|3|||
170575094|NCT02517398|616449411|FG007|Overall Study|Death|2|||
170575095|NCT02517398|616449412|FG008|Overall Study|Death|6|||
170575096|NCT02517398|616449413|FG009|Overall Study|Death|24|||
170575097|NCT02517398|616449414|FG010|Overall Study|Death|53|||
170575098|NCT02517398|616449415|FG011|Overall Study|Death|25|||
170575099|NCT02517398|616449416|FG012|Overall Study|Death|73|||
170575100|NCT02517398|616449417|FG013|Overall Study|Death|29|||
170575101|NCT02517398|616449418|FG014|Overall Study|Death|26|||
170575102|NCT02517398|616449419|FG015|Overall Study|Death|23|||
170575103|NCT02517398|616449420|FG016|Overall Study|Death|26|||
170575104|NCT02517398|616449421|FG017|Overall Study|Death|25|||
170575105|NCT02517398|616449422|FG018|Overall Study|Death|22|||
170575106|NCT02517398|616449423|FG019|Overall Study|Death|7|||
170575107|NCT02517398|616449424|FG020|Overall Study|Death|26|||
170575108|NCT02517398|616449425|FG021|Overall Study|Death|30|||
170575109|NCT02517398|616449426|FG022|Overall Study|Death|20|||
170575110|NCT02517398|616449404|FG000|Overall Study|Other|0|||
170575111|NCT02517398|616449405|FG001|Overall Study|Other|0|||
170575112|NCT02517398|616449406|FG002|Overall Study|Other|0|||
170575113|NCT02517398|616449407|FG003|Overall Study|Other|1|||
170575114|NCT02517398|616449408|FG004|Overall Study|Other|0|||
170575115|NCT02517398|616449409|FG005|Overall Study|Other|0|||
170575116|NCT02517398|616449410|FG006|Overall Study|Other|0|||
170575117|NCT02517398|616449411|FG007|Overall Study|Other|0|||
170575118|NCT02517398|616449412|FG008|Overall Study|Other|0|||
170575119|NCT02517398|616449413|FG009|Overall Study|Other|1|||
170575120|NCT02517398|616449414|FG010|Overall Study|Other|0|||
170575121|NCT02517398|616449415|FG011|Overall Study|Other|0|||
170575122|NCT02517398|616449416|FG012|Overall Study|Other|0|||
170575123|NCT02517398|616449417|FG013|Overall Study|Other|1|||
170575124|NCT02517398|616449418|FG014|Overall Study|Other|0|||
170649435|NCT01551420|616729156|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
170649436|NCT01551420|616729155|FG000|Screened for Part B Eligibility|Declined participation|8|||
170649437|NCT01551420|616729156|FG001|Screened for Part B Eligibility|Declined participation|1|||
170649438|NCT01551420|616729155|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
170649439|NCT01551420|616729156|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
170575125|NCT02517398|616449419|FG015|Overall Study|Other|1|||
170575126|NCT02517398|616449420|FG016|Overall Study|Other|1|||
170575127|NCT02517398|616449421|FG017|Overall Study|Other|0|||
170575128|NCT02517398|616449422|FG018|Overall Study|Other|0|||
170575129|NCT02517398|616449423|FG019|Overall Study|Other|1|||
170575130|NCT02517398|616449424|FG020|Overall Study|Other|0|||
170575131|NCT02517398|616449425|FG021|Overall Study|Other|0|||
170575132|NCT02517398|616449426|FG022|Overall Study|Other|0|||
170575133|NCT02517398|616449404|FG000|Overall Study|Lost to Follow-up|0|||
170575134|NCT02517398|616449405|FG001|Overall Study|Lost to Follow-up|0|||
170575135|NCT02517398|616449406|FG002|Overall Study|Lost to Follow-up|0|||
170575136|NCT02517398|616449407|FG003|Overall Study|Lost to Follow-up|0|||
170575137|NCT02517398|616449408|FG004|Overall Study|Lost to Follow-up|0|||
170575138|NCT02517398|616449409|FG005|Overall Study|Lost to Follow-up|0|||
170575139|NCT02517398|616449410|FG006|Overall Study|Lost to Follow-up|0|||
170575140|NCT02517398|616449411|FG007|Overall Study|Lost to Follow-up|0|||
170575141|NCT02517398|616449412|FG008|Overall Study|Lost to Follow-up|0|||
170575142|NCT02517398|616449413|FG009|Overall Study|Lost to Follow-up|1|||
170575143|NCT02517398|616449414|FG010|Overall Study|Lost to Follow-up|0|||
170575144|NCT02517398|616449415|FG011|Overall Study|Lost to Follow-up|2|||
170575145|NCT02517398|616449416|FG012|Overall Study|Lost to Follow-up|2|||
170575146|NCT02517398|616449417|FG013|Overall Study|Lost to Follow-up|0|||
170575147|NCT02517398|616449418|FG014|Overall Study|Lost to Follow-up|1|||
170575148|NCT02517398|616449419|FG015|Overall Study|Lost to Follow-up|1|||
170575149|NCT02517398|616449420|FG016|Overall Study|Lost to Follow-up|0|||
170575150|NCT02517398|616449421|FG017|Overall Study|Lost to Follow-up|3|||
170575151|NCT02517398|616449422|FG018|Overall Study|Lost to Follow-up|1|||
170575152|NCT02517398|616449423|FG019|Overall Study|Lost to Follow-up|0|||
170575153|NCT02517398|616449424|FG020|Overall Study|Lost to Follow-up|1|||
170575154|NCT02517398|616449425|FG021|Overall Study|Lost to Follow-up|0|||
170575155|NCT02517398|616449426|FG022|Overall Study|Lost to Follow-up|2|||
170575156|NCT02517398|616449404|FG000|Overall Study|Withdrew Consent|0|||
170575157|NCT02517398|616449405|FG001|Overall Study|Withdrew Consent|0|||
170575158|NCT02517398|616449406|FG002|Overall Study|Withdrew Consent|0|||
170575159|NCT02517398|616449407|FG003|Overall Study|Withdrew Consent|0|||
170909703|NCT03519178|617673580|FG003|Long-term Follow-up|Lost to Follow-up|0|||
170909704|NCT03519178|617673581|FG004|Long-term Follow-up|Lost to Follow-up|0|||
170909705|NCT03519178|617673582|FG005|Long-term Follow-up|Lost to Follow-up|0|||
170909706|NCT03519178|617673583|FG006|Long-term Follow-up|Lost to Follow-up|0|||
170909707|NCT03519178|617673584|FG007|Long-term Follow-up|Lost to Follow-up|0|||
170909708|NCT03519178|617673585|FG008|Long-term Follow-up|Lost to Follow-up|0|||
170909709|NCT03519178|617673586|FG009|Long-term Follow-up|Lost to Follow-up|0|||
170909710|NCT03519178|617673587|FG010|Long-term Follow-up|Lost to Follow-up|0|||
170909711|NCT03519178|617673588|FG011|Long-term Follow-up|Lost to Follow-up|0|||
170909712|NCT03519178|617673589|FG012|Long-term Follow-up|Lost to Follow-up|0|||
170909713|NCT03519178|617673590|FG013|Long-term Follow-up|Lost to Follow-up|1|||
170909714|NCT03519178|617673591|FG014|Long-term Follow-up|Lost to Follow-up|1|||
170909715|NCT03519178|617673577|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
170909716|NCT03519178|617673578|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
170909717|NCT03519178|617673579|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
170909718|NCT03519178|617673580|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
170909719|NCT03519178|617673581|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
170909720|NCT03519178|617673582|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
170575160|NCT02517398|616449408|FG004|Overall Study|Withdrew Consent|0|||
170575161|NCT02517398|616449409|FG005|Overall Study|Withdrew Consent|0|||
170575162|NCT02517398|616449410|FG006|Overall Study|Withdrew Consent|1|||
170575163|NCT02517398|616449411|FG007|Overall Study|Withdrew Consent|0|||
170575164|NCT02517398|616449412|FG008|Overall Study|Withdrew Consent|0|||
170575165|NCT02517398|616449413|FG009|Overall Study|Withdrew Consent|2|||
170575166|NCT02517398|616449414|FG010|Overall Study|Withdrew Consent|7|||
170575167|NCT02517398|616449415|FG011|Overall Study|Withdrew Consent|1|||
170575168|NCT02517398|616449416|FG012|Overall Study|Withdrew Consent|5|||
170575169|NCT02517398|616449417|FG013|Overall Study|Withdrew Consent|4|||
170575170|NCT02517398|616449418|FG014|Overall Study|Withdrew Consent|2|||
170575171|NCT02517398|616449419|FG015|Overall Study|Withdrew Consent|5|||
170575172|NCT02517398|616449420|FG016|Overall Study|Withdrew Consent|4|||
170575173|NCT02517398|616449421|FG017|Overall Study|Withdrew Consent|2|||
170575174|NCT02517398|616449422|FG018|Overall Study|Withdrew Consent|3|||
170575175|NCT02517398|616449423|FG019|Overall Study|Withdrew Consent|2|||
170575176|NCT02517398|616449424|FG020|Overall Study|Withdrew Consent|9|||
170575177|NCT02517398|616449425|FG021|Overall Study|Withdrew Consent|3|||
170575178|NCT02517398|616449426|FG022|Overall Study|Withdrew Consent|1|||
170575179|NCT04587869|616449427|FG000|Overall Study|Death|1|||
170575180|NCT04587869|616449428|FG001|Overall Study|Death|0|||
170575181|NCT04587869|616449427|FG000|Overall Study|Lost to Follow-up|27|||
170575182|NCT04587869|616449428|FG001|Overall Study|Lost to Follow-up|34|||
170575183|NCT04587869|616449427|FG000|Overall Study|Grant Termination|13|||
170575184|NCT04587869|616449428|FG001|Overall Study|Grant Termination|25|||
170575185|NCT04587869|616449427|FG000|Overall Study|too busy|2|||
170575186|NCT04587869|616449428|FG001|Overall Study|too busy|0|||
170575187|NCT04587869|616449427|FG000|Overall Study|Withdrawal by Subject|2|||
170575188|NCT04587869|616449428|FG001|Overall Study|Withdrawal by Subject|2|||
170575189|NCT04587869|616449427|FG000|Overall Study|Other|1|||
170575190|NCT04587869|616449428|FG001|Overall Study|Other|0|||
170575191|NCT02708680|616449429|FG000|Overall Study|Withdrawal by Subject|4|||
170575192|NCT02708680|616449430|FG001|Overall Study|Withdrawal by Subject|12|||
170575193|NCT02708680|616449431|FG002|Overall Study|Withdrawal by Subject|12|||
170575194|NCT02708680|616449429|FG000|Overall Study|Death|4|||
170575195|NCT02708680|616449430|FG001|Overall Study|Death|19|||
170575196|NCT02708680|616449431|FG002|Overall Study|Death|21|||
170575197|NCT02708680|616449429|FG000|Overall Study|Lost to Follow-up|0|||
170575198|NCT02708680|616449430|FG001|Overall Study|Lost to Follow-up|3|||
170575199|NCT02708680|616449431|FG002|Overall Study|Lost to Follow-up|3|||
170575200|NCT02708680|616449429|FG000|Overall Study|Study Terminated By Sponsor|0|||
170575201|NCT02708680|616449430|FG001|Overall Study|Study Terminated By Sponsor|5|||
170575202|NCT02708680|616449431|FG002|Overall Study|Study Terminated By Sponsor|4|||
170575203|NCT02708680|616449429|FG000|Overall Study|Other than Specified|0|||
170575204|NCT02708680|616449430|FG001|Overall Study|Other than Specified|0|||
170575205|NCT02708680|616449431|FG002|Overall Study|Other than Specified|1|||
170575206|NCT02708680|616449429|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
170575207|NCT02708680|616449430|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
170575208|NCT02708680|616449431|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
170575209|NCT01342926|616449432|FG000|Overall Study|Adverse Event|5|||
170575210|NCT01342926|616449433|FG001|Overall Study|Adverse Event|8|||
170575211|NCT01342926|616449434|FG002|Overall Study|Adverse Event|10|||
170575212|NCT01342926|616449435|FG003|Overall Study|Adverse Event|7|||
170575213|NCT01342926|616449432|FG000|Overall Study|Lost to Follow-up|0|||
170575214|NCT01342926|616449433|FG001|Overall Study|Lost to Follow-up|1|||
170575215|NCT01342926|616449434|FG002|Overall Study|Lost to Follow-up|1|||
170575216|NCT01342926|616449435|FG003|Overall Study|Lost to Follow-up|0|||
170575217|NCT01342926|616449432|FG000|Overall Study|Investigator Discretion|2|||
170575218|NCT01342926|616449433|FG001|Overall Study|Investigator Discretion|2|||
170575219|NCT01342926|616449434|FG002|Overall Study|Investigator Discretion|0|||
170575220|NCT01342926|616449435|FG003|Overall Study|Investigator Discretion|0|||
170575221|NCT01342926|616449432|FG000|Overall Study|Withdrawal by Subject|2|||
170575222|NCT01342926|616449433|FG001|Overall Study|Withdrawal by Subject|4|||
170575223|NCT01342926|616449434|FG002|Overall Study|Withdrawal by Subject|3|||
170575224|NCT01342926|616449435|FG003|Overall Study|Withdrawal by Subject|5|||
170575225|NCT00436436|616449436|FG000|Overall Study|Progression|4|||
170575226|NCT00436436|616449436|FG000|Overall Study|Adverse Event|2|||
170575227|NCT00436436|616449436|FG000|Overall Study|Death|6|||
170575228|NCT03654274|616449439|FG000|Overall Study|Adverse Event|19|||
170575229|NCT03654274|616449440|FG001|Overall Study|Adverse Event|23|||
170575230|NCT03654274|616449441|FG002|Overall Study|Adverse Event|24|||
170575231|NCT03654274|616449439|FG000|Overall Study|Protocol Deviation|0|||
170575232|NCT03654274|616449440|FG001|Overall Study|Protocol Deviation|2|||
170575233|NCT03654274|616449441|FG002|Overall Study|Protocol Deviation|0|||
170575234|NCT03654274|616449439|FG000|Overall Study|Lost to Follow-up|8|||
170575235|NCT03654274|616449440|FG001|Overall Study|Lost to Follow-up|6|||
170575236|NCT03654274|616449441|FG002|Overall Study|Lost to Follow-up|5|||
170575237|NCT03654274|616449439|FG000|Overall Study|Withdrawal by Subject|46|||
170575238|NCT03654274|616449440|FG001|Overall Study|Withdrawal by Subject|25|||
170575239|NCT03654274|616449441|FG002|Overall Study|Withdrawal by Subject|33|||
170575240|NCT03654274|616449439|FG000|Overall Study|Lack of Efficacy|4|||
170575241|NCT03654274|616449440|FG001|Overall Study|Lack of Efficacy|5|||
170575242|NCT03654274|616449441|FG002|Overall Study|Lack of Efficacy|7|||
170575243|NCT03654274|616449439|FG000|Overall Study|Pregnancy|2|||
170575244|NCT03654274|616449440|FG001|Overall Study|Pregnancy|2|||
170575245|NCT03654274|616449441|FG002|Overall Study|Pregnancy|1|||
170575246|NCT03654274|616449439|FG000|Overall Study|Other|27|||
170575247|NCT03654274|616449440|FG001|Overall Study|Other|29|||
170575248|NCT03654274|616449441|FG002|Overall Study|Other|32|||
170575249|NCT03654274|616449439|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
170575250|NCT03654274|616449440|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
170575251|NCT03654274|616449441|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
170575252|NCT01265992|616449444|FG000|Overall Study|Lost to Follow-up|1|||
170575253|NCT01265992|616449444|FG000|Overall Study|Withdrawal by Subject|1|||
170575254|NCT01265992|616449444|FG000|Overall Study|Adverse Event|1|||
170575255|NCT01265992|616449444|FG000|Overall Study|Administrative reasons|2|||
170575256|NCT01265992|616449444|FG000|Overall Study|Stopped treatment|3|||
170575257|NCT01265992|616449444|FG000|Overall Study|Did not receive treatment|1|||
170575258|NCT01102491|616449445|FG000|Overall Study|Protocol Violation|11|||
170575259|NCT01102491|616449446|FG001|Overall Study|Protocol Violation|12|||
170575260|NCT03008070|616449447|FG000|Overall Study|Adverse Event|3|||
170575261|NCT03008070|616449448|FG001|Overall Study|Adverse Event|3|||
170575262|NCT03008070|616449449|FG002|Overall Study|Adverse Event|3|||
170575263|NCT03008070|616449447|FG000|Overall Study|Lost to Follow-up|1|||
170575264|NCT03008070|616449448|FG001|Overall Study|Lost to Follow-up|1|||
170575265|NCT03008070|616449449|FG002|Overall Study|Lost to Follow-up|0|||
170575266|NCT03008070|616449447|FG000|Overall Study|Non compliance|0|||
170575267|NCT03008070|616449448|FG001|Overall Study|Non compliance|1|||
170575268|NCT03008070|616449449|FG002|Overall Study|Non compliance|1|||
170575269|NCT03008070|616449447|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
170575270|NCT03008070|616449448|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
170575271|NCT03008070|616449449|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
170575272|NCT03008070|616449447|FG000|Overall Study|Withdrawal by Subject|2|||
170575273|NCT03008070|616449448|FG001|Overall Study|Withdrawal by Subject|0|||
170575274|NCT03008070|616449449|FG002|Overall Study|Withdrawal by Subject|1|||
170575275|NCT03008070|616449447|FG000|Overall Study|Use of prohibited drug|0|||
170575276|NCT03008070|616449448|FG001|Overall Study|Use of prohibited drug|0|||
170575277|NCT03008070|616449449|FG002|Overall Study|Use of prohibited drug|2|||
170575278|NCT03941483|616449450|FG000|Overall Study|Miscellaneous|2|||
170575279|NCT03941483|616449451|FG001|Overall Study|Miscellaneous|3|||
170575280|NCT03941483|616449452|FG002|Overall Study|Miscellaneous|0|||
170575281|NCT03941483|616449450|FG000|Overall Study|Study Terminated by Sponsor|1|||
170649440|NCT01551420|616729155|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
170649441|NCT01551420|616729156|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
170575282|NCT03941483|616449451|FG001|Overall Study|Study Terminated by Sponsor|0|||
170575283|NCT03941483|616449452|FG002|Overall Study|Study Terminated by Sponsor|0|||
170575284|NCT03941483|616449450|FG000|Overall Study|Withdrawal by Subject|1|||
170575285|NCT03941483|616449451|FG001|Overall Study|Withdrawal by Subject|4|||
170575286|NCT03941483|616449452|FG002|Overall Study|Withdrawal by Subject|1|||
170575287|NCT03941483|616449450|FG000|Overall Study|Lost to Follow-up|2|||
170575288|NCT03941483|616449451|FG001|Overall Study|Lost to Follow-up|1|||
170575289|NCT03941483|616449452|FG002|Overall Study|Lost to Follow-up|8|||
170575290|NCT03941483|616449450|FG000|Overall Study|Death|3|||
170575291|NCT03941483|616449451|FG001|Overall Study|Death|2|||
170575292|NCT03941483|616449452|FG002|Overall Study|Death|6|||
170575293|NCT01444430|616449458|FG000|Overall Study|Withdrawal by Subject|53|||
170575294|NCT01444430|616449459|FG001|Overall Study|Withdrawal by Subject|72|||
170909721|NCT03519178|617673583|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
170909722|NCT03519178|617673584|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
170909723|NCT03519178|617673585|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
170909724|NCT03519178|617673586|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
170909725|NCT03519178|617673587|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
170909726|NCT03519178|617673588|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
170909727|NCT03519178|617673589|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
170909728|NCT03519178|617673590|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
170909729|NCT03519178|617673591|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
170909730|NCT03519178|617673577|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
170909731|NCT03519178|617673578|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
170909732|NCT03519178|617673579|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
170909733|NCT03519178|617673580|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
170909734|NCT03519178|617673581|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
170909735|NCT03519178|617673582|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
170909736|NCT03519178|617673583|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
170575295|NCT01444430|616449458|FG000|Overall Study|Death|6|||
170575296|NCT01444430|616449459|FG001|Overall Study|Death|8|||
170575297|NCT01444430|616449458|FG000|Overall Study|Lost to Follow-up|2|||
170575298|NCT01444430|616449459|FG001|Overall Study|Lost to Follow-up|0|||
170575299|NCT01444430|616449458|FG000|Overall Study|CRF termination module not completed.|0|||
170575300|NCT01444430|616449459|FG001|Overall Study|CRF termination module not completed.|1|||
170575301|NCT00617084|616451525|FG000|Overall Study|Withdrawal by Subject|5|||
170575302|NCT00617084|616451526|FG001|Overall Study|Withdrawal by Subject|7|||
170575303|NCT00617084|616451525|FG000|Overall Study|Missed 12 Months visit|16|||
170575304|NCT00617084|616451526|FG001|Overall Study|Missed 12 Months visit|19|||
170575305|NCT02222688|616451527|FG000|Overall Study|Withdrawal by Subject|0|||
170575306|NCT02222688|616451528|FG001|Overall Study|Withdrawal by Subject|0|||
170575307|NCT02222688|616451529|FG002|Overall Study|Withdrawal by Subject|0|||
170575308|NCT02222688|616451530|FG003|Overall Study|Withdrawal by Subject|2|||
170575309|NCT02222688|616451531|FG004|Overall Study|Withdrawal by Subject|1|||
170575310|NCT02222688|616451532|FG005|Overall Study|Withdrawal by Subject|0|||
170575311|NCT02222688|616451533|FG006|Overall Study|Withdrawal by Subject|1|||
170575312|NCT02222688|616451527|FG000|Overall Study|Disease progression|1|||
170575313|NCT02222688|616451528|FG001|Overall Study|Disease progression|0|||
170575314|NCT02222688|616451529|FG002|Overall Study|Disease progression|0|||
170575315|NCT02222688|616451530|FG003|Overall Study|Disease progression|0|||
170575316|NCT02222688|616451531|FG004|Overall Study|Disease progression|0|||
170575317|NCT02222688|616451532|FG005|Overall Study|Disease progression|0|||
170575318|NCT02222688|616451533|FG006|Overall Study|Disease progression|0|||
170575319|NCT00958360|616451539|FG000|Overall Study|Withdrawal by Subject|3|||
170575320|NCT00958360|616451540|FG001|Overall Study|Withdrawal by Subject|1|||
170575321|NCT00958360|616451539|FG000|Overall Study|Death|6|||
170575322|NCT00958360|616451540|FG001|Overall Study|Death|7|||
170575323|NCT00958360|616451539|FG000|Overall Study|Physician Decision|2|||
170575324|NCT00958360|616451540|FG001|Overall Study|Physician Decision|1|||
170575325|NCT00958360|616451539|FG000|Overall Study|Lost to Follow-up|0|||
170575326|NCT00958360|616451540|FG001|Overall Study|Lost to Follow-up|1|||
170575327|NCT01061723|616451541|FG000|Overall Study|Adverse Event|0|||
170575328|NCT01061723|616451542|FG001|Overall Study|Adverse Event|2|||
170575329|NCT01061723|616451543|FG002|Overall Study|Adverse Event|5|||
170575330|NCT01061723|616451544|FG003|Overall Study|Adverse Event|5|||
170575331|NCT01061723|616451545|FG004|Overall Study|Adverse Event|2|||
170575332|NCT01061723|616451546|FG005|Overall Study|Adverse Event|6|||
170575333|NCT01061723|616451541|FG000|Overall Study|Lack of Efficacy|2|||
170575334|NCT01061723|616451542|FG001|Overall Study|Lack of Efficacy|3|||
170575335|NCT01061723|616451543|FG002|Overall Study|Lack of Efficacy|4|||
170575336|NCT01061723|616451544|FG003|Overall Study|Lack of Efficacy|2|||
170575337|NCT01061723|616451545|FG004|Overall Study|Lack of Efficacy|1|||
170575338|NCT01061723|616451546|FG005|Overall Study|Lack of Efficacy|1|||
170575339|NCT01061723|616451541|FG000|Overall Study|Randomized but not treated|0|||
170909737|NCT03519178|617673584|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
170909738|NCT03519178|617673585|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
170909739|NCT03519178|617673586|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
170909740|NCT03519178|617673587|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
170909741|NCT03519178|617673588|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
170909742|NCT03519178|617673589|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
170909743|NCT03519178|617673590|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
170575340|NCT01061723|616451542|FG001|Overall Study|Randomized but not treated|0|||
170909744|NCT03519178|617673591|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
170909745|NCT03519178|617673577|FG000|Long-term Follow-up|Other|0|||
170575341|NCT01061723|616451543|FG002|Overall Study|Randomized but not treated|0|||
170575342|NCT01061723|616451544|FG003|Overall Study|Randomized but not treated|0|||
170575343|NCT01061723|616451545|FG004|Overall Study|Randomized but not treated|0|||
170575344|NCT01061723|616451546|FG005|Overall Study|Randomized but not treated|1|||
170575345|NCT01061723|616451541|FG000|Overall Study|Other than specified above|2|||
170575346|NCT01061723|616451542|FG001|Overall Study|Other than specified above|1|||
170575347|NCT01061723|616451543|FG002|Overall Study|Other than specified above|1|||
170575348|NCT01061723|616451544|FG003|Overall Study|Other than specified above|1|||
170575349|NCT01061723|616451545|FG004|Overall Study|Other than specified above|0|||
170575350|NCT01061723|616451546|FG005|Overall Study|Other than specified above|1|||
170575351|NCT02263326|616451547|FG000|Overall Study|Lost to Follow-up|1|||
170575352|NCT02263326|616451548|FG001|Overall Study|Lost to Follow-up|1|||
170575353|NCT00500357|616451549|FG000|Overall Study|Death|1|||
170575354|NCT01734785|616451550|FG000|Open-Label Period|Adverse Event|0|||
170575355|NCT01734785|616451551|FG001|Open-Label Period|Adverse Event|0|||
170575356|NCT01734785|616451552|FG002|Open-Label Period|Adverse Event|0|||
170575357|NCT01734785|616451553|FG003|Open-Label Period|Adverse Event|9|||
170575358|NCT01734785|616451550|FG000|Open-Label Period|Lack of Efficacy|0|||
170575359|NCT01734785|616451551|FG001|Open-Label Period|Lack of Efficacy|0|||
170575360|NCT01734785|616451552|FG002|Open-Label Period|Lack of Efficacy|0|||
170575361|NCT01734785|616451553|FG003|Open-Label Period|Lack of Efficacy|1|||
170575362|NCT01734785|616451550|FG000|Open-Label Period|Protocol Violation|0|||
170575363|NCT01734785|616451551|FG001|Open-Label Period|Protocol Violation|0|||
170575364|NCT01734785|616451552|FG002|Open-Label Period|Protocol Violation|0|||
170575365|NCT01734785|616451553|FG003|Open-Label Period|Protocol Violation|13|||
170575366|NCT01734785|616451550|FG000|Open-Label Period|Lost to Follow-up|0|||
170575367|NCT01734785|616451551|FG001|Open-Label Period|Lost to Follow-up|0|||
170575368|NCT01734785|616451552|FG002|Open-Label Period|Lost to Follow-up|0|||
170575369|NCT01734785|616451553|FG003|Open-Label Period|Lost to Follow-up|14|||
170575370|NCT01734785|616451550|FG000|Open-Label Period|Withdrawal by Subject|0|||
170575371|NCT01734785|616451551|FG001|Open-Label Period|Withdrawal by Subject|0|||
170575372|NCT01734785|616451552|FG002|Open-Label Period|Withdrawal by Subject|0|||
170575373|NCT01734785|616451553|FG003|Open-Label Period|Withdrawal by Subject|12|||
170575374|NCT01734785|616451550|FG000|Open-Label Period|Other Reasons|0|||
170575375|NCT01734785|616451551|FG001|Open-Label Period|Other Reasons|0|||
170575376|NCT01734785|616451552|FG002|Open-Label Period|Other Reasons|0|||
170575377|NCT01734785|616451553|FG003|Open-Label Period|Other Reasons|224|||
170575378|NCT01734785|616451550|FG000|Double-Blind Period|Adverse Event|0|||
170575379|NCT01734785|616451551|FG001|Double-Blind Period|Adverse Event|3|||
170575380|NCT01734785|616451552|FG002|Double-Blind Period|Adverse Event|2|||
170575381|NCT01734785|616451553|FG003|Double-Blind Period|Adverse Event|0|||
170575382|NCT01734785|616451550|FG000|Double-Blind Period|Lack of Efficacy|0|||
170575383|NCT01734785|616451551|FG001|Double-Blind Period|Lack of Efficacy|1|||
170575384|NCT01734785|616451552|FG002|Double-Blind Period|Lack of Efficacy|0|||
170575385|NCT01734785|616451553|FG003|Double-Blind Period|Lack of Efficacy|0|||
170575386|NCT01734785|616451550|FG000|Double-Blind Period|Protocol Violation|0|||
170575387|NCT01734785|616451551|FG001|Double-Blind Period|Protocol Violation|1|||
170575388|NCT01734785|616451552|FG002|Double-Blind Period|Protocol Violation|1|||
170575389|NCT01734785|616451553|FG003|Double-Blind Period|Protocol Violation|0|||
170575390|NCT01734785|616451550|FG000|Double-Blind Period|Lost to Follow-up|2|||
170575391|NCT01734785|616451551|FG001|Double-Blind Period|Lost to Follow-up|4|||
170909746|NCT03519178|617673578|FG001|Long-term Follow-up|Other|0|||
170909747|NCT03519178|617673579|FG002|Long-term Follow-up|Other|0|||
170909748|NCT03519178|617673580|FG003|Long-term Follow-up|Other|0|||
170909749|NCT03519178|617673581|FG004|Long-term Follow-up|Other|0|||
170909750|NCT03519178|617673582|FG005|Long-term Follow-up|Other|0|||
170909751|NCT03519178|617673583|FG006|Long-term Follow-up|Other|0|||
170909752|NCT03519178|617673584|FG007|Long-term Follow-up|Other|0|||
170909753|NCT03519178|617673585|FG008|Long-term Follow-up|Other|0|||
170909754|NCT03519178|617673586|FG009|Long-term Follow-up|Other|0|||
170909755|NCT03519178|617673587|FG010|Long-term Follow-up|Other|0|||
170649442|NCT01551420|616729155|FG000|Home Use (Part B)|Withdrawal by staff|0|||
170649443|NCT01551420|616729156|FG001|Home Use (Part B)|Withdrawal by staff|1|||
170649444|NCT00311584|616729157|FG000|Overall Study|Death|1|||
170909756|NCT03519178|617673588|FG011|Long-term Follow-up|Other|0|||
170909757|NCT03519178|617673589|FG012|Long-term Follow-up|Other|0|||
170909758|NCT03519178|617673590|FG013|Long-term Follow-up|Other|0|||
170909759|NCT03519178|617673591|FG014|Long-term Follow-up|Other|1|||
170909760|NCT03519178|617673577|FG000|Long-term Follow-up|Global deterioration of health status|0|||
170909761|NCT03519178|617673578|FG001|Long-term Follow-up|Global deterioration of health status|0|||
170909762|NCT03519178|617673579|FG002|Long-term Follow-up|Global deterioration of health status|0|||
170909763|NCT03519178|617673580|FG003|Long-term Follow-up|Global deterioration of health status|0|||
170575392|NCT01734785|616451552|FG002|Double-Blind Period|Lost to Follow-up|2|||
170575393|NCT01734785|616451553|FG003|Double-Blind Period|Lost to Follow-up|0|||
170575394|NCT01734785|616451550|FG000|Double-Blind Period|Withdrawal by Subject|2|||
170575395|NCT01734785|616451551|FG001|Double-Blind Period|Withdrawal by Subject|0|||
170575396|NCT01734785|616451552|FG002|Double-Blind Period|Withdrawal by Subject|0|||
170575397|NCT01734785|616451553|FG003|Double-Blind Period|Withdrawal by Subject|0|||
170575398|NCT01734785|616451550|FG000|Double-Blind Period|Not treated|1|||
170575399|NCT01734785|616451551|FG001|Double-Blind Period|Not treated|0|||
170575400|NCT01734785|616451552|FG002|Double-Blind Period|Not treated|0|||
170575401|NCT01734785|616451553|FG003|Double-Blind Period|Not treated|0|||
170649445|NCT00311584|616729158|FG001|Overall Study|Death|0|||
170909764|NCT03519178|617673581|FG004|Long-term Follow-up|Global deterioration of health status|0|||
170575402|NCT02397915|616451554|FG000|Period 1|Protocol Violation|0|||
170575403|NCT02397915|616451555|FG001|Period 1|Protocol Violation|1|||
170575404|NCT02397915|616451556|FG002|Period 1|Protocol Violation|0|||
170575405|NCT02397915|616451557|FG003|Period 1|Protocol Violation|0|||
170575406|NCT02397915|616451554|FG000|Period 1|Physician Decision|1|||
170575407|NCT02397915|616451555|FG001|Period 1|Physician Decision|0|||
170575408|NCT02397915|616451556|FG002|Period 1|Physician Decision|0|||
170575409|NCT02397915|616451557|FG003|Period 1|Physician Decision|0|||
170575410|NCT00368745|616451558|FG000|Double-blind Treatment Period|Adverse Event|6|||
170575411|NCT00368745|616451559|FG001|Double-blind Treatment Period|Adverse Event|6|||
170575412|NCT00368745|616451558|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
170575413|NCT00368745|616451559|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
170575414|NCT00368745|616451558|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
170575415|NCT00368745|616451559|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
170575416|NCT00368745|616451558|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
170575417|NCT00368745|616451559|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
170575418|NCT00368745|616451558|FG000|Double-blind Treatment Period|Other|7|||
170575419|NCT00368745|616451559|FG001|Double-blind Treatment Period|Other|6|||
170575420|NCT00293813|616451560|FG000|Overall Study|Physician Decision|0|||
170575421|NCT00293813|616451561|FG001|Overall Study|Physician Decision|1|||
170575422|NCT00293813|616451562|FG002|Overall Study|Physician Decision|0|||
170575423|NCT00293813|616451560|FG000|Overall Study|Adverse Event|3|||
170575424|NCT00293813|616451561|FG001|Overall Study|Adverse Event|1|||
170575425|NCT00293813|616451562|FG002|Overall Study|Adverse Event|1|||
170575426|NCT00293813|616451560|FG000|Overall Study|Withdrawal by Subject|7|||
170575427|NCT00293813|616451561|FG001|Overall Study|Withdrawal by Subject|4|||
170575428|NCT00293813|616451562|FG002|Overall Study|Withdrawal by Subject|4|||
170575429|NCT00293813|616451560|FG000|Overall Study|Lost to Follow-up|3|||
170575430|NCT00293813|616451561|FG001|Overall Study|Lost to Follow-up|2|||
170575431|NCT00293813|616451562|FG002|Overall Study|Lost to Follow-up|3|||
170575432|NCT00293813|616451560|FG000|Overall Study|Noncompliance|0|||
170575433|NCT00293813|616451561|FG001|Overall Study|Noncompliance|1|||
170575434|NCT00293813|616451562|FG002|Overall Study|Noncompliance|0|||
170575435|NCT01642901|616451563|FG000|12-month Follow-up|Withdrawal by Subject|1|||
170575436|NCT01642901|616451564|FG001|12-month Follow-up|Withdrawal by Subject|0|||
170575437|NCT00735553|616451565|FG000|Overall Study|Study prematurely terminated|77|||
170575438|NCT00770562|616451566|FG000|Overall Study|Did not take treatment|1|||
170575439|NCT00770562|616451567|FG001|Overall Study|Did not take treatment|1|||
170575440|NCT01194219|616451570|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
170575441|NCT01194219|616451571|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
170575442|NCT01194219|616451572|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
170575443|NCT01194219|616451573|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
170575444|NCT01194219|616451574|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
170575445|NCT01194219|616451575|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
170575446|NCT01194219|616451576|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
170575447|NCT01194219|616451577|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
170575448|NCT01194219|616451578|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
170575449|NCT01194219|616451579|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
170575450|NCT01194219|616451570|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
170575451|NCT01194219|616451571|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
170575452|NCT01194219|616451572|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
170575453|NCT01194219|616451573|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
170575454|NCT01194219|616451574|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
170575455|NCT01194219|616451575|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
170575456|NCT01194219|616451576|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
170575457|NCT01194219|616451577|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
170575458|NCT01194219|616451578|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
170575459|NCT01194219|616451579|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
170575460|NCT01194219|616451570|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
170575461|NCT01194219|616451571|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575462|NCT01194219|616451572|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575463|NCT01194219|616451573|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575464|NCT01194219|616451574|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575465|NCT01194219|616451575|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575466|NCT01194219|616451576|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575467|NCT01194219|616451577|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575468|NCT01194219|616451578|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575469|NCT01194219|616451579|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
170575470|NCT01194219|616451570|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
170575471|NCT01194219|616451571|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
170575472|NCT01194219|616451572|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
170575473|NCT01194219|616451573|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
170575474|NCT01194219|616451574|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
170575475|NCT01194219|616451575|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
170575476|NCT01194219|616451576|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
170575477|NCT01194219|616451577|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
170575478|NCT01194219|616451578|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
170575479|NCT01194219|616451579|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
170575480|NCT01194219|616451570|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575481|NCT01194219|616451571|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
170575482|NCT01194219|616451572|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575483|NCT01194219|616451573|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575484|NCT01194219|616451574|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575485|NCT01194219|616451575|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575486|NCT01194219|616451576|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575487|NCT01194219|616451577|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575488|NCT01194219|616451578|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575489|NCT01194219|616451579|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
170575490|NCT01194219|616451570|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
170575491|NCT01194219|616451571|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
170575492|NCT01194219|616451572|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
170575493|NCT01194219|616451573|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
170575494|NCT01194219|616451574|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
170575495|NCT01194219|616451575|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
170575496|NCT01194219|616451576|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
170575497|NCT01194219|616451577|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
170575498|NCT01194219|616451578|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
170575499|NCT01194219|616451579|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
170575500|NCT01194219|616451570|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
170649446|NCT00311584|616729157|FG000|Overall Study|Lack of Efficacy|12|||
170649447|NCT00311584|616729158|FG001|Overall Study|Lack of Efficacy|15|||
170808905|NCT00670449|617310424|FG000|Overall Study|Adverse Event|6|||
170808906|NCT00670449|617310425|FG001|Overall Study|Adverse Event|2|||
170808907|NCT00670449|617310426|FG002|Overall Study|Adverse Event|8|||
170808908|NCT00670449|617310427|FG003|Overall Study|Adverse Event|5|||
170808909|NCT00670449|617310424|FG000|Overall Study|Protocol Deviation|1|||
170808910|NCT00670449|617310425|FG001|Overall Study|Protocol Deviation|2|||
170808911|NCT00670449|617310426|FG002|Overall Study|Protocol Deviation|0|||
170808912|NCT00670449|617310427|FG003|Overall Study|Protocol Deviation|1|||
170808913|NCT00670449|617310424|FG000|Overall Study|Administrative Problems|0|||
170808914|NCT00670449|617310425|FG001|Overall Study|Administrative Problems|2|||
170808915|NCT00670449|617310426|FG002|Overall Study|Administrative Problems|0|||
170808916|NCT00670449|617310427|FG003|Overall Study|Administrative Problems|1|||
170575501|NCT01194219|616451571|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
170575502|NCT01194219|616451572|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
170808917|NCT00670449|617310424|FG000|Overall Study|Subject Withdrew Consent|0|||
170808918|NCT00670449|617310425|FG001|Overall Study|Subject Withdrew Consent|2|||
170808919|NCT00670449|617310426|FG002|Overall Study|Subject Withdrew Consent|0|||
170808920|NCT00670449|617310427|FG003|Overall Study|Subject Withdrew Consent|1|||
170808921|NCT00670449|617310424|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
170808922|NCT00670449|617310425|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170575503|NCT01194219|616451573|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
170575504|NCT01194219|616451574|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
170575505|NCT01194219|616451575|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
170575506|NCT01194219|616451576|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
170575507|NCT01194219|616451577|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
170575508|NCT01194219|616451578|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
170575509|NCT01194219|616451579|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
170575510|NCT01194219|616451570|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
170575511|NCT01194219|616451571|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
170575512|NCT01194219|616451572|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
170575513|NCT01194219|616451573|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
170575514|NCT01194219|616451574|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
170575515|NCT01194219|616451575|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
170575516|NCT01194219|616451576|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
170575517|NCT01194219|616451577|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
170575518|NCT01194219|616451578|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
170575519|NCT01194219|616451579|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
170575520|NCT01194219|616451570|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
170575521|NCT01194219|616451571|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
170575522|NCT01194219|616451572|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
170575523|NCT01194219|616451573|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
170575524|NCT01194219|616451574|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
170575525|NCT01194219|616451575|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
170575526|NCT01194219|616451576|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
170575527|NCT01194219|616451577|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
170575528|NCT01194219|616451578|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
170575529|NCT01194219|616451579|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
170575530|NCT01194219|616451570|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
170575531|NCT01194219|616451571|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
170575532|NCT01194219|616451572|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
170575533|NCT01194219|616451573|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
170575534|NCT01194219|616451574|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
170575535|NCT01194219|616451575|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
170575536|NCT01194219|616451576|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
170575537|NCT01194219|616451577|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
170575538|NCT01194219|616451578|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
170575539|NCT01194219|616451579|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
170575540|NCT01194219|616451570|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
170575541|NCT01194219|616451571|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
170575542|NCT01194219|616451572|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
170575543|NCT01194219|616451573|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
170575544|NCT01194219|616451574|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
170575545|NCT01194219|616451575|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
170575546|NCT01194219|616451576|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
170575547|NCT01194219|616451577|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
170575548|NCT01194219|616451578|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
170575549|NCT01194219|616451579|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
170575550|NCT01194219|616451570|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
170575551|NCT01194219|616451571|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
170575552|NCT01194219|616451572|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
170575553|NCT01194219|616451573|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
170575554|NCT01194219|616451574|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
170575555|NCT01194219|616451575|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
170575556|NCT01194219|616451576|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
170575557|NCT01194219|616451577|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
170808923|NCT00670449|617310426|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
170808924|NCT00670449|617310427|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170808925|NCT00670449|617310424|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
170808926|NCT00670449|617310425|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
170808927|NCT00670449|617310426|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
170808928|NCT00670449|617310427|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
170808929|NCT02637063|617310428|FG000|Overall Study|Lost to Follow-up|3|||
170808930|NCT02637063|617310429|FG001|Overall Study|Lost to Follow-up|2|||
170808931|NCT02637063|617310430|FG002|Overall Study|Lost to Follow-up|3|||
170808932|NCT02637063|617310428|FG000|Overall Study|Withdrawal by Subject|2|||
170808933|NCT02637063|617310429|FG001|Overall Study|Withdrawal by Subject|2|||
170808934|NCT02637063|617310430|FG002|Overall Study|Withdrawal by Subject|3|||
170808935|NCT00491400|617310431|FG000|Overall Study|Withdrawal by Subject|5|||
170808936|NCT00491400|617310432|FG001|Overall Study|Withdrawal by Subject|4|||
170808937|NCT02698475|617310433|FG000|Main Study Period|Lack of Efficacy|1|||
170575558|NCT01194219|616451578|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
170575559|NCT01194219|616451579|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
170575560|NCT01194219|616451570|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575561|NCT01194219|616451571|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575562|NCT01194219|616451572|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
170575563|NCT01194219|616451573|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575564|NCT01194219|616451574|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575565|NCT01194219|616451575|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575566|NCT01194219|616451576|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575567|NCT01194219|616451577|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575568|NCT01194219|616451578|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575569|NCT01194219|616451579|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
170575570|NCT01194219|616451570|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575571|NCT01194219|616451571|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575572|NCT01194219|616451572|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575573|NCT01194219|616451573|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
170575574|NCT01194219|616451574|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575575|NCT01194219|616451575|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575576|NCT01194219|616451576|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575577|NCT01194219|616451577|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575578|NCT01194219|616451578|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575579|NCT01194219|616451579|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
170575580|NCT01194219|616451570|FG000|Maintenance Phase Weeks16-32|Other|0|||
170575581|NCT01194219|616451571|FG001|Maintenance Phase Weeks16-32|Other|0|||
170575582|NCT01194219|616451572|FG002|Maintenance Phase Weeks16-32|Other|2|||
170575583|NCT01194219|616451573|FG003|Maintenance Phase Weeks16-32|Other|1|||
170575584|NCT01194219|616451574|FG004|Maintenance Phase Weeks16-32|Other|0|||
170575585|NCT01194219|616451575|FG005|Maintenance Phase Weeks16-32|Other|0|||
170575586|NCT01194219|616451576|FG006|Maintenance Phase Weeks16-32|Other|0|||
170575587|NCT01194219|616451577|FG007|Maintenance Phase Weeks16-32|Other|0|||
170575588|NCT01194219|616451578|FG008|Maintenance Phase Weeks16-32|Other|0|||
170575589|NCT01194219|616451579|FG009|Maintenance Phase Weeks16-32|Other|0|||
170575590|NCT01194219|616451570|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
170575591|NCT01194219|616451571|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
170575592|NCT01194219|616451572|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
170575593|NCT01194219|616451573|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
170575594|NCT01194219|616451574|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
170575595|NCT01194219|616451575|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
170575596|NCT01194219|616451576|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
170575597|NCT01194219|616451577|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
170575598|NCT01194219|616451578|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
170575599|NCT01194219|616451579|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
170575600|NCT01194219|616451570|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
170808938|NCT02698475|617310433|FG000|Main Study Period|Protocol Violation|2|||
170808939|NCT02698475|617310433|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
170808940|NCT02698475|617310433|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
170575601|NCT01194219|616451571|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
170575602|NCT01194219|616451572|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
170575603|NCT01194219|616451573|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
170575604|NCT01194219|616451574|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
170575605|NCT01194219|616451575|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
170575606|NCT01194219|616451576|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
170575607|NCT01194219|616451577|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
170575608|NCT01194219|616451578|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
170575609|NCT01194219|616451579|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
170575610|NCT01194219|616451570|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
170575611|NCT01194219|616451571|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
170575612|NCT01194219|616451572|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
170808941|NCT02698475|617310433|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
170808942|NCT02698475|617310433|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
170808943|NCT02698475|617310433|FG000|Long-Term Extension Period|Other|1|||
170808944|NCT02038049|617310438|FG000|Overall Study|Lost to Follow-up|1|||
170808945|NCT02038049|617310439|FG001|Overall Study|Lost to Follow-up|0|||
170808946|NCT02771366|617310440|FG000|Period 1|Withdrawal by Subject|0|||
170808947|NCT02771366|617310441|FG001|Period 1|Withdrawal by Subject|2|||
170909765|NCT03519178|617673582|FG005|Long-term Follow-up|Global deterioration of health status|0|||
170575613|NCT01194219|616451573|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
170575614|NCT01194219|616451574|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
170575615|NCT01194219|616451575|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
170575616|NCT01194219|616451576|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
170575617|NCT01194219|616451577|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
170575618|NCT01194219|616451578|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
170575619|NCT01194219|616451579|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
170575620|NCT01194219|616451570|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
170575621|NCT01194219|616451571|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
170575622|NCT01194219|616451572|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
170575623|NCT01194219|616451573|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
170575624|NCT01194219|616451574|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
170575625|NCT01194219|616451575|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
170575626|NCT01194219|616451576|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
170575627|NCT01194219|616451577|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
170575628|NCT01194219|616451578|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
170575629|NCT01194219|616451579|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
170575630|NCT01194219|616451570|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
170575631|NCT01194219|616451571|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
170575632|NCT01194219|616451572|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
170575633|NCT01194219|616451573|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
170575634|NCT01194219|616451574|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
170575635|NCT01194219|616451575|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
170575636|NCT01194219|616451576|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
170575637|NCT01194219|616451577|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
170575638|NCT01194219|616451578|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
170649448|NCT00311584|616729157|FG000|Overall Study|Physician Decision|4|||
170575639|NCT01194219|616451579|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
170575640|NCT01194219|616451570|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575641|NCT01194219|616451571|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575642|NCT01194219|616451572|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575643|NCT01194219|616451573|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575644|NCT01194219|616451574|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575645|NCT01194219|616451575|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575646|NCT01194219|616451576|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575647|NCT01194219|616451577|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
170575648|NCT01194219|616451578|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575649|NCT01194219|616451579|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
170575650|NCT01194219|616451570|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575651|NCT01194219|616451571|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575652|NCT01194219|616451572|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575653|NCT01194219|616451573|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575654|NCT01194219|616451574|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575655|NCT01194219|616451575|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575656|NCT01194219|616451576|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
170575657|NCT01194219|616451577|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575658|NCT01194219|616451578|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575659|NCT01194219|616451579|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
170575660|NCT01194219|616451570|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
170575661|NCT01194219|616451571|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
170575662|NCT01194219|616451572|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
170575663|NCT01194219|616451573|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
170575664|NCT01194219|616451574|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
170575665|NCT01194219|616451575|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
170575666|NCT01194219|616451576|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
170575667|NCT01194219|616451577|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
170575668|NCT01194219|616451578|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
170575669|NCT01194219|616451579|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
170575670|NCT01194219|616451570|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
170649449|NCT00311584|616729158|FG001|Overall Study|Physician Decision|5|||
170649450|NCT00311584|616729157|FG000|Overall Study|Withdrawal by Subject|1|||
170649451|NCT00311584|616729158|FG001|Overall Study|Withdrawal by Subject|1|||
170649452|NCT00311584|616729157|FG000|Overall Study|ineligible|2|||
170649453|NCT00311584|616729158|FG001|Overall Study|ineligible|2|||
170649454|NCT01525225|616729159|FG000|Enrollment|No longer met study criteria|1|||
170575671|NCT01194219|616451571|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
170575672|NCT01194219|616451572|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
170575673|NCT01194219|616451573|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
170575674|NCT01194219|616451574|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
170575675|NCT01194219|616451575|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
170575676|NCT01194219|616451576|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
170575677|NCT01194219|616451577|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
170575678|NCT01194219|616451578|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
170575679|NCT01194219|616451579|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
170575680|NCT01194219|616451570|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
170575681|NCT01194219|616451571|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
170575682|NCT01194219|616451572|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
170575683|NCT01194219|616451573|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
170575684|NCT01194219|616451574|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
170575685|NCT01194219|616451575|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
170575686|NCT01194219|616451576|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
170575687|NCT01194219|616451577|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
170575688|NCT01194219|616451578|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
170575689|NCT01194219|616451579|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
170575690|NCT01194219|616451570|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
170575691|NCT01194219|616451571|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
170575692|NCT01194219|616451572|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
170575693|NCT01194219|616451573|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
170575694|NCT01194219|616451574|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
170575695|NCT01194219|616451575|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
170575696|NCT01194219|616451576|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
170575697|NCT01194219|616451577|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
170575698|NCT01194219|616451578|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
170575699|NCT01194219|616451579|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
170575700|NCT01194219|616451570|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
170575701|NCT01194219|616451571|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
170575702|NCT01194219|616451572|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
170575703|NCT01194219|616451573|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
170575704|NCT01194219|616451574|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
170575705|NCT01194219|616451575|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
170575706|NCT01194219|616451576|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
170575707|NCT01194219|616451577|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
170575708|NCT01194219|616451578|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
170575709|NCT01194219|616451579|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
170575710|NCT01194219|616451570|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
170575711|NCT01194219|616451571|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
170575712|NCT01194219|616451572|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
170575713|NCT01194219|616451573|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
170575714|NCT01194219|616451574|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
170575715|NCT01194219|616451575|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
170575716|NCT01194219|616451576|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
170575717|NCT01194219|616451577|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
170575718|NCT01194219|616451578|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
170575719|NCT01194219|616451579|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
170575720|NCT01194219|616451570|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170575721|NCT01194219|616451571|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170575722|NCT01194219|616451572|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170575723|NCT01194219|616451573|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170575724|NCT01194219|616451574|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170575725|NCT01194219|616451575|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170575726|NCT01194219|616451576|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170575727|NCT01194219|616451577|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170575728|NCT01194219|616451578|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
170575729|NCT01194219|616451579|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
170808948|NCT02771366|617310440|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
170808949|NCT02771366|617310441|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
170575730|NCT01194219|616451570|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
170575731|NCT01194219|616451571|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
170575732|NCT01194219|616451572|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
170649455|NCT01525225|616729159|FG000|Enrollment|Other|1|||
170808950|NCT02660086|617310443|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
170808951|NCT02660086|617310444|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
170808952|NCT02660086|617310443|FG000|Overall Study- 12-month|Left full-time employment|12|||
170575733|NCT01194219|616451573|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
170575734|NCT01194219|616451574|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
170575735|NCT01194219|616451575|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
170575736|NCT01194219|616451576|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
170575737|NCT01194219|616451577|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
170575738|NCT01194219|616451578|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
170575739|NCT01194219|616451579|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
170575740|NCT00881530|616451581|FG000|Overall Study|Adverse Event|5|||
170575741|NCT00881530|616451582|FG001|Overall Study|Adverse Event|1|||
170575742|NCT00881530|616451583|FG002|Overall Study|Adverse Event|1|||
170575743|NCT00881530|616451584|FG003|Overall Study|Adverse Event|4|||
170575744|NCT00881530|616451585|FG004|Overall Study|Adverse Event|10|||
170909766|NCT03519178|617673583|FG006|Long-term Follow-up|Global deterioration of health status|0|||
170909767|NCT03519178|617673584|FG007|Long-term Follow-up|Global deterioration of health status|0|||
170909768|NCT03519178|617673585|FG008|Long-term Follow-up|Global deterioration of health status|0|||
170909769|NCT03519178|617673586|FG009|Long-term Follow-up|Global deterioration of health status|0|||
170909770|NCT03519178|617673587|FG010|Long-term Follow-up|Global deterioration of health status|0|||
170909771|NCT03519178|617673588|FG011|Long-term Follow-up|Global deterioration of health status|0|||
170909772|NCT03519178|617673589|FG012|Long-term Follow-up|Global deterioration of health status|0|||
170909773|NCT03519178|617673590|FG013|Long-term Follow-up|Global deterioration of health status|1|||
170909774|NCT03519178|617673591|FG014|Long-term Follow-up|Global deterioration of health status|0|||
170909775|NCT04358458|617673593|FG000|Overall Study|Death|1|||
170909776|NCT04358458|617673594|FG001|Overall Study|Death|1|||
170909777|NCT04358458|617673595|FG002|Overall Study|Death|3|||
170909778|NCT04358458|617673596|FG003|Overall Study|Death|8|||
170909779|NCT04358458|617673597|FG004|Overall Study|Death|1|||
170575745|NCT00881530|616451586|FG005|Overall Study|Adverse Event|2|||
170575746|NCT00881530|616451581|FG000|Overall Study|Lack of Efficacy|1|||
170575747|NCT00881530|616451582|FG001|Overall Study|Lack of Efficacy|0|||
170575748|NCT00881530|616451583|FG002|Overall Study|Lack of Efficacy|0|||
170575749|NCT00881530|616451584|FG003|Overall Study|Lack of Efficacy|0|||
170575750|NCT00881530|616451585|FG004|Overall Study|Lack of Efficacy|1|||
170575751|NCT00881530|616451586|FG005|Overall Study|Lack of Efficacy|1|||
170575752|NCT00881530|616451581|FG000|Overall Study|Not compliant with the protocol|0|||
170575753|NCT00881530|616451582|FG001|Overall Study|Not compliant with the protocol|0|||
170575754|NCT00881530|616451583|FG002|Overall Study|Not compliant with the protocol|0|||
170575755|NCT00881530|616451584|FG003|Overall Study|Not compliant with the protocol|0|||
170575756|NCT00881530|616451585|FG004|Overall Study|Not compliant with the protocol|2|||
170575757|NCT00881530|616451586|FG005|Overall Study|Not compliant with the protocol|0|||
170575758|NCT00881530|616451581|FG000|Overall Study|Lost to Follow-up|0|||
170575759|NCT00881530|616451582|FG001|Overall Study|Lost to Follow-up|1|||
170575760|NCT00881530|616451583|FG002|Overall Study|Lost to Follow-up|1|||
170575761|NCT00881530|616451584|FG003|Overall Study|Lost to Follow-up|3|||
170575762|NCT00881530|616451585|FG004|Overall Study|Lost to Follow-up|1|||
170575763|NCT00881530|616451586|FG005|Overall Study|Lost to Follow-up|0|||
170575764|NCT00881530|616451581|FG000|Overall Study|Refused to continue medication|7|||
170575765|NCT00881530|616451582|FG001|Overall Study|Refused to continue medication|2|||
170575766|NCT00881530|616451583|FG002|Overall Study|Refused to continue medication|1|||
170575767|NCT00881530|616451584|FG003|Overall Study|Refused to continue medication|2|||
170575768|NCT00881530|616451585|FG004|Overall Study|Refused to continue medication|0|||
170575769|NCT00881530|616451586|FG005|Overall Study|Refused to continue medication|0|||
170575770|NCT00881530|616451581|FG000|Overall Study|Other reason not defined above|1|||
170575771|NCT00881530|616451582|FG001|Overall Study|Other reason not defined above|1|||
170575772|NCT00881530|616451583|FG002|Overall Study|Other reason not defined above|2|||
170575773|NCT00881530|616451584|FG003|Overall Study|Other reason not defined above|0|||
170575774|NCT00881530|616451585|FG004|Overall Study|Other reason not defined above|0|||
170575775|NCT00881530|616451586|FG005|Overall Study|Other reason not defined above|2|||
170575776|NCT00003869|616451588|FG000|Overall Study|Adverse Event|14|||
170575777|NCT00003869|616451589|FG001|Overall Study|Adverse Event|3|||
170575778|NCT00003869|616451588|FG000|Overall Study|Withdrawal by Subject|21|||
170575779|NCT00003869|616451589|FG001|Overall Study|Withdrawal by Subject|3|||
170575780|NCT00003869|616451588|FG000|Overall Study|Death|1|||
170575781|NCT00003869|616451589|FG001|Overall Study|Death|2|||
170575782|NCT00003869|616451588|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
170575783|NCT00003869|616451589|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
170575784|NCT02544750|616451590|FG000|Overall Study|Physician Decision|3|||
170575785|NCT02544750|616451591|FG001|Overall Study|Physician Decision|1|||
170575786|NCT02544750|616451590|FG000|Overall Study|Other reasons|69|||
170909780|NCT04358458|617673598|FG005|Overall Study|Death|6|||
170909781|NCT04358458|617673599|FG006|Overall Study|Death|2|||
170575787|NCT02544750|616451591|FG001|Overall Study|Other reasons|39|||
170575788|NCT02544750|616451590|FG000|Overall Study|Met withdrawal criteria|2|||
170909782|NCT04358458|617673600|FG007|Overall Study|Death|3|||
170575789|NCT02544750|616451591|FG001|Overall Study|Met withdrawal criteria|2|||
170649456|NCT02656680|616730770|FG000|Overall Study|Lost to Follow-up|0|||
170575790|NCT02544750|616451590|FG000|Overall Study|Transition To Commercial Product|1|||
170575791|NCT02544750|616451591|FG001|Overall Study|Transition To Commercial Product|0|||
170575792|NCT02544750|616451590|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
170575793|NCT02544750|616451591|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
170575794|NCT02544750|616451590|FG000|Overall Study|Adverse Event|8|||
170575795|NCT02544750|616451591|FG001|Overall Study|Adverse Event|10|||
170575796|NCT02544750|616451590|FG000|Overall Study|Withdrawal by Subject|10|||
170575797|NCT02544750|616451591|FG001|Overall Study|Withdrawal by Subject|4|||
170575798|NCT02544750|616451590|FG000|Overall Study|Lost to Follow-up|1|||
170575799|NCT02544750|616451591|FG001|Overall Study|Lost to Follow-up|0|||
170575800|NCT03364231|616451592|FG000|Overall Study|Adverse Event|1|||
170575801|NCT03364231|616451593|FG001|Overall Study|Adverse Event|4|||
170575802|NCT03364231|616451592|FG000|Overall Study|Death|1|||
170575803|NCT03364231|616451593|FG001|Overall Study|Death|0|||
170575804|NCT03364231|616451592|FG000|Overall Study|Investigator Decision|2|||
170575805|NCT03364231|616451593|FG001|Overall Study|Investigator Decision|2|||
170575806|NCT03364231|616451592|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
170575807|NCT03364231|616451593|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
170575808|NCT03364231|616451592|FG000|Overall Study|Withdrawal of Subject Consent|1|||
170575809|NCT03364231|616451593|FG001|Overall Study|Withdrawal of Subject Consent|0|||
170575810|NCT03364231|616451592|FG000|Overall Study|Reason Not Specified|1|||
170575811|NCT03364231|616451593|FG001|Overall Study|Reason Not Specified|0|||
170575812|NCT03364231|616451592|FG000|Overall Study|Disease Progression|0|||
170575813|NCT03364231|616451593|FG001|Overall Study|Disease Progression|6|||
170575814|NCT00124072|616451598|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
170575815|NCT00124072|616451599|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
170575816|NCT00124072|616451600|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
170575817|NCT00124072|616451601|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
170575818|NCT00124072|616451598|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
170575819|NCT00124072|616451599|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
170575820|NCT00124072|616451600|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
170575821|NCT00124072|616451601|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
170575822|NCT00124072|616451598|FG000|Overall Study|Death|499|||
170575823|NCT00124072|616451599|FG001|Overall Study|Death|484|||
170575824|NCT00124072|616451600|FG002|Overall Study|Death|471|||
170575825|NCT00124072|616451601|FG003|Overall Study|Death|480|||
170575826|NCT00414076|616451602|FG000|Overall Study|Progression|1|||
170575827|NCT00414076|616451603|FG001|Overall Study|Progression|2|||
170575828|NCT00414076|616451602|FG000|Overall Study|Withdrawal by Subject|1|||
170575829|NCT00414076|616451603|FG001|Overall Study|Withdrawal by Subject|3|||
170575830|NCT00414076|616451602|FG000|Overall Study|Adverse Event|1|||
170575831|NCT00414076|616451603|FG001|Overall Study|Adverse Event|0|||
170575832|NCT00778336|616451604|FG000|Index Procedure-Discharge|Death|6|||
170575833|NCT00778336|616451605|FG001|Index Procedure-Discharge|Death|3|||
170575834|NCT00778336|616451606|FG002|Index Procedure-Discharge|Death|2|||
170575835|NCT00778336|616451607|FG003|Index Procedure-Discharge|Death|0|||
170575836|NCT00778336|616451604|FG000|3 Month Follow Up|Lost to Follow-up|15|||
170575837|NCT00778336|616451605|FG001|3 Month Follow Up|Lost to Follow-up|20|||
170575838|NCT00778336|616451606|FG002|3 Month Follow Up|Lost to Follow-up|3|||
170575839|NCT00778336|616451607|FG003|3 Month Follow Up|Lost to Follow-up|0|||
170575840|NCT00778336|616451604|FG000|3 Month Follow Up|Death|8|||
170575841|NCT00778336|616451605|FG001|3 Month Follow Up|Death|3|||
170575842|NCT00778336|616451606|FG002|3 Month Follow Up|Death|2|||
170575843|NCT00778336|616451607|FG003|3 Month Follow Up|Death|0|||
170575844|NCT04585269|616451613|FG000|Intervention|Withdrawal by Subject|9|||
170575845|NCT04585269|616451614|FG001|Intervention|Withdrawal by Subject|0|||
170575846|NCT04585269|616451613|FG000|Intervention|Unable to schedule|15|||
170575847|NCT04585269|616451614|FG001|Intervention|Unable to schedule|0|||
170575848|NCT04585269|616451613|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
170575849|NCT04585269|616451614|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
170575850|NCT04585269|616451613|FG000|FU Time 2 (3 months)|Death|2|||
170575851|NCT04585269|616451614|FG001|FU Time 2 (3 months)|Death|2|||
170575852|NCT04585269|616451613|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
170575853|NCT04585269|616451614|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
170575854|NCT04585269|616451613|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
170808953|NCT02660086|617310444|FG001|Overall Study- 12-month|Left full-time employment|20|||
170808954|NCT02660086|617310443|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
170808955|NCT02660086|617310444|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
170808956|NCT02660086|617310443|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
170808957|NCT02660086|617310444|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
170808958|NCT02660086|617310443|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
170808959|NCT02660086|617310444|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
170575855|NCT04585269|616451614|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
170575856|NCT04585269|616451613|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
170808960|NCT02660086|617310443|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
170808961|NCT02660086|617310444|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
170808962|NCT01377844|617310447|FG000|Overall Study|Withdrawal by Subject|25|||
170808963|NCT01377844|617310448|FG001|Overall Study|Withdrawal by Subject|28|||
170808964|NCT01377844|617310447|FG000|Overall Study|Protocol Violation|2|||
170808965|NCT01377844|617310448|FG001|Overall Study|Protocol Violation|3|||
170808966|NCT01377844|617310447|FG000|Overall Study|Adverse Event|3|||
170808967|NCT01377844|617310448|FG001|Overall Study|Adverse Event|0|||
170808968|NCT01377844|617310447|FG000|Overall Study|Physician Decision|6|||
170808969|NCT01377844|617310448|FG001|Overall Study|Physician Decision|3|||
170808970|NCT01377844|617310447|FG000|Overall Study|Study terminated by Sponsor|0|||
170808971|NCT01377844|617310448|FG001|Overall Study|Study terminated by Sponsor|1|||
170808972|NCT01214200|617310449|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
170808973|NCT01214200|617310449|FG000|Overall Study|Withdrawal by Subject|2|||
170808974|NCT02310581|617310450|FG000|Overall Study|Adverse Event|1|||
170808975|NCT02310581|617310451|FG001|Overall Study|Adverse Event|1|||
170808976|NCT02310581|617310452|FG002|Overall Study|Adverse Event|1|||
170808977|NCT02310581|617310453|FG003|Overall Study|Adverse Event|0|||
170808978|NCT02310581|617310450|FG000|Overall Study|Withdrawal by Subject|2|||
170808979|NCT02310581|617310451|FG001|Overall Study|Withdrawal by Subject|1|||
170808980|NCT02310581|617310452|FG002|Overall Study|Withdrawal by Subject|0|||
170808981|NCT02310581|617310453|FG003|Overall Study|Withdrawal by Subject|1|||
170808982|NCT04250636|617310454|FG000|Overall Study|Lost to Follow-up|2|||
170808983|NCT01779050|617310455|FG000|Overall Study|Withdrawal by Subject|1|||
170808984|NCT01779050|617310456|FG001|Overall Study|Withdrawal by Subject|0|||
170808985|NCT03403036|617310457|FG000|Overall Study|Lack of Efficacy|5|||
170808986|NCT01353274|617310458|FG000|Overall Study|No case report form (CRF) collected|28|||
170575857|NCT04585269|616451614|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
170575858|NCT04585269|616451613|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
170575859|NCT04585269|616451614|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
170575860|NCT04585269|616451613|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
170575861|NCT04585269|616451614|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
170575862|NCT03307785|616451617|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
170575863|NCT03307785|616451618|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575864|NCT03307785|616451619|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575865|NCT03307785|616451620|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575866|NCT03307785|616451621|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575867|NCT03307785|616451622|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575868|NCT03307785|616451623|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575869|NCT03307785|616451624|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575870|NCT03307785|616451625|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575871|NCT03307785|616451626|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575872|NCT03307785|616451627|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575873|NCT03307785|616451628|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575874|NCT03307785|616451629|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
170575875|NCT03307785|616451617|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
170575876|NCT03307785|616451618|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
170575877|NCT03307785|616451619|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575878|NCT03307785|616451620|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575879|NCT03307785|616451621|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575880|NCT03307785|616451622|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575881|NCT03307785|616451623|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170808987|NCT01409837|617310459|FG000|Overall Study|Withdrawal by Subject|2|||
170808988|NCT01409837|617310460|FG001|Overall Study|Withdrawal by Subject|1|||
170808989|NCT01409837|617310459|FG000|Overall Study|Lost to Follow-up|1|||
170808990|NCT01409837|617310460|FG001|Overall Study|Lost to Follow-up|0|||
170808991|NCT01409837|617310459|FG000|Overall Study|Physician Decision|0|||
170808992|NCT01409837|617310460|FG001|Overall Study|Physician Decision|1|||
170808993|NCT00022672|617310463|FG000|Main Phase: 24 Months|Adverse Event|6|||
170808994|NCT00022672|617310464|FG001|Main Phase: 24 Months|Adverse Event|0|||
170808995|NCT00022672|617310463|FG000|Main Phase: 24 Months|Death|0|||
170808996|NCT00022672|617310464|FG001|Main Phase: 24 Months|Death|3|||
170808997|NCT00022672|617310463|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
170575882|NCT03307785|616451624|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575883|NCT03307785|616451625|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170808998|NCT00022672|617310464|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
170808999|NCT00022672|617310463|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
170809000|NCT00022672|617310464|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
170809001|NCT00022672|617310463|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
170809002|NCT00022672|617310464|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
170809003|NCT00022672|617310463|FG000|Main Phase: 24 Months|Refused Treatment|3|||
170809004|NCT00022672|617310464|FG001|Main Phase: 24 Months|Refused Treatment|4|||
170575884|NCT03307785|616451626|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575885|NCT03307785|616451627|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575886|NCT03307785|616451628|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575887|NCT03307785|616451629|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
170575888|NCT03307785|616451617|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
170575889|NCT03307785|616451618|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
170575890|NCT03307785|616451619|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575891|NCT03307785|616451620|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575892|NCT03307785|616451621|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575893|NCT03307785|616451622|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575894|NCT03307785|616451623|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575895|NCT03307785|616451624|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575896|NCT03307785|616451625|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575897|NCT03307785|616451626|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575898|NCT03307785|616451627|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575899|NCT03307785|616451628|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575900|NCT03307785|616451629|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
170575901|NCT03307785|616451617|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
170575902|NCT03307785|616451618|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
170575903|NCT03307785|616451619|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575904|NCT03307785|616451620|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575905|NCT03307785|616451621|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575906|NCT03307785|616451622|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575907|NCT03307785|616451623|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575908|NCT03307785|616451624|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575909|NCT03307785|616451625|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575910|NCT03307785|616451626|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575911|NCT03307785|616451627|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575912|NCT03307785|616451628|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575913|NCT03307785|616451629|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
170575914|NCT03307785|616451617|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575915|NCT03307785|616451618|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575916|NCT03307785|616451619|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
170575917|NCT03307785|616451620|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575918|NCT03307785|616451621|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575919|NCT03307785|616451622|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575920|NCT03307785|616451623|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575921|NCT03307785|616451624|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575922|NCT03307785|616451625|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575923|NCT03307785|616451626|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575924|NCT03307785|616451627|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575925|NCT03307785|616451628|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575926|NCT03307785|616451629|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
170575927|NCT03307785|616451617|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575928|NCT03307785|616451618|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575929|NCT03307785|616451619|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
170575930|NCT03307785|616451620|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575931|NCT03307785|616451621|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575932|NCT03307785|616451622|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575933|NCT03307785|616451623|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575934|NCT03307785|616451624|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575935|NCT03307785|616451625|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575936|NCT03307785|616451626|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575937|NCT03307785|616451627|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575938|NCT03307785|616451628|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
170809005|NCT00022672|617310463|FG000|Main Phase: 24 Months|Failure to Return|1|||
170809006|NCT00022672|617310464|FG001|Main Phase: 24 Months|Failure to Return|1|||
170809007|NCT00022672|617310463|FG000|Main Phase: 24 Months|Other|1|||
170809008|NCT00022672|617310464|FG001|Main Phase: 24 Months|Other|0|||
170809009|NCT00022672|617310463|FG000|Extension Phase|Adverse Event|1|||
170809010|NCT00022672|617310464|FG001|Extension Phase|Adverse Event|3|||
170809011|NCT00022672|617310463|FG000|Extension Phase|Death|0|||
170809012|NCT00022672|617310464|FG001|Extension Phase|Death|1|||
170809013|NCT00022672|617310463|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
170809014|NCT00022672|617310464|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
170809015|NCT00022672|617310463|FG000|Extension Phase|Refused Treatment|0|||
170809016|NCT00022672|617310464|FG001|Extension Phase|Refused Treatment|2|||
170809017|NCT00022672|617310463|FG000|Extension Phase|Other|1|||
170575939|NCT03307785|616451629|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
170575940|NCT03307785|616451617|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170909783|NCT04358458|617673593|FG000|Overall Study|Lost to Follow-up|0|||
170909784|NCT04358458|617673594|FG001|Overall Study|Lost to Follow-up|0|||
170909785|NCT04358458|617673595|FG002|Overall Study|Lost to Follow-up|0|||
170909786|NCT04358458|617673596|FG003|Overall Study|Lost to Follow-up|0|||
170909787|NCT04358458|617673597|FG004|Overall Study|Lost to Follow-up|0|||
170909788|NCT04358458|617673598|FG005|Overall Study|Lost to Follow-up|0|||
170909789|NCT04358458|617673599|FG006|Overall Study|Lost to Follow-up|0|||
170575941|NCT03307785|616451618|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575942|NCT03307785|616451619|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
170575943|NCT03307785|616451620|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575944|NCT03307785|616451621|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575945|NCT03307785|616451622|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575946|NCT03307785|616451623|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575947|NCT03307785|616451624|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575948|NCT03307785|616451625|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575949|NCT03307785|616451626|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575950|NCT03307785|616451627|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575951|NCT03307785|616451628|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575952|NCT03307785|616451629|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
170575953|NCT03307785|616451617|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575954|NCT03307785|616451618|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575955|NCT03307785|616451619|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
170575956|NCT03307785|616451620|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575957|NCT03307785|616451621|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575958|NCT03307785|616451622|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575959|NCT03307785|616451623|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575960|NCT03307785|616451624|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575961|NCT03307785|616451625|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575962|NCT03307785|616451626|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575963|NCT03307785|616451627|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575964|NCT03307785|616451628|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575965|NCT03307785|616451629|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
170575966|NCT03307785|616451617|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575967|NCT03307785|616451618|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575968|NCT03307785|616451619|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
170909790|NCT04358458|617673600|FG007|Overall Study|Lost to Follow-up|1|||
170575969|NCT03307785|616451620|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575970|NCT03307785|616451621|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575971|NCT03307785|616451622|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575972|NCT03307785|616451623|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575973|NCT03307785|616451624|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575974|NCT03307785|616451625|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575975|NCT03307785|616451626|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575976|NCT03307785|616451627|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575977|NCT03307785|616451628|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575978|NCT03307785|616451629|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
170575979|NCT03307785|616451617|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575980|NCT03307785|616451618|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575981|NCT03307785|616451619|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575982|NCT03307785|616451620|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
170575983|NCT03307785|616451621|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
170575984|NCT03307785|616451622|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575985|NCT03307785|616451623|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575986|NCT03307785|616451624|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575987|NCT03307785|616451625|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170649457|NCT02656680|616730771|FG001|Overall Study|Lost to Follow-up|1|||
170649458|NCT02656680|616730772|FG002|Overall Study|Lost to Follow-up|7|||
170649459|NCT01095094|616730776|FG000|Overall Study|Withdrawal by Subject|1|||
170649460|NCT01095094|616730776|FG000|Overall Study|Death|1|||
170649461|NCT01095094|616730776|FG000|Overall Study|Physician Decision|1|||
170909791|NCT04358458|617673593|FG000|Overall Study|Site is closing study participation|0|||
170909792|NCT04358458|617673594|FG001|Overall Study|Site is closing study participation|0|||
170909793|NCT04358458|617673595|FG002|Overall Study|Site is closing study participation|0|||
170575988|NCT03307785|616451626|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575989|NCT03307785|616451627|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575990|NCT03307785|616451628|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575991|NCT03307785|616451629|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
170575992|NCT03307785|616451617|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
170575993|NCT03307785|616451618|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
170575994|NCT03307785|616451619|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
170575995|NCT03307785|616451620|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
170575996|NCT03307785|616451621|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
170575997|NCT03307785|616451622|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
170575998|NCT03307785|616451623|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
170575999|NCT03307785|616451624|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
170576000|NCT03307785|616451625|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
170576001|NCT03307785|616451626|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
170576002|NCT03307785|616451627|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
170576003|NCT03307785|616451628|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
170576004|NCT03307785|616451629|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
170576005|NCT03307785|616451617|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576006|NCT03307785|616451618|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576007|NCT03307785|616451619|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576008|NCT03307785|616451620|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
170576009|NCT03307785|616451621|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576010|NCT03307785|616451622|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576011|NCT03307785|616451623|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576012|NCT03307785|616451624|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576013|NCT03307785|616451625|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576014|NCT03307785|616451626|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576015|NCT03307785|616451627|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576016|NCT03307785|616451628|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576017|NCT03307785|616451629|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
170576018|NCT03307785|616451617|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576019|NCT03307785|616451618|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576020|NCT03307785|616451619|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576021|NCT03307785|616451620|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576022|NCT03307785|616451621|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
170576023|NCT03307785|616451622|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576024|NCT03307785|616451623|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576025|NCT03307785|616451624|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576026|NCT03307785|616451625|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576027|NCT03307785|616451626|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576028|NCT03307785|616451627|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576029|NCT03307785|616451628|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576030|NCT03307785|616451629|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
170576031|NCT03307785|616451617|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576032|NCT03307785|616451618|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576033|NCT03307785|616451619|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576034|NCT03307785|616451620|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576035|NCT03307785|616451621|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576036|NCT03307785|616451622|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
170576037|NCT03307785|616451623|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576038|NCT03307785|616451624|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576039|NCT03307785|616451625|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576040|NCT03307785|616451626|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576041|NCT03307785|616451627|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576042|NCT03307785|616451628|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576043|NCT03307785|616451629|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
170576044|NCT03307785|616451617|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576045|NCT03307785|616451618|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170809018|NCT00022672|617310464|FG001|Extension Phase|Other|1|||
170809019|NCT00599196|617310465|FG000|Overall Study|Lack of Efficacy|22|||
170809020|NCT00599196|617310465|FG000|Overall Study|Adverse Event|93|||
170809021|NCT00599196|617310465|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
170809022|NCT00599196|617310465|FG000|Overall Study|Subject withdrew consent|43|||
170809023|NCT00599196|617310465|FG000|Overall Study|Study ended per sponsor|197|||
170576046|NCT03307785|616451619|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576047|NCT03307785|616451620|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576048|NCT03307785|616451621|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576049|NCT03307785|616451622|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
170576050|NCT03307785|616451623|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576051|NCT03307785|616451624|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576052|NCT03307785|616451625|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576053|NCT03307785|616451626|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576054|NCT03307785|616451627|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576055|NCT03307785|616451628|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576056|NCT03307785|616451629|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
170576057|NCT03307785|616451617|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576058|NCT03307785|616451618|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576059|NCT03307785|616451619|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576060|NCT03307785|616451620|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576061|NCT03307785|616451621|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576062|NCT03307785|616451622|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
170576063|NCT03307785|616451623|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576064|NCT03307785|616451624|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576065|NCT03307785|616451625|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576066|NCT03307785|616451626|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576067|NCT03307785|616451627|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576068|NCT03307785|616451628|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576069|NCT03307785|616451629|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
170576070|NCT03307785|616451617|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576071|NCT03307785|616451618|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576072|NCT03307785|616451619|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576073|NCT03307785|616451620|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576074|NCT03307785|616451621|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576075|NCT03307785|616451622|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
170576076|NCT03307785|616451623|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576077|NCT03307785|616451624|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576078|NCT03307785|616451625|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576079|NCT03307785|616451626|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576080|NCT03307785|616451627|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576081|NCT03307785|616451628|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576082|NCT03307785|616451629|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
170576083|NCT03307785|616451617|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576084|NCT03307785|616451618|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576085|NCT03307785|616451619|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576086|NCT03307785|616451620|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576087|NCT03307785|616451621|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576088|NCT03307785|616451622|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
170576089|NCT03307785|616451623|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576090|NCT03307785|616451624|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576091|NCT03307785|616451625|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576092|NCT03307785|616451626|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576093|NCT03307785|616451627|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576094|NCT03307785|616451628|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576095|NCT03307785|616451629|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
170576096|NCT03307785|616451617|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576097|NCT03307785|616451618|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576098|NCT03307785|616451619|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576099|NCT03307785|616451620|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576100|NCT03307785|616451621|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576101|NCT03307785|616451622|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576102|NCT03307785|616451623|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
170576103|NCT03307785|616451624|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576104|NCT03307785|616451625|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576105|NCT03307785|616451626|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576106|NCT03307785|616451627|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576107|NCT03307785|616451628|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576108|NCT03307785|616451629|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
170576109|NCT03307785|616451617|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576110|NCT03307785|616451618|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576111|NCT03307785|616451619|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576112|NCT03307785|616451620|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576113|NCT03307785|616451621|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576114|NCT03307785|616451622|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576115|NCT03307785|616451623|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
170576116|NCT03307785|616451624|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576117|NCT03307785|616451625|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576118|NCT03307785|616451626|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576119|NCT03307785|616451627|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576120|NCT03307785|616451628|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576121|NCT03307785|616451629|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
170576122|NCT03307785|616451617|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576123|NCT03307785|616451618|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576124|NCT03307785|616451619|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576125|NCT03307785|616451620|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576126|NCT03307785|616451621|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576127|NCT03307785|616451622|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576128|NCT03307785|616451623|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576129|NCT03307785|616451624|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
170576130|NCT03307785|616451625|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576131|NCT03307785|616451626|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576132|NCT03307785|616451627|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576133|NCT03307785|616451628|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576134|NCT03307785|616451629|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
170576135|NCT03307785|616451617|FG000|PACT Phase: Up to 19 Months|Death|0|||
170576136|NCT03307785|616451618|FG001|PACT Phase: Up to 19 Months|Death|0|||
170576137|NCT03307785|616451619|FG002|PACT Phase: Up to 19 Months|Death|0|||
170576138|NCT03307785|616451620|FG003|PACT Phase: Up to 19 Months|Death|0|||
170576139|NCT03307785|616451621|FG004|PACT Phase: Up to 19 Months|Death|0|||
170576140|NCT03307785|616451622|FG005|PACT Phase: Up to 19 Months|Death|0|||
170576141|NCT03307785|616451623|FG006|PACT Phase: Up to 19 Months|Death|0|||
170576142|NCT03307785|616451624|FG007|PACT Phase: Up to 19 Months|Death|0|||
170576143|NCT03307785|616451625|FG008|PACT Phase: Up to 19 Months|Death|0|||
170576144|NCT03307785|616451626|FG009|PACT Phase: Up to 19 Months|Death|0|||
170576145|NCT03307785|616451627|FG010|PACT Phase: Up to 19 Months|Death|0|||
170576146|NCT03307785|616451628|FG011|PACT Phase: Up to 19 Months|Death|0|||
170576147|NCT03307785|616451629|FG012|PACT Phase: Up to 19 Months|Death|1|||
170576148|NCT02268383|616451635|FG000|Overall Study|Death|12|||
170576149|NCT02268383|616451635|FG000|Overall Study|Lost to Follow-up|2|||
170576150|NCT02268383|616451635|FG000|Overall Study|Withdrawal by Subject|9|||
170576151|NCT02268383|616451635|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
170576152|NCT02268383|616451635|FG000|Overall Study|Protocol deviation|3|||
170576153|NCT02268383|616451635|FG000|Overall Study|Sponsor decision|22|||
170576154|NCT02268383|616451635|FG000|Overall Study|Not reported|12|||
170576155|NCT00943761|616451638|FG000|Overall Study|Lost to Follow-up|2|||
170576156|NCT00943761|616451639|FG001|Overall Study|Lost to Follow-up|0|||
170809024|NCT00599196|617310465|FG000|Overall Study|Lost to Follow-up|17|||
170809025|NCT00599196|617310465|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
170809026|NCT00599196|617310465|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
170809027|NCT00599196|617310465|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
170576157|NCT00943761|616451638|FG000|Overall Study|Withdrawal by Subject|2|||
170576158|NCT00943761|616451639|FG001|Overall Study|Withdrawal by Subject|1|||
170809028|NCT00599196|617310465|FG000|Overall Study|Other: Pt Moved To Australia|1|||
170809029|NCT00599196|617310465|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
170809030|NCT00599196|617310465|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
170809031|NCT02575365|617310470|FG000|Overall Study|Lost to Follow-up|4|||
170909794|NCT04358458|617673596|FG003|Overall Study|Site is closing study participation|1|||
170909795|NCT04358458|617673597|FG004|Overall Study|Site is closing study participation|0|||
170909796|NCT04358458|617673598|FG005|Overall Study|Site is closing study participation|0|||
170909797|NCT04358458|617673599|FG006|Overall Study|Site is closing study participation|0|||
170909798|NCT04358458|617673600|FG007|Overall Study|Site is closing study participation|0|||
170909799|NCT04358458|617673593|FG000|Overall Study|Sponsor request|2|||
170909800|NCT04358458|617673594|FG001|Overall Study|Sponsor request|3|||
170909801|NCT04358458|617673595|FG002|Overall Study|Sponsor request|3|||
170576159|NCT04162470|616451642|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
170576160|NCT03382912|616451643|FG000|Overall Study|Physician Decision|0|||
170576161|NCT03382912|616451644|FG001|Overall Study|Physician Decision|1|||
170576162|NCT03382912|616451643|FG000|Overall Study|Sponsor Decision|6|||
170809032|NCT02392507|617310471|FG000|Induction Regimen|Death|3|||
170576163|NCT03382912|616451644|FG001|Overall Study|Sponsor Decision|6|||
170576164|NCT03382912|616451643|FG000|Overall Study|Withdrawal by Subject|0|||
170576165|NCT03382912|616451644|FG001|Overall Study|Withdrawal by Subject|5|||
170576166|NCT05588440|616451649|FG000|Overall Study|Sponsor Decision|2|||
170576167|NCT05588440|616451650|FG001|Overall Study|Sponsor Decision|0|||
170576168|NCT05588440|616451651|FG002|Overall Study|Sponsor Decision|1|||
170576169|NCT05588440|616451649|FG000|Overall Study|Death|1|||
170576170|NCT05588440|616451650|FG001|Overall Study|Death|1|||
170576171|NCT05588440|616451651|FG002|Overall Study|Death|1|||
170576172|NCT05588440|616451649|FG000|Overall Study|Screen Fail|0|||
170576173|NCT05588440|616451650|FG001|Overall Study|Screen Fail|1|||
170576174|NCT05588440|616451651|FG002|Overall Study|Screen Fail|1|||
170576175|NCT05588440|616451649|FG000|Overall Study|Withdrawal by Subject|0|||
170576176|NCT05588440|616451650|FG001|Overall Study|Withdrawal by Subject|0|||
170576177|NCT05588440|616451651|FG002|Overall Study|Withdrawal by Subject|1|||
170576178|NCT05526521|616451656|FG000|Overall Study|Withdrawal by Subject|0|||
170576179|NCT05526521|616451657|FG001|Overall Study|Withdrawal by Subject|1|||
170576180|NCT05526521|616451658|FG002|Overall Study|Withdrawal by Subject|0|||
170576181|NCT05526521|616451659|FG003|Overall Study|Withdrawal by Subject|0|||
170576182|NCT03929913|616451660|FG000|Overall Study|Death|4|||
170576183|NCT03929913|616451660|FG000|Overall Study|Lost to Follow-up|1|||
170576184|NCT03929913|616451660|FG000|Overall Study|Failed Procedure|2|||
170576185|NCT03919929|616451663|FG000|Overall Study|Withdrawal by Subject|0|||
170576186|NCT03919929|616451664|FG001|Overall Study|Withdrawal by Subject|4|||
170576187|NCT03919929|616451663|FG000|Overall Study|Screen Failure|0|||
170576188|NCT03919929|616451664|FG001|Overall Study|Screen Failure|5|||
170576189|NCT01402869|616451665|FG000|Overall Study|Required Tooth Extraction|0|||
170576190|NCT01402869|616451666|FG001|Overall Study|Required Tooth Extraction|0|||
170576191|NCT01402869|616451667|FG002|Overall Study|Required Tooth Extraction|1|||
170576192|NCT01154452|616451668|FG000|Phase Ib|Not Treated|1|||
170576193|NCT01154452|616451669|FG001|Phase Ib|Not Treated|0|||
170576194|NCT01154452|616451670|FG002|Phase Ib|Not Treated|0|||
170576195|NCT01154452|616451671|FG003|Phase Ib|Not Treated|0|||
170576196|NCT01154452|616451668|FG000|Phase Ib|Adverse Event|2|||
170576197|NCT01154452|616451669|FG001|Phase Ib|Adverse Event|1|||
170576198|NCT01154452|616451670|FG002|Phase Ib|Adverse Event|0|||
170576199|NCT01154452|616451671|FG003|Phase Ib|Adverse Event|0|||
170576200|NCT01154452|616451668|FG000|Phase II|Withdrawal by Subject|0|||
170576201|NCT01154452|616451669|FG001|Phase II|Withdrawal by Subject|0|||
170576202|NCT01154452|616451670|FG002|Phase II|Withdrawal by Subject|1|||
170576203|NCT01154452|616451671|FG003|Phase II|Withdrawal by Subject|2|||
170576204|NCT01154452|616451668|FG000|Phase II|Adverse Event|0|||
170576205|NCT01154452|616451669|FG001|Phase II|Adverse Event|0|||
170576206|NCT01154452|616451670|FG002|Phase II|Adverse Event|4|||
170576207|NCT01154452|616451671|FG003|Phase II|Adverse Event|4|||
170576208|NCT01544348|616451672|FG000|Overall Study|Lost to Follow-up|1|||
170576209|NCT01544348|616451673|FG001|Overall Study|Lost to Follow-up|0|||
170576210|NCT01544348|616451674|FG002|Overall Study|Lost to Follow-up|0|||
170576211|NCT01544348|616451675|FG003|Overall Study|Lost to Follow-up|0|||
170576212|NCT01544348|616451676|FG004|Overall Study|Lost to Follow-up|0|||
170576213|NCT01544348|616451677|FG005|Overall Study|Lost to Follow-up|0|||
170576214|NCT01544348|616451678|FG006|Overall Study|Lost to Follow-up|1|||
170576215|NCT01544348|616451679|FG007|Overall Study|Lost to Follow-up|0|||
170576216|NCT01544348|616451672|FG000|Overall Study|Withdrawal by Subject|1|||
170809033|NCT02392507|617310471|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
170809034|NCT02392507|617310471|FG000|Induction Regimen|Physician Decision|1|||
170809035|NCT02392507|617310471|FG000|Induction Regimen|Withdrawal by Subject|2|||
170809036|NCT02392507|617310471|FG000|Maintenance Regimen|Death|1|||
170809037|NCT02392507|617310471|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
170809038|NCT00273052|617310484|FG000|Overall Study|Withdrawal by Subject|16|||
170809039|NCT00273052|617310485|FG001|Overall Study|Withdrawal by Subject|19|||
170576217|NCT01544348|616451673|FG001|Overall Study|Withdrawal by Subject|0|||
170576218|NCT01544348|616451674|FG002|Overall Study|Withdrawal by Subject|0|||
170576219|NCT01544348|616451675|FG003|Overall Study|Withdrawal by Subject|0|||
170809040|NCT00273052|617310484|FG000|Overall Study|Adverse Event|21|||
170809041|NCT00273052|617310485|FG001|Overall Study|Adverse Event|19|||
170809042|NCT00273052|617310484|FG000|Overall Study|Protocol Violation|14|||
170809043|NCT00273052|617310485|FG001|Overall Study|Protocol Violation|18|||
170809044|NCT00273052|617310484|FG000|Overall Study|Lost to Follow-up|7|||
170576220|NCT01544348|616451676|FG004|Overall Study|Withdrawal by Subject|1|||
170576221|NCT01544348|616451677|FG005|Overall Study|Withdrawal by Subject|2|||
170576222|NCT01544348|616451678|FG006|Overall Study|Withdrawal by Subject|1|||
170576223|NCT01544348|616451679|FG007|Overall Study|Withdrawal by Subject|0|||
170576224|NCT01544348|616451672|FG000|Overall Study|Physician Decision|0|||
170576225|NCT01544348|616451673|FG001|Overall Study|Physician Decision|0|||
170576226|NCT01544348|616451674|FG002|Overall Study|Physician Decision|0|||
170576227|NCT01544348|616451675|FG003|Overall Study|Physician Decision|0|||
170576228|NCT01544348|616451676|FG004|Overall Study|Physician Decision|0|||
170576229|NCT01544348|616451677|FG005|Overall Study|Physician Decision|1|||
170576230|NCT01544348|616451678|FG006|Overall Study|Physician Decision|0|||
170576231|NCT01544348|616451679|FG007|Overall Study|Physician Decision|0|||
170576232|NCT00642707|616451680|FG000|Overall Study|Adverse Event|0|||
170576233|NCT00642707|616451681|FG001|Overall Study|Adverse Event|0|||
170576234|NCT00642707|616451682|FG002|Overall Study|Adverse Event|0|||
170576235|NCT00642707|616451683|FG003|Overall Study|Adverse Event|2|||
170576236|NCT00642707|616451680|FG000|Overall Study|Withdrawal by Subject|1|||
170576237|NCT00642707|616451681|FG001|Overall Study|Withdrawal by Subject|0|||
170576238|NCT00642707|616451682|FG002|Overall Study|Withdrawal by Subject|0|||
170576239|NCT00642707|616451683|FG003|Overall Study|Withdrawal by Subject|0|||
170576240|NCT02573948|616451686|FG000|Longitudinal Cohort|Death|9|||
170576241|NCT02573948|616451686|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
170576242|NCT02573948|616451686|FG000|Longitudinal Cohort|Incarcerated|25|||
170576243|NCT01837680|616451720|FG000|Overall Study|Lost to Follow-up|2|||
170576244|NCT01837680|616451721|FG001|Overall Study|Lost to Follow-up|2|||
170576245|NCT01837680|616451720|FG000|Overall Study|lack of insurance|0|||
170576246|NCT01837680|616451721|FG001|Overall Study|lack of insurance|2|||
170576247|NCT01837680|616451720|FG000|Overall Study|allergic reaction|6|||
170576248|NCT01837680|616451721|FG001|Overall Study|allergic reaction|0|||
170576249|NCT01837680|616451720|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
170576250|NCT01837680|616451721|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
170576251|NCT03960684|616451723|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
170576252|NCT03533660|616451724|FG000|Overall Study|Withdrawal by Subject|2|||
170576253|NCT03533660|616451725|FG001|Overall Study|Withdrawal by Subject|2|||
170576254|NCT03533660|616451724|FG000|Overall Study|Death|2|||
170576255|NCT03533660|616451725|FG001|Overall Study|Death|4|||
170576256|NCT03533660|616451724|FG000|Overall Study|Adverse Event|0|||
170576257|NCT03533660|616451725|FG001|Overall Study|Adverse Event|2|||
170576258|NCT05200572|616451728|FG000|Overall Study|Withdrawal by Subject|14|||
170576259|NCT01127607|616453749|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
170576260|NCT01127607|616453750|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
170576261|NCT01127607|616453749|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
170576262|NCT01127607|616453750|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
170576263|NCT01132651|616453751|FG000|Overall Study|Lost to Follow-up|1|||
170576264|NCT01132651|616453752|FG001|Overall Study|Lost to Follow-up|1|||
170576265|NCT05360966|616453753|FG000|Overall Study|Adverse Event|5|||
170576266|NCT05360966|616453754|FG001|Overall Study|Adverse Event|5|||
170576267|NCT05360966|616453753|FG000|Overall Study|Withdrawal of Consent|5|||
170576268|NCT05360966|616453754|FG001|Overall Study|Withdrawal of Consent|3|||
170576269|NCT05360966|616453753|FG000|Overall Study|Noncompliance|2|||
170576270|NCT05360966|616453754|FG001|Overall Study|Noncompliance|1|||
170576271|NCT05360966|616453753|FG000|Overall Study|Lost to Follow-up|2|||
170576272|NCT05360966|616453754|FG001|Overall Study|Lost to Follow-up|3|||
170576273|NCT05360966|616453753|FG000|Overall Study|Protocol Deviation|2|||
170576274|NCT05360966|616453754|FG001|Overall Study|Protocol Deviation|1|||
170809045|NCT00273052|617310485|FG001|Overall Study|Lost to Follow-up|25|||
170809046|NCT00273052|617310484|FG000|Overall Study|Lack of Efficacy|6|||
170809047|NCT00273052|617310485|FG001|Overall Study|Lack of Efficacy|4|||
170809048|NCT00273052|617310484|FG000|Overall Study|Non-Compliance|3|||
170809049|NCT00273052|617310485|FG001|Overall Study|Non-Compliance|1|||
170809050|NCT00273052|617310484|FG000|Overall Study|Other|2|||
170809051|NCT00273052|617310485|FG001|Overall Study|Other|0|||
170809052|NCT00273052|617310484|FG000|Overall Study|Worsening serum lipid levels|0|||
170809053|NCT00273052|617310485|FG001|Overall Study|Worsening serum lipid levels|2|||
170809054|NCT01951703|617310488|FG000|First Intervention|Withdrawal by Subject|1|||
170809055|NCT01951703|617310489|FG001|First Intervention|Withdrawal by Subject|0|||
170809056|NCT01951703|617310488|FG000|First Intervention|Subject was not compliant|1|||
170909802|NCT04358458|617673596|FG003|Overall Study|Sponsor request|0|||
170576275|NCT05360966|616453753|FG000|Overall Study|As specified in the Clinical Study Report|1|||
170576276|NCT05360966|616453754|FG001|Overall Study|As specified in the Clinical Study Report|3|||
170576277|NCT04439539|616453761|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
170576278|NCT04439539|616453762|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
170809057|NCT01951703|617310489|FG001|First Intervention|Subject was not compliant|1|||
170809058|NCT01951703|617310488|FG000|First Intervention|Physician Decision|1|||
170809059|NCT01951703|617310489|FG001|First Intervention|Physician Decision|0|||
170809060|NCT01951703|617310488|FG000|Second Intervention|Protocol Violation|0|||
170809061|NCT01951703|617310489|FG001|Second Intervention|Protocol Violation|1|||
170809062|NCT01951703|617310488|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
170809063|NCT01951703|617310489|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
170576279|NCT04439539|616453763|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
170576280|NCT04439539|616453761|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
170576281|NCT04439539|616453762|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
170576282|NCT04439539|616453763|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
170576283|NCT04439539|616453761|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
170576284|NCT04439539|616453762|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
170576285|NCT04439539|616453763|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
170576286|NCT01905943|616453764|FG000|Overall Study|Withdrawal of consent|90|||
170576287|NCT01905943|616453764|FG000|Overall Study|Lost to Follow-up|16|||
170576288|NCT01905943|616453764|FG000|Overall Study|Investigator discretion|7|||
170576289|NCT01905943|616453764|FG000|Overall Study|Death|186|||
170576290|NCT01905943|616453764|FG000|Overall Study|Adverse Event|3|||
170576291|NCT01905943|616453764|FG000|Overall Study|Other|12|||
170576292|NCT00590122|616453767|FG000|Overall Study|swallowed oral dissolving dose|1|||
170576293|NCT00590122|616453768|FG001|Overall Study|swallowed oral dissolving dose|0|||
170576294|NCT00603941|616453772|FG000|Overall Study|Disease progression|6|||
170576295|NCT00603941|616453773|FG001|Overall Study|Disease progression|7|||
170576296|NCT00603941|616453774|FG002|Overall Study|Disease progression|1|||
170576297|NCT00603941|616453772|FG000|Overall Study|Adverse Event|1|||
170576298|NCT00603941|616453773|FG001|Overall Study|Adverse Event|0|||
170576299|NCT00603941|616453774|FG002|Overall Study|Adverse Event|1|||
170576300|NCT00603941|616453772|FG000|Overall Study|Physician Decision|0|||
170576301|NCT00603941|616453773|FG001|Overall Study|Physician Decision|1|||
170576302|NCT00603941|616453774|FG002|Overall Study|Physician Decision|0|||
170576303|NCT00603941|616453772|FG000|Overall Study|Withdrawal by Subject|0|||
170576304|NCT00603941|616453773|FG001|Overall Study|Withdrawal by Subject|2|||
170576305|NCT00603941|616453774|FG002|Overall Study|Withdrawal by Subject|0|||
170576306|NCT03592771|616453775|FG000|Overall Study|Adverse Event|2|||
170576307|NCT03592771|616453776|FG001|Overall Study|Adverse Event|0|||
170576308|NCT03592771|616453777|FG002|Overall Study|Adverse Event|1|||
170576309|NCT03592771|616453775|FG000|Overall Study|Death|0|||
170576310|NCT03592771|616453776|FG001|Overall Study|Death|1|||
170576311|NCT03592771|616453777|FG002|Overall Study|Death|1|||
170576312|NCT03592771|616453775|FG000|Overall Study|Lost to Follow-up|5|||
170576313|NCT03592771|616453776|FG001|Overall Study|Lost to Follow-up|11|||
170576314|NCT03592771|616453777|FG002|Overall Study|Lost to Follow-up|15|||
170576315|NCT03592771|616453775|FG000|Overall Study|Withdrawal by Subject|0|||
170576316|NCT03592771|616453776|FG001|Overall Study|Withdrawal by Subject|2|||
170576317|NCT03592771|616453777|FG002|Overall Study|Withdrawal by Subject|0|||
170576318|NCT02707965|616453780|FG000|Overall Study|Withdrawal by Subject|0|||
170576319|NCT02707965|616453781|FG001|Overall Study|Withdrawal by Subject|0|||
170576320|NCT02707965|616453782|FG002|Overall Study|Withdrawal by Subject|1|||
170909803|NCT04358458|617673597|FG004|Overall Study|Sponsor request|2|||
170576321|NCT02707965|616453783|FG003|Overall Study|Withdrawal by Subject|0|||
170576322|NCT02707965|616453784|FG004|Overall Study|Withdrawal by Subject|0|||
170576323|NCT02707965|616453785|FG005|Overall Study|Withdrawal by Subject|0|||
170576324|NCT02707965|616453786|FG006|Overall Study|Withdrawal by Subject|0|||
170576325|NCT02707965|616453787|FG007|Overall Study|Withdrawal by Subject|2|||
170909804|NCT04358458|617673598|FG005|Overall Study|Sponsor request|3|||
170909805|NCT04358458|617673599|FG006|Overall Study|Sponsor request|1|||
170909806|NCT04358458|617673600|FG007|Overall Study|Sponsor request|1|||
170909807|NCT04358458|617673593|FG000|Overall Study|Withdrawal by Subject|0|||
170909808|NCT04358458|617673594|FG001|Overall Study|Withdrawal by Subject|0|||
170909809|NCT04358458|617673595|FG002|Overall Study|Withdrawal by Subject|1|||
170909810|NCT04358458|617673596|FG003|Overall Study|Withdrawal by Subject|1|||
170909811|NCT04358458|617673597|FG004|Overall Study|Withdrawal by Subject|0|||
170909812|NCT04358458|617673598|FG005|Overall Study|Withdrawal by Subject|1|||
170909813|NCT04358458|617673599|FG006|Overall Study|Withdrawal by Subject|0|||
170909814|NCT04358458|617673600|FG007|Overall Study|Withdrawal by Subject|1|||
170909815|NCT04636177|617673601|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
170909816|NCT04636177|617673602|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
170909817|NCT04636177|617673601|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
170576326|NCT02707965|616453788|FG008|Overall Study|Withdrawal by Subject|0|||
170576327|NCT02707965|616453789|FG009|Overall Study|Withdrawal by Subject|0|||
170576328|NCT02707965|616453790|FG010|Overall Study|Withdrawal by Subject|0|||
170576329|NCT02707965|616453791|FG011|Overall Study|Withdrawal by Subject|0|||
170576330|NCT02707965|616453792|FG012|Overall Study|Withdrawal by Subject|0|||
170909818|NCT04636177|617673602|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
170909819|NCT04636177|617673601|FG000|Single-arm portion|Withdrawal by Subject|1|||
170576331|NCT02707965|616453793|FG013|Overall Study|Withdrawal by Subject|0|||
170576332|NCT02707965|616453794|FG014|Overall Study|Withdrawal by Subject|0|||
170576333|NCT02707965|616453795|FG015|Overall Study|Withdrawal by Subject|0|||
170576334|NCT02707965|616453780|FG000|Overall Study|PI decisions|0|||
170576335|NCT02707965|616453781|FG001|Overall Study|PI decisions|0|||
170576336|NCT02707965|616453782|FG002|Overall Study|PI decisions|0|||
170576337|NCT02707965|616453783|FG003|Overall Study|PI decisions|0|||
170909820|NCT04636177|617673602|FG001|Single-arm portion|Withdrawal by Subject|0|||
170909821|NCT04636177|617673601|FG000|Single-arm portion|Adverse Event|1|||
170909822|NCT04636177|617673602|FG001|Single-arm portion|Adverse Event|0|||
170576338|NCT02707965|616453784|FG004|Overall Study|PI decisions|0|||
170576339|NCT02707965|616453785|FG005|Overall Study|PI decisions|0|||
170576340|NCT02707965|616453786|FG006|Overall Study|PI decisions|0|||
170576341|NCT02707965|616453787|FG007|Overall Study|PI decisions|0|||
170576342|NCT02707965|616453788|FG008|Overall Study|PI decisions|0|||
170576343|NCT02707965|616453789|FG009|Overall Study|PI decisions|0|||
170576344|NCT02707965|616453790|FG010|Overall Study|PI decisions|0|||
170576345|NCT02707965|616453791|FG011|Overall Study|PI decisions|0|||
170576346|NCT02707965|616453792|FG012|Overall Study|PI decisions|0|||
170576347|NCT02707965|616453793|FG013|Overall Study|PI decisions|0|||
170576348|NCT02707965|616453794|FG014|Overall Study|PI decisions|2|||
170576349|NCT02707965|616453795|FG015|Overall Study|PI decisions|0|||
170576350|NCT02707965|616453780|FG000|Overall Study|Protocol deviation|1|||
170576351|NCT02707965|616453781|FG001|Overall Study|Protocol deviation|1|||
170576352|NCT02707965|616453782|FG002|Overall Study|Protocol deviation|0|||
170576353|NCT02707965|616453783|FG003|Overall Study|Protocol deviation|0|||
170576354|NCT02707965|616453784|FG004|Overall Study|Protocol deviation|0|||
170576355|NCT02707965|616453785|FG005|Overall Study|Protocol deviation|0|||
170576356|NCT02707965|616453786|FG006|Overall Study|Protocol deviation|0|||
170576357|NCT02707965|616453787|FG007|Overall Study|Protocol deviation|1|||
170576358|NCT02707965|616453788|FG008|Overall Study|Protocol deviation|0|||
170576359|NCT02707965|616453789|FG009|Overall Study|Protocol deviation|0|||
170576360|NCT02707965|616453790|FG010|Overall Study|Protocol deviation|0|||
170576361|NCT02707965|616453791|FG011|Overall Study|Protocol deviation|0|||
170576362|NCT02707965|616453792|FG012|Overall Study|Protocol deviation|0|||
170576363|NCT02707965|616453793|FG013|Overall Study|Protocol deviation|0|||
170576364|NCT02707965|616453794|FG014|Overall Study|Protocol deviation|0|||
170576365|NCT02707965|616453795|FG015|Overall Study|Protocol deviation|0|||
170576366|NCT00249808|616453797|FG000|Overall Study|Other|27|||
170576367|NCT00249808|616453797|FG000|Overall Study|Protocol Violation|3|||
170576368|NCT00249808|616453797|FG000|Overall Study|Lost to Follow-up|8|||
170576369|NCT00249808|616453797|FG000|Overall Study|Adverse Event|81|||
170576370|NCT00249808|616453797|FG000|Overall Study|Lack of Efficacy|52|||
170576371|NCT00249808|616453797|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
170576372|NCT00711594|616453798|FG000|Overall Study|Progressive disease|2|||
170576373|NCT00711594|616453799|FG001|Overall Study|Progressive disease|2|||
170576374|NCT00711594|616453800|FG002|Overall Study|Progressive disease|6|||
170576375|NCT00711594|616453801|FG003|Overall Study|Progressive disease|44|||
170576376|NCT00711594|616453798|FG000|Overall Study|Other Adverse Event|1|||
170576377|NCT00711594|616453799|FG001|Overall Study|Other Adverse Event|0|||
170576378|NCT00711594|616453800|FG002|Overall Study|Other Adverse Event|0|||
170576379|NCT00711594|616453801|FG003|Overall Study|Other Adverse Event|16|||
170576380|NCT00711594|616453798|FG000|Overall Study|Withdrawal by Subject|0|||
170576381|NCT00711594|616453799|FG001|Overall Study|Withdrawal by Subject|1|||
170576382|NCT00711594|616453800|FG002|Overall Study|Withdrawal by Subject|0|||
170576383|NCT00711594|616453801|FG003|Overall Study|Withdrawal by Subject|2|||
170576384|NCT00310375|616453802|FG000|Primary Reporting Phase|Adverse Event|28|||
170576385|NCT00310375|616453803|FG001|Primary Reporting Phase|Adverse Event|22|||
170576386|NCT00310375|616453804|FG002|Primary Reporting Phase|Adverse Event|0|||
170576387|NCT00310375|616453802|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
170576388|NCT00310375|616453803|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
170576389|NCT00310375|616453804|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
170576390|NCT00310375|616453802|FG000|Primary Reporting Phase|Pregnancy|2|||
170576391|NCT00310375|616453803|FG001|Primary Reporting Phase|Pregnancy|2|||
170909823|NCT00744055|617674638|FG000|Overall Study|Withdrawal by Subject|6|||
170909824|NCT00744055|617674639|FG001|Overall Study|Withdrawal by Subject|9|||
170909825|NCT00744055|617674638|FG000|Overall Study|Lack of Efficacy|0|||
170909826|NCT00744055|617674639|FG001|Overall Study|Lack of Efficacy|1|||
170909827|NCT00744055|617674638|FG000|Overall Study|Physician Decision|0|||
170909828|NCT00744055|617674639|FG001|Overall Study|Physician Decision|2|||
170909829|NCT00744055|617674638|FG000|Overall Study|Protocol Violation|1|||
170909830|NCT00744055|617674639|FG001|Overall Study|Protocol Violation|1|||
170909831|NCT00744055|617674638|FG000|Overall Study|Lost to Follow-up|0|||
170576392|NCT00310375|616453804|FG002|Primary Reporting Phase|Pregnancy|0|||
170576393|NCT00310375|616453802|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
170576394|NCT00310375|616453803|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
170576395|NCT00310375|616453804|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
170576396|NCT00310375|616453802|FG000|Primary Reporting Phase|Protocol Violation|8|||
170576397|NCT00310375|616453803|FG001|Primary Reporting Phase|Protocol Violation|5|||
170576398|NCT00310375|616453804|FG002|Primary Reporting Phase|Protocol Violation|0|||
170576399|NCT00310375|616453802|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
170576400|NCT00310375|616453803|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
170576401|NCT00310375|616453804|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
170576402|NCT00310375|616453802|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
170576403|NCT00310375|616453803|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
170909832|NCT00744055|617674639|FG001|Overall Study|Lost to Follow-up|1|||
170909833|NCT05248945|617674640|FG000|Overall Study|Adverse Event|1|||
170909834|NCT05248945|617674640|FG000|Overall Study|Elevated Gamma-Glutamyl Transferase (GGT)|1|||
170909835|NCT05525975|617674641|FG000|Overall Study|Surgery cancellation|4|||
170909836|NCT05525975|617674642|FG001|Overall Study|Surgery cancellation|5|||
170909837|NCT05525975|617674641|FG000|Overall Study|didn't fill prescription|1|||
170909838|NCT05525975|617674642|FG001|Overall Study|didn't fill prescription|0|||
170909839|NCT05525975|617674641|FG000|Overall Study|Withdrawal by Subject|0|||
170909840|NCT05525975|617674642|FG001|Overall Study|Withdrawal by Subject|3|||
170909841|NCT01123889|617674643|FG000|Overall Study|Lost to Follow-up|3|||
170909842|NCT01123889|617674644|FG001|Overall Study|Lost to Follow-up|1|||
170909843|NCT01494038|617674645|FG000|Overall Study|Protocol Violation|1|||
170909844|NCT01494038|617674646|FG001|Overall Study|Protocol Violation|1|||
170909845|NCT01494038|617674645|FG000|Overall Study|Lost to Follow-up|18|||
170909846|NCT01494038|617674646|FG001|Overall Study|Lost to Follow-up|20|||
170909847|NCT01494038|617674645|FG000|Overall Study|Withdrawal by Subject|44|||
170909848|NCT01494038|617674646|FG001|Overall Study|Withdrawal by Subject|34|||
170909849|NCT01494038|617674645|FG000|Overall Study|Not able to get to clinic|21|||
170909850|NCT01494038|617674646|FG001|Overall Study|Not able to get to clinic|15|||
170909851|NCT01494038|617674645|FG000|Overall Study|Not willing to adhere to reqs|2|||
170909852|NCT01494038|617674646|FG001|Overall Study|Not willing to adhere to reqs|9|||
170909853|NCT01494038|617674645|FG000|Overall Study|Death|2|||
170909854|NCT01494038|617674646|FG001|Overall Study|Death|4|||
170909855|NCT05090423|617674647|FG000|Overall Study|Because of the covid-19|3|||
170909856|NCT05090423|617674648|FG001|Overall Study|Because of the covid-19|2|||
170909857|NCT05090423|617674647|FG000|Overall Study|repeated ankle sprain in daily of life|0|||
170576404|NCT00310375|616453804|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
170576405|NCT00310375|616453802|FG000|Primary Reporting Phase|Physician Decision|5|||
170576406|NCT00310375|616453803|FG001|Primary Reporting Phase|Physician Decision|3|||
170576407|NCT00310375|616453804|FG002|Primary Reporting Phase|Physician Decision|0|||
170576408|NCT00310375|616453802|FG000|Primary Reporting Phase|Request of the sponsor|2|||
170576409|NCT00310375|616453803|FG001|Primary Reporting Phase|Request of the sponsor|2|||
170576410|NCT00310375|616453804|FG002|Primary Reporting Phase|Request of the sponsor|0|||
170576411|NCT00310375|616453802|FG000|Primary Reporting Phase|Failed to return|1|||
170576412|NCT00310375|616453803|FG001|Primary Reporting Phase|Failed to return|3|||
170576413|NCT00310375|616453804|FG002|Primary Reporting Phase|Failed to return|0|||
170576414|NCT00310375|616453802|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
170576415|NCT00310375|616453803|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
170576416|NCT00310375|616453804|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
170576417|NCT00310375|616453802|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
170576418|NCT00310375|616453803|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
170576419|NCT00310375|616453804|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
170576420|NCT00310375|616453802|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
170576421|NCT00310375|616453803|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
170576422|NCT00310375|616453804|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
170576423|NCT00310375|616453802|FG000|Primary Reporting Phase|Site closure|3|||
170576424|NCT00310375|616453803|FG001|Primary Reporting Phase|Site closure|0|||
170576425|NCT00310375|616453804|FG002|Primary Reporting Phase|Site closure|0|||
170576426|NCT00310375|616453802|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
170576427|NCT00310375|616453803|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
170576428|NCT00310375|616453804|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
170576429|NCT00310375|616453802|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
170576430|NCT00310375|616453803|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
170576431|NCT00310375|616453804|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
170576432|NCT00310375|616453802|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
170576433|NCT00310375|616453803|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
170576434|NCT00310375|616453804|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
170576435|NCT00310375|616453802|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
170649462|NCT00464490|616730779|FG000|Overall Study|Physician Decision|11|||
170909858|NCT05090423|617674648|FG001|Overall Study|repeated ankle sprain in daily of life|1|||
170909859|NCT05733286|617674651|FG000|Overall Study|Never received study drug|2|||
170909860|NCT05733286|617674652|FG001|Overall Study|Never received study drug|3|||
170909861|NCT02138110|617674660|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
170909862|NCT02138110|617674660|FG000|Overall Scaffold Implantation|Death|3|||
170909863|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
170909864|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
170576436|NCT00310375|616453803|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
170576437|NCT00310375|616453804|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
170909865|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
170909866|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
170909867|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
170809064|NCT01009645|617310490|FG000|Overall Study|Lost to Follow-up|2|||
170809065|NCT01009645|617310491|FG001|Overall Study|Lost to Follow-up|8|||
170809066|NCT01009645|617310492|FG002|Overall Study|Lost to Follow-up|4|||
170809067|NCT01009645|617310493|FG003|Overall Study|Lost to Follow-up|5|||
170809068|NCT00487240|617310494|FG000|Overall Study|Withdrawal by Subject|12|||
170809069|NCT00487240|617310495|FG001|Overall Study|Withdrawal by Subject|6|||
170809070|NCT00487240|617310494|FG000|Overall Study|Lost to Follow-up|7|||
170809071|NCT00487240|617310495|FG001|Overall Study|Lost to Follow-up|6|||
170809072|NCT00487240|617310494|FG000|Overall Study|Adverse Event|0|||
170809073|NCT00487240|617310495|FG001|Overall Study|Adverse Event|4|||
170809074|NCT00487240|617310494|FG000|Overall Study|Protocol Violation|5|||
170809075|NCT00487240|617310495|FG001|Overall Study|Protocol Violation|5|||
170809076|NCT00487240|617310494|FG000|Overall Study|Entry Criteria Not Met|3|||
170809077|NCT00487240|617310495|FG001|Overall Study|Entry Criteria Not Met|4|||
170809078|NCT00487240|617310494|FG000|Overall Study|Sponsor Decision|2|||
170809079|NCT00487240|617310495|FG001|Overall Study|Sponsor Decision|1|||
170809080|NCT00487240|617310494|FG000|Overall Study|Physician Decision|2|||
170809081|NCT00487240|617310495|FG001|Overall Study|Physician Decision|0|||
170809082|NCT00439218|617310499|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
170809083|NCT04237792|617310500|FG000|Treatment (Day 1)|Adverse Event|1|||
170809084|NCT04237792|617310501|FG001|Treatment (Day 1)|Adverse Event|0|||
170809085|NCT04237792|617310502|FG002|Treatment (Day 1)|Adverse Event|0|||
170809086|NCT04237792|617310503|FG003|Treatment (Day 1)|Adverse Event|0|||
170809087|NCT04237792|617310504|FG004|Treatment (Day 1)|Adverse Event|1|||
170809088|NCT04237792|617310505|FG005|Treatment (Day 1)|Adverse Event|1|||
170576438|NCT04556591|616453805|FG000|Overall Study|Lost to Follow-up|1|||
170576439|NCT04556591|616453806|FG001|Overall Study|Lost to Follow-up|0|||
170576440|NCT04556591|616453805|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
170576441|NCT04556591|616453806|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
170576442|NCT00984165|616453807|FG000|Overall Study|Death on study|2|||
170576443|NCT00984165|616453808|FG001|Overall Study|Death on study|0|||
170576444|NCT00984165|616453809|FG002|Overall Study|Death on study|0|||
170576445|NCT00984165|616453810|FG003|Overall Study|Death on study|0|||
170576446|NCT00984165|616453807|FG000|Overall Study|Disease progression on study|5|||
170576447|NCT00984165|616453808|FG001|Overall Study|Disease progression on study|1|||
170576448|NCT00984165|616453809|FG002|Overall Study|Disease progression on study|0|||
170576449|NCT00984165|616453810|FG003|Overall Study|Disease progression on study|0|||
170576450|NCT00984165|616453807|FG000|Overall Study|Death of recipient|0|||
170576451|NCT00984165|616453808|FG001|Overall Study|Death of recipient|0|||
170576452|NCT00984165|616453809|FG002|Overall Study|Death of recipient|0|||
170576453|NCT00984165|616453810|FG003|Overall Study|Death of recipient|1|||
170576454|NCT00984165|616453807|FG000|Overall Study|New protocol|0|||
170576455|NCT00984165|616453808|FG001|Overall Study|New protocol|0|||
170576456|NCT00984165|616453809|FG002|Overall Study|New protocol|0|||
170576457|NCT00984165|616453810|FG003|Overall Study|New protocol|1|||
170576458|NCT00984165|616453807|FG000|Overall Study|P+/donor pair removed from protocol|0|||
170576459|NCT00984165|616453808|FG001|Overall Study|P+/donor pair removed from protocol|0|||
170576460|NCT00984165|616453809|FG002|Overall Study|P+/donor pair removed from protocol|0|||
170576461|NCT00984165|616453810|FG003|Overall Study|P+/donor pair removed from protocol|1|||
170576462|NCT00984165|616453807|FG000|Overall Study|removed with a pair recipient|0|||
170576463|NCT00984165|616453808|FG001|Overall Study|removed with a pair recipient|0|||
170576464|NCT00984165|616453809|FG002|Overall Study|removed with a pair recipient|0|||
170576465|NCT00984165|616453810|FG003|Overall Study|removed with a pair recipient|1|||
170576466|NCT03332173|616453811|FG000|Overall Study|Death|7|||
170576467|NCT03332173|616453811|FG000|Overall Study|Withdrawal by Subject|6|||
170576468|NCT03332173|616453811|FG000|Overall Study|Lost to Follow-up|2|||
170576469|NCT03332173|616453811|FG000|Overall Study|Transferred to long-term extension study|29|||
170576470|NCT04024436|616453812|FG000|Overall Study|Death|10|||
170576471|NCT04024436|616453813|FG001|Overall Study|Death|14|||
170576472|NCT04024436|616453814|FG002|Overall Study|Death|2|||
170576473|NCT04024436|616453815|FG003|Overall Study|Death|7|||
170576474|NCT04024436|616453812|FG000|Overall Study|Loss to follow up|1|||
170576475|NCT04024436|616453813|FG001|Overall Study|Loss to follow up|0|||
170576476|NCT04024436|616453814|FG002|Overall Study|Loss to follow up|0|||
170576477|NCT04024436|616453815|FG003|Overall Study|Loss to follow up|1|||
170576478|NCT04024436|616453812|FG000|Overall Study|Withdrawal of consent|2|||
170576479|NCT04024436|616453813|FG001|Overall Study|Withdrawal of consent|0|||
170576480|NCT04024436|616453814|FG002|Overall Study|Withdrawal of consent|0|||
170576481|NCT04024436|616453815|FG003|Overall Study|Withdrawal of consent|1|||
170576482|NCT04024436|616453812|FG000|Overall Study|Study termination by sponsor|4|||
170576483|NCT04024436|616453813|FG001|Overall Study|Study termination by sponsor|6|||
170576484|NCT04024436|616453814|FG002|Overall Study|Study termination by sponsor|2|||
170576485|NCT04024436|616453815|FG003|Overall Study|Study termination by sponsor|11|||
170809089|NCT04237792|617310500|FG000|Treatment (Day 1)|Other|0|||
170809090|NCT04237792|617310501|FG001|Treatment (Day 1)|Other|0|||
170809091|NCT04237792|617310502|FG002|Treatment (Day 1)|Other|1|||
170576486|NCT04024436|616453812|FG000|Overall Study|Reason Not Specified|0|||
170576487|NCT04024436|616453813|FG001|Overall Study|Reason Not Specified|1|||
170576488|NCT04024436|616453814|FG002|Overall Study|Reason Not Specified|0|||
170576489|NCT04024436|616453815|FG003|Overall Study|Reason Not Specified|2|||
170576490|NCT00540592|616453816|FG000|Overall Study|Adverse Event|0|||
170576491|NCT00540592|616453817|FG001|Overall Study|Adverse Event|1|||
170576492|NCT00540592|616453818|FG002|Overall Study|Adverse Event|0|||
170576493|NCT00540592|616453819|FG003|Overall Study|Adverse Event|0|||
170576494|NCT00540592|616453820|FG004|Overall Study|Adverse Event|1|||
170576495|NCT00540592|616453821|FG005|Overall Study|Adverse Event|0|||
170576496|NCT00540592|616453822|FG006|Overall Study|Adverse Event|0|||
170576497|NCT00540592|616453823|FG007|Overall Study|Adverse Event|1|||
170576498|NCT00540592|616453824|FG008|Overall Study|Adverse Event|1|||
170576499|NCT00540592|616453825|FG009|Overall Study|Adverse Event|2|||
170576500|NCT00540592|616453816|FG000|Overall Study|Lost to Follow-up|2|||
170576501|NCT00540592|616453817|FG001|Overall Study|Lost to Follow-up|0|||
170576502|NCT00540592|616453818|FG002|Overall Study|Lost to Follow-up|0|||
170576503|NCT00540592|616453819|FG003|Overall Study|Lost to Follow-up|0|||
170576504|NCT00540592|616453820|FG004|Overall Study|Lost to Follow-up|0|||
170576505|NCT00540592|616453821|FG005|Overall Study|Lost to Follow-up|0|||
170576506|NCT00540592|616453822|FG006|Overall Study|Lost to Follow-up|0|||
170576507|NCT00540592|616453823|FG007|Overall Study|Lost to Follow-up|0|||
170576508|NCT00540592|616453824|FG008|Overall Study|Lost to Follow-up|0|||
170576509|NCT00540592|616453825|FG009|Overall Study|Lost to Follow-up|0|||
170576510|NCT00540592|616453816|FG000|Overall Study|Withdrawal by Subject|0|||
170576511|NCT00540592|616453817|FG001|Overall Study|Withdrawal by Subject|0|||
170576512|NCT00540592|616453818|FG002|Overall Study|Withdrawal by Subject|1|||
170576513|NCT00540592|616453819|FG003|Overall Study|Withdrawal by Subject|1|||
170576514|NCT00540592|616453820|FG004|Overall Study|Withdrawal by Subject|0|||
170576515|NCT00540592|616453821|FG005|Overall Study|Withdrawal by Subject|0|||
170576516|NCT00540592|616453822|FG006|Overall Study|Withdrawal by Subject|0|||
170576517|NCT00540592|616453823|FG007|Overall Study|Withdrawal by Subject|0|||
170576518|NCT00540592|616453824|FG008|Overall Study|Withdrawal by Subject|0|||
170576519|NCT00540592|616453825|FG009|Overall Study|Withdrawal by Subject|0|||
170576520|NCT04908683|616453826|FG000|Overall Study|Failure to meet continuation criteria|34|||
170576521|NCT04908683|616453827|FG001|Overall Study|Failure to meet continuation criteria|22|||
170576522|NCT04908683|616453826|FG000|Overall Study|Initiated prohibited medication|3|||
170576523|NCT04908683|616453827|FG001|Overall Study|Initiated prohibited medication|0|||
170576524|NCT04908683|616453826|FG000|Overall Study|Randomized by mistake|1|||
170576525|NCT04908683|616453827|FG001|Overall Study|Randomized by mistake|0|||
170576526|NCT04908683|616453826|FG000|Overall Study|Lost to Follow-up|679|||
170576527|NCT04908683|616453827|FG001|Overall Study|Lost to Follow-up|341|||
170576528|NCT04908683|616453826|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
170576529|NCT04908683|616453827|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
170576530|NCT04908683|616453826|FG000|Overall Study|Physician Decision|44|||
170576531|NCT04908683|616453827|FG001|Overall Study|Physician Decision|35|||
170576532|NCT04908683|616453826|FG000|Overall Study|Technical problems|12|||
170576533|NCT04908683|616453827|FG001|Overall Study|Technical problems|9|||
170576534|NCT04908683|616453826|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
170576535|NCT04908683|616453827|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
170576536|NCT04908683|616453826|FG000|Overall Study|Protocol Violation|2|||
170576537|NCT04908683|616453827|FG001|Overall Study|Protocol Violation|0|||
170576538|NCT04908683|616453826|FG000|Overall Study|Withdrawal by Subject|1188|||
170576539|NCT04908683|616453827|FG001|Overall Study|Withdrawal by Subject|570|||
170576540|NCT04908683|616453826|FG000|Overall Study|Site Closure by Sponsor|6|||
170576541|NCT04908683|616453827|FG001|Overall Study|Site Closure by Sponsor|3|||
170576542|NCT04908683|616453826|FG000|Overall Study|Adverse Event|21|||
170576543|NCT04908683|616453827|FG001|Overall Study|Adverse Event|11|||
170576544|NCT04908683|616453826|FG000|Overall Study|Death|101|||
170576545|NCT04908683|616453827|FG001|Overall Study|Death|61|||
170576546|NCT04908683|616453826|FG000|Overall Study|Sponsor's decision|14398|||
170576547|NCT04908683|616453827|FG001|Overall Study|Sponsor's decision|7205|||
170576548|NCT04908683|616453826|FG000|Overall Study|Other|92|||
170576549|NCT04908683|616453827|FG001|Overall Study|Other|50|||
170576550|NCT04908683|616453826|FG000|Overall Study|Randomized not vaccinated|108|||
170576551|NCT04908683|616453827|FG001|Overall Study|Randomized not vaccinated|52|||
170576552|NCT05507567|616453828|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
170576553|NCT05507567|616453829|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
170576554|NCT05507567|616453830|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
170576555|NCT05507567|616453828|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
170576556|NCT05507567|616453829|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
170576557|NCT05507567|616453830|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
170649463|NCT00464490|616730780|FG001|Overall Study|Physician Decision|11|||
170576558|NCT05507567|616453828|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
170576559|NCT05507567|616453829|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
170576560|NCT05507567|616453830|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
170576561|NCT05507567|616453828|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
170576562|NCT05507567|616453829|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
170576563|NCT05507567|616453830|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
170576564|NCT01973231|616453831|FG000|Overall Study|Protocol Violation|1|||
170576565|NCT01973231|616453832|FG001|Overall Study|Protocol Violation|1|||
170576566|NCT01973231|616453831|FG000|Overall Study|Lost to Follow-up|1|||
170576567|NCT01973231|616453832|FG001|Overall Study|Lost to Follow-up|1|||
170576568|NCT01973231|616453831|FG000|Overall Study|unclassified|2|||
170576569|NCT01973231|616453832|FG001|Overall Study|unclassified|1|||
170576570|NCT01973231|616453831|FG000|Overall Study|Withdrawal by Subject|7|||
170576571|NCT01973231|616453832|FG001|Overall Study|Withdrawal by Subject|9|||
170576572|NCT01485796|616453833|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
170576573|NCT01485796|616453833|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
170576574|NCT01485796|616453833|FG000|Period 2: Epoch 2|Adverse Event|3|||
170576575|NCT01485796|616453833|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
170576576|NCT01485796|616453833|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
170576577|NCT01485796|616453833|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
170576578|NCT01485796|616453833|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
170576579|NCT01485796|616453833|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
170576580|NCT04830215|616453834|FG000|Overall Study|Adverse Event|6|||
170576581|NCT04830215|616453834|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
170576582|NCT04830215|616453834|FG000|Overall Study|Withdrawal by Subject|3|||
170576583|NCT04830215|616453834|FG000|Overall Study|Protocol Deviation|1|||
170576584|NCT05338710|616453838|FG000|Overall Study|Withdrawal by Subject|3|||
170576585|NCT02526212|616453839|FG000|Overall Study|Incarceration|1|||
170576586|NCT02526212|616453840|FG001|Overall Study|Incarceration|0|||
170576587|NCT02526212|616453839|FG000|Overall Study|Lost to Follow-up|1|||
170576588|NCT02526212|616453840|FG001|Overall Study|Lost to Follow-up|0|||
170576589|NCT02526212|616453839|FG000|Overall Study|Death|0|||
170576590|NCT02526212|616453840|FG001|Overall Study|Death|1|||
170576591|NCT00040742|616453841|FG000|Overall Study|Death|0|||
170576592|NCT00040742|616453842|FG001|Overall Study|Death|0|||
170576593|NCT00040742|616453843|FG002|Overall Study|Death|1|||
170576594|NCT00040742|616453844|FG003|Overall Study|Death|0|||
170576595|NCT00040742|616453841|FG000|Overall Study|Adverse Event|15|||
170576596|NCT00040742|616453842|FG001|Overall Study|Adverse Event|16|||
170576597|NCT00040742|616453843|FG002|Overall Study|Adverse Event|21|||
170576598|NCT00040742|616453844|FG003|Overall Study|Adverse Event|9|||
170576599|NCT00040742|616453841|FG000|Overall Study|Withdrawal by Subject|7|||
170576600|NCT00040742|616453842|FG001|Overall Study|Withdrawal by Subject|15|||
170576601|NCT00040742|616453843|FG002|Overall Study|Withdrawal by Subject|10|||
170576602|NCT00040742|616453844|FG003|Overall Study|Withdrawal by Subject|13|||
170576603|NCT00040742|616453841|FG000|Overall Study|Chemotoxicity|4|||
170576604|NCT00040742|616453842|FG001|Overall Study|Chemotoxicity|3|||
170576605|NCT00040742|616453843|FG002|Overall Study|Chemotoxicity|5|||
170576606|NCT00040742|616453844|FG003|Overall Study|Chemotoxicity|2|||
170576607|NCT00040742|616453841|FG000|Overall Study|Incomplete Forms|6|||
170809092|NCT04237792|617310503|FG003|Treatment (Day 1)|Other|0|||
170809093|NCT04237792|617310504|FG004|Treatment (Day 1)|Other|0|||
170809094|NCT04237792|617310505|FG005|Treatment (Day 1)|Other|1|||
170809095|NCT04237792|617310500|FG000|Treatment (Day 1)|Not treated|1|||
170809096|NCT04237792|617310501|FG001|Treatment (Day 1)|Not treated|1|||
170809097|NCT04237792|617310502|FG002|Treatment (Day 1)|Not treated|2|||
170576608|NCT00040742|616453842|FG001|Overall Study|Incomplete Forms|10|||
170576609|NCT00040742|616453843|FG002|Overall Study|Incomplete Forms|4|||
170576610|NCT00040742|616453844|FG003|Overall Study|Incomplete Forms|5|||
170576611|NCT00040742|616453841|FG000|Overall Study|Other medical|7|||
170576612|NCT00040742|616453842|FG001|Overall Study|Other medical|5|||
170576613|NCT00040742|616453843|FG002|Overall Study|Other medical|5|||
170576614|NCT00040742|616453844|FG003|Overall Study|Other medical|5|||
170576615|NCT02569476|616453845|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
170576616|NCT02569476|616453845|FG000|Overall Study|Death|33|||
170576617|NCT02569476|616453845|FG000|Overall Study|Withdrawal by Subject|9|||
170576618|NCT02569476|616453845|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
170576619|NCT02569476|616453845|FG000|Overall Study|Palliative care|1|||
170576620|NCT02569476|616453845|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
170576621|NCT02569476|616453845|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
170576622|NCT01340664|616453847|FG000|Overall Study|Adverse Event|0|||
170576623|NCT01340664|616453848|FG001|Overall Study|Adverse Event|1|||
170576624|NCT01340664|616453849|FG002|Overall Study|Adverse Event|7|||
170576625|NCT01340664|616453847|FG000|Overall Study|Lost to Follow-up|2|||
170576626|NCT01340664|616453848|FG001|Overall Study|Lost to Follow-up|0|||
170576627|NCT01340664|616453849|FG002|Overall Study|Lost to Follow-up|2|||
170809098|NCT04237792|617310503|FG003|Treatment (Day 1)|Not treated|1|||
170909868|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
170909869|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
170576628|NCT01340664|616453847|FG000|Overall Study|Withdrawal by Subject|2|||
170576629|NCT01340664|616453848|FG001|Overall Study|Withdrawal by Subject|4|||
170576630|NCT01340664|616453849|FG002|Overall Study|Withdrawal by Subject|0|||
170576631|NCT01340664|616453847|FG000|Overall Study|Glycemic withdrawal criteria|2|||
170576632|NCT01340664|616453848|FG001|Overall Study|Glycemic withdrawal criteria|0|||
170576633|NCT01340664|616453849|FG002|Overall Study|Glycemic withdrawal criteria|0|||
170576634|NCT01340664|616453847|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
170576635|NCT01340664|616453848|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
170576636|NCT01340664|616453849|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
170576637|NCT01340664|616453847|FG000|Overall Study|Other|1|||
170576638|NCT01340664|616453848|FG001|Overall Study|Other|2|||
170576639|NCT01340664|616453849|FG002|Overall Study|Other|2|||
170576640|NCT01926444|616453851|FG000|Overall Study|Colonoscopy not performed|0|||
170576641|NCT01926444|616453852|FG001|Overall Study|Colonoscopy not performed|0|||
170576642|NCT01926444|616453853|FG002|Overall Study|Colonoscopy not performed|4|||
170576643|NCT01926444|616453854|FG003|Overall Study|Colonoscopy not performed|2|||
170909870|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
170909871|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
170909872|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
170909873|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
170909874|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
170909875|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
170909876|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
170909877|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
170909878|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
170909879|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
170576644|NCT02520388|616453857|FG000|Overall Study|Physician Decision|1|||
170576645|NCT02520388|616453858|FG001|Overall Study|Physician Decision|0|||
170576646|NCT02520388|616453857|FG000|Overall Study|Subject or parent/guardian request|0|||
170576647|NCT02520388|616453858|FG001|Overall Study|Subject or parent/guardian request|6|||
170576648|NCT02520388|616453857|FG000|Overall Study|Adverse Event|1|||
170576649|NCT02520388|616453858|FG001|Overall Study|Adverse Event|4|||
170576650|NCT02520388|616453857|FG000|Overall Study|Lost to Follow-up|3|||
170576651|NCT02520388|616453858|FG001|Overall Study|Lost to Follow-up|2|||
170576652|NCT02520388|616453857|FG000|Overall Study|Other (reason not defined)|4|||
170576653|NCT02520388|616453858|FG001|Overall Study|Other (reason not defined)|4|||
170576654|NCT02623205|616453859|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
170576655|NCT02623205|616453860|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
170576656|NCT02725476|616453862|FG000|Overall Study|Physician Decision|2|||
170576657|NCT02725476|616453863|FG001|Overall Study|Physician Decision|0|||
170576658|NCT02725476|616453862|FG000|Overall Study|Adverse Event|1|||
170576659|NCT02725476|616453863|FG001|Overall Study|Adverse Event|1|||
170576660|NCT04188834|616453864|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
170576661|NCT00553436|616453865|FG000|Overall Study|Conversion to another procedure|1|||
170576662|NCT02455336|616453866|FG000|Overall Study|Withdrawal by Subject|0|||
170576663|NCT02455336|616453867|FG001|Overall Study|Withdrawal by Subject|2|||
170576664|NCT02455336|616453866|FG000|Overall Study|Adverse Event|3|||
170576665|NCT02455336|616453867|FG001|Overall Study|Adverse Event|0|||
170576666|NCT02455336|616453866|FG000|Overall Study|Non-responder to treatment|2|||
170576667|NCT02455336|616453867|FG001|Overall Study|Non-responder to treatment|0|||
170576668|NCT00391430|616453868|FG000|Overall Study|Withdrawal by Subject|3|||
170576669|NCT00391430|616453869|FG001|Overall Study|Withdrawal by Subject|0|||
170576670|NCT00391430|616453870|FG002|Overall Study|Withdrawal by Subject|12|||
170576671|NCT00577707|616453873|FG000|Overall Study|Withdrawal by Subject|3|||
170576672|NCT00707993|616453880|FG000|Overall Study|Adverse Event|16|||
170576673|NCT00707993|616453881|FG001|Overall Study|Adverse Event|20|||
170576674|NCT00707993|616453880|FG000|Overall Study|Protocol Violation|4|||
170909880|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
170909881|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Death|0|||
170909882|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Death|1|||
170576675|NCT00707993|616453881|FG001|Overall Study|Protocol Violation|7|||
170576676|NCT00707993|616453880|FG000|Overall Study|Lost to Follow-up|0|||
170576677|NCT00707993|616453881|FG001|Overall Study|Lost to Follow-up|4|||
170576678|NCT00707993|616453880|FG000|Overall Study|Withdrawal by Subject|12|||
170576679|NCT00707993|616453881|FG001|Overall Study|Withdrawal by Subject|16|||
170576680|NCT00707993|616453880|FG000|Overall Study|Hyperglycemic Rescue|55|||
170576681|NCT00707993|616453881|FG001|Overall Study|Hyperglycemic Rescue|47|||
170576682|NCT00707993|616453880|FG000|Overall Study|Other|2|||
170576683|NCT00707993|616453881|FG001|Overall Study|Other|0|||
170576684|NCT05005273|616453882|FG000|Overall Study|Study Terminated|1|||
170576685|NCT05005273|616453883|FG001|Overall Study|Study Terminated|0|||
170576686|NCT04409834|616453884|FG000|Overall Study|Death|55|||
170576687|NCT04409834|616453885|FG001|Overall Study|Death|62|||
170576688|NCT01671956|616453886|FG000|Overall Study|Disease progression|0|||
170576689|NCT01671956|616453887|FG001|Overall Study|Disease progression|1|||
170576690|NCT01671956|616453886|FG000|Overall Study|Withdrawal by Subject|1|||
170576691|NCT01671956|616453887|FG001|Overall Study|Withdrawal by Subject|1|||
170576692|NCT01671956|616453886|FG000|Overall Study|Adverse Event|1|||
170576693|NCT01671956|616453887|FG001|Overall Study|Adverse Event|0|||
170576694|NCT04266912|616453891|FG000|Overall Study|Withdrawal by Subject|1|||
170576695|NCT04266912|616453892|FG001|Overall Study|Withdrawal by Subject|0|||
170576696|NCT04266912|616453893|FG002|Overall Study|Withdrawal by Subject|0|||
170576697|NCT04266912|616453894|FG003|Overall Study|Withdrawal by Subject|0|||
170576698|NCT04266912|616453891|FG000|Overall Study|Progression|6|||
170576699|NCT04266912|616453892|FG001|Overall Study|Progression|6|||
170576700|NCT04266912|616453893|FG002|Overall Study|Progression|0|||
170576701|NCT04266912|616453894|FG003|Overall Study|Progression|10|||
170576702|NCT02685826|616453897|FG000|Overall Study|Adverse Event|2|||
170576703|NCT02685826|616453898|FG001|Overall Study|Adverse Event|0|||
170576704|NCT02685826|616453899|FG002|Overall Study|Adverse Event|1|||
170576705|NCT02685826|616453897|FG000|Overall Study|Progressive Disease|2|||
170576706|NCT02685826|616453898|FG001|Overall Study|Progressive Disease|1|||
170576707|NCT02685826|616453899|FG002|Overall Study|Progressive Disease|0|||
170576708|NCT02685826|616453897|FG000|Overall Study|Withdrawal by Subject|2|||
170576709|NCT02685826|616453898|FG001|Overall Study|Withdrawal by Subject|0|||
170576710|NCT02685826|616453899|FG002|Overall Study|Withdrawal by Subject|0|||
170576711|NCT02685826|616453897|FG000|Overall Study|Full Clinical Hold by FDA|19|||
170576712|NCT02685826|616453898|FG001|Overall Study|Full Clinical Hold by FDA|9|||
170576713|NCT02685826|616453899|FG002|Overall Study|Full Clinical Hold by FDA|20|||
170576714|NCT03816176|616453902|FG000|Overall Study|Miscellaneous|5|||
170576715|NCT03816176|616453902|FG000|Overall Study|Lack of Efficacy|4|||
170576716|NCT03816176|616453902|FG000|Overall Study|Adverse Event|3|||
170576717|NCT03581292|616453903|FG000|Overall Study|Physician Decision|9|||
170576718|NCT03581292|616453904|FG001|Overall Study|Physician Decision|5|||
170576719|NCT03581292|616453903|FG000|Overall Study|Withdrawal by Subject|3|||
170576720|NCT03581292|616453904|FG001|Overall Study|Withdrawal by Subject|0|||
170576721|NCT03581292|616453903|FG000|Overall Study|Withdrawal before Therapy Start|1|||
170576722|NCT03581292|616453904|FG001|Overall Study|Withdrawal before Therapy Start|0|||
170576723|NCT02524145|616453908|FG000|Overall Study|Withdrawal by Subject|2|||
170576724|NCT02524145|616453909|FG001|Overall Study|Withdrawal by Subject|2|||
170576725|NCT02524145|616453910|FG002|Overall Study|Withdrawal by Subject|3|||
170576726|NCT07214935|616453913|FG000|Overall Study|Adverse Event|1|||
170576727|NCT07214935|616453914|FG001|Overall Study|Adverse Event|1|||
170576728|NCT07214935|616453915|FG002|Overall Study|Adverse Event|1|||
170576729|NCT07214935|616453916|FG003|Overall Study|Adverse Event|0|||
170576730|NCT07214935|616453913|FG000|Overall Study|Lost to Follow-up|0|||
170576731|NCT07214935|616453914|FG001|Overall Study|Lost to Follow-up|1|||
170576732|NCT07214935|616453915|FG002|Overall Study|Lost to Follow-up|0|||
170576733|NCT07214935|616453916|FG003|Overall Study|Lost to Follow-up|0|||
170576734|NCT07214935|616453913|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
170576735|NCT07214935|616453914|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
170576736|NCT07214935|616453915|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
170576737|NCT07214935|616453916|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
170576738|NCT07214935|616453913|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
170576739|NCT07214935|616453914|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
170576740|NCT07214935|616453915|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
170576741|NCT07214935|616453916|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
170576742|NCT02712983|616455356|FG000|Treatment Phase|Adverse Event|3|||
170576743|NCT02712983|616455357|FG001|Treatment Phase|Adverse Event|1|||
170576744|NCT02712983|616455358|FG002|Treatment Phase|Adverse Event|1|||
170576745|NCT02712983|616455359|FG003|Treatment Phase|Adverse Event|4|||
170576746|NCT02712983|616455360|FG004|Treatment Phase|Adverse Event|3|||
170576747|NCT02712983|616455361|FG005|Treatment Phase|Adverse Event|0|||
170576748|NCT02712983|616455362|FG006|Treatment Phase|Adverse Event|6|||
170576749|NCT02712983|616455363|FG007|Treatment Phase|Adverse Event|6|||
170576750|NCT02712983|616455364|FG008|Treatment Phase|Adverse Event|1|||
170576751|NCT02712983|616455356|FG000|Treatment Phase|Protocol Deviation|0|||
170576752|NCT02712983|616455357|FG001|Treatment Phase|Protocol Deviation|0|||
170576753|NCT02712983|616455358|FG002|Treatment Phase|Protocol Deviation|0|||
170576754|NCT02712983|616455359|FG003|Treatment Phase|Protocol Deviation|2|||
170576755|NCT02712983|616455360|FG004|Treatment Phase|Protocol Deviation|0|||
170576756|NCT02712983|616455361|FG005|Treatment Phase|Protocol Deviation|0|||
170576757|NCT02712983|616455362|FG006|Treatment Phase|Protocol Deviation|1|||
170576758|NCT02712983|616455363|FG007|Treatment Phase|Protocol Deviation|0|||
170576759|NCT02712983|616455364|FG008|Treatment Phase|Protocol Deviation|0|||
170576760|NCT02712983|616455356|FG000|Treatment Phase|Technical Problems|0|||
170576761|NCT02712983|616455357|FG001|Treatment Phase|Technical Problems|0|||
170576762|NCT02712983|616455358|FG002|Treatment Phase|Technical Problems|0|||
170576763|NCT02712983|616455359|FG003|Treatment Phase|Technical Problems|0|||
170576764|NCT02712983|616455360|FG004|Treatment Phase|Technical Problems|0|||
170576765|NCT02712983|616455361|FG005|Treatment Phase|Technical Problems|0|||
170576766|NCT02712983|616455362|FG006|Treatment Phase|Technical Problems|1|||
170576767|NCT02712983|616455363|FG007|Treatment Phase|Technical Problems|0|||
170576768|NCT02712983|616455364|FG008|Treatment Phase|Technical Problems|0|||
170576769|NCT02712983|616455356|FG000|Treatment Phase|Physician Decision|0|||
170576770|NCT02712983|616455357|FG001|Treatment Phase|Physician Decision|0|||
170576771|NCT02712983|616455358|FG002|Treatment Phase|Physician Decision|0|||
170576772|NCT02712983|616455359|FG003|Treatment Phase|Physician Decision|0|||
170576773|NCT02712983|616455360|FG004|Treatment Phase|Physician Decision|0|||
170576774|NCT02712983|616455361|FG005|Treatment Phase|Physician Decision|0|||
170576775|NCT02712983|616455362|FG006|Treatment Phase|Physician Decision|0|||
170576776|NCT02712983|616455363|FG007|Treatment Phase|Physician Decision|1|||
170576777|NCT02712983|616455364|FG008|Treatment Phase|Physician Decision|1|||
170576778|NCT02712983|616455356|FG000|Treatment Phase|Subject Decision|2|||
170576779|NCT02712983|616455357|FG001|Treatment Phase|Subject Decision|0|||
170576780|NCT02712983|616455358|FG002|Treatment Phase|Subject Decision|0|||
170576781|NCT02712983|616455359|FG003|Treatment Phase|Subject Decision|2|||
170576782|NCT02712983|616455360|FG004|Treatment Phase|Subject Decision|1|||
170576783|NCT02712983|616455361|FG005|Treatment Phase|Subject Decision|0|||
170576784|NCT02712983|616455362|FG006|Treatment Phase|Subject Decision|1|||
170576785|NCT02712983|616455363|FG007|Treatment Phase|Subject Decision|2|||
170576786|NCT02712983|616455364|FG008|Treatment Phase|Subject Decision|0|||
170576787|NCT02712983|616455356|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
170576788|NCT02712983|616455357|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
170576789|NCT02712983|616455358|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
170576790|NCT02712983|616455359|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
170576791|NCT02712983|616455360|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
170576792|NCT02712983|616455361|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
170576793|NCT02712983|616455362|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
170576794|NCT02712983|616455363|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
170576795|NCT02712983|616455364|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
170576796|NCT02712983|616455356|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
170576797|NCT02712983|616455357|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
170576798|NCT02712983|616455358|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
170576799|NCT02712983|616455359|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
170576800|NCT02712983|616455360|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
170576801|NCT02712983|616455361|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
170576802|NCT02712983|616455362|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
170576803|NCT02712983|616455363|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
170576804|NCT02712983|616455364|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
170576805|NCT02712983|616455356|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
170576806|NCT02712983|616455357|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
170576807|NCT02712983|616455358|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
170576808|NCT02712983|616455359|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
170576809|NCT02712983|616455360|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
170576810|NCT02712983|616455361|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
170576811|NCT02712983|616455362|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
170576812|NCT02712983|616455363|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
170576813|NCT02712983|616455364|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
170576814|NCT00283803|616455365|FG000|Overall Study|Physician Decision|9|||
170576815|NCT00283803|616455365|FG000|Overall Study|Withdrawal by Subject|4|||
170576816|NCT02220855|616455366|FG000|Overall Study|Adverse Event|8|||
170576817|NCT02220855|616455366|FG000|Overall Study|Disease Progression|5|||
170576818|NCT02220855|616455366|FG000|Overall Study|Withdrawal by Subject|1|||
170576819|NCT05730725|616455367|FG000|Overall Study|Withdrawal by Subject|3|||
170576820|NCT05730725|616455368|FG001|Overall Study|Withdrawal by Subject|0|||
170576821|NCT05730725|616455369|FG002|Overall Study|Withdrawal by Subject|0|||
170576822|NCT05730725|616455370|FG003|Overall Study|Withdrawal by Subject|1|||
170576823|NCT05730725|616455367|FG000|Overall Study|Not Reported|1|||
170576824|NCT05730725|616455368|FG001|Overall Study|Not Reported|1|||
170576825|NCT05730725|616455369|FG002|Overall Study|Not Reported|1|||
170576826|NCT05730725|616455370|FG003|Overall Study|Not Reported|1|||
170576827|NCT02974140|616455372|FG000|Overall Study|Adverse Event|2|||
170576828|NCT02974140|616455372|FG000|Overall Study|Lost to Follow-up|1|||
170576829|NCT02974140|616455372|FG000|Overall Study|Study Terminated by Sponsor|36|||
170576830|NCT05959447|616455374|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
170576831|NCT05959447|616455375|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
170576832|NCT05959447|616455374|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
170576833|NCT05959447|616455375|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
170576834|NCT05959447|616455374|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
170576835|NCT05959447|616455375|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
170576836|NCT05959447|616455374|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
170576837|NCT05959447|616455375|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
170576838|NCT02522429|616455376|FG000|Overall Study|Lost to Follow-up|8|||
170576839|NCT02522429|616455376|FG000|Overall Study|Adverse Event|2|||
170576840|NCT02522429|616455376|FG000|Overall Study|Death|1|||
170576841|NCT02522429|616455376|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
170576842|NCT00294671|616455377|FG000|Overall Study|Lack of Efficacy|11|||
170576843|NCT00294671|616455378|FG001|Overall Study|Lack of Efficacy|23|||
170576844|NCT00294671|616455377|FG000|Overall Study|Liver transplant|7|||
170576845|NCT00294671|616455378|FG001|Overall Study|Liver transplant|9|||
170576846|NCT00294671|616455377|FG000|Overall Study|Drug related adverse event (AE)|4|||
170576847|NCT00294671|616455378|FG001|Overall Study|Drug related adverse event (AE)|2|||
170576848|NCT00294671|616455377|FG000|Overall Study|Non-drug related AE|3|||
170576849|NCT00294671|616455378|FG001|Overall Study|Non-drug related AE|2|||
170576850|NCT00294671|616455377|FG000|Overall Study|Lost to Follow-up|1|||
170576851|NCT00294671|616455378|FG001|Overall Study|Lost to Follow-up|3|||
170576852|NCT00294671|616455377|FG000|Overall Study|Non-compliance|1|||
170576853|NCT00294671|616455378|FG001|Overall Study|Non-compliance|0|||
170576854|NCT00294671|616455377|FG000|Overall Study|Death|0|||
170576855|NCT00294671|616455378|FG001|Overall Study|Death|1|||
170576856|NCT02140970|616455388|FG000|Overall Study|Lost to Follow-up|1|||
170576857|NCT02140970|616455389|FG001|Overall Study|Lost to Follow-up|2|||
170576858|NCT02140970|616455388|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
170576859|NCT02140970|616455389|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
170576860|NCT02140970|616455388|FG000|Overall Study|Did not meet inclusion criteria|0|||
170576861|NCT02140970|616455389|FG001|Overall Study|Did not meet inclusion criteria|1|||
170576862|NCT00485758|616455396|FG000|Overall Study|Adverse Event|102|||
170576863|NCT00485758|616455397|FG001|Overall Study|Adverse Event|31|||
170576864|NCT00485758|616455396|FG000|Overall Study|Death|0|||
170576865|NCT00485758|616455397|FG001|Overall Study|Death|1|||
170576866|NCT00485758|616455396|FG000|Overall Study|Lost to Follow-up|5|||
170576867|NCT00485758|616455397|FG001|Overall Study|Lost to Follow-up|1|||
170576868|NCT00485758|616455396|FG000|Overall Study|Physician Decision|3|||
170576869|NCT00485758|616455397|FG001|Overall Study|Physician Decision|3|||
170576870|NCT00485758|616455396|FG000|Overall Study|Protocol Violation|11|||
170576871|NCT00485758|616455397|FG001|Overall Study|Protocol Violation|2|||
170576872|NCT00485758|616455396|FG000|Overall Study|Withdrawal by Subject|32|||
170576873|NCT00485758|616455397|FG001|Overall Study|Withdrawal by Subject|27|||
170576874|NCT00485758|616455396|FG000|Overall Study|Study Terminated by Sponsor|3|||
170576875|NCT00485758|616455397|FG001|Overall Study|Study Terminated by Sponsor|0|||
170576876|NCT04123093|616455398|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
170576877|NCT04123093|616455399|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
170649464|NCT04896229|616730781|FG000|Overall Study|Lost to Follow-up|113|||
170649465|NCT04896229|616730782|FG001|Overall Study|Lost to Follow-up|113|||
170649466|NCT02984943|616730783|FG000|Overall Study|Withdrawal by Subject|3|||
170649467|NCT02984943|616730783|FG000|Overall Study|Physician Decision|1|||
170809099|NCT04237792|617310504|FG004|Treatment (Day 1)|Not treated|0|||
170809100|NCT04237792|617310505|FG005|Treatment (Day 1)|Not treated|1|||
170809101|NCT01829711|617310507|FG000|Overall Study|Lost to Follow-up|2|||
170576878|NCT04123093|616455398|FG000|Phase 2|Physician Decision|0|||
170576879|NCT04123093|616455399|FG001|Phase 2|Physician Decision|1|||
170576880|NCT04123093|616455398|FG000|Phase 2|Withdrawal by Subject|0|||
170576881|NCT04123093|616455399|FG001|Phase 2|Withdrawal by Subject|1|||
170576882|NCT00910910|616455401|FG000|Overall Study|Adverse Event|63|||
170576883|NCT00910910|616455402|FG001|Overall Study|Adverse Event|35|||
170576884|NCT00910910|616455401|FG000|Overall Study|PD without histologic change|27|||
170576885|NCT00910910|616455402|FG001|Overall Study|PD without histologic change|23|||
170576886|NCT00910910|616455401|FG000|Overall Study|PD with histologic change|0|||
170576887|NCT00910910|616455402|FG001|Overall Study|PD with histologic change|2|||
170576888|NCT00910910|616455401|FG000|Overall Study|Withdrawal by Subject|7|||
170576889|NCT00910910|616455402|FG001|Overall Study|Withdrawal by Subject|5|||
170649468|NCT01029405|616730788|FG000|Overall Study|Withdrawal by Subject|0|||
170809102|NCT01829711|617310507|FG000|Overall Study|Withdrawal by Subject|3|||
170809103|NCT01829711|617310507|FG000|Overall Study|Death|4|||
170576890|NCT00910910|616455401|FG000|Overall Study|Lost to Follow-up|2|||
170576891|NCT00910910|616455402|FG001|Overall Study|Lost to Follow-up|2|||
170576892|NCT00910910|616455401|FG000|Overall Study|Death|9|||
170576893|NCT00910910|616455402|FG001|Overall Study|Death|3|||
170576894|NCT00910910|616455401|FG000|Overall Study|Protocol Violation|2|||
170576895|NCT00910910|616455402|FG001|Overall Study|Protocol Violation|2|||
170576896|NCT00910910|616455401|FG000|Overall Study|Completed 13 cycles of treatment|0|||
170576897|NCT00910910|616455402|FG001|Overall Study|Completed 13 cycles of treatment|118|||
170576898|NCT00910910|616455401|FG000|Overall Study|Other|114|||
170576899|NCT00910910|616455402|FG001|Overall Study|Other|32|||
170576900|NCT00910910|616455401|FG000|Overall Study|Untreated before cycle 1|1|||
170576901|NCT00910910|616455402|FG001|Overall Study|Untreated before cycle 1|2|||
170576902|NCT02253433|616455408|FG000|Overall Study|Unable to Contact|9|||
170576903|NCT02253433|616455409|FG001|Overall Study|Unable to Contact|16|||
170576904|NCT02253433|616455408|FG000|Overall Study|Death|1|||
170576905|NCT02253433|616455409|FG001|Overall Study|Death|1|||
170576906|NCT02253433|616455408|FG000|Overall Study|No Longer Interested|3|||
170576907|NCT02253433|616455409|FG001|Overall Study|No Longer Interested|15|||
170576908|NCT02253433|616455408|FG000|Overall Study|Out of Study Area|2|||
170576909|NCT02253433|616455409|FG001|Overall Study|Out of Study Area|7|||
170576910|NCT02253433|616455408|FG000|Overall Study|Uncomfortable with home visitors|0|||
170576911|NCT02253433|616455409|FG001|Overall Study|Uncomfortable with home visitors|3|||
170576912|NCT02253433|616455408|FG000|Overall Study|Unstable Housing/Homeless|0|||
170576913|NCT02253433|616455409|FG001|Overall Study|Unstable Housing/Homeless|7|||
170576914|NCT02253433|616455408|FG000|Overall Study|Too Busy|0|||
170576915|NCT02253433|616455409|FG001|Overall Study|Too Busy|4|||
170576916|NCT02253433|616455408|FG000|Overall Study|Medical or Other Concerns|1|||
170576917|NCT02253433|616455409|FG001|Overall Study|Medical or Other Concerns|2|||
170576918|NCT04503551|616455410|FG000|Overall Study|Withdrawal by Subject|5|||
170576919|NCT04503551|616455411|FG001|Overall Study|Withdrawal by Subject|3|||
170576920|NCT04503551|616455410|FG000|Overall Study|Physician Decision|1|||
170576921|NCT04503551|616455411|FG001|Overall Study|Physician Decision|0|||
170576922|NCT04503551|616455410|FG000|Overall Study|Death|0|||
170576923|NCT04503551|616455411|FG001|Overall Study|Death|1|||
170576924|NCT04503551|616455410|FG000|Overall Study|Lost to Follow-up|1|||
170576925|NCT04503551|616455411|FG001|Overall Study|Lost to Follow-up|2|||
170576926|NCT04503551|616455410|FG000|Overall Study|Ongoing at Week 52|99|||
170576927|NCT04503551|616455411|FG001|Overall Study|Ongoing at Week 52|62|||
170576928|NCT00588237|616455415|FG000|Overall Study|Evaluable for toxicity only|3|||
170576929|NCT00588237|616455415|FG000|Overall Study|Patien not treated|1|||
170576930|NCT01390298|616455416|FG000|Overall Study|Death|1|||
170576931|NCT01390298|616455416|FG000|Overall Study|long term ICU admission|1|||
170576932|NCT01390298|616455416|FG000|Overall Study|Withdrawal by Subject|14|||
170576933|NCT01390298|616455416|FG000|Overall Study|Lost to Follow-up|7|||
170576934|NCT01390298|616455416|FG000|Overall Study|Surgery cancelled|1|||
170576935|NCT02443337|616455422|FG000|Overall Study|Adverse Event|0|||
170576936|NCT02443337|616455423|FG001|Overall Study|Adverse Event|1|||
170576937|NCT02443337|616455422|FG000|Overall Study|Clinical Progressive Disease|3|||
170576938|NCT02443337|616455423|FG001|Overall Study|Clinical Progressive Disease|0|||
170576939|NCT02443337|616455422|FG000|Overall Study|Withdrawal by Subject|2|||
170576940|NCT02443337|616455423|FG001|Overall Study|Withdrawal by Subject|1|||
170576941|NCT01071954|616455424|FG000|Overall Study|Noncompliance|4|||
170576942|NCT01071954|616455424|FG000|Overall Study|Adverse Event|1|||
170576943|NCT01071954|616455424|FG000|Overall Study|Withdrawal by Subject|11|||
170576944|NCT01071954|616455424|FG000|Overall Study|Requirement for Alternative Therapy|5|||
170576945|NCT01071954|616455424|FG000|Overall Study|Administrative Decision|5|||
170576946|NCT01071954|616455424|FG000|Overall Study|Protocol Specified Criteria|1|||
170576947|NCT01152788|616455425|FG000|Overall Study|Withdrawal by Subject|0|||
170576948|NCT01152788|616455426|FG001|Overall Study|Withdrawal by Subject|3|||
170576949|NCT01152788|616455425|FG000|Overall Study|No treatment|0|||
170576950|NCT01152788|616455426|FG001|Overall Study|No treatment|1|||
170576951|NCT04445519|616455427|FG000|Overall Study|Due to adaptive design|3|||
170576952|NCT04445519|616455428|FG001|Overall Study|Due to adaptive design|0|||
170576953|NCT04445519|616455429|FG002|Overall Study|Due to adaptive design|0|||
170576954|NCT04445519|616455427|FG000|Overall Study|Lost to Follow-up|0|||
170576955|NCT04445519|616455428|FG001|Overall Study|Lost to Follow-up|1|||
170576956|NCT04445519|616455429|FG002|Overall Study|Lost to Follow-up|4|||
170576957|NCT04445519|616455427|FG000|Overall Study|Sponsor or IRB Decision|0|||
170576958|NCT04445519|616455428|FG001|Overall Study|Sponsor or IRB Decision|1|||
170576959|NCT04445519|616455429|FG002|Overall Study|Sponsor or IRB Decision|2|||
170576960|NCT04445519|616455427|FG000|Overall Study|Withdrawal by Subject|0|||
170576961|NCT04445519|616455428|FG001|Overall Study|Withdrawal by Subject|3|||
170576962|NCT04445519|616455429|FG002|Overall Study|Withdrawal by Subject|3|||
170576963|NCT04445519|616455427|FG000|Overall Study|Adverse Event|0|||
170576964|NCT04445519|616455428|FG001|Overall Study|Adverse Event|8|||
170576965|NCT04445519|616455429|FG002|Overall Study|Adverse Event|6|||
170576966|NCT04445519|616455427|FG000|Overall Study|Other Reason|0|||
170576967|NCT04445519|616455428|FG001|Overall Study|Other Reason|1|||
170576968|NCT04445519|616455429|FG002|Overall Study|Other Reason|1|||
170576969|NCT04445519|616455427|FG000|Overall Study|Protocol Violation|0|||
170576970|NCT04445519|616455428|FG001|Overall Study|Protocol Violation|0|||
170576971|NCT04445519|616455429|FG002|Overall Study|Protocol Violation|1|||
170576972|NCT03782064|616455430|FG000|Overall Study|Lack of Efficacy|2|||
170576973|NCT03782064|616455430|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
170576974|NCT03072043|616455436|FG000|Overall Study|Death|0|||
170576975|NCT03072043|616455437|FG001|Overall Study|Death|0|||
170576976|NCT03072043|616455438|FG002|Overall Study|Death|3|||
170576977|NCT03072043|616455436|FG000|Overall Study|Adverse Event|0|||
170576978|NCT03072043|616455437|FG001|Overall Study|Adverse Event|0|||
170576979|NCT03072043|616455438|FG002|Overall Study|Adverse Event|2|||
170576980|NCT03072043|616455436|FG000|Overall Study|Withdrawal by Subject|0|||
170576981|NCT03072043|616455437|FG001|Overall Study|Withdrawal by Subject|0|||
170576982|NCT03072043|616455438|FG002|Overall Study|Withdrawal by Subject|4|||
170576983|NCT00645840|616455439|FG000|Overall Study|Protocol Violation|3|||
170576984|NCT02441101|616455446|FG000|Overall Study|Withdrawal by Subject|1|||
170576985|NCT02441101|616455447|FG001|Overall Study|Withdrawal by Subject|0|||
170576986|NCT02441101|616455446|FG000|Overall Study|Lost to Follow-up|1|||
170576987|NCT02441101|616455447|FG001|Overall Study|Lost to Follow-up|0|||
170576988|NCT02441101|616455446|FG000|Overall Study|PI relocated and study terminated|1|||
170576989|NCT02441101|616455447|FG001|Overall Study|PI relocated and study terminated|0|||
170576990|NCT04599803|616455450|FG000|Overall Study|Withdrawal by Subject|5|||
170576991|NCT04599803|616455450|FG000|Overall Study|Lost to Follow-up|26|||
170576992|NCT03035864|616455452|FG000|Treatment Period|Adverse Event|1|||
170576993|NCT03035864|616455453|FG001|Treatment Period|Adverse Event|0|||
170576994|NCT03035864|616455452|FG000|Treatment Period|Other|3|||
170576995|NCT03035864|616455453|FG001|Treatment Period|Other|1|||
170576996|NCT03035864|616455452|FG000|Follow-up Period|Adverse Event|1|||
170576997|NCT03035864|616455453|FG001|Follow-up Period|Adverse Event|0|||
170576998|NCT03035864|616455452|FG000|Follow-up Period|Lost to Follow-up|6|||
170576999|NCT03035864|616455453|FG001|Follow-up Period|Lost to Follow-up|2|||
170577000|NCT03035864|616455452|FG000|Follow-up Period|Physician Decision|1|||
170577001|NCT03035864|616455453|FG001|Follow-up Period|Physician Decision|0|||
170577002|NCT03035864|616455452|FG000|Follow-up Period|Other|3|||
170577003|NCT03035864|616455453|FG001|Follow-up Period|Other|2|||
170577004|NCT02375373|616455456|FG000|Overall Study|Withdrawal by Subject|11|||
170577005|NCT00407602|616455457|FG000|Overall Study|Death - unrelated to device|1|||
170577006|NCT00407602|616455457|FG000|Overall Study|Device explanted|5|||
170577007|NCT00407602|616455457|FG000|Overall Study|Withdrawal by Subject|1|||
170577008|NCT03706430|616455465|FG000|Overall Study|No A-Line placed|5|||
170577009|NCT03706430|616455465|FG000|Overall Study|Subject had gel nail polish|1|||
170577010|NCT03706430|616455465|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
170577011|NCT03706430|616455465|FG000|Overall Study|Cancelled Case|6|||
170577012|NCT03706430|616455465|FG000|Overall Study|Physician Decision|2|||
170577013|NCT01928433|616455466|FG000|Overall Study|Adverse Event|5|||
170577014|NCT01928433|616455467|FG001|Overall Study|Adverse Event|2|||
170577015|NCT01928433|616455468|FG002|Overall Study|Adverse Event|5|||
170577016|NCT01928433|616455466|FG000|Overall Study|Protocol Violation|0|||
170577017|NCT01928433|616455467|FG001|Overall Study|Protocol Violation|0|||
170577018|NCT01928433|616455468|FG002|Overall Study|Protocol Violation|2|||
170577019|NCT01928433|616455466|FG000|Overall Study|Lack of Efficacy|5|||
170577020|NCT01928433|616455467|FG001|Overall Study|Lack of Efficacy|4|||
170577021|NCT01928433|616455468|FG002|Overall Study|Lack of Efficacy|4|||
170577022|NCT01928433|616455466|FG000|Overall Study|Withdrawal by Subject|0|||
170577023|NCT01928433|616455467|FG001|Overall Study|Withdrawal by Subject|4|||
170577024|NCT01928433|616455468|FG002|Overall Study|Withdrawal by Subject|0|||
170577025|NCT01928433|616455466|FG000|Overall Study|Negative screening urine culture|7|||
170577026|NCT01928433|616455467|FG001|Overall Study|Negative screening urine culture|6|||
170577027|NCT01928433|616455468|FG002|Overall Study|Negative screening urine culture|10|||
170577028|NCT01928433|616455466|FG000|Overall Study|Lost to Follow-up|0|||
170577029|NCT01928433|616455467|FG001|Overall Study|Lost to Follow-up|2|||
170577030|NCT01928433|616455468|FG002|Overall Study|Lost to Follow-up|3|||
170577031|NCT01928433|616455466|FG000|Overall Study|Other reasons|3|||
170809104|NCT01829711|617310507|FG000|Overall Study|Started new therapies|17|||
170809105|NCT01829711|617310507|FG000|Overall Study|Adverse Event|3|||
170809106|NCT01829711|617310507|FG000|Overall Study|Due to progression of disease|13|||
170809107|NCT01829711|617310507|FG000|Overall Study|Due to lack of response|1|||
170809108|NCT01480258|617310508|FG000|Infant Series|Protocol Violation|2|||
170577032|NCT01928433|616455467|FG001|Overall Study|Other reasons|3|||
170577033|NCT01928433|616455468|FG002|Overall Study|Other reasons|4|||
170577034|NCT01392573|616455469|FG000|Overall Study|Adverse Event|1|||
170809109|NCT01480258|617310509|FG001|Infant Series|Protocol Violation|0|||
170577035|NCT01392573|616455470|FG001|Overall Study|Adverse Event|3|||
170577036|NCT01392573|616455469|FG000|Overall Study|Lack of Efficacy|1|||
170577037|NCT01392573|616455470|FG001|Overall Study|Lack of Efficacy|2|||
170577038|NCT01392573|616455469|FG000|Overall Study|Protocol Violation|0|||
170809110|NCT01480258|617310508|FG000|Infant Series|Physician Decision|0|||
170577039|NCT01392573|616455470|FG001|Overall Study|Protocol Violation|2|||
170577040|NCT01392573|616455469|FG000|Overall Study|Withdrawal Criteria|13|||
170577041|NCT01392573|616455470|FG001|Overall Study|Withdrawal Criteria|15|||
170577042|NCT01392573|616455469|FG000|Overall Study|Site closure|8|||
170577043|NCT01392573|616455470|FG001|Overall Study|Site closure|7|||
170577044|NCT01392573|616455469|FG000|Overall Study|Unclassified|9|||
170577045|NCT01392573|616455470|FG001|Overall Study|Unclassified|6|||
170577046|NCT00100802|616455471|FG000|Overall Study|Adverse Event|9|||
170577047|NCT00100802|616455471|FG000|Overall Study|Death|1|||
170577048|NCT00100802|616455471|FG000|Overall Study|Lack of Efficacy|47|||
170577049|NCT00100802|616455471|FG000|Overall Study|Physician Decision|5|||
170577050|NCT00100802|616455471|FG000|Overall Study|Protocol Violation|1|||
170577051|NCT00100802|616455471|FG000|Overall Study|Withdrawal by Subject|5|||
170577052|NCT00100802|616455471|FG000|Overall Study|Ineligible|12|||
170577053|NCT03381287|616455473|FG000|Overall Study|Withdrawal by Subject|0|||
170577054|NCT03381287|616455474|FG001|Overall Study|Withdrawal by Subject|1|||
170577055|NCT03381287|616455475|FG002|Overall Study|Withdrawal by Subject|0|||
170577056|NCT03381287|616455476|FG003|Overall Study|Withdrawal by Subject|0|||
170577057|NCT03381287|616455473|FG000|Overall Study|Adverse Event|0|||
170577058|NCT03381287|616455474|FG001|Overall Study|Adverse Event|0|||
170577059|NCT03381287|616455475|FG002|Overall Study|Adverse Event|0|||
170577060|NCT03381287|616455476|FG003|Overall Study|Adverse Event|1|||
170577061|NCT03381287|616455473|FG000|Overall Study|Physician Decision|0|||
170577062|NCT03381287|616455474|FG001|Overall Study|Physician Decision|0|||
170577063|NCT03381287|616455475|FG002|Overall Study|Physician Decision|0|||
170577064|NCT03381287|616455476|FG003|Overall Study|Physician Decision|1|||
170577065|NCT02709720|616455477|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
170577066|NCT02709720|616455477|FG000|Overall Study|Protocol Violation|1|||
170577067|NCT02709720|616455477|FG000|Overall Study|Not take study medication|1|||
170577068|NCT01198574|616455488|FG000|Overall Study|Resigned from schools|4|||
170577069|NCT01198574|616455489|FG001|Overall Study|Resigned from schools|1|||
170577070|NCT01198574|616455490|FG002|Overall Study|Resigned from schools|1|||
170577071|NCT01198574|616455491|FG003|Overall Study|Resigned from schools|4|||
170577072|NCT00325130|616455494|FG000|Overall Study|Lost to Follow-up|6|||
170577073|NCT00325130|616455495|FG001|Overall Study|Lost to Follow-up|14|||
170577074|NCT00325130|616455494|FG000|Overall Study|Withdrawal by Subject|12|||
170577075|NCT00325130|616455495|FG001|Overall Study|Withdrawal by Subject|14|||
170577076|NCT00325130|616455494|FG000|Overall Study|Protocol Deviation|0|||
170577077|NCT00325130|616455495|FG001|Overall Study|Protocol Deviation|1|||
170577078|NCT00325130|616455494|FG000|Overall Study|Moved|0|||
170577079|NCT00325130|616455495|FG001|Overall Study|Moved|1|||
170577080|NCT00325130|616455494|FG000|Overall Study|Patient Discontinued for Other|1|||
170577081|NCT00325130|616455495|FG001|Overall Study|Patient Discontinued for Other|0|||
170577082|NCT00948857|616457043|FG000|Overall Study|Lost to Follow-up|1|||
170577083|NCT00948857|616457044|FG001|Overall Study|Lost to Follow-up|0|||
170577084|NCT03430843|616457047|FG000|Overall Study|Death|233|||
170577085|NCT03430843|616457048|FG001|Overall Study|Death|233|||
170577086|NCT03430843|616457047|FG000|Overall Study|Sponsor Decision|17|||
170577087|NCT03430843|616457048|FG001|Overall Study|Sponsor Decision|6|||
170577088|NCT03430843|616457047|FG000|Overall Study|Withdrawal by Subject|5|||
170577089|NCT03430843|616457048|FG001|Overall Study|Withdrawal by Subject|14|||
170577090|NCT03430843|616457047|FG000|Overall Study|Lost to Follow-up|1|||
170577091|NCT03430843|616457048|FG001|Overall Study|Lost to Follow-up|3|||
170577092|NCT05396014|616457059|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
170577093|NCT05396014|616457060|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577094|NCT05396014|616457061|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577095|NCT05396014|616457062|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577096|NCT05396014|616457063|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577097|NCT05396014|616457064|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577098|NCT05396014|616457065|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577099|NCT05396014|616457066|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577100|NCT05396014|616457067|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577101|NCT05396014|616457068|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577102|NCT05396014|616457069|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577103|NCT05396014|616457070|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577104|NCT05396014|616457071|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577105|NCT05396014|616457072|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
170577106|NCT05396014|616457073|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577107|NCT05396014|616457074|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577108|NCT05396014|616457075|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577109|NCT05396014|616457076|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170809111|NCT01480258|617310509|FG001|Infant Series|Physician Decision|1|||
170809112|NCT01480258|617310508|FG000|Infant Series|Not Vaccinated|3|||
170809113|NCT01480258|617310509|FG001|Infant Series|Not Vaccinated|0|||
170809114|NCT01480258|617310508|FG000|Infant Series|Adverse Event|1|||
170577110|NCT05396014|616457077|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577111|NCT05396014|616457078|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577112|NCT05396014|616457079|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577113|NCT05396014|616457080|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577114|NCT05396014|616457081|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577115|NCT05396014|616457082|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577116|NCT05396014|616457083|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577117|NCT05396014|616457084|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577118|NCT05396014|616457085|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
170577119|NCT05396014|616457086|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577120|NCT05396014|616457087|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577121|NCT05396014|616457088|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577122|NCT05396014|616457089|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577123|NCT05396014|616457090|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577124|NCT05396014|616457091|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577125|NCT05396014|616457092|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577126|NCT05396014|616457093|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577127|NCT05396014|616457094|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577128|NCT05396014|616457095|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577129|NCT05396014|616457096|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577130|NCT05396014|616457097|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577131|NCT05396014|616457098|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
170577132|NCT05396014|616457099|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577133|NCT05396014|616457100|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577134|NCT05396014|616457101|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
170577135|NCT05396014|616457059|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
170577136|NCT05396014|616457060|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577137|NCT05396014|616457061|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577138|NCT05396014|616457062|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577139|NCT05396014|616457063|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577140|NCT05396014|616457064|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577141|NCT05396014|616457065|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577142|NCT05396014|616457066|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577143|NCT05396014|616457067|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577144|NCT05396014|616457068|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577145|NCT05396014|616457069|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577146|NCT05396014|616457070|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577147|NCT05396014|616457071|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577148|NCT05396014|616457072|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
170577149|NCT05396014|616457073|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577150|NCT05396014|616457074|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577151|NCT05396014|616457075|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577152|NCT05396014|616457076|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577153|NCT05396014|616457077|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577154|NCT05396014|616457078|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577155|NCT05396014|616457079|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577156|NCT05396014|616457080|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577157|NCT05396014|616457081|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577158|NCT05396014|616457082|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577159|NCT05396014|616457083|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577160|NCT05396014|616457084|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577161|NCT05396014|616457085|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
170577162|NCT05396014|616457086|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577163|NCT05396014|616457087|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577164|NCT05396014|616457088|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577165|NCT05396014|616457089|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577166|NCT05396014|616457090|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577167|NCT05396014|616457091|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577168|NCT05396014|616457092|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577169|NCT05396014|616457093|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577170|NCT05396014|616457094|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577171|NCT05396014|616457095|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577172|NCT05396014|616457096|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577173|NCT05396014|616457097|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577174|NCT05396014|616457098|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
170809115|NCT01480258|617310509|FG001|Infant Series|Adverse Event|1|||
170577175|NCT05396014|616457099|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577176|NCT05396014|616457100|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577177|NCT05396014|616457101|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
170577178|NCT05396014|616457059|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
170577179|NCT05396014|616457060|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577180|NCT05396014|616457061|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577181|NCT05396014|616457062|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577182|NCT05396014|616457063|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577183|NCT05396014|616457064|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577184|NCT05396014|616457065|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577185|NCT05396014|616457066|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577186|NCT05396014|616457067|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577187|NCT05396014|616457068|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577188|NCT05396014|616457069|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577189|NCT05396014|616457070|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577190|NCT05396014|616457071|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577191|NCT05396014|616457072|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
170577192|NCT05396014|616457073|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577193|NCT05396014|616457074|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577194|NCT05396014|616457075|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577195|NCT05396014|616457076|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577196|NCT05396014|616457077|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577197|NCT05396014|616457078|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577198|NCT05396014|616457079|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577199|NCT05396014|616457080|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577200|NCT05396014|616457081|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577201|NCT05396014|616457082|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577202|NCT05396014|616457083|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577203|NCT05396014|616457084|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577204|NCT05396014|616457085|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
170577205|NCT05396014|616457086|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577206|NCT05396014|616457087|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577207|NCT05396014|616457088|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577208|NCT05396014|616457089|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577209|NCT05396014|616457090|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577210|NCT05396014|616457091|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577211|NCT05396014|616457092|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577212|NCT05396014|616457093|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577213|NCT05396014|616457094|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577214|NCT05396014|616457095|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577215|NCT05396014|616457096|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577216|NCT05396014|616457097|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577217|NCT05396014|616457098|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
170577218|NCT05396014|616457099|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577219|NCT05396014|616457100|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577220|NCT05396014|616457101|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
170577221|NCT05396014|616457059|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577222|NCT05396014|616457060|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577223|NCT05396014|616457061|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577224|NCT05396014|616457062|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577225|NCT05396014|616457063|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577226|NCT05396014|616457064|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577227|NCT05396014|616457065|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577228|NCT05396014|616457066|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577229|NCT05396014|616457067|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577230|NCT05396014|616457068|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577231|NCT05396014|616457069|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577232|NCT05396014|616457070|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577233|NCT05396014|616457071|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577234|NCT05396014|616457072|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577235|NCT05396014|616457073|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577236|NCT05396014|616457074|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577237|NCT05396014|616457075|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577238|NCT05396014|616457076|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170809116|NCT01480258|617310508|FG000|Infant Series|Withdrawal by Subject|1|||
170809117|NCT01480258|617310509|FG001|Infant Series|Withdrawal by Subject|6|||
170809118|NCT01480258|617310508|FG000|Interim Period|Lost to Follow-up|0|||
170809119|NCT01480258|617310509|FG001|Interim Period|Lost to Follow-up|2|||
170809120|NCT01480258|617310508|FG000|Interim Period|Physician Decision|1|||
170577239|NCT05396014|616457077|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577240|NCT05396014|616457078|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577241|NCT05396014|616457079|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577242|NCT05396014|616457080|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577243|NCT05396014|616457081|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577244|NCT05396014|616457082|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577245|NCT05396014|616457083|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577246|NCT05396014|616457084|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577247|NCT05396014|616457085|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
170577248|NCT05396014|616457086|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577249|NCT05396014|616457087|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577250|NCT05396014|616457088|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577251|NCT05396014|616457089|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577252|NCT05396014|616457090|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577253|NCT05396014|616457091|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577254|NCT05396014|616457092|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577255|NCT05396014|616457093|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577256|NCT05396014|616457094|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577257|NCT05396014|616457095|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577258|NCT05396014|616457096|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577259|NCT05396014|616457097|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577260|NCT05396014|616457098|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
170577261|NCT05396014|616457099|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577262|NCT05396014|616457100|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577263|NCT05396014|616457101|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
170577264|NCT05396014|616457059|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577265|NCT05396014|616457060|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577266|NCT05396014|616457061|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577267|NCT05396014|616457062|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577268|NCT05396014|616457063|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577269|NCT05396014|616457064|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577270|NCT05396014|616457065|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577271|NCT05396014|616457066|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577272|NCT05396014|616457067|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577273|NCT05396014|616457068|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577274|NCT05396014|616457069|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577275|NCT05396014|616457070|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577276|NCT05396014|616457071|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577277|NCT05396014|616457072|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577278|NCT05396014|616457073|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577279|NCT05396014|616457074|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577280|NCT05396014|616457075|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577281|NCT05396014|616457076|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577282|NCT05396014|616457077|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577283|NCT05396014|616457078|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577284|NCT05396014|616457079|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577285|NCT05396014|616457080|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577286|NCT05396014|616457081|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577287|NCT05396014|616457082|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577288|NCT05396014|616457083|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577289|NCT05396014|616457084|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577290|NCT05396014|616457085|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
170577291|NCT05396014|616457086|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577292|NCT05396014|616457087|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577293|NCT05396014|616457088|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577294|NCT05396014|616457089|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577295|NCT05396014|616457090|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577296|NCT05396014|616457091|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577297|NCT05396014|616457092|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577298|NCT05396014|616457093|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577299|NCT05396014|616457094|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577300|NCT05396014|616457095|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577301|NCT05396014|616457096|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577302|NCT05396014|616457097|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170809121|NCT01480258|617310509|FG001|Interim Period|Physician Decision|0|||
170809122|NCT01480258|617310508|FG000|Interim Period|Protocol Violation|0|||
170577303|NCT05396014|616457098|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577304|NCT05396014|616457099|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577305|NCT05396014|616457100|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577306|NCT05396014|616457101|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
170577307|NCT05396014|616457059|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577308|NCT05396014|616457060|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577309|NCT05396014|616457061|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577310|NCT05396014|616457062|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577311|NCT05396014|616457063|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577312|NCT05396014|616457064|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577313|NCT05396014|616457065|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577314|NCT05396014|616457066|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577315|NCT05396014|616457067|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577316|NCT05396014|616457068|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577317|NCT05396014|616457069|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577318|NCT05396014|616457070|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577319|NCT05396014|616457071|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577320|NCT05396014|616457072|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
170577321|NCT05396014|616457073|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577322|NCT05396014|616457074|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577323|NCT05396014|616457075|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577324|NCT05396014|616457076|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577325|NCT05396014|616457077|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577326|NCT05396014|616457078|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577327|NCT05396014|616457079|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577328|NCT05396014|616457080|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577329|NCT05396014|616457081|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577330|NCT05396014|616457082|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577331|NCT05396014|616457083|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577332|NCT05396014|616457084|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577333|NCT05396014|616457085|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577334|NCT05396014|616457086|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577335|NCT05396014|616457087|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577336|NCT05396014|616457088|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577337|NCT05396014|616457089|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577338|NCT05396014|616457090|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577339|NCT05396014|616457091|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577340|NCT05396014|616457092|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577341|NCT05396014|616457093|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577342|NCT05396014|616457094|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577343|NCT05396014|616457095|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577344|NCT05396014|616457096|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577345|NCT05396014|616457097|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577346|NCT05396014|616457098|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577347|NCT05396014|616457099|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577348|NCT05396014|616457100|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577349|NCT05396014|616457101|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
170577350|NCT05396014|616457059|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
170577351|NCT05396014|616457060|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577352|NCT05396014|616457061|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577353|NCT05396014|616457062|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577354|NCT05396014|616457063|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577355|NCT05396014|616457064|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577356|NCT05396014|616457065|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577357|NCT05396014|616457066|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577358|NCT05396014|616457067|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577359|NCT05396014|616457068|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577360|NCT05396014|616457069|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577361|NCT05396014|616457070|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577362|NCT05396014|616457071|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577363|NCT05396014|616457072|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
170577364|NCT05396014|616457073|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577365|NCT05396014|616457074|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577366|NCT05396014|616457075|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577367|NCT05396014|616457076|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577368|NCT05396014|616457077|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577369|NCT05396014|616457078|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577370|NCT05396014|616457079|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577371|NCT05396014|616457080|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577372|NCT05396014|616457081|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577373|NCT05396014|616457082|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577374|NCT05396014|616457083|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577375|NCT05396014|616457084|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577376|NCT05396014|616457085|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577377|NCT05396014|616457086|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577378|NCT05396014|616457087|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577379|NCT05396014|616457088|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577380|NCT05396014|616457089|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577381|NCT05396014|616457090|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577382|NCT05396014|616457091|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577383|NCT05396014|616457092|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577384|NCT05396014|616457093|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577385|NCT05396014|616457094|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577386|NCT05396014|616457095|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577387|NCT05396014|616457096|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577388|NCT05396014|616457097|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577389|NCT05396014|616457098|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
170577390|NCT05396014|616457099|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577391|NCT05396014|616457100|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577392|NCT05396014|616457101|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
170577393|NCT05396014|616457059|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
170577394|NCT05396014|616457060|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577395|NCT05396014|616457061|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577396|NCT05396014|616457062|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577397|NCT05396014|616457063|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577398|NCT05396014|616457064|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577399|NCT05396014|616457065|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577400|NCT05396014|616457066|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577401|NCT05396014|616457067|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577402|NCT05396014|616457068|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577403|NCT05396014|616457069|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577404|NCT05396014|616457070|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577405|NCT05396014|616457071|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577406|NCT05396014|616457072|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577407|NCT05396014|616457073|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577408|NCT05396014|616457074|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577409|NCT05396014|616457075|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577410|NCT05396014|616457076|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577411|NCT05396014|616457077|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577412|NCT05396014|616457078|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577413|NCT05396014|616457079|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577414|NCT05396014|616457080|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577415|NCT05396014|616457081|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577416|NCT05396014|616457082|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577417|NCT05396014|616457083|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577418|NCT05396014|616457084|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577419|NCT05396014|616457085|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
170577420|NCT05396014|616457086|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577421|NCT05396014|616457087|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170809123|NCT01480258|617310509|FG001|Interim Period|Protocol Violation|1|||
170577422|NCT05396014|616457088|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577423|NCT05396014|616457089|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577424|NCT05396014|616457090|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577425|NCT05396014|616457091|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577426|NCT05396014|616457092|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577427|NCT05396014|616457093|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577428|NCT05396014|616457094|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577429|NCT05396014|616457095|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577430|NCT05396014|616457096|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577431|NCT05396014|616457097|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577432|NCT05396014|616457098|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577433|NCT05396014|616457099|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577434|NCT05396014|616457100|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577435|NCT05396014|616457101|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
170577436|NCT05396014|616457059|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577437|NCT05396014|616457060|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577438|NCT05396014|616457061|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577439|NCT05396014|616457062|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577440|NCT05396014|616457063|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577441|NCT05396014|616457064|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577442|NCT05396014|616457065|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577443|NCT05396014|616457066|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577444|NCT05396014|616457067|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577445|NCT05396014|616457068|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577446|NCT05396014|616457069|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577447|NCT05396014|616457070|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577448|NCT05396014|616457071|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577449|NCT05396014|616457072|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
170577450|NCT05396014|616457073|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577451|NCT05396014|616457074|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577452|NCT05396014|616457075|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577453|NCT05396014|616457076|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577454|NCT05396014|616457077|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577455|NCT05396014|616457078|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577456|NCT05396014|616457079|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577457|NCT05396014|616457080|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577458|NCT05396014|616457081|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577459|NCT05396014|616457082|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577460|NCT05396014|616457083|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577461|NCT05396014|616457084|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577462|NCT05396014|616457085|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577463|NCT05396014|616457086|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577464|NCT05396014|616457087|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577465|NCT05396014|616457088|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577466|NCT05396014|616457089|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577467|NCT05396014|616457090|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577468|NCT05396014|616457091|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577469|NCT05396014|616457092|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577470|NCT05396014|616457093|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577471|NCT05396014|616457094|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577472|NCT05396014|616457095|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577473|NCT05396014|616457096|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577474|NCT05396014|616457097|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577475|NCT05396014|616457098|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577476|NCT05396014|616457099|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577477|NCT05396014|616457100|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577478|NCT05396014|616457101|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
170577479|NCT05396014|616457059|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577480|NCT05396014|616457060|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577481|NCT05396014|616457061|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577482|NCT05396014|616457062|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
170577483|NCT05396014|616457063|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577484|NCT05396014|616457064|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577485|NCT05396014|616457065|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170809124|NCT01480258|617310508|FG000|Interim Period|Withdrawal by Subject|9|||
170809125|NCT01480258|617310509|FG001|Interim Period|Withdrawal by Subject|6|||
170577486|NCT05396014|616457066|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577487|NCT05396014|616457067|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
170577488|NCT05396014|616457068|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577489|NCT05396014|616457069|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577490|NCT05396014|616457070|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577491|NCT05396014|616457071|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577492|NCT05396014|616457072|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577493|NCT05396014|616457073|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577494|NCT05396014|616457074|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577495|NCT05396014|616457075|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577496|NCT05396014|616457076|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577497|NCT05396014|616457077|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577498|NCT05396014|616457078|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577499|NCT05396014|616457079|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577500|NCT05396014|616457080|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577501|NCT05396014|616457081|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577502|NCT05396014|616457082|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577503|NCT05396014|616457083|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577504|NCT05396014|616457084|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
170577505|NCT05396014|616457085|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577506|NCT05396014|616457086|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577507|NCT05396014|616457087|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577508|NCT05396014|616457088|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577509|NCT05396014|616457089|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577510|NCT05396014|616457090|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577511|NCT05396014|616457091|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577512|NCT05396014|616457092|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577513|NCT05396014|616457093|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577514|NCT05396014|616457094|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577515|NCT05396014|616457095|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577516|NCT05396014|616457096|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577517|NCT05396014|616457097|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577518|NCT05396014|616457098|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
170577519|NCT05396014|616457099|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
170577520|NCT05396014|616457100|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
170577521|NCT05396014|616457101|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
170577522|NCT05396014|616457059|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577523|NCT05396014|616457060|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577524|NCT05396014|616457061|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577525|NCT05396014|616457062|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577526|NCT05396014|616457063|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577527|NCT05396014|616457064|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577528|NCT05396014|616457065|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577529|NCT05396014|616457066|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577530|NCT05396014|616457067|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
170577531|NCT05396014|616457068|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577532|NCT05396014|616457069|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577533|NCT05396014|616457070|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577534|NCT05396014|616457071|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577535|NCT05396014|616457072|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577536|NCT05396014|616457073|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577537|NCT05396014|616457074|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577538|NCT05396014|616457075|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577539|NCT05396014|616457076|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577540|NCT05396014|616457077|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577541|NCT05396014|616457078|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577542|NCT05396014|616457079|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577543|NCT05396014|616457080|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577544|NCT05396014|616457081|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
170577545|NCT05396014|616457082|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577546|NCT05396014|616457083|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577547|NCT05396014|616457084|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577548|NCT05396014|616457085|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577549|NCT05396014|616457086|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577550|NCT05396014|616457087|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577551|NCT05396014|616457088|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577552|NCT05396014|616457089|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577553|NCT05396014|616457090|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577554|NCT05396014|616457091|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577555|NCT05396014|616457092|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577556|NCT05396014|616457093|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577557|NCT05396014|616457094|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
170577558|NCT05396014|616457095|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577559|NCT05396014|616457096|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577560|NCT05396014|616457097|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577561|NCT05396014|616457098|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
170577562|NCT05396014|616457099|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577563|NCT05396014|616457100|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
170577564|NCT05396014|616457101|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
170577565|NCT05396014|616457059|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577566|NCT05396014|616457060|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577567|NCT05396014|616457061|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577568|NCT05396014|616457062|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577569|NCT05396014|616457063|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577570|NCT05396014|616457064|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577571|NCT05396014|616457065|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577572|NCT05396014|616457066|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577573|NCT05396014|616457067|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577574|NCT05396014|616457068|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577575|NCT05396014|616457069|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577576|NCT05396014|616457070|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577577|NCT05396014|616457071|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577578|NCT05396014|616457072|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
170577579|NCT05396014|616457073|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577580|NCT05396014|616457074|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577581|NCT05396014|616457075|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577582|NCT05396014|616457076|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577583|NCT05396014|616457077|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577584|NCT05396014|616457078|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577585|NCT05396014|616457079|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577586|NCT05396014|616457080|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577587|NCT05396014|616457081|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577588|NCT05396014|616457082|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577589|NCT05396014|616457083|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577590|NCT05396014|616457084|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577591|NCT05396014|616457085|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
170577592|NCT05396014|616457086|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577593|NCT05396014|616457087|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577594|NCT05396014|616457088|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577595|NCT05396014|616457089|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577596|NCT05396014|616457090|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577597|NCT05396014|616457091|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577598|NCT05396014|616457092|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577599|NCT05396014|616457093|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
170577600|NCT05396014|616457094|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577601|NCT05396014|616457095|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577602|NCT05396014|616457096|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577603|NCT05396014|616457097|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577604|NCT05396014|616457098|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577605|NCT05396014|616457099|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577606|NCT05396014|616457100|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
170577607|NCT05396014|616457101|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
170577608|NCT05396014|616457059|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577609|NCT05396014|616457060|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577610|NCT05396014|616457061|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577611|NCT05396014|616457062|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170649469|NCT01029405|616730789|FG001|Overall Study|Withdrawal by Subject|1|||
170649470|NCT01029405|616730790|FG002|Overall Study|Withdrawal by Subject|2|||
170809126|NCT03052517|617310512|FG000|Overall Study|Study Terminated By Sponsor|928|||
170577612|NCT05396014|616457063|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577613|NCT05396014|616457064|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577614|NCT05396014|616457065|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577615|NCT05396014|616457066|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577616|NCT05396014|616457067|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577617|NCT05396014|616457068|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170649471|NCT01029405|616730791|FG003|Overall Study|Withdrawal by Subject|0|||
170577618|NCT05396014|616457069|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577619|NCT05396014|616457070|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577620|NCT05396014|616457071|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577621|NCT05396014|616457072|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577622|NCT05396014|616457073|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577623|NCT05396014|616457074|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577624|NCT05396014|616457075|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577625|NCT05396014|616457076|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577626|NCT05396014|616457077|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577627|NCT05396014|616457078|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577628|NCT05396014|616457079|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577629|NCT05396014|616457080|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577630|NCT05396014|616457081|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577631|NCT05396014|616457082|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577632|NCT05396014|616457083|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577633|NCT05396014|616457084|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577634|NCT05396014|616457085|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
170577635|NCT05396014|616457086|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577636|NCT05396014|616457087|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577637|NCT05396014|616457088|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577638|NCT05396014|616457089|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577639|NCT05396014|616457090|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577640|NCT05396014|616457091|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577641|NCT05396014|616457092|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577642|NCT05396014|616457093|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577643|NCT05396014|616457094|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577644|NCT05396014|616457095|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577645|NCT05396014|616457096|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577646|NCT05396014|616457097|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577647|NCT05396014|616457098|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577648|NCT05396014|616457099|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577649|NCT05396014|616457100|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577650|NCT05396014|616457101|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
170577651|NCT05258890|616457103|FG000|Overall Study|Patient withdrawal|6|||
170577652|NCT05258890|616457104|FG001|Overall Study|Patient withdrawal|7|||
170577653|NCT05258890|616457103|FG000|Overall Study|Patient lost to follow-up|10|||
170577654|NCT05258890|616457104|FG001|Overall Study|Patient lost to follow-up|3|||
170577655|NCT05258890|616457103|FG000|Overall Study|Social network member withdrawal|1|||
170577656|NCT05258890|616457104|FG001|Overall Study|Social network member withdrawal|0|||
170577657|NCT05258890|616457103|FG000|Overall Study|Social network member lost to follow-up|5|||
170577658|NCT05258890|616457104|FG001|Overall Study|Social network member lost to follow-up|0|||
170577659|NCT01238991|616457105|FG000|Overall Study|Adverse Event|1|||
170577660|NCT01238991|616457106|FG001|Overall Study|Adverse Event|0|||
170577661|NCT01238991|616457107|FG002|Overall Study|Adverse Event|3|||
170577662|NCT01238991|616457108|FG003|Overall Study|Adverse Event|1|||
170577663|NCT01238991|616457109|FG004|Overall Study|Adverse Event|1|||
170577664|NCT01238991|616457110|FG005|Overall Study|Adverse Event|0|||
170577665|NCT01238991|616457111|FG006|Overall Study|Adverse Event|1|||
170577666|NCT01238991|616457112|FG007|Overall Study|Adverse Event|1|||
170577667|NCT01238991|616457113|FG008|Overall Study|Adverse Event|0|||
170577668|NCT01238991|616457114|FG009|Overall Study|Adverse Event|0|||
170577669|NCT01238991|616457105|FG000|Overall Study|Death|0|||
170577670|NCT01238991|616457106|FG001|Overall Study|Death|0|||
170577671|NCT01238991|616457107|FG002|Overall Study|Death|0|||
170577672|NCT01238991|616457108|FG003|Overall Study|Death|1|||
170577673|NCT01238991|616457109|FG004|Overall Study|Death|0|||
170577674|NCT01238991|616457110|FG005|Overall Study|Death|0|||
170577675|NCT01238991|616457111|FG006|Overall Study|Death|0|||
170577676|NCT01238991|616457112|FG007|Overall Study|Death|0|||
170577677|NCT01238991|616457113|FG008|Overall Study|Death|0|||
170577678|NCT01238991|616457114|FG009|Overall Study|Death|0|||
170577679|NCT01238991|616457105|FG000|Overall Study|Lack of Efficacy|0|||
170577680|NCT01238991|616457106|FG001|Overall Study|Lack of Efficacy|0|||
170577681|NCT01238991|616457107|FG002|Overall Study|Lack of Efficacy|1|||
170577682|NCT01238991|616457108|FG003|Overall Study|Lack of Efficacy|0|||
170577683|NCT01238991|616457109|FG004|Overall Study|Lack of Efficacy|0|||
170577684|NCT01238991|616457110|FG005|Overall Study|Lack of Efficacy|0|||
170577685|NCT01238991|616457111|FG006|Overall Study|Lack of Efficacy|0|||
170577686|NCT01238991|616457112|FG007|Overall Study|Lack of Efficacy|0|||
170577687|NCT01238991|616457113|FG008|Overall Study|Lack of Efficacy|1|||
170577688|NCT01238991|616457114|FG009|Overall Study|Lack of Efficacy|0|||
170577689|NCT01238991|616457105|FG000|Overall Study|Withdrawal by Subject|0|||
170577690|NCT01238991|616457106|FG001|Overall Study|Withdrawal by Subject|0|||
170577691|NCT01238991|616457107|FG002|Overall Study|Withdrawal by Subject|1|||
170577692|NCT01238991|616457108|FG003|Overall Study|Withdrawal by Subject|0|||
170577693|NCT01238991|616457109|FG004|Overall Study|Withdrawal by Subject|0|||
170577694|NCT01238991|616457110|FG005|Overall Study|Withdrawal by Subject|0|||
170577695|NCT01238991|616457111|FG006|Overall Study|Withdrawal by Subject|0|||
170577696|NCT01238991|616457112|FG007|Overall Study|Withdrawal by Subject|0|||
170577697|NCT01238991|616457113|FG008|Overall Study|Withdrawal by Subject|0|||
170577698|NCT01238991|616457114|FG009|Overall Study|Withdrawal by Subject|0|||
170577699|NCT01238991|616457105|FG000|Overall Study|Study Terminated by Sponsor|0|||
170577700|NCT01238991|616457106|FG001|Overall Study|Study Terminated by Sponsor|0|||
170577701|NCT01238991|616457107|FG002|Overall Study|Study Terminated by Sponsor|0|||
170577702|NCT01238991|616457108|FG003|Overall Study|Study Terminated by Sponsor|0|||
170577703|NCT01238991|616457109|FG004|Overall Study|Study Terminated by Sponsor|1|||
170577704|NCT01238991|616457110|FG005|Overall Study|Study Terminated by Sponsor|0|||
170577705|NCT01238991|616457111|FG006|Overall Study|Study Terminated by Sponsor|7|||
170577706|NCT01238991|616457112|FG007|Overall Study|Study Terminated by Sponsor|4|||
170577707|NCT01238991|616457113|FG008|Overall Study|Study Terminated by Sponsor|2|||
170577708|NCT01238991|616457114|FG009|Overall Study|Study Terminated by Sponsor|2|||
170577709|NCT01238991|616457105|FG000|Overall Study|Caregiver's request|0|||
170577710|NCT01238991|616457106|FG001|Overall Study|Caregiver's request|0|||
170577711|NCT01238991|616457107|FG002|Overall Study|Caregiver's request|0|||
170577712|NCT01238991|616457108|FG003|Overall Study|Caregiver's request|0|||
170577713|NCT01238991|616457109|FG004|Overall Study|Caregiver's request|0|||
170577714|NCT01238991|616457110|FG005|Overall Study|Caregiver's request|0|||
170577715|NCT01238991|616457111|FG006|Overall Study|Caregiver's request|0|||
170577716|NCT01238991|616457112|FG007|Overall Study|Caregiver's request|0|||
170577717|NCT01238991|616457113|FG008|Overall Study|Caregiver's request|1|||
170577718|NCT01238991|616457114|FG009|Overall Study|Caregiver's request|0|||
170577719|NCT01238991|616457105|FG000|Overall Study|Admission to a nursing home|1|||
170577720|NCT01238991|616457106|FG001|Overall Study|Admission to a nursing home|0|||
170577721|NCT01238991|616457107|FG002|Overall Study|Admission to a nursing home|1|||
170577722|NCT01238991|616457108|FG003|Overall Study|Admission to a nursing home|0|||
170577723|NCT01238991|616457109|FG004|Overall Study|Admission to a nursing home|0|||
170577724|NCT01238991|616457110|FG005|Overall Study|Admission to a nursing home|0|||
170577725|NCT01238991|616457111|FG006|Overall Study|Admission to a nursing home|0|||
170577726|NCT01238991|616457112|FG007|Overall Study|Admission to a nursing home|0|||
170577727|NCT01238991|616457113|FG008|Overall Study|Admission to a nursing home|0|||
170577728|NCT01238991|616457114|FG009|Overall Study|Admission to a nursing home|0|||
170577729|NCT01893411|616457120|FG000|Overall Study|Protocol Violation|1|||
170577730|NCT01893411|616457121|FG001|Overall Study|Protocol Violation|0|||
170577731|NCT01893411|616457122|FG002|Overall Study|Protocol Violation|0|||
170577732|NCT01893411|616457120|FG000|Overall Study|Physician Decision|1|||
170577733|NCT01893411|616457121|FG001|Overall Study|Physician Decision|1|||
170577734|NCT01893411|616457122|FG002|Overall Study|Physician Decision|2|||
170577735|NCT01893411|616457120|FG000|Overall Study|Lack of Efficacy|2|||
170577736|NCT01893411|616457121|FG001|Overall Study|Lack of Efficacy|1|||
170577737|NCT01893411|616457122|FG002|Overall Study|Lack of Efficacy|0|||
170577738|NCT01893411|616457120|FG000|Overall Study|Other|3|||
170577739|NCT01893411|616457121|FG001|Overall Study|Other|1|||
170577740|NCT01893411|616457122|FG002|Overall Study|Other|3|||
170577741|NCT01893411|616457120|FG000|Overall Study|Adverse Event|1|||
170577742|NCT01893411|616457121|FG001|Overall Study|Adverse Event|0|||
170577743|NCT01893411|616457122|FG002|Overall Study|Adverse Event|0|||
170577744|NCT01893411|616457120|FG000|Overall Study|Withdrawal by Subject|7|||
170577745|NCT01893411|616457121|FG001|Overall Study|Withdrawal by Subject|4|||
170577746|NCT01893411|616457122|FG002|Overall Study|Withdrawal by Subject|3|||
170577747|NCT01893411|616457120|FG000|Overall Study|Lost to Follow-up|2|||
170577748|NCT01893411|616457121|FG001|Overall Study|Lost to Follow-up|0|||
170577749|NCT01893411|616457122|FG002|Overall Study|Lost to Follow-up|1|||
170577750|NCT00566982|616457123|FG000|Overall Study|Adverse Event|6|||
170577751|NCT00566982|616457124|FG001|Overall Study|Adverse Event|48|||
170577752|NCT00566982|616457123|FG000|Overall Study|Withdrawal by Subject|1|||
170649472|NCT01029405|616730788|FG000|Overall Study|Protocol Violation|0|||
170577753|NCT00566982|616457124|FG001|Overall Study|Withdrawal by Subject|14|||
170577754|NCT00566982|616457123|FG000|Overall Study|Protocol Violation|1|||
170577755|NCT00566982|616457124|FG001|Overall Study|Protocol Violation|4|||
170577756|NCT00566982|616457123|FG000|Overall Study|Lost to Follow-up|0|||
170577757|NCT00566982|616457124|FG001|Overall Study|Lost to Follow-up|1|||
170577758|NCT00566982|616457123|FG000|Overall Study|Other-family problems & doctor's request|0|||
170577759|NCT00566982|616457124|FG001|Overall Study|Other-family problems & doctor's request|2|||
170577760|NCT00854724|616457125|FG000|First Intervention|Withdrawal by Subject|1|||
170577761|NCT00854724|616457126|FG001|First Intervention|Withdrawal by Subject|1|||
170577762|NCT00854724|616457125|FG000|Washout|Protocol Violation|1|||
170577763|NCT00854724|616457126|FG001|Washout|Protocol Violation|0|||
170577764|NCT00854724|616457125|FG000|Washout|Withdrawal by Subject|0|||
170577765|NCT00854724|616457126|FG001|Washout|Withdrawal by Subject|1|||
170577766|NCT00854724|616457125|FG000|Second Intervention|Protocol Violation|1|||
170577767|NCT00854724|616457126|FG001|Second Intervention|Protocol Violation|0|||
170577768|NCT00854724|616457125|FG000|Second Intervention|Physician Decision|0|||
170577769|NCT00854724|616457126|FG001|Second Intervention|Physician Decision|1|||
170577770|NCT02013778|616457129|FG000|Overall Study|Death|4|||
170577771|NCT02013778|616457129|FG000|Overall Study|Withdrawal by Subject|1|||
170577772|NCT02013778|616457129|FG000|Overall Study|Physician Decision|1|||
170577773|NCT02013778|616457129|FG000|Overall Study|Adverse Event|1|||
170577774|NCT02719691|616457130|FG000|Overall Study|Physician Decision|0|||
170577775|NCT02719691|616457131|FG001|Overall Study|Physician Decision|0|||
170577776|NCT02719691|616457132|FG002|Overall Study|Physician Decision|1|||
170577777|NCT02719691|616457133|FG003|Overall Study|Physician Decision|0|||
170577778|NCT02719691|616457134|FG004|Overall Study|Physician Decision|0|||
170577779|NCT02719691|616457135|FG005|Overall Study|Physician Decision|0|||
170577780|NCT02719691|616457136|FG006|Overall Study|Physician Decision|0|||
170577781|NCT02719691|616457130|FG000|Overall Study|Withdrawal by Subject|0|||
170577782|NCT02719691|616457131|FG001|Overall Study|Withdrawal by Subject|0|||
170577783|NCT02719691|616457132|FG002|Overall Study|Withdrawal by Subject|0|||
170577784|NCT02719691|616457133|FG003|Overall Study|Withdrawal by Subject|0|||
170577785|NCT02719691|616457134|FG004|Overall Study|Withdrawal by Subject|0|||
170577786|NCT02719691|616457135|FG005|Overall Study|Withdrawal by Subject|1|||
170577787|NCT02719691|616457136|FG006|Overall Study|Withdrawal by Subject|0|||
170577788|NCT00336284|616457137|FG000|Overall Study|Death|52|||
170577789|NCT00336284|616457138|FG001|Overall Study|Death|26|||
170577790|NCT00336284|616457137|FG000|Overall Study|Lost to Follow-up|82|||
170577791|NCT00336284|616457138|FG001|Overall Study|Lost to Follow-up|61|||
170577792|NCT00336284|616457137|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
170577793|NCT00336284|616457138|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
170577794|NCT00861757|616457141|FG000|Overall Study|Adverse Event|1|||
170577795|NCT00861757|616457142|FG001|Overall Study|Adverse Event|5|||
170577796|NCT00861757|616457143|FG002|Overall Study|Adverse Event|7|||
170577797|NCT00861757|616457144|FG003|Overall Study|Adverse Event|2|||
170577798|NCT00861757|616457141|FG000|Overall Study|Entry Criteria Not Met|1|||
170577799|NCT00861757|616457142|FG001|Overall Study|Entry Criteria Not Met|2|||
170577800|NCT00861757|616457143|FG002|Overall Study|Entry Criteria Not Met|1|||
170577801|NCT00861757|616457144|FG003|Overall Study|Entry Criteria Not Met|1|||
170577802|NCT00861757|616457141|FG000|Overall Study|Lack of Efficacy|3|||
170577803|NCT00861757|616457142|FG001|Overall Study|Lack of Efficacy|1|||
170577804|NCT00861757|616457143|FG002|Overall Study|Lack of Efficacy|0|||
170577805|NCT00861757|616457144|FG003|Overall Study|Lack of Efficacy|1|||
170577806|NCT00861757|616457141|FG000|Overall Study|Lost to Follow-up|1|||
170577807|NCT00861757|616457142|FG001|Overall Study|Lost to Follow-up|0|||
170577808|NCT00861757|616457143|FG002|Overall Study|Lost to Follow-up|1|||
170577809|NCT00861757|616457144|FG003|Overall Study|Lost to Follow-up|1|||
170577810|NCT00861757|616457141|FG000|Overall Study|Physician Decision|0|||
170577811|NCT00861757|616457142|FG001|Overall Study|Physician Decision|0|||
170577812|NCT00861757|616457143|FG002|Overall Study|Physician Decision|0|||
170577813|NCT00861757|616457144|FG003|Overall Study|Physician Decision|1|||
170577814|NCT00861757|616457141|FG000|Overall Study|Protocol Violation|2|||
170577815|NCT00861757|616457142|FG001|Overall Study|Protocol Violation|2|||
170577816|NCT00861757|616457143|FG002|Overall Study|Protocol Violation|4|||
170577817|NCT00861757|616457144|FG003|Overall Study|Protocol Violation|1|||
170577818|NCT00861757|616457141|FG000|Overall Study|Withdrawal by Subject|1|||
170577819|NCT00861757|616457142|FG001|Overall Study|Withdrawal by Subject|5|||
170577820|NCT00861757|616457143|FG002|Overall Study|Withdrawal by Subject|5|||
170577821|NCT00861757|616457144|FG003|Overall Study|Withdrawal by Subject|2|||
170577822|NCT03308968|616457146|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
170577823|NCT03308968|616457147|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
170577824|NCT03308968|616457148|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
170577825|NCT03308968|616457146|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
170577826|NCT03308968|616457147|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
170577827|NCT03308968|616457148|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
170577828|NCT03308968|616457146|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
170909883|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Death|0|||
170909884|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
170909885|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
170909886|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
170909887|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
170577829|NCT03308968|616457147|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
170577830|NCT03308968|616457148|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
170577831|NCT03308968|616457146|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
170577832|NCT03308968|616457147|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
170577833|NCT03308968|616457148|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
170577834|NCT03308968|616457146|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
170577835|NCT03308968|616457147|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
170577836|NCT03308968|616457148|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
170577837|NCT03308968|616457146|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
170577838|NCT03308968|616457147|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
170577839|NCT03308968|616457148|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
170577840|NCT03308968|616457146|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
170577841|NCT03308968|616457147|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
170577842|NCT03308968|616457148|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
170577843|NCT03308968|616457146|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
170577844|NCT03308968|616457147|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
170577845|NCT03308968|616457148|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
170577846|NCT03308968|616457146|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
170577847|NCT03308968|616457147|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
170577848|NCT03308968|616457148|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
170577849|NCT03308968|616457146|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
170577850|NCT03308968|616457147|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
170577851|NCT03308968|616457148|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
170577852|NCT03308968|616457146|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
170577853|NCT03308968|616457147|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
170577854|NCT03308968|616457148|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
170577855|NCT03308968|616457146|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
170577856|NCT03308968|616457147|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
170577857|NCT03308968|616457148|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
170577858|NCT03308968|616457146|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
170577859|NCT03308968|616457147|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
170577860|NCT03308968|616457148|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
170577861|NCT03308968|616457146|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
170577862|NCT03308968|616457147|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
170577863|NCT03308968|616457148|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
170577864|NCT00135330|616457151|FG000|Overall Study|Adverse Event|2|||
170577865|NCT00135330|616457152|FG001|Overall Study|Adverse Event|5|||
170577866|NCT00135330|616457153|FG002|Overall Study|Adverse Event|1|||
170577867|NCT00135330|616457151|FG000|Overall Study|Lost to Follow-up|0|||
170577868|NCT00135330|616457152|FG001|Overall Study|Lost to Follow-up|2|||
170577869|NCT00135330|616457153|FG002|Overall Study|Lost to Follow-up|3|||
170577870|NCT00135330|616457151|FG000|Overall Study|Physician Decision|1|||
170577871|NCT00135330|616457152|FG001|Overall Study|Physician Decision|1|||
170577872|NCT00135330|616457153|FG002|Overall Study|Physician Decision|0|||
170577873|NCT00135330|616457151|FG000|Overall Study|Protocol Violation|4|||
170577874|NCT00135330|616457152|FG001|Overall Study|Protocol Violation|3|||
170577875|NCT00135330|616457153|FG002|Overall Study|Protocol Violation|3|||
170577876|NCT00135330|616457151|FG000|Overall Study|Patient Decision|5|||
170577877|NCT00135330|616457152|FG001|Overall Study|Patient Decision|1|||
170577878|NCT00135330|616457153|FG002|Overall Study|Patient Decision|4|||
170577879|NCT00135330|616457151|FG000|Overall Study|Sponsor Decision|0|||
170577880|NCT00135330|616457152|FG001|Overall Study|Sponsor Decision|1|||
170577881|NCT00135330|616457153|FG002|Overall Study|Sponsor Decision|0|||
170577882|NCT02096952|616457154|FG000|Overall Study|Adverse Event|1|||
170577883|NCT00624468|616457157|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
170577884|NCT00624468|616457158|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
170577885|NCT00624468|616457159|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
170577886|NCT00624468|616457160|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
170577887|NCT00624468|616457157|FG000|Double-blind Period|Withdrew Prematurely|1|||
170577888|NCT00624468|616457158|FG001|Double-blind Period|Withdrew Prematurely|1|||
170577889|NCT00624468|616457159|FG002|Double-blind Period|Withdrew Prematurely|0|||
170577890|NCT00624468|616457160|FG003|Double-blind Period|Withdrew Prematurely|0|||
170577891|NCT00624468|616457157|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
170577892|NCT00624468|616457158|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
170577893|NCT00624468|616457159|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
170577894|NCT00624468|616457160|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
170577895|NCT00624468|616457157|FG000|Safety Follow-up (SFU) Period|Other|0|||
170577896|NCT00624468|616457158|FG001|Safety Follow-up (SFU) Period|Other|0|||
170577897|NCT00624468|616457159|FG002|Safety Follow-up (SFU) Period|Other|1|||
170577898|NCT00624468|616457160|FG003|Safety Follow-up (SFU) Period|Other|1|||
170577899|NCT03520920|616457161|FG000|Overall Study|Death|13|||
170577900|NCT03520920|616457162|FG001|Overall Study|Death|1|||
170577901|NCT03520920|616457163|FG002|Overall Study|Death|0|||
170577902|NCT03520920|616457161|FG000|Overall Study|Withdrawal by Subject|2|||
170577903|NCT03520920|616457162|FG001|Overall Study|Withdrawal by Subject|1|||
170577904|NCT03520920|616457163|FG002|Overall Study|Withdrawal by Subject|0|||
170577905|NCT03520920|616457161|FG000|Overall Study|Study Terminated by the Sponsor|5|||
170577906|NCT03520920|616457162|FG001|Overall Study|Study Terminated by the Sponsor|14|||
170577907|NCT03520920|616457163|FG002|Overall Study|Study Terminated by the Sponsor|5|||
170577908|NCT00372619|616457166|FG000|Overall Study|Ineligible|0|||
170577909|NCT00372619|616457167|FG001|Overall Study|Ineligible|0|||
170577910|NCT00372619|616457168|FG002|Overall Study|Ineligible|0|||
170577911|NCT00372619|616457169|FG003|Overall Study|Ineligible|0|||
170577912|NCT00372619|616457170|FG004|Overall Study|Ineligible|0|||
170577913|NCT00372619|616457171|FG005|Overall Study|Ineligible|2|||
170577914|NCT00372619|616457172|FG006|Overall Study|Ineligible|0|||
170577915|NCT00372619|616457166|FG000|Overall Study|Inevaluable|0|||
170577916|NCT00372619|616457167|FG001|Overall Study|Inevaluable|0|||
170577917|NCT00372619|616457168|FG002|Overall Study|Inevaluable|0|||
170577918|NCT00372619|616457169|FG003|Overall Study|Inevaluable|0|||
170577919|NCT00372619|616457170|FG004|Overall Study|Inevaluable|0|||
170577920|NCT00372619|616457171|FG005|Overall Study|Inevaluable|1|||
170577921|NCT00372619|616457172|FG006|Overall Study|Inevaluable|0|||
170577922|NCT00066222|616457173|FG000|Overall Study|No protocol treatment received|1|||
170577923|NCT00405392|616457174|FG000|Overall Study|Adverse Event|15|||
170577924|NCT00405392|616457175|FG001|Overall Study|Adverse Event|14|||
170577925|NCT00405392|616457174|FG000|Overall Study|Did not meet Eligibility criteria|7|||
170577926|NCT00405392|616457175|FG001|Overall Study|Did not meet Eligibility criteria|2|||
170577927|NCT00405392|616457174|FG000|Overall Study|Withdrawal by Subject|4|||
170577928|NCT00405392|616457175|FG001|Overall Study|Withdrawal by Subject|3|||
170577929|NCT00405392|616457174|FG000|Overall Study|Lost to Follow-up|1|||
170577930|NCT00405392|616457175|FG001|Overall Study|Lost to Follow-up|2|||
170577931|NCT00405392|616457174|FG000|Overall Study|Data missing|2|||
170577932|NCT00405392|616457175|FG001|Overall Study|Data missing|0|||
170577933|NCT00405392|616457174|FG000|Overall Study|Non-compliance|0|||
170577934|NCT00405392|616457175|FG001|Overall Study|Non-compliance|1|||
170577935|NCT00405392|616457174|FG000|Overall Study|Other|1|||
170577936|NCT00405392|616457175|FG001|Overall Study|Other|5|||
170577937|NCT00635349|616457176|FG000|Overall Study|Other|8|||
170577938|NCT00635349|616457177|FG001|Overall Study|Other|6|||
170577939|NCT00635349|616457176|FG000|Overall Study|Protocol Violation|18|||
170577940|NCT00635349|616457177|FG001|Overall Study|Protocol Violation|22|||
170577941|NCT00635349|616457176|FG000|Overall Study|Withdrawal by Subject|3|||
170577942|NCT00635349|616457177|FG001|Overall Study|Withdrawal by Subject|8|||
170577943|NCT00635349|616457176|FG000|Overall Study|Lost to Follow-up|4|||
170577944|NCT00635349|616457177|FG001|Overall Study|Lost to Follow-up|3|||
170577945|NCT00635349|616457176|FG000|Overall Study|Adverse Event|11|||
170577946|NCT00635349|616457177|FG001|Overall Study|Adverse Event|9|||
170577947|NCT01703091|616457178|FG000|Overall Study|Adverse Event|5|||
170577948|NCT01703091|616457179|FG001|Overall Study|Adverse Event|3|||
170577949|NCT01703091|616457178|FG000|Overall Study|Physician Decision|2|||
170577950|NCT01703091|616457179|FG001|Overall Study|Physician Decision|1|||
170577951|NCT01703091|616457178|FG000|Overall Study|Withdrawal by Subject|1|||
170577952|NCT01703091|616457179|FG001|Overall Study|Withdrawal by Subject|0|||
170577953|NCT01703091|616457178|FG000|Overall Study|Sponsor Decision|1|||
170577954|NCT01703091|616457179|FG001|Overall Study|Sponsor Decision|0|||
170577955|NCT05384834|616457183|FG000|Overall Study|Lost to Follow-up|43|||
170577956|NCT05384834|616457183|FG000|Overall Study|Withdrawal by Subject|5|||
170577957|NCT01871545|616457184|FG000|Overall Study|Death|2|||
170577958|NCT01871545|616457185|FG001|Overall Study|Death|0|||
170577959|NCT01871545|616457184|FG000|Overall Study|Lack of Efficacy|11|||
170577960|NCT01871545|616457185|FG001|Overall Study|Lack of Efficacy|2|||
170577961|NCT01871545|616457184|FG000|Overall Study|Physician Decision|4|||
170577962|NCT01871545|616457185|FG001|Overall Study|Physician Decision|0|||
170577963|NCT01871545|616457184|FG000|Overall Study|Withdrawal by Subject|0|||
170577964|NCT01871545|616457185|FG001|Overall Study|Withdrawal by Subject|1|||
170577965|NCT01523743|616457186|FG000|Period 1|Adverse Event|1|||
170577966|NCT01523743|616457187|FG001|Period 1|Adverse Event|0|||
170577967|NCT01523743|616457186|FG000|Period 1|Withdrawal by Subject|6|||
170577968|NCT01523743|616457187|FG001|Period 1|Withdrawal by Subject|2|||
170577969|NCT01523743|616457186|FG000|Period 1|Lost to Follow-up|1|||
170577970|NCT01523743|616457187|FG001|Period 1|Lost to Follow-up|0|||
170577971|NCT01523743|616457186|FG000|Period 1|Lack of Efficacy|1|||
170577972|NCT01523743|616457187|FG001|Period 1|Lack of Efficacy|0|||
170577973|NCT01523743|616457186|FG000|Period 1|Felt unable to empty bladder|1|||
170577974|NCT01523743|616457187|FG001|Period 1|Felt unable to empty bladder|0|||
170577975|NCT01523743|616457186|FG000|Period 2|Withdrawal by Subject|0|||
170577976|NCT01523743|616457187|FG001|Period 2|Withdrawal by Subject|2|||
170577977|NCT01523743|616457186|FG000|Period 2|Adverse Event|1|||
170577978|NCT01523743|616457187|FG001|Period 2|Adverse Event|0|||
170577979|NCT04283656|616457188|FG000|Overall Study|Adverse Event|1|||
170577980|NCT04283656|616457189|FG001|Overall Study|Adverse Event|0|||
170577981|NCT04283656|616457188|FG000|Overall Study|Lost to Follow-up|0|||
170577982|NCT04283656|616457189|FG001|Overall Study|Lost to Follow-up|1|||
170577983|NCT00995436|616457191|FG000|Overall Study|Withdrawal by Subject|2|||
170577984|NCT00995436|616457192|FG001|Overall Study|Withdrawal by Subject|5|||
170577985|NCT00995436|616457193|FG002|Overall Study|Withdrawal by Subject|0|||
170577986|NCT01107392|616457194|FG000|Overall Study|Adverse Event|2|||
170577987|NCT01107392|616457195|FG001|Overall Study|Adverse Event|0|||
170577988|NCT01107392|616457194|FG000|Overall Study|Personal Reasons|2|||
170577989|NCT01107392|616457195|FG001|Overall Study|Personal Reasons|3|||
170577990|NCT01107392|616457194|FG000|Overall Study|Administrative decision|1|||
170577991|NCT01107392|616457195|FG001|Overall Study|Administrative decision|0|||
170577992|NCT01232127|616457196|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
170577993|NCT01232127|616457197|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
170577994|NCT01232127|616457198|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
170577995|NCT03162796|616457202|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
170577996|NCT03162796|616457203|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
170577997|NCT03162796|616457204|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
170577998|NCT03162796|616457202|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
170577999|NCT03162796|616457203|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
170578000|NCT03162796|616457204|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
170578001|NCT03162796|616457202|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
170578002|NCT03162796|616457203|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
170578003|NCT03162796|616457204|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
170578004|NCT03162796|616457202|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
170578005|NCT03162796|616457203|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
170578006|NCT03162796|616457204|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
170578007|NCT03162796|616457202|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
170578008|NCT03162796|616457203|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
170578009|NCT03162796|616457204|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
170578010|NCT03162796|616457202|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
170578011|NCT03162796|616457203|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
170578012|NCT03162796|616457204|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
170578013|NCT03162796|616457202|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
170578014|NCT03162796|616457203|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
170578015|NCT03162796|616457204|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
170578016|NCT03162796|616457202|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
170578017|NCT03162796|616457203|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
170578018|NCT03162796|616457204|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
170578019|NCT03162796|616457202|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
170578020|NCT03162796|616457203|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
170578021|NCT03162796|616457204|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
170578022|NCT03162796|616457202|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
170578023|NCT03162796|616457203|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
170578024|NCT03162796|616457204|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
170578025|NCT03162796|616457202|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
170578026|NCT03162796|616457203|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
170578027|NCT03162796|616457204|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
170578028|NCT02342288|616457208|FG000|Overall Study|no protocol anesthesiologist available|3|||
170578029|NCT02342288|616457209|FG001|Overall Study|no protocol anesthesiologist available|2|||
170578030|NCT02342288|616457208|FG000|Overall Study|anesthesia leak in system|1|||
170578031|NCT02342288|616457209|FG001|Overall Study|anesthesia leak in system|0|||
170578032|NCT02342288|616457208|FG000|Overall Study|Withdrawal by Subject|1|||
170578033|NCT02342288|616457209|FG001|Overall Study|Withdrawal by Subject|0|||
170578034|NCT02342288|616457208|FG000|Overall Study|coordinator contaminated with blood|0|||
170578035|NCT02342288|616457209|FG001|Overall Study|coordinator contaminated with blood|1|||
170578036|NCT02342288|616457208|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
170578037|NCT02342288|616457209|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
170578038|NCT02342288|616457208|FG000|Overall Study|coordinator not available|0|||
170578039|NCT02342288|616457209|FG001|Overall Study|coordinator not available|2|||
170578040|NCT03299244|616457210|FG000|Overall Study|Withdrawal by Subject|34|||
170578041|NCT03299244|616457211|FG001|Overall Study|Withdrawal by Subject|29|||
170578042|NCT03299244|616457210|FG000|Overall Study|Decision by Sponsor|4|||
170578043|NCT03299244|616457211|FG001|Overall Study|Decision by Sponsor|5|||
170578044|NCT03299244|616457210|FG000|Overall Study|Death|9|||
170578045|NCT03299244|616457211|FG001|Overall Study|Death|4|||
170578046|NCT00145626|616457213|FG000|Overall Study|Did not have NK infusions|2|||
170578047|NCT00145626|616457213|FG000|Overall Study|Turned 2 years old before treatment|1|||
170578048|NCT00145626|616457213|FG000|Overall Study|Death|1|||
170578049|NCT00145626|616457213|FG000|Overall Study|Withdrawal by Subject|1|||
170578050|NCT03744910|616458819|FG000|Overall Study|Withdrew Consent|1|||
170578051|NCT03744910|616458820|FG001|Overall Study|Withdrew Consent|8|||
170578052|NCT03744910|616458819|FG000|Overall Study|Physician Decision|5|||
170578053|NCT03744910|616458820|FG001|Overall Study|Physician Decision|4|||
170578054|NCT03744910|616458819|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
170578055|NCT03744910|616458820|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
170578056|NCT03744910|616458819|FG000|Overall Study|Lost to Follow-up|0|||
170578057|NCT03744910|616458820|FG001|Overall Study|Lost to Follow-up|1|||
170578058|NCT03744910|616458819|FG000|Overall Study|Other-unspecified|4|||
170578059|NCT03744910|616458820|FG001|Overall Study|Other-unspecified|1|||
170578060|NCT02744612|616458821|FG000|Overall Study|Withdrawal by Subject|0|||
170649473|NCT01029405|616730789|FG001|Overall Study|Protocol Violation|0|||
170578061|NCT02744612|616458822|FG001|Overall Study|Withdrawal by Subject|2|||
170578062|NCT03280303|616458823|FG000|Overall Study|Death|505|||
170578063|NCT03280303|616458823|FG000|Overall Study|Study terminated by sponsor|383|||
170578064|NCT03280303|616458823|FG000|Overall Study|Other|148|||
170578065|NCT03280303|616458823|FG000|Overall Study|No longer willing to participate in study|101|||
170578066|NCT03280303|616458823|FG000|Overall Study|Lost to follow up|39|||
170578067|NCT03280303|616458823|FG000|Overall Study|Adverse Event|20|||
170578068|NCT00064259|616458824|FG000|Overall Study|Adverse Event|1|||
170578069|NCT00064259|616458825|FG001|Overall Study|Adverse Event|0|||
170578070|NCT00064259|616458826|FG002|Overall Study|Adverse Event|0|||
170578071|NCT00064259|616458827|FG003|Overall Study|Adverse Event|1|||
170578072|NCT03419897|616458828|FG000|Overall Study|Death|180|||
170578073|NCT03419897|616458828|FG000|Overall Study|Lost to Follow-up|1|||
170578074|NCT03419897|616458828|FG000|Overall Study|Withdrawal by Subject|6|||
170578075|NCT03419897|616458828|FG000|Overall Study|Sponsor Decision|61|||
170578076|NCT03419897|616458828|FG000|Overall Study|Physician Decision|1|||
170578077|NCT00078806|616458833|FG000|Part 1A|Adverse Event|2|||
170578078|NCT00078806|616458834|FG001|Part 1A|Adverse Event|0|||
170578079|NCT00078806|616458835|FG002|Part 1A|Adverse Event|0|||
170578080|NCT00078806|616458836|FG003|Part 1A|Adverse Event|0|||
170578081|NCT00078806|616458833|FG000|Part 1A|Lack of Efficacy|7|||
170578082|NCT00078806|616458834|FG001|Part 1A|Lack of Efficacy|0|||
170809127|NCT03052517|617310513|FG001|Overall Study|Study Terminated By Sponsor|938|||
170809128|NCT03052517|617310514|FG002|Overall Study|Study Terminated By Sponsor|296|||
170809129|NCT03052517|617310512|FG000|Overall Study|Subject/Guardian Decision|50|||
170809130|NCT03052517|617310513|FG001|Overall Study|Subject/Guardian Decision|45|||
170809131|NCT03052517|617310514|FG002|Overall Study|Subject/Guardian Decision|22|||
170809132|NCT03052517|617310512|FG000|Overall Study|Lack of Efficacy|23|||
170809133|NCT03052517|617310513|FG001|Overall Study|Lack of Efficacy|14|||
170809134|NCT03052517|617310514|FG002|Overall Study|Lack of Efficacy|7|||
170809135|NCT03052517|617310512|FG000|Overall Study|Adverse Event|6|||
170809136|NCT03052517|617310513|FG001|Overall Study|Adverse Event|5|||
170809137|NCT03052517|617310514|FG002|Overall Study|Adverse Event|0|||
170809138|NCT03052517|617310512|FG000|Overall Study|Physician Decision|4|||
170809139|NCT03052517|617310513|FG001|Overall Study|Physician Decision|5|||
170809140|NCT03052517|617310514|FG002|Overall Study|Physician Decision|1|||
170809141|NCT03052517|617310512|FG000|Overall Study|Death|3|||
170809142|NCT03052517|617310513|FG001|Overall Study|Death|0|||
170809143|NCT03052517|617310514|FG002|Overall Study|Death|1|||
170809144|NCT03052517|617310512|FG000|Overall Study|Lost to Follow-up|2|||
170809145|NCT03052517|617310513|FG001|Overall Study|Lost to Follow-up|4|||
170809146|NCT03052517|617310514|FG002|Overall Study|Lost to Follow-up|0|||
170809147|NCT03052517|617310512|FG000|Overall Study|Pregnancy|1|||
170809148|NCT03052517|617310513|FG001|Overall Study|Pregnancy|0|||
170809149|NCT03052517|617310514|FG002|Overall Study|Pregnancy|1|||
170809150|NCT03052517|617310512|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
170809151|NCT03052517|617310513|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
170809152|NCT03052517|617310514|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
170809153|NCT03052517|617310512|FG000|Overall Study|Technical Problems|0|||
170578083|NCT00078806|616458835|FG002|Part 1A|Lack of Efficacy|0|||
170578084|NCT00078806|616458836|FG003|Part 1A|Lack of Efficacy|0|||
170578085|NCT00078806|616458833|FG000|Part 1A|Other|1|||
170578086|NCT00078806|616458834|FG001|Part 1A|Other|0|||
170578087|NCT00078806|616458835|FG002|Part 1A|Other|0|||
170578088|NCT00078806|616458836|FG003|Part 1A|Other|0|||
170578089|NCT00078806|616458833|FG000|Part 1B|Adverse Event|1|||
170578090|NCT00078806|616458834|FG001|Part 1B|Adverse Event|0|||
170578091|NCT00078806|616458835|FG002|Part 1B|Adverse Event|0|||
170809154|NCT03052517|617310513|FG001|Overall Study|Technical Problems|1|||
170809155|NCT03052517|617310514|FG002|Overall Study|Technical Problems|0|||
170809156|NCT04638816|617310515|FG000|Overall Study|Withdrawal by Subject|0|||
170809157|NCT04638816|617310516|FG001|Overall Study|Withdrawal by Subject|1|||
170809158|NCT04638816|617310515|FG000|Overall Study|Lost to Follow-up|0|||
170909888|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
170909889|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
170578092|NCT00078806|616458836|FG003|Part 1B|Adverse Event|0|||
170578093|NCT00078806|616458833|FG000|Part 1B|Lack of Efficacy|7|||
170578094|NCT00078806|616458834|FG001|Part 1B|Lack of Efficacy|0|||
170578095|NCT00078806|616458835|FG002|Part 1B|Lack of Efficacy|0|||
170578096|NCT00078806|616458836|FG003|Part 1B|Lack of Efficacy|0|||
170578097|NCT00078806|616458833|FG000|Part 2|Adverse Event|0|||
170809159|NCT04638816|617310516|FG001|Overall Study|Lost to Follow-up|1|||
170809160|NCT01328496|617310517|FG000|Overall Study|Significant Change in Health Status|1|||
170809161|NCT01328496|617310518|FG001|Overall Study|Significant Change in Health Status|0|||
170809162|NCT00665392|617310519|FG000|Overall Study|not treated|1|||
170809163|NCT03343704|617310527|FG000|Overall Study|Refused to complete follow up|0|||
170809164|NCT03343704|617310528|FG001|Overall Study|Refused to complete follow up|1|||
170578098|NCT00078806|616458834|FG001|Part 2|Adverse Event|1|||
170809165|NCT03343704|617310527|FG000|Overall Study|Death|0|||
170578099|NCT00078806|616458835|FG002|Part 2|Adverse Event|0|||
170578100|NCT00078806|616458836|FG003|Part 2|Adverse Event|0|||
170578101|NCT00161616|616458837|FG000|Overall Study|Withdrawal by Subject|6|||
170578102|NCT00161616|616458838|FG001|Overall Study|Withdrawal by Subject|5|||
170578103|NCT00161616|616458837|FG000|Overall Study|Physician Decision|1|||
170578104|NCT00161616|616458838|FG001|Overall Study|Physician Decision|0|||
170578105|NCT00161616|616458837|FG000|Overall Study|Death|1|||
170578106|NCT00161616|616458838|FG001|Overall Study|Death|1|||
170578107|NCT00161616|616458837|FG000|Overall Study|Lost to Follow-up|17|||
170578108|NCT00161616|616458838|FG001|Overall Study|Lost to Follow-up|13|||
170578109|NCT00161616|616458837|FG000|Overall Study|Protocol deviation|1|||
170578110|NCT00161616|616458838|FG001|Overall Study|Protocol deviation|0|||
170578111|NCT01961297|616458839|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
170578112|NCT01961297|616458840|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
170578113|NCT01521923|616458841|FG000|Overall Study|AE, serious fatal|1|||
170578114|NCT01521923|616458842|FG001|Overall Study|AE, serious fatal|0|||
170578115|NCT01521923|616458843|FG002|Overall Study|AE, serious fatal|0|||
170578116|NCT01521923|616458844|FG003|Overall Study|AE, serious fatal|0|||
170578117|NCT01521923|616458841|FG000|Overall Study|SAE, non-fatal|0|||
170578118|NCT01521923|616458842|FG001|Overall Study|SAE, non-fatal|2|||
170578119|NCT01521923|616458843|FG002|Overall Study|SAE, non-fatal|2|||
170578120|NCT01521923|616458844|FG003|Overall Study|SAE, non-fatal|0|||
170578121|NCT01521923|616458841|FG000|Overall Study|AE, non-serious, non-fatal|1|||
170578122|NCT01521923|616458842|FG001|Overall Study|AE, non-serious, non-fatal|3|||
170578123|NCT01521923|616458843|FG002|Overall Study|AE, non-serious, non-fatal|6|||
170578124|NCT01521923|616458844|FG003|Overall Study|AE, non-serious, non-fatal|2|||
170578125|NCT01521923|616458841|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
170578126|NCT01521923|616458842|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
170578127|NCT01521923|616458843|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
170578128|NCT01521923|616458844|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
170578129|NCT01521923|616458841|FG000|Overall Study|Lack of Efficacy|1|||
170578130|NCT01521923|616458842|FG001|Overall Study|Lack of Efficacy|1|||
170578131|NCT01521923|616458843|FG002|Overall Study|Lack of Efficacy|0|||
170578132|NCT01521923|616458844|FG003|Overall Study|Lack of Efficacy|0|||
170578133|NCT01521923|616458841|FG000|Overall Study|Protocol Violation|0|||
170578134|NCT01521923|616458842|FG001|Overall Study|Protocol Violation|0|||
170578135|NCT01521923|616458843|FG002|Overall Study|Protocol Violation|1|||
170578136|NCT01521923|616458844|FG003|Overall Study|Protocol Violation|0|||
170578137|NCT01521923|616458841|FG000|Overall Study|Lost to Follow-up|1|||
170578138|NCT01521923|616458842|FG001|Overall Study|Lost to Follow-up|0|||
170578139|NCT01521923|616458843|FG002|Overall Study|Lost to Follow-up|2|||
170578140|NCT01521923|616458844|FG003|Overall Study|Lost to Follow-up|1|||
170578141|NCT01521923|616458841|FG000|Overall Study|Withdrawal by Subject|1|||
170578142|NCT01521923|616458842|FG001|Overall Study|Withdrawal by Subject|1|||
170578143|NCT01521923|616458843|FG002|Overall Study|Withdrawal by Subject|1|||
170578144|NCT01521923|616458844|FG003|Overall Study|Withdrawal by Subject|2|||
170578145|NCT01521923|616458841|FG000|Overall Study|Other|2|||
170578146|NCT01521923|616458842|FG001|Overall Study|Other|1|||
170578147|NCT01521923|616458843|FG002|Overall Study|Other|3|||
170578148|NCT01521923|616458844|FG003|Overall Study|Other|6|||
170578149|NCT01521923|616458841|FG000|Overall Study|AE, captured in Period 1|0|||
170578150|NCT01521923|616458842|FG001|Overall Study|AE, captured in Period 1|1|||
170578151|NCT01521923|616458843|FG002|Overall Study|AE, captured in Period 1|0|||
170578152|NCT01521923|616458844|FG003|Overall Study|AE, captured in Period 1|1|||
170578153|NCT03037476|616458845|FG000|Overall Study|Lost to Follow-up|63|||
170578154|NCT03037476|616458846|FG001|Overall Study|Lost to Follow-up|46|||
170578155|NCT02141633|616458847|FG000|Overall Study|Physician Decision|1|||
170578156|NCT02141633|616458848|FG001|Overall Study|Physician Decision|0|||
170578157|NCT02403817|616458851|FG000|Overall Study|Withdrawal by Subject|5|||
170578158|NCT02403817|616458852|FG001|Overall Study|Withdrawal by Subject|0|||
170578159|NCT01947283|616458859|FG000|Overall Study|Death|1|||
170578160|NCT01947283|616458860|FG001|Overall Study|Death|1|||
170578161|NCT01947283|616458861|FG002|Overall Study|Death|1|||
170578162|NCT01947283|616458862|FG003|Overall Study|Death|0|||
170578163|NCT01947283|616458863|FG004|Overall Study|Death|0|||
170578164|NCT01947283|616458864|FG005|Overall Study|Death|0|||
170578165|NCT01947283|616458865|FG006|Overall Study|Death|0|||
170578166|NCT01947283|616458859|FG000|Overall Study|Lost to Follow-up|4|||
170578167|NCT01947283|616458860|FG001|Overall Study|Lost to Follow-up|6|||
170578168|NCT01947283|616458861|FG002|Overall Study|Lost to Follow-up|5|||
170578169|NCT01947283|616458862|FG003|Overall Study|Lost to Follow-up|5|||
170578170|NCT01947283|616458863|FG004|Overall Study|Lost to Follow-up|0|||
170578171|NCT01947283|616458864|FG005|Overall Study|Lost to Follow-up|2|||
170578172|NCT01947283|616458865|FG006|Overall Study|Lost to Follow-up|5|||
170578173|NCT01947283|616458859|FG000|Overall Study|Withdrawal by Subject|10|||
170578174|NCT01947283|616458860|FG001|Overall Study|Withdrawal by Subject|8|||
170578175|NCT01947283|616458861|FG002|Overall Study|Withdrawal by Subject|4|||
170578176|NCT01947283|616458862|FG003|Overall Study|Withdrawal by Subject|1|||
170578177|NCT01947283|616458863|FG004|Overall Study|Withdrawal by Subject|0|||
170578178|NCT01947283|616458864|FG005|Overall Study|Withdrawal by Subject|0|||
170578179|NCT01947283|616458865|FG006|Overall Study|Withdrawal by Subject|2|||
170578180|NCT01947283|616458859|FG000|Overall Study|No Clinical Recording|12|||
170578181|NCT01947283|616458860|FG001|Overall Study|No Clinical Recording|6|||
170578182|NCT01947283|616458861|FG002|Overall Study|No Clinical Recording|8|||
170578183|NCT01947283|616458862|FG003|Overall Study|No Clinical Recording|10|||
170578184|NCT01947283|616458863|FG004|Overall Study|No Clinical Recording|0|||
170578185|NCT01947283|616458864|FG005|Overall Study|No Clinical Recording|0|||
170578186|NCT01947283|616458865|FG006|Overall Study|No Clinical Recording|0|||
170578187|NCT01947283|616458859|FG000|Overall Study|Non-coding Clinical Recording language|0|||
170578188|NCT01947283|616458860|FG001|Overall Study|Non-coding Clinical Recording language|0|||
170578189|NCT01947283|616458861|FG002|Overall Study|Non-coding Clinical Recording language|0|||
170578190|NCT01947283|616458862|FG003|Overall Study|Non-coding Clinical Recording language|1|||
170578191|NCT01947283|616458863|FG004|Overall Study|Non-coding Clinical Recording language|0|||
170578192|NCT01947283|616458864|FG005|Overall Study|Non-coding Clinical Recording language|0|||
170909890|NCT00430781|617674662|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
170909891|NCT00430781|617674663|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
170909892|NCT00430781|617674664|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
170909893|NCT00430781|617674662|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
170909894|NCT00430781|617674663|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
170578193|NCT01947283|616458865|FG006|Overall Study|Non-coding Clinical Recording language|0|||
170578194|NCT01947283|616458859|FG000|Overall Study|Missing Follow-up Assessment|2|||
170578195|NCT01947283|616458860|FG001|Overall Study|Missing Follow-up Assessment|2|||
170578196|NCT01947283|616458861|FG002|Overall Study|Missing Follow-up Assessment|3|||
170578197|NCT01947283|616458862|FG003|Overall Study|Missing Follow-up Assessment|0|||
170578198|NCT01947283|616458863|FG004|Overall Study|Missing Follow-up Assessment|0|||
170578199|NCT01947283|616458864|FG005|Overall Study|Missing Follow-up Assessment|2|||
170578200|NCT01947283|616458865|FG006|Overall Study|Missing Follow-up Assessment|0|||
170578201|NCT01947283|616458859|FG000|Overall Study|No patients were enrolled in study|0|||
170578202|NCT01947283|616458860|FG001|Overall Study|No patients were enrolled in study|0|||
170578203|NCT01947283|616458861|FG002|Overall Study|No patients were enrolled in study|0|||
170578204|NCT01947283|616458862|FG003|Overall Study|No patients were enrolled in study|0|||
170578205|NCT01947283|616458863|FG004|Overall Study|No patients were enrolled in study|0|||
170578206|NCT01947283|616458864|FG005|Overall Study|No patients were enrolled in study|3|||
170578207|NCT01947283|616458865|FG006|Overall Study|No patients were enrolled in study|1|||
170578208|NCT01498692|616458866|FG000|Overall Study|Death|4|||
170578209|NCT01498692|616458866|FG000|Overall Study|Withdrawal by Subject|1|||
170578210|NCT01498692|616458866|FG000|Overall Study|Missed 12-month visit|3|||
170578211|NCT04729972|616458867|FG000|Overall Study|Adverse Event|1|||
170578212|NCT05002985|616458868|FG000|Overall Study|Withdrawal by Subject|1|||
170578213|NCT03782259|616458869|FG000|Overall Study|Lost to Follow-up|1|||
170578214|NCT03782259|616458870|FG001|Overall Study|Lost to Follow-up|1|||
170578215|NCT03782259|616458869|FG000|Overall Study|Moved out of state|0|||
170578216|NCT03782259|616458870|FG001|Overall Study|Moved out of state|2|||
170578217|NCT03782259|616458869|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
170578218|NCT03782259|616458870|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
170578219|NCT03782259|616458869|FG000|Overall Study|Subject discontinued intervention|1|||
170578220|NCT03782259|616458870|FG001|Overall Study|Subject discontinued intervention|0|||
170578221|NCT01208324|616458871|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
170578222|NCT01208324|616458872|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
170578223|NCT01208324|616458873|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
170578224|NCT01208324|616458874|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
170578225|NCT02705105|616458875|FG000|Treatment|Objective Disease Progression|1|||
170578226|NCT02705105|616458876|FG001|Treatment|Objective Disease Progression|50|||
170578227|NCT02705105|616458875|FG000|Treatment|Withdrawal by Subject|3|||
170578228|NCT02705105|616458876|FG001|Treatment|Withdrawal by Subject|5|||
170578229|NCT02705105|616458875|FG000|Treatment|Adverse Event|0|||
170578230|NCT02705105|616458876|FG001|Treatment|Adverse Event|17|||
170578231|NCT02705105|616458875|FG000|Treatment|Clinical Disease Progression|0|||
170578232|NCT02705105|616458876|FG001|Treatment|Clinical Disease Progression|32|||
170909895|NCT00430781|617674664|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
170909896|NCT00430781|617674662|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
170578233|NCT02705105|616458875|FG000|Treatment|Physician Decision|0|||
170578234|NCT02705105|616458876|FG001|Treatment|Physician Decision|3|||
170578235|NCT02705105|616458875|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
170578236|NCT02705105|616458876|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
170578237|NCT02705105|616458875|FG000|Follow-Up|Death|3|||
170578238|NCT02705105|616458876|FG001|Follow-Up|Death|68|||
170578239|NCT02705105|616458875|FG000|Follow-Up|Withdrawal by Subject|1|||
170578240|NCT02705105|616458876|FG001|Follow-Up|Withdrawal by Subject|14|||
170578241|NCT02705105|616458875|FG000|Follow-Up|Study Terminated|0|||
170578242|NCT02705105|616458876|FG001|Follow-Up|Study Terminated|26|||
170909897|NCT00430781|617674663|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
170909898|NCT00430781|617674664|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
170578243|NCT02705105|616458875|FG000|Follow-Up|Discontinued per Amendment 3|0|||
170578244|NCT02705105|616458876|FG001|Follow-Up|Discontinued per Amendment 3|2|||
170578245|NCT02943070|616458877|FG000|Overall Study|Physician Decision|1|||
170578246|NCT02943070|616458877|FG000|Overall Study|Adverse Event|2|||
170578247|NCT02943070|616458877|FG000|Overall Study|Death|2|||
170578248|NCT02943070|616458877|FG000|Overall Study|Withdrawal by Subject|3|||
170578249|NCT02943070|616458877|FG000|Overall Study|Lost to Follow-up|4|||
170578250|NCT02943070|616458877|FG000|Overall Study|Retreatment or TURP|13|||
170578251|NCT02943070|616458877|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
170578252|NCT00570778|616458878|FG000|Overall Study|Protocol deviation|2|||
170578253|NCT00570778|616458879|FG001|Overall Study|Protocol deviation|1|||
170578254|NCT00570778|616458880|FG002|Overall Study|Protocol deviation|2|||
170578255|NCT00570778|616458881|FG003|Overall Study|Protocol deviation|2|||
170578256|NCT00570778|616458878|FG000|Overall Study|Adverse Event|0|||
170578257|NCT00570778|616458879|FG001|Overall Study|Adverse Event|1|||
170909899|NCT00430781|617674662|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
170909900|NCT00430781|617674663|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
170909901|NCT00430781|617674664|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
170578258|NCT00570778|616458880|FG002|Overall Study|Adverse Event|4|||
170578259|NCT00570778|616458881|FG003|Overall Study|Adverse Event|1|||
170578260|NCT00570778|616458878|FG000|Overall Study|Subject withdrew consent|0|||
170578261|NCT00570778|616458879|FG001|Overall Study|Subject withdrew consent|1|||
170578262|NCT00570778|616458880|FG002|Overall Study|Subject withdrew consent|0|||
170578263|NCT00570778|616458881|FG003|Overall Study|Subject withdrew consent|1|||
170578264|NCT00570778|616458878|FG000|Overall Study|Abnormal test procedure|1|||
170578265|NCT00570778|616458879|FG001|Overall Study|Abnormal test procedure|0|||
170578266|NCT00570778|616458880|FG002|Overall Study|Abnormal test procedure|0|||
170578267|NCT00570778|616458881|FG003|Overall Study|Abnormal test procedure|0|||
170578268|NCT00570778|616458878|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170578269|NCT00570778|616458879|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170578270|NCT00570778|616458880|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170578271|NCT00570778|616458881|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
170578272|NCT00570778|616458878|FG000|Overall Study|Lost to Follow-up|0|||
170578273|NCT00570778|616458879|FG001|Overall Study|Lost to Follow-up|0|||
170578274|NCT00570778|616458880|FG002|Overall Study|Lost to Follow-up|1|||
170578275|NCT00570778|616458881|FG003|Overall Study|Lost to Follow-up|0|||
170578276|NCT00570778|616458878|FG000|Overall Study|Subject no longer requires study drug|0|||
170578277|NCT00570778|616458879|FG001|Overall Study|Subject no longer requires study drug|1|||
170578278|NCT00570778|616458880|FG002|Overall Study|Subject no longer requires study drug|0|||
170578279|NCT00570778|616458881|FG003|Overall Study|Subject no longer requires study drug|0|||
170578280|NCT00211172|616458884|FG000|Overall Study|Died or lost health plan eligibility|39|||
170578281|NCT00211172|616458885|FG001|Overall Study|Died or lost health plan eligibility|32|||
170578282|NCT02229825|616458891|FG000|Overall Study|Personal Reasons|0|||
170909902|NCT00430781|617674662|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
170909903|NCT00430781|617674663|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
170909904|NCT00430781|617674664|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
170578283|NCT02229825|616458892|FG001|Overall Study|Personal Reasons|1|||
170578284|NCT02229825|616458891|FG000|Overall Study|Refused continuing medication|7|||
170578285|NCT02229825|616458892|FG001|Overall Study|Refused continuing medication|6|||
170578286|NCT02229825|616458891|FG000|Overall Study|Lost to Follow-up|1|||
170578287|NCT02229825|616458892|FG001|Overall Study|Lost to Follow-up|2|||
170578288|NCT02229825|616458891|FG000|Overall Study|Protocol Violation|1|||
170578289|NCT02229825|616458892|FG001|Overall Study|Protocol Violation|1|||
170578290|NCT02229825|616458891|FG000|Overall Study|Lack of Efficacy|4|||
170578291|NCT02229825|616458892|FG001|Overall Study|Lack of Efficacy|10|||
170578292|NCT02229825|616458891|FG000|Overall Study|Adverse Event|11|||
170578293|NCT02229825|616458892|FG001|Overall Study|Adverse Event|9|||
170578294|NCT02229825|616458891|FG000|Overall Study|Not treated|0|||
170578295|NCT02229825|616458892|FG001|Overall Study|Not treated|1|||
170578296|NCT01309997|616458893|FG000|Overall Study|Adverse Event|1|||
170578297|NCT01309997|616458894|FG001|Overall Study|Adverse Event|0|||
170578298|NCT01309997|616458893|FG000|Overall Study|Death|1|||
170578299|NCT01309997|616458894|FG001|Overall Study|Death|3|||
170909905|NCT00430781|617674662|FG000|Final Analysis; 31 July 2008|Other|0|||
170909906|NCT00430781|617674663|FG001|Final Analysis; 31 July 2008|Other|1|||
170578300|NCT01309997|616458893|FG000|Overall Study|Lack of Efficacy|2|||
170578301|NCT01309997|616458894|FG001|Overall Study|Lack of Efficacy|2|||
170578302|NCT01309997|616458893|FG000|Overall Study|Withdrawal by Subject|1|||
170578303|NCT01309997|616458894|FG001|Overall Study|Withdrawal by Subject|1|||
170578304|NCT00282087|616458895|FG000|Overall Study|Death|1|||
170578305|NCT04474197|616458896|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
170578306|NCT04474197|616458897|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
170578307|NCT04474197|616458898|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
170578308|NCT04474197|616458899|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
170578309|NCT01532921|616458900|FG000|Overall Study|Death|3|||
170578310|NCT01532921|616458900|FG000|Overall Study|Withdrawal by Subject|2|||
170578311|NCT01532921|616458900|FG000|Overall Study|Lost to Follow-up|3|||
170578312|NCT01532921|616458900|FG000|Overall Study|Physician Decision|7|||
170578313|NCT01532921|616458900|FG000|Overall Study|Device was explanted during procedure|1|||
170578314|NCT03462641|616458901|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
170578315|NCT03462641|616458902|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
170578316|NCT03462641|616458901|FG000|Visit 2|Withdrawal by Subject|0|||
170578317|NCT03462641|616458902|FG001|Visit 2|Withdrawal by Subject|1|||
170578318|NCT01524224|616458911|FG000|Overall Study|Progressive Disease|1|||
170578319|NCT01524224|616458912|FG001|Overall Study|Progressive Disease|0|||
170578320|NCT01524224|616458913|FG002|Overall Study|Progressive Disease|2|||
170578321|NCT01524224|616458914|FG003|Overall Study|Progressive Disease|1|||
170578322|NCT01524224|616458915|FG004|Overall Study|Progressive Disease|2|||
170578323|NCT01524224|616458916|FG005|Overall Study|Progressive Disease|1|||
170578324|NCT01524224|616458917|FG006|Overall Study|Progressive Disease|1|||
170578325|NCT01524224|616458918|FG007|Overall Study|Progressive Disease|5|||
170578326|NCT01524224|616458911|FG000|Overall Study|Withdrawal by Subject|2|||
170578327|NCT01524224|616458912|FG001|Overall Study|Withdrawal by Subject|0|||
170578328|NCT01524224|616458913|FG002|Overall Study|Withdrawal by Subject|0|||
170578329|NCT01524224|616458914|FG003|Overall Study|Withdrawal by Subject|0|||
170578330|NCT01524224|616458915|FG004|Overall Study|Withdrawal by Subject|0|||
170578331|NCT01524224|616458916|FG005|Overall Study|Withdrawal by Subject|0|||
170578332|NCT01524224|616458917|FG006|Overall Study|Withdrawal by Subject|2|||
170578333|NCT01524224|616458918|FG007|Overall Study|Withdrawal by Subject|0|||
170578334|NCT01524224|616458911|FG000|Overall Study|Adverse Event|0|||
170578335|NCT01524224|616458912|FG001|Overall Study|Adverse Event|1|||
170578336|NCT01524224|616458913|FG002|Overall Study|Adverse Event|0|||
170578337|NCT01524224|616458914|FG003|Overall Study|Adverse Event|0|||
170578338|NCT01524224|616458915|FG004|Overall Study|Adverse Event|0|||
170578339|NCT01524224|616458916|FG005|Overall Study|Adverse Event|1|||
170578340|NCT01524224|616458917|FG006|Overall Study|Adverse Event|0|||
170578341|NCT01524224|616458918|FG007|Overall Study|Adverse Event|0|||
170578342|NCT01524224|616458911|FG000|Overall Study|Physician Decision|0|||
170578343|NCT01524224|616458912|FG001|Overall Study|Physician Decision|0|||
170578344|NCT01524224|616458913|FG002|Overall Study|Physician Decision|0|||
170578345|NCT01524224|616458914|FG003|Overall Study|Physician Decision|1|||
170578346|NCT01524224|616458915|FG004|Overall Study|Physician Decision|1|||
170578347|NCT01524224|616458916|FG005|Overall Study|Physician Decision|0|||
170578348|NCT01524224|616458917|FG006|Overall Study|Physician Decision|0|||
170578349|NCT01524224|616458918|FG007|Overall Study|Physician Decision|1|||
170578350|NCT01524224|616458911|FG000|Overall Study|Sponsor Decision|0|||
170578351|NCT01524224|616458912|FG001|Overall Study|Sponsor Decision|0|||
170578352|NCT01524224|616458913|FG002|Overall Study|Sponsor Decision|0|||
170578353|NCT01524224|616458914|FG003|Overall Study|Sponsor Decision|0|||
170578354|NCT01524224|616458915|FG004|Overall Study|Sponsor Decision|1|||
170578355|NCT01524224|616458916|FG005|Overall Study|Sponsor Decision|0|||
170578356|NCT01524224|616458917|FG006|Overall Study|Sponsor Decision|0|||
170578357|NCT01524224|616458918|FG007|Overall Study|Sponsor Decision|0|||
170578358|NCT05420961|616458926|FG000|Overall Study|Withdrawal by Subject|2|||
170578359|NCT05420961|616458927|FG001|Overall Study|Withdrawal by Subject|1|||
170578360|NCT05420961|616458928|FG002|Overall Study|Withdrawal by Subject|1|||
170578361|NCT05420961|616458929|FG003|Overall Study|Withdrawal by Subject|0|||
170578362|NCT05420961|616458930|FG004|Overall Study|Withdrawal by Subject|0|||
170578363|NCT05420961|616458926|FG000|Overall Study|Lost to Follow-up|0|||
170578364|NCT05420961|616458927|FG001|Overall Study|Lost to Follow-up|0|||
170578365|NCT05420961|616458928|FG002|Overall Study|Lost to Follow-up|1|||
170578366|NCT05420961|616458929|FG003|Overall Study|Lost to Follow-up|0|||
170809166|NCT03343704|617310528|FG001|Overall Study|Death|1|||
170578367|NCT05420961|616458930|FG004|Overall Study|Lost to Follow-up|0|||
170578368|NCT05420961|616458926|FG000|Overall Study|Randomized by mistake without study treatment|0|||
170578369|NCT05420961|616458927|FG001|Overall Study|Randomized by mistake without study treatment|0|||
170578370|NCT05420961|616458928|FG002|Overall Study|Randomized by mistake without study treatment|1|||
170578371|NCT05420961|616458929|FG003|Overall Study|Randomized by mistake without study treatment|0|||
170578372|NCT05420961|616458930|FG004|Overall Study|Randomized by mistake without study treatment|1|||
170578373|NCT01434654|616458931|FG000|Overall Study|Withdrawal by Subject|1|||
170578374|NCT01434654|616458932|FG001|Overall Study|Withdrawal by Subject|0|||
170578375|NCT01434654|616458931|FG000|Overall Study|Lost to Follow-up|1|||
170578376|NCT01434654|616458932|FG001|Overall Study|Lost to Follow-up|0|||
170578377|NCT00803361|616458933|FG000|Overall Study|Adverse Event|13|||
170578378|NCT00803361|616458934|FG001|Overall Study|Adverse Event|3|||
170578379|NCT00803361|616458933|FG000|Overall Study|Lack of Efficacy|4|||
170578380|NCT00803361|616458934|FG001|Overall Study|Lack of Efficacy|13|||
170578381|NCT00803361|616458933|FG000|Overall Study|Lost to Follow-up|1|||
170578382|NCT00803361|616458934|FG001|Overall Study|Lost to Follow-up|2|||
170578383|NCT00803361|616458933|FG000|Overall Study|Physician Decision|1|||
170578384|NCT00803361|616458934|FG001|Overall Study|Physician Decision|0|||
170578385|NCT00803361|616458933|FG000|Overall Study|Protocol Violation|2|||
170578386|NCT00803361|616458934|FG001|Overall Study|Protocol Violation|4|||
170578387|NCT00803361|616458933|FG000|Overall Study|Withdrawal by Subject|5|||
170578388|NCT00803361|616458934|FG001|Overall Study|Withdrawal by Subject|6|||
170578389|NCT00363142|616458935|FG000|Overall Study|Adverse Event|2|||
170578390|NCT00363142|616458936|FG001|Overall Study|Adverse Event|0|||
170578391|NCT00363142|616458935|FG000|Overall Study|Lack of Efficacy|0|||
170578392|NCT00363142|616458936|FG001|Overall Study|Lack of Efficacy|1|||
170578393|NCT00363142|616458935|FG000|Overall Study|Lost to Follow-up|1|||
170578394|NCT00363142|616458936|FG001|Overall Study|Lost to Follow-up|0|||
170578395|NCT00363142|616458935|FG000|Overall Study|Non-compliance|1|||
170578396|NCT00363142|616458936|FG001|Overall Study|Non-compliance|1|||
170578397|NCT00363142|616458935|FG000|Overall Study|Withdrawal by Subject|3|||
170578398|NCT00363142|616458936|FG001|Overall Study|Withdrawal by Subject|1|||
170578399|NCT02446769|616458937|FG000|Screening Period|Screen Failure|11|||
170578400|NCT02446769|616458938|FG001|Screening Period|Screen Failure|0|||
170578401|NCT02446769|616458939|FG002|Screening Period|Screen Failure|0|||
170578402|NCT02446769|616458937|FG000|Study Period|Randomized in Error|0|||
170578403|NCT02446769|616458938|FG001|Study Period|Randomized in Error|2|||
170578404|NCT02446769|616458939|FG002|Study Period|Randomized in Error|0|||
170578405|NCT04482439|616458940|FG000|Overall Study|Lost to Follow-up|1|||
170578406|NCT04482439|616458940|FG000|Overall Study|Unrelated illness|1|||
170578407|NCT02858440|616458943|FG000|Overall Study|Lost to Follow-up|3|||
170578408|NCT02858440|616458943|FG000|Overall Study|Protocol Violation|2|||
170578409|NCT02858440|616458943|FG000|Overall Study|Consent withdrawal|3|||
170578410|NCT02858440|616458943|FG000|Overall Study|Migrated/moved from study area|4|||
170578411|NCT00402324|616458944|FG000|Overall Study|Lost to Follow-up|11|||
170578412|NCT00402324|616458945|FG001|Overall Study|Lost to Follow-up|11|||
170578413|NCT00402324|616458944|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
170578414|NCT00402324|616458945|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
170578415|NCT00402324|616458944|FG000|Overall Study|Protocol Violation|8|||
170578416|NCT00402324|616458945|FG001|Overall Study|Protocol Violation|7|||
170578417|NCT00402324|616458944|FG000|Overall Study|Withdrawal by Subject|5|||
170578418|NCT00402324|616458945|FG001|Overall Study|Withdrawal by Subject|2|||
170578419|NCT00402324|616458944|FG000|Overall Study|Physician Decision|2|||
170578420|NCT00402324|616458945|FG001|Overall Study|Physician Decision|4|||
170578421|NCT00402324|616458944|FG000|Overall Study|Sponsor Decision|4|||
170578422|NCT00402324|616458945|FG001|Overall Study|Sponsor Decision|5|||
170578423|NCT00402324|616458944|FG000|Overall Study|Lack of Efficacy|1|||
170578424|NCT00402324|616458945|FG001|Overall Study|Lack of Efficacy|4|||
170578425|NCT00402324|616458944|FG000|Overall Study|Adverse Event|6|||
170578426|NCT00402324|616458945|FG001|Overall Study|Adverse Event|4|||
170578427|NCT00402324|616458944|FG000|Overall Study|Death|1|||
170578428|NCT00402324|616458945|FG001|Overall Study|Death|0|||
170578429|NCT02625220|616458946|FG000|Overall Study|Adverse Event|2|||
170578430|NCT02625220|616458946|FG000|Overall Study|Lost to Follow-up|2|||
170578431|NCT02625220|616458946|FG000|Overall Study|Protocol Violation|1|||
170578432|NCT02625220|616458946|FG000|Overall Study|Study discontinued at site|2|||
170578433|NCT02923531|616458947|FG000|Overall Study|Adverse Event|4|||
170578434|NCT02923531|616458947|FG000|Overall Study|Clinical Deterioration|1|||
170578435|NCT02923531|616458947|FG000|Overall Study|Disease Progression|3|||
170578436|NCT02923531|616458947|FG000|Overall Study|Study Termination|1|||
170578437|NCT02201329|616458948|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
170578438|NCT02201329|616458948|FG000|Overall Study|Withdrawal by Subject|2|||
170578439|NCT00997984|616458949|FG000|Overall Study|Adverse Event|1|||
170578440|NCT00997984|616458950|FG001|Overall Study|Adverse Event|8|||
170578441|NCT00997984|616458951|FG002|Overall Study|Adverse Event|8|||
170578442|NCT00997984|616458949|FG000|Overall Study|Protocol Violation|1|||
170578443|NCT00997984|616458950|FG001|Overall Study|Protocol Violation|3|||
170578444|NCT00997984|616458951|FG002|Overall Study|Protocol Violation|0|||
170578445|NCT00997984|616458949|FG000|Overall Study|Withdrawal by Subject|6|||
170578446|NCT00997984|616458950|FG001|Overall Study|Withdrawal by Subject|9|||
170578447|NCT00997984|616458951|FG002|Overall Study|Withdrawal by Subject|5|||
170578448|NCT00997984|616458949|FG000|Overall Study|Lost to Follow-up|8|||
170578449|NCT00997984|616458950|FG001|Overall Study|Lost to Follow-up|5|||
170578450|NCT00997984|616458951|FG002|Overall Study|Lost to Follow-up|4|||
170578451|NCT00997984|616458949|FG000|Overall Study|Lack of Efficacy|20|||
170578452|NCT00997984|616458950|FG001|Overall Study|Lack of Efficacy|6|||
170578453|NCT00997984|616458951|FG002|Overall Study|Lack of Efficacy|3|||
170578454|NCT00997984|616458949|FG000|Overall Study|Met exclusion criteria|1|||
170578455|NCT00997984|616458950|FG001|Overall Study|Met exclusion criteria|0|||
170578456|NCT00997984|616458951|FG002|Overall Study|Met exclusion criteria|0|||
170578457|NCT00997984|616458949|FG000|Overall Study|non-compliance|0|||
170578458|NCT00997984|616458950|FG001|Overall Study|non-compliance|2|||
170578459|NCT00997984|616458951|FG002|Overall Study|non-compliance|3|||
170578460|NCT00997984|616458949|FG000|Overall Study|Wrong medication dispensed|0|||
170578461|NCT00997984|616458950|FG001|Overall Study|Wrong medication dispensed|1|||
170578462|NCT00997984|616458951|FG002|Overall Study|Wrong medication dispensed|0|||
170578463|NCT00997984|616458949|FG000|Overall Study|Suicidal ideation|0|||
170578464|NCT00997984|616458950|FG001|Overall Study|Suicidal ideation|0|||
170578465|NCT00997984|616458951|FG002|Overall Study|Suicidal ideation|1|||
170578466|NCT00997984|616458949|FG000|Overall Study|Work schedule|0|||
170578467|NCT00997984|616458950|FG001|Overall Study|Work schedule|0|||
170578468|NCT00997984|616458951|FG002|Overall Study|Work schedule|2|||
170578469|NCT02997865|616458953|FG000|Overall Study|Death|2|||
170578470|NCT02997865|616458954|FG001|Overall Study|Death|1|||
170578471|NCT02997865|616458953|FG000|Overall Study|Lost to Follow-up|6|||
170578472|NCT02997865|616458954|FG001|Overall Study|Lost to Follow-up|3|||
170578473|NCT02997865|616458953|FG000|Overall Study|Withdrawal by Subject|5|||
170578474|NCT02997865|616458954|FG001|Overall Study|Withdrawal by Subject|0|||
170578475|NCT01823198|616458955|FG000|Overall Study|Physician Decision|0|||
170578476|NCT01823198|616458956|FG001|Overall Study|Physician Decision|1|||
170578477|NCT01823198|616458957|FG002|Overall Study|Physician Decision|0|||
170578478|NCT01823198|616458958|FG003|Overall Study|Physician Decision|0|||
170578479|NCT01823198|616458959|FG004|Overall Study|Physician Decision|0|||
170578480|NCT01823198|616458960|FG005|Overall Study|Physician Decision|3|||
170578481|NCT01823198|616458961|FG006|Overall Study|Physician Decision|3|||
170578482|NCT01119066|616458962|FG000|Overall Study|Withdrawal by Subject|4|||
170578483|NCT01119066|616458963|FG001|Overall Study|Withdrawal by Subject|6|||
170578484|NCT01119066|616458964|FG002|Overall Study|Withdrawal by Subject|0|||
170578485|NCT01119066|616458965|FG003|Overall Study|Withdrawal by Subject|0|||
170578486|NCT01119066|616458962|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
170578487|NCT01119066|616458963|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
170578488|NCT01119066|616458964|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
170578489|NCT01119066|616458965|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
170578490|NCT01119066|616458962|FG000|Overall Study|Relapse identified before transplant|1|||
170578491|NCT01119066|616458963|FG001|Overall Study|Relapse identified before transplant|0|||
170578492|NCT01119066|616458964|FG002|Overall Study|Relapse identified before transplant|0|||
170578493|NCT01119066|616458965|FG003|Overall Study|Relapse identified before transplant|0|||
170578494|NCT01119066|616458962|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
170578495|NCT01119066|616458963|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
170578496|NCT01119066|616458964|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
170578497|NCT01119066|616458965|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
170578498|NCT01119066|616458962|FG000|Overall Study|Relapse identified before transplant|0|||
170578499|NCT01119066|616458963|FG001|Overall Study|Relapse identified before transplant|4|||
170578500|NCT01119066|616458964|FG002|Overall Study|Relapse identified before transplant|0|||
170578501|NCT01119066|616458965|FG003|Overall Study|Relapse identified before transplant|0|||
170578502|NCT00783835|616458966|FG000|Overall Study|Adverse Event|3|||
170578503|NCT00783835|616458966|FG000|Overall Study|Medical Criteria|1|||
170578504|NCT00783835|616458966|FG000|Overall Study|Withdrawal by Subject|2|||
170578505|NCT00783835|616458966|FG000|Overall Study|Lost to Follow-up|1|||
170578506|NCT00783835|616458966|FG000|Overall Study|Participant not Adherent|3|||
170578507|NCT00295646|616458969|FG000|Overall Study|Protocol Violation|18|||
170578508|NCT00295646|616458970|FG001|Overall Study|Protocol Violation|20|||
170578509|NCT00295646|616458971|FG002|Overall Study|Protocol Violation|20|||
170578510|NCT00295646|616458972|FG003|Overall Study|Protocol Violation|18|||
170578511|NCT00295646|616458969|FG000|Overall Study|Withdrawal by Subject|8|||
170578512|NCT00295646|616458970|FG001|Overall Study|Withdrawal by Subject|9|||
170578513|NCT00295646|616458971|FG002|Overall Study|Withdrawal by Subject|11|||
170578514|NCT00295646|616458972|FG003|Overall Study|Withdrawal by Subject|14|||
170578515|NCT00295646|616458969|FG000|Overall Study|Lost to Follow-up|0|||
170578516|NCT00295646|616458970|FG001|Overall Study|Lost to Follow-up|5|||
170578517|NCT00295646|616458971|FG002|Overall Study|Lost to Follow-up|1|||
170578518|NCT00295646|616458972|FG003|Overall Study|Lost to Follow-up|5|||
170578519|NCT00295646|616458969|FG000|Overall Study|Death|9|||
170578520|NCT00295646|616458970|FG001|Overall Study|Death|7|||
170578521|NCT00295646|616458971|FG002|Overall Study|Death|18|||
170578522|NCT00295646|616458972|FG003|Overall Study|Death|8|||
170578523|NCT01945996|616458973|FG000|Overall Study|Lost to Follow-up|3|||
170578524|NCT01945996|616458974|FG001|Overall Study|Lost to Follow-up|5|||
170578525|NCT04660552|616458975|FG000|Overall Study|Withdrawal by Subject|3|||
170578526|NCT04660552|616458976|FG001|Overall Study|Withdrawal by Subject|1|||
170578527|NCT02550288|616460280|FG000|Overall Study|Adverse Event|0|||
170578528|NCT02550288|616460281|FG001|Overall Study|Adverse Event|1|||
170578529|NCT02550288|616460282|FG002|Overall Study|Adverse Event|0|||
170578530|NCT02550288|616460283|FG003|Overall Study|Adverse Event|0|||
170578531|NCT02550288|616460284|FG004|Overall Study|Adverse Event|0|||
170578532|NCT02550288|616460280|FG000|Overall Study|Physician Decision|0|||
170578533|NCT02550288|616460281|FG001|Overall Study|Physician Decision|0|||
170578534|NCT02550288|616460282|FG002|Overall Study|Physician Decision|0|||
170578535|NCT02550288|616460283|FG003|Overall Study|Physician Decision|1|||
170578536|NCT02550288|616460284|FG004|Overall Study|Physician Decision|0|||
170578537|NCT02550288|616460280|FG000|Overall Study|Protocol Violation|2|||
170578538|NCT02550288|616460281|FG001|Overall Study|Protocol Violation|2|||
170578539|NCT02550288|616460282|FG002|Overall Study|Protocol Violation|1|||
170578540|NCT02550288|616460283|FG003|Overall Study|Protocol Violation|0|||
170578541|NCT02550288|616460284|FG004|Overall Study|Protocol Violation|3|||
170578542|NCT02550288|616460280|FG000|Overall Study|Participant moved|0|||
170578543|NCT02550288|616460281|FG001|Overall Study|Participant moved|0|||
170578544|NCT02550288|616460282|FG002|Overall Study|Participant moved|0|||
170578545|NCT02550288|616460283|FG003|Overall Study|Participant moved|1|||
170578546|NCT02550288|616460284|FG004|Overall Study|Participant moved|0|||
170578547|NCT02550288|616460280|FG000|Overall Study|Withdrawal by Subject|0|||
170578548|NCT02550288|616460281|FG001|Overall Study|Withdrawal by Subject|0|||
170578549|NCT02550288|616460282|FG002|Overall Study|Withdrawal by Subject|0|||
170578550|NCT02550288|616460283|FG003|Overall Study|Withdrawal by Subject|1|||
170578551|NCT02550288|616460284|FG004|Overall Study|Withdrawal by Subject|0|||
170578552|NCT00988052|616460285|FG000|Overall Study|Missing|1|||
170578553|NCT00988052|616460286|FG001|Overall Study|Missing|0|||
170578554|NCT00988052|616460285|FG000|Overall Study|Teva requested subject withdrawal|3|||
170578555|NCT00988052|616460286|FG001|Overall Study|Teva requested subject withdrawal|1|||
170578556|NCT00988052|616460285|FG000|Overall Study|Death|1|||
170578557|NCT00988052|616460286|FG001|Overall Study|Death|3|||
170578558|NCT00988052|616460285|FG000|Overall Study|Protocol Violation|6|||
170578559|NCT00988052|616460286|FG001|Overall Study|Protocol Violation|5|||
170578560|NCT00988052|616460285|FG000|Overall Study|Pregnancy|6|||
170578561|NCT00988052|616460286|FG001|Overall Study|Pregnancy|6|||
170578562|NCT00988052|616460285|FG000|Overall Study|Lack of Efficacy|8|||
170578563|NCT00988052|616460286|FG001|Overall Study|Lack of Efficacy|7|||
170578564|NCT00988052|616460285|FG000|Overall Study|Lost to Follow-up|6|||
170578565|NCT00988052|616460286|FG001|Overall Study|Lost to Follow-up|11|||
170578566|NCT00988052|616460285|FG000|Overall Study|Physician Decision|27|||
170578567|NCT00988052|616460286|FG001|Overall Study|Physician Decision|28|||
170578568|NCT00988052|616460285|FG000|Overall Study|Adverse Event|35|||
170578569|NCT00988052|616460286|FG001|Overall Study|Adverse Event|28|||
170578570|NCT00988052|616460285|FG000|Overall Study|Withdrawal by Subject|90|||
170578571|NCT00988052|616460286|FG001|Overall Study|Withdrawal by Subject|91|||
170578572|NCT00988052|616460285|FG000|Overall Study|Study terminated by sponsor|240|||
170578573|NCT00988052|616460286|FG001|Overall Study|Study terminated by sponsor|236|||
170578574|NCT00842153|616460287|FG000|Overall Study|Adverse Event|0|||
170578575|NCT00842153|616460288|FG001|Overall Study|Adverse Event|1|||
170578576|NCT00842153|616460287|FG000|Overall Study|Lost to Follow-up|1|||
170578577|NCT00842153|616460288|FG001|Overall Study|Lost to Follow-up|2|||
170578578|NCT05312697|616460289|FG000|Overall Study|Sponsor Terminated Trial|2|||
170578579|NCT03012828|616460291|FG000|Overall Study|Lost to Follow-up|1|||
170578580|NCT03012828|616460292|FG001|Overall Study|Lost to Follow-up|0|||
170578581|NCT03012828|616460293|FG002|Overall Study|Lost to Follow-up|1|||
170578582|NCT03012828|616460294|FG003|Overall Study|Lost to Follow-up|0|||
170578583|NCT03012828|616460295|FG004|Overall Study|Lost to Follow-up|1|||
170578584|NCT03012828|616460296|FG005|Overall Study|Lost to Follow-up|0|||
170578585|NCT03012828|616460291|FG000|Overall Study|Withdrawal by Subject|0|||
170578586|NCT03012828|616460292|FG001|Overall Study|Withdrawal by Subject|0|||
170578587|NCT03012828|616460293|FG002|Overall Study|Withdrawal by Subject|1|||
170578588|NCT03012828|616460294|FG003|Overall Study|Withdrawal by Subject|0|||
170578589|NCT03012828|616460295|FG004|Overall Study|Withdrawal by Subject|0|||
170578590|NCT03012828|616460296|FG005|Overall Study|Withdrawal by Subject|1|||
170578591|NCT03012828|616460291|FG000|Overall Study|Non-compliance with protocol|0|||
170578592|NCT03012828|616460292|FG001|Overall Study|Non-compliance with protocol|0|||
170578593|NCT03012828|616460293|FG002|Overall Study|Non-compliance with protocol|0|||
170578594|NCT03012828|616460294|FG003|Overall Study|Non-compliance with protocol|0|||
170578595|NCT03012828|616460295|FG004|Overall Study|Non-compliance with protocol|1|||
170578596|NCT03012828|616460296|FG005|Overall Study|Non-compliance with protocol|0|||
170578597|NCT03012828|616460291|FG000|Overall Study|Delay to last visit would delay DBL|0|||
170578598|NCT03012828|616460292|FG001|Overall Study|Delay to last visit would delay DBL|0|||
170578599|NCT03012828|616460293|FG002|Overall Study|Delay to last visit would delay DBL|0|||
170578600|NCT03012828|616460294|FG003|Overall Study|Delay to last visit would delay DBL|0|||
170578601|NCT03012828|616460295|FG004|Overall Study|Delay to last visit would delay DBL|0|||
170578602|NCT03012828|616460296|FG005|Overall Study|Delay to last visit would delay DBL|1|||
170578603|NCT01509846|616460297|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
170578604|NCT01509846|616460298|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
170578605|NCT01509846|616460299|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
170649474|NCT01029405|616730790|FG002|Overall Study|Protocol Violation|0|||
170578606|NCT01509846|616460300|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
170578607|NCT01509846|616460301|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
170578608|NCT01509846|616460297|FG000|Received Vaccination 2|Illness|0|||
170578609|NCT01509846|616460298|FG001|Received Vaccination 2|Illness|0|||
170578610|NCT01509846|616460299|FG002|Received Vaccination 2|Illness|0|||
170578611|NCT01509846|616460300|FG003|Received Vaccination 2|Illness|0|||
170578612|NCT01509846|616460301|FG004|Received Vaccination 2|Illness|1|||
170578613|NCT01509846|616460297|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
170578614|NCT01509846|616460298|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
170578615|NCT01509846|616460299|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
170578616|NCT01509846|616460300|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
170578617|NCT01509846|616460301|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
170578618|NCT01509846|616460297|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
170578619|NCT01509846|616460298|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
170578620|NCT01509846|616460299|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
170578621|NCT01509846|616460300|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
170578622|NCT01509846|616460301|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
170578623|NCT01509846|616460297|FG000|Received Vaccination 3|Pregnancy|0|||
170578624|NCT01509846|616460298|FG001|Received Vaccination 3|Pregnancy|0|||
170578625|NCT01509846|616460299|FG002|Received Vaccination 3|Pregnancy|0|||
170578626|NCT01509846|616460300|FG003|Received Vaccination 3|Pregnancy|1|||
170578627|NCT01509846|616460301|FG004|Received Vaccination 3|Pregnancy|0|||
170578628|NCT01509846|616460297|FG000|Received Vaccination 3|Lost to Follow-up|0|||
170578629|NCT01509846|616460298|FG001|Received Vaccination 3|Lost to Follow-up|0|||
170578630|NCT01509846|616460299|FG002|Received Vaccination 3|Lost to Follow-up|1|||
170578631|NCT01509846|616460300|FG003|Received Vaccination 3|Lost to Follow-up|0|||
170578632|NCT01509846|616460301|FG004|Received Vaccination 3|Lost to Follow-up|0|||
170578633|NCT04396795|616460303|FG000|Month 1|Lost to Follow-up|2|||
170578634|NCT04396795|616460304|FG001|Month 1|Lost to Follow-up|3|||
170578635|NCT04396795|616460303|FG000|Month 3|Lost to Follow-up|1|||
170578636|NCT04396795|616460304|FG001|Month 3|Lost to Follow-up|3|||
170578637|NCT04396795|616460303|FG000|Month 6|Lost to Follow-up|3|||
170578638|NCT04396795|616460304|FG001|Month 6|Lost to Follow-up|3|||
170578639|NCT01637584|616460305|FG000|Overall Study|Withdrawal by Subject|1|||
170578640|NCT01637584|616460306|FG001|Overall Study|Withdrawal by Subject|3|||
170578641|NCT02366923|616460307|FG000|Overall Study|Withdrawal by Subject|1|||
170578642|NCT02366923|616460307|FG000|Overall Study|Positive Slit Lamp Findings|2|||
170578643|NCT02366923|616460307|FG000|Overall Study|High Astigmatism|3|||
170578644|NCT02484443|616460308|FG000|Overall Study|Lack of Efficacy|28|||
170578645|NCT02484443|616460308|FG000|Overall Study|Physician Decision|2|||
170578646|NCT02484443|616460308|FG000|Overall Study|Ineligible|2|||
170578647|NCT00992056|616460309|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
170578648|NCT00992056|616460310|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
170578649|NCT00992056|616460309|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
170578650|NCT00992056|616460310|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
170578651|NCT02689206|616460311|FG000|Overall Study|Adverse Event|0|||
170578652|NCT02689206|616460312|FG001|Overall Study|Adverse Event|0|||
170578653|NCT02689206|616460313|FG002|Overall Study|Adverse Event|1|||
170578654|NCT02689206|616460314|FG003|Overall Study|Adverse Event|0|||
170578655|NCT02689206|616460315|FG004|Overall Study|Adverse Event|2|||
170578656|NCT02689206|616460311|FG000|Overall Study|Protocol Violation|1|||
170578657|NCT02689206|616460312|FG001|Overall Study|Protocol Violation|0|||
170578658|NCT02689206|616460313|FG002|Overall Study|Protocol Violation|0|||
170578659|NCT02689206|616460314|FG003|Overall Study|Protocol Violation|1|||
170578660|NCT02689206|616460315|FG004|Overall Study|Protocol Violation|2|||
170578661|NCT02689206|616460311|FG000|Overall Study|Other: Reached stopping criteria|0|||
170578662|NCT02689206|616460312|FG001|Overall Study|Other: Reached stopping criteria|1|||
170578663|NCT02689206|616460313|FG002|Overall Study|Other: Reached stopping criteria|2|||
170578664|NCT02689206|616460314|FG003|Overall Study|Other: Reached stopping criteria|3|||
170809167|NCT03343704|617310527|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
170809168|NCT03343704|617310528|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
170809169|NCT07147257|617310529|FG000|Overall Study|Pregnancy|1|||
170809170|NCT07147257|617310530|FG001|Overall Study|Pregnancy|0|||
170809171|NCT07147257|617310529|FG000|Overall Study|Physician Decision|0|||
170578665|NCT02689206|616460315|FG004|Overall Study|Other: Reached stopping criteria|4|||
170578666|NCT02689206|616460311|FG000|Overall Study|Physician Decision|1|||
170809172|NCT07147257|617310530|FG001|Overall Study|Physician Decision|1|||
170578667|NCT02689206|616460312|FG001|Overall Study|Physician Decision|0|||
170578668|NCT02689206|616460313|FG002|Overall Study|Physician Decision|0|||
170578669|NCT02689206|616460314|FG003|Overall Study|Physician Decision|0|||
170578670|NCT02689206|616460315|FG004|Overall Study|Physician Decision|0|||
170578671|NCT02689206|616460311|FG000|Overall Study|Withdrawal by Subject|1|||
170578672|NCT02689206|616460312|FG001|Overall Study|Withdrawal by Subject|0|||
170578673|NCT02689206|616460313|FG002|Overall Study|Withdrawal by Subject|1|||
170578674|NCT02689206|616460314|FG003|Overall Study|Withdrawal by Subject|0|||
170578675|NCT02689206|616460315|FG004|Overall Study|Withdrawal by Subject|0|||
170578676|NCT00255723|616460317|FG000|Overall Study|Adverse Event|1|||
170578677|NCT00255723|616460318|FG001|Overall Study|Adverse Event|1|||
170578678|NCT00255723|616460317|FG000|Overall Study|Death|0|||
170578679|NCT00255723|616460318|FG001|Overall Study|Death|1|||
170578680|NCT00255723|616460317|FG000|Overall Study|Response Data Not Available|1|||
170578681|NCT00255723|616460318|FG001|Overall Study|Response Data Not Available|0|||
170578682|NCT00191945|616460320|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
170578683|NCT00191945|616460321|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
170578684|NCT00191945|616460320|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
170578685|NCT00191945|616460321|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
170578686|NCT00191945|616460320|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
170578687|NCT00191945|616460321|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
170578688|NCT00191945|616460320|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
170578689|NCT00191945|616460321|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
170578690|NCT00289289|616460324|FG000|Overall Study|Withdrawal by Subject|5|||
170578691|NCT00289289|616460325|FG001|Overall Study|Withdrawal by Subject|3|||
170578692|NCT00289289|616460326|FG002|Overall Study|Withdrawal by Subject|15|||
170578693|NCT00289289|616460324|FG000|Overall Study|Lost to Follow-up|1|||
170578694|NCT00289289|616460325|FG001|Overall Study|Lost to Follow-up|0|||
170578695|NCT00289289|616460326|FG002|Overall Study|Lost to Follow-up|1|||
170578696|NCT00289289|616460324|FG000|Overall Study|Death|4|||
170578697|NCT00289289|616460325|FG001|Overall Study|Death|2|||
170578698|NCT00289289|616460326|FG002|Overall Study|Death|5|||
170578699|NCT00289289|616460324|FG000|Overall Study|No implant attempted|0|||
170578700|NCT00289289|616460325|FG001|Overall Study|No implant attempted|0|||
170578701|NCT00289289|616460326|FG002|Overall Study|No implant attempted|1|||
170578702|NCT00289289|616460324|FG000|Overall Study|Physician Decision|1|||
170578703|NCT00289289|616460325|FG001|Overall Study|Physician Decision|0|||
170578704|NCT00289289|616460326|FG002|Overall Study|Physician Decision|6|||
170578705|NCT00289289|616460324|FG000|Overall Study|Non-study device implanted|2|||
170578706|NCT00289289|616460325|FG001|Overall Study|Non-study device implanted|1|||
170578707|NCT00289289|616460326|FG002|Overall Study|Non-study device implanted|3|||
170578708|NCT00289289|616460324|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
170578709|NCT00289289|616460325|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
170578710|NCT00289289|616460326|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
170578711|NCT00289289|616460324|FG000|Overall Study|Other Exit Reason|6|||
170578712|NCT00289289|616460325|FG001|Overall Study|Other Exit Reason|4|||
170578713|NCT00289289|616460326|FG002|Overall Study|Other Exit Reason|12|||
170578714|NCT01445613|616460327|FG000|30-day Follow-up|Withdrawal by Subject|6|||
170578715|NCT01445613|616460327|FG000|30-day Follow-up|Physician Decision|3|||
170578716|NCT01445613|616460327|FG000|30-day Follow-up|Missed visit|23|||
170578717|NCT01445613|616460327|FG000|30-day Follow-up|Death|3|||
170578718|NCT01445613|616460327|FG000|1-year Follow-up|Withdrawal by Subject|12|||
170578719|NCT01445613|616460327|FG000|1-year Follow-up|Missed visit|29|||
170809173|NCT07147257|617310529|FG000|Overall Study|Withdrawal by Subject|0|||
170578720|NCT01445613|616460327|FG000|1-year Follow-up|Lost to Follow-up|2|||
170578721|NCT01445613|616460327|FG000|1-year Follow-up|Death|30|||
170649475|NCT01029405|616730791|FG003|Overall Study|Protocol Violation|1|||
170649476|NCT01029405|616730788|FG000|Overall Study|Adverse Event|0|||
170809174|NCT07147257|617310530|FG001|Overall Study|Withdrawal by Subject|1|||
170809175|NCT07147257|617310529|FG000|Overall Study|Drug administration failure|0|||
170809176|NCT07147257|617310530|FG001|Overall Study|Drug administration failure|1|||
170809177|NCT00246129|617312234|FG000|Overall Study|Lost to Follow-up|1|||
170809178|NCT00246129|617312235|FG001|Overall Study|Lost to Follow-up|0|||
170809179|NCT00246129|617312234|FG000|Overall Study|Death|2|||
170809180|NCT00246129|617312235|FG001|Overall Study|Death|1|||
170809181|NCT00246129|617312234|FG000|Overall Study|suffered primary non-function|1|||
170809182|NCT00246129|617312235|FG001|Overall Study|suffered primary non-function|0|||
170809183|NCT00246129|617312234|FG000|Overall Study|grafts failed|3|||
170809184|NCT00246129|617312235|FG001|Overall Study|grafts failed|1|||
170809185|NCT01673594|617312238|FG000|Overall Study|Adverse Event|3|||
170809186|NCT01673594|617312239|FG001|Overall Study|Adverse Event|1|||
170578722|NCT01445613|616460327|FG000|1-year Follow-up|Physician Decision|2|||
170809187|NCT01673594|617312238|FG000|Overall Study|Lost to Follow-up|1|||
170809188|NCT01673594|617312239|FG001|Overall Study|Lost to Follow-up|0|||
170809189|NCT01673594|617312238|FG000|Overall Study|Physician Decision|2|||
170809190|NCT01673594|617312239|FG001|Overall Study|Physician Decision|4|||
170809191|NCT01673594|617312238|FG000|Overall Study|Withdrawal by Subject|0|||
170809192|NCT01673594|617312239|FG001|Overall Study|Withdrawal by Subject|1|||
170809193|NCT05005247|617312240|FG000|Overall Study|Withdrawal by Subject|0|||
170578723|NCT01445613|616460327|FG000|1-year Follow-up|Received a non-study stent|2|||
170578724|NCT03711370|616460328|FG000|Overall Study|Lost to Follow-up|16|||
170809194|NCT05005247|617312241|FG001|Overall Study|Withdrawal by Subject|1|||
170578725|NCT03711370|616460329|FG001|Overall Study|Lost to Follow-up|10|||
170578726|NCT03711370|616460328|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
170809195|NCT05005247|617312242|FG002|Overall Study|Withdrawal by Subject|0|||
170578727|NCT03711370|616460329|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
170578728|NCT01169701|616460332|FG000|Overall Study|Lost to Follow-up|1|||
170578729|NCT01169701|616460333|FG001|Overall Study|Lost to Follow-up|1|||
170578730|NCT01169701|616460332|FG000|Overall Study|Withdrawal by Subject|1|||
170578731|NCT01169701|616460333|FG001|Overall Study|Withdrawal by Subject|3|||
170578732|NCT01169701|616460332|FG000|Overall Study|Adverse Event|1|||
170578733|NCT01169701|616460333|FG001|Overall Study|Adverse Event|2|||
170578734|NCT01169701|616460332|FG000|Overall Study|Exclusion criteria|2|||
170578735|NCT01169701|616460333|FG001|Overall Study|Exclusion criteria|0|||
170578736|NCT01169701|616460332|FG000|Overall Study|Death|0|||
170578737|NCT01169701|616460333|FG001|Overall Study|Death|1|||
170578738|NCT01169701|616460332|FG000|Overall Study|Administrative problems|0|||
170578739|NCT01169701|616460333|FG001|Overall Study|Administrative problems|1|||
170578740|NCT01169701|616460332|FG000|Overall Study|Serious adverse event|0|||
170578741|NCT01169701|616460333|FG001|Overall Study|Serious adverse event|1|||
170578742|NCT01169701|616460332|FG000|Overall Study|Sponsor decision|0|||
170578743|NCT01169701|616460333|FG001|Overall Study|Sponsor decision|1|||
170578744|NCT01030952|616460334|FG000|Overall Study|Protocol Violation|0|||
170578745|NCT01030952|616460335|FG001|Overall Study|Protocol Violation|1|||
170578746|NCT01030952|616460334|FG000|Overall Study|Informed consent withdrawal|1|||
170578747|NCT01030952|616460335|FG001|Overall Study|Informed consent withdrawal|0|||
170578748|NCT01030952|616460334|FG000|Overall Study|Lost to Follow-up|0|||
170578749|NCT01030952|616460335|FG001|Overall Study|Lost to Follow-up|1|||
170578750|NCT01030952|616460334|FG000|Overall Study|Unexplained|1|||
170578751|NCT01030952|616460335|FG001|Overall Study|Unexplained|1|||
170578752|NCT03497039|616460337|FG000|Overall Study|Withdrawal by Subject|1|||
170578753|NCT03497039|616460338|FG001|Overall Study|Withdrawal by Subject|0|||
170578754|NCT03497039|616460337|FG000|Overall Study|Protocol Violation|0|||
170578755|NCT03497039|616460338|FG001|Overall Study|Protocol Violation|1|||
170578756|NCT02567799|616460339|FG000|Concurrent Chemoradiotherapy|Death|1|||
170578757|NCT02567799|616460340|FG001|Concurrent Chemoradiotherapy|Death|0|||
170578758|NCT02567799|616460341|FG002|Concurrent Chemoradiotherapy|Death|0|||
170578759|NCT02567799|616460339|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
170578760|NCT02567799|616460340|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
170578761|NCT02567799|616460341|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
170578762|NCT02567799|616460339|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
170578763|NCT02567799|616460340|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
170578764|NCT02567799|616460341|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
170578765|NCT02567799|616460339|FG000|Follow-up|Death|1|||
170578766|NCT02567799|616460340|FG001|Follow-up|Death|0|||
170578767|NCT02567799|616460341|FG002|Follow-up|Death|1|||
170578768|NCT02567799|616460339|FG000|Follow-up|Progressive Disease|1|||
170578769|NCT02567799|616460340|FG001|Follow-up|Progressive Disease|1|||
170578770|NCT02567799|616460341|FG002|Follow-up|Progressive Disease|3|||
170578771|NCT02100423|616460349|FG000|Overall Study|Death|1|||
170578772|NCT02100423|616460349|FG000|Overall Study|Withdrawal by Subject|3|||
170578773|NCT02100423|616460349|FG000|Overall Study|Adverse Event|1|||
170578774|NCT02100423|616460349|FG000|Overall Study|Physician Decision|1|||
170578775|NCT00703846|616460350|FG000|Overall Study|Adverse Event|8|||
170578776|NCT00703846|616460350|FG000|Overall Study|Lost to Follow-up|55|||
170578777|NCT00703846|616460350|FG000|Overall Study|Lack of Efficacy|15|||
170578778|NCT00703846|616460350|FG000|Overall Study|Noncompliance with Study Treatment|2|||
170578779|NCT00703846|616460350|FG000|Overall Study|Withdrawal by Subject|40|||
170578780|NCT00703846|616460350|FG000|Overall Study|Death|1|||
170578781|NCT00703846|616460350|FG000|Overall Study|Other|14|||
170578782|NCT00703846|616460350|FG000|Overall Study|Did Not Receive Study Drug|2|||
170578783|NCT04601532|616460351|FG000|Overall Study|Lost to Follow-up|1|||
170578784|NCT04601532|616460352|FG001|Overall Study|Lost to Follow-up|2|||
170809196|NCT03648541|617312243|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
170809197|NCT03648541|617312244|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
170809198|NCT03648541|617312243|FG000|Re-induction Period Only|Lack of Efficacy|7|||
170809199|NCT03648541|617312244|FG001|Re-induction Period Only|Lack of Efficacy|0|||
170578785|NCT04601532|616460351|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
170578786|NCT04601532|616460352|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
170578787|NCT02195700|616460353|FG000|Overall Study|Protocol Violation|0|||
170809200|NCT03648541|617312243|FG000|Maintenance Period Only|Missing|0|||
170578788|NCT02195700|616460354|FG001|Overall Study|Protocol Violation|2|||
170578789|NCT02195700|616460353|FG000|Overall Study|Noncompliance|1|||
170578790|NCT02195700|616460354|FG001|Overall Study|Noncompliance|0|||
170578791|NCT02195700|616460353|FG000|Overall Study|Adverse Event|1|||
170578792|NCT02195700|616460354|FG001|Overall Study|Adverse Event|2|||
170578793|NCT02195700|616460353|FG000|Overall Study|Withdrawal by Subject|3|||
170578794|NCT02195700|616460354|FG001|Overall Study|Withdrawal by Subject|2|||
170578795|NCT02195700|616460353|FG000|Overall Study|Lost to Follow-up|1|||
170578796|NCT02195700|616460354|FG001|Overall Study|Lost to Follow-up|1|||
170578797|NCT01352221|616460355|FG000|Double-blind Phase|Adverse Event|6|||
170578798|NCT01352221|616460356|FG001|Double-blind Phase|Adverse Event|4|||
170578799|NCT01352221|616460357|FG002|Double-blind Phase|Adverse Event|0|||
170578800|NCT01352221|616460358|FG003|Double-blind Phase|Adverse Event|0|||
170578801|NCT01352221|616460355|FG000|Double-blind Phase|Withdrawal by Subject|3|||
170578802|NCT01352221|616460356|FG001|Double-blind Phase|Withdrawal by Subject|5|||
170578803|NCT01352221|616460357|FG002|Double-blind Phase|Withdrawal by Subject|0|||
170578804|NCT01352221|616460358|FG003|Double-blind Phase|Withdrawal by Subject|0|||
170578805|NCT01352221|616460355|FG000|Double-blind Phase|Lost to Follow-up|0|||
170578806|NCT01352221|616460356|FG001|Double-blind Phase|Lost to Follow-up|1|||
170578807|NCT01352221|616460357|FG002|Double-blind Phase|Lost to Follow-up|0|||
170578808|NCT01352221|616460358|FG003|Double-blind Phase|Lost to Follow-up|0|||
170578809|NCT01352221|616460355|FG000|Double-blind Phase|Protocol Violation|0|||
170578810|NCT01352221|616460356|FG001|Double-blind Phase|Protocol Violation|1|||
170578811|NCT01352221|616460357|FG002|Double-blind Phase|Protocol Violation|0|||
170578812|NCT01352221|616460358|FG003|Double-blind Phase|Protocol Violation|0|||
170578813|NCT01352221|616460355|FG000|Open-label Phase|Physician Decision|0|||
170578814|NCT01352221|616460356|FG001|Open-label Phase|Physician Decision|0|||
170578815|NCT01352221|616460357|FG002|Open-label Phase|Physician Decision|2|||
170578816|NCT01352221|616460358|FG003|Open-label Phase|Physician Decision|1|||
170578817|NCT01352221|616460355|FG000|Open-label Phase|Pregnancy|0|||
170578818|NCT01352221|616460356|FG001|Open-label Phase|Pregnancy|0|||
170578819|NCT01352221|616460357|FG002|Open-label Phase|Pregnancy|1|||
170578820|NCT01352221|616460358|FG003|Open-label Phase|Pregnancy|0|||
170578821|NCT01352221|616460355|FG000|Open-label Phase|Adverse Event|0|||
170578822|NCT01352221|616460356|FG001|Open-label Phase|Adverse Event|0|||
170578823|NCT01352221|616460357|FG002|Open-label Phase|Adverse Event|8|||
170578824|NCT01352221|616460358|FG003|Open-label Phase|Adverse Event|4|||
170578825|NCT01352221|616460355|FG000|Open-label Phase|Withdrawal by Subject|0|||
170578826|NCT01352221|616460356|FG001|Open-label Phase|Withdrawal by Subject|0|||
170578827|NCT01352221|616460357|FG002|Open-label Phase|Withdrawal by Subject|1|||
170578828|NCT01352221|616460358|FG003|Open-label Phase|Withdrawal by Subject|6|||
170578829|NCT01352221|616460355|FG000|Open-label Phase|Worsening of IBD|0|||
170578830|NCT01352221|616460356|FG001|Open-label Phase|Worsening of IBD|0|||
170578831|NCT01352221|616460357|FG002|Open-label Phase|Worsening of IBD|1|||
170578832|NCT01352221|616460358|FG003|Open-label Phase|Worsening of IBD|0|||
170578833|NCT02566785|616460359|FG000|Overall Study|Lost to Follow-up|0|||
170578834|NCT02566785|616460360|FG001|Overall Study|Lost to Follow-up|2|||
170578835|NCT02566785|616460359|FG000|Overall Study|Worsening condition|1|||
170578836|NCT02566785|616460360|FG001|Overall Study|Worsening condition|1|||
170578837|NCT01597908|616460361|FG000|Randomized Phase|Death|217|||
170578838|NCT01597908|616460362|FG001|Randomized Phase|Death|238|||
170578839|NCT01597908|616460363|FG002|Randomized Phase|Death|0|||
170578840|NCT01597908|616460361|FG000|Randomized Phase|Sponsor Decision|93|||
170578841|NCT01597908|616460362|FG001|Randomized Phase|Sponsor Decision|39|||
170578842|NCT01597908|616460363|FG002|Randomized Phase|Sponsor Decision|0|||
170578843|NCT01597908|616460361|FG000|Randomized Phase|Lost to Follow-up|9|||
170578844|NCT01597908|616460362|FG001|Randomized Phase|Lost to Follow-up|16|||
170578845|NCT01597908|616460363|FG002|Randomized Phase|Lost to Follow-up|0|||
170578846|NCT01597908|616460361|FG000|Randomized Phase|Physician Decision|6|||
170578847|NCT01597908|616460362|FG001|Randomized Phase|Physician Decision|3|||
170578848|NCT01597908|616460363|FG002|Randomized Phase|Physician Decision|0|||
170578849|NCT01597908|616460361|FG000|Randomized Phase|Withdrawal by Subject|26|||
170578850|NCT01597908|616460362|FG001|Randomized Phase|Withdrawal by Subject|22|||
170578851|NCT01597908|616460363|FG002|Randomized Phase|Withdrawal by Subject|0|||
170578852|NCT01597908|616460361|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
170578853|NCT01597908|616460362|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
170578854|NCT01597908|616460363|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
170578855|NCT01597908|616460361|FG000|Crossover Phase|Death|0|||
170578856|NCT01597908|616460362|FG001|Crossover Phase|Death|0|||
170578857|NCT01597908|616460363|FG002|Crossover Phase|Death|11|||
170578858|NCT01597908|616460361|FG000|Crossover Phase|Withdrawal by Subject|0|||
170809201|NCT03648541|617312244|FG001|Maintenance Period Only|Missing|1|||
170809202|NCT03648541|617312243|FG000|Maintenance Period Only|Other not listed below|0|||
170809203|NCT03648541|617312244|FG001|Maintenance Period Only|Other not listed below|4|||
170578859|NCT01597908|616460362|FG001|Crossover Phase|Withdrawal by Subject|0|||
170578860|NCT01597908|616460363|FG002|Crossover Phase|Withdrawal by Subject|3|||
170578861|NCT01597908|616460361|FG000|Crossover Phase|Sponsor Decision|0|||
170578862|NCT01597908|616460362|FG001|Crossover Phase|Sponsor Decision|0|||
170578863|NCT01597908|616460363|FG002|Crossover Phase|Sponsor Decision|20|||
170578864|NCT00933608|616461801|FG000|Overall Study|Adverse Event|4|||
170578865|NCT00933608|616461802|FG001|Overall Study|Adverse Event|2|||
170578866|NCT00933608|616461801|FG000|Overall Study|Physician Decision|1|||
170578867|NCT00933608|616461802|FG001|Overall Study|Physician Decision|0|||
170578868|NCT01519791|616461807|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
170578869|NCT01519791|616461808|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
170578870|NCT01519791|616461807|FG000|Overall Study|Protocol Violation|6|||
170578871|NCT01519791|616461808|FG001|Overall Study|Protocol Violation|19|||
170578872|NCT01519791|616461807|FG000|Overall Study|Other Reason|87|||
170578873|NCT01519791|616461808|FG001|Overall Study|Other Reason|222|||
170578874|NCT01519791|616461807|FG000|Overall Study|subjects randomized in error|2|||
170578875|NCT01519791|616461808|FG001|Overall Study|subjects randomized in error|0|||
170578876|NCT01519791|616461807|FG000|Overall Study|Lack of Efficacy|16|||
170578877|NCT01519791|616461808|FG001|Overall Study|Lack of Efficacy|20|||
170578878|NCT01519791|616461807|FG000|Overall Study|SAE, non-fatal|6|||
170578879|NCT01519791|616461808|FG001|Overall Study|SAE, non-fatal|22|||
170578880|NCT01519791|616461807|FG000|Overall Study|AE, serious fatal|0|||
170578881|NCT01519791|616461808|FG001|Overall Study|AE, serious fatal|1|||
170578882|NCT01519791|616461807|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
170578883|NCT01519791|616461808|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
170578884|NCT01519791|616461807|FG000|Overall Study|AE, non-serious non-fatal|12|||
170578885|NCT01519791|616461808|FG001|Overall Study|AE, non-serious non-fatal|31|||
170578886|NCT01519791|616461807|FG000|Overall Study|Withdrawal by Subject|15|||
170578887|NCT01519791|616461808|FG001|Overall Study|Withdrawal by Subject|37|||
170578888|NCT01519791|616461807|FG000|Overall Study|Lost to Follow-up|6|||
170578889|NCT01519791|616461808|FG001|Overall Study|Lost to Follow-up|14|||
170578890|NCT00459875|616461809|FG000|Overall Study|Ineligible participant|1|||
170578891|NCT00459875|616461809|FG000|Overall Study|Adverse Event|2|||
170578892|NCT04908384|616461811|FG000|Overall Study|Lost to Follow-up|4|||
170649477|NCT01029405|616730789|FG001|Overall Study|Adverse Event|0|||
170649478|NCT01029405|616730790|FG002|Overall Study|Adverse Event|1|||
170649479|NCT01029405|616730791|FG003|Overall Study|Adverse Event|1|||
170809204|NCT03648541|617312243|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
170809205|NCT03648541|617312244|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
170809206|NCT03648541|617312243|FG000|Maintenance Period Only|Protocol Violation|0|||
170649480|NCT01029405|616730788|FG000|Overall Study|Lost to Follow-up|2|||
170909907|NCT00430781|617674664|FG002|Final Analysis; 31 July 2008|Other|0|||
170909908|NCT00430781|617674662|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
170909909|NCT00430781|617674663|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
170909910|NCT00430781|617674664|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
170909911|NCT00430781|617674662|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
170909912|NCT00430781|617674663|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
170909913|NCT00430781|617674664|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
170909914|NCT00430781|617674662|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
170909915|NCT00430781|617674663|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
170909916|NCT00430781|617674664|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
170909917|NCT00430781|617674662|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
170909918|NCT00430781|617674663|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
170909919|NCT00430781|617674664|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
170909920|NCT00430781|617674662|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
170909921|NCT00430781|617674663|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
170909922|NCT00430781|617674664|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
170909923|NCT00430781|617674662|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
170909924|NCT00430781|617674663|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
170909925|NCT00430781|617674664|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
170909926|NCT00430781|617674662|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
170909927|NCT00430781|617674663|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
170909928|NCT00430781|617674664|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
170909929|NCT01059812|617674671|FG000|Overall Study|Adverse Event|9|||
170909930|NCT01059812|617674672|FG001|Overall Study|Adverse Event|5|||
170909931|NCT01059812|617674671|FG000|Overall Study|Lack of Efficacy|2|||
170909932|NCT01059812|617674672|FG001|Overall Study|Lack of Efficacy|2|||
170909933|NCT01059812|617674671|FG000|Overall Study|Protocol Violation|3|||
170909934|NCT01059812|617674672|FG001|Overall Study|Protocol Violation|1|||
170909935|NCT01059812|617674671|FG000|Overall Study|Withdrawal Criteria|9|||
170909936|NCT01059812|617674672|FG001|Overall Study|Withdrawal Criteria|4|||
170909937|NCT01059812|617674671|FG000|Overall Study|Unclassified|14|||
170909938|NCT01059812|617674672|FG001|Overall Study|Unclassified|4|||
170909939|NCT00149214|617674674|FG000|Overall Study|Adverse Event|12|||
170909940|NCT00149214|617674675|FG001|Overall Study|Adverse Event|9|||
170909941|NCT00149214|617674674|FG000|Overall Study|Withdrawal by Subject|4|||
170909942|NCT00149214|617674675|FG001|Overall Study|Withdrawal by Subject|1|||
170909943|NCT00149214|617674674|FG000|Overall Study|Physician Decision|3|||
170909944|NCT00149214|617674675|FG001|Overall Study|Physician Decision|3|||
170909945|NCT00149214|617674674|FG000|Overall Study|Sponsor Decision|0|||
170909946|NCT00149214|617674675|FG001|Overall Study|Sponsor Decision|1|||
170909947|NCT00149214|617674674|FG000|Overall Study|Progressive Disease|7|||
170909948|NCT00149214|617674675|FG001|Overall Study|Progressive Disease|3|||
170909949|NCT04329923|617674685|FG000|Overall Study|Withdrawal by Subject|1|||
170909950|NCT04329923|617674686|FG001|Overall Study|Withdrawal by Subject|4|||
170909951|NCT04329923|617674687|FG002|Overall Study|Withdrawal by Subject|1|||
170909952|NCT04329923|617674688|FG003|Overall Study|Withdrawal by Subject|1|||
170909953|NCT04329923|617674689|FG004|Overall Study|Withdrawal by Subject|1|||
170909954|NCT04329923|617674690|FG005|Overall Study|Withdrawal by Subject|1|||
170909955|NCT04329923|617674685|FG000|Overall Study|early termination of study|0|||
170909956|NCT04329923|617674686|FG001|Overall Study|early termination of study|0|||
170909957|NCT04329923|617674687|FG002|Overall Study|early termination of study|0|||
170909958|NCT04329923|617674688|FG003|Overall Study|early termination of study|0|||
170909959|NCT04329923|617674689|FG004|Overall Study|early termination of study|1|||
170909960|NCT04329923|617674690|FG005|Overall Study|early termination of study|2|||
170909961|NCT04329923|617674685|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
170909962|NCT04329923|617674686|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
170909963|NCT04329923|617674687|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
170909964|NCT04329923|617674688|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
170909965|NCT04329923|617674689|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
170909966|NCT04329923|617674690|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
170909967|NCT01272180|617674691|FG000|Overall Study|Adverse Event|0|||
170909968|NCT01272180|617674692|FG001|Overall Study|Adverse Event|0|||
170909969|NCT01272180|617674693|FG002|Overall Study|Adverse Event|1|||
170909970|NCT01272180|617674694|FG003|Overall Study|Adverse Event|0|||
170909971|NCT01272180|617674691|FG000|Overall Study|Withdrawal by Subject|2|||
170909972|NCT01272180|617674692|FG001|Overall Study|Withdrawal by Subject|6|||
170909973|NCT01272180|617674693|FG002|Overall Study|Withdrawal by Subject|3|||
170909974|NCT01272180|617674694|FG003|Overall Study|Withdrawal by Subject|2|||
170909975|NCT01272180|617674691|FG000|Overall Study|Lost to Follow-up|15|||
170909976|NCT01272180|617674692|FG001|Overall Study|Lost to Follow-up|14|||
170909977|NCT01272180|617674693|FG002|Overall Study|Lost to Follow-up|8|||
170909978|NCT01272180|617674694|FG003|Overall Study|Lost to Follow-up|10|||
170909979|NCT01272180|617674691|FG000|Overall Study|Inappropriate enrollment|0|||
170909980|NCT01272180|617674692|FG001|Overall Study|Inappropriate enrollment|0|||
170809207|NCT03648541|617312244|FG001|Maintenance Period Only|Protocol Violation|1|||
170809208|NCT03648541|617312243|FG000|Maintenance Period Only|Lack of Efficacy|0|||
170809209|NCT03648541|617312244|FG001|Maintenance Period Only|Lack of Efficacy|18|||
170809210|NCT03648541|617312243|FG000|Maintenance Period Only|Adverse Event|0|||
170809211|NCT03648541|617312244|FG001|Maintenance Period Only|Adverse Event|4|||
170809212|NCT03648541|617312243|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
170809213|NCT03648541|617312244|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
170809214|NCT01852045|617312253|FG000|Overall Study|Adverse Event|1|||
170809215|NCT01852045|617312254|FG001|Overall Study|Adverse Event|0|||
170809216|NCT01852045|617312255|FG002|Overall Study|Adverse Event|0|||
170809217|NCT01852045|617312253|FG000|Overall Study|Lack of Efficacy|3|||
170809218|NCT01852045|617312254|FG001|Overall Study|Lack of Efficacy|0|||
170809219|NCT01852045|617312255|FG002|Overall Study|Lack of Efficacy|0|||
170809220|NCT01852045|617312253|FG000|Overall Study|Lost to Follow-up|0|||
170809221|NCT01852045|617312254|FG001|Overall Study|Lost to Follow-up|1|||
170809222|NCT01852045|617312255|FG002|Overall Study|Lost to Follow-up|1|||
170809223|NCT01852045|617312253|FG000|Overall Study|Withdrawal by Subject|1|||
170809224|NCT01852045|617312254|FG001|Overall Study|Withdrawal by Subject|0|||
170909981|NCT01272180|617674693|FG002|Overall Study|Inappropriate enrollment|1|||
170909982|NCT01272180|617674694|FG003|Overall Study|Inappropriate enrollment|1|||
170909983|NCT01272180|617674691|FG000|Overall Study|Protocol Violation|0|||
170909984|NCT01272180|617674692|FG001|Overall Study|Protocol Violation|1|||
170909985|NCT01272180|617674693|FG002|Overall Study|Protocol Violation|0|||
170909986|NCT01272180|617674694|FG003|Overall Study|Protocol Violation|1|||
170909987|NCT03700892|617674696|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
170909988|NCT03700892|617674697|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
170909989|NCT03700892|617674698|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
170909990|NCT00650585|617674699|FG000|Overall Study|Lost to Follow-up|505|||
170909991|NCT00650585|617674700|FG001|Overall Study|Lost to Follow-up|482|||
170909992|NCT00650585|617674699|FG000|Overall Study|No parental consent|935|||
170909993|NCT00650585|617674700|FG001|Overall Study|No parental consent|866|||
170909994|NCT00650585|617674699|FG000|Overall Study|Excluded/ruled ineligible|357|||
170909995|NCT00650585|617674700|FG001|Overall Study|Excluded/ruled ineligible|129|||
170909996|NCT00624338|617674707|FG000|Overall Study|Adverse Event|14|||
170909997|NCT00624338|617674708|FG001|Overall Study|Adverse Event|14|||
170909998|NCT00624338|617674709|FG002|Overall Study|Adverse Event|18|||
170909999|NCT00624338|617674707|FG000|Overall Study|Lost to Follow-up|1|||
170910000|NCT00624338|617674708|FG001|Overall Study|Lost to Follow-up|0|||
170910001|NCT00624338|617674709|FG002|Overall Study|Lost to Follow-up|0|||
170910002|NCT00624338|617674707|FG000|Overall Study|Lack of Efficacy|11|||
170910003|NCT00624338|617674708|FG001|Overall Study|Lack of Efficacy|3|||
170910004|NCT00624338|617674709|FG002|Overall Study|Lack of Efficacy|14|||
170910005|NCT00624338|617674707|FG000|Overall Study|Protocol Violation|3|||
170910006|NCT00624338|617674708|FG001|Overall Study|Protocol Violation|3|||
170910007|NCT00624338|617674709|FG002|Overall Study|Protocol Violation|2|||
170910008|NCT00624338|617674707|FG000|Overall Study|Death|0|||
170910009|NCT00624338|617674708|FG001|Overall Study|Death|2|||
170910010|NCT00624338|617674709|FG002|Overall Study|Death|0|||
170910011|NCT00624338|617674707|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
170910012|NCT00624338|617674708|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
170910013|NCT00624338|617674709|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
170910014|NCT00624338|617674707|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
170910015|NCT00624338|617674708|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
170910016|NCT00624338|617674709|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
170910017|NCT00624338|617674707|FG000|Overall Study|Other|15|||
170910018|NCT00624338|617674708|FG001|Overall Study|Other|5|||
170910019|NCT00624338|617674709|FG002|Overall Study|Other|9|||
170910020|NCT00624338|617674707|FG000|Overall Study|Randomized but not treated|2|||
170910021|NCT00624338|617674708|FG001|Overall Study|Randomized but not treated|1|||
170910022|NCT00624338|617674709|FG002|Overall Study|Randomized but not treated|3|||
170910023|NCT01476787|617674713|FG000|Treatment|Progression|64|||
170910024|NCT01476787|617674714|FG001|Treatment|Progression|71|||
170910025|NCT01476787|617674713|FG000|Treatment|Toxicity|44|||
170910026|NCT01476787|617674714|FG001|Treatment|Toxicity|16|||
170910027|NCT01476787|617674713|FG000|Treatment|Death|0|||
170910028|NCT01476787|617674714|FG001|Treatment|Death|1|||
170910029|NCT01476787|617674713|FG000|Treatment|Withdrawal by Subject|3|||
170910030|NCT01476787|617674714|FG001|Treatment|Withdrawal by Subject|14|||
170910031|NCT01476787|617674713|FG000|Treatment|Major protocol violation|1|||
170910032|NCT01476787|617674714|FG001|Treatment|Major protocol violation|6|||
170910033|NCT01476787|617674713|FG000|Treatment|Other reasons|10|||
170910034|NCT01476787|617674714|FG001|Treatment|Other reasons|22|||
170910035|NCT01476787|617674713|FG000|Treatment|Concurrent illness|12|||
170910036|NCT01476787|617674714|FG001|Treatment|Concurrent illness|9|||
170910037|NCT01476787|617674713|FG000|Treatment|Insufficient response|15|||
170910038|NCT01476787|617674714|FG001|Treatment|Insufficient response|3|||
170910039|NCT01476787|617674713|FG000|Treatment|Voluntary treatment discontinuation|8|||
170910040|NCT01476787|617674714|FG001|Treatment|Voluntary treatment discontinuation|4|||
170649481|NCT01029405|616730789|FG001|Overall Study|Lost to Follow-up|1|||
170649482|NCT01029405|616730790|FG002|Overall Study|Lost to Follow-up|1|||
170649483|NCT01029405|616730791|FG003|Overall Study|Lost to Follow-up|2|||
170809225|NCT01852045|617312255|FG002|Overall Study|Withdrawal by Subject|1|||
170809226|NCT01852045|617312253|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170809227|NCT01852045|617312254|FG001|Overall Study|Other Miscellaneous Reasons|3|||
170809228|NCT01852045|617312255|FG002|Overall Study|Other Miscellaneous Reasons|2|||
170809229|NCT01485887|617312256|FG000|Overall Study|Withdrawal by Subject|2|||
170809230|NCT01485887|617312256|FG000|Overall Study|Adverse Event|8|||
170809231|NCT01485887|617312256|FG000|Overall Study|Deterioration of primary disease|1|||
170809232|NCT01485887|617312256|FG000|Overall Study|Primary disease markedly improved|1|||
170809233|NCT00895245|617312257|FG000|Overall Study|Lack of Efficacy|6|||
170649484|NCT01029405|616730788|FG000|Overall Study|Other|0|||
170809234|NCT03418545|617312258|FG000|Overall Study|Withdrawal by Participant|2|||
170809235|NCT03418545|617312259|FG001|Overall Study|Withdrawal by Participant|4|||
170809236|NCT03418545|617312258|FG000|Overall Study|Lost to Follow-up|3|||
170649485|NCT01029405|616730789|FG001|Overall Study|Other|1|||
170809237|NCT03418545|617312259|FG001|Overall Study|Lost to Follow-up|5|||
170809238|NCT03418545|617312258|FG000|Overall Study|Reason Not Specified|0|||
170809239|NCT03418545|617312259|FG001|Overall Study|Reason Not Specified|1|||
170809240|NCT03418545|617312258|FG000|Overall Study|Missing Completion Status|0|||
170809241|NCT03418545|617312259|FG001|Overall Study|Missing Completion Status|1|||
170809242|NCT01365546|617312260|FG000|Overall Study|Withdrawal by Subject|1|||
170649486|NCT01029405|616730790|FG002|Overall Study|Other|0|||
170809243|NCT01365546|617312260|FG000|Overall Study|Screen failure|9|||
170649487|NCT01029405|616730791|FG003|Overall Study|Other|1|||
170649488|NCT02480712|616730792|FG000|Overall Study|Enrolled but Never Treated|1|||
170649489|NCT02480712|616730792|FG000|Overall Study|Lost to Follow-up|5|||
170649490|NCT02480712|616730792|FG000|Overall Study|Withdrew Consent|3|||
170649491|NCT02480712|616730792|FG000|Overall Study|Death|1|||
170649492|NCT02480712|616730792|FG000|Overall Study|Lack of Efficacy|1|||
170649493|NCT01860846|616730793|FG000|Overall Study|Lost to Follow-up|33|||
170649494|NCT01328444|616730796|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
170649495|NCT01328444|616730797|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
170649496|NCT01328444|616730798|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
170649497|NCT01328444|616730799|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
170649498|NCT01328444|616730800|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
170649499|NCT01328444|616730801|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
170649500|NCT01328444|616730796|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
170910041|NCT01591330|617674715|FG000|Period 1|Adverse Event|1|||
170910042|NCT01591330|617674716|FG001|Period 1|Adverse Event|0|||
170910043|NCT01591330|617674717|FG002|Period 1|Adverse Event|0|||
170910044|NCT01591330|617674718|FG003|Period 1|Adverse Event|0|||
170910045|NCT01591330|617674715|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
170910046|NCT01591330|617674716|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
170910047|NCT01591330|617674717|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
170910048|NCT01591330|617674718|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
170910049|NCT01591330|617674715|FG000|Period 2|Adverse Event|1|||
170910050|NCT01591330|617674716|FG001|Period 2|Adverse Event|0|||
170910051|NCT01591330|617674717|FG002|Period 2|Adverse Event|0|||
170910052|NCT01591330|617674718|FG003|Period 2|Adverse Event|0|||
170910053|NCT00524303|617674724|FG000|Overall Study|Lost to Follow-up|6|||
170910054|NCT00524303|617674725|FG001|Overall Study|Lost to Follow-up|0|||
170910055|NCT00524303|617674726|FG002|Overall Study|Lost to Follow-up|3|||
170910056|NCT00524303|617674724|FG000|Overall Study|Protocol Violation|0|||
170910057|NCT00524303|617674725|FG001|Overall Study|Protocol Violation|1|||
170910058|NCT00524303|617674726|FG002|Overall Study|Protocol Violation|1|||
170910059|NCT00524303|617674724|FG000|Overall Study|Withdrawal by Subject|3|||
170910060|NCT00524303|617674725|FG001|Overall Study|Withdrawal by Subject|0|||
170910061|NCT00524303|617674726|FG002|Overall Study|Withdrawal by Subject|4|||
170910062|NCT00524303|617674724|FG000|Overall Study|Death|0|||
170910063|NCT00524303|617674725|FG001|Overall Study|Death|2|||
170910064|NCT00524303|617674726|FG002|Overall Study|Death|3|||
170910065|NCT00524303|617674724|FG000|Overall Study|Adverse Event|1|||
170910066|NCT00524303|617674725|FG001|Overall Study|Adverse Event|2|||
170910067|NCT00524303|617674726|FG002|Overall Study|Adverse Event|3|||
170910068|NCT00524303|617674724|FG000|Overall Study|Did not Complete Study Dosing|1|||
170910069|NCT00524303|617674725|FG001|Overall Study|Did not Complete Study Dosing|0|||
170910070|NCT00524303|617674726|FG002|Overall Study|Did not Complete Study Dosing|0|||
170910071|NCT00524303|617674724|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
170910072|NCT00524303|617674725|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
170910073|NCT00524303|617674726|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
170910074|NCT00524303|617674724|FG000|Overall Study|Disease Progression|0|||
170910075|NCT00524303|617674725|FG001|Overall Study|Disease Progression|4|||
170910076|NCT00524303|617674726|FG002|Overall Study|Disease Progression|1|||
170910077|NCT00524303|617674724|FG000|Overall Study|Disease Recurrence|0|||
170910078|NCT00524303|617674725|FG001|Overall Study|Disease Recurrence|1|||
170910079|NCT00524303|617674726|FG002|Overall Study|Disease Recurrence|0|||
170910080|NCT00524303|617674724|FG000|Overall Study|Sponsor Request|0|||
170910081|NCT00524303|617674725|FG001|Overall Study|Sponsor Request|0|||
170910082|NCT00524303|617674726|FG002|Overall Study|Sponsor Request|1|||
170910083|NCT00524303|617674724|FG000|Overall Study|Physician Decision|0|||
170910084|NCT00524303|617674725|FG001|Overall Study|Physician Decision|0|||
170910085|NCT00524303|617674726|FG002|Overall Study|Physician Decision|1|||
170910086|NCT00524303|617674724|FG000|Overall Study|Completed 5 years|0|||
170910087|NCT00524303|617674725|FG001|Overall Study|Completed 5 years|0|||
170910088|NCT00524303|617674726|FG002|Overall Study|Completed 5 years|1|||
170910089|NCT00970294|617674727|FG000|Overall Study|Physician Decision|4|||
170910090|NCT00970294|617674727|FG000|Overall Study|Withdrawal by Subject|1|||
170910091|NCT01607892|617674730|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
170910092|NCT01607892|617674731|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
170910093|NCT01607892|617674732|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
170910094|NCT01607892|617674733|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
170910095|NCT01607892|617674734|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
170910096|NCT01607892|617674730|FG000|Overall Study|Death|4|||
170910097|NCT01607892|617674731|FG001|Overall Study|Death|2|||
170910098|NCT01607892|617674732|FG002|Overall Study|Death|8|||
170910099|NCT01607892|617674733|FG003|Overall Study|Death|10|||
170910100|NCT01607892|617674734|FG004|Overall Study|Death|3|||
170910101|NCT01607892|617674730|FG000|Overall Study|Investigator discretion|2|||
170910102|NCT01607892|617674731|FG001|Overall Study|Investigator discretion|4|||
170910103|NCT01607892|617674732|FG002|Overall Study|Investigator discretion|4|||
170910104|NCT01607892|617674733|FG003|Overall Study|Investigator discretion|8|||
170910105|NCT01607892|617674734|FG004|Overall Study|Investigator discretion|0|||
170910106|NCT01607892|617674730|FG000|Overall Study|Other treatments became available|1|||
170910107|NCT01607892|617674731|FG001|Overall Study|Other treatments became available|1|||
170910108|NCT01607892|617674732|FG002|Overall Study|Other treatments became available|0|||
170910109|NCT01607892|617674733|FG003|Overall Study|Other treatments became available|0|||
170910110|NCT01607892|617674734|FG004|Overall Study|Other treatments became available|2|||
170910111|NCT01607892|617674730|FG000|Overall Study|Intercurrent illness|1|||
170910112|NCT01607892|617674731|FG001|Overall Study|Intercurrent illness|0|||
170910113|NCT01607892|617674732|FG002|Overall Study|Intercurrent illness|0|||
170910114|NCT01607892|617674733|FG003|Overall Study|Intercurrent illness|3|||
170910115|NCT01607892|617674734|FG004|Overall Study|Intercurrent illness|0|||
170910116|NCT01607892|617674730|FG000|Overall Study|Non-Compliance with study procedures|0|||
170910117|NCT01607892|617674731|FG001|Overall Study|Non-Compliance with study procedures|0|||
170649501|NCT01328444|616730797|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
170649502|NCT01328444|616730798|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
170649503|NCT01328444|616730799|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
170649504|NCT01328444|616730800|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
170910118|NCT01607892|617674732|FG002|Overall Study|Non-Compliance with study procedures|1|||
170910119|NCT01607892|617674733|FG003|Overall Study|Non-Compliance with study procedures|0|||
170910120|NCT01607892|617674734|FG004|Overall Study|Non-Compliance with study procedures|0|||
170910121|NCT01607892|617674730|FG000|Overall Study|Consent withdrawn by participant|9|||
170910122|NCT01607892|617674731|FG001|Overall Study|Consent withdrawn by participant|4|||
170910123|NCT01607892|617674732|FG002|Overall Study|Consent withdrawn by participant|24|||
170910124|NCT01607892|617674733|FG003|Overall Study|Consent withdrawn by participant|14|||
170910125|NCT01607892|617674734|FG004|Overall Study|Consent withdrawn by participant|4|||
170910126|NCT01607892|617674730|FG000|Overall Study|Disease progression|38|||
170910127|NCT01607892|617674731|FG001|Overall Study|Disease progression|13|||
170910128|NCT01607892|617674732|FG002|Overall Study|Disease progression|37|||
170910129|NCT01607892|617674733|FG003|Overall Study|Disease progression|57|||
170910130|NCT01607892|617674734|FG004|Overall Study|Disease progression|9|||
170910131|NCT01607892|617674730|FG000|Overall Study|Incidence or severity of Adverse events|3|||
170910132|NCT01607892|617674731|FG001|Overall Study|Incidence or severity of Adverse events|3|||
170910133|NCT01607892|617674732|FG002|Overall Study|Incidence or severity of Adverse events|7|||
170910134|NCT01607892|617674733|FG003|Overall Study|Incidence or severity of Adverse events|2|||
170910135|NCT01607892|617674734|FG004|Overall Study|Incidence or severity of Adverse events|6|||
170910136|NCT01676116|617674735|FG000|Overall Study|Withdrawal criteria|2|||
170910137|NCT01676116|617674736|FG001|Overall Study|Withdrawal criteria|14|||
170910138|NCT01676116|617674735|FG000|Overall Study|Adverse Event|1|||
170910139|NCT01676116|617674736|FG001|Overall Study|Adverse Event|2|||
170910140|NCT01676116|617674735|FG000|Overall Study|Unclassified|4|||
170910141|NCT01676116|617674736|FG001|Overall Study|Unclassified|10|||
170910142|NCT01676116|617674735|FG000|Overall Study|Protocol Violation|9|||
170910143|NCT01676116|617674736|FG001|Overall Study|Protocol Violation|3|||
170910144|NCT01877655|617674737|FG000|Overall Study|Death|57|||
170910145|NCT01877655|617674738|FG001|Overall Study|Death|52|||
170910146|NCT01877655|617674737|FG000|Overall Study|Withdrawal by Subject|18|||
170910147|NCT01877655|617674738|FG001|Overall Study|Withdrawal by Subject|26|||
170910148|NCT01877655|617674737|FG000|Overall Study|Physician Decision|11|||
170910149|NCT01877655|617674738|FG001|Overall Study|Physician Decision|10|||
170910150|NCT01877655|617674737|FG000|Overall Study|Miscellaneous|4|||
170910151|NCT01877655|617674738|FG001|Overall Study|Miscellaneous|4|||
170910152|NCT01877655|617674737|FG000|Overall Study|Randomized but Never Received Drug|8|||
170910153|NCT01877655|617674738|FG001|Overall Study|Randomized but Never Received Drug|5|||
170910154|NCT02462889|617674739|FG000|Overall Study|Withdrawal by Subject|2|||
170910155|NCT02462889|617674740|FG001|Overall Study|Withdrawal by Subject|6|||
170910156|NCT02462889|617674739|FG000|Overall Study|Death|1|||
170910157|NCT02462889|617674740|FG001|Overall Study|Death|5|||
170910158|NCT03567187|617674744|FG000|Overall Study|Lost to Follow-up|18|||
170910159|NCT03497689|617674745|FG000|Overall Study|Adverse Event|2|||
170910160|NCT03497689|617674745|FG000|Overall Study|Death|1|||
170910161|NCT03497689|617674745|FG000|Overall Study|Physician Decision|1|||
170910162|NCT03497689|617674745|FG000|Overall Study|Withdrawal by Subject|1|||
170910163|NCT03497689|617674745|FG000|Overall Study|Protocol Violation|2|||
170910164|NCT05369208|617675891|FG000|Core Phase|Prohibited Medication Required|2|||
170910165|NCT05369208|617675891|FG000|Core Phase|Adverse Event|1|||
170910166|NCT05369208|617675891|FG000|Core Phase|Lack of Efficacy|1|||
170910167|NCT01269125|617675893|FG000|Overall Study|Adverse Event|3|||
170910168|NCT01269125|617675894|FG001|Overall Study|Adverse Event|5|||
170910169|NCT01269125|617675895|FG002|Overall Study|Adverse Event|0|||
170910170|NCT01269125|617675893|FG000|Overall Study|Lost to Follow-up|4|||
170910171|NCT01269125|617675894|FG001|Overall Study|Lost to Follow-up|0|||
170910172|NCT01269125|617675895|FG002|Overall Study|Lost to Follow-up|0|||
170910173|NCT05299892|617675896|FG000|Overall Study|Withdrawal by Subject|2|||
170809244|NCT01365546|617312260|FG000|Overall Study|Study termination|1|||
170809245|NCT03326856|617312261|FG000|Overall Study|Lost to Follow-up|1|||
170809246|NCT03326856|617312262|FG001|Overall Study|Lost to Follow-up|1|||
170809247|NCT03326856|617312263|FG002|Overall Study|Lost to Follow-up|0|||
170809248|NCT03326856|617312264|FG003|Overall Study|Lost to Follow-up|0|||
170809249|NCT03326856|617312265|FG004|Overall Study|Lost to Follow-up|0|||
170809250|NCT03162614|617312269|FG000|Overall Study|Lost to Follow-up|2|||
170809251|NCT03162614|617312270|FG001|Overall Study|Lost to Follow-up|1|||
170809252|NCT03162614|617312271|FG002|Overall Study|Lost to Follow-up|1|||
170809253|NCT03162614|617312272|FG003|Overall Study|Lost to Follow-up|1|||
170809254|NCT03162614|617312273|FG004|Overall Study|Lost to Follow-up|2|||
170809255|NCT03162614|617312274|FG005|Overall Study|Lost to Follow-up|0|||
170809256|NCT03162614|617312269|FG000|Overall Study|Protocol Violation|0|||
170809257|NCT03162614|617312270|FG001|Overall Study|Protocol Violation|1|||
170809258|NCT03162614|617312271|FG002|Overall Study|Protocol Violation|0|||
170809259|NCT03162614|617312272|FG003|Overall Study|Protocol Violation|1|||
170809260|NCT03162614|617312273|FG004|Overall Study|Protocol Violation|0|||
170809261|NCT03162614|617312274|FG005|Overall Study|Protocol Violation|0|||
170809262|NCT03162614|617312269|FG000|Overall Study|Withdrawal by Subject|2|||
170809263|NCT03162614|617312270|FG001|Overall Study|Withdrawal by Subject|1|||
170809264|NCT03162614|617312271|FG002|Overall Study|Withdrawal by Subject|1|||
170910174|NCT01451515|617675897|FG000|Overall Study|Death|0|||
170910175|NCT01451515|617675898|FG001|Overall Study|Death|1|||
170910176|NCT01451515|617675899|FG002|Overall Study|Death|0|||
170809265|NCT03162614|617312272|FG003|Overall Study|Withdrawal by Subject|1|||
170809266|NCT03162614|617312273|FG004|Overall Study|Withdrawal by Subject|0|||
170809267|NCT03162614|617312274|FG005|Overall Study|Withdrawal by Subject|0|||
170809268|NCT03162614|617312269|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
170809269|NCT03162614|617312270|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
170809270|NCT03162614|617312271|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
170809271|NCT03162614|617312272|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
170809272|NCT03162614|617312273|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
170809273|NCT03162614|617312274|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
170809274|NCT03861234|617312275|FG000|Overall Study|Not treated|0|||
170809275|NCT03861234|617312276|FG001|Overall Study|Not treated|0|||
170809276|NCT03861234|617312277|FG002|Overall Study|Not treated|0|||
170809277|NCT03861234|617312278|FG003|Overall Study|Not treated|0|||
170809278|NCT03861234|617312279|FG004|Overall Study|Not treated|0|||
170809279|NCT03861234|617312280|FG005|Overall Study|Not treated|1|||
170809280|NCT03861234|617312281|FG006|Overall Study|Not treated|0|||
170809281|NCT03861234|617312282|FG007|Overall Study|Not treated|0|||
170809282|NCT03861234|617312275|FG000|Overall Study|Adverse Event|0|||
170809283|NCT03861234|617312276|FG001|Overall Study|Adverse Event|0|||
170809284|NCT03861234|617312277|FG002|Overall Study|Adverse Event|0|||
170809285|NCT03861234|617312278|FG003|Overall Study|Adverse Event|0|||
170809286|NCT03861234|617312279|FG004|Overall Study|Adverse Event|0|||
170809287|NCT03861234|617312280|FG005|Overall Study|Adverse Event|1|||
170809288|NCT03861234|617312281|FG006|Overall Study|Adverse Event|0|||
170809289|NCT03861234|617312282|FG007|Overall Study|Adverse Event|0|||
170809290|NCT03861234|617312275|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
170809291|NCT03861234|617312276|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
170809292|NCT03861234|617312277|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
170809293|NCT03861234|617312278|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
170809294|NCT03861234|617312279|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
170809295|NCT03861234|617312280|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
170809296|NCT03861234|617312281|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
170809297|NCT03861234|617312282|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
170809298|NCT03861234|617312275|FG000|Overall Study|As per sponsor decision|0|||
170809299|NCT03861234|617312276|FG001|Overall Study|As per sponsor decision|0|||
170809300|NCT03861234|617312277|FG002|Overall Study|As per sponsor decision|0|||
170809301|NCT03861234|617312278|FG003|Overall Study|As per sponsor decision|0|||
170809302|NCT03861234|617312279|FG004|Overall Study|As per sponsor decision|0|||
170809303|NCT03861234|617312280|FG005|Overall Study|As per sponsor decision|0|||
170809304|NCT03861234|617312281|FG006|Overall Study|As per sponsor decision|1|||
170809305|NCT03861234|617312282|FG007|Overall Study|As per sponsor decision|0|||
170809306|NCT03861234|617312275|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
170809307|NCT03861234|617312276|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
170809308|NCT03861234|617312277|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
170809309|NCT03861234|617312278|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
170809310|NCT03861234|617312279|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
170809311|NCT03861234|617312280|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
170809312|NCT03861234|617312281|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
170809313|NCT03861234|617312282|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
170809314|NCT00621842|617312283|FG000|Overall Study|Adverse Event|6|||
170649505|NCT01328444|616730801|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
170649506|NCT01328444|616730796|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
170649507|NCT01328444|616730797|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
170649508|NCT01328444|616730798|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
170649509|NCT01328444|616730799|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
170910177|NCT01451515|617675897|FG000|Overall Study|Withdrawal by Subject|0|||
170910178|NCT01451515|617675898|FG001|Overall Study|Withdrawal by Subject|1|||
170910179|NCT01451515|617675899|FG002|Overall Study|Withdrawal by Subject|0|||
170910180|NCT01451515|617675897|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
170910181|NCT01451515|617675898|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
170910182|NCT01451515|617675899|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
170910183|NCT01451515|617675897|FG000|Overall Study|Relapse (except CNS)|1|||
170910184|NCT01451515|617675898|FG001|Overall Study|Relapse (except CNS)|1|||
170910185|NCT01451515|617675899|FG002|Overall Study|Relapse (except CNS)|0|||
170910186|NCT00852930|617675900|FG000|Overall Study|Withdrawal by Subject|1|||
170910187|NCT00852930|617675901|FG001|Overall Study|Withdrawal by Subject|1|||
170910188|NCT00852930|617675902|FG002|Overall Study|Withdrawal by Subject|1|||
170910189|NCT00852930|617675900|FG000|Overall Study|Physician Decision|0|||
170910190|NCT00852930|617675901|FG001|Overall Study|Physician Decision|0|||
170910191|NCT00852930|617675902|FG002|Overall Study|Physician Decision|1|||
170910192|NCT00537745|617675903|FG000|Overall Study|Did not meet eligibility criteria|2|||
170910193|NCT00537745|617675903|FG000|Overall Study|Withdrawal by Subject|2|||
170910194|NCT00537745|617675903|FG000|Overall Study|Subject unable to provide Interlock info|1|||
170910195|NCT02532543|617675905|FG000|Overall Study|Lost to Follow-up|0|||
170910196|NCT02532543|617675906|FG001|Overall Study|Lost to Follow-up|0|||
170910197|NCT02532543|617675907|FG002|Overall Study|Lost to Follow-up|1|||
170910198|NCT02532543|617675908|FG003|Overall Study|Lost to Follow-up|0|||
170910199|NCT02640612|617675909|FG000|Overall Study|Adverse Event|6|||
170910200|NCT02640612|617675910|FG001|Overall Study|Adverse Event|7|||
170910201|NCT02640612|617675911|FG002|Overall Study|Adverse Event|2|||
170910202|NCT02640612|617675909|FG000|Overall Study|Death|1|||
170910203|NCT02640612|617675910|FG001|Overall Study|Death|0|||
170910204|NCT02640612|617675911|FG002|Overall Study|Death|0|||
170910205|NCT02640612|617675909|FG000|Overall Study|Withdrawal by Subject|10|||
170910206|NCT02640612|617675910|FG001|Overall Study|Withdrawal by Subject|3|||
170910207|NCT02640612|617675911|FG002|Overall Study|Withdrawal by Subject|3|||
170910208|NCT02640612|617675909|FG000|Overall Study|Lost to Follow-up|4|||
170910209|NCT02640612|617675910|FG001|Overall Study|Lost to Follow-up|1|||
170910210|NCT02640612|617675911|FG002|Overall Study|Lost to Follow-up|1|||
170910211|NCT02640612|617675909|FG000|Overall Study|Protocol Violation|0|||
170910212|NCT02640612|617675910|FG001|Overall Study|Protocol Violation|2|||
170910213|NCT02640612|617675911|FG002|Overall Study|Protocol Violation|0|||
170910214|NCT02640612|617675909|FG000|Overall Study|Lack of Efficacy|1|||
170910215|NCT02640612|617675910|FG001|Overall Study|Lack of Efficacy|1|||
170910216|NCT02640612|617675911|FG002|Overall Study|Lack of Efficacy|0|||
170910217|NCT03233048|617675921|FG000|Overall Study|Withdrawal by Subject|1|||
170910218|NCT01856673|617675922|FG000|Overall Study|Withdrawal by Subject|44|||
170910219|NCT01856673|617675923|FG001|Overall Study|Withdrawal by Subject|50|||
170910220|NCT01856673|617675924|FG002|Overall Study|Withdrawal by Subject|33|||
170910221|NCT01856673|617675922|FG000|Overall Study|Lost to Follow-up|31|||
170910222|NCT01856673|617675923|FG001|Overall Study|Lost to Follow-up|34|||
170910223|NCT01856673|617675924|FG002|Overall Study|Lost to Follow-up|0|||
170910224|NCT01856673|617675922|FG000|Overall Study|Unknown reasons|9|||
170910225|NCT01856673|617675923|FG001|Overall Study|Unknown reasons|0|||
170910226|NCT01856673|617675924|FG002|Overall Study|Unknown reasons|0|||
170910227|NCT01856673|617675922|FG000|Overall Study|Psychologist decision|1|||
170910228|NCT01856673|617675923|FG001|Overall Study|Psychologist decision|0|||
170910229|NCT01856673|617675924|FG002|Overall Study|Psychologist decision|0|||
170910230|NCT01856673|617675922|FG000|Overall Study|Paperwork errors|8|||
170910231|NCT01856673|617675923|FG001|Overall Study|Paperwork errors|0|||
170910232|NCT01856673|617675924|FG002|Overall Study|Paperwork errors|0|||
170910233|NCT01856673|617675922|FG000|Overall Study|Death|1|||
170910234|NCT01856673|617675923|FG001|Overall Study|Death|1|||
170910235|NCT01856673|617675924|FG002|Overall Study|Death|0|||
170910236|NCT01856673|617675922|FG000|Overall Study|Protocol Violation|1|||
170910237|NCT01856673|617675923|FG001|Overall Study|Protocol Violation|0|||
170910238|NCT01856673|617675924|FG002|Overall Study|Protocol Violation|1|||
170910239|NCT03114969|617675925|FG000|Overall Study|Lost to Follow-up|0|||
170910240|NCT03114969|617675926|FG001|Overall Study|Lost to Follow-up|0|||
170910241|NCT03114969|617675927|FG002|Overall Study|Lost to Follow-up|3|||
170910242|NCT03114969|617675928|FG003|Overall Study|Lost to Follow-up|2|||
170910243|NCT03114969|617675929|FG004|Overall Study|Lost to Follow-up|0|||
170910244|NCT03114969|617675930|FG005|Overall Study|Lost to Follow-up|0|||
170910245|NCT03114969|617675931|FG006|Overall Study|Lost to Follow-up|0|||
170910246|NCT03114969|617675932|FG007|Overall Study|Lost to Follow-up|0|||
170910247|NCT03114969|617675933|FG008|Overall Study|Lost to Follow-up|0|||
170910248|NCT03114969|617675925|FG000|Overall Study|Adverse Event|0|||
170910249|NCT03114969|617675926|FG001|Overall Study|Adverse Event|0|||
170649510|NCT01328444|616730800|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
170649511|NCT01328444|616730801|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
170649512|NCT01328444|616730796|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
170649513|NCT01328444|616730797|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
170649514|NCT01328444|616730798|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
170649515|NCT01328444|616730799|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
170649516|NCT01328444|616730800|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
170649517|NCT01328444|616730801|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
170649518|NCT01328444|616730796|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
170649519|NCT01328444|616730797|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170649520|NCT01328444|616730798|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170649521|NCT01328444|616730799|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
170649522|NCT01328444|616730800|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170649523|NCT01328444|616730801|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
170649524|NCT01328444|616730796|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170649525|NCT01328444|616730797|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
170649526|NCT01328444|616730798|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
170649527|NCT01328444|616730799|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
170649528|NCT01328444|616730800|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
170649529|NCT01328444|616730801|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170649530|NCT01328444|616730796|FG000|Washout Period (14 Days)|Adverse Event|1|||
170649531|NCT01328444|616730797|FG001|Washout Period (14 Days)|Adverse Event|1|||
170649532|NCT01328444|616730798|FG002|Washout Period (14 Days)|Adverse Event|0|||
170649533|NCT01328444|616730799|FG003|Washout Period (14 Days)|Adverse Event|1|||
170649534|NCT01328444|616730800|FG004|Washout Period (14 Days)|Adverse Event|1|||
170649535|NCT01328444|616730801|FG005|Washout Period (14 Days)|Adverse Event|2|||
170649536|NCT01328444|616730796|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
170649537|NCT01328444|616730797|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
170649538|NCT01328444|616730798|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
170649539|NCT01328444|616730799|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
170649540|NCT01328444|616730800|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
170649541|NCT01328444|616730801|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
170649542|NCT01328444|616730796|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
170649543|NCT01328444|616730797|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
170649544|NCT01328444|616730798|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
170649545|NCT01328444|616730799|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
170649546|NCT01328444|616730800|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
170649547|NCT01328444|616730801|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
170649548|NCT01328444|616730796|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
170649549|NCT01328444|616730797|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
170649550|NCT01328444|616730798|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
170649551|NCT01328444|616730799|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
170649552|NCT01328444|616730800|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
170649553|NCT01328444|616730801|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
170649554|NCT01328444|616730796|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
170649555|NCT01328444|616730797|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
170649556|NCT01328444|616730798|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
170649557|NCT01328444|616730799|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
170649558|NCT01328444|616730800|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
170649559|NCT01328444|616730801|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
170649560|NCT01328444|616730796|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
170809315|NCT00621842|617312283|FG000|Overall Study|Withdrawal by Subject|7|||
170809316|NCT00621842|617312283|FG000|Overall Study|Protocol Violation|4|||
170809317|NCT00621842|617312283|FG000|Overall Study|Lack of Efficacy|2|||
170809318|NCT04397263|617312286|FG000|Overall Study|Withdrawal by Subject|2|||
170809319|NCT01074242|617312289|FG000|Overall Study|Case report before date of contract|40|||
170809320|NCT01074242|617312289|FG000|Overall Study|Lost to Follow-up|1|||
170809321|NCT01074242|617312289|FG000|Overall Study|Case report unclear|6|||
170649561|NCT01328444|616730797|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
170910250|NCT03114969|617675927|FG002|Overall Study|Adverse Event|1|||
170910251|NCT03114969|617675928|FG003|Overall Study|Adverse Event|0|||
170910252|NCT03114969|617675929|FG004|Overall Study|Adverse Event|0|||
170910253|NCT03114969|617675930|FG005|Overall Study|Adverse Event|1|||
170910254|NCT03114969|617675931|FG006|Overall Study|Adverse Event|1|||
170910255|NCT03114969|617675932|FG007|Overall Study|Adverse Event|0|||
170910256|NCT03114969|617675933|FG008|Overall Study|Adverse Event|2|||
170910257|NCT02436239|617675936|FG000|Open-Lable Treatment Period|Adverse Event|12|||
170910258|NCT02436239|617675937|FG001|Open-Lable Treatment Period|Adverse Event|3|||
170910259|NCT02436239|617675938|FG002|Open-Lable Treatment Period|Adverse Event|4|||
170910260|NCT02436239|617675939|FG003|Open-Lable Treatment Period|Adverse Event|2|||
170910261|NCT02436239|617675936|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
170910262|NCT02436239|617675937|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
170910263|NCT02436239|617675938|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
170910264|NCT02436239|617675939|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
170910265|NCT02436239|617675936|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
170910266|NCT02436239|617675937|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
170910267|NCT02436239|617675938|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
170910268|NCT02436239|617675939|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
170910269|NCT02436239|617675936|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
170910270|NCT02436239|617675937|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
170910271|NCT02436239|617675938|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
170910272|NCT02436239|617675939|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
170910273|NCT02436239|617675936|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
170910274|NCT02436239|617675937|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
170910275|NCT02436239|617675938|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
170910276|NCT02436239|617675939|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
170910277|NCT02436239|617675936|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
170910278|NCT02436239|617675937|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
170910279|NCT02436239|617675938|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
170910280|NCT02436239|617675939|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
170910281|NCT02436239|617675936|FG000|Open-Lable Treatment Period|Other Reason|1|||
170910282|NCT02436239|617675937|FG001|Open-Lable Treatment Period|Other Reason|1|||
170910283|NCT02436239|617675938|FG002|Open-Lable Treatment Period|Other Reason|0|||
170910284|NCT02436239|617675939|FG003|Open-Lable Treatment Period|Other Reason|0|||
170910285|NCT02436239|617675936|FG000|Down-Taper Period|Withdrawal by Subject|4|||
170910286|NCT02436239|617675937|FG001|Down-Taper Period|Withdrawal by Subject|4|||
170910287|NCT02436239|617675938|FG002|Down-Taper Period|Withdrawal by Subject|1|||
170910288|NCT02436239|617675939|FG003|Down-Taper Period|Withdrawal by Subject|2|||
170910289|NCT00414440|617675940|FG000|Core Period|Withdrawal by Subject|70|||
170910290|NCT00414440|617675941|FG001|Core Period|Withdrawal by Subject|32|||
170910291|NCT00414440|617675940|FG000|Extension Period|Lost to Follow-up|44|||
170910292|NCT00414440|617675941|FG001|Extension Period|Lost to Follow-up|52|||
170910293|NCT00414440|617675940|FG000|Extension Period|Did not consent to continue follow up|61|||
170910294|NCT00414440|617675941|FG001|Extension Period|Did not consent to continue follow up|54|||
170910295|NCT00414440|617675940|FG000|Extension Period|Other|1|||
170910296|NCT00414440|617675941|FG001|Extension Period|Other|1|||
170910297|NCT00414440|617675940|FG000|Extension Period|Administrative|16|||
170910298|NCT00414440|617675941|FG001|Extension Period|Administrative|16|||
170910299|NCT00414440|617675940|FG000|Extension Period|Death|1|||
170910300|NCT00414440|617675941|FG001|Extension Period|Death|2|||
170910301|NCT00414440|617675940|FG000|Extension Period|Withdrawal by Subject|9|||
170910302|NCT00414440|617675941|FG001|Extension Period|Withdrawal by Subject|7|||
170910303|NCT00414440|617675940|FG000|Extension Period|Not included in follow up period|18|||
170910304|NCT00414440|617675941|FG001|Extension Period|Not included in follow up period|8|||
170910305|NCT02168946|617675942|FG000|Overall Study|Adverse Event|8|||
170910306|NCT02168946|617675943|FG001|Overall Study|Adverse Event|5|||
170910307|NCT02168946|617675942|FG000|Overall Study|Lost to Follow-up|3|||
170910308|NCT02168946|617675943|FG001|Overall Study|Lost to Follow-up|0|||
170910309|NCT02168946|617675942|FG000|Overall Study|Subject unable to come back for visits|1|||
170910310|NCT02168946|617675943|FG001|Overall Study|Subject unable to come back for visits|0|||
170910311|NCT01743027|617675948|FG000|Overall Study|Adverse Event|2|||
170910312|NCT01743027|617675949|FG001|Overall Study|Adverse Event|0|||
170910313|NCT01743027|617675950|FG002|Overall Study|Adverse Event|0|||
170910314|NCT01743027|617675951|FG003|Overall Study|Adverse Event|0|||
170910315|NCT01743027|617675948|FG000|Overall Study|Lost to Follow-up|0|||
170910316|NCT01743027|617675949|FG001|Overall Study|Lost to Follow-up|0|||
170910317|NCT01743027|617675950|FG002|Overall Study|Lost to Follow-up|2|||
170910318|NCT01743027|617675951|FG003|Overall Study|Lost to Follow-up|0|||
170910319|NCT01743027|617675948|FG000|Overall Study|Progressive Disease|1|||
170910320|NCT01743027|617675949|FG001|Overall Study|Progressive Disease|4|||
170910321|NCT01743027|617675950|FG002|Overall Study|Progressive Disease|3|||
170910322|NCT01743027|617675951|FG003|Overall Study|Progressive Disease|0|||
170910323|NCT01743027|617675948|FG000|Overall Study|Protocol Violation|1|||
170910324|NCT01743027|617675949|FG001|Overall Study|Protocol Violation|1|||
170910325|NCT01743027|617675950|FG002|Overall Study|Protocol Violation|1|||
170910326|NCT01743027|617675951|FG003|Overall Study|Protocol Violation|0|||
170910327|NCT01743027|617675948|FG000|Overall Study|Withdrawal by Subject|1|||
170910328|NCT01743027|617675949|FG001|Overall Study|Withdrawal by Subject|0|||
170910329|NCT01743027|617675950|FG002|Overall Study|Withdrawal by Subject|3|||
170910330|NCT01743027|617675951|FG003|Overall Study|Withdrawal by Subject|1|||
170910331|NCT00138151|617675952|FG000|Overall Study|Withdrawal by Subject|3|||
170910332|NCT00138151|617675952|FG000|Overall Study|Physician Decision|1|||
170910333|NCT05270265|617675953|FG000|Overall Study|Lost to Follow-up|0|||
170910334|NCT05270265|617675954|FG001|Overall Study|Lost to Follow-up|1|||
170910335|NCT05270265|617675955|FG002|Overall Study|Lost to Follow-up|0|||
170910336|NCT02296684|617675958|FG000|Overall Study|Withdrawal by Subject|0|||
170910337|NCT02296684|617675959|FG001|Overall Study|Withdrawal by Subject|1|||
170910338|NCT02296684|617675960|FG002|Overall Study|Withdrawal by Subject|1|||
170910339|NCT02296684|617675958|FG000|Overall Study|Death|2|||
170910340|NCT02296684|617675959|FG001|Overall Study|Death|0|||
170910341|NCT02296684|617675960|FG002|Overall Study|Death|0|||
170910342|NCT00753922|617675961|FG000|Overall Study|Lost to Follow-up|155|||
170910343|NCT00753922|617675962|FG001|Overall Study|Lost to Follow-up|24|||
170910344|NCT00753922|617675963|FG002|Overall Study|Lost to Follow-up|28|||
170910345|NCT00753922|617675964|FG003|Overall Study|Lost to Follow-up|5|||
170910346|NCT00753922|617675961|FG000|Overall Study|Withdrawal by Subject|9|||
170910347|NCT00753922|617675962|FG001|Overall Study|Withdrawal by Subject|11|||
170910348|NCT00753922|617675963|FG002|Overall Study|Withdrawal by Subject|4|||
170910349|NCT00753922|617675964|FG003|Overall Study|Withdrawal by Subject|2|||
170910350|NCT00753922|617675961|FG000|Overall Study|Patient Non-compliance|55|||
170910351|NCT00753922|617675962|FG001|Overall Study|Patient Non-compliance|22|||
170910352|NCT00753922|617675963|FG002|Overall Study|Patient Non-compliance|14|||
170910353|NCT00753922|617675964|FG003|Overall Study|Patient Non-compliance|11|||
170910354|NCT00753922|617675961|FG000|Overall Study|Patients Not Completing Visit|11|||
170910355|NCT00753922|617675962|FG001|Overall Study|Patients Not Completing Visit|0|||
170910356|NCT00753922|617675963|FG002|Overall Study|Patients Not Completing Visit|1|||
170910357|NCT00753922|617675964|FG003|Overall Study|Patients Not Completing Visit|0|||
170910358|NCT00753922|617675961|FG000|Overall Study|Death|2|||
170910359|NCT00753922|617675962|FG001|Overall Study|Death|23|||
170910360|NCT00753922|617675963|FG002|Overall Study|Death|2|||
170910361|NCT00753922|617675964|FG003|Overall Study|Death|1|||
170910362|NCT00753922|617675961|FG000|Overall Study|Discontinuation Due to Explantation|14|||
170910363|NCT00753922|617675962|FG001|Overall Study|Discontinuation Due to Explantation|14|||
170910364|NCT00753922|617675963|FG002|Overall Study|Discontinuation Due to Explantation|14|||
170910365|NCT00753922|617675964|FG003|Overall Study|Discontinuation Due to Explantation|4|||
170910366|NCT01662999|617675965|FG000|Period 3|Withdrawal by Subject|0|||
170910367|NCT01662999|617675966|FG001|Period 3|Withdrawal by Subject|1|||
170910368|NCT01662999|617675967|FG002|Period 3|Withdrawal by Subject|0|||
170910369|NCT01662999|617675968|FG003|Period 3|Withdrawal by Subject|0|||
170910370|NCT01662999|617675969|FG004|Period 3|Withdrawal by Subject|0|||
170910371|NCT01662999|617675970|FG005|Period 3|Withdrawal by Subject|0|||
170910372|NCT03368404|617675975|FG000|Overall Study|Adverse Event|2|||
170910373|NCT03368404|617675976|FG001|Overall Study|Adverse Event|1|||
170910374|NCT03368404|617675975|FG000|Overall Study|Withdrawal by Subject|1|||
170910375|NCT03368404|617675976|FG001|Overall Study|Withdrawal by Subject|1|||
170910376|NCT04725682|617675977|FG000|Overall Study|Withdrawal by Subject|7|||
170910377|NCT04725682|617675978|FG001|Overall Study|Withdrawal by Subject|5|||
170910378|NCT04725682|617675977|FG000|Overall Study|Failed to comply with the requirements|2|||
170910379|NCT04725682|617675978|FG001|Overall Study|Failed to comply with the requirements|1|||
170910380|NCT04725682|617675977|FG000|Overall Study|Adverse Event|1|||
170910381|NCT04725682|617675978|FG001|Overall Study|Adverse Event|1|||
170910382|NCT04725682|617675977|FG000|Overall Study|Death|0|||
170910383|NCT04725682|617675978|FG001|Overall Study|Death|1|||
170910384|NCT00964795|617675979|FG000|Overall Study|Withdrawal by Subject|79|||
170910385|NCT00964795|617675979|FG000|Overall Study|Adverse Event|12|||
170910386|NCT00964795|617675979|FG000|Overall Study|Death|14|||
170910387|NCT00964795|617675979|FG000|Overall Study|Lost to Follow-up|7|||
170910388|NCT00964795|617675979|FG000|Overall Study|Termination of Study by Sponsor|169|||
170910389|NCT00964795|617675979|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
170910390|NCT00964795|617675979|FG000|Overall Study|Other|23|||
170910391|NCT01151137|617675984|FG000|Overall Study|Death|15|||
170910392|NCT01151137|617675985|FG001|Overall Study|Death|27|||
170910393|NCT01151137|617675984|FG000|Overall Study|Lost to Follow-up|1|||
170910394|NCT01151137|617675985|FG001|Overall Study|Lost to Follow-up|1|||
170910395|NCT01933672|617675986|FG000|Metformin Run-in Period|Adverse Event|1|||
170910396|NCT01933672|617675987|FG001|Metformin Run-in Period|Adverse Event|0|||
170910397|NCT01933672|617675988|FG002|Metformin Run-in Period|Adverse Event|0|||
170910398|NCT01933672|617675989|FG003|Metformin Run-in Period|Adverse Event|0|||
170910399|NCT01933672|617675990|FG004|Metformin Run-in Period|Adverse Event|0|||
170910400|NCT01933672|617675991|FG005|Metformin Run-in Period|Adverse Event|0|||
170910401|NCT01933672|617675992|FG006|Metformin Run-in Period|Adverse Event|0|||
170809322|NCT01074242|617312289|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
170809323|NCT01074242|617312289|FG000|Overall Study|Duplicate Case Report Form|5|||
170809324|NCT01957163|617312290|FG000|Overall Study|Adverse Event|5|||
170809325|NCT01957163|617312291|FG001|Overall Study|Adverse Event|2|||
170809326|NCT01957163|617312292|FG002|Overall Study|Adverse Event|4|||
170809327|NCT01957163|617312290|FG000|Overall Study|Lack of Efficacy|5|||
170809328|NCT01957163|617312291|FG001|Overall Study|Lack of Efficacy|4|||
170809329|NCT01957163|617312292|FG002|Overall Study|Lack of Efficacy|9|||
170809330|NCT01957163|617312290|FG000|Overall Study|Protocol Violation|1|||
170809331|NCT01957163|617312291|FG001|Overall Study|Protocol Violation|2|||
170809332|NCT01957163|617312292|FG002|Overall Study|Protocol Violation|0|||
170809333|NCT01957163|617312290|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
170809334|NCT01957163|617312291|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
170809335|NCT01957163|617312292|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
170809336|NCT01957163|617312290|FG000|Overall Study|Lost to Follow-up|0|||
170809337|NCT01957163|617312291|FG001|Overall Study|Lost to Follow-up|1|||
170809338|NCT01957163|617312292|FG002|Overall Study|Lost to Follow-up|0|||
170809339|NCT01957163|617312290|FG000|Overall Study|Withdrawal by Subject|4|||
170809340|NCT01957163|617312291|FG001|Overall Study|Withdrawal by Subject|2|||
170809341|NCT01957163|617312292|FG002|Overall Study|Withdrawal by Subject|4|||
170809342|NCT00380250|617312295|FG000|Overall Study|Withdrawal by Subject|39|||
170809343|NCT00380250|617312296|FG001|Overall Study|Withdrawal by Subject|28|||
170809344|NCT00380250|617312295|FG000|Overall Study|Adverse Event|20|||
170809345|NCT00380250|617312296|FG001|Overall Study|Adverse Event|9|||
170809346|NCT00380250|617312295|FG000|Overall Study|Lack of Efficacy|10|||
170809347|NCT00380250|617312296|FG001|Overall Study|Lack of Efficacy|8|||
170809348|NCT00380250|617312295|FG000|Overall Study|Protocol Violation|15|||
170809349|NCT00380250|617312296|FG001|Overall Study|Protocol Violation|5|||
170809350|NCT00380250|617312295|FG000|Overall Study|Lost to Follow-up|14|||
170809351|NCT00380250|617312296|FG001|Overall Study|Lost to Follow-up|5|||
170809352|NCT00380250|617312295|FG000|Overall Study|Physician Decision|1|||
170809353|NCT00380250|617312296|FG001|Overall Study|Physician Decision|0|||
170809354|NCT03822832|617312305|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
170809355|NCT03822832|617312306|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
170809356|NCT03822832|617312305|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
170809357|NCT03822832|617312306|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
170809358|NCT03822832|617312305|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
170809359|NCT03822832|617312306|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
170809360|NCT03822832|617312305|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
170809361|NCT03822832|617312306|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
170809362|NCT03822832|617312305|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
170809363|NCT03822832|617312306|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
170809364|NCT03822832|617312305|FG000|Re-allocation|Not re-allocated to open label period|2|||
170809365|NCT03822832|617312306|FG001|Re-allocation|Not re-allocated to open label period|6|||
170809366|NCT03822832|617312305|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
170809367|NCT03822832|617312306|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
170578893|NCT04908384|616461812|FG001|Overall Study|Lost to Follow-up|4|||
170578894|NCT04908384|616461813|FG002|Overall Study|Lost to Follow-up|0|||
170578895|NCT04908384|616461814|FG003|Overall Study|Lost to Follow-up|0|||
170578896|NCT00833469|616461815|FG000|Overall Study|Withdrawal by Subject|1|||
170578897|NCT00833469|616461815|FG000|Overall Study|Lost to Follow-up|1|||
170578898|NCT00576628|616461816|FG000|Overall Study|Adverse Event|11|||
170578899|NCT00576628|616461816|FG000|Overall Study|Death|2|||
170578900|NCT00576628|616461816|FG000|Overall Study|Failure to return|1|||
170578901|NCT00576628|616461816|FG000|Overall Study|Refused Treatment|8|||
170578902|NCT00576628|616461816|FG000|Overall Study|Pregnancy|1|||
170578903|NCT00576628|616461816|FG000|Overall Study|RBC transfusion|1|||
170578904|NCT00576628|616461816|FG000|Overall Study|Progression of Kidney Disease|1|||
170578905|NCT00576628|616461816|FG000|Overall Study|Progression of Renal Failure|1|||
170578906|NCT00576628|616461816|FG000|Overall Study|The patient move into other town|1|||
170578907|NCT00576628|616461816|FG000|Overall Study|Transplantation|1|||
170578908|NCT00576628|616461816|FG000|Overall Study|Dialysis|15|||
170578909|NCT01701362|616461817|FG000|Overall Study|Adverse events not related to study drug|1|||
170578910|NCT01701362|616461818|FG001|Overall Study|Adverse events not related to study drug|6|||
170649562|NCT01328444|616730798|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
170649563|NCT01328444|616730799|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
170649564|NCT01328444|616730800|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
170649565|NCT01328444|616730801|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
170649566|NCT01328444|616730796|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
170649567|NCT01328444|616730797|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
170649568|NCT01328444|616730798|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
170649569|NCT01328444|616730799|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
170649570|NCT01328444|616730800|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
170649571|NCT01328444|616730801|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
170649572|NCT01328444|616730796|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
170649573|NCT01328444|616730797|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
170649574|NCT01328444|616730798|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
170910402|NCT01933672|617675986|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
170910403|NCT01933672|617675987|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
170910404|NCT01933672|617675988|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
170910405|NCT01933672|617675989|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
170910406|NCT01933672|617675990|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
170910407|NCT01933672|617675991|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
170910408|NCT01933672|617675992|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
170910409|NCT01933672|617675986|FG000|Metformin Run-in Period|Other|5|||
170910410|NCT01933672|617675987|FG001|Metformin Run-in Period|Other|0|||
170649575|NCT01328444|616730799|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
170649576|NCT01328444|616730800|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
170910411|NCT01933672|617675988|FG002|Metformin Run-in Period|Other|0|||
170910412|NCT01933672|617675989|FG003|Metformin Run-in Period|Other|0|||
170910413|NCT01933672|617675990|FG004|Metformin Run-in Period|Other|0|||
170910414|NCT01933672|617675991|FG005|Metformin Run-in Period|Other|0|||
170910415|NCT01933672|617675992|FG006|Metformin Run-in Period|Other|0|||
170910416|NCT01933672|617675986|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910417|NCT01933672|617675987|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910418|NCT01933672|617675988|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910419|NCT01933672|617675989|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910420|NCT01933672|617675990|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
170649577|NCT01328444|616730801|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
170649578|NCT01328444|616730796|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170649579|NCT01328444|616730797|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170649580|NCT01328444|616730798|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170649581|NCT01328444|616730799|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170809368|NCT03822832|617312305|FG000|Period 2 - Open Label Period|Adverse Event|0|||
170809369|NCT03822832|617312306|FG001|Period 2 - Open Label Period|Adverse Event|3|||
170809370|NCT05169684|617312307|FG000|Overall Study|Adverse Event|1|||
170809371|NCT05169684|617312308|FG001|Overall Study|Adverse Event|3|||
170809372|NCT05169684|617312307|FG000|Overall Study|Physician Decision|0|||
170809373|NCT05169684|617312308|FG001|Overall Study|Physician Decision|1|||
170809374|NCT05169684|617312307|FG000|Overall Study|Progressive Disease|1|||
170809375|NCT05169684|617312308|FG001|Overall Study|Progressive Disease|1|||
170809376|NCT05169684|617312307|FG000|Overall Study|Participant request to discontinue treatment|0|||
170809377|NCT05169684|617312308|FG001|Overall Study|Participant request to discontinue treatment|1|||
170809378|NCT05169684|617312307|FG000|Overall Study|Other Reason|0|||
170809379|NCT05169684|617312308|FG001|Overall Study|Other Reason|1|||
170809380|NCT01668719|617312309|FG000|Phase I|On treatment|1|||
170809381|NCT01668719|617312310|FG001|Phase I|On treatment|0|||
170649582|NCT01328444|616730800|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170649583|NCT01328444|616730801|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170649584|NCT03241368|616730806|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
170649585|NCT03241368|616730806|FG000|Overall Study|Lost to Follow-up|1|||
170649586|NCT03241368|616730806|FG000|Overall Study|Physician Decision|6|||
170649587|NCT03241368|616730806|FG000|Overall Study|Withdrawal by Subject|6|||
170649588|NCT03241368|616730806|FG000|Overall Study|Protocol Violation|1|||
170649589|NCT01270802|616730807|FG000|Overall Study|Withdrawal by Subject|1|||
170649590|NCT01270802|616730808|FG001|Overall Study|Withdrawal by Subject|0|||
170649591|NCT01270802|616730807|FG000|Overall Study|Adverse Event|1|||
170649592|NCT01270802|616730808|FG001|Overall Study|Adverse Event|0|||
170649593|NCT01270802|616730807|FG000|Overall Study|Lost to Follow-up|0|||
170649594|NCT01270802|616730808|FG001|Overall Study|Lost to Follow-up|1|||
170649595|NCT04620798|616730811|FG000|Overall Study|Lost to Follow-up|126|||
170649596|NCT04620798|616730812|FG001|Overall Study|Lost to Follow-up|138|||
170910421|NCT01933672|617675991|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910422|NCT01933672|617675992|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910423|NCT01933672|617675986|FG000|First Intervention Period (12-16 Days)|Other|0|||
170910424|NCT01933672|617675987|FG001|First Intervention Period (12-16 Days)|Other|0|||
170910425|NCT01933672|617675988|FG002|First Intervention Period (12-16 Days)|Other|1|||
170910426|NCT01933672|617675989|FG003|First Intervention Period (12-16 Days)|Other|0|||
170910427|NCT01933672|617675990|FG004|First Intervention Period (12-16 Days)|Other|0|||
170910428|NCT01933672|617675991|FG005|First Intervention Period (12-16 Days)|Other|1|||
170910429|NCT01933672|617675992|FG006|First Intervention Period (12-16 Days)|Other|0|||
170910430|NCT01933672|617675986|FG000|Second Intervention Period (12-16 Days)|Other|0|||
170910431|NCT01933672|617675987|FG001|Second Intervention Period (12-16 Days)|Other|1|||
170910432|NCT01933672|617675988|FG002|Second Intervention Period (12-16 Days)|Other|1|||
170910433|NCT01933672|617675989|FG003|Second Intervention Period (12-16 Days)|Other|0|||
170910434|NCT01933672|617675990|FG004|Second Intervention Period (12-16 Days)|Other|0|||
170910435|NCT01933672|617675991|FG005|Second Intervention Period (12-16 Days)|Other|0|||
170910436|NCT01933672|617675992|FG006|Second Intervention Period (12-16 Days)|Other|0|||
170910437|NCT01933672|617675986|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910438|NCT01933672|617675987|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910439|NCT01933672|617675988|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910440|NCT01933672|617675989|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
170910441|NCT01933672|617675990|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910442|NCT01933672|617675991|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910443|NCT01933672|617675992|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
170910444|NCT01933672|617675986|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
170910445|NCT01933672|617675987|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
170910446|NCT01933672|617675988|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
170910447|NCT01933672|617675989|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
170910448|NCT01933672|617675990|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
170910449|NCT01933672|617675991|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
170910450|NCT01933672|617675992|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
170910451|NCT03734666|617675994|FG000|Overall Study|Other|7|||
170910452|NCT03734666|617675995|FG001|Overall Study|Other|4|||
170910453|NCT03734666|617675994|FG000|Overall Study|Lost to Follow-up|12|||
170910454|NCT03734666|617675995|FG001|Overall Study|Lost to Follow-up|12|||
170910455|NCT03022422|617676000|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
170910456|NCT03022422|617676001|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
170910457|NCT03022422|617676002|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
170910458|NCT03022422|617676003|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
170910459|NCT03022422|617676004|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
170910460|NCT03022422|617676005|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
170910461|NCT02104180|617676006|FG000|Overall Study|Protocol Violation|1|||
170910462|NCT02104180|617676007|FG001|Overall Study|Protocol Violation|0|||
170910463|NCT00538733|617676008|FG000|Overall Study|Adverse Event|8|||
170910464|NCT00538733|617676008|FG000|Overall Study|Death|1|||
170910465|NCT00538733|617676008|FG000|Overall Study|declined to participate|2|||
170910466|NCT00538733|617676008|FG000|Overall Study|still on therapy|1|||
170910467|NCT02606877|617676009|FG000|Overall Study|Adverse Event|3|||
170910468|NCT02606877|617676010|FG001|Overall Study|Adverse Event|0|||
170910469|NCT02606877|617676009|FG000|Overall Study|Non-compliance with protocol|0|||
170910470|NCT02606877|617676010|FG001|Overall Study|Non-compliance with protocol|1|||
170910471|NCT02606877|617676009|FG000|Overall Study|Other than listed above|1|||
170910472|NCT02606877|617676010|FG001|Overall Study|Other than listed above|0|||
170910473|NCT04952389|617676011|FG000|Overall Study|Withdrawal by Subject|8|||
170910474|NCT04952389|617676012|FG001|Overall Study|Withdrawal by Subject|4|||
170910475|NCT05561673|617676019|FG000|Overall Study|Lost to Follow-up|0|||
170910476|NCT05561673|617676020|FG001|Overall Study|Lost to Follow-up|1|||
170910477|NCT05561673|617676021|FG002|Overall Study|Lost to Follow-up|0|||
170649597|NCT01944839|616730816|FG000|Overall Study|Physician Decision|2|||
170649598|NCT01944839|616730817|FG001|Overall Study|Physician Decision|2|||
170649599|NCT01944839|616730816|FG000|Overall Study|Protocol Violation|0|||
170649600|NCT01944839|616730817|FG001|Overall Study|Protocol Violation|1|||
170649601|NCT01944839|616730816|FG000|Overall Study|Adverse Event|10|||
170649602|NCT01944839|616730817|FG001|Overall Study|Adverse Event|5|||
170649603|NCT01944839|616730816|FG000|Overall Study|Withdrawal by Subject|9|||
170649604|NCT01944839|616730817|FG001|Overall Study|Withdrawal by Subject|17|||
170649605|NCT01944839|616730816|FG000|Overall Study|Lost to Follow-up|1|||
170649606|NCT01944839|616730817|FG001|Overall Study|Lost to Follow-up|0|||
170649607|NCT01944839|616730816|FG000|Overall Study|Subject non-compliance|0|||
170649608|NCT01944839|616730817|FG001|Overall Study|Subject non-compliance|3|||
170649609|NCT05093790|616730819|FG000|Overall Study|Failure to meet continuation criteria|0|||
170649610|NCT05093790|616730820|FG001|Overall Study|Failure to meet continuation criteria|0|||
170649611|NCT05093790|616730821|FG002|Overall Study|Failure to meet continuation criteria|1|||
170649612|NCT05093790|616730822|FG003|Overall Study|Failure to meet continuation criteria|0|||
170649613|NCT05093790|616730819|FG000|Overall Study|Adverse Event|1|||
170649614|NCT05093790|616730820|FG001|Overall Study|Adverse Event|0|||
170649615|NCT05093790|616730821|FG002|Overall Study|Adverse Event|0|||
170649616|NCT05093790|616730822|FG003|Overall Study|Adverse Event|0|||
170649617|NCT01525901|616730823|FG000|Period 2: 12 Weeks|Adverse Event|0|||
170649618|NCT01525901|616730824|FG001|Period 2: 12 Weeks|Adverse Event|1|||
170649619|NCT01525901|616730825|FG002|Period 2: 12 Weeks|Adverse Event|0|||
170649620|NCT01525901|616730826|FG003|Period 2: 12 Weeks|Adverse Event|0|||
170649621|NCT04449029|616730827|FG000|Overall Study|Adverse Event|0|||
170649622|NCT04449029|616730828|FG001|Overall Study|Adverse Event|1|||
170649623|NCT04449029|616730829|FG002|Overall Study|Adverse Event|1|||
170809382|NCT01668719|617312311|FG002|Phase I|On treatment|0|||
170649624|NCT04449029|616730830|FG003|Overall Study|Adverse Event|0|||
170809383|NCT01668719|617312309|FG000|Phase I|Adverse Event|2|||
170809384|NCT01668719|617312310|FG001|Phase I|Adverse Event|0|||
170809385|NCT01668719|617312311|FG002|Phase I|Adverse Event|0|||
170809386|NCT01668719|617312309|FG000|Phase I|Progression/relapse|1|||
170649625|NCT04449029|616730831|FG004|Overall Study|Adverse Event|1|||
170649626|NCT04449029|616730832|FG005|Overall Study|Adverse Event|0|||
170809387|NCT01668719|617312310|FG001|Phase I|Progression/relapse|0|||
170809388|NCT01668719|617312311|FG002|Phase I|Progression/relapse|0|||
170578911|NCT01701362|616461817|FG000|Overall Study|Adverse events related to study drug|12|||
170578912|NCT01701362|616461818|FG001|Overall Study|Adverse events related to study drug|10|||
170578913|NCT01701362|616461817|FG000|Overall Study|Protocol Violation|5|||
170578914|NCT01701362|616461818|FG001|Overall Study|Protocol Violation|3|||
170578915|NCT01701362|616461817|FG000|Overall Study|No longer willing to participate|8|||
170578916|NCT01701362|616461818|FG001|Overall Study|No longer willing to participate|14|||
170578917|NCT01701362|616461817|FG000|Overall Study|Lost to Follow-up|6|||
170578918|NCT01701362|616461818|FG001|Overall Study|Lost to Follow-up|9|||
170578919|NCT01701362|616461817|FG000|Overall Study|Insufficient clinical response|6|||
170578920|NCT01701362|616461818|FG001|Overall Study|Insufficient clinical response|6|||
170578921|NCT01701362|616461817|FG000|Overall Study|Death|0|||
170578922|NCT01701362|616461818|FG001|Overall Study|Death|1|||
170578923|NCT01701362|616461817|FG000|Overall Study|Randomized but not treated|1|||
170578924|NCT01701362|616461818|FG001|Overall Study|Randomized but not treated|2|||
170578925|NCT01701362|616461817|FG000|Overall Study|Reasons other than those mentioned above|3|||
170578926|NCT01701362|616461818|FG001|Overall Study|Reasons other than those mentioned above|5|||
170578927|NCT00443872|616461821|FG000|Overall Study|Protocol Violation|7|||
170578928|NCT00443872|616461821|FG000|Overall Study|Lost to Follow-up|2|||
170578929|NCT00443872|616461821|FG000|Overall Study|Adverse Event|8|||
170578930|NCT01014767|616461822|FG000|Overall Study|PI left institution, data unavailable|12|||
170578931|NCT01014767|616461823|FG001|Overall Study|PI left institution, data unavailable|1|||
170578932|NCT01014767|616461824|FG002|Overall Study|PI left institution, data unavailable|4|||
170578933|NCT01014767|616461825|FG003|Overall Study|PI left institution, data unavailable|1|||
170578934|NCT03654040|616461826|FG000|Overall Study|Death|1|||
170578935|NCT03654040|616461827|FG001|Overall Study|Death|0|||
170578936|NCT03654040|616461826|FG000|Overall Study|Withdrawal by Subject|1|||
170578937|NCT03654040|616461827|FG001|Overall Study|Withdrawal by Subject|0|||
170578938|NCT03654040|616461826|FG000|Overall Study|Study terminated by sponsor|8|||
170578939|NCT03654040|616461827|FG001|Overall Study|Study terminated by sponsor|2|||
170578940|NCT03654040|616461826|FG000|Overall Study|Failure to initiate study therapy|2|||
170578941|NCT03654040|616461827|FG001|Overall Study|Failure to initiate study therapy|0|||
170578942|NCT03654040|616461826|FG000|Overall Study|Transplanted at another center|2|||
170578943|NCT03654040|616461827|FG001|Overall Study|Transplanted at another center|0|||
170578944|NCT03654040|616461826|FG000|Overall Study|Failure to meet eligibility criteria|14|||
170578945|NCT03654040|616461827|FG001|Overall Study|Failure to meet eligibility criteria|2|||
170578946|NCT03654040|616461826|FG000|Overall Study|No longer transplant candidate|1|||
170578947|NCT03654040|616461827|FG001|Overall Study|No longer transplant candidate|0|||
170578948|NCT03654040|616461826|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
170578949|NCT03654040|616461827|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
170578950|NCT03654040|616461826|FG000|Overall Study|Recipient ineligible|0|||
170578951|NCT03654040|616461827|FG001|Overall Study|Recipient ineligible|2|||
170578952|NCT03654040|616461826|FG000|Overall Study|Received deceased liver|0|||
170578953|NCT03654040|616461827|FG001|Overall Study|Received deceased liver|1|||
170578954|NCT01951586|616461828|FG000|Overall Study|Death|61|||
170578955|NCT01951586|616461829|FG001|Overall Study|Death|120|||
170578956|NCT01951586|616461828|FG000|Overall Study|Withdrawal by Subject|8|||
170578957|NCT01951586|616461829|FG001|Overall Study|Withdrawal by Subject|17|||
170578958|NCT01951586|616461828|FG000|Overall Study|Lost to Follow-up|0|||
170578959|NCT01951586|616461829|FG001|Overall Study|Lost to Follow-up|1|||
170578960|NCT01951586|616461828|FG000|Overall Study|Sponsor Decision|9|||
170578961|NCT01951586|616461829|FG001|Overall Study|Sponsor Decision|10|||
170578962|NCT03645421|616461832|FG000|Overall Study|Adverse Event|0|||
170578963|NCT03645421|616461833|FG001|Overall Study|Adverse Event|0|||
170578964|NCT03645421|616461834|FG002|Overall Study|Adverse Event|4|||
170578965|NCT03645421|616461835|FG003|Overall Study|Adverse Event|1|||
170578966|NCT03645421|616461832|FG000|Overall Study|Withdrawal by patient|0|||
170578967|NCT03645421|616461833|FG001|Overall Study|Withdrawal by patient|0|||
170578968|NCT03645421|616461834|FG002|Overall Study|Withdrawal by patient|0|||
170578969|NCT03645421|616461835|FG003|Overall Study|Withdrawal by patient|3|||
170578970|NCT03645421|616461832|FG000|Overall Study|Study specific withdrawal criteria|0|||
170578971|NCT03645421|616461833|FG001|Overall Study|Study specific withdrawal criteria|0|||
170578972|NCT03645421|616461834|FG002|Overall Study|Study specific withdrawal criteria|1|||
170578973|NCT03645421|616461835|FG003|Overall Study|Study specific withdrawal criteria|0|||
170578974|NCT02120781|616461836|FG000|Overall Study|Physician Decision|2|||
170578975|NCT02120781|616461837|FG001|Overall Study|Physician Decision|0|||
170578976|NCT02120781|616461836|FG000|Overall Study|Completion not documented|2|||
170578977|NCT02120781|616461837|FG001|Overall Study|Completion not documented|1|||
170578978|NCT03379259|616461843|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
170578979|NCT03379259|616461844|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
170578980|NCT03379259|616461845|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
170578981|NCT03379259|616461846|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
170809389|NCT01668719|617312309|FG000|Phase I|not protocol specified|2|||
170578982|NCT03379259|616461847|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
170809390|NCT01668719|617312310|FG001|Phase I|not protocol specified|0|||
170578983|NCT03379259|616461848|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
170578984|NCT03379259|616461843|FG000|Overall Study|Death|0|||
170578985|NCT03379259|616461844|FG001|Overall Study|Death|1|||
170578986|NCT03379259|616461845|FG002|Overall Study|Death|2|||
170578987|NCT03379259|616461846|FG003|Overall Study|Death|1|||
170578988|NCT03379259|616461847|FG004|Overall Study|Death|4|||
170578989|NCT03379259|616461848|FG005|Overall Study|Death|2|||
170578990|NCT03379259|616461843|FG000|Overall Study|Withdrawal by Subject|0|||
170578991|NCT03379259|616461844|FG001|Overall Study|Withdrawal by Subject|0|||
170578992|NCT03379259|616461845|FG002|Overall Study|Withdrawal by Subject|1|||
170578993|NCT03379259|616461846|FG003|Overall Study|Withdrawal by Subject|0|||
170578994|NCT03379259|616461847|FG004|Overall Study|Withdrawal by Subject|2|||
170578995|NCT03379259|616461848|FG005|Overall Study|Withdrawal by Subject|0|||
170578996|NCT03379259|616461843|FG000|Overall Study|Study terminated by sponsor|0|||
170578997|NCT03379259|616461844|FG001|Overall Study|Study terminated by sponsor|0|||
170578998|NCT03379259|616461845|FG002|Overall Study|Study terminated by sponsor|0|||
170578999|NCT03379259|616461846|FG003|Overall Study|Study terminated by sponsor|1|||
170579000|NCT03379259|616461847|FG004|Overall Study|Study terminated by sponsor|1|||
170579001|NCT03379259|616461848|FG005|Overall Study|Study terminated by sponsor|4|||
170579002|NCT03379259|616461843|FG000|Overall Study|Disease progression|0|||
170579003|NCT03379259|616461844|FG001|Overall Study|Disease progression|0|||
170579004|NCT03379259|616461845|FG002|Overall Study|Disease progression|0|||
170579005|NCT03379259|616461846|FG003|Overall Study|Disease progression|1|||
170579006|NCT03379259|616461847|FG004|Overall Study|Disease progression|0|||
170579007|NCT03379259|616461848|FG005|Overall Study|Disease progression|1|||
170579008|NCT03379259|616461843|FG000|Overall Study|Lost to Follow-up|0|||
170579009|NCT03379259|616461844|FG001|Overall Study|Lost to Follow-up|0|||
170579010|NCT03379259|616461845|FG002|Overall Study|Lost to Follow-up|0|||
170579011|NCT03379259|616461846|FG003|Overall Study|Lost to Follow-up|0|||
170579012|NCT03379259|616461847|FG004|Overall Study|Lost to Follow-up|1|||
170579013|NCT03379259|616461848|FG005|Overall Study|Lost to Follow-up|0|||
170579014|NCT03379259|616461843|FG000|Overall Study|Deteriorating condition|0|||
170579015|NCT03379259|616461844|FG001|Overall Study|Deteriorating condition|0|||
170579016|NCT03379259|616461845|FG002|Overall Study|Deteriorating condition|0|||
170579017|NCT03379259|616461846|FG003|Overall Study|Deteriorating condition|0|||
170579018|NCT03379259|616461847|FG004|Overall Study|Deteriorating condition|1|||
170579019|NCT03379259|616461848|FG005|Overall Study|Deteriorating condition|0|||
170579020|NCT03195660|616461849|FG000|Overall Study|The study was terminated|2|||
170579021|NCT00700622|616461850|FG000|Overall Study|Adverse Event|4|||
170579022|NCT00700622|616461851|FG001|Overall Study|Adverse Event|0|||
170579023|NCT00700622|616461850|FG000|Overall Study|Lost to Follow-up|0|||
170579024|NCT00700622|616461851|FG001|Overall Study|Lost to Follow-up|1|||
170579025|NCT00700622|616461850|FG000|Overall Study|Physician Decision|2|||
170579026|NCT00700622|616461851|FG001|Overall Study|Physician Decision|1|||
170579027|NCT00700622|616461850|FG000|Overall Study|Protocol Violation|0|||
170579028|NCT00700622|616461851|FG001|Overall Study|Protocol Violation|1|||
170579029|NCT00700622|616461850|FG000|Overall Study|Withdrawal by Subject|4|||
170579030|NCT00700622|616461851|FG001|Overall Study|Withdrawal by Subject|1|||
170579031|NCT00700622|616461850|FG000|Overall Study|Other|3|||
170579032|NCT00700622|616461851|FG001|Overall Study|Other|1|||
170579033|NCT00375427|616461852|FG000|Overall Study|Adverse Event|21|||
170579034|NCT00375427|616461853|FG001|Overall Study|Adverse Event|27|||
170579035|NCT00375427|616461852|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170579036|NCT00375427|616461853|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170579037|NCT00375427|616461852|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170579038|NCT00375427|616461853|FG001|Overall Study|Abnormal laboratory value(s)|2|||
170579039|NCT00375427|616461852|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170579040|NCT00375427|616461853|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
170579041|NCT00375427|616461852|FG000|Overall Study|Patient no longer requires study drug|3|||
170579042|NCT00375427|616461853|FG001|Overall Study|Patient no longer requires study drug|7|||
170579043|NCT00375427|616461852|FG000|Overall Study|Protocol Violation|10|||
170579044|NCT00375427|616461853|FG001|Overall Study|Protocol Violation|8|||
170579045|NCT00375427|616461852|FG000|Overall Study|Withdrawal by Subject|9|||
170579046|NCT00375427|616461853|FG001|Overall Study|Withdrawal by Subject|13|||
170579047|NCT00375427|616461852|FG000|Overall Study|Lost to Follow-up|1|||
170579048|NCT00375427|616461853|FG001|Overall Study|Lost to Follow-up|1|||
170579049|NCT00375427|616461852|FG000|Overall Study|Administrative reasons|0|||
170579050|NCT00375427|616461853|FG001|Overall Study|Administrative reasons|1|||
170579051|NCT00375427|616461852|FG000|Overall Study|Death|11|||
170579052|NCT00375427|616461853|FG001|Overall Study|Death|10|||
170579053|NCT03286543|616461859|FG000|Consented|Screen failure before randomization|2|||
170579054|NCT03286543|616461860|FG001|Consented|Screen failure before randomization|0|||
170579055|NCT03286543|616461861|FG002|Consented|Screen failure before randomization|0|||
170579056|NCT03286543|616461859|FG000|Consented|Screen failure before enrollment|4|||
170579057|NCT03286543|616461860|FG001|Consented|Screen failure before enrollment|0|||
170579058|NCT03286543|616461861|FG002|Consented|Screen failure before enrollment|0|||
170579059|NCT03286543|616461859|FG000|Consented|TKA cancelled after enrollment|1|||
170579060|NCT03286543|616461860|FG001|Consented|TKA cancelled after enrollment|0|||
170579061|NCT03286543|616461861|FG002|Consented|TKA cancelled after enrollment|0|||
170579062|NCT03286543|616461859|FG000|Consented|Withdrawn from study|12|||
170579063|NCT03286543|616461860|FG001|Consented|Withdrawn from study|0|||
170579064|NCT03286543|616461861|FG002|Consented|Withdrawn from study|0|||
170579065|NCT03286543|616461859|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
170579066|NCT03286543|616461860|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
170579067|NCT03286543|616461861|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
170579068|NCT03286543|616461859|FG000|Study Enrollment|Withdrawn from study|0|||
170579069|NCT03286543|616461860|FG001|Study Enrollment|Withdrawn from study|6|||
170579070|NCT03286543|616461861|FG002|Study Enrollment|Withdrawn from study|6|||
170579071|NCT02836717|616461865|FG000|Test Phase|Lack of Efficacy|14|||
170579072|NCT02836717|616461866|FG001|Test Phase|Lack of Efficacy|8|||
170579073|NCT02836717|616461867|FG002|Test Phase|Lack of Efficacy|0|||
170579074|NCT02836717|616461865|FG000|Study Phase|Adverse Event|2|||
170579075|NCT02836717|616461866|FG001|Study Phase|Adverse Event|0|||
170579076|NCT02836717|616461867|FG002|Study Phase|Adverse Event|0|||
170579077|NCT02836717|616461865|FG000|Study Phase|Lack of Efficacy|8|||
170579078|NCT02836717|616461866|FG001|Study Phase|Lack of Efficacy|6|||
170579079|NCT02836717|616461867|FG002|Study Phase|Lack of Efficacy|1|||
170579080|NCT02836717|616461865|FG000|Study Phase|Withdrawal by Subject|1|||
170579081|NCT02836717|616461866|FG001|Study Phase|Withdrawal by Subject|0|||
170579082|NCT02836717|616461867|FG002|Study Phase|Withdrawal by Subject|0|||
170579083|NCT02836717|616461865|FG000|Study Phase|Death|1|||
170579084|NCT02836717|616461866|FG001|Study Phase|Death|0|||
170579085|NCT02836717|616461867|FG002|Study Phase|Death|0|||
170579086|NCT02836717|616461865|FG000|Study Phase|abdominal surgeries|2|||
170579087|NCT02836717|616461866|FG001|Study Phase|abdominal surgeries|1|||
170579088|NCT02836717|616461867|FG002|Study Phase|abdominal surgeries|0|||
170579089|NCT00104416|616461868|FG000|Double-Blind Phase|Adverse Event|2|||
170579090|NCT00104416|616461869|FG001|Double-Blind Phase|Adverse Event|1|||
170579091|NCT00104416|616461870|FG002|Double-Blind Phase|Adverse Event|0|||
170579092|NCT00104416|616461871|FG003|Double-Blind Phase|Adverse Event|0|||
170579093|NCT00104416|616461872|FG004|Double-Blind Phase|Adverse Event|0|||
170579094|NCT00104416|616461868|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170579095|NCT00104416|616461869|FG001|Double-Blind Phase|Lost to Follow-up|1|||
170579096|NCT00104416|616461870|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170579097|NCT00104416|616461871|FG003|Double-Blind Phase|Lost to Follow-up|0|||
170579098|NCT00104416|616461872|FG004|Double-Blind Phase|Lost to Follow-up|0|||
170579099|NCT00104416|616461868|FG000|Double-Blind Phase|Protocol Violation|0|||
170579100|NCT00104416|616461869|FG001|Double-Blind Phase|Protocol Violation|1|||
170579101|NCT00104416|616461870|FG002|Double-Blind Phase|Protocol Violation|0|||
170579102|NCT00104416|616461871|FG003|Double-Blind Phase|Protocol Violation|0|||
170579103|NCT00104416|616461872|FG004|Double-Blind Phase|Protocol Violation|0|||
170579104|NCT00104416|616461868|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
170579105|NCT00104416|616461869|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
170579106|NCT00104416|616461870|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
170579107|NCT00104416|616461871|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
170579108|NCT00104416|616461872|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
170579109|NCT00104416|616461868|FG000|Double-Blind Phase|Pregnancy|1|||
170579110|NCT00104416|616461869|FG001|Double-Blind Phase|Pregnancy|0|||
170579111|NCT00104416|616461870|FG002|Double-Blind Phase|Pregnancy|0|||
170579112|NCT00104416|616461871|FG003|Double-Blind Phase|Pregnancy|0|||
170579113|NCT00104416|616461872|FG004|Double-Blind Phase|Pregnancy|0|||
170579114|NCT00104416|616461868|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
170579115|NCT00104416|616461869|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
170579116|NCT00104416|616461870|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
170579117|NCT00104416|616461871|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
170579118|NCT00104416|616461872|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
170579119|NCT00104416|616461868|FG000|Continuation Phase|Adverse Event|0|||
170579120|NCT00104416|616461869|FG001|Continuation Phase|Adverse Event|0|||
170579121|NCT00104416|616461870|FG002|Continuation Phase|Adverse Event|2|||
170579122|NCT00104416|616461871|FG003|Continuation Phase|Adverse Event|0|||
170579123|NCT00104416|616461872|FG004|Continuation Phase|Adverse Event|2|||
170579124|NCT00104416|616461868|FG000|Continuation Phase|Lost to Follow-up|0|||
170579125|NCT00104416|616461869|FG001|Continuation Phase|Lost to Follow-up|0|||
170579126|NCT00104416|616461870|FG002|Continuation Phase|Lost to Follow-up|1|||
170579127|NCT00104416|616461871|FG003|Continuation Phase|Lost to Follow-up|0|||
170910478|NCT05561673|617676022|FG003|Overall Study|Lost to Follow-up|1|||
170910479|NCT05561673|617676023|FG004|Overall Study|Lost to Follow-up|0|||
170579128|NCT00104416|616461872|FG004|Continuation Phase|Lost to Follow-up|1|||
170579129|NCT00104416|616461868|FG000|Continuation Phase|Withdrawal by Subject|0|||
170579130|NCT00104416|616461869|FG001|Continuation Phase|Withdrawal by Subject|0|||
170579131|NCT00104416|616461870|FG002|Continuation Phase|Withdrawal by Subject|2|||
170579132|NCT00104416|616461871|FG003|Continuation Phase|Withdrawal by Subject|1|||
170579133|NCT00104416|616461872|FG004|Continuation Phase|Withdrawal by Subject|1|||
170579134|NCT00104416|616461868|FG000|Continuation Phase|Pregnancy|0|||
170579135|NCT00104416|616461869|FG001|Continuation Phase|Pregnancy|0|||
170579136|NCT00104416|616461870|FG002|Continuation Phase|Pregnancy|1|||
170579137|NCT00104416|616461871|FG003|Continuation Phase|Pregnancy|1|||
170579138|NCT00104416|616461872|FG004|Continuation Phase|Pregnancy|0|||
170579139|NCT00104416|616461868|FG000|Continuation Phase|Non-compliance|0|||
170579140|NCT00104416|616461869|FG001|Continuation Phase|Non-compliance|0|||
170579141|NCT00104416|616461870|FG002|Continuation Phase|Non-compliance|0|||
170579142|NCT00104416|616461871|FG003|Continuation Phase|Non-compliance|0|||
170579143|NCT00104416|616461872|FG004|Continuation Phase|Non-compliance|1|||
170579144|NCT00438360|616461873|FG000|Overall Study|Adverse Event|6|||
170579145|NCT00438360|616461874|FG001|Overall Study|Adverse Event|1|||
170579146|NCT00438360|616461873|FG000|Overall Study|Lack of Efficacy|42|||
170579147|NCT00438360|616461874|FG001|Overall Study|Lack of Efficacy|27|||
170579148|NCT00438360|616461873|FG000|Overall Study|Other|24|||
170579149|NCT00438360|616461874|FG001|Overall Study|Other|15|||
170579150|NCT01804049|616461875|FG000|Overall Study|Adverse Event|2|||
170579151|NCT01804049|616461876|FG001|Overall Study|Adverse Event|10|||
170579152|NCT01804049|616461875|FG000|Overall Study|Lost to Follow-up|2|||
170579153|NCT01804049|616461876|FG001|Overall Study|Lost to Follow-up|1|||
170579154|NCT01804049|616461875|FG000|Overall Study|Decreased interest/personal|4|||
170579155|NCT01804049|616461876|FG001|Overall Study|Decreased interest/personal|5|||
170579156|NCT01804049|616461875|FG000|Overall Study|Other health concerns|2|||
170579157|NCT01804049|616461876|FG001|Overall Study|Other health concerns|7|||
170579158|NCT01804049|616461875|FG000|Overall Study|Moved out of area|0|||
170579159|NCT01804049|616461876|FG001|Overall Study|Moved out of area|7|||
170579160|NCT01804049|616461875|FG000|Overall Study|other MD recommended|1|||
170579161|NCT01804049|616461876|FG001|Overall Study|other MD recommended|1|||
170579162|NCT01804049|616461875|FG000|Overall Study|Enrollment in dual studies|0|||
170579163|NCT01804049|616461876|FG001|Overall Study|Enrollment in dual studies|1|||
170579164|NCT00070109|616461877|FG000|Overall Study|Death|1|||
170579165|NCT00070109|616461878|FG001|Overall Study|Death|1|||
170649627|NCT04449029|616730833|FG006|Overall Study|Adverse Event|1|||
170649628|NCT04449029|616730834|FG007|Overall Study|Adverse Event|0|||
170649629|NCT04449029|616730827|FG000|Overall Study|Lost to Follow-up|0|||
170649630|NCT04449029|616730828|FG001|Overall Study|Lost to Follow-up|1|||
170649631|NCT04449029|616730829|FG002|Overall Study|Lost to Follow-up|0|||
170649632|NCT04449029|616730830|FG003|Overall Study|Lost to Follow-up|0|||
170649633|NCT04449029|616730831|FG004|Overall Study|Lost to Follow-up|0|||
170649634|NCT04449029|616730832|FG005|Overall Study|Lost to Follow-up|0|||
170649635|NCT04449029|616730833|FG006|Overall Study|Lost to Follow-up|0|||
170649636|NCT04449029|616730834|FG007|Overall Study|Lost to Follow-up|0|||
170649637|NCT04449029|616730827|FG000|Overall Study|Protocol Violation|0|||
170649638|NCT04449029|616730828|FG001|Overall Study|Protocol Violation|1|||
170649639|NCT04449029|616730829|FG002|Overall Study|Protocol Violation|0|||
170649640|NCT04449029|616730830|FG003|Overall Study|Protocol Violation|0|||
170649641|NCT04449029|616730831|FG004|Overall Study|Protocol Violation|0|||
170649642|NCT04449029|616730832|FG005|Overall Study|Protocol Violation|0|||
170649643|NCT04449029|616730833|FG006|Overall Study|Protocol Violation|0|||
170910480|NCT05561673|617676019|FG000|Overall Study|Consent withdrawal, not due to (S)AE|0|||
170910481|NCT05561673|617676020|FG001|Overall Study|Consent withdrawal, not due to (S)AE|1|||
170910482|NCT05561673|617676021|FG002|Overall Study|Consent withdrawal, not due to (S)AE|0|||
170910483|NCT05561673|617676022|FG003|Overall Study|Consent withdrawal, not due to (S)AE|0|||
170910484|NCT05561673|617676023|FG004|Overall Study|Consent withdrawal, not due to (S)AE|0|||
170649644|NCT04449029|616730834|FG007|Overall Study|Protocol Violation|0|||
170649645|NCT04449029|616730827|FG000|Overall Study|Physician Decision|0|||
170649646|NCT04449029|616730828|FG001|Overall Study|Physician Decision|0|||
170649647|NCT04449029|616730829|FG002|Overall Study|Physician Decision|0|||
170649648|NCT04449029|616730830|FG003|Overall Study|Physician Decision|0|||
170910485|NCT05561673|617676019|FG000|Overall Study|Other|1|||
170910486|NCT05561673|617676020|FG001|Overall Study|Other|0|||
170910487|NCT05561673|617676021|FG002|Overall Study|Other|1|||
170649649|NCT04449029|616730831|FG004|Overall Study|Physician Decision|0|||
170649650|NCT04449029|616730832|FG005|Overall Study|Physician Decision|1|||
170579166|NCT00070109|616461879|FG002|Overall Study|Death|0|||
170579167|NCT00070109|616461880|FG003|Overall Study|Death|0|||
170579168|NCT00070109|616461881|FG004|Overall Study|Death|1|||
170579169|NCT00070109|616461877|FG000|Overall Study|Lack of Efficacy|6|||
170579170|NCT00070109|616461878|FG001|Overall Study|Lack of Efficacy|4|||
170649651|NCT04449029|616730833|FG006|Overall Study|Physician Decision|0|||
170910488|NCT05561673|617676022|FG003|Overall Study|Other|0|||
170910489|NCT05561673|617676023|FG004|Overall Study|Other|0|||
170579171|NCT00070109|616461879|FG002|Overall Study|Lack of Efficacy|5|||
170579172|NCT00070109|616461880|FG003|Overall Study|Lack of Efficacy|15|||
170579173|NCT00070109|616461881|FG004|Overall Study|Lack of Efficacy|5|||
170579174|NCT00070109|616461877|FG000|Overall Study|Physician Decision|1|||
170649652|NCT04449029|616730834|FG007|Overall Study|Physician Decision|0|||
170649653|NCT04449029|616730827|FG000|Overall Study|Withdrawal by Subject|3|||
170579175|NCT00070109|616461878|FG001|Overall Study|Physician Decision|0|||
170579176|NCT00070109|616461879|FG002|Overall Study|Physician Decision|0|||
170579177|NCT00070109|616461880|FG003|Overall Study|Physician Decision|0|||
170579178|NCT00070109|616461881|FG004|Overall Study|Physician Decision|0|||
170579179|NCT00070109|616461877|FG000|Overall Study|Withdrawal by Subject|0|||
170579180|NCT00070109|616461878|FG001|Overall Study|Withdrawal by Subject|1|||
170579181|NCT00070109|616461879|FG002|Overall Study|Withdrawal by Subject|1|||
170579182|NCT00070109|616461880|FG003|Overall Study|Withdrawal by Subject|0|||
170579183|NCT00070109|616461881|FG004|Overall Study|Withdrawal by Subject|0|||
170579184|NCT00070109|616461877|FG000|Overall Study|Adverse Event|0|||
170579185|NCT00070109|616461878|FG001|Overall Study|Adverse Event|0|||
170579186|NCT00070109|616461879|FG002|Overall Study|Adverse Event|2|||
170579187|NCT00070109|616461880|FG003|Overall Study|Adverse Event|4|||
170579188|NCT00070109|616461881|FG004|Overall Study|Adverse Event|2|||
170579189|NCT00070109|616461877|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
170579190|NCT00070109|616461878|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
170579191|NCT00070109|616461879|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
170579192|NCT00070109|616461880|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
170579193|NCT00070109|616461881|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
170579194|NCT03985943|616461882|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
170579195|NCT03985943|616461883|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
170579196|NCT03985943|616461884|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
170579197|NCT03985943|616461885|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
170579198|NCT03985943|616461886|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
170579199|NCT03985943|616461887|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
170579200|NCT03985943|616461882|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
170579201|NCT03985943|616461883|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
170579202|NCT03985943|616461884|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170579203|NCT03985943|616461885|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170579204|NCT03985943|616461886|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170579205|NCT03985943|616461887|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170579206|NCT03985943|616461882|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
170579207|NCT03985943|616461883|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
170579208|NCT03985943|616461884|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
170579209|NCT03985943|616461885|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
170579210|NCT03985943|616461886|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
170579211|NCT03985943|616461887|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
170579212|NCT03985943|616461882|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
170579213|NCT03985943|616461883|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
170579214|NCT03985943|616461884|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
170579215|NCT03985943|616461885|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
170579216|NCT03985943|616461886|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
170579217|NCT03985943|616461887|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
170579218|NCT03985943|616461882|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170910490|NCT05278104|617676024|FG000|Overall Study|Not treated|1|||
170910491|NCT05278104|617676025|FG001|Overall Study|Not treated|0|||
170910492|NCT05278104|617676024|FG000|Overall Study|Adverse Event|2|||
170910493|NCT05278104|617676025|FG001|Overall Study|Adverse Event|1|||
170910494|NCT05278104|617676024|FG000|Overall Study|Exclusion criteria not met|1|||
170910495|NCT05278104|617676025|FG001|Overall Study|Exclusion criteria not met|0|||
170910496|NCT05441670|617677225|FG000|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|0|||
170910497|NCT05441670|617677226|FG001|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|2|||
170910498|NCT02531035|617677228|FG000|Overall Study|Death|0|||
170910499|NCT02531035|617677229|FG001|Overall Study|Death|1|||
170910500|NCT02531035|617677228|FG000|Overall Study|Protocol Violation|1|||
170910501|NCT02531035|617677229|FG001|Overall Study|Protocol Violation|1|||
170910502|NCT02531035|617677228|FG000|Overall Study|Noncompliance with study drug|8|||
170910503|NCT02531035|617677229|FG001|Overall Study|Noncompliance with study drug|3|||
170910504|NCT02531035|617677228|FG000|Overall Study|Physician Decision|1|||
170910505|NCT02531035|617677229|FG001|Overall Study|Physician Decision|0|||
170910506|NCT02531035|617677228|FG000|Overall Study|Adverse Event|16|||
170910507|NCT02531035|617677229|FG001|Overall Study|Adverse Event|45|||
170910508|NCT02531035|617677228|FG000|Overall Study|Other|3|||
170910509|NCT02531035|617677229|FG001|Overall Study|Other|2|||
170910510|NCT02531035|617677228|FG000|Overall Study|Withdrawal by Subject|42|||
170579219|NCT03985943|616461883|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
170910511|NCT02531035|617677229|FG001|Overall Study|Withdrawal by Subject|32|||
170910512|NCT02531035|617677228|FG000|Overall Study|Lost to Follow-up|8|||
170910513|NCT02531035|617677229|FG001|Overall Study|Lost to Follow-up|10|||
170910514|NCT02531035|617677228|FG000|Overall Study|Randomized, not treated|2|||
170910515|NCT02531035|617677229|FG001|Overall Study|Randomized, not treated|1|||
170579220|NCT03985943|616461884|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170579221|NCT03985943|616461885|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170579222|NCT03985943|616461886|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170579223|NCT03985943|616461887|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170579224|NCT03985943|616461882|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
170579225|NCT03985943|616461883|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
170579226|NCT03985943|616461884|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
170579227|NCT03985943|616461885|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
170579228|NCT03985943|616461886|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
170579229|NCT03985943|616461887|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
170579230|NCT03985943|616461882|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
170579231|NCT03985943|616461883|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
170579232|NCT03985943|616461884|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
170579233|NCT03985943|616461885|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
170579234|NCT03985943|616461886|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
170579235|NCT03985943|616461887|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
170579236|NCT03985943|616461882|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
170579237|NCT03985943|616461883|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
170579238|NCT03985943|616461884|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
170579239|NCT03985943|616461885|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
170579240|NCT03985943|616461886|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
170579241|NCT03985943|616461887|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
170579242|NCT03985943|616461882|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
170579243|NCT03985943|616461883|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
170579244|NCT03985943|616461884|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
170579245|NCT03985943|616461885|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
170579246|NCT03985943|616461886|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
170579247|NCT03985943|616461887|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
170579248|NCT03985943|616461882|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
170579249|NCT03985943|616461883|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
170579250|NCT03985943|616461884|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
170579251|NCT03985943|616461885|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
170579252|NCT03985943|616461886|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
170579253|NCT03985943|616461887|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
170579254|NCT03985943|616461882|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
170910516|NCT02629393|617677230|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
170910517|NCT02629393|617677230|FG000|Overall Study|Physician Decision|1|||
170910518|NCT00151411|617677231|FG000|Overall Study|Lost to Follow-up|15|||
170910519|NCT00151411|617677232|FG001|Overall Study|Lost to Follow-up|19|||
170910520|NCT00151411|617677231|FG000|Overall Study|Withdrawal by Subject|12|||
170910521|NCT00151411|617677232|FG001|Overall Study|Withdrawal by Subject|20|||
170910522|NCT00151411|617677231|FG000|Overall Study|Adverse Event|6|||
170910523|NCT00151411|617677232|FG001|Overall Study|Adverse Event|0|||
170649654|NCT04449029|616730828|FG001|Overall Study|Withdrawal by Subject|0|||
170649655|NCT04449029|616730829|FG002|Overall Study|Withdrawal by Subject|1|||
170649656|NCT04449029|616730830|FG003|Overall Study|Withdrawal by Subject|1|||
170649657|NCT04449029|616730831|FG004|Overall Study|Withdrawal by Subject|5|||
170649658|NCT04449029|616730832|FG005|Overall Study|Withdrawal by Subject|1|||
170649659|NCT04449029|616730833|FG006|Overall Study|Withdrawal by Subject|4|||
170649660|NCT04449029|616730834|FG007|Overall Study|Withdrawal by Subject|0|||
170910524|NCT00151411|617677231|FG000|Overall Study|Pregnancy|0|||
170910525|NCT00151411|617677232|FG001|Overall Study|Pregnancy|4|||
170910526|NCT00417612|617677233|FG000|Overall Study|Errant diagnosis|0|||
170910527|NCT00417612|617677234|FG001|Overall Study|Errant diagnosis|1|||
170910528|NCT00417612|617677233|FG000|Overall Study|Adverse Event|2|||
170910529|NCT00417612|617677234|FG001|Overall Study|Adverse Event|0|||
170910530|NCT00417612|617677233|FG000|Overall Study|Protocol Violation|0|||
170910531|NCT00417612|617677234|FG001|Overall Study|Protocol Violation|2|||
170910532|NCT00417612|617677233|FG000|Overall Study|Lost to Follow-up|1|||
170910533|NCT00417612|617677234|FG001|Overall Study|Lost to Follow-up|0|||
170910534|NCT01283581|617677235|FG000|Overall Study|Lost to Follow-up|8|||
170910535|NCT01283581|617677236|FG001|Overall Study|Lost to Follow-up|6|||
170579255|NCT03985943|616461883|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
170649661|NCT02486627|616730841|FG000|Overall Study|Death|1|||
170649662|NCT02486627|616730842|FG001|Overall Study|Death|0|||
170910536|NCT01283581|617677237|FG002|Overall Study|Lost to Follow-up|8|||
170910537|NCT01283581|617677235|FG000|Overall Study|Withdrawal by Subject|2|||
170910538|NCT01283581|617677236|FG001|Overall Study|Withdrawal by Subject|5|||
170579256|NCT03985943|616461884|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
170579257|NCT03985943|616461885|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
170579258|NCT03985943|616461886|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
170579259|NCT03985943|616461887|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
170579260|NCT03985943|616461882|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170579261|NCT03985943|616461883|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170579262|NCT03985943|616461884|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170579263|NCT03985943|616461885|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
170579264|NCT03985943|616461886|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
170579265|NCT03985943|616461887|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
170579266|NCT03985943|616461882|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
170579267|NCT03985943|616461883|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
170579268|NCT03985943|616461884|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
170579269|NCT03985943|616461885|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
170579270|NCT03985943|616461886|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
170579271|NCT03985943|616461887|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
170579272|NCT03985943|616461882|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
170579273|NCT03985943|616461883|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
170579274|NCT03985943|616461884|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
170579275|NCT03985943|616461885|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
170579276|NCT03985943|616461886|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
170579277|NCT03985943|616461887|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
170579278|NCT03985943|616461882|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
170579279|NCT03985943|616461883|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
170579280|NCT03985943|616461884|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
170579281|NCT03985943|616461885|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
170579282|NCT03985943|616461886|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
170579283|NCT03985943|616461887|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
170579284|NCT02131311|616461888|FG000|Overall Study|Adverse Event|2|||
170579285|NCT02131311|616461888|FG000|Overall Study|Protocol Violation|1|||
170579286|NCT02131311|616461888|FG000|Overall Study|Lost to Follow-up|1|||
170579287|NCT01667133|616461889|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
170579288|NCT01667133|616461890|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
170579289|NCT01667133|616461891|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
170579290|NCT01667133|616461892|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
170579291|NCT01667133|616461893|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
170579292|NCT01667133|616461894|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
170579293|NCT01667133|616461895|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
170579294|NCT01667133|616461896|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
170579295|NCT01667133|616461897|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
170579296|NCT01667133|616461898|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
170579297|NCT01667133|616461899|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
170579298|NCT01667133|616461900|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
170579299|NCT01667133|616461889|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170579300|NCT01667133|616461890|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170579301|NCT01667133|616461891|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
170579302|NCT01667133|616461892|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170809391|NCT01668719|617312311|FG002|Phase I|not protocol specified|0|||
170809392|NCT01668719|617312309|FG000|Phase II|On treatment|0|||
170809393|NCT01668719|617312310|FG001|Phase II|On treatment|4|||
170809394|NCT01668719|617312311|FG002|Phase II|On treatment|3|||
170809395|NCT01668719|617312309|FG000|Phase II|Adverse Event|0|||
170809396|NCT01668719|617312310|FG001|Phase II|Adverse Event|18|||
170809397|NCT01668719|617312311|FG002|Phase II|Adverse Event|18|||
170809398|NCT01668719|617312309|FG000|Phase II|Refusal unrelated to adverse event|0|||
170809399|NCT01668719|617312310|FG001|Phase II|Refusal unrelated to adverse event|4|||
170809400|NCT01668719|617312311|FG002|Phase II|Refusal unrelated to adverse event|1|||
170910539|NCT01283581|617677237|FG002|Overall Study|Withdrawal by Subject|2|||
170910540|NCT01283581|617677235|FG000|Overall Study|Adverse Event|1|||
170910541|NCT01283581|617677236|FG001|Overall Study|Adverse Event|1|||
170910542|NCT01283581|617677237|FG002|Overall Study|Adverse Event|4|||
170579303|NCT01667133|616461893|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170649663|NCT02486627|616730841|FG000|Overall Study|Other Unspecified|0|||
170809401|NCT01668719|617312309|FG000|Phase II|Progression/relapse|0|||
170809402|NCT01668719|617312310|FG001|Phase II|Progression/relapse|13|||
170910543|NCT01283581|617677235|FG000|Overall Study|Physician Decision|0|||
170910544|NCT01283581|617677236|FG001|Overall Study|Physician Decision|1|||
170579304|NCT01667133|616461894|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170579305|NCT01667133|616461895|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170579306|NCT01667133|616461896|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170579307|NCT01667133|616461897|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170579308|NCT01667133|616461898|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170910545|NCT01283581|617677237|FG002|Overall Study|Physician Decision|2|||
170579309|NCT01667133|616461899|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170579310|NCT01667133|616461900|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
170579311|NCT01667133|616461889|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
170579312|NCT01667133|616461890|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
170579313|NCT01667133|616461891|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
170579314|NCT01667133|616461892|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
170579315|NCT01667133|616461893|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
170579316|NCT01667133|616461894|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
170579317|NCT01667133|616461895|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
170579318|NCT01667133|616461896|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
170579319|NCT01667133|616461897|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
170579320|NCT01667133|616461898|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
170579321|NCT01667133|616461899|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
170579322|NCT01667133|616461900|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
170579323|NCT01667133|616461889|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579324|NCT01667133|616461890|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579325|NCT01667133|616461891|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579326|NCT01667133|616461892|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
170579327|NCT01667133|616461893|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579328|NCT01667133|616461894|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579329|NCT01667133|616461895|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579330|NCT01667133|616461896|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579331|NCT01667133|616461897|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579332|NCT01667133|616461898|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579333|NCT01667133|616461899|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579334|NCT01667133|616461900|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
170579335|NCT01667133|616461889|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
170579336|NCT01667133|616461890|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
170579337|NCT01667133|616461891|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
170579338|NCT01667133|616461892|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
170579339|NCT01667133|616461893|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
170579340|NCT01667133|616461894|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
170809403|NCT01668719|617312311|FG002|Phase II|Progression/relapse|17|||
170579341|NCT01667133|616461895|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
170579342|NCT01667133|616461896|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
170579343|NCT01667133|616461897|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
170579344|NCT01667133|616461898|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
170579345|NCT01667133|616461899|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
170579346|NCT01667133|616461900|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
170579347|NCT01667133|616461889|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579348|NCT01667133|616461890|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579349|NCT01667133|616461891|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579350|NCT01667133|616461892|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579351|NCT01667133|616461893|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579352|NCT01667133|616461894|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579353|NCT01667133|616461895|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579354|NCT01667133|616461896|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579355|NCT01667133|616461897|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579356|NCT01667133|616461898|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
170579357|NCT01667133|616461899|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579358|NCT01667133|616461900|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
170579359|NCT01667133|616461889|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
170579360|NCT01667133|616461890|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
170579361|NCT01667133|616461891|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
170809404|NCT01668719|617312309|FG000|Phase II|Death|0|||
170809405|NCT01668719|617312310|FG001|Phase II|Death|0|||
170809406|NCT01668719|617312311|FG002|Phase II|Death|2|||
170809407|NCT01668719|617312309|FG000|Phase II|not protocol specified|0|||
170809408|NCT01668719|617312310|FG001|Phase II|not protocol specified|13|||
170809409|NCT01668719|617312311|FG002|Phase II|not protocol specified|7|||
170809410|NCT03539055|617312312|FG000|Overall Study|Death|4|||
170809411|NCT03539055|617312312|FG000|Overall Study|Lost to Follow-up|1|||
170579362|NCT01667133|616461892|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
170579363|NCT01667133|616461893|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
170809412|NCT03539055|617312312|FG000|Overall Study|Withdrawal by Subject|2|||
170809413|NCT03539055|617312312|FG000|Overall Study|Screen Fail|7|||
170579364|NCT01667133|616461894|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
170579365|NCT01667133|616461895|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
170579366|NCT01667133|616461896|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
170579367|NCT01667133|616461897|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
170649664|NCT02486627|616730842|FG001|Overall Study|Other Unspecified|2|||
170809414|NCT03539055|617312312|FG000|Overall Study|Drug Intolerance|2|||
170579368|NCT01667133|616461898|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
170579369|NCT01667133|616461899|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
170579370|NCT01667133|616461900|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
170579371|NCT01667133|616461889|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579372|NCT01667133|616461890|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579373|NCT01667133|616461891|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579374|NCT01667133|616461892|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579375|NCT01667133|616461893|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579376|NCT01667133|616461894|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579377|NCT01667133|616461895|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579378|NCT01667133|616461896|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579379|NCT01667133|616461897|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579380|NCT01667133|616461898|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
170579381|NCT01667133|616461899|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579382|NCT01667133|616461900|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
170579383|NCT01667133|616461889|FG000|Phase 2: Dose-expansion|Death|0|||
170579384|NCT01667133|616461890|FG001|Phase 2: Dose-expansion|Death|0|||
170579385|NCT01667133|616461891|FG002|Phase 2: Dose-expansion|Death|0|||
170579386|NCT01667133|616461892|FG003|Phase 2: Dose-expansion|Death|0|||
170579387|NCT01667133|616461893|FG004|Phase 2: Dose-expansion|Death|0|||
170579388|NCT01667133|616461894|FG005|Phase 2: Dose-expansion|Death|0|||
170579389|NCT01667133|616461895|FG006|Phase 2: Dose-expansion|Death|0|||
170579390|NCT01667133|616461896|FG007|Phase 2: Dose-expansion|Death|0|||
170579391|NCT01667133|616461897|FG008|Phase 2: Dose-expansion|Death|0|||
170579392|NCT01667133|616461898|FG009|Phase 2: Dose-expansion|Death|1|||
170579393|NCT01667133|616461899|FG010|Phase 2: Dose-expansion|Death|0|||
170579394|NCT01667133|616461900|FG011|Phase 2: Dose-expansion|Death|0|||
170579395|NCT01667133|616461889|FG000|Phase 2: Dose-expansion|Other|0|||
170579396|NCT01667133|616461890|FG001|Phase 2: Dose-expansion|Other|0|||
170579397|NCT01667133|616461891|FG002|Phase 2: Dose-expansion|Other|0|||
170579398|NCT01667133|616461892|FG003|Phase 2: Dose-expansion|Other|0|||
170579399|NCT01667133|616461893|FG004|Phase 2: Dose-expansion|Other|0|||
170579400|NCT01667133|616461894|FG005|Phase 2: Dose-expansion|Other|0|||
170579401|NCT01667133|616461895|FG006|Phase 2: Dose-expansion|Other|0|||
170579402|NCT01667133|616461896|FG007|Phase 2: Dose-expansion|Other|0|||
170579403|NCT01667133|616461897|FG008|Phase 2: Dose-expansion|Other|0|||
170579404|NCT01667133|616461898|FG009|Phase 2: Dose-expansion|Other|0|||
170579405|NCT01667133|616461899|FG010|Phase 2: Dose-expansion|Other|0|||
170579406|NCT01667133|616461900|FG011|Phase 2: Dose-expansion|Other|1|||
170579407|NCT01916824|616461907|FG000|Overall Study|Lost to Follow-up|3|||
170579408|NCT01916824|616461908|FG001|Overall Study|Lost to Follow-up|6|||
170579409|NCT01916824|616461907|FG000|Overall Study|Physician Decision|2|||
170910546|NCT01283581|617677235|FG000|Overall Study|Protocol Violation|0|||
170910547|NCT01283581|617677236|FG001|Overall Study|Protocol Violation|1|||
170910548|NCT01283581|617677237|FG002|Overall Study|Protocol Violation|2|||
170910549|NCT01283581|617677235|FG000|Overall Study|Noncompliance|1|||
170910550|NCT01283581|617677236|FG001|Overall Study|Noncompliance|0|||
170910551|NCT01283581|617677237|FG002|Overall Study|Noncompliance|0|||
170910552|NCT01283581|617677235|FG000|Overall Study|Investigator unblinded|0|||
170910553|NCT01283581|617677236|FG001|Overall Study|Investigator unblinded|0|||
170910554|NCT01283581|617677237|FG002|Overall Study|Investigator unblinded|1|||
170910555|NCT01283581|617677235|FG000|Overall Study|"Early termination"|0|||
170910556|NCT01283581|617677236|FG001|Overall Study|"Early termination"|0|||
170910557|NCT01283581|617677237|FG002|Overall Study|"Early termination"|1|||
170910558|NCT04426630|617677238|FG000|Overall Study|Death|4|||
170910559|NCT04426630|617677238|FG000|Overall Study|Lost to Follow-up|2|||
170910560|NCT02786537|617677239|FG000|As Randomized|Adverse Event|0|||
170910561|NCT02786537|617677240|FG001|As Randomized|Adverse Event|11|||
170910562|NCT02786537|617677241|FG002|As Randomized|Adverse Event|0|||
170579410|NCT01916824|616461908|FG001|Overall Study|Physician Decision|0|||
170579411|NCT01916824|616461907|FG000|Overall Study|Withdrawal by Subject|2|||
170579412|NCT01916824|616461908|FG001|Overall Study|Withdrawal by Subject|3|||
170579413|NCT03835481|616461911|FG000|Double-blind Period|Other not stated below|0|||
170910563|NCT02786537|617677242|FG003|As Randomized|Adverse Event|4|||
170579414|NCT03835481|616461912|FG001|Double-blind Period|Other not stated below|0|||
170579415|NCT03835481|616461913|FG002|Double-blind Period|Other not stated below|0|||
170579416|NCT03835481|616461914|FG003|Double-blind Period|Other not stated below|1|||
170910564|NCT02786537|617677243|FG004|As Randomized|Adverse Event|6|||
170579417|NCT03835481|616461915|FG004|Double-blind Period|Other not stated below|1|||
170579418|NCT03835481|616461911|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
170910565|NCT02786537|617677244|FG005|As Randomized|Adverse Event|2|||
170910566|NCT02786537|617677239|FG000|As Randomized|Lack of Efficacy|0|||
170910567|NCT02786537|617677240|FG001|As Randomized|Lack of Efficacy|0|||
170910568|NCT02786537|617677241|FG002|As Randomized|Lack of Efficacy|0|||
170579419|NCT03835481|616461912|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
170579420|NCT03835481|616461913|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
170579421|NCT03835481|616461914|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
170579422|NCT03835481|616461915|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
170579423|NCT03835481|616461911|FG000|Double-blind Period|Withdrawal by Subject|0|||
170579424|NCT03835481|616461912|FG001|Double-blind Period|Withdrawal by Subject|0|||
170579425|NCT03835481|616461913|FG002|Double-blind Period|Withdrawal by Subject|1|||
170579426|NCT03835481|616461914|FG003|Double-blind Period|Withdrawal by Subject|0|||
170579427|NCT03835481|616461915|FG004|Double-blind Period|Withdrawal by Subject|5|||
170579428|NCT03835481|616461911|FG000|Double-blind Period|Lost to Follow-up|0|||
170579429|NCT03835481|616461912|FG001|Double-blind Period|Lost to Follow-up|0|||
170579430|NCT03835481|616461913|FG002|Double-blind Period|Lost to Follow-up|0|||
170579431|NCT03835481|616461914|FG003|Double-blind Period|Lost to Follow-up|1|||
170579432|NCT03835481|616461915|FG004|Double-blind Period|Lost to Follow-up|0|||
170579433|NCT03835481|616461911|FG000|Double-blind Period|Protocol Violation|0|||
170579434|NCT03835481|616461912|FG001|Double-blind Period|Protocol Violation|2|||
170579435|NCT03835481|616461913|FG002|Double-blind Period|Protocol Violation|0|||
170579436|NCT03835481|616461914|FG003|Double-blind Period|Protocol Violation|1|||
170579437|NCT03835481|616461915|FG004|Double-blind Period|Protocol Violation|0|||
170579438|NCT03835481|616461911|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
170579439|NCT03835481|616461912|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
170579440|NCT03835481|616461913|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
170579441|NCT03835481|616461914|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
170579442|NCT03835481|616461915|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
170579443|NCT03835481|616461911|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
170579444|NCT03835481|616461912|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
170579445|NCT03835481|616461913|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
170579446|NCT03835481|616461914|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
170579447|NCT03835481|616461915|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
170579448|NCT03835481|616461911|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
170649665|NCT02486627|616730841|FG000|Overall Study|Consent Withdrawn by Participant|4|||
170649666|NCT02486627|616730842|FG001|Overall Study|Consent Withdrawn by Participant|3|||
170649667|NCT02486627|616730841|FG000|Overall Study|Significant Participant Noncompliance|1|||
170649668|NCT02486627|616730842|FG001|Overall Study|Significant Participant Noncompliance|1|||
170649669|NCT02486627|616730841|FG000|Overall Study|Lost to Follow-up|1|||
170649670|NCT02486627|616730842|FG001|Overall Study|Lost to Follow-up|3|||
170649671|NCT01073462|616730843|FG000|Overall Study|Death|14|||
170649672|NCT01073462|616730843|FG000|Overall Study|Kidney transplant|10|||
170649673|NCT01073462|616730843|FG000|Overall Study|Low parathyroid hormone levels|8|||
170649674|NCT01073462|616730843|FG000|Overall Study|Serious adverse event|2|||
170649675|NCT01073462|616730843|FG000|Overall Study|Lost to Follow-up|7|||
170649676|NCT01238588|616730846|FG000|Overall Study|Withdrawal by Subject|1|||
170649677|NCT01238588|616730846|FG000|Overall Study|Physician Decision|2|||
170649678|NCT00247611|616730847|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
170649679|NCT00247611|616730848|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
170649680|NCT00247611|616730847|FG000|Baselined|Completed baseline only|9|||
170649681|NCT00247611|616730848|FG001|Baselined|Completed baseline only|8|||
170649682|NCT01509053|616730849|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
170649683|NCT01509053|616730849|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
170649684|NCT01509053|616730849|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
170649685|NCT01509053|616730849|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
170649686|NCT01509053|616730849|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
170649687|NCT01509053|616730849|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
170649688|NCT01587898|616730850|FG000|Overall Study|Adverse Event|1|||
170649689|NCT01587898|616730851|FG001|Overall Study|Adverse Event|1|||
170649690|NCT01587898|616730852|FG002|Overall Study|Adverse Event|0|||
170649691|NCT01587898|616730853|FG003|Overall Study|Adverse Event|0|||
170649692|NCT01587898|616730850|FG000|Overall Study|Protocol Violation|0|||
170910569|NCT02786537|617677242|FG003|As Randomized|Lack of Efficacy|1|||
170579449|NCT03835481|616461912|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
170649693|NCT01587898|616730851|FG001|Overall Study|Protocol Violation|2|||
170649694|NCT01587898|616730852|FG002|Overall Study|Protocol Violation|1|||
170579450|NCT03835481|616461913|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
170649695|NCT01587898|616730853|FG003|Overall Study|Protocol Violation|1|||
170649696|NCT01587898|616730850|FG000|Overall Study|Lost to Follow-up|0|||
170649697|NCT01587898|616730851|FG001|Overall Study|Lost to Follow-up|0|||
170579451|NCT03835481|616461914|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
170579452|NCT03835481|616461915|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
170649698|NCT01587898|616730852|FG002|Overall Study|Lost to Follow-up|0|||
170649699|NCT01587898|616730853|FG003|Overall Study|Lost to Follow-up|1|||
170649700|NCT01587898|616730850|FG000|Overall Study|Withdrawal by Subject|2|||
170910570|NCT02786537|617677243|FG004|As Randomized|Lack of Efficacy|0|||
170579453|NCT03835481|616461911|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
170579454|NCT03835481|616461912|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
170579455|NCT03835481|616461913|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
170579456|NCT03835481|616461914|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
170579457|NCT03835481|616461915|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
170579458|NCT03835481|616461911|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
170579459|NCT03835481|616461912|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
170579460|NCT03835481|616461913|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
170579461|NCT03835481|616461914|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
170579462|NCT03835481|616461915|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
170579463|NCT03835481|616461911|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
170579464|NCT03835481|616461912|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
170579465|NCT03835481|616461913|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
170579466|NCT03835481|616461914|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
170579467|NCT03835481|616461915|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
170579468|NCT01536561|616461919|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
170579469|NCT01536561|616461919|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
170579470|NCT01536561|616461919|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
170579471|NCT01536561|616461919|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
170579472|NCT01536561|616461919|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
170579473|NCT01536561|616461919|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
170579474|NCT00431444|616461926|FG000|Overall Study|Protocol Violation|1|||
170579475|NCT00431444|616461927|FG001|Overall Study|Protocol Violation|4|||
170579476|NCT00431444|616461926|FG000|Overall Study|Adverse Event|2|||
170579477|NCT00431444|616461927|FG001|Overall Study|Adverse Event|1|||
170579478|NCT00431444|616461926|FG000|Overall Study|Withdrawal by Subject|1|||
170579479|NCT00431444|616461927|FG001|Overall Study|Withdrawal by Subject|1|||
170579480|NCT00431444|616461926|FG000|Overall Study|Lost to Follow-up|1|||
170579481|NCT00431444|616461927|FG001|Overall Study|Lost to Follow-up|0|||
170579482|NCT00431444|616461926|FG000|Overall Study|Administrative Problems|0|||
170579483|NCT00431444|616461927|FG001|Overall Study|Administrative Problems|1|||
170579484|NCT00429182|616461938|FG000|Overall Study|Not evaluable, Disease Progression|2|||
170579485|NCT00429182|616461938|FG000|Overall Study|Not eligible|5|||
170579486|NCT00790582|616461942|FG000|Overall Study|Death|14|||
170579487|NCT00790582|616461943|FG001|Overall Study|Death|32|||
170579488|NCT00790582|616461942|FG000|Overall Study|Physician Decision|7|||
170579489|NCT00790582|616461943|FG001|Overall Study|Physician Decision|1|||
170579490|NCT00790582|616461942|FG000|Overall Study|Lost to Follow-up|3|||
170579491|NCT00790582|616461943|FG001|Overall Study|Lost to Follow-up|3|||
170579492|NCT00790582|616461942|FG000|Overall Study|Withdrawal by Subject|7|||
170579493|NCT00790582|616461943|FG001|Overall Study|Withdrawal by Subject|51|||
170579494|NCT02949024|616461944|FG000|Overall Study|Withdrawal by Subject|0|||
170579495|NCT02949024|616461945|FG001|Overall Study|Withdrawal by Subject|1|||
170579496|NCT01027650|616461946|FG000|Overall Study|Personal Reasons|0|||
170579497|NCT01027650|616461947|FG001|Overall Study|Personal Reasons|0|||
170579498|NCT01027650|616461948|FG002|Overall Study|Personal Reasons|0|||
170579499|NCT01027650|616461949|FG003|Overall Study|Personal Reasons|0|||
170579500|NCT01027650|616461950|FG004|Overall Study|Personal Reasons|2|||
170579501|NCT01027650|616461951|FG005|Overall Study|Personal Reasons|1|||
170579502|NCT01027650|616461952|FG006|Overall Study|Personal Reasons|0|||
170579503|NCT01027650|616461953|FG007|Overall Study|Personal Reasons|0|||
170579504|NCT01027650|616461946|FG000|Overall Study|Lost to Follow-up|0|||
170579505|NCT01027650|616461947|FG001|Overall Study|Lost to Follow-up|0|||
170579506|NCT01027650|616461948|FG002|Overall Study|Lost to Follow-up|0|||
170579507|NCT01027650|616461949|FG003|Overall Study|Lost to Follow-up|0|||
170579508|NCT01027650|616461950|FG004|Overall Study|Lost to Follow-up|0|||
170579509|NCT01027650|616461951|FG005|Overall Study|Lost to Follow-up|0|||
170579510|NCT01027650|616461952|FG006|Overall Study|Lost to Follow-up|1|||
170579511|NCT01027650|616461953|FG007|Overall Study|Lost to Follow-up|0|||
170579512|NCT01027650|616461946|FG000|Overall Study|Lack of Efficacy|0|||
170579513|NCT01027650|616461947|FG001|Overall Study|Lack of Efficacy|0|||
170910571|NCT02786537|617677244|FG005|As Randomized|Lack of Efficacy|0|||
170579514|NCT01027650|616461948|FG002|Overall Study|Lack of Efficacy|0|||
170579515|NCT01027650|616461949|FG003|Overall Study|Lack of Efficacy|0|||
170579516|NCT01027650|616461950|FG004|Overall Study|Lack of Efficacy|0|||
170579517|NCT01027650|616461951|FG005|Overall Study|Lack of Efficacy|1|||
170579518|NCT01027650|616461952|FG006|Overall Study|Lack of Efficacy|0|||
170579519|NCT01027650|616461953|FG007|Overall Study|Lack of Efficacy|0|||
170579520|NCT00670930|616461954|FG000|Overall Study|Adminstrative Problem|0|||
170579521|NCT00670930|616461955|FG001|Overall Study|Adminstrative Problem|1|||
170579522|NCT00670930|616461954|FG000|Overall Study|Lost to Follow-up|1|||
170910572|NCT02786537|617677239|FG000|As Randomized|Withdrawal by Subject|1|||
170910573|NCT02786537|617677240|FG001|As Randomized|Withdrawal by Subject|2|||
170579523|NCT00670930|616461955|FG001|Overall Study|Lost to Follow-up|0|||
170579524|NCT00200967|616461956|FG000|First Treatment Period|Withdrawal by Subject|5|||
170579525|NCT00200967|616461957|FG001|First Treatment Period|Withdrawal by Subject|1|||
170579526|NCT00200967|616461956|FG000|First Treatment Period|Pregnancy|1|||
170579527|NCT00200967|616461957|FG001|First Treatment Period|Pregnancy|0|||
170579528|NCT00200967|616461956|FG000|Wash-out Period|Lost to Follow-up|0|||
170579529|NCT00200967|616461957|FG001|Wash-out Period|Lost to Follow-up|1|||
170579530|NCT00200967|616461956|FG000|Second Treatment Period|Withdrawal by Subject|1|||
170579531|NCT00200967|616461957|FG001|Second Treatment Period|Withdrawal by Subject|2|||
170579532|NCT00200967|616461956|FG000|Run-out Period|Lost to Follow-up|1|||
170579533|NCT00200967|616461957|FG001|Run-out Period|Lost to Follow-up|0|||
170579534|NCT00980460|616461961|FG000|Overall Study|Death|0|||
170579535|NCT00980460|616461962|FG001|Overall Study|Death|0|||
170579536|NCT00980460|616461963|FG002|Overall Study|Death|1|||
170579537|NCT00980460|616461964|FG003|Overall Study|Death|2|||
170579538|NCT00980460|616461965|FG004|Overall Study|Death|1|||
170579539|NCT00980460|616461961|FG000|Overall Study|Lack of Efficacy|0|||
170579540|NCT00980460|616461962|FG001|Overall Study|Lack of Efficacy|0|||
170579541|NCT00980460|616461963|FG002|Overall Study|Lack of Efficacy|10|||
170579542|NCT00980460|616461964|FG003|Overall Study|Lack of Efficacy|6|||
170579543|NCT00980460|616461965|FG004|Overall Study|Lack of Efficacy|8|||
170579544|NCT00980460|616461961|FG000|Overall Study|Lost to Follow-up|0|||
170579545|NCT00980460|616461962|FG001|Overall Study|Lost to Follow-up|0|||
170579546|NCT00980460|616461963|FG002|Overall Study|Lost to Follow-up|0|||
170579547|NCT00980460|616461964|FG003|Overall Study|Lost to Follow-up|1|||
170579548|NCT00980460|616461965|FG004|Overall Study|Lost to Follow-up|0|||
170579549|NCT00980460|616461961|FG000|Overall Study|Physician Decision|0|||
170579550|NCT00980460|616461962|FG001|Overall Study|Physician Decision|0|||
170579551|NCT00980460|616461963|FG002|Overall Study|Physician Decision|11|||
170579552|NCT00980460|616461964|FG003|Overall Study|Physician Decision|5|||
170579553|NCT00980460|616461965|FG004|Overall Study|Physician Decision|3|||
170579554|NCT00980460|616461961|FG000|Overall Study|Withdrawal by Subject|0|||
170579555|NCT00980460|616461962|FG001|Overall Study|Withdrawal by Subject|0|||
170579556|NCT00980460|616461963|FG002|Overall Study|Withdrawal by Subject|1|||
170910574|NCT02786537|617677241|FG002|As Randomized|Withdrawal by Subject|0|||
170910575|NCT02786537|617677242|FG003|As Randomized|Withdrawal by Subject|1|||
170910576|NCT02786537|617677243|FG004|As Randomized|Withdrawal by Subject|1|||
170910577|NCT02786537|617677244|FG005|As Randomized|Withdrawal by Subject|0|||
170910578|NCT02786537|617677239|FG000|As Randomized|Death|0|||
170579557|NCT00980460|616461964|FG003|Overall Study|Withdrawal by Subject|0|||
170579558|NCT00980460|616461965|FG004|Overall Study|Withdrawal by Subject|0|||
170579559|NCT00980460|616461961|FG000|Overall Study|Ineligible|0|||
170579560|NCT00980460|616461962|FG001|Overall Study|Ineligible|2|||
170579561|NCT00980460|616461963|FG002|Overall Study|Ineligible|3|||
170579562|NCT00980460|616461964|FG003|Overall Study|Ineligible|1|||
170579563|NCT00980460|616461965|FG004|Overall Study|Ineligible|4|||
170579564|NCT00980460|616461961|FG000|Overall Study|Refusal of further therapy|0|||
170579565|NCT00980460|616461962|FG001|Overall Study|Refusal of further therapy|2|||
170579566|NCT00980460|616461963|FG002|Overall Study|Refusal of further therapy|3|||
170579567|NCT00980460|616461964|FG003|Overall Study|Refusal of further therapy|2|||
170579568|NCT00980460|616461965|FG004|Overall Study|Refusal of further therapy|0|||
170579569|NCT00980460|616461961|FG000|Overall Study|No therapy within 42 days of resection|0|||
170579570|NCT00980460|616461962|FG001|Overall Study|No therapy within 42 days of resection|0|||
170579571|NCT00980460|616461963|FG002|Overall Study|No therapy within 42 days of resection|3|||
170579572|NCT00980460|616461964|FG003|Overall Study|No therapy within 42 days of resection|1|||
170579573|NCT00980460|616461965|FG004|Overall Study|No therapy within 42 days of resection|0|||
170579574|NCT00980460|616461961|FG000|Overall Study|No transplant by protocol timepoints|0|||
170579575|NCT00980460|616461962|FG001|Overall Study|No transplant by protocol timepoints|0|||
170579576|NCT00980460|616461963|FG002|Overall Study|No transplant by protocol timepoints|3|||
170579577|NCT00980460|616461964|FG003|Overall Study|No transplant by protocol timepoints|0|||
170579578|NCT00980460|616461965|FG004|Overall Study|No transplant by protocol timepoints|0|||
170579579|NCT05696444|616461966|FG000|Treatment|Physician Decision|0|||
170579580|NCT05696444|616461967|FG001|Treatment|Physician Decision|1|||
170579581|NCT05696444|616461968|FG002|Treatment|Physician Decision|0|||
170579582|NCT05696444|616461966|FG000|30 Days|Death|1|||
170910579|NCT02786537|617677240|FG001|As Randomized|Death|2|||
170579583|NCT05696444|616461967|FG001|30 Days|Death|1|||
170579584|NCT05696444|616461968|FG002|30 Days|Death|0|||
170579585|NCT05696444|616461966|FG000|30 Days|Missed Visit|1|||
170579586|NCT05696444|616461967|FG001|30 Days|Missed Visit|1|||
170579587|NCT05696444|616461968|FG002|30 Days|Missed Visit|1|||
170579588|NCT00875485|616464334|FG000|Challenge Dose Epoch|Pregnancy|1|||
170910580|NCT02786537|617677241|FG002|As Randomized|Death|0|||
170579589|NCT00875485|616464335|FG001|Challenge Dose Epoch|Pregnancy|0|||
170579590|NCT02908685|616464336|FG000|Part 1 OLE|Withdrawal by Subject|0|||
170579591|NCT02908685|616464337|FG001|Part 1 OLE|Withdrawal by Subject|0|||
170579592|NCT02908685|616464338|FG002|Part 1 OLE|Withdrawal by Subject|0|||
170579593|NCT02908685|616464339|FG003|Part 1 OLE|Withdrawal by Subject|0|||
170910581|NCT02786537|617677242|FG003|As Randomized|Death|3|||
170579594|NCT02908685|616464340|FG004|Part 1 OLE|Withdrawal by Subject|0|||
170579595|NCT02908685|616464341|FG005|Part 1 OLE|Withdrawal by Subject|0|||
170579596|NCT02908685|616464342|FG006|Part 1 OLE|Withdrawal by Subject|0|||
170579597|NCT02908685|616464343|FG007|Part 1 OLE|Withdrawal by Subject|0|||
170579598|NCT02908685|616464344|FG008|Part 1 OLE|Withdrawal by Subject|0|||
170579599|NCT02908685|616464345|FG009|Part 1 OLE|Withdrawal by Subject|0|||
170579600|NCT02908685|616464346|FG010|Part 1 OLE|Withdrawal by Subject|2|||
170579601|NCT02908685|616464347|FG011|Part 1 OLE|Withdrawal by Subject|1|||
170579602|NCT02908685|616464348|FG012|Part 1 OLE|Withdrawal by Subject|0|||
170579603|NCT02908685|616464349|FG013|Part 1 OLE|Withdrawal by Subject|0|||
170579604|NCT02908685|616464336|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579605|NCT02908685|616464337|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579606|NCT02908685|616464338|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579607|NCT02908685|616464339|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579608|NCT02908685|616464340|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579609|NCT02908685|616464341|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579610|NCT02908685|616464342|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579611|NCT02908685|616464343|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579612|NCT02908685|616464344|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579613|NCT02908685|616464345|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579614|NCT02908685|616464346|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579615|NCT02908685|616464347|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
170579616|NCT02908685|616464348|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
170579617|NCT02908685|616464349|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
170579618|NCT02908685|616464336|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579619|NCT02908685|616464337|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579620|NCT02908685|616464338|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579621|NCT02908685|616464339|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579622|NCT02908685|616464340|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579623|NCT02908685|616464341|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579624|NCT02908685|616464342|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579625|NCT02908685|616464343|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579626|NCT02908685|616464344|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579627|NCT02908685|616464345|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579628|NCT02908685|616464346|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579629|NCT02908685|616464347|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579630|NCT02908685|616464348|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
170579631|NCT02908685|616464349|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
170579632|NCT02908685|616464336|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579633|NCT02908685|616464337|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579634|NCT02908685|616464338|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579635|NCT02908685|616464339|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579636|NCT02908685|616464340|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579637|NCT02908685|616464341|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579638|NCT02908685|616464342|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579639|NCT02908685|616464343|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579640|NCT02908685|616464344|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579641|NCT02908685|616464345|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579642|NCT02908685|616464346|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579643|NCT02908685|616464347|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579644|NCT02908685|616464348|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
170579645|NCT02908685|616464349|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
170579646|NCT02908685|616464336|FG000|Part 2 OLE: > Month 24|Death|0|||
170579647|NCT02908685|616464337|FG001|Part 2 OLE: > Month 24|Death|0|||
170579648|NCT02908685|616464338|FG002|Part 2 OLE: > Month 24|Death|0|||
170579649|NCT02908685|616464339|FG003|Part 2 OLE: > Month 24|Death|0|||
170579650|NCT02908685|616464340|FG004|Part 2 OLE: > Month 24|Death|0|||
170579651|NCT02908685|616464341|FG005|Part 2 OLE: > Month 24|Death|0|||
170579652|NCT02908685|616464342|FG006|Part 2 OLE: > Month 24|Death|0|||
170579653|NCT02908685|616464343|FG007|Part 2 OLE: > Month 24|Death|0|||
170579654|NCT02908685|616464344|FG008|Part 2 OLE: > Month 24|Death|0|||
170579655|NCT02908685|616464345|FG009|Part 2 OLE: > Month 24|Death|0|||
170579656|NCT02908685|616464346|FG010|Part 2 OLE: > Month 24|Death|0|||
170809415|NCT04248803|617312314|FG000|Overall Study|Lost to Follow-up|7|||
170809416|NCT04248803|617312315|FG001|Overall Study|Lost to Follow-up|7|||
170809417|NCT04248803|617312316|FG002|Overall Study|Lost to Follow-up|7|||
170809418|NCT04248803|617312317|FG003|Overall Study|Lost to Follow-up|7|||
170809419|NCT04248803|617312318|FG004|Overall Study|Lost to Follow-up|7|||
170809420|NCT04248803|617312319|FG005|Overall Study|Lost to Follow-up|7|||
170809421|NCT03476798|617312322|FG000|Overall Study|Death|1|||
170579657|NCT02908685|616464347|FG011|Part 2 OLE: > Month 24|Death|0|||
170579658|NCT02908685|616464348|FG012|Part 2 OLE: > Month 24|Death|1|||
170579659|NCT02908685|616464349|FG013|Part 2 OLE: > Month 24|Death|0|||
170579660|NCT02908685|616464336|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
170579661|NCT02908685|616464337|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
170579662|NCT02908685|616464338|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
170579663|NCT02908685|616464339|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
170579664|NCT02908685|616464340|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
170579665|NCT02908685|616464341|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
170579666|NCT02908685|616464342|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
170579667|NCT02908685|616464343|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
170579668|NCT02908685|616464344|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
170579669|NCT02908685|616464345|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
170579670|NCT02908685|616464346|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
170579671|NCT02908685|616464347|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
170579672|NCT02908685|616464348|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
170579673|NCT02908685|616464349|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
170579674|NCT02908685|616464336|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579675|NCT02908685|616464337|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579676|NCT02908685|616464338|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579677|NCT02908685|616464339|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579678|NCT02908685|616464340|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579679|NCT02908685|616464341|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579680|NCT02908685|616464342|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579681|NCT02908685|616464343|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579682|NCT02908685|616464344|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579683|NCT02908685|616464345|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579684|NCT02908685|616464346|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579685|NCT02908685|616464347|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
170579686|NCT02908685|616464348|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
170579687|NCT02908685|616464349|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
170579688|NCT02954406|616464350|FG000|Overall Study|Adverse Event|0|||
170579689|NCT02954406|616464351|FG001|Overall Study|Adverse Event|1|||
170579690|NCT02954406|616464352|FG002|Overall Study|Adverse Event|0|||
170579691|NCT02954406|616464353|FG003|Overall Study|Adverse Event|0|||
170579692|NCT02954406|616464354|FG004|Overall Study|Adverse Event|1|||
170579693|NCT02954406|616464355|FG005|Overall Study|Adverse Event|0|||
170579694|NCT02954406|616464356|FG006|Overall Study|Adverse Event|0|||
170579695|NCT02954406|616464357|FG007|Overall Study|Adverse Event|0|||
170579696|NCT02954406|616464358|FG008|Overall Study|Adverse Event|1|||
170579697|NCT02954406|616464359|FG009|Overall Study|Adverse Event|1|||
170579698|NCT02954406|616464360|FG010|Overall Study|Adverse Event|0|||
170579699|NCT02954406|616464350|FG000|Overall Study|Progressive Disease|3|||
170579700|NCT02954406|616464351|FG001|Overall Study|Progressive Disease|4|||
170579701|NCT02954406|616464352|FG002|Overall Study|Progressive Disease|3|||
170579702|NCT02954406|616464353|FG003|Overall Study|Progressive Disease|4|||
170579703|NCT02954406|616464354|FG004|Overall Study|Progressive Disease|3|||
170579704|NCT02954406|616464355|FG005|Overall Study|Progressive Disease|3|||
170579705|NCT02954406|616464356|FG006|Overall Study|Progressive Disease|2|||
170579706|NCT02954406|616464357|FG007|Overall Study|Progressive Disease|2|||
170579707|NCT02954406|616464358|FG008|Overall Study|Progressive Disease|1|||
170579708|NCT02954406|616464359|FG009|Overall Study|Progressive Disease|1|||
170579709|NCT02954406|616464360|FG010|Overall Study|Progressive Disease|0|||
170579710|NCT02954406|616464350|FG000|Overall Study|Symptomatic Deterioration|0|||
170579711|NCT02954406|616464351|FG001|Overall Study|Symptomatic Deterioration|1|||
170579712|NCT02954406|616464352|FG002|Overall Study|Symptomatic Deterioration|0|||
170579713|NCT02954406|616464353|FG003|Overall Study|Symptomatic Deterioration|0|||
170579714|NCT02954406|616464354|FG004|Overall Study|Symptomatic Deterioration|0|||
170579715|NCT02954406|616464355|FG005|Overall Study|Symptomatic Deterioration|0|||
170579716|NCT02954406|616464356|FG006|Overall Study|Symptomatic Deterioration|0|||
170579717|NCT02954406|616464357|FG007|Overall Study|Symptomatic Deterioration|0|||
170579718|NCT02954406|616464358|FG008|Overall Study|Symptomatic Deterioration|0|||
170579719|NCT02954406|616464359|FG009|Overall Study|Symptomatic Deterioration|0|||
170579720|NCT02954406|616464360|FG010|Overall Study|Symptomatic Deterioration|0|||
170579721|NCT02954406|616464350|FG000|Overall Study|Death|0|||
170579722|NCT02954406|616464351|FG001|Overall Study|Death|0|||
170579723|NCT02954406|616464352|FG002|Overall Study|Death|0|||
170579724|NCT02954406|616464353|FG003|Overall Study|Death|0|||
170579725|NCT02954406|616464354|FG004|Overall Study|Death|1|||
170910582|NCT02786537|617677243|FG004|As Randomized|Death|1|||
170579726|NCT02954406|616464355|FG005|Overall Study|Death|0|||
170579727|NCT02954406|616464356|FG006|Overall Study|Death|0|||
170579728|NCT02954406|616464357|FG007|Overall Study|Death|0|||
170579729|NCT02954406|616464358|FG008|Overall Study|Death|1|||
170579730|NCT02954406|616464359|FG009|Overall Study|Death|1|||
170579731|NCT02954406|616464360|FG010|Overall Study|Death|0|||
170579732|NCT02954406|616464350|FG000|Overall Study|Reason Not Specified|0|||
170579733|NCT02954406|616464351|FG001|Overall Study|Reason Not Specified|0|||
170579734|NCT02954406|616464352|FG002|Overall Study|Reason Not Specified|3|||
170579735|NCT02954406|616464353|FG003|Overall Study|Reason Not Specified|2|||
170579736|NCT02954406|616464354|FG004|Overall Study|Reason Not Specified|2|||
170579737|NCT02954406|616464355|FG005|Overall Study|Reason Not Specified|0|||
170579738|NCT02954406|616464356|FG006|Overall Study|Reason Not Specified|1|||
170579739|NCT02954406|616464357|FG007|Overall Study|Reason Not Specified|0|||
170579740|NCT02954406|616464358|FG008|Overall Study|Reason Not Specified|1|||
170579741|NCT02954406|616464359|FG009|Overall Study|Reason Not Specified|0|||
170579742|NCT02954406|616464360|FG010|Overall Study|Reason Not Specified|0|||
170579743|NCT01691014|616464361|FG000|Overall Study|Premature Termination|1|||
170579744|NCT01691014|616464362|FG001|Overall Study|Premature Termination|6|||
170579745|NCT01691014|616464363|FG002|Overall Study|Premature Termination|0|||
170579746|NCT01691014|616464364|FG003|Overall Study|Premature Termination|3|||
170579747|NCT01691014|616464361|FG000|Overall Study|Other|0|||
170579748|NCT01691014|616464362|FG001|Overall Study|Other|0|||
170579749|NCT01691014|616464363|FG002|Overall Study|Other|2|||
170579750|NCT01691014|616464364|FG003|Overall Study|Other|0|||
170579751|NCT01691014|616464361|FG000|Overall Study|Withdrawal by Subject|0|||
170579752|NCT01691014|616464362|FG001|Overall Study|Withdrawal by Subject|1|||
170579753|NCT01691014|616464363|FG002|Overall Study|Withdrawal by Subject|1|||
170579754|NCT01691014|616464364|FG003|Overall Study|Withdrawal by Subject|1|||
170579755|NCT01691014|616464361|FG000|Overall Study|Adverse Event|0|||
170579756|NCT01691014|616464362|FG001|Overall Study|Adverse Event|5|||
170579757|NCT01691014|616464363|FG002|Overall Study|Adverse Event|1|||
170579758|NCT01691014|616464364|FG003|Overall Study|Adverse Event|1|||
170579759|NCT01691014|616464361|FG000|Overall Study|Lack of Efficacy|2|||
170579760|NCT01691014|616464362|FG001|Overall Study|Lack of Efficacy|3|||
170579761|NCT01691014|616464363|FG002|Overall Study|Lack of Efficacy|7|||
170579762|NCT01691014|616464364|FG003|Overall Study|Lack of Efficacy|0|||
170579763|NCT03062280|616464367|FG000|Overall Study|Adverse Event|1|||
170579764|NCT03062280|616464367|FG000|Overall Study|Death|1|||
170579765|NCT03062280|616464367|FG000|Overall Study|Fertility Treatment|2|||
170579766|NCT03062280|616464367|FG000|Overall Study|Physician Decision|2|||
170579767|NCT03062280|616464367|FG000|Overall Study|Pregnancy|5|||
170579768|NCT03062280|616464367|FG000|Overall Study|Withdrawal by Subject|11|||
170579769|NCT03522246|616464368|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
170579770|NCT03522246|616464369|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
170579771|NCT03522246|616464370|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
170579772|NCT03522246|616464371|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
170579773|NCT03522246|616464372|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
170579774|NCT00814580|616464373|FG000|Overall Study|Adverse Event|6|||
170579775|NCT00814580|616464374|FG001|Overall Study|Adverse Event|15|||
170579776|NCT00814580|616464373|FG000|Overall Study|Lack of Efficacy|18|||
170579777|NCT00814580|616464374|FG001|Overall Study|Lack of Efficacy|25|||
170579778|NCT00814580|616464373|FG000|Overall Study|Protocol Violation|2|||
170579779|NCT00814580|616464374|FG001|Overall Study|Protocol Violation|0|||
170579780|NCT00814580|616464373|FG000|Overall Study|Withdrawal by Subject|2|||
170579781|NCT00814580|616464374|FG001|Overall Study|Withdrawal by Subject|2|||
170579782|NCT00814580|616464373|FG000|Overall Study|Other|1|||
170579783|NCT00814580|616464374|FG001|Overall Study|Other|3|||
170579784|NCT00814580|616464373|FG000|Overall Study|Did Not Take Drug|2|||
170579785|NCT00814580|616464374|FG001|Overall Study|Did Not Take Drug|2|||
170579786|NCT01340625|616464375|FG000|First Intervention|Adverse Event|1|||
170579787|NCT01340625|616464376|FG001|First Intervention|Adverse Event|0|||
170579788|NCT01340625|616464375|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
170579789|NCT01340625|616464376|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
170579790|NCT05924165|616464381|FG000|Overall Study|Physician Decision|2|||
170579791|NCT05924165|616464382|FG001|Overall Study|Physician Decision|3|||
170579792|NCT05160415|616464383|FG000|Overall Study|Withdrawal by Subject|3|||
170579793|NCT05791565|616464386|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
170910583|NCT02786537|617677244|FG005|As Randomized|Death|0|||
170910584|NCT02786537|617677239|FG000|As Randomized|Non-compliance with study drug|1|||
170910585|NCT02786537|617677240|FG001|As Randomized|Non-compliance with study drug|11|||
170910586|NCT02786537|617677241|FG002|As Randomized|Non-compliance with study drug|0|||
170579794|NCT05791565|616464387|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
170910587|NCT02786537|617677242|FG003|As Randomized|Non-compliance with study drug|1|||
170579795|NCT01709110|616464396|FG000|Overall Study|Adverse Event|56|||
170579796|NCT01709110|616464397|FG001|Overall Study|Adverse Event|48|||
170579797|NCT01709110|616464396|FG000|Overall Study|Death|14|||
170579798|NCT01709110|616464397|FG001|Overall Study|Death|6|||
170579799|NCT01709110|616464396|FG000|Overall Study|Lost to Follow-up|7|||
170579800|NCT01709110|616464397|FG001|Overall Study|Lost to Follow-up|5|||
170579801|NCT01709110|616464396|FG000|Overall Study|Protocol Violation|4|||
170649701|NCT01587898|616730851|FG001|Overall Study|Withdrawal by Subject|1|||
170649702|NCT01587898|616730852|FG002|Overall Study|Withdrawal by Subject|0|||
170579802|NCT01709110|616464397|FG001|Overall Study|Protocol Violation|6|||
170579803|NCT01709110|616464396|FG000|Overall Study|Withdrawal by Subject|96|||
170809422|NCT03476798|617312322|FG000|Overall Study|Withdrawal by Subject|2|||
170809423|NCT03476798|617312322|FG000|Overall Study|Protocol Violation|2|||
170809424|NCT06269003|617312323|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
170809425|NCT06269003|617312324|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
170809426|NCT06269003|617312325|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
170809427|NCT06269003|617312326|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
170809428|NCT05615363|617312327|FG000|Overall Study|Adverse Event|0|||
170809429|NCT05615363|617312328|FG001|Overall Study|Adverse Event|4|||
170809430|NCT05615363|617312329|FG002|Overall Study|Adverse Event|4|||
170809431|NCT05615363|617312330|FG003|Overall Study|Adverse Event|3|||
170809432|NCT05615363|617312331|FG004|Overall Study|Adverse Event|1|||
170809433|NCT05615363|617312327|FG000|Overall Study|Physician Decision|2|||
170809434|NCT05615363|617312328|FG001|Overall Study|Physician Decision|0|||
170809435|NCT05615363|617312329|FG002|Overall Study|Physician Decision|4|||
170809436|NCT05615363|617312330|FG003|Overall Study|Physician Decision|1|||
170809437|NCT05615363|617312331|FG004|Overall Study|Physician Decision|3|||
170809438|NCT05615363|617312327|FG000|Overall Study|Protocol Violation|2|||
170809439|NCT05615363|617312328|FG001|Overall Study|Protocol Violation|0|||
170809440|NCT05615363|617312329|FG002|Overall Study|Protocol Violation|0|||
170809441|NCT05615363|617312330|FG003|Overall Study|Protocol Violation|0|||
170910588|NCT02786537|617677243|FG004|As Randomized|Non-compliance with study drug|0|||
170910589|NCT02786537|617677244|FG005|As Randomized|Non-compliance with study drug|1|||
170910590|NCT02786537|617677239|FG000|As Randomized|Lost to treatment follow-up|4|||
170809442|NCT05615363|617312331|FG004|Overall Study|Protocol Violation|1|||
170809443|NCT05615363|617312327|FG000|Overall Study|Withdrawal by Subject|0|||
170809444|NCT05615363|617312328|FG001|Overall Study|Withdrawal by Subject|0|||
170809445|NCT05615363|617312329|FG002|Overall Study|Withdrawal by Subject|1|||
170809446|NCT05615363|617312330|FG003|Overall Study|Withdrawal by Subject|0|||
170809447|NCT05615363|617312331|FG004|Overall Study|Withdrawal by Subject|0|||
170809448|NCT05865392|617312335|FG000|Overall Study|Withdrawal by Subject|4|||
170809449|NCT05865392|617312336|FG001|Overall Study|Withdrawal by Subject|0|||
170910591|NCT02786537|617677240|FG001|As Randomized|Lost to treatment follow-up|32|||
170579804|NCT01709110|616464397|FG001|Overall Study|Withdrawal by Subject|89|||
170579805|NCT01709110|616464396|FG000|Overall Study|Physician Decision|4|||
170579806|NCT01709110|616464397|FG001|Overall Study|Physician Decision|10|||
170579807|NCT01709110|616464396|FG000|Overall Study|Sponsor Decision|2|||
170579808|NCT01709110|616464397|FG001|Overall Study|Sponsor Decision|2|||
170579809|NCT01709110|616464396|FG000|Overall Study|Lack of Efficacy|1|||
170579810|NCT01709110|616464397|FG001|Overall Study|Lack of Efficacy|1|||
170579811|NCT01709110|616464396|FG000|Overall Study|Caregiver Decision|1|||
170579812|NCT01709110|616464397|FG001|Overall Study|Caregiver Decision|1|||
170579813|NCT02789345|616464398|FG000|Overall Study|Adverse Event|0|||
170579814|NCT02789345|616464399|FG001|Overall Study|Adverse Event|0|||
170579815|NCT02789345|616464400|FG002|Overall Study|Adverse Event|1|||
170579816|NCT02789345|616464398|FG000|Overall Study|Death|0|||
170579817|NCT02789345|616464399|FG001|Overall Study|Death|0|||
170579818|NCT02789345|616464400|FG002|Overall Study|Death|1|||
170579819|NCT02789345|616464398|FG000|Overall Study|Physician Decision|2|||
170579820|NCT02789345|616464399|FG001|Overall Study|Physician Decision|0|||
170579821|NCT02789345|616464400|FG002|Overall Study|Physician Decision|1|||
170579822|NCT02789345|616464398|FG000|Overall Study|Progressive Disease|1|||
170579823|NCT02789345|616464399|FG001|Overall Study|Progressive Disease|3|||
170579824|NCT02789345|616464400|FG002|Overall Study|Progressive Disease|14|||
170579825|NCT01164891|616464426|FG000|Overall Study|Disease Progression|5|||
170579826|NCT01164891|616464426|FG000|Overall Study|Adverse Event|1|||
170910592|NCT02786537|617677241|FG002|As Randomized|Lost to treatment follow-up|0|||
170579827|NCT00441142|616464427|FG000|Overall Study|Adverse Event|2|||
170809450|NCT05865392|617312335|FG000|Overall Study|Didn't meet inclusion criteria|4|||
170809451|NCT05865392|617312336|FG001|Overall Study|Didn't meet inclusion criteria|0|||
170809452|NCT05289037|617312337|FG000|Overall Study|Withdrawal by Subject|7|||
170809453|NCT05289037|617312338|FG001|Overall Study|Withdrawal by Subject|0|||
170579828|NCT00441142|616464428|FG001|Overall Study|Adverse Event|3|||
170579829|NCT00441142|616464429|FG002|Overall Study|Adverse Event|3|||
170579830|NCT00441142|616464430|FG003|Overall Study|Adverse Event|22|||
170579831|NCT00441142|616464427|FG000|Overall Study|Lack of Efficacy|3|||
170809454|NCT05289037|617312339|FG002|Overall Study|Withdrawal by Subject|3|||
170910593|NCT02786537|617677242|FG003|As Randomized|Lost to treatment follow-up|24|||
170579832|NCT00441142|616464428|FG001|Overall Study|Lack of Efficacy|3|||
170579833|NCT00441142|616464429|FG002|Overall Study|Lack of Efficacy|17|||
170579834|NCT00441142|616464430|FG003|Overall Study|Lack of Efficacy|32|||
170809455|NCT05289037|617312340|FG003|Overall Study|Withdrawal by Subject|3|||
170809456|NCT05289037|617312341|FG004|Overall Study|Withdrawal by Subject|1|||
170809457|NCT05289037|617312342|FG005|Overall Study|Withdrawal by Subject|5|||
170910594|NCT02786537|617677243|FG004|As Randomized|Lost to treatment follow-up|4|||
170910595|NCT02786537|617677244|FG005|As Randomized|Lost to treatment follow-up|4|||
170579835|NCT00441142|616464427|FG000|Overall Study|Withdrawal by Subject|0|||
170579836|NCT00441142|616464428|FG001|Overall Study|Withdrawal by Subject|0|||
170579837|NCT00441142|616464429|FG002|Overall Study|Withdrawal by Subject|2|||
170579838|NCT00441142|616464430|FG003|Overall Study|Withdrawal by Subject|10|||
170579839|NCT00441142|616464427|FG000|Overall Study|Patient still receiving active study tx|1|||
170579840|NCT00441142|616464428|FG001|Overall Study|Patient still receiving active study tx|0|||
170579841|NCT00441142|616464429|FG002|Overall Study|Patient still receiving active study tx|0|||
170579842|NCT00441142|616464430|FG003|Overall Study|Patient still receiving active study tx|2|||
170579843|NCT00441142|616464427|FG000|Overall Study|Physician Decision|0|||
170579844|NCT00441142|616464428|FG001|Overall Study|Physician Decision|1|||
170579845|NCT00441142|616464429|FG002|Overall Study|Physician Decision|0|||
170579846|NCT00441142|616464430|FG003|Overall Study|Physician Decision|1|||
170579847|NCT00441142|616464427|FG000|Overall Study|Death|0|||
170579848|NCT00441142|616464428|FG001|Overall Study|Death|0|||
170579849|NCT00441142|616464429|FG002|Overall Study|Death|0|||
170579850|NCT00441142|616464430|FG003|Overall Study|Death|1|||
170579851|NCT00338286|616464431|FG000|Overall Study|Withdrawal by Subject|50|||
170579852|NCT00338286|616464432|FG001|Overall Study|Withdrawal by Subject|54|||
170579853|NCT00338286|616464431|FG000|Overall Study|Lost to Follow-up|80|||
170579854|NCT00338286|616464432|FG001|Overall Study|Lost to Follow-up|66|||
170579855|NCT00338286|616464431|FG000|Overall Study|Other|103|||
170579856|NCT00338286|616464432|FG001|Overall Study|Other|93|||
170579857|NCT01265563|616464433|FG000|Overall Study|Withdrawal by Subject|0|||
170579858|NCT01265563|616464434|FG001|Overall Study|Withdrawal by Subject|1|||
170579859|NCT01265563|616464435|FG002|Overall Study|Withdrawal by Subject|1|||
170579860|NCT01265563|616464436|FG003|Overall Study|Withdrawal by Subject|0|||
170579861|NCT01265563|616464437|FG004|Overall Study|Withdrawal by Subject|2|||
170579862|NCT00022763|616464448|FG000|Overall Study|Adverse Event|1|||
170579863|NCT00022763|616464449|FG001|Overall Study|Adverse Event|2|||
170579864|NCT00022763|616464448|FG000|Overall Study|Injection Site Reactions|0|||
170579865|NCT00022763|616464449|FG001|Overall Study|Injection Site Reactions|2|||
170579866|NCT00022763|616464448|FG000|Overall Study|Death|0|||
170579867|NCT00022763|616464449|FG001|Overall Study|Death|1|||
170579868|NCT00022763|616464448|FG000|Overall Study|Lost to Follow-up|0|||
170579869|NCT00022763|616464449|FG001|Overall Study|Lost to Follow-up|3|||
170579870|NCT00022763|616464448|FG000|Overall Study|Withdrawal by Subject|4|||
170579871|NCT00022763|616464449|FG001|Overall Study|Withdrawal by Subject|7|||
170579872|NCT00022763|616464448|FG000|Overall Study|Insufficient Therapy|1|||
170579873|NCT00022763|616464449|FG001|Overall Study|Insufficient Therapy|0|||
170579874|NCT00022763|616464448|FG000|Overall Study|Admin|3|||
170579875|NCT00022763|616464449|FG001|Overall Study|Admin|2|||
170579876|NCT03248531|616464450|FG000|Overall Study|Adverse Event|0|||
170579877|NCT03248531|616464451|FG001|Overall Study|Adverse Event|0|||
170579878|NCT03248531|616464452|FG002|Overall Study|Adverse Event|1|||
170579879|NCT03248531|616464450|FG000|Overall Study|Lost to Follow-up|1|||
170579880|NCT03248531|616464451|FG001|Overall Study|Lost to Follow-up|0|||
170579881|NCT03248531|616464452|FG002|Overall Study|Lost to Follow-up|5|||
170579882|NCT03248531|616464450|FG000|Overall Study|Withdrawal by Subject|3|||
170579883|NCT03248531|616464451|FG001|Overall Study|Withdrawal by Subject|3|||
170579884|NCT03248531|616464452|FG002|Overall Study|Withdrawal by Subject|2|||
170579885|NCT03248531|616464450|FG000|Overall Study|Sponsor Request|0|||
170579886|NCT03248531|616464451|FG001|Overall Study|Sponsor Request|2|||
170579887|NCT03248531|616464452|FG002|Overall Study|Sponsor Request|0|||
170579888|NCT04908865|616464453|FG000|Overall Study|Adverse Event|2|||
170579889|NCT04908865|616464453|FG000|Overall Study|Lack of Efficacy|5|||
170579890|NCT04908865|616464453|FG000|Overall Study|Lost to Follow-up|1|||
170579891|NCT04075513|616464456|FG000|Overall Study|Withdrawal by Subject|2|||
170579892|NCT04075513|616464457|FG001|Overall Study|Withdrawal by Subject|2|||
170579893|NCT04075513|616464456|FG000|Overall Study|Lack of Efficacy|1|||
170579894|NCT04075513|616464457|FG001|Overall Study|Lack of Efficacy|0|||
170649703|NCT01587898|616730853|FG003|Overall Study|Withdrawal by Subject|0|||
170649704|NCT01587898|616730850|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
170809458|NCT05289037|617312343|FG006|Overall Study|Withdrawal by Subject|2|||
170809459|NCT05289037|617312344|FG007|Overall Study|Withdrawal by Subject|1|||
170809460|NCT05289037|617312345|FG008|Overall Study|Withdrawal by Subject|2|||
170579895|NCT04075513|616464456|FG000|Overall Study|Lost to Follow-up|4|||
170579896|NCT04075513|616464457|FG001|Overall Study|Lost to Follow-up|2|||
170579897|NCT04075513|616464456|FG000|Overall Study|Switch to insulin pump|1|||
170579898|NCT04075513|616464457|FG001|Overall Study|Switch to insulin pump|0|||
170579899|NCT05730335|616464458|FG000|Overall Study|Lost to Follow-up|8|||
170809461|NCT05289037|617312346|FG009|Overall Study|Withdrawal by Subject|2|||
170579900|NCT05730335|616464458|FG000|Overall Study|Withdrawal by Subject|6|||
170579901|NCT03249909|616464459|FG000|Overall Study|Withdrawal by Subject|3|||
170579902|NCT03249909|616464460|FG001|Overall Study|Withdrawal by Subject|0|||
170579903|NCT03249909|616464461|FG002|Overall Study|Withdrawal by Subject|0|||
170579904|NCT03249909|616464459|FG000|Overall Study|Adverse Event|3|||
170579905|NCT03249909|616464460|FG001|Overall Study|Adverse Event|0|||
170649705|NCT01587898|616730851|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
170579906|NCT03249909|616464461|FG002|Overall Study|Adverse Event|0|||
170579907|NCT03249909|616464459|FG000|Overall Study|Lost to Follow-up|0|||
170579908|NCT03249909|616464460|FG001|Overall Study|Lost to Follow-up|1|||
170579909|NCT03249909|616464461|FG002|Overall Study|Lost to Follow-up|0|||
170579910|NCT01277822|616464463|FG000|Overall Study|Adverse Event|2|||
170579911|NCT01277822|616464464|FG001|Overall Study|Adverse Event|1|||
170579912|NCT01277822|616464463|FG000|Overall Study|Withdrawal by Subject|6|||
170579913|NCT01277822|616464464|FG001|Overall Study|Withdrawal by Subject|7|||
170579914|NCT01277822|616464463|FG000|Overall Study|Physician Decision|1|||
170579915|NCT01277822|616464464|FG001|Overall Study|Physician Decision|1|||
170579916|NCT01277822|616464463|FG000|Overall Study|Protocol Violation|1|||
170579917|NCT01277822|616464464|FG001|Overall Study|Protocol Violation|0|||
170579918|NCT01277822|616464463|FG000|Overall Study|Lost to Follow-up|2|||
170579919|NCT01277822|616464464|FG001|Overall Study|Lost to Follow-up|1|||
170579920|NCT01277822|616464463|FG000|Overall Study|Contraindicated medication used|2|||
170579921|NCT01277822|616464464|FG001|Overall Study|Contraindicated medication used|1|||
170579922|NCT01277822|616464463|FG000|Overall Study|Participant moved|1|||
170579923|NCT01277822|616464464|FG001|Overall Study|Participant moved|0|||
170579924|NCT01066104|616464465|FG000|Overall Study|Adverse Event|1|||
170579925|NCT01066104|616464466|FG001|Overall Study|Adverse Event|1|||
170579926|NCT01066104|616464465|FG000|Overall Study|Protocol Violation|1|||
170579927|NCT01066104|616464466|FG001|Overall Study|Protocol Violation|0|||
170579928|NCT02595866|616464469|FG000|Overall Study|Adverse Event|2|||
170579929|NCT02595866|616464470|FG001|Overall Study|Adverse Event|5|||
170579930|NCT02595866|616464469|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
170579931|NCT02595866|616464470|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
170579932|NCT02595866|616464469|FG000|Overall Study|Death|0|||
170579933|NCT02595866|616464470|FG001|Overall Study|Death|1|||
170579934|NCT02595866|616464469|FG000|Overall Study|Incarceration|1|||
170579935|NCT02595866|616464470|FG001|Overall Study|Incarceration|0|||
170579936|NCT02595866|616464469|FG000|Overall Study|Lack of Efficacy|17|||
170579937|NCT02595866|616464470|FG001|Overall Study|Lack of Efficacy|7|||
170579938|NCT02595866|616464469|FG000|Overall Study|Physician Decision|4|||
170579939|NCT02595866|616464470|FG001|Overall Study|Physician Decision|3|||
170579940|NCT02595866|616464469|FG000|Overall Study|Switched to Alternative Treatment|1|||
170579941|NCT02595866|616464470|FG001|Overall Study|Switched to Alternative Treatment|0|||
170579942|NCT02595866|616464469|FG000|Overall Study|Study Terminated|0|||
170579943|NCT02595866|616464470|FG001|Overall Study|Study Terminated|4|||
170579944|NCT02595866|616464469|FG000|Overall Study|Withdrawal by Subject|6|||
170579945|NCT02595866|616464470|FG001|Overall Study|Withdrawal by Subject|1|||
170579946|NCT00851552|616464474|FG000|Overall Study|Death|2|||
170579947|NCT00851552|616464474|FG000|Overall Study|Adverse Event|1|||
170579948|NCT00851552|616464474|FG000|Overall Study|Disease Progression|4|||
170579949|NCT00177294|616464475|FG000|Overall Study|Withdrawal by Subject|7|||
170579950|NCT00177294|616464476|FG001|Overall Study|Withdrawal by Subject|5|||
170579951|NCT02998671|616464477|FG000|Period 1|Study Terminated By Sponsor|2|||
170579952|NCT02998671|616464478|FG001|Period 1|Study Terminated By Sponsor|1|||
170579953|NCT02998671|616464479|FG002|Period 1|Study Terminated By Sponsor|0|||
170579954|NCT02998671|616464480|FG003|Period 1|Study Terminated By Sponsor|0|||
170579955|NCT02998671|616464481|FG004|Period 1|Study Terminated By Sponsor|1|||
170579956|NCT02998671|616464477|FG000|Period 1|Withdrawal by Subject|1|||
170579957|NCT02998671|616464478|FG001|Period 1|Withdrawal by Subject|2|||
170579958|NCT02998671|616464479|FG002|Period 1|Withdrawal by Subject|0|||
170579959|NCT02998671|616464480|FG003|Period 1|Withdrawal by Subject|0|||
170579960|NCT02998671|616464481|FG004|Period 1|Withdrawal by Subject|2|||
170910596|NCT02786537|617677239|FG000|As Randomized|Incarceration|0|||
170910597|NCT02786537|617677240|FG001|As Randomized|Incarceration|1|||
170910598|NCT02786537|617677241|FG002|As Randomized|Incarceration|0|||
170910599|NCT02786537|617677242|FG003|As Randomized|Incarceration|0|||
170910600|NCT02786537|617677243|FG004|As Randomized|Incarceration|0|||
170910601|NCT02786537|617677244|FG005|As Randomized|Incarceration|0|||
170910602|NCT02786537|617677239|FG000|As Randomized|Opiate Dependency Relapse|0|||
170910603|NCT02786537|617677240|FG001|As Randomized|Opiate Dependency Relapse|1|||
170910604|NCT02786537|617677241|FG002|As Randomized|Opiate Dependency Relapse|0|||
170910605|NCT02786537|617677242|FG003|As Randomized|Opiate Dependency Relapse|0|||
170910606|NCT02786537|617677243|FG004|As Randomized|Opiate Dependency Relapse|0|||
170910607|NCT02786537|617677244|FG005|As Randomized|Opiate Dependency Relapse|0|||
170910608|NCT02786537|617677239|FG000|As Randomized|HCV drugs stolen from pt|0|||
170649706|NCT01587898|616730852|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
170579961|NCT02998671|616464477|FG000|Period 1|Pregnancy|1|||
170579962|NCT02998671|616464478|FG001|Period 1|Pregnancy|0|||
170579963|NCT02998671|616464479|FG002|Period 1|Pregnancy|0|||
170579964|NCT02998671|616464480|FG003|Period 1|Pregnancy|0|||
170579965|NCT02998671|616464481|FG004|Period 1|Pregnancy|0|||
170910609|NCT02786537|617677240|FG001|As Randomized|HCV drugs stolen from pt|1|||
170579966|NCT02998671|616464477|FG000|Period 1|Adverse Event|0|||
170579967|NCT02998671|616464478|FG001|Period 1|Adverse Event|0|||
170579968|NCT02998671|616464479|FG002|Period 1|Adverse Event|0|||
170579969|NCT02998671|616464480|FG003|Period 1|Adverse Event|0|||
170579970|NCT02998671|616464481|FG004|Period 1|Adverse Event|1|||
170579971|NCT02998671|616464477|FG000|Period 2|Adverse Event|0|||
170579972|NCT02998671|616464478|FG001|Period 2|Adverse Event|1|||
170579973|NCT02998671|616464479|FG002|Period 2|Adverse Event|0|||
170579974|NCT02998671|616464480|FG003|Period 2|Adverse Event|0|||
170579975|NCT02998671|616464481|FG004|Period 2|Adverse Event|0|||
170579976|NCT02998671|616464477|FG000|Period 2|Study Terminated By Sponsor|3|||
170579977|NCT02998671|616464478|FG001|Period 2|Study Terminated By Sponsor|5|||
170579978|NCT02998671|616464479|FG002|Period 2|Study Terminated By Sponsor|1|||
170579979|NCT02998671|616464480|FG003|Period 2|Study Terminated By Sponsor|3|||
170579980|NCT02998671|616464481|FG004|Period 2|Study Terminated By Sponsor|0|||
170579981|NCT02998671|616464477|FG000|Period 2|Withdrawal by Subject|0|||
170579982|NCT02998671|616464478|FG001|Period 2|Withdrawal by Subject|1|||
170579983|NCT02998671|616464479|FG002|Period 2|Withdrawal by Subject|0|||
170579984|NCT02998671|616464480|FG003|Period 2|Withdrawal by Subject|0|||
170579985|NCT02998671|616464481|FG004|Period 2|Withdrawal by Subject|0|||
170579986|NCT02998671|616464477|FG000|Period 2|Lost to Follow-up|0|||
170579987|NCT02998671|616464478|FG001|Period 2|Lost to Follow-up|0|||
170579988|NCT02998671|616464479|FG002|Period 2|Lost to Follow-up|0|||
170579989|NCT02998671|616464480|FG003|Period 2|Lost to Follow-up|1|||
170579990|NCT02998671|616464481|FG004|Period 2|Lost to Follow-up|0|||
170579991|NCT02038946|616464484|FG000|Overall Study|Death|5|||
170579992|NCT02038946|616464484|FG000|Overall Study|Withdrawal by Subject|3|||
170579993|NCT02038946|616464484|FG000|Overall Study|Lost to Follow-up|2|||
170579994|NCT02038946|616464484|FG000|Overall Study|Other reasons|2|||
170579995|NCT01558596|616464485|FG000|Overall Study|Withdrawal by Subject|1|||
170579996|NCT01558596|616464486|FG001|Overall Study|Withdrawal by Subject|0|||
170579997|NCT01558596|616464485|FG000|Overall Study|surgery elsewhere or cancelled|1|||
170579998|NCT01558596|616464486|FG001|Overall Study|surgery elsewhere or cancelled|1|||
170579999|NCT01558596|616464485|FG000|Overall Study|Protocol Violation|1|||
170580000|NCT01558596|616464486|FG001|Overall Study|Protocol Violation|0|||
170580001|NCT01437111|616464488|FG000|Overall Study|Adverse Event|2|||
170580002|NCT01437111|616464488|FG000|Overall Study|Withdrawal by Subject|4|||
170580003|NCT01437111|616464488|FG000|Overall Study|Not reported|5|||
170580004|NCT01437111|616464488|FG000|Overall Study|Physician Decision|1|||
170580005|NCT01437111|616464488|FG000|Overall Study|Lost to Follow-up|5|||
170580006|NCT01437111|616464488|FG000|Overall Study|Protocol Violation|1|||
170580007|NCT01479764|616464490|FG000|Randomized|Adverse Event|1|||
170580008|NCT01479764|616464491|FG001|Randomized|Adverse Event|1|||
170580009|NCT01479764|616464490|FG000|Randomized|Withdrawal by Subject|1|||
170580010|NCT01479764|616464491|FG001|Randomized|Withdrawal by Subject|0|||
170580011|NCT01479764|616464490|FG000|Treated|Lost to Follow-up|0|||
170580012|NCT01479764|616464491|FG001|Treated|Lost to Follow-up|2|||
170580013|NCT00260832|616464492|FG000|Overall Study|Adverse Event|26|||
170580014|NCT00260832|616464493|FG001|Overall Study|Adverse Event|19|||
170580015|NCT00260832|616464492|FG000|Overall Study|Progression|116|||
170580016|NCT00260832|616464493|FG001|Overall Study|Progression|96|||
170580017|NCT00260832|616464492|FG000|Overall Study|Withdrawal by Subject|15|||
170580018|NCT00260832|616464493|FG001|Overall Study|Withdrawal by Subject|17|||
170580019|NCT00260832|616464492|FG000|Overall Study|Physician Decision|15|||
170580020|NCT00260832|616464493|FG001|Overall Study|Physician Decision|9|||
170580021|NCT00260832|616464492|FG000|Overall Study|Death|43|||
170580022|NCT00260832|616464493|FG001|Overall Study|Death|62|||
170580023|NCT00260832|616464492|FG000|Overall Study|Other|10|||
170580024|NCT00260832|616464493|FG001|Overall Study|Other|7|||
170580025|NCT00260832|616464492|FG000|Overall Study|Protocol Violation|3|||
170580026|NCT00260832|616464493|FG001|Overall Study|Protocol Violation|1|||
170580027|NCT02473471|616464494|FG000|Overall Study|poor oral hygiene|2|||
170809462|NCT05289037|617312347|FG010|Overall Study|Withdrawal by Subject|1|||
170809463|NCT05289037|617312348|FG011|Overall Study|Withdrawal by Subject|0|||
170809464|NCT05289037|617312349|FG012|Overall Study|Withdrawal by Subject|1|||
170809465|NCT05289037|617312350|FG013|Overall Study|Withdrawal by Subject|2|||
170809466|NCT05289037|617312351|FG014|Overall Study|Withdrawal by Subject|0|||
170809467|NCT05289037|617312352|FG015|Overall Study|Withdrawal by Subject|3|||
170580028|NCT02473471|616464494|FG000|Overall Study|Lost to Follow-up|1|||
170580029|NCT03745638|616464495|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
170580030|NCT03745638|616464496|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
170580031|NCT03745638|616464497|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
170580032|NCT03745638|616464498|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170580033|NCT03745638|616464499|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170580034|NCT03745638|616464500|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170580035|NCT03745638|616464501|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170580036|NCT03745638|616464495|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
170580037|NCT03745638|616464496|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170580038|NCT03745638|616464497|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170580039|NCT03745638|616464498|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170580040|NCT03745638|616464499|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170580041|NCT03745638|616464500|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170580042|NCT03745638|616464501|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170580043|NCT03745638|616464495|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
170580044|NCT03745638|616464496|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
170580045|NCT03745638|616464497|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
170580046|NCT03745638|616464498|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170580047|NCT03745638|616464499|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170580048|NCT03745638|616464500|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170580049|NCT03745638|616464501|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170580050|NCT03745638|616464495|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
170580051|NCT03745638|616464496|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
170580052|NCT03745638|616464497|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170580053|NCT03745638|616464498|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170580054|NCT03745638|616464499|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170580055|NCT03745638|616464500|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170580056|NCT03745638|616464501|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170580057|NCT03745638|616464495|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
170580058|NCT03745638|616464496|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
170580059|NCT03745638|616464497|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
170580060|NCT03745638|616464498|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
170580061|NCT03745638|616464499|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
170580062|NCT03745638|616464500|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
170580063|NCT03745638|616464501|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
170580064|NCT03745638|616464495|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170580065|NCT03745638|616464496|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
170580066|NCT03745638|616464497|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170580067|NCT03745638|616464498|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170580068|NCT03745638|616464499|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170580069|NCT03745638|616464500|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170580070|NCT03745638|616464501|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170580071|NCT03745638|616464495|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
170580072|NCT03745638|616464496|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
170580073|NCT03745638|616464497|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
170580074|NCT03745638|616464498|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170580075|NCT03745638|616464499|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170580076|NCT03745638|616464500|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170580077|NCT03745638|616464501|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170580078|NCT03745638|616464495|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
170580079|NCT03745638|616464496|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
170580080|NCT03745638|616464497|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
170580081|NCT03745638|616464498|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
170580082|NCT03745638|616464499|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
170580083|NCT03745638|616464500|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
170580084|NCT03745638|616464501|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
170580085|NCT03745638|616464495|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170580086|NCT03745638|616464496|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170580087|NCT03745638|616464497|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170580088|NCT03745638|616464498|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170580089|NCT03745638|616464499|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170580090|NCT03745638|616464500|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
170580091|NCT03745638|616464501|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
170809468|NCT05289037|617312353|FG016|Overall Study|Withdrawal by Subject|3|||
170809469|NCT05289037|617312337|FG000|Overall Study|Lost to Follow-up|1|||
170809470|NCT05289037|617312338|FG001|Overall Study|Lost to Follow-up|4|||
170580092|NCT03745638|616464495|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170580093|NCT03745638|616464496|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170580094|NCT03745638|616464497|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170580095|NCT03745638|616464498|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
170809471|NCT05289037|617312339|FG002|Overall Study|Lost to Follow-up|3|||
170580096|NCT03745638|616464499|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170580097|NCT03745638|616464500|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
170580098|NCT03745638|616464501|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
170580099|NCT03745638|616464495|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170580100|NCT03745638|616464496|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170580101|NCT03745638|616464497|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170580102|NCT03745638|616464498|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
170580103|NCT03745638|616464499|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
170580104|NCT03745638|616464500|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
170580105|NCT03745638|616464501|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
170580106|NCT03745638|616464495|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170580107|NCT03745638|616464496|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170580108|NCT03745638|616464497|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170580109|NCT03745638|616464498|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170580110|NCT03745638|616464499|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
170580111|NCT03745638|616464500|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
170580112|NCT03745638|616464501|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170580113|NCT03745638|616464495|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170580114|NCT03745638|616464496|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170580115|NCT03745638|616464497|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170580116|NCT03745638|616464498|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170580117|NCT03745638|616464499|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170580118|NCT03745638|616464500|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
170580119|NCT03745638|616464501|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170580120|NCT03745638|616464495|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170580121|NCT03745638|616464496|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170580122|NCT03745638|616464497|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170580123|NCT03745638|616464498|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
170580124|NCT03745638|616464499|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
170580125|NCT03745638|616464500|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
170580126|NCT03745638|616464501|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
170580127|NCT03745638|616464495|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
170580128|NCT03745638|616464496|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
170580129|NCT03745638|616464497|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
170580130|NCT03745638|616464498|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
170580131|NCT03745638|616464499|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
170580132|NCT03745638|616464500|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
170580133|NCT03745638|616464501|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
170580134|NCT03082677|616464502|FG000|Overall Study|Not Treated|2|||
170580135|NCT01104545|616464505|FG000|Overall Study|Adverse Event|0|||
170580136|NCT01104545|616464506|FG001|Overall Study|Adverse Event|1|||
170580137|NCT01104545|616464507|FG002|Overall Study|Adverse Event|2|||
170580138|NCT00771927|616464508|FG000|Overall Study|Adverse Event|100|||
170580139|NCT00771927|616464509|FG001|Overall Study|Adverse Event|105|||
170580140|NCT00771927|616464508|FG000|Overall Study|Lack of Efficacy|70|||
170580141|NCT00771927|616464509|FG001|Overall Study|Lack of Efficacy|42|||
170580142|NCT00771927|616464508|FG000|Overall Study|Lost to Follow-up|46|||
170580143|NCT00771927|616464509|FG001|Overall Study|Lost to Follow-up|46|||
170580144|NCT00771927|616464508|FG000|Overall Study|Withdrawal by Subject|16|||
170580145|NCT00771927|616464509|FG001|Overall Study|Withdrawal by Subject|17|||
170580146|NCT00771927|616464508|FG000|Overall Study|Other reason|23|||
170580147|NCT00771927|616464509|FG001|Overall Study|Other reason|27|||
170580148|NCT02063984|616464515|FG000|Overall Study|Lost to Follow-up|6|||
170649707|NCT01587898|616730853|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
170580149|NCT02063984|616464516|FG001|Overall Study|Lost to Follow-up|5|||
170580150|NCT04222699|616464517|FG000|Overall Study|Lost to Follow-up|2|||
170580151|NCT02467192|616464518|FG000|Overall Study|Death|1|||
170649708|NCT01915303|616730854|FG000|Core Phase|Adverse Event|7|||
170649709|NCT01915303|616730854|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
170580152|NCT02467192|616464518|FG000|Overall Study|revealed to have pneumonia before|2|||
170580153|NCT01814046|616464519|FG000|Drug Administration|Death due to complications of RSV|1|||
170580154|NCT01814046|616464520|FG001|Drug Administration|Death due to complications of RSV|0|||
170580155|NCT01814046|616464521|FG002|Drug Administration|Death due to complications of RSV|0|||
170649710|NCT01915303|616730854|FG000|Core Phase|Death|2|||
170649711|NCT01915303|616730854|FG000|Core Phase|Protocol Violation|2|||
170580156|NCT01696981|616464522|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
170580157|NCT01696981|616464523|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
170580158|NCT01696981|616464522|FG000|Overall Study|Died Before Randomization|3|||
170580159|NCT01696981|616464523|FG001|Overall Study|Died Before Randomization|8|||
170580160|NCT01696981|616464522|FG000|Overall Study|Died Before ASU (Control)|278|||
170580161|NCT01696981|616464523|FG001|Overall Study|Died Before ASU (Control)|0|||
170580162|NCT01696981|616464522|FG000|Overall Study|Refused ASU (Control)|920|||
170580163|NCT01696981|616464523|FG001|Overall Study|Refused ASU (Control)|0|||
170580164|NCT01696981|616464522|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
170580165|NCT01696981|616464523|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
170580166|NCT03089047|616464524|FG000|Overall Study|Lost to Follow-up|1|||
170580167|NCT03089047|616464525|FG001|Overall Study|Lost to Follow-up|0|||
170580168|NCT03599518|616464526|FG000|Overall Study|Clinical progression|0|||
170580169|NCT03599518|616464527|FG001|Overall Study|Clinical progression|0|||
170580170|NCT03599518|616464528|FG002|Overall Study|Clinical progression|0|||
170580171|NCT03599518|616464529|FG003|Overall Study|Clinical progression|0|||
170580172|NCT03599518|616464530|FG004|Overall Study|Clinical progression|1|||
170580173|NCT03599518|616464526|FG000|Overall Study|Adverse Event|0|||
170580174|NCT03599518|616464527|FG001|Overall Study|Adverse Event|0|||
170580175|NCT03599518|616464528|FG002|Overall Study|Adverse Event|0|||
170580176|NCT03599518|616464529|FG003|Overall Study|Adverse Event|0|||
170580177|NCT03599518|616464530|FG004|Overall Study|Adverse Event|1|||
170580178|NCT03599518|616464526|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
170580179|NCT03599518|616464527|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
170580180|NCT03599518|616464528|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
170580181|NCT03599518|616464529|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
170580182|NCT03599518|616464530|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
170580183|NCT03599518|616464526|FG000|Overall Study|Participant withdrawal from study treatment|0|||
170580184|NCT03599518|616464527|FG001|Overall Study|Participant withdrawal from study treatment|0|||
170580185|NCT03599518|616464528|FG002|Overall Study|Participant withdrawal from study treatment|1|||
170580186|NCT03599518|616464529|FG003|Overall Study|Participant withdrawal from study treatment|0|||
170580187|NCT03599518|616464530|FG004|Overall Study|Participant withdrawal from study treatment|0|||
170580188|NCT02131662|616464545|FG000|Overall Study|Protocol Violation|1|||
170580189|NCT02131662|616464546|FG001|Overall Study|Protocol Violation|0|||
170580190|NCT02131662|616464547|FG002|Overall Study|Protocol Violation|0|||
170580191|NCT02131662|616464548|FG003|Overall Study|Protocol Violation|0|||
170580192|NCT02131662|616464549|FG004|Overall Study|Protocol Violation|0|||
170580193|NCT02131662|616464545|FG000|Overall Study|Other|2|||
170580194|NCT02131662|616464546|FG001|Overall Study|Other|4|||
170580195|NCT02131662|616464547|FG002|Overall Study|Other|3|||
170580196|NCT02131662|616464548|FG003|Overall Study|Other|3|||
170580197|NCT02131662|616464549|FG004|Overall Study|Other|4|||
170580198|NCT02131662|616464545|FG000|Overall Study|Adverse Event|0|||
170580199|NCT02131662|616464546|FG001|Overall Study|Adverse Event|1|||
170580200|NCT02131662|616464547|FG002|Overall Study|Adverse Event|1|||
170580201|NCT02131662|616464548|FG003|Overall Study|Adverse Event|1|||
170580202|NCT02131662|616464549|FG004|Overall Study|Adverse Event|3|||
170580203|NCT02131662|616464545|FG000|Overall Study|Pregnancy|0|||
170580204|NCT02131662|616464546|FG001|Overall Study|Pregnancy|1|||
170580205|NCT02131662|616464547|FG002|Overall Study|Pregnancy|0|||
170580206|NCT02131662|616464548|FG003|Overall Study|Pregnancy|1|||
170580207|NCT02131662|616464549|FG004|Overall Study|Pregnancy|0|||
170580208|NCT02131662|616464545|FG000|Overall Study|Wish for pregnancy|0|||
170580209|NCT02131662|616464546|FG001|Overall Study|Wish for pregnancy|0|||
170580210|NCT02131662|616464547|FG002|Overall Study|Wish for pregnancy|0|||
170580211|NCT02131662|616464548|FG003|Overall Study|Wish for pregnancy|0|||
170580212|NCT02131662|616464549|FG004|Overall Study|Wish for pregnancy|1|||
170649712|NCT01915303|616730854|FG000|Core Phase|Abnormal lab value|1|||
170580213|NCT02131662|616464545|FG000|Overall Study|Lack of Efficacy|1|||
170580214|NCT02131662|616464546|FG001|Overall Study|Lack of Efficacy|0|||
170580215|NCT02131662|616464547|FG002|Overall Study|Lack of Efficacy|0|||
170580216|NCT02131662|616464548|FG003|Overall Study|Lack of Efficacy|0|||
170580217|NCT02131662|616464549|FG004|Overall Study|Lack of Efficacy|1|||
170580218|NCT02131662|616464545|FG000|Overall Study|Withdrawal by Subject|1|||
170580219|NCT02131662|616464546|FG001|Overall Study|Withdrawal by Subject|5|||
170580220|NCT02131662|616464547|FG002|Overall Study|Withdrawal by Subject|1|||
170580221|NCT02131662|616464548|FG003|Overall Study|Withdrawal by Subject|5|||
170580222|NCT02131662|616464549|FG004|Overall Study|Withdrawal by Subject|6|||
170580223|NCT02131662|616464545|FG000|Overall Study|Lost to Follow-up|1|||
170580224|NCT02131662|616464546|FG001|Overall Study|Lost to Follow-up|3|||
170580225|NCT02131662|616464547|FG002|Overall Study|Lost to Follow-up|0|||
170580226|NCT02131662|616464548|FG003|Overall Study|Lost to Follow-up|9|||
170580227|NCT02131662|616464549|FG004|Overall Study|Lost to Follow-up|0|||
170580228|NCT02131662|616464545|FG000|Overall Study|Not treated|2|||
170580229|NCT02131662|616464546|FG001|Overall Study|Not treated|0|||
170580230|NCT02131662|616464547|FG002|Overall Study|Not treated|2|||
170580231|NCT02131662|616464548|FG003|Overall Study|Not treated|2|||
170580232|NCT02131662|616464549|FG004|Overall Study|Not treated|3|||
170580233|NCT03554018|616464550|FG000|Overall Study|Lost to Follow-up|3|||
170580234|NCT03554018|616464551|FG001|Overall Study|Lost to Follow-up|7|||
170580235|NCT03335150|616464552|FG000|Overall Study|Withdrawal by Subject|10|||
170580236|NCT03335150|616464553|FG001|Overall Study|Withdrawal by Subject|4|||
170580237|NCT03335150|616464552|FG000|Overall Study|Adverse Event|0|||
170580238|NCT03335150|616464553|FG001|Overall Study|Adverse Event|1|||
170580239|NCT01575808|616464560|FG000|Overall Study|Death|2|||
170580240|NCT01575808|616464561|FG001|Overall Study|Death|0|||
170580241|NCT01575808|616464560|FG000|Overall Study|Withdrawal by Subject|1|||
170580242|NCT01575808|616464561|FG001|Overall Study|Withdrawal by Subject|0|||
170580243|NCT02842086|616464564|FG000|Overall Study|Randomized but Never Treated|6|||
170580244|NCT02842086|616464565|FG001|Overall Study|Randomized but Never Treated|6|||
170580245|NCT02842086|616464564|FG000|Overall Study|Still in Double-Blind Phase|7|||
170580246|NCT02842086|616464565|FG001|Overall Study|Still in Double-Blind Phase|3|||
170580247|NCT02842086|616464564|FG000|Overall Study|Adverse Event|18|||
170580248|NCT02842086|616464565|FG001|Overall Study|Adverse Event|20|||
170580249|NCT02842086|616464564|FG000|Overall Study|Death|3|||
170580250|NCT02842086|616464565|FG001|Overall Study|Death|3|||
170580251|NCT02842086|616464564|FG000|Overall Study|Investigator's Discretion|9|||
170580252|NCT02842086|616464565|FG001|Overall Study|Investigator's Discretion|13|||
170580253|NCT02842086|616464564|FG000|Overall Study|Non-Compliance with Study Drug|9|||
170580254|NCT02842086|616464565|FG001|Overall Study|Non-Compliance with Study Drug|8|||
170580255|NCT02842086|616464564|FG000|Overall Study|Protocol Violation|8|||
170580256|NCT02842086|616464565|FG001|Overall Study|Protocol Violation|4|||
170580257|NCT02842086|616464564|FG000|Overall Study|Withdrew Consent|205|||
170580258|NCT02842086|616464565|FG001|Overall Study|Withdrew Consent|194|||
170580259|NCT02842086|616464564|FG000|Overall Study|Lost to Follow-up|274|||
170580260|NCT02842086|616464565|FG001|Overall Study|Lost to Follow-up|236|||
170580261|NCT02842086|616464564|FG000|Overall Study|HIV-1 Infection|5|||
170580262|NCT02842086|616464565|FG001|Overall Study|HIV-1 Infection|6|||
170580263|NCT00928187|616464566|FG000|Overall Study|Death|1|||
170580264|NCT00928187|616464567|FG001|Overall Study|Death|2|||
170580265|NCT00928187|616464568|FG002|Overall Study|Death|3|||
170580266|NCT00928187|616464566|FG000|Overall Study|Lost to Follow-up|1|||
170580267|NCT00928187|616464567|FG001|Overall Study|Lost to Follow-up|2|||
170580268|NCT00928187|616464568|FG002|Overall Study|Lost to Follow-up|1|||
170580269|NCT00928187|616464566|FG000|Overall Study|Withdrawal by Subject|0|||
170580270|NCT00928187|616464567|FG001|Overall Study|Withdrawal by Subject|1|||
170580271|NCT00928187|616464568|FG002|Overall Study|Withdrawal by Subject|1|||
170580272|NCT00928187|616464566|FG000|Overall Study|Protocol Violation|0|||
170580273|NCT00928187|616464567|FG001|Overall Study|Protocol Violation|1|||
170580274|NCT00928187|616464568|FG002|Overall Study|Protocol Violation|0|||
170580275|NCT01271010|616466398|FG000|Overall Study|Reason not specified|11|||
170580276|NCT01271010|616466398|FG000|Overall Study|Start of new CLL therapy|1|||
170580277|NCT01271010|616466398|FG000|Overall Study|Protocol Violation|1|||
170580278|NCT01271010|616466398|FG000|Overall Study|Death|2|||
170580279|NCT01271010|616466398|FG000|Overall Study|Progression and relapse of disease|1|||
170580280|NCT01271010|616466398|FG000|Overall Study|Withdrawal by Subject|18|||
170580281|NCT01271010|616466398|FG000|Overall Study|Disease progression|27|||
170580282|NCT01631747|616466399|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
170580283|NCT01631747|616466400|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
170580284|NCT01631747|616466399|FG000|Live Birth|Pregnancy Termination|1|||
170580285|NCT01631747|616466400|FG001|Live Birth|Pregnancy Termination|0|||
170580286|NCT01631747|616466399|FG000|Live Birth|MIscarriage|2|||
170580287|NCT01631747|616466400|FG001|Live Birth|MIscarriage|0|||
170580288|NCT01631747|616466399|FG000|Live Birth|Stillbirth|1|||
170580289|NCT01631747|616466400|FG001|Live Birth|Stillbirth|1|||
170580290|NCT01631747|616466399|FG000|One Year Infant Outcomes|Patient Refused|13|||
170580291|NCT01631747|616466400|FG001|One Year Infant Outcomes|Patient Refused|9|||
170580292|NCT00782171|616466401|FG000|Overall Study|Lost to Follow-up|2|||
170580293|NCT00782171|616466402|FG001|Overall Study|Lost to Follow-up|2|||
170910610|NCT02786537|617677241|FG002|As Randomized|HCV drugs stolen from pt|0|||
170910611|NCT02786537|617677242|FG003|As Randomized|HCV drugs stolen from pt|0|||
170910612|NCT02786537|617677243|FG004|As Randomized|HCV drugs stolen from pt|0|||
170910613|NCT02786537|617677244|FG005|As Randomized|HCV drugs stolen from pt|0|||
170580294|NCT00782171|616466401|FG000|Overall Study|Withdrawal by Subject|2|||
170580295|NCT00782171|616466402|FG001|Overall Study|Withdrawal by Subject|1|||
170580296|NCT00782171|616466401|FG000|Overall Study|complications|3|||
170580297|NCT00782171|616466402|FG001|Overall Study|complications|1|||
170580298|NCT00782171|616466401|FG000|Overall Study|others|7|||
170910614|NCT02786537|617677239|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
170580299|NCT00782171|616466402|FG001|Overall Study|others|9|||
170580300|NCT00782171|616466401|FG000|Overall Study|not eligible|8|||
170580301|NCT00782171|616466402|FG001|Overall Study|not eligible|6|||
170580302|NCT05897242|616466403|FG000|Overall Study|Lost to Follow-up|6|||
170580303|NCT05897242|616466404|FG001|Overall Study|Lost to Follow-up|1|||
170580304|NCT05897242|616466403|FG000|Overall Study|Incomplete|1|||
170580305|NCT05897242|616466404|FG001|Overall Study|Incomplete|0|||
170580306|NCT05897242|616466403|FG000|Overall Study|Withdrawal by Subject|1|||
170580307|NCT05897242|616466404|FG001|Overall Study|Withdrawal by Subject|0|||
170580308|NCT02482428|616466405|FG000|Overall Study|Lost to Follow-up|4|||
170580309|NCT02482428|616466406|FG001|Overall Study|Lost to Follow-up|9|||
170580310|NCT02482428|616466407|FG002|Overall Study|Lost to Follow-up|1|||
170580311|NCT02482428|616466408|FG003|Overall Study|Lost to Follow-up|2|||
170580312|NCT02482428|616466409|FG004|Overall Study|Lost to Follow-up|4|||
170580313|NCT02482428|616466405|FG000|Overall Study|Physician Decision|0|||
170580314|NCT02482428|616466406|FG001|Overall Study|Physician Decision|0|||
170580315|NCT02482428|616466407|FG002|Overall Study|Physician Decision|0|||
170580316|NCT02482428|616466408|FG003|Overall Study|Physician Decision|0|||
170580317|NCT02482428|616466409|FG004|Overall Study|Physician Decision|1|||
170580318|NCT02482428|616466405|FG000|Overall Study|protocol deviation|1|||
170580319|NCT02482428|616466406|FG001|Overall Study|protocol deviation|1|||
170580320|NCT02482428|616466407|FG002|Overall Study|protocol deviation|0|||
170580321|NCT02482428|616466408|FG003|Overall Study|protocol deviation|0|||
170580322|NCT02482428|616466409|FG004|Overall Study|protocol deviation|0|||
170580323|NCT02482428|616466405|FG000|Overall Study|subject/guardian decision|4|||
170580324|NCT02482428|616466406|FG001|Overall Study|subject/guardian decision|2|||
170580325|NCT02482428|616466407|FG002|Overall Study|subject/guardian decision|0|||
170580326|NCT02482428|616466408|FG003|Overall Study|subject/guardian decision|0|||
170580327|NCT02482428|616466409|FG004|Overall Study|subject/guardian decision|2|||
170580328|NCT00809835|616466412|FG000|Overall Study|Lost to Follow-up|7|||
170580329|NCT00809835|616466413|FG001|Overall Study|Lost to Follow-up|6|||
170580330|NCT00809835|616466414|FG002|Overall Study|Lost to Follow-up|10|||
170580331|NCT00809835|616466415|FG003|Overall Study|Lost to Follow-up|2|||
170580332|NCT00809835|616466412|FG000|Overall Study|Withdrawal by Subject|1|||
170580333|NCT00809835|616466413|FG001|Overall Study|Withdrawal by Subject|1|||
170580334|NCT00809835|616466414|FG002|Overall Study|Withdrawal by Subject|1|||
170580335|NCT00809835|616466415|FG003|Overall Study|Withdrawal by Subject|0|||
170580336|NCT02547038|616466416|FG000|Overall Study|Lost to Follow-up|3|||
170580337|NCT02547038|616466417|FG001|Overall Study|Lost to Follow-up|2|||
170580338|NCT00516893|616466418|FG000|Overall Study|Lost to Follow-up|4|||
170580339|NCT00516893|616466418|FG000|Overall Study|Adverse Event|3|||
170580340|NCT00516893|616466418|FG000|Overall Study|Withdrawal by Subject|2|||
170580341|NCT00516893|616466418|FG000|Overall Study|Noncompliance|2|||
170580342|NCT00516893|616466418|FG000|Overall Study|Death|1|||
170580343|NCT00516893|616466418|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
170580344|NCT00516893|616466418|FG000|Overall Study|Relocated|1|||
170580345|NCT00516893|616466418|FG000|Overall Study|Pregnancy|1|||
170580346|NCT00516893|616466418|FG000|Overall Study|Received Medication From Another Study|1|||
170580347|NCT01681186|616466421|FG000|Washout Period From Second Intervention|Adverse Event|0|||
170580348|NCT01681186|616466422|FG001|Washout Period From Second Intervention|Adverse Event|0|||
170580349|NCT01681186|616466423|FG002|Washout Period From Second Intervention|Adverse Event|0|||
170580350|NCT01681186|616466424|FG003|Washout Period From Second Intervention|Adverse Event|0|||
170580351|NCT01681186|616466425|FG004|Washout Period From Second Intervention|Adverse Event|0|||
170580352|NCT01681186|616466426|FG005|Washout Period From Second Intervention|Adverse Event|0|||
170580353|NCT01681186|616466427|FG006|Washout Period From Second Intervention|Adverse Event|1|||
170580354|NCT01681186|616466428|FG007|Washout Period From Second Intervention|Adverse Event|0|||
170580355|NCT01681186|616466421|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
170580356|NCT01681186|616466422|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
170580357|NCT01681186|616466423|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
170580358|NCT01681186|616466424|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
170580359|NCT01681186|616466425|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
170580360|NCT01681186|616466426|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
170580361|NCT01681186|616466427|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
170580362|NCT01681186|616466428|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
170580363|NCT01681186|616466421|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
170580364|NCT01681186|616466422|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
170649713|NCT01915303|616730854|FG000|Core Phase|Withdrawal by Subject|1|||
170580365|NCT01681186|616466423|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
170580366|NCT01681186|616466424|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
170580367|NCT01681186|616466425|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
170580368|NCT01681186|616466426|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
170580369|NCT01681186|616466427|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
170580370|NCT01681186|616466428|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
170809472|NCT05289037|617312340|FG003|Overall Study|Lost to Follow-up|3|||
170809473|NCT05289037|617312341|FG004|Overall Study|Lost to Follow-up|3|||
170809474|NCT05289037|617312342|FG005|Overall Study|Lost to Follow-up|2|||
170809475|NCT05289037|617312343|FG006|Overall Study|Lost to Follow-up|3|||
170580371|NCT01681186|616466421|FG000|Fourth Intervention|Protocol Violation|0|||
170649714|NCT01915303|616730854|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
170580372|NCT01681186|616466422|FG001|Fourth Intervention|Protocol Violation|0|||
170580373|NCT01681186|616466423|FG002|Fourth Intervention|Protocol Violation|0|||
170649715|NCT01915303|616730854|FG000|Extension Phase|Withdrawal by Subject|4|||
170649716|NCT01915303|616730854|FG000|Extension Phase|Adverse Event|3|||
170649717|NCT01915303|616730854|FG000|Extension Phase|Death|1|||
170649718|NCT01915303|616730854|FG000|Extension Phase|Protocol Violation|1|||
170649719|NCT02509117|616730856|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649720|NCT02509117|616730857|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
170649721|NCT02509117|616730858|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649722|NCT02509117|616730859|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649723|NCT02509117|616730860|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649724|NCT02509117|616730861|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649725|NCT02509117|616730862|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649726|NCT02509117|616730863|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649727|NCT02509117|616730864|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649728|NCT02509117|616730865|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
170649729|NCT02509117|616730856|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170649730|NCT02509117|616730857|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170649731|NCT02509117|616730858|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170649732|NCT02509117|616730859|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170580374|NCT01681186|616466424|FG003|Fourth Intervention|Protocol Violation|0|||
170580375|NCT01681186|616466425|FG004|Fourth Intervention|Protocol Violation|0|||
170580376|NCT01681186|616466426|FG005|Fourth Intervention|Protocol Violation|0|||
170580377|NCT01681186|616466427|FG006|Fourth Intervention|Protocol Violation|0|||
170580378|NCT01681186|616466428|FG007|Fourth Intervention|Protocol Violation|1|||
170580379|NCT03530995|616466429|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
170580380|NCT03530995|616466430|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
170580381|NCT03530995|616466429|FG000|Part 1 Period 3|Protocol Violation|1|||
170580382|NCT03530995|616466430|FG001|Part 1 Period 3|Protocol Violation|0|||
170580383|NCT03530995|616466429|FG000|Part 1 Period 4|Physician Decision|1|||
170580384|NCT03530995|616466430|FG001|Part 1 Period 4|Physician Decision|0|||
170580385|NCT03530995|616466429|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
170580386|NCT03530995|616466430|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
170580387|NCT01443364|616466431|FG000|Overall Study|Lack of Efficacy|14|||
170580388|NCT01443364|616466431|FG000|Overall Study|Lost to Follow-up|3|||
170580389|NCT01443364|616466431|FG000|Overall Study|Withdrawal by Subject|5|||
170580390|NCT01443364|616466431|FG000|Overall Study|Other Reason|4|||
170580391|NCT01443364|616466431|FG000|Overall Study|SAE, non-fatal|6|||
170580392|NCT01443364|616466431|FG000|Overall Study|AE, non-serious non-fatal|8|||
170580393|NCT01443364|616466431|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
170580394|NCT03206970|616466435|FG000|Overall Study|Death|21|||
170580395|NCT03206970|616466435|FG000|Overall Study|Withdrawal by Subject|13|||
170580396|NCT03206970|616466435|FG000|Overall Study|Lost to Follow-up|3|||
170580397|NCT03206970|616466435|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
170580398|NCT02516982|616466436|FG000|Overall Study|Called in to antenatal appointment|32|||
170580399|NCT02516982|616466437|FG001|Overall Study|Called in to antenatal appointment|35|||
170580400|NCT02516982|616466438|FG002|Overall Study|Called in to antenatal appointment|0|||
170580401|NCT02516982|616466439|FG003|Overall Study|Called in to antenatal appointment|0|||
170580402|NCT02516982|616466436|FG000|Overall Study|Withdrawal by Subject|0|||
170580403|NCT02516982|616466437|FG001|Overall Study|Withdrawal by Subject|0|||
170580404|NCT02516982|616466438|FG002|Overall Study|Withdrawal by Subject|1|||
170580405|NCT02516982|616466439|FG003|Overall Study|Withdrawal by Subject|2|||
170580406|NCT02516982|616466436|FG000|Overall Study|Protocol Violation|0|||
170580407|NCT02516982|616466437|FG001|Overall Study|Protocol Violation|0|||
170580408|NCT02516982|616466438|FG002|Overall Study|Protocol Violation|1|||
170580409|NCT02516982|616466439|FG003|Overall Study|Protocol Violation|1|||
170580410|NCT02516982|616466436|FG000|Overall Study|Did not install the app|0|||
170580411|NCT02516982|616466437|FG001|Overall Study|Did not install the app|0|||
170580412|NCT02516982|616466438|FG002|Overall Study|Did not install the app|46|||
170580413|NCT02516982|616466439|FG003|Overall Study|Did not install the app|47|||
170580414|NCT01977729|616466440|FG000|Overall Study|Study terminated|1|||
170649733|NCT02509117|616730860|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170910615|NCT02786537|617677240|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
170910616|NCT02786537|617677241|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
170580415|NCT05332392|616466443|FG000|Overall Study|Did not meet inclusion criteria|25|||
170580416|NCT05332392|616466443|FG000|Overall Study|Principal Investigator's decision|17|||
170580417|NCT05332392|616466443|FG000|Overall Study|Adverse Event|1|||
170580418|NCT05332392|616466443|FG000|Overall Study|Subject's decision|1|||
170580419|NCT01268046|616466444|FG000|Overall Study|Withdrawal by Subject|1|||
170580420|NCT01268046|616466445|FG001|Overall Study|Withdrawal by Subject|0|||
170580421|NCT01268046|616466446|FG002|Overall Study|Withdrawal by Subject|0|||
170580422|NCT01268046|616466447|FG003|Overall Study|Withdrawal by Subject|1|||
170580423|NCT01268046|616466444|FG000|Overall Study|Lost to Follow-up|0|||
170580424|NCT01268046|616466445|FG001|Overall Study|Lost to Follow-up|0|||
170580425|NCT01268046|616466446|FG002|Overall Study|Lost to Follow-up|1|||
170580426|NCT01268046|616466447|FG003|Overall Study|Lost to Follow-up|0|||
170580427|NCT03850093|616466448|FG000|Overall Study|Withdrawal by Subject|1|||
170580428|NCT03850093|616466449|FG001|Overall Study|Withdrawal by Subject|0|||
170580429|NCT03850093|616466450|FG002|Overall Study|Withdrawal by Subject|2|||
170580430|NCT00224120|616466451|FG000|Overall Study|Adverse Event|10|||
170580431|NCT00224120|616466452|FG001|Overall Study|Adverse Event|4|||
170580432|NCT00224120|616466451|FG000|Overall Study|Protocol Violation|1|||
170580433|NCT00224120|616466452|FG001|Overall Study|Protocol Violation|0|||
170580434|NCT00224120|616466451|FG000|Overall Study|Withdrawal by Subject|5|||
170580435|NCT00224120|616466452|FG001|Overall Study|Withdrawal by Subject|10|||
170580436|NCT00224120|616466451|FG000|Overall Study|Lack of Efficacy|0|||
170580437|NCT00224120|616466452|FG001|Overall Study|Lack of Efficacy|2|||
170580438|NCT00224120|616466451|FG000|Overall Study|Lost to Follow-up|2|||
170580439|NCT00224120|616466452|FG001|Overall Study|Lost to Follow-up|3|||
170580440|NCT00224120|616466451|FG000|Overall Study|Other|4|||
170580441|NCT00224120|616466452|FG001|Overall Study|Other|5|||
170580442|NCT03226249|616466455|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
170580443|NCT03226249|616466455|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
170580444|NCT03226249|616466455|FG000|Survival Follow-up|Patients still in follow-up.|30|||
170580445|NCT05286658|616466458|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
170580446|NCT05286658|616466458|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
170580447|NCT02819297|616466459|FG000|Overall Study|Withdrawal by Subject|25|||
170580448|NCT02819297|616466460|FG001|Overall Study|Withdrawal by Subject|13|||
170580449|NCT02819297|616466459|FG000|Overall Study|Lost to Follow-up|12|||
170580450|NCT02819297|616466460|FG001|Overall Study|Lost to Follow-up|14|||
170580451|NCT02819297|616466459|FG000|Overall Study|Adverse Event|12|||
170580452|NCT02819297|616466460|FG001|Overall Study|Adverse Event|10|||
170580453|NCT02819297|616466459|FG000|Overall Study|Physician Decision|5|||
170580454|NCT02819297|616466460|FG001|Overall Study|Physician Decision|5|||
170580455|NCT02819297|616466459|FG000|Overall Study|Lack of Efficacy|5|||
170580456|NCT02819297|616466460|FG001|Overall Study|Lack of Efficacy|8|||
170580457|NCT02819297|616466459|FG000|Overall Study|Protocol Violation|1|||
170580458|NCT02819297|616466460|FG001|Overall Study|Protocol Violation|2|||
170580459|NCT01670279|616466461|FG000|Overall Study|Adverse Event|0|||
170580460|NCT01670279|616466462|FG001|Overall Study|Adverse Event|1|||
170580461|NCT01670279|616466463|FG002|Overall Study|Adverse Event|0|||
170580462|NCT01670279|616466464|FG003|Overall Study|Adverse Event|0|||
170580463|NCT01670279|616466461|FG000|Overall Study|Physician Decision|0|||
170580464|NCT01670279|616466462|FG001|Overall Study|Physician Decision|1|||
170580465|NCT01670279|616466463|FG002|Overall Study|Physician Decision|0|||
170580466|NCT01670279|616466464|FG003|Overall Study|Physician Decision|0|||
170580467|NCT01670279|616466461|FG000|Overall Study|Participant met withdrawal criteria|0|||
170580468|NCT01670279|616466462|FG001|Overall Study|Participant met withdrawal criteria|0|||
170580469|NCT01670279|616466463|FG002|Overall Study|Participant met withdrawal criteria|0|||
170580470|NCT01670279|616466464|FG003|Overall Study|Participant met withdrawal criteria|1|||
170580471|NCT03248167|616466469|FG000|Overall Study|Withdrawal by Subject|2|||
170580472|NCT03248167|616466470|FG001|Overall Study|Withdrawal by Subject|2|||
170580473|NCT03248167|616466469|FG000|Overall Study|Physician Decision|0|||
170580474|NCT03248167|616466470|FG001|Overall Study|Physician Decision|1|||
170580475|NCT03248167|616466469|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
170580476|NCT03248167|616466470|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
170580477|NCT03248167|616466469|FG000|Overall Study|Lost to Follow-up|1|||
170580478|NCT03248167|616466470|FG001|Overall Study|Lost to Follow-up|0|||
170910617|NCT02786537|617677242|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
170910618|NCT02786537|617677243|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
170910619|NCT02786537|617677244|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
170910620|NCT02786537|617677239|FG000|As Randomized|Subject lost insurance|0|||
170910621|NCT02786537|617677240|FG001|As Randomized|Subject lost insurance|0|||
170910622|NCT02786537|617677241|FG002|As Randomized|Subject lost insurance|0|||
170910623|NCT02786537|617677242|FG003|As Randomized|Subject lost insurance|1|||
170910624|NCT02786537|617677243|FG004|As Randomized|Subject lost insurance|0|||
170910625|NCT02786537|617677244|FG005|As Randomized|Subject lost insurance|0|||
170580479|NCT02122146|616466471|FG000|Part 1: Dose Escalation|Death|0|||
170580480|NCT02122146|616466472|FG001|Part 1: Dose Escalation|Death|1|||
170910626|NCT02786537|617677239|FG000|As Treated|Adverse Event|0|||
170580481|NCT02122146|616466473|FG002|Part 1: Dose Escalation|Death|1|||
170580482|NCT02122146|616466474|FG003|Part 1: Dose Escalation|Death|0|||
170580483|NCT02122146|616466475|FG004|Part 1: Dose Escalation|Death|0|||
170580484|NCT02122146|616466476|FG005|Part 1: Dose Escalation|Death|0|||
170580485|NCT02122146|616466477|FG006|Part 1: Dose Escalation|Death|0|||
170910627|NCT02786537|617677240|FG001|As Treated|Adverse Event|11|||
170580486|NCT02122146|616466478|FG007|Part 1: Dose Escalation|Death|0|||
170580487|NCT02122146|616466471|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
170580488|NCT02122146|616466472|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
170580489|NCT02122146|616466473|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
170580490|NCT02122146|616466474|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
170580491|NCT02122146|616466475|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
170580492|NCT02122146|616466476|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
170580493|NCT02122146|616466477|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
170580494|NCT02122146|616466478|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
170580495|NCT02122146|616466471|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170580496|NCT02122146|616466472|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170580497|NCT02122146|616466473|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170580498|NCT02122146|616466474|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
170580499|NCT02122146|616466475|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170580500|NCT02122146|616466476|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170580501|NCT02122146|616466477|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170580502|NCT02122146|616466478|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170580503|NCT02122146|616466471|FG000|Part 1: Dose Escalation|Other|1|||
170580504|NCT02122146|616466472|FG001|Part 1: Dose Escalation|Other|0|||
170580505|NCT02122146|616466473|FG002|Part 1: Dose Escalation|Other|0|||
170580506|NCT02122146|616466474|FG003|Part 1: Dose Escalation|Other|0|||
170580507|NCT02122146|616466475|FG004|Part 1: Dose Escalation|Other|0|||
170580508|NCT02122146|616466476|FG005|Part 1: Dose Escalation|Other|1|||
170580509|NCT02122146|616466477|FG006|Part 1: Dose Escalation|Other|1|||
170580510|NCT02122146|616466478|FG007|Part 1: Dose Escalation|Other|2|||
170580511|NCT01001767|616466481|FG000|Overall Study|no baseline study performed|1|||
170580512|NCT01001767|616466482|FG001|Overall Study|no baseline study performed|0|||
170580513|NCT01001767|616466481|FG000|Overall Study|Protocol Violation|1|||
170580514|NCT01001767|616466482|FG001|Overall Study|Protocol Violation|0|||
170580515|NCT01001767|616466481|FG000|Overall Study|Lost to Follow-up|1|||
170580516|NCT01001767|616466482|FG001|Overall Study|Lost to Follow-up|0|||
170580517|NCT01001767|616466481|FG000|Overall Study|Physician Decision|1|||
170580518|NCT01001767|616466482|FG001|Overall Study|Physician Decision|0|||
170580519|NCT02584452|616466483|FG000|Overall Study|Physician Decision|1|||
170580520|NCT02584452|616466484|FG001|Overall Study|Physician Decision|1|||
170580521|NCT02584452|616466483|FG000|Overall Study|Lost to Follow-up|1|||
170580522|NCT02584452|616466484|FG001|Overall Study|Lost to Follow-up|1|||
170580523|NCT00902850|616466485|FG000|Overall Study|Physician Decision|2|||
170580524|NCT00902850|616466486|FG001|Overall Study|Physician Decision|2|||
170580525|NCT00564902|616466487|FG000|Overall Study|Withdrawal by Subject|0|||
170580526|NCT00564902|616466488|FG001|Overall Study|Withdrawal by Subject|3|||
170580527|NCT00564902|616466489|FG002|Overall Study|Withdrawal by Subject|4|||
170580528|NCT00564902|616466487|FG000|Overall Study|Death|1|||
170580529|NCT00564902|616466488|FG001|Overall Study|Death|1|||
170580530|NCT00564902|616466489|FG002|Overall Study|Death|0|||
170580531|NCT00958347|616466490|FG000|Overall Study|Death|43|||
170580532|NCT00958347|616466490|FG000|Overall Study|Withdrawal by Subject|23|||
170580533|NCT00958347|616466490|FG000|Overall Study|Lost to Follow-up|15|||
170580534|NCT00958347|616466490|FG000|Overall Study|revision/removal|10|||
170580535|NCT00958347|616466490|FG000|Overall Study|study termination|135|||
170580536|NCT04552288|616466493|FG000|Overall Study|Death|3|||
170580537|NCT04552288|616466493|FG000|Overall Study|Lost to Follow-up|6|||
170580538|NCT04552288|616466493|FG000|Overall Study|Physician Decision|3|||
170580539|NCT04552288|616466493|FG000|Overall Study|Protocol Violation|9|||
170580540|NCT04552288|616466493|FG000|Overall Study|Withdrawal by Subject|6|||
170580541|NCT04552288|616466493|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
170580542|NCT01917929|616466494|FG000|Overall Study|Death|8|||
170580543|NCT01917929|616466494|FG000|Overall Study|Lost to Follow-up|19|||
170580544|NCT01917929|616466494|FG000|Overall Study|Withdrawal by Subject|33|||
170580545|NCT01917929|616466494|FG000|Overall Study|Adverse Event|6|||
170580546|NCT01917929|616466494|FG000|Overall Study|Investigative Site Terminated|35|||
170580547|NCT01917929|616466494|FG000|Overall Study|Censored because study device not implanted|6|||
170580548|NCT01917929|616466494|FG000|Overall Study|Censored because surgery not performed|3|||
170580549|NCT01917929|616466494|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
170580550|NCT01917929|616466494|FG000|Overall Study|Sponsor terminated study|175|||
170580551|NCT04532294|616466495|FG000|Overall Study|Withdrawal by Subject|0|||
170580552|NCT04532294|616466496|FG001|Overall Study|Withdrawal by Subject|0|||
170580553|NCT04532294|616466497|FG002|Overall Study|Withdrawal by Subject|1|||
170580554|NCT04532294|616466495|FG000|Overall Study|Participants Not Dosed|0|||
170580555|NCT04532294|616466496|FG001|Overall Study|Participants Not Dosed|0|||
170580556|NCT04532294|616466497|FG002|Overall Study|Participants Not Dosed|2|||
170580557|NCT03583359|616466498|FG000|Overall Study|Withdrawal by Subject|15|||
170580558|NCT03583359|616466499|FG001|Overall Study|Withdrawal by Subject|6|||
170580559|NCT03583359|616466498|FG000|Overall Study|Lost to Follow-up|12|||
170580560|NCT03583359|616466499|FG001|Overall Study|Lost to Follow-up|3|||
170580561|NCT03583359|616466498|FG000|Overall Study|Adverse Event|0|||
170580562|NCT03583359|616466499|FG001|Overall Study|Adverse Event|1|||
170580563|NCT03583359|616466498|FG000|Overall Study|Protocol Violation|0|||
170580564|NCT03583359|616466499|FG001|Overall Study|Protocol Violation|1|||
170580565|NCT03583359|616466498|FG000|Overall Study|Other|2|||
170580566|NCT03583359|616466499|FG001|Overall Study|Other|1|||
170580567|NCT01831466|616466502|FG000|Overall Study|Protocol Violation|1|||
170580568|NCT01831466|616466503|FG001|Overall Study|Protocol Violation|1|||
170580569|NCT01831466|616466504|FG002|Overall Study|Protocol Violation|2|||
170580570|NCT01831466|616466505|FG003|Overall Study|Protocol Violation|0|||
170580571|NCT01831466|616466506|FG004|Overall Study|Protocol Violation|0|||
170580572|NCT01831466|616466507|FG005|Overall Study|Protocol Violation|1|||
170580573|NCT01831466|616466508|FG006|Overall Study|Protocol Violation|0|||
170580574|NCT01831466|616466509|FG007|Overall Study|Protocol Violation|0|||
170580575|NCT01831466|616466510|FG008|Overall Study|Protocol Violation|0|||
170580576|NCT01831466|616466511|FG009|Overall Study|Protocol Violation|0|||
170580577|NCT01831466|616466512|FG010|Overall Study|Protocol Violation|0|||
170580578|NCT01831466|616466513|FG011|Overall Study|Protocol Violation|0|||
170580579|NCT01831466|616466502|FG000|Overall Study|Other|2|||
170580580|NCT01831466|616466503|FG001|Overall Study|Other|3|||
170580581|NCT01831466|616466504|FG002|Overall Study|Other|2|||
170580582|NCT01831466|616466505|FG003|Overall Study|Other|2|||
170580583|NCT01831466|616466506|FG004|Overall Study|Other|2|||
170580584|NCT01831466|616466507|FG005|Overall Study|Other|1|||
170580585|NCT01831466|616466508|FG006|Overall Study|Other|0|||
170580586|NCT01831466|616466509|FG007|Overall Study|Other|0|||
170580587|NCT01831466|616466510|FG008|Overall Study|Other|0|||
170580588|NCT01831466|616466511|FG009|Overall Study|Other|0|||
170580589|NCT01831466|616466512|FG010|Overall Study|Other|0|||
170580590|NCT01831466|616466513|FG011|Overall Study|Other|0|||
170580591|NCT01831466|616466502|FG000|Overall Study|Non-compliance with study treatment|2|||
170580592|NCT01831466|616466503|FG001|Overall Study|Non-compliance with study treatment|1|||
170580593|NCT01831466|616466504|FG002|Overall Study|Non-compliance with study treatment|1|||
170580594|NCT01831466|616466505|FG003|Overall Study|Non-compliance with study treatment|0|||
170580595|NCT01831466|616466506|FG004|Overall Study|Non-compliance with study treatment|0|||
170580596|NCT01831466|616466507|FG005|Overall Study|Non-compliance with study treatment|1|||
170580597|NCT01831466|616466508|FG006|Overall Study|Non-compliance with study treatment|0|||
170580598|NCT01831466|616466509|FG007|Overall Study|Non-compliance with study treatment|0|||
170580599|NCT01831466|616466510|FG008|Overall Study|Non-compliance with study treatment|0|||
170580600|NCT01831466|616466511|FG009|Overall Study|Non-compliance with study treatment|0|||
170580601|NCT01831466|616466512|FG010|Overall Study|Non-compliance with study treatment|0|||
170580602|NCT01831466|616466513|FG011|Overall Study|Non-compliance with study treatment|0|||
170580603|NCT01831466|616466502|FG000|Overall Study|Death|0|||
170580604|NCT01831466|616466503|FG001|Overall Study|Death|1|||
170580605|NCT01831466|616466504|FG002|Overall Study|Death|0|||
170580606|NCT01831466|616466505|FG003|Overall Study|Death|0|||
170580607|NCT01831466|616466506|FG004|Overall Study|Death|0|||
170580608|NCT01831466|616466507|FG005|Overall Study|Death|0|||
170580609|NCT01831466|616466508|FG006|Overall Study|Death|0|||
170580610|NCT01831466|616466509|FG007|Overall Study|Death|0|||
170580611|NCT01831466|616466510|FG008|Overall Study|Death|0|||
170580612|NCT01831466|616466511|FG009|Overall Study|Death|0|||
170580613|NCT01831466|616466512|FG010|Overall Study|Death|0|||
170580614|NCT01831466|616466513|FG011|Overall Study|Death|0|||
170910628|NCT02786537|617677241|FG002|As Treated|Adverse Event|0|||
170910629|NCT02786537|617677242|FG003|As Treated|Adverse Event|4|||
170910630|NCT02786537|617677243|FG004|As Treated|Adverse Event|6|||
170910631|NCT02786537|617677244|FG005|As Treated|Adverse Event|2|||
170910632|NCT02786537|617677239|FG000|As Treated|Death|0|||
170580615|NCT01831466|616466502|FG000|Overall Study|Withdrawal by Subject|6|||
170580616|NCT01831466|616466503|FG001|Overall Study|Withdrawal by Subject|3|||
170580617|NCT01831466|616466504|FG002|Overall Study|Withdrawal by Subject|3|||
170580618|NCT01831466|616466505|FG003|Overall Study|Withdrawal by Subject|3|||
170580619|NCT01831466|616466506|FG004|Overall Study|Withdrawal by Subject|3|||
170580620|NCT01831466|616466507|FG005|Overall Study|Withdrawal by Subject|5|||
170910633|NCT02786537|617677240|FG001|As Treated|Death|2|||
170910634|NCT02786537|617677241|FG002|As Treated|Death|0|||
170580621|NCT01831466|616466508|FG006|Overall Study|Withdrawal by Subject|0|||
170580622|NCT01831466|616466509|FG007|Overall Study|Withdrawal by Subject|0|||
170580623|NCT01831466|616466510|FG008|Overall Study|Withdrawal by Subject|0|||
170580624|NCT01831466|616466511|FG009|Overall Study|Withdrawal by Subject|1|||
170580625|NCT01831466|616466512|FG010|Overall Study|Withdrawal by Subject|0|||
170580626|NCT01831466|616466513|FG011|Overall Study|Withdrawal by Subject|1|||
170580627|NCT01831466|616466502|FG000|Overall Study|Lost to Follow-up|0|||
170580628|NCT01831466|616466503|FG001|Overall Study|Lost to Follow-up|1|||
170580629|NCT01831466|616466504|FG002|Overall Study|Lost to Follow-up|4|||
170580630|NCT01831466|616466505|FG003|Overall Study|Lost to Follow-up|2|||
170910635|NCT02786537|617677242|FG003|As Treated|Death|3|||
170910636|NCT02786537|617677243|FG004|As Treated|Death|1|||
170910637|NCT02786537|617677244|FG005|As Treated|Death|0|||
170580631|NCT01831466|616466506|FG004|Overall Study|Lost to Follow-up|0|||
170580632|NCT01831466|616466507|FG005|Overall Study|Lost to Follow-up|3|||
170580633|NCT01831466|616466508|FG006|Overall Study|Lost to Follow-up|0|||
170580634|NCT01831466|616466509|FG007|Overall Study|Lost to Follow-up|0|||
170910638|NCT02786537|617677239|FG000|As Treated|Lack of Efficacy|0|||
170910639|NCT02786537|617677240|FG001|As Treated|Lack of Efficacy|0|||
170580635|NCT01831466|616466510|FG008|Overall Study|Lost to Follow-up|0|||
170580636|NCT01831466|616466511|FG009|Overall Study|Lost to Follow-up|1|||
170580637|NCT01831466|616466512|FG010|Overall Study|Lost to Follow-up|0|||
170580638|NCT01831466|616466513|FG011|Overall Study|Lost to Follow-up|1|||
170580639|NCT01831466|616466502|FG000|Overall Study|Lack of Efficacy|5|||
170580640|NCT01831466|616466503|FG001|Overall Study|Lack of Efficacy|8|||
170580641|NCT01831466|616466504|FG002|Overall Study|Lack of Efficacy|7|||
170580642|NCT01831466|616466505|FG003|Overall Study|Lack of Efficacy|6|||
170580643|NCT01831466|616466506|FG004|Overall Study|Lack of Efficacy|9|||
170580644|NCT01831466|616466507|FG005|Overall Study|Lack of Efficacy|8|||
170580645|NCT01831466|616466508|FG006|Overall Study|Lack of Efficacy|1|||
170580646|NCT01831466|616466509|FG007|Overall Study|Lack of Efficacy|1|||
170580647|NCT01831466|616466510|FG008|Overall Study|Lack of Efficacy|2|||
170580648|NCT01831466|616466511|FG009|Overall Study|Lack of Efficacy|2|||
170580649|NCT01831466|616466512|FG010|Overall Study|Lack of Efficacy|2|||
170580650|NCT01831466|616466513|FG011|Overall Study|Lack of Efficacy|0|||
170580651|NCT01831466|616466502|FG000|Overall Study|Adverse Event|0|||
170580652|NCT01831466|616466503|FG001|Overall Study|Adverse Event|0|||
170580653|NCT01831466|616466504|FG002|Overall Study|Adverse Event|4|||
170580654|NCT01831466|616466505|FG003|Overall Study|Adverse Event|6|||
170580655|NCT01831466|616466506|FG004|Overall Study|Adverse Event|3|||
170580656|NCT01831466|616466507|FG005|Overall Study|Adverse Event|7|||
170580657|NCT01831466|616466508|FG006|Overall Study|Adverse Event|0|||
170580658|NCT01831466|616466509|FG007|Overall Study|Adverse Event|1|||
170580659|NCT01831466|616466510|FG008|Overall Study|Adverse Event|1|||
170580660|NCT01831466|616466511|FG009|Overall Study|Adverse Event|1|||
170580661|NCT01831466|616466512|FG010|Overall Study|Adverse Event|0|||
170580662|NCT01831466|616466513|FG011|Overall Study|Adverse Event|2|||
170580663|NCT02798315|616466514|FG000|Overall Study|Failure to return|1|||
170580664|NCT00005947|616466515|FG000|Overall Study|Death|54|||
170580665|NCT00005947|616466516|FG001|Overall Study|Death|40|||
170580666|NCT00005947|616466515|FG000|Overall Study|Patient Refused to Continue|2|||
170580667|NCT00005947|616466516|FG001|Overall Study|Patient Refused to Continue|1|||
170580668|NCT00005947|616466515|FG000|Overall Study|Site Closure|1|||
170580669|NCT00005947|616466516|FG001|Overall Study|Site Closure|0|||
170580670|NCT02146131|616466517|FG000|Overall Study|Physician Decision|61|||
170580671|NCT02146131|616466518|FG001|Overall Study|Physician Decision|56|||
170580672|NCT00465972|616466521|FG000|Overall Study|Withdrawal by Subject|2|||
170580673|NCT00465972|616466522|FG001|Overall Study|Withdrawal by Subject|1|||
170580674|NCT04380753|616466528|FG000|Overall Study|Participants continuing study|4|||
170580675|NCT04380753|616466528|FG000|Overall Study|Death|2|||
170580676|NCT00130039|616466529|FG000|Overall Study|Withdrawal by Subject|15|||
170580677|NCT00130039|616466530|FG001|Overall Study|Withdrawal by Subject|11|||
170580678|NCT00130039|616466529|FG000|Overall Study|Lost to Follow-up|3|||
170580679|NCT00130039|616466530|FG001|Overall Study|Lost to Follow-up|1|||
170580680|NCT00130039|616466529|FG000|Overall Study|Adverse Event|4|||
170580681|NCT00130039|616466530|FG001|Overall Study|Adverse Event|2|||
170580682|NCT00130039|616466529|FG000|Overall Study|Physician Decision|3|||
170580683|NCT00130039|616466530|FG001|Overall Study|Physician Decision|0|||
170580684|NCT00130039|616466529|FG000|Overall Study|clinical events without follow up MRI|5|||
170580685|NCT00130039|616466530|FG001|Overall Study|clinical events without follow up MRI|4|||
170580686|NCT04776720|616466552|FG000|Overall Study|COVID Related|4|||
170580687|NCT04776720|616466553|FG001|Overall Study|COVID Related|2|||
170580688|NCT04776720|616466552|FG000|Overall Study|Adverse Event|2|||
170580689|NCT04776720|616466553|FG001|Overall Study|Adverse Event|0|||
170580690|NCT04776720|616466552|FG000|Overall Study|Serious Adverse Event|0|||
170580691|NCT04776720|616466553|FG001|Overall Study|Serious Adverse Event|1|||
170580692|NCT04776720|616466552|FG000|Overall Study|Too Busy|3|||
170580693|NCT04776720|616466553|FG001|Overall Study|Too Busy|1|||
170580694|NCT04776720|616466552|FG000|Overall Study|Lost to Follow-up|1|||
170580695|NCT04776720|616466553|FG001|Overall Study|Lost to Follow-up|2|||
170580696|NCT04776720|616466552|FG000|Overall Study|Family|2|||
170580697|NCT04776720|616466553|FG001|Overall Study|Family|2|||
170580698|NCT04776720|616466552|FG000|Overall Study|No remote technology access|0|||
170580699|NCT04776720|616466553|FG001|Overall Study|No remote technology access|1|||
170580700|NCT04776720|616466552|FG000|Overall Study|Withdrawal by Subject|1|||
170580701|NCT04776720|616466553|FG001|Overall Study|Withdrawal by Subject|0|||
170580702|NCT04776720|616466552|FG000|Overall Study|Cannot tolerate intervention|1|||
170580703|NCT04776720|616466553|FG001|Overall Study|Cannot tolerate intervention|0|||
170580704|NCT04776720|616466552|FG000|Overall Study|Incomplete outcome data|6|||
170580705|NCT04776720|616466553|FG001|Overall Study|Incomplete outcome data|1|||
170580706|NCT01740687|616466556|FG000|Overall Study|Lost to Follow-up|11|||
170910640|NCT02786537|617677241|FG002|As Treated|Lack of Efficacy|0|||
170580707|NCT01740687|616466556|FG000|Overall Study|Withdrawal by Subject|2|||
170580708|NCT01740687|616466556|FG000|Overall Study|other reason|22|||
170580709|NCT01740687|616466556|FG000|Overall Study|treatment not received|2|||
170580710|NCT01016132|616466561|FG000|Overall Study|Discomfort|1|||
170580711|NCT03306433|616466564|FG000|Overall Study|Lost to Follow-up|3|||
170580712|NCT03306433|616466564|FG000|Overall Study|Patient did not have teeth extracted|1|||
170580713|NCT03306433|616466564|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
170580714|NCT00803595|616466565|FG000|Overall Study|Adverse Event|3|||
170580715|NCT00803595|616466566|FG001|Overall Study|Adverse Event|4|||
170580716|NCT00803595|616466567|FG002|Overall Study|Adverse Event|1|||
170580717|NCT00803595|616466565|FG000|Overall Study|Protocol Violation|7|||
170580718|NCT00803595|616466566|FG001|Overall Study|Protocol Violation|2|||
170580719|NCT00803595|616466567|FG002|Overall Study|Protocol Violation|12|||
170580720|NCT00803595|616466565|FG000|Overall Study|Withdrawal by Subject|5|||
170580721|NCT00803595|616466566|FG001|Overall Study|Withdrawal by Subject|2|||
170580722|NCT00803595|616466567|FG002|Overall Study|Withdrawal by Subject|3|||
170580723|NCT00984594|616466568|FG000|Overall Study|Lost to Follow-up|1|||
170580724|NCT00984594|616466569|FG001|Overall Study|Lost to Follow-up|0|||
170580725|NCT00984594|616466568|FG000|Overall Study|Withdrawal by Subject|0|||
170580726|NCT00984594|616466569|FG001|Overall Study|Withdrawal by Subject|1|||
170580727|NCT00556439|616466570|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
170580728|NCT00556439|616466571|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
170580729|NCT00556439|616466572|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
170580730|NCT00556439|616466573|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
170580731|NCT00556439|616466570|FG000|Study Entry to Week 12|Physician Decision|1|||
170580732|NCT00556439|616466571|FG001|Study Entry to Week 12|Physician Decision|0|||
170580733|NCT00556439|616466572|FG002|Study Entry to Week 12|Physician Decision|0|||
170580734|NCT00556439|616466573|FG003|Study Entry to Week 12|Physician Decision|0|||
170580735|NCT00556439|616466570|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
170580736|NCT00556439|616466571|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
170580737|NCT00556439|616466572|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
170580738|NCT00556439|616466573|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
170580739|NCT00556439|616466570|FG000|Study Entry to Week 12|Recurrent infection|1|||
170580740|NCT00556439|616466571|FG001|Study Entry to Week 12|Recurrent infection|0|||
170580741|NCT00556439|616466572|FG002|Study Entry to Week 12|Recurrent infection|0|||
170580742|NCT00556439|616466573|FG003|Study Entry to Week 12|Recurrent infection|0|||
170580743|NCT00556439|616466570|FG000|Study Entry to Week 12|Malignancy|0|||
170580744|NCT00556439|616466571|FG001|Study Entry to Week 12|Malignancy|0|||
170580745|NCT00556439|616466572|FG002|Study Entry to Week 12|Malignancy|1|||
170580746|NCT00556439|616466573|FG003|Study Entry to Week 12|Malignancy|0|||
170580747|NCT00556439|616466570|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
170580748|NCT00556439|616466571|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
170580749|NCT00556439|616466572|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
170580750|NCT00556439|616466573|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
170580751|NCT00556439|616466570|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
170580752|NCT00556439|616466571|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
170580753|NCT00556439|616466572|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
170580754|NCT00556439|616466573|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
170580755|NCT00556439|616466570|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
170580756|NCT00556439|616466571|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
170580757|NCT00556439|616466572|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
170580758|NCT00556439|616466573|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
170580759|NCT00556439|616466570|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
170580760|NCT00556439|616466571|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
170580761|NCT00556439|616466572|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
170580762|NCT00556439|616466573|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
170580763|NCT00281099|616466576|FG000|Overall Study|Death|46|||
170580764|NCT00281099|616466577|FG001|Overall Study|Death|57|||
170580765|NCT00281099|616466576|FG000|Overall Study|Lost to Follow-up|10|||
170809476|NCT05289037|617312344|FG007|Overall Study|Lost to Follow-up|2|||
170809477|NCT05289037|617312345|FG008|Overall Study|Lost to Follow-up|2|||
170580766|NCT00281099|616466577|FG001|Overall Study|Lost to Follow-up|19|||
170580767|NCT00281099|616466576|FG000|Overall Study|Withdrawal by Subject|65|||
170580768|NCT00281099|616466577|FG001|Overall Study|Withdrawal by Subject|70|||
170580769|NCT00281099|616466576|FG000|Overall Study|Physician Decision|79|||
170580770|NCT00281099|616466577|FG001|Overall Study|Physician Decision|72|||
170809478|NCT05289037|617312346|FG009|Overall Study|Lost to Follow-up|1|||
170809479|NCT05289037|617312347|FG010|Overall Study|Lost to Follow-up|3|||
170809480|NCT05289037|617312348|FG011|Overall Study|Lost to Follow-up|4|||
170809481|NCT05289037|617312349|FG012|Overall Study|Lost to Follow-up|2|||
170809482|NCT05289037|617312350|FG013|Overall Study|Lost to Follow-up|7|||
170580771|NCT00281099|616466576|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
170580772|NCT00281099|616466577|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
170580773|NCT04308239|616467987|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
170580774|NCT04308239|616467988|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
170580775|NCT04308239|616467987|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
170809483|NCT05289037|617312351|FG014|Overall Study|Lost to Follow-up|4|||
170809484|NCT05289037|617312352|FG015|Overall Study|Lost to Follow-up|6|||
170580776|NCT04308239|616467988|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
170580777|NCT04308239|616467987|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
170580778|NCT04308239|616467988|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
170580779|NCT04308239|616467987|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
170580780|NCT04308239|616467988|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
170580781|NCT02199314|616467989|FG000|Overall Study|Withdrawal by Subject|6|||
170580782|NCT02199314|616467989|FG000|Overall Study|Physician Decision|10|||
170580783|NCT01986231|616467992|FG000|Overall Study|Adverse Event|1|||
170580784|NCT00623233|616467995|FG000|Overall Study|Adverse Event|10|||
170580785|NCT00623233|616467995|FG000|Overall Study|Physician Decision|10|||
170580786|NCT00623233|616467995|FG000|Overall Study|Lost to Follow-up|1|||
170580787|NCT00623233|616467995|FG000|Overall Study|Withdrawal by Subject|3|||
170580788|NCT00559845|616467996|FG000|Overall Study|Withdrew Consent|1|||
170580789|NCT00559845|616467996|FG000|Overall Study|Disease Progression|1|||
170580790|NCT00559845|616467996|FG000|Overall Study|Adverse Event|3|||
170580791|NCT00559845|616467996|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
170580792|NCT00559845|616467996|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
170580793|NCT00880269|616467997|FG000|Overall Study|Protocol Violation|1|||
170580794|NCT00880269|616467998|FG001|Overall Study|Protocol Violation|0|||
170580795|NCT00880269|616467997|FG000|Overall Study|Disease Progression|13|||
170580796|NCT00880269|616467998|FG001|Overall Study|Disease Progression|11|||
170580797|NCT00880269|616467997|FG000|Overall Study|New Cancer Therapy|1|||
170580798|NCT00880269|616467998|FG001|Overall Study|New Cancer Therapy|0|||
170580799|NCT00880269|616467997|FG000|Overall Study|Death|4|||
170580800|NCT00880269|616467998|FG001|Overall Study|Death|2|||
170580801|NCT00880269|616467997|FG000|Overall Study|Lost to Follow-up|0|||
170580802|NCT00880269|616467998|FG001|Overall Study|Lost to Follow-up|1|||
170580803|NCT00880269|616467997|FG000|Overall Study|Withdrawal by Subject|3|||
170580804|NCT00880269|616467998|FG001|Overall Study|Withdrawal by Subject|4|||
170580805|NCT00880269|616467997|FG000|Overall Study|Adverse Event|10|||
170580806|NCT00880269|616467998|FG001|Overall Study|Adverse Event|9|||
170580807|NCT03636893|616467999|FG000|Overall Study|Death|0|||
170580808|NCT03636893|616468000|FG001|Overall Study|Death|1|||
170580809|NCT03636893|616467999|FG000|Overall Study|Protocol Violation|0|||
170580810|NCT03636893|616468000|FG001|Overall Study|Protocol Violation|3|||
170580811|NCT03636893|616467999|FG000|Overall Study|Withdrawal by Subject|1|||
170580812|NCT03636893|616468000|FG001|Overall Study|Withdrawal by Subject|2|||
170580813|NCT03636893|616467999|FG000|Overall Study|Refusal to surgery|4|||
170580814|NCT03636893|616468000|FG001|Overall Study|Refusal to surgery|3|||
170580815|NCT03636893|616467999|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
170580816|NCT03636893|616468000|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
170580817|NCT03636893|616467999|FG000|Overall Study|Adverse Event|1|||
170580818|NCT03636893|616468000|FG001|Overall Study|Adverse Event|1|||
170580819|NCT02846389|616468001|FG000|Overall Study|Withdrawal by Subject|1|||
170580820|NCT02846389|616468002|FG001|Overall Study|Withdrawal by Subject|1|||
170580821|NCT03818607|616468004|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
170580822|NCT03818607|616468005|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
170580823|NCT03818607|616468004|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
170580824|NCT03818607|616468005|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
170580825|NCT03818607|616468004|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
170580826|NCT03818607|616468005|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
170580827|NCT01147250|616468006|FG000|Overall Study|Lost to Follow-up|14|||
170580828|NCT01147250|616468007|FG001|Overall Study|Lost to Follow-up|11|||
170580829|NCT01147250|616468006|FG000|Overall Study|Withdrawal by Subject|83|||
170580830|NCT01147250|616468007|FG001|Overall Study|Withdrawal by Subject|88|||
170580831|NCT01147250|616468006|FG000|Overall Study|Site termination by sponsor|13|||
170580832|NCT01147250|616468007|FG001|Overall Study|Site termination by sponsor|5|||
170580833|NCT01147250|616468006|FG000|Overall Study|Other than specified|0|||
170580834|NCT01147250|616468007|FG001|Overall Study|Other than specified|1|||
170580835|NCT01345929|616468011|FG000|Overall Study|Withdrawal by Subject|9|||
170580836|NCT01345929|616468012|FG001|Overall Study|Withdrawal by Subject|8|||
170580837|NCT01345929|616468011|FG000|Overall Study|Lost to Follow-up|9|||
170580838|NCT01345929|616468012|FG001|Overall Study|Lost to Follow-up|9|||
170580839|NCT01345929|616468011|FG000|Overall Study|Adverse Event|0|||
170580840|NCT01345929|616468012|FG001|Overall Study|Adverse Event|1|||
170580841|NCT01345929|616468011|FG000|Overall Study|Didn't meet eligibility criteria|2|||
170580842|NCT01345929|616468012|FG001|Overall Study|Didn't meet eligibility criteria|0|||
170580843|NCT01345929|616468011|FG000|Overall Study|40,000 CFU/ML|1|||
170580844|NCT01345929|616468012|FG001|Overall Study|40,000 CFU/ML|0|||
170580845|NCT01345929|616468011|FG000|Overall Study|Patient withdrawal|0|||
170580846|NCT01345929|616468012|FG001|Overall Study|Patient withdrawal|1|||
170580847|NCT02318368|616468013|FG000|Overall Study|Withdrawal by Subject|2|||
170580848|NCT02318368|616468014|FG001|Overall Study|Withdrawal by Subject|0|||
170580849|NCT02318368|616468013|FG000|Overall Study|Study terminated by the sponsor|5|||
170580850|NCT02318368|616468014|FG001|Overall Study|Study terminated by the sponsor|2|||
170649734|NCT02509117|616730861|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170649735|NCT02509117|616730862|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170649736|NCT02509117|616730863|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170649737|NCT02509117|616730864|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
170649738|NCT02509117|616730865|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
170649739|NCT02509117|616730856|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170649740|NCT02509117|616730857|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170649741|NCT02509117|616730858|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170580851|NCT02318368|616468013|FG000|Overall Study|Death|0|||
170580852|NCT02318368|616468014|FG001|Overall Study|Death|1|||
170580853|NCT01901614|616468015|FG000|Overall Study|Adverse Event|0|||
170580854|NCT01901614|616468016|FG001|Overall Study|Adverse Event|1|||
170580855|NCT01901614|616468015|FG000|Overall Study|Lost to Follow-up|1|||
170580856|NCT01901614|616468016|FG001|Overall Study|Lost to Follow-up|0|||
170580857|NCT01901614|616468015|FG000|Overall Study|Screen Fail|1|||
170580858|NCT01901614|616468016|FG001|Overall Study|Screen Fail|0|||
170580859|NCT03629223|616468017|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
170580860|NCT03629223|616468018|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
170580861|NCT03629223|616468019|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
170580862|NCT03629223|616468020|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
170580863|NCT03629223|616468021|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
170580864|NCT03629223|616468022|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
170580865|NCT03629223|616468017|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
170580866|NCT03629223|616468018|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
170580867|NCT03629223|616468019|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
170580868|NCT03629223|616468020|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
170580869|NCT03629223|616468021|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
170580870|NCT03629223|616468022|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
170580871|NCT03629223|616468017|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
170580872|NCT03629223|616468018|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
170580873|NCT03629223|616468019|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
170580874|NCT03629223|616468020|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
170580875|NCT03629223|616468021|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
170580876|NCT03629223|616468022|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
170580877|NCT03629223|616468017|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
170580878|NCT03629223|616468018|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
170580879|NCT03629223|616468019|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
170580880|NCT03629223|616468020|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
170580881|NCT03629223|616468021|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
170580882|NCT03629223|616468022|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
170580883|NCT03629223|616468017|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
170580884|NCT03629223|616468018|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
170580885|NCT03629223|616468019|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
170580886|NCT03629223|616468020|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
170580887|NCT03629223|616468021|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
170580888|NCT03629223|616468022|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
170580889|NCT01534351|616468023|FG000|Overall Study|Study Terminated Early|1|||
170580890|NCT01534351|616468024|FG001|Overall Study|Study Terminated Early|0|||
170580891|NCT01534351|616468025|FG002|Overall Study|Study Terminated Early|0|||
170580892|NCT02702609|616468026|FG000|Overall Study|Lost to Follow-up|8|||
170580893|NCT02702609|616468027|FG001|Overall Study|Lost to Follow-up|4|||
170580894|NCT02702609|616468026|FG000|Overall Study|Physician Decision|1|||
170580895|NCT02702609|616468027|FG001|Overall Study|Physician Decision|0|||
170580896|NCT02674464|616468028|FG000|Overall Study|Death|10|||
170580897|NCT02674464|616468029|FG001|Overall Study|Death|21|||
170580898|NCT02674464|616468028|FG000|Overall Study|Withdrawal by Subject|24|||
170580899|NCT02674464|616468029|FG001|Overall Study|Withdrawal by Subject|44|||
170580900|NCT02674464|616468028|FG000|Overall Study|Lost to Follow-up|97|||
170580901|NCT02674464|616468029|FG001|Overall Study|Lost to Follow-up|92|||
170649742|NCT02509117|616730859|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170649743|NCT02509117|616730860|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170649744|NCT02509117|616730861|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170649745|NCT02509117|616730862|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170649746|NCT02509117|616730863|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170649747|NCT02509117|616730864|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
170580902|NCT02674464|616468028|FG000|Overall Study|Outside survey window|6|||
170580903|NCT02674464|616468029|FG001|Overall Study|Outside survey window|3|||
170580904|NCT04153981|616468030|FG000|Overall Study|Death|1|||
170580905|NCT04153981|616468030|FG000|Overall Study|Withdrawal by Subject|24|||
170580906|NCT04153981|616468030|FG000|Overall Study|Lost to Follow-up|1|||
170580907|NCT04153981|616468030|FG000|Overall Study|Physician Decision|1|||
170580908|NCT04153981|616468030|FG000|Overall Study|Due to Unavailable Glucometer|1|||
170580909|NCT04153981|616468030|FG000|Overall Study|Covid 19|52|||
170580910|NCT04153981|616468030|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
170580911|NCT04153981|616468030|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
170580912|NCT01555073|616468031|FG000|Overall Study|Lost to Follow-up|1|||
170580913|NCT01555073|616468032|FG001|Overall Study|Lost to Follow-up|2|||
170580914|NCT01555073|616468033|FG002|Overall Study|Lost to Follow-up|0|||
170580915|NCT01555073|616468034|FG003|Overall Study|Lost to Follow-up|5|||
170580916|NCT01262638|616468035|FG000|Overall Study|Adverse Event|3|||
170580917|NCT01262638|616468036|FG001|Overall Study|Adverse Event|4|||
170580918|NCT01262638|616468037|FG002|Overall Study|Adverse Event|3|||
170580919|NCT01262638|616468038|FG003|Overall Study|Adverse Event|4|||
170580920|NCT01262638|616468035|FG000|Overall Study|Protocol Violation|1|||
170580921|NCT01262638|616468036|FG001|Overall Study|Protocol Violation|0|||
170580922|NCT01262638|616468037|FG002|Overall Study|Protocol Violation|0|||
170580923|NCT01262638|616468038|FG003|Overall Study|Protocol Violation|1|||
170580924|NCT01262638|616468035|FG000|Overall Study|Withdrawal by Subject|2|||
170580925|NCT01262638|616468036|FG001|Overall Study|Withdrawal by Subject|1|||
170580926|NCT01262638|616468037|FG002|Overall Study|Withdrawal by Subject|0|||
170580927|NCT01262638|616468038|FG003|Overall Study|Withdrawal by Subject|1|||
170580928|NCT01262638|616468035|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
170580929|NCT01262638|616468036|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
170580930|NCT01262638|616468037|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
170580931|NCT01262638|616468038|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
170580932|NCT01262638|616468035|FG000|Overall Study|Lost to Follow-up|1|||
170580933|NCT01262638|616468036|FG001|Overall Study|Lost to Follow-up|1|||
170580934|NCT01262638|616468037|FG002|Overall Study|Lost to Follow-up|1|||
170580935|NCT01262638|616468038|FG003|Overall Study|Lost to Follow-up|1|||
170580936|NCT01262638|616468035|FG000|Overall Study|Participant Went Out of Town|0|||
170580937|NCT01262638|616468036|FG001|Overall Study|Participant Went Out of Town|0|||
170580938|NCT01262638|616468037|FG002|Overall Study|Participant Went Out of Town|1|||
170580939|NCT01262638|616468038|FG003|Overall Study|Participant Went Out of Town|0|||
170580940|NCT01369199|616468039|FG000|Overall Study|Withdrawal by Subject|1|||
170580941|NCT01369199|616468039|FG000|Overall Study|Lost to Follow-up|2|||
170580942|NCT01355679|616468041|FG000|Overall Study|benign tumor types found at biopsy|2|||
170580943|NCT01071252|616468042|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
170580944|NCT01071252|616468043|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
170580945|NCT01071252|616468044|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
170580946|NCT01071252|616468045|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
170580947|NCT01071252|616468046|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
170580948|NCT01071252|616468042|FG000|Overall Study|Withdrawal by Subject|8|||
170580949|NCT01071252|616468043|FG001|Overall Study|Withdrawal by Subject|2|||
170580950|NCT01071252|616468044|FG002|Overall Study|Withdrawal by Subject|1|||
170580951|NCT01071252|616468045|FG003|Overall Study|Withdrawal by Subject|2|||
170580952|NCT01071252|616468046|FG004|Overall Study|Withdrawal by Subject|3|||
170580953|NCT01071252|616468042|FG000|Overall Study|administrative problems|1|||
170910641|NCT02786537|617677242|FG003|As Treated|Lack of Efficacy|1|||
170910642|NCT02786537|617677243|FG004|As Treated|Lack of Efficacy|0|||
170910643|NCT02786537|617677244|FG005|As Treated|Lack of Efficacy|0|||
170910644|NCT02786537|617677239|FG000|As Treated|Lost to Follow-up|4|||
170580954|NCT01071252|616468043|FG001|Overall Study|administrative problems|1|||
170580955|NCT01071252|616468044|FG002|Overall Study|administrative problems|0|||
170580956|NCT01071252|616468045|FG003|Overall Study|administrative problems|2|||
170580957|NCT01071252|616468046|FG004|Overall Study|administrative problems|1|||
170580958|NCT01071252|616468042|FG000|Overall Study|Lost to Follow-up|1|||
170580959|NCT01071252|616468043|FG001|Overall Study|Lost to Follow-up|0|||
170580960|NCT01071252|616468044|FG002|Overall Study|Lost to Follow-up|1|||
170580961|NCT01071252|616468045|FG003|Overall Study|Lost to Follow-up|2|||
170580962|NCT01071252|616468046|FG004|Overall Study|Lost to Follow-up|0|||
170580963|NCT01071252|616468042|FG000|Overall Study|Adverse Event|1|||
170910645|NCT02786537|617677240|FG001|As Treated|Lost to Follow-up|32|||
170910646|NCT02786537|617677241|FG002|As Treated|Lost to Follow-up|0|||
170580964|NCT01071252|616468043|FG001|Overall Study|Adverse Event|1|||
170580965|NCT01071252|616468044|FG002|Overall Study|Adverse Event|0|||
170580966|NCT01071252|616468045|FG003|Overall Study|Adverse Event|1|||
170580967|NCT01071252|616468046|FG004|Overall Study|Adverse Event|0|||
170580968|NCT01071252|616468042|FG000|Overall Study|Death|0|||
170580969|NCT01071252|616468043|FG001|Overall Study|Death|0|||
170580970|NCT01071252|616468044|FG002|Overall Study|Death|0|||
170580971|NCT01071252|616468045|FG003|Overall Study|Death|0|||
170580972|NCT01071252|616468046|FG004|Overall Study|Death|1|||
170580973|NCT00470262|616468050|FG000|Overall Study|Withdrawal by Subject|2|||
170580974|NCT00470262|616468051|FG001|Overall Study|Withdrawal by Subject|0|||
170580975|NCT02565147|616468054|FG000|Overall Study|Withdrawal by Subject|5|||
170580976|NCT02565147|616468055|FG001|Overall Study|Withdrawal by Subject|1|||
170910647|NCT02786537|617677242|FG003|As Treated|Lost to Follow-up|25|||
170580977|NCT02565147|616468054|FG000|Overall Study|Lost to Follow-up|0|||
170580978|NCT02565147|616468055|FG001|Overall Study|Lost to Follow-up|1|||
170580979|NCT02565147|616468054|FG000|Overall Study|Death|1|||
170580980|NCT02565147|616468055|FG001|Overall Study|Death|1|||
170580981|NCT00787839|616468056|FG000|Overall Study|Failure to have the OGTT was most common|404|||
170580982|NCT03902392|616468057|FG000|Overall Study|Lost to Follow-up|7|||
170580983|NCT03902392|616468058|FG001|Overall Study|Lost to Follow-up|7|||
170580984|NCT00244725|616468059|FG000|Overall Study|Lost to Follow-up|3|||
170580985|NCT00244725|616468060|FG001|Overall Study|Lost to Follow-up|4|||
170580986|NCT00244725|616468061|FG002|Overall Study|Lost to Follow-up|9|||
170580987|NCT00244725|616468062|FG003|Overall Study|Lost to Follow-up|2|||
170580988|NCT00244725|616468059|FG000|Overall Study|Withdrawal by Subject|9|||
170580989|NCT00244725|616468060|FG001|Overall Study|Withdrawal by Subject|7|||
170580990|NCT00244725|616468061|FG002|Overall Study|Withdrawal by Subject|7|||
170580991|NCT00244725|616468062|FG003|Overall Study|Withdrawal by Subject|8|||
170580992|NCT00244725|616468059|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
170580993|NCT00244725|616468060|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
170580994|NCT00244725|616468061|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
170580995|NCT00244725|616468062|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
170580996|NCT00244725|616468059|FG000|Overall Study|Physician Decision|3|||
170580997|NCT00244725|616468060|FG001|Overall Study|Physician Decision|0|||
170580998|NCT00244725|616468061|FG002|Overall Study|Physician Decision|1|||
170580999|NCT00244725|616468062|FG003|Overall Study|Physician Decision|2|||
170581000|NCT00244725|616468059|FG000|Overall Study|Adverse Events|3|||
170581001|NCT00244725|616468060|FG001|Overall Study|Adverse Events|1|||
170581002|NCT00244725|616468061|FG002|Overall Study|Adverse Events|4|||
170581003|NCT00244725|616468062|FG003|Overall Study|Adverse Events|4|||
170581004|NCT00244725|616468059|FG000|Overall Study|Withdrwal by participant|1|||
170581005|NCT00244725|616468060|FG001|Overall Study|Withdrwal by participant|0|||
170581006|NCT00244725|616468061|FG002|Overall Study|Withdrwal by participant|0|||
170581007|NCT00244725|616468062|FG003|Overall Study|Withdrwal by participant|1|||
170581008|NCT00244725|616468059|FG000|Overall Study|Liver function test abnormality|2|||
170581009|NCT00244725|616468060|FG001|Overall Study|Liver function test abnormality|0|||
170581010|NCT00244725|616468061|FG002|Overall Study|Liver function test abnormality|0|||
170581011|NCT00244725|616468062|FG003|Overall Study|Liver function test abnormality|1|||
170581012|NCT00244725|616468059|FG000|Overall Study|Sponsor withdrew the participant|1|||
170581013|NCT00244725|616468060|FG001|Overall Study|Sponsor withdrew the participant|0|||
170581014|NCT00244725|616468061|FG002|Overall Study|Sponsor withdrew the participant|0|||
170581015|NCT00244725|616468062|FG003|Overall Study|Sponsor withdrew the participant|1|||
170581016|NCT00244725|616468059|FG000|Overall Study|Mediciation Error|0|||
170581017|NCT00244725|616468060|FG001|Overall Study|Mediciation Error|1|||
170581018|NCT00244725|616468061|FG002|Overall Study|Mediciation Error|0|||
170581019|NCT00244725|616468062|FG003|Overall Study|Mediciation Error|0|||
170581020|NCT00244725|616468059|FG000|Overall Study|Rehab Refused to allow participantion|0|||
170581021|NCT00244725|616468060|FG001|Overall Study|Rehab Refused to allow participantion|1|||
170581022|NCT00244725|616468061|FG002|Overall Study|Rehab Refused to allow participantion|0|||
170581023|NCT00244725|616468062|FG003|Overall Study|Rehab Refused to allow participantion|0|||
170581024|NCT00244725|616468059|FG000|Overall Study|Headache|0|||
170581025|NCT00244725|616468060|FG001|Overall Study|Headache|1|||
170581026|NCT00244725|616468061|FG002|Overall Study|Headache|0|||
170581027|NCT00244725|616468062|FG003|Overall Study|Headache|0|||
170581028|NCT00244725|616468059|FG000|Overall Study|Received prohibited medication|0|||
170581029|NCT00244725|616468060|FG001|Overall Study|Received prohibited medication|1|||
170581030|NCT00244725|616468061|FG002|Overall Study|Received prohibited medication|0|||
170581031|NCT00244725|616468062|FG003|Overall Study|Received prohibited medication|1|||
170581032|NCT00244725|616468059|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
170581033|NCT00244725|616468060|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
170581034|NCT00244725|616468061|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
170581035|NCT00244725|616468062|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
170581036|NCT00244725|616468059|FG000|Overall Study|Administrative reason|0|||
170581037|NCT00244725|616468060|FG001|Overall Study|Administrative reason|0|||
170581038|NCT00244725|616468061|FG002|Overall Study|Administrative reason|1|||
170581039|NCT00244725|616468062|FG003|Overall Study|Administrative reason|0|||
170581040|NCT00244725|616468059|FG000|Overall Study|Vomit|0|||
170581041|NCT00244725|616468060|FG001|Overall Study|Vomit|0|||
170581042|NCT00244725|616468061|FG002|Overall Study|Vomit|1|||
170581043|NCT00244725|616468062|FG003|Overall Study|Vomit|0|||
170581044|NCT00244725|616468059|FG000|Overall Study|Failed to follow-up|0|||
170809485|NCT05289037|617312353|FG016|Overall Study|Lost to Follow-up|4|||
170581045|NCT00244725|616468060|FG001|Overall Study|Failed to follow-up|0|||
170581046|NCT00244725|616468061|FG002|Overall Study|Failed to follow-up|1|||
170581047|NCT00244725|616468062|FG003|Overall Study|Failed to follow-up|1|||
170581048|NCT04004221|616468063|FG000|Overall Study|Death|89|||
170581049|NCT04004221|616468063|FG000|Overall Study|Withdrawal by Subject|5|||
170581050|NCT04004221|616468063|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
170809486|NCT05289037|617312337|FG000|Overall Study|Death|0|||
170581051|NCT04004221|616468063|FG000|Overall Study|Sponsor Decision|9|||
170581052|NCT04004221|616468063|FG000|Overall Study|Participant refused to enter LTE|1|||
170581053|NCT01970241|616468066|FG000|Overall Study|Withdrawal by Subject|2|||
170581054|NCT01970241|616468067|FG001|Overall Study|Withdrawal by Subject|0|||
170581055|NCT01970241|616468066|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
170581056|NCT01970241|616468067|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
170581057|NCT03472495|616468068|FG000|Overall Study|Treatment no longer indicated|1|||
170581058|NCT03472495|616468069|FG001|Overall Study|Treatment no longer indicated|2|||
170581059|NCT03472495|616468068|FG000|Overall Study|Physician Decision|0|||
170581060|NCT03472495|616468069|FG001|Overall Study|Physician Decision|2|||
170581061|NCT02097719|616468074|FG000|Overall Study|Subject Withdrew Consent|1|||
170581062|NCT02097719|616468075|FG001|Overall Study|Subject Withdrew Consent|0|||
170581063|NCT02097719|616468074|FG000|Overall Study|Lost to Follow-up|0|||
170581064|NCT02097719|616468075|FG001|Overall Study|Lost to Follow-up|1|||
170581065|NCT02097719|616468074|FG000|Overall Study|Adverse Event|2|||
170581066|NCT02097719|616468075|FG001|Overall Study|Adverse Event|0|||
170581067|NCT03292640|616468076|FG000|Overall Study|Withdrawal by Subject|17|||
170581068|NCT03292640|616468077|FG001|Overall Study|Withdrawal by Subject|16|||
170581069|NCT03292640|616468076|FG000|Overall Study|Adverse Event|20|||
170581070|NCT03292640|616468077|FG001|Overall Study|Adverse Event|2|||
170581071|NCT03292640|616468076|FG000|Overall Study|Lost to Follow-up|24|||
170581072|NCT03292640|616468077|FG001|Overall Study|Lost to Follow-up|24|||
170581073|NCT02142803|616468078|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
170581074|NCT02142803|616468079|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
170581075|NCT02142803|616468080|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
170581076|NCT02142803|616468081|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
170581077|NCT05111002|616468082|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
170581078|NCT05111002|616468083|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
170581079|NCT05111002|616468082|FG000|Secondary Outcome|Lost to Follow-up|1|||
170581080|NCT05111002|616468083|FG001|Secondary Outcome|Lost to Follow-up|0|||
170581081|NCT00809926|616468084|FG000|Overall Study|Adverse Event|18|||
170581082|NCT00809926|616468085|FG001|Overall Study|Adverse Event|10|||
170581083|NCT00809926|616468084|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
170581084|NCT00809926|616468085|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170581085|NCT00809926|616468084|FG000|Overall Study|Patient withdrew consent|8|||
170581086|NCT00809926|616468085|FG001|Overall Study|Patient withdrew consent|6|||
170581087|NCT00809926|616468084|FG000|Overall Study|Lost to Follow-up|2|||
170581088|NCT00809926|616468085|FG001|Overall Study|Lost to Follow-up|1|||
170581089|NCT00809926|616468084|FG000|Overall Study|Administrative Problems|0|||
170581090|NCT00809926|616468085|FG001|Overall Study|Administrative Problems|1|||
170581091|NCT00809926|616468084|FG000|Overall Study|Protocol deviation|0|||
170581092|NCT00809926|616468085|FG001|Overall Study|Protocol deviation|2|||
170581093|NCT00972517|616468089|FG000|Overall Study|Adverse Event|0|||
170581094|NCT00972517|616468090|FG001|Overall Study|Adverse Event|0|||
170581095|NCT00972517|616468091|FG002|Overall Study|Adverse Event|0|||
170581096|NCT00972517|616468092|FG003|Overall Study|Adverse Event|1|||
170581097|NCT00972517|616468093|FG004|Overall Study|Adverse Event|0|||
170581098|NCT00972517|616468094|FG005|Overall Study|Adverse Event|0|||
170581099|NCT00972517|616468089|FG000|Overall Study|Withdrawal by Subject|0|||
170581100|NCT00972517|616468090|FG001|Overall Study|Withdrawal by Subject|1|||
170581101|NCT00972517|616468091|FG002|Overall Study|Withdrawal by Subject|0|||
170581102|NCT00972517|616468092|FG003|Overall Study|Withdrawal by Subject|2|||
170581103|NCT00972517|616468093|FG004|Overall Study|Withdrawal by Subject|1|||
170581104|NCT00972517|616468094|FG005|Overall Study|Withdrawal by Subject|0|||
170581105|NCT02311881|616468095|FG000|Overall Study|Did not meet the study criteria|2|||
170581106|NCT02311881|616468096|FG001|Overall Study|Did not meet the study criteria|2|||
170581107|NCT02311881|616468097|FG002|Overall Study|Did not meet the study criteria|0|||
170581108|NCT02311881|616468095|FG000|Overall Study|Adverse Event|7|||
170910648|NCT02786537|617677243|FG004|As Treated|Lost to Follow-up|4|||
170910649|NCT02786537|617677244|FG005|As Treated|Lost to Follow-up|4|||
170581109|NCT02311881|616468096|FG001|Overall Study|Adverse Event|15|||
170910650|NCT02786537|617677239|FG000|As Treated|Non-compliance with study drug|1|||
170910651|NCT02786537|617677240|FG001|As Treated|Non-compliance with study drug|11|||
170910652|NCT02786537|617677241|FG002|As Treated|Non-compliance with study drug|0|||
170910653|NCT02786537|617677242|FG003|As Treated|Non-compliance with study drug|1|||
170910654|NCT02786537|617677243|FG004|As Treated|Non-compliance with study drug|0|||
170910655|NCT02786537|617677244|FG005|As Treated|Non-compliance with study drug|1|||
170581110|NCT02311881|616468097|FG002|Overall Study|Adverse Event|8|||
170581111|NCT02311881|616468095|FG000|Overall Study|Lost to Follow-up|3|||
170581112|NCT02311881|616468096|FG001|Overall Study|Lost to Follow-up|3|||
170581113|NCT02311881|616468097|FG002|Overall Study|Lost to Follow-up|2|||
170581114|NCT02311881|616468095|FG000|Overall Study|Protocol Violation|1|||
170581115|NCT02311881|616468096|FG001|Overall Study|Protocol Violation|2|||
170581116|NCT02311881|616468097|FG002|Overall Study|Protocol Violation|3|||
170910656|NCT02786537|617677239|FG000|As Treated|Lost insurance|0|||
170910657|NCT02786537|617677240|FG001|As Treated|Lost insurance|0|||
170581117|NCT02311881|616468095|FG000|Overall Study|Withdrawal of consent|14|||
170581118|NCT02311881|616468096|FG001|Overall Study|Withdrawal of consent|16|||
170581119|NCT02311881|616468097|FG002|Overall Study|Withdrawal of consent|17|||
170581120|NCT02311881|616468095|FG000|Overall Study|Other|0|||
170581121|NCT02311881|616468096|FG001|Overall Study|Other|0|||
170581122|NCT02311881|616468097|FG002|Overall Study|Other|1|||
170581123|NCT02311881|616468095|FG000|Overall Study|Lack of Efficacy|1|||
170581124|NCT02311881|616468096|FG001|Overall Study|Lack of Efficacy|2|||
170581125|NCT02311881|616468097|FG002|Overall Study|Lack of Efficacy|0|||
170581126|NCT02311881|616468095|FG000|Overall Study|Subject has border line pregnancy test|1|||
170581127|NCT02311881|616468096|FG001|Overall Study|Subject has border line pregnancy test|0|||
170581128|NCT02311881|616468097|FG002|Overall Study|Subject has border line pregnancy test|0|||
170581129|NCT02311881|616468095|FG000|Overall Study|Withdrawal by Subject|3|||
170581130|NCT02311881|616468096|FG001|Overall Study|Withdrawal by Subject|1|||
170581131|NCT02311881|616468097|FG002|Overall Study|Withdrawal by Subject|4|||
170581132|NCT02311881|616468095|FG000|Overall Study|Sponsor Decision|1|||
170581133|NCT02311881|616468096|FG001|Overall Study|Sponsor Decision|1|||
170581134|NCT02311881|616468097|FG002|Overall Study|Sponsor Decision|1|||
170581135|NCT02311881|616468095|FG000|Overall Study|Protocol Deviation|1|||
170581136|NCT02311881|616468096|FG001|Overall Study|Protocol Deviation|0|||
170581137|NCT02311881|616468097|FG002|Overall Study|Protocol Deviation|0|||
170581138|NCT02311881|616468095|FG000|Overall Study|Non-Compliance|1|||
170581139|NCT02311881|616468096|FG001|Overall Study|Non-Compliance|0|||
170581140|NCT02311881|616468097|FG002|Overall Study|Non-Compliance|2|||
170581141|NCT02311881|616468095|FG000|Overall Study|Physician Decision|0|||
170581142|NCT02311881|616468096|FG001|Overall Study|Physician Decision|0|||
170581143|NCT02311881|616468097|FG002|Overall Study|Physician Decision|1|||
170581144|NCT02311881|616468095|FG000|Overall Study|Medical Monitor Discretion|0|||
170581145|NCT02311881|616468096|FG001|Overall Study|Medical Monitor Discretion|0|||
170581146|NCT02311881|616468097|FG002|Overall Study|Medical Monitor Discretion|1|||
170581147|NCT02311881|616468095|FG000|Overall Study|Participant taking another medication|0|||
170581148|NCT02311881|616468096|FG001|Overall Study|Participant taking another medication|0|||
170581149|NCT02311881|616468097|FG002|Overall Study|Participant taking another medication|1|||
170581150|NCT02311881|616468095|FG000|Overall Study|Serious Adverse Event|0|||
170581151|NCT02311881|616468096|FG001|Overall Study|Serious Adverse Event|1|||
170581152|NCT02311881|616468097|FG002|Overall Study|Serious Adverse Event|0|||
170581153|NCT00451958|616468098|FG000|CS21A (NCT00451958)|Adverse Event|21|||
170581154|NCT00451958|616468099|FG001|CS21A (NCT00451958)|Adverse Event|34|||
170581155|NCT00451958|616468100|FG002|CS21A (NCT00451958)|Adverse Event|14|||
170581156|NCT00451958|616468101|FG003|CS21A (NCT00451958)|Adverse Event|17|||
170581157|NCT00451958|616468102|FG004|CS21A (NCT00451958)|Adverse Event|0|||
170581158|NCT00451958|616468098|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
170581159|NCT00451958|616468099|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
170581160|NCT00451958|616468100|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
170581161|NCT00451958|616468101|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
170581162|NCT00451958|616468102|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
170581163|NCT00451958|616468098|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
170581164|NCT00451958|616468099|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
170581165|NCT00451958|616468100|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
170581166|NCT00451958|616468101|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
170581167|NCT00451958|616468102|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
170581168|NCT00451958|616468098|FG000|CS21A (NCT00451958)|Physician Decision|2|||
170581169|NCT00451958|616468099|FG001|CS21A (NCT00451958)|Physician Decision|4|||
170581170|NCT00451958|616468100|FG002|CS21A (NCT00451958)|Physician Decision|4|||
170581171|NCT00451958|616468101|FG003|CS21A (NCT00451958)|Physician Decision|4|||
170581172|NCT00451958|616468102|FG004|CS21A (NCT00451958)|Physician Decision|0|||
170581173|NCT00451958|616468098|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
170581174|NCT00451958|616468099|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
170581175|NCT00451958|616468100|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
170581176|NCT00451958|616468101|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
170581177|NCT00451958|616468102|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
170581178|NCT00451958|616468098|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
170581179|NCT00451958|616468099|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
170809487|NCT05289037|617312338|FG001|Overall Study|Death|0|||
170581180|NCT00451958|616468100|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
170581181|NCT00451958|616468101|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
170581182|NCT00451958|616468102|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
170581183|NCT03108521|616468103|FG000|Overall Study|Lost to Follow-up|3|||
170809488|NCT05289037|617312339|FG002|Overall Study|Death|0|||
170809489|NCT05289037|617312340|FG003|Overall Study|Death|0|||
170809490|NCT05289037|617312341|FG004|Overall Study|Death|0|||
170809491|NCT05289037|617312342|FG005|Overall Study|Death|1|||
170809492|NCT05289037|617312343|FG006|Overall Study|Death|0|||
170809493|NCT05289037|617312344|FG007|Overall Study|Death|0|||
170581184|NCT03108521|616468104|FG001|Overall Study|Lost to Follow-up|0|||
170581185|NCT03108521|616468103|FG000|Overall Study|Lack of Efficacy|2|||
170809494|NCT05289037|617312345|FG008|Overall Study|Death|0|||
170809495|NCT05289037|617312346|FG009|Overall Study|Death|0|||
170581186|NCT03108521|616468104|FG001|Overall Study|Lack of Efficacy|0|||
170581187|NCT03108521|616468103|FG000|Overall Study|Physician Decision|4|||
170581188|NCT03108521|616468104|FG001|Overall Study|Physician Decision|0|||
170581189|NCT03108521|616468103|FG000|Overall Study|Adverse Event|3|||
170581190|NCT03108521|616468104|FG001|Overall Study|Adverse Event|0|||
170581191|NCT06899737|616468110|FG000|Overall Study|Lost to Follow-up|19|||
170581192|NCT06899737|616468111|FG001|Overall Study|Lost to Follow-up|7|||
170581193|NCT03281629|616468113|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
170581194|NCT03281629|616468114|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
170581195|NCT03281629|616468113|FG000|Overall Study|Death|0|||
170581196|NCT03281629|616468114|FG001|Overall Study|Death|1|||
170581197|NCT03281629|616468113|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
170581198|NCT03281629|616468114|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
170581199|NCT02175277|616468115|FG000|Overall Study|Protocol-specified Criteria|1|||
170581200|NCT01082081|616468116|FG000|Overall Study|Lost to Follow-up|0|||
170581201|NCT01082081|616468117|FG001|Overall Study|Lost to Follow-up|0|||
170581202|NCT01082081|616468118|FG002|Overall Study|Lost to Follow-up|1|||
170581203|NCT01082081|616468116|FG000|Overall Study|Withdrawal by Subject|0|||
170581204|NCT01082081|616468117|FG001|Overall Study|Withdrawal by Subject|0|||
170809496|NCT05289037|617312347|FG010|Overall Study|Death|0|||
170809497|NCT05289037|617312348|FG011|Overall Study|Death|0|||
170809498|NCT05289037|617312349|FG012|Overall Study|Death|0|||
170809499|NCT05289037|617312350|FG013|Overall Study|Death|0|||
170809500|NCT05289037|617312351|FG014|Overall Study|Death|1|||
170809501|NCT05289037|617312352|FG015|Overall Study|Death|0|||
170809502|NCT05289037|617312353|FG016|Overall Study|Death|0|||
170809503|NCT05289037|617312337|FG000|Overall Study|Did not receive vaccine|0|||
170809504|NCT05289037|617312338|FG001|Overall Study|Did not receive vaccine|3|||
170809505|NCT05289037|617312339|FG002|Overall Study|Did not receive vaccine|0|||
170809506|NCT05289037|617312340|FG003|Overall Study|Did not receive vaccine|0|||
170809507|NCT05289037|617312341|FG004|Overall Study|Did not receive vaccine|1|||
170809508|NCT05289037|617312342|FG005|Overall Study|Did not receive vaccine|1|||
170809509|NCT05289037|617312343|FG006|Overall Study|Did not receive vaccine|1|||
170809510|NCT05289037|617312344|FG007|Overall Study|Did not receive vaccine|0|||
170809511|NCT05289037|617312345|FG008|Overall Study|Did not receive vaccine|0|||
170809512|NCT05289037|617312346|FG009|Overall Study|Did not receive vaccine|0|||
170809513|NCT05289037|617312347|FG010|Overall Study|Did not receive vaccine|0|||
170809514|NCT05289037|617312348|FG011|Overall Study|Did not receive vaccine|0|||
170809515|NCT05289037|617312349|FG012|Overall Study|Did not receive vaccine|0|||
170809516|NCT05289037|617312350|FG013|Overall Study|Did not receive vaccine|0|||
170809517|NCT05289037|617312351|FG014|Overall Study|Did not receive vaccine|1|||
170809518|NCT05289037|617312352|FG015|Overall Study|Did not receive vaccine|0|||
170809519|NCT05289037|617312353|FG016|Overall Study|Did not receive vaccine|0|||
170809520|NCT05289037|617312337|FG000|Overall Study|Unable to make last visit|0|||
170809521|NCT05289037|617312338|FG001|Overall Study|Unable to make last visit|0|||
170809522|NCT05289037|617312339|FG002|Overall Study|Unable to make last visit|1|||
170809523|NCT05289037|617312340|FG003|Overall Study|Unable to make last visit|0|||
170809524|NCT05289037|617312341|FG004|Overall Study|Unable to make last visit|0|||
170809525|NCT05289037|617312342|FG005|Overall Study|Unable to make last visit|0|||
170809526|NCT05289037|617312343|FG006|Overall Study|Unable to make last visit|0|||
170809527|NCT05289037|617312344|FG007|Overall Study|Unable to make last visit|0|||
170809528|NCT05289037|617312345|FG008|Overall Study|Unable to make last visit|0|||
170809529|NCT05289037|617312346|FG009|Overall Study|Unable to make last visit|0|||
170809530|NCT05289037|617312347|FG010|Overall Study|Unable to make last visit|0|||
170809531|NCT05289037|617312348|FG011|Overall Study|Unable to make last visit|0|||
170809532|NCT05289037|617312349|FG012|Overall Study|Unable to make last visit|0|||
170809533|NCT05289037|617312350|FG013|Overall Study|Unable to make last visit|0|||
170809534|NCT05289037|617312351|FG014|Overall Study|Unable to make last visit|0|||
170809535|NCT05289037|617312352|FG015|Overall Study|Unable to make last visit|0|||
170809536|NCT05289037|617312353|FG016|Overall Study|Unable to make last visit|0|||
170809537|NCT05289037|617312337|FG000|Overall Study|Protocol deviation|0|||
170581205|NCT01082081|616468118|FG002|Overall Study|Withdrawal by Subject|1|||
170581206|NCT01082081|616468116|FG000|Overall Study|Other Reason|0|||
170581207|NCT01082081|616468117|FG001|Overall Study|Other Reason|1|||
170581208|NCT01082081|616468118|FG002|Overall Study|Other Reason|0|||
170809538|NCT05289037|617312338|FG001|Overall Study|Protocol deviation|0|||
170910658|NCT02786537|617677241|FG002|As Treated|Lost insurance|0|||
170581209|NCT01042158|616468119|FG000|Overall Study|Physician Decision|1|||
170809539|NCT05289037|617312339|FG002|Overall Study|Protocol deviation|0|||
170910659|NCT02786537|617677242|FG003|As Treated|Lost insurance|1|||
170809540|NCT05289037|617312340|FG003|Overall Study|Protocol deviation|0|||
170809541|NCT05289037|617312341|FG004|Overall Study|Protocol deviation|0|||
170809542|NCT05289037|617312342|FG005|Overall Study|Protocol deviation|0|||
170581210|NCT01170273|616468121|FG000|Overall Study|Lost to Follow-up|6|||
170581211|NCT01170273|616468122|FG001|Overall Study|Lost to Follow-up|8|||
170581212|NCT01170273|616468121|FG000|Overall Study|Protocol Violation|1|||
170581213|NCT01170273|616468122|FG001|Overall Study|Protocol Violation|0|||
170581214|NCT01170273|616468121|FG000|Overall Study|Death|1|||
170581215|NCT01170273|616468122|FG001|Overall Study|Death|0|||
170581216|NCT01170273|616468121|FG000|Overall Study|Adverse Event|0|||
170581217|NCT01170273|616468122|FG001|Overall Study|Adverse Event|1|||
170581218|NCT03159468|616468123|FG000|Overall Study|Withdrawal by Subject|0|||
170581219|NCT03159468|616468124|FG001|Overall Study|Withdrawal by Subject|0|||
170581220|NCT03159468|616468125|FG002|Overall Study|Withdrawal by Subject|3|||
170581221|NCT03159468|616468126|FG003|Overall Study|Withdrawal by Subject|0|||
170581222|NCT03159468|616468127|FG004|Overall Study|Withdrawal by Subject|0|||
170581223|NCT03159468|616468128|FG005|Overall Study|Withdrawal by Subject|0|||
170581224|NCT00375674|616468131|FG000|Overall Study|Other|26|||
170581225|NCT00375674|616468132|FG001|Overall Study|Other|18|||
170581226|NCT00375674|616468131|FG000|Overall Study|Death|67|||
170581227|NCT00375674|616468132|FG001|Overall Study|Death|76|||
170581228|NCT00375674|616468131|FG000|Overall Study|Participants refused further follow-up|31|||
170581229|NCT00375674|616468132|FG001|Overall Study|Participants refused further follow-up|30|||
170581230|NCT00375674|616468131|FG000|Overall Study|Lost to Follow-up|17|||
170581231|NCT00375674|616468132|FG001|Overall Study|Lost to Follow-up|15|||
170581232|NCT00375674|616468131|FG000|Overall Study|Enrolled but not treated|3|||
170581233|NCT00375674|616468132|FG001|Overall Study|Enrolled but not treated|2|||
170581234|NCT02388165|616469426|FG000|Overall Study|Study terminated by sponsor|5|||
170581235|NCT02388165|616469427|FG001|Overall Study|Study terminated by sponsor|5|||
170581236|NCT02388165|616469426|FG000|Overall Study|Other|11|||
170581237|NCT02388165|616469427|FG001|Overall Study|Other|13|||
170581238|NCT02388165|616469426|FG000|Overall Study|No longer meet eligibility criteria|40|||
170581239|NCT02388165|616469427|FG001|Overall Study|No longer meet eligibility criteria|43|||
170581240|NCT02388165|616469426|FG000|Overall Study|Withdrawal of consent|31|||
170581241|NCT02388165|616469427|FG001|Overall Study|Withdrawal of consent|32|||
170581242|NCT02388165|616469426|FG000|Overall Study|Lost to Follow-up|19|||
170581243|NCT02388165|616469427|FG001|Overall Study|Lost to Follow-up|20|||
170581244|NCT02388165|616469426|FG000|Overall Study|Death|13|||
170581245|NCT02388165|616469427|FG001|Overall Study|Death|10|||
170581246|NCT02388165|616469426|FG000|Overall Study|Adverse Event|3|||
170581247|NCT02388165|616469427|FG001|Overall Study|Adverse Event|5|||
170581248|NCT02388165|616469426|FG000|Overall Study|Did not meet entrance criteria|5|||
170581249|NCT02388165|616469427|FG001|Overall Study|Did not meet entrance criteria|2|||
170581250|NCT03350035|616469429|FG000|Overall Study|Lack of Efficacy|2|||
170581251|NCT03350035|616469430|FG001|Overall Study|Lack of Efficacy|0|||
170581252|NCT03350035|616469431|FG002|Overall Study|Lack of Efficacy|0|||
170581253|NCT03350035|616469429|FG000|Overall Study|Subject discharged to hospice|0|||
170581254|NCT03350035|616469430|FG001|Overall Study|Subject discharged to hospice|0|||
170581255|NCT03350035|616469431|FG002|Overall Study|Subject discharged to hospice|1|||
170581256|NCT01545934|616469432|FG000|Overall Study|Withdrawal by Subject|4|||
170581257|NCT01545934|616469433|FG001|Overall Study|Withdrawal by Subject|3|||
170581258|NCT01545934|616469432|FG000|Overall Study|Lost to Follow-up|1|||
170581259|NCT01545934|616469433|FG001|Overall Study|Lost to Follow-up|0|||
170581260|NCT03654404|616469434|FG000|Overall Study|Death|1|||
170581261|NCT03654404|616469434|FG000|Overall Study|Lost to Follow-up|2|||
170581262|NCT03654404|616469434|FG000|Overall Study|Withdrawal by Subject|5|||
170581263|NCT00365105|616469435|FG000|Overall Study|Protocol Violation|5|||
170581264|NCT00365105|616469436|FG001|Overall Study|Protocol Violation|8|||
170581265|NCT02314156|616469437|FG000|Overall Study|Adverse Event|1|||
170581266|NCT02314156|616469438|FG001|Overall Study|Adverse Event|0|||
170581267|NCT02314156|616469437|FG000|Overall Study|Withdrawal by Subject|1|||
170581268|NCT02314156|616469438|FG001|Overall Study|Withdrawal by Subject|0|||
170581269|NCT00758069|616469441|FG000|Overall Study|Lack of Efficacy|0|||
170581270|NCT00758069|616469442|FG001|Overall Study|Lack of Efficacy|0|||
170649748|NCT02509117|616730865|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
170581271|NCT00758069|616469443|FG002|Overall Study|Lack of Efficacy|1|||
170581272|NCT00758069|616469441|FG000|Overall Study|Incorrect Study Drug|1|||
170581273|NCT00758069|616469442|FG001|Overall Study|Incorrect Study Drug|0|||
170581274|NCT00758069|616469443|FG002|Overall Study|Incorrect Study Drug|0|||
170581275|NCT04560816|616469444|FG000|Overall Study|Withdrawal by Subject|1|||
170581276|NCT04560816|616469445|FG001|Overall Study|Withdrawal by Subject|1|||
170581277|NCT04560816|616469446|FG002|Overall Study|Withdrawal by Subject|1|||
170581278|NCT04560816|616469447|FG003|Overall Study|Withdrawal by Subject|0|||
170581279|NCT04560816|616469448|FG004|Overall Study|Withdrawal by Subject|3|||
170581280|NCT04560816|616469449|FG005|Overall Study|Withdrawal by Subject|0|||
170581281|NCT04560816|616469444|FG000|Overall Study|Lost to Follow-up|1|||
170581282|NCT04560816|616469445|FG001|Overall Study|Lost to Follow-up|0|||
170581283|NCT04560816|616469446|FG002|Overall Study|Lost to Follow-up|0|||
170581284|NCT04560816|616469447|FG003|Overall Study|Lost to Follow-up|0|||
170581285|NCT04560816|616469448|FG004|Overall Study|Lost to Follow-up|0|||
170581286|NCT04560816|616469449|FG005|Overall Study|Lost to Follow-up|0|||
170581287|NCT04560816|616469444|FG000|Overall Study|Protocol Violation|1|||
170581288|NCT04560816|616469445|FG001|Overall Study|Protocol Violation|0|||
170581289|NCT04560816|616469446|FG002|Overall Study|Protocol Violation|0|||
170581290|NCT04560816|616469447|FG003|Overall Study|Protocol Violation|0|||
170581291|NCT04560816|616469448|FG004|Overall Study|Protocol Violation|0|||
170581292|NCT04560816|616469449|FG005|Overall Study|Protocol Violation|0|||
170581293|NCT02277691|616469450|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
170581294|NCT02277691|616469450|FG000|Overall Study|Voluntary Withdrawal|7|||
170581295|NCT02277691|616469450|FG000|Overall Study|Lack of Efficacy|5|||
170581296|NCT02277691|616469450|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
170581297|NCT02321319|616469453|FG000|Overall Study|Product discontinued|5|||
170581298|NCT02249091|616469456|FG000|Overall Study|Lack of Efficacy|8|||
170581299|NCT02249091|616469457|FG001|Overall Study|Lack of Efficacy|3|||
170581300|NCT02249091|616469456|FG000|Overall Study|Physician Decision|4|||
170581301|NCT02249091|616469457|FG001|Overall Study|Physician Decision|1|||
170581302|NCT02249091|616469456|FG000|Overall Study|Withdrawal by Subject|2|||
170581303|NCT02249091|616469457|FG001|Overall Study|Withdrawal by Subject|2|||
170581304|NCT02249091|616469456|FG000|Overall Study|Death|3|||
170581305|NCT02249091|616469457|FG001|Overall Study|Death|4|||
170581306|NCT02249091|616469456|FG000|Overall Study|Adverse Event|1|||
170581307|NCT02249091|616469457|FG001|Overall Study|Adverse Event|0|||
170581308|NCT02249091|616469456|FG000|Overall Study|Stable disease with following SCT|0|||
170581309|NCT02249091|616469457|FG001|Overall Study|Stable disease with following SCT|1|||
170581310|NCT02249091|616469456|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
170581311|NCT02249091|616469457|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
170581312|NCT02249091|616469456|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
170581313|NCT02249091|616469457|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
170581314|NCT02249091|616469456|FG000|Overall Study|Refractory AML|1|||
170581315|NCT02249091|616469457|FG001|Overall Study|Refractory AML|1|||
170581316|NCT02516098|616469458|FG000|Period 1|Protocol Violation|1|||
170581317|NCT02516098|616469459|FG001|Period 1|Protocol Violation|0|||
170581318|NCT02516098|616469458|FG000|Washout After Period 1|Adverse Event|0|||
170581319|NCT02516098|616469459|FG001|Washout After Period 1|Adverse Event|1|||
170581320|NCT02516098|616469458|FG000|Period 2|Withdrawal by Subject|0|||
170581321|NCT02516098|616469459|FG001|Period 2|Withdrawal by Subject|1|||
170581322|NCT01092780|616469460|FG000|Washout Period 1|Adverse Event|0|||
170581323|NCT01092780|616469461|FG001|Washout Period 1|Adverse Event|1|||
170581324|NCT01092780|616469462|FG002|Washout Period 1|Adverse Event|0|||
170581325|NCT01092780|616469463|FG003|Washout Period 1|Adverse Event|0|||
170581326|NCT01092780|616469460|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
170581327|NCT01092780|616469461|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
170581328|NCT01092780|616469462|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
170581329|NCT01092780|616469463|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
170581330|NCT01092780|616469460|FG000|Washout Period 2|Adverse Event|0|||
170581331|NCT01092780|616469461|FG001|Washout Period 2|Adverse Event|1|||
170581332|NCT01092780|616469462|FG002|Washout Period 2|Adverse Event|1|||
170581333|NCT01092780|616469463|FG003|Washout Period 2|Adverse Event|0|||
170581334|NCT01734395|616469464|FG000|Overall Study|Other|65|||
170910660|NCT02786537|617677243|FG004|As Treated|Lost insurance|0|||
170581335|NCT01734395|616469464|FG000|Overall Study|Lost to Follow-up|287|||
170581336|NCT01734395|616469464|FG000|Overall Study|Lack of Efficacy|5|||
170581337|NCT01734395|616469464|FG000|Overall Study|Adverse Event|40|||
170581338|NCT01734395|616469464|FG000|Overall Study|Withdrawal by Subject|10|||
170581339|NCT01734395|616469464|FG000|Overall Study|Missing the reasons for not completed|3|||
170581340|NCT01257230|616469465|FG000|Overall Study|Not Treated|0|||
170581341|NCT01257230|616469466|FG001|Overall Study|Not Treated|0|||
170581342|NCT01257230|616469467|FG002|Overall Study|Not Treated|1|||
170581343|NCT01257230|616469465|FG000|Overall Study|Adverse Event|2|||
170581344|NCT01257230|616469466|FG001|Overall Study|Adverse Event|0|||
170581345|NCT01257230|616469467|FG002|Overall Study|Adverse Event|0|||
170581346|NCT01257230|616469465|FG000|Overall Study|Lack of Efficacy|0|||
170649749|NCT00280748|616730875|FG000|Overall Study|Decline in performance|3|||
170649750|NCT00280748|616730875|FG000|Overall Study|Extra-cranial disease progression|1|||
170649751|NCT01433250|616730877|FG000|Overall Study|Protocol Violation|0|||
170649752|NCT01433250|616730878|FG001|Overall Study|Protocol Violation|1|||
170649753|NCT01433250|616730877|FG000|Overall Study|Withdrawal by Subject|3|||
170649754|NCT01433250|616730878|FG001|Overall Study|Withdrawal by Subject|2|||
170649755|NCT02437110|616730879|FG000|Screening|Lost to Follow-up|3|||
170649756|NCT02437110|616730879|FG000|Screening|Physician Decision|1|||
170649757|NCT02437110|616730879|FG000|ART|Adverse Event|3|||
170649758|NCT02437110|616730879|FG000|ART|Protocol Violation|3|||
170649759|NCT02437110|616730879|FG000|ART|Withdrawal by Subject|4|||
170649760|NCT02437110|616730879|FG000|ART|Lost to follow-up prior to start of intervention|1|||
170649761|NCT02437110|616730879|FG000|ART|Physician decision prior to start of intervention|2|||
170649762|NCT02437110|616730879|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
170581347|NCT01257230|616469466|FG001|Overall Study|Lack of Efficacy|1|||
170581348|NCT01257230|616469467|FG002|Overall Study|Lack of Efficacy|0|||
170581349|NCT01257230|616469465|FG000|Overall Study|Protocol Violation|3|||
170581350|NCT01257230|616469466|FG001|Overall Study|Protocol Violation|0|||
170581351|NCT01257230|616469467|FG002|Overall Study|Protocol Violation|1|||
170581352|NCT01257230|616469465|FG000|Overall Study|Withdrawal by Subject|0|||
170581353|NCT01257230|616469466|FG001|Overall Study|Withdrawal by Subject|4|||
170581354|NCT01257230|616469467|FG002|Overall Study|Withdrawal by Subject|1|||
170581355|NCT01257230|616469465|FG000|Overall Study|Other reason not defined above|1|||
170581356|NCT01257230|616469466|FG001|Overall Study|Other reason not defined above|5|||
170581357|NCT01257230|616469467|FG002|Overall Study|Other reason not defined above|3|||
170581358|NCT00765037|616469470|FG000|Overall Study|Lost to Follow-up|5|||
170581359|NCT00765037|616469470|FG000|Overall Study|Adverse Event|1|||
170581360|NCT02300558|616469471|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
170581361|NCT02300558|616469471|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
170581362|NCT02300558|616469471|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
170581363|NCT02300558|616469471|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
170581364|NCT00695955|616469472|FG000|Cohort 1|Adverse Event|26|||
170581365|NCT00695955|616469472|FG000|Cohort 1|Protocol Violation|2|||
170581366|NCT00695955|616469472|FG000|Cohort 1|Lost to Follow-up|30|||
170581367|NCT00695955|616469472|FG000|Cohort 1|Withdrawal by Subject|25|||
170581368|NCT00695955|616469472|FG000|Cohort 1|Lack of Efficacy|3|||
170581369|NCT00695955|616469472|FG000|Cohort 1|Other|16|||
170581370|NCT00695955|616469472|FG000|Cohort 2|Adverse Event|24|||
170581371|NCT00695955|616469472|FG000|Cohort 2|Protocol Violation|5|||
170581372|NCT00695955|616469472|FG000|Cohort 2|Lost to Follow-up|38|||
170581373|NCT00695955|616469472|FG000|Cohort 2|Withdrawal by Subject|28|||
170581374|NCT00695955|616469472|FG000|Cohort 2|Lack of Efficacy|4|||
170581375|NCT00695955|616469472|FG000|Cohort 2|Other|5|||
170581376|NCT03517371|616469473|FG000|Overall Study|Adverse Event|8|||
170581377|NCT03517371|616469474|FG001|Overall Study|Adverse Event|9|||
170581378|NCT03517371|616469473|FG000|Overall Study|Lost to Follow-up|1|||
170581379|NCT03517371|616469474|FG001|Overall Study|Lost to Follow-up|2|||
170581380|NCT03517371|616469473|FG000|Overall Study|Withdrawal by Subject|4|||
170581381|NCT03517371|616469474|FG001|Overall Study|Withdrawal by Subject|4|||
170581382|NCT03517371|616469473|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
170581383|NCT03517371|616469474|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
170581384|NCT03517371|616469473|FG000|Overall Study|COVID restrictions|2|||
170581385|NCT03517371|616469474|FG001|Overall Study|COVID restrictions|0|||
170581386|NCT03517371|616469473|FG000|Overall Study|Receiving DBS Surgery|0|||
170581387|NCT03517371|616469474|FG001|Overall Study|Receiving DBS Surgery|1|||
170581388|NCT05411822|616469475|FG000|Overall Study|Withdrawal by Subject|2|||
170581389|NCT05411822|616469476|FG001|Overall Study|Withdrawal by Subject|1|||
170581390|NCT00935493|616469479|FG000|Overall Study|Lost to Follow-up|1|||
170581391|NCT00935493|616469480|FG001|Overall Study|Lost to Follow-up|1|||
170581392|NCT00935493|616469481|FG002|Overall Study|Lost to Follow-up|1|||
170581393|NCT00935493|616469479|FG000|Overall Study|Treatment Discontinued|0|||
170581394|NCT00935493|616469480|FG001|Overall Study|Treatment Discontinued|1|||
170581395|NCT00935493|616469481|FG002|Overall Study|Treatment Discontinued|0|||
170581396|NCT00964002|616469482|FG000|Overall Study|Protocol Violation|8|||
170581397|NCT01939977|616469483|FG000|Overall Study|Adverse Event|4|||
170581398|NCT01939977|616469484|FG001|Overall Study|Adverse Event|3|||
170809543|NCT05289037|617312343|FG006|Overall Study|Protocol deviation|0|||
170809544|NCT05289037|617312344|FG007|Overall Study|Protocol deviation|0|||
170581399|NCT01939977|616469483|FG000|Overall Study|Lack of Efficacy|3|||
170581400|NCT01939977|616469484|FG001|Overall Study|Lack of Efficacy|0|||
170581401|NCT01939977|616469483|FG000|Overall Study|Physician Decision|1|||
170809545|NCT05289037|617312345|FG008|Overall Study|Protocol deviation|0|||
170809546|NCT05289037|617312346|FG009|Overall Study|Protocol deviation|0|||
170809547|NCT05289037|617312347|FG010|Overall Study|Protocol deviation|0|||
170809548|NCT05289037|617312348|FG011|Overall Study|Protocol deviation|0|||
170809549|NCT05289037|617312349|FG012|Overall Study|Protocol deviation|0|||
170809550|NCT05289037|617312350|FG013|Overall Study|Protocol deviation|0|||
170809551|NCT05289037|617312351|FG014|Overall Study|Protocol deviation|0|||
170809552|NCT05289037|617312352|FG015|Overall Study|Protocol deviation|1|||
170581402|NCT01939977|616469484|FG001|Overall Study|Physician Decision|1|||
170581403|NCT01939977|616469483|FG000|Overall Study|Withdrawal by Subject|0|||
170581404|NCT01939977|616469484|FG001|Overall Study|Withdrawal by Subject|2|||
170581405|NCT01939977|616469483|FG000|Overall Study|Did not meet inclusion criteria|1|||
170581406|NCT01939977|616469484|FG001|Overall Study|Did not meet inclusion criteria|0|||
170581407|NCT01939977|616469483|FG000|Overall Study|Did not receive study medication|0|||
170581408|NCT01939977|616469484|FG001|Overall Study|Did not receive study medication|1|||
170581409|NCT03213938|616469487|FG000|Overall Study|Lost to Follow-up|4|||
170581410|NCT03213938|616469488|FG001|Overall Study|Lost to Follow-up|3|||
170581411|NCT03213938|616469487|FG000|Overall Study|Lack of Efficacy|1|||
170581412|NCT03213938|616469488|FG001|Overall Study|Lack of Efficacy|0|||
170809553|NCT05289037|617312353|FG016|Overall Study|Protocol deviation|0|||
170809554|NCT04445831|617312356|FG000|Overall Study|Withdrawal by Subject|2|||
170581413|NCT03213938|616469487|FG000|Overall Study|Decline to participate|5|||
170581414|NCT03213938|616469488|FG001|Overall Study|Decline to participate|4|||
170581415|NCT03213938|616469487|FG000|Overall Study|Without reason|4|||
170581416|NCT03213938|616469488|FG001|Overall Study|Without reason|5|||
170581417|NCT01603043|616469491|FG000|Overall Study|Study Futility|7|||
170581418|NCT01603043|616469492|FG001|Overall Study|Study Futility|3|||
170581419|NCT00375505|616469493|FG000|Overall Study|Adverse Event|1|||
170581420|NCT00375505|616469494|FG001|Overall Study|Adverse Event|2|||
170581421|NCT02218697|616469497|FG000|Overall Study|Adverse Event|0|||
170581422|NCT02218697|616469498|FG001|Overall Study|Adverse Event|2|||
170581423|NCT02218697|616469497|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
170581424|NCT02218697|616469498|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
170581425|NCT02218697|616469497|FG000|Overall Study|Withdrawal by Subject|2|||
170581426|NCT02218697|616469498|FG001|Overall Study|Withdrawal by Subject|3|||
170581427|NCT01108731|616469499|FG000|Overall Study|Withdrawal by Subject|1|||
170581428|NCT01108731|616469500|FG001|Overall Study|Withdrawal by Subject|1|||
170581429|NCT01108731|616469499|FG000|Overall Study|Adverse Event|3|||
170581430|NCT01108731|616469500|FG001|Overall Study|Adverse Event|3|||
170581431|NCT05356910|616469501|FG000|Overall Study|Lost to Follow-up|10|||
170581432|NCT05356910|616469502|FG001|Overall Study|Lost to Follow-up|19|||
170581433|NCT05356910|616469503|FG002|Overall Study|Lost to Follow-up|0|||
170581434|NCT05356910|616469504|FG003|Overall Study|Lost to Follow-up|0|||
170581435|NCT05356910|616469501|FG000|Overall Study|Withdrawal by Subject|4|||
170581436|NCT05356910|616469502|FG001|Overall Study|Withdrawal by Subject|2|||
170581437|NCT05356910|616469503|FG002|Overall Study|Withdrawal by Subject|0|||
170581438|NCT05356910|616469504|FG003|Overall Study|Withdrawal by Subject|0|||
170581439|NCT02712996|616469505|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
170581440|NCT02712996|616469506|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
170581441|NCT01451749|616469507|FG000|Overall Study|Protocol Violation|14|||
170581442|NCT01451749|616469508|FG001|Overall Study|Protocol Violation|7|||
170581443|NCT01451749|616469507|FG000|Overall Study|Lost to Follow-up|15|||
170581444|NCT01451749|616469508|FG001|Overall Study|Lost to Follow-up|5|||
170581445|NCT01451749|616469507|FG000|Overall Study|Meet the exclusion criteria,and|1|||
170581446|NCT01451749|616469508|FG001|Overall Study|Meet the exclusion criteria,and|1|||
170581447|NCT01451749|616469507|FG000|Overall Study|Adverse Event|2|||
170581448|NCT01451749|616469508|FG001|Overall Study|Adverse Event|0|||
170581449|NCT01451749|616469507|FG000|Overall Study|Withdrawal by Subject|0|||
170581450|NCT01451749|616469508|FG001|Overall Study|Withdrawal by Subject|1|||
170581451|NCT00819156|616469511|FG000|Overall Study|Adverse Event|1|||
170581452|NCT00819156|616469512|FG001|Overall Study|Adverse Event|4|||
170581453|NCT00819156|616469513|FG002|Overall Study|Adverse Event|2|||
170581454|NCT00819156|616469514|FG003|Overall Study|Adverse Event|1|||
170581455|NCT00819156|616469515|FG004|Overall Study|Adverse Event|2|||
170581456|NCT00819156|616469516|FG005|Overall Study|Adverse Event|3|||
170581457|NCT00819156|616469511|FG000|Overall Study|Withdrawal by Subject|0|||
170581458|NCT00819156|616469512|FG001|Overall Study|Withdrawal by Subject|3|||
170581459|NCT00819156|616469513|FG002|Overall Study|Withdrawal by Subject|2|||
170581460|NCT00819156|616469514|FG003|Overall Study|Withdrawal by Subject|0|||
170581461|NCT00819156|616469515|FG004|Overall Study|Withdrawal by Subject|1|||
170581462|NCT00819156|616469516|FG005|Overall Study|Withdrawal by Subject|0|||
170581463|NCT00819156|616469511|FG000|Overall Study|Protocol Violation|1|||
170581464|NCT00819156|616469512|FG001|Overall Study|Protocol Violation|0|||
170581465|NCT00819156|616469513|FG002|Overall Study|Protocol Violation|1|||
170581466|NCT00819156|616469514|FG003|Overall Study|Protocol Violation|0|||
170581467|NCT00819156|616469515|FG004|Overall Study|Protocol Violation|0|||
170581468|NCT00819156|616469516|FG005|Overall Study|Protocol Violation|1|||
170581469|NCT00819156|616469511|FG000|Overall Study|Lost to Follow-up|0|||
170581470|NCT00819156|616469512|FG001|Overall Study|Lost to Follow-up|1|||
170581471|NCT00819156|616469513|FG002|Overall Study|Lost to Follow-up|0|||
170581472|NCT00819156|616469514|FG003|Overall Study|Lost to Follow-up|0|||
170910661|NCT02786537|617677244|FG005|As Treated|Lost insurance|0|||
170581473|NCT00819156|616469515|FG004|Overall Study|Lost to Follow-up|0|||
170581474|NCT00819156|616469516|FG005|Overall Study|Lost to Follow-up|2|||
170581475|NCT00819156|616469511|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
170581476|NCT00819156|616469512|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
170581477|NCT00819156|616469513|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
170581478|NCT00819156|616469514|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
170581479|NCT00819156|616469515|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
170910662|NCT02786537|617677239|FG000|As Treated|Withdrawal by Subject|1|||
170581480|NCT00819156|616469516|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
170581481|NCT00819156|616469511|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
170581482|NCT00819156|616469512|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
170581483|NCT00819156|616469513|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
170581484|NCT00819156|616469514|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
170581485|NCT00819156|616469515|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
170581486|NCT00819156|616469516|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
170910663|NCT02786537|617677240|FG001|As Treated|Withdrawal by Subject|2|||
170581487|NCT00819156|616469511|FG000|Overall Study|Prostate-specific antigen progression|0|||
170581488|NCT00819156|616469512|FG001|Overall Study|Prostate-specific antigen progression|0|||
170581489|NCT00819156|616469513|FG002|Overall Study|Prostate-specific antigen progression|0|||
170581490|NCT00819156|616469514|FG003|Overall Study|Prostate-specific antigen progression|0|||
170581491|NCT00819156|616469515|FG004|Overall Study|Prostate-specific antigen progression|1|||
170649763|NCT02437110|616730879|FG000|Post-ART|Lost to Follow-up|3|||
170649764|NCT02437110|616730879|FG000|Post-ART|Protocol Violation|4|||
170649765|NCT02437110|616730879|FG000|Post-ART|Withdrawal by Subject|3|||
170649766|NCT00834080|616730880|FG000|Overall Study|Adverse Event|7|||
170649767|NCT00834080|616730880|FG000|Overall Study|Lost to Follow-up|7|||
170649768|NCT00834080|616730880|FG000|Overall Study|Withdrawal by Subject|5|||
170649769|NCT00834080|616730880|FG000|Overall Study|Other - Pregnancy|1|||
170649770|NCT00834080|616730880|FG000|Overall Study|Other - False positive tests of the UDS|1|||
170649771|NCT00834080|616730880|FG000|Overall Study|Physician Decision|1|||
170649772|NCT00834080|616730880|FG000|Overall Study|Subject Relocated|1|||
170649773|NCT04345367|616730881|FG000|Overall Study|Other|3|||
170649774|NCT04345367|616730882|FG001|Overall Study|Other|4|||
170649775|NCT04345367|616730881|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
170649776|NCT04345367|616730882|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
170649777|NCT04345367|616730881|FG000|Overall Study|Withdrawal by Subject|11|||
170649778|NCT04345367|616730882|FG001|Overall Study|Withdrawal by Subject|11|||
170649779|NCT04345367|616730881|FG000|Overall Study|Protocol Violation|4|||
170649780|NCT04345367|616730882|FG001|Overall Study|Protocol Violation|3|||
170649781|NCT04345367|616730881|FG000|Overall Study|Lost to Follow-up|2|||
170649782|NCT04345367|616730882|FG001|Overall Study|Lost to Follow-up|4|||
170649783|NCT04345367|616730881|FG000|Overall Study|Lack of Efficacy|2|||
170649784|NCT04345367|616730882|FG001|Overall Study|Lack of Efficacy|0|||
170649785|NCT04345367|616730881|FG000|Overall Study|Death|2|||
170649786|NCT04345367|616730882|FG001|Overall Study|Death|0|||
170649787|NCT04345367|616730881|FG000|Overall Study|Adverse Event|10|||
170649788|NCT04345367|616730882|FG001|Overall Study|Adverse Event|9|||
170649789|NCT01227824|616730888|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
170649790|NCT01227824|616730889|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
170649791|NCT01227824|616730890|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
170649792|NCT01227824|616730888|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
170581492|NCT00819156|616469516|FG005|Overall Study|Prostate-specific antigen progression|0|||
170581493|NCT00851890|616469517|FG000|Overall Study|Lost to Follow-up|0|||
170581494|NCT00851890|616469518|FG001|Overall Study|Lost to Follow-up|1|||
170581495|NCT00851890|616469519|FG002|Overall Study|Lost to Follow-up|0|||
170581496|NCT00851890|616469520|FG003|Overall Study|Lost to Follow-up|1|||
170581497|NCT03135431|616469521|FG000|Overall Study|Study Surgeon not available|2|||
170581498|NCT03135431|616469522|FG001|Overall Study|Study Surgeon not available|0|||
170581499|NCT01063062|616469523|FG000|Overall Study|Patient withdrew consent|0|||
170581500|NCT01063062|616469524|FG001|Overall Study|Patient withdrew consent|1|||
170581501|NCT01063062|616469523|FG000|Overall Study|Adverse Event|2|||
170581502|NCT01063062|616469524|FG001|Overall Study|Adverse Event|4|||
170581503|NCT01063062|616469523|FG000|Overall Study|Protocol Violation|5|||
170581504|NCT01063062|616469524|FG001|Overall Study|Protocol Violation|4|||
170581505|NCT01063062|616469523|FG000|Overall Study|Investigator's request|1|||
170581506|NCT01063062|616469524|FG001|Overall Study|Investigator's request|0|||
170581507|NCT01063062|616469523|FG000|Overall Study|Lost to Follow-up|0|||
170581508|NCT01063062|616469524|FG001|Overall Study|Lost to Follow-up|2|||
170581509|NCT01063062|616469523|FG000|Overall Study|Miscellaneous reason|0|||
170581510|NCT01063062|616469524|FG001|Overall Study|Miscellaneous reason|1|||
170581511|NCT02015481|616469525|FG000|Overall Study|Death|1|||
170581512|NCT03122145|616469529|FG000|Overall Study|Concurrent respiratory disease|3|||
170649793|NCT01227824|616730889|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
170649794|NCT01227824|616730890|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
170649795|NCT01227824|616730888|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
170649796|NCT01227824|616730889|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
170809555|NCT04445831|617312357|FG001|Overall Study|Withdrawal by Subject|1|||
170809556|NCT04445831|617312358|FG002|Overall Study|Withdrawal by Subject|1|||
170809557|NCT04445831|617312359|FG003|Overall Study|Withdrawal by Subject|0|||
170809558|NCT04445831|617312360|FG004|Overall Study|Withdrawal by Subject|0|||
170809559|NCT04445831|617312361|FG005|Overall Study|Withdrawal by Subject|0|||
170809560|NCT04445831|617312362|FG006|Overall Study|Withdrawal by Subject|0|||
170809561|NCT04445831|617312356|FG000|Overall Study|Subject withdrawal by caregiver|0|||
170581513|NCT03122145|616469530|FG001|Overall Study|Concurrent respiratory disease|0|||
170581514|NCT02016716|616469535|FG000|Overall Study|Withdrawal by Subject|5|||
170581515|NCT02016716|616469536|FG001|Overall Study|Withdrawal by Subject|5|||
170649797|NCT01227824|616730890|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
170649798|NCT01227824|616730888|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
170581516|NCT02016716|616469537|FG002|Overall Study|Withdrawal by Subject|5|||
170581517|NCT02016716|616469535|FG000|Overall Study|Protocol-specified Criteria|0|||
170581518|NCT02016716|616469536|FG001|Overall Study|Protocol-specified Criteria|1|||
170581519|NCT02016716|616469537|FG002|Overall Study|Protocol-specified Criteria|0|||
170581520|NCT02016716|616469535|FG000|Overall Study|Lost to Follow-up|1|||
170581521|NCT02016716|616469536|FG001|Overall Study|Lost to Follow-up|2|||
170581522|NCT02016716|616469537|FG002|Overall Study|Lost to Follow-up|1|||
170581523|NCT00079391|616469538|FG000|Overall Study|Withdrawal by Subject|1|||
170581524|NCT00104728|616469539|FG000|Overall Study|screen failures|19|||
170581525|NCT01659996|616469540|FG000|Overall Study|Protocol Violation|3|||
170581526|NCT01659996|616469541|FG001|Overall Study|Protocol Violation|3|||
170581527|NCT01659996|616469542|FG002|Overall Study|Protocol Violation|3|||
170581528|NCT01659996|616469540|FG000|Overall Study|Lost to Follow-up|1|||
170581529|NCT01659996|616469541|FG001|Overall Study|Lost to Follow-up|3|||
170581530|NCT01659996|616469542|FG002|Overall Study|Lost to Follow-up|2|||
170581531|NCT01659996|616469540|FG000|Overall Study|Adverse Event|0|||
170581532|NCT01659996|616469541|FG001|Overall Study|Adverse Event|0|||
170581533|NCT01659996|616469542|FG002|Overall Study|Adverse Event|1|||
170581534|NCT01659996|616469540|FG000|Overall Study|Withdrawal by Subject|4|||
170581535|NCT01659996|616469541|FG001|Overall Study|Withdrawal by Subject|1|||
170581536|NCT01659996|616469542|FG002|Overall Study|Withdrawal by Subject|5|||
170649799|NCT01227824|616730889|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
170649800|NCT01227824|616730890|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
170581537|NCT03206918|616469543|FG000|Overall Study|Death|11|||
170581538|NCT03206918|616469543|FG000|Overall Study|Withdrawal by Subject|5|||
170581539|NCT03206918|616469543|FG000|Overall Study|Study terminated by sponsor|12|||
170581540|NCT03206918|616469543|FG000|Overall Study|Lost to Follow-up|3|||
170581541|NCT03206918|616469543|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
170581542|NCT02701764|616469544|FG000|Overall Study|Lost to Follow-up|0|||
170581543|NCT02701764|616469545|FG001|Overall Study|Lost to Follow-up|1|||
170581544|NCT03823287|616469546|FG000|Overall Study|Withdrawal by Subject|25|||
170581545|NCT03823287|616469547|FG001|Overall Study|Withdrawal by Subject|17|||
170581546|NCT03823287|616469546|FG000|Overall Study|Death|13|||
170581547|NCT03823287|616469547|FG001|Overall Study|Death|7|||
170581548|NCT03823287|616469546|FG000|Overall Study|Lost to Follow-up|7|||
170581549|NCT03823287|616469547|FG001|Overall Study|Lost to Follow-up|8|||
170581550|NCT03823287|616469546|FG000|Overall Study|Adverse Event|6|||
170581551|NCT03823287|616469547|FG001|Overall Study|Adverse Event|8|||
170581552|NCT03823287|616469546|FG000|Overall Study|Physician Decision|5|||
170581553|NCT03823287|616469547|FG001|Overall Study|Physician Decision|2|||
170581554|NCT03823287|616469546|FG000|Overall Study|Lack of Efficacy|2|||
170581555|NCT03823287|616469547|FG001|Overall Study|Lack of Efficacy|0|||
170581556|NCT03823287|616469546|FG000|Overall Study|Other|2|||
170581557|NCT03823287|616469547|FG001|Overall Study|Other|4|||
170581558|NCT03372551|616471061|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
170581559|NCT03372551|616471062|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
170581560|NCT04683029|616471074|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
170581561|NCT04683029|616471075|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
170581562|NCT04683029|616471076|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
170581563|NCT04683029|616471077|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
170581564|NCT04683029|616471074|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
170581565|NCT04683029|616471075|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
170581566|NCT04683029|616471076|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
170581567|NCT04683029|616471077|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
170581568|NCT04683029|616471074|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
170581569|NCT04683029|616471075|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
170581570|NCT04683029|616471076|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
170581571|NCT04683029|616471077|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
170581572|NCT04299308|616471081|FG000|Overall Study|Withdrawal by Subject|1|||
170649801|NCT01227824|616730888|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
170649802|NCT01227824|616730889|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
170649803|NCT01227824|616730890|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
170649804|NCT01227824|616730888|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
170649805|NCT01227824|616730889|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
170649806|NCT01227824|616730890|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
170649807|NCT01227824|616730888|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
170649808|NCT01227824|616730889|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
170581573|NCT04299308|616471082|FG001|Overall Study|Withdrawal by Subject|0|||
170581574|NCT04299308|616471081|FG000|Overall Study|issue with PET image (1)|1|||
170649809|NCT01227824|616730890|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
170581575|NCT04299308|616471082|FG001|Overall Study|issue with PET image (1)|0|||
170581576|NCT02920528|616471085|FG000|Overall Study|Incomplete Data|1|||
170581577|NCT02920528|616471086|FG001|Overall Study|Incomplete Data|1|||
170581578|NCT02920528|616471087|FG002|Overall Study|Incomplete Data|1|||
170581579|NCT02920528|616471085|FG000|Overall Study|Adverse Event|0|||
170581580|NCT02920528|616471086|FG001|Overall Study|Adverse Event|0|||
170649810|NCT01227824|616730888|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
170649811|NCT01227824|616730889|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
170649812|NCT01227824|616730890|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
170649813|NCT01227824|616730888|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
170581581|NCT02920528|616471087|FG002|Overall Study|Adverse Event|3|||
170581582|NCT02920528|616471085|FG000|Overall Study|Did not meet inclusion criteria|2|||
170581583|NCT02920528|616471086|FG001|Overall Study|Did not meet inclusion criteria|0|||
170581584|NCT02920528|616471087|FG002|Overall Study|Did not meet inclusion criteria|1|||
170581585|NCT00218634|616471089|FG000|Overall Study|Lost to Follow-up|8|||
170581586|NCT00218634|616471090|FG001|Overall Study|Lost to Follow-up|15|||
170581587|NCT00734604|616471091|FG000|Overall Study|Adverse Event|0|||
170581588|NCT00734604|616471092|FG001|Overall Study|Adverse Event|2|||
170581589|NCT00734604|616471093|FG002|Overall Study|Adverse Event|0|||
170581590|NCT00734604|616471094|FG003|Overall Study|Adverse Event|2|||
170581591|NCT00734604|616471095|FG004|Overall Study|Adverse Event|1|||
170581592|NCT00734604|616471096|FG005|Overall Study|Adverse Event|1|||
170581593|NCT00734604|616471091|FG000|Overall Study|Serious Adverse Event|1|||
170581594|NCT00734604|616471092|FG001|Overall Study|Serious Adverse Event|0|||
170581595|NCT00734604|616471093|FG002|Overall Study|Serious Adverse Event|1|||
170581596|NCT00734604|616471094|FG003|Overall Study|Serious Adverse Event|2|||
170581597|NCT00734604|616471095|FG004|Overall Study|Serious Adverse Event|0|||
170581598|NCT00734604|616471096|FG005|Overall Study|Serious Adverse Event|1|||
170581599|NCT00734604|616471091|FG000|Overall Study|Lost to Follow-up|1|||
170581600|NCT00734604|616471092|FG001|Overall Study|Lost to Follow-up|2|||
170581601|NCT00734604|616471093|FG002|Overall Study|Lost to Follow-up|2|||
170581602|NCT00734604|616471094|FG003|Overall Study|Lost to Follow-up|4|||
170581603|NCT00734604|616471095|FG004|Overall Study|Lost to Follow-up|2|||
170581604|NCT00734604|616471096|FG005|Overall Study|Lost to Follow-up|3|||
170581605|NCT00734604|616471091|FG000|Overall Study|Physician Decision|0|||
170581606|NCT00734604|616471092|FG001|Overall Study|Physician Decision|1|||
170581607|NCT00734604|616471093|FG002|Overall Study|Physician Decision|1|||
170581608|NCT00734604|616471094|FG003|Overall Study|Physician Decision|0|||
170581609|NCT00734604|616471095|FG004|Overall Study|Physician Decision|0|||
170581610|NCT00734604|616471096|FG005|Overall Study|Physician Decision|0|||
170581611|NCT00734604|616471091|FG000|Overall Study|Protocol Violation|0|||
170581612|NCT00734604|616471092|FG001|Overall Study|Protocol Violation|2|||
170581613|NCT00734604|616471093|FG002|Overall Study|Protocol Violation|0|||
170581614|NCT00734604|616471094|FG003|Overall Study|Protocol Violation|0|||
170581615|NCT00734604|616471095|FG004|Overall Study|Protocol Violation|1|||
170581616|NCT00734604|616471096|FG005|Overall Study|Protocol Violation|0|||
170581617|NCT00734604|616471091|FG000|Overall Study|Sponsor Decision|1|||
170581618|NCT00734604|616471092|FG001|Overall Study|Sponsor Decision|2|||
170581619|NCT00734604|616471093|FG002|Overall Study|Sponsor Decision|1|||
170581620|NCT00734604|616471094|FG003|Overall Study|Sponsor Decision|0|||
170581621|NCT00734604|616471095|FG004|Overall Study|Sponsor Decision|2|||
170581622|NCT00734604|616471096|FG005|Overall Study|Sponsor Decision|0|||
170581623|NCT00734604|616471091|FG000|Overall Study|Withdrawal by Subject|0|||
170581624|NCT00734604|616471092|FG001|Overall Study|Withdrawal by Subject|2|||
170581625|NCT00734604|616471093|FG002|Overall Study|Withdrawal by Subject|0|||
170581626|NCT00734604|616471094|FG003|Overall Study|Withdrawal by Subject|1|||
170581627|NCT00734604|616471095|FG004|Overall Study|Withdrawal by Subject|2|||
170581628|NCT00734604|616471096|FG005|Overall Study|Withdrawal by Subject|1|||
170581629|NCT00734604|616471091|FG000|Overall Study|Lack of Efficacy|0|||
170581630|NCT00734604|616471092|FG001|Overall Study|Lack of Efficacy|1|||
170581631|NCT00734604|616471093|FG002|Overall Study|Lack of Efficacy|1|||
170581632|NCT00734604|616471094|FG003|Overall Study|Lack of Efficacy|0|||
170581633|NCT00734604|616471095|FG004|Overall Study|Lack of Efficacy|0|||
170581634|NCT00734604|616471096|FG005|Overall Study|Lack of Efficacy|0|||
170581635|NCT02650804|616471097|FG000|Overall Study|Adverse Event|3|||
170581636|NCT02650804|616471098|FG001|Overall Study|Adverse Event|2|||
170581637|NCT02650804|616471097|FG000|Overall Study|Death|1|||
170581638|NCT02650804|616471098|FG001|Overall Study|Death|2|||
170581639|NCT02650804|616471097|FG000|Overall Study|Progressive Disease|7|||
170581640|NCT02650804|616471098|FG001|Overall Study|Progressive Disease|10|||
170581641|NCT02650804|616471097|FG000|Overall Study|Physician Decision|0|||
170581642|NCT02650804|616471098|FG001|Overall Study|Physician Decision|2|||
170581643|NCT02650804|616471097|FG000|Overall Study|Withdrawal by Subject|1|||
170581644|NCT02650804|616471098|FG001|Overall Study|Withdrawal by Subject|4|||
170581645|NCT02650804|616471097|FG000|Overall Study|Symptomatic deterioration|5|||
170581646|NCT02650804|616471098|FG001|Overall Study|Symptomatic deterioration|7|||
170581647|NCT02650804|616471097|FG000|Overall Study|Protocol Violation|0|||
170910664|NCT02786537|617677241|FG002|As Treated|Withdrawal by Subject|0|||
170581648|NCT02650804|616471098|FG001|Overall Study|Protocol Violation|1|||
170581649|NCT04848220|616471099|FG000|Overall Study|Unable to proceed to study procedure|0|||
170581650|NCT04848220|616471100|FG001|Overall Study|Unable to proceed to study procedure|1|||
170581651|NCT04848220|616471101|FG002|Overall Study|Unable to proceed to study procedure|0|||
170581652|NCT04848220|616471099|FG000|Overall Study|Fractional flow not significant|0|||
170581653|NCT04848220|616471100|FG001|Overall Study|Fractional flow not significant|1|||
170581654|NCT04848220|616471101|FG002|Overall Study|Fractional flow not significant|0|||
170581655|NCT02513485|616471110|FG000|Overall Study|Adverse Event|1|||
170581656|NCT02513485|616471111|FG001|Overall Study|Adverse Event|0|||
170581657|NCT02150057|616471127|FG000|Overall Study|Lost to Follow-up|6|||
170581658|NCT02150057|616471128|FG001|Overall Study|Lost to Follow-up|4|||
170581659|NCT00489424|616471129|FG000|Overall Study|Adverse Event|3|||
170581660|NCT00489424|616471130|FG001|Overall Study|Adverse Event|3|||
170581661|NCT00489424|616471131|FG002|Overall Study|Adverse Event|4|||
170581662|NCT00489424|616471129|FG000|Overall Study|Lack of Efficacy|1|||
170581663|NCT00489424|616471130|FG001|Overall Study|Lack of Efficacy|0|||
170581664|NCT00489424|616471131|FG002|Overall Study|Lack of Efficacy|0|||
170581665|NCT00489424|616471129|FG000|Overall Study|Administrative problems|0|||
170581666|NCT00489424|616471130|FG001|Overall Study|Administrative problems|2|||
170581667|NCT00489424|616471131|FG002|Overall Study|Administrative problems|1|||
170581668|NCT00654745|616471139|FG000|Overall Study|Adverse Event|12|||
170581669|NCT00654745|616471139|FG000|Overall Study|Lost to Follow-up|7|||
170581670|NCT00654745|616471139|FG000|Overall Study|Protocol Violation|11|||
170581671|NCT00654745|616471139|FG000|Overall Study|Withdrawal by Subject|10|||
170581672|NCT00654745|616471139|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
170581673|NCT04551963|616471140|FG000|Overall Study|Physician Decision|1|||
170581674|NCT04551963|616471141|FG001|Overall Study|Physician Decision|1|||
170581675|NCT04551963|616471140|FG000|Overall Study|Death|1|||
170581676|NCT04551963|616471141|FG001|Overall Study|Death|0|||
170581677|NCT02974855|616471142|FG000|Overall Study|Adverse Event|0|||
170581678|NCT02974855|616471143|FG001|Overall Study|Adverse Event|1|||
170581679|NCT02974855|616471144|FG002|Overall Study|Adverse Event|0|||
170581680|NCT02974855|616471145|FG003|Overall Study|Adverse Event|1|||
170581681|NCT01474772|616471146|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
170581682|NCT01474772|616471147|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
170581683|NCT01474772|616471146|FG000|Period 1|AE not Related to Study Drug|1|||
170581684|NCT01474772|616471147|FG001|Period 1|AE not Related to Study Drug|0|||
170581685|NCT01474772|616471146|FG000|Period 1|Withdrawal by Subject|3|||
170581686|NCT01474772|616471147|FG001|Period 1|Withdrawal by Subject|1|||
170581687|NCT01474772|616471146|FG000|Period 1|Lost to Follow-up|1|||
170581688|NCT01474772|616471147|FG001|Period 1|Lost to Follow-up|0|||
170581689|NCT01474772|616471146|FG000|Period 1|Reason not Specified|1|||
170581690|NCT01474772|616471147|FG001|Period 1|Reason not Specified|1|||
170581691|NCT01474772|616471146|FG000|Washout|AE not Related to Study Drug|2|||
170581692|NCT01474772|616471147|FG001|Washout|AE not Related to Study Drug|0|||
170581693|NCT01474772|616471146|FG000|Washout|Withdrawal by Subject|1|||
170581694|NCT01474772|616471147|FG001|Washout|Withdrawal by Subject|0|||
170581695|NCT01474772|616471146|FG000|Washout|Lost to Follow-up|0|||
170581696|NCT01474772|616471147|FG001|Washout|Lost to Follow-up|1|||
170581697|NCT01474772|616471146|FG000|Washout|Reason not Specified|0|||
170581698|NCT01474772|616471147|FG001|Washout|Reason not Specified|1|||
170581699|NCT01474772|616471146|FG000|Period 2|Death|0|||
170581700|NCT01474772|616471147|FG001|Period 2|Death|1|||
170581701|NCT01474772|616471146|FG000|Period 2|AE Related to Study Drug|0|||
170581702|NCT01474772|616471147|FG001|Period 2|AE Related to Study Drug|1|||
170581703|NCT01474772|616471146|FG000|Period 2|AE not Related to Study Drug|4|||
170581704|NCT01474772|616471147|FG001|Period 2|AE not Related to Study Drug|1|||
170581705|NCT01474772|616471146|FG000|Period 2|Lack of Efficacy|1|||
170581706|NCT01474772|616471147|FG001|Period 2|Lack of Efficacy|0|||
170581707|NCT01474772|616471146|FG000|Period 2|Withdrawal by Subject|3|||
170581708|NCT01474772|616471147|FG001|Period 2|Withdrawal by Subject|4|||
170581709|NCT01474772|616471146|FG000|Period 2|Lost to Follow-up|1|||
170581710|NCT01474772|616471147|FG001|Period 2|Lost to Follow-up|1|||
170581711|NCT01474772|616471146|FG000|Period 2|Reason not Specified|0|||
170581712|NCT01474772|616471147|FG001|Period 2|Reason not Specified|2|||
170581713|NCT01474772|616471146|FG000|Follow-up|AE not Related to Study Drug|0|||
170581714|NCT01474772|616471147|FG001|Follow-up|AE not Related to Study Drug|1|||
170581715|NCT00633074|616471148|FG000|Overall Study|Adverse Event|1|||
170581716|NCT00633074|616471149|FG001|Overall Study|Adverse Event|0|||
170581717|NCT00748618|616471150|FG000|Overall Study|Adverse Event|1|||
170581718|NCT00748618|616471151|FG001|Overall Study|Adverse Event|0|||
170581719|NCT00466947|616471152|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
170581720|NCT00466947|616471153|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
170581721|NCT00466947|616471152|FG000|Study End Analysis Period|Adverse Event|35|||
170581722|NCT00466947|616471153|FG001|Study End Analysis Period|Adverse Event|43|||
170581723|NCT00466947|616471152|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
170581724|NCT00466947|616471153|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
170581725|NCT00466947|616471152|FG000|Study End Analysis Period|Physician Decision|29|||
170581726|NCT00466947|616471153|FG001|Study End Analysis Period|Physician Decision|29|||
170581727|NCT00466947|616471152|FG000|Study End Analysis Period|Protocol Violation|9|||
170581728|NCT00466947|616471153|FG001|Study End Analysis Period|Protocol Violation|17|||
170581729|NCT00466947|616471152|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
170581730|NCT00466947|616471153|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
170581731|NCT00466947|616471152|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
170581732|NCT00466947|616471153|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
170581733|NCT00466947|616471152|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
170581734|NCT00466947|616471153|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
170581735|NCT00466947|616471152|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
170581736|NCT00466947|616471153|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
170581737|NCT00425698|616471154|FG000|Overall Study|Adverse Event|3|||
170581738|NCT00425698|616471155|FG001|Overall Study|Adverse Event|1|||
170581739|NCT00425698|616471154|FG000|Overall Study|Withdrawal by Subject|0|||
170581740|NCT00425698|616471155|FG001|Overall Study|Withdrawal by Subject|1|||
170581741|NCT02570152|616471156|FG000|Overall Study|Protocol Violation|2|||
170581742|NCT02570152|616471156|FG000|Overall Study|Migrated/moved from study area|13|||
170581743|NCT03497975|616471157|FG000|Overall Study|Withdrew Consent|34|||
170581744|NCT03497975|616471158|FG001|Overall Study|Withdrew Consent|35|||
170581745|NCT03497975|616471157|FG000|Overall Study|Lost to Follow-up|7|||
170581746|NCT03497975|616471158|FG001|Overall Study|Lost to Follow-up|7|||
170581747|NCT03497975|616471157|FG000|Overall Study|Physician Decision|4|||
170581748|NCT03497975|616471158|FG001|Overall Study|Physician Decision|5|||
170581749|NCT03497975|616471157|FG000|Overall Study|Discontinued|42|||
170581750|NCT03497975|616471158|FG001|Overall Study|Discontinued|39|||
170581751|NCT03497975|616471157|FG000|Overall Study|Reason Not Specified|15|||
170581752|NCT03497975|616471158|FG001|Overall Study|Reason Not Specified|14|||
170581753|NCT00716482|616471162|FG000|Overall Study|Lost to Follow-up|6|||
170581754|NCT00716482|616471162|FG000|Overall Study|Inadequate acquisition or analysis|50|||
170581755|NCT00716482|616471162|FG000|Overall Study|no pathology obtained|10|||
170581756|NCT00716482|616471162|FG000|Overall Study|technical/machine error|28|||
170581757|NCT00716482|616471162|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
170581758|NCT02027311|616471169|FG000|Overall Study|Protocol Violation|3|||
170581759|NCT02027311|616471170|FG001|Overall Study|Protocol Violation|2|||
170581760|NCT00506454|616471182|FG000|Overall Study|Withdrawal by Subject|1|||
170581761|NCT00506454|616471183|FG001|Overall Study|Withdrawal by Subject|1|||
170581762|NCT04470050|616471186|FG000|Double-blind Treatment Phase|Adverse Event|0|||
170581763|NCT04470050|616471187|FG001|Double-blind Treatment Phase|Adverse Event|0|||
170581764|NCT04470050|616471188|FG002|Double-blind Treatment Phase|Adverse Event|0|||
170581765|NCT04470050|616471189|FG003|Double-blind Treatment Phase|Adverse Event|1|||
170581766|NCT04470050|616471190|FG004|Double-blind Treatment Phase|Adverse Event|0|||
170581767|NCT04470050|616471191|FG005|Double-blind Treatment Phase|Adverse Event|0|||
170581768|NCT04470050|616471192|FG006|Double-blind Treatment Phase|Adverse Event|0|||
170581769|NCT04470050|616471186|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
170581770|NCT04470050|616471187|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
170581771|NCT04470050|616471188|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
170581772|NCT04470050|616471189|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
170581773|NCT04470050|616471190|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
170581774|NCT04470050|616471191|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
170581775|NCT04470050|616471192|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
170581776|NCT04470050|616471186|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
170581777|NCT04470050|616471187|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
170581778|NCT04470050|616471188|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
170581779|NCT04470050|616471189|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
170581780|NCT04470050|616471190|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
170581781|NCT04470050|616471191|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
170581782|NCT04470050|616471192|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
170581783|NCT03604172|616471195|FG000|Overall Study|Lost to Follow-up|1|||
170581784|NCT03604172|616471196|FG001|Overall Study|Lost to Follow-up|2|||
170581785|NCT00054327|616471197|FG000|Overall Study|Engraftment failure|1|||
170581786|NCT00054327|616471198|FG001|Overall Study|Engraftment failure|0|||
170581787|NCT00054327|616471199|FG002|Overall Study|Engraftment failure|0|||
170581788|NCT00054327|616471200|FG003|Overall Study|Engraftment failure|0|||
170581789|NCT00054327|616471201|FG004|Overall Study|Engraftment failure|0|||
170581790|NCT00054327|616471202|FG005|Overall Study|Engraftment failure|0|||
170581791|NCT01221753|616471206|FG000|Overall Study|Adverse Event|1|||
170581792|NCT03724981|616473651|FG000|First Device|Protocol Violation|1|||
170581793|NCT03724981|616473652|FG001|First Device|Protocol Violation|1|||
170581794|NCT01456195|616473653|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
170581795|NCT01456195|616473654|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
170581796|NCT01456195|616473655|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
170581797|NCT01456195|616473653|FG000|Overall Study|Lost to Follow-up|3|||
170581798|NCT01456195|616473654|FG001|Overall Study|Lost to Follow-up|1|||
170581799|NCT01456195|616473655|FG002|Overall Study|Lost to Follow-up|3|||
170581800|NCT01456195|616473653|FG000|Overall Study|Voluntary Withdrawal|5|||
170581801|NCT01456195|616473654|FG001|Overall Study|Voluntary Withdrawal|3|||
170581802|NCT01456195|616473655|FG002|Overall Study|Voluntary Withdrawal|7|||
170581803|NCT01456195|616473653|FG000|Overall Study|Lack of Efficacy|0|||
170581804|NCT01456195|616473654|FG001|Overall Study|Lack of Efficacy|1|||
170581805|NCT01456195|616473655|FG002|Overall Study|Lack of Efficacy|0|||
170649814|NCT01227824|616730889|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
170649815|NCT01227824|616730890|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
170649816|NCT01227824|616730888|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
170649817|NCT01227824|616730889|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
170649818|NCT01227824|616730890|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
170649819|NCT01227824|616730888|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
170649820|NCT01227824|616730889|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
170649821|NCT01227824|616730890|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
170649822|NCT01227824|616730888|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
170649823|NCT01227824|616730889|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
170581806|NCT01456195|616473653|FG000|Overall Study|Other Reasons|2|||
170581807|NCT01456195|616473654|FG001|Overall Study|Other Reasons|1|||
170581808|NCT01456195|616473655|FG002|Overall Study|Other Reasons|3|||
170581809|NCT02640625|616473656|FG000|Overall Study|Adverse Event|1|||
170581810|NCT02109432|616473657|FG000|Overall Study|Withdrawal by Subject|1|||
170581811|NCT00511433|616473665|FG000|Overall Study|Adverse Event|5|||
170581812|NCT00511433|616473666|FG001|Overall Study|Adverse Event|0|||
170581813|NCT00511433|616473665|FG000|Overall Study|Other Reason|1|||
170581814|NCT00511433|616473666|FG001|Overall Study|Other Reason|1|||
170581815|NCT01380535|616473669|FG000|Overall Study|Adverse Event|3|||
170581816|NCT01380535|616473670|FG001|Overall Study|Adverse Event|3|||
170581817|NCT01380535|616473669|FG000|Overall Study|Death|3|||
170581818|NCT01380535|616473670|FG001|Overall Study|Death|0|||
170581819|NCT01380535|616473669|FG000|Overall Study|Study site closed|0|||
170581820|NCT01380535|616473670|FG001|Overall Study|Study site closed|5|||
170581821|NCT01380535|616473669|FG000|Overall Study|Withdrawal by Subject|1|||
170581822|NCT01380535|616473670|FG001|Overall Study|Withdrawal by Subject|2|||
170581823|NCT01380535|616473669|FG000|Overall Study|Protocol Violation|0|||
170581824|NCT01380535|616473670|FG001|Overall Study|Protocol Violation|2|||
170581825|NCT01380535|616473669|FG000|Overall Study|Lack of Efficacy|0|||
170581826|NCT01380535|616473670|FG001|Overall Study|Lack of Efficacy|3|||
170581827|NCT01579565|616473671|FG000|Randomized|Adverse Event|1|||
170581828|NCT01579565|616473672|FG001|Randomized|Adverse Event|3|||
170581829|NCT01579565|616473671|FG000|Randomized|Withdrawal by Subject|3|||
170581830|NCT01579565|616473672|FG001|Randomized|Withdrawal by Subject|0|||
170581831|NCT01579565|616473671|FG000|Randomized|inadequate preoperative pupil dilation|0|||
170581832|NCT01579565|616473672|FG001|Randomized|inadequate preoperative pupil dilation|1|||
170581833|NCT01579565|616473671|FG000|Randomized|prohibited preoperative eating|1|||
170581834|NCT01579565|616473672|FG001|Randomized|prohibited preoperative eating|0|||
170581835|NCT01579565|616473671|FG000|Randomized|prohibited preoperative medication|0|||
170581836|NCT01579565|616473672|FG001|Randomized|prohibited preoperative medication|1|||
170581837|NCT01579565|616473671|FG000|Treated|Physician Decision|0|||
170581838|NCT01579565|616473672|FG001|Treated|Physician Decision|1|||
170581839|NCT01579565|616473671|FG000|Treated|Lost to Follow-up|2|||
170581840|NCT01579565|616473672|FG001|Treated|Lost to Follow-up|1|||
170581841|NCT01579565|616473671|FG000|Treated|declined to return for final visit|0|||
170581842|NCT01579565|616473672|FG001|Treated|declined to return for final visit|1|||
170581843|NCT02013206|616473673|FG000|Overall Study|Progressive disease (PD)|14|||
170581844|NCT02013206|616473674|FG001|Overall Study|Progressive disease (PD)|17|||
170581845|NCT02013206|616473673|FG000|Overall Study|Symptomatic deterioration|3|||
170581846|NCT02013206|616473674|FG001|Overall Study|Symptomatic deterioration|1|||
170581847|NCT02013206|616473673|FG000|Overall Study|Adverse Event|1|||
170581848|NCT02013206|616473674|FG001|Overall Study|Adverse Event|0|||
170581849|NCT02013206|616473673|FG000|Overall Study|Patient refusal|2|||
170649824|NCT01227824|616730890|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
170649825|NCT01227824|616730888|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
170910665|NCT02786537|617677242|FG003|As Treated|Withdrawal by Subject|0|||
170910666|NCT02786537|617677243|FG004|As Treated|Withdrawal by Subject|1|||
170910667|NCT02786537|617677244|FG005|As Treated|Withdrawal by Subject|0|||
170910668|NCT02786537|617677239|FG000|As Treated|Incarceration|0|||
170910669|NCT02786537|617677240|FG001|As Treated|Incarceration|1|||
170910670|NCT02786537|617677241|FG002|As Treated|Incarceration|0|||
170910671|NCT02786537|617677242|FG003|As Treated|Incarceration|0|||
170581850|NCT02013206|616473674|FG001|Overall Study|Patient refusal|0|||
170581851|NCT02013206|616473673|FG000|Overall Study|Patient non-compliance|1|||
170581852|NCT02013206|616473674|FG001|Overall Study|Patient non-compliance|0|||
170581853|NCT02013206|616473673|FG000|Overall Study|Death|1|||
170581854|NCT02013206|616473674|FG001|Overall Study|Death|2|||
170581855|NCT02013206|616473673|FG000|Overall Study|Other reasons off treatment|5|||
170581856|NCT02013206|616473674|FG001|Overall Study|Other reasons off treatment|2|||
170581857|NCT02867813|616473675|FG000|Overall Study|Withdrawal by Subject|57|||
170581858|NCT02867813|616473676|FG001|Overall Study|Withdrawal by Subject|56|||
170581859|NCT02867813|616473675|FG000|Overall Study|Decision by Sponsor|7|||
170581860|NCT02867813|616473676|FG001|Overall Study|Decision by Sponsor|7|||
170581861|NCT02867813|616473675|FG000|Overall Study|Lost to Follow-up|91|||
170581862|NCT02867813|616473676|FG001|Overall Study|Lost to Follow-up|78|||
170581863|NCT02867813|616473675|FG000|Overall Study|Missing|2|||
170581864|NCT02867813|616473676|FG001|Overall Study|Missing|1|||
170581865|NCT02867813|616473675|FG000|Overall Study|Death|294|||
170581866|NCT02867813|616473676|FG001|Overall Study|Death|268|||
170581867|NCT02791191|616473677|FG000|Overall Study|Adverse Event|2|||
170581868|NCT02791191|616473678|FG001|Overall Study|Adverse Event|4|||
170581869|NCT02791191|616473679|FG002|Overall Study|Adverse Event|5|||
170581870|NCT02791191|616473677|FG000|Overall Study|Lack of Efficacy|0|||
170581871|NCT02791191|616473678|FG001|Overall Study|Lack of Efficacy|1|||
170581872|NCT02791191|616473679|FG002|Overall Study|Lack of Efficacy|0|||
170581873|NCT02791191|616473677|FG000|Overall Study|Study Drug Non-Compliance|0|||
170581874|NCT02791191|616473678|FG001|Overall Study|Study Drug Non-Compliance|2|||
170581875|NCT02791191|616473679|FG002|Overall Study|Study Drug Non-Compliance|0|||
170581876|NCT02791191|616473677|FG000|Overall Study|Site Closed by Sponsor|1|||
170581877|NCT02791191|616473678|FG001|Overall Study|Site Closed by Sponsor|1|||
170581878|NCT02791191|616473679|FG002|Overall Study|Site Closed by Sponsor|3|||
170581879|NCT02791191|616473677|FG000|Overall Study|Progressive Disease|1|||
170581880|NCT02791191|616473678|FG001|Overall Study|Progressive Disease|0|||
170581881|NCT02791191|616473679|FG002|Overall Study|Progressive Disease|0|||
170581882|NCT02791191|616473677|FG000|Overall Study|Study Terminated by Sponsor|29|||
170581883|NCT02791191|616473678|FG001|Overall Study|Study Terminated by Sponsor|101|||
170581884|NCT02791191|616473679|FG002|Overall Study|Study Terminated by Sponsor|109|||
170581885|NCT02791191|616473677|FG000|Overall Study|Withdrawal by Subject|3|||
170581886|NCT02791191|616473678|FG001|Overall Study|Withdrawal by Subject|1|||
170581887|NCT02791191|616473679|FG002|Overall Study|Withdrawal by Subject|3|||
170581888|NCT02791191|616473677|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
170581889|NCT02791191|616473678|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
170581890|NCT02791191|616473679|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
170581891|NCT03596047|616473681|FG000|Overall Study|Withdrawal by Subject|7|||
170581892|NCT03596047|616473682|FG001|Overall Study|Withdrawal by Subject|4|||
170581893|NCT03596047|616473681|FG000|Overall Study|Lost to Follow-up|0|||
170581894|NCT03596047|616473682|FG001|Overall Study|Lost to Follow-up|2|||
170581895|NCT01696968|616473683|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
170581896|NCT01696968|616473684|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
170581897|NCT01696968|616473683|FG000|Overall Study|Died Before Randomization|3|||
170581898|NCT01696968|616473684|FG001|Overall Study|Died Before Randomization|8|||
170581899|NCT01696968|616473683|FG000|Overall Study|Died Before ASU (Control)|278|||
170581900|NCT01696968|616473684|FG001|Overall Study|Died Before ASU (Control)|0|||
170581901|NCT01696968|616473683|FG000|Overall Study|Refused ASU (Control)|920|||
170581902|NCT01696968|616473684|FG001|Overall Study|Refused ASU (Control)|0|||
170581903|NCT01696968|616473683|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
170581904|NCT01696968|616473684|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
170581905|NCT00301262|616473688|FG000|Double Blind Phase (DB)|Adverse Event|1|||
170581906|NCT00301262|616473689|FG001|Double Blind Phase (DB)|Adverse Event|0|||
170581907|NCT00301262|616473688|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
170581908|NCT00301262|616473689|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
170581909|NCT00301262|616473688|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
170581910|NCT00301262|616473689|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
170581911|NCT00301262|616473688|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
170809562|NCT04445831|617312357|FG001|Overall Study|Subject withdrawal by caregiver|1|||
170581912|NCT00301262|616473689|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
170581913|NCT00301262|616473688|FG000|Double Blind Phase (DB)|Other|1|||
170809563|NCT04445831|617312358|FG002|Overall Study|Subject withdrawal by caregiver|0|||
170809564|NCT04445831|617312359|FG003|Overall Study|Subject withdrawal by caregiver|0|||
170581914|NCT00301262|616473689|FG001|Double Blind Phase (DB)|Other|4|||
170581915|NCT00301262|616473688|FG000|Open Label Phase (OL)|Adverse Event|1|||
170581916|NCT00301262|616473689|FG001|Open Label Phase (OL)|Adverse Event|0|||
170581917|NCT00301262|616473688|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
170581918|NCT00301262|616473689|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
170809565|NCT04445831|617312360|FG004|Overall Study|Subject withdrawal by caregiver|0|||
170809566|NCT04445831|617312361|FG005|Overall Study|Subject withdrawal by caregiver|0|||
170809567|NCT04445831|617312362|FG006|Overall Study|Subject withdrawal by caregiver|0|||
170809568|NCT04912856|617312366|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
170581919|NCT00301262|616473688|FG000|Open Label Phase (OL)|Other|2|||
170581920|NCT00301262|616473689|FG001|Open Label Phase (OL)|Other|0|||
170581921|NCT02582814|616473690|FG000|Overall Study|Study-specific withdrawal criteria|1|||
170581922|NCT02582814|616473691|FG001|Overall Study|Study-specific withdrawal criteria|0|||
170581923|NCT02582814|616473690|FG000|Overall Study|Withdrawal by Subject|4|||
170581924|NCT02582814|616473691|FG001|Overall Study|Withdrawal by Subject|3|||
170581925|NCT02582814|616473690|FG000|Overall Study|Adverse Event|4|||
170581926|NCT02582814|616473691|FG001|Overall Study|Adverse Event|4|||
170581927|NCT02557100|616473695|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
170581928|NCT02557100|616473696|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
170581929|NCT02557100|616473697|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
170581930|NCT02557100|616473695|FG000|Single Blind Treatment Period|Death|0|||
170581931|NCT02557100|616473696|FG001|Single Blind Treatment Period|Death|1|||
170581932|NCT02557100|616473697|FG002|Single Blind Treatment Period|Death|0|||
170581933|NCT02557100|616473695|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
170581934|NCT02557100|616473696|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
170581935|NCT02557100|616473697|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
170581936|NCT02557100|616473695|FG000|Single Blind Treatment Period|Adverse Event|0|||
170809569|NCT04912856|617312367|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
170809570|NCT04912856|617312366|FG000|Overall Study|Not reported in synoptic CSR.|0|||
170809571|NCT04912856|617312367|FG001|Overall Study|Not reported in synoptic CSR.|1|||
170809572|NCT02434328|617312370|FG000|Overall Study|Adverse Event|9|||
170581937|NCT02557100|616473696|FG001|Single Blind Treatment Period|Adverse Event|1|||
170581938|NCT02557100|616473697|FG002|Single Blind Treatment Period|Adverse Event|0|||
170581939|NCT02557100|616473695|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
170581940|NCT02557100|616473696|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
170581941|NCT02557100|616473697|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
170581942|NCT02557100|616473695|FG000|Cumulative Abatacept Period|Other Reasons|0|||
170581943|NCT02557100|616473696|FG001|Cumulative Abatacept Period|Other Reasons|0|||
170581944|NCT02557100|616473697|FG002|Cumulative Abatacept Period|Other Reasons|1|||
170581945|NCT02557100|616473695|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
170809573|NCT02434328|617312371|FG001|Overall Study|Adverse Event|4|||
170809574|NCT02434328|617312370|FG000|Overall Study|Lack of Efficacy|0|||
170809575|NCT02434328|617312371|FG001|Overall Study|Lack of Efficacy|2|||
170809576|NCT02434328|617312370|FG000|Overall Study|Physician Decision|0|||
170809577|NCT02434328|617312371|FG001|Overall Study|Physician Decision|1|||
170809578|NCT02434328|617312370|FG000|Overall Study|Withdrawal by Subject|12|||
170809579|NCT02434328|617312371|FG001|Overall Study|Withdrawal by Subject|21|||
170809580|NCT02434328|617312370|FG000|Overall Study|Death|4|||
170809581|NCT02434328|617312371|FG001|Overall Study|Death|7|||
170809582|NCT02434328|617312370|FG000|Overall Study|Lost to Follow-up|1|||
170809583|NCT02434328|617312371|FG001|Overall Study|Lost to Follow-up|6|||
170809584|NCT02434328|617312370|FG000|Overall Study|Other|4|||
170809585|NCT02434328|617312371|FG001|Overall Study|Other|1|||
170809586|NCT04118894|617312373|FG000|Overall Study|Lost to Follow-up|21|||
170809587|NCT04118894|617312373|FG000|Overall Study|Withdrawal by Subject|10|||
170809588|NCT04118894|617312373|FG000|Overall Study|Adverse Event|4|||
170809589|NCT01185340|617313772|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
170809590|NCT01185340|617313773|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170809591|NCT01185340|617313774|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170809592|NCT01185340|617313775|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170809593|NCT01185340|617313772|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
170809594|NCT01185340|617313773|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170809595|NCT01185340|617313774|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170809596|NCT01185340|617313775|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170809597|NCT01185340|617313772|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
170809598|NCT01185340|617313773|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170809599|NCT01185340|617313774|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170581946|NCT02557100|616473696|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
170581947|NCT02557100|616473697|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
170581948|NCT02557100|616473695|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
170581949|NCT02557100|616473696|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
170581950|NCT02557100|616473697|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
170581951|NCT01558115|616473700|FG000|Overall Study|Withdrawal by Subject|3|||
170581952|NCT01558115|616473700|FG000|Overall Study|Study closed due to poor enrollment|4|||
170581953|NCT01436656|616473701|FG000|Dose Escalation|Death|1|||
170649826|NCT01227824|616730889|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
170809600|NCT01185340|617313775|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170809601|NCT01185340|617313772|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
170809602|NCT01185340|617313773|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170809603|NCT01185340|617313774|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170809604|NCT01185340|617313775|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170809605|NCT01185340|617313772|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
170809606|NCT01185340|617313773|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170809607|NCT01185340|617313774|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170809608|NCT01185340|617313775|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170809609|NCT01185340|617313772|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
170809610|NCT01185340|617313773|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170809611|NCT01185340|617313774|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170809612|NCT01185340|617313775|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170910672|NCT02786537|617677243|FG004|As Treated|Incarceration|0|||
170581954|NCT01436656|616473702|FG001|Dose Escalation|Death|3|||
170581955|NCT01436656|616473703|FG002|Dose Escalation|Death|1|||
170581956|NCT01436656|616473704|FG003|Dose Escalation|Death|0|||
170581957|NCT01436656|616473705|FG004|Dose Escalation|Death|2|||
170581958|NCT01436656|616473706|FG005|Dose Escalation|Death|1|||
170581959|NCT01436656|616473707|FG006|Dose Escalation|Death|1|||
170581960|NCT01436656|616473708|FG007|Dose Escalation|Death|1|||
170581961|NCT01436656|616473709|FG008|Dose Escalation|Death|1|||
170581962|NCT01436656|616473710|FG009|Dose Escalation|Death|0|||
170581963|NCT01436656|616473711|FG010|Dose Escalation|Death|0|||
170581964|NCT01436656|616473712|FG011|Dose Escalation|Death|0|||
170581965|NCT01436656|616473713|FG012|Dose Escalation|Death|0|||
170581966|NCT01436656|616473714|FG013|Dose Escalation|Death|0|||
170581967|NCT01436656|616473715|FG014|Dose Escalation|Death|0|||
170581968|NCT01436656|616473716|FG015|Dose Escalation|Death|0|||
170581969|NCT01436656|616473717|FG016|Dose Escalation|Death|0|||
170581970|NCT01436656|616473718|FG017|Dose Escalation|Death|0|||
170581971|NCT01436656|616473701|FG000|Dose Escalation|Protocol Violation|0|||
170581972|NCT01436656|616473702|FG001|Dose Escalation|Protocol Violation|0|||
170581973|NCT01436656|616473703|FG002|Dose Escalation|Protocol Violation|0|||
170581974|NCT01436656|616473704|FG003|Dose Escalation|Protocol Violation|0|||
170581975|NCT01436656|616473705|FG004|Dose Escalation|Protocol Violation|0|||
170581976|NCT01436656|616473706|FG005|Dose Escalation|Protocol Violation|1|||
170581977|NCT01436656|616473707|FG006|Dose Escalation|Protocol Violation|0|||
170581978|NCT01436656|616473708|FG007|Dose Escalation|Protocol Violation|0|||
170581979|NCT01436656|616473709|FG008|Dose Escalation|Protocol Violation|0|||
170581980|NCT01436656|616473710|FG009|Dose Escalation|Protocol Violation|0|||
170581981|NCT01436656|616473711|FG010|Dose Escalation|Protocol Violation|0|||
170581982|NCT01436656|616473712|FG011|Dose Escalation|Protocol Violation|0|||
170581983|NCT01436656|616473713|FG012|Dose Escalation|Protocol Violation|0|||
170581984|NCT01436656|616473714|FG013|Dose Escalation|Protocol Violation|0|||
170581985|NCT01436656|616473715|FG014|Dose Escalation|Protocol Violation|0|||
170581986|NCT01436656|616473716|FG015|Dose Escalation|Protocol Violation|0|||
170581987|NCT01436656|616473717|FG016|Dose Escalation|Protocol Violation|0|||
170581988|NCT01436656|616473718|FG017|Dose Escalation|Protocol Violation|0|||
170581989|NCT01436656|616473701|FG000|Dose Escalation|Withdrawal by Subject|0|||
170581990|NCT01436656|616473702|FG001|Dose Escalation|Withdrawal by Subject|0|||
170581991|NCT01436656|616473703|FG002|Dose Escalation|Withdrawal by Subject|0|||
170581992|NCT01436656|616473704|FG003|Dose Escalation|Withdrawal by Subject|0|||
170581993|NCT01436656|616473705|FG004|Dose Escalation|Withdrawal by Subject|1|||
170581994|NCT01436656|616473706|FG005|Dose Escalation|Withdrawal by Subject|0|||
170581995|NCT01436656|616473707|FG006|Dose Escalation|Withdrawal by Subject|0|||
170581996|NCT01436656|616473708|FG007|Dose Escalation|Withdrawal by Subject|2|||
170581997|NCT01436656|616473709|FG008|Dose Escalation|Withdrawal by Subject|0|||
170581998|NCT01436656|616473710|FG009|Dose Escalation|Withdrawal by Subject|1|||
170581999|NCT01436656|616473711|FG010|Dose Escalation|Withdrawal by Subject|1|||
170582000|NCT01436656|616473712|FG011|Dose Escalation|Withdrawal by Subject|0|||
170582001|NCT01436656|616473713|FG012|Dose Escalation|Withdrawal by Subject|0|||
170582002|NCT01436656|616473714|FG013|Dose Escalation|Withdrawal by Subject|0|||
170582003|NCT01436656|616473715|FG014|Dose Escalation|Withdrawal by Subject|0|||
170582004|NCT01436656|616473716|FG015|Dose Escalation|Withdrawal by Subject|0|||
170582005|NCT01436656|616473717|FG016|Dose Escalation|Withdrawal by Subject|0|||
170582006|NCT01436656|616473718|FG017|Dose Escalation|Withdrawal by Subject|0|||
170582007|NCT01436656|616473701|FG000|Dose Escalation|Administrative problems|0|||
170582008|NCT01436656|616473702|FG001|Dose Escalation|Administrative problems|1|||
170582009|NCT01436656|616473703|FG002|Dose Escalation|Administrative problems|0|||
170582010|NCT01436656|616473704|FG003|Dose Escalation|Administrative problems|0|||
170582011|NCT01436656|616473705|FG004|Dose Escalation|Administrative problems|0|||
170649827|NCT01227824|616730890|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
170649828|NCT01227824|616730888|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
170649829|NCT01227824|616730889|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
170649830|NCT01227824|616730890|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
170649831|NCT01227824|616730888|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
170649832|NCT01227824|616730889|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
170649833|NCT01227824|616730890|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
170649834|NCT00781885|616730891|FG000|Overall Study|Physician Decision|1|||
170649835|NCT02576145|616730892|FG000|Overall Study|Adverse Event|1|||
170582012|NCT01436656|616473706|FG005|Dose Escalation|Administrative problems|0|||
170582013|NCT01436656|616473707|FG006|Dose Escalation|Administrative problems|0|||
170582014|NCT01436656|616473708|FG007|Dose Escalation|Administrative problems|0|||
170582015|NCT01436656|616473709|FG008|Dose Escalation|Administrative problems|0|||
170582016|NCT01436656|616473710|FG009|Dose Escalation|Administrative problems|0|||
170582017|NCT01436656|616473711|FG010|Dose Escalation|Administrative problems|0|||
170582018|NCT01436656|616473712|FG011|Dose Escalation|Administrative problems|0|||
170582019|NCT01436656|616473713|FG012|Dose Escalation|Administrative problems|0|||
170582020|NCT01436656|616473714|FG013|Dose Escalation|Administrative problems|0|||
170582021|NCT01436656|616473715|FG014|Dose Escalation|Administrative problems|0|||
170582022|NCT01436656|616473716|FG015|Dose Escalation|Administrative problems|0|||
170582023|NCT01436656|616473717|FG016|Dose Escalation|Administrative problems|0|||
170649836|NCT02576145|616730893|FG001|Overall Study|Adverse Event|0|||
170582024|NCT01436656|616473718|FG017|Dose Escalation|Administrative problems|0|||
170582025|NCT01436656|616473701|FG000|Dose Escalation|Lost to Follow-up|1|||
170582026|NCT01436656|616473702|FG001|Dose Escalation|Lost to Follow-up|0|||
170582027|NCT01436656|616473703|FG002|Dose Escalation|Lost to Follow-up|0|||
170582028|NCT01436656|616473704|FG003|Dose Escalation|Lost to Follow-up|0|||
170582029|NCT01436656|616473705|FG004|Dose Escalation|Lost to Follow-up|1|||
170582030|NCT01436656|616473706|FG005|Dose Escalation|Lost to Follow-up|0|||
170582031|NCT01436656|616473707|FG006|Dose Escalation|Lost to Follow-up|0|||
170582032|NCT01436656|616473708|FG007|Dose Escalation|Lost to Follow-up|0|||
170582033|NCT01436656|616473709|FG008|Dose Escalation|Lost to Follow-up|0|||
170582034|NCT01436656|616473710|FG009|Dose Escalation|Lost to Follow-up|0|||
170582035|NCT01436656|616473711|FG010|Dose Escalation|Lost to Follow-up|0|||
170582036|NCT01436656|616473712|FG011|Dose Escalation|Lost to Follow-up|0|||
170582037|NCT01436656|616473713|FG012|Dose Escalation|Lost to Follow-up|0|||
170582038|NCT01436656|616473714|FG013|Dose Escalation|Lost to Follow-up|0|||
170582039|NCT01436656|616473715|FG014|Dose Escalation|Lost to Follow-up|0|||
170582040|NCT01436656|616473716|FG015|Dose Escalation|Lost to Follow-up|0|||
170582041|NCT01436656|616473717|FG016|Dose Escalation|Lost to Follow-up|0|||
170582042|NCT01436656|616473718|FG017|Dose Escalation|Lost to Follow-up|0|||
170582043|NCT01436656|616473701|FG000|Dose Escalation|New anti-cancer therapy|1|||
170582044|NCT01436656|616473702|FG001|Dose Escalation|New anti-cancer therapy|0|||
170582045|NCT01436656|616473703|FG002|Dose Escalation|New anti-cancer therapy|0|||
170582046|NCT01436656|616473704|FG003|Dose Escalation|New anti-cancer therapy|0|||
170582047|NCT01436656|616473705|FG004|Dose Escalation|New anti-cancer therapy|0|||
170582048|NCT01436656|616473706|FG005|Dose Escalation|New anti-cancer therapy|0|||
170582049|NCT01436656|616473707|FG006|Dose Escalation|New anti-cancer therapy|0|||
170582050|NCT01436656|616473708|FG007|Dose Escalation|New anti-cancer therapy|0|||
170582051|NCT01436656|616473709|FG008|Dose Escalation|New anti-cancer therapy|1|||
170582052|NCT01436656|616473710|FG009|Dose Escalation|New anti-cancer therapy|1|||
170582053|NCT01436656|616473711|FG010|Dose Escalation|New anti-cancer therapy|0|||
170582054|NCT01436656|616473712|FG011|Dose Escalation|New anti-cancer therapy|0|||
170582055|NCT01436656|616473713|FG012|Dose Escalation|New anti-cancer therapy|0|||
170582056|NCT01436656|616473714|FG013|Dose Escalation|New anti-cancer therapy|0|||
170582057|NCT01436656|616473715|FG014|Dose Escalation|New anti-cancer therapy|0|||
170582058|NCT01436656|616473716|FG015|Dose Escalation|New anti-cancer therapy|0|||
170582059|NCT01436656|616473717|FG016|Dose Escalation|New anti-cancer therapy|0|||
170582060|NCT01436656|616473718|FG017|Dose Escalation|New anti-cancer therapy|0|||
170582061|NCT01436656|616473701|FG000|Dose Expansion|Adverse Event|0|||
170582062|NCT01436656|616473702|FG001|Dose Expansion|Adverse Event|0|||
170582063|NCT01436656|616473703|FG002|Dose Expansion|Adverse Event|0|||
170582064|NCT01436656|616473704|FG003|Dose Expansion|Adverse Event|0|||
170582065|NCT01436656|616473705|FG004|Dose Expansion|Adverse Event|0|||
170582066|NCT01436656|616473706|FG005|Dose Expansion|Adverse Event|0|||
170582067|NCT01436656|616473707|FG006|Dose Expansion|Adverse Event|0|||
170582068|NCT01436656|616473708|FG007|Dose Expansion|Adverse Event|0|||
170582069|NCT01436656|616473709|FG008|Dose Expansion|Adverse Event|0|||
170582070|NCT01436656|616473710|FG009|Dose Expansion|Adverse Event|0|||
170582071|NCT01436656|616473711|FG010|Dose Expansion|Adverse Event|0|||
170582072|NCT01436656|616473712|FG011|Dose Expansion|Adverse Event|1|||
170582073|NCT01436656|616473713|FG012|Dose Expansion|Adverse Event|0|||
170582074|NCT01436656|616473714|FG013|Dose Expansion|Adverse Event|0|||
170582075|NCT01436656|616473715|FG014|Dose Expansion|Adverse Event|0|||
170582076|NCT01436656|616473716|FG015|Dose Expansion|Adverse Event|0|||
170582077|NCT01436656|616473717|FG016|Dose Expansion|Adverse Event|0|||
170582078|NCT01436656|616473718|FG017|Dose Expansion|Adverse Event|0|||
170582079|NCT01436656|616473701|FG000|Dose Expansion|Withdrawal by Subject|0|||
170649837|NCT02576145|616730892|FG000|Overall Study|Withdrawal by Subject|1|||
170649838|NCT02576145|616730893|FG001|Overall Study|Withdrawal by Subject|0|||
170649839|NCT02576145|616730892|FG000|Overall Study|Acute rejection|1|||
170649840|NCT02576145|616730893|FG001|Overall Study|Acute rejection|0|||
170649841|NCT02576145|616730892|FG000|Overall Study|Tetanus Titers Decreased|0|||
170649842|NCT02576145|616730893|FG001|Overall Study|Tetanus Titers Decreased|1|||
170649843|NCT01700387|616730899|FG000|Overall Study|Withdrawal by Subject|1|||
170582080|NCT01436656|616473702|FG001|Dose Expansion|Withdrawal by Subject|0|||
170582081|NCT01436656|616473703|FG002|Dose Expansion|Withdrawal by Subject|0|||
170582082|NCT01436656|616473704|FG003|Dose Expansion|Withdrawal by Subject|0|||
170582083|NCT01436656|616473705|FG004|Dose Expansion|Withdrawal by Subject|0|||
170582084|NCT01436656|616473706|FG005|Dose Expansion|Withdrawal by Subject|0|||
170582085|NCT01436656|616473707|FG006|Dose Expansion|Withdrawal by Subject|0|||
170582086|NCT01436656|616473708|FG007|Dose Expansion|Withdrawal by Subject|0|||
170582087|NCT01436656|616473709|FG008|Dose Expansion|Withdrawal by Subject|0|||
170582088|NCT01436656|616473710|FG009|Dose Expansion|Withdrawal by Subject|0|||
170582089|NCT01436656|616473711|FG010|Dose Expansion|Withdrawal by Subject|0|||
170582090|NCT01436656|616473712|FG011|Dose Expansion|Withdrawal by Subject|1|||
170582091|NCT01436656|616473713|FG012|Dose Expansion|Withdrawal by Subject|3|||
170582092|NCT01436656|616473714|FG013|Dose Expansion|Withdrawal by Subject|1|||
170649844|NCT01700387|616730900|FG001|Overall Study|Withdrawal by Subject|2|||
170582093|NCT01436656|616473715|FG014|Dose Expansion|Withdrawal by Subject|2|||
170582094|NCT01436656|616473716|FG015|Dose Expansion|Withdrawal by Subject|0|||
170582095|NCT01436656|616473717|FG016|Dose Expansion|Withdrawal by Subject|1|||
170582096|NCT01436656|616473718|FG017|Dose Expansion|Withdrawal by Subject|1|||
170582097|NCT01436656|616473701|FG000|Dose Expansion|Death|0|||
170582098|NCT01436656|616473702|FG001|Dose Expansion|Death|0|||
170582099|NCT01436656|616473703|FG002|Dose Expansion|Death|0|||
170582100|NCT01436656|616473704|FG003|Dose Expansion|Death|0|||
170582101|NCT01436656|616473705|FG004|Dose Expansion|Death|0|||
170582102|NCT01436656|616473706|FG005|Dose Expansion|Death|0|||
170582103|NCT01436656|616473707|FG006|Dose Expansion|Death|0|||
170582104|NCT01436656|616473708|FG007|Dose Expansion|Death|0|||
170582105|NCT01436656|616473709|FG008|Dose Expansion|Death|0|||
170582106|NCT01436656|616473710|FG009|Dose Expansion|Death|0|||
170582107|NCT01436656|616473711|FG010|Dose Expansion|Death|0|||
170582108|NCT01436656|616473712|FG011|Dose Expansion|Death|0|||
170582109|NCT01436656|616473713|FG012|Dose Expansion|Death|1|||
170582110|NCT01436656|616473714|FG013|Dose Expansion|Death|0|||
170582111|NCT01436656|616473715|FG014|Dose Expansion|Death|3|||
170582112|NCT01436656|616473716|FG015|Dose Expansion|Death|0|||
170582113|NCT01436656|616473717|FG016|Dose Expansion|Death|3|||
170582114|NCT01436656|616473718|FG017|Dose Expansion|Death|3|||
170582115|NCT01436656|616473701|FG000|Dose Expansion|Lost to Follow-up|0|||
170582116|NCT01436656|616473702|FG001|Dose Expansion|Lost to Follow-up|0|||
170582117|NCT01436656|616473703|FG002|Dose Expansion|Lost to Follow-up|0|||
170582118|NCT01436656|616473704|FG003|Dose Expansion|Lost to Follow-up|0|||
170582119|NCT01436656|616473705|FG004|Dose Expansion|Lost to Follow-up|0|||
170582120|NCT01436656|616473706|FG005|Dose Expansion|Lost to Follow-up|0|||
170582121|NCT01436656|616473707|FG006|Dose Expansion|Lost to Follow-up|0|||
170582122|NCT01436656|616473708|FG007|Dose Expansion|Lost to Follow-up|0|||
170582123|NCT01436656|616473709|FG008|Dose Expansion|Lost to Follow-up|0|||
170582124|NCT01436656|616473710|FG009|Dose Expansion|Lost to Follow-up|0|||
170582125|NCT01436656|616473711|FG010|Dose Expansion|Lost to Follow-up|0|||
170582126|NCT01436656|616473712|FG011|Dose Expansion|Lost to Follow-up|0|||
170582127|NCT01436656|616473713|FG012|Dose Expansion|Lost to Follow-up|0|||
170582128|NCT01436656|616473714|FG013|Dose Expansion|Lost to Follow-up|0|||
170582129|NCT01436656|616473715|FG014|Dose Expansion|Lost to Follow-up|0|||
170582130|NCT01436656|616473716|FG015|Dose Expansion|Lost to Follow-up|0|||
170582131|NCT01436656|616473717|FG016|Dose Expansion|Lost to Follow-up|0|||
170582132|NCT01436656|616473718|FG017|Dose Expansion|Lost to Follow-up|3|||
170582133|NCT01436656|616473701|FG000|Dose Expansion|Disease progression|0|||
170582134|NCT01436656|616473702|FG001|Dose Expansion|Disease progression|0|||
170582135|NCT01436656|616473703|FG002|Dose Expansion|Disease progression|0|||
170582136|NCT01436656|616473704|FG003|Dose Expansion|Disease progression|0|||
170582137|NCT01436656|616473705|FG004|Dose Expansion|Disease progression|0|||
170582138|NCT01436656|616473706|FG005|Dose Expansion|Disease progression|0|||
170582139|NCT01436656|616473707|FG006|Dose Expansion|Disease progression|0|||
170582140|NCT01436656|616473708|FG007|Dose Expansion|Disease progression|0|||
170582141|NCT01436656|616473709|FG008|Dose Expansion|Disease progression|0|||
170582142|NCT01436656|616473710|FG009|Dose Expansion|Disease progression|0|||
170582143|NCT01436656|616473711|FG010|Dose Expansion|Disease progression|0|||
170582144|NCT01436656|616473712|FG011|Dose Expansion|Disease progression|3|||
170582145|NCT01436656|616473713|FG012|Dose Expansion|Disease progression|1|||
170582146|NCT01436656|616473714|FG013|Dose Expansion|Disease progression|0|||
170582147|NCT01436656|616473715|FG014|Dose Expansion|Disease progression|1|||
170582148|NCT01436656|616473716|FG015|Dose Expansion|Disease progression|0|||
170582149|NCT01436656|616473717|FG016|Dose Expansion|Disease progression|0|||
170582150|NCT01436656|616473718|FG017|Dose Expansion|Disease progression|1|||
170582151|NCT01436656|616473701|FG000|Dose Expansion|New cancer therapy|0|||
170582152|NCT01436656|616473702|FG001|Dose Expansion|New cancer therapy|0|||
170649845|NCT01700387|616730899|FG000|Overall Study|Adverse Event|1|||
170910673|NCT02786537|617677244|FG005|As Treated|Incarceration|0|||
170910674|NCT02786537|617677239|FG000|As Treated|Opiate dependency relapse|0|||
170582153|NCT01436656|616473703|FG002|Dose Expansion|New cancer therapy|0|||
170582154|NCT01436656|616473704|FG003|Dose Expansion|New cancer therapy|0|||
170582155|NCT01436656|616473705|FG004|Dose Expansion|New cancer therapy|0|||
170582156|NCT01436656|616473706|FG005|Dose Expansion|New cancer therapy|0|||
170582157|NCT01436656|616473707|FG006|Dose Expansion|New cancer therapy|0|||
170582158|NCT01436656|616473708|FG007|Dose Expansion|New cancer therapy|0|||
170582159|NCT01436656|616473709|FG008|Dose Expansion|New cancer therapy|0|||
170582160|NCT01436656|616473710|FG009|Dose Expansion|New cancer therapy|0|||
170582161|NCT01436656|616473711|FG010|Dose Expansion|New cancer therapy|0|||
170582162|NCT01436656|616473712|FG011|Dose Expansion|New cancer therapy|1|||
170582163|NCT01436656|616473713|FG012|Dose Expansion|New cancer therapy|1|||
170582164|NCT01436656|616473714|FG013|Dose Expansion|New cancer therapy|0|||
170582165|NCT01436656|616473715|FG014|Dose Expansion|New cancer therapy|2|||
170582166|NCT01436656|616473716|FG015|Dose Expansion|New cancer therapy|0|||
170582167|NCT01436656|616473717|FG016|Dose Expansion|New cancer therapy|0|||
170582168|NCT01436656|616473718|FG017|Dose Expansion|New cancer therapy|0|||
170582169|NCT01667224|616473719|FG000|Overall Study|Withdrawal by Subject|3|||
170582170|NCT01667224|616473720|FG001|Overall Study|Withdrawal by Subject|1|||
170582171|NCT01667224|616473719|FG000|Overall Study|Protocol Violation|1|||
170582172|NCT01667224|616473720|FG001|Overall Study|Protocol Violation|1|||
170582173|NCT01450696|616473724|FG000|Overall Study|Never Treated|1|||
170582174|NCT01450696|616473725|FG001|Overall Study|Never Treated|1|||
170582175|NCT01450696|616473724|FG000|Overall Study|Death|77|||
170582176|NCT01450696|616473725|FG001|Overall Study|Death|84|||
170582177|NCT01450696|616473724|FG000|Overall Study|Lost to Follow-up|3|||
170582178|NCT01450696|616473725|FG001|Overall Study|Lost to Follow-up|3|||
170582179|NCT01450696|616473724|FG000|Overall Study|Non-Compliance|1|||
170582180|NCT01450696|616473725|FG001|Overall Study|Non-Compliance|0|||
170582181|NCT01450696|616473724|FG000|Overall Study|Withdrawal by Subject|13|||
170582182|NCT01450696|616473725|FG001|Overall Study|Withdrawal by Subject|2|||
170582183|NCT01450696|616473724|FG000|Overall Study|Study Terminated by Sponsor|53|||
170582184|NCT01450696|616473725|FG001|Overall Study|Study Terminated by Sponsor|58|||
170582185|NCT01843673|616473729|FG000|Overall Study|Lack of Efficacy|2|||
170582186|NCT01843673|616473729|FG000|Overall Study|Withdrawal by Subject|4|||
170582187|NCT00730041|616473732|FG000|Overall Study|Lost to Follow-up|0|||
170582188|NCT00730041|616473733|FG001|Overall Study|Lost to Follow-up|2|||
170582189|NCT02684617|616473736|FG000|Overall Study|Adverse Event|1|||
170582190|NCT02684617|616473737|FG001|Overall Study|Adverse Event|0|||
170582191|NCT02684617|616473738|FG002|Overall Study|Adverse Event|1|||
170582192|NCT02684617|616473736|FG000|Overall Study|Death|8|||
170582193|NCT02684617|616473737|FG001|Overall Study|Death|16|||
170582194|NCT02684617|616473738|FG002|Overall Study|Death|28|||
170582195|NCT02684617|616473736|FG000|Overall Study|Withdrawal by Subject|2|||
170582196|NCT02684617|616473737|FG001|Overall Study|Withdrawal by Subject|0|||
170582197|NCT02684617|616473738|FG002|Overall Study|Withdrawal by Subject|4|||
170582198|NCT02684617|616473736|FG000|Overall Study|Screen Failure|1|||
170582199|NCT02684617|616473737|FG001|Overall Study|Screen Failure|0|||
170582200|NCT02684617|616473738|FG002|Overall Study|Screen Failure|2|||
170582201|NCT02684617|616473736|FG000|Overall Study|Study Terminated by Sponsor|6|||
170582202|NCT02684617|616473737|FG001|Overall Study|Study Terminated by Sponsor|1|||
170582203|NCT02684617|616473738|FG002|Overall Study|Study Terminated by Sponsor|5|||
170582204|NCT00853242|616473739|FG000|Overall Study|Adverse Event|0|||
170582205|NCT00853242|616473740|FG001|Overall Study|Adverse Event|1|||
170582206|NCT00853242|616473741|FG002|Overall Study|Adverse Event|1|||
170582207|NCT00853242|616473742|FG003|Overall Study|Adverse Event|0|||
170582208|NCT00853242|616473743|FG004|Overall Study|Adverse Event|3|||
170582209|NCT00853242|616473744|FG005|Overall Study|Adverse Event|1|||
170582210|NCT00853242|616473745|FG006|Overall Study|Adverse Event|1|||
170582211|NCT00853242|616473739|FG000|Overall Study|Noncompliant|0|||
170582212|NCT00853242|616473740|FG001|Overall Study|Noncompliant|0|||
170582213|NCT00853242|616473741|FG002|Overall Study|Noncompliant|0|||
170582214|NCT00853242|616473742|FG003|Overall Study|Noncompliant|0|||
170582215|NCT00853242|616473743|FG004|Overall Study|Noncompliant|1|||
170582216|NCT00853242|616473744|FG005|Overall Study|Noncompliant|0|||
170582217|NCT00853242|616473745|FG006|Overall Study|Noncompliant|0|||
170582218|NCT00853242|616473739|FG000|Overall Study|Withdrawal by Subject|1|||
170582219|NCT00853242|616473740|FG001|Overall Study|Withdrawal by Subject|2|||
170582220|NCT00853242|616473741|FG002|Overall Study|Withdrawal by Subject|0|||
170582221|NCT00853242|616473742|FG003|Overall Study|Withdrawal by Subject|4|||
170582222|NCT00853242|616473743|FG004|Overall Study|Withdrawal by Subject|0|||
170649846|NCT01700387|616730900|FG001|Overall Study|Adverse Event|1|||
170809613|NCT01185340|617313772|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
170809614|NCT01185340|617313773|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170809615|NCT01185340|617313774|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170809616|NCT01185340|617313775|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170809617|NCT01185340|617313772|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
170809618|NCT01185340|617313773|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
170809619|NCT01185340|617313774|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
170809620|NCT01185340|617313775|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
170582223|NCT00853242|616473744|FG005|Overall Study|Withdrawal by Subject|0|||
170582224|NCT00853242|616473745|FG006|Overall Study|Withdrawal by Subject|2|||
170582225|NCT00853242|616473739|FG000|Overall Study|Other|2|||
170582226|NCT00853242|616473740|FG001|Overall Study|Other|0|||
170582227|NCT00853242|616473741|FG002|Overall Study|Other|2|||
170582228|NCT00853242|616473742|FG003|Overall Study|Other|0|||
170582229|NCT00853242|616473743|FG004|Overall Study|Other|0|||
170582230|NCT00853242|616473744|FG005|Overall Study|Other|1|||
170582231|NCT00853242|616473745|FG006|Overall Study|Other|2|||
170582232|NCT00606034|616473746|FG000|Overall Study|incarceration|1|||
170582233|NCT01471028|616473753|FG000|VTI-208|Adverse Event|39|||
170582234|NCT01471028|616473754|FG001|VTI-208|Adverse Event|41|||
170582235|NCT01471028|616473753|FG000|VTI-208|Withdrawal by Subject|0|||
170582236|NCT01471028|616473754|FG001|VTI-208|Withdrawal by Subject|2|||
170582237|NCT01471028|616473753|FG000|VTI-208|Lost to Follow-up|1|||
170582238|NCT01471028|616473754|FG001|VTI-208|Lost to Follow-up|1|||
170582239|NCT01471028|616473753|FG000|VTI-208E|Death|7|||
170582240|NCT01471028|616473754|FG001|VTI-208E|Death|10|||
170582241|NCT01471028|616473753|FG000|VTI-208E|Withdrawal by Subject|1|||
170582242|NCT01471028|616473754|FG001|VTI-208E|Withdrawal by Subject|0|||
170582243|NCT01471028|616473753|FG000|VTI-208E|Lost to Follow-up|0|||
170582244|NCT01471028|616473754|FG001|VTI-208E|Lost to Follow-up|2|||
170582245|NCT00904670|616473755|FG000|Open Label Phase|Withdrawal by Subject|2|||
170582246|NCT00904670|616473756|FG001|Open Label Phase|Withdrawal by Subject|0|||
170582247|NCT00904670|616473755|FG000|Open Label Phase|Adverse Event|2|||
170582248|NCT00904670|616473756|FG001|Open Label Phase|Adverse Event|0|||
170582249|NCT00904670|616473755|FG000|Open Label Phase|Lack of Efficacy|1|||
170582250|NCT00904670|616473756|FG001|Open Label Phase|Lack of Efficacy|0|||
170582251|NCT00904670|616473755|FG000|Open Label Phase|Lost to Follow-up|1|||
170582252|NCT00904670|616473756|FG001|Open Label Phase|Lost to Follow-up|0|||
170582253|NCT03768089|616473762|FG000|Part A|Lost to Follow-up|0|||
170582254|NCT03768089|616473763|FG001|Part A|Lost to Follow-up|0|||
170582255|NCT03768089|616473764|FG002|Part A|Lost to Follow-up|0|||
170582256|NCT03768089|616473765|FG003|Part A|Lost to Follow-up|0|||
170582257|NCT03768089|616473766|FG004|Part A|Lost to Follow-up|1|||
170582258|NCT03768089|616473767|FG005|Part A|Lost to Follow-up|0|||
170582259|NCT03768089|616473768|FG006|Part A|Lost to Follow-up|0|||
170582260|NCT03768089|616473769|FG007|Part A|Lost to Follow-up|0|||
170582261|NCT03768089|616473770|FG008|Part A|Lost to Follow-up|0|||
170582262|NCT03768089|616473771|FG009|Part A|Lost to Follow-up|0|||
170582263|NCT03768089|616473772|FG010|Part A|Lost to Follow-up|0|||
170582264|NCT03768089|616473773|FG011|Part A|Lost to Follow-up|0|||
170582265|NCT03768089|616473774|FG012|Part A|Lost to Follow-up|0|||
170582266|NCT03768089|616473775|FG013|Part A|Lost to Follow-up|0|||
170582267|NCT03768089|616473776|FG014|Part A|Lost to Follow-up|0|||
170582268|NCT03768089|616473777|FG015|Part A|Lost to Follow-up|0|||
170582269|NCT03768089|616473778|FG016|Part A|Lost to Follow-up|0|||
170582270|NCT03768089|616473779|FG017|Part A|Lost to Follow-up|0|||
170582271|NCT03768089|616473762|FG000|Part C|Randomized, Never Dosed|0|||
170582272|NCT03768089|616473763|FG001|Part C|Randomized, Never Dosed|0|||
170582273|NCT03768089|616473764|FG002|Part C|Randomized, Never Dosed|0|||
170582274|NCT03768089|616473765|FG003|Part C|Randomized, Never Dosed|0|||
170582275|NCT03768089|616473766|FG004|Part C|Randomized, Never Dosed|0|||
170582276|NCT03768089|616473767|FG005|Part C|Randomized, Never Dosed|0|||
170582277|NCT03768089|616473768|FG006|Part C|Randomized, Never Dosed|0|||
170582278|NCT03768089|616473769|FG007|Part C|Randomized, Never Dosed|0|||
170582279|NCT03768089|616473770|FG008|Part C|Randomized, Never Dosed|0|||
170582280|NCT03768089|616473771|FG009|Part C|Randomized, Never Dosed|0|||
170582281|NCT03768089|616473772|FG010|Part C|Randomized, Never Dosed|0|||
170582282|NCT03768089|616473773|FG011|Part C|Randomized, Never Dosed|0|||
170582283|NCT03768089|616473774|FG012|Part C|Randomized, Never Dosed|0|||
170582284|NCT03768089|616473775|FG013|Part C|Randomized, Never Dosed|0|||
170582285|NCT03768089|616473776|FG014|Part C|Randomized, Never Dosed|1|||
170582286|NCT03768089|616473777|FG015|Part C|Randomized, Never Dosed|0|||
170582287|NCT03768089|616473778|FG016|Part C|Randomized, Never Dosed|0|||
170582288|NCT03768089|616473779|FG017|Part C|Randomized, Never Dosed|0|||
170582289|NCT02091362|616473782|FG000|Period 1|Protocol Violation|1|||
170582290|NCT02091362|616473783|FG001|Period 1|Protocol Violation|0|||
170582291|NCT02091362|616473782|FG000|Period 1|Withdrawal by Subject|2|||
170582292|NCT02091362|616473783|FG001|Period 1|Withdrawal by Subject|3|||
170582293|NCT02091362|616473782|FG000|Period 1|Lost to Follow-up|0|||
170582294|NCT02091362|616473783|FG001|Period 1|Lost to Follow-up|1|||
170582295|NCT02091362|616473782|FG000|Period 1|Adverse Event|2|||
170582296|NCT02091362|616473783|FG001|Period 1|Adverse Event|0|||
170582297|NCT02091362|616473782|FG000|Wash-out|Lost to Follow-up|1|||
170582298|NCT02091362|616473783|FG001|Wash-out|Lost to Follow-up|1|||
170809621|NCT01185340|617313772|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
170809622|NCT01185340|617313773|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
170809623|NCT01185340|617313774|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
170809624|NCT01185340|617313775|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
170809625|NCT01185340|617313772|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
170582299|NCT02091362|616473782|FG000|Wash-out|Withdrawal by Subject|0|||
170582300|NCT02091362|616473783|FG001|Wash-out|Withdrawal by Subject|2|||
170582301|NCT02091362|616473782|FG000|Period 2|Adverse Event|1|||
170582302|NCT02091362|616473783|FG001|Period 2|Adverse Event|0|||
170582303|NCT02091362|616473782|FG000|Period 2|Lost to Follow-up|0|||
170582304|NCT02091362|616473783|FG001|Period 2|Lost to Follow-up|1|||
170582305|NCT02091362|616473782|FG000|Period 2|Withdrawal by Subject|1|||
170582306|NCT02091362|616473783|FG001|Period 2|Withdrawal by Subject|1|||
170582307|NCT02125838|616473788|FG000|Overall Study|Lost to Follow-up|4|||
170582308|NCT02125838|616473789|FG001|Overall Study|Lost to Follow-up|4|||
170582309|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
170582310|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
170582311|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
170582312|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
170582313|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Death|58|||
170582314|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Death|65|||
170582315|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Adverse Event|28|||
170582316|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Adverse Event|40|||
170582317|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Disease Progression|22|||
170582318|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Disease Progression|35|||
170649847|NCT01700387|616730899|FG000|Overall Study|Lost to Follow-up|2|||
170649848|NCT01700387|616730900|FG001|Overall Study|Lost to Follow-up|1|||
170649849|NCT04658940|616730901|FG000|Overall Study|Withdrawal by Subject|1|||
170649850|NCT00827931|616730904|FG000|Overall Study|Death|3|||
170649851|NCT00827931|616730905|FG001|Overall Study|Death|5|||
170582319|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Other|25|||
170582320|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Other|33|||
170582321|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
170582322|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
170582323|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Noncompliance|8|||
170582324|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Noncompliance|8|||
170582325|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
170582326|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
170582327|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
170582328|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
170582329|NCT00286091|616473790|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
170582330|NCT00286091|616473791|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
170582331|NCT00286091|616473790|FG000|Open-label Treatment Phase|Physician Decision|24|||
170582332|NCT00286091|616473791|FG001|Open-label Treatment Phase|Physician Decision|21|||
170582333|NCT00286091|616473790|FG000|Open-label Treatment Phase|Adverse Event|5|||
170582334|NCT00286091|616473791|FG001|Open-label Treatment Phase|Adverse Event|16|||
170582335|NCT00286091|616473790|FG000|Open-label Treatment Phase|Other|11|||
170582336|NCT00286091|616473791|FG001|Open-label Treatment Phase|Other|11|||
170582337|NCT00286091|616473790|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
170582338|NCT00286091|616473791|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
170582339|NCT00286091|616473790|FG000|Open-label Treatment Phase|Death|10|||
170582340|NCT00286091|616473791|FG001|Open-label Treatment Phase|Death|7|||
170582341|NCT00286091|616473790|FG000|Open-label Treatment Phase|Disease Progression|9|||
170582342|NCT00286091|616473791|FG001|Open-label Treatment Phase|Disease Progression|3|||
170582343|NCT00286091|616473790|FG000|Open-label Treatment Phase|Noncompliance|3|||
170582344|NCT00286091|616473791|FG001|Open-label Treatment Phase|Noncompliance|1|||
170582345|NCT00286091|616473790|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
170582346|NCT00286091|616473791|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
170582347|NCT00286091|616473790|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
170582348|NCT00286091|616473791|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
170582349|NCT00286091|616473790|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
170582350|NCT00286091|616473791|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
170582351|NCT03799952|616473792|FG000|Overall Study|Program was too easy, discontinued|1|||
170582352|NCT03799952|616473793|FG001|Overall Study|Program was too easy, discontinued|0|||
170582353|NCT03799952|616473792|FG000|Overall Study|Lost to Follow-up|0|||
170582354|NCT03799952|616473793|FG001|Overall Study|Lost to Follow-up|2|||
170582355|NCT02936869|616473794|FG000|Overall Study|Lost to Follow-up|1|||
170582356|NCT02936869|616473795|FG001|Overall Study|Lost to Follow-up|3|||
170582357|NCT02936869|616473794|FG000|Overall Study|Death|0|||
170582358|NCT02936869|616473795|FG001|Overall Study|Death|1|||
170582359|NCT02936869|616473794|FG000|Overall Study|Legal Case|0|||
170582360|NCT02936869|616473795|FG001|Overall Study|Legal Case|1|||
170582361|NCT02936869|616473794|FG000|Overall Study|Protocol Violation|1|||
170582362|NCT02936869|616473795|FG001|Overall Study|Protocol Violation|0|||
170582363|NCT03423238|616473796|FG000|Overall Study|Lost to Follow-up|1|||
170582364|NCT03423238|616473797|FG001|Overall Study|Lost to Follow-up|0|||
170582365|NCT03423238|616473796|FG000|Overall Study|Withdrawal by Subject|1|||
170582366|NCT03423238|616473797|FG001|Overall Study|Withdrawal by Subject|0|||
170582367|NCT05141175|616473800|FG000|Overall Study|Withdrawal by Subject|1|||
170582368|NCT02036580|616473801|FG000|Overall Study|Withdrawal by Subject|0|||
170582369|NCT02036580|616473802|FG001|Overall Study|Withdrawal by Subject|1|||
170649852|NCT00827931|616730904|FG000|Overall Study|Adverse Event|1|||
170649853|NCT00827931|616730905|FG001|Overall Study|Adverse Event|0|||
170649854|NCT00827931|616730904|FG000|Overall Study|Lost to Follow-up|1|||
170649855|NCT00827931|616730905|FG001|Overall Study|Lost to Follow-up|0|||
170582370|NCT02036580|616473803|FG002|Overall Study|Withdrawal by Subject|0|||
170582371|NCT02036580|616473801|FG000|Overall Study|Adverse Event|1|||
170582372|NCT02036580|616473802|FG001|Overall Study|Adverse Event|0|||
170649856|NCT00827931|616730904|FG000|Overall Study|Withdrawal by Subject|0|||
170649857|NCT00827931|616730905|FG001|Overall Study|Withdrawal by Subject|1|||
170582373|NCT02036580|616473803|FG002|Overall Study|Adverse Event|0|||
170582374|NCT03098433|616473808|FG000|Overall Study|Withdrawal by Subject|10|||
170649858|NCT00827931|616730904|FG000|Overall Study|Other|1|||
170649859|NCT00827931|616730905|FG001|Overall Study|Other|0|||
170649860|NCT02285062|616730906|FG000|Pre-Treatment Period|Protocol Violation|0|||
170582375|NCT01813058|616473809|FG000|Overall Study|Withdrawal by Subject|5|||
170582376|NCT01813058|616473810|FG001|Overall Study|Withdrawal by Subject|4|||
170582377|NCT03585764|616473811|FG000|Overall Study|Death|3|||
170582378|NCT03585764|616473812|FG001|Overall Study|Death|2|||
170582379|NCT03585764|616473813|FG002|Overall Study|Death|3|||
170582380|NCT03585764|616473814|FG003|Overall Study|Death|0|||
170582381|NCT03585764|616473811|FG000|Overall Study|Lost to Follow-up|0|||
170582382|NCT03585764|616473812|FG001|Overall Study|Lost to Follow-up|1|||
170582383|NCT03585764|616473813|FG002|Overall Study|Lost to Follow-up|0|||
170582384|NCT03585764|616473814|FG003|Overall Study|Lost to Follow-up|0|||
170582385|NCT03585764|616473811|FG000|Overall Study|Physician Decision|0|||
170582386|NCT03585764|616473812|FG001|Overall Study|Physician Decision|0|||
170582387|NCT03585764|616473813|FG002|Overall Study|Physician Decision|2|||
170582388|NCT03585764|616473814|FG003|Overall Study|Physician Decision|0|||
170582389|NCT03640507|616473815|FG000|Overall Study|Withdrawal by Subject|0|||
170582390|NCT03640507|616473816|FG001|Overall Study|Withdrawal by Subject|0|||
170582391|NCT03640507|616473817|FG002|Overall Study|Withdrawal by Subject|1|||
170582392|NCT01581021|616473819|FG000|Overall Study|Lost to Follow-up|4|||
170582393|NCT01581021|616473820|FG001|Overall Study|Lost to Follow-up|6|||
170582394|NCT01581021|616473819|FG000|Overall Study|More than 2 hooks in thoracic|3|||
170582395|NCT01581021|616473820|FG001|Overall Study|More than 2 hooks in thoracic|0|||
170582396|NCT01581021|616473819|FG000|Overall Study|Neuromuscular|2|||
170582397|NCT01581021|616473820|FG001|Overall Study|Neuromuscular|1|||
170582398|NCT01581021|616473819|FG000|Overall Study|Not Randomized|1|||
170582399|NCT01581021|616473820|FG001|Overall Study|Not Randomized|2|||
170582400|NCT01581021|616473819|FG000|Overall Study|Lenke 6 Classification|0|||
170582401|NCT01581021|616473820|FG001|Overall Study|Lenke 6 Classification|1|||
170582402|NCT01581021|616473819|FG000|Overall Study|Lack of Efficacy|0|||
170582403|NCT01581021|616473820|FG001|Overall Study|Lack of Efficacy|1|||
170582404|NCT03525600|616473821|FG000|Overall Study|Adverse Event|9|||
170582405|NCT03525600|616473822|FG001|Overall Study|Adverse Event|6|||
170582406|NCT03525600|616473823|FG002|Overall Study|Adverse Event|5|||
170582407|NCT03525600|616473824|FG003|Overall Study|Adverse Event|3|||
170582408|NCT03525600|616473821|FG000|Overall Study|Lost to Follow-up|2|||
170582409|NCT03525600|616473822|FG001|Overall Study|Lost to Follow-up|4|||
170582410|NCT03525600|616473823|FG002|Overall Study|Lost to Follow-up|4|||
170582411|NCT03525600|616473824|FG003|Overall Study|Lost to Follow-up|0|||
170582412|NCT03525600|616473821|FG000|Overall Study|Physician Decision|1|||
170582413|NCT03525600|616473822|FG001|Overall Study|Physician Decision|0|||
170582414|NCT03525600|616473823|FG002|Overall Study|Physician Decision|2|||
170582415|NCT03525600|616473824|FG003|Overall Study|Physician Decision|0|||
170582416|NCT03525600|616473821|FG000|Overall Study|Consent withdrawal|36|||
170582417|NCT03525600|616473822|FG001|Overall Study|Consent withdrawal|20|||
170582418|NCT03525600|616473823|FG002|Overall Study|Consent withdrawal|6|||
170582419|NCT03525600|616473824|FG003|Overall Study|Consent withdrawal|13|||
170582420|NCT03525600|616473821|FG000|Overall Study|Death|7|||
170582421|NCT03525600|616473822|FG001|Overall Study|Death|6|||
170582422|NCT03525600|616473823|FG002|Overall Study|Death|4|||
170582423|NCT03525600|616473824|FG003|Overall Study|Death|3|||
170582424|NCT03525600|616473821|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
170582425|NCT03525600|616473822|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
170582426|NCT03525600|616473823|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
170910675|NCT02786537|617677240|FG001|As Treated|Opiate dependency relapse|1|||
170910676|NCT02786537|617677241|FG002|As Treated|Opiate dependency relapse|0|||
170582427|NCT03525600|616473824|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
170582428|NCT03525600|616473821|FG000|Overall Study|Other|0|||
170582429|NCT03525600|616473822|FG001|Overall Study|Other|1|||
170582430|NCT03525600|616473823|FG002|Overall Study|Other|0|||
170582431|NCT03525600|616473824|FG003|Overall Study|Other|0|||
170582432|NCT02676895|616473825|FG000|Overall Study|Administrative reason|1|||
170582433|NCT02676895|616473826|FG001|Overall Study|Administrative reason|0|||
170582434|NCT02676895|616473827|FG002|Overall Study|Administrative reason|0|||
170582435|NCT02676895|616473825|FG000|Overall Study|Protocol Violation|1|||
170582436|NCT02676895|616473826|FG001|Overall Study|Protocol Violation|0|||
170582437|NCT02676895|616473827|FG002|Overall Study|Protocol Violation|0|||
170582438|NCT02676895|616473825|FG000|Overall Study|Adverse Event|0|||
170582439|NCT02676895|616473826|FG001|Overall Study|Adverse Event|3|||
170582440|NCT02676895|616473827|FG002|Overall Study|Adverse Event|1|||
170582441|NCT02676895|616473825|FG000|Overall Study|Lost to Follow-up|0|||
170582442|NCT02676895|616473826|FG001|Overall Study|Lost to Follow-up|0|||
170582443|NCT02676895|616473827|FG002|Overall Study|Lost to Follow-up|1|||
170582444|NCT02676895|616473825|FG000|Overall Study|Withdrawal by Subject|0|||
170582445|NCT02676895|616473826|FG001|Overall Study|Withdrawal by Subject|0|||
170582446|NCT02676895|616473827|FG002|Overall Study|Withdrawal by Subject|1|||
170582447|NCT01270880|616473833|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
170582448|NCT00976716|616473834|FG000|Overall Study|Adverse Event|1|||
170582449|NCT03028129|616473841|FG000|Overall Study|Adverse Event|13|||
170582450|NCT03028129|616473842|FG001|Overall Study|Adverse Event|2|||
170582451|NCT03028129|616473841|FG000|Overall Study|Lost to Follow-up|50|||
170582452|NCT03028129|616473842|FG001|Overall Study|Lost to Follow-up|38|||
170582453|NCT03028129|616473841|FG000|Overall Study|Physician Decision|0|||
170582454|NCT03028129|616473842|FG001|Overall Study|Physician Decision|1|||
170582455|NCT03028129|616473841|FG000|Overall Study|Protocol Violation|1|||
170582456|NCT03028129|616473842|FG001|Overall Study|Protocol Violation|1|||
170582457|NCT03028129|616473841|FG000|Overall Study|Withdrawal by Subject|62|||
170582458|NCT03028129|616473842|FG001|Overall Study|Withdrawal by Subject|45|||
170582459|NCT00923351|616473843|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
170582460|NCT00923351|616473844|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
170582461|NCT00923351|616473845|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
170582462|NCT00182078|616473846|FG000|Overall Study|Withdrawal by Subject|1|||
170582463|NCT00182078|616473847|FG001|Overall Study|Withdrawal by Subject|0|||
170582464|NCT00395486|616473852|FG000|Overall Study|Adverse Event|1|||
170582465|NCT00395486|616473853|FG001|Overall Study|Adverse Event|2|||
170582466|NCT00395486|616473852|FG000|Overall Study|Withdrawal by Subject|5|||
170582467|NCT00395486|616473853|FG001|Overall Study|Withdrawal by Subject|2|||
170582468|NCT00395486|616473852|FG000|Overall Study|Lost to Follow-up|0|||
170582469|NCT00395486|616473853|FG001|Overall Study|Lost to Follow-up|1|||
170582470|NCT01076205|616473854|FG000|Overall Study|Adverse Drug Reaction|299|||
170582471|NCT01076205|616473854|FG000|Overall Study|Lack of Effectiveness|1423|||
170582472|NCT01076205|616473854|FG000|Overall Study|Other Reason|1075|||
170582473|NCT01076205|616473854|FG000|Overall Study|Unknown Reason|71|||
170582474|NCT01076205|616473854|FG000|Overall Study|Lost to Follow-up|3151|||
170582475|NCT00361231|616473855|FG000|Overall Study|Physician Decision|3|||
170582476|NCT00361231|616473855|FG000|Overall Study|Symptomatic deterioration|5|||
170582477|NCT00361231|616473855|FG000|Overall Study|Radiographic disease progression|16|||
170582478|NCT00361231|616473855|FG000|Overall Study|Withdrawal by Subject|4|||
170582479|NCT00361231|616473855|FG000|Overall Study|Adverse Event|6|||
170582480|NCT02993822|616473862|FG000|Overall Study|Lack of Efficacy|1|||
170582481|NCT02993822|616473863|FG001|Overall Study|Lack of Efficacy|1|||
170582482|NCT02993822|616473864|FG002|Overall Study|Lack of Efficacy|0|||
170582483|NCT02993822|616473865|FG003|Overall Study|Lack of Efficacy|0|||
170582484|NCT02993822|616473862|FG000|Overall Study|Protocol Violation|1|||
170582485|NCT02993822|616473863|FG001|Overall Study|Protocol Violation|0|||
170582486|NCT02993822|616473864|FG002|Overall Study|Protocol Violation|0|||
170582487|NCT02993822|616473865|FG003|Overall Study|Protocol Violation|0|||
170582488|NCT02993822|616473862|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
170582489|NCT02993822|616473863|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
170582490|NCT02993822|616473864|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
170582491|NCT02993822|616473865|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
170582492|NCT02993822|616473862|FG000|Overall Study|Adverse Event|3|||
170582493|NCT02993822|616473863|FG001|Overall Study|Adverse Event|1|||
170582494|NCT02993822|616473864|FG002|Overall Study|Adverse Event|7|||
170582495|NCT02993822|616473865|FG003|Overall Study|Adverse Event|0|||
170582496|NCT02993822|616473862|FG000|Overall Study|Withdrawal by Subject|4|||
170582497|NCT02993822|616473863|FG001|Overall Study|Withdrawal by Subject|2|||
170582498|NCT02993822|616473864|FG002|Overall Study|Withdrawal by Subject|2|||
170582499|NCT02993822|616473865|FG003|Overall Study|Withdrawal by Subject|3|||
170582500|NCT02993822|616473862|FG000|Overall Study|Lost to Follow-up|1|||
170582501|NCT02993822|616473863|FG001|Overall Study|Lost to Follow-up|0|||
170582502|NCT02993822|616473864|FG002|Overall Study|Lost to Follow-up|1|||
170582503|NCT02993822|616473865|FG003|Overall Study|Lost to Follow-up|0|||
170582504|NCT04154293|616473866|FG000|Overall Study|Withdrawal by Subject|2|||
170582505|NCT04154293|616473867|FG001|Overall Study|Withdrawal by Subject|3|||
170582506|NCT04154293|616473868|FG002|Overall Study|Withdrawal by Subject|1|||
170582507|NCT04154293|616473866|FG000|Overall Study|Physician Decision|0|||
170582508|NCT04154293|616473867|FG001|Overall Study|Physician Decision|0|||
170582509|NCT04154293|616473868|FG002|Overall Study|Physician Decision|1|||
170582510|NCT04731298|616473869|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
170582511|NCT04731298|616473870|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
170582512|NCT00837161|616473871|FG000|Overall Study|refused hysterectomy|2|||
170582513|NCT01673854|616473876|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
170582514|NCT01673854|616473876|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
170582515|NCT01673854|616473876|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
170582516|NCT01673854|616473876|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
170582517|NCT01673854|616473876|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
170582518|NCT01673854|616473876|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
170582519|NCT01673854|616473876|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
170582520|NCT01673854|616473876|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
170582521|NCT01673854|616473876|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
170582522|NCT01673854|616473876|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
170582523|NCT01673854|616473876|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
170582524|NCT01673854|616473876|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
170582525|NCT00334737|616473877|FG000|Hospital Phase|Death|1|||
170582526|NCT00334737|616473878|FG001|Hospital Phase|Death|2|||
170910677|NCT02786537|617677242|FG003|As Treated|Opiate dependency relapse|0|||
170582527|NCT00334737|616473879|FG002|Hospital Phase|Death|3|||
170582528|NCT00334737|616473877|FG000|Hospital Phase|Withdrawal by Subject|0|||
170582529|NCT00334737|616473878|FG001|Hospital Phase|Withdrawal by Subject|0|||
170582530|NCT00334737|616473879|FG002|Hospital Phase|Withdrawal by Subject|1|||
170582531|NCT00334737|616473877|FG000|Hospital Phase|Did not receive study drug|1|||
170582532|NCT00334737|616473878|FG001|Hospital Phase|Did not receive study drug|0|||
170582533|NCT00334737|616473879|FG002|Hospital Phase|Did not receive study drug|0|||
170582534|NCT00334737|616473877|FG000|Follow up Phase|Lost to Follow-up|5|||
170582535|NCT00334737|616473878|FG001|Follow up Phase|Lost to Follow-up|3|||
170582536|NCT00334737|616473879|FG002|Follow up Phase|Lost to Follow-up|6|||
170582537|NCT00912782|616473880|FG000|Overall Study|Death|2|||
170582538|NCT00912782|616473881|FG001|Overall Study|Death|1|||
170582539|NCT00912782|616473880|FG000|Overall Study|Lost to Follow-up|0|||
170582540|NCT00912782|616473881|FG001|Overall Study|Lost to Follow-up|1|||
170582541|NCT00912782|616473880|FG000|Overall Study|Did not receive vascular access type|1|||
170582542|NCT00912782|616473881|FG001|Overall Study|Did not receive vascular access type|2|||
170582543|NCT00912782|616473880|FG000|Overall Study|Relocated before study completion|0|||
170582544|NCT00912782|616473881|FG001|Overall Study|Relocated before study completion|1|||
170582545|NCT03100539|616475730|FG000|Overall Study|Lost to Follow-up|60|||
170582546|NCT03100539|616475731|FG001|Overall Study|Lost to Follow-up|54|||
170582547|NCT03100539|616475732|FG002|Overall Study|Lost to Follow-up|17|||
170582548|NCT03100539|616475730|FG000|Overall Study|Uncollected|8|||
170582549|NCT03100539|616475731|FG001|Overall Study|Uncollected|8|||
170582550|NCT03100539|616475732|FG002|Overall Study|Uncollected|0|||
170582551|NCT03100539|616475730|FG000|Overall Study|Ally Health|0|||
170582552|NCT03100539|616475731|FG001|Overall Study|Ally Health|0|||
170582553|NCT03100539|616475732|FG002|Overall Study|Ally Health|3|||
170582554|NCT03100539|616475730|FG000|Overall Study|Disinterest|0|||
170582555|NCT03100539|616475731|FG001|Overall Study|Disinterest|0|||
170582556|NCT03100539|616475732|FG002|Overall Study|Disinterest|22|||
170582557|NCT03100539|616475730|FG000|Overall Study|Veteran Health|0|||
170582558|NCT03100539|616475731|FG001|Overall Study|Veteran Health|0|||
170582559|NCT03100539|616475732|FG002|Overall Study|Veteran Health|8|||
170582560|NCT03100539|616475730|FG000|Overall Study|Moved|0|||
170582561|NCT03100539|616475731|FG001|Overall Study|Moved|0|||
170582562|NCT03100539|616475732|FG002|Overall Study|Moved|1|||
170582563|NCT03100539|616475730|FG000|Overall Study|Scheduling Conflicts|0|||
170582564|NCT03100539|616475731|FG001|Overall Study|Scheduling Conflicts|0|||
170582565|NCT03100539|616475732|FG002|Overall Study|Scheduling Conflicts|12|||
170582566|NCT00185380|616475735|FG000|Overall Study|Adverse Event|41|||
170582567|NCT00185380|616475736|FG001|Overall Study|Adverse Event|43|||
170582568|NCT00185380|616475737|FG002|Overall Study|Adverse Event|48|||
170582569|NCT00185380|616475735|FG000|Overall Study|Lost to Follow-up|0|||
170582570|NCT00185380|616475736|FG001|Overall Study|Lost to Follow-up|4|||
170582571|NCT00185380|616475737|FG002|Overall Study|Lost to Follow-up|3|||
170582572|NCT00185380|616475735|FG000|Overall Study|Pregnancy|1|||
170582573|NCT00185380|616475736|FG001|Overall Study|Pregnancy|4|||
170582574|NCT00185380|616475737|FG002|Overall Study|Pregnancy|0|||
170582575|NCT00185380|616475735|FG000|Overall Study|Protocol Violation|2|||
170582576|NCT00185380|616475736|FG001|Overall Study|Protocol Violation|2|||
170582577|NCT00185380|616475737|FG002|Overall Study|Protocol Violation|1|||
170582578|NCT00185380|616475735|FG000|Overall Study|Withdrawal by Subject|1|||
170582579|NCT00185380|616475736|FG001|Overall Study|Withdrawal by Subject|2|||
170582580|NCT00185380|616475737|FG002|Overall Study|Withdrawal by Subject|0|||
170582581|NCT00185380|616475735|FG000|Overall Study|Failed insertion|1|||
170582582|NCT00185380|616475736|FG001|Overall Study|Failed insertion|1|||
170582583|NCT00185380|616475737|FG002|Overall Study|Failed insertion|2|||
170582584|NCT00185380|616475735|FG000|Overall Study|Planned pregnancy|9|||
170582585|NCT00185380|616475736|FG001|Overall Study|Planned pregnancy|12|||
170582586|NCT00185380|616475737|FG002|Overall Study|Planned pregnancy|12|||
170582587|NCT00185380|616475735|FG000|Overall Study|No need for contraception|3|||
170582588|NCT00185380|616475736|FG001|Overall Study|No need for contraception|3|||
170582589|NCT00185380|616475737|FG002|Overall Study|No need for contraception|3|||
170582590|NCT00185380|616475735|FG000|Overall Study|Could not attend visits|2|||
170582591|NCT00185380|616475736|FG001|Overall Study|Could not attend visits|0|||
170582592|NCT00185380|616475737|FG002|Overall Study|Could not attend visits|4|||
170582593|NCT00185380|616475735|FG000|Overall Study|personal reason|6|||
170582594|NCT00185380|616475736|FG001|Overall Study|personal reason|1|||
170582595|NCT00185380|616475737|FG002|Overall Study|personal reason|1|||
170582596|NCT02526524|616475738|FG000|Overall Study|Withdrawal by Subject|3|||
170582597|NCT02526524|616475739|FG001|Overall Study|Withdrawal by Subject|3|||
170582598|NCT02526524|616475740|FG002|Overall Study|Withdrawal by Subject|6|||
170582599|NCT02526524|616475741|FG003|Overall Study|Withdrawal by Subject|1|||
170582600|NCT02526524|616475742|FG004|Overall Study|Withdrawal by Subject|9|||
170582601|NCT02526524|616475743|FG005|Overall Study|Withdrawal by Subject|5|||
170582602|NCT02526524|616475738|FG000|Overall Study|Adverse Event|3|||
170582603|NCT02526524|616475739|FG001|Overall Study|Adverse Event|2|||
170582604|NCT02526524|616475740|FG002|Overall Study|Adverse Event|4|||
170582605|NCT02526524|616475741|FG003|Overall Study|Adverse Event|2|||
170582606|NCT02526524|616475742|FG004|Overall Study|Adverse Event|6|||
170582607|NCT02526524|616475743|FG005|Overall Study|Adverse Event|8|||
170582608|NCT02526524|616475738|FG000|Overall Study|Lost to Follow-up|2|||
170582609|NCT02526524|616475739|FG001|Overall Study|Lost to Follow-up|3|||
170582610|NCT02526524|616475740|FG002|Overall Study|Lost to Follow-up|8|||
170582611|NCT02526524|616475741|FG003|Overall Study|Lost to Follow-up|1|||
170582612|NCT02526524|616475742|FG004|Overall Study|Lost to Follow-up|2|||
170582613|NCT02526524|616475743|FG005|Overall Study|Lost to Follow-up|5|||
170582614|NCT02526524|616475738|FG000|Overall Study|Protocol Violation|3|||
170582615|NCT02526524|616475739|FG001|Overall Study|Protocol Violation|1|||
170582616|NCT02526524|616475740|FG002|Overall Study|Protocol Violation|5|||
170582617|NCT02526524|616475741|FG003|Overall Study|Protocol Violation|3|||
170582618|NCT02526524|616475742|FG004|Overall Study|Protocol Violation|4|||
170582619|NCT02526524|616475743|FG005|Overall Study|Protocol Violation|3|||
170582620|NCT02526524|616475738|FG000|Overall Study|Loss of Glucose Control|0|||
170582621|NCT02526524|616475739|FG001|Overall Study|Loss of Glucose Control|0|||
170582622|NCT02526524|616475740|FG002|Overall Study|Loss of Glucose Control|3|||
170582623|NCT02526524|616475741|FG003|Overall Study|Loss of Glucose Control|0|||
170582624|NCT02526524|616475742|FG004|Overall Study|Loss of Glucose Control|2|||
170582625|NCT02526524|616475743|FG005|Overall Study|Loss of Glucose Control|0|||
170582626|NCT02526524|616475738|FG000|Overall Study|Physician Decision|0|||
170582627|NCT02526524|616475739|FG001|Overall Study|Physician Decision|0|||
170582628|NCT02526524|616475740|FG002|Overall Study|Physician Decision|0|||
170582629|NCT02526524|616475741|FG003|Overall Study|Physician Decision|0|||
170582630|NCT02526524|616475742|FG004|Overall Study|Physician Decision|1|||
170582631|NCT02526524|616475743|FG005|Overall Study|Physician Decision|0|||
170582632|NCT02526524|616475738|FG000|Overall Study|Sponsor Decision|1|||
170582633|NCT02526524|616475739|FG001|Overall Study|Sponsor Decision|0|||
170582634|NCT02526524|616475740|FG002|Overall Study|Sponsor Decision|0|||
170582635|NCT02526524|616475741|FG003|Overall Study|Sponsor Decision|0|||
170582636|NCT02526524|616475742|FG004|Overall Study|Sponsor Decision|0|||
170582637|NCT02526524|616475743|FG005|Overall Study|Sponsor Decision|0|||
170582638|NCT00394251|616475744|FG000|Overall Study|Adverse Event|7|||
170582639|NCT00394251|616475745|FG001|Overall Study|Adverse Event|5|||
170582640|NCT00394251|616475744|FG000|Overall Study|Unacceptable Toxicity|20|||
170582641|NCT00394251|616475745|FG001|Overall Study|Unacceptable Toxicity|18|||
170582642|NCT00394251|616475744|FG000|Overall Study|Physician Decision|1|||
170582643|NCT00394251|616475745|FG001|Overall Study|Physician Decision|1|||
170582644|NCT00394251|616475744|FG000|Overall Study|Protocol Violation|0|||
170582645|NCT00394251|616475745|FG001|Overall Study|Protocol Violation|1|||
170582646|NCT00394251|616475744|FG000|Overall Study|Withdrawal by Subject|7|||
170582647|NCT00394251|616475745|FG001|Overall Study|Withdrawal by Subject|11|||
170582648|NCT00394251|616475744|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
170582649|NCT00394251|616475745|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
170582650|NCT04644276|616475746|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
170582651|NCT04644276|616475747|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
170582652|NCT04644276|616475748|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
170582653|NCT00705250|616475749|FG000|Overall Study|Withdrawal by Subject|1|||
170582654|NCT00705250|616475749|FG000|Overall Study|Patient died in car accident|1|||
170582655|NCT01406938|616475750|FG000|Induction Period|Subject/guardian decision|6|||
170582656|NCT01406938|616475751|FG001|Induction Period|Subject/guardian decision|8|||
170582657|NCT01406938|616475752|FG002|Induction Period|Subject/guardian decision|0|||
170582658|NCT01406938|616475753|FG003|Induction Period|Subject/guardian decision|0|||
170582659|NCT01406938|616475754|FG004|Induction Period|Subject/guardian decision|0|||
170582660|NCT01406938|616475755|FG005|Induction Period|Subject/guardian decision|0|||
170582661|NCT01406938|616475750|FG000|Induction Period|Protocol deviation|1|||
170582662|NCT01406938|616475751|FG001|Induction Period|Protocol deviation|0|||
170582663|NCT01406938|616475752|FG002|Induction Period|Protocol deviation|0|||
170582664|NCT01406938|616475753|FG003|Induction Period|Protocol deviation|0|||
170582665|NCT01406938|616475754|FG004|Induction Period|Protocol deviation|0|||
170582666|NCT01406938|616475755|FG005|Induction Period|Protocol deviation|0|||
170582667|NCT01406938|616475750|FG000|Induction Period|Adverse Event|8|||
170582668|NCT01406938|616475751|FG001|Induction Period|Adverse Event|9|||
170582669|NCT01406938|616475752|FG002|Induction Period|Adverse Event|0|||
170582670|NCT01406938|616475753|FG003|Induction Period|Adverse Event|0|||
170582671|NCT01406938|616475754|FG004|Induction Period|Adverse Event|0|||
170582672|NCT01406938|616475755|FG005|Induction Period|Adverse Event|0|||
170582673|NCT01406938|616475750|FG000|Induction Period|Lack of Efficacy|1|||
170582674|NCT01406938|616475751|FG001|Induction Period|Lack of Efficacy|0|||
170582675|NCT01406938|616475752|FG002|Induction Period|Lack of Efficacy|0|||
170582676|NCT01406938|616475753|FG003|Induction Period|Lack of Efficacy|0|||
170582677|NCT01406938|616475754|FG004|Induction Period|Lack of Efficacy|0|||
170582678|NCT01406938|616475755|FG005|Induction Period|Lack of Efficacy|0|||
170582679|NCT01406938|616475750|FG000|Induction Period|Lost to Follow-up|2|||
170582680|NCT01406938|616475751|FG001|Induction Period|Lost to Follow-up|3|||
170582681|NCT01406938|616475752|FG002|Induction Period|Lost to Follow-up|0|||
170582682|NCT01406938|616475753|FG003|Induction Period|Lost to Follow-up|0|||
170649861|NCT02285062|616730907|FG001|Pre-Treatment Period|Protocol Violation|2|||
170649862|NCT02285062|616730906|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
170809626|NCT01185340|617313773|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
170582683|NCT01406938|616475754|FG004|Induction Period|Lost to Follow-up|0|||
170582684|NCT01406938|616475755|FG005|Induction Period|Lost to Follow-up|0|||
170582685|NCT01406938|616475750|FG000|Maintenance Period|Adverse Event|0|||
170582686|NCT01406938|616475751|FG001|Maintenance Period|Adverse Event|0|||
170582687|NCT01406938|616475752|FG002|Maintenance Period|Adverse Event|2|||
170582688|NCT01406938|616475753|FG003|Maintenance Period|Adverse Event|8|||
170582689|NCT01406938|616475754|FG004|Maintenance Period|Adverse Event|4|||
170582690|NCT01406938|616475755|FG005|Maintenance Period|Adverse Event|2|||
170582691|NCT01406938|616475750|FG000|Maintenance Period|Death|0|||
170582692|NCT01406938|616475751|FG001|Maintenance Period|Death|0|||
170582693|NCT01406938|616475752|FG002|Maintenance Period|Death|0|||
170582694|NCT01406938|616475753|FG003|Maintenance Period|Death|0|||
170582695|NCT01406938|616475754|FG004|Maintenance Period|Death|1|||
170582696|NCT01406938|616475755|FG005|Maintenance Period|Death|0|||
170809627|NCT01185340|617313774|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
170582697|NCT01406938|616475750|FG000|Maintenance Period|Subject/guardian decision|0|||
170582698|NCT01406938|616475751|FG001|Maintenance Period|Subject/guardian decision|0|||
170582699|NCT01406938|616475752|FG002|Maintenance Period|Subject/guardian decision|11|||
170582700|NCT01406938|616475753|FG003|Maintenance Period|Subject/guardian decision|7|||
170582701|NCT01406938|616475754|FG004|Maintenance Period|Subject/guardian decision|10|||
170582702|NCT01406938|616475755|FG005|Maintenance Period|Subject/guardian decision|7|||
170582703|NCT01406938|616475750|FG000|Maintenance Period|Protocol Violation|0|||
170582704|NCT01406938|616475751|FG001|Maintenance Period|Protocol Violation|0|||
170582705|NCT01406938|616475752|FG002|Maintenance Period|Protocol Violation|2|||
170582706|NCT01406938|616475753|FG003|Maintenance Period|Protocol Violation|2|||
170582707|NCT01406938|616475754|FG004|Maintenance Period|Protocol Violation|2|||
170582708|NCT01406938|616475755|FG005|Maintenance Period|Protocol Violation|2|||
170582709|NCT01406938|616475750|FG000|Maintenance Period|Pregnancy|0|||
170582710|NCT01406938|616475751|FG001|Maintenance Period|Pregnancy|0|||
170582711|NCT01406938|616475752|FG002|Maintenance Period|Pregnancy|0|||
170582712|NCT01406938|616475753|FG003|Maintenance Period|Pregnancy|0|||
170582713|NCT01406938|616475754|FG004|Maintenance Period|Pregnancy|1|||
170582714|NCT01406938|616475755|FG005|Maintenance Period|Pregnancy|0|||
170582715|NCT01406938|616475750|FG000|Maintenance Period|Lost to Follow-up|0|||
170582716|NCT01406938|616475751|FG001|Maintenance Period|Lost to Follow-up|0|||
170582717|NCT01406938|616475752|FG002|Maintenance Period|Lost to Follow-up|0|||
170582718|NCT01406938|616475753|FG003|Maintenance Period|Lost to Follow-up|0|||
170582719|NCT01406938|616475754|FG004|Maintenance Period|Lost to Follow-up|4|||
170582720|NCT01406938|616475755|FG005|Maintenance Period|Lost to Follow-up|0|||
170582721|NCT01406938|616475750|FG000|Maintenance Period|Lack of Efficacy|0|||
170582722|NCT01406938|616475751|FG001|Maintenance Period|Lack of Efficacy|0|||
170582723|NCT01406938|616475752|FG002|Maintenance Period|Lack of Efficacy|2|||
170582724|NCT01406938|616475753|FG003|Maintenance Period|Lack of Efficacy|1|||
170582725|NCT01406938|616475754|FG004|Maintenance Period|Lack of Efficacy|3|||
170582726|NCT01406938|616475755|FG005|Maintenance Period|Lack of Efficacy|5|||
170582727|NCT01406938|616475750|FG000|Follow up|Lack of Efficacy|3|||
170582728|NCT01406938|616475751|FG001|Follow up|Lack of Efficacy|2|||
170582729|NCT01406938|616475752|FG002|Follow up|Lack of Efficacy|1|||
170582730|NCT01406938|616475753|FG003|Follow up|Lack of Efficacy|0|||
170582731|NCT01406938|616475754|FG004|Follow up|Lack of Efficacy|0|||
170582732|NCT01406938|616475755|FG005|Follow up|Lack of Efficacy|0|||
170582733|NCT01406938|616475750|FG000|Follow up|Patient/guardian decision|4|||
170582734|NCT01406938|616475751|FG001|Follow up|Patient/guardian decision|2|||
170582735|NCT01406938|616475752|FG002|Follow up|Patient/guardian decision|4|||
170582736|NCT01406938|616475753|FG003|Follow up|Patient/guardian decision|2|||
170582737|NCT01406938|616475754|FG004|Follow up|Patient/guardian decision|4|||
170582738|NCT01406938|616475755|FG005|Follow up|Patient/guardian decision|1|||
170582739|NCT01406938|616475750|FG000|Follow up|Protocol Violation|0|||
170582740|NCT01406938|616475751|FG001|Follow up|Protocol Violation|0|||
170582741|NCT01406938|616475752|FG002|Follow up|Protocol Violation|1|||
170582742|NCT01406938|616475753|FG003|Follow up|Protocol Violation|0|||
170582743|NCT01406938|616475754|FG004|Follow up|Protocol Violation|0|||
170582744|NCT01406938|616475755|FG005|Follow up|Protocol Violation|0|||
170582745|NCT01406938|616475750|FG000|Follow up|Physician Decision|0|||
170649863|NCT02285062|616730907|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
170809628|NCT01185340|617313775|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
170809629|NCT01185340|617313772|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
170809630|NCT01185340|617313773|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
170582746|NCT01406938|616475751|FG001|Follow up|Physician Decision|0|||
170582747|NCT01406938|616475752|FG002|Follow up|Physician Decision|2|||
170582748|NCT01406938|616475753|FG003|Follow up|Physician Decision|0|||
170582749|NCT01406938|616475754|FG004|Follow up|Physician Decision|3|||
170582750|NCT01406938|616475755|FG005|Follow up|Physician Decision|1|||
170582751|NCT01406938|616475750|FG000|Follow up|Lost to Follow-up|1|||
170582752|NCT01406938|616475751|FG001|Follow up|Lost to Follow-up|1|||
170582753|NCT01406938|616475752|FG002|Follow up|Lost to Follow-up|0|||
170582754|NCT01406938|616475753|FG003|Follow up|Lost to Follow-up|1|||
170582755|NCT01406938|616475754|FG004|Follow up|Lost to Follow-up|2|||
170582756|NCT01406938|616475755|FG005|Follow up|Lost to Follow-up|1|||
170582757|NCT01576146|616475758|FG000|Extension Period 1|Adverse Event|2|||
170582758|NCT01576146|616475758|FG000|Extension Period 1|Death|2|||
170582759|NCT01576146|616475758|FG000|Extension Period 1|Physician Decision|2|||
170582760|NCT01576146|616475758|FG000|Extension Period 1|Withdrawal by Subject|1|||
170582761|NCT01576146|616475758|FG000|Extension Period 1|Lost to Follow-up|1|||
170582762|NCT01576146|616475758|FG000|Extension Period 1|Parathyroidectomy|1|||
170582763|NCT01576146|616475758|FG000|Extension Period 1|Renal Transplant|1|||
170582764|NCT01576146|616475758|FG000|Extension Period 2|Sponsor Decision|13|||
170582765|NCT01576146|616475758|FG000|Extension Period 2|Death|1|||
170582766|NCT01576146|616475758|FG000|Extension Period 2|Adverse Event|1|||
170582767|NCT01576146|616475758|FG000|Extension Period 2|Renal Transplant|1|||
170582768|NCT01576146|616475758|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
170582769|NCT00962741|616475759|FG000|Overall Study|Failed to return|3|||
170582770|NCT00962741|616475759|FG000|Overall Study|Lost to Follow-up|2|||
170582771|NCT00962741|616475759|FG000|Overall Study|Withdrawal by Subject|1|||
170582772|NCT00962741|616475759|FG000|Overall Study|Lack of Efficacy|1|||
170582773|NCT00962741|616475759|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
170582774|NCT00316225|616475760|FG000|Overall Study|Adverse Event|2|||
170582775|NCT00316225|616475760|FG000|Overall Study|Physician Decision|3|||
170582776|NCT00316225|616475760|FG000|Overall Study|Progressive Disease|15|||
170582777|NCT00316225|616475760|FG000|Overall Study|Withdrawal by Subject|3|||
170582778|NCT00316225|616475760|FG000|Overall Study|Death|2|||
170582779|NCT01811485|616475761|FG000|Overall Study|Adverse Event|1|||
170649864|NCT01454778|616730914|FG000|Overall Study|Lost to Follow-up|2|||
170582780|NCT01811485|616475762|FG001|Overall Study|Adverse Event|3|||
170582781|NCT01811485|616475763|FG002|Overall Study|Adverse Event|2|||
170582782|NCT01811485|616475761|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170582783|NCT01811485|616475762|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170582784|NCT01811485|616475763|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
170582785|NCT01811485|616475761|FG000|Overall Study|Administrative problems|1|||
170582786|NCT01811485|616475762|FG001|Overall Study|Administrative problems|0|||
170582787|NCT01811485|616475763|FG002|Overall Study|Administrative problems|0|||
170582788|NCT01811485|616475761|FG000|Overall Study|Protocol Deviation|0|||
170582789|NCT01811485|616475762|FG001|Overall Study|Protocol Deviation|1|||
170582790|NCT01811485|616475763|FG002|Overall Study|Protocol Deviation|0|||
170582791|NCT00223808|616475764|FG000|Overall Study|<5 hrs therapy before discharge|3|||
170582792|NCT00223808|616475765|FG001|Overall Study|<5 hrs therapy before discharge|5|||
170582793|NCT00223808|616475766|FG002|Overall Study|<5 hrs therapy before discharge|5|||
170582794|NCT00878254|616475769|FG000|Overall Study|Physician Decision|1|||
170582795|NCT00878254|616475769|FG000|Overall Study|Death|1|||
170582796|NCT00878254|616475769|FG000|Overall Study|Withdrawal by Subject|1|||
170582797|NCT01995526|616475770|FG000|Overall Study|Physician Decision|1|||
170582798|NCT03367403|616475776|FG000|Overall Study|Adverse Event|20|||
170582799|NCT03367403|616475777|FG001|Overall Study|Adverse Event|6|||
170582800|NCT03367403|616475778|FG002|Overall Study|Adverse Event|2|||
170582801|NCT03367403|616475776|FG000|Overall Study|Withdrawal by Subject|12|||
170582802|NCT03367403|616475777|FG001|Overall Study|Withdrawal by Subject|13|||
170649865|NCT01454778|616730914|FG000|Overall Study|Death|1|||
170649866|NCT00336583|616732729|FG000|Overall Study|Lost to Follow-up|1|||
170649867|NCT00336583|616732729|FG000|Overall Study|Death|1|||
170649868|NCT00003830|616732730|FG000|Overall Study|No follow up data|3|||
170582803|NCT03367403|616475778|FG002|Overall Study|Withdrawal by Subject|1|||
170582804|NCT03367403|616475776|FG000|Overall Study|Death|1|||
170582805|NCT03367403|616475777|FG001|Overall Study|Death|2|||
170582806|NCT03367403|616475778|FG002|Overall Study|Death|0|||
170582807|NCT03367403|616475776|FG000|Overall Study|Physician Decision|0|||
170582808|NCT03367403|616475777|FG001|Overall Study|Physician Decision|1|||
170582809|NCT03367403|616475778|FG002|Overall Study|Physician Decision|0|||
170582810|NCT03367403|616475776|FG000|Overall Study|Protocol Violation|1|||
170582811|NCT03367403|616475777|FG001|Overall Study|Protocol Violation|1|||
170582812|NCT03367403|616475778|FG002|Overall Study|Protocol Violation|0|||
170582813|NCT03367403|616475776|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
170582814|NCT03367403|616475777|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
170582815|NCT03367403|616475778|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
170582816|NCT03367403|616475776|FG000|Overall Study|COVID-19|3|||
170582817|NCT03367403|616475777|FG001|Overall Study|COVID-19|6|||
170649869|NCT00003830|616732731|FG001|Overall Study|No follow up data|0|||
170649870|NCT00003830|616732730|FG000|Overall Study|Sentinel node positive patients|829|||
170582818|NCT03367403|616475778|FG002|Overall Study|COVID-19|0|||
170582819|NCT03367403|616475776|FG000|Overall Study|Abuse of Alcohol Intake|0|||
170582820|NCT03367403|616475777|FG001|Overall Study|Abuse of Alcohol Intake|1|||
170582821|NCT03367403|616475778|FG002|Overall Study|Abuse of Alcohol Intake|0|||
170649871|NCT00003830|616732731|FG001|Overall Study|Sentinel node positive patients|793|||
170582822|NCT03367403|616475776|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
170582823|NCT03367403|616475777|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
170582824|NCT03367403|616475778|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
170582825|NCT00194077|616475779|FG000|Overall Study|Lack of Efficacy|22|||
170582826|NCT00194077|616475780|FG001|Overall Study|Lack of Efficacy|29|||
170582827|NCT00194077|616475779|FG000|Overall Study|Study nonadherence|1|||
170582828|NCT00194077|616475780|FG001|Overall Study|Study nonadherence|0|||
170582829|NCT00194077|616475779|FG000|Overall Study|Withdrawal by Subject|1|||
170582830|NCT00194077|616475780|FG001|Overall Study|Withdrawal by Subject|1|||
170582831|NCT03470194|616475781|FG000|Overall Study|Lost to Follow-up|11|||
170582832|NCT03470194|616475782|FG001|Overall Study|Lost to Follow-up|17|||
170582833|NCT01822899|616475783|FG000|Overall Study|Adverse Event|6|||
170582834|NCT01822899|616475784|FG001|Overall Study|Adverse Event|5|||
170582835|NCT01822899|616475783|FG000|Overall Study|Lack of Efficacy|6|||
170582836|NCT01822899|616475784|FG001|Overall Study|Lack of Efficacy|3|||
170582837|NCT01822899|616475783|FG000|Overall Study|Protocol Violation|6|||
170582838|NCT01822899|616475784|FG001|Overall Study|Protocol Violation|3|||
170582839|NCT01822899|616475783|FG000|Overall Study|Lost to Follow-up|1|||
170582840|NCT01822899|616475784|FG001|Overall Study|Lost to Follow-up|0|||
170582841|NCT01822899|616475783|FG000|Overall Study|Withdrawal by Subject|5|||
170582842|NCT01822899|616475784|FG001|Overall Study|Withdrawal by Subject|7|||
170582843|NCT00759876|616475786|FG000|Overall Study|Sponsor terminated study early|36|||
170582844|NCT00152477|616475787|FG000|Chemotherapy Period|Adverse Event|9|||
170582845|NCT00152477|616475788|FG001|Chemotherapy Period|Adverse Event|4|||
170582846|NCT00152477|616475789|FG002|Chemotherapy Period|Adverse Event|5|||
170582847|NCT00152477|616475787|FG000|Chemotherapy Period|Death|1|||
170582848|NCT00152477|616475788|FG001|Chemotherapy Period|Death|3|||
170582849|NCT00152477|616475789|FG002|Chemotherapy Period|Death|3|||
170582850|NCT00152477|616475787|FG000|Chemotherapy Period|Lack of Efficacy|4|||
170582851|NCT00152477|616475788|FG001|Chemotherapy Period|Lack of Efficacy|5|||
170582852|NCT00152477|616475789|FG002|Chemotherapy Period|Lack of Efficacy|6|||
170582853|NCT00152477|616475787|FG000|Chemotherapy Period|Lost to Follow-up|1|||
170582854|NCT00152477|616475788|FG001|Chemotherapy Period|Lost to Follow-up|0|||
170582855|NCT00152477|616475789|FG002|Chemotherapy Period|Lost to Follow-up|1|||
170582856|NCT00152477|616475787|FG000|Chemotherapy Period|Protocol Violation|1|||
170582857|NCT00152477|616475788|FG001|Chemotherapy Period|Protocol Violation|1|||
170582858|NCT00152477|616475789|FG002|Chemotherapy Period|Protocol Violation|0|||
170582859|NCT00152477|616475787|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
170582860|NCT00152477|616475788|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
170582861|NCT00152477|616475789|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
170582862|NCT00152477|616475787|FG000|Chemotherapy Period|Progression of Disease|6|||
170582863|NCT00152477|616475788|FG001|Chemotherapy Period|Progression of Disease|8|||
170582864|NCT00152477|616475789|FG002|Chemotherapy Period|Progression of Disease|4|||
170582865|NCT00152477|616475787|FG000|Chemotherapy Period|Investigator decision|0|||
170582866|NCT00152477|616475788|FG001|Chemotherapy Period|Investigator decision|0|||
170582867|NCT00152477|616475789|FG002|Chemotherapy Period|Investigator decision|1|||
170582868|NCT00152477|616475787|FG000|Chemotherapy Period|Patient condition worsened|1|||
170582869|NCT00152477|616475788|FG001|Chemotherapy Period|Patient condition worsened|0|||
170582870|NCT00152477|616475789|FG002|Chemotherapy Period|Patient condition worsened|0|||
170582871|NCT00152477|616475787|FG000|Monotherapy Period|Adverse Event|1|||
170582872|NCT00152477|616475788|FG001|Monotherapy Period|Adverse Event|0|||
170582873|NCT00152477|616475789|FG002|Monotherapy Period|Adverse Event|5|||
170582874|NCT00152477|616475787|FG000|Monotherapy Period|Death|2|||
170582875|NCT00152477|616475788|FG001|Monotherapy Period|Death|0|||
170582876|NCT00152477|616475789|FG002|Monotherapy Period|Death|1|||
170582877|NCT00152477|616475787|FG000|Monotherapy Period|Lack of Efficacy|7|||
170582878|NCT00152477|616475788|FG001|Monotherapy Period|Lack of Efficacy|16|||
170582879|NCT00152477|616475789|FG002|Monotherapy Period|Lack of Efficacy|10|||
170582880|NCT00152477|616475787|FG000|Monotherapy Period|Protocol Violation|0|||
170649872|NCT00883688|616732732|FG000|Overall Study|Ineligible|2|||
170649873|NCT04389970|616732733|FG000|Overall Study|Lost to Follow-up|1|||
170649874|NCT00704522|616732735|FG000|Overall Study|Lack of Efficacy|65|||
170649875|NCT00704522|616732736|FG001|Overall Study|Lack of Efficacy|17|||
170649876|NCT00704522|616732735|FG000|Overall Study|Failure to appear again at hospital|56|||
170809631|NCT01185340|617313774|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
170582881|NCT00152477|616475788|FG001|Monotherapy Period|Protocol Violation|1|||
170582882|NCT00152477|616475789|FG002|Monotherapy Period|Protocol Violation|0|||
170582883|NCT00152477|616475787|FG000|Monotherapy Period|Withdrawal by Subject|0|||
170582884|NCT00152477|616475788|FG001|Monotherapy Period|Withdrawal by Subject|0|||
170582885|NCT00152477|616475789|FG002|Monotherapy Period|Withdrawal by Subject|4|||
170582886|NCT00152477|616475787|FG000|Monotherapy Period|Progression of Disease|5|||
170582887|NCT00152477|616475788|FG001|Monotherapy Period|Progression of Disease|11|||
170582888|NCT00152477|616475789|FG002|Monotherapy Period|Progression of Disease|12|||
170582889|NCT00152477|616475787|FG000|Monotherapy Period|Patient decision|0|||
170582890|NCT00152477|616475788|FG001|Monotherapy Period|Patient decision|1|||
170582891|NCT00152477|616475789|FG002|Monotherapy Period|Patient decision|1|||
170582892|NCT00152477|616475787|FG000|Monotherapy Period|Study personel decision|0|||
170582893|NCT00152477|616475788|FG001|Monotherapy Period|Study personel decision|0|||
170582894|NCT00152477|616475789|FG002|Monotherapy Period|Study personel decision|1|||
170582895|NCT00433966|616475790|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
170582896|NCT00433966|616475791|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
170582897|NCT00433966|616475792|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
170582898|NCT00433966|616475793|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
170582899|NCT00433966|616475790|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
170582900|NCT00433966|616475791|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
170582901|NCT00433966|616475792|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
170582902|NCT00433966|616475793|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
170582903|NCT00433966|616475790|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
170582904|NCT00433966|616475791|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
170582905|NCT00433966|616475792|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
170582906|NCT00433966|616475793|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
170582907|NCT00433966|616475790|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
170582908|NCT00433966|616475791|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
170582909|NCT00433966|616475792|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
170582910|NCT00433966|616475793|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
170582911|NCT00433966|616475790|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
170582912|NCT00433966|616475791|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
170582913|NCT00433966|616475792|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
170582914|NCT00433966|616475793|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
170582915|NCT05059301|616475794|FG000|Overall Study|Adverse Event|0|||
170582916|NCT05059301|616475795|FG001|Overall Study|Adverse Event|2|||
170582917|NCT05059301|616475796|FG002|Overall Study|Adverse Event|2|||
170582918|NCT05059301|616475794|FG000|Overall Study|Lost to Follow-up|2|||
170582919|NCT05059301|616475795|FG001|Overall Study|Lost to Follow-up|3|||
170582920|NCT05059301|616475796|FG002|Overall Study|Lost to Follow-up|3|||
170582921|NCT02141399|616475797|FG000|Overall Study|Adverse Event|158|||
170582922|NCT02141399|616475797|FG000|Overall Study|Lack of Efficacy|62|||
170582923|NCT02141399|616475797|FG000|Overall Study|Lost to Follow-up|151|||
170582924|NCT02141399|616475797|FG000|Overall Study|Non-compliance with study drug|18|||
170582925|NCT02141399|616475797|FG000|Overall Study|Other|45|||
170582926|NCT02141399|616475797|FG000|Overall Study|Physician Decision|17|||
170582927|NCT02141399|616475797|FG000|Overall Study|Pregnancy|3|||
170582928|NCT02141399|616475797|FG000|Overall Study|Protocol Violation|38|||
170582929|NCT02141399|616475797|FG000|Overall Study|Withdrawal by Subject|238|||
170582930|NCT02141399|616475797|FG000|Overall Study|Failure to meet eligibility criteria|14|||
170582931|NCT01126268|616475802|FG000|Overall Study|Adverse Event|1|||
170582932|NCT00615719|616475810|FG000|Overall Study|Physician Decision|5|||
170582933|NCT01864148|616475816|FG000|Overall Study|Other|2|||
170582934|NCT01864148|616475817|FG001|Overall Study|Other|1|||
170582935|NCT01864148|616475818|FG002|Overall Study|Other|1|||
170582936|NCT01864148|616475819|FG003|Overall Study|Other|3|||
170582937|NCT01864148|616475820|FG004|Overall Study|Other|1|||
170582938|NCT01864148|616475816|FG000|Overall Study|Death|0|||
170582939|NCT01864148|616475817|FG001|Overall Study|Death|0|||
170582940|NCT01864148|616475818|FG002|Overall Study|Death|0|||
170582941|NCT01864148|616475819|FG003|Overall Study|Death|1|||
170582942|NCT01864148|616475820|FG004|Overall Study|Death|0|||
170582943|NCT01864148|616475816|FG000|Overall Study|Investigator Decision|5|||
170582944|NCT01864148|616475817|FG001|Overall Study|Investigator Decision|0|||
170582945|NCT01864148|616475818|FG002|Overall Study|Investigator Decision|0|||
170582946|NCT01864148|616475819|FG003|Overall Study|Investigator Decision|4|||
170582947|NCT01864148|616475820|FG004|Overall Study|Investigator Decision|6|||
170910678|NCT02786537|617677243|FG004|As Treated|Opiate dependency relapse|0|||
170582948|NCT01864148|616475816|FG000|Overall Study|Withdrawal by Subject|9|||
170582949|NCT01864148|616475817|FG001|Overall Study|Withdrawal by Subject|2|||
170582950|NCT01864148|616475818|FG002|Overall Study|Withdrawal by Subject|6|||
170582951|NCT01864148|616475819|FG003|Overall Study|Withdrawal by Subject|8|||
170582952|NCT01864148|616475820|FG004|Overall Study|Withdrawal by Subject|8|||
170582953|NCT01864148|616475816|FG000|Overall Study|Lost to Follow-up|0|||
170582954|NCT01864148|616475817|FG001|Overall Study|Lost to Follow-up|0|||
170582955|NCT01864148|616475818|FG002|Overall Study|Lost to Follow-up|0|||
170582956|NCT01864148|616475819|FG003|Overall Study|Lost to Follow-up|2|||
170582957|NCT01864148|616475820|FG004|Overall Study|Lost to Follow-up|1|||
170910679|NCT02786537|617677244|FG005|As Treated|Opiate dependency relapse|0|||
170582958|NCT01864148|616475816|FG000|Overall Study|Adverse Event|4|||
170582959|NCT01864148|616475817|FG001|Overall Study|Adverse Event|2|||
170582960|NCT01864148|616475818|FG002|Overall Study|Adverse Event|4|||
170582961|NCT01864148|616475819|FG003|Overall Study|Adverse Event|7|||
170582962|NCT01864148|616475820|FG004|Overall Study|Adverse Event|7|||
170582963|NCT01864148|616475816|FG000|Overall Study|Not Dosed|0|||
170582964|NCT01864148|616475817|FG001|Overall Study|Not Dosed|0|||
170582965|NCT01864148|616475818|FG002|Overall Study|Not Dosed|0|||
170582966|NCT01864148|616475819|FG003|Overall Study|Not Dosed|1|||
170582967|NCT01864148|616475820|FG004|Overall Study|Not Dosed|0|||
170582968|NCT03928418|616475827|FG000|Overall Study|Lost to Follow-up|5|||
170582969|NCT03928418|616475828|FG001|Overall Study|Lost to Follow-up|3|||
170582970|NCT03928418|616475829|FG002|Overall Study|Lost to Follow-up|5|||
170582971|NCT03928418|616475827|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
170582972|NCT03928418|616475828|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
170582973|NCT03928418|616475829|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
170582974|NCT00778375|616475830|FG000|Overall Study|Ineligible|3|||
170582975|NCT05319600|616475831|FG000|Overall Study|Withdrawal by Subject|1|||
170582976|NCT05319600|616475832|FG001|Overall Study|Withdrawal by Subject|0|||
170582977|NCT05319600|616475831|FG000|Overall Study|Lost to Follow-up|0|||
170582978|NCT05319600|616475832|FG001|Overall Study|Lost to Follow-up|4|||
170582979|NCT02120300|616475835|FG000|Overall Study|Enrolled but Never Treated|2|||
170582980|NCT02120300|616475836|FG001|Overall Study|Enrolled but Never Treated|0|||
170582981|NCT02120300|616475837|FG002|Overall Study|Enrolled but Never Treated|0|||
170582982|NCT02120300|616475838|FG003|Overall Study|Enrolled but Never Treated|0|||
170582983|NCT02120300|616475835|FG000|Overall Study|Lack of Efficacy|0|||
170582984|NCT02120300|616475836|FG001|Overall Study|Lack of Efficacy|0|||
170582985|NCT02120300|616475837|FG002|Overall Study|Lack of Efficacy|0|||
170582986|NCT02120300|616475838|FG003|Overall Study|Lack of Efficacy|1|||
170582987|NCT02120300|616475835|FG000|Overall Study|Lost to Follow-up|1|||
170582988|NCT02120300|616475836|FG001|Overall Study|Lost to Follow-up|0|||
170582989|NCT02120300|616475837|FG002|Overall Study|Lost to Follow-up|0|||
170582990|NCT02120300|616475838|FG003|Overall Study|Lost to Follow-up|0|||
170582991|NCT00712725|616475839|FG000|Overall Study|Adverse Event|1|||
170582992|NCT00712725|616475840|FG001|Overall Study|Adverse Event|0|||
170582993|NCT00712725|616475841|FG002|Overall Study|Adverse Event|0|||
170582994|NCT00712725|616475842|FG003|Overall Study|Adverse Event|1|||
170582995|NCT00712725|616475843|FG004|Overall Study|Adverse Event|0|||
170582996|NCT00712725|616475844|FG005|Overall Study|Adverse Event|0|||
170582997|NCT00712725|616475845|FG006|Overall Study|Adverse Event|0|||
170582998|NCT00712725|616475846|FG007|Overall Study|Adverse Event|0|||
170582999|NCT00712725|616475839|FG000|Overall Study|Lost to Follow-up|3|||
170583000|NCT00712725|616475840|FG001|Overall Study|Lost to Follow-up|2|||
170583001|NCT00712725|616475841|FG002|Overall Study|Lost to Follow-up|1|||
170583002|NCT00712725|616475842|FG003|Overall Study|Lost to Follow-up|1|||
170583003|NCT00712725|616475843|FG004|Overall Study|Lost to Follow-up|2|||
170583004|NCT00712725|616475844|FG005|Overall Study|Lost to Follow-up|2|||
170583005|NCT00712725|616475845|FG006|Overall Study|Lost to Follow-up|3|||
170583006|NCT00712725|616475846|FG007|Overall Study|Lost to Follow-up|1|||
170583007|NCT00712725|616475839|FG000|Overall Study|Physician Decision|2|||
170583008|NCT00712725|616475840|FG001|Overall Study|Physician Decision|0|||
170583009|NCT00712725|616475841|FG002|Overall Study|Physician Decision|0|||
170583010|NCT00712725|616475842|FG003|Overall Study|Physician Decision|0|||
170583011|NCT00712725|616475843|FG004|Overall Study|Physician Decision|1|||
170583012|NCT00712725|616475844|FG005|Overall Study|Physician Decision|0|||
170583013|NCT00712725|616475845|FG006|Overall Study|Physician Decision|2|||
170583014|NCT00712725|616475846|FG007|Overall Study|Physician Decision|0|||
170583015|NCT00712725|616475839|FG000|Overall Study|Pregnancy|0|||
170910680|NCT02786537|617677239|FG000|As Treated|Drugs stolen from patient|0|||
170910681|NCT02786537|617677240|FG001|As Treated|Drugs stolen from patient|1|||
170649877|NCT00704522|616732736|FG001|Overall Study|Failure to appear again at hospital|10|||
170910682|NCT02786537|617677241|FG002|As Treated|Drugs stolen from patient|0|||
170910683|NCT02786537|617677242|FG003|As Treated|Drugs stolen from patient|0|||
170583016|NCT00712725|616475840|FG001|Overall Study|Pregnancy|1|||
170583017|NCT00712725|616475841|FG002|Overall Study|Pregnancy|0|||
170583018|NCT00712725|616475842|FG003|Overall Study|Pregnancy|0|||
170583019|NCT00712725|616475843|FG004|Overall Study|Pregnancy|1|||
170583020|NCT00712725|616475844|FG005|Overall Study|Pregnancy|0|||
170583021|NCT00712725|616475845|FG006|Overall Study|Pregnancy|2|||
170583022|NCT00712725|616475846|FG007|Overall Study|Pregnancy|0|||
170583023|NCT00712725|616475839|FG000|Overall Study|Protocol Violation|2|||
170583024|NCT00712725|616475840|FG001|Overall Study|Protocol Violation|0|||
170649878|NCT00704522|616732735|FG000|Overall Study|Withdrawal by Subject|17|||
170583025|NCT00712725|616475841|FG002|Overall Study|Protocol Violation|1|||
170583026|NCT00712725|616475842|FG003|Overall Study|Protocol Violation|3|||
170583027|NCT00712725|616475843|FG004|Overall Study|Protocol Violation|2|||
170583028|NCT00712725|616475844|FG005|Overall Study|Protocol Violation|0|||
170583029|NCT00712725|616475845|FG006|Overall Study|Protocol Violation|1|||
170583030|NCT00712725|616475846|FG007|Overall Study|Protocol Violation|1|||
170910684|NCT02786537|617677243|FG004|As Treated|Drugs stolen from patient|0|||
170583031|NCT00712725|616475839|FG000|Overall Study|Withdrawal by Subject|2|||
170583032|NCT00712725|616475840|FG001|Overall Study|Withdrawal by Subject|1|||
170583033|NCT00712725|616475841|FG002|Overall Study|Withdrawal by Subject|1|||
170583034|NCT00712725|616475842|FG003|Overall Study|Withdrawal by Subject|2|||
170910685|NCT02786537|617677244|FG005|As Treated|Drugs stolen from patient|0|||
170583035|NCT00712725|616475843|FG004|Overall Study|Withdrawal by Subject|1|||
170583036|NCT00712725|616475844|FG005|Overall Study|Withdrawal by Subject|1|||
170583037|NCT00712725|616475845|FG006|Overall Study|Withdrawal by Subject|1|||
170583038|NCT00712725|616475846|FG007|Overall Study|Withdrawal by Subject|2|||
170583039|NCT00712725|616475839|FG000|Overall Study|Lack of Qualifying Event|16|||
170583040|NCT00712725|616475840|FG001|Overall Study|Lack of Qualifying Event|2|||
170583041|NCT00712725|616475841|FG002|Overall Study|Lack of Qualifying Event|6|||
170583042|NCT00712725|616475842|FG003|Overall Study|Lack of Qualifying Event|8|||
170583043|NCT00712725|616475843|FG004|Overall Study|Lack of Qualifying Event|11|||
170583044|NCT00712725|616475844|FG005|Overall Study|Lack of Qualifying Event|13|||
170583045|NCT00712725|616475845|FG006|Overall Study|Lack of Qualifying Event|11|||
170583046|NCT00712725|616475846|FG007|Overall Study|Lack of Qualifying Event|6|||
170583047|NCT00712725|616475839|FG000|Overall Study|Protocol Specified Criteria|3|||
170583048|NCT00712725|616475840|FG001|Overall Study|Protocol Specified Criteria|0|||
170583049|NCT00712725|616475841|FG002|Overall Study|Protocol Specified Criteria|1|||
170583050|NCT00712725|616475842|FG003|Overall Study|Protocol Specified Criteria|2|||
170583051|NCT00712725|616475843|FG004|Overall Study|Protocol Specified Criteria|1|||
170583052|NCT00712725|616475844|FG005|Overall Study|Protocol Specified Criteria|0|||
170583053|NCT00712725|616475845|FG006|Overall Study|Protocol Specified Criteria|2|||
170583054|NCT00712725|616475846|FG007|Overall Study|Protocol Specified Criteria|1|||
170583055|NCT00335738|616475853|FG000|Overall Study|Physician Decision|6|||
170583056|NCT00335738|616475854|FG001|Overall Study|Physician Decision|0|||
170583057|NCT00335738|616475853|FG000|Overall Study|Withdrawal by Subject|2|||
170583058|NCT00335738|616475854|FG001|Overall Study|Withdrawal by Subject|0|||
170583059|NCT00335738|616475853|FG000|Overall Study|Ineligible|3|||
170583060|NCT00335738|616475854|FG001|Overall Study|Ineligible|4|||
170583061|NCT01732510|616475861|FG000|Overall Study|Adverse Event|0|||
170583062|NCT01732510|616475862|FG001|Overall Study|Adverse Event|1|||
170583063|NCT01732510|616475863|FG002|Overall Study|Adverse Event|1|||
170583064|NCT01732510|616475864|FG003|Overall Study|Adverse Event|0|||
170583065|NCT01732510|616475865|FG004|Overall Study|Adverse Event|0|||
170583066|NCT01732510|616475866|FG005|Overall Study|Adverse Event|0|||
170583067|NCT01732510|616475867|FG006|Overall Study|Adverse Event|1|||
170583068|NCT01732510|616475861|FG000|Overall Study|Protocol Violation|0|||
170583069|NCT01732510|616475862|FG001|Overall Study|Protocol Violation|0|||
170583070|NCT01732510|616475863|FG002|Overall Study|Protocol Violation|0|||
170583071|NCT01732510|616475864|FG003|Overall Study|Protocol Violation|1|||
170583072|NCT01732510|616475865|FG004|Overall Study|Protocol Violation|0|||
170583073|NCT01732510|616475866|FG005|Overall Study|Protocol Violation|0|||
170583074|NCT01732510|616475867|FG006|Overall Study|Protocol Violation|0|||
170583075|NCT01732510|616475861|FG000|Overall Study|Withdrawal by Subject|1|||
170583076|NCT01732510|616475862|FG001|Overall Study|Withdrawal by Subject|3|||
170583077|NCT01732510|616475863|FG002|Overall Study|Withdrawal by Subject|2|||
170583078|NCT01732510|616475864|FG003|Overall Study|Withdrawal by Subject|1|||
170583079|NCT01732510|616475865|FG004|Overall Study|Withdrawal by Subject|5|||
170583080|NCT01732510|616475866|FG005|Overall Study|Withdrawal by Subject|0|||
170583081|NCT01732510|616475867|FG006|Overall Study|Withdrawal by Subject|1|||
170583082|NCT01732510|616475861|FG000|Overall Study|Lost to Follow-up|0|||
170583083|NCT01732510|616475862|FG001|Overall Study|Lost to Follow-up|0|||
170583084|NCT01732510|616475863|FG002|Overall Study|Lost to Follow-up|1|||
170583085|NCT01732510|616475864|FG003|Overall Study|Lost to Follow-up|1|||
170583086|NCT01732510|616475865|FG004|Overall Study|Lost to Follow-up|0|||
170583087|NCT01732510|616475866|FG005|Overall Study|Lost to Follow-up|1|||
170583088|NCT01732510|616475867|FG006|Overall Study|Lost to Follow-up|0|||
170583089|NCT01732510|616475861|FG000|Overall Study|Physician Decision|0|||
170583090|NCT01732510|616475862|FG001|Overall Study|Physician Decision|1|||
170583091|NCT01732510|616475863|FG002|Overall Study|Physician Decision|0|||
170583092|NCT01732510|616475864|FG003|Overall Study|Physician Decision|0|||
170583093|NCT01732510|616475865|FG004|Overall Study|Physician Decision|0|||
170583094|NCT01732510|616475866|FG005|Overall Study|Physician Decision|0|||
170910686|NCT02786537|617677239|FG000|As Treated|Advised to stop tx after loss of meds|0|||
170910687|NCT02786537|617677240|FG001|As Treated|Advised to stop tx after loss of meds|1|||
170583095|NCT01732510|616475867|FG006|Overall Study|Physician Decision|0|||
170583096|NCT01732510|616475861|FG000|Overall Study|Pregnancy|0|||
170910688|NCT02786537|617677241|FG002|As Treated|Advised to stop tx after loss of meds|0|||
170910689|NCT02786537|617677242|FG003|As Treated|Advised to stop tx after loss of meds|0|||
170583097|NCT01732510|616475862|FG001|Overall Study|Pregnancy|0|||
170583098|NCT01732510|616475863|FG002|Overall Study|Pregnancy|0|||
170583099|NCT01732510|616475864|FG003|Overall Study|Pregnancy|1|||
170583100|NCT01732510|616475865|FG004|Overall Study|Pregnancy|0|||
170583101|NCT01732510|616475866|FG005|Overall Study|Pregnancy|0|||
170583102|NCT01732510|616475867|FG006|Overall Study|Pregnancy|0|||
170583103|NCT01732510|616475861|FG000|Overall Study|Study Terminated By Sponsor|0|||
170583104|NCT01732510|616475862|FG001|Overall Study|Study Terminated By Sponsor|0|||
170583105|NCT01732510|616475863|FG002|Overall Study|Study Terminated By Sponsor|0|||
170583106|NCT01732510|616475864|FG003|Overall Study|Study Terminated By Sponsor|1|||
170583107|NCT01732510|616475865|FG004|Overall Study|Study Terminated By Sponsor|0|||
170583108|NCT01732510|616475866|FG005|Overall Study|Study Terminated By Sponsor|12|||
170583109|NCT01732510|616475867|FG006|Overall Study|Study Terminated By Sponsor|6|||
170583110|NCT00290771|616475868|FG000|Overall Study|Disease progression|95|||
170583111|NCT00290771|616475869|FG001|Overall Study|Disease progression|73|||
170583112|NCT00290771|616475868|FG000|Overall Study|Death|11|||
170583113|NCT00290771|616475869|FG001|Overall Study|Death|10|||
170583114|NCT00290771|616475868|FG000|Overall Study|Adverse Event|12|||
170583115|NCT00290771|616475869|FG001|Overall Study|Adverse Event|6|||
170583116|NCT00290771|616475868|FG000|Overall Study|Withdrawal by Subject|5|||
170583117|NCT00290771|616475869|FG001|Overall Study|Withdrawal by Subject|6|||
170910690|NCT02786537|617677243|FG004|As Treated|Advised to stop tx after loss of meds|0|||
170910691|NCT02786537|617677244|FG005|As Treated|Advised to stop tx after loss of meds|0|||
170910692|NCT00077623|617677245|FG000|Overall Study|Adverse Event|1|||
170910693|NCT00077623|617677246|FG001|Overall Study|Adverse Event|0|||
170910694|NCT00077623|617677247|FG002|Overall Study|Adverse Event|1|||
170583118|NCT00290771|616475868|FG000|Overall Study|Administrative problems|2|||
170583119|NCT00290771|616475869|FG001|Overall Study|Administrative problems|1|||
170583120|NCT00290771|616475868|FG000|Overall Study|Protocol Violation|2|||
170583121|NCT00290771|616475869|FG001|Overall Study|Protocol Violation|0|||
170583122|NCT00290771|616475868|FG000|Overall Study|Lost to Follow-up|0|||
170583123|NCT00290771|616475869|FG001|Overall Study|Lost to Follow-up|1|||
170583124|NCT00313144|616475870|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
170583125|NCT00313144|616475870|FG000|Overall Study|Death|7|||
170583126|NCT00313144|616475870|FG000|Overall Study|Lost to Follow-up|5|||
170649879|NCT00704522|616732736|FG001|Overall Study|Withdrawal by Subject|8|||
170649880|NCT00704522|616732735|FG000|Overall Study|Adverse Event|9|||
170583127|NCT00313144|616475870|FG000|Overall Study|Withdrawal by Subject|4|||
170583128|NCT00313144|616475870|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
170583129|NCT00313144|616475870|FG000|Overall Study|Physician Decision|4|||
170583130|NCT00313144|616475870|FG000|Overall Study|Adverse event - transient|5|||
170583131|NCT00313144|616475870|FG000|Overall Study|Liver transplant|1|||
170583132|NCT00313144|616475870|FG000|Overall Study|Insurance (homecare provider) change|1|||
170583133|NCT00313144|616475870|FG000|Overall Study|Change to different product|1|||
170583134|NCT00313144|616475870|FG000|Overall Study|Due to termination of the study|66|||
170583135|NCT03403361|616475871|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
170583136|NCT02487654|616475873|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
170583137|NCT02487654|616475874|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
170583138|NCT02487654|616475873|FG000|Overall Study|Withdrawal by Subject|3|||
170583139|NCT02487654|616475874|FG001|Overall Study|Withdrawal by Subject|7|||
170583140|NCT02443116|616475877|FG000|Part 1|Adverse Event|2|||
170583141|NCT02443116|616475878|FG001|Part 1|Adverse Event|3|||
170583142|NCT02443116|616475879|FG002|Part 1|Adverse Event|0|||
170583143|NCT02443116|616475880|FG003|Part 1|Adverse Event|0|||
170583144|NCT02443116|616475881|FG004|Part 1|Adverse Event|0|||
170583145|NCT02443116|616475882|FG005|Part 1|Adverse Event|0|||
170649881|NCT00704522|616732736|FG001|Overall Study|Adverse Event|1|||
170649882|NCT00704522|616732735|FG000|Overall Study|Undefined causes|9|||
170649883|NCT00704522|616732736|FG001|Overall Study|Undefined causes|7|||
170649884|NCT00704522|616732735|FG000|Overall Study|No information on therapy end|27|||
170649885|NCT00704522|616732736|FG001|Overall Study|No information on therapy end|2|||
170649886|NCT02142387|616732737|FG000|Overall Study|<19 years old|49|||
170649887|NCT02142387|616732738|FG001|Overall Study|<19 years old|326|||
170649888|NCT02142387|616732737|FG000|Overall Study|non-cardiac etiology|504|||
170649889|NCT02142387|616732738|FG001|Overall Study|non-cardiac etiology|3431|||
170649890|NCT02142387|616732737|FG000|Overall Study|CPR not performed|74|||
170649891|NCT02142387|616732738|FG001|Overall Study|CPR not performed|473|||
170649892|NCT02142387|616732737|FG000|Overall Study|witnessed by paramedic|139|||
170649893|NCT02142387|616732738|FG001|Overall Study|witnessed by paramedic|917|||
170649894|NCT02142387|616732737|FG000|Overall Study|incomplete data|1|||
170649895|NCT02142387|616732738|FG001|Overall Study|incomplete data|9|||
170649896|NCT02142387|616732737|FG000|Overall Study|occurred not at home|298|||
170649897|NCT02142387|616732738|FG001|Overall Study|occurred not at home|2474|||
170649898|NCT02282345|616732741|FG000|Overall Study|Progression|0|||
170649899|NCT02282345|616732742|FG001|Overall Study|Progression|1|||
170649900|NCT00711516|616732743|FG000|Overall Study|Adverse Event|1|||
170649901|NCT00711516|616732744|FG001|Overall Study|Adverse Event|1|||
170649902|NCT00711516|616732743|FG000|Overall Study|Withdrawal by Subject|0|||
170649903|NCT00711516|616732744|FG001|Overall Study|Withdrawal by Subject|1|||
170910695|NCT00077623|617677245|FG000|Overall Study|Withdrawal by Subject|2|||
170583146|NCT02443116|616475883|FG006|Part 1|Adverse Event|0|||
170583147|NCT02443116|616475884|FG007|Part 1|Adverse Event|0|||
170583148|NCT02443116|616475885|FG008|Part 1|Adverse Event|0|||
170583149|NCT02443116|616475877|FG000|Part 1|Withdrew informed consent|0|||
170583150|NCT02443116|616475878|FG001|Part 1|Withdrew informed consent|1|||
170583151|NCT02443116|616475879|FG002|Part 1|Withdrew informed consent|0|||
170583152|NCT02443116|616475880|FG003|Part 1|Withdrew informed consent|0|||
170583153|NCT02443116|616475881|FG004|Part 1|Withdrew informed consent|0|||
170583154|NCT02443116|616475882|FG005|Part 1|Withdrew informed consent|0|||
170649904|NCT00711516|616732743|FG000|Overall Study|Protocol Violation|0|||
170649905|NCT00711516|616732744|FG001|Overall Study|Protocol Violation|1|||
170583155|NCT02443116|616475883|FG006|Part 1|Withdrew informed consent|0|||
170583156|NCT02443116|616475884|FG007|Part 1|Withdrew informed consent|0|||
170583157|NCT02443116|616475885|FG008|Part 1|Withdrew informed consent|0|||
170583158|NCT02443116|616475877|FG000|Part 1|Lost to Follow-up|0|||
170583159|NCT02443116|616475878|FG001|Part 1|Lost to Follow-up|0|||
170583160|NCT02443116|616475879|FG002|Part 1|Lost to Follow-up|2|||
170583161|NCT02443116|616475880|FG003|Part 1|Lost to Follow-up|0|||
170583162|NCT02443116|616475881|FG004|Part 1|Lost to Follow-up|0|||
170583163|NCT02443116|616475882|FG005|Part 1|Lost to Follow-up|0|||
170583164|NCT02443116|616475883|FG006|Part 1|Lost to Follow-up|0|||
170583165|NCT02443116|616475884|FG007|Part 1|Lost to Follow-up|0|||
170583166|NCT02443116|616475885|FG008|Part 1|Lost to Follow-up|0|||
170583167|NCT02443116|616475877|FG000|Part 1|Participant moved out of state|0|||
170583168|NCT02443116|616475878|FG001|Part 1|Participant moved out of state|0|||
170583169|NCT02443116|616475879|FG002|Part 1|Participant moved out of state|1|||
170583170|NCT02443116|616475880|FG003|Part 1|Participant moved out of state|0|||
170583171|NCT02443116|616475881|FG004|Part 1|Participant moved out of state|0|||
170583172|NCT02443116|616475882|FG005|Part 1|Participant moved out of state|0|||
170583173|NCT02443116|616475883|FG006|Part 1|Participant moved out of state|0|||
170583174|NCT02443116|616475884|FG007|Part 1|Participant moved out of state|0|||
170583175|NCT02443116|616475885|FG008|Part 1|Participant moved out of state|0|||
170583176|NCT02443116|616475877|FG000|Part 1|Participant enrolled in another clinical trial|0|||
170583177|NCT02443116|616475878|FG001|Part 1|Participant enrolled in another clinical trial|0|||
170583178|NCT02443116|616475879|FG002|Part 1|Participant enrolled in another clinical trial|1|||
170583179|NCT02443116|616475880|FG003|Part 1|Participant enrolled in another clinical trial|0|||
170583180|NCT02443116|616475881|FG004|Part 1|Participant enrolled in another clinical trial|0|||
170583181|NCT02443116|616475882|FG005|Part 1|Participant enrolled in another clinical trial|0|||
170583182|NCT02443116|616475883|FG006|Part 1|Participant enrolled in another clinical trial|0|||
170583183|NCT02443116|616475884|FG007|Part 1|Participant enrolled in another clinical trial|0|||
170583184|NCT02443116|616475885|FG008|Part 1|Participant enrolled in another clinical trial|0|||
170583185|NCT02443116|616475877|FG000|Part 2|Adverse Event|0|||
170583186|NCT02443116|616475878|FG001|Part 2|Adverse Event|0|||
170583187|NCT02443116|616475879|FG002|Part 2|Adverse Event|0|||
170583188|NCT02443116|616475880|FG003|Part 2|Adverse Event|0|||
170583189|NCT02443116|616475881|FG004|Part 2|Adverse Event|1|||
170583190|NCT02443116|616475882|FG005|Part 2|Adverse Event|1|||
170583191|NCT02443116|616475883|FG006|Part 2|Adverse Event|2|||
170583192|NCT02443116|616475884|FG007|Part 2|Adverse Event|0|||
170583193|NCT02443116|616475885|FG008|Part 2|Adverse Event|0|||
170583194|NCT02443116|616475877|FG000|Part 2|Withdrew informed consent|0|||
170583195|NCT02443116|616475878|FG001|Part 2|Withdrew informed consent|0|||
170583196|NCT02443116|616475879|FG002|Part 2|Withdrew informed consent|0|||
170583197|NCT02443116|616475880|FG003|Part 2|Withdrew informed consent|0|||
170583198|NCT02443116|616475881|FG004|Part 2|Withdrew informed consent|0|||
170583199|NCT02443116|616475882|FG005|Part 2|Withdrew informed consent|1|||
170583200|NCT02443116|616475883|FG006|Part 2|Withdrew informed consent|1|||
170583201|NCT02443116|616475884|FG007|Part 2|Withdrew informed consent|0|||
170583202|NCT02443116|616475885|FG008|Part 2|Withdrew informed consent|0|||
170649906|NCT01653132|616732748|FG000|First Intervention|Protocol Violation|1|||
170649907|NCT01653132|616732749|FG001|First Intervention|Protocol Violation|0|||
170649908|NCT02095132|616732750|FG000|Overall Study|Adverse Event|0|||
170583203|NCT02443116|616475877|FG000|Part 2|Inability to comply with protocol|0|||
170583204|NCT02443116|616475878|FG001|Part 2|Inability to comply with protocol|0|||
170583205|NCT02443116|616475879|FG002|Part 2|Inability to comply with protocol|0|||
170583206|NCT02443116|616475880|FG003|Part 2|Inability to comply with protocol|1|||
170583207|NCT02443116|616475881|FG004|Part 2|Inability to comply with protocol|0|||
170583208|NCT02443116|616475882|FG005|Part 2|Inability to comply with protocol|0|||
170583209|NCT02443116|616475883|FG006|Part 2|Inability to comply with protocol|0|||
170583210|NCT02443116|616475884|FG007|Part 2|Inability to comply with protocol|0|||
170583211|NCT02443116|616475885|FG008|Part 2|Inability to comply with protocol|0|||
170910696|NCT00077623|617677246|FG001|Overall Study|Withdrawal by Subject|10|||
170583212|NCT02443116|616475877|FG000|Part 2|Lost to Follow-up|0|||
170583213|NCT02443116|616475878|FG001|Part 2|Lost to Follow-up|0|||
170583214|NCT02443116|616475879|FG002|Part 2|Lost to Follow-up|0|||
170583215|NCT02443116|616475880|FG003|Part 2|Lost to Follow-up|1|||
170910697|NCT00077623|617677247|FG002|Overall Study|Withdrawal by Subject|1|||
170583216|NCT02443116|616475881|FG004|Part 2|Lost to Follow-up|0|||
170583217|NCT02443116|616475882|FG005|Part 2|Lost to Follow-up|0|||
170583218|NCT02443116|616475883|FG006|Part 2|Lost to Follow-up|0|||
170583219|NCT02443116|616475884|FG007|Part 2|Lost to Follow-up|0|||
170583220|NCT02443116|616475885|FG008|Part 2|Lost to Follow-up|0|||
170583221|NCT02443116|616475877|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
170583222|NCT02443116|616475878|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
170583223|NCT02443116|616475879|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
170649909|NCT02095132|616732751|FG001|Overall Study|Adverse Event|0|||
170649910|NCT02095132|616732752|FG002|Overall Study|Adverse Event|0|||
170583224|NCT02443116|616475880|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
170583225|NCT02443116|616475881|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
170583226|NCT02443116|616475882|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
170583227|NCT02443116|616475883|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
170583228|NCT02443116|616475884|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
170583229|NCT02443116|616475885|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
170583230|NCT02443116|616475877|FG000|Part 3|Adverse Event|0|||
170583231|NCT02443116|616475878|FG001|Part 3|Adverse Event|0|||
170583232|NCT02443116|616475879|FG002|Part 3|Adverse Event|0|||
170583233|NCT02443116|616475880|FG003|Part 3|Adverse Event|0|||
170583234|NCT02443116|616475881|FG004|Part 3|Adverse Event|0|||
170583235|NCT02443116|616475882|FG005|Part 3|Adverse Event|0|||
170583236|NCT02443116|616475883|FG006|Part 3|Adverse Event|0|||
170583237|NCT02443116|616475884|FG007|Part 3|Adverse Event|0|||
170583238|NCT02443116|616475885|FG008|Part 3|Adverse Event|1|||
170583239|NCT02443116|616475877|FG000|Part 3|Withdrew informed consent|0|||
170583240|NCT02443116|616475878|FG001|Part 3|Withdrew informed consent|0|||
170583241|NCT02443116|616475879|FG002|Part 3|Withdrew informed consent|0|||
170583242|NCT02443116|616475880|FG003|Part 3|Withdrew informed consent|0|||
170583243|NCT02443116|616475881|FG004|Part 3|Withdrew informed consent|0|||
170583244|NCT02443116|616475882|FG005|Part 3|Withdrew informed consent|0|||
170583245|NCT02443116|616475883|FG006|Part 3|Withdrew informed consent|0|||
170583246|NCT02443116|616475884|FG007|Part 3|Withdrew informed consent|3|||
170583247|NCT02443116|616475885|FG008|Part 3|Withdrew informed consent|2|||
170583248|NCT02443116|616475877|FG000|Part 3|Lost to Follow-up|0|||
170583249|NCT02443116|616475878|FG001|Part 3|Lost to Follow-up|0|||
170583250|NCT02443116|616475879|FG002|Part 3|Lost to Follow-up|0|||
170583251|NCT02443116|616475880|FG003|Part 3|Lost to Follow-up|0|||
170583252|NCT02443116|616475881|FG004|Part 3|Lost to Follow-up|0|||
170583253|NCT02443116|616475882|FG005|Part 3|Lost to Follow-up|0|||
170583254|NCT02443116|616475883|FG006|Part 3|Lost to Follow-up|0|||
170583255|NCT02443116|616475884|FG007|Part 3|Lost to Follow-up|1|||
170583256|NCT02443116|616475885|FG008|Part 3|Lost to Follow-up|2|||
170583257|NCT03594747|616475893|FG000|Overall Study|Death|78|||
170583258|NCT03594747|616475894|FG001|Overall Study|Death|86|||
170583259|NCT03594747|616475895|FG002|Overall Study|Death|87|||
170583260|NCT03594747|616475893|FG000|Overall Study|Withdrawal by Subject|5|||
170583261|NCT03594747|616475894|FG001|Overall Study|Withdrawal by Subject|2|||
170583262|NCT03594747|616475895|FG002|Overall Study|Withdrawal by Subject|11|||
170583263|NCT03594747|616475893|FG000|Overall Study|Lost to Follow-up|4|||
170583264|NCT03594747|616475894|FG001|Overall Study|Lost to Follow-up|1|||
170583265|NCT03594747|616475895|FG002|Overall Study|Lost to Follow-up|1|||
170583266|NCT03594747|616475893|FG000|Overall Study|Physician Decision|0|||
170583267|NCT03594747|616475894|FG001|Overall Study|Physician Decision|1|||
170809632|NCT01185340|617313775|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
170809633|NCT01185340|617313772|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
170583268|NCT03594747|616475895|FG002|Overall Study|Physician Decision|0|||
170583269|NCT03594747|616475893|FG000|Overall Study|Sponsor decision|23|||
170583270|NCT03594747|616475894|FG001|Overall Study|Sponsor decision|17|||
170583271|NCT03594747|616475895|FG002|Overall Study|Sponsor decision|16|||
170583272|NCT03594747|616475893|FG000|Overall Study|Did not meet inclusion criteria|0|||
170583273|NCT03594747|616475894|FG001|Overall Study|Did not meet inclusion criteria|0|||
170583274|NCT03594747|616475895|FG002|Overall Study|Did not meet inclusion criteria|1|||
170583275|NCT03594747|616475893|FG000|Overall Study|Transfer to long term extension study|10|||
170809634|NCT01185340|617313773|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
170583276|NCT03594747|616475894|FG001|Overall Study|Transfer to long term extension study|12|||
170583277|NCT03594747|616475895|FG002|Overall Study|Transfer to long term extension study|5|||
170583278|NCT04382586|616475896|FG000|Overall Study|Death|3|||
170583279|NCT04382586|616475897|FG001|Overall Study|Death|4|||
170583280|NCT04382586|616475896|FG000|Overall Study|Lost to Follow-up|11|||
170583281|NCT04382586|616475897|FG001|Overall Study|Lost to Follow-up|8|||
170583282|NCT04382586|616475896|FG000|Overall Study|Withdrawal by Subject|3|||
170809635|NCT01185340|617313774|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
170809636|NCT01185340|617313775|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
170809637|NCT01185340|617313772|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
170583283|NCT04382586|616475897|FG001|Overall Study|Withdrawal by Subject|1|||
170583284|NCT04382586|616475896|FG000|Overall Study|Physician Decision|0|||
170583285|NCT04382586|616475897|FG001|Overall Study|Physician Decision|3|||
170583286|NCT02265536|616475905|FG000|Overall Study|Adverse Event|1|||
170583287|NCT02265536|616475906|FG001|Overall Study|Adverse Event|0|||
170583288|NCT02265536|616475907|FG002|Overall Study|Adverse Event|0|||
170583289|NCT02265536|616475908|FG003|Overall Study|Adverse Event|0|||
170583290|NCT02265536|616475909|FG004|Overall Study|Adverse Event|1|||
170583291|NCT02265536|616475910|FG005|Overall Study|Adverse Event|0|||
170583292|NCT02265536|616475905|FG000|Overall Study|Physician Decision|0|||
170583293|NCT02265536|616475906|FG001|Overall Study|Physician Decision|0|||
170583294|NCT02265536|616475907|FG002|Overall Study|Physician Decision|0|||
170583295|NCT02265536|616475908|FG003|Overall Study|Physician Decision|0|||
170583296|NCT02265536|616475909|FG004|Overall Study|Physician Decision|2|||
170583297|NCT02265536|616475910|FG005|Overall Study|Physician Decision|0|||
170583298|NCT02265536|616475905|FG000|Overall Study|Withdrawal by Subject|0|||
170583299|NCT02265536|616475906|FG001|Overall Study|Withdrawal by Subject|3|||
170583300|NCT02265536|616475907|FG002|Overall Study|Withdrawal by Subject|0|||
170583301|NCT02265536|616475908|FG003|Overall Study|Withdrawal by Subject|0|||
170583302|NCT02265536|616475909|FG004|Overall Study|Withdrawal by Subject|0|||
170583303|NCT02265536|616475910|FG005|Overall Study|Withdrawal by Subject|0|||
170583304|NCT02907216|616475911|FG000|Overall Study|No benefit to be obtained by continuing|0|||
170583305|NCT02907216|616475912|FG001|Overall Study|No benefit to be obtained by continuing|1|||
170583306|NCT02907216|616475911|FG000|Overall Study|Withdrawal by Subject|1|||
170583307|NCT02907216|616475912|FG001|Overall Study|Withdrawal by Subject|0|||
170583308|NCT02597452|616475918|FG000|Overall Study|testing incomplete|30|||
170583309|NCT02931838|616475919|FG000|Overall Study|Reason not provided by investigator|1|||
170583310|NCT02931838|616475920|FG001|Overall Study|Reason not provided by investigator|0|||
170583311|NCT02931838|616475921|FG002|Overall Study|Reason not provided by investigator|1|||
170583312|NCT02931838|616475922|FG003|Overall Study|Reason not provided by investigator|0|||
170583313|NCT02931838|616475923|FG004|Overall Study|Reason not provided by investigator|0|||
170583314|NCT02931838|616475924|FG005|Overall Study|Reason not provided by investigator|0|||
170583315|NCT02931838|616475919|FG000|Overall Study|Poor/non-compliance|0|||
170583316|NCT02931838|616475920|FG001|Overall Study|Poor/non-compliance|0|||
170583317|NCT02931838|616475921|FG002|Overall Study|Poor/non-compliance|1|||
170583318|NCT02931838|616475922|FG003|Overall Study|Poor/non-compliance|0|||
170583319|NCT02931838|616475923|FG004|Overall Study|Poor/non-compliance|0|||
170583320|NCT02931838|616475924|FG005|Overall Study|Poor/non-compliance|0|||
170583321|NCT02931838|616475919|FG000|Overall Study|Lack of Efficacy|5|||
170583322|NCT02931838|616475920|FG001|Overall Study|Lack of Efficacy|4|||
170583323|NCT02931838|616475921|FG002|Overall Study|Lack of Efficacy|0|||
170583324|NCT02931838|616475922|FG003|Overall Study|Lack of Efficacy|0|||
170583325|NCT02931838|616475923|FG004|Overall Study|Lack of Efficacy|0|||
170583326|NCT02931838|616475924|FG005|Overall Study|Lack of Efficacy|1|||
170583327|NCT02931838|616475919|FG000|Overall Study|Lost to Follow-up|1|||
170583328|NCT02931838|616475920|FG001|Overall Study|Lost to Follow-up|0|||
170583329|NCT02931838|616475921|FG002|Overall Study|Lost to Follow-up|1|||
170583330|NCT02931838|616475922|FG003|Overall Study|Lost to Follow-up|1|||
170583331|NCT02931838|616475923|FG004|Overall Study|Lost to Follow-up|2|||
170583332|NCT02931838|616475924|FG005|Overall Study|Lost to Follow-up|0|||
170583333|NCT02931838|616475919|FG000|Overall Study|Subject request to discontinue treatment|4|||
170583334|NCT02931838|616475920|FG001|Overall Study|Subject request to discontinue treatment|3|||
170583335|NCT02931838|616475921|FG002|Overall Study|Subject request to discontinue treatment|3|||
170583336|NCT02931838|616475922|FG003|Overall Study|Subject request to discontinue treatment|0|||
170583337|NCT02931838|616475923|FG004|Overall Study|Subject request to discontinue treatment|1|||
170583338|NCT02931838|616475924|FG005|Overall Study|Subject request to discontinue treatment|0|||
170583339|NCT02931838|616475919|FG000|Overall Study|Withdrawal by Subject|1|||
170583340|NCT02931838|616475920|FG001|Overall Study|Withdrawal by Subject|2|||
170583341|NCT02931838|616475921|FG002|Overall Study|Withdrawal by Subject|0|||
170583342|NCT02931838|616475922|FG003|Overall Study|Withdrawal by Subject|1|||
170583343|NCT02931838|616475923|FG004|Overall Study|Withdrawal by Subject|0|||
170583344|NCT02931838|616475924|FG005|Overall Study|Withdrawal by Subject|0|||
170583345|NCT02931838|616475919|FG000|Overall Study|Adverse Event|2|||
170583346|NCT02931838|616475920|FG001|Overall Study|Adverse Event|1|||
170583347|NCT02931838|616475921|FG002|Overall Study|Adverse Event|2|||
170583348|NCT02931838|616475922|FG003|Overall Study|Adverse Event|1|||
170583349|NCT02931838|616475923|FG004|Overall Study|Adverse Event|3|||
170583350|NCT02931838|616475924|FG005|Overall Study|Adverse Event|1|||
170910698|NCT00077623|617677245|FG000|Overall Study|Other-Non safety reason|18|||
170910699|NCT00077623|617677246|FG001|Overall Study|Other-Non safety reason|15|||
170910700|NCT00077623|617677247|FG002|Overall Study|Other-Non safety reason|19|||
170910701|NCT00077623|617677245|FG000|Overall Study|Insufficient therapeutic response|2|||
170910702|NCT00077623|617677246|FG001|Overall Study|Insufficient therapeutic response|0|||
170583351|NCT01059864|616475925|FG000|Open-Label Run-In Phase|Adverse Event|7|||
170910703|NCT00077623|617677247|FG002|Overall Study|Insufficient therapeutic response|0|||
170910704|NCT00077623|617677245|FG000|Overall Study|Death|12|||
170910705|NCT00077623|617677246|FG001|Overall Study|Death|18|||
170583352|NCT01059864|616475926|FG001|Open-Label Run-In Phase|Adverse Event|0|||
170583353|NCT01059864|616475927|FG002|Open-Label Run-In Phase|Adverse Event|0|||
170583354|NCT01059864|616475925|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
170583355|NCT01059864|616475926|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
170583356|NCT01059864|616475927|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
170583357|NCT01059864|616475925|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
170583358|NCT01059864|616475926|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
170583359|NCT01059864|616475927|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
170583360|NCT01059864|616475925|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
170583361|NCT01059864|616475926|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
170583362|NCT01059864|616475927|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
170583363|NCT01059864|616475925|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
170583364|NCT01059864|616475926|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
170583365|NCT01059864|616475927|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
170583366|NCT01059864|616475925|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
170583367|NCT01059864|616475926|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
170583368|NCT01059864|616475927|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
170583369|NCT00790868|616478521|FG000|Overall Study|Withdrawal by Subject|4|||
170583370|NCT00790868|616478522|FG001|Overall Study|Withdrawal by Subject|5|||
170583371|NCT00790868|616478521|FG000|Overall Study|Lost to Follow-up|2|||
170583372|NCT00790868|616478522|FG001|Overall Study|Lost to Follow-up|12|||
170583373|NCT01448824|616478523|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
170583374|NCT01448824|616478524|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
170583375|NCT01448824|616478525|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
170583376|NCT01448824|616478526|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
170583377|NCT01448824|616478527|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
170583378|NCT01448824|616478528|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
170583379|NCT01448824|616478529|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
170583380|NCT01448824|616478530|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
170583381|NCT01448824|616478523|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
170583382|NCT01448824|616478524|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
170583383|NCT01448824|616478525|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
170583384|NCT01448824|616478526|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
170583385|NCT01448824|616478527|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
170583386|NCT01448824|616478528|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
170583387|NCT01448824|616478529|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
170583388|NCT01448824|616478530|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
170583389|NCT01448824|616478523|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
170583390|NCT01448824|616478524|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
170583391|NCT01448824|616478525|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
170583392|NCT01448824|616478526|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
170583393|NCT01448824|616478527|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
170583394|NCT01448824|616478528|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
170583395|NCT01448824|616478529|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
170583396|NCT01448824|616478530|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
170583397|NCT01448824|616478523|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
170649911|NCT02095132|616732753|FG003|Overall Study|Adverse Event|0|||
170649912|NCT02095132|616732754|FG004|Overall Study|Adverse Event|1|||
170583398|NCT01448824|616478524|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
170583399|NCT01448824|616478525|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
170583400|NCT01448824|616478526|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
170583401|NCT01448824|616478527|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
170583402|NCT01448824|616478528|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
170583403|NCT01448824|616478529|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
170583404|NCT01448824|616478530|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
170649913|NCT02095132|616732755|FG005|Overall Study|Adverse Event|0|||
170649914|NCT02095132|616732756|FG006|Overall Study|Adverse Event|1|||
170649915|NCT02095132|616732757|FG007|Overall Study|Adverse Event|0|||
170649916|NCT02095132|616732758|FG008|Overall Study|Adverse Event|0|||
170649917|NCT02095132|616732750|FG000|Overall Study|Death|0|||
170583405|NCT01448824|616478523|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
170583406|NCT01448824|616478524|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
170583407|NCT01448824|616478525|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
170649918|NCT02095132|616732751|FG001|Overall Study|Death|0|||
170649919|NCT02095132|616732752|FG002|Overall Study|Death|0|||
170583408|NCT01448824|616478526|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
170583409|NCT01448824|616478527|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
170583410|NCT01448824|616478528|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
170583411|NCT01448824|616478529|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
170583412|NCT01448824|616478530|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
170649920|NCT02095132|616732753|FG003|Overall Study|Death|0|||
170649921|NCT02095132|616732754|FG004|Overall Study|Death|0|||
170649922|NCT02095132|616732755|FG005|Overall Study|Death|0|||
170649923|NCT02095132|616732756|FG006|Overall Study|Death|1|||
170583413|NCT01448824|616478523|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
170583414|NCT01448824|616478524|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
170649924|NCT02095132|616732757|FG007|Overall Study|Death|0|||
170649925|NCT02095132|616732758|FG008|Overall Study|Death|0|||
170649926|NCT02095132|616732750|FG000|Overall Study|Lack of Efficacy|3|||
170583415|NCT01448824|616478525|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
170583416|NCT01448824|616478526|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
170583417|NCT01448824|616478527|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
170583418|NCT01448824|616478528|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
170583419|NCT01448824|616478529|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
170583420|NCT01448824|616478530|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
170583421|NCT01448824|616478523|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
170583422|NCT01448824|616478524|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
170583423|NCT01448824|616478525|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
170583424|NCT01448824|616478526|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
170583425|NCT01448824|616478527|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
170583426|NCT01448824|616478528|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
170583427|NCT01448824|616478529|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
170583428|NCT01448824|616478530|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
170583429|NCT01448824|616478523|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
170583430|NCT01448824|616478524|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
170583431|NCT01448824|616478525|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
170583432|NCT01448824|616478526|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
170583433|NCT01448824|616478527|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
170583434|NCT01448824|616478528|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
170583435|NCT01448824|616478529|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
170583436|NCT01448824|616478530|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
170583437|NCT02370537|616478533|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
170583438|NCT02370537|616478534|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
170583439|NCT02370537|616478535|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
170910706|NCT00077623|617677247|FG002|Overall Study|Death|11|||
170910707|NCT00077623|617677245|FG000|Overall Study|Failure to return|1|||
170910708|NCT00077623|617677246|FG001|Overall Study|Failure to return|0|||
170583440|NCT02370537|616478533|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
170583441|NCT02370537|616478534|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
170583442|NCT02370537|616478535|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
170583443|NCT02370537|616478533|FG000|Part B|Not randomised to receive treatment|1|||
170583444|NCT02370537|616478534|FG001|Part B|Not randomised to receive treatment|2|||
170583445|NCT02370537|616478535|FG002|Part B|Not randomised to receive treatment|259|||
170583446|NCT02370537|616478533|FG000|Part B|Withdrawal by Subject|0|||
170583447|NCT02370537|616478534|FG001|Part B|Withdrawal by Subject|1|||
170583448|NCT02370537|616478535|FG002|Part B|Withdrawal by Subject|0|||
170583449|NCT01952665|616478537|FG000|Overall Study|Physician Decision|3|||
170583450|NCT01952665|616478538|FG001|Overall Study|Physician Decision|2|||
170583451|NCT01952665|616478537|FG000|Overall Study|Lost to Follow-up|1|||
170583452|NCT01952665|616478538|FG001|Overall Study|Lost to Follow-up|2|||
170583453|NCT01952665|616478537|FG000|Overall Study|Adverse Event|2|||
170583454|NCT01952665|616478538|FG001|Overall Study|Adverse Event|1|||
170583455|NCT01952665|616478537|FG000|Overall Study|Protocol Violation|0|||
170583456|NCT01952665|616478538|FG001|Overall Study|Protocol Violation|1|||
170583457|NCT01537081|616478542|FG000|Overall Study|Adverse Event|5|||
170583458|NCT01537081|616478543|FG001|Overall Study|Adverse Event|2|||
170583459|NCT01537081|616478544|FG002|Overall Study|Adverse Event|2|||
170583460|NCT01537081|616478542|FG000|Overall Study|Lack of Efficacy|2|||
170649927|NCT02095132|616732751|FG001|Overall Study|Lack of Efficacy|5|||
170649928|NCT02095132|616732752|FG002|Overall Study|Lack of Efficacy|2|||
170649929|NCT02095132|616732753|FG003|Overall Study|Lack of Efficacy|8|||
170649930|NCT02095132|616732754|FG004|Overall Study|Lack of Efficacy|3|||
170583461|NCT01537081|616478543|FG001|Overall Study|Lack of Efficacy|1|||
170583462|NCT01537081|616478544|FG002|Overall Study|Lack of Efficacy|0|||
170583463|NCT01537081|616478542|FG000|Overall Study|Lost to Follow-up|17|||
170583464|NCT01537081|616478543|FG001|Overall Study|Lost to Follow-up|15|||
170583465|NCT01537081|616478544|FG002|Overall Study|Lost to Follow-up|9|||
170583466|NCT01537081|616478542|FG000|Overall Study|Protocol Violation|3|||
170583467|NCT01537081|616478543|FG001|Overall Study|Protocol Violation|2|||
170583468|NCT01537081|616478544|FG002|Overall Study|Protocol Violation|2|||
170583469|NCT01537081|616478542|FG000|Overall Study|Withdrawal by Subject|6|||
170583470|NCT01537081|616478543|FG001|Overall Study|Withdrawal by Subject|11|||
170649931|NCT02095132|616732755|FG005|Overall Study|Lack of Efficacy|6|||
170910709|NCT00077623|617677247|FG002|Overall Study|Failure to return|0|||
170910710|NCT00401973|617677248|FG000|Overall Study|Adverse Event|2|||
170583471|NCT01537081|616478544|FG002|Overall Study|Withdrawal by Subject|3|||
170583472|NCT01537081|616478542|FG000|Overall Study|Physician Decision|5|||
170583473|NCT01537081|616478543|FG001|Overall Study|Physician Decision|6|||
170583474|NCT01537081|616478544|FG002|Overall Study|Physician Decision|0|||
170583475|NCT01537081|616478542|FG000|Overall Study|Sponsor decision|0|||
170649932|NCT02095132|616732756|FG006|Overall Study|Lack of Efficacy|10|||
170649933|NCT02095132|616732757|FG007|Overall Study|Lack of Efficacy|9|||
170583476|NCT01537081|616478543|FG001|Overall Study|Sponsor decision|1|||
170583477|NCT01537081|616478544|FG002|Overall Study|Sponsor decision|0|||
170583478|NCT01537081|616478542|FG000|Overall Study|Assigned but never dosed|1|||
170583479|NCT01537081|616478543|FG001|Overall Study|Assigned but never dosed|0|||
170583480|NCT01537081|616478544|FG002|Overall Study|Assigned but never dosed|0|||
170583481|NCT02578680|616478551|FG000|Overall Study|Death|329|||
170583482|NCT02578680|616478552|FG001|Overall Study|Death|181|||
170583483|NCT02578680|616478551|FG000|Overall Study|Lost to Follow-up|3|||
170583484|NCT02578680|616478552|FG001|Overall Study|Lost to Follow-up|1|||
170583485|NCT02578680|616478551|FG000|Overall Study|Physician Decision|0|||
170583486|NCT02578680|616478552|FG001|Overall Study|Physician Decision|1|||
170583487|NCT02578680|616478551|FG000|Overall Study|Protocol Violation|1|||
170583488|NCT02578680|616478552|FG001|Overall Study|Protocol Violation|1|||
170583489|NCT02578680|616478551|FG000|Overall Study|Sponsor Decision|64|||
170583490|NCT02578680|616478552|FG001|Overall Study|Sponsor Decision|13|||
170583491|NCT02578680|616478551|FG000|Overall Study|Withdrawal by Subject|13|||
170583492|NCT02578680|616478552|FG001|Overall Study|Withdrawal by Subject|9|||
170583493|NCT05425732|616478559|FG000|Overall Study|Death|4|||
170583494|NCT05425732|616478560|FG001|Overall Study|Death|2|||
170583495|NCT05425732|616478561|FG002|Overall Study|Death|0|||
170583496|NCT05425732|616478562|FG003|Overall Study|Death|0|||
170583497|NCT05425732|616478559|FG000|Overall Study|Lost to Follow-up|10|||
170583498|NCT05425732|616478560|FG001|Overall Study|Lost to Follow-up|15|||
170583499|NCT05425732|616478561|FG002|Overall Study|Lost to Follow-up|5|||
170583500|NCT05425732|616478562|FG003|Overall Study|Lost to Follow-up|3|||
170583501|NCT05425732|616478559|FG000|Overall Study|Physician Decision|0|||
170583502|NCT05425732|616478560|FG001|Overall Study|Physician Decision|2|||
170583503|NCT05425732|616478561|FG002|Overall Study|Physician Decision|0|||
170583504|NCT05425732|616478562|FG003|Overall Study|Physician Decision|0|||
170583505|NCT05425732|616478559|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170583506|NCT05425732|616478560|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
170583507|NCT05425732|616478561|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170583508|NCT05425732|616478562|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170583509|NCT05425732|616478559|FG000|Overall Study|Withdrawal by Subject|4|||
170583510|NCT05425732|616478560|FG001|Overall Study|Withdrawal by Subject|8|||
170583511|NCT05425732|616478561|FG002|Overall Study|Withdrawal by Subject|1|||
170583512|NCT05425732|616478562|FG003|Overall Study|Withdrawal by Subject|1|||
170583513|NCT05425732|616478559|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
170583514|NCT05425732|616478560|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
170583515|NCT05425732|616478561|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
170583516|NCT05425732|616478562|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
170583517|NCT03727646|616478563|FG000|Overall Study|Adverse Event|1|||
170583518|NCT03727646|616478564|FG001|Overall Study|Adverse Event|0|||
170583519|NCT04753658|616478565|FG000|Overall Study|Progressive disease|7|||
170583520|NCT04753658|616478565|FG000|Overall Study|Other|7|||
170583521|NCT04753658|616478565|FG000|Overall Study|Adverse Event|1|||
170583522|NCT02290691|616478568|FG000|Overall Study|Noncompliance|0|||
170583523|NCT02290691|616478569|FG001|Overall Study|Noncompliance|1|||
170583524|NCT02290691|616478568|FG000|Overall Study|Withdrawal by Subject|1|||
170583525|NCT02290691|616478569|FG001|Overall Study|Withdrawal by Subject|1|||
170583526|NCT02290691|616478568|FG000|Overall Study|Lost to Follow-up|7|||
170649934|NCT02095132|616732758|FG008|Overall Study|Lack of Efficacy|8|||
170649935|NCT02095132|616732750|FG000|Overall Study|Physician Decision|1|||
170649936|NCT02095132|616732751|FG001|Overall Study|Physician Decision|0|||
170649937|NCT02095132|616732752|FG002|Overall Study|Physician Decision|0|||
170910711|NCT00401973|617677249|FG001|Overall Study|Adverse Event|8|||
170583527|NCT02290691|616478569|FG001|Overall Study|Lost to Follow-up|7|||
170583528|NCT00306293|616478571|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
170583529|NCT00306293|616478572|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
170583530|NCT00306293|616478571|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
170583531|NCT00306293|616478572|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
170583532|NCT00306293|616478571|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
170583533|NCT00306293|616478572|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
170583534|NCT00306293|616478571|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
170583535|NCT00306293|616478572|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
170583536|NCT00306293|616478571|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
170583537|NCT00306293|616478572|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
170583538|NCT00306293|616478571|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
170583539|NCT00306293|616478572|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
170583540|NCT00306293|616478571|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
170583541|NCT00306293|616478572|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
170583542|NCT00306293|616478571|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
170649938|NCT02095132|616732753|FG003|Overall Study|Physician Decision|0|||
170649939|NCT02095132|616732754|FG004|Overall Study|Physician Decision|0|||
170910712|NCT00401973|617677250|FG002|Overall Study|Adverse Event|4|||
170583543|NCT00306293|616478572|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
170583544|NCT02589665|616478575|FG000|Induction Period|Did not receive drug|0|||
170583545|NCT02589665|616478576|FG001|Induction Period|Did not receive drug|0|||
170583546|NCT02589665|616478577|FG002|Induction Period|Did not receive drug|0|||
170583547|NCT02589665|616478578|FG003|Induction Period|Did not receive drug|1|||
170583548|NCT02589665|616478579|FG004|Induction Period|Did not receive drug|0|||
170583549|NCT02589665|616478580|FG005|Induction Period|Did not receive drug|0|||
170583550|NCT02589665|616478581|FG006|Induction Period|Did not receive drug|0|||
170583551|NCT02589665|616478582|FG007|Induction Period|Did not receive drug|0|||
170583552|NCT02589665|616478583|FG008|Induction Period|Did not receive drug|0|||
170583553|NCT02589665|616478584|FG009|Induction Period|Did not receive drug|0|||
170583554|NCT02589665|616478575|FG000|Induction Period|Adverse Event|3|||
170583555|NCT02589665|616478576|FG001|Induction Period|Adverse Event|0|||
170583556|NCT02589665|616478577|FG002|Induction Period|Adverse Event|2|||
170583557|NCT02589665|616478578|FG003|Induction Period|Adverse Event|2|||
170583558|NCT02589665|616478579|FG004|Induction Period|Adverse Event|0|||
170583559|NCT02589665|616478580|FG005|Induction Period|Adverse Event|0|||
170583560|NCT02589665|616478581|FG006|Induction Period|Adverse Event|0|||
170583561|NCT02589665|616478582|FG007|Induction Period|Adverse Event|0|||
170583562|NCT02589665|616478583|FG008|Induction Period|Adverse Event|0|||
170583563|NCT02589665|616478584|FG009|Induction Period|Adverse Event|0|||
170583564|NCT02589665|616478575|FG000|Induction Period|Withdrawal by Subject|0|||
170583565|NCT02589665|616478576|FG001|Induction Period|Withdrawal by Subject|1|||
170583566|NCT02589665|616478577|FG002|Induction Period|Withdrawal by Subject|0|||
170583567|NCT02589665|616478578|FG003|Induction Period|Withdrawal by Subject|1|||
170583568|NCT02589665|616478579|FG004|Induction Period|Withdrawal by Subject|0|||
170583569|NCT02589665|616478580|FG005|Induction Period|Withdrawal by Subject|0|||
170583570|NCT02589665|616478581|FG006|Induction Period|Withdrawal by Subject|0|||
170583571|NCT02589665|616478582|FG007|Induction Period|Withdrawal by Subject|0|||
170583572|NCT02589665|616478583|FG008|Induction Period|Withdrawal by Subject|0|||
170583573|NCT02589665|616478584|FG009|Induction Period|Withdrawal by Subject|0|||
170583574|NCT02589665|616478575|FG000|Induction Period|Protocol Violation|0|||
170583575|NCT02589665|616478576|FG001|Induction Period|Protocol Violation|1|||
170583576|NCT02589665|616478577|FG002|Induction Period|Protocol Violation|0|||
170583577|NCT02589665|616478578|FG003|Induction Period|Protocol Violation|0|||
170583578|NCT02589665|616478579|FG004|Induction Period|Protocol Violation|0|||
170583579|NCT02589665|616478580|FG005|Induction Period|Protocol Violation|0|||
170583580|NCT02589665|616478581|FG006|Induction Period|Protocol Violation|0|||
170583581|NCT02589665|616478582|FG007|Induction Period|Protocol Violation|0|||
170583582|NCT02589665|616478583|FG008|Induction Period|Protocol Violation|0|||
170583583|NCT02589665|616478584|FG009|Induction Period|Protocol Violation|0|||
170583584|NCT02589665|616478575|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583585|NCT02589665|616478576|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583586|NCT02589665|616478577|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583587|NCT02589665|616478578|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583588|NCT02589665|616478579|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
170583589|NCT02589665|616478580|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
170583590|NCT02589665|616478581|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
170583591|NCT02589665|616478582|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583592|NCT02589665|616478583|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583593|NCT02589665|616478584|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583594|NCT02589665|616478575|FG000|Maintenance Period|Withdrawal by Subject|0|||
170583595|NCT02589665|616478576|FG001|Maintenance Period|Withdrawal by Subject|0|||
170583596|NCT02589665|616478577|FG002|Maintenance Period|Withdrawal by Subject|0|||
170583597|NCT02589665|616478578|FG003|Maintenance Period|Withdrawal by Subject|0|||
170583598|NCT02589665|616478579|FG004|Maintenance Period|Withdrawal by Subject|4|||
170583599|NCT02589665|616478580|FG005|Maintenance Period|Withdrawal by Subject|2|||
170583600|NCT02589665|616478581|FG006|Maintenance Period|Withdrawal by Subject|4|||
170583601|NCT02589665|616478582|FG007|Maintenance Period|Withdrawal by Subject|0|||
170583602|NCT02589665|616478583|FG008|Maintenance Period|Withdrawal by Subject|0|||
170583603|NCT02589665|616478584|FG009|Maintenance Period|Withdrawal by Subject|0|||
170583604|NCT02589665|616478575|FG000|Maintenance Period|Lack of Efficacy|0|||
170583605|NCT02589665|616478576|FG001|Maintenance Period|Lack of Efficacy|0|||
170583606|NCT02589665|616478577|FG002|Maintenance Period|Lack of Efficacy|0|||
170583607|NCT02589665|616478578|FG003|Maintenance Period|Lack of Efficacy|0|||
170583608|NCT02589665|616478579|FG004|Maintenance Period|Lack of Efficacy|2|||
170583609|NCT02589665|616478580|FG005|Maintenance Period|Lack of Efficacy|1|||
170583610|NCT02589665|616478581|FG006|Maintenance Period|Lack of Efficacy|0|||
170583611|NCT02589665|616478582|FG007|Maintenance Period|Lack of Efficacy|0|||
170583612|NCT02589665|616478583|FG008|Maintenance Period|Lack of Efficacy|0|||
170583613|NCT02589665|616478584|FG009|Maintenance Period|Lack of Efficacy|0|||
170583614|NCT02589665|616478575|FG000|Maintenance Period|Adverse Event|0|||
170583615|NCT02589665|616478576|FG001|Maintenance Period|Adverse Event|0|||
170583616|NCT02589665|616478577|FG002|Maintenance Period|Adverse Event|0|||
170583617|NCT02589665|616478578|FG003|Maintenance Period|Adverse Event|0|||
170583618|NCT02589665|616478579|FG004|Maintenance Period|Adverse Event|0|||
170583619|NCT02589665|616478580|FG005|Maintenance Period|Adverse Event|0|||
170583620|NCT02589665|616478581|FG006|Maintenance Period|Adverse Event|2|||
170583621|NCT02589665|616478582|FG007|Maintenance Period|Adverse Event|0|||
170583622|NCT02589665|616478583|FG008|Maintenance Period|Adverse Event|0|||
170583623|NCT02589665|616478584|FG009|Maintenance Period|Adverse Event|0|||
170583624|NCT02589665|616478575|FG000|Maintenance Period|Lost to Follow-up|0|||
170583625|NCT02589665|616478576|FG001|Maintenance Period|Lost to Follow-up|0|||
170583626|NCT02589665|616478577|FG002|Maintenance Period|Lost to Follow-up|0|||
170583627|NCT02589665|616478578|FG003|Maintenance Period|Lost to Follow-up|0|||
170583628|NCT02589665|616478579|FG004|Maintenance Period|Lost to Follow-up|0|||
170583629|NCT02589665|616478580|FG005|Maintenance Period|Lost to Follow-up|1|||
170583630|NCT02589665|616478581|FG006|Maintenance Period|Lost to Follow-up|0|||
170583631|NCT02589665|616478582|FG007|Maintenance Period|Lost to Follow-up|0|||
170583632|NCT02589665|616478583|FG008|Maintenance Period|Lost to Follow-up|0|||
170583633|NCT02589665|616478584|FG009|Maintenance Period|Lost to Follow-up|0|||
170583634|NCT02589665|616478575|FG000|Maintenance Period|Physician Decision|0|||
170583635|NCT02589665|616478576|FG001|Maintenance Period|Physician Decision|0|||
170583636|NCT02589665|616478577|FG002|Maintenance Period|Physician Decision|0|||
170583637|NCT02589665|616478578|FG003|Maintenance Period|Physician Decision|0|||
170583638|NCT02589665|616478579|FG004|Maintenance Period|Physician Decision|0|||
170583639|NCT02589665|616478580|FG005|Maintenance Period|Physician Decision|1|||
170583640|NCT02589665|616478581|FG006|Maintenance Period|Physician Decision|0|||
170583641|NCT02589665|616478582|FG007|Maintenance Period|Physician Decision|0|||
170583642|NCT02589665|616478583|FG008|Maintenance Period|Physician Decision|0|||
170583643|NCT02589665|616478584|FG009|Maintenance Period|Physician Decision|0|||
170583644|NCT02589665|616478575|FG000|Maintenance Period|Reason Not Collected|0|||
170583645|NCT02589665|616478576|FG001|Maintenance Period|Reason Not Collected|0|||
170583646|NCT02589665|616478577|FG002|Maintenance Period|Reason Not Collected|0|||
170583647|NCT02589665|616478578|FG003|Maintenance Period|Reason Not Collected|0|||
170583648|NCT02589665|616478579|FG004|Maintenance Period|Reason Not Collected|0|||
170583649|NCT02589665|616478580|FG005|Maintenance Period|Reason Not Collected|1|||
170583650|NCT02589665|616478581|FG006|Maintenance Period|Reason Not Collected|1|||
170583651|NCT02589665|616478582|FG007|Maintenance Period|Reason Not Collected|0|||
170583652|NCT02589665|616478583|FG008|Maintenance Period|Reason Not Collected|0|||
170583653|NCT02589665|616478584|FG009|Maintenance Period|Reason Not Collected|0|||
170583654|NCT02589665|616478575|FG000|Induction Extension Period|Adverse Event|0|||
170583655|NCT02589665|616478576|FG001|Induction Extension Period|Adverse Event|0|||
170583656|NCT02589665|616478577|FG002|Induction Extension Period|Adverse Event|0|||
170583657|NCT02589665|616478578|FG003|Induction Extension Period|Adverse Event|0|||
170583658|NCT02589665|616478579|FG004|Induction Extension Period|Adverse Event|0|||
170583659|NCT02589665|616478580|FG005|Induction Extension Period|Adverse Event|0|||
170583660|NCT02589665|616478581|FG006|Induction Extension Period|Adverse Event|0|||
170583661|NCT02589665|616478582|FG007|Induction Extension Period|Adverse Event|0|||
170583662|NCT02589665|616478583|FG008|Induction Extension Period|Adverse Event|4|||
170583663|NCT02589665|616478584|FG009|Induction Extension Period|Adverse Event|0|||
170583664|NCT02589665|616478575|FG000|Induction Extension Period|Lack of Efficacy|0|||
170583665|NCT02589665|616478576|FG001|Induction Extension Period|Lack of Efficacy|0|||
170583666|NCT02589665|616478577|FG002|Induction Extension Period|Lack of Efficacy|0|||
170583667|NCT02589665|616478578|FG003|Induction Extension Period|Lack of Efficacy|0|||
170583668|NCT02589665|616478579|FG004|Induction Extension Period|Lack of Efficacy|0|||
170583669|NCT02589665|616478580|FG005|Induction Extension Period|Lack of Efficacy|0|||
170583670|NCT02589665|616478581|FG006|Induction Extension Period|Lack of Efficacy|0|||
170583671|NCT02589665|616478582|FG007|Induction Extension Period|Lack of Efficacy|0|||
170583672|NCT02589665|616478583|FG008|Induction Extension Period|Lack of Efficacy|3|||
170583673|NCT02589665|616478584|FG009|Induction Extension Period|Lack of Efficacy|0|||
170583674|NCT02589665|616478575|FG000|Induction Extension Period|Withdrawal by Subject|0|||
170583675|NCT02589665|616478576|FG001|Induction Extension Period|Withdrawal by Subject|0|||
170583676|NCT02589665|616478577|FG002|Induction Extension Period|Withdrawal by Subject|0|||
170583677|NCT02589665|616478578|FG003|Induction Extension Period|Withdrawal by Subject|0|||
170583678|NCT02589665|616478579|FG004|Induction Extension Period|Withdrawal by Subject|0|||
170583679|NCT02589665|616478580|FG005|Induction Extension Period|Withdrawal by Subject|0|||
170583680|NCT02589665|616478581|FG006|Induction Extension Period|Withdrawal by Subject|0|||
170910713|NCT00401973|617677248|FG000|Overall Study|Clinical Relapse|0|||
170910714|NCT00401973|617677249|FG001|Overall Study|Clinical Relapse|1|||
170910715|NCT00401973|617677250|FG002|Overall Study|Clinical Relapse|1|||
170910716|NCT00401973|617677248|FG000|Overall Study|Lack of Efficacy|0|||
170583681|NCT02589665|616478582|FG007|Induction Extension Period|Withdrawal by Subject|2|||
170583682|NCT02589665|616478583|FG008|Induction Extension Period|Withdrawal by Subject|3|||
170583683|NCT02589665|616478584|FG009|Induction Extension Period|Withdrawal by Subject|0|||
170583684|NCT02589665|616478575|FG000|Induction Extension Period|Physician Decision|0|||
170649940|NCT02095132|616732755|FG005|Overall Study|Physician Decision|0|||
170649941|NCT02095132|616732756|FG006|Overall Study|Physician Decision|1|||
170910717|NCT00401973|617677249|FG001|Overall Study|Lack of Efficacy|0|||
170583685|NCT02589665|616478576|FG001|Induction Extension Period|Physician Decision|0|||
170583686|NCT02589665|616478577|FG002|Induction Extension Period|Physician Decision|0|||
170583687|NCT02589665|616478578|FG003|Induction Extension Period|Physician Decision|0|||
170583688|NCT02589665|616478579|FG004|Induction Extension Period|Physician Decision|0|||
170583689|NCT02589665|616478580|FG005|Induction Extension Period|Physician Decision|0|||
170583690|NCT02589665|616478581|FG006|Induction Extension Period|Physician Decision|0|||
170583691|NCT02589665|616478582|FG007|Induction Extension Period|Physician Decision|0|||
170583692|NCT02589665|616478583|FG008|Induction Extension Period|Physician Decision|1|||
170583693|NCT02589665|616478584|FG009|Induction Extension Period|Physician Decision|0|||
170583694|NCT02589665|616478575|FG000|Induction Extension Period|Reason Not Collected|0|||
170583695|NCT02589665|616478576|FG001|Induction Extension Period|Reason Not Collected|0|||
170583696|NCT02589665|616478577|FG002|Induction Extension Period|Reason Not Collected|0|||
170583697|NCT02589665|616478578|FG003|Induction Extension Period|Reason Not Collected|0|||
170583698|NCT02589665|616478579|FG004|Induction Extension Period|Reason Not Collected|0|||
170583699|NCT02589665|616478580|FG005|Induction Extension Period|Reason Not Collected|0|||
170583700|NCT02589665|616478581|FG006|Induction Extension Period|Reason Not Collected|0|||
170583701|NCT02589665|616478582|FG007|Induction Extension Period|Reason Not Collected|0|||
170583702|NCT02589665|616478583|FG008|Induction Extension Period|Reason Not Collected|1|||
170583703|NCT02589665|616478584|FG009|Induction Extension Period|Reason Not Collected|0|||
170583704|NCT02589665|616478575|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583705|NCT02589665|616478576|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583706|NCT02589665|616478577|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583707|NCT02589665|616478578|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583708|NCT02589665|616478579|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583709|NCT02589665|616478580|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583710|NCT02589665|616478581|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583711|NCT02589665|616478582|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583712|NCT02589665|616478583|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
170583713|NCT02589665|616478584|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
170583714|NCT02589665|616478575|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
170583715|NCT02589665|616478576|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
170583716|NCT02589665|616478577|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
170583717|NCT02589665|616478578|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
170583718|NCT02589665|616478579|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
170583719|NCT02589665|616478580|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
170583720|NCT02589665|616478581|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
170583721|NCT02589665|616478582|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
170583722|NCT02589665|616478583|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
170583723|NCT02589665|616478584|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
170583724|NCT02589665|616478575|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
170583725|NCT02589665|616478576|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
170583726|NCT02589665|616478577|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
170583727|NCT02589665|616478578|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
170583728|NCT02589665|616478579|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
170583729|NCT02589665|616478580|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
170583730|NCT02589665|616478581|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
170583731|NCT02589665|616478582|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
170583732|NCT02589665|616478583|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
170583733|NCT02589665|616478584|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
170583734|NCT02589665|616478575|FG000|Maintenance Extension Period|Adverse Event|0|||
170583735|NCT02589665|616478576|FG001|Maintenance Extension Period|Adverse Event|0|||
170583736|NCT02589665|616478577|FG002|Maintenance Extension Period|Adverse Event|0|||
170583737|NCT02589665|616478578|FG003|Maintenance Extension Period|Adverse Event|0|||
170583738|NCT02589665|616478579|FG004|Maintenance Extension Period|Adverse Event|0|||
170583739|NCT02589665|616478580|FG005|Maintenance Extension Period|Adverse Event|0|||
170583740|NCT02589665|616478581|FG006|Maintenance Extension Period|Adverse Event|0|||
170583741|NCT02589665|616478582|FG007|Maintenance Extension Period|Adverse Event|0|||
170583742|NCT02589665|616478583|FG008|Maintenance Extension Period|Adverse Event|0|||
170583743|NCT02589665|616478584|FG009|Maintenance Extension Period|Adverse Event|2|||
170583744|NCT02589665|616478575|FG000|Maintenance Extension Period|Non-responder|0|||
170583745|NCT02589665|616478576|FG001|Maintenance Extension Period|Non-responder|0|||
170583746|NCT02589665|616478577|FG002|Maintenance Extension Period|Non-responder|0|||
170583747|NCT02589665|616478578|FG003|Maintenance Extension Period|Non-responder|0|||
170583748|NCT02589665|616478579|FG004|Maintenance Extension Period|Non-responder|0|||
170809638|NCT01185340|617313773|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
170809639|NCT01185340|617313774|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
170809640|NCT01185340|617313775|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
170583749|NCT02589665|616478580|FG005|Maintenance Extension Period|Non-responder|0|||
170583750|NCT02589665|616478581|FG006|Maintenance Extension Period|Non-responder|0|||
170583751|NCT02589665|616478582|FG007|Maintenance Extension Period|Non-responder|0|||
170583752|NCT02589665|616478583|FG008|Maintenance Extension Period|Non-responder|0|||
170583753|NCT02589665|616478584|FG009|Maintenance Extension Period|Non-responder|1|||
170583754|NCT00978380|616478587|FG000|Overall Study|Protocol Violation|2|||
170583755|NCT00978380|616478587|FG000|Overall Study|Withdrawal criteria|9|||
170583756|NCT00978380|616478587|FG000|Overall Study|Unclassified|8|||
170583757|NCT00176488|616478588|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
170583758|NCT00327015|616478589|FG000|Overall Study|Lack of Efficacy|18|||
170583759|NCT00327015|616478590|FG001|Overall Study|Lack of Efficacy|18|||
170583760|NCT00327015|616478591|FG002|Overall Study|Lack of Efficacy|35|||
170583761|NCT00327015|616478592|FG003|Overall Study|Lack of Efficacy|29|||
170583762|NCT00327015|616478589|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
170583763|NCT00327015|616478590|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
170583764|NCT00327015|616478591|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
170583765|NCT00327015|616478592|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
170583766|NCT00327015|616478589|FG000|Overall Study|Lost to Follow-up|22|||
170583767|NCT00327015|616478590|FG001|Overall Study|Lost to Follow-up|23|||
170583768|NCT00327015|616478591|FG002|Overall Study|Lost to Follow-up|29|||
170583769|NCT00327015|616478592|FG003|Overall Study|Lost to Follow-up|22|||
170583770|NCT00327015|616478589|FG000|Overall Study|Adverse Event|14|||
170583771|NCT00327015|616478590|FG001|Overall Study|Adverse Event|10|||
170583772|NCT00327015|616478591|FG002|Overall Study|Adverse Event|14|||
170583773|NCT00327015|616478592|FG003|Overall Study|Adverse Event|14|||
170583774|NCT00327015|616478589|FG000|Overall Study|Subject no longer meets study criteria|4|||
170583775|NCT00327015|616478590|FG001|Overall Study|Subject no longer meets study criteria|2|||
170583776|NCT00327015|616478591|FG002|Overall Study|Subject no longer meets study criteria|8|||
170583777|NCT00327015|616478592|FG003|Overall Study|Subject no longer meets study criteria|7|||
170583778|NCT00327015|616478589|FG000|Overall Study|Poor/Noncompliance|11|||
170583779|NCT00327015|616478590|FG001|Overall Study|Poor/Noncompliance|8|||
170583780|NCT00327015|616478591|FG002|Overall Study|Poor/Noncompliance|4|||
170583781|NCT00327015|616478592|FG003|Overall Study|Poor/Noncompliance|5|||
170583782|NCT00327015|616478589|FG000|Overall Study|Physician Decision|0|||
170583783|NCT00327015|616478590|FG001|Overall Study|Physician Decision|1|||
170583784|NCT00327015|616478591|FG002|Overall Study|Physician Decision|3|||
170583785|NCT00327015|616478592|FG003|Overall Study|Physician Decision|2|||
170583786|NCT00327015|616478589|FG000|Overall Study|Death|1|||
170583787|NCT00327015|616478590|FG001|Overall Study|Death|2|||
170583788|NCT00327015|616478591|FG002|Overall Study|Death|2|||
170583789|NCT00327015|616478592|FG003|Overall Study|Death|3|||
170583790|NCT00327015|616478589|FG000|Overall Study|Pregnancy|0|||
170583791|NCT00327015|616478590|FG001|Overall Study|Pregnancy|2|||
170583792|NCT00327015|616478591|FG002|Overall Study|Pregnancy|1|||
170583793|NCT00327015|616478592|FG003|Overall Study|Pregnancy|1|||
170583794|NCT00327015|616478589|FG000|Overall Study|Administrative Reason by Sponsor|1|||
170583795|NCT00327015|616478590|FG001|Overall Study|Administrative Reason by Sponsor|2|||
170583796|NCT00327015|616478591|FG002|Overall Study|Administrative Reason by Sponsor|2|||
170583797|NCT00327015|616478592|FG003|Overall Study|Administrative Reason by Sponsor|1|||
170583798|NCT02923830|616478596|FG000|Overall Study|Physician Decision|13|||
170583799|NCT02923830|616478597|FG001|Overall Study|Physician Decision|15|||
170583800|NCT00837265|616478598|FG000|Pilot Phase|Withdrawal by Subject|0|||
170583801|NCT00837265|616478599|FG001|Pilot Phase|Withdrawal by Subject|2|||
170583802|NCT00837265|616478600|FG002|Pilot Phase|Withdrawal by Subject|3|||
170583803|NCT00837265|616478601|FG003|Pilot Phase|Withdrawal by Subject|2|||
170583804|NCT00837265|616478602|FG004|Pilot Phase|Withdrawal by Subject|0|||
170583805|NCT00837265|616478603|FG005|Pilot Phase|Withdrawal by Subject|0|||
170583806|NCT00837265|616478604|FG006|Pilot Phase|Withdrawal by Subject|0|||
170583807|NCT00837265|616478598|FG000|Pilot Phase|Decision of the investigator|2|||
170583808|NCT00837265|616478599|FG001|Pilot Phase|Decision of the investigator|1|||
170583809|NCT00837265|616478600|FG002|Pilot Phase|Decision of the investigator|0|||
170583810|NCT00837265|616478601|FG003|Pilot Phase|Decision of the investigator|0|||
170583811|NCT00837265|616478602|FG004|Pilot Phase|Decision of the investigator|0|||
170583812|NCT00837265|616478603|FG005|Pilot Phase|Decision of the investigator|0|||
170583813|NCT00837265|616478604|FG006|Pilot Phase|Decision of the investigator|0|||
170583814|NCT00837265|616478598|FG000|Pilot Phase|Adverse Event|1|||
170583815|NCT00837265|616478599|FG001|Pilot Phase|Adverse Event|0|||
170583816|NCT00837265|616478600|FG002|Pilot Phase|Adverse Event|0|||
170583817|NCT00837265|616478601|FG003|Pilot Phase|Adverse Event|0|||
170583818|NCT00837265|616478602|FG004|Pilot Phase|Adverse Event|0|||
170583819|NCT00837265|616478603|FG005|Pilot Phase|Adverse Event|0|||
170583820|NCT00837265|616478604|FG006|Pilot Phase|Adverse Event|0|||
170583821|NCT00837265|616478598|FG000|Pilot Phase|Disease progression|0|||
170583822|NCT00837265|616478599|FG001|Pilot Phase|Disease progression|0|||
170583823|NCT00837265|616478600|FG002|Pilot Phase|Disease progression|0|||
170583824|NCT00837265|616478601|FG003|Pilot Phase|Disease progression|1|||
170583825|NCT00837265|616478602|FG004|Pilot Phase|Disease progression|0|||
170583826|NCT00837265|616478603|FG005|Pilot Phase|Disease progression|0|||
170583827|NCT00837265|616478604|FG006|Pilot Phase|Disease progression|0|||
170583828|NCT00837265|616478598|FG000|Pilot Phase|Participant left the city|0|||
170583829|NCT00837265|616478599|FG001|Pilot Phase|Participant left the city|0|||
170583830|NCT00837265|616478600|FG002|Pilot Phase|Participant left the city|0|||
170583831|NCT00837265|616478601|FG003|Pilot Phase|Participant left the city|1|||
170583832|NCT00837265|616478602|FG004|Pilot Phase|Participant left the city|0|||
170583833|NCT00837265|616478603|FG005|Pilot Phase|Participant left the city|0|||
170583834|NCT00837265|616478604|FG006|Pilot Phase|Participant left the city|0|||
170583835|NCT00837265|616478598|FG000|Main Phase|Withdrawal by Subject|0|||
170583836|NCT00837265|616478599|FG001|Main Phase|Withdrawal by Subject|0|||
170583837|NCT00837265|616478600|FG002|Main Phase|Withdrawal by Subject|0|||
170583838|NCT00837265|616478601|FG003|Main Phase|Withdrawal by Subject|0|||
170583839|NCT00837265|616478602|FG004|Main Phase|Withdrawal by Subject|4|||
170583840|NCT00837265|616478603|FG005|Main Phase|Withdrawal by Subject|2|||
170583841|NCT00837265|616478604|FG006|Main Phase|Withdrawal by Subject|1|||
170583842|NCT00837265|616478598|FG000|Main Phase|Decision of the investigator|0|||
170583843|NCT00837265|616478599|FG001|Main Phase|Decision of the investigator|0|||
170583844|NCT00837265|616478600|FG002|Main Phase|Decision of the investigator|0|||
170583845|NCT00837265|616478601|FG003|Main Phase|Decision of the investigator|0|||
170583846|NCT00837265|616478602|FG004|Main Phase|Decision of the investigator|0|||
170583847|NCT00837265|616478603|FG005|Main Phase|Decision of the investigator|2|||
170583848|NCT00837265|616478604|FG006|Main Phase|Decision of the investigator|1|||
170583849|NCT00837265|616478598|FG000|Main Phase|Adverse Event|0|||
170583850|NCT00837265|616478599|FG001|Main Phase|Adverse Event|0|||
170583851|NCT00837265|616478600|FG002|Main Phase|Adverse Event|0|||
170583852|NCT00837265|616478601|FG003|Main Phase|Adverse Event|0|||
170583853|NCT00837265|616478602|FG004|Main Phase|Adverse Event|0|||
170583854|NCT00837265|616478603|FG005|Main Phase|Adverse Event|1|||
170583855|NCT00837265|616478604|FG006|Main Phase|Adverse Event|0|||
170583856|NCT00837265|616478598|FG000|Main Phase|Death|0|||
170583857|NCT00837265|616478599|FG001|Main Phase|Death|0|||
170583858|NCT00837265|616478600|FG002|Main Phase|Death|0|||
170583859|NCT00837265|616478601|FG003|Main Phase|Death|0|||
170583860|NCT00837265|616478602|FG004|Main Phase|Death|2|||
170583861|NCT00837265|616478603|FG005|Main Phase|Death|0|||
170583862|NCT00837265|616478604|FG006|Main Phase|Death|1|||
170583863|NCT00837265|616478598|FG000|Main Phase|Lost to Follow-up|0|||
170583864|NCT00837265|616478599|FG001|Main Phase|Lost to Follow-up|0|||
170583865|NCT00837265|616478600|FG002|Main Phase|Lost to Follow-up|0|||
170583866|NCT00837265|616478601|FG003|Main Phase|Lost to Follow-up|0|||
170583867|NCT00837265|616478602|FG004|Main Phase|Lost to Follow-up|1|||
170583868|NCT00837265|616478603|FG005|Main Phase|Lost to Follow-up|0|||
170583869|NCT00837265|616478604|FG006|Main Phase|Lost to Follow-up|0|||
170583870|NCT00837265|616478598|FG000|Main Phase|Principal investigator resignation|0|||
170583871|NCT00837265|616478599|FG001|Main Phase|Principal investigator resignation|0|||
170583872|NCT00837265|616478600|FG002|Main Phase|Principal investigator resignation|0|||
170583873|NCT00837265|616478601|FG003|Main Phase|Principal investigator resignation|0|||
170583874|NCT00837265|616478602|FG004|Main Phase|Principal investigator resignation|2|||
170583875|NCT00837265|616478603|FG005|Main Phase|Principal investigator resignation|0|||
170583876|NCT00837265|616478604|FG006|Main Phase|Principal investigator resignation|0|||
170583877|NCT00837265|616478598|FG000|Main Phase|Participant's personal reason|0|||
170583878|NCT00837265|616478599|FG001|Main Phase|Participant's personal reason|0|||
170583879|NCT00837265|616478600|FG002|Main Phase|Participant's personal reason|0|||
170583880|NCT00837265|616478601|FG003|Main Phase|Participant's personal reason|0|||
170583881|NCT00837265|616478602|FG004|Main Phase|Participant's personal reason|1|||
170583882|NCT00837265|616478603|FG005|Main Phase|Participant's personal reason|0|||
170583883|NCT00837265|616478604|FG006|Main Phase|Participant's personal reason|0|||
170583884|NCT00733291|616478605|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
170583885|NCT00733291|616478606|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
170583886|NCT00733291|616478607|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
170583887|NCT00733291|616478608|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
170583888|NCT01751906|616478615|FG000|Overall Study|Lost to Follow-up|151|||
170583889|NCT01751906|616478616|FG001|Overall Study|Lost to Follow-up|68|||
170583890|NCT01751906|616478615|FG000|Overall Study|Withdrawal by Subject|22|||
170583891|NCT01751906|616478616|FG001|Overall Study|Withdrawal by Subject|18|||
170583892|NCT01751906|616478615|FG000|Overall Study|Physician Decision|5|||
170583893|NCT01751906|616478616|FG001|Overall Study|Physician Decision|2|||
170649942|NCT02095132|616732757|FG007|Overall Study|Physician Decision|0|||
170583894|NCT01751906|616478615|FG000|Overall Study|Death|84|||
170583895|NCT01751906|616478616|FG001|Overall Study|Death|43|||
170583896|NCT01751906|616478615|FG000|Overall Study|Denied on premises for follow-up by law|1|||
170583897|NCT01751906|616478616|FG001|Overall Study|Denied on premises for follow-up by law|0|||
170583898|NCT01110330|616478621|FG000|Overall Study|Adverse Event|0|||
170583899|NCT01110330|616478622|FG001|Overall Study|Adverse Event|4|||
170583900|NCT01110330|616478623|FG002|Overall Study|Adverse Event|3|||
170583901|NCT01110330|616478621|FG000|Overall Study|Lack of Efficacy|3|||
170583902|NCT01110330|616478622|FG001|Overall Study|Lack of Efficacy|1|||
170583903|NCT01110330|616478623|FG002|Overall Study|Lack of Efficacy|1|||
170583904|NCT01110330|616478621|FG000|Overall Study|Lost to Follow-up|9|||
170583905|NCT01110330|616478622|FG001|Overall Study|Lost to Follow-up|10|||
170583906|NCT01110330|616478623|FG002|Overall Study|Lost to Follow-up|15|||
170583907|NCT01110330|616478621|FG000|Overall Study|Physician Decision|0|||
170583908|NCT01110330|616478622|FG001|Overall Study|Physician Decision|1|||
170583909|NCT01110330|616478623|FG002|Overall Study|Physician Decision|0|||
170583910|NCT01110330|616478621|FG000|Overall Study|Protocol Violation|2|||
170583911|NCT01110330|616478622|FG001|Overall Study|Protocol Violation|0|||
170583912|NCT01110330|616478623|FG002|Overall Study|Protocol Violation|4|||
170583913|NCT01110330|616478621|FG000|Overall Study|Withdrawal by Subject|0|||
170583914|NCT01110330|616478622|FG001|Overall Study|Withdrawal by Subject|6|||
170583915|NCT01110330|616478623|FG002|Overall Study|Withdrawal by Subject|2|||
170583916|NCT01110330|616478621|FG000|Overall Study|Other|1|||
170583917|NCT01110330|616478622|FG001|Overall Study|Other|1|||
170583918|NCT01110330|616478623|FG002|Overall Study|Other|1|||
170583919|NCT00510718|616478632|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
170583920|NCT00510718|616478633|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
170583921|NCT00510718|616478632|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
170583922|NCT00510718|616478633|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
170583923|NCT00510718|616478632|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
170583924|NCT00510718|616478633|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
170583925|NCT00510718|616478632|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
170583926|NCT00510718|616478633|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
170583927|NCT00510718|616478632|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
170583928|NCT00510718|616478633|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
170583929|NCT00510718|616478632|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
170583930|NCT00510718|616478633|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
170583931|NCT02759107|616478634|FG000|Overall Study|Adverse Event|0|||
170583932|NCT02759107|616478635|FG001|Overall Study|Adverse Event|0|||
170583933|NCT02759107|616478636|FG002|Overall Study|Adverse Event|0|||
170583934|NCT02759107|616478637|FG003|Overall Study|Adverse Event|0|||
170583935|NCT02759107|616478638|FG004|Overall Study|Adverse Event|0|||
170583936|NCT02759107|616478639|FG005|Overall Study|Adverse Event|0|||
170583937|NCT02759107|616478640|FG006|Overall Study|Adverse Event|0|||
170583938|NCT02759107|616478641|FG007|Overall Study|Adverse Event|0|||
170583939|NCT02759107|616478642|FG008|Overall Study|Adverse Event|0|||
170583940|NCT02759107|616478643|FG009|Overall Study|Adverse Event|0|||
170583941|NCT02759107|616478644|FG010|Overall Study|Adverse Event|0|||
170583942|NCT02759107|616478645|FG011|Overall Study|Adverse Event|0|||
170583943|NCT02759107|616478646|FG012|Overall Study|Adverse Event|2|||
170583944|NCT02759107|616478647|FG013|Overall Study|Adverse Event|0|||
170583945|NCT02759107|616478648|FG014|Overall Study|Adverse Event|0|||
170583946|NCT02759107|616478649|FG015|Overall Study|Adverse Event|1|||
170583947|NCT02759107|616478650|FG016|Overall Study|Adverse Event|0|||
170583948|NCT02759107|616478651|FG017|Overall Study|Adverse Event|2|||
170583949|NCT02759107|616478634|FG000|Overall Study|Scheduling Conflict|0|||
170583950|NCT02759107|616478635|FG001|Overall Study|Scheduling Conflict|0|||
170583951|NCT02759107|616478636|FG002|Overall Study|Scheduling Conflict|0|||
170583952|NCT02759107|616478637|FG003|Overall Study|Scheduling Conflict|0|||
170583953|NCT02759107|616478638|FG004|Overall Study|Scheduling Conflict|0|||
170583954|NCT02759107|616478639|FG005|Overall Study|Scheduling Conflict|0|||
170583955|NCT02759107|616478640|FG006|Overall Study|Scheduling Conflict|0|||
170583956|NCT02759107|616478641|FG007|Overall Study|Scheduling Conflict|0|||
170583957|NCT02759107|616478642|FG008|Overall Study|Scheduling Conflict|0|||
170583958|NCT02759107|616478643|FG009|Overall Study|Scheduling Conflict|1|||
170583959|NCT02759107|616478644|FG010|Overall Study|Scheduling Conflict|0|||
170583960|NCT02759107|616478645|FG011|Overall Study|Scheduling Conflict|0|||
170583961|NCT02759107|616478646|FG012|Overall Study|Scheduling Conflict|0|||
170583962|NCT02759107|616478647|FG013|Overall Study|Scheduling Conflict|0|||
170809641|NCT01185340|617313772|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
170809642|NCT01185340|617313773|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
170809643|NCT01185340|617313774|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
170809644|NCT01185340|617313775|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
170809645|NCT00087516|617313776|FG000|Overall Study|Adverse Event|10|||
170583963|NCT02759107|616478648|FG014|Overall Study|Scheduling Conflict|0|||
170583964|NCT02759107|616478649|FG015|Overall Study|Scheduling Conflict|0|||
170583965|NCT02759107|616478650|FG016|Overall Study|Scheduling Conflict|0|||
170583966|NCT02759107|616478651|FG017|Overall Study|Scheduling Conflict|0|||
170583967|NCT01089413|616478656|FG000|Overall Study|Lost to Follow-up|1|||
170809646|NCT00087516|617313777|FG001|Overall Study|Adverse Event|10|||
170809647|NCT00087516|617313778|FG002|Overall Study|Adverse Event|3|||
170809648|NCT00087516|617313779|FG003|Overall Study|Adverse Event|6|||
170910718|NCT00401973|617677250|FG002|Overall Study|Lack of Efficacy|3|||
170583968|NCT01089413|616478656|FG000|Overall Study|Progressive Disease|93|||
170583969|NCT01089413|616478656|FG000|Overall Study|Participant Withdrew Consent|1|||
170583970|NCT01089413|616478656|FG000|Overall Study|Unacceptable Toxicity|12|||
170583971|NCT01089413|616478656|FG000|Overall Study|Death|10|||
170583972|NCT01089413|616478656|FG000|Overall Study|Metastasectomy|13|||
170583973|NCT01089413|616478656|FG000|Overall Study|Other|71|||
170583974|NCT00591149|616478661|FG000|Overall Study|Adverse Event|4|||
170583975|NCT00591149|616478661|FG000|Overall Study|Withdrawal by Subject|1|||
170583976|NCT01549886|616478662|FG000|Overall Study|Sponsor's decision|2|||
170583977|NCT01549886|616478663|FG001|Overall Study|Sponsor's decision|3|||
170583978|NCT00473668|616478664|FG000|Overall Study|Withdrawal by Subject|0|||
170583979|NCT00473668|616478665|FG001|Overall Study|Withdrawal by Subject|2|||
170583980|NCT00473668|616478666|FG002|Overall Study|Withdrawal by Subject|0|||
170583981|NCT00473668|616478664|FG000|Overall Study|Migrated/moved from study area|3|||
170583982|NCT00473668|616478665|FG001|Overall Study|Migrated/moved from study area|2|||
170583983|NCT00473668|616478666|FG002|Overall Study|Migrated/moved from study area|0|||
170583984|NCT00473668|616478664|FG000|Overall Study|Lost to Follow-up|0|||
170583985|NCT00473668|616478665|FG001|Overall Study|Lost to Follow-up|4|||
170583986|NCT00473668|616478666|FG002|Overall Study|Lost to Follow-up|6|||
170583987|NCT00473668|616478664|FG000|Overall Study|Other|2|||
170583988|NCT00473668|616478665|FG001|Overall Study|Other|3|||
170583989|NCT00473668|616478666|FG002|Overall Study|Other|4|||
170583990|NCT02039219|616478667|FG000|Treatment|Withdrawal by Subject|1|||
170583991|NCT02039219|616478668|FG001|Treatment|Withdrawal by Subject|0|||
170583992|NCT02039219|616478667|FG000|Treatment|Adverse Event|0|||
170583993|NCT02039219|616478668|FG001|Treatment|Adverse Event|1|||
170583994|NCT02039219|616478667|FG000|Treatment|Physician Decision|1|||
170583995|NCT02039219|616478668|FG001|Treatment|Physician Decision|0|||
170583996|NCT02039219|616478667|FG000|Treatment|Lost to Follow-up|0|||
170583997|NCT02039219|616478668|FG001|Treatment|Lost to Follow-up|1|||
170583998|NCT02039219|616478667|FG000|Treatment|Protocol Violation|1|||
170583999|NCT02039219|616478668|FG001|Treatment|Protocol Violation|0|||
170584000|NCT02039219|616478667|FG000|Treatment|Death|1|||
170584001|NCT02039219|616478668|FG001|Treatment|Death|0|||
170584002|NCT02039219|616478667|FG000|Follow up|Adverse Event|0|||
170584003|NCT02039219|616478668|FG001|Follow up|Adverse Event|1|||
170584004|NCT02226562|616478669|FG000|Overall Study|Lost to Follow-up|0|||
170584005|NCT02226562|616478670|FG001|Overall Study|Lost to Follow-up|1|||
170584006|NCT02750345|616478671|FG000|Intervention 1|Adverse Event|0|||
170584007|NCT02750345|616478672|FG001|Intervention 1|Adverse Event|0|||
170584008|NCT02750345|616478673|FG002|Intervention 1|Adverse Event|0|||
170584009|NCT02750345|616478674|FG003|Intervention 1|Adverse Event|0|||
170584010|NCT02750345|616478675|FG004|Intervention 1|Adverse Event|1|||
170584011|NCT02750345|616478676|FG005|Intervention 1|Adverse Event|0|||
170584012|NCT00191724|616478677|FG000|Overall Study|Adverse Event|0|||
170584013|NCT00191724|616478678|FG001|Overall Study|Adverse Event|0|||
170584014|NCT00191724|616478679|FG002|Overall Study|Adverse Event|1|||
170584015|NCT00191724|616478680|FG003|Overall Study|Adverse Event|0|||
170584016|NCT00191724|616478681|FG004|Overall Study|Adverse Event|0|||
170584017|NCT00191724|616478677|FG000|Overall Study|Lost to Follow-up|1|||
170584018|NCT00191724|616478678|FG001|Overall Study|Lost to Follow-up|1|||
170584019|NCT00191724|616478679|FG002|Overall Study|Lost to Follow-up|0|||
170584020|NCT00191724|616478680|FG003|Overall Study|Lost to Follow-up|2|||
170584021|NCT00191724|616478681|FG004|Overall Study|Lost to Follow-up|3|||
170584022|NCT00191724|616478677|FG000|Overall Study|Withdrawal by Subject|0|||
170584023|NCT00191724|616478678|FG001|Overall Study|Withdrawal by Subject|0|||
170584024|NCT00191724|616478679|FG002|Overall Study|Withdrawal by Subject|0|||
170584025|NCT00191724|616478680|FG003|Overall Study|Withdrawal by Subject|1|||
170584026|NCT00191724|616478681|FG004|Overall Study|Withdrawal by Subject|0|||
170584027|NCT01296711|616478682|FG000|Overall Study|Adverse Event|3|||
170584028|NCT01296711|616478683|FG001|Overall Study|Adverse Event|1|||
170584029|NCT01296711|616478684|FG002|Overall Study|Adverse Event|4|||
170584030|NCT01296711|616478685|FG003|Overall Study|Adverse Event|3|||
170584031|NCT01296711|616478686|FG004|Overall Study|Adverse Event|1|||
170584032|NCT01296711|616478687|FG005|Overall Study|Adverse Event|6|||
170584033|NCT01296711|616478688|FG006|Overall Study|Adverse Event|11|||
170584034|NCT01296711|616478689|FG007|Overall Study|Adverse Event|3|||
170584035|NCT01296711|616478682|FG000|Overall Study|Lack of Efficacy|1|||
170584036|NCT01296711|616478683|FG001|Overall Study|Lack of Efficacy|4|||
170584037|NCT01296711|616478684|FG002|Overall Study|Lack of Efficacy|1|||
170584038|NCT01296711|616478685|FG003|Overall Study|Lack of Efficacy|1|||
170584039|NCT01296711|616478686|FG004|Overall Study|Lack of Efficacy|1|||
170584040|NCT01296711|616478687|FG005|Overall Study|Lack of Efficacy|0|||
170584041|NCT01296711|616478688|FG006|Overall Study|Lack of Efficacy|2|||
170584042|NCT01296711|616478689|FG007|Overall Study|Lack of Efficacy|3|||
170584043|NCT01296711|616478682|FG000|Overall Study|Lost to Follow-up|0|||
170584044|NCT01296711|616478683|FG001|Overall Study|Lost to Follow-up|0|||
170584045|NCT01296711|616478684|FG002|Overall Study|Lost to Follow-up|1|||
170584046|NCT01296711|616478685|FG003|Overall Study|Lost to Follow-up|1|||
170584047|NCT01296711|616478686|FG004|Overall Study|Lost to Follow-up|2|||
170584048|NCT01296711|616478687|FG005|Overall Study|Lost to Follow-up|0|||
170584049|NCT01296711|616478688|FG006|Overall Study|Lost to Follow-up|4|||
170584050|NCT01296711|616478689|FG007|Overall Study|Lost to Follow-up|2|||
170584051|NCT01296711|616478682|FG000|Overall Study|Protocol Violation|0|||
170584052|NCT01296711|616478683|FG001|Overall Study|Protocol Violation|0|||
170584053|NCT01296711|616478684|FG002|Overall Study|Protocol Violation|0|||
170584054|NCT01296711|616478685|FG003|Overall Study|Protocol Violation|1|||
170584055|NCT01296711|616478686|FG004|Overall Study|Protocol Violation|1|||
170584056|NCT01296711|616478687|FG005|Overall Study|Protocol Violation|0|||
170584057|NCT01296711|616478688|FG006|Overall Study|Protocol Violation|0|||
170584058|NCT01296711|616478689|FG007|Overall Study|Protocol Violation|0|||
170584059|NCT01296711|616478682|FG000|Overall Study|Withdrawal by Subject|4|||
170584060|NCT01296711|616478683|FG001|Overall Study|Withdrawal by Subject|2|||
170584061|NCT01296711|616478684|FG002|Overall Study|Withdrawal by Subject|2|||
170584062|NCT01296711|616478685|FG003|Overall Study|Withdrawal by Subject|1|||
170584063|NCT01296711|616478686|FG004|Overall Study|Withdrawal by Subject|1|||
170584064|NCT01296711|616478687|FG005|Overall Study|Withdrawal by Subject|1|||
170584065|NCT01296711|616478688|FG006|Overall Study|Withdrawal by Subject|2|||
170584066|NCT01296711|616478689|FG007|Overall Study|Withdrawal by Subject|1|||
170584067|NCT01296711|616478682|FG000|Overall Study|Study termination|8|||
170584068|NCT01296711|616478683|FG001|Overall Study|Study termination|1|||
170584069|NCT01296711|616478684|FG002|Overall Study|Study termination|5|||
170584070|NCT01296711|616478685|FG003|Overall Study|Study termination|4|||
170584071|NCT01296711|616478686|FG004|Overall Study|Study termination|4|||
170584072|NCT01296711|616478687|FG005|Overall Study|Study termination|4|||
170584073|NCT01296711|616478688|FG006|Overall Study|Study termination|8|||
170584074|NCT01296711|616478689|FG007|Overall Study|Study termination|10|||
170584075|NCT01296711|616478682|FG000|Overall Study|Continued elevated liver enzymes|0|||
170584076|NCT01296711|616478683|FG001|Overall Study|Continued elevated liver enzymes|0|||
170584077|NCT01296711|616478684|FG002|Overall Study|Continued elevated liver enzymes|0|||
170584078|NCT01296711|616478685|FG003|Overall Study|Continued elevated liver enzymes|1|||
170584079|NCT01296711|616478686|FG004|Overall Study|Continued elevated liver enzymes|0|||
170584080|NCT01296711|616478687|FG005|Overall Study|Continued elevated liver enzymes|0|||
170584081|NCT01296711|616478688|FG006|Overall Study|Continued elevated liver enzymes|0|||
170584082|NCT01296711|616478689|FG007|Overall Study|Continued elevated liver enzymes|0|||
170584083|NCT01296711|616478682|FG000|Overall Study|Methotrexate discontinued|0|||
170584084|NCT01296711|616478683|FG001|Overall Study|Methotrexate discontinued|0|||
170584085|NCT01296711|616478684|FG002|Overall Study|Methotrexate discontinued|0|||
170584086|NCT01296711|616478685|FG003|Overall Study|Methotrexate discontinued|1|||
170584087|NCT01296711|616478686|FG004|Overall Study|Methotrexate discontinued|0|||
170584088|NCT01296711|616478687|FG005|Overall Study|Methotrexate discontinued|0|||
170584089|NCT01296711|616478688|FG006|Overall Study|Methotrexate discontinued|0|||
170584090|NCT01296711|616478689|FG007|Overall Study|Methotrexate discontinued|0|||
170584091|NCT01296711|616478682|FG000|Overall Study|Investigator discretion|0|||
170584092|NCT01296711|616478683|FG001|Overall Study|Investigator discretion|0|||
170584093|NCT01296711|616478684|FG002|Overall Study|Investigator discretion|0|||
170584094|NCT01296711|616478685|FG003|Overall Study|Investigator discretion|0|||
170584095|NCT01296711|616478686|FG004|Overall Study|Investigator discretion|0|||
170584096|NCT01296711|616478687|FG005|Overall Study|Investigator discretion|0|||
170584097|NCT01296711|616478688|FG006|Overall Study|Investigator discretion|1|||
170584098|NCT01296711|616478689|FG007|Overall Study|Investigator discretion|0|||
170584099|NCT01296711|616478682|FG000|Overall Study|Other|0|||
170584100|NCT01296711|616478683|FG001|Overall Study|Other|0|||
170584101|NCT01296711|616478684|FG002|Overall Study|Other|0|||
170584102|NCT01296711|616478685|FG003|Overall Study|Other|0|||
170584103|NCT01296711|616478686|FG004|Overall Study|Other|0|||
170584104|NCT01296711|616478687|FG005|Overall Study|Other|0|||
170584105|NCT01296711|616478688|FG006|Overall Study|Other|1|||
170584106|NCT01296711|616478689|FG007|Overall Study|Other|0|||
170584107|NCT01296711|616478682|FG000|Overall Study|Required restricted steroid injections|0|||
170584108|NCT01296711|616478683|FG001|Overall Study|Required restricted steroid injections|0|||
170584109|NCT01296711|616478684|FG002|Overall Study|Required restricted steroid injections|0|||
170584110|NCT01296711|616478685|FG003|Overall Study|Required restricted steroid injections|0|||
170584111|NCT01296711|616478686|FG004|Overall Study|Required restricted steroid injections|0|||
170584112|NCT01296711|616478687|FG005|Overall Study|Required restricted steroid injections|0|||
170649943|NCT02095132|616732758|FG008|Overall Study|Physician Decision|2|||
170649944|NCT02095132|616732750|FG000|Overall Study|Withdrawal by Subject|0|||
170649945|NCT02095132|616732751|FG001|Overall Study|Withdrawal by Subject|0|||
170809649|NCT00087516|617313776|FG000|Overall Study|Lack of Efficacy|82|||
170584113|NCT01296711|616478688|FG006|Overall Study|Required restricted steroid injections|1|||
170584114|NCT01296711|616478689|FG007|Overall Study|Required restricted steroid injections|0|||
170584115|NCT01296711|616478682|FG000|Overall Study|Ongoing missed appointments|0|||
170584116|NCT01296711|616478683|FG001|Overall Study|Ongoing missed appointments|0|||
170584117|NCT01296711|616478684|FG002|Overall Study|Ongoing missed appointments|0|||
170584118|NCT01296711|616478685|FG003|Overall Study|Ongoing missed appointments|0|||
170584119|NCT01296711|616478686|FG004|Overall Study|Ongoing missed appointments|0|||
170584120|NCT01296711|616478687|FG005|Overall Study|Ongoing missed appointments|0|||
170584121|NCT01296711|616478688|FG006|Overall Study|Ongoing missed appointments|1|||
170584122|NCT01296711|616478689|FG007|Overall Study|Ongoing missed appointments|0|||
170584123|NCT01296711|616478682|FG000|Overall Study|Failure to comply with visits|0|||
170584124|NCT01296711|616478683|FG001|Overall Study|Failure to comply with visits|0|||
170584125|NCT01296711|616478684|FG002|Overall Study|Failure to comply with visits|0|||
170584126|NCT01296711|616478685|FG003|Overall Study|Failure to comply with visits|0|||
170584127|NCT01296711|616478686|FG004|Overall Study|Failure to comply with visits|0|||
170584128|NCT01296711|616478687|FG005|Overall Study|Failure to comply with visits|0|||
170584129|NCT01296711|616478688|FG006|Overall Study|Failure to comply with visits|0|||
170584130|NCT01296711|616478689|FG007|Overall Study|Failure to comply with visits|1|||
170584131|NCT01296711|616478682|FG000|Overall Study|Patient decision due to transport|0|||
170584132|NCT01296711|616478683|FG001|Overall Study|Patient decision due to transport|0|||
170584133|NCT01296711|616478684|FG002|Overall Study|Patient decision due to transport|0|||
170584134|NCT01296711|616478685|FG003|Overall Study|Patient decision due to transport|0|||
170584135|NCT01296711|616478686|FG004|Overall Study|Patient decision due to transport|0|||
170584136|NCT01296711|616478687|FG005|Overall Study|Patient decision due to transport|0|||
170584137|NCT01296711|616478688|FG006|Overall Study|Patient decision due to transport|0|||
170584138|NCT01296711|616478689|FG007|Overall Study|Patient decision due to transport|1|||
170584139|NCT01328535|616478690|FG000|Overall Study|Ineligible|1|||
170584140|NCT01205061|616478691|FG000|Overall Study|Adverse Event|4|||
170584141|NCT01205061|616478691|FG000|Overall Study|Withdrawal by Subject|11|||
170584142|NCT01205061|616478691|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
170584143|NCT01205061|616478691|FG000|Overall Study|Lost to Follow-up|9|||
170584144|NCT01205061|616478691|FG000|Overall Study|Other|1|||
170584145|NCT04026009|616478692|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170584146|NCT04026009|616478693|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170584147|NCT04026009|616478694|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
170584148|NCT04026009|616478695|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
170584149|NCT04026009|616478696|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
170584150|NCT04026009|616478692|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
170584151|NCT04026009|616478693|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
170584152|NCT04026009|616478694|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
170584153|NCT04026009|616478695|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
170584154|NCT04026009|616478696|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
170584155|NCT02957747|616478697|FG000|Overall Study|Withdrawal by Subject|0|||
170584156|NCT02957747|616478698|FG001|Overall Study|Withdrawal by Subject|3|||
170584157|NCT02957747|616478697|FG000|Overall Study|Lost to Follow-up|10|||
170584158|NCT02957747|616478698|FG001|Overall Study|Lost to Follow-up|5|||
170584159|NCT00888329|616478699|FG000|Overall Study|Physician Decision|6|||
170584160|NCT00888329|616478700|FG001|Overall Study|Physician Decision|9|||
170584161|NCT01439971|616478705|FG000|Overall Study|Required number in cohort dosed|0|||
170584162|NCT01439971|616478706|FG001|Overall Study|Required number in cohort dosed|1|||
170584163|NCT01439971|616478707|FG002|Overall Study|Required number in cohort dosed|2|||
170584164|NCT01439971|616478708|FG003|Overall Study|Required number in cohort dosed|0|||
170584165|NCT01439971|616478709|FG004|Overall Study|Required number in cohort dosed|1|||
170584166|NCT02628600|616478710|FG000|Overall Study|Death|2|||
170584167|NCT02628600|616478711|FG001|Overall Study|Death|1|||
170584168|NCT02628600|616478710|FG000|Overall Study|Adverse Event|3|||
170584169|NCT02628600|616478711|FG001|Overall Study|Adverse Event|20|||
170584170|NCT02628600|616478710|FG000|Overall Study|Protocol Violation|0|||
170584171|NCT02628600|616478711|FG001|Overall Study|Protocol Violation|1|||
170584172|NCT02628600|616478710|FG000|Overall Study|Lack of Efficacy|2|||
170584173|NCT02628600|616478711|FG001|Overall Study|Lack of Efficacy|0|||
170584174|NCT02628600|616478710|FG000|Overall Study|Withdrawal by Subject|13|||
170584175|NCT02628600|616478711|FG001|Overall Study|Withdrawal by Subject|8|||
170584176|NCT02628600|616478710|FG000|Overall Study|Lost to Follow-up|1|||
170584177|NCT02628600|616478711|FG001|Overall Study|Lost to Follow-up|0|||
170584178|NCT02628600|616478710|FG000|Overall Study|Physician Decision|2|||
170584179|NCT02628600|616478711|FG001|Overall Study|Physician Decision|2|||
170584180|NCT02628600|616478710|FG000|Overall Study|Other not specified|1|||
170584181|NCT02628600|616478711|FG001|Overall Study|Other not specified|0|||
170584182|NCT01963767|616478713|FG000|Overall Study|Withdrawal by Subject|4|||
170584183|NCT01963767|616478714|FG001|Overall Study|Withdrawal by Subject|2|||
170584184|NCT01963767|616478713|FG000|Overall Study|Adverse Event|2|||
170584185|NCT01963767|616478714|FG001|Overall Study|Adverse Event|0|||
170584186|NCT02709577|616478715|FG000|Overall Study|non-accommodating anatomy|0|||
170584187|NCT02709577|616478716|FG001|Overall Study|non-accommodating anatomy|1|||
170649946|NCT02095132|616732752|FG002|Overall Study|Withdrawal by Subject|2|||
170649947|NCT02095132|616732753|FG003|Overall Study|Withdrawal by Subject|2|||
170649948|NCT02095132|616732754|FG004|Overall Study|Withdrawal by Subject|3|||
170649949|NCT02095132|616732755|FG005|Overall Study|Withdrawal by Subject|0|||
170584188|NCT02709577|616478717|FG002|Overall Study|non-accommodating anatomy|0|||
170584189|NCT02709577|616478718|FG003|Overall Study|non-accommodating anatomy|0|||
170584190|NCT02709577|616478715|FG000|Overall Study|procedural complication|0|||
170584191|NCT02709577|616478716|FG001|Overall Study|procedural complication|1|||
170584192|NCT02709577|616478717|FG002|Overall Study|procedural complication|0|||
170584193|NCT02709577|616478718|FG003|Overall Study|procedural complication|0|||
170584194|NCT02709577|616478715|FG000|Overall Study|Withdrawal by Subject|2|||
170649950|NCT02095132|616732756|FG006|Overall Study|Withdrawal by Subject|5|||
170649951|NCT02095132|616732757|FG007|Overall Study|Withdrawal by Subject|0|||
170649952|NCT02095132|616732758|FG008|Overall Study|Withdrawal by Subject|0|||
170649953|NCT04905498|616732759|FG000|Overall Study|Lost to Follow-up|0|||
170649954|NCT04905498|616732760|FG001|Overall Study|Lost to Follow-up|2|||
170649955|NCT04905498|616732759|FG000|Overall Study|COVID lockdown|1|||
170649956|NCT04905498|616732760|FG001|Overall Study|COVID lockdown|0|||
170649957|NCT02677324|616732761|FG000|Overall Study|Disease Progression|6|||
170649958|NCT02677324|616732761|FG000|Overall Study|Inability to Swallow pills|1|||
170584195|NCT02709577|616478716|FG001|Overall Study|Withdrawal by Subject|3|||
170584196|NCT02709577|616478717|FG002|Overall Study|Withdrawal by Subject|2|||
170584197|NCT02709577|616478718|FG003|Overall Study|Withdrawal by Subject|0|||
170584198|NCT03763656|616478719|FG000|Overall Study|Physician Decision|1|||
170584199|NCT03763656|616478719|FG000|Overall Study|Protocol Violation|1|||
170584200|NCT03763656|616478719|FG000|Overall Study|Withdrawal by Subject|7|||
170584201|NCT03479541|616478722|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
170584202|NCT03479541|616478723|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
170584203|NCT03479541|616478724|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
170584204|NCT03479541|616478725|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
170584205|NCT03479541|616478722|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
170584206|NCT03479541|616478723|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
170584207|NCT03479541|616478724|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
170584208|NCT03479541|616478725|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
170584209|NCT03479541|616478722|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
170584210|NCT03479541|616478723|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
170584211|NCT03479541|616478724|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
170584212|NCT03479541|616478725|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
170584213|NCT03479541|616478722|FG000|Home Monitoring|Lost to Follow-up|0|||
170584214|NCT03479541|616478723|FG001|Home Monitoring|Lost to Follow-up|0|||
170584215|NCT03479541|616478724|FG002|Home Monitoring|Lost to Follow-up|8|||
170584216|NCT03479541|616478725|FG003|Home Monitoring|Lost to Follow-up|12|||
170584217|NCT03479541|616478722|FG000|Home Monitoring|Withdrawal by Subject|0|||
170584218|NCT03479541|616478723|FG001|Home Monitoring|Withdrawal by Subject|0|||
170584219|NCT03479541|616478724|FG002|Home Monitoring|Withdrawal by Subject|17|||
170584220|NCT03479541|616478725|FG003|Home Monitoring|Withdrawal by Subject|30|||
170584221|NCT03479541|616478722|FG000|Home Monitoring|Early Termination - PI Decision|0|||
170584222|NCT03479541|616478723|FG001|Home Monitoring|Early Termination - PI Decision|0|||
170584223|NCT03479541|616478724|FG002|Home Monitoring|Early Termination - PI Decision|4|||
170584224|NCT03479541|616478725|FG003|Home Monitoring|Early Termination - PI Decision|6|||
170584225|NCT03110029|616478726|FG000|Overall Study|Withdrawal by Subject|1|||
170584226|NCT03110029|616478727|FG001|Overall Study|Withdrawal by Subject|1|||
170584227|NCT01740089|616481152|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
170584228|NCT01740089|616481153|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
170584229|NCT01740089|616481154|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
170584230|NCT01740089|616481152|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
170584231|NCT01740089|616481153|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
170584232|NCT01740089|616481154|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
170584233|NCT01740089|616481152|FG000|After 12 Weeks|Lack of Efficacy|3|||
170584234|NCT01740089|616481153|FG001|After 12 Weeks|Lack of Efficacy|1|||
170584235|NCT01740089|616481154|FG002|After 12 Weeks|Lack of Efficacy|4|||
170649959|NCT02677324|616732761|FG000|Overall Study|Non-compliance|1|||
170649960|NCT02677324|616732761|FG000|Overall Study|Lack of Efficacy|1|||
170649961|NCT02677324|616732761|FG000|Overall Study|Medical insurance coverage|1|||
170584236|NCT01740089|616481152|FG000|After 12 Weeks|Adverse Event|2|||
170584237|NCT01740089|616481153|FG001|After 12 Weeks|Adverse Event|0|||
170809650|NCT00087516|617313777|FG001|Overall Study|Lack of Efficacy|80|||
170809651|NCT00087516|617313778|FG002|Overall Study|Lack of Efficacy|39|||
170809652|NCT00087516|617313779|FG003|Overall Study|Lack of Efficacy|29|||
170809653|NCT00087516|617313776|FG000|Overall Study|Lost to Follow-up|8|||
170809654|NCT00087516|617313777|FG001|Overall Study|Lost to Follow-up|6|||
170809655|NCT00087516|617313778|FG002|Overall Study|Lost to Follow-up|5|||
170809656|NCT00087516|617313779|FG003|Overall Study|Lost to Follow-up|5|||
170809657|NCT00087516|617313776|FG000|Overall Study|Protocol Violation|4|||
170809658|NCT00087516|617313777|FG001|Overall Study|Protocol Violation|8|||
170809659|NCT00087516|617313778|FG002|Overall Study|Protocol Violation|3|||
170809660|NCT00087516|617313779|FG003|Overall Study|Protocol Violation|6|||
170809661|NCT00087516|617313776|FG000|Overall Study|Withdrawal by Subject|16|||
170584238|NCT01740089|616481154|FG002|After 12 Weeks|Adverse Event|5|||
170584239|NCT01740089|616481152|FG000|After 12 Weeks|Protocol Violation|1|||
170584240|NCT01740089|616481153|FG001|After 12 Weeks|Protocol Violation|1|||
170649962|NCT02677324|616732761|FG000|Overall Study|Adverse Event|1|||
170649963|NCT02677324|616732761|FG000|Overall Study|IgM Myeloma diagnosis|1|||
170649964|NCT01268579|616732762|FG000|Overall Study|Adverse Event|1|||
170809662|NCT00087516|617313777|FG001|Overall Study|Withdrawal by Subject|27|||
170809663|NCT00087516|617313778|FG002|Overall Study|Withdrawal by Subject|11|||
170584241|NCT01740089|616481154|FG002|After 12 Weeks|Protocol Violation|1|||
170584242|NCT01740089|616481152|FG000|After 12 Weeks|Withdrawal by Subject|1|||
170584243|NCT01740089|616481153|FG001|After 12 Weeks|Withdrawal by Subject|1|||
170584244|NCT01740089|616481154|FG002|After 12 Weeks|Withdrawal by Subject|1|||
170584245|NCT00197145|616481155|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
170584246|NCT00197145|616481156|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
170584247|NCT00197145|616481155|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
170584248|NCT00197145|616481156|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
170584249|NCT00197145|616481155|FG000|Period 1: Randomized Treatment Phase|Other|2|||
170584250|NCT00197145|616481156|FG001|Period 1: Randomized Treatment Phase|Other|2|||
170584251|NCT00197145|616481155|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
170584252|NCT00197145|616481156|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
170584253|NCT00197145|616481155|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
170584254|NCT00197145|616481156|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
170584255|NCT00197145|616481155|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
170584256|NCT00197145|616481156|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
170584257|NCT00197145|616481155|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
170584258|NCT00197145|616481156|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
170584259|NCT00197145|616481155|FG000|Period 2 : Open Label Phase|Other|1|||
170584260|NCT00197145|616481156|FG001|Period 2 : Open Label Phase|Other|0|||
170584261|NCT02596958|616481160|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
170584262|NCT02596958|616481160|FG000|Overall Study|Cancer Progression|441|||
170584263|NCT02596958|616481160|FG000|Overall Study|Death From Cancer|112|||
170584264|NCT02596958|616481160|FG000|Overall Study|Death From Other Cause|33|||
170584265|NCT02596958|616481160|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
170584266|NCT02596958|616481160|FG000|Overall Study|Administrative Reasons/Other|231|||
170584267|NCT02596958|616481160|FG000|Overall Study|Lost to Follow-up|33|||
170584268|NCT02596958|616481160|FG000|Overall Study|Missing|32|||
170584269|NCT02596958|616481160|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
170584270|NCT01559259|616481161|FG000|Overall Study|Withdrawal by Subject|0|||
170584271|NCT01559259|616481162|FG001|Overall Study|Withdrawal by Subject|0|||
170584272|NCT01559259|616481163|FG002|Overall Study|Withdrawal by Subject|0|||
170584273|NCT01559259|616481164|FG003|Overall Study|Withdrawal by Subject|1|||
170584274|NCT01559259|616481165|FG004|Overall Study|Withdrawal by Subject|0|||
170584275|NCT01559259|616481161|FG000|Overall Study|Adverse Event|0|||
170584276|NCT01559259|616481162|FG001|Overall Study|Adverse Event|1|||
170584277|NCT01559259|616481163|FG002|Overall Study|Adverse Event|1|||
170584278|NCT01559259|616481164|FG003|Overall Study|Adverse Event|0|||
170584279|NCT01559259|616481165|FG004|Overall Study|Adverse Event|0|||
170584280|NCT01995669|616481166|FG000|Overall Study|Progression|2|||
170584281|NCT01995669|616481167|FG001|Overall Study|Progression|1|||
170584282|NCT01995669|616481168|FG002|Overall Study|Progression|1|||
170584283|NCT01995669|616481169|FG003|Overall Study|Progression|13|||
170584284|NCT01995669|616481166|FG000|Overall Study|Adverse Event|0|||
170584285|NCT01995669|616481167|FG001|Overall Study|Adverse Event|0|||
170584286|NCT01995669|616481168|FG002|Overall Study|Adverse Event|0|||
170584287|NCT01995669|616481169|FG003|Overall Study|Adverse Event|3|||
170584288|NCT01995669|616481166|FG000|Overall Study|Death|0|||
170584289|NCT01995669|616481167|FG001|Overall Study|Death|0|||
170584290|NCT01995669|616481168|FG002|Overall Study|Death|0|||
170584291|NCT01995669|616481169|FG003|Overall Study|Death|6|||
170584292|NCT01995669|616481166|FG000|Overall Study|Withdrawal by Subject|0|||
170584293|NCT01995669|616481167|FG001|Overall Study|Withdrawal by Subject|0|||
170584294|NCT01995669|616481168|FG002|Overall Study|Withdrawal by Subject|0|||
170584295|NCT01995669|616481169|FG003|Overall Study|Withdrawal by Subject|6|||
170584296|NCT01995669|616481166|FG000|Overall Study|Insurance Expired|0|||
170584297|NCT01995669|616481167|FG001|Overall Study|Insurance Expired|0|||
170584298|NCT01995669|616481168|FG002|Overall Study|Insurance Expired|0|||
170584299|NCT01995669|616481169|FG003|Overall Study|Insurance Expired|1|||
170584300|NCT05659719|616481170|FG000|Overall Study|At sponsor's request|0|||
170584301|NCT05659719|616481171|FG001|Overall Study|At sponsor's request|0|||
170584302|NCT05659719|616481172|FG002|Overall Study|At sponsor's request|0|||
170584303|NCT05659719|616481173|FG003|Overall Study|At sponsor's request|95|||
170584304|NCT05659719|616481170|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
170584305|NCT05659719|616481171|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
170584306|NCT05659719|616481172|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
170584307|NCT05659719|616481173|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
170584308|NCT05659719|616481170|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
170584309|NCT05659719|616481171|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
170584310|NCT05659719|616481172|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
170584311|NCT05659719|616481173|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
170584312|NCT05659719|616481170|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
170584313|NCT05659719|616481171|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
170584314|NCT05659719|616481172|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
170584315|NCT05659719|616481173|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
170584316|NCT05659719|616481170|FG000|Overall Study|Lost to Follow-up|0|||
170584317|NCT05659719|616481171|FG001|Overall Study|Lost to Follow-up|0|||
170584318|NCT05659719|616481172|FG002|Overall Study|Lost to Follow-up|0|||
170584319|NCT05659719|616481173|FG003|Overall Study|Lost to Follow-up|2|||
170584320|NCT05659719|616481170|FG000|Overall Study|Moved to another observational study|0|||
170584321|NCT05659719|616481171|FG001|Overall Study|Moved to another observational study|0|||
170584322|NCT05659719|616481172|FG002|Overall Study|Moved to another observational study|0|||
170584323|NCT05659719|616481173|FG003|Overall Study|Moved to another observational study|1|||
170584324|NCT05659719|616481170|FG000|Overall Study|The child was enrolled in an interventional study|0|||
170584325|NCT05659719|616481171|FG001|Overall Study|The child was enrolled in an interventional study|0|||
170584326|NCT05659719|616481172|FG002|Overall Study|The child was enrolled in an interventional study|0|||
170584327|NCT05659719|616481173|FG003|Overall Study|The child was enrolled in an interventional study|55|||
170584328|NCT05659719|616481170|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
170584329|NCT05659719|616481171|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
170584330|NCT05659719|616481172|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
170584331|NCT05659719|616481173|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
170584332|NCT05659719|616481170|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
170584333|NCT05659719|616481171|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
170584334|NCT05659719|616481172|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
170584335|NCT05659719|616481173|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
170584336|NCT01892436|616481174|FG000|Overall Study|Withdrawal by Subject|8|||
170584337|NCT01892436|616481175|FG001|Overall Study|Withdrawal by Subject|15|||
170584338|NCT01892436|616481176|FG002|Overall Study|Withdrawal by Subject|4|||
170584339|NCT01892436|616481177|FG003|Overall Study|Withdrawal by Subject|4|||
170584340|NCT01892436|616481174|FG000|Overall Study|Death|1|||
170584341|NCT01892436|616481175|FG001|Overall Study|Death|1|||
170584342|NCT01892436|616481176|FG002|Overall Study|Death|0|||
170584343|NCT01892436|616481177|FG003|Overall Study|Death|0|||
170584344|NCT01892436|616481174|FG000|Overall Study|Physician Decision|2|||
170584345|NCT01892436|616481175|FG001|Overall Study|Physician Decision|1|||
170584346|NCT01892436|616481176|FG002|Overall Study|Physician Decision|0|||
170584347|NCT01892436|616481177|FG003|Overall Study|Physician Decision|1|||
170584348|NCT01892436|616481174|FG000|Overall Study|Pregnancy|0|||
170584349|NCT01892436|616481175|FG001|Overall Study|Pregnancy|2|||
170584350|NCT01892436|616481176|FG002|Overall Study|Pregnancy|1|||
170584351|NCT01892436|616481177|FG003|Overall Study|Pregnancy|0|||
170809664|NCT00087516|617313779|FG003|Overall Study|Withdrawal by Subject|12|||
170809665|NCT00087516|617313776|FG000|Overall Study|Site terminated|0|||
170809666|NCT00087516|617313777|FG001|Overall Study|Site terminated|2|||
170809667|NCT00087516|617313778|FG002|Overall Study|Site terminated|1|||
170809668|NCT00087516|617313779|FG003|Overall Study|Site terminated|0|||
170809669|NCT00087516|617313776|FG000|Overall Study|Protocol specified discontinuation|35|||
170809670|NCT00087516|617313777|FG001|Overall Study|Protocol specified discontinuation|33|||
170809671|NCT00087516|617313778|FG002|Overall Study|Protocol specified discontinuation|33|||
170584352|NCT01892436|616481174|FG000|Overall Study|Technical problems|2|||
170809672|NCT00087516|617313779|FG003|Overall Study|Protocol specified discontinuation|26|||
170584353|NCT01892436|616481175|FG001|Overall Study|Technical problems|1|||
170584354|NCT01892436|616481176|FG002|Overall Study|Technical problems|1|||
170809673|NCT00087516|617313776|FG000|Overall Study|Patient moved|3|||
170809674|NCT00087516|617313777|FG001|Overall Study|Patient moved|2|||
170809675|NCT00087516|617313778|FG002|Overall Study|Patient moved|1|||
170809676|NCT00087516|617313779|FG003|Overall Study|Patient moved|0|||
170809677|NCT00087516|617313776|FG000|Overall Study|Patient was non-compliant|3|||
170809678|NCT00087516|617313777|FG001|Overall Study|Patient was non-compliant|1|||
170809679|NCT00087516|617313778|FG002|Overall Study|Patient was non-compliant|0|||
170809680|NCT00087516|617313779|FG003|Overall Study|Patient was non-compliant|0|||
170809681|NCT00087516|617313776|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
170809682|NCT00087516|617313777|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
170809683|NCT00087516|617313778|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
170809684|NCT00087516|617313779|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
170809685|NCT00087516|617313776|FG000|Overall Study|Other|0|||
170584355|NCT01892436|616481177|FG003|Overall Study|Technical problems|1|||
170584356|NCT01892436|616481174|FG000|Overall Study|Lack of Efficacy|1|||
170584357|NCT01892436|616481175|FG001|Overall Study|Lack of Efficacy|2|||
170584358|NCT01892436|616481176|FG002|Overall Study|Lack of Efficacy|2|||
170584359|NCT01892436|616481177|FG003|Overall Study|Lack of Efficacy|2|||
170584360|NCT01892436|616481174|FG000|Overall Study|Lost to Follow-up|1|||
170584361|NCT01892436|616481175|FG001|Overall Study|Lost to Follow-up|1|||
170584362|NCT01892436|616481176|FG002|Overall Study|Lost to Follow-up|1|||
170584363|NCT01892436|616481177|FG003|Overall Study|Lost to Follow-up|3|||
170584364|NCT01892436|616481174|FG000|Overall Study|non-compliance with treatment|1|||
170584365|NCT01892436|616481175|FG001|Overall Study|non-compliance with treatment|0|||
170584366|NCT01892436|616481176|FG002|Overall Study|non-compliance with treatment|0|||
170584367|NCT01892436|616481177|FG003|Overall Study|non-compliance with treatment|0|||
170584368|NCT01892436|616481174|FG000|Overall Study|Adverse Event|7|||
170584369|NCT01892436|616481175|FG001|Overall Study|Adverse Event|6|||
170584370|NCT01892436|616481176|FG002|Overall Study|Adverse Event|2|||
170584371|NCT01892436|616481177|FG003|Overall Study|Adverse Event|3|||
170584372|NCT02242435|616481179|FG000|Overall Study|Lost to Follow-up|3|||
170584373|NCT02242435|616481180|FG001|Overall Study|Lost to Follow-up|4|||
170584374|NCT02242435|616481179|FG000|Overall Study|Adverse Event|3|||
170584375|NCT02242435|616481180|FG001|Overall Study|Adverse Event|2|||
170584376|NCT02242435|616481179|FG000|Overall Study|Withdrawal by Subject|13|||
170584377|NCT02242435|616481180|FG001|Overall Study|Withdrawal by Subject|8|||
170584378|NCT02242435|616481179|FG000|Overall Study|Death|0|||
170584379|NCT02242435|616481180|FG001|Overall Study|Death|1|||
170584380|NCT02242435|616481179|FG000|Overall Study|Protocol Violation|1|||
170584381|NCT02242435|616481180|FG001|Overall Study|Protocol Violation|0|||
170584382|NCT02242435|616481179|FG000|Overall Study|Physician Decision|0|||
170584383|NCT02242435|616481180|FG001|Overall Study|Physician Decision|1|||
170584384|NCT00420004|616481184|FG000|Overall Study|Adverse Event|4|||
170584385|NCT00420004|616481185|FG001|Overall Study|Adverse Event|1|||
170584386|NCT00420004|616481186|FG002|Overall Study|Adverse Event|1|||
170584387|NCT00420004|616481184|FG000|Overall Study|Lack of Efficacy|5|||
170584388|NCT00420004|616481185|FG001|Overall Study|Lack of Efficacy|4|||
170584389|NCT00420004|616481186|FG002|Overall Study|Lack of Efficacy|1|||
170584390|NCT00420004|616481184|FG000|Overall Study|Lost to Follow-up|31|||
170584391|NCT00420004|616481185|FG001|Overall Study|Lost to Follow-up|12|||
170584392|NCT00420004|616481186|FG002|Overall Study|Lost to Follow-up|10|||
170584393|NCT00420004|616481184|FG000|Overall Study|Entry Criteria Not Met|0|||
170584394|NCT00420004|616481185|FG001|Overall Study|Entry Criteria Not Met|1|||
170584395|NCT00420004|616481186|FG002|Overall Study|Entry Criteria Not Met|0|||
170584396|NCT00420004|616481184|FG000|Overall Study|Physician Decision|14|||
170584397|NCT00420004|616481185|FG001|Overall Study|Physician Decision|4|||
170584398|NCT00420004|616481186|FG002|Overall Study|Physician Decision|2|||
170584399|NCT00420004|616481184|FG000|Overall Study|Protocol Violation|5|||
170584400|NCT00420004|616481185|FG001|Overall Study|Protocol Violation|4|||
170584401|NCT00420004|616481186|FG002|Overall Study|Protocol Violation|3|||
170584402|NCT00420004|616481184|FG000|Overall Study|Withdrawal by Subject|67|||
170584403|NCT00420004|616481185|FG001|Overall Study|Withdrawal by Subject|42|||
170584404|NCT00420004|616481186|FG002|Overall Study|Withdrawal by Subject|14|||
170584405|NCT00420004|616481184|FG000|Overall Study|Sponsor Decision|3|||
170584406|NCT00420004|616481185|FG001|Overall Study|Sponsor Decision|3|||
170584407|NCT00420004|616481186|FG002|Overall Study|Sponsor Decision|1|||
170584408|NCT01696994|616481187|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
170584409|NCT01696994|616481188|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
170584410|NCT01696994|616481187|FG000|Overall Study|Died Before Randomization|1|||
170584411|NCT01696994|616481188|FG001|Overall Study|Died Before Randomization|2|||
170584412|NCT01696994|616481187|FG000|Overall Study|Died Before ASU (Control)|73|||
170584413|NCT01696994|616481188|FG001|Overall Study|Died Before ASU (Control)|0|||
170649965|NCT01268579|616732762|FG000|Overall Study|Withdrawal by Subject|2|||
170584414|NCT01696994|616481187|FG000|Overall Study|No Ovaries at Baseline|4807|||
170649966|NCT02692651|616732763|FG000|Study Treatment|Death|7|||
170584415|NCT01696994|616481188|FG001|Overall Study|No Ovaries at Baseline|4851|||
170584416|NCT01696994|616481187|FG000|Overall Study|Refused ASU (Control)|311|||
170584417|NCT01696994|616481188|FG001|Overall Study|Refused ASU (Control)|0|||
170584418|NCT01696994|616481187|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
170649967|NCT02692651|616732764|FG001|Study Treatment|Death|3|||
170649968|NCT02692651|616732763|FG000|Study Treatment|comfort care|1|||
170649969|NCT02692651|616732764|FG001|Study Treatment|comfort care|1|||
170649970|NCT02692651|616732763|FG000|Study Treatment|Protocol violation per treating team preference|8|||
170649971|NCT02692651|616732764|FG001|Study Treatment|Protocol violation per treating team preference|6|||
170649972|NCT02692651|616732763|FG000|Post Study Treatment Follow-up|Death|4|||
170584419|NCT01696994|616481188|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
170584420|NCT00713349|616481190|FG000|Overall Study|Protocol Violation|1|||
170584421|NCT04569136|616481196|FG000|Overall Study|Lost to Follow-up|2|||
170584422|NCT04569136|616481197|FG001|Overall Study|Lost to Follow-up|0|||
170584423|NCT04569136|616481198|FG002|Overall Study|Lost to Follow-up|1|||
170584424|NCT00129701|616481204|FG000|Overall Study|Withdrawal by Subject|33|||
170584425|NCT03576066|616481205|FG000|Overall Study|Noncompliance with study drug|0|||
170584426|NCT03576066|616481206|FG001|Overall Study|Noncompliance with study drug|1|||
170649973|NCT02692651|616732764|FG001|Post Study Treatment Follow-up|Death|4|||
170584427|NCT01466660|616481207|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
170584428|NCT01466660|616481208|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
170584429|NCT01466660|616481207|FG000|Overall Study|Worsening of underlying cancer disease|5|||
170584430|NCT01466660|616481208|FG001|Overall Study|Worsening of underlying cancer disease|2|||
170584431|NCT01466660|616481207|FG000|Overall Study|Other adverse event|19|||
170584432|NCT01466660|616481208|FG001|Overall Study|Other adverse event|18|||
170584433|NCT01466660|616481207|FG000|Overall Study|Protocol Violation|2|||
170584434|NCT01466660|616481208|FG001|Overall Study|Protocol Violation|1|||
170584435|NCT01466660|616481207|FG000|Overall Study|Refused continuation of trial medication|4|||
170584436|NCT01466660|616481208|FG001|Overall Study|Refused continuation of trial medication|3|||
170584437|NCT01466660|616481207|FG000|Overall Study|Other reason not defined above|10|||
170584438|NCT01466660|616481208|FG001|Overall Study|Other reason not defined above|8|||
170584439|NCT00006164|616481209|FG000|Overall Study|Withdrew or lost to follow-up|70|||
170584440|NCT00006164|616481210|FG001|Overall Study|Withdrew or lost to follow-up|81|||
170584441|NCT00608023|616481211|FG000|Overall Study|Withdrawal by Subject|8|||
170584442|NCT00608023|616481212|FG001|Overall Study|Withdrawal by Subject|10|||
170584443|NCT00608023|616481213|FG002|Overall Study|Withdrawal by Subject|7|||
170584444|NCT00608023|616481211|FG000|Overall Study|Adverse Event|1|||
170584445|NCT00608023|616481212|FG001|Overall Study|Adverse Event|4|||
170584446|NCT00608023|616481213|FG002|Overall Study|Adverse Event|5|||
170584447|NCT00608023|616481211|FG000|Overall Study|Lost to Follow-up|2|||
170584448|NCT00608023|616481212|FG001|Overall Study|Lost to Follow-up|2|||
170584449|NCT00608023|616481213|FG002|Overall Study|Lost to Follow-up|1|||
170584450|NCT00608023|616481211|FG000|Overall Study|Protocol Violation|1|||
170584451|NCT00608023|616481212|FG001|Overall Study|Protocol Violation|3|||
170584452|NCT00608023|616481213|FG002|Overall Study|Protocol Violation|1|||
170584453|NCT00608023|616481211|FG000|Overall Study|Unknown reason|0|||
170584454|NCT00608023|616481212|FG001|Overall Study|Unknown reason|3|||
170584455|NCT00608023|616481213|FG002|Overall Study|Unknown reason|0|||
170584456|NCT01231321|616481216|FG000|Overall Study|Adverse Event|3|||
170584457|NCT01231321|616481216|FG000|Overall Study|Lack of Efficacy|2|||
170584458|NCT00967694|616481218|FG000|Overall Study|Withdrawal by Subject|6|||
170584459|NCT00245050|616481222|FG000|Overall Study|Adverse Event|3|||
170584460|NCT00245050|616481223|FG001|Overall Study|Adverse Event|2|||
170584461|NCT03275246|616481224|FG000|Overall Study|Protocol Violation|5|||
170584462|NCT03275246|616481224|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
170584463|NCT05526781|616481226|FG000|Overall Study|Lost to Follow-up|1|||
170584464|NCT03905265|616481227|FG000|Overall Study|Withdrawal by Subject|1|||
170584465|NCT03905265|616481228|FG001|Overall Study|Withdrawal by Subject|1|||
170584466|NCT03905265|616481229|FG002|Overall Study|Withdrawal by Subject|0|||
170584467|NCT03905265|616481230|FG003|Overall Study|Withdrawal by Subject|0|||
170584468|NCT01035463|616481232|FG000|Overall Study|Adverse Event|0|||
170584469|NCT01035463|616481233|FG001|Overall Study|Adverse Event|0|||
170584470|NCT01035463|616481234|FG002|Overall Study|Adverse Event|4|||
170649974|NCT03490981|616732765|FG000|Overall Study|Lost to Follow-up|1|||
170649975|NCT03490981|616732766|FG001|Overall Study|Lost to Follow-up|2|||
170809686|NCT00087516|617313777|FG001|Overall Study|Other|0|||
170809687|NCT00087516|617313778|FG002|Overall Study|Other|1|||
170809688|NCT00087516|617313779|FG003|Overall Study|Other|0|||
170584471|NCT01035463|616481235|FG003|Overall Study|Adverse Event|1|||
170584472|NCT01035463|616481236|FG004|Overall Study|Adverse Event|5|||
170584473|NCT01035463|616481237|FG005|Overall Study|Adverse Event|7|||
170649976|NCT00475423|616732767|FG000|Overall Study|Protocol Violation|5|||
170584474|NCT01035463|616481232|FG000|Overall Study|Withdrawal by Subject|0|||
170584475|NCT01035463|616481233|FG001|Overall Study|Withdrawal by Subject|2|||
170584476|NCT01035463|616481234|FG002|Overall Study|Withdrawal by Subject|1|||
170584477|NCT01035463|616481235|FG003|Overall Study|Withdrawal by Subject|0|||
170584478|NCT01035463|616481236|FG004|Overall Study|Withdrawal by Subject|1|||
170584479|NCT01035463|616481237|FG005|Overall Study|Withdrawal by Subject|4|||
170584480|NCT01035463|616481232|FG000|Overall Study|Disease progression|0|||
170584481|NCT01035463|616481233|FG001|Overall Study|Disease progression|0|||
170584482|NCT01035463|616481234|FG002|Overall Study|Disease progression|0|||
170584483|NCT01035463|616481235|FG003|Overall Study|Disease progression|0|||
170584484|NCT01035463|616481236|FG004|Overall Study|Disease progression|0|||
170584485|NCT01035463|616481237|FG005|Overall Study|Disease progression|3|||
170584486|NCT01035463|616481232|FG000|Overall Study|Other Malignancy|0|||
170584487|NCT01035463|616481233|FG001|Overall Study|Other Malignancy|0|||
170584488|NCT01035463|616481234|FG002|Overall Study|Other Malignancy|0|||
170584489|NCT01035463|616481235|FG003|Overall Study|Other Malignancy|0|||
170584490|NCT01035463|616481236|FG004|Overall Study|Other Malignancy|0|||
170584491|NCT01035463|616481237|FG005|Overall Study|Other Malignancy|2|||
170584492|NCT01035463|616481232|FG000|Overall Study|Other|0|||
170584493|NCT01035463|616481233|FG001|Overall Study|Other|0|||
170584494|NCT01035463|616481234|FG002|Overall Study|Other|0|||
170584495|NCT01035463|616481235|FG003|Overall Study|Other|1|||
170584496|NCT01035463|616481236|FG004|Overall Study|Other|0|||
170584497|NCT01035463|616481237|FG005|Overall Study|Other|2|||
170584498|NCT00758264|616481238|FG000|Active Phase|Withdrawal by Subject|0|||
170584499|NCT00758264|616481239|FG001|Active Phase|Withdrawal by Subject|0|||
170584500|NCT00758264|616481240|FG002|Active Phase|Withdrawal by Subject|1|||
170584501|NCT00758264|616481238|FG000|Active Phase|Lost to Follow-up|1|||
170584502|NCT00758264|616481239|FG001|Active Phase|Lost to Follow-up|0|||
170584503|NCT00758264|616481240|FG002|Active Phase|Lost to Follow-up|0|||
170584504|NCT00758264|616481238|FG000|Active Phase|Other|0|||
170584505|NCT00758264|616481239|FG001|Active Phase|Other|0|||
170584506|NCT00758264|616481240|FG002|Active Phase|Other|4|||
170584507|NCT01988662|616481241|FG000|Overall Study|Subject/guardian decision|1|||
170584508|NCT01988662|616481242|FG001|Overall Study|Subject/guardian decision|1|||
170584509|NCT01988662|616481241|FG000|Overall Study|Adverse Event|3|||
170584510|NCT01988662|616481242|FG001|Overall Study|Adverse Event|1|||
170584511|NCT03425006|616481243|FG000|Overall Study|Withdrawal by Subject|1|||
170584512|NCT03425006|616481243|FG000|Overall Study|Physician Decision|1|||
170584513|NCT03425006|616481243|FG000|Overall Study|Death|1|||
170649977|NCT00475423|616732767|FG000|Overall Study|Adverse Event|4|||
170649978|NCT00475423|616732767|FG000|Overall Study|Withdrawal by Subject|6|||
170649979|NCT00475423|616732767|FG000|Overall Study|Lack of Efficacy|8|||
170649980|NCT00475423|616732767|FG000|Overall Study|Death|1|||
170584514|NCT03748706|616481246|FG000|Overall Study|Lost to Follow-up|1|||
170584515|NCT03831191|616481247|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
170584516|NCT03831191|616481248|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
170584517|NCT03831191|616481249|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
170584518|NCT03831191|616481250|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
170584519|NCT03831191|616481251|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
170584520|NCT03831191|616481252|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
170584521|NCT03831191|616481253|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
170584522|NCT03831191|616481254|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
170584523|NCT03831191|616481255|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
170584524|NCT03831191|616481256|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
170584525|NCT03831191|616481257|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
170584526|NCT03831191|616481258|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
170584527|NCT03831191|616481259|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
170584528|NCT03831191|616481260|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
170584529|NCT03831191|616481261|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
170584530|NCT03831191|616481247|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
170584531|NCT03831191|616481248|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
170584532|NCT03831191|616481249|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584533|NCT03831191|616481250|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584534|NCT03831191|616481251|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584535|NCT03831191|616481252|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584536|NCT03831191|616481253|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170649981|NCT00475423|616732767|FG000|Overall Study|Reason not specified|1|||
170584537|NCT03831191|616481254|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584538|NCT03831191|616481255|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170649982|NCT00475423|616732767|FG000|Overall Study|Lost to Follow-up|7|||
170584539|NCT03831191|616481256|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170649983|NCT02239120|616732768|FG000|Overall Study|Death|56|||
170584540|NCT03831191|616481257|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584541|NCT03831191|616481258|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584542|NCT03831191|616481259|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584543|NCT03831191|616481260|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584544|NCT03831191|616481261|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
170584545|NCT03831191|616481247|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
170584546|NCT03831191|616481248|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
170584547|NCT03831191|616481249|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
170584548|NCT03831191|616481250|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
170584549|NCT03831191|616481251|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
170584550|NCT03831191|616481252|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
170649984|NCT02239120|616732769|FG001|Overall Study|Death|58|||
170649985|NCT02239120|616732768|FG000|Overall Study|Lost to Follow-up|19|||
170649986|NCT02239120|616732769|FG001|Overall Study|Lost to Follow-up|14|||
170584551|NCT03831191|616481253|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
170584552|NCT03831191|616481254|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
170584553|NCT03831191|616481255|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
170584554|NCT03831191|616481256|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
170584555|NCT03831191|616481257|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
170584556|NCT03831191|616481258|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
170584557|NCT03831191|616481259|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
170584558|NCT03831191|616481260|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
170584559|NCT03831191|616481261|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
170584560|NCT03831191|616481247|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
170584561|NCT03831191|616481248|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
170584562|NCT03831191|616481249|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
170584563|NCT03831191|616481250|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
170584564|NCT03831191|616481251|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
170584565|NCT03831191|616481252|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
170584566|NCT03831191|616481253|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
170584567|NCT03831191|616481254|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
170584568|NCT03831191|616481255|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
170584569|NCT03831191|616481256|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
170584570|NCT03831191|616481257|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
170584571|NCT03831191|616481258|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
170584572|NCT03831191|616481259|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
170584573|NCT03831191|616481260|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
170584574|NCT03831191|616481261|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
170584575|NCT03831191|616481247|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
170584576|NCT03831191|616481248|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
170584577|NCT03831191|616481249|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
170584578|NCT03831191|616481250|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
170584579|NCT03831191|616481251|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584580|NCT03831191|616481252|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584581|NCT03831191|616481253|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584582|NCT03831191|616481254|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584583|NCT03831191|616481255|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584584|NCT03831191|616481256|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584585|NCT03831191|616481257|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584586|NCT03831191|616481258|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584587|NCT03831191|616481259|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584588|NCT03831191|616481260|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584589|NCT03831191|616481261|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170584590|NCT03831191|616481247|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
170584591|NCT03831191|616481248|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
170584592|NCT03831191|616481249|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
170584593|NCT03831191|616481250|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
170584594|NCT03831191|616481251|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584595|NCT03831191|616481252|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584596|NCT03831191|616481253|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584597|NCT03831191|616481254|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584598|NCT03831191|616481255|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584599|NCT03831191|616481256|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584600|NCT03831191|616481257|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584601|NCT03831191|616481258|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584602|NCT03831191|616481259|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584603|NCT03831191|616481260|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584604|NCT03831191|616481261|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
170584605|NCT03831191|616481247|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584606|NCT03831191|616481248|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584607|NCT03831191|616481249|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584608|NCT03831191|616481250|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
170584609|NCT03831191|616481251|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584610|NCT03831191|616481252|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584611|NCT03831191|616481253|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584612|NCT03831191|616481254|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584613|NCT03831191|616481255|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584614|NCT03831191|616481256|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584615|NCT03831191|616481257|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584616|NCT03831191|616481258|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584617|NCT03831191|616481259|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584618|NCT03831191|616481260|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584619|NCT03831191|616481261|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
170584620|NCT03831191|616481247|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
170584621|NCT03831191|616481248|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
170584622|NCT03831191|616481249|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
170584623|NCT03831191|616481250|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
170584624|NCT03831191|616481251|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
170584625|NCT03831191|616481252|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
170584626|NCT03831191|616481253|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
170584627|NCT03831191|616481254|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
170584628|NCT03831191|616481255|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
170584629|NCT03831191|616481256|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
170584630|NCT03831191|616481257|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
170584631|NCT03831191|616481258|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
170584632|NCT03831191|616481259|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
170584633|NCT03831191|616481260|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
170584634|NCT03831191|616481261|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
170584635|NCT03831191|616481247|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584636|NCT03831191|616481248|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584637|NCT03831191|616481249|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584638|NCT03831191|616481250|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584639|NCT03831191|616481251|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584640|NCT03831191|616481252|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584641|NCT03831191|616481253|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584642|NCT03831191|616481254|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584643|NCT03831191|616481255|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584644|NCT03831191|616481256|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584645|NCT03831191|616481257|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584646|NCT03831191|616481258|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584647|NCT03831191|616481259|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584648|NCT03831191|616481260|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170584649|NCT03831191|616481261|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
170584650|NCT03831191|616481247|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584651|NCT03831191|616481248|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584652|NCT03831191|616481249|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584653|NCT03831191|616481250|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584654|NCT03831191|616481251|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584655|NCT03831191|616481252|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584656|NCT03831191|616481253|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584657|NCT03831191|616481254|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584658|NCT03831191|616481255|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584659|NCT03831191|616481256|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584660|NCT03831191|616481257|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584661|NCT03831191|616481258|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584662|NCT03831191|616481259|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584663|NCT03831191|616481260|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170584664|NCT03831191|616481261|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
170584665|NCT03070171|616481262|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
170584666|NCT03070171|616481263|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
170584667|NCT03070171|616481262|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
170584668|NCT03070171|616481263|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
170584669|NCT01177553|616481267|FG000|Overall Study|babies not yet 6 months of age|1|||
170584670|NCT01177553|616481268|FG001|Overall Study|babies not yet 6 months of age|0|||
170584671|NCT00610857|616481270|FG000|Overall Study|Not evaluable for response|2|||
170809689|NCT01719172|617313780|FG000|Overall Study|Lost to Follow-up|1|||
170809690|NCT01719172|617313780|FG000|Overall Study|Death|1|||
170809691|NCT02605174|617313784|FG000|Overall Study|Adverse Event|0|||
170584672|NCT01421303|616481271|FG000|Overall Study|Lost to Follow-up|13|||
170584673|NCT01421303|616481271|FG000|Overall Study|Non compliance with study procedure|1|||
170809692|NCT02605174|617313785|FG001|Overall Study|Adverse Event|0|||
170809693|NCT02605174|617313786|FG002|Overall Study|Adverse Event|1|||
170809694|NCT02605174|617313787|FG003|Overall Study|Adverse Event|0|||
170584674|NCT01421303|616481271|FG000|Overall Study|Other|7|||
170584675|NCT01421303|616481271|FG000|Overall Study|Withdrawal by Subject|1|||
170809695|NCT02605174|617313788|FG004|Overall Study|Adverse Event|4|||
170809696|NCT02605174|617313789|FG005|Overall Study|Adverse Event|0|||
170584676|NCT06003777|616481272|FG000|Period 1|Adverse Event|0|||
170584677|NCT06003777|616481273|FG001|Period 1|Adverse Event|0|||
170584678|NCT06003777|616481274|FG002|Period 1|Adverse Event|1|||
170584679|NCT06003777|616481275|FG003|Period 1|Adverse Event|0|||
170584680|NCT06003777|616481276|FG004|Period 1|Adverse Event|0|||
170809697|NCT02605174|617313790|FG006|Overall Study|Adverse Event|0|||
170809698|NCT02605174|617313784|FG000|Overall Study|Lost to Follow-up|20|||
170809699|NCT02605174|617313785|FG001|Overall Study|Lost to Follow-up|7|||
170809700|NCT02605174|617313786|FG002|Overall Study|Lost to Follow-up|27|||
170809701|NCT02605174|617313787|FG003|Overall Study|Lost to Follow-up|10|||
170809702|NCT02605174|617313788|FG004|Overall Study|Lost to Follow-up|20|||
170809703|NCT02605174|617313789|FG005|Overall Study|Lost to Follow-up|10|||
170809704|NCT02605174|617313790|FG006|Overall Study|Lost to Follow-up|29|||
170809705|NCT02605174|617313784|FG000|Overall Study|Protocol Violation|10|||
170809706|NCT02605174|617313785|FG001|Overall Study|Protocol Violation|4|||
170809707|NCT02605174|617313786|FG002|Overall Study|Protocol Violation|14|||
170809708|NCT02605174|617313787|FG003|Overall Study|Protocol Violation|6|||
170809709|NCT02605174|617313788|FG004|Overall Study|Protocol Violation|7|||
170809710|NCT02605174|617313789|FG005|Overall Study|Protocol Violation|7|||
170584681|NCT06003777|616481277|FG005|Period 1|Adverse Event|0|||
170584682|NCT06003777|616481278|FG006|Period 1|Adverse Event|0|||
170584683|NCT06003777|616481279|FG007|Period 1|Adverse Event|0|||
170584684|NCT06003777|616481280|FG008|Period 1|Adverse Event|0|||
170584685|NCT06003777|616481281|FG009|Period 1|Adverse Event|0|||
170584686|NCT06003777|616481282|FG010|Period 1|Adverse Event|0|||
170584687|NCT06003777|616481283|FG011|Period 1|Adverse Event|0|||
170584688|NCT06003777|616481272|FG000|Period 1|Withdrawal by Subject|0|||
170584689|NCT06003777|616481273|FG001|Period 1|Withdrawal by Subject|0|||
170584690|NCT06003777|616481274|FG002|Period 1|Withdrawal by Subject|0|||
170584691|NCT06003777|616481275|FG003|Period 1|Withdrawal by Subject|0|||
170584692|NCT06003777|616481276|FG004|Period 1|Withdrawal by Subject|1|||
170584693|NCT06003777|616481277|FG005|Period 1|Withdrawal by Subject|0|||
170584694|NCT06003777|616481278|FG006|Period 1|Withdrawal by Subject|0|||
170584695|NCT06003777|616481279|FG007|Period 1|Withdrawal by Subject|0|||
170584696|NCT06003777|616481280|FG008|Period 1|Withdrawal by Subject|0|||
170584697|NCT06003777|616481281|FG009|Period 1|Withdrawal by Subject|0|||
170910719|NCT00401973|617677248|FG000|Overall Study|Lost to Follow-up|2|||
170584698|NCT06003777|616481282|FG010|Period 1|Withdrawal by Subject|0|||
170584699|NCT06003777|616481283|FG011|Period 1|Withdrawal by Subject|0|||
170584700|NCT06003777|616481272|FG000|Period 2|Withdrawal by Subject|0|||
170584701|NCT06003777|616481273|FG001|Period 2|Withdrawal by Subject|0|||
170584702|NCT06003777|616481274|FG002|Period 2|Withdrawal by Subject|0|||
170584703|NCT06003777|616481275|FG003|Period 2|Withdrawal by Subject|0|||
170584704|NCT06003777|616481276|FG004|Period 2|Withdrawal by Subject|0|||
170584705|NCT06003777|616481277|FG005|Period 2|Withdrawal by Subject|0|||
170584706|NCT06003777|616481278|FG006|Period 2|Withdrawal by Subject|0|||
170584707|NCT06003777|616481279|FG007|Period 2|Withdrawal by Subject|0|||
170584708|NCT06003777|616481280|FG008|Period 2|Withdrawal by Subject|1|||
170584709|NCT06003777|616481281|FG009|Period 2|Withdrawal by Subject|0|||
170584710|NCT06003777|616481282|FG010|Period 2|Withdrawal by Subject|0|||
170584711|NCT06003777|616481283|FG011|Period 2|Withdrawal by Subject|0|||
170584712|NCT06003777|616481272|FG000|Period 3|Adverse Event|0|||
170584713|NCT06003777|616481273|FG001|Period 3|Adverse Event|0|||
170584714|NCT06003777|616481274|FG002|Period 3|Adverse Event|0|||
170584715|NCT06003777|616481275|FG003|Period 3|Adverse Event|0|||
170584716|NCT06003777|616481276|FG004|Period 3|Adverse Event|0|||
170584717|NCT06003777|616481277|FG005|Period 3|Adverse Event|0|||
170584718|NCT06003777|616481278|FG006|Period 3|Adverse Event|1|||
170584719|NCT06003777|616481279|FG007|Period 3|Adverse Event|0|||
170584720|NCT06003777|616481280|FG008|Period 3|Adverse Event|0|||
170584721|NCT06003777|616481281|FG009|Period 3|Adverse Event|0|||
170584722|NCT06003777|616481282|FG010|Period 3|Adverse Event|0|||
170584723|NCT06003777|616481283|FG011|Period 3|Adverse Event|0|||
170584724|NCT06003777|616481272|FG000|Period 4|No longer met eligibility criteria|0|||
170584725|NCT06003777|616481273|FG001|Period 4|No longer met eligibility criteria|0|||
170584726|NCT06003777|616481274|FG002|Period 4|No longer met eligibility criteria|1|||
170584727|NCT06003777|616481275|FG003|Period 4|No longer met eligibility criteria|0|||
170910720|NCT00401973|617677249|FG001|Overall Study|Lost to Follow-up|2|||
170584728|NCT06003777|616481276|FG004|Period 4|No longer met eligibility criteria|0|||
170584729|NCT06003777|616481277|FG005|Period 4|No longer met eligibility criteria|0|||
170809711|NCT02605174|617313790|FG006|Overall Study|Protocol Violation|12|||
170809712|NCT02605174|617313784|FG000|Overall Study|Pregnancy|1|||
170809713|NCT02605174|617313785|FG001|Overall Study|Pregnancy|0|||
170910721|NCT00401973|617677250|FG002|Overall Study|Lost to Follow-up|2|||
170584730|NCT06003777|616481278|FG006|Period 4|No longer met eligibility criteria|0|||
170584731|NCT06003777|616481279|FG007|Period 4|No longer met eligibility criteria|0|||
170809714|NCT02605174|617313786|FG002|Overall Study|Pregnancy|0|||
170809715|NCT02605174|617313787|FG003|Overall Study|Pregnancy|2|||
170584732|NCT06003777|616481280|FG008|Period 4|No longer met eligibility criteria|0|||
170584733|NCT06003777|616481281|FG009|Period 4|No longer met eligibility criteria|0|||
170584734|NCT06003777|616481282|FG010|Period 4|No longer met eligibility criteria|0|||
170584735|NCT06003777|616481283|FG011|Period 4|No longer met eligibility criteria|0|||
170584736|NCT06003777|616481272|FG000|Period 4|Withdrawal by Subject|0|||
170584737|NCT06003777|616481273|FG001|Period 4|Withdrawal by Subject|1|||
170584738|NCT06003777|616481274|FG002|Period 4|Withdrawal by Subject|0|||
170584739|NCT06003777|616481275|FG003|Period 4|Withdrawal by Subject|0|||
170584740|NCT06003777|616481276|FG004|Period 4|Withdrawal by Subject|0|||
170809716|NCT02605174|617313788|FG004|Overall Study|Pregnancy|0|||
170809717|NCT02605174|617313789|FG005|Overall Study|Pregnancy|0|||
170809718|NCT02605174|617313790|FG006|Overall Study|Pregnancy|0|||
170809719|NCT02605174|617313784|FG000|Overall Study|Withdrawal by Subject|9|||
170809720|NCT02605174|617313785|FG001|Overall Study|Withdrawal by Subject|6|||
170809721|NCT02605174|617313786|FG002|Overall Study|Withdrawal by Subject|14|||
170809722|NCT02605174|617313787|FG003|Overall Study|Withdrawal by Subject|11|||
170809723|NCT02605174|617313788|FG004|Overall Study|Withdrawal by Subject|6|||
170809724|NCT02605174|617313789|FG005|Overall Study|Withdrawal by Subject|4|||
170809725|NCT02605174|617313790|FG006|Overall Study|Withdrawal by Subject|15|||
170809726|NCT02605174|617313784|FG000|Overall Study|Physician Decision|2|||
170809727|NCT02605174|617313785|FG001|Overall Study|Physician Decision|0|||
170809728|NCT02605174|617313786|FG002|Overall Study|Physician Decision|0|||
170809729|NCT02605174|617313787|FG003|Overall Study|Physician Decision|0|||
170809730|NCT02605174|617313788|FG004|Overall Study|Physician Decision|0|||
170809731|NCT02605174|617313789|FG005|Overall Study|Physician Decision|0|||
170809732|NCT02605174|617313790|FG006|Overall Study|Physician Decision|3|||
170809733|NCT02605174|617313784|FG000|Overall Study|Randomization Failure|22|||
170809734|NCT02605174|617313785|FG001|Overall Study|Randomization Failure|6|||
170809735|NCT02605174|617313786|FG002|Overall Study|Randomization Failure|20|||
170809736|NCT02605174|617313787|FG003|Overall Study|Randomization Failure|7|||
170809737|NCT02605174|617313788|FG004|Overall Study|Randomization Failure|16|||
170809738|NCT02605174|617313789|FG005|Overall Study|Randomization Failure|11|||
170809739|NCT02605174|617313790|FG006|Overall Study|Randomization Failure|30|||
170809740|NCT01128959|617313793|FG000|Lead in Period|Adverse Event|3|||
170809741|NCT01128959|617313793|FG000|Treatment Period|Adverse Event|3|||
170809742|NCT01128959|617313793|FG000|Treatment Period|Withdrawal by Subject|1|||
170809743|NCT04938453|617313794|FG000|Washout Period 1|Adverse Event|1|||
170809744|NCT04938453|617313795|FG001|Washout Period 1|Adverse Event|0|||
170809745|NCT04938453|617313794|FG000|Washout Period 1|Physician Decision|0|||
170809746|NCT04938453|617313795|FG001|Washout Period 1|Physician Decision|1|||
170809747|NCT03292406|617313797|FG000|Overall Study|Progressive Disease|6|||
170809748|NCT03292406|617313798|FG001|Overall Study|Progressive Disease|3|||
170809749|NCT03292406|617313799|FG002|Overall Study|Progressive Disease|4|||
170809750|NCT03292406|617313797|FG000|Overall Study|Adverse Event|7|||
170809751|NCT03292406|617313798|FG001|Overall Study|Adverse Event|1|||
170809752|NCT03292406|617313799|FG002|Overall Study|Adverse Event|4|||
170809753|NCT03292406|617313797|FG000|Overall Study|Withdrawal by Subject|0|||
170809754|NCT03292406|617313798|FG001|Overall Study|Withdrawal by Subject|7|||
170809755|NCT03292406|617313799|FG002|Overall Study|Withdrawal by Subject|2|||
170809756|NCT03292406|617313797|FG000|Overall Study|Protocol Violation|0|||
170809757|NCT03292406|617313798|FG001|Overall Study|Protocol Violation|1|||
170809758|NCT03292406|617313799|FG002|Overall Study|Protocol Violation|1|||
170809759|NCT03292406|617313797|FG000|Overall Study|Other|0|||
170809760|NCT03292406|617313798|FG001|Overall Study|Other|1|||
170809761|NCT03292406|617313799|FG002|Overall Study|Other|2|||
170809762|NCT01450007|617313801|FG000|Overall Study|Late exclusion before treatment|2|||
170809763|NCT01450007|617313802|FG001|Overall Study|Late exclusion before treatment|3|||
170809764|NCT01450007|617313803|FG002|Overall Study|Late exclusion before treatment|2|||
170809765|NCT01450007|617313801|FG000|Overall Study|Protocol Violation|0|||
170809766|NCT01450007|617313802|FG001|Overall Study|Protocol Violation|1|||
170809767|NCT01450007|617313803|FG002|Overall Study|Protocol Violation|1|||
170809768|NCT01450007|617313801|FG000|Overall Study|Adverse Event|0|||
170809769|NCT01450007|617313802|FG001|Overall Study|Adverse Event|1|||
170809770|NCT01450007|617313803|FG002|Overall Study|Adverse Event|0|||
170809771|NCT03851094|617313805|FG000|Overall Study|Withdrawal by Subject|0|||
170809772|NCT03851094|617313806|FG001|Overall Study|Withdrawal by Subject|1|||
170809773|NCT03851094|617313805|FG000|Overall Study|Participant lost device|0|||
170809774|NCT03851094|617313806|FG001|Overall Study|Participant lost device|1|||
170809775|NCT03851094|617313805|FG000|Overall Study|Participant returned device|0|||
170910722|NCT00401973|617677248|FG000|Overall Study|Physician Decision|2|||
170910723|NCT00401973|617677249|FG001|Overall Study|Physician Decision|0|||
170910724|NCT00401973|617677250|FG002|Overall Study|Physician Decision|1|||
170809776|NCT03851094|617313806|FG001|Overall Study|Participant returned device|2|||
170809777|NCT01947491|617313807|FG000|Overall Study|Lost to Follow-up|5|||
170809778|NCT01947491|617313808|FG001|Overall Study|Lost to Follow-up|3|||
170809779|NCT01947491|617313809|FG002|Overall Study|Lost to Follow-up|1|||
170809780|NCT01947491|617313810|FG003|Overall Study|Lost to Follow-up|2|||
170809781|NCT01947491|617313807|FG000|Overall Study|Lack of Efficacy|1|||
170809782|NCT01947491|617313808|FG001|Overall Study|Lack of Efficacy|0|||
170809783|NCT01947491|617313809|FG002|Overall Study|Lack of Efficacy|0|||
170809784|NCT01947491|617313810|FG003|Overall Study|Lack of Efficacy|1|||
170809785|NCT01947491|617313807|FG000|Overall Study|Protocol Violation|1|||
170809786|NCT01947491|617313808|FG001|Overall Study|Protocol Violation|0|||
170809787|NCT01947491|617313809|FG002|Overall Study|Protocol Violation|0|||
170809788|NCT01947491|617313810|FG003|Overall Study|Protocol Violation|0|||
170809789|NCT01947491|617313807|FG000|Overall Study|Withdrawal by Subject|1|||
170809790|NCT01947491|617313808|FG001|Overall Study|Withdrawal by Subject|1|||
170809791|NCT01947491|617313809|FG002|Overall Study|Withdrawal by Subject|1|||
170584741|NCT06003777|616481277|FG005|Period 4|Withdrawal by Subject|0|||
170584742|NCT06003777|616481278|FG006|Period 4|Withdrawal by Subject|0|||
170584743|NCT06003777|616481279|FG007|Period 4|Withdrawal by Subject|0|||
170584744|NCT06003777|616481280|FG008|Period 4|Withdrawal by Subject|0|||
170584745|NCT06003777|616481281|FG009|Period 4|Withdrawal by Subject|0|||
170584746|NCT06003777|616481282|FG010|Period 4|Withdrawal by Subject|0|||
170584747|NCT06003777|616481283|FG011|Period 4|Withdrawal by Subject|0|||
170584748|NCT00690430|616481284|FG000|Core Phase|Abnormal Laboratory value|0|||
170584749|NCT00690430|616481285|FG001|Core Phase|Abnormal Laboratory value|1|||
170584750|NCT00690430|616481286|FG002|Core Phase|Abnormal Laboratory value|0|||
170584751|NCT00690430|616481284|FG000|Core Phase|Adverse Event|5|||
170584752|NCT00690430|616481285|FG001|Core Phase|Adverse Event|1|||
170584753|NCT00690430|616481286|FG002|Core Phase|Adverse Event|0|||
170584754|NCT00690430|616481284|FG000|Core Phase|Death|0|||
170584755|NCT00690430|616481285|FG001|Core Phase|Death|2|||
170584756|NCT00690430|616481286|FG002|Core Phase|Death|0|||
170584757|NCT00690430|616481284|FG000|Core Phase|Protocol Violation|1|||
170584758|NCT00690430|616481285|FG001|Core Phase|Protocol Violation|0|||
170584759|NCT00690430|616481286|FG002|Core Phase|Protocol Violation|0|||
170584760|NCT00690430|616481284|FG000|Core Phase|Withdrawal by Subject|3|||
170584761|NCT00690430|616481285|FG001|Core Phase|Withdrawal by Subject|3|||
170584762|NCT00690430|616481286|FG002|Core Phase|Withdrawal by Subject|0|||
170584763|NCT00690430|616481284|FG000|Core Phase|Subject no longer requires study drug|1|||
170584764|NCT00690430|616481285|FG001|Core Phase|Subject no longer requires study drug|0|||
170584765|NCT00690430|616481286|FG002|Core Phase|Subject no longer requires study drug|0|||
170584766|NCT00690430|616481284|FG000|Core Phase|Lack of Efficacy|8|||
170584767|NCT00690430|616481285|FG001|Core Phase|Lack of Efficacy|10|||
170584768|NCT00690430|616481286|FG002|Core Phase|Lack of Efficacy|0|||
170584769|NCT00690430|616481284|FG000|Core Phase|Administrative Problems|0|||
170584770|NCT00690430|616481285|FG001|Core Phase|Administrative Problems|1|||
170584771|NCT00690430|616481286|FG002|Core Phase|Administrative Problems|0|||
170584772|NCT00690430|616481284|FG000|Core Phase|Early Termination|0|||
170584773|NCT00690430|616481285|FG001|Core Phase|Early Termination|5|||
170584774|NCT00690430|616481286|FG002|Core Phase|Early Termination|0|||
170584775|NCT00690430|616481284|FG000|Extension Phase|Lack of Efficacy|3|||
170584776|NCT00690430|616481285|FG001|Extension Phase|Lack of Efficacy|1|||
170584777|NCT00690430|616481286|FG002|Extension Phase|Lack of Efficacy|4|||
170584778|NCT00690430|616481284|FG000|Extension Phase|Abnormal Lab Values|1|||
170584779|NCT00690430|616481285|FG001|Extension Phase|Abnormal Lab Values|0|||
170584780|NCT00690430|616481286|FG002|Extension Phase|Abnormal Lab Values|0|||
170584781|NCT00690430|616481284|FG000|Extension Phase|Abnormal test procedure results|1|||
170584782|NCT00690430|616481285|FG001|Extension Phase|Abnormal test procedure results|0|||
170584783|NCT00690430|616481286|FG002|Extension Phase|Abnormal test procedure results|0|||
170584784|NCT00690430|616481284|FG000|Extension Phase|Administrative Problems|0|||
170584785|NCT00690430|616481285|FG001|Extension Phase|Administrative Problems|1|||
170584786|NCT00690430|616481286|FG002|Extension Phase|Administrative Problems|1|||
170809792|NCT01947491|617313810|FG003|Overall Study|Withdrawal by Subject|0|||
170809793|NCT01947491|617313807|FG000|Overall Study|Worsening of condition|0|||
170809794|NCT01947491|617313808|FG001|Overall Study|Worsening of condition|1|||
170584787|NCT00690430|616481284|FG000|Extension Phase|Adverse Event|2|||
170584788|NCT00690430|616481285|FG001|Extension Phase|Adverse Event|1|||
170584789|NCT00690430|616481286|FG002|Extension Phase|Adverse Event|2|||
170584790|NCT00690430|616481284|FG000|Extension Phase|Death|1|||
170584791|NCT00690430|616481285|FG001|Extension Phase|Death|1|||
170584792|NCT00690430|616481286|FG002|Extension Phase|Death|1|||
170584793|NCT00690430|616481284|FG000|Extension Phase|Withdrawal by Subject|0|||
170584794|NCT00690430|616481285|FG001|Extension Phase|Withdrawal by Subject|0|||
170584795|NCT00690430|616481286|FG002|Extension Phase|Withdrawal by Subject|2|||
170584796|NCT00690430|616481284|FG000|Extension Phase|Early Termination|10|||
170584797|NCT00690430|616481285|FG001|Extension Phase|Early Termination|1|||
170584798|NCT00690430|616481286|FG002|Extension Phase|Early Termination|3|||
170584799|NCT01721486|616481295|FG000|Overall Study|Protocol Violation|1|||
170584800|NCT01721486|616481296|FG001|Overall Study|Protocol Violation|0|||
170584801|NCT01721486|616481295|FG000|Overall Study|Physician Decision|0|||
170584802|NCT01721486|616481296|FG001|Overall Study|Physician Decision|1|||
170584803|NCT00582712|616481297|FG000|Overall Study|Adverse Event|1|||
170584804|NCT00582712|616481297|FG000|Overall Study|Lack of Efficacy|1|||
170584805|NCT00582712|616481297|FG000|Overall Study|Withdrawal by Subject|1|||
170584806|NCT00582712|616481297|FG000|Overall Study|Complicating disease requiring treatment|1|||
170584807|NCT00613327|616481301|FG000|Overall Study|Adverse Event|38|||
170584808|NCT00613327|616481301|FG000|Overall Study|Lost to Follow-up|8|||
170584809|NCT00613327|616481301|FG000|Overall Study|Withdrawal by Subject|6|||
170584810|NCT00613327|616481301|FG000|Overall Study|Protocol Violation|2|||
170584811|NCT00613327|616481301|FG000|Overall Study|Other|47|||
170649987|NCT02496676|616732770|FG000|Phase 1 - Period 1|Adverse Event|0|||
170649988|NCT02496676|616732771|FG001|Phase 1 - Period 1|Adverse Event|1|||
170649989|NCT02496676|616732770|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
170584812|NCT00344318|616481302|FG000|Overall Study|Adverse Event|0|||
170584813|NCT00344318|616481303|FG001|Overall Study|Adverse Event|3|||
170584814|NCT00344318|616481304|FG002|Overall Study|Adverse Event|0|||
170584815|NCT00344318|616481305|FG003|Overall Study|Adverse Event|1|||
170584816|NCT00344318|616481302|FG000|Overall Study|Withdrawal by Subject|2|||
170584817|NCT00344318|616481303|FG001|Overall Study|Withdrawal by Subject|2|||
170584818|NCT00344318|616481304|FG002|Overall Study|Withdrawal by Subject|0|||
170584819|NCT00344318|616481305|FG003|Overall Study|Withdrawal by Subject|2|||
170584820|NCT00344318|616481302|FG000|Overall Study|Lost to Follow-up|2|||
170584821|NCT00344318|616481303|FG001|Overall Study|Lost to Follow-up|0|||
170584822|NCT00344318|616481304|FG002|Overall Study|Lost to Follow-up|1|||
170584823|NCT00344318|616481305|FG003|Overall Study|Lost to Follow-up|0|||
170584824|NCT00700882|616481311|FG000|Overall Study|Never received treatment|6|||
170584825|NCT00700882|616481311|FG000|Overall Study|Ineligible|2|||
170584826|NCT00700882|616481311|FG000|Overall Study|No KIT mutation|51|||
170584827|NCT01606176|616481312|FG000|Overall Study|Adverse Event|2|||
170584828|NCT01606176|616481313|FG001|Overall Study|Adverse Event|3|||
170584829|NCT01606176|616481312|FG000|Overall Study|Disease progression|1|||
170584830|NCT01606176|616481313|FG001|Overall Study|Disease progression|0|||
170584831|NCT01606176|616481312|FG000|Overall Study|Withdrawal by Subject|1|||
170584832|NCT01606176|616481313|FG001|Overall Study|Withdrawal by Subject|0|||
170584833|NCT01262560|616481314|FG000|Overall Study|Protocol Violation|0|||
170584834|NCT01262560|616481315|FG001|Overall Study|Protocol Violation|1|||
170584835|NCT01262560|616481316|FG002|Overall Study|Protocol Violation|2|||
170584836|NCT01932372|616481317|FG000|Overall Study|Not meeting eligibility criteria|33|||
170584837|NCT01932372|616481318|FG001|Overall Study|Not meeting eligibility criteria|179|||
170584838|NCT03194568|616481319|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
170584839|NCT05285644|616481322|FG000|Overall Study|Adverse Event|3|||
170584840|NCT05285644|616481323|FG001|Overall Study|Adverse Event|3|||
170584841|NCT05285644|616481322|FG000|Overall Study|Withdrawal of Consent|2|||
170584842|NCT05285644|616481323|FG001|Overall Study|Withdrawal of Consent|5|||
170649990|NCT02496676|616732771|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
170649991|NCT00420641|616732772|FG000|Overall Study|Adverse Event|3|||
170649992|NCT00420641|616732773|FG001|Overall Study|Adverse Event|25|||
170649993|NCT00420641|616732774|FG002|Overall Study|Adverse Event|10|||
170649994|NCT00420641|616732772|FG000|Overall Study|Lost to Follow-up|2|||
170584843|NCT05285644|616481322|FG000|Overall Study|Noncompliance|0|||
170584844|NCT05285644|616481323|FG001|Overall Study|Noncompliance|4|||
170584845|NCT05285644|616481322|FG000|Overall Study|Lost to Follow-up|4|||
170584846|NCT05285644|616481323|FG001|Overall Study|Lost to Follow-up|6|||
170649995|NCT00420641|616732773|FG001|Overall Study|Lost to Follow-up|4|||
170649996|NCT00420641|616732774|FG002|Overall Study|Lost to Follow-up|2|||
170649997|NCT00420641|616732772|FG000|Overall Study|Protocol Violation|8|||
170584847|NCT05285644|616481322|FG000|Overall Study|Disallowed Concurrent Medication|1|||
170584848|NCT05285644|616481323|FG001|Overall Study|Disallowed Concurrent Medication|1|||
170584849|NCT05285644|616481322|FG000|Overall Study|Investigator Decision|2|||
170584850|NCT05285644|616481323|FG001|Overall Study|Investigator Decision|0|||
170584851|NCT05285644|616481322|FG000|Overall Study|Protocol Deviation|1|||
170584852|NCT05285644|616481323|FG001|Overall Study|Protocol Deviation|0|||
170584853|NCT05285644|616481322|FG000|Overall Study|As specified in the Clinical Study Report|7|||
170584854|NCT05285644|616481323|FG001|Overall Study|As specified in the Clinical Study Report|3|||
170584855|NCT00920387|616481326|FG000|Stage 1|Adverse Event|1|||
170649998|NCT00420641|616732773|FG001|Overall Study|Protocol Violation|8|||
170649999|NCT00420641|616732774|FG002|Overall Study|Protocol Violation|7|||
170650000|NCT00420641|616732772|FG000|Overall Study|Withdrawal by Subject|15|||
170584856|NCT00920387|616481327|FG001|Stage 1|Adverse Event|0|||
170584857|NCT00920387|616481328|FG002|Stage 1|Adverse Event|0|||
170584858|NCT00349349|616481331|FG000|Overall Study|Adverse Event|5|||
170584859|NCT00349349|616481332|FG001|Overall Study|Adverse Event|6|||
170584860|NCT00349349|616481333|FG002|Overall Study|Adverse Event|2|||
170584861|NCT00349349|616481331|FG000|Overall Study|Withdrawal by Subject|5|||
170584862|NCT00349349|616481332|FG001|Overall Study|Withdrawal by Subject|2|||
170584863|NCT00349349|616481333|FG002|Overall Study|Withdrawal by Subject|1|||
170584864|NCT00349349|616481331|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
170584865|NCT00349349|616481332|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
170584866|NCT00349349|616481333|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
170584867|NCT00349349|616481331|FG000|Overall Study|Death|13|||
170584868|NCT00349349|616481332|FG001|Overall Study|Death|10|||
170584869|NCT00349349|616481333|FG002|Overall Study|Death|1|||
170584870|NCT00349349|616481331|FG000|Overall Study|Other Treatment Selected|2|||
170584871|NCT00349349|616481332|FG001|Overall Study|Other Treatment Selected|0|||
170584872|NCT00349349|616481333|FG002|Overall Study|Other Treatment Selected|0|||
170584873|NCT00349349|616481331|FG000|Overall Study|Participant Reduced General Condition|0|||
170584874|NCT00349349|616481332|FG001|Overall Study|Participant Reduced General Condition|1|||
170584875|NCT00349349|616481333|FG002|Overall Study|Participant Reduced General Condition|0|||
170584876|NCT00349349|616481331|FG000|Overall Study|Physician Decision|1|||
170584877|NCT00349349|616481332|FG001|Overall Study|Physician Decision|2|||
170584878|NCT00349349|616481333|FG002|Overall Study|Physician Decision|1|||
170584879|NCT00349349|616481331|FG000|Overall Study|No Response|0|||
170584880|NCT00349349|616481332|FG001|Overall Study|No Response|3|||
170584881|NCT00349349|616481333|FG002|Overall Study|No Response|0|||
170584882|NCT00349349|616481331|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
170584883|NCT00349349|616481332|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
170584884|NCT00349349|616481333|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
170584885|NCT02095873|616481334|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
170584886|NCT02095873|616481335|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
170584887|NCT02095873|616481334|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
170584888|NCT02095873|616481335|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
170584889|NCT02095873|616481334|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
170584890|NCT02095873|616481335|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
170584891|NCT00792740|616481337|FG000|Overall Study|Disease Worsening|3|||
170584892|NCT00792740|616481338|FG001|Overall Study|Disease Worsening|2|||
170584893|NCT00792740|616481337|FG000|Overall Study|Personal Reason|1|||
170584894|NCT00792740|616481338|FG001|Overall Study|Personal Reason|0|||
170584895|NCT00792740|616481337|FG000|Overall Study|Adverse Event|1|||
170584896|NCT00792740|616481338|FG001|Overall Study|Adverse Event|3|||
170584897|NCT00792740|616481337|FG000|Overall Study|Patient's withdrawal of consent|0|||
170584898|NCT00792740|616481338|FG001|Overall Study|Patient's withdrawal of consent|1|||
170584899|NCT00792740|616481337|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
170584900|NCT00792740|616481338|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
170584901|NCT00792740|616481337|FG000|Overall Study|Other reasons|0|||
170584902|NCT00792740|616481338|FG001|Overall Study|Other reasons|1|||
170584903|NCT02485639|616481339|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
170584904|NCT02485639|616481339|FG000|Overall Study|Early termination|4|||
170584905|NCT02485639|616481339|FG000|Overall Study|Withdrawal by Subject|4|||
170584906|NCT02524275|616481340|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
170584907|NCT02316353|616481343|FG000|Overall Study|Pregnancy|1|||
170584908|NCT02316353|616481344|FG001|Overall Study|Pregnancy|3|||
170584909|NCT02316353|616481343|FG000|Overall Study|Adverse Event|1|||
170584910|NCT02316353|616481344|FG001|Overall Study|Adverse Event|3|||
170584911|NCT02316353|616481343|FG000|Overall Study|Withdrawal by Subject|6|||
170584912|NCT02316353|616481344|FG001|Overall Study|Withdrawal by Subject|2|||
170584913|NCT01263015|616482550|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
170584914|NCT01263015|616482551|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
170584915|NCT01263015|616482550|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
170584916|NCT01263015|616482551|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
170584917|NCT01263015|616482550|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
170584918|NCT01263015|616482551|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
170584919|NCT01263015|616482550|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
170584920|NCT01263015|616482551|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
170584921|NCT01263015|616482550|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
170584922|NCT01263015|616482551|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
170584923|NCT01263015|616482550|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
170584924|NCT01263015|616482551|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
170584925|NCT01263015|616482550|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
170584926|NCT01263015|616482551|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
170584927|NCT01263015|616482550|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
170584928|NCT01263015|616482551|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
170584929|NCT01263015|616482550|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
170584930|NCT01263015|616482551|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
170584931|NCT01263015|616482550|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
170584932|NCT01263015|616482551|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
170584933|NCT01263015|616482550|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
170584934|NCT01263015|616482551|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
170910725|NCT00401973|617677248|FG000|Overall Study|Protocol Violation|1|||
170910726|NCT00401973|617677249|FG001|Overall Study|Protocol Violation|2|||
170910727|NCT00401973|617677250|FG002|Overall Study|Protocol Violation|3|||
170910728|NCT00401973|617677248|FG000|Overall Study|Sponsor Decision|0|||
170910729|NCT00401973|617677249|FG001|Overall Study|Sponsor Decision|1|||
170910730|NCT00401973|617677250|FG002|Overall Study|Sponsor Decision|0|||
170910731|NCT00401973|617677248|FG000|Overall Study|Withdrawal by Subject|4|||
170910732|NCT00401973|617677249|FG001|Overall Study|Withdrawal by Subject|12|||
170910733|NCT00401973|617677250|FG002|Overall Study|Withdrawal by Subject|9|||
170910734|NCT01357239|617677252|FG000|Stratum: All Patients|Adverse Event|0|||
170910735|NCT01357239|617677253|FG001|Stratum: All Patients|Adverse Event|0|||
170910736|NCT01357239|617677254|FG002|Stratum: All Patients|Adverse Event|1|||
170584935|NCT01263015|616482550|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
170584936|NCT01263015|616482551|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
170584937|NCT05599451|616482552|FG000|Overall Study|Not randomized|11|||
170584938|NCT05599451|616482553|FG001|Overall Study|Not randomized|0|||
170584939|NCT05599451|616482554|FG002|Overall Study|Not randomized|0|||
170584940|NCT05599451|616482555|FG003|Overall Study|Not randomized|0|||
170584941|NCT05599451|616482556|FG004|Overall Study|Not randomized|0|||
170584942|NCT05599451|616482552|FG000|Overall Study|Physician Decision|0|||
170584943|NCT05599451|616482553|FG001|Overall Study|Physician Decision|0|||
170584944|NCT05599451|616482554|FG002|Overall Study|Physician Decision|0|||
170584945|NCT05599451|616482555|FG003|Overall Study|Physician Decision|1|||
170584946|NCT05599451|616482556|FG004|Overall Study|Physician Decision|0|||
170584947|NCT02723006|616482557|FG000|Overall Study|Withdrawal by Subject|0|||
170584948|NCT02723006|616482558|FG001|Overall Study|Withdrawal by Subject|1|||
170584949|NCT02723006|616482559|FG002|Overall Study|Withdrawal by Subject|1|||
170584950|NCT02723006|616482557|FG000|Overall Study|Study Terminated by Sponsor|1|||
170584951|NCT02723006|616482558|FG001|Overall Study|Study Terminated by Sponsor|6|||
170584952|NCT02723006|616482559|FG002|Overall Study|Study Terminated by Sponsor|6|||
170584953|NCT00882583|616482560|FG000|Overall Study|Physician Decision|1|||
170584954|NCT00882583|616482561|FG001|Overall Study|Physician Decision|0|||
170584955|NCT00882583|616482560|FG000|Overall Study|Adverse Event|0|||
170584956|NCT00882583|616482561|FG001|Overall Study|Adverse Event|1|||
170910737|NCT01357239|617677255|FG003|Stratum: All Patients|Adverse Event|1|||
170584957|NCT00983515|616482562|FG000|Ritonavir Alone|liver panel out of range|6|||
170584958|NCT00983515|616482562|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
170584959|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Adverse Event|76|||
170584960|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Adverse Event|0|||
170910738|NCT01357239|617677252|FG000|Stratum: All Patients|Subject withdrew consent|0|||
170910739|NCT01357239|617677253|FG001|Stratum: All Patients|Subject withdrew consent|0|||
170910740|NCT01357239|617677254|FG002|Stratum: All Patients|Subject withdrew consent|1|||
170910741|NCT01357239|617677255|FG003|Stratum: All Patients|Subject withdrew consent|1|||
170584961|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Adverse Event|0|||
170584962|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Death|3|||
170584963|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Death|0|||
170584964|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Death|0|||
170584965|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
170584966|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
170584967|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
170584968|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Physician Decision|9|||
170584969|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Physician Decision|0|||
170584970|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Physician Decision|0|||
170584971|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
170584972|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
170584973|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
170584974|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Disease progression|45|||
170584975|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Disease progression|0|||
170584976|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Disease progression|0|||
170584977|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
170584978|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
170584979|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
170584980|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
170910742|NCT01357239|617677252|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
170910743|NCT01357239|617677253|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
170910744|NCT01357239|617677254|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
170910745|NCT01357239|617677255|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
170584981|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
170584982|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
170584983|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
170584984|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
170584985|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
170584986|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
170584987|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
170584988|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
170584989|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
170584990|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
170584991|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
170584992|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
170584993|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
170584994|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
170584995|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
170584996|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
170584997|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
170584998|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
170584999|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
170585000|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
170585001|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
170585002|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
170585003|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
170585004|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Promotor request|1|||
170585005|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Promotor request|0|||
170585006|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Promotor request|0|||
170585007|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
170585008|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
170585009|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
170585010|NCT01461928|616482563|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
170585011|NCT01461928|616482564|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
170585012|NCT01461928|616482565|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
170585013|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Death|3|||
170585014|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Death|0|||
170585015|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Death|0|||
170585016|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
170585017|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
170585018|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
170585019|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
170585020|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
170585021|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
170585022|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Diseases progression|91|||
170585023|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Diseases progression|0|||
170585024|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Diseases progression|0|||
170585025|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Adverse Event|70|||
170585026|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Adverse Event|0|||
170585027|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Adverse Event|0|||
170585028|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Physician Decision|9|||
170585029|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Physician Decision|0|||
170585030|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Physician Decision|0|||
170585031|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
170585032|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
170585033|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
170585034|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
170585035|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
170585036|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
170585037|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
170585038|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
170585039|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
170585040|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Not compliant|1|||
170585041|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Not compliant|0|||
170585042|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Not compliant|0|||
170585043|NCT01461928|616482563|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
170585044|NCT01461928|616482564|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
170585045|NCT01461928|616482565|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
170585046|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Adverse Event|0|||
170585047|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Adverse Event|2|||
170809795|NCT01947491|617313809|FG002|Overall Study|Worsening of condition|0|||
170809796|NCT01947491|617313810|FG003|Overall Study|Worsening of condition|0|||
170809797|NCT01947491|617313807|FG000|Overall Study|Adverse Event|0|||
170809798|NCT01947491|617313808|FG001|Overall Study|Adverse Event|1|||
170809799|NCT01947491|617313809|FG002|Overall Study|Adverse Event|0|||
170809800|NCT01947491|617313810|FG003|Overall Study|Adverse Event|2|||
170809801|NCT02224755|617313811|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
170809802|NCT02224755|617313812|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
170809803|NCT02224755|617313811|FG000|Two Year Follow up Post-implant|Death|103|||
170809804|NCT02224755|617313812|FG001|Two Year Follow up Post-implant|Death|98|||
170809805|NCT02224755|617313811|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
170809806|NCT02224755|617313812|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
170809807|NCT02224755|617313811|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
170809808|NCT02224755|617313812|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
170809809|NCT02224755|617313811|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
170809810|NCT02224755|617313812|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
170809811|NCT02067663|617313813|FG000|Overall Study|Lost to Follow-up|13|||
170809812|NCT02067663|617313814|FG001|Overall Study|Lost to Follow-up|14|||
170809813|NCT02827201|617313815|FG000|Overall Study|Death|1|||
170809814|NCT02827201|617313816|FG001|Overall Study|Death|2|||
170809815|NCT02827201|617313815|FG000|Overall Study|Patients not treated|1|||
170809816|NCT02827201|617313816|FG001|Overall Study|Patients not treated|1|||
170809817|NCT04311983|617313817|FG000|Overall Study|Lost to Follow-up|421|||
170809818|NCT04311983|617313818|FG001|Overall Study|Lost to Follow-up|456|||
170809819|NCT04311983|617313817|FG000|Overall Study|Incomplete survey|7|||
170809820|NCT04311983|617313818|FG001|Overall Study|Incomplete survey|9|||
170809821|NCT04311983|617313817|FG000|Overall Study|Death|1|||
170809822|NCT04311983|617313818|FG001|Overall Study|Death|0|||
170809823|NCT00240994|617313819|FG000|Overall Study|Lost to Follow-up|1|||
170809824|NCT00240994|617313819|FG000|Overall Study|Protocol Violation|1|||
170809825|NCT00240994|617313819|FG000|Overall Study|Graft failure|1|||
170809826|NCT02630186|617313820|FG000|Overall Study|Withdrawal by Subject|1|||
170809827|NCT01205126|617313821|FG000|Titration Phase|Adverse Event|5|||
170809828|NCT01205126|617313822|FG001|Titration Phase|Adverse Event|3|||
170809829|NCT01205126|617313821|FG000|Titration Phase|Withdrawal by Subject|5|||
170809830|NCT01205126|617313822|FG001|Titration Phase|Withdrawal by Subject|5|||
170809831|NCT01205126|617313821|FG000|Titration Phase|Lost to Follow-up|2|||
170809832|NCT01205126|617313822|FG001|Titration Phase|Lost to Follow-up|2|||
170809833|NCT01205126|617313821|FG000|Titration Phase|No stable titration dose|1|||
170809834|NCT01205126|617313822|FG001|Titration Phase|No stable titration dose|0|||
170809835|NCT01205126|617313821|FG000|Titration Phase|More than maximum dosage required|2|||
170809836|NCT01205126|617313822|FG001|Titration Phase|More than maximum dosage required|3|||
170809837|NCT01205126|617313821|FG000|Titration Phase|Other|8|||
170809838|NCT01205126|617313822|FG001|Titration Phase|Other|6|||
170809839|NCT01205126|617313821|FG000|Between Titration & Maintenance Phase|Other|0|||
170809840|NCT01205126|617313822|FG001|Between Titration & Maintenance Phase|Other|4|||
170809841|NCT01205126|617313821|FG000|Maintenance Phase|Adverse Event|3|||
170809842|NCT01205126|617313822|FG001|Maintenance Phase|Adverse Event|7|||
170809843|NCT01205126|617313821|FG000|Maintenance Phase|Death|4|||
170809844|NCT01205126|617313822|FG001|Maintenance Phase|Death|4|||
170809845|NCT01205126|617313821|FG000|Maintenance Phase|More than the maximum dosage required|5|||
170809846|NCT01205126|617313822|FG001|Maintenance Phase|More than the maximum dosage required|5|||
170809847|NCT01205126|617313821|FG000|Maintenance Phase|Prohibited drugs used|1|||
170809848|NCT01205126|617313822|FG001|Maintenance Phase|Prohibited drugs used|0|||
170809849|NCT01205126|617313821|FG000|Maintenance Phase|Other|11|||
170809850|NCT01205126|617313822|FG001|Maintenance Phase|Other|8|||
170809851|NCT01205126|617313821|FG000|Maintenance Phase|Lost to Follow-up|5|||
170809852|NCT01205126|617313822|FG001|Maintenance Phase|Lost to Follow-up|5|||
170585048|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Adverse Event|0|||
170585049|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Death|0|||
170585050|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Death|10|||
170809853|NCT01205126|617313821|FG000|Maintenance Phase|Withdrawal by Subject|8|||
170809854|NCT01205126|617313822|FG001|Maintenance Phase|Withdrawal by Subject|11|||
170809855|NCT03316170|617313830|FG000|Overall Study|Death|1|||
170809856|NCT03316170|617313831|FG001|Overall Study|Death|0|||
170809857|NCT03316170|617313830|FG000|Overall Study|Lost to Follow-up|6|||
170809858|NCT03316170|617313831|FG001|Overall Study|Lost to Follow-up|7|||
170809859|NCT02935673|617313832|FG000|Overall Study|Adverse Event|0|||
170809860|NCT02935673|617313833|FG001|Overall Study|Adverse Event|1|||
170809861|NCT02935673|617313834|FG002|Overall Study|Adverse Event|0|||
170809862|NCT02935673|617313832|FG000|Overall Study|Withdrawal by Subject|1|||
170809863|NCT02935673|617313833|FG001|Overall Study|Withdrawal by Subject|2|||
170809864|NCT02935673|617313834|FG002|Overall Study|Withdrawal by Subject|0|||
170809865|NCT04070105|617313835|FG000|Overall Study|Lost to Follow-up|0|||
170809866|NCT04070105|617313836|FG001|Overall Study|Lost to Follow-up|0|||
170809867|NCT04070105|617313837|FG002|Overall Study|Lost to Follow-up|0|||
170809868|NCT04070105|617313838|FG003|Overall Study|Lost to Follow-up|0|||
170585051|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Death|8|||
170585052|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Physician Decision|0|||
170585053|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Physician Decision|0|||
170585054|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Physician Decision|4|||
170585055|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
170585056|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
170585057|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
170585058|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Moved to another town|0|||
170585059|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Moved to another town|1|||
170585060|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Moved to another town|0|||
170585061|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Disease progression|0|||
170585062|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Disease progression|0|||
170585063|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Disease progression|3|||
170585064|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
170585065|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
170585066|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
170585067|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
170585068|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
170585069|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
170585070|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
170585071|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
170585072|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
170585073|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
170585074|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
170585075|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
170585076|NCT01461928|616482563|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
170585077|NCT01461928|616482564|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
170585078|NCT01461928|616482565|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
170585079|NCT01962987|616482569|FG000|Overall Study|Adverse Event|4|||
170585080|NCT01962987|616482570|FG001|Overall Study|Adverse Event|4|||
170585081|NCT01962987|616482571|FG002|Overall Study|Adverse Event|0|||
170585082|NCT01962987|616482569|FG000|Overall Study|Lost to Follow-up|0|||
170585083|NCT01962987|616482570|FG001|Overall Study|Lost to Follow-up|0|||
170585084|NCT01962987|616482571|FG002|Overall Study|Lost to Follow-up|1|||
170585085|NCT01962987|616482569|FG000|Overall Study|Non compliance with dosing requirements|4|||
170585086|NCT01962987|616482570|FG001|Overall Study|Non compliance with dosing requirements|2|||
170585087|NCT01962987|616482571|FG002|Overall Study|Non compliance with dosing requirements|0|||
170585088|NCT01962987|616482569|FG000|Overall Study|Miscellaneous|1|||
170585089|NCT01962987|616482570|FG001|Overall Study|Miscellaneous|9|||
170585090|NCT01962987|616482571|FG002|Overall Study|Miscellaneous|2|||
170585091|NCT01962987|616482569|FG000|Overall Study|Restricted medication|5|||
170585092|NCT01962987|616482570|FG001|Overall Study|Restricted medication|1|||
170585093|NCT01962987|616482571|FG002|Overall Study|Restricted medication|1|||
170585094|NCT01962987|616482569|FG000|Overall Study|Serious Adverse Event|1|||
170585095|NCT01962987|616482570|FG001|Overall Study|Serious Adverse Event|0|||
170585096|NCT01962987|616482571|FG002|Overall Study|Serious Adverse Event|0|||
170585097|NCT01962987|616482569|FG000|Overall Study|Withdrawal by Subject|11|||
170585098|NCT01962987|616482570|FG001|Overall Study|Withdrawal by Subject|10|||
170585099|NCT01962987|616482571|FG002|Overall Study|Withdrawal by Subject|6|||
170585100|NCT01962987|616482569|FG000|Overall Study|Randomized in Error|4|||
170585101|NCT01962987|616482570|FG001|Overall Study|Randomized in Error|2|||
170809869|NCT04070105|617313839|FG004|Overall Study|Lost to Follow-up|0|||
170809870|NCT04070105|617313840|FG005|Overall Study|Lost to Follow-up|1|||
170809871|NCT00923078|617313846|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
170585102|NCT01962987|616482571|FG002|Overall Study|Randomized in Error|2|||
170585103|NCT01606787|616482577|FG000|Overall Study|Withdrawal by Subject|4|||
170585104|NCT01606787|616482578|FG001|Overall Study|Withdrawal by Subject|5|||
170585105|NCT01606787|616482577|FG000|Overall Study|Surgery canceled|0|||
170585106|NCT01606787|616482578|FG001|Overall Study|Surgery canceled|2|||
170585107|NCT01814878|616482579|FG000|Overall Study|Adverse Event|16|||
170585108|NCT01814878|616482580|FG001|Overall Study|Adverse Event|5|||
170585109|NCT01814878|616482579|FG000|Overall Study|Withdrawal by Subject|20|||
170585110|NCT01814878|616482580|FG001|Overall Study|Withdrawal by Subject|16|||
170585111|NCT01814878|616482579|FG000|Overall Study|Protocol Violation|5|||
170585112|NCT01814878|616482580|FG001|Overall Study|Protocol Violation|5|||
170585113|NCT01814878|616482579|FG000|Overall Study|Physician Decision|3|||
170585114|NCT01814878|616482580|FG001|Overall Study|Physician Decision|1|||
170585115|NCT01814878|616482579|FG000|Overall Study|Screening failure (drop-out)|0|||
170585116|NCT01814878|616482580|FG001|Overall Study|Screening failure (drop-out)|3|||
170585117|NCT01814878|616482579|FG000|Overall Study|Other|2|||
170585118|NCT01814878|616482580|FG001|Overall Study|Other|0|||
170585119|NCT02379221|616482581|FG000|Overall Study|Lost to Follow-up|1|||
170585120|NCT03764631|616482584|FG000|Overall Study|Personal Reasons|3|||
170585121|NCT03764631|616482585|FG001|Overall Study|Personal Reasons|2|||
170585122|NCT03764631|616482584|FG000|Overall Study|Switching Therapy|3|||
170585123|NCT03764631|616482585|FG001|Overall Study|Switching Therapy|3|||
170585124|NCT03764631|616482584|FG000|Overall Study|Adverse Event|0|||
170585125|NCT03764631|616482585|FG001|Overall Study|Adverse Event|1|||
170585126|NCT03764631|616482584|FG000|Overall Study|Lost to Follow-up|33|||
170585127|NCT03764631|616482585|FG001|Overall Study|Lost to Follow-up|41|||
170585128|NCT03764631|616482584|FG000|Overall Study|No data as study site was closed|2|||
170585129|NCT03764631|616482585|FG001|Overall Study|No data as study site was closed|6|||
170585130|NCT01289353|616482586|FG000|Overall Study|Lost to Follow-up|2|||
170585131|NCT03299881|616482587|FG000|Overall Study|Study Termination|17|||
170585132|NCT03299881|616482588|FG001|Overall Study|Study Termination|13|||
170585133|NCT04021524|616482594|FG000|Overall Study|Change in surgical intervention|0|||
170585134|NCT04021524|616482595|FG001|Overall Study|Change in surgical intervention|1|||
170585135|NCT04484649|616482596|FG000|Overall Study|Lost to Follow-up|2|||
170585136|NCT04484649|616482597|FG001|Overall Study|Lost to Follow-up|1|||
170585137|NCT04484649|616482596|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
170585138|NCT04484649|616482597|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
170585139|NCT02752633|616482599|FG000|Overall Study|Withdrawal by Subject|1|||
170585140|NCT03176472|616482602|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
170585141|NCT03176472|616482603|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
170585142|NCT03176472|616482602|FG000|Double Blind Treatment Period|Adverse Event|0|||
170585143|NCT03176472|616482603|FG001|Double Blind Treatment Period|Adverse Event|5|||
170585144|NCT03176472|616482602|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
170585145|NCT03176472|616482603|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
170585146|NCT03176472|616482602|FG000|Double Blind Treatment Period|Physician Decision|0|||
170585147|NCT03176472|616482603|FG001|Double Blind Treatment Period|Physician Decision|1|||
170585148|NCT03176472|616482602|FG000|Double Blind Treatment Period|Protocol Violation|1|||
170585149|NCT03176472|616482603|FG001|Double Blind Treatment Period|Protocol Violation|0|||
170585150|NCT03176472|616482602|FG000|Double Blind Treatment Period|Not Provided|1|||
170585151|NCT03176472|616482603|FG001|Double Blind Treatment Period|Not Provided|0|||
170585152|NCT03176472|616482602|FG000|Open Label Extension|Withdrawal by Subject|3|||
170585153|NCT03176472|616482603|FG001|Open Label Extension|Withdrawal by Subject|4|||
170585154|NCT03176472|616482602|FG000|Open Label Extension|Adverse Event|2|||
170585155|NCT03176472|616482603|FG001|Open Label Extension|Adverse Event|4|||
170585156|NCT03176472|616482602|FG000|Open Label Extension|Lost to Follow-up|1|||
170585157|NCT03176472|616482603|FG001|Open Label Extension|Lost to Follow-up|2|||
170585158|NCT03176472|616482602|FG000|Open Label Extension|Protocol Violation|0|||
170585159|NCT03176472|616482603|FG001|Open Label Extension|Protocol Violation|1|||
170650001|NCT00420641|616732773|FG001|Overall Study|Withdrawal by Subject|21|||
170650002|NCT00420641|616732774|FG002|Overall Study|Withdrawal by Subject|14|||
170809872|NCT00923078|617313847|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
170585160|NCT03176472|616482602|FG000|Open Label Extension|Not Provided|2|||
170585161|NCT03176472|616482603|FG001|Open Label Extension|Not Provided|1|||
170585162|NCT00596154|616482604|FG000|Overall Study|Not Evaluable|2|||
170585163|NCT01626118|616482605|FG000|Overall Study|Lack of Efficacy|1|||
170585164|NCT01626118|616482606|FG001|Overall Study|Lack of Efficacy|0|||
170585165|NCT01626118|616482607|FG002|Overall Study|Lack of Efficacy|1|||
170585166|NCT01626118|616482608|FG003|Overall Study|Lack of Efficacy|3|||
170585167|NCT01626118|616482605|FG000|Overall Study|Lost to Follow-up|1|||
170585168|NCT01626118|616482606|FG001|Overall Study|Lost to Follow-up|0|||
170585169|NCT01626118|616482607|FG002|Overall Study|Lost to Follow-up|0|||
170585170|NCT01626118|616482608|FG003|Overall Study|Lost to Follow-up|0|||
170585171|NCT01626118|616482605|FG000|Overall Study|Adverse Event|0|||
170585172|NCT01626118|616482606|FG001|Overall Study|Adverse Event|1|||
170585173|NCT01626118|616482607|FG002|Overall Study|Adverse Event|1|||
170585174|NCT01626118|616482608|FG003|Overall Study|Adverse Event|0|||
170585175|NCT01626118|616482605|FG000|Overall Study|Investigator Decision|0|||
170585176|NCT01626118|616482606|FG001|Overall Study|Investigator Decision|1|||
170585177|NCT01626118|616482607|FG002|Overall Study|Investigator Decision|0|||
170585178|NCT01626118|616482608|FG003|Overall Study|Investigator Decision|0|||
170585179|NCT00002540|616482609|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
170585180|NCT00002540|616482610|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
170585181|NCT00002540|616482609|FG000|Overall Study|Died Before Randomization|2|||
170585182|NCT00002540|616482610|FG001|Overall Study|Died Before Randomization|6|||
170585183|NCT00002540|616482609|FG000|Overall Study|Died Before ASU (Control)|202|||
170585184|NCT00002540|616482610|FG001|Overall Study|Died Before ASU (Control)|0|||
170585185|NCT00002540|616482609|FG000|Overall Study|Refused ASU (Control)|597|||
170585186|NCT00002540|616482610|FG001|Overall Study|Refused ASU (Control)|0|||
170585187|NCT00002540|616482609|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
170585188|NCT00002540|616482610|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
170585189|NCT04826094|616482611|FG000|Overall Study|Lost to Follow-up|2|||
170809873|NCT00923078|617313848|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
170585190|NCT04826094|616482612|FG001|Overall Study|Lost to Follow-up|1|||
170650003|NCT00420641|616732772|FG000|Overall Study|Lack of Efficacy|6|||
170585191|NCT04826094|616482613|FG002|Overall Study|Lost to Follow-up|0|||
170585192|NCT04826094|616482614|FG003|Overall Study|Lost to Follow-up|0|||
170585193|NCT04826094|616482615|FG004|Overall Study|Lost to Follow-up|1|||
170585194|NCT04826094|616482616|FG005|Overall Study|Lost to Follow-up|3|||
170585195|NCT04826094|616482617|FG006|Overall Study|Lost to Follow-up|1|||
170585196|NCT04826094|616482618|FG007|Overall Study|Lost to Follow-up|1|||
170585197|NCT04826094|616482611|FG000|Overall Study|Participant withdrew consent|1|||
170585198|NCT04826094|616482612|FG001|Overall Study|Participant withdrew consent|0|||
170585199|NCT04826094|616482613|FG002|Overall Study|Participant withdrew consent|0|||
170585200|NCT04826094|616482614|FG003|Overall Study|Participant withdrew consent|1|||
170585201|NCT04826094|616482615|FG004|Overall Study|Participant withdrew consent|1|||
170585202|NCT04826094|616482616|FG005|Overall Study|Participant withdrew consent|1|||
170585203|NCT04826094|616482617|FG006|Overall Study|Participant withdrew consent|0|||
170585204|NCT04826094|616482618|FG007|Overall Study|Participant withdrew consent|1|||
170585205|NCT04826094|616482611|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
170585206|NCT04826094|616482612|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
170585207|NCT04826094|616482613|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
170585208|NCT04826094|616482614|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
170585209|NCT04826094|616482615|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
170585210|NCT04826094|616482616|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
170585211|NCT04826094|616482617|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
170585212|NCT04826094|616482618|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
170585213|NCT04826094|616482611|FG000|Overall Study|Withdrawn by Investigator|0|||
170585214|NCT04826094|616482612|FG001|Overall Study|Withdrawn by Investigator|0|||
170585215|NCT04826094|616482613|FG002|Overall Study|Withdrawn by Investigator|0|||
170585216|NCT04826094|616482614|FG003|Overall Study|Withdrawn by Investigator|0|||
170585217|NCT04826094|616482615|FG004|Overall Study|Withdrawn by Investigator|0|||
170585218|NCT04826094|616482616|FG005|Overall Study|Withdrawn by Investigator|1|||
170585219|NCT04826094|616482617|FG006|Overall Study|Withdrawn by Investigator|0|||
170585220|NCT04826094|616482618|FG007|Overall Study|Withdrawn by Investigator|1|||
170585221|NCT04826094|616482611|FG000|Overall Study|Other: Moved from area|1|||
170585222|NCT04826094|616482612|FG001|Overall Study|Other: Moved from area|1|||
170585223|NCT04826094|616482613|FG002|Overall Study|Other: Moved from area|1|||
170585224|NCT04826094|616482614|FG003|Overall Study|Other: Moved from area|0|||
170585225|NCT04826094|616482615|FG004|Overall Study|Other: Moved from area|0|||
170585226|NCT04826094|616482616|FG005|Overall Study|Other: Moved from area|0|||
170585227|NCT04826094|616482617|FG006|Overall Study|Other: Moved from area|0|||
170585228|NCT04826094|616482618|FG007|Overall Study|Other: Moved from area|0|||
170585229|NCT04826094|616482611|FG000|Overall Study|Other: Declined|0|||
170585230|NCT04826094|616482612|FG001|Overall Study|Other: Declined|0|||
170585231|NCT04826094|616482613|FG002|Overall Study|Other: Declined|0|||
170585232|NCT04826094|616482614|FG003|Overall Study|Other: Declined|0|||
170585233|NCT04826094|616482615|FG004|Overall Study|Other: Declined|1|||
170585234|NCT04826094|616482616|FG005|Overall Study|Other: Declined|0|||
170585235|NCT04826094|616482617|FG006|Overall Study|Other: Declined|0|||
170585236|NCT04826094|616482618|FG007|Overall Study|Other: Declined|0|||
170585237|NCT04826094|616482611|FG000|Overall Study|Other: Vaccine not administered|0|||
170585238|NCT04826094|616482612|FG001|Overall Study|Other: Vaccine not administered|0|||
170585239|NCT04826094|616482613|FG002|Overall Study|Other: Vaccine not administered|1|||
170585240|NCT04826094|616482614|FG003|Overall Study|Other: Vaccine not administered|0|||
170585241|NCT04826094|616482615|FG004|Overall Study|Other: Vaccine not administered|0|||
170585242|NCT04826094|616482616|FG005|Overall Study|Other: Vaccine not administered|1|||
170585243|NCT04826094|616482617|FG006|Overall Study|Other: Vaccine not administered|1|||
170585244|NCT04826094|616482618|FG007|Overall Study|Other: Vaccine not administered|3|||
170585245|NCT03931382|616482619|FG000|Overall Study|Equipment malfunction|2|||
170585246|NCT03931382|616482620|FG001|Overall Study|Equipment malfunction|0|||
170585247|NCT03931382|616482621|FG002|Overall Study|Equipment malfunction|2|||
170585248|NCT03931382|616482619|FG000|Overall Study|Withdrawal by Subject|0|||
170585249|NCT03931382|616482620|FG001|Overall Study|Withdrawal by Subject|1|||
170585250|NCT03931382|616482621|FG002|Overall Study|Withdrawal by Subject|0|||
170585251|NCT02151903|616482622|FG000|Overall Study|Withdrawal by Subject|1|||
170585252|NCT02151903|616482623|FG001|Overall Study|Withdrawal by Subject|0|||
170585253|NCT02151903|616482622|FG000|Overall Study|Progressive disease|2|||
170585254|NCT02151903|616482623|FG001|Overall Study|Progressive disease|1|||
170585255|NCT01054560|616482624|FG000|Overall Study|Death|10|||
170585256|NCT01054560|616482625|FG001|Overall Study|Death|21|||
170585257|NCT01054560|616482624|FG000|Overall Study|Lost to Follow-up|2|||
170585258|NCT01054560|616482625|FG001|Overall Study|Lost to Follow-up|5|||
170585259|NCT01054560|616482624|FG000|Overall Study|Withdrawal by Subject|0|||
170585260|NCT01054560|616482625|FG001|Overall Study|Withdrawal by Subject|2|||
170585261|NCT01054560|616482624|FG000|Overall Study|Physician Decision|1|||
170585262|NCT01054560|616482625|FG001|Overall Study|Physician Decision|0|||
170585263|NCT01500252|616482626|FG000|Overall Study|Death|4|||
170585264|NCT01500252|616482627|FG001|Overall Study|Death|2|||
170585265|NCT01500252|616482626|FG000|Overall Study|Lost to Follow-up|5|||
170585266|NCT01500252|616482627|FG001|Overall Study|Lost to Follow-up|4|||
170585267|NCT03490292|616482628|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
170585268|NCT03490292|616482629|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
170585269|NCT03490292|616482628|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
170585270|NCT03490292|616482629|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
170585271|NCT03490292|616482628|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
170585272|NCT03490292|616482629|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
170585273|NCT03490292|616482628|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
170585274|NCT03490292|616482629|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
170585275|NCT03490292|616482628|FG000|1 Year Follow Up Post Last Dose|Death|1|||
170585276|NCT03490292|616482629|FG001|1 Year Follow Up Post Last Dose|Death|1|||
170585277|NCT01106651|616482630|FG000|Overall Study|Adverse Event|17|||
170585278|NCT01106651|616482631|FG001|Overall Study|Adverse Event|9|||
170585279|NCT01106651|616482632|FG002|Overall Study|Adverse Event|23|||
170585280|NCT01106651|616482630|FG000|Overall Study|Lost to Follow-up|8|||
170585281|NCT01106651|616482631|FG001|Overall Study|Lost to Follow-up|2|||
170585282|NCT01106651|616482632|FG002|Overall Study|Lost to Follow-up|6|||
170585283|NCT01106651|616482630|FG000|Overall Study|Physician Decision|4|||
170585284|NCT01106651|616482631|FG001|Overall Study|Physician Decision|3|||
170585285|NCT01106651|616482632|FG002|Overall Study|Physician Decision|1|||
170585286|NCT01106651|616482630|FG000|Overall Study|Protocol Violation|1|||
170585287|NCT01106651|616482631|FG001|Overall Study|Protocol Violation|2|||
170585288|NCT01106651|616482632|FG002|Overall Study|Protocol Violation|1|||
170585289|NCT01106651|616482630|FG000|Overall Study|Withdrawal by Subject|14|||
170585290|NCT01106651|616482631|FG001|Overall Study|Withdrawal by Subject|7|||
170585291|NCT01106651|616482632|FG002|Overall Study|Withdrawal by Subject|4|||
170585292|NCT01106651|616482630|FG000|Overall Study|Noncompliance with study drug|1|||
170585293|NCT01106651|616482631|FG001|Overall Study|Noncompliance with study drug|0|||
170585294|NCT01106651|616482632|FG002|Overall Study|Noncompliance with study drug|2|||
170585295|NCT01106651|616482630|FG000|Overall Study|Other|34|||
170585296|NCT01106651|616482631|FG001|Overall Study|Other|31|||
170585297|NCT01106651|616482632|FG002|Overall Study|Other|21|||
170585298|NCT01106651|616482630|FG000|Overall Study|Death|0|||
170585299|NCT01106651|616482631|FG001|Overall Study|Death|3|||
170585300|NCT01106651|616482632|FG002|Overall Study|Death|0|||
170585301|NCT02466425|616482636|FG000|Overall Study|Adverse Event|3|||
170585302|NCT02466425|616482637|FG001|Overall Study|Adverse Event|11|||
170585303|NCT02466425|616482636|FG000|Overall Study|Lack of Efficacy|4|||
170585304|NCT02466425|616482637|FG001|Overall Study|Lack of Efficacy|1|||
170585305|NCT02466425|616482636|FG000|Overall Study|Lost to Follow-up|3|||
170585306|NCT02466425|616482637|FG001|Overall Study|Lost to Follow-up|0|||
170585307|NCT02466425|616482636|FG000|Overall Study|Protocol Violation|1|||
170585308|NCT02466425|616482637|FG001|Overall Study|Protocol Violation|0|||
170585309|NCT02466425|616482636|FG000|Overall Study|Withdrawal by Subject|0|||
170585310|NCT02466425|616482637|FG001|Overall Study|Withdrawal by Subject|1|||
170585311|NCT02466425|616482636|FG000|Overall Study|Other|1|||
170585312|NCT02466425|616482637|FG001|Overall Study|Other|3|||
170585313|NCT02466425|616482636|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
170585314|NCT02466425|616482637|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170585315|NCT01901289|616482638|FG000|Overall Study|Death|32|||
170585316|NCT01901289|616482638|FG000|Overall Study|Lost to Follow-up|16|||
170585317|NCT01901289|616482638|FG000|Overall Study|Withdrawal by Subject|35|||
170585318|NCT01901289|616482638|FG000|Overall Study|Other type of endpoint met|2|||
170585319|NCT00889603|616482639|FG000|Overall Study|Adverse Event|7|||
170585320|NCT00889603|616482639|FG000|Overall Study|Death|3|||
170585321|NCT00889603|616482639|FG000|Overall Study|Lost to Follow-up|19|||
170585322|NCT00889603|616482639|FG000|Overall Study|No longer willing to participant in stud|4|||
170585323|NCT00889603|616482639|FG000|Overall Study|Other|4|||
170585324|NCT01208961|616482642|FG000|High-Fat Period III|Protocol Violation|1|||
170585325|NCT01208961|616482643|FG001|High-Fat Period III|Protocol Violation|0|||
170585326|NCT05427539|616482645|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
170585327|NCT05427539|616482646|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
170585328|NCT05427539|616482645|FG000|Period 1|Withdrawal by Subject|1|||
170585329|NCT05427539|616482646|FG001|Period 1|Withdrawal by Subject|0|||
170585330|NCT05129449|616482649|FG000|Overall Study|Protocol Violation|1|||
170585331|NCT04238481|616482654|FG000|Overall Study|Miscellaneous|0|||
170585332|NCT04238481|616482655|FG001|Overall Study|Miscellaneous|1|||
170585333|NCT04238481|616482656|FG002|Overall Study|Miscellaneous|0|||
170585334|NCT04238481|616482657|FG003|Overall Study|Miscellaneous|0|||
170585335|NCT02247011|616482658|FG000|Overall Study|Poor quality of radiological results|125|||
170585336|NCT02152371|616482660|FG000|Overall Study|Adverse Event|6|||
170585337|NCT02152371|616482661|FG001|Overall Study|Adverse Event|2|||
170585338|NCT02152371|616482660|FG000|Overall Study|Withdrawal by Subject|3|||
170585339|NCT02152371|616482661|FG001|Overall Study|Withdrawal by Subject|7|||
170585340|NCT02152371|616482660|FG000|Overall Study|Protocol Violation|2|||
170585341|NCT02152371|616482661|FG001|Overall Study|Protocol Violation|3|||
170585342|NCT02152371|616482660|FG000|Overall Study|Lost to Follow-up|1|||
170585343|NCT02152371|616482661|FG001|Overall Study|Lost to Follow-up|0|||
170585344|NCT02152371|616482660|FG000|Overall Study|Lack of Efficacy|0|||
170585345|NCT02152371|616482661|FG001|Overall Study|Lack of Efficacy|1|||
170585346|NCT02152371|616482660|FG000|Overall Study|Physician Decision|0|||
170585347|NCT02152371|616482661|FG001|Overall Study|Physician Decision|2|||
170585348|NCT02152371|616482660|FG000|Overall Study|Reason Not Given|0|||
170585349|NCT02152371|616482661|FG001|Overall Study|Reason Not Given|1|||
170585350|NCT00656058|616482663|FG000|Overall Study|Withdrawal by Subject|2|||
170585351|NCT00656058|616482663|FG000|Overall Study|Withdrawal by Subject|4|||
170585352|NCT02901054|616482664|FG000|Overall Study|Physician Decision|1|||
170585353|NCT02901054|616482664|FG000|Overall Study|Withdrawal by Subject|3|||
170585354|NCT02099344|616482666|FG000|Overall Study|Physician Decision|1|||
170585355|NCT02099344|616482667|FG001|Overall Study|Physician Decision|0|||
170585356|NCT00350870|616482668|FG000|Overall Study|Withdrawal by Subject|21|||
170585357|NCT00350870|616482669|FG001|Overall Study|Withdrawal by Subject|17|||
170585358|NCT00350870|616482670|FG002|Overall Study|Withdrawal by Subject|15|||
170585359|NCT00350870|616482671|FG003|Overall Study|Withdrawal by Subject|14|||
170585360|NCT00350870|616482668|FG000|Overall Study|Physician Decision|1|||
170585361|NCT00350870|616482669|FG001|Overall Study|Physician Decision|0|||
170585362|NCT00350870|616482670|FG002|Overall Study|Physician Decision|1|||
170585363|NCT00350870|616482671|FG003|Overall Study|Physician Decision|1|||
170585364|NCT02839720|616482672|FG000|Overall Study|Adverse Event|2|||
170585365|NCT02839720|616482672|FG000|Overall Study|Non-compliance|2|||
170585366|NCT02839720|616482672|FG000|Overall Study|Intercurrent Illness|1|||
170585367|NCT02839720|616482672|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
170585368|NCT00349921|616482673|FG000|First Spinal Injection|Physician Decision|1|||
170585369|NCT00349921|616482674|FG001|First Spinal Injection|Physician Decision|0|||
170585370|NCT00349921|616482675|FG002|First Spinal Injection|Physician Decision|0|||
170585371|NCT00349921|616482676|FG003|First Spinal Injection|Physician Decision|0|||
170585372|NCT00349921|616482673|FG000|First Spinal Injection|Adverse Event|0|||
170585373|NCT00349921|616482674|FG001|First Spinal Injection|Adverse Event|0|||
170585374|NCT00349921|616482675|FG002|First Spinal Injection|Adverse Event|1|||
170585375|NCT00349921|616482676|FG003|First Spinal Injection|Adverse Event|0|||
170585376|NCT01866111|616482679|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
170585377|NCT01866111|616482680|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
170585378|NCT01866111|616482681|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
170585379|NCT01866111|616482682|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
170585380|NCT01866111|616482679|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
170585381|NCT01866111|616482680|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
170585382|NCT01866111|616482681|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
170585383|NCT01866111|616482682|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
170585384|NCT01866111|616482679|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
170585385|NCT01866111|616482680|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
170585386|NCT01866111|616482681|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
170585387|NCT01866111|616482682|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
170585388|NCT01866111|616482679|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
170585389|NCT01866111|616482680|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
170585390|NCT01866111|616482681|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
170585391|NCT01866111|616482682|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
170585392|NCT01866111|616482679|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
170585393|NCT01866111|616482680|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
170585394|NCT01866111|616482681|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
170809874|NCT00923078|617313846|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
170585395|NCT01866111|616482682|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
170585396|NCT01866111|616482679|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
170585397|NCT01866111|616482680|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
170585398|NCT01866111|616482681|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
170585399|NCT01866111|616482682|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
170585400|NCT01866111|616482679|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
170585401|NCT01866111|616482680|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
170585402|NCT01866111|616482681|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
170585403|NCT01866111|616482682|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
170585404|NCT01866111|616482679|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
170585405|NCT01866111|616482680|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
170585406|NCT01866111|616482681|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
170585407|NCT01866111|616482682|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
170585408|NCT01866111|616482679|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
170585409|NCT01866111|616482680|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
170809875|NCT00923078|617313847|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
170809876|NCT00923078|617313848|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
170585410|NCT01866111|616482681|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
170585411|NCT01866111|616482682|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
170585412|NCT01866111|616482679|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
170585413|NCT01866111|616482680|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
170585414|NCT01866111|616482681|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
170585415|NCT01866111|616482682|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
170585416|NCT01866111|616482679|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
170585417|NCT01866111|616482680|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
170585418|NCT01866111|616482681|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
170585419|NCT01866111|616482682|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
170585420|NCT01866111|616482679|FG000|Open-label Extension Study YKP3089C017|Death|1|||
170585421|NCT01866111|616482680|FG001|Open-label Extension Study YKP3089C017|Death|1|||
170585422|NCT01866111|616482681|FG002|Open-label Extension Study YKP3089C017|Death|3|||
170585423|NCT01866111|616482682|FG003|Open-label Extension Study YKP3089C017|Death|2|||
170585424|NCT01866111|616482679|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
170585425|NCT01866111|616482680|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
170585426|NCT01866111|616482681|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
170585427|NCT01866111|616482682|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
170585428|NCT01866111|616482679|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
170585429|NCT01866111|616482680|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
170585430|NCT01866111|616482681|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
170585431|NCT01866111|616482682|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
170585432|NCT01866111|616482679|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
170585433|NCT01866111|616482680|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
170585434|NCT01866111|616482681|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
170585435|NCT01866111|616482682|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
170585436|NCT06099223|616482683|FG000|Overall Study|Preoperative surveys missed|0|||
170585437|NCT06099223|616482684|FG001|Overall Study|Preoperative surveys missed|1|||
170585438|NCT01802580|616482685|FG000|Overall Study|Physician Decision|1|||
170585439|NCT01802580|616482686|FG001|Overall Study|Physician Decision|0|||
170585440|NCT01802580|616482685|FG000|Overall Study|Protocol Violation|2|||
170585441|NCT01802580|616482686|FG001|Overall Study|Protocol Violation|0|||
170585442|NCT01802580|616482685|FG000|Overall Study|Withdrawal by Subject|5|||
170585443|NCT01802580|616482686|FG001|Overall Study|Withdrawal by Subject|6|||
170585444|NCT01802580|616482685|FG000|Overall Study|Other|1|||
170585445|NCT01802580|616482686|FG001|Overall Study|Other|3|||
170585446|NCT01802580|616482685|FG000|Overall Study|Lack of Efficacy|0|||
170585447|NCT01802580|616482686|FG001|Overall Study|Lack of Efficacy|2|||
170585448|NCT02791516|616482687|FG000|Overall Study|Withdrawal by Subject|1|||
170585449|NCT02791516|616482688|FG001|Overall Study|Withdrawal by Subject|1|||
170585450|NCT01044745|616485850|FG000|Overall Study|Ineiligible|2|||
170585451|NCT00789581|616485854|FG000|AC Therapy|Adverse Event|2|||
170585452|NCT00789581|616485855|FG001|AC Therapy|Adverse Event|3|||
170585453|NCT00789581|616485854|FG000|AC Therapy|Withdrawal by Subject|4|||
170585454|NCT00789581|616485855|FG001|AC Therapy|Withdrawal by Subject|7|||
170585455|NCT00789581|616485854|FG000|AC Therapy|Disease recurrence|3|||
170585456|NCT00789581|616485855|FG001|AC Therapy|Disease recurrence|1|||
170585457|NCT00789581|616485854|FG000|AC Therapy|Intercurrent Illness|1|||
170585458|NCT00789581|616485855|FG001|AC Therapy|Intercurrent Illness|0|||
170585459|NCT00789581|616485854|FG000|AC Therapy|Never Treated|1|||
170585460|NCT00789581|616485855|FG001|AC Therapy|Never Treated|4|||
170585461|NCT00789581|616485854|FG000|AC Therapy|Other|0|||
170585462|NCT00789581|616485855|FG001|AC Therapy|Other|2|||
170585463|NCT00789581|616485854|FG000|Adjuvant Therapy|Never treated|2|||
170585464|NCT00789581|616485855|FG001|Adjuvant Therapy|Never treated|2|||
170585465|NCT00789581|616485854|FG000|Adjuvant Therapy|Adverse Event|20|||
170585466|NCT00789581|616485855|FG001|Adjuvant Therapy|Adverse Event|44|||
170585467|NCT00789581|616485854|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
170585468|NCT00789581|616485855|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
170585469|NCT00789581|616485854|FG000|Adjuvant Therapy|Disease recurrence|2|||
170585470|NCT00789581|616485855|FG001|Adjuvant Therapy|Disease recurrence|1|||
170585471|NCT00789581|616485854|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
170585472|NCT00789581|616485855|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
170585473|NCT00789581|616485854|FG000|Adjuvant Therapy|Protocol Violation|1|||
170585474|NCT00789581|616485855|FG001|Adjuvant Therapy|Protocol Violation|1|||
170585475|NCT00789581|616485854|FG000|Adjuvant Therapy|Other|0|||
170585476|NCT00789581|616485855|FG001|Adjuvant Therapy|Other|1|||
170585477|NCT01468207|616485856|FG000|Treatment Period 1|Adverse Event|1|||
170585478|NCT01468207|616485857|FG001|Treatment Period 1|Adverse Event|0|||
170585479|NCT01468207|616485858|FG002|Treatment Period 1|Adverse Event|0|||
170585480|NCT01468207|616485859|FG003|Treatment Period 1|Adverse Event|0|||
170585481|NCT01468207|616485860|FG004|Treatment Period 1|Adverse Event|0|||
170585482|NCT01468207|616485861|FG005|Treatment Period 1|Adverse Event|0|||
170585483|NCT01468207|616485856|FG000|Treatment Period 1|Protocol Violation|1|||
170585484|NCT01468207|616485857|FG001|Treatment Period 1|Protocol Violation|1|||
170585485|NCT01468207|616485858|FG002|Treatment Period 1|Protocol Violation|0|||
170585486|NCT01468207|616485859|FG003|Treatment Period 1|Protocol Violation|0|||
170585487|NCT01468207|616485860|FG004|Treatment Period 1|Protocol Violation|0|||
170585488|NCT01468207|616485861|FG005|Treatment Period 1|Protocol Violation|0|||
170585489|NCT01468207|616485856|FG000|Treatment Period 1|Withdrawal by Subject|5|||
170585490|NCT01468207|616485857|FG001|Treatment Period 1|Withdrawal by Subject|4|||
170585491|NCT01468207|616485858|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170585492|NCT01468207|616485859|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170585493|NCT01468207|616485860|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170585494|NCT01468207|616485861|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170585495|NCT01468207|616485856|FG000|Treatment Period 1|Lost to Follow-up|2|||
170585496|NCT01468207|616485857|FG001|Treatment Period 1|Lost to Follow-up|1|||
170585497|NCT01468207|616485858|FG002|Treatment Period 1|Lost to Follow-up|0|||
170585498|NCT01468207|616485859|FG003|Treatment Period 1|Lost to Follow-up|0|||
170585499|NCT01468207|616485860|FG004|Treatment Period 1|Lost to Follow-up|0|||
170585500|NCT01468207|616485861|FG005|Treatment Period 1|Lost to Follow-up|0|||
170585501|NCT01468207|616485856|FG000|Treatment Period 1|Other|0|||
170585502|NCT01468207|616485857|FG001|Treatment Period 1|Other|2|||
170585503|NCT01468207|616485858|FG002|Treatment Period 1|Other|0|||
170585504|NCT01468207|616485859|FG003|Treatment Period 1|Other|0|||
170585505|NCT01468207|616485860|FG004|Treatment Period 1|Other|0|||
170585506|NCT01468207|616485861|FG005|Treatment Period 1|Other|0|||
170585507|NCT01468207|616485856|FG000|Treatment Period 2|Adverse Event|0|||
170585508|NCT01468207|616485857|FG001|Treatment Period 2|Adverse Event|0|||
170585509|NCT01468207|616485858|FG002|Treatment Period 2|Adverse Event|6|||
170585510|NCT01468207|616485859|FG003|Treatment Period 2|Adverse Event|1|||
170585511|NCT01468207|616485860|FG004|Treatment Period 2|Adverse Event|2|||
170585512|NCT01468207|616485861|FG005|Treatment Period 2|Adverse Event|1|||
170585513|NCT01468207|616485856|FG000|Treatment Period 2|Lack of Efficacy|0|||
170585514|NCT01468207|616485857|FG001|Treatment Period 2|Lack of Efficacy|0|||
170585515|NCT01468207|616485858|FG002|Treatment Period 2|Lack of Efficacy|1|||
170585516|NCT01468207|616485859|FG003|Treatment Period 2|Lack of Efficacy|1|||
170585517|NCT01468207|616485860|FG004|Treatment Period 2|Lack of Efficacy|0|||
170585518|NCT01468207|616485861|FG005|Treatment Period 2|Lack of Efficacy|2|||
170585519|NCT01468207|616485856|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170585520|NCT01468207|616485857|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170585521|NCT01468207|616485858|FG002|Treatment Period 2|Withdrawal by Subject|5|||
170585522|NCT01468207|616485859|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170585523|NCT01468207|616485860|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170585524|NCT01468207|616485861|FG005|Treatment Period 2|Withdrawal by Subject|2|||
170585525|NCT01468207|616485856|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
170585526|NCT01468207|616485857|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
170585527|NCT01468207|616485858|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
170585528|NCT01468207|616485859|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
170585529|NCT01468207|616485860|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
170585530|NCT01468207|616485861|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
170585531|NCT01468207|616485856|FG000|Treatment Period 2|Lost to Follow-up|0|||
170809877|NCT01858688|617313849|FG000|Overall Study|Withdrawal by Subject|8|||
170809878|NCT01858688|617313849|FG000|Overall Study|Participant began another therapy|3|||
170585532|NCT01468207|616485857|FG001|Treatment Period 2|Lost to Follow-up|0|||
170585533|NCT01468207|616485858|FG002|Treatment Period 2|Lost to Follow-up|5|||
170585534|NCT01468207|616485859|FG003|Treatment Period 2|Lost to Follow-up|1|||
170585535|NCT01468207|616485860|FG004|Treatment Period 2|Lost to Follow-up|0|||
170585536|NCT01468207|616485861|FG005|Treatment Period 2|Lost to Follow-up|0|||
170585537|NCT01468207|616485856|FG000|Treatment Period 2|Other|0|||
170809879|NCT01858688|617313849|FG000|Overall Study|Physician Decision|2|||
170585538|NCT01468207|616485857|FG001|Treatment Period 2|Other|0|||
170585539|NCT01468207|616485858|FG002|Treatment Period 2|Other|5|||
170585540|NCT01468207|616485859|FG003|Treatment Period 2|Other|1|||
170585541|NCT01468207|616485860|FG004|Treatment Period 2|Other|1|||
170585542|NCT01468207|616485861|FG005|Treatment Period 2|Other|2|||
170585543|NCT00470093|616485862|FG000|Overall Study|Adverse Event|2|||
170585544|NCT00539513|616485863|FG000|Overall Study|Withdrawal by Subject|2|||
170585545|NCT00539513|616485864|FG001|Overall Study|Withdrawal by Subject|1|||
170585546|NCT00539513|616485863|FG000|Overall Study|Lost to Follow-up|0|||
170585547|NCT00539513|616485864|FG001|Overall Study|Lost to Follow-up|1|||
170585548|NCT03002818|616485865|FG000|Overall Study|Decision of the investigator|1|||
170585549|NCT01328041|616485866|FG000|Overall Study|Adverse Event|7|||
170585550|NCT01328041|616485866|FG000|Overall Study|Lack of Efficacy|27|||
170585551|NCT01328041|616485866|FG000|Overall Study|Protocol Violation|7|||
170809880|NCT01858688|617313849|FG000|Overall Study|Progressive Disease|2|||
170585552|NCT01328041|616485866|FG000|Overall Study|Lost to Follow-up|7|||
170585553|NCT01328041|616485866|FG000|Overall Study|Physician Decision|2|||
170585554|NCT01328041|616485866|FG000|Overall Study|Withdrawal by Subject|7|||
170585555|NCT00664560|616485867|FG000|Overall Study|Adverse Event|19|||
170585556|NCT00664560|616485868|FG001|Overall Study|Adverse Event|16|||
170585557|NCT00664560|616485869|FG002|Overall Study|Adverse Event|7|||
170585558|NCT00664560|616485867|FG000|Overall Study|Withdrawal by Subject|9|||
170585559|NCT00664560|616485868|FG001|Overall Study|Withdrawal by Subject|13|||
170585560|NCT00664560|616485869|FG002|Overall Study|Withdrawal by Subject|7|||
170585561|NCT00664560|616485867|FG000|Overall Study|Lost to Follow-up|0|||
170585562|NCT00664560|616485868|FG001|Overall Study|Lost to Follow-up|2|||
170585563|NCT00664560|616485869|FG002|Overall Study|Lost to Follow-up|0|||
170585564|NCT00664560|616485867|FG000|Overall Study|Other|11|||
170585565|NCT00664560|616485868|FG001|Overall Study|Other|4|||
170585566|NCT00664560|616485869|FG002|Overall Study|Other|5|||
170585567|NCT00711113|616485873|FG000|Overall Study|Lost to Follow-up|9|||
170585568|NCT00711113|616485873|FG000|Overall Study|Implant lost|2|||
170585569|NCT02456636|616485874|FG000|Overall Study|Death|0|||
170585570|NCT02456636|616485875|FG001|Overall Study|Death|3|||
170585571|NCT02456636|616485876|FG002|Overall Study|Death|0|||
170585572|NCT02456636|616485874|FG000|Overall Study|Pregnancy|1|||
170585573|NCT02456636|616485875|FG001|Overall Study|Pregnancy|3|||
170585574|NCT02456636|616485876|FG002|Overall Study|Pregnancy|5|||
170585575|NCT02456636|616485874|FG000|Overall Study|Physician Decision|4|||
170585576|NCT02456636|616485875|FG001|Overall Study|Physician Decision|5|||
170585577|NCT02456636|616485876|FG002|Overall Study|Physician Decision|4|||
170585578|NCT02456636|616485874|FG000|Overall Study|Withdrawal by Subject|13|||
170585579|NCT02456636|616485875|FG001|Overall Study|Withdrawal by Subject|14|||
170585580|NCT02456636|616485876|FG002|Overall Study|Withdrawal by Subject|16|||
170585581|NCT02456636|616485874|FG000|Overall Study|Lost to Follow-up|50|||
170585582|NCT02456636|616485875|FG001|Overall Study|Lost to Follow-up|44|||
170585583|NCT02456636|616485876|FG002|Overall Study|Lost to Follow-up|50|||
170585584|NCT05312632|616485882|FG000|Overall Study|Adverse Event|12|||
170585585|NCT05312632|616485882|FG000|Overall Study|Withdrawal by Subject|10|||
170585586|NCT05312632|616485882|FG000|Overall Study|Lack of Efficacy|4|||
170585587|NCT05312632|616485882|FG000|Overall Study|Non-compliance with study procedures|9|||
170585588|NCT05312632|616485882|FG000|Overall Study|Other|4|||
170585589|NCT01610557|616485883|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
170585590|NCT01610557|616485884|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
170585591|NCT01610557|616485885|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
170585592|NCT01610557|616485886|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
170585593|NCT01610557|616485887|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
170585594|NCT01610557|616485883|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
170585595|NCT01610557|616485884|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
170585596|NCT01610557|616485885|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
170585597|NCT01610557|616485886|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
170585598|NCT01610557|616485887|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
170585599|NCT02003638|616485888|FG000|Overall Study|Withdrawal by Subject|1|||
170585600|NCT02003638|616485889|FG001|Overall Study|Withdrawal by Subject|0|||
170585601|NCT04115748|616485895|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
170585602|NCT04115748|616485896|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
170585603|NCT04115748|616485897|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
170585604|NCT04115748|616485898|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
170585605|NCT04115748|616485899|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
170585606|NCT04115748|616485900|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
170585607|NCT04115748|616485901|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
170585608|NCT04115748|616485902|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
170650004|NCT00420641|616732773|FG001|Overall Study|Lack of Efficacy|5|||
170650005|NCT00420641|616732774|FG002|Overall Study|Lack of Efficacy|4|||
170585609|NCT04115748|616485903|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
170585610|NCT04115748|616485904|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
170585611|NCT04115748|616485895|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585612|NCT04115748|616485896|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585613|NCT04115748|616485897|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585614|NCT04115748|616485898|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
170585615|NCT04115748|616485899|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585616|NCT04115748|616485900|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585617|NCT04115748|616485901|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585618|NCT04115748|616485902|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585619|NCT04115748|616485903|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585620|NCT04115748|616485904|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
170585621|NCT04115748|616485895|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
170585622|NCT04115748|616485896|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
170650006|NCT00420641|616732772|FG000|Overall Study|Non-compliance|7|||
170650007|NCT00420641|616732773|FG001|Overall Study|Non-compliance|5|||
170809881|NCT01858688|617313849|FG000|Overall Study|Reason not reproted|5|||
170809882|NCT03042767|617313853|FG000|Overall Study|Lost to Follow-up|1|||
170809883|NCT03042767|617313854|FG001|Overall Study|Lost to Follow-up|2|||
170585623|NCT04115748|616485897|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
170585624|NCT04115748|616485898|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
170585625|NCT04115748|616485899|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
170585626|NCT04115748|616485900|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
170585627|NCT04115748|616485901|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
170585628|NCT04115748|616485902|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
170585629|NCT04115748|616485903|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
170585630|NCT04115748|616485904|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
170585631|NCT04115748|616485895|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585632|NCT04115748|616485896|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585633|NCT04115748|616485897|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585634|NCT04115748|616485898|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585635|NCT04115748|616485899|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585636|NCT04115748|616485900|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585637|NCT04115748|616485901|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585638|NCT04115748|616485902|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585639|NCT04115748|616485903|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
170585640|NCT04115748|616485904|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
170585641|NCT01200407|616485907|FG000|Overall Study|Lost to Follow-up|56|||
170585642|NCT01200407|616485907|FG000|Overall Study|Adverse Event|3|||
170585643|NCT01200407|616485907|FG000|Overall Study|Withdrawal by Subject|4|||
170585644|NCT01200407|616485907|FG000|Overall Study|Other|19|||
170585645|NCT00519376|616485908|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585646|NCT00519376|616485909|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585647|NCT00519376|616485910|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585648|NCT00519376|616485911|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585649|NCT00519376|616485912|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585650|NCT00519376|616485913|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585651|NCT00519376|616485914|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585652|NCT00519376|616485915|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585653|NCT00519376|616485916|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585654|NCT00519376|616485917|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585655|NCT00519376|616485918|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585656|NCT00519376|616485919|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585657|NCT00519376|616485920|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
170585658|NCT00519376|616485921|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585659|NCT00519376|616485922|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585660|NCT00519376|616485923|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
170585661|NCT00519376|616485908|FG000|Treatment Period 4|Lost to Follow-up|0|||
170585662|NCT00519376|616485909|FG001|Treatment Period 4|Lost to Follow-up|0|||
170585663|NCT00519376|616485910|FG002|Treatment Period 4|Lost to Follow-up|1|||
170585664|NCT00519376|616485911|FG003|Treatment Period 4|Lost to Follow-up|0|||
170585665|NCT00519376|616485912|FG004|Treatment Period 4|Lost to Follow-up|0|||
170585666|NCT00519376|616485913|FG005|Treatment Period 4|Lost to Follow-up|0|||
170585667|NCT00519376|616485914|FG006|Treatment Period 4|Lost to Follow-up|0|||
170585668|NCT00519376|616485915|FG007|Treatment Period 4|Lost to Follow-up|0|||
170585669|NCT00519376|616485916|FG008|Treatment Period 4|Lost to Follow-up|0|||
170585670|NCT00519376|616485917|FG009|Treatment Period 4|Lost to Follow-up|0|||
170585671|NCT00519376|616485918|FG010|Treatment Period 4|Lost to Follow-up|0|||
170585672|NCT00519376|616485919|FG011|Treatment Period 4|Lost to Follow-up|0|||
170585673|NCT00519376|616485920|FG012|Treatment Period 4|Lost to Follow-up|0|||
170585674|NCT00519376|616485921|FG013|Treatment Period 4|Lost to Follow-up|0|||
170585675|NCT00519376|616485922|FG014|Treatment Period 4|Lost to Follow-up|0|||
170585676|NCT00519376|616485923|FG015|Treatment Period 4|Lost to Follow-up|0|||
170585677|NCT00489736|616485924|FG000|Overall Study|Lack of Efficacy|53|||
170585678|NCT00489736|616485925|FG001|Overall Study|Lack of Efficacy|14|||
170585679|NCT00489736|616485924|FG000|Overall Study|Adverse Event|32|||
170585680|NCT00489736|616485925|FG001|Overall Study|Adverse Event|45|||
170585681|NCT00489736|616485924|FG000|Overall Study|Poor compliance|6|||
170585682|NCT00489736|616485925|FG001|Overall Study|Poor compliance|2|||
170585683|NCT00489736|616485924|FG000|Overall Study|Not coded/ Not pre-specified|5|||
170585684|NCT00489736|616485925|FG001|Overall Study|Not coded/ Not pre-specified|8|||
170910746|NCT01357239|617677252|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
170910747|NCT01357239|617677253|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
170585685|NCT06422364|616485929|FG000|Overall Study|Withdrawn due to study closure|0|||
170585686|NCT06422364|616485930|FG001|Overall Study|Withdrawn due to study closure|2|||
170585687|NCT05260073|616485931|FG000|Overall Study|Physician Decision|1|||
170585688|NCT05260073|616485931|FG000|Overall Study|Withdrawal by Subject|6|||
170910748|NCT01357239|617677254|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
170809884|NCT02382640|617313855|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
170809885|NCT02382640|617313856|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
170585689|NCT05260073|616485931|FG000|Overall Study|Lost to Follow-up|14|||
170585690|NCT03458910|616485932|FG000|Overall Study|Withdrawal by Subject|7|||
170585691|NCT03458910|616485933|FG001|Overall Study|Withdrawal by Subject|8|||
170585692|NCT03458910|616485934|FG002|Overall Study|Withdrawal by Subject|6|||
170585693|NCT03458910|616485935|FG003|Overall Study|Withdrawal by Subject|4|||
170585694|NCT03458910|616485932|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
170585695|NCT03458910|616485933|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
170585696|NCT03458910|616485934|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
170585697|NCT03458910|616485935|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
170585698|NCT05275010|616485936|FG000|Overall Study|Reason Not Specified|4|||
170585699|NCT05275010|616485937|FG001|Overall Study|Reason Not Specified|1|||
170585700|NCT05275010|616485936|FG000|Overall Study|Withdrawal by Subject|1|||
170585701|NCT05275010|616485937|FG001|Overall Study|Withdrawal by Subject|0|||
170585702|NCT05275010|616485936|FG000|Overall Study|Lost to Follow-up|0|||
170585703|NCT05275010|616485937|FG001|Overall Study|Lost to Follow-up|1|||
170585704|NCT01681069|616485940|FG000|Overall Study|Withdrawal by Subject|4|||
170585705|NCT01681069|616485941|FG001|Overall Study|Withdrawal by Subject|5|||
170585706|NCT01681069|616485940|FG000|Overall Study|Protocol Violation|1|||
170585707|NCT01681069|616485941|FG001|Overall Study|Protocol Violation|1|||
170585708|NCT01681069|616485940|FG000|Overall Study|Adverse Event|0|||
170585709|NCT01681069|616485941|FG001|Overall Study|Adverse Event|1|||
170585710|NCT01463696|616485942|FG000|Overall Study|Adverse Event|0|||
170585711|NCT01463696|616485943|FG001|Overall Study|Adverse Event|1|||
170585712|NCT01463696|616485944|FG002|Overall Study|Adverse Event|0|||
170585713|NCT01463696|616485945|FG003|Overall Study|Adverse Event|2|||
170585714|NCT01463696|616485946|FG004|Overall Study|Adverse Event|0|||
170585715|NCT01463696|616485947|FG005|Overall Study|Adverse Event|1|||
170585716|NCT01463696|616485948|FG006|Overall Study|Adverse Event|3|||
170585717|NCT01463696|616485949|FG007|Overall Study|Adverse Event|2|||
170585718|NCT01463696|616485942|FG000|Overall Study|Lost to Follow-up|0|||
170585719|NCT01463696|616485943|FG001|Overall Study|Lost to Follow-up|0|||
170585720|NCT01463696|616485944|FG002|Overall Study|Lost to Follow-up|1|||
170585721|NCT01463696|616485945|FG003|Overall Study|Lost to Follow-up|0|||
170585722|NCT01463696|616485946|FG004|Overall Study|Lost to Follow-up|0|||
170585723|NCT01463696|616485947|FG005|Overall Study|Lost to Follow-up|0|||
170585724|NCT01463696|616485948|FG006|Overall Study|Lost to Follow-up|0|||
170585725|NCT01463696|616485949|FG007|Overall Study|Lost to Follow-up|0|||
170585726|NCT01463696|616485942|FG000|Overall Study|Progressive Disease|0|||
170585727|NCT01463696|616485943|FG001|Overall Study|Progressive Disease|1|||
170585728|NCT01463696|616485944|FG002|Overall Study|Progressive Disease|0|||
170585729|NCT01463696|616485945|FG003|Overall Study|Progressive Disease|1|||
170585730|NCT01463696|616485946|FG004|Overall Study|Progressive Disease|0|||
170585731|NCT01463696|616485947|FG005|Overall Study|Progressive Disease|1|||
170585732|NCT01463696|616485948|FG006|Overall Study|Progressive Disease|4|||
170585733|NCT01463696|616485949|FG007|Overall Study|Progressive Disease|2|||
170585734|NCT01463696|616485942|FG000|Overall Study|Withdrawal by Subject|0|||
170585735|NCT01463696|616485943|FG001|Overall Study|Withdrawal by Subject|0|||
170585736|NCT01463696|616485944|FG002|Overall Study|Withdrawal by Subject|0|||
170585737|NCT01463696|616485945|FG003|Overall Study|Withdrawal by Subject|1|||
170585738|NCT01463696|616485946|FG004|Overall Study|Withdrawal by Subject|1|||
170809886|NCT02382640|617313857|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
170809887|NCT02382640|617313858|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
170809888|NCT02449902|617313862|FG000|Overall Study|Adverse Event|0|||
170809889|NCT02449902|617313863|FG001|Overall Study|Adverse Event|1|||
170809890|NCT02449902|617313862|FG000|Overall Study|Withdrawal by Subject|0|||
170809891|NCT02449902|617313863|FG001|Overall Study|Withdrawal by Subject|1|||
170809892|NCT01989104|617313865|FG000|Overall Study|Withdrawal by Subject|3|||
170809893|NCT01989104|617313866|FG001|Overall Study|Withdrawal by Subject|0|||
170585739|NCT01463696|616485947|FG005|Overall Study|Withdrawal by Subject|1|||
170585740|NCT01463696|616485948|FG006|Overall Study|Withdrawal by Subject|2|||
170585741|NCT01463696|616485949|FG007|Overall Study|Withdrawal by Subject|0|||
170585742|NCT01463696|616485942|FG000|Overall Study|Not Treated|0|||
170809894|NCT01989104|617313867|FG002|Overall Study|Withdrawal by Subject|0|||
170910749|NCT01357239|617677255|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
170910750|NCT01357239|617677252|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
170585743|NCT01463696|616485943|FG001|Overall Study|Not Treated|0|||
170650008|NCT00420641|616732774|FG002|Overall Study|Non-compliance|4|||
170809895|NCT01989104|617313868|FG003|Overall Study|Withdrawal by Subject|0|||
170585744|NCT01463696|616485944|FG002|Overall Study|Not Treated|0|||
170585745|NCT01463696|616485945|FG003|Overall Study|Not Treated|0|||
170585746|NCT01463696|616485946|FG004|Overall Study|Not Treated|0|||
170585747|NCT01463696|616485947|FG005|Overall Study|Not Treated|0|||
170585748|NCT01463696|616485948|FG006|Overall Study|Not Treated|1|||
170585749|NCT01463696|616485949|FG007|Overall Study|Not Treated|0|||
170809896|NCT01989104|617313869|FG004|Overall Study|Withdrawal by Subject|0|||
170585750|NCT03883165|616485950|FG000|Overall Study|Withdrawal by Subject|4|||
170585751|NCT03883165|616485951|FG001|Overall Study|Withdrawal by Subject|3|||
170585752|NCT02301546|616485954|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
170585753|NCT02301546|616485955|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
170585754|NCT02301546|616485954|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
170585755|NCT02301546|616485955|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
170585756|NCT02301546|616485954|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
170585757|NCT02301546|616485955|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
170585758|NCT02301546|616485954|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
170585759|NCT02301546|616485955|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
170585760|NCT02301546|616485954|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
170585761|NCT02301546|616485955|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
170585762|NCT02301546|616485954|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
170585763|NCT02301546|616485955|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
170585764|NCT02301546|616485954|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
170585765|NCT02301546|616485955|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
170585766|NCT02743949|616485957|FG000|Overall Study|Adverse Event|0|||
170585767|NCT02743949|616485958|FG001|Overall Study|Adverse Event|0|||
170585768|NCT02743949|616485959|FG002|Overall Study|Adverse Event|2|||
170585769|NCT02743949|616485957|FG000|Overall Study|Significant Protocol Deviation|2|||
170585770|NCT02743949|616485958|FG001|Overall Study|Significant Protocol Deviation|0|||
170585771|NCT02743949|616485959|FG002|Overall Study|Significant Protocol Deviation|1|||
170585772|NCT02743949|616485957|FG000|Overall Study|Voluntary Withdrawal|2|||
170585773|NCT02743949|616485958|FG001|Overall Study|Voluntary Withdrawal|1|||
170585774|NCT02743949|616485959|FG002|Overall Study|Voluntary Withdrawal|0|||
170585775|NCT03389555|616485960|FG000|Overall Study|Protocol Violation|1|||
170585776|NCT03389555|616485961|FG001|Overall Study|Protocol Violation|3|||
170585777|NCT03389555|616485960|FG000|Overall Study|Death|1|||
170585778|NCT03389555|616485961|FG001|Overall Study|Death|0|||
170585779|NCT01885208|616485962|FG000|Overall Study|Unclassified|32|||
170585780|NCT01885208|616485963|FG001|Overall Study|Unclassified|38|||
170585781|NCT00920218|616485964|FG000|Overall Study|Serious Adverse Event|2|||
170585782|NCT00920218|616485965|FG001|Overall Study|Serious Adverse Event|0|||
170585783|NCT00920218|616485966|FG002|Overall Study|Serious Adverse Event|2|||
170585784|NCT00920218|616485967|FG003|Overall Study|Serious Adverse Event|1|||
170585785|NCT00920218|616485964|FG000|Overall Study|Withdrawal by Subject|0|||
170585786|NCT00920218|616485965|FG001|Overall Study|Withdrawal by Subject|3|||
170585787|NCT00920218|616485966|FG002|Overall Study|Withdrawal by Subject|2|||
170585788|NCT00920218|616485967|FG003|Overall Study|Withdrawal by Subject|0|||
170585789|NCT00920218|616485964|FG000|Overall Study|Migrated/moved from study area|0|||
170585790|NCT00920218|616485965|FG001|Overall Study|Migrated/moved from study area|0|||
170585791|NCT00920218|616485966|FG002|Overall Study|Migrated/moved from study area|1|||
170585792|NCT00920218|616485967|FG003|Overall Study|Migrated/moved from study area|0|||
170585793|NCT00920218|616485964|FG000|Overall Study|Lost to Follow-up|0|||
170585794|NCT00920218|616485965|FG001|Overall Study|Lost to Follow-up|1|||
170585795|NCT00920218|616485966|FG002|Overall Study|Lost to Follow-up|0|||
170585796|NCT00920218|616485967|FG003|Overall Study|Lost to Follow-up|3|||
170585797|NCT00920218|616485964|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
170585798|NCT00920218|616485965|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
170585799|NCT00920218|616485966|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
170585800|NCT00920218|616485967|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
170585801|NCT00920218|616485964|FG000|Overall Study|Other|0|||
170585802|NCT00920218|616485965|FG001|Overall Study|Other|0|||
170585803|NCT00920218|616485966|FG002|Overall Study|Other|1|||
170585804|NCT00920218|616485967|FG003|Overall Study|Other|0|||
170585805|NCT00923975|616485968|FG000|Overall Study|Did not meet inclusion criteria|1|||
170585806|NCT01005316|616485971|FG000|Overall Study|Adverse Event|0|||
170585807|NCT01005316|616485972|FG001|Overall Study|Adverse Event|0|||
170585808|NCT01005316|616485973|FG002|Overall Study|Adverse Event|0|||
170585809|NCT01005316|616485974|FG003|Overall Study|Adverse Event|1|||
170585810|NCT01005316|616485971|FG000|Overall Study|Death|20|||
170585811|NCT01005316|616485972|FG001|Overall Study|Death|5|||
170910751|NCT01357239|617677253|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
170910752|NCT01357239|617677254|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
170585812|NCT01005316|616485973|FG002|Overall Study|Death|1|||
170585813|NCT01005316|616485974|FG003|Overall Study|Death|15|||
170585814|NCT01005316|616485971|FG000|Overall Study|Study Termination|5|||
170585815|NCT01005316|616485972|FG001|Overall Study|Study Termination|63|||
170585816|NCT01005316|616485973|FG002|Overall Study|Study Termination|9|||
170585817|NCT01005316|616485974|FG003|Overall Study|Study Termination|85|||
170585818|NCT01005316|616485971|FG000|Overall Study|Lost to Follow-up|1|||
170585819|NCT01005316|616485972|FG001|Overall Study|Lost to Follow-up|3|||
170585820|NCT01005316|616485973|FG002|Overall Study|Lost to Follow-up|0|||
170585821|NCT01005316|616485974|FG003|Overall Study|Lost to Follow-up|2|||
170585822|NCT01005316|616485971|FG000|Overall Study|Physician Decision|6|||
170585823|NCT01005316|616485972|FG001|Overall Study|Physician Decision|0|||
170585824|NCT01005316|616485973|FG002|Overall Study|Physician Decision|0|||
170585825|NCT01005316|616485974|FG003|Overall Study|Physician Decision|0|||
170585826|NCT01005316|616485971|FG000|Overall Study|Sponsor Decision|6|||
170585827|NCT01005316|616485972|FG001|Overall Study|Sponsor Decision|3|||
170585828|NCT01005316|616485973|FG002|Overall Study|Sponsor Decision|0|||
170585829|NCT01005316|616485974|FG003|Overall Study|Sponsor Decision|0|||
170585830|NCT01005316|616485971|FG000|Overall Study|Withdrawal by Subject|1|||
170585831|NCT01005316|616485972|FG001|Overall Study|Withdrawal by Subject|1|||
170585832|NCT01005316|616485973|FG002|Overall Study|Withdrawal by Subject|0|||
170585833|NCT01005316|616485974|FG003|Overall Study|Withdrawal by Subject|2|||
170585834|NCT01005316|616485971|FG000|Overall Study|Consented to Another Study|2|||
170585835|NCT01005316|616485972|FG001|Overall Study|Consented to Another Study|0|||
170585836|NCT01005316|616485973|FG002|Overall Study|Consented to Another Study|0|||
170585837|NCT01005316|616485974|FG003|Overall Study|Consented to Another Study|0|||
170585838|NCT01005316|616485971|FG000|Overall Study|Delisted|8|||
170585839|NCT01005316|616485972|FG001|Overall Study|Delisted|0|||
170585840|NCT01005316|616485973|FG002|Overall Study|Delisted|0|||
170585841|NCT01005316|616485974|FG003|Overall Study|Delisted|0|||
170585842|NCT01005316|616485971|FG000|Overall Study|Transferred Care|1|||
170585843|NCT01005316|616485972|FG001|Overall Study|Transferred Care|0|||
170585844|NCT01005316|616485973|FG002|Overall Study|Transferred Care|1|||
170585845|NCT01005316|616485974|FG003|Overall Study|Transferred Care|3|||
170585846|NCT01005316|616485971|FG000|Overall Study|Retransplanted|0|||
170585847|NCT01005316|616485972|FG001|Overall Study|Retransplanted|1|||
170585848|NCT01005316|616485973|FG002|Overall Study|Retransplanted|0|||
170585849|NCT01005316|616485974|FG003|Overall Study|Retransplanted|0|||
170585850|NCT00960011|616485978|FG000|Overall Study|Death|5|||
170585851|NCT00960011|616485979|FG001|Overall Study|Death|0|||
170585852|NCT00960011|616485978|FG000|Overall Study|Lost to Follow-up|6|||
170585853|NCT00960011|616485979|FG001|Overall Study|Lost to Follow-up|2|||
170585854|NCT04417218|616485980|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
170585855|NCT04417218|616485981|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
170585856|NCT01846663|616485990|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
170585857|NCT01846663|616485991|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
170585858|NCT01846663|616485990|FG000|Overall Study|Withdrawal by Subject|1|||
170585859|NCT01846663|616485991|FG001|Overall Study|Withdrawal by Subject|0|||
170585860|NCT01846663|616485990|FG000|Overall Study|Adverse Event|1|||
170585861|NCT01846663|616485991|FG001|Overall Study|Adverse Event|2|||
170585862|NCT03655054|616485996|FG000|Overall Study|Lost to Follow-up|1|||
170585863|NCT00813865|616485997|FG000|Overall Study|Failure to Respond|3|||
170585864|NCT00813865|616485997|FG000|Overall Study|Lost to Follow-up|3|||
170585865|NCT00813865|616485997|FG000|Overall Study|Withdrawal by Subject|1|||
170585866|NCT04295681|616485998|FG000|Overall Study|Eligibility error|1|||
170585867|NCT04295681|616485999|FG001|Overall Study|Eligibility error|3|||
170585868|NCT01923363|616486003|FG000|Overall Study|Protocol Violation|1|||
170585869|NCT01832493|616486004|FG000|Overall Study|Physician Decision|2|||
170585870|NCT01832493|616486004|FG000|Overall Study|Protocol Violation|4|||
170585871|NCT01832493|616486004|FG000|Overall Study|Unable to place LV lead|2|||
170585872|NCT01814397|616486007|FG000|Overall Study|Adverse Event|7|||
170585873|NCT01814397|616486007|FG000|Overall Study|Withdrawal by Subject|7|||
170585874|NCT00244933|616486011|FG000|Overall Study|Not response evaluable|2|||
170585875|NCT00866047|616486012|FG000|Treatment Period|Progressive disease|13|||
170585876|NCT00866047|616486012|FG000|Treatment Period|Adverse Event|16|||
170585877|NCT00866047|616486012|FG000|Treatment Period|Physician Decision|14|||
170585878|NCT00866047|616486012|FG000|Treatment Period|Withdrawal by Subject|5|||
170585879|NCT00866047|616486012|FG000|Follow-up Period|Lost to Follow-up|5|||
170585880|NCT02928029|616486014|FG000|Overall Study|Withdrawal by Subject|0|||
170585881|NCT02928029|616486015|FG001|Overall Study|Withdrawal by Subject|1|||
170585882|NCT02928029|616486014|FG000|Overall Study|Radiological progression|1|||
170585883|NCT02928029|616486015|FG001|Overall Study|Radiological progression|0|||
170809897|NCT05613088|617313870|FG000|Treatment|Ongoing Study Treatment|9|||
170585884|NCT02928029|616486014|FG000|Overall Study|Clinical progression|1|||
170585885|NCT02928029|616486015|FG001|Overall Study|Clinical progression|2|||
170585886|NCT02928029|616486014|FG000|Overall Study|AE not related to clinical progression|1|||
170585887|NCT02928029|616486015|FG001|Overall Study|AE not related to clinical progression|1|||
170585888|NCT03703817|616486017|FG000|Overall Study|Not meeting eligibility criteria|7|||
170585889|NCT03703817|616486018|FG001|Overall Study|Not meeting eligibility criteria|4|||
170585890|NCT00616018|616486032|FG000|Overall Study|Protocol Violation|3|||
170585891|NCT01818258|616486033|FG000|Overall Study|Death|3|||
170585892|NCT01818258|616486034|FG001|Overall Study|Death|0|||
170585893|NCT01818258|616486033|FG000|Overall Study|Withdrawal by Subject|0|||
170585894|NCT01818258|616486034|FG001|Overall Study|Withdrawal by Subject|1|||
170585895|NCT01818258|616486033|FG000|Overall Study|Lost to Follow-up|0|||
170585896|NCT01818258|616486034|FG001|Overall Study|Lost to Follow-up|1|||
170650009|NCT00420641|616732772|FG000|Overall Study|Other|4|||
170585897|NCT01818258|616486033|FG000|Overall Study|Unable to Travel to Clinic|0|||
170585898|NCT01818258|616486034|FG001|Overall Study|Unable to Travel to Clinic|1|||
170585899|NCT02684058|616486037|FG000|Treatment Period|Progressive disease|4|||
170585900|NCT02684058|616486038|FG001|Treatment Period|Progressive disease|10|||
170585901|NCT02684058|616486039|FG002|Treatment Period|Progressive disease|19|||
170585902|NCT02684058|616486037|FG000|Treatment Period|Adverse Event|3|||
170585903|NCT02684058|616486038|FG001|Treatment Period|Adverse Event|8|||
170585904|NCT02684058|616486039|FG002|Treatment Period|Adverse Event|1|||
170585905|NCT02684058|616486037|FG000|Treatment Period|Physician Decision|5|||
170585906|NCT02684058|616486038|FG001|Treatment Period|Physician Decision|1|||
170585907|NCT02684058|616486039|FG002|Treatment Period|Physician Decision|2|||
170585908|NCT02684058|616486037|FG000|Treatment Period|New therapy for study indication|1|||
170585909|NCT02684058|616486038|FG001|Treatment Period|New therapy for study indication|0|||
170585910|NCT02684058|616486039|FG002|Treatment Period|New therapy for study indication|0|||
170585911|NCT02684058|616486037|FG000|Treatment Period|Protocol deviation|0|||
170585912|NCT02684058|616486038|FG001|Treatment Period|Protocol deviation|1|||
170585913|NCT02684058|616486039|FG002|Treatment Period|Protocol deviation|0|||
170585914|NCT02684058|616486037|FG000|Treatment Period|Subject/guardian decision|4|||
170585915|NCT02684058|616486038|FG001|Treatment Period|Subject/guardian decision|3|||
170585916|NCT02684058|616486039|FG002|Treatment Period|Subject/guardian decision|0|||
170585917|NCT02684058|616486037|FG000|Treatment Period|Death|0|||
170585918|NCT02684058|616486038|FG001|Treatment Period|Death|0|||
170585919|NCT02684058|616486039|FG002|Treatment Period|Death|2|||
170585920|NCT02684058|616486037|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
170585921|NCT02684058|616486038|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
170585922|NCT02684058|616486039|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
170585923|NCT02684058|616486037|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
170585924|NCT02684058|616486038|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
170585925|NCT02684058|616486039|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
170585926|NCT02684058|616486037|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
170585927|NCT02684058|616486038|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
170585928|NCT02684058|616486039|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
170585929|NCT02684058|616486037|FG000|Post-treatment Efficacy Follow-up|Death|0|||
170585930|NCT02684058|616486038|FG001|Post-treatment Efficacy Follow-up|Death|0|||
170585931|NCT02684058|616486039|FG002|Post-treatment Efficacy Follow-up|Death|3|||
170585932|NCT02684058|616486037|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
170585933|NCT02684058|616486038|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
170585934|NCT02684058|616486039|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
170585935|NCT02684058|616486037|FG000|Post-treatment Survival Follow-up|Death|0|||
170585936|NCT02684058|616486038|FG001|Post-treatment Survival Follow-up|Death|0|||
170585937|NCT02684058|616486039|FG002|Post-treatment Survival Follow-up|Death|7|||
170585938|NCT02684058|616486037|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
170585939|NCT02684058|616486038|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
170585940|NCT02684058|616486039|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
170585941|NCT02684058|616486037|FG000|Crossover Treatment Period|Progressive disease|0|||
170585942|NCT02684058|616486038|FG001|Crossover Treatment Period|Progressive disease|1|||
170585943|NCT02684058|616486039|FG002|Crossover Treatment Period|Progressive disease|0|||
170585944|NCT01221623|616486042|FG000|Overall Study|Withdrawal by Subject|19|||
170585945|NCT01221623|616486043|FG001|Overall Study|Withdrawal by Subject|8|||
170585946|NCT01221623|616486042|FG000|Overall Study|Lost to Follow-up|7|||
170585947|NCT01221623|616486043|FG001|Overall Study|Lost to Follow-up|1|||
170585948|NCT01221623|616486042|FG000|Overall Study|Adverse Event|6|||
170585949|NCT01221623|616486043|FG001|Overall Study|Adverse Event|3|||
170585950|NCT01221623|616486042|FG000|Overall Study|Death|1|||
170585951|NCT01221623|616486043|FG001|Overall Study|Death|0|||
170585952|NCT01221623|616486042|FG000|Overall Study|Other|5|||
170585953|NCT01221623|616486043|FG001|Overall Study|Other|2|||
170585954|NCT04283994|616486044|FG000|Overall Study|Death|11|||
170585955|NCT04283994|616486045|FG001|Overall Study|Death|20|||
170585956|NCT04283994|616486046|FG002|Overall Study|Death|11|||
170585957|NCT04283994|616486047|FG003|Overall Study|Death|0|||
170585958|NCT04283994|616486048|FG004|Overall Study|Death|0|||
170585959|NCT04283994|616486049|FG005|Overall Study|Death|0|||
170585960|NCT04283994|616486050|FG006|Overall Study|Death|0|||
170585961|NCT04283994|616486044|FG000|Overall Study|Withdrawal by Subject|16|||
170585962|NCT04283994|616486045|FG001|Overall Study|Withdrawal by Subject|4|||
170585963|NCT04283994|616486046|FG002|Overall Study|Withdrawal by Subject|6|||
170585964|NCT04283994|616486047|FG003|Overall Study|Withdrawal by Subject|1|||
170585965|NCT04283994|616486048|FG004|Overall Study|Withdrawal by Subject|0|||
170585966|NCT04283994|616486049|FG005|Overall Study|Withdrawal by Subject|1|||
170585967|NCT04283994|616486050|FG006|Overall Study|Withdrawal by Subject|0|||
170585968|NCT01463111|616487588|FG000|Overall Study|Withdrawal by Subject|2|||
170809898|NCT05613088|617313871|FG001|Treatment|Ongoing Study Treatment|2|||
170809899|NCT05613088|617313870|FG000|Treatment|Adverse Event|3|||
170809900|NCT05613088|617313871|FG001|Treatment|Adverse Event|1|||
170809901|NCT05613088|617313870|FG000|Treatment|Other Reasons|0|||
170809902|NCT05613088|617313871|FG001|Treatment|Other Reasons|1|||
170809903|NCT05613088|617313870|FG000|Treatment|Progressive Disease|58|||
170809904|NCT05613088|617313871|FG001|Treatment|Progressive Disease|26|||
170809905|NCT05613088|617313870|FG000|Treatment|Withdrawal by Subject|0|||
170910753|NCT01357239|617677255|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
170910754|NCT00891657|617677256|FG000|Overall Study|Withdrawal by Subject|1|||
170910755|NCT00891657|617677257|FG001|Overall Study|Withdrawal by Subject|1|||
170910756|NCT03133481|617677258|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
170910757|NCT03133481|617677259|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
170910758|NCT01254344|617677260|FG000|Overall Study|Adverse Event|2|||
170910759|NCT01254344|617677261|FG001|Overall Study|Adverse Event|5|||
170910760|NCT01254344|617677260|FG000|Overall Study|Physician Decision|7|||
170910761|NCT01254344|617677261|FG001|Overall Study|Physician Decision|4|||
170910762|NCT01254344|617677260|FG000|Overall Study|Protocol Violation|1|||
170910763|NCT01254344|617677261|FG001|Overall Study|Protocol Violation|4|||
170910764|NCT01254344|617677260|FG000|Overall Study|Withdrawal by Subject|3|||
170910765|NCT01254344|617677261|FG001|Overall Study|Withdrawal by Subject|6|||
170910766|NCT00467649|617677262|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
170910767|NCT00467649|617677263|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
170910768|NCT00467649|617677264|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
170910769|NCT00467649|617677265|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
170910770|NCT00467649|617677266|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
170910771|NCT00467649|617677267|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
170910772|NCT00467649|617677262|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
170910773|NCT00467649|617677263|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
170910774|NCT00467649|617677264|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
170910775|NCT00467649|617677265|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
170910776|NCT00467649|617677266|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
170910777|NCT00467649|617677267|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
170910778|NCT00467649|617677262|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
170910779|NCT00467649|617677263|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
170910780|NCT00467649|617677264|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
170910781|NCT00467649|617677265|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
170910782|NCT00467649|617677266|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
170910783|NCT00467649|617677267|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
170910784|NCT00467649|617677262|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
170910785|NCT00467649|617677263|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
170910786|NCT00467649|617677264|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
170910787|NCT00467649|617677265|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
170910788|NCT00467649|617677266|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
170910789|NCT00467649|617677267|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
170910790|NCT00467649|617677262|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
170910791|NCT00467649|617677263|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
170910792|NCT00467649|617677264|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
170910793|NCT00467649|617677265|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
170910794|NCT00467649|617677266|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
170910795|NCT00467649|617677267|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
170910796|NCT00467649|617677262|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
170910797|NCT00467649|617677263|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
170910798|NCT00467649|617677264|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
170910799|NCT00467649|617677265|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
170910800|NCT00467649|617677266|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
170910801|NCT00467649|617677267|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
170585969|NCT01463111|616487588|FG000|Overall Study|Lost to Follow-up|5|||
170585970|NCT01463111|616487588|FG000|Overall Study|Physician Decision|2|||
170809906|NCT05613088|617313871|FG001|Treatment|Withdrawal by Subject|4|||
170809907|NCT05352230|617313876|FG000|First Intervention (3 Months)|study terminated|2|||
170809908|NCT05352230|617313877|FG001|First Intervention (3 Months)|study terminated|2|||
170910802|NCT00467649|617677262|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
170910803|NCT00467649|617677263|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
170910804|NCT00467649|617677264|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
170910805|NCT00467649|617677265|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
170809909|NCT02686658|617313883|FG000|Overall Study|Adverse Event|0|||
170809910|NCT02686658|617313884|FG001|Overall Study|Adverse Event|0|||
170809911|NCT02686658|617313885|FG002|Overall Study|Adverse Event|1|||
170809912|NCT02686658|617313886|FG003|Overall Study|Adverse Event|1|||
170809913|NCT02686658|617313887|FG004|Overall Study|Adverse Event|2|||
170809914|NCT02686658|617313888|FG005|Overall Study|Adverse Event|1|||
170809915|NCT02686658|617313883|FG000|Overall Study|Investigator decision|0|||
170809916|NCT02686658|617313884|FG001|Overall Study|Investigator decision|0|||
170809917|NCT02686658|617313885|FG002|Overall Study|Investigator decision|0|||
170809918|NCT02686658|617313886|FG003|Overall Study|Investigator decision|1|||
170809919|NCT02686658|617313887|FG004|Overall Study|Investigator decision|2|||
170809920|NCT02686658|617313888|FG005|Overall Study|Investigator decision|1|||
170809921|NCT02686658|617313883|FG000|Overall Study|Sponsor decision|1|||
170809922|NCT02686658|617313884|FG001|Overall Study|Sponsor decision|2|||
170809923|NCT02686658|617313885|FG002|Overall Study|Sponsor decision|1|||
170809924|NCT02686658|617313886|FG003|Overall Study|Sponsor decision|5|||
170809925|NCT02686658|617313887|FG004|Overall Study|Sponsor decision|13|||
170809926|NCT02686658|617313888|FG005|Overall Study|Sponsor decision|2|||
170809927|NCT02686658|617313883|FG000|Overall Study|Lost to Follow-up|0|||
170809928|NCT02686658|617313884|FG001|Overall Study|Lost to Follow-up|0|||
170809929|NCT02686658|617313885|FG002|Overall Study|Lost to Follow-up|2|||
170809930|NCT02686658|617313886|FG003|Overall Study|Lost to Follow-up|0|||
170809931|NCT02686658|617313887|FG004|Overall Study|Lost to Follow-up|0|||
170809932|NCT02686658|617313888|FG005|Overall Study|Lost to Follow-up|1|||
170809933|NCT02686658|617313883|FG000|Overall Study|Death|1|||
170809934|NCT02686658|617313884|FG001|Overall Study|Death|0|||
170809935|NCT02686658|617313885|FG002|Overall Study|Death|0|||
170585971|NCT01159171|616487592|FG000|Overall Study|Adverse Event|11|||
170585972|NCT01159171|616487592|FG000|Overall Study|Progression of Disease|28|||
170585973|NCT01159171|616487592|FG000|Overall Study|Protocol Violation|1|||
170585974|NCT01159171|616487592|FG000|Overall Study|Need for Surgery|5|||
170585975|NCT01159171|616487592|FG000|Overall Study|Medical Decision|4|||
170585976|NCT01159171|616487592|FG000|Overall Study|Death|1|||
170585977|NCT01145352|616487595|FG000|Overall Study|Found to have been registered twice|6|||
170585978|NCT01145352|616487595|FG000|Overall Study|Treated before marketing approval|4|||
170585979|NCT01145352|616487595|FG000|Overall Study|Syringe formulation was used|1|||
170585980|NCT02264665|616487596|FG000|Overall Study|Other|0|||
170585981|NCT02264665|616487597|FG001|Overall Study|Other|0|||
170585982|NCT02264665|616487598|FG002|Overall Study|Other|3|||
170585983|NCT02264665|616487599|FG003|Overall Study|Other|0|||
170585984|NCT02264665|616487600|FG004|Overall Study|Other|0|||
170585985|NCT02264665|616487601|FG005|Overall Study|Other|0|||
170585986|NCT02264665|616487602|FG006|Overall Study|Other|0|||
170585987|NCT02264665|616487596|FG000|Overall Study|Death|9|||
170585988|NCT02264665|616487597|FG001|Overall Study|Death|8|||
170585989|NCT02264665|616487598|FG002|Overall Study|Death|13|||
170585990|NCT02264665|616487599|FG003|Overall Study|Death|5|||
170585991|NCT02264665|616487600|FG004|Overall Study|Death|0|||
170585992|NCT02264665|616487601|FG005|Overall Study|Death|0|||
170585993|NCT02264665|616487602|FG006|Overall Study|Death|1|||
170585994|NCT02264665|616487596|FG000|Overall Study|Lost to Follow-up|1|||
170585995|NCT02264665|616487597|FG001|Overall Study|Lost to Follow-up|0|||
170585996|NCT02264665|616487598|FG002|Overall Study|Lost to Follow-up|2|||
170585997|NCT02264665|616487599|FG003|Overall Study|Lost to Follow-up|1|||
170585998|NCT02264665|616487600|FG004|Overall Study|Lost to Follow-up|0|||
170585999|NCT02264665|616487601|FG005|Overall Study|Lost to Follow-up|0|||
170586000|NCT02264665|616487602|FG006|Overall Study|Lost to Follow-up|0|||
170809936|NCT02686658|617313886|FG003|Overall Study|Death|1|||
170809937|NCT02686658|617313887|FG004|Overall Study|Death|1|||
170809938|NCT02686658|617313888|FG005|Overall Study|Death|1|||
170809939|NCT02686658|617313883|FG000|Overall Study|Withdrawal by Subject|2|||
170586001|NCT02264665|616487596|FG000|Overall Study|Participant decision|0|||
170586002|NCT02264665|616487597|FG001|Overall Study|Participant decision|0|||
170586003|NCT02264665|616487598|FG002|Overall Study|Participant decision|0|||
170586004|NCT02264665|616487599|FG003|Overall Study|Participant decision|1|||
170586005|NCT02264665|616487600|FG004|Overall Study|Participant decision|0|||
170586006|NCT02264665|616487601|FG005|Overall Study|Participant decision|0|||
170809940|NCT02686658|617313884|FG001|Overall Study|Withdrawal by Subject|5|||
170586007|NCT02264665|616487602|FG006|Overall Study|Participant decision|0|||
170586008|NCT02264665|616487596|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
170586009|NCT02264665|616487597|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
170586010|NCT02264665|616487598|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
170586011|NCT02264665|616487599|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
170586012|NCT02264665|616487600|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
170586013|NCT02264665|616487601|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
170809941|NCT02686658|617313885|FG002|Overall Study|Withdrawal by Subject|4|||
170809942|NCT02686658|617313886|FG003|Overall Study|Withdrawal by Subject|4|||
170809943|NCT02686658|617313887|FG004|Overall Study|Withdrawal by Subject|17|||
170809944|NCT02686658|617313888|FG005|Overall Study|Withdrawal by Subject|8|||
170809945|NCT02686658|617313883|FG000|Overall Study|Placed in hospice care|0|||
170650010|NCT00420641|616732773|FG001|Overall Study|Other|4|||
170586014|NCT02264665|616487602|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
170586015|NCT02264665|616487596|FG000|Overall Study|Data Missing|0|||
170586016|NCT02264665|616487597|FG001|Overall Study|Data Missing|0|||
170586017|NCT02264665|616487598|FG002|Overall Study|Data Missing|1|||
170586018|NCT02264665|616487599|FG003|Overall Study|Data Missing|0|||
170586019|NCT02264665|616487600|FG004|Overall Study|Data Missing|0|||
170586020|NCT02264665|616487601|FG005|Overall Study|Data Missing|0|||
170586021|NCT02264665|616487602|FG006|Overall Study|Data Missing|0|||
170586022|NCT05289271|616487603|FG000|Overall Study|Mistakenly allocated, untreated|1|||
170586023|NCT05289271|616487604|FG001|Overall Study|Mistakenly allocated, untreated|0|||
170586024|NCT03392883|616487605|FG000|Overall Study|Lost to Follow-up|122|||
170586025|NCT03392883|616487606|FG001|Overall Study|Lost to Follow-up|13|||
170586026|NCT03392883|616487607|FG002|Overall Study|Lost to Follow-up|9|||
170586027|NCT03392883|616487605|FG000|Overall Study|Death|4|||
170586028|NCT03392883|616487606|FG001|Overall Study|Death|0|||
170586029|NCT03392883|616487607|FG002|Overall Study|Death|0|||
170586030|NCT03392883|616487605|FG000|Overall Study|Lack of Efficacy|29|||
170586031|NCT03392883|616487606|FG001|Overall Study|Lack of Efficacy|0|||
170586032|NCT03392883|616487607|FG002|Overall Study|Lack of Efficacy|0|||
170586033|NCT03392883|616487605|FG000|Overall Study|Withdrawal by Subject|180|||
170586034|NCT03392883|616487606|FG001|Overall Study|Withdrawal by Subject|0|||
170586035|NCT03392883|616487607|FG002|Overall Study|Withdrawal by Subject|0|||
170586036|NCT03392883|616487605|FG000|Overall Study|Adverse Event|1|||
170586037|NCT03392883|616487606|FG001|Overall Study|Adverse Event|0|||
170586038|NCT03392883|616487607|FG002|Overall Study|Adverse Event|0|||
170586039|NCT02688088|616487610|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
170586040|NCT02688088|616487611|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
170586041|NCT02688088|616487612|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
170586042|NCT02688088|616487613|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
170586043|NCT02688088|616487614|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
170586044|NCT02688088|616487610|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
170586045|NCT02688088|616487611|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
170586046|NCT02688088|616487612|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
170586047|NCT02688088|616487613|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
170586048|NCT02688088|616487614|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
170586049|NCT02688088|616487610|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
170586050|NCT02688088|616487611|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
170586051|NCT02688088|616487612|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
170586052|NCT02688088|616487613|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
170586053|NCT02688088|616487614|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
170586054|NCT02688088|616487610|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
170586055|NCT02688088|616487611|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
170586056|NCT02688088|616487612|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
170586057|NCT02688088|616487613|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
170586058|NCT02688088|616487614|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
170586059|NCT02688088|616487610|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
170586060|NCT02688088|616487611|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
170586061|NCT02688088|616487612|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
170586062|NCT02688088|616487613|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
170586063|NCT02688088|616487614|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
170586064|NCT02688088|616487610|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
170586065|NCT02688088|616487611|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
170586066|NCT02688088|616487612|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
170650011|NCT00420641|616732774|FG002|Overall Study|Other|3|||
170650012|NCT02586506|616732780|FG000|Overall Study|Protocol Violation|6|||
170650013|NCT02586506|616732780|FG000|Overall Study|Lost to Follow-up|1|||
170586067|NCT02688088|616487613|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
170586068|NCT02688088|616487614|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
170586069|NCT02688088|616487610|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
170586070|NCT02688088|616487611|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
170586071|NCT02688088|616487612|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
170586072|NCT02688088|616487613|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
170586073|NCT02688088|616487614|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
170586074|NCT02688088|616487610|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
170586075|NCT02688088|616487611|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
170650014|NCT02586506|616732780|FG000|Overall Study|Other Reason|2|||
170586076|NCT02688088|616487612|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
170910806|NCT00467649|617677266|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
170910807|NCT00467649|617677267|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
170910808|NCT03633331|617677270|FG000|Overall Study|Withdrawal by Subject|1|||
170910809|NCT00491530|617677271|FG000|Overall Study|Adverse Event|6|||
170910810|NCT00491530|617677272|FG001|Overall Study|Adverse Event|1|||
170910811|NCT00491530|617677273|FG002|Overall Study|Adverse Event|2|||
170910812|NCT00491530|617677271|FG000|Overall Study|Withdrawal by Subject|3|||
170910813|NCT00491530|617677272|FG001|Overall Study|Withdrawal by Subject|0|||
170910814|NCT00491530|617677273|FG002|Overall Study|Withdrawal by Subject|0|||
170910815|NCT00491530|617677271|FG000|Overall Study|Lost to Follow-up|3|||
170910816|NCT00491530|617677272|FG001|Overall Study|Lost to Follow-up|2|||
170910817|NCT00491530|617677273|FG002|Overall Study|Lost to Follow-up|2|||
170910818|NCT00491530|617677271|FG000|Overall Study|Lack of Efficacy|0|||
170910819|NCT00491530|617677272|FG001|Overall Study|Lack of Efficacy|1|||
170910820|NCT00491530|617677273|FG002|Overall Study|Lack of Efficacy|0|||
170910821|NCT00491530|617677271|FG000|Overall Study|Investigator Discretion|0|||
170910822|NCT00491530|617677272|FG001|Overall Study|Investigator Discretion|1|||
170910823|NCT00491530|617677273|FG002|Overall Study|Investigator Discretion|0|||
170910824|NCT00491530|617677271|FG000|Overall Study|Patient Request|0|||
170910825|NCT00491530|617677272|FG001|Overall Study|Patient Request|1|||
170910826|NCT00491530|617677273|FG002|Overall Study|Patient Request|0|||
170910827|NCT00491530|617677271|FG000|Overall Study|Use of Prohibited Medication|0|||
170910828|NCT00491530|617677272|FG001|Overall Study|Use of Prohibited Medication|0|||
170910829|NCT00491530|617677273|FG002|Overall Study|Use of Prohibited Medication|1|||
170910830|NCT01396525|617677274|FG000|Overall Study|Withdrawal by Subject|8|||
170910831|NCT01396525|617677274|FG000|Overall Study|Death|14|||
170910832|NCT01396525|617677274|FG000|Overall Study|Lost to Follow-up|4|||
170910833|NCT00949650|617677275|FG000|Overall Study|Progressive disease|188|||
170586077|NCT02688088|616487613|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
170586078|NCT02688088|616487614|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
170586079|NCT02688088|616487610|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
170586080|NCT02688088|616487611|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
170586081|NCT02688088|616487612|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
170586082|NCT02688088|616487613|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
170586083|NCT02688088|616487614|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
170586084|NCT03812185|616487615|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
170586085|NCT01801436|616487630|FG000|Overall Study|Withdrawal by Subject|3|||
170586086|NCT01801436|616487630|FG000|Overall Study|Adverse Event|2|||
170586087|NCT01801436|616487630|FG000|Overall Study|Progressive disease|4|||
170586088|NCT04085458|616487631|FG000|Overall Study|Other|1|||
170586089|NCT04085458|616487631|FG000|Overall Study|Withdrawal by Subject|2|||
170586090|NCT04085458|616487631|FG000|Overall Study|Adverse Event|2|||
170586091|NCT03632993|616487632|FG000|Overall Study|Withdrawal by Subject|1|||
170586092|NCT03632993|616487633|FG001|Overall Study|Withdrawal by Subject|0|||
170586093|NCT03632993|616487634|FG002|Overall Study|Withdrawal by Subject|0|||
170586094|NCT03632993|616487635|FG003|Overall Study|Withdrawal by Subject|0|||
170586095|NCT03632993|616487636|FG004|Overall Study|Withdrawal by Subject|0|||
170586096|NCT03632993|616487637|FG005|Overall Study|Withdrawal by Subject|0|||
170586097|NCT03632993|616487638|FG006|Overall Study|Withdrawal by Subject|0|||
170910834|NCT00949650|617677276|FG001|Overall Study|Progressive disease|19|||
170910835|NCT00949650|617677275|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
170910836|NCT00949650|617677276|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
170910837|NCT00949650|617677275|FG000|Overall Study|Other Adverse Event (AE)|28|||
170910838|NCT00949650|617677276|FG001|Overall Study|Other Adverse Event (AE)|17|||
170586098|NCT03632993|616487639|FG007|Overall Study|Withdrawal by Subject|0|||
170586099|NCT03632993|616487640|FG008|Overall Study|Withdrawal by Subject|0|||
170586100|NCT03632993|616487641|FG009|Overall Study|Withdrawal by Subject|1|||
170586101|NCT03632993|616487632|FG000|Overall Study|Protocol Non-compliance|0|||
170586102|NCT03632993|616487633|FG001|Overall Study|Protocol Non-compliance|1|||
170586103|NCT03632993|616487634|FG002|Overall Study|Protocol Non-compliance|0|||
170586104|NCT03632993|616487635|FG003|Overall Study|Protocol Non-compliance|0|||
170586105|NCT03632993|616487636|FG004|Overall Study|Protocol Non-compliance|0|||
170586106|NCT03632993|616487637|FG005|Overall Study|Protocol Non-compliance|0|||
170586107|NCT03632993|616487638|FG006|Overall Study|Protocol Non-compliance|0|||
170586108|NCT03632993|616487639|FG007|Overall Study|Protocol Non-compliance|0|||
170586109|NCT03632993|616487640|FG008|Overall Study|Protocol Non-compliance|0|||
170910839|NCT00949650|617677275|FG000|Overall Study|Protocol Violation|1|||
170910840|NCT00949650|617677276|FG001|Overall Study|Protocol Violation|4|||
170910841|NCT00949650|617677275|FG000|Overall Study|Refusal to continue medication|7|||
170910842|NCT00949650|617677276|FG001|Overall Study|Refusal to continue medication|11|||
170910843|NCT00949650|617677275|FG000|Overall Study|Not treated|1|||
170910844|NCT00949650|617677276|FG001|Overall Study|Not treated|4|||
170910845|NCT00949650|617677275|FG000|Overall Study|Other not specified above|5|||
170586110|NCT03632993|616487641|FG009|Overall Study|Protocol Non-compliance|0|||
170586111|NCT03632993|616487632|FG000|Overall Study|Lost to Follow-up|0|||
170586112|NCT03632993|616487633|FG001|Overall Study|Lost to Follow-up|0|||
170586113|NCT03632993|616487634|FG002|Overall Study|Lost to Follow-up|0|||
170586114|NCT03632993|616487635|FG003|Overall Study|Lost to Follow-up|0|||
170586115|NCT03632993|616487636|FG004|Overall Study|Lost to Follow-up|0|||
170586116|NCT03632993|616487637|FG005|Overall Study|Lost to Follow-up|1|||
170586117|NCT03632993|616487638|FG006|Overall Study|Lost to Follow-up|0|||
170586118|NCT03632993|616487639|FG007|Overall Study|Lost to Follow-up|1|||
170586119|NCT03632993|616487640|FG008|Overall Study|Lost to Follow-up|0|||
170586120|NCT03632993|616487641|FG009|Overall Study|Lost to Follow-up|0|||
170586121|NCT03632993|616487632|FG000|Overall Study|Adverse Event|0|||
170586122|NCT03632993|616487633|FG001|Overall Study|Adverse Event|0|||
170586123|NCT03632993|616487634|FG002|Overall Study|Adverse Event|0|||
170586124|NCT03632993|616487635|FG003|Overall Study|Adverse Event|0|||
170586125|NCT03632993|616487636|FG004|Overall Study|Adverse Event|0|||
170586126|NCT03632993|616487637|FG005|Overall Study|Adverse Event|1|||
170586127|NCT03632993|616487638|FG006|Overall Study|Adverse Event|0|||
170586128|NCT03632993|616487639|FG007|Overall Study|Adverse Event|1|||
170586129|NCT03632993|616487640|FG008|Overall Study|Adverse Event|0|||
170586130|NCT03632993|616487641|FG009|Overall Study|Adverse Event|0|||
170586131|NCT01921218|616487642|FG000|Overall Study|Death|2|||
170586132|NCT01921218|616487643|FG001|Overall Study|Death|1|||
170586133|NCT01921218|616487642|FG000|Overall Study|Withdrawal by Subject|0|||
170586134|NCT01921218|616487643|FG001|Overall Study|Withdrawal by Subject|2|||
170586135|NCT01921218|616487642|FG000|Overall Study|Kidney transplant|1|||
170586136|NCT01921218|616487643|FG001|Overall Study|Kidney transplant|1|||
170586137|NCT00873041|616487648|FG000|Core Study|Adverse Event|2|||
170586138|NCT00873041|616487649|FG001|Core Study|Adverse Event|3|||
170586139|NCT00873041|616487650|FG002|Core Study|Adverse Event|1|||
170586140|NCT00873041|616487648|FG000|Core Study|Withdrawal by Subject|1|||
170586141|NCT00873041|616487649|FG001|Core Study|Withdrawal by Subject|2|||
170586142|NCT00873041|616487650|FG002|Core Study|Withdrawal by Subject|2|||
170586143|NCT00873041|616487648|FG000|Core Study|Lost to Follow-up|3|||
170586144|NCT00873041|616487649|FG001|Core Study|Lost to Follow-up|1|||
170586145|NCT00873041|616487650|FG002|Core Study|Lost to Follow-up|0|||
170586146|NCT00873041|616487648|FG000|Core Study|Abnormal laboratory value|0|||
170586147|NCT00873041|616487649|FG001|Core Study|Abnormal laboratory value|0|||
170586148|NCT00873041|616487650|FG002|Core Study|Abnormal laboratory value|1|||
170586149|NCT00873041|616487648|FG000|Core Study|Protocol deviation|1|||
170586150|NCT00873041|616487649|FG001|Core Study|Protocol deviation|0|||
170586151|NCT00873041|616487650|FG002|Core Study|Protocol deviation|1|||
170586152|NCT00873041|616487648|FG000|Extension Study|Adverse Event|1|||
170586153|NCT00873041|616487649|FG001|Extension Study|Adverse Event|0|||
170586154|NCT00873041|616487650|FG002|Extension Study|Adverse Event|1|||
170586155|NCT00873041|616487648|FG000|Extension Study|Administrative reasons|0|||
170586156|NCT00873041|616487649|FG001|Extension Study|Administrative reasons|0|||
170586157|NCT00873041|616487650|FG002|Extension Study|Administrative reasons|1|||
170586158|NCT00090142|616487653|FG000|Treatment Period I|Lost to Follow-up|1|||
170586159|NCT00090142|616487654|FG001|Treatment Period I|Lost to Follow-up|2|||
170586160|NCT00090142|616487653|FG000|Treatment Period I|Protocol Violation|2|||
170586161|NCT00090142|616487654|FG001|Treatment Period I|Protocol Violation|0|||
170586162|NCT00090142|616487653|FG000|Treatment Period I|Withdrawal by Subject|2|||
170586163|NCT00090142|616487654|FG001|Treatment Period I|Withdrawal by Subject|0|||
170586164|NCT00090142|616487653|FG000|Treatment Period I|Other|0|||
170586165|NCT00090142|616487654|FG001|Treatment Period I|Other|1|||
170586166|NCT00090142|616487653|FG000|Treatment Period II|Other|1|||
170650015|NCT00609362|616732799|FG000|Overall Study|Withdrawal by Subject|2|||
170586167|NCT00090142|616487654|FG001|Treatment Period II|Other|0|||
170586168|NCT01126437|616487655|FG000|Overall Study|Not treated|11|||
170586169|NCT01126437|616487656|FG001|Overall Study|Not treated|18|||
170586170|NCT01126437|616487657|FG002|Overall Study|Not treated|19|||
170586171|NCT01126437|616487655|FG000|Overall Study|Sites with data irregularities/fraud|6|||
170586172|NCT01126437|616487656|FG001|Overall Study|Sites with data irregularities/fraud|6|||
170586173|NCT01126437|616487657|FG002|Overall Study|Sites with data irregularities/fraud|7|||
170586174|NCT01126437|616487655|FG000|Overall Study|Adverse Event|602|||
170650016|NCT00609362|616732800|FG001|Overall Study|Withdrawal by Subject|1|||
170809946|NCT02686658|617313884|FG001|Overall Study|Placed in hospice care|0|||
170809947|NCT02686658|617313885|FG002|Overall Study|Placed in hospice care|1|||
170809948|NCT02686658|617313886|FG003|Overall Study|Placed in hospice care|0|||
170809949|NCT02686658|617313887|FG004|Overall Study|Placed in hospice care|0|||
170809950|NCT02686658|617313888|FG005|Overall Study|Placed in hospice care|0|||
170809951|NCT02686658|617313883|FG000|Overall Study|Participant non-compliance|0|||
170586175|NCT01126437|616487656|FG001|Overall Study|Adverse Event|606|||
170586176|NCT01126437|616487657|FG002|Overall Study|Adverse Event|635|||
170586177|NCT01126437|616487655|FG000|Overall Study|Lack of Efficacy|65|||
170650017|NCT00609362|616732799|FG000|Overall Study|Adverse Event|1|||
170586178|NCT01126437|616487656|FG001|Overall Study|Lack of Efficacy|60|||
170586179|NCT01126437|616487657|FG002|Overall Study|Lack of Efficacy|59|||
170650018|NCT00609362|616732800|FG001|Overall Study|Adverse Event|0|||
170586180|NCT01126437|616487655|FG000|Overall Study|Protocol Violation|64|||
170809952|NCT02686658|617313884|FG001|Overall Study|Participant non-compliance|0|||
170586181|NCT01126437|616487656|FG001|Overall Study|Protocol Violation|66|||
170586182|NCT01126437|616487657|FG002|Overall Study|Protocol Violation|41|||
170586183|NCT01126437|616487655|FG000|Overall Study|Lost to Follow-up|52|||
170586184|NCT01126437|616487656|FG001|Overall Study|Lost to Follow-up|63|||
170586185|NCT01126437|616487657|FG002|Overall Study|Lost to Follow-up|55|||
170586186|NCT01126437|616487655|FG000|Overall Study|Withdrawal by Subject|331|||
170586187|NCT01126437|616487656|FG001|Overall Study|Withdrawal by Subject|335|||
170586188|NCT01126437|616487657|FG002|Overall Study|Withdrawal by Subject|319|||
170586189|NCT01126437|616487655|FG000|Overall Study|Other reason not specified|210|||
170910846|NCT00949650|617677276|FG001|Overall Study|Other not specified above|0|||
170910847|NCT00971321|617677277|FG000|Up to Month 7|Withdrawal by Subject|1|||
170910848|NCT00971321|617677278|FG001|Up to Month 7|Withdrawal by Subject|0|||
170586190|NCT01126437|616487656|FG001|Overall Study|Other reason not specified|176|||
170586191|NCT01126437|616487657|FG002|Overall Study|Other reason not specified|178|||
170586192|NCT00006046|616487663|FG000|Overall Study|Adverse Event|3|||
170586193|NCT00006046|616487664|FG001|Overall Study|Adverse Event|0|||
170586194|NCT00006046|616487665|FG002|Overall Study|Adverse Event|0|||
170586195|NCT00006046|616487666|FG003|Overall Study|Adverse Event|0|||
170586196|NCT00006046|616487667|FG004|Overall Study|Adverse Event|0|||
170586197|NCT00006046|616487663|FG000|Overall Study|Disease Progression|2|||
170586198|NCT00006046|616487664|FG001|Overall Study|Disease Progression|0|||
170586199|NCT00006046|616487665|FG002|Overall Study|Disease Progression|0|||
170586200|NCT00006046|616487666|FG003|Overall Study|Disease Progression|0|||
170586201|NCT00006046|616487667|FG004|Overall Study|Disease Progression|0|||
170586202|NCT03272828|616487668|FG000|Overall Study|Lost to Follow-up|7|||
170586203|NCT03272828|616487669|FG001|Overall Study|Lost to Follow-up|7|||
170586204|NCT03272828|616487668|FG000|Overall Study|Withdrawal by Subject|2|||
170586205|NCT03272828|616487669|FG001|Overall Study|Withdrawal by Subject|0|||
170586206|NCT03272828|616487668|FG000|Overall Study|Deceased|1|||
170586207|NCT03272828|616487669|FG001|Overall Study|Deceased|1|||
170586208|NCT03272828|616487668|FG000|Overall Study|Failed implant|1|||
170586209|NCT03272828|616487669|FG001|Overall Study|Failed implant|2|||
170586210|NCT00642369|616487679|FG000|Overall Study|Adverse Event|2|||
170586211|NCT00642369|616487680|FG001|Overall Study|Adverse Event|3|||
170586212|NCT00642369|616487679|FG000|Overall Study|Withdrawal by Subject|1|||
170586213|NCT00642369|616487680|FG001|Overall Study|Withdrawal by Subject|0|||
170586214|NCT00642369|616487679|FG000|Overall Study|misdiagnosis|0|||
170586215|NCT00642369|616487680|FG001|Overall Study|misdiagnosis|1|||
170586216|NCT00642369|616487679|FG000|Overall Study|Lack of Efficacy|2|||
170586217|NCT00642369|616487680|FG001|Overall Study|Lack of Efficacy|2|||
170586218|NCT00585546|616487681|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
170586219|NCT00585546|616487681|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
170586220|NCT01562314|616487682|FG000|Overall Study|Adverse Event|10|||
170586221|NCT01562314|616487683|FG001|Overall Study|Adverse Event|5|||
170586222|NCT01562314|616487682|FG000|Overall Study|Met Withdrawal Criteria|3|||
170586223|NCT01562314|616487683|FG001|Overall Study|Met Withdrawal Criteria|2|||
170586224|NCT01562314|616487682|FG000|Overall Study|Withdrawal by Subject|0|||
170586225|NCT01562314|616487683|FG001|Overall Study|Withdrawal by Subject|1|||
170586226|NCT03077438|616487690|FG000|Overall Study|Protocol Violation|3|||
170586227|NCT03077438|616487691|FG001|Overall Study|Protocol Violation|5|||
170586228|NCT03077438|616487690|FG000|Overall Study|Withdrawal by Subject|3|||
170586229|NCT03077438|616487691|FG001|Overall Study|Withdrawal by Subject|6|||
170586230|NCT03077438|616487690|FG000|Overall Study|Lost to Follow-up|6|||
170586231|NCT03077438|616487691|FG001|Overall Study|Lost to Follow-up|3|||
170910849|NCT00971321|617677277|FG000|Up to Month 7|Migrated/moved from study area|3|||
170910850|NCT00971321|617677278|FG001|Up to Month 7|Migrated/moved from study area|2|||
170910851|NCT00971321|617677277|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
170910852|NCT00971321|617677278|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
170910853|NCT00971321|617677277|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
170586232|NCT00996281|616487705|FG000|Overall Study|Adverse Event|75|||
170586233|NCT00996281|616487706|FG001|Overall Study|Adverse Event|37|||
170586234|NCT00996281|616487705|FG000|Overall Study|Major Protocol Deviation|6|||
170586235|NCT00996281|616487706|FG001|Overall Study|Major Protocol Deviation|7|||
170586236|NCT00996281|616487705|FG000|Overall Study|Lost to Follow-up|14|||
170586237|NCT00996281|616487706|FG001|Overall Study|Lost to Follow-up|16|||
170910854|NCT00971321|617677278|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
170910855|NCT00971321|617677277|FG000|Up to Month 11-12|Lost to Follow-up|1|||
170586238|NCT00996281|616487705|FG000|Overall Study|Withdrawal by Subject|31|||
170586239|NCT00996281|616487706|FG001|Overall Study|Withdrawal by Subject|20|||
170586240|NCT00996281|616487705|FG000|Overall Study|Lack of Efficacy|0|||
170586241|NCT00996281|616487706|FG001|Overall Study|Lack of Efficacy|2|||
170586242|NCT00996281|616487705|FG000|Overall Study|Other|5|||
170586243|NCT00996281|616487706|FG001|Overall Study|Other|7|||
170586244|NCT03888235|616487707|FG000|Overall Study|Lost to Follow-up|1|||
170586245|NCT03888235|616487708|FG001|Overall Study|Lost to Follow-up|1|||
170586246|NCT03888235|616487709|FG002|Overall Study|Lost to Follow-up|0|||
170586247|NCT00675441|616487720|FG000|Overall Study|Withdrawal by Subject|2|||
170586248|NCT00675441|616487720|FG000|Overall Study|Death|1|||
170586249|NCT03802630|616487724|FG000|Overall Study|Study terminated by sponsor|130|||
170586250|NCT03802630|616487725|FG001|Overall Study|Study terminated by sponsor|134|||
170586251|NCT03802630|616487724|FG000|Overall Study|Subject decision|16|||
170586252|NCT03802630|616487725|FG001|Overall Study|Subject decision|9|||
170586253|NCT03802630|616487724|FG000|Overall Study|Adverse Event|3|||
170586254|NCT03802630|616487725|FG001|Overall Study|Adverse Event|1|||
170586255|NCT03802630|616487724|FG000|Overall Study|Lost to Follow-up|2|||
170586256|NCT03802630|616487725|FG001|Overall Study|Lost to Follow-up|2|||
170586257|NCT03802630|616487724|FG000|Overall Study|Physician Decision|2|||
170586258|NCT03802630|616487725|FG001|Overall Study|Physician Decision|0|||
170586259|NCT03802630|616487724|FG000|Overall Study|Death|0|||
170586260|NCT03802630|616487725|FG001|Overall Study|Death|2|||
170586261|NCT03989349|616487726|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
170586262|NCT03989349|616487727|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170586263|NCT03989349|616487728|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170586264|NCT03989349|616487729|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170586265|NCT03989349|616487730|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170586266|NCT03989349|616487731|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
170586267|NCT03989349|616487726|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
170586268|NCT03989349|616487727|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
170586269|NCT03989349|616487728|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
170586270|NCT03989349|616487729|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
170586271|NCT03989349|616487730|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
170586272|NCT03989349|616487731|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
170586273|NCT03989349|616487726|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
170586274|NCT03989349|616487727|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
170586275|NCT03989349|616487728|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
170586276|NCT03989349|616487729|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
170586277|NCT03989349|616487730|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
170586278|NCT03989349|616487731|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
170586279|NCT03989349|616487726|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
170586280|NCT03989349|616487727|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
170586281|NCT03989349|616487728|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170586282|NCT03989349|616487729|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170586283|NCT03989349|616487730|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170586284|NCT03989349|616487731|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
170650019|NCT00548405|616732801|FG000|Overall Study|Adverse Event|6|||
170650020|NCT00548405|616732802|FG001|Overall Study|Adverse Event|2|||
170650021|NCT00548405|616732803|FG002|Overall Study|Adverse Event|0|||
170650022|NCT00548405|616732801|FG000|Overall Study|Lack of Efficacy|6|||
170650023|NCT00548405|616732802|FG001|Overall Study|Lack of Efficacy|0|||
170650024|NCT00548405|616732803|FG002|Overall Study|Lack of Efficacy|0|||
170650025|NCT00548405|616732801|FG000|Overall Study|Physician Decision|3|||
170650026|NCT00548405|616732802|FG001|Overall Study|Physician Decision|4|||
170650027|NCT00548405|616732803|FG002|Overall Study|Physician Decision|1|||
170650028|NCT00548405|616732801|FG000|Overall Study|Pregnancy|1|||
170650029|NCT00548405|616732802|FG001|Overall Study|Pregnancy|0|||
170650030|NCT00548405|616732803|FG002|Overall Study|Pregnancy|0|||
170650031|NCT00548405|616732801|FG000|Overall Study|Protocol Violation|1|||
170650032|NCT00548405|616732802|FG001|Overall Study|Protocol Violation|0|||
170650033|NCT00548405|616732803|FG002|Overall Study|Protocol Violation|0|||
170650034|NCT00548405|616732801|FG000|Overall Study|Withdrawal by Subject|36|||
170586285|NCT03989349|616487726|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
170586286|NCT03989349|616487727|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
170586287|NCT03989349|616487728|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
170586288|NCT03989349|616487729|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
170586289|NCT03989349|616487730|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
170586290|NCT03989349|616487731|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
170586291|NCT03989349|616487726|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
170586292|NCT03989349|616487727|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
170650035|NCT00548405|616732802|FG001|Overall Study|Withdrawal by Subject|12|||
170586293|NCT03989349|616487728|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
170650036|NCT00548405|616732803|FG002|Overall Study|Withdrawal by Subject|5|||
170650037|NCT00548405|616732801|FG000|Overall Study|Lost to Follow-up|1|||
170650038|NCT00548405|616732802|FG001|Overall Study|Lost to Follow-up|1|||
170650039|NCT00548405|616732803|FG002|Overall Study|Lost to Follow-up|2|||
170650040|NCT00548405|616732801|FG000|Overall Study|Death|0|||
170650041|NCT00548405|616732802|FG001|Overall Study|Death|1|||
170650042|NCT00548405|616732803|FG002|Overall Study|Death|1|||
170650043|NCT00548405|616732801|FG000|Overall Study|Sponsor decision|1|||
170586294|NCT03989349|616487729|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
170586295|NCT03989349|616487730|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
170586296|NCT03989349|616487731|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
170586297|NCT03989349|616487726|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
170586298|NCT03989349|616487727|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
170586299|NCT03989349|616487728|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
170586300|NCT03989349|616487729|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
170586301|NCT03989349|616487730|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
170586302|NCT03989349|616487731|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
170586303|NCT03989349|616487726|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
170586304|NCT03989349|616487727|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
170586305|NCT03989349|616487728|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
170586306|NCT03989349|616487729|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
170586307|NCT03989349|616487730|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
170586308|NCT03989349|616487731|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
170586309|NCT03989349|616487726|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
170586310|NCT03989349|616487727|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
170586311|NCT03989349|616487728|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
170586312|NCT03989349|616487729|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
170586313|NCT03989349|616487730|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
170586314|NCT03989349|616487731|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
170586315|NCT03989349|616487726|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
170586316|NCT03989349|616487727|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
170586317|NCT03989349|616487728|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
170586318|NCT03989349|616487729|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
170586319|NCT03989349|616487730|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
170586320|NCT03989349|616487731|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
170586321|NCT03989349|616487726|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170586322|NCT03989349|616487727|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170586323|NCT03989349|616487728|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
170586324|NCT03989349|616487729|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170586325|NCT03989349|616487730|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
170586326|NCT03989349|616487731|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170586327|NCT03989349|616487726|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
170586328|NCT03989349|616487727|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
170586329|NCT03989349|616487728|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
170586330|NCT03989349|616487729|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
170586331|NCT03989349|616487730|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
170586332|NCT03989349|616487731|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
170586333|NCT03989349|616487726|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
170586334|NCT03989349|616487727|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
170586335|NCT03989349|616487728|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
170586336|NCT03989349|616487729|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
170586337|NCT03989349|616487730|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
170586338|NCT03989349|616487731|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
170586339|NCT03989349|616487726|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
170586340|NCT03989349|616487727|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
170586341|NCT03989349|616487728|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
170586342|NCT03989349|616487729|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
170586343|NCT03989349|616487730|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
170586344|NCT03989349|616487731|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
170586345|NCT02248649|616487732|FG000|Overall Study|Death|7|||
170586346|NCT02248649|616487733|FG001|Overall Study|Death|11|||
170586347|NCT02248649|616487732|FG000|Overall Study|Lost to Follow-up|14|||
170586348|NCT02248649|616487733|FG001|Overall Study|Lost to Follow-up|10|||
170586349|NCT01327053|616487736|FG000|Overall Study|Adverse Event|23|||
170586350|NCT01327053|616487737|FG001|Overall Study|Adverse Event|57|||
170586351|NCT01327053|616487736|FG000|Overall Study|Patient/guardian decision|11|||
170586352|NCT01327053|616487737|FG001|Overall Study|Patient/guardian decision|35|||
170586353|NCT01327053|616487736|FG000|Overall Study|Physician Decision|10|||
170586354|NCT01327053|616487737|FG001|Overall Study|Physician Decision|14|||
170586355|NCT01327053|616487736|FG000|Overall Study|Death|1|||
170586356|NCT01327053|616487737|FG001|Overall Study|Death|5|||
170586357|NCT01327053|616487736|FG000|Overall Study|Lost to Follow-up|2|||
170586358|NCT01327053|616487737|FG001|Overall Study|Lost to Follow-up|4|||
170586359|NCT01327053|616487736|FG000|Overall Study|Non-compliance with study treatment|0|||
170586360|NCT01327053|616487737|FG001|Overall Study|Non-compliance with study treatment|5|||
170586361|NCT01327053|616487736|FG000|Overall Study|Study terminated by Sponsor|1|||
170586362|NCT01327053|616487737|FG001|Overall Study|Study terminated by Sponsor|3|||
170586363|NCT01327053|616487736|FG000|Overall Study|Progressive disease|31|||
170586364|NCT01327053|616487737|FG001|Overall Study|Progressive disease|26|||
170586365|NCT01327053|616487736|FG000|Overall Study|Protocol Violation|0|||
170586366|NCT01327053|616487737|FG001|Overall Study|Protocol Violation|1|||
170586367|NCT01327053|616487736|FG000|Overall Study|Untreated|0|||
170586368|NCT01327053|616487737|FG001|Overall Study|Untreated|1|||
170586369|NCT00778258|616487742|FG000|Overall Study|Adverse Event|1|||
170586370|NCT00778258|616487743|FG001|Overall Study|Adverse Event|0|||
170586371|NCT00778258|616487744|FG002|Overall Study|Adverse Event|0|||
170586372|NCT00778258|616487745|FG003|Overall Study|Adverse Event|0|||
170586373|NCT00778258|616487746|FG004|Overall Study|Adverse Event|0|||
170586374|NCT00778258|616487747|FG005|Overall Study|Adverse Event|1|||
170586375|NCT00778258|616487748|FG006|Overall Study|Adverse Event|0|||
170586376|NCT00778258|616487749|FG007|Overall Study|Adverse Event|0|||
170586377|NCT00778258|616487750|FG008|Overall Study|Adverse Event|0|||
170586378|NCT00778258|616487742|FG000|Overall Study|Lost to Follow-up|0|||
170586379|NCT00778258|616487743|FG001|Overall Study|Lost to Follow-up|0|||
170586380|NCT00778258|616487744|FG002|Overall Study|Lost to Follow-up|2|||
170586381|NCT00778258|616487745|FG003|Overall Study|Lost to Follow-up|0|||
170586382|NCT00778258|616487746|FG004|Overall Study|Lost to Follow-up|0|||
170586383|NCT00778258|616487747|FG005|Overall Study|Lost to Follow-up|3|||
170586384|NCT00778258|616487748|FG006|Overall Study|Lost to Follow-up|2|||
170586385|NCT00778258|616487749|FG007|Overall Study|Lost to Follow-up|2|||
170586386|NCT00778258|616487750|FG008|Overall Study|Lost to Follow-up|0|||
170586387|NCT00778258|616487742|FG000|Overall Study|Withdrawal by Subject|6|||
170586388|NCT00778258|616487743|FG001|Overall Study|Withdrawal by Subject|2|||
170586389|NCT00778258|616487744|FG002|Overall Study|Withdrawal by Subject|8|||
170586390|NCT00778258|616487745|FG003|Overall Study|Withdrawal by Subject|2|||
170586391|NCT00778258|616487746|FG004|Overall Study|Withdrawal by Subject|0|||
170586392|NCT00778258|616487747|FG005|Overall Study|Withdrawal by Subject|6|||
170586393|NCT00778258|616487748|FG006|Overall Study|Withdrawal by Subject|12|||
170586394|NCT00778258|616487749|FG007|Overall Study|Withdrawal by Subject|12|||
170586395|NCT00778258|616487750|FG008|Overall Study|Withdrawal by Subject|4|||
170586396|NCT00778258|616487742|FG000|Overall Study|New Contraindication|0|||
170586397|NCT00778258|616487743|FG001|Overall Study|New Contraindication|0|||
170586398|NCT00778258|616487744|FG002|Overall Study|New Contraindication|0|||
170586399|NCT00778258|616487745|FG003|Overall Study|New Contraindication|0|||
170586400|NCT00778258|616487746|FG004|Overall Study|New Contraindication|0|||
170586401|NCT00778258|616487747|FG005|Overall Study|New Contraindication|0|||
170586402|NCT00778258|616487748|FG006|Overall Study|New Contraindication|0|||
170586403|NCT00778258|616487749|FG007|Overall Study|New Contraindication|1|||
170586404|NCT00778258|616487750|FG008|Overall Study|New Contraindication|0|||
170586405|NCT00778258|616487742|FG000|Overall Study|Non-compliance|0|||
170586406|NCT00778258|616487743|FG001|Overall Study|Non-compliance|0|||
170586407|NCT00778258|616487744|FG002|Overall Study|Non-compliance|0|||
170586408|NCT00778258|616487745|FG003|Overall Study|Non-compliance|1|||
170586409|NCT00778258|616487746|FG004|Overall Study|Non-compliance|0|||
170586410|NCT00778258|616487747|FG005|Overall Study|Non-compliance|0|||
170586411|NCT00778258|616487748|FG006|Overall Study|Non-compliance|0|||
170586412|NCT00778258|616487749|FG007|Overall Study|Non-compliance|0|||
170586413|NCT00778258|616487750|FG008|Overall Study|Non-compliance|0|||
170586414|NCT00778258|616487742|FG000|Overall Study|Other|0|||
170586415|NCT00778258|616487743|FG001|Overall Study|Other|0|||
170586416|NCT00778258|616487744|FG002|Overall Study|Other|0|||
170586417|NCT00778258|616487745|FG003|Overall Study|Other|0|||
170586418|NCT00778258|616487746|FG004|Overall Study|Other|0|||
170586419|NCT00778258|616487747|FG005|Overall Study|Other|0|||
170586420|NCT00778258|616487748|FG006|Overall Study|Other|1|||
170586421|NCT00778258|616487749|FG007|Overall Study|Other|0|||
170586422|NCT00778258|616487750|FG008|Overall Study|Other|0|||
170650044|NCT00548405|616732802|FG001|Overall Study|Sponsor decision|0|||
170650045|NCT00548405|616732803|FG002|Overall Study|Sponsor decision|0|||
170650046|NCT00548405|616732801|FG000|Overall Study|Randomized but not treated|1|||
170650047|NCT00548405|616732802|FG001|Overall Study|Randomized but not treated|0|||
170650048|NCT00548405|616732803|FG002|Overall Study|Randomized but not treated|0|||
170809953|NCT02686658|617313885|FG002|Overall Study|Participant non-compliance|0|||
170650049|NCT05027971|616732807|FG000|Overall Study|Physician Decision|7|||
170650050|NCT05027971|616732808|FG001|Overall Study|Physician Decision|3|||
170586423|NCT00583752|616487753|FG000|Overall Study|Lost to Follow-up|5|||
170586424|NCT00583752|616487754|FG001|Overall Study|Lost to Follow-up|5|||
170586425|NCT00107900|616487755|FG000|Overall Study|Adverse Event|3|||
170586426|NCT00107900|616487756|FG001|Overall Study|Adverse Event|2|||
170586427|NCT00107900|616487757|FG002|Overall Study|Adverse Event|10|||
170586428|NCT00107900|616487758|FG003|Overall Study|Adverse Event|3|||
170586429|NCT00107900|616487759|FG004|Overall Study|Adverse Event|5|||
170586430|NCT00107900|616487760|FG005|Overall Study|Adverse Event|3|||
170586431|NCT00107900|616487755|FG000|Overall Study|Death|0|||
170910856|NCT00971321|617677278|FG001|Up to Month 11-12|Lost to Follow-up|0|||
170586432|NCT00107900|616487756|FG001|Overall Study|Death|0|||
170586433|NCT00107900|616487757|FG002|Overall Study|Death|0|||
170586434|NCT00107900|616487758|FG003|Overall Study|Death|0|||
170586435|NCT00107900|616487759|FG004|Overall Study|Death|1|||
170586436|NCT00107900|616487760|FG005|Overall Study|Death|0|||
170586437|NCT00107900|616487755|FG000|Overall Study|Lost to Follow-up|4|||
170586438|NCT00107900|616487756|FG001|Overall Study|Lost to Follow-up|1|||
170586439|NCT00107900|616487757|FG002|Overall Study|Lost to Follow-up|3|||
170586440|NCT00107900|616487758|FG003|Overall Study|Lost to Follow-up|2|||
170586441|NCT00107900|616487759|FG004|Overall Study|Lost to Follow-up|5|||
170586442|NCT00107900|616487760|FG005|Overall Study|Lost to Follow-up|5|||
170586443|NCT00107900|616487755|FG000|Overall Study|Protocol Violation|1|||
170586444|NCT00107900|616487756|FG001|Overall Study|Protocol Violation|0|||
170586445|NCT00107900|616487757|FG002|Overall Study|Protocol Violation|5|||
170586446|NCT00107900|616487758|FG003|Overall Study|Protocol Violation|5|||
170586447|NCT00107900|616487759|FG004|Overall Study|Protocol Violation|7|||
170586448|NCT00107900|616487760|FG005|Overall Study|Protocol Violation|0|||
170586449|NCT00107900|616487755|FG000|Overall Study|Withdrawal by Subject|1|||
170586450|NCT00107900|616487756|FG001|Overall Study|Withdrawal by Subject|0|||
170586451|NCT00107900|616487757|FG002|Overall Study|Withdrawal by Subject|5|||
170586452|NCT00107900|616487758|FG003|Overall Study|Withdrawal by Subject|0|||
170586453|NCT00107900|616487759|FG004|Overall Study|Withdrawal by Subject|1|||
170586454|NCT00107900|616487760|FG005|Overall Study|Withdrawal by Subject|1|||
170586455|NCT00107900|616487755|FG000|Overall Study|Administrative Reasons|1|||
170586456|NCT00107900|616487756|FG001|Overall Study|Administrative Reasons|0|||
170586457|NCT00107900|616487757|FG002|Overall Study|Administrative Reasons|2|||
170910857|NCT04601272|617677280|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
170910858|NCT04601272|617677281|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
170910859|NCT04601272|617677282|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
170910860|NCT04382651|617677287|FG000|Overall Study|Death|26|||
170910861|NCT04382651|617677288|FG001|Overall Study|Death|23|||
170586458|NCT00107900|616487758|FG003|Overall Study|Administrative Reasons|2|||
170586459|NCT00107900|616487759|FG004|Overall Study|Administrative Reasons|2|||
170586460|NCT00107900|616487760|FG005|Overall Study|Administrative Reasons|0|||
170586461|NCT00871923|616489209|FG000|Overall Study|Death|1|||
170586462|NCT00871923|616489209|FG000|Overall Study|Withdrawal by Subject|1|||
170586463|NCT00496483|616489215|FG000|Overall Study|Not dosed|9|||
170586464|NCT00496483|616489215|FG000|Overall Study|Adverse Event|2|||
170586465|NCT00496483|616489215|FG000|Overall Study|Lack of Efficacy|1|||
170586466|NCT00303446|616489217|FG000|Overall Study|Withdrawal by Subject|2|||
170586467|NCT00303446|616489218|FG001|Overall Study|Withdrawal by Subject|2|||
170586468|NCT00303446|616489217|FG000|Overall Study|Death|0|||
170586469|NCT00303446|616489218|FG001|Overall Study|Death|1|||
170586470|NCT00303446|616489217|FG000|Overall Study|Physician Decision|0|||
170586471|NCT00303446|616489218|FG001|Overall Study|Physician Decision|1|||
170586472|NCT04258995|616489219|FG000|Overall Study|Lost to Follow-up|1|||
170586473|NCT04258995|616489220|FG001|Overall Study|Lost to Follow-up|1|||
170586474|NCT03285958|616489222|FG000|Overall Study|Lost to Follow-up|1|||
170586475|NCT03285958|616489223|FG001|Overall Study|Lost to Follow-up|1|||
170586476|NCT03285958|616489222|FG000|Overall Study|Withdrawal by Subject|1|||
170586477|NCT03285958|616489223|FG001|Overall Study|Withdrawal by Subject|0|||
170586478|NCT03285958|616489222|FG000|Overall Study|Not able to attend required orientation|3|||
170586479|NCT03285958|616489223|FG001|Overall Study|Not able to attend required orientation|0|||
170586480|NCT03116828|616489225|FG000|Overall Study|Adverse Event|1|||
170586481|NCT03116828|616489226|FG001|Overall Study|Adverse Event|10|||
170586482|NCT03116828|616489225|FG000|Overall Study|Withdrawal by Subject|4|||
170586483|NCT03116828|616489226|FG001|Overall Study|Withdrawal by Subject|8|||
170586484|NCT03116828|616489225|FG000|Overall Study|OTHER|3|||
170586485|NCT03116828|616489226|FG001|Overall Study|OTHER|3|||
170586486|NCT02998203|616489229|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
170586487|NCT02998203|616489230|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
170586488|NCT02998203|616489229|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
170586489|NCT02998203|616489230|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
170586490|NCT02447250|616489244|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
170586491|NCT02447250|616489244|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
170586492|NCT02447250|616489244|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
170586493|NCT04952597|616489245|FG000|Overall Study|Death|12|||
170910862|NCT04382651|617677287|FG000|Overall Study|Lost to Follow-up|3|||
170586494|NCT04952597|616489246|FG001|Overall Study|Death|13|||
170586495|NCT04952597|616489247|FG002|Overall Study|Death|14|||
170586496|NCT04952597|616489245|FG000|Overall Study|Withdrawal by Subject|1|||
170586497|NCT04952597|616489246|FG001|Overall Study|Withdrawal by Subject|0|||
170586498|NCT04952597|616489247|FG002|Overall Study|Withdrawal by Subject|3|||
170586499|NCT04952597|616489245|FG000|Overall Study|Lost to Follow-up|0|||
170586500|NCT04952597|616489246|FG001|Overall Study|Lost to Follow-up|1|||
170586501|NCT04952597|616489247|FG002|Overall Study|Lost to Follow-up|1|||
170586502|NCT00632827|616489248|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
170586503|NCT00632827|616489248|FG000|Overall Study|Death|2|||
170586504|NCT00632827|616489248|FG000|Overall Study|Adverse Event|5|||
170586505|NCT00632827|616489248|FG000|Overall Study|Lost to Follow-up|1|||
170586506|NCT01498575|616489249|FG000|Overall Sample|Withdrawal by Subject|60|||
170586507|NCT01498575|616489250|FG001|Overall Sample|Withdrawal by Subject|14|||
170586508|NCT01498575|616489249|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
170586509|NCT01498575|616489250|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
170586510|NCT01498575|616489249|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
170586511|NCT01498575|616489250|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
170586512|NCT00368836|616489251|FG000|Phase II|Screen Failure|1|||
170586513|NCT00368836|616489251|FG000|Phase II|Withdrawal by Subject|1|||
170586514|NCT00368836|616489251|FG000|Phase II|unable to collect blood and/or breath|17|||
170586515|NCT00368836|616489251|FG000|Phase II|Protocol Violation|2|||
170586516|NCT01082874|616489253|FG000|Overall Study|Lost to Follow-up|10|||
170586517|NCT01082874|616489254|FG001|Overall Study|Lost to Follow-up|10|||
170586518|NCT01082874|616489255|FG002|Overall Study|Lost to Follow-up|6|||
170586519|NCT01082874|616489256|FG003|Overall Study|Lost to Follow-up|10|||
170586520|NCT01082874|616489253|FG000|Overall Study|Withdrawal by Subject|1|||
170586521|NCT01082874|616489254|FG001|Overall Study|Withdrawal by Subject|2|||
170586522|NCT01082874|616489255|FG002|Overall Study|Withdrawal by Subject|5|||
170586523|NCT01082874|616489256|FG003|Overall Study|Withdrawal by Subject|3|||
170586524|NCT01345591|616489266|FG000|Overall Study|Lost to Follow-up|1|||
170586525|NCT02851797|616489275|FG000|Overall Study|Withdrawal by Subject|4|||
170586526|NCT02851797|616489276|FG001|Overall Study|Withdrawal by Subject|2|||
170586527|NCT02851797|616489275|FG000|Overall Study|Adverse Event|3|||
170586528|NCT02851797|616489276|FG001|Overall Study|Adverse Event|0|||
170586529|NCT01229254|616489282|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
170586530|NCT01229254|616489283|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
170586531|NCT01229254|616489284|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
170586532|NCT01229254|616489282|FG000|Overall Study|Adverse Event|4|||
170586533|NCT01229254|616489283|FG001|Overall Study|Adverse Event|5|||
170586534|NCT01229254|616489284|FG002|Overall Study|Adverse Event|3|||
170586535|NCT01229254|616489282|FG000|Overall Study|Lost to Follow-up|3|||
170586536|NCT01229254|616489283|FG001|Overall Study|Lost to Follow-up|0|||
170586537|NCT01229254|616489284|FG002|Overall Study|Lost to Follow-up|1|||
170586538|NCT01229254|616489282|FG000|Overall Study|Physician Decision|0|||
170586539|NCT01229254|616489283|FG001|Overall Study|Physician Decision|3|||
170586540|NCT01229254|616489284|FG002|Overall Study|Physician Decision|0|||
170586541|NCT01229254|616489282|FG000|Overall Study|Protocol Violation|4|||
170586542|NCT01229254|616489283|FG001|Overall Study|Protocol Violation|6|||
170586543|NCT01229254|616489284|FG002|Overall Study|Protocol Violation|5|||
170586544|NCT01229254|616489282|FG000|Overall Study|Withdrawal by Subject|1|||
170586545|NCT01229254|616489283|FG001|Overall Study|Withdrawal by Subject|0|||
170586546|NCT01229254|616489284|FG002|Overall Study|Withdrawal by Subject|1|||
170586547|NCT01229254|616489282|FG000|Overall Study|Non-compliance with Study Drug|0|||
170586548|NCT01229254|616489283|FG001|Overall Study|Non-compliance with Study Drug|1|||
170586549|NCT01229254|616489284|FG002|Overall Study|Non-compliance with Study Drug|1|||
170586550|NCT01534260|616489285|FG000|Overall Study|Adverse Event|1|||
170586551|NCT01534260|616489286|FG001|Overall Study|Adverse Event|8|||
170586552|NCT01534260|616489285|FG000|Overall Study|Death|2|||
170586553|NCT01534260|616489286|FG001|Overall Study|Death|0|||
170586554|NCT01534260|616489285|FG000|Overall Study|Lack of Efficacy|1|||
170586555|NCT01534260|616489286|FG001|Overall Study|Lack of Efficacy|1|||
170586556|NCT01534260|616489285|FG000|Overall Study|Withdrawal by Subject|1|||
170586557|NCT01534260|616489286|FG001|Overall Study|Withdrawal by Subject|3|||
170586558|NCT01534260|616489285|FG000|Overall Study|Disease Progression|8|||
170586559|NCT01534260|616489286|FG001|Overall Study|Disease Progression|6|||
170910863|NCT04382651|617677288|FG001|Overall Study|Lost to Follow-up|4|||
170586560|NCT01534260|616489285|FG000|Overall Study|Physician Decision|3|||
170586561|NCT01534260|616489286|FG001|Overall Study|Physician Decision|1|||
170586562|NCT01534260|616489285|FG000|Overall Study|No treatment, per protocol|0|||
170586563|NCT01534260|616489286|FG001|Overall Study|No treatment, per protocol|1|||
170586564|NCT00404755|616489287|FG000|Phase I (Bupropion)|Adverse Event|3|||
170586565|NCT00404755|616489287|FG000|Phase I (Bupropion)|Other|1|||
170910864|NCT04382651|617677287|FG000|Overall Study|Withdrawal by Subject|2|||
170910865|NCT04382651|617677288|FG001|Overall Study|Withdrawal by Subject|0|||
170910866|NCT04382651|617677287|FG000|Overall Study|Physician Decision|0|||
170586566|NCT00404755|616489287|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
170586567|NCT05145322|616489290|FG000|Overall Study|Lost to Follow-up|4|||
170586568|NCT05145322|616489291|FG001|Overall Study|Lost to Follow-up|5|||
170586569|NCT06359028|616489292|FG000|Overall Study|Adverse Event|1|||
170586570|NCT06359028|616489293|FG001|Overall Study|Adverse Event|0|||
170586571|NCT06359028|616489292|FG000|Overall Study|Withdrawal by Subject|1|||
170586572|NCT06359028|616489293|FG001|Overall Study|Withdrawal by Subject|0|||
170586573|NCT04700540|616489294|FG000|Overall Study|Withdrawal by Subject|12|||
170809954|NCT02686658|617313886|FG003|Overall Study|Participant non-compliance|0|||
170809955|NCT02686658|617313887|FG004|Overall Study|Participant non-compliance|0|||
170809956|NCT02686658|617313888|FG005|Overall Study|Participant non-compliance|1|||
170809957|NCT02686658|617313883|FG000|Overall Study|Concern over coronavirus disease care|0|||
170809958|NCT02686658|617313884|FG001|Overall Study|Concern over coronavirus disease care|0|||
170809959|NCT02686658|617313885|FG002|Overall Study|Concern over coronavirus disease care|0|||
170809960|NCT02686658|617313886|FG003|Overall Study|Concern over coronavirus disease care|0|||
170809961|NCT02686658|617313887|FG004|Overall Study|Concern over coronavirus disease care|2|||
170809962|NCT02686658|617313888|FG005|Overall Study|Concern over coronavirus disease care|1|||
170586574|NCT04700540|616489295|FG001|Overall Study|Withdrawal by Subject|8|||
170586575|NCT04700540|616489294|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
170586576|NCT04700540|616489295|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
170586577|NCT05248997|616489296|FG000|Overall Study|Lost to Follow-up|1|||
170586578|NCT05248997|616489297|FG001|Overall Study|Lost to Follow-up|1|||
170586579|NCT05248997|616489296|FG000|Overall Study|Randomized but not treated|32|||
170586580|NCT05248997|616489297|FG001|Overall Study|Randomized but not treated|25|||
170586581|NCT03515551|616489298|FG000|Overall Study|Death|4|||
170586582|NCT03515551|616489299|FG001|Overall Study|Death|1|||
170586583|NCT03515551|616489300|FG002|Overall Study|Death|2|||
170586584|NCT03515551|616489301|FG003|Overall Study|Death|2|||
170586585|NCT03515551|616489302|FG004|Overall Study|Death|2|||
170586586|NCT03515551|616489303|FG005|Overall Study|Death|4|||
170586587|NCT03515551|616489304|FG006|Overall Study|Death|1|||
170586588|NCT03515551|616489298|FG000|Overall Study|Lost to Follow-up|0|||
170586589|NCT03515551|616489299|FG001|Overall Study|Lost to Follow-up|0|||
170586590|NCT03515551|616489300|FG002|Overall Study|Lost to Follow-up|1|||
170586591|NCT03515551|616489301|FG003|Overall Study|Lost to Follow-up|0|||
170586592|NCT03515551|616489302|FG004|Overall Study|Lost to Follow-up|0|||
170586593|NCT03515551|616489303|FG005|Overall Study|Lost to Follow-up|0|||
170586594|NCT03515551|616489304|FG006|Overall Study|Lost to Follow-up|0|||
170586595|NCT03515551|616489298|FG000|Overall Study|Withdrawal by Subject|0|||
170586596|NCT03515551|616489299|FG001|Overall Study|Withdrawal by Subject|1|||
170586597|NCT03515551|616489300|FG002|Overall Study|Withdrawal by Subject|0|||
170586598|NCT03515551|616489301|FG003|Overall Study|Withdrawal by Subject|0|||
170586599|NCT03515551|616489302|FG004|Overall Study|Withdrawal by Subject|0|||
170586600|NCT03515551|616489303|FG005|Overall Study|Withdrawal by Subject|0|||
170586601|NCT03515551|616489304|FG006|Overall Study|Withdrawal by Subject|1|||
170586602|NCT03515551|616489298|FG000|Overall Study|Study ended by sponsor|0|||
170586603|NCT03515551|616489299|FG001|Overall Study|Study ended by sponsor|0|||
170586604|NCT03515551|616489300|FG002|Overall Study|Study ended by sponsor|2|||
170586605|NCT03515551|616489301|FG003|Overall Study|Study ended by sponsor|1|||
170586606|NCT03515551|616489302|FG004|Overall Study|Study ended by sponsor|3|||
170586607|NCT03515551|616489303|FG005|Overall Study|Study ended by sponsor|0|||
170586608|NCT03515551|616489304|FG006|Overall Study|Study ended by sponsor|3|||
170586609|NCT03515551|616489298|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
170586610|NCT03515551|616489299|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
170586611|NCT03515551|616489300|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
170586612|NCT03515551|616489301|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
170586613|NCT03515551|616489302|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
170586614|NCT03515551|616489303|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
170586615|NCT03515551|616489304|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
170809963|NCT02309294|617313891|FG000|Overall Study|Withdrawal by Subject|2|||
170809964|NCT01227421|617313892|FG000|Overall Study|Lost to Follow-up|6|||
170809965|NCT01227421|617313893|FG001|Overall Study|Lost to Follow-up|7|||
170586616|NCT00673231|616489305|FG000|Overall Study|Withdrawal by Subject|14|||
170586617|NCT00673231|616489306|FG001|Overall Study|Withdrawal by Subject|10|||
170586618|NCT00673231|616489307|FG002|Overall Study|Withdrawal by Subject|8|||
170586619|NCT00673231|616489308|FG003|Overall Study|Withdrawal by Subject|6|||
170586620|NCT00673231|616489305|FG000|Overall Study|Adverse Event|6|||
170586621|NCT00673231|616489306|FG001|Overall Study|Adverse Event|5|||
170586622|NCT00673231|616489307|FG002|Overall Study|Adverse Event|9|||
170586623|NCT00673231|616489308|FG003|Overall Study|Adverse Event|6|||
170809966|NCT01227421|617313894|FG002|Overall Study|Lost to Follow-up|5|||
170809967|NCT01227421|617313892|FG000|Overall Study|Adverse Event|2|||
170910867|NCT04382651|617677288|FG001|Overall Study|Physician Decision|1|||
170910868|NCT00450866|617677292|FG000|Overall Study|Adverse Event|0|||
170586624|NCT00673231|616489305|FG000|Overall Study|Lost to Follow-up|1|||
170586625|NCT00673231|616489306|FG001|Overall Study|Lost to Follow-up|2|||
170586626|NCT00673231|616489307|FG002|Overall Study|Lost to Follow-up|1|||
170586627|NCT00673231|616489308|FG003|Overall Study|Lost to Follow-up|2|||
170586628|NCT00673231|616489305|FG000|Overall Study|Death|0|||
170809968|NCT01227421|617313893|FG001|Overall Study|Adverse Event|7|||
170910869|NCT00450866|617677293|FG001|Overall Study|Adverse Event|1|||
170586629|NCT00673231|616489306|FG001|Overall Study|Death|0|||
170586630|NCT00673231|616489307|FG002|Overall Study|Death|1|||
170586631|NCT00673231|616489308|FG003|Overall Study|Death|0|||
170586632|NCT00673231|616489305|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
170586633|NCT00673231|616489306|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
170586634|NCT00673231|616489307|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
170586635|NCT00673231|616489308|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
170586636|NCT02952313|616489309|FG000|Primary Endpoint|Lost to Follow-up|4|||
170586637|NCT02952313|616489309|FG000|Primary Endpoint|Withdrawal by Subject|1|||
170586638|NCT02952313|616489309|FG000|Primary Endpoint|Lack of Efficacy|1|||
170586639|NCT02952313|616489309|FG000|Primary Endpoint|Missed visit|1|||
170586640|NCT02952313|616489309|FG000|Long-term Follow-up|Lost to Follow-up|12|||
170586641|NCT02952313|616489309|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
170586642|NCT02952313|616489309|FG000|Long-term Follow-up|Lack of Efficacy|6|||
170586643|NCT02952313|616489309|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
170586644|NCT02952313|616489309|FG000|Long-term Follow-up|Physician Decision|1|||
170586645|NCT02952313|616489309|FG000|Long-term Follow-up|Death|1|||
170586646|NCT05593913|616489314|FG000|Overall Study|Insufficient image quality|39|||
170586647|NCT04470908|616489315|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
170586648|NCT04376684|616489316|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
170586649|NCT04376684|616489317|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
170586650|NCT04376684|616489318|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
170586651|NCT04376684|616489319|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
170586652|NCT04376684|616489316|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
170586653|NCT04376684|616489317|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
170586654|NCT04376684|616489318|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
170586655|NCT04376684|616489319|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
170586656|NCT04376684|616489316|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
170586657|NCT04376684|616489317|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
170586658|NCT04376684|616489318|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
170586659|NCT04376684|616489319|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
170586660|NCT04376684|616489316|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
170586661|NCT04376684|616489317|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
170586662|NCT04376684|616489318|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
170586663|NCT04376684|616489319|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
170586664|NCT04376684|616489316|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
170586665|NCT04376684|616489317|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
170586666|NCT04376684|616489318|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
170586667|NCT04376684|616489319|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
170586668|NCT04376684|616489316|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
170586669|NCT04376684|616489317|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
170586670|NCT04376684|616489318|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
170586671|NCT04376684|616489319|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
170586672|NCT04376684|616489316|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
170586673|NCT04376684|616489317|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
170586674|NCT04376684|616489318|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
170586675|NCT04376684|616489319|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
170586676|NCT01666119|616489320|FG000|Overall Study|Adverse Event|6|||
170586677|NCT01666119|616489320|FG000|Overall Study|Withdrawal by Subject|16|||
170586678|NCT01666119|616489320|FG000|Overall Study|Lost to Follow-up|7|||
170586679|NCT01666119|616489320|FG000|Overall Study|non compliance with study medication, pa|18|||
170586680|NCT01666119|616489320|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
170586681|NCT02470585|616489333|FG000|Overall Study|Death|224|||
170586682|NCT02470585|616489334|FG001|Overall Study|Death|227|||
170586683|NCT02470585|616489335|FG002|Overall Study|Death|199|||
170809969|NCT01227421|617313894|FG002|Overall Study|Adverse Event|2|||
170809970|NCT01227421|617313892|FG000|Overall Study|Withdrawal by Subject|1|||
170809971|NCT01227421|617313893|FG001|Overall Study|Withdrawal by Subject|2|||
170809972|NCT01227421|617313894|FG002|Overall Study|Withdrawal by Subject|1|||
170586684|NCT02470585|616489333|FG000|Overall Study|Withdrew consent|21|||
170586685|NCT02470585|616489334|FG001|Overall Study|Withdrew consent|22|||
170586686|NCT02470585|616489335|FG002|Overall Study|Withdrew consent|31|||
170586687|NCT02470585|616489333|FG000|Overall Study|Lost to Follow-up|8|||
170586688|NCT02470585|616489334|FG001|Overall Study|Lost to Follow-up|15|||
170586689|NCT02470585|616489335|FG002|Overall Study|Lost to Follow-up|13|||
170586690|NCT02470585|616489333|FG000|Overall Study|Sponsor discontinued study|117|||
170586691|NCT02470585|616489334|FG001|Overall Study|Sponsor discontinued study|110|||
170586692|NCT02470585|616489335|FG002|Overall Study|Sponsor discontinued study|122|||
170586693|NCT02470585|616489333|FG000|Overall Study|Other, not specified|5|||
170586694|NCT02470585|616489334|FG001|Overall Study|Other, not specified|7|||
170586695|NCT02470585|616489335|FG002|Overall Study|Other, not specified|14|||
170586696|NCT02470585|616489333|FG000|Overall Study|Missing due to site non-compliance|0|||
170586697|NCT02470585|616489334|FG001|Overall Study|Missing due to site non-compliance|2|||
170586698|NCT02470585|616489335|FG002|Overall Study|Missing due to site non-compliance|3|||
170586699|NCT02602275|616489336|FG000|Day 1|Physician Decision|0|||
170586700|NCT02602275|616489337|FG001|Day 1|Physician Decision|1|||
170809973|NCT01227421|617313892|FG000|Overall Study|Protocol Violation|1|||
170586701|NCT00157196|616489340|FG000|Overall Study|Ongoing at data cut-off|9|||
170586702|NCT05005013|616489341|FG000|Overall Study|Withdrawal by Subject|5|||
170586703|NCT05005013|616489342|FG001|Overall Study|Withdrawal by Subject|1|||
170586704|NCT05005013|616489341|FG000|Overall Study|Lost to Follow-up|3|||
170586705|NCT05005013|616489342|FG001|Overall Study|Lost to Follow-up|1|||
170586706|NCT05005013|616489341|FG000|Overall Study|Ineligibility|1|||
170586707|NCT05005013|616489342|FG001|Overall Study|Ineligibility|1|||
170586708|NCT03255967|616489345|FG000|Overall Study|Adverse Event|26|||
170586709|NCT03255967|616489346|FG001|Overall Study|Adverse Event|30|||
170586710|NCT03255967|616489345|FG000|Overall Study|Withdrawal by Subject|6|||
170586711|NCT03255967|616489346|FG001|Overall Study|Withdrawal by Subject|6|||
170809974|NCT01227421|617313893|FG001|Overall Study|Protocol Violation|1|||
170809975|NCT01227421|617313894|FG002|Overall Study|Protocol Violation|2|||
170809976|NCT01227421|617313892|FG000|Overall Study|Randomized in error|1|||
170809977|NCT01227421|617313893|FG001|Overall Study|Randomized in error|1|||
170809978|NCT01227421|617313894|FG002|Overall Study|Randomized in error|0|||
170809979|NCT00570505|617313895|FG000|Overall Study|Adverse Event|7|||
170809980|NCT00570505|617313895|FG000|Overall Study|Withdrawal by Subject|7|||
170586712|NCT03255967|616489345|FG000|Overall Study|Schedule conflict|6|||
170586713|NCT03255967|616489346|FG001|Overall Study|Schedule conflict|4|||
170586714|NCT03255967|616489345|FG000|Overall Study|POA did not sign consent form|2|||
170586715|NCT03255967|616489346|FG001|Overall Study|POA did not sign consent form|0|||
170586716|NCT04091581|616489347|FG000|Overall Study|Lost to Follow-up|0|||
170586717|NCT04091581|616489348|FG001|Overall Study|Lost to Follow-up|1|||
170586718|NCT01795495|616489349|FG000|Overall Study|Protocol Violation|1|||
170586719|NCT01795495|616489350|FG001|Overall Study|Protocol Violation|0|||
170586720|NCT01795495|616489351|FG002|Overall Study|Protocol Violation|1|||
170586721|NCT01795495|616489349|FG000|Overall Study|Physician Decision|0|||
170809981|NCT00570505|617313895|FG000|Overall Study|Lost to Follow-up|23|||
170809982|NCT00570505|617313895|FG000|Overall Study|Other loss to follow-up|4|||
170809983|NCT00614614|617313897|FG000|Primary Vaccination Phase|Adverse Event|6|||
170809984|NCT00614614|617313898|FG001|Primary Vaccination Phase|Adverse Event|0|||
170809985|NCT00614614|617313899|FG002|Primary Vaccination Phase|Adverse Event|0|||
170809986|NCT00614614|617313900|FG003|Primary Vaccination Phase|Adverse Event|0|||
170809987|NCT00614614|617313901|FG004|Primary Vaccination Phase|Adverse Event|0|||
170809988|NCT00614614|617313897|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
170809989|NCT00614614|617313898|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
170809990|NCT00614614|617313899|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
170809991|NCT00614614|617313900|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
170809992|NCT00614614|617313901|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
170809993|NCT00614614|617313897|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
170809994|NCT00614614|617313898|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
170809995|NCT00614614|617313899|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
170809996|NCT00614614|617313900|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
170809997|NCT00614614|617313901|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
170809998|NCT00614614|617313897|FG000|Primary Vaccination Phase|Protocol Violation|9|||
170809999|NCT00614614|617313898|FG001|Primary Vaccination Phase|Protocol Violation|3|||
170810000|NCT00614614|617313899|FG002|Primary Vaccination Phase|Protocol Violation|0|||
170810001|NCT00614614|617313900|FG003|Primary Vaccination Phase|Protocol Violation|0|||
170810002|NCT00614614|617313901|FG004|Primary Vaccination Phase|Protocol Violation|0|||
170810003|NCT00614614|617313897|FG000|Primary Vaccination Phase|Other|4|||
170810004|NCT00614614|617313898|FG001|Primary Vaccination Phase|Other|0|||
170810005|NCT00614614|617313899|FG002|Primary Vaccination Phase|Other|0|||
170810006|NCT00614614|617313900|FG003|Primary Vaccination Phase|Other|0|||
170810007|NCT00614614|617313901|FG004|Primary Vaccination Phase|Other|0|||
170810008|NCT00614614|617313897|FG000|Booster Vaccination Phase|Adverse Event|0|||
170910870|NCT00450866|617677292|FG000|Overall Study|Withdrawal by Subject|5|||
170910871|NCT00450866|617677293|FG001|Overall Study|Withdrawal by Subject|2|||
170586722|NCT01795495|616489350|FG001|Overall Study|Physician Decision|0|||
170586723|NCT01795495|616489351|FG002|Overall Study|Physician Decision|1|||
170586724|NCT03315793|616489352|FG000|Overall Study|Adverse Event|4|||
170586725|NCT03315793|616489353|FG001|Overall Study|Adverse Event|2|||
170586726|NCT03315793|616489352|FG000|Overall Study|Protocol Deviation|1|||
170910872|NCT00450866|617677292|FG000|Overall Study|Death|1|||
170910873|NCT00450866|617677293|FG001|Overall Study|Death|0|||
170910874|NCT00450866|617677292|FG000|Overall Study|Physician Decision|1|||
170586727|NCT03315793|616489353|FG001|Overall Study|Protocol Deviation|0|||
170586728|NCT03315793|616489352|FG000|Overall Study|Difficult for regular visit|0|||
170910875|NCT00450866|617677293|FG001|Overall Study|Physician Decision|0|||
170810009|NCT00614614|617313898|FG001|Booster Vaccination Phase|Adverse Event|0|||
170586729|NCT03315793|616489353|FG001|Overall Study|Difficult for regular visit|1|||
170810010|NCT00614614|617313899|FG002|Booster Vaccination Phase|Adverse Event|1|||
170810011|NCT00614614|617313900|FG003|Booster Vaccination Phase|Adverse Event|1|||
170910876|NCT02619253|617677296|FG000|Overall Study|Adverse Event|0|||
170586730|NCT01331837|616489354|FG000|Overall Study|Death|30|||
170810012|NCT00614614|617313901|FG004|Booster Vaccination Phase|Adverse Event|0|||
170910877|NCT02619253|617677297|FG001|Overall Study|Adverse Event|0|||
170586731|NCT01331837|616489355|FG001|Overall Study|Death|34|||
170586732|NCT01331837|616489354|FG000|Overall Study|Lost to Follow-up|3|||
170586733|NCT01331837|616489355|FG001|Overall Study|Lost to Follow-up|1|||
170586734|NCT01331837|616489354|FG000|Overall Study|Info not recorded|10|||
170586735|NCT01331837|616489355|FG001|Overall Study|Info not recorded|16|||
170586736|NCT01331837|616489354|FG000|Overall Study|Withdrawal by Subject|13|||
170586737|NCT01331837|616489355|FG001|Overall Study|Withdrawal by Subject|16|||
170586738|NCT05243745|616491503|FG000|Overall Study|Withdrawal by Subject|0|||
170586739|NCT05243745|616491504|FG001|Overall Study|Withdrawal by Subject|0|||
170586740|NCT05243745|616491505|FG002|Overall Study|Withdrawal by Subject|0|||
170586741|NCT05243745|616491506|FG003|Overall Study|Withdrawal by Subject|1|||
170586742|NCT05243745|616491503|FG000|Overall Study|Unable to Attend Visit 6|0|||
170586743|NCT05243745|616491504|FG001|Overall Study|Unable to Attend Visit 6|0|||
170586744|NCT05243745|616491505|FG002|Overall Study|Unable to Attend Visit 6|1|||
170586745|NCT05243745|616491506|FG003|Overall Study|Unable to Attend Visit 6|0|||
170586746|NCT03842969|616491507|FG000|Overall Study|Participant declined follow-up visit|0|||
170586747|NCT03842969|616491508|FG001|Overall Study|Participant declined follow-up visit|1|||
170586748|NCT03842969|616491509|FG002|Overall Study|Participant declined follow-up visit|0|||
170586749|NCT03842969|616491507|FG000|Overall Study|Sponsor's decision|12|||
170586750|NCT03842969|616491508|FG001|Overall Study|Sponsor's decision|99|||
170586751|NCT03842969|616491509|FG002|Overall Study|Sponsor's decision|61|||
170586752|NCT03842969|616491507|FG000|Overall Study|Pregnancy|0|||
170586753|NCT03842969|616491508|FG001|Overall Study|Pregnancy|0|||
170586754|NCT03842969|616491509|FG002|Overall Study|Pregnancy|1|||
170586755|NCT03842969|616491507|FG000|Overall Study|Death|1|||
170586756|NCT03842969|616491508|FG001|Overall Study|Death|0|||
170586757|NCT03842969|616491509|FG002|Overall Study|Death|1|||
170586758|NCT03842969|616491507|FG000|Overall Study|Withdrawal by Subject|3|||
170586759|NCT03842969|616491508|FG001|Overall Study|Withdrawal by Subject|30|||
170586760|NCT03842969|616491509|FG002|Overall Study|Withdrawal by Subject|18|||
170586761|NCT03842969|616491507|FG000|Overall Study|Protocol Violation|1|||
170586762|NCT03842969|616491508|FG001|Overall Study|Protocol Violation|1|||
170586763|NCT03842969|616491509|FG002|Overall Study|Protocol Violation|0|||
170586764|NCT03842969|616491507|FG000|Overall Study|Physician Decision|0|||
170586765|NCT03842969|616491508|FG001|Overall Study|Physician Decision|3|||
170586766|NCT03842969|616491509|FG002|Overall Study|Physician Decision|0|||
170586767|NCT03842969|616491507|FG000|Overall Study|Lost to Follow-up|0|||
170586768|NCT03842969|616491508|FG001|Overall Study|Lost to Follow-up|2|||
170586769|NCT03842969|616491509|FG002|Overall Study|Lost to Follow-up|0|||
170586770|NCT03842969|616491507|FG000|Overall Study|Adverse Event|0|||
170586771|NCT03842969|616491508|FG001|Overall Study|Adverse Event|2|||
170586772|NCT03842969|616491509|FG002|Overall Study|Adverse Event|0|||
170586773|NCT04187144|616491510|FG000|Overall Study|Lost to Follow-up|12|||
170586774|NCT04187144|616491511|FG001|Overall Study|Lost to Follow-up|11|||
170586775|NCT04187144|616491510|FG000|Overall Study|Withdrawal by Subject|20|||
170586776|NCT04187144|616491511|FG001|Overall Study|Withdrawal by Subject|18|||
170586777|NCT04187144|616491510|FG000|Overall Study|Adverse Event|19|||
170586778|NCT04187144|616491511|FG001|Overall Study|Adverse Event|4|||
170586779|NCT04187144|616491510|FG000|Overall Study|Physician Decision|5|||
170586780|NCT04187144|616491511|FG001|Overall Study|Physician Decision|3|||
170586781|NCT04187144|616491510|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
170586782|NCT04187144|616491511|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
170586783|NCT04187144|616491510|FG000|Overall Study|Protocol Deviation|1|||
170586784|NCT04187144|616491511|FG001|Overall Study|Protocol Deviation|4|||
170586785|NCT00316693|616491512|FG000|Overall Study|Adverse Event|6|||
170586786|NCT00316693|616491513|FG001|Overall Study|Adverse Event|1|||
170586787|NCT00316693|616491512|FG000|Overall Study|Protocol Violation|1|||
170586788|NCT00316693|616491513|FG001|Overall Study|Protocol Violation|0|||
170586789|NCT00316693|616491512|FG000|Overall Study|Withdrawal by Subject|6|||
170586790|NCT00316693|616491513|FG001|Overall Study|Withdrawal by Subject|6|||
170586791|NCT00316693|616491512|FG000|Overall Study|Lost to Follow-up|26|||
170586792|NCT00316693|616491513|FG001|Overall Study|Lost to Follow-up|34|||
170586793|NCT00316693|616491512|FG000|Overall Study|Other|38|||
170586794|NCT00316693|616491513|FG001|Overall Study|Other|44|||
170586795|NCT01967823|616491514|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
170586796|NCT02449889|616491530|FG000|Overall Study|Adverse Event|1|||
170586797|NCT02449889|616491531|FG001|Overall Study|Adverse Event|2|||
170586798|NCT02449889|616491532|FG002|Overall Study|Adverse Event|0|||
170586799|NCT02449889|616491530|FG000|Overall Study|Protocol Violation|0|||
170586800|NCT02449889|616491531|FG001|Overall Study|Protocol Violation|4|||
170586801|NCT02449889|616491532|FG002|Overall Study|Protocol Violation|1|||
170586802|NCT00313313|616491533|FG000|Overall Study|Lack of Efficacy|14|||
170586803|NCT00313313|616491534|FG001|Overall Study|Lack of Efficacy|9|||
170586804|NCT00313313|616491535|FG002|Overall Study|Lack of Efficacy|20|||
170586805|NCT00313313|616491533|FG000|Overall Study|Withdrawal of consent by subject|18|||
170586806|NCT00313313|616491534|FG001|Overall Study|Withdrawal of consent by subject|17|||
170586807|NCT00313313|616491535|FG002|Overall Study|Withdrawal of consent by subject|31|||
170810013|NCT00614614|617313897|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
170810014|NCT00614614|617313898|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
170810015|NCT00614614|617313899|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
170810016|NCT00614614|617313900|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
170810017|NCT00614614|617313901|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
170810018|NCT00614614|617313897|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
170810019|NCT00614614|617313898|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
170810020|NCT00614614|617313899|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
170810021|NCT00614614|617313900|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
170810022|NCT00614614|617313901|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
170810023|NCT00614614|617313897|FG000|Booster Vaccination Phase|Protocol Violation|0|||
170810024|NCT00614614|617313898|FG001|Booster Vaccination Phase|Protocol Violation|0|||
170810025|NCT00614614|617313899|FG002|Booster Vaccination Phase|Protocol Violation|2|||
170810026|NCT00614614|617313900|FG003|Booster Vaccination Phase|Protocol Violation|3|||
170810027|NCT00614614|617313901|FG004|Booster Vaccination Phase|Protocol Violation|0|||
170810028|NCT00614614|617313897|FG000|Booster Vaccination Phase|Other|0|||
170810029|NCT00614614|617313898|FG001|Booster Vaccination Phase|Other|1|||
170810030|NCT00614614|617313899|FG002|Booster Vaccination Phase|Other|3|||
170810031|NCT00614614|617313900|FG003|Booster Vaccination Phase|Other|2|||
170810032|NCT00614614|617313901|FG004|Booster Vaccination Phase|Other|1|||
170810033|NCT05212285|617313902|FG000|Overall Study|Lack of Efficacy|12|||
170810034|NCT05212285|617313903|FG001|Overall Study|Lack of Efficacy|8|||
170810035|NCT05212285|617313902|FG000|Overall Study|Withdrawal by Subject|8|||
170810036|NCT05212285|617313903|FG001|Overall Study|Withdrawal by Subject|1|||
170810037|NCT05212285|617313902|FG000|Overall Study|Lost to Follow-up|13|||
170810038|NCT05212285|617313903|FG001|Overall Study|Lost to Follow-up|1|||
170810039|NCT05212285|617313902|FG000|Overall Study|miss data|21|||
170810040|NCT05212285|617313903|FG001|Overall Study|miss data|2|||
170810041|NCT01000805|617313905|FG000|Overall Study|Adverse Event|21|||
170810042|NCT01000805|617313906|FG001|Overall Study|Adverse Event|9|||
170810043|NCT01000805|617313905|FG000|Overall Study|Lack of Efficacy|5|||
170810044|NCT01000805|617313906|FG001|Overall Study|Lack of Efficacy|16|||
170586808|NCT00313313|616491533|FG000|Overall Study|Lost to Follow-up|10|||
170586809|NCT00313313|616491534|FG001|Overall Study|Lost to Follow-up|7|||
170586810|NCT00313313|616491535|FG002|Overall Study|Lost to Follow-up|9|||
170586811|NCT00313313|616491533|FG000|Overall Study|Adverse Event|15|||
170586812|NCT00313313|616491534|FG001|Overall Study|Adverse Event|16|||
170586813|NCT00313313|616491535|FG002|Overall Study|Adverse Event|12|||
170586814|NCT00313313|616491533|FG000|Overall Study|Physician Decision|2|||
170586815|NCT00313313|616491534|FG001|Overall Study|Physician Decision|6|||
170586816|NCT00313313|616491535|FG002|Overall Study|Physician Decision|4|||
170586817|NCT00313313|616491533|FG000|Overall Study|Poor/Noncompliance|3|||
170586818|NCT00313313|616491534|FG001|Overall Study|Poor/Noncompliance|6|||
170586819|NCT00313313|616491535|FG002|Overall Study|Poor/Noncompliance|2|||
170586820|NCT00313313|616491533|FG000|Overall Study|Pregnancy|1|||
170586821|NCT00313313|616491534|FG001|Overall Study|Pregnancy|2|||
170586822|NCT00313313|616491535|FG002|Overall Study|Pregnancy|0|||
170586823|NCT00313313|616491533|FG000|Overall Study|Death|0|||
170586824|NCT00313313|616491534|FG001|Overall Study|Death|0|||
170586825|NCT00313313|616491535|FG002|Overall Study|Death|2|||
170810045|NCT01000805|617313905|FG000|Overall Study|Lost to Follow-up|16|||
170810046|NCT01000805|617313906|FG001|Overall Study|Lost to Follow-up|21|||
170810047|NCT01000805|617313905|FG000|Overall Study|Physician Decision|0|||
170810048|NCT01000805|617313906|FG001|Overall Study|Physician Decision|1|||
170810049|NCT01000805|617313905|FG000|Overall Study|Protocol Violation|12|||
170810050|NCT01000805|617313906|FG001|Overall Study|Protocol Violation|8|||
170810051|NCT01000805|617313905|FG000|Overall Study|Withdrawal by Subject|16|||
170810052|NCT01000805|617313906|FG001|Overall Study|Withdrawal by Subject|6|||
170810053|NCT01000805|617313905|FG000|Overall Study|Sponsor Decision|0|||
170810054|NCT01000805|617313906|FG001|Overall Study|Sponsor Decision|1|||
170810055|NCT02334215|617313909|FG000|Overall Study|Death|1|||
170810056|NCT02334215|617313910|FG001|Overall Study|Death|1|||
170810057|NCT02334215|617313911|FG002|Overall Study|Death|0|||
170810058|NCT02334215|617313909|FG000|Overall Study|Lost to Follow-up|1|||
170810059|NCT02334215|617313910|FG001|Overall Study|Lost to Follow-up|0|||
170810060|NCT02334215|617313911|FG002|Overall Study|Lost to Follow-up|4|||
170810061|NCT02334215|617313909|FG000|Overall Study|Withdrawal by Subject|2|||
170810062|NCT02334215|617313910|FG001|Overall Study|Withdrawal by Subject|2|||
170586826|NCT00313313|616491533|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
170810063|NCT02334215|617313911|FG002|Overall Study|Withdrawal by Subject|1|||
170810064|NCT02334215|617313909|FG000|Overall Study|Not released from incarceration on time|3|||
170586827|NCT00313313|616491534|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
170586828|NCT00313313|616491535|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
170586829|NCT03622112|616491537|FG000|Overall Study|Withdrawal by Subject|6|||
170586830|NCT03622112|616491538|FG001|Overall Study|Withdrawal by Subject|2|||
170586831|NCT03622112|616491539|FG002|Overall Study|Withdrawal by Subject|4|||
170586832|NCT03622112|616491540|FG003|Overall Study|Withdrawal by Subject|2|||
170586833|NCT03622112|616491541|FG004|Overall Study|Withdrawal by Subject|1|||
170586834|NCT03622112|616491542|FG005|Overall Study|Withdrawal by Subject|2|||
170586835|NCT03622112|616491543|FG006|Overall Study|Withdrawal by Subject|2|||
170586836|NCT03622112|616491537|FG000|Overall Study|Death|0|||
170586837|NCT03622112|616491538|FG001|Overall Study|Death|0|||
170586838|NCT03622112|616491539|FG002|Overall Study|Death|0|||
170586839|NCT03622112|616491540|FG003|Overall Study|Death|1|||
170586840|NCT03622112|616491541|FG004|Overall Study|Death|0|||
170586841|NCT03622112|616491542|FG005|Overall Study|Death|0|||
170586842|NCT03622112|616491543|FG006|Overall Study|Death|0|||
170586843|NCT03622112|616491537|FG000|Overall Study|Lost to Follow-up|1|||
170586844|NCT03622112|616491538|FG001|Overall Study|Lost to Follow-up|1|||
170586845|NCT03622112|616491539|FG002|Overall Study|Lost to Follow-up|0|||
170586846|NCT03622112|616491540|FG003|Overall Study|Lost to Follow-up|0|||
170586847|NCT03622112|616491541|FG004|Overall Study|Lost to Follow-up|0|||
170586848|NCT03622112|616491542|FG005|Overall Study|Lost to Follow-up|0|||
170586849|NCT03622112|616491543|FG006|Overall Study|Lost to Follow-up|0|||
170586850|NCT03622112|616491537|FG000|Overall Study|Study-specific withdrawal criteria|10|||
170586851|NCT03622112|616491538|FG001|Overall Study|Study-specific withdrawal criteria|8|||
170586852|NCT03622112|616491539|FG002|Overall Study|Study-specific withdrawal criteria|7|||
170586853|NCT03622112|616491540|FG003|Overall Study|Study-specific withdrawal criteria|6|||
170586854|NCT03622112|616491541|FG004|Overall Study|Study-specific withdrawal criteria|4|||
170586855|NCT03622112|616491542|FG005|Overall Study|Study-specific withdrawal criteria|18|||
170586856|NCT03622112|616491543|FG006|Overall Study|Study-specific withdrawal criteria|4|||
170586857|NCT03622112|616491537|FG000|Overall Study|Protocol Violation|2|||
170586858|NCT03622112|616491538|FG001|Overall Study|Protocol Violation|0|||
170586859|NCT03622112|616491539|FG002|Overall Study|Protocol Violation|1|||
170586860|NCT03622112|616491540|FG003|Overall Study|Protocol Violation|1|||
170586861|NCT03622112|616491541|FG004|Overall Study|Protocol Violation|0|||
170586862|NCT03622112|616491542|FG005|Overall Study|Protocol Violation|0|||
170586863|NCT03622112|616491543|FG006|Overall Study|Protocol Violation|0|||
170586864|NCT03622112|616491537|FG000|Overall Study|Adverse Event|6|||
170586865|NCT03622112|616491538|FG001|Overall Study|Adverse Event|8|||
170586866|NCT03622112|616491539|FG002|Overall Study|Adverse Event|4|||
170586867|NCT03622112|616491540|FG003|Overall Study|Adverse Event|11|||
170586868|NCT03622112|616491541|FG004|Overall Study|Adverse Event|4|||
170586869|NCT03622112|616491542|FG005|Overall Study|Adverse Event|20|||
170586870|NCT03622112|616491543|FG006|Overall Study|Adverse Event|2|||
170586871|NCT03622112|616491537|FG000|Overall Study|Reason not specified|0|||
170586872|NCT03622112|616491538|FG001|Overall Study|Reason not specified|1|||
170586873|NCT03622112|616491539|FG002|Overall Study|Reason not specified|0|||
170586874|NCT03622112|616491540|FG003|Overall Study|Reason not specified|1|||
170586875|NCT03622112|616491541|FG004|Overall Study|Reason not specified|1|||
170586876|NCT03622112|616491542|FG005|Overall Study|Reason not specified|2|||
170586877|NCT03622112|616491543|FG006|Overall Study|Reason not specified|1|||
170586878|NCT00590824|616491544|FG000|Overall Study|Disease could not be resected|0|||
170586879|NCT00590824|616491545|FG001|Overall Study|Disease could not be resected|2|||
170586880|NCT00590824|616491546|FG002|Overall Study|Disease could not be resected|1|||
170586881|NCT00590824|616491547|FG003|Overall Study|Disease could not be resected|0|||
170810065|NCT02334215|617313910|FG001|Overall Study|Not released from incarceration on time|3|||
170586882|NCT00590824|616491544|FG000|Overall Study|Adverse Event|0|||
170586883|NCT00590824|616491545|FG001|Overall Study|Adverse Event|0|||
170586884|NCT00590824|616491546|FG002|Overall Study|Adverse Event|0|||
170586885|NCT00590824|616491547|FG003|Overall Study|Adverse Event|1|||
170586886|NCT02210689|616491548|FG000|Overall Study|Withdrawal by Subject|7|||
170586887|NCT02210689|616491549|FG001|Overall Study|Withdrawal by Subject|4|||
170586888|NCT02210689|616491550|FG002|Overall Study|Withdrawal by Subject|2|||
170586889|NCT02210689|616491548|FG000|Overall Study|Adverse Event|0|||
170586890|NCT02210689|616491549|FG001|Overall Study|Adverse Event|1|||
170586891|NCT02210689|616491550|FG002|Overall Study|Adverse Event|0|||
170586892|NCT02210689|616491548|FG000|Overall Study|Protocol Violation|1|||
170586893|NCT02210689|616491549|FG001|Overall Study|Protocol Violation|0|||
170586894|NCT02210689|616491550|FG002|Overall Study|Protocol Violation|0|||
170586895|NCT02210689|616491548|FG000|Overall Study|Lost to Follow-up|11|||
170810066|NCT02334215|617313911|FG002|Overall Study|Not released from incarceration on time|3|||
170586896|NCT02210689|616491549|FG001|Overall Study|Lost to Follow-up|9|||
170586897|NCT02210689|616491550|FG002|Overall Study|Lost to Follow-up|5|||
170586898|NCT02210689|616491548|FG000|Overall Study|Pregnancy|0|||
170586899|NCT02210689|616491549|FG001|Overall Study|Pregnancy|1|||
170810067|NCT02334215|617313909|FG000|Overall Study|Incarcerated|0|||
170810068|NCT02334215|617313910|FG001|Overall Study|Incarcerated|0|||
170810069|NCT02334215|617313911|FG002|Overall Study|Incarcerated|7|||
170586900|NCT02210689|616491550|FG002|Overall Study|Pregnancy|0|||
170586901|NCT02210689|616491548|FG000|Overall Study|Lack of Efficacy|0|||
170586902|NCT02210689|616491549|FG001|Overall Study|Lack of Efficacy|1|||
170586903|NCT02210689|616491550|FG002|Overall Study|Lack of Efficacy|5|||
170586904|NCT02210689|616491548|FG000|Overall Study|Prohibited medication|2|||
170586905|NCT02210689|616491549|FG001|Overall Study|Prohibited medication|8|||
170586906|NCT02210689|616491550|FG002|Overall Study|Prohibited medication|1|||
170586907|NCT02210689|616491548|FG000|Overall Study|Negative Nugent score at baseline|6|||
170586908|NCT02210689|616491549|FG001|Overall Study|Negative Nugent score at baseline|2|||
170586909|NCT02210689|616491550|FG002|Overall Study|Negative Nugent score at baseline|2|||
170586910|NCT02210689|616491548|FG000|Overall Study|Other|25|||
170586911|NCT02210689|616491549|FG001|Overall Study|Other|21|||
170586912|NCT02210689|616491550|FG002|Overall Study|Other|8|||
170586913|NCT00075946|616491551|FG000|Overall Study|Path ineligible: undetermined histology|0|||
170586914|NCT00075946|616491552|FG001|Overall Study|Path ineligible: undetermined histology|0|||
170586915|NCT00075946|616491553|FG002|Overall Study|Path ineligible: undetermined histology|0|||
170586916|NCT00075946|616491554|FG003|Overall Study|Path ineligible: undetermined histology|0|||
170586917|NCT00075946|616491555|FG004|Overall Study|Path ineligible: undetermined histology|6|||
170586918|NCT00075946|616491551|FG000|Overall Study|Did not achieve response after induction|0|||
170586919|NCT00075946|616491552|FG001|Overall Study|Did not achieve response after induction|0|||
170586920|NCT00075946|616491553|FG002|Overall Study|Did not achieve response after induction|0|||
170586921|NCT00075946|616491554|FG003|Overall Study|Did not achieve response after induction|0|||
170586922|NCT00075946|616491555|FG004|Overall Study|Did not achieve response after induction|182|||
170586923|NCT00075946|616491551|FG000|Overall Study|Incorrectly randomized (no response)|5|||
170586924|NCT00075946|616491552|FG001|Overall Study|Incorrectly randomized (no response)|5|||
170586925|NCT00075946|616491553|FG002|Overall Study|Incorrectly randomized (no response)|5|||
170586926|NCT00075946|616491554|FG003|Overall Study|Incorrectly randomized (no response)|1|||
170586927|NCT00075946|616491555|FG004|Overall Study|Incorrectly randomized (no response)|0|||
170586928|NCT00075946|616491551|FG000|Overall Study|Adverse Event|2|||
170586929|NCT00075946|616491552|FG001|Overall Study|Adverse Event|10|||
170586930|NCT00075946|616491553|FG002|Overall Study|Adverse Event|0|||
170586931|NCT00075946|616491554|FG003|Overall Study|Adverse Event|2|||
170586932|NCT00075946|616491555|FG004|Overall Study|Adverse Event|0|||
170586933|NCT00075946|616491551|FG000|Overall Study|Death|0|||
170586934|NCT00075946|616491552|FG001|Overall Study|Death|1|||
170586935|NCT00075946|616491553|FG002|Overall Study|Death|0|||
170586936|NCT00075946|616491554|FG003|Overall Study|Death|0|||
170586937|NCT00075946|616491555|FG004|Overall Study|Death|0|||
170586938|NCT00075946|616491551|FG000|Overall Study|Withdrawal by Subject|23|||
170586939|NCT00075946|616491552|FG001|Overall Study|Withdrawal by Subject|58|||
170586940|NCT00075946|616491553|FG002|Overall Study|Withdrawal by Subject|4|||
170586941|NCT00075946|616491554|FG003|Overall Study|Withdrawal by Subject|9|||
170586942|NCT00075946|616491555|FG004|Overall Study|Withdrawal by Subject|0|||
170586943|NCT00075946|616491551|FG000|Overall Study|Alternative therapy|16|||
170586944|NCT00075946|616491552|FG001|Overall Study|Alternative therapy|2|||
170586945|NCT00075946|616491553|FG002|Overall Study|Alternative therapy|5|||
170586946|NCT00075946|616491554|FG003|Overall Study|Alternative therapy|0|||
170586947|NCT00075946|616491555|FG004|Overall Study|Alternative therapy|0|||
170586948|NCT00075946|616491551|FG000|Overall Study|Other complicating disease|7|||
170586949|NCT00075946|616491552|FG001|Overall Study|Other complicating disease|13|||
170586950|NCT00075946|616491553|FG002|Overall Study|Other complicating disease|1|||
170586951|NCT00075946|616491554|FG003|Overall Study|Other complicating disease|4|||
170586952|NCT00075946|616491555|FG004|Overall Study|Other complicating disease|0|||
170586953|NCT00075946|616491551|FG000|Overall Study|No response to retreatment|23|||
170586954|NCT00075946|616491552|FG001|Overall Study|No response to retreatment|0|||
170586955|NCT00075946|616491553|FG002|Overall Study|No response to retreatment|2|||
170586956|NCT00075946|616491554|FG003|Overall Study|No response to retreatment|0|||
170586957|NCT00075946|616491555|FG004|Overall Study|No response to retreatment|0|||
170586958|NCT00075946|616491551|FG000|Overall Study|Time to progression less than 6 months|15|||
170586959|NCT00075946|616491552|FG001|Overall Study|Time to progression less than 6 months|30|||
170810070|NCT02969356|617313912|FG000|Overall Study|Adverse Event|7|||
170810071|NCT02969356|617313912|FG000|Overall Study|Consent withdrawn|2|||
170586960|NCT00075946|616491553|FG002|Overall Study|Time to progression less than 6 months|8|||
170586961|NCT00075946|616491554|FG003|Overall Study|Time to progression less than 6 months|3|||
170586962|NCT00075946|616491555|FG004|Overall Study|Time to progression less than 6 months|0|||
170586963|NCT00075946|616491551|FG000|Overall Study|Other|57|||
170586964|NCT00075946|616491552|FG001|Overall Study|Other|32|||
170810072|NCT02969356|617313912|FG000|Overall Study|Lost to Follow-up|3|||
170910878|NCT02619253|617677298|FG002|Overall Study|Adverse Event|1|||
170586965|NCT00075946|616491553|FG002|Overall Study|Other|3|||
170586966|NCT00075946|616491554|FG003|Overall Study|Other|11|||
170586967|NCT00075946|616491555|FG004|Overall Study|Other|0|||
170586968|NCT04154605|616491557|FG000|Overall Study|Procedure Canceled|1|||
170586969|NCT04154605|616491558|FG001|Overall Study|Procedure Canceled|1|||
170586970|NCT04154605|616491557|FG000|Overall Study|Missed follow up|1|||
170586971|NCT04154605|616491558|FG001|Overall Study|Missed follow up|1|||
170586972|NCT04154605|616491557|FG000|Overall Study|Withdrawal by Subject|1|||
170586973|NCT04154605|616491558|FG001|Overall Study|Withdrawal by Subject|0|||
170586974|NCT03718884|616491561|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
170586975|NCT03718884|616491562|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
170586976|NCT03718884|616491561|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
170586977|NCT03718884|616491562|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
170586978|NCT00367744|616491567|FG000|Overall Study|Lost to Follow-up|4|||
170586979|NCT00367744|616491568|FG001|Overall Study|Lost to Follow-up|5|||
170586980|NCT03664674|616491569|FG000|Overall Study|Adverse Event|1|||
170586981|NCT03664674|616491570|FG001|Overall Study|Adverse Event|1|||
170586982|NCT03664674|616491569|FG000|Overall Study|Physician Decision|0|||
170586983|NCT03664674|616491570|FG001|Overall Study|Physician Decision|1|||
170586984|NCT03664674|616491569|FG000|Overall Study|Withdrawal by Subject|2|||
170586985|NCT03664674|616491570|FG001|Overall Study|Withdrawal by Subject|0|||
170586986|NCT01342965|616491573|FG000|Overall Study|Death|58|||
170586987|NCT01342965|616491574|FG001|Overall Study|Death|57|||
170586988|NCT01342965|616491573|FG000|Overall Study|Lost to Follow-up|5|||
170586989|NCT01342965|616491574|FG001|Overall Study|Lost to Follow-up|3|||
170586990|NCT01342965|616491573|FG000|Overall Study|Other Reasons- Unspecified|44|||
170586991|NCT01342965|616491574|FG001|Overall Study|Other Reasons- Unspecified|38|||
170586992|NCT01342965|616491573|FG000|Overall Study|Withdrawal by Subject|2|||
170586993|NCT01342965|616491574|FG001|Overall Study|Withdrawal by Subject|9|||
170586994|NCT01453205|616491575|FG000|Overall Study|Lost to Follow-up|3|||
170586995|NCT01453205|616491576|FG001|Overall Study|Lost to Follow-up|0|||
170586996|NCT01453205|616491577|FG002|Overall Study|Lost to Follow-up|1|||
170586997|NCT01453205|616491575|FG000|Overall Study|Withdrawal by Subject|8|||
170586998|NCT01453205|616491576|FG001|Overall Study|Withdrawal by Subject|3|||
170586999|NCT01453205|616491577|FG002|Overall Study|Withdrawal by Subject|0|||
170587000|NCT01453205|616491575|FG000|Overall Study|Death|24|||
170587001|NCT01453205|616491576|FG001|Overall Study|Death|22|||
170587002|NCT01453205|616491577|FG002|Overall Study|Death|18|||
170587003|NCT01453205|616491575|FG000|Overall Study|Other|45|||
170587004|NCT01453205|616491576|FG001|Overall Study|Other|27|||
170587005|NCT01453205|616491577|FG002|Overall Study|Other|35|||
170587006|NCT01301066|616491587|FG000|Overall Study|Lost to Follow-up|5|||
170587007|NCT01301066|616491588|FG001|Overall Study|Lost to Follow-up|11|||
170650051|NCT05027971|616732807|FG000|Overall Study|Lost to Follow-up|1|||
170650052|NCT05027971|616732808|FG001|Overall Study|Lost to Follow-up|1|||
170650053|NCT05027971|616732807|FG000|Overall Study|Withdrawal by Subject|0|||
170650054|NCT05027971|616732808|FG001|Overall Study|Withdrawal by Subject|2|||
170650055|NCT05027971|616732807|FG000|Overall Study|Non-study fiber used.|0|||
170650056|NCT05027971|616732808|FG001|Overall Study|Non-study fiber used.|1|||
170650057|NCT05027971|616732807|FG000|Overall Study|Protocol Violation|0|||
170650058|NCT05027971|616732808|FG001|Overall Study|Protocol Violation|2|||
170650059|NCT02025556|616732809|FG000|Overall Study|Adverse Event|0|||
170650060|NCT02025556|616732810|FG001|Overall Study|Adverse Event|4|||
170650061|NCT02025556|616732811|FG002|Overall Study|Adverse Event|2|||
170650062|NCT02025556|616732809|FG000|Overall Study|Lack of Efficacy|2|||
170650063|NCT02025556|616732810|FG001|Overall Study|Lack of Efficacy|1|||
170650064|NCT02025556|616732811|FG002|Overall Study|Lack of Efficacy|0|||
170650065|NCT02025556|616732809|FG000|Overall Study|Protocol Violation|2|||
170650066|NCT02025556|616732810|FG001|Overall Study|Protocol Violation|1|||
170650067|NCT02025556|616732811|FG002|Overall Study|Protocol Violation|0|||
170650068|NCT02025556|616732809|FG000|Overall Study|Withdrawal by Subject|0|||
170650069|NCT02025556|616732810|FG001|Overall Study|Withdrawal by Subject|3|||
170650070|NCT02025556|616732811|FG002|Overall Study|Withdrawal by Subject|6|||
170650071|NCT02025556|616732809|FG000|Overall Study|Lost to Follow-up|2|||
170810073|NCT02969356|617313912|FG000|Overall Study|Did not need to be reinjected|6|||
170810074|NCT02969356|617313912|FG000|Overall Study|Personal reasons|5|||
170810075|NCT04369664|617315473|FG000|Overall Study|Physician Decision|1|||
170810076|NCT04369664|617315474|FG001|Overall Study|Physician Decision|0|||
170810077|NCT03840200|617315475|FG000|Overall Study|Death|6|||
170810078|NCT03840200|617315476|FG001|Overall Study|Death|3|||
170810079|NCT03840200|617315477|FG002|Overall Study|Death|6|||
170810080|NCT03840200|617315478|FG003|Overall Study|Death|10|||
170810081|NCT03840200|617315475|FG000|Overall Study|Reason Not Specified|2|||
170810082|NCT03840200|617315476|FG001|Overall Study|Reason Not Specified|2|||
170810083|NCT03840200|617315477|FG002|Overall Study|Reason Not Specified|1|||
170810084|NCT03840200|617315478|FG003|Overall Study|Reason Not Specified|15|||
170810085|NCT03840200|617315475|FG000|Overall Study|Physician Decision|0|||
170650072|NCT02025556|616732810|FG001|Overall Study|Lost to Follow-up|4|||
170650073|NCT02025556|616732811|FG002|Overall Study|Lost to Follow-up|0|||
170650074|NCT02025556|616732809|FG000|Overall Study|Reason not reported|0|||
170587008|NCT01301066|616491587|FG000|Overall Study|Protocol Violation|8|||
170587009|NCT01301066|616491588|FG001|Overall Study|Protocol Violation|7|||
170587010|NCT01301066|616491587|FG000|Overall Study|Withdrawal by Subject|4|||
170587011|NCT01301066|616491588|FG001|Overall Study|Withdrawal by Subject|9|||
170587012|NCT01301066|616491587|FG000|Overall Study|Adverse Event|6|||
170587013|NCT01301066|616491588|FG001|Overall Study|Adverse Event|6|||
170587014|NCT01301066|616491587|FG000|Overall Study|Sponsor Decision|2|||
170587015|NCT01301066|616491588|FG001|Overall Study|Sponsor Decision|1|||
170587016|NCT01301066|616491587|FG000|Overall Study|Physician Decision|0|||
170587017|NCT01301066|616491588|FG001|Overall Study|Physician Decision|1|||
170587018|NCT01301066|616491587|FG000|Overall Study|Other|2|||
170587019|NCT01301066|616491588|FG001|Overall Study|Other|0|||
170587020|NCT02241733|616491589|FG000|Overall Study|Lost to Follow-up|9|||
170587021|NCT02241733|616491590|FG001|Overall Study|Lost to Follow-up|4|||
170587022|NCT02241733|616491589|FG000|Overall Study|Physician Decision|6|||
170587023|NCT02241733|616491590|FG001|Overall Study|Physician Decision|2|||
170587024|NCT02241733|616491589|FG000|Overall Study|Withdrawal by Subject|0|||
170587025|NCT02241733|616491590|FG001|Overall Study|Withdrawal by Subject|2|||
170587026|NCT02241733|616491589|FG000|Overall Study|Death|0|||
170587027|NCT02241733|616491590|FG001|Overall Study|Death|2|||
170587028|NCT04003207|616491591|FG000|Overall Study|Protocol Violation|1|||
170587029|NCT04934800|616491594|FG000|Overall Study|Other|1|||
170810086|NCT03840200|617315476|FG001|Overall Study|Physician Decision|0|||
170810087|NCT03840200|617315477|FG002|Overall Study|Physician Decision|0|||
170587030|NCT04934800|616491594|FG000|Overall Study|Withdrawal by Subject|5|||
170587031|NCT04934800|616491594|FG000|Overall Study|Lack of Efficacy|1|||
170587032|NCT04934800|616491594|FG000|Overall Study|Adverse Event|9|||
170587033|NCT04934800|616491594|FG000|Overall Study|Lost to Follow-up|5|||
170587034|NCT04934800|616491594|FG000|Overall Study|Enrolled but not treated|1|||
170587035|NCT00516906|616491595|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
170587036|NCT00516906|616491596|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
170587037|NCT02118766|616491597|FG000|Overall Study|Adverse Event|7|||
170587038|NCT02118766|616491598|FG001|Overall Study|Adverse Event|2|||
170587039|NCT02118766|616491597|FG000|Overall Study|Withdrawal by Subject|3|||
170587040|NCT02118766|616491598|FG001|Overall Study|Withdrawal by Subject|6|||
170587041|NCT02118766|616491597|FG000|Overall Study|Lost to Follow-up|5|||
170587042|NCT02118766|616491598|FG001|Overall Study|Lost to Follow-up|4|||
170587043|NCT02118766|616491597|FG000|Overall Study|Withdrawal by parent/guardian|12|||
170587044|NCT02118766|616491598|FG001|Overall Study|Withdrawal by parent/guardian|18|||
170587045|NCT02118766|616491597|FG000|Overall Study|Other|3|||
170587046|NCT02118766|616491598|FG001|Overall Study|Other|1|||
170587047|NCT01252186|616491602|FG000|Overall Study|Adverse Event|9|||
170587048|NCT01252186|616491603|FG001|Overall Study|Adverse Event|6|||
170587049|NCT01252186|616491604|FG002|Overall Study|Adverse Event|8|||
170587050|NCT01252186|616491602|FG000|Overall Study|Withdrawal by Subject|2|||
170587051|NCT01252186|616491603|FG001|Overall Study|Withdrawal by Subject|5|||
170587052|NCT01252186|616491604|FG002|Overall Study|Withdrawal by Subject|2|||
170587053|NCT01252186|616491602|FG000|Overall Study|Physician Decision|0|||
170587054|NCT01252186|616491603|FG001|Overall Study|Physician Decision|0|||
170587055|NCT01252186|616491604|FG002|Overall Study|Physician Decision|1|||
170587056|NCT01252186|616491602|FG000|Overall Study|Non-compliance|0|||
170587057|NCT01252186|616491603|FG001|Overall Study|Non-compliance|3|||
170587058|NCT01252186|616491604|FG002|Overall Study|Non-compliance|4|||
170587059|NCT01252186|616491602|FG000|Overall Study|Protocol Violation|0|||
170587060|NCT01252186|616491603|FG001|Overall Study|Protocol Violation|0|||
170587061|NCT01252186|616491604|FG002|Overall Study|Protocol Violation|1|||
170587062|NCT01252186|616491602|FG000|Overall Study|Pregnancy|2|||
170810088|NCT03840200|617315478|FG003|Overall Study|Physician Decision|2|||
170810089|NCT03840200|617315475|FG000|Overall Study|Progressive Disease|0|||
170810090|NCT03840200|617315476|FG001|Overall Study|Progressive Disease|0|||
170810091|NCT03840200|617315477|FG002|Overall Study|Progressive Disease|0|||
170810092|NCT03840200|617315478|FG003|Overall Study|Progressive Disease|1|||
170587063|NCT01252186|616491603|FG001|Overall Study|Pregnancy|2|||
170587064|NCT01252186|616491604|FG002|Overall Study|Pregnancy|0|||
170587065|NCT01252186|616491602|FG000|Overall Study|Sponsor Request|2|||
170587066|NCT01252186|616491603|FG001|Overall Study|Sponsor Request|1|||
170587067|NCT01252186|616491604|FG002|Overall Study|Sponsor Request|0|||
170587068|NCT01252186|616491602|FG000|Overall Study|Lost to Follow-up|10|||
170587069|NCT01252186|616491603|FG001|Overall Study|Lost to Follow-up|10|||
170587070|NCT01252186|616491604|FG002|Overall Study|Lost to Follow-up|11|||
170587071|NCT01252186|616491602|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
170587072|NCT01252186|616491603|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
170587073|NCT01252186|616491604|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
170587074|NCT04621240|616491615|FG000|Overall Study|Withdrawal by Subject|36|||
170587075|NCT05032690|616491622|FG000|Period 1|Adverse Event|0|||
170810093|NCT03840200|617315475|FG000|Overall Study|Withdrawal by Subject|0|||
170810094|NCT03840200|617315476|FG001|Overall Study|Withdrawal by Subject|1|||
170587076|NCT05032690|616491623|FG001|Period 1|Adverse Event|1|||
170587077|NCT05032690|616491624|FG002|Period 1|Adverse Event|0|||
170587078|NCT05032690|616491625|FG003|Period 1|Adverse Event|0|||
170587079|NCT05032690|616491622|FG000|Period 1|Withdrawal by Subject|1|||
170587080|NCT05032690|616491623|FG001|Period 1|Withdrawal by Subject|0|||
170587081|NCT05032690|616491624|FG002|Period 1|Withdrawal by Subject|0|||
170587082|NCT05032690|616491625|FG003|Period 1|Withdrawal by Subject|0|||
170587083|NCT05032690|616491622|FG000|Period 1|No longer meets eligibility criteria|0|||
170587084|NCT05032690|616491623|FG001|Period 1|No longer meets eligibility criteria|1|||
170587085|NCT05032690|616491624|FG002|Period 1|No longer meets eligibility criteria|0|||
170587086|NCT05032690|616491625|FG003|Period 1|No longer meets eligibility criteria|0|||
170587087|NCT05032690|616491622|FG000|Period 2|Adverse Event|1|||
170587088|NCT05032690|616491623|FG001|Period 2|Adverse Event|0|||
170587089|NCT05032690|616491624|FG002|Period 2|Adverse Event|0|||
170587090|NCT05032690|616491625|FG003|Period 2|Adverse Event|0|||
170587091|NCT05032690|616491622|FG000|Period 2|Withdrawal by Subject|0|||
170587092|NCT05032690|616491623|FG001|Period 2|Withdrawal by Subject|1|||
170587093|NCT05032690|616491624|FG002|Period 2|Withdrawal by Subject|0|||
170587094|NCT05032690|616491625|FG003|Period 2|Withdrawal by Subject|0|||
170587095|NCT05032690|616491622|FG000|Period 2|No longer meets eligibility criteria|0|||
170587096|NCT05032690|616491623|FG001|Period 2|No longer meets eligibility criteria|1|||
170587097|NCT05032690|616491624|FG002|Period 2|No longer meets eligibility criteria|0|||
170587098|NCT05032690|616491625|FG003|Period 2|No longer meets eligibility criteria|0|||
170587099|NCT05032690|616491622|FG000|Period 3|Adverse Event|0|||
170587100|NCT05032690|616491623|FG001|Period 3|Adverse Event|1|||
170587101|NCT05032690|616491624|FG002|Period 3|Adverse Event|0|||
170587102|NCT05032690|616491625|FG003|Period 3|Adverse Event|0|||
170587103|NCT00487942|616491626|FG000|Overall Study|Adverse Event|1|||
170587104|NCT00487942|616491627|FG001|Overall Study|Adverse Event|1|||
170587105|NCT00487942|616491628|FG002|Overall Study|Adverse Event|1|||
170587106|NCT00487942|616491629|FG003|Overall Study|Adverse Event|1|||
170587107|NCT00487942|616491626|FG000|Overall Study|Lost to Follow-up|1|||
170587108|NCT00487942|616491627|FG001|Overall Study|Lost to Follow-up|0|||
170587109|NCT00487942|616491628|FG002|Overall Study|Lost to Follow-up|0|||
170587110|NCT00487942|616491629|FG003|Overall Study|Lost to Follow-up|1|||
170587111|NCT00487942|616491626|FG000|Overall Study|Protocol Violation|1|||
170587112|NCT00487942|616491627|FG001|Overall Study|Protocol Violation|1|||
170587113|NCT00487942|616491628|FG002|Overall Study|Protocol Violation|0|||
170587114|NCT00487942|616491629|FG003|Overall Study|Protocol Violation|0|||
170587115|NCT00487942|616491626|FG000|Overall Study|Withdrawal by Subject|0|||
170910879|NCT02619253|617677299|FG003|Overall Study|Adverse Event|1|||
170910880|NCT02619253|617677300|FG004|Overall Study|Adverse Event|3|||
170910881|NCT02619253|617677296|FG000|Overall Study|Alternative Therapy|0|||
170910882|NCT02619253|617677297|FG001|Overall Study|Alternative Therapy|0|||
170910883|NCT02619253|617677298|FG002|Overall Study|Alternative Therapy|1|||
170910884|NCT02619253|617677299|FG003|Overall Study|Alternative Therapy|0|||
170587116|NCT00487942|616491627|FG001|Overall Study|Withdrawal by Subject|1|||
170587117|NCT00487942|616491628|FG002|Overall Study|Withdrawal by Subject|2|||
170587118|NCT00487942|616491629|FG003|Overall Study|Withdrawal by Subject|0|||
170587119|NCT02298179|616491630|FG000|Overall Study|Lost to Follow-up|0|||
170587120|NCT02298179|616491631|FG001|Overall Study|Lost to Follow-up|0|||
170587121|NCT02298179|616491632|FG002|Overall Study|Lost to Follow-up|1|||
170587122|NCT02298179|616491633|FG003|Overall Study|Lost to Follow-up|0|||
170587123|NCT02298179|616491634|FG004|Overall Study|Lost to Follow-up|0|||
170587124|NCT02298179|616491635|FG005|Overall Study|Lost to Follow-up|0|||
170910885|NCT02619253|617677300|FG004|Overall Study|Alternative Therapy|0|||
170910886|NCT02619253|617677296|FG000|Overall Study|Death|0|||
170910887|NCT02619253|617677297|FG001|Overall Study|Death|0|||
170587125|NCT02298179|616491636|FG006|Overall Study|Lost to Follow-up|0|||
170587126|NCT02298179|616491637|FG007|Overall Study|Lost to Follow-up|1|||
170587127|NCT02298179|616491638|FG008|Overall Study|Lost to Follow-up|0|||
170587128|NCT02298179|616491639|FG009|Overall Study|Lost to Follow-up|0|||
170587129|NCT02298179|616491640|FG010|Overall Study|Lost to Follow-up|0|||
170650075|NCT02025556|616732810|FG001|Overall Study|Reason not reported|0|||
170650076|NCT02025556|616732811|FG002|Overall Study|Reason not reported|1|||
170650077|NCT02582684|616732812|FG000|Overall Study|Unable to contact subject/parent|4|||
170910888|NCT02619253|617677298|FG002|Overall Study|Death|0|||
170910889|NCT02619253|617677299|FG003|Overall Study|Death|1|||
170587130|NCT02298179|616491641|FG011|Overall Study|Lost to Follow-up|0|||
170587131|NCT00661726|616491642|FG000|Overall Study|Adverse Event|1|||
170587132|NCT00780143|616491643|FG000|Overall Study|Progressive disease|1|||
170587133|NCT00780143|616491643|FG000|Overall Study|Toxicity|1|||
170587134|NCT00780143|616491643|FG000|Overall Study|Adverse Event|1|||
170587135|NCT02147197|616491646|FG000|Overall Study|Adverse Event|1|||
170587136|NCT02147197|616491647|FG001|Overall Study|Adverse Event|0|||
170587137|NCT02147197|616491648|FG002|Overall Study|Adverse Event|0|||
170650078|NCT02582684|616732812|FG000|Overall Study|Subject not able to get to clinic|10|||
170650079|NCT02582684|616732812|FG000|Overall Study|Subject withdrew consent|1|||
170910890|NCT02619253|617677300|FG004|Overall Study|Death|0|||
170910891|NCT02619253|617677296|FG000|Overall Study|Disease Progression|4|||
170587138|NCT02147197|616491646|FG000|Overall Study|Withdrawal of Consent|4|||
170587139|NCT02147197|616491647|FG001|Overall Study|Withdrawal of Consent|3|||
170587140|NCT02147197|616491648|FG002|Overall Study|Withdrawal of Consent|2|||
170587141|NCT02147197|616491646|FG000|Overall Study|Lost to Follow-up|2|||
170587142|NCT02147197|616491647|FG001|Overall Study|Lost to Follow-up|3|||
170587143|NCT02147197|616491648|FG002|Overall Study|Lost to Follow-up|1|||
170587144|NCT02147197|616491646|FG000|Overall Study|Protocol Violation|1|||
170587145|NCT02147197|616491647|FG001|Overall Study|Protocol Violation|0|||
170587146|NCT02147197|616491648|FG002|Overall Study|Protocol Violation|3|||
170587147|NCT02147197|616491646|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170587148|NCT02147197|616491647|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170587149|NCT02147197|616491648|FG002|Overall Study|Other Miscellaneous Reasons|3|||
170587150|NCT01700959|616491649|FG000|Overall Study|Adverse Event|0|||
170587151|NCT01700959|616491650|FG001|Overall Study|Adverse Event|1|||
170587152|NCT01700959|616491651|FG002|Overall Study|Adverse Event|1|||
170587153|NCT01700959|616491652|FG003|Overall Study|Adverse Event|2|||
170587154|NCT01700959|616491653|FG004|Overall Study|Adverse Event|0|||
170587155|NCT01700959|616491654|FG005|Overall Study|Adverse Event|2|||
170587156|NCT01700959|616491649|FG000|Overall Study|Withdrawal by Subject|15|||
170587157|NCT01700959|616491650|FG001|Overall Study|Withdrawal by Subject|9|||
170587158|NCT01700959|616491651|FG002|Overall Study|Withdrawal by Subject|12|||
170587159|NCT01700959|616491652|FG003|Overall Study|Withdrawal by Subject|11|||
170587160|NCT01700959|616491653|FG004|Overall Study|Withdrawal by Subject|8|||
170587161|NCT01700959|616491654|FG005|Overall Study|Withdrawal by Subject|12|||
170587162|NCT01700959|616491649|FG000|Overall Study|Ineligible|2|||
170587163|NCT01700959|616491650|FG001|Overall Study|Ineligible|1|||
170587164|NCT01700959|616491651|FG002|Overall Study|Ineligible|2|||
170587165|NCT01700959|616491652|FG003|Overall Study|Ineligible|0|||
170587166|NCT01700959|616491653|FG004|Overall Study|Ineligible|0|||
170587167|NCT01700959|616491654|FG005|Overall Study|Ineligible|1|||
170587168|NCT01700959|616491649|FG000|Overall Study|Noncompliant|9|||
170587169|NCT01700959|616491650|FG001|Overall Study|Noncompliant|9|||
170587170|NCT01700959|616491651|FG002|Overall Study|Noncompliant|17|||
170587171|NCT01700959|616491652|FG003|Overall Study|Noncompliant|18|||
170587172|NCT01700959|616491653|FG004|Overall Study|Noncompliant|15|||
170587173|NCT01700959|616491654|FG005|Overall Study|Noncompliant|9|||
170587174|NCT01700959|616491649|FG000|Overall Study|Side effects|1|||
170587175|NCT01700959|616491650|FG001|Overall Study|Side effects|4|||
170587176|NCT01700959|616491651|FG002|Overall Study|Side effects|8|||
170587177|NCT01700959|616491652|FG003|Overall Study|Side effects|4|||
170587178|NCT01700959|616491653|FG004|Overall Study|Side effects|4|||
170587179|NCT01700959|616491654|FG005|Overall Study|Side effects|1|||
170587180|NCT00830375|616491655|FG000|Overall Study|Lost to Follow-up|1|||
170587181|NCT02461290|616491656|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
170587182|NCT02461290|616491656|FG000|Overall Study|Lost to Follow-up|3|||
170587183|NCT03319953|616491664|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
170587184|NCT03319953|616491665|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
170810095|NCT03840200|617315477|FG002|Overall Study|Withdrawal by Subject|0|||
170810096|NCT03840200|617315478|FG003|Overall Study|Withdrawal by Subject|2|||
170810097|NCT00264576|617315481|FG000|Overall Study|Lost to Follow-up|1|||
170810098|NCT00264576|617315482|FG001|Overall Study|Lost to Follow-up|1|||
170810099|NCT04633200|617315483|FG000|Overall Study|Lost to Follow-up|3|||
170810100|NCT04633200|617315484|FG001|Overall Study|Lost to Follow-up|5|||
170810101|NCT01190124|617315485|FG000|Overall Study|Death|3|||
170810102|NCT01190124|617315486|FG001|Overall Study|Death|0|||
170810103|NCT01190124|617315487|FG002|Overall Study|Death|0|||
170810104|NCT01190124|617315485|FG000|Overall Study|Therapeutic Failure|12|||
170810105|NCT01190124|617315486|FG001|Overall Study|Therapeutic Failure|0|||
170810106|NCT01190124|617315487|FG002|Overall Study|Therapeutic Failure|1|||
170810107|NCT01190124|617315485|FG000|Overall Study|Lost to Follow-up|2|||
170810108|NCT01190124|617315486|FG001|Overall Study|Lost to Follow-up|0|||
170810109|NCT01190124|617315487|FG002|Overall Study|Lost to Follow-up|0|||
170810110|NCT02713594|617315488|FG000|Overall Study|Withdrawal by Subject|32|||
170810111|NCT02713594|617315489|FG001|Overall Study|Withdrawal by Subject|22|||
170810112|NCT02713594|617315488|FG000|Overall Study|Lost to Follow-up|358|||
170810113|NCT02713594|617315489|FG001|Overall Study|Lost to Follow-up|374|||
170810114|NCT03690219|617315491|FG000|Overall Study|no injuries|9|||
170587185|NCT03319953|616491666|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
170587186|NCT03319953|616491667|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
170587187|NCT03319953|616491664|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
170587188|NCT03319953|616491665|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
170587189|NCT03319953|616491666|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
170587190|NCT03319953|616491667|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
170587191|NCT02438384|616491668|FG000|Overall Study|Lost to Follow-up|8|||
170587192|NCT02438384|616491669|FG001|Overall Study|Lost to Follow-up|6|||
170587193|NCT02438384|616491670|FG002|Overall Study|Lost to Follow-up|4|||
170587194|NCT04027049|616491672|FG000|Overall Study|Withdrawn by family|1|||
170810115|NCT03690219|617315492|FG001|Overall Study|no injuries|20|||
170810116|NCT03690219|617315491|FG000|Overall Study|missing information|7|||
170587195|NCT04027049|616491673|FG001|Overall Study|Withdrawn by family|0|||
170587196|NCT04027049|616491672|FG000|Overall Study|Participant safety|1|||
170587197|NCT04027049|616491673|FG001|Overall Study|Participant safety|0|||
170587198|NCT02650128|616491676|FG000|Overall Study|Death|2|||
170587199|NCT02226198|616494189|FG000|Lead-in Phase|Protocol Violation|1|||
170587200|NCT02226198|616494190|FG001|Lead-in Phase|Protocol Violation|0|||
170587201|NCT02226198|616494191|FG002|Lead-in Phase|Protocol Violation|0|||
170587202|NCT02226198|616494189|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
170587203|NCT02226198|616494190|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
170587204|NCT02226198|616494191|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
170587205|NCT01440517|616494194|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
170587206|NCT00896363|616494196|FG000|Overall Study|Adverse Event|3|||
170587207|NCT00896363|616494197|FG001|Overall Study|Adverse Event|4|||
170587208|NCT00896363|616494198|FG002|Overall Study|Adverse Event|2|||
170587209|NCT00896363|616494196|FG000|Overall Study|Lack of Efficacy|0|||
170587210|NCT00896363|616494197|FG001|Overall Study|Lack of Efficacy|2|||
170587211|NCT00896363|616494198|FG002|Overall Study|Lack of Efficacy|1|||
170587212|NCT00896363|616494196|FG000|Overall Study|Withdrawal by Subject|3|||
170587213|NCT00896363|616494197|FG001|Overall Study|Withdrawal by Subject|5|||
170587214|NCT00896363|616494198|FG002|Overall Study|Withdrawal by Subject|5|||
170587215|NCT01730339|616494199|FG000|Overall Study|Withdrawal by Subject|3|||
170587216|NCT01730339|616494200|FG001|Overall Study|Withdrawal by Subject|2|||
170587217|NCT01730339|616494199|FG000|Overall Study|Lost to Follow-up|1|||
170587218|NCT01730339|616494200|FG001|Overall Study|Lost to Follow-up|1|||
170587219|NCT01730339|616494199|FG000|Overall Study|Un-specified|1|||
170587220|NCT01730339|616494200|FG001|Overall Study|Un-specified|0|||
170587221|NCT00413894|616494201|FG000|Overall Study|Withdrawal by Subject|10|||
170587222|NCT00413894|616494201|FG000|Overall Study|Administrative Reasons|1|||
170587223|NCT00413894|616494201|FG000|Overall Study|Hb <10 grams/deciliter|12|||
170587224|NCT00413894|616494201|FG000|Overall Study|Adverse Event|28|||
170587225|NCT00413894|616494201|FG000|Overall Study|Protocol Violation|11|||
170587226|NCT00413894|616494201|FG000|Overall Study|Other|18|||
170587227|NCT01529515|616494216|FG000|TRANSITION PHASE|Adverse Event|16|||
170587228|NCT01529515|616494217|FG001|TRANSITION PHASE|Adverse Event|0|||
170587229|NCT01529515|616494218|FG002|TRANSITION PHASE|Adverse Event|0|||
170587230|NCT01529515|616494219|FG003|TRANSITION PHASE|Adverse Event|0|||
170587231|NCT01529515|616494216|FG000|TRANSITION PHASE|Death|1|||
170587232|NCT01529515|616494217|FG001|TRANSITION PHASE|Death|0|||
170587233|NCT01529515|616494218|FG002|TRANSITION PHASE|Death|0|||
170587234|NCT01529515|616494219|FG003|TRANSITION PHASE|Death|0|||
170587235|NCT01529515|616494216|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
170587236|NCT01529515|616494217|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
170587237|NCT01529515|616494218|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
170587238|NCT01529515|616494219|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
170587239|NCT01529515|616494216|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
170587240|NCT01529515|616494217|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
170587241|NCT01529515|616494218|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
170587242|NCT01529515|616494219|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
170587243|NCT01529515|616494216|FG000|TRANSITION PHASE|Protocol Violation|4|||
170587244|NCT01529515|616494217|FG001|TRANSITION PHASE|Protocol Violation|0|||
170587245|NCT01529515|616494218|FG002|TRANSITION PHASE|Protocol Violation|0|||
170587246|NCT01529515|616494219|FG003|TRANSITION PHASE|Protocol Violation|0|||
170587247|NCT01529515|616494216|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
170587248|NCT01529515|616494217|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
170587249|NCT01529515|616494218|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
170587250|NCT01529515|616494219|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
170587251|NCT01529515|616494216|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
170587252|NCT01529515|616494217|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
170587253|NCT01529515|616494218|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
170587254|NCT01529515|616494219|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
170587255|NCT01529515|616494216|FG000|TRANSITION PHASE|Other|9|||
170587256|NCT01529515|616494217|FG001|TRANSITION PHASE|Other|0|||
170910892|NCT02619253|617677297|FG001|Overall Study|Disease Progression|2|||
170587257|NCT01529515|616494218|FG002|TRANSITION PHASE|Other|0|||
170587258|NCT01529515|616494219|FG003|TRANSITION PHASE|Other|0|||
170587259|NCT01529515|616494216|FG000|MAINTENANCE PHASE|Adverse Event|0|||
170587260|NCT01529515|616494217|FG001|MAINTENANCE PHASE|Adverse Event|10|||
170587261|NCT01529515|616494218|FG002|MAINTENANCE PHASE|Adverse Event|0|||
170587262|NCT01529515|616494219|FG003|MAINTENANCE PHASE|Adverse Event|0|||
170587263|NCT01529515|616494216|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
170587264|NCT01529515|616494217|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
170910893|NCT02619253|617677298|FG002|Overall Study|Disease Progression|8|||
170587265|NCT01529515|616494218|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
170587266|NCT01529515|616494219|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
170587267|NCT01529515|616494216|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
170587268|NCT01529515|616494217|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
170587269|NCT01529515|616494218|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
170910894|NCT02619253|617677299|FG003|Overall Study|Disease Progression|9|||
170587270|NCT01529515|616494219|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
170587271|NCT01529515|616494216|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
170587272|NCT01529515|616494217|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
170587273|NCT01529515|616494218|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
170587274|NCT01529515|616494219|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
170587275|NCT01529515|616494216|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
170587276|NCT01529515|616494217|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
170587277|NCT01529515|616494218|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
170587278|NCT01529515|616494219|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
170587279|NCT01529515|616494216|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
170587280|NCT01529515|616494217|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
170587281|NCT01529515|616494218|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
170587282|NCT01529515|616494219|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
170587283|NCT01529515|616494216|FG000|MAINTENANCE PHASE|Other|0|||
170587284|NCT01529515|616494217|FG001|MAINTENANCE PHASE|Other|10|||
170587285|NCT01529515|616494218|FG002|MAINTENANCE PHASE|Other|0|||
170587286|NCT01529515|616494219|FG003|MAINTENANCE PHASE|Other|0|||
170587287|NCT01529515|616494216|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
170587288|NCT01529515|616494217|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
170587289|NCT01529515|616494218|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
170587290|NCT01529515|616494219|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
170587291|NCT01529515|616494216|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
170587292|NCT01529515|616494217|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
170587293|NCT01529515|616494218|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
170587294|NCT01529515|616494219|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
170587295|NCT01529515|616494216|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
170587296|NCT01529515|616494217|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
170587297|NCT01529515|616494218|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
170587298|NCT01529515|616494219|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
170587299|NCT01529515|616494216|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
170587300|NCT01529515|616494217|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
170587301|NCT01529515|616494218|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
170587302|NCT01529515|616494219|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
170587303|NCT01529515|616494216|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
170587304|NCT01529515|616494217|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
170587305|NCT01529515|616494218|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
170587306|NCT01529515|616494219|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
170587307|NCT01529515|616494216|FG000|DOUBLE BLIND PHASE|Other|0|||
170587308|NCT01529515|616494217|FG001|DOUBLE BLIND PHASE|Other|0|||
170587309|NCT01529515|616494218|FG002|DOUBLE BLIND PHASE|Other|9|||
170587310|NCT01529515|616494219|FG003|DOUBLE BLIND PHASE|Other|2|||
170587311|NCT03920293|616494220|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
170587312|NCT03920293|616494221|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
170587313|NCT03920293|616494220|FG000|Randomized-Controlled Period|Physician Decision|1|||
170587314|NCT03920293|616494221|FG001|Randomized-Controlled Period|Physician Decision|2|||
170587315|NCT03920293|616494220|FG000|Randomized-Controlled Period|Adverse Event|0|||
170587316|NCT03920293|616494221|FG001|Randomized-Controlled Period|Adverse Event|2|||
170587317|NCT03920293|616494220|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
170587318|NCT03920293|616494221|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
170587319|NCT03920293|616494220|FG000|Randomized-Controlled Period|Death|2|||
170587320|NCT03920293|616494221|FG001|Randomized-Controlled Period|Death|0|||
170587321|NCT03920293|616494220|FG000|Randomized-Controlled Period|Protocol Violation|1|||
170587322|NCT03920293|616494221|FG001|Randomized-Controlled Period|Protocol Violation|0|||
170587323|NCT03920293|616494220|FG000|Randomized-Controlled Period|Noncompliance|1|||
170587324|NCT03920293|616494221|FG001|Randomized-Controlled Period|Noncompliance|0|||
170587325|NCT03920293|616494220|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
170587326|NCT03920293|616494221|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
170587327|NCT03920293|616494220|FG000|Open- Label Extension Period|Death|3|||
170587328|NCT03920293|616494221|FG001|Open- Label Extension Period|Death|3|||
170587329|NCT03920293|616494220|FG000|Open- Label Extension Period|Physician Decision|5|||
170587330|NCT03920293|616494221|FG001|Open- Label Extension Period|Physician Decision|3|||
170587331|NCT03920293|616494220|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
170587332|NCT03920293|616494221|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
170587333|NCT03344549|616494224|FG000|Overall Study|Withdrawal by Subject|3|||
170587334|NCT03344549|616494225|FG001|Overall Study|Withdrawal by Subject|2|||
170587335|NCT03344549|616494224|FG000|Overall Study|Dialysis|2|||
170587336|NCT03344549|616494225|FG001|Overall Study|Dialysis|0|||
170587337|NCT03344549|616494224|FG000|Overall Study|Cancer|1|||
170587338|NCT03344549|616494225|FG001|Overall Study|Cancer|0|||
170587339|NCT03344549|616494224|FG000|Overall Study|Lack of electronic device|1|||
170587340|NCT03344549|616494225|FG001|Overall Study|Lack of electronic device|0|||
170587341|NCT03344549|616494224|FG000|Overall Study|Transportation difficulty|0|||
170587342|NCT03344549|616494225|FG001|Overall Study|Transportation difficulty|13|||
170587343|NCT01165320|616494231|FG000|Overall Study|Clinical adverse experience|2|||
170587344|NCT01165320|616494232|FG001|Overall Study|Clinical adverse experience|1|||
170587345|NCT01165320|616494233|FG002|Overall Study|Clinical adverse experience|0|||
170587346|NCT01165320|616494231|FG000|Overall Study|Laboratory adverse experience|1|||
170587347|NCT01165320|616494232|FG001|Overall Study|Laboratory adverse experience|0|||
170587348|NCT01165320|616494233|FG002|Overall Study|Laboratory adverse experience|0|||
170587349|NCT01165320|616494231|FG000|Overall Study|Lack of Efficacy|0|||
170587350|NCT01165320|616494232|FG001|Overall Study|Lack of Efficacy|2|||
170587351|NCT01165320|616494233|FG002|Overall Study|Lack of Efficacy|0|||
170587352|NCT01165320|616494231|FG000|Overall Study|Reason unknown|0|||
170587353|NCT01165320|616494232|FG001|Overall Study|Reason unknown|1|||
170587354|NCT01165320|616494233|FG002|Overall Study|Reason unknown|0|||
170587355|NCT03305419|616494235|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
170587356|NCT03305419|616494236|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
170587357|NCT03305419|616494237|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
170587358|NCT03305419|616494238|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
170587359|NCT03305419|616494239|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
170587360|NCT03305419|616494240|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
170587361|NCT03305419|616494241|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
170587362|NCT03305419|616494242|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
170587363|NCT03305419|616494235|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
170587364|NCT03305419|616494236|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
170587365|NCT03305419|616494237|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
170587366|NCT03305419|616494238|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
170587367|NCT03305419|616494239|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
170587368|NCT03305419|616494240|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
170587369|NCT03305419|616494241|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
170587370|NCT03305419|616494242|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
170587371|NCT03305419|616494235|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
170587372|NCT03305419|616494236|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
170587373|NCT03305419|616494237|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
170587374|NCT03305419|616494238|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
170587375|NCT03305419|616494239|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
170587376|NCT03305419|616494240|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
170587377|NCT03305419|616494241|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
170587378|NCT03305419|616494242|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
170587379|NCT03305419|616494235|FG000|Part B (14 Days)|Adverse Event|0|||
170587380|NCT03305419|616494236|FG001|Part B (14 Days)|Adverse Event|0|||
170587381|NCT03305419|616494237|FG002|Part B (14 Days)|Adverse Event|0|||
170587382|NCT03305419|616494238|FG003|Part B (14 Days)|Adverse Event|0|||
170587383|NCT03305419|616494239|FG004|Part B (14 Days)|Adverse Event|1|||
170587384|NCT03305419|616494240|FG005|Part B (14 Days)|Adverse Event|2|||
170587385|NCT03305419|616494241|FG006|Part B (14 Days)|Adverse Event|4|||
170587386|NCT03305419|616494242|FG007|Part B (14 Days)|Adverse Event|0|||
170587387|NCT03305419|616494235|FG000|Part B (14 Days)|Physician Decision|0|||
170587388|NCT03305419|616494236|FG001|Part B (14 Days)|Physician Decision|0|||
170587389|NCT03305419|616494237|FG002|Part B (14 Days)|Physician Decision|0|||
170587390|NCT03305419|616494238|FG003|Part B (14 Days)|Physician Decision|0|||
170587391|NCT03305419|616494239|FG004|Part B (14 Days)|Physician Decision|2|||
170587392|NCT03305419|616494240|FG005|Part B (14 Days)|Physician Decision|8|||
170587393|NCT03305419|616494241|FG006|Part B (14 Days)|Physician Decision|1|||
170587394|NCT03305419|616494242|FG007|Part B (14 Days)|Physician Decision|0|||
170587395|NCT01155466|616494243|FG000|Overall Study|Adverse Event|13|||
170587396|NCT01155466|616494244|FG001|Overall Study|Adverse Event|15|||
170587397|NCT01155466|616494245|FG002|Overall Study|Adverse Event|6|||
170587398|NCT01155466|616494246|FG003|Overall Study|Adverse Event|17|||
170587399|NCT01155466|616494247|FG004|Overall Study|Adverse Event|18|||
170587400|NCT01155466|616494243|FG000|Overall Study|Lost to Follow-up|0|||
170587401|NCT01155466|616494244|FG001|Overall Study|Lost to Follow-up|0|||
170587402|NCT01155466|616494245|FG002|Overall Study|Lost to Follow-up|0|||
170587403|NCT01155466|616494246|FG003|Overall Study|Lost to Follow-up|0|||
170587404|NCT01155466|616494247|FG004|Overall Study|Lost to Follow-up|2|||
170587405|NCT01155466|616494243|FG000|Overall Study|Withdrawal by Subject|7|||
170587406|NCT01155466|616494244|FG001|Overall Study|Withdrawal by Subject|5|||
170587407|NCT01155466|616494245|FG002|Overall Study|Withdrawal by Subject|9|||
170587408|NCT01155466|616494246|FG003|Overall Study|Withdrawal by Subject|4|||
170587409|NCT01155466|616494247|FG004|Overall Study|Withdrawal by Subject|4|||
170587410|NCT01155466|616494243|FG000|Overall Study|Protocol Violation|0|||
170587411|NCT01155466|616494244|FG001|Overall Study|Protocol Violation|0|||
170587412|NCT01155466|616494245|FG002|Overall Study|Protocol Violation|2|||
170587413|NCT01155466|616494246|FG003|Overall Study|Protocol Violation|0|||
170587414|NCT01155466|616494247|FG004|Overall Study|Protocol Violation|1|||
170587415|NCT01155466|616494243|FG000|Overall Study|Administrative|0|||
170587416|NCT01155466|616494244|FG001|Overall Study|Administrative|3|||
170910895|NCT02619253|617677300|FG004|Overall Study|Disease Progression|10|||
170910896|NCT02619253|617677296|FG000|Overall Study|Needed a disqualifying therapy|0|||
170587417|NCT01155466|616494245|FG002|Overall Study|Administrative|0|||
170587418|NCT01155466|616494246|FG003|Overall Study|Administrative|0|||
170587419|NCT01155466|616494247|FG004|Overall Study|Administrative|0|||
170910897|NCT02619253|617677297|FG001|Overall Study|Needed a disqualifying therapy|0|||
170910898|NCT02619253|617677298|FG002|Overall Study|Needed a disqualifying therapy|1|||
170910899|NCT02619253|617677299|FG003|Overall Study|Needed a disqualifying therapy|0|||
170910900|NCT02619253|617677300|FG004|Overall Study|Needed a disqualifying therapy|0|||
170910901|NCT02619253|617677296|FG000|Overall Study|Transferred to hospice|0|||
170910902|NCT02619253|617677297|FG001|Overall Study|Transferred to hospice|0|||
170910903|NCT02619253|617677298|FG002|Overall Study|Transferred to hospice|1|||
170910904|NCT02619253|617677299|FG003|Overall Study|Transferred to hospice|0|||
170910905|NCT02619253|617677300|FG004|Overall Study|Transferred to hospice|0|||
170910906|NCT02619253|617677296|FG000|Overall Study|Physician Decision|0|||
170910907|NCT02619253|617677297|FG001|Overall Study|Physician Decision|1|||
170910908|NCT02619253|617677298|FG002|Overall Study|Physician Decision|2|||
170910909|NCT02619253|617677299|FG003|Overall Study|Physician Decision|3|||
170910910|NCT02619253|617677300|FG004|Overall Study|Physician Decision|0|||
170910911|NCT02619253|617677296|FG000|Overall Study|Withdrawal by Subject|0|||
170910912|NCT02619253|617677297|FG001|Overall Study|Withdrawal by Subject|1|||
170910913|NCT02619253|617677298|FG002|Overall Study|Withdrawal by Subject|0|||
170910914|NCT02619253|617677299|FG003|Overall Study|Withdrawal by Subject|0|||
170910915|NCT02619253|617677300|FG004|Overall Study|Withdrawal by Subject|2|||
170910916|NCT02111811|617677303|FG000|Treatment Phase|Lost to Follow-up|22|||
170587420|NCT01155466|616494243|FG000|Overall Study|Randomized not treated|2|||
170587421|NCT01155466|616494244|FG001|Overall Study|Randomized not treated|2|||
170587422|NCT01155466|616494245|FG002|Overall Study|Randomized not treated|3|||
170587423|NCT01155466|616494246|FG003|Overall Study|Randomized not treated|0|||
170587424|NCT01155466|616494247|FG004|Overall Study|Randomized not treated|2|||
170587425|NCT02075047|616494248|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
170587426|NCT02075047|616494249|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
170587427|NCT02075047|616494248|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
170587428|NCT02075047|616494249|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
170587429|NCT02075047|616494248|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
170587430|NCT02075047|616494249|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
170587431|NCT02075047|616494248|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
170587432|NCT02075047|616494249|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
170587433|NCT02075047|616494248|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
170587434|NCT02075047|616494249|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
170587435|NCT02075047|616494248|FG000|Treatment Phase (4 Weeks)|Other|1|||
170587436|NCT02075047|616494249|FG001|Treatment Phase (4 Weeks)|Other|1|||
170587437|NCT02075047|616494248|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
170587438|NCT02075047|616494249|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
170587439|NCT02075047|616494248|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
170810117|NCT03690219|617315492|FG001|Overall Study|missing information|7|||
170810118|NCT01523392|617315493|FG000|Treatment Period 1|Withdrawal by Subject|2|||
170810119|NCT01523392|617315494|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170810120|NCT01523392|617315493|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
170810121|NCT01523392|617315494|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
170810122|NCT01523392|617315493|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
170810123|NCT01523392|617315494|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
170810124|NCT01808534|617315497|FG000|Overall Study|Disease progression|3|||
170810125|NCT01808534|617315497|FG000|Overall Study|Physician Decision|1|||
170810126|NCT00671853|617315498|FG000|Overall Study|Lack of Efficacy|3|||
170810127|NCT00671853|617315499|FG001|Overall Study|Lack of Efficacy|7|||
170810128|NCT00671853|617315498|FG000|Overall Study|Adverse Event|7|||
170810129|NCT00671853|617315499|FG001|Overall Study|Adverse Event|1|||
170810130|NCT00671853|617315498|FG000|Overall Study|Withdrawal by Subject|1|||
170810131|NCT00671853|617315499|FG001|Overall Study|Withdrawal by Subject|5|||
170810132|NCT00671853|617315498|FG000|Overall Study|Lost to Follow-up|8|||
170810133|NCT00671853|617315499|FG001|Overall Study|Lost to Follow-up|8|||
170810134|NCT00671853|617315498|FG000|Overall Study|Physician Decision|0|||
170810135|NCT00671853|617315499|FG001|Overall Study|Physician Decision|2|||
170810136|NCT00671853|617315498|FG000|Overall Study|Non-adherence with study procedures|1|||
170810137|NCT00671853|617315499|FG001|Overall Study|Non-adherence with study procedures|4|||
170810138|NCT02354417|617315500|FG000|Overall Study|Physician Decision|1|||
170910917|NCT02111811|617677304|FG001|Treatment Phase|Lost to Follow-up|18|||
170910918|NCT02111811|617677303|FG000|Treatment Phase|Death|2|||
170587440|NCT02075047|616494249|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
170910919|NCT02111811|617677304|FG001|Treatment Phase|Death|0|||
170587441|NCT02075047|616494248|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
170810139|NCT02092285|617315501|FG000|Induction Phase|Adverse Event|7|||
170810140|NCT02092285|617315501|FG000|Induction Phase|Physician Decision|4|||
170810141|NCT02092285|617315501|FG000|Induction Phase|Pregnancy|1|||
170910920|NCT02111811|617677303|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
170910921|NCT02111811|617677304|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
170910922|NCT02111811|617677303|FG000|Follow up Period (Aim 2)|Death|2|||
170910923|NCT02111811|617677304|FG001|Follow up Period (Aim 2)|Death|0|||
170910924|NCT03443024|617677307|FG000|Overall Study|Adverse Event|2|||
170910925|NCT03443024|617677308|FG001|Overall Study|Adverse Event|4|||
170910926|NCT03443024|617677309|FG002|Overall Study|Adverse Event|3|||
170910927|NCT03443024|617677310|FG003|Overall Study|Adverse Event|1|||
170910928|NCT03443024|617677307|FG000|Overall Study|Lost to Follow-up|9|||
170910929|NCT03443024|617677308|FG001|Overall Study|Lost to Follow-up|9|||
170910930|NCT03443024|617677309|FG002|Overall Study|Lost to Follow-up|7|||
170910931|NCT03443024|617677310|FG003|Overall Study|Lost to Follow-up|5|||
170910932|NCT03443024|617677307|FG000|Overall Study|Withdrawal by Subject|8|||
170587442|NCT02075047|616494249|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
170587443|NCT02075047|616494248|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
170587444|NCT02075047|616494249|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
170587445|NCT02075047|616494248|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
170587446|NCT02075047|616494249|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
170587447|NCT02075047|616494248|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
170587448|NCT02075047|616494249|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
170587449|NCT02075047|616494248|FG000|Follow up Phase (5 Weeks)|Other|1|||
170587450|NCT02075047|616494249|FG001|Follow up Phase (5 Weeks)|Other|2|||
170587451|NCT02075047|616494248|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
170587452|NCT02075047|616494249|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
170587453|NCT02231892|616494250|FG000|Overall Study|Lost to Follow-up|1|||
170587454|NCT02231892|616494251|FG001|Overall Study|Lost to Follow-up|0|||
170587455|NCT02231892|616494252|FG002|Overall Study|Lost to Follow-up|3|||
170587456|NCT02231892|616494250|FG000|Overall Study|Withdrawal by Subject|4|||
170587457|NCT02231892|616494251|FG001|Overall Study|Withdrawal by Subject|3|||
170587458|NCT02231892|616494252|FG002|Overall Study|Withdrawal by Subject|15|||
170587459|NCT02231892|616494250|FG000|Overall Study|Physician Decision|0|||
170587460|NCT02231892|616494251|FG001|Overall Study|Physician Decision|2|||
170587461|NCT02231892|616494252|FG002|Overall Study|Physician Decision|4|||
170587462|NCT02231892|616494250|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
170587463|NCT02231892|616494251|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
170587464|NCT02231892|616494252|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
170587465|NCT02231892|616494250|FG000|Overall Study|Participant motor threshold was >83%|0|||
170587466|NCT02231892|616494251|FG001|Overall Study|Participant motor threshold was >83%|0|||
170587467|NCT02231892|616494252|FG002|Overall Study|Participant motor threshold was >83%|9|||
170587468|NCT02231892|616494250|FG000|Overall Study|Could not find motor threshold|2|||
170587469|NCT02231892|616494251|FG001|Overall Study|Could not find motor threshold|0|||
170587470|NCT02231892|616494252|FG002|Overall Study|Could not find motor threshold|1|||
170587471|NCT02231892|616494250|FG000|Overall Study|Could not find reliable motor hotspot|0|||
170587472|NCT02231892|616494251|FG001|Overall Study|Could not find reliable motor hotspot|0|||
170587473|NCT02231892|616494252|FG002|Overall Study|Could not find reliable motor hotspot|1|||
170587474|NCT03832322|616494253|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
170587475|NCT03832322|616494254|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
170910933|NCT03443024|617677308|FG001|Overall Study|Withdrawal by Subject|15|||
170910934|NCT03443024|617677309|FG002|Overall Study|Withdrawal by Subject|9|||
170910935|NCT03443024|617677310|FG003|Overall Study|Withdrawal by Subject|23|||
170910936|NCT03443024|617677307|FG000|Overall Study|Physician Decision|1|||
170587476|NCT00515294|616494256|FG000|Overall Study|Lost to Follow-up|3|||
170587477|NCT00515294|616494257|FG001|Overall Study|Lost to Follow-up|2|||
170587478|NCT00515294|616494258|FG002|Overall Study|Lost to Follow-up|3|||
170587479|NCT00515294|616494259|FG003|Overall Study|Lost to Follow-up|1|||
170587480|NCT00515294|616494256|FG000|Overall Study|Driver simulator problems|1|||
170587481|NCT00515294|616494257|FG001|Overall Study|Driver simulator problems|1|||
170587482|NCT00515294|616494258|FG002|Overall Study|Driver simulator problems|1|||
170910937|NCT03443024|617677308|FG001|Overall Study|Physician Decision|2|||
170910938|NCT03443024|617677309|FG002|Overall Study|Physician Decision|0|||
170587483|NCT00515294|616494259|FG003|Overall Study|Driver simulator problems|3|||
170587484|NCT00515294|616494256|FG000|Overall Study|Caffeine amount inaccurate|5|||
170587485|NCT00515294|616494257|FG001|Overall Study|Caffeine amount inaccurate|0|||
170587486|NCT00515294|616494258|FG002|Overall Study|Caffeine amount inaccurate|7|||
170587487|NCT00515294|616494259|FG003|Overall Study|Caffeine amount inaccurate|0|||
170587488|NCT03770728|616494262|FG000|Overall Study|Adverse Event|1|||
170587489|NCT03770728|616494263|FG001|Overall Study|Adverse Event|0|||
170587490|NCT03770728|616494264|FG002|Overall Study|Adverse Event|1|||
170587491|NCT03770728|616494265|FG003|Overall Study|Adverse Event|0|||
170587492|NCT03770728|616494262|FG000|Overall Study|Poor compliance to protocol|0|||
170587493|NCT03770728|616494263|FG001|Overall Study|Poor compliance to protocol|0|||
170587494|NCT03770728|616494264|FG002|Overall Study|Poor compliance to protocol|1|||
170587495|NCT03770728|616494265|FG003|Overall Study|Poor compliance to protocol|0|||
170910939|NCT03443024|617677310|FG003|Overall Study|Physician Decision|1|||
170587496|NCT03770728|616494262|FG000|Overall Study|Withdrawal by Subject|13|||
170587497|NCT03770728|616494263|FG001|Overall Study|Withdrawal by Subject|8|||
170587498|NCT03770728|616494264|FG002|Overall Study|Withdrawal by Subject|9|||
170587499|NCT03770728|616494265|FG003|Overall Study|Withdrawal by Subject|13|||
170587500|NCT03770728|616494262|FG000|Overall Study|Other than specified|24|||
170587501|NCT03770728|616494263|FG001|Overall Study|Other than specified|23|||
170587502|NCT03770728|616494264|FG002|Overall Study|Other than specified|21|||
170587503|NCT03770728|616494265|FG003|Overall Study|Other than specified|22|||
170587504|NCT00503776|616494266|FG000|Overall Study|Withdrawal by Subject|1|||
170587505|NCT00503776|616494267|FG001|Overall Study|Withdrawal by Subject|0|||
170587506|NCT00503776|616494268|FG002|Overall Study|Withdrawal by Subject|1|||
170587507|NCT00503776|616494269|FG003|Overall Study|Withdrawal by Subject|1|||
170587508|NCT00503776|616494266|FG000|Overall Study|Physician Decision|0|||
170587509|NCT00503776|616494267|FG001|Overall Study|Physician Decision|0|||
170587510|NCT00503776|616494268|FG002|Overall Study|Physician Decision|1|||
170587511|NCT00503776|616494269|FG003|Overall Study|Physician Decision|1|||
170587512|NCT02778555|616494270|FG000|Overall Study|Withdrawal by Subject|55|||
170587513|NCT02778555|616494271|FG001|Overall Study|Withdrawal by Subject|32|||
170587514|NCT02778555|616494272|FG002|Overall Study|Withdrawal by Subject|107|||
170587515|NCT02379988|616494273|FG000|Overall Study|Not eligible|1|||
170587516|NCT02509039|616494274|FG000|Overall Study|Adverse Event|0|||
170587517|NCT02509039|616494275|FG001|Overall Study|Adverse Event|1|||
170587518|NCT02509039|616494276|FG002|Overall Study|Adverse Event|1|||
170587519|NCT02509039|616494277|FG003|Overall Study|Adverse Event|1|||
170587520|NCT02509039|616494274|FG000|Overall Study|Withdrawal by Subject|0|||
170587521|NCT02509039|616494275|FG001|Overall Study|Withdrawal by Subject|0|||
170587522|NCT02509039|616494276|FG002|Overall Study|Withdrawal by Subject|1|||
170587523|NCT02509039|616494277|FG003|Overall Study|Withdrawal by Subject|0|||
170587524|NCT02509039|616494274|FG000|Overall Study|Progressive disease|2|||
170587525|NCT02509039|616494275|FG001|Overall Study|Progressive disease|2|||
170587526|NCT02509039|616494276|FG002|Overall Study|Progressive disease|1|||
170587527|NCT02509039|616494277|FG003|Overall Study|Progressive disease|5|||
170587528|NCT02509039|616494274|FG000|Overall Study|Study terminated by Sponsor|1|||
170587529|NCT02509039|616494275|FG001|Overall Study|Study terminated by Sponsor|0|||
170587530|NCT02509039|616494276|FG002|Overall Study|Study terminated by Sponsor|0|||
170587531|NCT02509039|616494277|FG003|Overall Study|Study terminated by Sponsor|0|||
170587532|NCT00223977|616494280|FG000|Overall Study|Adverse Event|7|||
170587533|NCT00223977|616494281|FG001|Overall Study|Adverse Event|10|||
170587534|NCT00223977|616494282|FG002|Overall Study|Adverse Event|0|||
170587535|NCT00223977|616494280|FG000|Overall Study|Protocol Violation|0|||
170587536|NCT00223977|616494281|FG001|Overall Study|Protocol Violation|0|||
170587537|NCT00223977|616494282|FG002|Overall Study|Protocol Violation|1|||
170587538|NCT00223977|616494280|FG000|Overall Study|Withdrawal by Subject|1|||
170587539|NCT00223977|616494281|FG001|Overall Study|Withdrawal by Subject|1|||
170587540|NCT00223977|616494282|FG002|Overall Study|Withdrawal by Subject|2|||
170587541|NCT00223977|616494280|FG000|Overall Study|Other|1|||
170587542|NCT00223977|616494281|FG001|Overall Study|Other|0|||
170587543|NCT00223977|616494282|FG002|Overall Study|Other|0|||
170810142|NCT02092285|617315501|FG000|Induction Phase|Relapse/Recurrence|7|||
170810143|NCT02092285|617315501|FG000|Induction Phase|Withdrawal by Subject|2|||
170810144|NCT02092285|617315501|FG000|Induction Phase|Lack of Efficacy|14|||
170810145|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
170810146|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
170810147|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
170810148|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
170810149|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
170810150|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
170810151|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
170810152|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
170810153|NCT02092285|617315501|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
170910940|NCT03443024|617677307|FG000|Overall Study|Sponsor Decision|1|||
170587544|NCT01895543|616494283|FG000|Overall Study|Withdrawal by Subject|43|||
170587545|NCT01895543|616494283|FG000|Overall Study|Lost to Follow-up|25|||
170587546|NCT01895543|616494283|FG000|Overall Study|Adverse Event|28|||
170587547|NCT01895543|616494283|FG000|Overall Study|Subject's substantial non-compliance|6|||
170587548|NCT01895543|616494283|FG000|Overall Study|Protocol Violation|1|||
170587549|NCT01895543|616494283|FG000|Overall Study|Physician Decision|2|||
170587550|NCT01895543|616494283|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
170587551|NCT02359045|616494286|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
170587552|NCT02359045|616494287|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170587553|NCT02359045|616494286|FG000|Overall Study|Lost to Follow-up|1|||
170587554|NCT02359045|616494287|FG001|Overall Study|Lost to Follow-up|1|||
170587555|NCT02359045|616494286|FG000|Overall Study|Adverse Event|0|||
170587556|NCT02359045|616494287|FG001|Overall Study|Adverse Event|1|||
170587557|NCT00856206|616494291|FG000|Overall Study|Protocol Violation|6|||
170587558|NCT00856206|616494292|FG001|Overall Study|Protocol Violation|18|||
170810154|NCT03142932|617315504|FG000|Overall Study|Lost to Follow-up|2|||
170810155|NCT03142932|617315505|FG001|Overall Study|Lost to Follow-up|11|||
170810156|NCT02128269|617315506|FG000|Treatment Period|Adverse Event|1|||
170810157|NCT02128269|617315506|FG000|Treatment Period|Physician Decision|1|||
170810158|NCT02007070|617315507|FG000|Overall Study|Adverse Event|4|||
170810159|NCT02007070|617315507|FG000|Overall Study|Clinical Progression|4|||
170810160|NCT02007070|617315507|FG000|Overall Study|Death|1|||
170810161|NCT02007070|617315507|FG000|Overall Study|Protocol Violation|2|||
170810162|NCT02007070|617315507|FG000|Overall Study|Physician Decision|1|||
170587559|NCT00856206|616494291|FG000|Overall Study|Adverse Event|10|||
170587560|NCT00856206|616494292|FG001|Overall Study|Adverse Event|46|||
170587561|NCT00856206|616494291|FG000|Overall Study|Lack of Efficacy|1|||
170587562|NCT00856206|616494292|FG001|Overall Study|Lack of Efficacy|2|||
170587563|NCT00856206|616494291|FG000|Overall Study|Withdrawal by Subject|15|||
170587564|NCT00856206|616494292|FG001|Overall Study|Withdrawal by Subject|36|||
170587565|NCT00856206|616494291|FG000|Overall Study|Lost to Follow-up|13|||
170587566|NCT00856206|616494292|FG001|Overall Study|Lost to Follow-up|39|||
170587567|NCT00856206|616494291|FG000|Overall Study|Death|2|||
170587568|NCT00856206|616494292|FG001|Overall Study|Death|2|||
170587569|NCT00856206|616494291|FG000|Overall Study|Decision by the Sponsor|4|||
170587570|NCT00856206|616494292|FG001|Overall Study|Decision by the Sponsor|8|||
170587571|NCT00856206|616494291|FG000|Overall Study|Other than specified above|3|||
170587572|NCT00856206|616494292|FG001|Overall Study|Other than specified above|10|||
170587573|NCT02780856|616494293|FG000|Overall Study|Lost to Follow-up|1|||
170587574|NCT03028415|616494297|FG000|Overall Study|Lost to Follow-up|6|||
170587575|NCT03028415|616494298|FG001|Overall Study|Lost to Follow-up|3|||
170587576|NCT03028415|616494297|FG000|Overall Study|Withdrawal by Subject|1|||
170587577|NCT03028415|616494298|FG001|Overall Study|Withdrawal by Subject|0|||
170587578|NCT03028415|616494297|FG000|Overall Study|Discontinued due to COVID-19|1|||
170587579|NCT03028415|616494298|FG001|Overall Study|Discontinued due to COVID-19|0|||
170587580|NCT02308163|616494308|FG000|Overall Study|Not fulfill eligible criteria|1|||
170587581|NCT02308163|616494309|FG001|Overall Study|Not fulfill eligible criteria|2|||
170587582|NCT02308163|616494310|FG002|Overall Study|Not fulfill eligible criteria|0|||
170587583|NCT02308163|616494311|FG003|Overall Study|Not fulfill eligible criteria|1|||
170587584|NCT02308163|616494312|FG004|Overall Study|Not fulfill eligible criteria|1|||
170587585|NCT02308163|616494308|FG000|Overall Study|Adverse Event|9|||
170587586|NCT02308163|616494309|FG001|Overall Study|Adverse Event|5|||
170587587|NCT02308163|616494310|FG002|Overall Study|Adverse Event|2|||
170587588|NCT02308163|616494311|FG003|Overall Study|Adverse Event|2|||
170587589|NCT02308163|616494312|FG004|Overall Study|Adverse Event|11|||
170587590|NCT02308163|616494308|FG000|Overall Study|Lack of Efficacy|11|||
170587591|NCT02308163|616494309|FG001|Overall Study|Lack of Efficacy|3|||
170587592|NCT02308163|616494310|FG002|Overall Study|Lack of Efficacy|8|||
170587593|NCT02308163|616494311|FG003|Overall Study|Lack of Efficacy|4|||
170587594|NCT02308163|616494312|FG004|Overall Study|Lack of Efficacy|6|||
170587595|NCT02308163|616494308|FG000|Overall Study|Withdrawal of consent|2|||
170587596|NCT02308163|616494309|FG001|Overall Study|Withdrawal of consent|3|||
170587597|NCT02308163|616494310|FG002|Overall Study|Withdrawal of consent|0|||
170587598|NCT02308163|616494311|FG003|Overall Study|Withdrawal of consent|2|||
170587599|NCT02308163|616494312|FG004|Overall Study|Withdrawal of consent|6|||
170587600|NCT02308163|616494308|FG000|Overall Study|Protocol Violation|3|||
170587601|NCT02308163|616494309|FG001|Overall Study|Protocol Violation|3|||
170587602|NCT02308163|616494310|FG002|Overall Study|Protocol Violation|3|||
170587603|NCT02308163|616494311|FG003|Overall Study|Protocol Violation|2|||
170810163|NCT02007070|617315507|FG000|Overall Study|Progressive Disease|21|||
170810164|NCT00403845|617315508|FG000|Treatment Period 1|Subject withdrew consent|1|||
170810165|NCT00403845|617315509|FG001|Treatment Period 1|Subject withdrew consent|0|||
170910941|NCT03443024|617677308|FG001|Overall Study|Sponsor Decision|1|||
170910942|NCT03443024|617677309|FG002|Overall Study|Sponsor Decision|0|||
170910943|NCT03443024|617677310|FG003|Overall Study|Sponsor Decision|0|||
170910944|NCT03443024|617677307|FG000|Overall Study|Protocol Deviation|0|||
170587604|NCT02308163|616494312|FG004|Overall Study|Protocol Violation|5|||
170587605|NCT02308163|616494308|FG000|Overall Study|Lab data met discontinuation criteria|3|||
170587606|NCT02308163|616494309|FG001|Overall Study|Lab data met discontinuation criteria|0|||
170587607|NCT02308163|616494310|FG002|Overall Study|Lab data met discontinuation criteria|0|||
170587608|NCT02308163|616494311|FG003|Overall Study|Lab data met discontinuation criteria|2|||
170587609|NCT02308163|616494312|FG004|Overall Study|Lab data met discontinuation criteria|0|||
170587610|NCT02308163|616494308|FG000|Overall Study|Miscellaneous|2|||
170587611|NCT02308163|616494309|FG001|Overall Study|Miscellaneous|2|||
170587612|NCT02308163|616494310|FG002|Overall Study|Miscellaneous|1|||
170587613|NCT02308163|616494311|FG003|Overall Study|Miscellaneous|0|||
170587614|NCT02308163|616494312|FG004|Overall Study|Miscellaneous|5|||
170587615|NCT05596734|616494313|FG000|Substudy A|Withdrawal by Subject|1|||
170587616|NCT05596734|616494314|FG001|Substudy A|Withdrawal by Subject|0|||
170587617|NCT05596734|616494315|FG002|Substudy A|Withdrawal by Subject|0|||
170810166|NCT00403845|617315510|FG002|Treatment Period 1|Subject withdrew consent|0|||
170810167|NCT00403845|617315511|FG003|Treatment Period 1|Subject withdrew consent|0|||
170810168|NCT00403845|617315508|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
170587618|NCT05596734|616494316|FG003|Substudy A|Withdrawal by Subject|0|||
170587619|NCT05596734|616494317|FG004|Substudy A|Withdrawal by Subject|0|||
170587620|NCT05596734|616494318|FG005|Substudy A|Withdrawal by Subject|0|||
170587621|NCT05596734|616494319|FG006|Substudy A|Withdrawal by Subject|1|||
170587622|NCT05596734|616494320|FG007|Substudy A|Withdrawal by Subject|0|||
170587623|NCT05596734|616494321|FG008|Substudy A|Withdrawal by Subject|0|||
170587624|NCT05596734|616494322|FG009|Substudy A|Withdrawal by Subject|0|||
170587625|NCT05596734|616494323|FG010|Substudy A|Withdrawal by Subject|0|||
170587626|NCT05596734|616494324|FG011|Substudy A|Withdrawal by Subject|0|||
170587627|NCT05596734|616494325|FG012|Substudy A|Withdrawal by Subject|0|||
170587628|NCT05596734|616494326|FG013|Substudy A|Withdrawal by Subject|0|||
170587629|NCT05596734|616494327|FG014|Substudy A|Withdrawal by Subject|0|||
170587630|NCT05596734|616494328|FG015|Substudy A|Withdrawal by Subject|0|||
170587631|NCT05596734|616494329|FG016|Substudy A|Withdrawal by Subject|0|||
170587632|NCT05596734|616494330|FG017|Substudy A|Withdrawal by Subject|0|||
170587633|NCT05596734|616494331|FG018|Substudy A|Withdrawal by Subject|0|||
170587634|NCT05596734|616494332|FG019|Substudy A|Withdrawal by Subject|0|||
170587635|NCT05596734|616494333|FG020|Substudy A|Withdrawal by Subject|0|||
170587636|NCT05596734|616494334|FG021|Substudy A|Withdrawal by Subject|0|||
170587637|NCT05596734|616494335|FG022|Substudy A|Withdrawal by Subject|0|||
170587638|NCT05596734|616494336|FG023|Substudy A|Withdrawal by Subject|0|||
170587639|NCT05596734|616494313|FG000|Substudy A|Lost to Follow-up|1|||
170587640|NCT05596734|616494314|FG001|Substudy A|Lost to Follow-up|0|||
170587641|NCT05596734|616494315|FG002|Substudy A|Lost to Follow-up|1|||
170587642|NCT05596734|616494316|FG003|Substudy A|Lost to Follow-up|0|||
170587643|NCT05596734|616494317|FG004|Substudy A|Lost to Follow-up|0|||
170587644|NCT05596734|616494318|FG005|Substudy A|Lost to Follow-up|0|||
170587645|NCT05596734|616494319|FG006|Substudy A|Lost to Follow-up|0|||
170587646|NCT05596734|616494320|FG007|Substudy A|Lost to Follow-up|0|||
170587647|NCT05596734|616494321|FG008|Substudy A|Lost to Follow-up|0|||
170587648|NCT05596734|616494322|FG009|Substudy A|Lost to Follow-up|0|||
170587649|NCT05596734|616494323|FG010|Substudy A|Lost to Follow-up|0|||
170587650|NCT05596734|616494324|FG011|Substudy A|Lost to Follow-up|0|||
170587651|NCT05596734|616494325|FG012|Substudy A|Lost to Follow-up|0|||
170587652|NCT05596734|616494326|FG013|Substudy A|Lost to Follow-up|0|||
170587653|NCT05596734|616494327|FG014|Substudy A|Lost to Follow-up|0|||
170587654|NCT05596734|616494328|FG015|Substudy A|Lost to Follow-up|0|||
170587655|NCT05596734|616494329|FG016|Substudy A|Lost to Follow-up|0|||
170587656|NCT05596734|616494330|FG017|Substudy A|Lost to Follow-up|0|||
170587657|NCT05596734|616494331|FG018|Substudy A|Lost to Follow-up|0|||
170587658|NCT05596734|616494332|FG019|Substudy A|Lost to Follow-up|0|||
170587659|NCT05596734|616494333|FG020|Substudy A|Lost to Follow-up|0|||
170587660|NCT05596734|616494334|FG021|Substudy A|Lost to Follow-up|0|||
170587661|NCT05596734|616494335|FG022|Substudy A|Lost to Follow-up|0|||
170587662|NCT05596734|616494336|FG023|Substudy A|Lost to Follow-up|0|||
170587663|NCT05596734|616494313|FG000|Substudy B|Withdrawal by Subject|0|||
170587664|NCT05596734|616494314|FG001|Substudy B|Withdrawal by Subject|0|||
170587665|NCT05596734|616494315|FG002|Substudy B|Withdrawal by Subject|0|||
170587666|NCT05596734|616494316|FG003|Substudy B|Withdrawal by Subject|0|||
170587667|NCT05596734|616494317|FG004|Substudy B|Withdrawal by Subject|0|||
170587668|NCT05596734|616494318|FG005|Substudy B|Withdrawal by Subject|0|||
170587669|NCT05596734|616494319|FG006|Substudy B|Withdrawal by Subject|0|||
170587670|NCT05596734|616494320|FG007|Substudy B|Withdrawal by Subject|0|||
170587671|NCT05596734|616494321|FG008|Substudy B|Withdrawal by Subject|0|||
170587672|NCT05596734|616494322|FG009|Substudy B|Withdrawal by Subject|0|||
170587673|NCT05596734|616494323|FG010|Substudy B|Withdrawal by Subject|0|||
170587674|NCT05596734|616494324|FG011|Substudy B|Withdrawal by Subject|0|||
170587675|NCT05596734|616494325|FG012|Substudy B|Withdrawal by Subject|1|||
170587676|NCT05596734|616494326|FG013|Substudy B|Withdrawal by Subject|0|||
170587677|NCT05596734|616494327|FG014|Substudy B|Withdrawal by Subject|1|||
170587678|NCT05596734|616494328|FG015|Substudy B|Withdrawal by Subject|2|||
170587679|NCT05596734|616494329|FG016|Substudy B|Withdrawal by Subject|2|||
170587680|NCT05596734|616494330|FG017|Substudy B|Withdrawal by Subject|1|||
170587681|NCT05596734|616494331|FG018|Substudy B|Withdrawal by Subject|2|||
170587682|NCT05596734|616494332|FG019|Substudy B|Withdrawal by Subject|0|||
170587683|NCT05596734|616494333|FG020|Substudy B|Withdrawal by Subject|0|||
170587684|NCT05596734|616494334|FG021|Substudy B|Withdrawal by Subject|0|||
170587685|NCT05596734|616494335|FG022|Substudy B|Withdrawal by Subject|0|||
170587686|NCT05596734|616494336|FG023|Substudy B|Withdrawal by Subject|1|||
170587687|NCT05596734|616494313|FG000|Substudy B|Physician Decision|0|||
170587688|NCT05596734|616494314|FG001|Substudy B|Physician Decision|0|||
170587689|NCT05596734|616494315|FG002|Substudy B|Physician Decision|0|||
170587690|NCT05596734|616494316|FG003|Substudy B|Physician Decision|0|||
170587691|NCT05596734|616494317|FG004|Substudy B|Physician Decision|0|||
170810169|NCT00403845|617315509|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
170587692|NCT05596734|616494318|FG005|Substudy B|Physician Decision|0|||
170587693|NCT05596734|616494319|FG006|Substudy B|Physician Decision|0|||
170587694|NCT05596734|616494320|FG007|Substudy B|Physician Decision|0|||
170587695|NCT05596734|616494321|FG008|Substudy B|Physician Decision|0|||
170587696|NCT05596734|616494322|FG009|Substudy B|Physician Decision|0|||
170587697|NCT05596734|616494323|FG010|Substudy B|Physician Decision|0|||
170910945|NCT03443024|617677308|FG001|Overall Study|Protocol Deviation|0|||
170587698|NCT05596734|616494324|FG011|Substudy B|Physician Decision|0|||
170587699|NCT05596734|616494325|FG012|Substudy B|Physician Decision|0|||
170587700|NCT05596734|616494326|FG013|Substudy B|Physician Decision|0|||
170587701|NCT05596734|616494327|FG014|Substudy B|Physician Decision|0|||
170587702|NCT05596734|616494328|FG015|Substudy B|Physician Decision|1|||
170587703|NCT05596734|616494329|FG016|Substudy B|Physician Decision|0|||
170587704|NCT05596734|616494330|FG017|Substudy B|Physician Decision|0|||
170587705|NCT05596734|616494331|FG018|Substudy B|Physician Decision|0|||
170587706|NCT05596734|616494332|FG019|Substudy B|Physician Decision|0|||
170587707|NCT05596734|616494333|FG020|Substudy B|Physician Decision|0|||
170910946|NCT03443024|617677309|FG002|Overall Study|Protocol Deviation|0|||
170910947|NCT03443024|617677310|FG003|Overall Study|Protocol Deviation|2|||
170910948|NCT01359982|617677313|FG000|Overall Study|Adverse Event|2|||
170910949|NCT01359982|617677314|FG001|Overall Study|Adverse Event|0|||
170587708|NCT05596734|616494334|FG021|Substudy B|Physician Decision|0|||
170910950|NCT01359982|617677315|FG002|Overall Study|Adverse Event|0|||
170910951|NCT01359982|617677316|FG003|Overall Study|Adverse Event|1|||
170910952|NCT01359982|617677317|FG004|Overall Study|Adverse Event|0|||
170910953|NCT01359982|617677318|FG005|Overall Study|Adverse Event|0|||
170587709|NCT05596734|616494335|FG022|Substudy B|Physician Decision|0|||
170587710|NCT05596734|616494336|FG023|Substudy B|Physician Decision|0|||
170587711|NCT05596734|616494313|FG000|Substudy B|Lost to Follow-up|0|||
170587712|NCT05596734|616494314|FG001|Substudy B|Lost to Follow-up|0|||
170587713|NCT05596734|616494315|FG002|Substudy B|Lost to Follow-up|0|||
170587714|NCT05596734|616494316|FG003|Substudy B|Lost to Follow-up|0|||
170587715|NCT05596734|616494317|FG004|Substudy B|Lost to Follow-up|0|||
170587716|NCT05596734|616494318|FG005|Substudy B|Lost to Follow-up|0|||
170587717|NCT05596734|616494319|FG006|Substudy B|Lost to Follow-up|0|||
170587718|NCT05596734|616494320|FG007|Substudy B|Lost to Follow-up|0|||
170587719|NCT05596734|616494321|FG008|Substudy B|Lost to Follow-up|0|||
170587720|NCT05596734|616494322|FG009|Substudy B|Lost to Follow-up|0|||
170587721|NCT05596734|616494323|FG010|Substudy B|Lost to Follow-up|0|||
170587722|NCT05596734|616494324|FG011|Substudy B|Lost to Follow-up|0|||
170587723|NCT05596734|616494325|FG012|Substudy B|Lost to Follow-up|1|||
170587724|NCT05596734|616494326|FG013|Substudy B|Lost to Follow-up|0|||
170587725|NCT05596734|616494327|FG014|Substudy B|Lost to Follow-up|1|||
170587726|NCT05596734|616494328|FG015|Substudy B|Lost to Follow-up|1|||
170587727|NCT05596734|616494329|FG016|Substudy B|Lost to Follow-up|0|||
170587728|NCT05596734|616494330|FG017|Substudy B|Lost to Follow-up|0|||
170587729|NCT05596734|616494331|FG018|Substudy B|Lost to Follow-up|0|||
170810170|NCT00403845|617315510|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
170810171|NCT00403845|617315511|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
170810172|NCT00403845|617315508|FG000|Treatment Period 2|Subject withdrew consent|1|||
170810173|NCT00403845|617315509|FG001|Treatment Period 2|Subject withdrew consent|0|||
170810174|NCT00403845|617315510|FG002|Treatment Period 2|Subject withdrew consent|0|||
170810175|NCT00403845|617315511|FG003|Treatment Period 2|Subject withdrew consent|0|||
170810176|NCT00403845|617315508|FG000|Treatment Period 3|Subject withdrew consent|0|||
170810177|NCT00403845|617315509|FG001|Treatment Period 3|Subject withdrew consent|0|||
170810178|NCT00403845|617315510|FG002|Treatment Period 3|Subject withdrew consent|0|||
170810179|NCT00403845|617315511|FG003|Treatment Period 3|Subject withdrew consent|1|||
170810180|NCT00403845|617315508|FG000|Treatment Period 3|Adverse Event|0|||
170810181|NCT00403845|617315509|FG001|Treatment Period 3|Adverse Event|0|||
170810182|NCT00403845|617315510|FG002|Treatment Period 3|Adverse Event|0|||
170810183|NCT00403845|617315511|FG003|Treatment Period 3|Adverse Event|1|||
170810184|NCT01836523|617315512|FG000|Overall Study|Adverse Event|15|||
170810185|NCT01836523|617315513|FG001|Overall Study|Adverse Event|41|||
170810186|NCT01836523|617315514|FG002|Overall Study|Adverse Event|49|||
170810187|NCT01836523|617315515|FG003|Overall Study|Adverse Event|14|||
170810188|NCT01836523|617315512|FG000|Overall Study|Protocol Violation|6|||
170810189|NCT01836523|617315513|FG001|Overall Study|Protocol Violation|3|||
170810190|NCT01836523|617315514|FG002|Overall Study|Protocol Violation|2|||
170810191|NCT01836523|617315515|FG003|Overall Study|Protocol Violation|4|||
170810192|NCT01836523|617315512|FG000|Overall Study|Met Withdrawal Criteria|13|||
170810193|NCT01836523|617315513|FG001|Overall Study|Met Withdrawal Criteria|13|||
170810194|NCT01836523|617315514|FG002|Overall Study|Met Withdrawal Criteria|21|||
170810195|NCT01836523|617315515|FG003|Overall Study|Met Withdrawal Criteria|27|||
170810196|NCT01836523|617315512|FG000|Overall Study|Unclassified|17|||
170810197|NCT01836523|617315513|FG001|Overall Study|Unclassified|28|||
170810198|NCT01836523|617315514|FG002|Overall Study|Unclassified|19|||
170810199|NCT01836523|617315515|FG003|Overall Study|Unclassified|29|||
170810200|NCT01640288|617315516|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
170810201|NCT01640288|617315517|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
170810202|NCT01640288|617315516|FG000|Overall Study|Screen Failure|20|||
170810203|NCT01640288|617315517|FG001|Overall Study|Screen Failure|18|||
170810204|NCT01640288|617315516|FG000|Overall Study|Withdrawn by PI|5|||
170810205|NCT01640288|617315517|FG001|Overall Study|Withdrawn by PI|0|||
170810206|NCT01640288|617315516|FG000|Overall Study|Withdrawal by Subject|1|||
170910954|NCT01359982|617677313|FG000|Overall Study|Death|1|||
170587730|NCT05596734|616494332|FG019|Substudy B|Lost to Follow-up|0|||
170587731|NCT05596734|616494333|FG020|Substudy B|Lost to Follow-up|0|||
170587732|NCT05596734|616494334|FG021|Substudy B|Lost to Follow-up|0|||
170587733|NCT05596734|616494335|FG022|Substudy B|Lost to Follow-up|0|||
170587734|NCT05596734|616494336|FG023|Substudy B|Lost to Follow-up|0|||
170587735|NCT01974206|616494339|FG000|Overall Study|Did Not Take Study Drug|0|||
170587736|NCT01974206|616494340|FG001|Overall Study|Did Not Take Study Drug|1|||
170587737|NCT01974206|616494339|FG000|Overall Study|Physician Decision|1|||
170587738|NCT01974206|616494340|FG001|Overall Study|Physician Decision|0|||
170587739|NCT01974206|616494339|FG000|Overall Study|Withdrawal by Subject|3|||
170587740|NCT01974206|616494340|FG001|Overall Study|Withdrawal by Subject|0|||
170587741|NCT01974206|616494339|FG000|Overall Study|Lost to Follow-up|1|||
170587742|NCT01974206|616494340|FG001|Overall Study|Lost to Follow-up|0|||
170587743|NCT01974206|616494339|FG000|Overall Study|Death|1|||
170587744|NCT01974206|616494340|FG001|Overall Study|Death|0|||
170587745|NCT02059499|616494343|FG000|Upto Week 20|Lost to Follow-up|2|||
170587746|NCT02059499|616494344|FG001|Upto Week 20|Lost to Follow-up|6|||
170587747|NCT02059499|616494345|FG002|Upto Week 20|Lost to Follow-up|0|||
170587748|NCT02059499|616494343|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
170587749|NCT02059499|616494344|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
170587750|NCT02059499|616494345|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
170587751|NCT02059499|616494343|FG000|Upto Week 20|Withdrawal by Subject|1|||
170587752|NCT02059499|616494344|FG001|Upto Week 20|Withdrawal by Subject|1|||
170587753|NCT02059499|616494345|FG002|Upto Week 20|Withdrawal by Subject|0|||
170587754|NCT02059499|616494343|FG000|Upto Week 20|No treatment per protocol criteria|0|||
170587755|NCT02059499|616494344|FG001|Upto Week 20|No treatment per protocol criteria|0|||
170587756|NCT02059499|616494345|FG002|Upto Week 20|No treatment per protocol criteria|5|||
170587757|NCT02059499|616494343|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
170587758|NCT02059499|616494344|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
170587759|NCT02059499|616494345|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
170587760|NCT02059499|616494343|FG000|Post-week 20|Lost to Follow-up|0|||
170587761|NCT02059499|616494344|FG001|Post-week 20|Lost to Follow-up|2|||
170587762|NCT02059499|616494345|FG002|Post-week 20|Lost to Follow-up|0|||
170587763|NCT02059499|616494343|FG000|Post-week 20|Withdrawal by Subject|0|||
170587764|NCT02059499|616494344|FG001|Post-week 20|Withdrawal by Subject|1|||
170587765|NCT02059499|616494345|FG002|Post-week 20|Withdrawal by Subject|0|||
170587766|NCT02059499|616494343|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
170587767|NCT02059499|616494344|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
170587768|NCT02059499|616494345|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
170587769|NCT04210245|616494346|FG000|Overall Study|Adverse Event|0|||
170587770|NCT04210245|616494347|FG001|Overall Study|Adverse Event|3|||
170587771|NCT04210245|616494348|FG002|Overall Study|Adverse Event|6|||
170587772|NCT04210245|616494349|FG003|Overall Study|Adverse Event|0|||
170587773|NCT04210245|616494346|FG000|Overall Study|Withdrawal by Subject|0|||
170587774|NCT04210245|616494347|FG001|Overall Study|Withdrawal by Subject|1|||
170587775|NCT04210245|616494348|FG002|Overall Study|Withdrawal by Subject|4|||
170587776|NCT04210245|616494349|FG003|Overall Study|Withdrawal by Subject|4|||
170587777|NCT04210245|616494346|FG000|Overall Study|Lost to Follow-up|0|||
170587778|NCT04210245|616494347|FG001|Overall Study|Lost to Follow-up|1|||
170587779|NCT04210245|616494348|FG002|Overall Study|Lost to Follow-up|1|||
170587780|NCT04210245|616494349|FG003|Overall Study|Lost to Follow-up|1|||
170587781|NCT04210245|616494346|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
170587782|NCT04210245|616494347|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
170587783|NCT04210245|616494348|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
170587784|NCT04210245|616494349|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
170587785|NCT00211757|616494352|FG000|Overall Study|Withdrawal by Subject|1|||
170587786|NCT00211757|616494353|FG001|Overall Study|Withdrawal by Subject|1|||
170587787|NCT00211757|616494352|FG000|Overall Study|Lack of Efficacy|0|||
170587788|NCT00211757|616494353|FG001|Overall Study|Lack of Efficacy|1|||
170587789|NCT05151445|616494354|FG000|Overall Study|Withdrawal by Subject|3|||
170587790|NCT02644096|616494357|FG000|Overall Study|Withdrawal by Subject|28|||
170587791|NCT02644096|616494358|FG001|Overall Study|Withdrawal by Subject|25|||
170587792|NCT01457014|616494359|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
170587793|NCT01457014|616494360|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
170587794|NCT01457014|616494361|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
170587795|NCT01457014|616494362|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
170587796|NCT01457014|616494359|FG000|First Night|Withdrawal by Subject|3|||
170587797|NCT01457014|616494360|FG001|First Night|Withdrawal by Subject|0|||
170587798|NCT01457014|616494361|FG002|First Night|Withdrawal by Subject|0|||
170587799|NCT01457014|616494362|FG003|First Night|Withdrawal by Subject|0|||
170587800|NCT00322452|616494363|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170587801|NCT00322452|616494364|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170587802|NCT00322452|616494363|FG000|Overall Study|Lost to Follow-up|5|||
170587803|NCT00322452|616494364|FG001|Overall Study|Lost to Follow-up|2|||
170587804|NCT00322452|616494363|FG000|Overall Study|Withdrawal by Subject|19|||
170587805|NCT00322452|616494364|FG001|Overall Study|Withdrawal by Subject|46|||
170587806|NCT00322452|616494363|FG000|Overall Study|Death|223|||
170587807|NCT00322452|616494364|FG001|Overall Study|Death|227|||
170587808|NCT00526656|616494365|FG000|Overall Study|Death|1|||
170587809|NCT00526656|616494365|FG000|Overall Study|Refused surgery|1|||
170587810|NCT00098748|616494366|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
170587811|NCT00098748|616494367|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
170587812|NCT00098748|616494368|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
170587813|NCT00098748|616494366|FG000|Received Study Treatment|Death|2|||
170587814|NCT00098748|616494367|FG001|Received Study Treatment|Death|1|||
170587815|NCT00098748|616494368|FG002|Received Study Treatment|Death|2|||
170587816|NCT00098748|616494366|FG000|Received Study Treatment|Adverse Event|1|||
170587817|NCT00098748|616494367|FG001|Received Study Treatment|Adverse Event|2|||
170587818|NCT00098748|616494368|FG002|Received Study Treatment|Adverse Event|5|||
170587819|NCT00098748|616494366|FG000|Received Study Treatment|Lack of Efficacy|40|||
170587820|NCT00098748|616494367|FG001|Received Study Treatment|Lack of Efficacy|27|||
170587821|NCT00098748|616494368|FG002|Received Study Treatment|Lack of Efficacy|27|||
170587822|NCT00098748|616494366|FG000|Received Study Treatment|Other|2|||
170587823|NCT00098748|616494367|FG001|Received Study Treatment|Other|2|||
170587824|NCT00098748|616494368|FG002|Received Study Treatment|Other|6|||
170587825|NCT00098748|616494366|FG000|Received Study Treatment|Subject defaulted|3|||
170587826|NCT00098748|616494367|FG001|Received Study Treatment|Subject defaulted|4|||
170587827|NCT00098748|616494368|FG002|Received Study Treatment|Subject defaulted|4|||
170587828|NCT00098748|616494366|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
170587829|NCT00098748|616494367|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
170587830|NCT00098748|616494368|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
170587831|NCT00098748|616494366|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
170587832|NCT00098748|616494367|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
170587833|NCT00098748|616494368|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
170587834|NCT00098748|616494366|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
170587835|NCT00098748|616494367|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
170587836|NCT00098748|616494368|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
170587837|NCT00098748|616494366|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
170587838|NCT00098748|616494367|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
170587839|NCT00098748|616494368|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
170587840|NCT00098748|616494366|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
170587841|NCT00098748|616494367|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
170587842|NCT00098748|616494368|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
170587843|NCT00642174|616495966|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
170587844|NCT00642174|616495967|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
170587845|NCT04225676|616495972|FG000|Overall Study|Physician Decision|1|||
170587846|NCT04225676|616495972|FG000|Overall Study|Lack of Efficacy|1|||
170587847|NCT04225676|616495972|FG000|Overall Study|Study terminated by sponsor|3|||
170587848|NCT01257568|616495973|FG000|Overall Study|Lost to Follow-up|2|||
170587849|NCT01257568|616495973|FG000|Overall Study|Withdrawal by Subject|6|||
170587850|NCT01257568|616495973|FG000|Overall Study|Terminated|1|||
170587851|NCT01257568|616495973|FG000|Overall Study|Component Revision|24|||
170587852|NCT01739933|616495977|FG000|Overall Study|Death|89|||
170587853|NCT01739933|616495978|FG001|Overall Study|Death|86|||
170587854|NCT01739933|616495977|FG000|Overall Study|Withdrawal by Subject|10|||
170587855|NCT01739933|616495978|FG001|Overall Study|Withdrawal by Subject|8|||
170587856|NCT01739933|616495977|FG000|Overall Study|Lost to Follow-up|3|||
170587857|NCT01739933|616495978|FG001|Overall Study|Lost to Follow-up|10|||
170810207|NCT01640288|617315517|FG001|Overall Study|Withdrawal by Subject|0|||
170810208|NCT00749944|617315518|FG000|Overall Study|Lost to Follow-up|2|||
170810209|NCT00749944|617315519|FG001|Overall Study|Lost to Follow-up|1|||
170810210|NCT00749944|617315518|FG000|Overall Study|Other|1|||
170587858|NCT01739933|616495977|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
170587859|NCT01739933|616495978|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
170587860|NCT04098367|616495979|FG000|Overall Study|Adverse Event|0|||
170587861|NCT04098367|616495980|FG001|Overall Study|Adverse Event|0|||
170587862|NCT04098367|616495981|FG002|Overall Study|Adverse Event|1|||
170587863|NCT04098367|616495979|FG000|Overall Study|Lost to Follow-up|1|||
170587864|NCT04098367|616495980|FG001|Overall Study|Lost to Follow-up|5|||
170587865|NCT04098367|616495981|FG002|Overall Study|Lost to Follow-up|2|||
170587866|NCT04098367|616495979|FG000|Overall Study|Withdrawal by Subject|0|||
170587867|NCT04098367|616495980|FG001|Overall Study|Withdrawal by Subject|0|||
170587868|NCT04098367|616495981|FG002|Overall Study|Withdrawal by Subject|1|||
170587869|NCT04098367|616495979|FG000|Overall Study|Sick . Could not attend visit|1|||
170587870|NCT04098367|616495980|FG001|Overall Study|Sick . Could not attend visit|0|||
170810211|NCT00749944|617315519|FG001|Overall Study|Other|0|||
170810212|NCT00749944|617315518|FG000|Overall Study|Withdrawal by Subject|2|||
170587871|NCT04098367|616495981|FG002|Overall Study|Sick . Could not attend visit|0|||
170587872|NCT00908115|616495984|FG000|Overall Study|Other|14|||
170587873|NCT00445939|616495985|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
170587874|NCT00445939|616495986|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
170587875|NCT00445939|616495987|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
170587876|NCT00445939|616495988|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
170587877|NCT00445939|616495985|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
170587878|NCT00445939|616495986|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
170587879|NCT00445939|616495987|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
170587880|NCT00445939|616495988|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
170587881|NCT00378599|616495989|FG000|Overall Study|Adverse Event|38|||
170587882|NCT00378599|616495989|FG000|Overall Study|Protocol Violation|2|||
170587883|NCT00378599|616495989|FG000|Overall Study|Treatment failure|7|||
170587884|NCT00378599|616495989|FG000|Overall Study|Withdrawal by Subject|5|||
170587885|NCT00416715|616495992|FG000|Overall Study|Not evaluable for joint aches|7|||
170587886|NCT00416715|616495992|FG000|Overall Study|Vitamin D levels not evaluable|8|||
170587887|NCT00347438|616495995|FG000|Overall Study|Withdrawal by Subject|1|||
170587888|NCT00347438|616495995|FG000|Overall Study|Physician Decision|1|||
170587889|NCT01973387|616495996|FG000|Overall Study|Adverse Event|14|||
170587890|NCT01973387|616495997|FG001|Overall Study|Adverse Event|4|||
170587891|NCT01973387|616495996|FG000|Overall Study|Withdrawal by Subject|7|||
170587892|NCT01973387|616495997|FG001|Overall Study|Withdrawal by Subject|4|||
170587893|NCT01973387|616495996|FG000|Overall Study|Study terminated by sponsor|63|||
170587894|NCT01973387|616495997|FG001|Overall Study|Study terminated by sponsor|0|||
170587895|NCT01973387|616495996|FG000|Overall Study|Progressive disease or relapse|16|||
170587896|NCT01973387|616495997|FG001|Overall Study|Progressive disease or relapse|5|||
170587897|NCT01973387|616495996|FG000|Overall Study|Death|4|||
170587898|NCT01973387|616495997|FG001|Overall Study|Death|3|||
170587899|NCT01973387|616495996|FG000|Overall Study|Randomized, not treated|2|||
170587900|NCT01973387|616495997|FG001|Overall Study|Randomized, not treated|2|||
170587901|NCT00322023|616496001|FG000|Overall Study|various|0|||
170587902|NCT00322023|616496002|FG001|Overall Study|various|2|||
170587903|NCT00322023|616496003|FG002|Overall Study|various|6|||
170587904|NCT03327220|616496004|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
170587905|NCT03327220|616496005|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
170587906|NCT03327220|616496004|FG000|Overall Study|Investigator Decision|2|||
170587907|NCT03327220|616496005|FG001|Overall Study|Investigator Decision|0|||
170587908|NCT03327220|616496004|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
170587909|NCT03327220|616496005|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
170587910|NCT03327220|616496004|FG000|Overall Study|Fungal infection|1|||
170587911|NCT03327220|616496005|FG001|Overall Study|Fungal infection|0|||
170587912|NCT03327220|616496004|FG000|Overall Study|Discharged to Rehabilitation|0|||
170587913|NCT03327220|616496005|FG001|Overall Study|Discharged to Rehabilitation|1|||
170587914|NCT03327220|616496004|FG000|Overall Study|Missing|1|||
170587915|NCT03327220|616496005|FG001|Overall Study|Missing|0|||
170587916|NCT00523705|616496008|FG000|Overall Study|No time for study.|0|||
170587917|NCT00523705|616496009|FG001|Overall Study|No time for study.|1|||
170587918|NCT00693017|616496010|FG000|Overall Study|Sponsor Decision|2|||
170587919|NCT00693017|616496011|FG001|Overall Study|Sponsor Decision|1|||
170587920|NCT00693017|616496010|FG000|Overall Study|Death|0|||
170587921|NCT00693017|616496011|FG001|Overall Study|Death|1|||
170587922|NCT00688324|616496016|FG000|Overall Study|Withdrawal by Subject|2|||
170587923|NCT00688324|616496016|FG000|Overall Study|Physician Decision|5|||
170587924|NCT00688324|616496016|FG000|Overall Study|Lost to Follow-up|1|||
170587925|NCT01972308|616496017|FG000|Overall Study|Withdrawal by Subject|0|||
170587926|NCT01972308|616496018|FG001|Overall Study|Withdrawal by Subject|1|||
170587927|NCT01972308|616496017|FG000|Overall Study|Lost to Follow-up|4|||
170587928|NCT01972308|616496018|FG001|Overall Study|Lost to Follow-up|6|||
170587929|NCT01972308|616496017|FG000|Overall Study|Death|4|||
170587930|NCT01972308|616496018|FG001|Overall Study|Death|1|||
170587931|NCT00847665|616496020|FG000|Overall Study|Withdrawal by Subject|1|||
170587932|NCT00847665|616496021|FG001|Overall Study|Withdrawal by Subject|0|||
170587933|NCT03575065|616496029|FG000|Overall Study|Death|31|||
170587934|NCT03575065|616496030|FG001|Overall Study|Death|12|||
170810213|NCT00749944|617315519|FG001|Overall Study|Withdrawal by Subject|0|||
170810214|NCT00624377|617315520|FG000|Overall Study|Lost to Follow-up|355|||
170810215|NCT00624377|617315520|FG000|Overall Study|Withdrawal by Subject|100|||
170587935|NCT03575065|616496029|FG000|Overall Study|Sponsor's Decision|28|||
170587936|NCT03575065|616496030|FG001|Overall Study|Sponsor's Decision|13|||
170587937|NCT03575065|616496029|FG000|Overall Study|Withdrawal by Subject|2|||
170587938|NCT03575065|616496030|FG001|Overall Study|Withdrawal by Subject|1|||
170587939|NCT03575065|616496029|FG000|Overall Study|Lost to Follow-up|1|||
170810216|NCT00624377|617315520|FG000|Overall Study|Adverse Event|14|||
170810217|NCT00624377|617315520|FG000|Overall Study|Other|91|||
170587940|NCT03575065|616496030|FG001|Overall Study|Lost to Follow-up|0|||
170587941|NCT01779856|616496031|FG000|Overall Study|Withdrawal by Subject|15|||
170587942|NCT01779856|616496031|FG000|Overall Study|Death|3|||
170587943|NCT01779856|616496031|FG000|Overall Study|Physician Decision|1|||
170587944|NCT01779856|616496031|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
170587945|NCT01779856|616496031|FG000|Overall Study|Delays in scheduling implant|1|||
170587946|NCT01779856|616496031|FG000|Overall Study|Subject ineligible for Implant|2|||
170587947|NCT00676520|616496035|FG000|Overall Study|Withdrawal by Subject|163|||
170587948|NCT00676520|616496035|FG000|Overall Study|Lost to Follow-up|162|||
170587949|NCT00676520|616496035|FG000|Overall Study|Death|159|||
170587950|NCT00676520|616496035|FG000|Overall Study|Physician Decision|20|||
170587951|NCT00676520|616496035|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
170587952|NCT00676520|616496035|FG000|Overall Study|Other Reason|18|||
170587953|NCT03960580|616496036|FG000|Overall Study|Adverse Event|2|||
170587954|NCT03960580|616496037|FG001|Overall Study|Adverse Event|1|||
170587955|NCT03960580|616496038|FG002|Overall Study|Adverse Event|1|||
170587956|NCT03960580|616496036|FG000|Overall Study|Lost to Follow-up|1|||
170587957|NCT03960580|616496037|FG001|Overall Study|Lost to Follow-up|0|||
170587958|NCT03960580|616496038|FG002|Overall Study|Lost to Follow-up|0|||
170587959|NCT03960580|616496036|FG000|Overall Study|Lack of Efficacy|2|||
170587960|NCT03960580|616496037|FG001|Overall Study|Lack of Efficacy|1|||
170587961|NCT03960580|616496038|FG002|Overall Study|Lack of Efficacy|0|||
170587962|NCT03960580|616496036|FG000|Overall Study|Protocol Violation|0|||
170587963|NCT03960580|616496037|FG001|Overall Study|Protocol Violation|0|||
170587964|NCT03960580|616496038|FG002|Overall Study|Protocol Violation|1|||
170587965|NCT03960580|616496036|FG000|Overall Study|Withdrawal by Subject|1|||
170587966|NCT03960580|616496037|FG001|Overall Study|Withdrawal by Subject|1|||
170587967|NCT03960580|616496038|FG002|Overall Study|Withdrawal by Subject|1|||
170587968|NCT03960580|616496036|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
170587969|NCT03960580|616496037|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
170810218|NCT00624377|617315520|FG000|Overall Study|Non-evaluable population|84|||
170810219|NCT01072149|617315524|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810220|NCT01072149|617315525|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810221|NCT01072149|617315526|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
170810222|NCT01072149|617315527|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810223|NCT01072149|617315528|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810224|NCT01072149|617315529|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810225|NCT01072149|617315530|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810226|NCT01072149|617315531|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810227|NCT01072149|617315532|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810228|NCT01072149|617315533|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810229|NCT01072149|617315534|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810230|NCT01072149|617315535|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810231|NCT01072149|617315536|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810232|NCT01072149|617315537|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810233|NCT01072149|617315538|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810234|NCT01072149|617315539|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810235|NCT01072149|617315540|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810236|NCT01072149|617315541|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
170810237|NCT01072149|617315524|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810238|NCT01072149|617315525|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170910955|NCT01359982|617677314|FG001|Overall Study|Death|0|||
170910956|NCT01359982|617677315|FG002|Overall Study|Death|0|||
170587970|NCT03960580|616496038|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
170587971|NCT02135029|616496051|FG000|Overall Study|Adverse Event|2|||
170587972|NCT02135029|616496052|FG001|Overall Study|Adverse Event|2|||
170587973|NCT02135029|616496053|FG002|Overall Study|Adverse Event|2|||
170587974|NCT02135029|616496051|FG000|Overall Study|Lost to Follow-up|0|||
170587975|NCT02135029|616496052|FG001|Overall Study|Lost to Follow-up|1|||
170587976|NCT02135029|616496053|FG002|Overall Study|Lost to Follow-up|0|||
170810239|NCT01072149|617315526|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810240|NCT01072149|617315527|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810241|NCT01072149|617315528|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810242|NCT01072149|617315529|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810243|NCT01072149|617315530|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810244|NCT01072149|617315531|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170910957|NCT01359982|617677316|FG003|Overall Study|Death|0|||
170910958|NCT01359982|617677317|FG004|Overall Study|Death|0|||
170910959|NCT01359982|617677318|FG005|Overall Study|Death|0|||
170587977|NCT02135029|616496051|FG000|Overall Study|Withdrawal by Subject|2|||
170587978|NCT02135029|616496052|FG001|Overall Study|Withdrawal by Subject|0|||
170587979|NCT02135029|616496053|FG002|Overall Study|Withdrawal by Subject|1|||
170587980|NCT02135029|616496051|FG000|Overall Study|Other|0|||
170587981|NCT02135029|616496052|FG001|Overall Study|Other|1|||
170587982|NCT02135029|616496053|FG002|Overall Study|Other|0|||
170910960|NCT02782715|617677320|FG000|Overall Study|Withdrawal by Subject|1|||
170910961|NCT00069121|617677321|FG000|Overall Study|Death|286|||
170910962|NCT00069121|617677322|FG001|Overall Study|Death|242|||
170910963|NCT00069121|617677321|FG000|Overall Study|Withdrawal by Subject|18|||
170910964|NCT00069121|617677322|FG001|Overall Study|Withdrawal by Subject|20|||
170910965|NCT00069121|617677321|FG000|Overall Study|Lost to Follow-up|63|||
170910966|NCT00069121|617677322|FG001|Overall Study|Lost to Follow-up|63|||
170910967|NCT04800315|617677331|FG000|Randomization|Did not receive study treatment|1|||
170910968|NCT04800315|617677332|FG001|Randomization|Did not receive study treatment|0|||
170910969|NCT04800315|617677333|FG002|Randomization|Did not receive study treatment|0|||
170910970|NCT04800315|617677334|FG003|Randomization|Did not receive study treatment|0|||
170910971|NCT04800315|617677331|FG000|Treatment Period|Adverse Event|4|||
170910972|NCT04800315|617677332|FG001|Treatment Period|Adverse Event|2|||
170910973|NCT04800315|617677333|FG002|Treatment Period|Adverse Event|1|||
170910974|NCT04800315|617677334|FG003|Treatment Period|Adverse Event|2|||
170910975|NCT04800315|617677331|FG000|Treatment Period|Lack of Efficacy|1|||
170587983|NCT02135029|616496051|FG000|Overall Study|Death|0|||
170587984|NCT02135029|616496052|FG001|Overall Study|Death|1|||
170587985|NCT02135029|616496053|FG002|Overall Study|Death|0|||
170587986|NCT03466099|616496055|FG000|Overall Study|Adverse Event|1|||
170587987|NCT03466099|616496056|FG001|Overall Study|Adverse Event|1|||
170587988|NCT03466099|616496057|FG002|Overall Study|Adverse Event|1|||
170587989|NCT03466099|616496055|FG000|Overall Study|Withdrawal by Subject|2|||
170587990|NCT03466099|616496056|FG001|Overall Study|Withdrawal by Subject|3|||
170587991|NCT03466099|616496057|FG002|Overall Study|Withdrawal by Subject|1|||
170587992|NCT03466099|616496055|FG000|Overall Study|Use of rescue medication|8|||
170587993|NCT03466099|616496056|FG001|Overall Study|Use of rescue medication|9|||
170587994|NCT03466099|616496057|FG002|Overall Study|Use of rescue medication|13|||
170587995|NCT03466099|616496055|FG000|Overall Study|Rescued without meeting criteria|4|||
170587996|NCT03466099|616496056|FG001|Overall Study|Rescued without meeting criteria|1|||
170587997|NCT03466099|616496057|FG002|Overall Study|Rescued without meeting criteria|1|||
170587998|NCT03466099|616496055|FG000|Overall Study|Subject compliance|2|||
170587999|NCT03466099|616496056|FG001|Overall Study|Subject compliance|0|||
170588000|NCT03466099|616496057|FG002|Overall Study|Subject compliance|0|||
170588001|NCT03466099|616496055|FG000|Overall Study|Worsening disease|0|||
170588002|NCT03466099|616496056|FG001|Overall Study|Worsening disease|0|||
170588003|NCT03466099|616496057|FG002|Overall Study|Worsening disease|1|||
170588004|NCT03359785|616496060|FG000|Overall Study|Protocol Violation|0|||
170588005|NCT03359785|616496061|FG001|Overall Study|Protocol Violation|1|||
170588006|NCT03359785|616496062|FG002|Overall Study|Protocol Violation|0|||
170588007|NCT03359785|616496063|FG003|Overall Study|Protocol Violation|0|||
170588008|NCT03359785|616496060|FG000|Overall Study|Early study termination due to study pause|0|||
170588009|NCT03359785|616496061|FG001|Overall Study|Early study termination due to study pause|0|||
170588010|NCT03359785|616496062|FG002|Overall Study|Early study termination due to study pause|2|||
170588011|NCT03359785|616496063|FG003|Overall Study|Early study termination due to study pause|0|||
170588012|NCT03359785|616496060|FG000|Overall Study|Withdrawal by Subject|2|||
170588013|NCT03359785|616496061|FG001|Overall Study|Withdrawal by Subject|2|||
170588014|NCT03359785|616496062|FG002|Overall Study|Withdrawal by Subject|0|||
170588015|NCT03359785|616496063|FG003|Overall Study|Withdrawal by Subject|0|||
170588016|NCT01920568|616496067|FG000|Overall Study|Adverse Event|27|||
170588017|NCT01920568|616496068|FG001|Overall Study|Adverse Event|8|||
170910976|NCT04800315|617677332|FG001|Treatment Period|Lack of Efficacy|0|||
170910977|NCT04800315|617677333|FG002|Treatment Period|Lack of Efficacy|0|||
170910978|NCT04800315|617677334|FG003|Treatment Period|Lack of Efficacy|3|||
170910979|NCT04800315|617677331|FG000|Treatment Period|Lost to Follow-up|0|||
170910980|NCT04800315|617677332|FG001|Treatment Period|Lost to Follow-up|1|||
170910981|NCT04800315|617677333|FG002|Treatment Period|Lost to Follow-up|2|||
170910982|NCT04800315|617677334|FG003|Treatment Period|Lost to Follow-up|2|||
170910983|NCT04800315|617677331|FG000|Treatment Period|Withdrawal by participant|0|||
170910984|NCT04800315|617677332|FG001|Treatment Period|Withdrawal by participant|0|||
170910985|NCT04800315|617677333|FG002|Treatment Period|Withdrawal by participant|0|||
170588018|NCT01920568|616496067|FG000|Overall Study|Protocol Violation|5|||
170588019|NCT01920568|616496068|FG001|Overall Study|Protocol Violation|3|||
170588020|NCT01920568|616496067|FG000|Overall Study|Lost to Follow-up|2|||
170588021|NCT01920568|616496068|FG001|Overall Study|Lost to Follow-up|2|||
170588022|NCT01920568|616496067|FG000|Overall Study|Physician Decision|13|||
170588023|NCT01920568|616496068|FG001|Overall Study|Physician Decision|4|||
170588024|NCT01920568|616496067|FG000|Overall Study|Withdrawal by Subject|79|||
170910986|NCT04800315|617677334|FG003|Treatment Period|Withdrawal by participant|4|||
170910987|NCT04800315|617677331|FG000|Treatment Period|Other Reasons|0|||
170910988|NCT04800315|617677332|FG001|Treatment Period|Other Reasons|2|||
170588025|NCT01920568|616496068|FG001|Overall Study|Withdrawal by Subject|55|||
170910989|NCT04800315|617677333|FG002|Treatment Period|Other Reasons|0|||
170910990|NCT04800315|617677334|FG003|Treatment Period|Other Reasons|1|||
170910991|NCT00196937|617677337|FG000|Overall Study|Serious Adverse Event|1|||
170588026|NCT01920568|616496067|FG000|Overall Study|Death due to disease progression|25|||
170588027|NCT01920568|616496068|FG001|Overall Study|Death due to disease progression|12|||
170588028|NCT00252694|616496076|FG000|Overall Study|Withdrawal by Subject|83|||
170588029|NCT00252694|616496077|FG001|Overall Study|Withdrawal by Subject|91|||
170910992|NCT00196937|617677338|FG001|Overall Study|Serious Adverse Event|0|||
170588030|NCT00252694|616496076|FG000|Overall Study|Death|36|||
170588031|NCT00252694|616496077|FG001|Overall Study|Death|34|||
170588032|NCT00252694|616496076|FG000|Overall Study|Mostly Lost to Follow Up|8|||
170810245|NCT01072149|617315532|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810246|NCT01072149|617315533|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810247|NCT01072149|617315534|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810248|NCT01072149|617315535|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810249|NCT01072149|617315536|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810250|NCT01072149|617315537|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810251|NCT01072149|617315538|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810252|NCT01072149|617315539|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810253|NCT01072149|617315540|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
170810254|NCT01072149|617315541|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
170810255|NCT01072149|617315524|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170588033|NCT00252694|616496077|FG001|Overall Study|Mostly Lost to Follow Up|13|||
170588034|NCT00252694|616496076|FG000|Overall Study|Patient Moving|17|||
170588035|NCT00252694|616496077|FG001|Overall Study|Patient Moving|16|||
170588036|NCT04584346|616496087|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
170588037|NCT04584346|616496088|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
170588038|NCT00503581|616496089|FG000|Overall Study|Study closed|3|||
170588039|NCT00503581|616496090|FG001|Overall Study|Study closed|4|||
170588040|NCT00503581|616496091|FG002|Overall Study|Study closed|2|||
170588041|NCT04262882|616496096|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
170588042|NCT04262882|616496097|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
170588043|NCT04262882|616496096|FG000|Overall Study|Lost to Follow-up|1|||
170588044|NCT04262882|616496097|FG001|Overall Study|Lost to Follow-up|0|||
170588045|NCT00468676|616496100|FG000|Overall Study|Lost to Follow-up|14|||
170588046|NCT00468676|616496101|FG001|Overall Study|Lost to Follow-up|11|||
170588047|NCT00468676|616496100|FG000|Overall Study|Death|2|||
170588048|NCT00468676|616496101|FG001|Overall Study|Death|1|||
170588049|NCT00541866|616496103|FG000|Overall Study|Adverse Event|3|||
170588050|NCT00541866|616496104|FG001|Overall Study|Adverse Event|0|||
170588051|NCT00541866|616496105|FG002|Overall Study|Adverse Event|0|||
170588052|NCT00541866|616496106|FG003|Overall Study|Adverse Event|0|||
170588053|NCT00541866|616496107|FG004|Overall Study|Adverse Event|0|||
170588054|NCT00541866|616496103|FG000|Overall Study|Death|1|||
170588055|NCT00541866|616496104|FG001|Overall Study|Death|0|||
170588056|NCT00541866|616496105|FG002|Overall Study|Death|0|||
170588057|NCT00541866|616496106|FG003|Overall Study|Death|0|||
170588058|NCT00541866|616496107|FG004|Overall Study|Death|0|||
170588059|NCT00541866|616496103|FG000|Overall Study|Lack of Efficacy|19|||
170588060|NCT00541866|616496104|FG001|Overall Study|Lack of Efficacy|15|||
170588061|NCT00541866|616496105|FG002|Overall Study|Lack of Efficacy|10|||
170588062|NCT00541866|616496106|FG003|Overall Study|Lack of Efficacy|12|||
170588063|NCT00541866|616496107|FG004|Overall Study|Lack of Efficacy|14|||
170588064|NCT00541866|616496103|FG000|Overall Study|Not Reported or Other|11|||
170588065|NCT00541866|616496104|FG001|Overall Study|Not Reported or Other|3|||
170588066|NCT00541866|616496105|FG002|Overall Study|Not Reported or Other|3|||
170588067|NCT00541866|616496106|FG003|Overall Study|Not Reported or Other|3|||
170588068|NCT00541866|616496107|FG004|Overall Study|Not Reported or Other|1|||
170588069|NCT00541866|616496103|FG000|Overall Study|Physician Decision|0|||
170588070|NCT00541866|616496104|FG001|Overall Study|Physician Decision|0|||
170588071|NCT00541866|616496105|FG002|Overall Study|Physician Decision|2|||
170588072|NCT00541866|616496106|FG003|Overall Study|Physician Decision|1|||
170588073|NCT00541866|616496107|FG004|Overall Study|Physician Decision|0|||
170588074|NCT02256384|616496119|FG000|Overall Study|Withdrawal by Subject|12|||
170588075|NCT02256384|616496119|FG000|Overall Study|Equipment not capturing data|2|||
170588076|NCT02825420|616496121|FG000|Overall Study|Death|30|||
170588077|NCT02825420|616496122|FG001|Overall Study|Death|12|||
170588078|NCT02825420|616496121|FG000|Overall Study|Progressive disease|6|||
170588079|NCT02825420|616496122|FG001|Overall Study|Progressive disease|1|||
170588080|NCT02825420|616496121|FG000|Overall Study|Lost to Follow-up|2|||
170588081|NCT02825420|616496122|FG001|Overall Study|Lost to Follow-up|2|||
170588082|NCT02825420|616496121|FG000|Overall Study|Withdrawal by Subject|1|||
170588083|NCT02825420|616496122|FG001|Overall Study|Withdrawal by Subject|1|||
170588084|NCT02825420|616496121|FG000|Overall Study|Protocol amendment not signed|1|||
170588085|NCT02825420|616496122|FG001|Overall Study|Protocol amendment not signed|1|||
170588086|NCT02825420|616496121|FG000|Overall Study|Physician Decision|1|||
170588087|NCT02825420|616496122|FG001|Overall Study|Physician Decision|0|||
170588088|NCT02825420|616496121|FG000|Overall Study|Did not receive PLD|2|||
170588089|NCT02825420|616496122|FG001|Overall Study|Did not receive PLD|0|||
170588090|NCT01288612|616497953|FG000|Overall Study|Unable to contact|11|||
170588091|NCT01288612|616497954|FG001|Overall Study|Unable to contact|16|||
170588092|NCT01288612|616497955|FG002|Overall Study|Unable to contact|20|||
170588093|NCT01288612|616497953|FG000|Overall Study|Declined|78|||
170588094|NCT01288612|616497954|FG001|Overall Study|Declined|63|||
170588095|NCT01288612|616497955|FG002|Overall Study|Declined|62|||
170588096|NCT01288612|616497953|FG000|Overall Study|Unable to intubate|0|||
170588097|NCT01288612|616497954|FG001|Overall Study|Unable to intubate|3|||
170588098|NCT01288612|616497955|FG002|Overall Study|Unable to intubate|0|||
170588099|NCT03095027|616497956|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
170588100|NCT03095027|616497957|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
170588101|NCT02982018|616497960|FG000|Overall Study|Incorrect Lens Dispensed|1|||
170588102|NCT02982018|616497961|FG001|Overall Study|Incorrect Lens Dispensed|0|||
170588103|NCT02982018|616497960|FG000|Overall Study|Protocol Violation|1|||
170588104|NCT02982018|616497961|FG001|Overall Study|Protocol Violation|1|||
170588105|NCT02982018|616497960|FG000|Overall Study|Adverse Event|1|||
170588106|NCT02982018|616497961|FG001|Overall Study|Adverse Event|1|||
170588107|NCT02982018|616497960|FG000|Overall Study|Lens Discomfort|2|||
170588108|NCT02982018|616497961|FG001|Overall Study|Lens Discomfort|0|||
170588109|NCT02982018|616497960|FG000|Overall Study|Withdrawal by Subject|0|||
170588110|NCT02982018|616497961|FG001|Overall Study|Withdrawal by Subject|1|||
170588111|NCT03245736|616497963|FG000|Overall Study|Adverse Event|1|||
170588112|NCT03245736|616497963|FG000|Overall Study|Progressive Disease|4|||
170588113|NCT01942161|616497964|FG000|Overall Study|Adverse Event|1|||
170588114|NCT01942161|616497965|FG001|Overall Study|Adverse Event|2|||
170588115|NCT01942161|616497966|FG002|Overall Study|Adverse Event|5|||
170588116|NCT01942161|616497964|FG000|Overall Study|Physician Decision|3|||
170588117|NCT01942161|616497965|FG001|Overall Study|Physician Decision|1|||
170588118|NCT01942161|616497966|FG002|Overall Study|Physician Decision|0|||
170588119|NCT01942161|616497964|FG000|Overall Study|Protocol Violation|1|||
170588120|NCT01942161|616497965|FG001|Overall Study|Protocol Violation|0|||
170588121|NCT01942161|616497966|FG002|Overall Study|Protocol Violation|0|||
170588122|NCT01942161|616497964|FG000|Overall Study|Withdrawal by Subject|3|||
170588123|NCT01942161|616497965|FG001|Overall Study|Withdrawal by Subject|3|||
170588124|NCT01942161|616497966|FG002|Overall Study|Withdrawal by Subject|1|||
170588125|NCT02019108|616497970|FG000|Overall Study|Lost to Follow-up|5|||
170588126|NCT02019108|616497971|FG001|Overall Study|Lost to Follow-up|7|||
170588127|NCT00132691|616497972|FG000|Overall Study|Lost to Follow-up|5|||
170588128|NCT00132691|616497973|FG001|Overall Study|Lost to Follow-up|8|||
170588129|NCT00132691|616497972|FG000|Overall Study|Missed 2-year visit|4|||
170588130|NCT00132691|616497973|FG001|Overall Study|Missed 2-year visit|4|||
170588131|NCT00132691|616497972|FG000|Overall Study|Death|2|||
170588132|NCT00132691|616497973|FG001|Overall Study|Death|0|||
170588133|NCT02251717|616497974|FG000|Overall Study|Adverse Event|0|||
170588134|NCT02251717|616497975|FG001|Overall Study|Adverse Event|1|||
170588135|NCT02251717|616497974|FG000|Overall Study|Withdrew Consent|1|||
170588136|NCT02251717|616497975|FG001|Overall Study|Withdrew Consent|0|||
170588137|NCT03356977|616497976|FG000|Overall Study|Lost to Follow-up|3|||
170588138|NCT03356977|616497976|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170588139|NCT01728077|616497982|FG000|Overall Study|Lack of Efficacy|3|||
170650080|NCT02582684|616732812|FG000|Overall Study|Found to be ineligible after enrollment|2|||
170588140|NCT01728077|616497983|FG001|Overall Study|Lack of Efficacy|1|||
170588141|NCT01728077|616497982|FG000|Overall Study|Lost to Follow-up|1|||
170588142|NCT01728077|616497983|FG001|Overall Study|Lost to Follow-up|0|||
170588143|NCT01728077|616497982|FG000|Overall Study|Subject choice|2|||
170588144|NCT01728077|616497983|FG001|Overall Study|Subject choice|3|||
170588145|NCT01728077|616497982|FG000|Overall Study|Death|0|||
170588146|NCT01728077|616497983|FG001|Overall Study|Death|1|||
170588147|NCT01728077|616497982|FG000|Overall Study|Patient moving|1|||
170588148|NCT01728077|616497983|FG001|Overall Study|Patient moving|0|||
170588149|NCT01728077|616497982|FG000|Overall Study|Non compliance|1|||
170588150|NCT01728077|616497983|FG001|Overall Study|Non compliance|0|||
170588151|NCT03224507|616497984|FG000|Overall Study|Death|3|||
170588152|NCT03224507|616497985|FG001|Overall Study|Death|0|||
170588153|NCT03224507|616497984|FG000|Overall Study|Lack of Efficacy|6|||
170588154|NCT03224507|616497985|FG001|Overall Study|Lack of Efficacy|0|||
170588155|NCT03224507|616497984|FG000|Overall Study|Withdrawal by Subject|6|||
170588156|NCT03224507|616497985|FG001|Overall Study|Withdrawal by Subject|0|||
170588157|NCT02545517|616497986|FG000|Overall Study|Death|2|||
170588158|NCT02545517|616497987|FG001|Overall Study|Death|2|||
170588159|NCT02545517|616497988|FG002|Overall Study|Death|1|||
170588160|NCT02545517|616497986|FG000|Overall Study|Lost to Follow-up|14|||
170588161|NCT02545517|616497987|FG001|Overall Study|Lost to Follow-up|13|||
170588162|NCT02545517|616497988|FG002|Overall Study|Lost to Follow-up|17|||
170588163|NCT02545517|616497986|FG000|Overall Study|Protocol Violation|0|||
170588164|NCT02545517|616497987|FG001|Overall Study|Protocol Violation|1|||
170588165|NCT02545517|616497988|FG002|Overall Study|Protocol Violation|1|||
170588166|NCT02545517|616497986|FG000|Overall Study|Withdrawal by Subject|5|||
170588167|NCT02545517|616497987|FG001|Overall Study|Withdrawal by Subject|8|||
170588168|NCT02545517|616497988|FG002|Overall Study|Withdrawal by Subject|9|||
170588169|NCT02545517|616497986|FG000|Overall Study|Administrative reason|5|||
170588170|NCT02545517|616497987|FG001|Overall Study|Administrative reason|6|||
170588171|NCT02545517|616497988|FG002|Overall Study|Administrative reason|10|||
170588172|NCT02545517|616497986|FG000|Overall Study|Other|2|||
170588173|NCT02545517|616497987|FG001|Overall Study|Other|4|||
170588174|NCT02545517|616497988|FG002|Overall Study|Other|3|||
170588175|NCT01691885|616497992|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
170588176|NCT01691885|616497993|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
170588177|NCT01691885|616497992|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
170588178|NCT01691885|616497993|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
170588179|NCT02442310|616497994|FG000|Overall Study|Adverse Event|2|||
170588180|NCT02442310|616497994|FG000|Overall Study|Withdrawal by Subject|1|||
170588181|NCT01190475|616497996|FG000|Overall Study|Withdrawal by Subject|0|||
170588182|NCT01190475|616497997|FG001|Overall Study|Withdrawal by Subject|0|||
170588183|NCT01190475|616497998|FG002|Overall Study|Withdrawal by Subject|1|||
170588184|NCT00624585|616497999|FG000|Overall Study|Death|3|||
170588185|NCT00624585|616497999|FG000|Overall Study|Disease Progression|6|||
170588186|NCT00624585|616497999|FG000|Overall Study|Adverse Event|3|||
170588187|NCT04154345|616498002|FG000|Overall Study|Covid-19 pandemic|4|||
170588188|NCT03333252|616498007|FG000|Overall Study|Adverse Event|10|||
170588189|NCT03333252|616498008|FG001|Overall Study|Adverse Event|6|||
170588190|NCT03333252|616498009|FG002|Overall Study|Adverse Event|5|||
170588191|NCT03333252|616498010|FG003|Overall Study|Adverse Event|2|||
170588192|NCT03333252|616498007|FG000|Overall Study|Death|1|||
170588193|NCT03333252|616498008|FG001|Overall Study|Death|3|||
170588194|NCT03333252|616498009|FG002|Overall Study|Death|0|||
170588195|NCT03333252|616498010|FG003|Overall Study|Death|0|||
170588196|NCT03333252|616498007|FG000|Overall Study|Lack of Efficacy|8|||
170588197|NCT03333252|616498008|FG001|Overall Study|Lack of Efficacy|4|||
170588198|NCT03333252|616498009|FG002|Overall Study|Lack of Efficacy|0|||
170588199|NCT03333252|616498010|FG003|Overall Study|Lack of Efficacy|7|||
170588200|NCT03333252|616498007|FG000|Overall Study|Lost to Follow-up|0|||
170588201|NCT03333252|616498008|FG001|Overall Study|Lost to Follow-up|5|||
170588202|NCT03333252|616498009|FG002|Overall Study|Lost to Follow-up|9|||
170588203|NCT03333252|616498010|FG003|Overall Study|Lost to Follow-up|3|||
170588204|NCT03333252|616498007|FG000|Overall Study|Withdrawal by Subject|14|||
170588205|NCT03333252|616498008|FG001|Overall Study|Withdrawal by Subject|24|||
170588206|NCT03333252|616498009|FG002|Overall Study|Withdrawal by Subject|11|||
170588207|NCT03333252|616498010|FG003|Overall Study|Withdrawal by Subject|17|||
170588208|NCT00744978|616498028|FG000|Period 1|Lost to Follow-up|1|||
170588209|NCT00744978|616498029|FG001|Period 1|Lost to Follow-up|0|||
170588210|NCT00744978|616498028|FG000|Period 1|Withdrawal by Subject|0|||
170650081|NCT01878149|616732813|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
170650082|NCT01878149|616732814|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
170588211|NCT00744978|616498029|FG001|Period 1|Withdrawal by Subject|2|||
170588212|NCT00744978|616498028|FG000|Period 1|Other|0|||
170588213|NCT00744978|616498029|FG001|Period 1|Other|2|||
170588214|NCT00744978|616498028|FG000|Period 1|Adverse Event|4|||
170588215|NCT00744978|616498029|FG001|Period 1|Adverse Event|0|||
170588216|NCT00744978|616498028|FG000|Period 1|Randomized but not Treated|1|||
170588217|NCT00744978|616498029|FG001|Period 1|Randomized but not Treated|1|||
170588218|NCT00744978|616498028|FG000|Period 2|Adverse Event|0|||
170588219|NCT00744978|616498029|FG001|Period 2|Adverse Event|1|||
170588220|NCT03773133|616498030|FG000|Overall Study|Screen Failure|8|||
170588221|NCT00107315|616498034|FG000|Overall Study|Disease Progression|9|||
170588222|NCT00107315|616498034|FG000|Overall Study|Adverse Event|4|||
170588223|NCT00107315|616498034|FG000|Overall Study|Withdrawal by Subject|2|||
170588224|NCT03943550|616498039|FG000|Overall Study|Adverse Event|0|||
170588225|NCT03943550|616498040|FG001|Overall Study|Adverse Event|0|||
170588226|NCT03943550|616498041|FG002|Overall Study|Adverse Event|1|||
170588227|NCT03943550|616498039|FG000|Overall Study|Lost to Follow-up|0|||
170588228|NCT03943550|616498040|FG001|Overall Study|Lost to Follow-up|0|||
170588229|NCT03943550|616498041|FG002|Overall Study|Lost to Follow-up|1|||
170588230|NCT03943550|616498039|FG000|Overall Study|Progressive Disease|0|||
170588231|NCT03943550|616498040|FG001|Overall Study|Progressive Disease|0|||
170588232|NCT03943550|616498041|FG002|Overall Study|Progressive Disease|2|||
170588233|NCT03943550|616498039|FG000|Overall Study|Participant Moved Out of the Country|0|||
170588234|NCT03943550|616498040|FG001|Overall Study|Participant Moved Out of the Country|1|||
170588235|NCT03943550|616498041|FG002|Overall Study|Participant Moved Out of the Country|0|||
170588236|NCT01703208|616498042|FG000|Overall Study|Death|61|||
170588237|NCT01703208|616498043|FG001|Overall Study|Death|48|||
170588238|NCT01703208|616498042|FG000|Overall Study|Lack of Efficacy|1|||
170588239|NCT01703208|616498043|FG001|Overall Study|Lack of Efficacy|2|||
170588240|NCT01703208|616498042|FG000|Overall Study|Lost to Follow-up|68|||
170588241|NCT01703208|616498043|FG001|Overall Study|Lost to Follow-up|62|||
170588242|NCT01703208|616498042|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170588243|NCT01703208|616498043|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170588244|NCT01703208|616498042|FG000|Overall Study|Excluded Medication|1|||
170588245|NCT01703208|616498043|FG001|Overall Study|Excluded Medication|2|||
170588246|NCT01703208|616498042|FG000|Overall Study|Site Discontinued Study Participation|23|||
170588247|NCT01703208|616498043|FG001|Overall Study|Site Discontinued Study Participation|27|||
170588248|NCT01703208|616498042|FG000|Overall Study|Physician Decision|11|||
170588249|NCT01703208|616498043|FG001|Overall Study|Physician Decision|13|||
170650083|NCT01738477|616732824|FG000|Overall Study|Lost to Follow-up|1|||
170650084|NCT01738477|616732825|FG001|Overall Study|Lost to Follow-up|4|||
170650085|NCT00502203|616732826|FG000|Overall Study|Inevaluable|1|||
170650086|NCT00796991|616732827|FG000|Overall Study|Adverse Event|0|||
170650087|NCT00796991|616732828|FG001|Overall Study|Adverse Event|0|||
170650088|NCT00796991|616732829|FG002|Overall Study|Adverse Event|1|||
170650089|NCT00796991|616732827|FG000|Overall Study|Death|2|||
170650090|NCT00796991|616732828|FG001|Overall Study|Death|0|||
170650091|NCT00796991|616732829|FG002|Overall Study|Death|0|||
170650092|NCT00796991|616732827|FG000|Overall Study|Disease Progression|10|||
170650093|NCT00796991|616732828|FG001|Overall Study|Disease Progression|9|||
170650094|NCT00796991|616732829|FG002|Overall Study|Disease Progression|7|||
170650095|NCT00796991|616732827|FG000|Overall Study|Study Drug Toxicity|3|||
170650096|NCT00796991|616732828|FG001|Overall Study|Study Drug Toxicity|3|||
170650097|NCT00796991|616732829|FG002|Overall Study|Study Drug Toxicity|5|||
170650098|NCT00796991|616732827|FG000|Overall Study|Withdrawal by Subject|0|||
170650099|NCT00796991|616732828|FG001|Overall Study|Withdrawal by Subject|0|||
170650100|NCT00796991|616732829|FG002|Overall Study|Withdrawal by Subject|1|||
170650101|NCT00171834|616732830|FG000|Overall Study|Adverse Event|2|||
170650102|NCT00171834|616732831|FG001|Overall Study|Adverse Event|1|||
170650103|NCT00171834|616732832|FG002|Overall Study|Adverse Event|3|||
170650104|NCT00171834|616732833|FG003|Overall Study|Adverse Event|2|||
170650105|NCT00171834|616732834|FG004|Overall Study|Adverse Event|2|||
170650106|NCT00171834|616732835|FG005|Overall Study|Adverse Event|15|||
170650107|NCT00171834|616732836|FG006|Overall Study|Adverse Event|1|||
170650108|NCT00171834|616732830|FG000|Overall Study|Withdrawal by Subject|0|||
170650109|NCT00171834|616732831|FG001|Overall Study|Withdrawal by Subject|2|||
170650110|NCT00171834|616732832|FG002|Overall Study|Withdrawal by Subject|0|||
170650111|NCT00171834|616732833|FG003|Overall Study|Withdrawal by Subject|1|||
170650112|NCT00171834|616732834|FG004|Overall Study|Withdrawal by Subject|1|||
170650113|NCT00171834|616732835|FG005|Overall Study|Withdrawal by Subject|1|||
170650114|NCT00171834|616732836|FG006|Overall Study|Withdrawal by Subject|0|||
170650115|NCT00171834|616732830|FG000|Overall Study|Death from study indication|0|||
170650116|NCT00171834|616732831|FG001|Overall Study|Death from study indication|1|||
170650117|NCT00171834|616732832|FG002|Overall Study|Death from study indication|0|||
170650118|NCT00171834|616732833|FG003|Overall Study|Death from study indication|0|||
170650119|NCT00171834|616732834|FG004|Overall Study|Death from study indication|1|||
170650120|NCT00171834|616732835|FG005|Overall Study|Death from study indication|0|||
170650121|NCT00171834|616732836|FG006|Overall Study|Death from study indication|0|||
170588250|NCT01703208|616498042|FG000|Overall Study|Progressive disease|2|||
170588251|NCT01703208|616498043|FG001|Overall Study|Progressive disease|2|||
170650122|NCT00171834|616732830|FG000|Overall Study|Disease Progression|4|||
170650123|NCT00171834|616732831|FG001|Overall Study|Disease Progression|8|||
170650124|NCT00171834|616732832|FG002|Overall Study|Disease Progression|8|||
170650125|NCT00171834|616732833|FG003|Overall Study|Disease Progression|9|||
170650126|NCT00171834|616732834|FG004|Overall Study|Disease Progression|2|||
170650127|NCT00171834|616732835|FG005|Overall Study|Disease Progression|18|||
170650128|NCT00171834|616732836|FG006|Overall Study|Disease Progression|3|||
170810256|NCT01072149|617315525|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170650129|NCT00171834|616732830|FG000|Overall Study|Treatment Duration Completed|0|||
170650130|NCT00171834|616732831|FG001|Overall Study|Treatment Duration Completed|0|||
170650131|NCT00171834|616732832|FG002|Overall Study|Treatment Duration Completed|1|||
170650132|NCT00171834|616732833|FG003|Overall Study|Treatment Duration Completed|0|||
170650133|NCT00171834|616732834|FG004|Overall Study|Treatment Duration Completed|2|||
170650134|NCT00171834|616732835|FG005|Overall Study|Treatment Duration Completed|1|||
170650135|NCT00171834|616732836|FG006|Overall Study|Treatment Duration Completed|0|||
170588252|NCT01703208|616498042|FG000|Overall Study|Protocol Violation|1|||
170588253|NCT01703208|616498043|FG001|Overall Study|Protocol Violation|1|||
170588254|NCT01703208|616498042|FG000|Overall Study|Study Terminated by Sponsor|1710|||
170588255|NCT01703208|616498043|FG001|Overall Study|Study Terminated by Sponsor|1716|||
170588256|NCT01703208|616498042|FG000|Overall Study|Withdrawal by Subject|205|||
170588257|NCT01703208|616498043|FG001|Overall Study|Withdrawal by Subject|209|||
170588258|NCT01703208|616498042|FG000|Overall Study|Adverse Event|14|||
170588259|NCT01703208|616498043|FG001|Overall Study|Adverse Event|19|||
170588260|NCT01703208|616498042|FG000|Overall Study|Technical Problems|0|||
170588261|NCT01703208|616498043|FG001|Overall Study|Technical Problems|1|||
170588262|NCT01703208|616498042|FG000|Overall Study|Protocol Deviation|2|||
170588263|NCT01703208|616498043|FG001|Overall Study|Protocol Deviation|0|||
170588264|NCT01224821|616498044|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
170588265|NCT01224821|616498044|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
170588266|NCT01224821|616498044|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
170588267|NCT01224821|616498044|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
170588268|NCT01224821|616498044|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
170588269|NCT01224821|616498044|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
170588270|NCT01224821|616498044|FG000|Long-Term Follow-Up|Death|2|||
170588271|NCT01224821|616498044|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
170588272|NCT02174523|616498045|FG000|Overall Study|Withdrawal by Subject|1|||
170588273|NCT02174523|616498046|FG001|Overall Study|Withdrawal by Subject|0|||
170588274|NCT00794365|616498047|FG000|Overall Study|Lost to Follow-up|38|||
170588275|NCT00794365|616498047|FG000|Overall Study|Other|17|||
170588276|NCT00794365|616498047|FG000|Overall Study|Poor Compliance|11|||
170588277|NCT00794365|616498047|FG000|Overall Study|Adverse Event|10|||
170588278|NCT00794365|616498047|FG000|Overall Study|Lack of Efficacy|3|||
170588279|NCT01451931|616498048|FG000|Overall Study|Lost to Follow-up|17|||
170588280|NCT01451931|616498049|FG001|Overall Study|Lost to Follow-up|36|||
170588281|NCT01451931|616498050|FG002|Overall Study|Lost to Follow-up|21|||
170588282|NCT01451931|616498048|FG000|Overall Study|Withdrawal by Subject|16|||
170588283|NCT01451931|616498049|FG001|Overall Study|Withdrawal by Subject|22|||
170588284|NCT01451931|616498050|FG002|Overall Study|Withdrawal by Subject|22|||
170588285|NCT01271712|616498051|FG000|Double Blind Treatment|Death|2|||
170588286|NCT01271712|616498052|FG001|Double Blind Treatment|Death|0|||
170588287|NCT01271712|616498051|FG000|Double Blind Treatment|Lack of Efficacy|1|||
170588288|NCT01271712|616498052|FG001|Double Blind Treatment|Lack of Efficacy|0|||
170588289|NCT01271712|616498051|FG000|Double Blind Treatment|Adverse Event|9|||
170588290|NCT01271712|616498052|FG001|Double Blind Treatment|Adverse Event|4|||
170588291|NCT01271712|616498051|FG000|Double Blind Treatment|Progressive disease|23|||
170588292|NCT01271712|616498052|FG001|Double Blind Treatment|Progressive disease|3|||
170588293|NCT01271712|616498051|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
170588294|NCT01271712|616498052|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
170588295|NCT01271712|616498051|FG000|Double Blind Treatment|Non compliance with study drug|2|||
170588296|NCT01271712|616498052|FG001|Double Blind Treatment|Non compliance with study drug|0|||
170588297|NCT01271712|616498051|FG000|Double Blind Treatment|receive no study drug|1|||
170588298|NCT01271712|616498052|FG001|Double Blind Treatment|receive no study drug|0|||
170588299|NCT01271712|616498051|FG000|Open Label Treatment|Death|6|||
170588300|NCT01271712|616498052|FG001|Open Label Treatment|Death|5|||
170588301|NCT01271712|616498051|FG000|Open Label Treatment|Withdrawal by Subject|6|||
170588302|NCT01271712|616498052|FG001|Open Label Treatment|Withdrawal by Subject|11|||
170588303|NCT01271712|616498051|FG000|Open Label Treatment|Physician Decision|2|||
170588304|NCT01271712|616498052|FG001|Open Label Treatment|Physician Decision|0|||
170588305|NCT01271712|616498051|FG000|Open Label Treatment|Adverse Event|14|||
170588306|NCT01271712|616498052|FG001|Open Label Treatment|Adverse Event|8|||
170588307|NCT01271712|616498051|FG000|Open Label Treatment|Progressive disease|59|||
170588308|NCT01271712|616498052|FG001|Open Label Treatment|Progressive disease|32|||
170588309|NCT01271712|616498051|FG000|Open Label Treatment|transferred to rollover study|1|||
170588310|NCT01271712|616498052|FG001|Open Label Treatment|transferred to rollover study|0|||
170588311|NCT01271712|616498051|FG000|Open Label Treatment|Non-compliance with study drug|1|||
170588312|NCT01271712|616498052|FG001|Open Label Treatment|Non-compliance with study drug|0|||
170588313|NCT01271712|616498051|FG000|Open Label Treatment|Protocol Violation|0|||
170588314|NCT01271712|616498052|FG001|Open Label Treatment|Protocol Violation|1|||
170588315|NCT01271712|616498051|FG000|Open Label Treatment|Switching to other therapy|2|||
170588316|NCT01271712|616498052|FG001|Open Label Treatment|Switching to other therapy|1|||
170588317|NCT01271712|616498051|FG000|Safety Follow-up|Death|11|||
170588318|NCT01271712|616498052|FG001|Safety Follow-up|Death|7|||
170588319|NCT01271712|616498051|FG000|Safety Follow-up|Withdrawal by Subject|4|||
170588320|NCT01271712|616498052|FG001|Safety Follow-up|Withdrawal by Subject|2|||
170588321|NCT01271712|616498051|FG000|Safety Follow-up|Protocol Violation|1|||
170588322|NCT01271712|616498052|FG001|Safety Follow-up|Protocol Violation|1|||
170588323|NCT01271712|616498051|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
170588324|NCT01271712|616498052|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
170588325|NCT01271712|616498051|FG000|Safety Follow-up|No follow-up|1|||
170588326|NCT01271712|616498052|FG001|Safety Follow-up|No follow-up|1|||
170588327|NCT01271712|616498051|FG000|Safety Follow-up|Progressive disease|1|||
170588328|NCT01271712|616498052|FG001|Safety Follow-up|Progressive disease|0|||
170588329|NCT01271712|616498051|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
170588330|NCT01271712|616498052|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
170588331|NCT00096226|616498055|FG000|Overall Study|Ineligible|2|||
170588332|NCT00096226|616498055|FG000|Overall Study|Protocol treatment not started|1|||
170588333|NCT02685748|616498059|FG000|Overall Study|Withdrawal by Subject|3|||
170588334|NCT02685748|616498060|FG001|Overall Study|Withdrawal by Subject|2|||
170588335|NCT02979093|616498061|FG000|First Scan Session|Scanning data problems|1|||
170588336|NCT02979093|616498062|FG001|First Scan Session|Scanning data problems|2|||
170588337|NCT02979093|616498063|FG002|First Scan Session|Scanning data problems|2|||
170588338|NCT02979093|616498064|FG003|First Scan Session|Scanning data problems|0|||
170588339|NCT02979093|616498061|FG000|Second Scan Session|Scanning data problems|3|||
170588340|NCT02979093|616498062|FG001|Second Scan Session|Scanning data problems|0|||
170588341|NCT02979093|616498063|FG002|Second Scan Session|Scanning data problems|1|||
170588342|NCT02979093|616498064|FG003|Second Scan Session|Scanning data problems|3|||
170588343|NCT03006458|616498069|FG000|First Intervention|Unsatisfied Vision|0|||
170588344|NCT03006458|616498070|FG001|First Intervention|Unsatisfied Vision|3|||
170810257|NCT01072149|617315526|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810258|NCT01072149|617315527|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810259|NCT01072149|617315528|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810260|NCT01072149|617315529|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810261|NCT01072149|617315530|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810262|NCT01072149|617315531|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810263|NCT01072149|617315532|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810264|NCT01072149|617315533|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810265|NCT01072149|617315534|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
170810266|NCT01072149|617315535|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810267|NCT01072149|617315536|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810268|NCT01072149|617315537|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810269|NCT01072149|617315538|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810270|NCT01072149|617315539|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810271|NCT01072149|617315540|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810272|NCT01072149|617315541|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
170810273|NCT01072149|617315524|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810274|NCT01072149|617315525|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
170810275|NCT01072149|617315526|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810276|NCT01072149|617315527|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810277|NCT01072149|617315528|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810278|NCT01072149|617315529|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810279|NCT01072149|617315530|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810280|NCT01072149|617315531|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810281|NCT01072149|617315532|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810282|NCT01072149|617315533|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810283|NCT01072149|617315534|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810284|NCT01072149|617315535|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810285|NCT01072149|617315536|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810286|NCT01072149|617315537|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810287|NCT01072149|617315538|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810288|NCT01072149|617315539|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810289|NCT01072149|617315540|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810290|NCT01072149|617315541|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
170810291|NCT01072149|617315524|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810292|NCT01072149|617315525|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810293|NCT01072149|617315526|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
170810294|NCT01072149|617315527|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810295|NCT01072149|617315528|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810296|NCT01072149|617315529|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810297|NCT01072149|617315530|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810298|NCT01072149|617315531|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810299|NCT01072149|617315532|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810300|NCT01072149|617315533|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810301|NCT01072149|617315534|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810302|NCT01072149|617315535|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810303|NCT01072149|617315536|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170588345|NCT02438683|616498073|FG000|Overall Study|Adverse Event|1|||
170588346|NCT02438683|616498074|FG001|Overall Study|Adverse Event|0|||
170588347|NCT02438683|616498075|FG002|Overall Study|Adverse Event|0|||
170588348|NCT02438683|616498076|FG003|Overall Study|Adverse Event|0|||
170588349|NCT02438683|616498077|FG004|Overall Study|Adverse Event|0|||
170588350|NCT02438683|616498078|FG005|Overall Study|Adverse Event|0|||
170588351|NCT02701777|616498090|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
170588352|NCT02701777|616498091|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
170588353|NCT02701777|616498092|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
170588354|NCT02701777|616498093|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
170588355|NCT02701777|616498090|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
170588356|NCT02701777|616498091|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
170588357|NCT02701777|616498092|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
170588358|NCT02701777|616498093|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
170588359|NCT03549871|616498094|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
170588360|NCT03549871|616498095|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
170588361|NCT03549871|616498094|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
170588362|NCT03549871|616498095|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
170588363|NCT03549871|616498094|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
170588364|NCT03549871|616498095|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
170588365|NCT03549871|616498094|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
170588366|NCT03549871|616498095|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
170588367|NCT03549871|616498094|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
170588368|NCT03549871|616498095|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
170588369|NCT03549871|616498094|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
170588370|NCT03549871|616498095|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
170588371|NCT03549871|616498094|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
170588372|NCT03549871|616498095|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
170588373|NCT03549871|616498094|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
170588374|NCT03549871|616498095|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
170588375|NCT03549871|616498094|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
170588376|NCT03549871|616498095|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
170588377|NCT03549871|616498094|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
170588378|NCT03549871|616498095|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
170588379|NCT03549871|616498094|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
170588380|NCT03549871|616498095|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
170588381|NCT01369680|616498096|FG000|Overall Study|Lost to Follow-up|0|||
170588382|NCT01369680|616498097|FG001|Overall Study|Lost to Follow-up|0|||
170588383|NCT01369680|616498098|FG002|Overall Study|Lost to Follow-up|1|||
170588384|NCT01369680|616498099|FG003|Overall Study|Lost to Follow-up|2|||
170588385|NCT03559517|616498100|FG000|Overall Study|Withdrawal by Subject|1|||
170588386|NCT03559517|616498101|FG001|Overall Study|Withdrawal by Subject|0|||
170588387|NCT03559517|616498102|FG002|Overall Study|Withdrawal by Subject|0|||
170588388|NCT01846299|616498103|FG000|Overall Study|Physician Decision|4|||
170588389|NCT01846299|616498104|FG001|Overall Study|Physician Decision|2|||
170588390|NCT01846299|616498103|FG000|Overall Study|Protocol deviation|1|||
170588391|NCT01846299|616498104|FG001|Overall Study|Protocol deviation|0|||
170588392|NCT01846299|616498103|FG000|Overall Study|Death|1|||
170588393|NCT01846299|616498104|FG001|Overall Study|Death|2|||
170588394|NCT01846299|616498103|FG000|Overall Study|Lost to Follow-up|3|||
170588395|NCT01846299|616498104|FG001|Overall Study|Lost to Follow-up|0|||
170588396|NCT01846299|616498103|FG000|Overall Study|Withdrawal by Subject|1|||
170588397|NCT01846299|616498104|FG001|Overall Study|Withdrawal by Subject|6|||
170588398|NCT01846299|616498103|FG000|Overall Study|Adverse Event|2|||
170588399|NCT01846299|616498104|FG001|Overall Study|Adverse Event|0|||
170588400|NCT01713283|616498105|FG000|Overall Study|Lack of Efficacy|10|||
170588401|NCT01713283|616498106|FG001|Overall Study|Lack of Efficacy|2|||
170588402|NCT01713283|616498105|FG000|Overall Study|Lost to Follow-up|1|||
170588403|NCT01713283|616498106|FG001|Overall Study|Lost to Follow-up|1|||
170588404|NCT02927925|616498116|FG000|Overall Study|Death|16|||
170588405|NCT02927925|616498116|FG000|Overall Study|Physician Decision|1|||
170910993|NCT00196937|617677339|FG002|Overall Study|Serious Adverse Event|0|||
170910994|NCT00196937|617677337|FG000|Overall Study|Non-serious adverse event|1|||
170910995|NCT00196937|617677338|FG001|Overall Study|Non-serious adverse event|1|||
170588406|NCT02927925|616498116|FG000|Overall Study|Withdrawal by Subject|11|||
170588407|NCT02927925|616498116|FG000|Overall Study|Other|3|||
170588408|NCT02927925|616498116|FG000|Overall Study|Disease progression at clinical cutoff|1|||
170588409|NCT03966885|616500028|FG000|Overall Study|Death|1|||
170588410|NCT03966885|616500029|FG001|Overall Study|Death|0|||
170588411|NCT03966885|616500028|FG000|Overall Study|Lost to Follow-up|1|||
170588412|NCT03966885|616500029|FG001|Overall Study|Lost to Follow-up|2|||
170588413|NCT03966885|616500028|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
170588414|NCT03966885|616500029|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
170910996|NCT00196937|617677339|FG002|Overall Study|Non-serious adverse event|1|||
170910997|NCT00196937|617677337|FG000|Overall Study|Withdrawal by Subject|0|||
170910998|NCT00196937|617677338|FG001|Overall Study|Withdrawal by Subject|0|||
170588415|NCT03966885|616500028|FG000|Overall Study|Moved from study area.|0|||
170588416|NCT03966885|616500029|FG001|Overall Study|Moved from study area.|2|||
170588417|NCT00798317|616500030|FG000|Overall Study|Physician Decision|0|||
170588418|NCT00798317|616500031|FG001|Overall Study|Physician Decision|1|||
170588419|NCT00798317|616500030|FG000|Overall Study|Withdrawal by Subject|5|||
170588420|NCT00798317|616500031|FG001|Overall Study|Withdrawal by Subject|4|||
170588421|NCT00798317|616500030|FG000|Overall Study|Lost to Follow-up|2|||
170588422|NCT00798317|616500031|FG001|Overall Study|Lost to Follow-up|2|||
170588423|NCT00798317|616500030|FG000|Overall Study|Adverse Event|2|||
170588424|NCT00798317|616500031|FG001|Overall Study|Adverse Event|0|||
170588425|NCT00798317|616500030|FG000|Overall Study|Death|1|||
170588426|NCT00798317|616500031|FG001|Overall Study|Death|0|||
170588427|NCT00919867|616500032|FG000|First Intervention|Withdrawal by Subject|0|||
170588428|NCT00919867|616500033|FG001|First Intervention|Withdrawal by Subject|0|||
170588429|NCT00919867|616500034|FG002|First Intervention|Withdrawal by Subject|1|||
170588430|NCT00919867|616500035|FG003|First Intervention|Withdrawal by Subject|0|||
170588431|NCT00919867|616500036|FG004|First Intervention|Withdrawal by Subject|0|||
170588432|NCT00919867|616500037|FG005|First Intervention|Withdrawal by Subject|0|||
170588433|NCT00919867|616500032|FG000|First Intervention|Physician Decision|0|||
170588434|NCT00919867|616500033|FG001|First Intervention|Physician Decision|0|||
170588435|NCT00919867|616500034|FG002|First Intervention|Physician Decision|0|||
170588436|NCT00919867|616500035|FG003|First Intervention|Physician Decision|0|||
170588437|NCT00919867|616500036|FG004|First Intervention|Physician Decision|0|||
170588438|NCT00919867|616500037|FG005|First Intervention|Physician Decision|1|||
170588439|NCT01007435|616500040|FG000|Overall Study|Adverse Event|16|||
170588440|NCT01007435|616500041|FG001|Overall Study|Adverse Event|25|||
170588441|NCT01007435|616500042|FG002|Overall Study|Adverse Event|47|||
170588442|NCT01007435|616500043|FG003|Overall Study|Adverse Event|31|||
170588443|NCT01007435|616500040|FG000|Overall Study|Death|2|||
170588444|NCT01007435|616500041|FG001|Overall Study|Death|4|||
170588445|NCT01007435|616500042|FG002|Overall Study|Death|2|||
170588446|NCT01007435|616500043|FG003|Overall Study|Death|1|||
170588447|NCT01007435|616500040|FG000|Overall Study|Insufficient Therapeutic Response|21|||
170588448|NCT01007435|616500041|FG001|Overall Study|Insufficient Therapeutic Response|7|||
170588449|NCT01007435|616500042|FG002|Overall Study|Insufficient Therapeutic Response|2|||
170588450|NCT01007435|616500043|FG003|Overall Study|Insufficient Therapeutic Response|9|||
170588451|NCT01007435|616500040|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
170588452|NCT01007435|616500041|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
170588453|NCT01007435|616500042|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
170588454|NCT01007435|616500043|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
170588455|NCT01007435|616500040|FG000|Overall Study|Other Protocol Violation|2|||
170588456|NCT01007435|616500041|FG001|Overall Study|Other Protocol Violation|0|||
170588457|NCT01007435|616500042|FG002|Overall Study|Other Protocol Violation|1|||
170588458|NCT01007435|616500043|FG003|Overall Study|Other Protocol Violation|0|||
170588459|NCT01007435|616500040|FG000|Overall Study|Refused Treatment|13|||
170588460|NCT01007435|616500041|FG001|Overall Study|Refused Treatment|13|||
170588461|NCT01007435|616500042|FG002|Overall Study|Refused Treatment|5|||
170588462|NCT01007435|616500043|FG003|Overall Study|Refused Treatment|8|||
170588463|NCT01007435|616500040|FG000|Overall Study|Failure to Return|5|||
170588464|NCT01007435|616500041|FG001|Overall Study|Failure to Return|4|||
170588465|NCT01007435|616500042|FG002|Overall Study|Failure to Return|3|||
170588466|NCT01007435|616500043|FG003|Overall Study|Failure to Return|6|||
170588467|NCT01007435|616500040|FG000|Overall Study|Reason not Specified|1|||
170910999|NCT00196937|617677339|FG002|Overall Study|Withdrawal by Subject|2|||
170911000|NCT00196937|617677337|FG000|Overall Study|Lost to Follow-up|4|||
170911001|NCT00196937|617677338|FG001|Overall Study|Lost to Follow-up|3|||
170911002|NCT00196937|617677339|FG002|Overall Study|Lost to Follow-up|3|||
170911003|NCT00196937|617677337|FG000|Overall Study|Other|3|||
170911004|NCT00196937|617677338|FG001|Overall Study|Other|1|||
170588468|NCT01007435|616500041|FG001|Overall Study|Reason not Specified|1|||
170588469|NCT01007435|616500042|FG002|Overall Study|Reason not Specified|2|||
170588470|NCT01007435|616500043|FG003|Overall Study|Reason not Specified|1|||
170588471|NCT01032291|616500044|FG000|Safety Lead-in|Adverse Event|1|||
170650136|NCT00439738|616732838|FG000|Overall Study|Withdrawal by Subject|16|||
170911005|NCT00196937|617677339|FG002|Overall Study|Other|1|||
170911006|NCT02973815|617677340|FG000|Post Intervention|Death|1|||
170588472|NCT01032291|616500045|FG001|Safety Lead-in|Adverse Event|0|||
170588473|NCT01032291|616500046|FG002|Safety Lead-in|Adverse Event|0|||
170588474|NCT01032291|616500044|FG000|Safety Lead-in|Death|1|||
170588475|NCT01032291|616500045|FG001|Safety Lead-in|Death|0|||
170588476|NCT01032291|616500046|FG002|Safety Lead-in|Death|0|||
170588477|NCT01032291|616500044|FG000|Proof of Concept|Adverse Event|0|||
170911007|NCT02973815|617677341|FG001|Post Intervention|Death|0|||
170588478|NCT01032291|616500045|FG001|Proof of Concept|Adverse Event|5|||
170588479|NCT01032291|616500046|FG002|Proof of Concept|Adverse Event|1|||
170588480|NCT01032291|616500044|FG000|Proof of Concept|Death|0|||
170588481|NCT01032291|616500045|FG001|Proof of Concept|Death|1|||
170588482|NCT01032291|616500046|FG002|Proof of Concept|Death|2|||
170588483|NCT01032291|616500044|FG000|Proof of Concept|Lack of Efficacy|0|||
170588484|NCT01032291|616500045|FG001|Proof of Concept|Lack of Efficacy|1|||
170588485|NCT01032291|616500046|FG002|Proof of Concept|Lack of Efficacy|0|||
170588486|NCT01032291|616500044|FG000|Proof of Concept|Never Received Study Drug|0|||
170588487|NCT01032291|616500045|FG001|Proof of Concept|Never Received Study Drug|1|||
170588488|NCT01032291|616500046|FG002|Proof of Concept|Never Received Study Drug|0|||
170588489|NCT02576535|616500047|FG000|Overall Study|Withdrawal by Subject|2|||
170588490|NCT03334851|616500048|FG000|Overall Study|Other|0|||
170588491|NCT03334851|616500049|FG001|Overall Study|Other|0|||
170588492|NCT03334851|616500050|FG002|Overall Study|Other|0|||
170588493|NCT03334851|616500051|FG003|Overall Study|Other|0|||
170588494|NCT03334851|616500052|FG004|Overall Study|Other|0|||
170588495|NCT03334851|616500053|FG005|Overall Study|Other|0|||
170588496|NCT03334851|616500054|FG006|Overall Study|Other|0|||
170588497|NCT03334851|616500055|FG007|Overall Study|Other|1|||
170588498|NCT03334851|616500056|FG008|Overall Study|Other|0|||
170588499|NCT03334851|616500057|FG009|Overall Study|Other|0|||
170588500|NCT03334851|616500058|FG010|Overall Study|Other|0|||
170588501|NCT03334851|616500059|FG011|Overall Study|Other|0|||
170588502|NCT03334851|616500060|FG012|Overall Study|Other|0|||
170588503|NCT03334851|616500048|FG000|Overall Study|Adverse Event|0|||
170588504|NCT03334851|616500049|FG001|Overall Study|Adverse Event|0|||
170588505|NCT03334851|616500050|FG002|Overall Study|Adverse Event|0|||
170588506|NCT03334851|616500051|FG003|Overall Study|Adverse Event|0|||
170588507|NCT03334851|616500052|FG004|Overall Study|Adverse Event|0|||
170588508|NCT03334851|616500053|FG005|Overall Study|Adverse Event|0|||
170588509|NCT03334851|616500054|FG006|Overall Study|Adverse Event|0|||
170588510|NCT03334851|616500055|FG007|Overall Study|Adverse Event|1|||
170810304|NCT01072149|617315537|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170810305|NCT01072149|617315538|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170588511|NCT03334851|616500056|FG008|Overall Study|Adverse Event|0|||
170588512|NCT03334851|616500057|FG009|Overall Study|Adverse Event|0|||
170588513|NCT03334851|616500058|FG010|Overall Study|Adverse Event|0|||
170588514|NCT03334851|616500059|FG011|Overall Study|Adverse Event|0|||
170588515|NCT03334851|616500060|FG012|Overall Study|Adverse Event|0|||
170588516|NCT03334851|616500048|FG000|Overall Study|Withdrawal by Subject|0|||
170588517|NCT03334851|616500049|FG001|Overall Study|Withdrawal by Subject|0|||
170588518|NCT03334851|616500050|FG002|Overall Study|Withdrawal by Subject|0|||
170588519|NCT03334851|616500051|FG003|Overall Study|Withdrawal by Subject|0|||
170588520|NCT03334851|616500052|FG004|Overall Study|Withdrawal by Subject|0|||
170588521|NCT03334851|616500053|FG005|Overall Study|Withdrawal by Subject|0|||
170588522|NCT03334851|616500054|FG006|Overall Study|Withdrawal by Subject|0|||
170588523|NCT03334851|616500055|FG007|Overall Study|Withdrawal by Subject|0|||
170588524|NCT03334851|616500056|FG008|Overall Study|Withdrawal by Subject|0|||
170588525|NCT03334851|616500057|FG009|Overall Study|Withdrawal by Subject|0|||
170588526|NCT03334851|616500058|FG010|Overall Study|Withdrawal by Subject|1|||
170588527|NCT03334851|616500059|FG011|Overall Study|Withdrawal by Subject|0|||
170588528|NCT03334851|616500060|FG012|Overall Study|Withdrawal by Subject|1|||
170588529|NCT03334851|616500048|FG000|Overall Study|Lost to Follow-up|0|||
170588530|NCT03334851|616500049|FG001|Overall Study|Lost to Follow-up|0|||
170588531|NCT03334851|616500050|FG002|Overall Study|Lost to Follow-up|0|||
170588532|NCT03334851|616500051|FG003|Overall Study|Lost to Follow-up|0|||
170588533|NCT03334851|616500052|FG004|Overall Study|Lost to Follow-up|0|||
170588534|NCT03334851|616500053|FG005|Overall Study|Lost to Follow-up|0|||
170588535|NCT03334851|616500054|FG006|Overall Study|Lost to Follow-up|0|||
170588536|NCT03334851|616500055|FG007|Overall Study|Lost to Follow-up|0|||
170810306|NCT01072149|617315539|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170588537|NCT03334851|616500056|FG008|Overall Study|Lost to Follow-up|0|||
170588538|NCT03334851|616500057|FG009|Overall Study|Lost to Follow-up|0|||
170588539|NCT03334851|616500058|FG010|Overall Study|Lost to Follow-up|2|||
170588540|NCT03334851|616500059|FG011|Overall Study|Lost to Follow-up|1|||
170588541|NCT03334851|616500060|FG012|Overall Study|Lost to Follow-up|0|||
170588542|NCT03555981|616500061|FG000|Overall Study|Lost to Follow-up|0|||
170588543|NCT03555981|616500062|FG001|Overall Study|Lost to Follow-up|2|||
170588544|NCT00543803|616500064|FG000|Overall Study|Adverse Event|14|||
170588545|NCT00543803|616500064|FG000|Overall Study|Lack of Efficacy|22|||
170588546|NCT00543803|616500064|FG000|Overall Study|Lost to Follow-up|20|||
170588547|NCT00543803|616500064|FG000|Overall Study|Other|86|||
170588548|NCT00939029|616500065|FG000|Overall Study|Withdrawal by Subject|3|||
170588549|NCT00939029|616500066|FG001|Overall Study|Withdrawal by Subject|7|||
170588550|NCT00939029|616500065|FG000|Overall Study|Lost to Follow-up|3|||
170588551|NCT00939029|616500066|FG001|Overall Study|Lost to Follow-up|4|||
170588552|NCT00939029|616500065|FG000|Overall Study|Adverse Event|0|||
170588553|NCT00939029|616500066|FG001|Overall Study|Adverse Event|1|||
170588554|NCT00396136|616500067|FG000|Overall Study|Death|43|||
170588555|NCT00396136|616500067|FG000|Overall Study|Withdrawal by Subject|59|||
170588556|NCT00396136|616500067|FG000|Overall Study|Lost to Follow-up|15|||
170588557|NCT00396136|616500067|FG000|Overall Study|Study device explanted|8|||
170588558|NCT04686084|616500069|FG000|Overall Study|Lost to Follow-up|1|||
170588559|NCT01535599|616500071|FG000|Overall Study|Adverse Event|6|||
170588560|NCT01535599|616500072|FG001|Overall Study|Adverse Event|15|||
170588561|NCT01535599|616500071|FG000|Overall Study|Lost to Follow-up|3|||
170588562|NCT01535599|616500072|FG001|Overall Study|Lost to Follow-up|4|||
170588563|NCT01535599|616500071|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
170588564|NCT01535599|616500072|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
170588565|NCT01535599|616500071|FG000|Overall Study|Treatment Failure|33|||
170588566|NCT01535599|616500072|FG001|Overall Study|Treatment Failure|66|||
170588567|NCT01535599|616500071|FG000|Overall Study|BL Culture + for Group A Strep|0|||
170588568|NCT01535599|616500072|FG001|Overall Study|BL Culture + for Group A Strep|1|||
170588569|NCT01535599|616500071|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
170588570|NCT01535599|616500072|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
170588571|NCT01535599|616500071|FG000|Overall Study|Randomized in Error|2|||
170588572|NCT01535599|616500072|FG001|Overall Study|Randomized in Error|4|||
170588573|NCT01535599|616500071|FG000|Overall Study|Did not use product|1|||
170588574|NCT01535599|616500072|FG001|Overall Study|Did not use product|0|||
170588575|NCT01535599|616500071|FG000|Overall Study|Other|1|||
170588576|NCT01535599|616500072|FG001|Overall Study|Other|0|||
170588577|NCT01535599|616500071|FG000|Overall Study|Stopped medication|0|||
170588578|NCT01535599|616500072|FG001|Overall Study|Stopped medication|1|||
170588579|NCT01535599|616500071|FG000|Overall Study|Noncompliance|0|||
170588580|NCT01535599|616500072|FG001|Overall Study|Noncompliance|1|||
170588581|NCT03350256|616500073|FG000|Overall Study|Inclusion/exclusion violation|4|||
170588582|NCT03350256|616500073|FG000|Overall Study|Recommended for other therapies|2|||
170588583|NCT03350256|616500073|FG000|Overall Study|Protocol Violation|3|||
170588584|NCT03350256|616500073|FG000|Overall Study|Non compliance|2|||
170588585|NCT03350256|616500073|FG000|Overall Study|Denial by insurance|1|||
170588586|NCT03350256|616500073|FG000|Overall Study|Adverse Event|2|||
170588587|NCT03350256|616500073|FG000|Overall Study|Trial failure|12|||
170588588|NCT03350256|616500073|FG000|Overall Study|Did not proceed to permanent implant|3|||
170588589|NCT03350256|616500073|FG000|Overall Study|Withdrawal by Subject|3|||
170588590|NCT03350256|616500073|FG000|Overall Study|Subject moving out of state|1|||
170588591|NCT03350256|616500073|FG000|Overall Study|Lost to Follow-up|1|||
170588592|NCT03350256|616500073|FG000|Overall Study|Lack of Efficacy|2|||
170588593|NCT01425359|616500074|FG000|Overall Study|Randomized but Not Treated|2|||
170588594|NCT01425359|616500075|FG001|Overall Study|Randomized but Not Treated|3|||
170810307|NCT01072149|617315540|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170588595|NCT01425359|616500074|FG000|Overall Study|Adverse Event|9|||
170588596|NCT01425359|616500075|FG001|Overall Study|Adverse Event|8|||
170588597|NCT01425359|616500074|FG000|Overall Study|Revascularization|0|||
170588598|NCT01425359|616500075|FG001|Overall Study|Revascularization|1|||
170588599|NCT01425359|616500074|FG000|Overall Study|Death|0|||
170588600|NCT01425359|616500075|FG001|Overall Study|Death|1|||
170588601|NCT01425359|616500074|FG000|Overall Study|Unsatisfactory Response|1|||
170588602|NCT01425359|616500075|FG001|Overall Study|Unsatisfactory Response|0|||
170588603|NCT01425359|616500074|FG000|Overall Study|Protocol Violation|1|||
170588604|NCT01425359|616500075|FG001|Overall Study|Protocol Violation|2|||
170588605|NCT01425359|616500074|FG000|Overall Study|Subject Withdrew Consent|1|||
170588606|NCT01425359|616500075|FG001|Overall Study|Subject Withdrew Consent|2|||
170588607|NCT01425359|616500074|FG000|Overall Study|Investigator's Discretion|2|||
170588608|NCT01425359|616500075|FG001|Overall Study|Investigator's Discretion|0|||
170588609|NCT01425359|616500074|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
170588610|NCT01425359|616500075|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
170588611|NCT00666588|616500078|FG000|Overall Study|ineligible|2|||
170588612|NCT00666588|616500079|FG001|Overall Study|ineligible|0|||
170588613|NCT00666588|616500080|FG002|Overall Study|ineligible|0|||
170588614|NCT00666588|616500081|FG003|Overall Study|ineligible|2|||
170588615|NCT00666588|616500078|FG000|Overall Study|inevaluable|2|||
170588616|NCT00666588|616500079|FG001|Overall Study|inevaluable|0|||
170588617|NCT00666588|616500080|FG002|Overall Study|inevaluable|0|||
170588618|NCT00666588|616500081|FG003|Overall Study|inevaluable|0|||
170588619|NCT03172325|616500085|FG000|Overall Study|Adverse Event|2|||
170588620|NCT03172325|616500086|FG001|Overall Study|Adverse Event|3|||
170588621|NCT03172325|616500085|FG000|Overall Study|Positive PPD|1|||
170588622|NCT03172325|616500086|FG001|Overall Study|Positive PPD|0|||
170588623|NCT03172325|616500085|FG000|Overall Study|Poor Compliance|1|||
170588624|NCT03172325|616500086|FG001|Overall Study|Poor Compliance|1|||
170588625|NCT00823212|616500088|FG000|Overall Study|Death|8|||
170588626|NCT00823212|616500089|FG001|Overall Study|Death|10|||
170588627|NCT00823212|616500088|FG000|Overall Study|Withdrawal by Subject|6|||
170588628|NCT00823212|616500089|FG001|Overall Study|Withdrawal by Subject|1|||
170810308|NCT01072149|617315541|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
170588629|NCT00823212|616500088|FG000|Overall Study|Incarcerated|0|||
170588630|NCT00823212|616500089|FG001|Overall Study|Incarcerated|1|||
170588631|NCT00823212|616500088|FG000|Overall Study|Missed 12-month visit|21|||
170588632|NCT00823212|616500089|FG001|Overall Study|Missed 12-month visit|21|||
170588633|NCT01694121|616500090|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
170588634|NCT01694121|616500091|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
170588635|NCT00791479|616500095|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
170588636|NCT00791479|616500096|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
170588637|NCT00791479|616500097|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
170588638|NCT00791479|616500098|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
170588639|NCT00791479|616500099|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
170588640|NCT00791479|616500100|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
170588641|NCT00791479|616500095|FG000|Overall Study|Adverse Event|0|||
170588642|NCT00791479|616500096|FG001|Overall Study|Adverse Event|1|||
170588643|NCT00791479|616500097|FG002|Overall Study|Adverse Event|0|||
170588644|NCT00791479|616500098|FG003|Overall Study|Adverse Event|2|||
170588645|NCT00791479|616500099|FG004|Overall Study|Adverse Event|0|||
170588646|NCT00791479|616500100|FG005|Overall Study|Adverse Event|1|||
170588647|NCT00791479|616500095|FG000|Overall Study|Lost to Follow-up|0|||
170588648|NCT00791479|616500096|FG001|Overall Study|Lost to Follow-up|1|||
170588649|NCT00791479|616500097|FG002|Overall Study|Lost to Follow-up|0|||
170588650|NCT00791479|616500098|FG003|Overall Study|Lost to Follow-up|0|||
170588651|NCT00791479|616500099|FG004|Overall Study|Lost to Follow-up|0|||
170588652|NCT00791479|616500100|FG005|Overall Study|Lost to Follow-up|1|||
170588653|NCT00791479|616500095|FG000|Overall Study|Protocol Violation|2|||
170588654|NCT00791479|616500096|FG001|Overall Study|Protocol Violation|1|||
170588655|NCT00791479|616500097|FG002|Overall Study|Protocol Violation|0|||
170588656|NCT00791479|616500098|FG003|Overall Study|Protocol Violation|1|||
170588657|NCT00791479|616500099|FG004|Overall Study|Protocol Violation|0|||
170588658|NCT00791479|616500100|FG005|Overall Study|Protocol Violation|0|||
170588659|NCT00791479|616500095|FG000|Overall Study|Withdrawal by Subject|0|||
170588660|NCT00791479|616500096|FG001|Overall Study|Withdrawal by Subject|0|||
170588661|NCT00791479|616500097|FG002|Overall Study|Withdrawal by Subject|0|||
170588662|NCT00791479|616500098|FG003|Overall Study|Withdrawal by Subject|1|||
170588663|NCT00791479|616500099|FG004|Overall Study|Withdrawal by Subject|0|||
170588664|NCT00791479|616500100|FG005|Overall Study|Withdrawal by Subject|1|||
170588665|NCT01778049|616500101|FG000|Open Label Treatment Period|Adverse Event|5|||
170588666|NCT01778049|616500102|FG001|Open Label Treatment Period|Adverse Event|15|||
170588667|NCT01778049|616500103|FG002|Open Label Treatment Period|Adverse Event|0|||
170588668|NCT01778049|616500104|FG003|Open Label Treatment Period|Adverse Event|0|||
170588669|NCT01778049|616500105|FG004|Open Label Treatment Period|Adverse Event|0|||
170588670|NCT01778049|616500106|FG005|Open Label Treatment Period|Adverse Event|0|||
170588671|NCT01778049|616500101|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
170588672|NCT01778049|616500102|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
170588673|NCT01778049|616500103|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
170588674|NCT01778049|616500104|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
170588675|NCT01778049|616500105|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
170588676|NCT01778049|616500106|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
170588677|NCT01778049|616500101|FG000|Open Label Treatment Period|Protocol Violation|5|||
170588678|NCT01778049|616500102|FG001|Open Label Treatment Period|Protocol Violation|5|||
170588679|NCT01778049|616500103|FG002|Open Label Treatment Period|Protocol Violation|0|||
170588680|NCT01778049|616500104|FG003|Open Label Treatment Period|Protocol Violation|0|||
170588681|NCT01778049|616500105|FG004|Open Label Treatment Period|Protocol Violation|0|||
170588682|NCT01778049|616500106|FG005|Open Label Treatment Period|Protocol Violation|0|||
170588683|NCT01778049|616500101|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
170588684|NCT01778049|616500102|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
170588685|NCT01778049|616500103|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
170588686|NCT01778049|616500104|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
170588687|NCT01778049|616500105|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
170588688|NCT01778049|616500106|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
170588689|NCT01778049|616500101|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
170588690|NCT01778049|616500102|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
170588691|NCT01778049|616500103|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
170588692|NCT01778049|616500104|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
170588693|NCT01778049|616500105|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
170588694|NCT01778049|616500106|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
170588695|NCT01778049|616500101|FG000|Open Label Treatment Period|Not treated|2|||
170588696|NCT01778049|616500102|FG001|Open Label Treatment Period|Not treated|1|||
170588697|NCT01778049|616500103|FG002|Open Label Treatment Period|Not treated|0|||
170588698|NCT01778049|616500104|FG003|Open Label Treatment Period|Not treated|0|||
170588699|NCT01778049|616500105|FG004|Open Label Treatment Period|Not treated|0|||
170588700|NCT01778049|616500106|FG005|Open Label Treatment Period|Not treated|0|||
170588701|NCT01778049|616500101|FG000|Open Label Treatment Period|Other reason not defined above|77|||
170588702|NCT01778049|616500102|FG001|Open Label Treatment Period|Other reason not defined above|94|||
170588703|NCT01778049|616500103|FG002|Open Label Treatment Period|Other reason not defined above|0|||
170588704|NCT01778049|616500104|FG003|Open Label Treatment Period|Other reason not defined above|0|||
170588705|NCT01778049|616500105|FG004|Open Label Treatment Period|Other reason not defined above|0|||
170588706|NCT01778049|616500106|FG005|Open Label Treatment Period|Other reason not defined above|0|||
170588707|NCT01778049|616500101|FG000|Double Blind Treatment Period|Adverse Event|0|||
170588708|NCT01778049|616500102|FG001|Double Blind Treatment Period|Adverse Event|0|||
170588709|NCT01778049|616500103|FG002|Double Blind Treatment Period|Adverse Event|4|||
170588710|NCT01778049|616500104|FG003|Double Blind Treatment Period|Adverse Event|5|||
170588711|NCT01778049|616500105|FG004|Double Blind Treatment Period|Adverse Event|3|||
170588712|NCT01778049|616500106|FG005|Double Blind Treatment Period|Adverse Event|2|||
170588713|NCT01778049|616500101|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
170588714|NCT01778049|616500102|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
170588715|NCT01778049|616500103|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
170588716|NCT01778049|616500104|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
170588717|NCT01778049|616500105|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
170588718|NCT01778049|616500106|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
170588719|NCT01778049|616500101|FG000|Double Blind Treatment Period|Protocol Violation|0|||
170588720|NCT01778049|616500102|FG001|Double Blind Treatment Period|Protocol Violation|0|||
170588721|NCT01778049|616500103|FG002|Double Blind Treatment Period|Protocol Violation|2|||
170588722|NCT01778049|616500104|FG003|Double Blind Treatment Period|Protocol Violation|0|||
170588723|NCT01778049|616500105|FG004|Double Blind Treatment Period|Protocol Violation|0|||
170588724|NCT01778049|616500106|FG005|Double Blind Treatment Period|Protocol Violation|0|||
170588725|NCT01778049|616500101|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
170588726|NCT01778049|616500102|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
170588727|NCT01778049|616500103|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
170588728|NCT01778049|616500104|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
170588729|NCT01778049|616500105|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
170588730|NCT01778049|616500106|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
170588731|NCT01778049|616500101|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
170588732|NCT01778049|616500102|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
170588733|NCT01778049|616500103|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
170588734|NCT01778049|616500104|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
170588735|NCT01778049|616500105|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
170588736|NCT01778049|616500106|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
170588737|NCT01778049|616500101|FG000|Double Blind Treatment Period|Not treated|0|||
170588738|NCT01778049|616500102|FG001|Double Blind Treatment Period|Not treated|0|||
170588739|NCT01778049|616500103|FG002|Double Blind Treatment Period|Not treated|0|||
170588740|NCT01778049|616500104|FG003|Double Blind Treatment Period|Not treated|2|||
170588741|NCT01778049|616500105|FG004|Double Blind Treatment Period|Not treated|2|||
170588742|NCT01778049|616500106|FG005|Double Blind Treatment Period|Not treated|0|||
170588743|NCT01778049|616500101|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
170588744|NCT01778049|616500102|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
170588745|NCT01778049|616500103|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
170588746|NCT01778049|616500104|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
170588747|NCT01778049|616500105|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
170588748|NCT01778049|616500106|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
170588749|NCT02285114|616500107|FG000|Main Phase|Investigator's Discretion|0|||
170588750|NCT02285114|616500108|FG001|Main Phase|Investigator's Discretion|2|||
170588751|NCT02285114|616500109|FG002|Main Phase|Investigator's Discretion|0|||
170588752|NCT02285114|616500110|FG003|Main Phase|Investigator's Discretion|0|||
170588753|NCT02285114|616500111|FG004|Main Phase|Investigator's Discretion|0|||
170588754|NCT02285114|616500112|FG005|Main Phase|Investigator's Discretion|0|||
170588755|NCT02285114|616500107|FG000|Main Phase|Enrolled but Never Treated|1|||
170588756|NCT02285114|616500108|FG001|Main Phase|Enrolled but Never Treated|0|||
170588757|NCT02285114|616500109|FG002|Main Phase|Enrolled but Never Treated|0|||
170588758|NCT02285114|616500110|FG003|Main Phase|Enrolled but Never Treated|0|||
170588759|NCT02285114|616500111|FG004|Main Phase|Enrolled but Never Treated|0|||
170588760|NCT02285114|616500112|FG005|Main Phase|Enrolled but Never Treated|0|||
170588761|NCT02285114|616500107|FG000|Main Phase|Withdrew Consent|0|||
170588762|NCT02285114|616500108|FG001|Main Phase|Withdrew Consent|0|||
170588763|NCT02285114|616500109|FG002|Main Phase|Withdrew Consent|1|||
170588764|NCT02285114|616500110|FG003|Main Phase|Withdrew Consent|0|||
170588765|NCT02285114|616500111|FG004|Main Phase|Withdrew Consent|0|||
170588766|NCT02285114|616500112|FG005|Main Phase|Withdrew Consent|0|||
170588767|NCT02285114|616500107|FG000|Extension Phase|Investigator's Discretion|0|||
170588768|NCT02285114|616500108|FG001|Extension Phase|Investigator's Discretion|0|||
170810309|NCT01072149|617315524|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810310|NCT01072149|617315525|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810311|NCT01072149|617315526|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810312|NCT01072149|617315527|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810313|NCT01072149|617315528|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810314|NCT01072149|617315529|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
170588769|NCT02285114|616500109|FG002|Extension Phase|Investigator's Discretion|0|||
170588770|NCT02285114|616500110|FG003|Extension Phase|Investigator's Discretion|14|||
170588771|NCT02285114|616500111|FG004|Extension Phase|Investigator's Discretion|1|||
170588772|NCT02285114|616500112|FG005|Extension Phase|Investigator's Discretion|0|||
170588773|NCT02285114|616500107|FG000|Extension Phase|Lost to Follow-up|0|||
170588774|NCT02285114|616500108|FG001|Extension Phase|Lost to Follow-up|0|||
170588775|NCT02285114|616500109|FG002|Extension Phase|Lost to Follow-up|0|||
170588776|NCT02285114|616500110|FG003|Extension Phase|Lost to Follow-up|1|||
170588777|NCT02285114|616500111|FG004|Extension Phase|Lost to Follow-up|1|||
170588778|NCT02285114|616500112|FG005|Extension Phase|Lost to Follow-up|0|||
170588779|NCT02285114|616500107|FG000|Extension Phase|Non-compliance with Study Drug|0|||
170588780|NCT02285114|616500108|FG001|Extension Phase|Non-compliance with Study Drug|0|||
170588781|NCT02285114|616500109|FG002|Extension Phase|Non-compliance with Study Drug|0|||
170588782|NCT02285114|616500110|FG003|Extension Phase|Non-compliance with Study Drug|2|||
170588783|NCT02285114|616500111|FG004|Extension Phase|Non-compliance with Study Drug|0|||
170588784|NCT02285114|616500112|FG005|Extension Phase|Non-compliance with Study Drug|0|||
170588785|NCT02285114|616500107|FG000|Extension Phase|Pregnancy|0|||
170588786|NCT02285114|616500108|FG001|Extension Phase|Pregnancy|0|||
170588787|NCT02285114|616500109|FG002|Extension Phase|Pregnancy|0|||
170588788|NCT02285114|616500110|FG003|Extension Phase|Pregnancy|1|||
170588789|NCT02285114|616500111|FG004|Extension Phase|Pregnancy|0|||
170588790|NCT02285114|616500112|FG005|Extension Phase|Pregnancy|0|||
170588791|NCT04979897|616500117|FG000|Overall Study|Death|1|||
170588792|NCT04979897|616500118|FG001|Overall Study|Death|8|||
170588793|NCT04979897|616500117|FG000|Overall Study|Lost to Follow-up|111|||
170588794|NCT04979897|616500118|FG001|Overall Study|Lost to Follow-up|56|||
170588795|NCT04979897|616500117|FG000|Overall Study|Withdrawal by Subject|7|||
170588796|NCT04979897|616500118|FG001|Overall Study|Withdrawal by Subject|2|||
170588797|NCT03405935|616500119|FG000|Overall Study|Adverse Event|3|||
170588798|NCT03405935|616500119|FG000|Overall Study|Death|2|||
170588799|NCT03405935|616500119|FG000|Overall Study|Withdrawal by Subject|1|||
170588800|NCT03405935|616500119|FG000|Overall Study|Lost to Follow-up|2|||
170588801|NCT01774097|616500125|FG000|Overall Study|Withdrawal by Subject|1|||
170588802|NCT01774097|616500126|FG001|Overall Study|Withdrawal by Subject|1|||
170588803|NCT01774097|616500125|FG000|Overall Study|Adverse Event|1|||
170588804|NCT01774097|616500126|FG001|Overall Study|Adverse Event|1|||
170588805|NCT00934947|616500129|FG000|Overall Study|Adverse Event|0|||
170588806|NCT00934947|616500130|FG001|Overall Study|Adverse Event|2|||
170588807|NCT00557310|616500131|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
170588808|NCT00557310|616500131|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
170588809|NCT00557310|616500131|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
170588810|NCT00557310|616500131|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
170588811|NCT00557310|616500131|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
170588812|NCT00557310|616500131|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
170588813|NCT03276026|616500137|FG000|Overall Study|Protocol Violation|1|||
170588814|NCT03276026|616500138|FG001|Overall Study|Protocol Violation|0|||
170588815|NCT03650803|616500139|FG000|Overall Study|Lost to Follow-up|6|||
170588816|NCT01639339|616500142|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
170588817|NCT01639339|616500143|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
170588818|NCT01639339|616500142|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
170588819|NCT01639339|616500143|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
170588820|NCT01639339|616500142|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
170588821|NCT01639339|616500143|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
170650137|NCT00439738|616732839|FG001|Overall Study|Withdrawal by Subject|13|||
170650138|NCT00439738|616732838|FG000|Overall Study|Adverse Event|6|||
170650139|NCT00439738|616732839|FG001|Overall Study|Adverse Event|4|||
170650140|NCT00439738|616732838|FG000|Overall Study|Lost to Follow-up|5|||
170650141|NCT00439738|616732839|FG001|Overall Study|Lost to Follow-up|6|||
170588822|NCT01639339|616500142|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
170588823|NCT01639339|616500143|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
170588824|NCT01639339|616500142|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
170650142|NCT00439738|616732838|FG000|Overall Study|Protocol Violation|6|||
170810315|NCT01072149|617315530|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
170588825|NCT01639339|616500143|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
170588826|NCT01639339|616500142|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
170588827|NCT01639339|616500143|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
170588828|NCT01639339|616500142|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
170588829|NCT01639339|616500143|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
170650143|NCT00439738|616732839|FG001|Overall Study|Protocol Violation|3|||
170588830|NCT01639339|616500142|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
170810316|NCT01072149|617315531|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
170810317|NCT01072149|617315532|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
170588831|NCT01639339|616500143|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
170650144|NCT00439738|616732838|FG000|Overall Study|Lack of Efficacy|2|||
170650145|NCT00439738|616732839|FG001|Overall Study|Lack of Efficacy|2|||
170588832|NCT01639339|616500142|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
170588833|NCT01639339|616500143|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
170588834|NCT01639339|616500142|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
170588835|NCT01639339|616500143|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
170588836|NCT02649218|616500144|FG000|Overall Study|Adverse Event|8|||
170588837|NCT02649218|616500144|FG000|Overall Study|Lack of Efficacy|8|||
170588838|NCT02649218|616500144|FG000|Overall Study|Pregnancy|3|||
170588839|NCT02649218|616500144|FG000|Overall Study|Protocol Violation|3|||
170588840|NCT02649218|616500144|FG000|Overall Study|Physician Decision|1|||
170588841|NCT02649218|616500144|FG000|Overall Study|Withdrawal by Subject|2|||
170588842|NCT01170598|616500145|FG000|Overall Study|Withdrawal by Subject|1|||
170588843|NCT01170598|616500145|FG000|Overall Study|Death|3|||
170588844|NCT01170598|616500145|FG000|Overall Study|Lost to Follow-up|1|||
170588845|NCT01170598|616500145|FG000|Overall Study|Refused|1|||
170588846|NCT03894969|616500146|FG000|Overall Study|Adverse Event|0|||
170588847|NCT03894969|616500147|FG001|Overall Study|Adverse Event|2|||
170588848|NCT03894969|616500148|FG002|Overall Study|Adverse Event|0|||
170588849|NCT03894969|616500149|FG003|Overall Study|Adverse Event|1|||
170588850|NCT03894969|616500150|FG004|Overall Study|Adverse Event|2|||
170588851|NCT03894969|616500146|FG000|Overall Study|Lost to Follow-up|3|||
170588852|NCT03894969|616500147|FG001|Overall Study|Lost to Follow-up|1|||
170588853|NCT03894969|616500148|FG002|Overall Study|Lost to Follow-up|1|||
170588854|NCT03894969|616500149|FG003|Overall Study|Lost to Follow-up|0|||
170650146|NCT00439738|616732838|FG000|Overall Study|Abnormal Lab Values|1|||
170650147|NCT00439738|616732839|FG001|Overall Study|Abnormal Lab Values|0|||
170650148|NCT02650921|616732845|FG000|Overall Study|Withdrawal by Subject|4|||
170650149|NCT02650921|616732845|FG000|Overall Study|Lost to Follow-up|2|||
170650150|NCT02650921|616732845|FG000|Overall Study|Adverse Event|1|||
170650151|NCT02650921|616732845|FG000|Overall Study|Due to Medical Condition|1|||
170650152|NCT00783302|616732846|FG000|Overall Study|Lost to Follow-up|17|||
170650153|NCT00783302|616732846|FG000|Overall Study|Technical Problems|11|||
170810318|NCT01072149|617315533|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810319|NCT01072149|617315534|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810320|NCT01072149|617315535|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810321|NCT01072149|617315536|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810322|NCT01072149|617315537|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810323|NCT01072149|617315538|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810324|NCT01072149|617315539|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810325|NCT01072149|617315540|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810326|NCT01072149|617315541|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
170810327|NCT01072149|617315524|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
170810328|NCT01072149|617315525|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
170810329|NCT01072149|617315526|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
170911008|NCT02973815|617677340|FG000|Post Intervention|Lost to Follow-up|7|||
170911009|NCT02973815|617677341|FG001|Post Intervention|Lost to Follow-up|24|||
170911010|NCT02973815|617677340|FG000|Follow-up|Lost to Follow-up|2|||
170911011|NCT02973815|617677341|FG001|Follow-up|Lost to Follow-up|0|||
170911012|NCT05176847|617679039|FG000|Overall Study|Lost to Follow-up|23|||
170911013|NCT05176847|617679040|FG001|Overall Study|Lost to Follow-up|36|||
170911014|NCT05176847|617679039|FG000|Overall Study|Withdrawal by Subject|7|||
170911015|NCT05176847|617679040|FG001|Overall Study|Withdrawal by Subject|12|||
170911016|NCT05176847|617679039|FG000|Overall Study|Removed from analysis|1|||
170911017|NCT05176847|617679040|FG001|Overall Study|Removed from analysis|0|||
170911018|NCT01266148|617679041|FG000|Overall Study|Adverse Event|2|||
170911019|NCT01266148|617679042|FG001|Overall Study|Adverse Event|0|||
170911020|NCT01266148|617679041|FG000|Overall Study|Ongoing rejection|1|||
170911021|NCT01266148|617679042|FG001|Overall Study|Ongoing rejection|0|||
170911022|NCT01266148|617679041|FG000|Overall Study|2 2R rejections|1|||
170911023|NCT01266148|617679042|FG001|Overall Study|2 2R rejections|0|||
170911024|NCT01266148|617679041|FG000|Overall Study|Death|2|||
170911025|NCT01266148|617679042|FG001|Overall Study|Death|3|||
170911026|NCT01266148|617679041|FG000|Overall Study|missing mGFR value + AE|1|||
170911027|NCT01266148|617679042|FG001|Overall Study|missing mGFR value + AE|0|||
170911028|NCT01712438|617679043|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
170911029|NCT01712438|617679043|FG000|Overall Study|Ongoing ITI treatment|6|||
170911030|NCT01712438|617679043|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
170911031|NCT01712438|617679043|FG000|Overall Study|Prematurely Discontinued|25|||
170911032|NCT01981122|617679044|FG000|Overall Study|Withdrawal by Subject|0|||
170911033|NCT01981122|617679045|FG001|Overall Study|Withdrawal by Subject|2|||
170911034|NCT01981122|617679044|FG000|Overall Study|Protocol Violation|0|||
170911035|NCT01981122|617679045|FG001|Overall Study|Protocol Violation|1|||
170588855|NCT03894969|616500150|FG004|Overall Study|Lost to Follow-up|0|||
170588856|NCT03894969|616500146|FG000|Overall Study|Withdrawal by Subject|2|||
170588857|NCT03894969|616500147|FG001|Overall Study|Withdrawal by Subject|1|||
170650154|NCT00783302|616732846|FG000|Overall Study|Protocol Violation|3|||
170588858|NCT03894969|616500148|FG002|Overall Study|Withdrawal by Subject|3|||
170650155|NCT00783302|616732846|FG000|Overall Study|Physician Decision|1|||
170911036|NCT01981122|617679044|FG000|Overall Study|Lost to Follow-up|0|||
170911037|NCT01981122|617679045|FG001|Overall Study|Lost to Follow-up|1|||
170911038|NCT01981122|617679044|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
170911039|NCT01981122|617679045|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
170911040|NCT01981122|617679044|FG000|Overall Study|Death|14|||
170911041|NCT01981122|617679045|FG001|Overall Study|Death|15|||
170911042|NCT00089843|617679051|FG000|Overall Study|Withdrawal by Subject|1|||
170911043|NCT00089843|617679052|FG001|Overall Study|Withdrawal by Subject|4|||
170911044|NCT00089843|617679053|FG002|Overall Study|Withdrawal by Subject|5|||
170911045|NCT00089843|617679054|FG003|Overall Study|Withdrawal by Subject|6|||
170911046|NCT00089843|617679051|FG000|Overall Study|Physician Decision|1|||
170911047|NCT00089843|617679052|FG001|Overall Study|Physician Decision|0|||
170911048|NCT00089843|617679053|FG002|Overall Study|Physician Decision|0|||
170911049|NCT00089843|617679054|FG003|Overall Study|Physician Decision|1|||
170911050|NCT02413255|617679057|FG000|Overall Study|Voluntary Withdrawal|0|||
170911051|NCT02413255|617679058|FG001|Overall Study|Voluntary Withdrawal|0|||
170911052|NCT02413255|617679059|FG002|Overall Study|Voluntary Withdrawal|0|||
170911053|NCT02413255|617679060|FG003|Overall Study|Voluntary Withdrawal|0|||
170911054|NCT02413255|617679061|FG004|Overall Study|Voluntary Withdrawal|0|||
170911055|NCT02413255|617679062|FG005|Overall Study|Voluntary Withdrawal|0|||
170911056|NCT02413255|617679063|FG006|Overall Study|Voluntary Withdrawal|0|||
170588859|NCT03894969|616500149|FG003|Overall Study|Withdrawal by Subject|4|||
170588860|NCT03894969|616500150|FG004|Overall Study|Withdrawal by Subject|8|||
170588861|NCT03894969|616500146|FG000|Overall Study|Other|0|||
170588862|NCT03894969|616500147|FG001|Overall Study|Other|0|||
170588863|NCT03894969|616500148|FG002|Overall Study|Other|0|||
170588864|NCT03894969|616500149|FG003|Overall Study|Other|0|||
170588865|NCT03894969|616500150|FG004|Overall Study|Other|3|||
170588866|NCT03894969|616500146|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
170911057|NCT02413255|617679064|FG007|Overall Study|Voluntary Withdrawal|0|||
170911058|NCT02413255|617679065|FG008|Overall Study|Voluntary Withdrawal|0|||
170911059|NCT02413255|617679066|FG009|Overall Study|Voluntary Withdrawal|0|||
170911060|NCT02413255|617679067|FG010|Overall Study|Voluntary Withdrawal|0|||
170911061|NCT02413255|617679068|FG011|Overall Study|Voluntary Withdrawal|0|||
170911062|NCT02413255|617679069|FG012|Overall Study|Voluntary Withdrawal|0|||
170911063|NCT02413255|617679070|FG013|Overall Study|Voluntary Withdrawal|0|||
170911064|NCT02413255|617679071|FG014|Overall Study|Voluntary Withdrawal|1|||
170911065|NCT02413255|617679072|FG015|Overall Study|Voluntary Withdrawal|0|||
170911066|NCT02413255|617679073|FG016|Overall Study|Voluntary Withdrawal|0|||
170911067|NCT00882713|617679076|FG000|Overall Study|Adverse Event|2|||
170911068|NCT00882713|617679076|FG000|Overall Study|Death|3|||
170911069|NCT00882713|617679076|FG000|Overall Study|Administrative reasons|4|||
170911070|NCT00882713|617679076|FG000|Overall Study|refused treatment/withdrew consent|4|||
170911071|NCT00882713|617679076|FG000|Overall Study|Blood transfusion|2|||
170911072|NCT00882713|617679076|FG000|Overall Study|Insufficient therapeutic response|3|||
170588867|NCT03894969|616500147|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
170650156|NCT00783302|616732846|FG000|Overall Study|Withdrawal by Subject|3|||
170650157|NCT01087788|616732847|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
170650158|NCT01087788|616732848|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
170650159|NCT01087788|616732849|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
170650160|NCT01087788|616732847|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
170650161|NCT01087788|616732848|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
170650162|NCT01087788|616732849|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
170650163|NCT01087788|616732847|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
170650164|NCT01087788|616732848|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
170650165|NCT01087788|616732849|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
170650166|NCT01087788|616732847|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
170650167|NCT01087788|616732848|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
170650168|NCT01087788|616732849|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
170650169|NCT01087788|616732847|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
170650170|NCT01087788|616732848|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
170650171|NCT01087788|616732849|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
170650172|NCT01087788|616732847|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
170588868|NCT03894969|616500148|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
170650173|NCT01087788|616732848|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
170650174|NCT01087788|616732849|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
170650175|NCT01087788|616732847|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
170911073|NCT00882713|617679076|FG000|Overall Study|Failure to return|2|||
170911074|NCT00882713|617679076|FG000|Overall Study|Other - Reasons|2|||
170911075|NCT05523362|617679079|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
170911076|NCT05523362|617679079|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
170911077|NCT05523362|617679079|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
170911078|NCT05523362|617679079|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
170911079|NCT02584634|617679080|FG000|Overall Study|Adverse Event|3|||
170588869|NCT03894969|616500149|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
170588870|NCT03894969|616500150|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
170588871|NCT03894969|616500146|FG000|Overall Study|Solicited Adverse Event|0|||
170588872|NCT03894969|616500147|FG001|Overall Study|Solicited Adverse Event|1|||
170588873|NCT03894969|616500148|FG002|Overall Study|Solicited Adverse Event|0|||
170588874|NCT03894969|616500149|FG003|Overall Study|Solicited Adverse Event|0|||
170588875|NCT03894969|616500150|FG004|Overall Study|Solicited Adverse Event|0|||
170588876|NCT00230282|616500151|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
170588877|NCT00230282|616500151|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
170588878|NCT00230282|616500151|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
170588879|NCT00230282|616500151|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
170588880|NCT06107803|616500152|FG000|Overall Study|Adverse Event|1|||
170588881|NCT06107803|616500152|FG000|Overall Study|Withdrawal by Subject|2|||
170588882|NCT06107803|616500152|FG000|Overall Study|Protocol Violation|1|||
170588883|NCT03099174|616500154|FG000|Overall Study|Withdrawal by Subject|0|||
170588884|NCT03099174|616500155|FG001|Overall Study|Withdrawal by Subject|0|||
170588885|NCT03099174|616500156|FG002|Overall Study|Withdrawal by Subject|1|||
170588886|NCT03099174|616500157|FG003|Overall Study|Withdrawal by Subject|0|||
170588887|NCT03099174|616500158|FG004|Overall Study|Withdrawal by Subject|2|||
170588888|NCT03099174|616500159|FG005|Overall Study|Withdrawal by Subject|2|||
170588889|NCT03099174|616500160|FG006|Overall Study|Withdrawal by Subject|1|||
170588890|NCT03099174|616500161|FG007|Overall Study|Withdrawal by Subject|4|||
170588891|NCT03099174|616500154|FG000|Overall Study|Adverse Event|0|||
170588892|NCT03099174|616500155|FG001|Overall Study|Adverse Event|1|||
170588893|NCT03099174|616500156|FG002|Overall Study|Adverse Event|1|||
170588894|NCT03099174|616500157|FG003|Overall Study|Adverse Event|2|||
170588895|NCT03099174|616500158|FG004|Overall Study|Adverse Event|5|||
170588896|NCT03099174|616500159|FG005|Overall Study|Adverse Event|3|||
170588897|NCT03099174|616500160|FG006|Overall Study|Adverse Event|6|||
170588898|NCT03099174|616500161|FG007|Overall Study|Adverse Event|4|||
170588899|NCT03099174|616500154|FG000|Overall Study|Other than listed|6|||
170588900|NCT03099174|616500155|FG001|Overall Study|Other than listed|6|||
170588901|NCT03099174|616500156|FG002|Overall Study|Other than listed|5|||
170588902|NCT03099174|616500157|FG003|Overall Study|Other than listed|6|||
170911080|NCT02584634|617679081|FG001|Overall Study|Adverse Event|5|||
170911081|NCT02584634|617679080|FG000|Overall Study|Death|0|||
170911082|NCT02584634|617679081|FG001|Overall Study|Death|1|||
170911083|NCT02584634|617679080|FG000|Overall Study|Lost to Follow-up|0|||
170911084|NCT02584634|617679081|FG001|Overall Study|Lost to Follow-up|1|||
170911085|NCT02584634|617679080|FG000|Overall Study|Physician Decision|1|||
170911086|NCT02584634|617679081|FG001|Overall Study|Physician Decision|2|||
170911087|NCT02584634|617679080|FG000|Overall Study|Progressive disease|7|||
170911088|NCT02584634|617679081|FG001|Overall Study|Progressive disease|15|||
170911089|NCT02584634|617679080|FG000|Overall Study|Withdrawal by Subject|1|||
170588903|NCT03099174|616500158|FG004|Overall Study|Other than listed|19|||
170588904|NCT03099174|616500159|FG005|Overall Study|Other than listed|10|||
170588905|NCT03099174|616500160|FG006|Overall Study|Other than listed|26|||
170588906|NCT03099174|616500161|FG007|Overall Study|Other than listed|23|||
170588907|NCT03070223|616500163|FG000|Overall Study|Lost to Follow-up|34|||
170588908|NCT03070223|616500164|FG001|Overall Study|Lost to Follow-up|27|||
170588909|NCT03070223|616500163|FG000|Overall Study|Withdrawal by Subject|12|||
170588910|NCT03070223|616500164|FG001|Overall Study|Withdrawal by Subject|22|||
170588911|NCT03070223|616500163|FG000|Overall Study|Protocol Violation|0|||
170588912|NCT03070223|616500164|FG001|Overall Study|Protocol Violation|1|||
170810330|NCT01072149|617315527|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
170810331|NCT01072149|617315528|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
170810332|NCT01072149|617315529|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
170810333|NCT01072149|617315530|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
170810334|NCT01072149|617315531|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
170810335|NCT01072149|617315532|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
170810336|NCT01072149|617315533|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
170810337|NCT01072149|617315534|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
170810338|NCT01072149|617315535|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
170810339|NCT01072149|617315536|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
170810340|NCT01072149|617315537|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
170810341|NCT01072149|617315538|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
170810342|NCT01072149|617315539|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
170810343|NCT01072149|617315540|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
170810344|NCT01072149|617315541|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
170810345|NCT01072149|617315524|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810346|NCT01072149|617315525|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810347|NCT01072149|617315526|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810348|NCT01072149|617315527|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810349|NCT01072149|617315528|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810350|NCT01072149|617315529|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170588913|NCT03219034|616500166|FG000|Overall Study|Lost to Follow-up|9|||
170911090|NCT02584634|617679081|FG001|Overall Study|Withdrawal by Subject|1|||
170911091|NCT02584634|617679080|FG000|Overall Study|Other|0|||
170911092|NCT02584634|617679081|FG001|Overall Study|Other|6|||
170911093|NCT04075604|617679082|FG000|Overall Study|Adverse Event|0|||
170911094|NCT04075604|617679083|FG001|Overall Study|Adverse Event|0|||
170911095|NCT04075604|617679084|FG002|Overall Study|Adverse Event|3|||
170911096|NCT04075604|617679082|FG000|Overall Study|Participant request to discontinue study treatment|0|||
170911097|NCT04075604|617679083|FG001|Overall Study|Participant request to discontinue study treatment|0|||
170911098|NCT04075604|617679084|FG002|Overall Study|Participant request to discontinue study treatment|1|||
170911099|NCT04075604|617679082|FG000|Overall Study|Participant withdrew consent|0|||
170911100|NCT04075604|617679083|FG001|Overall Study|Participant withdrew consent|0|||
170911101|NCT04075604|617679084|FG002|Overall Study|Participant withdrew consent|1|||
170911102|NCT04075604|617679082|FG000|Overall Study|Other reasons|1|||
170911103|NCT04075604|617679083|FG001|Overall Study|Other reasons|0|||
170911104|NCT04075604|617679084|FG002|Overall Study|Other reasons|0|||
170911105|NCT04075604|617679082|FG000|Overall Study|Disease progression|0|||
170911106|NCT04075604|617679083|FG001|Overall Study|Disease progression|1|||
170911107|NCT04075604|617679084|FG002|Overall Study|Disease progression|0|||
170911108|NCT04075604|617679082|FG000|Overall Study|Study drug toxicity|0|||
170911109|NCT04075604|617679083|FG001|Overall Study|Study drug toxicity|5|||
170911110|NCT04075604|617679084|FG002|Overall Study|Study drug toxicity|1|||
170911111|NCT02760602|617679085|FG000|Overall Study|Withdrawal by Subject|1|||
170911112|NCT02760602|617679086|FG001|Overall Study|Withdrawal by Subject|0|||
170911113|NCT02760602|617679085|FG000|Overall Study|Terminated by sponsor|12|||
170911114|NCT02760602|617679086|FG001|Overall Study|Terminated by sponsor|13|||
170911115|NCT02564120|617679091|FG000|Overall Study|Did not return release forms|160|||
170911116|NCT02564120|617679091|FG000|Overall Study|Death|58|||
170911117|NCT02564120|617679091|FG000|Overall Study|Withdrawal by Subject|204|||
170911118|NCT02564120|617679091|FG000|Overall Study|Other medical condition|24|||
170911119|NCT00791128|617679092|FG000|Overall Study|Adverse Event|4|||
170911120|NCT00791128|617679092|FG000|Overall Study|Device migration|2|||
170911121|NCT00791128|617679092|FG000|Overall Study|non-compliance by subject|2|||
170911122|NCT00791128|617679092|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
170911123|NCT01260181|617679093|FG000|Overall Study|Decision of Investigator|1|||
170911124|NCT03351244|617679094|FG000|Overall Study|Adverse Event|7|||
170911125|NCT03351244|617679095|FG001|Overall Study|Adverse Event|11|||
170588914|NCT03219034|616500167|FG001|Overall Study|Lost to Follow-up|13|||
170588915|NCT03219034|616500166|FG000|Overall Study|Additional dental work needed|1|||
170588916|NCT03219034|616500167|FG001|Overall Study|Additional dental work needed|0|||
170588917|NCT03219034|616500166|FG000|Overall Study|UPPP Surgery|1|||
170588918|NCT03219034|616500167|FG001|Overall Study|UPPP Surgery|0|||
170588919|NCT03219034|616500166|FG000|Overall Study|Dental sensitivity|0|||
170588920|NCT03219034|616500167|FG001|Overall Study|Dental sensitivity|1|||
170588921|NCT03219034|616500166|FG000|Overall Study|Death in family|0|||
170588922|NCT03219034|616500167|FG001|Overall Study|Death in family|1|||
170588923|NCT00118846|616500168|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
170588924|NCT00118846|616500169|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
170588925|NCT00118846|616500168|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
170588926|NCT00118846|616500169|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
170588927|NCT00118846|616500168|FG000|Overall Study|Physician Decision|1|||
170588928|NCT00118846|616500169|FG001|Overall Study|Physician Decision|0|||
170588929|NCT00118846|616500168|FG000|Overall Study|Medical condition|2|||
170588930|NCT00118846|616500169|FG001|Overall Study|Medical condition|2|||
170588931|NCT00118846|616500168|FG000|Overall Study|Lost to Follow-up|0|||
170588932|NCT00118846|616500169|FG001|Overall Study|Lost to Follow-up|2|||
170588933|NCT00118846|616500168|FG000|Overall Study|Personal reason|4|||
170588934|NCT00118846|616500169|FG001|Overall Study|Personal reason|5|||
170588935|NCT00443053|616500171|FG000|Overall Study|Adverse Event|2|||
170588936|NCT00443053|616500172|FG001|Overall Study|Adverse Event|1|||
170588937|NCT00443053|616500171|FG000|Overall Study|Withdrawal by Subject|9|||
170911126|NCT03351244|617679096|FG002|Overall Study|Adverse Event|12|||
170911127|NCT03351244|617679094|FG000|Overall Study|Investigator's decision|0|||
170911128|NCT03351244|617679095|FG001|Overall Study|Investigator's decision|0|||
170911129|NCT03351244|617679096|FG002|Overall Study|Investigator's decision|2|||
170588938|NCT00443053|616500172|FG001|Overall Study|Withdrawal by Subject|18|||
170588939|NCT00443053|616500171|FG000|Overall Study|Lost to Follow-up|4|||
170650176|NCT01087788|616732848|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
170911130|NCT03351244|617679094|FG000|Overall Study|System error|0|||
170911131|NCT03351244|617679095|FG001|Overall Study|System error|0|||
170911132|NCT03351244|617679096|FG002|Overall Study|System error|2|||
170911133|NCT03351244|617679094|FG000|Overall Study|COVID-19 restrictions|3|||
170911134|NCT03351244|617679095|FG001|Overall Study|COVID-19 restrictions|0|||
170588940|NCT00443053|616500172|FG001|Overall Study|Lost to Follow-up|5|||
170588941|NCT00443053|616500171|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
170588942|NCT00443053|616500172|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
170911135|NCT03351244|617679096|FG002|Overall Study|COVID-19 restrictions|1|||
170911136|NCT03351244|617679094|FG000|Overall Study|Non-compliance|2|||
170911137|NCT03351244|617679095|FG001|Overall Study|Non-compliance|5|||
170911138|NCT03351244|617679096|FG002|Overall Study|Non-compliance|0|||
170911139|NCT03351244|617679094|FG000|Overall Study|Withdrawal by Subject|11|||
170911140|NCT03351244|617679095|FG001|Overall Study|Withdrawal by Subject|16|||
170911141|NCT03351244|617679096|FG002|Overall Study|Withdrawal by Subject|13|||
170911142|NCT03351244|617679094|FG000|Overall Study|Lost to Follow-up|2|||
170911143|NCT03351244|617679095|FG001|Overall Study|Lost to Follow-up|6|||
170911144|NCT03351244|617679096|FG002|Overall Study|Lost to Follow-up|4|||
170911145|NCT03351244|617679094|FG000|Overall Study|Protocol Violation|2|||
170911146|NCT03351244|617679095|FG001|Overall Study|Protocol Violation|2|||
170911147|NCT03351244|617679096|FG002|Overall Study|Protocol Violation|0|||
170911148|NCT01966731|617679097|FG000|Overall Study|Death|2|||
170911149|NCT01966731|617679097|FG000|Overall Study|Lost to Follow-up|1|||
170911150|NCT01966731|617679097|FG000|Overall Study|Physician Decision|2|||
170911151|NCT01966731|617679097|FG000|Overall Study|Follow up is not complete|600|||
170911152|NCT01966731|617679097|FG000|Overall Study|Screening Failure|29|||
170911153|NCT01966731|617679097|FG000|Overall Study|Found to be ineligible|1|||
170588943|NCT00443053|616500171|FG000|Overall Study|Noncompliance|2|||
170588944|NCT00443053|616500172|FG001|Overall Study|Noncompliance|1|||
170588945|NCT00443053|616500171|FG000|Overall Study|Other|3|||
170588946|NCT00443053|616500172|FG001|Overall Study|Other|4|||
170588947|NCT00443053|616500171|FG000|Overall Study|Physician Decision|0|||
170588948|NCT00443053|616500172|FG001|Overall Study|Physician Decision|4|||
170588949|NCT00721578|616500173|FG000|Overall Study|Death|1|||
170588950|NCT00721578|616500174|FG001|Overall Study|Death|1|||
170588951|NCT00721578|616500173|FG000|Overall Study|Withdrawal by Subject|1|||
170588952|NCT00721578|616500174|FG001|Overall Study|Withdrawal by Subject|1|||
170588953|NCT01944098|616500175|FG000|Overall Study|Physician Decision|1|||
170588954|NCT01944098|616500176|FG001|Overall Study|Physician Decision|0|||
170588955|NCT02136680|616500177|FG000|Overall Study|No Longer Interested|1|||
170588956|NCT02136680|616500178|FG001|Overall Study|No Longer Interested|1|||
170588957|NCT02136680|616500177|FG000|Overall Study|No longer receiving care at clinic|3|||
170588958|NCT02136680|616500178|FG001|Overall Study|No longer receiving care at clinic|5|||
170588959|NCT02136680|616500177|FG000|Overall Study|Moved away|5|||
170588960|NCT02136680|616500178|FG001|Overall Study|Moved away|4|||
170588961|NCT02136680|616500177|FG000|Overall Study|Unable to schedule|17|||
170588962|NCT02136680|616500178|FG001|Overall Study|Unable to schedule|16|||
170588963|NCT02136680|616500177|FG000|Overall Study|Study ended before interview due|6|||
170588964|NCT02136680|616500178|FG001|Overall Study|Study ended before interview due|3|||
170588965|NCT04669262|616500180|FG000|Overall Study|Withdrawal by Subject|0|||
170588966|NCT04669262|616500181|FG001|Overall Study|Withdrawal by Subject|0|||
170588967|NCT04669262|616500182|FG002|Overall Study|Withdrawal by Subject|0|||
170588968|NCT04669262|616500183|FG003|Overall Study|Withdrawal by Subject|1|||
170588969|NCT04669262|616500180|FG000|Overall Study|Randomized but Not Treated|0|||
170588970|NCT04669262|616500181|FG001|Overall Study|Randomized but Not Treated|1|||
170588971|NCT04669262|616500182|FG002|Overall Study|Randomized but Not Treated|0|||
170588972|NCT04669262|616500183|FG003|Overall Study|Randomized but Not Treated|0|||
170588973|NCT00082368|616500186|FG000|Overall Study|Not treated-pt had poor IV access|1|||
170588974|NCT00737568|616500187|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
170588975|NCT00737568|616500188|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
170810351|NCT01072149|617315530|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810352|NCT01072149|617315531|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810353|NCT01072149|617315532|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810354|NCT01072149|617315533|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810355|NCT01072149|617315534|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810356|NCT01072149|617315535|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810357|NCT01072149|617315536|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810358|NCT01072149|617315537|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810359|NCT01072149|617315538|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810360|NCT01072149|617315539|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
170810361|NCT01072149|617315540|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810362|NCT01072149|617315541|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
170810363|NCT01072149|617315524|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
170810364|NCT01072149|617315525|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
170810365|NCT01072149|617315526|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
170810366|NCT01072149|617315527|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
170810367|NCT01072149|617315528|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
170911154|NCT00474253|617679100|FG000|Overall Study|Withdrew consent|2|||
170911155|NCT00474253|617679101|FG001|Overall Study|Withdrew consent|0|||
170911156|NCT00474253|617679100|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
170588976|NCT00737568|616500187|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
170588977|NCT00737568|616500188|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
170588978|NCT00737568|616500187|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
170911157|NCT00474253|617679101|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
170911158|NCT00474253|617679100|FG000|Overall Study|Lost to Follow-up|1|||
170911159|NCT00474253|617679101|FG001|Overall Study|Lost to Follow-up|0|||
170911160|NCT00474253|617679100|FG000|Overall Study|Discharged prior to study completion|0|||
170911161|NCT00474253|617679101|FG001|Overall Study|Discharged prior to study completion|1|||
170911162|NCT01165229|617679102|FG000|Overall Study|Serious Adverse Event|456|||
170911163|NCT01165229|617679103|FG001|Overall Study|Serious Adverse Event|487|||
170911164|NCT01165229|617679102|FG000|Overall Study|Non-Serious Adverse Event|47|||
170911165|NCT01165229|617679103|FG001|Overall Study|Non-Serious Adverse Event|15|||
170911166|NCT01165229|617679102|FG000|Overall Study|Protocol Violation|6|||
170911167|NCT01165229|617679103|FG001|Overall Study|Protocol Violation|8|||
170911168|NCT01165229|617679102|FG000|Overall Study|Withdrawal by Subject|387|||
170911169|NCT01165229|617679103|FG001|Overall Study|Withdrawal by Subject|396|||
170911170|NCT01165229|617679102|FG000|Overall Study|Migrated/moved from study area|51|||
170911171|NCT01165229|617679103|FG001|Overall Study|Migrated/moved from study area|46|||
170911172|NCT01165229|617679102|FG000|Overall Study|Lost to Follow-up|123|||
170911173|NCT01165229|617679103|FG001|Overall Study|Lost to Follow-up|133|||
170911174|NCT01165229|617679102|FG000|Overall Study|Suspected HZ Episode|2|||
170911175|NCT01165229|617679103|FG001|Overall Study|Suspected HZ Episode|2|||
170911176|NCT01165229|617679102|FG000|Overall Study|No reason from the subject|108|||
170911177|NCT01165229|617679103|FG001|Overall Study|No reason from the subject|102|||
170911178|NCT01165229|617679102|FG000|Overall Study|Unknown completion status|0|||
170911179|NCT01165229|617679103|FG001|Overall Study|Unknown completion status|1|||
170911180|NCT00637728|617679112|FG000|Double-blind Phase|Adverse Event|1|||
170911181|NCT00637728|617679113|FG001|Double-blind Phase|Adverse Event|0|||
170911182|NCT00637728|617679114|FG002|Double-blind Phase|Adverse Event|0|||
170911183|NCT00637728|617679112|FG000|Double-blind Phase|Non-compliance|2|||
170911184|NCT00637728|617679113|FG001|Double-blind Phase|Non-compliance|0|||
170911185|NCT00637728|617679114|FG002|Double-blind Phase|Non-compliance|0|||
170911186|NCT00637728|617679112|FG000|Double-blind Phase|Study Discontinued|1|||
170911187|NCT00637728|617679113|FG001|Double-blind Phase|Study Discontinued|1|||
170911188|NCT00637728|617679114|FG002|Double-blind Phase|Study Discontinued|0|||
170911189|NCT03000452|617679115|FG000|Treatment Period|Death|1|||
170911190|NCT03000452|617679115|FG000|Treatment Period|Progressive Disease (PD)|14|||
170911191|NCT03000452|617679115|FG000|Treatment Period|Physician Decision|1|||
170911192|NCT03000452|617679115|FG000|Treatment Period|Miscellaneous|2|||
170588979|NCT00737568|616500188|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
170588980|NCT00737568|616500187|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
170650177|NCT01087788|616732849|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
170650178|NCT01087788|616732847|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
170650179|NCT01087788|616732848|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
170650180|NCT01087788|616732849|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
170650181|NCT01087788|616732847|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
170650182|NCT01087788|616732848|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
170650183|NCT01087788|616732849|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
170650184|NCT01087788|616732847|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
170650185|NCT01087788|616732848|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
170911193|NCT03000452|617679115|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
170911194|NCT03000452|617679115|FG000|Follow-Up Period|Death|3|||
170911195|NCT03000452|617679115|FG000|Follow-Up Period|Withdrawal by Subject|3|||
170911196|NCT00593112|617679118|FG000|Overall Study|Scan Anxiety|3|||
170588981|NCT00737568|616500188|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
170588982|NCT00737568|616500187|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
170588983|NCT00737568|616500188|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
170588984|NCT00737568|616500187|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
170588985|NCT00737568|616500188|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
170588986|NCT00737568|616500187|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
170588987|NCT00737568|616500188|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
170588988|NCT00737568|616500187|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
170588989|NCT00737568|616500188|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
170588990|NCT00737568|616500187|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
170588991|NCT00737568|616500188|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
170650186|NCT01087788|616732849|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
170650187|NCT01087788|616732847|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
170911197|NCT00593112|617679119|FG001|Overall Study|Scan Anxiety|0|||
170911198|NCT00593112|617679118|FG000|Overall Study|Abnormal Scan|1|||
170911199|NCT00593112|617679119|FG001|Overall Study|Abnormal Scan|0|||
170911200|NCT00593112|617679118|FG000|Overall Study|Unreadable Scan|1|||
170911201|NCT00593112|617679119|FG001|Overall Study|Unreadable Scan|0|||
170911202|NCT00593112|617679118|FG000|Overall Study|Withdrawal by Subject|5|||
170911203|NCT00593112|617679119|FG001|Overall Study|Withdrawal by Subject|0|||
170588992|NCT00350272|616500189|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
170588993|NCT00350272|616500190|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
170588994|NCT00350272|616500189|FG000|Blinded 12-Week Treatment|Death|1|||
170588995|NCT00350272|616500190|FG001|Blinded 12-Week Treatment|Death|0|||
170588996|NCT00350272|616500189|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
170588997|NCT00350272|616500190|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
170588998|NCT00350272|616500189|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
170588999|NCT00350272|616500190|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
170589000|NCT00350272|616500189|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
170589001|NCT00350272|616500190|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
170589002|NCT00350272|616500189|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
170589003|NCT00350272|616500190|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
170589004|NCT00350272|616500189|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
170589005|NCT00350272|616500190|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
170589006|NCT00350272|616500189|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
170589007|NCT00350272|616500190|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
170589008|NCT00350272|616500189|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
170589009|NCT00350272|616500190|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
170589010|NCT00350272|616500189|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
170589011|NCT00350272|616500190|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
170589012|NCT00350272|616500189|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
170589013|NCT00350272|616500190|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
170589014|NCT01080768|616500191|FG000|Overall Study|Protocol Deviation|2|||
170589015|NCT01080768|616500192|FG001|Overall Study|Protocol Deviation|1|||
170589016|NCT01939002|616500197|FG000|Overall Study|Adverse Event|13|||
170589017|NCT01939002|616500198|FG001|Overall Study|Adverse Event|13|||
170589018|NCT01939002|616500197|FG000|Overall Study|Withdrawal by Subject|5|||
170589019|NCT01939002|616500198|FG001|Overall Study|Withdrawal by Subject|3|||
170589020|NCT01939002|616500197|FG000|Overall Study|Other|1|||
170589021|NCT01939002|616500198|FG001|Overall Study|Other|2|||
170589022|NCT01774253|616500199|FG000|Overall Study|Lack of Efficacy|4|||
170589023|NCT01774253|616500199|FG000|Overall Study|Physician Decision|2|||
170589024|NCT01774253|616500199|FG000|Overall Study|Withdrawal by Subject|2|||
170589025|NCT01774253|616500199|FG000|Overall Study|Death|1|||
170589026|NCT03730961|616500200|FG000|Overall Study|Adverse Event|0|||
170810368|NCT01072149|617315529|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
170810369|NCT01072149|617315530|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
170810370|NCT01072149|617315531|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
170810371|NCT01072149|617315532|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
170810372|NCT01072149|617315533|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
170810373|NCT01072149|617315534|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
170810374|NCT01072149|617315535|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
170810375|NCT01072149|617315536|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
170810376|NCT01072149|617315537|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
170810377|NCT01072149|617315538|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
170810378|NCT01072149|617315539|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
170810379|NCT01072149|617315540|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
170810380|NCT01072149|617315541|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
170810381|NCT01072149|617315524|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810382|NCT01072149|617315525|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810383|NCT01072149|617315526|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810384|NCT01072149|617315527|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810385|NCT01072149|617315528|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810386|NCT01072149|617315529|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810387|NCT01072149|617315530|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810388|NCT01072149|617315531|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810389|NCT01072149|617315532|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810390|NCT01072149|617315533|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810391|NCT01072149|617315534|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810392|NCT01072149|617315535|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810393|NCT01072149|617315536|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
170810394|NCT01072149|617315537|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810395|NCT01072149|617315538|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810396|NCT01072149|617315539|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810397|NCT01072149|617315540|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810398|NCT01072149|617315541|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
170810399|NCT01072149|617315524|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170589027|NCT03730961|616500201|FG001|Overall Study|Adverse Event|1|||
170589028|NCT04035564|616501908|FG000|Overall Study|Protocol Violation|1|||
170589029|NCT04035564|616501909|FG001|Overall Study|Protocol Violation|2|||
170589030|NCT04035564|616501908|FG000|Overall Study|No laboratory available|2|||
170589031|NCT04035564|616501909|FG001|Overall Study|No laboratory available|2|||
170589032|NCT04035564|616501908|FG000|Overall Study|Guardian declined consent|1|||
170589033|NCT04035564|616501909|FG001|Overall Study|Guardian declined consent|2|||
170589034|NCT03361189|616501910|FG000|Overall Study|Received heart transplant|1|||
170589035|NCT03361189|616501911|FG001|Overall Study|Received heart transplant|0|||
170589036|NCT03361189|616501910|FG000|Overall Study|Pacemake replacement|0|||
170589037|NCT03361189|616501911|FG001|Overall Study|Pacemake replacement|1|||
170589038|NCT03505788|616501912|FG000|Overall Study|Lost to Follow-up|2|||
170589039|NCT03505788|616501913|FG001|Overall Study|Lost to Follow-up|1|||
170589040|NCT03505788|616501912|FG000|Overall Study|Withdrawal by Subject|1|||
170650188|NCT01087788|616732848|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
170650189|NCT01087788|616732849|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
170650190|NCT01087788|616732847|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
170650191|NCT01087788|616732848|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
170650192|NCT01087788|616732849|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
170650193|NCT01087788|616732847|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
170650194|NCT01087788|616732848|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
170911204|NCT03455543|617679120|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
170911205|NCT03455543|617679121|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
170911206|NCT03455543|617679122|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
170911207|NCT03455543|617679120|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
170911208|NCT03455543|617679121|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
170911209|NCT03455543|617679122|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
170911210|NCT03455543|617679120|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
170911211|NCT03455543|617679121|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
170911212|NCT03455543|617679122|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
170911213|NCT03455543|617679120|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
170911214|NCT03455543|617679121|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
170911215|NCT03455543|617679122|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
170911216|NCT03455543|617679120|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
170911217|NCT03455543|617679121|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
170911218|NCT03455543|617679122|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
170911219|NCT03455543|617679120|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
170911220|NCT03455543|617679121|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
170911221|NCT03455543|617679122|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
170911222|NCT03455543|617679120|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
170911223|NCT03455543|617679121|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
170911224|NCT03455543|617679122|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
170911225|NCT03455543|617679120|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
170911226|NCT03455543|617679121|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
170911227|NCT03455543|617679122|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
170911228|NCT03455543|617679120|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
170911229|NCT03455543|617679121|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
170911230|NCT03455543|617679122|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
170911231|NCT01720667|617679126|FG000|Overall Study|Adverse Event|1|||
170911232|NCT01720667|617679127|FG001|Overall Study|Adverse Event|1|||
170589041|NCT03505788|616501913|FG001|Overall Study|Withdrawal by Subject|3|||
170589042|NCT03505788|616501912|FG000|Overall Study|Physician Decision|0|||
170589043|NCT03505788|616501913|FG001|Overall Study|Physician Decision|1|||
170589044|NCT00521599|616501918|FG000|Overall Study|Adverse Event|5|||
170589045|NCT00521599|616501919|FG001|Overall Study|Adverse Event|7|||
170589046|NCT00521599|616501920|FG002|Overall Study|Adverse Event|6|||
170589047|NCT00521599|616501918|FG000|Overall Study|Treatment Failure|8|||
170589048|NCT00521599|616501919|FG001|Overall Study|Treatment Failure|9|||
170589049|NCT00521599|616501920|FG002|Overall Study|Treatment Failure|22|||
170650195|NCT01087788|616732849|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
170650196|NCT01087788|616732847|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
170650197|NCT01087788|616732848|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
170650198|NCT01087788|616732849|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
170650199|NCT01087788|616732847|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
170650200|NCT01087788|616732848|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
170650201|NCT01087788|616732849|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
170650202|NCT01087788|616732847|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
170650203|NCT01087788|616732848|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
170650204|NCT01087788|616732849|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
170650205|NCT01087788|616732847|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
170589050|NCT00521599|616501918|FG000|Overall Study|Lost to Follow-up|2|||
170589051|NCT00521599|616501919|FG001|Overall Study|Lost to Follow-up|1|||
170589052|NCT00521599|616501920|FG002|Overall Study|Lost to Follow-up|2|||
170589053|NCT00521599|616501918|FG000|Overall Study|Withdrawal by Subject|3|||
170589054|NCT00521599|616501919|FG001|Overall Study|Withdrawal by Subject|5|||
170589055|NCT00521599|616501920|FG002|Overall Study|Withdrawal by Subject|1|||
170589056|NCT00521599|616501918|FG000|Overall Study|Withdrawal by subject treatment related|3|||
170589057|NCT00521599|616501919|FG001|Overall Study|Withdrawal by subject treatment related|1|||
170589058|NCT00521599|616501920|FG002|Overall Study|Withdrawal by subject treatment related|2|||
170589059|NCT00521599|616501918|FG000|Overall Study|Protocol Violation|2|||
170589060|NCT00521599|616501919|FG001|Overall Study|Protocol Violation|4|||
170589061|NCT00521599|616501920|FG002|Overall Study|Protocol Violation|2|||
170589062|NCT00521599|616501918|FG000|Overall Study|Did not meet protocol eligibility|2|||
170589063|NCT00521599|616501919|FG001|Overall Study|Did not meet protocol eligibility|2|||
170589064|NCT00521599|616501920|FG002|Overall Study|Did not meet protocol eligibility|1|||
170589065|NCT02186652|616501921|FG000|Overall Study|Lost to Follow-up|2|||
170589066|NCT02186652|616501922|FG001|Overall Study|Lost to Follow-up|0|||
170589067|NCT00496197|616501923|FG000|Overall Study|Discontinued study due to death|43|||
170589068|NCT00496197|616501923|FG000|Overall Study|Adverse Event|13|||
170589069|NCT00496197|616501923|FG000|Overall Study|Does not meet entrance criteria|5|||
170589070|NCT00496197|616501923|FG000|Overall Study|Insufficient clinical response|3|||
170589071|NCT00496197|616501923|FG000|Overall Study|Insufficient bacteriological response|10|||
170589072|NCT00496197|616501923|FG000|Overall Study|Lost to Follow-up|11|||
170589073|NCT00496197|616501923|FG000|Overall Study|Withdrawal by Subject|11|||
170589074|NCT00496197|616501923|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
170589075|NCT00496197|616501923|FG000|Overall Study|Other|14|||
170589076|NCT00496197|616501923|FG000|Overall Study|Protocol Violation|8|||
170589077|NCT04431713|616501924|FG000|Overall Study|Withdrawal by Subject|2|||
170589078|NCT04431713|616501925|FG001|Overall Study|Withdrawal by Subject|0|||
170589079|NCT04431713|616501924|FG000|Overall Study|Death|2|||
170589080|NCT04431713|616501925|FG001|Overall Study|Death|2|||
170589081|NCT00149994|616501926|FG000|Overall Study|Administrative problems:|1|||
170589082|NCT00149994|616501927|FG001|Overall Study|Administrative problems:|0|||
170589083|NCT00149994|616501926|FG000|Overall Study|Protocol Violation|0|||
170589084|NCT00149994|616501927|FG001|Overall Study|Protocol Violation|1|||
170589085|NCT01610713|616501928|FG000|Overall Study|Adverse Event|3|||
170589086|NCT01610713|616501929|FG001|Overall Study|Adverse Event|0|||
170589087|NCT01610713|616501928|FG000|Overall Study|Lack of Efficacy|1|||
170589088|NCT01610713|616501929|FG001|Overall Study|Lack of Efficacy|0|||
170589089|NCT01610713|616501928|FG000|Overall Study|low mood and poor motivation|1|||
170589090|NCT01610713|616501929|FG001|Overall Study|low mood and poor motivation|0|||
170589091|NCT01610713|616501928|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
170589092|NCT01610713|616501929|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
170589093|NCT01610713|616501928|FG000|Overall Study|Lost to Follow-up|0|||
170589094|NCT01610713|616501929|FG001|Overall Study|Lost to Follow-up|1|||
170589095|NCT04600076|616501934|FG000|Overall Study|Lost to Follow-up|3|||
170589096|NCT02891681|616501935|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
170589097|NCT02891681|616501936|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
170589098|NCT02891681|616501937|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
170589099|NCT02891681|616501935|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
170589100|NCT02891681|616501936|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
170589101|NCT02891681|616501937|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
170589102|NCT02891681|616501935|FG000|Overall Study|Taken off study after first imaging appointment|1|||
170589103|NCT02891681|616501936|FG001|Overall Study|Taken off study after first imaging appointment|0|||
170589104|NCT02891681|616501937|FG002|Overall Study|Taken off study after first imaging appointment|0|||
170589105|NCT02351349|616501938|FG000|Overall Study|Withdrawal by Subject|2|||
170589106|NCT02351349|616501939|FG001|Overall Study|Withdrawal by Subject|3|||
170589107|NCT00683917|616501940|FG000|Overall Study|Study prematurely terminated|10|||
170589108|NCT04173260|616501945|FG000|Overall Study|Early termination|4|||
170589109|NCT04730635|616501946|FG000|Overall Study|Lost to Follow-up|1|||
170589110|NCT04730635|616501947|FG001|Overall Study|Lost to Follow-up|0|||
170589111|NCT04730635|616501946|FG000|Overall Study|Withdrawal by Subject|0|||
170589112|NCT04730635|616501947|FG001|Overall Study|Withdrawal by Subject|1|||
170589113|NCT01468233|616501950|FG000|Treatment Period 1|Adverse Event|5|||
170589114|NCT01468233|616501951|FG001|Treatment Period 1|Adverse Event|3|||
170589115|NCT01468233|616501952|FG002|Treatment Period 1|Adverse Event|0|||
170589116|NCT01468233|616501953|FG003|Treatment Period 1|Adverse Event|0|||
170589117|NCT01468233|616501954|FG004|Treatment Period 1|Adverse Event|0|||
170589118|NCT01468233|616501955|FG005|Treatment Period 1|Adverse Event|0|||
170589119|NCT01468233|616501950|FG000|Treatment Period 1|Withdrawal by Subject|3|||
170589120|NCT01468233|616501951|FG001|Treatment Period 1|Withdrawal by Subject|4|||
170589121|NCT01468233|616501952|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170589122|NCT01468233|616501953|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170650206|NCT01087788|616732848|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
170650207|NCT01087788|616732849|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
170650208|NCT01087788|616732847|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
170650209|NCT01087788|616732848|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
170650210|NCT01087788|616732849|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
170650211|NCT01087788|616732847|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
170650212|NCT01087788|616732848|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
170650213|NCT01087788|616732849|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
170650214|NCT01087788|616732847|FG000|24-weeks Dose-blind Period|Patient moved|0|||
170650215|NCT01087788|616732848|FG001|24-weeks Dose-blind Period|Patient moved|0|||
170650216|NCT01087788|616732849|FG002|24-weeks Dose-blind Period|Patient moved|1|||
170650217|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
170650218|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
170650219|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
170650220|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
170650221|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
170810400|NCT01072149|617315525|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810401|NCT01072149|617315526|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
170650222|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
170650223|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
170650224|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
170650225|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
170650226|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
170650227|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
170650228|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
170650229|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
170650230|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
170650231|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
170650232|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
170650233|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
170911233|NCT01720667|617679126|FG000|Overall Study|Withdrawal by Subject|3|||
170911234|NCT01720667|617679127|FG001|Overall Study|Withdrawal by Subject|0|||
170911235|NCT03396471|617679131|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
170911236|NCT03396471|617679131|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
170911237|NCT03396471|617679131|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
170911238|NCT03396471|617679131|FG000|Study Treatment - Up to 22 Months|Death|2|||
170911239|NCT03396471|617679131|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
170911240|NCT03396471|617679131|FG000|Follow up - Up to 2 Years|Death|9|||
170911241|NCT03396471|617679131|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
170911242|NCT03396471|617679131|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
170911243|NCT03396471|617679131|FG000|Follow up - Up to 2 Years|study terminated|1|||
170911244|NCT03396471|617679131|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
170911245|NCT03396471|617679131|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
170911246|NCT02117050|617679132|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
170911247|NCT00546819|617679133|FG000|Overall Study|Adverse Event|2|||
170911248|NCT00546819|617679134|FG001|Overall Study|Adverse Event|3|||
170911249|NCT00546819|617679133|FG000|Overall Study|Lost to Follow-up|2|||
170911250|NCT00546819|617679134|FG001|Overall Study|Lost to Follow-up|1|||
170911251|NCT00546819|617679133|FG000|Overall Study|Withdrawal by Subject|4|||
170911252|NCT00546819|617679134|FG001|Overall Study|Withdrawal by Subject|2|||
170911253|NCT03240081|617679145|FG000|Overall Study|Withdrawal by Subject|0|||
170911254|NCT03240081|617679146|FG001|Overall Study|Withdrawal by Subject|2|||
170911255|NCT03240081|617679145|FG000|Overall Study|Lost to Follow-up|0|||
170911256|NCT03240081|617679146|FG001|Overall Study|Lost to Follow-up|1|||
170911257|NCT00883753|617679147|FG000|Overall Study|Adverse Event|37|||
170911258|NCT00883753|617679147|FG000|Overall Study|Death|2|||
170650234|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
170650235|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
170650236|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
170810402|NCT01072149|617315527|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810403|NCT01072149|617315528|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810404|NCT01072149|617315529|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810405|NCT01072149|617315530|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810406|NCT01072149|617315531|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810407|NCT01072149|617315532|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810408|NCT01072149|617315533|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810409|NCT01072149|617315534|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810410|NCT01072149|617315535|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810411|NCT01072149|617315536|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810412|NCT01072149|617315537|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
170810413|NCT01072149|617315538|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170911259|NCT00883753|617679147|FG000|Overall Study|Insufficient therapeutic response|16|||
170911260|NCT00883753|617679147|FG000|Overall Study|Lost to Follow-up|4|||
170589123|NCT01468233|616501954|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170589124|NCT01468233|616501955|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170589125|NCT01468233|616501950|FG000|Treatment Period 1|Lost to Follow-up|3|||
170589126|NCT01468233|616501951|FG001|Treatment Period 1|Lost to Follow-up|0|||
170589127|NCT01468233|616501952|FG002|Treatment Period 1|Lost to Follow-up|0|||
170589128|NCT01468233|616501953|FG003|Treatment Period 1|Lost to Follow-up|0|||
170589129|NCT01468233|616501954|FG004|Treatment Period 1|Lost to Follow-up|0|||
170589130|NCT01468233|616501955|FG005|Treatment Period 1|Lost to Follow-up|0|||
170650237|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
170650238|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
170650239|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
170650240|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
170650241|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
170650242|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
170650243|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
170650244|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
170650245|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
170650246|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
170650247|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
170650248|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
170650249|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
170650250|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
170650251|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
170650252|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
170650253|NCT01087788|616732847|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
170650254|NCT01087788|616732848|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
170650255|NCT01087788|616732849|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
170650256|NCT00927940|616732854|FG000|Overall Study|Death|1|||
170650257|NCT03007888|616732855|FG000|First Intervention (14 Days)|Adverse Event|1|||
170650258|NCT03007888|616732856|FG001|First Intervention (14 Days)|Adverse Event|0|||
170650259|NCT01806662|616732858|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
170650260|NCT01806662|616732859|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
170650261|NCT01806662|616732858|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
170650262|NCT01806662|616732859|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
170650263|NCT01806662|616732858|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
170650264|NCT01806662|616732859|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
170650265|NCT01806662|616732858|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
170650266|NCT01806662|616732859|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
170650267|NCT00043550|616732861|FG000|Overall Study|Withdrawal by Subject|22|||
170650268|NCT00043550|616732862|FG001|Overall Study|Withdrawal by Subject|12|||
170650269|NCT00043550|616732863|FG002|Overall Study|Withdrawal by Subject|20|||
170650270|NCT01917656|616732866|FG000|Overall Study|Adverse Event|11|||
170650271|NCT01917656|616732867|FG001|Overall Study|Adverse Event|0|||
170650272|NCT01917656|616732866|FG000|Overall Study|Withdrawal criteria|8|||
170650273|NCT01917656|616732867|FG001|Overall Study|Withdrawal criteria|14|||
170650274|NCT01917656|616732866|FG000|Overall Study|Unclassified|0|||
170650275|NCT01917656|616732867|FG001|Overall Study|Unclassified|3|||
170650276|NCT01917656|616732866|FG000|Overall Study|Withdrawal by Subject|4|||
170650277|NCT01917656|616732867|FG001|Overall Study|Withdrawal by Subject|3|||
170650278|NCT01917656|616732866|FG000|Overall Study|Lost to Follow-up|3|||
170650279|NCT01917656|616732867|FG001|Overall Study|Lost to Follow-up|4|||
170650280|NCT02015221|616732868|FG000|Overall Study|Withdrawal by Subject|8|||
170650281|NCT02015221|616732869|FG001|Overall Study|Withdrawal by Subject|6|||
170650282|NCT02015221|616732868|FG000|Overall Study|Lost to Follow-up|1|||
170650283|NCT02015221|616732869|FG001|Overall Study|Lost to Follow-up|0|||
170810414|NCT01072149|617315539|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810415|NCT01072149|617315540|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810416|NCT01072149|617315541|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
170810417|NCT01102426|617315542|FG000|Overall Study|Randomized but not treated|4|||
170589131|NCT01468233|616501950|FG000|Treatment Period 1|Other|1|||
170589132|NCT01468233|616501951|FG001|Treatment Period 1|Other|1|||
170589133|NCT01468233|616501952|FG002|Treatment Period 1|Other|0|||
170589134|NCT01468233|616501953|FG003|Treatment Period 1|Other|0|||
170589135|NCT01468233|616501954|FG004|Treatment Period 1|Other|0|||
170589136|NCT01468233|616501955|FG005|Treatment Period 1|Other|0|||
170589137|NCT01468233|616501950|FG000|Treatment Period 2|Adverse Event|0|||
170589138|NCT01468233|616501951|FG001|Treatment Period 2|Adverse Event|0|||
170589139|NCT01468233|616501952|FG002|Treatment Period 2|Adverse Event|3|||
170589140|NCT01468233|616501953|FG003|Treatment Period 2|Adverse Event|0|||
170589141|NCT01468233|616501954|FG004|Treatment Period 2|Adverse Event|2|||
170589142|NCT01468233|616501955|FG005|Treatment Period 2|Adverse Event|1|||
170589143|NCT01468233|616501950|FG000|Treatment Period 2|Lack of Efficacy|0|||
170589144|NCT01468233|616501951|FG001|Treatment Period 2|Lack of Efficacy|0|||
170589145|NCT01468233|616501952|FG002|Treatment Period 2|Lack of Efficacy|9|||
170589146|NCT01468233|616501953|FG003|Treatment Period 2|Lack of Efficacy|2|||
170589147|NCT01468233|616501954|FG004|Treatment Period 2|Lack of Efficacy|0|||
170589148|NCT01468233|616501955|FG005|Treatment Period 2|Lack of Efficacy|1|||
170589149|NCT01468233|616501950|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170589150|NCT01468233|616501951|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170589151|NCT01468233|616501952|FG002|Treatment Period 2|Withdrawal by Subject|9|||
170589152|NCT01468233|616501953|FG003|Treatment Period 2|Withdrawal by Subject|1|||
170911261|NCT00883753|617679147|FG000|Overall Study|Violation of selection criteria at entry|7|||
170911262|NCT00883753|617679147|FG000|Overall Study|Protocol Violation|2|||
170911263|NCT00883753|617679147|FG000|Overall Study|Refused treatment|4|||
170911264|NCT00883753|617679147|FG000|Overall Study|Withdrew consent|10|||
170911265|NCT00883753|617679147|FG000|Overall Study|Investigator's decision|17|||
170911266|NCT00883753|617679147|FG000|Overall Study|Administrative/Other|8|||
170911267|NCT02859415|617679148|FG000|Overall Study|Physician Decision|1|||
170911268|NCT02859415|617679149|FG001|Overall Study|Physician Decision|0|||
170911269|NCT02859415|617679148|FG000|Overall Study|Off treatment due to cardiac event|0|||
170911270|NCT02859415|617679149|FG001|Overall Study|Off treatment due to cardiac event|1|||
170911271|NCT04925570|617679152|FG000|Overall Study|Protocol Violation|24|||
170911272|NCT04925570|617679153|FG001|Overall Study|Protocol Violation|30|||
170911273|NCT04925570|617679152|FG000|Overall Study|Withdrawal by Subject|0|||
170911274|NCT04925570|617679153|FG001|Overall Study|Withdrawal by Subject|2|||
170911275|NCT02675517|617679154|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
170911276|NCT02675517|617679154|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
170911277|NCT01088412|617679155|FG000|Overall Study|Adverse Event|38|||
170911278|NCT01088412|617679156|FG001|Overall Study|Adverse Event|0|||
170911279|NCT01088412|617679157|FG002|Overall Study|Adverse Event|0|||
170911280|NCT01088412|617679155|FG000|Overall Study|Death|42|||
170589153|NCT01468233|616501954|FG004|Treatment Period 2|Withdrawal by Subject|1|||
170589154|NCT01468233|616501955|FG005|Treatment Period 2|Withdrawal by Subject|1|||
170589155|NCT01468233|616501950|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
170589156|NCT01468233|616501951|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
170810418|NCT01102426|617315543|FG001|Overall Study|Randomized but not treated|1|||
170810419|NCT01102426|617315542|FG000|Overall Study|Adverse Events (treatment-related)|15|||
170810420|NCT01102426|617315543|FG001|Overall Study|Adverse Events (treatment-related)|8|||
170810421|NCT01102426|617315542|FG000|Overall Study|Physician Decision|9|||
170810422|NCT01102426|617315543|FG001|Overall Study|Physician Decision|6|||
170810423|NCT01102426|617315542|FG000|Overall Study|Progressive Disease|85|||
170810424|NCT01102426|617315543|FG001|Overall Study|Progressive Disease|44|||
170810425|NCT01102426|617315542|FG000|Overall Study|Adverse Events (unrelated to|9|||
170810426|NCT01102426|617315543|FG001|Overall Study|Adverse Events (unrelated to|1|||
170810427|NCT01102426|617315542|FG000|Overall Study|Patient Refusal|24|||
170810428|NCT01102426|617315543|FG001|Overall Study|Patient Refusal|12|||
170810429|NCT01102426|617315542|FG000|Overall Study|Death (due to adverse events|0|||
170810430|NCT01102426|617315543|FG001|Overall Study|Death (due to adverse events|1|||
170810431|NCT01102426|617315542|FG000|Overall Study|Death (non-related to the study|19|||
170810432|NCT01102426|617315543|FG001|Overall Study|Death (non-related to the study|8|||
170810433|NCT00871494|617315546|FG000|Overall Study|Protocol Violation|5|||
170810434|NCT00871494|617315546|FG000|Overall Study|Lack of Efficacy|4|||
170810435|NCT00871494|617315546|FG000|Overall Study|Adverse Event|4|||
170810436|NCT00871494|617315546|FG000|Overall Study|Lost to Follow-up|1|||
170810437|NCT02234141|617315547|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
170810438|NCT02234141|617315548|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
170810439|NCT02234141|617315549|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
170810440|NCT02234141|617315550|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
170810441|NCT02234141|617315551|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
170810442|NCT02234141|617315552|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
170810443|NCT02234141|617315553|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
170911281|NCT01088412|617679156|FG001|Overall Study|Death|6|||
170589157|NCT01468233|616501952|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
170911282|NCT01088412|617679157|FG002|Overall Study|Death|0|||
170911283|NCT01088412|617679155|FG000|Overall Study|Other Reason per Case Report Form|2089|||
170911284|NCT01088412|617679156|FG001|Overall Study|Other Reason per Case Report Form|103|||
170589158|NCT01468233|616501953|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
170911285|NCT01088412|617679157|FG002|Overall Study|Other Reason per Case Report Form|9|||
170589159|NCT01468233|616501954|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
170911286|NCT01088412|617679155|FG000|Overall Study|Withdrawal by Subject|1761|||
170911287|NCT01088412|617679156|FG001|Overall Study|Withdrawal by Subject|25|||
170911288|NCT01088412|617679157|FG002|Overall Study|Withdrawal by Subject|1|||
170911289|NCT01088412|617679155|FG000|Overall Study|Received Another GH Product|79|||
170911290|NCT01088412|617679156|FG001|Overall Study|Received Another GH Product|0|||
170911291|NCT01088412|617679157|FG002|Overall Study|Received Another GH Product|0|||
170911292|NCT01088412|617679155|FG000|Overall Study|Participant Moved|601|||
170911293|NCT01088412|617679156|FG001|Overall Study|Participant Moved|21|||
170911294|NCT01088412|617679157|FG002|Overall Study|Participant Moved|2|||
170911295|NCT01088412|617679155|FG000|Overall Study|Physician Decision|1041|||
170911296|NCT01088412|617679156|FG001|Overall Study|Physician Decision|8|||
170911297|NCT01088412|617679157|FG002|Overall Study|Physician Decision|4|||
170911298|NCT01088412|617679155|FG000|Overall Study|Sponsor Decision|4467|||
170911299|NCT01088412|617679156|FG001|Overall Study|Sponsor Decision|79|||
170911300|NCT01088412|617679157|FG002|Overall Study|Sponsor Decision|23|||
170911301|NCT01088412|617679155|FG000|Overall Study|Third Party Required to Change Brand|487|||
170911302|NCT01088412|617679156|FG001|Overall Study|Third Party Required to Change Brand|0|||
170911303|NCT01088412|617679157|FG002|Overall Study|Third Party Required to Change Brand|0|||
170911304|NCT01088412|617679155|FG000|Overall Study|Lost to Follow-up|3052|||
170911305|NCT01088412|617679156|FG001|Overall Study|Lost to Follow-up|130|||
170911306|NCT01088412|617679157|FG002|Overall Study|Lost to Follow-up|11|||
170911307|NCT01088412|617679155|FG000|Overall Study|Study Summary Not Completed|4360|||
170911308|NCT01088412|617679156|FG001|Overall Study|Study Summary Not Completed|64|||
170911309|NCT01088412|617679157|FG002|Overall Study|Study Summary Not Completed|22|||
170911310|NCT00793104|617679158|FG000|Overall Study|Lost to Follow-up|1|||
170911311|NCT03494725|617679159|FG000|Overall Study|Withdrawal by Subject|0|||
170911312|NCT03494725|617679160|FG001|Overall Study|Withdrawal by Subject|2|||
170911313|NCT03494725|617679159|FG000|Overall Study|Antibiotic use|1|||
170911314|NCT03494725|617679160|FG001|Overall Study|Antibiotic use|0|||
170911315|NCT05593432|617679161|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
170911316|NCT05593432|617679162|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
170911317|NCT05593432|617679163|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
170911318|NCT05593432|617679164|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
170911319|NCT05593432|617679161|FG000|16-Week OLE Period|Lack of Efficacy|0|||
170911320|NCT05593432|617679162|FG001|16-Week OLE Period|Lack of Efficacy|0|||
170911321|NCT05593432|617679163|FG002|16-Week OLE Period|Lack of Efficacy|0|||
170911322|NCT05593432|617679164|FG003|16-Week OLE Period|Lack of Efficacy|1|||
170911323|NCT05593432|617679161|FG000|16-Week OLE Period|Lost to Follow-up|0|||
170589160|NCT01468233|616501955|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
170589161|NCT01468233|616501950|FG000|Treatment Period 2|Lost to Follow-up|0|||
170589162|NCT01468233|616501951|FG001|Treatment Period 2|Lost to Follow-up|0|||
170589163|NCT01468233|616501952|FG002|Treatment Period 2|Lost to Follow-up|3|||
170589164|NCT01468233|616501953|FG003|Treatment Period 2|Lost to Follow-up|0|||
170589165|NCT01468233|616501954|FG004|Treatment Period 2|Lost to Follow-up|2|||
170589166|NCT01468233|616501955|FG005|Treatment Period 2|Lost to Follow-up|0|||
170589167|NCT01468233|616501950|FG000|Treatment Period 2|Other|0|||
170589168|NCT01468233|616501951|FG001|Treatment Period 2|Other|0|||
170589169|NCT01468233|616501952|FG002|Treatment Period 2|Other|3|||
170589170|NCT01468233|616501953|FG003|Treatment Period 2|Other|0|||
170589171|NCT01468233|616501954|FG004|Treatment Period 2|Other|1|||
170589172|NCT01468233|616501955|FG005|Treatment Period 2|Other|0|||
170589173|NCT00522418|616501956|FG000|Overall Study|Local IRB Consent Violation|5|||
170589174|NCT00522418|616501957|FG001|Overall Study|Local IRB Consent Violation|5|||
170589175|NCT00522418|616501956|FG000|Overall Study|Early Study Termination|46|||
170589176|NCT00522418|616501957|FG001|Overall Study|Early Study Termination|47|||
170589177|NCT00522418|616501956|FG000|Overall Study|Noncompliance|2|||
170589178|NCT00522418|616501957|FG001|Overall Study|Noncompliance|2|||
170589179|NCT00522418|616501956|FG000|Overall Study|Reason Not Specified|3|||
170589180|NCT00522418|616501957|FG001|Overall Study|Reason Not Specified|1|||
170911324|NCT05593432|617679162|FG001|16-Week OLE Period|Lost to Follow-up|0|||
170911325|NCT05593432|617679163|FG002|16-Week OLE Period|Lost to Follow-up|1|||
170911326|NCT05593432|617679164|FG003|16-Week OLE Period|Lost to Follow-up|2|||
170911327|NCT05593432|617679161|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
170589181|NCT00522418|616501956|FG000|Overall Study|Consent Withdraw|1|||
170589182|NCT00522418|616501957|FG001|Overall Study|Consent Withdraw|2|||
170589183|NCT00522418|616501956|FG000|Overall Study|Lack of Efficacy|0|||
170911328|NCT05593432|617679162|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
170589184|NCT00522418|616501957|FG001|Overall Study|Lack of Efficacy|1|||
170589185|NCT01777542|616501958|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
170589186|NCT01777542|616501959|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
170589187|NCT01632241|616501960|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
170589188|NCT01632241|616501961|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
170589189|NCT01632241|616501960|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
170589190|NCT01632241|616501961|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
170589191|NCT01632241|616501960|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
170589192|NCT01632241|616501961|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
170589193|NCT01632241|616501960|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
170589194|NCT01632241|616501961|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
170589195|NCT01632241|616501960|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
170589196|NCT01632241|616501961|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
170589197|NCT01632241|616501960|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
170589198|NCT01632241|616501961|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
170589199|NCT01632241|616501960|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
170589200|NCT01632241|616501961|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
170589201|NCT01632241|616501960|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
170589202|NCT01632241|616501961|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
170589203|NCT01632241|616501960|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
170589204|NCT01632241|616501961|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
170589205|NCT01632241|616501960|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
170589206|NCT01632241|616501961|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
170589207|NCT01632241|616501960|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
170589208|NCT01632241|616501961|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
170589209|NCT01632241|616501960|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
170589210|NCT01632241|616501961|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
170589211|NCT01632241|616501960|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
170589212|NCT01632241|616501961|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
170589213|NCT01632241|616501960|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
170589214|NCT01632241|616501961|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
170589215|NCT01202188|616501962|FG000|Overall Study|Protocol deviation|14|||
170589216|NCT01202188|616501963|FG001|Overall Study|Protocol deviation|8|||
170589217|NCT01202188|616501964|FG002|Overall Study|Protocol deviation|12|||
170589218|NCT01202188|616501965|FG003|Overall Study|Protocol deviation|10|||
170589219|NCT01202188|616501966|FG004|Overall Study|Protocol deviation|11|||
170589220|NCT01202188|616501962|FG000|Overall Study|Subject withdrew consent|12|||
170589221|NCT01202188|616501963|FG001|Overall Study|Subject withdrew consent|13|||
170589222|NCT01202188|616501964|FG002|Overall Study|Subject withdrew consent|22|||
170589223|NCT01202188|616501965|FG003|Overall Study|Subject withdrew consent|11|||
170589224|NCT01202188|616501966|FG004|Overall Study|Subject withdrew consent|13|||
170589225|NCT01202188|616501962|FG000|Overall Study|Adverse Event|5|||
170589226|NCT01202188|616501963|FG001|Overall Study|Adverse Event|23|||
170589227|NCT01202188|616501964|FG002|Overall Study|Adverse Event|13|||
170589228|NCT01202188|616501965|FG003|Overall Study|Adverse Event|10|||
170589229|NCT01202188|616501966|FG004|Overall Study|Adverse Event|10|||
170589230|NCT01202188|616501962|FG000|Overall Study|Administrative problems|3|||
170589231|NCT01202188|616501963|FG001|Overall Study|Administrative problems|2|||
170589232|NCT01202188|616501964|FG002|Overall Study|Administrative problems|1|||
170589233|NCT01202188|616501965|FG003|Overall Study|Administrative problems|1|||
170589234|NCT01202188|616501966|FG004|Overall Study|Administrative problems|2|||
170589235|NCT01202188|616501962|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170589236|NCT01202188|616501963|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
170589237|NCT01202188|616501964|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
170589238|NCT01202188|616501965|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
170589239|NCT01202188|616501966|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
170589240|NCT01202188|616501962|FG000|Overall Study|Lost to Follow-up|1|||
170589241|NCT01202188|616501963|FG001|Overall Study|Lost to Follow-up|1|||
170589242|NCT01202188|616501964|FG002|Overall Study|Lost to Follow-up|0|||
170589243|NCT01202188|616501965|FG003|Overall Study|Lost to Follow-up|4|||
170589244|NCT01202188|616501966|FG004|Overall Study|Lost to Follow-up|1|||
170589245|NCT01202188|616501962|FG000|Overall Study|Death|1|||
170589246|NCT01202188|616501963|FG001|Overall Study|Death|1|||
170589247|NCT01202188|616501964|FG002|Overall Study|Death|1|||
170589248|NCT01202188|616501965|FG003|Overall Study|Death|1|||
170589249|NCT01202188|616501966|FG004|Overall Study|Death|0|||
170589250|NCT01202188|616501962|FG000|Overall Study|Abnormal test procedure result (s)|0|||
170589251|NCT01202188|616501963|FG001|Overall Study|Abnormal test procedure result (s)|0|||
170589252|NCT01202188|616501964|FG002|Overall Study|Abnormal test procedure result (s)|2|||
170589253|NCT01202188|616501965|FG003|Overall Study|Abnormal test procedure result (s)|0|||
170589254|NCT01202188|616501966|FG004|Overall Study|Abnormal test procedure result (s)|0|||
170589255|NCT00027378|616501967|FG000|Overall Study|Physician Decision|0|||
170650284|NCT01306929|616732870|FG000|Overall Study|Withdrawal by Subject|23|||
170650285|NCT01306929|616732870|FG000|Overall Study|Adverse Event|21|||
170589256|NCT00027378|616501968|FG001|Overall Study|Physician Decision|3|||
170589257|NCT05605691|616501970|FG000|Overall Study|Lost to Follow-up|1|||
170589258|NCT01030874|616501971|FG000|Overall Study|Withdrawal by Subject|1|||
170589259|NCT01030874|616501972|FG001|Overall Study|Withdrawal by Subject|0|||
170589260|NCT01030874|616501971|FG000|Overall Study|Discharged in first 2 weeks|17|||
170589261|NCT01030874|616501972|FG001|Overall Study|Discharged in first 2 weeks|16|||
170589262|NCT01638013|616501973|FG000|Overall Study|Adverse Event|36|||
170589263|NCT01638013|616501974|FG001|Overall Study|Adverse Event|29|||
170589264|NCT01638013|616501975|FG002|Overall Study|Adverse Event|48|||
170589265|NCT01638013|616501973|FG000|Overall Study|Lack of Efficacy|39|||
170589266|NCT01638013|616501974|FG001|Overall Study|Lack of Efficacy|11|||
170589267|NCT01638013|616501975|FG002|Overall Study|Lack of Efficacy|14|||
170589268|NCT01638013|616501973|FG000|Overall Study|Protocol Violation|10|||
170589269|NCT01638013|616501974|FG001|Overall Study|Protocol Violation|7|||
170589270|NCT01638013|616501975|FG002|Overall Study|Protocol Violation|11|||
170589271|NCT01638013|616501973|FG000|Overall Study|Met discontinuation criteria|4|||
170589272|NCT01638013|616501974|FG001|Overall Study|Met discontinuation criteria|0|||
170589273|NCT01638013|616501975|FG002|Overall Study|Met discontinuation criteria|7|||
170589274|NCT01638013|616501973|FG000|Overall Study|Subject Lost to Follow up|1|||
170589275|NCT01638013|616501974|FG001|Overall Study|Subject Lost to Follow up|0|||
170589276|NCT01638013|616501975|FG002|Overall Study|Subject Lost to Follow up|1|||
170589277|NCT01638013|616501973|FG000|Overall Study|Miscellaneous|25|||
170589278|NCT01638013|616501974|FG001|Overall Study|Miscellaneous|19|||
170589279|NCT01638013|616501975|FG002|Overall Study|Miscellaneous|23|||
170589280|NCT01638013|616501973|FG000|Overall Study|Withdrawal of Consent|16|||
170589281|NCT01638013|616501974|FG001|Overall Study|Withdrawal of Consent|12|||
170589282|NCT01638013|616501975|FG002|Overall Study|Withdrawal of Consent|16|||
170589283|NCT01638013|616501973|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
170589284|NCT01638013|616501974|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
170589285|NCT01638013|616501975|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
170589286|NCT01330628|616501982|FG000|Overall Study|Death|2|||
170589287|NCT01330628|616501983|FG001|Overall Study|Death|3|||
170589288|NCT01330628|616501982|FG000|Overall Study|Lost to Follow-up|5|||
170589289|NCT01330628|616501983|FG001|Overall Study|Lost to Follow-up|6|||
170589290|NCT01330628|616501982|FG000|Overall Study|Adverse Event|44|||
170589291|NCT01330628|616501983|FG001|Overall Study|Adverse Event|25|||
170589292|NCT01330628|616501982|FG000|Overall Study|Withdrawn|18|||
170589293|NCT01330628|616501983|FG001|Overall Study|Withdrawn|6|||
170589294|NCT01330628|616501982|FG000|Overall Study|Didn't receive study treatment|1|||
170589295|NCT01330628|616501983|FG001|Overall Study|Didn't receive study treatment|0|||
170589296|NCT01357161|616501984|FG000|Part 1 (Open Label Run-in)|Death|5|||
170589297|NCT01357161|616501985|FG001|Part 1 (Open Label Run-in)|Death|0|||
170589298|NCT01357161|616501986|FG002|Part 1 (Open Label Run-in)|Death|0|||
170589299|NCT01357161|616501984|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
170589300|NCT01357161|616501985|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
170589301|NCT01357161|616501986|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
170589302|NCT01357161|616501984|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
170589303|NCT01357161|616501985|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
170589304|NCT01357161|616501986|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
170589305|NCT01357161|616501984|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
170589306|NCT01357161|616501985|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
170589307|NCT01357161|616501986|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
170589308|NCT01357161|616501984|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
170650286|NCT01306929|616732870|FG000|Overall Study|Physician Decision|13|||
170650287|NCT01306929|616732870|FG000|Overall Study|Death|8|||
170650288|NCT01306929|616732870|FG000|Overall Study|Withdrawal by parent/guardian|5|||
170589309|NCT01357161|616501985|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
170589310|NCT01357161|616501986|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
170589311|NCT01357161|616501984|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
170589312|NCT01357161|616501985|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
170589313|NCT01357161|616501986|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
170589314|NCT01357161|616501984|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
170589315|NCT01357161|616501985|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
170589316|NCT01357161|616501986|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
170589317|NCT01357161|616501984|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
170589318|NCT01357161|616501985|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
170650289|NCT01306929|616732870|FG000|Overall Study|Protocol Violation|3|||
170589319|NCT01357161|616501986|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
170589320|NCT01357161|616501984|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
170589321|NCT01357161|616501985|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
170589322|NCT01357161|616501986|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
170589323|NCT01357161|616501984|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
170589324|NCT01357161|616501985|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
170589325|NCT01357161|616501986|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
170589326|NCT01357161|616501984|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
170589327|NCT01357161|616501985|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
170589328|NCT01357161|616501986|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
170589329|NCT03349645|616501987|FG000|Overall Study|Sponsor Terminated Study|75|||
170589330|NCT03349645|616501987|FG000|Overall Study|Withdrawal by Subject|4|||
170589331|NCT03349645|616501987|FG000|Overall Study|Protocol Violation|1|||
170589332|NCT03349645|616501987|FG000|Overall Study|Other|2|||
170589333|NCT03761394|616501988|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
170589334|NCT03761394|616501989|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
170589335|NCT03761394|616501990|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
170810444|NCT02234141|617315547|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
170810445|NCT02234141|617315548|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
170589336|NCT03761394|616501991|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
170589337|NCT03761394|616501988|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
170589338|NCT03761394|616501989|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
170589339|NCT03761394|616501990|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
170589340|NCT03761394|616501991|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
170589341|NCT03761394|616501988|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
170589342|NCT03761394|616501989|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
170589343|NCT03761394|616501990|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
170589344|NCT03761394|616501991|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
170589345|NCT03761394|616501988|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
170589346|NCT03761394|616501989|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
170589347|NCT03761394|616501990|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
170589348|NCT03761394|616501991|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
170589349|NCT00772369|616501995|FG000|Overall Study|Did not return record release form|1|||
170589350|NCT00075725|616501996|FG000|Overall Study|Adverse Event|6|||
170589351|NCT00075725|616501997|FG001|Overall Study|Adverse Event|6|||
170589352|NCT00075725|616501998|FG002|Overall Study|Adverse Event|20|||
170589353|NCT00075725|616501999|FG003|Overall Study|Adverse Event|8|||
170589354|NCT00075725|616502000|FG004|Overall Study|Adverse Event|4|||
170589355|NCT00075725|616502001|FG005|Overall Study|Adverse Event|38|||
170589356|NCT00075725|616502002|FG006|Overall Study|Adverse Event|3|||
170589357|NCT00075725|616502003|FG007|Overall Study|Adverse Event|51|||
170589358|NCT00075725|616502004|FG008|Overall Study|Adverse Event|15|||
170589359|NCT00075725|616502005|FG009|Overall Study|Adverse Event|4|||
170589360|NCT00075725|616502006|FG010|Overall Study|Adverse Event|2|||
170589361|NCT00075725|616502007|FG011|Overall Study|Adverse Event|2|||
170589362|NCT00075725|616501996|FG000|Overall Study|Death|3|||
170589363|NCT00075725|616501997|FG001|Overall Study|Death|5|||
170589364|NCT00075725|616501998|FG002|Overall Study|Death|10|||
170589365|NCT00075725|616501999|FG003|Overall Study|Death|2|||
170589366|NCT00075725|616502000|FG004|Overall Study|Death|3|||
170589367|NCT00075725|616502001|FG005|Overall Study|Death|25|||
170589368|NCT00075725|616502002|FG006|Overall Study|Death|4|||
170589369|NCT00075725|616502003|FG007|Overall Study|Death|22|||
170589370|NCT00075725|616502004|FG008|Overall Study|Death|14|||
170589371|NCT00075725|616502005|FG009|Overall Study|Death|4|||
170589372|NCT00075725|616502006|FG010|Overall Study|Death|3|||
170589373|NCT00075725|616502007|FG011|Overall Study|Death|0|||
170589374|NCT00075725|616501996|FG000|Overall Study|Lost to Follow-up|1|||
170810446|NCT02234141|617315549|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
170589375|NCT00075725|616501997|FG001|Overall Study|Lost to Follow-up|1|||
170589376|NCT00075725|616501998|FG002|Overall Study|Lost to Follow-up|4|||
170589377|NCT00075725|616501999|FG003|Overall Study|Lost to Follow-up|1|||
170589378|NCT00075725|616502000|FG004|Overall Study|Lost to Follow-up|0|||
170589379|NCT00075725|616502001|FG005|Overall Study|Lost to Follow-up|13|||
170589380|NCT00075725|616502002|FG006|Overall Study|Lost to Follow-up|2|||
170589381|NCT00075725|616502003|FG007|Overall Study|Lost to Follow-up|4|||
170589382|NCT00075725|616502004|FG008|Overall Study|Lost to Follow-up|1|||
170589383|NCT00075725|616502005|FG009|Overall Study|Lost to Follow-up|0|||
170589384|NCT00075725|616502006|FG010|Overall Study|Lost to Follow-up|0|||
170589385|NCT00075725|616502007|FG011|Overall Study|Lost to Follow-up|0|||
170589386|NCT00075725|616501996|FG000|Overall Study|Physician Decision|2|||
170589387|NCT00075725|616501997|FG001|Overall Study|Physician Decision|6|||
170810447|NCT02234141|617315550|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
170810448|NCT02234141|617315551|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
170589388|NCT00075725|616501998|FG002|Overall Study|Physician Decision|5|||
170589389|NCT00075725|616501999|FG003|Overall Study|Physician Decision|8|||
170589390|NCT00075725|616502000|FG004|Overall Study|Physician Decision|4|||
170589391|NCT00075725|616502001|FG005|Overall Study|Physician Decision|19|||
170589392|NCT00075725|616502002|FG006|Overall Study|Physician Decision|3|||
170589393|NCT00075725|616502003|FG007|Overall Study|Physician Decision|17|||
170589394|NCT00075725|616502004|FG008|Overall Study|Physician Decision|5|||
170589395|NCT00075725|616502005|FG009|Overall Study|Physician Decision|0|||
170589396|NCT00075725|616502006|FG010|Overall Study|Physician Decision|1|||
170589397|NCT00075725|616502007|FG011|Overall Study|Physician Decision|0|||
170589398|NCT00075725|616501996|FG000|Overall Study|Pregnancy|0|||
170589399|NCT00075725|616501997|FG001|Overall Study|Pregnancy|0|||
170589400|NCT00075725|616501998|FG002|Overall Study|Pregnancy|0|||
170589401|NCT00075725|616501999|FG003|Overall Study|Pregnancy|0|||
170589402|NCT00075725|616502000|FG004|Overall Study|Pregnancy|0|||
170589403|NCT00075725|616502001|FG005|Overall Study|Pregnancy|1|||
170589404|NCT00075725|616502002|FG006|Overall Study|Pregnancy|0|||
170589405|NCT00075725|616502003|FG007|Overall Study|Pregnancy|1|||
170589406|NCT00075725|616502004|FG008|Overall Study|Pregnancy|0|||
170589407|NCT00075725|616502005|FG009|Overall Study|Pregnancy|0|||
170589408|NCT00075725|616502006|FG010|Overall Study|Pregnancy|0|||
170589409|NCT00075725|616502007|FG011|Overall Study|Pregnancy|0|||
170589410|NCT00075725|616501996|FG000|Overall Study|Protocol Violation|1|||
170589411|NCT00075725|616501997|FG001|Overall Study|Protocol Violation|1|||
170589412|NCT00075725|616501998|FG002|Overall Study|Protocol Violation|0|||
170589413|NCT00075725|616501999|FG003|Overall Study|Protocol Violation|3|||
170589414|NCT00075725|616502000|FG004|Overall Study|Protocol Violation|3|||
170589415|NCT00075725|616502001|FG005|Overall Study|Protocol Violation|2|||
170589416|NCT00075725|616502002|FG006|Overall Study|Protocol Violation|1|||
170589417|NCT00075725|616502003|FG007|Overall Study|Protocol Violation|2|||
170589418|NCT00075725|616502004|FG008|Overall Study|Protocol Violation|3|||
170589419|NCT00075725|616502005|FG009|Overall Study|Protocol Violation|0|||
170589420|NCT00075725|616502006|FG010|Overall Study|Protocol Violation|0|||
170589421|NCT00075725|616502007|FG011|Overall Study|Protocol Violation|1|||
170589422|NCT00075725|616501996|FG000|Overall Study|Withdrawal by Subject|12|||
170589423|NCT00075725|616501997|FG001|Overall Study|Withdrawal by Subject|3|||
170589424|NCT00075725|616501998|FG002|Overall Study|Withdrawal by Subject|6|||
170589425|NCT00075725|616501999|FG003|Overall Study|Withdrawal by Subject|10|||
170589426|NCT00075725|616502000|FG004|Overall Study|Withdrawal by Subject|6|||
170589427|NCT00075725|616502001|FG005|Overall Study|Withdrawal by Subject|27|||
170589428|NCT00075725|616502002|FG006|Overall Study|Withdrawal by Subject|7|||
170589429|NCT00075725|616502003|FG007|Overall Study|Withdrawal by Subject|31|||
170589430|NCT00075725|616502004|FG008|Overall Study|Withdrawal by Subject|10|||
170589431|NCT00075725|616502005|FG009|Overall Study|Withdrawal by Subject|2|||
170589432|NCT00075725|616502006|FG010|Overall Study|Withdrawal by Subject|0|||
170589433|NCT00075725|616502007|FG011|Overall Study|Withdrawal by Subject|0|||
170589434|NCT00075725|616501996|FG000|Overall Study|Disease Progression, all other reasons|17|||
170589435|NCT00075725|616501997|FG001|Overall Study|Disease Progression, all other reasons|5|||
170589436|NCT00075725|616501998|FG002|Overall Study|Disease Progression, all other reasons|33|||
170589437|NCT00075725|616501999|FG003|Overall Study|Disease Progression, all other reasons|6|||
170589438|NCT00075725|616502000|FG004|Overall Study|Disease Progression, all other reasons|21|||
170589439|NCT00075725|616502001|FG005|Overall Study|Disease Progression, all other reasons|59|||
170589440|NCT00075725|616502002|FG006|Overall Study|Disease Progression, all other reasons|20|||
170589441|NCT00075725|616502003|FG007|Overall Study|Disease Progression, all other reasons|46|||
170589442|NCT00075725|616502004|FG008|Overall Study|Disease Progression, all other reasons|21|||
170589443|NCT00075725|616502005|FG009|Overall Study|Disease Progression, all other reasons|4|||
170589444|NCT00075725|616502006|FG010|Overall Study|Disease Progression, all other reasons|0|||
170589445|NCT00075725|616502007|FG011|Overall Study|Disease Progression, all other reasons|5|||
170589446|NCT00075725|616501996|FG000|Overall Study|Patient off treatment|0|||
170589447|NCT00075725|616501997|FG001|Overall Study|Patient off treatment|0|||
170589448|NCT00075725|616501998|FG002|Overall Study|Patient off treatment|1|||
170589449|NCT00075725|616501999|FG003|Overall Study|Patient off treatment|2|||
170589450|NCT00075725|616502000|FG004|Overall Study|Patient off treatment|1|||
170589451|NCT00075725|616502001|FG005|Overall Study|Patient off treatment|0|||
170589452|NCT00075725|616502002|FG006|Overall Study|Patient off treatment|0|||
170589453|NCT00075725|616502003|FG007|Overall Study|Patient off treatment|2|||
170589454|NCT00075725|616502004|FG008|Overall Study|Patient off treatment|1|||
170589455|NCT00075725|616502005|FG009|Overall Study|Patient off treatment|0|||
170589456|NCT00075725|616502006|FG010|Overall Study|Patient off treatment|0|||
170589457|NCT00075725|616502007|FG011|Overall Study|Patient off treatment|0|||
170589458|NCT00075725|616501996|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
170589459|NCT00075725|616501997|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
170589460|NCT00075725|616501998|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
170589461|NCT00075725|616501999|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
170589462|NCT00075725|616502000|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
170589463|NCT00075725|616502001|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
170589464|NCT00075725|616502002|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
170589465|NCT00075725|616502003|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
170589466|NCT00075725|616502004|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
170589467|NCT00075725|616502005|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
170589468|NCT00075725|616502006|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
170589469|NCT00075725|616502007|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
170589470|NCT00075725|616501996|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
170589471|NCT00075725|616501997|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
170589472|NCT00075725|616501998|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
170911329|NCT05593432|617679163|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
170911330|NCT05593432|617679164|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
170911331|NCT01926886|617679165|FG000|Overall Study|Administrative/other|1|||
170911332|NCT01926886|617679166|FG001|Overall Study|Administrative/other|0|||
170911333|NCT01926886|617679165|FG000|Overall Study|Adverse event/intercurrent illness|4|||
170911334|NCT01926886|617679166|FG001|Overall Study|Adverse event/intercurrent illness|0|||
170911335|NCT01926886|617679165|FG000|Overall Study|Disease progression/recurrence|4|||
170911336|NCT01926886|617679166|FG001|Overall Study|Disease progression/recurrence|0|||
170911337|NCT01926886|617679165|FG000|Overall Study|Withdrawal by Subject|15|||
170911338|NCT01926886|617679166|FG001|Overall Study|Withdrawal by Subject|0|||
170911339|NCT01926886|617679165|FG000|Overall Study|Failure to return|3|||
170911340|NCT01926886|617679166|FG001|Overall Study|Failure to return|0|||
170911341|NCT01926886|617679165|FG000|Overall Study|Recurrence of disease|1|||
170911342|NCT01926886|617679166|FG001|Overall Study|Recurrence of disease|0|||
170911343|NCT01926886|617679165|FG000|Overall Study|Progression of disease|2|||
170911344|NCT01926886|617679166|FG001|Overall Study|Progression of disease|0|||
170911345|NCT01926886|617679165|FG000|Overall Study|Death|1|||
170911346|NCT01926886|617679166|FG001|Overall Study|Death|0|||
170911347|NCT01926886|617679165|FG000|Overall Study|Did not cooperate|1|||
170911348|NCT01926886|617679166|FG001|Overall Study|Did not cooperate|0|||
170911349|NCT02986373|617679167|FG000|Overall Study|Adverse Event|4|||
170911350|NCT02986373|617679167|FG000|Overall Study|Lost to Follow-up|1|||
170911351|NCT02986373|617679167|FG000|Overall Study|Withdrawal by Subject|10|||
170911352|NCT02986373|617679167|FG000|Overall Study|Other|24|||
170911353|NCT02273973|617679168|FG000|Overall Study|Adverse Event|4|||
170911354|NCT02273973|617679169|FG001|Overall Study|Adverse Event|0|||
170911355|NCT02273973|617679168|FG000|Overall Study|Withdrawal by Subject|2|||
170911356|NCT02273973|617679169|FG001|Overall Study|Withdrawal by Subject|3|||
170911357|NCT02273973|617679168|FG000|Overall Study|Death|1|||
170911358|NCT02273973|617679169|FG001|Overall Study|Death|0|||
170911359|NCT02273973|617679168|FG000|Overall Study|Non-compliance|1|||
170911360|NCT02273973|617679169|FG001|Overall Study|Non-compliance|0|||
170911361|NCT02273973|617679168|FG000|Overall Study|Protocol Violation|1|||
170911362|NCT02273973|617679169|FG001|Overall Study|Protocol Violation|0|||
170911363|NCT02273973|617679168|FG000|Overall Study|Progression of disease|0|||
170911364|NCT02273973|617679169|FG001|Overall Study|Progression of disease|2|||
170911365|NCT02273973|617679168|FG000|Overall Study|Lost to Follow-up|0|||
170911366|NCT02273973|617679169|FG001|Overall Study|Lost to Follow-up|1|||
170911367|NCT02273973|617679168|FG000|Overall Study|Physician Decision|0|||
170911368|NCT02273973|617679169|FG001|Overall Study|Physician Decision|1|||
170911369|NCT02273973|617679168|FG000|Overall Study|Reason not specified|0|||
170911370|NCT02273973|617679169|FG001|Overall Study|Reason not specified|1|||
170911371|NCT03246529|617679170|FG000|Core Study (until 100 d post-transplant)|Adverse Event|0|||
170911372|NCT03246529|617679171|FG001|Core Study (until 100 d post-transplant)|Adverse Event|2|||
170911373|NCT03246529|617679172|FG002|Core Study (until 100 d post-transplant)|Adverse Event|0|||
170911374|NCT03246529|617679170|FG000|Core Study (until 100 d post-transplant)|Lost to Follow-up|0|||
170911375|NCT03246529|617679171|FG001|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
170911376|NCT03246529|617679172|FG002|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
170911377|NCT03246529|617679170|FG000|Core Study (until 100 d post-transplant)|Other Reasons|0|||
170911378|NCT03246529|617679171|FG001|Core Study (until 100 d post-transplant)|Other Reasons|2|||
170911379|NCT03246529|617679172|FG002|Core Study (until 100 d post-transplant)|Other Reasons|2|||
170911380|NCT03246529|617679170|FG000|Core Study (until 100 d post-transplant)|Physician Decision|0|||
170911381|NCT03246529|617679171|FG001|Core Study (until 100 d post-transplant)|Physician Decision|0|||
170911382|NCT03246529|617679172|FG002|Core Study (until 100 d post-transplant)|Physician Decision|1|||
170589473|NCT00075725|616501999|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
170589474|NCT00075725|616502000|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
170589475|NCT00075725|616502001|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
170911383|NCT03246529|617679170|FG000|Core Study (until 100 d post-transplant)|Withdrawal by Subject|0|||
170911384|NCT03246529|617679171|FG001|Core Study (until 100 d post-transplant)|Withdrawal by Subject|1|||
170911385|NCT03246529|617679172|FG002|Core Study (until 100 d post-transplant)|Withdrawal by Subject|4|||
170911386|NCT03246529|617679170|FG000|Follow-up period at 1 year FU Completion|Disease progression|2|||
170911387|NCT03246529|617679171|FG001|Follow-up period at 1 year FU Completion|Disease progression|1|||
170911388|NCT03246529|617679172|FG002|Follow-up period at 1 year FU Completion|Disease progression|1|||
170911389|NCT03246529|617679170|FG000|Follow-up period at 1 year FU Completion|Lost to Follow-up|1|||
170911390|NCT03246529|617679171|FG001|Follow-up period at 1 year FU Completion|Lost to Follow-up|3|||
170911391|NCT03246529|617679172|FG002|Follow-up period at 1 year FU Completion|Lost to Follow-up|0|||
170911392|NCT03246529|617679170|FG000|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
170911393|NCT03246529|617679171|FG001|Follow-up period at 1 year FU Completion|Withdrawal by Subject|3|||
170911394|NCT03246529|617679172|FG002|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
170911395|NCT03246529|617679170|FG000|Follow-up period at 1 year FU Completion|Death|0|||
170911396|NCT03246529|617679171|FG001|Follow-up period at 1 year FU Completion|Death|0|||
170911397|NCT03246529|617679172|FG002|Follow-up period at 1 year FU Completion|Death|1|||
170911398|NCT01287117|617679173|FG000|Overall Study|Adverse Event|2|||
170911399|NCT01287117|617679174|FG001|Overall Study|Adverse Event|1|||
170911400|NCT01287117|617679175|FG002|Overall Study|Adverse Event|1|||
170911401|NCT01287117|617679176|FG003|Overall Study|Adverse Event|1|||
170911402|NCT01287117|617679173|FG000|Overall Study|Lost to Follow-up|1|||
170911403|NCT01287117|617679174|FG001|Overall Study|Lost to Follow-up|1|||
170911404|NCT01287117|617679175|FG002|Overall Study|Lost to Follow-up|0|||
170911405|NCT01287117|617679176|FG003|Overall Study|Lost to Follow-up|0|||
170911406|NCT01287117|617679173|FG000|Overall Study|Physician Decision|0|||
170911407|NCT01287117|617679174|FG001|Overall Study|Physician Decision|1|||
170911408|NCT01287117|617679175|FG002|Overall Study|Physician Decision|1|||
170911409|NCT01287117|617679176|FG003|Overall Study|Physician Decision|1|||
170911410|NCT01287117|617679173|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
170911411|NCT01287117|617679174|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
170911412|NCT01287117|617679175|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
170911413|NCT01287117|617679176|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
170911414|NCT01287117|617679173|FG000|Overall Study|Disease Progression|10|||
170911415|NCT01287117|617679174|FG001|Overall Study|Disease Progression|5|||
170911416|NCT01287117|617679175|FG002|Overall Study|Disease Progression|6|||
170911417|NCT01287117|617679176|FG003|Overall Study|Disease Progression|5|||
170911418|NCT01769404|617679177|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
170911419|NCT01769404|617679178|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
170911420|NCT01769404|617679177|FG000|Treatment Period 1|Withdrawal by Subject|3|||
170589476|NCT00075725|616502002|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
170589477|NCT00075725|616502003|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
170589478|NCT00075725|616502004|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
170589479|NCT00075725|616502005|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
170589480|NCT00075725|616502006|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
170589481|NCT00075725|616502007|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
170589482|NCT00075725|616501996|FG000|Overall Study|Pt non compliant with therapy|2|||
170589483|NCT00075725|616501997|FG001|Overall Study|Pt non compliant with therapy|1|||
170589484|NCT00075725|616501998|FG002|Overall Study|Pt non compliant with therapy|1|||
170589485|NCT00075725|616501999|FG003|Overall Study|Pt non compliant with therapy|0|||
170589486|NCT00075725|616502000|FG004|Overall Study|Pt non compliant with therapy|2|||
170589487|NCT00075725|616502001|FG005|Overall Study|Pt non compliant with therapy|14|||
170589488|NCT00075725|616502002|FG006|Overall Study|Pt non compliant with therapy|2|||
170589489|NCT00075725|616502003|FG007|Overall Study|Pt non compliant with therapy|5|||
170589490|NCT00075725|616502004|FG008|Overall Study|Pt non compliant with therapy|3|||
170589491|NCT00075725|616502005|FG009|Overall Study|Pt non compliant with therapy|0|||
170589492|NCT00075725|616502006|FG010|Overall Study|Pt non compliant with therapy|0|||
170589493|NCT00075725|616502007|FG011|Overall Study|Pt non compliant with therapy|0|||
170589494|NCT00075725|616501996|FG000|Overall Study|Pt age out of range for treatment|0|||
170589495|NCT00075725|616501997|FG001|Overall Study|Pt age out of range for treatment|1|||
170589496|NCT00075725|616501998|FG002|Overall Study|Pt age out of range for treatment|0|||
170589497|NCT00075725|616501999|FG003|Overall Study|Pt age out of range for treatment|0|||
170589498|NCT00075725|616502000|FG004|Overall Study|Pt age out of range for treatment|0|||
170589499|NCT00075725|616502001|FG005|Overall Study|Pt age out of range for treatment|1|||
170589500|NCT00075725|616502002|FG006|Overall Study|Pt age out of range for treatment|0|||
170589501|NCT00075725|616502003|FG007|Overall Study|Pt age out of range for treatment|1|||
170650290|NCT01306929|616732870|FG000|Overall Study|Non-compliance with study drug|2|||
170589502|NCT00075725|616502004|FG008|Overall Study|Pt age out of range for treatment|0|||
170589503|NCT00075725|616502005|FG009|Overall Study|Pt age out of range for treatment|0|||
170650291|NCT01306929|616732870|FG000|Overall Study|Lost to Follow-up|2|||
170650292|NCT01306929|616732870|FG000|Overall Study|Various|17|||
170650293|NCT01870076|616732872|FG000|Overall Study|Withdrawal by Subject|1|||
170650294|NCT01870076|616732873|FG001|Overall Study|Withdrawal by Subject|0|||
170650295|NCT01870076|616732874|FG002|Overall Study|Withdrawal by Subject|1|||
170911421|NCT01769404|617679178|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170911422|NCT01769404|617679177|FG000|Treatment Period 1|Sponsor decision|1|||
170911423|NCT01769404|617679178|FG001|Treatment Period 1|Sponsor decision|0|||
170911424|NCT01769404|617679177|FG000|Treatment Period 2|Sponsor decision|7|||
170589504|NCT00075725|616502006|FG010|Overall Study|Pt age out of range for treatment|0|||
170589505|NCT00075725|616502007|FG011|Overall Study|Pt age out of range for treatment|0|||
170589506|NCT00075725|616501996|FG000|Overall Study|Insurance issues|0|||
170589507|NCT00075725|616501997|FG001|Overall Study|Insurance issues|1|||
170589508|NCT00075725|616501998|FG002|Overall Study|Insurance issues|0|||
170589509|NCT00075725|616501999|FG003|Overall Study|Insurance issues|1|||
170589510|NCT00075725|616502000|FG004|Overall Study|Insurance issues|1|||
170589511|NCT00075725|616502001|FG005|Overall Study|Insurance issues|1|||
170589512|NCT00075725|616502002|FG006|Overall Study|Insurance issues|0|||
170589513|NCT00075725|616502003|FG007|Overall Study|Insurance issues|1|||
170589514|NCT00075725|616502004|FG008|Overall Study|Insurance issues|0|||
170589515|NCT00075725|616502005|FG009|Overall Study|Insurance issues|0|||
170589516|NCT00075725|616502006|FG010|Overall Study|Insurance issues|0|||
170589517|NCT00075725|616502007|FG011|Overall Study|Insurance issues|0|||
170589518|NCT00075725|616501996|FG000|Overall Study|MRD positive after extended ind|0|||
170589519|NCT00075725|616501997|FG001|Overall Study|MRD positive after extended ind|1|||
170589520|NCT00075725|616501998|FG002|Overall Study|MRD positive after extended ind|1|||
170589521|NCT00075725|616501999|FG003|Overall Study|MRD positive after extended ind|0|||
170589522|NCT00075725|616502000|FG004|Overall Study|MRD positive after extended ind|1|||
170589523|NCT00075725|616502001|FG005|Overall Study|MRD positive after extended ind|2|||
170589524|NCT00075725|616502002|FG006|Overall Study|MRD positive after extended ind|0|||
170589525|NCT00075725|616502003|FG007|Overall Study|MRD positive after extended ind|1|||
170589526|NCT00075725|616502004|FG008|Overall Study|MRD positive after extended ind|0|||
170589527|NCT00075725|616502005|FG009|Overall Study|MRD positive after extended ind|0|||
170589528|NCT00075725|616502006|FG010|Overall Study|MRD positive after extended ind|0|||
170589529|NCT00075725|616502007|FG011|Overall Study|MRD positive after extended ind|0|||
170589530|NCT00075725|616501996|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
170589531|NCT00075725|616501997|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
170589532|NCT00075725|616501998|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
170589533|NCT00075725|616501999|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
170589534|NCT00075725|616502000|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
170589535|NCT00075725|616502001|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
170589536|NCT00075725|616502002|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
170589537|NCT00075725|616502003|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
170589538|NCT00075725|616502004|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
170589539|NCT00075725|616502005|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
170589540|NCT00075725|616502006|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
170589541|NCT00075725|616502007|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
170589542|NCT00075725|616501996|FG000|Overall Study|Inevaluable|1|||
170589543|NCT00075725|616501997|FG001|Overall Study|Inevaluable|1|||
170589544|NCT00075725|616501998|FG002|Overall Study|Inevaluable|4|||
170589545|NCT00075725|616501999|FG003|Overall Study|Inevaluable|2|||
170589546|NCT00075725|616502000|FG004|Overall Study|Inevaluable|2|||
170589547|NCT00075725|616502001|FG005|Overall Study|Inevaluable|9|||
170589548|NCT00075725|616502002|FG006|Overall Study|Inevaluable|1|||
170810449|NCT02234141|617315552|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
170810450|NCT02234141|617315553|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
170810451|NCT02234141|617315547|FG000|Treatment Period (24 Weeks)|Death|1|||
170810452|NCT02234141|617315548|FG001|Treatment Period (24 Weeks)|Death|2|||
170810453|NCT02234141|617315549|FG002|Treatment Period (24 Weeks)|Death|0|||
170810454|NCT02234141|617315550|FG003|Treatment Period (24 Weeks)|Death|1|||
170810455|NCT02234141|617315551|FG004|Treatment Period (24 Weeks)|Death|0|||
170810456|NCT02234141|617315552|FG005|Treatment Period (24 Weeks)|Death|0|||
170810457|NCT02234141|617315553|FG006|Treatment Period (24 Weeks)|Death|0|||
170810458|NCT02234141|617315547|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
170810459|NCT02234141|617315548|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
170810460|NCT02234141|617315549|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
170810461|NCT02234141|617315550|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
170810462|NCT02234141|617315551|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
170589549|NCT00075725|616502003|FG007|Overall Study|Inevaluable|11|||
170589550|NCT00075725|616502004|FG008|Overall Study|Inevaluable|2|||
170589551|NCT00075725|616502005|FG009|Overall Study|Inevaluable|0|||
170589552|NCT00075725|616502006|FG010|Overall Study|Inevaluable|1|||
170589553|NCT00075725|616502007|FG011|Overall Study|Inevaluable|0|||
170589554|NCT00075725|616501996|FG000|Overall Study|Other|4|||
170589555|NCT00075725|616501997|FG001|Overall Study|Other|2|||
170589556|NCT00075725|616501998|FG002|Overall Study|Other|1|||
170589557|NCT00075725|616501999|FG003|Overall Study|Other|1|||
170589558|NCT00075725|616502000|FG004|Overall Study|Other|1|||
170589559|NCT00075725|616502001|FG005|Overall Study|Other|4|||
170810463|NCT02234141|617315552|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
170810464|NCT02234141|617315553|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
170810465|NCT02234141|617315547|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
170589560|NCT00075725|616502002|FG006|Overall Study|Other|2|||
170589561|NCT00075725|616502003|FG007|Overall Study|Other|9|||
170589562|NCT00075725|616502004|FG008|Overall Study|Other|2|||
170589563|NCT00075725|616502005|FG009|Overall Study|Other|1|||
170589564|NCT00075725|616502006|FG010|Overall Study|Other|0|||
170589565|NCT00075725|616502007|FG011|Overall Study|Other|3|||
170589566|NCT00075725|616501996|FG000|Overall Study|Pt trying to find a BM donor|0|||
170589567|NCT00075725|616501997|FG001|Overall Study|Pt trying to find a BM donor|1|||
170589568|NCT00075725|616501998|FG002|Overall Study|Pt trying to find a BM donor|0|||
170589569|NCT00075725|616501999|FG003|Overall Study|Pt trying to find a BM donor|0|||
170589570|NCT00075725|616502000|FG004|Overall Study|Pt trying to find a BM donor|0|||
170589571|NCT00075725|616502001|FG005|Overall Study|Pt trying to find a BM donor|0|||
170589572|NCT00075725|616502002|FG006|Overall Study|Pt trying to find a BM donor|0|||
170810466|NCT02234141|617315548|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
170810467|NCT02234141|617315549|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
170810468|NCT02234141|617315550|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
170810469|NCT02234141|617315551|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
170810470|NCT02234141|617315552|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
170810471|NCT02234141|617315553|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
170810472|NCT02234141|617315547|FG000|Long-Term Treatment Period|Death|0|||
170810473|NCT02234141|617315548|FG001|Long-Term Treatment Period|Death|0|||
170810474|NCT02234141|617315549|FG002|Long-Term Treatment Period|Death|0|||
170810475|NCT02234141|617315550|FG003|Long-Term Treatment Period|Death|0|||
170810476|NCT02234141|617315551|FG004|Long-Term Treatment Period|Death|0|||
170810477|NCT02234141|617315552|FG005|Long-Term Treatment Period|Death|1|||
170810478|NCT02234141|617315553|FG006|Long-Term Treatment Period|Death|0|||
170810479|NCT02234141|617315547|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
170810480|NCT02234141|617315548|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
170810481|NCT02234141|617315549|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
170810482|NCT02234141|617315550|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
170810483|NCT02234141|617315551|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
170810484|NCT02234141|617315552|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
170810485|NCT02234141|617315553|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
170810486|NCT02234141|617315547|FG000|Long-Term Treatment Period|Adverse Event|4|||
170810487|NCT02234141|617315548|FG001|Long-Term Treatment Period|Adverse Event|0|||
170810488|NCT02234141|617315549|FG002|Long-Term Treatment Period|Adverse Event|5|||
170810489|NCT02234141|617315550|FG003|Long-Term Treatment Period|Adverse Event|0|||
170810490|NCT02234141|617315551|FG004|Long-Term Treatment Period|Adverse Event|1|||
170810491|NCT02234141|617315552|FG005|Long-Term Treatment Period|Adverse Event|1|||
170810492|NCT02234141|617315553|FG006|Long-Term Treatment Period|Adverse Event|1|||
170810493|NCT02234141|617315547|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
170810494|NCT02234141|617315548|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
170810495|NCT02234141|617315549|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
170810496|NCT02234141|617315550|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
170810497|NCT02234141|617315551|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
170810498|NCT02234141|617315552|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
170810499|NCT02234141|617315553|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
170810500|NCT02234141|617315547|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
170810501|NCT02234141|617315548|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
170810502|NCT02234141|617315549|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
170810503|NCT02234141|617315550|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
170810504|NCT02234141|617315551|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
170810505|NCT02234141|617315552|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
170810506|NCT02234141|617315553|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
170810507|NCT03265132|617315554|FG000|Overall Study|Adverse Event|0|||
170810508|NCT03265132|617315555|FG001|Overall Study|Adverse Event|1|||
170810509|NCT03265132|617315554|FG000|Overall Study|Lack of Efficacy|0|||
170810510|NCT03265132|617315555|FG001|Overall Study|Lack of Efficacy|2|||
170810511|NCT03265132|617315554|FG000|Overall Study|Progressive disease|0|||
170810512|NCT03265132|617315555|FG001|Overall Study|Progressive disease|2|||
170911425|NCT01769404|617679178|FG001|Treatment Period 2|Sponsor decision|0|||
170911426|NCT03191396|617680879|FG000|Overall Study|Lost to Follow-up|0|||
170911427|NCT03191396|617680880|FG001|Overall Study|Lost to Follow-up|3|||
170911428|NCT03191396|617680879|FG000|Overall Study|Withdrawal by Subject|3|||
170911429|NCT03191396|617680880|FG001|Overall Study|Withdrawal by Subject|2|||
170911430|NCT05094154|617680883|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
170911431|NCT05094154|617680884|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
170589573|NCT00075725|616502003|FG007|Overall Study|Pt trying to find a BM donor|0|||
170589574|NCT00075725|616502004|FG008|Overall Study|Pt trying to find a BM donor|0|||
170810513|NCT03265132|617315554|FG000|Overall Study|Withdrawal by Subject|0|||
170810514|NCT03265132|617315555|FG001|Overall Study|Withdrawal by Subject|1|||
170810515|NCT02095678|617315556|FG000|Overall Study|Withdrawal by Subject|0|||
170810516|NCT02095678|617315557|FG001|Overall Study|Withdrawal by Subject|1|||
170810517|NCT02095678|617315556|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
170810518|NCT02095678|617315557|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
170589575|NCT00075725|616502005|FG009|Overall Study|Pt trying to find a BM donor|0|||
170911432|NCT05094154|617680883|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
170911433|NCT05094154|617680884|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
170911434|NCT02452970|617680885|FG000|Overall Study|Adverse Event|1|||
170911435|NCT02100657|617680892|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
170911436|NCT02100657|617680893|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
170911437|NCT02100657|617680894|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
170911438|NCT02100657|617680892|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
170911439|NCT02100657|617680893|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
170911440|NCT02100657|617680894|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
170911441|NCT02100657|617680892|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
170911442|NCT02100657|617680893|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
170911443|NCT02100657|617680894|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
170911444|NCT02100657|617680892|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
170911445|NCT02100657|617680893|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
170911446|NCT02100657|617680894|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
170911447|NCT02100657|617680892|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
170911448|NCT02100657|617680893|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
170911449|NCT02100657|617680894|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
170911450|NCT02100657|617680892|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
170911451|NCT02100657|617680893|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
170911452|NCT02100657|617680894|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
170911453|NCT02100657|617680892|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
170911454|NCT02100657|617680893|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
170911455|NCT02100657|617680894|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
170911456|NCT02100657|617680892|FG000|Cohort 3: Dose Level 3|Death|0|||
170911457|NCT02100657|617680893|FG001|Cohort 3: Dose Level 3|Death|0|||
170911458|NCT02100657|617680894|FG002|Cohort 3: Dose Level 3|Death|1|||
170911459|NCT02100657|617680892|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
170911460|NCT02100657|617680893|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
170911461|NCT02100657|617680894|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
170911462|NCT02100657|617680892|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
170911463|NCT02100657|617680893|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
170911464|NCT02100657|617680894|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
170911465|NCT02100657|617680892|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
170911466|NCT02100657|617680893|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
170911467|NCT02100657|617680894|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
170911468|NCT02100657|617680892|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
170911469|NCT02100657|617680893|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
170911470|NCT02100657|617680894|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
170911471|NCT02100657|617680892|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
170911472|NCT02100657|617680893|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
170911473|NCT02100657|617680894|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
170911474|NCT01240811|617680897|FG000|Overall Study|Physician Decision|0|||
170911475|NCT01240811|617680898|FG001|Overall Study|Physician Decision|1|||
170911476|NCT01240811|617680899|FG002|Overall Study|Physician Decision|0|||
170911477|NCT01240811|617680897|FG000|Overall Study|Withdrawal by Subject|0|||
170911478|NCT01240811|617680898|FG001|Overall Study|Withdrawal by Subject|0|||
170911479|NCT01240811|617680899|FG002|Overall Study|Withdrawal by Subject|1|||
170911480|NCT01543490|617680906|FG000|Overall Study|Adverse Event|4|||
170911481|NCT01543490|617680907|FG001|Overall Study|Adverse Event|0|||
170911482|NCT01543490|617680906|FG000|Overall Study|Physician Decision|1|||
170911483|NCT01543490|617680907|FG001|Overall Study|Physician Decision|0|||
170911484|NCT01543490|617680906|FG000|Overall Study|Lack of Efficacy|3|||
170911485|NCT01543490|617680907|FG001|Overall Study|Lack of Efficacy|3|||
170911486|NCT01543490|617680906|FG000|Overall Study|Lost to Follow-up|5|||
170589576|NCT00075725|616502006|FG010|Overall Study|Pt trying to find a BM donor|0|||
170589577|NCT00075725|616502007|FG011|Overall Study|Pt trying to find a BM donor|0|||
170589578|NCT00075725|616501996|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
170589579|NCT00075725|616501997|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
170589580|NCT00075725|616501998|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
170589581|NCT00075725|616501999|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
170589582|NCT00075725|616502000|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
170911487|NCT01543490|617680907|FG001|Overall Study|Lost to Follow-up|0|||
170911488|NCT01543490|617680906|FG000|Overall Study|Withdrawal by Subject|2|||
170911489|NCT01543490|617680907|FG001|Overall Study|Withdrawal by Subject|0|||
170911490|NCT01543490|617680906|FG000|Overall Study|Other-Various Administrative Reasons|1|||
170911491|NCT01543490|617680907|FG001|Overall Study|Other-Various Administrative Reasons|2|||
170911492|NCT04168645|617680910|FG000|Overall Study|Lost to Follow-up|23|||
170911493|NCT04168645|617680911|FG001|Overall Study|Lost to Follow-up|28|||
170911494|NCT04168645|617680912|FG002|Overall Study|Lost to Follow-up|15|||
170911495|NCT04168645|617680913|FG003|Overall Study|Lost to Follow-up|12|||
170589583|NCT00075725|616502001|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
170589584|NCT00075725|616502002|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
170810519|NCT02095678|617315556|FG000|Overall Study|lesion impacted by previous treatment|1|||
170810520|NCT02095678|617315557|FG001|Overall Study|lesion impacted by previous treatment|1|||
170810521|NCT02095678|617315556|FG000|Overall Study|No Confirmed Diagnosis|0|||
170810522|NCT02095678|617315557|FG001|Overall Study|No Confirmed Diagnosis|3|||
170810523|NCT02095678|617315556|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
170810524|NCT02095678|617315557|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
170810525|NCT02095678|617315556|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
170810526|NCT02095678|617315557|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
170810527|NCT00666705|617315563|FG000|Overall Study|Withdrawal by Subject|1|||
170589585|NCT00075725|616502003|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
170589586|NCT00075725|616502004|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
170589587|NCT00075725|616502005|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
170589588|NCT00075725|616502006|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
170589589|NCT00075725|616502007|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
170589590|NCT00075725|616501996|FG000|Overall Study|Unsuccessful institutional transfer|0|||
170589591|NCT00075725|616501997|FG001|Overall Study|Unsuccessful institutional transfer|0|||
170589592|NCT00075725|616501998|FG002|Overall Study|Unsuccessful institutional transfer|2|||
170589593|NCT00075725|616501999|FG003|Overall Study|Unsuccessful institutional transfer|0|||
170589594|NCT00075725|616502000|FG004|Overall Study|Unsuccessful institutional transfer|0|||
170589595|NCT00075725|616502001|FG005|Overall Study|Unsuccessful institutional transfer|0|||
170589596|NCT00075725|616502002|FG006|Overall Study|Unsuccessful institutional transfer|0|||
170810528|NCT03259568|617315564|FG000|Overall Study|Participant performance was low|3|||
170810529|NCT02706483|617315565|FG000|Overall Study|Adverse Event|97|||
170810530|NCT02706483|617315565|FG000|Overall Study|Death|1|||
170810531|NCT02706483|617315565|FG000|Overall Study|Lack of Efficacy|39|||
170810532|NCT02706483|617315565|FG000|Overall Study|Lost to Follow-up|101|||
170810533|NCT02706483|617315565|FG000|Overall Study|Non-compliance with study drug|15|||
170810534|NCT02706483|617315565|FG000|Overall Study|Physician Decision|6|||
170810535|NCT02706483|617315565|FG000|Overall Study|Pregnancy|6|||
170810536|NCT02706483|617315565|FG000|Overall Study|Protocol Violation|18|||
170810537|NCT02706483|617315565|FG000|Overall Study|Withdrawal by Subject|136|||
170810538|NCT02706483|617315565|FG000|Overall Study|Non-compliance with visits|6|||
170810539|NCT02706483|617315565|FG000|Overall Study|Site closure|4|||
170810540|NCT02706483|617315565|FG000|Overall Study|Subject moved|1|||
170810541|NCT04660799|617315566|FG000|Overall Study|Progressive Disease|1|||
170810542|NCT04660799|617315567|FG001|Overall Study|Progressive Disease|1|||
170810543|NCT04660799|617315566|FG000|Overall Study|Death|2|||
170810544|NCT04660799|617315567|FG001|Overall Study|Death|1|||
170810545|NCT04660799|617315566|FG000|Overall Study|Adverse Event|2|||
170810546|NCT04660799|617315567|FG001|Overall Study|Adverse Event|1|||
170810547|NCT04660799|617315566|FG000|Overall Study|Withdrawal by Subject|2|||
170810548|NCT04660799|617315567|FG001|Overall Study|Withdrawal by Subject|5|||
170810549|NCT04248868|617315568|FG000|Overall Study|Death|1|||
170810550|NCT04248868|617315568|FG000|Overall Study|Lost to Follow-up|3|||
170810551|NCT04248868|617315568|FG000|Overall Study|Protocol Violation|2|||
170810552|NCT03131713|617315573|FG000|Overall Study|Lost to Follow-up|5|||
170810553|NCT03131713|617315574|FG001|Overall Study|Lost to Follow-up|0|||
170589597|NCT00075725|616502003|FG007|Overall Study|Unsuccessful institutional transfer|0|||
170589598|NCT00075725|616502004|FG008|Overall Study|Unsuccessful institutional transfer|0|||
170589599|NCT00075725|616502005|FG009|Overall Study|Unsuccessful institutional transfer|1|||
170589600|NCT00075725|616502006|FG010|Overall Study|Unsuccessful institutional transfer|0|||
170589601|NCT00075725|616502007|FG011|Overall Study|Unsuccessful institutional transfer|0|||
170589602|NCT00075725|616501996|FG000|Overall Study|specimen(s) not submitted|0|||
170589603|NCT00075725|616501997|FG001|Overall Study|specimen(s) not submitted|0|||
170589604|NCT00075725|616501998|FG002|Overall Study|specimen(s) not submitted|2|||
170589605|NCT00075725|616501999|FG003|Overall Study|specimen(s) not submitted|0|||
170589606|NCT00075725|616502000|FG004|Overall Study|specimen(s) not submitted|0|||
170589607|NCT00075725|616502001|FG005|Overall Study|specimen(s) not submitted|0|||
170589608|NCT00075725|616502002|FG006|Overall Study|specimen(s) not submitted|0|||
170589609|NCT00075725|616502003|FG007|Overall Study|specimen(s) not submitted|0|||
170650296|NCT01870076|616732875|FG003|Overall Study|Withdrawal by Subject|0|||
170650297|NCT00995566|616732876|FG000|Overall Study|Adverse Event|2|||
170650298|NCT00995566|616732876|FG000|Overall Study|Early study termination|52|||
170589610|NCT00075725|616502004|FG008|Overall Study|specimen(s) not submitted|0|||
170589611|NCT00075725|616502005|FG009|Overall Study|specimen(s) not submitted|0|||
170810554|NCT01976507|617315575|FG000|Overall Study|Adverse Event|6|||
170810555|NCT01976507|617315575|FG000|Overall Study|ablation not done, drug not given|1|||
170810556|NCT01972776|617315576|FG000|Part 1|Withdrawal by Subject|0|||
170810557|NCT01972776|617315577|FG001|Part 1|Withdrawal by Subject|0|||
170810558|NCT01972776|617315578|FG002|Part 1|Withdrawal by Subject|1|||
170810559|NCT01972776|617315579|FG003|Part 1|Withdrawal by Subject|0|||
170810560|NCT01972776|617315580|FG004|Part 1|Withdrawal by Subject|0|||
170810561|NCT01972776|617315581|FG005|Part 1|Withdrawal by Subject|0|||
170911496|NCT04168645|617680910|FG000|Overall Study|Death|1|||
170911497|NCT04168645|617680911|FG001|Overall Study|Death|1|||
170911498|NCT04168645|617680912|FG002|Overall Study|Death|0|||
170911499|NCT04168645|617680913|FG003|Overall Study|Death|0|||
170911500|NCT04168645|617680910|FG000|Overall Study|Withdrawal by Subject|5|||
170911501|NCT04168645|617680911|FG001|Overall Study|Withdrawal by Subject|2|||
170911502|NCT04168645|617680912|FG002|Overall Study|Withdrawal by Subject|2|||
170911503|NCT04168645|617680913|FG003|Overall Study|Withdrawal by Subject|2|||
170911504|NCT04168645|617680910|FG000|Overall Study|Administrative Withdrawal|3|||
170911505|NCT04168645|617680911|FG001|Overall Study|Administrative Withdrawal|1|||
170911506|NCT04168645|617680912|FG002|Overall Study|Administrative Withdrawal|1|||
170911507|NCT04168645|617680913|FG003|Overall Study|Administrative Withdrawal|3|||
170911508|NCT00474630|617680921|FG000|Overall Study|Adverse Event|98|||
170911509|NCT00474630|617680922|FG001|Overall Study|Adverse Event|26|||
170911510|NCT00474630|617680921|FG000|Overall Study|Lost to Follow-up|22|||
170911511|NCT00474630|617680922|FG001|Overall Study|Lost to Follow-up|15|||
170589612|NCT00075725|616502006|FG010|Overall Study|specimen(s) not submitted|0|||
170589613|NCT00075725|616502007|FG011|Overall Study|specimen(s) not submitted|0|||
170589614|NCT00075725|616501996|FG000|Overall Study|Pt went to transplant|0|||
170589615|NCT00075725|616501997|FG001|Overall Study|Pt went to transplant|0|||
170589616|NCT00075725|616501998|FG002|Overall Study|Pt went to transplant|0|||
170589617|NCT00075725|616501999|FG003|Overall Study|Pt went to transplant|1|||
170589618|NCT00075725|616502000|FG004|Overall Study|Pt went to transplant|0|||
170589619|NCT00075725|616502001|FG005|Overall Study|Pt went to transplant|1|||
170589620|NCT00075725|616502002|FG006|Overall Study|Pt went to transplant|0|||
170589621|NCT00075725|616502003|FG007|Overall Study|Pt went to transplant|0|||
170589622|NCT00075725|616502004|FG008|Overall Study|Pt went to transplant|0|||
170589623|NCT00075725|616502005|FG009|Overall Study|Pt went to transplant|0|||
170589624|NCT00075725|616502006|FG010|Overall Study|Pt went to transplant|0|||
170589625|NCT00075725|616502007|FG011|Overall Study|Pt went to transplant|0|||
170589626|NCT00075725|616501996|FG000|Overall Study|Pt received additional steroids|0|||
170589627|NCT00075725|616501997|FG001|Overall Study|Pt received additional steroids|0|||
170589628|NCT00075725|616501998|FG002|Overall Study|Pt received additional steroids|0|||
170589629|NCT00075725|616501999|FG003|Overall Study|Pt received additional steroids|1|||
170589630|NCT00075725|616502000|FG004|Overall Study|Pt received additional steroids|0|||
170589631|NCT00075725|616502001|FG005|Overall Study|Pt received additional steroids|0|||
170589632|NCT00075725|616502002|FG006|Overall Study|Pt received additional steroids|0|||
170589633|NCT00075725|616502003|FG007|Overall Study|Pt received additional steroids|0|||
170589634|NCT00075725|616502004|FG008|Overall Study|Pt received additional steroids|0|||
170589635|NCT00075725|616502005|FG009|Overall Study|Pt received additional steroids|0|||
170589636|NCT00075725|616502006|FG010|Overall Study|Pt received additional steroids|0|||
170589637|NCT00075725|616502007|FG011|Overall Study|Pt received additional steroids|0|||
170589638|NCT00075725|616501996|FG000|Overall Study|Pt relocated|0|||
170589639|NCT00075725|616501997|FG001|Overall Study|Pt relocated|0|||
170589640|NCT00075725|616501998|FG002|Overall Study|Pt relocated|0|||
170589641|NCT00075725|616501999|FG003|Overall Study|Pt relocated|2|||
170589642|NCT00075725|616502000|FG004|Overall Study|Pt relocated|0|||
170589643|NCT00075725|616502001|FG005|Overall Study|Pt relocated|1|||
170589644|NCT00075725|616502002|FG006|Overall Study|Pt relocated|1|||
170589645|NCT00075725|616502003|FG007|Overall Study|Pt relocated|2|||
170589646|NCT00075725|616502004|FG008|Overall Study|Pt relocated|1|||
170589647|NCT00075725|616502005|FG009|Overall Study|Pt relocated|0|||
170589648|NCT00075725|616502006|FG010|Overall Study|Pt relocated|0|||
170589649|NCT00075725|616502007|FG011|Overall Study|Pt relocated|0|||
170589650|NCT00075725|616501996|FG000|Overall Study|Institution Terminated|0|||
170589651|NCT00075725|616501997|FG001|Overall Study|Institution Terminated|0|||
170589652|NCT00075725|616501998|FG002|Overall Study|Institution Terminated|0|||
170589653|NCT00075725|616501999|FG003|Overall Study|Institution Terminated|0|||
170589654|NCT00075725|616502000|FG004|Overall Study|Institution Terminated|1|||
170589655|NCT00075725|616502001|FG005|Overall Study|Institution Terminated|0|||
170589656|NCT00075725|616502002|FG006|Overall Study|Institution Terminated|0|||
170589657|NCT00075725|616502003|FG007|Overall Study|Institution Terminated|3|||
170589658|NCT00075725|616502004|FG008|Overall Study|Institution Terminated|0|||
170589659|NCT00075725|616502005|FG009|Overall Study|Institution Terminated|0|||
170589660|NCT00075725|616502006|FG010|Overall Study|Institution Terminated|0|||
170589661|NCT00075725|616502007|FG011|Overall Study|Institution Terminated|0|||
170589662|NCT00075725|616501996|FG000|Overall Study|Study Closure|1|||
170589663|NCT00075725|616501997|FG001|Overall Study|Study Closure|0|||
170911512|NCT00474630|617680921|FG000|Overall Study|Withdrawal by Subject|21|||
170911513|NCT00474630|617680922|FG001|Overall Study|Withdrawal by Subject|15|||
170589664|NCT00075725|616501998|FG002|Overall Study|Study Closure|0|||
170589665|NCT00075725|616501999|FG003|Overall Study|Study Closure|0|||
170589666|NCT00075725|616502000|FG004|Overall Study|Study Closure|1|||
170911514|NCT00474630|617680921|FG000|Overall Study|Protocol Violation|3|||
170589667|NCT00075725|616502001|FG005|Overall Study|Study Closure|3|||
170911515|NCT00474630|617680922|FG001|Overall Study|Protocol Violation|4|||
170911516|NCT00474630|617680921|FG000|Overall Study|Lack of Efficacy|5|||
170589668|NCT00075725|616502002|FG006|Overall Study|Study Closure|0|||
170589669|NCT00075725|616502003|FG007|Overall Study|Study Closure|1|||
170589670|NCT00075725|616502004|FG008|Overall Study|Study Closure|0|||
170589671|NCT00075725|616502005|FG009|Overall Study|Study Closure|0|||
170589672|NCT00075725|616502006|FG010|Overall Study|Study Closure|0|||
170589673|NCT00075725|616502007|FG011|Overall Study|Study Closure|0|||
170589674|NCT00075725|616501996|FG000|Overall Study|Other complications|0|||
170589675|NCT00075725|616501997|FG001|Overall Study|Other complications|0|||
170589676|NCT00075725|616501998|FG002|Overall Study|Other complications|0|||
170589677|NCT00075725|616501999|FG003|Overall Study|Other complications|0|||
170589678|NCT00075725|616502000|FG004|Overall Study|Other complications|0|||
170589679|NCT00075725|616502001|FG005|Overall Study|Other complications|1|||
170589680|NCT00075725|616502002|FG006|Overall Study|Other complications|0|||
170589681|NCT00075725|616502003|FG007|Overall Study|Other complications|0|||
170589682|NCT00075725|616502004|FG008|Overall Study|Other complications|0|||
170589683|NCT00075725|616502005|FG009|Overall Study|Other complications|0|||
170650299|NCT00436501|616732881|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
170650300|NCT00436501|616732882|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
170650301|NCT00436501|616732881|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
170650302|NCT00436501|616732882|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
170650303|NCT03011892|616732891|FG000|Double Blind (DB) Period|Adverse Event|0|||
170650304|NCT03011892|616732892|FG001|Double Blind (DB) Period|Adverse Event|1|||
170650305|NCT03011892|616732893|FG002|Double Blind (DB) Period|Adverse Event|1|||
170650306|NCT03011892|616732894|FG003|Double Blind (DB) Period|Adverse Event|0|||
170650307|NCT03011892|616732895|FG004|Double Blind (DB) Period|Adverse Event|0|||
170650308|NCT03011892|616732896|FG005|Double Blind (DB) Period|Adverse Event|0|||
170650309|NCT03011892|616732897|FG006|Double Blind (DB) Period|Adverse Event|0|||
170650310|NCT03011892|616732898|FG007|Double Blind (DB) Period|Adverse Event|0|||
170650311|NCT03011892|616732899|FG008|Double Blind (DB) Period|Adverse Event|0|||
170650312|NCT03011892|616732900|FG009|Double Blind (DB) Period|Adverse Event|0|||
170650313|NCT03011892|616732901|FG010|Double Blind (DB) Period|Adverse Event|0|||
170650314|NCT03011892|616732902|FG011|Double Blind (DB) Period|Adverse Event|0|||
170650315|NCT03011892|616732891|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
170650316|NCT03011892|616732892|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
170650317|NCT03011892|616732893|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
170650318|NCT03011892|616732894|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
170650319|NCT03011892|616732895|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
170911517|NCT00474630|617680922|FG001|Overall Study|Lack of Efficacy|6|||
170911518|NCT00474630|617680921|FG000|Overall Study|Drug noncompliance, other|11|||
170911519|NCT00474630|617680922|FG001|Overall Study|Drug noncompliance, other|4|||
170911520|NCT01335971|617680923|FG000|Overall Study|Withdrawal by Subject|1|||
170911521|NCT01335971|617680924|FG001|Overall Study|Withdrawal by Subject|0|||
170911522|NCT01335971|617680925|FG002|Overall Study|Withdrawal by Subject|0|||
170911523|NCT01335971|617680923|FG000|Overall Study|Did not complete bronchoscopy|1|||
170911524|NCT01335971|617680924|FG001|Overall Study|Did not complete bronchoscopy|1|||
170911525|NCT01335971|617680925|FG002|Overall Study|Did not complete bronchoscopy|1|||
170911526|NCT00098345|617680926|FG000|Overall Study|Adverse Event|7|||
170911527|NCT00098345|617680926|FG000|Overall Study|Withdrawal by Subject|2|||
170911528|NCT00098345|617680926|FG000|Overall Study|progression|4|||
170911529|NCT01295905|617680927|FG000|Overall Study|Did not meet inclusion criteria|1|||
170911530|NCT01295905|617680928|FG001|Overall Study|Did not meet inclusion criteria|0|||
170911531|NCT01295905|617680927|FG000|Overall Study|Met exclusion criteria|1|||
170911532|NCT01295905|617680928|FG001|Overall Study|Met exclusion criteria|0|||
170911533|NCT03069690|617680929|FG000|Pregnancy Intervention|Pregnancy loss|9|||
170911534|NCT03069690|617680930|FG001|Pregnancy Intervention|Pregnancy loss|4|||
170911535|NCT03069690|617680931|FG002|Pregnancy Intervention|Pregnancy loss|0|||
170911536|NCT03069690|617680932|FG003|Pregnancy Intervention|Pregnancy loss|0|||
170911537|NCT03069690|617680933|FG004|Pregnancy Intervention|Pregnancy loss|0|||
170911538|NCT03069690|617680934|FG005|Pregnancy Intervention|Pregnancy loss|0|||
170911539|NCT03069690|617680929|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
170650320|NCT03011892|616732896|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
170911540|NCT03069690|617680930|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
170911541|NCT03069690|617680931|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
170911542|NCT03069690|617680932|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
170911543|NCT03069690|617680933|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
170589684|NCT00075725|616502006|FG010|Overall Study|Other complications|0|||
170589685|NCT00075725|616502007|FG011|Overall Study|Other complications|0|||
170650321|NCT03011892|616732897|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
170650322|NCT03011892|616732898|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
170911544|NCT03069690|617680934|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
170911545|NCT03069690|617680929|FG000|Postpartum Intervention|Lost to Follow-up|0|||
170589686|NCT00075725|616501996|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
170589687|NCT00075725|616501997|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
170650323|NCT03011892|616732899|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
170911546|NCT03069690|617680930|FG001|Postpartum Intervention|Lost to Follow-up|0|||
170911547|NCT03069690|617680931|FG002|Postpartum Intervention|Lost to Follow-up|5|||
170589688|NCT00075725|616501998|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
170589689|NCT00075725|616501999|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
170589690|NCT00075725|616502000|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
170589691|NCT00075725|616502001|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
170589692|NCT00075725|616502002|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
170589693|NCT00075725|616502003|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
170589694|NCT00075725|616502004|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
170589695|NCT00075725|616502005|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
170589696|NCT00075725|616502006|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
170589697|NCT00075725|616502007|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
170589698|NCT00075725|616501996|FG000|Overall Study|Pt incarcerated|0|||
170589699|NCT00075725|616501997|FG001|Overall Study|Pt incarcerated|0|||
170589700|NCT00075725|616501998|FG002|Overall Study|Pt incarcerated|0|||
170589701|NCT00075725|616501999|FG003|Overall Study|Pt incarcerated|0|||
170589702|NCT00075725|616502000|FG004|Overall Study|Pt incarcerated|0|||
170589703|NCT00075725|616502001|FG005|Overall Study|Pt incarcerated|0|||
170589704|NCT00075725|616502002|FG006|Overall Study|Pt incarcerated|0|||
170589705|NCT00075725|616502003|FG007|Overall Study|Pt incarcerated|1|||
170589706|NCT00075725|616502004|FG008|Overall Study|Pt incarcerated|0|||
170589707|NCT00075725|616502005|FG009|Overall Study|Pt incarcerated|0|||
170589708|NCT00075725|616502006|FG010|Overall Study|Pt incarcerated|0|||
170589709|NCT00075725|616502007|FG011|Overall Study|Pt incarcerated|0|||
170589710|NCT02240368|616502011|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
170589711|NCT02240368|616502012|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
170589712|NCT02240368|616502013|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
170589713|NCT02240368|616502011|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
170589714|NCT02240368|616502012|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
170589715|NCT02240368|616502013|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
170589716|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Death|1|||
170589717|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Death|1|||
170589718|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Death|0|||
170589719|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Death|0|||
170589720|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Death|1|||
170589721|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Death|0|||
170589722|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Death|0|||
170589723|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Death|0|||
170589724|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Death|0|||
170589725|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Death|0|||
170589726|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
170589727|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
170589728|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
170589729|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
170589730|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
170589731|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
170589732|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
170589733|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
170589734|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
170589735|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
170589736|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589737|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589738|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589739|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589740|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
170589741|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589742|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589743|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589744|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589745|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
170589746|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
170589747|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170589748|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170589749|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170810562|NCT01972776|617315576|FG000|Part 1|Adverse Event|0|||
170810563|NCT01972776|617315577|FG001|Part 1|Adverse Event|0|||
170810564|NCT01972776|617315578|FG002|Part 1|Adverse Event|1|||
170810565|NCT01972776|617315579|FG003|Part 1|Adverse Event|1|||
170810566|NCT01972776|617315580|FG004|Part 1|Adverse Event|0|||
170810567|NCT01972776|617315581|FG005|Part 1|Adverse Event|0|||
170589750|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170589751|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170589752|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170589753|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170810568|NCT01972776|617315576|FG000|Part 2|Adverse Event|0|||
170810569|NCT01972776|617315577|FG001|Part 2|Adverse Event|0|||
170911548|NCT03069690|617680932|FG003|Postpartum Intervention|Lost to Follow-up|5|||
170911549|NCT03069690|617680933|FG004|Postpartum Intervention|Lost to Follow-up|2|||
170911550|NCT03069690|617680934|FG005|Postpartum Intervention|Lost to Follow-up|4|||
170911551|NCT03842709|617680935|FG000|Overall Study|Withdrawal by Subject|3|||
170911552|NCT03842709|617680936|FG001|Overall Study|Withdrawal by Subject|3|||
170911553|NCT03842709|617680935|FG000|Overall Study|Lost to Follow-up|1|||
170911554|NCT03842709|617680936|FG001|Overall Study|Lost to Follow-up|0|||
170911555|NCT00641147|617680937|FG000|Completed 4 Months.|Physician Decision|1|||
170911556|NCT00641147|617680938|FG001|Completed 4 Months.|Physician Decision|0|||
170911557|NCT00641147|617680937|FG000|Completed 4 Months.|Adverse Event|1|||
170911558|NCT00641147|617680938|FG001|Completed 4 Months.|Adverse Event|0|||
170911559|NCT00641147|617680937|FG000|Completed 8 Months.|Physician Decision|2|||
170911560|NCT00641147|617680938|FG001|Completed 8 Months.|Physician Decision|1|||
170911561|NCT00641147|617680937|FG000|Completed 8 Months.|non compliance|1|||
170911562|NCT00641147|617680938|FG001|Completed 8 Months.|non compliance|0|||
170911563|NCT00641147|617680937|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
170911564|NCT00641147|617680938|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
170911565|NCT00641147|617680937|FG000|Completed 12 Months.|Physician Decision|1|||
170911566|NCT00641147|617680938|FG001|Completed 12 Months.|Physician Decision|1|||
170911567|NCT00641147|617680937|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
170911568|NCT00641147|617680938|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
170911569|NCT00641147|617680937|FG000|Completed 16 Months.|Physician Decision|1|||
170911570|NCT00641147|617680938|FG001|Completed 16 Months.|Physician Decision|0|||
170911571|NCT00641147|617680937|FG000|Completed 16 Months.|Lost to Follow-up|1|||
170911572|NCT00641147|617680938|FG001|Completed 16 Months.|Lost to Follow-up|0|||
170911573|NCT01873950|617680942|FG000|Period 5|Withdrawal by Subject|0|||
170911574|NCT01873950|617680943|FG001|Period 5|Withdrawal by Subject|0|||
170589754|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170589755|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
170589756|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
170589757|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
170589758|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
170589759|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
170589760|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
170589761|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
170589762|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
170589763|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
170589764|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
170589765|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
170589766|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
170589767|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
170589768|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
170589769|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
170589770|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
170589771|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
170589772|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
170589773|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
170589774|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
170589775|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
170589776|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
170589777|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
170589778|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
170589779|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
170589780|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
170589781|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
170589782|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
170589783|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
170589784|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
170589785|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
170589786|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
170589787|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
170589788|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
170589789|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589790|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
170589791|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170911575|NCT01873950|617680944|FG002|Period 5|Withdrawal by Subject|0|||
170911576|NCT01873950|617680945|FG003|Period 5|Withdrawal by Subject|1|||
170911577|NCT01873950|617680946|FG004|Period 5|Withdrawal by Subject|0|||
170589792|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589793|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589794|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589795|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589796|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
170589797|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
170589798|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
170589799|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
170589800|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
170589801|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
170589802|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
170589803|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
170589804|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
170589805|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
170589806|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
170589807|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
170589808|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589809|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
170589810|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
170589811|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589812|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589813|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589814|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589815|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589816|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589817|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589818|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
170589819|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589820|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
170589821|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589822|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589823|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589824|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589825|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589826|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
170589827|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
170589828|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
170589829|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
170589830|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
170589831|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
170589832|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
170589833|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
170589834|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
170589835|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
170589836|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589837|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589838|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589839|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
170650324|NCT03011892|616732900|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
170650325|NCT03011892|616732901|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
170650326|NCT03011892|616732902|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
170650327|NCT03011892|616732891|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
170810570|NCT01972776|617315578|FG002|Part 2|Adverse Event|0|||
170589840|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
170589841|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589842|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589843|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589844|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589845|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589846|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
170589847|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170589848|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
170589849|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
170589850|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
170589851|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170589852|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170589853|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170589854|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170589855|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170589856|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
170589857|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589858|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589859|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589860|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
170589861|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589862|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589863|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589864|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589865|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
170589866|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170589867|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170589868|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170589869|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170650328|NCT03011892|616732892|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
170650329|NCT03011892|616732893|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
170650330|NCT03011892|616732894|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
170650331|NCT03011892|616732895|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
170650332|NCT03011892|616732896|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
170650333|NCT03011892|616732897|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
170650334|NCT03011892|616732898|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
170650335|NCT03011892|616732899|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
170650336|NCT03011892|616732900|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
170650337|NCT03011892|616732901|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
170650338|NCT03011892|616732902|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
170650339|NCT03011892|616732891|FG000|Double Blind (DB) Period|Other|1|||
170650340|NCT03011892|616732892|FG001|Double Blind (DB) Period|Other|1|||
170650341|NCT03011892|616732893|FG002|Double Blind (DB) Period|Other|1|||
170650342|NCT03011892|616732894|FG003|Double Blind (DB) Period|Other|0|||
170650343|NCT03011892|616732895|FG004|Double Blind (DB) Period|Other|1|||
170650344|NCT03011892|616732896|FG005|Double Blind (DB) Period|Other|0|||
170650345|NCT03011892|616732897|FG006|Double Blind (DB) Period|Other|0|||
170650346|NCT03011892|616732898|FG007|Double Blind (DB) Period|Other|0|||
170650347|NCT03011892|616732899|FG008|Double Blind (DB) Period|Other|0|||
170650348|NCT03011892|616732900|FG009|Double Blind (DB) Period|Other|0|||
170650349|NCT03011892|616732901|FG010|Double Blind (DB) Period|Other|0|||
170650350|NCT03011892|616732902|FG011|Double Blind (DB) Period|Other|0|||
170810571|NCT01972776|617315579|FG003|Part 2|Adverse Event|0|||
170810572|NCT01972776|617315580|FG004|Part 2|Adverse Event|3|||
170810573|NCT01972776|617315581|FG005|Part 2|Adverse Event|0|||
170810574|NCT01972776|617315576|FG000|Part 2|Administrative problems|0|||
170810575|NCT01972776|617315577|FG001|Part 2|Administrative problems|0|||
170810576|NCT01972776|617315578|FG002|Part 2|Administrative problems|0|||
170810577|NCT01972776|617315579|FG003|Part 2|Administrative problems|0|||
170810578|NCT01972776|617315580|FG004|Part 2|Administrative problems|10|||
170810579|NCT01972776|617315581|FG005|Part 2|Administrative problems|7|||
170810580|NCT01228734|617315585|FG000|Overall Study|Randomized, but not treated|0|||
170810581|NCT01228734|617315586|FG001|Overall Study|Randomized, but not treated|4|||
170589870|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
170589871|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170589872|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170589873|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170589874|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170589875|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170589876|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
170589877|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
170589878|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
170589879|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
170589880|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
170589881|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
170589882|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
170589883|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
170810582|NCT00089791|617315587|FG000|Overall Study|Physician Decision|6|||
170589884|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
170810583|NCT00089791|617315588|FG001|Overall Study|Physician Decision|3|||
170589885|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
170589886|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
170589887|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
170589888|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
170589889|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
170589890|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
170589891|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
170589892|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
170589893|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
170589894|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
170589895|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
170589896|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
170589897|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
170589898|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
170589899|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
170589900|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
170589901|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
170589902|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
170589903|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
170589904|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
170589905|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
170589906|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Other|5|||
170589907|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Other|1|||
170589908|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Other|0|||
170589909|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Other|3|||
170589910|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Other|0|||
170589911|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Other|0|||
170589912|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Other|0|||
170589913|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Other|0|||
170589914|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Other|0|||
170589915|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Other|0|||
170589916|NCT03352557|616502014|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589917|NCT03352557|616502015|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589918|NCT03352557|616502016|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589919|NCT03352557|616502017|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589920|NCT03352557|616502018|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
170589921|NCT03352557|616502019|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589922|NCT03352557|616502020|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589923|NCT03352557|616502021|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589924|NCT03352557|616502022|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589925|NCT03352557|616502023|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
170589926|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Death|0|||
170589927|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Death|0|||
170589928|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Death|0|||
170589929|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Death|0|||
170589930|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Death|0|||
170589931|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Death|1|||
170810584|NCT00089791|617315587|FG000|Overall Study|Adverse Event|81|||
170810585|NCT00089791|617315588|FG001|Overall Study|Adverse Event|93|||
170810586|NCT00089791|617315587|FG000|Overall Study|Withdrawal by Subject|403|||
170589932|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Death|0|||
170911578|NCT00537823|617680948|FG000|Overall Study|Adverse Event|2|||
170589933|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Death|1|||
170589934|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Death|1|||
170589935|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Death|1|||
170589936|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589937|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589938|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589939|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589940|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589941|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
170589942|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589943|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589944|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589945|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
170589946|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589947|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589948|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589949|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589950|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589951|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589952|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589953|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589954|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
170589955|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
170589956|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
170589957|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
170589958|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
170589959|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
170589960|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
170589961|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
170589962|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
170589963|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
170589964|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
170589965|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
170589966|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589967|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589968|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589969|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589970|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589971|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
170589972|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
170589973|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
170589974|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
170589975|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
170589976|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589977|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589978|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589979|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589980|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589981|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
170589982|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589983|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
170589984|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
170589985|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
170589986|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
170650351|NCT03011892|616732891|FG000|Double Blind (DB) Period|Physician Decision|1|||
170650352|NCT03011892|616732892|FG001|Double Blind (DB) Period|Physician Decision|0|||
170650353|NCT03011892|616732893|FG002|Double Blind (DB) Period|Physician Decision|1|||
170650354|NCT03011892|616732894|FG003|Double Blind (DB) Period|Physician Decision|0|||
170650355|NCT03011892|616732895|FG004|Double Blind (DB) Period|Physician Decision|0|||
170589987|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
170589988|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
170589989|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
170589990|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
170589991|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
170589992|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
170589993|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
170589994|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
170589995|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
170589996|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589997|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589998|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170589999|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170590000|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170590001|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170590002|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170590003|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
170590004|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
170590005|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
170590006|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590007|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590008|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590009|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590010|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590011|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590012|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590013|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
170590014|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590015|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
170590016|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590017|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590018|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590019|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590020|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590021|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590022|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590023|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
170590024|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590025|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
170590026|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170590027|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170590028|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170590029|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170590030|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170650356|NCT03011892|616732896|FG005|Double Blind (DB) Period|Physician Decision|0|||
170650357|NCT03011892|616732897|FG006|Double Blind (DB) Period|Physician Decision|0|||
170650358|NCT03011892|616732898|FG007|Double Blind (DB) Period|Physician Decision|0|||
170650359|NCT03011892|616732899|FG008|Double Blind (DB) Period|Physician Decision|0|||
170650360|NCT03011892|616732900|FG009|Double Blind (DB) Period|Physician Decision|0|||
170650361|NCT03011892|616732901|FG010|Double Blind (DB) Period|Physician Decision|0|||
170650362|NCT03011892|616732902|FG011|Double Blind (DB) Period|Physician Decision|0|||
170650363|NCT03011892|616732891|FG000|Double Blind (DB) Period|Pregnancy|0|||
170650364|NCT03011892|616732892|FG001|Double Blind (DB) Period|Pregnancy|0|||
170650365|NCT03011892|616732893|FG002|Double Blind (DB) Period|Pregnancy|0|||
170650366|NCT03011892|616732894|FG003|Double Blind (DB) Period|Pregnancy|0|||
170650367|NCT03011892|616732895|FG004|Double Blind (DB) Period|Pregnancy|1|||
170810587|NCT00089791|617315588|FG001|Overall Study|Withdrawal by Subject|344|||
170810588|NCT00089791|617315587|FG000|Overall Study|Death|78|||
170590031|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170590032|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170590033|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
170590034|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
170590035|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
170590036|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
170590037|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
170590038|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
170590039|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
170590040|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
170590041|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
170590042|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
170590043|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
170590044|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
170590045|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
170590046|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170590047|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170590048|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170590049|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170650368|NCT03011892|616732896|FG005|Double Blind (DB) Period|Pregnancy|0|||
170650369|NCT03011892|616732897|FG006|Double Blind (DB) Period|Pregnancy|0|||
170650370|NCT03011892|616732898|FG007|Double Blind (DB) Period|Pregnancy|0|||
170650371|NCT03011892|616732899|FG008|Double Blind (DB) Period|Pregnancy|0|||
170650372|NCT03011892|616732900|FG009|Double Blind (DB) Period|Pregnancy|0|||
170650373|NCT03011892|616732901|FG010|Double Blind (DB) Period|Pregnancy|0|||
170650374|NCT03011892|616732902|FG011|Double Blind (DB) Period|Pregnancy|0|||
170650375|NCT03011892|616732891|FG000|Double Blind (DB) Period|Protocol Violation|1|||
170650376|NCT03011892|616732892|FG001|Double Blind (DB) Period|Protocol Violation|0|||
170650377|NCT03011892|616732893|FG002|Double Blind (DB) Period|Protocol Violation|0|||
170650378|NCT03011892|616732894|FG003|Double Blind (DB) Period|Protocol Violation|0|||
170650379|NCT03011892|616732895|FG004|Double Blind (DB) Period|Protocol Violation|0|||
170650380|NCT03011892|616732896|FG005|Double Blind (DB) Period|Protocol Violation|0|||
170650381|NCT03011892|616732897|FG006|Double Blind (DB) Period|Protocol Violation|0|||
170650382|NCT03011892|616732898|FG007|Double Blind (DB) Period|Protocol Violation|0|||
170650383|NCT03011892|616732899|FG008|Double Blind (DB) Period|Protocol Violation|0|||
170650384|NCT03011892|616732900|FG009|Double Blind (DB) Period|Protocol Violation|0|||
170650385|NCT03011892|616732901|FG010|Double Blind (DB) Period|Protocol Violation|0|||
170650386|NCT03011892|616732902|FG011|Double Blind (DB) Period|Protocol Violation|0|||
170650387|NCT03011892|616732891|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
170650388|NCT03011892|616732892|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
170650389|NCT03011892|616732893|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
170650390|NCT03011892|616732894|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
170650391|NCT03011892|616732895|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
170650392|NCT03011892|616732896|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
170650393|NCT03011892|616732897|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
170650394|NCT03011892|616732898|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
170650395|NCT03011892|616732899|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
170650396|NCT03011892|616732900|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
170650397|NCT03011892|616732901|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
170650398|NCT03011892|616732902|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
170650399|NCT03011892|616732891|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
170650400|NCT03011892|616732892|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
170650401|NCT03011892|616732893|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
170650402|NCT03011892|616732894|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
170650403|NCT03011892|616732895|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
170650404|NCT03011892|616732896|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
170650405|NCT03011892|616732897|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
170650406|NCT03011892|616732898|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
170650407|NCT03011892|616732899|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
170650408|NCT03011892|616732900|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
170650409|NCT03011892|616732901|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
170650410|NCT03011892|616732902|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
170650411|NCT03011892|616732891|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
170650412|NCT03011892|616732892|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
170650413|NCT03011892|616732893|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
170650414|NCT03011892|616732894|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
170590050|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170590051|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170590052|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170590053|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170590054|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
170590055|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
170590056|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
170590057|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
170590058|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
170590059|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
170590060|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
170590061|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
170590062|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
170590063|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
170590064|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
170590065|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
170590066|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
170590067|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
170590068|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
170590069|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
170590070|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
170590071|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
170590072|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
170590073|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
170590074|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
170590075|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
170590076|NCT03352557|616502014|FG000|LTE Period: Week 80 to Week 173|Other|0|||
170590077|NCT03352557|616502015|FG001|LTE Period: Week 80 to Week 173|Other|0|||
170590078|NCT03352557|616502016|FG002|LTE Period: Week 80 to Week 173|Other|0|||
170590079|NCT03352557|616502017|FG003|LTE Period: Week 80 to Week 173|Other|0|||
170590080|NCT03352557|616502018|FG004|LTE Period: Week 80 to Week 173|Other|0|||
170590081|NCT03352557|616502019|FG005|LTE Period: Week 80 to Week 173|Other|0|||
170590082|NCT03352557|616502020|FG006|LTE Period: Week 80 to Week 173|Other|0|||
170590083|NCT03352557|616502021|FG007|LTE Period: Week 80 to Week 173|Other|1|||
170590084|NCT03352557|616502022|FG008|LTE Period: Week 80 to Week 173|Other|0|||
170590085|NCT03352557|616502023|FG009|LTE Period: Week 80 to Week 173|Other|0|||
170590086|NCT03510468|616502024|FG000|Overall Study|Lost to Follow-up|1|||
170590087|NCT03510468|616502024|FG000|Overall Study|Adverse Event|5|||
170590088|NCT03510468|616502024|FG000|Overall Study|Physician Decision|1|||
170590089|NCT03510468|616502024|FG000|Overall Study|non-compliant with treatment|2|||
170590090|NCT03510468|616502024|FG000|Overall Study|Missed visit|1|||
170590091|NCT03372460|616502026|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
170590092|NCT03372460|616502027|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
170590093|NCT00871117|616502035|FG000|Overall Study|Lost to Follow-up|5|||
170590094|NCT00871117|616502036|FG001|Overall Study|Lost to Follow-up|6|||
170590095|NCT00871117|616502035|FG000|Overall Study|Other|0|||
170590096|NCT00871117|616502036|FG001|Overall Study|Other|4|||
170590097|NCT00916058|616502037|FG000|Phase 1|Screen Failure|0|||
170590098|NCT00916058|616502038|FG001|Phase 1|Screen Failure|0|||
170590099|NCT00916058|616502039|FG002|Phase 1|Screen Failure|0|||
170590100|NCT00916058|616502040|FG003|Phase 1|Screen Failure|0|||
170590101|NCT00916058|616502041|FG004|Phase 1|Screen Failure|0|||
170590102|NCT00916058|616502042|FG005|Phase 1|Screen Failure|1|||
170590103|NCT00916058|616502043|FG006|Phase 1|Screen Failure|0|||
170590104|NCT00916058|616502037|FG000|Phase 2|Screen Failure|0|||
170590105|NCT00916058|616502038|FG001|Phase 2|Screen Failure|0|||
170590106|NCT00916058|616502039|FG002|Phase 2|Screen Failure|0|||
170590107|NCT00916058|616502040|FG003|Phase 2|Screen Failure|0|||
170590108|NCT00916058|616502041|FG004|Phase 2|Screen Failure|0|||
170590109|NCT00916058|616502042|FG005|Phase 2|Screen Failure|0|||
170590110|NCT00916058|616502043|FG006|Phase 2|Screen Failure|3|||
170590111|NCT04962230|616502054|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
170590112|NCT04962230|616502054|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
170590113|NCT02275117|616502055|FG000|Overall Study|Adverse Event|0|||
170590114|NCT02275117|616502056|FG001|Overall Study|Adverse Event|0|||
170590115|NCT02275117|616502057|FG002|Overall Study|Adverse Event|0|||
170590116|NCT02275117|616502058|FG003|Overall Study|Adverse Event|0|||
170590117|NCT02275117|616502059|FG004|Overall Study|Adverse Event|1|||
170590118|NCT02275117|616502055|FG000|Overall Study|Lack of Efficacy|6|||
170590119|NCT02275117|616502056|FG001|Overall Study|Lack of Efficacy|7|||
170590120|NCT02275117|616502057|FG002|Overall Study|Lack of Efficacy|5|||
170590121|NCT02275117|616502058|FG003|Overall Study|Lack of Efficacy|2|||
170590122|NCT02275117|616502059|FG004|Overall Study|Lack of Efficacy|10|||
170590123|NCT02275117|616502055|FG000|Overall Study|Lost to Follow-up|11|||
170590124|NCT02275117|616502056|FG001|Overall Study|Lost to Follow-up|16|||
170590125|NCT02275117|616502057|FG002|Overall Study|Lost to Follow-up|15|||
170590126|NCT02275117|616502058|FG003|Overall Study|Lost to Follow-up|16|||
170590127|NCT02275117|616502059|FG004|Overall Study|Lost to Follow-up|8|||
170590128|NCT02275117|616502055|FG000|Overall Study|Physician Decision|0|||
170590129|NCT02275117|616502056|FG001|Overall Study|Physician Decision|1|||
170590130|NCT02275117|616502057|FG002|Overall Study|Physician Decision|1|||
170590131|NCT02275117|616502058|FG003|Overall Study|Physician Decision|0|||
170590132|NCT02275117|616502059|FG004|Overall Study|Physician Decision|1|||
170590133|NCT02275117|616502055|FG000|Overall Study|Protocol Violation|1|||
170590134|NCT02275117|616502056|FG001|Overall Study|Protocol Violation|0|||
170590135|NCT02275117|616502057|FG002|Overall Study|Protocol Violation|1|||
170590136|NCT02275117|616502058|FG003|Overall Study|Protocol Violation|1|||
170590137|NCT02275117|616502059|FG004|Overall Study|Protocol Violation|0|||
170590138|NCT02275117|616502055|FG000|Overall Study|Withdrawal by Subject|6|||
170590139|NCT02275117|616502056|FG001|Overall Study|Withdrawal by Subject|4|||
170590140|NCT02275117|616502057|FG002|Overall Study|Withdrawal by Subject|7|||
170590141|NCT02275117|616502058|FG003|Overall Study|Withdrawal by Subject|3|||
170590142|NCT02275117|616502059|FG004|Overall Study|Withdrawal by Subject|3|||
170590143|NCT02275117|616502055|FG000|Overall Study|Terminated by Sponsor|4|||
170590144|NCT02275117|616502056|FG001|Overall Study|Terminated by Sponsor|4|||
170590145|NCT02275117|616502057|FG002|Overall Study|Terminated by Sponsor|4|||
170590146|NCT02275117|616502058|FG003|Overall Study|Terminated by Sponsor|6|||
170590147|NCT02275117|616502059|FG004|Overall Study|Terminated by Sponsor|4|||
170590148|NCT02275117|616502055|FG000|Overall Study|Worsening of Study Indication|0|||
170590149|NCT02275117|616502056|FG001|Overall Study|Worsening of Study Indication|1|||
170590150|NCT02275117|616502057|FG002|Overall Study|Worsening of Study Indication|2|||
170590151|NCT02275117|616502058|FG003|Overall Study|Worsening of Study Indication|0|||
170590152|NCT02275117|616502059|FG004|Overall Study|Worsening of Study Indication|0|||
170590153|NCT02275117|616502055|FG000|Overall Study|Study Burden|5|||
170590154|NCT02275117|616502056|FG001|Overall Study|Study Burden|4|||
170590155|NCT02275117|616502057|FG002|Overall Study|Study Burden|7|||
170590156|NCT02275117|616502058|FG003|Overall Study|Study Burden|5|||
170590157|NCT02275117|616502059|FG004|Overall Study|Study Burden|7|||
170590158|NCT02275117|616502055|FG000|Overall Study|Other|1|||
170650415|NCT03011892|616732895|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
170650416|NCT03011892|616732896|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
170650417|NCT03011892|616732897|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
170650418|NCT03011892|616732898|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
170650419|NCT03011892|616732899|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
170650420|NCT03011892|616732900|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
170650421|NCT03011892|616732901|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
170650422|NCT03011892|616732902|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
170911579|NCT00537823|617680949|FG001|Overall Study|Adverse Event|0|||
170911580|NCT05372315|617680950|FG000|Overall Study|Withdrawal by Subject|1|||
170911581|NCT05372315|617680951|FG001|Overall Study|Withdrawal by Subject|0|||
170911582|NCT01512368|617680955|FG000|Overall Study|Protocol Violation|3|||
170911583|NCT00328198|617680956|FG000|Treatment|Adverse Event|21|||
170911584|NCT00328198|617680956|FG000|Treatment|Death|1|||
170911585|NCT00328198|617680956|FG000|Treatment|Physician Decision|5|||
170911586|NCT00328198|617680956|FG000|Treatment|Withdrawal by Subject|5|||
170911587|NCT00328198|617680956|FG000|Treatment|Evidence of disease progression|2|||
170911588|NCT00328198|617680956|FG000|Treatment|Non-compliance|1|||
170911589|NCT00328198|617680956|FG000|Treatment|Confirmed complete response, MRD -|3|||
170911590|NCT00328198|617680956|FG000|Follow-up|Lost to Follow-up|4|||
170911591|NCT00328198|617680956|FG000|Follow-up|Death|31|||
170911592|NCT02717546|617680957|FG000|Overall Study|Lost to Follow-up|12|||
170911593|NCT04407507|617680960|FG000|Overall Study|Withdrawal by Subject|0|||
170911594|NCT04407507|617680961|FG001|Overall Study|Withdrawal by Subject|1|||
170911595|NCT01499576|617680962|FG000|Overall Study|Physician Decision|12|||
170911596|NCT01499576|617680962|FG000|Overall Study|Withdrawal by Subject|9|||
170911597|NCT00909090|617680969|FG000|Overall Study|Lost to Follow-up|17|||
170911598|NCT00909090|617680970|FG001|Overall Study|Lost to Follow-up|17|||
170911599|NCT00234104|617680973|FG000|Overall Study|Adverse Event|4|||
170911600|NCT00234104|617680974|FG001|Overall Study|Adverse Event|0|||
170911601|NCT00234104|617680975|FG002|Overall Study|Adverse Event|3|||
170911602|NCT00234104|617680976|FG003|Overall Study|Adverse Event|5|||
170911603|NCT00234104|617680973|FG000|Overall Study|Protocol Violation|0|||
170911604|NCT00234104|617680974|FG001|Overall Study|Protocol Violation|0|||
170911605|NCT00234104|617680975|FG002|Overall Study|Protocol Violation|0|||
170911606|NCT00234104|617680976|FG003|Overall Study|Protocol Violation|1|||
170590159|NCT02275117|616502056|FG001|Overall Study|Other|0|||
170590160|NCT02275117|616502057|FG002|Overall Study|Other|0|||
170590161|NCT02275117|616502058|FG003|Overall Study|Other|0|||
170590162|NCT02275117|616502059|FG004|Overall Study|Other|2|||
170650423|NCT03011892|616732891|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
170911607|NCT00234104|617680973|FG000|Overall Study|Physician Decision|0|||
170911608|NCT00234104|617680974|FG001|Overall Study|Physician Decision|1|||
170911609|NCT00234104|617680975|FG002|Overall Study|Physician Decision|2|||
170911610|NCT00234104|617680976|FG003|Overall Study|Physician Decision|2|||
170590163|NCT01444027|616502072|FG000|Overall Study|Withdrawal by Subject|4|||
170590164|NCT01444027|616502073|FG001|Overall Study|Withdrawal by Subject|10|||
170590165|NCT01444027|616502074|FG002|Overall Study|Withdrawal by Subject|24|||
170590166|NCT01444027|616502072|FG000|Overall Study|Lost to Follow-up|26|||
170590167|NCT01444027|616502073|FG001|Overall Study|Lost to Follow-up|20|||
170590168|NCT01444027|616502074|FG002|Overall Study|Lost to Follow-up|14|||
170590169|NCT00840060|616503601|FG000|Overall Study|Withdrawal by Subject|1|||
170590170|NCT00840060|616503602|FG001|Overall Study|Withdrawal by Subject|0|||
170590171|NCT00840060|616503601|FG000|Overall Study|Change in emotional/behavioral status|0|||
170590172|NCT00840060|616503602|FG001|Overall Study|Change in emotional/behavioral status|1|||
170590173|NCT02032407|616503603|FG000|Overall Study|Lost to Follow-up|2|||
170590174|NCT02032407|616503603|FG000|Overall Study|Pregnancy|1|||
170590175|NCT02032407|616503603|FG000|Overall Study|Other Miscellaneous Reasons|2|||
170590176|NCT01514240|616503604|FG000|Overall Study|Adverse Event|4|||
170590177|NCT01514240|616503605|FG001|Overall Study|Adverse Event|4|||
170590178|NCT01514240|616503604|FG000|Overall Study|Subject Decision|2|||
170590179|NCT01514240|616503605|FG001|Overall Study|Subject Decision|7|||
170590180|NCT00509093|616503608|FG000|Overall Study|Adverse Event|10|||
170590181|NCT00509093|616503608|FG000|Overall Study|Disease Progression|9|||
170590182|NCT00509093|616503608|FG000|Overall Study|Transformed into MDS|1|||
170590183|NCT00509093|616503608|FG000|Overall Study|Withdrawal by Subject|3|||
170590184|NCT00509093|616503608|FG000|Overall Study|Physician Decision|1|||
170590185|NCT05013424|616503609|FG000|Overall Study|Lost to Follow-up|1|||
170590186|NCT05013424|616503610|FG001|Overall Study|Lost to Follow-up|1|||
170590187|NCT05013424|616503611|FG002|Overall Study|Lost to Follow-up|1|||
170590188|NCT05013424|616503609|FG000|Overall Study|Withdrawal by Subject|0|||
170590189|NCT05013424|616503610|FG001|Overall Study|Withdrawal by Subject|1|||
170590190|NCT05013424|616503611|FG002|Overall Study|Withdrawal by Subject|0|||
170590191|NCT01103063|616503612|FG000|Overall Study|Adverse Event|3|||
170590192|NCT01103063|616503613|FG001|Overall Study|Adverse Event|1|||
170590193|NCT01103063|616503612|FG000|Overall Study|Lost to Follow-up|68|||
170590194|NCT01103063|616503613|FG001|Overall Study|Lost to Follow-up|51|||
170590195|NCT01103063|616503612|FG000|Overall Study|Withdrawal by Subject|60|||
170590196|NCT01103063|616503613|FG001|Overall Study|Withdrawal by Subject|15|||
170590197|NCT01103063|616503612|FG000|Overall Study|Other|16|||
170590198|NCT01103063|616503613|FG001|Overall Study|Other|11|||
170590199|NCT01103063|616503612|FG000|Overall Study|Protocol Violation|1|||
170590200|NCT01103063|616503613|FG001|Overall Study|Protocol Violation|0|||
170590201|NCT01103063|616503612|FG000|Overall Study|Study terminated by Sponsor|326|||
170590202|NCT01103063|616503613|FG001|Overall Study|Study terminated by Sponsor|342|||
170590203|NCT01103063|616503612|FG000|Overall Study|Death|3|||
170590204|NCT01103063|616503613|FG001|Overall Study|Death|1|||
170590205|NCT05275582|616503614|FG000|Overall Study|Lost to Follow-up|1|||
170590206|NCT05275582|616503615|FG001|Overall Study|Lost to Follow-up|0|||
170590207|NCT05275582|616503614|FG000|Overall Study|Withdrawal by Subject|0|||
170590208|NCT05275582|616503615|FG001|Overall Study|Withdrawal by Subject|2|||
170590209|NCT05275582|616503614|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
170590210|NCT05275582|616503615|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
170590211|NCT05275582|616503614|FG000|Overall Study|Death|1|||
170590212|NCT05275582|616503615|FG001|Overall Study|Death|0|||
170590213|NCT05275582|616503614|FG000|Overall Study|Protocol Violation|1|||
170590214|NCT05275582|616503615|FG001|Overall Study|Protocol Violation|0|||
170590215|NCT03602885|616503620|FG000|Overall Study|Lost to Follow-up|3|||
170590216|NCT03602885|616503621|FG001|Overall Study|Lost to Follow-up|0|||
170590217|NCT01685801|616503627|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
170590218|NCT01685801|616503628|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
170590219|NCT01685801|616503629|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
170590220|NCT01685801|616503630|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
170590221|NCT01685801|616503627|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
170590222|NCT01685801|616503628|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
170590223|NCT01685801|616503629|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
170650424|NCT03011892|616732892|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
170650425|NCT03011892|616732893|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
170650426|NCT03011892|616732894|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
170650427|NCT03011892|616732895|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
170650428|NCT03011892|616732896|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
170590224|NCT01685801|616503630|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
170590225|NCT00113399|616503631|FG000|Overall Study|Death|1|||
170590226|NCT00113399|616503632|FG001|Overall Study|Death|1|||
170590227|NCT00113399|616503631|FG000|Overall Study|Withdrawal by Subject|1|||
170590228|NCT00113399|616503632|FG001|Overall Study|Withdrawal by Subject|2|||
170590229|NCT00113399|616503631|FG000|Overall Study|Complete Response|0|||
170590230|NCT00113399|616503632|FG001|Overall Study|Complete Response|1|||
170590231|NCT00113399|616503631|FG000|Overall Study|Other|0|||
170590232|NCT00113399|616503632|FG001|Overall Study|Other|1|||
170590233|NCT00385944|616503634|FG000|1st Maintenance Dose Period|Physician Decision|1|||
170650429|NCT03011892|616732897|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
170590234|NCT00385944|616503635|FG001|1st Maintenance Dose Period|Physician Decision|0|||
170590235|NCT00385944|616503636|FG002|1st Maintenance Dose Period|Physician Decision|0|||
170590236|NCT00385944|616503634|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
170590237|NCT00385944|616503635|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
170590238|NCT00385944|616503636|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
170590239|NCT00385944|616503634|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
170590240|NCT00385944|616503635|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
170590241|NCT00385944|616503636|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
170590242|NCT00385944|616503634|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
170590243|NCT00385944|616503635|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
170590244|NCT00385944|616503636|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
170590245|NCT00543296|616503642|FG000|Overall Study|Physician Decision|7|||
170590246|NCT03136497|616503643|FG000|Overall Study|Screen Failure|1|||
170590247|NCT03136497|616503644|FG001|Overall Study|Screen Failure|0|||
170590248|NCT03136497|616503645|FG002|Overall Study|Screen Failure|0|||
170590249|NCT04659174|616503648|FG000|Overall Study|Sponsor decision to discontinue study|0|||
170590250|NCT04659174|616503649|FG001|Overall Study|Sponsor decision to discontinue study|2|||
170590251|NCT04659174|616503648|FG000|Overall Study|Lost to Follow-up|9|||
170590252|NCT04659174|616503649|FG001|Overall Study|Lost to Follow-up|11|||
170590253|NCT04659174|616503648|FG000|Overall Study|Adverse Event|8|||
170590254|NCT04659174|616503649|FG001|Overall Study|Adverse Event|5|||
170590255|NCT04659174|616503648|FG000|Overall Study|Withdrawal by Subject|17|||
170590256|NCT04659174|616503649|FG001|Overall Study|Withdrawal by Subject|33|||
170590257|NCT04659174|616503648|FG000|Overall Study|Progressive disease|0|||
170590258|NCT04659174|616503649|FG001|Overall Study|Progressive disease|2|||
170590259|NCT04659174|616503648|FG000|Overall Study|Other reasons|0|||
170590260|NCT04659174|616503649|FG001|Overall Study|Other reasons|2|||
170590261|NCT04659174|616503648|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
170590262|NCT04659174|616503649|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
170590263|NCT04659174|616503648|FG000|Overall Study|Alcohol or illegal drug use|0|||
170590264|NCT04659174|616503649|FG001|Overall Study|Alcohol or illegal drug use|3|||
170590265|NCT04659174|616503648|FG000|Overall Study|Violation of entry criteria|1|||
170590266|NCT04659174|616503649|FG001|Overall Study|Violation of entry criteria|0|||
170590267|NCT04659174|616503648|FG000|Overall Study|Death|0|||
170590268|NCT04659174|616503649|FG001|Overall Study|Death|1|||
170590269|NCT03447314|616503652|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
170590270|NCT03447314|616503653|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
170590271|NCT03447314|616503654|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
170590272|NCT03447314|616503655|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
170590273|NCT03447314|616503656|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
170590274|NCT03447314|616503657|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
170590275|NCT03447314|616503658|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
170590276|NCT03447314|616503659|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590277|NCT03447314|616503660|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590278|NCT03447314|616503661|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590279|NCT03447314|616503662|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
170590280|NCT03447314|616503663|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
170590281|NCT03447314|616503664|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590282|NCT03447314|616503665|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590283|NCT03447314|616503666|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590284|NCT03447314|616503667|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590285|NCT03447314|616503668|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590286|NCT03447314|616503669|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
170590287|NCT03447314|616503652|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
170590288|NCT03447314|616503653|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590289|NCT03447314|616503654|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
170590290|NCT03447314|616503655|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590291|NCT03447314|616503656|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590292|NCT03447314|616503657|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
170590293|NCT03447314|616503658|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
170590294|NCT03447314|616503659|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590295|NCT03447314|616503660|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590296|NCT03447314|616503661|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590297|NCT03447314|616503662|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590298|NCT03447314|616503663|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590299|NCT03447314|616503664|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590300|NCT03447314|616503665|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590301|NCT03447314|616503666|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590302|NCT03447314|616503667|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590303|NCT03447314|616503668|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590304|NCT03447314|616503669|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
170590305|NCT03447314|616503652|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590306|NCT03447314|616503653|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590307|NCT03447314|616503654|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
170590308|NCT03447314|616503655|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590309|NCT03447314|616503656|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590310|NCT03447314|616503657|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590311|NCT03447314|616503658|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590312|NCT03447314|616503659|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590313|NCT03447314|616503660|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590314|NCT03447314|616503661|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590315|NCT03447314|616503662|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590316|NCT03447314|616503663|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590317|NCT03447314|616503664|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590318|NCT03447314|616503665|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590319|NCT03447314|616503666|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590320|NCT03447314|616503667|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590321|NCT03447314|616503668|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590322|NCT03447314|616503669|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
170590323|NCT03447314|616503652|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590324|NCT03447314|616503653|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590325|NCT03447314|616503654|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
170590326|NCT03447314|616503655|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590327|NCT03447314|616503656|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590328|NCT03447314|616503657|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590329|NCT03447314|616503658|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590330|NCT03447314|616503659|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590331|NCT03447314|616503660|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590332|NCT03447314|616503661|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590333|NCT03447314|616503662|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590334|NCT03447314|616503663|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590335|NCT03447314|616503664|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590336|NCT03447314|616503665|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590337|NCT03447314|616503666|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590338|NCT03447314|616503667|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590339|NCT03447314|616503668|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590340|NCT03447314|616503669|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
170590341|NCT03447314|616503652|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590342|NCT03447314|616503653|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590343|NCT03447314|616503654|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590344|NCT03447314|616503655|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590345|NCT03447314|616503656|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590346|NCT03447314|616503657|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590347|NCT03447314|616503658|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590348|NCT03447314|616503659|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590349|NCT03447314|616503660|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590350|NCT03447314|616503661|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590351|NCT03447314|616503662|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
170590352|NCT03447314|616503663|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590353|NCT03447314|616503664|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590354|NCT03447314|616503665|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590355|NCT03447314|616503666|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590356|NCT03447314|616503667|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590357|NCT03447314|616503668|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590358|NCT03447314|616503669|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
170590359|NCT03447314|616503652|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590360|NCT03447314|616503653|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170650430|NCT03011892|616732898|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
170650431|NCT03011892|616732899|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
170911611|NCT02926573|617680977|FG000|Overall Study|Nausea|1|||
170911612|NCT02926573|617680978|FG001|Overall Study|Nausea|0|||
170911613|NCT02926573|617680977|FG000|Overall Study|Remain intubated|2|||
170911614|NCT02926573|617680978|FG001|Overall Study|Remain intubated|2|||
170911615|NCT02926573|617680977|FG000|Overall Study|Change in surgery plan|3|||
170911616|NCT02926573|617680978|FG001|Overall Study|Change in surgery plan|1|||
170911617|NCT02926573|617680977|FG000|Overall Study|Change to outpatient status|5|||
170590361|NCT03447314|616503654|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590362|NCT03447314|616503655|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
170590363|NCT03447314|616503656|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590364|NCT03447314|616503657|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
170911618|NCT02926573|617680978|FG001|Overall Study|Change to outpatient status|1|||
170911619|NCT02926573|617680977|FG000|Overall Study|Withdrawal by Subject|0|||
170911620|NCT02926573|617680978|FG001|Overall Study|Withdrawal by Subject|2|||
170911621|NCT02926573|617680977|FG000|Overall Study|Return to operating room|0|||
170911622|NCT02926573|617680978|FG001|Overall Study|Return to operating room|2|||
170590365|NCT03447314|616503658|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590366|NCT03447314|616503659|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590367|NCT03447314|616503660|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590368|NCT03447314|616503661|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590369|NCT03447314|616503662|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590370|NCT03447314|616503663|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590371|NCT03447314|616503664|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590372|NCT03447314|616503665|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590373|NCT03447314|616503666|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590374|NCT03447314|616503667|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590375|NCT03447314|616503668|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590376|NCT03447314|616503669|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
170590377|NCT04049266|616503672|FG000|Overall Study|Adverse Event|16|||
170590378|NCT04049266|616503673|FG001|Overall Study|Adverse Event|9|||
170590379|NCT04049266|616503672|FG000|Overall Study|Non-compliance with study drug|0|||
170590380|NCT04049266|616503673|FG001|Overall Study|Non-compliance with study drug|3|||
170590381|NCT04049266|616503672|FG000|Overall Study|Withdrawal by Subject|6|||
170590382|NCT04049266|616503673|FG001|Overall Study|Withdrawal by Subject|10|||
170590383|NCT04049266|616503672|FG000|Overall Study|Lost to Follow-up|2|||
170590384|NCT04049266|616503673|FG001|Overall Study|Lost to Follow-up|2|||
170590385|NCT04049266|616503672|FG000|Overall Study|Progressive disease|11|||
170590386|NCT04049266|616503673|FG001|Overall Study|Progressive disease|2|||
170590387|NCT04049266|616503672|FG000|Overall Study|Physician Decision|1|||
170590388|NCT04049266|616503673|FG001|Overall Study|Physician Decision|0|||
170590389|NCT04049266|616503672|FG000|Overall Study|Patient moved out of state|1|||
170590390|NCT04049266|616503673|FG001|Overall Study|Patient moved out of state|0|||
170590391|NCT04422561|616503674|FG000|Overall Study|Lost to Follow-up|25|||
170590392|NCT04422561|616503675|FG001|Overall Study|Lost to Follow-up|11|||
170590393|NCT02378298|616503676|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
170590394|NCT02378298|616503677|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
170590395|NCT02378298|616503678|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
170590396|NCT02378298|616503676|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
170590397|NCT02378298|616503677|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
170590398|NCT02378298|616503678|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
170590399|NCT02378298|616503676|FG000|Surveillance (19-68 Weeks)|Death|1|||
170590400|NCT02378298|616503677|FG001|Surveillance (19-68 Weeks)|Death|0|||
170590401|NCT02378298|616503678|FG002|Surveillance (19-68 Weeks)|Death|0|||
170590402|NCT00578877|616503679|FG000|Overall Study|Lost to Follow-up|8|||
170590403|NCT00578877|616503680|FG001|Overall Study|Lost to Follow-up|10|||
170650432|NCT03011892|616732900|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
170590404|NCT00578877|616503679|FG000|Overall Study|early discontinue|61|||
170590405|NCT00578877|616503680|FG001|Overall Study|early discontinue|101|||
170590406|NCT00578877|616503679|FG000|Overall Study|did not provide follow-up data|12|||
170590407|NCT00578877|616503680|FG001|Overall Study|did not provide follow-up data|17|||
170590408|NCT02437409|616503685|FG000|Overall Study|Withdrawal by Subject|3|||
170590409|NCT02437409|616503685|FG000|Overall Study|Screening failure|12|||
170590410|NCT03541187|616503688|FG000|Overall Study|Lost to Follow-up|2|||
170590411|NCT03541187|616503689|FG001|Overall Study|Lost to Follow-up|6|||
170590412|NCT03541187|616503688|FG000|Overall Study|Pregnancy|0|||
170590413|NCT03541187|616503689|FG001|Overall Study|Pregnancy|1|||
170650433|NCT03011892|616732901|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
170650434|NCT03011892|616732902|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
170911623|NCT02926573|617680977|FG000|Overall Study|Delirium|0|||
170590414|NCT03541187|616503688|FG000|Overall Study|Withdrawal by Subject|6|||
170590415|NCT03541187|616503689|FG001|Overall Study|Withdrawal by Subject|2|||
170590416|NCT03541187|616503688|FG000|Overall Study|Moved out of town|1|||
170590417|NCT03541187|616503689|FG001|Overall Study|Moved out of town|0|||
170590418|NCT03541187|616503688|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
170590419|NCT03541187|616503689|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
170590420|NCT03541187|616503688|FG000|Overall Study|Did not meet randomization criteria|1|||
170590421|NCT03541187|616503689|FG001|Overall Study|Did not meet randomization criteria|1|||
170590422|NCT03541187|616503688|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
170590423|NCT03541187|616503689|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
170590424|NCT03541187|616503688|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
170590425|NCT03541187|616503689|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
170590426|NCT02851407|616503694|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170590427|NCT02851407|616503695|FG001|Overall Study|Withdrawal by parent/guardian|7|||
170590428|NCT02851407|616503694|FG000|Overall Study|Protocol deviation|0|||
170590429|NCT02851407|616503695|FG001|Overall Study|Protocol deviation|1|||
170590430|NCT02851407|616503694|FG000|Overall Study|Transferred to another hospital to continue|1|||
170590431|NCT02851407|616503695|FG001|Overall Study|Transferred to another hospital to continue|0|||
170590432|NCT02851407|616503694|FG000|Overall Study|Other Death|30|||
170590433|NCT02851407|616503695|FG001|Overall Study|Other Death|20|||
170590434|NCT02851407|616503694|FG000|Overall Study|Adverse event, serious fatal|6|||
170590435|NCT02851407|616503695|FG001|Overall Study|Adverse event, serious fatal|8|||
170650435|NCT03011892|616732891|FG000|Open Label (OL) Period|Reason not specified|0|||
170650436|NCT03011892|616732892|FG001|Open Label (OL) Period|Reason not specified|0|||
170650437|NCT03011892|616732893|FG002|Open Label (OL) Period|Reason not specified|0|||
170650438|NCT03011892|616732894|FG003|Open Label (OL) Period|Reason not specified|0|||
170650439|NCT03011892|616732895|FG004|Open Label (OL) Period|Reason not specified|0|||
170650440|NCT03011892|616732896|FG005|Open Label (OL) Period|Reason not specified|0|||
170650441|NCT03011892|616732897|FG006|Open Label (OL) Period|Reason not specified|0|||
170650442|NCT03011892|616732898|FG007|Open Label (OL) Period|Reason not specified|1|||
170650443|NCT03011892|616732899|FG008|Open Label (OL) Period|Reason not specified|0|||
170650444|NCT03011892|616732900|FG009|Open Label (OL) Period|Reason not specified|0|||
170650445|NCT03011892|616732901|FG010|Open Label (OL) Period|Reason not specified|0|||
170650446|NCT03011892|616732902|FG011|Open Label (OL) Period|Reason not specified|0|||
170650447|NCT00608569|616732903|FG000|Overall Study|Death|4|||
170650448|NCT00608569|616732904|FG001|Overall Study|Death|3|||
170911624|NCT02926573|617680978|FG001|Overall Study|Delirium|1|||
170911625|NCT02052960|617680979|FG000|Overall Study|Adverse Event|19|||
170911626|NCT02052960|617680980|FG001|Overall Study|Adverse Event|17|||
170911627|NCT02052960|617680979|FG000|Overall Study|Protocol Violation|4|||
170911628|NCT02052960|617680980|FG001|Overall Study|Protocol Violation|3|||
170911629|NCT02052960|617680979|FG000|Overall Study|Withdrawal by Subject|6|||
170911630|NCT02052960|617680980|FG001|Overall Study|Withdrawal by Subject|11|||
170911631|NCT02052960|617680979|FG000|Overall Study|Other|25|||
170911632|NCT02052960|617680980|FG001|Overall Study|Other|15|||
170911633|NCT02460822|617680981|FG000|Overall Study|Withdrawal by Subject|1|||
170650449|NCT00608569|616732903|FG000|Overall Study|Lost to Follow-up|4|||
170650450|NCT00608569|616732904|FG001|Overall Study|Lost to Follow-up|5|||
170650451|NCT00608569|616732903|FG000|Overall Study|Withdrawal by Subject|1|||
170650452|NCT00608569|616732904|FG001|Overall Study|Withdrawal by Subject|0|||
170650453|NCT00608569|616732903|FG000|Overall Study|Adverse Event|1|||
170650454|NCT00608569|616732904|FG001|Overall Study|Adverse Event|0|||
170650455|NCT00608569|616732903|FG000|Overall Study|Unable to adhere with study requirements|0|||
170650456|NCT00608569|616732904|FG001|Overall Study|Unable to adhere with study requirements|1|||
170911634|NCT04045613|617680982|FG000|Overall Study|Adverse Event|2|||
170911635|NCT04045613|617680983|FG001|Overall Study|Adverse Event|2|||
170911636|NCT04045613|617680984|FG002|Overall Study|Adverse Event|1|||
170911637|NCT04045613|617680985|FG003|Overall Study|Adverse Event|1|||
170590436|NCT02851407|616503694|FG000|Overall Study|Consent withdrawn by participant|5|||
170590437|NCT02851407|616503695|FG001|Overall Study|Consent withdrawn by participant|3|||
170590438|NCT02851407|616503694|FG000|Overall Study|Screen failure|2|||
170590439|NCT02851407|616503695|FG001|Overall Study|Screen failure|1|||
170590440|NCT02851407|616503694|FG000|Overall Study|Disease relapse|9|||
170590441|NCT02851407|616503695|FG001|Overall Study|Disease relapse|6|||
170590442|NCT02851407|616503694|FG000|Overall Study|Physician Decision|7|||
170590443|NCT02851407|616503695|FG001|Overall Study|Physician Decision|6|||
170590444|NCT02851407|616503694|FG000|Overall Study|Transferred to hospital closer to home|0|||
170590445|NCT02851407|616503695|FG001|Overall Study|Transferred to hospital closer to home|1|||
170650457|NCT00821509|616732907|FG000|Overall Study|Withdrawal by Subject|12|||
170650458|NCT00821509|616732908|FG001|Overall Study|Withdrawal by Subject|11|||
170650459|NCT00821509|616732909|FG002|Overall Study|Withdrawal by Subject|34|||
170650460|NCT03678870|616732910|FG000|Overall Study|prescribed non- protocol medications|10|||
170911638|NCT04045613|617680986|FG004|Overall Study|Adverse Event|0|||
170590446|NCT02851407|616503694|FG000|Overall Study|Enrolled in an investigational study|0|||
170590447|NCT02851407|616503695|FG001|Overall Study|Enrolled in an investigational study|1|||
170590448|NCT02851407|616503694|FG000|Overall Study|Early recovery|1|||
170590449|NCT02851407|616503695|FG001|Overall Study|Early recovery|0|||
170590450|NCT02851407|616503694|FG000|Overall Study|Adverse event, non-fatal|7|||
170590451|NCT02851407|616503695|FG001|Overall Study|Adverse event, non-fatal|5|||
170590452|NCT02851407|616503694|FG000|Overall Study|Lost to Follow-up|0|||
170590453|NCT02851407|616503695|FG001|Overall Study|Lost to Follow-up|2|||
170590454|NCT03298984|616503696|FG000|Overall Study|Physician Decision|1|||
170590455|NCT03298984|616503697|FG001|Overall Study|Physician Decision|0|||
170590456|NCT03298984|616503698|FG002|Overall Study|Physician Decision|0|||
170590457|NCT03298984|616503699|FG003|Overall Study|Physician Decision|6|||
170590458|NCT03298984|616503696|FG000|Overall Study|Lack of Efficacy|0|||
170590459|NCT03298984|616503697|FG001|Overall Study|Lack of Efficacy|1|||
170590460|NCT03298984|616503698|FG002|Overall Study|Lack of Efficacy|1|||
170590461|NCT03298984|616503699|FG003|Overall Study|Lack of Efficacy|4|||
170590462|NCT03298984|616503696|FG000|Overall Study|Relapsed disease (following remission)|0|||
170590463|NCT03298984|616503697|FG001|Overall Study|Relapsed disease (following remission)|0|||
170590464|NCT03298984|616503698|FG002|Overall Study|Relapsed disease (following remission)|1|||
170590465|NCT03298984|616503699|FG003|Overall Study|Relapsed disease (following remission)|1|||
170590466|NCT03298984|616503696|FG000|Overall Study|Adverse Event|0|||
170590467|NCT03298984|616503697|FG001|Overall Study|Adverse Event|0|||
170590468|NCT03298984|616503698|FG002|Overall Study|Adverse Event|0|||
170590469|NCT03298984|616503699|FG003|Overall Study|Adverse Event|1|||
170590470|NCT03298984|616503696|FG000|Overall Study|Death|0|||
170590471|NCT03298984|616503697|FG001|Overall Study|Death|0|||
170590472|NCT03298984|616503698|FG002|Overall Study|Death|0|||
170590473|NCT03298984|616503699|FG003|Overall Study|Death|2|||
170590474|NCT03298984|616503696|FG000|Overall Study|Insurance Company Decision|0|||
170590475|NCT03298984|616503697|FG001|Overall Study|Insurance Company Decision|0|||
170590476|NCT03298984|616503698|FG002|Overall Study|Insurance Company Decision|0|||
170590477|NCT03298984|616503699|FG003|Overall Study|Insurance Company Decision|1|||
170590478|NCT02585830|616503702|FG000|Overall Study|Withdrawal by Subject|3|||
170590479|NCT00068250|616503703|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
170590480|NCT00068250|616503704|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
170590481|NCT00068250|616503705|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
170590482|NCT00068250|616503706|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
170590483|NCT00235391|616503707|FG000|Overall Study|Adverse Event|4|||
170590484|NCT00235391|616503708|FG001|Overall Study|Adverse Event|5|||
170590485|NCT00235391|616503709|FG002|Overall Study|Adverse Event|10|||
170590486|NCT00235391|616503710|FG003|Overall Study|Adverse Event|72|||
170590487|NCT00235391|616503711|FG004|Overall Study|Adverse Event|5|||
170590488|NCT00235391|616503712|FG005|Overall Study|Adverse Event|2|||
170590489|NCT00235391|616503707|FG000|Overall Study|Abnormal laboratory value(s)|3|||
170590490|NCT00235391|616503708|FG001|Overall Study|Abnormal laboratory value(s)|5|||
170590491|NCT00235391|616503709|FG002|Overall Study|Abnormal laboratory value(s)|4|||
170590492|NCT00235391|616503710|FG003|Overall Study|Abnormal laboratory value(s)|27|||
170590493|NCT00235391|616503711|FG004|Overall Study|Abnormal laboratory value(s)|1|||
170590494|NCT00235391|616503712|FG005|Overall Study|Abnormal laboratory value(s)|2|||
170590495|NCT00235391|616503707|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170590496|NCT00235391|616503708|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170590497|NCT00235391|616503709|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
170590498|NCT00235391|616503710|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
170590499|NCT00235391|616503711|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
170590500|NCT00235391|616503712|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
170590501|NCT00235391|616503707|FG000|Overall Study|Condition no longer requires treatment|3|||
170590502|NCT00235391|616503708|FG001|Overall Study|Condition no longer requires treatment|0|||
170590503|NCT00235391|616503709|FG002|Overall Study|Condition no longer requires treatment|0|||
170590504|NCT00235391|616503710|FG003|Overall Study|Condition no longer requires treatment|11|||
170590505|NCT00235391|616503711|FG004|Overall Study|Condition no longer requires treatment|1|||
170590506|NCT00235391|616503712|FG005|Overall Study|Condition no longer requires treatment|0|||
170590507|NCT00235391|616503707|FG000|Overall Study|Protocol deviation|0|||
170590508|NCT00235391|616503708|FG001|Overall Study|Protocol deviation|0|||
170590509|NCT00235391|616503709|FG002|Overall Study|Protocol deviation|1|||
170650461|NCT03678870|616732911|FG001|Overall Study|prescribed non- protocol medications|6|||
170590510|NCT00235391|616503710|FG003|Overall Study|Protocol deviation|11|||
170590511|NCT00235391|616503711|FG004|Overall Study|Protocol deviation|0|||
170590512|NCT00235391|616503712|FG005|Overall Study|Protocol deviation|0|||
170590513|NCT00235391|616503707|FG000|Overall Study|Withdrawal by Subject|2|||
170590514|NCT00235391|616503708|FG001|Overall Study|Withdrawal by Subject|3|||
170590515|NCT00235391|616503709|FG002|Overall Study|Withdrawal by Subject|3|||
170590516|NCT00235391|616503710|FG003|Overall Study|Withdrawal by Subject|61|||
170590517|NCT00235391|616503711|FG004|Overall Study|Withdrawal by Subject|5|||
170590518|NCT00235391|616503712|FG005|Overall Study|Withdrawal by Subject|0|||
170590519|NCT00235391|616503707|FG000|Overall Study|Lost to Follow-up|0|||
170590520|NCT00235391|616503708|FG001|Overall Study|Lost to Follow-up|3|||
170590521|NCT00235391|616503709|FG002|Overall Study|Lost to Follow-up|3|||
170590522|NCT00235391|616503710|FG003|Overall Study|Lost to Follow-up|16|||
170590523|NCT00235391|616503711|FG004|Overall Study|Lost to Follow-up|0|||
170590524|NCT00235391|616503712|FG005|Overall Study|Lost to Follow-up|0|||
170590525|NCT00235391|616503707|FG000|Overall Study|Administrative problems|0|||
170590526|NCT00235391|616503708|FG001|Overall Study|Administrative problems|0|||
170590527|NCT00235391|616503709|FG002|Overall Study|Administrative problems|0|||
170590528|NCT00235391|616503710|FG003|Overall Study|Administrative problems|1|||
170590529|NCT00235391|616503711|FG004|Overall Study|Administrative problems|0|||
170590530|NCT00235391|616503712|FG005|Overall Study|Administrative problems|0|||
170590531|NCT00235391|616503707|FG000|Overall Study|Death|0|||
170590532|NCT00235391|616503708|FG001|Overall Study|Death|0|||
170590533|NCT00235391|616503709|FG002|Overall Study|Death|1|||
170590534|NCT00235391|616503710|FG003|Overall Study|Death|4|||
170590535|NCT00235391|616503711|FG004|Overall Study|Death|0|||
170590536|NCT00235391|616503712|FG005|Overall Study|Death|0|||
170590537|NCT01824823|616503713|FG000|Overall Study|Lack of Efficacy|1|||
170590538|NCT01824823|616503714|FG001|Overall Study|Lack of Efficacy|1|||
170590539|NCT01824823|616503713|FG000|Overall Study|Off-treatment reason not submitted|1|||
170590540|NCT01824823|616503714|FG001|Overall Study|Off-treatment reason not submitted|0|||
170590541|NCT00580034|616503715|FG000|Overall Study|Toxicity|10|||
170590542|NCT00580034|616503716|FG001|Overall Study|Toxicity|0|||
170590543|NCT02910401|616503719|FG000|Overall Study|Study closure Study closure|0|||
170590544|NCT02910401|616503720|FG001|Overall Study|Study closure Study closure|0|||
170590545|NCT02910401|616503721|FG002|Overall Study|Study closure Study closure|2|||
170590546|NCT02910401|616503719|FG000|Overall Study|Physician Decision|1|||
170650462|NCT03678870|616732910|FG000|Overall Study|Lost to Follow-up|3|||
170650463|NCT03678870|616732911|FG001|Overall Study|Lost to Follow-up|2|||
170650464|NCT00807573|616732913|FG000|Overall Study|Withdrawal by Subject|1|||
170650465|NCT00807573|616732913|FG000|Overall Study|Adverse Event|1|||
170650466|NCT03612856|616732914|FG000|Pre-dose Period|Physician Decision|0|||
170650467|NCT03612856|616732915|FG001|Pre-dose Period|Physician Decision|1|||
170650468|NCT03612856|616732916|FG002|Pre-dose Period|Physician Decision|1|||
170650469|NCT03612856|616732914|FG000|Pre-dose Period|Withdrawal by Subject|0|||
170650470|NCT03612856|616732915|FG001|Pre-dose Period|Withdrawal by Subject|1|||
170650471|NCT03612856|616732916|FG002|Pre-dose Period|Withdrawal by Subject|0|||
170650472|NCT01576159|616732917|FG000|Overall Study|Withdrawal by Subject|0|||
170650473|NCT01576159|616732918|FG001|Overall Study|Withdrawal by Subject|1|||
170650474|NCT01576159|616732919|FG002|Overall Study|Withdrawal by Subject|0|||
170650475|NCT01576159|616732920|FG003|Overall Study|Withdrawal by Subject|0|||
170650476|NCT01576159|616732917|FG000|Overall Study|Physician Decision|0|||
170650477|NCT01576159|616732918|FG001|Overall Study|Physician Decision|0|||
170650478|NCT01576159|616732919|FG002|Overall Study|Physician Decision|1|||
170650479|NCT01576159|616732920|FG003|Overall Study|Physician Decision|0|||
170650480|NCT01576159|616732917|FG000|Overall Study|Lost to Follow-up|0|||
170650481|NCT01576159|616732918|FG001|Overall Study|Lost to Follow-up|0|||
170650482|NCT01576159|616732919|FG002|Overall Study|Lost to Follow-up|0|||
170650483|NCT01576159|616732920|FG003|Overall Study|Lost to Follow-up|1|||
170650484|NCT01576159|616732917|FG000|Overall Study|Protocol Violation|1|||
170650485|NCT01576159|616732918|FG001|Overall Study|Protocol Violation|0|||
170650486|NCT01576159|616732919|FG002|Overall Study|Protocol Violation|0|||
170650487|NCT01576159|616732920|FG003|Overall Study|Protocol Violation|0|||
170650488|NCT04395001|616734371|FG000|Overall Study|Lost to Follow-up|8|||
170650489|NCT04395001|616734372|FG001|Overall Study|Lost to Follow-up|9|||
170650490|NCT04395001|616734373|FG002|Overall Study|Lost to Follow-up|5|||
170650491|NCT04395001|616734371|FG000|Overall Study|Withdrawal by Subject|3|||
170650492|NCT04395001|616734372|FG001|Overall Study|Withdrawal by Subject|1|||
170650493|NCT04395001|616734373|FG002|Overall Study|Withdrawal by Subject|3|||
170650494|NCT04395001|616734371|FG000|Overall Study|missed appointment|7|||
170650495|NCT04395001|616734372|FG001|Overall Study|missed appointment|4|||
170650496|NCT04395001|616734373|FG002|Overall Study|missed appointment|1|||
170590547|NCT02910401|616503720|FG001|Overall Study|Physician Decision|0|||
170590548|NCT02910401|616503721|FG002|Overall Study|Physician Decision|0|||
170590549|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
170590550|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
170590551|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Death|0|||
170590552|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Death|0|||
170590553|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
170590554|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
170590555|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
170650497|NCT00635024|616734374|FG000|Overall Study|Adverse Event|1|||
170650498|NCT02296138|616734375|FG000|Overall Study|Adverse Event|348|||
170650499|NCT02296138|616734376|FG001|Overall Study|Adverse Event|259|||
170650500|NCT02296138|616734375|FG000|Overall Study|Lack of Efficacy|59|||
170590556|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
170650501|NCT02296138|616734376|FG001|Overall Study|Lack of Efficacy|37|||
170650502|NCT02296138|616734375|FG000|Overall Study|Protocol Violation|35|||
170590557|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
170590558|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
170590559|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
170590560|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
170590561|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
170590562|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
170590563|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
170590564|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
170590565|NCT00433160|616503724|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
170590566|NCT00433160|616503725|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
170590567|NCT00433160|616503724|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
170590568|NCT00433160|616503725|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
170590569|NCT00433160|616503724|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
170590570|NCT00433160|616503725|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
170590571|NCT00433160|616503724|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
170590572|NCT00433160|616503725|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
170590573|NCT00433160|616503724|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
170590574|NCT00433160|616503725|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
170590575|NCT00433160|616503724|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
170590576|NCT00433160|616503725|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
170590577|NCT00433160|616503724|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
170590578|NCT00433160|616503725|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
170590579|NCT00433160|616503724|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
170590580|NCT00433160|616503725|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
170590581|NCT03222973|616503726|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
170590582|NCT03222973|616503727|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
170590583|NCT03222973|616503728|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
170590584|NCT03222973|616503729|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
170590585|NCT03222973|616503726|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
170590586|NCT03222973|616503727|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
170590587|NCT03222973|616503728|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
170590588|NCT03222973|616503729|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
170590589|NCT03222973|616503726|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
170590590|NCT03222973|616503727|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
170590591|NCT03222973|616503728|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
170590592|NCT03222973|616503729|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
170590593|NCT03222973|616503726|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
170590594|NCT03222973|616503727|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
170590595|NCT03222973|616503728|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
170590596|NCT03222973|616503729|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
170590597|NCT03222973|616503726|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
170590598|NCT03222973|616503727|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
170590599|NCT03222973|616503728|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
170590600|NCT03222973|616503729|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
170590601|NCT03222973|616503726|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
170590602|NCT03222973|616503727|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
170590603|NCT03222973|616503728|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
170590604|NCT03222973|616503729|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
170590605|NCT03222973|616503726|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
170590606|NCT03222973|616503727|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
170590607|NCT03222973|616503728|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
170590608|NCT03222973|616503729|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
170590609|NCT03222973|616503726|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
170590610|NCT03222973|616503727|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
170590611|NCT03222973|616503728|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
170810589|NCT00089791|617315588|FG001|Overall Study|Death|62|||
170810590|NCT00089791|617315587|FG000|Overall Study|Disease progression|7|||
170810591|NCT00089791|617315588|FG001|Overall Study|Disease progression|3|||
170810592|NCT00089791|617315587|FG000|Overall Study|Ineligibility determined|12|||
170810593|NCT00089791|617315588|FG001|Overall Study|Ineligibility determined|9|||
170810594|NCT00089791|617315587|FG000|Overall Study|Lost to Follow-up|57|||
170810595|NCT00089791|617315588|FG001|Overall Study|Lost to Follow-up|57|||
170810596|NCT00089791|617315587|FG000|Overall Study|Noncompliance|17|||
170810597|NCT00089791|617315588|FG001|Overall Study|Noncompliance|13|||
170810598|NCT00089791|617315587|FG000|Overall Study|Other|20|||
170810599|NCT00089791|617315588|FG001|Overall Study|Other|32|||
170810600|NCT00089791|617315587|FG000|Overall Study|Protocol deviation|12|||
170810601|NCT00089791|617315588|FG001|Overall Study|Protocol deviation|10|||
170810602|NCT00089791|617315587|FG000|Overall Study|Requirement for alternative therapy|7|||
170810603|NCT00089791|617315588|FG001|Overall Study|Requirement for alternative therapy|4|||
170810604|NCT01543204|617315591|FG000|Overall Study|Non-compliance|1|||
170810605|NCT01543204|617315591|FG000|Overall Study|Adverse Event|1|||
170911639|NCT04045613|617680987|FG005|Overall Study|Adverse Event|0|||
170911640|NCT04045613|617680988|FG006|Overall Study|Adverse Event|1|||
170911641|NCT04045613|617680982|FG000|Overall Study|Withdrawal by Subject|0|||
170590612|NCT03222973|616503729|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
170590613|NCT03222973|616503726|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
170590614|NCT03222973|616503727|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
170590615|NCT03222973|616503728|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
170590616|NCT03222973|616503729|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
170590617|NCT03222973|616503726|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
170590618|NCT03222973|616503727|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
170590619|NCT03222973|616503728|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
170590620|NCT03222973|616503729|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
170590621|NCT03222973|616503726|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
170590622|NCT03222973|616503727|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
170590623|NCT03222973|616503728|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
170590624|NCT03222973|616503729|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
170590625|NCT03222973|616503726|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
170590626|NCT03222973|616503727|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
170590627|NCT03222973|616503728|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
170590628|NCT03222973|616503729|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
170590629|NCT02080481|616503730|FG000|Overall Study|Never received a block.|1|||
170590630|NCT02080481|616503731|FG001|Overall Study|Never received a block.|0|||
170590631|NCT02439450|616503732|FG000|Overall Study|Adverse Event|4|||
170590632|NCT02439450|616503733|FG001|Overall Study|Adverse Event|1|||
170590633|NCT02439450|616503734|FG002|Overall Study|Adverse Event|0|||
170590634|NCT02439450|616503735|FG003|Overall Study|Adverse Event|0|||
170590635|NCT02439450|616503732|FG000|Overall Study|Withdrawal by Subject|1|||
170590636|NCT02439450|616503733|FG001|Overall Study|Withdrawal by Subject|2|||
170590637|NCT02439450|616503734|FG002|Overall Study|Withdrawal by Subject|0|||
170590638|NCT02439450|616503735|FG003|Overall Study|Withdrawal by Subject|0|||
170590639|NCT02439450|616503732|FG000|Overall Study|Death|3|||
170590640|NCT02439450|616503733|FG001|Overall Study|Death|0|||
170590641|NCT02439450|616503734|FG002|Overall Study|Death|0|||
170590642|NCT02439450|616503735|FG003|Overall Study|Death|1|||
170590643|NCT02439450|616503732|FG000|Overall Study|Progressive Disease|18|||
170590644|NCT02439450|616503733|FG001|Overall Study|Progressive Disease|41|||
170590645|NCT02439450|616503734|FG002|Overall Study|Progressive Disease|2|||
170590646|NCT02439450|616503735|FG003|Overall Study|Progressive Disease|3|||
170590647|NCT01560637|616503738|FG000|Overall Study|Adverse Event|63|||
170590648|NCT01560637|616503738|FG000|Overall Study|Death|69|||
170590649|NCT01560637|616503738|FG000|Overall Study|Lost to Follow-up|8|||
170590650|NCT01560637|616503738|FG000|Overall Study|Protocol Violation|8|||
170590651|NCT01560637|616503738|FG000|Overall Study|Withdrawal by Subject|24|||
170590652|NCT01560637|616503738|FG000|Overall Study|Progressive Disease|20|||
170590653|NCT01560637|616503738|FG000|Overall Study|Other Reason Not Specified|6|||
170590654|NCT00549900|616505303|FG000|Overall Study|Adverse Event|1|||
170590655|NCT04143217|616505308|FG000|Overall Study|Withdrawal by Subject|42|||
170590656|NCT04143217|616505308|FG000|Overall Study|Adverse Event|29|||
170590657|NCT04143217|616505308|FG000|Overall Study|Lost to Follow-up|29|||
170590658|NCT04143217|616505308|FG000|Overall Study|Lack of Efficacy|15|||
170590659|NCT04143217|616505308|FG000|Overall Study|Physician Decision|1|||
170590660|NCT04143217|616505308|FG000|Overall Study|Non-Compliance With Study Drug|6|||
170590661|NCT04143217|616505308|FG000|Overall Study|Other, Multiple Categories|11|||
170590662|NCT01278407|616505310|FG000|Confirmatory Phase|Adverse Event|5|||
170590663|NCT01278407|616505311|FG001|Confirmatory Phase|Adverse Event|10|||
170590664|NCT01278407|616505312|FG002|Confirmatory Phase|Adverse Event|1|||
170650503|NCT02296138|616734376|FG001|Overall Study|Protocol Violation|36|||
170911642|NCT04045613|617680983|FG001|Overall Study|Withdrawal by Subject|5|||
170911643|NCT04045613|617680984|FG002|Overall Study|Withdrawal by Subject|0|||
170590665|NCT01278407|616505313|FG003|Confirmatory Phase|Adverse Event|0|||
170590666|NCT01278407|616505314|FG004|Confirmatory Phase|Adverse Event|0|||
170590667|NCT01278407|616505310|FG000|Confirmatory Phase|Participant's Choice|3|||
170590668|NCT01278407|616505311|FG001|Confirmatory Phase|Participant's Choice|5|||
170590669|NCT01278407|616505312|FG002|Confirmatory Phase|Participant's Choice|3|||
170590670|NCT01278407|616505313|FG003|Confirmatory Phase|Participant's Choice|0|||
170590671|NCT01278407|616505314|FG004|Confirmatory Phase|Participant's Choice|0|||
170590672|NCT01278407|616505310|FG000|Confirmatory Phase|Other|1|||
170590673|NCT01278407|616505311|FG001|Confirmatory Phase|Other|1|||
170590674|NCT01278407|616505312|FG002|Confirmatory Phase|Other|2|||
170911644|NCT04045613|617680985|FG003|Overall Study|Withdrawal by Subject|0|||
170590675|NCT01278407|616505313|FG003|Confirmatory Phase|Other|0|||
170590676|NCT01278407|616505314|FG004|Confirmatory Phase|Other|0|||
170590677|NCT01278407|616505310|FG000|Extension Phase|Adverse Event|0|||
170590678|NCT01278407|616505311|FG001|Extension Phase|Adverse Event|0|||
170590679|NCT01278407|616505312|FG002|Extension Phase|Adverse Event|0|||
170590680|NCT01278407|616505313|FG003|Extension Phase|Adverse Event|7|||
170650504|NCT02296138|616734375|FG000|Overall Study|Lost to Follow-up|9|||
170650505|NCT02296138|616734376|FG001|Overall Study|Lost to Follow-up|12|||
170650506|NCT02296138|616734375|FG000|Overall Study|Withdrawal by Subject|184|||
170650507|NCT02296138|616734376|FG001|Overall Study|Withdrawal by Subject|131|||
170650508|NCT02296138|616734375|FG000|Overall Study|Not Treated|1|||
170650509|NCT02296138|616734376|FG001|Overall Study|Not Treated|1|||
170650510|NCT02296138|616734375|FG000|Overall Study|Patients with data irregularities|10|||
170650511|NCT02296138|616734376|FG001|Overall Study|Patients with data irregularities|11|||
170650512|NCT02296138|616734375|FG000|Overall Study|Other than specified|15|||
170650513|NCT02296138|616734376|FG001|Overall Study|Other than specified|13|||
170650514|NCT04369924|616734377|FG000|Overall Study|Lost to Follow-up|302|||
170650515|NCT04369924|616734378|FG001|Overall Study|Lost to Follow-up|339|||
170650516|NCT01895361|616734379|FG000|Overall Study|Adverse Event|1|||
170650517|NCT01895361|616734380|FG001|Overall Study|Adverse Event|1|||
170650518|NCT01895361|616734381|FG002|Overall Study|Adverse Event|3|||
170650519|NCT01895361|616734379|FG000|Overall Study|Death|2|||
170650520|NCT01895361|616734380|FG001|Overall Study|Death|1|||
170650521|NCT01895361|616734381|FG002|Overall Study|Death|2|||
170650522|NCT01895361|616734379|FG000|Overall Study|Lost to Follow-up|4|||
170650523|NCT01895361|616734380|FG001|Overall Study|Lost to Follow-up|4|||
170650524|NCT01895361|616734381|FG002|Overall Study|Lost to Follow-up|6|||
170650525|NCT01895361|616734379|FG000|Overall Study|Non-compliance with study|1|||
170650526|NCT01895361|616734380|FG001|Overall Study|Non-compliance with study|3|||
170650527|NCT01895361|616734381|FG002|Overall Study|Non-compliance with study|1|||
170650528|NCT01895361|616734379|FG000|Overall Study|Physician Decision|2|||
170650529|NCT01895361|616734380|FG001|Overall Study|Physician Decision|2|||
170650530|NCT01895361|616734381|FG002|Overall Study|Physician Decision|2|||
170650531|NCT01895361|616734379|FG000|Overall Study|Withdrawal by Subject|7|||
170650532|NCT01895361|616734380|FG001|Overall Study|Withdrawal by Subject|6|||
170650533|NCT01895361|616734381|FG002|Overall Study|Withdrawal by Subject|6|||
170650534|NCT01895361|616734379|FG000|Overall Study|Lack of Efficacy|0|||
170650535|NCT01895361|616734380|FG001|Overall Study|Lack of Efficacy|1|||
170810606|NCT01543204|617315591|FG000|Overall Study|Withdrawal by Subject|4|||
170810607|NCT01543204|617315591|FG000|Overall Study|Requirement for Alternative Therapy|1|||
170590681|NCT01278407|616505314|FG004|Extension Phase|Adverse Event|16|||
170590682|NCT01278407|616505310|FG000|Extension Phase|Participant's Choice|0|||
170590683|NCT01278407|616505311|FG001|Extension Phase|Participant's Choice|0|||
170590684|NCT01278407|616505312|FG002|Extension Phase|Participant's Choice|0|||
170590685|NCT01278407|616505313|FG003|Extension Phase|Participant's Choice|4|||
170590686|NCT01278407|616505314|FG004|Extension Phase|Participant's Choice|11|||
170590687|NCT01278407|616505310|FG000|Extension Phase|Other|0|||
170590688|NCT01278407|616505311|FG001|Extension Phase|Other|0|||
170590689|NCT01278407|616505312|FG002|Extension Phase|Other|0|||
170590690|NCT01278407|616505313|FG003|Extension Phase|Other|1|||
170590691|NCT01278407|616505314|FG004|Extension Phase|Other|3|||
170590692|NCT03710876|616505315|FG000|Overall Study|Death|0|||
170590693|NCT03710876|616505316|FG001|Overall Study|Death|2|||
170590694|NCT03710876|616505315|FG000|Overall Study|Withdrawal by Subject|0|||
170590695|NCT03710876|616505316|FG001|Overall Study|Withdrawal by Subject|2|||
170590696|NCT01460719|616505317|FG000|Overall Study|Adverse Event|1|||
170590697|NCT01460719|616505317|FG000|Overall Study|Withdrawal by Subject|1|||
170590698|NCT01187446|616505319|FG000|Overall Study|Patient started non-protocol therapy|0|||
170590699|NCT01187446|616505320|FG001|Overall Study|Patient started non-protocol therapy|1|||
170590700|NCT03022097|616505323|FG000|Overall Study|Adverse Event|3|||
170590701|NCT03022097|616505324|FG001|Overall Study|Adverse Event|4|||
170590702|NCT03022097|616505325|FG002|Overall Study|Adverse Event|1|||
170590703|NCT03022097|616505326|FG003|Overall Study|Adverse Event|3|||
170590704|NCT03022097|616505323|FG000|Overall Study|Progressive Disease|2|||
170590705|NCT03022097|616505324|FG001|Overall Study|Progressive Disease|0|||
170590706|NCT03022097|616505325|FG002|Overall Study|Progressive Disease|5|||
170590707|NCT03022097|616505326|FG003|Overall Study|Progressive Disease|2|||
170590708|NCT03022097|616505323|FG000|Overall Study|Lack of Efficacy|0|||
170590709|NCT03022097|616505324|FG001|Overall Study|Lack of Efficacy|0|||
170590710|NCT03022097|616505325|FG002|Overall Study|Lack of Efficacy|3|||
170590711|NCT03022097|616505326|FG003|Overall Study|Lack of Efficacy|3|||
170590712|NCT03022097|616505323|FG000|Overall Study|Protocol Violation|1|||
170590713|NCT03022097|616505324|FG001|Overall Study|Protocol Violation|0|||
170590714|NCT03022097|616505325|FG002|Overall Study|Protocol Violation|1|||
170590715|NCT03022097|616505326|FG003|Overall Study|Protocol Violation|0|||
170590716|NCT03022097|616505323|FG000|Overall Study|Withdrawal by Subject|11|||
170590717|NCT03022097|616505324|FG001|Overall Study|Withdrawal by Subject|13|||
170590718|NCT03022097|616505325|FG002|Overall Study|Withdrawal by Subject|15|||
170810608|NCT01543204|617315591|FG000|Overall Study|Lost to Follow-up|1|||
170650536|NCT01895361|616734381|FG002|Overall Study|Lack of Efficacy|0|||
170650537|NCT01895361|616734379|FG000|Overall Study|Reasons different from categories above|7|||
170650538|NCT01895361|616734380|FG001|Overall Study|Reasons different from categories above|3|||
170650539|NCT01895361|616734381|FG002|Overall Study|Reasons different from categories above|4|||
170650540|NCT03312751|616734382|FG000|Overall Study|Death|7|||
170650541|NCT03312751|616734383|FG001|Overall Study|Death|9|||
170810609|NCT01220999|617315592|FG000|Overall Study|Progressive disease|0|||
170590719|NCT03022097|616505326|FG003|Overall Study|Withdrawal by Subject|21|||
170590720|NCT03022097|616505323|FG000|Overall Study|Lost to Follow-up|0|||
170590721|NCT03022097|616505324|FG001|Overall Study|Lost to Follow-up|0|||
170590722|NCT03022097|616505325|FG002|Overall Study|Lost to Follow-up|1|||
170590723|NCT03022097|616505326|FG003|Overall Study|Lost to Follow-up|1|||
170590724|NCT03022097|616505323|FG000|Overall Study|Other|4|||
170590725|NCT03022097|616505324|FG001|Overall Study|Other|1|||
170590726|NCT03022097|616505325|FG002|Overall Study|Other|6|||
170590727|NCT03022097|616505326|FG003|Overall Study|Other|4|||
170590728|NCT03022097|616505323|FG000|Overall Study|Due to COVID-19 pandemic|0|||
170590729|NCT03022097|616505324|FG001|Overall Study|Due to COVID-19 pandemic|1|||
170590730|NCT03022097|616505325|FG002|Overall Study|Due to COVID-19 pandemic|0|||
170590731|NCT03022097|616505326|FG003|Overall Study|Due to COVID-19 pandemic|0|||
170590732|NCT00937404|616505327|FG000|Overall Study|Protocol Violation|1|||
170590733|NCT00937404|616505327|FG000|Overall Study|Withdrawal by Subject|1|||
170590734|NCT01482169|616505329|FG000|Overall Study|Physician Decision|2|||
170590735|NCT01574157|616505333|FG000|Overall Study|Withdrawal by Subject|4|||
170590736|NCT01574157|616505334|FG001|Overall Study|Withdrawal by Subject|5|||
170590737|NCT01574157|616505333|FG000|Overall Study|Lost to Follow-up|0|||
170590738|NCT01574157|616505334|FG001|Overall Study|Lost to Follow-up|3|||
170590739|NCT00457821|616505339|FG000|Part 2|Withdrawal by Subject|0|||
170590740|NCT00457821|616505340|FG001|Part 2|Withdrawal by Subject|0|||
170590741|NCT00457821|616505341|FG002|Part 2|Withdrawal by Subject|0|||
170590742|NCT00457821|616505342|FG003|Part 2|Withdrawal by Subject|0|||
170590743|NCT00457821|616505343|FG004|Part 2|Withdrawal by Subject|0|||
170590744|NCT00457821|616505344|FG005|Part 2|Withdrawal by Subject|0|||
170590745|NCT00457821|616505345|FG006|Part 2|Withdrawal by Subject|0|||
170590746|NCT00457821|616505346|FG007|Part 2|Withdrawal by Subject|1|||
170590747|NCT00445848|616505350|FG000|Overall Study|Adverse Event|14|||
170590748|NCT00445848|616505350|FG000|Overall Study|Withdrawal by Subject|4|||
170590749|NCT00445848|616505350|FG000|Overall Study|Progression|62|||
170590750|NCT00445848|616505350|FG000|Overall Study|Other-Not protocol specified|5|||
170590751|NCT00330928|616505353|FG000|Overall Study|Lost to Follow-up|6|||
170590752|NCT00330928|616505353|FG000|Overall Study|Physician Decision|9|||
170590753|NCT00330928|616505353|FG000|Overall Study|Death|1|||
170590754|NCT00330928|616505353|FG000|Overall Study|IVUS could not be performed.|1|||
170590755|NCT00790647|616505358|FG000|Overall Study|Adverse Event|1|||
170590756|NCT03028480|616505359|FG000|Overall Study|No revisit after the first prescription date|2|||
170590757|NCT03028480|616505359|FG000|Overall Study|Did not use the drug|1|||
170590758|NCT03028480|616505359|FG000|Overall Study|Violation of the enrollment deadline|10|||
170590759|NCT03028480|616505359|FG000|Overall Study|Case report forms were not collected|21|||
170590760|NCT00835640|616505363|FG000|Second Intervention|Protocol Violation|1|||
170590761|NCT00835640|616505364|FG001|Second Intervention|Protocol Violation|0|||
170590762|NCT00812006|616505365|FG000|Overall Study|Lost to Follow-up|0|||
170590763|NCT00812006|616505366|FG001|Overall Study|Lost to Follow-up|0|||
170590764|NCT00812006|616505367|FG002|Overall Study|Lost to Follow-up|2|||
170590765|NCT00812006|616505365|FG000|Overall Study|Physician Decision|0|||
170590766|NCT00812006|616505366|FG001|Overall Study|Physician Decision|0|||
170590767|NCT00812006|616505367|FG002|Overall Study|Physician Decision|1|||
170590768|NCT00812006|616505365|FG000|Overall Study|Withdrawal by Subject|2|||
170590769|NCT00812006|616505366|FG001|Overall Study|Withdrawal by Subject|1|||
170590770|NCT00812006|616505367|FG002|Overall Study|Withdrawal by Subject|1|||
170590771|NCT00812006|616505365|FG000|Overall Study|Lack of Qualifying Event|4|||
170590772|NCT00812006|616505366|FG001|Overall Study|Lack of Qualifying Event|2|||
170590773|NCT00812006|616505367|FG002|Overall Study|Lack of Qualifying Event|2|||
170590774|NCT00246025|616505368|FG000|Overall Study|Adverse Event|7|||
170590775|NCT00246025|616505369|FG001|Overall Study|Adverse Event|9|||
170590776|NCT00246025|616505370|FG002|Overall Study|Adverse Event|9|||
170590777|NCT00246025|616505371|FG003|Overall Study|Adverse Event|10|||
170590778|NCT00246025|616505368|FG000|Overall Study|Withdrawal by Subject|3|||
170590779|NCT00246025|616505369|FG001|Overall Study|Withdrawal by Subject|0|||
170911645|NCT04045613|617680986|FG004|Overall Study|Withdrawal by Subject|0|||
170911646|NCT04045613|617680987|FG005|Overall Study|Withdrawal by Subject|1|||
170590780|NCT00246025|616505370|FG002|Overall Study|Withdrawal by Subject|1|||
170590781|NCT00246025|616505371|FG003|Overall Study|Withdrawal by Subject|2|||
170590782|NCT00246025|616505368|FG000|Overall Study|unsuitable medical history was found|0|||
170590783|NCT00246025|616505369|FG001|Overall Study|unsuitable medical history was found|0|||
170590784|NCT00246025|616505370|FG002|Overall Study|unsuitable medical history was found|0|||
170650542|NCT03312751|616734382|FG000|Overall Study|Study discontinuation due to other reason|0|||
170911647|NCT04045613|617680988|FG006|Overall Study|Withdrawal by Subject|0|||
170590785|NCT00246025|616505371|FG003|Overall Study|unsuitable medical history was found|1|||
170590786|NCT03385265|616505374|FG000|Overall Study|Withdrawal by Subject|5|||
170590787|NCT03385265|616505375|FG001|Overall Study|Withdrawal by Subject|2|||
170590788|NCT03385265|616505376|FG002|Overall Study|Withdrawal by Subject|5|||
170590789|NCT03385265|616505377|FG003|Overall Study|Withdrawal by Subject|2|||
170650543|NCT03312751|616734383|FG001|Overall Study|Study discontinuation due to other reason|1|||
170590790|NCT01218100|616505380|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
170590791|NCT01218100|616505381|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
170590792|NCT01218100|616505382|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
170590793|NCT01218100|616505383|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
170590794|NCT01218100|616505380|FG000|Overall Study|Adverse Event|4|||
170590795|NCT01218100|616505381|FG001|Overall Study|Adverse Event|6|||
170590796|NCT01218100|616505382|FG002|Overall Study|Adverse Event|6|||
170590797|NCT01218100|616505383|FG003|Overall Study|Adverse Event|7|||
170590798|NCT01218100|616505380|FG000|Overall Study|Lack of Efficacy|9|||
170590799|NCT01218100|616505381|FG001|Overall Study|Lack of Efficacy|6|||
170590800|NCT01218100|616505382|FG002|Overall Study|Lack of Efficacy|5|||
170590801|NCT01218100|616505383|FG003|Overall Study|Lack of Efficacy|12|||
170590802|NCT01218100|616505380|FG000|Overall Study|Protocol Violation|0|||
170590803|NCT01218100|616505381|FG001|Overall Study|Protocol Violation|0|||
170590804|NCT01218100|616505382|FG002|Overall Study|Protocol Violation|1|||
170590805|NCT01218100|616505383|FG003|Overall Study|Protocol Violation|1|||
170590806|NCT01218100|616505380|FG000|Overall Study|Withdrawal by Subject|5|||
170590807|NCT01218100|616505381|FG001|Overall Study|Withdrawal by Subject|2|||
170590808|NCT01218100|616505382|FG002|Overall Study|Withdrawal by Subject|6|||
170590809|NCT01218100|616505383|FG003|Overall Study|Withdrawal by Subject|7|||
170590810|NCT01218100|616505380|FG000|Overall Study|Lost to Follow-up|3|||
170590811|NCT01218100|616505381|FG001|Overall Study|Lost to Follow-up|8|||
170590812|NCT01218100|616505382|FG002|Overall Study|Lost to Follow-up|2|||
170590813|NCT01218100|616505383|FG003|Overall Study|Lost to Follow-up|1|||
170590814|NCT01218100|616505380|FG000|Overall Study|Other Reason|2|||
170590815|NCT01218100|616505381|FG001|Overall Study|Other Reason|2|||
170590816|NCT01218100|616505382|FG002|Overall Study|Other Reason|6|||
170590817|NCT01218100|616505383|FG003|Overall Study|Other Reason|4|||
170590818|NCT02437305|616505385|FG000|Overall Study|Lost to Follow-up|18|||
170590819|NCT02437305|616505386|FG001|Overall Study|Lost to Follow-up|12|||
170590820|NCT03220581|616505389|FG000|Overall Study|Withdrawal by Subject|0|||
170590821|NCT03220581|616505390|FG001|Overall Study|Withdrawal by Subject|1|||
170590822|NCT03220581|616505389|FG000|Overall Study|Lost to Follow-up|3|||
170590823|NCT03220581|616505390|FG001|Overall Study|Lost to Follow-up|6|||
170590824|NCT02434354|616505391|FG000|Overall Study|screen fail|3|||
170590825|NCT01185964|616505392|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
170590826|NCT01185964|616505393|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
170590827|NCT01185964|616505394|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
170590828|NCT01185964|616505395|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
170590829|NCT01185964|616505392|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
170590830|NCT01185964|616505393|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
170590831|NCT01185964|616505394|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
170590832|NCT01185964|616505395|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
170590833|NCT01185964|616505392|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
170590834|NCT01185964|616505393|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
170590835|NCT01185964|616505394|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
170590836|NCT01185964|616505395|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
170590837|NCT01185964|616505392|FG000|Phase 1b and Phase 2|Adverse Event|1|||
170590838|NCT01185964|616505393|FG001|Phase 1b and Phase 2|Adverse Event|0|||
170590839|NCT01185964|616505394|FG002|Phase 1b and Phase 2|Adverse Event|2|||
170590840|NCT01185964|616505395|FG003|Phase 1b and Phase 2|Adverse Event|0|||
170590841|NCT01185964|616505392|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
170590842|NCT01185964|616505393|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
170590843|NCT01185964|616505394|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
170650544|NCT05463198|616734384|FG000|Overall Study|Withdrawal by Subject|19|||
170650545|NCT05463198|616734384|FG000|Overall Study|Procedure Notes Missing|18|||
170810610|NCT01220999|617315593|FG001|Overall Study|Progressive disease|0|||
170590844|NCT01185964|616505395|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
170590845|NCT01185964|616505392|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
170590846|NCT01185964|616505393|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
170590847|NCT01185964|616505394|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
170650546|NCT01214174|616734385|FG000|Overall Study|Withdrawal by Subject|0|||
170650547|NCT01214174|616734386|FG001|Overall Study|Withdrawal by Subject|0|||
170810611|NCT01220999|617315594|FG002|Overall Study|Progressive disease|1|||
170810612|NCT01220999|617315595|FG003|Overall Study|Progressive disease|0|||
170810613|NCT01220999|617315596|FG004|Overall Study|Progressive disease|0|||
170810614|NCT01560429|617315597|FG000|Overall Study|Protocol Violation|3|||
170810615|NCT01560429|617315598|FG001|Overall Study|Protocol Violation|6|||
170810616|NCT00721734|617315599|FG000|Overall Study|Progressive Disease|3|||
170810617|NCT00721734|617315600|FG001|Overall Study|Progressive Disease|10|||
170810618|NCT00721734|617315601|FG002|Overall Study|Progressive Disease|4|||
170810619|NCT00721734|617315602|FG003|Overall Study|Progressive Disease|5|||
170810620|NCT00721734|617315603|FG004|Overall Study|Progressive Disease|2|||
170590848|NCT01185964|616505395|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
170590849|NCT01185964|616505392|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
170590850|NCT01185964|616505393|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
170590851|NCT01185964|616505394|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
170590852|NCT01185964|616505395|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
170590853|NCT01185964|616505392|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
170590854|NCT01185964|616505393|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
170590855|NCT01185964|616505394|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
170590856|NCT01185964|616505395|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
170590857|NCT01920893|616505396|FG000|Overall Study|Adverse Event|5|||
170590858|NCT01920893|616505397|FG001|Overall Study|Adverse Event|2|||
170590859|NCT01920893|616505396|FG000|Overall Study|Lack of Efficacy|2|||
170590860|NCT01920893|616505397|FG001|Overall Study|Lack of Efficacy|0|||
170590861|NCT03440918|616505398|FG000|Overall Study|Protocol Violation|0|||
170590862|NCT03440918|616505399|FG001|Overall Study|Protocol Violation|16|||
170590863|NCT04346108|616505411|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
170590864|NCT04346108|616505412|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
170590865|NCT04346108|616505413|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
170590866|NCT04346108|616505411|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
170590867|NCT04346108|616505412|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
170590868|NCT04346108|616505413|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
170590869|NCT01081301|616505417|FG000|Overall Study|Bereaved|3|||
170590870|NCT01081301|616505417|FG000|Overall Study|Too busy|5|||
170590871|NCT01081301|616505417|FG000|Overall Study|Patient too ill|2|||
170590872|NCT01081301|616505417|FG000|Overall Study|Lost to Follow-up|4|||
170590873|NCT04508751|616505420|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
170590874|NCT04508751|616505421|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
170590875|NCT04508751|616505422|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
170590876|NCT02014480|616505423|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
170590877|NCT02014480|616505424|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
170590878|NCT02014480|616505425|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
170590879|NCT02014480|616505426|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
170590880|NCT02014480|616505427|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
170590881|NCT02014480|616505428|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
170590882|NCT02014480|616505423|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170590883|NCT02014480|616505424|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170590884|NCT02014480|616505425|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170590885|NCT02014480|616505426|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
170590886|NCT02014480|616505427|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170590887|NCT02014480|616505428|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170590888|NCT02014480|616505423|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170590889|NCT02014480|616505424|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170590890|NCT02014480|616505425|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
170590891|NCT02014480|616505426|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170590892|NCT02014480|616505427|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170590893|NCT02014480|616505428|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
170590894|NCT02014480|616505423|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
170590895|NCT02014480|616505424|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
170590896|NCT02014480|616505425|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
170590897|NCT02014480|616505426|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
170590898|NCT02014480|616505427|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170590899|NCT02014480|616505428|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170590900|NCT02014480|616505423|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170590901|NCT02014480|616505424|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
170590902|NCT02014480|616505425|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170590903|NCT02014480|616505426|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170590904|NCT02014480|616505427|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170590905|NCT02014480|616505428|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
170590906|NCT02014480|616505423|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
170590907|NCT02014480|616505424|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
170590908|NCT02014480|616505425|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
170590909|NCT02014480|616505426|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
170590910|NCT02014480|616505427|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
170590911|NCT02014480|616505428|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
170590912|NCT02014480|616505423|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170590913|NCT02014480|616505424|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170590914|NCT02014480|616505425|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170590915|NCT02014480|616505426|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170590916|NCT02014480|616505427|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170590917|NCT02014480|616505428|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
170590918|NCT01338610|616505429|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
170590919|NCT01338610|616505430|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
170590920|NCT01338610|616505431|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
170590921|NCT01338610|616505429|FG000|Overall Study|Protocol Violation|1|||
170590922|NCT01338610|616505430|FG001|Overall Study|Protocol Violation|0|||
170590923|NCT01338610|616505431|FG002|Overall Study|Protocol Violation|1|||
170590924|NCT01338610|616505429|FG000|Overall Study|Adverse Event|3|||
170590925|NCT01338610|616505430|FG001|Overall Study|Adverse Event|0|||
170590926|NCT01338610|616505431|FG002|Overall Study|Adverse Event|0|||
170590927|NCT00724854|616505432|FG000|Overall Study|Lack of Efficacy|187|||
170590928|NCT00724854|616505433|FG001|Overall Study|Lack of Efficacy|13|||
170590929|NCT00724854|616505432|FG000|Overall Study|Lost to Follow-up|87|||
170590930|NCT00724854|616505433|FG001|Overall Study|Lost to Follow-up|10|||
170590931|NCT00724854|616505432|FG000|Overall Study|Adverse Event|62|||
170590932|NCT00724854|616505433|FG001|Overall Study|Adverse Event|4|||
170590933|NCT00724854|616505432|FG000|Overall Study|Other|42|||
170590934|NCT00724854|616505433|FG001|Overall Study|Other|3|||
170590935|NCT00724854|616505432|FG000|Overall Study|Death|11|||
170590936|NCT00724854|616505433|FG001|Overall Study|Death|0|||
170590937|NCT00724854|616505432|FG000|Overall Study|Change of treatment|7|||
170590938|NCT00724854|616505433|FG001|Overall Study|Change of treatment|0|||
170590939|NCT00724854|616505432|FG000|Overall Study|Withdrawal by Subject|5|||
170590940|NCT00724854|616505433|FG001|Overall Study|Withdrawal by Subject|0|||
170590941|NCT00724854|616505432|FG000|Overall Study|Adverse event + lack of efficacy|2|||
170590942|NCT00724854|616505433|FG001|Overall Study|Adverse event + lack of efficacy|1|||
170590943|NCT01865812|616505434|FG000|Primary Treatment Phase|Adverse Event|2|||
170590944|NCT01865812|616505435|FG001|Primary Treatment Phase|Adverse Event|0|||
170590945|NCT01865812|616505434|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
170590946|NCT01865812|616505435|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
170590947|NCT01865812|616505434|FG000|Long-term Safety Extension Phase|Pruritus|0|||
170590948|NCT01865812|616505435|FG001|Long-term Safety Extension Phase|Pruritus|3|||
170590949|NCT01865812|616505434|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
170590950|NCT01865812|616505435|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
170590951|NCT01865812|616505434|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
170590952|NCT01865812|616505435|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
170590953|NCT02046226|616505436|FG000|Overall Study|Lost to Follow-up|7|||
170590954|NCT00171925|616505437|FG000|Overall Study|Adverse Event|10|||
170590955|NCT00171925|616505438|FG001|Overall Study|Adverse Event|6|||
170590956|NCT00171925|616505437|FG000|Overall Study|Protocol Violation|1|||
170590957|NCT00171925|616505438|FG001|Overall Study|Protocol Violation|1|||
170590958|NCT00171925|616505437|FG000|Overall Study|Withdrawal by Subject|6|||
170590959|NCT00171925|616505438|FG001|Overall Study|Withdrawal by Subject|9|||
170590960|NCT00171925|616505437|FG000|Overall Study|Lost to Follow-up|2|||
170590961|NCT00171925|616505438|FG001|Overall Study|Lost to Follow-up|2|||
170590962|NCT00171925|616505437|FG000|Overall Study|Administrative problems|10|||
170590963|NCT00171925|616505438|FG001|Overall Study|Administrative problems|11|||
170590964|NCT00171925|616505437|FG000|Overall Study|Death|1|||
170590965|NCT00171925|616505438|FG001|Overall Study|Death|2|||
170590966|NCT02692040|616505439|FG000|Overall Study|Protocol Violation|0|||
170590967|NCT02692040|616505440|FG001|Overall Study|Protocol Violation|0|||
170911648|NCT04045613|617680982|FG000|Overall Study|Physician Decision|2|||
170911649|NCT04045613|617680983|FG001|Overall Study|Physician Decision|0|||
170590968|NCT02692040|616505441|FG002|Overall Study|Protocol Violation|0|||
170590969|NCT02692040|616505442|FG003|Overall Study|Protocol Violation|0|||
170590970|NCT02692040|616505443|FG004|Overall Study|Protocol Violation|0|||
170590971|NCT02692040|616505444|FG005|Overall Study|Protocol Violation|0|||
170590972|NCT02692040|616505445|FG006|Overall Study|Protocol Violation|0|||
170590973|NCT02692040|616505446|FG007|Overall Study|Protocol Violation|0|||
170911650|NCT04045613|617680984|FG002|Overall Study|Physician Decision|0|||
170911651|NCT04045613|617680985|FG003|Overall Study|Physician Decision|0|||
170911652|NCT04045613|617680986|FG004|Overall Study|Physician Decision|1|||
170911653|NCT04045613|617680987|FG005|Overall Study|Physician Decision|0|||
170590974|NCT02692040|616505447|FG008|Overall Study|Protocol Violation|0|||
170590975|NCT02692040|616505448|FG009|Overall Study|Protocol Violation|0|||
170590976|NCT02692040|616505449|FG010|Overall Study|Protocol Violation|0|||
170590977|NCT02692040|616505450|FG011|Overall Study|Protocol Violation|0|||
170590978|NCT02692040|616505451|FG012|Overall Study|Protocol Violation|1|||
170590979|NCT02692040|616505452|FG013|Overall Study|Protocol Violation|0|||
170590980|NCT02692040|616505453|FG014|Overall Study|Protocol Violation|0|||
170590981|NCT02692040|616505454|FG015|Overall Study|Protocol Violation|0|||
170590982|NCT02692040|616505455|FG016|Overall Study|Protocol Violation|0|||
170911654|NCT04045613|617680988|FG006|Overall Study|Physician Decision|0|||
170590983|NCT02692040|616505439|FG000|Overall Study|Adverse Event|0|||
170590984|NCT02692040|616505440|FG001|Overall Study|Adverse Event|0|||
170590985|NCT02692040|616505441|FG002|Overall Study|Adverse Event|0|||
170911655|NCT04045613|617680982|FG000|Overall Study|Death|3|||
170911656|NCT04045613|617680983|FG001|Overall Study|Death|0|||
170590986|NCT02692040|616505442|FG003|Overall Study|Adverse Event|0|||
170590987|NCT02692040|616505443|FG004|Overall Study|Adverse Event|0|||
170590988|NCT02692040|616505444|FG005|Overall Study|Adverse Event|0|||
170590989|NCT02692040|616505445|FG006|Overall Study|Adverse Event|0|||
170590990|NCT02692040|616505446|FG007|Overall Study|Adverse Event|0|||
170590991|NCT02692040|616505447|FG008|Overall Study|Adverse Event|0|||
170590992|NCT02692040|616505448|FG009|Overall Study|Adverse Event|0|||
170590993|NCT02692040|616505449|FG010|Overall Study|Adverse Event|0|||
170590994|NCT02692040|616505450|FG011|Overall Study|Adverse Event|0|||
170590995|NCT02692040|616505451|FG012|Overall Study|Adverse Event|0|||
170590996|NCT02692040|616505452|FG013|Overall Study|Adverse Event|3|||
170590997|NCT02692040|616505453|FG014|Overall Study|Adverse Event|1|||
170590998|NCT02692040|616505454|FG015|Overall Study|Adverse Event|1|||
170590999|NCT02692040|616505455|FG016|Overall Study|Adverse Event|0|||
170591000|NCT00054691|616505461|FG000|Overall Study|Unmeasurable Disease|2|||
170591001|NCT00054691|616505461|FG000|Overall Study|Noncompliant|1|||
170591002|NCT00717522|616505462|FG000|Overall Study|Disease Progression|5|||
170591003|NCT00717522|616505462|FG000|Overall Study|Adverse Event|1|||
170591004|NCT00717522|616505462|FG000|Overall Study|Death|1|||
170591005|NCT01799239|616505463|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
170591006|NCT01799239|616505464|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
170591007|NCT01799239|616505463|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
170591008|NCT01799239|616505464|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
170591009|NCT01799239|616505463|FG000|Period 1 (7 Days)|Protocol Violation|0|||
170591010|NCT01799239|616505464|FG001|Period 1 (7 Days)|Protocol Violation|1|||
170591011|NCT01799239|616505463|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
170591012|NCT01799239|616505464|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
170591013|NCT01799239|616505463|FG000|Period 2 (7 Days)|Protocol Violation|1|||
170591014|NCT01799239|616505464|FG001|Period 2 (7 Days)|Protocol Violation|0|||
170591015|NCT01561755|616505465|FG000|Overall Study|Lost to Follow-up|0|||
170591016|NCT01561755|616505466|FG001|Overall Study|Lost to Follow-up|1|||
170591017|NCT01605227|616505467|FG000|Overall Study|Did not receive study treatment|2|||
170591018|NCT01605227|616505468|FG001|Overall Study|Did not receive study treatment|3|||
170591019|NCT01605227|616505467|FG000|Overall Study|Adverse Event|228|||
170591020|NCT01605227|616505468|FG001|Overall Study|Adverse Event|42|||
170591021|NCT01605227|616505467|FG000|Overall Study|Progressive Disease|132|||
170591022|NCT01605227|616505468|FG001|Overall Study|Progressive Disease|128|||
170591023|NCT01605227|616505467|FG000|Overall Study|Clinical Deterioration|227|||
170591024|NCT01605227|616505468|FG001|Overall Study|Clinical Deterioration|133|||
170591025|NCT01605227|616505467|FG000|Overall Study|Lost to Follow-up|1|||
170591026|NCT01605227|616505468|FG001|Overall Study|Lost to Follow-up|0|||
170591027|NCT01605227|616505467|FG000|Overall Study|Protocol Violation|1|||
170591028|NCT01605227|616505468|FG001|Overall Study|Protocol Violation|0|||
170591029|NCT01605227|616505467|FG000|Overall Study|Physician Decision|9|||
170591030|NCT01605227|616505468|FG001|Overall Study|Physician Decision|7|||
170591031|NCT01605227|616505467|FG000|Overall Study|Withdrawal by Subject|18|||
170591032|NCT01605227|616505468|FG001|Overall Study|Withdrawal by Subject|14|||
170591033|NCT01605227|616505467|FG000|Overall Study|Sponsor Decision|2|||
170591034|NCT01605227|616505468|FG001|Overall Study|Sponsor Decision|0|||
170591035|NCT01605227|616505467|FG000|Overall Study|Started New Therapy|1|||
170591036|NCT01605227|616505468|FG001|Overall Study|Started New Therapy|0|||
170591037|NCT01605227|616505467|FG000|Overall Study|Subject Decision|0|||
170591038|NCT01605227|616505468|FG001|Overall Study|Subject Decision|1|||
170591039|NCT01605227|616505467|FG000|Overall Study|Dose Held >6 weeks|0|||
170591040|NCT01605227|616505468|FG001|Overall Study|Dose Held >6 weeks|1|||
170591041|NCT01166958|616505469|FG000|Overall Study|Withdrawal by Subject|1|||
170591042|NCT01166958|616505470|FG001|Overall Study|Withdrawal by Subject|0|||
170591043|NCT04209114|616505471|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
170591044|NCT04209114|616505472|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
170591045|NCT04209114|616505473|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
170591046|NCT04209114|616505471|FG000|Pre-Treatment Phase|Other reasons|0|||
170591047|NCT04209114|616505472|FG001|Pre-Treatment Phase|Other reasons|0|||
170591048|NCT04209114|616505473|FG002|Pre-Treatment Phase|Other reasons|1|||
170591049|NCT04209114|616505471|FG000|Pre-Treatment Phase|Death|0|||
170810621|NCT00721734|617315599|FG000|Overall Study|Adverse Event|3|||
170591050|NCT04209114|616505472|FG001|Pre-Treatment Phase|Death|0|||
170591051|NCT04209114|616505473|FG002|Pre-Treatment Phase|Death|1|||
170591052|NCT04209114|616505471|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
170591053|NCT04209114|616505472|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
170591054|NCT04209114|616505473|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
170591055|NCT04209114|616505471|FG000|Treatment Phase|Other reasons|5|||
170591056|NCT04209114|616505472|FG001|Treatment Phase|Other reasons|3|||
170591057|NCT04209114|616505473|FG002|Treatment Phase|Other reasons|0|||
170591058|NCT04209114|616505471|FG000|Treatment Phase|Lost to Follow-up|1|||
170591059|NCT04209114|616505472|FG001|Treatment Phase|Lost to Follow-up|0|||
170591060|NCT04209114|616505473|FG002|Treatment Phase|Lost to Follow-up|0|||
170591061|NCT04209114|616505471|FG000|Treatment Phase|Participant withdrew consent|1|||
170591062|NCT04209114|616505472|FG001|Treatment Phase|Participant withdrew consent|0|||
170911657|NCT04045613|617680984|FG002|Overall Study|Death|0|||
170911658|NCT04045613|617680985|FG003|Overall Study|Death|0|||
170911659|NCT04045613|617680986|FG004|Overall Study|Death|0|||
170591063|NCT04209114|616505473|FG002|Treatment Phase|Participant withdrew consent|0|||
170591064|NCT04209114|616505471|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
170591065|NCT04209114|616505472|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
170591066|NCT04209114|616505473|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
170591067|NCT04209114|616505471|FG000|Treatment Phase|Death|4|||
170591068|NCT04209114|616505472|FG001|Treatment Phase|Death|1|||
170591069|NCT04209114|616505473|FG002|Treatment Phase|Death|0|||
170591070|NCT04209114|616505471|FG000|Treatment Phase|Study drug toxicity|4|||
170591071|NCT04209114|616505472|FG001|Treatment Phase|Study drug toxicity|6|||
170591072|NCT04209114|616505473|FG002|Treatment Phase|Study drug toxicity|0|||
170591073|NCT04209114|616505471|FG000|Treatment Phase|Disease progression|6|||
170591074|NCT04209114|616505472|FG001|Treatment Phase|Disease progression|9|||
170591075|NCT04209114|616505473|FG002|Treatment Phase|Disease progression|0|||
170591076|NCT02410824|616505480|FG000|First Intervention (One Week)|Headache|0|||
170591077|NCT02410824|616505481|FG001|First Intervention (One Week)|Headache|1|||
170591078|NCT02436408|616505482|FG000|Overall Study|Death|1|||
170591079|NCT01300819|616505483|FG000|Overall Study|Adverse Event|9|||
170591080|NCT01300819|616505484|FG001|Overall Study|Adverse Event|27|||
170591081|NCT01300819|616505483|FG000|Overall Study|Lack of Efficacy|2|||
170591082|NCT01300819|616505484|FG001|Overall Study|Lack of Efficacy|1|||
170591083|NCT01300819|616505483|FG000|Overall Study|Withdrawal by Subject|10|||
170591084|NCT01300819|616505484|FG001|Overall Study|Withdrawal by Subject|12|||
170591085|NCT01300819|616505483|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
170591086|NCT01300819|616505484|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
170591087|NCT01300819|616505483|FG000|Overall Study|Refusal to down titrate study drug|0|||
170591088|NCT01300819|616505484|FG001|Overall Study|Refusal to down titrate study drug|1|||
170591089|NCT01300819|616505483|FG000|Overall Study|Administrative reason|0|||
170591090|NCT01300819|616505484|FG001|Overall Study|Administrative reason|1|||
170591091|NCT01300819|616505483|FG000|Overall Study|Safety follow up not done by mistake|0|||
170591092|NCT01300819|616505484|FG001|Overall Study|Safety follow up not done by mistake|1|||
170591093|NCT01300819|616505483|FG000|Overall Study|Follow up call was not done|1|||
170591094|NCT01300819|616505484|FG001|Overall Study|Follow up call was not done|0|||
170591095|NCT01038713|616505488|FG000|Overall Study|Patient to hospice|1|||
170591096|NCT01038713|616505489|FG001|Overall Study|Patient to hospice|1|||
170591097|NCT01038713|616505490|FG002|Overall Study|Patient to hospice|1|||
170591098|NCT01038713|616505488|FG000|Overall Study|Lost to Follow-up|3|||
170591099|NCT01038713|616505489|FG001|Overall Study|Lost to Follow-up|0|||
170591100|NCT01038713|616505490|FG002|Overall Study|Lost to Follow-up|0|||
170591101|NCT01038713|616505488|FG000|Overall Study|Neuroendocrine Tumor|0|||
170591102|NCT01038713|616505489|FG001|Overall Study|Neuroendocrine Tumor|1|||
170591103|NCT01038713|616505490|FG002|Overall Study|Neuroendocrine Tumor|0|||
170591104|NCT01038713|616505488|FG000|Overall Study|died from PEP|0|||
170591105|NCT01038713|616505489|FG001|Overall Study|died from PEP|1|||
170591106|NCT01038713|616505490|FG002|Overall Study|died from PEP|0|||
170591107|NCT01038713|616505488|FG000|Overall Study|Autoimmune Pancreatitis|1|||
170591108|NCT01038713|616505489|FG001|Overall Study|Autoimmune Pancreatitis|0|||
170591109|NCT01038713|616505490|FG002|Overall Study|Autoimmune Pancreatitis|0|||
170591110|NCT00320372|616505491|FG000|Overall Study|Physician Decision|4|||
170591111|NCT00320372|616505492|FG001|Overall Study|Physician Decision|7|||
170591112|NCT00320372|616505491|FG000|Overall Study|Death|7|||
170591113|NCT00320372|616505492|FG001|Overall Study|Death|8|||
170591114|NCT00320372|616505491|FG000|Overall Study|Withdrawal by Subject|55|||
170591115|NCT00320372|616505492|FG001|Overall Study|Withdrawal by Subject|37|||
170591116|NCT00320372|616505491|FG000|Overall Study|Non-Compliance|40|||
170591117|NCT00320372|616505492|FG001|Overall Study|Non-Compliance|39|||
170591118|NCT00320372|616505491|FG000|Overall Study|Did not Meet (I/E)|3|||
170591119|NCT00320372|616505492|FG001|Overall Study|Did not Meet (I/E)|1|||
170591120|NCT00320372|616505491|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
170591121|NCT00320372|616505492|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
170591122|NCT04063787|616505493|FG000|Overall Study|Inadequate Doppler data|4|||
170591123|NCT04063787|616505493|FG000|Overall Study|Lost to Follow-up|2|||
170591124|NCT04063787|616505493|FG000|Overall Study|Death|3|||
170591125|NCT03551665|616505496|FG000|Overall Study|Lost to Follow-up|11|||
170591126|NCT03551665|616505497|FG001|Overall Study|Lost to Follow-up|2|||
170591127|NCT00734071|616507134|FG000|Overall Study|Adverse Event|4|||
170911660|NCT04045613|617680987|FG005|Overall Study|Death|0|||
170591128|NCT00734071|616507135|FG001|Overall Study|Adverse Event|3|||
170591129|NCT00734071|616507134|FG000|Overall Study|Lack of Efficacy|3|||
170591130|NCT00734071|616507135|FG001|Overall Study|Lack of Efficacy|1|||
170591131|NCT00734071|616507134|FG000|Overall Study|Noncompliance|2|||
170591132|NCT00734071|616507135|FG001|Overall Study|Noncompliance|2|||
170591133|NCT00734071|616507134|FG000|Overall Study|Protocol Deviations|3|||
170591134|NCT00734071|616507135|FG001|Overall Study|Protocol Deviations|4|||
170591135|NCT00734071|616507134|FG000|Overall Study|Voluntary Withdrawal|9|||
170911661|NCT04045613|617680988|FG006|Overall Study|Death|1|||
170591136|NCT00734071|616507135|FG001|Overall Study|Voluntary Withdrawal|7|||
170591137|NCT00734071|616507134|FG000|Overall Study|Lost to Follow-up|16|||
170591138|NCT00734071|616507135|FG001|Overall Study|Lost to Follow-up|8|||
170591139|NCT00734071|616507134|FG000|Overall Study|Other|1|||
170591140|NCT00734071|616507135|FG001|Overall Study|Other|2|||
170591141|NCT03899064|616507139|FG000|Overall Study|Lost to Follow-up|1|||
170591142|NCT03899064|616507139|FG000|Overall Study|Protocol Violation|2|||
170591143|NCT03899064|616507139|FG000|Overall Study|Withdrawal by Subject|2|||
170591144|NCT03899064|616507139|FG000|Overall Study|Other|2|||
170591145|NCT03283098|616507140|FG000|Overall Study|Withdrawal by Subject|0|||
170591146|NCT03283098|616507141|FG001|Overall Study|Withdrawal by Subject|1|||
170591147|NCT02210832|616507142|FG000|Overall Study|Pregnancy termination .|3|||
170591148|NCT02210832|616507143|FG001|Overall Study|Pregnancy termination .|4|||
170591149|NCT02210832|616507144|FG002|Overall Study|Pregnancy termination .|1|||
170591150|NCT02210832|616507142|FG000|Overall Study|Lost to Follow-up|26|||
170591151|NCT02210832|616507143|FG001|Overall Study|Lost to Follow-up|32|||
170591152|NCT02210832|616507144|FG002|Overall Study|Lost to Follow-up|17|||
170591153|NCT00471887|616507150|FG000|Overall Study|Adverse Event|9|||
170591154|NCT01069861|616507157|FG000|Overall Study|Death|1|||
170591155|NCT01069861|616507157|FG000|Overall Study|Adverse Event|1|||
170591156|NCT01069861|616507157|FG000|Overall Study|Did not meet entrance criteria|1|||
170591157|NCT00354107|616507158|FG000|Overall Study|Adverse Event|2|||
170591158|NCT00354107|616507158|FG000|Overall Study|Physician Decision|2|||
170591159|NCT00354107|616507158|FG000|Overall Study|Withdrawal by Subject|1|||
170591160|NCT01176565|616507163|FG000|Overall Study|Lost to Follow-up|12|||
170591161|NCT01176565|616507164|FG001|Overall Study|Lost to Follow-up|16|||
170591162|NCT01176565|616507163|FG000|Overall Study|Withdrawal by Subject|7|||
170591163|NCT01176565|616507164|FG001|Overall Study|Withdrawal by Subject|1|||
170591164|NCT01176565|616507163|FG000|Overall Study|Not Analyzed (any other reason)|1|||
170591165|NCT01176565|616507164|FG001|Overall Study|Not Analyzed (any other reason)|2|||
170591166|NCT02323126|616507165|FG000|Overall Study|Patient / guardian decision|0|||
170591167|NCT02323126|616507166|FG001|Overall Study|Patient / guardian decision|1|||
170591168|NCT02323126|616507167|FG002|Overall Study|Patient / guardian decision|2|||
170591169|NCT02323126|616507165|FG000|Overall Study|Progressive disease|14|||
170591170|NCT02323126|616507166|FG001|Overall Study|Progressive disease|8|||
170591171|NCT02323126|616507167|FG002|Overall Study|Progressive disease|14|||
170591172|NCT02323126|616507165|FG000|Overall Study|Physician Decision|0|||
170591173|NCT02323126|616507166|FG001|Overall Study|Physician Decision|1|||
170591174|NCT02323126|616507167|FG002|Overall Study|Physician Decision|3|||
170591175|NCT02323126|616507165|FG000|Overall Study|Death|1|||
170591176|NCT02323126|616507166|FG001|Overall Study|Death|1|||
170591177|NCT02323126|616507167|FG002|Overall Study|Death|4|||
170591178|NCT02323126|616507165|FG000|Overall Study|Adverse Event|3|||
170591179|NCT02323126|616507166|FG001|Overall Study|Adverse Event|5|||
170591180|NCT02323126|616507167|FG002|Overall Study|Adverse Event|7|||
170591181|NCT04043234|616507168|FG000|Overall Study|Lost to Follow-up|1|||
170591182|NCT04043234|616507168|FG000|Overall Study|Withdrawal by Subject|1|||
170591183|NCT01007123|616507173|FG000|Overall Study|Adverse Event|3|||
170591184|NCT01007123|616507174|FG001|Overall Study|Adverse Event|4|||
170591185|NCT01007123|616507175|FG002|Overall Study|Adverse Event|7|||
170591186|NCT01007123|616507176|FG003|Overall Study|Adverse Event|1|||
170591187|NCT01007123|616507173|FG000|Overall Study|Lack of Efficacy|1|||
170591188|NCT01007123|616507174|FG001|Overall Study|Lack of Efficacy|0|||
170591189|NCT01007123|616507175|FG002|Overall Study|Lack of Efficacy|1|||
170591190|NCT01007123|616507176|FG003|Overall Study|Lack of Efficacy|4|||
170591191|NCT01007123|616507173|FG000|Overall Study|Protocol Violation|1|||
170591192|NCT01007123|616507174|FG001|Overall Study|Protocol Violation|1|||
170591193|NCT01007123|616507175|FG002|Overall Study|Protocol Violation|2|||
170591194|NCT01007123|616507176|FG003|Overall Study|Protocol Violation|1|||
170591195|NCT01007123|616507173|FG000|Overall Study|Withdrawal by Subject|1|||
170591196|NCT01007123|616507174|FG001|Overall Study|Withdrawal by Subject|0|||
170591197|NCT01007123|616507175|FG002|Overall Study|Withdrawal by Subject|1|||
170591198|NCT01007123|616507176|FG003|Overall Study|Withdrawal by Subject|0|||
170591199|NCT01007123|616507173|FG000|Overall Study|Lost to Follow-up|0|||
170591200|NCT01007123|616507174|FG001|Overall Study|Lost to Follow-up|1|||
170650548|NCT01214174|616734387|FG002|Overall Study|Withdrawal by Subject|1|||
170911662|NCT04045613|617680982|FG000|Overall Study|Other reasons|0|||
170911663|NCT04045613|617680983|FG001|Overall Study|Other reasons|1|||
170591201|NCT01007123|616507175|FG002|Overall Study|Lost to Follow-up|0|||
170591202|NCT01007123|616507176|FG003|Overall Study|Lost to Follow-up|0|||
170591203|NCT02838901|616507177|FG000|Overall Study|Withdrawal by Subject|1|||
170591204|NCT02838901|616507178|FG001|Overall Study|Withdrawal by Subject|1|||
170591205|NCT02838901|616507177|FG000|Overall Study|Lost to Follow-up|1|||
170591206|NCT02838901|616507178|FG001|Overall Study|Lost to Follow-up|1|||
170591207|NCT02680041|616507180|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
170591208|NCT02680041|616507180|FG000|Overall Study|Lost to Follow-up|2|||
170591209|NCT02324205|616507181|FG000|Overall Study|Withdrawal by Subject|37|||
170591210|NCT00320255|616507182|FG000|Overall Study|Lack of Efficacy|1|||
170591211|NCT00320255|616507183|FG001|Overall Study|Lack of Efficacy|0|||
170650549|NCT02815280|616734395|FG000|Double-Blind Phase|Adverse Event|1|||
170650550|NCT02815280|616734396|FG001|Double-Blind Phase|Adverse Event|1|||
170650551|NCT02815280|616734395|FG000|Double-Blind Phase|Lost to Follow-up|10|||
170650552|NCT02815280|616734396|FG001|Double-Blind Phase|Lost to Follow-up|9|||
170650553|NCT02815280|616734395|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
170650554|NCT02815280|616734396|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
170650555|NCT02815280|616734395|FG000|Double-Blind Phase|Protocol Violation|2|||
170650556|NCT02815280|616734396|FG001|Double-Blind Phase|Protocol Violation|2|||
170650557|NCT02815280|616734395|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
170650558|NCT02815280|616734396|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
170650559|NCT02815280|616734395|FG000|Open-Label Phase|Adverse Event|2|||
170650560|NCT02815280|616734396|FG001|Open-Label Phase|Adverse Event|3|||
170650561|NCT02815280|616734395|FG000|Open-Label Phase|Lost to Follow-up|18|||
170650562|NCT02815280|616734396|FG001|Open-Label Phase|Lost to Follow-up|9|||
170650563|NCT02815280|616734395|FG000|Open-Label Phase|Withdrawal by Subject|33|||
170650564|NCT02815280|616734396|FG001|Open-Label Phase|Withdrawal by Subject|18|||
170650565|NCT02815280|616734395|FG000|Open-Label Phase|Protocol Violation|3|||
170650566|NCT02815280|616734396|FG001|Open-Label Phase|Protocol Violation|0|||
170650567|NCT02815280|616734395|FG000|Open-Label Phase|Administrative|26|||
170650568|NCT02815280|616734396|FG001|Open-Label Phase|Administrative|12|||
170911664|NCT04045613|617680984|FG002|Overall Study|Other reasons|0|||
170911665|NCT04045613|617680985|FG003|Overall Study|Other reasons|0|||
170650569|NCT02815280|616734395|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
170650570|NCT02815280|616734396|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
170650571|NCT00770146|616734397|FG000|Treatment Period|Withdrawal by Subject|6|||
170650572|NCT00770146|616734398|FG001|Treatment Period|Withdrawal by Subject|13|||
170650573|NCT00770146|616734397|FG000|Treatment Period|Adverse Event|2|||
170650574|NCT00770146|616734398|FG001|Treatment Period|Adverse Event|26|||
170650575|NCT00770146|616734397|FG000|Treatment Period|Other|1|||
170650576|NCT00770146|616734398|FG001|Treatment Period|Other|5|||
170911666|NCT04045613|617680986|FG004|Overall Study|Other reasons|0|||
170911667|NCT04045613|617680987|FG005|Overall Study|Other reasons|0|||
170591212|NCT00320255|616507184|FG002|Overall Study|Lack of Efficacy|0|||
170591213|NCT00320255|616507185|FG003|Overall Study|Lack of Efficacy|0|||
170591214|NCT00320255|616507186|FG004|Overall Study|Lack of Efficacy|0|||
170591215|NCT00320255|616507187|FG005|Overall Study|Lack of Efficacy|0|||
170591216|NCT00320255|616507182|FG000|Overall Study|Adverse Event|5|||
170591217|NCT00320255|616507183|FG001|Overall Study|Adverse Event|2|||
170591218|NCT00320255|616507184|FG002|Overall Study|Adverse Event|3|||
170591219|NCT00320255|616507185|FG003|Overall Study|Adverse Event|2|||
170591220|NCT00320255|616507186|FG004|Overall Study|Adverse Event|0|||
170591221|NCT00320255|616507187|FG005|Overall Study|Adverse Event|0|||
170591222|NCT00320255|616507182|FG000|Overall Study|Withdrawal by Subject|1|||
170591223|NCT00320255|616507183|FG001|Overall Study|Withdrawal by Subject|2|||
170591224|NCT00320255|616507184|FG002|Overall Study|Withdrawal by Subject|2|||
170591225|NCT00320255|616507185|FG003|Overall Study|Withdrawal by Subject|4|||
170591226|NCT00320255|616507186|FG004|Overall Study|Withdrawal by Subject|0|||
170591227|NCT00320255|616507187|FG005|Overall Study|Withdrawal by Subject|0|||
170591228|NCT00320255|616507182|FG000|Overall Study|Poor compliance/noncompliance|1|||
170591229|NCT00320255|616507183|FG001|Overall Study|Poor compliance/noncompliance|1|||
170591230|NCT00320255|616507184|FG002|Overall Study|Poor compliance/noncompliance|0|||
170591231|NCT00320255|616507185|FG003|Overall Study|Poor compliance/noncompliance|1|||
170591232|NCT00320255|616507186|FG004|Overall Study|Poor compliance/noncompliance|0|||
170591233|NCT00320255|616507187|FG005|Overall Study|Poor compliance/noncompliance|0|||
170591234|NCT00320255|616507182|FG000|Overall Study|No longer meets study criteria|0|||
170591235|NCT00320255|616507183|FG001|Overall Study|No longer meets study criteria|0|||
170591236|NCT00320255|616507184|FG002|Overall Study|No longer meets study criteria|0|||
170591237|NCT00320255|616507185|FG003|Overall Study|No longer meets study criteria|1|||
170591238|NCT00320255|616507186|FG004|Overall Study|No longer meets study criteria|0|||
170591239|NCT00320255|616507187|FG005|Overall Study|No longer meets study criteria|0|||
170591240|NCT00320255|616507182|FG000|Overall Study|Other|3|||
170591241|NCT00320255|616507183|FG001|Overall Study|Other|2|||
170591242|NCT00320255|616507184|FG002|Overall Study|Other|1|||
170650577|NCT00770146|616734397|FG000|Treatment Period|Protocol non-compliance|0|||
170650578|NCT00770146|616734398|FG001|Treatment Period|Protocol non-compliance|1|||
170911668|NCT04045613|617680988|FG006|Overall Study|Other reasons|1|||
170911669|NCT04045613|617680982|FG000|Overall Study|Progressive disease: Clinical progression|1|||
170591243|NCT00320255|616507185|FG003|Overall Study|Other|0|||
170591244|NCT00320255|616507186|FG004|Overall Study|Other|0|||
170591245|NCT00320255|616507187|FG005|Overall Study|Other|0|||
170591246|NCT00613925|616507188|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
170591247|NCT00613925|616507189|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
170591248|NCT02781792|616507193|FG000|Overall Study|Adverse Event|1|||
170911670|NCT04045613|617680983|FG001|Overall Study|Progressive disease: Clinical progression|0|||
170591249|NCT02781792|616507194|FG001|Overall Study|Adverse Event|2|||
170591250|NCT02781792|616507193|FG000|Overall Study|Withdrawal by Subject|3|||
170591251|NCT02781792|616507194|FG001|Overall Study|Withdrawal by Subject|1|||
170591252|NCT02781792|616507193|FG000|Overall Study|Lack of Efficacy|1|||
170591253|NCT02781792|616507194|FG001|Overall Study|Lack of Efficacy|1|||
170591254|NCT02781792|616507193|FG000|Overall Study|Hospice|0|||
170591255|NCT02781792|616507194|FG001|Overall Study|Hospice|1|||
170591256|NCT03538444|616507203|FG000|Overall Study|opioid withdrawal|1|||
170591257|NCT03538444|616507204|FG001|Overall Study|opioid withdrawal|0|||
170591258|NCT03640052|616507212|FG000|Overall Study|Lost to Follow-up|0|||
170591259|NCT03640052|616507213|FG001|Overall Study|Lost to Follow-up|1|||
170591260|NCT03640052|616507214|FG002|Overall Study|Lost to Follow-up|0|||
170591261|NCT03640052|616507215|FG003|Overall Study|Lost to Follow-up|0|||
170591262|NCT03640052|616507216|FG004|Overall Study|Lost to Follow-up|0|||
170591263|NCT04239222|616507217|FG000|Baseline|Withdrawal by Subject|0|||
170591264|NCT04239222|616507218|FG001|Baseline|Withdrawal by Subject|0|||
170591265|NCT04239222|616507219|FG002|Baseline|Withdrawal by Subject|1|||
170591266|NCT04239222|616507220|FG003|Baseline|Withdrawal by Subject|1|||
170810622|NCT00721734|617315600|FG001|Overall Study|Adverse Event|1|||
170810623|NCT00721734|617315601|FG002|Overall Study|Adverse Event|4|||
170591267|NCT04239222|616507217|FG000|First Foot Assignment|Withdrawal by Subject|0|||
170591268|NCT04239222|616507218|FG001|First Foot Assignment|Withdrawal by Subject|0|||
170591269|NCT04239222|616507219|FG002|First Foot Assignment|Withdrawal by Subject|1|||
170591270|NCT04239222|616507220|FG003|First Foot Assignment|Withdrawal by Subject|0|||
170591271|NCT04239222|616507217|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
170591272|NCT04239222|616507218|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
170591273|NCT04239222|616507219|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
170591274|NCT04239222|616507220|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
170591275|NCT00090233|616507226|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
170591276|NCT00090233|616507227|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
170591277|NCT00090233|616507226|FG000|Overall Study|Adverse Event|214|||
170591278|NCT00090233|616507227|FG001|Overall Study|Adverse Event|198|||
170591279|NCT00090233|616507226|FG000|Overall Study|Lost to Follow-up|68|||
170591280|NCT00090233|616507227|FG001|Overall Study|Lost to Follow-up|95|||
170591281|NCT00090233|616507226|FG000|Overall Study|Protocol Violation|960|||
170591282|NCT00090233|616507227|FG001|Overall Study|Protocol Violation|1022|||
170591283|NCT00090233|616507226|FG000|Overall Study|Withdrawal by Subject|182|||
170591284|NCT00090233|616507227|FG001|Overall Study|Withdrawal by Subject|211|||
170591285|NCT00090233|616507226|FG000|Overall Study|Moved|203|||
170591286|NCT00090233|616507227|FG001|Overall Study|Moved|189|||
170591287|NCT00090233|616507226|FG000|Overall Study|Other|1211|||
170591288|NCT00090233|616507227|FG001|Overall Study|Other|1160|||
170591289|NCT00090233|616507226|FG000|Overall Study|Data not available at data cut-off point|1552|||
170591290|NCT00090233|616507227|FG001|Overall Study|Data not available at data cut-off point|1563|||
170591291|NCT04863248|616507228|FG000|Overall Study|Sponsor Terminated|4|||
170591292|NCT04863248|616507229|FG001|Overall Study|Sponsor Terminated|1|||
170591293|NCT04863248|616507228|FG000|Overall Study|Death|0|||
170591294|NCT04863248|616507229|FG001|Overall Study|Death|1|||
170591295|NCT04863248|616507228|FG000|Overall Study|Withdrawal by Subject|0|||
170591296|NCT04863248|616507229|FG001|Overall Study|Withdrawal by Subject|1|||
170591297|NCT01779869|616507232|FG000|Overall Study|Physician Decision|2|||
170591298|NCT02536300|616507233|FG000|Overall Study|Investigator's Discretion|17|||
170591299|NCT02536300|616507234|FG001|Overall Study|Investigator's Discretion|11|||
170591300|NCT02536300|616507235|FG002|Overall Study|Investigator's Discretion|2|||
170591301|NCT02536300|616507233|FG000|Overall Study|Progressive Disease|11|||
170591302|NCT02536300|616507234|FG001|Overall Study|Progressive Disease|7|||
170591303|NCT02536300|616507235|FG002|Overall Study|Progressive Disease|6|||
170591304|NCT02536300|616507233|FG000|Overall Study|Study Terminated by Sponsor|6|||
170591305|NCT02536300|616507234|FG001|Overall Study|Study Terminated by Sponsor|4|||
170591306|NCT02536300|616507235|FG002|Overall Study|Study Terminated by Sponsor|7|||
170591307|NCT02536300|616507233|FG000|Overall Study|Death|7|||
170591308|NCT02536300|616507234|FG001|Overall Study|Death|0|||
170810624|NCT00721734|617315602|FG003|Overall Study|Adverse Event|0|||
170591309|NCT02536300|616507235|FG002|Overall Study|Death|5|||
170591310|NCT02536300|616507233|FG000|Overall Study|Withdrew Consent|4|||
170591311|NCT02536300|616507234|FG001|Overall Study|Withdrew Consent|2|||
170591312|NCT02536300|616507235|FG002|Overall Study|Withdrew Consent|0|||
170591313|NCT02536300|616507233|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
170591314|NCT02536300|616507234|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
170591315|NCT02536300|616507235|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
170591316|NCT02536300|616507233|FG000|Overall Study|Enrolled but Never Treated|0|||
170810625|NCT00721734|617315603|FG004|Overall Study|Adverse Event|3|||
170591317|NCT02536300|616507234|FG001|Overall Study|Enrolled but Never Treated|0|||
170810626|NCT00721734|617315599|FG000|Overall Study|Withdrawal by Subject|2|||
170591318|NCT02536300|616507235|FG002|Overall Study|Enrolled but Never Treated|1|||
170810627|NCT00721734|617315600|FG001|Overall Study|Withdrawal by Subject|1|||
170591319|NCT02536300|616507233|FG000|Overall Study|Non-compliance With Study Drug|1|||
170591320|NCT02536300|616507234|FG001|Overall Study|Non-compliance With Study Drug|0|||
170591321|NCT02536300|616507235|FG002|Overall Study|Non-compliance With Study Drug|0|||
170591322|NCT02536300|616507233|FG000|Overall Study|Protocol Violation|0|||
170591323|NCT02536300|616507234|FG001|Overall Study|Protocol Violation|1|||
170591324|NCT02536300|616507235|FG002|Overall Study|Protocol Violation|0|||
170591325|NCT01691105|616507241|FG000|1 Month Follow-up|Lost to Follow-up|41|||
170591326|NCT01691105|616507242|FG001|1 Month Follow-up|Lost to Follow-up|38|||
170591327|NCT01691105|616507241|FG000|1 Month Follow-up|Death|2|||
170591328|NCT01691105|616507242|FG001|1 Month Follow-up|Death|3|||
170591329|NCT01691105|616507241|FG000|6 Month Follow-up|Lost to Follow-up|39|||
170591330|NCT01691105|616507242|FG001|6 Month Follow-up|Lost to Follow-up|58|||
170591331|NCT01691105|616507241|FG000|6 Month Follow-up|Death|13|||
170591332|NCT01691105|616507242|FG001|6 Month Follow-up|Death|13|||
170591333|NCT01691105|616507241|FG000|12 Month Follow-up|Lost to Follow-up|50|||
170591334|NCT01691105|616507242|FG001|12 Month Follow-up|Lost to Follow-up|71|||
170591335|NCT01691105|616507241|FG000|12 Month Follow-up|Death|22|||
170591336|NCT01691105|616507242|FG001|12 Month Follow-up|Death|30|||
170591337|NCT01691105|616507241|FG000|12 Month Biochemical Verification|Death|22|||
170591338|NCT01691105|616507242|FG001|12 Month Biochemical Verification|Death|30|||
170591339|NCT01691105|616507241|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
170591340|NCT01691105|616507242|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
170591341|NCT01691105|616507241|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
170591342|NCT01691105|616507242|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
170591343|NCT00957944|616507243|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
170591344|NCT00957944|616507244|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
170591345|NCT01133626|616507251|FG000|Overall Study|Adverse Event|0|||
170591346|NCT01133626|616507252|FG001|Overall Study|Adverse Event|1|||
170591347|NCT01133626|616507253|FG002|Overall Study|Adverse Event|0|||
170591348|NCT01133626|616507251|FG000|Overall Study|Withdrawal by Subject|1|||
170591349|NCT01133626|616507252|FG001|Overall Study|Withdrawal by Subject|2|||
170591350|NCT01133626|616507253|FG002|Overall Study|Withdrawal by Subject|2|||
170591351|NCT01133626|616507251|FG000|Overall Study|Other|0|||
170591352|NCT01133626|616507252|FG001|Overall Study|Other|2|||
170591353|NCT01133626|616507253|FG002|Overall Study|Other|0|||
170591354|NCT00855933|616507255|FG000|Overall Study|Withdrawal by Subject|0|||
170591355|NCT00855933|616507256|FG001|Overall Study|Withdrawal by Subject|1|||
170591356|NCT00951080|616507257|FG000|Overall Study|Adverse Event|3|||
170591357|NCT00951080|616507258|FG001|Overall Study|Adverse Event|3|||
170591358|NCT00951080|616507257|FG000|Overall Study|Lost to Follow-up|0|||
170591359|NCT00951080|616507258|FG001|Overall Study|Lost to Follow-up|1|||
170591360|NCT00951080|616507257|FG000|Overall Study|Physician Decision|4|||
170591361|NCT00951080|616507258|FG001|Overall Study|Physician Decision|1|||
170591362|NCT00951080|616507257|FG000|Overall Study|Other|19|||
170591363|NCT00951080|616507258|FG001|Overall Study|Other|22|||
170591364|NCT01960998|616507259|FG000|Overall Study|Lost to Follow-up|3|||
170591365|NCT01960998|616507260|FG001|Overall Study|Lost to Follow-up|7|||
170591366|NCT01960998|616507259|FG000|Overall Study|Death|0|||
170591367|NCT01960998|616507260|FG001|Overall Study|Death|1|||
170591368|NCT01960998|616507259|FG000|Overall Study|Withdrawal by Subject|8|||
170591369|NCT01960998|616507260|FG001|Overall Study|Withdrawal by Subject|2|||
170591370|NCT01960998|616507259|FG000|Overall Study|lost computer access|0|||
170591371|NCT01960998|616507260|FG001|Overall Study|lost computer access|1|||
170591372|NCT03199053|616507261|FG000|ST Period|Withdrawal by Subject|2|||
170591373|NCT03199053|616507262|FG001|ST Period|Withdrawal by Subject|4|||
170591374|NCT03199053|616507263|FG002|ST Period|Withdrawal by Subject|6|||
170591375|NCT03199053|616507261|FG000|ST Period|Withdrawal by parent/guardian|1|||
170591376|NCT03199053|616507262|FG001|ST Period|Withdrawal by parent/guardian|1|||
170591377|NCT03199053|616507263|FG002|ST Period|Withdrawal by parent/guardian|1|||
170591378|NCT03199053|616507261|FG000|ST Period|Lost to Follow-up|2|||
170591379|NCT03199053|616507262|FG001|ST Period|Lost to Follow-up|0|||
170591380|NCT03199053|616507263|FG002|ST Period|Lost to Follow-up|1|||
170591381|NCT03199053|616507261|FG000|LT Period|Withdrawal by Subject|1|||
170591382|NCT03199053|616507262|FG001|LT Period|Withdrawal by Subject|3|||
170591383|NCT03199053|616507263|FG002|LT Period|Withdrawal by Subject|3|||
170591384|NCT03199053|616507261|FG000|LT Period|Withdrawal by parent/guardian|0|||
170591385|NCT03199053|616507262|FG001|LT Period|Withdrawal by parent/guardian|0|||
170591386|NCT03199053|616507263|FG002|LT Period|Withdrawal by parent/guardian|1|||
170650579|NCT00770146|616734397|FG000|Follow-up Period|Withdrawal by Subject|7|||
170911671|NCT04045613|617680984|FG002|Overall Study|Progressive disease: Clinical progression|3|||
170911672|NCT04045613|617680985|FG003|Overall Study|Progressive disease: Clinical progression|1|||
170591387|NCT03199053|616507261|FG000|LT Period|Lost to Follow-up|0|||
170591388|NCT03199053|616507262|FG001|LT Period|Lost to Follow-up|1|||
170591389|NCT03199053|616507263|FG002|LT Period|Lost to Follow-up|1|||
170591390|NCT03199053|616507261|FG000|LT Period|Miscellaneous|0|||
170591391|NCT03199053|616507262|FG001|LT Period|Miscellaneous|0|||
170591392|NCT03199053|616507263|FG002|LT Period|Miscellaneous|2|||
170591393|NCT03199053|616507261|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
170591394|NCT03199053|616507262|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
170591395|NCT03199053|616507263|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
170591396|NCT03199053|616507261|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
170591397|NCT03199053|616507262|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
170591398|NCT03199053|616507263|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
170591399|NCT03199053|616507261|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
170591400|NCT03199053|616507262|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
170591401|NCT03199053|616507263|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
170591402|NCT03199053|616507261|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
170591403|NCT03199053|616507262|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
170591404|NCT03199053|616507263|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
170591405|NCT01904149|616507264|FG000|Overall Study|Adverse Event|3|||
170591406|NCT01904149|616507265|FG001|Overall Study|Adverse Event|4|||
170591407|NCT01904149|616507266|FG002|Overall Study|Adverse Event|0|||
170591408|NCT01904149|616507267|FG003|Overall Study|Adverse Event|1|||
170591409|NCT01904149|616507268|FG004|Overall Study|Adverse Event|1|||
170591410|NCT01904149|616507269|FG005|Overall Study|Adverse Event|2|||
170591411|NCT01904149|616507264|FG000|Overall Study|Lack of Efficacy|0|||
170591412|NCT01904149|616507265|FG001|Overall Study|Lack of Efficacy|3|||
170591413|NCT01904149|616507266|FG002|Overall Study|Lack of Efficacy|1|||
170591414|NCT01904149|616507267|FG003|Overall Study|Lack of Efficacy|3|||
170591415|NCT01904149|616507268|FG004|Overall Study|Lack of Efficacy|3|||
170591416|NCT01904149|616507269|FG005|Overall Study|Lack of Efficacy|1|||
170591417|NCT01904149|616507264|FG000|Overall Study|Withdrawal by Subject|1|||
170591418|NCT01904149|616507265|FG001|Overall Study|Withdrawal by Subject|3|||
170591419|NCT01904149|616507266|FG002|Overall Study|Withdrawal by Subject|1|||
170591420|NCT01904149|616507267|FG003|Overall Study|Withdrawal by Subject|0|||
170591421|NCT01904149|616507268|FG004|Overall Study|Withdrawal by Subject|1|||
170591422|NCT01904149|616507269|FG005|Overall Study|Withdrawal by Subject|0|||
170591423|NCT01904149|616507264|FG000|Overall Study|Protocol Violation|0|||
170591424|NCT01904149|616507265|FG001|Overall Study|Protocol Violation|1|||
170591425|NCT01904149|616507266|FG002|Overall Study|Protocol Violation|0|||
170591426|NCT01904149|616507267|FG003|Overall Study|Protocol Violation|0|||
170591427|NCT01904149|616507268|FG004|Overall Study|Protocol Violation|0|||
170591428|NCT01904149|616507269|FG005|Overall Study|Protocol Violation|0|||
170591429|NCT01904149|616507264|FG000|Overall Study|non compliance with study drug|1|||
170591430|NCT01904149|616507265|FG001|Overall Study|non compliance with study drug|0|||
170591431|NCT01904149|616507266|FG002|Overall Study|non compliance with study drug|0|||
170591432|NCT01904149|616507267|FG003|Overall Study|non compliance with study drug|0|||
170591433|NCT01904149|616507268|FG004|Overall Study|non compliance with study drug|0|||
170591434|NCT01904149|616507269|FG005|Overall Study|non compliance with study drug|0|||
170591435|NCT05136898|616507271|FG000|Overall Study|Adverse Event|2|||
170591436|NCT01994863|616507272|FG000|Period 1|Adverse Event|4|||
170591437|NCT01994863|616507273|FG001|Period 1|Adverse Event|0|||
170591438|NCT01994863|616507272|FG000|Period 1|Withdrawal by Subject|1|||
170591439|NCT01994863|616507273|FG001|Period 1|Withdrawal by Subject|0|||
170591440|NCT01994863|616507272|FG000|Period 1|Trial stopped by sponsor|1|||
170591441|NCT01994863|616507273|FG001|Period 1|Trial stopped by sponsor|3|||
170591442|NCT01994863|616507272|FG000|Period 1|Lack of Efficacy|1|||
170591443|NCT01994863|616507273|FG001|Period 1|Lack of Efficacy|0|||
170591444|NCT01994863|616507272|FG000|Period 2|Adverse Event|0|||
170591445|NCT01994863|616507273|FG001|Period 2|Adverse Event|1|||
170591446|NCT01994863|616507272|FG000|Period 2|Lack of Efficacy|0|||
170591447|NCT01994863|616507273|FG001|Period 2|Lack of Efficacy|2|||
170591448|NCT01994863|616507272|FG000|Period 2|Withdrawal by Subject|1|||
170591449|NCT01994863|616507273|FG001|Period 2|Withdrawal by Subject|1|||
170591450|NCT02229214|616507275|FG000|Overall Study|Adverse Event|2|||
170591451|NCT02229214|616507276|FG001|Overall Study|Adverse Event|0|||
170591452|NCT02229214|616507275|FG000|Overall Study|Withdrawal by Subject|4|||
170591453|NCT02229214|616507276|FG001|Overall Study|Withdrawal by Subject|0|||
170591454|NCT00931723|616507285|FG000|Overall Study|Withdrawal by Subject|11|||
170591455|NCT00931723|616507286|FG001|Overall Study|Withdrawal by Subject|13|||
170591456|NCT00931723|616507285|FG000|Overall Study|Adverse Event|6|||
170650580|NCT00770146|616734398|FG001|Follow-up Period|Withdrawal by Subject|13|||
170591457|NCT00931723|616507286|FG001|Overall Study|Adverse Event|13|||
170591458|NCT00931723|616507285|FG000|Overall Study|Lithium found in blood|0|||
170591459|NCT00931723|616507286|FG001|Overall Study|Lithium found in blood|1|||
170591460|NCT00931723|616507285|FG000|Overall Study|Condition under investigation worsened|1|||
170591461|NCT00931723|616507286|FG001|Overall Study|Condition under investigation worsened|2|||
170591462|NCT00931723|616507285|FG000|Overall Study|Lost to Follow-up|1|||
170591463|NCT00931723|616507286|FG001|Overall Study|Lost to Follow-up|2|||
170591464|NCT00931723|616507285|FG000|Overall Study|Study-specific discontinuation criteria|1|||
170591465|NCT00931723|616507286|FG001|Overall Study|Study-specific discontinuation criteria|1|||
170591466|NCT00931723|616507285|FG000|Overall Study|Severe non-compliance to protocol|2|||
170591467|NCT00931723|616507286|FG001|Overall Study|Severe non-compliance to protocol|0|||
170591468|NCT00931723|616507285|FG000|Overall Study|Safety reasons|0|||
170591469|NCT00931723|616507286|FG001|Overall Study|Safety reasons|1|||
170591470|NCT00931723|616507285|FG000|Overall Study|Took prohibited concomitant medication|0|||
170591471|NCT00931723|616507286|FG001|Overall Study|Took prohibited concomitant medication|1|||
170591472|NCT00931723|616507285|FG000|Overall Study|Lack or insufficient theraputic response|2|||
170591473|NCT00931723|616507286|FG001|Overall Study|Lack or insufficient theraputic response|5|||
170591474|NCT00931723|616507285|FG000|Overall Study|Sponsor decision|1|||
170591475|NCT00931723|616507286|FG001|Overall Study|Sponsor decision|0|||
170591476|NCT00931723|616507285|FG000|Overall Study|Late hospital discharge|1|||
170591477|NCT00931723|616507286|FG001|Overall Study|Late hospital discharge|0|||
170591478|NCT03305081|616507293|FG000|Overall Study|Lost to Follow-up|10|||
170591479|NCT03305081|616507294|FG001|Overall Study|Lost to Follow-up|15|||
170591480|NCT01571284|616507295|FG000|Overall Study|Participant's decision|84|||
170591481|NCT01571284|616507295|FG000|Overall Study|Lost to Follow-up|3|||
170591482|NCT01571284|616507295|FG000|Overall Study|Enrolled but not treated|2|||
170591483|NCT01571284|616507295|FG000|Overall Study|Other than specified above|80|||
170591484|NCT04612842|616507296|FG000|Overall Study|Lost to Follow-up|20|||
170591485|NCT04612842|616507297|FG001|Overall Study|Lost to Follow-up|11|||
170591486|NCT04612842|616507296|FG000|Overall Study|Withdrawal by Subject|26|||
170591487|NCT04612842|616507297|FG001|Overall Study|Withdrawal by Subject|15|||
170591488|NCT04612842|616507296|FG000|Overall Study|Death|2|||
170591489|NCT04612842|616507297|FG001|Overall Study|Death|2|||
170591490|NCT01819129|616507298|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
170591491|NCT01819129|616507299|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
170591492|NCT01819129|616507298|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
170591493|NCT01819129|616507299|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
170591494|NCT01819129|616507298|FG000|Overall Study|Other, Subject moved out of the country|0|||
170591495|NCT01819129|616507299|FG001|Overall Study|Other, Subject moved out of the country|1|||
170591496|NCT01819129|616507298|FG000|Overall Study|Withdrawal by Subject|15|||
170591497|NCT01819129|616507299|FG001|Overall Study|Withdrawal by Subject|15|||
170591498|NCT01819129|616507298|FG000|Overall Study|Lost to Follow-up|5|||
170591499|NCT01819129|616507299|FG001|Overall Study|Lost to Follow-up|2|||
170591500|NCT01819129|616507298|FG000|Overall Study|Lack of Efficacy|0|||
170591501|NCT01819129|616507299|FG001|Overall Study|Lack of Efficacy|1|||
170591502|NCT01819129|616507298|FG000|Overall Study|Adverse Event|1|||
170591503|NCT01819129|616507299|FG001|Overall Study|Adverse Event|4|||
170591504|NCT01819129|616507298|FG000|Overall Study|Death|1|||
170591505|NCT01819129|616507299|FG001|Overall Study|Death|1|||
170591506|NCT01819129|616507298|FG000|Overall Study|Withdrawal Criteria|20|||
170591507|NCT01819129|616507299|FG001|Overall Study|Withdrawal Criteria|15|||
170591508|NCT03777917|616507300|FG000|Overall Study|Withdrawal by Subject|1|||
170591509|NCT03777917|616507301|FG001|Overall Study|Withdrawal by Subject|0|||
170591510|NCT03777917|616507300|FG000|Overall Study|Physician Decision|1|||
170591511|NCT03777917|616507301|FG001|Overall Study|Physician Decision|0|||
170591512|NCT03777917|616507300|FG000|Overall Study|Lost to Follow-up|6|||
170591513|NCT03777917|616507301|FG001|Overall Study|Lost to Follow-up|2|||
170591514|NCT03777917|616507300|FG000|Overall Study|Other|1|||
170591515|NCT03777917|616507301|FG001|Overall Study|Other|0|||
170591516|NCT00428220|616509787|FG000|Overall Study|Participant died|8|||
170591517|NCT00428220|616509787|FG000|Overall Study|Global deterioration of health status|7|||
170591518|NCT00428220|616509787|FG000|Overall Study|Lost to Follow-up|4|||
170591519|NCT00428220|616509787|FG000|Overall Study|Objective progression or relapse|123|||
170591520|NCT00428220|616509787|FG000|Overall Study|Participant refused continued treatment|7|||
170591521|NCT00428220|616509787|FG000|Overall Study|Adverse Event|51|||
170591522|NCT00428220|616509787|FG000|Overall Study|Other|23|||
170591523|NCT03131596|616509788|FG000|Overall Study|Protocol Violation|3|||
170591524|NCT03131596|616509789|FG001|Overall Study|Protocol Violation|3|||
170591525|NCT03131596|616509788|FG000|Overall Study|Lost to Follow-up|3|||
170591526|NCT03131596|616509789|FG001|Overall Study|Lost to Follow-up|0|||
170591527|NCT02534935|616509792|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
170591528|NCT02534935|616509793|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
170591529|NCT02534935|616509794|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
170591530|NCT02534935|616509792|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
170591531|NCT02534935|616509793|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
170591532|NCT02534935|616509794|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
170591533|NCT02534935|616509792|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
170591534|NCT02534935|616509793|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
170911673|NCT04045613|617680986|FG004|Overall Study|Progressive disease: Clinical progression|1|||
170591535|NCT02534935|616509794|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
170591536|NCT02534935|616509792|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
170591537|NCT02534935|616509793|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
170591538|NCT02534935|616509794|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
170911674|NCT04045613|617680987|FG005|Overall Study|Progressive disease: Clinical progression|3|||
170591539|NCT02534935|616509792|FG000|Stage 1: 24 Months|Adverse Event|0|||
170591540|NCT02534935|616509793|FG001|Stage 1: 24 Months|Adverse Event|2|||
170591541|NCT02534935|616509794|FG002|Stage 1: 24 Months|Adverse Event|0|||
170591542|NCT02534935|616509792|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
170591543|NCT02534935|616509793|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
170591544|NCT02534935|616509794|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
170591545|NCT02534935|616509792|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
170591546|NCT02534935|616509793|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
170591547|NCT02534935|616509794|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
170591548|NCT02754141|616509795|FG000|Overall Study|Disease progression|11|||
170591549|NCT02754141|616509796|FG001|Overall Study|Disease progression|7|||
170591550|NCT02754141|616509797|FG002|Overall Study|Disease progression|8|||
170591551|NCT02754141|616509798|FG003|Overall Study|Disease progression|5|||
170591552|NCT02754141|616509799|FG004|Overall Study|Disease progression|7|||
170591553|NCT02754141|616509800|FG005|Overall Study|Disease progression|7|||
170591554|NCT02754141|616509801|FG006|Overall Study|Disease progression|7|||
170591555|NCT02754141|616509802|FG007|Overall Study|Disease progression|6|||
170591556|NCT02754141|616509803|FG008|Overall Study|Disease progression|11|||
170591557|NCT02754141|616509804|FG009|Overall Study|Disease progression|16|||
170591558|NCT02754141|616509805|FG010|Overall Study|Disease progression|18|||
170591559|NCT02754141|616509806|FG011|Overall Study|Disease progression|13|||
170591560|NCT02754141|616509807|FG012|Overall Study|Disease progression|10|||
170591561|NCT02754141|616509808|FG013|Overall Study|Disease progression|12|||
170591562|NCT02754141|616509809|FG014|Overall Study|Disease progression|12|||
170591563|NCT02754141|616509810|FG015|Overall Study|Disease progression|14|||
170591564|NCT02754141|616509811|FG016|Overall Study|Disease progression|0|||
170591565|NCT02754141|616509812|FG017|Overall Study|Disease progression|1|||
170591566|NCT02754141|616509795|FG000|Overall Study|Study drug toxicity|1|||
170591567|NCT02754141|616509796|FG001|Overall Study|Study drug toxicity|1|||
170591568|NCT02754141|616509797|FG002|Overall Study|Study drug toxicity|0|||
170591569|NCT02754141|616509798|FG003|Overall Study|Study drug toxicity|0|||
170591570|NCT02754141|616509799|FG004|Overall Study|Study drug toxicity|0|||
170650581|NCT00770146|616734397|FG000|Follow-up Period|Adverse Event|0|||
170650582|NCT00770146|616734398|FG001|Follow-up Period|Adverse Event|2|||
170650583|NCT00770146|616734397|FG000|Follow-up Period|Other|4|||
170650584|NCT00770146|616734398|FG001|Follow-up Period|Other|5|||
170650585|NCT01009281|616734401|FG000|Overall Study|Administrative problems|7|||
170650586|NCT00924170|616734402|FG000|Overall Study|Refused further treatment|0|||
170650587|NCT00924170|616734403|FG001|Overall Study|Refused further treatment|1|||
170650588|NCT00924170|616734402|FG000|Overall Study|Physician Decision|0|||
170650589|NCT00924170|616734403|FG001|Overall Study|Physician Decision|1|||
170650590|NCT00924170|616734402|FG000|Overall Study|Progressive disease|3|||
170650591|NCT00924170|616734403|FG001|Overall Study|Progressive disease|6|||
170650592|NCT00924170|616734402|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
170650593|NCT00924170|616734403|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
170650594|NCT00924170|616734402|FG000|Overall Study|Death|1|||
170650595|NCT00924170|616734403|FG001|Overall Study|Death|0|||
170650596|NCT01624870|616734406|FG000|Overall Study|Death|19|||
170650597|NCT01624870|616734406|FG000|Overall Study|Withdrawal by Subject|1|||
170650598|NCT01624870|616734406|FG000|Overall Study|CoreValve not implanted|6|||
170650599|NCT01624870|616734406|FG000|Overall Study|Lost to follow up|1|||
170650600|NCT04672252|616734408|FG000|Overall Study|Protocol Violation|1|||
170650601|NCT04672252|616734409|FG001|Overall Study|Protocol Violation|0|||
170650602|NCT06390839|616734410|FG000|Overall Study|Ineligible|2|||
170650603|NCT06390839|616734410|FG000|Overall Study|Never start protocol therapy|3|||
170650604|NCT06390839|616734410|FG000|Overall Study|Adverse Event|1|||
170650605|NCT06390839|616734410|FG000|Overall Study|Alternative therapy|2|||
170650606|NCT06390839|616734410|FG000|Overall Study|Death|3|||
170650607|NCT06390839|616734410|FG000|Overall Study|Disease progression|28|||
170650608|NCT06390839|616734410|FG000|Overall Study|Withdrawal by Subject|2|||
170650609|NCT06390839|616734410|FG000|Overall Study|Complicating disease|1|||
170650610|NCT06390839|616734410|FG000|Overall Study|Noncompliance|1|||
170650611|NCT03735238|616734411|FG000|Overall Study|Did not want to participate in research|3|||
170650612|NCT03735238|616734411|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
170650613|NCT01431638|616734412|FG000|Overall Study|Adverse Event|1|||
170591571|NCT02754141|616509800|FG005|Overall Study|Study drug toxicity|0|||
170591572|NCT02754141|616509801|FG006|Overall Study|Study drug toxicity|0|||
170591573|NCT02754141|616509802|FG007|Overall Study|Study drug toxicity|0|||
170591574|NCT02754141|616509803|FG008|Overall Study|Study drug toxicity|0|||
170650614|NCT01431638|616734413|FG001|Overall Study|Adverse Event|3|||
170650615|NCT01431638|616734414|FG002|Overall Study|Adverse Event|1|||
170650616|NCT01431638|616734412|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170591575|NCT02754141|616509804|FG009|Overall Study|Study drug toxicity|0|||
170591576|NCT02754141|616509805|FG010|Overall Study|Study drug toxicity|2|||
170591577|NCT02754141|616509806|FG011|Overall Study|Study drug toxicity|1|||
170591578|NCT02754141|616509807|FG012|Overall Study|Study drug toxicity|1|||
170591579|NCT02754141|616509808|FG013|Overall Study|Study drug toxicity|0|||
170591580|NCT02754141|616509809|FG014|Overall Study|Study drug toxicity|0|||
170591581|NCT02754141|616509810|FG015|Overall Study|Study drug toxicity|0|||
170591582|NCT02754141|616509811|FG016|Overall Study|Study drug toxicity|0|||
170591583|NCT02754141|616509812|FG017|Overall Study|Study drug toxicity|0|||
170591584|NCT02754141|616509795|FG000|Overall Study|AE unrelated to study drug|1|||
170591585|NCT02754141|616509796|FG001|Overall Study|AE unrelated to study drug|1|||
170591586|NCT02754141|616509797|FG002|Overall Study|AE unrelated to study drug|0|||
170591587|NCT02754141|616509798|FG003|Overall Study|AE unrelated to study drug|1|||
170591588|NCT02754141|616509799|FG004|Overall Study|AE unrelated to study drug|3|||
170591589|NCT02754141|616509800|FG005|Overall Study|AE unrelated to study drug|2|||
170591590|NCT02754141|616509801|FG006|Overall Study|AE unrelated to study drug|1|||
170591591|NCT02754141|616509802|FG007|Overall Study|AE unrelated to study drug|0|||
170591592|NCT02754141|616509803|FG008|Overall Study|AE unrelated to study drug|0|||
170591593|NCT02754141|616509804|FG009|Overall Study|AE unrelated to study drug|0|||
170591594|NCT02754141|616509805|FG010|Overall Study|AE unrelated to study drug|0|||
170591595|NCT02754141|616509806|FG011|Overall Study|AE unrelated to study drug|0|||
170591596|NCT02754141|616509807|FG012|Overall Study|AE unrelated to study drug|0|||
170911675|NCT04045613|617680988|FG006|Overall Study|Progressive disease: Clinical progression|3|||
170591597|NCT02754141|616509808|FG013|Overall Study|AE unrelated to study drug|0|||
170591598|NCT02754141|616509809|FG014|Overall Study|AE unrelated to study drug|0|||
170591599|NCT02754141|616509810|FG015|Overall Study|AE unrelated to study drug|0|||
170591600|NCT02754141|616509811|FG016|Overall Study|AE unrelated to study drug|0|||
170591601|NCT02754141|616509812|FG017|Overall Study|AE unrelated to study drug|0|||
170591602|NCT02754141|616509795|FG000|Overall Study|Request to discontinue|0|||
170591603|NCT02754141|616509796|FG001|Overall Study|Request to discontinue|0|||
170591604|NCT02754141|616509797|FG002|Overall Study|Request to discontinue|0|||
170591605|NCT02754141|616509798|FG003|Overall Study|Request to discontinue|0|||
170591606|NCT02754141|616509799|FG004|Overall Study|Request to discontinue|0|||
170591607|NCT02754141|616509800|FG005|Overall Study|Request to discontinue|0|||
170591608|NCT02754141|616509801|FG006|Overall Study|Request to discontinue|0|||
170591609|NCT02754141|616509802|FG007|Overall Study|Request to discontinue|0|||
170591610|NCT02754141|616509803|FG008|Overall Study|Request to discontinue|1|||
170591611|NCT02754141|616509804|FG009|Overall Study|Request to discontinue|0|||
170591612|NCT02754141|616509805|FG010|Overall Study|Request to discontinue|0|||
170591613|NCT02754141|616509806|FG011|Overall Study|Request to discontinue|0|||
170591614|NCT02754141|616509807|FG012|Overall Study|Request to discontinue|0|||
170591615|NCT02754141|616509808|FG013|Overall Study|Request to discontinue|1|||
170911676|NCT04045613|617680982|FG000|Overall Study|Progressive disease: Radiological progression|24|||
170911677|NCT04045613|617680983|FG001|Overall Study|Progressive disease: Radiological progression|6|||
170591616|NCT02754141|616509809|FG014|Overall Study|Request to discontinue|1|||
170591617|NCT02754141|616509810|FG015|Overall Study|Request to discontinue|0|||
170591618|NCT02754141|616509811|FG016|Overall Study|Request to discontinue|0|||
170591619|NCT02754141|616509812|FG017|Overall Study|Request to discontinue|0|||
170591620|NCT02754141|616509795|FG000|Overall Study|Withdrew consent|0|||
170591621|NCT02754141|616509796|FG001|Overall Study|Withdrew consent|0|||
170591622|NCT02754141|616509797|FG002|Overall Study|Withdrew consent|0|||
170591623|NCT02754141|616509798|FG003|Overall Study|Withdrew consent|0|||
170591624|NCT02754141|616509799|FG004|Overall Study|Withdrew consent|0|||
170591625|NCT02754141|616509800|FG005|Overall Study|Withdrew consent|0|||
170591626|NCT02754141|616509801|FG006|Overall Study|Withdrew consent|0|||
170591627|NCT02754141|616509802|FG007|Overall Study|Withdrew consent|0|||
170591628|NCT02754141|616509803|FG008|Overall Study|Withdrew consent|0|||
170591629|NCT02754141|616509804|FG009|Overall Study|Withdrew consent|1|||
170591630|NCT02754141|616509805|FG010|Overall Study|Withdrew consent|0|||
170591631|NCT02754141|616509806|FG011|Overall Study|Withdrew consent|0|||
170591632|NCT02754141|616509807|FG012|Overall Study|Withdrew consent|0|||
170591633|NCT02754141|616509808|FG013|Overall Study|Withdrew consent|0|||
170591634|NCT02754141|616509809|FG014|Overall Study|Withdrew consent|0|||
170591635|NCT02754141|616509810|FG015|Overall Study|Withdrew consent|0|||
170591636|NCT02754141|616509811|FG016|Overall Study|Withdrew consent|0|||
170591637|NCT02754141|616509812|FG017|Overall Study|Withdrew consent|0|||
170591638|NCT02754141|616509795|FG000|Overall Study|Maximum clinical benefit|0|||
170591639|NCT02754141|616509796|FG001|Overall Study|Maximum clinical benefit|0|||
170591640|NCT02754141|616509797|FG002|Overall Study|Maximum clinical benefit|0|||
170591641|NCT02754141|616509798|FG003|Overall Study|Maximum clinical benefit|1|||
170911678|NCT04045613|617680984|FG002|Overall Study|Progressive disease: Radiological progression|8|||
170591642|NCT02754141|616509799|FG004|Overall Study|Maximum clinical benefit|0|||
170591643|NCT02754141|616509800|FG005|Overall Study|Maximum clinical benefit|0|||
170591644|NCT02754141|616509801|FG006|Overall Study|Maximum clinical benefit|0|||
170591645|NCT02754141|616509802|FG007|Overall Study|Maximum clinical benefit|0|||
170591646|NCT02754141|616509803|FG008|Overall Study|Maximum clinical benefit|0|||
170591647|NCT02754141|616509804|FG009|Overall Study|Maximum clinical benefit|0|||
170591648|NCT02754141|616509805|FG010|Overall Study|Maximum clinical benefit|0|||
170591649|NCT02754141|616509806|FG011|Overall Study|Maximum clinical benefit|0|||
170591650|NCT02754141|616509807|FG012|Overall Study|Maximum clinical benefit|0|||
170591651|NCT02754141|616509808|FG013|Overall Study|Maximum clinical benefit|0|||
170591652|NCT02754141|616509809|FG014|Overall Study|Maximum clinical benefit|0|||
170591653|NCT02754141|616509810|FG015|Overall Study|Maximum clinical benefit|0|||
170591654|NCT02754141|616509811|FG016|Overall Study|Maximum clinical benefit|0|||
170591655|NCT02754141|616509812|FG017|Overall Study|Maximum clinical benefit|0|||
170591656|NCT02754141|616509795|FG000|Overall Study|No longer meets study criteria|0|||
170591657|NCT02754141|616509796|FG001|Overall Study|No longer meets study criteria|0|||
170591658|NCT02754141|616509797|FG002|Overall Study|No longer meets study criteria|0|||
170591659|NCT02754141|616509798|FG003|Overall Study|No longer meets study criteria|1|||
170591660|NCT02754141|616509799|FG004|Overall Study|No longer meets study criteria|0|||
170591661|NCT02754141|616509800|FG005|Overall Study|No longer meets study criteria|0|||
170591662|NCT02754141|616509801|FG006|Overall Study|No longer meets study criteria|0|||
170591663|NCT02754141|616509802|FG007|Overall Study|No longer meets study criteria|0|||
170591664|NCT02754141|616509803|FG008|Overall Study|No longer meets study criteria|0|||
170591665|NCT02754141|616509804|FG009|Overall Study|No longer meets study criteria|0|||
170591666|NCT02754141|616509805|FG010|Overall Study|No longer meets study criteria|0|||
170591667|NCT02754141|616509806|FG011|Overall Study|No longer meets study criteria|0|||
170591668|NCT02754141|616509807|FG012|Overall Study|No longer meets study criteria|0|||
170591669|NCT02754141|616509808|FG013|Overall Study|No longer meets study criteria|0|||
170591670|NCT02754141|616509809|FG014|Overall Study|No longer meets study criteria|0|||
170591671|NCT02754141|616509810|FG015|Overall Study|No longer meets study criteria|0|||
170591672|NCT02754141|616509811|FG016|Overall Study|No longer meets study criteria|0|||
170591673|NCT02754141|616509812|FG017|Overall Study|No longer meets study criteria|0|||
170591674|NCT02754141|616509795|FG000|Overall Study|Other reasons|0|||
170591675|NCT02754141|616509796|FG001|Overall Study|Other reasons|0|||
170591676|NCT02754141|616509797|FG002|Overall Study|Other reasons|0|||
170591677|NCT02754141|616509798|FG003|Overall Study|Other reasons|0|||
170591678|NCT02754141|616509799|FG004|Overall Study|Other reasons|0|||
170591679|NCT02754141|616509800|FG005|Overall Study|Other reasons|0|||
170591680|NCT02754141|616509801|FG006|Overall Study|Other reasons|0|||
170591681|NCT02754141|616509802|FG007|Overall Study|Other reasons|1|||
170591682|NCT02754141|616509803|FG008|Overall Study|Other reasons|0|||
170591683|NCT02754141|616509804|FG009|Overall Study|Other reasons|0|||
170591684|NCT02754141|616509805|FG010|Overall Study|Other reasons|0|||
170591685|NCT02754141|616509806|FG011|Overall Study|Other reasons|0|||
170650617|NCT01431638|616734413|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170650618|NCT01431638|616734414|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
170650619|NCT01431638|616734412|FG000|Overall Study|Participants condition no longer requires study drug|0|||
170650620|NCT01431638|616734413|FG001|Overall Study|Participants condition no longer requires study drug|1|||
170650621|NCT01431638|616734414|FG002|Overall Study|Participants condition no longer requires study drug|0|||
170650622|NCT01431638|616734412|FG000|Overall Study|Participant withdrew consent|14|||
170650623|NCT01431638|616734413|FG001|Overall Study|Participant withdrew consent|5|||
170650624|NCT01431638|616734414|FG002|Overall Study|Participant withdrew consent|8|||
170650625|NCT01431638|616734412|FG000|Overall Study|Lost to Follow-up|7|||
170650626|NCT01431638|616734413|FG001|Overall Study|Lost to Follow-up|9|||
170650627|NCT01431638|616734414|FG002|Overall Study|Lost to Follow-up|7|||
170650628|NCT01431638|616734412|FG000|Overall Study|Administrative problems|1|||
170650629|NCT01431638|616734413|FG001|Overall Study|Administrative problems|4|||
170650630|NCT01431638|616734414|FG002|Overall Study|Administrative problems|6|||
170650631|NCT01431638|616734412|FG000|Overall Study|Death|1|||
170650632|NCT01431638|616734413|FG001|Overall Study|Death|0|||
170650633|NCT01431638|616734414|FG002|Overall Study|Death|0|||
170650634|NCT01431638|616734412|FG000|Overall Study|Protocol deviation|1|||
170650635|NCT01431638|616734413|FG001|Overall Study|Protocol deviation|1|||
170650636|NCT01431638|616734414|FG002|Overall Study|Protocol deviation|4|||
170650637|NCT01431638|616734412|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
170650638|NCT01431638|616734413|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
170650639|NCT01431638|616734414|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
170650640|NCT01261780|616734415|FG000|Overall Study|Withdrawal by Subject|1|||
170650641|NCT01261780|616734416|FG001|Overall Study|Withdrawal by Subject|0|||
170650642|NCT01261780|616734415|FG000|Overall Study|Event not related to subject|1|||
170650643|NCT01261780|616734416|FG001|Overall Study|Event not related to subject|2|||
170650644|NCT01239732|616734417|FG000|Overall Study|Termination of study per protocol|667|||
170650645|NCT01239732|616734417|FG000|Overall Study|Death|226|||
170650646|NCT01239732|616734417|FG000|Overall Study|Withdrawal by Subject|87|||
170650647|NCT01239732|616734417|FG000|Overall Study|Adverse Event|6|||
170591686|NCT02754141|616509807|FG012|Overall Study|Other reasons|2|||
170591687|NCT02754141|616509808|FG013|Overall Study|Other reasons|0|||
170591688|NCT02754141|616509809|FG014|Overall Study|Other reasons|0|||
170591689|NCT02754141|616509810|FG015|Overall Study|Other reasons|0|||
170591690|NCT02754141|616509811|FG016|Overall Study|Other reasons|0|||
170650648|NCT01239732|616734417|FG000|Overall Study|Protocol Violation|3|||
170650649|NCT01239732|616734417|FG000|Overall Study|Participant non compliance|5|||
170591691|NCT02754141|616509812|FG017|Overall Study|Other reasons|0|||
170591692|NCT02754141|616509795|FG000|Overall Study|Completed treatment as per protocol|0|||
170591693|NCT02754141|616509796|FG001|Overall Study|Completed treatment as per protocol|1|||
170911679|NCT04045613|617680985|FG003|Overall Study|Progressive disease: Radiological progression|0|||
170911680|NCT04045613|617680986|FG004|Overall Study|Progressive disease: Radiological progression|6|||
170911681|NCT04045613|617680987|FG005|Overall Study|Progressive disease: Radiological progression|6|||
170911682|NCT04045613|617680988|FG006|Overall Study|Progressive disease: Radiological progression|11|||
170911683|NCT01633060|617680989|FG000|Randomization Phase|Protocol deviation|1|||
170911684|NCT01633060|617680990|FG001|Randomization Phase|Protocol deviation|2|||
170911685|NCT01633060|617680989|FG000|Randomization Phase|Technical problem|0|||
170911686|NCT01633060|617680990|FG001|Randomization Phase|Technical problem|1|||
170911687|NCT01633060|617680989|FG000|Treatment Phase|Adverse Event|24|||
170911688|NCT01633060|617680990|FG001|Treatment Phase|Adverse Event|3|||
170911689|NCT01633060|617680989|FG000|Treatment Phase|Lost to Follow-up|1|||
170911690|NCT01633060|617680990|FG001|Treatment Phase|Lost to Follow-up|0|||
170911691|NCT01633060|617680989|FG000|Treatment Phase|Physician Decision|16|||
170911692|NCT01633060|617680990|FG001|Treatment Phase|Physician Decision|7|||
170911693|NCT01633060|617680989|FG000|Treatment Phase|Progressive Disease|210|||
170911694|NCT01633060|617680990|FG001|Treatment Phase|Progressive Disease|120|||
170911695|NCT01633060|617680989|FG000|Treatment Phase|Protocol Deviation|1|||
170911696|NCT01633060|617680990|FG001|Treatment Phase|Protocol Deviation|0|||
170911697|NCT01633060|617680989|FG000|Treatment Phase|Study Terminated by sponsor|7|||
170911698|NCT01633060|617680990|FG001|Treatment Phase|Study Terminated by sponsor|3|||
170911699|NCT01633060|617680989|FG000|Treatment Phase|Subject/guardian decision|25|||
170911700|NCT01633060|617680990|FG001|Treatment Phase|Subject/guardian decision|4|||
170911701|NCT01633060|617680989|FG000|Treatment Phase|Death|4|||
170911702|NCT01633060|617680990|FG001|Treatment Phase|Death|3|||
170911703|NCT01633060|617680989|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
170911704|NCT01633060|617680990|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
170911705|NCT01633060|617680989|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
170911706|NCT01633060|617680990|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
170911707|NCT01633060|617680989|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
170911708|NCT01633060|617680990|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
170911709|NCT01633060|617680989|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
170911710|NCT01633060|617680990|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
170911711|NCT01633060|617680989|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
170911712|NCT01633060|617680990|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
170911713|NCT01633060|617680989|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
170911714|NCT01633060|617680990|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
170911715|NCT01009294|617680991|FG000|Overall Study|Study discontinued by Sponsor|6|||
170911716|NCT03671369|617680992|FG000|Overall Study|Other|1|||
170911717|NCT03671369|617680992|FG000|Overall Study|Withdrawal by Subject|289|||
170911718|NCT03671369|617680992|FG000|Overall Study|Not willing to be vaccinated|1|||
170911719|NCT02732912|617680993|FG000|Overall Study|Discharged before night|2|||
170591694|NCT02754141|616509797|FG002|Overall Study|Completed treatment as per protocol|0|||
170591695|NCT02754141|616509798|FG003|Overall Study|Completed treatment as per protocol|0|||
170591696|NCT02754141|616509799|FG004|Overall Study|Completed treatment as per protocol|0|||
170591697|NCT02754141|616509800|FG005|Overall Study|Completed treatment as per protocol|0|||
170591698|NCT02754141|616509801|FG006|Overall Study|Completed treatment as per protocol|0|||
170591699|NCT02754141|616509802|FG007|Overall Study|Completed treatment as per protocol|0|||
170591700|NCT02754141|616509803|FG008|Overall Study|Completed treatment as per protocol|0|||
170591701|NCT02754141|616509804|FG009|Overall Study|Completed treatment as per protocol|0|||
170591702|NCT02754141|616509805|FG010|Overall Study|Completed treatment as per protocol|0|||
170591703|NCT02754141|616509806|FG011|Overall Study|Completed treatment as per protocol|0|||
170591704|NCT02754141|616509807|FG012|Overall Study|Completed treatment as per protocol|1|||
170591705|NCT02754141|616509808|FG013|Overall Study|Completed treatment as per protocol|0|||
170591706|NCT02754141|616509809|FG014|Overall Study|Completed treatment as per protocol|0|||
170591707|NCT02754141|616509810|FG015|Overall Study|Completed treatment as per protocol|0|||
170591708|NCT02754141|616509811|FG016|Overall Study|Completed treatment as per protocol|0|||
170911720|NCT02732912|617680994|FG001|Overall Study|Discharged before night|6|||
170591709|NCT02754141|616509812|FG017|Overall Study|Completed treatment as per protocol|0|||
170591710|NCT02754141|616509795|FG000|Overall Study|Not completing monotherapy|0|||
170591711|NCT02754141|616509796|FG001|Overall Study|Not completing monotherapy|0|||
170591712|NCT02754141|616509797|FG002|Overall Study|Not completing monotherapy|0|||
170591713|NCT02754141|616509798|FG003|Overall Study|Not completing monotherapy|0|||
170911721|NCT02732912|617680993|FG000|Overall Study|Incomplete completion of questionnaire|2|||
170591714|NCT02754141|616509799|FG004|Overall Study|Not completing monotherapy|0|||
170591715|NCT02754141|616509800|FG005|Overall Study|Not completing monotherapy|0|||
170911722|NCT02732912|617680994|FG001|Overall Study|Incomplete completion of questionnaire|3|||
170911723|NCT02732912|617680993|FG000|Overall Study|No outcome; discharged or refused|6|||
170911724|NCT02732912|617680994|FG001|Overall Study|No outcome; discharged or refused|9|||
170911725|NCT05121103|617680998|FG000|Overall Study|Progressive disease|2|||
170911726|NCT05121103|617680999|FG001|Overall Study|Progressive disease|1|||
170911727|NCT05121103|617681000|FG002|Overall Study|Progressive disease|6|||
170650650|NCT01239732|616734417|FG000|Overall Study|Study termination by sponsor|2|||
170650651|NCT01239732|616734417|FG000|Overall Study|Investigator's decision|4|||
170911728|NCT05121103|617680998|FG000|Overall Study|Physician Decision|2|||
170911729|NCT05121103|617680999|FG001|Overall Study|Physician Decision|1|||
170911730|NCT05121103|617681000|FG002|Overall Study|Physician Decision|0|||
170911731|NCT05121103|617680998|FG000|Overall Study|Withdrawal by Subject|0|||
170911732|NCT05121103|617680999|FG001|Overall Study|Withdrawal by Subject|1|||
170911733|NCT05121103|617681000|FG002|Overall Study|Withdrawal by Subject|0|||
170911734|NCT02983292|617681007|FG000|Overall Study|Participant unwell & cannot travel|2|||
170911735|NCT02983292|617681007|FG000|Overall Study|Lost to Follow-up|3|||
170911736|NCT02983292|617681007|FG000|Overall Study|Participant withdrew consent|2|||
170911737|NCT02983292|617681007|FG000|Overall Study|Revision|7|||
170911738|NCT02983292|617681007|FG000|Overall Study|Death|1|||
170911739|NCT02983292|617681007|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
170911740|NCT02983292|617681007|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
170911741|NCT02983292|617681007|FG000|Overall Study|Participant relocation|1|||
170911742|NCT00586690|617681014|FG000|Overall Study|Death|2|||
170591716|NCT02754141|616509801|FG006|Overall Study|Not completing monotherapy|0|||
170591717|NCT02754141|616509802|FG007|Overall Study|Not completing monotherapy|0|||
170591718|NCT02754141|616509803|FG008|Overall Study|Not completing monotherapy|0|||
170591719|NCT02754141|616509804|FG009|Overall Study|Not completing monotherapy|0|||
170591720|NCT02754141|616509805|FG010|Overall Study|Not completing monotherapy|0|||
170591721|NCT02754141|616509806|FG011|Overall Study|Not completing monotherapy|0|||
170591722|NCT02754141|616509807|FG012|Overall Study|Not completing monotherapy|0|||
170591723|NCT02754141|616509808|FG013|Overall Study|Not completing monotherapy|1|||
170591724|NCT02754141|616509809|FG014|Overall Study|Not completing monotherapy|0|||
170591725|NCT02754141|616509810|FG015|Overall Study|Not completing monotherapy|0|||
170591726|NCT02754141|616509811|FG016|Overall Study|Not completing monotherapy|0|||
170591727|NCT02754141|616509812|FG017|Overall Study|Not completing monotherapy|0|||
170591728|NCT01655381|616509813|FG000|Overall Study|Investigator Decision|1|||
170591729|NCT01655381|616509813|FG000|Overall Study|Moved to Another City|1|||
170591730|NCT01655381|616509813|FG000|Overall Study|Insufficient Treatment Response|1|||
170591731|NCT04195438|616509814|FG000|Overall Study|Withdrawal by Subject|1|||
170591732|NCT01156389|616509815|FG000|Overall Study|Elevated liver enzymes|4|||
170591733|NCT01156389|616509816|FG001|Overall Study|Elevated liver enzymes|0|||
170591734|NCT01156389|616509815|FG000|Overall Study|Vomiting|0|||
170591735|NCT01156389|616509816|FG001|Overall Study|Vomiting|1|||
170591736|NCT01703117|616509817|FG000|Overall Study|Adverse Event|4|||
170591737|NCT01703117|616509818|FG001|Overall Study|Adverse Event|3|||
170591738|NCT01703117|616509817|FG000|Overall Study|Withdrawal by Subject|0|||
170591739|NCT01703117|616509818|FG001|Overall Study|Withdrawal by Subject|1|||
170591740|NCT00623545|616509822|FG000|Overall Study|Adverse Event|6|||
170591741|NCT00623545|616509822|FG000|Overall Study|Withdrawal by Subject|4|||
170591742|NCT05479097|616509825|FG000|Overall Study|Withdrawal by Subject|2|||
170591743|NCT04126564|616509826|FG000|Overall Study|Withdrawal by Subject|0|||
170591744|NCT04126564|616509827|FG001|Overall Study|Withdrawal by Subject|2|||
170591745|NCT04126564|616509826|FG000|Overall Study|Lost to Follow-up|0|||
170591746|NCT04126564|616509827|FG001|Overall Study|Lost to Follow-up|1|||
170591747|NCT04706273|616509830|FG000|Overall Study|Withdrawal by Subject|27|||
170591748|NCT04706273|616509830|FG000|Overall Study|Physician Decision|1|||
170591749|NCT04706273|616509830|FG000|Overall Study|Lost to Follow-up|42|||
170591750|NCT04706273|616509830|FG000|Overall Study|Death|85|||
170591751|NCT04706273|616509830|FG000|Overall Study|Amputation that removes study device|2|||
170591752|NCT04706273|616509830|FG000|Overall Study|Surgical bypass|3|||
170591753|NCT04706273|616509830|FG000|Overall Study|Changing hospital|23|||
170591754|NCT04706273|616509830|FG000|Overall Study|Unable to attend hospital|2|||
170591755|NCT00869050|616509834|FG000|Overall Study|Screen Failure|3|||
170591756|NCT05463744|616509835|FG000|Treatment Period|Withdrawal by Subject|19|||
170591757|NCT05463744|616509836|FG001|Treatment Period|Withdrawal by Subject|16|||
170591758|NCT05463744|616509835|FG000|Treatment Period|Adverse Event|4|||
170591759|NCT05463744|616509836|FG001|Treatment Period|Adverse Event|4|||
170591760|NCT05463744|616509835|FG000|Treatment Period|Pregnancy|0|||
170591761|NCT05463744|616509836|FG001|Treatment Period|Pregnancy|3|||
170591762|NCT05463744|616509835|FG000|Treatment Period|Lost to Follow-up|1|||
170591763|NCT05463744|616509836|FG001|Treatment Period|Lost to Follow-up|3|||
170591764|NCT05463744|616509835|FG000|Treatment Period|Inadvertent enrollment|2|||
170591765|NCT05463744|616509836|FG001|Treatment Period|Inadvertent enrollment|1|||
170591766|NCT05463744|616509835|FG000|Treatment Period|Death|0|||
170591767|NCT05463744|616509836|FG001|Treatment Period|Death|1|||
170591768|NCT05463744|616509835|FG000|Treatment Period|Non-compliance with Study Drug|1|||
170591769|NCT05463744|616509836|FG001|Treatment Period|Non-compliance with Study Drug|0|||
170591770|NCT05463744|616509835|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
170911743|NCT00586690|617681015|FG001|Overall Study|Death|0|||
170911744|NCT00586690|617681014|FG000|Overall Study|Disease Progression|10|||
170591771|NCT05463744|616509836|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
170591772|NCT05463744|616509835|FG000|Treatment Period|Physician Decision|0|||
170591773|NCT05463744|616509836|FG001|Treatment Period|Physician Decision|1|||
170591774|NCT05463744|616509835|FG000|Follow-Up Period|Withdrawal by Subject|3|||
170591775|NCT05463744|616509836|FG001|Follow-Up Period|Withdrawal by Subject|1|||
170591776|NCT05463744|616509835|FG000|Follow-Up Period|Lost to Follow-up|1|||
170591777|NCT05463744|616509836|FG001|Follow-Up Period|Lost to Follow-up|1|||
170591778|NCT00759356|616509837|FG000|Overall Study|Adverse Event|0|||
170591779|NCT00759356|616509838|FG001|Overall Study|Adverse Event|1|||
170591780|NCT00759356|616509837|FG000|Overall Study|Withdrawal by Subject|0|||
170591781|NCT00759356|616509838|FG001|Overall Study|Withdrawal by Subject|2|||
170591782|NCT00759356|616509837|FG000|Overall Study|Subject was unable to return|1|||
170591783|NCT00759356|616509838|FG001|Overall Study|Subject was unable to return|0|||
170591784|NCT02403635|616509841|FG000|Overall Study|Not eligible|9|||
170591785|NCT03554772|616509842|FG000|Overall Study|Lost to Follow-up|0|||
170591786|NCT03554772|616509843|FG001|Overall Study|Lost to Follow-up|0|||
170591787|NCT03554772|616509844|FG002|Overall Study|Lost to Follow-up|0|||
170591788|NCT03554772|616509845|FG003|Overall Study|Lost to Follow-up|2|||
170591789|NCT03263923|616509846|FG000|Overall Study|Withdrawal by Subject|10|||
170591790|NCT03263923|616509847|FG001|Overall Study|Withdrawal by Subject|8|||
170591791|NCT03263923|616509846|FG000|Overall Study|Lost to Follow-up|15|||
170591792|NCT03263923|616509847|FG001|Overall Study|Lost to Follow-up|13|||
170591793|NCT01998893|616509848|FG000|Overall Study|Adverse Event|2|||
170591794|NCT01998893|616509848|FG000|Overall Study|Death|1|||
170591795|NCT01998893|616509848|FG000|Overall Study|Lost to Follow-up|8|||
170591796|NCT01998893|616509848|FG000|Overall Study|Physician Decision|2|||
170591797|NCT01998893|616509848|FG000|Overall Study|Protocol Violation|2|||
170591798|NCT01998893|616509848|FG000|Overall Study|Withdrawal by Subject|1|||
170591799|NCT01998893|616509848|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
170591800|NCT03276052|616509849|FG000|Overall Study|Withdrawal by Subject|5|||
170591801|NCT03276052|616509849|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
170591802|NCT01323270|616509850|FG000|Overall Study|Withdrawal by Subject|19|||
170591803|NCT01323270|616509851|FG001|Overall Study|Withdrawal by Subject|10|||
170591804|NCT01323270|616509850|FG000|Overall Study|Protocol Violation|9|||
170591805|NCT01323270|616509851|FG001|Overall Study|Protocol Violation|7|||
170591806|NCT01323270|616509850|FG000|Overall Study|Lost to Follow-up|4|||
170591807|NCT01323270|616509851|FG001|Overall Study|Lost to Follow-up|6|||
170591808|NCT01323270|616509850|FG000|Overall Study|Adverse Event|8|||
170591809|NCT01323270|616509851|FG001|Overall Study|Adverse Event|0|||
170591810|NCT01323270|616509850|FG000|Overall Study|Other|0|||
170591811|NCT01323270|616509851|FG001|Overall Study|Other|3|||
170591812|NCT01323270|616509850|FG000|Overall Study|Physician Decision|0|||
170591813|NCT01323270|616509851|FG001|Overall Study|Physician Decision|2|||
170591814|NCT01323270|616509850|FG000|Overall Study|Not eligible|1|||
170591815|NCT01323270|616509851|FG001|Overall Study|Not eligible|1|||
170591816|NCT01323270|616509850|FG000|Overall Study|Death|1|||
170591817|NCT01323270|616509851|FG001|Overall Study|Death|0|||
170591818|NCT01323270|616509850|FG000|Overall Study|Randomized, but not vaccinated|1|||
170591819|NCT01323270|616509851|FG001|Overall Study|Randomized, but not vaccinated|0|||
170591820|NCT03054350|616509857|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
170591821|NCT03054350|616509858|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
170591822|NCT03054350|616509859|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
170591823|NCT03054350|616509860|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
170591824|NCT03054350|616509861|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
170591825|NCT03054350|616509862|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
170591826|NCT03054350|616509857|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
170591827|NCT03054350|616509858|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
170591828|NCT03054350|616509859|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
170591829|NCT03054350|616509860|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
170810628|NCT00721734|617315601|FG002|Overall Study|Withdrawal by Subject|0|||
170810629|NCT00721734|617315602|FG003|Overall Study|Withdrawal by Subject|0|||
170810630|NCT00721734|617315603|FG004|Overall Study|Withdrawal by Subject|1|||
170810631|NCT00721734|617315599|FG000|Overall Study|Other|0|||
170810632|NCT00721734|617315600|FG001|Overall Study|Other|0|||
170810633|NCT00721734|617315601|FG002|Overall Study|Other|0|||
170810634|NCT00721734|617315602|FG003|Overall Study|Other|1|||
170810635|NCT00721734|617315603|FG004|Overall Study|Other|0|||
170591830|NCT03054350|616509861|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
170591831|NCT03054350|616509862|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
170591832|NCT03054350|616509857|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
170810636|NCT05074433|617315604|FG000|Overall Study|Adverse Event|0|||
170591833|NCT03054350|616509858|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
170591834|NCT03054350|616509859|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
170591835|NCT03054350|616509860|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
170810637|NCT05074433|617315605|FG001|Overall Study|Adverse Event|2|||
170810638|NCT05074433|617315606|FG002|Overall Study|Adverse Event|0|||
170591836|NCT03054350|616509861|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
170591837|NCT03054350|616509862|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
170591838|NCT03054350|616509857|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
170591839|NCT03054350|616509858|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
170591840|NCT03054350|616509859|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
170591841|NCT03054350|616509860|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
170591842|NCT03054350|616509861|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
170591843|NCT03054350|616509862|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
170591844|NCT01643850|616509863|FG000|Overall Study|Withdrawal by Subject|0|||
170591845|NCT01643850|616509864|FG001|Overall Study|Withdrawal by Subject|0|||
170591846|NCT01643850|616509865|FG002|Overall Study|Withdrawal by Subject|0|||
170591847|NCT01643850|616509866|FG003|Overall Study|Withdrawal by Subject|0|||
170591848|NCT01643850|616509867|FG004|Overall Study|Withdrawal by Subject|1|||
170591849|NCT01643850|616509868|FG005|Overall Study|Withdrawal by Subject|0|||
170591850|NCT01643850|616509869|FG006|Overall Study|Withdrawal by Subject|0|||
170591851|NCT01643850|616509870|FG007|Overall Study|Withdrawal by Subject|0|||
170591852|NCT01643850|616509871|FG008|Overall Study|Withdrawal by Subject|0|||
170591853|NCT01643850|616509863|FG000|Overall Study|Lost to Follow-up|0|||
170591854|NCT01643850|616509864|FG001|Overall Study|Lost to Follow-up|0|||
170591855|NCT01643850|616509865|FG002|Overall Study|Lost to Follow-up|0|||
170591856|NCT01643850|616509866|FG003|Overall Study|Lost to Follow-up|0|||
170591857|NCT01643850|616509867|FG004|Overall Study|Lost to Follow-up|0|||
170591858|NCT01643850|616509868|FG005|Overall Study|Lost to Follow-up|0|||
170591859|NCT01643850|616509869|FG006|Overall Study|Lost to Follow-up|1|||
170591860|NCT01643850|616509870|FG007|Overall Study|Lost to Follow-up|0|||
170591861|NCT01643850|616509871|FG008|Overall Study|Lost to Follow-up|1|||
170591862|NCT01643850|616509863|FG000|Overall Study|Adverse Event|0|||
170591863|NCT01643850|616509864|FG001|Overall Study|Adverse Event|0|||
170591864|NCT01643850|616509865|FG002|Overall Study|Adverse Event|0|||
170591865|NCT01643850|616509866|FG003|Overall Study|Adverse Event|0|||
170591866|NCT01643850|616509867|FG004|Overall Study|Adverse Event|1|||
170591867|NCT01643850|616509868|FG005|Overall Study|Adverse Event|0|||
170591868|NCT01643850|616509869|FG006|Overall Study|Adverse Event|0|||
170591869|NCT01643850|616509870|FG007|Overall Study|Adverse Event|0|||
170591870|NCT01643850|616509871|FG008|Overall Study|Adverse Event|0|||
170591871|NCT01643850|616509863|FG000|Overall Study|Administrative Problems|0|||
170591872|NCT01643850|616509864|FG001|Overall Study|Administrative Problems|0|||
170591873|NCT01643850|616509865|FG002|Overall Study|Administrative Problems|1|||
170591874|NCT01643850|616509866|FG003|Overall Study|Administrative Problems|0|||
170591875|NCT01643850|616509867|FG004|Overall Study|Administrative Problems|1|||
170591876|NCT01643850|616509868|FG005|Overall Study|Administrative Problems|0|||
170591877|NCT01643850|616509869|FG006|Overall Study|Administrative Problems|0|||
170591878|NCT01643850|616509870|FG007|Overall Study|Administrative Problems|0|||
170591879|NCT01643850|616509871|FG008|Overall Study|Administrative Problems|0|||
170591880|NCT00907803|616509872|FG000|Overall Study|Withdrawal of consent - long commute|1|||
170591881|NCT00907803|616509873|FG001|Overall Study|Withdrawal of consent - long commute|0|||
170591882|NCT00907803|616509874|FG002|Overall Study|Withdrawal of consent - long commute|0|||
170591883|NCT00907803|616509872|FG000|Overall Study|Adverse Event|2|||
170591884|NCT00907803|616509873|FG001|Overall Study|Adverse Event|0|||
170591885|NCT00907803|616509874|FG002|Overall Study|Adverse Event|0|||
170591886|NCT00907803|616509872|FG000|Overall Study|Withdrawal by Subject|0|||
170591887|NCT00907803|616509873|FG001|Overall Study|Withdrawal by Subject|1|||
170591888|NCT00907803|616509874|FG002|Overall Study|Withdrawal by Subject|0|||
170591889|NCT00907803|616509872|FG000|Overall Study|Lost to Follow-up|0|||
170591890|NCT00907803|616509873|FG001|Overall Study|Lost to Follow-up|1|||
170591891|NCT00907803|616509874|FG002|Overall Study|Lost to Follow-up|0|||
170591892|NCT00907803|616509872|FG000|Overall Study|Protocol Violation|0|||
170591893|NCT00907803|616509873|FG001|Overall Study|Protocol Violation|1|||
170591894|NCT00907803|616509874|FG002|Overall Study|Protocol Violation|0|||
170650652|NCT01239732|616734417|FG000|Overall Study|Treatment failure|2|||
170650653|NCT01239732|616734417|FG000|Overall Study|Other|19|||
170650654|NCT03836001|616734418|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
170650655|NCT03836001|616734419|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
170810639|NCT05074433|617315607|FG003|Overall Study|Adverse Event|1|||
170591895|NCT03242772|616509875|FG000|Overall Study|Lost to Follow-up|2|||
170591896|NCT03242772|616509876|FG001|Overall Study|Lost to Follow-up|0|||
170591897|NCT03242772|616509875|FG000|Overall Study|Physician Decision|0|||
170591898|NCT03242772|616509876|FG001|Overall Study|Physician Decision|1|||
170591899|NCT03242772|616509875|FG000|Overall Study|Withdrawal by Subject|1|||
170591900|NCT03242772|616509876|FG001|Overall Study|Withdrawal by Subject|0|||
170591901|NCT04677660|616509877|FG000|Overall Study|Lost to Follow-up|0|||
170591902|NCT04677660|616509878|FG001|Overall Study|Lost to Follow-up|2|||
170591903|NCT04677660|616509877|FG000|Overall Study|Withdrawal by Subject|0|||
170591904|NCT04677660|616509878|FG001|Overall Study|Withdrawal by Subject|1|||
170650656|NCT03836001|616734420|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
170810640|NCT05074433|617315604|FG000|Overall Study|Sponsor Request|0|||
170591905|NCT04677660|616509877|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
170591906|NCT04677660|616509878|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
170591907|NCT02499900|616509879|FG000|Core Study Period|Other|1|||
170591908|NCT02499900|616509880|FG001|Core Study Period|Other|4|||
170591909|NCT02499900|616509879|FG000|Core Study Period|Lost to Follow-up|1|||
170591910|NCT02499900|616509880|FG001|Core Study Period|Lost to Follow-up|2|||
170591911|NCT02499900|616509879|FG000|Core Study Period|Per sponsor request|0|||
170591912|NCT02499900|616509880|FG001|Core Study Period|Per sponsor request|1|||
170591913|NCT02499900|616509879|FG000|Core Study Period|Pregnancy|1|||
170591914|NCT02499900|616509880|FG001|Core Study Period|Pregnancy|0|||
170591915|NCT02499900|616509879|FG000|Core Study Period|Protocol Violation|3|||
170591916|NCT02499900|616509880|FG001|Core Study Period|Protocol Violation|0|||
170591917|NCT02499900|616509879|FG000|Core Study Period|Withdrawal by Subject|11|||
170591918|NCT02499900|616509880|FG001|Core Study Period|Withdrawal by Subject|10|||
170591919|NCT02499900|616509879|FG000|Core Study Period|Adverse Event|18|||
170591920|NCT02499900|616509880|FG001|Core Study Period|Adverse Event|14|||
170591921|NCT02499900|616509879|FG000|Core Study Period|Death|0|||
170591922|NCT02499900|616509880|FG001|Core Study Period|Death|1|||
170591923|NCT02499900|616509879|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
170591924|NCT02499900|616509880|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
170591925|NCT02499900|616509879|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
170591926|NCT02499900|616509880|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
170591927|NCT02499900|616509879|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
170591928|NCT02499900|616509880|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
170591929|NCT02499900|616509879|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
170591930|NCT02499900|616509880|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
170591931|NCT02499900|616509879|FG000|Extension Study Period|Adverse Event|2|||
170591932|NCT02499900|616509880|FG001|Extension Study Period|Adverse Event|4|||
170591933|NCT02499900|616509879|FG000|Extension Study Period|Withdrawal by Subject|5|||
170591934|NCT02499900|616509880|FG001|Extension Study Period|Withdrawal by Subject|2|||
170591935|NCT02499900|616509879|FG000|Extension Study Period|Physician Decision|2|||
170591936|NCT02499900|616509880|FG001|Extension Study Period|Physician Decision|5|||
170591937|NCT02499900|616509879|FG000|Extension Study Period|Pregnancy|1|||
170591938|NCT02499900|616509880|FG001|Extension Study Period|Pregnancy|2|||
170591939|NCT02499900|616509879|FG000|Extension Study Period|Lost to Follow-up|2|||
170591940|NCT02499900|616509880|FG001|Extension Study Period|Lost to Follow-up|5|||
170591941|NCT02499900|616509879|FG000|Extension Study Period|Other|0|||
170591942|NCT02499900|616509880|FG001|Extension Study Period|Other|2|||
170591943|NCT01170065|616509897|FG000|Overall Study|Adverse Event|17|||
170591944|NCT01170065|616509898|FG001|Overall Study|Adverse Event|50|||
170591945|NCT01170065|616509899|FG002|Overall Study|Adverse Event|10|||
170591946|NCT01170065|616509897|FG000|Overall Study|Lost to Follow-up|1|||
170591947|NCT01170065|616509898|FG001|Overall Study|Lost to Follow-up|4|||
170591948|NCT01170065|616509899|FG002|Overall Study|Lost to Follow-up|1|||
170591949|NCT01170065|616509897|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
170591950|NCT01170065|616509898|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
170591951|NCT01170065|616509899|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
170591952|NCT01170065|616509897|FG000|Overall Study|Reason other than specified|3|||
170591953|NCT01170065|616509898|FG001|Overall Study|Reason other than specified|8|||
170591954|NCT01170065|616509899|FG002|Overall Study|Reason other than specified|3|||
170591955|NCT01170065|616509897|FG000|Overall Study|Ongoing after planned observation time|5|||
170591956|NCT01170065|616509898|FG001|Overall Study|Ongoing after planned observation time|26|||
170591957|NCT01170065|616509899|FG002|Overall Study|Ongoing after planned observation time|10|||
170591958|NCT01089023|616509900|FG000|Overall Study|Lost to Follow-up|3|||
170591959|NCT01089023|616509900|FG000|Overall Study|Adverse Event|1|||
170591960|NCT01089023|616509900|FG000|Overall Study|Withdrawal by Subject|1|||
170591961|NCT01089023|616509900|FG000|Overall Study|Protocol Violation|1|||
170591962|NCT01089023|616509900|FG000|Overall Study|Lack of Efficacy|1|||
170591963|NCT02323204|616509905|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
170591964|NCT02323204|616509906|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
170591965|NCT02323204|616509907|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
170810641|NCT05074433|617315605|FG001|Overall Study|Sponsor Request|1|||
170810642|NCT05074433|617315606|FG002|Overall Study|Sponsor Request|1|||
170810643|NCT05074433|617315607|FG003|Overall Study|Sponsor Request|0|||
170810644|NCT05074433|617315604|FG000|Overall Study|Death|1|||
170810645|NCT05074433|617315605|FG001|Overall Study|Death|0|||
170810646|NCT05074433|617315606|FG002|Overall Study|Death|0|||
170810647|NCT05074433|617315607|FG003|Overall Study|Death|0|||
170810648|NCT05074433|617315604|FG000|Overall Study|Lost to Follow-up|0|||
170810649|NCT05074433|617315605|FG001|Overall Study|Lost to Follow-up|0|||
170810650|NCT05074433|617315606|FG002|Overall Study|Lost to Follow-up|2|||
170810651|NCT05074433|617315607|FG003|Overall Study|Lost to Follow-up|0|||
170810652|NCT05074433|617315604|FG000|Overall Study|Subject Decision|8|||
170810653|NCT05074433|617315605|FG001|Overall Study|Subject Decision|6|||
170810654|NCT05074433|617315606|FG002|Overall Study|Subject Decision|4|||
170591966|NCT02323204|616509908|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
170591967|NCT02323204|616509905|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
170591968|NCT02323204|616509906|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
170591969|NCT02323204|616509907|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
170591970|NCT02323204|616509908|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
170591971|NCT02323204|616509905|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
170591972|NCT02323204|616509906|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
170591973|NCT02323204|616509907|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
170591974|NCT02323204|616509908|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
170591975|NCT02323204|616509905|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
170591976|NCT02323204|616509906|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
170591977|NCT02323204|616509907|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
170591978|NCT02323204|616509908|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
170591979|NCT02323204|616509905|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
170591980|NCT02323204|616509906|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
170591981|NCT02323204|616509907|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
170591982|NCT02323204|616509908|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
170591983|NCT02323204|616509905|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
170591984|NCT02323204|616509906|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
170591985|NCT02323204|616509907|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
170591986|NCT02323204|616509908|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
170591987|NCT02323204|616509905|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
170591988|NCT02323204|616509906|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
170591989|NCT02323204|616509907|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
170591990|NCT02323204|616509908|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
170591991|NCT02323204|616509905|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
170591992|NCT02323204|616509906|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
170591993|NCT02323204|616509907|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
170591994|NCT02323204|616509908|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
170591995|NCT02323204|616509905|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
170591996|NCT02323204|616509906|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
170810655|NCT05074433|617315607|FG003|Overall Study|Subject Decision|5|||
170810656|NCT05484661|617315611|FG000|Overall Study|Withdrawal by Subject|1|||
170810657|NCT05484661|617315612|FG001|Overall Study|Withdrawal by Subject|0|||
170810658|NCT02203032|617315618|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
170810659|NCT02203032|617315619|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
170810660|NCT02203032|617315620|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
170810661|NCT02203032|617315621|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
170810662|NCT02203032|617315618|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
170810663|NCT02203032|617315619|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
170810664|NCT02203032|617315620|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
170810665|NCT02203032|617315621|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
170810666|NCT02203032|617315618|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
170810667|NCT02203032|617315619|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
170810668|NCT02203032|617315620|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
170810669|NCT02203032|617315621|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
170810670|NCT02203032|617315618|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
170591997|NCT02323204|616509907|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
170591998|NCT02323204|616509908|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
170591999|NCT03576755|616509909|FG000|Overall Study|Withdrawal by Subject|1|||
170592000|NCT03576755|616509910|FG001|Overall Study|Withdrawal by Subject|0|||
170592001|NCT03576755|616509911|FG002|Overall Study|Withdrawal by Subject|0|||
170592002|NCT03576755|616509912|FG003|Overall Study|Withdrawal by Subject|0|||
170592003|NCT01598753|616509913|FG000|Overall Study|Adverse Event|1|||
170592004|NCT01598753|616509914|FG001|Overall Study|Adverse Event|9|||
170592005|NCT01598753|616509915|FG002|Overall Study|Adverse Event|1|||
170592006|NCT01598753|616509916|FG003|Overall Study|Adverse Event|7|||
170592007|NCT01598753|616509913|FG000|Overall Study|Lost to Follow-up|4|||
170592008|NCT01598753|616509914|FG001|Overall Study|Lost to Follow-up|3|||
170592009|NCT01598753|616509915|FG002|Overall Study|Lost to Follow-up|7|||
170592010|NCT01598753|616509916|FG003|Overall Study|Lost to Follow-up|5|||
170592011|NCT01598753|616509913|FG000|Overall Study|Physician Decision|0|||
170592012|NCT01598753|616509914|FG001|Overall Study|Physician Decision|1|||
170592013|NCT01598753|616509915|FG002|Overall Study|Physician Decision|0|||
170592014|NCT01598753|616509916|FG003|Overall Study|Physician Decision|2|||
170810671|NCT02203032|617315619|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
170810672|NCT02203032|617315620|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
170911745|NCT00586690|617681015|FG001|Overall Study|Disease Progression|0|||
170911746|NCT00586690|617681014|FG000|Overall Study|Adverse Event|1|||
170592015|NCT01598753|616509913|FG000|Overall Study|Withdrawal by Subject|7|||
170592016|NCT01598753|616509914|FG001|Overall Study|Withdrawal by Subject|2|||
170592017|NCT01598753|616509915|FG002|Overall Study|Withdrawal by Subject|0|||
170592018|NCT01598753|616509916|FG003|Overall Study|Withdrawal by Subject|1|||
170592019|NCT01095653|616509919|FG000|Overall Study|Lack of Efficacy|3|||
170592020|NCT01095653|616509920|FG001|Overall Study|Lack of Efficacy|0|||
170592021|NCT01095653|616509921|FG002|Overall Study|Lack of Efficacy|0|||
170592022|NCT01095653|616509919|FG000|Overall Study|Adverse Event|1|||
170592023|NCT01095653|616509920|FG001|Overall Study|Adverse Event|4|||
170592024|NCT01095653|616509921|FG002|Overall Study|Adverse Event|4|||
170592025|NCT01095653|616509919|FG000|Overall Study|Lost to Follow-up|1|||
170592026|NCT01095653|616509920|FG001|Overall Study|Lost to Follow-up|0|||
170592027|NCT01095653|616509921|FG002|Overall Study|Lost to Follow-up|4|||
170592028|NCT01095653|616509919|FG000|Overall Study|Withdrawal by Subject|4|||
170592029|NCT01095653|616509920|FG001|Overall Study|Withdrawal by Subject|5|||
170592030|NCT01095653|616509921|FG002|Overall Study|Withdrawal by Subject|3|||
170592031|NCT01095653|616509919|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
170592032|NCT01095653|616509920|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
170592033|NCT01095653|616509921|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
170592034|NCT02752958|616509923|FG000|Overall Study|Adverse Event|3|||
170592035|NCT02752958|616509923|FG000|Overall Study|Lost to Follow-up|1|||
170592036|NCT02752958|616509923|FG000|Overall Study|Protocol Violation|1|||
170592037|NCT02752958|616509923|FG000|Overall Study|Withdrawal by Subject|2|||
170592038|NCT02752958|616509923|FG000|Overall Study|Other (Reason not specified)|2|||
170592039|NCT02836873|616509924|FG000|Overall Study|Protocol Violation|0|||
170592040|NCT02836873|616509925|FG001|Overall Study|Protocol Violation|1|||
170592041|NCT02836873|616509924|FG000|Overall Study|Adverse Event|1|||
170592042|NCT02836873|616509925|FG001|Overall Study|Adverse Event|4|||
170592043|NCT02836873|616509924|FG000|Overall Study|Withdrawal by Subject|2|||
170592044|NCT02836873|616509925|FG001|Overall Study|Withdrawal by Subject|2|||
170592045|NCT02836873|616509924|FG000|Overall Study|Lost to Follow-up|1|||
170592046|NCT02836873|616509925|FG001|Overall Study|Lost to Follow-up|3|||
170592047|NCT02836873|616509924|FG000|Overall Study|Physician Decision|0|||
170592048|NCT02836873|616509925|FG001|Overall Study|Physician Decision|1|||
170592049|NCT02836873|616509924|FG000|Overall Study|Other|1|||
170592050|NCT02836873|616509925|FG001|Overall Study|Other|0|||
170592051|NCT00853125|616509926|FG000|Overall Study|Study participant's donor was CMV +|1|||
170592052|NCT02914548|616509927|FG000|Overall Study|Adverse Event|15|||
170592053|NCT02914548|616509928|FG001|Overall Study|Adverse Event|7|||
170592054|NCT02914548|616509929|FG002|Overall Study|Adverse Event|15|||
170592055|NCT02914548|616509927|FG000|Overall Study|Physician Decision|2|||
170592056|NCT02914548|616509928|FG001|Overall Study|Physician Decision|2|||
170592057|NCT02914548|616509929|FG002|Overall Study|Physician Decision|0|||
170592058|NCT02914548|616509927|FG000|Overall Study|Protocol Violation|1|||
170592059|NCT02914548|616509928|FG001|Overall Study|Protocol Violation|0|||
170592060|NCT02914548|616509929|FG002|Overall Study|Protocol Violation|0|||
170592061|NCT02914548|616509927|FG000|Overall Study|Withdrawal by Subject|3|||
170592062|NCT02914548|616509928|FG001|Overall Study|Withdrawal by Subject|4|||
170592063|NCT02914548|616509929|FG002|Overall Study|Withdrawal by Subject|4|||
170592064|NCT02914548|616509927|FG000|Overall Study|>40% of body surface area|0|||
170592065|NCT02914548|616509928|FG001|Overall Study|>40% of body surface area|1|||
170592066|NCT02914548|616509929|FG002|Overall Study|>40% of body surface area|1|||
170592067|NCT03746600|616509930|FG000|Overall Study|Withdrawal by Subject|3|||
170650657|NCT03836001|616734418|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
170650658|NCT03836001|616734419|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
170592068|NCT03746600|616509931|FG001|Overall Study|Withdrawal by Subject|3|||
170592069|NCT03746600|616509930|FG000|Overall Study|dismissed from study|1|||
170592070|NCT03746600|616509931|FG001|Overall Study|dismissed from study|0|||
170592071|NCT03746600|616509930|FG000|Overall Study|Lost to Follow-up|1|||
170592072|NCT03746600|616509931|FG001|Overall Study|Lost to Follow-up|0|||
170592073|NCT02142283|616509933|FG000|Overall Study|Death|20|||
170650659|NCT03836001|616734420|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
170810673|NCT02203032|617315621|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
170592074|NCT02142283|616509934|FG001|Overall Study|Death|18|||
170592075|NCT02142283|616509933|FG000|Overall Study|Withdrawal by Subject|1|||
170592076|NCT02142283|616509934|FG001|Overall Study|Withdrawal by Subject|3|||
170592077|NCT02460783|616509935|FG000|Overall Study|Withdrawal by Subject|1|||
170592078|NCT02460783|616509936|FG001|Overall Study|Withdrawal by Subject|3|||
170592079|NCT02460783|616509935|FG000|Overall Study|Lost to Follow-up|1|||
170592080|NCT02460783|616509936|FG001|Overall Study|Lost to Follow-up|1|||
170810674|NCT02203032|617315618|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
170810675|NCT02203032|617315619|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
170810676|NCT02203032|617315620|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
170810677|NCT02203032|617315621|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
170810678|NCT02203032|617315618|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
170810679|NCT02203032|617315619|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
170592081|NCT01484834|616509937|FG000|Overall Study|Lost to Follow-up|5|||
170592082|NCT01484834|616509938|FG001|Overall Study|Lost to Follow-up|8|||
170592083|NCT01484834|616509939|FG002|Overall Study|Lost to Follow-up|1|||
170592084|NCT01484834|616509940|FG003|Overall Study|Lost to Follow-up|4|||
170592085|NCT01371643|616509941|FG000|Overall Study|Withdrawal by Subject|3|||
170592086|NCT01371643|616509942|FG001|Overall Study|Withdrawal by Subject|0|||
170592087|NCT03754582|616509943|FG000|Treatment Phase|Adverse Event|0|||
170592088|NCT03754582|616509944|FG001|Treatment Phase|Adverse Event|1|||
170592089|NCT03754582|616509945|FG002|Treatment Phase|Adverse Event|0|||
170592090|NCT03754582|616509943|FG000|Follow-up Phase|Other|0|||
170592091|NCT03754582|616509944|FG001|Follow-up Phase|Other|0|||
170592092|NCT03754582|616509945|FG002|Follow-up Phase|Other|1|||
170592093|NCT01253265|616509949|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
170592094|NCT01253265|616509950|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
170592095|NCT01253265|616509951|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
170592096|NCT01253265|616509952|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
170592097|NCT01253265|616509953|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
170592098|NCT01253265|616509949|FG000|Overall Study|Withdrawal by Subject|0|||
170592099|NCT01253265|616509950|FG001|Overall Study|Withdrawal by Subject|0|||
170592100|NCT01253265|616509951|FG002|Overall Study|Withdrawal by Subject|0|||
170592101|NCT01253265|616509952|FG003|Overall Study|Withdrawal by Subject|0|||
170592102|NCT01253265|616509953|FG004|Overall Study|Withdrawal by Subject|1|||
170592103|NCT00343915|616509954|FG000|Primary Study|Withdrawal by Subject|1|||
170592104|NCT00343915|616509955|FG001|Primary Study|Withdrawal by Subject|0|||
170592105|NCT00343915|616509954|FG000|Primary Study|Lost to Follow-up|2|||
170592106|NCT00343915|616509955|FG001|Primary Study|Lost to Follow-up|3|||
170592107|NCT00343915|616509954|FG000|Primary Study|Other|1|||
170592108|NCT00343915|616509955|FG001|Primary Study|Other|0|||
170592109|NCT01719003|616509958|FG000|Overall Study|Non compliant with protocol|1|||
170592110|NCT01719003|616509959|FG001|Overall Study|Non compliant with protocol|1|||
170592111|NCT01719003|616509960|FG002|Overall Study|Non compliant with protocol|0|||
170592112|NCT01719003|616509961|FG003|Overall Study|Non compliant with protocol|1|||
170592113|NCT01719003|616509962|FG004|Overall Study|Non compliant with protocol|2|||
170592114|NCT01719003|616509963|FG005|Overall Study|Non compliant with protocol|1|||
170592115|NCT01719003|616509964|FG006|Overall Study|Non compliant with protocol|2|||
170592116|NCT01719003|616509965|FG007|Overall Study|Non compliant with protocol|3|||
170592117|NCT01719003|616509966|FG008|Overall Study|Non compliant with protocol|0|||
170592118|NCT01719003|616509958|FG000|Overall Study|Adverse Event|6|||
170592119|NCT01719003|616509959|FG001|Overall Study|Adverse Event|5|||
170592120|NCT01719003|616509960|FG002|Overall Study|Adverse Event|4|||
170592121|NCT01719003|616509961|FG003|Overall Study|Adverse Event|3|||
170592122|NCT01719003|616509962|FG004|Overall Study|Adverse Event|4|||
170592123|NCT01719003|616509963|FG005|Overall Study|Adverse Event|3|||
170592124|NCT01719003|616509964|FG006|Overall Study|Adverse Event|6|||
170592125|NCT01719003|616509965|FG007|Overall Study|Adverse Event|5|||
170592126|NCT01719003|616509966|FG008|Overall Study|Adverse Event|0|||
170592127|NCT01719003|616509958|FG000|Overall Study|Lost to Follow-up|0|||
170592128|NCT01719003|616509959|FG001|Overall Study|Lost to Follow-up|6|||
170592129|NCT01719003|616509960|FG002|Overall Study|Lost to Follow-up|7|||
170592130|NCT01719003|616509961|FG003|Overall Study|Lost to Follow-up|2|||
170592131|NCT01719003|616509962|FG004|Overall Study|Lost to Follow-up|3|||
170592132|NCT01719003|616509963|FG005|Overall Study|Lost to Follow-up|4|||
170592133|NCT01719003|616509964|FG006|Overall Study|Lost to Follow-up|3|||
170592134|NCT01719003|616509965|FG007|Overall Study|Lost to Follow-up|2|||
170592135|NCT01719003|616509966|FG008|Overall Study|Lost to Follow-up|2|||
170592136|NCT01719003|616509958|FG000|Overall Study|Refusal to continue, not due to AE|2|||
170592137|NCT01719003|616509959|FG001|Overall Study|Refusal to continue, not due to AE|5|||
170592138|NCT01719003|616509960|FG002|Overall Study|Refusal to continue, not due to AE|4|||
170592139|NCT01719003|616509961|FG003|Overall Study|Refusal to continue, not due to AE|4|||
170592140|NCT01719003|616509962|FG004|Overall Study|Refusal to continue, not due to AE|4|||
170592141|NCT01719003|616509963|FG005|Overall Study|Refusal to continue, not due to AE|3|||
170592142|NCT01719003|616509964|FG006|Overall Study|Refusal to continue, not due to AE|8|||
170592143|NCT01719003|616509965|FG007|Overall Study|Refusal to continue, not due to AE|7|||
170810680|NCT02203032|617315620|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
170810681|NCT02203032|617315621|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
170592144|NCT01719003|616509966|FG008|Overall Study|Refusal to continue, not due to AE|1|||
170592145|NCT01719003|616509958|FG000|Overall Study|Reason other than those specified|0|||
170592146|NCT01719003|616509959|FG001|Overall Study|Reason other than those specified|0|||
170810682|NCT02203032|617315618|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
170810683|NCT02203032|617315619|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
170592147|NCT01719003|616509960|FG002|Overall Study|Reason other than those specified|2|||
170592148|NCT01719003|616509961|FG003|Overall Study|Reason other than those specified|3|||
170592149|NCT01719003|616509962|FG004|Overall Study|Reason other than those specified|4|||
170592150|NCT01719003|616509963|FG005|Overall Study|Reason other than those specified|1|||
170592151|NCT01719003|616509964|FG006|Overall Study|Reason other than those specified|0|||
170592152|NCT01719003|616509965|FG007|Overall Study|Reason other than those specified|3|||
170592153|NCT01719003|616509966|FG008|Overall Study|Reason other than those specified|1|||
170592154|NCT01719003|616509958|FG000|Overall Study|Lack of Efficacy|0|||
170592155|NCT01719003|616509959|FG001|Overall Study|Lack of Efficacy|0|||
170592156|NCT01719003|616509960|FG002|Overall Study|Lack of Efficacy|0|||
170592157|NCT01719003|616509961|FG003|Overall Study|Lack of Efficacy|0|||
170592158|NCT01719003|616509962|FG004|Overall Study|Lack of Efficacy|0|||
170592159|NCT01719003|616509963|FG005|Overall Study|Lack of Efficacy|0|||
170592160|NCT01719003|616509964|FG006|Overall Study|Lack of Efficacy|1|||
170592161|NCT01719003|616509965|FG007|Overall Study|Lack of Efficacy|0|||
170592162|NCT01719003|616509966|FG008|Overall Study|Lack of Efficacy|0|||
170592163|NCT01667562|616509967|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
170592164|NCT01667562|616509968|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
170592165|NCT01667562|616509967|FG000|Erlotinib Phase|Lost to Follow-up|0|||
170592166|NCT01667562|616509968|FG001|Erlotinib Phase|Lost to Follow-up|1|||
170592167|NCT01667562|616509967|FG000|Erlotinib Phase|Adverse Event|0|||
170592168|NCT01667562|616509968|FG001|Erlotinib Phase|Adverse Event|1|||
170592169|NCT01667562|616509967|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
170592170|NCT01667562|616509968|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
170592171|NCT02130986|616509969|FG000|Overall Study|Withdrawal by Subject|4|||
170592172|NCT02130986|616509970|FG001|Overall Study|Withdrawal by Subject|4|||
170592173|NCT02130986|616509969|FG000|Overall Study|Lost to Follow-up|151|||
170592174|NCT02130986|616509970|FG001|Overall Study|Lost to Follow-up|160|||
170592175|NCT01028716|616509971|FG000|Overall Study|Physician Decision|1|||
170592176|NCT01129882|616509972|FG000|Overall Study|Adverse Event|39|||
170592177|NCT01129882|616509972|FG000|Overall Study|Death|6|||
170592178|NCT01129882|616509972|FG000|Overall Study|Lack of Efficacy|5|||
170592179|NCT01129882|616509972|FG000|Overall Study|Lost to Follow-up|13|||
170592180|NCT01129882|616509972|FG000|Overall Study|Physician Decision|27|||
170592181|NCT01129882|616509972|FG000|Overall Study|Protocol Deviation|3|||
170592182|NCT01129882|616509972|FG000|Overall Study|Withdrawal Criteria Met|19|||
170592183|NCT01129882|616509972|FG000|Overall Study|Trial Termination by Sponsor|6|||
170592184|NCT01129882|616509972|FG000|Overall Study|Withdrawal by Subject|160|||
170592185|NCT00536874|616509973|FG000|Overall Study|Adverse Event|1|||
170592186|NCT00536874|616509973|FG000|Overall Study|Death|2|||
170592187|NCT00536874|616509973|FG000|Overall Study|Withdrawal by Subject|1|||
170592188|NCT02084238|616509974|FG000|Overall Study|Lost to Follow-up|2|||
170592189|NCT00391391|616509975|FG000|Overall Study|Adverse Event|0|||
170592190|NCT00391391|616509976|FG001|Overall Study|Adverse Event|0|||
170592191|NCT00391391|616509977|FG002|Overall Study|Adverse Event|0|||
170592192|NCT00391391|616509978|FG003|Overall Study|Adverse Event|1|||
170592193|NCT00391391|616509975|FG000|Overall Study|Lost to Follow-up|1|||
170592194|NCT00391391|616509976|FG001|Overall Study|Lost to Follow-up|3|||
170592195|NCT00391391|616509977|FG002|Overall Study|Lost to Follow-up|7|||
170592196|NCT00391391|616509978|FG003|Overall Study|Lost to Follow-up|4|||
170592197|NCT00391391|616509975|FG000|Overall Study|Protocol Violation|2|||
170592198|NCT00391391|616509976|FG001|Overall Study|Protocol Violation|3|||
170592199|NCT00391391|616509977|FG002|Overall Study|Protocol Violation|6|||
170592200|NCT00391391|616509978|FG003|Overall Study|Protocol Violation|7|||
170592201|NCT00391391|616509975|FG000|Overall Study|Withdrawal by Subject|6|||
170592202|NCT00391391|616509976|FG001|Overall Study|Withdrawal by Subject|4|||
170592203|NCT00391391|616509977|FG002|Overall Study|Withdrawal by Subject|10|||
170592204|NCT00391391|616509978|FG003|Overall Study|Withdrawal by Subject|7|||
170592205|NCT02649855|616509979|FG000|Overall Study|Refused further treatment|2|||
170592206|NCT02649855|616509980|FG001|Overall Study|Refused further treatment|1|||
170592207|NCT02649855|616509981|FG002|Overall Study|Refused further treatment|1|||
170592208|NCT02649855|616509979|FG000|Overall Study|Withdrew consent|0|||
170592209|NCT02649855|616509980|FG001|Overall Study|Withdrew consent|1|||
170592210|NCT02649855|616509981|FG002|Overall Study|Withdrew consent|0|||
170592211|NCT02649855|616509979|FG000|Overall Study|Switched to alternative treatment|0|||
170911747|NCT00586690|617681015|FG001|Overall Study|Adverse Event|0|||
170592212|NCT02649855|616509980|FG001|Overall Study|Switched to alternative treatment|1|||
170592213|NCT02649855|616509981|FG002|Overall Study|Switched to alternative treatment|1|||
170592214|NCT02649855|616509979|FG000|Overall Study|Principal investigator discretion|0|||
170592215|NCT02649855|616509980|FG001|Overall Study|Principal investigator discretion|1|||
170911748|NCT00586690|617681014|FG000|Overall Study|Lack of Efficacy|2|||
170592216|NCT02649855|616509981|FG002|Overall Study|Principal investigator discretion|1|||
170592217|NCT02649855|616509979|FG000|Overall Study|No treatment, per protocol|1|||
170592218|NCT02649855|616509980|FG001|Overall Study|No treatment, per protocol|0|||
170592219|NCT02649855|616509981|FG002|Overall Study|No treatment, per protocol|0|||
170592220|NCT02649855|616509979|FG000|Overall Study|Initiate new treatment|1|||
170592221|NCT02649855|616509980|FG001|Overall Study|Initiate new treatment|0|||
170592222|NCT02649855|616509981|FG002|Overall Study|Initiate new treatment|0|||
170592223|NCT04411420|616511929|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
170592224|NCT04411420|616511930|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
170592225|NCT04411420|616511929|FG000|Survey Subset|Lost to Follow-up|134|||
170592226|NCT04411420|616511930|FG001|Survey Subset|Lost to Follow-up|120|||
170592227|NCT03187834|616511931|FG000|Overall Study|Lost to Follow-up|0|||
170592228|NCT03187834|616511932|FG001|Overall Study|Lost to Follow-up|1|||
170592229|NCT03187834|616511933|FG002|Overall Study|Lost to Follow-up|2|||
170592230|NCT03187834|616511934|FG003|Overall Study|Lost to Follow-up|2|||
170592231|NCT03187834|616511931|FG000|Overall Study|Had invalid anthropometric measurements|5|||
170592232|NCT03187834|616511932|FG001|Overall Study|Had invalid anthropometric measurements|3|||
170592233|NCT03187834|616511933|FG002|Overall Study|Had invalid anthropometric measurements|4|||
170592234|NCT03187834|616511934|FG003|Overall Study|Had invalid anthropometric measurements|2|||
170592235|NCT00583791|616511935|FG000|Overall Study|Other|67|||
170592236|NCT00583791|616511935|FG000|Overall Study|Death|6|||
170592237|NCT00203021|616511936|FG000|Overall Study|Death|4|||
170592238|NCT00203021|616511937|FG001|Overall Study|Death|1|||
170592239|NCT00203021|616511936|FG000|Overall Study|Adverse Event|10|||
170592240|NCT00203021|616511937|FG001|Overall Study|Adverse Event|5|||
170592241|NCT00203021|616511936|FG000|Overall Study|Withdrawal by Subject|45|||
170592242|NCT00203021|616511937|FG001|Overall Study|Withdrawal by Subject|48|||
170592243|NCT00203021|616511936|FG000|Overall Study|Lost to Follow-up|9|||
170592244|NCT00203021|616511937|FG001|Overall Study|Lost to Follow-up|7|||
170592245|NCT00203021|616511936|FG000|Overall Study|Other than specified|11|||
170592246|NCT00203021|616511937|FG001|Overall Study|Other than specified|16|||
170592247|NCT03941964|616511947|FG000|Overall Study|Adverse Event|1|||
170592248|NCT03941964|616511948|FG001|Overall Study|Adverse Event|8|||
170592249|NCT03941964|616511947|FG000|Overall Study|Progressive disease|7|||
170592250|NCT03941964|616511948|FG001|Overall Study|Progressive disease|3|||
170592251|NCT03941964|616511947|FG000|Overall Study|Lack of Efficacy|0|||
170592252|NCT03941964|616511948|FG001|Overall Study|Lack of Efficacy|1|||
170592253|NCT03941964|616511947|FG000|Overall Study|Death|3|||
170592254|NCT03941964|616511948|FG001|Overall Study|Death|1|||
170911749|NCT00586690|617681015|FG001|Overall Study|Lack of Efficacy|0|||
170911750|NCT00586690|617681014|FG000|Overall Study|Lab can't accommodate|1|||
170911751|NCT00586690|617681015|FG001|Overall Study|Lab can't accommodate|0|||
170911752|NCT02453841|617681016|FG000|Overall Study|Protocol Violation|1|||
170592255|NCT03941964|616511947|FG000|Overall Study|Withdrew consent|1|||
170592256|NCT03941964|616511948|FG001|Overall Study|Withdrew consent|3|||
170592257|NCT03941964|616511947|FG000|Overall Study|Physician Decision|9|||
170592258|NCT03941964|616511948|FG001|Overall Study|Physician Decision|2|||
170592259|NCT03941964|616511947|FG000|Overall Study|Other, not specified|2|||
170592260|NCT03941964|616511948|FG001|Overall Study|Other, not specified|1|||
170592261|NCT02279719|616511952|FG000|Overall Study|Patients randomized but never treated|0|||
170592262|NCT02279719|616511953|FG001|Overall Study|Patients randomized but never treated|0|||
170592263|NCT02279719|616511954|FG002|Overall Study|Patients randomized but never treated|0|||
170592264|NCT02279719|616511955|FG003|Overall Study|Patients randomized but never treated|0|||
170592265|NCT02279719|616511956|FG004|Overall Study|Patients randomized but never treated|3|||
170592266|NCT02279719|616511957|FG005|Overall Study|Patients randomized but never treated|0|||
170592267|NCT02279719|616511958|FG006|Overall Study|Patients randomized but never treated|3|||
170592268|NCT03883113|616511969|FG000|Overall Study|Physician Decision|4|||
170592269|NCT03883113|616511970|FG001|Overall Study|Physician Decision|2|||
170592270|NCT03883113|616511969|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
170592271|NCT03883113|616511970|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
170592272|NCT03883113|616511969|FG000|Overall Study|Pregnancy|1|||
170592273|NCT03883113|616511970|FG001|Overall Study|Pregnancy|0|||
170592274|NCT03883113|616511969|FG000|Overall Study|Adverse Event|0|||
170592275|NCT03883113|616511970|FG001|Overall Study|Adverse Event|1|||
170592276|NCT03883113|616511969|FG000|Overall Study|Withdrawal by Subject|1|||
170592277|NCT03883113|616511970|FG001|Overall Study|Withdrawal by Subject|2|||
170592278|NCT03883113|616511969|FG000|Overall Study|Lost to Follow-up|1|||
170592279|NCT03883113|616511970|FG001|Overall Study|Lost to Follow-up|0|||
170911753|NCT02453841|617681016|FG000|Overall Study|Unable to obtain blood samples|2|||
170911754|NCT01751646|617681017|FG000|Overall Study|Lost to Follow-up|5|||
170911755|NCT01751646|617681018|FG001|Overall Study|Lost to Follow-up|1|||
170911756|NCT01751646|617681017|FG000|Overall Study|Withdrawal by Subject|0|||
170911757|NCT01751646|617681018|FG001|Overall Study|Withdrawal by Subject|4|||
170911758|NCT01751646|617681017|FG000|Overall Study|Starting hormone therapy|1|||
170911759|NCT01751646|617681018|FG001|Overall Study|Starting hormone therapy|0|||
170911760|NCT01751646|617681017|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
170592280|NCT04465877|616511971|FG000|Overall Study|Noncompliant with study requirements|0|||
170592281|NCT04465877|616511972|FG001|Overall Study|Noncompliant with study requirements|0|||
170592282|NCT04465877|616511973|FG002|Overall Study|Noncompliant with study requirements|1|||
170592283|NCT04465877|616511974|FG003|Overall Study|Noncompliant with study requirements|0|||
170592284|NCT01396265|616511975|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
170592285|NCT02446418|616511976|FG000|Overall Study|Adverse Event|4|||
170592286|NCT02446418|616511977|FG001|Overall Study|Adverse Event|8|||
170592287|NCT02446418|616511976|FG000|Overall Study|Physician Decision|5|||
170592288|NCT02446418|616511977|FG001|Overall Study|Physician Decision|1|||
170592289|NCT02446418|616511976|FG000|Overall Study|Withdrawal by Subject|3|||
170592290|NCT02446418|616511977|FG001|Overall Study|Withdrawal by Subject|3|||
170592291|NCT02446418|616511976|FG000|Overall Study|Lost to Follow-up|2|||
170592292|NCT02446418|616511977|FG001|Overall Study|Lost to Follow-up|2|||
170592293|NCT02446418|616511976|FG000|Overall Study|Protocol Violation|1|||
170592294|NCT02446418|616511977|FG001|Overall Study|Protocol Violation|2|||
170592295|NCT02446418|616511976|FG000|Overall Study|Lack of Efficacy|2|||
170592296|NCT02446418|616511977|FG001|Overall Study|Lack of Efficacy|0|||
170592297|NCT02446418|616511976|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
170592298|NCT02446418|616511977|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
170592299|NCT03421743|616511980|FG000|Overall Study|Lack of Efficacy|1|||
170592300|NCT03421743|616511981|FG001|Overall Study|Lack of Efficacy|0|||
170592301|NCT03421743|616511980|FG000|Overall Study|Adverse Event|2|||
170592302|NCT03421743|616511981|FG001|Overall Study|Adverse Event|1|||
170592303|NCT03421743|616511980|FG000|Overall Study|Withdrawal by Subject|0|||
170592304|NCT03421743|616511981|FG001|Overall Study|Withdrawal by Subject|1|||
170592305|NCT00435162|616511982|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
170592306|NCT00435162|616511983|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
170592307|NCT00435162|616511984|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
170592308|NCT00435162|616511985|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
170592309|NCT00435162|616511986|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
170592310|NCT00435162|616511987|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
170592311|NCT03023826|616511997|FG000|Period 1|Withdrawal by Subject|0|||
170592312|NCT03023826|616511998|FG001|Period 1|Withdrawal by Subject|0|||
170592313|NCT03023826|616511999|FG002|Period 1|Withdrawal by Subject|0|||
170592314|NCT03023826|616512000|FG003|Period 1|Withdrawal by Subject|0|||
170592315|NCT03023826|616512001|FG004|Period 1|Withdrawal by Subject|1|||
170592316|NCT03023826|616512002|FG005|Period 1|Withdrawal by Subject|0|||
170592317|NCT00977938|616512008|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
170592318|NCT00977938|616512009|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
170592319|NCT00977938|616512010|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
170592320|NCT00977938|616512011|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
170592321|NCT00977938|616512008|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
170592322|NCT00977938|616512009|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
170592323|NCT00977938|616512010|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
170592324|NCT00977938|616512011|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
170592325|NCT00977938|616512008|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
170592326|NCT00977938|616512009|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
170592327|NCT00977938|616512010|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
170592328|NCT00977938|616512011|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
170592329|NCT00977938|616512008|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
170592330|NCT00977938|616512009|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
170592331|NCT00977938|616512010|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
170592332|NCT00977938|616512011|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
170592333|NCT00977938|616512008|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
170592334|NCT00977938|616512009|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
170592335|NCT00977938|616512010|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
170592336|NCT00977938|616512011|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
170592337|NCT00977938|616512008|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
170592338|NCT00977938|616512009|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
170592339|NCT00977938|616512010|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
170592340|NCT00977938|616512011|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
170592341|NCT00747344|616512014|FG000|Controlled Period|Adverse Event|3|||
170592342|NCT00747344|616512015|FG001|Controlled Period|Adverse Event|0|||
170592343|NCT00747344|616512016|FG002|Controlled Period|Adverse Event|0|||
170592344|NCT00747344|616512017|FG003|Controlled Period|Adverse Event|0|||
170592345|NCT00747344|616512014|FG000|Controlled Period|Lack of Efficacy|2|||
170592346|NCT00747344|616512015|FG001|Controlled Period|Lack of Efficacy|1|||
170592347|NCT00747344|616512016|FG002|Controlled Period|Lack of Efficacy|0|||
170592348|NCT00747344|616512017|FG003|Controlled Period|Lack of Efficacy|0|||
170592349|NCT00747344|616512014|FG000|Controlled Period|Other|0|||
170592350|NCT00747344|616512015|FG001|Controlled Period|Other|3|||
170810684|NCT02203032|617315620|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
170810685|NCT02203032|617315621|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
170810686|NCT02203032|617315618|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
170810687|NCT02203032|617315619|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
170810688|NCT02203032|617315620|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
170810689|NCT02203032|617315621|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
170810690|NCT02203032|617315618|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
170810691|NCT02203032|617315619|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
170810692|NCT02203032|617315620|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
170810693|NCT02203032|617315621|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
170911761|NCT01751646|617681018|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
170911762|NCT01751646|617681017|FG000|Overall Study|Inadvertent enrollment|1|||
170911763|NCT01751646|617681018|FG001|Overall Study|Inadvertent enrollment|1|||
170911764|NCT01751646|617681017|FG000|Overall Study|Moved out of the area|1|||
170911765|NCT01751646|617681018|FG001|Overall Study|Moved out of the area|5|||
170911766|NCT01751646|617681017|FG000|Overall Study|Inability to attend required visits|0|||
170911767|NCT01751646|617681018|FG001|Overall Study|Inability to attend required visits|1|||
170911768|NCT01751646|617681017|FG000|Overall Study|Off study due to multiple obligations|0|||
170911769|NCT01751646|617681018|FG001|Overall Study|Off study due to multiple obligations|1|||
170911770|NCT01751646|617681017|FG000|Overall Study|Fails to comply with study requirements|0|||
170911771|NCT01751646|617681018|FG001|Overall Study|Fails to comply with study requirements|1|||
170911772|NCT01751646|617681017|FG000|Overall Study|Childcare issues|1|||
170911773|NCT01751646|617681018|FG001|Overall Study|Childcare issues|1|||
170911774|NCT02190591|617681019|FG000|Overall Study|Withdrawal by Subject|1|||
170911775|NCT02190591|617681020|FG001|Overall Study|Withdrawal by Subject|8|||
170911776|NCT02190591|617681019|FG000|Overall Study|Protocol Violation|1|||
170911777|NCT02190591|617681020|FG001|Overall Study|Protocol Violation|0|||
170911778|NCT02190591|617681019|FG000|Overall Study|did not use peanut ball as instructed|0|||
170911779|NCT02190591|617681020|FG001|Overall Study|did not use peanut ball as instructed|2|||
170911780|NCT02190591|617681019|FG000|Overall Study|face presentation so she was ineligible|0|||
170911781|NCT02190591|617681020|FG001|Overall Study|face presentation so she was ineligible|1|||
170911782|NCT03851510|617681021|FG000|Overall Study|Screen Fail|1|||
170911783|NCT03851510|617681021|FG000|Overall Study|Adverse Event|1|||
170911784|NCT03851510|617681021|FG000|Overall Study|Withdrawal by Subject|1|||
170911785|NCT02426086|617681026|FG000|Overall Study|Death|33|||
170911786|NCT02426086|617681027|FG001|Overall Study|Death|36|||
170911787|NCT02426086|617681026|FG000|Overall Study|Lost to Follow-up|2|||
170911788|NCT02426086|617681027|FG001|Overall Study|Lost to Follow-up|0|||
170911789|NCT02426086|617681026|FG000|Overall Study|Study Terminated by Sponsor|5|||
170911790|NCT02426086|617681027|FG001|Overall Study|Study Terminated by Sponsor|14|||
170911791|NCT02426086|617681026|FG000|Overall Study|Withdrawal by Subject|8|||
170911792|NCT02426086|617681027|FG001|Overall Study|Withdrawal by Subject|9|||
170911793|NCT04542291|617681028|FG000|Overall Study|Adverse Event|1|||
170911794|NCT04542291|617681028|FG000|Overall Study|Physician Decision|2|||
170911795|NCT03478683|617681029|FG000|Overall Study|Adverse Event|5|||
170911796|NCT03478683|617681030|FG001|Overall Study|Adverse Event|3|||
170911797|NCT03478683|617681029|FG000|Overall Study|Lost to Follow-up|0|||
170911798|NCT03478683|617681030|FG001|Overall Study|Lost to Follow-up|5|||
170911799|NCT03478683|617681029|FG000|Overall Study|Physician Decision|1|||
170911800|NCT03478683|617681030|FG001|Overall Study|Physician Decision|3|||
170911801|NCT03478683|617681029|FG000|Overall Study|Withdrawal by Subject|7|||
170911802|NCT03478683|617681030|FG001|Overall Study|Withdrawal by Subject|7|||
170911803|NCT05866185|617681037|FG000|Overall Study|Lost to Follow-up|2|||
170911804|NCT05866185|617681038|FG001|Overall Study|Lost to Follow-up|4|||
170911805|NCT05866185|617681039|FG002|Overall Study|Lost to Follow-up|4|||
170911806|NCT05866185|617681040|FG003|Overall Study|Lost to Follow-up|6|||
170911807|NCT00793585|617681041|FG000|Overall Study|Adverse Event|1|||
170911808|NCT00793585|617681042|FG001|Overall Study|Adverse Event|1|||
170911809|NCT00793585|617681041|FG000|Overall Study|Protocol Violation|1|||
170911810|NCT00793585|617681042|FG001|Overall Study|Protocol Violation|2|||
170911811|NCT00095121|617681049|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
170911812|NCT00095121|617681050|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
170911813|NCT00095121|617681049|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
170911814|NCT00095121|617681050|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
170911815|NCT05635838|617682030|FG000|16-Week DBVC Period|Adverse Event|2|||
170911816|NCT05635838|617682031|FG001|16-Week DBVC Period|Adverse Event|0|||
170911817|NCT05635838|617682032|FG002|16-Week DBVC Period|Adverse Event|0|||
170911818|NCT05635838|617682033|FG003|16-Week DBVC Period|Adverse Event|0|||
170911819|NCT05635838|617682030|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
170911820|NCT05635838|617682031|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
170911821|NCT05635838|617682032|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
170911822|NCT05635838|617682033|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
170911823|NCT05635838|617682030|FG000|16-Week DBVC Period|Physician Decision|0|||
170911824|NCT05635838|617682031|FG001|16-Week DBVC Period|Physician Decision|1|||
170911825|NCT05635838|617682032|FG002|16-Week DBVC Period|Physician Decision|0|||
170911826|NCT05635838|617682033|FG003|16-Week DBVC Period|Physician Decision|0|||
170911827|NCT05635838|617682030|FG000|16-Week DBVC Period|Protocol Violation|1|||
170911828|NCT05635838|617682031|FG001|16-Week DBVC Period|Protocol Violation|0|||
170911829|NCT05635838|617682032|FG002|16-Week DBVC Period|Protocol Violation|0|||
170911830|NCT05635838|617682033|FG003|16-Week DBVC Period|Protocol Violation|0|||
170911831|NCT05635838|617682030|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
170911832|NCT05635838|617682031|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
170911833|NCT05635838|617682032|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
170911834|NCT05635838|617682033|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
170911835|NCT05635838|617682030|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
170810694|NCT02203032|617315618|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
170810695|NCT02203032|617315619|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
170810696|NCT02203032|617315620|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
170810697|NCT02203032|617315621|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
170810698|NCT02203032|617315618|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
170810699|NCT02203032|617315619|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
170810700|NCT02203032|617315620|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
170810701|NCT02203032|617315621|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
170810702|NCT02203032|617315618|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
170810703|NCT02203032|617315619|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
170810704|NCT02203032|617315620|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
170810705|NCT02203032|617315621|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
170810706|NCT04748341|617315622|FG000|Overall Study|Lost to Follow-up|1|||
170810707|NCT04748341|617315623|FG001|Overall Study|Lost to Follow-up|1|||
170810708|NCT05426109|617315624|FG000|Overall Study|Withdrawal by Subject|0|||
170810709|NCT05426109|617315625|FG001|Overall Study|Withdrawal by Subject|1|||
170810710|NCT03905642|617315628|FG000|Overall Study|Withdrawal by Subject|3|||
170810711|NCT03905642|617315628|FG000|Overall Study|Pregnancy|1|||
170810712|NCT03905642|617315628|FG000|Overall Study|Adverse Event|1|||
170810713|NCT03905642|617315628|FG000|Overall Study|Lack of Efficacy|1|||
170810714|NCT03905642|617315628|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
170911836|NCT05635838|617682031|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
170911837|NCT05635838|617682032|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
170911838|NCT05635838|617682033|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
170592351|NCT00747344|616512016|FG002|Controlled Period|Other|0|||
170592352|NCT00747344|616512017|FG003|Controlled Period|Other|0|||
170592353|NCT00747344|616512014|FG000|After Controlled Period|Adverse Event|0|||
170592354|NCT00747344|616512015|FG001|After Controlled Period|Adverse Event|0|||
170592355|NCT00747344|616512016|FG002|After Controlled Period|Adverse Event|0|||
170592356|NCT00747344|616512017|FG003|After Controlled Period|Adverse Event|1|||
170592357|NCT01646645|616512018|FG000|Overall Study|No Treated|1|||
170592358|NCT01646645|616512018|FG000|Overall Study|Inevaluable Donor|29|||
170592359|NCT02374814|616512019|FG000|Overall Study|Lost to Follow-up|1|||
170592360|NCT02374814|616512020|FG001|Overall Study|Lost to Follow-up|1|||
170592361|NCT02374814|616512021|FG002|Overall Study|Lost to Follow-up|0|||
170592362|NCT02374814|616512022|FG003|Overall Study|Lost to Follow-up|1|||
170592363|NCT02374814|616512023|FG004|Overall Study|Lost to Follow-up|0|||
170592364|NCT02374814|616512024|FG005|Overall Study|Lost to Follow-up|0|||
170592365|NCT02374814|616512019|FG000|Overall Study|Withdrawal by Subject|0|||
170592366|NCT02374814|616512020|FG001|Overall Study|Withdrawal by Subject|0|||
170592367|NCT02374814|616512021|FG002|Overall Study|Withdrawal by Subject|1|||
170592368|NCT02374814|616512022|FG003|Overall Study|Withdrawal by Subject|1|||
170592369|NCT02374814|616512023|FG004|Overall Study|Withdrawal by Subject|0|||
170592370|NCT02374814|616512024|FG005|Overall Study|Withdrawal by Subject|0|||
170592371|NCT00884039|616512028|FG000|Overall Study|Withdrawal by Subject|0|||
170592372|NCT00884039|616512029|FG001|Overall Study|Withdrawal by Subject|1|||
170592373|NCT00884039|616512028|FG000|Overall Study|Lack of Efficacy|2|||
170592374|NCT00884039|616512029|FG001|Overall Study|Lack of Efficacy|0|||
170592375|NCT01286987|616512036|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
170592376|NCT01286987|616512037|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
170592377|NCT01286987|616512038|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
170592378|NCT01286987|616512039|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
170650660|NCT03836001|616734418|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
170650661|NCT03836001|616734419|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
170650662|NCT03836001|616734420|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
170650663|NCT03836001|616734418|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
170650664|NCT03836001|616734419|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
170650665|NCT03836001|616734420|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
170650666|NCT01755026|616734421|FG000|Overall Study|Adverse Event|1|||
170650667|NCT01755026|616734422|FG001|Overall Study|Adverse Event|0|||
170911839|NCT05635838|617682030|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
170911840|NCT05635838|617682031|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
170592379|NCT01286987|616512040|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
170592380|NCT01286987|616512041|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
170592381|NCT01286987|616512042|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
170592382|NCT01286987|616512043|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
170592383|NCT01286987|616512044|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
170592384|NCT01286987|616512045|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
170650668|NCT01755026|616734421|FG000|Overall Study|Withdrawal by Subject|1|||
170650669|NCT01755026|616734422|FG001|Overall Study|Withdrawal by Subject|1|||
170810715|NCT02159989|617315629|FG000|Overall Study|Adverse Event|1|||
170810716|NCT02159989|617315630|FG001|Overall Study|Adverse Event|0|||
170810717|NCT02159989|617315631|FG002|Overall Study|Adverse Event|0|||
170810718|NCT02159989|617315632|FG003|Overall Study|Adverse Event|0|||
170592385|NCT01286987|616512046|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
170592386|NCT01286987|616512047|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
170592387|NCT01286987|616512048|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
170592388|NCT01286987|616512049|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
170592389|NCT01286987|616512050|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
170592390|NCT01286987|616512036|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
170592391|NCT01286987|616512037|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
170650670|NCT00392379|616734423|FG000|Overall Study|Withdrawal by Subject|17|||
170650671|NCT00392379|616734424|FG001|Overall Study|Withdrawal by Subject|28|||
170650672|NCT00392379|616734423|FG000|Overall Study|Lost to Follow-up|4|||
170650673|NCT00392379|616734424|FG001|Overall Study|Lost to Follow-up|9|||
170650674|NCT00392379|616734423|FG000|Overall Study|Adverse Event|1|||
170650675|NCT00392379|616734424|FG001|Overall Study|Adverse Event|1|||
170650676|NCT00308581|616734425|FG000|Induction Phase|Adverse Event|0|||
170650677|NCT00308581|616734426|FG001|Induction Phase|Adverse Event|0|||
170650678|NCT00308581|616734427|FG002|Induction Phase|Adverse Event|37|||
170650679|NCT00308581|616734425|FG000|Induction Phase|Lack of Efficacy|0|||
170650680|NCT00308581|616734426|FG001|Induction Phase|Lack of Efficacy|0|||
170650681|NCT00308581|616734427|FG002|Induction Phase|Lack of Efficacy|121|||
170650682|NCT00308581|616734425|FG000|Induction Phase|Withdrawal by Subject|0|||
170650683|NCT00308581|616734426|FG001|Induction Phase|Withdrawal by Subject|0|||
170650684|NCT00308581|616734427|FG002|Induction Phase|Withdrawal by Subject|5|||
170650685|NCT00308581|616734425|FG000|Induction Phase|Unknown reason|0|||
170650686|NCT00308581|616734426|FG001|Induction Phase|Unknown reason|0|||
170650687|NCT00308581|616734427|FG002|Induction Phase|Unknown reason|3|||
170650688|NCT00308581|616734425|FG000|Randomized Maintenance Phase|Adverse Event|10|||
170650689|NCT00308581|616734426|FG001|Randomized Maintenance Phase|Adverse Event|17|||
170650690|NCT00308581|616734427|FG002|Randomized Maintenance Phase|Adverse Event|0|||
170650691|NCT00308581|616734425|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
170650692|NCT00308581|616734426|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
170650693|NCT00308581|616734427|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
170650694|NCT00308581|616734425|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
170650695|NCT00308581|616734426|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
170650696|NCT00308581|616734427|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
170650697|NCT00308581|616734425|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
170650698|NCT00308581|616734426|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
170592392|NCT01286987|616512038|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
170592393|NCT01286987|616512039|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
170650699|NCT00308581|616734427|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
170650700|NCT00308581|616734425|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
170650701|NCT00308581|616734426|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
170650702|NCT00308581|616734427|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
170650703|NCT00308581|616734425|FG000|Randomized Maintenance Phase|Unknown reason|3|||
170650704|NCT00308581|616734426|FG001|Randomized Maintenance Phase|Unknown reason|0|||
170650705|NCT00308581|616734427|FG002|Randomized Maintenance Phase|Unknown reason|0|||
170650706|NCT00899353|616734428|FG000|Overall Study|Adverse Event|2|||
170650707|NCT00899353|616734428|FG000|Overall Study|Lost to Follow-up|1|||
170650708|NCT00899353|616734428|FG000|Overall Study|Withdrawal by Subject|2|||
170650709|NCT02730793|616734434|FG000|Overall Study|Physician Decision|0|||
170650710|NCT02730793|616734435|FG001|Overall Study|Physician Decision|1|||
170650711|NCT02730793|616734434|FG000|Overall Study|Withdrawal by Subject|0|||
170650712|NCT02730793|616734435|FG001|Overall Study|Withdrawal by Subject|1|||
170650713|NCT01284491|616734436|FG000|Overall Study|Study termination|13|||
170650714|NCT02365233|616734437|FG000|Overall Study|IRB withheld the data|1|||
170650715|NCT02365233|616734438|FG001|Overall Study|IRB withheld the data|2|||
170650716|NCT02365233|616734439|FG002|Overall Study|IRB withheld the data|2|||
170650717|NCT01978938|616734440|FG000|Overall Study|Lost to Follow-up|12|||
170650718|NCT01978938|616734441|FG001|Overall Study|Lost to Follow-up|6|||
170650719|NCT01978938|616734440|FG000|Overall Study|Withdrawal by Subject|8|||
170650720|NCT01978938|616734441|FG001|Overall Study|Withdrawal by Subject|4|||
170650721|NCT01978938|616734440|FG000|Overall Study|Adverse Event, non-fatal|2|||
170650722|NCT01978938|616734441|FG001|Overall Study|Adverse Event, non-fatal|1|||
170650723|NCT01978938|616734440|FG000|Overall Study|Participant noncompliance|1|||
170650724|NCT01978938|616734441|FG001|Overall Study|Participant noncompliance|1|||
170650725|NCT01978938|616734440|FG000|Overall Study|Did not meet inclusion criteria|0|||
170650726|NCT01978938|616734441|FG001|Overall Study|Did not meet inclusion criteria|1|||
170650727|NCT01978938|616734440|FG000|Overall Study|Previously scheduled procedure|0|||
170650728|NCT01978938|616734441|FG001|Overall Study|Previously scheduled procedure|1|||
170650729|NCT03579602|616734444|FG000|Overall Study|Subject unable to receive study drug|0|||
170650730|NCT03579602|616734445|FG001|Overall Study|Subject unable to receive study drug|2|||
170650731|NCT03579602|616734444|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
170650732|NCT03579602|616734445|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
170911841|NCT05635838|617682032|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
170592394|NCT01286987|616512040|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
170592395|NCT01286987|616512041|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
170592396|NCT01286987|616512042|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
170592397|NCT01286987|616512043|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
170592398|NCT01286987|616512044|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
170592399|NCT01286987|616512045|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
170592400|NCT01286987|616512046|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
170592401|NCT01286987|616512047|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
170592402|NCT01286987|616512048|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
170592403|NCT01286987|616512049|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
170592404|NCT01286987|616512050|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
170592405|NCT01286987|616512036|FG000|Part 1: Dose Escalation|Physician Decision|0|||
170592406|NCT01286987|616512037|FG001|Part 1: Dose Escalation|Physician Decision|0|||
170592407|NCT01286987|616512038|FG002|Part 1: Dose Escalation|Physician Decision|0|||
170592408|NCT01286987|616512039|FG003|Part 1: Dose Escalation|Physician Decision|0|||
170592409|NCT01286987|616512040|FG004|Part 1: Dose Escalation|Physician Decision|1|||
170592410|NCT01286987|616512041|FG005|Part 1: Dose Escalation|Physician Decision|0|||
170592411|NCT01286987|616512042|FG006|Part 1: Dose Escalation|Physician Decision|0|||
170592412|NCT01286987|616512043|FG007|Part 1: Dose Escalation|Physician Decision|0|||
170592413|NCT01286987|616512044|FG008|Part 1: Dose Escalation|Physician Decision|0|||
170592414|NCT01286987|616512045|FG009|Part 1: Dose Escalation|Physician Decision|0|||
170592415|NCT01286987|616512046|FG010|Part 1: Dose Escalation|Physician Decision|0|||
170592416|NCT01286987|616512047|FG011|Part 1: Dose Escalation|Physician Decision|0|||
170592417|NCT01286987|616512048|FG012|Part 1: Dose Escalation|Physician Decision|0|||
170911842|NCT05635838|617682033|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
170911843|NCT05635838|617682030|FG000|16-Week OLE Period|Adverse Event|0|||
170911844|NCT05635838|617682031|FG001|16-Week OLE Period|Adverse Event|0|||
170911845|NCT05635838|617682032|FG002|16-Week OLE Period|Adverse Event|0|||
170911846|NCT05635838|617682033|FG003|16-Week OLE Period|Adverse Event|2|||
170911847|NCT05635838|617682030|FG000|16-Week OLE Period|Lost to Follow-up|0|||
170911848|NCT05635838|617682031|FG001|16-Week OLE Period|Lost to Follow-up|0|||
170911849|NCT05635838|617682032|FG002|16-Week OLE Period|Lost to Follow-up|1|||
170911850|NCT05635838|617682033|FG003|16-Week OLE Period|Lost to Follow-up|3|||
170911851|NCT05635838|617682030|FG000|16-Week OLE Period|Physician Decision|0|||
170911852|NCT05635838|617682031|FG001|16-Week OLE Period|Physician Decision|0|||
170911853|NCT05635838|617682032|FG002|16-Week OLE Period|Physician Decision|0|||
170911854|NCT05635838|617682033|FG003|16-Week OLE Period|Physician Decision|1|||
170911855|NCT05635838|617682030|FG000|16-Week OLE Period|Protocol Violation|0|||
170911856|NCT05635838|617682031|FG001|16-Week OLE Period|Protocol Violation|0|||
170911857|NCT05635838|617682032|FG002|16-Week OLE Period|Protocol Violation|1|||
170911858|NCT05635838|617682033|FG003|16-Week OLE Period|Protocol Violation|1|||
170911859|NCT05635838|617682030|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
170911860|NCT05635838|617682031|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
170911861|NCT05635838|617682032|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
170911862|NCT05635838|617682033|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
170911863|NCT05635838|617682030|FG000|16-Week OLE Period|Pregnancy|0|||
170911864|NCT05635838|617682031|FG001|16-Week OLE Period|Pregnancy|0|||
170911865|NCT05635838|617682032|FG002|16-Week OLE Period|Pregnancy|1|||
170911866|NCT05635838|617682033|FG003|16-Week OLE Period|Pregnancy|0|||
170592418|NCT01286987|616512049|FG013|Part 1: Dose Escalation|Physician Decision|0|||
170592419|NCT01286987|616512050|FG014|Part 1: Dose Escalation|Physician Decision|0|||
170592420|NCT01286987|616512036|FG000|Part 2: Dose Expansion|Death|0|||
170592421|NCT01286987|616512037|FG001|Part 2: Dose Expansion|Death|0|||
170592422|NCT01286987|616512038|FG002|Part 2: Dose Expansion|Death|0|||
170592423|NCT01286987|616512039|FG003|Part 2: Dose Expansion|Death|0|||
170592424|NCT01286987|616512040|FG004|Part 2: Dose Expansion|Death|0|||
170592425|NCT01286987|616512041|FG005|Part 2: Dose Expansion|Death|0|||
170592426|NCT01286987|616512042|FG006|Part 2: Dose Expansion|Death|0|||
170592427|NCT01286987|616512043|FG007|Part 2: Dose Expansion|Death|0|||
170592428|NCT01286987|616512044|FG008|Part 2: Dose Expansion|Death|0|||
170592429|NCT01286987|616512045|FG009|Part 2: Dose Expansion|Death|0|||
170592430|NCT01286987|616512046|FG010|Part 2: Dose Expansion|Death|0|||
170592431|NCT01286987|616512047|FG011|Part 2: Dose Expansion|Death|0|||
170592432|NCT01286987|616512048|FG012|Part 2: Dose Expansion|Death|1|||
170592433|NCT01286987|616512049|FG013|Part 2: Dose Expansion|Death|1|||
170592434|NCT01286987|616512050|FG014|Part 2: Dose Expansion|Death|0|||
170592435|NCT01286987|616512036|FG000|Part 2: Dose Expansion|Physician Decision|0|||
170592436|NCT01286987|616512037|FG001|Part 2: Dose Expansion|Physician Decision|0|||
170592437|NCT01286987|616512038|FG002|Part 2: Dose Expansion|Physician Decision|0|||
170592438|NCT01286987|616512039|FG003|Part 2: Dose Expansion|Physician Decision|0|||
170592439|NCT01286987|616512040|FG004|Part 2: Dose Expansion|Physician Decision|0|||
170592440|NCT01286987|616512041|FG005|Part 2: Dose Expansion|Physician Decision|0|||
170911867|NCT02699515|617682040|FG000|Overall Study|Death|3|||
170911868|NCT02699515|617682041|FG001|Overall Study|Death|3|||
170911869|NCT02699515|617682042|FG002|Overall Study|Death|3|||
170592441|NCT01286987|616512042|FG006|Part 2: Dose Expansion|Physician Decision|0|||
170592442|NCT01286987|616512043|FG007|Part 2: Dose Expansion|Physician Decision|0|||
170592443|NCT01286987|616512044|FG008|Part 2: Dose Expansion|Physician Decision|0|||
170592444|NCT01286987|616512045|FG009|Part 2: Dose Expansion|Physician Decision|0|||
170592445|NCT01286987|616512046|FG010|Part 2: Dose Expansion|Physician Decision|1|||
170592446|NCT01286987|616512047|FG011|Part 2: Dose Expansion|Physician Decision|1|||
170592447|NCT01286987|616512048|FG012|Part 2: Dose Expansion|Physician Decision|0|||
170592448|NCT01286987|616512049|FG013|Part 2: Dose Expansion|Physician Decision|1|||
170592449|NCT01286987|616512050|FG014|Part 2: Dose Expansion|Physician Decision|0|||
170592450|NCT01286987|616512036|FG000|Part 2: Dose Expansion|Other|0|||
170592451|NCT01286987|616512037|FG001|Part 2: Dose Expansion|Other|0|||
170592452|NCT01286987|616512038|FG002|Part 2: Dose Expansion|Other|0|||
170592453|NCT01286987|616512039|FG003|Part 2: Dose Expansion|Other|0|||
170592454|NCT01286987|616512040|FG004|Part 2: Dose Expansion|Other|0|||
170592455|NCT01286987|616512041|FG005|Part 2: Dose Expansion|Other|0|||
170592456|NCT01286987|616512042|FG006|Part 2: Dose Expansion|Other|0|||
170592457|NCT01286987|616512043|FG007|Part 2: Dose Expansion|Other|0|||
170592458|NCT01286987|616512044|FG008|Part 2: Dose Expansion|Other|0|||
170592459|NCT01286987|616512045|FG009|Part 2: Dose Expansion|Other|0|||
170592460|NCT01286987|616512046|FG010|Part 2: Dose Expansion|Other|0|||
170592461|NCT01286987|616512047|FG011|Part 2: Dose Expansion|Other|0|||
170592462|NCT01286987|616512048|FG012|Part 2: Dose Expansion|Other|0|||
170592463|NCT01286987|616512049|FG013|Part 2: Dose Expansion|Other|1|||
170592464|NCT01286987|616512050|FG014|Part 2: Dose Expansion|Other|0|||
170592465|NCT01286987|616512036|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
170592466|NCT01286987|616512037|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
170592467|NCT01286987|616512038|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
170592468|NCT01286987|616512039|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
170592469|NCT01286987|616512040|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
170592470|NCT01286987|616512041|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
170592471|NCT01286987|616512042|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
170592472|NCT01286987|616512043|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
170592473|NCT01286987|616512044|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
170592474|NCT01286987|616512045|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
170592475|NCT01286987|616512046|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
170592476|NCT01286987|616512047|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
170592477|NCT01286987|616512048|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
170592478|NCT01286987|616512049|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
170592479|NCT01286987|616512050|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
170592480|NCT01286987|616512036|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
170592481|NCT01286987|616512037|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
170592482|NCT01286987|616512038|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
170592483|NCT01286987|616512039|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
170592484|NCT01286987|616512040|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
170592485|NCT01286987|616512041|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
170592486|NCT01286987|616512042|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
170592487|NCT01286987|616512043|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
170592488|NCT01286987|616512044|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
170592489|NCT01286987|616512045|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
170592490|NCT01286987|616512046|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
170592491|NCT01286987|616512047|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
170592492|NCT01286987|616512048|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
170592493|NCT01286987|616512049|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
170592494|NCT01286987|616512050|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
170592495|NCT01286987|616512036|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592496|NCT01286987|616512037|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592497|NCT01286987|616512038|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592498|NCT01286987|616512039|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592499|NCT01286987|616512040|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592500|NCT01286987|616512041|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592501|NCT01286987|616512042|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592502|NCT01286987|616512043|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592503|NCT01286987|616512044|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592504|NCT01286987|616512045|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592505|NCT01286987|616512046|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
170592506|NCT01286987|616512047|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592507|NCT01286987|616512048|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592508|NCT01286987|616512049|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592509|NCT01286987|616512050|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
170592510|NCT02847858|616512051|FG000|Overall Study|Lost to Follow-up|401|||
170592511|NCT02847858|616512052|FG001|Overall Study|Lost to Follow-up|269|||
170592512|NCT00624819|616512053|FG000|Follow-up Period: Year 4|Parents decision|0|||
170810719|NCT02159989|617315633|FG004|Overall Study|Adverse Event|1|||
170810720|NCT02159989|617315634|FG005|Overall Study|Adverse Event|0|||
170810721|NCT02159989|617315635|FG006|Overall Study|Adverse Event|1|||
170810722|NCT02159989|617315636|FG007|Overall Study|Adverse Event|2|||
170810723|NCT02159989|617315637|FG008|Overall Study|Adverse Event|0|||
170810724|NCT02159989|617315638|FG009|Overall Study|Adverse Event|2|||
170810725|NCT02159989|617315639|FG010|Overall Study|Adverse Event|1|||
170592513|NCT00624819|616512054|FG001|Follow-up Period: Year 4|Parents decision|0|||
170810726|NCT02159989|617315629|FG000|Overall Study|Death|0|||
170810727|NCT02159989|617315630|FG001|Overall Study|Death|0|||
170810728|NCT02159989|617315631|FG002|Overall Study|Death|0|||
170810729|NCT02159989|617315632|FG003|Overall Study|Death|0|||
170810730|NCT02159989|617315633|FG004|Overall Study|Death|0|||
170592514|NCT00624819|616512055|FG002|Follow-up Period: Year 4|Parents decision|1|||
170592515|NCT00624819|616512056|FG003|Follow-up Period: Year 4|Parents decision|0|||
170592516|NCT00624819|616512053|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
170592517|NCT00624819|616512054|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
170592518|NCT00624819|616512055|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
170592519|NCT00624819|616512056|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
170592520|NCT02826421|616512059|FG000|Overall Study|Adverse Event|1|||
170592521|NCT02826421|616512060|FG001|Overall Study|Adverse Event|0|||
170592522|NCT02826421|616512061|FG002|Overall Study|Adverse Event|0|||
170592523|NCT02826421|616512062|FG003|Overall Study|Adverse Event|1|||
170592524|NCT02826421|616512059|FG000|Overall Study|Withdrawal by Subject|1|||
170592525|NCT02826421|616512060|FG001|Overall Study|Withdrawal by Subject|3|||
170592526|NCT02826421|616512061|FG002|Overall Study|Withdrawal by Subject|1|||
170592527|NCT02826421|616512062|FG003|Overall Study|Withdrawal by Subject|1|||
170592528|NCT02826421|616512059|FG000|Overall Study|Reason not given|1|||
170810731|NCT02159989|617315634|FG005|Overall Study|Death|0|||
170810732|NCT02159989|617315635|FG006|Overall Study|Death|0|||
170810733|NCT02159989|617315636|FG007|Overall Study|Death|0|||
170810734|NCT02159989|617315637|FG008|Overall Study|Death|0|||
170810735|NCT02159989|617315638|FG009|Overall Study|Death|0|||
170810736|NCT02159989|617315639|FG010|Overall Study|Death|1|||
170810737|NCT02159989|617315629|FG000|Overall Study|Lack of Efficacy|2|||
170810738|NCT02159989|617315630|FG001|Overall Study|Lack of Efficacy|3|||
170810739|NCT02159989|617315631|FG002|Overall Study|Lack of Efficacy|3|||
170810740|NCT02159989|617315632|FG003|Overall Study|Lack of Efficacy|0|||
170810741|NCT02159989|617315633|FG004|Overall Study|Lack of Efficacy|2|||
170810742|NCT02159989|617315634|FG005|Overall Study|Lack of Efficacy|3|||
170810743|NCT02159989|617315635|FG006|Overall Study|Lack of Efficacy|3|||
170810744|NCT02159989|617315636|FG007|Overall Study|Lack of Efficacy|1|||
170810745|NCT02159989|617315637|FG008|Overall Study|Lack of Efficacy|3|||
170650733|NCT03041129|616734446|FG000|Overall Study|Withdrawal by Subject|2|||
170650734|NCT03041129|616734447|FG001|Overall Study|Withdrawal by Subject|0|||
170650735|NCT03041129|616734448|FG002|Overall Study|Withdrawal by Subject|0|||
170810746|NCT02159989|617315638|FG009|Overall Study|Lack of Efficacy|6|||
170810747|NCT02159989|617315639|FG010|Overall Study|Lack of Efficacy|7|||
170592529|NCT02826421|616512060|FG001|Overall Study|Reason not given|0|||
170592530|NCT02826421|616512061|FG002|Overall Study|Reason not given|1|||
170592531|NCT02826421|616512062|FG003|Overall Study|Reason not given|0|||
170592532|NCT02210221|616512065|FG000|Overall Study|Lack of Efficacy|7|||
170592533|NCT02210221|616512065|FG000|Overall Study|Withdrawal by Subject|43|||
170592534|NCT02078102|616512072|FG000|Overall Study|Adverse Event|1|||
170592535|NCT02078102|616512073|FG001|Overall Study|Adverse Event|0|||
170592536|NCT02078102|616512072|FG000|Overall Study|Withdrawal by Subject|1|||
170592537|NCT02078102|616512073|FG001|Overall Study|Withdrawal by Subject|0|||
170592538|NCT02078102|616512072|FG000|Overall Study|Physician Decision|0|||
170592539|NCT02078102|616512073|FG001|Overall Study|Physician Decision|1|||
170592540|NCT03093974|616512076|FG000|Overall Study|Withdrawal by Subject|32|||
170592541|NCT03093974|616512077|FG001|Overall Study|Withdrawal by Subject|27|||
170650736|NCT03041129|616734449|FG003|Overall Study|Withdrawal by Subject|0|||
170810748|NCT02159989|617315629|FG000|Overall Study|Lost to Follow-up|0|||
170911870|NCT02699515|617682043|FG003|Overall Study|Death|23|||
170592542|NCT03093974|616512076|FG000|Overall Study|Adverse Event|17|||
170592543|NCT03093974|616512077|FG001|Overall Study|Adverse Event|24|||
170592544|NCT03093974|616512076|FG000|Overall Study|Death|0|||
170810749|NCT02159989|617315630|FG001|Overall Study|Lost to Follow-up|0|||
170810750|NCT02159989|617315631|FG002|Overall Study|Lost to Follow-up|0|||
170810751|NCT02159989|617315632|FG003|Overall Study|Lost to Follow-up|1|||
170810752|NCT02159989|617315633|FG004|Overall Study|Lost to Follow-up|0|||
170810753|NCT02159989|617315634|FG005|Overall Study|Lost to Follow-up|0|||
170592545|NCT03093974|616512077|FG001|Overall Study|Death|1|||
170592546|NCT03093974|616512076|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170810754|NCT02159989|617315635|FG006|Overall Study|Lost to Follow-up|0|||
170592547|NCT03093974|616512077|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170650737|NCT00890045|616734450|FG000|Overall Study|Death|0|||
170810755|NCT02159989|617315636|FG007|Overall Study|Lost to Follow-up|0|||
170810756|NCT02159989|617315637|FG008|Overall Study|Lost to Follow-up|0|||
170810757|NCT02159989|617315638|FG009|Overall Study|Lost to Follow-up|0|||
170592548|NCT03093974|616512076|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
170592549|NCT03093974|616512077|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
170592550|NCT03093974|616512076|FG000|Overall Study|Lost to Follow-up|0|||
170592551|NCT03093974|616512077|FG001|Overall Study|Lost to Follow-up|1|||
170592552|NCT03093974|616512076|FG000|Overall Study|Other|1|||
170592553|NCT03093974|616512077|FG001|Overall Study|Other|2|||
170592554|NCT02185014|616512080|FG000|Overall Study|Adverse Event|18|||
170592555|NCT02185014|616512080|FG000|Overall Study|Withdrew Consent|8|||
170592556|NCT02185014|616512080|FG000|Overall Study|Lost to Follow-up|4|||
170592557|NCT02185014|616512080|FG000|Overall Study|Lack of Efficacy|14|||
170592558|NCT02185014|616512080|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
170592559|NCT02185014|616512080|FG000|Overall Study|Subject Noncompliance|1|||
170592560|NCT02185014|616512080|FG000|Overall Study|Other|4|||
170592561|NCT02141490|616512082|FG000|Overall Study|Screening failures|4|||
170592562|NCT02141490|616512083|FG001|Overall Study|Screening failures|0|||
170592563|NCT02141490|616512084|FG002|Overall Study|Screening failures|0|||
170592564|NCT01009346|616512088|FG000|Overall Study|Adverse Event|4|||
170592565|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
170592566|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
170592567|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
170592568|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
170592569|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
170592570|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
170592571|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
170592572|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
170592573|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
170592574|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
170592575|NCT03906656|616512091|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
170592576|NCT03906656|616512092|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
170592577|NCT03906656|616512091|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
170592578|NCT03906656|616512092|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
170592579|NCT03906656|616512091|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
170592580|NCT03906656|616512092|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
170592581|NCT03906656|616512091|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
170592582|NCT03906656|616512092|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
170592583|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
170592584|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
170592585|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
170592586|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
170592587|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
170592588|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
170592589|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
170592590|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
170592591|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
170592592|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
170592593|NCT03906656|616512091|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
170592594|NCT03906656|616512092|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
170592595|NCT03906656|616512091|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
170592596|NCT03906656|616512092|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
170592597|NCT03906656|616512091|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
170592598|NCT03906656|616512092|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
170592599|NCT03906656|616512091|FG000|Home Use 2 (3 Months)|Death|2|||
170592600|NCT03906656|616512092|FG001|Home Use 2 (3 Months)|Death|0|||
170592601|NCT03906656|616512091|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
170592602|NCT03906656|616512092|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
170592603|NCT03906656|616512091|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
170592604|NCT03906656|616512092|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
170592605|NCT00033540|616512093|FG000|Overall Study|Adverse Event|14|||
170592606|NCT00033540|616512093|FG000|Overall Study|Death|1|||
170592607|NCT00033540|616512093|FG000|Overall Study|Progression|26|||
170592608|NCT00033540|616512093|FG000|Overall Study|Withdrawal by Subject|6|||
170592609|NCT00033540|616512093|FG000|Overall Study|Other|5|||
170592610|NCT00033540|616512093|FG000|Overall Study|Ineligible|3|||
170592611|NCT00033540|616512093|FG000|Overall Study|Never received treatment|2|||
170592612|NCT00405964|616512094|FG000|Overall Study|Treatment Failure|17|||
170592613|NCT00405964|616512095|FG001|Overall Study|Treatment Failure|45|||
170911871|NCT02699515|617682044|FG004|Overall Study|Death|22|||
170911872|NCT02699515|617682045|FG005|Overall Study|Death|23|||
170592614|NCT00405964|616512094|FG000|Overall Study|Adverse Event|7|||
170592615|NCT00405964|616512095|FG001|Overall Study|Adverse Event|16|||
170911873|NCT02699515|617682046|FG006|Overall Study|Death|3|||
170911874|NCT02699515|617682047|FG007|Overall Study|Death|5|||
170911875|NCT02699515|617682040|FG000|Overall Study|Withdrawal by Subject|0|||
170592616|NCT00405964|616512094|FG000|Overall Study|Lost to Follow-up|5|||
170592617|NCT00405964|616512095|FG001|Overall Study|Lost to Follow-up|5|||
170592618|NCT00405964|616512094|FG000|Overall Study|Withdrawal by Subject|19|||
170592619|NCT00405964|616512095|FG001|Overall Study|Withdrawal by Subject|23|||
170592620|NCT00405964|616512094|FG000|Overall Study|Protocol Violation|11|||
170592621|NCT00405964|616512095|FG001|Overall Study|Protocol Violation|6|||
170592622|NCT00066469|616512096|FG000|Overall Study|Death|3|||
170592623|NCT00066469|616512096|FG000|Overall Study|Lack of Efficacy|9|||
170592624|NCT00066469|616512096|FG000|Overall Study|Lost to Follow-up|1|||
170592625|NCT00066469|616512096|FG000|Overall Study|Physician Decision|1|||
170592626|NCT00066469|616512096|FG000|Overall Study|Withdrawal by Subject|1|||
170592627|NCT00066469|616512096|FG000|Overall Study|ineligible|1|||
170592628|NCT00711802|616512097|FG000|Overall Study|Not treated (no further detail)|2|||
170592629|NCT00711802|616512098|FG001|Overall Study|Not treated (no further detail)|1|||
170592630|NCT00711802|616512099|FG002|Overall Study|Not treated (no further detail)|2|||
170592631|NCT00711802|616512100|FG003|Overall Study|Not treated (no further detail)|0|||
170592632|NCT00711802|616512101|FG004|Overall Study|Not treated (no further detail)|2|||
170592633|NCT00711802|616512102|FG005|Overall Study|Not treated (no further detail)|0|||
170592634|NCT00711802|616512103|FG006|Overall Study|Not treated (no further detail)|0|||
170592635|NCT00711802|616512104|FG007|Overall Study|Not treated (no further detail)|0|||
170592636|NCT00711802|616512097|FG000|Overall Study|Adverse Event|0|||
170592637|NCT00711802|616512098|FG001|Overall Study|Adverse Event|0|||
170592638|NCT00711802|616512099|FG002|Overall Study|Adverse Event|0|||
170592639|NCT00711802|616512100|FG003|Overall Study|Adverse Event|0|||
170592640|NCT00711802|616512101|FG004|Overall Study|Adverse Event|1|||
170592641|NCT00711802|616512102|FG005|Overall Study|Adverse Event|1|||
170592642|NCT00711802|616512103|FG006|Overall Study|Adverse Event|0|||
170592643|NCT00711802|616512104|FG007|Overall Study|Adverse Event|0|||
170592644|NCT00711802|616512097|FG000|Overall Study|Microbiological failure|0|||
170592645|NCT00711802|616512098|FG001|Overall Study|Microbiological failure|1|||
170592646|NCT00711802|616512099|FG002|Overall Study|Microbiological failure|0|||
170592647|NCT00711802|616512100|FG003|Overall Study|Microbiological failure|0|||
170592648|NCT00711802|616512101|FG004|Overall Study|Microbiological failure|0|||
170592649|NCT00711802|616512102|FG005|Overall Study|Microbiological failure|1|||
170592650|NCT00711802|616512103|FG006|Overall Study|Microbiological failure|0|||
170592651|NCT00711802|616512104|FG007|Overall Study|Microbiological failure|0|||
170592652|NCT00711802|616512097|FG000|Overall Study|Protocol Violation|0|||
170592653|NCT00711802|616512098|FG001|Overall Study|Protocol Violation|0|||
170592654|NCT00711802|616512099|FG002|Overall Study|Protocol Violation|0|||
170592655|NCT00711802|616512100|FG003|Overall Study|Protocol Violation|1|||
170592656|NCT00711802|616512101|FG004|Overall Study|Protocol Violation|0|||
170592657|NCT00711802|616512102|FG005|Overall Study|Protocol Violation|0|||
170592658|NCT00711802|616512103|FG006|Overall Study|Protocol Violation|0|||
170592659|NCT00711802|616512104|FG007|Overall Study|Protocol Violation|0|||
170592660|NCT00711802|616512097|FG000|Overall Study|Physician Decision|0|||
170592661|NCT00711802|616512098|FG001|Overall Study|Physician Decision|2|||
170592662|NCT00711802|616512099|FG002|Overall Study|Physician Decision|0|||
170592663|NCT00711802|616512100|FG003|Overall Study|Physician Decision|0|||
170592664|NCT00711802|616512101|FG004|Overall Study|Physician Decision|0|||
170592665|NCT00711802|616512102|FG005|Overall Study|Physician Decision|0|||
170592666|NCT00711802|616512103|FG006|Overall Study|Physician Decision|0|||
170592667|NCT00711802|616512104|FG007|Overall Study|Physician Decision|0|||
170592668|NCT00711802|616512097|FG000|Overall Study|Withdrawal by Subject|0|||
170592669|NCT00711802|616512098|FG001|Overall Study|Withdrawal by Subject|1|||
170592670|NCT00711802|616512099|FG002|Overall Study|Withdrawal by Subject|0|||
170592671|NCT00711802|616512100|FG003|Overall Study|Withdrawal by Subject|1|||
170592672|NCT00711802|616512101|FG004|Overall Study|Withdrawal by Subject|0|||
170592673|NCT00711802|616512102|FG005|Overall Study|Withdrawal by Subject|0|||
170592674|NCT00711802|616512103|FG006|Overall Study|Withdrawal by Subject|0|||
170810758|NCT02159989|617315639|FG010|Overall Study|Lost to Follow-up|1|||
170810759|NCT02159989|617315629|FG000|Overall Study|Withdrawal by Subject|2|||
170810760|NCT02159989|617315630|FG001|Overall Study|Withdrawal by Subject|0|||
170592675|NCT00711802|616512104|FG007|Overall Study|Withdrawal by Subject|0|||
170592676|NCT00711802|616512097|FG000|Overall Study|Lost to Follow-up|0|||
170592677|NCT00711802|616512098|FG001|Overall Study|Lost to Follow-up|0|||
170592678|NCT00711802|616512099|FG002|Overall Study|Lost to Follow-up|3|||
170592679|NCT00711802|616512100|FG003|Overall Study|Lost to Follow-up|1|||
170810761|NCT02159989|617315631|FG002|Overall Study|Withdrawal by Subject|0|||
170592680|NCT00711802|616512101|FG004|Overall Study|Lost to Follow-up|10|||
170592681|NCT00711802|616512102|FG005|Overall Study|Lost to Follow-up|6|||
170592682|NCT00711802|616512103|FG006|Overall Study|Lost to Follow-up|4|||
170592683|NCT00711802|616512104|FG007|Overall Study|Lost to Follow-up|2|||
170592684|NCT00711802|616512097|FG000|Overall Study|Reason not reported|0|||
170592685|NCT00711802|616512098|FG001|Overall Study|Reason not reported|1|||
170592686|NCT00711802|616512099|FG002|Overall Study|Reason not reported|1|||
170592687|NCT00711802|616512100|FG003|Overall Study|Reason not reported|0|||
170592688|NCT00711802|616512101|FG004|Overall Study|Reason not reported|1|||
170592689|NCT00711802|616512102|FG005|Overall Study|Reason not reported|0|||
170592690|NCT00711802|616512103|FG006|Overall Study|Reason not reported|1|||
170592691|NCT00711802|616512104|FG007|Overall Study|Reason not reported|0|||
170592692|NCT00882908|616512106|FG000|Overall Study|Adverse Event|0|||
170592693|NCT00882908|616512107|FG001|Overall Study|Adverse Event|0|||
170592694|NCT00882908|616512108|FG002|Overall Study|Adverse Event|1|||
170592695|NCT00882908|616512109|FG003|Overall Study|Adverse Event|0|||
170592696|NCT00882908|616512110|FG004|Overall Study|Adverse Event|1|||
170592697|NCT00882908|616512106|FG000|Overall Study|Lost to Follow-up|3|||
170592698|NCT00882908|616512107|FG001|Overall Study|Lost to Follow-up|5|||
170592699|NCT00882908|616512108|FG002|Overall Study|Lost to Follow-up|3|||
170592700|NCT00882908|616512109|FG003|Overall Study|Lost to Follow-up|1|||
170592701|NCT00882908|616512110|FG004|Overall Study|Lost to Follow-up|2|||
170592702|NCT00882908|616512106|FG000|Overall Study|Protocol Violation|0|||
170592703|NCT00882908|616512107|FG001|Overall Study|Protocol Violation|1|||
170592704|NCT00882908|616512108|FG002|Overall Study|Protocol Violation|0|||
170592705|NCT00882908|616512109|FG003|Overall Study|Protocol Violation|0|||
170592706|NCT00882908|616512110|FG004|Overall Study|Protocol Violation|0|||
170592707|NCT00882908|616512106|FG000|Overall Study|Withdrawal by Subject|0|||
170592708|NCT00882908|616512107|FG001|Overall Study|Withdrawal by Subject|0|||
170592709|NCT00882908|616512108|FG002|Overall Study|Withdrawal by Subject|3|||
170592710|NCT00882908|616512109|FG003|Overall Study|Withdrawal by Subject|5|||
170592711|NCT00882908|616512110|FG004|Overall Study|Withdrawal by Subject|2|||
170592712|NCT00882908|616512106|FG000|Overall Study|Subject reached a virologic endpoint|0|||
170592713|NCT00882908|616512107|FG001|Overall Study|Subject reached a virologic endpoint|0|||
170592714|NCT00882908|616512108|FG002|Overall Study|Subject reached a virologic endpoint|0|||
170592715|NCT00882908|616512109|FG003|Overall Study|Subject reached a virologic endpoint|0|||
170592716|NCT00882908|616512110|FG004|Overall Study|Subject reached a virologic endpoint|1|||
170592717|NCT00882908|616512106|FG000|Overall Study|Study terminated in error|0|||
170592718|NCT00882908|616512107|FG001|Overall Study|Study terminated in error|0|||
170592719|NCT00882908|616512108|FG002|Overall Study|Study terminated in error|0|||
170592720|NCT00882908|616512109|FG003|Overall Study|Study terminated in error|1|||
170592721|NCT00882908|616512110|FG004|Overall Study|Study terminated in error|0|||
170592722|NCT05291936|616512111|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
170592723|NCT05291936|616512112|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
170592724|NCT05291936|616512111|FG000|Period 1|Withdrew Consent during study|1|||
170592725|NCT05291936|616512112|FG001|Period 1|Withdrew Consent during study|0|||
170592726|NCT05291936|616512111|FG000|Period 2|Adverse Event|0|||
170592727|NCT05291936|616512112|FG001|Period 2|Adverse Event|1|||
170592728|NCT05291936|616512111|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
170592729|NCT05291936|616512112|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
170592730|NCT00581828|616512113|FG000|Overall Study|Protocol Violation|1|||
170592731|NCT02981407|616512116|FG000|Overall Study|Withdrawal by Subject|2|||
170592732|NCT02981407|616512117|FG001|Overall Study|Withdrawal by Subject|0|||
170592733|NCT00700102|616512118|FG000|Overall Study|Died|394|||
170592734|NCT00700102|616512119|FG001|Overall Study|Died|385|||
170592735|NCT00700102|616512118|FG000|Overall Study|Lost to Follow-up|8|||
170592736|NCT00700102|616512119|FG001|Overall Study|Lost to Follow-up|10|||
170592737|NCT02818036|616512122|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
170592738|NCT02818036|616512123|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
170592739|NCT02818036|616512122|FG000|Overall Study|Withdrawal by Subject|1|||
170592740|NCT02818036|616512123|FG001|Overall Study|Withdrawal by Subject|0|||
170592741|NCT01154283|616512124|FG000|0-6 Weeks|Withdrawal by Subject|7|||
170592742|NCT01154283|616512125|FG001|0-6 Weeks|Withdrawal by Subject|2|||
170592743|NCT01154283|616512124|FG000|0-6 Weeks|Death|0|||
170592744|NCT01154283|616512125|FG001|0-6 Weeks|Death|1|||
170592745|NCT01154283|616512124|FG000|7-12 Weeks|Death|1|||
170650738|NCT00890045|616734451|FG001|Overall Study|Death|1|||
170650739|NCT00890045|616734450|FG000|Overall Study|Did not receive HeRO Graft|0|||
170592746|NCT01154283|616512125|FG001|7-12 Weeks|Death|0|||
170592747|NCT01154283|616512124|FG000|7-12 Weeks|Withdrawal by Subject|0|||
170592748|NCT01154283|616512125|FG001|7-12 Weeks|Withdrawal by Subject|1|||
170810762|NCT02159989|617315632|FG003|Overall Study|Withdrawal by Subject|2|||
170810763|NCT02159989|617315633|FG004|Overall Study|Withdrawal by Subject|1|||
170810764|NCT02159989|617315634|FG005|Overall Study|Withdrawal by Subject|0|||
170810765|NCT02159989|617315635|FG006|Overall Study|Withdrawal by Subject|3|||
170810766|NCT02159989|617315636|FG007|Overall Study|Withdrawal by Subject|1|||
170592749|NCT00930969|616512126|FG000|Overall Study|Death|5|||
170592750|NCT00930969|616512126|FG000|Overall Study|Lost to Follow-up|1|||
170592751|NCT00930969|616512126|FG000|Overall Study|Physician Decision|13|||
170592752|NCT00930969|616512126|FG000|Overall Study|Withdrawal by Subject|19|||
170592753|NCT01287221|616512127|FG000|Overall Study|Lack of Perceived Benefit|1|||
170592754|NCT01287221|616512128|FG001|Overall Study|Lack of Perceived Benefit|1|||
170592755|NCT01287221|616512127|FG000|Overall Study|Adverse Event|3|||
170592756|NCT01287221|616512128|FG001|Overall Study|Adverse Event|3|||
170592757|NCT01287221|616512127|FG000|Overall Study|Withdrawal by Subject|0|||
170592758|NCT01287221|616512128|FG001|Overall Study|Withdrawal by Subject|1|||
170650740|NCT00890045|616734451|FG001|Overall Study|Did not receive HeRO Graft|2|||
170592759|NCT01416441|616512129|FG000|Overall Study|Lost to Follow-up|5|||
170592760|NCT01416441|616512129|FG000|Overall Study|Adverse Event|6|||
170592761|NCT01416441|616512129|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
170592762|NCT01416441|616512129|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
170592763|NCT01416441|616512129|FG000|Overall Study|Investigator Withdrew Subject|2|||
170592764|NCT01416441|616512129|FG000|Overall Study|Subject Withdrew Consent|12|||
170592765|NCT01416441|616512129|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
170592766|NCT03959982|616514161|FG000|Overall Study|Withdrawal by Subject|1|||
170592767|NCT03959982|616514162|FG001|Overall Study|Withdrawal by Subject|0|||
170592768|NCT03959982|616514161|FG000|Overall Study|Physician Decision|2|||
170592769|NCT03959982|616514162|FG001|Overall Study|Physician Decision|0|||
170592770|NCT03959982|616514161|FG000|Overall Study|Lost to Follow-up|1|||
170592771|NCT03959982|616514162|FG001|Overall Study|Lost to Follow-up|0|||
170592772|NCT04030247|616514163|FG000|Overall Study|Withdrawal by Subject|4|||
170592773|NCT04030247|616514163|FG000|Overall Study|Lost to Follow-up|13|||
170592774|NCT02191605|616514164|FG000|Overall Study|Lost to Follow-up|9|||
170592775|NCT02191605|616514165|FG001|Overall Study|Lost to Follow-up|4|||
170592776|NCT02191605|616514166|FG002|Overall Study|Lost to Follow-up|7|||
170592777|NCT02191605|616514167|FG003|Overall Study|Lost to Follow-up|3|||
170592778|NCT02191605|616514168|FG004|Overall Study|Lost to Follow-up|4|||
170592779|NCT03654885|616514171|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
170592780|NCT03654885|616514172|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
170592781|NCT03654885|616514171|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
170592782|NCT03654885|616514172|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
170592783|NCT03654885|616514171|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
170592784|NCT03654885|616514172|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
170592785|NCT03654885|616514171|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
170592786|NCT03654885|616514172|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
170592787|NCT03654885|616514171|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
170592788|NCT03654885|616514172|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
170592789|NCT03654885|616514171|FG000|Overall Study|Adverse Event in Study Eye|3|||
170592790|NCT03654885|616514172|FG001|Overall Study|Adverse Event in Study Eye|0|||
170592791|NCT03654885|616514171|FG000|Overall Study|Consent Withdrawn|1|||
170592792|NCT03654885|616514172|FG001|Overall Study|Consent Withdrawn|0|||
170592793|NCT03654885|616514171|FG000|Overall Study|Death|3|||
170592794|NCT03654885|616514172|FG001|Overall Study|Death|1|||
170592795|NCT03654885|616514171|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
170592796|NCT03654885|616514172|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
170592797|NCT03654885|616514171|FG000|Overall Study|Lost to Follow-up|3|||
170592798|NCT03654885|616514172|FG001|Overall Study|Lost to Follow-up|3|||
170592799|NCT00240110|616514175|FG000|Overall Study|Lost to Follow-up|6|||
170592800|NCT00240110|616514176|FG001|Overall Study|Lost to Follow-up|7|||
170592801|NCT03559699|616514177|FG000|Overall Study|Withdrawal by Subject|6|||
170592802|NCT03559699|616514177|FG000|Overall Study|Lost to Follow-up|1|||
170592803|NCT00031460|616514178|FG000|Overall Study|Lost to Follow-up|0|||
170592804|NCT00031460|616514179|FG001|Overall Study|Lost to Follow-up|1|||
170592805|NCT00031460|616514178|FG000|Overall Study|Withdrawal by Subject|1|||
170592806|NCT00031460|616514179|FG001|Overall Study|Withdrawal by Subject|1|||
170592807|NCT00031460|616514178|FG000|Overall Study|Non-Compliant|1|||
170592808|NCT00031460|616514179|FG001|Overall Study|Non-Compliant|1|||
170592809|NCT00031460|616514178|FG000|Overall Study|Death|0|||
170592810|NCT00031460|616514179|FG001|Overall Study|Death|1|||
170592811|NCT00031460|616514178|FG000|Overall Study|Reactivation of Disease|5|||
170592812|NCT00031460|616514179|FG001|Overall Study|Reactivation of Disease|9|||
170592813|NCT00031460|616514178|FG000|Overall Study|Disruption of blinded drug supply|2|||
170592814|NCT00031460|616514179|FG001|Overall Study|Disruption of blinded drug supply|0|||
170592815|NCT00031460|616514178|FG000|Overall Study|Confirmed unevaluable|0|||
170592816|NCT00031460|616514179|FG001|Overall Study|Confirmed unevaluable|1|||
170592817|NCT02080260|616514182|FG000|Overall Study|Death|18|||
170592818|NCT02080260|616514182|FG000|Overall Study|Withdrawal by Subject|1|||
170592819|NCT05438602|616514187|FG000|Treatment (15 Days)|Adverse Event|2|||
170592820|NCT05438602|616514188|FG001|Treatment (15 Days)|Adverse Event|1|||
170592821|NCT05438602|616514189|FG002|Treatment (15 Days)|Adverse Event|3|||
170592822|NCT05438602|616514187|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
170592823|NCT05438602|616514188|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
170592824|NCT05438602|616514189|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
170592825|NCT05438602|616514187|FG000|Treatment (15 Days)|Other|0|||
170592826|NCT05438602|616514188|FG001|Treatment (15 Days)|Other|0|||
170592827|NCT05438602|616514189|FG002|Treatment (15 Days)|Other|1|||
170592828|NCT05438602|616514187|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
170592829|NCT05438602|616514188|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
170592830|NCT05438602|616514189|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
170592831|NCT05438602|616514187|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
170592832|NCT05438602|616514188|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
170592833|NCT05438602|616514189|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
170592834|NCT05438602|616514187|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
170592835|NCT05438602|616514188|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
170592836|NCT05438602|616514189|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
170592837|NCT05438602|616514187|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
170592838|NCT05438602|616514188|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
170592839|NCT05438602|616514189|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
170592840|NCT05438602|616514187|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
170592841|NCT05438602|616514188|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
170592842|NCT05438602|616514189|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
170592843|NCT05438602|616514187|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
170592844|NCT05438602|616514188|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
170592845|NCT05438602|616514189|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
170592846|NCT05438602|616514187|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
170592847|NCT05438602|616514188|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
170592848|NCT05438602|616514189|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
170592849|NCT01930890|616514190|FG000|Overall Study|Study Termination|14|||
170592850|NCT01930890|616514191|FG001|Overall Study|Study Termination|28|||
170592851|NCT01930890|616514192|FG002|Overall Study|Study Termination|13|||
170592852|NCT01930890|616514193|FG003|Overall Study|Study Termination|25|||
170592853|NCT01930890|616514190|FG000|Overall Study|Death|0|||
170592854|NCT01930890|616514191|FG001|Overall Study|Death|0|||
170592855|NCT01930890|616514192|FG002|Overall Study|Death|0|||
170592856|NCT01930890|616514193|FG003|Overall Study|Death|1|||
170592857|NCT01930890|616514190|FG000|Overall Study|Investigator Decision|0|||
170592858|NCT01930890|616514191|FG001|Overall Study|Investigator Decision|1|||
170592859|NCT01930890|616514192|FG002|Overall Study|Investigator Decision|0|||
170592860|NCT01930890|616514193|FG003|Overall Study|Investigator Decision|0|||
170592861|NCT01930890|616514190|FG000|Overall Study|Consent Withdrawn|0|||
170592862|NCT01930890|616514191|FG001|Overall Study|Consent Withdrawn|3|||
170592863|NCT01930890|616514192|FG002|Overall Study|Consent Withdrawn|0|||
170592864|NCT01930890|616514193|FG003|Overall Study|Consent Withdrawn|1|||
170592865|NCT01930890|616514190|FG000|Overall Study|Adverse Event|0|||
170592866|NCT01930890|616514191|FG001|Overall Study|Adverse Event|1|||
170592867|NCT01930890|616514192|FG002|Overall Study|Adverse Event|0|||
170592868|NCT01930890|616514193|FG003|Overall Study|Adverse Event|0|||
170592869|NCT03204890|616514194|FG000|Overall Study|Withdrawal by Subject|1|||
170592870|NCT02091284|616514195|FG000|Overall Study|Withdrawal by Subject|2|||
170592871|NCT02091284|616514196|FG001|Overall Study|Withdrawal by Subject|1|||
170592872|NCT02091284|616514195|FG000|Overall Study|unreliable data|1|||
170592873|NCT02091284|616514196|FG001|Overall Study|unreliable data|0|||
170592874|NCT02853435|616514197|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
170592875|NCT02853435|616514198|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
170592876|NCT02853435|616514199|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
170592877|NCT02853435|616514200|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
170592878|NCT02853435|616514201|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
170592879|NCT02853435|616514202|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
170592880|NCT04524455|616514215|FG000|Overall Study|Death|3|||
170592881|NCT04524455|616514216|FG001|Overall Study|Death|3|||
170592882|NCT04524455|616514215|FG000|Overall Study|Decision by Sponsor|0|||
170592883|NCT04524455|616514216|FG001|Overall Study|Decision by Sponsor|2|||
170592884|NCT04524455|616514215|FG000|Overall Study|Withdrawal of Consent From Study|1|||
170592885|NCT04524455|616514216|FG001|Overall Study|Withdrawal of Consent From Study|0|||
170592886|NCT04524455|616514215|FG000|Overall Study|Lost to Follow-up|0|||
170592887|NCT04524455|616514216|FG001|Overall Study|Lost to Follow-up|1|||
170592888|NCT00490776|616514217|FG000|Overall Study|Withdrawal by Subject|1|||
170592889|NCT00490776|616514217|FG000|Overall Study|Administrative Problems|1|||
170592890|NCT00490776|616514217|FG000|Overall Study|Death|1|||
170592891|NCT00490776|616514217|FG000|Overall Study|New Cancer Therapy|1|||
170592892|NCT00490776|616514217|FG000|Overall Study|Disease Progression|5|||
170592893|NCT03383783|616514218|FG000|Overall Study|Withdrawal by Subject|2|||
170592894|NCT00585221|616514225|FG000|Overall Study|Protocol Violation|8|||
170592895|NCT03784846|616514229|FG000|Pre-COVID Study|Lost to Follow-up|3|||
170592896|NCT03784846|616514230|FG001|Pre-COVID Study|Lost to Follow-up|3|||
170592897|NCT03784846|616514231|FG002|Pre-COVID Study|Lost to Follow-up|2|||
170592898|NCT03784846|616514229|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
170592899|NCT03784846|616514230|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
170592900|NCT03784846|616514231|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
170592901|NCT03784846|616514229|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
170810767|NCT02159989|617315637|FG008|Overall Study|Withdrawal by Subject|0|||
170810768|NCT02159989|617315638|FG009|Overall Study|Withdrawal by Subject|0|||
170592902|NCT03784846|616514230|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
170592903|NCT03784846|616514231|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
170592904|NCT03784846|616514229|FG000|Post-COVID Study|Lost to Follow-up|3|||
170592905|NCT03784846|616514230|FG001|Post-COVID Study|Lost to Follow-up|5|||
170592906|NCT03784846|616514231|FG002|Post-COVID Study|Lost to Follow-up|1|||
170592907|NCT03784846|616514229|FG000|Post-COVID Study|Withdrawal by Subject|1|||
170592908|NCT03784846|616514230|FG001|Post-COVID Study|Withdrawal by Subject|2|||
170592909|NCT03784846|616514231|FG002|Post-COVID Study|Withdrawal by Subject|0|||
170592910|NCT00867087|616514232|FG000|Overall Study|Other|1|||
170592911|NCT00867087|616514232|FG000|Overall Study|Withdrawal by Subject|4|||
170592912|NCT00867087|616514232|FG000|Overall Study|Death|37|||
170592913|NCT01238835|616514235|FG000|Overall Study|Death|124|||
170592914|NCT01238835|616514235|FG000|Overall Study|Withdrawal by Subject|9|||
170592915|NCT01238835|616514235|FG000|Overall Study|Lost to Follow-up|1|||
170592916|NCT01238835|616514235|FG000|Overall Study|Site early discontinuation|2|||
170592917|NCT00554619|616514236|FG000|Overall Study|Adverse Event|1|||
170592918|NCT00554619|616514236|FG000|Overall Study|Physician Decision|1|||
170592919|NCT00554619|616514236|FG000|Overall Study|Liver Function Test Abnormality|1|||
170592920|NCT02088073|616514240|FG000|Acute Phase|Withdrawal by Subject|5|||
170592921|NCT02088073|616514241|FG001|Acute Phase|Withdrawal by Subject|0|||
170592922|NCT02088073|616514242|FG002|Acute Phase|Withdrawal by Subject|0|||
170592923|NCT02088073|616514243|FG003|Acute Phase|Withdrawal by Subject|0|||
170592924|NCT02088073|616514244|FG004|Acute Phase|Withdrawal by Subject|0|||
170592925|NCT02088073|616514240|FG000|Acute Phase|Hyperkalemia|2|||
170592926|NCT02088073|616514241|FG001|Acute Phase|Hyperkalemia|0|||
170592927|NCT02088073|616514242|FG002|Acute Phase|Hyperkalemia|0|||
170592928|NCT02088073|616514243|FG003|Acute Phase|Hyperkalemia|0|||
170592929|NCT02088073|616514244|FG004|Acute Phase|Hyperkalemia|0|||
170592930|NCT02088073|616514240|FG000|Maintanance Phase|Withdrawal by Subject|0|||
170592931|NCT02088073|616514241|FG001|Maintanance Phase|Withdrawal by Subject|2|||
170592932|NCT02088073|616514242|FG002|Maintanance Phase|Withdrawal by Subject|0|||
170592933|NCT02088073|616514243|FG003|Maintanance Phase|Withdrawal by Subject|0|||
170592934|NCT02088073|616514244|FG004|Maintanance Phase|Withdrawal by Subject|0|||
170592935|NCT02088073|616514240|FG000|Maintanance Phase|Adverse Event|0|||
170592936|NCT02088073|616514241|FG001|Maintanance Phase|Adverse Event|0|||
170592937|NCT02088073|616514242|FG002|Maintanance Phase|Adverse Event|3|||
170592938|NCT02088073|616514243|FG003|Maintanance Phase|Adverse Event|0|||
170592939|NCT02088073|616514244|FG004|Maintanance Phase|Adverse Event|1|||
170592940|NCT02088073|616514240|FG000|Maintanance Phase|Physician Decision|0|||
170592941|NCT02088073|616514241|FG001|Maintanance Phase|Physician Decision|0|||
170592942|NCT02088073|616514242|FG002|Maintanance Phase|Physician Decision|0|||
170592943|NCT02088073|616514243|FG003|Maintanance Phase|Physician Decision|0|||
170592944|NCT02088073|616514244|FG004|Maintanance Phase|Physician Decision|1|||
170592945|NCT02088073|616514240|FG000|Maintanance Phase|Sponsor's decision|0|||
170592946|NCT02088073|616514241|FG001|Maintanance Phase|Sponsor's decision|2|||
170592947|NCT02088073|616514242|FG002|Maintanance Phase|Sponsor's decision|0|||
170592948|NCT02088073|616514243|FG003|Maintanance Phase|Sponsor's decision|2|||
170592949|NCT02088073|616514244|FG004|Maintanance Phase|Sponsor's decision|1|||
170592950|NCT02088073|616514240|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
170592951|NCT02088073|616514241|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
170592952|NCT02088073|616514242|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
170592953|NCT02088073|616514243|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
170592954|NCT02088073|616514244|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
170592955|NCT02088073|616514240|FG000|Maintanance Phase|Miscellaneous|0|||
170592956|NCT02088073|616514241|FG001|Maintanance Phase|Miscellaneous|2|||
170592957|NCT02088073|616514242|FG002|Maintanance Phase|Miscellaneous|1|||
170592958|NCT02088073|616514243|FG003|Maintanance Phase|Miscellaneous|2|||
170592959|NCT02088073|616514244|FG004|Maintanance Phase|Miscellaneous|1|||
170592960|NCT02088073|616514240|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
170592961|NCT02088073|616514241|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
170592962|NCT02088073|616514242|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
170592963|NCT02088073|616514243|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
170592964|NCT02088073|616514244|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
170592965|NCT02088073|616514240|FG000|Maintanance Phase|Subject compliance|0|||
170592966|NCT02088073|616514241|FG001|Maintanance Phase|Subject compliance|1|||
170592967|NCT02088073|616514242|FG002|Maintanance Phase|Subject compliance|0|||
170592968|NCT02088073|616514243|FG003|Maintanance Phase|Subject compliance|0|||
170592969|NCT02088073|616514244|FG004|Maintanance Phase|Subject compliance|0|||
170592970|NCT03060512|616514249|FG000|Overall Study|Adverse Event|4|||
170592971|NCT03060512|616514250|FG001|Overall Study|Adverse Event|6|||
170592972|NCT03060512|616514249|FG000|Overall Study|Lost to Follow-up|1|||
170650741|NCT00890045|616734450|FG000|Overall Study|Lost to Follow-up|5|||
170592973|NCT03060512|616514250|FG001|Overall Study|Lost to Follow-up|1|||
170592974|NCT03060512|616514249|FG000|Overall Study|Withdrawal by Subject|1|||
170592975|NCT03060512|616514250|FG001|Overall Study|Withdrawal by Subject|0|||
170592976|NCT03060512|616514249|FG000|Overall Study|Non-compliance with study medication|1|||
170592977|NCT03060512|616514250|FG001|Overall Study|Non-compliance with study medication|2|||
170592978|NCT02118597|616514251|FG000|Overall Study|Sponsor terminated the study|14|||
170592979|NCT02118597|616514251|FG000|Overall Study|Serious Adverse Event|1|||
170810769|NCT02159989|617315639|FG010|Overall Study|Withdrawal by Subject|0|||
170810770|NCT02159989|617315629|FG000|Overall Study|New treatment|0|||
170810771|NCT02159989|617315630|FG001|Overall Study|New treatment|1|||
170810772|NCT02159989|617315631|FG002|Overall Study|New treatment|0|||
170810773|NCT02159989|617315632|FG003|Overall Study|New treatment|0|||
170810774|NCT02159989|617315633|FG004|Overall Study|New treatment|0|||
170810775|NCT02159989|617315634|FG005|Overall Study|New treatment|0|||
170810776|NCT02159989|617315635|FG006|Overall Study|New treatment|0|||
170592980|NCT02118597|616514251|FG000|Overall Study|Investigator's decision|1|||
170592981|NCT00694096|616514254|FG000|Overall Study|Withdrawal by Subject|5|||
170592982|NCT02182440|616514258|FG000|Overall Study|Adverse Event|0|||
170592983|NCT02182440|616514259|FG001|Overall Study|Adverse Event|1|||
170592984|NCT02182440|616514260|FG002|Overall Study|Adverse Event|0|||
170592985|NCT02182440|616514261|FG003|Overall Study|Adverse Event|0|||
170592986|NCT02182440|616514258|FG000|Overall Study|Death|31|||
170592987|NCT02182440|616514259|FG001|Overall Study|Death|8|||
170592988|NCT02182440|616514260|FG002|Overall Study|Death|5|||
170592989|NCT02182440|616514261|FG003|Overall Study|Death|16|||
170592990|NCT02182440|616514258|FG000|Overall Study|Protocol Violation|0|||
170592991|NCT02182440|616514259|FG001|Overall Study|Protocol Violation|1|||
170592992|NCT02182440|616514260|FG002|Overall Study|Protocol Violation|0|||
170592993|NCT02182440|616514261|FG003|Overall Study|Protocol Violation|0|||
170592994|NCT02182440|616514258|FG000|Overall Study|Physician Decision|1|||
170592995|NCT02182440|616514259|FG001|Overall Study|Physician Decision|0|||
170592996|NCT02182440|616514260|FG002|Overall Study|Physician Decision|0|||
170592997|NCT02182440|616514261|FG003|Overall Study|Physician Decision|0|||
170592998|NCT02182440|616514258|FG000|Overall Study|Withdrawal by Subject|1|||
170592999|NCT02182440|616514259|FG001|Overall Study|Withdrawal by Subject|1|||
170593000|NCT02182440|616514260|FG002|Overall Study|Withdrawal by Subject|3|||
170593001|NCT02182440|616514261|FG003|Overall Study|Withdrawal by Subject|4|||
170593002|NCT02182440|616514258|FG000|Overall Study|different, e.g adm other hospital|12|||
170593003|NCT02182440|616514259|FG001|Overall Study|different, e.g adm other hospital|3|||
170593004|NCT02182440|616514260|FG002|Overall Study|different, e.g adm other hospital|3|||
170810777|NCT02159989|617315636|FG007|Overall Study|New treatment|0|||
170810778|NCT02159989|617315637|FG008|Overall Study|New treatment|0|||
170810779|NCT02159989|617315638|FG009|Overall Study|New treatment|0|||
170810780|NCT02159989|617315639|FG010|Overall Study|New treatment|0|||
170810781|NCT02159989|617315629|FG000|Overall Study|Insurance Issues|0|||
170810782|NCT02159989|617315630|FG001|Overall Study|Insurance Issues|0|||
170810783|NCT02159989|617315631|FG002|Overall Study|Insurance Issues|0|||
170810784|NCT02159989|617315632|FG003|Overall Study|Insurance Issues|0|||
170810785|NCT02159989|617315633|FG004|Overall Study|Insurance Issues|0|||
170810786|NCT02159989|617315634|FG005|Overall Study|Insurance Issues|0|||
170810787|NCT02159989|617315635|FG006|Overall Study|Insurance Issues|0|||
170810788|NCT02159989|617315636|FG007|Overall Study|Insurance Issues|0|||
170810789|NCT02159989|617315637|FG008|Overall Study|Insurance Issues|0|||
170810790|NCT02159989|617315638|FG009|Overall Study|Insurance Issues|1|||
170810791|NCT02159989|617315639|FG010|Overall Study|Insurance Issues|0|||
170810792|NCT04535414|617315640|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
170810793|NCT04535414|617315641|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
170810794|NCT04535414|617315640|FG000|Overall Study|Cancelled appointment|1|||
170810795|NCT04535414|617315641|FG001|Overall Study|Cancelled appointment|0|||
170810796|NCT04535414|617315640|FG000|Overall Study|cancelled - food in stomach|2|||
170593005|NCT02182440|616514261|FG003|Overall Study|different, e.g adm other hospital|10|||
170593006|NCT00072293|616514262|FG000|Overall Study|Lost to Follow-up|1|||
170593007|NCT00072293|616514263|FG001|Overall Study|Lost to Follow-up|1|||
170593008|NCT00072293|616514262|FG000|Overall Study|Withdrawal by Subject|0|||
170593009|NCT00072293|616514263|FG001|Overall Study|Withdrawal by Subject|1|||
170593010|NCT02680574|616514264|FG000|Overall Study|Death|137|||
170593011|NCT02680574|616514265|FG001|Overall Study|Death|137|||
170593012|NCT02680574|616514264|FG000|Overall Study|Withdrawal by Subject|17|||
170593013|NCT02680574|616514265|FG001|Overall Study|Withdrawal by Subject|9|||
170593014|NCT02680574|616514264|FG000|Overall Study|Lost to Follow-up|4|||
170593015|NCT02680574|616514265|FG001|Overall Study|Lost to Follow-up|6|||
170810797|NCT04535414|617315641|FG001|Overall Study|cancelled - food in stomach|0|||
170810798|NCT04535414|617315640|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
170810799|NCT04535414|617315641|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
170650742|NCT00890045|616734451|FG001|Overall Study|Lost to Follow-up|7|||
170810800|NCT04535414|617315640|FG000|Overall Study|Withdrawal by Subject|0|||
170650743|NCT00483756|616734452|FG000|Overall Study|Death|2|||
170810801|NCT04535414|617315641|FG001|Overall Study|Withdrawal by Subject|1|||
170593016|NCT02594098|616514268|FG000|Overall Study|Lack of Efficacy|17|||
170593017|NCT02594098|616514269|FG001|Overall Study|Lack of Efficacy|6|||
170593018|NCT02594098|616514268|FG000|Overall Study|Withdrawal by Subject|1|||
170593019|NCT02594098|616514269|FG001|Overall Study|Withdrawal by Subject|3|||
170593020|NCT02594098|616514268|FG000|Overall Study|Terminated participation|6|||
170593021|NCT02594098|616514269|FG001|Overall Study|Terminated participation|2|||
170810802|NCT01848483|617317406|FG000|Overall Study|Death|2|||
170593022|NCT02594098|616514268|FG000|Overall Study|Seek alternative treatment|2|||
170593023|NCT02594098|616514269|FG001|Overall Study|Seek alternative treatment|1|||
170593024|NCT02594098|616514268|FG000|Overall Study|Other|0|||
170593025|NCT02594098|616514269|FG001|Overall Study|Other|1|||
170593026|NCT01813721|616514270|FG000|Overall Study|Ineligibility determined|63|||
170593027|NCT01813721|616514270|FG000|Overall Study|Withdrawal by Subject|1|||
170593028|NCT02370641|616514271|FG000|Overall Study|dropped study|4|||
170593029|NCT02370641|616514272|FG001|Overall Study|dropped study|2|||
170593030|NCT02133664|616514275|FG000|Overall Study|Lost to Follow-up|2|||
170593031|NCT02133664|616514276|FG001|Overall Study|Lost to Follow-up|1|||
170593032|NCT02133664|616514275|FG000|Overall Study|Adverse Event|3|||
170593033|NCT02133664|616514276|FG001|Overall Study|Adverse Event|6|||
170593034|NCT01036529|616514277|FG000|Overall Study|Adverse Event|0|||
170593035|NCT01036529|616514278|FG001|Overall Study|Adverse Event|1|||
170593036|NCT01036529|616514277|FG000|Overall Study|Lost to Follow-up|0|||
170593037|NCT01036529|616514278|FG001|Overall Study|Lost to Follow-up|1|||
170593038|NCT01036529|616514277|FG000|Overall Study|Physician Decision|1|||
170593039|NCT01036529|616514278|FG001|Overall Study|Physician Decision|0|||
170593040|NCT01036529|616514277|FG000|Overall Study|Withdrawal by Subject|1|||
170593041|NCT01036529|616514278|FG001|Overall Study|Withdrawal by Subject|1|||
170593042|NCT01036529|616514277|FG000|Overall Study|Sponsor study termination|11|||
170593043|NCT01036529|616514278|FG001|Overall Study|Sponsor study termination|12|||
170593044|NCT00541099|616514279|FG000|Overall Study|Ineligible|3|||
170593045|NCT03271047|616514280|FG000|Phase 1b: Dose Finding Period|Death|8|||
170593046|NCT03271047|616514281|FG001|Phase 1b: Dose Finding Period|Death|8|||
170593047|NCT03271047|616514282|FG002|Phase 1b: Dose Finding Period|Death|0|||
170593048|NCT03271047|616514283|FG003|Phase 1b: Dose Finding Period|Death|0|||
170593049|NCT03271047|616514280|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
170593050|NCT03271047|616514281|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
170593051|NCT03271047|616514282|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
170593052|NCT03271047|616514283|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
170593053|NCT03271047|616514280|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
170593054|NCT03271047|616514281|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
170593055|NCT03271047|616514282|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
170593056|NCT03271047|616514283|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
170593057|NCT03271047|616514280|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
170593058|NCT03271047|616514281|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
170593059|NCT03271047|616514282|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
170593060|NCT03271047|616514283|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
170593061|NCT03271047|616514280|FG000|Randomized Phase 2 Period|Other|0|||
170593062|NCT03271047|616514281|FG001|Randomized Phase 2 Period|Other|0|||
170593063|NCT03271047|616514282|FG002|Randomized Phase 2 Period|Other|0|||
170593064|NCT03271047|616514283|FG003|Randomized Phase 2 Period|Other|1|||
170593065|NCT03271047|616514280|FG000|Randomized Phase 2 Period|Death|0|||
170593066|NCT03271047|616514281|FG001|Randomized Phase 2 Period|Death|0|||
170593067|NCT03271047|616514282|FG002|Randomized Phase 2 Period|Death|20|||
170593068|NCT03271047|616514283|FG003|Randomized Phase 2 Period|Death|21|||
170593069|NCT03271047|616514280|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
170593070|NCT03271047|616514281|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
170593071|NCT03271047|616514282|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
170593072|NCT03271047|616514283|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
170593073|NCT03271047|616514280|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
170593074|NCT03271047|616514281|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
170593075|NCT03271047|616514282|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
170593076|NCT03271047|616514283|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
170593077|NCT03271047|616514280|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
170593078|NCT03271047|616514281|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
170593079|NCT03271047|616514282|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
170593080|NCT03271047|616514283|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
170593081|NCT03283150|616514285|FG000|Overall Study|Withdrawal by Subject|6|||
170593082|NCT03283150|616514286|FG001|Overall Study|Withdrawal by Subject|0|||
170593083|NCT03283150|616514287|FG002|Overall Study|Withdrawal by Subject|0|||
170593084|NCT02370095|616514288|FG000|Overall Study|Withdrawal by Subject|0|||
170593085|NCT02370095|616514289|FG001|Overall Study|Withdrawal by Subject|1|||
170593086|NCT02525939|616514293|FG000|Overall Study|Lost to Follow-up|27|||
170593087|NCT02525939|616514294|FG001|Overall Study|Lost to Follow-up|24|||
170593088|NCT02525939|616514293|FG000|Overall Study|Physician Decision|0|||
170593089|NCT02525939|616514294|FG001|Overall Study|Physician Decision|1|||
170593090|NCT02525939|616514293|FG000|Overall Study|Withdrawal by Subject|24|||
170593091|NCT02525939|616514294|FG001|Overall Study|Withdrawal by Subject|39|||
170593092|NCT02525939|616514293|FG000|Overall Study|Death|180|||
170593093|NCT02525939|616514294|FG001|Overall Study|Death|179|||
170593094|NCT05590000|616514295|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
170593095|NCT00392808|616514297|FG000|Overall Study|Lost to Follow-up|3|||
170593096|NCT00392808|616514298|FG001|Overall Study|Lost to Follow-up|2|||
170593097|NCT00392808|616514299|FG002|Overall Study|Lost to Follow-up|1|||
170593098|NCT00392808|616514300|FG003|Overall Study|Lost to Follow-up|2|||
170593099|NCT00392808|616514297|FG000|Overall Study|Unable to withdraw blood|3|||
170593100|NCT00392808|616514298|FG001|Overall Study|Unable to withdraw blood|1|||
170593101|NCT00392808|616514299|FG002|Overall Study|Unable to withdraw blood|1|||
170593102|NCT00392808|616514300|FG003|Overall Study|Unable to withdraw blood|2|||
170593103|NCT00042432|616514303|FG000|Overall Study|Adverse Event|4|||
170593104|NCT00042432|616514304|FG001|Overall Study|Adverse Event|1|||
170593105|NCT00042432|616514303|FG000|Overall Study|Withdrawal by Subject|1|||
170593106|NCT00042432|616514304|FG001|Overall Study|Withdrawal by Subject|3|||
170593107|NCT00042432|616514303|FG000|Overall Study|Death|0|||
170593108|NCT00042432|616514304|FG001|Overall Study|Death|2|||
170593109|NCT00042432|616514303|FG000|Overall Study|Ineligibility determined|1|||
170593110|NCT00042432|616514304|FG001|Overall Study|Ineligibility determined|0|||
170593111|NCT00042432|616514303|FG000|Overall Study|Initiation of maintenance dialysis|1|||
170593112|NCT00042432|616514304|FG001|Overall Study|Initiation of maintenance dialysis|1|||
170593113|NCT00042432|616514303|FG000|Overall Study|Other|2|||
170593114|NCT00042432|616514304|FG001|Overall Study|Other|0|||
170593115|NCT01853072|616514305|FG000|Overall Study|Adverse event prior to treatment|0|||
170593116|NCT01853072|616514306|FG001|Overall Study|Adverse event prior to treatment|1|||
170593117|NCT01853072|616514305|FG000|Overall Study|Adverse Event|0|||
170593118|NCT01853072|616514306|FG001|Overall Study|Adverse Event|3|||
170593119|NCT01853072|616514305|FG000|Overall Study|Death|1|||
170593120|NCT01853072|616514306|FG001|Overall Study|Death|4|||
170593121|NCT01853072|616514305|FG000|Overall Study|Lost to Follow-up|0|||
170593122|NCT01853072|616514306|FG001|Overall Study|Lost to Follow-up|3|||
170593123|NCT01853072|616514305|FG000|Overall Study|Non-compliance with study drug|0|||
170593124|NCT01853072|616514306|FG001|Overall Study|Non-compliance with study drug|1|||
170593125|NCT01853072|616514305|FG000|Overall Study|Physician Decision|1|||
170593126|NCT01853072|616514306|FG001|Overall Study|Physician Decision|1|||
170593127|NCT01853072|616514305|FG000|Overall Study|Withdrawal by Subject|1|||
170593128|NCT01853072|616514306|FG001|Overall Study|Withdrawal by Subject|2|||
170593129|NCT01853072|616514305|FG000|Overall Study|Reason not specified|9|||
170593130|NCT01853072|616514306|FG001|Overall Study|Reason not specified|6|||
170593131|NCT01527383|616514307|FG000|Overall Study|Adverse Event|5|||
170593132|NCT01527383|616514308|FG001|Overall Study|Adverse Event|0|||
170593133|NCT01527383|616514307|FG000|Overall Study|Lost to Follow-up|3|||
170593134|NCT01527383|616514308|FG001|Overall Study|Lost to Follow-up|0|||
170593135|NCT01527383|616514307|FG000|Overall Study|Physician Decision|2|||
170593136|NCT01527383|616514308|FG001|Overall Study|Physician Decision|0|||
170593137|NCT01527383|616514307|FG000|Overall Study|Pregnancy|1|||
170593138|NCT01527383|616514308|FG001|Overall Study|Pregnancy|0|||
170593139|NCT01527383|616514307|FG000|Overall Study|Protocol Violation|1|||
170593140|NCT01527383|616514308|FG001|Overall Study|Protocol Violation|0|||
170593141|NCT01527383|616514307|FG000|Overall Study|Screen failure|1|||
170593142|NCT01527383|616514308|FG001|Overall Study|Screen failure|0|||
170593143|NCT01527383|616514307|FG000|Overall Study|Participant moved|0|||
170593144|NCT01527383|616514308|FG001|Overall Study|Participant moved|1|||
170593145|NCT01527383|616514307|FG000|Overall Study|Withdrawal by Subject|2|||
170593146|NCT01527383|616514308|FG001|Overall Study|Withdrawal by Subject|3|||
170593147|NCT03081858|616516267|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
170593148|NCT03081858|616516268|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
170593149|NCT03081858|616516269|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
170593150|NCT03081858|616516270|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
170593151|NCT00664326|616516277|FG000|Overall Study|Adverse Event|14|||
170593152|NCT00664326|616516277|FG000|Overall Study|Noncompliance with study medication|3|||
170593153|NCT00664326|616516277|FG000|Overall Study|Withdrawal by Subject|1|||
170593154|NCT00664326|616516277|FG000|Overall Study|Physician Decision|1|||
170593155|NCT00664326|616516277|FG000|Overall Study|Other Reasons|3|||
170593156|NCT00664326|616516277|FG000|Overall Study|Death|2|||
170593157|NCT00664326|616516277|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
170593158|NCT00387647|616516278|FG000|Overall Study|Death|18|||
170593159|NCT00758589|616516279|FG000|Overall Study|Adverse Event|3|||
170593160|NCT00758589|616516280|FG001|Overall Study|Adverse Event|2|||
170810803|NCT01848483|617317407|FG001|Overall Study|Death|1|||
170810804|NCT01848483|617317406|FG000|Overall Study|Lost to Follow-up|6|||
170593161|NCT00758589|616516281|FG002|Overall Study|Adverse Event|5|||
170593162|NCT00758589|616516282|FG003|Overall Study|Adverse Event|4|||
170810805|NCT01848483|617317407|FG001|Overall Study|Lost to Follow-up|8|||
170593163|NCT00758589|616516279|FG000|Overall Study|Withdrawal by Subject|0|||
170593164|NCT00758589|616516280|FG001|Overall Study|Withdrawal by Subject|1|||
170593165|NCT00758589|616516281|FG002|Overall Study|Withdrawal by Subject|1|||
170593166|NCT00758589|616516282|FG003|Overall Study|Withdrawal by Subject|1|||
170593167|NCT00758589|616516279|FG000|Overall Study|Palm stopped to work|0|||
170593168|NCT00758589|616516280|FG001|Overall Study|Palm stopped to work|0|||
170911876|NCT02699515|617682041|FG001|Overall Study|Withdrawal by Subject|0|||
170911877|NCT02699515|617682042|FG002|Overall Study|Withdrawal by Subject|3|||
170911878|NCT02699515|617682043|FG003|Overall Study|Withdrawal by Subject|1|||
170911879|NCT02699515|617682044|FG004|Overall Study|Withdrawal by Subject|5|||
170911880|NCT02699515|617682045|FG005|Overall Study|Withdrawal by Subject|3|||
170911881|NCT02699515|617682046|FG006|Overall Study|Withdrawal by Subject|0|||
170911882|NCT02699515|617682047|FG007|Overall Study|Withdrawal by Subject|1|||
170911883|NCT02699515|617682040|FG000|Overall Study|Other|1|||
170911884|NCT02699515|617682041|FG001|Overall Study|Other|0|||
170911885|NCT02699515|617682042|FG002|Overall Study|Other|1|||
170911886|NCT02699515|617682043|FG003|Overall Study|Other|6|||
170911887|NCT02699515|617682044|FG004|Overall Study|Other|4|||
170911888|NCT02699515|617682045|FG005|Overall Study|Other|3|||
170911889|NCT02699515|617682046|FG006|Overall Study|Other|0|||
170911890|NCT02699515|617682047|FG007|Overall Study|Other|0|||
170911891|NCT05243550|617682048|FG000|Overall Study|Ongoing in the Study|171|||
170911892|NCT05243550|617682048|FG000|Overall Study|Withdrawal by Subject|10|||
170593169|NCT00758589|616516281|FG002|Overall Study|Palm stopped to work|0|||
170593170|NCT00758589|616516282|FG003|Overall Study|Palm stopped to work|1|||
170593171|NCT01309269|616516285|FG000|Overall Study|Adverse Event|56|||
170593172|NCT01309269|616516285|FG000|Overall Study|Withdrawal by Subject|25|||
170593173|NCT01309269|616516285|FG000|Overall Study|Lack of Acceptance|15|||
170593174|NCT01309269|616516285|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
170593175|NCT01309269|616516285|FG000|Overall Study|Kidney Transplant|25|||
170593176|NCT01309269|616516285|FG000|Overall Study|Administrative Problems|141|||
170593177|NCT01309269|616516285|FG000|Overall Study|Other|256|||
170593178|NCT01309269|616516285|FG000|Overall Study|Other|1|||
170593179|NCT01309269|616516285|FG000|Overall Study|Study Completion Data Not Recorded|95|||
170593180|NCT01309269|616516285|FG000|Overall Study|Enrolled but not Treated|107|||
170593181|NCT00241631|616516306|FG000|Run in (2 Weeks)|Physician Decision|3|||
170593182|NCT00241631|616516307|FG001|Run in (2 Weeks)|Physician Decision|3|||
170593183|NCT00241631|616516306|FG000|Phase 1 (4 Weeks)|sore throat|1|||
170593184|NCT00241631|616516307|FG001|Phase 1 (4 Weeks)|sore throat|0|||
170593185|NCT00241631|616516306|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
170593186|NCT00241631|616516307|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
170593187|NCT00241631|616516306|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
170593188|NCT00241631|616516307|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
170593189|NCT00241631|616516306|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
170593190|NCT00241631|616516307|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
170593191|NCT03958656|616516308|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
170593192|NCT03958656|616516309|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
170593193|NCT03958656|616516310|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
170593194|NCT03958656|616516311|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
170593195|NCT03958656|616516308|FG000|Overall Study|No longer meets eligibility criteria|0|||
170593196|NCT03958656|616516309|FG001|Overall Study|No longer meets eligibility criteria|0|||
170593197|NCT03958656|616516310|FG002|Overall Study|No longer meets eligibility criteria|1|||
170593198|NCT03958656|616516311|FG003|Overall Study|No longer meets eligibility criteria|0|||
170593199|NCT03958656|616516308|FG000|Overall Study|Started anti-cancer treatment|0|||
170593200|NCT03958656|616516309|FG001|Overall Study|Started anti-cancer treatment|0|||
170593201|NCT03958656|616516310|FG002|Overall Study|Started anti-cancer treatment|1|||
170593202|NCT03958656|616516311|FG003|Overall Study|Started anti-cancer treatment|0|||
170593203|NCT01767493|616516314|FG000|Overall Study|screen failures|3|||
170593204|NCT03444766|616516317|FG000|Overall Study|Other Reasons|2|||
170593205|NCT03444766|616516317|FG000|Overall Study|Participant Withdrew Consent|5|||
170593206|NCT03444766|616516317|FG000|Overall Study|Lost to Follow-up|2|||
170593207|NCT03444766|616516317|FG000|Overall Study|Death|2|||
170593208|NCT03444766|616516317|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
170593209|NCT03444766|616516317|FG000|Overall Study|Disease Progression|49|||
170593210|NCT02788201|616516318|FG000|Overall Study|Death|1|||
170593211|NCT02788201|616516319|FG001|Overall Study|Death|1|||
170593212|NCT02788201|616516320|FG002|Overall Study|Death|1|||
170593213|NCT02788201|616516321|FG003|Overall Study|Death|1|||
170593214|NCT02788201|616516322|FG004|Overall Study|Death|0|||
170911893|NCT05243550|617682048|FG000|Overall Study|Lost to Follow-up|7|||
170911894|NCT05243550|617682048|FG000|Overall Study|Adverse Event|3|||
170593215|NCT02788201|616516323|FG005|Overall Study|Death|1|||
170593216|NCT02788201|616516318|FG000|Overall Study|Ineligible|0|||
170593217|NCT02788201|616516319|FG001|Overall Study|Ineligible|0|||
170593218|NCT02788201|616516320|FG002|Overall Study|Ineligible|0|||
170911895|NCT05243550|617682048|FG000|Overall Study|Noncompliance|1|||
170911896|NCT05243550|617682048|FG000|Overall Study|Physician Decision|1|||
170593219|NCT02788201|616516321|FG003|Overall Study|Ineligible|0|||
170911897|NCT05243550|617682048|FG000|Overall Study|Other Reason|4|||
170911898|NCT02031146|617682049|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
170911899|NCT02031146|617682050|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
170911900|NCT02031146|617682051|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
170911901|NCT02031146|617682052|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
170911902|NCT02031146|617682053|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
170911903|NCT02031146|617682054|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
170911904|NCT02031146|617682055|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
170911905|NCT01486316|617682056|FG000|Overall Study|Device explanted with/without re-implant|3|||
170593220|NCT02788201|616516322|FG004|Overall Study|Ineligible|0|||
170593221|NCT02788201|616516323|FG005|Overall Study|Ineligible|1|||
170593222|NCT02788201|616516318|FG000|Overall Study|Withdrawal by Subject|0|||
170593223|NCT02788201|616516319|FG001|Overall Study|Withdrawal by Subject|0|||
170593224|NCT02788201|616516320|FG002|Overall Study|Withdrawal by Subject|0|||
170593225|NCT02788201|616516321|FG003|Overall Study|Withdrawal by Subject|0|||
170593226|NCT02788201|616516322|FG004|Overall Study|Withdrawal by Subject|0|||
170593227|NCT02788201|616516323|FG005|Overall Study|Withdrawal by Subject|1|||
170593228|NCT02214225|616516324|FG000|Overall Study|Lost to Follow-up|46|||
170593229|NCT02214225|616516325|FG001|Overall Study|Lost to Follow-up|18|||
170593230|NCT02214225|616516326|FG002|Overall Study|Lost to Follow-up|18|||
170593231|NCT02214225|616516324|FG000|Overall Study|Withdrawal by Subject|2|||
170593232|NCT02214225|616516325|FG001|Overall Study|Withdrawal by Subject|0|||
170593233|NCT02214225|616516326|FG002|Overall Study|Withdrawal by Subject|2|||
170593234|NCT02214225|616516324|FG000|Overall Study|Death|5|||
170593235|NCT02214225|616516325|FG001|Overall Study|Death|0|||
170593236|NCT02214225|616516326|FG002|Overall Study|Death|1|||
170593237|NCT02214225|616516324|FG000|Overall Study|randomized in error, not vaccinated|2|||
170593238|NCT02214225|616516325|FG001|Overall Study|randomized in error, not vaccinated|1|||
170593239|NCT02214225|616516326|FG002|Overall Study|randomized in error, not vaccinated|1|||
170593240|NCT03987932|616516327|FG000|Overall Study|Lost to Follow-up|2|||
170593241|NCT03987932|616516328|FG001|Overall Study|Lost to Follow-up|1|||
170593242|NCT03987932|616516329|FG002|Overall Study|Lost to Follow-up|1|||
170593243|NCT03987932|616516327|FG000|Overall Study|Non-study related elective surgery|0|||
170593244|NCT03987932|616516328|FG001|Overall Study|Non-study related elective surgery|0|||
170593245|NCT03987932|616516329|FG002|Overall Study|Non-study related elective surgery|1|||
170593246|NCT01669421|616516333|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
170593247|NCT01669421|616516333|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
170593248|NCT02813668|616516336|FG000|Overall Study|Death|4|||
170593249|NCT02813668|616516336|FG000|Overall Study|Lost to Follow-up|509|||
170593250|NCT02813668|616516336|FG000|Overall Study|Withdrawal by Subject|148|||
170593251|NCT02813668|616516336|FG000|Overall Study|No longer at worksite|85|||
170593252|NCT02813668|616516336|FG000|Overall Study|Medical reasons not related to the study|4|||
170593253|NCT00681564|616516337|FG000|Overall Study|Lost to Follow-up|6|||
170593254|NCT00681564|616516338|FG001|Overall Study|Lost to Follow-up|6|||
170593255|NCT00681564|616516337|FG000|Overall Study|Withdrawal by Subject|0|||
170593256|NCT00681564|616516338|FG001|Overall Study|Withdrawal by Subject|1|||
170593257|NCT00681564|616516337|FG000|Overall Study|Death|0|||
170593258|NCT00681564|616516338|FG001|Overall Study|Death|1|||
170593259|NCT04662073|616516339|FG000|Overall Study|Withdrawal by Subject|1|||
170593260|NCT04662073|616516340|FG001|Overall Study|Withdrawal by Subject|0|||
170593261|NCT02961790|616516341|FG000|Overall Study|Canceled|4|||
170593262|NCT02961790|616516342|FG001|Overall Study|Canceled|5|||
170593263|NCT02961790|616516343|FG002|Overall Study|Canceled|1|||
170593264|NCT02961790|616516344|FG003|Overall Study|Canceled|4|||
170593265|NCT02961790|616516341|FG000|Overall Study|without baseline data|4|||
170593266|NCT02961790|616516342|FG001|Overall Study|without baseline data|0|||
170593267|NCT02961790|616516343|FG002|Overall Study|without baseline data|1|||
170593268|NCT02961790|616516344|FG003|Overall Study|without baseline data|0|||
170593269|NCT02961790|616516341|FG000|Overall Study|without post baseline data|7|||
170593270|NCT02961790|616516342|FG001|Overall Study|without post baseline data|6|||
170593271|NCT02961790|616516343|FG002|Overall Study|without post baseline data|4|||
170593272|NCT02961790|616516344|FG003|Overall Study|without post baseline data|1|||
170593273|NCT01866423|616516348|FG000|Overall Study|Lack of Efficacy|3|||
170593274|NCT01866423|616516348|FG000|Overall Study|Sponsor Decision|1|||
170593275|NCT02387164|616516349|FG000|Overall Study|Lost to Follow-up|2|||
170593276|NCT02387164|616516350|FG001|Overall Study|Lost to Follow-up|0|||
170593277|NCT02387164|616516349|FG000|Overall Study|Diagnosed|1|||
170593278|NCT02387164|616516350|FG001|Overall Study|Diagnosed|2|||
170593279|NCT03366103|616516351|FG000|Overall Study|Disease Progression|3|||
170593280|NCT03366103|616516352|FG001|Overall Study|Disease Progression|1|||
170593281|NCT03366103|616516353|FG002|Overall Study|Disease Progression|0|||
170593282|NCT03366103|616516351|FG000|Overall Study|Adverse Event|0|||
170593283|NCT03366103|616516352|FG001|Overall Study|Adverse Event|1|||
170593284|NCT03366103|616516353|FG002|Overall Study|Adverse Event|0|||
170593285|NCT01319721|616516365|FG000|Overall Study|Lost to Follow-up|1|||
170593286|NCT01319721|616516366|FG001|Overall Study|Lost to Follow-up|6|||
170593287|NCT02653495|616516370|FG000|Overall Study|Lost to Follow-up|2|||
170593288|NCT02653495|616516371|FG001|Overall Study|Lost to Follow-up|0|||
170593289|NCT02653495|616516370|FG000|Overall Study|Screening Failure|10|||
170593290|NCT02653495|616516371|FG001|Overall Study|Screening Failure|0|||
170593291|NCT03515941|616516374|FG000|Overall Study|Adverse Event|1|||
170593292|NCT03515941|616516375|FG001|Overall Study|Adverse Event|0|||
170593293|NCT00468845|616516376|FG000|Overall Study|Adverse Event|9|||
170593294|NCT00468845|616516377|FG001|Overall Study|Adverse Event|14|||
170593295|NCT00468845|616516378|FG002|Overall Study|Adverse Event|11|||
170593296|NCT00468845|616516376|FG000|Overall Study|Lost to Follow-up|2|||
170593297|NCT00468845|616516377|FG001|Overall Study|Lost to Follow-up|1|||
170593298|NCT00468845|616516378|FG002|Overall Study|Lost to Follow-up|2|||
170593299|NCT00468845|616516376|FG000|Overall Study|Other|4|||
170593300|NCT00468845|616516377|FG001|Overall Study|Other|9|||
170593301|NCT00468845|616516378|FG002|Overall Study|Other|5|||
170593302|NCT00468845|616516376|FG000|Overall Study|No longer willing to participate|5|||
170593303|NCT00468845|616516377|FG001|Overall Study|No longer willing to participate|6|||
170593304|NCT00468845|616516378|FG002|Overall Study|No longer willing to participate|10|||
170593305|NCT00468845|616516376|FG000|Overall Study|Randomized, not treated|1|||
170593306|NCT00468845|616516377|FG001|Overall Study|Randomized, not treated|4|||
170593307|NCT00468845|616516378|FG002|Overall Study|Randomized, not treated|2|||
170593308|NCT02761694|616516379|FG000|Overall Study|Lack of Efficacy|0|||
170593309|NCT02761694|616516380|FG001|Overall Study|Lack of Efficacy|0|||
170593310|NCT02761694|616516381|FG002|Overall Study|Lack of Efficacy|0|||
170593311|NCT02761694|616516382|FG003|Overall Study|Lack of Efficacy|0|||
170593312|NCT02761694|616516383|FG004|Overall Study|Lack of Efficacy|0|||
170593313|NCT02761694|616516384|FG005|Overall Study|Lack of Efficacy|0|||
170593314|NCT02761694|616516385|FG006|Overall Study|Lack of Efficacy|6|||
170593315|NCT02761694|616516386|FG007|Overall Study|Lack of Efficacy|0|||
170593316|NCT02761694|616516387|FG008|Overall Study|Lack of Efficacy|0|||
170593317|NCT02761694|616516388|FG009|Overall Study|Lack of Efficacy|1|||
170593318|NCT02761694|616516389|FG010|Overall Study|Lack of Efficacy|1|||
170593319|NCT02761694|616516390|FG011|Overall Study|Lack of Efficacy|4|||
170593320|NCT02761694|616516379|FG000|Overall Study|Death|0|||
170593321|NCT02761694|616516380|FG001|Overall Study|Death|0|||
170593322|NCT02761694|616516381|FG002|Overall Study|Death|0|||
170593323|NCT02761694|616516382|FG003|Overall Study|Death|0|||
170593324|NCT02761694|616516383|FG004|Overall Study|Death|0|||
170593325|NCT02761694|616516384|FG005|Overall Study|Death|0|||
170593326|NCT02761694|616516385|FG006|Overall Study|Death|2|||
170593327|NCT02761694|616516386|FG007|Overall Study|Death|0|||
170593328|NCT02761694|616516387|FG008|Overall Study|Death|2|||
170593329|NCT02761694|616516388|FG009|Overall Study|Death|2|||
170593330|NCT02761694|616516389|FG010|Overall Study|Death|1|||
170593331|NCT02761694|616516390|FG011|Overall Study|Death|0|||
170593332|NCT02761694|616516379|FG000|Overall Study|Physician Decision|0|||
170593333|NCT02761694|616516380|FG001|Overall Study|Physician Decision|0|||
170593334|NCT02761694|616516381|FG002|Overall Study|Physician Decision|0|||
170593335|NCT02761694|616516382|FG003|Overall Study|Physician Decision|0|||
170593336|NCT02761694|616516383|FG004|Overall Study|Physician Decision|0|||
170593337|NCT02761694|616516384|FG005|Overall Study|Physician Decision|0|||
170593338|NCT02761694|616516385|FG006|Overall Study|Physician Decision|1|||
170593339|NCT02761694|616516386|FG007|Overall Study|Physician Decision|0|||
170593340|NCT02761694|616516387|FG008|Overall Study|Physician Decision|0|||
170593341|NCT02761694|616516388|FG009|Overall Study|Physician Decision|0|||
170593342|NCT02761694|616516389|FG010|Overall Study|Physician Decision|0|||
170593343|NCT02761694|616516390|FG011|Overall Study|Physician Decision|0|||
170593344|NCT02761694|616516379|FG000|Overall Study|Withdrawal by Subject|0|||
170593345|NCT02761694|616516380|FG001|Overall Study|Withdrawal by Subject|0|||
170593346|NCT02761694|616516381|FG002|Overall Study|Withdrawal by Subject|0|||
170593347|NCT02761694|616516382|FG003|Overall Study|Withdrawal by Subject|1|||
170593348|NCT02761694|616516383|FG004|Overall Study|Withdrawal by Subject|0|||
170593349|NCT02761694|616516384|FG005|Overall Study|Withdrawal by Subject|0|||
170593350|NCT02761694|616516385|FG006|Overall Study|Withdrawal by Subject|4|||
170593351|NCT02761694|616516386|FG007|Overall Study|Withdrawal by Subject|0|||
170810806|NCT01848483|617317406|FG000|Overall Study|Withdrawal by Subject|1|||
170810807|NCT01848483|617317407|FG001|Overall Study|Withdrawal by Subject|0|||
170593352|NCT02761694|616516387|FG008|Overall Study|Withdrawal by Subject|2|||
170593353|NCT02761694|616516388|FG009|Overall Study|Withdrawal by Subject|1|||
170593354|NCT02761694|616516389|FG010|Overall Study|Withdrawal by Subject|0|||
170593355|NCT02761694|616516390|FG011|Overall Study|Withdrawal by Subject|0|||
170593356|NCT02761694|616516379|FG000|Overall Study|Lost to Follow-up|0|||
170593357|NCT02761694|616516380|FG001|Overall Study|Lost to Follow-up|0|||
170593358|NCT02761694|616516381|FG002|Overall Study|Lost to Follow-up|0|||
170593359|NCT02761694|616516382|FG003|Overall Study|Lost to Follow-up|0|||
170593360|NCT02761694|616516383|FG004|Overall Study|Lost to Follow-up|0|||
170593361|NCT02761694|616516384|FG005|Overall Study|Lost to Follow-up|0|||
170593362|NCT02761694|616516385|FG006|Overall Study|Lost to Follow-up|1|||
170593363|NCT02761694|616516386|FG007|Overall Study|Lost to Follow-up|0|||
170593364|NCT02761694|616516387|FG008|Overall Study|Lost to Follow-up|0|||
170593365|NCT02761694|616516388|FG009|Overall Study|Lost to Follow-up|0|||
170593366|NCT02761694|616516389|FG010|Overall Study|Lost to Follow-up|0|||
170593367|NCT02761694|616516390|FG011|Overall Study|Lost to Follow-up|1|||
170593368|NCT02761694|616516379|FG000|Overall Study|Adverse Event|0|||
170593369|NCT02761694|616516380|FG001|Overall Study|Adverse Event|0|||
170593370|NCT02761694|616516381|FG002|Overall Study|Adverse Event|0|||
170593371|NCT02761694|616516382|FG003|Overall Study|Adverse Event|0|||
170593372|NCT02761694|616516383|FG004|Overall Study|Adverse Event|0|||
170593373|NCT02761694|616516384|FG005|Overall Study|Adverse Event|0|||
170593374|NCT02761694|616516385|FG006|Overall Study|Adverse Event|1|||
170593375|NCT02761694|616516386|FG007|Overall Study|Adverse Event|0|||
170593376|NCT02761694|616516387|FG008|Overall Study|Adverse Event|1|||
170593377|NCT02761694|616516388|FG009|Overall Study|Adverse Event|0|||
170593378|NCT02761694|616516389|FG010|Overall Study|Adverse Event|0|||
170593379|NCT02761694|616516390|FG011|Overall Study|Adverse Event|1|||
170593380|NCT02761694|616516379|FG000|Overall Study|Other|4|||
170593381|NCT02761694|616516380|FG001|Overall Study|Other|4|||
170593382|NCT02761694|616516381|FG002|Overall Study|Other|1|||
170593383|NCT02761694|616516382|FG003|Overall Study|Other|2|||
170593384|NCT02761694|616516383|FG004|Overall Study|Other|3|||
170593385|NCT02761694|616516384|FG005|Overall Study|Other|3|||
170593386|NCT02761694|616516385|FG006|Overall Study|Other|18|||
170593387|NCT02761694|616516386|FG007|Overall Study|Other|8|||
170593388|NCT02761694|616516387|FG008|Overall Study|Other|0|||
170593389|NCT02761694|616516388|FG009|Overall Study|Other|1|||
170593390|NCT02761694|616516389|FG010|Overall Study|Other|1|||
170593391|NCT02761694|616516390|FG011|Overall Study|Other|0|||
170593392|NCT02395055|616516399|FG000|Overall Study|Withdrawal by Subject|7|||
170593393|NCT02395055|616516400|FG001|Overall Study|Withdrawal by Subject|3|||
170593394|NCT01896271|616516401|FG000|Overall Study|Physician Decision|10|||
170593395|NCT03002623|616516405|FG000|Overall Study|Lost to Follow-up|1|||
170593396|NCT03002623|616516406|FG001|Overall Study|Lost to Follow-up|0|||
170593397|NCT03002623|616516405|FG000|Overall Study|Physician Decision|1|||
170593398|NCT03002623|616516406|FG001|Overall Study|Physician Decision|1|||
170593399|NCT00844805|616516409|FG000|Treatment Phase|Adverse Event|5|||
170593400|NCT00844805|616516410|FG001|Treatment Phase|Adverse Event|1|||
170593401|NCT00844805|616516411|FG002|Treatment Phase|Adverse Event|0|||
170593402|NCT00844805|616516412|FG003|Treatment Phase|Adverse Event|0|||
170593403|NCT00844805|616516409|FG000|Treatment Phase|Withdrawal by Subject|3|||
170593404|NCT00844805|616516410|FG001|Treatment Phase|Withdrawal by Subject|4|||
170593405|NCT00844805|616516411|FG002|Treatment Phase|Withdrawal by Subject|0|||
170593406|NCT00844805|616516412|FG003|Treatment Phase|Withdrawal by Subject|0|||
170593407|NCT00844805|616516409|FG000|Treatment Phase|Noncompliance With Protocol|1|||
170593408|NCT00844805|616516410|FG001|Treatment Phase|Noncompliance With Protocol|0|||
170593409|NCT00844805|616516411|FG002|Treatment Phase|Noncompliance With Protocol|0|||
170593410|NCT00844805|616516412|FG003|Treatment Phase|Noncompliance With Protocol|0|||
170593411|NCT00844805|616516409|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
170650744|NCT00483756|616734453|FG001|Overall Study|Death|0|||
170650745|NCT00483756|616734454|FG002|Overall Study|Death|1|||
170650746|NCT00483756|616734452|FG000|Overall Study|Adverse Event|19|||
170650747|NCT00483756|616734453|FG001|Overall Study|Adverse Event|38|||
170650748|NCT00483756|616734454|FG002|Overall Study|Adverse Event|40|||
170650749|NCT00483756|616734452|FG000|Overall Study|Lack of Efficacy|1|||
170650750|NCT00483756|616734453|FG001|Overall Study|Lack of Efficacy|0|||
170650751|NCT00483756|616734454|FG002|Overall Study|Lack of Efficacy|0|||
170650752|NCT00483756|616734452|FG000|Overall Study|Lost to Follow-up|3|||
170650753|NCT00483756|616734453|FG001|Overall Study|Lost to Follow-up|1|||
170650754|NCT00483756|616734454|FG002|Overall Study|Lost to Follow-up|0|||
170650755|NCT00483756|616734452|FG000|Overall Study|Withdrawal by Subject|5|||
170810808|NCT01848483|617317406|FG000|Overall Study|Incarceration|2|||
170810809|NCT01848483|617317407|FG001|Overall Study|Incarceration|2|||
170810810|NCT02202317|617317411|FG000|Overall Study|Lost to Follow-up|1|||
170810811|NCT02338999|617317412|FG000|First Intervention|Withdrawal by Subject|3|||
170810812|NCT02338999|617317413|FG001|First Intervention|Withdrawal by Subject|1|||
170810813|NCT02338999|617317412|FG000|Washout Period|Withdrawal by Subject|0|||
170810814|NCT02338999|617317413|FG001|Washout Period|Withdrawal by Subject|2|||
170810815|NCT02338999|617317412|FG000|Second Intervention|Withdrawal by Subject|0|||
170810816|NCT02338999|617317413|FG001|Second Intervention|Withdrawal by Subject|2|||
170810817|NCT02701296|617317414|FG000|Overall Study|Incomplete Data|0|||
170810818|NCT02701296|617317415|FG001|Overall Study|Incomplete Data|2|||
170810819|NCT00484198|617317416|FG000|Overall Study|Participant Withdrew Consent|12|||
170810820|NCT00484198|617317417|FG001|Overall Study|Participant Withdrew Consent|21|||
170810821|NCT00484198|617317418|FG002|Overall Study|Participant Withdrew Consent|47|||
170810822|NCT00484198|617317419|FG003|Overall Study|Participant Withdrew Consent|59|||
170810823|NCT00484198|617317416|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
170810824|NCT00484198|617317417|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
170593412|NCT00844805|616516410|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
170593413|NCT00844805|616516411|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
170593414|NCT00844805|616516412|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
170593415|NCT00844805|616516409|FG000|Follow-Up Phase|Adverse Event|0|||
170650756|NCT00483756|616734453|FG001|Overall Study|Withdrawal by Subject|3|||
170593416|NCT00844805|616516410|FG001|Follow-Up Phase|Adverse Event|0|||
170593417|NCT00844805|616516411|FG002|Follow-Up Phase|Adverse Event|1|||
170593418|NCT00844805|616516412|FG003|Follow-Up Phase|Adverse Event|0|||
170593419|NCT00844805|616516409|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
170593420|NCT00844805|616516410|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
170593421|NCT00844805|616516411|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
170593422|NCT00844805|616516412|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
170593423|NCT00844805|616516409|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
170593424|NCT00844805|616516410|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
170593425|NCT00844805|616516411|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
170593426|NCT00844805|616516412|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
170593427|NCT00844805|616516409|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
170593428|NCT00844805|616516410|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
170593429|NCT00844805|616516411|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
170593430|NCT00844805|616516412|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
170593431|NCT00844805|616516409|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
170593432|NCT00844805|616516410|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
170593433|NCT00844805|616516411|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
170593434|NCT00844805|616516412|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
170593435|NCT00259298|616516413|FG000|Overall Study|Withdrawal by Subject|1|||
170593436|NCT00259298|616516413|FG000|Overall Study|Physician Decision|2|||
170593437|NCT00526110|616516417|FG000|Overall Study|Adverse Event|2|||
170593438|NCT00526110|616516418|FG001|Overall Study|Adverse Event|9|||
170593439|NCT00526110|616516417|FG000|Overall Study|Disease Progression|0|||
170593440|NCT00526110|616516418|FG001|Overall Study|Disease Progression|19|||
170593441|NCT00526110|616516417|FG000|Overall Study|Maximal Response|0|||
170593442|NCT00526110|616516418|FG001|Overall Study|Maximal Response|6|||
170593443|NCT00526110|616516417|FG000|Overall Study|Withdrawal by Subject|0|||
170593444|NCT00526110|616516418|FG001|Overall Study|Withdrawal by Subject|2|||
170593445|NCT00526110|616516417|FG000|Overall Study|Poor Tolerance|0|||
170593446|NCT00526110|616516418|FG001|Overall Study|Poor Tolerance|5|||
170593447|NCT01011933|616516419|FG000|Overall Study|Wrong cell type|1|||
170593448|NCT01011933|616516419|FG000|Overall Study|Improper pre-protocol Rx|1|||
170593449|NCT01011933|616516419|FG000|Overall Study|Inadequate pathology|1|||
170593450|NCT01011933|616516419|FG000|Overall Study|Never treated|1|||
170593451|NCT01400243|616516420|FG000|Overall Study|Protocol Violation|8|||
170593452|NCT01400243|616516421|FG001|Overall Study|Protocol Violation|11|||
170593453|NCT00953680|616516422|FG000|Period 1|Withdrawal by Subject|0|||
170593454|NCT00953680|616516423|FG001|Period 1|Withdrawal by Subject|1|||
170593455|NCT02726880|616516424|FG000|Overall Study|Withdrawal by Subject|2|||
170593456|NCT02726880|616516425|FG001|Overall Study|Withdrawal by Subject|0|||
170593457|NCT02726880|616516424|FG000|Overall Study|Lost to Follow-up|1|||
170593458|NCT02726880|616516425|FG001|Overall Study|Lost to Follow-up|3|||
170593459|NCT04316741|616516426|FG000|Baseline Enrollment|Lost to Follow-up|1|||
170593460|NCT04316741|616516427|FG001|Baseline Enrollment|Lost to Follow-up|1|||
170593461|NCT04316741|616516426|FG000|Immediate Post-Test|Lost to Follow-up|5|||
170593462|NCT04316741|616516427|FG001|Immediate Post-Test|Lost to Follow-up|1|||
170593463|NCT04316741|616516426|FG000|1-month Post-test|Lost to Follow-up|7|||
170593464|NCT04316741|616516427|FG001|1-month Post-test|Lost to Follow-up|2|||
170593465|NCT04316741|616516426|FG000|3-month Follow-up|Lost to Follow-up|10|||
170593466|NCT04316741|616516427|FG001|3-month Follow-up|Lost to Follow-up|2|||
170593467|NCT01510145|616516428|FG000|Overall Study|Adverse Event|6|||
170593468|NCT01510145|616516428|FG000|Overall Study|Lost to Follow-up|5|||
170593469|NCT01510145|616516428|FG000|Overall Study|Withdrawal by Subject|6|||
170593470|NCT01510145|616516428|FG000|Overall Study|Relative reported subject withdrew|1|||
170593471|NCT00787202|616516429|FG000|Overall Study|Adverse Event|3|||
170593472|NCT00787202|616516430|FG001|Overall Study|Adverse Event|2|||
170593473|NCT00787202|616516431|FG002|Overall Study|Adverse Event|0|||
170593474|NCT00787202|616516432|FG003|Overall Study|Adverse Event|0|||
170593475|NCT00787202|616516433|FG004|Overall Study|Adverse Event|2|||
170593476|NCT00787202|616516429|FG000|Overall Study|Lack of Efficacy|5|||
170593477|NCT00787202|616516430|FG001|Overall Study|Lack of Efficacy|6|||
170593478|NCT00787202|616516431|FG002|Overall Study|Lack of Efficacy|5|||
170593479|NCT00787202|616516432|FG003|Overall Study|Lack of Efficacy|2|||
170593480|NCT00787202|616516433|FG004|Overall Study|Lack of Efficacy|1|||
170593481|NCT00787202|616516429|FG000|Overall Study|Lost to Follow-up|1|||
170593482|NCT00787202|616516430|FG001|Overall Study|Lost to Follow-up|0|||
170593483|NCT00787202|616516431|FG002|Overall Study|Lost to Follow-up|0|||
170593484|NCT00787202|616516432|FG003|Overall Study|Lost to Follow-up|0|||
170593485|NCT00787202|616516433|FG004|Overall Study|Lost to Follow-up|0|||
170593486|NCT00787202|616516429|FG000|Overall Study|Withdrawal by Subject|2|||
170593487|NCT00787202|616516430|FG001|Overall Study|Withdrawal by Subject|2|||
170593488|NCT00787202|616516431|FG002|Overall Study|Withdrawal by Subject|2|||
170593489|NCT00787202|616516432|FG003|Overall Study|Withdrawal by Subject|0|||
170593490|NCT00787202|616516433|FG004|Overall Study|Withdrawal by Subject|0|||
170593491|NCT00787202|616516429|FG000|Overall Study|Protocol Violation|2|||
170593492|NCT00787202|616516430|FG001|Overall Study|Protocol Violation|1|||
170593493|NCT00787202|616516431|FG002|Overall Study|Protocol Violation|0|||
170593494|NCT00787202|616516432|FG003|Overall Study|Protocol Violation|0|||
170593495|NCT00787202|616516433|FG004|Overall Study|Protocol Violation|1|||
170810825|NCT00484198|617317418|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
170810826|NCT00484198|617317419|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
170810827|NCT00484198|617317416|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
170810828|NCT00484198|617317417|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
170810829|NCT00484198|617317418|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
170810830|NCT00484198|617317419|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
170810831|NCT00484198|617317416|FG000|Overall Study|Adverse Event|3|||
170810832|NCT00484198|617317417|FG001|Overall Study|Adverse Event|11|||
170810833|NCT00484198|617317418|FG002|Overall Study|Adverse Event|32|||
170810834|NCT00484198|617317419|FG003|Overall Study|Adverse Event|31|||
170810835|NCT00484198|617317416|FG000|Overall Study|Protocol Violation|0|||
170810836|NCT00484198|617317417|FG001|Overall Study|Protocol Violation|5|||
170810837|NCT00484198|617317418|FG002|Overall Study|Protocol Violation|6|||
170810838|NCT00484198|617317419|FG003|Overall Study|Protocol Violation|8|||
170810839|NCT00484198|617317416|FG000|Overall Study|Other|7|||
170810840|NCT00484198|617317417|FG001|Overall Study|Other|10|||
170810841|NCT00484198|617317418|FG002|Overall Study|Other|31|||
170810842|NCT00484198|617317419|FG003|Overall Study|Other|28|||
170810843|NCT01332266|617317420|FG000|Phase 1b|Death|3|||
170810844|NCT01332266|617317421|FG001|Phase 1b|Death|3|||
170810845|NCT01332266|617317422|FG002|Phase 1b|Death|2|||
170810846|NCT01332266|617317423|FG003|Phase 1b|Death|0|||
170810847|NCT01332266|617317424|FG004|Phase 1b|Death|0|||
170810848|NCT01332266|617317420|FG000|Phase 1b|Lost to Follow-up|0|||
170810849|NCT01332266|617317421|FG001|Phase 1b|Lost to Follow-up|1|||
170810850|NCT01332266|617317422|FG002|Phase 1b|Lost to Follow-up|0|||
170810851|NCT01332266|617317423|FG003|Phase 1b|Lost to Follow-up|0|||
170810852|NCT01332266|617317424|FG004|Phase 1b|Lost to Follow-up|0|||
170810853|NCT01332266|617317420|FG000|Phase 1b|Withdrawal by Subject|1|||
170810854|NCT01332266|617317421|FG001|Phase 1b|Withdrawal by Subject|1|||
170810855|NCT01332266|617317422|FG002|Phase 1b|Withdrawal by Subject|1|||
170810856|NCT01332266|617317423|FG003|Phase 1b|Withdrawal by Subject|0|||
170810857|NCT01332266|617317424|FG004|Phase 1b|Withdrawal by Subject|0|||
170810858|NCT01332266|617317420|FG000|Phase 2|Death|0|||
170810859|NCT01332266|617317421|FG001|Phase 2|Death|0|||
170810860|NCT01332266|617317422|FG002|Phase 2|Death|0|||
170810861|NCT01332266|617317423|FG003|Phase 2|Death|33|||
170810862|NCT01332266|617317424|FG004|Phase 2|Death|36|||
170810863|NCT01332266|617317420|FG000|Phase 2|Lost to Follow-up|0|||
170810864|NCT01332266|617317421|FG001|Phase 2|Lost to Follow-up|0|||
170810865|NCT01332266|617317422|FG002|Phase 2|Lost to Follow-up|0|||
170810866|NCT01332266|617317423|FG003|Phase 2|Lost to Follow-up|2|||
170810867|NCT01332266|617317424|FG004|Phase 2|Lost to Follow-up|0|||
170810868|NCT01332266|617317420|FG000|Phase 2|Physician Decision|0|||
170810869|NCT01332266|617317421|FG001|Phase 2|Physician Decision|0|||
170810870|NCT01332266|617317422|FG002|Phase 2|Physician Decision|0|||
170810871|NCT01332266|617317423|FG003|Phase 2|Physician Decision|3|||
170810872|NCT01332266|617317424|FG004|Phase 2|Physician Decision|1|||
170810873|NCT01332266|617317420|FG000|Phase 2|Symptomatic deterioration|0|||
170810874|NCT01332266|617317421|FG001|Phase 2|Symptomatic deterioration|0|||
170810875|NCT01332266|617317422|FG002|Phase 2|Symptomatic deterioration|0|||
170810876|NCT01332266|617317423|FG003|Phase 2|Symptomatic deterioration|0|||
170810877|NCT01332266|617317424|FG004|Phase 2|Symptomatic deterioration|1|||
170810878|NCT01332266|617317420|FG000|Phase 2|Progression Disease|0|||
170810879|NCT01332266|617317421|FG001|Phase 2|Progression Disease|0|||
170810880|NCT01332266|617317422|FG002|Phase 2|Progression Disease|0|||
170810881|NCT01332266|617317423|FG003|Phase 2|Progression Disease|2|||
170810882|NCT01332266|617317424|FG004|Phase 2|Progression Disease|1|||
170810883|NCT01332266|617317420|FG000|Phase 2|Withdrawal by Subject|0|||
170810884|NCT01332266|617317421|FG001|Phase 2|Withdrawal by Subject|0|||
170810885|NCT01332266|617317422|FG002|Phase 2|Withdrawal by Subject|0|||
170810886|NCT01332266|617317423|FG003|Phase 2|Withdrawal by Subject|2|||
170810887|NCT01332266|617317424|FG004|Phase 2|Withdrawal by Subject|2|||
170810888|NCT01536704|617317427|FG000|Washout Period 1|Withdrawal by Subject|1|||
170810889|NCT01536704|617317428|FG001|Washout Period 1|Withdrawal by Subject|2|||
170810890|NCT01536704|617317429|FG002|Washout Period 1|Withdrawal by Subject|0|||
170810891|NCT01536704|617317430|FG003|Washout Period 1|Withdrawal by Subject|0|||
170810892|NCT01536704|617317427|FG000|Washout Period 2|Adverse Event|1|||
170810893|NCT01536704|617317428|FG001|Washout Period 2|Adverse Event|0|||
170810894|NCT01536704|617317429|FG002|Washout Period 2|Adverse Event|0|||
170810895|NCT01536704|617317430|FG003|Washout Period 2|Adverse Event|0|||
170810896|NCT01536704|617317427|FG000|Washout Period 2|Withdrawal by Subject|0|||
170810897|NCT01536704|617317428|FG001|Washout Period 2|Withdrawal by Subject|0|||
170810898|NCT01536704|617317429|FG002|Washout Period 2|Withdrawal by Subject|0|||
170810899|NCT01536704|617317430|FG003|Washout Period 2|Withdrawal by Subject|1|||
170810900|NCT01536704|617317427|FG000|Period 3|Adverse Event|0|||
170810901|NCT01536704|617317428|FG001|Period 3|Adverse Event|0|||
170810902|NCT01536704|617317429|FG002|Period 3|Adverse Event|0|||
170810903|NCT01536704|617317430|FG003|Period 3|Adverse Event|1|||
170810904|NCT01536704|617317427|FG000|Washout Period 3|Adverse Event|0|||
170810905|NCT01536704|617317428|FG001|Washout Period 3|Adverse Event|0|||
170810906|NCT01536704|617317429|FG002|Washout Period 3|Adverse Event|1|||
170593496|NCT00787202|616516429|FG000|Overall Study|Randomized, not treated|1|||
170593497|NCT00787202|616516430|FG001|Overall Study|Randomized, not treated|0|||
170593498|NCT00787202|616516431|FG002|Overall Study|Randomized, not treated|0|||
170593499|NCT00787202|616516432|FG003|Overall Study|Randomized, not treated|0|||
170593500|NCT00787202|616516433|FG004|Overall Study|Randomized, not treated|0|||
170593501|NCT01442064|616516434|FG000|Overall Study|Adverse Event|2|||
170593502|NCT01442064|616516435|FG001|Overall Study|Adverse Event|2|||
170593503|NCT01442064|616516436|FG002|Overall Study|Adverse Event|2|||
170593504|NCT01442064|616516437|FG003|Overall Study|Adverse Event|1|||
170593505|NCT01442064|616516438|FG004|Overall Study|Adverse Event|2|||
170593506|NCT01442064|616516439|FG005|Overall Study|Adverse Event|0|||
170593507|NCT01442064|616516434|FG000|Overall Study|Death|0|||
170593508|NCT01442064|616516435|FG001|Overall Study|Death|1|||
170593509|NCT01442064|616516436|FG002|Overall Study|Death|3|||
170593510|NCT01442064|616516437|FG003|Overall Study|Death|3|||
170593511|NCT01442064|616516438|FG004|Overall Study|Death|1|||
170593512|NCT01442064|616516439|FG005|Overall Study|Death|3|||
170593513|NCT01442064|616516434|FG000|Overall Study|Lost to Follow-up|5|||
170593514|NCT01442064|616516435|FG001|Overall Study|Lost to Follow-up|5|||
170593515|NCT01442064|616516436|FG002|Overall Study|Lost to Follow-up|1|||
170593516|NCT01442064|616516437|FG003|Overall Study|Lost to Follow-up|1|||
170593517|NCT01442064|616516438|FG004|Overall Study|Lost to Follow-up|3|||
170593518|NCT01442064|616516439|FG005|Overall Study|Lost to Follow-up|3|||
170593519|NCT01442064|616516434|FG000|Overall Study|Physician Decision|1|||
170593520|NCT01442064|616516435|FG001|Overall Study|Physician Decision|1|||
170593521|NCT01442064|616516436|FG002|Overall Study|Physician Decision|2|||
170593522|NCT01442064|616516437|FG003|Overall Study|Physician Decision|3|||
170593523|NCT01442064|616516438|FG004|Overall Study|Physician Decision|3|||
170593524|NCT01442064|616516439|FG005|Overall Study|Physician Decision|1|||
170593525|NCT01442064|616516434|FG000|Overall Study|Withdrawal by Subject|6|||
170593526|NCT01442064|616516435|FG001|Overall Study|Withdrawal by Subject|3|||
170593527|NCT01442064|616516436|FG002|Overall Study|Withdrawal by Subject|2|||
170650757|NCT00483756|616734454|FG002|Overall Study|Withdrawal by Subject|4|||
170650758|NCT00483756|616734452|FG000|Overall Study|Other|2|||
170650759|NCT00483756|616734453|FG001|Overall Study|Other|4|||
170650760|NCT00483756|616734454|FG002|Overall Study|Other|3|||
170650761|NCT00483756|616734452|FG000|Overall Study|Randomized, Not Treated|1|||
170650762|NCT00483756|616734453|FG001|Overall Study|Randomized, Not Treated|4|||
170650763|NCT00483756|616734454|FG002|Overall Study|Randomized, Not Treated|4|||
170650764|NCT02282293|616734463|FG000|Overall Study|Lost to Follow-up|2|||
170650765|NCT02282293|616734464|FG001|Overall Study|Lost to Follow-up|2|||
170650766|NCT02282293|616734463|FG000|Overall Study|Unable to comply with study procedures|1|||
170650767|NCT02282293|616734464|FG001|Overall Study|Unable to comply with study procedures|0|||
170650768|NCT02282293|616734463|FG000|Overall Study|Moved out of study area|0|||
170911906|NCT01486316|617682057|FG001|Overall Study|Device explanted with/without re-implant|2|||
170911907|NCT01486316|617682058|FG002|Overall Study|Device explanted with/without re-implant|0|||
170911908|NCT01486316|617682059|FG003|Overall Study|Device explanted with/without re-implant|2|||
170911909|NCT01486316|617682056|FG000|Overall Study|Not meeting eligibility criteria|0|||
170911910|NCT01486316|617682057|FG001|Overall Study|Not meeting eligibility criteria|0|||
170911911|NCT01486316|617682058|FG002|Overall Study|Not meeting eligibility criteria|1|||
170911912|NCT01486316|617682059|FG003|Overall Study|Not meeting eligibility criteria|0|||
170911913|NCT01486316|617682056|FG000|Overall Study|Withdrawal by Subject|1|||
170911914|NCT01486316|617682057|FG001|Overall Study|Withdrawal by Subject|0|||
170911915|NCT01486316|617682058|FG002|Overall Study|Withdrawal by Subject|3|||
170911916|NCT01486316|617682059|FG003|Overall Study|Withdrawal by Subject|0|||
170911917|NCT01486316|617682056|FG000|Overall Study|Physician Decision|0|||
170911918|NCT01486316|617682057|FG001|Overall Study|Physician Decision|0|||
170911919|NCT01486316|617682058|FG002|Overall Study|Physician Decision|1|||
170911920|NCT01486316|617682059|FG003|Overall Study|Physician Decision|0|||
170911921|NCT01486316|617682056|FG000|Overall Study|Death|0|||
170911922|NCT01486316|617682057|FG001|Overall Study|Death|1|||
170593528|NCT01442064|616516437|FG003|Overall Study|Withdrawal by Subject|2|||
170593529|NCT01442064|616516438|FG004|Overall Study|Withdrawal by Subject|2|||
170593530|NCT01442064|616516439|FG005|Overall Study|Withdrawal by Subject|1|||
170593531|NCT01442064|616516434|FG000|Overall Study|Sponsor decision|82|||
170593532|NCT01442064|616516435|FG001|Overall Study|Sponsor decision|88|||
170593533|NCT01442064|616516436|FG002|Overall Study|Sponsor decision|92|||
170593534|NCT01442064|616516437|FG003|Overall Study|Sponsor decision|88|||
170911923|NCT01486316|617682058|FG002|Overall Study|Death|0|||
170911924|NCT01486316|617682059|FG003|Overall Study|Death|0|||
170593535|NCT01442064|616516438|FG004|Overall Study|Sponsor decision|95|||
170593536|NCT01442064|616516439|FG005|Overall Study|Sponsor decision|87|||
170593537|NCT01442064|616516434|FG000|Overall Study|Subject non-compliance|0|||
170650769|NCT02282293|616734464|FG001|Overall Study|Moved out of study area|1|||
170650770|NCT02312687|616734476|FG000|Overall Study|Other, Not Specified|1|||
170650771|NCT00906971|616734477|FG000|Overall Study|Withdrawal by Subject|8|||
170911925|NCT00375934|617682067|FG000|Overall Study|Adverse Event|1|||
170911926|NCT00375934|617682068|FG001|Overall Study|Adverse Event|1|||
170593538|NCT01442064|616516435|FG001|Overall Study|Subject non-compliance|0|||
170593539|NCT01442064|616516436|FG002|Overall Study|Subject non-compliance|0|||
170593540|NCT01442064|616516437|FG003|Overall Study|Subject non-compliance|0|||
170593541|NCT01442064|616516438|FG004|Overall Study|Subject non-compliance|0|||
170593542|NCT01442064|616516439|FG005|Overall Study|Subject non-compliance|2|||
170593543|NCT01442064|616516434|FG000|Overall Study|Condition mandated other intervention|1|||
170593544|NCT01442064|616516435|FG001|Overall Study|Condition mandated other intervention|1|||
170593545|NCT01442064|616516436|FG002|Overall Study|Condition mandated other intervention|2|||
170593546|NCT01442064|616516437|FG003|Overall Study|Condition mandated other intervention|0|||
170593547|NCT01442064|616516438|FG004|Overall Study|Condition mandated other intervention|0|||
170593548|NCT01442064|616516439|FG005|Overall Study|Condition mandated other intervention|2|||
170593549|NCT01360398|616516440|FG000|Overall Study|Withdrawal by Subject|14|||
170593550|NCT01360398|616516440|FG000|Overall Study|Other|7|||
170593551|NCT01360398|616516440|FG000|Overall Study|Migrated/moved from study area|1|||
170593552|NCT01453946|616516441|FG000|Overall Study|Did not receive drug for the taper phase|1|||
170593553|NCT01453946|616516441|FG000|Overall Study|Protocol Violation|2|||
170593554|NCT01453946|616516441|FG000|Overall Study|Lack of Efficacy|3|||
170593555|NCT01453946|616516441|FG000|Overall Study|Adverse Event|3|||
170593556|NCT02153346|616516442|FG000|Overall Study|Lost to Follow-up|11|||
170593557|NCT02827500|616516444|FG000|Overall Study|Death|7|||
170593558|NCT02827500|616516445|FG001|Overall Study|Death|3|||
170593559|NCT02827500|616516444|FG000|Overall Study|Lost to Follow-up|1|||
170593560|NCT02827500|616516445|FG001|Overall Study|Lost to Follow-up|1|||
170593561|NCT02827500|616516444|FG000|Overall Study|Withdrawal by Subject|3|||
170593562|NCT02827500|616516445|FG001|Overall Study|Withdrawal by Subject|1|||
170593563|NCT02827500|616516444|FG000|Overall Study|Missing primary endpoint data|3|||
170593564|NCT02827500|616516445|FG001|Overall Study|Missing primary endpoint data|1|||
170593565|NCT02827500|616516444|FG000|Overall Study|Other|5|||
170593566|NCT02827500|616516445|FG001|Overall Study|Other|1|||
170593567|NCT01822535|616516446|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
170593568|NCT01822535|616516447|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
170593569|NCT01822535|616516446|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
170593570|NCT01822535|616516447|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
170593571|NCT01822535|616516446|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
170593572|NCT01822535|616516447|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
170593573|NCT02279498|616516448|FG000|Overall Study|Adverse Event|3|||
170593574|NCT02279498|616516449|FG001|Overall Study|Adverse Event|0|||
170593575|NCT02279498|616516448|FG000|Overall Study|Lack of Efficacy|4|||
170593576|NCT02279498|616516449|FG001|Overall Study|Lack of Efficacy|0|||
170593577|NCT02279498|616516448|FG000|Overall Study|Lost to Follow-up|0|||
170593578|NCT02279498|616516449|FG001|Overall Study|Lost to Follow-up|1|||
170593579|NCT02279498|616516448|FG000|Overall Study|Withdrawal by Subject|9|||
170593580|NCT02279498|616516449|FG001|Overall Study|Withdrawal by Subject|2|||
170593581|NCT02279498|616516448|FG000|Overall Study|Undefined|2|||
170593582|NCT02279498|616516449|FG001|Overall Study|Undefined|1|||
170593583|NCT00737711|616516452|FG000|Overall Study|Adverse Event|2|||
170593584|NCT00737711|616516452|FG000|Overall Study|Death|8|||
170593585|NCT00737711|616516452|FG000|Overall Study|Failure to return|4|||
170593586|NCT00737711|616516452|FG000|Overall Study|Protocol Violation|1|||
170593587|NCT00737711|616516452|FG000|Overall Study|Withdrawal by Subject|5|||
170593588|NCT00737711|616516452|FG000|Overall Study|Blood transfusion|6|||
170593589|NCT00737711|616516452|FG000|Overall Study|Other|5|||
170593590|NCT00969761|616516455|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
170593591|NCT00969761|616516456|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
170593592|NCT00969761|616516457|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
170593593|NCT00969761|616516458|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
170593594|NCT00969761|616516459|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
170593595|NCT00969761|616516460|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
170593596|NCT00969761|616516461|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
170593597|NCT00969761|616516462|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
170593598|NCT00969761|616516463|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
170810907|NCT01536704|617317430|FG003|Washout Period 3|Adverse Event|0|||
170810908|NCT04658784|617317431|FG000|6-month Follow-up|Lost to Follow-up|2|||
170810909|NCT04658784|617317432|FG001|6-month Follow-up|Lost to Follow-up|5|||
170810910|NCT03490032|617317433|FG000|Overall Study|family issue (child custody)|1|||
170810911|NCT03490032|617317434|FG001|Overall Study|family issue (child custody)|0|||
170810912|NCT03490032|617317435|FG002|Overall Study|family issue (child custody)|0|||
170810913|NCT02958553|617317436|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
170810914|NCT02958553|617317436|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
170810915|NCT00308308|617317438|FG000|Overall Study|Adverse Event|17|||
170810916|NCT00308308|617317439|FG001|Overall Study|Adverse Event|2|||
170810917|NCT00308308|617317438|FG000|Overall Study|Lost to Follow-up|5|||
170810918|NCT00308308|617317439|FG001|Overall Study|Lost to Follow-up|5|||
170810919|NCT00308308|617317438|FG000|Overall Study|Physician Decision|15|||
170810920|NCT00308308|617317439|FG001|Overall Study|Physician Decision|7|||
170810921|NCT00308308|617317438|FG000|Overall Study|Protocol Violation|3|||
170810922|NCT00308308|617317439|FG001|Overall Study|Protocol Violation|14|||
170810923|NCT00308308|617317438|FG000|Overall Study|Withdrawal by Subject|47|||
170810924|NCT00308308|617317439|FG001|Overall Study|Withdrawal by Subject|19|||
170810925|NCT00308308|617317438|FG000|Overall Study|Various|7|||
170810926|NCT00308308|617317439|FG001|Overall Study|Various|5|||
170810927|NCT00308308|617317438|FG000|Overall Study|Randomized but not dosed|8|||
170810928|NCT00308308|617317439|FG001|Overall Study|Randomized but not dosed|16|||
170810929|NCT00308308|617317438|FG000|Overall Study|Other|1|||
170810930|NCT00308308|617317439|FG001|Overall Study|Other|0|||
170810931|NCT01686152|617317440|FG000|Overall Study|Withdrawal by Subject|11|||
170810932|NCT01686152|617317441|FG001|Overall Study|Withdrawal by Subject|11|||
170810933|NCT01686152|617317442|FG002|Overall Study|Withdrawal by Subject|3|||
170810934|NCT01686152|617317440|FG000|Overall Study|Drug Code Unblinded|0|||
170810935|NCT01686152|617317441|FG001|Overall Study|Drug Code Unblinded|1|||
170810936|NCT01686152|617317442|FG002|Overall Study|Drug Code Unblinded|0|||
170810937|NCT01686152|617317440|FG000|Overall Study|Protocol Violation|6|||
170810938|NCT01686152|617317441|FG001|Overall Study|Protocol Violation|1|||
170810939|NCT01686152|617317442|FG002|Overall Study|Protocol Violation|0|||
170810940|NCT01686152|617317440|FG000|Overall Study|Adverse Event|12|||
170810941|NCT01686152|617317441|FG001|Overall Study|Adverse Event|11|||
170810942|NCT01686152|617317442|FG002|Overall Study|Adverse Event|0|||
170810943|NCT01686152|617317440|FG000|Overall Study|Lack of Efficacy|0|||
170810944|NCT01686152|617317441|FG001|Overall Study|Lack of Efficacy|0|||
170810945|NCT01686152|617317442|FG002|Overall Study|Lack of Efficacy|1|||
170810946|NCT01686152|617317440|FG000|Overall Study|IP Non-compliance|5|||
170810947|NCT01686152|617317441|FG001|Overall Study|IP Non-compliance|5|||
170810948|NCT01686152|617317442|FG002|Overall Study|IP Non-compliance|0|||
170810949|NCT01686152|617317440|FG000|Overall Study|Lost to Follow-up|7|||
170810950|NCT01686152|617317441|FG001|Overall Study|Lost to Follow-up|6|||
170810951|NCT01686152|617317442|FG002|Overall Study|Lost to Follow-up|5|||
170810952|NCT01802333|617317445|FG000|Overall Study|Ineligible|2|||
170810953|NCT01802333|617317446|FG001|Overall Study|Ineligible|6|||
170810954|NCT01802333|617317447|FG002|Overall Study|Ineligible|8|||
170810955|NCT01802333|617317445|FG000|Overall Study|Adverse Event|1|||
170810956|NCT01802333|617317446|FG001|Overall Study|Adverse Event|8|||
170810957|NCT01802333|617317447|FG002|Overall Study|Adverse Event|8|||
170810958|NCT01802333|617317445|FG000|Overall Study|Withdrawal by Subject|6|||
170810959|NCT01802333|617317446|FG001|Overall Study|Withdrawal by Subject|6|||
170810960|NCT01802333|617317447|FG002|Overall Study|Withdrawal by Subject|5|||
170810961|NCT01802333|617317445|FG000|Overall Study|Progression/relapse|1|||
170810962|NCT01802333|617317446|FG001|Overall Study|Progression/relapse|3|||
170810963|NCT01802333|617317447|FG002|Overall Study|Progression/relapse|0|||
170810964|NCT01802333|617317445|FG000|Overall Study|Death|7|||
170810965|NCT01802333|617317446|FG001|Overall Study|Death|14|||
170810966|NCT01802333|617317447|FG002|Overall Study|Death|13|||
170810967|NCT01802333|617317445|FG000|Overall Study|Other - not protocol specified|32|||
170810968|NCT01802333|617317446|FG001|Overall Study|Other - not protocol specified|22|||
170810969|NCT01802333|617317447|FG002|Overall Study|Other - not protocol specified|24|||
170810970|NCT01802333|617317445|FG000|Overall Study|Did not start treatment|0|||
170810971|NCT01802333|617317446|FG001|Overall Study|Did not start treatment|2|||
170810972|NCT01802333|617317447|FG002|Overall Study|Did not start treatment|5|||
170810973|NCT00704340|617317451|FG000|Overall Study|Lost to Follow-up|2|||
170810974|NCT00704340|617317452|FG001|Overall Study|Lost to Follow-up|1|||
170810975|NCT00704340|617317451|FG000|Overall Study|Death|0|||
170810976|NCT00704340|617317452|FG001|Overall Study|Death|1|||
170810977|NCT01019135|617317453|FG000|Overall Study|Did not receive allocated intervention|12|||
170810978|NCT01019135|617317454|FG001|Overall Study|Did not receive allocated intervention|6|||
170593599|NCT00969761|616516464|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
170810979|NCT01019135|617317455|FG002|Overall Study|Did not receive allocated intervention|25|||
170593600|NCT00969761|616516465|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
170593601|NCT00969761|616516466|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
170593602|NCT00969761|616516455|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593603|NCT00969761|616516456|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593604|NCT00969761|616516457|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
170810980|NCT01019135|617317453|FG000|Overall Study|Did not attend CR|8|||
170810981|NCT01019135|617317454|FG001|Overall Study|Did not attend CR|13|||
170810982|NCT01019135|617317455|FG002|Overall Study|Did not attend CR|6|||
170810983|NCT00703092|617317458|FG000|Overall Study|Withdrawal by Subject|2|||
170810984|NCT01021748|617317459|FG000|Overall Study|Adverse Event|2|||
170810985|NCT01021748|617317460|FG001|Overall Study|Adverse Event|1|||
170810986|NCT01021748|617317461|FG002|Overall Study|Adverse Event|2|||
170810987|NCT01021748|617317462|FG003|Overall Study|Adverse Event|0|||
170810988|NCT01021748|617317463|FG004|Overall Study|Adverse Event|2|||
170810989|NCT01021748|617317464|FG005|Overall Study|Adverse Event|0|||
170593605|NCT00969761|616516458|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593606|NCT00969761|616516459|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593607|NCT00969761|616516460|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593608|NCT00969761|616516461|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593609|NCT00969761|616516462|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593610|NCT00969761|616516463|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593611|NCT00969761|616516464|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593612|NCT00969761|616516465|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593613|NCT00969761|616516466|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
170593614|NCT00969761|616516455|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170810990|NCT01021748|617317465|FG006|Overall Study|Adverse Event|1|||
170810991|NCT01021748|617317466|FG007|Overall Study|Adverse Event|0|||
170593615|NCT00969761|616516456|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593616|NCT00969761|616516457|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
170593617|NCT00969761|616516458|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593618|NCT00969761|616516459|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593619|NCT00969761|616516460|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593620|NCT00969761|616516461|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593621|NCT00969761|616516462|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593622|NCT00969761|616516463|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593623|NCT00969761|616516464|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593624|NCT00969761|616516465|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593625|NCT00969761|616516466|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
170593626|NCT00969761|616516455|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593627|NCT00969761|616516456|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593628|NCT00969761|616516457|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593629|NCT00969761|616516458|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593630|NCT00969761|616516459|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593631|NCT00969761|616516460|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593632|NCT00969761|616516461|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593633|NCT00969761|616516462|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593634|NCT00969761|616516463|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
170593635|NCT00969761|616516464|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593636|NCT00969761|616516465|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593637|NCT00969761|616516466|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
170593638|NCT00969761|616516455|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
170593639|NCT00969761|616516456|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
170593640|NCT00969761|616516457|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
170593641|NCT00969761|616516458|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
170593642|NCT00969761|616516459|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
170593643|NCT00969761|616516460|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
170593644|NCT00969761|616516461|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
170593645|NCT00969761|616516462|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
170593646|NCT00969761|616516463|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
170593647|NCT00969761|616516464|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
170593648|NCT00969761|616516465|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
170593649|NCT00969761|616516466|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
170593650|NCT00969761|616516455|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593651|NCT00969761|616516456|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593652|NCT00969761|616516457|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593653|NCT00969761|616516458|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
170593654|NCT00969761|616516459|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
170593655|NCT00969761|616516460|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593656|NCT00969761|616516461|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593657|NCT00969761|616516462|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593658|NCT00969761|616516463|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
170593659|NCT00969761|616516464|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593660|NCT00969761|616516465|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593661|NCT00969761|616516466|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
170593662|NCT03762616|616516467|FG000|Overall Study|Protocol Violation|2|||
170593663|NCT03647267|616518463|FG000|Overall Study|Lost to Follow-up|1|||
170593664|NCT03647267|616518464|FG001|Overall Study|Lost to Follow-up|0|||
170593665|NCT00151372|616518465|FG000|Overall Study|Death|12|||
170810992|NCT01021748|617317467|FG008|Overall Study|Adverse Event|7|||
170911927|NCT00375934|617682067|FG000|Overall Study|Withdrawal by Subject|2|||
170911928|NCT00375934|617682068|FG001|Overall Study|Withdrawal by Subject|2|||
170593666|NCT00151372|616518466|FG001|Overall Study|Death|11|||
170593667|NCT00151372|616518465|FG000|Overall Study|Lost to Follow-up|5|||
170593668|NCT00151372|616518466|FG001|Overall Study|Lost to Follow-up|5|||
170593669|NCT00151372|616518465|FG000|Overall Study|Too sick medically to continue|5|||
170593670|NCT00151372|616518466|FG001|Overall Study|Too sick medically to continue|6|||
170593671|NCT00151372|616518465|FG000|Overall Study|Withdrawal by Subject|7|||
170593672|NCT00151372|616518466|FG001|Overall Study|Withdrawal by Subject|7|||
170593673|NCT01282294|616518469|FG000|Overall Study|Lost to Follow-up|14|||
170593674|NCT01282294|616518469|FG000|Overall Study|Screening failure|1|||
170911929|NCT00375934|617682067|FG000|Overall Study|Lack of Efficacy|0|||
170911930|NCT00375934|617682068|FG001|Overall Study|Lack of Efficacy|2|||
170911931|NCT00375934|617682067|FG000|Overall Study|Physician Decision|0|||
170911932|NCT00375934|617682068|FG001|Overall Study|Physician Decision|1|||
170911933|NCT01853228|617682074|FG000|Phase 1|Lack of Efficacy|8|||
170911934|NCT01853228|617682075|FG001|Phase 1|Lack of Efficacy|0|||
170911935|NCT01853228|617682074|FG000|Phase 1|Other|1|||
170911936|NCT01853228|617682075|FG001|Phase 1|Other|0|||
170911937|NCT01853228|617682074|FG000|Phase 2|Physician Decision|0|||
170911938|NCT01853228|617682075|FG001|Phase 2|Physician Decision|1|||
170911939|NCT01853228|617682074|FG000|Phase 2|Proceed To Transplant|0|||
170911940|NCT01853228|617682075|FG001|Phase 2|Proceed To Transplant|3|||
170911941|NCT01853228|617682074|FG000|Phase 2|Lack of Efficacy|0|||
170911942|NCT01853228|617682075|FG001|Phase 2|Lack of Efficacy|4|||
170911943|NCT02400346|617682076|FG000|Overall Study|Adverse Event|24|||
170911944|NCT02400346|617682076|FG000|Overall Study|Lack of Efficacy|9|||
170911945|NCT02400346|617682076|FG000|Overall Study|Non-compliance with IMP|1|||
170911946|NCT02400346|617682076|FG000|Overall Study|Withdrawal by Subject|7|||
170911947|NCT02400346|617682076|FG000|Overall Study|Administrative or other reason(s)|2|||
170911948|NCT02400346|617682076|FG000|Overall Study|Lost to Follow-up|1|||
170911949|NCT01040832|617682077|FG000|Overall Study|Adverse Event|4|||
170911950|NCT01040832|617682078|FG001|Overall Study|Adverse Event|5|||
170911951|NCT01040832|617682077|FG000|Overall Study|Death|4|||
170911952|NCT01040832|617682078|FG001|Overall Study|Death|6|||
170911953|NCT01040832|617682077|FG000|Overall Study|Withdrawal by Subject|2|||
170911954|NCT01040832|617682078|FG001|Overall Study|Withdrawal by Subject|3|||
170911955|NCT01040832|617682077|FG000|Overall Study|Progressive disease|32|||
170911956|NCT01040832|617682078|FG001|Overall Study|Progressive disease|17|||
170911957|NCT01040832|617682077|FG000|Overall Study|Symptomatic deterioration|2|||
170593675|NCT01282294|616518469|FG000|Overall Study|Adverse Event|1|||
170593676|NCT01282294|616518469|FG000|Overall Study|Patient non-compliance|2|||
170593677|NCT01282294|616518469|FG000|Overall Study|Physician Decision|1|||
170593678|NCT03747120|616518472|FG000|Overall Study|treatment related toxicity|3|||
170593679|NCT03747120|616518473|FG001|Overall Study|treatment related toxicity|0|||
170593680|NCT03747120|616518474|FG002|Overall Study|treatment related toxicity|0|||
170593681|NCT03747120|616518472|FG000|Overall Study|Withdrawal by Subject|0|||
170593682|NCT03747120|616518473|FG001|Overall Study|Withdrawal by Subject|1|||
170593683|NCT03747120|616518474|FG002|Overall Study|Withdrawal by Subject|2|||
170593684|NCT00289198|616518476|FG000|Overall Study|Adverse Event|0|||
170593685|NCT00289198|616518477|FG001|Overall Study|Adverse Event|2|||
170593686|NCT00289198|616518476|FG000|Overall Study|Protocol Violation|2|||
170593687|NCT00289198|616518477|FG001|Overall Study|Protocol Violation|1|||
170593688|NCT00289198|616518476|FG000|Overall Study|Withdrawal by Subject|4|||
170593689|NCT00289198|616518477|FG001|Overall Study|Withdrawal by Subject|1|||
170593690|NCT00289198|616518476|FG000|Overall Study|Lack of Efficacy|2|||
170593691|NCT00289198|616518477|FG001|Overall Study|Lack of Efficacy|0|||
170593692|NCT00289198|616518476|FG000|Overall Study|Other: Low compliance|0|||
170593693|NCT00289198|616518477|FG001|Overall Study|Other: Low compliance|1|||
170593694|NCT00289198|616518476|FG000|Overall Study|Other: Physician's decision|0|||
170593695|NCT00289198|616518477|FG001|Overall Study|Other: Physician's decision|1|||
170593696|NCT00289198|616518476|FG000|Overall Study|Other: Unable to attend on schedule|2|||
170593697|NCT00289198|616518477|FG001|Overall Study|Other: Unable to attend on schedule|1|||
170593698|NCT00289198|616518476|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
170593699|NCT00289198|616518477|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
170593700|NCT00289198|616518476|FG000|Overall Study|Other: Impossible to come on visit|0|||
170593701|NCT00289198|616518477|FG001|Overall Study|Other: Impossible to come on visit|1|||
170593702|NCT01344538|616518481|FG000|Overall Study|Adverse Event|1|||
170593703|NCT01344538|616518482|FG001|Overall Study|Adverse Event|1|||
170593704|NCT01344538|616518481|FG000|Overall Study|Lost to Follow-up|1|||
170593705|NCT01344538|616518482|FG001|Overall Study|Lost to Follow-up|0|||
170593706|NCT01340937|616518483|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
170593707|NCT01340937|616518484|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
170911958|NCT01040832|617682078|FG001|Overall Study|Symptomatic deterioration|5|||
170911959|NCT01040832|617682077|FG000|Overall Study|Other|2|||
170911960|NCT01040832|617682078|FG001|Overall Study|Other|1|||
170911961|NCT01518699|617682079|FG000|Period 2|Protocol Violation|1|||
170911962|NCT01518699|617682080|FG001|Period 2|Protocol Violation|1|||
170593708|NCT01340937|616518485|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
170593709|NCT01340937|616518486|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
170593710|NCT01340937|616518483|FG000|Period 1: Infant Series|Adverse Event|0|||
170593711|NCT01340937|616518484|FG001|Period 1: Infant Series|Adverse Event|1|||
170593712|NCT01340937|616518485|FG002|Period 1: Infant Series|Adverse Event|4|||
170593713|NCT01340937|616518486|FG003|Period 1: Infant Series|Adverse Event|0|||
170593714|NCT01340937|616518483|FG000|Period 1: Infant Series|Death|2|||
170593715|NCT01340937|616518484|FG001|Period 1: Infant Series|Death|0|||
170593716|NCT01340937|616518485|FG002|Period 1: Infant Series|Death|2|||
170593717|NCT01340937|616518486|FG003|Period 1: Infant Series|Death|0|||
170593718|NCT01340937|616518483|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
170593719|NCT01340937|616518484|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
170593720|NCT01340937|616518485|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
170593721|NCT01340937|616518486|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
170593722|NCT01340937|616518483|FG000|Period 1: Infant Series|Physician Decision|2|||
170593723|NCT01340937|616518484|FG001|Period 1: Infant Series|Physician Decision|3|||
170593724|NCT01340937|616518485|FG002|Period 1: Infant Series|Physician Decision|1|||
170593725|NCT01340937|616518486|FG003|Period 1: Infant Series|Physician Decision|0|||
170593726|NCT01340937|616518483|FG000|Period 1: Infant Series|Protocol Violation|1|||
170593727|NCT01340937|616518484|FG001|Period 1: Infant Series|Protocol Violation|4|||
170593728|NCT01340937|616518485|FG002|Period 1: Infant Series|Protocol Violation|4|||
170593729|NCT01340937|616518486|FG003|Period 1: Infant Series|Protocol Violation|3|||
170593730|NCT01340937|616518483|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
170593731|NCT01340937|616518484|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
170593732|NCT01340937|616518485|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
170593733|NCT01340937|616518486|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
170593734|NCT01340937|616518483|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
170593735|NCT01340937|616518484|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
170593736|NCT01340937|616518485|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
170593737|NCT01340937|616518486|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
170593738|NCT01340937|616518483|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
170593739|NCT01340937|616518484|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
170593740|NCT01340937|616518485|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
170593741|NCT01340937|616518486|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
170593742|NCT01340937|616518483|FG000|Period 2: Interim Period|Adverse Event|1|||
170593743|NCT01340937|616518484|FG001|Period 2: Interim Period|Adverse Event|0|||
170593744|NCT01340937|616518485|FG002|Period 2: Interim Period|Adverse Event|1|||
170593745|NCT01340937|616518486|FG003|Period 2: Interim Period|Adverse Event|0|||
170593746|NCT01340937|616518483|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
170593747|NCT01340937|616518484|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
170593748|NCT01340937|616518485|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
170593749|NCT01340937|616518486|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
170593750|NCT01340937|616518483|FG000|Period 2: Interim Period|Physician Decision|0|||
170593751|NCT01340937|616518484|FG001|Period 2: Interim Period|Physician Decision|1|||
170593752|NCT01340937|616518485|FG002|Period 2: Interim Period|Physician Decision|1|||
170593753|NCT01340937|616518486|FG003|Period 2: Interim Period|Physician Decision|0|||
170593754|NCT01340937|616518483|FG000|Period 2: Interim Period|Protocol Violation|5|||
170593755|NCT01340937|616518484|FG001|Period 2: Interim Period|Protocol Violation|3|||
170593756|NCT01340937|616518485|FG002|Period 2: Interim Period|Protocol Violation|6|||
170593757|NCT01340937|616518486|FG003|Period 2: Interim Period|Protocol Violation|3|||
170593758|NCT01340937|616518483|FG000|Period 2: Interim Period|Technical problems|4|||
170593759|NCT01340937|616518484|FG001|Period 2: Interim Period|Technical problems|4|||
170593760|NCT01340937|616518485|FG002|Period 2: Interim Period|Technical problems|6|||
170593761|NCT01340937|616518486|FG003|Period 2: Interim Period|Technical problems|3|||
170593762|NCT01340937|616518483|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
170593763|NCT01340937|616518484|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
170810993|NCT01021748|617317459|FG000|Overall Study|Physician Decision|1|||
170593764|NCT01340937|616518485|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
170593765|NCT01340937|616518486|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
170593766|NCT01340937|616518483|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
170593767|NCT01340937|616518484|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
170593768|NCT01340937|616518485|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
170593769|NCT01340937|616518486|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
170593770|NCT01340937|616518483|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
170593771|NCT01340937|616518484|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
170593772|NCT01340937|616518485|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
170593773|NCT01340937|616518486|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
170593774|NCT01340937|616518483|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
170593775|NCT01340937|616518484|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
170593776|NCT01340937|616518485|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
170593777|NCT01340937|616518486|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
170593778|NCT00440310|616518487|FG000|Overall Study|Lost to Follow-up|4|||
170593779|NCT00440310|616518488|FG001|Overall Study|Lost to Follow-up|5|||
170593780|NCT00440310|616518487|FG000|Overall Study|Protocol Violation|0|||
170593781|NCT00440310|616518488|FG001|Overall Study|Protocol Violation|1|||
170593782|NCT00440310|616518487|FG000|Overall Study|Withdrawal by Subject|15|||
170593783|NCT00440310|616518488|FG001|Overall Study|Withdrawal by Subject|14|||
170593784|NCT00440310|616518487|FG000|Overall Study|No Reply at EOS|7|||
170593785|NCT00440310|616518488|FG001|Overall Study|No Reply at EOS|7|||
170593786|NCT00440310|616518487|FG000|Overall Study|Other|1|||
170593787|NCT00440310|616518488|FG001|Overall Study|Other|0|||
170593788|NCT00440310|616518487|FG000|Overall Study|Status Unknown|1|||
170593789|NCT00440310|616518488|FG001|Overall Study|Status Unknown|3|||
170593790|NCT04599166|616518493|FG000|Overall Study|Technological failure connecting to study app|80|||
170593791|NCT02317809|616518494|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
170593792|NCT02317809|616518495|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
170593793|NCT02317809|616518494|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
170593794|NCT02317809|616518495|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
170593795|NCT00294645|616518498|FG000|Overall Study|Death|10|||
170593796|NCT00294645|616518499|FG001|Overall Study|Death|18|||
170593797|NCT00294645|616518498|FG000|Overall Study|Lost to Follow-up|1|||
170593798|NCT00294645|616518499|FG001|Overall Study|Lost to Follow-up|10|||
170593799|NCT00294645|616518498|FG000|Overall Study|Withdrawal by Subject|18|||
170593800|NCT00294645|616518499|FG001|Overall Study|Withdrawal by Subject|34|||
170593801|NCT00294645|616518498|FG000|Overall Study|Physician Decision|15|||
170593802|NCT00294645|616518499|FG001|Overall Study|Physician Decision|20|||
170593803|NCT00294645|616518498|FG000|Overall Study|Other|4|||
170593804|NCT00294645|616518499|FG001|Overall Study|Other|10|||
170593805|NCT02509052|616518502|FG000|Overall Study|Non compliance|0|||
170593806|NCT02509052|616518503|FG001|Overall Study|Non compliance|0|||
170593807|NCT02509052|616518504|FG002|Overall Study|Non compliance|1|||
170593808|NCT03362931|616518505|FG000|Overall Study|Adverse Event|1|||
170593809|NCT03362931|616518505|FG000|Overall Study|Death|2|||
170593810|NCT01133405|616518506|FG000|Period 1|Withdrawal by Subject|0|||
170593811|NCT01133405|616518507|FG001|Period 1|Withdrawal by Subject|1|||
170593812|NCT01133405|616518508|FG002|Period 1|Withdrawal by Subject|0|||
170593813|NCT01133405|616518509|FG003|Period 1|Withdrawal by Subject|1|||
170593814|NCT01133405|616518510|FG004|Period 1|Withdrawal by Subject|0|||
170593815|NCT01133405|616518511|FG005|Period 1|Withdrawal by Subject|1|||
170593816|NCT01133405|616518512|FG006|Period 1|Withdrawal by Subject|0|||
170593817|NCT01133405|616518513|FG007|Period 1|Withdrawal by Subject|0|||
170593818|NCT01133405|616518514|FG008|Period 1|Withdrawal by Subject|0|||
170593819|NCT01133405|616518515|FG009|Period 1|Withdrawal by Subject|0|||
170593820|NCT01133405|616518506|FG000|Period 1|Physician Decision|0|||
170593821|NCT01133405|616518507|FG001|Period 1|Physician Decision|0|||
170593822|NCT01133405|616518508|FG002|Period 1|Physician Decision|0|||
170593823|NCT01133405|616518509|FG003|Period 1|Physician Decision|1|||
170593824|NCT01133405|616518510|FG004|Period 1|Physician Decision|0|||
170593825|NCT01133405|616518511|FG005|Period 1|Physician Decision|0|||
170593826|NCT01133405|616518512|FG006|Period 1|Physician Decision|0|||
170593827|NCT01133405|616518513|FG007|Period 1|Physician Decision|0|||
170810994|NCT01021748|617317460|FG001|Overall Study|Physician Decision|0|||
170810995|NCT01021748|617317461|FG002|Overall Study|Physician Decision|1|||
170810996|NCT01021748|617317462|FG003|Overall Study|Physician Decision|1|||
170810997|NCT01021748|617317463|FG004|Overall Study|Physician Decision|0|||
170810998|NCT01021748|617317464|FG005|Overall Study|Physician Decision|0|||
170810999|NCT01021748|617317465|FG006|Overall Study|Physician Decision|1|||
170811000|NCT01021748|617317466|FG007|Overall Study|Physician Decision|1|||
170811001|NCT01021748|617317467|FG008|Overall Study|Physician Decision|2|||
170593828|NCT01133405|616518514|FG008|Period 1|Physician Decision|0|||
170593829|NCT01133405|616518515|FG009|Period 1|Physician Decision|0|||
170593830|NCT01133405|616518506|FG000|Period 1|Discontinued after randomization|1|||
170593831|NCT01133405|616518507|FG001|Period 1|Discontinued after randomization|0|||
170593832|NCT01133405|616518508|FG002|Period 1|Discontinued after randomization|0|||
170593833|NCT01133405|616518509|FG003|Period 1|Discontinued after randomization|0|||
170593834|NCT01133405|616518510|FG004|Period 1|Discontinued after randomization|0|||
170593835|NCT01133405|616518511|FG005|Period 1|Discontinued after randomization|0|||
170593836|NCT01133405|616518512|FG006|Period 1|Discontinued after randomization|1|||
170593837|NCT01133405|616518513|FG007|Period 1|Discontinued after randomization|0|||
170593838|NCT01133405|616518514|FG008|Period 1|Discontinued after randomization|0|||
170593839|NCT01133405|616518515|FG009|Period 1|Discontinued after randomization|0|||
170593840|NCT01133405|616518506|FG000|Period 1|Received drug only in period 2|0|||
170593841|NCT01133405|616518507|FG001|Period 1|Received drug only in period 2|1|||
170593842|NCT01133405|616518508|FG002|Period 1|Received drug only in period 2|0|||
170593843|NCT01133405|616518509|FG003|Period 1|Received drug only in period 2|2|||
170593844|NCT01133405|616518510|FG004|Period 1|Received drug only in period 2|0|||
170593845|NCT01133405|616518511|FG005|Period 1|Received drug only in period 2|1|||
170811002|NCT01021748|617317459|FG000|Overall Study|Progressive Disease|3|||
170911963|NCT01518699|617682081|FG002|Period 2|Protocol Violation|0|||
170593846|NCT01133405|616518512|FG006|Period 1|Received drug only in period 2|0|||
170593847|NCT01133405|616518513|FG007|Period 1|Received drug only in period 2|0|||
170593848|NCT01133405|616518514|FG008|Period 1|Received drug only in period 2|0|||
170593849|NCT01133405|616518515|FG009|Period 1|Received drug only in period 2|0|||
170593850|NCT01133405|616518506|FG000|Period 1|Received drug only in period 3|0|||
170593851|NCT01133405|616518507|FG001|Period 1|Received drug only in period 3|1|||
170593852|NCT01133405|616518508|FG002|Period 1|Received drug only in period 3|1|||
170593853|NCT01133405|616518509|FG003|Period 1|Received drug only in period 3|0|||
170593854|NCT01133405|616518510|FG004|Period 1|Received drug only in period 3|0|||
170593855|NCT01133405|616518511|FG005|Period 1|Received drug only in period 3|0|||
170593856|NCT01133405|616518512|FG006|Period 1|Received drug only in period 3|0|||
170593857|NCT01133405|616518513|FG007|Period 1|Received drug only in period 3|0|||
170593858|NCT01133405|616518514|FG008|Period 1|Received drug only in period 3|0|||
170593859|NCT01133405|616518515|FG009|Period 1|Received drug only in period 3|0|||
170593860|NCT01133405|616518506|FG000|Period 2|Adverse Event|0|||
170593861|NCT01133405|616518507|FG001|Period 2|Adverse Event|0|||
170593862|NCT01133405|616518508|FG002|Period 2|Adverse Event|1|||
170593863|NCT01133405|616518509|FG003|Period 2|Adverse Event|0|||
170593864|NCT01133405|616518510|FG004|Period 2|Adverse Event|0|||
170593865|NCT01133405|616518511|FG005|Period 2|Adverse Event|0|||
170593866|NCT01133405|616518512|FG006|Period 2|Adverse Event|0|||
170593867|NCT01133405|616518513|FG007|Period 2|Adverse Event|0|||
170593868|NCT01133405|616518514|FG008|Period 2|Adverse Event|0|||
170593869|NCT01133405|616518515|FG009|Period 2|Adverse Event|0|||
170593870|NCT01133405|616518506|FG000|Period 2|Withdrawal by Subject|0|||
170593871|NCT01133405|616518507|FG001|Period 2|Withdrawal by Subject|0|||
170593872|NCT01133405|616518508|FG002|Period 2|Withdrawal by Subject|0|||
170593873|NCT01133405|616518509|FG003|Period 2|Withdrawal by Subject|1|||
170593874|NCT01133405|616518510|FG004|Period 2|Withdrawal by Subject|0|||
170593875|NCT01133405|616518511|FG005|Period 2|Withdrawal by Subject|1|||
170593876|NCT01133405|616518512|FG006|Period 2|Withdrawal by Subject|0|||
170593877|NCT01133405|616518513|FG007|Period 2|Withdrawal by Subject|0|||
170593878|NCT01133405|616518514|FG008|Period 2|Withdrawal by Subject|0|||
170593879|NCT01133405|616518515|FG009|Period 2|Withdrawal by Subject|0|||
170593880|NCT01133405|616518506|FG000|Period 2|Entry Criteria Not Met|0|||
170593881|NCT01133405|616518507|FG001|Period 2|Entry Criteria Not Met|1|||
170593882|NCT01133405|616518508|FG002|Period 2|Entry Criteria Not Met|0|||
170593883|NCT01133405|616518509|FG003|Period 2|Entry Criteria Not Met|0|||
170593884|NCT01133405|616518510|FG004|Period 2|Entry Criteria Not Met|0|||
170593885|NCT01133405|616518511|FG005|Period 2|Entry Criteria Not Met|0|||
170593886|NCT01133405|616518512|FG006|Period 2|Entry Criteria Not Met|0|||
170593887|NCT01133405|616518513|FG007|Period 2|Entry Criteria Not Met|0|||
170593888|NCT01133405|616518514|FG008|Period 2|Entry Criteria Not Met|0|||
170593889|NCT01133405|616518515|FG009|Period 2|Entry Criteria Not Met|0|||
170593890|NCT01133405|616518506|FG000|Period 2|Physician Decision|0|||
170593891|NCT01133405|616518507|FG001|Period 2|Physician Decision|0|||
170593892|NCT01133405|616518508|FG002|Period 2|Physician Decision|0|||
170593893|NCT01133405|616518509|FG003|Period 2|Physician Decision|0|||
170593894|NCT01133405|616518510|FG004|Period 2|Physician Decision|0|||
170593895|NCT01133405|616518511|FG005|Period 2|Physician Decision|1|||
170650772|NCT00906971|616734478|FG001|Overall Study|Withdrawal by Subject|2|||
170650773|NCT00906971|616734477|FG000|Overall Study|Lost to Follow-up|0|||
170650774|NCT00906971|616734478|FG001|Overall Study|Lost to Follow-up|1|||
170650775|NCT00545129|616734481|FG000|Overall Study|Lack of Efficacy|2|||
170650776|NCT00545129|616734482|FG001|Overall Study|Lack of Efficacy|5|||
170650777|NCT00545129|616734481|FG000|Overall Study|Death|2|||
170650778|NCT00545129|616734482|FG001|Overall Study|Death|1|||
170650779|NCT00545129|616734481|FG000|Overall Study|Adverse Event|1|||
170650780|NCT00545129|616734482|FG001|Overall Study|Adverse Event|1|||
170650781|NCT00545129|616734481|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
170593896|NCT01133405|616518512|FG006|Period 2|Physician Decision|0|||
170593897|NCT01133405|616518513|FG007|Period 2|Physician Decision|0|||
170593898|NCT01133405|616518514|FG008|Period 2|Physician Decision|0|||
170593899|NCT01133405|616518515|FG009|Period 2|Physician Decision|0|||
170593900|NCT03300024|616518516|FG000|Overall Study|Physician Decision|4|||
170593901|NCT03300024|616518517|FG001|Overall Study|Physician Decision|6|||
170593902|NCT02419131|616518518|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
170593903|NCT02419131|616518519|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
170593904|NCT02419131|616518520|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
170650782|NCT00545129|616734482|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
170593905|NCT02419131|616518518|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
170593906|NCT02419131|616518519|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
170593907|NCT02419131|616518520|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
170593908|NCT05426031|616518521|FG000|Overall Study|Circulatory Arrest|3|||
170593909|NCT05426031|616518522|FG001|Overall Study|Circulatory Arrest|2|||
170593910|NCT00089986|616518523|FG000|Overall Study|Adverse Event|6|||
170650783|NCT00545129|616734481|FG000|Overall Study|Other|3|||
170650784|NCT00545129|616734482|FG001|Overall Study|Other|3|||
170593911|NCT00089986|616518524|FG001|Overall Study|Adverse Event|9|||
170593912|NCT00089986|616518525|FG002|Overall Study|Adverse Event|6|||
170593913|NCT00089986|616518523|FG000|Overall Study|Lost to Follow-up|3|||
170593914|NCT00089986|616518524|FG001|Overall Study|Lost to Follow-up|1|||
170593915|NCT00089986|616518525|FG002|Overall Study|Lost to Follow-up|1|||
170593916|NCT00089986|616518523|FG000|Overall Study|Protocol Violation|0|||
170593917|NCT00089986|616518524|FG001|Overall Study|Protocol Violation|1|||
170593918|NCT00089986|616518525|FG002|Overall Study|Protocol Violation|0|||
170593919|NCT00089986|616518523|FG000|Overall Study|Patient transferred to another hospital|2|||
170593920|NCT00089986|616518524|FG001|Overall Study|Patient transferred to another hospital|1|||
170593921|NCT00089986|616518525|FG002|Overall Study|Patient transferred to another hospital|0|||
170593922|NCT00089986|616518523|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
170593923|NCT00089986|616518524|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
170593924|NCT00089986|616518525|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
170593925|NCT00089986|616518523|FG000|Overall Study|Hemohlobin stopping rule|0|||
170593926|NCT00089986|616518524|FG001|Overall Study|Hemohlobin stopping rule|1|||
170593927|NCT00089986|616518525|FG002|Overall Study|Hemohlobin stopping rule|0|||
170593928|NCT00089986|616518523|FG000|Overall Study|Investigator decision to withdrew|0|||
170593929|NCT00089986|616518524|FG001|Overall Study|Investigator decision to withdrew|1|||
170593930|NCT00089986|616518525|FG002|Overall Study|Investigator decision to withdrew|0|||
170593931|NCT00089986|616518523|FG000|Overall Study|Enrollment in another study|0|||
170593932|NCT00089986|616518524|FG001|Overall Study|Enrollment in another study|1|||
170593933|NCT00089986|616518525|FG002|Overall Study|Enrollment in another study|0|||
170593934|NCT00089986|616518523|FG000|Overall Study|Family decision|0|||
170593935|NCT00089986|616518524|FG001|Overall Study|Family decision|1|||
170811003|NCT01021748|617317460|FG001|Overall Study|Progressive Disease|3|||
170811004|NCT01021748|617317461|FG002|Overall Study|Progressive Disease|4|||
170811005|NCT01021748|617317462|FG003|Overall Study|Progressive Disease|6|||
170811006|NCT01021748|617317463|FG004|Overall Study|Progressive Disease|7|||
170811007|NCT01021748|617317464|FG005|Overall Study|Progressive Disease|3|||
170811008|NCT01021748|617317465|FG006|Overall Study|Progressive Disease|0|||
170811009|NCT01021748|617317466|FG007|Overall Study|Progressive Disease|5|||
170811010|NCT01021748|617317467|FG008|Overall Study|Progressive Disease|6|||
170811011|NCT01021748|617317459|FG000|Overall Study|Withdrawal by Subject|0|||
170811012|NCT01021748|617317460|FG001|Overall Study|Withdrawal by Subject|0|||
170811013|NCT01021748|617317461|FG002|Overall Study|Withdrawal by Subject|0|||
170811014|NCT01021748|617317462|FG003|Overall Study|Withdrawal by Subject|0|||
170811015|NCT01021748|617317463|FG004|Overall Study|Withdrawal by Subject|0|||
170811016|NCT01021748|617317464|FG005|Overall Study|Withdrawal by Subject|0|||
170811017|NCT01021748|617317465|FG006|Overall Study|Withdrawal by Subject|1|||
170811018|NCT01021748|617317466|FG007|Overall Study|Withdrawal by Subject|0|||
170811019|NCT01021748|617317467|FG008|Overall Study|Withdrawal by Subject|1|||
170811020|NCT01021748|617317459|FG000|Overall Study|Not Treated|0|||
170811021|NCT01021748|617317460|FG001|Overall Study|Not Treated|1|||
170811022|NCT01021748|617317461|FG002|Overall Study|Not Treated|0|||
170811023|NCT01021748|617317462|FG003|Overall Study|Not Treated|0|||
170811024|NCT01021748|617317463|FG004|Overall Study|Not Treated|0|||
170811025|NCT01021748|617317464|FG005|Overall Study|Not Treated|0|||
170811026|NCT01021748|617317465|FG006|Overall Study|Not Treated|0|||
170811027|NCT01021748|617317466|FG007|Overall Study|Not Treated|0|||
170811028|NCT01021748|617317467|FG008|Overall Study|Not Treated|0|||
170811029|NCT02309515|617317469|FG000|Overall Study|Withdrawal by Subject|0|||
170811030|NCT02309515|617317470|FG001|Overall Study|Withdrawal by Subject|1|||
170811031|NCT02547974|617317476|FG000|Overall Study|Withdrawal by Subject|1|||
170811032|NCT02547974|617317477|FG001|Overall Study|Withdrawal by Subject|0|||
170811033|NCT02547974|617317478|FG002|Overall Study|Withdrawal by Subject|0|||
170811034|NCT02547974|617317479|FG003|Overall Study|Withdrawal by Subject|0|||
170811035|NCT00807599|617317496|FG000|Overall Study|Not treated on protocol study|0|||
170811036|NCT00807599|617317497|FG001|Overall Study|Not treated on protocol study|0|||
170811037|NCT00807599|617317498|FG002|Overall Study|Not treated on protocol study|2|||
170811038|NCT00807599|617317496|FG000|Overall Study|Adverse Event|0|||
170811039|NCT00807599|617317497|FG001|Overall Study|Adverse Event|0|||
170811040|NCT00807599|617317498|FG002|Overall Study|Adverse Event|5|||
170811041|NCT00807599|617317496|FG000|Overall Study|Inadequate response to induction|0|||
170811042|NCT00807599|617317497|FG001|Overall Study|Inadequate response to induction|0|||
170811043|NCT00807599|617317498|FG002|Overall Study|Inadequate response to induction|9|||
170811044|NCT00807599|617317496|FG000|Overall Study|Withdrawal by Subject|0|||
170811045|NCT00807599|617317497|FG001|Overall Study|Withdrawal by Subject|0|||
170811046|NCT00807599|617317498|FG002|Overall Study|Withdrawal by Subject|1|||
170811047|NCT03128099|617317499|FG000|Overall Study|High dose task was too long|0|||
170811048|NCT03128099|617317500|FG001|Overall Study|High dose task was too long|4|||
170811049|NCT03128099|617317501|FG002|Overall Study|High dose task was too long|0|||
170811050|NCT03128099|617317499|FG000|Overall Study|Participant got a full time job.|1|||
170811051|NCT03128099|617317500|FG001|Overall Study|Participant got a full time job.|0|||
170811052|NCT03128099|617317501|FG002|Overall Study|Participant got a full time job.|0|||
170811053|NCT03128099|617317499|FG000|Overall Study|Became homeless and lost contact|1|||
170593936|NCT00089986|616518525|FG002|Overall Study|Family decision|0|||
170593937|NCT00089986|616518523|FG000|Overall Study|Do not resuscitate (DNR)|0|||
170593938|NCT00089986|616518524|FG001|Overall Study|Do not resuscitate (DNR)|0|||
170593939|NCT00089986|616518525|FG002|Overall Study|Do not resuscitate (DNR)|1|||
170593940|NCT00089986|616518523|FG000|Overall Study|Withdrawal by Subject|3|||
170593941|NCT00089986|616518524|FG001|Overall Study|Withdrawal by Subject|6|||
170593942|NCT00089986|616518525|FG002|Overall Study|Withdrawal by Subject|2|||
170593943|NCT01118520|616518529|FG000|Overall Study|AAA repair|9|||
170593944|NCT01118520|616518530|FG001|Overall Study|AAA repair|7|||
170593945|NCT01118520|616518531|FG002|Overall Study|AAA repair|9|||
170593946|NCT01118520|616518529|FG000|Overall Study|Adverse Event|3|||
170593947|NCT01118520|616518530|FG001|Overall Study|Adverse Event|3|||
170593948|NCT01118520|616518531|FG002|Overall Study|Adverse Event|3|||
170593949|NCT01118520|616518529|FG000|Overall Study|Withdrawal by Subject|8|||
170911964|NCT01518699|617682082|FG003|Period 2|Protocol Violation|0|||
170911965|NCT01518699|617682083|FG004|Period 2|Protocol Violation|0|||
170911966|NCT01518699|617682084|FG005|Period 2|Protocol Violation|0|||
170911967|NCT01518699|617682079|FG000|Period 2|Lost to Follow-up|0|||
170593950|NCT01118520|616518530|FG001|Overall Study|Withdrawal by Subject|13|||
170593951|NCT01118520|616518531|FG002|Overall Study|Withdrawal by Subject|8|||
170593952|NCT01071200|616518533|FG000|Overall Study|Lack of ovarian response|1|||
170593953|NCT01071200|616518534|FG001|Overall Study|Lack of ovarian response|1|||
170593954|NCT01071200|616518533|FG000|Overall Study|No fertilization|4|||
170593955|NCT01071200|616518534|FG001|Overall Study|No fertilization|0|||
170593956|NCT01071200|616518533|FG000|Overall Study|No oocytes retrieved|1|||
170593957|NCT01071200|616518534|FG001|Overall Study|No oocytes retrieved|1|||
170593958|NCT01071200|616518533|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
170811054|NCT03128099|617317500|FG001|Overall Study|Became homeless and lost contact|0|||
170811055|NCT03128099|617317501|FG002|Overall Study|Became homeless and lost contact|0|||
170811056|NCT03128099|617317499|FG000|Overall Study|Did not complete all the assessments|0|||
170811057|NCT03128099|617317500|FG001|Overall Study|Did not complete all the assessments|0|||
170811058|NCT03128099|617317501|FG002|Overall Study|Did not complete all the assessments|1|||
170811059|NCT02161458|617317502|FG000|Overall Study|Withdrawal by Subject|0|||
170811060|NCT02161458|617317503|FG001|Overall Study|Withdrawal by Subject|4|||
170811061|NCT02161458|617317504|FG002|Overall Study|Withdrawal by Subject|4|||
170811062|NCT02161458|617317505|FG003|Overall Study|Withdrawal by Subject|0|||
170811063|NCT02161458|617317502|FG000|Overall Study|Lost to Follow-up|0|||
170811064|NCT02161458|617317503|FG001|Overall Study|Lost to Follow-up|2|||
170811065|NCT02161458|617317504|FG002|Overall Study|Lost to Follow-up|1|||
170811066|NCT02161458|617317505|FG003|Overall Study|Lost to Follow-up|0|||
170811067|NCT00148122|617317506|FG000|Overall Study|Withdrawal by Subject|2|||
170811068|NCT03136861|617317507|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
170811069|NCT03136861|617317508|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
170811070|NCT03136861|617317509|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
170811071|NCT03136861|617317510|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
170811072|NCT03136861|617317511|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
170811073|NCT03136861|617317512|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
170811074|NCT03136861|617317513|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
170811075|NCT03136861|617317507|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
170811076|NCT03136861|617317508|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
170811077|NCT03136861|617317509|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
170811078|NCT03136861|617317510|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
170811079|NCT03136861|617317511|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
170811080|NCT03136861|617317512|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
170811081|NCT03136861|617317513|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
170811082|NCT03136861|617317507|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
170811083|NCT03136861|617317508|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
170811084|NCT03136861|617317509|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
170811085|NCT03136861|617317510|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
170911968|NCT01518699|617682080|FG001|Period 2|Lost to Follow-up|1|||
170911969|NCT01518699|617682081|FG002|Period 2|Lost to Follow-up|0|||
170593959|NCT01071200|616518534|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
170593960|NCT01071200|616518533|FG000|Overall Study|No viable embryos|0|||
170593961|NCT01071200|616518534|FG001|Overall Study|No viable embryos|1|||
170593962|NCT03831880|616518536|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
170593963|NCT03831880|616518537|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
170593964|NCT03831880|616518536|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
170593965|NCT03831880|616518537|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
170593966|NCT01852825|616518538|FG000|Overall Study|Withdrawal by Subject|2|||
170593967|NCT01852825|616518539|FG001|Overall Study|Withdrawal by Subject|0|||
170593968|NCT01852825|616518540|FG002|Overall Study|Withdrawal by Subject|0|||
170593969|NCT02969590|616518541|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
170593970|NCT02969590|616518542|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
170811086|NCT03136861|617317511|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
170811087|NCT03136861|617317512|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
170811088|NCT03136861|617317513|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
170811089|NCT03136861|617317507|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
170811090|NCT03136861|617317508|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
170811091|NCT03136861|617317509|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
170811092|NCT03136861|617317510|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
170811093|NCT03136861|617317511|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
170811094|NCT03136861|617317512|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
170811095|NCT03136861|617317513|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
170811096|NCT03136861|617317507|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
170811097|NCT03136861|617317508|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
170811098|NCT03136861|617317509|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
170811099|NCT03136861|617317510|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
170811100|NCT03136861|617317511|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
170811101|NCT03136861|617317512|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
170811102|NCT03136861|617317513|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
170811103|NCT03136861|617317507|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
170593971|NCT02969590|616518543|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
170593972|NCT01414205|616518544|FG000|Overall Study|Death|5|||
170593973|NCT01414205|616518545|FG001|Overall Study|Death|1|||
170593974|NCT01414205|616518544|FG000|Overall Study|Lost to Follow-up|1|||
170593975|NCT01414205|616518545|FG001|Overall Study|Lost to Follow-up|4|||
170593976|NCT01414205|616518544|FG000|Overall Study|Physician Decision|0|||
170593977|NCT01414205|616518545|FG001|Overall Study|Physician Decision|1|||
170593978|NCT01414205|616518544|FG000|Overall Study|Randomized but not Treated|1|||
170593979|NCT01414205|616518545|FG001|Overall Study|Randomized but not Treated|1|||
170593980|NCT01765426|616518546|FG000|Overall Study|Lost to Follow-up|0|||
170593981|NCT01765426|616518547|FG001|Overall Study|Lost to Follow-up|1|||
170593982|NCT01765426|616518548|FG002|Overall Study|Lost to Follow-up|0|||
170811104|NCT03136861|617317508|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
170811105|NCT03136861|617317509|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
170593983|NCT01765426|616518549|FG003|Overall Study|Lost to Follow-up|0|||
170593984|NCT01166373|616518550|FG000|Overall Study|Lost to Follow-up|3|||
170593985|NCT01166373|616518551|FG001|Overall Study|Lost to Follow-up|2|||
170593986|NCT01166373|616518552|FG002|Overall Study|Lost to Follow-up|2|||
170811106|NCT03136861|617317510|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
170811107|NCT03136861|617317511|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
170811108|NCT03136861|617317512|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
170811109|NCT03136861|617317513|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
170811110|NCT03136861|617317507|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
170811111|NCT03136861|617317508|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
170811112|NCT03136861|617317509|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
170811113|NCT03136861|617317510|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
170811114|NCT03136861|617317511|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
170811115|NCT03136861|617317512|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
170811116|NCT03136861|617317513|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
170811117|NCT03136861|617317507|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
170811118|NCT03136861|617317508|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
170811119|NCT03136861|617317509|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
170811120|NCT03136861|617317510|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
170811121|NCT03136861|617317511|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
170811122|NCT03136861|617317512|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
170811123|NCT03136861|617317513|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
170811124|NCT01328756|617317519|FG000|Overall Study|Protocol Violation|4|||
170811125|NCT01328756|617317519|FG000|Overall Study|Adverse Event|39|||
170811126|NCT01328756|617317519|FG000|Overall Study|Lack of Efficacy|5|||
170811127|NCT01328756|617317519|FG000|Overall Study|Withdrawal by Subject|41|||
170811128|NCT01328756|617317519|FG000|Overall Study|Lost to Follow-up|5|||
170811129|NCT01328756|617317519|FG000|Overall Study|Other|29|||
170593987|NCT01166373|616518553|FG003|Overall Study|Lost to Follow-up|2|||
170650785|NCT03104816|616734483|FG000|Overall Study|Lack of Efficacy|0|||
170811130|NCT02362789|617317525|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
170911970|NCT01518699|617682082|FG003|Period 2|Lost to Follow-up|0|||
170593988|NCT01166373|616518550|FG000|Overall Study|Withdrawal by Subject|1|||
170593989|NCT01166373|616518551|FG001|Overall Study|Withdrawal by Subject|2|||
170593990|NCT01166373|616518552|FG002|Overall Study|Withdrawal by Subject|2|||
170593991|NCT01166373|616518553|FG003|Overall Study|Withdrawal by Subject|3|||
170593992|NCT01166373|616518550|FG000|Overall Study|Physician Decision|1|||
170593993|NCT01166373|616518551|FG001|Overall Study|Physician Decision|0|||
170593994|NCT01166373|616518552|FG002|Overall Study|Physician Decision|0|||
170593995|NCT01166373|616518553|FG003|Overall Study|Physician Decision|0|||
170593996|NCT01146288|616518554|FG000|First Intervention(1 Day)|Adverse Event|0|||
170593997|NCT01146288|616518555|FG001|First Intervention(1 Day)|Adverse Event|1|||
170593998|NCT02498067|616518559|FG000|Overall Study|Lost to Follow-up|22|||
170593999|NCT02498067|616518559|FG000|Overall Study|Did not meet inclusion criteria|11|||
170594000|NCT01874275|616518562|FG000|Overall Study|Lost to Follow-up|1|||
170594001|NCT01874275|616518563|FG001|Overall Study|Lost to Follow-up|0|||
170594002|NCT00762996|616518572|FG000|Period One|Protocol Violation|0|||
170594003|NCT00762996|616518573|FG001|Period One|Protocol Violation|0|||
170911971|NCT01518699|617682083|FG004|Period 2|Lost to Follow-up|0|||
170911972|NCT01518699|617682084|FG005|Period 2|Lost to Follow-up|0|||
170911973|NCT01518699|617682079|FG000|Period 2|Adverse Event|1|||
170911974|NCT01518699|617682080|FG001|Period 2|Adverse Event|0|||
170911975|NCT01518699|617682081|FG002|Period 2|Adverse Event|0|||
170911976|NCT01518699|617682082|FG003|Period 2|Adverse Event|0|||
170911977|NCT01518699|617682083|FG004|Period 2|Adverse Event|0|||
170911978|NCT01518699|617682084|FG005|Period 2|Adverse Event|0|||
170911979|NCT01300286|617682085|FG000|Overall Study|did not get dosed|1|||
170911980|NCT02767570|617682088|FG000|Overall Study|Lost to Follow-up|3|||
170911981|NCT02767570|617682089|FG001|Overall Study|Lost to Follow-up|0|||
170911982|NCT02767570|617682088|FG000|Overall Study|COVID shutdown|2|||
170594004|NCT00762996|616518574|FG002|Period One|Protocol Violation|1|||
170594005|NCT00762996|616518575|FG003|Period One|Protocol Violation|0|||
170594006|NCT00762996|616518572|FG000|Period One|ineligible|0|||
170594007|NCT00762996|616518573|FG001|Period One|ineligible|0|||
170594008|NCT00762996|616518574|FG002|Period One|ineligible|1|||
170594009|NCT00762996|616518575|FG003|Period One|ineligible|1|||
170594010|NCT00762996|616518572|FG000|Period One|Adverse Event|0|||
170594011|NCT00762996|616518573|FG001|Period One|Adverse Event|0|||
170594012|NCT00762996|616518574|FG002|Period One|Adverse Event|1|||
170594013|NCT00762996|616518575|FG003|Period One|Adverse Event|0|||
170594014|NCT00762996|616518572|FG000|Period One|Withdrawal by Subject|0|||
170594015|NCT00762996|616518573|FG001|Period One|Withdrawal by Subject|0|||
170594016|NCT00762996|616518574|FG002|Period One|Withdrawal by Subject|1|||
170594017|NCT00762996|616518575|FG003|Period One|Withdrawal by Subject|0|||
170594018|NCT00933244|616518576|FG000|Overall Study|Withdrawal by Subject|5|||
170594019|NCT00933244|616518577|FG001|Overall Study|Withdrawal by Subject|1|||
170594020|NCT00933244|616518578|FG002|Overall Study|Withdrawal by Subject|3|||
170594021|NCT01174004|616518579|FG000|Overall Study|Adverse Event|2|||
170594022|NCT01174004|616518580|FG001|Overall Study|Adverse Event|10|||
170594023|NCT01174004|616518579|FG000|Overall Study|Withdrawal by Subject|2|||
170594024|NCT01174004|616518580|FG001|Overall Study|Withdrawal by Subject|3|||
170594025|NCT01174004|616518579|FG000|Overall Study|At Discretion of Sponsor|2|||
170594026|NCT01174004|616518580|FG001|Overall Study|At Discretion of Sponsor|2|||
170594027|NCT01174004|616518579|FG000|Overall Study|Protocol Violation|0|||
170594028|NCT01174004|616518580|FG001|Overall Study|Protocol Violation|1|||
170594029|NCT01174004|616518579|FG000|Overall Study|Physician Decision|1|||
170594030|NCT01174004|616518580|FG001|Overall Study|Physician Decision|0|||
170594031|NCT01143896|616518585|FG000|Overall Study|Did not complete Baseline Interview|5|||
170594032|NCT01143896|616518586|FG001|Overall Study|Did not complete Baseline Interview|4|||
170594033|NCT01143896|616518585|FG000|Overall Study|Lost to Follow-up|18|||
170594034|NCT01143896|616518586|FG001|Overall Study|Lost to Follow-up|13|||
170594035|NCT01143896|616518585|FG000|Overall Study|Withdrawal by Subject|13|||
170594036|NCT01143896|616518586|FG001|Overall Study|Withdrawal by Subject|5|||
170594037|NCT01143896|616518585|FG000|Overall Study|Death|6|||
170594038|NCT01143896|616518586|FG001|Overall Study|Death|3|||
170594039|NCT00495521|616518587|FG000|Overall Study|Physician Decision|0|||
170911983|NCT02767570|617682089|FG001|Overall Study|COVID shutdown|5|||
170911984|NCT02767570|617682088|FG000|Overall Study|Increased pain|2|||
170594040|NCT00495521|616518588|FG001|Overall Study|Physician Decision|1|||
170594041|NCT01318070|616518589|FG000|Overall Study|Adverse Event|1|||
170594042|NCT01318070|616518590|FG001|Overall Study|Adverse Event|1|||
170594043|NCT01318070|616518591|FG002|Overall Study|Adverse Event|5|||
170594044|NCT01318070|616518589|FG000|Overall Study|Withdrawal by Subject|0|||
170594045|NCT01318070|616518590|FG001|Overall Study|Withdrawal by Subject|1|||
170594046|NCT01318070|616518591|FG002|Overall Study|Withdrawal by Subject|1|||
170594047|NCT01318070|616518589|FG000|Overall Study|Lack of Efficacy|0|||
170911985|NCT02767570|617682089|FG001|Overall Study|Increased pain|0|||
170594048|NCT01318070|616518590|FG001|Overall Study|Lack of Efficacy|0|||
170594049|NCT01318070|616518591|FG002|Overall Study|Lack of Efficacy|1|||
170594050|NCT01318070|616518589|FG000|Overall Study|Principal Investigator Discretion|1|||
170594051|NCT01318070|616518590|FG001|Overall Study|Principal Investigator Discretion|0|||
170594052|NCT01318070|616518591|FG002|Overall Study|Principal Investigator Discretion|0|||
170594053|NCT02782325|616518594|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
170594054|NCT02782325|616518595|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
170911986|NCT02767570|617682088|FG000|Overall Study|Withdrawal by Subject|1|||
170911987|NCT02767570|617682089|FG001|Overall Study|Withdrawal by Subject|3|||
170911988|NCT02767570|617682088|FG000|Overall Study|Unrelated medical issue|1|||
170911989|NCT02767570|617682089|FG001|Overall Study|Unrelated medical issue|1|||
170911990|NCT02767570|617682088|FG000|Overall Study|Received intra-articular injection|0|||
170911991|NCT02767570|617682089|FG001|Overall Study|Received intra-articular injection|1|||
170911992|NCT03692910|617682091|FG000|Overall Study|Lost to Follow-up|4|||
170911993|NCT03692910|617682092|FG001|Overall Study|Lost to Follow-up|0|||
170911994|NCT03692910|617682093|FG002|Overall Study|Lost to Follow-up|0|||
170911995|NCT03692910|617682091|FG000|Overall Study|Withdrawal by Subject|2|||
170911996|NCT03692910|617682092|FG001|Overall Study|Withdrawal by Subject|0|||
170911997|NCT03692910|617682093|FG002|Overall Study|Withdrawal by Subject|0|||
170911998|NCT01306058|617682100|FG000|Overall Study|Death|1|||
170911999|NCT01306058|617682100|FG000|Overall Study|Enrolled but did not get treatment|1|||
170912000|NCT00224107|617682101|FG000|Overall Study|Adverse Event|20|||
170912001|NCT00224107|617682102|FG001|Overall Study|Adverse Event|6|||
170912002|NCT00224107|617682101|FG000|Overall Study|Protocol Violation|2|||
170912003|NCT00224107|617682102|FG001|Overall Study|Protocol Violation|3|||
170912004|NCT00224107|617682101|FG000|Overall Study|Withdrawal by Subject|1|||
170912005|NCT00224107|617682102|FG001|Overall Study|Withdrawal by Subject|4|||
170912006|NCT00224107|617682101|FG000|Overall Study|Lack of Efficacy|2|||
170912007|NCT00224107|617682102|FG001|Overall Study|Lack of Efficacy|0|||
170912008|NCT00224107|617682101|FG000|Overall Study|Lost to Follow-up|4|||
170912009|NCT00224107|617682102|FG001|Overall Study|Lost to Follow-up|0|||
170912010|NCT00224107|617682101|FG000|Overall Study|Physician Decision|1|||
170912011|NCT00224107|617682102|FG001|Overall Study|Physician Decision|0|||
170912012|NCT00224107|617682101|FG000|Overall Study|Other|1|||
170912013|NCT00224107|617682102|FG001|Overall Study|Other|1|||
170912014|NCT01334125|617682103|FG000|Overall Study|Lost to Follow-up|3|||
170912015|NCT01334125|617682104|FG001|Overall Study|Lost to Follow-up|3|||
170912016|NCT01408537|617682107|FG000|Overall Study|Withdrawal by Subject|2|||
170912017|NCT01408537|617682107|FG000|Overall Study|Protocol Violation|3|||
170912018|NCT01408537|617682107|FG000|Overall Study|Lost to Follow-up|3|||
170912019|NCT00915005|617682108|FG000|Overall Study|Withdrawal by Subject|4|||
170912020|NCT00915005|617682109|FG001|Overall Study|Withdrawal by Subject|4|||
170912021|NCT00915005|617682108|FG000|Overall Study|Patient preferred protons therapy|6|||
170912022|NCT00915005|617682109|FG001|Overall Study|Patient preferred protons therapy|0|||
170912023|NCT00915005|617682108|FG000|Overall Study|Insurance denial|3|||
170912024|NCT00915005|617682109|FG001|Overall Study|Insurance denial|15|||
170912025|NCT01183858|617682110|FG000|Overall Study|Death not related to Progressive Disease|5|||
170912026|NCT01183858|617682111|FG001|Overall Study|Death not related to Progressive Disease|6|||
170912027|NCT01183858|617682110|FG000|Overall Study|Adverse Event|14|||
170912028|NCT01183858|617682111|FG001|Overall Study|Adverse Event|11|||
170912029|NCT01183858|617682110|FG000|Overall Study|Investigator's Decision|0|||
170912030|NCT01183858|617682111|FG001|Overall Study|Investigator's Decision|3|||
170912031|NCT01183858|617682110|FG000|Overall Study|Insufficient Therapeutic Response|2|||
170912032|NCT01183858|617682111|FG001|Overall Study|Insufficient Therapeutic Response|0|||
170912033|NCT01183858|617682110|FG000|Overall Study|Refused Treatment|1|||
170912034|NCT01183858|617682111|FG001|Overall Study|Refused Treatment|4|||
170912035|NCT01183858|617682110|FG000|Overall Study|Withdrew Consent|4|||
170912036|NCT01183858|617682111|FG001|Overall Study|Withdrew Consent|4|||
170912037|NCT01183858|617682110|FG000|Overall Study|Discontinued Smoking|3|||
170912038|NCT01183858|617682111|FG001|Overall Study|Discontinued Smoking|1|||
170912039|NCT01183858|617682110|FG000|Overall Study|Protocol Violation|1|||
170912040|NCT01183858|617682111|FG001|Overall Study|Protocol Violation|0|||
170912041|NCT01183858|617682110|FG000|Overall Study|Administrative/Other|6|||
170912042|NCT01183858|617682111|FG001|Overall Study|Administrative/Other|6|||
170912043|NCT01183858|617682110|FG000|Overall Study|Progressive Disease|112|||
170594055|NCT02782325|616518596|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
170594056|NCT02782325|616518594|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
170594057|NCT02782325|616518595|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
170594058|NCT02782325|616518596|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
170912044|NCT01183858|617682111|FG001|Overall Study|Progressive Disease|115|||
170912045|NCT01183858|617682110|FG000|Overall Study|Death related to Progressive Disease|4|||
170912046|NCT01183858|617682111|FG001|Overall Study|Death related to Progressive Disease|5|||
170594059|NCT00693472|616518597|FG000|Part 1|Adverse Event|1|||
170594060|NCT00693472|616518598|FG001|Part 1|Adverse Event|1|||
170594061|NCT00693472|616518599|FG002|Part 1|Adverse Event|0|||
170912047|NCT01183858|617682110|FG000|Overall Study|Lost to Follow-up|1|||
170912048|NCT01183858|617682111|FG001|Overall Study|Lost to Follow-up|1|||
170912049|NCT00779038|617682114|FG000|Overall Study|Study Prematurely Terminated|13|||
170594062|NCT00693472|616518600|FG003|Part 1|Adverse Event|0|||
170594063|NCT00693472|616518597|FG000|Part 1|Lost to Follow-up|0|||
170594064|NCT00693472|616518598|FG001|Part 1|Lost to Follow-up|1|||
170912050|NCT01570491|617682115|FG000|Overall Study|Lost to Follow-up|3|||
170912051|NCT01570491|617682116|FG001|Overall Study|Lost to Follow-up|1|||
170912052|NCT01570491|617682115|FG000|Overall Study|treatment: not given or discontinued|2|||
170594065|NCT00693472|616518599|FG002|Part 1|Lost to Follow-up|0|||
170912053|NCT01570491|617682116|FG001|Overall Study|treatment: not given or discontinued|0|||
170594066|NCT00693472|616518600|FG003|Part 1|Lost to Follow-up|0|||
170594067|NCT00693472|616518597|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
170594068|NCT00693472|616518598|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
170594069|NCT00693472|616518599|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
170594070|NCT00693472|616518600|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
170594071|NCT00693472|616518597|FG000|Part 2|Adverse Event|0|||
170594072|NCT00693472|616518598|FG001|Part 2|Adverse Event|0|||
170594073|NCT00693472|616518599|FG002|Part 2|Adverse Event|1|||
170594074|NCT00693472|616518600|FG003|Part 2|Adverse Event|0|||
170594075|NCT00693472|616518597|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
170594076|NCT00693472|616518598|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
170594077|NCT00693472|616518599|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
170594078|NCT00693472|616518600|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
170594079|NCT00746733|616518601|FG000|Second Intervention|Adverse Event|1|||
170594080|NCT00746733|616518602|FG001|Second Intervention|Adverse Event|0|||
170594081|NCT00746733|616518601|FG000|Third Intervention|Withdrawal by Subject|1|||
170594082|NCT00746733|616518602|FG001|Third Intervention|Withdrawal by Subject|1|||
170594083|NCT00849875|616518603|FG000|Overall Study|Death|28|||
170594084|NCT00849875|616518603|FG000|Overall Study|Ongoing (unknown completion status)|11|||
170594085|NCT00849875|616518603|FG000|Overall Study|Others|6|||
170594086|NCT00849875|616518603|FG000|Overall Study|Lost to Follow-up|2|||
170594087|NCT00657150|616518604|FG000|Overall Study|Adverse Event|19|||
170594088|NCT00657150|616518605|FG001|Overall Study|Adverse Event|10|||
170594089|NCT00657150|616518604|FG000|Overall Study|Non-compliant with protocol|5|||
170594090|NCT00657150|616518605|FG001|Overall Study|Non-compliant with protocol|9|||
170594091|NCT00657150|616518604|FG000|Overall Study|Lost to Follow-up|2|||
170594092|NCT00657150|616518605|FG001|Overall Study|Lost to Follow-up|0|||
170594093|NCT00657150|616518604|FG000|Overall Study|Withdrawal by Subject|51|||
170594094|NCT00657150|616518605|FG001|Overall Study|Withdrawal by Subject|36|||
170594095|NCT00657150|616518604|FG000|Overall Study|Other|38|||
170594096|NCT00657150|616518605|FG001|Overall Study|Other|38|||
170594097|NCT00657150|616518604|FG000|Treatment|Adverse Event|60|||
170594098|NCT00657150|616518605|FG001|Treatment|Adverse Event|53|||
170594099|NCT00657150|616518604|FG000|Treatment|Non-compliant with protocol|10|||
170594100|NCT00657150|616518605|FG001|Treatment|Non-compliant with protocol|9|||
170594101|NCT00657150|616518604|FG000|Treatment|Lost to Follow-up|1|||
170594102|NCT00657150|616518605|FG001|Treatment|Lost to Follow-up|0|||
170594103|NCT00657150|616518604|FG000|Treatment|Withdrawal by Subject|23|||
170594104|NCT00657150|616518605|FG001|Treatment|Withdrawal by Subject|20|||
170594105|NCT00657150|616518604|FG000|Treatment|Other|13|||
170594106|NCT00657150|616518605|FG001|Treatment|Other|15|||
170594107|NCT00432744|616518607|FG000|Months 0-6|Withdrawal by Subject|4|||
170594108|NCT00432744|616518608|FG001|Months 0-6|Withdrawal by Subject|4|||
170594109|NCT00432744|616518607|FG000|Months 0-6|Too disabled to score|1|||
170594110|NCT00432744|616518608|FG001|Months 0-6|Too disabled to score|0|||
170594111|NCT00432744|616518607|FG000|Months 7 - 12|Withdrawal by Subject|1|||
170594112|NCT00432744|616518608|FG001|Months 7 - 12|Withdrawal by Subject|0|||
170594113|NCT00432744|616518607|FG000|Months 7 - 12|Too disabled to score|0|||
170594114|NCT00432744|616518608|FG001|Months 7 - 12|Too disabled to score|1|||
170594115|NCT00554099|616518611|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
170594116|NCT00554099|616518612|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
170594117|NCT00554099|616518613|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
170594118|NCT00554099|616518611|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
170594119|NCT00554099|616518612|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
170594120|NCT00554099|616518613|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
170594121|NCT00554099|616518611|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
170594122|NCT00554099|616518612|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170594123|NCT00554099|616518613|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
170594124|NCT00554099|616518611|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
170594125|NCT00554099|616518612|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
170594126|NCT00554099|616518613|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
170594127|NCT00554099|616518611|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
170594128|NCT00554099|616518612|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
170594129|NCT00554099|616518613|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
170811131|NCT02362789|617317526|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
170594130|NCT00554099|616518611|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
170594131|NCT00554099|616518612|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
170594132|NCT00554099|616518613|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
170912054|NCT02614794|617682118|FG000|Overall Study|Death|258|||
170594133|NCT00554099|616518611|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
170594134|NCT00554099|616518612|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
170594135|NCT00554099|616518613|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
170594136|NCT00554099|616518611|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
170594137|NCT00554099|616518612|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
170594138|NCT00554099|616518613|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
170912055|NCT02614794|617682119|FG001|Overall Study|Death|151|||
170912056|NCT02614794|617682118|FG000|Overall Study|Study closure by Sponsor|119|||
170912057|NCT02614794|617682119|FG001|Overall Study|Study closure by Sponsor|45|||
170912058|NCT02614794|617682118|FG000|Overall Study|Withdrawal by Subject|24|||
170912059|NCT02614794|617682119|FG001|Overall Study|Withdrawal by Subject|5|||
170912060|NCT02614794|617682118|FG000|Overall Study|Lost to Follow-up|7|||
170912061|NCT02614794|617682119|FG001|Overall Study|Lost to Follow-up|0|||
170912062|NCT02614794|617682118|FG000|Overall Study|Physician Decision|1|||
170912063|NCT02614794|617682119|FG001|Overall Study|Physician Decision|1|||
170912064|NCT02614794|617682118|FG000|Overall Study|Hospital closure|1|||
170912065|NCT02614794|617682119|FG001|Overall Study|Hospital closure|0|||
170912066|NCT01507545|617682124|FG000|Overall Study|Withdrawal by Subject|6|||
170912067|NCT01507545|617682125|FG001|Overall Study|Withdrawal by Subject|2|||
170912068|NCT01507545|617682124|FG000|Overall Study|Lost to Follow-up|1|||
170912069|NCT01507545|617682125|FG001|Overall Study|Lost to Follow-up|0|||
170912070|NCT01507545|617682124|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
170912071|NCT01507545|617682125|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
170912072|NCT01507545|617682124|FG000|Overall Study|Progressive disease|60|||
170912073|NCT01507545|617682125|FG001|Overall Study|Progressive disease|27|||
170912074|NCT01507545|617682124|FG000|Overall Study|Other|6|||
170912075|NCT01507545|617682125|FG001|Overall Study|Other|4|||
170912076|NCT02612077|617682127|FG000|Overall Study|Adverse Event|3|||
170912077|NCT02612077|617682127|FG000|Overall Study|Withdrawal by Subject|9|||
170912078|NCT02612077|617682127|FG000|Overall Study|Protocol Violation|28|||
170912079|NCT02612077|617682127|FG000|Overall Study|Lost to Follow-up|20|||
170912080|NCT02612077|617682127|FG000|Overall Study|Death|377|||
170912081|NCT02612077|617682127|FG000|Overall Study|Moved or Changed Medical Team|23|||
170912082|NCT02612077|617682127|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
170912083|NCT02612077|617682127|FG000|Overall Study|Disease Progression|3|||
170912084|NCT02612077|617682127|FG000|Overall Study|Unknown reason|2|||
170912085|NCT01753518|617682128|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
170912086|NCT01753518|617682129|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
170912087|NCT01753518|617682128|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
170912088|NCT01753518|617682129|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
170912089|NCT01753518|617682128|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
170912090|NCT01753518|617682129|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
170912091|NCT01753518|617682128|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
170912092|NCT01753518|617682129|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
170594139|NCT00554099|616518611|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
170594140|NCT00554099|616518612|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
170594141|NCT00554099|616518613|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
170594142|NCT04342689|616518617|FG000|Overall Study|Withdrawal by Subject|32|||
170594143|NCT04342689|616518618|FG001|Overall Study|Withdrawal by Subject|33|||
170594144|NCT04342689|616518617|FG000|Overall Study|Lost to Follow-up|10|||
170594145|NCT04342689|616518618|FG001|Overall Study|Lost to Follow-up|12|||
170594146|NCT01460407|616518619|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
170594147|NCT01460407|616518620|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
170594148|NCT00475865|616518623|FG000|Overall Study|Adverse Event|0|||
170594149|NCT00475865|616518624|FG001|Overall Study|Adverse Event|3|||
170594150|NCT00475865|616518625|FG002|Overall Study|Adverse Event|4|||
170594151|NCT00475865|616518623|FG000|Overall Study|Lack of Efficacy|1|||
170594152|NCT00475865|616518624|FG001|Overall Study|Lack of Efficacy|0|||
170594153|NCT00475865|616518625|FG002|Overall Study|Lack of Efficacy|0|||
170594154|NCT00475865|616518623|FG000|Overall Study|Progressive disease|0|||
170594155|NCT00475865|616518624|FG001|Overall Study|Progressive disease|1|||
170594156|NCT00475865|616518625|FG002|Overall Study|Progressive disease|2|||
170594157|NCT00475865|616518623|FG000|Overall Study|Participant did not wish to continue|1|||
170594158|NCT00475865|616518624|FG001|Overall Study|Participant did not wish to continue|0|||
170594159|NCT00475865|616518625|FG002|Overall Study|Participant did not wish to continue|0|||
170594160|NCT00475865|616518623|FG000|Overall Study|Other than above|0|||
170594161|NCT00475865|616518624|FG001|Overall Study|Other than above|1|||
170650786|NCT03104816|616734484|FG001|Overall Study|Lack of Efficacy|2|||
170912093|NCT00940342|617682130|FG000|Overall Study|Adverse Event|0|||
170912094|NCT00940342|617682131|FG001|Overall Study|Adverse Event|2|||
170912095|NCT00940342|617682132|FG002|Overall Study|Adverse Event|1|||
170650787|NCT03104816|616734485|FG002|Overall Study|Lack of Efficacy|0|||
170650788|NCT03104816|616734483|FG000|Overall Study|Protocol Violation|2|||
170912096|NCT00514449|617682135|FG000|Overall Study|Withdrawal by Subject|1|||
170912097|NCT00514449|617682136|FG001|Overall Study|Withdrawal by Subject|2|||
170594162|NCT00475865|616518625|FG002|Overall Study|Other than above|0|||
170912098|NCT00514449|617682135|FG000|Overall Study|Protocol Violation|1|||
170912099|NCT00514449|617682136|FG001|Overall Study|Protocol Violation|2|||
170912100|NCT00514449|617682135|FG000|Overall Study|Lost to Follow-up|1|||
170594163|NCT03553498|616518627|FG000|Overall Study|Missing primary outcome|1|||
170650789|NCT03104816|616734484|FG001|Overall Study|Protocol Violation|0|||
170912101|NCT00514449|617682136|FG001|Overall Study|Lost to Follow-up|0|||
170912102|NCT00149825|617682140|FG000|Overall Study|Intolerance to medication side effects|1|||
170594164|NCT03553498|616518628|FG001|Overall Study|Missing primary outcome|2|||
170594165|NCT01498185|616518629|FG000|Overall Study|Adverse Event|0|||
170594166|NCT01498185|616518630|FG001|Overall Study|Adverse Event|0|||
170594167|NCT01498185|616518631|FG002|Overall Study|Adverse Event|0|||
170594168|NCT01498185|616518632|FG003|Overall Study|Adverse Event|1|||
170594169|NCT01498185|616518633|FG004|Overall Study|Adverse Event|0|||
170594170|NCT01498185|616518629|FG000|Overall Study|Withdrawal by Subject|1|||
170594171|NCT01498185|616518630|FG001|Overall Study|Withdrawal by Subject|1|||
170594172|NCT01498185|616518631|FG002|Overall Study|Withdrawal by Subject|0|||
170594173|NCT01498185|616518632|FG003|Overall Study|Withdrawal by Subject|2|||
170594174|NCT01498185|616518633|FG004|Overall Study|Withdrawal by Subject|1|||
170594175|NCT01498185|616518629|FG000|Overall Study|No longer met criteria, etc|0|||
170594176|NCT01498185|616518630|FG001|Overall Study|No longer met criteria, etc|0|||
170594177|NCT01498185|616518631|FG002|Overall Study|No longer met criteria, etc|0|||
170594178|NCT01498185|616518632|FG003|Overall Study|No longer met criteria, etc|0|||
170594179|NCT01498185|616518633|FG004|Overall Study|No longer met criteria, etc|2|||
170594180|NCT00846040|616518635|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
170594181|NCT00846040|616518636|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
170594182|NCT00846040|616518637|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
170594183|NCT00846040|616518635|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
170594184|NCT00846040|616518636|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
170594185|NCT00846040|616518637|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
170594186|NCT01710527|616518638|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
170594187|NCT01710527|616518639|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
170594188|NCT00831701|616518640|FG000|Overall Study|Withdrawal by Subject|2|||
170594189|NCT00831701|616518641|FG001|Overall Study|Withdrawal by Subject|0|||
170594190|NCT00831701|616518640|FG000|Overall Study|Stone expulsion before first medication|2|||
170594191|NCT00831701|616518641|FG001|Overall Study|Stone expulsion before first medication|2|||
170594192|NCT00831701|616518640|FG000|Overall Study|Lost to Follow-up|1|||
170594193|NCT00831701|616518641|FG001|Overall Study|Lost to Follow-up|3|||
170594194|NCT02366767|616518642|FG000|Overall Study|left for home after 1 day at camp|1|||
170594195|NCT02366767|616518643|FG001|Overall Study|left for home after 1 day at camp|0|||
170594196|NCT00262847|616520844|FG000|Overall Study|Disease Progression|309|||
170594197|NCT00262847|616520845|FG001|Overall Study|Disease Progression|274|||
170594198|NCT00262847|616520846|FG002|Overall Study|Disease Progression|195|||
170594199|NCT00262847|616520844|FG000|Overall Study|Patient Refusal|41|||
170594200|NCT00262847|616520845|FG001|Overall Study|Patient Refusal|52|||
170594201|NCT00262847|616520846|FG002|Overall Study|Patient Refusal|47|||
170594202|NCT00262847|616520844|FG000|Overall Study|Adverse Event|74|||
170594203|NCT00262847|616520845|FG001|Overall Study|Adverse Event|88|||
170594204|NCT00262847|616520846|FG002|Overall Study|Adverse Event|108|||
170594205|NCT00262847|616520844|FG000|Overall Study|Death|8|||
170594206|NCT00262847|616520845|FG001|Overall Study|Death|8|||
170594207|NCT00262847|616520846|FG002|Overall Study|Death|11|||
170594208|NCT00262847|616520844|FG000|Overall Study|Concomitant disease|3|||
170594209|NCT00262847|616520845|FG001|Overall Study|Concomitant disease|2|||
170650790|NCT03104816|616734485|FG002|Overall Study|Protocol Violation|2|||
170650791|NCT01426789|616734486|FG000|Part 1|Protocol deviation|0|||
170650792|NCT01426789|616734487|FG001|Part 1|Protocol deviation|1|||
170650793|NCT01426789|616734488|FG002|Part 1|Protocol deviation|0|||
170650794|NCT01426789|616734489|FG003|Part 1|Protocol deviation|0|||
170650795|NCT01426789|616734490|FG004|Part 1|Protocol deviation|0|||
170650796|NCT01426789|616734491|FG005|Part 1|Protocol deviation|0|||
170811132|NCT02362789|617317527|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
170811133|NCT02362789|617317525|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
170811134|NCT02362789|617317526|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
170811135|NCT02362789|617317527|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
170811136|NCT02362789|617317525|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
170811137|NCT02362789|617317526|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
170811138|NCT02362789|617317527|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
170811139|NCT02362789|617317525|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
170811140|NCT02362789|617317526|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
170811141|NCT02362789|617317527|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
170811142|NCT02362789|617317525|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
170811143|NCT02362789|617317526|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
170811144|NCT02362789|617317527|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
170811145|NCT02251652|617317528|FG000|Overall Study|Withdrawal by Subject|1|||
170811146|NCT01989689|617317529|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
170811147|NCT01989689|617317530|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
170811148|NCT01989689|617317529|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
170811149|NCT01989689|617317530|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
170650797|NCT01426789|616734486|FG000|Part 1|Lost to Follow-up|1|||
170594210|NCT00262847|616520846|FG002|Overall Study|Concomitant disease|4|||
170594211|NCT00262847|616520844|FG000|Overall Study|Other Reasons|79|||
170650798|NCT01426789|616734487|FG001|Part 1|Lost to Follow-up|2|||
170650799|NCT01426789|616734488|FG002|Part 1|Lost to Follow-up|0|||
170650800|NCT01426789|616734489|FG003|Part 1|Lost to Follow-up|0|||
170650801|NCT01426789|616734490|FG004|Part 1|Lost to Follow-up|0|||
170650802|NCT01426789|616734491|FG005|Part 1|Lost to Follow-up|0|||
170650803|NCT01426789|616734486|FG000|Part 1|Lack of Efficacy|2|||
170650804|NCT01426789|616734487|FG001|Part 1|Lack of Efficacy|1|||
170650805|NCT01426789|616734488|FG002|Part 1|Lack of Efficacy|0|||
170650806|NCT01426789|616734489|FG003|Part 1|Lack of Efficacy|0|||
170650807|NCT01426789|616734490|FG004|Part 1|Lack of Efficacy|0|||
170650808|NCT01426789|616734491|FG005|Part 1|Lack of Efficacy|0|||
170650809|NCT01426789|616734486|FG000|Part 1|Adverse Event|3|||
170650810|NCT01426789|616734487|FG001|Part 1|Adverse Event|0|||
170650811|NCT01426789|616734488|FG002|Part 1|Adverse Event|0|||
170650812|NCT01426789|616734489|FG003|Part 1|Adverse Event|0|||
170650813|NCT01426789|616734490|FG004|Part 1|Adverse Event|0|||
170650814|NCT01426789|616734491|FG005|Part 1|Adverse Event|0|||
170650815|NCT01426789|616734486|FG000|Part 2|Protocol deviation|0|||
170650816|NCT01426789|616734487|FG001|Part 2|Protocol deviation|0|||
170650817|NCT01426789|616734488|FG002|Part 2|Protocol deviation|1|||
170650818|NCT01426789|616734489|FG003|Part 2|Protocol deviation|0|||
170650819|NCT01426789|616734490|FG004|Part 2|Protocol deviation|0|||
170650820|NCT01426789|616734491|FG005|Part 2|Protocol deviation|0|||
170650821|NCT01426789|616734486|FG000|Part 2|Death|0|||
170650822|NCT01426789|616734487|FG001|Part 2|Death|0|||
170650823|NCT01426789|616734488|FG002|Part 2|Death|1|||
170650824|NCT01426789|616734489|FG003|Part 2|Death|0|||
170650825|NCT01426789|616734490|FG004|Part 2|Death|1|||
170594212|NCT00262847|616520845|FG001|Overall Study|Other Reasons|88|||
170594213|NCT00262847|616520846|FG002|Overall Study|Other Reasons|27|||
170594214|NCT00262847|616520844|FG000|Overall Study|Did not receive study treatment|4|||
170594215|NCT00262847|616520845|FG001|Overall Study|Did not receive study treatment|1|||
170594216|NCT00262847|616520846|FG002|Overall Study|Did not receive study treatment|4|||
170594217|NCT00528996|616520847|FG000|Overall Study|Other reasons than listing|6|||
170594218|NCT00528996|616520848|FG001|Overall Study|Other reasons than listing|7|||
170594219|NCT00528996|616520849|FG002|Overall Study|Other reasons than listing|14|||
170594220|NCT00528996|616520850|FG003|Overall Study|Other reasons than listing|11|||
170594221|NCT00528996|616520851|FG004|Overall Study|Other reasons than listing|5|||
170594222|NCT00528996|616520847|FG000|Overall Study|Refused continue medication|16|||
170650826|NCT01426789|616734491|FG005|Part 2|Death|0|||
170650827|NCT01426789|616734486|FG000|Part 2|Administrative problems|0|||
170650828|NCT01426789|616734487|FG001|Part 2|Administrative problems|0|||
170650829|NCT01426789|616734488|FG002|Part 2|Administrative problems|2|||
170811150|NCT02066636|617317531|FG000|Overall Study|Disease progression|51|||
170594223|NCT00528996|616520848|FG001|Overall Study|Refused continue medication|0|||
170594224|NCT00528996|616520849|FG002|Overall Study|Refused continue medication|3|||
170594225|NCT00528996|616520850|FG003|Overall Study|Refused continue medication|3|||
170650830|NCT01426789|616734489|FG003|Part 2|Administrative problems|0|||
170811151|NCT02066636|617317532|FG001|Overall Study|Disease progression|60|||
170811152|NCT02066636|617317533|FG002|Overall Study|Disease progression|700|||
170811153|NCT02066636|617317531|FG000|Overall Study|Study drug toxicity|13|||
170811154|NCT02066636|617317532|FG001|Overall Study|Study drug toxicity|2|||
170811155|NCT02066636|617317533|FG002|Overall Study|Study drug toxicity|58|||
170811156|NCT02066636|617317531|FG000|Overall Study|Death|4|||
170811157|NCT02066636|617317532|FG001|Overall Study|Death|2|||
170811158|NCT02066636|617317533|FG002|Overall Study|Death|158|||
170811159|NCT02066636|617317531|FG000|Overall Study|Adverse event unrelated to study drug|6|||
170811160|NCT02066636|617317532|FG001|Overall Study|Adverse event unrelated to study drug|4|||
170811161|NCT02066636|617317533|FG002|Overall Study|Adverse event unrelated to study drug|45|||
170811162|NCT02066636|617317531|FG000|Overall Study|Participant request to discontinue treatment|12|||
170811163|NCT02066636|617317532|FG001|Overall Study|Participant request to discontinue treatment|12|||
170811164|NCT02066636|617317533|FG002|Overall Study|Participant request to discontinue treatment|70|||
170811165|NCT02066636|617317531|FG000|Overall Study|Participant withdrew consent|10|||
170811166|NCT02066636|617317532|FG001|Overall Study|Participant withdrew consent|18|||
170811167|NCT02066636|617317533|FG002|Overall Study|Participant withdrew consent|61|||
170594226|NCT00528996|616520851|FG004|Overall Study|Refused continue medication|6|||
170594227|NCT00528996|616520847|FG000|Overall Study|Lost to Follow-up|2|||
170650831|NCT01426789|616734490|FG004|Part 2|Administrative problems|1|||
170650832|NCT01426789|616734491|FG005|Part 2|Administrative problems|0|||
170650833|NCT01426789|616734486|FG000|Part 2|Lost to Follow-up|0|||
170811168|NCT02066636|617317531|FG000|Overall Study|Lost to Follow-up|0|||
170811169|NCT02066636|617317532|FG001|Overall Study|Lost to Follow-up|2|||
170811170|NCT02066636|617317533|FG002|Overall Study|Lost to Follow-up|2|||
170811171|NCT02066636|617317531|FG000|Overall Study|Maximum clinical benefit|2|||
170650834|NCT01426789|616734487|FG001|Part 2|Lost to Follow-up|0|||
170650835|NCT01426789|616734488|FG002|Part 2|Lost to Follow-up|4|||
170650836|NCT01426789|616734489|FG003|Part 2|Lost to Follow-up|0|||
170650837|NCT01426789|616734490|FG004|Part 2|Lost to Follow-up|1|||
170650838|NCT01426789|616734491|FG005|Part 2|Lost to Follow-up|0|||
170650839|NCT01426789|616734486|FG000|Part 2|Withdrawal by Subject|0|||
170650840|NCT01426789|616734487|FG001|Part 2|Withdrawal by Subject|0|||
170650841|NCT01426789|616734488|FG002|Part 2|Withdrawal by Subject|0|||
170594228|NCT00528996|616520848|FG001|Overall Study|Lost to Follow-up|0|||
170594229|NCT00528996|616520849|FG002|Overall Study|Lost to Follow-up|4|||
170594230|NCT00528996|616520850|FG003|Overall Study|Lost to Follow-up|1|||
170594231|NCT00528996|616520851|FG004|Overall Study|Lost to Follow-up|3|||
170594232|NCT00528996|616520847|FG000|Overall Study|Protocol Violation|1|||
170594233|NCT00528996|616520848|FG001|Overall Study|Protocol Violation|2|||
170594234|NCT00528996|616520849|FG002|Overall Study|Protocol Violation|3|||
170594235|NCT00528996|616520850|FG003|Overall Study|Protocol Violation|3|||
170594236|NCT00528996|616520851|FG004|Overall Study|Protocol Violation|2|||
170594237|NCT00528996|616520847|FG000|Overall Study|Lack of Efficacy|7|||
170594238|NCT00528996|616520848|FG001|Overall Study|Lack of Efficacy|2|||
170594239|NCT00528996|616520849|FG002|Overall Study|Lack of Efficacy|1|||
170594240|NCT00528996|616520850|FG003|Overall Study|Lack of Efficacy|3|||
170594241|NCT00528996|616520851|FG004|Overall Study|Lack of Efficacy|3|||
170594242|NCT00528996|616520847|FG000|Overall Study|Adverse Event|32|||
170594243|NCT00528996|616520848|FG001|Overall Study|Adverse Event|13|||
170594244|NCT00528996|616520849|FG002|Overall Study|Adverse Event|18|||
170594245|NCT00528996|616520850|FG003|Overall Study|Adverse Event|29|||
170594246|NCT00528996|616520851|FG004|Overall Study|Adverse Event|18|||
170594247|NCT03495102|616520852|FG000|Overall Study|Adverse Event|5|||
170594248|NCT03495102|616520853|FG001|Overall Study|Adverse Event|7|||
170594249|NCT03495102|616520854|FG002|Overall Study|Adverse Event|10|||
170594250|NCT03495102|616520852|FG000|Overall Study|Death|3|||
170594251|NCT03495102|616520853|FG001|Overall Study|Death|4|||
170594252|NCT03495102|616520854|FG002|Overall Study|Death|4|||
170594253|NCT03495102|616520852|FG000|Overall Study|Lost to Follow-up|15|||
170594254|NCT03495102|616520853|FG001|Overall Study|Lost to Follow-up|16|||
170594255|NCT03495102|616520854|FG002|Overall Study|Lost to Follow-up|17|||
170594256|NCT03495102|616520852|FG000|Overall Study|Physician Decision|2|||
170594257|NCT03495102|616520853|FG001|Overall Study|Physician Decision|0|||
170594258|NCT03495102|616520854|FG002|Overall Study|Physician Decision|2|||
170594259|NCT03495102|616520852|FG000|Overall Study|Withdrawal by Subject|25|||
170594260|NCT03495102|616520853|FG001|Overall Study|Withdrawal by Subject|36|||
170594261|NCT03495102|616520854|FG002|Overall Study|Withdrawal by Subject|18|||
170594262|NCT03495102|616520852|FG000|Overall Study|Protocol Violation|1|||
170594263|NCT03495102|616520853|FG001|Overall Study|Protocol Violation|1|||
170594264|NCT03495102|616520854|FG002|Overall Study|Protocol Violation|0|||
170594265|NCT03495102|616520852|FG000|Overall Study|Site Closure|3|||
170594266|NCT03495102|616520853|FG001|Overall Study|Site Closure|1|||
170594267|NCT03495102|616520854|FG002|Overall Study|Site Closure|2|||
170594268|NCT03495102|616520852|FG000|Overall Study|Non-compliance|1|||
170594269|NCT03495102|616520853|FG001|Overall Study|Non-compliance|0|||
170594270|NCT03495102|616520854|FG002|Overall Study|Non-compliance|0|||
170594271|NCT03495102|616520852|FG000|Overall Study|Participant Duplicated at Another Site|0|||
170594272|NCT03495102|616520853|FG001|Overall Study|Participant Duplicated at Another Site|0|||
170594273|NCT03495102|616520854|FG002|Overall Study|Participant Duplicated at Another Site|1|||
170594274|NCT03495102|616520852|FG000|Overall Study|Primary Care Physician Recommendation|0|||
170594275|NCT03495102|616520853|FG001|Overall Study|Primary Care Physician Recommendation|1|||
170594276|NCT03495102|616520854|FG002|Overall Study|Primary Care Physician Recommendation|0|||
170594277|NCT03495102|616520852|FG000|Overall Study|Relocated to Another Country|0|||
170594278|NCT03495102|616520853|FG001|Overall Study|Relocated to Another Country|1|||
170594279|NCT03495102|616520854|FG002|Overall Study|Relocated to Another Country|0|||
170594280|NCT03495102|616520852|FG000|Overall Study|Participant was in Rehabilitation|1|||
170594281|NCT03495102|616520853|FG001|Overall Study|Participant was in Rehabilitation|0|||
170594282|NCT03495102|616520854|FG002|Overall Study|Participant was in Rehabilitation|0|||
170594283|NCT01161537|616520855|FG000|Part B|Withdrawal by Subject|2|||
170594284|NCT05079477|616520856|FG000|Overall Study|Lost to Follow-up|2|||
170594285|NCT05079477|616520857|FG001|Overall Study|Lost to Follow-up|0|||
170594286|NCT05079477|616520856|FG000|Overall Study|Withdrawal by Subject|1|||
170594287|NCT05079477|616520857|FG001|Overall Study|Withdrawal by Subject|0|||
170594288|NCT05079477|616520856|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
170594289|NCT05079477|616520857|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
170650842|NCT01426789|616734489|FG003|Part 2|Withdrawal by Subject|1|||
170811172|NCT02066636|617317532|FG001|Overall Study|Maximum clinical benefit|2|||
170811173|NCT02066636|617317533|FG002|Overall Study|Maximum clinical benefit|3|||
170811174|NCT02066636|617317531|FG000|Overall Study|Poor/non-compliance|2|||
170811175|NCT02066636|617317532|FG001|Overall Study|Poor/non-compliance|1|||
170594290|NCT05079477|616520856|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
170594291|NCT05079477|616520857|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
170594292|NCT05320393|616520858|FG000|Overall Study|Withdrawal by Subject|1|||
170594293|NCT05320393|616520859|FG001|Overall Study|Withdrawal by Subject|0|||
170594294|NCT05320393|616520860|FG002|Overall Study|Withdrawal by Subject|2|||
170594295|NCT05320393|616520858|FG000|Overall Study|Lost to Follow-up|1|||
170594296|NCT05320393|616520859|FG001|Overall Study|Lost to Follow-up|2|||
170650843|NCT01426789|616734490|FG004|Part 2|Withdrawal by Subject|2|||
170811176|NCT02066636|617317533|FG002|Overall Study|Poor/non-compliance|1|||
170912103|NCT00149825|617682141|FG001|Overall Study|Intolerance to medication side effects|2|||
170912104|NCT00149825|617682140|FG000|Overall Study|Time commitments|2|||
170594297|NCT05320393|616520860|FG002|Overall Study|Lost to Follow-up|1|||
170594298|NCT05320393|616520858|FG000|Overall Study|Moved; too much driving|0|||
170594299|NCT05320393|616520859|FG001|Overall Study|Moved; too much driving|0|||
170594300|NCT05320393|616520860|FG002|Overall Study|Moved; too much driving|2|||
170594301|NCT05320393|616520858|FG000|Overall Study|Did not receive treatment|0|||
170594302|NCT05320393|616520859|FG001|Overall Study|Did not receive treatment|0|||
170594303|NCT05320393|616520860|FG002|Overall Study|Did not receive treatment|1|||
170594304|NCT05160766|616520861|FG000|Overall Study|Adverse Event|0|||
170594305|NCT05160766|616520862|FG001|Overall Study|Adverse Event|1|||
170594306|NCT05160766|616520863|FG002|Overall Study|Adverse Event|0|||
170594307|NCT05160766|616520864|FG003|Overall Study|Adverse Event|0|||
170594308|NCT05160766|616520861|FG000|Overall Study|COVID-19 infection|0|||
170594309|NCT05160766|616520862|FG001|Overall Study|COVID-19 infection|1|||
170594310|NCT05160766|616520863|FG002|Overall Study|COVID-19 infection|0|||
170594311|NCT05160766|616520864|FG003|Overall Study|COVID-19 infection|0|||
170594312|NCT05160766|616520861|FG000|Overall Study|travel time|1|||
170594313|NCT05160766|616520862|FG001|Overall Study|travel time|0|||
170594314|NCT05160766|616520863|FG002|Overall Study|travel time|0|||
170594315|NCT05160766|616520864|FG003|Overall Study|travel time|1|||
170594316|NCT05160766|616520861|FG000|Overall Study|Withdrawal by Subject|3|||
170594317|NCT05160766|616520862|FG001|Overall Study|Withdrawal by Subject|5|||
170594318|NCT05160766|616520863|FG002|Overall Study|Withdrawal by Subject|4|||
170594319|NCT05160766|616520864|FG003|Overall Study|Withdrawal by Subject|2|||
170594320|NCT05160766|616520861|FG000|Overall Study|Death|0|||
170594321|NCT05160766|616520862|FG001|Overall Study|Death|0|||
170594322|NCT05160766|616520863|FG002|Overall Study|Death|2|||
170594323|NCT05160766|616520864|FG003|Overall Study|Death|5|||
170594324|NCT05160766|616520861|FG000|Overall Study|Lost to Follow-up|0|||
170594325|NCT05160766|616520862|FG001|Overall Study|Lost to Follow-up|0|||
170594326|NCT05160766|616520863|FG002|Overall Study|Lost to Follow-up|1|||
170594327|NCT05160766|616520864|FG003|Overall Study|Lost to Follow-up|2|||
170594328|NCT05160766|616520861|FG000|Overall Study|No show|0|||
170594329|NCT05160766|616520862|FG001|Overall Study|No show|0|||
170594330|NCT05160766|616520863|FG002|Overall Study|No show|1|||
170594331|NCT05160766|616520864|FG003|Overall Study|No show|1|||
170594332|NCT05160766|616520861|FG000|Overall Study|Physician Decision|0|||
170594333|NCT05160766|616520862|FG001|Overall Study|Physician Decision|0|||
170594334|NCT05160766|616520863|FG002|Overall Study|Physician Decision|0|||
170594335|NCT05160766|616520864|FG003|Overall Study|Physician Decision|1|||
170594336|NCT05160766|616520861|FG000|Overall Study|Protocol Violation|0|||
170594337|NCT05160766|616520862|FG001|Overall Study|Protocol Violation|0|||
170594338|NCT05160766|616520863|FG002|Overall Study|Protocol Violation|1|||
170594339|NCT05160766|616520864|FG003|Overall Study|Protocol Violation|0|||
170594340|NCT01688739|616520865|FG000|Overall Study|Administrative Decision|1|||
170594341|NCT01688739|616520866|FG001|Overall Study|Administrative Decision|0|||
170594342|NCT01688739|616520867|FG002|Overall Study|Administrative Decision|0|||
170594343|NCT01688739|616520868|FG003|Overall Study|Administrative Decision|0|||
170594344|NCT01688739|616520869|FG004|Overall Study|Administrative Decision|0|||
170594345|NCT01688739|616520870|FG005|Overall Study|Administrative Decision|0|||
170594346|NCT01688739|616520871|FG006|Overall Study|Administrative Decision|0|||
170650844|NCT01426789|616734491|FG005|Part 2|Withdrawal by Subject|0|||
170650845|NCT01426789|616734486|FG000|Part 2|Lack of Efficacy|0|||
170650846|NCT01426789|616734487|FG001|Part 2|Lack of Efficacy|0|||
170650847|NCT01426789|616734488|FG002|Part 2|Lack of Efficacy|5|||
170912105|NCT00149825|617682141|FG001|Overall Study|Time commitments|1|||
170912106|NCT00149825|617682140|FG000|Overall Study|Not liking insomnia therapy|1|||
170912107|NCT00149825|617682141|FG001|Overall Study|Not liking insomnia therapy|0|||
170912108|NCT00149825|617682140|FG000|Overall Study|Other|1|||
170912109|NCT00149825|617682141|FG001|Overall Study|Other|0|||
170912110|NCT00857246|617682144|FG000|Induction Regimen|Adverse Event|1|||
170912111|NCT00857246|617682144|FG000|Induction Regimen|disease-related complications|1|||
170594347|NCT01688739|616520872|FG007|Overall Study|Administrative Decision|0|||
170594348|NCT01688739|616520873|FG008|Overall Study|Administrative Decision|0|||
170594349|NCT01688739|616520874|FG009|Overall Study|Administrative Decision|0|||
170650848|NCT01426789|616734489|FG003|Part 2|Lack of Efficacy|0|||
170594350|NCT00996801|616520875|FG000|Overall Study|Adverse Event|6|||
170594351|NCT00996801|616520876|FG001|Overall Study|Adverse Event|4|||
170650849|NCT01426789|616734490|FG004|Part 2|Lack of Efficacy|2|||
170594352|NCT00996801|616520877|FG002|Overall Study|Adverse Event|12|||
170594353|NCT00996801|616520878|FG003|Overall Study|Adverse Event|17|||
170594354|NCT00996801|616520879|FG004|Overall Study|Adverse Event|31|||
170594355|NCT00996801|616520880|FG005|Overall Study|Adverse Event|3|||
170594356|NCT00996801|616520875|FG000|Overall Study|Lack of Efficacy|3|||
170594357|NCT00996801|616520876|FG001|Overall Study|Lack of Efficacy|0|||
170594358|NCT00996801|616520877|FG002|Overall Study|Lack of Efficacy|1|||
170650850|NCT01426789|616734491|FG005|Part 2|Lack of Efficacy|0|||
170650851|NCT01426789|616734486|FG000|Part 2|Adverse Event|0|||
170912112|NCT00857246|617682144|FG000|Induction Regimen|Withdrawal by Subject|1|||
170912113|NCT00857246|617682144|FG000|Surgery (Curative)|disease progression|6|||
170594359|NCT00996801|616520878|FG003|Overall Study|Lack of Efficacy|3|||
170594360|NCT00996801|616520879|FG004|Overall Study|Lack of Efficacy|0|||
170594361|NCT00996801|616520880|FG005|Overall Study|Lack of Efficacy|1|||
170594362|NCT00996801|616520875|FG000|Overall Study|Lost to Follow-up|0|||
170594363|NCT00996801|616520876|FG001|Overall Study|Lost to Follow-up|0|||
170594364|NCT00996801|616520877|FG002|Overall Study|Lost to Follow-up|0|||
170594365|NCT00996801|616520878|FG003|Overall Study|Lost to Follow-up|3|||
170594366|NCT00996801|616520879|FG004|Overall Study|Lost to Follow-up|3|||
170594367|NCT00996801|616520880|FG005|Overall Study|Lost to Follow-up|2|||
170594368|NCT00996801|616520875|FG000|Overall Study|Physician Decision|0|||
170594369|NCT00996801|616520876|FG001|Overall Study|Physician Decision|0|||
170594370|NCT00996801|616520877|FG002|Overall Study|Physician Decision|0|||
170594371|NCT00996801|616520878|FG003|Overall Study|Physician Decision|1|||
170594372|NCT00996801|616520879|FG004|Overall Study|Physician Decision|0|||
170594373|NCT00996801|616520880|FG005|Overall Study|Physician Decision|0|||
170594374|NCT00996801|616520875|FG000|Overall Study|Progressive Disease|0|||
170594375|NCT00996801|616520876|FG001|Overall Study|Progressive Disease|1|||
170594376|NCT00996801|616520877|FG002|Overall Study|Progressive Disease|0|||
170594377|NCT00996801|616520878|FG003|Overall Study|Progressive Disease|0|||
170594378|NCT00996801|616520879|FG004|Overall Study|Progressive Disease|0|||
170594379|NCT00996801|616520880|FG005|Overall Study|Progressive Disease|0|||
170594380|NCT00996801|616520875|FG000|Overall Study|Protocol Violation|3|||
170594381|NCT00996801|616520876|FG001|Overall Study|Protocol Violation|4|||
170594382|NCT00996801|616520877|FG002|Overall Study|Protocol Violation|1|||
170594383|NCT00996801|616520878|FG003|Overall Study|Protocol Violation|2|||
170594384|NCT00996801|616520879|FG004|Overall Study|Protocol Violation|3|||
170594385|NCT00996801|616520880|FG005|Overall Study|Protocol Violation|4|||
170594386|NCT00996801|616520875|FG000|Overall Study|Study Terminated by Sponsor|0|||
170594387|NCT00996801|616520876|FG001|Overall Study|Study Terminated by Sponsor|1|||
170594388|NCT00996801|616520877|FG002|Overall Study|Study Terminated by Sponsor|0|||
170594389|NCT00996801|616520878|FG003|Overall Study|Study Terminated by Sponsor|0|||
170594390|NCT00996801|616520879|FG004|Overall Study|Study Terminated by Sponsor|46|||
170594391|NCT00996801|616520880|FG005|Overall Study|Study Terminated by Sponsor|0|||
170594392|NCT00996801|616520875|FG000|Overall Study|Withdrawal by Subject|8|||
170594393|NCT00996801|616520876|FG001|Overall Study|Withdrawal by Subject|6|||
170594394|NCT00996801|616520877|FG002|Overall Study|Withdrawal by Subject|9|||
170594395|NCT00996801|616520878|FG003|Overall Study|Withdrawal by Subject|5|||
170594396|NCT00996801|616520879|FG004|Overall Study|Withdrawal by Subject|5|||
170594397|NCT00996801|616520880|FG005|Overall Study|Withdrawal by Subject|9|||
170594398|NCT03369431|616520887|FG000|Overall Study|Lost to Follow-up|1|||
170594399|NCT03369431|616520888|FG001|Overall Study|Lost to Follow-up|3|||
170594400|NCT03369431|616520887|FG000|Overall Study|Withdrawal by Subject|2|||
170594401|NCT03369431|616520888|FG001|Overall Study|Withdrawal by Subject|3|||
170594402|NCT03369431|616520887|FG000|Overall Study|Protocol Violation|1|||
170811177|NCT02066636|617317531|FG000|Overall Study|Participant no loner meets study criteria|3|||
170811178|NCT02066636|617317532|FG001|Overall Study|Participant no loner meets study criteria|2|||
170594403|NCT03369431|616520888|FG001|Overall Study|Protocol Violation|1|||
170594404|NCT01266317|616520890|FG000|Overall Study|Withdrawal by Subject|2|||
170594405|NCT02753127|616520891|FG000|Overall Study|Lost to Follow-up|13|||
170594406|NCT02753127|616520892|FG001|Overall Study|Lost to Follow-up|11|||
170594407|NCT02753127|616520891|FG000|Overall Study|Withdrawal by Subject|37|||
170594408|NCT02753127|616520892|FG001|Overall Study|Withdrawal by Subject|47|||
170594409|NCT02753127|616520891|FG000|Overall Study|Other|3|||
170594410|NCT02753127|616520892|FG001|Overall Study|Other|8|||
170594411|NCT02753127|616520891|FG000|Overall Study|Hospice|0|||
170594412|NCT02753127|616520892|FG001|Overall Study|Hospice|2|||
170594413|NCT00046930|616520900|FG000|Overall Study|Ineligible|12|||
170594414|NCT00046930|616520901|FG001|Overall Study|Ineligible|4|||
170594415|NCT02469415|616520902|FG000|Overall Study|Withdrawal by Subject|1|||
170594416|NCT02469415|616520902|FG000|Overall Study|Investigational agent placed on hold|2|||
170594417|NCT01657760|616520905|FG000|Overall Study|Withdrawal by Subject|0|||
170594418|NCT01657760|616520906|FG001|Overall Study|Withdrawal by Subject|0|||
170594419|NCT01657760|616520907|FG002|Overall Study|Withdrawal by Subject|0|||
170594420|NCT01657760|616520908|FG003|Overall Study|Withdrawal by Subject|1|||
170594421|NCT01657760|616520905|FG000|Overall Study|Physician Decision|1|||
170594422|NCT01657760|616520906|FG001|Overall Study|Physician Decision|1|||
170594423|NCT01657760|616520907|FG002|Overall Study|Physician Decision|1|||
170594424|NCT01657760|616520908|FG003|Overall Study|Physician Decision|2|||
170594425|NCT02119156|616520909|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
170594426|NCT02119156|616520910|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
170594427|NCT02119156|616520911|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
170594428|NCT02119156|616520909|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
170594429|NCT02119156|616520910|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
170594430|NCT02119156|616520911|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
170594431|NCT02119156|616520909|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
170594432|NCT02119156|616520910|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
170594433|NCT02119156|616520911|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
170594434|NCT02119156|616520909|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
170594435|NCT02119156|616520910|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
170594436|NCT02119156|616520911|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
170594437|NCT02119156|616520909|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
170594438|NCT02119156|616520910|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
170594439|NCT02119156|616520911|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
170594440|NCT00350623|616520918|FG000|Overall Study|Lost to Follow-up|8|||
170594441|NCT00350623|616520919|FG001|Overall Study|Lost to Follow-up|3|||
170594442|NCT00350623|616520920|FG002|Overall Study|Lost to Follow-up|4|||
170594443|NCT00350623|616520918|FG000|Overall Study|Withdrawal by Subject|0|||
170594444|NCT00350623|616520919|FG001|Overall Study|Withdrawal by Subject|1|||
170594445|NCT00350623|616520920|FG002|Overall Study|Withdrawal by Subject|1|||
170594446|NCT00350623|616520918|FG000|Overall Study|patient traveling outside the country|0|||
170594447|NCT00350623|616520919|FG001|Overall Study|patient traveling outside the country|0|||
170594448|NCT00350623|616520920|FG002|Overall Study|patient traveling outside the country|1|||
170594449|NCT00940485|616520924|FG000|Overall Study|HBeAb positive at Baseline|3|||
170912114|NCT00857246|617682144|FG000|ChemoRT|Withdrawal by Subject|1|||
170912115|NCT00857246|617682144|FG000|ChemoRT|Adverse Event|2|||
170912116|NCT00847561|617682145|FG000|Overall Study|Withdrawal by Subject|4|||
170912117|NCT00847561|617682146|FG001|Overall Study|Withdrawal by Subject|3|||
170912118|NCT00847561|617682145|FG000|Overall Study|Unable to schedule|9|||
170912119|NCT00847561|617682146|FG001|Overall Study|Unable to schedule|1|||
170912120|NCT01821677|617682147|FG000|Overall Study|Adverse Event|4|||
170912121|NCT01821677|617682148|FG001|Overall Study|Adverse Event|6|||
170912122|NCT01821677|617682149|FG002|Overall Study|Adverse Event|5|||
170912123|NCT01821677|617682147|FG000|Overall Study|Physician Decision|1|||
170912124|NCT01821677|617682148|FG001|Overall Study|Physician Decision|4|||
170912125|NCT01821677|617682149|FG002|Overall Study|Physician Decision|1|||
170912126|NCT01821677|617682147|FG000|Overall Study|Non-compliance|0|||
170912127|NCT01821677|617682148|FG001|Overall Study|Non-compliance|1|||
170912128|NCT01821677|617682149|FG002|Overall Study|Non-compliance|2|||
170912129|NCT01821677|617682147|FG000|Overall Study|Lost to Follow-up|2|||
170912130|NCT01821677|617682148|FG001|Overall Study|Lost to Follow-up|1|||
170912131|NCT01821677|617682149|FG002|Overall Study|Lost to Follow-up|3|||
170912132|NCT01821677|617682147|FG000|Overall Study|Protocol Violation|0|||
170912133|NCT01821677|617682148|FG001|Overall Study|Protocol Violation|0|||
170912134|NCT01821677|617682149|FG002|Overall Study|Protocol Violation|2|||
170912135|NCT01821677|617682147|FG000|Overall Study|Withdrawal by Subject|7|||
170912136|NCT01821677|617682148|FG001|Overall Study|Withdrawal by Subject|3|||
170912137|NCT01821677|617682149|FG002|Overall Study|Withdrawal by Subject|2|||
170912138|NCT01821677|617682147|FG000|Overall Study|Other|9|||
170912139|NCT01821677|617682148|FG001|Overall Study|Other|0|||
170912140|NCT01821677|617682149|FG002|Overall Study|Other|0|||
170912141|NCT02277444|617682158|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
170912142|NCT02277444|617682158|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
170912143|NCT02277444|617682158|FG000|Treatment Period (Week 0-52)|Other|1|||
170912144|NCT02277444|617682158|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
170912145|NCT02277444|617682158|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
170912146|NCT02277444|617682158|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
170912147|NCT02277444|617682158|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
170912148|NCT02277444|617682158|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
170912149|NCT02277444|617682158|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
170912150|NCT04513158|617682159|FG000|Overall Study|Screen Failure|1|||
170912151|NCT02114203|617683837|FG000|Overall Study|Adverse Event|0|||
170912152|NCT02114203|617683838|FG001|Overall Study|Adverse Event|1|||
170912153|NCT02114203|617683839|FG002|Overall Study|Adverse Event|0|||
170912154|NCT02114203|617683837|FG000|Overall Study|Withdrawal by Subject|0|||
170912155|NCT02114203|617683838|FG001|Overall Study|Withdrawal by Subject|1|||
170912156|NCT02114203|617683839|FG002|Overall Study|Withdrawal by Subject|0|||
170912157|NCT03635190|617683841|FG000|Overall Study|Lost to Follow-up|4|||
170912158|NCT03635190|617683841|FG000|Overall Study|Death|3|||
170912159|NCT03635190|617683841|FG000|Overall Study|Withdrawal by Subject|1|||
170912160|NCT03635190|617683841|FG000|Overall Study|Patient moved and did not return for follow up|1|||
170912161|NCT00486226|617683842|FG000|Overall Study|Death|3|||
170912162|NCT00486226|617683842|FG000|Overall Study|Adverse Event|1|||
170912163|NCT00486226|617683842|FG000|Overall Study|Withdrawal by Subject|1|||
170912164|NCT00486226|617683842|FG000|Overall Study|Lost to Follow-up|8|||
170912165|NCT01259492|617683843|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
170912166|NCT01259492|617683844|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
170594450|NCT00940485|616520925|FG001|Overall Study|HBeAb positive at Baseline|2|||
170912167|NCT01259492|617683845|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
170912168|NCT01259492|617683846|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
170912169|NCT01259492|617683843|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
170912170|NCT01259492|617683844|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
170912171|NCT01259492|617683845|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
170912172|NCT01259492|617683846|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
170912173|NCT01259492|617683843|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
170912174|NCT01259492|617683844|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
170912175|NCT01259492|617683845|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
170912176|NCT01259492|617683846|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
170912177|NCT01259492|617683843|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
170912178|NCT01259492|617683844|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
170912179|NCT01259492|617683845|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
170912180|NCT01259492|617683846|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
170912181|NCT01259492|617683843|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
170912182|NCT01259492|617683844|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
170912183|NCT01259492|617683845|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
170912184|NCT01259492|617683846|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
170912185|NCT01259492|617683843|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
170912186|NCT01259492|617683844|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
170912187|NCT01259492|617683845|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
170912188|NCT01259492|617683846|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
170912189|NCT01259492|617683843|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
170912190|NCT01259492|617683844|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
170912191|NCT01259492|617683845|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
170912192|NCT01259492|617683846|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
170912193|NCT01259492|617683843|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
170912194|NCT01259492|617683844|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
170912195|NCT01259492|617683845|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
170912196|NCT01259492|617683846|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
170912197|NCT01259492|617683843|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
170912198|NCT01259492|617683844|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
170912199|NCT01259492|617683845|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
170912200|NCT01259492|617683846|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
170912201|NCT01259492|617683843|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
170912202|NCT01259492|617683844|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
170912203|NCT01259492|617683845|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
170912204|NCT01259492|617683846|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
170912205|NCT01259492|617683843|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
170912206|NCT01259492|617683844|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
170912207|NCT01259492|617683845|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
170912208|NCT01259492|617683846|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
170912209|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
170912210|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
170912211|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
170912212|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
170912213|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
170912214|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
170912215|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
170912216|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
170912217|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
170912218|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
170912219|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
170912220|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
170912221|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
170912222|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
170912223|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
170912224|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
170912225|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
170912226|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
170594451|NCT00940485|616520924|FG000|Overall Study|Lost to Follow-up|2|||
170594452|NCT00940485|616520925|FG001|Overall Study|Lost to Follow-up|3|||
170594453|NCT00940485|616520924|FG000|Overall Study|Adverse Event|8|||
170594454|NCT00940485|616520925|FG001|Overall Study|Adverse Event|0|||
170594455|NCT00940485|616520924|FG000|Overall Study|Withdrawal by Subject|1|||
170594456|NCT00940485|616520925|FG001|Overall Study|Withdrawal by Subject|1|||
170594457|NCT00940485|616520924|FG000|Overall Study|Others|1|||
170594458|NCT00940485|616520925|FG001|Overall Study|Others|1|||
170594459|NCT01113580|616520926|FG000|Overall Study|Protocol Violation|1|||
170594460|NCT01113580|616520927|FG001|Overall Study|Protocol Violation|0|||
170912227|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
170912228|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
170912229|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
170594461|NCT02936284|616520931|FG000|Overall Study|Withdrawal by Subject|3|||
170594462|NCT02936284|616520932|FG001|Overall Study|Withdrawal by Subject|1|||
170594463|NCT02936284|616520931|FG000|Overall Study|Lost to Follow-up|7|||
170594464|NCT02936284|616520932|FG001|Overall Study|Lost to Follow-up|8|||
170594465|NCT01610596|616520944|FG000|Overall Study|Lost to Follow-up|0|||
170594466|NCT01610596|616520945|FG001|Overall Study|Lost to Follow-up|1|||
170594467|NCT01519674|616520952|FG000|Overall Study|Adverse Event|3|||
170594468|NCT01519674|616520953|FG001|Overall Study|Adverse Event|3|||
170594469|NCT01519674|616520954|FG002|Overall Study|Adverse Event|0|||
170594470|NCT01519674|616520952|FG000|Overall Study|Lack of Efficacy|1|||
170594471|NCT01519674|616520953|FG001|Overall Study|Lack of Efficacy|1|||
170594472|NCT01519674|616520954|FG002|Overall Study|Lack of Efficacy|1|||
170594473|NCT01519674|616520952|FG000|Overall Study|Protocol Violation|0|||
170594474|NCT01519674|616520953|FG001|Overall Study|Protocol Violation|3|||
170594475|NCT01519674|616520954|FG002|Overall Study|Protocol Violation|1|||
170594476|NCT01519674|616520952|FG000|Overall Study|Withdrawal Criteria|7|||
170594477|NCT01519674|616520953|FG001|Overall Study|Withdrawal Criteria|2|||
170594478|NCT01519674|616520954|FG002|Overall Study|Withdrawal Criteria|7|||
170594479|NCT01519674|616520952|FG000|Overall Study|Unsclassified|10|||
170594480|NCT01519674|616520953|FG001|Overall Study|Unsclassified|4|||
170594481|NCT01519674|616520954|FG002|Overall Study|Unsclassified|3|||
170594482|NCT00799591|616520957|FG000|Overall Study|De-escalation of doses|20|||
170594483|NCT00799591|616520957|FG000|Overall Study|Death|14|||
170594484|NCT00799591|616520957|FG000|Overall Study|Technical failure|12|||
170594485|NCT00799591|616520957|FG000|Overall Study|Resistant germ|11|||
170594486|NCT00799591|616520957|FG000|Overall Study|New infection|4|||
170594487|NCT00799591|616520957|FG000|Overall Study|Resistance germ and technical failure|2|||
170594488|NCT00799591|616520957|FG000|Overall Study|Persistance of fever undetermined origin|1|||
170594489|NCT00799591|616520957|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
170594490|NCT00799591|616520957|FG000|Overall Study|Infectious origin not probable|1|||
170594491|NCT01974752|616520959|FG000|Overall Study|Death|33|||
170594492|NCT01974752|616520960|FG001|Overall Study|Death|11|||
170594493|NCT01974752|616520959|FG000|Overall Study|Lost to Follow-up|2|||
170594494|NCT01974752|616520960|FG001|Overall Study|Lost to Follow-up|0|||
170594495|NCT01974752|616520959|FG000|Overall Study|Withdrawal by Subject|2|||
170594496|NCT01974752|616520960|FG001|Overall Study|Withdrawal by Subject|3|||
170594497|NCT01974752|616520959|FG000|Overall Study|Other Eligibility Criteria|0|||
170594498|NCT01974752|616520960|FG001|Overall Study|Other Eligibility Criteria|1|||
170594499|NCT02435680|616520961|FG000|Overall Study|Physician Decision|3|||
170594500|NCT02435680|616520962|FG001|Overall Study|Physician Decision|0|||
170594501|NCT02435680|616520963|FG002|Overall Study|Physician Decision|0|||
170594502|NCT02435680|616520961|FG000|Overall Study|subject / guardian decision|0|||
170594503|NCT02435680|616520962|FG001|Overall Study|subject / guardian decision|3|||
170594504|NCT02435680|616520963|FG002|Overall Study|subject / guardian decision|2|||
170594505|NCT02435680|616520961|FG000|Overall Study|Adverse Event|8|||
170594506|NCT02435680|616520962|FG001|Overall Study|Adverse Event|3|||
170594507|NCT02435680|616520963|FG002|Overall Study|Adverse Event|2|||
170594508|NCT02435680|616520961|FG000|Overall Study|progressive disease|10|||
170594509|NCT02435680|616520962|FG001|Overall Study|progressive disease|7|||
170594510|NCT02435680|616520963|FG002|Overall Study|progressive disease|11|||
170594511|NCT02435680|616520961|FG000|Overall Study|not treated|0|||
170594512|NCT02435680|616520962|FG001|Overall Study|not treated|0|||
170594513|NCT02435680|616520963|FG002|Overall Study|not treated|1|||
170594514|NCT02233738|616520964|FG000|Overall Study|Lost to Follow-up|5|||
170594515|NCT02233738|616520965|FG001|Overall Study|Lost to Follow-up|12|||
170594516|NCT02233738|616520964|FG000|Overall Study|Death|0|||
170594517|NCT02233738|616520965|FG001|Overall Study|Death|1|||
170594518|NCT02233738|616520964|FG000|Overall Study|Withdrawal by Subject|0|||
170594519|NCT02233738|616520965|FG001|Overall Study|Withdrawal by Subject|1|||
170594520|NCT02233738|616520964|FG000|Overall Study|Did not return after Baseline|3|||
170594521|NCT02233738|616520965|FG001|Overall Study|Did not return after Baseline|2|||
170594522|NCT00096174|616520966|FG000|Overall Study|Lack of Efficacy|9|||
170594523|NCT00096174|616520966|FG000|Overall Study|Adverse Event|15|||
170594524|NCT00096174|616520966|FG000|Overall Study|Death|6|||
170650852|NCT01426789|616734487|FG001|Part 2|Adverse Event|0|||
170811179|NCT02066636|617317533|FG002|Overall Study|Participant no loner meets study criteria|28|||
170811180|NCT02066636|617317531|FG000|Overall Study|Administrative reasons by sponsor|8|||
170811181|NCT02066636|617317532|FG001|Overall Study|Administrative reasons by sponsor|5|||
170811182|NCT02066636|617317533|FG002|Overall Study|Administrative reasons by sponsor|0|||
170811183|NCT02066636|617317531|FG000|Overall Study|Other reasons|16|||
170811184|NCT02066636|617317532|FG001|Overall Study|Other reasons|15|||
170811185|NCT02066636|617317533|FG002|Overall Study|Other reasons|50|||
170811186|NCT03567616|617317544|FG000|Overall Study|Disease progression|4|||
170811187|NCT03567616|617317544|FG000|Overall Study|Withdrawal by Subject|1|||
170811188|NCT03567616|617317544|FG000|Overall Study|Physician Decision|1|||
170811189|NCT03567616|617317544|FG000|Overall Study|Death|1|||
170811190|NCT03567616|617317544|FG000|Overall Study|Adverse Event|1|||
170912230|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
170594525|NCT00096174|616520966|FG000|Overall Study|Withdrawal by Subject|15|||
170594526|NCT00096174|616520966|FG000|Overall Study|Not started protocol therapy|3|||
170594527|NCT00096174|616520966|FG000|Overall Study|Ineligible|6|||
170912231|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
170912232|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
170912233|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
170912234|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
170912235|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
170912236|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
170912237|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
170912238|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
170912239|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
170912240|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
170912241|NCT01259492|617683843|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
170912242|NCT01259492|617683844|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
170912243|NCT01259492|617683845|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
170912244|NCT01259492|617683846|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
170912245|NCT00500149|617683848|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
170912246|NCT00500149|617683849|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
170912247|NCT00500149|617683848|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
170912248|NCT00500149|617683849|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
170912249|NCT00500149|617683848|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
170912250|NCT00500149|617683849|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
170912251|NCT00500149|617683848|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
170912252|NCT00500149|617683849|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
170912253|NCT00500149|617683848|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
170912254|NCT00500149|617683849|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
170912255|NCT00500149|617683848|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
170912256|NCT00500149|617683849|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
170594528|NCT00096174|616520966|FG000|Overall Study|other reason|8|||
170594529|NCT00953524|616520967|FG000|Overall Study|Adverse Event|2|||
170594530|NCT00953524|616520968|FG001|Overall Study|Adverse Event|0|||
170594531|NCT00953524|616520969|FG002|Overall Study|Adverse Event|1|||
170811191|NCT00875706|617317547|FG000|Overall Study|Withdrawal by Subject|1|||
170811192|NCT00875706|617317548|FG001|Overall Study|Withdrawal by Subject|0|||
170811193|NCT00875706|617317549|FG002|Overall Study|Withdrawal by Subject|0|||
170811194|NCT03775213|617317550|FG000|Overall Study|Withdrawal by Subject|51|||
170811195|NCT03775213|617317551|FG001|Overall Study|Withdrawal by Subject|53|||
170811196|NCT03775213|617317550|FG000|Overall Study|Incomplete Survey|7|||
170811197|NCT03775213|617317551|FG001|Overall Study|Incomplete Survey|7|||
170811198|NCT00786188|617317552|FG000|Overall Study|Adverse Event|3|||
170811199|NCT00786188|617317553|FG001|Overall Study|Adverse Event|1|||
170594532|NCT00953524|616520970|FG003|Overall Study|Adverse Event|2|||
170594533|NCT00953524|616520967|FG000|Overall Study|Protocol Violation|18|||
170594534|NCT00953524|616520968|FG001|Overall Study|Protocol Violation|10|||
170594535|NCT00953524|616520969|FG002|Overall Study|Protocol Violation|11|||
170594536|NCT00953524|616520970|FG003|Overall Study|Protocol Violation|6|||
170594537|NCT00953524|616520967|FG000|Overall Study|Lost to Follow-up|0|||
170594538|NCT00953524|616520968|FG001|Overall Study|Lost to Follow-up|1|||
170594539|NCT00953524|616520969|FG002|Overall Study|Lost to Follow-up|1|||
170594540|NCT00953524|616520970|FG003|Overall Study|Lost to Follow-up|0|||
170811200|NCT00786188|617317552|FG000|Overall Study|Withdrawal by Subject|2|||
170912257|NCT00500149|617683848|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
170912258|NCT00500149|617683849|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
170912259|NCT01157169|617683850|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
170912260|NCT01157169|617683851|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
170912261|NCT01157169|617683850|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
170912262|NCT01157169|617683851|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
170912263|NCT01330381|617683852|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
170912264|NCT01330381|617683853|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
170594541|NCT00953524|616520967|FG000|Overall Study|Withdrawal by Subject|2|||
170594542|NCT00953524|616520968|FG001|Overall Study|Withdrawal by Subject|4|||
170594543|NCT00953524|616520969|FG002|Overall Study|Withdrawal by Subject|1|||
170594544|NCT00953524|616520970|FG003|Overall Study|Withdrawal by Subject|0|||
170594545|NCT02098369|616520974|FG000|Overall Study|Withdrawal by Subject|1|||
170594546|NCT02098369|616520975|FG001|Overall Study|Withdrawal by Subject|5|||
170594547|NCT02098369|616520976|FG002|Overall Study|Withdrawal by Subject|0|||
170650853|NCT01426789|616734488|FG002|Part 2|Adverse Event|2|||
170912265|NCT01330381|617683854|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
170594548|NCT02098369|616520974|FG000|Overall Study|Lost to Follow-up|5|||
170811201|NCT00786188|617317553|FG001|Overall Study|Withdrawal by Subject|0|||
170811202|NCT00326183|617317554|FG000|Overall Study|Lost to Follow-up|104|||
170594549|NCT02098369|616520975|FG001|Overall Study|Lost to Follow-up|1|||
170594550|NCT02098369|616520976|FG002|Overall Study|Lost to Follow-up|3|||
170912266|NCT01330381|617683852|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
170594551|NCT02098369|616520974|FG000|Overall Study|Death|1|||
170594552|NCT02098369|616520975|FG001|Overall Study|Death|1|||
170594553|NCT02098369|616520976|FG002|Overall Study|Death|1|||
170594554|NCT02098369|616520974|FG000|Overall Study|Other|0|||
170594555|NCT02098369|616520975|FG001|Overall Study|Other|2|||
170594556|NCT02098369|616520976|FG002|Overall Study|Other|1|||
170594557|NCT00570037|616520978|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
170594558|NCT00570037|616520979|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
170594559|NCT00293709|616520980|FG000|Overall Study|Other|47|||
170594560|NCT03946124|616520981|FG000|Overall Study|Withdrawal by Subject|19|||
170594561|NCT04065074|616520986|FG000|Overall Study|Adverse Event|1|||
170594562|NCT04065074|616520986|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
170594563|NCT02334683|616520988|FG000|First 12 Week Period|Lost to Follow-up|1|||
170594564|NCT02334683|616520989|FG001|First 12 Week Period|Lost to Follow-up|0|||
170594565|NCT02334683|616520988|FG000|Second 12 Week Period|Adverse Event|0|||
170594566|NCT02334683|616520989|FG001|Second 12 Week Period|Adverse Event|1|||
170594567|NCT01062841|616520990|FG000|Overall Study|Indwelling Device Removed|41|||
170594568|NCT01062841|616520991|FG001|Overall Study|Indwelling Device Removed|48|||
170594569|NCT01062841|616520990|FG000|Overall Study|Death|3|||
170594570|NCT01062841|616520991|FG001|Overall Study|Death|5|||
170594571|NCT01062841|616520990|FG000|Overall Study|Withdrawal by Subject|2|||
170594572|NCT01062841|616520991|FG001|Overall Study|Withdrawal by Subject|0|||
170594573|NCT01062841|616520990|FG000|Overall Study|Withdrawal by Study|3|||
170594574|NCT01062841|616520991|FG001|Overall Study|Withdrawal by Study|0|||
170594575|NCT02046174|616520992|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
170594576|NCT02046174|616520993|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
170594577|NCT00413920|616520997|FG000|Overall Study|Adverse Event|9|||
170594578|NCT00413920|616520998|FG001|Overall Study|Adverse Event|11|||
170594579|NCT00413920|616520997|FG000|Overall Study|Lack of Efficacy|11|||
170594580|NCT00413920|616520998|FG001|Overall Study|Lack of Efficacy|9|||
170594581|NCT00413920|616520997|FG000|Overall Study|Death|3|||
170594582|NCT00413920|616520998|FG001|Overall Study|Death|5|||
170594583|NCT00413920|616520997|FG000|Overall Study|Graft Loss|5|||
170594584|NCT00413920|616520998|FG001|Overall Study|Graft Loss|3|||
170594585|NCT03158012|616521000|FG000|Overall Study|Withdrawal by Subject|0|||
170594586|NCT03158012|616521001|FG001|Overall Study|Withdrawal by Subject|1|||
170594587|NCT01891344|616521002|FG000|Overall Study|Ongoing|6|||
170594588|NCT01891344|616521003|FG001|Overall Study|Ongoing|2|||
170594589|NCT01891344|616521004|FG002|Overall Study|Ongoing|0|||
170594590|NCT01891344|616521005|FG003|Overall Study|Ongoing|1|||
170594591|NCT01891344|616521006|FG004|Overall Study|Ongoing|4|||
170594592|NCT01891344|616521007|FG005|Overall Study|Ongoing|1|||
170594593|NCT01891344|616521008|FG006|Overall Study|Ongoing|0|||
170912267|NCT01330381|617683853|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
170912268|NCT01330381|617683854|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
170594594|NCT01891344|616521009|FG007|Overall Study|Ongoing|0|||
170594595|NCT00186537|616521015|FG000|Overall Study|Withdrawal by Subject|4|||
170594596|NCT00186537|616521016|FG001|Overall Study|Withdrawal by Subject|0|||
170594597|NCT00186537|616521017|FG002|Overall Study|Withdrawal by Subject|3|||
170594598|NCT00186537|616521015|FG000|Overall Study|ALT > 1.5 x ULN|3|||
170594599|NCT00186537|616521016|FG001|Overall Study|ALT > 1.5 x ULN|0|||
170594600|NCT00186537|616521017|FG002|Overall Study|ALT > 1.5 x ULN|0|||
170594601|NCT00787930|616521024|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
170594602|NCT04957758|616521025|FG000|Overall Study|Adverse Event|1|||
170594603|NCT04957758|616521026|FG001|Overall Study|Adverse Event|0|||
170594604|NCT04957758|616521025|FG000|Overall Study|Lost to Follow-up|0|||
170594605|NCT04957758|616521026|FG001|Overall Study|Lost to Follow-up|2|||
170594606|NCT04957758|616521025|FG000|Overall Study|Withdrawal by Subject|4|||
170594607|NCT04957758|616521026|FG001|Overall Study|Withdrawal by Subject|2|||
170594608|NCT04957758|616521025|FG000|Overall Study|Protocol Violation|0|||
170912269|NCT01330381|617683852|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
170912270|NCT01330381|617683853|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
170594609|NCT04957758|616521026|FG001|Overall Study|Protocol Violation|1|||
170912271|NCT01330381|617683854|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
170594610|NCT02513823|616521027|FG000|Overall Study|Lost to Follow-up|4|||
170594611|NCT02513823|616521027|FG000|Overall Study|Physician Decision|1|||
170594612|NCT03353922|616521028|FG000|Overall Study|Withdrawal by Subject|1|||
170594613|NCT03353922|616521029|FG001|Overall Study|Withdrawal by Subject|0|||
170594614|NCT03353922|616521030|FG002|Overall Study|Withdrawal by Subject|1|||
170594615|NCT03353922|616521031|FG003|Overall Study|Withdrawal by Subject|1|||
170594616|NCT03353922|616521032|FG004|Overall Study|Withdrawal by Subject|0|||
170594617|NCT03353922|616521033|FG005|Overall Study|Withdrawal by Subject|0|||
170912272|NCT01330381|617683852|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
170594618|NCT03353922|616521028|FG000|Overall Study|Adverse Event|0|||
170594619|NCT03353922|616521029|FG001|Overall Study|Adverse Event|1|||
170594620|NCT03353922|616521030|FG002|Overall Study|Adverse Event|0|||
170594621|NCT03353922|616521031|FG003|Overall Study|Adverse Event|0|||
170594622|NCT03353922|616521032|FG004|Overall Study|Adverse Event|0|||
170594623|NCT03353922|616521033|FG005|Overall Study|Adverse Event|0|||
170594624|NCT00886119|616521034|FG000|Period 1|Did not meet inclusion criteria|1|||
170594625|NCT00886119|616521035|FG001|Period 1|Did not meet inclusion criteria|0|||
170594626|NCT01294462|616521036|FG000|Overall Study|Lost to Follow-up|1|||
170594627|NCT01294462|616521037|FG001|Overall Study|Lost to Follow-up|0|||
170594628|NCT01294462|616521036|FG000|Overall Study|Withdrawal by Subject|65|||
170594629|NCT01294462|616521037|FG001|Overall Study|Withdrawal by Subject|63|||
170594630|NCT02743780|616521038|FG000|Part 3 (7 Days)|Adverse Event|0|||
170594631|NCT02743780|616521039|FG001|Part 3 (7 Days)|Adverse Event|0|||
170594632|NCT02743780|616521040|FG002|Part 3 (7 Days)|Adverse Event|1|||
170594633|NCT02743780|616521041|FG003|Part 3 (7 Days)|Adverse Event|0|||
170594634|NCT02743780|616521042|FG004|Part 3 (7 Days)|Adverse Event|0|||
170594635|NCT00394901|616521043|FG000|Baseline Phase|Protocol Violation|0|||
170594636|NCT00394901|616521044|FG001|Baseline Phase|Protocol Violation|0|||
170594637|NCT00394901|616521045|FG002|Baseline Phase|Protocol Violation|1|||
170594638|NCT00394901|616521046|FG003|Baseline Phase|Protocol Violation|0|||
170594639|NCT00394901|616521043|FG000|Double-blind Phase|Adverse Event|5|||
170594640|NCT00394901|616521044|FG001|Double-blind Phase|Adverse Event|7|||
170594641|NCT00394901|616521045|FG002|Double-blind Phase|Adverse Event|16|||
170594642|NCT00394901|616521046|FG003|Double-blind Phase|Adverse Event|20|||
170594643|NCT00394901|616521043|FG000|Double-blind Phase|Lack of Efficacy|6|||
170594644|NCT00394901|616521044|FG001|Double-blind Phase|Lack of Efficacy|4|||
170594645|NCT00394901|616521045|FG002|Double-blind Phase|Lack of Efficacy|1|||
170594646|NCT00394901|616521046|FG003|Double-blind Phase|Lack of Efficacy|3|||
170594647|NCT00394901|616521043|FG000|Double-blind Phase|Withdrawal by Subject|2|||
170594648|NCT00394901|616521044|FG001|Double-blind Phase|Withdrawal by Subject|0|||
170594649|NCT00394901|616521045|FG002|Double-blind Phase|Withdrawal by Subject|0|||
170594650|NCT00394901|616521046|FG003|Double-blind Phase|Withdrawal by Subject|0|||
170594651|NCT00394901|616521043|FG000|Double-blind Phase|Lost to Follow-up|0|||
170594652|NCT00394901|616521044|FG001|Double-blind Phase|Lost to Follow-up|0|||
170594653|NCT00394901|616521045|FG002|Double-blind Phase|Lost to Follow-up|0|||
170594654|NCT00394901|616521046|FG003|Double-blind Phase|Lost to Follow-up|1|||
170594655|NCT00394901|616521043|FG000|Double-blind Phase|Protocol Violation|0|||
170594656|NCT00394901|616521044|FG001|Double-blind Phase|Protocol Violation|0|||
170594657|NCT00394901|616521045|FG002|Double-blind Phase|Protocol Violation|0|||
170594658|NCT00394901|616521046|FG003|Double-blind Phase|Protocol Violation|1|||
170594659|NCT00394901|616521043|FG000|Double-blind Phase|Death|1|||
170594660|NCT00394901|616521044|FG001|Double-blind Phase|Death|0|||
170594661|NCT00394901|616521045|FG002|Double-blind Phase|Death|0|||
170594662|NCT00394901|616521046|FG003|Double-blind Phase|Death|0|||
170594663|NCT00394901|616521043|FG000|Double-blind Phase|Subject's Personal Reason|1|||
170594664|NCT00394901|616521044|FG001|Double-blind Phase|Subject's Personal Reason|0|||
170594665|NCT00394901|616521045|FG002|Double-blind Phase|Subject's Personal Reason|0|||
170594666|NCT00394901|616521046|FG003|Double-blind Phase|Subject's Personal Reason|1|||
170594667|NCT00394901|616521043|FG000|Double-blind Phase|Lack of Compliance|0|||
170594668|NCT00394901|616521044|FG001|Double-blind Phase|Lack of Compliance|3|||
170594669|NCT00394901|616521045|FG002|Double-blind Phase|Lack of Compliance|0|||
170594670|NCT00394901|616521046|FG003|Double-blind Phase|Lack of Compliance|0|||
170594671|NCT00394901|616521043|FG000|Double-blind Phase|Entry into another study was found|0|||
170594672|NCT00394901|616521044|FG001|Double-blind Phase|Entry into another study was found|0|||
170594673|NCT00394901|616521045|FG002|Double-blind Phase|Entry into another study was found|1|||
170594674|NCT00394901|616521046|FG003|Double-blind Phase|Entry into another study was found|0|||
170594675|NCT00394901|616521043|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
170594676|NCT00394901|616521044|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
170594677|NCT00394901|616521045|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
170594678|NCT00394901|616521046|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
170594679|NCT01286077|616522767|FG000|Overall Study|Adverse Event|2|||
170594680|NCT01286077|616522768|FG001|Overall Study|Adverse Event|0|||
170594681|NCT01286077|616522767|FG000|Overall Study|Death|1|||
170594682|NCT01286077|616522768|FG001|Overall Study|Death|0|||
170912273|NCT01330381|617683853|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
170594683|NCT01286077|616522767|FG000|Overall Study|Protocol Violation|1|||
170594684|NCT01286077|616522768|FG001|Overall Study|Protocol Violation|1|||
170594685|NCT01286077|616522767|FG000|Overall Study|Withdrawal by Subject|0|||
170594686|NCT01286077|616522768|FG001|Overall Study|Withdrawal by Subject|2|||
170594687|NCT01286077|616522767|FG000|Overall Study|Intercurrent illness|1|||
170594688|NCT01286077|616522768|FG001|Overall Study|Intercurrent illness|0|||
170594689|NCT01286077|616522767|FG000|Overall Study|Non-compliance|1|||
170594690|NCT01286077|616522768|FG001|Overall Study|Non-compliance|0|||
170594691|NCT01286077|616522767|FG000|Overall Study|The subject starts with alternative MMY|0|||
170594692|NCT01286077|616522768|FG001|Overall Study|The subject starts with alternative MMY|3|||
170594693|NCT01286077|616522767|FG000|Overall Study|Patient's decision to stop treatment|3|||
170650854|NCT01426789|616734489|FG003|Part 2|Adverse Event|0|||
170594694|NCT01286077|616522768|FG001|Overall Study|Patient's decision to stop treatment|0|||
170594695|NCT01286077|616522767|FG000|Overall Study|Progression of disease|0|||
170594696|NCT01286077|616522768|FG001|Overall Study|Progression of disease|1|||
170594697|NCT01286077|616522767|FG000|Overall Study|refill medication not received in time|1|||
170594698|NCT01286077|616522768|FG001|Overall Study|refill medication not received in time|0|||
170594699|NCT02559414|616522770|FG000|Overall Study|Lost to Follow-up|0|||
170594700|NCT02559414|616522771|FG001|Overall Study|Lost to Follow-up|1|||
170594701|NCT02559414|616522772|FG002|Overall Study|Lost to Follow-up|0|||
170594702|NCT02559414|616522770|FG000|Overall Study|Withdrawal by Subject|1|||
170594703|NCT02559414|616522771|FG001|Overall Study|Withdrawal by Subject|0|||
170594704|NCT02559414|616522772|FG002|Overall Study|Withdrawal by Subject|1|||
170594705|NCT02559414|616522770|FG000|Overall Study|Other|0|||
170594706|NCT02559414|616522771|FG001|Overall Study|Other|1|||
170594707|NCT02559414|616522772|FG002|Overall Study|Other|1|||
170594708|NCT01062061|616522773|FG000|Overall Study|Enrolled more than once|2|||
170594709|NCT01062061|616522773|FG000|Overall Study|Investigated before study start|13|||
170594710|NCT01062061|616522773|FG000|Overall Study|Outside chief indications|10|||
170594711|NCT01062061|616522773|FG000|Overall Study|Failed to meet inclusion criteria|2|||
170594712|NCT00004445|616522774|FG000|Overall Study|Physician Decision|2|||
170594713|NCT00004445|616522774|FG000|Overall Study|Withdrawal by Subject|1|||
170594714|NCT00076336|616522775|FG000|Overall Study|Death|13|||
170594715|NCT00076336|616522776|FG001|Overall Study|Death|17|||
170594716|NCT00076336|616522775|FG000|Overall Study|Adverse Event|4|||
170594717|NCT00076336|616522776|FG001|Overall Study|Adverse Event|4|||
170594718|NCT00076336|616522775|FG000|Overall Study|Lost to Follow-up|4|||
170594719|NCT00076336|616522776|FG001|Overall Study|Lost to Follow-up|4|||
170594720|NCT00076336|616522775|FG000|Overall Study|Non-Compliance|2|||
170594721|NCT00076336|616522776|FG001|Overall Study|Non-Compliance|0|||
170594722|NCT00076336|616522775|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
170594723|NCT00076336|616522776|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
170594724|NCT00076336|616522775|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
170594725|NCT00076336|616522776|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
170594726|NCT00076336|616522775|FG000|Overall Study|Liver Transplantation|3|||
170594727|NCT00076336|616522776|FG001|Overall Study|Liver Transplantation|3|||
170594728|NCT00076336|616522775|FG000|Overall Study|Virologic Breakthrough|14|||
170594729|NCT00076336|616522776|FG001|Overall Study|Virologic Breakthrough|16|||
170912274|NCT01330381|617683854|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
170912275|NCT01330381|617683852|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
170912276|NCT01330381|617683853|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
170912277|NCT01330381|617683854|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
170912278|NCT01330381|617683852|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
170912279|NCT01330381|617683853|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
170912280|NCT01330381|617683854|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
170912281|NCT01330381|617683852|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
170912282|NCT01330381|617683853|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
170912283|NCT01330381|617683854|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
170811203|NCT00326183|617317555|FG001|Overall Study|Lost to Follow-up|56|||
170811204|NCT00326183|617317554|FG000|Overall Study|Protocol Violation|6|||
170912284|NCT01330381|617683852|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
170912285|NCT01330381|617683853|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
170811205|NCT00326183|617317555|FG001|Overall Study|Protocol Violation|3|||
170811206|NCT00326183|617317554|FG000|Overall Study|Withdrawal by Subject|35|||
170912286|NCT01330381|617683854|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
170811207|NCT00326183|617317555|FG001|Overall Study|Withdrawal by Subject|7|||
170811208|NCT00326183|617317554|FG000|Overall Study|Subject Moved|7|||
170811209|NCT00326183|617317555|FG001|Overall Study|Subject Moved|4|||
170811210|NCT00326183|617317554|FG000|Overall Study|Other|47|||
170811211|NCT00326183|617317555|FG001|Overall Study|Other|13|||
170811212|NCT00326183|617317554|FG000|Overall Study|Adverse Event|1|||
170811213|NCT00326183|617317555|FG001|Overall Study|Adverse Event|0|||
170811214|NCT00824408|617317557|FG000|Run-in Phase|Progressive disease|4|||
170811215|NCT00824408|617317558|FG001|Run-in Phase|Progressive disease|4|||
170912287|NCT01330381|617683852|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
170594730|NCT00076336|616522775|FG000|Overall Study|Treatment failure|4|||
170594731|NCT00076336|616522776|FG001|Overall Study|Treatment failure|5|||
170594732|NCT00524589|616522777|FG000|Overall Study|Withdrawal by Subject|2|||
170594733|NCT00524589|616522777|FG000|Overall Study|Disease Progression|16|||
170594734|NCT01457950|616522784|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
170594735|NCT01457950|616522785|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
170594736|NCT01457950|616522786|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
170594737|NCT01457950|616522787|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
170594738|NCT01457950|616522784|FG000|Double-Blind Phase|Protocol Violation|2|||
170811216|NCT00824408|617317559|FG002|Run-in Phase|Progressive disease|0|||
170594739|NCT01457950|616522785|FG001|Double-Blind Phase|Protocol Violation|1|||
170594740|NCT01457950|616522786|FG002|Double-Blind Phase|Protocol Violation|0|||
170594741|NCT01457950|616522787|FG003|Double-Blind Phase|Protocol Violation|0|||
170594742|NCT01457950|616522784|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
170594743|NCT01457950|616522785|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
170811217|NCT00824408|617317560|FG003|Run-in Phase|Progressive disease|0|||
170811218|NCT00824408|617317561|FG004|Run-in Phase|Progressive disease|0|||
170811219|NCT00824408|617317557|FG000|Run-in Phase|Adverse Event|1|||
170811220|NCT00824408|617317558|FG001|Run-in Phase|Adverse Event|1|||
170811221|NCT00824408|617317559|FG002|Run-in Phase|Adverse Event|0|||
170811222|NCT00824408|617317560|FG003|Run-in Phase|Adverse Event|0|||
170811223|NCT00824408|617317561|FG004|Run-in Phase|Adverse Event|0|||
170811224|NCT00824408|617317557|FG000|Run-in Phase|Refused to continue medication|1|||
170811225|NCT00824408|617317558|FG001|Run-in Phase|Refused to continue medication|0|||
170811226|NCT00824408|617317559|FG002|Run-in Phase|Refused to continue medication|0|||
170811227|NCT00824408|617317560|FG003|Run-in Phase|Refused to continue medication|0|||
170811228|NCT00824408|617317561|FG004|Run-in Phase|Refused to continue medication|0|||
170811229|NCT00824408|617317557|FG000|Run-in Phase|Other reason not defined above|0|||
170811230|NCT00824408|617317558|FG001|Run-in Phase|Other reason not defined above|1|||
170811231|NCT00824408|617317559|FG002|Run-in Phase|Other reason not defined above|0|||
170811232|NCT00824408|617317560|FG003|Run-in Phase|Other reason not defined above|0|||
170811233|NCT00824408|617317561|FG004|Run-in Phase|Other reason not defined above|0|||
170811234|NCT00824408|617317557|FG000|Randomized Phase|Not treated|0|||
170811235|NCT00824408|617317558|FG001|Randomized Phase|Not treated|0|||
170811236|NCT00824408|617317559|FG002|Randomized Phase|Not treated|1|||
170811237|NCT00824408|617317560|FG003|Randomized Phase|Not treated|1|||
170811238|NCT00824408|617317561|FG004|Randomized Phase|Not treated|1|||
170811239|NCT00824408|617317557|FG000|Randomized Phase|Progressive disease|0|||
170811240|NCT00824408|617317558|FG001|Randomized Phase|Progressive disease|0|||
170811241|NCT00824408|617317559|FG002|Randomized Phase|Progressive disease|25|||
170811242|NCT00824408|617317560|FG003|Randomized Phase|Progressive disease|36|||
170811243|NCT00824408|617317561|FG004|Randomized Phase|Progressive disease|34|||
170811244|NCT00824408|617317557|FG000|Randomized Phase|Adverse Event|0|||
170811245|NCT00824408|617317558|FG001|Randomized Phase|Adverse Event|0|||
170811246|NCT00824408|617317559|FG002|Randomized Phase|Adverse Event|4|||
170811247|NCT00824408|617317560|FG003|Randomized Phase|Adverse Event|5|||
170811248|NCT00824408|617317561|FG004|Randomized Phase|Adverse Event|5|||
170811249|NCT00824408|617317557|FG000|Randomized Phase|Refused to continue medication|0|||
170811250|NCT00824408|617317558|FG001|Randomized Phase|Refused to continue medication|0|||
170811251|NCT00824408|617317559|FG002|Randomized Phase|Refused to continue medication|2|||
170811252|NCT00824408|617317560|FG003|Randomized Phase|Refused to continue medication|2|||
170811253|NCT00824408|617317561|FG004|Randomized Phase|Refused to continue medication|2|||
170912288|NCT01330381|617683853|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
170912289|NCT01330381|617683854|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
170912290|NCT01330381|617683852|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
170912291|NCT01330381|617683853|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
170912292|NCT01330381|617683854|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
170912293|NCT03846947|617683855|FG000|Overall Study|technical issues with imaging sequence|2|||
170912294|NCT00663858|617683856|FG000|Overall Study|Adverse Event|9|||
170912295|NCT00663858|617683857|FG001|Overall Study|Adverse Event|1|||
170912296|NCT00663858|617683858|FG002|Overall Study|Adverse Event|6|||
170912297|NCT00663858|617683856|FG000|Overall Study|Lack of Efficacy|5|||
170912298|NCT00663858|617683857|FG001|Overall Study|Lack of Efficacy|1|||
170912299|NCT00663858|617683858|FG002|Overall Study|Lack of Efficacy|3|||
170912300|NCT00663858|617683856|FG000|Overall Study|Withdrawal by Subject|7|||
170912301|NCT00663858|617683857|FG001|Overall Study|Withdrawal by Subject|3|||
170912302|NCT00663858|617683858|FG002|Overall Study|Withdrawal by Subject|3|||
170912303|NCT00663858|617683856|FG000|Overall Study|Protocol Violation|5|||
170912304|NCT00663858|617683857|FG001|Overall Study|Protocol Violation|3|||
170912305|NCT00663858|617683858|FG002|Overall Study|Protocol Violation|4|||
170811254|NCT00824408|617317557|FG000|Randomized Phase|Other reason not defined above|0|||
170811255|NCT00824408|617317558|FG001|Randomized Phase|Other reason not defined above|0|||
170811256|NCT00824408|617317559|FG002|Randomized Phase|Other reason not defined above|4|||
170811257|NCT00824408|617317560|FG003|Randomized Phase|Other reason not defined above|2|||
170811258|NCT00824408|617317561|FG004|Randomized Phase|Other reason not defined above|4|||
170912306|NCT00663858|617683856|FG000|Overall Study|Other|8|||
170912307|NCT00663858|617683857|FG001|Overall Study|Other|2|||
170912308|NCT00663858|617683858|FG002|Overall Study|Other|4|||
170594744|NCT01457950|616522786|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
170594745|NCT01457950|616522787|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
170811259|NCT01263496|617317569|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
170811260|NCT01263496|617317570|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
170811261|NCT01263496|617317571|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
170811262|NCT01263496|617317572|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
170811263|NCT01263496|617317573|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
170650855|NCT01426789|616734490|FG004|Part 2|Adverse Event|1|||
170650856|NCT01426789|616734491|FG005|Part 2|Adverse Event|0|||
170650857|NCT01159431|616734497|FG000|Overall Study|Adverse Event|1|||
170650858|NCT01159431|616734498|FG001|Overall Study|Adverse Event|2|||
170650859|NCT01159431|616734497|FG000|Overall Study|non-compliance|1|||
170650860|NCT01159431|616734498|FG001|Overall Study|non-compliance|1|||
170650861|NCT01159431|616734497|FG000|Overall Study|Lack of Efficacy|0|||
170650862|NCT01159431|616734498|FG001|Overall Study|Lack of Efficacy|3|||
170650863|NCT00130442|616736284|FG000|Overall Study|Withdrawal by Subject|0|||
170650864|NCT00130442|616736285|FG001|Overall Study|Withdrawal by Subject|1|||
170650865|NCT00130442|616736284|FG000|Overall Study|did not meet criteria|1|||
170650866|NCT00130442|616736285|FG001|Overall Study|did not meet criteria|1|||
170650867|NCT00814333|616736286|FG000|Enrollment|Lost to Follow-up|1|||
170650868|NCT00814333|616736287|FG001|Enrollment|Lost to Follow-up|0|||
170650869|NCT00910247|616736288|FG000|Overall Study|Adverse Event|15|||
170650870|NCT00910247|616736288|FG000|Overall Study|Death|2|||
170650871|NCT00910247|616736288|FG000|Overall Study|Lost to Follow-up|10|||
170650872|NCT00910247|616736288|FG000|Overall Study|Physician Decision|3|||
170650873|NCT00910247|616736288|FG000|Overall Study|Protocol Violation|10|||
170650874|NCT00910247|616736288|FG000|Overall Study|Withdrawal by Subject|25|||
170650875|NCT00910247|616736288|FG000|Overall Study|Not collected|4|||
170650876|NCT03387150|616736289|FG000|Overall Study|Withdrawal by Subject|3|||
170650877|NCT03387150|616736290|FG001|Overall Study|Withdrawal by Subject|0|||
170650878|NCT03387150|616736291|FG002|Overall Study|Withdrawal by Subject|3|||
170650879|NCT03387150|616736292|FG003|Overall Study|Withdrawal by Subject|4|||
170650880|NCT03387150|616736293|FG004|Overall Study|Withdrawal by Subject|1|||
170650881|NCT03387150|616736294|FG005|Overall Study|Withdrawal by Subject|2|||
170650882|NCT03387150|616736295|FG006|Overall Study|Withdrawal by Subject|0|||
170650883|NCT03387150|616736289|FG000|Overall Study|Lost to Follow-up|3|||
170650884|NCT03387150|616736290|FG001|Overall Study|Lost to Follow-up|2|||
170650885|NCT03387150|616736291|FG002|Overall Study|Lost to Follow-up|2|||
170650886|NCT03387150|616736292|FG003|Overall Study|Lost to Follow-up|3|||
170811264|NCT01263496|617317574|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
170811265|NCT01263496|617317575|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
170811266|NCT01263496|617317576|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
170811267|NCT01263496|617317577|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
170811268|NCT01263496|617317569|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170811269|NCT01263496|617317570|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170811270|NCT01263496|617317571|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170811271|NCT01263496|617317572|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
170811272|NCT01263496|617317573|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
170811273|NCT01263496|617317574|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170811274|NCT01263496|617317575|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170811275|NCT01263496|617317576|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170811276|NCT01263496|617317577|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
170811277|NCT01263496|617317569|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
170811278|NCT01263496|617317570|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
170811279|NCT01263496|617317571|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
170811280|NCT01263496|617317572|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
170811281|NCT01263496|617317573|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
170811282|NCT01263496|617317574|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
170811283|NCT01263496|617317575|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
170811284|NCT01263496|617317576|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
170811285|NCT01263496|617317577|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
170811286|NCT01263496|617317569|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170811287|NCT01263496|617317570|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
170811288|NCT01263496|617317571|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170811289|NCT01263496|617317572|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170811290|NCT01263496|617317573|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170811291|NCT01263496|617317574|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170811292|NCT01263496|617317575|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170811293|NCT01263496|617317576|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170811294|NCT01263496|617317577|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
170811295|NCT01263496|617317569|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
170811296|NCT01263496|617317570|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
170811297|NCT01263496|617317571|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
170811298|NCT01263496|617317572|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
170811299|NCT01263496|617317573|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
170650887|NCT03387150|616736293|FG004|Overall Study|Lost to Follow-up|3|||
170650888|NCT03387150|616736294|FG005|Overall Study|Lost to Follow-up|3|||
170650889|NCT03387150|616736295|FG006|Overall Study|Lost to Follow-up|0|||
170650890|NCT03387150|616736289|FG000|Overall Study|Participant unable to adhere to visit|0|||
170650891|NCT03387150|616736290|FG001|Overall Study|Participant unable to adhere to visit|1|||
170650892|NCT03387150|616736291|FG002|Overall Study|Participant unable to adhere to visit|0|||
170650893|NCT03387150|616736292|FG003|Overall Study|Participant unable to adhere to visit|0|||
170650894|NCT03387150|616736293|FG004|Overall Study|Participant unable to adhere to visit|2|||
170650895|NCT03387150|616736294|FG005|Overall Study|Participant unable to adhere to visit|2|||
170650896|NCT03387150|616736295|FG006|Overall Study|Participant unable to adhere to visit|0|||
170650897|NCT02919969|616736296|FG000|Overall Study|Lack of Efficacy|22|||
170650898|NCT02919969|616736296|FG000|Overall Study|Death|4|||
170650899|NCT02919969|616736296|FG000|Overall Study|Physician Decision|3|||
170650900|NCT02919969|616736296|FG000|Overall Study|Withdrawal by Subject|2|||
170650901|NCT01842633|616736297|FG000|Overall Study|Screen Failure|1|||
170650902|NCT01842633|616736298|FG001|Overall Study|Screen Failure|0|||
170912309|NCT01539837|617683859|FG000|Overall Study|reduce neutrophil level|0|||
170912310|NCT01539837|617683860|FG001|Overall Study|reduce neutrophil level|1|||
170912311|NCT01539837|617683861|FG002|Overall Study|reduce neutrophil level|1|||
170912312|NCT01539837|617683859|FG000|Overall Study|bad compliance|0|||
170912313|NCT01539837|617683860|FG001|Overall Study|bad compliance|0|||
170912314|NCT01539837|617683861|FG002|Overall Study|bad compliance|1|||
170912315|NCT00849693|617683862|FG000|Acute Treatment Phase|Adverse Event|12|||
170912316|NCT00849693|617683863|FG001|Acute Treatment Phase|Adverse Event|7|||
170912317|NCT00849693|617683864|FG002|Acute Treatment Phase|Adverse Event|6|||
170912318|NCT00849693|617683865|FG003|Acute Treatment Phase|Adverse Event|4|||
170912319|NCT00849693|617683862|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
170912320|NCT00849693|617683863|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
170912321|NCT00849693|617683864|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
170912322|NCT00849693|617683865|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
170912323|NCT00849693|617683862|FG000|Acute Treatment Phase|Protocol Violation|1|||
170912324|NCT00849693|617683863|FG001|Acute Treatment Phase|Protocol Violation|5|||
170912325|NCT00849693|617683864|FG002|Acute Treatment Phase|Protocol Violation|2|||
170912326|NCT00849693|617683865|FG003|Acute Treatment Phase|Protocol Violation|6|||
170594746|NCT01457950|616522784|FG000|Open-Label Phase|Adverse Event|0|||
170594747|NCT01457950|616522785|FG001|Open-Label Phase|Adverse Event|0|||
170594748|NCT01457950|616522786|FG002|Open-Label Phase|Adverse Event|0|||
170594749|NCT01457950|616522787|FG003|Open-Label Phase|Adverse Event|1|||
170594750|NCT01457950|616522784|FG000|Open-Label Phase|Protocol Violation|0|||
170594751|NCT01457950|616522785|FG001|Open-Label Phase|Protocol Violation|0|||
170594752|NCT01457950|616522786|FG002|Open-Label Phase|Protocol Violation|0|||
170594753|NCT01457950|616522787|FG003|Open-Label Phase|Protocol Violation|1|||
170594754|NCT01457950|616522784|FG000|Open-Label Phase|Withdrawal by Subject|0|||
170594755|NCT01457950|616522785|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170594756|NCT01457950|616522786|FG002|Open-Label Phase|Withdrawal by Subject|2|||
170594757|NCT01457950|616522787|FG003|Open-Label Phase|Withdrawal by Subject|0|||
170594758|NCT03351114|616522791|FG000|Overall Study|Withdrawal by Subject|1|||
170594759|NCT01665430|616522795|FG000|Overall Study|Adverse Event|1|||
170594760|NCT01665430|616522795|FG000|Overall Study|Withdrawal by Subject|6|||
170594761|NCT01665430|616522795|FG000|Overall Study|Other Unspecified|2|||
170594762|NCT02310230|616522800|FG000|Overall Study|Physician Decision|1|||
170594763|NCT02310230|616522801|FG001|Overall Study|Physician Decision|3|||
170594764|NCT02310230|616522800|FG000|Overall Study|monitor baseline taken after induction|2|||
170594765|NCT02310230|616522801|FG001|Overall Study|monitor baseline taken after induction|7|||
170594766|NCT02310230|616522800|FG000|Overall Study|Poor signal quality|5|||
170594767|NCT02310230|616522801|FG001|Overall Study|Poor signal quality|8|||
170594768|NCT02310230|616522800|FG000|Overall Study|Case cancelled|1|||
170594769|NCT02310230|616522801|FG001|Overall Study|Case cancelled|0|||
170594770|NCT00989235|616522803|FG000|Overall Study|Death|0|||
170594771|NCT00989235|616522804|FG001|Overall Study|Death|1|||
170594772|NCT00989235|616522803|FG000|Overall Study|Adverse Event|0|||
170594773|NCT00989235|616522804|FG001|Overall Study|Adverse Event|1|||
170594774|NCT00989235|616522803|FG000|Overall Study|Lack of Efficacy|1|||
170594775|NCT00989235|616522804|FG001|Overall Study|Lack of Efficacy|0|||
170594776|NCT00989235|616522803|FG000|Overall Study|Withdrawal of Consent|1|||
170650903|NCT01842633|616736299|FG002|Overall Study|Screen Failure|0|||
170912327|NCT00849693|617683862|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
170912328|NCT00849693|617683863|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
170912329|NCT00849693|617683864|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
170912330|NCT00849693|617683865|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
170594777|NCT00989235|616522804|FG001|Overall Study|Withdrawal of Consent|1|||
170594778|NCT00989235|616522803|FG000|Overall Study|Desire to Become Pregnant|1|||
170594779|NCT00989235|616522804|FG001|Overall Study|Desire to Become Pregnant|0|||
170594780|NCT00989235|616522803|FG000|Overall Study|Randomized by Mistake|0|||
170594781|NCT00989235|616522804|FG001|Overall Study|Randomized by Mistake|2|||
170650904|NCT01842633|616736297|FG000|Overall Study|Adverse Event|1|||
170650905|NCT01842633|616736298|FG001|Overall Study|Adverse Event|1|||
170912331|NCT00849693|617683862|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
170594782|NCT00989235|616522803|FG000|Overall Study|Lost to Follow-up|0|||
170594783|NCT00989235|616522804|FG001|Overall Study|Lost to Follow-up|1|||
170594784|NCT00545532|616522805|FG000|Overall Study|Withdrawal by Subject|1|||
170594785|NCT00545532|616522806|FG001|Overall Study|Withdrawal by Subject|3|||
170594786|NCT00545532|616522805|FG000|Overall Study|Lost to Follow-up|5|||
170594787|NCT00545532|616522806|FG001|Overall Study|Lost to Follow-up|6|||
170594788|NCT00545532|616522805|FG000|Overall Study|Death|0|||
170594789|NCT00545532|616522806|FG001|Overall Study|Death|1|||
170594790|NCT03593681|616522807|FG000|Overall Study|Inadequate sample collected|12|||
170594791|NCT03593681|616522807|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
170594792|NCT03593681|616522807|FG000|Overall Study|Protocol Violation|3|||
170594793|NCT03593681|616522807|FG000|Overall Study|Withdrawal by Subject|3|||
170912332|NCT00849693|617683863|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
170912333|NCT00849693|617683864|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
170912334|NCT00849693|617683865|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
170912335|NCT00849693|617683862|FG000|Acute Treatment Phase|Physician Decision|2|||
170912336|NCT00849693|617683863|FG001|Acute Treatment Phase|Physician Decision|1|||
170912337|NCT00849693|617683864|FG002|Acute Treatment Phase|Physician Decision|2|||
170912338|NCT00849693|617683865|FG003|Acute Treatment Phase|Physician Decision|1|||
170912339|NCT00849693|617683862|FG000|Acute Treatment Phase|Sponsor decision|0|||
170912340|NCT00849693|617683863|FG001|Acute Treatment Phase|Sponsor decision|0|||
170912341|NCT00849693|617683864|FG002|Acute Treatment Phase|Sponsor decision|1|||
170912342|NCT00849693|617683865|FG003|Acute Treatment Phase|Sponsor decision|0|||
170912343|NCT00849693|617683862|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
170912344|NCT00849693|617683863|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
170912345|NCT00849693|617683864|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
170912346|NCT00849693|617683865|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
170594794|NCT03593681|616522807|FG000|Overall Study|Procedure not attempted|3|||
170594795|NCT03593681|616522807|FG000|Overall Study|Adverse Event|2|||
170594796|NCT03593681|616522807|FG000|Overall Study|Physician Decision|1|||
170594797|NCT01149486|616522812|FG000|First Intervention|Adverse Event|0|||
170594798|NCT01149486|616522813|FG001|First Intervention|Adverse Event|1|||
170594799|NCT03630302|616522814|FG000|Surgery|hardware issue prevented LFP recordings|1|||
170594800|NCT03630302|616522814|FG000|3 Month Visit|Adverse Event|2|||
170594801|NCT03630302|616522814|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
170594802|NCT01135914|616522815|FG000|Overall Study|Withdrawal by Subject|1|||
170594803|NCT01135914|616522816|FG001|Overall Study|Withdrawal by Subject|3|||
170912347|NCT00849693|617683862|FG000|Extension Phase|Adverse Event|4|||
170912348|NCT00849693|617683863|FG001|Extension Phase|Adverse Event|6|||
170912349|NCT00849693|617683864|FG002|Extension Phase|Adverse Event|3|||
170912350|NCT00849693|617683865|FG003|Extension Phase|Adverse Event|7|||
170912351|NCT00849693|617683862|FG000|Extension Phase|Lost to Follow-up|7|||
170912352|NCT00849693|617683863|FG001|Extension Phase|Lost to Follow-up|5|||
170912353|NCT00849693|617683864|FG002|Extension Phase|Lost to Follow-up|6|||
170912354|NCT00849693|617683865|FG003|Extension Phase|Lost to Follow-up|6|||
170912355|NCT00849693|617683862|FG000|Extension Phase|Protocol Violation|0|||
170912356|NCT00849693|617683863|FG001|Extension Phase|Protocol Violation|3|||
170912357|NCT00849693|617683864|FG002|Extension Phase|Protocol Violation|2|||
170912358|NCT00849693|617683865|FG003|Extension Phase|Protocol Violation|3|||
170912359|NCT00849693|617683862|FG000|Extension Phase|Withdrawal by Subject|6|||
170912360|NCT00849693|617683863|FG001|Extension Phase|Withdrawal by Subject|9|||
170912361|NCT00849693|617683864|FG002|Extension Phase|Withdrawal by Subject|10|||
170912362|NCT00849693|617683865|FG003|Extension Phase|Withdrawal by Subject|15|||
170912363|NCT00849693|617683862|FG000|Extension Phase|Parent or caregiver decision|9|||
170912364|NCT00849693|617683863|FG001|Extension Phase|Parent or caregiver decision|4|||
170912365|NCT00849693|617683864|FG002|Extension Phase|Parent or caregiver decision|10|||
170912366|NCT00849693|617683865|FG003|Extension Phase|Parent or caregiver decision|5|||
170912367|NCT00849693|617683862|FG000|Extension Phase|Physician Decision|1|||
170912368|NCT00849693|617683863|FG001|Extension Phase|Physician Decision|1|||
170912369|NCT00849693|617683864|FG002|Extension Phase|Physician Decision|2|||
170912370|NCT00849693|617683865|FG003|Extension Phase|Physician Decision|0|||
170912371|NCT00849693|617683862|FG000|Extension Phase|Sponsor decision|1|||
170912372|NCT00849693|617683863|FG001|Extension Phase|Sponsor decision|0|||
170912373|NCT00849693|617683864|FG002|Extension Phase|Sponsor decision|0|||
170912374|NCT00849693|617683865|FG003|Extension Phase|Sponsor decision|1|||
170912375|NCT00849693|617683862|FG000|Extension Phase|Lack of Efficacy|2|||
170912376|NCT00849693|617683863|FG001|Extension Phase|Lack of Efficacy|2|||
170594804|NCT01135914|616522817|FG002|Overall Study|Withdrawal by Subject|6|||
170594805|NCT01135914|616522815|FG000|Overall Study|Lost to Follow-up|1|||
170594806|NCT01135914|616522816|FG001|Overall Study|Lost to Follow-up|0|||
170594807|NCT01135914|616522817|FG002|Overall Study|Lost to Follow-up|1|||
170912377|NCT00849693|617683864|FG002|Extension Phase|Lack of Efficacy|2|||
170594808|NCT01135914|616522815|FG000|Overall Study|Protocol Violation|0|||
170594809|NCT01135914|616522816|FG001|Overall Study|Protocol Violation|0|||
170912378|NCT00849693|617683865|FG003|Extension Phase|Lack of Efficacy|1|||
170912379|NCT01978912|617683868|FG000|Overall Study|Adverse Event|0|||
170912380|NCT01978912|617683869|FG001|Overall Study|Adverse Event|1|||
170594810|NCT01135914|616522817|FG002|Overall Study|Protocol Violation|3|||
170594811|NCT01135914|616522815|FG000|Overall Study|Lack of Efficacy|2|||
170594812|NCT01135914|616522816|FG001|Overall Study|Lack of Efficacy|1|||
170594813|NCT01135914|616522817|FG002|Overall Study|Lack of Efficacy|10|||
170594814|NCT01135914|616522815|FG000|Overall Study|Adverse Event|0|||
170594815|NCT01135914|616522816|FG001|Overall Study|Adverse Event|1|||
170594816|NCT01135914|616522817|FG002|Overall Study|Adverse Event|2|||
170594817|NCT00598078|616522818|FG000|Period 2 (Day 2)|Adverse Event|1|||
170594818|NCT00598078|616522819|FG001|Period 2 (Day 2)|Adverse Event|0|||
170594819|NCT01479595|616522824|FG000|Overall Study|Protocol deviation|0|||
170594820|NCT01479595|616522825|FG001|Overall Study|Protocol deviation|1|||
170594821|NCT01479595|616522824|FG000|Overall Study|Adverse Event|2|||
170594822|NCT01479595|616522825|FG001|Overall Study|Adverse Event|1|||
170594823|NCT02120365|616522826|FG000|Overall Study|Withdrawal by Subject|0|||
170594824|NCT02120365|616522827|FG001|Overall Study|Withdrawal by Subject|0|||
170594825|NCT02120365|616522828|FG002|Overall Study|Withdrawal by Subject|2|||
170594826|NCT02120365|616522829|FG003|Overall Study|Withdrawal by Subject|4|||
170594827|NCT02120365|616522830|FG004|Overall Study|Withdrawal by Subject|0|||
170594828|NCT02120365|616522831|FG005|Overall Study|Withdrawal by Subject|2|||
170594829|NCT01344629|616522832|FG000|Crossover Period 2|Withdrawal by Subject|0|||
170594830|NCT01344629|616522833|FG001|Crossover Period 2|Withdrawal by Subject|1|||
170594831|NCT02305849|616522834|FG000|Overall Study|Adverse Event|10|||
170594832|NCT02305849|616522835|FG001|Overall Study|Adverse Event|12|||
170594833|NCT02305849|616522836|FG002|Overall Study|Adverse Event|7|||
170594834|NCT02305849|616522837|FG003|Overall Study|Adverse Event|3|||
170594835|NCT02305849|616522834|FG000|Overall Study|Lack of Efficacy|10|||
170594836|NCT02305849|616522835|FG001|Overall Study|Lack of Efficacy|6|||
170594837|NCT02305849|616522836|FG002|Overall Study|Lack of Efficacy|3|||
170594838|NCT02305849|616522837|FG003|Overall Study|Lack of Efficacy|9|||
170594839|NCT02305849|616522834|FG000|Overall Study|Withdrawal by Subject|2|||
170594840|NCT02305849|616522835|FG001|Overall Study|Withdrawal by Subject|2|||
170594841|NCT02305849|616522836|FG002|Overall Study|Withdrawal by Subject|1|||
170594842|NCT02305849|616522837|FG003|Overall Study|Withdrawal by Subject|4|||
170594843|NCT02305849|616522834|FG000|Overall Study|Lost to Follow-up|0|||
170594844|NCT02305849|616522835|FG001|Overall Study|Lost to Follow-up|2|||
170594845|NCT02305849|616522836|FG002|Overall Study|Lost to Follow-up|0|||
170594846|NCT02305849|616522837|FG003|Overall Study|Lost to Follow-up|0|||
170594847|NCT02305849|616522834|FG000|Overall Study|Protocol Violation|3|||
170594848|NCT02305849|616522835|FG001|Overall Study|Protocol Violation|2|||
170594849|NCT02305849|616522836|FG002|Overall Study|Protocol Violation|1|||
170594850|NCT02305849|616522837|FG003|Overall Study|Protocol Violation|1|||
170594851|NCT02305849|616522834|FG000|Overall Study|Lab data met discontinuation criteria|0|||
170594852|NCT02305849|616522835|FG001|Overall Study|Lab data met discontinuation criteria|1|||
170594853|NCT02305849|616522836|FG002|Overall Study|Lab data met discontinuation criteria|2|||
170594854|NCT02305849|616522837|FG003|Overall Study|Lab data met discontinuation criteria|1|||
170594855|NCT02305849|616522834|FG000|Overall Study|Miscellaneous|1|||
170594856|NCT02305849|616522835|FG001|Overall Study|Miscellaneous|2|||
170594857|NCT02305849|616522836|FG002|Overall Study|Miscellaneous|4|||
170594858|NCT02305849|616522837|FG003|Overall Study|Miscellaneous|1|||
170594859|NCT02305849|616522834|FG000|Overall Study|Not fulfill eligibility criteria|1|||
170594860|NCT02305849|616522835|FG001|Overall Study|Not fulfill eligibility criteria|1|||
170594861|NCT02305849|616522836|FG002|Overall Study|Not fulfill eligibility criteria|0|||
170594862|NCT02305849|616522837|FG003|Overall Study|Not fulfill eligibility criteria|0|||
170594863|NCT00355342|616522838|FG000|Overall Study|Adverse Event|13|||
170594864|NCT00355342|616522839|FG001|Overall Study|Adverse Event|15|||
170594865|NCT00355342|616522838|FG000|Overall Study|Lost to Follow-up|4|||
170594866|NCT00355342|616522839|FG001|Overall Study|Lost to Follow-up|2|||
170811300|NCT01263496|617317574|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
170594867|NCT00355342|616522838|FG000|Overall Study|Withdrawal by Subject|14|||
170594868|NCT00355342|616522839|FG001|Overall Study|Withdrawal by Subject|11|||
170594869|NCT00355342|616522838|FG000|Overall Study|Sponsor terminated study|2|||
170594870|NCT00355342|616522839|FG001|Overall Study|Sponsor terminated study|2|||
170811301|NCT01263496|617317575|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
170811302|NCT01263496|617317576|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
170811303|NCT01263496|617317577|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
170594871|NCT00355342|616522838|FG000|Overall Study|Overcompliant-PI discretion|1|||
170594872|NCT00355342|616522839|FG001|Overall Study|Overcompliant-PI discretion|0|||
170594873|NCT00355342|616522838|FG000|Overall Study|Use of prohibited medication|1|||
170594874|NCT00355342|616522839|FG001|Overall Study|Use of prohibited medication|0|||
170594875|NCT00355342|616522838|FG000|Overall Study|COPD exacerbation|1|||
170594876|NCT00355342|616522839|FG001|Overall Study|COPD exacerbation|1|||
170594877|NCT00355342|616522838|FG000|Overall Study|Dispensed wrong study drug kit|1|||
170594878|NCT00355342|616522839|FG001|Overall Study|Dispensed wrong study drug kit|0|||
170594879|NCT00355342|616522838|FG000|Overall Study|Non-compliance with Dexa scans|1|||
170594880|NCT00355342|616522839|FG001|Overall Study|Non-compliance with Dexa scans|0|||
170594881|NCT00355342|616522838|FG000|Overall Study|Withdrawal by participant and physician|1|||
170594882|NCT00355342|616522839|FG001|Overall Study|Withdrawal by participant and physician|0|||
170594883|NCT00355342|616522838|FG000|Overall Study|Participant relocated|0|||
170594884|NCT00355342|616522839|FG001|Overall Study|Participant relocated|1|||
170594885|NCT00355342|616522838|FG000|Overall Study|Participant discontinued study drug|0|||
170594886|NCT00355342|616522839|FG001|Overall Study|Participant discontinued study drug|1|||
170594887|NCT00355342|616522838|FG000|Overall Study|Study management|0|||
170594888|NCT00355342|616522839|FG001|Overall Study|Study management|1|||
170594889|NCT00355342|616522838|FG000|Overall Study|Protocol Violation|0|||
170912381|NCT01978912|617683870|FG002|Overall Study|Adverse Event|0|||
170912382|NCT01978912|617683871|FG003|Overall Study|Adverse Event|0|||
170912383|NCT01978912|617683868|FG000|Overall Study|Lost to Follow-up|1|||
170912384|NCT01978912|617683869|FG001|Overall Study|Lost to Follow-up|1|||
170912385|NCT01978912|617683870|FG002|Overall Study|Lost to Follow-up|0|||
170912386|NCT01978912|617683871|FG003|Overall Study|Lost to Follow-up|1|||
170912387|NCT01978912|617683868|FG000|Overall Study|Withdrawal by Subject|1|||
170912388|NCT01978912|617683869|FG001|Overall Study|Withdrawal by Subject|0|||
170912389|NCT01978912|617683870|FG002|Overall Study|Withdrawal by Subject|2|||
170912390|NCT01978912|617683871|FG003|Overall Study|Withdrawal by Subject|2|||
170912391|NCT01978912|617683868|FG000|Overall Study|Lumbar Surgery|1|||
170912392|NCT01978912|617683869|FG001|Overall Study|Lumbar Surgery|0|||
170912393|NCT01978912|617683870|FG002|Overall Study|Lumbar Surgery|1|||
170912394|NCT01978912|617683871|FG003|Overall Study|Lumbar Surgery|0|||
170912395|NCT01978912|617683868|FG000|Overall Study|Intradiscal Steroid Injection|0|||
170912396|NCT01978912|617683869|FG001|Overall Study|Intradiscal Steroid Injection|1|||
170912397|NCT01978912|617683870|FG002|Overall Study|Intradiscal Steroid Injection|0|||
170912398|NCT01978912|617683871|FG003|Overall Study|Intradiscal Steroid Injection|0|||
170912399|NCT00907478|617683883|FG000|Overall Study|Ineligibility determined|0|||
170912400|NCT00907478|617683884|FG001|Overall Study|Ineligibility determined|0|||
170912401|NCT00907478|617683885|FG002|Overall Study|Ineligibility determined|1|||
170912402|NCT00907478|617683883|FG000|Overall Study|Noncompliance|0|||
170912403|NCT00907478|617683884|FG001|Overall Study|Noncompliance|0|||
170912404|NCT00907478|617683885|FG002|Overall Study|Noncompliance|1|||
170912405|NCT00907478|617683883|FG000|Overall Study|Adverse Event|3|||
170912406|NCT00907478|617683884|FG001|Overall Study|Adverse Event|1|||
170912407|NCT00907478|617683885|FG002|Overall Study|Adverse Event|2|||
170912408|NCT00907478|617683883|FG000|Overall Study|Withdrawal by Subject|8|||
170912409|NCT00907478|617683884|FG001|Overall Study|Withdrawal by Subject|9|||
170912410|NCT00907478|617683885|FG002|Overall Study|Withdrawal by Subject|6|||
170912411|NCT00907478|617683883|FG000|Overall Study|Requirement for alternative therapy|1|||
170912412|NCT00907478|617683884|FG001|Overall Study|Requirement for alternative therapy|2|||
170912413|NCT00907478|617683885|FG002|Overall Study|Requirement for alternative therapy|3|||
170912414|NCT00907478|617683883|FG000|Overall Study|Physician Decision|2|||
170912415|NCT00907478|617683884|FG001|Overall Study|Physician Decision|0|||
170912416|NCT00907478|617683885|FG002|Overall Study|Physician Decision|3|||
170912417|NCT00907478|617683883|FG000|Overall Study|Death|4|||
170912418|NCT00907478|617683884|FG001|Overall Study|Death|2|||
170912419|NCT00907478|617683885|FG002|Overall Study|Death|1|||
170912420|NCT00907478|617683883|FG000|Overall Study|Protocol-specified criteria|5|||
170912421|NCT00907478|617683884|FG001|Overall Study|Protocol-specified criteria|2|||
170912422|NCT00907478|617683885|FG002|Overall Study|Protocol-specified criteria|3|||
170912423|NCT00907478|617683883|FG000|Overall Study|Pregnancy|0|||
170594890|NCT00355342|616522839|FG001|Overall Study|Protocol Violation|1|||
170594891|NCT00355342|616522838|FG000|Overall Study|Use of protocol excluded medication|0|||
170594892|NCT00355342|616522839|FG001|Overall Study|Use of protocol excluded medication|1|||
170594893|NCT02689076|616522840|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
170594894|NCT02689076|616522841|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
170912424|NCT00907478|617683884|FG001|Overall Study|Pregnancy|1|||
170912425|NCT00907478|617683885|FG002|Overall Study|Pregnancy|1|||
170912426|NCT00907478|617683883|FG000|Overall Study|Lost to Follow-up|1|||
170912427|NCT00907478|617683884|FG001|Overall Study|Lost to Follow-up|0|||
170912428|NCT00907478|617683885|FG002|Overall Study|Lost to Follow-up|0|||
170912429|NCT00907478|617683883|FG000|Overall Study|Other|3|||
170912430|NCT00907478|617683884|FG001|Overall Study|Other|0|||
170912431|NCT00907478|617683885|FG002|Overall Study|Other|1|||
170912432|NCT02855411|617683886|FG000|Overall Study|Study terminated by sponsor|21|||
170912433|NCT02855411|617683886|FG000|Overall Study|Does not meet entrance criteria|14|||
170912434|NCT03707977|617683889|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
170912435|NCT03707977|617683890|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
170912436|NCT03707977|617683891|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
170912437|NCT03707977|617683889|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
170912438|NCT03707977|617683890|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
170912439|NCT03707977|617683891|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
170912440|NCT01629667|617683898|FG000|Overall Study|Lost to Follow-up|0|||
170912441|NCT01629667|617683899|FG001|Overall Study|Lost to Follow-up|1|||
170912442|NCT01629667|617683900|FG002|Overall Study|Lost to Follow-up|1|||
170594895|NCT02689076|616522842|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
170594896|NCT02689076|616522840|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
170594897|NCT02689076|616522841|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
170594898|NCT02689076|616522842|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
170594899|NCT02689076|616522840|FG000|Overall Study|Did not have an HIE match|2|||
170594900|NCT02689076|616522841|FG001|Overall Study|Did not have an HIE match|0|||
170594901|NCT02689076|616522842|FG002|Overall Study|Did not have an HIE match|0|||
170594902|NCT02689076|616522840|FG000|Overall Study|Death during non-VA encounter|2|||
170594903|NCT02689076|616522841|FG001|Overall Study|Death during non-VA encounter|5|||
170594904|NCT02689076|616522842|FG002|Overall Study|Death during non-VA encounter|0|||
170594905|NCT02689076|616522840|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
170594906|NCT02689076|616522841|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
170594907|NCT02689076|616522842|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
170594908|NCT02689076|616522840|FG000|Overall Study|Participant no longer active in VA system|1|||
170594909|NCT02689076|616522841|FG001|Overall Study|Participant no longer active in VA system|0|||
170594910|NCT02689076|616522842|FG002|Overall Study|Participant no longer active in VA system|0|||
170594911|NCT02689076|616522840|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
170594912|NCT02689076|616522841|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
170594913|NCT02689076|616522842|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
170594914|NCT00434759|616522845|FG000|Overall Study|Lack of Efficacy|5|||
170594915|NCT00434759|616522846|FG001|Overall Study|Lack of Efficacy|4|||
170594916|NCT00434759|616522845|FG000|Overall Study|Withdrawal by Subject|17|||
170912443|NCT01629667|617683898|FG000|Overall Study|Withdrawal by Subject|31|||
170594917|NCT00434759|616522846|FG001|Overall Study|Withdrawal by Subject|1|||
170594918|NCT00434759|616522845|FG000|Overall Study|family affairs|2|||
170594919|NCT00434759|616522846|FG001|Overall Study|family affairs|0|||
170594920|NCT00334282|616522849|FG000|Overall Study|Lost to Follow-up|11|||
170594921|NCT00334282|616522850|FG001|Overall Study|Lost to Follow-up|5|||
170594922|NCT00334282|616522849|FG000|Overall Study|Withdrawal by Subject|17|||
170594923|NCT00334282|616522850|FG001|Overall Study|Withdrawal by Subject|3|||
170594924|NCT00334282|616522849|FG000|Overall Study|Death|194|||
170912444|NCT01629667|617683899|FG001|Overall Study|Withdrawal by Subject|20|||
170594925|NCT00334282|616522850|FG001|Overall Study|Death|100|||
170594926|NCT00276094|616522856|FG000|Overall Study|Adverse Event|15|||
170594927|NCT00276094|616522857|FG001|Overall Study|Adverse Event|13|||
170594928|NCT00276094|616522858|FG002|Overall Study|Adverse Event|11|||
170594929|NCT00276094|616522856|FG000|Overall Study|Withdrawal by Subject|14|||
170594930|NCT00276094|616522857|FG001|Overall Study|Withdrawal by Subject|14|||
170594931|NCT00276094|616522858|FG002|Overall Study|Withdrawal by Subject|12|||
170912445|NCT01629667|617683900|FG002|Overall Study|Withdrawal by Subject|28|||
170912446|NCT01629667|617683898|FG000|Overall Study|Death|1|||
170912447|NCT01629667|617683899|FG001|Overall Study|Death|5|||
170912448|NCT01629667|617683900|FG002|Overall Study|Death|3|||
170912449|NCT01629667|617683898|FG000|Overall Study|Randomized, not treated|2|||
170912450|NCT01629667|617683899|FG001|Overall Study|Randomized, not treated|1|||
170912451|NCT01629667|617683900|FG002|Overall Study|Randomized, not treated|0|||
170912452|NCT01629667|617683898|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
170912453|NCT01629667|617683899|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
170912454|NCT01629667|617683900|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
170912455|NCT01629667|617683898|FG000|Overall Study|Requiring lung transplant|2|||
170912456|NCT01629667|617683899|FG001|Overall Study|Requiring lung transplant|1|||
170912457|NCT01629667|617683900|FG002|Overall Study|Requiring lung transplant|3|||
170912458|NCT01629667|617683898|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
170912459|NCT01629667|617683899|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
170912460|NCT01629667|617683900|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
170912461|NCT01629667|617683898|FG000|Overall Study|Started other medicine|1|||
170912462|NCT01629667|617683899|FG001|Overall Study|Started other medicine|0|||
170912463|NCT01629667|617683900|FG002|Overall Study|Started other medicine|1|||
170912464|NCT01629667|617683898|FG000|Overall Study|Site error in safety follow-up|0|||
170594932|NCT00276094|616522856|FG000|Overall Study|Protocol Violation|16|||
170594933|NCT00276094|616522857|FG001|Overall Study|Protocol Violation|7|||
170594934|NCT00276094|616522858|FG002|Overall Study|Protocol Violation|10|||
170594935|NCT00276094|616522856|FG000|Overall Study|Lost to Follow-up|8|||
170594936|NCT00276094|616522857|FG001|Overall Study|Lost to Follow-up|6|||
170594937|NCT00276094|616522858|FG002|Overall Study|Lost to Follow-up|4|||
170912465|NCT01629667|617683899|FG001|Overall Study|Site error in safety follow-up|0|||
170912466|NCT01629667|617683900|FG002|Overall Study|Site error in safety follow-up|1|||
170912467|NCT01629667|617683898|FG000|Overall Study|Enrolled in another clinical study|0|||
170912468|NCT01629667|617683899|FG001|Overall Study|Enrolled in another clinical study|1|||
170594938|NCT00276094|616522856|FG000|Overall Study|Other-Subject moved out of country|1|||
170912469|NCT01629667|617683900|FG002|Overall Study|Enrolled in another clinical study|0|||
170912470|NCT01629667|617683898|FG000|Overall Study|Code break|1|||
170912471|NCT01629667|617683899|FG001|Overall Study|Code break|0|||
170912472|NCT01629667|617683900|FG002|Overall Study|Code break|0|||
170912473|NCT00553059|617683901|FG000|Overall Study|Deemed ineligible|1|||
170912474|NCT00553059|617683902|FG001|Overall Study|Deemed ineligible|1|||
170912475|NCT00553059|617683901|FG000|Overall Study|Drug supply not available|0|||
170912476|NCT00553059|617683902|FG001|Overall Study|Drug supply not available|1|||
170912477|NCT00984659|617683903|FG000|2-week Run-in Period|Adverse Event|8|||
170912478|NCT00984659|617683904|FG001|2-week Run-in Period|Adverse Event|0|||
170912479|NCT00984659|617683905|FG002|2-week Run-in Period|Adverse Event|0|||
170912480|NCT00984659|617683906|FG003|2-week Run-in Period|Adverse Event|0|||
170912481|NCT00984659|617683903|FG000|2-week Run-in Period|Protocol Violation|5|||
170912482|NCT00984659|617683904|FG001|2-week Run-in Period|Protocol Violation|0|||
170912483|NCT00984659|617683905|FG002|2-week Run-in Period|Protocol Violation|0|||
170912484|NCT00984659|617683906|FG003|2-week Run-in Period|Protocol Violation|0|||
170912485|NCT00984659|617683903|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
170912486|NCT00984659|617683904|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
170912487|NCT00984659|617683905|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
170912488|NCT00984659|617683906|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
170912489|NCT00984659|617683903|FG000|2-week Run-in Period|Lost to Follow-up|3|||
170912490|NCT00984659|617683904|FG001|2-week Run-in Period|Lost to Follow-up|0|||
170912491|NCT00984659|617683905|FG002|2-week Run-in Period|Lost to Follow-up|0|||
170912492|NCT00984659|617683906|FG003|2-week Run-in Period|Lost to Follow-up|0|||
170912493|NCT00984659|617683903|FG000|2-week Run-in Period|Physician Decision|10|||
170594939|NCT00276094|616522857|FG001|Overall Study|Other-Subject moved out of country|0|||
170912494|NCT00984659|617683904|FG001|2-week Run-in Period|Physician Decision|0|||
170912495|NCT00984659|617683905|FG002|2-week Run-in Period|Physician Decision|0|||
170912496|NCT00984659|617683906|FG003|2-week Run-in Period|Physician Decision|0|||
170912497|NCT00984659|617683903|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
170912498|NCT00984659|617683904|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
170912499|NCT00984659|617683905|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
170912500|NCT00984659|617683906|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
170912501|NCT00984659|617683903|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
170594940|NCT00276094|616522858|FG002|Overall Study|Other-Subject moved out of country|0|||
170594941|NCT00276094|616522856|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
170594942|NCT00276094|616522857|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
170594943|NCT00276094|616522858|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
170594944|NCT00276094|616522856|FG000|Overall Study|Other-Lack of efficacy|1|||
170594945|NCT00276094|616522857|FG001|Overall Study|Other-Lack of efficacy|0|||
170594946|NCT00276094|616522858|FG002|Overall Study|Other-Lack of efficacy|0|||
170594947|NCT00276094|616522856|FG000|Overall Study|Other-Refused follow-up visit|1|||
170594948|NCT00276094|616522857|FG001|Overall Study|Other-Refused follow-up visit|0|||
170594949|NCT00276094|616522858|FG002|Overall Study|Other-Refused follow-up visit|0|||
170594950|NCT00276094|616522856|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
170594951|NCT00276094|616522857|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
170594952|NCT00276094|616522858|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
170594953|NCT00276094|616522856|FG000|Overall Study|Other-Relocation|0|||
170594954|NCT00276094|616522857|FG001|Overall Study|Other-Relocation|1|||
170594955|NCT00276094|616522858|FG002|Overall Study|Other-Relocation|0|||
170594956|NCT00276094|616522856|FG000|Overall Study|Other-Study medication lost|0|||
170594957|NCT00276094|616522857|FG001|Overall Study|Other-Study medication lost|0|||
170594958|NCT00276094|616522858|FG002|Overall Study|Other-Study medication lost|1|||
170594959|NCT00461305|616522861|FG000|Treatment|Adverse Event|26|||
170594960|NCT00461305|616522862|FG001|Treatment|Adverse Event|3|||
170594961|NCT00461305|616522861|FG000|Treatment|Lost to Follow-up|4|||
170594962|NCT00461305|616522862|FG001|Treatment|Lost to Follow-up|2|||
170594963|NCT00461305|616522861|FG000|Treatment|Protocol Violation|13|||
170594964|NCT00461305|616522862|FG001|Treatment|Protocol Violation|2|||
170594965|NCT00461305|616522861|FG000|Treatment|Withdrawal by Subject|48|||
170594966|NCT00461305|616522862|FG001|Treatment|Withdrawal by Subject|2|||
170594967|NCT00461305|616522861|FG000|Treatment|Never dispensed|5|||
170594968|NCT00461305|616522862|FG001|Treatment|Never dispensed|0|||
170594969|NCT00461305|616522861|FG000|Treatment|Study drug not taken|1|||
170912502|NCT00984659|617683904|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
170912503|NCT00984659|617683905|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
170912504|NCT00984659|617683906|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
170912505|NCT00984659|617683903|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
170912506|NCT00984659|617683904|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
170594970|NCT00461305|616522862|FG001|Treatment|Study drug not taken|0|||
170594971|NCT00461305|616522861|FG000|Treatment|Partially missing diary|2|||
170594972|NCT00461305|616522862|FG001|Treatment|Partially missing diary|0|||
170594973|NCT00461305|616522861|FG000|Treatment|Other (missing drug etc)|2|||
170594974|NCT00461305|616522862|FG001|Treatment|Other (missing drug etc)|0|||
170594975|NCT00461305|616522861|FG000|Continued Treatment|Adverse Event|26|||
170912507|NCT00984659|617683905|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
170912508|NCT00984659|617683906|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
170912509|NCT00984659|617683903|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
170912510|NCT00984659|617683904|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
170912511|NCT00984659|617683905|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
170912512|NCT00984659|617683906|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
170912513|NCT00984659|617683903|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
170912514|NCT00984659|617683904|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
170912515|NCT00984659|617683905|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
170912516|NCT00984659|617683906|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
170912517|NCT00984659|617683903|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
170912518|NCT00984659|617683904|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
170912519|NCT00984659|617683905|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
170912520|NCT00984659|617683906|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
170912521|NCT00984659|617683903|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
170912522|NCT00984659|617683904|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
170912523|NCT00984659|617683905|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
170912524|NCT00984659|617683906|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
170912525|NCT03952650|617683907|FG000|Overall Study|TRAVEL|0|||
170912526|NCT03952650|617683908|FG001|Overall Study|TRAVEL|4|||
170912527|NCT03952650|617683909|FG002|Overall Study|TRAVEL|0|||
170912528|NCT03952650|617683910|FG003|Overall Study|TRAVEL|4|||
170912529|NCT03952650|617683911|FG004|Overall Study|TRAVEL|0|||
170912530|NCT03952650|617683912|FG005|Overall Study|TRAVEL|3|||
170912531|NCT03952650|617683913|FG006|Overall Study|TRAVEL|2|||
170912532|NCT03952650|617683907|FG000|Overall Study|Withdrawal by Subject|0|||
170912533|NCT03952650|617683908|FG001|Overall Study|Withdrawal by Subject|2|||
170912534|NCT03952650|617683909|FG002|Overall Study|Withdrawal by Subject|0|||
170912535|NCT03952650|617683910|FG003|Overall Study|Withdrawal by Subject|3|||
170912536|NCT03952650|617683911|FG004|Overall Study|Withdrawal by Subject|0|||
170912537|NCT03952650|617683912|FG005|Overall Study|Withdrawal by Subject|1|||
170912538|NCT03952650|617683913|FG006|Overall Study|Withdrawal by Subject|1|||
170912539|NCT03952650|617683907|FG000|Overall Study|Lost to Follow-up|0|||
170912540|NCT03952650|617683908|FG001|Overall Study|Lost to Follow-up|1|||
170912541|NCT03952650|617683909|FG002|Overall Study|Lost to Follow-up|0|||
170912542|NCT03952650|617683910|FG003|Overall Study|Lost to Follow-up|0|||
170912543|NCT03952650|617683911|FG004|Overall Study|Lost to Follow-up|0|||
170912544|NCT03952650|617683912|FG005|Overall Study|Lost to Follow-up|1|||
170912545|NCT03952650|617683913|FG006|Overall Study|Lost to Follow-up|1|||
170912546|NCT03952650|617683907|FG000|Overall Study|Received wrong vaccine and travelled|0|||
170912547|NCT03952650|617683908|FG001|Overall Study|Received wrong vaccine and travelled|0|||
170912548|NCT03952650|617683909|FG002|Overall Study|Received wrong vaccine and travelled|0|||
170912549|NCT03952650|617683910|FG003|Overall Study|Received wrong vaccine and travelled|0|||
170912550|NCT03952650|617683911|FG004|Overall Study|Received wrong vaccine and travelled|0|||
170912551|NCT03952650|617683912|FG005|Overall Study|Received wrong vaccine and travelled|1|||
170912552|NCT03952650|617683913|FG006|Overall Study|Received wrong vaccine and travelled|0|||
170912553|NCT03952650|617683907|FG000|Overall Study|Unable to make study visit|0|||
170912554|NCT03952650|617683908|FG001|Overall Study|Unable to make study visit|0|||
170912555|NCT03952650|617683909|FG002|Overall Study|Unable to make study visit|0|||
170912556|NCT03952650|617683910|FG003|Overall Study|Unable to make study visit|0|||
170912557|NCT03952650|617683911|FG004|Overall Study|Unable to make study visit|0|||
170912558|NCT03952650|617683912|FG005|Overall Study|Unable to make study visit|1|||
170912559|NCT03952650|617683913|FG006|Overall Study|Unable to make study visit|0|||
170912560|NCT00592683|617683915|FG000|Overall Study|Found ineligible|0|||
170912561|NCT00592683|617683916|FG001|Overall Study|Found ineligible|1|||
170912562|NCT00592683|617683915|FG000|Overall Study|Withdrawal by Subject|1|||
170650906|NCT01842633|616736299|FG002|Overall Study|Adverse Event|0|||
170650907|NCT01842633|616736297|FG000|Overall Study|Withdrawal by Subject|0|||
170650908|NCT01842633|616736298|FG001|Overall Study|Withdrawal by Subject|1|||
170650909|NCT01842633|616736299|FG002|Overall Study|Withdrawal by Subject|0|||
170650910|NCT01842633|616736297|FG000|Overall Study|Technical issues|1|||
170650911|NCT01842633|616736298|FG001|Overall Study|Technical issues|0|||
170912563|NCT00592683|617683916|FG001|Overall Study|Withdrawal by Subject|0|||
170912564|NCT00592683|617683915|FG000|Overall Study|Adverse Event|0|||
170912565|NCT00592683|617683916|FG001|Overall Study|Adverse Event|2|||
170912566|NCT00592683|617683915|FG000|Overall Study|Protocol Violation|1|||
170912567|NCT00592683|617683916|FG001|Overall Study|Protocol Violation|0|||
170912568|NCT00592683|617683915|FG000|Overall Study|Study drug expired|1|||
170912569|NCT00592683|617683916|FG001|Overall Study|Study drug expired|0|||
170912570|NCT00592683|617683915|FG000|Overall Study|Other|1|||
170912571|NCT00592683|617683916|FG001|Overall Study|Other|0|||
170912572|NCT00592683|617683915|FG000|Overall Study|Lost to Follow-up|0|||
170912573|NCT00592683|617683916|FG001|Overall Study|Lost to Follow-up|1|||
170650912|NCT01842633|616736299|FG002|Overall Study|Technical issues|0|||
170594976|NCT00461305|616522862|FG001|Continued Treatment|Adverse Event|0|||
170594977|NCT00461305|616522861|FG000|Continued Treatment|Lost to Follow-up|4|||
170594978|NCT00461305|616522862|FG001|Continued Treatment|Lost to Follow-up|0|||
170594979|NCT00461305|616522861|FG000|Continued Treatment|Protocol Violation|13|||
170594980|NCT00461305|616522862|FG001|Continued Treatment|Protocol Violation|0|||
170594981|NCT00461305|616522861|FG000|Continued Treatment|Withdrawal by Subject|48|||
170594982|NCT00461305|616522862|FG001|Continued Treatment|Withdrawal by Subject|0|||
170594983|NCT00461305|616522861|FG000|Continued Treatment|Partially missing diary|2|||
170594984|NCT00461305|616522862|FG001|Continued Treatment|Partially missing diary|0|||
170594985|NCT00461305|616522861|FG000|Continued Treatment|Other (missing drug etc)|2|||
170594986|NCT00461305|616522862|FG001|Continued Treatment|Other (missing drug etc)|0|||
170594987|NCT00787137|616522863|FG000|Overall Study|Study Termination|0|||
170594988|NCT00787137|616522864|FG001|Overall Study|Study Termination|0|||
170594989|NCT00787137|616522865|FG002|Overall Study|Study Termination|1|||
170594990|NCT02075632|616522867|FG000|Overall Study|Adverse Event|1|||
170594991|NCT02075632|616522868|FG001|Overall Study|Adverse Event|1|||
170594992|NCT02075632|616522867|FG000|Overall Study|Lost to Follow-up|0|||
170594993|NCT02075632|616522868|FG001|Overall Study|Lost to Follow-up|3|||
170594994|NCT02075632|616522867|FG000|Overall Study|Withdrawal by Subject|0|||
170594995|NCT02075632|616522868|FG001|Overall Study|Withdrawal by Subject|1|||
170594996|NCT03464422|616522869|FG000|Overall Study|Lost to Follow-up|2|||
170594997|NCT03464422|616522869|FG000|Overall Study|Withdrawal by Subject|2|||
170594998|NCT01628367|616522875|FG000|Overall Study|Adverse Event|1|||
170594999|NCT01628367|616522876|FG001|Overall Study|Adverse Event|0|||
170595000|NCT00740714|616522877|FG000|Overall Study|Withdrawal by Subject|17|||
170595001|NCT00740714|616522878|FG001|Overall Study|Withdrawal by Subject|19|||
170595002|NCT00740714|616522879|FG002|Overall Study|Withdrawal by Subject|29|||
170595003|NCT03688555|616522880|FG000|Treatment Period|Adverse Event|0|||
170595004|NCT03688555|616522881|FG001|Treatment Period|Adverse Event|0|||
170595005|NCT03688555|616522882|FG002|Treatment Period|Adverse Event|1|||
170595006|NCT02278614|616522886|FG000|Overall Study|Withdrawal by Subject|3|||
170595007|NCT02278614|616522887|FG001|Overall Study|Withdrawal by Subject|5|||
170595008|NCT02278614|616522886|FG000|Overall Study|Adverse Event|1|||
170595009|NCT02278614|616522887|FG001|Overall Study|Adverse Event|0|||
170595010|NCT02278614|616522886|FG000|Overall Study|left eye was not eligible|1|||
170595011|NCT02278614|616522887|FG001|Overall Study|left eye was not eligible|0|||
170595012|NCT00160654|616522892|FG000|Overall Study|Adverse Event|14|||
170595013|NCT00160654|616522892|FG000|Overall Study|Lack of Efficacy|4|||
170595014|NCT00160654|616522892|FG000|Overall Study|Lost to Follow-up|2|||
170595015|NCT00160654|616522892|FG000|Overall Study|Intake of expired drug|7|||
170595016|NCT00160654|616522892|FG000|Overall Study|Psychological trauma|1|||
170595017|NCT00160654|616522892|FG000|Overall Study|Sponsor decision|1|||
170595018|NCT00160654|616522892|FG000|Overall Study|Patient met exclusion criteria|1|||
170595019|NCT00160654|616522892|FG000|Overall Study|Patient decision|1|||
170595020|NCT00160654|616522892|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
170595021|NCT00160654|616522892|FG000|Overall Study|Met exclusion criteria|1|||
170595022|NCT00456599|616522896|FG000|Overall Study|Non-compliance|1|||
170595023|NCT00456599|616522896|FG000|Overall Study|Withdrawal by Subject|2|||
170595024|NCT02198235|616522897|FG000|Overall Study|Lost to Follow-up|3|||
170595025|NCT02198235|616522898|FG001|Overall Study|Lost to Follow-up|2|||
170595026|NCT02198235|616522899|FG002|Overall Study|Lost to Follow-up|2|||
170595027|NCT00624780|616522900|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
170595028|NCT00624780|616522901|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
170595029|NCT00624780|616522902|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
170595030|NCT00624780|616522903|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
170595031|NCT00624780|616522904|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
170595032|NCT00624780|616522905|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
170595033|NCT00624780|616522900|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
170595034|NCT00624780|616522901|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
170595035|NCT00624780|616522902|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
170595036|NCT00624780|616522903|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
170595037|NCT00624780|616522904|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
170595038|NCT00624780|616522905|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
170595039|NCT00624780|616522900|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
170595040|NCT00624780|616522901|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
170595041|NCT00624780|616522902|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
170595042|NCT00624780|616522903|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
170595043|NCT00624780|616522904|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
170595044|NCT00624780|616522905|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
170595045|NCT00624780|616522900|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
170595046|NCT00624780|616522901|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
170595047|NCT00624780|616522902|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
170912574|NCT00201201|617683917|FG000|Overall Study|Death|0|||
170912575|NCT00201201|617683918|FG001|Overall Study|Death|2|||
170595048|NCT00624780|616522903|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
170595049|NCT00624780|616522904|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
170595050|NCT00624780|616522905|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
170595051|NCT00624780|616522900|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
170595052|NCT00624780|616522901|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
170595053|NCT00624780|616522902|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
170595054|NCT00624780|616522903|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
170595055|NCT00624780|616522904|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
170595056|NCT00624780|616522905|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
170595057|NCT00624780|616522900|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
170595058|NCT00624780|616522901|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
170595059|NCT00624780|616522902|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
170595060|NCT00624780|616522903|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
170595061|NCT00624780|616522904|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
170595062|NCT00624780|616522905|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
170595063|NCT00624780|616522900|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
170595064|NCT00624780|616522901|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
170912576|NCT00201201|617683917|FG000|Overall Study|Withdrawal by Subject|5|||
170912577|NCT00201201|617683918|FG001|Overall Study|Withdrawal by Subject|5|||
170912578|NCT00545818|617683924|FG000|Overall Study|Protocol Violation|1|||
170912579|NCT00545818|617683925|FG001|Overall Study|Protocol Violation|0|||
170912580|NCT00545818|617683924|FG000|Overall Study|Adverse Event|1|||
170912581|NCT00545818|617683925|FG001|Overall Study|Adverse Event|1|||
170912582|NCT00545818|617683924|FG000|Overall Study|Lost to Follow-up|1|||
170912583|NCT00545818|617683925|FG001|Overall Study|Lost to Follow-up|6|||
170912584|NCT02623361|617683928|FG000|Overall Study|Protocol Violation|0|||
170912585|NCT02623361|617683929|FG001|Overall Study|Protocol Violation|1|||
170912586|NCT02623361|617683928|FG000|Overall Study|Withdrawal by Subject|0|||
170912587|NCT02623361|617683929|FG001|Overall Study|Withdrawal by Subject|1|||
170912588|NCT02927171|617683932|FG000|Overall Study|Lost to Follow-up|0|||
170912589|NCT02927171|617683933|FG001|Overall Study|Lost to Follow-up|1|||
170912590|NCT04530825|617683934|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
170912591|NCT04530825|617683935|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
170912592|NCT04530825|617683936|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
170912593|NCT04530825|617683937|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
170912594|NCT04530825|617683934|FG000|Overall Study|Did not complete follow-up|3|||
170912595|NCT04530825|617683935|FG001|Overall Study|Did not complete follow-up|0|||
170912596|NCT04530825|617683936|FG002|Overall Study|Did not complete follow-up|0|||
170912597|NCT04530825|617683937|FG003|Overall Study|Did not complete follow-up|0|||
170912598|NCT04101422|617683938|FG000|Overall Study|Ineligible|1|||
170912599|NCT04101422|617683939|FG001|Overall Study|Ineligible|0|||
170912600|NCT04101422|617683940|FG002|Overall Study|Ineligible|9|||
170912601|NCT04101422|617683941|FG003|Overall Study|Ineligible|0|||
170912602|NCT04101422|617683938|FG000|Overall Study|Withdrawal by Subject|0|||
170912603|NCT04101422|617683939|FG001|Overall Study|Withdrawal by Subject|0|||
170912604|NCT04101422|617683940|FG002|Overall Study|Withdrawal by Subject|1|||
170912605|NCT04101422|617683941|FG003|Overall Study|Withdrawal by Subject|0|||
170912606|NCT04101422|617683938|FG000|Overall Study|Not attending to the stimuli|0|||
170912607|NCT04101422|617683939|FG001|Overall Study|Not attending to the stimuli|0|||
170912608|NCT04101422|617683940|FG002|Overall Study|Not attending to the stimuli|4|||
170912609|NCT04101422|617683941|FG003|Overall Study|Not attending to the stimuli|0|||
170912610|NCT04101422|617683938|FG000|Overall Study|Did not download app|0|||
170912611|NCT04101422|617683939|FG001|Overall Study|Did not download app|0|||
170912612|NCT04101422|617683940|FG002|Overall Study|Did not download app|0|||
170912613|NCT04101422|617683941|FG003|Overall Study|Did not download app|17|||
170912614|NCT04101422|617683938|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
170912615|NCT04101422|617683939|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
170912616|NCT04101422|617683940|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
170912617|NCT04101422|617683941|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
170912618|NCT00850499|617683942|FG000|Overall Study|Adverse Event|3|||
170912619|NCT00850499|617683943|FG001|Overall Study|Adverse Event|1|||
170912620|NCT00850499|617683942|FG000|Overall Study|Lack of Efficacy|0|||
170912621|NCT00850499|617683943|FG001|Overall Study|Lack of Efficacy|1|||
170912622|NCT01319929|617683946|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
170595065|NCT00624780|616522902|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
170595066|NCT00624780|616522903|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
170595067|NCT00624780|616522904|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
170912623|NCT01319929|617683947|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
170912624|NCT01319929|617683946|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
170912625|NCT01319929|617683947|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
170912626|NCT01319929|617683946|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
170912627|NCT01319929|617683947|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
170912628|NCT01319929|617683946|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
170912629|NCT01319929|617683947|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
170912630|NCT01319929|617683946|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
170912631|NCT01319929|617683947|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
170912632|NCT03237845|617683948|FG000|Overall Study|Adverse Event|0|||
170912633|NCT03237845|617683949|FG001|Overall Study|Adverse Event|1|||
170912634|NCT03237845|617683948|FG000|Overall Study|Lost to Follow-up|13|||
170912635|NCT03237845|617683949|FG001|Overall Study|Lost to Follow-up|10|||
170912636|NCT03237845|617683948|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
170912637|NCT03237845|617683949|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
170912638|NCT03237845|617683948|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
170912639|NCT03237845|617683949|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
170912640|NCT03237845|617683948|FG000|Overall Study|Physician Decision|1|||
170912641|NCT03237845|617683949|FG001|Overall Study|Physician Decision|2|||
170912642|NCT03237845|617683948|FG000|Overall Study|Pregnancy|1|||
170912643|NCT03237845|617683949|FG001|Overall Study|Pregnancy|0|||
170912644|NCT03237845|617683948|FG000|Overall Study|Protocol Deviation|0|||
170912645|NCT03237845|617683949|FG001|Overall Study|Protocol Deviation|1|||
170912646|NCT03237845|617683948|FG000|Overall Study|Technical Problems|8|||
170912647|NCT03237845|617683949|FG001|Overall Study|Technical Problems|1|||
170912648|NCT03237845|617683948|FG000|Overall Study|Withdrawal by Subject|3|||
170912649|NCT03237845|617683949|FG001|Overall Study|Withdrawal by Subject|3|||
170912650|NCT03237845|617683948|FG000|Overall Study|Other Reasons|4|||
170912651|NCT03237845|617683949|FG001|Overall Study|Other Reasons|0|||
170912652|NCT01749735|617683950|FG000|Overall Study|Withdrawal by Subject|1|||
170912653|NCT01749735|617683951|FG001|Overall Study|Withdrawal by Subject|0|||
170912654|NCT01221233|617683952|FG000|Overall Study|Withdrawal by Subject|3|||
170912655|NCT01221233|617683953|FG001|Overall Study|Withdrawal by Subject|1|||
170912656|NCT03865407|617683954|FG000|Overall Study|Adverse Event|1|||
170912657|NCT03865407|617683955|FG001|Overall Study|Adverse Event|0|||
170912658|NCT03865407|617683954|FG000|Overall Study|Withdrawal by Subject|1|||
170912659|NCT03865407|617683955|FG001|Overall Study|Withdrawal by Subject|0|||
170912660|NCT03865407|617683954|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
170912661|NCT03865407|617683955|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
170912662|NCT01645280|617683956|FG000|Overall Study|Death|0|||
170912663|NCT01645280|617683957|FG001|Overall Study|Death|1|||
170912664|NCT01645280|617683958|FG002|Overall Study|Death|0|||
170912665|NCT01645280|617683959|FG003|Overall Study|Death|0|||
170912666|NCT01645280|617683960|FG004|Overall Study|Death|0|||
170912667|NCT01645280|617683956|FG000|Overall Study|Withdrawal by Subject|4|||
170912668|NCT01645280|617683957|FG001|Overall Study|Withdrawal by Subject|0|||
170912669|NCT01645280|617683958|FG002|Overall Study|Withdrawal by Subject|2|||
170912670|NCT01645280|617683959|FG003|Overall Study|Withdrawal by Subject|4|||
170912671|NCT01645280|617683960|FG004|Overall Study|Withdrawal by Subject|5|||
170595068|NCT00624780|616522905|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
170595069|NCT00624780|616522900|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
170595070|NCT00624780|616522901|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
170595071|NCT00624780|616522902|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
170595072|NCT00624780|616522903|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
170595073|NCT00624780|616522904|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
170595074|NCT00624780|616522905|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
170595075|NCT00624780|616522900|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
170595076|NCT00624780|616522901|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
170595077|NCT00624780|616522902|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
170595078|NCT00624780|616522903|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
170595079|NCT00624780|616522904|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
170595080|NCT00624780|616522905|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
170595081|NCT00624780|616522900|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
170912672|NCT01645280|617683956|FG000|Overall Study|Lost to Follow-up|0|||
170912673|NCT01645280|617683957|FG001|Overall Study|Lost to Follow-up|0|||
170912674|NCT01645280|617683958|FG002|Overall Study|Lost to Follow-up|0|||
170912675|NCT01645280|617683959|FG003|Overall Study|Lost to Follow-up|2|||
170912676|NCT01645280|617683960|FG004|Overall Study|Lost to Follow-up|1|||
170912677|NCT01645280|617683956|FG000|Overall Study|Other|1|||
170912678|NCT01645280|617683957|FG001|Overall Study|Other|1|||
170811304|NCT01263496|617317569|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
170811305|NCT01263496|617317570|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
170811306|NCT01263496|617317571|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
170811307|NCT01263496|617317572|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
170811308|NCT01263496|617317573|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
170811309|NCT01263496|617317574|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
170811310|NCT01263496|617317575|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
170811311|NCT01263496|617317576|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
170811312|NCT01263496|617317577|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
170811313|NCT01263496|617317569|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170811314|NCT01263496|617317570|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170811315|NCT01263496|617317571|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170811316|NCT01263496|617317572|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170595082|NCT00624780|616522901|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
170595083|NCT00624780|616522902|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
170595084|NCT00624780|616522903|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
170595085|NCT00624780|616522904|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
170595086|NCT00624780|616522905|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
170595087|NCT00624780|616522900|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
170595088|NCT00624780|616522901|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
170595089|NCT00624780|616522902|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
170595090|NCT00624780|616522903|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
170595091|NCT00624780|616522904|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
170595092|NCT00624780|616522905|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
170595093|NCT00624780|616522900|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
170595094|NCT00624780|616522901|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
170595095|NCT00624780|616522902|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
170595096|NCT00624780|616522903|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
170595097|NCT00624780|616522904|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
170595098|NCT00624780|616522905|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
170595099|NCT00624780|616522900|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
170595100|NCT00624780|616522901|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
170595101|NCT00624780|616522902|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
170595102|NCT00624780|616522903|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
170595103|NCT00624780|616522904|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
170595104|NCT00624780|616522905|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
170595105|NCT00624780|616522900|FG000|Follow-up (Week 26)|Death|0|||
170595106|NCT00624780|616522901|FG001|Follow-up (Week 26)|Death|0|||
170595107|NCT00624780|616522902|FG002|Follow-up (Week 26)|Death|1|||
170595108|NCT00624780|616522903|FG003|Follow-up (Week 26)|Death|0|||
170595109|NCT00624780|616522904|FG004|Follow-up (Week 26)|Death|0|||
170595110|NCT00624780|616522905|FG005|Follow-up (Week 26)|Death|0|||
170595111|NCT00624780|616522900|FG000|Follow-up (Week 26)|Adverse Event|0|||
170595112|NCT00624780|616522901|FG001|Follow-up (Week 26)|Adverse Event|0|||
170595113|NCT00624780|616522902|FG002|Follow-up (Week 26)|Adverse Event|0|||
170595114|NCT00624780|616522903|FG003|Follow-up (Week 26)|Adverse Event|0|||
170595115|NCT00624780|616522904|FG004|Follow-up (Week 26)|Adverse Event|1|||
170595116|NCT00624780|616522905|FG005|Follow-up (Week 26)|Adverse Event|0|||
170595117|NCT00624780|616522900|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
170595118|NCT00624780|616522901|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
170595119|NCT00624780|616522902|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
170595120|NCT00624780|616522903|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
170595121|NCT00624780|616522904|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
170595122|NCT00624780|616522905|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
170595123|NCT00624780|616522900|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
170595124|NCT00624780|616522901|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
170595125|NCT00624780|616522902|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
170595126|NCT00624780|616522903|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
170595127|NCT00624780|616522904|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
170595128|NCT00624780|616522905|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
170595129|NCT00624780|616522900|FG000|Follow-up (Week 26)|Other|1|||
170595130|NCT00624780|616522901|FG001|Follow-up (Week 26)|Other|1|||
170595131|NCT00624780|616522902|FG002|Follow-up (Week 26)|Other|0|||
170595132|NCT00624780|616522903|FG003|Follow-up (Week 26)|Other|0|||
170595133|NCT00624780|616522904|FG004|Follow-up (Week 26)|Other|0|||
170595134|NCT00624780|616522905|FG005|Follow-up (Week 26)|Other|0|||
170595135|NCT00260065|616522906|FG000|Overall Study|Progressive Disease|22|||
170595136|NCT00260065|616522906|FG000|Overall Study|Adverse Event|17|||
170595137|NCT00260065|616522906|FG000|Overall Study|Death|13|||
170595138|NCT00260065|616522906|FG000|Overall Study|Withdrawal by Subject|13|||
170595139|NCT00260065|616522906|FG000|Overall Study|Physician Decision|19|||
170595140|NCT00260065|616522906|FG000|Overall Study|Not otherwise specified|8|||
170595141|NCT00260065|616522906|FG000|Overall Study|Medication Noncompliance|1|||
170912679|NCT01645280|617683958|FG002|Overall Study|Other|2|||
170912680|NCT01645280|617683959|FG003|Overall Study|Other|0|||
170912681|NCT01645280|617683960|FG004|Overall Study|Other|0|||
170912682|NCT01645280|617683956|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
170912683|NCT01645280|617683957|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
170912684|NCT01645280|617683958|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
170912685|NCT01645280|617683959|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
170912686|NCT01645280|617683960|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
170912687|NCT00611455|617683961|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
170912688|NCT00611455|617683962|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
170912689|NCT00611455|617683963|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170912690|NCT00611455|617683961|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
170912691|NCT00611455|617683962|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
170912692|NCT00611455|617683963|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
170912693|NCT00611455|617683961|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
170912694|NCT00611455|617683962|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
170912695|NCT00611455|617683963|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170912696|NCT00611455|617683961|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
170912697|NCT00611455|617683962|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
170912698|NCT00611455|617683963|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170912699|NCT00611455|617683961|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
170912700|NCT00611455|617683962|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
170912701|NCT00611455|617683963|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
170912702|NCT00611455|617683961|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
170912703|NCT00611455|617683962|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
170912704|NCT00611455|617683963|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
170912705|NCT00611455|617683961|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
170912706|NCT00611455|617683962|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
170912707|NCT00611455|617683963|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
170912708|NCT00611455|617683961|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
170912709|NCT00611455|617683962|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
170912710|NCT00611455|617683963|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
170912711|NCT00611455|617683961|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
170912712|NCT00611455|617683962|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
170912713|NCT00611455|617683963|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
170912714|NCT00611455|617683961|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
170912715|NCT00611455|617683962|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
170912716|NCT00611455|617683963|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
170912717|NCT00611455|617683961|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
170912718|NCT00611455|617683962|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
170912719|NCT00611455|617683963|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
170912720|NCT00611455|617683961|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
170912721|NCT00611455|617683962|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
170912722|NCT00611455|617683963|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
170912723|NCT00611455|617683961|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
170912724|NCT00611455|617683962|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
170912725|NCT00611455|617683963|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
170912726|NCT00611455|617683961|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
170912727|NCT00611455|617683962|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
170912728|NCT00611455|617683963|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
170912729|NCT00611455|617683961|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
170912730|NCT00611455|617683962|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
170912731|NCT00611455|617683963|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
170912732|NCT00611455|617683961|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
170912733|NCT00611455|617683962|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
170912734|NCT00611455|617683963|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
170912735|NCT00611455|617683961|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
170912736|NCT00611455|617683962|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
170595142|NCT04068519|616522907|FG000|Dose Verification|Death|15|||
170595143|NCT04068519|616522907|FG000|Dose Verification|Withdrawal by Subject|1|||
170912737|NCT00611455|617683963|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
170912738|NCT00611455|617683961|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
170595144|NCT04068519|616522907|FG000|Pharmacokinetic Sub-study|Death|35|||
170595145|NCT04068519|616522907|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
170595146|NCT04068519|616522907|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
170595147|NCT04068519|616522907|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
170595148|NCT04068519|616522907|FG000|Indication Expansion|Death|152|||
170650913|NCT05347147|616736300|FG000|Overall Study|Lost to Follow-up|0|||
170650914|NCT05347147|616736301|FG001|Overall Study|Lost to Follow-up|1|||
170650915|NCT05347147|616736300|FG000|Overall Study|Sponsor request|3|||
170650916|NCT05347147|616736301|FG001|Overall Study|Sponsor request|3|||
170650917|NCT05347147|616736300|FG000|Overall Study|Study termination|2|||
170650918|NCT05347147|616736301|FG001|Overall Study|Study termination|1|||
170650919|NCT02093351|616736302|FG000|Part A|Adverse Event|0|||
170650920|NCT02093351|616736303|FG001|Part A|Adverse Event|1|||
170650921|NCT02093351|616736304|FG002|Part A|Adverse Event|1|||
170650922|NCT02093351|616736305|FG003|Part A|Adverse Event|0|||
170912739|NCT00611455|617683962|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
170912740|NCT00611455|617683963|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
170912741|NCT00611455|617683961|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
170912742|NCT00611455|617683962|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
170912743|NCT00611455|617683963|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
170912744|NCT00611455|617683961|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
170912745|NCT00611455|617683962|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
170912746|NCT00611455|617683963|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
170912747|NCT00611455|617683961|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
170912748|NCT00611455|617683962|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
170912749|NCT00611455|617683963|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
170912750|NCT03849560|617683964|FG000|Overall Study|Withdrawal by Subject|1|||
170912751|NCT03849560|617683965|FG001|Overall Study|Withdrawal by Subject|0|||
170912752|NCT03849560|617683966|FG002|Overall Study|Withdrawal by Subject|0|||
170912753|NCT00553787|617683976|FG000|Overall Study|Adverse Event|34|||
170912754|NCT00553787|617683977|FG001|Overall Study|Adverse Event|21|||
170912755|NCT00553787|617683978|FG002|Overall Study|Adverse Event|67|||
170912756|NCT00553787|617683976|FG000|Overall Study|Lost to Follow-up|132|||
170912757|NCT00553787|617683977|FG001|Overall Study|Lost to Follow-up|44|||
170912758|NCT00553787|617683978|FG002|Overall Study|Lost to Follow-up|78|||
170912759|NCT00553787|617683976|FG000|Overall Study|Withdrawal by Subject|151|||
170912760|NCT00553787|617683977|FG001|Overall Study|Withdrawal by Subject|40|||
170912761|NCT00553787|617683978|FG002|Overall Study|Withdrawal by Subject|83|||
170912762|NCT00553787|617683976|FG000|Overall Study|Lack of Efficacy|31|||
170912763|NCT00553787|617683977|FG001|Overall Study|Lack of Efficacy|1|||
170912764|NCT00553787|617683978|FG002|Overall Study|Lack of Efficacy|3|||
170912765|NCT00553787|617683976|FG000|Overall Study|Pregnancy|0|||
170912766|NCT00553787|617683977|FG001|Overall Study|Pregnancy|1|||
170912767|NCT00553787|617683978|FG002|Overall Study|Pregnancy|2|||
170912768|NCT00553787|617683976|FG000|Overall Study|non compliance|4|||
170912769|NCT00553787|617683977|FG001|Overall Study|non compliance|0|||
170912770|NCT00553787|617683978|FG002|Overall Study|non compliance|11|||
170912771|NCT00553787|617683976|FG000|Overall Study|Requirement for restricted medication|8|||
170912772|NCT00553787|617683977|FG001|Overall Study|Requirement for restricted medication|7|||
170912773|NCT00553787|617683978|FG002|Overall Study|Requirement for restricted medication|5|||
170912774|NCT00553787|617683976|FG000|Overall Study|Other|18|||
170912775|NCT00553787|617683977|FG001|Overall Study|Other|10|||
170912776|NCT00553787|617683978|FG002|Overall Study|Other|13|||
170912777|NCT00301067|617683980|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
170912778|NCT00301067|617683981|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
170912779|NCT00301067|617683982|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
170912780|NCT00301067|617683983|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
170912781|NCT00301067|617683980|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
170912782|NCT00301067|617683981|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
170912783|NCT00301067|617683982|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
170912784|NCT00301067|617683983|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
170650923|NCT02093351|616736302|FG000|Part A|Condition under investigation worsened|2|||
170912785|NCT00301067|617683980|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
170912786|NCT00301067|617683981|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
170650924|NCT02093351|616736303|FG001|Part A|Condition under investigation worsened|0|||
170650925|NCT02093351|616736304|FG002|Part A|Condition under investigation worsened|2|||
170650926|NCT02093351|616736305|FG003|Part A|Condition under investigation worsened|0|||
170650927|NCT02093351|616736302|FG000|Part A|Death|0|||
170650928|NCT02093351|616736303|FG001|Part A|Death|1|||
170650929|NCT02093351|616736304|FG002|Part A|Death|0|||
170650930|NCT02093351|616736305|FG003|Part A|Death|0|||
170912787|NCT00301067|617683982|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
170912788|NCT00301067|617683983|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
170912789|NCT00301067|617683980|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
170595149|NCT04068519|616522907|FG000|Indication Expansion|Withdrawal by Subject|10|||
170595150|NCT04068519|616522907|FG000|Indication Expansion|Lost to Follow-up|7|||
170595151|NCT00358436|616524243|FG000|Overall Study|Adverse Event|29|||
170595152|NCT00358436|616524244|FG001|Overall Study|Adverse Event|13|||
170811317|NCT01263496|617317573|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170811318|NCT01263496|617317574|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170811319|NCT01263496|617317575|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170595153|NCT00358436|616524243|FG000|Overall Study|Lack of Efficacy|34|||
170595154|NCT00358436|616524244|FG001|Overall Study|Lack of Efficacy|36|||
170595155|NCT00358436|616524243|FG000|Overall Study|Lost to Follow-up|11|||
170595156|NCT00358436|616524244|FG001|Overall Study|Lost to Follow-up|6|||
170595157|NCT00358436|616524243|FG000|Overall Study|Protocol Violation|8|||
170595158|NCT00358436|616524244|FG001|Overall Study|Protocol Violation|3|||
170595159|NCT00358436|616524243|FG000|Overall Study|Withdrawal by Subject|40|||
170595160|NCT00358436|616524244|FG001|Overall Study|Withdrawal by Subject|17|||
170595161|NCT00358436|616524243|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
170595162|NCT00358436|616524244|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
170595163|NCT00358436|616524243|FG000|Overall Study|COPD exacerbation|22|||
170595164|NCT00358436|616524244|FG001|Overall Study|COPD exacerbation|10|||
170595165|NCT00358436|616524243|FG000|Overall Study|Other|6|||
170595166|NCT00358436|616524244|FG001|Overall Study|Other|1|||
170595167|NCT03938324|616524245|FG000|Overall Study|Lost to Follow-up|42|||
170595168|NCT03938324|616524246|FG001|Overall Study|Lost to Follow-up|21|||
170595169|NCT03938324|616524245|FG000|Overall Study|Withdrawal by Subject|6|||
170595170|NCT03938324|616524246|FG001|Overall Study|Withdrawal by Subject|1|||
170595171|NCT02769962|616524247|FG000|Overall Study|Physician Decision|0|||
170595172|NCT02769962|616524248|FG001|Overall Study|Physician Decision|0|||
170595173|NCT02769962|616524249|FG002|Overall Study|Physician Decision|0|||
170595174|NCT02769962|616524250|FG003|Overall Study|Physician Decision|0|||
170595175|NCT02769962|616524251|FG004|Overall Study|Physician Decision|0|||
170595176|NCT02769962|616524252|FG005|Overall Study|Physician Decision|1|||
170595177|NCT02769962|616524253|FG006|Overall Study|Physician Decision|0|||
170595178|NCT02769962|616524254|FG007|Overall Study|Physician Decision|1|||
170595179|NCT02769962|616524247|FG000|Overall Study|Refused further treatment|0|||
170595180|NCT02769962|616524248|FG001|Overall Study|Refused further treatment|0|||
170595181|NCT02769962|616524249|FG002|Overall Study|Refused further treatment|0|||
170595182|NCT02769962|616524250|FG003|Overall Study|Refused further treatment|0|||
170595183|NCT02769962|616524251|FG004|Overall Study|Refused further treatment|0|||
170595184|NCT02769962|616524252|FG005|Overall Study|Refused further treatment|1|||
170595185|NCT02769962|616524253|FG006|Overall Study|Refused further treatment|1|||
170595186|NCT02769962|616524254|FG007|Overall Study|Refused further treatment|0|||
170595187|NCT05565937|616524255|FG000|Overall Study|Adverse Event|0|||
170595188|NCT05565937|616524256|FG001|Overall Study|Adverse Event|1|||
170595189|NCT05565937|616524255|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
170650931|NCT02093351|616736302|FG000|Part B|Patient decision|0|||
170811320|NCT01263496|617317576|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
170811321|NCT01263496|617317577|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170811322|NCT01827839|617317578|FG000|Overall Study|Adverse Event|1|||
170811323|NCT01827839|617317578|FG000|Overall Study|Consent Withdrawal|2|||
170811324|NCT02241785|617317579|FG000|Overall Study|Sponsor Termination|43|||
170811325|NCT02241785|617317579|FG000|Overall Study|Withdrawal by Subject|1|||
170811326|NCT02241785|617317579|FG000|Overall Study|Lost to Follow-up|2|||
170811327|NCT02241785|617317579|FG000|Overall Study|Adverse Event|1|||
170811328|NCT03662659|617317580|FG000|Pre-treatment|Participant no longer met study criteria|1|||
170811329|NCT03662659|617317581|FG001|Pre-treatment|Participant no longer met study criteria|1|||
170811330|NCT03662659|617317580|FG000|Pre-treatment|Other reasons|1|||
170912790|NCT00301067|617683981|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
170595190|NCT05565937|616524256|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
170650932|NCT02093351|616736303|FG001|Part B|Patient decision|0|||
170811331|NCT03662659|617317581|FG001|Pre-treatment|Other reasons|0|||
170811332|NCT03662659|617317580|FG000|Treatment|Completed Treatment|0|||
170811333|NCT03662659|617317581|FG001|Treatment|Completed Treatment|2|||
170811334|NCT03662659|617317580|FG000|Treatment|Disease Progression|85|||
170811335|NCT03662659|617317581|FG001|Treatment|Disease Progression|97|||
170811336|NCT03662659|617317580|FG000|Treatment|Study Drug Toxicity|19|||
170912791|NCT00301067|617683982|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
170595191|NCT05565937|616524255|FG000|Overall Study|Lost to Follow-up|2|||
170595192|NCT05565937|616524256|FG001|Overall Study|Lost to Follow-up|0|||
170595193|NCT05565937|616524255|FG000|Overall Study|Pregnancy|0|||
170595194|NCT05565937|616524256|FG001|Overall Study|Pregnancy|2|||
170595195|NCT05565937|616524255|FG000|Overall Study|Anisometropia|0|||
170595196|NCT05565937|616524256|FG001|Overall Study|Anisometropia|1|||
170595197|NCT04544683|616524257|FG000|Overall Study|Lost to Follow-up|2|||
170595198|NCT04544683|616524257|FG000|Overall Study|Underwent cervical spine surgery|6|||
170650933|NCT02093351|616736304|FG002|Part B|Patient decision|0|||
170811337|NCT03662659|617317581|FG001|Treatment|Study Drug Toxicity|9|||
170811338|NCT03662659|617317580|FG000|Treatment|Death|11|||
170811339|NCT03662659|617317581|FG001|Treatment|Death|9|||
170811340|NCT03662659|617317580|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
170811341|NCT03662659|617317581|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
170811342|NCT03662659|617317580|FG000|Treatment|Withdrawal by Subject|1|||
170811343|NCT03662659|617317581|FG001|Treatment|Withdrawal by Subject|1|||
170811344|NCT03662659|617317580|FG000|Treatment|Poor/Non-compliance|1|||
170811345|NCT03662659|617317581|FG001|Treatment|Poor/Non-compliance|0|||
170811346|NCT03662659|617317580|FG000|Treatment|Participant no longer meets study criteria|1|||
170595199|NCT01073930|616524258|FG000|Overall Study|Withdrawal by Subject|3|||
170595200|NCT01073930|616524259|FG001|Overall Study|Withdrawal by Subject|2|||
170595201|NCT01073930|616524258|FG000|Overall Study|Lost to Follow-up|0|||
170595202|NCT01073930|616524259|FG001|Overall Study|Lost to Follow-up|1|||
170595203|NCT01073930|616524258|FG000|Overall Study|Adverse Event|0|||
170595204|NCT01073930|616524259|FG001|Overall Study|Adverse Event|1|||
170595205|NCT01073930|616524258|FG000|Overall Study|Noncompliance with study drug|0|||
170595206|NCT01073930|616524259|FG001|Overall Study|Noncompliance with study drug|1|||
170595207|NCT01073930|616524258|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
170595208|NCT01073930|616524259|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
170595209|NCT01266590|616524260|FG000|Overall Study|Adverse Event|3|||
170595210|NCT01266590|616524260|FG000|Overall Study|Lost to Follow-up|1|||
170595211|NCT01266590|616524260|FG000|Overall Study|Withdrawal by Subject|1|||
170811347|NCT03662659|617317581|FG001|Treatment|Participant no longer meets study criteria|0|||
170811348|NCT03662659|617317580|FG000|Treatment|Other reasons|10|||
170811349|NCT03662659|617317581|FG001|Treatment|Other reasons|8|||
170811350|NCT03662659|617317580|FG000|Treatment|Administrative reasons by sponsor|1|||
170811351|NCT03662659|617317581|FG001|Treatment|Administrative reasons by sponsor|0|||
170811352|NCT03662659|617317580|FG000|Treatment|maximum clinical benefit|0|||
170595212|NCT01266590|616524260|FG000|Overall Study|Physician Decision|1|||
170595213|NCT00511134|616524261|FG000|Overall Study|Withdrawal by Subject|0|||
170595214|NCT00511134|616524262|FG001|Overall Study|Withdrawal by Subject|2|||
170595215|NCT01949090|616524263|FG000|Overall Study|Serious Adverse Event|0|||
170595216|NCT01949090|616524264|FG001|Overall Study|Serious Adverse Event|1|||
170595217|NCT01949090|616524265|FG002|Overall Study|Serious Adverse Event|2|||
170595218|NCT01949090|616524266|FG003|Overall Study|Serious Adverse Event|0|||
170595219|NCT01949090|616524267|FG004|Overall Study|Serious Adverse Event|1|||
170595220|NCT01949090|616524263|FG000|Overall Study|Withdrawal by Subject|2|||
170595221|NCT01949090|616524264|FG001|Overall Study|Withdrawal by Subject|0|||
170595222|NCT01949090|616524265|FG002|Overall Study|Withdrawal by Subject|0|||
170595223|NCT01949090|616524266|FG003|Overall Study|Withdrawal by Subject|0|||
170595224|NCT01949090|616524267|FG004|Overall Study|Withdrawal by Subject|1|||
170595225|NCT01949090|616524263|FG000|Overall Study|Protocol non-compliance|0|||
170595226|NCT01949090|616524264|FG001|Overall Study|Protocol non-compliance|0|||
170595227|NCT01949090|616524265|FG002|Overall Study|Protocol non-compliance|0|||
170595228|NCT01949090|616524266|FG003|Overall Study|Protocol non-compliance|0|||
170595229|NCT01949090|616524267|FG004|Overall Study|Protocol non-compliance|1|||
170595230|NCT01949090|616524263|FG000|Overall Study|Lost to Follow-up|2|||
170595231|NCT01949090|616524264|FG001|Overall Study|Lost to Follow-up|1|||
170595232|NCT01949090|616524265|FG002|Overall Study|Lost to Follow-up|0|||
170595233|NCT01949090|616524266|FG003|Overall Study|Lost to Follow-up|1|||
170595234|NCT01949090|616524267|FG004|Overall Study|Lost to Follow-up|1|||
170595235|NCT00541346|616524268|FG000|Follow-up|Adverse Event|1|||
170595236|NCT02008773|616524271|FG000|Overall Study|Adverse Event|3|||
170595237|NCT02008773|616524272|FG001|Overall Study|Adverse Event|3|||
170595238|NCT02008773|616524273|FG002|Overall Study|Adverse Event|1|||
170595239|NCT02008773|616524274|FG003|Overall Study|Adverse Event|2|||
170595240|NCT02008773|616524271|FG000|Overall Study|Medication Non-compliance|2|||
170595241|NCT02008773|616524272|FG001|Overall Study|Medication Non-compliance|1|||
170811353|NCT03662659|617317581|FG001|Treatment|maximum clinical benefit|2|||
170595242|NCT02008773|616524273|FG002|Overall Study|Medication Non-compliance|3|||
170595243|NCT02008773|616524274|FG003|Overall Study|Medication Non-compliance|2|||
170595244|NCT02008773|616524271|FG000|Overall Study|Withdrawal by Subject|8|||
170811354|NCT00515112|617319247|FG000|Overall Study|Death|0|||
170811355|NCT00515112|617319248|FG001|Overall Study|Death|1|||
170811356|NCT00515112|617319247|FG000|Overall Study|The study was terminated|3|||
170595245|NCT02008773|616524272|FG001|Overall Study|Withdrawal by Subject|4|||
170595246|NCT02008773|616524273|FG002|Overall Study|Withdrawal by Subject|7|||
170811357|NCT00515112|617319248|FG001|Overall Study|The study was terminated|2|||
170811358|NCT01148017|617319253|FG000|Overall Study|Withdrawal by Subject|31|||
170595247|NCT02008773|616524274|FG003|Overall Study|Withdrawal by Subject|6|||
170595248|NCT02008773|616524271|FG000|Overall Study|Lost to Follow-up|0|||
170595249|NCT02008773|616524272|FG001|Overall Study|Lost to Follow-up|1|||
170811359|NCT01148017|617319254|FG001|Overall Study|Withdrawal by Subject|14|||
170811360|NCT01148017|617319255|FG002|Overall Study|Withdrawal by Subject|0|||
170595250|NCT02008773|616524273|FG002|Overall Study|Lost to Follow-up|3|||
170595251|NCT02008773|616524274|FG003|Overall Study|Lost to Follow-up|2|||
170595252|NCT02654236|616524277|FG000|Overall Study|Withdrawal by Subject|0|||
170595253|NCT02654236|616524278|FG001|Overall Study|Withdrawal by Subject|0|||
170595254|NCT02654236|616524279|FG002|Overall Study|Withdrawal by Subject|2|||
170595255|NCT02408523|616524280|FG000|Overall Study|Adverse Event|4|||
170595256|NCT02408523|616524281|FG001|Overall Study|Adverse Event|10|||
170595257|NCT02408523|616524280|FG000|Overall Study|Lack of Efficacy|0|||
170595258|NCT02408523|616524281|FG001|Overall Study|Lack of Efficacy|1|||
170595259|NCT02408523|616524280|FG000|Overall Study|Protocol Violation|1|||
170595260|NCT02408523|616524281|FG001|Overall Study|Protocol Violation|2|||
170595261|NCT02408523|616524280|FG000|Overall Study|Lost to Follow-up|2|||
170595262|NCT02408523|616524281|FG001|Overall Study|Lost to Follow-up|3|||
170595263|NCT02408523|616524280|FG000|Overall Study|Withdrawal by Subject|3|||
170595264|NCT02408523|616524281|FG001|Overall Study|Withdrawal by Subject|1|||
170595265|NCT02408523|616524280|FG000|Overall Study|Sponsor request|1|||
170595266|NCT02408523|616524281|FG001|Overall Study|Sponsor request|0|||
170595267|NCT02408523|616524280|FG000|Overall Study|Did not satisfy extension conditions|0|||
170595268|NCT02408523|616524281|FG001|Overall Study|Did not satisfy extension conditions|1|||
170595269|NCT01549873|616524282|FG000|Overall Study|Physician Decision|0|||
170595270|NCT01549873|616524283|FG001|Overall Study|Physician Decision|1|||
170595271|NCT02943915|616524284|FG000|Overall Study|Withdrawal by Subject|2|||
170595272|NCT02943915|616524285|FG001|Overall Study|Withdrawal by Subject|1|||
170595273|NCT02943915|616524286|FG002|Overall Study|Withdrawal by Subject|0|||
170595274|NCT02943915|616524287|FG003|Overall Study|Withdrawal by Subject|0|||
170595275|NCT02943915|616524284|FG000|Overall Study|Lost to Follow-up|3|||
170595276|NCT02943915|616524285|FG001|Overall Study|Lost to Follow-up|1|||
170595277|NCT02943915|616524286|FG002|Overall Study|Lost to Follow-up|0|||
170595278|NCT02943915|616524287|FG003|Overall Study|Lost to Follow-up|0|||
170595279|NCT02943915|616524284|FG000|Overall Study|excluded|0|||
170595280|NCT02943915|616524285|FG001|Overall Study|excluded|1|||
170595281|NCT02943915|616524286|FG002|Overall Study|excluded|0|||
170595282|NCT02943915|616524287|FG003|Overall Study|excluded|0|||
170595283|NCT03769311|616524288|FG000|Overall Study|Withdrawal by Subject|1|||
170595284|NCT04284813|616524294|FG000|Overall Study|Withdrawal by Subject|1|||
170595285|NCT02785458|616524295|FG000|1 Month|Withdrawal by Subject|2|||
170595286|NCT02785458|616524296|FG001|1 Month|Withdrawal by Subject|1|||
170595287|NCT02785458|616524295|FG000|1 Month|Lost to Follow-up|38|||
170595288|NCT02785458|616524296|FG001|1 Month|Lost to Follow-up|31|||
170811361|NCT01148017|617319256|FG003|Overall Study|Withdrawal by Subject|0|||
170811362|NCT01148017|617319253|FG000|Overall Study|Lost to Follow-up|23|||
170811363|NCT01148017|617319254|FG001|Overall Study|Lost to Follow-up|10|||
170811364|NCT01148017|617319255|FG002|Overall Study|Lost to Follow-up|0|||
170811365|NCT01148017|617319256|FG003|Overall Study|Lost to Follow-up|0|||
170811366|NCT01148017|617319253|FG000|Overall Study|Inappropriate enrollment|1|||
170811367|NCT01148017|617319254|FG001|Overall Study|Inappropriate enrollment|0|||
170811368|NCT01148017|617319255|FG002|Overall Study|Inappropriate enrollment|0|||
170811369|NCT01148017|617319256|FG003|Overall Study|Inappropriate enrollment|0|||
170811370|NCT01148017|617319253|FG000|Overall Study|Administrative reason|22|||
170811371|NCT01148017|617319254|FG001|Overall Study|Administrative reason|9|||
170811372|NCT01148017|617319255|FG002|Overall Study|Administrative reason|0|||
170811373|NCT01148017|617319256|FG003|Overall Study|Administrative reason|0|||
170811374|NCT01148017|617319253|FG000|Overall Study|Unable to classify|3|||
170811375|NCT01148017|617319254|FG001|Overall Study|Unable to classify|1|||
170811376|NCT01148017|617319255|FG002|Overall Study|Unable to classify|0|||
170811377|NCT01148017|617319256|FG003|Overall Study|Unable to classify|0|||
170811378|NCT02236611|617319257|FG000|Overall Study|Adverse Event|10|||
170811379|NCT02236611|617319258|FG001|Overall Study|Adverse Event|16|||
170811380|NCT02236611|617319257|FG000|Overall Study|Lack of Efficacy|4|||
170811381|NCT02236611|617319258|FG001|Overall Study|Lack of Efficacy|7|||
170811382|NCT02236611|617319257|FG000|Overall Study|Lost to Follow-up|0|||
170811383|NCT02236611|617319258|FG001|Overall Study|Lost to Follow-up|2|||
170811384|NCT02236611|617319257|FG000|Overall Study|Protocol deviation|3|||
170811385|NCT02236611|617319258|FG001|Overall Study|Protocol deviation|5|||
170811386|NCT02236611|617319257|FG000|Overall Study|Withdrew consent|9|||
170811387|NCT02236611|617319258|FG001|Overall Study|Withdrew consent|4|||
170811388|NCT00486954|617319259|FG000|Pilot Part|Adverse Event|4|||
170811389|NCT00486954|617319260|FG001|Pilot Part|Adverse Event|0|||
170811390|NCT00486954|617319261|FG002|Pilot Part|Adverse Event|5|||
170811391|NCT00486954|617319262|FG003|Pilot Part|Adverse Event|0|||
170811392|NCT00486954|617319263|FG004|Pilot Part|Adverse Event|0|||
170811393|NCT00486954|617319259|FG000|Pilot Part|Disease Progression|2|||
170811394|NCT00486954|617319260|FG001|Pilot Part|Disease Progression|0|||
170595289|NCT02785458|616524295|FG000|1 Month|Deemed Ineligible|1|||
170811395|NCT00486954|617319261|FG002|Pilot Part|Disease Progression|1|||
170811396|NCT00486954|617319262|FG003|Pilot Part|Disease Progression|0|||
170811397|NCT00486954|617319263|FG004|Pilot Part|Disease Progression|0|||
170595290|NCT02785458|616524296|FG001|1 Month|Deemed Ineligible|0|||
170595291|NCT02785458|616524295|FG000|1 Month|Completed Evaluation by Baseline|42|||
170595292|NCT02785458|616524296|FG001|1 Month|Completed Evaluation by Baseline|39|||
170595293|NCT02785458|616524295|FG000|1 Month|Partial Interview|0|||
170595294|NCT02785458|616524296|FG001|1 Month|Partial Interview|4|||
170811398|NCT00486954|617319259|FG000|Randomized Part|Lost to Follow-up|0|||
170595295|NCT02785458|616524295|FG000|3 Months|Withdrawal by Subject|3|||
170595296|NCT02785458|616524296|FG001|3 Months|Withdrawal by Subject|1|||
170595297|NCT02785458|616524295|FG000|3 Months|Lost to Follow-up|25|||
170595298|NCT02785458|616524296|FG001|3 Months|Lost to Follow-up|21|||
170595299|NCT02785458|616524295|FG000|3 Months|Completed Evaluation at 1 Month|100|||
170595300|NCT02785458|616524296|FG001|3 Months|Completed Evaluation at 1 Month|89|||
170595301|NCT00900146|616524297|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
170595302|NCT00900146|616524298|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
170595303|NCT00900146|616524299|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
170595304|NCT00900146|616524300|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
170595305|NCT00900146|616524301|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
170595306|NCT00900146|616524297|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
170595307|NCT00900146|616524298|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
170595308|NCT00900146|616524299|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
170595309|NCT00900146|616524300|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
170595310|NCT00900146|616524301|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
170595311|NCT00900146|616524297|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
170595312|NCT00900146|616524298|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
170595313|NCT00900146|616524299|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
170595314|NCT00900146|616524300|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
170595315|NCT00900146|616524301|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
170595316|NCT00900146|616524297|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
170595317|NCT00900146|616524298|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
170595318|NCT00900146|616524299|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
170595319|NCT00900146|616524300|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
170595320|NCT00900146|616524301|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
170595321|NCT00900146|616524297|FG000|Intermediate: Period III|Lost to Follow-up|2|||
170595322|NCT00900146|616524298|FG001|Intermediate: Period III|Lost to Follow-up|0|||
170595323|NCT00900146|616524299|FG002|Intermediate: Period III|Lost to Follow-up|0|||
170595324|NCT00900146|616524300|FG003|Intermediate: Period III|Lost to Follow-up|0|||
170595325|NCT00900146|616524301|FG004|Intermediate: Period III|Lost to Follow-up|1|||
170595326|NCT00900146|616524297|FG000|Intermediate: Period III|Administrative problems|85|||
170595327|NCT00900146|616524298|FG001|Intermediate: Period III|Administrative problems|92|||
170595328|NCT00900146|616524299|FG002|Intermediate: Period III|Administrative problems|84|||
170595329|NCT00900146|616524300|FG003|Intermediate: Period III|Administrative problems|90|||
170595330|NCT00900146|616524301|FG004|Intermediate: Period III|Administrative problems|163|||
170595331|NCT00610441|616524307|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
170595332|NCT00610441|616524308|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
170595333|NCT00610441|616524309|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
170595334|NCT00610441|616524310|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
170595335|NCT00610441|616524307|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
170595336|NCT00610441|616524308|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
170595337|NCT00610441|616524309|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
170595338|NCT00610441|616524310|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
170595339|NCT00610441|616524307|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
170595340|NCT00610441|616524308|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
170595341|NCT00610441|616524309|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
170595342|NCT00610441|616524310|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
170595343|NCT00610441|616524307|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
170595344|NCT00610441|616524308|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
170595345|NCT00610441|616524309|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
170595346|NCT00610441|616524310|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
170595347|NCT00610441|616524307|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
170595348|NCT00610441|616524308|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
170595349|NCT00610441|616524309|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
170595350|NCT00610441|616524310|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
170595351|NCT00610441|616524307|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
170595352|NCT00610441|616524308|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
170595353|NCT00610441|616524309|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
170595354|NCT00610441|616524310|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
170595355|NCT00610441|616524307|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
170595356|NCT00610441|616524308|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
170595357|NCT00610441|616524309|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
170595358|NCT00610441|616524310|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
170595359|NCT00610441|616524307|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
170595360|NCT00610441|616524308|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
170595361|NCT00610441|616524309|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
170595362|NCT00610441|616524310|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
170595363|NCT00610441|616524307|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
170595364|NCT00610441|616524308|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
170595365|NCT00610441|616524309|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
170595366|NCT00610441|616524310|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
170595367|NCT02966795|616524315|FG000|Overall Study|Patient Left the Country|0|||
170595368|NCT02966795|616524316|FG001|Overall Study|Patient Left the Country|1|||
170595369|NCT01945775|616524318|FG000|Overall Study|Death|214|||
170595370|NCT01945775|616524319|FG001|Overall Study|Death|98|||
170595371|NCT01945775|616524318|FG000|Overall Study|Lost to Follow-up|12|||
170595372|NCT01945775|616524319|FG001|Overall Study|Lost to Follow-up|7|||
170595373|NCT01945775|616524318|FG000|Overall Study|Withdrawal by Subject|11|||
170811399|NCT00486954|617319260|FG001|Randomized Part|Lost to Follow-up|0|||
170595374|NCT01945775|616524319|FG001|Overall Study|Withdrawal by Subject|21|||
170595375|NCT01945775|616524318|FG000|Overall Study|Other|50|||
170595376|NCT01945775|616524319|FG001|Overall Study|Other|18|||
170595377|NCT01886690|616524320|FG000|Overall Study|Protocol Violation|0|||
170595378|NCT01886690|616524321|FG001|Overall Study|Protocol Violation|1|||
170595379|NCT01886690|616524320|FG000|Overall Study|Personal Reasons|0|||
170595380|NCT01886690|616524321|FG001|Overall Study|Personal Reasons|1|||
170595381|NCT03461406|616524322|FG000|Overall Study|Death|1|||
170811400|NCT00486954|617319261|FG002|Randomized Part|Lost to Follow-up|0|||
170811401|NCT00486954|617319262|FG003|Randomized Part|Lost to Follow-up|0|||
170811402|NCT00486954|617319263|FG004|Randomized Part|Lost to Follow-up|1|||
170811403|NCT00486954|617319259|FG000|Randomized Part|Withdrawal by Subject|0|||
170811404|NCT00486954|617319260|FG001|Randomized Part|Withdrawal by Subject|0|||
170811405|NCT00486954|617319261|FG002|Randomized Part|Withdrawal by Subject|0|||
170811406|NCT00486954|617319262|FG003|Randomized Part|Withdrawal by Subject|1|||
170811407|NCT00486954|617319263|FG004|Randomized Part|Withdrawal by Subject|0|||
170811408|NCT00486954|617319259|FG000|Randomized Part|Sponsor Terminated Study|0|||
170811409|NCT00486954|617319260|FG001|Randomized Part|Sponsor Terminated Study|0|||
170811410|NCT00486954|617319261|FG002|Randomized Part|Sponsor Terminated Study|0|||
170811411|NCT00486954|617319262|FG003|Randomized Part|Sponsor Terminated Study|19|||
170811412|NCT00486954|617319263|FG004|Randomized Part|Sponsor Terminated Study|13|||
170811413|NCT03236779|617319264|FG000|Overall Study|Lost to Follow-up|13|||
170811414|NCT03236779|617319265|FG001|Overall Study|Lost to Follow-up|21|||
170811415|NCT00929526|617319266|FG000|Overall Study|Withdrawal by Subject|1|||
170811416|NCT00929526|617319267|FG001|Overall Study|Withdrawal by Subject|11|||
170811417|NCT00929526|617319266|FG000|Overall Study|Lost to Follow-up|8|||
170811418|NCT00929526|617319267|FG001|Overall Study|Lost to Follow-up|12|||
170811419|NCT00929526|617319266|FG000|Overall Study|Other|8|||
170811420|NCT00929526|617319267|FG001|Overall Study|Other|6|||
170811421|NCT00578344|617319268|FG000|Overall Study|Insurance problems|1|||
170811422|NCT00578344|617319268|FG000|Overall Study|Graft failure|1|||
170811423|NCT02169414|617319269|FG000|Overall Study|Withdrawal by Subject|1|||
170811424|NCT02169414|617319270|FG001|Overall Study|Withdrawal by Subject|0|||
170811425|NCT02169414|617319271|FG002|Overall Study|Withdrawal by Subject|0|||
170811426|NCT02169414|617319272|FG003|Overall Study|Withdrawal by Subject|0|||
170811427|NCT02169414|617319269|FG000|Overall Study|Adverse Event|0|||
170811428|NCT02169414|617319270|FG001|Overall Study|Adverse Event|1|||
170811429|NCT02169414|617319271|FG002|Overall Study|Adverse Event|0|||
170811430|NCT02169414|617319272|FG003|Overall Study|Adverse Event|0|||
170811431|NCT03374254|617319275|FG000|Overall Study|Death|5|||
170811432|NCT03374254|617319276|FG001|Overall Study|Death|16|||
170811433|NCT03374254|617319277|FG002|Overall Study|Death|13|||
170811434|NCT03374254|617319278|FG003|Overall Study|Death|11|||
170811435|NCT03374254|617319279|FG004|Overall Study|Death|9|||
170811436|NCT03374254|617319280|FG005|Overall Study|Death|12|||
170811437|NCT03374254|617319281|FG006|Overall Study|Death|11|||
170811438|NCT03374254|617319282|FG007|Overall Study|Death|6|||
170811439|NCT03374254|617319283|FG008|Overall Study|Death|7|||
170811440|NCT03374254|617319275|FG000|Overall Study|Lost to Follow-up|0|||
170811441|NCT03374254|617319276|FG001|Overall Study|Lost to Follow-up|0|||
170811442|NCT03374254|617319277|FG002|Overall Study|Lost to Follow-up|0|||
170811443|NCT03374254|617319278|FG003|Overall Study|Lost to Follow-up|0|||
170811444|NCT03374254|617319279|FG004|Overall Study|Lost to Follow-up|0|||
170811445|NCT03374254|617319280|FG005|Overall Study|Lost to Follow-up|0|||
170811446|NCT03374254|617319281|FG006|Overall Study|Lost to Follow-up|2|||
170811447|NCT03374254|617319282|FG007|Overall Study|Lost to Follow-up|0|||
170811448|NCT03374254|617319283|FG008|Overall Study|Lost to Follow-up|0|||
170811449|NCT03374254|617319275|FG000|Overall Study|Sponsor Decision|1|||
170811450|NCT03374254|617319276|FG001|Overall Study|Sponsor Decision|0|||
170811451|NCT03374254|617319277|FG002|Overall Study|Sponsor Decision|2|||
170595382|NCT03461406|616524323|FG001|Overall Study|Death|2|||
170595383|NCT03461406|616524322|FG000|Overall Study|Consent Withdrawn by Participant|0|||
170811452|NCT03374254|617319278|FG003|Overall Study|Sponsor Decision|3|||
170811453|NCT03374254|617319279|FG004|Overall Study|Sponsor Decision|2|||
170811454|NCT03374254|617319280|FG005|Overall Study|Sponsor Decision|3|||
170595384|NCT03461406|616524323|FG001|Overall Study|Consent Withdrawn by Participant|1|||
170811455|NCT03374254|617319281|FG006|Overall Study|Sponsor Decision|3|||
170811456|NCT03374254|617319282|FG007|Overall Study|Sponsor Decision|3|||
170811457|NCT03374254|617319283|FG008|Overall Study|Sponsor Decision|4|||
170811458|NCT03374254|617319275|FG000|Overall Study|Withdrawal by Subject|0|||
170811459|NCT03374254|617319276|FG001|Overall Study|Withdrawal by Subject|0|||
170595385|NCT03461406|616524322|FG000|Overall Study|Screen Failure|3|||
170595386|NCT03461406|616524323|FG001|Overall Study|Screen Failure|1|||
170595387|NCT03461406|616524322|FG000|Overall Study|Reason not Specified|1|||
170595388|NCT03461406|616524323|FG001|Overall Study|Reason not Specified|3|||
170595389|NCT03461406|616524322|FG000|Overall Study|Lost to Follow-up|3|||
170595390|NCT03461406|616524323|FG001|Overall Study|Lost to Follow-up|0|||
170595391|NCT03077698|616524324|FG000|Progestin Monotherapy|Stable Disease|8|||
170595392|NCT03077698|616524325|FG001|Progestin Monotherapy|Stable Disease|0|||
170595393|NCT03077698|616524324|FG000|Progestin Monotherapy|Adverse Event|1|||
170595394|NCT03077698|616524325|FG001|Progestin Monotherapy|Adverse Event|0|||
170595395|NCT03077698|616524324|FG000|Progestin Monotherapy|Death|1|||
170595396|NCT03077698|616524325|FG001|Progestin Monotherapy|Death|0|||
170595397|NCT03077698|616524324|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
170595398|NCT03077698|616524325|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
170595399|NCT03077698|616524324|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
170595400|NCT03077698|616524325|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
170595401|NCT03077698|616524324|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
170595402|NCT03077698|616524325|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
170595403|NCT03077698|616524324|FG000|Safety Follow Up|Withdrawal by Subject|2|||
170595404|NCT03077698|616524325|FG001|Safety Follow Up|Withdrawal by Subject|1|||
170595405|NCT03077698|616524324|FG000|Safety Follow Up|Transfer of care to hospice|1|||
170595406|NCT03077698|616524325|FG001|Safety Follow Up|Transfer of care to hospice|0|||
170595407|NCT01439074|616524327|FG000|Overall Study|Lost to Follow-up|3|||
170595408|NCT01439074|616524328|FG001|Overall Study|Lost to Follow-up|4|||
170595409|NCT01439074|616524327|FG000|Overall Study|Subject shedding|1|||
170595410|NCT01439074|616524328|FG001|Overall Study|Subject shedding|0|||
170595411|NCT01439074|616524327|FG000|Overall Study|Withdrawal by Subject|1|||
170595412|NCT01439074|616524328|FG001|Overall Study|Withdrawal by Subject|5|||
170595413|NCT01439074|616524327|FG000|Overall Study|Other|4|||
170595414|NCT01439074|616524328|FG001|Overall Study|Other|4|||
170595415|NCT01140568|616524329|FG000|Overall Study|disease progression|31|||
170595416|NCT01140568|616524329|FG000|Overall Study|Withdrawal by Subject|1|||
170595417|NCT01140568|616524329|FG000|Overall Study|Screen Fail|4|||
170595418|NCT03618628|616524330|FG000|Overall Study|Death|1|||
170595419|NCT03618628|616524330|FG000|Overall Study|Lost to Follow-up|1|||
170595420|NCT01969500|616524331|FG000|Overall Study|Death|0|||
170595421|NCT01969500|616524332|FG001|Overall Study|Death|1|||
170595422|NCT01969500|616524331|FG000|Overall Study|extended hospitalization|1|||
170595423|NCT01969500|616524332|FG001|Overall Study|extended hospitalization|1|||
170595424|NCT02193087|616524333|FG000|Overall Study|Adverse Event|2|||
170595425|NCT02193087|616524334|FG001|Overall Study|Adverse Event|0|||
170595426|NCT02193087|616524335|FG002|Overall Study|Adverse Event|0|||
170595427|NCT02193087|616524336|FG003|Overall Study|Adverse Event|11|||
170595428|NCT02193087|616524333|FG000|Overall Study|Lost to Follow-up|14|||
170595429|NCT02193087|616524334|FG001|Overall Study|Lost to Follow-up|6|||
170595430|NCT02193087|616524335|FG002|Overall Study|Lost to Follow-up|4|||
170595431|NCT02193087|616524336|FG003|Overall Study|Lost to Follow-up|37|||
170595432|NCT02193087|616524333|FG000|Overall Study|Protocol Violation|2|||
170595433|NCT02193087|616524334|FG001|Overall Study|Protocol Violation|0|||
170595434|NCT02193087|616524335|FG002|Overall Study|Protocol Violation|1|||
170595435|NCT02193087|616524336|FG003|Overall Study|Protocol Violation|2|||
170595436|NCT02193087|616524333|FG000|Overall Study|Withdrawal by Subject|10|||
170595437|NCT02193087|616524334|FG001|Overall Study|Withdrawal by Subject|3|||
170595438|NCT02193087|616524335|FG002|Overall Study|Withdrawal by Subject|1|||
170595439|NCT02193087|616524336|FG003|Overall Study|Withdrawal by Subject|19|||
170595440|NCT02193087|616524333|FG000|Overall Study|Other Reason Not Specified|7|||
170595441|NCT02193087|616524334|FG001|Overall Study|Other Reason Not Specified|2|||
170595442|NCT02193087|616524335|FG002|Overall Study|Other Reason Not Specified|1|||
170595443|NCT02193087|616524336|FG003|Overall Study|Other Reason Not Specified|9|||
170595444|NCT02193087|616524333|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
170595445|NCT02193087|616524334|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
170650934|NCT02093351|616736305|FG003|Part B|Patient decision|3|||
170595446|NCT02193087|616524335|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
170595447|NCT02193087|616524336|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
170595448|NCT04096820|616524337|FG000|Overall Study|Did not return for intervention|2|||
170650935|NCT02093351|616736302|FG000|Part B|Disease progression|0|||
170811460|NCT03374254|617319277|FG002|Overall Study|Withdrawal by Subject|0|||
170595449|NCT04096820|616524337|FG000|Overall Study|Death|1|||
170650936|NCT02093351|616736303|FG001|Part B|Disease progression|0|||
170650937|NCT02093351|616736304|FG002|Part B|Disease progression|0|||
170811461|NCT03374254|617319278|FG003|Overall Study|Withdrawal by Subject|2|||
170595450|NCT02463032|616524338|FG000|Overall Study|Lack of Efficacy|61|||
170595451|NCT02463032|616524339|FG001|Overall Study|Lack of Efficacy|50|||
170595452|NCT02463032|616524338|FG000|Overall Study|Death|8|||
170595453|NCT02463032|616524339|FG001|Overall Study|Death|8|||
170595454|NCT02463032|616524338|FG000|Overall Study|Adverse Event|2|||
170595455|NCT02463032|616524339|FG001|Overall Study|Adverse Event|6|||
170595456|NCT04941807|616524340|FG000|Overall Study|Lost to Follow-up|1|||
170595457|NCT04941807|616524341|FG001|Overall Study|Lost to Follow-up|1|||
170595458|NCT01100567|616524342|FG000|Overall Study|Withdrawal by Subject|5|||
170595459|NCT01100567|616524343|FG001|Overall Study|Withdrawal by Subject|8|||
170595460|NCT01100567|616524342|FG000|Overall Study|Early Hospital Discharge|6|||
170595461|NCT01100567|616524343|FG001|Overall Study|Early Hospital Discharge|4|||
170595462|NCT01100567|616524342|FG000|Overall Study|Lost to Follow-up|1|||
170595463|NCT01100567|616524343|FG001|Overall Study|Lost to Follow-up|2|||
170595464|NCT01100567|616524342|FG000|Overall Study|Physician Decision|0|||
170595465|NCT01100567|616524343|FG001|Overall Study|Physician Decision|1|||
170595466|NCT01100567|616524342|FG000|Overall Study|Deemed ineligible after consent|0|||
170595467|NCT01100567|616524343|FG001|Overall Study|Deemed ineligible after consent|1|||
170595468|NCT00946322|616524346|FG000|Pre-treatment|participant failure to follow up|1|||
170595469|NCT00946322|616524346|FG000|Post-treatment|participant failure to follow up|2|||
170595470|NCT03697993|616524351|FG000|Overall Study|Became Ineligible after Enrollment|1|||
170595471|NCT03697993|616524352|FG001|Overall Study|Became Ineligible after Enrollment|3|||
170595472|NCT03697993|616524351|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
170595473|NCT03697993|616524352|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
170595474|NCT03697993|616524351|FG000|Overall Study|Lost to Follow-up|3|||
170595475|NCT03697993|616524352|FG001|Overall Study|Lost to Follow-up|0|||
170595476|NCT03697993|616524351|FG000|Overall Study|Physician Decision|4|||
170595477|NCT03697993|616524352|FG001|Overall Study|Physician Decision|0|||
170595478|NCT03697993|616524351|FG000|Overall Study|Initial Urine Culture Negative|0|||
170595479|NCT03697993|616524352|FG001|Overall Study|Initial Urine Culture Negative|1|||
170595480|NCT04384107|616524353|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
170595481|NCT04384107|616524354|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
170595482|NCT04384107|616524353|FG000|Overall Study|Lost to Follow-up|1|||
170595483|NCT04384107|616524354|FG001|Overall Study|Lost to Follow-up|0|||
170595484|NCT01591863|616524355|FG000|Overall Study|Adverse Event|3|||
170595485|NCT01591863|616524355|FG000|Overall Study|Withdrawal by Subject|1|||
170595486|NCT01591863|616524355|FG000|Overall Study|recurrence|9|||
170595487|NCT01591863|616524355|FG000|Overall Study|Lack of Efficacy|1|||
170595488|NCT01751776|616524356|FG000|Overall Study|Adverse Event|0|||
170595489|NCT01751776|616524357|FG001|Overall Study|Adverse Event|0|||
170595490|NCT01751776|616524358|FG002|Overall Study|Adverse Event|0|||
170595491|NCT01751776|616524359|FG003|Overall Study|Adverse Event|0|||
170595492|NCT01751776|616524360|FG004|Overall Study|Adverse Event|0|||
170595493|NCT01751776|616524361|FG005|Overall Study|Adverse Event|0|||
170595494|NCT01751776|616524362|FG006|Overall Study|Adverse Event|4|||
170595495|NCT01751776|616524363|FG007|Overall Study|Adverse Event|2|||
170595496|NCT01751776|616524356|FG000|Overall Study|Consent withdrawn|0|||
170595497|NCT01751776|616524357|FG001|Overall Study|Consent withdrawn|0|||
170595498|NCT01751776|616524358|FG002|Overall Study|Consent withdrawn|0|||
170595499|NCT01751776|616524359|FG003|Overall Study|Consent withdrawn|0|||
170595500|NCT01751776|616524360|FG004|Overall Study|Consent withdrawn|0|||
170595501|NCT01751776|616524361|FG005|Overall Study|Consent withdrawn|0|||
170595502|NCT01751776|616524362|FG006|Overall Study|Consent withdrawn|0|||
170595503|NCT01751776|616524363|FG007|Overall Study|Consent withdrawn|1|||
170595504|NCT01751776|616524356|FG000|Overall Study|Other reason not specified above|0|||
170595505|NCT01751776|616524357|FG001|Overall Study|Other reason not specified above|0|||
170595506|NCT01751776|616524358|FG002|Overall Study|Other reason not specified above|0|||
170595507|NCT01751776|616524359|FG003|Overall Study|Other reason not specified above|0|||
170595508|NCT01751776|616524360|FG004|Overall Study|Other reason not specified above|0|||
170595509|NCT01751776|616524361|FG005|Overall Study|Other reason not specified above|0|||
170595510|NCT01751776|616524362|FG006|Overall Study|Other reason not specified above|0|||
170595511|NCT01751776|616524363|FG007|Overall Study|Other reason not specified above|1|||
170650938|NCT02093351|616736305|FG003|Part B|Disease progression|4|||
170650939|NCT02093351|616736302|FG000|Part B|Complete response|0|||
170595512|NCT02739321|616524367|FG000|Overall Study|Lack of Efficacy|1|||
170595513|NCT02739321|616524368|FG001|Overall Study|Lack of Efficacy|1|||
170595514|NCT02739321|616524367|FG000|Overall Study|Lost to Follow-up|1|||
170595515|NCT02739321|616524368|FG001|Overall Study|Lost to Follow-up|1|||
170595516|NCT02739321|616524367|FG000|Overall Study|Withdrawal by Subject|1|||
170595517|NCT02739321|616524368|FG001|Overall Study|Withdrawal by Subject|2|||
170595518|NCT01711866|616524369|FG000|Overall Study|Noncompliant|3|||
170595519|NCT01711866|616524369|FG000|Overall Study|Withdrawal by Subject|3|||
170595520|NCT01711866|616524369|FG000|Overall Study|Adverse Event|2|||
170650940|NCT02093351|616736303|FG001|Part B|Complete response|0|||
170595521|NCT02558400|616524370|FG000|Overall Study|Adverse Event|47|||
170595522|NCT02558400|616524371|FG001|Overall Study|Adverse Event|53|||
170595523|NCT02558400|616524372|FG002|Overall Study|Adverse Event|4|||
170595524|NCT02558400|616524370|FG000|Overall Study|Withdrawal by Subject|13|||
170595525|NCT02558400|616524371|FG001|Overall Study|Withdrawal by Subject|9|||
170595526|NCT02558400|616524372|FG002|Overall Study|Withdrawal by Subject|8|||
170595527|NCT02558400|616524370|FG000|Overall Study|Non-Compliant|0|||
170595528|NCT02558400|616524371|FG001|Overall Study|Non-Compliant|1|||
170595529|NCT02558400|616524372|FG002|Overall Study|Non-Compliant|3|||
170595530|NCT02558400|616524370|FG000|Overall Study|Lost to Follow-up|5|||
170595531|NCT02558400|616524371|FG001|Overall Study|Lost to Follow-up|5|||
170595532|NCT02558400|616524372|FG002|Overall Study|Lost to Follow-up|4|||
170595533|NCT02558400|616524370|FG000|Overall Study|Lack of Efficacy|0|||
170595534|NCT02558400|616524371|FG001|Overall Study|Lack of Efficacy|13|||
170595535|NCT02558400|616524372|FG002|Overall Study|Lack of Efficacy|1|||
170595536|NCT02558400|616524370|FG000|Overall Study|Disallowed Concurrent Medication|6|||
170595537|NCT02558400|616524371|FG001|Overall Study|Disallowed Concurrent Medication|7|||
170595538|NCT02558400|616524372|FG002|Overall Study|Disallowed Concurrent Medication|5|||
170595539|NCT02558400|616524370|FG000|Overall Study|Physician Decision|2|||
170595540|NCT02558400|616524371|FG001|Overall Study|Physician Decision|2|||
170595541|NCT02558400|616524372|FG002|Overall Study|Physician Decision|0|||
170595542|NCT02558400|616524370|FG000|Overall Study|Protocol Violation|6|||
170595543|NCT02558400|616524371|FG001|Overall Study|Protocol Violation|3|||
170595544|NCT02558400|616524372|FG002|Overall Study|Protocol Violation|8|||
170595545|NCT02558400|616524370|FG000|Overall Study|Death|0|||
170595546|NCT02558400|616524371|FG001|Overall Study|Death|1|||
170595547|NCT02558400|616524372|FG002|Overall Study|Death|0|||
170595548|NCT02558400|616524370|FG000|Overall Study|Ineligible for the study|0|||
170595549|NCT02558400|616524371|FG001|Overall Study|Ineligible for the study|2|||
170595550|NCT02558400|616524372|FG002|Overall Study|Ineligible for the study|0|||
170595551|NCT00459537|616524373|FG000|Overall Study|Adverse Event|1|||
170595552|NCT00459537|616524374|FG001|Overall Study|Adverse Event|6|||
170595553|NCT00459537|616524373|FG000|Overall Study|Lack of Efficacy|10|||
170595554|NCT00459537|616524374|FG001|Overall Study|Lack of Efficacy|11|||
170595555|NCT00459537|616524373|FG000|Overall Study|Withdrawal by Subject|20|||
170595556|NCT00459537|616524374|FG001|Overall Study|Withdrawal by Subject|26|||
170595557|NCT00459537|616524373|FG000|Overall Study|Lost to Follow-up|27|||
170595558|NCT00459537|616524374|FG001|Overall Study|Lost to Follow-up|30|||
170595559|NCT00459537|616524373|FG000|Overall Study|Administrative problems|3|||
170595560|NCT00459537|616524374|FG001|Overall Study|Administrative problems|0|||
170595561|NCT00459537|616524373|FG000|Overall Study|Protocol Violation|4|||
170912792|NCT00301067|617683983|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
170912793|NCT00301067|617683980|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
170912794|NCT00301067|617683981|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
170912795|NCT00301067|617683982|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
170912796|NCT00301067|617683983|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
170912797|NCT00301067|617683980|FG000|Follow up Until Death|Alive at last data cut point|1|||
170912798|NCT00301067|617683981|FG001|Follow up Until Death|Alive at last data cut point|0|||
170912799|NCT00301067|617683982|FG002|Follow up Until Death|Alive at last data cut point|0|||
170912800|NCT00301067|617683983|FG003|Follow up Until Death|Alive at last data cut point|1|||
170912801|NCT05897853|617683984|FG000|Overall Study|Lost to Follow-up|2|||
170912802|NCT05897853|617683985|FG001|Overall Study|Lost to Follow-up|0|||
170912803|NCT05897853|617683984|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
170912804|NCT05897853|617683985|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
170912805|NCT01450137|617683986|FG000|Up to Week 12|Adverse Event|2|||
170912806|NCT01450137|617683987|FG001|Up to Week 12|Adverse Event|1|||
170912807|NCT01450137|617683986|FG000|Up to Week 12|Withdrawal by Subject|0|||
170912808|NCT01450137|617683987|FG001|Up to Week 12|Withdrawal by Subject|2|||
170912809|NCT01450137|617683986|FG000|Week 12 to Study End|Death|0|||
170595562|NCT00459537|616524374|FG001|Overall Study|Protocol Violation|3|||
170595563|NCT00459537|616524373|FG000|Overall Study|Missing|1|||
170595564|NCT00459537|616524374|FG001|Overall Study|Missing|0|||
170595565|NCT03172130|616525905|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
170595566|NCT03172130|616525906|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
170595567|NCT01825941|616525907|FG000|Overall Study|Lost to Follow-up|4|||
170595568|NCT01825941|616525908|FG001|Overall Study|Lost to Follow-up|1|||
170595569|NCT02831933|616525909|FG000|Overall Study|Physician Decision|11|||
170595570|NCT05065190|616525914|FG000|Overall Study|Other than listed|2|||
170595571|NCT05065190|616525915|FG001|Overall Study|Other than listed|12|||
170595572|NCT05065190|616525914|FG000|Overall Study|Lack of Efficacy|4|||
170595573|NCT05065190|616525915|FG001|Overall Study|Lack of Efficacy|0|||
170595574|NCT05065190|616525914|FG000|Overall Study|Adverse Event|1|||
170595575|NCT05065190|616525915|FG001|Overall Study|Adverse Event|10|||
170595576|NCT04732949|616525923|FG000|Overall Study|Withdrawal by Subject|23|||
170595577|NCT04732949|616525924|FG001|Overall Study|Withdrawal by Subject|27|||
170595578|NCT04732949|616525923|FG000|Overall Study|Protocol Violation|0|||
170595579|NCT04732949|616525924|FG001|Overall Study|Protocol Violation|1|||
170595580|NCT04732949|616525923|FG000|Overall Study|Non-compliance|0|||
170595581|NCT04732949|616525924|FG001|Overall Study|Non-compliance|2|||
170595582|NCT04732949|616525923|FG000|Overall Study|Physician Decision|2|||
170595583|NCT04732949|616525924|FG001|Overall Study|Physician Decision|1|||
170595584|NCT04732949|616525923|FG000|Overall Study|Serious adverse event (Fatal)|16|||
170595585|NCT04732949|616525924|FG001|Overall Study|Serious adverse event (Fatal)|18|||
170595586|NCT04732949|616525923|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
170595587|NCT04732949|616525924|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
170595588|NCT04732949|616525923|FG000|Overall Study|Non-serious adverse event|1|||
170595589|NCT04732949|616525924|FG001|Overall Study|Non-serious adverse event|3|||
170595590|NCT04732949|616525923|FG000|Overall Study|Lost to Follow-up|26|||
170595591|NCT04732949|616525924|FG001|Overall Study|Lost to Follow-up|27|||
170595592|NCT04732949|616525923|FG000|Overall Study|Other|6|||
170595593|NCT04732949|616525924|FG001|Overall Study|Other|3|||
170595594|NCT01023672|616525925|FG000|Overall Study|Worsening disease|2|||
170595595|NCT01023672|616525925|FG000|Overall Study|Death|1|||
170595596|NCT03627065|616525928|FG000|Overall Study|Study Terminated by sponsor|1|||
170595597|NCT03627065|616525928|FG000|Overall Study|Withdrawal by Subject|2|||
170595598|NCT01304329|616525929|FG000|Third Intervention (3 Days)|Adverse Event|0|||
170595599|NCT01304329|616525930|FG001|Third Intervention (3 Days)|Adverse Event|1|||
170595600|NCT01304329|616525931|FG002|Third Intervention (3 Days)|Adverse Event|0|||
170595601|NCT01304329|616525932|FG003|Third Intervention (3 Days)|Adverse Event|0|||
170595602|NCT01304329|616525933|FG004|Third Intervention (3 Days)|Adverse Event|0|||
170595603|NCT01304329|616525934|FG005|Third Intervention (3 Days)|Adverse Event|0|||
170595604|NCT05545644|616525939|FG000|Overall Study|Lost to Follow-up|4|||
170595605|NCT05545644|616525940|FG001|Overall Study|Lost to Follow-up|3|||
170595606|NCT02876328|616525943|FG000|Overall Study|Death|2|||
170595607|NCT02876328|616525944|FG001|Overall Study|Death|1|||
170595608|NCT02876328|616525945|FG002|Overall Study|Death|3|||
170595609|NCT02876328|616525946|FG003|Overall Study|Death|0|||
170912810|NCT01450137|617683987|FG001|Week 12 to Study End|Death|1|||
170912811|NCT01450137|617683986|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
170912812|NCT01450137|617683987|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
170912813|NCT02609399|617683988|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
170912814|NCT02609399|617683989|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
170912815|NCT02609399|617683988|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
170912816|NCT02609399|617683989|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
170912817|NCT02609399|617683988|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
170912818|NCT02609399|617683989|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
170912819|NCT01208181|617683993|FG000|Part 1|Withdrawal by Subject|11|||
170912820|NCT01208181|617683994|FG001|Part 1|Withdrawal by Subject|10|||
170912821|NCT01208181|617683995|FG002|Part 1|Withdrawal by Subject|0|||
170912822|NCT01208181|617683996|FG003|Part 1|Withdrawal by Subject|0|||
170912823|NCT01208181|617683997|FG004|Part 1|Withdrawal by Subject|0|||
170912824|NCT01208181|617683993|FG000|Part 1|Technical problem|5|||
170912825|NCT01208181|617683994|FG001|Part 1|Technical problem|0|||
170912826|NCT01208181|617683995|FG002|Part 1|Technical problem|0|||
170912827|NCT01208181|617683996|FG003|Part 1|Technical problem|0|||
170912828|NCT01208181|617683997|FG004|Part 1|Technical problem|0|||
170912829|NCT01208181|617683993|FG000|Part 1|Protocol Violation|10|||
170912830|NCT01208181|617683994|FG001|Part 1|Protocol Violation|5|||
170912831|NCT01208181|617683995|FG002|Part 1|Protocol Violation|0|||
170912832|NCT01208181|617683996|FG003|Part 1|Protocol Violation|0|||
170912833|NCT01208181|617683997|FG004|Part 1|Protocol Violation|0|||
170912834|NCT01208181|617683993|FG000|Part 1|Physician Decision|4|||
170912835|NCT01208181|617683994|FG001|Part 1|Physician Decision|0|||
170912836|NCT01208181|617683995|FG002|Part 1|Physician Decision|0|||
170912837|NCT01208181|617683996|FG003|Part 1|Physician Decision|0|||
170912838|NCT01208181|617683997|FG004|Part 1|Physician Decision|0|||
170912839|NCT01208181|617683993|FG000|Part 1|Non-compliance with study drug|1|||
170595610|NCT02876328|616525947|FG004|Overall Study|Death|0|||
170912840|NCT01208181|617683994|FG001|Part 1|Non-compliance with study drug|1|||
170912841|NCT01208181|617683995|FG002|Part 1|Non-compliance with study drug|0|||
170912842|NCT01208181|617683996|FG003|Part 1|Non-compliance with study drug|0|||
170595611|NCT02876328|616525948|FG005|Overall Study|Death|0|||
170595612|NCT02876328|616525949|FG006|Overall Study|Death|1|||
170595613|NCT02876328|616525950|FG007|Overall Study|Death|3|||
170595614|NCT02876328|616525951|FG008|Overall Study|Death|0|||
170595615|NCT02876328|616525952|FG009|Overall Study|Death|1|||
170595616|NCT02876328|616525953|FG010|Overall Study|Death|1|||
170595617|NCT02876328|616525954|FG011|Overall Study|Death|0|||
170595618|NCT02876328|616525955|FG012|Overall Study|Death|0|||
170912843|NCT01208181|617683997|FG004|Part 1|Non-compliance with study drug|0|||
170595619|NCT02876328|616525956|FG013|Overall Study|Death|0|||
170912844|NCT01208181|617683993|FG000|Part 1|Lost to Follow-up|5|||
170912845|NCT01208181|617683994|FG001|Part 1|Lost to Follow-up|3|||
170912846|NCT01208181|617683995|FG002|Part 1|Lost to Follow-up|0|||
170595620|NCT02876328|616525957|FG014|Overall Study|Death|0|||
170595621|NCT02876328|616525958|FG015|Overall Study|Death|0|||
170595622|NCT02876328|616525959|FG016|Overall Study|Death|1|||
170595623|NCT02876328|616525960|FG017|Overall Study|Death|1|||
170595624|NCT02876328|616525961|FG018|Overall Study|Death|0|||
170595625|NCT02876328|616525962|FG019|Overall Study|Death|0|||
170811462|NCT03374254|617319279|FG004|Overall Study|Withdrawal by Subject|0|||
170811463|NCT03374254|617319280|FG005|Overall Study|Withdrawal by Subject|1|||
170811464|NCT03374254|617319281|FG006|Overall Study|Withdrawal by Subject|0|||
170811465|NCT03374254|617319282|FG007|Overall Study|Withdrawal by Subject|0|||
170811466|NCT03374254|617319283|FG008|Overall Study|Withdrawal by Subject|0|||
170811467|NCT02784834|617319286|FG000|Overall Study|Lack of Efficacy|1|||
170811468|NCT01215253|617319287|FG000|Overall Study|Withdrawal by Subject|57|||
170811469|NCT01215253|617319288|FG001|Overall Study|Withdrawal by Subject|35|||
170811470|NCT01215253|617319287|FG000|Overall Study|Physician Decision|9|||
170811471|NCT01215253|617319288|FG001|Overall Study|Physician Decision|12|||
170811472|NCT01215253|617319287|FG000|Overall Study|Lost to Follow-up|6|||
170811473|NCT01215253|617319288|FG001|Overall Study|Lost to Follow-up|4|||
170811474|NCT01215253|617319287|FG000|Overall Study|Other|14|||
170811475|NCT01215253|617319288|FG001|Overall Study|Other|12|||
170811476|NCT02404441|617319290|FG000|Phase 1 Part|Adverse Event|1|||
170811477|NCT02404441|617319291|FG001|Phase 1 Part|Adverse Event|0|||
170811478|NCT02404441|617319292|FG002|Phase 1 Part|Adverse Event|0|||
170811479|NCT02404441|617319293|FG003|Phase 1 Part|Adverse Event|0|||
170811480|NCT02404441|617319294|FG004|Phase 1 Part|Adverse Event|0|||
170811481|NCT02404441|617319295|FG005|Phase 1 Part|Adverse Event|0|||
170811482|NCT02404441|617319296|FG006|Phase 1 Part|Adverse Event|0|||
170811483|NCT02404441|617319297|FG007|Phase 1 Part|Adverse Event|0|||
170811484|NCT02404441|617319298|FG008|Phase 1 Part|Adverse Event|0|||
170811485|NCT02404441|617319299|FG009|Phase 1 Part|Adverse Event|0|||
170811486|NCT02404441|617319290|FG000|Phase 1 Part|Physician Decision|0|||
170811487|NCT02404441|617319291|FG001|Phase 1 Part|Physician Decision|1|||
170811488|NCT02404441|617319292|FG002|Phase 1 Part|Physician Decision|0|||
170811489|NCT02404441|617319293|FG003|Phase 1 Part|Physician Decision|0|||
170811490|NCT02404441|617319294|FG004|Phase 1 Part|Physician Decision|0|||
170811491|NCT02404441|617319295|FG005|Phase 1 Part|Physician Decision|0|||
170811492|NCT02404441|617319296|FG006|Phase 1 Part|Physician Decision|0|||
170811493|NCT02404441|617319297|FG007|Phase 1 Part|Physician Decision|0|||
170595626|NCT02876328|616525963|FG020|Overall Study|Death|0|||
170595627|NCT02876328|616525964|FG021|Overall Study|Death|1|||
170595628|NCT02876328|616525965|FG022|Overall Study|Death|0|||
170595629|NCT02876328|616525966|FG023|Overall Study|Death|0|||
170595630|NCT02876328|616525943|FG000|Overall Study|Withdrawal by Subject|0|||
170595631|NCT02876328|616525944|FG001|Overall Study|Withdrawal by Subject|2|||
170595632|NCT02876328|616525945|FG002|Overall Study|Withdrawal by Subject|3|||
170595633|NCT02876328|616525946|FG003|Overall Study|Withdrawal by Subject|3|||
170595634|NCT02876328|616525947|FG004|Overall Study|Withdrawal by Subject|0|||
170595635|NCT02876328|616525948|FG005|Overall Study|Withdrawal by Subject|1|||
170595636|NCT02876328|616525949|FG006|Overall Study|Withdrawal by Subject|0|||
170595637|NCT02876328|616525950|FG007|Overall Study|Withdrawal by Subject|1|||
170595638|NCT02876328|616525951|FG008|Overall Study|Withdrawal by Subject|1|||
170595639|NCT02876328|616525952|FG009|Overall Study|Withdrawal by Subject|2|||
170595640|NCT02876328|616525953|FG010|Overall Study|Withdrawal by Subject|0|||
170595641|NCT02876328|616525954|FG011|Overall Study|Withdrawal by Subject|0|||
170595642|NCT02876328|616525955|FG012|Overall Study|Withdrawal by Subject|0|||
170595643|NCT02876328|616525956|FG013|Overall Study|Withdrawal by Subject|0|||
170595644|NCT02876328|616525957|FG014|Overall Study|Withdrawal by Subject|0|||
170595645|NCT02876328|616525958|FG015|Overall Study|Withdrawal by Subject|0|||
170595646|NCT02876328|616525959|FG016|Overall Study|Withdrawal by Subject|1|||
170595647|NCT02876328|616525960|FG017|Overall Study|Withdrawal by Subject|3|||
170595648|NCT02876328|616525961|FG018|Overall Study|Withdrawal by Subject|0|||
170595649|NCT02876328|616525962|FG019|Overall Study|Withdrawal by Subject|0|||
170595650|NCT02876328|616525963|FG020|Overall Study|Withdrawal by Subject|1|||
170595651|NCT02876328|616525964|FG021|Overall Study|Withdrawal by Subject|0|||
170595652|NCT02876328|616525965|FG022|Overall Study|Withdrawal by Subject|0|||
170595653|NCT02876328|616525966|FG023|Overall Study|Withdrawal by Subject|0|||
170811494|NCT02404441|617319298|FG008|Phase 1 Part|Physician Decision|0|||
170811495|NCT02404441|617319299|FG009|Phase 1 Part|Physician Decision|0|||
170811496|NCT02404441|617319290|FG000|Phase 1 Part|Progressive Disease|14|||
170811497|NCT02404441|617319291|FG001|Phase 1 Part|Progressive Disease|11|||
170811498|NCT02404441|617319292|FG002|Phase 1 Part|Progressive Disease|7|||
170811499|NCT02404441|617319293|FG003|Phase 1 Part|Progressive Disease|6|||
170811500|NCT02404441|617319294|FG004|Phase 1 Part|Progressive Disease|9|||
170595654|NCT02876328|616525943|FG000|Overall Study|Missed 12 Month Visit|15|||
170811501|NCT02404441|617319295|FG005|Phase 1 Part|Progressive Disease|0|||
170811502|NCT02404441|617319296|FG006|Phase 1 Part|Progressive Disease|0|||
170811503|NCT02404441|617319297|FG007|Phase 1 Part|Progressive Disease|0|||
170595655|NCT02876328|616525944|FG001|Overall Study|Missed 12 Month Visit|10|||
170595656|NCT02876328|616525945|FG002|Overall Study|Missed 12 Month Visit|11|||
170595657|NCT02876328|616525946|FG003|Overall Study|Missed 12 Month Visit|6|||
170595658|NCT02876328|616525947|FG004|Overall Study|Missed 12 Month Visit|10|||
170595659|NCT02876328|616525948|FG005|Overall Study|Missed 12 Month Visit|14|||
170595660|NCT02876328|616525949|FG006|Overall Study|Missed 12 Month Visit|3|||
170595661|NCT02876328|616525950|FG007|Overall Study|Missed 12 Month Visit|8|||
170595662|NCT02876328|616525951|FG008|Overall Study|Missed 12 Month Visit|9|||
170595663|NCT02876328|616525952|FG009|Overall Study|Missed 12 Month Visit|5|||
170595664|NCT02876328|616525953|FG010|Overall Study|Missed 12 Month Visit|4|||
170595665|NCT02876328|616525954|FG011|Overall Study|Missed 12 Month Visit|1|||
170595666|NCT02876328|616525955|FG012|Overall Study|Missed 12 Month Visit|5|||
170595667|NCT02876328|616525956|FG013|Overall Study|Missed 12 Month Visit|4|||
170595668|NCT02876328|616525957|FG014|Overall Study|Missed 12 Month Visit|4|||
170595669|NCT02876328|616525958|FG015|Overall Study|Missed 12 Month Visit|4|||
170595670|NCT02876328|616525959|FG016|Overall Study|Missed 12 Month Visit|3|||
170595671|NCT02876328|616525960|FG017|Overall Study|Missed 12 Month Visit|6|||
170595672|NCT02876328|616525961|FG018|Overall Study|Missed 12 Month Visit|2|||
170595673|NCT02876328|616525962|FG019|Overall Study|Missed 12 Month Visit|2|||
170595674|NCT02876328|616525963|FG020|Overall Study|Missed 12 Month Visit|11|||
170595675|NCT02876328|616525964|FG021|Overall Study|Missed 12 Month Visit|7|||
170595676|NCT02876328|616525965|FG022|Overall Study|Missed 12 Month Visit|1|||
170595677|NCT02876328|616525966|FG023|Overall Study|Missed 12 Month Visit|0|||
170595678|NCT01287195|616525967|FG000|Overall Study|Withdrawal by Subject|2|||
170595679|NCT05432167|616525968|FG000|Overall Study|Adverse Event|0|||
170595680|NCT05432167|616525969|FG001|Overall Study|Adverse Event|2|||
170595681|NCT05432167|616525970|FG002|Overall Study|Adverse Event|1|||
170595682|NCT05432167|616525968|FG000|Overall Study|Lost to Follow-up|3|||
170595683|NCT05432167|616525969|FG001|Overall Study|Lost to Follow-up|3|||
170595684|NCT05432167|616525970|FG002|Overall Study|Lost to Follow-up|2|||
170650941|NCT02093351|616736304|FG002|Part B|Complete response|0|||
170650942|NCT02093351|616736305|FG003|Part B|Complete response|1|||
170650943|NCT02093351|616736302|FG000|Part B|Adverse event + disease progression|0|||
170650944|NCT02093351|616736303|FG001|Part B|Adverse event + disease progression|0|||
170650945|NCT02093351|616736304|FG002|Part B|Adverse event + disease progression|0|||
170650946|NCT02093351|616736305|FG003|Part B|Adverse event + disease progression|1|||
170650947|NCT02093351|616736302|FG000|Part B|Lack of therapeutic response|0|||
170650948|NCT02093351|616736303|FG001|Part B|Lack of therapeutic response|0|||
170811504|NCT02404441|617319298|FG008|Phase 1 Part|Progressive Disease|0|||
170811505|NCT02404441|617319299|FG009|Phase 1 Part|Progressive Disease|0|||
170811506|NCT02404441|617319290|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
170811507|NCT02404441|617319291|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
170811508|NCT02404441|617319292|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
170811509|NCT02404441|617319293|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
170811510|NCT02404441|617319294|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
170811511|NCT02404441|617319295|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
170811512|NCT02404441|617319296|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
170811513|NCT02404441|617319297|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
170811514|NCT02404441|617319298|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
170811515|NCT02404441|617319299|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
170811516|NCT02404441|617319290|FG000|Phase 1 Part|Death|1|||
170811517|NCT02404441|617319291|FG001|Phase 1 Part|Death|1|||
170811518|NCT02404441|617319292|FG002|Phase 1 Part|Death|1|||
170811519|NCT02404441|617319293|FG003|Phase 1 Part|Death|0|||
170811520|NCT02404441|617319294|FG004|Phase 1 Part|Death|1|||
170811521|NCT02404441|617319295|FG005|Phase 1 Part|Death|0|||
170811522|NCT02404441|617319296|FG006|Phase 1 Part|Death|0|||
170811523|NCT02404441|617319297|FG007|Phase 1 Part|Death|0|||
170811524|NCT02404441|617319298|FG008|Phase 1 Part|Death|0|||
170811525|NCT02404441|617319299|FG009|Phase 1 Part|Death|0|||
170811526|NCT02404441|617319290|FG000|Phase 2 Part|Adverse Event|0|||
170811527|NCT02404441|617319291|FG001|Phase 2 Part|Adverse Event|0|||
170811528|NCT02404441|617319292|FG002|Phase 2 Part|Adverse Event|0|||
170811529|NCT02404441|617319293|FG003|Phase 2 Part|Adverse Event|0|||
170811530|NCT02404441|617319294|FG004|Phase 2 Part|Adverse Event|0|||
170811531|NCT02404441|617319295|FG005|Phase 2 Part|Adverse Event|2|||
170811532|NCT02404441|617319296|FG006|Phase 2 Part|Adverse Event|3|||
170811533|NCT02404441|617319297|FG007|Phase 2 Part|Adverse Event|3|||
170811534|NCT02404441|617319298|FG008|Phase 2 Part|Adverse Event|6|||
170811535|NCT02404441|617319299|FG009|Phase 2 Part|Adverse Event|1|||
170595685|NCT05432167|616525968|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
170595686|NCT05432167|616525969|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
170650949|NCT02093351|616736304|FG002|Part B|Lack of therapeutic response|0|||
170811536|NCT02404441|617319290|FG000|Phase 2 Part|Physician Decision|0|||
170595687|NCT05432167|616525970|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
170595688|NCT05432167|616525968|FG000|Overall Study|Physician Decision|1|||
170595689|NCT05432167|616525969|FG001|Overall Study|Physician Decision|0|||
170595690|NCT05432167|616525970|FG002|Overall Study|Physician Decision|0|||
170595691|NCT05432167|616525968|FG000|Overall Study|Withdrawal by Subject|7|||
170595692|NCT05432167|616525969|FG001|Overall Study|Withdrawal by Subject|4|||
170595693|NCT05432167|616525970|FG002|Overall Study|Withdrawal by Subject|11|||
170595694|NCT05432167|616525968|FG000|Overall Study|Other|0|||
170595695|NCT05432167|616525969|FG001|Overall Study|Other|0|||
170595696|NCT05432167|616525970|FG002|Overall Study|Other|1|||
170595697|NCT02068118|616525973|FG000|18-month Comparative Study Period|Death|90|||
170595698|NCT02068118|616525974|FG001|18-month Comparative Study Period|Death|97|||
170595699|NCT02068118|616525973|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
170595700|NCT02068118|616525974|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
170595701|NCT02068118|616525973|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
170595702|NCT02068118|616525974|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
170595703|NCT02068118|616525973|FG000|18-month Comparative Study Period|Heart transplant|9|||
170595704|NCT02068118|616525974|FG001|18-month Comparative Study Period|Heart transplant|15|||
170595705|NCT02068118|616525973|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
170595706|NCT02068118|616525974|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
170595707|NCT02068118|616525973|FG000|18-month Comparative Study Period|Hemiplegia|0|||
170595708|NCT02068118|616525974|FG001|18-month Comparative Study Period|Hemiplegia|1|||
170595709|NCT02068118|616525973|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
170595710|NCT02068118|616525974|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
170595711|NCT02068118|616525973|FG000|18-month Comparative Study Period|Move|0|||
170595712|NCT02068118|616525974|FG001|18-month Comparative Study Period|Move|1|||
170595713|NCT02068118|616525973|FG000|18-month Comparative Study Period|Hearing loss|0|||
170595714|NCT02068118|616525974|FG001|18-month Comparative Study Period|Hearing loss|1|||
170595715|NCT02068118|616525973|FG000|Extension Period|Death|0|||
170595716|NCT02068118|616525974|FG001|Extension Period|Death|2|||
170595717|NCT02068118|616525973|FG000|Extension Period|Withdrawal by Subject|1|||
170595718|NCT02068118|616525974|FG001|Extension Period|Withdrawal by Subject|0|||
170595719|NCT02068118|616525973|FG000|Extension Period|Heart transplant|1|||
170811537|NCT02404441|617319291|FG001|Phase 2 Part|Physician Decision|0|||
170811538|NCT02404441|617319292|FG002|Phase 2 Part|Physician Decision|0|||
170811539|NCT02404441|617319293|FG003|Phase 2 Part|Physician Decision|0|||
170811540|NCT02404441|617319294|FG004|Phase 2 Part|Physician Decision|0|||
170811541|NCT02404441|617319295|FG005|Phase 2 Part|Physician Decision|7|||
170811542|NCT02404441|617319296|FG006|Phase 2 Part|Physician Decision|9|||
170811543|NCT02404441|617319297|FG007|Phase 2 Part|Physician Decision|2|||
170811544|NCT02404441|617319298|FG008|Phase 2 Part|Physician Decision|1|||
170811545|NCT02404441|617319299|FG009|Phase 2 Part|Physician Decision|3|||
170811546|NCT02404441|617319290|FG000|Phase 2 Part|Progressive disease|0|||
170811547|NCT02404441|617319291|FG001|Phase 2 Part|Progressive disease|0|||
170811548|NCT02404441|617319292|FG002|Phase 2 Part|Progressive disease|0|||
170811549|NCT02404441|617319293|FG003|Phase 2 Part|Progressive disease|0|||
170811550|NCT02404441|617319294|FG004|Phase 2 Part|Progressive disease|0|||
170811551|NCT02404441|617319295|FG005|Phase 2 Part|Progressive disease|43|||
170811552|NCT02404441|617319296|FG006|Phase 2 Part|Progressive disease|32|||
170811553|NCT02404441|617319297|FG007|Phase 2 Part|Progressive disease|31|||
170811554|NCT02404441|617319298|FG008|Phase 2 Part|Progressive disease|39|||
170811555|NCT02404441|617319299|FG009|Phase 2 Part|Progressive disease|27|||
170811556|NCT02404441|617319290|FG000|Phase 2 Part|Subject/guardian decision|0|||
170811557|NCT02404441|617319291|FG001|Phase 2 Part|Subject/guardian decision|0|||
170811558|NCT02404441|617319292|FG002|Phase 2 Part|Subject/guardian decision|0|||
170811559|NCT02404441|617319293|FG003|Phase 2 Part|Subject/guardian decision|0|||
170811560|NCT02404441|617319294|FG004|Phase 2 Part|Subject/guardian decision|0|||
170811561|NCT02404441|617319295|FG005|Phase 2 Part|Subject/guardian decision|3|||
170811562|NCT02404441|617319296|FG006|Phase 2 Part|Subject/guardian decision|9|||
170811563|NCT02404441|617319297|FG007|Phase 2 Part|Subject/guardian decision|0|||
170811564|NCT02404441|617319298|FG008|Phase 2 Part|Subject/guardian decision|3|||
170811565|NCT02404441|617319299|FG009|Phase 2 Part|Subject/guardian decision|2|||
170811566|NCT02404441|617319290|FG000|Phase 2 Part|Death|0|||
170811567|NCT02404441|617319291|FG001|Phase 2 Part|Death|0|||
170811568|NCT02404441|617319292|FG002|Phase 2 Part|Death|0|||
170811569|NCT02404441|617319293|FG003|Phase 2 Part|Death|0|||
170811570|NCT02404441|617319294|FG004|Phase 2 Part|Death|0|||
170811571|NCT02404441|617319295|FG005|Phase 2 Part|Death|4|||
170595720|NCT02068118|616525974|FG001|Extension Period|Heart transplant|0|||
170595721|NCT02068118|616525973|FG000|Extension Period|Wrong device use|0|||
170595722|NCT02068118|616525974|FG001|Extension Period|Wrong device use|1|||
170650950|NCT02093351|616736305|FG003|Part B|Lack of therapeutic response|12|||
170811572|NCT02404441|617319296|FG006|Phase 2 Part|Death|8|||
170811573|NCT02404441|617319297|FG007|Phase 2 Part|Death|4|||
170811574|NCT02404441|617319298|FG008|Phase 2 Part|Death|10|||
170811575|NCT02404441|617319299|FG009|Phase 2 Part|Death|9|||
170811576|NCT03909100|617319300|FG000|Overall Study|Protocol Deviation|2|||
170912847|NCT01208181|617683996|FG003|Part 1|Lost to Follow-up|0|||
170912848|NCT01208181|617683997|FG004|Part 1|Lost to Follow-up|1|||
170912849|NCT01208181|617683993|FG000|Part 1|Lack of Efficacy|37|||
170912850|NCT01208181|617683994|FG001|Part 1|Lack of Efficacy|12|||
170912851|NCT01208181|617683995|FG002|Part 1|Lack of Efficacy|0|||
170912852|NCT01208181|617683996|FG003|Part 1|Lack of Efficacy|0|||
170912853|NCT01208181|617683997|FG004|Part 1|Lack of Efficacy|17|||
170912854|NCT01208181|617683993|FG000|Part 1|Adverse Event|26|||
170912855|NCT01208181|617683994|FG001|Part 1|Adverse Event|24|||
170912856|NCT01208181|617683995|FG002|Part 1|Adverse Event|0|||
170912857|NCT01208181|617683996|FG003|Part 1|Adverse Event|0|||
170912858|NCT01208181|617683997|FG004|Part 1|Adverse Event|4|||
170912859|NCT01208181|617683993|FG000|Part 2|Adverse Event|0|||
170912860|NCT01208181|617683994|FG001|Part 2|Adverse Event|0|||
170912861|NCT01208181|617683995|FG002|Part 2|Adverse Event|6|||
170912862|NCT01208181|617683996|FG003|Part 2|Adverse Event|7|||
170912863|NCT01208181|617683997|FG004|Part 2|Adverse Event|0|||
170912864|NCT01208181|617683993|FG000|Part 2|Withdrawal by Subject|0|||
170912865|NCT01208181|617683994|FG001|Part 2|Withdrawal by Subject|0|||
170912866|NCT01208181|617683995|FG002|Part 2|Withdrawal by Subject|1|||
170912867|NCT01208181|617683996|FG003|Part 2|Withdrawal by Subject|1|||
170912868|NCT01208181|617683997|FG004|Part 2|Withdrawal by Subject|0|||
170912869|NCT01208181|617683993|FG000|Part 2|Protocol Violation|0|||
170912870|NCT01208181|617683994|FG001|Part 2|Protocol Violation|0|||
170912871|NCT01208181|617683995|FG002|Part 2|Protocol Violation|1|||
170912872|NCT01208181|617683996|FG003|Part 2|Protocol Violation|0|||
170912873|NCT01208181|617683997|FG004|Part 2|Protocol Violation|0|||
170912874|NCT01208181|617683993|FG000|Part 2|Physician Decision|0|||
170912875|NCT01208181|617683994|FG001|Part 2|Physician Decision|0|||
170912876|NCT01208181|617683995|FG002|Part 2|Physician Decision|1|||
170912877|NCT01208181|617683996|FG003|Part 2|Physician Decision|2|||
170912878|NCT01208181|617683997|FG004|Part 2|Physician Decision|0|||
170912879|NCT01208181|617683993|FG000|Part 2|Non-compliance with study drug|0|||
170912880|NCT01208181|617683994|FG001|Part 2|Non-compliance with study drug|0|||
170912881|NCT01208181|617683995|FG002|Part 2|Non-compliance with study drug|1|||
170912882|NCT01208181|617683996|FG003|Part 2|Non-compliance with study drug|1|||
170912883|NCT01208181|617683997|FG004|Part 2|Non-compliance with study drug|0|||
170912884|NCT01208181|617683993|FG000|Part 2|Lost to Follow-up|0|||
170912885|NCT01208181|617683994|FG001|Part 2|Lost to Follow-up|0|||
170650951|NCT02093351|616736302|FG000|Part B|Condition under investigation worsened|0|||
170912886|NCT01208181|617683995|FG002|Part 2|Lost to Follow-up|1|||
170912887|NCT01208181|617683996|FG003|Part 2|Lost to Follow-up|2|||
170912888|NCT01208181|617683997|FG004|Part 2|Lost to Follow-up|0|||
170912889|NCT01208181|617683993|FG000|Part 2|Lack of Efficacy|0|||
170912890|NCT01208181|617683994|FG001|Part 2|Lack of Efficacy|0|||
170912891|NCT01208181|617683995|FG002|Part 2|Lack of Efficacy|5|||
170912892|NCT01208181|617683996|FG003|Part 2|Lack of Efficacy|7|||
170912893|NCT01208181|617683997|FG004|Part 2|Lack of Efficacy|0|||
170912894|NCT01457339|617683998|FG000|Period 3 (100 mg)|Adverse Event|0|||
170912895|NCT01457339|617683999|FG001|Period 3 (100 mg)|Adverse Event|1|||
170912896|NCT01457339|617683998|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
170912897|NCT01457339|617683999|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
170912898|NCT01457339|617683998|FG000|Period 6 (250 mg)|Family Emergency|1|||
170912899|NCT01457339|617683999|FG001|Period 6 (250 mg)|Family Emergency|0|||
170912900|NCT01457339|617683998|FG000|Period 6 (250 mg)|Personal appointment|0|||
170595723|NCT00353873|616525977|FG000|Overall Study|Protocol Violation|1|||
170595724|NCT00353873|616525978|FG001|Overall Study|Protocol Violation|2|||
170595725|NCT00353873|616525977|FG000|Overall Study|Exacerbation|1|||
170595726|NCT00353873|616525978|FG001|Overall Study|Exacerbation|0|||
170595727|NCT00353873|616525977|FG000|Overall Study|Adverse Event|1|||
170595728|NCT00353873|616525978|FG001|Overall Study|Adverse Event|0|||
170595729|NCT00353873|616525977|FG000|Overall Study|Physician Decision|2|||
170595730|NCT00353873|616525978|FG001|Overall Study|Physician Decision|0|||
170595731|NCT00353873|616525977|FG000|Overall Study|Withdrawal by Subject|1|||
170912901|NCT01457339|617683999|FG001|Period 6 (250 mg)|Personal appointment|1|||
170912902|NCT00306891|617684001|FG000|Part A|Withdrawal by Subject|1|||
170912903|NCT00306891|617684002|FG001|Part A|Withdrawal by Subject|1|||
170912904|NCT00306891|617684003|FG002|Part A|Withdrawal by Subject|0|||
170912905|NCT00306891|617684004|FG003|Part A|Withdrawal by Subject|0|||
170912906|NCT00306891|617684001|FG000|Part A|Condition under investigation worsened|2|||
170912907|NCT00306891|617684002|FG001|Part A|Condition under investigation worsened|2|||
170912908|NCT00306891|617684003|FG002|Part A|Condition under investigation worsened|0|||
170912909|NCT00306891|617684004|FG003|Part A|Condition under investigation worsened|0|||
170912910|NCT00306891|617684001|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
170912911|NCT00306891|617684002|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
170912912|NCT00306891|617684003|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
170912913|NCT00306891|617684004|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
170912914|NCT00306891|617684001|FG000|Part A|Partial bowel obstruction|1|||
170912915|NCT00306891|617684002|FG001|Part A|Partial bowel obstruction|0|||
170912916|NCT00306891|617684003|FG002|Part A|Partial bowel obstruction|0|||
170912917|NCT00306891|617684004|FG003|Part A|Partial bowel obstruction|0|||
170912918|NCT00306891|617684001|FG000|Part A|Reaccumul. of ascites following drainage|0|||
170912919|NCT00306891|617684002|FG001|Part A|Reaccumul. of ascites following drainage|1|||
170912920|NCT00306891|617684003|FG002|Part A|Reaccumul. of ascites following drainage|0|||
170912921|NCT00306891|617684004|FG003|Part A|Reaccumul. of ascites following drainage|0|||
170912922|NCT00306891|617684001|FG000|Part A|Suspicion of second malignancy|0|||
170912923|NCT00306891|617684002|FG001|Part A|Suspicion of second malignancy|1|||
170912924|NCT00306891|617684003|FG002|Part A|Suspicion of second malignancy|0|||
170912925|NCT00306891|617684004|FG003|Part A|Suspicion of second malignancy|0|||
170912926|NCT00306891|617684001|FG000|Part A|QTC interval outwith elig. criteria|1|||
170912927|NCT00306891|617684002|FG001|Part A|QTC interval outwith elig. criteria|0|||
170912928|NCT00306891|617684003|FG002|Part A|QTC interval outwith elig. criteria|0|||
170912929|NCT00306891|617684004|FG003|Part A|QTC interval outwith elig. criteria|0|||
170912930|NCT00306891|617684001|FG000|Part B|Death|0|||
170912931|NCT00306891|617684002|FG001|Part B|Death|0|||
170912932|NCT00306891|617684003|FG002|Part B|Death|1|||
170912933|NCT00306891|617684004|FG003|Part B|Death|2|||
170912934|NCT00306891|617684001|FG000|Part B|Adverse Event|0|||
170912935|NCT00306891|617684002|FG001|Part B|Adverse Event|0|||
170912936|NCT00306891|617684003|FG002|Part B|Adverse Event|5|||
170912937|NCT00306891|617684004|FG003|Part B|Adverse Event|5|||
170912938|NCT00306891|617684001|FG000|Part B|Withdrawal by Subject|0|||
170912939|NCT00306891|617684002|FG001|Part B|Withdrawal by Subject|0|||
170912940|NCT00306891|617684003|FG002|Part B|Withdrawal by Subject|3|||
170912941|NCT00306891|617684004|FG003|Part B|Withdrawal by Subject|1|||
170912942|NCT00306891|617684001|FG000|Part B|Condition under investigation worsened|0|||
170912943|NCT00306891|617684002|FG001|Part B|Condition under investigation worsened|0|||
170912944|NCT00306891|617684003|FG002|Part B|Condition under investigation worsened|2|||
170912945|NCT00306891|617684004|FG003|Part B|Condition under investigation worsened|8|||
170912946|NCT00306891|617684001|FG000|Part B|Development of study specific disc crit.|0|||
170912947|NCT00306891|617684002|FG001|Part B|Development of study specific disc crit.|0|||
170912948|NCT00306891|617684003|FG002|Part B|Development of study specific disc crit.|0|||
170912949|NCT00306891|617684004|FG003|Part B|Development of study specific disc crit.|1|||
170912950|NCT00853905|617684006|FG000|Overall Study|Lost to Follow-up|1|||
170912951|NCT00853905|617684007|FG001|Overall Study|Lost to Follow-up|3|||
170912952|NCT00853905|617684006|FG000|Overall Study|Withdrawal by Subject|0|||
170912953|NCT00853905|617684007|FG001|Overall Study|Withdrawal by Subject|1|||
170650952|NCT02093351|616736303|FG001|Part B|Condition under investigation worsened|0|||
170912954|NCT00853905|617684006|FG000|Overall Study|never had surgery|1|||
170595732|NCT00353873|616525978|FG001|Overall Study|Withdrawal by Subject|1|||
170912955|NCT00853905|617684007|FG001|Overall Study|never had surgery|0|||
170912956|NCT01333189|617684008|FG000|Overall Study|Time constraints|1|||
170912957|NCT01333189|617684009|FG001|Overall Study|Time constraints|0|||
170595733|NCT01420627|616525979|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
170595734|NCT00837876|616525980|FG000|Overall Study|Death|2|||
170595735|NCT00837876|616525980|FG000|Overall Study|Adverse Event|7|||
170912958|NCT01333189|617684008|FG000|Overall Study|Adverse Event|1|||
170811577|NCT03909100|617319300|FG000|Overall Study|Technical Problems|4|||
170912959|NCT01333189|617684009|FG001|Overall Study|Adverse Event|0|||
170912960|NCT01333189|617684008|FG000|Overall Study|Transportation difficulties|0|||
170912961|NCT01333189|617684009|FG001|Overall Study|Transportation difficulties|1|||
170912962|NCT01333189|617684008|FG000|Overall Study|Moved from region|0|||
170912963|NCT01333189|617684009|FG001|Overall Study|Moved from region|1|||
170912964|NCT00035815|617684016|FG000|Overall Study|Withdrawal by Subject|17|||
170912965|NCT00035815|617684017|FG001|Overall Study|Withdrawal by Subject|11|||
170912966|NCT04267562|617685802|FG000|Assessed for Eligibility|Screen Failure|64|||
170912967|NCT04267562|617685802|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
170912968|NCT04267562|617685802|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
170912969|NCT04267562|617685802|FG000|Assessed for Eligibility|Site closure|6|||
170912970|NCT04267562|617685802|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
170912971|NCT04267562|617685802|FG000|Assessed for Eligibility|Physician Decision|1|||
170912972|NCT04267562|617685802|FG000|Month 24|Elective hysterectomy|1|||
170912973|NCT04267562|617685802|FG000|Month 24|Lost to Follow-up|1|||
170912974|NCT04267562|617685802|FG000|Month 36|Elective hysterectomy|2|||
170912975|NCT04267562|617685802|FG000|Month 36|Lost to Follow-up|3|||
170912976|NCT00893113|617685806|FG000|Overall Study|Lost to Follow-up|4|||
170912977|NCT00893113|617685807|FG001|Overall Study|Lost to Follow-up|8|||
170912978|NCT00893113|617685806|FG000|Overall Study|Early Termination|1|||
170912979|NCT00893113|617685807|FG001|Overall Study|Early Termination|1|||
170912980|NCT00893113|617685806|FG000|Overall Study|Withdrew Consent|8|||
170912981|NCT00893113|617685807|FG001|Overall Study|Withdrew Consent|7|||
170595736|NCT00837876|616525980|FG000|Overall Study|Physician Decision|1|||
170595737|NCT00837876|616525980|FG000|Overall Study|Withdrawal by Subject|3|||
170595738|NCT00837876|616525980|FG000|Overall Study|disease progression|24|||
170595739|NCT00453973|616525981|FG000|Overall Study|Adverse Event|4|||
170595740|NCT00453973|616525982|FG001|Overall Study|Adverse Event|9|||
170595741|NCT00453973|616525981|FG000|Overall Study|Withdrawal by Subject|7|||
170595742|NCT00453973|616525982|FG001|Overall Study|Withdrawal by Subject|6|||
170595743|NCT00453973|616525981|FG000|Overall Study|PI Decision|0|||
170595744|NCT00453973|616525982|FG001|Overall Study|PI Decision|2|||
170811578|NCT03909100|617319300|FG000|Overall Study|Withdrawal by Subject|4|||
170811579|NCT03909100|617319300|FG000|Overall Study|Lost to Follow-up|1|||
170811580|NCT03909100|617319300|FG000|Overall Study|Reason not Specified|4|||
170811581|NCT00088166|617319301|FG000|Overall Study|Adverse Event|11|||
170811582|NCT00088166|617319302|FG001|Overall Study|Adverse Event|9|||
170811583|NCT00088166|617319301|FG000|Overall Study|Death|3|||
170811584|NCT00088166|617319302|FG001|Overall Study|Death|1|||
170811585|NCT00088166|617319301|FG000|Overall Study|Lost to Follow-up|0|||
170811586|NCT00088166|617319302|FG001|Overall Study|Lost to Follow-up|1|||
170811587|NCT00088166|617319301|FG000|Overall Study|Physician Decision|4|||
170811588|NCT00088166|617319302|FG001|Overall Study|Physician Decision|1|||
170811589|NCT00088166|617319301|FG000|Overall Study|Protocol Violation|1|||
170811590|NCT00088166|617319302|FG001|Overall Study|Protocol Violation|5|||
170811591|NCT00088166|617319301|FG000|Overall Study|Patient deterioration|29|||
170811592|NCT00088166|617319302|FG001|Overall Study|Patient deterioration|39|||
170811593|NCT00088166|617319301|FG000|Overall Study|Withdrawal by Subject|5|||
170811594|NCT00088166|617319302|FG001|Overall Study|Withdrawal by Subject|5|||
170811595|NCT02671266|617319303|FG000|Overall Study|Withdrawal by Subject|1|||
170811596|NCT02671266|617319304|FG001|Overall Study|Withdrawal by Subject|1|||
170811597|NCT00681109|617319307|FG000|Overall Study|Lost to Follow-up|2|||
170811598|NCT00681109|617319308|FG001|Overall Study|Lost to Follow-up|6|||
170811599|NCT00681109|617319309|FG002|Overall Study|Lost to Follow-up|0|||
170811600|NCT01794299|617319311|FG000|Overall Study|ATIR manufacturing not possible|1|||
170811601|NCT01794299|617319311|FG000|Overall Study|Death|14|||
170811602|NCT01794299|617319311|FG000|Overall Study|Graft failure|1|||
170811603|NCT01794299|617319311|FG000|Overall Study|ATIR batch rejected|2|||
170811604|NCT01794299|617319311|FG000|Overall Study|Relapse|2|||
170811605|NCT01794299|617319311|FG000|Overall Study|Discontinued from active follow-up|1|||
170811606|NCT01794299|617319311|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
170811607|NCT01029704|617319314|FG000|Overall Study|Adverse Event|0|||
170811608|NCT01029704|617319315|FG001|Overall Study|Adverse Event|0|||
170811609|NCT01029704|617319316|FG002|Overall Study|Adverse Event|0|||
170811610|NCT01029704|617319317|FG003|Overall Study|Adverse Event|0|||
170811611|NCT01029704|617319318|FG004|Overall Study|Adverse Event|0|||
170811612|NCT01029704|617319319|FG005|Overall Study|Adverse Event|0|||
170811613|NCT01029704|617319320|FG006|Overall Study|Adverse Event|1|||
170811614|NCT01029704|617319321|FG007|Overall Study|Adverse Event|1|||
170912982|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
170912983|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
170912984|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
170912985|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
170912986|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Death|8|||
170595745|NCT00453973|616525981|FG000|Overall Study|Relocation|1|||
170595746|NCT00453973|616525982|FG001|Overall Study|Relocation|0|||
170811615|NCT01029704|617319322|FG008|Overall Study|Adverse Event|0|||
170811616|NCT01029704|617319314|FG000|Overall Study|Withdrawal by Subject|0|||
170595747|NCT00453973|616525981|FG000|Overall Study|Renal transplant|1|||
170595748|NCT00453973|616525982|FG001|Overall Study|Renal transplant|1|||
170595749|NCT00453973|616525981|FG000|Overall Study|Site closed by sponsor|3|||
170595750|NCT00453973|616525982|FG001|Overall Study|Site closed by sponsor|0|||
170595751|NCT00453973|616525981|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
170595752|NCT00453973|616525982|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
170595753|NCT03743064|616525987|FG000|Overall Study|Adverse Event|7|||
170595754|NCT03743064|616525988|FG001|Overall Study|Adverse Event|9|||
170595755|NCT03743064|616525987|FG000|Overall Study|Death|25|||
170595756|NCT03743064|616525988|FG001|Overall Study|Death|28|||
170595757|NCT03743064|616525987|FG000|Overall Study|Lost to Follow-up|3|||
170595758|NCT03743064|616525988|FG001|Overall Study|Lost to Follow-up|6|||
170595759|NCT03743064|616525987|FG000|Overall Study|Withdrawal by Subject|28|||
170595760|NCT03743064|616525988|FG001|Overall Study|Withdrawal by Subject|25|||
170595761|NCT03743064|616525987|FG000|Overall Study|Physician Decision|2|||
170595762|NCT03743064|616525988|FG001|Overall Study|Physician Decision|4|||
170595763|NCT03743064|616525987|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
170595764|NCT03743064|616525988|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
170595765|NCT02759315|616525989|FG000|Overall Study|Adverse Event|0|||
170811617|NCT01029704|617319315|FG001|Overall Study|Withdrawal by Subject|0|||
170912987|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Death|3|||
170912988|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
170912989|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
170912990|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
170912991|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
170811618|NCT01029704|617319316|FG002|Overall Study|Withdrawal by Subject|0|||
170811619|NCT01029704|617319317|FG003|Overall Study|Withdrawal by Subject|0|||
170811620|NCT01029704|617319318|FG004|Overall Study|Withdrawal by Subject|2|||
170811621|NCT01029704|617319319|FG005|Overall Study|Withdrawal by Subject|1|||
170811622|NCT01029704|617319320|FG006|Overall Study|Withdrawal by Subject|1|||
170811623|NCT01029704|617319321|FG007|Overall Study|Withdrawal by Subject|1|||
170811624|NCT01029704|617319322|FG008|Overall Study|Withdrawal by Subject|0|||
170811625|NCT01029704|617319314|FG000|Overall Study|Lost to Follow-up|0|||
170811626|NCT01029704|617319315|FG001|Overall Study|Lost to Follow-up|0|||
170811627|NCT01029704|617319316|FG002|Overall Study|Lost to Follow-up|0|||
170811628|NCT01029704|617319317|FG003|Overall Study|Lost to Follow-up|0|||
170811629|NCT01029704|617319318|FG004|Overall Study|Lost to Follow-up|0|||
170811630|NCT01029704|617319319|FG005|Overall Study|Lost to Follow-up|0|||
170811631|NCT01029704|617319320|FG006|Overall Study|Lost to Follow-up|1|||
170811632|NCT01029704|617319321|FG007|Overall Study|Lost to Follow-up|1|||
170811633|NCT01029704|617319322|FG008|Overall Study|Lost to Follow-up|1|||
170811634|NCT01029704|617319314|FG000|Overall Study|Lack of Efficacy|0|||
170811635|NCT01029704|617319315|FG001|Overall Study|Lack of Efficacy|0|||
170811636|NCT01029704|617319316|FG002|Overall Study|Lack of Efficacy|0|||
170811637|NCT01029704|617319317|FG003|Overall Study|Lack of Efficacy|0|||
170811638|NCT01029704|617319318|FG004|Overall Study|Lack of Efficacy|2|||
170811639|NCT01029704|617319319|FG005|Overall Study|Lack of Efficacy|3|||
170811640|NCT01029704|617319320|FG006|Overall Study|Lack of Efficacy|1|||
170811641|NCT01029704|617319321|FG007|Overall Study|Lack of Efficacy|2|||
170811642|NCT01029704|617319322|FG008|Overall Study|Lack of Efficacy|0|||
170811643|NCT01029704|617319314|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
170811644|NCT01029704|617319315|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
170811645|NCT01029704|617319316|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
170811646|NCT01029704|617319317|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
170811647|NCT01029704|617319318|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
170811648|NCT01029704|617319319|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
170811649|NCT01029704|617319320|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
170811650|NCT01029704|617319321|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
170811651|NCT01029704|617319322|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
170811652|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
170811653|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
170811654|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
170811655|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
170811656|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Death|0|||
170811657|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Death|0|||
170811658|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Death|1|||
170595766|NCT02759315|616525990|FG001|Overall Study|Adverse Event|0|||
170650953|NCT02093351|616736304|FG002|Part B|Condition under investigation worsened|0|||
170811659|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Death|0|||
170595767|NCT02759315|616525991|FG002|Overall Study|Adverse Event|0|||
170595768|NCT02759315|616525992|FG003|Overall Study|Adverse Event|1|||
170595769|NCT02759315|616525993|FG004|Overall Study|Adverse Event|0|||
170595770|NCT02759315|616525989|FG000|Overall Study|Death|0|||
170595771|NCT02759315|616525990|FG001|Overall Study|Death|0|||
170595772|NCT02759315|616525991|FG002|Overall Study|Death|1|||
170595773|NCT02759315|616525992|FG003|Overall Study|Death|0|||
170595774|NCT02759315|616525993|FG004|Overall Study|Death|0|||
170595775|NCT02759315|616525989|FG000|Overall Study|Lost to Follow-up|2|||
170595776|NCT02759315|616525990|FG001|Overall Study|Lost to Follow-up|0|||
170595777|NCT02759315|616525991|FG002|Overall Study|Lost to Follow-up|4|||
170595778|NCT02759315|616525992|FG003|Overall Study|Lost to Follow-up|0|||
170595779|NCT02759315|616525993|FG004|Overall Study|Lost to Follow-up|0|||
170912992|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
170912993|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
170912994|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
170912995|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
170912996|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
170912997|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
170912998|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
170912999|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
170913000|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
170913001|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
170913002|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
170913003|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
170913004|NCT00494871|617685814|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
170913005|NCT00494871|617685815|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
170913006|NCT00494871|617685814|FG000|Follow-up (FU) Period|Adverse Event|1|||
170913007|NCT00494871|617685815|FG001|Follow-up (FU) Period|Adverse Event|1|||
170913008|NCT00494871|617685814|FG000|Follow-up (FU) Period|Death|13|||
170913009|NCT00494871|617685815|FG001|Follow-up (FU) Period|Death|12|||
170913010|NCT00494871|617685814|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
170913011|NCT00494871|617685815|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
170913012|NCT00494871|617685814|FG000|Follow-up (FU) Period|Physician Decision|0|||
170913013|NCT00494871|617685815|FG001|Follow-up (FU) Period|Physician Decision|1|||
170913014|NCT00494871|617685814|FG000|Follow-up (FU) Period|Protocol Violation|1|||
170913015|NCT00494871|617685815|FG001|Follow-up (FU) Period|Protocol Violation|0|||
170913016|NCT00494871|617685814|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
170913017|NCT00494871|617685815|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
170913018|NCT00494871|617685814|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
170913019|NCT00494871|617685815|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
170913020|NCT03060577|617685816|FG000|Overall Study|Withdrawal by Subject|25|||
170595780|NCT02759315|616525989|FG000|Overall Study|Protocol Violation|0|||
170595781|NCT02759315|616525990|FG001|Overall Study|Protocol Violation|1|||
170595782|NCT02759315|616525991|FG002|Overall Study|Protocol Violation|0|||
170595783|NCT02759315|616525992|FG003|Overall Study|Protocol Violation|0|||
170595784|NCT02759315|616525993|FG004|Overall Study|Protocol Violation|0|||
170595785|NCT02759315|616525989|FG000|Overall Study|Study terminated prior to completion|2|||
170595786|NCT02759315|616525990|FG001|Overall Study|Study terminated prior to completion|0|||
170595787|NCT02759315|616525991|FG002|Overall Study|Study terminated prior to completion|5|||
170595788|NCT02759315|616525992|FG003|Overall Study|Study terminated prior to completion|0|||
170595789|NCT02759315|616525993|FG004|Overall Study|Study terminated prior to completion|1|||
170595790|NCT02648217|616525996|FG000|Overall Study|Adverse Event|0|||
170595791|NCT02648217|616525997|FG001|Overall Study|Adverse Event|1|||
170595792|NCT02648217|616525996|FG000|Overall Study|Lost to Follow-up|1|||
170595793|NCT02648217|616525997|FG001|Overall Study|Lost to Follow-up|1|||
170595794|NCT02648217|616525996|FG000|Overall Study|Withdrawal by Subject|4|||
170595795|NCT02648217|616525997|FG001|Overall Study|Withdrawal by Subject|3|||
170595796|NCT02648217|616525996|FG000|Overall Study|Unclassified|5|||
170595797|NCT02648217|616525997|FG001|Overall Study|Unclassified|0|||
170595798|NCT02553538|616525998|FG000|Overall Study|Could Not Reach by Telephone|133|||
170595799|NCT02553538|616525999|FG001|Overall Study|Could Not Reach by Telephone|0|||
170595800|NCT02553538|616525998|FG000|Overall Study|Died or Left Network|54|||
170595801|NCT02553538|616525999|FG001|Overall Study|Died or Left Network|56|||
170595802|NCT00870194|616526000|FG000|Overall Study|Adverse Event|10|||
170595803|NCT00870194|616526001|FG001|Overall Study|Adverse Event|5|||
170595804|NCT00870194|616526000|FG000|Overall Study|Lack of Efficacy|0|||
170650954|NCT02093351|616736305|FG003|Part B|Condition under investigation worsened|39|||
170595805|NCT00870194|616526001|FG001|Overall Study|Lack of Efficacy|1|||
170595806|NCT00870194|616526000|FG000|Overall Study|Lost to Follow-up|2|||
170595807|NCT00870194|616526001|FG001|Overall Study|Lost to Follow-up|0|||
170595808|NCT00870194|616526000|FG000|Overall Study|Physician Decision|3|||
170595809|NCT00870194|616526001|FG001|Overall Study|Physician Decision|1|||
170595810|NCT00870194|616526000|FG000|Overall Study|Protocol Violation|3|||
170595811|NCT00870194|616526001|FG001|Overall Study|Protocol Violation|3|||
170595812|NCT00870194|616526000|FG000|Overall Study|Entry Criteria Not Met|1|||
170595813|NCT00870194|616526001|FG001|Overall Study|Entry Criteria Not Met|2|||
170595814|NCT00870194|616526000|FG000|Overall Study|Subject Decision|7|||
170595815|NCT00870194|616526001|FG001|Overall Study|Subject Decision|2|||
170595816|NCT01406015|616526002|FG000|Overall Study|Withdrawal by Subject|3|||
170595817|NCT01406015|616526003|FG001|Overall Study|Withdrawal by Subject|3|||
170595818|NCT00707746|616526004|FG000|Treatment Period|Adverse Event|2|||
170595819|NCT00707746|616526005|FG001|Treatment Period|Adverse Event|4|||
170595820|NCT00707746|616526004|FG000|Treatment Period|Ineligibility|0|||
170595821|NCT00707746|616526005|FG001|Treatment Period|Ineligibility|1|||
170595822|NCT01352741|616526020|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
170595823|NCT01352741|616526021|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
170595824|NCT01352741|616526020|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
170595825|NCT01352741|616526021|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
170595826|NCT01352741|616526020|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
170595827|NCT01352741|616526021|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
170595828|NCT01352741|616526020|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
170595829|NCT01352741|616526021|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
170595830|NCT01352741|616526020|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
170595831|NCT01352741|616526021|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
170595832|NCT01352741|616526020|FG000|Open-label Tapentadol Titration Period|Other|4|||
170595833|NCT01352741|616526021|FG001|Open-label Tapentadol Titration Period|Other|0|||
170595834|NCT01352741|616526020|FG000|Double-blind Comparative Period|Protocol Violation|2|||
170595835|NCT01352741|616526021|FG001|Double-blind Comparative Period|Protocol Violation|0|||
170595836|NCT01352741|616526020|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
170595837|NCT01352741|616526021|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
170595838|NCT01352741|616526020|FG000|Double-blind Comparative Period|Adverse Event|16|||
170595839|NCT01352741|616526021|FG001|Double-blind Comparative Period|Adverse Event|17|||
170595840|NCT01352741|616526020|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
170595841|NCT01352741|616526021|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
170595842|NCT01352741|616526020|FG000|Double-blind Comparative Period|Death|0|||
170595843|NCT01352741|616526021|FG001|Double-blind Comparative Period|Death|1|||
170595844|NCT01352741|616526020|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
170595845|NCT01352741|616526021|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
170595846|NCT01352741|616526020|FG000|Double-blind Comparative Period|Other|1|||
170595847|NCT01352741|616526021|FG001|Double-blind Comparative Period|Other|2|||
170595848|NCT01352741|616526020|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
170595849|NCT01352741|616526021|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
170595850|NCT01352741|616526020|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
170913021|NCT03060577|617685817|FG001|Overall Study|Withdrawal by Subject|5|||
170913022|NCT03060577|617685816|FG000|Overall Study|Physician Decision|4|||
170913023|NCT03060577|617685817|FG001|Overall Study|Physician Decision|3|||
170913024|NCT03060577|617685816|FG000|Overall Study|Lost to Follow-up|3|||
170913025|NCT03060577|617685817|FG001|Overall Study|Lost to Follow-up|0|||
170913026|NCT03060577|617685816|FG000|Overall Study|Death|7|||
170913027|NCT03060577|617685817|FG001|Overall Study|Death|1|||
170913028|NCT03060577|617685816|FG000|Overall Study|Adverse Event|9|||
170913029|NCT03060577|617685817|FG001|Overall Study|Adverse Event|1|||
170913030|NCT03060577|617685816|FG000|Overall Study|Inclusion/Exclusion|1|||
170913031|NCT03060577|617685817|FG001|Overall Study|Inclusion/Exclusion|0|||
170913032|NCT03060577|617685816|FG000|Overall Study|Other|8|||
170913033|NCT03060577|617685817|FG001|Overall Study|Other|2|||
170913034|NCT02940886|617685818|FG000|Overall Study|Adverse Event|7|||
170913035|NCT02940886|617685819|FG001|Overall Study|Adverse Event|3|||
170913036|NCT02940886|617685818|FG000|Overall Study|Protocol Violation|0|||
170913037|NCT02940886|617685819|FG001|Overall Study|Protocol Violation|2|||
170913038|NCT02940886|617685818|FG000|Overall Study|Withdrawal by Subject|28|||
170913039|NCT02940886|617685819|FG001|Overall Study|Withdrawal by Subject|20|||
170595851|NCT01352741|616526021|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
170595852|NCT01352741|616526020|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
170595853|NCT01352741|616526021|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
170595854|NCT01352741|616526020|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
170595855|NCT01352741|616526021|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
170595856|NCT04070326|616526023|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
170913040|NCT02940886|617685818|FG000|Overall Study|Death|1|||
170913041|NCT02940886|617685819|FG001|Overall Study|Death|0|||
170595857|NCT04070326|616526024|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
170913042|NCT02940886|617685818|FG000|Overall Study|Lack of Efficacy|1|||
170595858|NCT01367704|616526025|FG000|Overall Study|Lost to Follow-up|47|||
170913043|NCT02940886|617685819|FG001|Overall Study|Lack of Efficacy|0|||
170913044|NCT02940886|617685818|FG000|Overall Study|Lost to Follow-up|49|||
170913045|NCT02940886|617685819|FG001|Overall Study|Lost to Follow-up|21|||
170595859|NCT01367704|616526026|FG001|Overall Study|Lost to Follow-up|161|||
170595860|NCT00645528|616526029|FG000|Overall Study|Did not show up for Visit 2|7|||
170595861|NCT02741570|616526037|FG000|Pre-Treatment Period|Other reasons|0|||
170595862|NCT02741570|616526038|FG001|Pre-Treatment Period|Other reasons|3|||
170595863|NCT02741570|616526037|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
170595864|NCT02741570|616526038|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
170595865|NCT02741570|616526037|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
170595866|NCT02741570|616526038|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
170595867|NCT02741570|616526037|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
170595868|NCT02741570|616526038|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
170595869|NCT02741570|616526037|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
170595870|NCT02741570|616526038|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
170595871|NCT02741570|616526037|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
170595872|NCT02741570|616526038|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
170595873|NCT02741570|616526037|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
170595874|NCT02741570|616526038|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
170811660|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
170811661|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
170595875|NCT02741570|616526037|FG000|Pre-Treatment Period|Death|0|||
170595876|NCT02741570|616526038|FG001|Pre-Treatment Period|Death|1|||
170595877|NCT02741570|616526037|FG000|Pre-Treatment Period|Disease progression|0|||
170595878|NCT02741570|616526038|FG001|Pre-Treatment Period|Disease progression|1|||
170595879|NCT02741570|616526037|FG000|Treatment Period|Other reasons|47|||
170595880|NCT02741570|616526038|FG001|Treatment Period|Other reasons|12|||
170595881|NCT02741570|616526037|FG000|Treatment Period|Poor/non-compliance|0|||
170595882|NCT02741570|616526038|FG001|Treatment Period|Poor/non-compliance|2|||
170595883|NCT02741570|616526037|FG000|Treatment Period|Maximum clinical benefit|4|||
170595884|NCT02741570|616526038|FG001|Treatment Period|Maximum clinical benefit|6|||
170595885|NCT02741570|616526037|FG000|Treatment Period|Lost to Follow-up|1|||
170595886|NCT02741570|616526038|FG001|Treatment Period|Lost to Follow-up|3|||
170595887|NCT02741570|616526037|FG000|Treatment Period|Participant withdrew consent|9|||
170595888|NCT02741570|616526038|FG001|Treatment Period|Participant withdrew consent|13|||
170595889|NCT02741570|616526037|FG000|Treatment Period|Participant request to discontinue treatment|8|||
170595890|NCT02741570|616526038|FG001|Treatment Period|Participant request to discontinue treatment|23|||
170595891|NCT02741570|616526037|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
170595892|NCT02741570|616526038|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
170595893|NCT02741570|616526037|FG000|Treatment Period|Death|9|||
170595894|NCT02741570|616526038|FG001|Treatment Period|Death|7|||
170595895|NCT02741570|616526037|FG000|Treatment Period|Study drug toxicity|55|||
170595896|NCT02741570|616526038|FG001|Treatment Period|Study drug toxicity|47|||
170595897|NCT02741570|616526037|FG000|Treatment Period|Disease progression|294|||
170811662|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
170811663|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
170811664|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
170811665|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
170811666|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
170811667|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
170811668|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
170811669|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
170811670|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
170811671|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
170811672|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
170811673|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
170811674|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
170811675|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
170811676|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
170811677|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
170811678|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
170811679|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
170811680|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Other|2|||
170811681|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Other|0|||
170811682|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Other|0|||
170811683|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Other|0|||
170811684|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
170595898|NCT02741570|616526038|FG001|Treatment Period|Disease progression|301|||
170595899|NCT02741570|616526037|FG000|Treatment Period|Administrative reason by sponsor|0|||
170595900|NCT02741570|616526038|FG001|Treatment Period|Administrative reason by sponsor|1|||
170595901|NCT03352453|616526040|FG000|Overall Study|Miscellaneous Reasons|1|||
170595902|NCT03352453|616526041|FG001|Overall Study|Miscellaneous Reasons|2|||
170595903|NCT03352453|616526040|FG000|Overall Study|Lack of Efficacy|1|||
170595904|NCT03352453|616526041|FG001|Overall Study|Lack of Efficacy|0|||
170913046|NCT02940886|617685818|FG000|Overall Study|Physician Decision|9|||
170913047|NCT02940886|617685819|FG001|Overall Study|Physician Decision|4|||
170913048|NCT02940886|617685818|FG000|Overall Study|Sponsor decision|0|||
170913049|NCT02940886|617685819|FG001|Overall Study|Sponsor decision|1|||
170913050|NCT02940886|617685818|FG000|Overall Study|No treatment|7|||
170913051|NCT02940886|617685819|FG001|Overall Study|No treatment|2|||
170913052|NCT02940886|617685818|FG000|Overall Study|Enrolment error|0|||
170595905|NCT03352453|616526040|FG000|Overall Study|Withdrawal by Subject|8|||
170595906|NCT03352453|616526041|FG001|Overall Study|Withdrawal by Subject|14|||
170595907|NCT03352453|616526040|FG000|Overall Study|Study Terminated by Sponsor|2|||
170595908|NCT03352453|616526041|FG001|Overall Study|Study Terminated by Sponsor|1|||
170595909|NCT03352453|616526040|FG000|Overall Study|Protocol Deviation|1|||
170595910|NCT03352453|616526041|FG001|Overall Study|Protocol Deviation|0|||
170595911|NCT03352453|616526040|FG000|Overall Study|Lost to Follow-up|7|||
170595912|NCT03352453|616526041|FG001|Overall Study|Lost to Follow-up|6|||
170595913|NCT03352453|616526040|FG000|Overall Study|Adverse Event|2|||
170595914|NCT03352453|616526041|FG001|Overall Study|Adverse Event|9|||
170595915|NCT01241760|616526044|FG000|Overall Study|Adverse Event|1|||
170595916|NCT01241760|616526045|FG001|Overall Study|Adverse Event|0|||
170595917|NCT01241760|616526044|FG000|Overall Study|Lost to Follow-up|18|||
170595918|NCT01241760|616526045|FG001|Overall Study|Lost to Follow-up|22|||
170595919|NCT01241760|616526044|FG000|Overall Study|Withdrawal by Subject|13|||
170595920|NCT01241760|616526045|FG001|Overall Study|Withdrawal by Subject|13|||
170595921|NCT01241760|616526044|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
170595922|NCT01241760|616526045|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
170595923|NCT01241760|616526044|FG000|Overall Study|Other|1|||
170595924|NCT01241760|616526045|FG001|Overall Study|Other|1|||
170595925|NCT03158272|616526046|FG000|Overall Study|Disease progression|3|||
170595926|NCT03158272|616526047|FG001|Overall Study|Disease progression|3|||
170595927|NCT03158272|616526048|FG002|Overall Study|Disease progression|4|||
170595928|NCT03158272|616526049|FG003|Overall Study|Disease progression|6|||
170595929|NCT03158272|616526046|FG000|Overall Study|Death|0|||
170595930|NCT03158272|616526047|FG001|Overall Study|Death|0|||
170595931|NCT03158272|616526048|FG002|Overall Study|Death|1|||
170595932|NCT03158272|616526049|FG003|Overall Study|Death|0|||
170595933|NCT03158272|616526046|FG000|Overall Study|Other reasons|0|||
170595934|NCT03158272|616526047|FG001|Overall Study|Other reasons|0|||
170595935|NCT03158272|616526048|FG002|Overall Study|Other reasons|1|||
170595936|NCT03158272|616526049|FG003|Overall Study|Other reasons|0|||
170595937|NCT03158272|616526046|FG000|Overall Study|Adverse event unrelated to the drug|0|||
170595938|NCT03158272|616526047|FG001|Overall Study|Adverse event unrelated to the drug|1|||
170595939|NCT03158272|616526048|FG002|Overall Study|Adverse event unrelated to the drug|0|||
170595940|NCT03158272|616526049|FG003|Overall Study|Adverse event unrelated to the drug|0|||
170595941|NCT00514020|616526050|FG000|Overall Study|Adverse Event|6|||
170595942|NCT00514020|616526050|FG000|Overall Study|Withdrawal by Subject|3|||
170595943|NCT00514020|616526050|FG000|Overall Study|Physician Decision|1|||
170595944|NCT00514020|616526050|FG000|Overall Study|disease progression|9|||
170595945|NCT00514020|616526050|FG000|Overall Study|other complicating disease|2|||
170595946|NCT00514020|616526050|FG000|Overall Study|patient went to radiation treatment|1|||
170595947|NCT00514020|616526050|FG000|Overall Study|"patients moved to the no tx group"|6|||
170595948|NCT01688921|616526051|FG000|Overall Study|Lost to Follow-up|7|||
170595949|NCT01688921|616526052|FG001|Overall Study|Lost to Follow-up|13|||
170595950|NCT01688921|616526051|FG000|Overall Study|Physician Decision|6|||
170595951|NCT01688921|616526052|FG001|Overall Study|Physician Decision|1|||
170595952|NCT01688921|616526051|FG000|Overall Study|Protocol Violation|0|||
170595953|NCT01688921|616526052|FG001|Overall Study|Protocol Violation|1|||
170811685|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
170811686|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
170811687|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
170811688|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
170811689|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
170811690|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
170811691|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
170811692|NCT03845517|617319323|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
170811693|NCT03845517|617319324|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
170811694|NCT03845517|617319325|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
170811695|NCT03845517|617319326|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
170811696|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
170595954|NCT01688921|616526051|FG000|Overall Study|informed consent|3|||
170595955|NCT01688921|616526052|FG001|Overall Study|informed consent|0|||
170595956|NCT01636713|616526053|FG000|Overall Study|Adverse Event|16|||
170811697|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
170595957|NCT01636713|616526054|FG001|Overall Study|Adverse Event|16|||
170595958|NCT01636713|616526055|FG002|Overall Study|Adverse Event|7|||
170913053|NCT02940886|617685819|FG001|Overall Study|Enrolment error|1|||
170595959|NCT01636713|616526053|FG000|Overall Study|Lack of Efficacy|6|||
170595960|NCT01636713|616526054|FG001|Overall Study|Lack of Efficacy|6|||
170913054|NCT03042611|617685820|FG000|Core Phase|Withdrawal by Subject|13|||
170913055|NCT03042611|617685821|FG001|Core Phase|Withdrawal by Subject|4|||
170913056|NCT03042611|617685822|FG002|Core Phase|Withdrawal by Subject|0|||
170913057|NCT03042611|617685823|FG003|Core Phase|Withdrawal by Subject|0|||
170913058|NCT03042611|617685820|FG000|Core Phase|Death|232|||
170913059|NCT03042611|617685821|FG001|Core Phase|Death|110|||
170913060|NCT03042611|617685822|FG002|Core Phase|Death|0|||
170913061|NCT03042611|617685823|FG003|Core Phase|Death|0|||
170913062|NCT03042611|617685820|FG000|Core Phase|Lost to Follow-up|4|||
170913063|NCT03042611|617685821|FG001|Core Phase|Lost to Follow-up|7|||
170913064|NCT03042611|617685822|FG002|Core Phase|Lost to Follow-up|0|||
170913065|NCT03042611|617685823|FG003|Core Phase|Lost to Follow-up|0|||
170913066|NCT03042611|617685820|FG000|Core Phase|Physician Decision|7|||
170913067|NCT03042611|617685821|FG001|Core Phase|Physician Decision|2|||
170913068|NCT03042611|617685822|FG002|Core Phase|Physician Decision|0|||
170913069|NCT03042611|617685823|FG003|Core Phase|Physician Decision|0|||
170913070|NCT03042611|617685820|FG000|Core Phase|Study Closed|0|||
170913071|NCT03042611|617685821|FG001|Core Phase|Study Closed|1|||
170913072|NCT03042611|617685822|FG002|Core Phase|Study Closed|0|||
170913073|NCT03042611|617685823|FG003|Core Phase|Study Closed|0|||
170913074|NCT03042611|617685820|FG000|Extension Phase|Death|0|||
170913075|NCT03042611|617685821|FG001|Extension Phase|Death|0|||
170913076|NCT03042611|617685822|FG002|Extension Phase|Death|34|||
170913077|NCT03042611|617685823|FG003|Extension Phase|Death|16|||
170913078|NCT03042611|617685820|FG000|Extension Phase|Lost to Follow-up|0|||
170913079|NCT03042611|617685821|FG001|Extension Phase|Lost to Follow-up|0|||
170913080|NCT03042611|617685822|FG002|Extension Phase|Lost to Follow-up|1|||
170913081|NCT03042611|617685823|FG003|Extension Phase|Lost to Follow-up|1|||
170913082|NCT03042611|617685820|FG000|Extension Phase|Study Closed|0|||
170913083|NCT03042611|617685821|FG001|Extension Phase|Study Closed|0|||
170913084|NCT03042611|617685822|FG002|Extension Phase|Study Closed|17|||
170913085|NCT03042611|617685823|FG003|Extension Phase|Study Closed|11|||
170913086|NCT03216265|617685824|FG000|Overall Study|Adverse Event|2|||
170595961|NCT01636713|616526055|FG002|Overall Study|Lack of Efficacy|2|||
170595962|NCT01636713|616526053|FG000|Overall Study|Protocol Violation|3|||
170595963|NCT01636713|616526054|FG001|Overall Study|Protocol Violation|0|||
170595964|NCT01636713|616526055|FG002|Overall Study|Protocol Violation|1|||
170595965|NCT01636713|616526053|FG000|Overall Study|Lost to Follow-up|0|||
170595966|NCT01636713|616526054|FG001|Overall Study|Lost to Follow-up|0|||
170595967|NCT01636713|616526055|FG002|Overall Study|Lost to Follow-up|1|||
170595968|NCT01636713|616526053|FG000|Overall Study|Withdrawal by Subject|5|||
170595969|NCT01636713|616526054|FG001|Overall Study|Withdrawal by Subject|4|||
170595970|NCT01636713|616526055|FG002|Overall Study|Withdrawal by Subject|8|||
170595971|NCT01636713|616526053|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
170595972|NCT01636713|616526054|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
170595973|NCT01636713|616526055|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
170595974|NCT03582813|616526064|FG000|Overall Study|Lost to Follow-up|18|||
170595975|NCT03582813|616526065|FG001|Overall Study|Lost to Follow-up|21|||
170595976|NCT03582813|616526064|FG000|Overall Study|Withdrawal by Subject|1|||
170595977|NCT03582813|616526065|FG001|Overall Study|Withdrawal by Subject|0|||
170595978|NCT02525094|616526070|FG000|Overall Study|Lost to Follow-up|2|||
170595979|NCT02525094|616526071|FG001|Overall Study|Lost to Follow-up|1|||
170595980|NCT02525094|616526070|FG000|Overall Study|Withdrawal by Subject|5|||
170595981|NCT02525094|616526071|FG001|Overall Study|Withdrawal by Subject|6|||
170595982|NCT02525094|616526070|FG000|Overall Study|Not Treated|1|||
170595983|NCT02525094|616526071|FG001|Overall Study|Not Treated|1|||
170595984|NCT02117349|616526072|FG000|Overall Study|Withdrawal by Subject|1|||
170595985|NCT02117349|616526073|FG001|Overall Study|Withdrawal by Subject|0|||
170595986|NCT02117349|616526072|FG000|Overall Study|Lost to Follow-up|1|||
170595987|NCT02117349|616526073|FG001|Overall Study|Lost to Follow-up|1|||
170595988|NCT02117349|616526072|FG000|Overall Study|Death|1|||
170595989|NCT02117349|616526073|FG001|Overall Study|Death|0|||
170595990|NCT02242981|616526074|FG000|Overall Study|Withdrawal by Subject|1|||
170595991|NCT03474081|616526079|FG000|Overall Study|Adverse Event|6|||
170595992|NCT03474081|616526080|FG001|Overall Study|Adverse Event|3|||
170595993|NCT03474081|616526079|FG000|Overall Study|Lost to Follow-up|2|||
170650955|NCT02093351|616736302|FG000|Part B|Adverse Event|0|||
170650956|NCT02093351|616736303|FG001|Part B|Adverse Event|0|||
170913087|NCT03216265|617685825|FG001|Overall Study|Adverse Event|0|||
170913088|NCT03216265|617685826|FG002|Overall Study|Adverse Event|2|||
170913089|NCT03216265|617685824|FG000|Overall Study|Lost to Follow-up|0|||
170913090|NCT03216265|617685825|FG001|Overall Study|Lost to Follow-up|1|||
170913091|NCT03216265|617685826|FG002|Overall Study|Lost to Follow-up|0|||
170595994|NCT03474081|616526080|FG001|Overall Study|Lost to Follow-up|1|||
170595995|NCT03474081|616526079|FG000|Overall Study|Physician Decision|3|||
170595996|NCT03474081|616526080|FG001|Overall Study|Physician Decision|2|||
170595997|NCT03474081|616526079|FG000|Overall Study|Withdrawal by Subject|5|||
170650957|NCT02093351|616736304|FG002|Part B|Adverse Event|0|||
170913092|NCT03216265|617685824|FG000|Overall Study|Withdrawal by Subject|0|||
170913093|NCT03216265|617685825|FG001|Overall Study|Withdrawal by Subject|0|||
170913094|NCT03216265|617685826|FG002|Overall Study|Withdrawal by Subject|1|||
170913095|NCT00950690|617685829|FG000|Overall Study|Death|4|||
170595998|NCT03474081|616526080|FG001|Overall Study|Withdrawal by Subject|7|||
170595999|NCT03474081|616526079|FG000|Overall Study|Investigator site closed|1|||
170596000|NCT03474081|616526080|FG001|Overall Study|Investigator site closed|0|||
170596001|NCT02230683|616526083|FG000|Overall Study|Adverse Event|1|||
170596002|NCT02440789|616526086|FG000|Overall Study|Withdrawal by Subject|3|||
170596003|NCT02440789|616526086|FG000|Overall Study|Not willing to adhere to reqs|1|||
170811698|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
170811699|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
170811700|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Death|0|||
170811701|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Death|0|||
170811702|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Death|1|||
170811703|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Death|1|||
170811704|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
170811705|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
170811706|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
170811707|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
170811708|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
170811709|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
170811710|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
170811711|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
170811712|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
170811713|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
170811714|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
170811715|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
170811716|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Other|1|||
170811717|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Other|0|||
170811718|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Other|1|||
170811719|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Other|0|||
170811720|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
170811721|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
170811722|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
170811723|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
170811724|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
170811725|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
170811726|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
170811727|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
170811728|NCT03845517|617319323|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
170811729|NCT03845517|617319324|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
170811730|NCT03845517|617319325|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
170811731|NCT03845517|617319326|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
170811732|NCT01109979|617319327|FG000|Overall Study|Physician Decision|2|||
170811733|NCT01109979|617319328|FG001|Overall Study|Physician Decision|0|||
170811734|NCT01109979|617319327|FG000|Overall Study|Withdrawal by Subject|0|||
170811735|NCT01109979|617319328|FG001|Overall Study|Withdrawal by Subject|1|||
170811736|NCT00391170|617319329|FG000|Overall Study|Withdrawal by Subject|1|||
170811737|NCT00391170|617319330|FG001|Overall Study|Withdrawal by Subject|0|||
170811738|NCT00391170|617319329|FG000|Overall Study|Adverse Event|3|||
170811739|NCT00391170|617319330|FG001|Overall Study|Adverse Event|2|||
170811740|NCT00391170|617319329|FG000|Overall Study|Physician Decision|2|||
170811741|NCT00391170|617319330|FG001|Overall Study|Physician Decision|2|||
170811742|NCT00705159|617319331|FG000|Overall Study|Withdrawal by Subject|0|||
170811743|NCT00705159|617319332|FG001|Overall Study|Withdrawal by Subject|1|||
170811744|NCT00705159|617319333|FG002|Overall Study|Withdrawal by Subject|1|||
170811745|NCT00705159|617319334|FG003|Overall Study|Withdrawal by Subject|1|||
170811746|NCT00705159|617319331|FG000|Overall Study|Protocol Violation|0|||
170811747|NCT00705159|617319332|FG001|Overall Study|Protocol Violation|1|||
170811748|NCT00705159|617319333|FG002|Overall Study|Protocol Violation|0|||
170811749|NCT00705159|617319334|FG003|Overall Study|Protocol Violation|0|||
170811750|NCT00705159|617319331|FG000|Overall Study|Adverse Event|0|||
170811751|NCT00705159|617319332|FG001|Overall Study|Adverse Event|0|||
170811752|NCT00705159|617319333|FG002|Overall Study|Adverse Event|1|||
170811753|NCT00705159|617319334|FG003|Overall Study|Adverse Event|0|||
170811754|NCT00705159|617319331|FG000|Overall Study|Lost to Follow-up|0|||
170811755|NCT00705159|617319332|FG001|Overall Study|Lost to Follow-up|0|||
170811756|NCT00705159|617319333|FG002|Overall Study|Lost to Follow-up|3|||
170811757|NCT00705159|617319334|FG003|Overall Study|Lost to Follow-up|2|||
170811758|NCT00705159|617319331|FG000|Overall Study|Screen Failure|0|||
170811759|NCT00705159|617319332|FG001|Overall Study|Screen Failure|0|||
170811760|NCT00705159|617319333|FG002|Overall Study|Screen Failure|0|||
170811761|NCT00705159|617319334|FG003|Overall Study|Screen Failure|1|||
170811762|NCT03035942|617319335|FG000|Overall Study|Adverse Event|8|||
170811763|NCT03035942|617319336|FG001|Overall Study|Adverse Event|4|||
170811764|NCT03035942|617319337|FG002|Overall Study|Adverse Event|5|||
170913096|NCT00950690|617685829|FG000|Overall Study|Adverse Event|15|||
170913097|NCT00950690|617685829|FG000|Overall Study|Lack of Efficacy|22|||
170811765|NCT05163353|617319338|FG000|Overall Study|Adverse Event|1|||
170596004|NCT00546260|616526090|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
170596005|NCT00546260|616526091|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
170596006|NCT03780959|616526092|FG000|Part 1|Adverse Event|1|||
170596007|NCT03780959|616526093|FG001|Part 1|Adverse Event|0|||
170596008|NCT03780959|616526094|FG002|Part 1|Adverse Event|0|||
170596009|NCT03780959|616526092|FG000|Part 1|Withdrawal by Subject|1|||
170596010|NCT03780959|616526093|FG001|Part 1|Withdrawal by Subject|0|||
170596011|NCT03780959|616526094|FG002|Part 1|Withdrawal by Subject|0|||
170596012|NCT03780959|616526092|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
170596013|NCT03780959|616526093|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
170596014|NCT03780959|616526094|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
170596015|NCT03780959|616526092|FG000|Part 1|Response Status|2|||
170596016|NCT03780959|616526093|FG001|Part 1|Response Status|0|||
170596017|NCT03780959|616526094|FG002|Part 1|Response Status|0|||
170596018|NCT03780959|616526092|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
170596019|NCT03780959|616526093|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
170596020|NCT03780959|616526094|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
170596021|NCT03780959|616526092|FG000|Part 2|Response Status|0|||
170596022|NCT03780959|616526093|FG001|Part 2|Response Status|18|||
170596023|NCT03780959|616526094|FG002|Part 2|Response Status|6|||
170596024|NCT04435600|616527848|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170596025|NCT04435600|616527849|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170596026|NCT04435600|616527850|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
170650958|NCT02093351|616736305|FG003|Part B|Adverse Event|2|||
170650959|NCT02093351|616736302|FG000|Part B|Death|0|||
170650960|NCT02093351|616736303|FG001|Part B|Death|0|||
170650961|NCT02093351|616736304|FG002|Part B|Death|0|||
170650962|NCT02093351|616736305|FG003|Part B|Death|1|||
170650963|NCT03718299|616736306|FG000|Overall Study|Adverse Event|1|||
170650964|NCT03718299|616736306|FG000|Overall Study|Withdrawal by Subject|6|||
170650965|NCT03718299|616736306|FG000|Overall Study|Physician Decision|2|||
170650966|NCT03718299|616736306|FG000|Overall Study|Lost to Follow-up|1|||
170650967|NCT04535167|616736312|FG000|Treatment|Adverse Event|0|||
170650968|NCT04535167|616736313|FG001|Treatment|Adverse Event|0|||
170650969|NCT04535167|616736314|FG002|Treatment|Adverse Event|0|||
170650970|NCT04535167|616736315|FG003|Treatment|Adverse Event|0|||
170650971|NCT04535167|616736316|FG004|Treatment|Adverse Event|0|||
170650972|NCT04535167|616736317|FG005|Treatment|Adverse Event|0|||
170650973|NCT04535167|616736318|FG006|Treatment|Adverse Event|1|||
170650974|NCT04535167|616736312|FG000|Follow-Up|Death|0|||
170650975|NCT04535167|616736313|FG001|Follow-Up|Death|0|||
170650976|NCT04535167|616736314|FG002|Follow-Up|Death|0|||
170650977|NCT04535167|616736315|FG003|Follow-Up|Death|0|||
170650978|NCT04535167|616736316|FG004|Follow-Up|Death|0|||
170650979|NCT04535167|616736317|FG005|Follow-Up|Death|0|||
170650980|NCT04535167|616736318|FG006|Follow-Up|Death|1|||
170650981|NCT04535167|616736312|FG000|Follow-Up|Lost to Follow-up|0|||
170650982|NCT04535167|616736313|FG001|Follow-Up|Lost to Follow-up|0|||
170650983|NCT04535167|616736314|FG002|Follow-Up|Lost to Follow-up|0|||
170650984|NCT04535167|616736315|FG003|Follow-Up|Lost to Follow-up|1|||
170913098|NCT00950690|617685829|FG000|Overall Study|Lost to Follow-up|40|||
170913099|NCT00950690|617685829|FG000|Overall Study|Other|163|||
170913100|NCT00092547|617685830|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
170913101|NCT00092547|617685831|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
170913102|NCT00092547|617685832|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
170913103|NCT00092547|617685830|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
170913104|NCT00092547|617685831|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
170913105|NCT00092547|617685832|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
170913106|NCT00092547|617685830|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
170913107|NCT00092547|617685831|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
170913108|NCT00092547|617685832|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
170913109|NCT00092547|617685830|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
170913110|NCT00092547|617685831|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
170913111|NCT00092547|617685832|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
170913112|NCT00092547|617685830|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
170913113|NCT00092547|617685831|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
170913114|NCT00092547|617685832|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
170913115|NCT00092547|617685830|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
170596027|NCT04435600|616527851|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170596028|NCT04435600|616527852|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170596029|NCT04435600|616527853|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170596030|NCT04435600|616527854|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170596031|NCT04435600|616527855|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170650985|NCT04535167|616736316|FG004|Follow-Up|Lost to Follow-up|0|||
170650986|NCT04535167|616736317|FG005|Follow-Up|Lost to Follow-up|0|||
170650987|NCT04535167|616736318|FG006|Follow-Up|Lost to Follow-up|0|||
170650988|NCT04656275|616736323|FG000|Overall Study|Study terminated by sponsor|2|||
170913116|NCT00092547|617685831|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
170913117|NCT00092547|617685832|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
170913118|NCT00092547|617685830|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
170913119|NCT00092547|617685831|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
170913120|NCT00092547|617685832|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
170913121|NCT00092547|617685830|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
170913122|NCT00092547|617685831|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
170913123|NCT00092547|617685832|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
170913124|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
170913125|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
170596032|NCT04435600|616527856|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170596033|NCT04435600|616527857|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
170596034|NCT04435600|616527848|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596035|NCT04435600|616527849|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596036|NCT04435600|616527850|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596037|NCT04435600|616527851|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596038|NCT04435600|616527852|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596039|NCT04435600|616527853|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596040|NCT04435600|616527854|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596041|NCT04435600|616527855|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596042|NCT04435600|616527856|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
170596043|NCT04435600|616527857|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
170596044|NCT04435600|616527848|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596045|NCT04435600|616527849|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596046|NCT04435600|616527850|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596047|NCT04435600|616527851|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596048|NCT04435600|616527852|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596049|NCT04435600|616527853|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596050|NCT04435600|616527854|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596051|NCT04435600|616527855|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596052|NCT04435600|616527856|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
170596053|NCT04435600|616527857|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
170596054|NCT04435600|616527848|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596055|NCT04435600|616527849|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596056|NCT04435600|616527850|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596057|NCT04435600|616527851|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596058|NCT04435600|616527852|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596059|NCT04435600|616527853|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596060|NCT04435600|616527854|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596061|NCT04435600|616527855|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596062|NCT04435600|616527856|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
170596063|NCT04435600|616527857|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
170596064|NCT01751139|616527863|FG000|Overall Study|Other|135|||
170596065|NCT01751139|616527863|FG000|Overall Study|Sponsor study termination|1609|||
170596066|NCT01751139|616527863|FG000|Overall Study|Lost to Follow-up|240|||
170596067|NCT01751139|616527863|FG000|Overall Study|Withdrawal by Subject|251|||
170596068|NCT01751139|616527863|FG000|Overall Study|Adverse Event|1|||
170596069|NCT01751139|616527863|FG000|Overall Study|Death|31|||
170596070|NCT00098722|616527864|FG000|Double Blind Phase|Adverse Event|7|||
170596071|NCT00098722|616527865|FG001|Double Blind Phase|Adverse Event|7|||
170596072|NCT00098722|616527866|FG002|Double Blind Phase|Adverse Event|3|||
170596073|NCT00098722|616527867|FG003|Double Blind Phase|Adverse Event|0|||
170596074|NCT00098722|616527868|FG004|Double Blind Phase|Adverse Event|0|||
170596075|NCT00098722|616527869|FG005|Double Blind Phase|Adverse Event|0|||
170596076|NCT00098722|616527870|FG006|Double Blind Phase|Adverse Event|0|||
170596077|NCT00098722|616527864|FG000|Double Blind Phase|Death|2|||
170596078|NCT00098722|616527865|FG001|Double Blind Phase|Death|5|||
170596079|NCT00098722|616527866|FG002|Double Blind Phase|Death|0|||
170596080|NCT00098722|616527867|FG003|Double Blind Phase|Death|0|||
170596081|NCT00098722|616527868|FG004|Double Blind Phase|Death|0|||
170596082|NCT00098722|616527869|FG005|Double Blind Phase|Death|0|||
170596083|NCT00098722|616527870|FG006|Double Blind Phase|Death|0|||
170596084|NCT00098722|616527864|FG000|Double Blind Phase|Lack of Efficacy|21|||
170596085|NCT00098722|616527865|FG001|Double Blind Phase|Lack of Efficacy|23|||
170596086|NCT00098722|616527866|FG002|Double Blind Phase|Lack of Efficacy|15|||
170596087|NCT00098722|616527867|FG003|Double Blind Phase|Lack of Efficacy|0|||
170596088|NCT00098722|616527868|FG004|Double Blind Phase|Lack of Efficacy|0|||
170596089|NCT00098722|616527869|FG005|Double Blind Phase|Lack of Efficacy|0|||
170596090|NCT00098722|616527870|FG006|Double Blind Phase|Lack of Efficacy|0|||
170596091|NCT00098722|616527864|FG000|Double Blind Phase|Participant defaulted|16|||
170596092|NCT00098722|616527865|FG001|Double Blind Phase|Participant defaulted|11|||
170596093|NCT00098722|616527866|FG002|Double Blind Phase|Participant defaulted|9|||
170596094|NCT00098722|616527867|FG003|Double Blind Phase|Participant defaulted|0|||
170596095|NCT00098722|616527868|FG004|Double Blind Phase|Participant defaulted|0|||
170596096|NCT00098722|616527869|FG005|Double Blind Phase|Participant defaulted|0|||
170596097|NCT00098722|616527870|FG006|Double Blind Phase|Participant defaulted|0|||
170596098|NCT00098722|616527864|FG000|Double Blind Phase|Pregnancy|1|||
170596099|NCT00098722|616527865|FG001|Double Blind Phase|Pregnancy|0|||
170596100|NCT00098722|616527866|FG002|Double Blind Phase|Pregnancy|0|||
170596101|NCT00098722|616527867|FG003|Double Blind Phase|Pregnancy|0|||
170596102|NCT00098722|616527868|FG004|Double Blind Phase|Pregnancy|0|||
170596103|NCT00098722|616527869|FG005|Double Blind Phase|Pregnancy|0|||
170596104|NCT00098722|616527870|FG006|Double Blind Phase|Pregnancy|0|||
170596105|NCT00098722|616527864|FG000|Double Blind Phase|Randomized, not treated|4|||
170596106|NCT00098722|616527865|FG001|Double Blind Phase|Randomized, not treated|3|||
170596107|NCT00098722|616527866|FG002|Double Blind Phase|Randomized, not treated|3|||
170596108|NCT00098722|616527867|FG003|Double Blind Phase|Randomized, not treated|0|||
170596109|NCT00098722|616527868|FG004|Double Blind Phase|Randomized, not treated|0|||
170596110|NCT00098722|616527869|FG005|Double Blind Phase|Randomized, not treated|0|||
170596111|NCT00098722|616527870|FG006|Double Blind Phase|Randomized, not treated|0|||
170596112|NCT00098722|616527864|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
170596113|NCT00098722|616527865|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
170596114|NCT00098722|616527866|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
170596115|NCT00098722|616527867|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
170596116|NCT00098722|616527868|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
170596117|NCT00098722|616527869|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
170596118|NCT00098722|616527870|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
170596119|NCT00098722|616527864|FG000|Double Blind Phase|Other|7|||
170596120|NCT00098722|616527865|FG001|Double Blind Phase|Other|8|||
170596121|NCT00098722|616527866|FG002|Double Blind Phase|Other|7|||
170596122|NCT00098722|616527867|FG003|Double Blind Phase|Other|0|||
170596123|NCT00098722|616527868|FG004|Double Blind Phase|Other|0|||
170596124|NCT00098722|616527869|FG005|Double Blind Phase|Other|0|||
170596125|NCT00098722|616527870|FG006|Double Blind Phase|Other|0|||
170596126|NCT00098722|616527864|FG000|Open Label Phase|Adverse Event|0|||
170596127|NCT00098722|616527865|FG001|Open Label Phase|Adverse Event|0|||
170596128|NCT00098722|616527866|FG002|Open Label Phase|Adverse Event|0|||
170650989|NCT04656275|616736324|FG001|Overall Study|Study terminated by sponsor|4|||
170650990|NCT00713310|616736325|FG000|Overall Study|Adverse Event|5|||
170650991|NCT00713310|616736326|FG001|Overall Study|Adverse Event|2|||
170650992|NCT00713310|616736325|FG000|Overall Study|Lack of Efficacy|0|||
170811766|NCT05163353|617319339|FG001|Overall Study|Adverse Event|0|||
170811767|NCT05163353|617319338|FG000|Overall Study|Withdrawal by Subject|21|||
170811768|NCT05163353|617319339|FG001|Overall Study|Withdrawal by Subject|6|||
170811769|NCT05163353|617319338|FG000|Overall Study|Protocol Violation|0|||
170811770|NCT05163353|617319339|FG001|Overall Study|Protocol Violation|1|||
170811771|NCT05163353|617319338|FG000|Overall Study|Lost to Follow-up|13|||
170811772|NCT05163353|617319339|FG001|Overall Study|Lost to Follow-up|2|||
170811773|NCT06086028|617319341|FG000|Overall Study|Withdrawal by Subject|1|||
170811774|NCT06086028|617319342|FG001|Overall Study|Withdrawal by Subject|1|||
170811775|NCT06086028|617319341|FG000|Overall Study|Lost to Follow-up|2|||
170811776|NCT06086028|617319342|FG001|Overall Study|Lost to Follow-up|3|||
170811777|NCT02102724|617319345|FG000|Overall Study|Lost to Follow-up|1|||
170811778|NCT02102724|617319346|FG001|Overall Study|Lost to Follow-up|0|||
170811779|NCT02102724|617319345|FG000|Overall Study|surgery for brain aneurysm|1|||
170811780|NCT02102724|617319346|FG001|Overall Study|surgery for brain aneurysm|1|||
170811781|NCT02521493|617319347|FG000|Overall Study|Death|3|||
170811782|NCT02521493|617319348|FG001|Overall Study|Death|4|||
170811783|NCT02521493|617319349|FG002|Overall Study|Death|1|||
170811784|NCT02521493|617319347|FG000|Overall Study|Physician Decision|19|||
170811785|NCT02521493|617319348|FG001|Overall Study|Physician Decision|1|||
170811786|NCT02521493|617319349|FG002|Overall Study|Physician Decision|2|||
170811787|NCT02521493|617319347|FG000|Overall Study|Withdrawal by Subject|3|||
170811788|NCT02521493|617319348|FG001|Overall Study|Withdrawal by Subject|0|||
170811789|NCT02521493|617319349|FG002|Overall Study|Withdrawal by Subject|0|||
170811790|NCT02521493|617319347|FG000|Overall Study|Ineligible|0|||
170811791|NCT02521493|617319348|FG001|Overall Study|Ineligible|1|||
170811792|NCT02521493|617319349|FG002|Overall Study|Ineligible|0|||
170811793|NCT02521493|617319347|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
170596129|NCT00098722|616527867|FG003|Open Label Phase|Adverse Event|5|||
170596130|NCT00098722|616527868|FG004|Open Label Phase|Adverse Event|0|||
170596131|NCT00098722|616527869|FG005|Open Label Phase|Adverse Event|0|||
170596132|NCT00098722|616527870|FG006|Open Label Phase|Adverse Event|0|||
170596133|NCT00098722|616527864|FG000|Open Label Phase|Death|0|||
170596134|NCT00098722|616527865|FG001|Open Label Phase|Death|0|||
170596135|NCT00098722|616527866|FG002|Open Label Phase|Death|0|||
170596136|NCT00098722|616527867|FG003|Open Label Phase|Death|2|||
170811794|NCT02521493|617319348|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
170811795|NCT02521493|617319349|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
170811796|NCT02521493|617319347|FG000|Overall Study|No MRD result|0|||
170811797|NCT02521493|617319348|FG001|Overall Study|No MRD result|0|||
170596137|NCT00098722|616527868|FG004|Open Label Phase|Death|0|||
170596138|NCT00098722|616527869|FG005|Open Label Phase|Death|0|||
170596139|NCT00098722|616527870|FG006|Open Label Phase|Death|0|||
170596140|NCT00098722|616527864|FG000|Open Label Phase|Lack of Efficacy|0|||
170596141|NCT00098722|616527865|FG001|Open Label Phase|Lack of Efficacy|0|||
170596142|NCT00098722|616527866|FG002|Open Label Phase|Lack of Efficacy|0|||
170596143|NCT00098722|616527867|FG003|Open Label Phase|Lack of Efficacy|8|||
170596144|NCT00098722|616527868|FG004|Open Label Phase|Lack of Efficacy|0|||
170596145|NCT00098722|616527869|FG005|Open Label Phase|Lack of Efficacy|0|||
170596146|NCT00098722|616527870|FG006|Open Label Phase|Lack of Efficacy|0|||
170596147|NCT00098722|616527864|FG000|Open Label Phase|Pregnancy|0|||
170596148|NCT00098722|616527865|FG001|Open Label Phase|Pregnancy|0|||
170596149|NCT00098722|616527866|FG002|Open Label Phase|Pregnancy|0|||
170596150|NCT00098722|616527867|FG003|Open Label Phase|Pregnancy|1|||
170596151|NCT00098722|616527868|FG004|Open Label Phase|Pregnancy|0|||
170596152|NCT00098722|616527869|FG005|Open Label Phase|Pregnancy|0|||
170596153|NCT00098722|616527870|FG006|Open Label Phase|Pregnancy|0|||
170596154|NCT00098722|616527864|FG000|Open Label Phase|Participant defaulted|0|||
170596155|NCT00098722|616527865|FG001|Open Label Phase|Participant defaulted|0|||
170596156|NCT00098722|616527866|FG002|Open Label Phase|Participant defaulted|0|||
170596157|NCT00098722|616527867|FG003|Open Label Phase|Participant defaulted|18|||
170596158|NCT00098722|616527868|FG004|Open Label Phase|Participant defaulted|0|||
170596159|NCT00098722|616527869|FG005|Open Label Phase|Participant defaulted|0|||
170596160|NCT00098722|616527870|FG006|Open Label Phase|Participant defaulted|0|||
170596161|NCT00098722|616527864|FG000|Open Label Phase|Ongoing at cut-off date|0|||
170596162|NCT00098722|616527865|FG001|Open Label Phase|Ongoing at cut-off date|0|||
170596163|NCT00098722|616527866|FG002|Open Label Phase|Ongoing at cut-off date|0|||
170596164|NCT00098722|616527867|FG003|Open Label Phase|Ongoing at cut-off date|220|||
170596165|NCT00098722|616527868|FG004|Open Label Phase|Ongoing at cut-off date|50|||
170596166|NCT00098722|616527869|FG005|Open Label Phase|Ongoing at cut-off date|0|||
170596167|NCT00098722|616527870|FG006|Open Label Phase|Ongoing at cut-off date|0|||
170596168|NCT00098722|616527864|FG000|Open Label Phase|Other|0|||
170596169|NCT00098722|616527865|FG001|Open Label Phase|Other|0|||
170596170|NCT00098722|616527866|FG002|Open Label Phase|Other|0|||
170596171|NCT00098722|616527867|FG003|Open Label Phase|Other|18|||
170596172|NCT00098722|616527868|FG004|Open Label Phase|Other|0|||
170596173|NCT00098722|616527869|FG005|Open Label Phase|Other|0|||
170596174|NCT00098722|616527870|FG006|Open Label Phase|Other|0|||
170596175|NCT00098722|616527864|FG000|Observation Phase|Death|0|||
170596176|NCT00098722|616527865|FG001|Observation Phase|Death|0|||
170596177|NCT00098722|616527866|FG002|Observation Phase|Death|0|||
170596178|NCT00098722|616527867|FG003|Observation Phase|Death|0|||
170596179|NCT00098722|616527868|FG004|Observation Phase|Death|0|||
170596180|NCT00098722|616527869|FG005|Observation Phase|Death|5|||
170596181|NCT00098722|616527870|FG006|Observation Phase|Death|3|||
170596182|NCT00098722|616527864|FG000|Observation Phase|Lack of Efficacy|0|||
170596183|NCT00098722|616527865|FG001|Observation Phase|Lack of Efficacy|0|||
170596184|NCT00098722|616527866|FG002|Observation Phase|Lack of Efficacy|0|||
170596185|NCT00098722|616527867|FG003|Observation Phase|Lack of Efficacy|0|||
170596186|NCT00098722|616527868|FG004|Observation Phase|Lack of Efficacy|0|||
170811798|NCT02521493|617319349|FG002|Overall Study|No MRD result|4|||
170811799|NCT01323790|617319350|FG000|Overall Study|Other|3|||
170811800|NCT01323790|617319351|FG001|Overall Study|Other|2|||
170811801|NCT01323790|617319352|FG002|Overall Study|Other|1|||
170811802|NCT01323790|617319350|FG000|Overall Study|Lost to Follow-up|11|||
170811803|NCT01323790|617319351|FG001|Overall Study|Lost to Follow-up|9|||
170811804|NCT01323790|617319352|FG002|Overall Study|Lost to Follow-up|9|||
170596187|NCT00098722|616527869|FG005|Observation Phase|Lack of Efficacy|2|||
170596188|NCT00098722|616527870|FG006|Observation Phase|Lack of Efficacy|0|||
170596189|NCT00098722|616527864|FG000|Observation Phase|Participant defaulted|0|||
170596190|NCT00098722|616527865|FG001|Observation Phase|Participant defaulted|0|||
170596191|NCT00098722|616527866|FG002|Observation Phase|Participant defaulted|0|||
170596192|NCT00098722|616527867|FG003|Observation Phase|Participant defaulted|0|||
170596193|NCT00098722|616527868|FG004|Observation Phase|Participant defaulted|0|||
170596194|NCT00098722|616527869|FG005|Observation Phase|Participant defaulted|17|||
170596195|NCT00098722|616527870|FG006|Observation Phase|Participant defaulted|4|||
170596196|NCT00098722|616527864|FG000|Observation Phase|Other|0|||
170596197|NCT00098722|616527865|FG001|Observation Phase|Other|0|||
170596198|NCT00098722|616527866|FG002|Observation Phase|Other|0|||
170596199|NCT00098722|616527867|FG003|Observation Phase|Other|0|||
170596200|NCT00098722|616527868|FG004|Observation Phase|Other|0|||
170596201|NCT00098722|616527869|FG005|Observation Phase|Other|21|||
170596202|NCT00098722|616527870|FG006|Observation Phase|Other|10|||
170811805|NCT01323790|617319350|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
170596203|NCT06250738|616527871|FG000|Overall Study|Lost to Follow-up|1|||
170596204|NCT02428205|616527873|FG000|Overall Study|Lack of Efficacy|1|||
170596205|NCT02428205|616527874|FG001|Overall Study|Lack of Efficacy|0|||
170596206|NCT02428205|616527873|FG000|Overall Study|Lost to Follow-up|1|||
170596207|NCT02428205|616527874|FG001|Overall Study|Lost to Follow-up|1|||
170596208|NCT02428205|616527873|FG000|Overall Study|Worse behavior|0|||
170596209|NCT02428205|616527874|FG001|Overall Study|Worse behavior|1|||
170596210|NCT02046070|616527875|FG000|Overall Study|Progressive Disease|18|||
170596211|NCT02046070|616527876|FG001|Overall Study|Progressive Disease|11|||
170596212|NCT02046070|616527877|FG002|Overall Study|Progressive Disease|40|||
170596213|NCT02046070|616527875|FG000|Overall Study|Adverse Event|8|||
170596214|NCT02046070|616527876|FG001|Overall Study|Adverse Event|10|||
170596215|NCT02046070|616527877|FG002|Overall Study|Adverse Event|17|||
170596216|NCT02046070|616527875|FG000|Overall Study|Withdrawal by Subject|1|||
170596217|NCT02046070|616527876|FG001|Overall Study|Withdrawal by Subject|2|||
170596218|NCT02046070|616527877|FG002|Overall Study|Withdrawal by Subject|6|||
170596219|NCT02046070|616527875|FG000|Overall Study|Study Terminated by Sponsor|1|||
170596220|NCT02046070|616527876|FG001|Overall Study|Study Terminated by Sponsor|1|||
170596221|NCT02046070|616527877|FG002|Overall Study|Study Terminated by Sponsor|1|||
170596222|NCT02046070|616527875|FG000|Overall Study|Reason not Specified|4|||
170596223|NCT02046070|616527876|FG001|Overall Study|Reason not Specified|4|||
170596224|NCT02046070|616527877|FG002|Overall Study|Reason not Specified|6|||
170596225|NCT05601102|616527879|FG000|Overall Study|Death|1|||
170596226|NCT05601102|616527880|FG001|Overall Study|Death|2|||
170596227|NCT05601102|616527879|FG000|Overall Study|Withdrawal by Subject|1|||
170596228|NCT05601102|616527880|FG001|Overall Study|Withdrawal by Subject|1|||
170596229|NCT05601102|616527879|FG000|Overall Study|Lost to Follow-up|0|||
170596230|NCT05601102|616527880|FG001|Overall Study|Lost to Follow-up|2|||
170596231|NCT00159913|616527885|FG000|Overall Study|Adverse Event|1|||
170596232|NCT00159913|616527886|FG001|Overall Study|Adverse Event|0|||
170596233|NCT00159913|616527887|FG002|Overall Study|Adverse Event|1|||
170596234|NCT00159913|616527888|FG003|Overall Study|Adverse Event|0|||
170596235|NCT00159913|616527885|FG000|Overall Study|Withdrawal by Subject|0|||
170596236|NCT00159913|616527886|FG001|Overall Study|Withdrawal by Subject|0|||
170596237|NCT00159913|616527887|FG002|Overall Study|Withdrawal by Subject|0|||
170596238|NCT00159913|616527888|FG003|Overall Study|Withdrawal by Subject|1|||
170596239|NCT00159913|616527885|FG000|Overall Study|Lost to Follow-up|0|||
170596240|NCT00159913|616527886|FG001|Overall Study|Lost to Follow-up|0|||
170596241|NCT00159913|616527887|FG002|Overall Study|Lost to Follow-up|0|||
170596242|NCT00159913|616527888|FG003|Overall Study|Lost to Follow-up|1|||
170596243|NCT00159913|616527885|FG000|Overall Study|Protocol Violation|1|||
170596244|NCT00159913|616527886|FG001|Overall Study|Protocol Violation|0|||
170596245|NCT00159913|616527887|FG002|Overall Study|Protocol Violation|1|||
170596246|NCT00159913|616527888|FG003|Overall Study|Protocol Violation|0|||
170596247|NCT03294135|616527889|FG000|Overall Study|Serious Adverse Event|1|||
170596248|NCT03294135|616527890|FG001|Overall Study|Serious Adverse Event|0|||
170596249|NCT03294135|616527891|FG002|Overall Study|Serious Adverse Event|0|||
170596250|NCT03294135|616527889|FG000|Overall Study|Lost to Follow-up|1|||
170596251|NCT03294135|616527890|FG001|Overall Study|Lost to Follow-up|0|||
170596252|NCT03294135|616527891|FG002|Overall Study|Lost to Follow-up|1|||
170596253|NCT03294135|616527889|FG000|Overall Study|Withdrawal by Subject|0|||
170596254|NCT03294135|616527890|FG001|Overall Study|Withdrawal by Subject|0|||
170596255|NCT03294135|616527891|FG002|Overall Study|Withdrawal by Subject|1|||
170596256|NCT03294135|616527889|FG000|Overall Study|Other|2|||
170596257|NCT03294135|616527890|FG001|Overall Study|Other|0|||
170596258|NCT03294135|616527891|FG002|Overall Study|Other|0|||
170596259|NCT02590562|616527892|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
170596260|NCT02763254|616527893|FG000|Overall Study|Adverse Event|1|||
170596261|NCT00824005|616527894|FG000|Overall Study|Death|0|||
170596262|NCT00824005|616527895|FG001|Overall Study|Death|1|||
170596263|NCT00824005|616527894|FG000|Overall Study|Lost to Follow-up|0|||
170596264|NCT00824005|616527895|FG001|Overall Study|Lost to Follow-up|1|||
170596265|NCT01510184|616527896|FG000|Overall Study|Sponsor discretion|28|||
170596266|NCT01510184|616527897|FG001|Overall Study|Sponsor discretion|28|||
170596267|NCT01510184|616527896|FG000|Overall Study|Death|1|||
170596268|NCT01510184|616527897|FG001|Overall Study|Death|2|||
170596269|NCT01510184|616527896|FG000|Overall Study|Withdrawal by Subject|1|||
170596270|NCT01510184|616527897|FG001|Overall Study|Withdrawal by Subject|4|||
170596271|NCT01510184|616527896|FG000|Overall Study|Other|0|||
170596272|NCT01510184|616527897|FG001|Overall Study|Other|1|||
170596273|NCT01143051|616527898|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
170596274|NCT01143051|616527899|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
170596275|NCT01143051|616527900|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
170596276|NCT01143051|616527901|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
170596277|NCT01143051|616527902|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
170596278|NCT01143051|616527903|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
170596279|NCT01143051|616527898|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
170596280|NCT01143051|616527899|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
170596281|NCT01143051|616527900|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
170596282|NCT01143051|616527901|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
170596283|NCT01143051|616527902|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
170596284|NCT01143051|616527903|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
170596285|NCT02677844|616527904|FG000|Period 3|Withdrawal by Subject|0|||
170596286|NCT02677844|616527905|FG001|Period 3|Withdrawal by Subject|0|||
170596287|NCT02677844|616527906|FG002|Period 3|Withdrawal by Subject|0|||
170596288|NCT02677844|616527907|FG003|Period 3|Withdrawal by Subject|1|||
170596289|NCT02677844|616527908|FG004|Period 3|Withdrawal by Subject|0|||
170596290|NCT02677844|616527909|FG005|Period 3|Withdrawal by Subject|0|||
170596291|NCT02677844|616527910|FG006|Period 3|Withdrawal by Subject|0|||
170596292|NCT00385723|616527911|FG000|Overall Study|Lost to Follow-up|1|||
170596293|NCT00385723|616527912|FG001|Overall Study|Lost to Follow-up|1|||
170596294|NCT00385723|616527913|FG002|Overall Study|Lost to Follow-up|0|||
170650993|NCT00713310|616736326|FG001|Overall Study|Lack of Efficacy|2|||
170650994|NCT00713310|616736325|FG000|Overall Study|Withdrawal by Subject|0|||
170650995|NCT00713310|616736326|FG001|Overall Study|Withdrawal by Subject|2|||
170650996|NCT01993836|616736327|FG000|Overall Study|Surgery Cancelled|3|||
170650997|NCT01993836|616736328|FG001|Overall Study|Surgery Cancelled|0|||
170650998|NCT01993836|616736329|FG002|Overall Study|Surgery Cancelled|0|||
170650999|NCT01993836|616736327|FG000|Overall Study|Physician Decision|2|||
170651000|NCT01993836|616736328|FG001|Overall Study|Physician Decision|1|||
170651001|NCT01993836|616736329|FG002|Overall Study|Physician Decision|0|||
170651002|NCT01993836|616736327|FG000|Overall Study|Death|0|||
170651003|NCT01993836|616736328|FG001|Overall Study|Death|2|||
170651004|NCT01993836|616736329|FG002|Overall Study|Death|0|||
170651005|NCT01993836|616736327|FG000|Overall Study|Withdrawal by Subject|12|||
170651006|NCT01993836|616736328|FG001|Overall Study|Withdrawal by Subject|10|||
170651007|NCT01993836|616736329|FG002|Overall Study|Withdrawal by Subject|5|||
170651008|NCT00686634|616736330|FG000|Overall Study|Protocol Violation|6|||
170651009|NCT03828370|616736334|FG000|3 Month Follow-up|Lost to Follow-up|4|||
170651010|NCT03828370|616736335|FG001|3 Month Follow-up|Lost to Follow-up|12|||
170651011|NCT03828370|616736334|FG000|9 Month Follow up|Lost to Follow-up|12|||
170651012|NCT03828370|616736335|FG001|9 Month Follow up|Lost to Follow-up|20|||
170651013|NCT00761150|616736336|FG000|Open-label Period|Adverse Event|36|||
170651014|NCT00761150|616736337|FG001|Open-label Period|Adverse Event|0|||
170651015|NCT00761150|616736338|FG002|Open-label Period|Adverse Event|0|||
170651016|NCT00761150|616736336|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
170651017|NCT00761150|616736337|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
170651018|NCT00761150|616736338|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
170651019|NCT00761150|616736336|FG000|Open-label Period|Lost to Follow-up|7|||
170651020|NCT00761150|616736337|FG001|Open-label Period|Lost to Follow-up|0|||
170651021|NCT00761150|616736338|FG002|Open-label Period|Lost to Follow-up|0|||
170651022|NCT00761150|616736336|FG000|Open-label Period|Lack of Efficacy|4|||
170651023|NCT00761150|616736337|FG001|Open-label Period|Lack of Efficacy|0|||
170651024|NCT00761150|616736338|FG002|Open-label Period|Lack of Efficacy|0|||
170651025|NCT00761150|616736336|FG000|Open-label Period|Withdrawal by Subject|5|||
170651026|NCT00761150|616736337|FG001|Open-label Period|Withdrawal by Subject|0|||
170651027|NCT00761150|616736338|FG002|Open-label Period|Withdrawal by Subject|0|||
170651028|NCT00761150|616736336|FG000|Open-label Period|Noncompliance|2|||
170651029|NCT00761150|616736337|FG001|Open-label Period|Noncompliance|0|||
170651030|NCT00761150|616736338|FG002|Open-label Period|Noncompliance|0|||
170651031|NCT00761150|616736336|FG000|Open-label Period|Other|5|||
170651032|NCT00761150|616736337|FG001|Open-label Period|Other|0|||
170811806|NCT01323790|617319351|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
170811807|NCT01323790|617319352|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
170811808|NCT01323790|617319350|FG000|Overall Study|Lack of Efficacy|3|||
170811809|NCT01323790|617319351|FG001|Overall Study|Lack of Efficacy|0|||
170596295|NCT00385723|616527911|FG000|Overall Study|Withdrawal by Subject|1|||
170596296|NCT00385723|616527912|FG001|Overall Study|Withdrawal by Subject|0|||
170596297|NCT00385723|616527913|FG002|Overall Study|Withdrawal by Subject|2|||
170596298|NCT03458702|616527914|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
170596299|NCT03458702|616527915|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
170596300|NCT03458702|616527914|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
170596301|NCT03458702|616527915|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
170596302|NCT02231762|616527918|FG000|Combination Phase|Adverse Event|10|||
170596303|NCT02231762|616527919|FG001|Combination Phase|Adverse Event|0|||
170596304|NCT02231762|616527920|FG002|Combination Phase|Adverse Event|0|||
170596305|NCT02231762|616527921|FG003|Combination Phase|Adverse Event|0|||
170596306|NCT02231762|616527918|FG000|Combination Phase|Withdrawal by Subject|2|||
170596307|NCT02231762|616527919|FG001|Combination Phase|Withdrawal by Subject|0|||
170596308|NCT02231762|616527920|FG002|Combination Phase|Withdrawal by Subject|0|||
170596309|NCT02231762|616527921|FG003|Combination Phase|Withdrawal by Subject|0|||
170596310|NCT02231762|616527918|FG000|Combination Phase|Disease Progression|6|||
170596311|NCT02231762|616527919|FG001|Combination Phase|Disease Progression|0|||
170596312|NCT02231762|616527920|FG002|Combination Phase|Disease Progression|0|||
170596313|NCT02231762|616527921|FG003|Combination Phase|Disease Progression|0|||
170596314|NCT02231762|616527918|FG000|Combination Phase|Did not meet inclusion criteria|1|||
170596315|NCT02231762|616527919|FG001|Combination Phase|Did not meet inclusion criteria|0|||
170651033|NCT00761150|616736338|FG002|Open-label Period|Other|0|||
170651034|NCT00761150|616736336|FG000|Double-blind Period|Lack of Efficacy|0|||
170651035|NCT00761150|616736337|FG001|Double-blind Period|Lack of Efficacy|2|||
170811810|NCT01323790|617319352|FG002|Overall Study|Lack of Efficacy|3|||
170811811|NCT01323790|617319350|FG000|Overall Study|Adverse Event|11|||
170811812|NCT01323790|617319351|FG001|Overall Study|Adverse Event|24|||
170811813|NCT01323790|617319352|FG002|Overall Study|Adverse Event|12|||
170811814|NCT01323790|617319350|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
170811815|NCT01323790|617319351|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
170811816|NCT01323790|617319352|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
170811817|NCT01323790|617319350|FG000|Overall Study|Withdrawal by Subject|23|||
170811818|NCT01323790|617319351|FG001|Overall Study|Withdrawal by Subject|20|||
170913126|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
170596316|NCT02231762|616527920|FG002|Combination Phase|Did not meet inclusion criteria|0|||
170596317|NCT02231762|616527921|FG003|Combination Phase|Did not meet inclusion criteria|0|||
170596318|NCT02231762|616527918|FG000|Combination Phase|Protocol Violation|1|||
170596319|NCT02231762|616527919|FG001|Combination Phase|Protocol Violation|0|||
170596320|NCT02231762|616527920|FG002|Combination Phase|Protocol Violation|0|||
170596321|NCT02231762|616527921|FG003|Combination Phase|Protocol Violation|0|||
170596322|NCT02231762|616527918|FG000|Maintenance Phase|Disease progression|0|||
170596323|NCT02231762|616527919|FG001|Maintenance Phase|Disease progression|3|||
170596324|NCT02231762|616527920|FG002|Maintenance Phase|Disease progression|4|||
170596325|NCT02231762|616527921|FG003|Maintenance Phase|Disease progression|3|||
170596326|NCT02231762|616527918|FG000|Maintenance Phase|Adverse Event|0|||
170596327|NCT02231762|616527919|FG001|Maintenance Phase|Adverse Event|0|||
170596328|NCT02231762|616527920|FG002|Maintenance Phase|Adverse Event|1|||
170596329|NCT02231762|616527921|FG003|Maintenance Phase|Adverse Event|2|||
170596330|NCT03455829|616527922|FG000|Overall Study|Death|2|||
170596331|NCT03455829|616527923|FG001|Overall Study|Death|3|||
170596332|NCT03455829|616527924|FG002|Overall Study|Death|2|||
170596333|NCT03455829|616527925|FG003|Overall Study|Death|4|||
170596334|NCT03455829|616527926|FG004|Overall Study|Death|2|||
170596335|NCT03455829|616527922|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
170596336|NCT03455829|616527923|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
170596337|NCT03455829|616527924|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
170596338|NCT03455829|616527925|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
170596339|NCT03455829|616527926|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
170596340|NCT03455829|616527922|FG000|Overall Study|Disease progression|0|||
170596341|NCT03455829|616527923|FG001|Overall Study|Disease progression|0|||
170596342|NCT03455829|616527924|FG002|Overall Study|Disease progression|0|||
170596343|NCT03455829|616527925|FG003|Overall Study|Disease progression|1|||
170596344|NCT03455829|616527926|FG004|Overall Study|Disease progression|1|||
170596345|NCT00168103|616527931|FG000|Overall Study|Withdrawal by Subject|1|||
170596346|NCT00168103|616527932|FG001|Overall Study|Withdrawal by Subject|2|||
170596347|NCT00168103|616527933|FG002|Overall Study|Withdrawal by Subject|1|||
170596348|NCT00168103|616527934|FG003|Overall Study|Withdrawal by Subject|0|||
170596349|NCT00168103|616527931|FG000|Overall Study|Lost to Follow-up|1|||
170596350|NCT00168103|616527932|FG001|Overall Study|Lost to Follow-up|3|||
170596351|NCT00168103|616527933|FG002|Overall Study|Lost to Follow-up|0|||
170596352|NCT00168103|616527934|FG003|Overall Study|Lost to Follow-up|0|||
170596353|NCT03249935|616527935|FG000|Overall Study|Discharged from facility early|36|||
170596354|NCT03249935|616527935|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
170596355|NCT03249935|616527935|FG000|Overall Study|Protocol Violation|5|||
170596356|NCT05824936|616527938|FG000|Overall Study|Lost to Follow-up|1|||
170596357|NCT00096018|616527939|FG000|Overall Study|Became Ineligible (not treated)|0|||
170596358|NCT00096018|616527940|FG001|Overall Study|Became Ineligible (not treated)|3|||
170596359|NCT00096018|616527939|FG000|Overall Study|Miscellaneous (not treated)|0|||
170596360|NCT00096018|616527940|FG001|Overall Study|Miscellaneous (not treated)|2|||
170596361|NCT00096018|616527939|FG000|Overall Study|Adverse Event|0|||
170596362|NCT00096018|616527940|FG001|Overall Study|Adverse Event|5|||
170596363|NCT00096018|616527939|FG000|Overall Study|Death|0|||
170596364|NCT00096018|616527940|FG001|Overall Study|Death|1|||
170596365|NCT00096018|616527939|FG000|Overall Study|Withdrawal by Subject|0|||
170596366|NCT00096018|616527940|FG001|Overall Study|Withdrawal by Subject|2|||
170596367|NCT00096018|616527939|FG000|Overall Study|Miscellaneous|2|||
170596368|NCT00096018|616527940|FG001|Overall Study|Miscellaneous|1|||
170596369|NCT00689793|616527941|FG000|Overall Study|Lost to Follow-up|4|||
170596370|NCT00689793|616527942|FG001|Overall Study|Lost to Follow-up|5|||
170596371|NCT00483041|616527943|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
170596372|NCT00483041|616527944|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
170596373|NCT00931801|616527948|FG000|Overall Study|Adverse Event|0|||
170596374|NCT00931801|616527949|FG001|Overall Study|Adverse Event|0|||
170596375|NCT00931801|616527950|FG002|Overall Study|Adverse Event|1|||
170596376|NCT00931801|616527948|FG000|Overall Study|Lost to Follow-up|0|||
170596377|NCT00931801|616527949|FG001|Overall Study|Lost to Follow-up|1|||
170596378|NCT00931801|616527950|FG002|Overall Study|Lost to Follow-up|0|||
170596379|NCT00931801|616527948|FG000|Overall Study|Withdrawal by Subject|1|||
170596380|NCT00931801|616527949|FG001|Overall Study|Withdrawal by Subject|0|||
170596381|NCT00931801|616527950|FG002|Overall Study|Withdrawal by Subject|0|||
170811819|NCT01323790|617319352|FG002|Overall Study|Withdrawal by Subject|13|||
170913127|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
170913128|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
170913129|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
170913130|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
170913131|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
170913132|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
170913133|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
170913134|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
170913135|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
170913136|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
170913137|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
170913138|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
170913139|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
170913140|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
170913141|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
170913142|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
170913143|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
170913144|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
170913145|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
170913146|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
170913147|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
170913148|NCT00092547|617685830|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
170913149|NCT00092547|617685831|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
170913150|NCT00092547|617685832|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
170913151|NCT00092547|617685830|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
170913152|NCT00092547|617685831|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
170913153|NCT00092547|617685832|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
170913154|NCT00092547|617685830|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
170913155|NCT00092547|617685831|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
170913156|NCT00092547|617685832|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
170913157|NCT00092547|617685830|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
170913158|NCT00092547|617685831|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
170913159|NCT00092547|617685832|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
170913160|NCT00092547|617685830|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
170913161|NCT00092547|617685831|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
170913162|NCT00092547|617685832|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
170913163|NCT01166659|617685833|FG000|Overall Study|Subject Decision|8|||
170913164|NCT01166659|617685833|FG000|Overall Study|Investigator Decision|2|||
170913165|NCT01166659|617685833|FG000|Overall Study|Death|1|||
170913166|NCT01166659|617685833|FG000|Overall Study|Lost to Follow-up|1|||
170913167|NCT01166659|617685833|FG000|Overall Study|Study Closed at Site|1|||
170913168|NCT04275310|617685843|FG000|Overall Study|Non-randomized due to running out of funding|4|||
170913169|NCT04275310|617685844|FG001|Overall Study|Non-randomized due to running out of funding|0|||
170913170|NCT01650779|617685850|FG000|Overall Study|Withdrawal by Subject|1|||
170913171|NCT01103349|617685852|FG000|Overall Study|Adverse Event|8|||
170913172|NCT01103349|617685853|FG001|Overall Study|Adverse Event|5|||
170913173|NCT01103349|617685854|FG002|Overall Study|Adverse Event|3|||
170596382|NCT00931801|616527948|FG000|Overall Study|Confirmed Virologic Failure|0|||
170596383|NCT00931801|616527949|FG001|Overall Study|Confirmed Virologic Failure|0|||
170596384|NCT00931801|616527950|FG002|Overall Study|Confirmed Virologic Failure|3|||
170596385|NCT01133275|616527957|FG000|Overall Study|Withdrawal by Subject|1|||
170596386|NCT01133275|616527957|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
170596387|NCT01635764|616527958|FG000|Overall Study|Adverse Event|46|||
170596388|NCT01635764|616527958|FG000|Overall Study|Lack of Efficacy|76|||
170596389|NCT01635764|616527958|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
170596390|NCT01635764|616527958|FG000|Overall Study|Protocol Deviation|1|||
170596391|NCT01635764|616527958|FG000|Overall Study|Withdrew Consent|67|||
170596392|NCT01635764|616527958|FG000|Overall Study|Lost to Follow-up|53|||
170596393|NCT01635764|616527958|FG000|Overall Study|Other|28|||
170596394|NCT02266875|616527961|FG000|Overall Study|Withdrawal by Subject|9|||
170596395|NCT02266875|616527962|FG001|Overall Study|Withdrawal by Subject|0|||
170596396|NCT02266875|616527961|FG000|Overall Study|Lost to Follow-up|2|||
170596397|NCT02266875|616527962|FG001|Overall Study|Lost to Follow-up|0|||
170596398|NCT00413010|616527963|FG000|Overall Study|Adverse Event|8|||
170596399|NCT00413010|616527964|FG001|Overall Study|Adverse Event|4|||
170596400|NCT00413010|616527963|FG000|Overall Study|Laboratory abnormality|0|||
170596401|NCT00413010|616527964|FG001|Overall Study|Laboratory abnormality|2|||
170596402|NCT00413010|616527963|FG000|Overall Study|Lack of Efficacy|0|||
170596403|NCT00413010|616527964|FG001|Overall Study|Lack of Efficacy|3|||
170596404|NCT00413010|616527963|FG000|Overall Study|Lost to Follow-up|3|||
170596405|NCT00413010|616527964|FG001|Overall Study|Lost to Follow-up|0|||
170596406|NCT00413010|616527963|FG000|Overall Study|Withdrawal by Subject|7|||
170596407|NCT00413010|616527964|FG001|Overall Study|Withdrawal by Subject|2|||
170596408|NCT00413010|616527963|FG000|Overall Study|Due to termination of the study|54|||
170596409|NCT00413010|616527964|FG001|Overall Study|Due to termination of the study|52|||
170596410|NCT01816906|616527969|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
170596411|NCT01816906|616527970|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
170596412|NCT01816906|616527969|FG000|Six Months|Lost to Follow-up|14|||
170596413|NCT01816906|616527970|FG001|Six Months|Lost to Follow-up|16|||
170596414|NCT01816906|616527969|FG000|12 Months|Adverse Event|2|||
170596415|NCT01816906|616527970|FG001|12 Months|Adverse Event|2|||
170596416|NCT01816906|616527969|FG000|12 Months|Death|0|||
170596417|NCT01816906|616527970|FG001|12 Months|Death|2|||
170596418|NCT01816906|616527969|FG000|12 Months|Lost to Follow-up|2|||
170596419|NCT01816906|616527970|FG001|12 Months|Lost to Follow-up|1|||
170596420|NCT04375397|616527971|FG000|Overall Study|Death|1|||
170596421|NCT04375397|616527972|FG001|Overall Study|Death|1|||
170596422|NCT04375397|616527971|FG000|Overall Study|Withdrew consent|2|||
170596423|NCT04375397|616527972|FG001|Overall Study|Withdrew consent|0|||
170596424|NCT04375397|616527971|FG000|Overall Study|Lost to Follow-up|6|||
170596425|NCT04375397|616527972|FG001|Overall Study|Lost to Follow-up|4|||
170596426|NCT04375397|616527971|FG000|Overall Study|Other, not specified|0|||
170596427|NCT04375397|616527972|FG001|Overall Study|Other, not specified|1|||
170596428|NCT00086502|616527974|FG000|Overall Study|Adverse Event|11|||
170596429|NCT00086502|616527975|FG001|Overall Study|Adverse Event|2|||
170596430|NCT00086502|616527974|FG000|Overall Study|Lack of Efficacy|0|||
170596431|NCT00086502|616527975|FG001|Overall Study|Lack of Efficacy|2|||
170596432|NCT00086502|616527974|FG000|Overall Study|Lost to Follow-up|3|||
170596433|NCT00086502|616527975|FG001|Overall Study|Lost to Follow-up|1|||
170596434|NCT00086502|616527974|FG000|Overall Study|Physician Decision|1|||
170596435|NCT00086502|616527975|FG001|Overall Study|Physician Decision|1|||
170596436|NCT00086502|616527974|FG000|Overall Study|Pregnancy|0|||
170596437|NCT00086502|616527975|FG001|Overall Study|Pregnancy|1|||
170596438|NCT00086502|616527974|FG000|Overall Study|Protocol Violation|3|||
170651036|NCT00761150|616736338|FG002|Double-blind Period|Lack of Efficacy|19|||
170913174|NCT01103349|617685852|FG000|Overall Study|Consent withdrawn|1|||
170913175|NCT01103349|617685853|FG001|Overall Study|Consent withdrawn|0|||
170913176|NCT01103349|617685854|FG002|Overall Study|Consent withdrawn|0|||
170913177|NCT01103349|617685852|FG000|Overall Study|Incorrectly included in the trial|1|||
170913178|NCT01103349|617685853|FG001|Overall Study|Incorrectly included in the trial|0|||
170913179|NCT01103349|617685854|FG002|Overall Study|Incorrectly included in the trial|0|||
170913180|NCT01103349|617685852|FG000|Overall Study|Withdrawal by Subject|1|||
170913181|NCT01103349|617685853|FG001|Overall Study|Withdrawal by Subject|1|||
170913182|NCT01103349|617685854|FG002|Overall Study|Withdrawal by Subject|0|||
170913183|NCT01103349|617685852|FG000|Overall Study|did not want to take trial medication|0|||
170913184|NCT01103349|617685853|FG001|Overall Study|did not want to take trial medication|1|||
170913185|NCT01103349|617685854|FG002|Overall Study|did not want to take trial medication|0|||
170913186|NCT01103349|617685852|FG000|Overall Study|forgot to take medication|0|||
170913187|NCT01103349|617685853|FG001|Overall Study|forgot to take medication|0|||
170913188|NCT01103349|617685854|FG002|Overall Study|forgot to take medication|1|||
170913189|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
170913190|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
170913191|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
170913192|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
170913193|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
170596439|NCT00086502|616527975|FG001|Overall Study|Protocol Violation|3|||
170596440|NCT00086502|616527974|FG000|Overall Study|Withdrawal by Subject|5|||
170596441|NCT00086502|616527975|FG001|Overall Study|Withdrawal by Subject|6|||
170596442|NCT00086502|616527974|FG000|Overall Study|Patient Moved|1|||
170596443|NCT00086502|616527975|FG001|Overall Study|Patient Moved|1|||
170596444|NCT00086502|616527974|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
170651037|NCT00761150|616736336|FG000|Double-blind Period|Adverse Event|0|||
170651038|NCT00761150|616736337|FG001|Double-blind Period|Adverse Event|3|||
170913194|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
170913195|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
170913196|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
170913197|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
170913198|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
170913199|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
170596445|NCT00086502|616527975|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
170596446|NCT00086502|616527974|FG000|Overall Study|Patient Accidentally Unblinded|1|||
170596447|NCT00086502|616527975|FG001|Overall Study|Patient Accidentally Unblinded|0|||
170596448|NCT03412604|616527976|FG000|Overall Study|Withdrawal by Subject|1|||
170596449|NCT00993499|616527977|FG000|Run-in Period (8 Days)|Adverse Event|0|||
170596450|NCT00993499|616527978|FG001|Run-in Period (8 Days)|Adverse Event|1|||
170596451|NCT00993499|616527979|FG002|Run-in Period (8 Days)|Adverse Event|0|||
170596452|NCT00993499|616527980|FG003|Run-in Period (8 Days)|Adverse Event|0|||
170596453|NCT00993499|616527981|FG004|Run-in Period (8 Days)|Adverse Event|0|||
170596454|NCT00993499|616527982|FG005|Run-in Period (8 Days)|Adverse Event|0|||
170596455|NCT00993499|616527977|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
170596456|NCT00993499|616527978|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
170596457|NCT00993499|616527979|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
170596458|NCT00993499|616527980|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
170596459|NCT00993499|616527981|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
170596460|NCT00993499|616527982|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
170596461|NCT00993499|616527977|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
170596462|NCT00993499|616527978|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
170596463|NCT00993499|616527979|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
170596464|NCT00993499|616527980|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
170596465|NCT00993499|616527981|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
170596466|NCT00993499|616527982|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
170596467|NCT00993499|616527977|FG000|Run-in Period (8 Days)|Progressive disease|0|||
170596468|NCT00993499|616527978|FG001|Run-in Period (8 Days)|Progressive disease|1|||
170596469|NCT00993499|616527979|FG002|Run-in Period (8 Days)|Progressive disease|1|||
170596470|NCT00993499|616527980|FG003|Run-in Period (8 Days)|Progressive disease|0|||
170596471|NCT00993499|616527981|FG004|Run-in Period (8 Days)|Progressive disease|0|||
170596472|NCT00993499|616527982|FG005|Run-in Period (8 Days)|Progressive disease|0|||
170596473|NCT00993499|616527977|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
170596474|NCT00993499|616527978|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
170811820|NCT01323790|617319350|FG000|Overall Study|Did Not Receive Treatment|2|||
170811821|NCT01323790|617319351|FG001|Overall Study|Did Not Receive Treatment|0|||
170811822|NCT01323790|617319352|FG002|Overall Study|Did Not Receive Treatment|1|||
170811823|NCT01323790|617319350|FG000|Overall Study|Severe non-compliance with protocol|2|||
170811824|NCT01323790|617319351|FG001|Overall Study|Severe non-compliance with protocol|2|||
170811825|NCT01323790|617319352|FG002|Overall Study|Severe non-compliance with protocol|2|||
170811826|NCT01880736|617319353|FG000|Overall Study|Adverse Event|0|||
170811827|NCT01880736|617319354|FG001|Overall Study|Adverse Event|0|||
170811828|NCT01880736|617319355|FG002|Overall Study|Adverse Event|0|||
170811829|NCT01880736|617319356|FG003|Overall Study|Adverse Event|1|||
170811830|NCT01880736|617319353|FG000|Overall Study|Withdrawal Criteria|1|||
170811831|NCT01880736|617319354|FG001|Overall Study|Withdrawal Criteria|2|||
170811832|NCT01880736|617319355|FG002|Overall Study|Withdrawal Criteria|1|||
170811833|NCT01880736|617319356|FG003|Overall Study|Withdrawal Criteria|5|||
170811834|NCT05995977|617319360|FG000|Overall Study|Withdrawal by Subject|1|||
170811835|NCT05995977|617319361|FG001|Overall Study|Withdrawal by Subject|4|||
170811836|NCT05995977|617319360|FG000|Overall Study|Lost to Follow-up|2|||
170811837|NCT05995977|617319361|FG001|Overall Study|Lost to Follow-up|0|||
170811838|NCT04181788|617319362|FG000|TREATMENT|Adverse Event|0|||
170811839|NCT04181788|617319363|FG001|TREATMENT|Adverse Event|2|||
170811840|NCT04181788|617319364|FG002|TREATMENT|Adverse Event|1|||
170811841|NCT04181788|617319365|FG003|TREATMENT|Adverse Event|0|||
170811842|NCT04181788|617319366|FG004|TREATMENT|Adverse Event|1|||
170811843|NCT04181788|617319367|FG005|TREATMENT|Adverse Event|3|||
170811844|NCT04181788|617319362|FG000|TREATMENT|Death|0|||
170811845|NCT04181788|617319363|FG001|TREATMENT|Death|0|||
170811846|NCT04181788|617319364|FG002|TREATMENT|Death|0|||
170811847|NCT04181788|617319365|FG003|TREATMENT|Death|0|||
170811848|NCT04181788|617319366|FG004|TREATMENT|Death|8|||
170811849|NCT04181788|617319367|FG005|TREATMENT|Death|8|||
170811850|NCT04181788|617319362|FG000|TREATMENT|Physician Decision|0|||
170811851|NCT04181788|617319363|FG001|TREATMENT|Physician Decision|0|||
170811852|NCT04181788|617319364|FG002|TREATMENT|Physician Decision|0|||
170811853|NCT04181788|617319365|FG003|TREATMENT|Physician Decision|0|||
170811854|NCT04181788|617319366|FG004|TREATMENT|Physician Decision|0|||
170811855|NCT04181788|617319367|FG005|TREATMENT|Physician Decision|1|||
170811856|NCT04181788|617319362|FG000|TREATMENT|Progressive disease|3|||
170811857|NCT04181788|617319363|FG001|TREATMENT|Progressive disease|3|||
170811858|NCT04181788|617319364|FG002|TREATMENT|Progressive disease|5|||
170811859|NCT04181788|617319365|FG003|TREATMENT|Progressive disease|7|||
170811860|NCT04181788|617319366|FG004|TREATMENT|Progressive disease|20|||
170811861|NCT04181788|617319367|FG005|TREATMENT|Progressive disease|38|||
170811862|NCT04181788|617319362|FG000|TREATMENT|Global deterioration of health status|0|||
170811863|NCT04181788|617319363|FG001|TREATMENT|Global deterioration of health status|2|||
170811864|NCT04181788|617319364|FG002|TREATMENT|Global deterioration of health status|0|||
170811865|NCT04181788|617319365|FG003|TREATMENT|Global deterioration of health status|0|||
170811866|NCT04181788|617319366|FG004|TREATMENT|Global deterioration of health status|2|||
170811867|NCT04181788|617319367|FG005|TREATMENT|Global deterioration of health status|8|||
170811868|NCT04181788|617319362|FG000|TREATMENT|Withdrawal by Subject|1|||
170811869|NCT04181788|617319363|FG001|TREATMENT|Withdrawal by Subject|2|||
170811870|NCT04181788|617319364|FG002|TREATMENT|Withdrawal by Subject|0|||
170811871|NCT04181788|617319365|FG003|TREATMENT|Withdrawal by Subject|0|||
170811872|NCT04181788|617319366|FG004|TREATMENT|Withdrawal by Subject|3|||
170811873|NCT04181788|617319367|FG005|TREATMENT|Withdrawal by Subject|5|||
170913200|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
170913201|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
170913202|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
170596475|NCT00993499|616527979|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
170596476|NCT00993499|616527980|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
170596477|NCT00993499|616527981|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
170596478|NCT00993499|616527982|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
170596479|NCT00993499|616527977|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
170596480|NCT00993499|616527978|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
170596481|NCT00993499|616527979|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
170596482|NCT00993499|616527980|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
170596483|NCT00993499|616527981|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
170596484|NCT00993499|616527982|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
170596485|NCT00993499|616527977|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
170596486|NCT00993499|616527978|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
170596487|NCT00993499|616527979|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
170596488|NCT00993499|616527980|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
170596489|NCT00993499|616527981|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
170596490|NCT00993499|616527982|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
170596491|NCT00993499|616527977|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
170596492|NCT00993499|616527978|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
170596493|NCT00993499|616527979|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
170596494|NCT00993499|616527980|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
170596495|NCT00993499|616527981|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
170596496|NCT00993499|616527982|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
170596497|NCT00993499|616527977|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
170596498|NCT00993499|616527978|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
170596499|NCT00993499|616527979|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
170596500|NCT00993499|616527980|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
170596501|NCT00993499|616527981|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
170596502|NCT00993499|616527982|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
170596503|NCT00993499|616527977|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
170596504|NCT00993499|616527978|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
170596505|NCT00993499|616527979|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
170596506|NCT00993499|616527980|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
170596507|NCT00993499|616527981|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
170596508|NCT00993499|616527982|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
170596509|NCT00993499|616527977|FG000|Discontinued After Starting Course 3|DLT|1|||
170596510|NCT00993499|616527978|FG001|Discontinued After Starting Course 3|DLT|0|||
170596511|NCT00993499|616527979|FG002|Discontinued After Starting Course 3|DLT|2|||
170596512|NCT00993499|616527980|FG003|Discontinued After Starting Course 3|DLT|1|||
170596513|NCT00993499|616527981|FG004|Discontinued After Starting Course 3|DLT|0|||
170596514|NCT00993499|616527982|FG005|Discontinued After Starting Course 3|DLT|0|||
170596515|NCT00993499|616527977|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
170596516|NCT00993499|616527978|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
170596517|NCT00993499|616527979|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
170596518|NCT00993499|616527980|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
170596519|NCT00993499|616527981|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
170596520|NCT00993499|616527982|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
170596521|NCT01443130|616527983|FG000|Overall Study|Lost to Follow-up|44|||
170596522|NCT01443130|616527984|FG001|Overall Study|Lost to Follow-up|42|||
170596523|NCT01443130|616527985|FG002|Overall Study|Lost to Follow-up|50|||
170596524|NCT01443130|616527986|FG003|Overall Study|Lost to Follow-up|23|||
170596525|NCT01443130|616527987|FG004|Overall Study|Lost to Follow-up|25|||
170596526|NCT01443130|616527988|FG005|Overall Study|Lost to Follow-up|21|||
170596527|NCT01443130|616527983|FG000|Overall Study|Death|0|||
170596528|NCT01443130|616527984|FG001|Overall Study|Death|1|||
170596529|NCT01443130|616527985|FG002|Overall Study|Death|0|||
170596530|NCT01443130|616527986|FG003|Overall Study|Death|7|||
170596531|NCT01443130|616527987|FG004|Overall Study|Death|10|||
170596532|NCT01443130|616527988|FG005|Overall Study|Death|8|||
170596533|NCT01443130|616527983|FG000|Overall Study|Adverse Event|2|||
170651039|NCT00761150|616736338|FG002|Double-blind Period|Adverse Event|3|||
170596534|NCT01443130|616527984|FG001|Overall Study|Adverse Event|1|||
170651040|NCT00761150|616736336|FG000|Double-blind Period|Withdrawal by Subject|0|||
170651041|NCT00761150|616736337|FG001|Double-blind Period|Withdrawal by Subject|3|||
170651042|NCT00761150|616736338|FG002|Double-blind Period|Withdrawal by Subject|2|||
170596535|NCT01443130|616527985|FG002|Overall Study|Adverse Event|1|||
170596536|NCT01443130|616527986|FG003|Overall Study|Adverse Event|0|||
170596537|NCT01443130|616527987|FG004|Overall Study|Adverse Event|0|||
170596538|NCT01443130|616527988|FG005|Overall Study|Adverse Event|0|||
170596539|NCT01443130|616527983|FG000|Overall Study|Protocol Violation|2|||
170596540|NCT01443130|616527984|FG001|Overall Study|Protocol Violation|1|||
170596541|NCT01443130|616527985|FG002|Overall Study|Protocol Violation|3|||
170596542|NCT01443130|616527986|FG003|Overall Study|Protocol Violation|2|||
170596543|NCT01443130|616527987|FG004|Overall Study|Protocol Violation|2|||
170596544|NCT01443130|616527988|FG005|Overall Study|Protocol Violation|3|||
170596545|NCT01443130|616527983|FG000|Overall Study|Withdrawal by Subject|15|||
170596546|NCT01443130|616527984|FG001|Overall Study|Withdrawal by Subject|14|||
170596547|NCT01443130|616527985|FG002|Overall Study|Withdrawal by Subject|12|||
170596548|NCT01443130|616527986|FG003|Overall Study|Withdrawal by Subject|7|||
170596549|NCT01443130|616527987|FG004|Overall Study|Withdrawal by Subject|7|||
170596550|NCT01443130|616527988|FG005|Overall Study|Withdrawal by Subject|2|||
170596551|NCT01443130|616527983|FG000|Overall Study|Death of Subject's Infant|5|||
170596552|NCT01443130|616527984|FG001|Overall Study|Death of Subject's Infant|10|||
170596553|NCT01443130|616527985|FG002|Overall Study|Death of Subject's Infant|11|||
170596554|NCT01443130|616527986|FG003|Overall Study|Death of Subject's Infant|0|||
170596555|NCT01443130|616527987|FG004|Overall Study|Death of Subject's Infant|0|||
170596556|NCT01443130|616527988|FG005|Overall Study|Death of Subject's Infant|0|||
170596557|NCT02758301|616527989|FG000|Overall Study|Death|12|||
170596558|NCT02758301|616527990|FG001|Overall Study|Death|0|||
170596559|NCT02758301|616527989|FG000|Overall Study|Physician Decision|10|||
170596560|NCT02758301|616527990|FG001|Overall Study|Physician Decision|1|||
170596561|NCT02758301|616527989|FG000|Overall Study|Withdrawal by Subject|5|||
170596562|NCT02758301|616527990|FG001|Overall Study|Withdrawal by Subject|6|||
170596563|NCT02758301|616527989|FG000|Overall Study|Lost to Follow-up|7|||
170596564|NCT02758301|616527990|FG001|Overall Study|Lost to Follow-up|0|||
170596565|NCT02758301|616527989|FG000|Overall Study|Protocol Violation|0|||
170596566|NCT02758301|616527990|FG001|Overall Study|Protocol Violation|1|||
170596567|NCT00364533|616527991|FG000|Overall Study|Adverse Event|8|||
170596568|NCT00364533|616527992|FG001|Overall Study|Adverse Event|7|||
170596569|NCT00364533|616527993|FG002|Overall Study|Adverse Event|15|||
170596570|NCT00364533|616527994|FG003|Overall Study|Adverse Event|5|||
170596571|NCT00364533|616527995|FG004|Overall Study|Adverse Event|2|||
170596572|NCT00364533|616527991|FG000|Overall Study|Withdrawal by Subject|4|||
170596573|NCT00364533|616527992|FG001|Overall Study|Withdrawal by Subject|8|||
170596574|NCT00364533|616527993|FG002|Overall Study|Withdrawal by Subject|6|||
170596575|NCT00364533|616527994|FG003|Overall Study|Withdrawal by Subject|6|||
170596576|NCT00364533|616527995|FG004|Overall Study|Withdrawal by Subject|6|||
170596577|NCT00364533|616527991|FG000|Overall Study|Lack of Efficacy|22|||
170596578|NCT00364533|616527992|FG001|Overall Study|Lack of Efficacy|22|||
170596579|NCT00364533|616527993|FG002|Overall Study|Lack of Efficacy|21|||
170596580|NCT00364533|616527994|FG003|Overall Study|Lack of Efficacy|17|||
170596581|NCT00364533|616527995|FG004|Overall Study|Lack of Efficacy|42|||
170596582|NCT00364533|616527991|FG000|Overall Study|Subject discharged from hospital|4|||
170596583|NCT00364533|616527992|FG001|Overall Study|Subject discharged from hospital|1|||
170596584|NCT00364533|616527993|FG002|Overall Study|Subject discharged from hospital|2|||
170596585|NCT00364533|616527994|FG003|Overall Study|Subject discharged from hospital|3|||
170596586|NCT00364533|616527995|FG004|Overall Study|Subject discharged from hospital|1|||
170596587|NCT00364533|616527991|FG000|Overall Study|Variations in drug compliance|2|||
170811874|NCT04181788|617319362|FG000|TREATMENT|Other unspecified|0|||
170811875|NCT04181788|617319363|FG001|TREATMENT|Other unspecified|0|||
170811876|NCT04181788|617319364|FG002|TREATMENT|Other unspecified|0|||
170811877|NCT04181788|617319365|FG003|TREATMENT|Other unspecified|0|||
170596588|NCT00364533|616527992|FG001|Overall Study|Variations in drug compliance|1|||
170596589|NCT00364533|616527993|FG002|Overall Study|Variations in drug compliance|1|||
170596590|NCT00364533|616527994|FG003|Overall Study|Variations in drug compliance|0|||
170596591|NCT00364533|616527995|FG004|Overall Study|Variations in drug compliance|0|||
170596592|NCT00364533|616527991|FG000|Overall Study|Non-compliance|1|||
170596593|NCT00364533|616527992|FG001|Overall Study|Non-compliance|0|||
170596594|NCT00364533|616527993|FG002|Overall Study|Non-compliance|0|||
170596595|NCT00364533|616527994|FG003|Overall Study|Non-compliance|0|||
170811878|NCT04181788|617319366|FG004|TREATMENT|Other unspecified|0|||
170596596|NCT00364533|616527995|FG004|Overall Study|Non-compliance|0|||
170596597|NCT00364533|616527991|FG000|Overall Study|Protocol Violation|1|||
170596598|NCT00364533|616527992|FG001|Overall Study|Protocol Violation|1|||
170596599|NCT00364533|616527993|FG002|Overall Study|Protocol Violation|0|||
170596600|NCT00364533|616527994|FG003|Overall Study|Protocol Violation|0|||
170811879|NCT04181788|617319367|FG005|TREATMENT|Other unspecified|2|||
170811880|NCT04181788|617319362|FG000|TREATMENT|Ongoing|0|||
170596601|NCT00364533|616527995|FG004|Overall Study|Protocol Violation|0|||
170596602|NCT00582738|616527996|FG000|Overall Study|Administrative Problems|7|||
170596603|NCT00582738|616527997|FG001|Overall Study|Administrative Problems|8|||
170596604|NCT00582738|616527996|FG000|Overall Study|Adverse Event|0|||
170596605|NCT00582738|616527997|FG001|Overall Study|Adverse Event|5|||
170596606|NCT00582738|616527996|FG000|Overall Study|Graft Lost|0|||
170596607|NCT00582738|616527997|FG001|Overall Study|Graft Lost|1|||
170596608|NCT00582738|616527996|FG000|Overall Study|Other|1|||
170596609|NCT00582738|616527997|FG001|Overall Study|Other|0|||
170596610|NCT00582738|616527996|FG000|Overall Study|Protocol Violation|1|||
170596611|NCT00582738|616527997|FG001|Overall Study|Protocol Violation|1|||
170596612|NCT00582738|616527996|FG000|Overall Study|Withdrawal by Subject|0|||
170596613|NCT00582738|616527997|FG001|Overall Study|Withdrawal by Subject|3|||
170596614|NCT01167907|616528000|FG000|Overall Study|Protocol Violation|1|||
170596615|NCT01167907|616528001|FG001|Overall Study|Protocol Violation|0|||
170596616|NCT01167907|616528000|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
170596617|NCT01167907|616528001|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
170596618|NCT00612508|616528002|FG000|Overall Study|Withdrawal by Subject|3|||
170596619|NCT00612508|616528003|FG001|Overall Study|Withdrawal by Subject|4|||
170596620|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
170596621|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
170596622|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
170596623|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
170596624|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
170596625|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
170596626|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
170596627|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
170596628|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
170596629|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
170596630|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
170596631|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
170596632|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
170596633|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
170596634|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
170596635|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
170596636|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
170596637|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
170596638|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
170596639|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
170596640|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
170596641|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
170596642|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
170596643|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
170596644|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
170596645|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
170596646|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
170596647|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
170596648|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
170596649|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
170596650|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
170596651|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
170596652|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
170596653|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
170596654|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
170596655|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
170596656|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
170596657|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
170913203|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
170913204|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
170913205|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
170913206|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
170913207|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
170596658|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
170596659|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
170596660|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
170596661|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
170913208|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
170913209|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
170596662|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
170596663|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
170596664|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
170596665|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
170596666|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
170596667|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
170596668|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
170596669|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
170596670|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
170596671|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
170596672|NCT02008357|616528004|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
170596673|NCT02008357|616528005|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
170596674|NCT02008357|616528004|FG000|Open-label Extension Period|Adverse Event|8|||
170596675|NCT02008357|616528005|FG001|Open-label Extension Period|Adverse Event|7|||
170596676|NCT02008357|616528004|FG000|Open-label Extension Period|Death|7|||
170596677|NCT02008357|616528005|FG001|Open-label Extension Period|Death|4|||
170596678|NCT02008357|616528004|FG000|Open-label Extension Period|Lack of Efficacy|9|||
170596679|NCT02008357|616528005|FG001|Open-label Extension Period|Lack of Efficacy|5|||
170596680|NCT02008357|616528004|FG000|Open-label Extension Period|Lost to Follow-up|2|||
170596681|NCT02008357|616528005|FG001|Open-label Extension Period|Lost to Follow-up|2|||
170596682|NCT02008357|616528004|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
170596683|NCT02008357|616528005|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
170596684|NCT02008357|616528004|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
170596685|NCT02008357|616528005|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
170596686|NCT02008357|616528004|FG000|Open-label Extension Period|Safety Risk|2|||
170596687|NCT02008357|616528005|FG001|Open-label Extension Period|Safety Risk|1|||
170596688|NCT02008357|616528004|FG000|Open-label Extension Period|Non-Compliance|0|||
170596689|NCT02008357|616528005|FG001|Open-label Extension Period|Non-Compliance|1|||
170596690|NCT02008357|616528004|FG000|Open-label Extension Period|Investigator Recommendation|0|||
170596691|NCT02008357|616528005|FG001|Open-label Extension Period|Investigator Recommendation|1|||
170596692|NCT02008357|616528004|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
170596693|NCT02008357|616528005|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
170596694|NCT02008357|616528004|FG000|Open-label Extension Period|Coordinating Center Request|2|||
170596695|NCT02008357|616528005|FG001|Open-label Extension Period|Coordinating Center Request|4|||
170596696|NCT02008357|616528004|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
170596697|NCT02008357|616528005|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
170596698|NCT02008357|616528004|FG000|Open-label Extension Period|Study Ended|20|||
170596699|NCT02008357|616528005|FG001|Open-label Extension Period|Study Ended|25|||
170596700|NCT02008357|616528004|FG000|Open-label Extension Period|Personal Reasons|0|||
170596701|NCT02008357|616528005|FG001|Open-label Extension Period|Personal Reasons|1|||
170596702|NCT02008357|616528004|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
170596703|NCT02008357|616528005|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
170596704|NCT02008357|616528004|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
170596705|NCT02008357|616528005|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
170596706|NCT02008357|616528004|FG000|Open-label Extension Period|Other|2|||
170596707|NCT02008357|616528005|FG001|Open-label Extension Period|Other|0|||
170913210|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
170596708|NCT02312219|616528006|FG000|Overall Study|Withdrawal by Subject|1|||
170596709|NCT02312219|616528007|FG001|Overall Study|Withdrawal by Subject|2|||
170596710|NCT02312219|616528006|FG000|Overall Study|could not schedule imaging in time|0|||
170596711|NCT02312219|616528007|FG001|Overall Study|could not schedule imaging in time|2|||
170596712|NCT02312219|616528006|FG000|Overall Study|Other|0|||
170913211|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
170913212|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
170913213|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
170913214|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
170596713|NCT02312219|616528007|FG001|Overall Study|Other|1|||
170596714|NCT02312219|616528006|FG000|Overall Study|Not randomized. Ineligible|0|||
170913215|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
170913216|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
170596715|NCT02312219|616528007|FG001|Overall Study|Not randomized. Ineligible|1|||
170651043|NCT00761150|616736336|FG000|Double-blind Period|Lost to Follow-up|0|||
170651044|NCT00761150|616736337|FG001|Double-blind Period|Lost to Follow-up|2|||
170651045|NCT00761150|616736338|FG002|Double-blind Period|Lost to Follow-up|1|||
170651046|NCT00761150|616736336|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
170651047|NCT00761150|616736337|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
170596716|NCT00276614|616528010|FG000|Overall Study|Progression of disease under study|3|||
170596717|NCT01048866|616528013|FG000|Overall Study|Adverse Event|1|||
170596718|NCT01048866|616528014|FG001|Overall Study|Adverse Event|0|||
170596719|NCT01048866|616528013|FG000|Overall Study|Protocol Violation|1|||
170596720|NCT01048866|616528014|FG001|Overall Study|Protocol Violation|0|||
170596721|NCT01048866|616528013|FG000|Overall Study|Physician Decision|1|||
170596722|NCT01048866|616528014|FG001|Overall Study|Physician Decision|0|||
170596723|NCT01048866|616528013|FG000|Overall Study|Withdrawal by Subject|0|||
170596724|NCT01048866|616528014|FG001|Overall Study|Withdrawal by Subject|2|||
170596725|NCT01048866|616528013|FG000|Overall Study|Lost to Follow-up|0|||
170596726|NCT01048866|616528014|FG001|Overall Study|Lost to Follow-up|2|||
170596727|NCT01048866|616528013|FG000|Overall Study|Other|1|||
170596728|NCT01048866|616528014|FG001|Overall Study|Other|1|||
170596729|NCT01977690|616528019|FG000|Overall Study|Withdrawal by Subject|0|||
170596730|NCT01977690|616528020|FG001|Overall Study|Withdrawal by Subject|4|||
170596731|NCT02210091|616528022|FG000|Overall Study|Physician Decision|0|||
170596732|NCT02210091|616528023|FG001|Overall Study|Physician Decision|1|||
170596733|NCT02210091|616528022|FG000|Overall Study|Withdrawal by Sponsor|0|||
170596734|NCT02210091|616528023|FG001|Overall Study|Withdrawal by Sponsor|1|||
170596735|NCT01831817|616528024|FG000|Overall Study|Lost to Follow-up|1|||
170596736|NCT01831817|616528025|FG001|Overall Study|Lost to Follow-up|0|||
170596737|NCT01831817|616528026|FG002|Overall Study|Lost to Follow-up|0|||
170596738|NCT01831817|616528027|FG003|Overall Study|Lost to Follow-up|0|||
170596739|NCT01831817|616528024|FG000|Overall Study|Withdrawl of Consent|3|||
170596740|NCT01831817|616528025|FG001|Overall Study|Withdrawl of Consent|0|||
170596741|NCT01831817|616528026|FG002|Overall Study|Withdrawl of Consent|0|||
170596742|NCT01831817|616528027|FG003|Overall Study|Withdrawl of Consent|0|||
170596743|NCT00958217|616528028|FG000|Overall Study|Death|2|||
170596744|NCT00958217|616528029|FG001|Overall Study|Death|1|||
170596745|NCT00958217|616528028|FG000|Overall Study|Withdrawal by Subject|4|||
170596746|NCT00958217|616528029|FG001|Overall Study|Withdrawal by Subject|3|||
170596747|NCT00958217|616528028|FG000|Overall Study|Lost to Follow-up|17|||
170596748|NCT00958217|616528029|FG001|Overall Study|Lost to Follow-up|19|||
170596749|NCT00958217|616528028|FG000|Overall Study|Moved out of area|1|||
170596750|NCT00958217|616528029|FG001|Overall Study|Moved out of area|1|||
170596751|NCT00958217|616528028|FG000|Overall Study|Inpatient hospitalization|0|||
170596752|NCT00958217|616528029|FG001|Overall Study|Inpatient hospitalization|1|||
170596753|NCT01999218|616528031|FG000|Overall Study|Hyperglycemia|18|||
170596754|NCT01999218|616528032|FG001|Overall Study|Hyperglycemia|17|||
170596755|NCT01999218|616528033|FG002|Overall Study|Hyperglycemia|17|||
170596756|NCT01999218|616528031|FG000|Overall Study|Lack of Efficacy|1|||
170596757|NCT01999218|616528032|FG001|Overall Study|Lack of Efficacy|0|||
170596758|NCT01999218|616528033|FG002|Overall Study|Lack of Efficacy|1|||
170596759|NCT01999218|616528031|FG000|Overall Study|Lost to Follow-up|22|||
170596760|NCT01999218|616528032|FG001|Overall Study|Lost to Follow-up|17|||
170596761|NCT01999218|616528033|FG002|Overall Study|Lost to Follow-up|18|||
170596762|NCT01999218|616528031|FG000|Overall Study|Non-Compliance With Study Drug|6|||
170596763|NCT01999218|616528032|FG001|Overall Study|Non-Compliance With Study Drug|4|||
170596764|NCT01999218|616528033|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170596765|NCT01999218|616528031|FG000|Overall Study|Physician Decision|1|||
170596766|NCT01999218|616528032|FG001|Overall Study|Physician Decision|4|||
170596767|NCT01999218|616528033|FG002|Overall Study|Physician Decision|6|||
170596768|NCT01999218|616528031|FG000|Overall Study|Protocol Violation|4|||
170596769|NCT01999218|616528032|FG001|Overall Study|Protocol Violation|5|||
170596770|NCT01999218|616528033|FG002|Overall Study|Protocol Violation|4|||
170596771|NCT01999218|616528031|FG000|Overall Study|Screen failure|0|||
170596772|NCT01999218|616528032|FG001|Overall Study|Screen failure|1|||
170596773|NCT01999218|616528033|FG002|Overall Study|Screen failure|0|||
170651048|NCT00761150|616736338|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
170913217|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
170913218|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
170596774|NCT01999218|616528031|FG000|Overall Study|Study Terminated By Sponsor|7|||
170596775|NCT01999218|616528032|FG001|Overall Study|Study Terminated By Sponsor|5|||
170596776|NCT01999218|616528033|FG002|Overall Study|Study Terminated By Sponsor|12|||
170596777|NCT01999218|616528031|FG000|Overall Study|Participant moves|2|||
170913219|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
170596778|NCT01999218|616528032|FG001|Overall Study|Participant moves|5|||
170596779|NCT01999218|616528033|FG002|Overall Study|Participant moves|3|||
170596780|NCT01999218|616528031|FG000|Overall Study|Withdrawal by Subject|28|||
170596781|NCT01999218|616528032|FG001|Overall Study|Withdrawal by Subject|29|||
170596782|NCT01999218|616528033|FG002|Overall Study|Withdrawal by Subject|34|||
170596783|NCT01999218|616528031|FG000|Overall Study|Creatinine/eGFR|0|||
170596784|NCT01999218|616528032|FG001|Overall Study|Creatinine/eGFR|0|||
170596785|NCT01999218|616528033|FG002|Overall Study|Creatinine/eGFR|1|||
170596786|NCT01999218|616528031|FG000|Overall Study|Death|7|||
170596787|NCT01999218|616528032|FG001|Overall Study|Death|1|||
170596788|NCT01999218|616528033|FG002|Overall Study|Death|2|||
170596789|NCT01999218|616528031|FG000|Overall Study|Excluded Medication|1|||
170596790|NCT01999218|616528032|FG001|Overall Study|Excluded Medication|1|||
170811881|NCT04181788|617319363|FG001|TREATMENT|Ongoing|3|||
170596791|NCT01999218|616528033|FG002|Overall Study|Excluded Medication|2|||
170596792|NCT01999218|616528031|FG000|Overall Study|Adverse Event|9|||
170596793|NCT01999218|616528032|FG001|Overall Study|Adverse Event|7|||
170596794|NCT01999218|616528033|FG002|Overall Study|Adverse Event|7|||
170596795|NCT01999218|616528031|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
170596796|NCT01999218|616528032|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
170596797|NCT01999218|616528033|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
170596798|NCT01192568|616529620|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
170596799|NCT01192568|616529621|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
170596800|NCT01192568|616529622|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
170596801|NCT01192568|616529623|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
170596802|NCT01192568|616529620|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
170596803|NCT01192568|616529621|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
170596804|NCT01192568|616529622|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
170596805|NCT01192568|616529623|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
170596806|NCT06359080|616529624|FG000|Overall Study|Withdrawal by Subject|3|||
170596807|NCT02783170|616529629|FG000|Overall Study|Randomized but not Vaccinated|1|||
170596808|NCT02783170|616529630|FG001|Overall Study|Randomized but not Vaccinated|0|||
170596809|NCT05063539|616529633|FG000|Overall Study|Adverse Event|1|||
170596810|NCT05063539|616529634|FG001|Overall Study|Adverse Event|2|||
170596811|NCT05063539|616529635|FG002|Overall Study|Adverse Event|1|||
170596812|NCT05063539|616529633|FG000|Overall Study|Death|0|||
170596813|NCT05063539|616529634|FG001|Overall Study|Death|1|||
170596814|NCT05063539|616529635|FG002|Overall Study|Death|1|||
170596815|NCT05063539|616529633|FG000|Overall Study|Lost to Follow-up|0|||
170596816|NCT05063539|616529634|FG001|Overall Study|Lost to Follow-up|1|||
170596817|NCT05063539|616529635|FG002|Overall Study|Lost to Follow-up|0|||
170596818|NCT05063539|616529633|FG000|Overall Study|Physician Decision|4|||
170596819|NCT05063539|616529634|FG001|Overall Study|Physician Decision|3|||
170596820|NCT05063539|616529635|FG002|Overall Study|Physician Decision|1|||
170596821|NCT05063539|616529633|FG000|Overall Study|Progressive Disease|0|||
170596822|NCT05063539|616529634|FG001|Overall Study|Progressive Disease|2|||
170596823|NCT05063539|616529635|FG002|Overall Study|Progressive Disease|0|||
170596824|NCT05063539|616529633|FG000|Overall Study|Withdrawal by Subject|17|||
170596825|NCT05063539|616529634|FG001|Overall Study|Withdrawal by Subject|26|||
170596826|NCT05063539|616529635|FG002|Overall Study|Withdrawal by Subject|14|||
170596827|NCT05063539|616529633|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
170596828|NCT05063539|616529634|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
170596829|NCT05063539|616529635|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
170596830|NCT05063539|616529633|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
170596831|NCT05063539|616529634|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
170596832|NCT05063539|616529635|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
170596833|NCT05063539|616529633|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
170596834|NCT05063539|616529634|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
170596835|NCT05063539|616529635|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
170596836|NCT05063539|616529633|FG000|Overall Study|Discontinued due to Common Close Design|0|||
170596837|NCT05063539|616529634|FG001|Overall Study|Discontinued due to Common Close Design|1|||
170596838|NCT05063539|616529635|FG002|Overall Study|Discontinued due to Common Close Design|0|||
170596839|NCT05063539|616529633|FG000|Overall Study|Participant not co-operative|0|||
170596840|NCT05063539|616529634|FG001|Overall Study|Participant not co-operative|1|||
170596841|NCT05063539|616529635|FG002|Overall Study|Participant not co-operative|0|||
170596842|NCT05063539|616529633|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
170596843|NCT05063539|616529634|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
170596844|NCT05063539|616529635|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
170596845|NCT05063539|616529633|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
170596846|NCT05063539|616529634|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
170596847|NCT05063539|616529635|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
170596848|NCT04256512|616529636|FG000|Overall Study|Withdrawal by Subject|1|||
170596849|NCT03199469|616529637|FG000|Overall Study|Randomized, not treated|0|||
170596850|NCT03199469|616529638|FG001|Overall Study|Randomized, not treated|3|||
170596851|NCT03199469|616529637|FG000|Overall Study|Withdrawal by Subject|1|||
170596852|NCT03199469|616529638|FG001|Overall Study|Withdrawal by Subject|0|||
170596853|NCT03199469|616529637|FG000|Overall Study|Death|1|||
170596854|NCT03199469|616529638|FG001|Overall Study|Death|3|||
170596855|NCT03199469|616529637|FG000|Overall Study|Ongoing|5|||
170596856|NCT03199469|616529638|FG001|Overall Study|Ongoing|14|||
170596857|NCT02804750|616529644|FG000|Period 1|Adverse Event|0|||
170596858|NCT02804750|616529645|FG001|Period 1|Adverse Event|2|||
170651049|NCT00761150|616736336|FG000|Double-blind Period|Noncompliance|0|||
170596859|NCT02804750|616529644|FG000|Period 1|Withdrawal by Subject|0|||
170596860|NCT02804750|616529645|FG001|Period 1|Withdrawal by Subject|1|||
170596861|NCT02804750|616529644|FG000|Period 2|Adverse Event|1|||
170596862|NCT02804750|616529645|FG001|Period 2|Adverse Event|0|||
170596863|NCT02804750|616529644|FG000|Period 3|Adverse Event|0|||
170596864|NCT02804750|616529645|FG001|Period 3|Adverse Event|2|||
170596865|NCT02804750|616529644|FG000|Period 4|Adverse Event|0|||
170596866|NCT02804750|616529645|FG001|Period 4|Adverse Event|5|||
170596867|NCT01867086|616529649|FG000|Overall Study|Disease Progression|1|||
170596868|NCT04257929|616529659|FG000|Overall Study|Adverse Event|1|||
170596869|NCT04257929|616529660|FG001|Overall Study|Adverse Event|0|||
170596870|NCT04257929|616529661|FG002|Overall Study|Adverse Event|1|||
170596871|NCT04257929|616529659|FG000|Overall Study|Withdrawal by Subject|1|||
170596872|NCT04257929|616529660|FG001|Overall Study|Withdrawal by Subject|0|||
170596873|NCT04257929|616529661|FG002|Overall Study|Withdrawal by Subject|0|||
170596874|NCT04257929|616529659|FG000|Overall Study|COVID-19|0|||
170596875|NCT04257929|616529660|FG001|Overall Study|COVID-19|1|||
170596876|NCT04257929|616529661|FG002|Overall Study|COVID-19|1|||
170596877|NCT04257929|616529659|FG000|Overall Study|Lost to Follow-up|0|||
170596878|NCT04257929|616529660|FG001|Overall Study|Lost to Follow-up|0|||
170596879|NCT04257929|616529661|FG002|Overall Study|Lost to Follow-up|1|||
170596880|NCT03826342|616529662|FG000|Overall Study|Withdrawal by Subject|8|||
170596881|NCT03826342|616529663|FG001|Overall Study|Withdrawal by Subject|1|||
170596882|NCT03826342|616529662|FG000|Overall Study|Lost to Follow-up|7|||
170596883|NCT03826342|616529663|FG001|Overall Study|Lost to Follow-up|7|||
170596884|NCT03826342|616529662|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
170596885|NCT03826342|616529663|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
170596886|NCT02212678|616529666|FG000|Overall Study|Adverse Event|1|||
170596887|NCT02337634|616529667|FG000|Overall Study|Protocol Violation|3|||
170596888|NCT02337634|616529668|FG001|Overall Study|Protocol Violation|1|||
170811882|NCT04181788|617319364|FG002|TREATMENT|Ongoing|0|||
170811883|NCT04181788|617319365|FG003|TREATMENT|Ongoing|5|||
170811884|NCT04181788|617319366|FG004|TREATMENT|Ongoing|7|||
170596889|NCT02337634|616529667|FG000|Overall Study|Lost to Follow-up|1|||
170596890|NCT02337634|616529668|FG001|Overall Study|Lost to Follow-up|0|||
170596891|NCT04030962|616529669|FG000|Stage 2|Adverse Event|0|||
170596892|NCT04030962|616529670|FG001|Stage 2|Adverse Event|0|||
170596893|NCT04030962|616529671|FG002|Stage 2|Adverse Event|0|||
170596894|NCT04030962|616529672|FG003|Stage 2|Adverse Event|0|||
170596895|NCT04030962|616529673|FG004|Stage 2|Adverse Event|0|||
170596896|NCT04030962|616529674|FG005|Stage 2|Adverse Event|0|||
170596897|NCT04030962|616529675|FG006|Stage 2|Adverse Event|0|||
170596898|NCT04030962|616529676|FG007|Stage 2|Adverse Event|0|||
170596899|NCT04030962|616529677|FG008|Stage 2|Adverse Event|1|||
170596900|NCT04030962|616529678|FG009|Stage 2|Adverse Event|0|||
170596901|NCT04030962|616529679|FG010|Stage 2|Adverse Event|1|||
170596902|NCT04030962|616529680|FG011|Stage 2|Adverse Event|1|||
170596903|NCT04030962|616529681|FG012|Stage 2|Adverse Event|1|||
170596904|NCT04030962|616529669|FG000|Stage 2|Withdrawal by Subject|0|||
170596905|NCT04030962|616529670|FG001|Stage 2|Withdrawal by Subject|0|||
170596906|NCT04030962|616529671|FG002|Stage 2|Withdrawal by Subject|0|||
170596907|NCT04030962|616529672|FG003|Stage 2|Withdrawal by Subject|0|||
170596908|NCT04030962|616529673|FG004|Stage 2|Withdrawal by Subject|0|||
170596909|NCT04030962|616529674|FG005|Stage 2|Withdrawal by Subject|0|||
170596910|NCT04030962|616529675|FG006|Stage 2|Withdrawal by Subject|0|||
170596911|NCT04030962|616529676|FG007|Stage 2|Withdrawal by Subject|0|||
170596912|NCT04030962|616529677|FG008|Stage 2|Withdrawal by Subject|1|||
170596913|NCT04030962|616529678|FG009|Stage 2|Withdrawal by Subject|0|||
170596914|NCT04030962|616529679|FG010|Stage 2|Withdrawal by Subject|0|||
170596915|NCT04030962|616529680|FG011|Stage 2|Withdrawal by Subject|2|||
170596916|NCT04030962|616529681|FG012|Stage 2|Withdrawal by Subject|1|||
170596917|NCT04030962|616529669|FG000|Stage 2|Lost to Follow-up|0|||
170596918|NCT04030962|616529670|FG001|Stage 2|Lost to Follow-up|0|||
170596919|NCT04030962|616529671|FG002|Stage 2|Lost to Follow-up|0|||
170596920|NCT04030962|616529672|FG003|Stage 2|Lost to Follow-up|0|||
170596921|NCT04030962|616529673|FG004|Stage 2|Lost to Follow-up|0|||
170596922|NCT04030962|616529674|FG005|Stage 2|Lost to Follow-up|0|||
170596923|NCT04030962|616529675|FG006|Stage 2|Lost to Follow-up|0|||
170596924|NCT04030962|616529676|FG007|Stage 2|Lost to Follow-up|0|||
170596925|NCT04030962|616529677|FG008|Stage 2|Lost to Follow-up|1|||
170596926|NCT04030962|616529678|FG009|Stage 2|Lost to Follow-up|0|||
170596927|NCT04030962|616529679|FG010|Stage 2|Lost to Follow-up|0|||
170596928|NCT04030962|616529680|FG011|Stage 2|Lost to Follow-up|0|||
170596929|NCT04030962|616529681|FG012|Stage 2|Lost to Follow-up|0|||
170811885|NCT04181788|617319367|FG005|TREATMENT|Ongoing|15|||
170596930|NCT04030962|616529669|FG000|Stage 2|Technical Problems|0|||
170596931|NCT04030962|616529670|FG001|Stage 2|Technical Problems|0|||
170596932|NCT04030962|616529671|FG002|Stage 2|Technical Problems|0|||
170596933|NCT04030962|616529672|FG003|Stage 2|Technical Problems|0|||
170596934|NCT04030962|616529673|FG004|Stage 2|Technical Problems|0|||
170596935|NCT04030962|616529674|FG005|Stage 2|Technical Problems|0|||
170596936|NCT04030962|616529675|FG006|Stage 2|Technical Problems|0|||
170596937|NCT04030962|616529676|FG007|Stage 2|Technical Problems|0|||
170811886|NCT04181788|617319362|FG000|FOLLOW-UP|Death|0|||
170651050|NCT00761150|616736337|FG001|Double-blind Period|Noncompliance|1|||
170651051|NCT00761150|616736338|FG002|Double-blind Period|Noncompliance|0|||
170651052|NCT00761150|616736336|FG000|Double-blind Period|Other|0|||
170651053|NCT00761150|616736337|FG001|Double-blind Period|Other|3|||
170651054|NCT00761150|616736338|FG002|Double-blind Period|Other|3|||
170651055|NCT00282464|616736345|FG000|Overall Study|Adverse Event|26|||
170651056|NCT00282464|616736346|FG001|Overall Study|Adverse Event|20|||
170651057|NCT00282464|616736345|FG000|Overall Study|Lack of Efficacy|8|||
170651058|NCT00282464|616736346|FG001|Overall Study|Lack of Efficacy|8|||
170651059|NCT00282464|616736345|FG000|Overall Study|Lost to Follow-up|10|||
170651060|NCT00282464|616736346|FG001|Overall Study|Lost to Follow-up|10|||
170651061|NCT00282464|616736345|FG000|Overall Study|Withdrawal by Subject|24|||
170651062|NCT00282464|616736346|FG001|Overall Study|Withdrawal by Subject|10|||
170651063|NCT00282464|616736345|FG000|Overall Study|laboratory abnormality|1|||
170651064|NCT00282464|616736346|FG001|Overall Study|laboratory abnormality|2|||
170651065|NCT00282464|616736345|FG000|Overall Study|Protocol Violation|0|||
170651066|NCT00282464|616736346|FG001|Overall Study|Protocol Violation|7|||
170651067|NCT00282464|616736345|FG000|Overall Study|Patient moved|1|||
170651068|NCT00282464|616736346|FG001|Overall Study|Patient moved|0|||
170651069|NCT00282464|616736345|FG000|Overall Study|patient non-compliant|3|||
170651070|NCT00282464|616736346|FG001|Overall Study|patient non-compliant|0|||
170651071|NCT00282464|616736345|FG000|Overall Study|patient no show|0|||
170651072|NCT00282464|616736346|FG001|Overall Study|patient no show|1|||
170651073|NCT00282464|616736345|FG000|Overall Study|patient incarcerated|0|||
170651074|NCT00282464|616736346|FG001|Overall Study|patient incarcerated|1|||
170651075|NCT00282464|616736345|FG000|Overall Study|family crisis|0|||
170651076|NCT00282464|616736346|FG001|Overall Study|family crisis|1|||
170651077|NCT00282464|616736345|FG000|Overall Study|dispensed wrong kit|0|||
170651078|NCT00282464|616736346|FG001|Overall Study|dispensed wrong kit|1|||
170651079|NCT00282464|616736345|FG000|Overall Study|dropped due to missed visits|0|||
170651080|NCT00282464|616736346|FG001|Overall Study|dropped due to missed visits|1|||
170651081|NCT00466687|616736347|FG000|Overall Study|Adverse Event|1|||
170651082|NCT00466687|616736347|FG000|Overall Study|Other complicating illness|3|||
170651083|NCT00466687|616736347|FG000|Overall Study|Withdrawal by Subject|1|||
170651084|NCT00466687|616736347|FG000|Overall Study|Disease progression|29|||
170651085|NCT01925989|616736348|FG000|Period 1|Sponsor Decision|1|||
170651086|NCT01925989|616736349|FG001|Period 1|Sponsor Decision|1|||
170651087|NCT01925989|616736350|FG002|Period 1|Sponsor Decision|0|||
170651088|NCT01925989|616736348|FG000|Period 1|Withdrawal by Subject|0|||
170651089|NCT01925989|616736349|FG001|Period 1|Withdrawal by Subject|1|||
170651090|NCT01925989|616736350|FG002|Period 1|Withdrawal by Subject|0|||
170651091|NCT00868517|616736356|FG000|Overall Study|Withdrawal by Subject|3|||
170651092|NCT00868517|616736357|FG001|Overall Study|Withdrawal by Subject|3|||
170651093|NCT00868517|616736358|FG002|Overall Study|Withdrawal by Subject|2|||
170651094|NCT00868517|616736356|FG000|Overall Study|Protocol Violation|1|||
170651095|NCT00868517|616736357|FG001|Overall Study|Protocol Violation|1|||
170651096|NCT00868517|616736358|FG002|Overall Study|Protocol Violation|0|||
170651097|NCT00046891|616736359|FG000|Overall Study|Cancels|5|||
170651098|NCT00046891|616736360|FG001|Overall Study|Cancels|9|||
170811887|NCT04181788|617319363|FG001|FOLLOW-UP|Death|0|||
170811888|NCT04181788|617319364|FG002|FOLLOW-UP|Death|1|||
170811889|NCT04181788|617319365|FG003|FOLLOW-UP|Death|2|||
170811890|NCT04181788|617319366|FG004|FOLLOW-UP|Death|8|||
170811891|NCT04181788|617319367|FG005|FOLLOW-UP|Death|20|||
170651099|NCT00046891|616736359|FG000|Overall Study|Ineligible|1|||
170651100|NCT00046891|616736360|FG001|Overall Study|Ineligible|1|||
170651101|NCT00046891|616736359|FG000|Overall Study|Withdrawal by Subject|18|||
170651102|NCT00046891|616736360|FG001|Overall Study|Withdrawal by Subject|15|||
170651103|NCT00046891|616736359|FG000|Overall Study|Adverse Event|5|||
170651104|NCT00046891|616736360|FG001|Overall Study|Adverse Event|5|||
170651105|NCT01721577|616736361|FG000|Overall Study|Lack of Efficacy|1|||
170651106|NCT01721577|616736362|FG001|Overall Study|Lack of Efficacy|0|||
170651107|NCT01721577|616736361|FG000|Overall Study|Death|1|||
170651108|NCT01721577|616736362|FG001|Overall Study|Death|0|||
170651109|NCT01721577|616736361|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
170651110|NCT01721577|616736362|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
170651111|NCT01721577|616736361|FG000|Overall Study|Adverse Event|0|||
170651112|NCT01721577|616736362|FG001|Overall Study|Adverse Event|2|||
170651113|NCT03901456|616736364|FG000|Overall Study|Withdrawal by Subject|0|||
170651114|NCT03901456|616736365|FG001|Overall Study|Withdrawal by Subject|0|||
170651115|NCT03901456|616736366|FG002|Overall Study|Withdrawal by Subject|1|||
170811892|NCT04181788|617319362|FG000|FOLLOW-UP|Lost to Follow-up|0|||
170811893|NCT04181788|617319363|FG001|FOLLOW-UP|Lost to Follow-up|0|||
170811894|NCT04181788|617319364|FG002|FOLLOW-UP|Lost to Follow-up|0|||
170651116|NCT03901456|616736364|FG000|Overall Study|Lost to Follow-up|0|||
170651117|NCT03901456|616736365|FG001|Overall Study|Lost to Follow-up|1|||
170651118|NCT03901456|616736366|FG002|Overall Study|Lost to Follow-up|0|||
170651119|NCT06400251|616736367|FG000|Overall Study|Never Start Protocol Therapy|1|||
170651120|NCT06400251|616736367|FG000|Overall Study|Ineligible|2|||
170651121|NCT06400251|616736367|FG000|Overall Study|Mutation Status Not Confirmed|3|||
170811895|NCT04181788|617319365|FG003|FOLLOW-UP|Lost to Follow-up|0|||
170913220|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
170913221|NCT00958568|617685861|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
170913222|NCT00958568|617685862|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
170913223|NCT00958568|617685863|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
170913224|NCT00958568|617685864|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
170913225|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
170913226|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
170913227|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
170913228|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
170913229|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
170913230|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
170913231|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
170913232|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
170596938|NCT04030962|616529677|FG008|Stage 2|Technical Problems|0|||
170596939|NCT04030962|616529678|FG009|Stage 2|Technical Problems|0|||
170596940|NCT04030962|616529679|FG010|Stage 2|Technical Problems|0|||
170596941|NCT04030962|616529680|FG011|Stage 2|Technical Problems|1|||
170596942|NCT04030962|616529681|FG012|Stage 2|Technical Problems|0|||
170596943|NCT02888743|616529682|FG000|Overall Study|Withdrawal by Subject|1|||
170596944|NCT02888743|616529683|FG001|Overall Study|Withdrawal by Subject|2|||
170596945|NCT02888743|616529684|FG002|Overall Study|Withdrawal by Subject|2|||
170596946|NCT02888743|616529685|FG003|Overall Study|Withdrawal by Subject|0|||
170596947|NCT02888743|616529686|FG004|Overall Study|Withdrawal by Subject|1|||
170596948|NCT02888743|616529682|FG000|Overall Study|Disease progression before treatment|2|||
170596949|NCT02888743|616529683|FG001|Overall Study|Disease progression before treatment|0|||
170596950|NCT02888743|616529684|FG002|Overall Study|Disease progression before treatment|2|||
170596951|NCT02888743|616529685|FG003|Overall Study|Disease progression before treatment|0|||
170596952|NCT02888743|616529686|FG004|Overall Study|Disease progression before treatment|0|||
170596953|NCT02888743|616529682|FG000|Overall Study|Patient ineligible|1|||
170596954|NCT02888743|616529683|FG001|Overall Study|Patient ineligible|2|||
170596955|NCT02888743|616529684|FG002|Overall Study|Patient ineligible|0|||
170596956|NCT02888743|616529685|FG003|Overall Study|Patient ineligible|0|||
170596957|NCT02888743|616529686|FG004|Overall Study|Patient ineligible|0|||
170596958|NCT05288166|616529693|FG000|Overall Study|Adverse Event|1|||
170596959|NCT05288166|616529694|FG001|Overall Study|Adverse Event|0|||
170596960|NCT05288166|616529693|FG000|Overall Study|Lost to Follow-up|2|||
170596961|NCT05288166|616529694|FG001|Overall Study|Lost to Follow-up|0|||
170596962|NCT05288166|616529693|FG000|Overall Study|Physician Decision|0|||
170596963|NCT05288166|616529694|FG001|Overall Study|Physician Decision|2|||
170596964|NCT05288166|616529693|FG000|Overall Study|Screen Failure|1|||
170596965|NCT05288166|616529694|FG001|Overall Study|Screen Failure|1|||
170596966|NCT05288166|616529693|FG000|Overall Study|Withdrawal by Subject|4|||
170596967|NCT05288166|616529694|FG001|Overall Study|Withdrawal by Subject|2|||
170596968|NCT05288166|616529693|FG000|Overall Study|On Study Treatment|408|||
170596969|NCT05288166|616529694|FG001|Overall Study|On Study Treatment|418|||
170596970|NCT01114360|616529695|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
170596971|NCT01114360|616529696|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
170596972|NCT04912895|616529701|FG000|Overall Study|Unable to provide specimen|2|||
170596973|NCT04912895|616529702|FG001|Overall Study|Unable to provide specimen|0|||
170596974|NCT04912895|616529703|FG002|Overall Study|Unable to provide specimen|0|||
170596975|NCT01146652|616529704|FG000|Overall Study|Adverse Event|506|||
170596976|NCT01146652|616529705|FG001|Overall Study|Adverse Event|15|||
170596977|NCT01146652|616529704|FG000|Overall Study|Lack of Efficacy|91|||
170596978|NCT01146652|616529705|FG001|Overall Study|Lack of Efficacy|7|||
170596979|NCT01146652|616529704|FG000|Overall Study|Poor compliance to protocol|38|||
170596980|NCT01146652|616529705|FG001|Overall Study|Poor compliance to protocol|1|||
170596981|NCT01146652|616529704|FG000|Overall Study|Other unspecified reasons|314|||
170596982|NCT01146652|616529705|FG001|Overall Study|Other unspecified reasons|22|||
170596983|NCT01146652|616529704|FG000|Overall Study|Enrolled but not treated|2|||
170596984|NCT01146652|616529705|FG001|Overall Study|Enrolled but not treated|0|||
170596985|NCT00431951|616529706|FG000|Overall Study|Inability to follow study procedures|1|||
170596986|NCT00431951|616529707|FG001|Overall Study|Inability to follow study procedures|0|||
170596987|NCT00431951|616529708|FG002|Overall Study|Inability to follow study procedures|1|||
170596988|NCT00431951|616529709|FG003|Overall Study|Inability to follow study procedures|2|||
170596989|NCT00431951|616529706|FG000|Overall Study|Lost to Follow-up|0|||
170596990|NCT00431951|616529707|FG001|Overall Study|Lost to Follow-up|1|||
170596991|NCT00431951|616529708|FG002|Overall Study|Lost to Follow-up|0|||
170596992|NCT00431951|616529709|FG003|Overall Study|Lost to Follow-up|0|||
170596993|NCT00431951|616529706|FG000|Overall Study|Withdrawal by Subject|0|||
170596994|NCT00431951|616529707|FG001|Overall Study|Withdrawal by Subject|1|||
170596995|NCT00431951|616529708|FG002|Overall Study|Withdrawal by Subject|0|||
170596996|NCT00431951|616529709|FG003|Overall Study|Withdrawal by Subject|0|||
170811896|NCT04181788|617319366|FG004|FOLLOW-UP|Lost to Follow-up|0|||
170811897|NCT04181788|617319367|FG005|FOLLOW-UP|Lost to Follow-up|2|||
170811898|NCT04181788|617319362|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
170811899|NCT04181788|617319363|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
170811900|NCT04181788|617319364|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
170811901|NCT04181788|617319365|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
170811902|NCT04181788|617319366|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
170811903|NCT04181788|617319367|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
170811904|NCT04181788|617319362|FG000|FOLLOW-UP|Other unspecified|0|||
170811905|NCT04181788|617319363|FG001|FOLLOW-UP|Other unspecified|1|||
170811906|NCT04181788|617319364|FG002|FOLLOW-UP|Other unspecified|0|||
170811907|NCT04181788|617319365|FG003|FOLLOW-UP|Other unspecified|0|||
170596997|NCT00431951|616529706|FG000|Overall Study|Adverse Event|0|||
170596998|NCT00431951|616529707|FG001|Overall Study|Adverse Event|0|||
170596999|NCT00431951|616529708|FG002|Overall Study|Adverse Event|1|||
170597000|NCT00431951|616529709|FG003|Overall Study|Adverse Event|0|||
170597001|NCT02255565|616529711|FG000|Overall Study|Withdrawal by Subject|0|||
170597002|NCT02255565|616529712|FG001|Overall Study|Withdrawal by Subject|1|||
170811908|NCT04181788|617319366|FG004|FOLLOW-UP|Other unspecified|0|||
170811909|NCT04181788|617319367|FG005|FOLLOW-UP|Other unspecified|3|||
170811910|NCT04181788|617319362|FG000|FOLLOW-UP|Ongoing|0|||
170811911|NCT04181788|617319363|FG001|FOLLOW-UP|Ongoing|0|||
170811912|NCT04181788|617319364|FG002|FOLLOW-UP|Ongoing|1|||
170811913|NCT04181788|617319365|FG003|FOLLOW-UP|Ongoing|3|||
170811914|NCT04181788|617319366|FG004|FOLLOW-UP|Ongoing|2|||
170811915|NCT04181788|617319367|FG005|FOLLOW-UP|Ongoing|2|||
170811916|NCT04937504|617319368|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
170811917|NCT04937504|617319369|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
170811918|NCT04937504|617319368|FG000|9 Months Assessment|Lost to Follow-up|3|||
170811919|NCT04937504|617319369|FG001|9 Months Assessment|Lost to Follow-up|2|||
170811920|NCT04852978|617319370|FG000|Overall Study|Physician Decision|0|||
170811921|NCT04852978|617319371|FG001|Overall Study|Physician Decision|1|||
170811922|NCT04852978|617319372|FG002|Overall Study|Physician Decision|0|||
170811923|NCT04852978|617319373|FG003|Overall Study|Physician Decision|0|||
170811924|NCT04852978|617319374|FG004|Overall Study|Physician Decision|0|||
170811925|NCT04852978|617319375|FG005|Overall Study|Physician Decision|0|||
170811926|NCT04852978|617319376|FG006|Overall Study|Physician Decision|0|||
170811927|NCT04852978|617319377|FG007|Overall Study|Physician Decision|2|||
170811928|NCT04852978|617319378|FG008|Overall Study|Physician Decision|0|||
170811929|NCT04852978|617319370|FG000|Overall Study|Sponsor request|0|||
170913233|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
170913234|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
170913235|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
170913236|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
170597003|NCT02255565|616529713|FG002|Overall Study|Withdrawal by Subject|0|||
170597004|NCT02699450|616529714|FG000|Overall Study|Death|2|||
170597005|NCT02699450|616529715|FG001|Overall Study|Death|1|||
170597006|NCT02699450|616529716|FG002|Overall Study|Death|2|||
170597007|NCT02699450|616529714|FG000|Overall Study|Met Criteria for Study Exit|0|||
170597008|NCT02699450|616529715|FG001|Overall Study|Met Criteria for Study Exit|0|||
170597009|NCT02699450|616529716|FG002|Overall Study|Met Criteria for Study Exit|1|||
170597010|NCT02699450|616529714|FG000|Overall Study|Protocol Violation|4|||
170597011|NCT02699450|616529715|FG001|Overall Study|Protocol Violation|3|||
170597012|NCT02699450|616529716|FG002|Overall Study|Protocol Violation|5|||
170597013|NCT02699450|616529714|FG000|Overall Study|Lost to Follow-up|3|||
170597014|NCT02699450|616529715|FG001|Overall Study|Lost to Follow-up|0|||
170651122|NCT06400251|616736367|FG000|Overall Study|Disease Progression|25|||
170811930|NCT04852978|617319371|FG001|Overall Study|Sponsor request|0|||
170811931|NCT04852978|617319372|FG002|Overall Study|Sponsor request|1|||
170811932|NCT04852978|617319373|FG003|Overall Study|Sponsor request|0|||
170811933|NCT04852978|617319374|FG004|Overall Study|Sponsor request|0|||
170811934|NCT04852978|617319375|FG005|Overall Study|Sponsor request|0|||
170913237|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
170913238|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
170597015|NCT02699450|616529716|FG002|Overall Study|Lost to Follow-up|5|||
170597016|NCT02699450|616529714|FG000|Overall Study|Physician Decision|2|||
170597017|NCT02699450|616529715|FG001|Overall Study|Physician Decision|0|||
170597018|NCT02699450|616529716|FG002|Overall Study|Physician Decision|0|||
170811935|NCT04852978|617319376|FG006|Overall Study|Sponsor request|0|||
170811936|NCT04852978|617319377|FG007|Overall Study|Sponsor request|0|||
170811937|NCT04852978|617319378|FG008|Overall Study|Sponsor request|0|||
170811938|NCT04852978|617319370|FG000|Overall Study|Death|0|||
170811939|NCT04852978|617319371|FG001|Overall Study|Death|0|||
170811940|NCT04852978|617319372|FG002|Overall Study|Death|0|||
170597019|NCT02699450|616529714|FG000|Overall Study|Withdrawal by Subject|3|||
170597020|NCT02699450|616529715|FG001|Overall Study|Withdrawal by Subject|1|||
170811941|NCT04852978|617319373|FG003|Overall Study|Death|0|||
170811942|NCT04852978|617319374|FG004|Overall Study|Death|0|||
170811943|NCT04852978|617319375|FG005|Overall Study|Death|0|||
170811944|NCT04852978|617319376|FG006|Overall Study|Death|1|||
170913239|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
170913240|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
170913241|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
170913242|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
170913243|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
170913244|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
170913245|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
170913246|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
170913247|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
170913248|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
170913249|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
170913250|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
170913251|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
170913252|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
170913253|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
170913254|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
170913255|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
170913256|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
170913257|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
170913258|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
170913259|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
170913260|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
170913261|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
170913262|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
170913263|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
170913264|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
170913265|NCT00958568|617685861|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
170913266|NCT00958568|617685862|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
170913267|NCT00958568|617685863|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
170913268|NCT00958568|617685864|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
170913269|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
170913270|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
170913271|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
170913272|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
170913273|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
170913274|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
170913275|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
170913276|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
170913277|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
170913278|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
170913279|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
170913280|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
170913281|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
170913282|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
170913283|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
170913284|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
170913285|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
170913286|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
170913287|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
170913288|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
170913289|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
170913290|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
170913291|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
170913292|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
170913293|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
170913294|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
170913295|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
170913296|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
170913297|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
170651123|NCT06400251|616736367|FG000|Overall Study|Adverse Event|1|||
170651124|NCT06400251|616736367|FG000|Overall Study|Complicating Disease|1|||
170651125|NCT06400251|616736367|FG000|Overall Study|Physician Decision|2|||
170651126|NCT04098224|616736368|FG000|Overall Study|Adverse Event|1|||
170913298|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
170913299|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
170913300|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
170913301|NCT00958568|617685861|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
170913302|NCT00958568|617685862|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
170913303|NCT00958568|617685863|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
170913304|NCT00958568|617685864|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
170913305|NCT00972244|617685865|FG000|Overall Study|Incorrect Enrolment|1|||
170651127|NCT04098224|616736369|FG001|Overall Study|Adverse Event|0|||
170651128|NCT04098224|616736368|FG000|Overall Study|Physician Decision|1|||
170651129|NCT04098224|616736369|FG001|Overall Study|Physician Decision|0|||
170651130|NCT04098224|616736368|FG000|Overall Study|Patient not required enteral feeding|1|||
170651131|NCT04098224|616736369|FG001|Overall Study|Patient not required enteral feeding|0|||
170651132|NCT04098224|616736368|FG000|Overall Study|Patient failure nasogastric tube|1|||
170651133|NCT04098224|616736369|FG001|Overall Study|Patient failure nasogastric tube|0|||
170651134|NCT04098224|616736368|FG000|Overall Study|Patient early extubation|1|||
170913306|NCT00972244|617685866|FG001|Overall Study|Incorrect Enrolment|0|||
170913307|NCT00972244|617685867|FG002|Overall Study|Incorrect Enrolment|0|||
170913308|NCT00972244|617685868|FG003|Overall Study|Incorrect Enrolment|0|||
170913309|NCT00972244|617685869|FG004|Overall Study|Incorrect Enrolment|0|||
170913310|NCT00972244|617685865|FG000|Overall Study|Adverse Event|0|||
170913311|NCT00972244|617685866|FG001|Overall Study|Adverse Event|1|||
170913312|NCT00972244|617685867|FG002|Overall Study|Adverse Event|1|||
170913313|NCT00972244|617685868|FG003|Overall Study|Adverse Event|0|||
170913314|NCT00972244|617685869|FG004|Overall Study|Adverse Event|0|||
170913315|NCT00972244|617685865|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
170913316|NCT00972244|617685866|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
170913317|NCT00972244|617685867|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
170913318|NCT00972244|617685868|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
170913319|NCT00972244|617685869|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
170913320|NCT00972244|617685865|FG000|Overall Study|Withdrawal by Subject|1|||
170913321|NCT00972244|617685866|FG001|Overall Study|Withdrawal by Subject|2|||
170913322|NCT00972244|617685867|FG002|Overall Study|Withdrawal by Subject|1|||
170913323|NCT00972244|617685868|FG003|Overall Study|Withdrawal by Subject|0|||
170913324|NCT00972244|617685869|FG004|Overall Study|Withdrawal by Subject|1|||
170913325|NCT00972244|617685865|FG000|Overall Study|Safety|0|||
170913326|NCT00972244|617685866|FG001|Overall Study|Safety|0|||
170913327|NCT00972244|617685867|FG002|Overall Study|Safety|0|||
170913328|NCT00972244|617685868|FG003|Overall Study|Safety|0|||
170913329|NCT00972244|617685869|FG004|Overall Study|Safety|1|||
170913330|NCT00972244|617685865|FG000|Overall Study|Death|1|||
170913331|NCT00972244|617685866|FG001|Overall Study|Death|0|||
170597021|NCT02699450|616529716|FG002|Overall Study|Withdrawal by Subject|2|||
170597022|NCT02699450|616529714|FG000|Overall Study|Adverse Event|1|||
170597023|NCT02699450|616529715|FG001|Overall Study|Adverse Event|0|||
170597024|NCT02699450|616529716|FG002|Overall Study|Adverse Event|0|||
170597025|NCT00810901|616529717|FG000|Overall Study|Lost to Follow-up|88|||
170597026|NCT00810901|616529718|FG001|Overall Study|Lost to Follow-up|58|||
170597027|NCT01920152|616529720|FG000|Overall Study|Withdrawal by Subject|1|||
170597028|NCT01920152|616529721|FG001|Overall Study|Withdrawal by Subject|2|||
170597029|NCT01842581|616529729|FG000|Overall Study|Adverse Event|6|||
170597030|NCT01842581|616529730|FG001|Overall Study|Adverse Event|4|||
170597031|NCT01842581|616529729|FG000|Overall Study|HE breakthrough|26|||
170597032|NCT01842581|616529730|FG001|Overall Study|HE breakthrough|13|||
170597033|NCT01842581|616529729|FG000|Overall Study|Liver transplant|2|||
170597034|NCT01842581|616529730|FG001|Overall Study|Liver transplant|0|||
170597035|NCT01842581|616529729|FG000|Overall Study|Lost to Follow-up|2|||
170597036|NCT01842581|616529730|FG001|Overall Study|Lost to Follow-up|5|||
170597037|NCT01842581|616529729|FG000|Overall Study|Withdrawal by Subject|5|||
170597038|NCT01842581|616529730|FG001|Overall Study|Withdrawal by Subject|7|||
170597039|NCT01842581|616529729|FG000|Overall Study|Other than specified|3|||
170597040|NCT01842581|616529730|FG001|Overall Study|Other than specified|1|||
170597041|NCT00283868|616529736|FG000|Overall Study|Lost to Follow-up|7|||
170597042|NCT00283868|616529737|FG001|Overall Study|Lost to Follow-up|8|||
170597043|NCT01515475|616529738|FG000|Overall Study|Lost to Follow-up|20|||
170597044|NCT01515475|616529739|FG001|Overall Study|Lost to Follow-up|15|||
170597045|NCT01515475|616529740|FG002|Overall Study|Lost to Follow-up|12|||
170597046|NCT01515475|616529741|FG003|Overall Study|Lost to Follow-up|12|||
170913332|NCT00972244|617685867|FG002|Overall Study|Death|0|||
170913333|NCT00972244|617685868|FG003|Overall Study|Death|0|||
170597047|NCT01219933|616529747|FG000|Overall Study|Adverse Event|8|||
170913334|NCT00972244|617685869|FG004|Overall Study|Death|0|||
170597048|NCT01219933|616529747|FG000|Overall Study|No LDA reached|5|||
170597049|NCT01219933|616529747|FG000|Overall Study|No LDA maintained|7|||
170651135|NCT04098224|616736369|FG001|Overall Study|Patient early extubation|3|||
170651136|NCT01203852|616736373|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
170651137|NCT01203852|616736373|FG000|Washout 2 Weeks|Physician Decision|46|||
170597050|NCT01219933|616529747|FG000|Overall Study|Lost to Follow-up|3|||
170597051|NCT01219933|616529747|FG000|Overall Study|GC free|1|||
170597052|NCT01219933|616529747|FG000|Overall Study|Withdrawal by Subject|5|||
170597053|NCT01219933|616529747|FG000|Overall Study|Protocol Violation|8|||
170597054|NCT01219933|616529747|FG000|Overall Study|Lack of Efficacy|1|||
170597055|NCT03149003|616529748|FG000|Overall Study|Randomized but not treated|0|||
170597056|NCT03149003|616529749|FG001|Overall Study|Randomized but not treated|1|||
170597057|NCT03149003|616529750|FG002|Overall Study|Randomized but not treated|18|||
170597058|NCT00613080|616529755|FG000|Overall Study|Ineligible / no protocol treatment|11|||
170597059|NCT02905006|616531014|FG000|Overall Study|Adverse Event|1|||
170597060|NCT02905006|616531015|FG001|Overall Study|Adverse Event|1|||
170597061|NCT02905006|616531016|FG002|Overall Study|Adverse Event|1|||
170597062|NCT02905006|616531017|FG003|Overall Study|Adverse Event|1|||
170597063|NCT02905006|616531018|FG004|Overall Study|Adverse Event|0|||
170597064|NCT02905006|616531019|FG005|Overall Study|Adverse Event|1|||
170597065|NCT02905006|616531014|FG000|Overall Study|Lack of Efficacy|1|||
170597066|NCT02905006|616531015|FG001|Overall Study|Lack of Efficacy|0|||
170597067|NCT02905006|616531016|FG002|Overall Study|Lack of Efficacy|0|||
170597068|NCT02905006|616531017|FG003|Overall Study|Lack of Efficacy|0|||
170597069|NCT02905006|616531018|FG004|Overall Study|Lack of Efficacy|0|||
170597070|NCT02905006|616531019|FG005|Overall Study|Lack of Efficacy|0|||
170597071|NCT02905006|616531014|FG000|Overall Study|Protocol Violation|2|||
170597072|NCT02905006|616531015|FG001|Overall Study|Protocol Violation|0|||
170597073|NCT02905006|616531016|FG002|Overall Study|Protocol Violation|0|||
170597074|NCT02905006|616531017|FG003|Overall Study|Protocol Violation|0|||
170597075|NCT02905006|616531018|FG004|Overall Study|Protocol Violation|0|||
170597076|NCT02905006|616531019|FG005|Overall Study|Protocol Violation|0|||
170597077|NCT02905006|616531014|FG000|Overall Study|Lost to Follow-up|0|||
170651138|NCT02720094|616736377|FG000|Overall Study|Ongoing|2210|||
170651139|NCT02720094|616736378|FG001|Overall Study|Ongoing|2203|||
170651140|NCT02720094|616736377|FG000|Overall Study|Scheduled exit visit/end of study|2|||
170651141|NCT02720094|616736378|FG001|Overall Study|Scheduled exit visit/end of study|1|||
170651142|NCT02720094|616736377|FG000|Overall Study|Death|4|||
170651143|NCT02720094|616736378|FG001|Overall Study|Death|7|||
170651144|NCT02720094|616736377|FG000|Overall Study|Withdrawal by Subject|55|||
170651145|NCT02720094|616736378|FG001|Overall Study|Withdrawal by Subject|56|||
170651146|NCT02720094|616736377|FG000|Overall Study|Lost to Follow-up|2|||
170651147|NCT02720094|616736378|FG001|Overall Study|Lost to Follow-up|7|||
170651148|NCT02720094|616736377|FG000|Overall Study|Physician Decision|1|||
170651149|NCT02720094|616736378|FG001|Overall Study|Physician Decision|3|||
170651150|NCT02720094|616736377|FG000|Overall Study|Inappropriate enrollment|1|||
170651151|NCT02720094|616736378|FG001|Overall Study|Inappropriate enrollment|3|||
170651152|NCT02720094|616736377|FG000|Overall Study|Relocation|1|||
170651153|NCT02720094|616736378|FG001|Overall Study|Relocation|1|||
170651154|NCT00899392|616736381|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
170651155|NCT00899392|616736382|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
170651156|NCT02694757|616736389|FG000|Overall Study|Lack of Efficacy|3|||
170651157|NCT00934843|616736390|FG000|Overall Study|Protocol Violation|0|||
170651158|NCT00934843|616736391|FG001|Overall Study|Protocol Violation|1|||
170651159|NCT03400956|616736392|FG000|Treatment Period 1|Adverse Event|0|||
170651160|NCT03400956|616736393|FG001|Treatment Period 1|Adverse Event|1|||
170651161|NCT03400956|616736394|FG002|Treatment Period 1|Adverse Event|0|||
170651162|NCT03400956|616736392|FG000|Treatment Period 1|Lost to Follow-up|0|||
170811945|NCT04852978|617319377|FG007|Overall Study|Death|0|||
170811946|NCT04852978|617319378|FG008|Overall Study|Death|0|||
170811947|NCT04852978|617319370|FG000|Overall Study|Lost to Follow-up|3|||
170597078|NCT02905006|616531015|FG001|Overall Study|Lost to Follow-up|0|||
170597079|NCT02905006|616531016|FG002|Overall Study|Lost to Follow-up|0|||
170597080|NCT02905006|616531017|FG003|Overall Study|Lost to Follow-up|1|||
170597081|NCT02905006|616531018|FG004|Overall Study|Lost to Follow-up|1|||
170597082|NCT02905006|616531019|FG005|Overall Study|Lost to Follow-up|0|||
170597083|NCT02905006|616531014|FG000|Overall Study|Withdrawal by Subject|0|||
170597084|NCT02905006|616531015|FG001|Overall Study|Withdrawal by Subject|0|||
170651163|NCT03400956|616736393|FG001|Treatment Period 1|Lost to Follow-up|0|||
170651164|NCT03400956|616736394|FG002|Treatment Period 1|Lost to Follow-up|1|||
170651165|NCT03400956|616736392|FG000|Treatment Period 1|Protocol Violation|0|||
170811948|NCT04852978|617319371|FG001|Overall Study|Lost to Follow-up|2|||
170811949|NCT04852978|617319372|FG002|Overall Study|Lost to Follow-up|2|||
170651166|NCT03400956|616736393|FG001|Treatment Period 1|Protocol Violation|2|||
170651167|NCT03400956|616736394|FG002|Treatment Period 1|Protocol Violation|0|||
170651168|NCT03400956|616736392|FG000|Treatment Period 1|Study terminated by sponsor|3|||
170651169|NCT03400956|616736393|FG001|Treatment Period 1|Study terminated by sponsor|1|||
170811950|NCT04852978|617319373|FG003|Overall Study|Lost to Follow-up|0|||
170811951|NCT04852978|617319374|FG004|Overall Study|Lost to Follow-up|2|||
170811952|NCT04852978|617319375|FG005|Overall Study|Lost to Follow-up|4|||
170811953|NCT04852978|617319376|FG006|Overall Study|Lost to Follow-up|1|||
170811954|NCT04852978|617319377|FG007|Overall Study|Lost to Follow-up|2|||
170811955|NCT04852978|617319378|FG008|Overall Study|Lost to Follow-up|2|||
170811956|NCT04852978|617319370|FG000|Overall Study|Withdrawal by Subject|4|||
170651170|NCT03400956|616736394|FG002|Treatment Period 1|Study terminated by sponsor|1|||
170651171|NCT03400956|616736392|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170651172|NCT03400956|616736393|FG001|Treatment Period 1|Withdrawal by Subject|2|||
170651173|NCT03400956|616736394|FG002|Treatment Period 1|Withdrawal by Subject|4|||
170811957|NCT04852978|617319371|FG001|Overall Study|Withdrawal by Subject|2|||
170597085|NCT02905006|616531016|FG002|Overall Study|Withdrawal by Subject|1|||
170597086|NCT02905006|616531017|FG003|Overall Study|Withdrawal by Subject|1|||
170597087|NCT02905006|616531018|FG004|Overall Study|Withdrawal by Subject|0|||
170597088|NCT02905006|616531019|FG005|Overall Study|Withdrawal by Subject|1|||
170597089|NCT02905006|616531014|FG000|Overall Study|Screening exclusion criteria met|1|||
170597090|NCT02905006|616531015|FG001|Overall Study|Screening exclusion criteria met|0|||
170597091|NCT02905006|616531016|FG002|Overall Study|Screening exclusion criteria met|0|||
170597092|NCT02905006|616531017|FG003|Overall Study|Screening exclusion criteria met|0|||
170597093|NCT02905006|616531018|FG004|Overall Study|Screening exclusion criteria met|0|||
170597094|NCT02905006|616531019|FG005|Overall Study|Screening exclusion criteria met|0|||
170597095|NCT02905006|616531014|FG000|Overall Study|Lab withdrawal criterion met|0|||
170597096|NCT02905006|616531015|FG001|Overall Study|Lab withdrawal criterion met|1|||
170597097|NCT02905006|616531016|FG002|Overall Study|Lab withdrawal criterion met|2|||
170597098|NCT02905006|616531017|FG003|Overall Study|Lab withdrawal criterion met|2|||
170597099|NCT02905006|616531018|FG004|Overall Study|Lab withdrawal criterion met|2|||
170597100|NCT02905006|616531019|FG005|Overall Study|Lab withdrawal criterion met|1|||
170597101|NCT02905006|616531014|FG000|Overall Study|Positive for Tuberculosis|0|||
170597102|NCT02905006|616531015|FG001|Overall Study|Positive for Tuberculosis|1|||
170597103|NCT02905006|616531016|FG002|Overall Study|Positive for Tuberculosis|0|||
170597104|NCT02905006|616531017|FG003|Overall Study|Positive for Tuberculosis|0|||
170597105|NCT02905006|616531018|FG004|Overall Study|Positive for Tuberculosis|0|||
170597106|NCT02905006|616531019|FG005|Overall Study|Positive for Tuberculosis|0|||
170597107|NCT02905006|616531014|FG000|Overall Study|Subject positive for Hep B|0|||
170597108|NCT02905006|616531015|FG001|Overall Study|Subject positive for Hep B|0|||
170597109|NCT02905006|616531016|FG002|Overall Study|Subject positive for Hep B|1|||
170597110|NCT02905006|616531017|FG003|Overall Study|Subject positive for Hep B|0|||
170597111|NCT02905006|616531018|FG004|Overall Study|Subject positive for Hep B|0|||
170597112|NCT02905006|616531019|FG005|Overall Study|Subject positive for Hep B|0|||
170597113|NCT02905006|616531014|FG000|Overall Study|Patient moved abroad|0|||
170597114|NCT02905006|616531015|FG001|Overall Study|Patient moved abroad|0|||
170597115|NCT02905006|616531016|FG002|Overall Study|Patient moved abroad|0|||
170597116|NCT02905006|616531017|FG003|Overall Study|Patient moved abroad|1|||
170597117|NCT02905006|616531018|FG004|Overall Study|Patient moved abroad|0|||
170811958|NCT04852978|617319372|FG002|Overall Study|Withdrawal by Subject|2|||
170811959|NCT04852978|617319373|FG003|Overall Study|Withdrawal by Subject|1|||
170811960|NCT04852978|617319374|FG004|Overall Study|Withdrawal by Subject|5|||
170811961|NCT04852978|617319375|FG005|Overall Study|Withdrawal by Subject|3|||
170811962|NCT04852978|617319376|FG006|Overall Study|Withdrawal by Subject|2|||
170811963|NCT04852978|617319377|FG007|Overall Study|Withdrawal by Subject|2|||
170811964|NCT04852978|617319378|FG008|Overall Study|Withdrawal by Subject|1|||
170811965|NCT03786471|617319382|FG000|Overall Study|Death|254|||
170811966|NCT03786471|617319383|FG001|Overall Study|Death|223|||
170811967|NCT03786471|617319384|FG002|Overall Study|Death|37|||
170811968|NCT03786471|617319382|FG000|Overall Study|Lost to Follow-up|63|||
170811969|NCT03786471|617319383|FG001|Overall Study|Lost to Follow-up|50|||
170811970|NCT03786471|617319384|FG002|Overall Study|Lost to Follow-up|15|||
170811971|NCT03786471|617319382|FG000|Overall Study|Withdrawal by Subject|99|||
170811972|NCT03786471|617319383|FG001|Overall Study|Withdrawal by Subject|81|||
170811973|NCT03786471|617319384|FG002|Overall Study|Withdrawal by Subject|11|||
170811974|NCT02196259|617321206|FG000|Overall Study|Researcher choice|0|||
170811975|NCT02196259|617321207|FG001|Overall Study|Researcher choice|0|||
170811976|NCT02196259|617321208|FG002|Overall Study|Researcher choice|1|||
170811977|NCT02196259|617321206|FG000|Overall Study|Partial data analysis|0|||
170811978|NCT02196259|617321207|FG001|Overall Study|Partial data analysis|3|||
170811979|NCT02196259|617321208|FG002|Overall Study|Partial data analysis|0|||
170597118|NCT02905006|616531019|FG005|Overall Study|Patient moved abroad|0|||
170597119|NCT02905006|616531014|FG000|Overall Study|Patient randomized by mistake|0|||
170597120|NCT02905006|616531015|FG001|Overall Study|Patient randomized by mistake|0|||
170597121|NCT02905006|616531016|FG002|Overall Study|Patient randomized by mistake|0|||
170651174|NCT03400956|616736392|FG000|Treatment Period 1|Other|1|||
170811980|NCT01668355|617321210|FG000|Overall Study|Death|3|||
170811981|NCT01668355|617321211|FG001|Overall Study|Death|1|||
170811982|NCT01668355|617321210|FG000|Overall Study|Withdrawal by Subject|6|||
170811983|NCT01668355|617321211|FG001|Overall Study|Withdrawal by Subject|1|||
170651175|NCT03400956|616736393|FG001|Treatment Period 1|Other|2|||
170651176|NCT03400956|616736394|FG002|Treatment Period 1|Other|3|||
170913335|NCT00972244|617685865|FG000|Overall Study|Various|0|||
170913336|NCT00972244|617685866|FG001|Overall Study|Various|0|||
170913337|NCT00972244|617685867|FG002|Overall Study|Various|0|||
170913338|NCT00972244|617685868|FG003|Overall Study|Various|0|||
170913339|NCT00972244|617685869|FG004|Overall Study|Various|2|||
170913340|NCT02397655|617685870|FG000|Overall Study|data not completed|1301|||
170913341|NCT01736683|617685871|FG000|Overall Study|Disease Relapse|0|||
170913342|NCT01736683|617685872|FG001|Overall Study|Disease Relapse|0|||
170913343|NCT01736683|617685873|FG002|Overall Study|Disease Relapse|2|||
170913344|NCT01736683|617685874|FG003|Overall Study|Disease Relapse|1|||
170913345|NCT01736683|617685875|FG004|Overall Study|Disease Relapse|0|||
170913346|NCT01736683|617685871|FG000|Overall Study|Adverse Event|0|||
170913347|NCT01736683|617685872|FG001|Overall Study|Adverse Event|2|||
170913348|NCT01736683|617685873|FG002|Overall Study|Adverse Event|2|||
170913349|NCT01736683|617685874|FG003|Overall Study|Adverse Event|3|||
170913350|NCT01736683|617685875|FG004|Overall Study|Adverse Event|2|||
170913351|NCT01736683|617685871|FG000|Overall Study|Withdrawal by Subject|0|||
170913352|NCT01736683|617685872|FG001|Overall Study|Withdrawal by Subject|0|||
170913353|NCT01736683|617685873|FG002|Overall Study|Withdrawal by Subject|3|||
170913354|NCT01736683|617685874|FG003|Overall Study|Withdrawal by Subject|1|||
170913355|NCT01736683|617685875|FG004|Overall Study|Withdrawal by Subject|1|||
170913356|NCT01736683|617685871|FG000|Overall Study|Lack of Therapeutic Effect|7|||
170913357|NCT01736683|617685872|FG001|Overall Study|Lack of Therapeutic Effect|4|||
170913358|NCT01736683|617685873|FG002|Overall Study|Lack of Therapeutic Effect|13|||
170913359|NCT01736683|617685874|FG003|Overall Study|Lack of Therapeutic Effect|20|||
170913360|NCT01736683|617685875|FG004|Overall Study|Lack of Therapeutic Effect|1|||
170913361|NCT01736683|617685871|FG000|Overall Study|Progressive Disease|0|||
170913362|NCT01736683|617685872|FG001|Overall Study|Progressive Disease|0|||
170913363|NCT01736683|617685873|FG002|Overall Study|Progressive Disease|0|||
170913364|NCT01736683|617685874|FG003|Overall Study|Progressive Disease|1|||
170913365|NCT01736683|617685875|FG004|Overall Study|Progressive Disease|0|||
170913366|NCT01736683|617685871|FG000|Overall Study|Other|0|||
170913367|NCT01736683|617685872|FG001|Overall Study|Other|0|||
170913368|NCT01736683|617685873|FG002|Overall Study|Other|1|||
170913369|NCT01736683|617685874|FG003|Overall Study|Other|9|||
170913370|NCT01736683|617685875|FG004|Overall Study|Other|1|||
170913371|NCT03249350|617685877|FG000|Overall Study|Participant did not initiate treatment|5|||
170913372|NCT03249350|617685878|FG001|Overall Study|Participant did not initiate treatment|8|||
170913373|NCT04458857|617685880|FG000|Overall Study|Adverse Event|0|||
170913374|NCT04458857|617685881|FG001|Overall Study|Adverse Event|1|||
170913375|NCT04458857|617685882|FG002|Overall Study|Adverse Event|0|||
170913376|NCT04458857|617685880|FG000|Overall Study|Withdrawal by Subject|2|||
170913377|NCT04458857|617685881|FG001|Overall Study|Withdrawal by Subject|0|||
170913378|NCT04458857|617685882|FG002|Overall Study|Withdrawal by Subject|0|||
170913379|NCT04458857|617685880|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170913380|NCT04458857|617685881|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170913381|NCT04458857|617685882|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170913382|NCT04458857|617685880|FG000|Overall Study|Non-compliance with study drug|0|||
170913383|NCT04458857|617685881|FG001|Overall Study|Non-compliance with study drug|1|||
170913384|NCT04458857|617685882|FG002|Overall Study|Non-compliance with study drug|0|||
170913385|NCT04458857|617685880|FG000|Overall Study|Lost to Follow-up|4|||
170913386|NCT04458857|617685881|FG001|Overall Study|Lost to Follow-up|1|||
170913387|NCT04458857|617685882|FG002|Overall Study|Lost to Follow-up|0|||
170913388|NCT00995371|617685883|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
170913389|NCT00995371|617685884|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
170913390|NCT00673673|617685885|FG000|Overall Study|Progressive disease|27|||
170913391|NCT00673673|617685885|FG000|Overall Study|Adverse Event|4|||
170913392|NCT00673673|617685885|FG000|Overall Study|Withdrawal by Subject|3|||
170913393|NCT00673673|617685885|FG000|Overall Study|Investigators' discretion|2|||
170913394|NCT00312377|617685889|FG000|Overall Study|Death|403|||
170913395|NCT00312377|617685890|FG001|Overall Study|Death|418|||
170597122|NCT02905006|616531017|FG003|Overall Study|Patient randomized by mistake|0|||
170597123|NCT02905006|616531018|FG004|Overall Study|Patient randomized by mistake|0|||
170597124|NCT02905006|616531019|FG005|Overall Study|Patient randomized by mistake|1|||
170597125|NCT02797184|616531020|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
170651177|NCT03400956|616736392|FG000|Post-treatment Period 1|Adverse Event|0|||
170913396|NCT00312377|617685889|FG000|Overall Study|Withdrawal by Subject|23|||
170913397|NCT00312377|617685890|FG001|Overall Study|Withdrawal by Subject|30|||
170913398|NCT00312377|617685889|FG000|Overall Study|Lost to Follow-up|9|||
170913399|NCT00312377|617685890|FG001|Overall Study|Lost to Follow-up|12|||
170913400|NCT00312377|617685889|FG000|Overall Study|Non-compliance|0|||
170913401|NCT00312377|617685890|FG001|Overall Study|Non-compliance|2|||
170913402|NCT00312377|617685889|FG000|Overall Study|Randomised but never received treatment|6|||
170913403|NCT00312377|617685890|FG001|Overall Study|Randomised but never received treatment|6|||
170597126|NCT02797184|616531021|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
170597127|NCT05149313|616531022|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
170597128|NCT05149313|616531023|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
170597129|NCT05149313|616531024|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
170597130|NCT05149313|616531025|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
170597131|NCT05149313|616531022|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
170597132|NCT05149313|616531023|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
170597133|NCT05149313|616531024|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
170597134|NCT05149313|616531025|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
170597135|NCT05149313|616531022|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
170597136|NCT05149313|616531023|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
170597137|NCT05149313|616531024|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
170597138|NCT05149313|616531025|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
170597139|NCT05149313|616531022|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
170597140|NCT05149313|616531023|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
170597141|NCT05149313|616531024|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
170913404|NCT00312377|617685889|FG000|Overall Study|Discontinue treatment survival follow up|202|||
170597142|NCT05149313|616531025|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
170597143|NCT05149313|616531022|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
170597144|NCT05149313|616531023|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
170597145|NCT05149313|616531024|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
170597146|NCT05149313|616531025|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
170597147|NCT05149313|616531022|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
170597148|NCT05149313|616531023|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
170597149|NCT05149313|616531024|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
170597150|NCT05149313|616531025|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
170597151|NCT05149313|616531022|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
170597152|NCT05149313|616531023|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
170597153|NCT05149313|616531024|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
170597154|NCT05149313|616531025|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
170597155|NCT05149313|616531022|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170597156|NCT05149313|616531023|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
170597157|NCT05149313|616531024|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
170597158|NCT05149313|616531025|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
170597159|NCT05149313|616531022|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
170597160|NCT05149313|616531023|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
170597161|NCT05149313|616531024|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
170597162|NCT05149313|616531025|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
170597163|NCT05149313|616531022|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170597164|NCT05149313|616531023|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170597165|NCT05149313|616531024|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
170597166|NCT05149313|616531025|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
170597167|NCT05149313|616531022|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
170597168|NCT05149313|616531023|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
170597169|NCT05149313|616531024|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
170597170|NCT05149313|616531025|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
170597171|NCT00527319|616531036|FG000|Overall Study|Withdrawal by Subject|5|||
170597172|NCT00527319|616531037|FG001|Overall Study|Withdrawal by Subject|0|||
170597173|NCT00527319|616531038|FG002|Overall Study|Withdrawal by Subject|1|||
170597174|NCT00527319|616531036|FG000|Overall Study|Lost to Follow-up|1|||
170597175|NCT00527319|616531037|FG001|Overall Study|Lost to Follow-up|0|||
170597176|NCT00527319|616531038|FG002|Overall Study|Lost to Follow-up|0|||
170597177|NCT00527319|616531036|FG000|Overall Study|Death|0|||
170597178|NCT00527319|616531037|FG001|Overall Study|Death|3|||
170597179|NCT00527319|616531038|FG002|Overall Study|Death|1|||
170597180|NCT00527319|616531036|FG000|Overall Study|Intercurrent Medical Illness|0|||
170597181|NCT00527319|616531037|FG001|Overall Study|Intercurrent Medical Illness|1|||
170597182|NCT00527319|616531038|FG002|Overall Study|Intercurrent Medical Illness|3|||
170597183|NCT00527319|616531036|FG000|Overall Study|Adverse Event|0|||
170597184|NCT00527319|616531037|FG001|Overall Study|Adverse Event|0|||
170597185|NCT00527319|616531038|FG002|Overall Study|Adverse Event|1|||
170597186|NCT03007745|616531040|FG000|Overall Study|Sleep test negative for OSA|53|||
170597187|NCT03007745|616531041|FG001|Overall Study|Sleep test negative for OSA|49|||
170913405|NCT00312377|617685890|FG001|Overall Study|Discontinue treatment survival follow up|200|||
170913406|NCT00312377|617685889|FG000|Overall Study|Site ended participation in study|1|||
170597188|NCT03007745|616531040|FG000|Overall Study|Physician Decision|6|||
170597189|NCT03007745|616531041|FG001|Overall Study|Physician Decision|9|||
170597190|NCT03007745|616531040|FG000|Overall Study|Withdrawal by Subject|38|||
170597191|NCT03007745|616531041|FG001|Overall Study|Withdrawal by Subject|16|||
170913407|NCT00312377|617685890|FG001|Overall Study|Site ended participation in study|0|||
170913408|NCT04538950|617685891|FG000|Overall Study|Pulmonary Issues|2|||
170913409|NCT04538950|617685891|FG000|Overall Study|illness|2|||
170913410|NCT04579393|617685896|FG000|Overall Study|Withdrawal by Subject|2|||
170913411|NCT04579393|617685897|FG001|Overall Study|Withdrawal by Subject|2|||
170913412|NCT04579393|617685896|FG000|Overall Study|Death|1|||
170913413|NCT04579393|617685897|FG001|Overall Study|Death|3|||
170913414|NCT01739595|617685900|FG000|Overall Study|Adverse Event|3|||
170913415|NCT01739595|617685901|FG001|Overall Study|Adverse Event|0|||
170913416|NCT01739595|617685902|FG002|Overall Study|Adverse Event|0|||
170913417|NCT01739595|617685900|FG000|Overall Study|Lost to Follow-up|2|||
170913418|NCT01739595|617685901|FG001|Overall Study|Lost to Follow-up|0|||
170913419|NCT01739595|617685902|FG002|Overall Study|Lost to Follow-up|0|||
170913420|NCT01739595|617685900|FG000|Overall Study|Withdrawal by Subject|2|||
170913421|NCT01739595|617685901|FG001|Overall Study|Withdrawal by Subject|1|||
170913422|NCT01739595|617685902|FG002|Overall Study|Withdrawal by Subject|2|||
170597192|NCT03007745|616531040|FG000|Overall Study|Lost to Follow-up|19|||
170597193|NCT03007745|616531041|FG001|Overall Study|Lost to Follow-up|25|||
170597194|NCT03007745|616531040|FG000|Overall Study|Unable to login to website|17|||
170597195|NCT03007745|616531041|FG001|Overall Study|Unable to login to website|4|||
170597196|NCT03344172|616531042|FG000|Overall Study|Received <1 dose of treatment|1|||
170597197|NCT03344172|616531043|FG001|Overall Study|Received <1 dose of treatment|0|||
170597198|NCT01145053|616531049|FG000|Overall Study|Adverse Event|22|||
170597199|NCT01145053|616531049|FG000|Overall Study|Lost to Follow-up|28|||
170597200|NCT01145053|616531049|FG000|Overall Study|Withdrawal by Subject|25|||
170597201|NCT01145053|616531049|FG000|Overall Study|Other|18|||
170597202|NCT01804582|616531050|FG000|Overall Study|Lost to Follow-up|47|||
170597203|NCT01804582|616531051|FG001|Overall Study|Lost to Follow-up|56|||
170597204|NCT01804582|616531050|FG000|Overall Study|Physician Decision|2|||
170597205|NCT01804582|616531051|FG001|Overall Study|Physician Decision|0|||
170597206|NCT02981524|616531054|FG000|Overall Study|Progressive Disease|14|||
170597207|NCT02981524|616531054|FG000|Overall Study|Death (unrelated)|1|||
170597208|NCT02981524|616531054|FG000|Overall Study|Treatment Related Toxicity|1|||
170597209|NCT02981524|616531054|FG000|Overall Study|Withdrawal by Subject|1|||
170597210|NCT00520013|616531055|FG000|Overall Study|Withdrawal by Subject|0|||
170597211|NCT00520013|616531056|FG001|Overall Study|Withdrawal by Subject|0|||
170597212|NCT00520013|616531057|FG002|Overall Study|Withdrawal by Subject|1|||
170597213|NCT00520013|616531055|FG000|Overall Study|Adverse Event|2|||
170597214|NCT00520013|616531056|FG001|Overall Study|Adverse Event|10|||
170597215|NCT00520013|616531057|FG002|Overall Study|Adverse Event|7|||
170597216|NCT00520013|616531055|FG000|Overall Study|Progressive Disease|7|||
170597217|NCT00520013|616531056|FG001|Overall Study|Progressive Disease|3|||
170597218|NCT00520013|616531057|FG002|Overall Study|Progressive Disease|0|||
170597219|NCT00520013|616531055|FG000|Overall Study|Clinical Progression|3|||
170597220|NCT00520013|616531056|FG001|Overall Study|Clinical Progression|1|||
170597221|NCT00520013|616531057|FG002|Overall Study|Clinical Progression|0|||
170597222|NCT00520013|616531055|FG000|Overall Study|Death|0|||
170597223|NCT00520013|616531056|FG001|Overall Study|Death|1|||
170597224|NCT00520013|616531057|FG002|Overall Study|Death|0|||
170597225|NCT00520013|616531055|FG000|Overall Study|Physician Decision|0|||
170597226|NCT00520013|616531056|FG001|Overall Study|Physician Decision|0|||
170597227|NCT00520013|616531057|FG002|Overall Study|Physician Decision|3|||
170597228|NCT03684304|616531059|FG000|Overall Study|Lost to Follow-up|19|||
170597229|NCT03684304|616531060|FG001|Overall Study|Lost to Follow-up|17|||
170597230|NCT01390779|616531061|FG000|Overall Study|Physician Decision|1|||
170597231|NCT00765882|616531062|FG000|Overall Study|Adverse Event|10|||
170597232|NCT00765882|616531063|FG001|Overall Study|Adverse Event|21|||
170597233|NCT00765882|616531064|FG002|Overall Study|Adverse Event|20|||
170597234|NCT00765882|616531062|FG000|Overall Study|Lack of Efficacy|4|||
170597235|NCT00765882|616531063|FG001|Overall Study|Lack of Efficacy|0|||
170597236|NCT00765882|616531064|FG002|Overall Study|Lack of Efficacy|1|||
170597237|NCT00765882|616531062|FG000|Overall Study|Protocol Violation|4|||
170597238|NCT00765882|616531063|FG001|Overall Study|Protocol Violation|3|||
170597239|NCT00765882|616531064|FG002|Overall Study|Protocol Violation|1|||
170597240|NCT00765882|616531062|FG000|Overall Study|Withdrawal by Subject|2|||
170597241|NCT00765882|616531063|FG001|Overall Study|Withdrawal by Subject|6|||
170913423|NCT01739595|617685900|FG000|Overall Study|Eligibility issue|3|||
170913424|NCT01739595|617685901|FG001|Overall Study|Eligibility issue|0|||
170597242|NCT00765882|616531064|FG002|Overall Study|Withdrawal by Subject|6|||
170597243|NCT00765882|616531062|FG000|Overall Study|Lost to Follow-up|1|||
170597244|NCT00765882|616531063|FG001|Overall Study|Lost to Follow-up|9|||
170597245|NCT00765882|616531064|FG002|Overall Study|Lost to Follow-up|6|||
170597246|NCT00765882|616531062|FG000|Overall Study|Other Reason|3|||
170597247|NCT00765882|616531063|FG001|Overall Study|Other Reason|1|||
170597248|NCT00765882|616531064|FG002|Overall Study|Other Reason|2|||
170597249|NCT01697462|616531065|FG000|Overall Study|Disease Progression|1|||
170597250|NCT01697462|616531065|FG000|Overall Study|Adverse Event|6|||
170913425|NCT01739595|617685902|FG002|Overall Study|Eligibility issue|0|||
170811984|NCT02659059|617321212|FG000|Overall Study|Other reasons|6|||
170811985|NCT02659059|617321213|FG001|Overall Study|Other reasons|1|||
170811986|NCT02659059|617321212|FG000|Overall Study|Disease Progression|143|||
170811987|NCT02659059|617321213|FG001|Overall Study|Disease Progression|16|||
170811988|NCT02659059|617321212|FG000|Overall Study|Study Drug toxicity|56|||
170811989|NCT02659059|617321213|FG001|Overall Study|Study Drug toxicity|9|||
170811990|NCT02659059|617321212|FG000|Overall Study|Death|3|||
170811991|NCT02659059|617321213|FG001|Overall Study|Death|1|||
170811992|NCT02659059|617321212|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
170811993|NCT02659059|617321213|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
170811994|NCT02659059|617321212|FG000|Overall Study|Participant request to discontinue study treatment|5|||
170811995|NCT02659059|617321213|FG001|Overall Study|Participant request to discontinue study treatment|0|||
170811996|NCT02659059|617321212|FG000|Overall Study|Participant withdrew consent|6|||
170811997|NCT02659059|617321213|FG001|Overall Study|Participant withdrew consent|1|||
170811998|NCT00535626|617321214|FG000|Overall Study|Death|15|||
170811999|NCT00535626|617321214|FG000|Overall Study|Lost to Follow-up|29|||
170812000|NCT00535626|617321214|FG000|Overall Study|Withdrawal by Subject|20|||
170812001|NCT00535626|617321214|FG000|Overall Study|Removal/revision of study component|8|||
170812002|NCT00535626|617321214|FG000|Overall Study|Subject terminated|31|||
170812003|NCT00535626|617321214|FG000|Overall Study|Unable to return|2|||
170812004|NCT02489799|617321215|FG000|Overall Study|Lost to Follow-up|4|||
170812005|NCT02489799|617321216|FG001|Overall Study|Lost to Follow-up|1|||
170812006|NCT02489799|617321215|FG000|Overall Study|Failure to Maintain Eligibility|4|||
170812007|NCT02489799|617321216|FG001|Overall Study|Failure to Maintain Eligibility|6|||
170812008|NCT02489799|617321215|FG000|Overall Study|Withdrawal by Subject|1|||
170812009|NCT02489799|617321216|FG001|Overall Study|Withdrawal by Subject|1|||
170812010|NCT02489799|617321215|FG000|Overall Study|Death|0|||
170812011|NCT02489799|617321216|FG001|Overall Study|Death|1|||
170812012|NCT04809623|617321217|FG000|Overall Study|Study Terminated by Sponsor|1|||
170812013|NCT04809623|617321218|FG001|Overall Study|Study Terminated by Sponsor|0|||
170812014|NCT03041090|617321219|FG000|Overall Study|technical error|0|||
170812015|NCT03041090|617321220|FG001|Overall Study|technical error|3|||
170812016|NCT02446015|617321225|FG000|Overall Study|Adverse Event|0|||
170812017|NCT02446015|617321226|FG001|Overall Study|Adverse Event|1|||
170812018|NCT02446015|617321225|FG000|Overall Study|Withdrawal by Subject|1|||
170812019|NCT02446015|617321226|FG001|Overall Study|Withdrawal by Subject|0|||
170812020|NCT00603798|617321227|FG000|Overall Study|Adverse Event|4|||
170812021|NCT00603798|617321228|FG001|Overall Study|Adverse Event|2|||
170812022|NCT00603798|617321229|FG002|Overall Study|Adverse Event|1|||
170812023|NCT00603798|617321227|FG000|Overall Study|Withdrawal by Subject|4|||
170812024|NCT00603798|617321228|FG001|Overall Study|Withdrawal by Subject|3|||
170812025|NCT00603798|617321229|FG002|Overall Study|Withdrawal by Subject|4|||
170812026|NCT00603798|617321227|FG000|Overall Study|Lost to Follow-up|1|||
170812027|NCT00603798|617321228|FG001|Overall Study|Lost to Follow-up|0|||
170812028|NCT00603798|617321229|FG002|Overall Study|Lost to Follow-up|1|||
170812029|NCT00603798|617321227|FG000|Overall Study|Non-compliance with study procedures|0|||
170812030|NCT00603798|617321228|FG001|Overall Study|Non-compliance with study procedures|1|||
170812031|NCT00603798|617321229|FG002|Overall Study|Non-compliance with study procedures|0|||
170812032|NCT00603798|617321227|FG000|Overall Study|Not due to AE|1|||
170812033|NCT00603798|617321228|FG001|Overall Study|Not due to AE|1|||
170812034|NCT00603798|617321229|FG002|Overall Study|Not due to AE|4|||
170812035|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
170812036|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
170812037|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
170812038|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
170913426|NCT01739595|617685900|FG000|Overall Study|Protocol Violation|1|||
170913427|NCT01739595|617685901|FG001|Overall Study|Protocol Violation|0|||
170913428|NCT01739595|617685902|FG002|Overall Study|Protocol Violation|0|||
170913429|NCT01739595|617685900|FG000|Overall Study|Lab assessment|1|||
170812039|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Adverse Event|7|||
170812040|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Adverse Event|8|||
170812041|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Adverse Event|8|||
170812042|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Adverse Event|9|||
170812043|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
170812044|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
170913430|NCT01739595|617685901|FG001|Overall Study|Lab assessment|0|||
170913431|NCT01739595|617685902|FG002|Overall Study|Lab assessment|0|||
170812045|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
170812046|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
170812047|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
170812048|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
170812049|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
170812050|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
170913432|NCT01739595|617685900|FG000|Overall Study|Drug discrepancy|1|||
170597251|NCT01697462|616531065|FG000|Overall Study|Lost to Follow-up|21|||
170651178|NCT03400956|616736393|FG001|Post-treatment Period 1|Adverse Event|0|||
170651179|NCT03400956|616736394|FG002|Post-treatment Period 1|Adverse Event|1|||
170651180|NCT03400956|616736392|FG000|Post-treatment Period 1|Physician Decision|2|||
170651181|NCT03400956|616736393|FG001|Post-treatment Period 1|Physician Decision|3|||
170651182|NCT03400956|616736394|FG002|Post-treatment Period 1|Physician Decision|0|||
170651183|NCT03400956|616736392|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
170651184|NCT03400956|616736393|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
170651185|NCT03400956|616736394|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
170651186|NCT03400956|616736392|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
170651187|NCT03400956|616736393|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
170651188|NCT03400956|616736394|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
170651189|NCT03400956|616736392|FG000|Post-treatment Period 1|Other|4|||
170651190|NCT03400956|616736393|FG001|Post-treatment Period 1|Other|3|||
170651191|NCT03400956|616736394|FG002|Post-treatment Period 1|Other|4|||
170651192|NCT03400956|616736392|FG000|Treatment Period 2|Adverse Event|2|||
170651193|NCT03400956|616736393|FG001|Treatment Period 2|Adverse Event|1|||
170651194|NCT03400956|616736394|FG002|Treatment Period 2|Adverse Event|1|||
170651195|NCT03400956|616736392|FG000|Treatment Period 2|Lost to Follow-up|1|||
170651196|NCT03400956|616736393|FG001|Treatment Period 2|Lost to Follow-up|1|||
170651197|NCT03400956|616736394|FG002|Treatment Period 2|Lost to Follow-up|0|||
170651198|NCT03400956|616736392|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170651199|NCT03400956|616736393|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170651200|NCT03400956|616736394|FG002|Treatment Period 2|Withdrawal by Subject|3|||
170651201|NCT03400956|616736392|FG000|Treatment Period 2|Other|1|||
170651202|NCT03400956|616736393|FG001|Treatment Period 2|Other|1|||
170651203|NCT03400956|616736394|FG002|Treatment Period 2|Other|0|||
170651204|NCT03400956|616736392|FG000|Follow-up Period|Withdrawal by Subject|0|||
170651205|NCT03400956|616736393|FG001|Follow-up Period|Withdrawal by Subject|0|||
170651206|NCT03400956|616736394|FG002|Follow-up Period|Withdrawal by Subject|1|||
170651207|NCT03400956|616736392|FG000|Follow-up Period|Other|0|||
170651208|NCT03400956|616736393|FG001|Follow-up Period|Other|0|||
170651209|NCT03400956|616736394|FG002|Follow-up Period|Other|1|||
170651210|NCT00160667|616736395|FG000|Overall Study|Adverse Event|3|||
170651211|NCT00160667|616736396|FG001|Overall Study|Adverse Event|1|||
170651212|NCT00160667|616736397|FG002|Overall Study|Adverse Event|4|||
170651213|NCT00160667|616736395|FG000|Overall Study|Withdrawal by Subject|2|||
170651214|NCT00160667|616736396|FG001|Overall Study|Withdrawal by Subject|0|||
170651215|NCT00160667|616736397|FG002|Overall Study|Withdrawal by Subject|1|||
170597252|NCT01697462|616531065|FG000|Overall Study|Withdrawal by Subject|12|||
170597253|NCT01697462|616531065|FG000|Overall Study|Investigator Decision|21|||
170597254|NCT01697462|616531065|FG000|Overall Study|Death|1|||
170597255|NCT01697462|616531065|FG000|Overall Study|Other|10|||
170597256|NCT01697462|616531065|FG000|Overall Study|Missing|5|||
170597257|NCT03532932|616531074|FG000|Overall Study|Protocol Deviation|33|||
170597258|NCT03532932|616531075|FG001|Overall Study|Protocol Deviation|31|||
170597259|NCT03532932|616531074|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
170597260|NCT03532932|616531075|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
170597261|NCT03532932|616531074|FG000|Overall Study|Withdrawal by Subject|2|||
170597262|NCT03532932|616531075|FG001|Overall Study|Withdrawal by Subject|0|||
170597263|NCT03532932|616531074|FG000|Overall Study|Lost to Follow-up|15|||
170597264|NCT03532932|616531075|FG001|Overall Study|Lost to Follow-up|9|||
170597265|NCT03532932|616531074|FG000|Overall Study|Adverse Event|4|||
170597266|NCT03532932|616531075|FG001|Overall Study|Adverse Event|3|||
170597267|NCT03532932|616531074|FG000|Overall Study|Death|0|||
170597268|NCT03532932|616531075|FG001|Overall Study|Death|2|||
170597269|NCT03532932|616531074|FG000|Overall Study|Other|11|||
170597270|NCT03532932|616531075|FG001|Overall Study|Other|16|||
170597271|NCT03689712|616531078|FG000|Overall Study|Adverse Event|1|||
170597272|NCT03689712|616531079|FG001|Overall Study|Adverse Event|0|||
170597273|NCT03689712|616531078|FG000|Overall Study|Death|20|||
170597274|NCT03689712|616531079|FG001|Overall Study|Death|10|||
170651216|NCT00160667|616736395|FG000|Overall Study|Lack of Efficacy|0|||
170651217|NCT00160667|616736396|FG001|Overall Study|Lack of Efficacy|1|||
170651218|NCT00160667|616736397|FG002|Overall Study|Lack of Efficacy|0|||
170597275|NCT03689712|616531078|FG000|Overall Study|Lost to Follow-up|6|||
170597276|NCT03689712|616531079|FG001|Overall Study|Lost to Follow-up|6|||
170597277|NCT03689712|616531078|FG000|Overall Study|Other|1|||
170597278|NCT03689712|616531079|FG001|Overall Study|Other|0|||
170597279|NCT03689712|616531078|FG000|Overall Study|Patient Non-Compliance|0|||
170651219|NCT00160667|616736395|FG000|Overall Study|Protocol Violation|0|||
170651220|NCT00160667|616736396|FG001|Overall Study|Protocol Violation|1|||
170651221|NCT00160667|616736397|FG002|Overall Study|Protocol Violation|0|||
170651222|NCT00160667|616736395|FG000|Overall Study|Patient decision|0|||
170651223|NCT00160667|616736396|FG001|Overall Study|Patient decision|0|||
170651224|NCT00160667|616736397|FG002|Overall Study|Patient decision|1|||
170651225|NCT02048241|616736398|FG000|Overall Study|Withdrawal by Subject|0|||
170651226|NCT02048241|616736399|FG001|Overall Study|Withdrawal by Subject|1|||
170651227|NCT03709576|616736402|FG000|Overall Study|progression prior to enrollment|1|||
170651228|NCT00495040|616736411|FG000|Overall Study|Withdrawal by Subject|3|||
170651229|NCT01829243|616736412|FG000|First Intervention|Screen Failure|4|||
170651230|NCT01829243|616736413|FG001|First Intervention|Screen Failure|2|||
170651231|NCT03985878|616736414|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
170651232|NCT03985878|616736414|FG000|Overall Study|Study Terminated by Sponsor|12|||
170651233|NCT03985878|616736414|FG000|Overall Study|Withdrawal by Subject|1|||
170651234|NCT00169442|616736415|FG000|Overall Study|Withdrawal by Subject|0|||
170651235|NCT00169442|616736416|FG001|Overall Study|Withdrawal by Subject|0|||
170651236|NCT00169442|616736417|FG002|Overall Study|Withdrawal by Subject|1|||
170651237|NCT00169442|616736418|FG003|Overall Study|Withdrawal by Subject|0|||
170651238|NCT00169442|616736419|FG004|Overall Study|Withdrawal by Subject|0|||
170651239|NCT00169442|616736420|FG005|Overall Study|Withdrawal by Subject|0|||
170651240|NCT00169442|616736415|FG000|Overall Study|Migrated/moved from study area|0|||
170651241|NCT00169442|616736416|FG001|Overall Study|Migrated/moved from study area|0|||
170651242|NCT00169442|616736417|FG002|Overall Study|Migrated/moved from study area|0|||
170651243|NCT00169442|616736418|FG003|Overall Study|Migrated/moved from study area|0|||
170651244|NCT00169442|616736419|FG004|Overall Study|Migrated/moved from study area|0|||
170651245|NCT00169442|616736420|FG005|Overall Study|Migrated/moved from study area|2|||
170651246|NCT00169442|616736415|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
170651247|NCT00169442|616736416|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
170651248|NCT00169442|616736417|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
170651249|NCT00169442|616736418|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
170651250|NCT00169442|616736419|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
170651251|NCT00169442|616736420|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
170651252|NCT00169442|616736415|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
170651253|NCT00169442|616736416|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
170651254|NCT00169442|616736417|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
170651255|NCT00169442|616736418|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
170651256|NCT00169442|616736419|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
170651257|NCT00169442|616736420|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
170651258|NCT01007253|616736421|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
170651259|NCT01007253|616736422|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
170651260|NCT01007253|616736423|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
170651261|NCT01007253|616736424|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
170651262|NCT03353740|616736427|FG000|Overall Study|Images for these participants not viable|52|||
170651263|NCT01227629|616736428|FG000|Overall Study|Adverse Event|2|||
170651264|NCT01227629|616736429|FG001|Overall Study|Adverse Event|2|||
170651265|NCT01227629|616736430|FG002|Overall Study|Adverse Event|1|||
170651266|NCT01227629|616736431|FG003|Overall Study|Adverse Event|6|||
170651267|NCT01227629|616736432|FG004|Overall Study|Adverse Event|1|||
170651268|NCT01227629|616736433|FG005|Overall Study|Adverse Event|1|||
170651269|NCT01227629|616736434|FG006|Overall Study|Adverse Event|6|||
170651270|NCT01227629|616736435|FG007|Overall Study|Adverse Event|6|||
170651271|NCT01227629|616736436|FG008|Overall Study|Adverse Event|4|||
170651272|NCT01227629|616736437|FG009|Overall Study|Adverse Event|0|||
170651273|NCT01227629|616736428|FG000|Overall Study|Protocol Violation|0|||
170651274|NCT01227629|616736429|FG001|Overall Study|Protocol Violation|0|||
170651275|NCT01227629|616736430|FG002|Overall Study|Protocol Violation|0|||
170913433|NCT01739595|617685901|FG001|Overall Study|Drug discrepancy|0|||
170913434|NCT01739595|617685902|FG002|Overall Study|Drug discrepancy|0|||
170913435|NCT00393458|617685903|FG000|Overall Study|Adverse Event|35|||
170913436|NCT00393458|617685904|FG001|Overall Study|Adverse Event|24|||
170913437|NCT00393458|617685905|FG002|Overall Study|Adverse Event|40|||
170913438|NCT00393458|617685906|FG003|Overall Study|Adverse Event|35|||
170913439|NCT00393458|617685903|FG000|Overall Study|Subject withdrew consent|27|||
170651276|NCT01227629|616736431|FG003|Overall Study|Protocol Violation|1|||
170651277|NCT01227629|616736432|FG004|Overall Study|Protocol Violation|0|||
170651278|NCT01227629|616736433|FG005|Overall Study|Protocol Violation|0|||
170651279|NCT01227629|616736434|FG006|Overall Study|Protocol Violation|0|||
170651280|NCT01227629|616736435|FG007|Overall Study|Protocol Violation|0|||
170651281|NCT01227629|616736436|FG008|Overall Study|Protocol Violation|0|||
170651282|NCT01227629|616736437|FG009|Overall Study|Protocol Violation|0|||
170651283|NCT01227629|616736428|FG000|Overall Study|Lost to Follow-up|0|||
170651284|NCT01227629|616736429|FG001|Overall Study|Lost to Follow-up|0|||
170913440|NCT00393458|617685904|FG001|Overall Study|Subject withdrew consent|40|||
170651285|NCT01227629|616736430|FG002|Overall Study|Lost to Follow-up|0|||
170651286|NCT01227629|616736431|FG003|Overall Study|Lost to Follow-up|0|||
170651287|NCT01227629|616736432|FG004|Overall Study|Lost to Follow-up|1|||
170651288|NCT01227629|616736433|FG005|Overall Study|Lost to Follow-up|0|||
170651289|NCT01227629|616736434|FG006|Overall Study|Lost to Follow-up|0|||
170651290|NCT01227629|616736435|FG007|Overall Study|Lost to Follow-up|0|||
170651291|NCT01227629|616736436|FG008|Overall Study|Lost to Follow-up|0|||
170651292|NCT01227629|616736437|FG009|Overall Study|Lost to Follow-up|0|||
170651293|NCT01227629|616736428|FG000|Overall Study|Withdrawal by Subject|0|||
170913441|NCT00393458|617685905|FG002|Overall Study|Subject withdrew consent|33|||
170913442|NCT00393458|617685906|FG003|Overall Study|Subject withdrew consent|50|||
170651294|NCT01227629|616736429|FG001|Overall Study|Withdrawal by Subject|0|||
170651295|NCT01227629|616736430|FG002|Overall Study|Withdrawal by Subject|0|||
170651296|NCT01227629|616736431|FG003|Overall Study|Withdrawal by Subject|0|||
170651297|NCT01227629|616736432|FG004|Overall Study|Withdrawal by Subject|0|||
170651298|NCT01227629|616736433|FG005|Overall Study|Withdrawal by Subject|0|||
170651299|NCT01227629|616736434|FG006|Overall Study|Withdrawal by Subject|2|||
170597280|NCT03689712|616531079|FG001|Overall Study|Patient Non-Compliance|1|||
170597281|NCT03689712|616531078|FG000|Overall Study|Withdrawal by Subject|20|||
170597282|NCT03689712|616531079|FG001|Overall Study|Withdrawal by Subject|4|||
170597283|NCT03689712|616531078|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
170597284|NCT03689712|616531079|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
170597285|NCT03689712|616531078|FG000|Overall Study|Randomized but not Treated|13|||
170651300|NCT01227629|616736435|FG007|Overall Study|Withdrawal by Subject|0|||
170651301|NCT01227629|616736436|FG008|Overall Study|Withdrawal by Subject|0|||
170651302|NCT01227629|616736437|FG009|Overall Study|Withdrawal by Subject|1|||
170651303|NCT01227629|616736428|FG000|Overall Study|Other|0|||
170651304|NCT01227629|616736429|FG001|Overall Study|Other|0|||
170651305|NCT01227629|616736430|FG002|Overall Study|Other|0|||
170651306|NCT01227629|616736431|FG003|Overall Study|Other|1|||
170651307|NCT01227629|616736432|FG004|Overall Study|Other|0|||
170651308|NCT01227629|616736433|FG005|Overall Study|Other|0|||
170651309|NCT01227629|616736434|FG006|Overall Study|Other|0|||
170651310|NCT01227629|616736435|FG007|Overall Study|Other|0|||
170651311|NCT01227629|616736436|FG008|Overall Study|Other|2|||
170651312|NCT01227629|616736437|FG009|Overall Study|Other|1|||
170651313|NCT02232880|616736439|FG000|Overall Study|study stopped prior to randomization|1|||
170651314|NCT00881868|616736445|FG000|Overall Study|Adverse Event|0|||
170651315|NCT00881868|616736446|FG001|Overall Study|Adverse Event|1|||
170651316|NCT00881868|616736445|FG000|Overall Study|Lost to Follow-up|2|||
170651317|NCT00881868|616736446|FG001|Overall Study|Lost to Follow-up|1|||
170651318|NCT00881868|616736445|FG000|Overall Study|Physician Decision|4|||
170651319|NCT00881868|616736446|FG001|Overall Study|Physician Decision|0|||
170651320|NCT00881868|616736445|FG000|Overall Study|Protocol Violation|2|||
170651321|NCT00881868|616736446|FG001|Overall Study|Protocol Violation|0|||
170651322|NCT02880956|616736449|FG000|Overall Study|Adverse Event|3|||
170651323|NCT02880956|616736450|FG001|Overall Study|Adverse Event|6|||
170651324|NCT02880956|616736451|FG002|Overall Study|Adverse Event|5|||
170651325|NCT02880956|616736452|FG003|Overall Study|Adverse Event|4|||
170651326|NCT02880956|616736449|FG000|Overall Study|Withdrawal by Subject|9|||
170651327|NCT02880956|616736450|FG001|Overall Study|Withdrawal by Subject|4|||
170651328|NCT02880956|616736451|FG002|Overall Study|Withdrawal by Subject|6|||
170651329|NCT02880956|616736452|FG003|Overall Study|Withdrawal by Subject|11|||
170651330|NCT02880956|616736449|FG000|Overall Study|Lost to Follow-up|0|||
170651331|NCT02880956|616736450|FG001|Overall Study|Lost to Follow-up|1|||
170651332|NCT02880956|616736451|FG002|Overall Study|Lost to Follow-up|0|||
170651333|NCT02880956|616736452|FG003|Overall Study|Lost to Follow-up|0|||
170651334|NCT02880956|616736449|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
170651335|NCT02880956|616736450|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
170651336|NCT02880956|616736451|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
170651337|NCT02880956|616736452|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
170651338|NCT02880956|616736449|FG000|Overall Study|Other, Not Specified|4|||
170651339|NCT02880956|616736450|FG001|Overall Study|Other, Not Specified|2|||
170651340|NCT02880956|616736451|FG002|Overall Study|Other, Not Specified|0|||
170651341|NCT02880956|616736452|FG003|Overall Study|Other, Not Specified|3|||
170651342|NCT00884377|616738121|FG000|Overall Study|Withdrawal by Subject|1|||
170651343|NCT00884377|616738122|FG001|Overall Study|Withdrawal by Subject|0|||
170651344|NCT00884377|616738121|FG000|Overall Study|Could not confirm diagnosis|1|||
170651345|NCT00884377|616738122|FG001|Overall Study|Could not confirm diagnosis|0|||
170651346|NCT00884377|616738121|FG000|Overall Study|Physician Decision|0|||
170812051|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Pregnancy|0|||
170651347|NCT00884377|616738122|FG001|Overall Study|Physician Decision|1|||
170651348|NCT04085367|616738123|FG000|Overall Study|Adverse Event|1|||
170651349|NCT04085367|616738124|FG001|Overall Study|Adverse Event|1|||
170651350|NCT04085367|616738123|FG000|Overall Study|Withdrawal by Subject|13|||
170651351|NCT04085367|616738124|FG001|Overall Study|Withdrawal by Subject|4|||
170651352|NCT04085367|616738123|FG000|Overall Study|Lost to Follow-up|3|||
170651353|NCT04085367|616738124|FG001|Overall Study|Lost to Follow-up|1|||
170651354|NCT04085367|616738123|FG000|Overall Study|Other unspecified|2|||
170651355|NCT04085367|616738124|FG001|Overall Study|Other unspecified|1|||
170651356|NCT04085367|616738123|FG000|Overall Study|Status Unknown|1|||
170651357|NCT04085367|616738124|FG001|Overall Study|Status Unknown|1|||
170651358|NCT02616601|616738131|FG000|Overall Study|Withdrawal by Subject|4|||
170597286|NCT03689712|616531079|FG001|Overall Study|Randomized but not Treated|7|||
170651359|NCT02616601|616738132|FG001|Overall Study|Withdrawal by Subject|4|||
170651360|NCT02616601|616738133|FG002|Overall Study|Withdrawal by Subject|3|||
170651361|NCT02616601|616738131|FG000|Overall Study|Adverse Event|2|||
170651362|NCT02616601|616738132|FG001|Overall Study|Adverse Event|0|||
170651363|NCT02616601|616738133|FG002|Overall Study|Adverse Event|2|||
170597287|NCT03689712|616531078|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
170597288|NCT03689712|616531079|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
170597289|NCT02956850|616531084|FG000|Overall Study|Withdrawal by Subject|0|||
170597290|NCT02956850|616531085|FG001|Overall Study|Withdrawal by Subject|0|||
170597291|NCT02956850|616531086|FG002|Overall Study|Withdrawal by Subject|0|||
170597292|NCT02956850|616531087|FG003|Overall Study|Withdrawal by Subject|0|||
170597293|NCT02956850|616531088|FG004|Overall Study|Withdrawal by Subject|0|||
170597294|NCT02956850|616531089|FG005|Overall Study|Withdrawal by Subject|0|||
170597295|NCT02956850|616531090|FG006|Overall Study|Withdrawal by Subject|0|||
170597296|NCT02956850|616531091|FG007|Overall Study|Withdrawal by Subject|0|||
170651364|NCT02616601|616738131|FG000|Overall Study|Death|1|||
170651365|NCT02616601|616738132|FG001|Overall Study|Death|0|||
170651366|NCT02616601|616738133|FG002|Overall Study|Death|0|||
170651367|NCT02616601|616738131|FG000|Overall Study|Lost to Follow-up|1|||
170651368|NCT02616601|616738132|FG001|Overall Study|Lost to Follow-up|0|||
170651369|NCT02616601|616738133|FG002|Overall Study|Lost to Follow-up|1|||
170651370|NCT02616601|616738131|FG000|Overall Study|Non-Compliance with Test Article|1|||
170651371|NCT02616601|616738132|FG001|Overall Study|Non-Compliance with Test Article|0|||
170651372|NCT02616601|616738133|FG002|Overall Study|Non-Compliance with Test Article|1|||
170651373|NCT00371761|616738134|FG000|Overall Study|Adverse Event|1|||
170651374|NCT00371761|616738135|FG001|Overall Study|Adverse Event|1|||
170651375|NCT00371761|616738134|FG000|Overall Study|Withdrawal by Subject|1|||
170651376|NCT00371761|616738135|FG001|Overall Study|Withdrawal by Subject|3|||
170651377|NCT00371761|616738134|FG000|Overall Study|Investigator Judgment|2|||
170651378|NCT00371761|616738135|FG001|Overall Study|Investigator Judgment|3|||
170651379|NCT00371761|616738134|FG000|Overall Study|Study termination|4|||
170651380|NCT00371761|616738135|FG001|Overall Study|Study termination|3|||
170651381|NCT03754972|616738136|FG000|Overall Study|Protocol Violation|25|||
170651382|NCT05954143|616738139|FG000|Overall Study|Progressive Disease|1|||
170651383|NCT05954143|616738140|FG001|Overall Study|Progressive Disease|0|||
170651384|NCT05954143|616738139|FG000|Overall Study|Physician Decision|1|||
170651385|NCT05954143|616738140|FG001|Overall Study|Physician Decision|0|||
170651386|NCT05954143|616738139|FG000|Overall Study|Study Terminated by Sponsor|2|||
170651387|NCT05954143|616738140|FG001|Overall Study|Study Terminated by Sponsor|4|||
170651388|NCT05954143|616738139|FG000|Overall Study|Death|1|||
170651389|NCT05954143|616738140|FG001|Overall Study|Death|0|||
170651390|NCT05954143|616738139|FG000|Overall Study|Withdrawal by Subject|0|||
170812052|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Pregnancy|2|||
170812053|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Pregnancy|2|||
170812054|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Pregnancy|0|||
170597297|NCT02956850|616531092|FG008|Overall Study|Withdrawal by Subject|0|||
170597298|NCT02956850|616531093|FG009|Overall Study|Withdrawal by Subject|0|||
170597299|NCT02956850|616531094|FG010|Overall Study|Withdrawal by Subject|0|||
170597300|NCT02956850|616531095|FG011|Overall Study|Withdrawal by Subject|0|||
170597301|NCT02956850|616531096|FG012|Overall Study|Withdrawal by Subject|0|||
170597302|NCT02956850|616531097|FG013|Overall Study|Withdrawal by Subject|0|||
170597303|NCT02956850|616531098|FG014|Overall Study|Withdrawal by Subject|0|||
170597304|NCT02956850|616531099|FG015|Overall Study|Withdrawal by Subject|0|||
170597305|NCT02956850|616531100|FG016|Overall Study|Withdrawal by Subject|0|||
170597306|NCT02956850|616531101|FG017|Overall Study|Withdrawal by Subject|1|||
170597307|NCT00708734|616531102|FG000|Overall Study|scheduling conflict|2|||
170597308|NCT00708734|616531102|FG000|Overall Study|moved|1|||
170597309|NCT00708734|616531102|FG000|Overall Study|leg injury|1|||
170597310|NCT00708734|616531102|FG000|Overall Study|knee replacement|1|||
170597311|NCT00708734|616531102|FG000|Overall Study|vertigo|1|||
170597312|NCT00708734|616531102|FG000|Overall Study|leg fracture|1|||
170651391|NCT05954143|616738140|FG001|Overall Study|Withdrawal by Subject|1|||
170651392|NCT05954143|616738139|FG000|Overall Study|Other|1|||
170651393|NCT05954143|616738140|FG001|Overall Study|Other|0|||
170651394|NCT01958489|616738143|FG000|Period 2|Adverse Event|0|||
170651395|NCT01958489|616738144|FG001|Period 2|Adverse Event|1|||
170651396|NCT00329901|616738145|FG000|Overall Study|Withdrawal by Subject|4|||
170651397|NCT00329901|616738146|FG001|Overall Study|Withdrawal by Subject|3|||
170651398|NCT00329901|616738147|FG002|Overall Study|Withdrawal by Subject|2|||
170651399|NCT00329901|616738145|FG000|Overall Study|Lost to Follow-up|2|||
170651400|NCT00329901|616738146|FG001|Overall Study|Lost to Follow-up|0|||
170651401|NCT00329901|616738147|FG002|Overall Study|Lost to Follow-up|1|||
170651402|NCT00329901|616738145|FG000|Overall Study|Protocol Violation|1|||
170651403|NCT00329901|616738146|FG001|Overall Study|Protocol Violation|0|||
170812055|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Non-compliance|1|||
170597313|NCT02634606|616531103|FG000|Overall Study|unable to obtain the drug at start|13|||
170597314|NCT01996592|616531110|FG000|Overall Study|no response to text/no diary entry|32|||
170597315|NCT01996592|616531110|FG000|Overall Study|change in surgical date|4|||
170651404|NCT00329901|616738147|FG002|Overall Study|Protocol Violation|1|||
170651405|NCT00329901|616738145|FG000|Overall Study|Unable to classify|2|||
170651406|NCT00329901|616738146|FG001|Overall Study|Unable to classify|2|||
170651407|NCT00329901|616738147|FG002|Overall Study|Unable to classify|0|||
170812056|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Non-compliance|0|||
170597316|NCT01996592|616531110|FG000|Overall Study|Withdrawal by Subject|5|||
170597317|NCT01996592|616531110|FG000|Overall Study|change in mode of delivery|4|||
170597318|NCT00815191|616531113|FG000|Overall Study|Protocol Violation|1|||
170597319|NCT00815191|616531114|FG001|Overall Study|Protocol Violation|1|||
170597320|NCT02900170|616531115|FG000|Overall Study|Lost to Follow-up|8|||
170597321|NCT01814670|616531116|FG000|Overall Study|Protocol Violation|12|||
170597322|NCT01873729|616531117|FG000|Overall Study|Withdrawal by Subject|1|||
170597323|NCT01741532|616531118|FG000|Overall Study|Adverse Event|4|||
170597324|NCT01741532|616531119|FG001|Overall Study|Adverse Event|0|||
170597325|NCT01741532|616531118|FG000|Overall Study|Withdrawal by Subject|1|||
170597326|NCT01741532|616531119|FG001|Overall Study|Withdrawal by Subject|1|||
170597327|NCT01741532|616531118|FG000|Overall Study|Protocol Violation|0|||
170597328|NCT01741532|616531119|FG001|Overall Study|Protocol Violation|1|||
170597329|NCT01741532|616531118|FG000|Overall Study|Worsening of the disease|3|||
170597330|NCT01741532|616531119|FG001|Overall Study|Worsening of the disease|1|||
170597331|NCT01741532|616531118|FG000|Overall Study|Sponsor decision|1|||
170597332|NCT01741532|616531119|FG001|Overall Study|Sponsor decision|0|||
170597333|NCT01741532|616531118|FG000|Overall Study|Medical event|1|||
170597334|NCT01741532|616531119|FG001|Overall Study|Medical event|0|||
170597335|NCT00973102|616531120|FG000|Overall Study|Protocol Violation|1|||
170597336|NCT00973102|616531121|FG001|Overall Study|Protocol Violation|0|||
170597337|NCT00973102|616531120|FG000|Overall Study|Prisoner|0|||
170651408|NCT01209832|616738148|FG000|Period 1|Sponsor Decision and was not dosed|1|||
170651409|NCT01209832|616738148|FG000|Period 2|Sponsor Decision|1|||
170651410|NCT03485495|616738149|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
170651411|NCT03485495|616738150|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
170651412|NCT04559529|616738151|FG000|First Intervention (1 Day)|Adverse Event|0|||
170651413|NCT04559529|616738152|FG001|First Intervention (1 Day)|Adverse Event|0|||
170651414|NCT04559529|616738153|FG002|First Intervention (1 Day)|Adverse Event|0|||
170651415|NCT04559529|616738154|FG003|First Intervention (1 Day)|Adverse Event|1|||
170651416|NCT04559529|616738151|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
170651417|NCT04559529|616738152|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
170597338|NCT00973102|616531121|FG001|Overall Study|Prisoner|1|||
170597339|NCT01066780|616531122|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
170597340|NCT01066780|616531123|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
170597341|NCT02360293|616531124|FG000|Overall Study|Lost to Follow-up|73|||
170597342|NCT02360293|616531125|FG001|Overall Study|Lost to Follow-up|95|||
170597343|NCT02360293|616531124|FG000|Overall Study|Withdrawal by Subject|2|||
170597344|NCT02360293|616531125|FG001|Overall Study|Withdrawal by Subject|1|||
170597345|NCT02360293|616531124|FG000|Overall Study|Excluded|1|||
170597346|NCT02360293|616531125|FG001|Overall Study|Excluded|0|||
170597347|NCT02226549|616531126|FG000|Overall Study|Randomized but Never Treated|1|||
170597348|NCT02226549|616531127|FG001|Overall Study|Randomized but Never Treated|0|||
170597349|NCT02226549|616531126|FG000|Overall Study|Lost to Follow-up|0|||
170597350|NCT02226549|616531127|FG001|Overall Study|Lost to Follow-up|1|||
170597351|NCT02012686|616531128|FG000|Overall Study|muscle contraction|0|||
170597352|NCT02012686|616531129|FG001|Overall Study|muscle contraction|1|||
170597353|NCT02012686|616531128|FG000|Overall Study|electrocardiography monitoring noise|0|||
170597354|NCT02012686|616531129|FG001|Overall Study|electrocardiography monitoring noise|1|||
170597355|NCT03099148|616531130|FG000|Wash-out|scheduling conflict|0|||
170597356|NCT03099148|616531131|FG001|Wash-out|scheduling conflict|1|||
170597357|NCT03099148|616531132|FG002|Wash-out|scheduling conflict|0|||
170597358|NCT03099148|616531133|FG003|Wash-out|scheduling conflict|0|||
170597359|NCT03099148|616531130|FG000|Wash-out|Adverse Event|0|||
170597360|NCT03099148|616531131|FG001|Wash-out|Adverse Event|1|||
170597361|NCT03099148|616531132|FG002|Wash-out|Adverse Event|0|||
170597362|NCT03099148|616531133|FG003|Wash-out|Adverse Event|0|||
170597363|NCT01269385|616531134|FG000|Overall Study|Adverse Event|1|||
170651418|NCT04559529|616738153|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
170651419|NCT04559529|616738154|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
170651420|NCT04559529|616738151|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
170651421|NCT04559529|616738152|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
170597364|NCT01269385|616531135|FG001|Overall Study|Adverse Event|1|||
170597365|NCT01269385|616531136|FG002|Overall Study|Adverse Event|0|||
170597366|NCT01269385|616531137|FG003|Overall Study|Adverse Event|0|||
170597367|NCT01703065|616531140|FG000|Overall Study|Lack of Efficacy|1|||
170597368|NCT01703065|616531141|FG001|Overall Study|Lack of Efficacy|0|||
170597369|NCT00687609|616531144|FG000|Overall Study|Physician Decision|1|||
170597370|NCT00687609|616531144|FG000|Overall Study|Withdrawal by Subject|2|||
170597371|NCT00837759|616532466|FG000|Overall Study|Protocol Violation|3|||
170597372|NCT00837759|616532466|FG000|Overall Study|Lost to Follow-up|1|||
170597373|NCT02593825|616532467|FG000|Intervention|Lost to Follow-up|10|||
170597374|NCT02593825|616532468|FG001|Intervention|Lost to Follow-up|12|||
170597375|NCT04692077|616532472|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
170597376|NCT05431387|616532473|FG000|Overall Study|Adverse Event|1|||
170597377|NCT05431387|616532474|FG001|Overall Study|Adverse Event|0|||
170597378|NCT05431387|616532473|FG000|Overall Study|Withdrawal by Subject|4|||
170597379|NCT05431387|616532474|FG001|Overall Study|Withdrawal by Subject|4|||
170597380|NCT05431387|616532473|FG000|Overall Study|Physician Decision|0|||
170597381|NCT05431387|616532474|FG001|Overall Study|Physician Decision|1|||
170597382|NCT05431387|616532473|FG000|Overall Study|Lost to Follow-up|5|||
170597383|NCT05431387|616532474|FG001|Overall Study|Lost to Follow-up|9|||
170597384|NCT05431387|616532473|FG000|Overall Study|Other, Not Specified|1|||
170597385|NCT05431387|616532474|FG001|Overall Study|Other, Not Specified|4|||
170597386|NCT04271475|616532475|FG000|DB Period: Day 1 up to EODBT|Death|1|||
170597387|NCT04271475|616532476|FG001|DB Period: Day 1 up to EODBT|Death|0|||
170597388|NCT04271475|616532477|FG002|DB Period: Day 1 up to EODBT|Death|0|||
170597389|NCT04271475|616532478|FG003|DB Period: Day 1 up to EODBT|Death|0|||
170597390|NCT04271475|616532475|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
170597391|NCT04271475|616532476|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
170597392|NCT04271475|616532477|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
170597393|NCT04271475|616532478|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
170597394|NCT04271475|616532475|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
170597395|NCT04271475|616532476|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
170597396|NCT04271475|616532477|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
170597397|NCT04271475|616532478|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
170597398|NCT04271475|616532475|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
170597399|NCT04271475|616532476|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
170597400|NCT04271475|616532477|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
170597401|NCT04271475|616532478|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
170597402|NCT04271475|616532475|FG000|DB Period: Day 1 up to EODBT|Other|8|||
170597403|NCT04271475|616532476|FG001|DB Period: Day 1 up to EODBT|Other|5|||
170597404|NCT04271475|616532477|FG002|DB Period: Day 1 up to EODBT|Other|0|||
170597405|NCT04271475|616532478|FG003|DB Period: Day 1 up to EODBT|Other|0|||
170597406|NCT04271475|616532475|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
170597407|NCT04271475|616532476|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
170597408|NCT04271475|616532477|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
170597409|NCT04271475|616532478|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
170597410|NCT04271475|616532475|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
170597411|NCT04271475|616532476|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
170597412|NCT04271475|616532477|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
170597413|NCT04271475|616532478|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
170597414|NCT04088331|616532484|FG000|Overall Study|Lost to Follow-up|3|||
170597415|NCT04088331|616532484|FG000|Overall Study|Withdrawal by Subject|7|||
170597416|NCT04088331|616532484|FG000|Overall Study|Adverse Event|4|||
170597417|NCT01818284|616532486|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
170597418|NCT01818284|616532487|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
170597419|NCT01818284|616532486|FG000|Overall Study|Death|0|||
170597420|NCT01818284|616532487|FG001|Overall Study|Death|2|||
170597421|NCT03171545|616532490|FG000|Baseline|Withdrawal by Subject|0|||
170597422|NCT03171545|616532491|FG001|Baseline|Withdrawal by Subject|0|||
170597423|NCT03171545|616532492|FG002|Baseline|Withdrawal by Subject|1|||
170597424|NCT03171545|616532493|FG003|Baseline|Withdrawal by Subject|2|||
170597425|NCT03171545|616532490|FG000|Baseline|Transferred out of clinic|4|||
170597426|NCT03171545|616532491|FG001|Baseline|Transferred out of clinic|0|||
170597427|NCT03171545|616532492|FG002|Baseline|Transferred out of clinic|2|||
170597428|NCT03171545|616532493|FG003|Baseline|Transferred out of clinic|0|||
170597429|NCT03171545|616532490|FG000|Baseline|Death|1|||
170597430|NCT03171545|616532491|FG001|Baseline|Death|2|||
170913443|NCT00393458|617685903|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
170597431|NCT03171545|616532492|FG002|Baseline|Death|1|||
170597432|NCT03171545|616532493|FG003|Baseline|Death|5|||
170597433|NCT03171545|616532490|FG000|Baseline|Recovered renal function|0|||
170597434|NCT03171545|616532491|FG001|Baseline|Recovered renal function|0|||
170597435|NCT03171545|616532492|FG002|Baseline|Recovered renal function|1|||
170597436|NCT03171545|616532493|FG003|Baseline|Recovered renal function|0|||
170597437|NCT03171545|616532490|FG000|Baseline|Received transplant|0|||
170597438|NCT03171545|616532491|FG001|Baseline|Received transplant|0|||
170597439|NCT03171545|616532492|FG002|Baseline|Received transplant|1|||
170913444|NCT00393458|617685904|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
170812057|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Non-compliance|0|||
170812058|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Non-compliance|3|||
170812059|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Other|3|||
170812060|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Other|0|||
170812061|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Other|3|||
170812062|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Other|2|||
170812063|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
170812064|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
170812065|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
170812066|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
170812067|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
170812068|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
170812069|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
170812070|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
170812071|NCT02143713|617321230|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
170812072|NCT02143713|617321231|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
170812073|NCT02143713|617321232|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
170812074|NCT02143713|617321233|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
170812075|NCT02143713|617321230|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
170812076|NCT02143713|617321231|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
170812077|NCT02143713|617321232|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
170812078|NCT02143713|617321233|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
170812079|NCT02143713|617321230|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
170812080|NCT02143713|617321231|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
170812081|NCT02143713|617321232|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
170812082|NCT02143713|617321233|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
170812083|NCT02143713|617321230|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
170812084|NCT02143713|617321231|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
170812085|NCT02143713|617321232|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
170812086|NCT02143713|617321233|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
170812087|NCT02143713|617321230|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
170812088|NCT02143713|617321231|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
170812089|NCT02143713|617321232|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
170812090|NCT02143713|617321233|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
170812091|NCT02143713|617321230|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
170812092|NCT02143713|617321231|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
170812093|NCT02143713|617321232|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
170812094|NCT02143713|617321233|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
170812095|NCT02143713|617321230|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
170812096|NCT02143713|617321231|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
170812097|NCT02143713|617321232|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
170812098|NCT02143713|617321233|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
170812099|NCT01768572|617321236|FG000|Overall Study|Adverse Event|7|||
170812100|NCT01768572|617321237|FG001|Overall Study|Adverse Event|8|||
170812101|NCT01768572|617321238|FG002|Overall Study|Adverse Event|4|||
170812102|NCT01768572|617321236|FG000|Overall Study|Lack of Efficacy|1|||
170812103|NCT01768572|617321237|FG001|Overall Study|Lack of Efficacy|3|||
170812104|NCT01768572|617321238|FG002|Overall Study|Lack of Efficacy|1|||
170812105|NCT01768572|617321236|FG000|Overall Study|Other, Not due to an adverse event|1|||
170812106|NCT01768572|617321237|FG001|Overall Study|Other, Not due to an adverse event|1|||
170812107|NCT01768572|617321238|FG002|Overall Study|Other, Not due to an adverse event|1|||
170812108|NCT02245620|617321239|FG000|Overall Study|Physician Decision|1|||
170812109|NCT02245620|617321240|FG001|Overall Study|Physician Decision|1|||
170812110|NCT01999335|617321241|FG000|Overall Study|Discontinued before receiving treatment|0|||
170812111|NCT01999335|617321242|FG001|Overall Study|Discontinued before receiving treatment|0|||
170812112|NCT01999335|617321243|FG002|Overall Study|Discontinued before receiving treatment|0|||
170812113|NCT01999335|617321244|FG003|Overall Study|Discontinued before receiving treatment|0|||
170812114|NCT01999335|617321245|FG004|Overall Study|Discontinued before receiving treatment|2|||
170812115|NCT00080119|617321246|FG000|Overall Study|Discontinued because of study closure|0|||
170812116|NCT00080119|617321247|FG001|Overall Study|Discontinued because of study closure|0|||
170812117|NCT00080119|617321248|FG002|Overall Study|Discontinued because of study closure|130|||
170812118|NCT00080119|617321249|FG003|Overall Study|Discontinued because of study closure|141|||
170913445|NCT00393458|617685905|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
170913446|NCT00393458|617685906|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
170913447|NCT00393458|617685903|FG000|Overall Study|Protocol deviation|11|||
170597440|NCT03171545|616532493|FG003|Baseline|Received transplant|0|||
170597441|NCT03171545|616532490|FG000|Baseline|No longer receiving in-center hemodialysis|0|||
170913448|NCT00393458|617685904|FG001|Overall Study|Protocol deviation|11|||
170597442|NCT03171545|616532491|FG001|Baseline|No longer receiving in-center hemodialysis|2|||
170597443|NCT03171545|616532492|FG002|Baseline|No longer receiving in-center hemodialysis|3|||
170597444|NCT03171545|616532493|FG003|Baseline|No longer receiving in-center hemodialysis|0|||
170597445|NCT03171545|616532490|FG000|Intervention|Withdrawal by Subject|2|||
170597446|NCT03171545|616532491|FG001|Intervention|Withdrawal by Subject|0|||
170597447|NCT03171545|616532492|FG002|Intervention|Withdrawal by Subject|0|||
170597448|NCT03171545|616532493|FG003|Intervention|Withdrawal by Subject|4|||
170597449|NCT03171545|616532490|FG000|Intervention|Transferred out of clinic|12|||
170597450|NCT03171545|616532491|FG001|Intervention|Transferred out of clinic|9|||
170597451|NCT03171545|616532492|FG002|Intervention|Transferred out of clinic|17|||
170597452|NCT03171545|616532493|FG003|Intervention|Transferred out of clinic|9|||
170597453|NCT03171545|616532490|FG000|Intervention|Death|26|||
170597454|NCT03171545|616532491|FG001|Intervention|Death|16|||
170597455|NCT03171545|616532492|FG002|Intervention|Death|29|||
170597456|NCT03171545|616532493|FG003|Intervention|Death|14|||
170597457|NCT03171545|616532490|FG000|Intervention|Received transplant|7|||
170597458|NCT03171545|616532491|FG001|Intervention|Received transplant|5|||
170597459|NCT03171545|616532492|FG002|Intervention|Received transplant|3|||
170597460|NCT03171545|616532493|FG003|Intervention|Received transplant|6|||
170597461|NCT03171545|616532490|FG000|Intervention|No longer receiving in-center hemodialysis|7|||
170597462|NCT03171545|616532491|FG001|Intervention|No longer receiving in-center hemodialysis|4|||
170597463|NCT03171545|616532492|FG002|Intervention|No longer receiving in-center hemodialysis|4|||
170597464|NCT03171545|616532493|FG003|Intervention|No longer receiving in-center hemodialysis|6|||
170597465|NCT03171545|616532490|FG000|Intervention|Lost to Follow-up|0|||
170597466|NCT03171545|616532491|FG001|Intervention|Lost to Follow-up|1|||
170597467|NCT03171545|616532492|FG002|Intervention|Lost to Follow-up|0|||
170597468|NCT03171545|616532493|FG003|Intervention|Lost to Follow-up|0|||
170597469|NCT03171545|616532490|FG000|Follow up|Withdrawal by Subject|1|||
170597470|NCT03171545|616532491|FG001|Follow up|Withdrawal by Subject|1|||
170597471|NCT03171545|616532492|FG002|Follow up|Withdrawal by Subject|0|||
170597472|NCT03171545|616532493|FG003|Follow up|Withdrawal by Subject|0|||
170597473|NCT03171545|616532490|FG000|Follow up|Transferred out of clinic|4|||
170597474|NCT03171545|616532491|FG001|Follow up|Transferred out of clinic|4|||
170597475|NCT03171545|616532492|FG002|Follow up|Transferred out of clinic|12|||
170597476|NCT03171545|616532493|FG003|Follow up|Transferred out of clinic|7|||
170597477|NCT03171545|616532490|FG000|Follow up|Death|18|||
170597478|NCT03171545|616532491|FG001|Follow up|Death|12|||
170597479|NCT03171545|616532492|FG002|Follow up|Death|5|||
170597480|NCT03171545|616532493|FG003|Follow up|Death|8|||
170597481|NCT03171545|616532490|FG000|Follow up|Received transplant|4|||
170597482|NCT03171545|616532491|FG001|Follow up|Received transplant|1|||
170597483|NCT03171545|616532492|FG002|Follow up|Received transplant|0|||
170597484|NCT03171545|616532493|FG003|Follow up|Received transplant|1|||
170597485|NCT03171545|616532490|FG000|Follow up|No longer receiving in-center hemodialysis|4|||
170597486|NCT03171545|616532491|FG001|Follow up|No longer receiving in-center hemodialysis|2|||
170597487|NCT03171545|616532492|FG002|Follow up|No longer receiving in-center hemodialysis|1|||
170597488|NCT03171545|616532493|FG003|Follow up|No longer receiving in-center hemodialysis|0|||
170597489|NCT03171545|616532490|FG000|Follow up|Lost to Follow-up|1|||
170597490|NCT03171545|616532491|FG001|Follow up|Lost to Follow-up|2|||
170597491|NCT03171545|616532492|FG002|Follow up|Lost to Follow-up|3|||
170597492|NCT03171545|616532493|FG003|Follow up|Lost to Follow-up|1|||
170597493|NCT04007796|616532494|FG000|Overall Study|Exclusion criterion met during the trial|1|||
170597494|NCT04007796|616532495|FG001|Overall Study|Exclusion criterion met during the trial|1|||
170597495|NCT04007796|616532494|FG000|Overall Study|Withdrawal by Subject|1|||
170597496|NCT04007796|616532495|FG001|Overall Study|Withdrawal by Subject|0|||
170597497|NCT01300351|616532496|FG000|Overall Study|Did not receive treatment|2|||
170651422|NCT04559529|616738153|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
170651423|NCT04559529|616738154|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
170597498|NCT01300351|616532497|FG001|Overall Study|Did not receive treatment|0|||
170597499|NCT01300351|616532496|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
170597500|NCT01300351|616532497|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
170597501|NCT01300351|616532496|FG000|Overall Study|Lost to Follow-up|0|||
170597502|NCT01300351|616532497|FG001|Overall Study|Lost to Follow-up|1|||
170597503|NCT01300351|616532496|FG000|Overall Study|Adverse Event|0|||
170597504|NCT01300351|616532497|FG001|Overall Study|Adverse Event|4|||
170597505|NCT01300351|616532496|FG000|Overall Study|Withdrawal by Subject|7|||
170597506|NCT01300351|616532497|FG001|Overall Study|Withdrawal by Subject|10|||
170597507|NCT00673881|616532500|FG000|Overall Study|Withdrawal by Subject|1|||
170597508|NCT02258529|616532501|FG000|Overall Study|Study Terminated by Sponsor|9|||
170597509|NCT02258529|616532501|FG000|Overall Study|Adverse Event|1|||
170597510|NCT01995552|616532504|FG000|Overall Study|Protocol Violation|1|||
170597511|NCT01995552|616532504|FG000|Overall Study|Lack of Efficacy|15|||
170597512|NCT01995552|616532504|FG000|Overall Study|Death|1|||
170597513|NCT00286221|616532505|FG000|Overall Study|Protocol Violation|2|||
170597514|NCT00286221|616532506|FG001|Overall Study|Protocol Violation|1|||
170597515|NCT00286221|616532507|FG002|Overall Study|Protocol Violation|6|||
170597516|NCT00286221|616532508|FG003|Overall Study|Protocol Violation|4|||
170597517|NCT00286221|616532505|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
170597518|NCT00286221|616532506|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
170597519|NCT00286221|616532507|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
170597520|NCT00286221|616532508|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
170597521|NCT00286221|616532505|FG000|Overall Study|Inability to trigger PCA|2|||
170597522|NCT00286221|616532506|FG001|Overall Study|Inability to trigger PCA|0|||
170597523|NCT00286221|616532507|FG002|Overall Study|Inability to trigger PCA|0|||
170597524|NCT00286221|616532508|FG003|Overall Study|Inability to trigger PCA|0|||
170597525|NCT00286221|616532505|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
170597526|NCT00286221|616532506|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
170597527|NCT00286221|616532507|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
170597528|NCT00286221|616532508|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
170597529|NCT00357656|616532509|FG000|Overall Study|Other, No surgery performed|0|||
170597530|NCT00357656|616532510|FG001|Overall Study|Other, No surgery performed|3|||
170597531|NCT02573246|616532511|FG000|Overall Study|Lost to Follow-up|2|||
170597532|NCT02573246|616532512|FG001|Overall Study|Lost to Follow-up|0|||
170597533|NCT02573246|616532513|FG002|Overall Study|Lost to Follow-up|0|||
170597534|NCT02573246|616532514|FG003|Overall Study|Lost to Follow-up|0|||
170597535|NCT02573246|616532515|FG004|Overall Study|Lost to Follow-up|1|||
170597536|NCT02573246|616532511|FG000|Overall Study|Withdrawal by Subject|0|||
170597537|NCT02573246|616532512|FG001|Overall Study|Withdrawal by Subject|0|||
170597538|NCT02573246|616532513|FG002|Overall Study|Withdrawal by Subject|0|||
170597539|NCT02573246|616532514|FG003|Overall Study|Withdrawal by Subject|0|||
170597540|NCT02573246|616532515|FG004|Overall Study|Withdrawal by Subject|1|||
170597541|NCT02573246|616532511|FG000|Overall Study|Physician Decision|1|||
170597542|NCT02573246|616532512|FG001|Overall Study|Physician Decision|1|||
170597543|NCT02573246|616532513|FG002|Overall Study|Physician Decision|3|||
170597544|NCT02573246|616532514|FG003|Overall Study|Physician Decision|2|||
170597545|NCT02573246|616532515|FG004|Overall Study|Physician Decision|2|||
170597546|NCT01902888|616532517|FG000|Overall Study|Study Terminated|3|||
170597547|NCT02256267|616532521|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
170597548|NCT02256267|616532521|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
170597549|NCT01685983|616532522|FG000|Overall Study|Adverse Event|7|||
170597550|NCT01685983|616532522|FG000|Overall Study|Death|1|||
170597551|NCT01685983|616532522|FG000|Overall Study|Withdrawal by Subject|19|||
170597552|NCT01685983|616532522|FG000|Overall Study|Protocol Violation|2|||
170597553|NCT01685983|616532522|FG000|Overall Study|Physician Decision|13|||
170597554|NCT01685983|616532522|FG000|Overall Study|Other|7|||
170597555|NCT01685983|616532522|FG000|Overall Study|Progressive Disease|32|||
170597556|NCT01685983|616532522|FG000|Overall Study|Noncompliance with Study Drug|1|||
170597557|NCT00857948|616532523|FG000|Overall Study|Withdrawal by Subject|2|||
170597558|NCT00857948|616532524|FG001|Overall Study|Withdrawal by Subject|0|||
170597559|NCT00857948|616532525|FG002|Overall Study|Withdrawal by Subject|0|||
170597560|NCT00857948|616532526|FG003|Overall Study|Withdrawal by Subject|0|||
170597561|NCT00857948|616532523|FG000|Overall Study|Protocol Violation|1|||
170597562|NCT00857948|616532524|FG001|Overall Study|Protocol Violation|0|||
170597563|NCT00857948|616532525|FG002|Overall Study|Protocol Violation|1|||
170597564|NCT00857948|616532526|FG003|Overall Study|Protocol Violation|0|||
170597565|NCT01827332|616532528|FG000|Overall Study|Lost to Follow-up|2|||
170597566|NCT01827332|616532529|FG001|Overall Study|Lost to Follow-up|1|||
170597567|NCT01739803|616532531|FG000|Overall Study|Lost to Follow-up|9|||
170597568|NCT01739803|616532532|FG001|Overall Study|Lost to Follow-up|6|||
170597569|NCT03759041|616532537|FG000|Overall Study|Withdrawal by Subject|4|||
170597570|NCT03759041|616532538|FG001|Overall Study|Withdrawal by Subject|10|||
170597571|NCT03759041|616532539|FG002|Overall Study|Withdrawal by Subject|10|||
170597572|NCT03759041|616532537|FG000|Overall Study|Adverse Event|1|||
170597573|NCT03759041|616532538|FG001|Overall Study|Adverse Event|3|||
170597574|NCT03759041|616532539|FG002|Overall Study|Adverse Event|4|||
170597575|NCT03759041|616532537|FG000|Overall Study|Lack of Efficacy|0|||
170651424|NCT02217527|616738155|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
170651425|NCT02217527|616738156|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
170651426|NCT02217527|616738155|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
170651427|NCT02217527|616738156|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
170597576|NCT03759041|616532538|FG001|Overall Study|Lack of Efficacy|0|||
170597577|NCT03759041|616532539|FG002|Overall Study|Lack of Efficacy|1|||
170597578|NCT03759041|616532537|FG000|Overall Study|Study Terminated by Sponsor|15|||
170597579|NCT03759041|616532538|FG001|Overall Study|Study Terminated by Sponsor|16|||
170597580|NCT03759041|616532539|FG002|Overall Study|Study Terminated by Sponsor|10|||
170597581|NCT03759041|616532537|FG000|Overall Study|Other reason for discontinuation|0|||
170597582|NCT03759041|616532538|FG001|Overall Study|Other reason for discontinuation|2|||
170597583|NCT03759041|616532539|FG002|Overall Study|Other reason for discontinuation|1|||
170597584|NCT03759041|616532537|FG000|Overall Study|Lost to Follow-up|7|||
170597585|NCT03759041|616532538|FG001|Overall Study|Lost to Follow-up|2|||
170597586|NCT03759041|616532539|FG002|Overall Study|Lost to Follow-up|2|||
170597587|NCT03759041|616532537|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
170812119|NCT00080119|617321246|FG000|Overall Study|Unable to get to clinic|24|||
170812120|NCT00080119|617321247|FG001|Overall Study|Unable to get to clinic|24|||
170812121|NCT00080119|617321248|FG002|Overall Study|Unable to get to clinic|7|||
170597588|NCT03759041|616532538|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
170597589|NCT03759041|616532539|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
170597590|NCT02449018|616532540|FG000|Overall Study|Abnormal laboratory value|0|||
170597591|NCT02449018|616532541|FG001|Overall Study|Abnormal laboratory value|1|||
170597592|NCT02449018|616532540|FG000|Overall Study|Administrative problems|1|||
170812122|NCT00080119|617321249|FG003|Overall Study|Unable to get to clinic|1|||
170812123|NCT00080119|617321246|FG000|Overall Study|Consent withdrawn|13|||
170812124|NCT00080119|617321247|FG001|Overall Study|Consent withdrawn|17|||
170812125|NCT00080119|617321248|FG002|Overall Study|Consent withdrawn|4|||
170812126|NCT00080119|617321249|FG003|Overall Study|Consent withdrawn|6|||
170812127|NCT00080119|617321246|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
170812128|NCT00080119|617321247|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
170812129|NCT00080119|617321248|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
170812130|NCT00080119|617321249|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
170812131|NCT00080119|617321246|FG000|Overall Study|Lost to Follow-up|16|||
170812132|NCT00080119|617321247|FG001|Overall Study|Lost to Follow-up|19|||
170812133|NCT00080119|617321248|FG002|Overall Study|Lost to Follow-up|19|||
170812134|NCT00080119|617321249|FG003|Overall Study|Lost to Follow-up|14|||
170812135|NCT04766996|617321250|FG000|Overall Study|Withdrawal by Subject|1|||
170812136|NCT04766996|617321251|FG001|Overall Study|Withdrawal by Subject|0|||
170812137|NCT04766996|617321252|FG002|Overall Study|Withdrawal by Subject|13|||
170812138|NCT01322386|617321253|FG000|Overall Study|Protocol Violation|0|||
170812139|NCT01322386|617321254|FG001|Overall Study|Protocol Violation|1|||
170812140|NCT01322386|617321253|FG000|Overall Study|Physician Decision|0|||
170812141|NCT01322386|617321254|FG001|Overall Study|Physician Decision|1|||
170812142|NCT02291861|617321260|FG000|Overall Study|Adverse Event|2|||
170812143|NCT02291861|617321261|FG001|Overall Study|Adverse Event|4|||
170812144|NCT02291861|617321262|FG002|Overall Study|Adverse Event|1|||
170812145|NCT02291861|617321263|FG003|Overall Study|Adverse Event|2|||
170812146|NCT02291861|617321260|FG000|Overall Study|Death|0|||
170812147|NCT02291861|617321261|FG001|Overall Study|Death|0|||
170812148|NCT02291861|617321262|FG002|Overall Study|Death|1|||
170812149|NCT02291861|617321263|FG003|Overall Study|Death|1|||
170812150|NCT02291861|617321260|FG000|Overall Study|Protocol Violation|1|||
170812151|NCT02291861|617321261|FG001|Overall Study|Protocol Violation|0|||
170812152|NCT02291861|617321262|FG002|Overall Study|Protocol Violation|0|||
170812153|NCT02291861|617321263|FG003|Overall Study|Protocol Violation|1|||
170812154|NCT02291861|617321260|FG000|Overall Study|Withdrawal by Subject|1|||
170812155|NCT02291861|617321261|FG001|Overall Study|Withdrawal by Subject|2|||
170812156|NCT02291861|617321262|FG002|Overall Study|Withdrawal by Subject|1|||
170812157|NCT02291861|617321263|FG003|Overall Study|Withdrawal by Subject|4|||
170812158|NCT02291861|617321260|FG000|Overall Study|Noncompliance|1|||
170812159|NCT02291861|617321261|FG001|Overall Study|Noncompliance|1|||
170812160|NCT02291861|617321262|FG002|Overall Study|Noncompliance|2|||
170812161|NCT02291861|617321263|FG003|Overall Study|Noncompliance|1|||
170812162|NCT02291861|617321260|FG000|Overall Study|Lost to Follow-up|2|||
170812163|NCT02291861|617321261|FG001|Overall Study|Lost to Follow-up|1|||
170812164|NCT02291861|617321262|FG002|Overall Study|Lost to Follow-up|4|||
170812165|NCT02291861|617321263|FG003|Overall Study|Lost to Follow-up|0|||
170812166|NCT02291861|617321260|FG000|Overall Study|Other|0|||
170812167|NCT02291861|617321261|FG001|Overall Study|Other|0|||
170812168|NCT02291861|617321262|FG002|Overall Study|Other|0|||
170812169|NCT02291861|617321263|FG003|Overall Study|Other|1|||
170812170|NCT03390166|617321267|FG000|Overall Study|Death|0|||
170812171|NCT03390166|617321268|FG001|Overall Study|Death|1|||
170812172|NCT03390166|617321267|FG000|Overall Study|Lost to Follow-up|6|||
170812173|NCT03390166|617321268|FG001|Overall Study|Lost to Follow-up|4|||
170812174|NCT03390166|617321267|FG000|Overall Study|Physician Decision|2|||
170812175|NCT03390166|617321268|FG001|Overall Study|Physician Decision|1|||
170597593|NCT02449018|616532541|FG001|Overall Study|Administrative problems|0|||
170812176|NCT03390166|617321267|FG000|Overall Study|Move from study area|3|||
170812177|NCT03390166|617321268|FG001|Overall Study|Move from study area|2|||
170812178|NCT03390166|617321267|FG000|Overall Study|To militarycamp for conscript|1|||
170812179|NCT03390166|617321268|FG001|Overall Study|To militarycamp for conscript|0|||
170812180|NCT03390166|617321267|FG000|Overall Study|To drug therapy course|0|||
170913449|NCT00393458|617685905|FG002|Overall Study|Protocol deviation|11|||
170913450|NCT00393458|617685906|FG003|Overall Study|Protocol deviation|10|||
170913451|NCT00393458|617685903|FG000|Overall Study|Administrative problems|7|||
170597594|NCT02449018|616532540|FG000|Overall Study|Adverse Event|5|||
170597595|NCT02449018|616532541|FG001|Overall Study|Adverse Event|1|||
170812181|NCT03390166|617321268|FG001|Overall Study|To drug therapy course|1|||
170812182|NCT03390166|617321267|FG000|Overall Study|Move to work oversea|0|||
170812183|NCT03390166|617321268|FG001|Overall Study|Move to work oversea|1|||
170812184|NCT02037568|617321269|FG000|Overall Study|Withdrawal by Subject|17|||
170913452|NCT00393458|617685904|FG001|Overall Study|Administrative problems|8|||
170597596|NCT02449018|616532540|FG000|Overall Study|Protocol deviation|4|||
170597597|NCT02449018|616532541|FG001|Overall Study|Protocol deviation|0|||
170597598|NCT02449018|616532540|FG000|Overall Study|Patient decision|2|||
170597599|NCT02449018|616532541|FG001|Overall Study|Patient decision|0|||
170597600|NCT01522404|616532550|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
170597601|NCT01522404|616532551|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
170597602|NCT01522404|616532550|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
170597603|NCT01522404|616532551|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
170651428|NCT01381562|616738159|FG000|Overall Study|Adverse Event|0|||
170651429|NCT01381562|616738160|FG001|Overall Study|Adverse Event|1|||
170651430|NCT01381562|616738161|FG002|Overall Study|Adverse Event|0|||
170651431|NCT02660138|616738162|FG000|Overall Study|Adverse Event|0|||
170651432|NCT02660138|616738163|FG001|Overall Study|Adverse Event|3|||
170651433|NCT02660138|616738164|FG002|Overall Study|Adverse Event|2|||
170651434|NCT02660138|616738162|FG000|Overall Study|Lack of Efficacy|1|||
170651435|NCT02660138|616738163|FG001|Overall Study|Lack of Efficacy|2|||
170651436|NCT02660138|616738164|FG002|Overall Study|Lack of Efficacy|1|||
170651437|NCT02660138|616738162|FG000|Overall Study|Withdrawal by Subject|7|||
170651438|NCT02660138|616738163|FG001|Overall Study|Withdrawal by Subject|6|||
170651439|NCT02660138|616738164|FG002|Overall Study|Withdrawal by Subject|6|||
170651440|NCT02660138|616738162|FG000|Overall Study|Lost to Follow-up|4|||
170651441|NCT02660138|616738163|FG001|Overall Study|Lost to Follow-up|4|||
170651442|NCT02660138|616738164|FG002|Overall Study|Lost to Follow-up|1|||
170651443|NCT02660138|616738162|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
170651444|NCT02660138|616738163|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
170651445|NCT02660138|616738164|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
170651446|NCT02660138|616738162|FG000|Overall Study|Other|1|||
170651447|NCT02660138|616738163|FG001|Overall Study|Other|1|||
170651448|NCT02660138|616738164|FG002|Overall Study|Other|0|||
170651449|NCT02660138|616738162|FG000|Overall Study|Not treated|0|||
170651450|NCT02660138|616738163|FG001|Overall Study|Not treated|1|||
170651451|NCT02660138|616738164|FG002|Overall Study|Not treated|0|||
170651452|NCT00095147|616738168|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
170651453|NCT00095147|616738169|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
170651454|NCT00095147|616738170|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
170651455|NCT00095147|616738171|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
170651456|NCT00095147|616738172|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
170651457|NCT00095147|616738168|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
170651458|NCT00095147|616738169|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
170651459|NCT00095147|616738170|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
170651460|NCT00095147|616738171|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
170651461|NCT00095147|616738172|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
170651462|NCT00095147|616738168|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
170651463|NCT00095147|616738169|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
170651464|NCT00095147|616738170|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
170651465|NCT00095147|616738171|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
170812185|NCT02037568|617321270|FG001|Overall Study|Withdrawal by Subject|24|||
170812186|NCT02037568|617321269|FG000|Overall Study|Lost to Follow-up|16|||
170812187|NCT02037568|617321270|FG001|Overall Study|Lost to Follow-up|13|||
170812188|NCT02037568|617321269|FG000|Overall Study|Screen Failure|3|||
170812189|NCT02037568|617321270|FG001|Overall Study|Screen Failure|1|||
170812190|NCT02037568|617321269|FG000|Overall Study|Patient did not receive transplant|0|||
170812191|NCT02037568|617321270|FG001|Overall Study|Patient did not receive transplant|1|||
170812192|NCT04492475|617321271|FG000|Overall Study|Enrolled but not treated|8|||
170812193|NCT04492475|617321272|FG001|Overall Study|Enrolled but not treated|8|||
170812194|NCT04492475|617321271|FG000|Overall Study|Withdrawal by Subject|4|||
170812195|NCT04492475|617321272|FG001|Overall Study|Withdrawal by Subject|0|||
170812196|NCT04492475|617321271|FG000|Overall Study|Became ineligible after enrollment|2|||
170812197|NCT04492475|617321272|FG001|Overall Study|Became ineligible after enrollment|0|||
170812198|NCT03200574|617321282|FG000|Overall Study|Death|4|||
170913453|NCT00393458|617685905|FG002|Overall Study|Administrative problems|5|||
170913454|NCT00393458|617685906|FG003|Overall Study|Administrative problems|2|||
170913455|NCT00393458|617685903|FG000|Overall Study|Lost to Follow-up|5|||
170913456|NCT00393458|617685904|FG001|Overall Study|Lost to Follow-up|6|||
170913457|NCT00393458|617685905|FG002|Overall Study|Lost to Follow-up|5|||
170913458|NCT00393458|617685906|FG003|Overall Study|Lost to Follow-up|3|||
170913459|NCT00393458|617685903|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170812199|NCT03200574|617321282|FG000|Overall Study|Withdrawal by Subject|8|||
170913460|NCT00393458|617685904|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170651466|NCT00095147|616738172|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
170651467|NCT00095147|616738168|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
170651468|NCT00095147|616738169|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
170651469|NCT00095147|616738170|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
170812200|NCT03200574|617321282|FG000|Overall Study|Long-Term need for anticoagulation|1|||
170812201|NCT03200574|617321282|FG000|Overall Study|Relocation|2|||
170597604|NCT01522404|616532550|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
170597605|NCT01522404|616532551|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
170597606|NCT02698371|616532552|FG000|All Participants Flow|Lost to Follow-up|3|||
170597607|NCT02698371|616532552|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
170597608|NCT02698371|616532552|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
170597609|NCT02698371|616532552|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
170597610|NCT02698371|616532552|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
170597611|NCT02698371|616532552|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
170597612|NCT02698371|616532552|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
170597613|NCT01490294|616532556|FG000|Overall Study|Prematurely discontinuation|4|||
170597614|NCT01490294|616532557|FG001|Overall Study|Prematurely discontinuation|0|||
170597615|NCT01490294|616532558|FG002|Overall Study|Prematurely discontinuation|1|||
170597616|NCT01490294|616532559|FG003|Overall Study|Prematurely discontinuation|1|||
170597617|NCT01490294|616532556|FG000|Overall Study|Adverse Event|1|||
170597618|NCT01490294|616532557|FG001|Overall Study|Adverse Event|0|||
170597619|NCT01490294|616532558|FG002|Overall Study|Adverse Event|0|||
170597620|NCT01490294|616532559|FG003|Overall Study|Adverse Event|0|||
170597621|NCT04208087|616532562|FG000|Overall Study|Adverse Event|1|||
170597622|NCT04208087|616532563|FG001|Overall Study|Adverse Event|0|||
170597623|NCT04208087|616532564|FG002|Overall Study|Adverse Event|0|||
170597624|NCT04208087|616532565|FG003|Overall Study|Adverse Event|0|||
170597625|NCT04208087|616532566|FG004|Overall Study|Adverse Event|0|||
170597626|NCT04208087|616532562|FG000|Overall Study|Withdrawal by Subject|0|||
170597627|NCT04208087|616532563|FG001|Overall Study|Withdrawal by Subject|0|||
170597628|NCT04208087|616532564|FG002|Overall Study|Withdrawal by Subject|1|||
170597629|NCT04208087|616532565|FG003|Overall Study|Withdrawal by Subject|0|||
170597630|NCT04208087|616532566|FG004|Overall Study|Withdrawal by Subject|0|||
170597631|NCT04208087|616532562|FG000|Overall Study|Other|0|||
170597632|NCT04208087|616532563|FG001|Overall Study|Other|0|||
170597633|NCT04208087|616532564|FG002|Overall Study|Other|0|||
170597634|NCT04208087|616532565|FG003|Overall Study|Other|0|||
170597635|NCT04208087|616532566|FG004|Overall Study|Other|1|||
170597636|NCT01198509|616532567|FG000|Overall Study|Withdrawal by Subject|1|||
170597637|NCT01198509|616532568|FG001|Overall Study|Withdrawal by Subject|0|||
170597638|NCT01198509|616532569|FG002|Overall Study|Withdrawal by Subject|0|||
170597639|NCT01198509|616532570|FG003|Overall Study|Withdrawal by Subject|0|||
170597640|NCT01198509|616532571|FG004|Overall Study|Withdrawal by Subject|0|||
170597641|NCT01198509|616532572|FG005|Overall Study|Withdrawal by Subject|0|||
170597642|NCT01440881|616532573|FG000|Overall Study|Death|0|||
170597643|NCT01440881|616532574|FG001|Overall Study|Death|1|||
170597644|NCT02644356|616532576|FG000|Overall Study|Withdrawal by Subject|2|||
170597645|NCT02290938|616532577|FG000|Overall Study|Lost to Follow-up|14|||
170597646|NCT02290938|616532578|FG001|Overall Study|Lost to Follow-up|43|||
170597647|NCT00897390|616532579|FG000|Overall Study|Adverse Event|2|||
170597648|NCT00897390|616532579|FG000|Overall Study|No Longer Met Study Criteria|1|||
170597649|NCT00897390|616532579|FG000|Overall Study|Personal Reasons|1|||
170597650|NCT00897390|616532579|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
170597651|NCT04514341|616532580|FG000|Step 2 (Months 19-21)|In a 3-month delay period|0|||
170597652|NCT04514341|616532581|FG001|Step 2 (Months 19-21)|In a 3-month delay period|15725|||
170597653|NCT04514341|616532580|FG000|Step 4 (Months 31-33)|In a 3-month delay period|0|||
170597654|NCT04514341|616532581|FG001|Step 4 (Months 31-33)|In a 3-month delay period|15037|||
170597655|NCT01216683|616533911|FG000|Induction|Never started treatment|0|||
170597656|NCT01216683|616533912|FG001|Induction|Never started treatment|6|||
170597657|NCT01216683|616533913|FG002|Induction|Never started treatment|3|||
170597658|NCT01216683|616533911|FG000|Induction|Lack of Efficacy|4|||
170597659|NCT01216683|616533912|FG001|Induction|Lack of Efficacy|3|||
170597660|NCT01216683|616533913|FG002|Induction|Lack of Efficacy|7|||
170597661|NCT01216683|616533911|FG000|Induction|Adverse Event|0|||
170651470|NCT00095147|616738171|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
170597662|NCT01216683|616533912|FG001|Induction|Adverse Event|5|||
170651471|NCT00095147|616738172|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
170597663|NCT01216683|616533913|FG002|Induction|Adverse Event|5|||
170597664|NCT01216683|616533911|FG000|Induction|Death|0|||
170597665|NCT01216683|616533912|FG001|Induction|Death|0|||
170597666|NCT01216683|616533913|FG002|Induction|Death|2|||
170597667|NCT01216683|616533911|FG000|Induction|Withdrawal by Subject|0|||
170651472|NCT00095147|616738168|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
170651473|NCT00095147|616738169|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
170597668|NCT01216683|616533912|FG001|Induction|Withdrawal by Subject|4|||
170597669|NCT01216683|616533913|FG002|Induction|Withdrawal by Subject|2|||
170597670|NCT01216683|616533911|FG000|Induction|Other disease|0|||
170597671|NCT01216683|616533912|FG001|Induction|Other disease|1|||
170597672|NCT01216683|616533913|FG002|Induction|Other disease|2|||
170597673|NCT01216683|616533911|FG000|Continuation|Lack of Efficacy|3|||
170597674|NCT01216683|616533912|FG001|Continuation|Lack of Efficacy|2|||
170597675|NCT01216683|616533913|FG002|Continuation|Lack of Efficacy|7|||
170597676|NCT01216683|616533911|FG000|Continuation|Adverse Event|5|||
170597677|NCT01216683|616533912|FG001|Continuation|Adverse Event|3|||
170597678|NCT01216683|616533913|FG002|Continuation|Adverse Event|16|||
170597679|NCT01216683|616533911|FG000|Continuation|Death|1|||
170597680|NCT01216683|616533912|FG001|Continuation|Death|0|||
170597681|NCT01216683|616533913|FG002|Continuation|Death|2|||
170597682|NCT01216683|616533911|FG000|Continuation|Withdrawal by Subject|4|||
170597683|NCT01216683|616533912|FG001|Continuation|Withdrawal by Subject|5|||
170597684|NCT01216683|616533913|FG002|Continuation|Withdrawal by Subject|9|||
170812202|NCT03200574|617321282|FG000|Overall Study|Lost to Follow-up|2|||
170812203|NCT02833948|617321283|FG000|Overall Study|Death|2|||
170812204|NCT02833948|617321284|FG001|Overall Study|Death|3|||
170812205|NCT02833948|617321283|FG000|Overall Study|were not scanned|8|||
170812206|NCT02833948|617321284|FG001|Overall Study|were not scanned|13|||
170812207|NCT02833948|617321283|FG000|Overall Study|scans could not be evaluated|5|||
170812208|NCT02833948|617321284|FG001|Overall Study|scans could not be evaluated|2|||
170812209|NCT02691702|617321285|FG000|Overall Study|Adverse Event|1|||
170812210|NCT02691702|617321286|FG001|Overall Study|Adverse Event|0|||
170812211|NCT02691702|617321287|FG002|Overall Study|Adverse Event|0|||
170812212|NCT02691702|617321288|FG003|Overall Study|Adverse Event|0|||
170812213|NCT02691702|617321289|FG004|Overall Study|Adverse Event|0|||
170812214|NCT02691702|617321290|FG005|Overall Study|Adverse Event|0|||
170812215|NCT02691702|617321291|FG006|Overall Study|Adverse Event|0|||
170812216|NCT02691702|617321292|FG007|Overall Study|Adverse Event|0|||
170812217|NCT02691702|617321293|FG008|Overall Study|Adverse Event|1|||
170812218|NCT02691702|617321294|FG009|Overall Study|Adverse Event|0|||
170812219|NCT02691702|617321295|FG010|Overall Study|Adverse Event|1|||
170812220|NCT02691702|617321285|FG000|Overall Study|Lost to Follow-up|0|||
170812221|NCT02691702|617321286|FG001|Overall Study|Lost to Follow-up|0|||
170812222|NCT02691702|617321287|FG002|Overall Study|Lost to Follow-up|1|||
170812223|NCT02691702|617321288|FG003|Overall Study|Lost to Follow-up|0|||
170812224|NCT02691702|617321289|FG004|Overall Study|Lost to Follow-up|0|||
170812225|NCT02691702|617321290|FG005|Overall Study|Lost to Follow-up|2|||
170812226|NCT02691702|617321291|FG006|Overall Study|Lost to Follow-up|0|||
170812227|NCT02691702|617321292|FG007|Overall Study|Lost to Follow-up|0|||
170812228|NCT02691702|617321293|FG008|Overall Study|Lost to Follow-up|0|||
170812229|NCT02691702|617321294|FG009|Overall Study|Lost to Follow-up|0|||
170812230|NCT02691702|617321295|FG010|Overall Study|Lost to Follow-up|1|||
170812231|NCT02691702|617321285|FG000|Overall Study|Withdrawal by Subject|1|||
170812232|NCT02691702|617321286|FG001|Overall Study|Withdrawal by Subject|1|||
170812233|NCT02691702|617321287|FG002|Overall Study|Withdrawal by Subject|0|||
170812234|NCT02691702|617321288|FG003|Overall Study|Withdrawal by Subject|0|||
170812235|NCT02691702|617321289|FG004|Overall Study|Withdrawal by Subject|0|||
170812236|NCT02691702|617321290|FG005|Overall Study|Withdrawal by Subject|1|||
170812237|NCT02691702|617321291|FG006|Overall Study|Withdrawal by Subject|2|||
170812238|NCT02691702|617321292|FG007|Overall Study|Withdrawal by Subject|0|||
170812239|NCT02691702|617321293|FG008|Overall Study|Withdrawal by Subject|0|||
170812240|NCT02691702|617321294|FG009|Overall Study|Withdrawal by Subject|0|||
170812241|NCT02691702|617321295|FG010|Overall Study|Withdrawal by Subject|0|||
170812242|NCT02691702|617321285|FG000|Overall Study|Other|0|||
170812243|NCT02691702|617321286|FG001|Overall Study|Other|0|||
170812244|NCT02691702|617321287|FG002|Overall Study|Other|0|||
170812245|NCT02691702|617321288|FG003|Overall Study|Other|0|||
170812246|NCT02691702|617321289|FG004|Overall Study|Other|0|||
170812247|NCT02691702|617321290|FG005|Overall Study|Other|0|||
170597685|NCT01216683|616533911|FG000|Continuation|Other diseases|0|||
170597686|NCT01216683|616533912|FG001|Continuation|Other diseases|2|||
170597687|NCT01216683|616533913|FG002|Continuation|Other diseases|1|||
170597688|NCT01216683|616533911|FG000|Continuation|Physician Decision|1|||
170597689|NCT01216683|616533912|FG001|Continuation|Physician Decision|0|||
170597690|NCT01216683|616533913|FG002|Continuation|Physician Decision|1|||
170597691|NCT01216683|616533911|FG000|Continuation|Non-compliance|1|||
170597692|NCT01216683|616533912|FG001|Continuation|Non-compliance|0|||
170597693|NCT01216683|616533913|FG002|Continuation|Non-compliance|1|||
170597694|NCT01216683|616533911|FG000|Continuation|Insurance change|0|||
170597695|NCT01216683|616533912|FG001|Continuation|Insurance change|1|||
170597696|NCT01216683|616533913|FG002|Continuation|Insurance change|0|||
170597697|NCT01216683|616533911|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
170812248|NCT02691702|617321291|FG006|Overall Study|Other|1|||
170597698|NCT01216683|616533912|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
170597699|NCT01216683|616533913|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
170597700|NCT01216683|616533911|FG000|Continuation|Not reported|0|||
170597701|NCT01216683|616533912|FG001|Continuation|Not reported|0|||
170812249|NCT02691702|617321292|FG007|Overall Study|Other|0|||
170812250|NCT02691702|617321293|FG008|Overall Study|Other|1|||
170812251|NCT02691702|617321294|FG009|Overall Study|Other|0|||
170812252|NCT02691702|617321295|FG010|Overall Study|Other|0|||
170597702|NCT01216683|616533913|FG002|Continuation|Not reported|1|||
170597703|NCT01216683|616533911|FG000|Continuation|Never started treatment|0|||
170597704|NCT01216683|616533912|FG001|Continuation|Never started treatment|1|||
170597705|NCT01216683|616533913|FG002|Continuation|Never started treatment|5|||
170597706|NCT04500769|616533914|FG000|Overall Study|Withdrawal by Subject|5|||
170597707|NCT05011513|616533915|FG000|Overall Study|Death|0|||
170597708|NCT05011513|616533916|FG001|Overall Study|Death|1|||
170597709|NCT05011513|616533915|FG000|Overall Study|Lost to Follow-up|4|||
170597710|NCT05011513|616533916|FG001|Overall Study|Lost to Follow-up|0|||
170597711|NCT05011513|616533915|FG000|Overall Study|Withdrawal by Subject|18|||
170597712|NCT05011513|616533916|FG001|Overall Study|Withdrawal by Subject|17|||
170597713|NCT05011513|616533915|FG000|Overall Study|Other|4|||
170597714|NCT05011513|616533916|FG001|Overall Study|Other|2|||
170597715|NCT03667690|616533917|FG000|Overall Study|Adverse Event|0|||
170597716|NCT03667690|616533918|FG001|Overall Study|Adverse Event|3|||
170597717|NCT03667690|616533917|FG000|Overall Study|Death|22|||
170597718|NCT03667690|616533918|FG001|Overall Study|Death|21|||
170597719|NCT03667690|616533917|FG000|Overall Study|Lost to Follow-up|4|||
170597720|NCT03667690|616533918|FG001|Overall Study|Lost to Follow-up|5|||
170597721|NCT03667690|616533917|FG000|Overall Study|Withdrawal by Subject|7|||
170597722|NCT03667690|616533918|FG001|Overall Study|Withdrawal by Subject|8|||
170597723|NCT03667690|616533917|FG000|Overall Study|Subject could not return for additional investigational product|1|||
170597724|NCT03667690|616533918|FG001|Overall Study|Subject could not return for additional investigational product|0|||
170597725|NCT03667690|616533917|FG000|Overall Study|Subject discharged to hospice care|2|||
170597726|NCT03667690|616533918|FG001|Overall Study|Subject discharged to hospice care|0|||
170597727|NCT03667690|616533917|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
170597728|NCT03667690|616533918|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
170597729|NCT03667690|616533917|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
170597730|NCT03667690|616533918|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
170651474|NCT00095147|616738170|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
170651475|NCT00095147|616738171|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
170651476|NCT00095147|616738172|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
170651477|NCT00095147|616738168|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
170651478|NCT00095147|616738169|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
170651479|NCT00095147|616738170|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
170651480|NCT00095147|616738171|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
170651481|NCT00095147|616738172|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
170651482|NCT00095147|616738168|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
170651483|NCT00095147|616738169|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
170651484|NCT00095147|616738170|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
170651485|NCT00095147|616738171|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
170651486|NCT00095147|616738172|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
170651487|NCT00095147|616738168|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
170651488|NCT00095147|616738169|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
170651489|NCT00095147|616738170|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
170651490|NCT00095147|616738171|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
170651491|NCT00095147|616738172|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
170651492|NCT00095147|616738168|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
170651493|NCT00095147|616738169|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
170651494|NCT00095147|616738170|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
170651495|NCT00095147|616738171|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
170651496|NCT00095147|616738172|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
170651497|NCT00095147|616738168|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
170651498|NCT00095147|616738169|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
170651499|NCT00095147|616738170|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
170651500|NCT00095147|616738171|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
170812253|NCT02691702|617321285|FG000|Overall Study|Protocol Violation|0|||
170812254|NCT02691702|617321286|FG001|Overall Study|Protocol Violation|0|||
170812255|NCT02691702|617321287|FG002|Overall Study|Protocol Violation|0|||
170812256|NCT02691702|617321288|FG003|Overall Study|Protocol Violation|0|||
170812257|NCT02691702|617321289|FG004|Overall Study|Protocol Violation|0|||
170812258|NCT02691702|617321290|FG005|Overall Study|Protocol Violation|0|||
170597731|NCT03667690|616533917|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
170597732|NCT03667690|616533918|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
170651501|NCT00095147|616738172|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
170651502|NCT00095147|616738168|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
170812259|NCT02691702|617321291|FG006|Overall Study|Protocol Violation|0|||
170812260|NCT02691702|617321292|FG007|Overall Study|Protocol Violation|0|||
170812261|NCT02691702|617321293|FG008|Overall Study|Protocol Violation|0|||
170812262|NCT02691702|617321294|FG009|Overall Study|Protocol Violation|2|||
170812263|NCT02691702|617321295|FG010|Overall Study|Protocol Violation|0|||
170812264|NCT03205488|617321296|FG000|Overall Study|Adverse Event|1|||
170812265|NCT03205488|617321297|FG001|Overall Study|Adverse Event|2|||
170812266|NCT03205488|617321298|FG002|Overall Study|Adverse Event|4|||
170812267|NCT03205488|617321296|FG000|Overall Study|Protocol Violation|0|||
170812268|NCT03205488|617321297|FG001|Overall Study|Protocol Violation|0|||
170812269|NCT03205488|617321298|FG002|Overall Study|Protocol Violation|1|||
170812270|NCT03652610|617321299|FG000|Overall Study|Lost to Follow-up|1|||
170812271|NCT03652610|617321300|FG001|Overall Study|Lost to Follow-up|0|||
170812272|NCT03652610|617321299|FG000|Overall Study|Withdrawal by Subject|3|||
170812273|NCT03652610|617321300|FG001|Overall Study|Withdrawal by Subject|5|||
170812274|NCT04867382|617321303|FG000|Overall Study|Did not complete the survey|2|||
170812275|NCT04867382|617321304|FG001|Overall Study|Did not complete the survey|1|||
170812276|NCT04821271|617321305|FG000|Period 1|Withdrawal by Subject|2|||
170812277|NCT04821271|617321306|FG001|Period 1|Withdrawal by Subject|0|||
170812278|NCT03803475|617321310|FG000|Overall Study|Physician Decision|1|||
170812279|NCT00266656|617321314|FG000|Overall Study|Death|1|||
170812280|NCT00266656|617321315|FG001|Overall Study|Death|0|||
170812281|NCT00266656|617321314|FG000|Overall Study|Lost to Follow-up|4|||
170812282|NCT00266656|617321315|FG001|Overall Study|Lost to Follow-up|1|||
170812283|NCT00266656|617321314|FG000|Overall Study|Withdrawal by Subject|4|||
170812284|NCT00266656|617321315|FG001|Overall Study|Withdrawal by Subject|2|||
170812285|NCT00266656|617321314|FG000|Overall Study|Did Not Reach Final Height|4|||
170812286|NCT00266656|617321315|FG001|Overall Study|Did Not Reach Final Height|8|||
170812287|NCT00266656|617321314|FG000|Overall Study|Parent/Caregiver Decision|1|||
170812288|NCT00266656|617321315|FG001|Overall Study|Parent/Caregiver Decision|2|||
170812289|NCT01218594|617321316|FG000|Overall Study|Death|1|||
170812290|NCT01218594|617321316|FG000|Overall Study|Withdrawal by Subject|3|||
170812291|NCT01218594|617321316|FG000|Overall Study|Adverse Event|2|||
170812292|NCT01218594|617321316|FG000|Overall Study|Physician Decision|6|||
170812293|NCT01915914|617321318|FG000|Acute Phase|Withdrawal by Subject|4|||
170812294|NCT01915914|617321319|FG001|Acute Phase|Withdrawal by Subject|0|||
170812295|NCT01915914|617321320|FG002|Acute Phase|Withdrawal by Subject|0|||
170812296|NCT01915914|617321321|FG003|Acute Phase|Withdrawal by Subject|0|||
170812297|NCT01915914|617321318|FG000|Acute Phase|Lost to Follow-up|4|||
170812298|NCT01915914|617321319|FG001|Acute Phase|Lost to Follow-up|0|||
170812299|NCT01915914|617321320|FG002|Acute Phase|Lost to Follow-up|0|||
170812300|NCT01915914|617321321|FG003|Acute Phase|Lost to Follow-up|0|||
170812301|NCT01915914|617321318|FG000|Acute Phase|Physician Decision|1|||
170812302|NCT01915914|617321319|FG001|Acute Phase|Physician Decision|0|||
170812303|NCT01915914|617321320|FG002|Acute Phase|Physician Decision|0|||
170812304|NCT01915914|617321321|FG003|Acute Phase|Physician Decision|0|||
170812305|NCT01915914|617321318|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
170812306|NCT01915914|617321319|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
170812307|NCT01915914|617321320|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
170812308|NCT01915914|617321321|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
170812309|NCT01915914|617321318|FG000|Acute Phase|"Not Achieved treatment success"|1|||
170812310|NCT01915914|617321319|FG001|Acute Phase|"Not Achieved treatment success"|0|||
170812311|NCT01915914|617321320|FG002|Acute Phase|"Not Achieved treatment success"|0|||
170812312|NCT01915914|617321321|FG003|Acute Phase|"Not Achieved treatment success"|0|||
170812313|NCT01915914|617321318|FG000|Acute Phase|Missing|1|||
170812314|NCT01915914|617321319|FG001|Acute Phase|Missing|0|||
170812315|NCT01915914|617321320|FG002|Acute Phase|Missing|0|||
170812316|NCT01915914|617321321|FG003|Acute Phase|Missing|0|||
170812317|NCT01915914|617321318|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170913461|NCT00393458|617685905|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170913462|NCT00393458|617685906|FG003|Overall Study|Abnormal laboratory value(s)|0|||
170812318|NCT01915914|617321319|FG001|Maintenance Phase|Withdrawal by Subject|1|||
170812319|NCT01915914|617321320|FG002|Maintenance Phase|Withdrawal by Subject|1|||
170913463|NCT00393458|617685903|FG000|Overall Study|Death|1|||
170913464|NCT00393458|617685904|FG001|Overall Study|Death|1|||
170913465|NCT00393458|617685905|FG002|Overall Study|Death|5|||
170913466|NCT00393458|617685906|FG003|Overall Study|Death|5|||
170913467|NCT00393458|617685903|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170913468|NCT00393458|617685904|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170913469|NCT00393458|617685905|FG002|Overall Study|Abnormal test procedure result(s)|1|||
170913470|NCT00393458|617685906|FG003|Overall Study|Abnormal test procedure result(s)|2|||
170812320|NCT01915914|617321321|FG003|Maintenance Phase|Withdrawal by Subject|0|||
170812321|NCT01915914|617321318|FG000|Maintenance Phase|Lost to Follow-up|0|||
170812322|NCT01915914|617321319|FG001|Maintenance Phase|Lost to Follow-up|4|||
170812323|NCT01915914|617321320|FG002|Maintenance Phase|Lost to Follow-up|1|||
170812324|NCT01915914|617321321|FG003|Maintenance Phase|Lost to Follow-up|0|||
170812325|NCT01915914|617321318|FG000|Maintenance Phase|Missing|0|||
170812326|NCT01915914|617321319|FG001|Maintenance Phase|Missing|1|||
170812327|NCT01915914|617321320|FG002|Maintenance Phase|Missing|0|||
170812328|NCT01915914|617321321|FG003|Maintenance Phase|Missing|0|||
170812329|NCT01915914|617321318|FG000|Follow-up Phase|Withdrawal by Subject|0|||
170812330|NCT01915914|617321319|FG001|Follow-up Phase|Withdrawal by Subject|0|||
170812331|NCT01915914|617321320|FG002|Follow-up Phase|Withdrawal by Subject|0|||
170812332|NCT01915914|617321321|FG003|Follow-up Phase|Withdrawal by Subject|1|||
170812333|NCT01915914|617321318|FG000|Follow-up Phase|Physician Decision|0|||
170812334|NCT01915914|617321319|FG001|Follow-up Phase|Physician Decision|0|||
170812335|NCT01915914|617321320|FG002|Follow-up Phase|Physician Decision|0|||
170812336|NCT01915914|617321321|FG003|Follow-up Phase|Physician Decision|1|||
170812337|NCT00428714|617321323|FG000|Overall Study|Progressive Disease|28|||
170812338|NCT00428714|617321324|FG001|Overall Study|Progressive Disease|36|||
170812339|NCT00428714|617321323|FG000|Overall Study|Withdrawal by Subject|0|||
170812340|NCT00428714|617321324|FG001|Overall Study|Withdrawal by Subject|3|||
170812341|NCT00428714|617321323|FG000|Overall Study|Adverse Event|0|||
170812342|NCT00428714|617321324|FG001|Overall Study|Adverse Event|2|||
170812343|NCT00428714|617321323|FG000|Overall Study|Physician Decision|1|||
170812344|NCT00428714|617321324|FG001|Overall Study|Physician Decision|1|||
170812345|NCT00428714|617321323|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
170812346|NCT00428714|617321324|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
170812347|NCT00428714|617321323|FG000|Overall Study|Death due to other then PD|1|||
170812348|NCT00428714|617321324|FG001|Overall Study|Death due to other then PD|0|||
170812349|NCT00513071|617321325|FG000|Overall Study|Adverse Event|1|||
170812350|NCT00513071|617321325|FG000|Overall Study|Withdrawal by Subject|1|||
170812351|NCT00513071|617321325|FG000|Overall Study|Physician Decision|3|||
170812352|NCT00667732|617321326|FG000|Run -In (8 Weeks)|Adverse Event|4|||
170812353|NCT00667732|617321327|FG001|Run -In (8 Weeks)|Adverse Event|0|||
170812354|NCT00667732|617321328|FG002|Run -In (8 Weeks)|Adverse Event|0|||
170812355|NCT00667732|617321326|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
170812356|NCT00667732|617321327|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
170812357|NCT00667732|617321328|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
170812358|NCT00667732|617321326|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
170812359|NCT00667732|617321327|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
170812360|NCT00667732|617321328|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
170812361|NCT02106325|617321329|FG000|Phase 1|Lost to Follow-up|2|||
170812362|NCT02106325|617321330|FG001|Phase 1|Lost to Follow-up|2|||
170812363|NCT02106325|617321329|FG000|Phase 2|Lost to Follow-up|2|||
170812364|NCT02106325|617321330|FG001|Phase 2|Lost to Follow-up|3|||
170812365|NCT02106325|617321329|FG000|Phase 3|Lost to Follow-up|2|||
170812366|NCT02106325|617321330|FG001|Phase 3|Lost to Follow-up|1|||
170812367|NCT00452114|617321331|FG000|Overall Study|Physician Decision|3|||
170812368|NCT00452114|617321332|FG001|Overall Study|Physician Decision|3|||
170812369|NCT02144285|617321338|FG000|Overall Study|Withdrawal by Subject|0|||
170812370|NCT02144285|617321339|FG001|Overall Study|Withdrawal by Subject|0|||
170812371|NCT02144285|617321340|FG002|Overall Study|Withdrawal by Subject|0|||
170812372|NCT02144285|617321341|FG003|Overall Study|Withdrawal by Subject|0|||
170812373|NCT02144285|617321342|FG004|Overall Study|Withdrawal by Subject|1|||
170812374|NCT02144285|617321343|FG005|Overall Study|Withdrawal by Subject|0|||
170812375|NCT02144285|617321344|FG006|Overall Study|Withdrawal by Subject|0|||
170812376|NCT02144285|617321345|FG007|Overall Study|Withdrawal by Subject|0|||
170812377|NCT02144285|617321346|FG008|Overall Study|Withdrawal by Subject|0|||
170812378|NCT02144285|617321347|FG009|Overall Study|Withdrawal by Subject|0|||
170812379|NCT04602728|617321350|FG000|Overall Study|Lost to Follow-up|4|||
170812380|NCT04602728|617321351|FG001|Overall Study|Lost to Follow-up|4|||
170812381|NCT02485925|617321366|FG000|Overall Study|Withdrawal by Subject|3|||
170812382|NCT02485925|617321366|FG000|Overall Study|Death|1|||
170812383|NCT02485925|617321366|FG000|Overall Study|Lost to Follow-up|11|||
170812384|NCT00747149|617322599|FG000|Overall Study|Adverse Event|0|||
170812385|NCT00747149|617322600|FG001|Overall Study|Adverse Event|15|||
170812386|NCT00747149|617322599|FG000|Overall Study|Lost to Follow-up|0|||
170812387|NCT00747149|617322600|FG001|Overall Study|Lost to Follow-up|10|||
170812388|NCT00747149|617322599|FG000|Overall Study|Withdrawal by Subject|0|||
170812389|NCT00747149|617322600|FG001|Overall Study|Withdrawal by Subject|6|||
170812390|NCT00747149|617322599|FG000|Overall Study|Did not receive treatment|0|||
170913471|NCT00393458|617685903|FG000|Overall Study|Subject no longer requires study drug|0|||
170597733|NCT03667690|616533917|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
170597734|NCT03667690|616533918|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
170812391|NCT00747149|617322600|FG001|Overall Study|Did not receive treatment|1|||
170812392|NCT00747149|617322599|FG000|Overall Study|Incorrect enrollment|0|||
170812393|NCT00747149|617322600|FG001|Overall Study|Incorrect enrollment|6|||
170812394|NCT00747149|617322599|FG000|Overall Study|Severe non-compliance to protocol|0|||
170812395|NCT00747149|617322600|FG001|Overall Study|Severe non-compliance to protocol|1|||
170812396|NCT00747149|617322599|FG000|Overall Study|Not reported|1|||
170812397|NCT00747149|617322600|FG001|Overall Study|Not reported|4|||
170812398|NCT05006703|617322601|FG000|Overall Study|Withdrawal by Subject|1|||
170812399|NCT05006703|617322602|FG001|Overall Study|Withdrawal by Subject|0|||
170812400|NCT05006703|617322601|FG000|Overall Study|Lost to Follow-up|13|||
170812401|NCT05006703|617322602|FG001|Overall Study|Lost to Follow-up|5|||
170812402|NCT00443820|617322603|FG000|Overall Study|Adverse Event|1|||
170597735|NCT03667690|616533917|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
170597736|NCT03667690|616533918|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
170597737|NCT01350115|616533919|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
170597738|NCT01350115|616533920|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
170597739|NCT01350115|616533919|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
170597740|NCT01350115|616533920|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
170597741|NCT01350115|616533919|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
170597742|NCT01350115|616533920|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
170597743|NCT04327024|616533921|FG000|Overall Study|Death|1|||
170597744|NCT04327024|616533922|FG001|Overall Study|Death|2|||
170597745|NCT04327024|616533923|FG002|Overall Study|Death|1|||
170597746|NCT04327024|616533921|FG000|Overall Study|Non-compliance with study drug|0|||
170597747|NCT04327024|616533922|FG001|Overall Study|Non-compliance with study drug|1|||
170597748|NCT04327024|616533923|FG002|Overall Study|Non-compliance with study drug|0|||
170651503|NCT00095147|616738169|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
170651504|NCT00095147|616738170|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
170651505|NCT00095147|616738171|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
170651506|NCT00095147|616738172|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
170651507|NCT00095147|616738168|FG000|Long-term Extension Period|Death|0|||
170651508|NCT00095147|616738169|FG001|Long-term Extension Period|Death|0|||
170651509|NCT00095147|616738170|FG002|Long-term Extension Period|Death|0|||
170651510|NCT00095147|616738171|FG003|Long-term Extension Period|Death|0|||
170651511|NCT00095147|616738172|FG004|Long-term Extension Period|Death|3|||
170651512|NCT00095147|616738168|FG000|Long-term Extension Period|Adverse Event|0|||
170651513|NCT00095147|616738169|FG001|Long-term Extension Period|Adverse Event|0|||
170651514|NCT00095147|616738170|FG002|Long-term Extension Period|Adverse Event|0|||
170651515|NCT00095147|616738171|FG003|Long-term Extension Period|Adverse Event|0|||
170651516|NCT00095147|616738172|FG004|Long-term Extension Period|Adverse Event|11|||
170651517|NCT00095147|616738168|FG000|Long-term Extension Period|Lack of Efficacy|0|||
170651518|NCT00095147|616738169|FG001|Long-term Extension Period|Lack of Efficacy|0|||
170651519|NCT00095147|616738170|FG002|Long-term Extension Period|Lack of Efficacy|0|||
170651520|NCT00095147|616738171|FG003|Long-term Extension Period|Lack of Efficacy|0|||
170651521|NCT00095147|616738172|FG004|Long-term Extension Period|Lack of Efficacy|9|||
170651522|NCT00095147|616738168|FG000|Long-term Extension Period|Lost to Follow-up|0|||
170651523|NCT00095147|616738169|FG001|Long-term Extension Period|Lost to Follow-up|0|||
170651524|NCT00095147|616738170|FG002|Long-term Extension Period|Lost to Follow-up|0|||
170651525|NCT00095147|616738171|FG003|Long-term Extension Period|Lost to Follow-up|0|||
170651526|NCT00095147|616738172|FG004|Long-term Extension Period|Lost to Follow-up|6|||
170651527|NCT00095147|616738168|FG000|Long-term Extension Period|Withdrawal of consent|0|||
170651528|NCT00095147|616738169|FG001|Long-term Extension Period|Withdrawal of consent|0|||
170651529|NCT00095147|616738170|FG002|Long-term Extension Period|Withdrawal of consent|0|||
170651530|NCT00095147|616738171|FG003|Long-term Extension Period|Withdrawal of consent|0|||
170651531|NCT00095147|616738172|FG004|Long-term Extension Period|Withdrawal of consent|12|||
170651532|NCT00095147|616738168|FG000|Long-term Extension Period|Pregnancy|0|||
170651533|NCT00095147|616738169|FG001|Long-term Extension Period|Pregnancy|0|||
170651534|NCT00095147|616738170|FG002|Long-term Extension Period|Pregnancy|0|||
170651535|NCT00095147|616738171|FG003|Long-term Extension Period|Pregnancy|0|||
170651536|NCT00095147|616738172|FG004|Long-term Extension Period|Pregnancy|1|||
170651537|NCT00095147|616738168|FG000|Long-term Extension Period|No longer meets study criteria|0|||
170651538|NCT00095147|616738169|FG001|Long-term Extension Period|No longer meets study criteria|0|||
170651539|NCT00095147|616738170|FG002|Long-term Extension Period|No longer meets study criteria|0|||
170651540|NCT00095147|616738171|FG003|Long-term Extension Period|No longer meets study criteria|0|||
170651541|NCT00095147|616738172|FG004|Long-term Extension Period|No longer meets study criteria|1|||
170651542|NCT00095147|616738168|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
170651543|NCT00095147|616738169|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
170651544|NCT00095147|616738170|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
170651545|NCT00095147|616738171|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
170651546|NCT00095147|616738172|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
170651547|NCT00095147|616738168|FG000|Long-term Extension Period|Leaving country|0|||
170651548|NCT00095147|616738169|FG001|Long-term Extension Period|Leaving country|0|||
170651549|NCT00095147|616738170|FG002|Long-term Extension Period|Leaving country|0|||
170651550|NCT00095147|616738171|FG003|Long-term Extension Period|Leaving country|0|||
170651551|NCT00095147|616738172|FG004|Long-term Extension Period|Leaving country|1|||
170651552|NCT02395302|616738173|FG000|Overall Study|Screen Failure|3|||
170651553|NCT02395302|616738173|FG000|Overall Study|Run In Failure|7|||
170651554|NCT02395302|616738173|FG000|Overall Study|Withdrawal by Subject|2|||
170651555|NCT02395302|616738173|FG000|Overall Study|Physician Decision|2|||
170651556|NCT04604132|616738174|FG000|Overall Study|Adverse Event|2|||
170651557|NCT04604132|616738175|FG001|Overall Study|Adverse Event|0|||
170651558|NCT04604132|616738176|FG002|Overall Study|Adverse Event|0|||
170597749|NCT04327024|616533921|FG000|Overall Study|Withdrawal by Subject|1|||
170597750|NCT04327024|616533922|FG001|Overall Study|Withdrawal by Subject|1|||
170597751|NCT04327024|616533923|FG002|Overall Study|Withdrawal by Subject|2|||
170597752|NCT04744831|616533927|FG000|Overall Study|Adverse Event|6|||
170597753|NCT04744831|616533928|FG001|Overall Study|Adverse Event|4|||
170597754|NCT04744831|616533927|FG000|Overall Study|Clinical Progression|5|||
170597755|NCT04744831|616533928|FG001|Overall Study|Clinical Progression|5|||
170597756|NCT04744831|616533927|FG000|Overall Study|Death|2|||
170597757|NCT04744831|616533928|FG001|Overall Study|Death|1|||
170597758|NCT04744831|616533927|FG000|Overall Study|Other|5|||
170597759|NCT04744831|616533928|FG001|Overall Study|Other|1|||
170597760|NCT04744831|616533927|FG000|Overall Study|Progressive Disease|63|||
170597761|NCT04744831|616533928|FG001|Overall Study|Progressive Disease|29|||
170597762|NCT04744831|616533927|FG000|Overall Study|Withdrawal by Subject|1|||
170597763|NCT04744831|616533928|FG001|Overall Study|Withdrawal by Subject|0|||
170597764|NCT05818137|616533929|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
170597765|NCT05818137|616533929|FG000|Extension Treatment Period|Ongoing participants|44|||
170597766|NCT05925374|616533932|FG000|Overall Study|Lost to Follow-up|13|||
170597767|NCT03320330|616533933|FG000|Overall Study|Lack of Efficacy|5|||
170597768|NCT03320330|616533934|FG001|Overall Study|Lack of Efficacy|5|||
170597769|NCT03320330|616533935|FG002|Overall Study|Lack of Efficacy|14|||
170597770|NCT03320330|616533933|FG000|Overall Study|Physician Decision|1|||
170597771|NCT03320330|616533934|FG001|Overall Study|Physician Decision|0|||
170597772|NCT03320330|616533935|FG002|Overall Study|Physician Decision|0|||
170597773|NCT03323736|616533936|FG000|Overall Study|Screen Failure|14|||
170597774|NCT03323736|616533937|FG001|Overall Study|Screen Failure|9|||
170597775|NCT03323736|616533938|FG002|Overall Study|Screen Failure|1|||
170597776|NCT03323736|616533936|FG000|Overall Study|Withdrawal Before Treatment|3|||
170597777|NCT03323736|616533937|FG001|Overall Study|Withdrawal Before Treatment|1|||
170597778|NCT03323736|616533938|FG002|Overall Study|Withdrawal Before Treatment|1|||
170597779|NCT03323736|616533936|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
170597780|NCT03323736|616533937|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
170597781|NCT03323736|616533938|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
170597782|NCT05206370|616533942|FG000|Overall Study|Adverse Event|3|||
170597783|NCT05206370|616533943|FG001|Overall Study|Adverse Event|4|||
170597784|NCT05206370|616533944|FG002|Overall Study|Adverse Event|5|||
170597785|NCT05206370|616533942|FG000|Overall Study|Withdrawal by Subject|27|||
170597786|NCT05206370|616533943|FG001|Overall Study|Withdrawal by Subject|30|||
170597787|NCT05206370|616533944|FG002|Overall Study|Withdrawal by Subject|24|||
170597788|NCT05206370|616533942|FG000|Overall Study|Physician Decision|1|||
170597789|NCT05206370|616533943|FG001|Overall Study|Physician Decision|3|||
170597790|NCT05206370|616533944|FG002|Overall Study|Physician Decision|2|||
170597791|NCT05206370|616533942|FG000|Overall Study|Death|0|||
170597792|NCT05206370|616533943|FG001|Overall Study|Death|1|||
170597793|NCT05206370|616533944|FG002|Overall Study|Death|3|||
170597794|NCT05206370|616533942|FG000|Overall Study|Lost to Follow-up|23|||
170597795|NCT05206370|616533943|FG001|Overall Study|Lost to Follow-up|16|||
170597796|NCT05206370|616533944|FG002|Overall Study|Lost to Follow-up|14|||
170597797|NCT05206370|616533942|FG000|Overall Study|Other, Nor Specified|2|||
170597798|NCT05206370|616533943|FG001|Overall Study|Other, Nor Specified|2|||
170597799|NCT05206370|616533944|FG002|Overall Study|Other, Nor Specified|4|||
170597800|NCT04998851|616533945|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
170597801|NCT04998851|616533946|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
170597802|NCT04998851|616533945|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
170597803|NCT04998851|616533946|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
170597804|NCT03199391|616533951|FG000|Overall Study|Death|1|||
170597805|NCT03199391|616533951|FG000|Overall Study|Lost to Follow-up|3|||
170597806|NCT03199391|616533951|FG000|Overall Study|Adverse Event|2|||
170597807|NCT03199391|616533951|FG000|Overall Study|Withdrawal by Subject|10|||
170597808|NCT06036914|616533952|FG000|Overall Study|Withdrawal by Subject|1|||
170597809|NCT06036914|616533953|FG001|Overall Study|Withdrawal by Subject|0|||
170597810|NCT04697381|616533954|FG000|Extension Period|Adverse Event|0|||
170597811|NCT04697381|616533955|FG001|Extension Period|Adverse Event|0|||
170597812|NCT04697381|616533956|FG002|Extension Period|Adverse Event|3|||
170597813|NCT04697381|616533954|FG000|Extension Period|Physician Decision|0|||
170597814|NCT04697381|616533955|FG001|Extension Period|Physician Decision|0|||
170597815|NCT04697381|616533956|FG002|Extension Period|Physician Decision|2|||
170597816|NCT04697381|616533954|FG000|Extension Period|Other|0|||
170597817|NCT04697381|616533955|FG001|Extension Period|Other|0|||
170597818|NCT04697381|616533956|FG002|Extension Period|Other|1|||
170597819|NCT05702918|616533961|FG000|Overall Study|Withdrawal by Subject|0|||
170597820|NCT05702918|616533962|FG001|Overall Study|Withdrawal by Subject|2|||
170597821|NCT05702918|616533961|FG000|Overall Study|Lost to Follow-up|0|||
170597822|NCT05702918|616533962|FG001|Overall Study|Lost to Follow-up|2|||
170597823|NCT05702918|616533961|FG000|Overall Study|Unrelated injury|2|||
170597824|NCT05702918|616533962|FG001|Overall Study|Unrelated injury|0|||
170597825|NCT03500172|616533966|FG000|Period 1: Baseline Randomization|Death|0|||
170597826|NCT03500172|616533967|FG001|Period 1: Baseline Randomization|Death|0|||
170597827|NCT03500172|616533968|FG002|Period 1: Baseline Randomization|Death|0|||
170597828|NCT03500172|616533969|FG003|Period 1: Baseline Randomization|Death|0|||
170597829|NCT03500172|616533970|FG004|Period 1: Baseline Randomization|Death|0|||
170597830|NCT03500172|616533971|FG005|Period 1: Baseline Randomization|Death|0|||
170597831|NCT03500172|616533972|FG006|Period 1: Baseline Randomization|Death|0|||
170597832|NCT03500172|616533973|FG007|Period 1: Baseline Randomization|Death|0|||
170597833|NCT03500172|616533974|FG008|Period 1: Baseline Randomization|Death|0|||
170597834|NCT03500172|616533975|FG009|Period 1: Baseline Randomization|Death|2|||
170597835|NCT03500172|616533976|FG010|Period 1: Baseline Randomization|Death|0|||
170597836|NCT03500172|616533966|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
170597837|NCT03500172|616533967|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
170597838|NCT03500172|616533968|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
170597839|NCT03500172|616533969|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
170597840|NCT03500172|616533970|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
170597841|NCT03500172|616533971|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
170597842|NCT03500172|616533972|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
170597843|NCT03500172|616533973|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
170597844|NCT03500172|616533974|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
170597845|NCT03500172|616533975|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
170597846|NCT03500172|616533976|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
170597847|NCT03500172|616533966|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
170597848|NCT03500172|616533967|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
170597849|NCT03500172|616533968|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
170597850|NCT03500172|616533969|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
170597851|NCT03500172|616533970|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
170597852|NCT03500172|616533971|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
170597853|NCT03500172|616533972|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
170597854|NCT03500172|616533973|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
170597855|NCT03500172|616533974|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
170597856|NCT03500172|616533975|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
170597857|NCT03500172|616533976|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
170597858|NCT03500172|616533966|FG000|Period 2: Re-Randomization|Death|0|||
170597859|NCT03500172|616533967|FG001|Period 2: Re-Randomization|Death|0|||
170597860|NCT03500172|616533968|FG002|Period 2: Re-Randomization|Death|0|||
170597861|NCT03500172|616533969|FG003|Period 2: Re-Randomization|Death|4|||
170597862|NCT03500172|616533970|FG004|Period 2: Re-Randomization|Death|2|||
170597863|NCT03500172|616533971|FG005|Period 2: Re-Randomization|Death|0|||
170597864|NCT03500172|616533972|FG006|Period 2: Re-Randomization|Death|5|||
170597865|NCT03500172|616533973|FG007|Period 2: Re-Randomization|Death|2|||
170597866|NCT03500172|616533974|FG008|Period 2: Re-Randomization|Death|0|||
170597867|NCT03500172|616533975|FG009|Period 2: Re-Randomization|Death|0|||
170597868|NCT03500172|616533976|FG010|Period 2: Re-Randomization|Death|0|||
170597869|NCT03298451|616533983|FG000|Overall Study|Death|275|||
170597870|NCT03298451|616533984|FG001|Overall Study|Death|260|||
170597871|NCT03298451|616533985|FG002|Overall Study|Death|122|||
170812403|NCT00443820|617322604|FG001|Overall Study|Adverse Event|1|||
170812404|NCT00443820|617322605|FG002|Overall Study|Adverse Event|0|||
170597872|NCT03298451|616533986|FG003|Overall Study|Death|280|||
170597873|NCT03298451|616533983|FG000|Overall Study|Lost to Follow-up|1|||
170597874|NCT03298451|616533984|FG001|Overall Study|Lost to Follow-up|1|||
170597875|NCT03298451|616533985|FG002|Overall Study|Lost to Follow-up|0|||
170597876|NCT03298451|616533986|FG003|Overall Study|Lost to Follow-up|7|||
170597877|NCT03298451|616533983|FG000|Overall Study|Withdrawal by Subject|9|||
170597878|NCT03298451|616533984|FG001|Overall Study|Withdrawal by Subject|7|||
170913472|NCT00393458|617685904|FG001|Overall Study|Subject no longer requires study drug|1|||
170913473|NCT00393458|617685905|FG002|Overall Study|Subject no longer requires study drug|0|||
170597879|NCT03298451|616533985|FG002|Overall Study|Withdrawal by Subject|1|||
170597880|NCT03298451|616533986|FG003|Overall Study|Withdrawal by Subject|20|||
170597881|NCT03106415|616533989|FG000|Phase 1|Withdrawal by Subject|1|||
170597882|NCT03106415|616533990|FG001|Phase 1|Withdrawal by Subject|0|||
170597883|NCT03106415|616533991|FG002|Phase 1|Withdrawal by Subject|0|||
170597884|NCT03106415|616533989|FG000|Phase 1|Adverse Event|1|||
170597885|NCT03106415|616533990|FG001|Phase 1|Adverse Event|1|||
170597886|NCT03106415|616533991|FG002|Phase 1|Adverse Event|0|||
170597887|NCT03106415|616533989|FG000|Phase 1|Protocol Violation|0|||
170597888|NCT03106415|616533990|FG001|Phase 1|Protocol Violation|1|||
170597889|NCT03106415|616533991|FG002|Phase 1|Protocol Violation|0|||
170597890|NCT04522973|616533992|FG000|Overall Study|Lost to Follow-up|4|||
170597891|NCT04522973|616533992|FG000|Overall Study|Could not adhere to study schedule|1|||
170597892|NCT03573401|616533993|FG000|Overall Study|Withdrawal by Subject|2|||
170597893|NCT03573401|616533994|FG001|Overall Study|Withdrawal by Subject|0|||
170597894|NCT03573401|616533993|FG000|Overall Study|Subject non-compliance with study schedule|1|||
170597895|NCT03573401|616533994|FG001|Overall Study|Subject non-compliance with study schedule|0|||
170597896|NCT03573401|616533993|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
170597897|NCT03573401|616533994|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
170597898|NCT03573401|616533993|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
170597899|NCT03573401|616533994|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
170597900|NCT03968159|616533995|FG000|Overall Study|Adverse Event|4|||
170597901|NCT03968159|616533996|FG001|Overall Study|Adverse Event|4|||
170597902|NCT03968159|616533995|FG000|Overall Study|Lost to Follow-up|1|||
170597903|NCT03968159|616533996|FG001|Overall Study|Lost to Follow-up|1|||
170597904|NCT03968159|616533995|FG000|Overall Study|Use of prohibited medication|0|||
170597905|NCT03968159|616533996|FG001|Overall Study|Use of prohibited medication|1|||
170597906|NCT03968159|616533995|FG000|Overall Study|Protocol Violation|2|||
170597907|NCT03968159|616533996|FG001|Overall Study|Protocol Violation|2|||
170597908|NCT03968159|616533995|FG000|Overall Study|Withdrawal by Subject|4|||
170597909|NCT03968159|616533996|FG001|Overall Study|Withdrawal by Subject|6|||
170597910|NCT03968159|616533995|FG000|Overall Study|Lack of Efficacy|0|||
170597911|NCT03968159|616533996|FG001|Overall Study|Lack of Efficacy|1|||
170597912|NCT03968159|616533995|FG000|Overall Study|Not further specified|2|||
170597913|NCT03968159|616533996|FG001|Overall Study|Not further specified|0|||
170597914|NCT05579249|616533997|FG000|Overall Study|Withdrawal by Subject|1|||
170597915|NCT05579249|616533998|FG001|Overall Study|Withdrawal by Subject|3|||
170913474|NCT00393458|617685906|FG003|Overall Study|Subject no longer requires study drug|0|||
170913475|NCT01282814|617685913|FG000|First Intervention|Emesis During Dosing Interval|0|||
170913476|NCT01282814|617685914|FG001|First Intervention|Emesis During Dosing Interval|3|||
170597916|NCT05579249|616533997|FG000|Overall Study|Lost to Follow-up|33|||
170597917|NCT05579249|616533998|FG001|Overall Study|Lost to Follow-up|52|||
170597918|NCT05579249|616533997|FG000|Overall Study|Physician Decision|2|||
170597919|NCT05579249|616533998|FG001|Overall Study|Physician Decision|2|||
170597920|NCT05579249|616533997|FG000|Overall Study|Death|0|||
170597921|NCT05579249|616533998|FG001|Overall Study|Death|2|||
170597922|NCT01299571|616533999|FG000|Overall Study|Protocol Violation|107|||
170597923|NCT00864851|616534000|FG000|Overall Study|Withdrawal by Subject|0|||
170597924|NCT00864851|616534001|FG001|Overall Study|Withdrawal by Subject|1|||
170597925|NCT00864851|616534002|FG002|Overall Study|Withdrawal by Subject|0|||
170597926|NCT00864851|616534000|FG000|Overall Study|Physician Decision|1|||
170597927|NCT00864851|616534001|FG001|Overall Study|Physician Decision|0|||
170597928|NCT00864851|616534002|FG002|Overall Study|Physician Decision|0|||
170597929|NCT00864851|616534000|FG000|Overall Study|Death|1|||
170597930|NCT00864851|616534001|FG001|Overall Study|Death|0|||
170597931|NCT00864851|616534002|FG002|Overall Study|Death|0|||
170597932|NCT00864851|616534000|FG000|Overall Study|Patient uncooperative|1|||
170597933|NCT00864851|616534001|FG001|Overall Study|Patient uncooperative|0|||
170597934|NCT00864851|616534002|FG002|Overall Study|Patient uncooperative|0|||
170597935|NCT00443781|616534003|FG000|Overall Study|Lost to Follow-up|10|||
170597936|NCT00443781|616534003|FG000|Overall Study|Physician Decision|2|||
170597937|NCT00443781|616534003|FG000|Overall Study|Protocol Violation|1|||
170913477|NCT01282814|617685913|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
170913478|NCT01282814|617685914|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
170597938|NCT00443781|616534003|FG000|Overall Study|Withdrawal by Subject|6|||
170597939|NCT00443781|616534003|FG000|Overall Study|Unable to comply with study follow up|2|||
170597940|NCT00443781|616534003|FG000|Overall Study|Investigator terminated participation|1|||
170597941|NCT00443781|616534003|FG000|Overall Study|Insurance not covered|2|||
170597942|NCT00443781|616534003|FG000|Overall Study|PD/FAD not done|1|||
170597943|NCT00430937|616534004|FG000|Overall Study|Adverse Event|3|||
170597944|NCT00430937|616534005|FG001|Overall Study|Adverse Event|8|||
170597945|NCT00430937|616534004|FG000|Overall Study|Death|0|||
170597946|NCT00430937|616534005|FG001|Overall Study|Death|1|||
170597947|NCT00430937|616534004|FG000|Overall Study|Lost to Follow-up|6|||
170597948|NCT00430937|616534005|FG001|Overall Study|Lost to Follow-up|6|||
170597949|NCT00430937|616534004|FG000|Overall Study|Withdrawal by Subject|5|||
170597950|NCT00430937|616534005|FG001|Overall Study|Withdrawal by Subject|2|||
170597951|NCT00430937|616534004|FG000|Overall Study|Protocol Violation|3|||
170597952|NCT00430937|616534005|FG001|Overall Study|Protocol Violation|2|||
170597953|NCT00430937|616534004|FG000|Overall Study|Lack of Efficacy|6|||
170597954|NCT00430937|616534005|FG001|Overall Study|Lack of Efficacy|5|||
170597955|NCT00430937|616534004|FG000|Overall Study|Inappropriate enrollment|2|||
170597956|NCT00430937|616534005|FG001|Overall Study|Inappropriate enrollment|1|||
170597957|NCT00430937|616534004|FG000|Overall Study|Administrative reasons|1|||
170597958|NCT00430937|616534005|FG001|Overall Study|Administrative reasons|0|||
170597959|NCT00430937|616534004|FG000|Overall Study|Protocol discontinuation criteria met|1|||
170597960|NCT00430937|616534005|FG001|Overall Study|Protocol discontinuation criteria met|2|||
170597961|NCT00430937|616534004|FG000|Overall Study|Unable to classify|0|||
170597962|NCT00430937|616534005|FG001|Overall Study|Unable to classify|1|||
170597963|NCT02124772|616534006|FG000|Overall Study|Lack of Efficacy|2|||
170597964|NCT02124772|616534007|FG001|Overall Study|Lack of Efficacy|0|||
170597965|NCT02124772|616534008|FG002|Overall Study|Lack of Efficacy|0|||
170597966|NCT02124772|616534009|FG003|Overall Study|Lack of Efficacy|1|||
170597967|NCT02124772|616534010|FG004|Overall Study|Lack of Efficacy|2|||
170597968|NCT02124772|616534011|FG005|Overall Study|Lack of Efficacy|3|||
170597969|NCT02124772|616534012|FG006|Overall Study|Lack of Efficacy|0|||
170597970|NCT02124772|616534013|FG007|Overall Study|Lack of Efficacy|2|||
170597971|NCT02124772|616534014|FG008|Overall Study|Lack of Efficacy|0|||
170597972|NCT02124772|616534015|FG009|Overall Study|Lack of Efficacy|1|||
170597973|NCT02124772|616534016|FG010|Overall Study|Lack of Efficacy|0|||
170597974|NCT02124772|616534017|FG011|Overall Study|Lack of Efficacy|0|||
170597975|NCT02124772|616534018|FG012|Overall Study|Lack of Efficacy|1|||
170597976|NCT02124772|616534006|FG000|Overall Study|Adverse Event|1|||
170597977|NCT02124772|616534007|FG001|Overall Study|Adverse Event|4|||
170597978|NCT02124772|616534008|FG002|Overall Study|Adverse Event|1|||
170651559|NCT04604132|616738177|FG003|Overall Study|Adverse Event|1|||
170651560|NCT04604132|616738178|FG004|Overall Study|Adverse Event|2|||
170651561|NCT04604132|616738174|FG000|Overall Study|Study terminated by sponsor|0|||
170651562|NCT04604132|616738175|FG001|Overall Study|Study terminated by sponsor|0|||
170651563|NCT04604132|616738176|FG002|Overall Study|Study terminated by sponsor|0|||
170651564|NCT04604132|616738177|FG003|Overall Study|Study terminated by sponsor|0|||
170651565|NCT04604132|616738178|FG004|Overall Study|Study terminated by sponsor|1|||
170651566|NCT04604132|616738174|FG000|Overall Study|Progressive disease: Clinical progression|0|||
170651567|NCT04604132|616738175|FG001|Overall Study|Progressive disease: Clinical progression|0|||
170651568|NCT04604132|616738176|FG002|Overall Study|Progressive disease: Clinical progression|1|||
170651569|NCT04604132|616738177|FG003|Overall Study|Progressive disease: Clinical progression|0|||
170651570|NCT04604132|616738178|FG004|Overall Study|Progressive disease: Clinical progression|0|||
170651571|NCT04604132|616738174|FG000|Overall Study|Progressive disease: Radiological progression|8|||
170651572|NCT04604132|616738175|FG001|Overall Study|Progressive disease: Radiological progression|7|||
170651573|NCT04604132|616738176|FG002|Overall Study|Progressive disease: Radiological progression|10|||
170651574|NCT04604132|616738177|FG003|Overall Study|Progressive disease: Radiological progression|4|||
170651575|NCT04604132|616738178|FG004|Overall Study|Progressive disease: Radiological progression|3|||
170812405|NCT00443820|617322606|FG003|Overall Study|Adverse Event|0|||
170812406|NCT00443820|617322603|FG000|Overall Study|Lack of Efficacy|3|||
170812407|NCT00443820|617322604|FG001|Overall Study|Lack of Efficacy|2|||
170812408|NCT00443820|617322605|FG002|Overall Study|Lack of Efficacy|1|||
170812409|NCT00443820|617322606|FG003|Overall Study|Lack of Efficacy|1|||
170812410|NCT00443820|617322603|FG000|Overall Study|Protocol Violation|2|||
170812411|NCT00443820|617322604|FG001|Overall Study|Protocol Violation|1|||
170812412|NCT00443820|617322605|FG002|Overall Study|Protocol Violation|2|||
170812413|NCT00443820|617322606|FG003|Overall Study|Protocol Violation|1|||
170812414|NCT00443820|617322603|FG000|Overall Study|Withdrawal by Subject|6|||
170597979|NCT02124772|616534009|FG003|Overall Study|Adverse Event|5|||
170597980|NCT02124772|616534010|FG004|Overall Study|Adverse Event|2|||
170597981|NCT02124772|616534011|FG005|Overall Study|Adverse Event|1|||
170651576|NCT04604132|616738174|FG000|Overall Study|Death|3|||
170651577|NCT04604132|616738175|FG001|Overall Study|Death|1|||
170651578|NCT04604132|616738176|FG002|Overall Study|Death|2|||
170651579|NCT04604132|616738177|FG003|Overall Study|Death|1|||
170651580|NCT04604132|616738178|FG004|Overall Study|Death|0|||
170812415|NCT00443820|617322604|FG001|Overall Study|Withdrawal by Subject|7|||
170597982|NCT02124772|616534012|FG006|Overall Study|Adverse Event|1|||
170597983|NCT02124772|616534013|FG007|Overall Study|Adverse Event|5|||
170597984|NCT02124772|616534014|FG008|Overall Study|Adverse Event|0|||
170597985|NCT02124772|616534015|FG009|Overall Study|Adverse Event|3|||
170597986|NCT02124772|616534016|FG010|Overall Study|Adverse Event|1|||
170651581|NCT00952380|616738179|FG000|Overall Study|Other|0|||
170651582|NCT00952380|616738180|FG001|Overall Study|Other|0|||
170651583|NCT00952380|616738181|FG002|Overall Study|Other|0|||
170812416|NCT00443820|617322605|FG002|Overall Study|Withdrawal by Subject|8|||
170597987|NCT02124772|616534017|FG011|Overall Study|Adverse Event|3|||
170812417|NCT00443820|617322606|FG003|Overall Study|Withdrawal by Subject|9|||
170812418|NCT00443820|617322603|FG000|Overall Study|Lost to Follow-up|9|||
170812419|NCT00443820|617322604|FG001|Overall Study|Lost to Follow-up|8|||
170812420|NCT00443820|617322605|FG002|Overall Study|Lost to Follow-up|6|||
170812421|NCT00443820|617322606|FG003|Overall Study|Lost to Follow-up|5|||
170812422|NCT00443820|617322603|FG000|Overall Study|Administrative problems|0|||
170812423|NCT00443820|617322604|FG001|Overall Study|Administrative problems|0|||
170812424|NCT00443820|617322605|FG002|Overall Study|Administrative problems|0|||
170812425|NCT00443820|617322606|FG003|Overall Study|Administrative problems|1|||
170812426|NCT00443820|617322603|FG000|Overall Study|Death|0|||
170812427|NCT00443820|617322604|FG001|Overall Study|Death|0|||
170812428|NCT00443820|617322605|FG002|Overall Study|Death|1|||
170812429|NCT00443820|617322606|FG003|Overall Study|Death|0|||
170913479|NCT02704429|617685923|FG000|Part A: 24 Weeks|Adverse Event|3|||
170913480|NCT02704429|617685924|FG001|Part A: 24 Weeks|Adverse Event|0|||
170597988|NCT02124772|616534018|FG012|Overall Study|Adverse Event|1|||
170597989|NCT02124772|616534006|FG000|Overall Study|Withdrawal consent|0|||
170597990|NCT02124772|616534007|FG001|Overall Study|Withdrawal consent|1|||
170597991|NCT02124772|616534008|FG002|Overall Study|Withdrawal consent|1|||
170597992|NCT02124772|616534009|FG003|Overall Study|Withdrawal consent|1|||
170597993|NCT02124772|616534010|FG004|Overall Study|Withdrawal consent|0|||
170597994|NCT02124772|616534011|FG005|Overall Study|Withdrawal consent|1|||
170597995|NCT02124772|616534012|FG006|Overall Study|Withdrawal consent|1|||
170597996|NCT02124772|616534013|FG007|Overall Study|Withdrawal consent|0|||
170597997|NCT02124772|616534014|FG008|Overall Study|Withdrawal consent|0|||
170597998|NCT02124772|616534015|FG009|Overall Study|Withdrawal consent|1|||
170597999|NCT02124772|616534016|FG010|Overall Study|Withdrawal consent|0|||
170598000|NCT02124772|616534017|FG011|Overall Study|Withdrawal consent|1|||
170598001|NCT02124772|616534018|FG012|Overall Study|Withdrawal consent|0|||
170598002|NCT02124772|616534006|FG000|Overall Study|Investigator discretion|0|||
170598003|NCT02124772|616534007|FG001|Overall Study|Investigator discretion|2|||
170598004|NCT02124772|616534008|FG002|Overall Study|Investigator discretion|2|||
170598005|NCT02124772|616534009|FG003|Overall Study|Investigator discretion|1|||
170598006|NCT02124772|616534010|FG004|Overall Study|Investigator discretion|1|||
170598007|NCT02124772|616534011|FG005|Overall Study|Investigator discretion|0|||
170598008|NCT02124772|616534012|FG006|Overall Study|Investigator discretion|1|||
170598009|NCT02124772|616534013|FG007|Overall Study|Investigator discretion|0|||
170598010|NCT02124772|616534014|FG008|Overall Study|Investigator discretion|0|||
170598011|NCT02124772|616534015|FG009|Overall Study|Investigator discretion|1|||
170598012|NCT02124772|616534016|FG010|Overall Study|Investigator discretion|0|||
170598013|NCT02124772|616534017|FG011|Overall Study|Investigator discretion|1|||
170598014|NCT02124772|616534018|FG012|Overall Study|Investigator discretion|0|||
170598015|NCT02124772|616534006|FG000|Overall Study|Progressive disease|0|||
170598016|NCT02124772|616534007|FG001|Overall Study|Progressive disease|0|||
170598017|NCT02124772|616534008|FG002|Overall Study|Progressive disease|0|||
170598018|NCT02124772|616534009|FG003|Overall Study|Progressive disease|0|||
170598019|NCT02124772|616534010|FG004|Overall Study|Progressive disease|0|||
170598020|NCT02124772|616534011|FG005|Overall Study|Progressive disease|0|||
170598021|NCT02124772|616534012|FG006|Overall Study|Progressive disease|1|||
170598022|NCT02124772|616534013|FG007|Overall Study|Progressive disease|1|||
170598023|NCT02124772|616534014|FG008|Overall Study|Progressive disease|0|||
170598024|NCT02124772|616534015|FG009|Overall Study|Progressive disease|0|||
170598025|NCT02124772|616534016|FG010|Overall Study|Progressive disease|0|||
170598026|NCT02124772|616534017|FG011|Overall Study|Progressive disease|0|||
170598027|NCT02124772|616534018|FG012|Overall Study|Progressive disease|0|||
170598028|NCT02124772|616534006|FG000|Overall Study|Other|0|||
170598029|NCT02124772|616534007|FG001|Overall Study|Other|7|||
170913481|NCT02704429|617685923|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
170913482|NCT02704429|617685924|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
170913483|NCT00104104|617685925|FG000|Overall Study|Adverse Event|8|||
170913484|NCT00104104|617685926|FG001|Overall Study|Adverse Event|8|||
170598030|NCT02124772|616534008|FG002|Overall Study|Other|2|||
170598031|NCT02124772|616534009|FG003|Overall Study|Other|5|||
170598032|NCT02124772|616534010|FG004|Overall Study|Other|4|||
170598033|NCT02124772|616534011|FG005|Overall Study|Other|3|||
170598034|NCT02124772|616534012|FG006|Overall Study|Other|4|||
170812430|NCT02121808|617322608|FG000|Overall Study|Technical problem|3|||
170812431|NCT00070707|617322609|FG000|Overall Study|Adverse Event|1|||
170598035|NCT02124772|616534013|FG007|Overall Study|Other|1|||
170598036|NCT02124772|616534014|FG008|Overall Study|Other|1|||
170598037|NCT02124772|616534015|FG009|Overall Study|Other|1|||
170913485|NCT00104104|617685925|FG000|Overall Study|Abnormal laboratory value(s)|20|||
170913486|NCT00104104|617685926|FG001|Overall Study|Abnormal laboratory value(s)|14|||
170598038|NCT02124772|616534016|FG010|Overall Study|Other|1|||
170598039|NCT02124772|616534017|FG011|Overall Study|Other|1|||
170598040|NCT02124772|616534018|FG012|Overall Study|Other|0|||
170598041|NCT02713529|616534019|FG000|Overall Study|Withdrawal by Subject|3|||
170598042|NCT02713529|616534020|FG001|Overall Study|Withdrawal by Subject|1|||
170812432|NCT00070707|617322610|FG001|Overall Study|Adverse Event|2|||
170812433|NCT00070707|617322609|FG000|Overall Study|Lack of Efficacy|4|||
170812434|NCT00070707|617322610|FG001|Overall Study|Lack of Efficacy|1|||
170598043|NCT02713529|616534021|FG002|Overall Study|Withdrawal by Subject|4|||
170598044|NCT02713529|616534022|FG003|Overall Study|Withdrawal by Subject|2|||
170598045|NCT02713529|616534023|FG004|Overall Study|Withdrawal by Subject|0|||
170598046|NCT02713529|616534024|FG005|Overall Study|Withdrawal by Subject|1|||
170598047|NCT02713529|616534025|FG006|Overall Study|Withdrawal by Subject|1|||
170598048|NCT02713529|616534019|FG000|Overall Study|Lost to Follow-up|1|||
170598049|NCT02713529|616534020|FG001|Overall Study|Lost to Follow-up|0|||
170598050|NCT02713529|616534021|FG002|Overall Study|Lost to Follow-up|1|||
170598051|NCT02713529|616534022|FG003|Overall Study|Lost to Follow-up|0|||
170598052|NCT02713529|616534023|FG004|Overall Study|Lost to Follow-up|0|||
170598053|NCT02713529|616534024|FG005|Overall Study|Lost to Follow-up|0|||
170598054|NCT02713529|616534025|FG006|Overall Study|Lost to Follow-up|0|||
170598055|NCT02713529|616534019|FG000|Overall Study|Death|3|||
170598056|NCT02713529|616534020|FG001|Overall Study|Death|3|||
170598057|NCT02713529|616534021|FG002|Overall Study|Death|26|||
170598058|NCT02713529|616534022|FG003|Overall Study|Death|27|||
170598059|NCT02713529|616534023|FG004|Overall Study|Death|3|||
170598060|NCT02713529|616534024|FG005|Overall Study|Death|13|||
170598061|NCT02713529|616534025|FG006|Overall Study|Death|3|||
170598062|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
170598063|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
170598064|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
170598065|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
170598066|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
170598067|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
170598068|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
170598069|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
170598070|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
170598071|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
170598072|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
170598073|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
170598074|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
170598075|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
170598076|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
170598077|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
170598078|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
170598079|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
170598080|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
170598081|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
170598082|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
170598083|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
170598084|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
170598085|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
170598086|NCT01672866|616534026|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
170598087|NCT01672866|616534027|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
170598088|NCT01672866|616534028|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
170598089|NCT01672866|616534026|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
170598090|NCT01672866|616534027|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
170598091|NCT01672866|616534028|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
170598092|NCT01672866|616534026|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
170598093|NCT01672866|616534027|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
170598094|NCT01672866|616534028|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
170598095|NCT01672866|616534026|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
170812435|NCT00070707|617322609|FG000|Overall Study|Protocol Violation|8|||
170598096|NCT01672866|616534027|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
170598097|NCT01672866|616534028|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
170598098|NCT01672866|616534026|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
170598099|NCT01672866|616534027|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
170598100|NCT01672866|616534028|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
170598101|NCT02100475|616535426|FG000|Overall Study|Unclassified|1|||
170598102|NCT02100475|616535427|FG001|Overall Study|Unclassified|2|||
170598103|NCT02100475|616535426|FG000|Overall Study|Withdrawal criteria|1|||
170598104|NCT02100475|616535427|FG001|Overall Study|Withdrawal criteria|0|||
170598105|NCT01597635|616535428|FG000|Part A|Adverse Event|3|||
170598106|NCT01597635|616535429|FG001|Part A|Adverse Event|0|||
170598107|NCT01597635|616535430|FG002|Part A|Adverse Event|0|||
170598108|NCT01597635|616535428|FG000|Part B|Adverse Event|0|||
170598109|NCT01597635|616535429|FG001|Part B|Adverse Event|0|||
170598110|NCT01597635|616535430|FG002|Part B|Adverse Event|1|||
170598111|NCT01597635|616535428|FG000|Part B|Protocol Violation|0|||
170812436|NCT00070707|617322610|FG001|Overall Study|Protocol Violation|4|||
170651584|NCT00952380|616738182|FG003|Overall Study|Other|0|||
170651585|NCT00952380|616738183|FG004|Overall Study|Other|1|||
170651586|NCT00952380|616738179|FG000|Overall Study|Withdrawal by Subject|0|||
170651587|NCT00952380|616738180|FG001|Overall Study|Withdrawal by Subject|0|||
170651588|NCT00952380|616738181|FG002|Overall Study|Withdrawal by Subject|1|||
170651589|NCT00952380|616738182|FG003|Overall Study|Withdrawal by Subject|0|||
170651590|NCT00952380|616738183|FG004|Overall Study|Withdrawal by Subject|2|||
170651591|NCT00952380|616738179|FG000|Overall Study|Adverse Event|0|||
170651592|NCT00952380|616738180|FG001|Overall Study|Adverse Event|1|||
170651593|NCT00952380|616738181|FG002|Overall Study|Adverse Event|0|||
170651594|NCT00952380|616738182|FG003|Overall Study|Adverse Event|0|||
170651595|NCT00952380|616738183|FG004|Overall Study|Adverse Event|3|||
170651596|NCT00952380|616738179|FG000|Overall Study|Physician Decision|0|||
170651597|NCT00952380|616738180|FG001|Overall Study|Physician Decision|0|||
170651598|NCT00952380|616738181|FG002|Overall Study|Physician Decision|1|||
170651599|NCT00952380|616738182|FG003|Overall Study|Physician Decision|2|||
170651600|NCT00952380|616738183|FG004|Overall Study|Physician Decision|0|||
170651601|NCT00952380|616738179|FG000|Overall Study|Non-compliant to protocol|0|||
170651602|NCT00952380|616738180|FG001|Overall Study|Non-compliant to protocol|0|||
170651603|NCT00952380|616738181|FG002|Overall Study|Non-compliant to protocol|0|||
170651604|NCT00952380|616738182|FG003|Overall Study|Non-compliant to protocol|1|||
170651605|NCT00952380|616738183|FG004|Overall Study|Non-compliant to protocol|0|||
170651606|NCT00534313|616738185|FG000|Short-term Period|Adverse Event|1|||
170651607|NCT00534313|616738186|FG001|Short-term Period|Adverse Event|2|||
170651608|NCT00534313|616738187|FG002|Short-term Period|Adverse Event|1|||
170651609|NCT00534313|616738188|FG003|Short-term Period|Adverse Event|3|||
170651610|NCT00534313|616738185|FG000|Short-term Period|Lack of Efficacy|3|||
170651611|NCT00534313|616738186|FG001|Short-term Period|Lack of Efficacy|4|||
170651612|NCT00534313|616738187|FG002|Short-term Period|Lack of Efficacy|0|||
170651613|NCT00534313|616738188|FG003|Short-term Period|Lack of Efficacy|3|||
170651614|NCT00534313|616738185|FG000|Short-term Period|Participant not meeting study criteria|0|||
170651615|NCT00534313|616738186|FG001|Short-term Period|Participant not meeting study criteria|0|||
170651616|NCT00534313|616738187|FG002|Short-term Period|Participant not meeting study criteria|0|||
170651617|NCT00534313|616738188|FG003|Short-term Period|Participant not meeting study criteria|1|||
170651618|NCT00534313|616738185|FG000|Short-term Period|Participant withdrew consent|2|||
170651619|NCT00534313|616738186|FG001|Short-term Period|Participant withdrew consent|0|||
170651620|NCT00534313|616738187|FG002|Short-term Period|Participant withdrew consent|0|||
170651621|NCT00534313|616738188|FG003|Short-term Period|Participant withdrew consent|2|||
170651622|NCT00534313|616738185|FG000|Short-term Period|Pregnancy|0|||
170651623|NCT00534313|616738186|FG001|Short-term Period|Pregnancy|0|||
170651624|NCT00534313|616738187|FG002|Short-term Period|Pregnancy|1|||
170651625|NCT00534313|616738188|FG003|Short-term Period|Pregnancy|0|||
170651626|NCT00534313|616738185|FG000|Long-term Period|Adverse Event|2|||
170651627|NCT00534313|616738186|FG001|Long-term Period|Adverse Event|1|||
170651628|NCT00534313|616738187|FG002|Long-term Period|Adverse Event|0|||
170651629|NCT00534313|616738188|FG003|Long-term Period|Adverse Event|1|||
170651630|NCT00534313|616738185|FG000|Long-term Period|Lack of Efficacy|14|||
170651631|NCT00534313|616738186|FG001|Long-term Period|Lack of Efficacy|10|||
170651632|NCT00534313|616738187|FG002|Long-term Period|Lack of Efficacy|14|||
170651633|NCT00534313|616738188|FG003|Long-term Period|Lack of Efficacy|12|||
170651634|NCT00534313|616738185|FG000|Long-term Period|Lost to Follow-up|1|||
170651635|NCT00534313|616738186|FG001|Long-term Period|Lost to Follow-up|2|||
170651636|NCT00534313|616738187|FG002|Long-term Period|Lost to Follow-up|0|||
170651637|NCT00534313|616738188|FG003|Long-term Period|Lost to Follow-up|0|||
170651638|NCT00534313|616738185|FG000|Long-term Period|Withdrawal by Subject|2|||
170651639|NCT00534313|616738186|FG001|Long-term Period|Withdrawal by Subject|2|||
170651640|NCT00534313|616738187|FG002|Long-term Period|Withdrawal by Subject|0|||
170651641|NCT00534313|616738188|FG003|Long-term Period|Withdrawal by Subject|0|||
170651642|NCT00534313|616738185|FG000|Long-term Period|No longer meets study criteria|0|||
170651643|NCT00534313|616738186|FG001|Long-term Period|No longer meets study criteria|1|||
170651644|NCT00534313|616738187|FG002|Long-term Period|No longer meets study criteria|0|||
170651645|NCT00534313|616738188|FG003|Long-term Period|No longer meets study criteria|0|||
170651646|NCT00534313|616738185|FG000|Long-term Period|Poor compliance/noncompliance|0|||
170651647|NCT00534313|616738186|FG001|Long-term Period|Poor compliance/noncompliance|1|||
170651648|NCT00534313|616738187|FG002|Long-term Period|Poor compliance/noncompliance|1|||
170651649|NCT00534313|616738188|FG003|Long-term Period|Poor compliance/noncompliance|0|||
170651650|NCT00534313|616738185|FG000|Long-term Period|Administrative reason by sponsor|17|||
170651651|NCT00534313|616738186|FG001|Long-term Period|Administrative reason by sponsor|15|||
170651652|NCT00534313|616738187|FG002|Long-term Period|Administrative reason by sponsor|26|||
170651653|NCT00534313|616738188|FG003|Long-term Period|Administrative reason by sponsor|18|||
170651654|NCT00534313|616738185|FG000|Long-term Period|Other|1|||
170651655|NCT00534313|616738186|FG001|Long-term Period|Other|2|||
170651656|NCT00534313|616738187|FG002|Long-term Period|Other|2|||
170651657|NCT00534313|616738188|FG003|Long-term Period|Other|2|||
170651658|NCT00402233|616738189|FG000|Overall Study|Adverse Event|1|||
170651659|NCT00402233|616738190|FG001|Overall Study|Adverse Event|7|||
170598112|NCT01597635|616535429|FG001|Part B|Protocol Violation|1|||
170598113|NCT01597635|616535430|FG002|Part B|Protocol Violation|0|||
170598114|NCT01597635|616535428|FG000|Part B|Protocol-defined stopping criteria|0|||
170598115|NCT01597635|616535429|FG001|Part B|Protocol-defined stopping criteria|4|||
170598116|NCT01597635|616535430|FG002|Part B|Protocol-defined stopping criteria|3|||
170598117|NCT01597635|616535428|FG000|Part B|Withdrawal by Subject|0|||
170598118|NCT01597635|616535429|FG001|Part B|Withdrawal by Subject|1|||
170598119|NCT01597635|616535430|FG002|Part B|Withdrawal by Subject|0|||
170598120|NCT02805725|616535431|FG000|Phase I (Dose escalation part)|Clinical progression|0|||
170598121|NCT02805725|616535432|FG001|Phase I (Dose escalation part)|Clinical progression|0|||
170598122|NCT02805725|616535433|FG002|Phase I (Dose escalation part)|Clinical progression|1|||
170598123|NCT02805725|616535434|FG003|Phase I (Dose escalation part)|Clinical progression|0|||
170598124|NCT02805725|616535435|FG004|Phase I (Dose escalation part)|Clinical progression|0|||
170598125|NCT02805725|616535431|FG000|Phase I (Dose escalation part)|Adverse Event|0|||
170598126|NCT02805725|616535432|FG001|Phase I (Dose escalation part)|Adverse Event|0|||
170598127|NCT02805725|616535433|FG002|Phase I (Dose escalation part)|Adverse Event|1|||
170598128|NCT02805725|616535434|FG003|Phase I (Dose escalation part)|Adverse Event|2|||
170598129|NCT02805725|616535435|FG004|Phase I (Dose escalation part)|Adverse Event|0|||
170598130|NCT02805725|616535431|FG000|Phase II|Protocol Violation|0|||
170598131|NCT02805725|616535432|FG001|Phase II|Protocol Violation|0|||
170598132|NCT02805725|616535433|FG002|Phase II|Protocol Violation|0|||
170598133|NCT02805725|616535434|FG003|Phase II|Protocol Violation|0|||
170598134|NCT02805725|616535435|FG004|Phase II|Protocol Violation|6|||
170598135|NCT06024096|616535438|FG000|Overall Study|Lost to Follow-up|2|||
170598136|NCT06024096|616535439|FG001|Overall Study|Lost to Follow-up|5|||
170598137|NCT06024096|616535438|FG000|Overall Study|Physician Decision|0|||
170598138|NCT06024096|616535439|FG001|Overall Study|Physician Decision|1|||
170598139|NCT06024096|616535438|FG000|Overall Study|Withdrawal by Subject|2|||
170598140|NCT06024096|616535439|FG001|Overall Study|Withdrawal by Subject|3|||
170598141|NCT00344500|616535441|FG000|Overall Study|Adverse Event|6|||
170598142|NCT00344500|616535442|FG001|Overall Study|Adverse Event|2|||
170598143|NCT00344500|616535443|FG002|Overall Study|Adverse Event|0|||
170598144|NCT00344500|616535441|FG000|Overall Study|Lost to Follow-up|5|||
170598145|NCT00344500|616535442|FG001|Overall Study|Lost to Follow-up|13|||
170598146|NCT00344500|616535443|FG002|Overall Study|Lost to Follow-up|1|||
170598147|NCT00344500|616535441|FG000|Overall Study|Withdrawal by Subject|7|||
170598148|NCT00344500|616535442|FG001|Overall Study|Withdrawal by Subject|10|||
170598149|NCT00344500|616535443|FG002|Overall Study|Withdrawal by Subject|0|||
170913487|NCT00104104|617685925|FG000|Overall Study|Lack of Efficacy|0|||
170598150|NCT00344500|616535441|FG000|Overall Study|Protocol Violation|4|||
170598151|NCT00344500|616535442|FG001|Overall Study|Protocol Violation|7|||
170598152|NCT00344500|616535443|FG002|Overall Study|Protocol Violation|1|||
170598153|NCT00344500|616535441|FG000|Overall Study|Not Noted|1|||
170598154|NCT00344500|616535442|FG001|Overall Study|Not Noted|3|||
170598155|NCT00344500|616535443|FG002|Overall Study|Not Noted|0|||
170598156|NCT04938037|616535444|FG000|Overall Study|Lost to Follow-up|4|||
170598157|NCT04938037|616535445|FG001|Overall Study|Lost to Follow-up|3|||
170598158|NCT04037254|616535448|FG000|Overall Study|Protocol Violation|1|||
170598159|NCT04037254|616535449|FG001|Overall Study|Protocol Violation|0|||
170598160|NCT04037254|616535450|FG002|Overall Study|Protocol Violation|0|||
170598161|NCT04037254|616535451|FG003|Overall Study|Protocol Violation|0|||
170598162|NCT04037254|616535452|FG004|Overall Study|Protocol Violation|0|||
170598163|NCT04037254|616535448|FG000|Overall Study|Withdrawal by Subject|0|||
170598164|NCT04037254|616535449|FG001|Overall Study|Withdrawal by Subject|0|||
170598165|NCT04037254|616535450|FG002|Overall Study|Withdrawal by Subject|1|||
170598166|NCT04037254|616535451|FG003|Overall Study|Withdrawal by Subject|0|||
170598167|NCT04037254|616535452|FG004|Overall Study|Withdrawal by Subject|0|||
170598168|NCT04037254|616535448|FG000|Overall Study|Delayed or incomplete treatment|0|||
170651660|NCT00402233|616738191|FG002|Overall Study|Adverse Event|9|||
170651661|NCT00402233|616738192|FG003|Overall Study|Adverse Event|9|||
170651662|NCT00402233|616738189|FG000|Overall Study|Protocol Violation|0|||
170913488|NCT00104104|617685926|FG001|Overall Study|Lack of Efficacy|3|||
170913489|NCT00104104|617685925|FG000|Overall Study|Condition no longer requires study drug|7|||
170913490|NCT00104104|617685926|FG001|Overall Study|Condition no longer requires study drug|4|||
170913491|NCT00104104|617685925|FG000|Overall Study|Protocol Violation|5|||
170913492|NCT00104104|617685926|FG001|Overall Study|Protocol Violation|2|||
170598169|NCT04037254|616535449|FG001|Overall Study|Delayed or incomplete treatment|2|||
170598170|NCT04037254|616535450|FG002|Overall Study|Delayed or incomplete treatment|1|||
170598171|NCT04037254|616535451|FG003|Overall Study|Delayed or incomplete treatment|0|||
170598172|NCT04037254|616535452|FG004|Overall Study|Delayed or incomplete treatment|0|||
170598173|NCT01806064|616535453|FG000|Overall Study|Randomized Not Enrolled|0|||
170598174|NCT01806064|616535454|FG001|Overall Study|Randomized Not Enrolled|0|||
170598175|NCT01806064|616535455|FG002|Overall Study|Randomized Not Enrolled|0|||
170651663|NCT00402233|616738190|FG001|Overall Study|Protocol Violation|1|||
170598176|NCT01806064|616535456|FG003|Overall Study|Randomized Not Enrolled|1|||
170598177|NCT01806064|616535457|FG004|Overall Study|Randomized Not Enrolled|2|||
170913493|NCT00104104|617685925|FG000|Overall Study|Withdrawal by Subject|11|||
170812437|NCT00070707|617322609|FG000|Overall Study|Unrelated to Study Medication|1|||
170812438|NCT00070707|617322610|FG001|Overall Study|Unrelated to Study Medication|0|||
170812439|NCT04909593|617322611|FG000|Overall Study|Withdrawal by Subject|1|||
170812440|NCT01090739|617322615|FG000|Enrollment|Withdrawal by Subject|24|||
170812441|NCT01090739|617322615|FG000|Enrollment|Protocol Violation|14|||
170812442|NCT01090739|617322615|FG000|Enrollment|Lost to Follow-up|5|||
170812443|NCT01090739|617322615|FG000|Enrollment|Physician Decision|5|||
170812444|NCT01090739|617322615|FG000|Enrollment|Sponsor termination of site|4|||
170812445|NCT01090739|617322615|FG000|Enrollment|Study implant limit reached|2|||
170812446|NCT01090739|617322615|FG000|Enrollment|Adverse Event|1|||
170812447|NCT01090739|617322615|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
170812448|NCT01090739|617322615|FG000|12 Month Follow-up|Lost to Follow-up|1|||
170812449|NCT01090739|617322615|FG000|12 Month Follow-up|Physician Decision|1|||
170812450|NCT01090739|617322615|FG000|12 Month Follow-up|Death|1|||
170812451|NCT01090739|617322615|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
170812452|NCT01090739|617322615|FG000|24 Month Follow-up|Lost to Follow-up|1|||
170812453|NCT01090739|617322615|FG000|24 Month Follow-up|Death|1|||
170812454|NCT01090739|617322615|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
170812455|NCT01090739|617322615|FG000|36 Month Follow-up|Visit still pending|17|||
170812456|NCT03547154|617322623|FG000|Overall Study|Disease Progression/Recurrence|6|||
170812457|NCT03547154|617322624|FG001|Overall Study|Disease Progression/Recurrence|14|||
170598178|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
170812458|NCT03547154|617322623|FG000|Overall Study|Adverse Event|26|||
170812459|NCT03547154|617322624|FG001|Overall Study|Adverse Event|31|||
170812460|NCT03547154|617322623|FG000|Overall Study|Protocol Violation|6|||
170812461|NCT03547154|617322624|FG001|Overall Study|Protocol Violation|1|||
170812462|NCT03547154|617322623|FG000|Overall Study|Physician Decision|4|||
170812463|NCT03547154|617322624|FG001|Overall Study|Physician Decision|3|||
170598179|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
170598180|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
170598181|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
170598182|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
170598183|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
170598184|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
170598185|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
170598186|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
170598187|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
170598188|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
170598189|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
170598190|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
170598191|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
170598192|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
170598193|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
170598194|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
170598195|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
170598196|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
170598197|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
170598198|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
170598199|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
170598200|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
170598201|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
170598202|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
170598203|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
170598204|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
170598205|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
170598206|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
170598207|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
170598208|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
170598209|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
170598210|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
170598211|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
170598212|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
170812464|NCT03547154|617322623|FG000|Overall Study|Insufficient Therapeutic Response|13|||
170812465|NCT03547154|617322624|FG001|Overall Study|Insufficient Therapeutic Response|10|||
170598213|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
170598214|NCT02198794|616535458|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
170598215|NCT02198794|616535459|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
170812466|NCT03547154|617322623|FG000|Overall Study|Withdrawal by Subject|10|||
170812467|NCT03547154|617322624|FG001|Overall Study|Withdrawal by Subject|6|||
170812468|NCT03547154|617322623|FG000|Overall Study|Not Selected|0|||
170812469|NCT03547154|617322624|FG001|Overall Study|Not Selected|1|||
170812470|NCT03547154|617322623|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
170598216|NCT02198794|616535460|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
170598217|NCT02198794|616535461|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
170598218|NCT02198794|616535458|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
170598219|NCT02198794|616535459|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
170598220|NCT02198794|616535460|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
170598221|NCT02198794|616535461|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
170598222|NCT02198794|616535458|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
170598223|NCT02198794|616535459|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
170598224|NCT02198794|616535460|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
170598225|NCT02198794|616535461|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
170598226|NCT02198794|616535458|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
170598227|NCT02198794|616535459|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
170598228|NCT02198794|616535460|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
170598229|NCT02198794|616535461|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
170598230|NCT02198794|616535458|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
170598231|NCT02198794|616535459|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
170598232|NCT02198794|616535460|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
170812471|NCT03547154|617322624|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
170812472|NCT02988713|617322625|FG000|Overall Study|Withdrawal by Subject|1|||
170598233|NCT02198794|616535461|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
170598234|NCT02198794|616535458|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
170598235|NCT02198794|616535459|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
170598236|NCT02198794|616535460|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
170598237|NCT02198794|616535461|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
170598238|NCT01306656|616535463|FG000|Overall Study|Lost to Follow-up|1|||
170598239|NCT01306656|616535464|FG001|Overall Study|Lost to Follow-up|0|||
170598240|NCT02504580|616535465|FG000|Overall Study|Other|1|||
170598241|NCT02504580|616535466|FG001|Overall Study|Other|0|||
170598242|NCT02504580|616535467|FG002|Overall Study|Other|0|||
170598243|NCT02504580|616535468|FG003|Overall Study|Other|2|||
170598244|NCT02504580|616535469|FG004|Overall Study|Other|1|||
170598245|NCT02504580|616535470|FG005|Overall Study|Other|1|||
170598246|NCT02504580|616535471|FG006|Overall Study|Other|1|||
170598247|NCT02504580|616535472|FG007|Overall Study|Other|2|||
170598248|NCT02504580|616535473|FG008|Overall Study|Other|0|||
170598249|NCT02504580|616535474|FG009|Overall Study|Other|0|||
170598250|NCT02504580|616535475|FG010|Overall Study|Other|0|||
170598251|NCT02504580|616535476|FG011|Overall Study|Other|2|||
170598252|NCT02504580|616535465|FG000|Overall Study|Subject refusal to continue|0|||
170598253|NCT02504580|616535466|FG001|Overall Study|Subject refusal to continue|1|||
170598254|NCT02504580|616535467|FG002|Overall Study|Subject refusal to continue|0|||
170598255|NCT02504580|616535468|FG003|Overall Study|Subject refusal to continue|0|||
170598256|NCT02504580|616535469|FG004|Overall Study|Subject refusal to continue|0|||
170598257|NCT02504580|616535470|FG005|Overall Study|Subject refusal to continue|0|||
170598258|NCT02504580|616535471|FG006|Overall Study|Subject refusal to continue|0|||
170598259|NCT02504580|616535472|FG007|Overall Study|Subject refusal to continue|0|||
170598260|NCT02504580|616535473|FG008|Overall Study|Subject refusal to continue|0|||
170598261|NCT02504580|616535474|FG009|Overall Study|Subject refusal to continue|0|||
170598262|NCT02504580|616535475|FG010|Overall Study|Subject refusal to continue|0|||
170598263|NCT02504580|616535476|FG011|Overall Study|Subject refusal to continue|0|||
170598264|NCT01918332|616535480|FG000|Overall Study|Adverse Event|0|||
170598265|NCT01918332|616535481|FG001|Overall Study|Adverse Event|0|||
170598266|NCT01918332|616535482|FG002|Overall Study|Adverse Event|0|||
170598267|NCT01918332|616535483|FG003|Overall Study|Adverse Event|1|||
170598268|NCT01918332|616535480|FG000|Overall Study|Withdrawal by Subject|2|||
170598269|NCT01918332|616535481|FG001|Overall Study|Withdrawal by Subject|3|||
170598270|NCT01918332|616535482|FG002|Overall Study|Withdrawal by Subject|2|||
170598271|NCT01918332|616535483|FG003|Overall Study|Withdrawal by Subject|3|||
170598272|NCT01918332|616535480|FG000|Overall Study|Protocol Violation|6|||
170598273|NCT01918332|616535481|FG001|Overall Study|Protocol Violation|2|||
170598274|NCT01918332|616535482|FG002|Overall Study|Protocol Violation|6|||
170812473|NCT02988713|617322625|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
170812474|NCT03006393|617322626|FG000|Overall Study|Withdrawal by Subject|1|||
170598275|NCT01918332|616535483|FG003|Overall Study|Protocol Violation|3|||
170598276|NCT01918332|616535480|FG000|Overall Study|lipid result by central lab did not meet|0|||
170598277|NCT01918332|616535481|FG001|Overall Study|lipid result by central lab did not meet|0|||
170598278|NCT01918332|616535482|FG002|Overall Study|lipid result by central lab did not meet|1|||
170598279|NCT01918332|616535483|FG003|Overall Study|lipid result by central lab did not meet|0|||
170598280|NCT00701805|616535484|FG000|Overall Study|Withdrawal by Subject|3|||
170598281|NCT00701805|616535485|FG001|Overall Study|Withdrawal by Subject|1|||
170598282|NCT00701805|616535486|FG002|Overall Study|Withdrawal by Subject|4|||
170598283|NCT00701805|616535487|FG003|Overall Study|Withdrawal by Subject|3|||
170598284|NCT00701805|616535484|FG000|Overall Study|Adverse Event|0|||
170598285|NCT00701805|616535485|FG001|Overall Study|Adverse Event|1|||
170598286|NCT00701805|616535486|FG002|Overall Study|Adverse Event|1|||
170598287|NCT00701805|616535487|FG003|Overall Study|Adverse Event|0|||
170598288|NCT00701805|616535484|FG000|Overall Study|Missed 7 consecutive doses|0|||
170598289|NCT00701805|616535485|FG001|Overall Study|Missed 7 consecutive doses|1|||
170598290|NCT00701805|616535486|FG002|Overall Study|Missed 7 consecutive doses|0|||
170598291|NCT00701805|616535487|FG003|Overall Study|Missed 7 consecutive doses|0|||
170598292|NCT00701805|616535484|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
170598293|NCT00701805|616535485|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
170598294|NCT00701805|616535486|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
170598295|NCT00701805|616535487|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
170598296|NCT00701805|616535484|FG000|Overall Study|Physician decision, change of therapy|0|||
170598297|NCT00701805|616535485|FG001|Overall Study|Physician decision, change of therapy|0|||
170598298|NCT00701805|616535486|FG002|Overall Study|Physician decision, change of therapy|0|||
170598299|NCT00701805|616535487|FG003|Overall Study|Physician decision, change of therapy|1|||
170598300|NCT00701805|616535484|FG000|Overall Study|Difficult to travel to dialysis site|0|||
170598301|NCT00701805|616535485|FG001|Overall Study|Difficult to travel to dialysis site|0|||
170598302|NCT00701805|616535486|FG002|Overall Study|Difficult to travel to dialysis site|1|||
170598303|NCT00701805|616535487|FG003|Overall Study|Difficult to travel to dialysis site|0|||
170598304|NCT00701805|616535484|FG000|Overall Study|Resumption criteria were not met|0|||
170598305|NCT00701805|616535485|FG001|Overall Study|Resumption criteria were not met|1|||
170598306|NCT00701805|616535486|FG002|Overall Study|Resumption criteria were not met|0|||
170598307|NCT00701805|616535487|FG003|Overall Study|Resumption criteria were not met|0|||
170598308|NCT00527982|616535488|FG000|Overall Study|Physician Decision|1|||
170598309|NCT00527982|616535489|FG001|Overall Study|Physician Decision|0|||
170598310|NCT02252965|616535494|FG000|Overall Study|Adverse Event|9|||
170598311|NCT02252965|616535495|FG001|Overall Study|Adverse Event|14|||
170598312|NCT02252965|616535494|FG000|Overall Study|Lost to Follow-up|16|||
170598313|NCT02252965|616535495|FG001|Overall Study|Lost to Follow-up|8|||
170598314|NCT02252965|616535494|FG000|Overall Study|Protocol Violation|4|||
170598315|NCT02252965|616535495|FG001|Overall Study|Protocol Violation|5|||
170598316|NCT02252965|616535494|FG000|Overall Study|Lack of Efficacy|0|||
170598317|NCT02252965|616535495|FG001|Overall Study|Lack of Efficacy|2|||
170598318|NCT02252965|616535494|FG000|Overall Study|Withdrawal by Subject|7|||
170598319|NCT02252965|616535495|FG001|Overall Study|Withdrawal by Subject|9|||
170598320|NCT02252965|616535494|FG000|Overall Study|Other|4|||
170598321|NCT02252965|616535495|FG001|Overall Study|Other|5|||
170598322|NCT06038123|616535502|FG000|Overall Study|Withdrawal by Subject|1|||
170598323|NCT06038123|616535502|FG000|Overall Study|not return due to femur fracture|1|||
170598324|NCT02478164|616535503|FG000|Overall Study|Lack of Efficacy|13|||
170598325|NCT02478164|616535503|FG000|Overall Study|Adverse Event|1|||
170598326|NCT02478164|616535503|FG000|Overall Study|Withdrawal by Subject|1|||
170598327|NCT04051827|616535504|FG000|Overall Study|Death|1|||
170598328|NCT04051827|616535504|FG000|Overall Study|Withdrawal by Subject|4|||
170598329|NCT04051827|616535504|FG000|Overall Study|Progressive disease|16|||
170598330|NCT04051827|616535504|FG000|Overall Study|Physician Decision|1|||
170598331|NCT04051827|616535504|FG000|Overall Study|Other|4|||
170598332|NCT05779007|616535505|FG000|Overall Study|not meeting eligibility criteria|3517|||
170598333|NCT05779007|616535506|FG001|Overall Study|not meeting eligibility criteria|2009|||
170598334|NCT01424566|616535507|FG000|Single-blind Treatment|Adverse Event|71|||
170812475|NCT03006393|617322627|FG001|Overall Study|Withdrawal by Subject|1|||
170812476|NCT03006393|617322626|FG000|Overall Study|Pregnancy|0|||
170812477|NCT03006393|617322627|FG001|Overall Study|Pregnancy|1|||
170812478|NCT03006393|617322626|FG000|Overall Study|Lost to Follow-up|0|||
170812479|NCT03006393|617322627|FG001|Overall Study|Lost to Follow-up|1|||
170812480|NCT00244751|617322632|FG000|Overall Study|Adverse Event|7|||
170812481|NCT00244751|617322633|FG001|Overall Study|Adverse Event|7|||
170812482|NCT00244751|617322634|FG002|Overall Study|Adverse Event|5|||
170812483|NCT00244751|617322632|FG000|Overall Study|Lost to Follow-up|0|||
170812484|NCT00244751|617322633|FG001|Overall Study|Lost to Follow-up|1|||
170812485|NCT00244751|617322634|FG002|Overall Study|Lost to Follow-up|0|||
170598335|NCT01424566|616535508|FG001|Single-blind Treatment|Adverse Event|0|||
170598336|NCT01424566|616535509|FG002|Single-blind Treatment|Adverse Event|0|||
170598337|NCT01424566|616535507|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
170598338|NCT01424566|616535508|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
170598339|NCT01424566|616535509|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
170598340|NCT01424566|616535507|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
170598341|NCT01424566|616535508|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
170598342|NCT01424566|616535509|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
170598343|NCT01424566|616535507|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
170598344|NCT01424566|616535508|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
170598345|NCT01424566|616535509|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
170598346|NCT01424566|616535507|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
170598347|NCT01424566|616535508|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
170598348|NCT01424566|616535509|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
170598349|NCT01424566|616535507|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
170598350|NCT01424566|616535508|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
170598351|NCT01424566|616535509|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
170598352|NCT01424566|616535507|FG000|Double-blind Treatment|Adverse Event|0|||
170598353|NCT01424566|616535508|FG001|Double-blind Treatment|Adverse Event|21|||
170598354|NCT01424566|616535509|FG002|Double-blind Treatment|Adverse Event|13|||
170598355|NCT01424566|616535507|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
170598356|NCT01424566|616535508|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
170598357|NCT01424566|616535509|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
170598358|NCT01424566|616535507|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
170598359|NCT01424566|616535508|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
170598360|NCT01424566|616535509|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
170598361|NCT01424566|616535507|FG000|Double-blind Treatment|Lack of Efficacy|0|||
170598362|NCT01424566|616535508|FG001|Double-blind Treatment|Lack of Efficacy|1|||
170598363|NCT01424566|616535509|FG002|Double-blind Treatment|Lack of Efficacy|1|||
170598364|NCT01533922|616535513|FG000|Overall Study|Adverse Event|5|||
170598365|NCT01533922|616535514|FG001|Overall Study|Adverse Event|8|||
170598366|NCT01533922|616535515|FG002|Overall Study|Adverse Event|6|||
170598367|NCT01533922|616535516|FG003|Overall Study|Adverse Event|3|||
170598368|NCT01533922|616535517|FG004|Overall Study|Adverse Event|4|||
170598369|NCT01533922|616535513|FG000|Overall Study|Lack of Efficacy|0|||
170598370|NCT01533922|616535514|FG001|Overall Study|Lack of Efficacy|0|||
170598371|NCT01533922|616535515|FG002|Overall Study|Lack of Efficacy|1|||
170598372|NCT01533922|616535516|FG003|Overall Study|Lack of Efficacy|0|||
170598373|NCT01533922|616535517|FG004|Overall Study|Lack of Efficacy|0|||
170598374|NCT01533922|616535513|FG000|Overall Study|Protocol Violation|0|||
170598375|NCT01533922|616535514|FG001|Overall Study|Protocol Violation|3|||
170598376|NCT01533922|616535515|FG002|Overall Study|Protocol Violation|0|||
170598377|NCT01533922|616535516|FG003|Overall Study|Protocol Violation|0|||
170598378|NCT01533922|616535517|FG004|Overall Study|Protocol Violation|1|||
170598379|NCT01533922|616535513|FG000|Overall Study|Withdrawal by Subject|3|||
170598380|NCT01533922|616535514|FG001|Overall Study|Withdrawal by Subject|1|||
170598381|NCT01533922|616535515|FG002|Overall Study|Withdrawal by Subject|2|||
170598382|NCT01533922|616535516|FG003|Overall Study|Withdrawal by Subject|2|||
170598383|NCT01533922|616535517|FG004|Overall Study|Withdrawal by Subject|1|||
170598384|NCT01533922|616535513|FG000|Overall Study|Other reason not defined above|2|||
170598385|NCT01533922|616535514|FG001|Overall Study|Other reason not defined above|0|||
170598386|NCT01533922|616535515|FG002|Overall Study|Other reason not defined above|1|||
170598387|NCT01533922|616535516|FG003|Overall Study|Other reason not defined above|0|||
170598388|NCT01533922|616535517|FG004|Overall Study|Other reason not defined above|0|||
170598389|NCT01267175|616535521|FG000|Overall Study|Withdrawal by Subject|1|||
170598390|NCT01267175|616535521|FG000|Overall Study|Lost to Follow-up|1|||
170598391|NCT00895661|616535522|FG000|Overall Study|Death|1|||
170598392|NCT00895661|616535522|FG000|Overall Study|reason unknown|2|||
170598393|NCT02006069|616535523|FG000|Overall Study|MPP other programming|239|||
170598394|NCT02006069|616535524|FG001|Overall Study|MPP other programming|0|||
170598395|NCT02006069|616535523|FG000|Overall Study|RV only pacing|0|||
170598396|NCT02006069|616535524|FG001|Overall Study|RV only pacing|3|||
170598397|NCT02989805|616535527|FG000|Overall Study|invalid consent|6|||
170598398|NCT02989805|616535528|FG001|Overall Study|invalid consent|4|||
170598399|NCT05028517|616535529|FG000|Overall Study|Lost to Follow-up|13|||
170598400|NCT05028517|616535530|FG001|Overall Study|Lost to Follow-up|20|||
170598401|NCT05028517|616535531|FG002|Overall Study|Lost to Follow-up|12|||
170598402|NCT05028517|616535529|FG000|Overall Study|Withdrawal by Subject|0|||
170598403|NCT05028517|616535530|FG001|Overall Study|Withdrawal by Subject|0|||
170598404|NCT05028517|616535531|FG002|Overall Study|Withdrawal by Subject|1|||
170598405|NCT02776033|616535532|FG000|Overall Study|Withdrawal by Subject|0|||
170598406|NCT02776033|616535533|FG001|Overall Study|Withdrawal by Subject|0|||
170598407|NCT02776033|616535534|FG002|Overall Study|Withdrawal by Subject|2|||
170598408|NCT02776033|616535532|FG000|Overall Study|Physician Decision|2|||
170598409|NCT02776033|616535533|FG001|Overall Study|Physician Decision|0|||
170598410|NCT02776033|616535534|FG002|Overall Study|Physician Decision|0|||
170598411|NCT02776033|616535532|FG000|Overall Study|Lost to Follow-up|1|||
170598412|NCT02776033|616535533|FG001|Overall Study|Lost to Follow-up|0|||
170651664|NCT00402233|616738191|FG002|Overall Study|Protocol Violation|0|||
170598413|NCT02776033|616535534|FG002|Overall Study|Lost to Follow-up|0|||
170598414|NCT02776033|616535532|FG000|Overall Study|Adverse Event|1|||
170598415|NCT02776033|616535533|FG001|Overall Study|Adverse Event|2|||
170598416|NCT02776033|616535534|FG002|Overall Study|Adverse Event|0|||
170598417|NCT00316888|616535538|FG000|Overall Study|Adverse Event|4|||
170598418|NCT00316888|616535539|FG001|Overall Study|Adverse Event|5|||
170598419|NCT00316888|616535538|FG000|Overall Study|Withdrawal by Subject|2|||
170598420|NCT00316888|616535539|FG001|Overall Study|Withdrawal by Subject|2|||
170598421|NCT00316888|616535538|FG000|Overall Study|Not start protocol therapy|0|||
170598422|NCT00316888|616535539|FG001|Overall Study|Not start protocol therapy|1|||
170598423|NCT00685373|616535540|FG000|Overall Study|Adverse Event|3|||
170598424|NCT00685373|616535540|FG000|Overall Study|Withdrawal by Subject|5|||
170598425|NCT00685373|616535540|FG000|Overall Study|Lack of Efficacy|3|||
170598426|NCT00685373|616535540|FG000|Overall Study|Condition no longer requires study drug|1|||
170598427|NCT00685373|616535540|FG000|Overall Study|Lost to Follow-up|2|||
170598428|NCT00685373|616535540|FG000|Overall Study|Protocol Violation|1|||
170598429|NCT00652899|616535541|FG000|Overall Study|Death|1|||
170598430|NCT00652899|616535541|FG000|Overall Study|Treating physician decision|1|||
170598431|NCT01302054|616535542|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
170598432|NCT01302054|616535543|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
170598433|NCT01302054|616535544|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
170598434|NCT01302054|616535542|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
170598435|NCT01302054|616535543|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
170598436|NCT01302054|616535544|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
170598437|NCT01302054|616535542|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
170598438|NCT01302054|616535543|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
170598439|NCT01302054|616535544|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
170598440|NCT01302054|616535542|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
170598441|NCT01302054|616535543|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
170598442|NCT01302054|616535544|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
170598443|NCT01302054|616535542|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
170598444|NCT01302054|616535543|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
170598445|NCT01302054|616535544|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
170598446|NCT01302054|616535542|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
170598447|NCT01302054|616535543|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
170598448|NCT01302054|616535544|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
170598449|NCT01302054|616535542|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
170598450|NCT01302054|616535543|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
170598451|NCT01302054|616535544|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
170598452|NCT01302054|616535542|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
170598453|NCT01302054|616535543|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
170598454|NCT01302054|616535544|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
170598455|NCT01302054|616535542|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
170598456|NCT01302054|616535543|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
170598457|NCT01302054|616535544|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
170598458|NCT01302054|616535542|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170598459|NCT01302054|616535543|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
170598460|NCT01302054|616535544|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
170598461|NCT01302054|616535542|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
170598462|NCT01302054|616535543|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
170598463|NCT01302054|616535544|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
170598464|NCT01302054|616535542|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
170598465|NCT01302054|616535543|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
170598466|NCT01302054|616535544|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
170598467|NCT01302054|616535542|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
170598468|NCT01302054|616535543|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
170598469|NCT01302054|616535544|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
170598470|NCT01302054|616535542|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
170598471|NCT01302054|616535543|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
170598472|NCT01302054|616535544|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
170598473|NCT01302054|616535542|FG000|Double-Blind Treatment Phase|Other|0|||
170598474|NCT01302054|616535543|FG001|Double-Blind Treatment Phase|Other|4|||
170598475|NCT01302054|616535544|FG002|Double-Blind Treatment Phase|Other|9|||
170598476|NCT03757130|616535548|FG000|Overall Study|Lost to Follow-up|0|||
170598477|NCT03757130|616535549|FG001|Overall Study|Lost to Follow-up|0|||
170598478|NCT03757130|616535550|FG002|Overall Study|Lost to Follow-up|0|||
170598479|NCT03757130|616535551|FG003|Overall Study|Lost to Follow-up|1|||
170598480|NCT03757130|616535552|FG004|Overall Study|Lost to Follow-up|0|||
170598481|NCT03757130|616535553|FG005|Overall Study|Lost to Follow-up|0|||
170598482|NCT03757130|616535554|FG006|Overall Study|Lost to Follow-up|0|||
170598483|NCT03757130|616535555|FG007|Overall Study|Lost to Follow-up|1|||
170598484|NCT03757130|616535548|FG000|Overall Study|Withdrawal by Subject|0|||
170598485|NCT03757130|616535549|FG001|Overall Study|Withdrawal by Subject|0|||
170598486|NCT03757130|616535550|FG002|Overall Study|Withdrawal by Subject|0|||
170812486|NCT00244751|617322632|FG000|Overall Study|Protocol Violation|1|||
170812487|NCT00244751|617322633|FG001|Overall Study|Protocol Violation|0|||
170812488|NCT00244751|617322634|FG002|Overall Study|Protocol Violation|1|||
170598487|NCT03757130|616535551|FG003|Overall Study|Withdrawal by Subject|0|||
170598488|NCT03757130|616535552|FG004|Overall Study|Withdrawal by Subject|0|||
170598489|NCT03757130|616535553|FG005|Overall Study|Withdrawal by Subject|0|||
170598490|NCT03757130|616535554|FG006|Overall Study|Withdrawal by Subject|1|||
170598491|NCT03757130|616535555|FG007|Overall Study|Withdrawal by Subject|0|||
170812489|NCT00244751|617322632|FG000|Overall Study|Withdrawal by Subject|7|||
170812490|NCT00244751|617322633|FG001|Overall Study|Withdrawal by Subject|5|||
170812491|NCT00244751|617322634|FG002|Overall Study|Withdrawal by Subject|3|||
170812492|NCT00244751|617322632|FG000|Overall Study|Elevated liver enzymes|1|||
170812493|NCT00244751|617322633|FG001|Overall Study|Elevated liver enzymes|0|||
170812494|NCT00244751|617322634|FG002|Overall Study|Elevated liver enzymes|0|||
170812495|NCT00244751|617322632|FG000|Overall Study|Lack of compliance with protocol|0|||
170812496|NCT00244751|617322633|FG001|Overall Study|Lack of compliance with protocol|1|||
170812497|NCT00244751|617322634|FG002|Overall Study|Lack of compliance with protocol|0|||
170812498|NCT00244751|617322632|FG000|Overall Study|Safety reasons|0|||
170812499|NCT00244751|617322633|FG001|Overall Study|Safety reasons|1|||
170812500|NCT00244751|617322634|FG002|Overall Study|Safety reasons|0|||
170812501|NCT00244751|617322632|FG000|Overall Study|Participant randomized by mistake|0|||
170812502|NCT00244751|617322633|FG001|Overall Study|Participant randomized by mistake|0|||
170812503|NCT00244751|617322634|FG002|Overall Study|Participant randomized by mistake|1|||
170812504|NCT02877680|617322635|FG000|Overall Study|Lost to Follow-up|1|||
170812505|NCT02877680|617322636|FG001|Overall Study|Lost to Follow-up|1|||
170812506|NCT01133678|617322637|FG000|Overall Study|Death|1|||
170913494|NCT00104104|617685926|FG001|Overall Study|Withdrawal by Subject|15|||
170598492|NCT02855944|616535556|FG000|Period 1: Treatment|Ongoing|14|||
170598493|NCT02855944|616535557|FG001|Period 1: Treatment|Ongoing|0|||
170598494|NCT02855944|616535556|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
170598495|NCT02855944|616535557|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
170598496|NCT02855944|616535556|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
170598497|NCT02855944|616535557|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
170598498|NCT00966719|616535558|FG000|Overall Study|Lost to Follow-up|6|||
170598499|NCT00966719|616535559|FG001|Overall Study|Lost to Follow-up|11|||
170598500|NCT01439126|616535560|FG000|Overall Study|Adverse Event|2|||
170598501|NCT01439126|616535561|FG001|Overall Study|Adverse Event|0|||
170598502|NCT01439126|616535560|FG000|Overall Study|Withdrawal by Subject|5|||
170598503|NCT01439126|616535561|FG001|Overall Study|Withdrawal by Subject|21|||
170598504|NCT01439126|616535560|FG000|Overall Study|Protocol Violation|6|||
170598505|NCT01439126|616535561|FG001|Overall Study|Protocol Violation|4|||
170598506|NCT01439126|616535560|FG000|Overall Study|Lost to Follow-up|6|||
170598507|NCT01439126|616535561|FG001|Overall Study|Lost to Follow-up|3|||
170598508|NCT01439126|616535560|FG000|Overall Study|Other-Use of prohibited treatment|0|||
170598509|NCT01439126|616535561|FG001|Overall Study|Other-Use of prohibited treatment|2|||
170598510|NCT01439126|616535560|FG000|Overall Study|Other-Miscellaneous|12|||
170598511|NCT01439126|616535561|FG001|Overall Study|Other-Miscellaneous|12|||
170598512|NCT03242018|616535562|FG000|Overall Study|Adverse Event|7|||
170598513|NCT03242018|616535563|FG001|Overall Study|Adverse Event|7|||
170598514|NCT03242018|616535564|FG002|Overall Study|Adverse Event|6|||
170598515|NCT03242018|616535562|FG000|Overall Study|Lost to Follow-up|2|||
170598516|NCT03242018|616535563|FG001|Overall Study|Lost to Follow-up|2|||
170598517|NCT03242018|616535564|FG002|Overall Study|Lost to Follow-up|2|||
170598518|NCT03242018|616535562|FG000|Overall Study|At the Participant's Own Request|5|||
170598519|NCT03242018|616535563|FG001|Overall Study|At the Participant's Own Request|1|||
170598520|NCT03242018|616535564|FG002|Overall Study|At the Participant's Own Request|4|||
170598521|NCT03242018|616535562|FG000|Overall Study|Reason Not Specified|3|||
170598522|NCT03242018|616535563|FG001|Overall Study|Reason Not Specified|4|||
170598523|NCT03242018|616535564|FG002|Overall Study|Reason Not Specified|1|||
170598524|NCT03242018|616535562|FG000|Overall Study|Study Terminated by Sponsor|1|||
170598525|NCT03242018|616535563|FG001|Overall Study|Study Terminated by Sponsor|0|||
170598526|NCT03242018|616535564|FG002|Overall Study|Study Terminated by Sponsor|1|||
170598527|NCT00160199|616535565|FG000|Overall Study|Adverse Event|5|||
170598528|NCT00160199|616535566|FG001|Overall Study|Adverse Event|14|||
170598529|NCT00160199|616535565|FG000|Overall Study|Lack of Efficacy|0|||
170598530|NCT00160199|616535566|FG001|Overall Study|Lack of Efficacy|1|||
170598531|NCT00160199|616535565|FG000|Overall Study|Lost to Follow-up|7|||
170598532|NCT00160199|616535566|FG001|Overall Study|Lost to Follow-up|7|||
170598533|NCT00160199|616535565|FG000|Overall Study|Withdrawal by Subject|4|||
170598534|NCT00160199|616535566|FG001|Overall Study|Withdrawal by Subject|6|||
170598535|NCT00160199|616535565|FG000|Overall Study|Administrative|0|||
170913495|NCT00104104|617685925|FG000|Overall Study|Lost to Follow-up|3|||
170812507|NCT01133678|617322638|FG001|Overall Study|Death|1|||
170598536|NCT00160199|616535566|FG001|Overall Study|Administrative|1|||
170598537|NCT00160199|616535565|FG000|Overall Study|Protocol Violation|8|||
170598538|NCT00160199|616535566|FG001|Overall Study|Protocol Violation|8|||
170598539|NCT03262116|616535567|FG000|Overall Study|Physician Decision|0|||
170598540|NCT03262116|616535568|FG001|Overall Study|Physician Decision|2|||
170598541|NCT03262116|616535569|FG002|Overall Study|Physician Decision|1|||
170598542|NCT03262116|616535570|FG003|Overall Study|Physician Decision|1|||
170598543|NCT03262116|616535571|FG004|Overall Study|Physician Decision|1|||
170598544|NCT03262116|616535572|FG005|Overall Study|Physician Decision|2|||
170598545|NCT02365285|616535573|FG000|Overall Study|Physician Decision|0|||
170598546|NCT02365285|616535574|FG001|Overall Study|Physician Decision|1|||
170812508|NCT00526994|617322645|FG000|Overall Study|Lost to Follow-up|98|||
170651665|NCT00402233|616738192|FG003|Overall Study|Protocol Violation|0|||
170598547|NCT02365285|616535575|FG002|Overall Study|Physician Decision|1|||
170598548|NCT02365285|616535576|FG003|Overall Study|Physician Decision|0|||
170598549|NCT02365285|616535573|FG000|Overall Study|Adverse Event|0|||
170598550|NCT02365285|616535574|FG001|Overall Study|Adverse Event|0|||
170598551|NCT02365285|616535575|FG002|Overall Study|Adverse Event|0|||
170598552|NCT02365285|616535576|FG003|Overall Study|Adverse Event|2|||
170598553|NCT00525824|616535577|FG000|Overall Study|Adverse Event|7|||
170598554|NCT00525824|616535578|FG001|Overall Study|Adverse Event|11|||
170598555|NCT00525824|616535579|FG002|Overall Study|Adverse Event|6|||
170598556|NCT00525824|616535580|FG003|Overall Study|Adverse Event|7|||
170598557|NCT00525824|616535577|FG000|Overall Study|Withdrawal by Subject|5|||
170598558|NCT00525824|616535578|FG001|Overall Study|Withdrawal by Subject|9|||
170598559|NCT00525824|616535579|FG002|Overall Study|Withdrawal by Subject|3|||
170598560|NCT00525824|616535580|FG003|Overall Study|Withdrawal by Subject|4|||
170598561|NCT00525824|616535577|FG000|Overall Study|Lost to Follow-up|4|||
170598562|NCT00525824|616535578|FG001|Overall Study|Lost to Follow-up|2|||
170598563|NCT00525824|616535579|FG002|Overall Study|Lost to Follow-up|4|||
170598564|NCT00525824|616535580|FG003|Overall Study|Lost to Follow-up|0|||
170598565|NCT00525824|616535577|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
170598566|NCT00525824|616535578|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
170598567|NCT00525824|616535579|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
170598568|NCT00525824|616535580|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
170598569|NCT00525824|616535577|FG000|Overall Study|Severe non-compliance|0|||
170598570|NCT00525824|616535578|FG001|Overall Study|Severe non-compliance|1|||
170598571|NCT00525824|616535579|FG002|Overall Study|Severe non-compliance|1|||
170598572|NCT00525824|616535580|FG003|Overall Study|Severe non-compliance|1|||
170598573|NCT00525824|616535577|FG000|Overall Study|Safety reasons|1|||
170598574|NCT00525824|616535578|FG001|Overall Study|Safety reasons|0|||
170598575|NCT00525824|616535579|FG002|Overall Study|Safety reasons|1|||
170598576|NCT00525824|616535580|FG003|Overall Study|Safety reasons|0|||
170598577|NCT00525824|616535577|FG000|Overall Study|Other|1|||
170598578|NCT00525824|616535578|FG001|Overall Study|Other|3|||
170598579|NCT00525824|616535579|FG002|Overall Study|Other|3|||
170598580|NCT00525824|616535580|FG003|Overall Study|Other|1|||
170598581|NCT00444067|616535588|FG000|Overall Study|Lost to Follow-up|0|||
170598582|NCT00444067|616535589|FG001|Overall Study|Lost to Follow-up|1|||
170598583|NCT00267150|616535590|FG000|Overall Study|Adverse Event|1|||
170598584|NCT02720692|616537011|FG000|Overall Study|Withdrawal by Subject|3|||
170598585|NCT02720692|616537012|FG001|Overall Study|Withdrawal by Subject|0|||
170598586|NCT02720692|616537011|FG000|Overall Study|Physician Decision|1|||
170598587|NCT02720692|616537012|FG001|Overall Study|Physician Decision|0|||
170598588|NCT02720692|616537011|FG000|Overall Study|Lost to Follow-up|8|||
170598589|NCT02720692|616537012|FG001|Overall Study|Lost to Follow-up|3|||
170598590|NCT02720692|616537011|FG000|Overall Study|Subject unable to return for visit|1|||
170598591|NCT02720692|616537012|FG001|Overall Study|Subject unable to return for visit|0|||
170598592|NCT01769196|616537013|FG000|Overall Study|Adverse Event|24|||
170598593|NCT01769196|616537014|FG001|Overall Study|Adverse Event|20|||
170598594|NCT01769196|616537013|FG000|Overall Study|Death|21|||
170598595|NCT01769196|616537014|FG001|Overall Study|Death|26|||
170598596|NCT01769196|616537013|FG000|Overall Study|Investigator Discretion|7|||
170598597|NCT01769196|616537014|FG001|Overall Study|Investigator Discretion|3|||
170598598|NCT01769196|616537013|FG000|Overall Study|Lack of Efficacy|3|||
170598599|NCT01769196|616537014|FG001|Overall Study|Lack of Efficacy|2|||
170598600|NCT01769196|616537013|FG000|Overall Study|Progressive disease|11|||
170598601|NCT01769196|616537014|FG001|Overall Study|Progressive disease|6|||
170598602|NCT01769196|616537013|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
170598603|NCT01769196|616537014|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
170598604|NCT01769196|616537013|FG000|Overall Study|Protocol Violation|0|||
170598605|NCT01769196|616537014|FG001|Overall Study|Protocol Violation|3|||
170651666|NCT00402233|616738189|FG000|Overall Study|Withdrawal by Subject|2|||
170651667|NCT00402233|616738190|FG001|Overall Study|Withdrawal by Subject|1|||
170598606|NCT01769196|616537013|FG000|Overall Study|Study terminated by sponsor|160|||
170598607|NCT01769196|616537014|FG001|Overall Study|Study terminated by sponsor|161|||
170598608|NCT01769196|616537013|FG000|Overall Study|Participant never dosed with study drug|1|||
170598609|NCT01769196|616537014|FG001|Overall Study|Participant never dosed with study drug|0|||
170598610|NCT01769196|616537013|FG000|Overall Study|Withdrew consent|36|||
170598611|NCT01769196|616537014|FG001|Overall Study|Withdrew consent|40|||
170598612|NCT00765063|616537015|FG000|Overall Study|Lack of Efficacy|5|||
170598613|NCT00765063|616537015|FG000|Overall Study|Withdrawal by Subject|1|||
170598614|NCT00765063|616537015|FG000|Overall Study|Other|16|||
170598615|NCT00765063|616537015|FG000|Overall Study|Protocol Violation|6|||
170598616|NCT00765063|616537015|FG000|Overall Study|Adverse Event|4|||
170598617|NCT03614325|616537016|FG000|Overall Study|Withdrawal by Subject|0|||
170598618|NCT03614325|616537017|FG001|Overall Study|Withdrawal by Subject|2|||
170598619|NCT03614325|616537016|FG000|Overall Study|Surgery Cancelled|2|||
170598620|NCT03614325|616537017|FG001|Overall Study|Surgery Cancelled|1|||
170598621|NCT03614325|616537016|FG000|Overall Study|Lost to Follow-up|2|||
170598622|NCT03614325|616537017|FG001|Overall Study|Lost to Follow-up|1|||
170598623|NCT03614325|616537016|FG000|Overall Study|Surgery never scheduled|1|||
170598624|NCT03614325|616537017|FG001|Overall Study|Surgery never scheduled|0|||
170598625|NCT00321464|616537018|FG000|Overall Study|Death|169|||
170598626|NCT00321464|616537019|FG001|Overall Study|Death|174|||
170598627|NCT00321464|616537018|FG000|Overall Study|Disease progression|124|||
170598628|NCT00321464|616537019|FG001|Overall Study|Disease progression|124|||
170598629|NCT00321464|616537018|FG000|Overall Study|Withdrawal by Subject|117|||
170598630|NCT00321464|616537019|FG001|Overall Study|Withdrawal by Subject|118|||
170598631|NCT00321464|616537018|FG000|Overall Study|Participant request|57|||
170598632|NCT00321464|616537019|FG001|Overall Study|Participant request|61|||
170598633|NCT00321464|616537018|FG000|Overall Study|Adverse Event|43|||
170598634|NCT00321464|616537019|FG001|Overall Study|Adverse Event|28|||
170598635|NCT00321464|616537018|FG000|Overall Study|Physician Decision|15|||
170598636|NCT00321464|616537019|FG001|Overall Study|Physician Decision|14|||
170598637|NCT00321464|616537018|FG000|Overall Study|Noncompliance|4|||
170598638|NCT00321464|616537019|FG001|Overall Study|Noncompliance|10|||
170598639|NCT00321464|616537018|FG000|Overall Study|Lost to Follow-up|7|||
170598640|NCT00321464|616537019|FG001|Overall Study|Lost to Follow-up|8|||
170598641|NCT00321464|616537018|FG000|Overall Study|Protocol deviation|0|||
170598642|NCT00321464|616537019|FG001|Overall Study|Protocol deviation|2|||
170598643|NCT00321464|616537018|FG000|Overall Study|Ineligibility determined|2|||
170598644|NCT00321464|616537019|FG001|Overall Study|Ineligibility determined|1|||
170598645|NCT00321464|616537018|FG000|Overall Study|Other|21|||
170598646|NCT00321464|616537019|FG001|Overall Study|Other|18|||
170598647|NCT01673620|616537025|FG000|Overall Study|Adverse Event|1|||
170598648|NCT01673620|616537026|FG001|Overall Study|Adverse Event|0|||
170598649|NCT00652951|616537027|FG000|Booster Phase|Adverse event, non-fatal|0|||
170598650|NCT00652951|616537028|FG001|Booster Phase|Adverse event, non-fatal|1|||
170598651|NCT00652951|616537029|FG002|Booster Phase|Adverse event, non-fatal|0|||
170598652|NCT00652951|616537027|FG000|Booster Phase|Other|1|||
170598653|NCT00652951|616537028|FG001|Booster Phase|Other|0|||
170598654|NCT00652951|616537029|FG002|Booster Phase|Other|0|||
170598655|NCT01022424|616537030|FG000|Overall Study|Adverse Event|1|||
170598656|NCT01022424|616537030|FG000|Overall Study|Physician Decision|1|||
170598657|NCT01022424|616537030|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
170598658|NCT01206582|616537031|FG000|Overall Study|Withdrew prior to study|1|||
170598659|NCT01206582|616537032|FG001|Overall Study|Withdrew prior to study|0|||
170598660|NCT01206582|616537031|FG000|Overall Study|Discontinued intervention before week 8|1|||
170598661|NCT01206582|616537032|FG001|Overall Study|Discontinued intervention before week 8|2|||
170598662|NCT02100969|616537035|FG000|Overall Study|Did not pass screening phase|1|||
170598663|NCT01629953|616537036|FG000|Overall Study|Death|3|||
170598664|NCT01629953|616537037|FG001|Overall Study|Death|1|||
170598665|NCT01629953|616537036|FG000|Overall Study|Lost to Follow-up|10|||
170598666|NCT01629953|616537037|FG001|Overall Study|Lost to Follow-up|14|||
170598667|NCT00720343|616537038|FG000|Overall Study|Lost to Follow-up|1|||
170598668|NCT00720343|616537039|FG001|Overall Study|Lost to Follow-up|0|||
170598669|NCT00720343|616537038|FG000|Overall Study|Protocol Violation|0|||
170651668|NCT00402233|616738191|FG002|Overall Study|Withdrawal by Subject|2|||
170651669|NCT00402233|616738192|FG003|Overall Study|Withdrawal by Subject|2|||
170651670|NCT00402233|616738189|FG000|Overall Study|Worsening of disease under study|2|||
170651671|NCT00402233|616738190|FG001|Overall Study|Worsening of disease under study|0|||
170651672|NCT00402233|616738191|FG002|Overall Study|Worsening of disease under study|0|||
170651673|NCT00402233|616738192|FG003|Overall Study|Worsening of disease under study|0|||
170651674|NCT00402233|616738189|FG000|Overall Study|Worsening of other pre-existing disease|0|||
170651675|NCT00402233|616738190|FG001|Overall Study|Worsening of other pre-existing disease|1|||
170651676|NCT00402233|616738191|FG002|Overall Study|Worsening of other pre-existing disease|0|||
170651677|NCT00402233|616738192|FG003|Overall Study|Worsening of other pre-existing disease|0|||
170651678|NCT00621621|616738201|FG000|Overall Study|Subjects were exited at EP study|30|||
170651679|NCT00621621|616738202|FG001|Overall Study|Subjects were exited at EP study|0|||
170651680|NCT01894568|616738205|FG000|Overall Study|Adverse Event|2|||
170812509|NCT00526994|617322646|FG001|Overall Study|Lost to Follow-up|108|||
170812510|NCT00526994|617322647|FG002|Overall Study|Lost to Follow-up|96|||
170598670|NCT00720343|616537039|FG001|Overall Study|Protocol Violation|2|||
170598671|NCT03459365|616537044|FG000|Overall Study|Withdrawal by Subject|6|||
170598672|NCT03459365|616537044|FG000|Overall Study|Protocol Violation|8|||
170598673|NCT02702180|616537045|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
170598674|NCT02702180|616537046|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
170598675|NCT02702180|616537047|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170598676|NCT02702180|616537045|FG000|Double-blind Treatment Period|Adverse Event|0|||
170598677|NCT02702180|616537046|FG001|Double-blind Treatment Period|Adverse Event|0|||
170598678|NCT02702180|616537047|FG002|Double-blind Treatment Period|Adverse Event|1|||
170598679|NCT02702180|616537045|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
170651681|NCT01894568|616738206|FG001|Overall Study|Adverse Event|3|||
170651682|NCT01894568|616738205|FG000|Overall Study|Protocol required discontinuation|2|||
170812511|NCT00526994|617322645|FG000|Overall Study|Death|4|||
170913496|NCT00104104|617685926|FG001|Overall Study|Lost to Follow-up|7|||
170598680|NCT02702180|616537046|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
170598681|NCT02702180|616537047|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
170598682|NCT02702180|616537045|FG000|Double-blind Treatment Period|Protocol Violation|0|||
170598683|NCT02702180|616537046|FG001|Double-blind Treatment Period|Protocol Violation|0|||
170598684|NCT02702180|616537047|FG002|Double-blind Treatment Period|Protocol Violation|2|||
170598685|NCT02702180|616537045|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
170598686|NCT02702180|616537046|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
170598687|NCT02702180|616537047|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
170598688|NCT02702180|616537045|FG000|Open-label Treatment Period|Withdrawn in error|0|||
170598689|NCT02702180|616537046|FG001|Open-label Treatment Period|Withdrawn in error|0|||
170598690|NCT02702180|616537047|FG002|Open-label Treatment Period|Withdrawn in error|1|||
170913497|NCT00104104|617685925|FG000|Overall Study|Administrative problems|12|||
170913498|NCT00104104|617685926|FG001|Overall Study|Administrative problems|13|||
170598691|NCT00785980|616537048|FG000|7 Day Washout Period|Protocol Violation|3|||
170598692|NCT00528801|616537049|FG000|Overall Study|Withdrawal by Subject|1|||
170598693|NCT00528801|616537050|FG001|Overall Study|Withdrawal by Subject|1|||
170598694|NCT00528801|616537049|FG000|Overall Study|Protocol Violation|11|||
170598695|NCT00528801|616537050|FG001|Overall Study|Protocol Violation|5|||
170598696|NCT00528801|616537049|FG000|Overall Study|Lost to Follow-up|15|||
170598697|NCT00528801|616537050|FG001|Overall Study|Lost to Follow-up|4|||
170598698|NCT00528801|616537049|FG000|Overall Study|Administrative Reasons|0|||
170598699|NCT00528801|616537050|FG001|Overall Study|Administrative Reasons|1|||
170598700|NCT02207491|616537051|FG000|Overall Study|Adverse Event|20|||
170598701|NCT02207491|616537052|FG001|Overall Study|Adverse Event|4|||
170598702|NCT02207491|616537051|FG000|Overall Study|Withdrawal by Subject|3|||
170598703|NCT02207491|616537052|FG001|Overall Study|Withdrawal by Subject|2|||
170598704|NCT02207491|616537051|FG000|Overall Study|Non-compliant|0|||
170598705|NCT02207491|616537052|FG001|Overall Study|Non-compliant|1|||
170598706|NCT02207491|616537051|FG000|Overall Study|Lost to Follow-up|0|||
170598707|NCT02207491|616537052|FG001|Overall Study|Lost to Follow-up|1|||
170598708|NCT02207491|616537051|FG000|Overall Study|Lack of Efficacy|3|||
170598709|NCT02207491|616537052|FG001|Overall Study|Lack of Efficacy|0|||
170598710|NCT02207491|616537051|FG000|Overall Study|Physician Decision|2|||
170598711|NCT02207491|616537052|FG001|Overall Study|Physician Decision|0|||
170598712|NCT02207491|616537051|FG000|Overall Study|Protocol Violation|3|||
170598713|NCT02207491|616537052|FG001|Overall Study|Protocol Violation|5|||
170598714|NCT00599755|616537053|FG000|Overall Study|Adverse Event|11|||
170598715|NCT00599755|616537053|FG000|Overall Study|Withdrawal by Subject|2|||
170598716|NCT00599755|616537053|FG000|Overall Study|Progression of Disease|3|||
170598717|NCT00599755|616537053|FG000|Overall Study|Other Reason|2|||
170598718|NCT00599755|616537053|FG000|Overall Study|No data available|1|||
170598719|NCT00477152|616537054|FG000|Overall Study|Parent withdrew consent|2|||
170598720|NCT00477152|616537054|FG000|Overall Study|Adverse Event|1|||
170598721|NCT00372697|616537055|FG000|Overall Study|Protocol Violation|1|||
170598722|NCT00372697|616537056|FG001|Overall Study|Protocol Violation|1|||
170598723|NCT00680368|616537057|FG000|Overall Study|not supervised, not eligible|15|||
170598724|NCT02690649|616537058|FG000|Overall Study|Withdrawal by Subject|1|||
170598725|NCT02690649|616537059|FG001|Overall Study|Withdrawal by Subject|1|||
170598726|NCT02690649|616537058|FG000|Overall Study|Protocol Violation|0|||
170598727|NCT02690649|616537059|FG001|Overall Study|Protocol Violation|3|||
170598728|NCT02066129|616537060|FG000|Overall Study|Lost to Follow-up|13|||
170598729|NCT02066129|616537061|FG001|Overall Study|Lost to Follow-up|12|||
170598730|NCT02066129|616537060|FG000|Overall Study|Withdrawal by Subject|7|||
170598731|NCT02066129|616537061|FG001|Overall Study|Withdrawal by Subject|10|||
170598732|NCT02066129|616537060|FG000|Overall Study|Lack of Efficacy|8|||
170598733|NCT02066129|616537061|FG001|Overall Study|Lack of Efficacy|10|||
170598734|NCT02066129|616537060|FG000|Overall Study|Physician Decision|1|||
170598735|NCT02066129|616537061|FG001|Overall Study|Physician Decision|1|||
170598736|NCT02642965|616537062|FG000|Overall Study|Lack of Efficacy|4|||
170598737|NCT02642965|616537062|FG000|Overall Study|Physician Decision|9|||
170598738|NCT01600053|616537065|FG000|Overall Study|Adverse Event|2|||
170598739|NCT01600053|616537065|FG000|Overall Study|trial will not meet the interim endpoint|9|||
170598740|NCT01565941|616537068|FG000|Overall Study|Withdrawn by parent/guardian|3|||
170598741|NCT01565941|616537069|FG001|Overall Study|Withdrawn by parent/guardian|2|||
170598742|NCT01565941|616537068|FG000|Overall Study|Randomized; did not receive intevention|8|||
170598743|NCT01565941|616537069|FG001|Overall Study|Randomized; did not receive intevention|2|||
170598744|NCT03230292|616537070|FG000|Overall Study|Adverse Event|1|||
170598745|NCT03230292|616537070|FG000|Overall Study|Protocol Violation|1|||
170598746|NCT03230292|616537070|FG000|Overall Study|Lost to Follow-up|1|||
170598747|NCT03230292|616537070|FG000|Overall Study|Withdrawal by Subject|3|||
170598748|NCT01639755|616537073|FG000|Overall Study|Study Ongoing|15|||
170598749|NCT01639755|616537073|FG000|Overall Study|Patient had device explantation|4|||
170598750|NCT00635089|616537077|FG000|Overall Study|Adverse Event|7|||
170598751|NCT00635089|616537077|FG000|Overall Study|Lack of Efficacy|28|||
170598752|NCT00635089|616537077|FG000|Overall Study|Protocol Deviation|4|||
170598753|NCT00635089|616537077|FG000|Overall Study|Lost to Follow-up|8|||
170812512|NCT00526994|617322646|FG001|Overall Study|Death|3|||
170812513|NCT00526994|617322647|FG002|Overall Study|Death|3|||
170812514|NCT00526994|617322645|FG000|Overall Study|Withdrawal by Subject|2|||
170812515|NCT00526994|617322646|FG001|Overall Study|Withdrawal by Subject|7|||
170812516|NCT00526994|617322647|FG002|Overall Study|Withdrawal by Subject|5|||
170812517|NCT00526994|617322645|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
170812518|NCT00526994|617322646|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
170812519|NCT00526994|617322647|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
170812520|NCT03026166|617322648|FG000|Overall Study|Death|22|||
170812521|NCT03026166|617322649|FG001|Overall Study|Death|7|||
170812522|NCT03026166|617322648|FG000|Overall Study|Physician Decision|2|||
170812523|NCT03026166|617322649|FG001|Overall Study|Physician Decision|0|||
170812524|NCT03026166|617322648|FG000|Overall Study|Withdrawal by Subject|1|||
170812525|NCT03026166|617322649|FG001|Overall Study|Withdrawal by Subject|2|||
170812526|NCT03026166|617322648|FG000|Overall Study|Lost to Follow-up|1|||
170812527|NCT03026166|617322649|FG001|Overall Study|Lost to Follow-up|0|||
170812528|NCT03026166|617322648|FG000|Overall Study|Study Terminated by Sponsor|3|||
170812529|NCT03026166|617322649|FG001|Overall Study|Study Terminated by Sponsor|3|||
170812530|NCT03026166|617322648|FG000|Overall Study|Other|1|||
170812531|NCT03026166|617322649|FG001|Overall Study|Other|0|||
170812532|NCT05270460|617322650|FG000|Overall Study|Adverse Event|0|||
170812533|NCT05270460|617322651|FG001|Overall Study|Adverse Event|1|||
170812534|NCT05270460|617322652|FG002|Overall Study|Adverse Event|0|||
170812535|NCT05270460|617322650|FG000|Overall Study|Early Termination|0|||
170812536|NCT05270460|617322651|FG001|Overall Study|Early Termination|1|||
170812537|NCT05270460|617322652|FG002|Overall Study|Early Termination|0|||
170812538|NCT04183491|617322653|FG000|Overall Study|Withdrawal by Subject|0|||
170812539|NCT04183491|617322654|FG001|Overall Study|Withdrawal by Subject|0|||
170812540|NCT04183491|617322655|FG002|Overall Study|Withdrawal by Subject|1|||
170812541|NCT04183491|617322656|FG003|Overall Study|Withdrawal by Subject|0|||
170812542|NCT04183491|617322657|FG004|Overall Study|Withdrawal by Subject|0|||
170812543|NCT04183491|617322658|FG005|Overall Study|Withdrawal by Subject|1|||
170812544|NCT04183491|617322659|FG006|Overall Study|Withdrawal by Subject|0|||
170812545|NCT01262456|617322660|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
170812546|NCT01262456|617322661|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
170812547|NCT01262456|617322662|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
170812548|NCT01262456|617322660|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
170812549|NCT01262456|617322661|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
170812550|NCT01262456|617322662|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
170812551|NCT01262456|617322660|FG000|3-Month Double-Blind Period|Adverse Event|6|||
170812552|NCT01262456|617322661|FG001|3-Month Double-Blind Period|Adverse Event|4|||
170812553|NCT01262456|617322662|FG002|3-Month Double-Blind Period|Adverse Event|8|||
170812554|NCT01262456|617322660|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
170812555|NCT01262456|617322661|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
170812556|NCT01262456|617322662|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
170812557|NCT01262456|617322660|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
170812558|NCT01262456|617322661|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
170812559|NCT01262456|617322662|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
170812560|NCT01262456|617322660|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
170812561|NCT01262456|617322661|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
170812562|NCT01262456|617322662|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
170812563|NCT01262456|617322660|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
170812564|NCT01262456|617322661|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
170812565|NCT01262456|617322662|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
170812566|NCT01262456|617322660|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
170812567|NCT01262456|617322661|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
170812568|NCT01262456|617322662|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
170812569|NCT01262456|617322660|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
170812570|NCT01262456|617322661|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
170812571|NCT01262456|617322662|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
170812572|NCT03938272|617322663|FG000|Overall Study|Withdrawal by Subject|1|||
170812573|NCT03938272|617322664|FG001|Overall Study|Withdrawal by Subject|0|||
170812574|NCT03938272|617322663|FG000|Overall Study|Physician Decision|0|||
170812575|NCT03938272|617322664|FG001|Overall Study|Physician Decision|2|||
170812576|NCT03938272|617322663|FG000|Overall Study|Study termination by sponsor|10|||
170812577|NCT03938272|617322664|FG001|Overall Study|Study termination by sponsor|8|||
170812578|NCT02538094|617322665|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
170812579|NCT02538094|617322666|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
170812580|NCT02538094|617322665|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
170812581|NCT02538094|617322666|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
170812582|NCT03288506|617322667|FG000|Overall Study|Withdrawal by Subject|52|||
170812583|NCT03692871|617322674|FG000|Overall Study|Death|1|||
170812584|NCT03692871|617322675|FG001|Overall Study|Death|1|||
170812585|NCT03692871|617322674|FG000|Overall Study|Lost to Follow-up|24|||
170598754|NCT00635089|616537077|FG000|Overall Study|Other|31|||
170598755|NCT01617447|616537078|FG000|Overall Study|Adverse Event|0|||
170598756|NCT01617447|616537079|FG001|Overall Study|Adverse Event|1|||
170598757|NCT01617447|616537078|FG000|Overall Study|Physician Decision|0|||
170598758|NCT01617447|616537079|FG001|Overall Study|Physician Decision|2|||
170598759|NCT02636946|616537081|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
170598760|NCT02636946|616537082|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
170598761|NCT02636946|616537081|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
170598762|NCT02636946|616537082|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
170598763|NCT02636946|616537081|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
170598764|NCT02636946|616537082|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
170598765|NCT02636946|616537081|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
170598766|NCT02636946|616537082|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
170598767|NCT02636946|616537081|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
170598768|NCT02636946|616537082|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
170598769|NCT02636946|616537081|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
170598770|NCT02636946|616537082|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
170598771|NCT01283542|616537083|FG000|Main Phase|Acute or progressive vision loss|1|||
170598772|NCT01283542|616537083|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
170598773|NCT01283542|616537083|FG000|Main Phase|abnormal laboratory values|5|||
170598774|NCT01283542|616537083|FG000|Extension Phase|Physician Decision|1|||
170598775|NCT01283542|616537083|FG000|Extension Phase|Adverse Event|1|||
170598776|NCT01283542|616537083|FG000|Extension Phase|Administrative problems|1|||
170598777|NCT04405245|616537084|FG000|Overall Study|Adverse Event|0|||
170598778|NCT04405245|616537085|FG001|Overall Study|Adverse Event|1|||
170598779|NCT04405245|616537086|FG002|Overall Study|Adverse Event|0|||
170598780|NCT00477269|616537089|FG000|Core Study|Adverse Event|6|||
170598781|NCT00477269|616537090|FG001|Core Study|Adverse Event|4|||
170598782|NCT00477269|616537091|FG002|Core Study|Adverse Event|0|||
170598783|NCT00477269|616537089|FG000|Core Study|Death|3|||
170598784|NCT00477269|616537090|FG001|Core Study|Death|3|||
170598785|NCT00477269|616537091|FG002|Core Study|Death|0|||
170598786|NCT00477269|616537089|FG000|Core Study|Withdrawn Consent|0|||
170598787|NCT00477269|616537090|FG001|Core Study|Withdrawn Consent|1|||
170598788|NCT00477269|616537091|FG002|Core Study|Withdrawn Consent|0|||
170598789|NCT00477269|616537089|FG000|Open Label Extension|Adverse Event|0|||
170598790|NCT00477269|616537090|FG001|Open Label Extension|Adverse Event|0|||
170598791|NCT00477269|616537091|FG002|Open Label Extension|Adverse Event|4|||
170598792|NCT00477269|616537089|FG000|Open Label Extension|Abnormal laboratory values|0|||
170598793|NCT00477269|616537090|FG001|Open Label Extension|Abnormal laboratory values|0|||
170598794|NCT00477269|616537091|FG002|Open Label Extension|Abnormal laboratory values|1|||
170598795|NCT00477269|616537089|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
170598796|NCT00477269|616537090|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
170598797|NCT00477269|616537091|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
170598798|NCT00477269|616537089|FG000|Open Label Extension|Adminiatrative problems|0|||
170598799|NCT00477269|616537090|FG001|Open Label Extension|Adminiatrative problems|0|||
170598800|NCT00477269|616537091|FG002|Open Label Extension|Adminiatrative problems|2|||
170598801|NCT00477269|616537089|FG000|Open Label Extension|Death|0|||
170598802|NCT00477269|616537090|FG001|Open Label Extension|Death|0|||
170598803|NCT00477269|616537091|FG002|Open Label Extension|Death|4|||
170598804|NCT02391961|616537092|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
170598805|NCT02391961|616537093|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
170598806|NCT02391961|616537092|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
170598807|NCT02391961|616537093|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
170598808|NCT02391961|616537092|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
170598809|NCT02391961|616537093|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
170598810|NCT02725593|616537094|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
170598811|NCT02725593|616537095|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
170598812|NCT02725593|616537094|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
170598813|NCT02725593|616537095|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
170598814|NCT02725593|616537094|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
170598815|NCT02725593|616537095|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
170598816|NCT02725593|616537094|FG000|Long Term Extension|Withdrawal by Subject|1|||
170598817|NCT02725593|616537095|FG001|Long Term Extension|Withdrawal by Subject|3|||
170598818|NCT01455220|616537099|FG000|Overall Study|screen fail|30|||
170598819|NCT00969436|616537104|FG000|Overall Study|Protocol Violation|1|||
170598820|NCT00969436|616537105|FG001|Overall Study|Protocol Violation|3|||
170598821|NCT00969436|616537106|FG002|Overall Study|Protocol Violation|0|||
170598822|NCT00969436|616537104|FG000|Overall Study|Migrated/moved from study area|12|||
170598823|NCT00969436|616537105|FG001|Overall Study|Migrated/moved from study area|10|||
170812586|NCT03692871|617322675|FG001|Overall Study|Lost to Follow-up|9|||
170812587|NCT03692871|617322674|FG000|Overall Study|Physician Decision|22|||
170812588|NCT03692871|617322675|FG001|Overall Study|Physician Decision|7|||
170812589|NCT03692871|617322674|FG000|Overall Study|Protocol Deviation|1|||
170812590|NCT03692871|617322675|FG001|Overall Study|Protocol Deviation|0|||
170812591|NCT03692871|617322674|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
170812592|NCT03692871|617322675|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
170812593|NCT03031782|617322677|FG000|Treatment Period 1|Lack of Efficacy|3|||
170812594|NCT03031782|617322678|FG001|Treatment Period 1|Lack of Efficacy|0|||
170812595|NCT03031782|617322679|FG002|Treatment Period 1|Lack of Efficacy|0|||
170812596|NCT03031782|617322680|FG003|Treatment Period 1|Lack of Efficacy|0|||
170812597|NCT03031782|617322681|FG004|Treatment Period 1|Lack of Efficacy|0|||
170812598|NCT03031782|617322677|FG000|Treatment Period 2|Physician Decision|0|||
170812599|NCT03031782|617322678|FG001|Treatment Period 2|Physician Decision|1|||
170812600|NCT03031782|617322679|FG002|Treatment Period 2|Physician Decision|0|||
170812601|NCT03031782|617322680|FG003|Treatment Period 2|Physician Decision|0|||
170812602|NCT03031782|617322681|FG004|Treatment Period 2|Physician Decision|3|||
170812603|NCT03031782|617322677|FG000|Treatment Period 2|Lack of Efficacy|0|||
170812604|NCT03031782|617322678|FG001|Treatment Period 2|Lack of Efficacy|1|||
170812605|NCT03031782|617322679|FG002|Treatment Period 2|Lack of Efficacy|0|||
170812606|NCT03031782|617322680|FG003|Treatment Period 2|Lack of Efficacy|0|||
170812607|NCT03031782|617322681|FG004|Treatment Period 2|Lack of Efficacy|1|||
170812608|NCT03031782|617322677|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170812609|NCT03031782|617322678|FG001|Treatment Period 2|Withdrawal by Subject|3|||
170812610|NCT03031782|617322679|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170812611|NCT03031782|617322680|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170812612|NCT03031782|617322681|FG004|Treatment Period 2|Withdrawal by Subject|1|||
170812613|NCT03031782|617322677|FG000|Treatment Period 2|Adverse Event|0|||
170812614|NCT03031782|617322678|FG001|Treatment Period 2|Adverse Event|1|||
170812615|NCT03031782|617322679|FG002|Treatment Period 2|Adverse Event|2|||
170812616|NCT03031782|617322680|FG003|Treatment Period 2|Adverse Event|0|||
170812617|NCT03031782|617322681|FG004|Treatment Period 2|Adverse Event|0|||
170812618|NCT03031782|617322677|FG000|Treatment Period 3|Withdrawal by Subject|0|||
170812619|NCT03031782|617322678|FG001|Treatment Period 3|Withdrawal by Subject|0|||
170812620|NCT03031782|617322679|FG002|Treatment Period 3|Withdrawal by Subject|0|||
170812621|NCT03031782|617322680|FG003|Treatment Period 3|Withdrawal by Subject|1|||
170812622|NCT03031782|617322681|FG004|Treatment Period 3|Withdrawal by Subject|0|||
170812623|NCT01930188|617322682|FG000|Overall Study|unclassified|4|||
170812624|NCT01930188|617322683|FG001|Overall Study|unclassified|5|||
170812625|NCT01930188|617322684|FG002|Overall Study|unclassified|3|||
170812626|NCT01930188|617322682|FG000|Overall Study|Missing follow-up information|2|||
170812627|NCT01930188|617322683|FG001|Overall Study|Missing follow-up information|2|||
170812628|NCT01930188|617322684|FG002|Overall Study|Missing follow-up information|3|||
170812629|NCT01930188|617322682|FG000|Overall Study|Lost to Follow-up|5|||
170812630|NCT01930188|617322683|FG001|Overall Study|Lost to Follow-up|2|||
170812631|NCT01930188|617322684|FG002|Overall Study|Lost to Follow-up|2|||
170812632|NCT01930188|617322682|FG000|Overall Study|Death|2|||
170812633|NCT01930188|617322683|FG001|Overall Study|Death|1|||
170812634|NCT01930188|617322684|FG002|Overall Study|Death|3|||
170812635|NCT01930188|617322682|FG000|Overall Study|Withdrawal by Subject|9|||
170812636|NCT01930188|617322683|FG001|Overall Study|Withdrawal by Subject|11|||
170812637|NCT01930188|617322684|FG002|Overall Study|Withdrawal by Subject|8|||
170812638|NCT00680771|617322688|FG000|Overall Study|Withdrawal by Subject|1|||
170812639|NCT00680771|617322689|FG001|Overall Study|Withdrawal by Subject|0|||
170913499|NCT00104104|617685925|FG000|Overall Study|Death|9|||
170913500|NCT00104104|617685926|FG001|Overall Study|Death|6|||
170913501|NCT02053246|617685928|FG000|Overall Study|Withdrawal by Subject|3|||
170913502|NCT02053246|617685928|FG000|Overall Study|Physician Decision|1|||
170913503|NCT02707757|617685929|FG000|Overall Study|Protocol Violation|3|||
170913504|NCT02707757|617685930|FG001|Overall Study|Protocol Violation|2|||
170913505|NCT02707757|617685929|FG000|Overall Study|Withdrawal by Subject|2|||
170913506|NCT02707757|617685930|FG001|Overall Study|Withdrawal by Subject|0|||
170913507|NCT02707757|617685929|FG000|Overall Study|Death|0|||
170913508|NCT02707757|617685930|FG001|Overall Study|Death|1|||
170913509|NCT02707757|617685929|FG000|Overall Study|Adverse Event|6|||
170913510|NCT02707757|617685930|FG001|Overall Study|Adverse Event|4|||
170913511|NCT02707757|617685929|FG000|Overall Study|Renal transplant/elective operation|1|||
170812640|NCT00680771|617322688|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
170812641|NCT00680771|617322689|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
170812642|NCT00680771|617322688|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
170812643|NCT00680771|617322689|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
170812644|NCT01316913|617322690|FG000|Overall Study|Adverse Event|17|||
170812645|NCT01316913|617322691|FG001|Overall Study|Adverse Event|20|||
170812646|NCT01316913|617322692|FG002|Overall Study|Adverse Event|15|||
170812647|NCT01316913|617322693|FG003|Overall Study|Adverse Event|11|||
170812648|NCT01316913|617322690|FG000|Overall Study|Lack of Efficacy|22|||
170812649|NCT01316913|617322691|FG001|Overall Study|Lack of Efficacy|12|||
170812650|NCT01316913|617322692|FG002|Overall Study|Lack of Efficacy|9|||
170812651|NCT01316913|617322693|FG003|Overall Study|Lack of Efficacy|13|||
170812652|NCT01316913|617322690|FG000|Overall Study|Protocol Violation|1|||
170812653|NCT01316913|617322691|FG001|Overall Study|Protocol Violation|4|||
170812654|NCT01316913|617322692|FG002|Overall Study|Protocol Violation|4|||
170812655|NCT01316913|617322693|FG003|Overall Study|Protocol Violation|1|||
170812656|NCT01316913|617322690|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
170812657|NCT01316913|617322691|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
170812658|NCT01316913|617322692|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
170812659|NCT01316913|617322693|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
170812660|NCT01316913|617322690|FG000|Overall Study|Lost to Follow-up|0|||
170812661|NCT01316913|617322691|FG001|Overall Study|Lost to Follow-up|1|||
170812662|NCT01316913|617322692|FG002|Overall Study|Lost to Follow-up|0|||
170812663|NCT01316913|617322693|FG003|Overall Study|Lost to Follow-up|2|||
170913512|NCT02707757|617685930|FG001|Overall Study|Renal transplant/elective operation|5|||
170913513|NCT01056523|617685931|FG000|Overall Study|Death|1|||
170913514|NCT01056523|617685932|FG001|Overall Study|Death|0|||
170913515|NCT01056523|617685933|FG002|Overall Study|Death|2|||
170913516|NCT01056523|617685934|FG003|Overall Study|Death|3|||
170913517|NCT01056523|617685935|FG004|Overall Study|Death|0|||
170913518|NCT01056523|617685936|FG005|Overall Study|Death|0|||
170913519|NCT01056523|617685937|FG006|Overall Study|Death|1|||
170812664|NCT01316913|617322690|FG000|Overall Study|Withdrawal by Subject|10|||
170812665|NCT01316913|617322691|FG001|Overall Study|Withdrawal by Subject|9|||
170812666|NCT01316913|617322692|FG002|Overall Study|Withdrawal by Subject|10|||
170812667|NCT01316913|617322693|FG003|Overall Study|Withdrawal by Subject|6|||
170812668|NCT02008916|617322694|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
170812669|NCT02008916|617322695|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
170812670|NCT02008916|617322696|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
170812671|NCT02008916|617322694|FG000|Week 16 - 156|Adverse Event|4|||
170812672|NCT02008916|617322695|FG001|Week 16 - 156|Adverse Event|2|||
170812673|NCT02008916|617322696|FG002|Week 16 - 156|Adverse Event|3|||
170812674|NCT02008916|617322694|FG000|Week 16 - 156|Withdrawal by Subject|7|||
170812675|NCT02008916|617322695|FG001|Week 16 - 156|Withdrawal by Subject|3|||
170812676|NCT02008916|617322696|FG002|Week 16 - 156|Withdrawal by Subject|5|||
170812677|NCT02008916|617322694|FG000|Week 16 - 156|No longer requires treatment|0|||
170812678|NCT02008916|617322695|FG001|Week 16 - 156|No longer requires treatment|1|||
170812679|NCT02008916|617322696|FG002|Week 16 - 156|No longer requires treatment|0|||
170812680|NCT02008916|617322694|FG000|Week 16 - 156|Lost to Follow-up|5|||
170812681|NCT02008916|617322695|FG001|Week 16 - 156|Lost to Follow-up|0|||
170812682|NCT02008916|617322696|FG002|Week 16 - 156|Lost to Follow-up|0|||
170812683|NCT02008916|617322694|FG000|Week 16 - 156|Lack of Efficacy|3|||
170812684|NCT02008916|617322695|FG001|Week 16 - 156|Lack of Efficacy|5|||
170812685|NCT02008916|617322696|FG002|Week 16 - 156|Lack of Efficacy|2|||
170913520|NCT02209597|617685940|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
170913521|NCT02209597|617685940|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
170913522|NCT02209597|617685940|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
170913523|NCT02209597|617685940|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
170913524|NCT02961764|617685945|FG000|Overall Study|Protocol Violation|0|||
170651683|NCT01894568|616738206|FG001|Overall Study|Protocol required discontinuation|1|||
170651684|NCT01894568|616738205|FG000|Overall Study|Withdrawal by Subject|5|||
170812686|NCT02008916|617322694|FG000|Week 16 - 156|Pregnancy|0|||
170812687|NCT02008916|617322695|FG001|Week 16 - 156|Pregnancy|1|||
170812688|NCT02008916|617322696|FG002|Week 16 - 156|Pregnancy|0|||
170812689|NCT02008916|617322694|FG000|Week 16 - 156|Physician Decision|0|||
170812690|NCT02008916|617322695|FG001|Week 16 - 156|Physician Decision|1|||
170812691|NCT02008916|617322696|FG002|Week 16 - 156|Physician Decision|0|||
170812692|NCT02950961|617322697|FG000|Overall Study|Study had to stop due to COVID.|7|||
170812693|NCT02807857|617322700|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
170812694|NCT02807857|617322700|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
170812695|NCT02807857|617322700|FG000|Follow-Up Set|Withdrawal by Subject|8|||
170812696|NCT02807857|617322700|FG000|Follow-Up Set|Lost to Follow-up|7|||
170812697|NCT02807857|617322700|FG000|Follow-Up Set|Physician Decision|6|||
170812698|NCT02807857|617322700|FG000|Follow-Up Set|Adverse Event|3|||
170812699|NCT02807857|617322700|FG000|Follow-Up Set|Death|27|||
170812700|NCT02807857|617322700|FG000|Follow-Up Set|Relocation|2|||
170812701|NCT02114515|617322702|FG000|Overall Study|Lost to Follow-up|52|||
170812702|NCT02114515|617322703|FG001|Overall Study|Lost to Follow-up|55|||
170812703|NCT02114515|617322702|FG000|Overall Study|Death|12|||
170812704|NCT02114515|617322703|FG001|Overall Study|Death|12|||
170812705|NCT02114515|617322702|FG000|Overall Study|Withdrawal by Subject|4|||
170812706|NCT02114515|617322703|FG001|Overall Study|Withdrawal by Subject|22|||
170812707|NCT02114515|617322702|FG000|Overall Study|Other|65|||
170812708|NCT02114515|617322703|FG001|Overall Study|Other|61|||
170812709|NCT05184062|617322707|FG000|Overall Study|Lost to Follow-up|5|||
170812710|NCT05184062|617322708|FG001|Overall Study|Lost to Follow-up|1|||
170812711|NCT05184062|617322707|FG000|Overall Study|Withdrawal by Subject|1|||
170812712|NCT05184062|617322708|FG001|Overall Study|Withdrawal by Subject|0|||
170812713|NCT05338476|617322709|FG000|Period 2|Adverse Event|0|||
170812714|NCT05338476|617322710|FG001|Period 2|Adverse Event|1|||
170812715|NCT02831049|617322715|FG000|Overall Study|Lost to Follow-up|0|||
170812716|NCT02831049|617322716|FG001|Overall Study|Lost to Follow-up|0|||
170812717|NCT02831049|617322717|FG002|Overall Study|Lost to Follow-up|1|||
170812718|NCT02831049|617322715|FG000|Overall Study|Withdrawal by Subject|0|||
170812719|NCT02831049|617322716|FG001|Overall Study|Withdrawal by Subject|1|||
170812720|NCT02831049|617322717|FG002|Overall Study|Withdrawal by Subject|1|||
170812721|NCT02831049|617322715|FG000|Overall Study|Pandemic shutdown|1|||
170812722|NCT02831049|617322716|FG001|Overall Study|Pandemic shutdown|0|||
170812723|NCT02831049|617322717|FG002|Overall Study|Pandemic shutdown|0|||
170812724|NCT00711555|617324044|FG000|Overall Study|Adverse Event|3|||
170812725|NCT05522777|617324049|FG000|Overall Study|Lack of Efficacy|1|||
170812726|NCT05522777|617324049|FG000|Overall Study|Withdrawal by Subject|1|||
170812727|NCT03141177|617324050|FG000|Overall Study|Death|62|||
170812728|NCT03141177|617324051|FG001|Overall Study|Death|13|||
170812729|NCT03141177|617324052|FG002|Overall Study|Death|84|||
170812730|NCT03141177|617324050|FG000|Overall Study|Participant withdrew consent|9|||
170812731|NCT03141177|617324051|FG001|Overall Study|Participant withdrew consent|2|||
170812732|NCT03141177|617324052|FG002|Overall Study|Participant withdrew consent|13|||
170812733|NCT03141177|617324050|FG000|Overall Study|Not reported|1|||
170812734|NCT03141177|617324051|FG001|Overall Study|Not reported|0|||
170812735|NCT03141177|617324052|FG002|Overall Study|Not reported|1|||
170812736|NCT03141177|617324050|FG000|Overall Study|Lost to Follow-up|2|||
170812737|NCT03141177|617324051|FG001|Overall Study|Lost to Follow-up|1|||
170812738|NCT03141177|617324052|FG002|Overall Study|Lost to Follow-up|1|||
170812739|NCT03141177|617324050|FG000|Overall Study|Other reasons|4|||
170812740|NCT03141177|617324051|FG001|Overall Study|Other reasons|0|||
170812741|NCT03141177|617324052|FG002|Overall Study|Other reasons|11|||
170812742|NCT03141177|617324050|FG000|Overall Study|Participants did not start treatment period|3|||
170812743|NCT03141177|617324051|FG001|Overall Study|Participants did not start treatment period|0|||
170812744|NCT03141177|617324052|FG002|Overall Study|Participants did not start treatment period|8|||
170913525|NCT02961764|617685946|FG001|Overall Study|Protocol Violation|1|||
170913526|NCT02961764|617685945|FG000|Overall Study|Death|2|||
170913527|NCT02961764|617685946|FG001|Overall Study|Death|0|||
170913528|NCT02961764|617685945|FG000|Overall Study|Lost to Follow-up|35|||
170913529|NCT02961764|617685946|FG001|Overall Study|Lost to Follow-up|24|||
170913530|NCT02961764|617685945|FG000|Overall Study|Withdrawal by Subject|2|||
170913531|NCT02961764|617685946|FG001|Overall Study|Withdrawal by Subject|0|||
170913532|NCT04285723|617685950|FG000|Overall Study|Subject decision|1|||
170913533|NCT04285723|617685951|FG001|Overall Study|Subject decision|2|||
170913534|NCT04285723|617685950|FG000|Overall Study|Physician Decision|1|||
170913535|NCT04285723|617685951|FG001|Overall Study|Physician Decision|0|||
170913536|NCT04285723|617685950|FG000|Overall Study|No efficiency|1|||
170913537|NCT04285723|617685951|FG001|Overall Study|No efficiency|0|||
170812745|NCT00215943|617324055|FG000|Overall Study|Disease Progression|3|||
170812746|NCT00215943|617324056|FG001|Overall Study|Disease Progression|5|||
170812747|NCT00215943|617324055|FG000|Overall Study|Alternate therapy|0|||
170812748|NCT00215943|617324056|FG001|Overall Study|Alternate therapy|1|||
170812749|NCT00215943|617324055|FG000|Overall Study|Adverse Event|3|||
170812750|NCT00215943|617324056|FG001|Overall Study|Adverse Event|6|||
170812751|NCT00215943|617324055|FG000|Overall Study|Other disease|0|||
170812752|NCT00215943|617324056|FG001|Overall Study|Other disease|1|||
170812753|NCT00215943|617324055|FG000|Overall Study|Other complications|3|||
170812754|NCT00215943|617324056|FG001|Overall Study|Other complications|1|||
170812755|NCT02164578|617324057|FG000|Treatment Period|Withdrawal by Subject|3|||
170812756|NCT02164578|617324058|FG001|Treatment Period|Withdrawal by Subject|3|||
170913538|NCT00778999|617685952|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
170913539|NCT00778999|617685953|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
170812757|NCT02164578|617324057|FG000|Treatment Period|Adverse Event|13|||
170651685|NCT01894568|616738206|FG001|Overall Study|Withdrawal by Subject|5|||
170651686|NCT01894568|616738205|FG000|Overall Study|Physician Decision|1|||
170651687|NCT01894568|616738206|FG001|Overall Study|Physician Decision|0|||
170651688|NCT01894568|616738205|FG000|Overall Study|Lost to Follow-up|0|||
170651689|NCT01894568|616738206|FG001|Overall Study|Lost to Follow-up|1|||
170651690|NCT00969280|616738207|FG000|Overall Study|Protocol Violation|2|||
170651691|NCT00969280|616738208|FG001|Overall Study|Protocol Violation|1|||
170651692|NCT00969280|616738207|FG000|Overall Study|Withdrawal by Subject|0|||
170651693|NCT00969280|616738208|FG001|Overall Study|Withdrawal by Subject|1|||
170651694|NCT00969280|616738207|FG000|Overall Study|infection of influenza A(H1N1)|0|||
170651695|NCT00969280|616738208|FG001|Overall Study|infection of influenza A(H1N1)|1|||
170651696|NCT01089361|616738211|FG000|Overall Study|Death|1|||
170651697|NCT01089361|616738212|FG001|Overall Study|Death|0|||
170651698|NCT03036800|616738216|FG000|Overall Study|Protocol Violation|1|||
170651699|NCT03036800|616738217|FG001|Overall Study|Protocol Violation|0|||
170651700|NCT03036800|616738216|FG000|Overall Study|Non-compliance|1|||
170651701|NCT03036800|616738217|FG001|Overall Study|Non-compliance|0|||
170651702|NCT03036800|616738216|FG000|Overall Study|Lost to Follow-up|1|||
170651703|NCT03036800|616738217|FG001|Overall Study|Lost to Follow-up|0|||
170651704|NCT03036800|616738216|FG000|Overall Study|Death|1|||
170651705|NCT03036800|616738217|FG001|Overall Study|Death|0|||
170651706|NCT03036800|616738216|FG000|Overall Study|Tolerance|5|||
170651707|NCT03036800|616738217|FG001|Overall Study|Tolerance|0|||
170651708|NCT03036800|616738216|FG000|Overall Study|Unknown/no reason given|50|||
170651709|NCT03036800|616738217|FG001|Overall Study|Unknown/no reason given|39|||
170651710|NCT01077154|616738218|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
170651711|NCT01077154|616738219|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
170651712|NCT01077154|616738218|FG000|Overall Study|Withdrawal by Subject|369|||
170651713|NCT01077154|616738219|FG001|Overall Study|Withdrawal by Subject|385|||
170651714|NCT01077154|616738218|FG000|Overall Study|Death|215|||
170651715|NCT01077154|616738219|FG001|Overall Study|Death|214|||
170651716|NCT01077154|616738218|FG000|Overall Study|Lost to Follow-up|43|||
170651717|NCT01077154|616738219|FG001|Overall Study|Lost to Follow-up|35|||
170651718|NCT01077154|616738218|FG000|Overall Study|Noncompliance|22|||
170651719|NCT01077154|616738219|FG001|Overall Study|Noncompliance|20|||
170651720|NCT01077154|616738218|FG000|Overall Study|Disease Progression|18|||
170651721|NCT01077154|616738219|FG001|Overall Study|Disease Progression|20|||
170651722|NCT01077154|616738218|FG000|Overall Study|Ineligibility Determined|10|||
170651723|NCT01077154|616738219|FG001|Overall Study|Ineligibility Determined|14|||
170651724|NCT01077154|616738218|FG000|Overall Study|Other|14|||
170651725|NCT01077154|616738219|FG001|Overall Study|Other|11|||
170651726|NCT01077154|616738218|FG000|Overall Study|Adverse Event|9|||
170651727|NCT01077154|616738219|FG001|Overall Study|Adverse Event|9|||
170651728|NCT01077154|616738218|FG000|Overall Study|Administrative Decision|1|||
170651729|NCT01077154|616738219|FG001|Overall Study|Administrative Decision|6|||
170651730|NCT01077154|616738218|FG000|Overall Study|Protocol Deviation|1|||
170812758|NCT02164578|617324058|FG001|Treatment Period|Adverse Event|6|||
170812759|NCT02164578|617324057|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
170812760|NCT02164578|617324058|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
170812761|NCT02164578|617324057|FG000|Treatment Period|Protocol Violation|0|||
170651731|NCT01077154|616738219|FG001|Overall Study|Protocol Deviation|0|||
170651732|NCT03976648|616738226|FG000|Overall Study|Adverse Event|0|||
170651733|NCT03976648|616738227|FG001|Overall Study|Adverse Event|2|||
170651734|NCT03976648|616738226|FG000|Overall Study|Study terminated by sponsor|21|||
170651735|NCT03976648|616738227|FG001|Overall Study|Study terminated by sponsor|8|||
170651736|NCT03645434|616738228|FG000|Period 1|Adverse Event|0|||
170598824|NCT00969436|616537106|FG002|Overall Study|Migrated/moved from study area|2|||
170598825|NCT00969436|616537104|FG000|Overall Study|Father - serious health problem|0|||
170598826|NCT00969436|616537105|FG001|Overall Study|Father - serious health problem|0|||
170598827|NCT00969436|616537106|FG002|Overall Study|Father - serious health problem|1|||
170598828|NCT00969436|616537104|FG000|Overall Study|Parents personal problem|0|||
170598829|NCT00969436|616537105|FG001|Overall Study|Parents personal problem|0|||
170598830|NCT00969436|616537106|FG002|Overall Study|Parents personal problem|1|||
170598831|NCT00969436|616537104|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
170598832|NCT00969436|616537105|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
170598833|NCT00969436|616537106|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
170598834|NCT00969436|616537104|FG000|Overall Study|Withdrawal by Subject|3|||
170598835|NCT00969436|616537105|FG001|Overall Study|Withdrawal by Subject|0|||
170598836|NCT00969436|616537106|FG002|Overall Study|Withdrawal by Subject|2|||
170598837|NCT00969436|616537104|FG000|Overall Study|Lost to Follow-up|8|||
170598838|NCT00969436|616537105|FG001|Overall Study|Lost to Follow-up|8|||
170598839|NCT00969436|616537106|FG002|Overall Study|Lost to Follow-up|5|||
170598840|NCT00351273|616537107|FG000|Overall Study|Lost to Follow-up|1|||
170598841|NCT00351273|616537108|FG001|Overall Study|Lost to Follow-up|2|||
170598842|NCT00351273|616537109|FG002|Overall Study|Lost to Follow-up|5|||
170598843|NCT02544373|616537114|FG000|Overall Study|Lost to Follow-up|5|||
170598844|NCT02544373|616537115|FG001|Overall Study|Lost to Follow-up|3|||
170598845|NCT02544373|616537114|FG000|Overall Study|Withdrawal by Subject|8|||
170598846|NCT02544373|616537115|FG001|Overall Study|Withdrawal by Subject|2|||
170598847|NCT01839656|616537119|FG000|Overall Study|Withdrawal by Subject|1|||
170598848|NCT01839656|616537120|FG001|Overall Study|Withdrawal by Subject|1|||
170598849|NCT01839656|616537119|FG000|Overall Study|Adverse event, serious fatal|1|||
170913540|NCT00778999|617685952|FG000|Overall Study|Did not receive recFSH|14|||
170913541|NCT00778999|617685953|FG001|Overall Study|Did not receive recFSH|20|||
170913542|NCT02032524|617685954|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
170913543|NCT02032524|617685955|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
170913544|NCT02032524|617685956|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
170913545|NCT02032524|617685957|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
170913546|NCT02032524|617685958|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
170913547|NCT02032524|617685959|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
170913548|NCT02032524|617685954|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
170913549|NCT02032524|617685955|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
170913550|NCT02032524|617685956|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
170913551|NCT02032524|617685957|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
170913552|NCT02032524|617685958|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
170913553|NCT02032524|617685959|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
170913554|NCT02032524|617685954|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
170913555|NCT02032524|617685955|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
170913556|NCT02032524|617685956|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
170913557|NCT02032524|617685957|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
170913558|NCT02032524|617685958|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
170913559|NCT02032524|617685959|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
170913560|NCT02032524|617685954|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
170913561|NCT02032524|617685955|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
170913562|NCT02032524|617685956|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
170913563|NCT02032524|617685957|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
170913564|NCT02032524|617685958|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
170913565|NCT02032524|617685959|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
170913566|NCT02032524|617685954|FG000|Period 2: LTS13769 Study|Other|0|||
170913567|NCT02032524|617685955|FG001|Period 2: LTS13769 Study|Other|0|||
170913568|NCT02032524|617685956|FG002|Period 2: LTS13769 Study|Other|0|||
170913569|NCT02032524|617685957|FG003|Period 2: LTS13769 Study|Other|0|||
170913570|NCT02032524|617685958|FG004|Period 2: LTS13769 Study|Other|0|||
170913571|NCT02032524|617685959|FG005|Period 2: LTS13769 Study|Other|1|||
170913572|NCT02903511|617685963|FG000|Overall Study|Withdrawal by Subject|1|||
170913573|NCT02903511|617685964|FG001|Overall Study|Withdrawal by Subject|0|||
170913574|NCT02903511|617685963|FG000|Overall Study|Lost to Follow-up|3|||
170913575|NCT02903511|617685964|FG001|Overall Study|Lost to Follow-up|2|||
170913576|NCT00969618|617685965|FG000|Overall Study|Adverse Event|29|||
170913577|NCT00969618|617685965|FG000|Overall Study|Entry Criteria Not Met|3|||
170913578|NCT00969618|617685965|FG000|Overall Study|Lack of Efficacy|2|||
170913579|NCT00969618|617685965|FG000|Overall Study|Lost to Follow-up|7|||
170913580|NCT00969618|617685965|FG000|Overall Study|Physician Decision|1|||
170913581|NCT00969618|617685965|FG000|Overall Study|Protocol Violation|9|||
170913582|NCT00969618|617685965|FG000|Overall Study|Withdrawal by Subject|27|||
170913583|NCT01089725|617685966|FG000|Overall Study|Adverse Event|1|||
170913584|NCT01089725|617685967|FG001|Overall Study|Adverse Event|1|||
170913585|NCT01089725|617685968|FG002|Overall Study|Adverse Event|0|||
170913586|NCT01089725|617685969|FG003|Overall Study|Adverse Event|0|||
170913587|NCT01089725|617685970|FG004|Overall Study|Adverse Event|2|||
170913588|NCT01089725|617685966|FG000|Overall Study|Lack of Efficacy|4|||
170913589|NCT01089725|617685967|FG001|Overall Study|Lack of Efficacy|3|||
170812762|NCT02164578|617324058|FG001|Treatment Period|Protocol Violation|2|||
170812763|NCT02164578|617324057|FG000|Extension Period|Withdrawal by Subject|2|||
170812764|NCT02164578|617324058|FG001|Extension Period|Withdrawal by Subject|0|||
170812765|NCT02164578|617324057|FG000|Extension Period|Adverse Event|4|||
170812766|NCT02164578|617324058|FG001|Extension Period|Adverse Event|0|||
170812767|NCT02164578|617324057|FG000|Extension Period|Expiry of study medication|1|||
170812768|NCT02164578|617324058|FG001|Extension Period|Expiry of study medication|0|||
170812769|NCT02164578|617324057|FG000|Extension Period|Protocol Violation|0|||
170812770|NCT02164578|617324058|FG001|Extension Period|Protocol Violation|1|||
170812771|NCT03924193|617324064|FG000|Overall Study|Adverse Event|10|||
170812772|NCT03924193|617324065|FG001|Overall Study|Adverse Event|0|||
170812773|NCT03924193|617324066|FG002|Overall Study|Adverse Event|10|||
170812774|NCT03924193|617324064|FG000|Overall Study|Withdrawal by Subject|5|||
170812775|NCT03924193|617324065|FG001|Overall Study|Withdrawal by Subject|10|||
170812776|NCT03924193|617324066|FG002|Overall Study|Withdrawal by Subject|2|||
170812777|NCT01562275|617324067|FG000|Stage 1|Adverse Event|0|||
170812778|NCT01562275|617324068|FG001|Stage 1|Adverse Event|0|||
170812779|NCT01562275|617324069|FG002|Stage 1|Adverse Event|0|||
170812780|NCT01562275|617324070|FG003|Stage 1|Adverse Event|1|||
170812781|NCT01562275|617324071|FG004|Stage 1|Adverse Event|1|||
170812782|NCT01562275|617324072|FG005|Stage 1|Adverse Event|0|||
170812783|NCT01562275|617324073|FG006|Stage 1|Adverse Event|0|||
170812784|NCT01562275|617324074|FG007|Stage 1|Adverse Event|0|||
170812785|NCT01562275|617324075|FG008|Stage 1|Adverse Event|0|||
170812786|NCT01562275|617324076|FG009|Stage 1|Adverse Event|1|||
170812787|NCT01562275|617324077|FG010|Stage 1|Adverse Event|0|||
170812788|NCT01562275|617324078|FG011|Stage 1|Adverse Event|0|||
170812789|NCT01562275|617324079|FG012|Stage 1|Adverse Event|0|||
170812790|NCT01562275|617324067|FG000|Stage 1|Death|1|||
170812791|NCT01562275|617324068|FG001|Stage 1|Death|0|||
170812792|NCT01562275|617324069|FG002|Stage 1|Death|0|||
170812793|NCT01562275|617324070|FG003|Stage 1|Death|0|||
170812794|NCT01562275|617324071|FG004|Stage 1|Death|0|||
170812795|NCT01562275|617324072|FG005|Stage 1|Death|0|||
170812796|NCT01562275|617324073|FG006|Stage 1|Death|0|||
170812797|NCT01562275|617324074|FG007|Stage 1|Death|0|||
170812798|NCT01562275|617324075|FG008|Stage 1|Death|0|||
170812799|NCT01562275|617324076|FG009|Stage 1|Death|0|||
170812800|NCT01562275|617324077|FG010|Stage 1|Death|0|||
170812801|NCT01562275|617324078|FG011|Stage 1|Death|0|||
170812802|NCT01562275|617324079|FG012|Stage 1|Death|0|||
170812803|NCT01562275|617324067|FG000|Stage 1|Non Compliance|0|||
170812804|NCT01562275|617324068|FG001|Stage 1|Non Compliance|0|||
170812805|NCT01562275|617324069|FG002|Stage 1|Non Compliance|1|||
170812806|NCT01562275|617324070|FG003|Stage 1|Non Compliance|0|||
170812807|NCT01562275|617324071|FG004|Stage 1|Non Compliance|0|||
170812808|NCT01562275|617324072|FG005|Stage 1|Non Compliance|0|||
170812809|NCT01562275|617324073|FG006|Stage 1|Non Compliance|0|||
170812810|NCT01562275|617324074|FG007|Stage 1|Non Compliance|0|||
170812811|NCT01562275|617324075|FG008|Stage 1|Non Compliance|0|||
170812812|NCT01562275|617324076|FG009|Stage 1|Non Compliance|0|||
170812813|NCT01562275|617324077|FG010|Stage 1|Non Compliance|0|||
170812814|NCT01562275|617324078|FG011|Stage 1|Non Compliance|0|||
170812815|NCT01562275|617324079|FG012|Stage 1|Non Compliance|0|||
170812816|NCT01562275|617324067|FG000|Stage 1|Physician Decision|0|||
170812817|NCT01562275|617324068|FG001|Stage 1|Physician Decision|0|||
170812818|NCT01562275|617324069|FG002|Stage 1|Physician Decision|0|||
170812819|NCT01562275|617324070|FG003|Stage 1|Physician Decision|0|||
170913590|NCT01089725|617685968|FG002|Overall Study|Lack of Efficacy|1|||
170913591|NCT01089725|617685969|FG003|Overall Study|Lack of Efficacy|0|||
170812820|NCT01562275|617324071|FG004|Stage 1|Physician Decision|1|||
170812821|NCT01562275|617324072|FG005|Stage 1|Physician Decision|0|||
170812822|NCT01562275|617324073|FG006|Stage 1|Physician Decision|1|||
170812823|NCT01562275|617324074|FG007|Stage 1|Physician Decision|0|||
170812824|NCT01562275|617324075|FG008|Stage 1|Physician Decision|1|||
170812825|NCT01562275|617324076|FG009|Stage 1|Physician Decision|0|||
170913592|NCT01089725|617685970|FG004|Overall Study|Lack of Efficacy|4|||
170812826|NCT01562275|617324077|FG010|Stage 1|Physician Decision|0|||
170812827|NCT01562275|617324078|FG011|Stage 1|Physician Decision|0|||
170913593|NCT01089725|617685966|FG000|Overall Study|Lost to Follow-up|2|||
170812828|NCT01562275|617324079|FG012|Stage 1|Physician Decision|0|||
170812829|NCT01562275|617324067|FG000|Stage 1|Progression of Disease|2|||
170812830|NCT01562275|617324068|FG001|Stage 1|Progression of Disease|6|||
170812831|NCT01562275|617324069|FG002|Stage 1|Progression of Disease|2|||
170812832|NCT01562275|617324070|FG003|Stage 1|Progression of Disease|1|||
170812833|NCT01562275|617324071|FG004|Stage 1|Progression of Disease|2|||
170812834|NCT01562275|617324072|FG005|Stage 1|Progression of Disease|4|||
170913594|NCT01089725|617685967|FG001|Overall Study|Lost to Follow-up|2|||
170913595|NCT01089725|617685968|FG002|Overall Study|Lost to Follow-up|0|||
170913596|NCT01089725|617685969|FG003|Overall Study|Lost to Follow-up|3|||
170913597|NCT01089725|617685970|FG004|Overall Study|Lost to Follow-up|0|||
170913598|NCT01089725|617685966|FG000|Overall Study|Protocol Violation|0|||
170913599|NCT01089725|617685967|FG001|Overall Study|Protocol Violation|0|||
170913600|NCT01089725|617685968|FG002|Overall Study|Protocol Violation|1|||
170598850|NCT01839656|616537120|FG001|Overall Study|Adverse event, serious fatal|4|||
170598851|NCT01839656|616537119|FG000|Overall Study|Early study closure|0|||
170598852|NCT01839656|616537120|FG001|Overall Study|Early study closure|11|||
170598853|NCT01839656|616537119|FG000|Overall Study|Adverse Event|1|||
170598854|NCT01839656|616537120|FG001|Overall Study|Adverse Event|0|||
170598855|NCT01595581|616537135|FG000|Overall Study|Withdrawal by Subject|1|||
170812835|NCT01562275|617324073|FG006|Stage 1|Progression of Disease|1|||
170812836|NCT01562275|617324074|FG007|Stage 1|Progression of Disease|7|||
170598856|NCT01595581|616537136|FG001|Overall Study|Withdrawal by Subject|0|||
170598857|NCT02621073|616537137|FG000|Overall Study|Lost to Follow-up|0|||
170598858|NCT02621073|616537138|FG001|Overall Study|Lost to Follow-up|1|||
170812837|NCT01562275|617324075|FG008|Stage 1|Progression of Disease|2|||
170812838|NCT01562275|617324076|FG009|Stage 1|Progression of Disease|5|||
170598859|NCT02621073|616537137|FG000|Overall Study|Physician Decision|3|||
170651737|NCT03645434|616738229|FG001|Period 1|Adverse Event|0|||
170651738|NCT03645434|616738230|FG002|Period 1|Adverse Event|0|||
170598860|NCT02621073|616537138|FG001|Overall Study|Physician Decision|2|||
170651739|NCT03645434|616738231|FG003|Period 1|Adverse Event|1|||
170812839|NCT01562275|617324077|FG010|Stage 1|Progression of Disease|3|||
170812840|NCT01562275|617324078|FG011|Stage 1|Progression of Disease|0|||
170812841|NCT01562275|617324079|FG012|Stage 1|Progression of Disease|0|||
170812842|NCT01562275|617324067|FG000|Stage 1|Withdrawal by Subject|0|||
170812843|NCT01562275|617324068|FG001|Stage 1|Withdrawal by Subject|1|||
170812844|NCT01562275|617324069|FG002|Stage 1|Withdrawal by Subject|0|||
170812845|NCT01562275|617324070|FG003|Stage 1|Withdrawal by Subject|2|||
170598861|NCT00499746|616537139|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
170598862|NCT00499746|616537139|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
170598863|NCT00499746|616537139|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
170598864|NCT00499746|616537139|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
170812846|NCT01562275|617324071|FG004|Stage 1|Withdrawal by Subject|0|||
170812847|NCT01562275|617324072|FG005|Stage 1|Withdrawal by Subject|0|||
170812848|NCT01562275|617324073|FG006|Stage 1|Withdrawal by Subject|1|||
170812849|NCT01562275|617324074|FG007|Stage 1|Withdrawal by Subject|0|||
170812850|NCT01562275|617324075|FG008|Stage 1|Withdrawal by Subject|0|||
170812851|NCT01562275|617324076|FG009|Stage 1|Withdrawal by Subject|1|||
170812852|NCT01562275|617324077|FG010|Stage 1|Withdrawal by Subject|0|||
170812853|NCT01562275|617324078|FG011|Stage 1|Withdrawal by Subject|0|||
170812854|NCT01562275|617324079|FG012|Stage 1|Withdrawal by Subject|0|||
170812855|NCT01562275|617324067|FG000|Stage 2|Death|0|||
170812856|NCT01562275|617324068|FG001|Stage 2|Death|0|||
170812857|NCT01562275|617324069|FG002|Stage 2|Death|0|||
170812858|NCT01562275|617324070|FG003|Stage 2|Death|0|||
170812859|NCT01562275|617324071|FG004|Stage 2|Death|0|||
170812860|NCT01562275|617324072|FG005|Stage 2|Death|0|||
170812861|NCT01562275|617324073|FG006|Stage 2|Death|0|||
170812862|NCT01562275|617324074|FG007|Stage 2|Death|0|||
170812863|NCT01562275|617324075|FG008|Stage 2|Death|0|||
170812864|NCT01562275|617324076|FG009|Stage 2|Death|0|||
170812865|NCT01562275|617324077|FG010|Stage 2|Death|0|||
170812866|NCT01562275|617324078|FG011|Stage 2|Death|2|||
170812867|NCT01562275|617324079|FG012|Stage 2|Death|1|||
170812868|NCT01562275|617324067|FG000|Stage 2|Progression of Disease|0|||
170812869|NCT01562275|617324068|FG001|Stage 2|Progression of Disease|0|||
170812870|NCT01562275|617324069|FG002|Stage 2|Progression of Disease|0|||
170812871|NCT01562275|617324070|FG003|Stage 2|Progression of Disease|0|||
170812872|NCT01562275|617324071|FG004|Stage 2|Progression of Disease|0|||
170812873|NCT01562275|617324072|FG005|Stage 2|Progression of Disease|0|||
170812874|NCT01562275|617324073|FG006|Stage 2|Progression of Disease|0|||
170812875|NCT01562275|617324074|FG007|Stage 2|Progression of Disease|0|||
170812876|NCT01562275|617324075|FG008|Stage 2|Progression of Disease|0|||
170812877|NCT01562275|617324076|FG009|Stage 2|Progression of Disease|0|||
170812878|NCT01562275|617324077|FG010|Stage 2|Progression of Disease|0|||
170812879|NCT01562275|617324078|FG011|Stage 2|Progression of Disease|12|||
170812880|NCT01562275|617324079|FG012|Stage 2|Progression of Disease|4|||
170812881|NCT01863368|617324080|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
170812882|NCT01863368|617324081|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
170812883|NCT01863368|617324080|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
170812884|NCT01863368|617324081|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
170812885|NCT01863368|617324080|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
170812886|NCT01863368|617324081|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
170812887|NCT01863368|617324080|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
170812888|NCT01863368|617324081|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
170812889|NCT01863368|617324080|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
170598865|NCT00558272|616537140|FG000|Overall Study|Adverse Event|10|||
170598866|NCT00558272|616537141|FG001|Overall Study|Adverse Event|0|||
170598867|NCT00558272|616537140|FG000|Overall Study|Death|1|||
170598868|NCT00558272|616537141|FG001|Overall Study|Death|0|||
170598869|NCT00558272|616537140|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
170598870|NCT00558272|616537141|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
170598871|NCT00558272|616537140|FG000|Overall Study|AZ study team decision|0|||
170812890|NCT01863368|617324081|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
170812891|NCT01863368|617324080|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
170812892|NCT01863368|617324081|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
170812893|NCT00647699|617324082|FG000|Overall Study|Lost to Follow-up|5|||
170812894|NCT00647699|617324083|FG001|Overall Study|Lost to Follow-up|4|||
170812895|NCT00647699|617324082|FG000|Overall Study|Withdrawal by Subject|3|||
170812896|NCT00647699|617324083|FG001|Overall Study|Withdrawal by Subject|8|||
170812897|NCT01018992|617324084|FG000|Overall Study|Adverse Event|8|||
170812898|NCT01018992|617324085|FG001|Overall Study|Adverse Event|3|||
170812899|NCT01018992|617324084|FG000|Overall Study|Withdrawal by Subject|3|||
170812900|NCT01018992|617324085|FG001|Overall Study|Withdrawal by Subject|8|||
170812901|NCT01018992|617324084|FG000|Overall Study|Protocol Violation|0|||
170598872|NCT00558272|616537141|FG001|Overall Study|AZ study team decision|1|||
170651740|NCT03645434|616738232|FG004|Period 1|Adverse Event|0|||
170812902|NCT01018992|617324085|FG001|Overall Study|Protocol Violation|4|||
170812903|NCT01018992|617324084|FG000|Overall Study|Lost to Follow-up|5|||
170812904|NCT01018992|617324085|FG001|Overall Study|Lost to Follow-up|1|||
170812905|NCT03029585|617324086|FG000|Overall Study|Death|1|||
170598873|NCT00558272|616537140|FG000|Overall Study|Incorrectly enrolled|1|||
170598874|NCT00558272|616537141|FG001|Overall Study|Incorrectly enrolled|0|||
170598875|NCT00558272|616537140|FG000|Overall Study|Withdrawal by Subject|0|||
170598876|NCT00558272|616537141|FG001|Overall Study|Withdrawal by Subject|1|||
170598877|NCT00279812|616537142|FG000|Overall Study|Protocol Violation|1|||
170598878|NCT00279812|616537143|FG001|Overall Study|Protocol Violation|1|||
170598879|NCT00279812|616537144|FG002|Overall Study|Protocol Violation|0|||
170598880|NCT00279812|616537145|FG003|Overall Study|Protocol Violation|0|||
170598881|NCT00279812|616537146|FG004|Overall Study|Protocol Violation|1|||
170598882|NCT00279812|616537147|FG005|Overall Study|Protocol Violation|0|||
170598883|NCT00279812|616537142|FG000|Overall Study|Withdrawal by Subject|0|||
170598884|NCT00279812|616537143|FG001|Overall Study|Withdrawal by Subject|4|||
170598885|NCT00279812|616537144|FG002|Overall Study|Withdrawal by Subject|2|||
170598886|NCT00279812|616537145|FG003|Overall Study|Withdrawal by Subject|0|||
170598887|NCT00279812|616537146|FG004|Overall Study|Withdrawal by Subject|0|||
170598888|NCT00279812|616537147|FG005|Overall Study|Withdrawal by Subject|0|||
170598889|NCT00279812|616537142|FG000|Overall Study|Adverse Event|0|||
170598890|NCT00279812|616537143|FG001|Overall Study|Adverse Event|1|||
170598891|NCT00279812|616537144|FG002|Overall Study|Adverse Event|1|||
170598892|NCT00279812|616537145|FG003|Overall Study|Adverse Event|0|||
170598893|NCT00279812|616537146|FG004|Overall Study|Adverse Event|2|||
170598894|NCT00279812|616537147|FG005|Overall Study|Adverse Event|1|||
170598895|NCT02806960|616538652|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
170598896|NCT02806960|616538653|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
170598897|NCT02806960|616538654|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
170598898|NCT02806960|616538655|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
170598899|NCT04599465|616538656|FG000|Overall Study|Physician Decision|1|||
170598900|NCT04599465|616538656|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
170598901|NCT04566601|616538657|FG000|Overall Study|Other than listed|13|||
170598902|NCT04566601|616538658|FG001|Overall Study|Other than listed|4|||
170598903|NCT04566601|616538659|FG002|Overall Study|Other than listed|2|||
170598904|NCT04566601|616538660|FG003|Overall Study|Other than listed|1|||
170598905|NCT04566601|616538661|FG004|Overall Study|Other than listed|4|||
170598906|NCT04566601|616538657|FG000|Overall Study|Protocol deviation|3|||
170598907|NCT04566601|616538658|FG001|Overall Study|Protocol deviation|0|||
170598908|NCT04566601|616538659|FG002|Overall Study|Protocol deviation|1|||
170598909|NCT04566601|616538660|FG003|Overall Study|Protocol deviation|1|||
170598910|NCT04566601|616538661|FG004|Overall Study|Protocol deviation|1|||
170598911|NCT04566601|616538657|FG000|Overall Study|Technical problems|0|||
170598912|NCT04566601|616538658|FG001|Overall Study|Technical problems|0|||
170598913|NCT04566601|616538659|FG002|Overall Study|Technical problems|1|||
170598914|NCT04566601|616538660|FG003|Overall Study|Technical problems|0|||
170598915|NCT04566601|616538661|FG004|Overall Study|Technical problems|0|||
170598916|NCT04566601|616538657|FG000|Overall Study|No reason available|3|||
170598917|NCT04566601|616538658|FG001|Overall Study|No reason available|2|||
170598918|NCT04566601|616538659|FG002|Overall Study|No reason available|7|||
170598919|NCT04566601|616538660|FG003|Overall Study|No reason available|1|||
170598920|NCT04566601|616538661|FG004|Overall Study|No reason available|5|||
170598921|NCT04566601|616538657|FG000|Overall Study|Burden of study procedures|3|||
170598922|NCT04566601|616538658|FG001|Overall Study|Burden of study procedures|0|||
170598923|NCT04566601|616538659|FG002|Overall Study|Burden of study procedures|0|||
170598924|NCT04566601|616538660|FG003|Overall Study|Burden of study procedures|3|||
170598925|NCT04566601|616538661|FG004|Overall Study|Burden of study procedures|1|||
170598926|NCT04566601|616538657|FG000|Overall Study|Change of residence|2|||
170812906|NCT03029585|617324087|FG001|Overall Study|Death|1|||
170812907|NCT03029585|617324086|FG000|Overall Study|Withdrawal by Subject|1|||
170812908|NCT03029585|617324087|FG001|Overall Study|Withdrawal by Subject|0|||
170812909|NCT01241448|617324092|FG000|Overall Study|Adverse Event|1|||
170812910|NCT01241448|617324093|FG001|Overall Study|Adverse Event|0|||
170812911|NCT01241448|617324094|FG002|Overall Study|Adverse Event|2|||
170812912|NCT01241448|617324095|FG003|Overall Study|Adverse Event|2|||
170812913|NCT01241448|617324092|FG000|Overall Study|Lost to Follow-up|2|||
170812914|NCT01241448|617324093|FG001|Overall Study|Lost to Follow-up|1|||
170812915|NCT01241448|617324094|FG002|Overall Study|Lost to Follow-up|1|||
170812916|NCT01241448|617324095|FG003|Overall Study|Lost to Follow-up|1|||
170812917|NCT01241448|617324092|FG000|Overall Study|Physician Decision|0|||
170812918|NCT01241448|617324093|FG001|Overall Study|Physician Decision|2|||
170812919|NCT01241448|617324094|FG002|Overall Study|Physician Decision|0|||
170812920|NCT01241448|617324095|FG003|Overall Study|Physician Decision|0|||
170812921|NCT01241448|617324092|FG000|Overall Study|Protocol Violation|10|||
170812922|NCT01241448|617324093|FG001|Overall Study|Protocol Violation|5|||
170812923|NCT01241448|617324094|FG002|Overall Study|Protocol Violation|3|||
170812924|NCT01241448|617324095|FG003|Overall Study|Protocol Violation|6|||
170812925|NCT01241448|617324092|FG000|Overall Study|Sponsor Decision|17|||
170812926|NCT01241448|617324093|FG001|Overall Study|Sponsor Decision|14|||
170812927|NCT01241448|617324094|FG002|Overall Study|Sponsor Decision|12|||
170812928|NCT01241448|617324095|FG003|Overall Study|Sponsor Decision|6|||
170812929|NCT01241448|617324092|FG000|Overall Study|Withdrawal by Subject|4|||
170812930|NCT01241448|617324093|FG001|Overall Study|Withdrawal by Subject|5|||
170812931|NCT01241448|617324094|FG002|Overall Study|Withdrawal by Subject|3|||
170812932|NCT01241448|617324095|FG003|Overall Study|Withdrawal by Subject|6|||
170812933|NCT01241448|617324092|FG000|Overall Study|Excluded due to data integrity issues|3|||
170812934|NCT01241448|617324093|FG001|Overall Study|Excluded due to data integrity issues|2|||
170598927|NCT04566601|616538658|FG001|Overall Study|Change of residence|2|||
170651741|NCT03645434|616738233|FG005|Period 1|Adverse Event|0|||
170651742|NCT03645434|616738228|FG000|Period 1|COPD exacerbation|0|||
170651743|NCT03645434|616738229|FG001|Period 1|COPD exacerbation|0|||
170651744|NCT03645434|616738230|FG002|Period 1|COPD exacerbation|0|||
170651745|NCT03645434|616738231|FG003|Period 1|COPD exacerbation|0|||
170651746|NCT03645434|616738232|FG004|Period 1|COPD exacerbation|1|||
170651747|NCT03645434|616738233|FG005|Period 1|COPD exacerbation|0|||
170651748|NCT01155167|616738234|FG000|Overall Study|Insufficient ultrasound data|2|||
170651749|NCT01155167|616738235|FG001|Overall Study|Insufficient ultrasound data|0|||
170651750|NCT01155167|616738234|FG000|Overall Study|Access site changed to femoral artery|1|||
170651751|NCT01155167|616738235|FG001|Overall Study|Access site changed to femoral artery|0|||
170651752|NCT00167778|616738237|FG000|Overall Study|Withdrawal by Subject|1|||
170651753|NCT02654717|616738238|FG000|Overall Study|Adverse Event|2|||
170651754|NCT02654717|616738239|FG001|Overall Study|Adverse Event|2|||
170651755|NCT02654717|616738238|FG000|Overall Study|Protocol Violation|1|||
170651756|NCT02654717|616738239|FG001|Overall Study|Protocol Violation|2|||
170651757|NCT02654717|616738238|FG000|Overall Study|Withdrawal by Subject|0|||
170651758|NCT02654717|616738239|FG001|Overall Study|Withdrawal by Subject|1|||
170651759|NCT02654717|616738238|FG000|Overall Study|Non-permitted medication|3|||
170651760|NCT02654717|616738239|FG001|Overall Study|Non-permitted medication|0|||
170651761|NCT01451437|616738243|FG000|Overall Study|Adverse Event|0|||
170651762|NCT01451437|616738244|FG001|Overall Study|Adverse Event|0|||
170812935|NCT01241448|617324094|FG002|Overall Study|Excluded due to data integrity issues|2|||
170812936|NCT01241448|617324095|FG003|Overall Study|Excluded due to data integrity issues|2|||
170812937|NCT02400749|617324096|FG000|Week 0 -16|Withdrawal by Subject|5|||
170812938|NCT02400749|617324097|FG001|Week 0 -16|Withdrawal by Subject|5|||
170812939|NCT02400749|617324096|FG000|Week 0 -16|Adverse Event|3|||
170598928|NCT04566601|616538659|FG002|Overall Study|Change of residence|0|||
170598929|NCT04566601|616538660|FG003|Overall Study|Change of residence|1|||
170598930|NCT04566601|616538661|FG004|Overall Study|Change of residence|2|||
170598931|NCT04566601|616538657|FG000|Overall Study|Perceived lack of efficacy|2|||
170598932|NCT04566601|616538658|FG001|Overall Study|Perceived lack of efficacy|0|||
170598933|NCT04566601|616538659|FG002|Overall Study|Perceived lack of efficacy|1|||
170598934|NCT04566601|616538660|FG003|Overall Study|Perceived lack of efficacy|1|||
170598935|NCT04566601|616538661|FG004|Overall Study|Perceived lack of efficacy|2|||
170598936|NCT04566601|616538657|FG000|Overall Study|Adverse Event|7|||
170598937|NCT04566601|616538658|FG001|Overall Study|Adverse Event|4|||
170598938|NCT04566601|616538659|FG002|Overall Study|Adverse Event|6|||
170812940|NCT02400749|617324097|FG001|Week 0 -16|Adverse Event|1|||
170812941|NCT02400749|617324096|FG000|Week 0 -16|Lost to Follow-up|2|||
170812942|NCT02400749|617324097|FG001|Week 0 -16|Lost to Follow-up|0|||
170812943|NCT02400749|617324096|FG000|Week 0 -16|Protocol Violation|1|||
170812944|NCT02400749|617324097|FG001|Week 0 -16|Protocol Violation|0|||
170812945|NCT02400749|617324096|FG000|Week 17 - 32|Withdrawal by Subject|3|||
170812946|NCT02400749|617324097|FG001|Week 17 - 32|Withdrawal by Subject|2|||
170812947|NCT02400749|617324096|FG000|Week 17 - 32|Adverse Event|2|||
170812948|NCT02400749|617324097|FG001|Week 17 - 32|Adverse Event|1|||
170812949|NCT02002689|617324098|FG000|Overall Study|Disease Progression|7|||
170812950|NCT02002689|617324098|FG000|Overall Study|Adverse Event|3|||
170812951|NCT00304278|617324101|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
170812952|NCT00304278|617324101|FG000|Overall Study|PT had medical condition preventing TX|1|||
170812953|NCT01304940|617324102|FG000|Overall Study|not meet symptom severity requirement|3|||
170812954|NCT01304940|617324103|FG001|Overall Study|not meet symptom severity requirement|0|||
170812955|NCT00278395|617324108|FG000|Overall Study|Adverse Event|2|||
170812956|NCT00278395|617324108|FG000|Overall Study|Nonevaluable|1|||
170812957|NCT02065895|617324109|FG000|Overall Study|Protocol Violation|1|||
170812958|NCT02065895|617324110|FG001|Overall Study|Protocol Violation|0|||
170812959|NCT02065895|617324111|FG002|Overall Study|Protocol Violation|0|||
170812960|NCT02065895|617324112|FG003|Overall Study|Protocol Violation|1|||
170812961|NCT02065895|617324113|FG004|Overall Study|Protocol Violation|0|||
170812962|NCT02065895|617324114|FG005|Overall Study|Protocol Violation|0|||
170812963|NCT02065895|617324109|FG000|Overall Study|Scheduling conflicts|0|||
170812964|NCT02065895|617324110|FG001|Overall Study|Scheduling conflicts|1|||
170812965|NCT02065895|617324111|FG002|Overall Study|Scheduling conflicts|0|||
170812966|NCT02065895|617324112|FG003|Overall Study|Scheduling conflicts|0|||
170598939|NCT04566601|616538660|FG003|Overall Study|Adverse Event|5|||
170598940|NCT04566601|616538661|FG004|Overall Study|Adverse Event|12|||
170598941|NCT02522325|616538663|FG000|Overall Study|Adverse Event|0|||
170598942|NCT02522325|616538664|FG001|Overall Study|Adverse Event|1|||
170598943|NCT01209078|616538665|FG000|Overall Study|Adverse Event|5|||
170598944|NCT01209078|616538666|FG001|Overall Study|Adverse Event|0|||
170598945|NCT01209078|616538665|FG000|Overall Study|Lost to Follow-up|4|||
170598946|NCT01209078|616538666|FG001|Overall Study|Lost to Follow-up|0|||
170598947|NCT01209078|616538665|FG000|Overall Study|Physician Decision|5|||
170598948|NCT01209078|616538666|FG001|Overall Study|Physician Decision|2|||
170598949|NCT01209078|616538665|FG000|Overall Study|Withdrawal by Subject|2|||
170598950|NCT01209078|616538666|FG001|Overall Study|Withdrawal by Subject|1|||
170598951|NCT01939366|616538670|FG000|Overall Study|Adverse Event|8|||
170598952|NCT01939366|616538671|FG001|Overall Study|Adverse Event|17|||
170598953|NCT01939366|616538672|FG002|Overall Study|Adverse Event|30|||
170598954|NCT01939366|616538673|FG003|Overall Study|Adverse Event|8|||
170598955|NCT01939366|616538674|FG004|Overall Study|Adverse Event|5|||
170598956|NCT01939366|616538670|FG000|Overall Study|Lack of Efficacy|2|||
170598957|NCT01939366|616538671|FG001|Overall Study|Lack of Efficacy|1|||
170598958|NCT01939366|616538672|FG002|Overall Study|Lack of Efficacy|1|||
170598959|NCT01939366|616538673|FG003|Overall Study|Lack of Efficacy|1|||
170598960|NCT01939366|616538674|FG004|Overall Study|Lack of Efficacy|3|||
170598961|NCT01939366|616538670|FG000|Overall Study|Lost to Follow-up|1|||
170598962|NCT01939366|616538671|FG001|Overall Study|Lost to Follow-up|1|||
170598963|NCT01939366|616538672|FG002|Overall Study|Lost to Follow-up|0|||
170598964|NCT01939366|616538673|FG003|Overall Study|Lost to Follow-up|0|||
170598965|NCT01939366|616538674|FG004|Overall Study|Lost to Follow-up|0|||
170598966|NCT01939366|616538670|FG000|Overall Study|Withdrawal by Subject|1|||
170598967|NCT01939366|616538671|FG001|Overall Study|Withdrawal by Subject|0|||
170913601|NCT01089725|617685969|FG003|Overall Study|Protocol Violation|1|||
170913602|NCT01089725|617685970|FG004|Overall Study|Protocol Violation|0|||
170913603|NCT01089725|617685966|FG000|Overall Study|Withdrawal by Subject|5|||
170913604|NCT01089725|617685967|FG001|Overall Study|Withdrawal by Subject|5|||
170913605|NCT01089725|617685968|FG002|Overall Study|Withdrawal by Subject|4|||
170598968|NCT01939366|616538672|FG002|Overall Study|Withdrawal by Subject|2|||
170598969|NCT01939366|616538673|FG003|Overall Study|Withdrawal by Subject|2|||
170598970|NCT01939366|616538674|FG004|Overall Study|Withdrawal by Subject|3|||
170598971|NCT01939366|616538670|FG000|Overall Study|Inclusion criteria not met|0|||
170598972|NCT01939366|616538671|FG001|Overall Study|Inclusion criteria not met|1|||
170598973|NCT01939366|616538672|FG002|Overall Study|Inclusion criteria not met|1|||
170598974|NCT01939366|616538673|FG003|Overall Study|Inclusion criteria not met|0|||
170598975|NCT01939366|616538674|FG004|Overall Study|Inclusion criteria not met|1|||
170598976|NCT01939366|616538670|FG000|Overall Study|Other|0|||
170598977|NCT01939366|616538671|FG001|Overall Study|Other|0|||
170598978|NCT01939366|616538672|FG002|Overall Study|Other|2|||
170598979|NCT01939366|616538673|FG003|Overall Study|Other|2|||
170598980|NCT01939366|616538674|FG004|Overall Study|Other|1|||
170598981|NCT01939366|616538670|FG000|Overall Study|Protocol Violation|0|||
170598982|NCT01939366|616538671|FG001|Overall Study|Protocol Violation|0|||
170598983|NCT01939366|616538672|FG002|Overall Study|Protocol Violation|0|||
170598984|NCT01939366|616538673|FG003|Overall Study|Protocol Violation|1|||
170913606|NCT01089725|617685969|FG003|Overall Study|Withdrawal by Subject|5|||
170913607|NCT01089725|617685970|FG004|Overall Study|Withdrawal by Subject|4|||
170598985|NCT01939366|616538674|FG004|Overall Study|Protocol Violation|0|||
170598986|NCT01939366|616538670|FG000|Overall Study|Sponsor decision|0|||
170598987|NCT01939366|616538671|FG001|Overall Study|Sponsor decision|0|||
170598988|NCT01939366|616538672|FG002|Overall Study|Sponsor decision|0|||
170598989|NCT01939366|616538673|FG003|Overall Study|Sponsor decision|0|||
170598990|NCT01939366|616538674|FG004|Overall Study|Sponsor decision|2|||
170598991|NCT01939366|616538670|FG000|Overall Study|GCP non-compliance at site|2|||
170598992|NCT01939366|616538671|FG001|Overall Study|GCP non-compliance at site|3|||
170598993|NCT01939366|616538672|FG002|Overall Study|GCP non-compliance at site|2|||
170598994|NCT01939366|616538673|FG003|Overall Study|GCP non-compliance at site|3|||
170598995|NCT01939366|616538674|FG004|Overall Study|GCP non-compliance at site|3|||
170598996|NCT04201093|616538677|FG000|Overall Study|Adverse Event|6|||
170598997|NCT04201093|616538678|FG001|Overall Study|Adverse Event|29|||
170598998|NCT04201093|616538679|FG002|Overall Study|Adverse Event|35|||
170598999|NCT04201093|616538677|FG000|Overall Study|Death|2|||
170599000|NCT04201093|616538678|FG001|Overall Study|Death|1|||
170599001|NCT04201093|616538679|FG002|Overall Study|Death|0|||
170599002|NCT04201093|616538677|FG000|Overall Study|Lack of Efficacy|5|||
170599003|NCT04201093|616538678|FG001|Overall Study|Lack of Efficacy|1|||
170599004|NCT04201093|616538679|FG002|Overall Study|Lack of Efficacy|2|||
170599005|NCT04201093|616538677|FG000|Overall Study|Lost to Follow-up|0|||
170599006|NCT04201093|616538678|FG001|Overall Study|Lost to Follow-up|0|||
170913608|NCT01089725|617685966|FG000|Overall Study|Study Terminated by Sponsor|51|||
170913609|NCT01089725|617685967|FG001|Overall Study|Study Terminated by Sponsor|56|||
170913610|NCT01089725|617685968|FG002|Overall Study|Study Terminated by Sponsor|53|||
170913611|NCT01089725|617685969|FG003|Overall Study|Study Terminated by Sponsor|68|||
170913612|NCT01089725|617685970|FG004|Overall Study|Study Terminated by Sponsor|68|||
170913613|NCT01089725|617685966|FG000|Overall Study|Randomized, but not treated|0|||
170913614|NCT01089725|617685967|FG001|Overall Study|Randomized, but not treated|1|||
170913615|NCT01089725|617685968|FG002|Overall Study|Randomized, but not treated|2|||
170913616|NCT01089725|617685969|FG003|Overall Study|Randomized, but not treated|1|||
170913617|NCT01089725|617685970|FG004|Overall Study|Randomized, but not treated|2|||
170913618|NCT01089725|617685966|FG000|Overall Study|Other|3|||
170913619|NCT01089725|617685967|FG001|Overall Study|Other|0|||
170913620|NCT01089725|617685968|FG002|Overall Study|Other|0|||
170913621|NCT01089725|617685969|FG003|Overall Study|Other|1|||
170913622|NCT01089725|617685970|FG004|Overall Study|Other|0|||
170913623|NCT01894516|617687609|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
170913624|NCT01894516|617687610|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
170913625|NCT01894516|617687611|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
170913626|NCT01894516|617687612|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
170913627|NCT01894516|617687609|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
170913628|NCT01894516|617687610|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170913629|NCT01894516|617687611|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170913630|NCT01894516|617687612|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170913631|NCT01894516|617687609|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
170913632|NCT01894516|617687610|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
170913633|NCT01894516|617687611|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
170913634|NCT01894516|617687612|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
170913635|NCT01894516|617687609|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
170913636|NCT01894516|617687610|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
170599007|NCT04201093|616538679|FG002|Overall Study|Lost to Follow-up|1|||
170599008|NCT04201093|616538677|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
170599009|NCT04201093|616538678|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
170599010|NCT04201093|616538679|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
170599011|NCT04201093|616538677|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
170599012|NCT04201093|616538678|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
170913637|NCT01894516|617687611|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
170913638|NCT01894516|617687612|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
170913639|NCT01894516|617687609|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
170913640|NCT01894516|617687610|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
170913641|NCT01894516|617687611|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
170913642|NCT01894516|617687612|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
170913643|NCT01894516|617687609|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
170913644|NCT01894516|617687610|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
170913645|NCT01894516|617687611|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
170913646|NCT01894516|617687612|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
170913647|NCT01894516|617687609|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
170913648|NCT01894516|617687610|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
170913649|NCT01894516|617687611|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
170913650|NCT01894516|617687612|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
170913651|NCT01894516|617687609|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
170913652|NCT01894516|617687610|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
170913653|NCT01894516|617687611|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
170913654|NCT01894516|617687612|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
170913655|NCT00408421|617687619|FG000|Treatment Initial Randomization|Adverse Event|5|||
170913656|NCT00408421|617687620|FG001|Treatment Initial Randomization|Adverse Event|9|||
170913657|NCT00408421|617687621|FG002|Treatment Initial Randomization|Adverse Event|0|||
170913658|NCT00408421|617687619|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
170913659|NCT00408421|617687620|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
170913660|NCT00408421|617687621|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
170913661|NCT00408421|617687619|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
170913662|NCT00408421|617687620|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
170913663|NCT00408421|617687621|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
170913664|NCT00408421|617687619|FG000|Treatment Initial Randomization|Physician Decision|1|||
170913665|NCT00408421|617687620|FG001|Treatment Initial Randomization|Physician Decision|0|||
170913666|NCT00408421|617687621|FG002|Treatment Initial Randomization|Physician Decision|0|||
170913667|NCT00408421|617687619|FG000|Treatment Initial Randomization|Protocol Violation|0|||
170913668|NCT00408421|617687620|FG001|Treatment Initial Randomization|Protocol Violation|1|||
170913669|NCT00408421|617687621|FG002|Treatment Initial Randomization|Protocol Violation|0|||
170913670|NCT00408421|617687619|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
170913671|NCT00408421|617687620|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
170913672|NCT00408421|617687621|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
170913673|NCT00408421|617687619|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
170913674|NCT00408421|617687620|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
170913675|NCT00408421|617687621|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
170913676|NCT00408421|617687619|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
170913677|NCT00408421|617687620|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
170913678|NCT00408421|617687621|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
170913679|NCT00408421|617687619|FG000|Treatment Re-Randomization|Adverse Event|2|||
170913680|NCT00408421|617687620|FG001|Treatment Re-Randomization|Adverse Event|2|||
170913681|NCT00408421|617687621|FG002|Treatment Re-Randomization|Adverse Event|4|||
170913682|NCT00408421|617687619|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
170913683|NCT00408421|617687620|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
170913684|NCT00408421|617687621|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
170913685|NCT00408421|617687619|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
170913686|NCT00408421|617687620|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
170913687|NCT00408421|617687621|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
170913688|NCT00408421|617687619|FG000|Treatment Re-Randomization|Physician Decision|1|||
170913689|NCT00408421|617687620|FG001|Treatment Re-Randomization|Physician Decision|3|||
170913690|NCT00408421|617687621|FG002|Treatment Re-Randomization|Physician Decision|0|||
170913691|NCT00408421|617687619|FG000|Treatment Re-Randomization|Protocol Violation|1|||
170913692|NCT00408421|617687620|FG001|Treatment Re-Randomization|Protocol Violation|1|||
170913693|NCT00408421|617687621|FG002|Treatment Re-Randomization|Protocol Violation|0|||
170913694|NCT00408421|617687619|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
170913695|NCT00408421|617687620|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
170913696|NCT00408421|617687621|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
170913697|NCT03009539|617687622|FG000|Overall Study|Lost to Follow-up|132|||
170913698|NCT03009539|617687623|FG001|Overall Study|Lost to Follow-up|113|||
170913699|NCT03009539|617687624|FG002|Overall Study|Lost to Follow-up|132|||
170599013|NCT04201093|616538679|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
170599014|NCT04201093|616538677|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
170599015|NCT04201093|616538678|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
170599016|NCT04201093|616538679|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
170599017|NCT04201093|616538677|FG000|Overall Study|Physician Decision|1|||
170599018|NCT04201093|616538678|FG001|Overall Study|Physician Decision|0|||
170599019|NCT04201093|616538679|FG002|Overall Study|Physician Decision|0|||
170599020|NCT04201093|616538677|FG000|Overall Study|Protocol Deviation|1|||
170599021|NCT04201093|616538678|FG001|Overall Study|Protocol Deviation|0|||
170599022|NCT04201093|616538679|FG002|Overall Study|Protocol Deviation|0|||
170599023|NCT04201093|616538677|FG000|Overall Study|Site Terminated by Sponsor|5|||
170599024|NCT04201093|616538678|FG001|Overall Study|Site Terminated by Sponsor|3|||
170599025|NCT04201093|616538679|FG002|Overall Study|Site Terminated by Sponsor|1|||
170599026|NCT04201093|616538677|FG000|Overall Study|Withdrawal by Subject|7|||
170599027|NCT04201093|616538678|FG001|Overall Study|Withdrawal by Subject|8|||
170599028|NCT04201093|616538679|FG002|Overall Study|Withdrawal by Subject|15|||
170599029|NCT04201093|616538677|FG000|Overall Study|Other|0|||
170599030|NCT04201093|616538678|FG001|Overall Study|Other|1|||
170599031|NCT04201093|616538679|FG002|Overall Study|Other|2|||
170599032|NCT02596230|616538680|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
170599033|NCT02596230|616538681|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
170599034|NCT02596230|616538682|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
170599035|NCT02596230|616538683|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
170599036|NCT02596230|616538684|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
170599037|NCT02596230|616538680|FG000|Objective 2, One Year|Lost to Follow-up|0|||
170599038|NCT02596230|616538681|FG001|Objective 2, One Year|Lost to Follow-up|41|||
170599039|NCT02596230|616538682|FG002|Objective 2, One Year|Lost to Follow-up|41|||
170599040|NCT02596230|616538683|FG003|Objective 2, One Year|Lost to Follow-up|32|||
170599041|NCT02596230|616538684|FG004|Objective 2, One Year|Lost to Follow-up|46|||
170599042|NCT02596230|616538680|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
170599043|NCT02596230|616538681|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
170599044|NCT02596230|616538682|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
170599045|NCT02596230|616538683|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
170599046|NCT02596230|616538684|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
170599047|NCT02596230|616538680|FG000|Objective 2, One Year|Adverse drug reaction|0|||
170599048|NCT02596230|616538681|FG001|Objective 2, One Year|Adverse drug reaction|1|||
170599049|NCT02596230|616538682|FG002|Objective 2, One Year|Adverse drug reaction|0|||
170599050|NCT02596230|616538683|FG003|Objective 2, One Year|Adverse drug reaction|0|||
170599051|NCT02596230|616538684|FG004|Objective 2, One Year|Adverse drug reaction|0|||
170599052|NCT02596230|616538680|FG000|Objective 2, One Year|Death|0|||
170599053|NCT02596230|616538681|FG001|Objective 2, One Year|Death|12|||
170599054|NCT02596230|616538682|FG002|Objective 2, One Year|Death|41|||
170599055|NCT02596230|616538683|FG003|Objective 2, One Year|Death|21|||
170599056|NCT02596230|616538684|FG004|Objective 2, One Year|Death|30|||
170599057|NCT02596230|616538680|FG000|Objective 2, One Year|Other|0|||
170599058|NCT02596230|616538681|FG001|Objective 2, One Year|Other|3|||
170599059|NCT02596230|616538682|FG002|Objective 2, One Year|Other|2|||
170599060|NCT02596230|616538683|FG003|Objective 2, One Year|Other|0|||
170599061|NCT02596230|616538684|FG004|Objective 2, One Year|Other|0|||
170599062|NCT02708485|616538689|FG000|Overall Study|Withdrawal by Subject|3|||
170599063|NCT02708485|616538690|FG001|Overall Study|Withdrawal by Subject|2|||
170599064|NCT00231413|616538691|FG000|Overall Study|Non-serious AE|0|||
170913700|NCT03009539|617687625|FG003|Overall Study|Lost to Follow-up|113|||
170913701|NCT00710034|617687626|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
170599065|NCT00231413|616538692|FG001|Overall Study|Non-serious AE|0|||
170599066|NCT00231413|616538693|FG002|Overall Study|Non-serious AE|1|||
170599067|NCT00231413|616538694|FG003|Overall Study|Non-serious AE|0|||
170599068|NCT00231413|616538695|FG004|Overall Study|Non-serious AE|0|||
170599069|NCT00231413|616538696|FG005|Overall Study|Non-serious AE|0|||
170599070|NCT00231413|616538697|FG006|Overall Study|Non-serious AE|1|||
170599071|NCT00231413|616538691|FG000|Overall Study|Withdrawal by Subject|3|||
170599072|NCT00231413|616538692|FG001|Overall Study|Withdrawal by Subject|1|||
170599073|NCT00231413|616538693|FG002|Overall Study|Withdrawal by Subject|4|||
170599074|NCT00231413|616538694|FG003|Overall Study|Withdrawal by Subject|2|||
170599075|NCT00231413|616538695|FG004|Overall Study|Withdrawal by Subject|2|||
170599076|NCT00231413|616538696|FG005|Overall Study|Withdrawal by Subject|0|||
170599077|NCT00231413|616538697|FG006|Overall Study|Withdrawal by Subject|3|||
170599078|NCT00231413|616538691|FG000|Overall Study|Migrated/moved from study area|0|||
170599079|NCT00231413|616538692|FG001|Overall Study|Migrated/moved from study area|0|||
170599080|NCT00231413|616538693|FG002|Overall Study|Migrated/moved from study area|1|||
170913702|NCT00710034|617687627|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
170913703|NCT00710034|617687626|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
170599081|NCT00231413|616538694|FG003|Overall Study|Migrated/moved from study area|0|||
170599082|NCT00231413|616538695|FG004|Overall Study|Migrated/moved from study area|0|||
170599083|NCT00231413|616538696|FG005|Overall Study|Migrated/moved from study area|1|||
170913704|NCT00710034|617687627|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
170599084|NCT00231413|616538697|FG006|Overall Study|Migrated/moved from study area|0|||
170599085|NCT00231413|616538691|FG000|Overall Study|Lost to Follow-up|4|||
170913705|NCT00710034|617687626|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
170599086|NCT00231413|616538692|FG001|Overall Study|Lost to Follow-up|4|||
170599087|NCT00231413|616538693|FG002|Overall Study|Lost to Follow-up|1|||
170913706|NCT00710034|617687627|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
170599088|NCT00231413|616538694|FG003|Overall Study|Lost to Follow-up|1|||
170599089|NCT00231413|616538695|FG004|Overall Study|Lost to Follow-up|1|||
170599090|NCT00231413|616538696|FG005|Overall Study|Lost to Follow-up|4|||
170599091|NCT00231413|616538697|FG006|Overall Study|Lost to Follow-up|0|||
170599092|NCT00231413|616538691|FG000|Overall Study|Pregnancy|1|||
170599093|NCT00231413|616538692|FG001|Overall Study|Pregnancy|0|||
170599094|NCT00231413|616538693|FG002|Overall Study|Pregnancy|0|||
170599095|NCT00231413|616538694|FG003|Overall Study|Pregnancy|0|||
170599096|NCT00231413|616538695|FG004|Overall Study|Pregnancy|0|||
170599097|NCT00231413|616538696|FG005|Overall Study|Pregnancy|0|||
170599098|NCT00231413|616538697|FG006|Overall Study|Pregnancy|0|||
170599099|NCT03779503|616538698|FG000|First Intervention|Adverse Event|0|||
170599100|NCT03779503|616538699|FG001|First Intervention|Adverse Event|1|||
170599101|NCT03779503|616538698|FG000|First Intervention|Withdrawal by Subject|1|||
170599102|NCT03779503|616538699|FG001|First Intervention|Withdrawal by Subject|0|||
170599103|NCT03242252|616538701|FG000|Overall Study|At the Participant's own Request|18|||
170599104|NCT03242252|616538702|FG001|Overall Study|At the Participant's own Request|10|||
170599105|NCT03242252|616538703|FG002|Overall Study|At the Participant's own Request|15|||
170599106|NCT03242252|616538701|FG000|Overall Study|Adverse Event|8|||
170599107|NCT03242252|616538702|FG001|Overall Study|Adverse Event|6|||
170599108|NCT03242252|616538703|FG002|Overall Study|Adverse Event|9|||
170599109|NCT03242252|616538701|FG000|Overall Study|Poor Compliance to Protocol|0|||
170599110|NCT03242252|616538702|FG001|Overall Study|Poor Compliance to Protocol|2|||
170599111|NCT03242252|616538703|FG002|Overall Study|Poor Compliance to Protocol|3|||
170599112|NCT03242252|616538701|FG000|Overall Study|Study Terminated by Sponsor|1|||
170599113|NCT03242252|616538702|FG001|Overall Study|Study Terminated by Sponsor|0|||
170599114|NCT03242252|616538703|FG002|Overall Study|Study Terminated by Sponsor|0|||
170599115|NCT03242252|616538701|FG000|Overall Study|Reason not Specified|4|||
170599116|NCT03242252|616538702|FG001|Overall Study|Reason not Specified|4|||
170599117|NCT03242252|616538703|FG002|Overall Study|Reason not Specified|1|||
170599118|NCT03242252|616538701|FG000|Overall Study|Lost to Follow-up|5|||
170599119|NCT03242252|616538702|FG001|Overall Study|Lost to Follow-up|1|||
170599120|NCT03242252|616538703|FG002|Overall Study|Lost to Follow-up|4|||
170599121|NCT01659255|616538704|FG000|Overall Study|Adverse Event|0|||
170599122|NCT01659255|616538705|FG001|Overall Study|Adverse Event|0|||
170599123|NCT01659255|616538706|FG002|Overall Study|Adverse Event|0|||
170599124|NCT01659255|616538707|FG003|Overall Study|Adverse Event|0|||
170599125|NCT01659255|616538708|FG004|Overall Study|Adverse Event|0|||
170599126|NCT01659255|616538709|FG005|Overall Study|Adverse Event|1|||
170599127|NCT01659255|616538710|FG006|Overall Study|Adverse Event|1|||
170599128|NCT01659255|616538711|FG007|Overall Study|Adverse Event|0|||
170599129|NCT01659255|616538712|FG008|Overall Study|Adverse Event|0|||
170599130|NCT01659255|616538713|FG009|Overall Study|Adverse Event|1|||
170599131|NCT01659255|616538714|FG010|Overall Study|Adverse Event|0|||
170599132|NCT01659255|616538715|FG011|Overall Study|Adverse Event|1|||
170599133|NCT01659255|616538716|FG012|Overall Study|Adverse Event|0|||
170599134|NCT01659255|616538717|FG013|Overall Study|Adverse Event|2|||
170599135|NCT01659255|616538718|FG014|Overall Study|Adverse Event|0|||
170599136|NCT01659255|616538719|FG015|Overall Study|Adverse Event|1|||
170599137|NCT01659255|616538720|FG016|Overall Study|Adverse Event|0|||
170599138|NCT01659255|616538704|FG000|Overall Study|Death|0|||
170599139|NCT01659255|616538705|FG001|Overall Study|Death|1|||
170599140|NCT01659255|616538706|FG002|Overall Study|Death|0|||
170599141|NCT01659255|616538707|FG003|Overall Study|Death|0|||
170599142|NCT01659255|616538708|FG004|Overall Study|Death|0|||
170599143|NCT01659255|616538709|FG005|Overall Study|Death|0|||
170599144|NCT01659255|616538710|FG006|Overall Study|Death|0|||
170599145|NCT01659255|616538711|FG007|Overall Study|Death|1|||
170599146|NCT01659255|616538712|FG008|Overall Study|Death|1|||
170599147|NCT01659255|616538713|FG009|Overall Study|Death|0|||
170599148|NCT01659255|616538714|FG010|Overall Study|Death|0|||
170599149|NCT01659255|616538715|FG011|Overall Study|Death|0|||
170599150|NCT01659255|616538716|FG012|Overall Study|Death|1|||
170599151|NCT01659255|616538717|FG013|Overall Study|Death|1|||
170599152|NCT01659255|616538718|FG014|Overall Study|Death|2|||
170599153|NCT01659255|616538719|FG015|Overall Study|Death|1|||
170599154|NCT01659255|616538720|FG016|Overall Study|Death|0|||
170599155|NCT01659255|616538704|FG000|Overall Study|Progressive Disease|2|||
170599156|NCT01659255|616538705|FG001|Overall Study|Progressive Disease|0|||
170599157|NCT01659255|616538706|FG002|Overall Study|Progressive Disease|0|||
170599158|NCT01659255|616538707|FG003|Overall Study|Progressive Disease|0|||
170599159|NCT01659255|616538708|FG004|Overall Study|Progressive Disease|0|||
170599160|NCT01659255|616538709|FG005|Overall Study|Progressive Disease|0|||
170651763|NCT01451437|616738245|FG002|Overall Study|Adverse Event|0|||
170651764|NCT01451437|616738246|FG003|Overall Study|Adverse Event|0|||
170651765|NCT01451437|616738247|FG004|Overall Study|Adverse Event|0|||
170651766|NCT01451437|616738248|FG005|Overall Study|Adverse Event|1|||
170651767|NCT01451437|616738249|FG006|Overall Study|Adverse Event|1|||
170651768|NCT01451437|616738250|FG007|Overall Study|Adverse Event|2|||
170651769|NCT01451437|616738251|FG008|Overall Study|Adverse Event|1|||
170651770|NCT01451437|616738243|FG000|Overall Study|Physician Decision|1|||
170651771|NCT01451437|616738244|FG001|Overall Study|Physician Decision|1|||
170651772|NCT01451437|616738245|FG002|Overall Study|Physician Decision|2|||
170651773|NCT01451437|616738246|FG003|Overall Study|Physician Decision|0|||
170812967|NCT02065895|617324113|FG004|Overall Study|Scheduling conflicts|0|||
170599161|NCT01659255|616538710|FG006|Overall Study|Progressive Disease|0|||
170599162|NCT01659255|616538711|FG007|Overall Study|Progressive Disease|1|||
170599163|NCT01659255|616538712|FG008|Overall Study|Progressive Disease|0|||
170599164|NCT01659255|616538713|FG009|Overall Study|Progressive Disease|2|||
170599165|NCT01659255|616538714|FG010|Overall Study|Progressive Disease|2|||
170599166|NCT01659255|616538715|FG011|Overall Study|Progressive Disease|3|||
170599167|NCT01659255|616538716|FG012|Overall Study|Progressive Disease|5|||
170599168|NCT01659255|616538717|FG013|Overall Study|Progressive Disease|13|||
170599169|NCT01659255|616538718|FG014|Overall Study|Progressive Disease|6|||
170599170|NCT01659255|616538719|FG015|Overall Study|Progressive Disease|2|||
170599171|NCT01659255|616538720|FG016|Overall Study|Progressive Disease|3|||
170599172|NCT01659255|616538704|FG000|Overall Study|Withdrew Consent|0|||
170599173|NCT01659255|616538705|FG001|Overall Study|Withdrew Consent|0|||
170599174|NCT01659255|616538706|FG002|Overall Study|Withdrew Consent|0|||
170651774|NCT01451437|616738247|FG004|Overall Study|Physician Decision|0|||
170651775|NCT01451437|616738248|FG005|Overall Study|Physician Decision|0|||
170651776|NCT01451437|616738249|FG006|Overall Study|Physician Decision|0|||
170651777|NCT01451437|616738250|FG007|Overall Study|Physician Decision|0|||
170651778|NCT01451437|616738251|FG008|Overall Study|Physician Decision|0|||
170651779|NCT01451437|616738243|FG000|Overall Study|Disease Progression|0|||
170651780|NCT01451437|616738244|FG001|Overall Study|Disease Progression|0|||
170812968|NCT02065895|617324114|FG005|Overall Study|Scheduling conflicts|0|||
170812969|NCT03740737|617324115|FG000|Overall Study|Protocol deviation|13|||
170812970|NCT03740737|617324116|FG001|Overall Study|Protocol deviation|0|||
170812971|NCT03740737|617324115|FG000|Overall Study|Adverse Event|2|||
170812972|NCT03740737|617324116|FG001|Overall Study|Adverse Event|0|||
170812973|NCT03740737|617324115|FG000|Overall Study|Lost to Follow-up|1|||
170812974|NCT03740737|617324116|FG001|Overall Study|Lost to Follow-up|0|||
170812975|NCT03740737|617324115|FG000|Overall Study|Randomization failure|1|||
170812976|NCT03740737|617324116|FG001|Overall Study|Randomization failure|0|||
170812977|NCT03740737|617324115|FG000|Overall Study|Participant withdrew consent|1|||
170812978|NCT03740737|617324116|FG001|Overall Study|Participant withdrew consent|0|||
170812979|NCT03740737|617324115|FG000|Overall Study|Participant withdrew from trial|2|||
170812980|NCT03740737|617324116|FG001|Overall Study|Participant withdrew from trial|1|||
170913707|NCT00710034|617687626|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
170913708|NCT00710034|617687627|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
170913709|NCT00710034|617687626|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
170913710|NCT00710034|617687627|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
170913711|NCT00710034|617687626|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
170913712|NCT00710034|617687627|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
170599175|NCT01659255|616538707|FG003|Overall Study|Withdrew Consent|0|||
170599176|NCT01659255|616538708|FG004|Overall Study|Withdrew Consent|0|||
170599177|NCT01659255|616538709|FG005|Overall Study|Withdrew Consent|0|||
170599178|NCT01659255|616538710|FG006|Overall Study|Withdrew Consent|0|||
170599179|NCT01659255|616538711|FG007|Overall Study|Withdrew Consent|0|||
170599180|NCT01659255|616538712|FG008|Overall Study|Withdrew Consent|0|||
170599181|NCT01659255|616538713|FG009|Overall Study|Withdrew Consent|0|||
170599182|NCT01659255|616538714|FG010|Overall Study|Withdrew Consent|1|||
170599183|NCT01659255|616538715|FG011|Overall Study|Withdrew Consent|0|||
170599184|NCT01659255|616538716|FG012|Overall Study|Withdrew Consent|0|||
170599185|NCT01659255|616538717|FG013|Overall Study|Withdrew Consent|1|||
170599186|NCT01659255|616538718|FG014|Overall Study|Withdrew Consent|0|||
170599187|NCT01659255|616538719|FG015|Overall Study|Withdrew Consent|0|||
170599188|NCT01659255|616538720|FG016|Overall Study|Withdrew Consent|0|||
170599189|NCT01659255|616538704|FG000|Overall Study|Investigator Decision|0|||
170599190|NCT01659255|616538705|FG001|Overall Study|Investigator Decision|0|||
170651781|NCT01451437|616738245|FG002|Overall Study|Disease Progression|1|||
170651782|NCT01451437|616738246|FG003|Overall Study|Disease Progression|1|||
170812981|NCT00507429|617324117|FG000|Treatment Phase|Disease Progression|12|||
170812982|NCT00507429|617324118|FG001|Treatment Phase|Disease Progression|5|||
170599191|NCT01659255|616538706|FG002|Overall Study|Investigator Decision|0|||
170599192|NCT01659255|616538707|FG003|Overall Study|Investigator Decision|0|||
170599193|NCT01659255|616538708|FG004|Overall Study|Investigator Decision|0|||
170651783|NCT01451437|616738247|FG004|Overall Study|Disease Progression|3|||
170599194|NCT01659255|616538709|FG005|Overall Study|Investigator Decision|0|||
170599195|NCT01659255|616538710|FG006|Overall Study|Investigator Decision|0|||
170599196|NCT01659255|616538711|FG007|Overall Study|Investigator Decision|0|||
170599197|NCT01659255|616538712|FG008|Overall Study|Investigator Decision|0|||
170599198|NCT01659255|616538713|FG009|Overall Study|Investigator Decision|0|||
170599199|NCT01659255|616538714|FG010|Overall Study|Investigator Decision|0|||
170599200|NCT01659255|616538715|FG011|Overall Study|Investigator Decision|0|||
170599201|NCT01659255|616538716|FG012|Overall Study|Investigator Decision|1|||
170599202|NCT01659255|616538717|FG013|Overall Study|Investigator Decision|1|||
170599203|NCT01659255|616538718|FG014|Overall Study|Investigator Decision|0|||
170599204|NCT01659255|616538719|FG015|Overall Study|Investigator Decision|0|||
170599205|NCT01659255|616538720|FG016|Overall Study|Investigator Decision|0|||
170599206|NCT01659255|616538704|FG000|Overall Study|Sponsor's Decision|0|||
170599207|NCT01659255|616538705|FG001|Overall Study|Sponsor's Decision|0|||
170599208|NCT01659255|616538706|FG002|Overall Study|Sponsor's Decision|0|||
170599209|NCT01659255|616538707|FG003|Overall Study|Sponsor's Decision|0|||
170599210|NCT01659255|616538708|FG004|Overall Study|Sponsor's Decision|0|||
170599211|NCT01659255|616538709|FG005|Overall Study|Sponsor's Decision|0|||
170599212|NCT01659255|616538710|FG006|Overall Study|Sponsor's Decision|1|||
170599213|NCT01659255|616538711|FG007|Overall Study|Sponsor's Decision|0|||
170599214|NCT01659255|616538712|FG008|Overall Study|Sponsor's Decision|0|||
170599215|NCT01659255|616538713|FG009|Overall Study|Sponsor's Decision|0|||
170599216|NCT01659255|616538714|FG010|Overall Study|Sponsor's Decision|0|||
170599217|NCT01659255|616538715|FG011|Overall Study|Sponsor's Decision|0|||
170599218|NCT01659255|616538716|FG012|Overall Study|Sponsor's Decision|0|||
170599219|NCT01659255|616538717|FG013|Overall Study|Sponsor's Decision|0|||
170599220|NCT01659255|616538718|FG014|Overall Study|Sponsor's Decision|0|||
170812983|NCT00507429|617324117|FG000|Treatment Phase|Adverse Event|12|||
170812984|NCT00507429|617324118|FG001|Treatment Phase|Adverse Event|5|||
170812985|NCT00507429|617324117|FG000|Treatment Phase|Withdrawal by Subject|3|||
170812986|NCT00507429|617324118|FG001|Treatment Phase|Withdrawal by Subject|3|||
170812987|NCT00507429|617324117|FG000|Treatment Phase|Physician Decision|4|||
170812988|NCT00507429|617324118|FG001|Treatment Phase|Physician Decision|2|||
170812989|NCT00507429|617324117|FG000|Treatment Phase|Other|6|||
170812990|NCT00507429|617324118|FG001|Treatment Phase|Other|3|||
170812991|NCT00507429|617324117|FG000|Maintenance Phase|Progressive Disease|14|||
170812992|NCT00507429|617324118|FG001|Maintenance Phase|Progressive Disease|0|||
170812993|NCT04025762|617324122|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
170812994|NCT04025762|617324123|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
170812995|NCT00569166|617324128|FG000|Overall Study|Withdrawal by Subject|7|||
170812996|NCT00569166|617324129|FG001|Overall Study|Withdrawal by Subject|5|||
170599221|NCT01659255|616538719|FG015|Overall Study|Sponsor's Decision|0|||
170599222|NCT01659255|616538720|FG016|Overall Study|Sponsor's Decision|0|||
170599223|NCT01659255|616538704|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599224|NCT01659255|616538705|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599225|NCT01659255|616538706|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170651784|NCT01451437|616738248|FG005|Overall Study|Disease Progression|2|||
170651785|NCT01451437|616738249|FG006|Overall Study|Disease Progression|3|||
170651786|NCT01451437|616738250|FG007|Overall Study|Disease Progression|1|||
170651787|NCT01451437|616738251|FG008|Overall Study|Disease Progression|3|||
170651788|NCT01451437|616738243|FG000|Overall Study|Protocol Violation|0|||
170651789|NCT01451437|616738244|FG001|Overall Study|Protocol Violation|0|||
170651790|NCT01451437|616738245|FG002|Overall Study|Protocol Violation|0|||
170812997|NCT00569166|617324130|FG002|Overall Study|Withdrawal by Subject|3|||
170599226|NCT01659255|616538707|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599227|NCT01659255|616538708|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170651791|NCT01451437|616738246|FG003|Overall Study|Protocol Violation|0|||
170599228|NCT01659255|616538709|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599229|NCT01659255|616538710|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599230|NCT01659255|616538711|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599231|NCT01659255|616538712|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599232|NCT01659255|616538713|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599233|NCT01659255|616538714|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599234|NCT01659255|616538715|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599235|NCT01659255|616538716|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599236|NCT01659255|616538717|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599237|NCT01659255|616538718|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599238|NCT01659255|616538719|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
170599239|NCT01659255|616538720|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
170599240|NCT01659255|616538704|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
170599241|NCT01659255|616538705|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
170599242|NCT01659255|616538706|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
170599243|NCT01659255|616538707|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
170599244|NCT01659255|616538708|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
170599245|NCT01659255|616538709|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
170599246|NCT01659255|616538710|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
170599247|NCT01659255|616538711|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
170599248|NCT01659255|616538712|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
170599249|NCT01659255|616538713|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
170599250|NCT01659255|616538714|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
170651792|NCT01451437|616738247|FG004|Overall Study|Protocol Violation|0|||
170913713|NCT00710034|617687626|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
170913714|NCT00710034|617687627|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
170913715|NCT00710034|617687626|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
170913716|NCT00710034|617687627|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
170913717|NCT00710034|617687626|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
170913718|NCT00710034|617687627|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
170913719|NCT00710034|617687626|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
170913720|NCT00710034|617687627|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
170913721|NCT00710034|617687626|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
170913722|NCT00710034|617687627|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
170913723|NCT03825042|617687628|FG000|Overall Study|Adverse Event|1|||
170913724|NCT03825042|617687629|FG001|Overall Study|Adverse Event|0|||
170913725|NCT03825042|617687628|FG000|Overall Study|Withdrawal by Subject|1|||
170913726|NCT03825042|617687629|FG001|Overall Study|Withdrawal by Subject|0|||
170913727|NCT01058369|617687638|FG000|Overall Study|Adverse Event|1|||
170913728|NCT01058369|617687638|FG000|Overall Study|Early termination study|1|||
170913729|NCT01713036|617687640|FG000|Overall Study|Death|1|||
170913730|NCT00283712|617687645|FG000|Overall Study|Death|0|||
170913731|NCT00283712|617687646|FG001|Overall Study|Death|1|||
170913732|NCT00090285|617687647|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
170913733|NCT00090285|617687648|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
170913734|NCT00090285|617687649|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
170913735|NCT00090285|617687650|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
170913736|NCT00090285|617687651|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
170913737|NCT00090285|617687652|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
170913738|NCT00090285|617687647|FG000|Base Study Vaccination Period|Adverse Event|2|||
170913739|NCT00090285|617687648|FG001|Base Study Vaccination Period|Adverse Event|4|||
170913740|NCT00090285|617687649|FG002|Base Study Vaccination Period|Adverse Event|0|||
170913741|NCT00090285|617687650|FG003|Base Study Vaccination Period|Adverse Event|0|||
170913742|NCT00090285|617687651|FG004|Base Study Vaccination Period|Adverse Event|0|||
170913743|NCT00090285|617687652|FG005|Base Study Vaccination Period|Adverse Event|0|||
170913744|NCT00090285|617687647|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
170913745|NCT00090285|617687648|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
170913746|NCT00090285|617687649|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
170913747|NCT00090285|617687650|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
170913748|NCT00090285|617687651|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
170913749|NCT00090285|617687652|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
170913750|NCT00090285|617687647|FG000|Base Study Vaccination Period|Protocol Violation|2|||
170913751|NCT00090285|617687648|FG001|Base Study Vaccination Period|Protocol Violation|3|||
170913752|NCT00090285|617687649|FG002|Base Study Vaccination Period|Protocol Violation|0|||
170913753|NCT00090285|617687650|FG003|Base Study Vaccination Period|Protocol Violation|0|||
170913754|NCT00090285|617687651|FG004|Base Study Vaccination Period|Protocol Violation|0|||
170913755|NCT00090285|617687652|FG005|Base Study Vaccination Period|Protocol Violation|0|||
170913756|NCT00090285|617687647|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
170913757|NCT00090285|617687648|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
170913758|NCT00090285|617687649|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
170913759|NCT00090285|617687650|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
170913760|NCT00090285|617687651|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
170913761|NCT00090285|617687652|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
170913762|NCT00090285|617687647|FG000|Base Study Vaccination Period|Uncooperative|2|||
170913763|NCT00090285|617687648|FG001|Base Study Vaccination Period|Uncooperative|2|||
170913764|NCT00090285|617687649|FG002|Base Study Vaccination Period|Uncooperative|0|||
170913765|NCT00090285|617687650|FG003|Base Study Vaccination Period|Uncooperative|0|||
170913766|NCT00090285|617687651|FG004|Base Study Vaccination Period|Uncooperative|0|||
170913767|NCT00090285|617687652|FG005|Base Study Vaccination Period|Uncooperative|0|||
170599251|NCT01659255|616538715|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
170599252|NCT01659255|616538716|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
170599253|NCT01659255|616538717|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
170599254|NCT01659255|616538718|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
170599255|NCT01659255|616538719|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
170599256|NCT01659255|616538720|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
170599257|NCT01116427|616538724|FG000|Core Phase|Adverse Event|0|||
170599258|NCT01116427|616538725|FG001|Core Phase|Adverse Event|1|||
170599259|NCT01116427|616538724|FG000|Core Phase|Lost to Follow-up|1|||
170651793|NCT01451437|616738248|FG005|Overall Study|Protocol Violation|0|||
170651794|NCT01451437|616738249|FG006|Overall Study|Protocol Violation|1|||
170651795|NCT01451437|616738250|FG007|Overall Study|Protocol Violation|0|||
170651796|NCT01451437|616738251|FG008|Overall Study|Protocol Violation|0|||
170651797|NCT01451437|616738243|FG000|Overall Study|Withdrawal by Subject|0|||
170651798|NCT01451437|616738244|FG001|Overall Study|Withdrawal by Subject|0|||
170651799|NCT01451437|616738245|FG002|Overall Study|Withdrawal by Subject|0|||
170651800|NCT01451437|616738246|FG003|Overall Study|Withdrawal by Subject|0|||
170651801|NCT01451437|616738247|FG004|Overall Study|Withdrawal by Subject|1|||
170651802|NCT01451437|616738248|FG005|Overall Study|Withdrawal by Subject|0|||
170651803|NCT01451437|616738249|FG006|Overall Study|Withdrawal by Subject|1|||
170651804|NCT01451437|616738250|FG007|Overall Study|Withdrawal by Subject|0|||
170651805|NCT01451437|616738251|FG008|Overall Study|Withdrawal by Subject|0|||
170651806|NCT01527357|616739959|FG000|Overall Study|Death|8|||
170651807|NCT01527357|616739960|FG001|Overall Study|Death|2|||
170651808|NCT01527357|616739959|FG000|Overall Study|Lost to Follow-up|6|||
170651809|NCT01527357|616739960|FG001|Overall Study|Lost to Follow-up|4|||
170812998|NCT00569166|617324128|FG000|Overall Study|Lost to Follow-up|2|||
170651810|NCT01527357|616739959|FG000|Overall Study|Withdrew Consent|1|||
170651811|NCT01527357|616739960|FG001|Overall Study|Withdrew Consent|1|||
170651812|NCT01527357|616739959|FG000|Overall Study|Non-compliance|0|||
170651813|NCT01527357|616739960|FG001|Overall Study|Non-compliance|1|||
170651814|NCT01527357|616739959|FG000|Overall Study|No Day 29 Visit|0|||
170651815|NCT01527357|616739960|FG001|Overall Study|No Day 29 Visit|1|||
170651816|NCT01527357|616739959|FG000|Overall Study|Did Not Receive Treatment|2|||
170651817|NCT01527357|616739960|FG001|Overall Study|Did Not Receive Treatment|0|||
170651818|NCT02292784|616739961|FG000|Overall Study|Lost to Follow-up|1|||
170651819|NCT02292784|616739962|FG001|Overall Study|Lost to Follow-up|17|||
170651820|NCT02292784|616739963|FG002|Overall Study|Lost to Follow-up|18|||
170651821|NCT02292784|616739961|FG000|Overall Study|Withdrawal by Subject|0|||
170651822|NCT02292784|616739962|FG001|Overall Study|Withdrawal by Subject|3|||
170651823|NCT02292784|616739963|FG002|Overall Study|Withdrawal by Subject|3|||
170812999|NCT00569166|617324129|FG001|Overall Study|Lost to Follow-up|1|||
170599260|NCT01116427|616538725|FG001|Core Phase|Lost to Follow-up|0|||
170599261|NCT01116427|616538724|FG000|Core Phase|Withdrawal by Subject|3|||
170599262|NCT01116427|616538725|FG001|Core Phase|Withdrawal by Subject|0|||
170599263|NCT01116427|616538724|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
170599264|NCT01116427|616538725|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
170599265|NCT01116427|616538724|FG000|Extension Phase|Adverse Event|1|||
170599266|NCT01116427|616538725|FG001|Extension Phase|Adverse Event|1|||
170599267|NCT01116427|616538724|FG000|Extension Phase|Lost to Follow-up|2|||
170599268|NCT01116427|616538725|FG001|Extension Phase|Lost to Follow-up|0|||
170599269|NCT01116427|616538724|FG000|Extension Phase|Withdrawal by Subject|5|||
170599270|NCT01116427|616538725|FG001|Extension Phase|Withdrawal by Subject|1|||
170599271|NCT01116427|616538724|FG000|Extension Phase|Not using appropriate birth control|1|||
170599272|NCT01116427|616538725|FG001|Extension Phase|Not using appropriate birth control|0|||
170651824|NCT00622739|616739964|FG000|Overall Study|Physician Decision|1|||
170599273|NCT01423916|616538729|FG000|Overall Study|Adverse Event|5|||
170599274|NCT01423916|616538730|FG001|Overall Study|Adverse Event|9|||
170599275|NCT01423916|616538731|FG002|Overall Study|Adverse Event|2|||
170599276|NCT01423916|616538729|FG000|Overall Study|Met Withdrawal Criteria|1|||
170599277|NCT01423916|616538730|FG001|Overall Study|Met Withdrawal Criteria|1|||
170813000|NCT00569166|617324130|FG002|Overall Study|Lost to Follow-up|1|||
170599278|NCT01423916|616538731|FG002|Overall Study|Met Withdrawal Criteria|1|||
170599279|NCT01423916|616538729|FG000|Overall Study|Physician Decision|1|||
170599280|NCT01423916|616538730|FG001|Overall Study|Physician Decision|0|||
170599281|NCT01423916|616538731|FG002|Overall Study|Physician Decision|1|||
170599282|NCT01423916|616538729|FG000|Overall Study|Withdrawal by Subject|3|||
170599283|NCT01423916|616538730|FG001|Overall Study|Withdrawal by Subject|10|||
170599284|NCT01423916|616538731|FG002|Overall Study|Withdrawal by Subject|3|||
170599285|NCT01423916|616538729|FG000|Overall Study|Protocol Deviation|1|||
170599286|NCT01423916|616538730|FG001|Overall Study|Protocol Deviation|0|||
170599287|NCT01423916|616538731|FG002|Overall Study|Protocol Deviation|0|||
170599288|NCT04094584|616538732|FG000|Overall Study|No interest in study|88|||
170599289|NCT04094584|616538732|FG000|Overall Study|Unwilling to undergo screening tests|36|||
170599290|NCT04094584|616538732|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
170599291|NCT04094584|616538732|FG000|Overall Study|Opioid use|7|||
170813001|NCT03340961|617324131|FG000|Overall Study|Adverse Event|1|||
170813002|NCT03340961|617324132|FG001|Overall Study|Adverse Event|3|||
170813003|NCT03340961|617324133|FG002|Overall Study|Adverse Event|2|||
170813004|NCT03340961|617324134|FG003|Overall Study|Adverse Event|4|||
170599292|NCT04094584|616538732|FG000|Overall Study|Need for major surgery in study period|4|||
170599293|NCT04094584|616538732|FG000|Overall Study|eligible but declined enrollment|4|||
170599294|NCT04094584|616538732|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
170599295|NCT04094584|616538732|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
170599296|NCT04094584|616538732|FG000|Overall Study|Lost to Follow-up|3|||
170599297|NCT04094584|616538732|FG000|Overall Study|Withdrawal by Subject|2|||
170599298|NCT00657371|616538733|FG000|Overall Study|Poor bowel preparation|15|||
170599299|NCT00657371|616538733|FG000|Overall Study|Unable to intubate the cecum|5|||
170599300|NCT00657371|616538733|FG000|Overall Study|Protocol Violation|2|||
170599301|NCT00657371|616538733|FG000|Overall Study|Device- related reasons|13|||
170599302|NCT00657371|616538733|FG000|Overall Study|Pre-existing medical condition|4|||
170599303|NCT02713867|616538734|FG000|Randomization|Other Reason|2|||
170599304|NCT02713867|616538735|FG001|Randomization|Other Reason|1|||
170599305|NCT02713867|616538734|FG000|Randomization|Participant Withdrew consent|0|||
170599306|NCT02713867|616538735|FG001|Randomization|Participant Withdrew consent|2|||
170599307|NCT02713867|616538734|FG000|Treatment Period|Other Reasons|22|||
170599308|NCT02713867|616538735|FG001|Treatment Period|Other Reasons|28|||
170599309|NCT02713867|616538734|FG000|Treatment Period|Administrative reason by sponsor|21|||
170599310|NCT02713867|616538735|FG001|Treatment Period|Administrative reason by sponsor|16|||
170813005|NCT03340961|617324131|FG000|Overall Study|Lost to Follow-up|0|||
170599311|NCT02713867|616538734|FG000|Treatment Period|No longer meets study criteria|2|||
170599312|NCT02713867|616538735|FG001|Treatment Period|No longer meets study criteria|1|||
170599313|NCT02713867|616538734|FG000|Treatment Period|Poor/Non Compliance|1|||
170599314|NCT02713867|616538735|FG001|Treatment Period|Poor/Non Compliance|0|||
170599315|NCT02713867|616538734|FG000|Treatment Period|Maximum Clinical Benefit|5|||
170599316|NCT02713867|616538735|FG001|Treatment Period|Maximum Clinical Benefit|6|||
170599317|NCT02713867|616538734|FG000|Treatment Period|Withdrew consent|3|||
170599318|NCT02713867|616538735|FG001|Treatment Period|Withdrew consent|6|||
170599319|NCT02713867|616538734|FG000|Treatment Period|Requested to Discontinue|8|||
170599320|NCT02713867|616538735|FG001|Treatment Period|Requested to Discontinue|8|||
170599321|NCT02713867|616538734|FG000|Treatment Period|AE unrelated to Study Drug|11|||
170813006|NCT03340961|617324132|FG001|Overall Study|Lost to Follow-up|1|||
170813007|NCT03340961|617324133|FG002|Overall Study|Lost to Follow-up|0|||
170913768|NCT00090285|617687647|FG000|Base Study Vaccination Period|Moved|20|||
170913769|NCT00090285|617687648|FG001|Base Study Vaccination Period|Moved|21|||
170913770|NCT00090285|617687649|FG002|Base Study Vaccination Period|Moved|0|||
170913771|NCT00090285|617687650|FG003|Base Study Vaccination Period|Moved|0|||
170913772|NCT00090285|617687651|FG004|Base Study Vaccination Period|Moved|0|||
170913773|NCT00090285|617687652|FG005|Base Study Vaccination Period|Moved|0|||
170913774|NCT00090285|617687647|FG000|Base Study Vaccination Period|Site Terminated|1|||
170913775|NCT00090285|617687648|FG001|Base Study Vaccination Period|Site Terminated|0|||
170913776|NCT00090285|617687649|FG002|Base Study Vaccination Period|Site Terminated|0|||
170599322|NCT02713867|616538735|FG001|Treatment Period|AE unrelated to Study Drug|10|||
170599323|NCT02713867|616538734|FG000|Treatment Period|Death|7|||
170599324|NCT02713867|616538735|FG001|Treatment Period|Death|3|||
170599325|NCT02713867|616538734|FG000|Treatment Period|Study Drug Toxicity|16|||
170599326|NCT02713867|616538735|FG001|Treatment Period|Study Drug Toxicity|19|||
170599327|NCT02713867|616538734|FG000|Treatment Period|Disease Progression|82|||
170599328|NCT02713867|616538735|FG001|Treatment Period|Disease Progression|83|||
170599329|NCT02635347|616538740|FG000|Overall Study|Failed screening|20|||
170599330|NCT02635347|616538741|FG001|Overall Study|Failed screening|7|||
170599331|NCT05059977|616538744|FG000|Overall Study|Withdrawal by Subject|0|||
170599332|NCT05059977|616538745|FG001|Overall Study|Withdrawal by Subject|0|||
170599333|NCT05059977|616538746|FG002|Overall Study|Withdrawal by Subject|1|||
170599334|NCT03443427|616538747|FG000|Overall Study|Adverse Event|2|||
170599335|NCT03443427|616538748|FG001|Overall Study|Adverse Event|3|||
170599336|NCT03443427|616538747|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
170599337|NCT03443427|616538748|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
170599338|NCT03443427|616538747|FG000|Overall Study|Other|4|||
170599339|NCT03443427|616538748|FG001|Overall Study|Other|6|||
170599340|NCT00576472|616538749|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599341|NCT00576472|616538750|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599342|NCT00576472|616538751|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599343|NCT00576472|616538752|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
170599344|NCT00576472|616538753|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599345|NCT00576472|616538754|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599346|NCT00576472|616538755|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599347|NCT00576472|616538756|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599348|NCT00576472|616538757|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599349|NCT00576472|616538758|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599350|NCT00576472|616538759|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599351|NCT00576472|616538760|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599352|NCT00576472|616538761|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599353|NCT00576472|616538762|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599354|NCT00576472|616538763|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
170599355|NCT00576472|616538749|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
170599356|NCT00576472|616538750|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
170599357|NCT00576472|616538751|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
170599358|NCT00576472|616538752|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
170599359|NCT00576472|616538753|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
170599360|NCT00576472|616538754|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
170599361|NCT00576472|616538755|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
170913777|NCT00090285|617687650|FG003|Base Study Vaccination Period|Site Terminated|0|||
170913778|NCT00090285|617687651|FG004|Base Study Vaccination Period|Site Terminated|0|||
170913779|NCT00090285|617687652|FG005|Base Study Vaccination Period|Site Terminated|0|||
170599362|NCT00576472|616538756|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
170599363|NCT00576472|616538757|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
170599364|NCT00576472|616538758|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
170599365|NCT00576472|616538759|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
170599366|NCT00576472|616538760|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
170599367|NCT00576472|616538761|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
170599368|NCT00576472|616538762|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
170599369|NCT00576472|616538763|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
170599370|NCT00576472|616538749|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599371|NCT00576472|616538750|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599372|NCT00576472|616538751|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599373|NCT00576472|616538752|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
170599374|NCT00576472|616538753|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599375|NCT00576472|616538754|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170913780|NCT00090285|617687647|FG000|Base Study Vaccination Period|Other|2|||
170913781|NCT00090285|617687648|FG001|Base Study Vaccination Period|Other|2|||
170913782|NCT00090285|617687649|FG002|Base Study Vaccination Period|Other|0|||
170599376|NCT00576472|616538755|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599377|NCT00576472|616538756|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599378|NCT00576472|616538757|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170913783|NCT00090285|617687650|FG003|Base Study Vaccination Period|Other|0|||
170913784|NCT00090285|617687651|FG004|Base Study Vaccination Period|Other|0|||
170913785|NCT00090285|617687652|FG005|Base Study Vaccination Period|Other|0|||
170913786|NCT00090285|617687647|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
170913787|NCT00090285|617687648|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
170913788|NCT00090285|617687649|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
170913789|NCT00090285|617687650|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
170913790|NCT00090285|617687651|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
170913791|NCT00090285|617687652|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
170599379|NCT00576472|616538758|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599380|NCT00576472|616538759|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599381|NCT00576472|616538760|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599382|NCT00576472|616538761|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599383|NCT00576472|616538762|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599384|NCT00576472|616538763|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
170599385|NCT00576472|616538749|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
170599386|NCT00576472|616538750|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
170599387|NCT00576472|616538751|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
170599388|NCT00576472|616538752|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
170599389|NCT00576472|616538753|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
170599390|NCT00576472|616538754|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
170599391|NCT00576472|616538755|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
170599392|NCT00576472|616538756|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
170599393|NCT00576472|616538757|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
170599394|NCT00576472|616538758|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
170599395|NCT00576472|616538759|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
170599396|NCT00576472|616538760|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
170599397|NCT00576472|616538761|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
170599398|NCT00576472|616538762|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
170599399|NCT00576472|616538763|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
170599400|NCT00576472|616538749|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599401|NCT00576472|616538750|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599402|NCT00576472|616538751|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599403|NCT00576472|616538752|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
170599404|NCT00576472|616538753|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599405|NCT00576472|616538754|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599406|NCT00576472|616538755|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599407|NCT00576472|616538756|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599408|NCT00576472|616538757|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599409|NCT00576472|616538758|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599410|NCT00576472|616538759|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599411|NCT00576472|616538760|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599412|NCT00576472|616538761|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599413|NCT00576472|616538762|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599414|NCT00576472|616538763|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
170599415|NCT00576472|616538749|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599416|NCT00576472|616538750|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599417|NCT00576472|616538751|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599418|NCT00576472|616538752|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599419|NCT00576472|616538753|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599420|NCT00576472|616538754|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599421|NCT00576472|616538755|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
170599422|NCT00576472|616538756|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599423|NCT00576472|616538757|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599424|NCT00576472|616538758|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599425|NCT00576472|616538759|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599426|NCT00576472|616538760|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
170651825|NCT00622739|616739965|FG001|Overall Study|Physician Decision|0|||
170651826|NCT00622739|616739964|FG000|Overall Study|Adverse Event|1|||
170651827|NCT00622739|616739965|FG001|Overall Study|Adverse Event|2|||
170913792|NCT00090285|617687647|FG000|Base Study Vaccination Period|HIV positive|1|||
170913793|NCT00090285|617687648|FG001|Base Study Vaccination Period|HIV positive|1|||
170913794|NCT00090285|617687649|FG002|Base Study Vaccination Period|HIV positive|0|||
170599427|NCT00576472|616538761|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599428|NCT00576472|616538762|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599429|NCT00576472|616538763|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
170599430|NCT00576472|616538749|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
170599431|NCT00576472|616538750|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
170599432|NCT00576472|616538751|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
170599433|NCT00576472|616538752|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
170599434|NCT00576472|616538753|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
170599435|NCT00576472|616538754|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
170599436|NCT00576472|616538755|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
170599437|NCT00576472|616538756|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
170599438|NCT00576472|616538757|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
170599439|NCT00576472|616538758|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
170599440|NCT00576472|616538759|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
170599441|NCT00576472|616538760|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
170599442|NCT00576472|616538761|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
170599443|NCT00576472|616538762|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
170599444|NCT00576472|616538763|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
170599445|NCT00576472|616538749|FG000|MPH Cross Over Phase|Physician Decision|0|||
170599446|NCT00576472|616538750|FG001|MPH Cross Over Phase|Physician Decision|0|||
170599447|NCT00576472|616538751|FG002|MPH Cross Over Phase|Physician Decision|0|||
170599448|NCT00576472|616538752|FG003|MPH Cross Over Phase|Physician Decision|0|||
170599449|NCT00576472|616538753|FG004|MPH Cross Over Phase|Physician Decision|0|||
170599450|NCT00576472|616538754|FG005|MPH Cross Over Phase|Physician Decision|0|||
170599451|NCT00576472|616538755|FG006|MPH Cross Over Phase|Physician Decision|4|||
170599452|NCT00576472|616538756|FG007|MPH Cross Over Phase|Physician Decision|0|||
170599453|NCT00576472|616538757|FG008|MPH Cross Over Phase|Physician Decision|0|||
170599454|NCT00576472|616538758|FG009|MPH Cross Over Phase|Physician Decision|0|||
170599455|NCT00576472|616538759|FG010|MPH Cross Over Phase|Physician Decision|0|||
170599456|NCT00576472|616538760|FG011|MPH Cross Over Phase|Physician Decision|0|||
170599457|NCT00576472|616538761|FG012|MPH Cross Over Phase|Physician Decision|0|||
170599458|NCT00576472|616538762|FG013|MPH Cross Over Phase|Physician Decision|0|||
170599459|NCT00576472|616538763|FG014|MPH Cross Over Phase|Physician Decision|0|||
170599460|NCT00576472|616538749|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599461|NCT00576472|616538750|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599462|NCT00576472|616538751|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599463|NCT00576472|616538752|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599464|NCT00576472|616538753|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599465|NCT00576472|616538754|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599466|NCT00576472|616538755|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599467|NCT00576472|616538756|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599468|NCT00576472|616538757|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
170599469|NCT00576472|616538758|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599470|NCT00576472|616538759|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
170599471|NCT00576472|616538760|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
170599472|NCT00576472|616538761|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599473|NCT00576472|616538762|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599474|NCT00576472|616538763|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
170599475|NCT00576472|616538749|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599476|NCT00576472|616538750|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599477|NCT00576472|616538751|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599478|NCT00576472|616538752|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599479|NCT00576472|616538753|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599480|NCT00576472|616538754|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599481|NCT00576472|616538755|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599482|NCT00576472|616538756|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599483|NCT00576472|616538757|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599484|NCT00576472|616538758|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599485|NCT00576472|616538759|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599486|NCT00576472|616538760|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599487|NCT00576472|616538761|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599488|NCT00576472|616538762|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
170599489|NCT00576472|616538763|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
170599490|NCT00576472|616538749|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
170599491|NCT00576472|616538750|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
170599492|NCT00576472|616538751|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
170813008|NCT03340961|617324134|FG003|Overall Study|Lost to Follow-up|1|||
170813009|NCT03340961|617324131|FG000|Overall Study|Withdrawal by Subject|3|||
170813010|NCT03340961|617324132|FG001|Overall Study|Withdrawal by Subject|2|||
170813011|NCT03340961|617324133|FG002|Overall Study|Withdrawal by Subject|4|||
170599493|NCT00576472|616538752|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
170599494|NCT00576472|616538753|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
170599495|NCT00576472|616538754|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
170599496|NCT00576472|616538755|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
170599497|NCT00576472|616538756|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
170599498|NCT00576472|616538757|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
170813012|NCT03340961|617324134|FG003|Overall Study|Withdrawal by Subject|7|||
170599499|NCT00576472|616538758|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
170599500|NCT00576472|616538759|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
170599501|NCT00576472|616538760|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
170599502|NCT00576472|616538761|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
170599503|NCT00576472|616538762|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
170599504|NCT00576472|616538763|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
170599505|NCT00576472|616538749|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
170599506|NCT00576472|616538750|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
170599507|NCT00576472|616538751|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
170599508|NCT00576472|616538752|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
170599509|NCT00576472|616538753|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
170599510|NCT00576472|616538754|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
170599511|NCT00576472|616538755|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
170599512|NCT00576472|616538756|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
170599513|NCT00576472|616538757|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
170599514|NCT00576472|616538758|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
170599515|NCT00576472|616538759|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
170599516|NCT00576472|616538760|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
170599517|NCT00576472|616538761|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
170599518|NCT00576472|616538762|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
170599519|NCT00576472|616538763|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
170599520|NCT00576472|616538749|FG000|MPH Home Maintenance Phase|Side effects|0|||
170599521|NCT00576472|616538750|FG001|MPH Home Maintenance Phase|Side effects|0|||
170599522|NCT00576472|616538751|FG002|MPH Home Maintenance Phase|Side effects|0|||
170599523|NCT00576472|616538752|FG003|MPH Home Maintenance Phase|Side effects|0|||
170599524|NCT00576472|616538753|FG004|MPH Home Maintenance Phase|Side effects|0|||
170599525|NCT00576472|616538754|FG005|MPH Home Maintenance Phase|Side effects|0|||
170599526|NCT00576472|616538755|FG006|MPH Home Maintenance Phase|Side effects|0|||
170599527|NCT00576472|616538756|FG007|MPH Home Maintenance Phase|Side effects|0|||
170599528|NCT00576472|616538757|FG008|MPH Home Maintenance Phase|Side effects|0|||
170599529|NCT00576472|616538758|FG009|MPH Home Maintenance Phase|Side effects|0|||
170599530|NCT00576472|616538759|FG010|MPH Home Maintenance Phase|Side effects|0|||
170599531|NCT00576472|616538760|FG011|MPH Home Maintenance Phase|Side effects|0|||
170599532|NCT00576472|616538761|FG012|MPH Home Maintenance Phase|Side effects|0|||
170599533|NCT00576472|616538762|FG013|MPH Home Maintenance Phase|Side effects|0|||
170599534|NCT00576472|616538763|FG014|MPH Home Maintenance Phase|Side effects|8|||
170599535|NCT00576472|616538749|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599536|NCT00576472|616538750|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599537|NCT00576472|616538751|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599538|NCT00576472|616538752|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599539|NCT00576472|616538753|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599540|NCT00576472|616538754|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599541|NCT00576472|616538755|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599542|NCT00576472|616538756|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599543|NCT00576472|616538757|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599544|NCT00576472|616538758|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599545|NCT00576472|616538759|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599546|NCT00576472|616538760|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599547|NCT00576472|616538761|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599548|NCT00576472|616538762|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
170599549|NCT00576472|616538763|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
170599550|NCT00576472|616538749|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
170599551|NCT00576472|616538750|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
170599552|NCT00576472|616538751|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
170599553|NCT00576472|616538752|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
170599554|NCT00576472|616538753|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
170599555|NCT00576472|616538754|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
170599556|NCT00576472|616538755|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
170599557|NCT00576472|616538756|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
170599558|NCT00576472|616538757|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
170599559|NCT00576472|616538758|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
170599560|NCT00576472|616538759|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
170599561|NCT00576472|616538760|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
170599562|NCT00576472|616538761|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
170599563|NCT00576472|616538762|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
170599564|NCT00576472|616538763|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
170599565|NCT00576472|616538749|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599566|NCT00576472|616538750|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599567|NCT00576472|616538751|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599568|NCT00576472|616538752|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599569|NCT00576472|616538753|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599570|NCT00576472|616538754|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599571|NCT00576472|616538755|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599572|NCT00576472|616538756|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599573|NCT00576472|616538757|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599574|NCT00576472|616538758|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599575|NCT00576472|616538759|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599576|NCT00576472|616538760|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599577|NCT00576472|616538761|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599578|NCT00576472|616538762|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
170599579|NCT00576472|616538763|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
170599580|NCT03089944|616538765|FG000|Overall Study|Lost to Follow-up|8|||
170599581|NCT03089944|616538765|FG000|Overall Study|Withdrew Consent|2|||
170599582|NCT03089944|616538765|FG000|Overall Study|Adverse Event|1|||
170599583|NCT03089944|616538765|FG000|Overall Study|Other|1|||
170599584|NCT03689244|616538766|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
170599585|NCT03689244|616538767|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
170599586|NCT03689244|616538768|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
170599587|NCT03689244|616538769|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
170599588|NCT03689244|616538766|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
170599589|NCT03689244|616538767|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
170599590|NCT03689244|616538768|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
170599591|NCT03689244|616538769|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
170599592|NCT03689244|616538766|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
170599593|NCT03689244|616538767|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
170599594|NCT03689244|616538768|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
170599595|NCT03689244|616538769|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
170599596|NCT03689244|616538766|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
170599597|NCT03689244|616538767|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
170599598|NCT03689244|616538768|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
170599599|NCT03689244|616538769|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
170599600|NCT03689244|616538766|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
170599601|NCT03689244|616538767|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
170599602|NCT03689244|616538768|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
170599603|NCT03689244|616538769|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
170599604|NCT03689244|616538766|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
170599605|NCT03689244|616538767|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
170599606|NCT03689244|616538768|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
170599607|NCT03689244|616538769|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
170599608|NCT03689244|616538766|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
170599609|NCT03689244|616538767|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
170599610|NCT03689244|616538768|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
170599611|NCT03689244|616538769|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
170599612|NCT03689244|616538766|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
170599613|NCT03689244|616538767|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
170599614|NCT03689244|616538768|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
170599615|NCT03689244|616538769|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
170599616|NCT02308488|616538770|FG000|Overall Study|Withdrawal by Subject|2|||
170599617|NCT01541917|616538771|FG000|Overall Study|Lost to Follow-up|2|||
170599618|NCT01541917|616538772|FG001|Overall Study|Lost to Follow-up|2|||
170599619|NCT01541917|616538771|FG000|Overall Study|Withdrawal by Subject|13|||
170599620|NCT01541917|616538772|FG001|Overall Study|Withdrawal by Subject|7|||
170599621|NCT00121641|616538773|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
170599622|NCT00121641|616538774|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
170599623|NCT00121641|616538775|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
170651828|NCT00622739|616739964|FG000|Overall Study|Lack of Efficacy|0|||
170651829|NCT00622739|616739965|FG001|Overall Study|Lack of Efficacy|2|||
170651830|NCT00622739|616739964|FG000|Overall Study|Withdrawal by Subject|0|||
170651831|NCT00622739|616739965|FG001|Overall Study|Withdrawal by Subject|1|||
170651832|NCT00622739|616739964|FG000|Overall Study|Lost to Follow-up|0|||
170651833|NCT00622739|616739965|FG001|Overall Study|Lost to Follow-up|1|||
170651834|NCT04006119|616739966|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
170651835|NCT04006119|616739966|FG000|End of Treatment Veledimex|Adverse Event|2|||
170651836|NCT04006119|616739966|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
170651837|NCT04006119|616739966|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
170599624|NCT00121641|616538776|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
170599625|NCT00121641|616538777|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
170651838|NCT04006119|616739966|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
170651839|NCT04006119|616739966|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
170651840|NCT02519855|616739967|FG000|Overall Study|Adverse Event|0|||
170651841|NCT02519855|616739968|FG001|Overall Study|Adverse Event|1|||
170651842|NCT02519855|616739967|FG000|Overall Study|Lost to Follow-up|3|||
170651843|NCT02519855|616739968|FG001|Overall Study|Lost to Follow-up|3|||
170651844|NCT03621475|616739969|FG000|Overall Study|No longer required restraints at initiation|0|||
170651845|NCT03621475|616739970|FG001|Overall Study|No longer required restraints at initiation|1|||
170651846|NCT03565367|616739971|FG000|Overall Study|No scan due to technical issues|4|||
170651847|NCT03565367|616739972|FG001|Overall Study|No scan due to technical issues|0|||
170651848|NCT01099709|616739975|FG000|Period 1|Withdrawal by Subject|0|||
170651849|NCT01099709|616739976|FG001|Period 1|Withdrawal by Subject|1|||
170651850|NCT01099709|616739975|FG000|Period 1|Positive cotinine test|0|||
170651851|NCT01099709|616739976|FG001|Period 1|Positive cotinine test|1|||
170813013|NCT03340961|617324131|FG000|Overall Study|Use of prohibited treatment|0|||
170813014|NCT03340961|617324132|FG001|Overall Study|Use of prohibited treatment|3|||
170599626|NCT00121641|616538773|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
170599627|NCT00121641|616538774|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
170599628|NCT00121641|616538775|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
170599629|NCT00121641|616538776|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
170599630|NCT00121641|616538777|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
170599631|NCT00121641|616538773|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
170599632|NCT00121641|616538774|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
170651852|NCT01099709|616739975|FG000|Period 1|Adverse Event|1|||
170651853|NCT01099709|616739976|FG001|Period 1|Adverse Event|0|||
170651854|NCT00706849|616739977|FG000|Treatment Period|Adverse Event|0|||
170651855|NCT00706849|616739978|FG001|Treatment Period|Adverse Event|9|||
170651856|NCT00706849|616739977|FG000|Treatment Period|Other|0|||
170651857|NCT00706849|616739978|FG001|Treatment Period|Other|1|||
170813015|NCT03340961|617324133|FG002|Overall Study|Use of prohibited treatment|2|||
170813016|NCT03340961|617324134|FG003|Overall Study|Use of prohibited treatment|4|||
170599633|NCT00121641|616538775|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
170599634|NCT00121641|616538776|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
170599635|NCT00121641|616538777|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
170599636|NCT00121641|616538773|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
170599637|NCT00121641|616538774|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
170599638|NCT00121641|616538775|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
170599639|NCT00121641|616538776|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
170599640|NCT00121641|616538777|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
170599641|NCT00121641|616538773|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
170599642|NCT00121641|616538774|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
170599643|NCT00121641|616538775|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
170599644|NCT00121641|616538776|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
170599645|NCT00121641|616538777|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
170599646|NCT00121641|616538773|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
170599647|NCT00121641|616538774|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
170599648|NCT00121641|616538775|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
170599649|NCT00121641|616538776|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
170599650|NCT00121641|616538777|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
170599651|NCT00121641|616538773|FG000|24-week Short-term Treatment Period|Other Reason|1|||
170599652|NCT00121641|616538774|FG001|24-week Short-term Treatment Period|Other Reason|0|||
170599653|NCT00121641|616538775|FG002|24-week Short-term Treatment Period|Other Reason|0|||
170599654|NCT00121641|616538776|FG003|24-week Short-term Treatment Period|Other Reason|0|||
170599655|NCT00121641|616538777|FG004|24-week Short-term Treatment Period|Other Reason|0|||
170599656|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
170599657|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
170599658|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
170599659|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
170599660|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
170599661|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
170599662|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
170599663|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
170599664|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
170599665|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
170599666|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
170599667|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
170599668|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
170599669|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
170599670|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
170599671|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
170599672|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
170599673|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
170599674|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
170599675|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
170599676|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
170599677|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
170599678|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
170599679|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
170599680|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
170599681|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
170599682|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
170599683|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
170599684|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
170599685|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
170599686|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
170599687|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
170599688|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
170599689|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
170599690|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
170599691|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
170599692|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
170599693|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
170599694|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
170599695|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
170599696|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Death|0|||
170599697|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Death|0|||
170599698|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Death|0|||
170599699|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Death|1|||
170599700|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Death|0|||
170599701|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Missing|0|||
170599702|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Missing|0|||
170599703|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Missing|1|||
170599704|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Missing|0|||
170599705|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Missing|0|||
170599706|NCT00121641|616538773|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
170599707|NCT00121641|616538774|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
170599708|NCT00121641|616538775|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
170599709|NCT00121641|616538776|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
170599710|NCT00121641|616538777|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
170599711|NCT03263780|616538778|FG000|Overall Study|Withdrawal by Subject|3|||
170599712|NCT03263780|616538778|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
170599713|NCT01504204|616538779|FG000|Overall Study|Lost to Follow-up|1|||
170599714|NCT01504204|616538780|FG001|Overall Study|Lost to Follow-up|1|||
170599715|NCT01969721|616538808|FG000|Overall Study|Adverse Event|3|||
170599716|NCT01969721|616538809|FG001|Overall Study|Adverse Event|8|||
170599717|NCT01969721|616538810|FG002|Overall Study|Adverse Event|3|||
170599718|NCT01969721|616538811|FG003|Overall Study|Adverse Event|2|||
170599719|NCT01969721|616538808|FG000|Overall Study|Lack of Efficacy|0|||
170599720|NCT01969721|616538809|FG001|Overall Study|Lack of Efficacy|0|||
170599721|NCT01969721|616538810|FG002|Overall Study|Lack of Efficacy|1|||
170599722|NCT01969721|616538811|FG003|Overall Study|Lack of Efficacy|0|||
170599723|NCT01969721|616538808|FG000|Overall Study|Non compliant with protocol|1|||
170599724|NCT01969721|616538809|FG001|Overall Study|Non compliant with protocol|1|||
170599725|NCT01969721|616538810|FG002|Overall Study|Non compliant with protocol|0|||
170599726|NCT01969721|616538811|FG003|Overall Study|Non compliant with protocol|2|||
170599727|NCT01969721|616538808|FG000|Overall Study|Other not defined above|0|||
170599728|NCT01969721|616538809|FG001|Overall Study|Other not defined above|2|||
170599729|NCT01969721|616538810|FG002|Overall Study|Other not defined above|0|||
170599730|NCT01969721|616538811|FG003|Overall Study|Other not defined above|0|||
170599731|NCT01969721|616538808|FG000|Overall Study|Discontinued during washout periods.|0|||
170599732|NCT01969721|616538809|FG001|Overall Study|Discontinued during washout periods.|1|||
170599733|NCT01969721|616538810|FG002|Overall Study|Discontinued during washout periods.|1|||
170599734|NCT01969721|616538811|FG003|Overall Study|Discontinued during washout periods.|2|||
170599735|NCT00495755|616538812|FG000|Overall Study|Adverse Event|3|||
170599736|NCT01012323|616538813|FG000|Overall Study|Investigator Judgment|1|||
170599737|NCT02920957|616538816|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
170599738|NCT02920957|616538817|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
170599739|NCT02920957|616538816|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
170599740|NCT02920957|616538817|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
170599741|NCT02920957|616538816|FG000|First Intervention : 1 Month|Adverse Event|1|||
170599742|NCT02920957|616538817|FG001|First Intervention : 1 Month|Adverse Event|0|||
170599743|NCT02920957|616538816|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
170599744|NCT02920957|616538817|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
170599745|NCT00737633|616538825|FG000|Overall Study|Study terminated by sponsor|44|||
170599746|NCT00737633|616538826|FG001|Overall Study|Study terminated by sponsor|55|||
170599747|NCT00737633|616538825|FG000|Overall Study|Lost to Follow-up|0|||
170599748|NCT00737633|616538826|FG001|Overall Study|Lost to Follow-up|1|||
170599749|NCT00737633|616538825|FG000|Overall Study|protocol non-compliance|0|||
170599750|NCT00737633|616538826|FG001|Overall Study|protocol non-compliance|1|||
170599751|NCT01789606|616538827|FG000|Overall Study|Participant not Purchased the Product|0|||
170599752|NCT01789606|616538828|FG001|Overall Study|Participant not Purchased the Product|20|||
170599753|NCT01789606|616538827|FG000|Overall Study|Withdrawal by Subject|0|||
170599754|NCT01789606|616538828|FG001|Overall Study|Withdrawal by Subject|1|||
170599755|NCT01789606|616538827|FG000|Overall Study|Ineligible|6|||
170599756|NCT01789606|616538828|FG001|Overall Study|Ineligible|2|||
170599757|NCT01789606|616538827|FG000|Overall Study|Administrative Reasons|17|||
170599758|NCT01789606|616538828|FG001|Overall Study|Administrative Reasons|6|||
170599759|NCT01789606|616538827|FG000|Overall Study|No Study Medication Taken|0|||
170913795|NCT00090285|617687650|FG003|Base Study Vaccination Period|HIV positive|0|||
170599760|NCT01789606|616538828|FG001|Overall Study|No Study Medication Taken|1|||
170599761|NCT01789606|616538827|FG000|Overall Study|Protocol Violation|0|||
170599762|NCT01789606|616538828|FG001|Overall Study|Protocol Violation|55|||
170599763|NCT01789606|616538827|FG000|Overall Study|Adverse Event|0|||
170599764|NCT01789606|616538828|FG001|Overall Study|Adverse Event|3|||
170599765|NCT01789606|616538827|FG000|Overall Study|Lost to Follow-up|0|||
170599766|NCT01789606|616538828|FG001|Overall Study|Lost to Follow-up|14|||
170599767|NCT01789606|616538827|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
170599768|NCT01789606|616538828|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
170813017|NCT03340961|617324131|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
170599769|NCT03109184|616540443|FG000|Overall Study|Lost to Follow-up|6|||
170599770|NCT03109184|616540444|FG001|Overall Study|Lost to Follow-up|6|||
170599771|NCT03109184|616540443|FG000|Overall Study|Withdrawal by Subject|1|||
170599772|NCT03109184|616540444|FG001|Overall Study|Withdrawal by Subject|1|||
170599773|NCT03268941|616540445|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
170599774|NCT03268941|616540446|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
170599775|NCT03268941|616540447|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
170599776|NCT03268941|616540448|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
170599777|NCT03268941|616540449|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
170599778|NCT03268941|616540450|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
170599779|NCT03268941|616540451|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
170599780|NCT03268941|616540445|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
170599781|NCT03268941|616540446|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
170599782|NCT03268941|616540447|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
170599783|NCT03268941|616540448|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
170599784|NCT03268941|616540449|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
170599785|NCT03268941|616540450|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
170599786|NCT03268941|616540451|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
170599787|NCT03268941|616540445|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
170599788|NCT03268941|616540446|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
170599789|NCT03268941|616540447|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
170599790|NCT03268941|616540448|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
170599791|NCT03268941|616540449|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
170599792|NCT03268941|616540450|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
170599793|NCT03268941|616540451|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
170599794|NCT03268941|616540445|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
170599795|NCT03268941|616540446|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
170599796|NCT03268941|616540447|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
170599797|NCT03268941|616540448|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
170599798|NCT03268941|616540449|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
170599799|NCT03268941|616540450|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
170599800|NCT03268941|616540451|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
170599801|NCT03268941|616540445|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
170599802|NCT03268941|616540446|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
170599803|NCT03268941|616540447|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
170599804|NCT03268941|616540448|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
170599805|NCT03268941|616540449|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
170599806|NCT03268941|616540450|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
170599807|NCT03268941|616540451|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
170813018|NCT03340961|617324132|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
170813019|NCT03340961|617324133|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
170813020|NCT03340961|617324134|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
170813021|NCT03340961|617324131|FG000|Overall Study|Subject developed an exclusion criterion|0|||
170813022|NCT03340961|617324132|FG001|Overall Study|Subject developed an exclusion criterion|1|||
170599808|NCT03878758|616540452|FG000|Overall Study|Withdrawal by Subject|1|||
170599809|NCT03878758|616540452|FG000|Overall Study|Protocol defined|2|||
170813023|NCT03340961|617324133|FG002|Overall Study|Subject developed an exclusion criterion|0|||
170599810|NCT03878758|616540452|FG000|Overall Study|Improper consent documentation|1|||
170599811|NCT04680975|616540453|FG000|Overall Study|Adverse Event|3|||
170599812|NCT04680975|616540453|FG000|Overall Study|Death|1|||
170599813|NCT04680975|616540453|FG000|Overall Study|Progressive Disease|1|||
170599814|NCT04680975|616540453|FG000|Overall Study|Withdrawal by Subject|1|||
170599815|NCT02017522|616540454|FG000|Overall Study|Withdrawal by Subject|1|||
170599816|NCT01100528|616540460|FG000|Overall Study|Death|1|||
170599817|NCT01100528|616540460|FG000|Overall Study|Withdrawal by Subject|2|||
170599818|NCT02771626|616540461|FG000|Overall Study|Adverse Event|1|||
170599819|NCT02771626|616540462|FG001|Overall Study|Adverse Event|5|||
170813024|NCT03340961|617324134|FG003|Overall Study|Subject developed an exclusion criterion|0|||
170599820|NCT02771626|616540463|FG002|Overall Study|Adverse Event|3|||
170813025|NCT03340961|617324131|FG000|Overall Study|Protocol Violation|1|||
170813026|NCT03340961|617324132|FG001|Overall Study|Protocol Violation|0|||
170813027|NCT03340961|617324133|FG002|Overall Study|Protocol Violation|1|||
170813028|NCT03340961|617324134|FG003|Overall Study|Protocol Violation|0|||
170813029|NCT03340961|617324131|FG000|Overall Study|Adverse Event|1|||
170813030|NCT03340961|617324132|FG001|Overall Study|Adverse Event|1|||
170813031|NCT03340961|617324133|FG002|Overall Study|Adverse Event|0|||
170813032|NCT03340961|617324134|FG003|Overall Study|Adverse Event|0|||
170813033|NCT03340961|617324131|FG000|Overall Study|Lack of Efficacy|0|||
170813034|NCT03340961|617324132|FG001|Overall Study|Lack of Efficacy|0|||
170813035|NCT03340961|617324133|FG002|Overall Study|Lack of Efficacy|0|||
170599821|NCT02771626|616540464|FG003|Overall Study|Adverse Event|0|||
170599822|NCT02771626|616540465|FG004|Overall Study|Adverse Event|1|||
170599823|NCT02771626|616540466|FG005|Overall Study|Adverse Event|1|||
170599824|NCT02771626|616540461|FG000|Overall Study|Radiologic Disease Progression|6|||
170599825|NCT02771626|616540462|FG001|Overall Study|Radiologic Disease Progression|13|||
170599826|NCT02771626|616540463|FG002|Overall Study|Radiologic Disease Progression|10|||
170599827|NCT02771626|616540464|FG003|Overall Study|Radiologic Disease Progression|7|||
170599828|NCT02771626|616540465|FG004|Overall Study|Radiologic Disease Progression|28|||
170599829|NCT02771626|616540466|FG005|Overall Study|Radiologic Disease Progression|15|||
170599830|NCT02771626|616540461|FG000|Overall Study|Symptomatic Deterioration|0|||
170599831|NCT02771626|616540462|FG001|Overall Study|Symptomatic Deterioration|4|||
170599832|NCT02771626|616540463|FG002|Overall Study|Symptomatic Deterioration|2|||
170599833|NCT02771626|616540464|FG003|Overall Study|Symptomatic Deterioration|0|||
170599834|NCT02771626|616540465|FG004|Overall Study|Symptomatic Deterioration|5|||
170599835|NCT02771626|616540466|FG005|Overall Study|Symptomatic Deterioration|2|||
170599836|NCT02771626|616540461|FG000|Overall Study|Participant Request|0|||
170599837|NCT02771626|616540462|FG001|Overall Study|Participant Request|1|||
170599838|NCT02771626|616540463|FG002|Overall Study|Participant Request|0|||
170599839|NCT02771626|616540464|FG003|Overall Study|Participant Request|2|||
170599840|NCT02771626|616540465|FG004|Overall Study|Participant Request|0|||
170599841|NCT02771626|616540466|FG005|Overall Study|Participant Request|1|||
170599842|NCT02771626|616540461|FG000|Overall Study|Investigator Decision|0|||
170599843|NCT02771626|616540462|FG001|Overall Study|Investigator Decision|1|||
170599844|NCT02771626|616540463|FG002|Overall Study|Investigator Decision|0|||
170599845|NCT02771626|616540464|FG003|Overall Study|Investigator Decision|0|||
170599846|NCT02771626|616540465|FG004|Overall Study|Investigator Decision|1|||
170599847|NCT02771626|616540466|FG005|Overall Study|Investigator Decision|0|||
170599848|NCT02771626|616540461|FG000|Overall Study|Study Termination by Sponsor|0|||
170599849|NCT02771626|616540462|FG001|Overall Study|Study Termination by Sponsor|2|||
170599850|NCT02771626|616540463|FG002|Overall Study|Study Termination by Sponsor|1|||
170599851|NCT02771626|616540464|FG003|Overall Study|Study Termination by Sponsor|0|||
170599852|NCT02771626|616540465|FG004|Overall Study|Study Termination by Sponsor|1|||
170599853|NCT02771626|616540466|FG005|Overall Study|Study Termination by Sponsor|0|||
170599854|NCT02771626|616540461|FG000|Overall Study|Informed Consent Withdrawn|0|||
170599855|NCT02771626|616540462|FG001|Overall Study|Informed Consent Withdrawn|0|||
170599856|NCT02771626|616540463|FG002|Overall Study|Informed Consent Withdrawn|1|||
170599857|NCT02771626|616540464|FG003|Overall Study|Informed Consent Withdrawn|0|||
170599858|NCT02771626|616540465|FG004|Overall Study|Informed Consent Withdrawn|1|||
170599859|NCT02771626|616540466|FG005|Overall Study|Informed Consent Withdrawn|1|||
170599860|NCT02771626|616540461|FG000|Overall Study|Other, Not Specified|1|||
170599861|NCT02771626|616540462|FG001|Overall Study|Other, Not Specified|0|||
170599862|NCT02771626|616540463|FG002|Overall Study|Other, Not Specified|0|||
170599863|NCT02771626|616540464|FG003|Overall Study|Other, Not Specified|0|||
170599864|NCT02771626|616540465|FG004|Overall Study|Other, Not Specified|0|||
170599865|NCT02771626|616540466|FG005|Overall Study|Other, Not Specified|1|||
170599866|NCT03316950|616540467|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
170599867|NCT03316950|616540468|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
170599868|NCT03316950|616540469|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
170599869|NCT03316950|616540470|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
170599870|NCT03316950|616540467|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
170599871|NCT03316950|616540468|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
170599872|NCT03316950|616540469|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
170599873|NCT03316950|616540470|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
170599874|NCT03316950|616540467|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
170599875|NCT03316950|616540468|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
170599876|NCT03316950|616540469|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
170599877|NCT03316950|616540470|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
170599878|NCT00106691|616540471|FG000|Overall Study|Adverse Event|60|||
170599879|NCT00106691|616540472|FG001|Overall Study|Adverse Event|64|||
170599880|NCT00106691|616540471|FG000|Overall Study|Lost to Follow-up|23|||
170599881|NCT00106691|616540472|FG001|Overall Study|Lost to Follow-up|18|||
170599882|NCT00106691|616540471|FG000|Overall Study|Physician Decision|18|||
170599883|NCT00106691|616540472|FG001|Overall Study|Physician Decision|21|||
170599884|NCT00106691|616540471|FG000|Overall Study|Protocol Violation|13|||
170599885|NCT00106691|616540472|FG001|Overall Study|Protocol Violation|18|||
170599886|NCT00106691|616540471|FG000|Overall Study|Withdrawal by Subject|75|||
170599887|NCT00106691|616540472|FG001|Overall Study|Withdrawal by Subject|70|||
170599888|NCT00106691|616540471|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
170599889|NCT00106691|616540472|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
170913796|NCT00090285|617687651|FG004|Base Study Vaccination Period|HIV positive|0|||
170599890|NCT00106691|616540471|FG000|Overall Study|QTc>480|3|||
170599891|NCT00106691|616540472|FG001|Overall Study|QTc>480|1|||
170599892|NCT00106691|616540471|FG000|Overall Study|mililtary deployment|2|||
170599893|NCT00106691|616540472|FG001|Overall Study|mililtary deployment|0|||
170913797|NCT00090285|617687652|FG005|Base Study Vaccination Period|HIV positive|0|||
170599894|NCT00106691|616540471|FG000|Overall Study|Study Site Closing/PI Moved|1|||
170599895|NCT00106691|616540472|FG001|Overall Study|Study Site Closing/PI Moved|2|||
170599896|NCT00106691|616540471|FG000|Overall Study|Cardiologist recommendation|1|||
170599897|NCT00106691|616540472|FG001|Overall Study|Cardiologist recommendation|0|||
170599898|NCT00106691|616540471|FG000|Overall Study|Pt. moved to another state|1|||
170599899|NCT00106691|616540472|FG001|Overall Study|Pt. moved to another state|0|||
170599900|NCT00106691|616540471|FG000|Overall Study|Taking exclusionary avodart|1|||
170599901|NCT00106691|616540472|FG001|Overall Study|Taking exclusionary avodart|0|||
170599902|NCT00106691|616540471|FG000|Overall Study|Not able to discontinue plavix|0|||
170599903|NCT00106691|616540472|FG001|Overall Study|Not able to discontinue plavix|1|||
170599904|NCT01754194|616540473|FG000|Overall Study|Lost to Follow-up|39|||
170599905|NCT01754194|616540474|FG001|Overall Study|Lost to Follow-up|14|||
170599906|NCT01754194|616540473|FG000|Overall Study|Withdrawal by Subject|4|||
170599907|NCT01754194|616540474|FG001|Overall Study|Withdrawal by Subject|5|||
170599908|NCT01754194|616540473|FG000|Overall Study|Other|9|||
170599909|NCT01754194|616540474|FG001|Overall Study|Other|8|||
170599910|NCT02392403|616540475|FG000|Overall Study|Adverse Event|1|||
170599911|NCT02392403|616540475|FG000|Overall Study|Death|1|||
170599912|NCT02392403|616540475|FG000|Overall Study|Withdrawal by Subject|1|||
170599913|NCT02639338|616540483|FG000|Overall Study|Lost to Follow-up|2|||
170599914|NCT02639338|616540484|FG001|Overall Study|Lost to Follow-up|2|||
170599915|NCT02639338|616540483|FG000|Overall Study|Withdrew Consent|1|||
170599916|NCT02639338|616540484|FG001|Overall Study|Withdrew Consent|2|||
170599917|NCT02639338|616540483|FG000|Overall Study|Death|1|||
170599918|NCT02639338|616540484|FG001|Overall Study|Death|0|||
170599919|NCT02639338|616540483|FG000|Overall Study|Randomized but Not Treated|0|||
170599920|NCT02639338|616540484|FG001|Overall Study|Randomized but Not Treated|1|||
170599921|NCT02715726|616540485|FG000|Overall Study|Adverse Event|2|||
170599922|NCT02715726|616540486|FG001|Overall Study|Adverse Event|6|||
170599923|NCT02715726|616540485|FG000|Overall Study|Protocol Violation|1|||
170599924|NCT02715726|616540486|FG001|Overall Study|Protocol Violation|0|||
170599925|NCT02715726|616540485|FG000|Overall Study|Death|2|||
170599926|NCT02715726|616540486|FG001|Overall Study|Death|1|||
170599927|NCT02715726|616540485|FG000|Overall Study|Participant moved|1|||
170651858|NCT00706849|616739977|FG000|Follow-up Period|Withdrawal by Subject|0|||
170599928|NCT02715726|616540486|FG001|Overall Study|Participant moved|3|||
170599929|NCT02715726|616540485|FG000|Overall Study|Other than specified above|11|||
170599930|NCT02715726|616540486|FG001|Overall Study|Other than specified above|15|||
170599931|NCT02715726|616540485|FG000|Overall Study|Randomized but not treated|1|||
170599932|NCT02715726|616540486|FG001|Overall Study|Randomized but not treated|2|||
170599933|NCT01177969|616540487|FG000|Overall Study|Protocol Violation|2|||
170599934|NCT01177969|616540488|FG001|Overall Study|Protocol Violation|1|||
170599935|NCT01177969|616540487|FG000|Overall Study|Withdrawal by Subject|1|||
170599936|NCT01177969|616540488|FG001|Overall Study|Withdrawal by Subject|2|||
170599937|NCT04047420|616540491|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
170599938|NCT04047420|616540491|FG000|Washout Period|Refused Participation|2|||
170599939|NCT03629912|616540499|FG000|Overall Study|Lost to Follow-up|19|||
170599940|NCT03629912|616540500|FG001|Overall Study|Lost to Follow-up|7|||
170599941|NCT03629912|616540501|FG002|Overall Study|Lost to Follow-up|5|||
170599942|NCT03629912|616540502|FG003|Overall Study|Lost to Follow-up|1|||
170599943|NCT03629912|616540499|FG000|Overall Study|Withdrawal by Subject|6|||
170599944|NCT03629912|616540500|FG001|Overall Study|Withdrawal by Subject|0|||
170599945|NCT03629912|616540501|FG002|Overall Study|Withdrawal by Subject|1|||
170599946|NCT03629912|616540502|FG003|Overall Study|Withdrawal by Subject|2|||
170599947|NCT03629912|616540499|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
170599948|NCT03629912|616540500|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
170599949|NCT03629912|616540501|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
170599950|NCT03629912|616540502|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
170599951|NCT03629912|616540499|FG000|Overall Study|Death|1|||
170599952|NCT03629912|616540500|FG001|Overall Study|Death|0|||
170599953|NCT03629912|616540501|FG002|Overall Study|Death|0|||
170599954|NCT03629912|616540502|FG003|Overall Study|Death|0|||
170599955|NCT02608450|616540503|FG000|Overall Study|Lost to Follow-up|39|||
170599956|NCT02608450|616540504|FG001|Overall Study|Lost to Follow-up|32|||
170599957|NCT02608450|616540503|FG000|Overall Study|Withdrawal by Subject|21|||
170599958|NCT02608450|616540504|FG001|Overall Study|Withdrawal by Subject|15|||
170599959|NCT02608450|616540503|FG000|Overall Study|Adverse Event|3|||
170599960|NCT02608450|616540504|FG001|Overall Study|Adverse Event|6|||
170599961|NCT02608450|616540503|FG000|Overall Study|Withdrawal by parent|2|||
170599962|NCT02608450|616540504|FG001|Overall Study|Withdrawal by parent|3|||
170599963|NCT02608450|616540503|FG000|Overall Study|Lack of Efficacy|0|||
170599964|NCT02608450|616540504|FG001|Overall Study|Lack of Efficacy|3|||
170599965|NCT02608450|616540503|FG000|Overall Study|Noncompliance with study drug|0|||
170599966|NCT02608450|616540504|FG001|Overall Study|Noncompliance with study drug|2|||
170599967|NCT02608450|616540503|FG000|Overall Study|Physician Decision|0|||
170599968|NCT02608450|616540504|FG001|Overall Study|Physician Decision|1|||
170599969|NCT02608450|616540503|FG000|Overall Study|Pregnancy|0|||
170599970|NCT02608450|616540504|FG001|Overall Study|Pregnancy|1|||
170599971|NCT02608450|616540503|FG000|Overall Study|Progressive disease|1|||
170599972|NCT02608450|616540504|FG001|Overall Study|Progressive disease|0|||
170599973|NCT02608450|616540503|FG000|Overall Study|Multiple reasons|0|||
170599974|NCT02608450|616540504|FG001|Overall Study|Multiple reasons|2|||
170599975|NCT02565810|616540505|FG000|Overall Study|Withdrawal by Subject|1|||
170599976|NCT02576860|616540510|FG000|Overall Study|Adverse Event|6|||
170599977|NCT02576860|616540511|FG001|Overall Study|Adverse Event|6|||
170599978|NCT02576860|616540510|FG000|Overall Study|Lost to Follow-up|5|||
170599979|NCT02576860|616540511|FG001|Overall Study|Lost to Follow-up|7|||
170599980|NCT02576860|616540510|FG000|Overall Study|Physician Decision|0|||
170599981|NCT02576860|616540511|FG001|Overall Study|Physician Decision|1|||
170599982|NCT02576860|616540510|FG000|Overall Study|Protocol Violation|0|||
170599983|NCT02576860|616540511|FG001|Overall Study|Protocol Violation|2|||
170599984|NCT02576860|616540510|FG000|Overall Study|Withdrawal by Subject|13|||
170599985|NCT02576860|616540511|FG001|Overall Study|Withdrawal by Subject|8|||
170599986|NCT02576860|616540510|FG000|Overall Study|Disallowed medication|1|||
170599987|NCT02576860|616540511|FG001|Overall Study|Disallowed medication|0|||
170599988|NCT00780273|616540512|FG000|Overall Study|Death|1|||
170599989|NCT00780273|616540512|FG000|Overall Study|Lost to Follow-up|1|||
170599990|NCT01792518|616540517|FG000|Overall Study|Adverse Event|3|||
170599991|NCT01792518|616540518|FG001|Overall Study|Adverse Event|4|||
170599992|NCT01792518|616540517|FG000|Overall Study|Protocol Violation|0|||
170599993|NCT01792518|616540518|FG001|Overall Study|Protocol Violation|1|||
170599994|NCT01792518|616540517|FG000|Overall Study|Lost to Follow-up|3|||
170599995|NCT01792518|616540518|FG001|Overall Study|Lost to Follow-up|1|||
170599996|NCT01792518|616540517|FG000|Overall Study|Withdrawal by Subject|2|||
170599997|NCT01792518|616540518|FG001|Overall Study|Withdrawal by Subject|0|||
170599998|NCT01792518|616540517|FG000|Overall Study|Other Reason|0|||
170599999|NCT01792518|616540518|FG001|Overall Study|Other Reason|1|||
170600000|NCT01353911|616540519|FG000|Overall Study|Lost to Follow-up|2|||
170813036|NCT03340961|617324134|FG003|Overall Study|Lack of Efficacy|1|||
170813037|NCT01853384|617324135|FG000|Randomized|Adverse Event|5|||
170600001|NCT01353911|616540520|FG001|Overall Study|Lost to Follow-up|6|||
170600002|NCT01353911|616540521|FG002|Overall Study|Lost to Follow-up|4|||
170600003|NCT01353911|616540522|FG003|Overall Study|Lost to Follow-up|0|||
170600004|NCT01353911|616540523|FG004|Overall Study|Lost to Follow-up|4|||
170600005|NCT01353911|616540524|FG005|Overall Study|Lost to Follow-up|4|||
170600006|NCT01353911|616540525|FG006|Overall Study|Lost to Follow-up|3|||
170600007|NCT01353911|616540526|FG007|Overall Study|Lost to Follow-up|6|||
170600008|NCT01353911|616540519|FG000|Overall Study|Withdrawal by Subject|2|||
170813038|NCT01853384|617324136|FG001|Randomized|Adverse Event|3|||
170600009|NCT01353911|616540520|FG001|Overall Study|Withdrawal by Subject|3|||
170600010|NCT01353911|616540521|FG002|Overall Study|Withdrawal by Subject|4|||
170600011|NCT01353911|616540522|FG003|Overall Study|Withdrawal by Subject|2|||
170600012|NCT01353911|616540523|FG004|Overall Study|Withdrawal by Subject|2|||
170600013|NCT01353911|616540524|FG005|Overall Study|Withdrawal by Subject|3|||
170600014|NCT01353911|616540525|FG006|Overall Study|Withdrawal by Subject|3|||
170600015|NCT01353911|616540526|FG007|Overall Study|Withdrawal by Subject|9|||
170600016|NCT01353911|616540519|FG000|Overall Study|Status Not Recorded|4|||
170600017|NCT01353911|616540520|FG001|Overall Study|Status Not Recorded|0|||
170600018|NCT01353911|616540521|FG002|Overall Study|Status Not Recorded|1|||
170600019|NCT01353911|616540522|FG003|Overall Study|Status Not Recorded|0|||
170600020|NCT01353911|616540523|FG004|Overall Study|Status Not Recorded|0|||
170600021|NCT01353911|616540524|FG005|Overall Study|Status Not Recorded|0|||
170600022|NCT01353911|616540525|FG006|Overall Study|Status Not Recorded|0|||
170600023|NCT01353911|616540526|FG007|Overall Study|Status Not Recorded|0|||
170600024|NCT01565564|616540541|FG000|Overall Study|Lost to Follow-up|5|||
170600025|NCT01565564|616540542|FG001|Overall Study|Lost to Follow-up|1|||
170600026|NCT03995355|616540543|FG000|Overall Study|Adverse Event|1|||
170600027|NCT03995355|616540544|FG001|Overall Study|Adverse Event|0|||
170600028|NCT03995355|616540543|FG000|Overall Study|Withdrawal by Subject|1|||
170600029|NCT03995355|616540544|FG001|Overall Study|Withdrawal by Subject|0|||
170600030|NCT03995355|616540543|FG000|Overall Study|Scheduling Issues|0|||
170600031|NCT03995355|616540544|FG001|Overall Study|Scheduling Issues|1|||
170600032|NCT00249613|616540545|FG000|12 Month Follow-up|Death|1|||
170600033|NCT00249613|616540546|FG001|12 Month Follow-up|Death|1|||
170600034|NCT00249613|616540545|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
170600035|NCT00249613|616540546|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
170600036|NCT00249613|616540545|FG000|12 Month Follow-up|Lost to Follow-up|10|||
170600037|NCT00249613|616540546|FG001|12 Month Follow-up|Lost to Follow-up|8|||
170600038|NCT00806442|616540547|FG000|Overall Study|Lost to Follow-up|3|||
170600039|NCT00806442|616540548|FG001|Overall Study|Lost to Follow-up|2|||
170600040|NCT00806442|616540547|FG000|Overall Study|Withdrawal by Subject|1|||
170600041|NCT00806442|616540548|FG001|Overall Study|Withdrawal by Subject|5|||
170600042|NCT04032080|616540549|FG000|Overall Study|Death|6|||
170600043|NCT02528357|616540558|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600044|NCT02528357|616540559|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
170600045|NCT02528357|616540560|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600046|NCT02528357|616540561|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600047|NCT02528357|616540562|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600048|NCT02528357|616540563|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600049|NCT02528357|616540564|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600050|NCT02528357|616540565|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600051|NCT02528357|616540566|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600052|NCT02528357|616540567|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600053|NCT02528357|616540568|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600054|NCT02528357|616540569|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600055|NCT02528357|616540570|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600056|NCT02528357|616540571|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600057|NCT02528357|616540572|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600058|NCT02528357|616540573|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600059|NCT02528357|616540574|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600060|NCT02528357|616540575|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600061|NCT02528357|616540576|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
170600062|NCT02528357|616540558|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600063|NCT02528357|616540559|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600064|NCT02528357|616540560|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600065|NCT02528357|616540561|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
170600066|NCT02528357|616540562|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600067|NCT02528357|616540563|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
170600068|NCT02528357|616540564|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600069|NCT02528357|616540565|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
170600070|NCT02528357|616540566|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600071|NCT02528357|616540567|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600072|NCT02528357|616540568|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600073|NCT02528357|616540569|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600074|NCT02528357|616540570|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600075|NCT02528357|616540571|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170813039|NCT01853384|617324135|FG000|Randomized|Death|1|||
170813040|NCT01853384|617324136|FG001|Randomized|Death|2|||
170813041|NCT01853384|617324135|FG000|Randomized|Lost to Follow-up|1|||
170600076|NCT02528357|616540572|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600077|NCT02528357|616540573|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600078|NCT02528357|616540574|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600079|NCT02528357|616540575|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600080|NCT02528357|616540576|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
170600081|NCT02528357|616540558|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600082|NCT02528357|616540559|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600083|NCT02528357|616540560|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
170600084|NCT02528357|616540561|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600085|NCT02528357|616540562|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
170600086|NCT02528357|616540563|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600087|NCT02528357|616540564|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
170600088|NCT02528357|616540565|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
170600089|NCT02528357|616540566|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600090|NCT02528357|616540567|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600091|NCT02528357|616540568|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600092|NCT02528357|616540569|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600093|NCT02528357|616540570|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600094|NCT02528357|616540571|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600095|NCT02528357|616540572|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600096|NCT02528357|616540573|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600097|NCT02528357|616540574|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600098|NCT02528357|616540575|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600099|NCT02528357|616540576|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
170600100|NCT02528357|616540558|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600101|NCT02528357|616540559|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600102|NCT02528357|616540560|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600103|NCT02528357|616540561|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600104|NCT02528357|616540562|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
170600105|NCT02528357|616540563|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600106|NCT02528357|616540564|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600107|NCT02528357|616540565|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600108|NCT02528357|616540566|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600109|NCT02528357|616540567|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600110|NCT02528357|616540568|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600111|NCT02528357|616540569|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600112|NCT02528357|616540570|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600113|NCT02528357|616540571|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600114|NCT02528357|616540572|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600115|NCT02528357|616540573|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600116|NCT02528357|616540574|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600117|NCT02528357|616540575|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600118|NCT02528357|616540576|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600119|NCT02528357|616540558|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170651859|NCT00706849|616739978|FG001|Follow-up Period|Withdrawal by Subject|2|||
170651860|NCT00706849|616739977|FG000|Follow-up Period|Protocol non-compliance|0|||
170651861|NCT00706849|616739978|FG001|Follow-up Period|Protocol non-compliance|1|||
170651862|NCT01611454|616739979|FG000|Overall Study|Lack of Efficacy|18|||
170651863|NCT01611454|616739980|FG001|Overall Study|Lack of Efficacy|10|||
170651864|NCT00920907|616739982|FG000|Induction Period|Adverse Event|0|||
170651865|NCT00920907|616739983|FG001|Induction Period|Adverse Event|2|||
170651866|NCT00920907|616739982|FG000|Induction Period|Death|1|||
170651867|NCT00920907|616739983|FG001|Induction Period|Death|1|||
170813042|NCT01853384|617324136|FG001|Randomized|Lost to Follow-up|1|||
170813043|NCT01853384|617324135|FG000|Randomized|Withdrawal by Subject|5|||
170813044|NCT01853384|617324136|FG001|Randomized|Withdrawal by Subject|3|||
170813045|NCT01853384|617324135|FG000|Randomized|Sponsor Decision|47|||
170813046|NCT01853384|617324136|FG001|Randomized|Sponsor Decision|34|||
170651868|NCT00920907|616739982|FG000|Induction Period|Disease Progression|12|||
170813047|NCT01853384|617324135|FG000|Randomized|Other|3|||
170813048|NCT01853384|617324136|FG001|Randomized|Other|3|||
170600120|NCT02528357|616540559|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600121|NCT02528357|616540560|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600122|NCT02528357|616540561|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600123|NCT02528357|616540562|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600124|NCT02528357|616540563|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600125|NCT02528357|616540564|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600126|NCT02528357|616540565|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600127|NCT02528357|616540566|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600128|NCT02528357|616540567|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600129|NCT02528357|616540568|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600130|NCT02528357|616540569|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600131|NCT02528357|616540570|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600132|NCT02528357|616540571|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
170600133|NCT02528357|616540572|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
170600134|NCT02528357|616540573|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600135|NCT02528357|616540574|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600136|NCT02528357|616540575|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600137|NCT02528357|616540576|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
170600138|NCT02528357|616540558|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600139|NCT02528357|616540559|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600140|NCT02528357|616540560|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600141|NCT02528357|616540561|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600142|NCT02528357|616540562|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600143|NCT02528357|616540563|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600144|NCT02528357|616540564|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600145|NCT02528357|616540565|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600146|NCT02528357|616540566|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600147|NCT02528357|616540567|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600148|NCT02528357|616540568|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600149|NCT02528357|616540569|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600150|NCT02528357|616540570|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600151|NCT02528357|616540571|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
170600152|NCT02528357|616540572|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600153|NCT02528357|616540573|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600154|NCT02528357|616540574|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600155|NCT02528357|616540575|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600156|NCT02528357|616540576|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
170600157|NCT02528357|616540558|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600158|NCT02528357|616540559|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600159|NCT02528357|616540560|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600160|NCT02528357|616540561|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600161|NCT02528357|616540562|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600162|NCT02528357|616540563|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600163|NCT02528357|616540564|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600164|NCT02528357|616540565|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600165|NCT02528357|616540566|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600166|NCT02528357|616540567|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600167|NCT02528357|616540568|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
170600168|NCT02528357|616540569|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600169|NCT02528357|616540570|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
170600170|NCT02528357|616540571|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
170600171|NCT02528357|616540572|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
170600172|NCT02528357|616540573|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600173|NCT02528357|616540574|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170600174|NCT02528357|616540575|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170913798|NCT00090285|617687647|FG000|Base Study Follow-up Period|Adverse Event|3|||
170600175|NCT02528357|616540576|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
170913799|NCT00090285|617687648|FG001|Base Study Follow-up Period|Adverse Event|10|||
170913800|NCT00090285|617687649|FG002|Base Study Follow-up Period|Adverse Event|0|||
170913801|NCT00090285|617687650|FG003|Base Study Follow-up Period|Adverse Event|0|||
170913802|NCT00090285|617687651|FG004|Base Study Follow-up Period|Adverse Event|0|||
170913803|NCT00090285|617687652|FG005|Base Study Follow-up Period|Adverse Event|0|||
170913804|NCT00090285|617687647|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
170600176|NCT02528357|616540558|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600177|NCT02528357|616540559|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600178|NCT02528357|616540560|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600179|NCT02528357|616540561|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600180|NCT02528357|616540562|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600181|NCT02528357|616540563|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600182|NCT02528357|616540564|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600183|NCT02528357|616540565|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600184|NCT02528357|616540566|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
170600185|NCT02528357|616540567|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
170600186|NCT02528357|616540568|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600187|NCT02528357|616540569|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
170600188|NCT02528357|616540570|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
170600189|NCT02528357|616540571|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
170600190|NCT02528357|616540572|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
170600191|NCT02528357|616540573|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600192|NCT02528357|616540574|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600193|NCT02528357|616540575|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600194|NCT02528357|616540576|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600195|NCT02528357|616540558|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600196|NCT02528357|616540559|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600197|NCT02528357|616540560|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600198|NCT02528357|616540561|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600199|NCT02528357|616540562|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600200|NCT02528357|616540563|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600201|NCT02528357|616540564|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600202|NCT02528357|616540565|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600203|NCT02528357|616540566|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600204|NCT02528357|616540567|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600205|NCT02528357|616540568|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600206|NCT02528357|616540569|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600207|NCT02528357|616540570|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600208|NCT02528357|616540571|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600209|NCT02528357|616540572|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600210|NCT02528357|616540573|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600211|NCT02528357|616540574|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
170600212|NCT02528357|616540575|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600213|NCT02528357|616540576|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
170600214|NCT02528357|616540558|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600215|NCT02528357|616540559|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600216|NCT02528357|616540560|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600217|NCT02528357|616540561|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600218|NCT02528357|616540562|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600219|NCT02528357|616540563|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600220|NCT02528357|616540564|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600221|NCT02528357|616540565|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600222|NCT02528357|616540566|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600223|NCT02528357|616540567|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600224|NCT02528357|616540568|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600225|NCT02528357|616540569|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170651869|NCT00920907|616739983|FG001|Induction Period|Disease Progression|11|||
170651870|NCT00920907|616739982|FG000|Induction Period|Study Drug Toxicity|8|||
170651871|NCT00920907|616739983|FG001|Induction Period|Study Drug Toxicity|6|||
170651872|NCT00920907|616739982|FG000|Induction Period|No longer meets study criteria|0|||
170651873|NCT00920907|616739983|FG001|Induction Period|No longer meets study criteria|1|||
170600226|NCT02528357|616540570|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600227|NCT02528357|616540571|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600228|NCT02528357|616540572|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600229|NCT02528357|616540573|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
170600230|NCT02528357|616540574|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
170651874|NCT00920907|616739982|FG000|Induction Period|Withdrawal by Subject|1|||
170651875|NCT00920907|616739983|FG001|Induction Period|Withdrawal by Subject|1|||
170651876|NCT00920907|616739982|FG000|Maintenance Period|Disease Progression|3|||
170651877|NCT00920907|616739983|FG001|Maintenance Period|Disease Progression|7|||
170651878|NCT00920907|616739982|FG000|Maintenance Period|Administrative (study closure)|7|||
170651879|NCT00920907|616739983|FG001|Maintenance Period|Administrative (study closure)|2|||
170651880|NCT00920907|616739982|FG000|Maintenance Period|Study Drug Toxicity|0|||
170651881|NCT00920907|616739983|FG001|Maintenance Period|Study Drug Toxicity|2|||
170651882|NCT00920907|616739982|FG000|Maintenance Period|Death|1|||
170651883|NCT00920907|616739983|FG001|Maintenance Period|Death|1|||
170651884|NCT00920907|616739982|FG000|Maintenance Period|Withdrawal by Subject|1|||
170651885|NCT00920907|616739983|FG001|Maintenance Period|Withdrawal by Subject|0|||
170651886|NCT00920907|616739982|FG000|Maintenance Period|Adverse Event|0|||
170651887|NCT00920907|616739983|FG001|Maintenance Period|Adverse Event|1|||
170651888|NCT01275339|616739986|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
170651889|NCT01275339|616739987|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
170651890|NCT01275339|616739988|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
170651891|NCT01275339|616739989|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
170651892|NCT01275339|616739986|FG000|Overall Study|Withdrawal by Subject|0|||
170651893|NCT01275339|616739987|FG001|Overall Study|Withdrawal by Subject|0|||
170651894|NCT01275339|616739988|FG002|Overall Study|Withdrawal by Subject|1|||
170651895|NCT01275339|616739989|FG003|Overall Study|Withdrawal by Subject|0|||
170651896|NCT03123185|616739991|FG000|Overall Study|Withdrawal by Subject|0|||
170651897|NCT03123185|616739992|FG001|Overall Study|Withdrawal by Subject|0|||
170651898|NCT03123185|616739993|FG002|Overall Study|Withdrawal by Subject|0|||
170651899|NCT03123185|616739994|FG003|Overall Study|Withdrawal by Subject|0|||
170651900|NCT03123185|616739995|FG004|Overall Study|Withdrawal by Subject|0|||
170651901|NCT03123185|616739996|FG005|Overall Study|Withdrawal by Subject|0|||
170651902|NCT03123185|616739997|FG006|Overall Study|Withdrawal by Subject|0|||
170651903|NCT03123185|616739998|FG007|Overall Study|Withdrawal by Subject|0|||
170651904|NCT03123185|616739999|FG008|Overall Study|Withdrawal by Subject|0|||
170600231|NCT02528357|616540575|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
170600232|NCT02528357|616540576|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
170600233|NCT00199888|616540580|FG000|Overall Study|Lost to Follow-up|1|||
170600234|NCT02745535|616540582|FG000|Overall Study|Death|1|||
170600235|NCT02745535|616540582|FG000|Overall Study|Adverse Event|3|||
170600236|NCT02745535|616540582|FG000|Overall Study|Lost to Follow-up|2|||
170600237|NCT03180307|616540585|FG000|Overall Study|Lost to Follow-up|2|||
170600238|NCT03180307|616540586|FG001|Overall Study|Lost to Follow-up|0|||
170600239|NCT03180307|616540585|FG000|Overall Study|Death|1|||
170600240|NCT03180307|616540586|FG001|Overall Study|Death|0|||
170600241|NCT03180307|616540585|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
170600242|NCT03180307|616540586|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
170600243|NCT03159104|616540587|FG000|Overall Study|Violation of inclusion criteria|1|||
170600244|NCT03159104|616540588|FG001|Overall Study|Violation of inclusion criteria|2|||
170600245|NCT01563172|616540592|FG000|Overall Study|Adverse Event|5|||
170600246|NCT01563172|616540592|FG000|Overall Study|Lost to Follow-up|2|||
170600247|NCT01563172|616540592|FG000|Overall Study|Other (Protocol deviation)|5|||
170600248|NCT01563172|616540592|FG000|Overall Study|Other (Not specified)|1|||
170600249|NCT01105377|616540593|FG000|Overall Study|Withdrawal by Subject|0|||
170600250|NCT01105377|616540594|FG001|Overall Study|Withdrawal by Subject|1|||
170600251|NCT02409342|616540601|FG000|Overall Study|Death|211|||
170600252|NCT02409342|616540602|FG001|Overall Study|Death|201|||
170600253|NCT02409342|616540601|FG000|Overall Study|Withdrawal by Subject|24|||
170600254|NCT02409342|616540602|FG001|Overall Study|Withdrawal by Subject|17|||
170600255|NCT02409342|616540601|FG000|Overall Study|Study Terminated By Sponsor|48|||
170600256|NCT02409342|616540602|FG001|Overall Study|Study Terminated By Sponsor|59|||
170600257|NCT02409342|616540601|FG000|Overall Study|Lost to Follow-up|3|||
170600258|NCT02409342|616540602|FG001|Overall Study|Lost to Follow-up|5|||
170651905|NCT03123185|616740000|FG009|Overall Study|Withdrawal by Subject|0|||
170651906|NCT03123185|616740001|FG010|Overall Study|Withdrawal by Subject|0|||
170651907|NCT03123185|616740002|FG011|Overall Study|Withdrawal by Subject|0|||
170651908|NCT03123185|616740003|FG012|Overall Study|Withdrawal by Subject|1|||
170651909|NCT03123185|616740004|FG013|Overall Study|Withdrawal by Subject|0|||
170600259|NCT02409342|616540601|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
170600260|NCT02409342|616540602|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
170600261|NCT02409342|616540601|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
170600262|NCT02409342|616540602|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
170600263|NCT02409342|616540601|FG000|Overall Study|Sponsor Decision|1|||
170600264|NCT02409342|616540602|FG001|Overall Study|Sponsor Decision|0|||
170600265|NCT00649428|616542335|FG000|Overall Study|Adverse Event|2|||
170600266|NCT00649428|616542336|FG001|Overall Study|Adverse Event|2|||
170600267|NCT00649428|616542335|FG000|Overall Study|Withdrawal by Subject|6|||
170600268|NCT00649428|616542336|FG001|Overall Study|Withdrawal by Subject|6|||
170600269|NCT00649428|616542335|FG000|Overall Study|Lost to Follow-up|1|||
170600270|NCT00649428|616542336|FG001|Overall Study|Lost to Follow-up|3|||
170600271|NCT00649428|616542335|FG000|Overall Study|Insufficient manufacturing yield|5|||
170600272|NCT00649428|616542336|FG001|Overall Study|Insufficient manufacturing yield|1|||
170600273|NCT00649428|616542335|FG000|Overall Study|Protocol Violation|6|||
170600274|NCT00649428|616542336|FG001|Overall Study|Protocol Violation|2|||
170600275|NCT00649428|616542335|FG000|Overall Study|Physician Decision|0|||
170600276|NCT00649428|616542336|FG001|Overall Study|Physician Decision|1|||
170600277|NCT02503501|616542338|FG000|Overall Study|Physician Decision|1|||
170600278|NCT02503501|616542339|FG001|Overall Study|Physician Decision|0|||
170600279|NCT02503501|616542338|FG000|Overall Study|Protocol Violation|0|||
170600280|NCT02503501|616542339|FG001|Overall Study|Protocol Violation|1|||
170600281|NCT02503501|616542338|FG000|Overall Study|Withdrawal by Subject|0|||
170600282|NCT02503501|616542339|FG001|Overall Study|Withdrawal by Subject|2|||
170600283|NCT01740401|616542340|FG000|Overall Study|Progression of disease|6|||
170600284|NCT01740401|616542340|FG000|Overall Study|Adverse Event|2|||
170600285|NCT01740401|616542340|FG000|Overall Study|Did not reach primary endpoint|2|||
170600286|NCT00448747|616542352|FG000|Overall Study|collapsed veins|1|||
170600287|NCT00448747|616542353|FG001|Overall Study|collapsed veins|0|||
170600288|NCT00007020|616542354|FG000|Overall Study|Death|16|||
170600289|NCT00007020|616542354|FG000|Overall Study|Lost to Follow-up|13|||
170600290|NCT00007020|616542354|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
170600291|NCT00007020|616542354|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
170600292|NCT00007020|616542354|FG000|Overall Study|Pt cared for by outside physician|4|||
170600293|NCT00007020|616542354|FG000|Overall Study|No evidence of treatment|6|||
170600294|NCT01276223|616542355|FG000|Overall Study|Adverse Event|7|||
170600295|NCT01276223|616542356|FG001|Overall Study|Adverse Event|4|||
170600296|NCT01276223|616542357|FG002|Overall Study|Adverse Event|1|||
170600297|NCT01276223|616542355|FG000|Overall Study|Lost to Follow-up|0|||
170600298|NCT01276223|616542356|FG001|Overall Study|Lost to Follow-up|0|||
170600299|NCT01276223|616542357|FG002|Overall Study|Lost to Follow-up|1|||
170600300|NCT01276223|616542355|FG000|Overall Study|Other|0|||
170600301|NCT01276223|616542356|FG001|Overall Study|Other|0|||
170600302|NCT01276223|616542357|FG002|Overall Study|Other|1|||
170600303|NCT01276223|616542355|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
170600304|NCT01276223|616542356|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
170600305|NCT01276223|616542357|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
170600306|NCT01276223|616542355|FG000|Overall Study|Protocol Violation|1|||
170600307|NCT01276223|616542356|FG001|Overall Study|Protocol Violation|0|||
170600308|NCT01276223|616542357|FG002|Overall Study|Protocol Violation|0|||
170600309|NCT01571232|616542358|FG000|Overall Study|Lost to Follow-up|0|||
170600310|NCT01571232|616542359|FG001|Overall Study|Lost to Follow-up|1|||
170600311|NCT01571232|616542358|FG000|Overall Study|Withdrawal by Subject|1|||
170600312|NCT01571232|616542359|FG001|Overall Study|Withdrawal by Subject|0|||
170600313|NCT00771615|616542360|FG000|Overall Study|Withdrawal by Subject|0|||
170600314|NCT00771615|616542361|FG001|Overall Study|Withdrawal by Subject|1|||
170600315|NCT00771615|616542362|FG002|Overall Study|Withdrawal by Subject|0|||
170600316|NCT00771615|616542363|FG003|Overall Study|Withdrawal by Subject|0|||
170600317|NCT00771615|616542364|FG004|Overall Study|Withdrawal by Subject|0|||
170600318|NCT00771615|616542365|FG005|Overall Study|Withdrawal by Subject|0|||
170600319|NCT00771615|616542366|FG006|Overall Study|Withdrawal by Subject|0|||
170600320|NCT00771615|616542367|FG007|Overall Study|Withdrawal by Subject|1|||
170600321|NCT00771615|616542368|FG008|Overall Study|Withdrawal by Subject|0|||
170600322|NCT00771615|616542360|FG000|Overall Study|Lost to Follow-up|1|||
170600323|NCT00771615|616542361|FG001|Overall Study|Lost to Follow-up|1|||
170600324|NCT00771615|616542362|FG002|Overall Study|Lost to Follow-up|1|||
170600325|NCT00771615|616542363|FG003|Overall Study|Lost to Follow-up|1|||
170600326|NCT00771615|616542364|FG004|Overall Study|Lost to Follow-up|0|||
170600327|NCT00771615|616542365|FG005|Overall Study|Lost to Follow-up|1|||
170600328|NCT00771615|616542366|FG006|Overall Study|Lost to Follow-up|1|||
170600329|NCT00771615|616542367|FG007|Overall Study|Lost to Follow-up|0|||
170600330|NCT00771615|616542368|FG008|Overall Study|Lost to Follow-up|0|||
170600331|NCT04736628|616542370|FG000|Overall Study|Not treated|0|||
170600332|NCT04736628|616542371|FG001|Overall Study|Not treated|0|||
170600333|NCT04736628|616542372|FG002|Overall Study|Not treated|0|||
170600334|NCT04736628|616542373|FG003|Overall Study|Not treated|2|||
170600335|NCT04736628|616542370|FG000|Overall Study|Other reason than listed|1|||
170600336|NCT04736628|616542371|FG001|Overall Study|Other reason than listed|2|||
170600337|NCT04736628|616542372|FG002|Overall Study|Other reason than listed|2|||
170600338|NCT04736628|616542373|FG003|Overall Study|Other reason than listed|3|||
170600339|NCT04736628|616542370|FG000|Overall Study|Protocol deviation|0|||
170600340|NCT04736628|616542371|FG001|Overall Study|Protocol deviation|0|||
170600341|NCT04736628|616542372|FG002|Overall Study|Protocol deviation|0|||
170600342|NCT04736628|616542373|FG003|Overall Study|Protocol deviation|1|||
170600343|NCT04736628|616542370|FG000|Overall Study|Burden of study procedures|1|||
170600344|NCT04736628|616542371|FG001|Overall Study|Burden of study procedures|0|||
170600345|NCT04736628|616542372|FG002|Overall Study|Burden of study procedures|0|||
170600346|NCT04736628|616542373|FG003|Overall Study|Burden of study procedures|1|||
170600347|NCT04736628|616542370|FG000|Overall Study|Change of residence|0|||
170600348|NCT04736628|616542371|FG001|Overall Study|Change of residence|1|||
170600349|NCT04736628|616542372|FG002|Overall Study|Change of residence|0|||
170600350|NCT04736628|616542373|FG003|Overall Study|Change of residence|0|||
170600351|NCT04736628|616542370|FG000|Overall Study|Perceived lack of efficacy|1|||
170600352|NCT04736628|616542371|FG001|Overall Study|Perceived lack of efficacy|0|||
170600353|NCT04736628|616542372|FG002|Overall Study|Perceived lack of efficacy|0|||
170600354|NCT04736628|616542373|FG003|Overall Study|Perceived lack of efficacy|1|||
170600355|NCT04736628|616542370|FG000|Overall Study|Adverse Event|3|||
170600356|NCT04736628|616542371|FG001|Overall Study|Adverse Event|2|||
170600357|NCT04736628|616542372|FG002|Overall Study|Adverse Event|4|||
170600358|NCT04736628|616542373|FG003|Overall Study|Adverse Event|3|||
170600359|NCT04279613|616542374|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
170600360|NCT04279613|616542375|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
170600361|NCT04279613|616542376|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
170600362|NCT04279613|616542377|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
170600363|NCT04279613|616542378|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
170600364|NCT04279613|616542374|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
170600365|NCT04279613|616542375|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
170600366|NCT04279613|616542376|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
170600367|NCT04279613|616542377|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
170600368|NCT04279613|616542378|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
170600369|NCT04279613|616542374|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
170600370|NCT04279613|616542375|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
170600371|NCT04279613|616542376|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
170600372|NCT04279613|616542377|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
170600373|NCT04279613|616542378|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
170600374|NCT04279613|616542374|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
170600375|NCT04279613|616542375|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
170600376|NCT04279613|616542376|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
170600377|NCT04279613|616542377|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
170600378|NCT04279613|616542378|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
170600379|NCT04279613|616542374|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
170600380|NCT04279613|616542375|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
170600381|NCT04279613|616542376|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
170600382|NCT04279613|616542377|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
170600383|NCT04279613|616542378|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
170600384|NCT02540668|616542379|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
170600385|NCT02540668|616542380|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
170651910|NCT00923364|616740007|FG000|Overall Study|Death|3|||
170651911|NCT00923364|616740008|FG001|Overall Study|Death|0|||
170651912|NCT00923364|616740007|FG000|Overall Study|Did not go to transplant|1|||
170651913|NCT00923364|616740008|FG001|Overall Study|Did not go to transplant|0|||
170651914|NCT01931670|616740010|FG000|Treatment Period|Exclusionary Medication Received|1|||
170651915|NCT01931670|616740011|FG001|Treatment Period|Exclusionary Medication Received|1|||
170600386|NCT03270891|616542381|FG000|Overall Study|Lost to Follow-up|3|||
170651916|NCT01931670|616740012|FG002|Treatment Period|Exclusionary Medication Received|1|||
170651917|NCT01931670|616740010|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
170651918|NCT01931670|616740011|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
170651919|NCT01931670|616740012|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
170651920|NCT01931670|616740010|FG000|Treatment Period|Subject Noncompliant|4|||
170651921|NCT01931670|616740011|FG001|Treatment Period|Subject Noncompliant|9|||
170651922|NCT01931670|616740012|FG002|Treatment Period|Subject Noncompliant|5|||
170600387|NCT03270891|616542382|FG001|Overall Study|Lost to Follow-up|6|||
170600388|NCT03270891|616542383|FG002|Overall Study|Lost to Follow-up|0|||
170600389|NCT03270891|616542381|FG000|Overall Study|Withdrawal by Subject|1|||
170600390|NCT03270891|616542382|FG001|Overall Study|Withdrawal by Subject|0|||
170600391|NCT03270891|616542383|FG002|Overall Study|Withdrawal by Subject|0|||
170600392|NCT03270891|616542381|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
170600393|NCT03270891|616542382|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
170600394|NCT03270891|616542383|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
170600395|NCT02066415|616542388|FG000|Overall Study|Decision by Sponsor|5|||
170913805|NCT00090285|617687648|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
170600396|NCT02066415|616542389|FG001|Overall Study|Decision by Sponsor|4|||
170600397|NCT02066415|616542390|FG002|Overall Study|Decision by Sponsor|2|||
170600398|NCT02066415|616542388|FG000|Overall Study|Withdrawal by Subject|9|||
170600399|NCT02066415|616542389|FG001|Overall Study|Withdrawal by Subject|1|||
170600400|NCT02066415|616542390|FG002|Overall Study|Withdrawal by Subject|4|||
170600401|NCT02066415|616542388|FG000|Overall Study|Lost to Follow-up|7|||
170600402|NCT02066415|616542389|FG001|Overall Study|Lost to Follow-up|2|||
170600403|NCT02066415|616542390|FG002|Overall Study|Lost to Follow-up|2|||
170600404|NCT02276547|616542391|FG000|Overall Study|Death|2|||
170600405|NCT02276547|616542391|FG000|Overall Study|Explant|2|||
170600406|NCT00530920|616542392|FG000|Overall Study|Randomized but not treated|0|||
170600407|NCT00530920|616542393|FG001|Overall Study|Randomized but not treated|2|||
170600408|NCT00530920|616542394|FG002|Overall Study|Randomized but not treated|0|||
170600409|NCT00530920|616542392|FG000|Overall Study|Adverse Event|0|||
170600410|NCT00530920|616542393|FG001|Overall Study|Adverse Event|0|||
170600411|NCT00530920|616542394|FG002|Overall Study|Adverse Event|3|||
170600412|NCT00530920|616542392|FG000|Overall Study|Withdrawal by Subject|0|||
170600413|NCT00530920|616542393|FG001|Overall Study|Withdrawal by Subject|0|||
170600414|NCT00530920|616542394|FG002|Overall Study|Withdrawal by Subject|1|||
170600415|NCT00907296|616542395|FG000|Overall Study|Ineligibility Determined|1|||
170600416|NCT00907296|616542396|FG001|Overall Study|Ineligibility Determined|0|||
170600417|NCT00907296|616542397|FG002|Overall Study|Ineligibility Determined|0|||
170600418|NCT00907296|616542398|FG003|Overall Study|Ineligibility Determined|1|||
170600419|NCT00907296|616542399|FG004|Overall Study|Ineligibility Determined|0|||
170600420|NCT00907296|616542400|FG005|Overall Study|Ineligibility Determined|0|||
170600421|NCT00907296|616542401|FG006|Overall Study|Ineligibility Determined|0|||
170600422|NCT00907296|616542402|FG007|Overall Study|Ineligibility Determined|1|||
170600423|NCT00907296|616542403|FG008|Overall Study|Ineligibility Determined|0|||
170600424|NCT00907296|616542404|FG009|Overall Study|Ineligibility Determined|0|||
170600425|NCT00907296|616542395|FG000|Overall Study|Protocol Deviation|0|||
170600426|NCT00907296|616542396|FG001|Overall Study|Protocol Deviation|1|||
170600427|NCT00907296|616542397|FG002|Overall Study|Protocol Deviation|0|||
170600428|NCT00907296|616542398|FG003|Overall Study|Protocol Deviation|0|||
170600429|NCT00907296|616542399|FG004|Overall Study|Protocol Deviation|0|||
170600430|NCT00907296|616542400|FG005|Overall Study|Protocol Deviation|0|||
170600431|NCT00907296|616542401|FG006|Overall Study|Protocol Deviation|0|||
170600432|NCT00907296|616542402|FG007|Overall Study|Protocol Deviation|0|||
170600433|NCT00907296|616542403|FG008|Overall Study|Protocol Deviation|0|||
170600434|NCT00907296|616542404|FG009|Overall Study|Protocol Deviation|0|||
170600435|NCT00907296|616542395|FG000|Overall Study|Noncompliance|1|||
170600436|NCT00907296|616542396|FG001|Overall Study|Noncompliance|1|||
170600437|NCT00907296|616542397|FG002|Overall Study|Noncompliance|1|||
170600438|NCT00907296|616542398|FG003|Overall Study|Noncompliance|0|||
170600439|NCT00907296|616542399|FG004|Overall Study|Noncompliance|0|||
170600440|NCT00907296|616542400|FG005|Overall Study|Noncompliance|1|||
170600441|NCT00907296|616542401|FG006|Overall Study|Noncompliance|0|||
170600442|NCT00907296|616542402|FG007|Overall Study|Noncompliance|2|||
170600443|NCT00907296|616542403|FG008|Overall Study|Noncompliance|0|||
170600444|NCT00907296|616542404|FG009|Overall Study|Noncompliance|0|||
170600445|NCT00907296|616542395|FG000|Overall Study|Adverse Event|2|||
170600446|NCT00907296|616542396|FG001|Overall Study|Adverse Event|0|||
170600447|NCT00907296|616542397|FG002|Overall Study|Adverse Event|0|||
170600448|NCT00907296|616542398|FG003|Overall Study|Adverse Event|0|||
170600449|NCT00907296|616542399|FG004|Overall Study|Adverse Event|0|||
170600450|NCT00907296|616542400|FG005|Overall Study|Adverse Event|0|||
170600451|NCT00907296|616542401|FG006|Overall Study|Adverse Event|1|||
170600452|NCT00907296|616542402|FG007|Overall Study|Adverse Event|0|||
170600453|NCT00907296|616542403|FG008|Overall Study|Adverse Event|0|||
170600454|NCT00907296|616542404|FG009|Overall Study|Adverse Event|1|||
170600455|NCT00907296|616542395|FG000|Overall Study|Withdrawal by Subject|7|||
170600456|NCT00907296|616542396|FG001|Overall Study|Withdrawal by Subject|2|||
170600457|NCT00907296|616542397|FG002|Overall Study|Withdrawal by Subject|1|||
170600458|NCT00907296|616542398|FG003|Overall Study|Withdrawal by Subject|1|||
170913806|NCT00090285|617687649|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
170600459|NCT00907296|616542399|FG004|Overall Study|Withdrawal by Subject|1|||
170600460|NCT00907296|616542400|FG005|Overall Study|Withdrawal by Subject|5|||
170600461|NCT00907296|616542401|FG006|Overall Study|Withdrawal by Subject|3|||
170600462|NCT00907296|616542402|FG007|Overall Study|Withdrawal by Subject|2|||
170600463|NCT00907296|616542403|FG008|Overall Study|Withdrawal by Subject|4|||
170600464|NCT00907296|616542404|FG009|Overall Study|Withdrawal by Subject|2|||
170600465|NCT00907296|616542395|FG000|Overall Study|Lost to Follow-up|9|||
170600466|NCT00907296|616542396|FG001|Overall Study|Lost to Follow-up|1|||
170600467|NCT00907296|616542397|FG002|Overall Study|Lost to Follow-up|0|||
170600468|NCT00907296|616542398|FG003|Overall Study|Lost to Follow-up|2|||
170600469|NCT00907296|616542399|FG004|Overall Study|Lost to Follow-up|0|||
170600470|NCT00907296|616542400|FG005|Overall Study|Lost to Follow-up|3|||
170600471|NCT00907296|616542401|FG006|Overall Study|Lost to Follow-up|2|||
170600472|NCT00907296|616542402|FG007|Overall Study|Lost to Follow-up|2|||
170600473|NCT00907296|616542403|FG008|Overall Study|Lost to Follow-up|0|||
170600474|NCT00907296|616542404|FG009|Overall Study|Lost to Follow-up|4|||
170600475|NCT00791557|616542406|FG000|Overall Study|Adverse Event|1|||
170600476|NCT02616393|616542412|FG000|Overall Study|Death|5|||
170600477|NCT02616393|616542413|FG001|Overall Study|Death|12|||
170600478|NCT02616393|616542414|FG002|Overall Study|Death|1|||
170600479|NCT02616393|616542412|FG000|Overall Study|Termination by Sponsor|4|||
170600480|NCT02616393|616542413|FG001|Overall Study|Termination by Sponsor|5|||
170600481|NCT02616393|616542414|FG002|Overall Study|Termination by Sponsor|2|||
170600482|NCT02616393|616542412|FG000|Overall Study|Other|3|||
170600483|NCT02616393|616542413|FG001|Overall Study|Other|0|||
170600484|NCT02616393|616542414|FG002|Overall Study|Other|0|||
170600485|NCT02616393|616542412|FG000|Overall Study|Withdrawal by Subject|1|||
170600486|NCT02616393|616542413|FG001|Overall Study|Withdrawal by Subject|1|||
170600487|NCT02616393|616542414|FG002|Overall Study|Withdrawal by Subject|0|||
170600488|NCT02616393|616542412|FG000|Overall Study|Lost to Follow-up|0|||
170600489|NCT02616393|616542413|FG001|Overall Study|Lost to Follow-up|2|||
170600490|NCT02616393|616542414|FG002|Overall Study|Lost to Follow-up|0|||
170600491|NCT04135859|616542417|FG000|Overall Study|Withdrawal by Subject|1|||
170600492|NCT04135859|616542418|FG001|Overall Study|Withdrawal by Subject|0|||
170600493|NCT04135859|616542417|FG000|Overall Study|Withdrawal due to screening failure|1|||
170600494|NCT04135859|616542418|FG001|Overall Study|Withdrawal due to screening failure|2|||
170600495|NCT04135859|616542417|FG000|Overall Study|Did not complete stress test|3|||
170600496|NCT04135859|616542418|FG001|Overall Study|Did not complete stress test|3|||
170600497|NCT04135859|616542417|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
170600498|NCT04135859|616542418|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
170600499|NCT00493636|616542419|FG000|Overall Study|Withdrawal by Subject|1|||
170600500|NCT00493636|616542420|FG001|Overall Study|Withdrawal by Subject|0|||
170600501|NCT00493636|616542419|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
170600502|NCT00493636|616542420|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
170600503|NCT00493636|616542419|FG000|Overall Study|Mis-randomization|1|||
170600504|NCT00493636|616542420|FG001|Overall Study|Mis-randomization|1|||
170600505|NCT02049138|616542424|FG000|Overall Study|Adverse Event|46|||
170600506|NCT02049138|616542425|FG001|Overall Study|Adverse Event|25|||
170600507|NCT02049138|616542426|FG002|Overall Study|Adverse Event|1|||
170600508|NCT02049138|616542424|FG000|Overall Study|Withdrawal by Subject|57|||
170600509|NCT02049138|616542425|FG001|Overall Study|Withdrawal by Subject|21|||
170600510|NCT02049138|616542426|FG002|Overall Study|Withdrawal by Subject|5|||
170600511|NCT02049138|616542424|FG000|Overall Study|Lost to Follow-up|18|||
170600512|NCT02049138|616542425|FG001|Overall Study|Lost to Follow-up|5|||
170600513|NCT02049138|616542426|FG002|Overall Study|Lost to Follow-up|1|||
170600514|NCT02049138|616542424|FG000|Overall Study|Lack of Efficacy|10|||
170600515|NCT02049138|616542425|FG001|Overall Study|Lack of Efficacy|26|||
170600516|NCT02049138|616542426|FG002|Overall Study|Lack of Efficacy|1|||
170600517|NCT02049138|616542424|FG000|Overall Study|Non-Compliance|15|||
170600518|NCT02049138|616542425|FG001|Overall Study|Non-Compliance|6|||
170600519|NCT02049138|616542426|FG002|Overall Study|Non-Compliance|0|||
170600520|NCT02049138|616542424|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
170600521|NCT02049138|616542425|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
170600522|NCT02049138|616542426|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
170600523|NCT02049138|616542424|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
170600524|NCT02049138|616542425|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
170600525|NCT02049138|616542426|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
170600526|NCT02049138|616542424|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
170600527|NCT02049138|616542425|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
170600528|NCT02049138|616542426|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
170600529|NCT02049138|616542424|FG000|Overall Study|Other|15|||
170600530|NCT02049138|616542425|FG001|Overall Study|Other|13|||
170600531|NCT02049138|616542426|FG002|Overall Study|Other|0|||
170600532|NCT02049138|616542424|FG000|Overall Study|Missing|0|||
170600533|NCT02049138|616542425|FG001|Overall Study|Missing|1|||
170600534|NCT02049138|616542426|FG002|Overall Study|Missing|0|||
170600535|NCT04109976|616542427|FG000|Overall Study|Withdrawal by Subject|1|||
170600536|NCT04109976|616542428|FG001|Overall Study|Withdrawal by Subject|0|||
170600537|NCT00257660|616542429|FG000|Overall Study|Lack of Efficacy|5|||
170600538|NCT00257660|616542430|FG001|Overall Study|Lack of Efficacy|23|||
170600539|NCT00257660|616542429|FG000|Overall Study|Withdrawal by Subject|2|||
170600540|NCT00257660|616542430|FG001|Overall Study|Withdrawal by Subject|0|||
170600541|NCT00257660|616542429|FG000|Overall Study|Lost to Follow-up|1|||
170600542|NCT00257660|616542430|FG001|Overall Study|Lost to Follow-up|0|||
170600543|NCT00257660|616542429|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
170600544|NCT00257660|616542430|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
170600545|NCT00257660|616542429|FG000|Overall Study|No longer wanted to do blood draws|1|||
170600546|NCT00257660|616542430|FG001|Overall Study|No longer wanted to do blood draws|0|||
170600547|NCT00491608|616542431|FG000|Overall Study|Death|2|||
170600548|NCT00491608|616542431|FG000|Overall Study|Withdrawal by Subject|1|||
170600549|NCT05086510|616542436|FG000|Overall Study|Lost to Follow-up|0|||
170600550|NCT05086510|616542437|FG001|Overall Study|Lost to Follow-up|2|||
170600551|NCT05086510|616542436|FG000|Overall Study|Death|0|||
170600552|NCT05086510|616542437|FG001|Overall Study|Death|2|||
170600553|NCT00654004|616542441|FG000|Overall Study|Lost to Follow-up|1|||
170600554|NCT00654004|616542442|FG001|Overall Study|Lost to Follow-up|0|||
170600555|NCT04881747|616542445|FG000|Period 2 Washout|Adverse Event|1|||
170600556|NCT04881747|616542446|FG001|Period 2 Washout|Adverse Event|0|||
170600557|NCT04881747|616542447|FG002|Period 2 Washout|Adverse Event|0|||
170600558|NCT04881747|616542448|FG003|Period 2 Washout|Adverse Event|0|||
170600559|NCT04881747|616542449|FG004|Period 2 Washout|Adverse Event|1|||
170600560|NCT04881747|616542450|FG005|Period 2 Washout|Adverse Event|0|||
170600561|NCT04881747|616542445|FG000|Period 2 Washout|Withdrawal by Subject|1|||
170600562|NCT04881747|616542446|FG001|Period 2 Washout|Withdrawal by Subject|0|||
170600563|NCT04881747|616542447|FG002|Period 2 Washout|Withdrawal by Subject|0|||
170600564|NCT04881747|616542448|FG003|Period 2 Washout|Withdrawal by Subject|1|||
170600565|NCT04881747|616542449|FG004|Period 2 Washout|Withdrawal by Subject|0|||
170600566|NCT04881747|616542450|FG005|Period 2 Washout|Withdrawal by Subject|0|||
170600567|NCT01378429|616542459|FG000|Overall Study|Noncompliance with study drug|1|||
170600568|NCT01378429|616542460|FG001|Overall Study|Noncompliance with study drug|0|||
170600569|NCT02966015|616542462|FG000|Inclusion Visit|did not answer questionnaire|8|||
170600570|NCT02966015|616542463|FG001|Inclusion Visit|did not answer questionnaire|3|||
170600571|NCT02356887|616542464|FG000|Overall Study|poor compliance|2|||
170600572|NCT05219669|616542467|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
170600573|NCT05219669|616542468|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
170600574|NCT05219669|616542469|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
170600575|NCT05219669|616542470|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
170600576|NCT05219669|616542471|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
170600577|NCT05219669|616542472|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
170600578|NCT03134183|616542474|FG000|Overall Study|Withdrawal by Subject|1|||
170600579|NCT03134183|616542475|FG001|Overall Study|Withdrawal by Subject|1|||
170600580|NCT00330668|616542478|FG000|BID Dosing Period|Adverse Event|1|||
170600581|NCT00330668|616542478|FG000|BID Dosing Period|Lost to Follow-up|7|||
170600582|NCT00330668|616542478|FG000|BID Dosing Period|Non-Compliance|5|||
170600583|NCT00330668|616542478|FG000|BID Dosing Period|Withdrawal by Subject|19|||
170600584|NCT00330668|616542478|FG000|BID Dosing Period|Sponsor's decision|1|||
170600585|NCT00330668|616542478|FG000|BID Dosing Period|Other|3|||
170600586|NCT00330668|616542478|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
170600587|NCT00330668|616542478|FG000|QD Dosing Period|Other|1|||
170600588|NCT00330668|616542478|FG000|QD Dosing Period|Withdrawal by Subject|1|||
170600589|NCT00330668|616542478|FG000|QD Dosing Period|Lost to Follow-up|2|||
170600590|NCT04023682|616542479|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
170600591|NCT01638559|616542484|FG000|Overall Study|Lost to Follow-up|1|||
170600592|NCT01638559|616542484|FG000|Overall Study|Withdrawal by Subject|1|||
170600593|NCT01638559|616542484|FG000|Overall Study|Subject declined to travel for biopsy|1|||
170600594|NCT02014584|616542488|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
170600595|NCT02014584|616542489|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
170600596|NCT02014584|616542490|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
170600597|NCT02014584|616542491|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
170600598|NCT02014584|616542492|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
170600599|NCT02014584|616542493|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
170600600|NCT02014584|616542488|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
170600601|NCT02014584|616542489|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
170600602|NCT02014584|616542490|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
170600603|NCT02014584|616542491|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
170600604|NCT02014584|616542492|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
170600605|NCT02014584|616542493|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
170600606|NCT02014584|616542488|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
170600607|NCT02014584|616542489|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
170600608|NCT02014584|616542490|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
170600609|NCT02014584|616542491|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
170600610|NCT02014584|616542492|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
170600611|NCT02014584|616542493|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
170600612|NCT02014584|616542488|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
170600613|NCT02014584|616542489|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
170600614|NCT02014584|616542490|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
170651923|NCT01931670|616740010|FG000|Treatment Period|Adverse Event|19|||
170600615|NCT02014584|616542491|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
170600616|NCT02014584|616542492|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
170600617|NCT02014584|616542493|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
170600618|NCT02014584|616542488|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
170600619|NCT02014584|616542489|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
170600620|NCT02014584|616542490|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
170600621|NCT02014584|616542491|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
170600622|NCT02014584|616542492|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
170600623|NCT02014584|616542493|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
170600624|NCT03442296|616542494|FG000|3 Month Follow-up|Death|3|||
170600625|NCT03442296|616542495|FG001|3 Month Follow-up|Death|1|||
170600626|NCT03442296|616542494|FG000|3 Month Follow-up|Lost to Follow-up|1|||
170600627|NCT03442296|616542495|FG001|3 Month Follow-up|Lost to Follow-up|1|||
170600628|NCT03442296|616542494|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
170600629|NCT03442296|616542495|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
170600630|NCT03442296|616542494|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
170600631|NCT03442296|616542495|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
170600632|NCT03442296|616542494|FG000|12 Month Follow-up|Incomplete measurement|1|||
170600633|NCT03442296|616542495|FG001|12 Month Follow-up|Incomplete measurement|1|||
170600634|NCT00447122|616542496|FG000|Overall Study|worsening medical condition -came off|0|||
170600635|NCT00447122|616542497|FG001|Overall Study|worsening medical condition -came off|1|||
170600636|NCT00447122|616542498|FG002|Overall Study|worsening medical condition -came off|0|||
170600637|NCT00447122|616542499|FG003|Overall Study|worsening medical condition -came off|0|||
170600638|NCT01274429|616542500|FG000|Overall Study|Study closed do to lack of funding|5|||
170600639|NCT01439373|616542503|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
170600640|NCT01439373|616542504|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
170600641|NCT01439373|616542503|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
170600642|NCT01439373|616542504|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
170600643|NCT04046250|616542507|FG000|Overall Study|Death|0|||
170600644|NCT04046250|616542508|FG001|Overall Study|Death|1|||
170600645|NCT04046250|616542507|FG000|Overall Study|Withdrawal by Subject|3|||
170600646|NCT04046250|616542508|FG001|Overall Study|Withdrawal by Subject|3|||
170600647|NCT03834220|616542511|FG000|Overall Study|Adverse Event|1|||
170600648|NCT03834220|616542512|FG001|Overall Study|Adverse Event|0|||
170600649|NCT03834220|616542513|FG002|Overall Study|Adverse Event|0|||
170600650|NCT03834220|616542511|FG000|Overall Study|Death|8|||
170600651|NCT03834220|616542512|FG001|Overall Study|Death|1|||
170600652|NCT03834220|616542513|FG002|Overall Study|Death|17|||
170600653|NCT03834220|616542511|FG000|Overall Study|Reason not Specified|9|||
170600654|NCT03834220|616542512|FG001|Overall Study|Reason not Specified|0|||
170600655|NCT03834220|616542513|FG002|Overall Study|Reason not Specified|6|||
170600656|NCT03834220|616542511|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
170600657|NCT03834220|616542512|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
170600658|NCT03834220|616542513|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
170600659|NCT03834220|616542511|FG000|Overall Study|Withdrawal of Consent|2|||
170600660|NCT03834220|616542512|FG001|Overall Study|Withdrawal of Consent|2|||
170600661|NCT03834220|616542513|FG002|Overall Study|Withdrawal of Consent|2|||
170600662|NCT03684694|616542515|FG000|Phase 1|Withdrawal by Subject|1|||
170600663|NCT03684694|616542516|FG001|Phase 1|Withdrawal by Subject|0|||
170600664|NCT03684694|616542517|FG002|Phase 1|Withdrawal by Subject|0|||
170600665|NCT03684694|616542518|FG003|Phase 1|Withdrawal by Subject|0|||
170600666|NCT03684694|616542519|FG004|Phase 1|Withdrawal by Subject|0|||
170600667|NCT03684694|616542520|FG005|Phase 1|Withdrawal by Subject|0|||
170600668|NCT03684694|616542515|FG000|Phase 1|Investigator/Sponsor Decision|12|||
170600669|NCT03684694|616542516|FG001|Phase 1|Investigator/Sponsor Decision|2|||
170600670|NCT03684694|616542517|FG002|Phase 1|Investigator/Sponsor Decision|1|||
170651924|NCT01931670|616740011|FG001|Treatment Period|Adverse Event|8|||
170651925|NCT01931670|616740012|FG002|Treatment Period|Adverse Event|21|||
170651926|NCT01931670|616740010|FG000|Treatment Period|Lack of Efficacy|11|||
170651927|NCT01931670|616740011|FG001|Treatment Period|Lack of Efficacy|2|||
170651928|NCT01931670|616740012|FG002|Treatment Period|Lack of Efficacy|2|||
170813049|NCT01853384|617324135|FG000|Completed Follow up Visit 1|Early Termination|13|||
170813050|NCT01853384|617324136|FG001|Completed Follow up Visit 1|Early Termination|9|||
170813051|NCT01853384|617324135|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
170600671|NCT03684694|616542518|FG003|Phase 1|Investigator/Sponsor Decision|0|||
170600672|NCT03684694|616542519|FG004|Phase 1|Investigator/Sponsor Decision|0|||
170600673|NCT03684694|616542520|FG005|Phase 1|Investigator/Sponsor Decision|0|||
170600674|NCT03684694|616542515|FG000|Phase 1|Death|24|||
170600675|NCT03684694|616542516|FG001|Phase 1|Death|0|||
170600676|NCT03684694|616542517|FG002|Phase 1|Death|3|||
170600677|NCT03684694|616542518|FG003|Phase 1|Death|0|||
170600678|NCT03684694|616542519|FG004|Phase 1|Death|0|||
170600679|NCT03684694|616542520|FG005|Phase 1|Death|0|||
170651929|NCT01931670|616740010|FG000|Treatment Period|Pregnancy|7|||
170600680|NCT03684694|616542515|FG000|Phase 1|Lost to Follow-up|0|||
170600681|NCT03684694|616542516|FG001|Phase 1|Lost to Follow-up|0|||
170600682|NCT03684694|616542517|FG002|Phase 1|Lost to Follow-up|1|||
170600683|NCT03684694|616542518|FG003|Phase 1|Lost to Follow-up|0|||
170600684|NCT03684694|616542519|FG004|Phase 1|Lost to Follow-up|0|||
170600685|NCT03684694|616542520|FG005|Phase 1|Lost to Follow-up|0|||
170600686|NCT03684694|616542515|FG000|Phase 1|Miscellaneous|0|||
170600687|NCT03684694|616542516|FG001|Phase 1|Miscellaneous|1|||
170600688|NCT03684694|616542517|FG002|Phase 1|Miscellaneous|0|||
170600689|NCT03684694|616542518|FG003|Phase 1|Miscellaneous|0|||
170600690|NCT03684694|616542519|FG004|Phase 1|Miscellaneous|0|||
170600691|NCT03684694|616542520|FG005|Phase 1|Miscellaneous|0|||
170600692|NCT03684694|616542515|FG000|Phase 2|Withdrawal by Subject|0|||
170600693|NCT03684694|616542516|FG001|Phase 2|Withdrawal by Subject|0|||
170600694|NCT03684694|616542517|FG002|Phase 2|Withdrawal by Subject|0|||
170600695|NCT03684694|616542518|FG003|Phase 2|Withdrawal by Subject|0|||
170600696|NCT03684694|616542519|FG004|Phase 2|Withdrawal by Subject|0|||
170600697|NCT03684694|616542520|FG005|Phase 2|Withdrawal by Subject|1|||
170600698|NCT03684694|616542515|FG000|Phase 2|Investigator/Sponsor Decision|0|||
170600699|NCT03684694|616542516|FG001|Phase 2|Investigator/Sponsor Decision|0|||
170600700|NCT03684694|616542517|FG002|Phase 2|Investigator/Sponsor Decision|0|||
170600701|NCT03684694|616542518|FG003|Phase 2|Investigator/Sponsor Decision|17|||
170600702|NCT03684694|616542519|FG004|Phase 2|Investigator/Sponsor Decision|16|||
170600703|NCT03684694|616542520|FG005|Phase 2|Investigator/Sponsor Decision|6|||
170600704|NCT03684694|616542515|FG000|Phase 2|Death|0|||
170600705|NCT03684694|616542516|FG001|Phase 2|Death|0|||
170600706|NCT03684694|616542517|FG002|Phase 2|Death|0|||
170600707|NCT03684694|616542518|FG003|Phase 2|Death|28|||
170600708|NCT03684694|616542519|FG004|Phase 2|Death|14|||
170600709|NCT03684694|616542520|FG005|Phase 2|Death|3|||
170600710|NCT03684694|616542515|FG000|Phase 2|Lost to Follow-up|0|||
170813052|NCT01853384|617324136|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
170813053|NCT01853384|617324135|FG000|Completed Follow up Visit 2|Adverse Event|1|||
170813054|NCT01853384|617324136|FG001|Completed Follow up Visit 2|Adverse Event|0|||
170600711|NCT03684694|616542516|FG001|Phase 2|Lost to Follow-up|0|||
170600712|NCT03684694|616542517|FG002|Phase 2|Lost to Follow-up|0|||
170600713|NCT03684694|616542518|FG003|Phase 2|Lost to Follow-up|1|||
170600714|NCT03684694|616542519|FG004|Phase 2|Lost to Follow-up|0|||
170600715|NCT03684694|616542520|FG005|Phase 2|Lost to Follow-up|0|||
170600716|NCT03684694|616542515|FG000|Phase 2|Miscellaneous|0|||
170600717|NCT03684694|616542516|FG001|Phase 2|Miscellaneous|0|||
170600718|NCT03684694|616542517|FG002|Phase 2|Miscellaneous|0|||
170600719|NCT03684694|616542518|FG003|Phase 2|Miscellaneous|3|||
170600720|NCT03684694|616542519|FG004|Phase 2|Miscellaneous|0|||
170600721|NCT03684694|616542520|FG005|Phase 2|Miscellaneous|0|||
170600722|NCT00602420|616544355|FG000|Overall Study|Death|1|||
170600723|NCT00602420|616544356|FG001|Overall Study|Death|4|||
170600724|NCT00602420|616544355|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
170600725|NCT00602420|616544356|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
170600726|NCT00602420|616544355|FG000|Overall Study|Withdrawal by Subject|18|||
170600727|NCT00602420|616544356|FG001|Overall Study|Withdrawal by Subject|17|||
170600728|NCT00602420|616544355|FG000|Overall Study|Adverse Event|1|||
170813055|NCT01853384|617324135|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
170600729|NCT00602420|616544356|FG001|Overall Study|Adverse Event|0|||
170600730|NCT02315560|616544357|FG000|Overall Study|noncompliance by subjects|3|||
170600731|NCT02008227|616544358|FG000|Overall Study|Lost to Follow-up|7|||
170600732|NCT02008227|616544359|FG001|Overall Study|Lost to Follow-up|9|||
170600733|NCT02008227|616544358|FG000|Overall Study|Death|494|||
170600734|NCT02008227|616544359|FG001|Overall Study|Death|485|||
170600735|NCT02008227|616544358|FG000|Overall Study|Withdrawal by Subject|67|||
170813056|NCT01853384|617324136|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
170600736|NCT02008227|616544359|FG001|Overall Study|Withdrawal by Subject|36|||
170600737|NCT02008227|616544358|FG000|Overall Study|Study Terminated By Sponsor|44|||
170600738|NCT02008227|616544359|FG001|Overall Study|Study Terminated By Sponsor|83|||
170600739|NCT03221842|616544367|FG000|Period 1 (Open-label)|Adverse Event|4|||
170600740|NCT03221842|616544368|FG001|Period 1 (Open-label)|Adverse Event|0|||
170600741|NCT03221842|616544367|FG000|Period 1 (Open-label)|Physician Decision|2|||
170600742|NCT03221842|616544368|FG001|Period 1 (Open-label)|Physician Decision|0|||
170600743|NCT03221842|616544367|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
170813057|NCT01853384|617324135|FG000|Completed Follow up Visit 2|Death|1|||
170600744|NCT03221842|616544368|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
170600745|NCT03221842|616544367|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
170600746|NCT03221842|616544368|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
170600747|NCT03221842|616544367|FG000|Period 1 (Open-label)|Other|2|||
170600748|NCT03221842|616544368|FG001|Period 1 (Open-label)|Other|0|||
170813058|NCT01853384|617324136|FG001|Completed Follow up Visit 2|Death|0|||
170600749|NCT03221842|616544367|FG000|Period 2 (Randomized, Blinded)|Death|0|||
170600750|NCT03221842|616544368|FG001|Period 2 (Randomized, Blinded)|Death|1|||
170600751|NCT03221842|616544367|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
170600752|NCT03221842|616544368|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
170600753|NCT00387725|616544369|FG000|Overall Study|Adverse Event|0|||
170600754|NCT00387725|616544370|FG001|Overall Study|Adverse Event|0|||
170600755|NCT00387725|616544371|FG002|Overall Study|Adverse Event|0|||
170600756|NCT00387725|616544372|FG003|Overall Study|Adverse Event|1|||
170600757|NCT00387725|616544369|FG000|Overall Study|Protocol Violation|0|||
170600758|NCT00387725|616544370|FG001|Overall Study|Protocol Violation|1|||
170600759|NCT00387725|616544371|FG002|Overall Study|Protocol Violation|0|||
170600760|NCT00387725|616544372|FG003|Overall Study|Protocol Violation|0|||
170600761|NCT00387725|616544369|FG000|Overall Study|Withdrawal by Subject|1|||
170600762|NCT00387725|616544370|FG001|Overall Study|Withdrawal by Subject|0|||
170600763|NCT00387725|616544371|FG002|Overall Study|Withdrawal by Subject|1|||
170600764|NCT00387725|616544372|FG003|Overall Study|Withdrawal by Subject|0|||
170600765|NCT00387725|616544369|FG000|Overall Study|Parent/legal guardian request|0|||
170600766|NCT00387725|616544370|FG001|Overall Study|Parent/legal guardian request|0|||
170600767|NCT00387725|616544371|FG002|Overall Study|Parent/legal guardian request|1|||
170600768|NCT00387725|616544372|FG003|Overall Study|Parent/legal guardian request|1|||
170600769|NCT00568126|616544373|FG000|Overall Study|Adverse Event|3|||
170600770|NCT00568126|616544374|FG001|Overall Study|Adverse Event|0|||
170600771|NCT00568126|616544373|FG000|Overall Study|Withdrawal by Subject|2|||
170600772|NCT00568126|616544374|FG001|Overall Study|Withdrawal by Subject|3|||
170600773|NCT00568126|616544373|FG000|Overall Study|Lost to Follow-up|4|||
170600774|NCT00568126|616544374|FG001|Overall Study|Lost to Follow-up|3|||
170600775|NCT00568126|616544373|FG000|Overall Study|Lack of Efficacy|0|||
170600776|NCT00568126|616544374|FG001|Overall Study|Lack of Efficacy|1|||
170600777|NCT00568126|616544373|FG000|Overall Study|Physician Decision|2|||
170600778|NCT00568126|616544374|FG001|Overall Study|Physician Decision|2|||
170600779|NCT02615691|616544377|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
170600780|NCT02615691|616544377|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
170600781|NCT02615691|616544377|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
170600782|NCT02615691|616544377|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
170600783|NCT00881504|616544378|FG000|Overall Study|Withdrawal by Subject|1|||
170600784|NCT01272869|616544379|FG000|Period 2 (14 Days)|Adverse Event|1|||
170600785|NCT01272869|616544380|FG001|Period 2 (14 Days)|Adverse Event|0|||
170600786|NCT02271945|616544381|FG000|Overall Study|Death|3|||
170600787|NCT02271945|616544382|FG001|Overall Study|Death|3|||
170600788|NCT02271945|616544381|FG000|Overall Study|Withdrawal by Subject|1|||
170600789|NCT02271945|616544382|FG001|Overall Study|Withdrawal by Subject|1|||
170600790|NCT02271945|616544381|FG000|Overall Study|Other|1|||
170600791|NCT02271945|616544382|FG001|Overall Study|Other|1|||
170600792|NCT00615030|616544383|FG000|Period I|Administrative problem|0|||
170600793|NCT00615030|616544384|FG001|Period I|Administrative problem|0|||
170600794|NCT00615030|616544385|FG002|Period I|Administrative problem|0|||
170600795|NCT00615030|616544386|FG003|Period I|Administrative problem|0|||
170600796|NCT00615030|616544387|FG004|Period I|Administrative problem|1|||
170600797|NCT00615030|616544388|FG005|Period I|Administrative problem|0|||
170600798|NCT00615030|616544389|FG006|Period I|Administrative problem|0|||
170600799|NCT00615030|616544390|FG007|Period I|Administrative problem|0|||
170600800|NCT00615030|616544391|FG008|Period I|Administrative problem|0|||
170600801|NCT00615030|616544392|FG009|Period I|Administrative problem|0|||
170600802|NCT00615030|616544393|FG010|Period I|Administrative problem|0|||
170600803|NCT00615030|616544394|FG011|Period I|Administrative problem|0|||
170600804|NCT00615030|616544383|FG000|Period I|Protocol deviation|1|||
170600805|NCT00615030|616544384|FG001|Period I|Protocol deviation|0|||
170600806|NCT00615030|616544385|FG002|Period I|Protocol deviation|0|||
170600807|NCT00615030|616544386|FG003|Period I|Protocol deviation|0|||
170600808|NCT00615030|616544387|FG004|Period I|Protocol deviation|0|||
170600809|NCT00615030|616544388|FG005|Period I|Protocol deviation|0|||
170600810|NCT00615030|616544389|FG006|Period I|Protocol deviation|0|||
170600811|NCT00615030|616544390|FG007|Period I|Protocol deviation|0|||
170600812|NCT00615030|616544391|FG008|Period I|Protocol deviation|0|||
170813059|NCT01853384|617324135|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
170813060|NCT01853384|617324136|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
170813061|NCT05124210|617324137|FG000|Overall Study|Lost to Follow-up|1|||
170813062|NCT05124210|617324138|FG001|Overall Study|Lost to Follow-up|0|||
170813063|NCT05124210|617324137|FG000|Overall Study|Withdrawal by Subject|1|||
170813064|NCT05124210|617324138|FG001|Overall Study|Withdrawal by Subject|0|||
170813065|NCT00638456|617324139|FG000|Overall Study|Withdrawal by Subject|6|||
170813066|NCT00638456|617324140|FG001|Overall Study|Withdrawal by Subject|2|||
170813067|NCT04803734|617324141|FG000|Overall Study|Withdrawal by Subject|0|||
170813068|NCT04803734|617324142|FG001|Overall Study|Withdrawal by Subject|1|||
170600813|NCT00615030|616544392|FG009|Period I|Protocol deviation|0|||
170600814|NCT00615030|616544393|FG010|Period I|Protocol deviation|0|||
170600815|NCT00615030|616544394|FG011|Period I|Protocol deviation|0|||
170600816|NCT00615030|616544383|FG000|Period I|Subject withdrew consent|0|||
170600817|NCT00615030|616544384|FG001|Period I|Subject withdrew consent|0|||
170600818|NCT00615030|616544385|FG002|Period I|Subject withdrew consent|0|||
170600819|NCT00615030|616544386|FG003|Period I|Subject withdrew consent|0|||
170913807|NCT00090285|617687650|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
170913808|NCT00090285|617687651|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
170913809|NCT00090285|617687652|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
170913810|NCT00090285|617687647|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
170913811|NCT00090285|617687648|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
170913812|NCT00090285|617687649|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
170913813|NCT00090285|617687650|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
170913814|NCT00090285|617687651|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
170913815|NCT00090285|617687652|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
170913816|NCT00090285|617687647|FG000|Base Study Follow-up Period|Moved|41|||
170913817|NCT00090285|617687648|FG001|Base Study Follow-up Period|Moved|36|||
170913818|NCT00090285|617687649|FG002|Base Study Follow-up Period|Moved|0|||
170913819|NCT00090285|617687650|FG003|Base Study Follow-up Period|Moved|0|||
170913820|NCT00090285|617687651|FG004|Base Study Follow-up Period|Moved|0|||
170600820|NCT00615030|616544387|FG004|Period I|Subject withdrew consent|0|||
170600821|NCT00615030|616544388|FG005|Period I|Subject withdrew consent|0|||
170600822|NCT00615030|616544389|FG006|Period I|Subject withdrew consent|0|||
170600823|NCT00615030|616544390|FG007|Period I|Subject withdrew consent|0|||
170600824|NCT00615030|616544391|FG008|Period I|Subject withdrew consent|1|||
170600825|NCT00615030|616544392|FG009|Period I|Subject withdrew consent|0|||
170600826|NCT00615030|616544393|FG010|Period I|Subject withdrew consent|1|||
170600827|NCT00615030|616544394|FG011|Period I|Subject withdrew consent|1|||
170600828|NCT00615030|616544383|FG000|Period I|Abnormal laboratory value(s)|0|||
170600829|NCT00615030|616544384|FG001|Period I|Abnormal laboratory value(s)|0|||
170600830|NCT00615030|616544385|FG002|Period I|Abnormal laboratory value(s)|0|||
170600831|NCT00615030|616544386|FG003|Period I|Abnormal laboratory value(s)|0|||
170600832|NCT00615030|616544387|FG004|Period I|Abnormal laboratory value(s)|0|||
170600833|NCT00615030|616544388|FG005|Period I|Abnormal laboratory value(s)|1|||
170600834|NCT00615030|616544389|FG006|Period I|Abnormal laboratory value(s)|0|||
170600835|NCT00615030|616544390|FG007|Period I|Abnormal laboratory value(s)|0|||
170600836|NCT00615030|616544391|FG008|Period I|Abnormal laboratory value(s)|0|||
170600837|NCT00615030|616544392|FG009|Period I|Abnormal laboratory value(s)|0|||
170600838|NCT00615030|616544393|FG010|Period I|Abnormal laboratory value(s)|0|||
170600839|NCT00615030|616544394|FG011|Period I|Abnormal laboratory value(s)|0|||
170600840|NCT00615030|616544383|FG000|Period II|Adverse Event|0|||
170600841|NCT00615030|616544384|FG001|Period II|Adverse Event|0|||
170600842|NCT00615030|616544385|FG002|Period II|Adverse Event|1|||
170600843|NCT00615030|616544386|FG003|Period II|Adverse Event|0|||
170600844|NCT00615030|616544387|FG004|Period II|Adverse Event|0|||
170600845|NCT00615030|616544388|FG005|Period II|Adverse Event|0|||
170600846|NCT00615030|616544389|FG006|Period II|Adverse Event|0|||
170600847|NCT00615030|616544390|FG007|Period II|Adverse Event|0|||
170600848|NCT00615030|616544391|FG008|Period II|Adverse Event|1|||
170600849|NCT00615030|616544392|FG009|Period II|Adverse Event|0|||
170600850|NCT00615030|616544393|FG010|Period II|Adverse Event|0|||
170600851|NCT00615030|616544394|FG011|Period II|Adverse Event|0|||
170600852|NCT00615030|616544383|FG000|Period II|Subject withdrew consent|0|||
170600853|NCT00615030|616544384|FG001|Period II|Subject withdrew consent|0|||
170600854|NCT00615030|616544385|FG002|Period II|Subject withdrew consent|0|||
170600855|NCT00615030|616544386|FG003|Period II|Subject withdrew consent|1|||
170600856|NCT00615030|616544387|FG004|Period II|Subject withdrew consent|0|||
170651930|NCT01931670|616740011|FG001|Treatment Period|Pregnancy|2|||
170651931|NCT01931670|616740012|FG002|Treatment Period|Pregnancy|0|||
170651932|NCT01931670|616740010|FG000|Treatment Period|Other|8|||
170651933|NCT01931670|616740011|FG001|Treatment Period|Other|7|||
170651934|NCT01931670|616740012|FG002|Treatment Period|Other|2|||
170651935|NCT01931670|616740010|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
170651936|NCT01931670|616740011|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
170651937|NCT01931670|616740012|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
170651938|NCT01931670|616740010|FG000|Treatment Period|Lost to Follow-up|19|||
170651939|NCT01931670|616740011|FG001|Treatment Period|Lost to Follow-up|5|||
170651940|NCT01931670|616740012|FG002|Treatment Period|Lost to Follow-up|7|||
170651941|NCT01931670|616740010|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
170651942|NCT01931670|616740011|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
170913821|NCT00090285|617687652|FG005|Base Study Follow-up Period|Moved|0|||
170913822|NCT00090285|617687647|FG000|Base Study Follow-up Period|Other|2|||
170600857|NCT00615030|616544388|FG005|Period II|Subject withdrew consent|0|||
170600858|NCT00615030|616544389|FG006|Period II|Subject withdrew consent|1|||
170600859|NCT00615030|616544390|FG007|Period II|Subject withdrew consent|0|||
170913823|NCT00090285|617687648|FG001|Base Study Follow-up Period|Other|0|||
170600860|NCT00615030|616544391|FG008|Period II|Subject withdrew consent|0|||
170600861|NCT00615030|616544392|FG009|Period II|Subject withdrew consent|0|||
170600862|NCT00615030|616544393|FG010|Period II|Subject withdrew consent|0|||
170600863|NCT00615030|616544394|FG011|Period II|Subject withdrew consent|0|||
170600864|NCT00615030|616544383|FG000|Period III|Administrative problems|1|||
170600865|NCT00615030|616544384|FG001|Period III|Administrative problems|0|||
170651943|NCT01931670|616740012|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
170600866|NCT00615030|616544385|FG002|Period III|Administrative problems|0|||
170600867|NCT00615030|616544386|FG003|Period III|Administrative problems|1|||
170600868|NCT00615030|616544387|FG004|Period III|Administrative problems|0|||
170600869|NCT00615030|616544388|FG005|Period III|Administrative problems|0|||
170600870|NCT00615030|616544389|FG006|Period III|Administrative problems|0|||
170600871|NCT00615030|616544390|FG007|Period III|Administrative problems|0|||
170600872|NCT00615030|616544391|FG008|Period III|Administrative problems|0|||
170600873|NCT00615030|616544392|FG009|Period III|Administrative problems|0|||
170600874|NCT00615030|616544393|FG010|Period III|Administrative problems|0|||
170600875|NCT00615030|616544394|FG011|Period III|Administrative problems|0|||
170600876|NCT00308074|616544397|FG000|Overall Study|Withdrawal by Subject|1|||
170600877|NCT03002311|616544398|FG000|Overall Study|Lost to Follow-up|13|||
170600878|NCT03002311|616544399|FG001|Overall Study|Lost to Follow-up|26|||
170600879|NCT03002311|616544398|FG000|Overall Study|Referral provider called to schedule app|3|||
170600880|NCT03002311|616544399|FG001|Overall Study|Referral provider called to schedule app|3|||
170600881|NCT03002311|616544398|FG000|Overall Study|Physician Decision|3|||
170600882|NCT03002311|616544399|FG001|Overall Study|Physician Decision|1|||
170600883|NCT02704689|616544400|FG000|Overall Study|Physician Decision|1|||
170600884|NCT02704689|616544400|FG000|Overall Study|Study device not implanted|2|||
170600885|NCT05194267|616544403|FG000|Overall Study|Withdrawal by Subject|2|||
170600886|NCT01329939|616544404|FG000|Overall Study|Lost to Follow-up|3|||
170600887|NCT01329939|616544405|FG001|Overall Study|Lost to Follow-up|0|||
170600888|NCT01329939|616544406|FG002|Overall Study|Lost to Follow-up|1|||
170600889|NCT01329939|616544407|FG003|Overall Study|Lost to Follow-up|2|||
170600890|NCT01329939|616544404|FG000|Overall Study|Withdrawal by Subject|0|||
170600891|NCT01329939|616544405|FG001|Overall Study|Withdrawal by Subject|1|||
170600892|NCT01329939|616544406|FG002|Overall Study|Withdrawal by Subject|0|||
170600893|NCT01329939|616544407|FG003|Overall Study|Withdrawal by Subject|0|||
170600894|NCT01329939|616544404|FG000|Overall Study|Adverse Event|0|||
170600895|NCT01329939|616544405|FG001|Overall Study|Adverse Event|0|||
170600896|NCT01329939|616544406|FG002|Overall Study|Adverse Event|0|||
170600897|NCT01329939|616544407|FG003|Overall Study|Adverse Event|3|||
170600898|NCT01079936|616544409|FG000|Phase I: MTD|First Remission Status|2|||
170600899|NCT01079936|616544410|FG001|Phase I: MTD|First Remission Status|0|||
170600900|NCT01079936|616544411|FG002|Phase I: MTD|First Remission Status|0|||
170600901|NCT01079936|616544412|FG003|Phase I: MTD|First Remission Status|0|||
170600902|NCT01079936|616544413|FG004|Phase I: MTD|First Remission Status|0|||
170600903|NCT01079936|616544409|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
170600904|NCT01079936|616544410|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
170600905|NCT01079936|616544411|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
170913824|NCT00090285|617687649|FG002|Base Study Follow-up Period|Other|0|||
170913825|NCT00090285|617687650|FG003|Base Study Follow-up Period|Other|0|||
170913826|NCT00090285|617687651|FG004|Base Study Follow-up Period|Other|0|||
170913827|NCT00090285|617687652|FG005|Base Study Follow-up Period|Other|0|||
170913828|NCT00090285|617687647|FG000|Base Study Follow-up Period|Protocol Violation|1|||
170913829|NCT00090285|617687648|FG001|Base Study Follow-up Period|Protocol Violation|0|||
170913830|NCT00090285|617687649|FG002|Base Study Follow-up Period|Protocol Violation|0|||
170913831|NCT00090285|617687650|FG003|Base Study Follow-up Period|Protocol Violation|0|||
170913832|NCT00090285|617687651|FG004|Base Study Follow-up Period|Protocol Violation|0|||
170913833|NCT00090285|617687652|FG005|Base Study Follow-up Period|Protocol Violation|0|||
170913834|NCT00090285|617687647|FG000|Base Study Follow-up Period|Uncooperative|3|||
170913835|NCT00090285|617687648|FG001|Base Study Follow-up Period|Uncooperative|4|||
170600906|NCT01079936|616544412|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
170600907|NCT01079936|616544413|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
170600908|NCT01079936|616544409|FG000|Phase II|Adverse Event|0|||
170600909|NCT01079936|616544410|FG001|Phase II|Adverse Event|0|||
170600910|NCT01079936|616544411|FG002|Phase II|Adverse Event|1|||
170600911|NCT01079936|616544412|FG003|Phase II|Adverse Event|0|||
170600912|NCT01079936|616544413|FG004|Phase II|Adverse Event|0|||
170600913|NCT01079936|616544409|FG000|Phase II|Insurance Issue|0|||
170600914|NCT01079936|616544410|FG001|Phase II|Insurance Issue|0|||
170600915|NCT01079936|616544411|FG002|Phase II|Insurance Issue|0|||
170600916|NCT01079936|616544412|FG003|Phase II|Insurance Issue|0|||
170600917|NCT01079936|616544413|FG004|Phase II|Insurance Issue|1|||
170600918|NCT02322190|616544414|FG000|Overall Study|Death on study|1|||
170600919|NCT02322190|616544415|FG001|Overall Study|Death on study|0|||
170600920|NCT02294734|616544416|FG000|Overall Study|Adverse Event|5|||
170600921|NCT02294734|616544417|FG001|Overall Study|Adverse Event|5|||
170600922|NCT02294734|616544416|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
170600923|NCT02294734|616544417|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
170600924|NCT02294734|616544416|FG000|Overall Study|Lost to Follow-up|2|||
170600925|NCT02294734|616544417|FG001|Overall Study|Lost to Follow-up|0|||
170600926|NCT02294734|616544416|FG000|Overall Study|Physician Decision|2|||
170600927|NCT02294734|616544417|FG001|Overall Study|Physician Decision|1|||
170600928|NCT02294734|616544416|FG000|Overall Study|Withdrawal by Subject|4|||
170913836|NCT00090285|617687649|FG002|Base Study Follow-up Period|Uncooperative|0|||
170600929|NCT02294734|616544417|FG001|Overall Study|Withdrawal by Subject|2|||
170600930|NCT03344640|616544418|FG000|Overall Study|Adverse Event|1|||
170600931|NCT03344640|616544419|FG001|Overall Study|Adverse Event|0|||
170600932|NCT03344640|616544418|FG000|Overall Study|Physician Decision|1|||
170600933|NCT03344640|616544419|FG001|Overall Study|Physician Decision|1|||
170600934|NCT03344640|616544418|FG000|Overall Study|Withdrawal by Subject|1|||
170600935|NCT03344640|616544419|FG001|Overall Study|Withdrawal by Subject|2|||
170600936|NCT03344640|616544418|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
170600937|NCT03344640|616544419|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
170600938|NCT00548717|616544420|FG000|Overall Study|Death|5|||
170600939|NCT00548717|616544421|FG001|Overall Study|Death|2|||
170600940|NCT00548717|616544420|FG000|Overall Study|Relapse|3|||
170600941|NCT00548717|616544421|FG001|Overall Study|Relapse|0|||
170600942|NCT00548717|616544420|FG000|Overall Study|Alternative treatment for GVHD|1|||
170600943|NCT00548717|616544421|FG001|Overall Study|Alternative treatment for GVHD|0|||
170600944|NCT01943552|616544422|FG000|Overall Study|Adverse Event|3|||
170600945|NCT01943552|616544423|FG001|Overall Study|Adverse Event|2|||
170600946|NCT01943552|616544422|FG000|Overall Study|Withdrawal by Subject|6|||
170600947|NCT01943552|616544423|FG001|Overall Study|Withdrawal by Subject|6|||
170600948|NCT01943552|616544422|FG000|Overall Study|Other Reasons|16|||
170600949|NCT01943552|616544423|FG001|Overall Study|Other Reasons|17|||
170600950|NCT02445573|616544424|FG000|Overall Study|Withdrawal by Subject|1|||
170600951|NCT02445573|616544425|FG001|Overall Study|Withdrawal by Subject|1|||
170600952|NCT02445573|616544424|FG000|Overall Study|Lost to Follow-up|0|||
170600953|NCT02445573|616544425|FG001|Overall Study|Lost to Follow-up|1|||
170600954|NCT01475162|616544426|FG000|Overall Study|Physician Decision|1|||
170600955|NCT01475162|616544426|FG000|Overall Study|Death|10|||
170600956|NCT01475162|616544426|FG000|Overall Study|Study closed for safety|3|||
170600957|NCT00908037|616544427|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600958|NCT00908037|616544428|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600959|NCT00908037|616544429|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600960|NCT00908037|616544430|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600961|NCT00908037|616544431|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
170600962|NCT00908037|616544432|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600963|NCT00908037|616544433|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
170600964|NCT00908037|616544434|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600965|NCT00908037|616544435|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
170600966|NCT00908037|616544436|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600967|NCT00908037|616544437|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600968|NCT00908037|616544438|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
170600969|NCT00908037|616544427|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600970|NCT00908037|616544428|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600971|NCT00908037|616544429|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600972|NCT00908037|616544430|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600973|NCT00908037|616544431|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
170600974|NCT00908037|616544432|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600975|NCT00908037|616544433|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600976|NCT00908037|616544434|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600977|NCT00908037|616544435|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
170600978|NCT00908037|616544436|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600979|NCT00908037|616544437|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600980|NCT00908037|616544438|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
170600981|NCT00908037|616544427|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600982|NCT00908037|616544428|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600983|NCT00908037|616544429|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600984|NCT00908037|616544430|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
170600985|NCT00908037|616544431|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600986|NCT00908037|616544432|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600987|NCT00908037|616544433|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
170600988|NCT00908037|616544434|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600989|NCT00908037|616544435|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600990|NCT00908037|616544436|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600991|NCT00908037|616544437|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170813069|NCT04803734|617324141|FG000|Overall Study|Protocol Violation|0|||
170813070|NCT04803734|617324142|FG001|Overall Study|Protocol Violation|1|||
170813071|NCT04328467|617324143|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
170813072|NCT04328467|617324144|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
170813073|NCT04328467|617324145|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
170813074|NCT02753075|617324153|FG000|Overall Study|Adverse Event|2|||
170813075|NCT02753075|617324154|FG001|Overall Study|Adverse Event|1|||
170813076|NCT02753075|617324155|FG002|Overall Study|Adverse Event|0|||
170813077|NCT02753075|617324153|FG000|Overall Study|Lost to Follow-up|2|||
170813078|NCT02753075|617324154|FG001|Overall Study|Lost to Follow-up|0|||
170813079|NCT02753075|617324155|FG002|Overall Study|Lost to Follow-up|0|||
170813080|NCT02753075|617324153|FG000|Overall Study|Withdrawal of Consent|1|||
170813081|NCT02753075|617324154|FG001|Overall Study|Withdrawal of Consent|1|||
170813082|NCT02753075|617324155|FG002|Overall Study|Withdrawal of Consent|3|||
170813083|NCT02753075|617324153|FG000|Overall Study|Physician Decision|3|||
170813084|NCT02753075|617324154|FG001|Overall Study|Physician Decision|1|||
170813085|NCT02753075|617324155|FG002|Overall Study|Physician Decision|0|||
170813086|NCT01393600|617324156|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
170813087|NCT01393600|617324157|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
170813088|NCT01393600|617324158|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
170813089|NCT01393600|617324159|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
170813090|NCT01393600|617324156|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
170813091|NCT01393600|617324157|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
170813092|NCT01393600|617324158|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
170913837|NCT00090285|617687650|FG003|Base Study Follow-up Period|Uncooperative|0|||
170600992|NCT00908037|616544438|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
170600993|NCT00908037|616544427|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170600994|NCT00908037|616544428|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170600995|NCT00908037|616544429|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170600996|NCT00908037|616544430|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170600997|NCT00908037|616544431|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170600998|NCT00908037|616544432|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170600999|NCT00908037|616544433|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170601000|NCT00908037|616544434|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170601001|NCT00908037|616544435|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170601002|NCT00908037|616544436|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170601003|NCT00908037|616544437|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
170601004|NCT00908037|616544438|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
170601005|NCT00908037|616544427|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601006|NCT00908037|616544428|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601007|NCT00908037|616544429|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601008|NCT00908037|616544430|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601009|NCT00908037|616544431|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601010|NCT00908037|616544432|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601011|NCT00908037|616544433|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601012|NCT00908037|616544434|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601013|NCT00908037|616544435|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601014|NCT00908037|616544436|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
170601015|NCT00908037|616544437|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
170601016|NCT00908037|616544438|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
170601017|NCT00908037|616544427|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601018|NCT00908037|616544428|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601019|NCT00908037|616544429|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601020|NCT00908037|616544430|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601021|NCT00908037|616544431|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601022|NCT00908037|616544432|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601023|NCT00908037|616544433|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601024|NCT00908037|616544434|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601025|NCT00908037|616544435|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601026|NCT00908037|616544436|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
170601027|NCT00908037|616544437|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170813093|NCT01393600|617324159|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
170813094|NCT01393600|617324156|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
170813095|NCT01393600|617324157|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
170813096|NCT01393600|617324158|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
170813097|NCT01393600|617324159|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
170913838|NCT00090285|617687651|FG004|Base Study Follow-up Period|Uncooperative|0|||
170651944|NCT01931670|616740010|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
170651945|NCT01931670|616740011|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
170813098|NCT01393600|617324156|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
170813099|NCT01393600|617324157|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
170813100|NCT01393600|617324158|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
170813101|NCT01393600|617324159|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
170601028|NCT00908037|616544438|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
170601029|NCT00908037|616544427|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601030|NCT00908037|616544428|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601031|NCT00908037|616544429|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601032|NCT00908037|616544430|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601033|NCT00908037|616544431|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601034|NCT00908037|616544432|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601035|NCT00908037|616544433|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601036|NCT00908037|616544434|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601037|NCT00908037|616544435|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601038|NCT00908037|616544436|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601039|NCT00908037|616544437|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
170601040|NCT00908037|616544438|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
170601041|NCT00908037|616544427|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601042|NCT00908037|616544428|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601043|NCT00908037|616544429|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601044|NCT00908037|616544430|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601045|NCT00908037|616544431|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601046|NCT00908037|616544432|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601047|NCT00908037|616544433|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601048|NCT00908037|616544434|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601049|NCT00908037|616544435|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601050|NCT00908037|616544436|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
170601051|NCT00908037|616544437|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601052|NCT00908037|616544438|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
170601053|NCT00908037|616544427|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601054|NCT00908037|616544428|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601055|NCT00908037|616544429|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601056|NCT00908037|616544430|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601057|NCT00908037|616544431|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601058|NCT00908037|616544432|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601059|NCT00908037|616544433|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170651946|NCT01931670|616740012|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
170651947|NCT01931670|616740010|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
170651948|NCT01931670|616740011|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
170651949|NCT01931670|616740012|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
170651950|NCT01931670|616740010|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
170651951|NCT01931670|616740011|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
170651952|NCT01931670|616740012|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
170651953|NCT01931670|616740010|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
170651954|NCT01931670|616740011|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
170651955|NCT01931670|616740012|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
170651956|NCT01931670|616740010|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
170651957|NCT01931670|616740011|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
170651958|NCT01931670|616740012|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
170651959|NCT00976508|616740014|FG000|Overall Study|Death|7|||
170651960|NCT00976508|616740015|FG001|Overall Study|Death|1|||
170651961|NCT00976508|616740014|FG000|Overall Study|Lost to Follow-up|1|||
170651962|NCT00976508|616740015|FG001|Overall Study|Lost to Follow-up|0|||
170651963|NCT00976508|616740014|FG000|Overall Study|Withdrawal by Subject|1|||
170651964|NCT00976508|616740015|FG001|Overall Study|Withdrawal by Subject|0|||
170651965|NCT00976508|616740014|FG000|Overall Study|Disease Progression|4|||
170651966|NCT00976508|616740015|FG001|Overall Study|Disease Progression|4|||
170813102|NCT01393600|617324156|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
170813103|NCT01393600|617324157|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
170813104|NCT01393600|617324158|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
170813105|NCT01393600|617324159|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
170813106|NCT01393600|617324156|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
170813107|NCT01393600|617324157|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
170813108|NCT01393600|617324158|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
170813109|NCT01393600|617324159|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
170813110|NCT01393600|617324156|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
170813111|NCT01393600|617324157|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
170813112|NCT01393600|617324158|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
170813113|NCT01393600|617324159|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
170813114|NCT00889863|617324163|FG000|Part I: Open Label|Death|1|||
170813115|NCT00889863|617324164|FG001|Part I: Open Label|Death|0|||
170601060|NCT00908037|616544434|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601061|NCT00908037|616544435|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601062|NCT00908037|616544436|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601063|NCT00908037|616544437|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
170601064|NCT00908037|616544438|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
170601065|NCT04268173|616544439|FG000|Overall Study|Lost to Follow-up|75|||
170601066|NCT04268173|616544440|FG001|Overall Study|Lost to Follow-up|108|||
170601067|NCT01147900|616544441|FG000|At Year 10|Lost to Follow-up|0|||
170601068|NCT01147900|616544442|FG001|At Year 10|Lost to Follow-up|1|||
170601069|NCT01147900|616544443|FG002|At Year 10|Lost to Follow-up|0|||
170601070|NCT05026853|616544445|FG000|Overall Study|Cancelled appointment|1|||
170601071|NCT05026853|616544446|FG001|Overall Study|Cancelled appointment|0|||
170601072|NCT05026853|616544445|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
170601073|NCT05026853|616544446|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
170601074|NCT05026853|616544445|FG000|Overall Study|Did not complete 12-week survey|16|||
170601075|NCT05026853|616544446|FG001|Overall Study|Did not complete 12-week survey|16|||
170601076|NCT02723175|616544451|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
170601077|NCT02723175|616544452|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
170601078|NCT02723175|616544451|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
170601079|NCT02723175|616544452|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
170601080|NCT03233438|616544453|FG000|Overall Study|Lost to Follow-up|4|||
170601081|NCT03233438|616544454|FG001|Overall Study|Lost to Follow-up|9|||
170601082|NCT03233438|616544453|FG000|Overall Study|Withdrawal by Subject|2|||
170651967|NCT00976508|616740014|FG000|Overall Study|Subject Enrolled in Hospice|1|||
170651968|NCT00976508|616740015|FG001|Overall Study|Subject Enrolled in Hospice|0|||
170651969|NCT00976508|616740014|FG000|Overall Study|Terminated by the Sponsor|0|||
170651970|NCT00976508|616740015|FG001|Overall Study|Terminated by the Sponsor|1|||
170651971|NCT04352127|616740016|FG000|Overall Study|Unable to obtain readings|4|||
170651972|NCT04352127|616740017|FG001|Overall Study|Unable to obtain readings|1|||
170651973|NCT01992159|616740018|FG000|Overall Study|Withdrawal by Subject|4|||
170651974|NCT01992159|616740019|FG001|Overall Study|Withdrawal by Subject|7|||
170651975|NCT01992159|616740020|FG002|Overall Study|Withdrawal by Subject|0|||
170651976|NCT01992159|616740021|FG003|Overall Study|Withdrawal by Subject|3|||
170651977|NCT01992159|616740018|FG000|Overall Study|Adverse Event|0|||
170651978|NCT01992159|616740019|FG001|Overall Study|Adverse Event|1|||
170651979|NCT01992159|616740020|FG002|Overall Study|Adverse Event|0|||
170651980|NCT01992159|616740021|FG003|Overall Study|Adverse Event|1|||
170651981|NCT01992159|616740018|FG000|Overall Study|Death|0|||
170651982|NCT01992159|616740019|FG001|Overall Study|Death|0|||
170651983|NCT01992159|616740020|FG002|Overall Study|Death|1|||
170651984|NCT01992159|616740021|FG003|Overall Study|Death|0|||
170651985|NCT03023046|616740024|FG000|Overall Study|Withdrawal by Subject|1|||
170651986|NCT00640835|616740027|FG000|Overall Study|Adverse Event|5|||
170651987|NCT00640835|616740028|FG001|Overall Study|Adverse Event|3|||
170651988|NCT00640835|616740027|FG000|Overall Study|Withdrawal by Subject|12|||
170651989|NCT00640835|616740028|FG001|Overall Study|Withdrawal by Subject|14|||
170651990|NCT00640835|616740027|FG000|Overall Study|Physician Decision|10|||
170651991|NCT00640835|616740028|FG001|Overall Study|Physician Decision|14|||
170651992|NCT00640835|616740027|FG000|Overall Study|Sponsor's Decision|11|||
170651993|NCT00640835|616740028|FG001|Overall Study|Sponsor's Decision|7|||
170651994|NCT00640835|616740027|FG000|Overall Study|Protocol Violation|2|||
170651995|NCT00640835|616740028|FG001|Overall Study|Protocol Violation|2|||
170651996|NCT00640835|616740027|FG000|Overall Study|Lost to Follow-up|17|||
170651997|NCT00640835|616740028|FG001|Overall Study|Lost to Follow-up|13|||
170651998|NCT00640835|616740027|FG000|Overall Study|Other Reason|19|||
170651999|NCT00640835|616740028|FG001|Overall Study|Other Reason|4|||
170652000|NCT00470158|616740029|FG000|Overall Study|Death|0|||
170652001|NCT00470158|616740030|FG001|Overall Study|Death|0|||
170652002|NCT00470158|616740031|FG002|Overall Study|Death|0|||
170652003|NCT00470158|616740032|FG003|Overall Study|Death|0|||
170652004|NCT00470158|616740033|FG004|Overall Study|Death|2|||
170813116|NCT00889863|617324163|FG000|Part I: Open Label|Adverse Event|4|||
170813117|NCT00889863|617324164|FG001|Part I: Open Label|Adverse Event|0|||
170813118|NCT00889863|617324163|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
170601083|NCT03233438|616544454|FG001|Overall Study|Withdrawal by Subject|1|||
170652005|NCT00470158|616740029|FG000|Overall Study|Lost to Follow-up|7|||
170652006|NCT00470158|616740030|FG001|Overall Study|Lost to Follow-up|8|||
170652007|NCT00470158|616740031|FG002|Overall Study|Lost to Follow-up|8|||
170652008|NCT00470158|616740032|FG003|Overall Study|Lost to Follow-up|5|||
170652009|NCT00470158|616740033|FG004|Overall Study|Lost to Follow-up|4|||
170652010|NCT00470158|616740029|FG000|Overall Study|Protocol Violation|1|||
170652011|NCT00470158|616740030|FG001|Overall Study|Protocol Violation|0|||
170652012|NCT00470158|616740031|FG002|Overall Study|Protocol Violation|0|||
170813119|NCT00889863|617324164|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
170813120|NCT00889863|617324163|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
170813121|NCT00889863|617324164|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
170813122|NCT00889863|617324163|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
170813123|NCT00889863|617324164|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
170601084|NCT03233438|616544453|FG000|Overall Study|No recording of dalbavancin|0|||
170601085|NCT03233438|616544454|FG001|Overall Study|No recording of dalbavancin|1|||
170601086|NCT00025155|616544458|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
170601087|NCT00025155|616544458|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
170601088|NCT00413374|616544459|FG000|Overall Study|Ineligible due to screening criteria.|3|||
170601089|NCT00413374|616544460|FG001|Overall Study|Ineligible due to screening criteria.|0|||
170601090|NCT00413374|616544459|FG000|Overall Study|Adverse Event|1|||
170601091|NCT00413374|616544460|FG001|Overall Study|Adverse Event|0|||
170601092|NCT00413374|616544459|FG000|Overall Study|Lost to Follow-up|1|||
170601093|NCT00413374|616544460|FG001|Overall Study|Lost to Follow-up|0|||
170601094|NCT00413374|616544459|FG000|Overall Study|Surgery|1|||
170601095|NCT00413374|616544460|FG001|Overall Study|Surgery|0|||
170601096|NCT00552760|616544461|FG000|Overall Study|Adverse Event|3|||
170601097|NCT00552760|616544462|FG001|Overall Study|Adverse Event|5|||
170601098|NCT00552760|616544461|FG000|Overall Study|Relapsed- Depressed Event|10|||
170601099|NCT00552760|616544462|FG001|Overall Study|Relapsed- Depressed Event|16|||
170601100|NCT00552760|616544461|FG000|Overall Study|Relapse- Manic Event|3|||
170601101|NCT00552760|616544462|FG001|Overall Study|Relapse- Manic Event|3|||
170601102|NCT00552760|616544461|FG000|Overall Study|Relapsed- Mixed Event|3|||
170601103|NCT00552760|616544462|FG001|Overall Study|Relapsed- Mixed Event|5|||
170813124|NCT00889863|617324163|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
170813125|NCT00889863|617324164|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
170601104|NCT00552760|616544461|FG000|Overall Study|Protocol Violation|0|||
170601105|NCT00552760|616544462|FG001|Overall Study|Protocol Violation|1|||
170601106|NCT00552760|616544461|FG000|Overall Study|Lost to Follow-up|1|||
170813126|NCT00889863|617324163|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
170813127|NCT00889863|617324164|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
170813128|NCT00441168|617324165|FG000|Treatment Period|Death|3|||
170813129|NCT00441168|617324166|FG001|Treatment Period|Death|0|||
170813130|NCT00441168|617324165|FG000|Treatment Period|Adverse Event|1|||
170813131|NCT00441168|617324166|FG001|Treatment Period|Adverse Event|2|||
170813132|NCT00441168|617324165|FG000|Treatment Period|Progressive Disease|0|||
170813133|NCT00441168|617324166|FG001|Treatment Period|Progressive Disease|2|||
170813134|NCT00441168|617324165|FG000|Treatment Period|Protocol Violation|0|||
170813135|NCT00441168|617324166|FG001|Treatment Period|Protocol Violation|1|||
170813136|NCT00441168|617324165|FG000|Treatment Period|Lost to Follow-up|0|||
170813137|NCT00441168|617324166|FG001|Treatment Period|Lost to Follow-up|1|||
170813138|NCT00441168|617324165|FG000|Treatment Period|Withdrawal by Subject|3|||
170813139|NCT00441168|617324166|FG001|Treatment Period|Withdrawal by Subject|0|||
170813140|NCT00441168|617324165|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
170813141|NCT00441168|617324166|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
170813142|NCT00441168|617324165|FG000|Treatment Period|refractory disease|1|||
170813143|NCT00441168|617324166|FG001|Treatment Period|refractory disease|0|||
170813144|NCT00441168|617324165|FG000|Follow-up Period|Death|3|||
170813145|NCT00441168|617324166|FG001|Follow-up Period|Death|0|||
170813146|NCT00441168|617324165|FG000|Follow-up Period|Lost to Follow-up|5|||
170813147|NCT00441168|617324166|FG001|Follow-up Period|Lost to Follow-up|6|||
170813148|NCT00441168|617324165|FG000|Follow-up Period|Withdrawal by Subject|3|||
170813149|NCT00441168|617324166|FG001|Follow-up Period|Withdrawal by Subject|0|||
170813150|NCT00441168|617324165|FG000|Follow-up Period|Other|1|||
170813151|NCT00441168|617324166|FG001|Follow-up Period|Other|3|||
170813152|NCT00988429|617324167|FG000|Overall Study|Adverse Event|9|||
170813153|NCT00988429|617324168|FG001|Overall Study|Adverse Event|21|||
170813154|NCT00988429|617324169|FG002|Overall Study|Adverse Event|45|||
170813155|NCT00988429|617324167|FG000|Overall Study|Lack of Efficacy|0|||
170813156|NCT00988429|617324168|FG001|Overall Study|Lack of Efficacy|0|||
170813157|NCT00988429|617324169|FG002|Overall Study|Lack of Efficacy|1|||
170813158|NCT00988429|617324167|FG000|Overall Study|Non-Compliance with Study Drug|5|||
170813159|NCT00988429|617324168|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170813160|NCT00988429|617324169|FG002|Overall Study|Non-Compliance with Study Drug|3|||
170813161|NCT00988429|617324167|FG000|Overall Study|Physician Decision|1|||
170813162|NCT00988429|617324168|FG001|Overall Study|Physician Decision|0|||
170813163|NCT00988429|617324169|FG002|Overall Study|Physician Decision|3|||
170813164|NCT00988429|617324167|FG000|Overall Study|Pregnancy|2|||
170601107|NCT00552760|616544462|FG001|Overall Study|Lost to Follow-up|1|||
170601108|NCT00552760|616544461|FG000|Overall Study|Non-compliance|1|||
170601109|NCT00552760|616544462|FG001|Overall Study|Non-compliance|1|||
170601110|NCT00552760|616544461|FG000|Overall Study|Medical Condition|1|||
170813165|NCT00988429|617324168|FG001|Overall Study|Pregnancy|1|||
170601111|NCT00552760|616544462|FG001|Overall Study|Medical Condition|1|||
170601112|NCT00552760|616544461|FG000|Overall Study|Withdrawal by Subject|3|||
170601113|NCT00552760|616544462|FG001|Overall Study|Withdrawal by Subject|0|||
170601114|NCT00552760|616544461|FG000|Overall Study|Medication Change|1|||
170601115|NCT00552760|616544462|FG001|Overall Study|Medication Change|0|||
170601116|NCT03022981|616544463|FG000|Overall Study|Adverse Event|0|||
170601117|NCT03022981|616544464|FG001|Overall Study|Adverse Event|1|||
170601118|NCT03022981|616544465|FG002|Overall Study|Adverse Event|0|||
170601119|NCT03022981|616544463|FG000|Overall Study|Investigator's Discretion|0|||
170601120|NCT03022981|616544464|FG001|Overall Study|Investigator's Discretion|1|||
170601121|NCT03022981|616544465|FG002|Overall Study|Investigator's Discretion|2|||
170601122|NCT03022981|616544463|FG000|Overall Study|Lost to Follow-up|6|||
170601123|NCT03022981|616544464|FG001|Overall Study|Lost to Follow-up|2|||
170601124|NCT03022981|616544465|FG002|Overall Study|Lost to Follow-up|1|||
170601125|NCT03022981|616544463|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170601126|NCT03022981|616544464|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170601127|NCT03022981|616544465|FG002|Overall Study|Non-Compliance With Study Drug|2|||
170601128|NCT03022981|616544463|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
170601129|NCT03022981|616544464|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
170601130|NCT03022981|616544465|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
170601131|NCT00094107|616544467|FG000|Overall Study|Lack of Efficacy|23|||
170601132|NCT00094107|616544467|FG000|Overall Study|Death|5|||
170601133|NCT00094107|616544467|FG000|Overall Study|Adverse Event|3|||
170601134|NCT00094107|616544467|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
170601135|NCT00494507|616544470|FG000|Double-Blind Phase|Adverse Event|2|||
170601136|NCT00494507|616544471|FG001|Double-Blind Phase|Adverse Event|0|||
170601137|NCT00494507|616544472|FG002|Double-Blind Phase|Adverse Event|1|||
170652013|NCT00470158|616740032|FG003|Overall Study|Protocol Violation|0|||
170652014|NCT00470158|616740033|FG004|Overall Study|Protocol Violation|0|||
170652015|NCT01249118|616740034|FG000|First Washout Period|Physician Decision|0|||
170652016|NCT01249118|616740035|FG001|First Washout Period|Physician Decision|1|||
170652017|NCT01249118|616740036|FG002|First Washout Period|Physician Decision|0|||
170652018|NCT00880685|616740037|FG000|Memantine 10mg|Lost to Follow-up|2|||
170652019|NCT00880685|616740037|FG000|Memantine 20mg|Withdrawal by Subject|1|||
170652020|NCT04179890|616740038|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
170652021|NCT04179890|616740039|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
170652022|NCT04179890|616740038|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
170652023|NCT04179890|616740039|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
170652024|NCT04179890|616740038|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
170652025|NCT04179890|616740039|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
170652026|NCT04179890|616740038|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
170652027|NCT04179890|616740039|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
170652028|NCT04179890|616740038|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
170652029|NCT04179890|616740039|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
170652030|NCT04179890|616740038|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
170652031|NCT04179890|616740039|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
170652032|NCT04179890|616740038|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
170652033|NCT04179890|616740039|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
170652034|NCT04179890|616740038|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
170652035|NCT04179890|616740039|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
170652036|NCT04179890|616740038|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
170652037|NCT04179890|616740039|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
170813166|NCT00988429|617324169|FG002|Overall Study|Pregnancy|0|||
170813167|NCT00988429|617324167|FG000|Overall Study|Protocol Violation|4|||
170813168|NCT00988429|617324168|FG001|Overall Study|Protocol Violation|3|||
170813169|NCT00988429|617324169|FG002|Overall Study|Protocol Violation|3|||
170813170|NCT00988429|617324167|FG000|Overall Study|Withdrawal by Subject|7|||
170813171|NCT00988429|617324168|FG001|Overall Study|Withdrawal by Subject|7|||
170601138|NCT00494507|616544473|FG003|Double-Blind Phase|Adverse Event|0|||
170601139|NCT00494507|616544470|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
170601140|NCT00494507|616544471|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
170601141|NCT00494507|616544472|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
170601142|NCT00494507|616544473|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
170601143|NCT00494507|616544470|FG000|Double-Blind Phase|Subject Non-compliance|0|||
170601144|NCT00494507|616544471|FG001|Double-Blind Phase|Subject Non-compliance|0|||
170601145|NCT00494507|616544472|FG002|Double-Blind Phase|Subject Non-compliance|1|||
170601146|NCT00494507|616544473|FG003|Double-Blind Phase|Subject Non-compliance|0|||
170601147|NCT00494507|616544470|FG000|Double-Blind Phase|Negative DNA test|0|||
170601148|NCT00494507|616544471|FG001|Double-Blind Phase|Negative DNA test|0|||
170601149|NCT00494507|616544472|FG002|Double-Blind Phase|Negative DNA test|0|||
170601150|NCT00494507|616544473|FG003|Double-Blind Phase|Negative DNA test|1|||
170601151|NCT00494507|616544470|FG000|Open-Label Phase|Adverse Event|0|||
170601152|NCT00494507|616544471|FG001|Open-Label Phase|Adverse Event|1|||
170601153|NCT00494507|616544472|FG002|Open-Label Phase|Adverse Event|5|||
170601154|NCT00494507|616544473|FG003|Open-Label Phase|Adverse Event|3|||
170601155|NCT00494507|616544470|FG000|Open-Label Phase|Worsening Disease|0|||
170601156|NCT00494507|616544471|FG001|Open-Label Phase|Worsening Disease|0|||
170601157|NCT00494507|616544472|FG002|Open-Label Phase|Worsening Disease|0|||
170601158|NCT00494507|616544473|FG003|Open-Label Phase|Worsening Disease|2|||
170601159|NCT03615066|616544474|FG000|Main Study|Withdrew Consent|0|||
170601160|NCT03615066|616544475|FG001|Main Study|Withdrew Consent|1|||
170601161|NCT03615066|616544476|FG002|Main Study|Withdrew Consent|1|||
170601162|NCT03615066|616544474|FG000|Main Study|Lost to Follow-up|0|||
170601163|NCT03615066|616544475|FG001|Main Study|Lost to Follow-up|0|||
170601164|NCT03615066|616544476|FG002|Main Study|Lost to Follow-up|1|||
170601165|NCT03615066|616544474|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
170601166|NCT03615066|616544475|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
170601167|NCT03615066|616544476|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
170601168|NCT03615066|616544474|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
170601169|NCT03615066|616544475|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
170601170|NCT03615066|616544476|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
170601171|NCT03615066|616544474|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
170601172|NCT03615066|616544475|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
170601173|NCT03615066|616544476|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
170601174|NCT00924404|616544477|FG000|Overall Study|Lost to Follow-up|6|||
170601175|NCT00924404|616544478|FG001|Overall Study|Lost to Follow-up|4|||
170601176|NCT03831945|616544481|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
170601177|NCT03831945|616544482|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
170601178|NCT03831945|616544481|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
170601179|NCT03831945|616544482|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
170601180|NCT03831945|616544481|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
170601181|NCT03831945|616544482|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
170601182|NCT03426631|616544483|FG000|Overall Study|Lost to Follow-up|0|||
170601183|NCT03426631|616544484|FG001|Overall Study|Lost to Follow-up|1|||
170601184|NCT00587847|616544485|FG000|Overall Study|Lack of Efficacy|5|||
170601185|NCT00587847|616544485|FG000|Overall Study|Adverse Event|2|||
170601186|NCT00343382|616544486|FG000|Overall Study|Adverse Event|2|||
170601187|NCT00343382|616544487|FG001|Overall Study|Adverse Event|10|||
170601188|NCT00343382|616544488|FG002|Overall Study|Adverse Event|7|||
170601189|NCT00343382|616544486|FG000|Overall Study|Withdrawal by Subject|1|||
170601190|NCT00343382|616544487|FG001|Overall Study|Withdrawal by Subject|2|||
170601191|NCT00343382|616544488|FG002|Overall Study|Withdrawal by Subject|6|||
170601192|NCT00343382|616544486|FG000|Overall Study|Other Reason Not Specified|1|||
170601193|NCT00343382|616544487|FG001|Overall Study|Other Reason Not Specified|2|||
170601194|NCT00343382|616544488|FG002|Overall Study|Other Reason Not Specified|4|||
170601195|NCT03729245|616544489|FG000|Overall Study|Lost to Follow-up|5|||
170601196|NCT03729245|616544490|FG001|Overall Study|Lost to Follow-up|6|||
170601197|NCT03729245|616544489|FG000|Overall Study|Withdrawal by Subject|16|||
170601198|NCT03729245|616544490|FG001|Overall Study|Withdrawal by Subject|19|||
170601199|NCT03729245|616544489|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
170601200|NCT03729245|616544490|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
170601201|NCT00500760|616544496|FG000|Overall Study|Death|32|||
170601202|NCT00500760|616544497|FG001|Overall Study|Death|15|||
170601203|NCT00500760|616544496|FG000|Overall Study|Withdrawal by Subject|5|||
170601204|NCT00500760|616544497|FG001|Overall Study|Withdrawal by Subject|7|||
170601205|NCT00500760|616544496|FG000|Overall Study|Administrative decision|2|||
170601206|NCT00500760|616544497|FG001|Overall Study|Administrative decision|0|||
170601207|NCT00500760|616544496|FG000|Overall Study|Lost to Follow-up|3|||
170601208|NCT00500760|616544497|FG001|Overall Study|Lost to Follow-up|0|||
170813172|NCT00988429|617324169|FG002|Overall Study|Withdrawal by Subject|12|||
170813173|NCT00988429|617324167|FG000|Overall Study|Administrative Reasons|1|||
170601209|NCT00500760|616544496|FG000|Overall Study|Other|1|||
170601210|NCT00500760|616544497|FG001|Overall Study|Other|2|||
170601211|NCT00129961|616544499|FG000|Overall Study|Adverse Event|1|||
170601212|NCT00129961|616544500|FG001|Overall Study|Adverse Event|0|||
170813174|NCT00988429|617324168|FG001|Overall Study|Administrative Reasons|2|||
170813175|NCT00988429|617324169|FG002|Overall Study|Administrative Reasons|1|||
170813176|NCT00988429|617324167|FG000|Overall Study|other reasons|8|||
170813177|NCT00988429|617324168|FG001|Overall Study|other reasons|8|||
170813178|NCT00988429|617324169|FG002|Overall Study|other reasons|1|||
170813179|NCT02964234|617324170|FG000|Overall Study|Lost to Follow-up|22|||
170813180|NCT02964234|617324171|FG001|Overall Study|Lost to Follow-up|13|||
170601213|NCT00129961|616544499|FG000|Overall Study|Death|1|||
170601214|NCT00129961|616544500|FG001|Overall Study|Death|1|||
170601215|NCT00129961|616544499|FG000|Overall Study|Withdrawal by Sponsor|14|||
170601216|NCT00129961|616544500|FG001|Overall Study|Withdrawal by Sponsor|20|||
170601217|NCT00129961|616544499|FG000|Overall Study|Physician Decision|1|||
170601218|NCT00129961|616544500|FG001|Overall Study|Physician Decision|0|||
170601219|NCT00129961|616544499|FG000|Overall Study|Withdrawal by Subject|2|||
170601220|NCT00129961|616544500|FG001|Overall Study|Withdrawal by Subject|1|||
170601221|NCT00129961|616544499|FG000|Overall Study|Missing Record|0|||
170601222|NCT00129961|616544500|FG001|Overall Study|Missing Record|1|||
170601223|NCT00084487|616544503|FG000|Overall Study|Death|1|||
170601224|NCT02241187|616544504|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
170601225|NCT02404649|616544505|FG000|Overall Study|Adverse Event|1|||
170601226|NCT02404649|616544506|FG001|Overall Study|Adverse Event|2|||
170601227|NCT02265796|616544507|FG000|Overall Study|Death|1|||
170601228|NCT02265796|616544508|FG001|Overall Study|Death|0|||
170601229|NCT02265796|616544507|FG000|Overall Study|started on excluded medication|1|||
170601230|NCT02265796|616544508|FG001|Overall Study|started on excluded medication|0|||
170601231|NCT02265796|616544507|FG000|Overall Study|Withdrawal by Subject|1|||
170601232|NCT02265796|616544508|FG001|Overall Study|Withdrawal by Subject|1|||
170601233|NCT04311463|616544511|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
170601234|NCT04311463|616544512|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
170601235|NCT04311463|616544511|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
170601236|NCT04311463|616544512|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
170601237|NCT04311463|616544511|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
170601238|NCT04311463|616544512|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
170601239|NCT00952614|616544513|FG000|Overall Study|Death|3|||
170601240|NCT00952614|616544513|FG000|Overall Study|Lost to Follow-up|3|||
170601241|NCT00952614|616544513|FG000|Overall Study|other reason|1|||
170601242|NCT00454649|616544515|FG000|Overall Study|Lack of Efficacy|2|||
170601243|NCT00454649|616544516|FG001|Overall Study|Lack of Efficacy|2|||
170601244|NCT00454649|616544517|FG002|Overall Study|Lack of Efficacy|10|||
170601245|NCT00454649|616544518|FG003|Overall Study|Lack of Efficacy|3|||
170601246|NCT00454649|616544519|FG004|Overall Study|Lack of Efficacy|0|||
170601247|NCT00454649|616544520|FG005|Overall Study|Lack of Efficacy|4|||
170601248|NCT00454649|616544521|FG006|Overall Study|Lack of Efficacy|5|||
170601249|NCT00454649|616544522|FG007|Overall Study|Lack of Efficacy|13|||
170601250|NCT00454649|616544523|FG008|Overall Study|Lack of Efficacy|10|||
170601251|NCT00454649|616544524|FG009|Overall Study|Lack of Efficacy|2|||
170601252|NCT00454649|616544515|FG000|Overall Study|Adverse Event|0|||
170601253|NCT00454649|616544516|FG001|Overall Study|Adverse Event|1|||
170601254|NCT00454649|616544517|FG002|Overall Study|Adverse Event|3|||
170601255|NCT00454649|616544518|FG003|Overall Study|Adverse Event|0|||
170601256|NCT00454649|616544519|FG004|Overall Study|Adverse Event|1|||
170601257|NCT00454649|616544520|FG005|Overall Study|Adverse Event|2|||
170601258|NCT00454649|616544521|FG006|Overall Study|Adverse Event|3|||
170601259|NCT00454649|616544522|FG007|Overall Study|Adverse Event|4|||
170601260|NCT00454649|616544523|FG008|Overall Study|Adverse Event|6|||
170601261|NCT00454649|616544524|FG009|Overall Study|Adverse Event|2|||
170601262|NCT00454649|616544515|FG000|Overall Study|Lost to Follow-up|0|||
170601263|NCT00454649|616544516|FG001|Overall Study|Lost to Follow-up|0|||
170601264|NCT00454649|616544517|FG002|Overall Study|Lost to Follow-up|1|||
170601265|NCT00454649|616544518|FG003|Overall Study|Lost to Follow-up|0|||
170601266|NCT00454649|616544519|FG004|Overall Study|Lost to Follow-up|0|||
170601267|NCT00454649|616544520|FG005|Overall Study|Lost to Follow-up|0|||
170601268|NCT00454649|616544521|FG006|Overall Study|Lost to Follow-up|1|||
170601269|NCT00454649|616544522|FG007|Overall Study|Lost to Follow-up|0|||
170601270|NCT00454649|616544523|FG008|Overall Study|Lost to Follow-up|0|||
170601271|NCT00454649|616544524|FG009|Overall Study|Lost to Follow-up|0|||
170652038|NCT00997438|616740041|FG000|Overall Study|Blood draw difficulty|2|||
170913839|NCT00090285|617687652|FG005|Base Study Follow-up Period|Uncooperative|0|||
170601272|NCT00454649|616544515|FG000|Overall Study|Other|1|||
170601273|NCT00454649|616544516|FG001|Overall Study|Other|1|||
170601274|NCT00454649|616544517|FG002|Overall Study|Other|5|||
170601275|NCT00454649|616544518|FG003|Overall Study|Other|3|||
170601276|NCT00454649|616544519|FG004|Overall Study|Other|0|||
170601277|NCT00454649|616544520|FG005|Overall Study|Other|0|||
170601278|NCT00454649|616544521|FG006|Overall Study|Other|0|||
170601279|NCT00454649|616544522|FG007|Overall Study|Other|0|||
170601280|NCT00454649|616544523|FG008|Overall Study|Other|3|||
170601281|NCT00454649|616544524|FG009|Overall Study|Other|1|||
170813181|NCT01799993|617324172|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
170652039|NCT00997438|616740042|FG001|Overall Study|Blood draw difficulty|0|||
170652040|NCT00997438|616740043|FG002|Overall Study|Blood draw difficulty|1|||
170601282|NCT00454649|616544515|FG000|Overall Study|Withdrawal by Subject|0|||
170601283|NCT00454649|616544516|FG001|Overall Study|Withdrawal by Subject|0|||
170601284|NCT00454649|616544517|FG002|Overall Study|Withdrawal by Subject|0|||
170601285|NCT00454649|616544518|FG003|Overall Study|Withdrawal by Subject|0|||
170601286|NCT00454649|616544519|FG004|Overall Study|Withdrawal by Subject|0|||
170601287|NCT00454649|616544520|FG005|Overall Study|Withdrawal by Subject|1|||
170601288|NCT00454649|616544521|FG006|Overall Study|Withdrawal by Subject|0|||
170601289|NCT00454649|616544522|FG007|Overall Study|Withdrawal by Subject|2|||
170601290|NCT00454649|616544523|FG008|Overall Study|Withdrawal by Subject|1|||
170601291|NCT00454649|616544524|FG009|Overall Study|Withdrawal by Subject|0|||
170601292|NCT01291277|616544529|FG000|Overall Study|Death|2|||
170601293|NCT01291277|616544530|FG001|Overall Study|Death|2|||
170601294|NCT01291277|616544529|FG000|Overall Study|Lost to Follow-up|3|||
170601295|NCT01291277|616544530|FG001|Overall Study|Lost to Follow-up|1|||
170601296|NCT00483002|616544534|FG000|Overall Study|Adverse Event|68|||
170601297|NCT00483002|616544534|FG000|Overall Study|Lack of Efficacy|555|||
170601298|NCT00483002|616544534|FG000|Overall Study|Lost to Follow-up|962|||
170601299|NCT00483002|616544534|FG000|Overall Study|Other|2|||
170601300|NCT00483002|616544534|FG000|Overall Study|Other|967|||
170601301|NCT02651220|616544535|FG000|Overall Study|Adverse Event|1|||
170601302|NCT02651220|616544536|FG001|Overall Study|Adverse Event|5|||
170601303|NCT02651220|616544537|FG002|Overall Study|Adverse Event|1|||
170601304|NCT02651220|616544535|FG000|Overall Study|Lost to Follow-up|8|||
170601305|NCT02651220|616544536|FG001|Overall Study|Lost to Follow-up|14|||
170601306|NCT02651220|616544537|FG002|Overall Study|Lost to Follow-up|14|||
170601307|NCT02651220|616544535|FG000|Overall Study|Non-Compliance with Study Drug|4|||
170601308|NCT02651220|616544536|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170601309|NCT02651220|616544537|FG002|Overall Study|Non-Compliance with Study Drug|1|||
170601310|NCT02651220|616544535|FG000|Overall Study|Pregnancy|1|||
170601311|NCT02651220|616544536|FG001|Overall Study|Pregnancy|0|||
170601312|NCT02651220|616544537|FG002|Overall Study|Pregnancy|1|||
170601313|NCT02651220|616544535|FG000|Overall Study|Protocol Violation|0|||
170601314|NCT02651220|616544536|FG001|Overall Study|Protocol Violation|0|||
170601315|NCT02651220|616544537|FG002|Overall Study|Protocol Violation|1|||
170601316|NCT02651220|616544535|FG000|Overall Study|Withdrawal by Subject|5|||
170601317|NCT02651220|616544536|FG001|Overall Study|Withdrawal by Subject|6|||
170601318|NCT02651220|616544537|FG002|Overall Study|Withdrawal by Subject|8|||
170601319|NCT02651220|616544535|FG000|Overall Study|Miscellaneous|4|||
170601320|NCT02651220|616544536|FG001|Overall Study|Miscellaneous|1|||
170601321|NCT02651220|616544537|FG002|Overall Study|Miscellaneous|2|||
170601322|NCT02651220|616544535|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170601323|NCT02651220|616544536|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170601324|NCT02651220|616544537|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
170601325|NCT04576897|616544542|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
170601326|NCT02593318|616544545|FG000|Overall Study|Withdrawal by Subject|1|||
170601327|NCT02593318|616544546|FG001|Overall Study|Withdrawal by Subject|1|||
170601328|NCT00527332|616544547|FG000|Overall Study|Protocol Violation|4|||
170601329|NCT00527332|616544548|FG001|Overall Study|Protocol Violation|8|||
170601330|NCT00527332|616544547|FG000|Overall Study|Withdrew consent|5|||
170601331|NCT00527332|616544548|FG001|Overall Study|Withdrew consent|1|||
170601332|NCT01815840|616546478|FG000|Overall Study|Missing|1|||
170601333|NCT01815840|616546479|FG001|Overall Study|Missing|0|||
170601334|NCT01815840|616546478|FG000|Overall Study|Withdrew Consent|31|||
170601335|NCT01815840|616546479|FG001|Overall Study|Withdrew Consent|30|||
170601336|NCT01815840|616546478|FG000|Overall Study|Administrative/Other|1|||
170601337|NCT01815840|616546479|FG001|Overall Study|Administrative/Other|3|||
170601338|NCT01815840|616546478|FG000|Overall Study|Adverse Event|10|||
170601339|NCT01815840|616546479|FG001|Overall Study|Adverse Event|16|||
170601340|NCT01815840|616546478|FG000|Overall Study|Death|2|||
170601341|NCT01815840|616546479|FG001|Overall Study|Death|2|||
170601342|NCT01815840|616546478|FG000|Overall Study|Disease progression|3|||
170601343|NCT01815840|616546479|FG001|Overall Study|Disease progression|2|||
170601344|NCT01815840|616546478|FG000|Overall Study|Investigators Decision|2|||
170601345|NCT01815840|616546479|FG001|Overall Study|Investigators Decision|3|||
170601346|NCT01815840|616546478|FG000|Overall Study|Lost to Follow-up|3|||
170601347|NCT01815840|616546479|FG001|Overall Study|Lost to Follow-up|6|||
170601348|NCT01815840|616546478|FG000|Overall Study|Refused Treatment|5|||
170601349|NCT01815840|616546479|FG001|Overall Study|Refused Treatment|1|||
170652041|NCT00997438|616740041|FG000|Overall Study|Withdrawal by Subject|1|||
170601350|NCT01815840|616546478|FG000|Overall Study|Sponsor Termination Treatment|1|||
170601351|NCT01815840|616546479|FG001|Overall Study|Sponsor Termination Treatment|0|||
170601352|NCT00434642|616546481|FG000|Blinded Treatment Phase|Adverse Event|12|||
170601353|NCT00434642|616546482|FG001|Blinded Treatment Phase|Adverse Event|58|||
170601354|NCT00434642|616546481|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
170601355|NCT00434642|616546482|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
170601356|NCT00434642|616546481|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
170601357|NCT00434642|616546482|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
170601358|NCT00434642|616546481|FG000|Blinded Treatment Phase|Physician Decision|19|||
170601359|NCT00434642|616546482|FG001|Blinded Treatment Phase|Physician Decision|27|||
170601360|NCT00434642|616546481|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
170601361|NCT00434642|616546482|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
170601362|NCT00434642|616546481|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
170601363|NCT00434642|616546482|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
170601364|NCT00434642|616546481|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
170601365|NCT00434642|616546482|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
170601366|NCT00434642|616546481|FG000|Open-label Treatment Phase|Adverse Event|0|||
170601367|NCT00434642|616546482|FG001|Open-label Treatment Phase|Adverse Event|5|||
170601368|NCT00434642|616546481|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
170601369|NCT00434642|616546482|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
170601370|NCT02241343|616546483|FG000|Overall Study|Adverse Event|1|||
170601371|NCT02429791|616546485|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
170601372|NCT02429791|616546486|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
170601373|NCT02429791|616546485|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
170601374|NCT02429791|616546486|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
170601375|NCT02429791|616546485|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
170601376|NCT02429791|616546486|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
170601377|NCT02429791|616546485|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
170601378|NCT02429791|616546486|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
170601379|NCT02429791|616546485|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
170601380|NCT02429791|616546486|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
170601381|NCT02429791|616546485|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
170601382|NCT02429791|616546486|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
170601383|NCT02429791|616546485|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
170601384|NCT02429791|616546486|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
170601385|NCT02429791|616546485|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
170601386|NCT02429791|616546486|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
170601387|NCT02429791|616546485|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
170601388|NCT02429791|616546486|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
170601389|NCT02429791|616546485|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
170601390|NCT02429791|616546486|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
170601391|NCT02429791|616546485|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
170601392|NCT02429791|616546486|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
170601393|NCT02429791|616546485|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
170601394|NCT02429791|616546486|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
170601395|NCT02429791|616546485|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
170601396|NCT02429791|616546486|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
170601397|NCT02429791|616546485|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
170601398|NCT02429791|616546486|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
170601399|NCT02429791|616546485|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
170601400|NCT02429791|616546486|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
170601401|NCT02429791|616546485|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
170601402|NCT02429791|616546486|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
170601403|NCT02429791|616546485|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
170601404|NCT02429791|616546486|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
170601405|NCT02429791|616546485|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
170601406|NCT02429791|616546486|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
170601407|NCT03722524|616546489|FG000|Overall Study|Protocol Violation|86|||
170601408|NCT03722524|616546489|FG000|Overall Study|Adverse Event|7|||
170601409|NCT03722524|616546489|FG000|Overall Study|Lost to Follow-up|1|||
170601410|NCT03722524|616546489|FG000|Overall Study|Reason is not stated|1|||
170601411|NCT03722524|616546489|FG000|Overall Study|Physician Decision|1|||
170601412|NCT03722524|616546489|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
170601413|NCT00802893|616546490|FG000|Overall Study|study terminated|3|||
170601414|NCT00849108|616546491|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
170601415|NCT00849108|616546492|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
170601416|NCT00849108|616546491|FG000|Cohort 2 Efficacy|Adverse Event|0|||
170601417|NCT00849108|616546492|FG001|Cohort 2 Efficacy|Adverse Event|1|||
170601418|NCT00849108|616546491|FG000|Cohort 2 Efficacy|Other|0|||
170601419|NCT00849108|616546492|FG001|Cohort 2 Efficacy|Other|9|||
170652042|NCT00997438|616740042|FG001|Overall Study|Withdrawal by Subject|1|||
170652043|NCT00997438|616740043|FG002|Overall Study|Withdrawal by Subject|0|||
170601420|NCT04676867|616546493|FG000|Overall Study|Screen failure|0|||
170601421|NCT04676867|616546494|FG001|Overall Study|Screen failure|0|||
170652044|NCT00997438|616740041|FG000|Overall Study|Exclusion criteria at visit 1|2|||
170601422|NCT04676867|616546495|FG002|Overall Study|Screen failure|6|||
170601423|NCT04676867|616546496|FG003|Overall Study|Screen failure|2|||
170601424|NCT04676867|616546493|FG000|Overall Study|Death|0|||
170601425|NCT04676867|616546494|FG001|Overall Study|Death|0|||
170601426|NCT04676867|616546495|FG002|Overall Study|Death|1|||
170601427|NCT04676867|616546496|FG003|Overall Study|Death|0|||
170601428|NCT04676867|616546493|FG000|Overall Study|Withdrawal by Subject|2|||
170601429|NCT04676867|616546494|FG001|Overall Study|Withdrawal by Subject|2|||
170601430|NCT04676867|616546495|FG002|Overall Study|Withdrawal by Subject|4|||
170601431|NCT04676867|616546496|FG003|Overall Study|Withdrawal by Subject|4|||
170601432|NCT04676867|616546493|FG000|Overall Study|Lost to Follow-up|1|||
170601433|NCT04676867|616546494|FG001|Overall Study|Lost to Follow-up|0|||
170601434|NCT04676867|616546495|FG002|Overall Study|Lost to Follow-up|0|||
170601435|NCT04676867|616546496|FG003|Overall Study|Lost to Follow-up|0|||
170601436|NCT03157583|616546502|FG000|Overall Study|Other (did not meet study criteria)|1|||
170601437|NCT02809053|616546503|FG000|Overall Study|Death|0|||
170601438|NCT02809053|616546504|FG001|Overall Study|Death|1|||
170601439|NCT02809053|616546503|FG000|Overall Study|Lost to Follow-up|3|||
170601440|NCT02809053|616546504|FG001|Overall Study|Lost to Follow-up|1|||
170601441|NCT02809053|616546503|FG000|Overall Study|Withdrawal by Subject|2|||
170601442|NCT02809053|616546504|FG001|Overall Study|Withdrawal by Subject|3|||
170601443|NCT02809053|616546503|FG000|Overall Study|Disease Progression|2|||
170601444|NCT02809053|616546504|FG001|Overall Study|Disease Progression|1|||
170601445|NCT00551291|616546505|FG000|Overall Study|Physician Decision|1|||
170601446|NCT00884832|616546506|FG000|Overall Study|Withdrawal by Subject|0|||
170601447|NCT00884832|616546507|FG001|Overall Study|Withdrawal by Subject|1|||
170601448|NCT02337725|616546508|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
170601449|NCT02337725|616546509|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
170601450|NCT02337725|616546508|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
170601451|NCT02337725|616546509|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
170601452|NCT02337725|616546508|FG000|Overall Study|Major Protocol Deviation|0|||
170601453|NCT02337725|616546509|FG001|Overall Study|Major Protocol Deviation|1|||
170601454|NCT02337725|616546508|FG000|Overall Study|Voluntary Withdrawal|14|||
170601455|NCT02337725|616546509|FG001|Overall Study|Voluntary Withdrawal|3|||
170601456|NCT02337725|616546508|FG000|Overall Study|Lack of Efficacy|4|||
170601457|NCT02337725|616546509|FG001|Overall Study|Lack of Efficacy|0|||
170601458|NCT01571453|616546510|FG000|Overall Study|Adverse Event|14|||
170601459|NCT01571453|616546511|FG001|Overall Study|Adverse Event|32|||
170601460|NCT01571453|616546510|FG000|Overall Study|Lack of Efficacy|8|||
170601461|NCT01571453|616546511|FG001|Overall Study|Lack of Efficacy|3|||
170601462|NCT01571453|616546510|FG000|Overall Study|Non-compliance|2|||
170601463|NCT01571453|616546511|FG001|Overall Study|Non-compliance|4|||
170601464|NCT01571453|616546510|FG000|Overall Study|Protocol Violation|1|||
170601465|NCT01571453|616546511|FG001|Overall Study|Protocol Violation|5|||
170601466|NCT01571453|616546510|FG000|Overall Study|Withdrawal of consent|5|||
170601467|NCT01571453|616546511|FG001|Overall Study|Withdrawal of consent|13|||
170601468|NCT01571453|616546510|FG000|Overall Study|Lost to Follow-up|4|||
170601469|NCT01571453|616546511|FG001|Overall Study|Lost to Follow-up|2|||
170601470|NCT01571453|616546510|FG000|Overall Study|Administrative or other reason(s)|4|||
170601471|NCT01571453|616546511|FG001|Overall Study|Administrative or other reason(s)|3|||
170601472|NCT01264770|616546512|FG000|Overall Study|Not reported|0|||
170601473|NCT01264770|616546513|FG001|Overall Study|Not reported|0|||
170601474|NCT01264770|616546514|FG002|Overall Study|Not reported|1|||
170601475|NCT01264770|616546515|FG003|Overall Study|Not reported|0|||
170601476|NCT01264770|616546516|FG004|Overall Study|Not reported|0|||
170601477|NCT01264770|616546517|FG005|Overall Study|Not reported|0|||
170601478|NCT01264770|616546512|FG000|Overall Study|e.g., change in circumstances|8|||
170601479|NCT01264770|616546513|FG001|Overall Study|e.g., change in circumstances|3|||
170601480|NCT01264770|616546514|FG002|Overall Study|e.g., change in circumstances|3|||
170601481|NCT01264770|616546515|FG003|Overall Study|e.g., change in circumstances|3|||
170601482|NCT01264770|616546516|FG004|Overall Study|e.g., change in circumstances|4|||
170601483|NCT01264770|616546517|FG005|Overall Study|e.g., change in circumstances|4|||
170601484|NCT01264770|616546512|FG000|Overall Study|Severe non-compliance to protocol|0|||
170601485|NCT01264770|616546513|FG001|Overall Study|Severe non-compliance to protocol|0|||
170601486|NCT01264770|616546514|FG002|Overall Study|Severe non-compliance to protocol|1|||
170601487|NCT01264770|616546515|FG003|Overall Study|Severe non-compliance to protocol|1|||
170601488|NCT01264770|616546516|FG004|Overall Study|Severe non-compliance to protocol|0|||
170601489|NCT01264770|616546517|FG005|Overall Study|Severe non-compliance to protocol|0|||
170601490|NCT01264770|616546512|FG000|Overall Study|Lack of therapeutic response|1|||
170601491|NCT01264770|616546513|FG001|Overall Study|Lack of therapeutic response|0|||
170601492|NCT01264770|616546514|FG002|Overall Study|Lack of therapeutic response|2|||
170601493|NCT01264770|616546515|FG003|Overall Study|Lack of therapeutic response|1|||
170601494|NCT01264770|616546516|FG004|Overall Study|Lack of therapeutic response|1|||
170601495|NCT01264770|616546517|FG005|Overall Study|Lack of therapeutic response|0|||
170601496|NCT01264770|616546512|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
170601497|NCT01264770|616546513|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
170601498|NCT01264770|616546514|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
170601499|NCT01264770|616546515|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
170601500|NCT01264770|616546516|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
170601501|NCT01264770|616546517|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
170601502|NCT01264770|616546512|FG000|Overall Study|Lost to Follow-up|0|||
170601503|NCT01264770|616546513|FG001|Overall Study|Lost to Follow-up|0|||
170601504|NCT01264770|616546514|FG002|Overall Study|Lost to Follow-up|1|||
170601505|NCT01264770|616546515|FG003|Overall Study|Lost to Follow-up|1|||
170601506|NCT01264770|616546516|FG004|Overall Study|Lost to Follow-up|0|||
170601507|NCT01264770|616546517|FG005|Overall Study|Lost to Follow-up|0|||
170601508|NCT01264770|616546512|FG000|Overall Study|Adverse Event|7|||
170601509|NCT01264770|616546513|FG001|Overall Study|Adverse Event|7|||
170601510|NCT01264770|616546514|FG002|Overall Study|Adverse Event|8|||
170601511|NCT01264770|616546515|FG003|Overall Study|Adverse Event|0|||
170601512|NCT01264770|616546516|FG004|Overall Study|Adverse Event|2|||
170601513|NCT01264770|616546517|FG005|Overall Study|Adverse Event|1|||
170601514|NCT01985360|616546518|FG000|Overall Study|Withdrawal by Subject|4|||
170601515|NCT01985360|616546519|FG001|Overall Study|Withdrawal by Subject|0|||
170601516|NCT01985360|616546518|FG000|Overall Study|Lost to Follow-up|5|||
170601517|NCT01985360|616546519|FG001|Overall Study|Lost to Follow-up|3|||
170601518|NCT02976103|616546520|FG000|Overall Study|Withdrawal by Subject|1|||
170601519|NCT02976103|616546521|FG001|Overall Study|Withdrawal by Subject|0|||
170601520|NCT02976103|616546520|FG000|Overall Study|Lost to Follow-up|12|||
170601521|NCT02976103|616546521|FG001|Overall Study|Lost to Follow-up|8|||
170601522|NCT03691779|616546524|FG000|Part B (24 Weeks)|Adverse Event|0|||
170601523|NCT03691779|616546525|FG001|Part B (24 Weeks)|Adverse Event|1|||
170601524|NCT03691779|616546524|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
170601525|NCT03691779|616546525|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
170601526|NCT00694304|616546526|FG000|Overall Study|Adverse Event|42|||
170601527|NCT00694304|616546526|FG000|Overall Study|Lack of Efficacy|35|||
170601528|NCT00694304|616546526|FG000|Overall Study|Non-compliance With Study Product|16|||
170601529|NCT00694304|616546526|FG000|Overall Study|Protocol Violation|6|||
170601530|NCT00694304|616546526|FG000|Overall Study|Withdrawal of Consent|61|||
170601531|NCT00694304|616546526|FG000|Overall Study|Lost to Follow-up|15|||
170601532|NCT00694304|616546526|FG000|Overall Study|Administrative or Other Reasons|32|||
170601533|NCT00521222|616546527|FG000|Overall Study|Lost to Follow-up|0|||
170601534|NCT00521222|616546528|FG001|Overall Study|Lost to Follow-up|0|||
170601535|NCT00521222|616546529|FG002|Overall Study|Lost to Follow-up|1|||
170601536|NCT00521222|616546530|FG003|Overall Study|Lost to Follow-up|1|||
170601537|NCT00521222|616546527|FG000|Overall Study|Withdrawal by Subject|0|||
170601538|NCT00521222|616546528|FG001|Overall Study|Withdrawal by Subject|0|||
170601539|NCT00521222|616546529|FG002|Overall Study|Withdrawal by Subject|2|||
170601540|NCT00521222|616546530|FG003|Overall Study|Withdrawal by Subject|0|||
170601541|NCT00521222|616546527|FG000|Overall Study|Physician Decision|0|||
170601542|NCT00521222|616546528|FG001|Overall Study|Physician Decision|1|||
170601543|NCT00521222|616546529|FG002|Overall Study|Physician Decision|0|||
170601544|NCT00521222|616546530|FG003|Overall Study|Physician Decision|1|||
170601545|NCT03869333|616546532|FG000|Overall Study|Lost to Follow-up|1|||
170601546|NCT03869333|616546533|FG001|Overall Study|Lost to Follow-up|0|||
170601547|NCT03869333|616546534|FG002|Overall Study|Lost to Follow-up|0|||
170601548|NCT03869333|616546535|FG003|Overall Study|Lost to Follow-up|0|||
170601549|NCT03869333|616546532|FG000|Overall Study|Pregnancy|1|||
170601550|NCT03869333|616546533|FG001|Overall Study|Pregnancy|0|||
170601551|NCT03869333|616546534|FG002|Overall Study|Pregnancy|0|||
170601552|NCT03869333|616546535|FG003|Overall Study|Pregnancy|0|||
170601553|NCT03869333|616546532|FG000|Overall Study|Physician Decision|0|||
170601554|NCT03869333|616546533|FG001|Overall Study|Physician Decision|1|||
170601555|NCT03869333|616546534|FG002|Overall Study|Physician Decision|0|||
170601556|NCT03869333|616546535|FG003|Overall Study|Physician Decision|0|||
170652045|NCT00997438|616740042|FG001|Overall Study|Exclusion criteria at visit 1|2|||
170652046|NCT00997438|616740043|FG002|Overall Study|Exclusion criteria at visit 1|3|||
170652047|NCT01236118|616740044|FG000|Overall Study|Adverse Event|2|||
170652048|NCT01236118|616740045|FG001|Overall Study|Adverse Event|0|||
170652049|NCT01236118|616740046|FG002|Overall Study|Adverse Event|2|||
170652050|NCT01236118|616740044|FG000|Overall Study|Physician Decision|0|||
170652051|NCT01236118|616740045|FG001|Overall Study|Physician Decision|1|||
170652052|NCT01236118|616740046|FG002|Overall Study|Physician Decision|0|||
170652053|NCT01236118|616740044|FG000|Overall Study|Withdrawal by Subject|0|||
170652054|NCT01236118|616740045|FG001|Overall Study|Withdrawal by Subject|0|||
170652055|NCT01236118|616740046|FG002|Overall Study|Withdrawal by Subject|1|||
170652056|NCT00095238|616740047|FG000|Overall Study|Lack of Efficacy|9|||
170652057|NCT00095238|616740048|FG001|Overall Study|Lack of Efficacy|9|||
170652058|NCT00095238|616740047|FG000|Overall Study|Adverse Event|331|||
170652059|NCT00095238|616740048|FG001|Overall Study|Adverse Event|287|||
170601557|NCT01064687|616546536|FG000|Overall Study|Adverse Event|9|||
170601558|NCT01064687|616546537|FG001|Overall Study|Adverse Event|4|||
170652060|NCT00095238|616740047|FG000|Overall Study|Subject Withdrew Consent|208|||
170601559|NCT01064687|616546538|FG002|Overall Study|Adverse Event|10|||
170601560|NCT01064687|616546539|FG003|Overall Study|Adverse Event|3|||
170601561|NCT01064687|616546536|FG000|Overall Study|Death|1|||
170601562|NCT01064687|616546537|FG001|Overall Study|Death|1|||
170601563|NCT01064687|616546538|FG002|Overall Study|Death|0|||
170601564|NCT01064687|616546539|FG003|Overall Study|Death|0|||
170601565|NCT01064687|616546536|FG000|Overall Study|Entry Criteria Not Met|3|||
170601566|NCT01064687|616546537|FG001|Overall Study|Entry Criteria Not Met|0|||
170601567|NCT01064687|616546538|FG002|Overall Study|Entry Criteria Not Met|0|||
170601568|NCT01064687|616546539|FG003|Overall Study|Entry Criteria Not Met|0|||
170601569|NCT01064687|616546536|FG000|Overall Study|Lack of Efficacy|1|||
170601570|NCT01064687|616546537|FG001|Overall Study|Lack of Efficacy|0|||
170601571|NCT01064687|616546538|FG002|Overall Study|Lack of Efficacy|2|||
170601572|NCT01064687|616546539|FG003|Overall Study|Lack of Efficacy|3|||
170601573|NCT01064687|616546536|FG000|Overall Study|Lost to Follow-up|7|||
170601574|NCT01064687|616546537|FG001|Overall Study|Lost to Follow-up|10|||
170601575|NCT01064687|616546538|FG002|Overall Study|Lost to Follow-up|13|||
170601576|NCT01064687|616546539|FG003|Overall Study|Lost to Follow-up|5|||
170601577|NCT01064687|616546536|FG000|Overall Study|Physician Decision|2|||
170601578|NCT01064687|616546537|FG001|Overall Study|Physician Decision|2|||
170601579|NCT01064687|616546538|FG002|Overall Study|Physician Decision|0|||
170601580|NCT01064687|616546539|FG003|Overall Study|Physician Decision|0|||
170601581|NCT01064687|616546536|FG000|Overall Study|Protocol Violation|1|||
170601582|NCT01064687|616546537|FG001|Overall Study|Protocol Violation|1|||
170601583|NCT01064687|616546538|FG002|Overall Study|Protocol Violation|0|||
170601584|NCT01064687|616546539|FG003|Overall Study|Protocol Violation|1|||
170601585|NCT01064687|616546536|FG000|Overall Study|Sponsor Decision|0|||
170601586|NCT01064687|616546537|FG001|Overall Study|Sponsor Decision|0|||
170601587|NCT01064687|616546538|FG002|Overall Study|Sponsor Decision|3|||
170601588|NCT01064687|616546539|FG003|Overall Study|Sponsor Decision|0|||
170601589|NCT01064687|616546536|FG000|Overall Study|Withdrawal by Subject|9|||
170601590|NCT01064687|616546537|FG001|Overall Study|Withdrawal by Subject|7|||
170601591|NCT01064687|616546538|FG002|Overall Study|Withdrawal by Subject|12|||
170601592|NCT01064687|616546539|FG003|Overall Study|Withdrawal by Subject|5|||
170601593|NCT01064687|616546536|FG000|Overall Study|Treatment Noncompliance|1|||
170601594|NCT01064687|616546537|FG001|Overall Study|Treatment Noncompliance|1|||
170601595|NCT01064687|616546538|FG002|Overall Study|Treatment Noncompliance|1|||
170601596|NCT01064687|616546539|FG003|Overall Study|Treatment Noncompliance|0|||
170601597|NCT00619489|616546540|FG000|Overall Study|Adverse Event|0|||
170601598|NCT00619489|616546541|FG001|Overall Study|Adverse Event|7|||
170601599|NCT00619489|616546540|FG000|Overall Study|Withdrawal by Subject|1|||
170601600|NCT00619489|616546541|FG001|Overall Study|Withdrawal by Subject|1|||
170601601|NCT00619489|616546540|FG000|Overall Study|Lack of Efficacy|0|||
170601602|NCT00619489|616546541|FG001|Overall Study|Lack of Efficacy|11|||
170601603|NCT00619489|616546540|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
170601604|NCT00619489|616546541|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
170601605|NCT02177838|616546544|FG000|Overall Study|Withdrawal by Subject|1|||
170601606|NCT02177838|616546544|FG000|Overall Study|Physician Decision|1|||
170601607|NCT02177838|616546544|FG000|Overall Study|Death|1|||
170601608|NCT00845065|616546546|FG000|Overall Study|Adverse Event|3|||
170601609|NCT00845065|616546547|FG001|Overall Study|Adverse Event|23|||
170601610|NCT00845065|616546546|FG000|Overall Study|Lack of Efficacy|43|||
170601611|NCT00845065|616546547|FG001|Overall Study|Lack of Efficacy|21|||
170601612|NCT00845065|616546546|FG000|Overall Study|Non-Medical Reasons|1|||
170601613|NCT00845065|616546547|FG001|Overall Study|Non-Medical Reasons|11|||
170601614|NCT02299076|616546548|FG000|Overall Study|Fraudulent Entries|20|||
170601615|NCT02299076|616546549|FG001|Overall Study|Fraudulent Entries|14|||
170601616|NCT00162266|616546550|FG000|Double-Blind Period|Adverse Event|5|||
170601617|NCT00162266|616546551|FG001|Double-Blind Period|Adverse Event|9|||
170601618|NCT00162266|616546552|FG002|Double-Blind Period|Adverse Event|11|||
170601619|NCT00162266|616546553|FG003|Double-Blind Period|Adverse Event|0|||
170601620|NCT00162266|616546550|FG000|Double-Blind Period|Death|0|||
170601621|NCT00162266|616546551|FG001|Double-Blind Period|Death|1|||
170601622|NCT00162266|616546552|FG002|Double-Blind Period|Death|0|||
170601623|NCT00162266|616546553|FG003|Double-Blind Period|Death|0|||
170601624|NCT00162266|616546550|FG000|Double-Blind Period|Lost to Follow-up|1|||
170601625|NCT00162266|616546551|FG001|Double-Blind Period|Lost to Follow-up|2|||
170601626|NCT00162266|616546552|FG002|Double-Blind Period|Lost to Follow-up|0|||
170601627|NCT00162266|616546553|FG003|Double-Blind Period|Lost to Follow-up|0|||
170601628|NCT00162266|616546550|FG000|Double-Blind Period|Other Reason|1|||
170601629|NCT00162266|616546551|FG001|Double-Blind Period|Other Reason|0|||
170601630|NCT00162266|616546552|FG002|Double-Blind Period|Other Reason|1|||
170601631|NCT00162266|616546553|FG003|Double-Blind Period|Other Reason|0|||
170601632|NCT00162266|616546550|FG000|Double-Blind Period|Lack of Efficacy|13|||
170601633|NCT00162266|616546551|FG001|Double-Blind Period|Lack of Efficacy|17|||
170601634|NCT00162266|616546552|FG002|Double-Blind Period|Lack of Efficacy|30|||
170601635|NCT00162266|616546553|FG003|Double-Blind Period|Lack of Efficacy|0|||
170601636|NCT00162266|616546550|FG000|Double-Blind Period|Withdrawal by Subject|5|||
170652061|NCT00095238|616740048|FG001|Overall Study|Subject Withdrew Consent|223|||
170652062|NCT00095238|616740047|FG000|Overall Study|Death|154|||
170652063|NCT00095238|616740048|FG001|Overall Study|Death|170|||
170652064|NCT00095238|616740047|FG000|Overall Study|Lost to Follow-up|19|||
170601637|NCT00162266|616546551|FG001|Double-Blind Period|Withdrawal by Subject|2|||
170601638|NCT00162266|616546552|FG002|Double-Blind Period|Withdrawal by Subject|6|||
170601639|NCT00162266|616546553|FG003|Double-Blind Period|Withdrawal by Subject|0|||
170601640|NCT00162266|616546550|FG000|Open-Label Period|Death|0|||
170601641|NCT00162266|616546551|FG001|Open-Label Period|Death|0|||
170601642|NCT00162266|616546552|FG002|Open-Label Period|Death|0|||
170601643|NCT00162266|616546553|FG003|Open-Label Period|Death|7|||
170601644|NCT00162266|616546550|FG000|Open-Label Period|Adverse Event|0|||
170601645|NCT00162266|616546551|FG001|Open-Label Period|Adverse Event|0|||
170601646|NCT00162266|616546552|FG002|Open-Label Period|Adverse Event|0|||
170601647|NCT00162266|616546553|FG003|Open-Label Period|Adverse Event|46|||
170601648|NCT00162266|616546550|FG000|Open-Label Period|Lack of Efficacy|0|||
170601649|NCT00162266|616546551|FG001|Open-Label Period|Lack of Efficacy|0|||
170601650|NCT00162266|616546552|FG002|Open-Label Period|Lack of Efficacy|0|||
170601651|NCT00162266|616546553|FG003|Open-Label Period|Lack of Efficacy|26|||
170601652|NCT00162266|616546550|FG000|Open-Label Period|Lost to Follow-up|0|||
170601653|NCT00162266|616546551|FG001|Open-Label Period|Lost to Follow-up|0|||
170601654|NCT00162266|616546552|FG002|Open-Label Period|Lost to Follow-up|0|||
170601655|NCT00162266|616546553|FG003|Open-Label Period|Lost to Follow-up|3|||
170601656|NCT00162266|616546550|FG000|Open-Label Period|Withdrawal by Subject|0|||
170601657|NCT00162266|616546551|FG001|Open-Label Period|Withdrawal by Subject|0|||
170601658|NCT00162266|616546552|FG002|Open-Label Period|Withdrawal by Subject|0|||
170601659|NCT00162266|616546553|FG003|Open-Label Period|Withdrawal by Subject|31|||
170601660|NCT00162266|616546550|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
170601661|NCT00162266|616546551|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
170601662|NCT00162266|616546552|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
170601663|NCT00162266|616546553|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
170601664|NCT00162266|616546550|FG000|Open-Label Period|Other Reasons|0|||
170601665|NCT00162266|616546551|FG001|Open-Label Period|Other Reasons|0|||
170601666|NCT00162266|616546552|FG002|Open-Label Period|Other Reasons|0|||
170601667|NCT00162266|616546553|FG003|Open-Label Period|Other Reasons|15|||
170601668|NCT02228096|616546557|FG000|Overall Study|Study terminated by Sponsor|24|||
170601669|NCT02228096|616546557|FG000|Overall Study|Lack of Efficacy|18|||
170601670|NCT02228096|616546557|FG000|Overall Study|Death|12|||
170601671|NCT02228096|616546557|FG000|Overall Study|Physician Decision|3|||
170601672|NCT02228096|616546557|FG000|Overall Study|Subject/guardian decision|2|||
170601673|NCT02228096|616546557|FG000|Overall Study|New therapy for study indication|1|||
170601674|NCT02228096|616546557|FG000|Overall Study|Enrolled, not infused|11|||
170601675|NCT02273960|616546558|FG000|Short Term Period|Lost to Follow-up|1|||
170601676|NCT02273960|616546559|FG001|Short Term Period|Lost to Follow-up|0|||
170601677|NCT02273960|616546560|FG002|Short Term Period|Lost to Follow-up|0|||
170601678|NCT02273960|616546561|FG003|Short Term Period|Lost to Follow-up|0|||
170601679|NCT02273960|616546558|FG000|Short Term Period|Lack of Efficacy|0|||
170601680|NCT02273960|616546559|FG001|Short Term Period|Lack of Efficacy|0|||
170601681|NCT02273960|616546560|FG002|Short Term Period|Lack of Efficacy|0|||
170813182|NCT01799993|617324173|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
170813183|NCT01799993|617324172|FG000|Overall Study|Death|61|||
170601682|NCT02273960|616546561|FG003|Short Term Period|Lack of Efficacy|1|||
170601683|NCT02273960|616546558|FG000|Short Term Period|ST complete, not entering LTE|4|||
170601684|NCT02273960|616546559|FG001|Short Term Period|ST complete, not entering LTE|6|||
170601685|NCT02273960|616546560|FG002|Short Term Period|ST complete, not entering LTE|4|||
170601686|NCT02273960|616546561|FG003|Short Term Period|ST complete, not entering LTE|5|||
170601687|NCT02273960|616546558|FG000|Long Term Extension|Death|0|||
170601688|NCT02273960|616546559|FG001|Long Term Extension|Death|0|||
170601689|NCT02273960|616546560|FG002|Long Term Extension|Death|0|||
170601690|NCT02273960|616546561|FG003|Long Term Extension|Death|1|||
170601691|NCT02477553|616546562|FG000|Overall Study|Screening up-to-date|12|||
170601692|NCT02477553|616546563|FG001|Overall Study|Screening up-to-date|13|||
170601693|NCT02477553|616546562|FG000|Overall Study|No MD visit|1|||
170601694|NCT02477553|616546563|FG001|Overall Study|No MD visit|1|||
170813184|NCT01799993|617324173|FG001|Overall Study|Death|45|||
170601695|NCT02477553|616546562|FG000|Overall Study|Workup consistent w/CRC|1|||
170601696|NCT02477553|616546563|FG001|Overall Study|Workup consistent w/CRC|1|||
170601697|NCT02477553|616546562|FG000|Overall Study|Technical issues with intervention|2|||
170601698|NCT02477553|616546563|FG001|Overall Study|Technical issues with intervention|0|||
170601699|NCT02477553|616546562|FG000|Overall Study|Elevated risk for CRC|2|||
170601700|NCT02477553|616546563|FG001|Overall Study|Elevated risk for CRC|2|||
170601701|NCT02477553|616546562|FG000|Overall Study|MD advised against screening|1|||
170601702|NCT02477553|616546563|FG001|Overall Study|MD advised against screening|3|||
170601703|NCT02477553|616546562|FG000|Overall Study|patient deceased|1|||
170601704|NCT02477553|616546563|FG001|Overall Study|patient deceased|0|||
170652065|NCT00095238|616740048|FG001|Overall Study|Lost to Follow-up|24|||
170813185|NCT01799993|617324172|FG000|Overall Study|Withdrawal by Subject|23|||
170601705|NCT00377364|616546565|FG000|Overall Study|Lost to Follow-up|1|||
170601706|NCT00377364|616546566|FG001|Overall Study|Lost to Follow-up|0|||
170601707|NCT00377364|616546565|FG000|Overall Study|Withdrawal by Subject|1|||
170601708|NCT00377364|616546566|FG001|Overall Study|Withdrawal by Subject|0|||
170601709|NCT02925728|616546567|FG000|Overall Study|Death|3|||
170601710|NCT02925728|616546568|FG001|Overall Study|Death|5|||
170601711|NCT02925728|616546567|FG000|Overall Study|Physician Decision|1|||
170601712|NCT02925728|616546568|FG001|Overall Study|Physician Decision|0|||
170601713|NCT02925728|616546567|FG000|Overall Study|Withdrawal by Subject|1|||
170601714|NCT02925728|616546568|FG001|Overall Study|Withdrawal by Subject|0|||
170601715|NCT02963701|616546569|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
170601716|NCT02963701|616546570|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
170601717|NCT03480009|616546571|FG000|Overall Study|Lost to Follow-up|4|||
170601718|NCT03480009|616546572|FG001|Overall Study|Lost to Follow-up|5|||
170601719|NCT03480009|616546573|FG002|Overall Study|Lost to Follow-up|4|||
170601720|NCT03480009|616546574|FG003|Overall Study|Lost to Follow-up|0|||
170601721|NCT00086411|616546578|FG000|Overall Study|Lost to Follow-up|11|||
170601722|NCT00086411|616546579|FG001|Overall Study|Lost to Follow-up|11|||
170601723|NCT00086411|616546580|FG002|Overall Study|Lost to Follow-up|13|||
170601724|NCT00086411|616546581|FG003|Overall Study|Lost to Follow-up|12|||
170601725|NCT00752726|616546586|FG000|Overall Study|Lost to Follow-up|2|||
170601726|NCT00752726|616546587|FG001|Overall Study|Lost to Follow-up|1|||
170601727|NCT00752726|616546586|FG000|Overall Study|Adverse Event|3|||
170601728|NCT00752726|616546587|FG001|Overall Study|Adverse Event|0|||
170601729|NCT00752726|616546586|FG000|Overall Study|Withdrawal by Subject|5|||
170601730|NCT00752726|616546587|FG001|Overall Study|Withdrawal by Subject|10|||
170601731|NCT00752726|616546586|FG000|Overall Study|Other Reason|1|||
170601732|NCT00752726|616546587|FG001|Overall Study|Other Reason|2|||
170601733|NCT01895309|616546588|FG000|Overall Study|Adverse Event|13|||
170601734|NCT01895309|616546589|FG001|Overall Study|Adverse Event|17|||
170601735|NCT01895309|616546588|FG000|Overall Study|Protocol Violation|1|||
170601736|NCT01895309|616546589|FG001|Overall Study|Protocol Violation|0|||
170601737|NCT01895309|616546588|FG000|Overall Study|Lack of Efficacy|1|||
170601738|NCT01895309|616546589|FG001|Overall Study|Lack of Efficacy|3|||
170601739|NCT01895309|616546588|FG000|Overall Study|Lost to Follow-up|1|||
170601740|NCT01895309|616546589|FG001|Overall Study|Lost to Follow-up|3|||
170601741|NCT01895309|616546588|FG000|Overall Study|Physician Decision|15|||
170601742|NCT01895309|616546589|FG001|Overall Study|Physician Decision|10|||
170601743|NCT01895309|616546588|FG000|Overall Study|Withdrawal by Subject|9|||
170601744|NCT01895309|616546589|FG001|Overall Study|Withdrawal by Subject|18|||
170601745|NCT01555125|616546592|FG000|Induction Period|Lost to Follow-up|0|||
170601746|NCT01555125|616546593|FG001|Induction Period|Lost to Follow-up|2|||
170601747|NCT01555125|616546594|FG002|Induction Period|Lost to Follow-up|0|||
170601748|NCT01555125|616546595|FG003|Induction Period|Lost to Follow-up|0|||
170601749|NCT01555125|616546596|FG004|Induction Period|Lost to Follow-up|0|||
170601750|NCT01555125|616546592|FG000|Induction Period|Adverse Event|0|||
170601751|NCT01555125|616546593|FG001|Induction Period|Adverse Event|1|||
170601752|NCT01555125|616546594|FG002|Induction Period|Adverse Event|0|||
170601753|NCT01555125|616546595|FG003|Induction Period|Adverse Event|0|||
170601754|NCT01555125|616546596|FG004|Induction Period|Adverse Event|1|||
170601755|NCT01555125|616546592|FG000|Induction Period|Subject / guardian decision|0|||
170601756|NCT01555125|616546593|FG001|Induction Period|Subject / guardian decision|0|||
170813186|NCT01799993|617324173|FG001|Overall Study|Withdrawal by Subject|24|||
170813187|NCT01799993|617324172|FG000|Overall Study|Lost to Follow-up|5|||
170813188|NCT01799993|617324173|FG001|Overall Study|Lost to Follow-up|8|||
170813189|NCT01799993|617324172|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
170813190|NCT01799993|617324173|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
170813191|NCT01799993|617324172|FG000|Overall Study|Protocol driven decision point|0|||
170813192|NCT01799993|617324173|FG001|Overall Study|Protocol driven decision point|3|||
170813193|NCT01799993|617324172|FG000|Overall Study|Protocol Violation|1|||
170601757|NCT01555125|616546594|FG002|Induction Period|Subject / guardian decision|0|||
170601758|NCT01555125|616546595|FG003|Induction Period|Subject / guardian decision|0|||
170601759|NCT01555125|616546596|FG004|Induction Period|Subject / guardian decision|2|||
170601760|NCT01555125|616546592|FG000|Induction Period|Death|1|||
170601761|NCT01555125|616546593|FG001|Induction Period|Death|0|||
170601762|NCT01555125|616546594|FG002|Induction Period|Death|0|||
170601763|NCT01555125|616546595|FG003|Induction Period|Death|0|||
170601764|NCT01555125|616546596|FG004|Induction Period|Death|0|||
170601765|NCT01555125|616546592|FG000|Maintenance Period|Adverse Event|1|||
170601766|NCT01555125|616546593|FG001|Maintenance Period|Adverse Event|1|||
170601767|NCT01555125|616546594|FG002|Maintenance Period|Adverse Event|0|||
170601768|NCT01555125|616546595|FG003|Maintenance Period|Adverse Event|0|||
170601769|NCT01555125|616546596|FG004|Maintenance Period|Adverse Event|0|||
170601770|NCT01555125|616546592|FG000|Maintenance Period|Subject / guardian decision|1|||
170601771|NCT01555125|616546593|FG001|Maintenance Period|Subject / guardian decision|2|||
170601772|NCT01555125|616546594|FG002|Maintenance Period|Subject / guardian decision|0|||
170813194|NCT01799993|617324173|FG001|Overall Study|Protocol Violation|1|||
170813195|NCT01799993|617324172|FG000|Overall Study|Deterioration of general conditions|2|||
170601773|NCT01555125|616546595|FG003|Maintenance Period|Subject / guardian decision|0|||
170601774|NCT01555125|616546596|FG004|Maintenance Period|Subject / guardian decision|0|||
170601775|NCT01555125|616546592|FG000|Maintenance Period|Lost to Follow-up|2|||
170601776|NCT01555125|616546593|FG001|Maintenance Period|Lost to Follow-up|0|||
170601777|NCT01555125|616546594|FG002|Maintenance Period|Lost to Follow-up|0|||
170601778|NCT01555125|616546595|FG003|Maintenance Period|Lost to Follow-up|1|||
170601779|NCT01555125|616546596|FG004|Maintenance Period|Lost to Follow-up|0|||
170601780|NCT01555125|616546592|FG000|Maintenance Period|Lack of Efficacy|6|||
170601781|NCT01555125|616546593|FG001|Maintenance Period|Lack of Efficacy|1|||
170601782|NCT01555125|616546594|FG002|Maintenance Period|Lack of Efficacy|3|||
170601783|NCT01555125|616546595|FG003|Maintenance Period|Lack of Efficacy|0|||
170601784|NCT01555125|616546596|FG004|Maintenance Period|Lack of Efficacy|0|||
170601785|NCT01555125|616546592|FG000|Maintenance Period|Physician Decision|0|||
170601786|NCT01555125|616546593|FG001|Maintenance Period|Physician Decision|0|||
170601787|NCT01555125|616546594|FG002|Maintenance Period|Physician Decision|1|||
170601788|NCT01555125|616546595|FG003|Maintenance Period|Physician Decision|0|||
170601789|NCT01555125|616546596|FG004|Maintenance Period|Physician Decision|0|||
170601790|NCT01555125|616546592|FG000|Maintenance Period|Death|0|||
170601791|NCT01555125|616546593|FG001|Maintenance Period|Death|0|||
170601792|NCT01555125|616546594|FG002|Maintenance Period|Death|0|||
170601793|NCT01555125|616546595|FG003|Maintenance Period|Death|1|||
170601794|NCT01555125|616546596|FG004|Maintenance Period|Death|0|||
170601795|NCT01555125|616546592|FG000|Extension|Adverse Event|1|||
170601796|NCT01555125|616546593|FG001|Extension|Adverse Event|2|||
170601797|NCT01555125|616546594|FG002|Extension|Adverse Event|1|||
170601798|NCT01555125|616546595|FG003|Extension|Adverse Event|1|||
170601799|NCT01555125|616546596|FG004|Extension|Adverse Event|0|||
170601800|NCT01555125|616546592|FG000|Extension|Protocol deviation|1|||
170601801|NCT01555125|616546593|FG001|Extension|Protocol deviation|0|||
170601802|NCT01555125|616546594|FG002|Extension|Protocol deviation|0|||
170601803|NCT01555125|616546595|FG003|Extension|Protocol deviation|0|||
170601804|NCT01555125|616546596|FG004|Extension|Protocol deviation|0|||
170601805|NCT01555125|616546592|FG000|Extension|Lack of Efficacy|7|||
170601806|NCT01555125|616546593|FG001|Extension|Lack of Efficacy|6|||
170601807|NCT01555125|616546594|FG002|Extension|Lack of Efficacy|3|||
170601808|NCT01555125|616546595|FG003|Extension|Lack of Efficacy|0|||
170601809|NCT01555125|616546596|FG004|Extension|Lack of Efficacy|0|||
170601810|NCT01555125|616546592|FG000|Extension|Lost to Follow-up|2|||
170601811|NCT01555125|616546593|FG001|Extension|Lost to Follow-up|1|||
170601812|NCT01555125|616546594|FG002|Extension|Lost to Follow-up|2|||
170601813|NCT01555125|616546595|FG003|Extension|Lost to Follow-up|0|||
170601814|NCT01555125|616546596|FG004|Extension|Lost to Follow-up|0|||
170601815|NCT01555125|616546592|FG000|Extension|Study terminated by sponsor|32|||
170601816|NCT01555125|616546593|FG001|Extension|Study terminated by sponsor|33|||
170601817|NCT01555125|616546594|FG002|Extension|Study terminated by sponsor|16|||
170601818|NCT01555125|616546595|FG003|Extension|Study terminated by sponsor|20|||
170601819|NCT01555125|616546596|FG004|Extension|Study terminated by sponsor|0|||
170601820|NCT01555125|616546592|FG000|Extension|Subject/guardian decision|1|||
170601821|NCT01555125|616546593|FG001|Extension|Subject/guardian decision|9|||
170601822|NCT01555125|616546594|FG002|Extension|Subject/guardian decision|1|||
170601823|NCT01555125|616546595|FG003|Extension|Subject/guardian decision|0|||
170601824|NCT01555125|616546596|FG004|Extension|Subject/guardian decision|0|||
170601825|NCT01555125|616546592|FG000|Extension|Technical Problems|1|||
170601826|NCT01555125|616546593|FG001|Extension|Technical Problems|0|||
170601827|NCT01555125|616546594|FG002|Extension|Technical Problems|0|||
170601828|NCT01555125|616546595|FG003|Extension|Technical Problems|1|||
170601829|NCT01555125|616546596|FG004|Extension|Technical Problems|0|||
170601830|NCT01555125|616546592|FG000|Follow-Up Period|Lost to Follow-up|1|||
170601831|NCT01555125|616546593|FG001|Follow-Up Period|Lost to Follow-up|0|||
170601832|NCT01555125|616546594|FG002|Follow-Up Period|Lost to Follow-up|0|||
170601833|NCT01555125|616546595|FG003|Follow-Up Period|Lost to Follow-up|0|||
170601834|NCT01555125|616546596|FG004|Follow-Up Period|Lost to Follow-up|0|||
170601835|NCT01555125|616546592|FG000|Follow-Up Period|Subject / guardian decision|3|||
170601836|NCT01555125|616546593|FG001|Follow-Up Period|Subject / guardian decision|1|||
170601837|NCT01555125|616546594|FG002|Follow-Up Period|Subject / guardian decision|1|||
170601838|NCT01555125|616546595|FG003|Follow-Up Period|Subject / guardian decision|1|||
170601839|NCT01555125|616546596|FG004|Follow-Up Period|Subject / guardian decision|0|||
170601840|NCT04268745|616546599|FG000|Overall Study|Lost to Follow-up|2|||
170601841|NCT04268745|616546600|FG001|Overall Study|Lost to Follow-up|3|||
170601842|NCT04268745|616546599|FG000|Overall Study|Withdrawal by Subject|4|||
170601843|NCT04268745|616546600|FG001|Overall Study|Withdrawal by Subject|2|||
170601844|NCT04268745|616546599|FG000|Overall Study|Death in the family|1|||
170601845|NCT04268745|616546600|FG001|Overall Study|Death in the family|0|||
170601846|NCT02039856|616546601|FG000|Overall Study|Death|5|||
170601847|NCT02039856|616546602|FG001|Overall Study|Death|3|||
170601848|NCT02039856|616546601|FG000|Overall Study|Partial survey completion|61|||
170601849|NCT02039856|616546602|FG001|Overall Study|Partial survey completion|26|||
170601850|NCT02039856|616546601|FG000|Overall Study|Lost to Follow-up|388|||
170601851|NCT02039856|616546602|FG001|Overall Study|Lost to Follow-up|206|||
170601852|NCT02039856|616546601|FG000|Overall Study|Withdrawal by Subject|1573|||
170601853|NCT02039856|616546602|FG001|Overall Study|Withdrawal by Subject|618|||
170601854|NCT05327361|616546615|FG000|Overall Study|Lost to Follow-up|4|||
170601855|NCT00626405|616546616|FG000|Overall Study|Deemed Ineligible|1|||
170601856|NCT00626405|616546617|FG001|Overall Study|Deemed Ineligible|0|||
170601857|NCT00626405|616546616|FG000|Overall Study|Withdrawal by Subject|0|||
170601858|NCT00626405|616546617|FG001|Overall Study|Withdrawal by Subject|1|||
170601859|NCT01174173|616546618|FG000|Overall Study|drug-drug interaction|1|||
170652066|NCT00095238|616740047|FG000|Overall Study|Noncompliance|44|||
170652067|NCT00095238|616740048|FG001|Overall Study|Noncompliance|45|||
170652068|NCT00095238|616740047|FG000|Overall Study|No longer met study criteria|4|||
170652069|NCT00095238|616740048|FG001|Overall Study|No longer met study criteria|5|||
170652070|NCT00095238|616740047|FG000|Overall Study|Study terminated by sponsor|0|||
170652071|NCT00095238|616740048|FG001|Overall Study|Study terminated by sponsor|1|||
170652072|NCT00095238|616740047|FG000|Overall Study|Missing|1|||
170652073|NCT00095238|616740048|FG001|Overall Study|Missing|0|||
170652074|NCT00095238|616740047|FG000|Overall Study|Other Reasons|87|||
170652075|NCT00095238|616740048|FG001|Overall Study|Other Reasons|88|||
170652076|NCT00978432|616740049|FG000|Overall Study|Withdrawal by Subject|0|||
170652077|NCT00978432|616740050|FG001|Overall Study|Withdrawal by Subject|0|||
170652078|NCT00978432|616740051|FG002|Overall Study|Withdrawal by Subject|1|||
170652079|NCT00978432|616740049|FG000|Overall Study|Lack of Efficacy|1|||
170652080|NCT00978432|616740050|FG001|Overall Study|Lack of Efficacy|1|||
170652081|NCT00978432|616740051|FG002|Overall Study|Lack of Efficacy|3|||
170652082|NCT00978432|616740049|FG000|Overall Study|Adverse Event|2|||
170652083|NCT00978432|616740050|FG001|Overall Study|Adverse Event|0|||
170652084|NCT00978432|616740051|FG002|Overall Study|Adverse Event|1|||
170652085|NCT02579928|616740052|FG000|Overall Study|Withdrawal by Subject|1|||
170652086|NCT02579928|616740053|FG001|Overall Study|Withdrawal by Subject|0|||
170652087|NCT04300751|616740054|FG000|Overall Study|Withdrawal by Subject|1|||
170652088|NCT00732940|616740057|FG000|Overall Study|Withdrawal by Subject|1|||
170652089|NCT00732940|616740058|FG001|Overall Study|Withdrawal by Subject|2|||
170652090|NCT00732940|616740057|FG000|Overall Study|Adverse Event|0|||
170652091|NCT00732940|616740058|FG001|Overall Study|Adverse Event|1|||
170652092|NCT00732940|616740057|FG000|Overall Study|Lost to Follow-up|1|||
170652093|NCT00732940|616740058|FG001|Overall Study|Lost to Follow-up|0|||
170652094|NCT01642732|616740060|FG000|Overall Study|Withdrawal by Subject|1|||
170652095|NCT00492063|616740061|FG000|Overall Study|Death|0|||
170652096|NCT00492063|616740062|FG001|Overall Study|Death|0|||
170652097|NCT00492063|616740063|FG002|Overall Study|Death|1|||
170652098|NCT00492063|616740064|FG003|Overall Study|Death|2|||
170652099|NCT00492063|616740061|FG000|Overall Study|Withdrawal by Subject|4|||
170652100|NCT00492063|616740062|FG001|Overall Study|Withdrawal by Subject|3|||
170652101|NCT00492063|616740063|FG002|Overall Study|Withdrawal by Subject|5|||
170652102|NCT00492063|616740064|FG003|Overall Study|Withdrawal by Subject|4|||
170652103|NCT00492063|616740061|FG000|Overall Study|Lost to Follow-up|6|||
170652104|NCT00492063|616740062|FG001|Overall Study|Lost to Follow-up|11|||
170652105|NCT00492063|616740063|FG002|Overall Study|Lost to Follow-up|5|||
170652106|NCT00492063|616740064|FG003|Overall Study|Lost to Follow-up|3|||
170652107|NCT00492063|616740061|FG000|Overall Study|Protocol Violation|0|||
170652108|NCT00492063|616740062|FG001|Overall Study|Protocol Violation|0|||
170652109|NCT00492063|616740063|FG002|Overall Study|Protocol Violation|0|||
170652110|NCT00492063|616740064|FG003|Overall Study|Protocol Violation|1|||
170652111|NCT00510653|616740068|FG000|Overall Study|Withdrawal by Subject|8|||
170652112|NCT00510653|616740068|FG000|Overall Study|Monetary|3|||
170652113|NCT00710762|616740069|FG000|Overall Study|Progressive disease|27|||
170652114|NCT00710762|616740070|FG001|Overall Study|Progressive disease|30|||
170652115|NCT00710762|616740069|FG000|Overall Study|Adverse Event other disease worsening|2|||
170652116|NCT00710762|616740070|FG001|Overall Study|Adverse Event other disease worsening|1|||
170652117|NCT00710762|616740069|FG000|Overall Study|Other Adverse Event|7|||
170652118|NCT00710762|616740070|FG001|Overall Study|Other Adverse Event|7|||
170652119|NCT00710762|616740069|FG000|Overall Study|Lost to Follow-up|1|||
170652120|NCT00710762|616740070|FG001|Overall Study|Lost to Follow-up|0|||
170652121|NCT00710762|616740069|FG000|Overall Study|Reason other than listed above|2|||
170652122|NCT00710762|616740070|FG001|Overall Study|Reason other than listed above|2|||
170652123|NCT01947855|616740071|FG000|Overall Study|Withdrawal by Subject|1|||
170652124|NCT01947855|616740072|FG001|Overall Study|Withdrawal by Subject|0|||
170652125|NCT01947855|616740073|FG002|Overall Study|Withdrawal by Subject|0|||
170652126|NCT01892384|616740074|FG000|Overall Study|Withdrawal by Subject|1|||
170652127|NCT01892384|616740075|FG001|Overall Study|Withdrawal by Subject|1|||
170652128|NCT01892384|616740076|FG002|Overall Study|Withdrawal by Subject|0|||
170652129|NCT01892384|616740077|FG003|Overall Study|Withdrawal by Subject|0|||
170652130|NCT00592774|616740078|FG000|Overall Study|Adverse Event|5|||
170913840|NCT00090285|617687647|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
170601860|NCT05066165|616549492|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
170601861|NCT05066165|616549493|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
170601862|NCT05066165|616549492|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
170601863|NCT05066165|616549493|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
170601864|NCT03210961|616549494|FG000|Overall Study|Adverse Event|0|||
170601865|NCT03210961|616549495|FG001|Overall Study|Adverse Event|0|||
170601866|NCT03210961|616549496|FG002|Overall Study|Adverse Event|0|||
170601867|NCT03210961|616549497|FG003|Overall Study|Adverse Event|0|||
170601868|NCT03210961|616549498|FG004|Overall Study|Adverse Event|0|||
170601869|NCT03210961|616549499|FG005|Overall Study|Adverse Event|0|||
170601870|NCT03210961|616549500|FG006|Overall Study|Adverse Event|0|||
170601871|NCT03210961|616549501|FG007|Overall Study|Adverse Event|0|||
170601872|NCT03210961|616549502|FG008|Overall Study|Adverse Event|0|||
170601873|NCT03210961|616549503|FG009|Overall Study|Adverse Event|0|||
170601874|NCT03210961|616549504|FG010|Overall Study|Adverse Event|0|||
170601875|NCT03210961|616549505|FG011|Overall Study|Adverse Event|0|||
170601876|NCT03210961|616549506|FG012|Overall Study|Adverse Event|0|||
170601877|NCT03210961|616549507|FG013|Overall Study|Adverse Event|1|||
170601878|NCT03210961|616549508|FG014|Overall Study|Adverse Event|0|||
170601879|NCT03210961|616549494|FG000|Overall Study|Lost to Follow-up|0|||
170601880|NCT03210961|616549495|FG001|Overall Study|Lost to Follow-up|0|||
170601881|NCT03210961|616549496|FG002|Overall Study|Lost to Follow-up|0|||
170601882|NCT03210961|616549497|FG003|Overall Study|Lost to Follow-up|0|||
170601883|NCT03210961|616549498|FG004|Overall Study|Lost to Follow-up|0|||
170601884|NCT03210961|616549499|FG005|Overall Study|Lost to Follow-up|0|||
170601885|NCT03210961|616549500|FG006|Overall Study|Lost to Follow-up|0|||
170601886|NCT03210961|616549501|FG007|Overall Study|Lost to Follow-up|0|||
170601887|NCT03210961|616549502|FG008|Overall Study|Lost to Follow-up|0|||
170601888|NCT03210961|616549503|FG009|Overall Study|Lost to Follow-up|0|||
170601889|NCT03210961|616549504|FG010|Overall Study|Lost to Follow-up|0|||
170601890|NCT03210961|616549505|FG011|Overall Study|Lost to Follow-up|0|||
170601891|NCT03210961|616549506|FG012|Overall Study|Lost to Follow-up|0|||
170601892|NCT03210961|616549507|FG013|Overall Study|Lost to Follow-up|0|||
170601893|NCT03210961|616549508|FG014|Overall Study|Lost to Follow-up|1|||
170601894|NCT03210961|616549494|FG000|Overall Study|Withdrawal by Subject|0|||
170601895|NCT03210961|616549495|FG001|Overall Study|Withdrawal by Subject|0|||
170601896|NCT03210961|616549496|FG002|Overall Study|Withdrawal by Subject|0|||
170601897|NCT03210961|616549497|FG003|Overall Study|Withdrawal by Subject|0|||
170601898|NCT03210961|616549498|FG004|Overall Study|Withdrawal by Subject|0|||
170601899|NCT03210961|616549499|FG005|Overall Study|Withdrawal by Subject|0|||
170601900|NCT03210961|616549500|FG006|Overall Study|Withdrawal by Subject|0|||
170601901|NCT03210961|616549501|FG007|Overall Study|Withdrawal by Subject|0|||
170601902|NCT03210961|616549502|FG008|Overall Study|Withdrawal by Subject|0|||
170601903|NCT03210961|616549503|FG009|Overall Study|Withdrawal by Subject|0|||
170601904|NCT03210961|616549504|FG010|Overall Study|Withdrawal by Subject|0|||
170601905|NCT03210961|616549505|FG011|Overall Study|Withdrawal by Subject|0|||
170601906|NCT03210961|616549506|FG012|Overall Study|Withdrawal by Subject|0|||
170601907|NCT03210961|616549507|FG013|Overall Study|Withdrawal by Subject|0|||
170601908|NCT03210961|616549508|FG014|Overall Study|Withdrawal by Subject|1|||
170601909|NCT03210961|616549494|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601910|NCT03210961|616549495|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601911|NCT03210961|616549496|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601912|NCT03210961|616549497|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601913|NCT03210961|616549498|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601914|NCT03210961|616549499|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601915|NCT03210961|616549500|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601916|NCT03210961|616549501|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
170652131|NCT00592774|616740079|FG001|Overall Study|Adverse Event|19|||
170652132|NCT00592774|616740080|FG002|Overall Study|Adverse Event|2|||
170652133|NCT00592774|616740081|FG003|Overall Study|Adverse Event|14|||
170652134|NCT00592774|616740082|FG004|Overall Study|Adverse Event|8|||
170813196|NCT01799993|617324173|FG001|Overall Study|Deterioration of general conditions|0|||
170601917|NCT03210961|616549502|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601918|NCT03210961|616549503|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601919|NCT03210961|616549504|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601920|NCT03210961|616549505|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601921|NCT03210961|616549506|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601922|NCT03210961|616549507|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
170601923|NCT03210961|616549508|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
170601924|NCT03210961|616549494|FG000|Overall Study|Other|0|||
170601925|NCT03210961|616549495|FG001|Overall Study|Other|0|||
170652135|NCT00592774|616740078|FG000|Overall Study|Protocol Violation|0|||
170652136|NCT00592774|616740079|FG001|Overall Study|Protocol Violation|1|||
170652137|NCT00592774|616740080|FG002|Overall Study|Protocol Violation|0|||
170652138|NCT00592774|616740081|FG003|Overall Study|Protocol Violation|0|||
170601926|NCT03210961|616549496|FG002|Overall Study|Other|0|||
170601927|NCT03210961|616549497|FG003|Overall Study|Other|1|||
170601928|NCT03210961|616549498|FG004|Overall Study|Other|0|||
170601929|NCT03210961|616549499|FG005|Overall Study|Other|0|||
170601930|NCT03210961|616549500|FG006|Overall Study|Other|1|||
170601931|NCT03210961|616549501|FG007|Overall Study|Other|0|||
170601932|NCT03210961|616549502|FG008|Overall Study|Other|0|||
170601933|NCT03210961|616549503|FG009|Overall Study|Other|0|||
170601934|NCT03210961|616549504|FG010|Overall Study|Other|1|||
170601935|NCT03210961|616549505|FG011|Overall Study|Other|0|||
170601936|NCT03210961|616549506|FG012|Overall Study|Other|2|||
170601937|NCT03210961|616549507|FG013|Overall Study|Other|2|||
170601938|NCT03210961|616549508|FG014|Overall Study|Other|0|||
170601939|NCT02467582|616549509|FG000|Allocation|Withdrawal by Subject|1|||
170601940|NCT02467582|616549510|FG001|Allocation|Withdrawal by Subject|0|||
170601941|NCT02467582|616549509|FG000|Follow-up|Death|5|||
170601942|NCT02467582|616549510|FG001|Follow-up|Death|4|||
170601943|NCT02467582|616549509|FG000|Follow-up|Lost to Follow-up|6|||
170601944|NCT02467582|616549510|FG001|Follow-up|Lost to Follow-up|5|||
170601945|NCT01370265|616549511|FG000|First Intervention|Adverse Event|1|||
170601946|NCT01370265|616549512|FG001|First Intervention|Adverse Event|1|||
170601947|NCT03343626|616549513|FG000|Overall Study|Lost to Follow-up|4|||
170601948|NCT03343626|616549514|FG001|Overall Study|Lost to Follow-up|3|||
170601949|NCT03343626|616549515|FG002|Overall Study|Lost to Follow-up|2|||
170601950|NCT03343626|616549516|FG003|Overall Study|Lost to Follow-up|5|||
170601951|NCT03343626|616549517|FG004|Overall Study|Lost to Follow-up|4|||
170601952|NCT03343626|616549518|FG005|Overall Study|Lost to Follow-up|4|||
170601953|NCT03343626|616549519|FG006|Overall Study|Lost to Follow-up|4|||
170601954|NCT03343626|616549520|FG007|Overall Study|Lost to Follow-up|7|||
170652139|NCT00592774|616740082|FG004|Overall Study|Protocol Violation|1|||
170652140|NCT00592774|616740078|FG000|Overall Study|Withdrawal by Subject|3|||
170652141|NCT00592774|616740079|FG001|Overall Study|Withdrawal by Subject|7|||
170652142|NCT00592774|616740080|FG002|Overall Study|Withdrawal by Subject|0|||
170652143|NCT00592774|616740081|FG003|Overall Study|Withdrawal by Subject|0|||
170652144|NCT00592774|616740082|FG004|Overall Study|Withdrawal by Subject|0|||
170652145|NCT00592774|616740078|FG000|Overall Study|Lack of Efficacy|3|||
170652146|NCT00592774|616740079|FG001|Overall Study|Lack of Efficacy|3|||
170652147|NCT00592774|616740080|FG002|Overall Study|Lack of Efficacy|0|||
170652148|NCT00592774|616740081|FG003|Overall Study|Lack of Efficacy|0|||
170652149|NCT00592774|616740082|FG004|Overall Study|Lack of Efficacy|2|||
170652150|NCT00592774|616740078|FG000|Overall Study|Physician Decision|0|||
170652151|NCT00592774|616740079|FG001|Overall Study|Physician Decision|1|||
170652152|NCT00592774|616740080|FG002|Overall Study|Physician Decision|1|||
170652153|NCT00592774|616740081|FG003|Overall Study|Physician Decision|0|||
170652154|NCT00592774|616740082|FG004|Overall Study|Physician Decision|1|||
170652155|NCT00592774|616740078|FG000|Overall Study|Other|0|||
170652156|NCT00592774|616740079|FG001|Overall Study|Other|1|||
170652157|NCT00592774|616740080|FG002|Overall Study|Other|1|||
170652158|NCT00592774|616740081|FG003|Overall Study|Other|0|||
170652159|NCT00592774|616740082|FG004|Overall Study|Other|2|||
170652160|NCT01700439|616740083|FG000|Overall Study|Lost to Follow-up|47|||
170652161|NCT01700439|616740083|FG000|Overall Study|Withdrawal by Subject|183|||
170652162|NCT01700439|616740083|FG000|Overall Study|Death|186|||
170652163|NCT01120067|616740090|FG000|Overall Study|Lost to Follow-up|3|||
170652164|NCT01120067|616740091|FG001|Overall Study|Lost to Follow-up|1|||
170652165|NCT01120067|616740090|FG000|Overall Study|fail to engage >3 sessions|2|||
170652166|NCT01120067|616740091|FG001|Overall Study|fail to engage >3 sessions|0|||
170652167|NCT00053898|616740093|FG000|Overall Study|No follow-up data from any source|9|||
170913841|NCT00090285|617687648|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
170913842|NCT00090285|617687649|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
170913843|NCT00090285|617687650|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
170913844|NCT00090285|617687651|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
170652168|NCT00053898|616740094|FG001|Overall Study|No follow-up data from any source|12|||
170652169|NCT00053898|616740093|FG000|Overall Study|Follow-up from telephone contact only|5|||
170652170|NCT00053898|616740094|FG001|Overall Study|Follow-up from telephone contact only|1|||
170652171|NCT00266877|616740095|FG000|Overall Study|Death|1|||
170913845|NCT00090285|617687652|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
170913846|NCT00090285|617687647|FG000|Extension 1|Adverse Event|0|||
170601955|NCT03343626|616549513|FG000|Overall Study|Withdrawal of Consent|2|||
170601956|NCT03343626|616549514|FG001|Overall Study|Withdrawal of Consent|1|||
170652172|NCT00266877|616740096|FG001|Overall Study|Death|1|||
170601957|NCT03343626|616549515|FG002|Overall Study|Withdrawal of Consent|0|||
170601958|NCT03343626|616549516|FG003|Overall Study|Withdrawal of Consent|3|||
170601959|NCT03343626|616549517|FG004|Overall Study|Withdrawal of Consent|3|||
170601960|NCT03343626|616549518|FG005|Overall Study|Withdrawal of Consent|1|||
170601961|NCT03343626|616549519|FG006|Overall Study|Withdrawal of Consent|1|||
170601962|NCT03343626|616549520|FG007|Overall Study|Withdrawal of Consent|2|||
170652173|NCT00266877|616740097|FG002|Overall Study|Death|1|||
170652174|NCT00266877|616740095|FG000|Overall Study|Adverse Event|6|||
170652175|NCT00266877|616740096|FG001|Overall Study|Adverse Event|4|||
170913847|NCT00090285|617687648|FG001|Extension 1|Adverse Event|0|||
170601963|NCT03343626|616549513|FG000|Overall Study|Reason not Specified|0|||
170601964|NCT03343626|616549514|FG001|Overall Study|Reason not Specified|1|||
170601965|NCT03343626|616549515|FG002|Overall Study|Reason not Specified|0|||
170601966|NCT03343626|616549516|FG003|Overall Study|Reason not Specified|0|||
170601967|NCT03343626|616549517|FG004|Overall Study|Reason not Specified|0|||
170601968|NCT03343626|616549518|FG005|Overall Study|Reason not Specified|0|||
170601969|NCT03343626|616549519|FG006|Overall Study|Reason not Specified|0|||
170601970|NCT03343626|616549520|FG007|Overall Study|Reason not Specified|1|||
170601971|NCT03343626|616549513|FG000|Overall Study|Data Entry Error|0|||
170601972|NCT03343626|616549514|FG001|Overall Study|Data Entry Error|0|||
170601973|NCT03343626|616549515|FG002|Overall Study|Data Entry Error|0|||
170601974|NCT03343626|616549516|FG003|Overall Study|Data Entry Error|0|||
170601975|NCT03343626|616549517|FG004|Overall Study|Data Entry Error|0|||
170601976|NCT03343626|616549518|FG005|Overall Study|Data Entry Error|0|||
170601977|NCT03343626|616549519|FG006|Overall Study|Data Entry Error|0|||
170601978|NCT03343626|616549520|FG007|Overall Study|Data Entry Error|1|||
170601979|NCT00703924|616549531|FG000|Overall Study|Withdrawal by Subject|1|||
170601980|NCT00703924|616549532|FG001|Overall Study|Withdrawal by Subject|1|||
170601981|NCT00965575|616549542|FG000|Overall Study|subject unwillingness to swallow study c|1|||
170601982|NCT00965575|616549543|FG001|Overall Study|subject unwillingness to swallow study c|0|||
170601983|NCT01900054|616549549|FG000|Overall Study|Physician Decision|1|||
170601984|NCT01900054|616549549|FG000|Overall Study|Withdrawal by Subject|1|||
170601985|NCT03047031|616549550|FG000|Overall Study|Other than listed|1|||
170601986|NCT03047031|616549551|FG001|Overall Study|Other than listed|0|||
170601987|NCT03047031|616549552|FG002|Overall Study|Other than listed|0|||
170601988|NCT03047031|616549550|FG000|Overall Study|Lost to Follow-up|4|||
170601989|NCT03047031|616549551|FG001|Overall Study|Lost to Follow-up|0|||
170601990|NCT03047031|616549552|FG002|Overall Study|Lost to Follow-up|0|||
170601991|NCT03047031|616549550|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
170601992|NCT03047031|616549551|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
170601993|NCT03047031|616549552|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
170601994|NCT03047031|616549550|FG000|Overall Study|Adverse Event|1|||
170601995|NCT03047031|616549551|FG001|Overall Study|Adverse Event|0|||
170601996|NCT03047031|616549552|FG002|Overall Study|Adverse Event|0|||
170601997|NCT03047031|616549550|FG000|Overall Study|Withdrawal by Subject|2|||
170601998|NCT03047031|616549551|FG001|Overall Study|Withdrawal by Subject|0|||
170601999|NCT03047031|616549552|FG002|Overall Study|Withdrawal by Subject|0|||
170602000|NCT03047031|616549550|FG000|Overall Study|Change to other medication|2|||
170602001|NCT03047031|616549551|FG001|Overall Study|Change to other medication|0|||
170602002|NCT03047031|616549552|FG002|Overall Study|Change to other medication|0|||
170602003|NCT03047031|616549550|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
170602004|NCT03047031|616549551|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
170602005|NCT03047031|616549552|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
170602006|NCT01959841|616549553|FG000|Overall Study|Adverse Event|1|||
170602007|NCT01959841|616549554|FG001|Overall Study|Adverse Event|3|||
170602008|NCT01959841|616549555|FG002|Overall Study|Adverse Event|2|||
170602009|NCT01959841|616549553|FG000|Overall Study|Lack of Efficacy|5|||
170602010|NCT01959841|616549554|FG001|Overall Study|Lack of Efficacy|0|||
170602011|NCT01959841|616549555|FG002|Overall Study|Lack of Efficacy|0|||
170602012|NCT01959841|616549553|FG000|Overall Study|Lost to Follow-up|1|||
170602013|NCT01959841|616549554|FG001|Overall Study|Lost to Follow-up|1|||
170602014|NCT01959841|616549555|FG002|Overall Study|Lost to Follow-up|0|||
170602015|NCT01959841|616549553|FG000|Overall Study|Physician Decision|0|||
170602016|NCT01959841|616549554|FG001|Overall Study|Physician Decision|2|||
170602017|NCT01959841|616549555|FG002|Overall Study|Physician Decision|3|||
170602018|NCT01959841|616549553|FG000|Overall Study|Protocol Violation|16|||
170602019|NCT01959841|616549554|FG001|Overall Study|Protocol Violation|23|||
170602020|NCT01959841|616549555|FG002|Overall Study|Protocol Violation|16|||
170602021|NCT01959841|616549553|FG000|Overall Study|Withdrawal by Subject|7|||
170602022|NCT01959841|616549554|FG001|Overall Study|Withdrawal by Subject|7|||
170602023|NCT01959841|616549555|FG002|Overall Study|Withdrawal by Subject|5|||
170602024|NCT01959841|616549553|FG000|Overall Study|Clinical laboratory value|2|||
170602025|NCT01959841|616549554|FG001|Overall Study|Clinical laboratory value|6|||
170602026|NCT01959841|616549555|FG002|Overall Study|Clinical laboratory value|6|||
170602027|NCT01959841|616549553|FG000|Overall Study|Platelet count below on day1 or 4|11|||
170813197|NCT01799993|617324172|FG000|Overall Study|Screen failure|0|||
170813198|NCT01799993|617324173|FG001|Overall Study|Screen failure|1|||
170813199|NCT01799993|617324172|FG000|Overall Study|Adverse Event|1|||
170813200|NCT01799993|617324173|FG001|Overall Study|Adverse Event|0|||
170602028|NCT01959841|616549554|FG001|Overall Study|Platelet count below on day1 or 4|15|||
170602029|NCT01959841|616549555|FG002|Overall Study|Platelet count below on day1 or 4|11|||
170652176|NCT00266877|616740097|FG002|Overall Study|Adverse Event|1|||
170602030|NCT01041287|616549557|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
170652177|NCT00266877|616740095|FG000|Overall Study|Physician Decision|2|||
170813201|NCT01799993|617324172|FG000|Overall Study|Lack of Efficacy|1|||
170813202|NCT01799993|617324173|FG001|Overall Study|Lack of Efficacy|0|||
170602031|NCT01041287|616549558|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
170602032|NCT01041287|616549557|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
170602033|NCT01041287|616549558|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
170602034|NCT00655629|616549571|FG000|Overall Study|Adverse Event|4|||
170602035|NCT00655629|616549572|FG001|Overall Study|Adverse Event|1|||
170602036|NCT00655629|616549571|FG000|Overall Study|Lack of Efficacy|2|||
170602037|NCT00655629|616549572|FG001|Overall Study|Lack of Efficacy|12|||
170602038|NCT00655629|616549571|FG000|Overall Study|Lost to Follow-up|4|||
170602039|NCT00655629|616549572|FG001|Overall Study|Lost to Follow-up|3|||
170602040|NCT00655629|616549571|FG000|Overall Study|Protocol Violation|5|||
170602041|NCT00655629|616549572|FG001|Overall Study|Protocol Violation|3|||
170602042|NCT00655629|616549571|FG000|Overall Study|consent withdrawn|6|||
170602043|NCT00655629|616549572|FG001|Overall Study|consent withdrawn|4|||
170602044|NCT03416127|616549575|FG000|Overall Study|Withdrawal by Subject|0|||
170602045|NCT03416127|616549576|FG001|Overall Study|Withdrawal by Subject|1|||
170602046|NCT03416127|616549577|FG002|Overall Study|Withdrawal by Subject|1|||
170602047|NCT01971008|616549578|FG000|Overall Study|Protocol Violation|2|||
170602048|NCT01971008|616549579|FG001|Overall Study|Protocol Violation|1|||
170602049|NCT00082407|616549582|FG000|Overall Study|Adverse Event|20|||
170602050|NCT00082407|616549583|FG001|Overall Study|Adverse Event|0|||
170602051|NCT00082407|616549582|FG000|Overall Study|Protocol Violation|14|||
170602052|NCT00082407|616549583|FG001|Overall Study|Protocol Violation|12|||
170602053|NCT00082407|616549582|FG000|Overall Study|Patient Decision|13|||
170602054|NCT00082407|616549583|FG001|Overall Study|Patient Decision|6|||
170602055|NCT00082407|616549582|FG000|Overall Study|Physician Decision|5|||
170602056|NCT00082407|616549583|FG001|Overall Study|Physician Decision|3|||
170602057|NCT00082407|616549582|FG000|Overall Study|Loss of Glucose Control|2|||
170602058|NCT00082407|616549583|FG001|Overall Study|Loss of Glucose Control|2|||
170602059|NCT00082407|616549582|FG000|Overall Study|Death|2|||
170602060|NCT00082407|616549583|FG001|Overall Study|Death|1|||
170602061|NCT00082407|616549582|FG000|Overall Study|Lost to Follow-up|0|||
170602062|NCT00082407|616549583|FG001|Overall Study|Lost to Follow-up|3|||
170602063|NCT01754493|616549584|FG000|Overall Study|Adverse Event|1|||
170602064|NCT01754493|616549584|FG000|Overall Study|Lost to Follow-up|3|||
170602065|NCT01754493|616549584|FG000|Overall Study|Withdrawal by Subject|1|||
170602066|NCT01754493|616549584|FG000|Overall Study|Moved out of town|1|||
170602067|NCT01754493|616549584|FG000|Overall Study|Scheduling conflict|1|||
170602068|NCT03464019|616549585|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
170602069|NCT03464019|616549586|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
170602070|NCT03464019|616549587|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
170602071|NCT03464019|616549585|FG000|NODE-301 Part 1|Ablation|0|||
170602072|NCT03464019|616549586|FG001|NODE-301 Part 1|Ablation|0|||
170602073|NCT03464019|616549587|FG002|NODE-301 Part 1|Ablation|16|||
170602074|NCT03464019|616549585|FG000|NODE-301 Part 1|Test Dose Failure|0|||
170602075|NCT03464019|616549586|FG001|NODE-301 Part 1|Test Dose Failure|0|||
170602076|NCT03464019|616549587|FG002|NODE-301 Part 1|Test Dose Failure|8|||
170602077|NCT03464019|616549585|FG000|NODE-301 Part 1|Adverse Event|0|||
170602078|NCT03464019|616549586|FG001|NODE-301 Part 1|Adverse Event|0|||
170602079|NCT03464019|616549587|FG002|NODE-301 Part 1|Adverse Event|5|||
170602080|NCT03464019|616549585|FG000|NODE-301 Part 1|Physician Decision|0|||
170602081|NCT03464019|616549586|FG001|NODE-301 Part 1|Physician Decision|0|||
170602082|NCT03464019|616549587|FG002|NODE-301 Part 1|Physician Decision|4|||
170602083|NCT03464019|616549585|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
170602084|NCT03464019|616549586|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
170602085|NCT03464019|616549587|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
170602086|NCT03464019|616549585|FG000|NODE-301 Part 1|Protocol Violation|0|||
170602087|NCT03464019|616549586|FG001|NODE-301 Part 1|Protocol Violation|0|||
170602088|NCT03464019|616549587|FG002|NODE-301 Part 1|Protocol Violation|2|||
170602089|NCT03464019|616549585|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
170652178|NCT00266877|616740096|FG001|Overall Study|Physician Decision|1|||
170652179|NCT00266877|616740097|FG002|Overall Study|Physician Decision|1|||
170652180|NCT00266877|616740095|FG000|Overall Study|Withdrawal by Subject|3|||
170652181|NCT00266877|616740096|FG001|Overall Study|Withdrawal by Subject|1|||
170602090|NCT03464019|616549586|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
170913848|NCT00090285|617687649|FG002|Extension 1|Adverse Event|2|||
170913849|NCT00090285|617687650|FG003|Extension 1|Adverse Event|0|||
170913850|NCT00090285|617687651|FG004|Extension 1|Adverse Event|0|||
170913851|NCT00090285|617687652|FG005|Extension 1|Adverse Event|0|||
170602091|NCT03464019|616549587|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
170602092|NCT03464019|616549585|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
170602093|NCT03464019|616549586|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
170602094|NCT03464019|616549587|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
170602095|NCT03464019|616549585|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
170602096|NCT03464019|616549586|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
170602097|NCT03464019|616549587|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
170913852|NCT00090285|617687647|FG000|Extension 1|Lost to Follow-up|0|||
170913853|NCT00090285|617687648|FG001|Extension 1|Lost to Follow-up|0|||
170602098|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
170602099|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
170602100|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
170602101|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
170602102|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
170602103|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
170602104|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
170602105|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
170602106|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
170602107|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
170602108|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
170602109|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
170602110|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
170602111|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
170602112|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
170602113|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
170602114|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
170602115|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
170602116|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
170602117|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
170602118|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
170602119|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
170602120|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
170602121|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
170602122|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
170602123|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
170602124|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
170602125|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
170602126|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
170602127|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
170602128|NCT03464019|616549585|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
170602129|NCT03464019|616549586|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
170602130|NCT03464019|616549587|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
170602131|NCT00767806|616549588|FG000|Overall Study|Adverse Event|30|||
170602132|NCT00767806|616549589|FG001|Overall Study|Adverse Event|11|||
170602133|NCT00767806|616549588|FG000|Overall Study|Withdrawal by Subject|8|||
170602134|NCT00767806|616549589|FG001|Overall Study|Withdrawal by Subject|13|||
170602135|NCT00767806|616549588|FG000|Overall Study|Protocol Violation|6|||
170602136|NCT00767806|616549589|FG001|Overall Study|Protocol Violation|5|||
170602137|NCT00767806|616549588|FG000|Overall Study|Lack of Efficacy|1|||
170602138|NCT00767806|616549589|FG001|Overall Study|Lack of Efficacy|9|||
170602139|NCT00767806|616549588|FG000|Overall Study|Physician Decision|4|||
170652182|NCT00266877|616740097|FG002|Overall Study|Withdrawal by Subject|1|||
170652183|NCT00266877|616740095|FG000|Overall Study|Disease Progression|72|||
170652184|NCT00266877|616740096|FG001|Overall Study|Disease Progression|37|||
170652185|NCT00266877|616740097|FG002|Overall Study|Disease Progression|23|||
170813203|NCT01799993|617324172|FG000|Overall Study|Recovery|0|||
170602140|NCT00767806|616549589|FG001|Overall Study|Physician Decision|3|||
170602141|NCT00767806|616549588|FG000|Overall Study|Lost to Follow-up|1|||
170602142|NCT00767806|616549589|FG001|Overall Study|Lost to Follow-up|4|||
170602143|NCT00767806|616549588|FG000|Overall Study|Entry Criteria Not Met|1|||
170602144|NCT00767806|616549589|FG001|Overall Study|Entry Criteria Not Met|1|||
170602145|NCT00767806|616549588|FG000|Overall Study|Sponsor Decision|0|||
170813204|NCT01799993|617324173|FG001|Overall Study|Recovery|1|||
170813205|NCT01799993|617324172|FG000|Overall Study|Logistical difficulties|1|||
170813206|NCT01799993|617324173|FG001|Overall Study|Logistical difficulties|0|||
170813207|NCT01799993|617324172|FG000|Overall Study|Protocol deviation|1|||
170813208|NCT01799993|617324173|FG001|Overall Study|Protocol deviation|0|||
170813209|NCT01799993|617324172|FG000|Overall Study|Non-compliance with medical device|1|||
170813210|NCT01799993|617324173|FG001|Overall Study|Non-compliance with medical device|0|||
170813211|NCT01799993|617324172|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170813212|NCT01799993|617324173|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170813213|NCT01799993|617324172|FG000|Overall Study|Other|1|||
170813214|NCT01799993|617324173|FG001|Overall Study|Other|0|||
170813215|NCT01799993|617324172|FG000|Overall Study|Subject didn't return for follow-up|0|||
170813216|NCT01799993|617324173|FG001|Overall Study|Subject didn't return for follow-up|1|||
170813217|NCT04410445|617324174|FG000|Overall Study|Lost to Follow-up|3|||
170813218|NCT04410445|617324175|FG001|Overall Study|Lost to Follow-up|9|||
170813219|NCT04410445|617324174|FG000|Overall Study|Withdrawal by Subject|27|||
170813220|NCT04410445|617324175|FG001|Overall Study|Withdrawal by Subject|15|||
170813221|NCT01320683|617324176|FG000|Overall Study|Positive antibody response|1|||
170813222|NCT01123356|617324177|FG000|Overall Study|Adverse Event|2|||
170813223|NCT01123356|617324177|FG000|Overall Study|Lack of Efficacy|4|||
170813224|NCT01123356|617324177|FG000|Overall Study|Withdrawal by Subject|1|||
170602146|NCT00767806|616549589|FG001|Overall Study|Sponsor Decision|1|||
170602147|NCT02489942|616549590|FG000|Overall Study|Request by patient|602|||
170602148|NCT02489942|616549590|FG000|Overall Study|Improvement/remission|157|||
170602149|NCT02489942|616549590|FG000|Overall Study|No change/Progressive disease|263|||
170602150|NCT02489942|616549590|FG000|Overall Study|Adverse Event|522|||
170602151|NCT02489942|616549590|FG000|Overall Study|Other personal reasons|1218|||
170602152|NCT02489942|616549590|FG000|Overall Study|Lost to Follow-up|456|||
170602153|NCT02489942|616549590|FG000|Overall Study|Not continuously investigated|7|||
170602154|NCT02489942|616549590|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
170602155|NCT02489942|616549590|FG000|Overall Study|Multiple registration|1|||
170813225|NCT04361617|617324180|FG000|Overall Study|Withdrawal by Subject|0|||
170602156|NCT02489942|616549590|FG000|Overall Study|No patient visit after entry|100|||
170602157|NCT02489942|616549590|FG000|Overall Study|No treatment with Jardiance|2|||
170602158|NCT02489942|616549590|FG000|Overall Study|Patient received Jardiance before registration|1|||
170602159|NCT02489942|616549590|FG000|Overall Study|No CRF collected|86|||
170602160|NCT00858208|616549591|FG000|Overall Study|Adverse Event|3|||
170602161|NCT00858208|616549591|FG000|Overall Study|Lost to Follow-up|26|||
170602162|NCT00858208|616549591|FG000|Overall Study|Participant refused|40|||
170602163|NCT00858208|616549591|FG000|Overall Study|Other|10|||
170602164|NCT01272635|616549592|FG000|Overall Study|Lost to Follow-up|31|||
170602165|NCT01272635|616549593|FG001|Overall Study|Lost to Follow-up|20|||
170602166|NCT01272635|616549594|FG002|Overall Study|Lost to Follow-up|31|||
170602167|NCT01272635|616549595|FG003|Overall Study|Lost to Follow-up|23|||
170602168|NCT01543776|616549596|FG000|Overall Study|Withdrawal by Subject|2|||
170602169|NCT01543776|616549597|FG001|Overall Study|Withdrawal by Subject|2|||
170602170|NCT00306527|616549598|FG000|Overall Study|Lost to Follow-up|3|||
170602171|NCT00306527|616549599|FG001|Overall Study|Lost to Follow-up|4|||
170602172|NCT00306527|616549600|FG002|Overall Study|Lost to Follow-up|3|||
170602173|NCT00306527|616549601|FG003|Overall Study|Lost to Follow-up|0|||
170602174|NCT00306527|616549598|FG000|Overall Study|Withdrawal by Subject|2|||
170602175|NCT00306527|616549599|FG001|Overall Study|Withdrawal by Subject|3|||
170602176|NCT00306527|616549600|FG002|Overall Study|Withdrawal by Subject|0|||
170602177|NCT00306527|616549601|FG003|Overall Study|Withdrawal by Subject|3|||
170602178|NCT00306527|616549598|FG000|Overall Study|Adverse Event|0|||
170602179|NCT00306527|616549599|FG001|Overall Study|Adverse Event|0|||
170602180|NCT00306527|616549600|FG002|Overall Study|Adverse Event|1|||
170602181|NCT00306527|616549601|FG003|Overall Study|Adverse Event|1|||
170602182|NCT00306527|616549598|FG000|Overall Study|Death|1|||
170602183|NCT00306527|616549599|FG001|Overall Study|Death|0|||
170602184|NCT00306527|616549600|FG002|Overall Study|Death|1|||
170602185|NCT00306527|616549601|FG003|Overall Study|Death|2|||
170813226|NCT04361617|617324181|FG001|Overall Study|Withdrawal by Subject|1|||
170813227|NCT00700999|617324189|FG000|Overall Study|Lost to Follow-up|7|||
170813228|NCT00700999|617324190|FG001|Overall Study|Lost to Follow-up|7|||
170813229|NCT00700999|617324189|FG000|Overall Study|Excluded - did not meet study criteria|0|||
170813230|NCT00700999|617324190|FG001|Overall Study|Excluded - did not meet study criteria|1|||
170813231|NCT00700999|617324189|FG000|Overall Study|Withdrawal by Subject|8|||
170813232|NCT00700999|617324190|FG001|Overall Study|Withdrawal by Subject|1|||
170813233|NCT02170207|617324191|FG000|Overall Study|Case report forms unavailable|5|||
170813234|NCT05445557|617324192|FG000|Double Blind Part|Lost to Follow-up|1|||
170813235|NCT02915783|617324193|FG000|Overall Study|Death|21|||
170813236|NCT02915783|617324193|FG000|Overall Study|Lost to Follow-up|1|||
170813237|NCT02915783|617324193|FG000|Overall Study|Withdrawal by Subject|2|||
170813238|NCT00960206|617324194|FG000|Overall Study|Death|7|||
170813239|NCT00960206|617324195|FG001|Overall Study|Death|4|||
170813240|NCT00960206|617324196|FG002|Overall Study|Death|1|||
170813241|NCT00960206|617324194|FG000|Overall Study|Unwilling/Unable to return|1|||
170813242|NCT00960206|617324195|FG001|Overall Study|Unwilling/Unable to return|2|||
170813243|NCT00960206|617324196|FG002|Overall Study|Unwilling/Unable to return|0|||
170813244|NCT00960206|617324194|FG000|Overall Study|Lost to Follow-up|8|||
170813245|NCT00960206|617324195|FG001|Overall Study|Lost to Follow-up|14|||
170813246|NCT00960206|617324196|FG002|Overall Study|Lost to Follow-up|8|||
170602186|NCT00567359|616549602|FG000|Overall Study|Withdrawal by Subject|1|||
170602187|NCT02397057|616549603|FG000|Overall Study|Withdrawal by Subject|6|||
170602188|NCT02397057|616549604|FG001|Overall Study|Withdrawal by Subject|7|||
170602189|NCT02397057|616549603|FG000|Overall Study|Lost to Follow-up|4|||
170602190|NCT02397057|616549604|FG001|Overall Study|Lost to Follow-up|3|||
170602191|NCT02397057|616549603|FG000|Overall Study|Death|1|||
170602192|NCT02397057|616549604|FG001|Overall Study|Death|0|||
170602193|NCT02397057|616549603|FG000|Overall Study|Adverse Event|0|||
170602194|NCT02397057|616549604|FG001|Overall Study|Adverse Event|1|||
170602195|NCT02397057|616549603|FG000|Overall Study|Physician Decision|0|||
170602196|NCT02397057|616549604|FG001|Overall Study|Physician Decision|1|||
170602197|NCT02397057|616549603|FG000|Overall Study|Subject did not receive study drug|0|||
170602198|NCT02397057|616549604|FG001|Overall Study|Subject did not receive study drug|1|||
170602199|NCT02352753|616549605|FG000|6-Month Dosing Period|Decision by sponsor|2|||
170602200|NCT02352753|616549605|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
170602201|NCT02352753|616549605|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
170602202|NCT02352753|616549605|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
170602203|NCT02352753|616549605|FG000|3-Month Dosing Period|Decision by sponsor|14|||
170602204|NCT02352753|616549605|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
170602205|NCT00126776|616549606|FG000|Overall Study|follow up complete on all patients|0|||
170602206|NCT00126776|616549607|FG001|Overall Study|follow up complete on all patients|0|||
170602207|NCT00679172|616549610|FG000|Overall Study|Non-compliance|1|||
170602208|NCT00679172|616549611|FG001|Overall Study|Non-compliance|1|||
170602209|NCT00679172|616549612|FG002|Overall Study|Non-compliance|0|||
170602210|NCT00679172|616549613|FG003|Overall Study|Non-compliance|1|||
170602211|NCT00679172|616549614|FG004|Overall Study|Non-compliance|0|||
170602212|NCT00679172|616549610|FG000|Overall Study|Other not specified|0|||
170813247|NCT00960206|617324194|FG000|Overall Study|Withdrawal by Subject|2|||
170813248|NCT00960206|617324195|FG001|Overall Study|Withdrawal by Subject|4|||
170813249|NCT00960206|617324196|FG002|Overall Study|Withdrawal by Subject|0|||
170813250|NCT00960206|617324194|FG000|Overall Study|Revision of study component|2|||
170813251|NCT00960206|617324195|FG001|Overall Study|Revision of study component|2|||
170813252|NCT00960206|617324196|FG002|Overall Study|Revision of study component|2|||
170813253|NCT00960206|617324194|FG000|Overall Study|Missing 10 year data|20|||
170813254|NCT00960206|617324195|FG001|Overall Study|Missing 10 year data|1|||
170813255|NCT00960206|617324196|FG002|Overall Study|Missing 10 year data|1|||
170813256|NCT01736475|617324197|FG000|Overall Study|Adverse Event|4|||
170813257|NCT01736475|617324198|FG001|Overall Study|Adverse Event|0|||
170813258|NCT01736475|617324197|FG000|Overall Study|Withdrawal by Subject|2|||
170813259|NCT01736475|617324198|FG001|Overall Study|Withdrawal by Subject|0|||
170813260|NCT01736475|617324197|FG000|Overall Study|Protocol Violation|4|||
170813261|NCT01736475|617324198|FG001|Overall Study|Protocol Violation|0|||
170813262|NCT01736475|617324197|FG000|Overall Study|Other - Screen failure|1|||
170813263|NCT01736475|617324198|FG001|Overall Study|Other - Screen failure|0|||
170813264|NCT01736475|617324197|FG000|Overall Study|Other - Surgical procedure|1|||
170813265|NCT01736475|617324198|FG001|Overall Study|Other - Surgical procedure|0|||
170813266|NCT03242863|617324200|FG000|Study Week 1|Withdrawal by Subject|0|||
170813267|NCT03242863|617324201|FG001|Study Week 1|Withdrawal by Subject|1|||
170813268|NCT03242863|617324202|FG002|Study Week 1|Withdrawal by Subject|0|||
170813269|NCT03242863|617324203|FG003|Study Week 1|Withdrawal by Subject|0|||
170813270|NCT03242863|617324204|FG004|Study Week 1|Withdrawal by Subject|3|||
170813271|NCT03242863|617324205|FG005|Study Week 1|Withdrawal by Subject|0|||
170813272|NCT05066230|617325836|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
170813273|NCT05066230|617325837|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
170813274|NCT05066230|617325836|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
170813275|NCT05066230|617325837|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
170813276|NCT05066230|617325836|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
170813277|NCT05066230|617325837|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
170813278|NCT05066230|617325836|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
170813279|NCT05066230|617325837|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
170813280|NCT05066230|617325836|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
170813281|NCT05066230|617325837|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
170813282|NCT05066230|617325836|FG000|After Week 48|Adverse Event|1|||
170813283|NCT05066230|617325837|FG001|After Week 48|Adverse Event|0|||
170813284|NCT05066230|617325836|FG000|After Week 48|Non-compliance with study schedule|1|||
170813285|NCT05066230|617325837|FG001|After Week 48|Non-compliance with study schedule|0|||
170813286|NCT05066230|617325836|FG000|After Week 48|Withdrawal by Subject|0|||
170813287|NCT05066230|617325837|FG001|After Week 48|Withdrawal by Subject|1|||
170813288|NCT05066230|617325836|FG000|After Week 48|Lost to Follow-up|3|||
170913854|NCT00090285|617687649|FG002|Extension 1|Lost to Follow-up|35|||
170913855|NCT00090285|617687650|FG003|Extension 1|Lost to Follow-up|0|||
170913856|NCT00090285|617687651|FG004|Extension 1|Lost to Follow-up|0|||
170602213|NCT00679172|616549611|FG001|Overall Study|Other not specified|0|||
170602214|NCT00679172|616549612|FG002|Overall Study|Other not specified|1|||
170602215|NCT00679172|616549613|FG003|Overall Study|Other not specified|0|||
170602216|NCT00679172|616549614|FG004|Overall Study|Other not specified|0|||
170602217|NCT00417963|616549615|FG000|Overall Study|Lost to Follow-up|3|||
170602218|NCT00417963|616549615|FG000|Overall Study|Withdrawal by Subject|18|||
170602219|NCT00417963|616549615|FG000|Overall Study|Death|17|||
170602220|NCT00417963|616549615|FG000|Overall Study|Study device could not be deployed|3|||
170602221|NCT01055314|616549616|FG000|Overall Study|Adverse Event|7|||
170602222|NCT01055314|616549617|FG001|Overall Study|Adverse Event|4|||
170602223|NCT01055314|616549616|FG000|Overall Study|Death|2|||
170602224|NCT01055314|616549617|FG001|Overall Study|Death|1|||
170913857|NCT00090285|617687652|FG005|Extension 1|Lost to Follow-up|0|||
170913858|NCT00090285|617687647|FG000|Extension 1|Withdrawal by Subject|0|||
170602225|NCT01055314|616549616|FG000|Overall Study|Lack of Efficacy|11|||
170602226|NCT01055314|616549617|FG001|Overall Study|Lack of Efficacy|19|||
170602227|NCT01055314|616549616|FG000|Overall Study|Physician Decision|10|||
170602228|NCT01055314|616549617|FG001|Overall Study|Physician Decision|5|||
170602229|NCT01055314|616549616|FG000|Overall Study|Withdrawal by Subject|1|||
170602230|NCT01055314|616549617|FG001|Overall Study|Withdrawal by Subject|0|||
170602231|NCT01055314|616549616|FG000|Overall Study|Ineligible|3|||
170602232|NCT01055314|616549617|FG001|Overall Study|Ineligible|5|||
170602233|NCT01055314|616549616|FG000|Overall Study|Refusal of further protocol therapy|10|||
170602234|NCT01055314|616549617|FG001|Overall Study|Refusal of further protocol therapy|4|||
170602235|NCT01055314|616549616|FG000|Overall Study|No treatment|1|||
170602236|NCT01055314|616549617|FG001|Overall Study|No treatment|0|||
170602237|NCT00753454|616549618|FG000|Overall Study|Adverse Event|4|||
170602238|NCT00753454|616549618|FG000|Overall Study|Lack of Efficacy|1|||
170602239|NCT00753454|616549618|FG000|Overall Study|Lost to Follow-up|3|||
170602240|NCT00753454|616549618|FG000|Overall Study|Withdrawal by Subject|5|||
170602241|NCT00753454|616549618|FG000|Overall Study|Investigator Decision|1|||
170602242|NCT05856227|616549627|FG000|Overall Study|Adverse Event|0|||
170602243|NCT05856227|616549628|FG001|Overall Study|Adverse Event|1|||
170602244|NCT05856227|616549627|FG000|Overall Study|Due to Investigator absence|1|||
170602245|NCT05856227|616549628|FG001|Overall Study|Due to Investigator absence|0|||
170602246|NCT05856227|616549627|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
170602247|NCT05856227|616549628|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
170602248|NCT05011058|616549629|FG000|Overall Study|Sponsor Decision|2|||
170602249|NCT05011058|616549630|FG001|Overall Study|Sponsor Decision|0|||
170602250|NCT05011058|616549631|FG002|Overall Study|Sponsor Decision|14|||
170602251|NCT05011058|616549632|FG003|Overall Study|Sponsor Decision|0|||
170602252|NCT05011058|616549633|FG004|Overall Study|Sponsor Decision|0|||
170602253|NCT05011058|616549634|FG005|Overall Study|Sponsor Decision|1|||
170602254|NCT05011058|616549635|FG006|Overall Study|Sponsor Decision|0|||
170602255|NCT05011058|616549636|FG007|Overall Study|Sponsor Decision|5|||
170602256|NCT03908476|616549637|FG000|Overall Study|Death|3|||
170602257|NCT03908476|616549638|FG001|Overall Study|Death|0|||
170602258|NCT03908476|616549637|FG000|Overall Study|Lost to Follow-up|3|||
170602259|NCT03908476|616549638|FG001|Overall Study|Lost to Follow-up|1|||
170602260|NCT03908476|616549637|FG000|Overall Study|Withdrawal by Subject|7|||
170602261|NCT03908476|616549638|FG001|Overall Study|Withdrawal by Subject|1|||
170602262|NCT03908476|616549637|FG000|Overall Study|Physician Decision|2|||
170602263|NCT03908476|616549638|FG001|Overall Study|Physician Decision|0|||
170602264|NCT03908476|616549637|FG000|Overall Study|System Explanted and not Replaced|4|||
170602265|NCT03908476|616549638|FG001|Overall Study|System Explanted and not Replaced|0|||
170602266|NCT03908476|616549637|FG000|Overall Study|Intrathecal Pump|1|||
170602267|NCT03908476|616549638|FG001|Overall Study|Intrathecal Pump|0|||
170602268|NCT03908476|616549637|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
170602269|NCT03908476|616549638|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
170602270|NCT02868229|616549639|FG000|Overall Study|Adverse Event|1|||
170602271|NCT02868229|616549640|FG001|Overall Study|Adverse Event|0|||
170602272|NCT02868229|616549641|FG002|Overall Study|Adverse Event|0|||
170602273|NCT02868229|616549642|FG003|Overall Study|Adverse Event|1|||
170602274|NCT02868229|616549639|FG000|Overall Study|Death|0|||
170602275|NCT02868229|616549640|FG001|Overall Study|Death|0|||
170602276|NCT02868229|616549641|FG002|Overall Study|Death|1|||
170602277|NCT02868229|616549642|FG003|Overall Study|Death|1|||
170602278|NCT02868229|616549639|FG000|Overall Study|Missed dose|0|||
170602279|NCT02868229|616549640|FG001|Overall Study|Missed dose|0|||
170602280|NCT02868229|616549641|FG002|Overall Study|Missed dose|0|||
170602281|NCT02868229|616549642|FG003|Overall Study|Missed dose|3|||
170602282|NCT00320424|616549643|FG000|Overall Study|Adverse Event|3|||
170602283|NCT00320424|616549643|FG000|Overall Study|Other|3|||
170602284|NCT06151288|616549645|FG000|Overall Study|Lost to Follow-up|4|||
170602285|NCT06151288|616549646|FG001|Overall Study|Lost to Follow-up|2|||
170602286|NCT06151288|616549647|FG002|Overall Study|Lost to Follow-up|4|||
170602287|NCT06151288|616549648|FG003|Overall Study|Lost to Follow-up|3|||
170602288|NCT06151288|616549645|FG000|Overall Study|Withdrawal by Subject|4|||
170602289|NCT06151288|616549646|FG001|Overall Study|Withdrawal by Subject|5|||
170602290|NCT06151288|616549647|FG002|Overall Study|Withdrawal by Subject|1|||
170602291|NCT06151288|616549648|FG003|Overall Study|Withdrawal by Subject|1|||
170652186|NCT00266877|616740095|FG000|Overall Study|Symptomatic Deterioration|6|||
170602292|NCT02211313|616549649|FG000|Overall Study|Treatment Failure|5|||
170602293|NCT02211313|616549650|FG001|Overall Study|Treatment Failure|2|||
170602294|NCT02211313|616549649|FG000|Overall Study|No Follow up Questionnaires|1|||
170602295|NCT02211313|616549650|FG001|Overall Study|No Follow up Questionnaires|1|||
170602296|NCT00545103|616549652|FG000|Overall Study|Lack of Efficacy|48|||
170602297|NCT00545103|616549653|FG001|Overall Study|Lack of Efficacy|45|||
170602298|NCT00545103|616549654|FG002|Overall Study|Lack of Efficacy|31|||
170602299|NCT00545103|616549655|FG003|Overall Study|Lack of Efficacy|27|||
170602300|NCT00545103|616549652|FG000|Overall Study|Withdrawal by Subject|6|||
170602301|NCT00545103|616549653|FG001|Overall Study|Withdrawal by Subject|10|||
170602302|NCT00545103|616549654|FG002|Overall Study|Withdrawal by Subject|18|||
170602303|NCT00545103|616549655|FG003|Overall Study|Withdrawal by Subject|22|||
170602304|NCT00545103|616549652|FG000|Overall Study|Adverse Event|11|||
170602305|NCT00545103|616549653|FG001|Overall Study|Adverse Event|12|||
170602306|NCT00545103|616549654|FG002|Overall Study|Adverse Event|17|||
170602307|NCT00545103|616549655|FG003|Overall Study|Adverse Event|10|||
170602308|NCT00545103|616549652|FG000|Overall Study|Lost to Follow-up|4|||
170813289|NCT05066230|617325837|FG001|After Week 48|Lost to Follow-up|3|||
170813290|NCT05066230|617325836|FG000|After Week 48|Sponsor Request|115|||
170813291|NCT05066230|617325837|FG001|After Week 48|Sponsor Request|111|||
170813292|NCT02507297|617325838|FG000|Overall Study|Withdrawal by Subject|1|||
170813293|NCT02507297|617325839|FG001|Overall Study|Withdrawal by Subject|0|||
170813294|NCT02507297|617325838|FG000|Overall Study|Lost to Follow-up|0|||
170602309|NCT00545103|616549653|FG001|Overall Study|Lost to Follow-up|6|||
170602310|NCT00545103|616549654|FG002|Overall Study|Lost to Follow-up|3|||
170602311|NCT00545103|616549655|FG003|Overall Study|Lost to Follow-up|4|||
170602312|NCT00545103|616549652|FG000|Overall Study|Protocol Violation|1|||
170602313|NCT00545103|616549653|FG001|Overall Study|Protocol Violation|2|||
170602314|NCT00545103|616549654|FG002|Overall Study|Protocol Violation|3|||
170602315|NCT00545103|616549655|FG003|Overall Study|Protocol Violation|0|||
170602316|NCT00545103|616549652|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
170602317|NCT00545103|616549653|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
170602318|NCT00545103|616549654|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
170602319|NCT00545103|616549655|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
170602320|NCT00545103|616549652|FG000|Overall Study|Difficult to open package|0|||
170602321|NCT00545103|616549653|FG001|Overall Study|Difficult to open package|0|||
170602322|NCT00545103|616549654|FG002|Overall Study|Difficult to open package|0|||
170602323|NCT00545103|616549655|FG003|Overall Study|Difficult to open package|1|||
170602324|NCT00545103|616549652|FG000|Overall Study|Investigational product not taken|1|||
170602325|NCT00545103|616549653|FG001|Overall Study|Investigational product not taken|0|||
170602326|NCT00545103|616549654|FG002|Overall Study|Investigational product not taken|0|||
170602327|NCT00545103|616549655|FG003|Overall Study|Investigational product not taken|1|||
170602328|NCT00545103|616549652|FG000|Overall Study|Wish to start a family|0|||
170602329|NCT00545103|616549653|FG001|Overall Study|Wish to start a family|0|||
170602330|NCT00545103|616549654|FG002|Overall Study|Wish to start a family|0|||
170602331|NCT00545103|616549655|FG003|Overall Study|Wish to start a family|1|||
170602332|NCT00545103|616549652|FG000|Overall Study|Diverticulitis crisis|0|||
170602333|NCT00545103|616549653|FG001|Overall Study|Diverticulitis crisis|0|||
170602334|NCT00545103|616549654|FG002|Overall Study|Diverticulitis crisis|0|||
170602335|NCT00545103|616549655|FG003|Overall Study|Diverticulitis crisis|1|||
170602336|NCT00545103|616549652|FG000|Overall Study|Personal reasons|1|||
170602337|NCT00545103|616549653|FG001|Overall Study|Personal reasons|0|||
170602338|NCT00545103|616549654|FG002|Overall Study|Personal reasons|0|||
170602339|NCT00545103|616549655|FG003|Overall Study|Personal reasons|0|||
170602340|NCT00545103|616549652|FG000|Overall Study|Subject's decision|1|||
170602341|NCT00545103|616549653|FG001|Overall Study|Subject's decision|0|||
170602342|NCT00545103|616549654|FG002|Overall Study|Subject's decision|0|||
170602343|NCT00545103|616549655|FG003|Overall Study|Subject's decision|0|||
170602344|NCT00545103|616549652|FG000|Overall Study|Noncompliance|0|||
170602345|NCT00545103|616549653|FG001|Overall Study|Noncompliance|1|||
170602346|NCT00545103|616549654|FG002|Overall Study|Noncompliance|0|||
170602347|NCT00545103|616549655|FG003|Overall Study|Noncompliance|0|||
170602348|NCT00545103|616549652|FG000|Overall Study|Investigator decision|0|||
170602349|NCT00545103|616549653|FG001|Overall Study|Investigator decision|0|||
170602350|NCT00545103|616549654|FG002|Overall Study|Investigator decision|1|||
170602351|NCT00545103|616549655|FG003|Overall Study|Investigator decision|0|||
170602352|NCT00545103|616549652|FG000|Overall Study|Subject moved|0|||
170602353|NCT00545103|616549653|FG001|Overall Study|Subject moved|1|||
170602354|NCT00545103|616549654|FG002|Overall Study|Subject moved|0|||
170602355|NCT00545103|616549655|FG003|Overall Study|Subject moved|0|||
170602356|NCT00545103|616549652|FG000|Overall Study|Use of prohibited medication|0|||
170602357|NCT00545103|616549653|FG001|Overall Study|Use of prohibited medication|0|||
170602358|NCT00545103|616549654|FG002|Overall Study|Use of prohibited medication|1|||
170602359|NCT00545103|616549655|FG003|Overall Study|Use of prohibited medication|0|||
170602360|NCT00545103|616549652|FG000|Overall Study|Does not want to take study drug anymore|1|||
170602361|NCT00545103|616549653|FG001|Overall Study|Does not want to take study drug anymore|0|||
170602362|NCT00545103|616549654|FG002|Overall Study|Does not want to take study drug anymore|1|||
170602363|NCT00545103|616549655|FG003|Overall Study|Does not want to take study drug anymore|0|||
170813295|NCT02507297|617325839|FG001|Overall Study|Lost to Follow-up|1|||
170813296|NCT00307489|617325842|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
170602364|NCT00545103|616549652|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
170602365|NCT00545103|616549653|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
170602366|NCT00545103|616549654|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
170602367|NCT00545103|616549655|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
170602368|NCT00545103|616549652|FG000|Overall Study|Death|0|||
170602369|NCT00545103|616549653|FG001|Overall Study|Death|1|||
170602370|NCT00545103|616549654|FG002|Overall Study|Death|0|||
170813297|NCT00307489|617325843|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
170913859|NCT00090285|617687648|FG001|Extension 1|Withdrawal by Subject|0|||
170602371|NCT00545103|616549655|FG003|Overall Study|Death|0|||
170602372|NCT02358044|616549656|FG000|Overall Study|Adverse Event|0|||
170602373|NCT02358044|616549657|FG001|Overall Study|Adverse Event|1|||
170602374|NCT02358044|616549656|FG000|Overall Study|Lost to Follow-up|2|||
170602375|NCT02358044|616549657|FG001|Overall Study|Lost to Follow-up|1|||
170602376|NCT02358044|616549656|FG000|Overall Study|Physician Decision|0|||
170602377|NCT02358044|616549657|FG001|Overall Study|Physician Decision|1|||
170602378|NCT02358044|616549656|FG000|Overall Study|Withdrawal by Subject|0|||
170602379|NCT02358044|616549657|FG001|Overall Study|Withdrawal by Subject|4|||
170602380|NCT01732913|616549658|FG000|Overall Study|Study Terminated by Sponsor|105|||
170602381|NCT01732913|616549659|FG001|Overall Study|Study Terminated by Sponsor|55|||
170602382|NCT01732913|616549658|FG000|Overall Study|Withdrawal by Subject|27|||
170602383|NCT01732913|616549659|FG001|Overall Study|Withdrawal by Subject|4|||
170602384|NCT01732913|616549658|FG000|Overall Study|Physician Decision|14|||
170602385|NCT01732913|616549659|FG001|Overall Study|Physician Decision|7|||
170602386|NCT01732913|616549658|FG000|Overall Study|Other|7|||
170602387|NCT01732913|616549659|FG001|Overall Study|Other|1|||
170602388|NCT01732913|616549658|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
170602389|NCT01732913|616549659|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
170602390|NCT00903331|616549660|FG000|Overall Study|Death|4|||
170813298|NCT00307489|617325842|FG000|Baseline Through Week 48|Physician Decision|1|||
170813299|NCT00307489|617325843|FG001|Baseline Through Week 48|Physician Decision|0|||
170813300|NCT00307489|617325842|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
170813301|NCT00307489|617325843|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
170602391|NCT00903331|616549661|FG001|Overall Study|Death|8|||
170602392|NCT00903331|616549660|FG000|Overall Study|Withdrawal of consent|1|||
170602393|NCT00903331|616549661|FG001|Overall Study|Withdrawal of consent|8|||
170602394|NCT00903331|616549660|FG000|Overall Study|Lung transplant|0|||
170602395|NCT00903331|616549661|FG001|Overall Study|Lung transplant|2|||
170602396|NCT02437084|616549662|FG000|Overall Study|Withdrawal by Subject|2|||
170813302|NCT00307489|617325842|FG000|Week 48 Through Week 168|Adverse Event|1|||
170813303|NCT00307489|617325843|FG001|Week 48 Through Week 168|Adverse Event|0|||
170813304|NCT00307489|617325842|FG000|Week 48 Through Week 168|Physician Decision|1|||
170813305|NCT00307489|617325843|FG001|Week 48 Through Week 168|Physician Decision|0|||
170813306|NCT00307489|617325842|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
170813307|NCT00307489|617325843|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
170813308|NCT00307489|617325842|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
170813309|NCT00307489|617325843|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
170813310|NCT00307489|617325842|FG000|Week 48 Through Week 168|Death|0|||
170813311|NCT00307489|617325843|FG001|Week 48 Through Week 168|Death|1|||
170602397|NCT02437084|616549662|FG000|Overall Study|Physician Decision|1|||
170602398|NCT00454181|616549665|FG000|Overall Study|Adverse Event|1|||
170602399|NCT00454181|616549666|FG001|Overall Study|Adverse Event|1|||
170602400|NCT00454181|616549665|FG000|Overall Study|Lost to Follow-up|11|||
170602401|NCT00454181|616549666|FG001|Overall Study|Lost to Follow-up|1|||
170602402|NCT00454181|616549665|FG000|Overall Study|Protocol Violation|1|||
170602403|NCT00454181|616549666|FG001|Overall Study|Protocol Violation|1|||
170602404|NCT00454181|616549665|FG000|Overall Study|Withdrawal by Subject|2|||
170602405|NCT00454181|616549666|FG001|Overall Study|Withdrawal by Subject|0|||
170602406|NCT01927055|616549668|FG000|Open-label|Adverse Event|6|||
170602407|NCT01927055|616549669|FG001|Open-label|Adverse Event|0|||
170602408|NCT01927055|616549670|FG002|Open-label|Adverse Event|0|||
170602409|NCT01927055|616549668|FG000|Open-label|Withdrawal by Subject|1|||
170602410|NCT01927055|616549669|FG001|Open-label|Withdrawal by Subject|0|||
170602411|NCT01927055|616549670|FG002|Open-label|Withdrawal by Subject|0|||
170602412|NCT01927055|616549668|FG000|Open-label|Study Stopped|4|||
170602413|NCT01927055|616549669|FG001|Open-label|Study Stopped|0|||
170602414|NCT01927055|616549670|FG002|Open-label|Study Stopped|0|||
170602415|NCT01927055|616549668|FG000|Open-label|Supine Hypertension|4|||
170602416|NCT01927055|616549669|FG001|Open-label|Supine Hypertension|0|||
170602417|NCT01927055|616549670|FG002|Open-label|Supine Hypertension|0|||
170602418|NCT01927055|616549668|FG000|Open-label|Difficulty attending study visits|1|||
170602419|NCT01927055|616549669|FG001|Open-label|Difficulty attending study visits|0|||
170602420|NCT01927055|616549670|FG002|Open-label|Difficulty attending study visits|0|||
170602421|NCT01927055|616549668|FG000|Double-Blind|Adverse Event|0|||
170602422|NCT01927055|616549669|FG001|Double-Blind|Adverse Event|1|||
170602423|NCT01927055|616549670|FG002|Double-Blind|Adverse Event|1|||
170602424|NCT01927055|616549668|FG000|Double-Blind|Protocol Violation|0|||
170602425|NCT01927055|616549669|FG001|Double-Blind|Protocol Violation|0|||
170602426|NCT01927055|616549670|FG002|Double-Blind|Protocol Violation|1|||
170602427|NCT01927055|616549668|FG000|Double-Blind|Withdrawal by Subject|0|||
170602428|NCT01927055|616549669|FG001|Double-Blind|Withdrawal by Subject|2|||
170602429|NCT01927055|616549670|FG002|Double-Blind|Withdrawal by Subject|3|||
170602430|NCT01927055|616549668|FG000|Double-Blind|Study Stopped|0|||
170602431|NCT01927055|616549669|FG001|Double-Blind|Study Stopped|7|||
170602432|NCT01927055|616549670|FG002|Double-Blind|Study Stopped|7|||
170602433|NCT01927055|616549668|FG000|Double-Blind|Supine Hypertension|0|||
170602434|NCT01927055|616549669|FG001|Double-Blind|Supine Hypertension|0|||
170602435|NCT01927055|616549670|FG002|Double-Blind|Supine Hypertension|1|||
170602436|NCT01927055|616549668|FG000|Double-Blind|Extended Vacation|0|||
170602437|NCT01927055|616549669|FG001|Double-Blind|Extended Vacation|1|||
170602438|NCT01927055|616549670|FG002|Double-Blind|Extended Vacation|0|||
170602439|NCT02598128|616549671|FG000|Period A: Days -7 to -1|Adverse Event|1|||
170602440|NCT02598128|616549672|FG001|Period A: Days -7 to -1|Adverse Event|0|||
170602441|NCT02598128|616549673|FG002|Period A: Days -7 to -1|Adverse Event|0|||
170602442|NCT02598128|616549674|FG003|Period A: Days -7 to -1|Adverse Event|0|||
170602443|NCT03040986|616549675|FG000|Overall Study|Hospice|1|||
170602444|NCT03040986|616549676|FG001|Overall Study|Hospice|0|||
170602445|NCT03040986|616549675|FG000|Overall Study|Adverse Event|2|||
170602446|NCT03040986|616549676|FG001|Overall Study|Adverse Event|1|||
170602447|NCT03040986|616549675|FG000|Overall Study|Disease progression on study|3|||
170602448|NCT03040986|616549676|FG001|Overall Study|Disease progression on study|1|||
170602449|NCT02383433|616549677|FG000|Overall Study|Disease progression|2|||
170602450|NCT01345682|616549678|FG000|Overall Study|Progressive disease per RECIST|226|||
170602451|NCT01345682|616549679|FG001|Overall Study|Progressive disease per RECIST|93|||
170602452|NCT01345682|616549678|FG000|Overall Study|Worsening of underlying cancer disease|23|||
170602453|NCT01345682|616549679|FG001|Overall Study|Worsening of underlying cancer disease|12|||
170602454|NCT01345682|616549678|FG000|Overall Study|Adverse Event|51|||
170602455|NCT01345682|616549679|FG001|Overall Study|Adverse Event|41|||
170602456|NCT01345682|616549678|FG000|Overall Study|Non-compliance with protocol|0|||
170602457|NCT01345682|616549679|FG001|Overall Study|Non-compliance with protocol|1|||
170602458|NCT01345682|616549678|FG000|Overall Study|Lost to Follow-up|0|||
170602459|NCT01345682|616549679|FG001|Overall Study|Lost to Follow-up|1|||
170602460|NCT01345682|616549678|FG000|Overall Study|Refused to continue trial medication|16|||
170602461|NCT01345682|616549679|FG001|Overall Study|Refused to continue trial medication|9|||
170602462|NCT01345682|616549678|FG000|Overall Study|Not treated|2|||
170602463|NCT01345682|616549679|FG001|Overall Study|Not treated|1|||
170602464|NCT01345682|616549678|FG000|Overall Study|Reason other than those specified above|4|||
170602465|NCT01345682|616549679|FG001|Overall Study|Reason other than those specified above|3|||
170602466|NCT00896649|616549680|FG000|Overall Study|Physician Decision|1|||
170602467|NCT00896649|616549680|FG000|Overall Study|Pregnancy|1|||
170602468|NCT00896649|616549680|FG000|Overall Study|missing documentation|1|||
170602469|NCT00896649|616549680|FG000|Overall Study|technical difficulties|2|||
170602470|NCT03592368|616551443|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
170602471|NCT03592368|616551444|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
170602472|NCT03592368|616551445|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
170602473|NCT03592368|616551446|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
170602474|NCT03592368|616551443|FG000|Overall Study|Adverse Event|0|||
170602475|NCT03592368|616551444|FG001|Overall Study|Adverse Event|0|||
170602476|NCT03592368|616551445|FG002|Overall Study|Adverse Event|0|||
170602477|NCT03592368|616551446|FG003|Overall Study|Adverse Event|1|||
170602478|NCT03592368|616551443|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
170602479|NCT03592368|616551444|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
170602480|NCT03592368|616551445|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
170602481|NCT03592368|616551446|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
170602482|NCT03831100|616551447|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
170602483|NCT03831100|616551448|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
170602484|NCT00742417|616551452|FG000|Randomized|Withdrawal by legal representative|0|||
170602485|NCT00742417|616551453|FG001|Randomized|Withdrawal by legal representative|1|||
170602486|NCT00742417|616551452|FG000|Randomized|Withdrawal by Subject|1|||
170602487|NCT00742417|616551453|FG001|Randomized|Withdrawal by Subject|0|||
170602488|NCT00742417|616551452|FG000|Randomized|Physician Decision|1|||
170602489|NCT00742417|616551453|FG001|Randomized|Physician Decision|0|||
170602490|NCT00742417|616551452|FG000|Intensive Period|Withdrawal by Subject|1|||
170602491|NCT00742417|616551453|FG001|Intensive Period|Withdrawal by Subject|1|||
170602492|NCT00742417|616551452|FG000|Intensive Period|Adverse Event|2|||
170602493|NCT00742417|616551453|FG001|Intensive Period|Adverse Event|0|||
170602494|NCT03775512|616551456|FG000|Overall Study|Death|1|||
170602495|NCT03775512|616551457|FG001|Overall Study|Death|1|||
170602496|NCT03775512|616551456|FG000|Overall Study|Withdrawal by Subject|7|||
170602497|NCT03775512|616551457|FG001|Overall Study|Withdrawal by Subject|4|||
170602498|NCT03775512|616551456|FG000|Overall Study|Lost to Follow-up|5|||
170602499|NCT03775512|616551457|FG001|Overall Study|Lost to Follow-up|5|||
170602500|NCT03775512|616551456|FG000|Overall Study|Excluded before Catheter insertion|14|||
170602501|NCT03775512|616551457|FG001|Overall Study|Excluded before Catheter insertion|5|||
170602502|NCT03775512|616551456|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
170602503|NCT03775512|616551457|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
170913860|NCT00090285|617687649|FG002|Extension 1|Withdrawal by Subject|13|||
170602504|NCT03775512|616551456|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
170602505|NCT03775512|616551457|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
170602506|NCT01835223|616551458|FG000|Overall Study|Adverse Event|1|||
170602507|NCT01835223|616551459|FG001|Overall Study|Adverse Event|0|||
170602508|NCT01835223|616551458|FG000|Overall Study|Withdrawal by Subject|2|||
170602509|NCT01835223|616551459|FG001|Overall Study|Withdrawal by Subject|0|||
170602510|NCT01835223|616551458|FG000|Overall Study|Disease progression|2|||
170602511|NCT01835223|616551459|FG001|Overall Study|Disease progression|1|||
170602512|NCT01835223|616551458|FG000|Overall Study|Became Inelligible|4|||
170602513|NCT01835223|616551459|FG001|Overall Study|Became Inelligible|0|||
170602514|NCT00495625|616551460|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
170602515|NCT03679624|616551461|FG000|Overall Study|Adverse Event|1|||
170602516|NCT03679624|616551462|FG001|Overall Study|Adverse Event|0|||
170602517|NCT00704288|616551464|FG000|Overall Treatment Period|Adverse Event|11|||
170602518|NCT00704288|616551465|FG001|Overall Treatment Period|Adverse Event|8|||
170602519|NCT00704288|616551466|FG002|Overall Treatment Period|Adverse Event|22|||
170602520|NCT00704288|616551464|FG000|Overall Treatment Period|Death|0|||
170602521|NCT00704288|616551465|FG001|Overall Treatment Period|Death|0|||
170602522|NCT00704288|616551466|FG002|Overall Treatment Period|Death|1|||
170602523|NCT00704288|616551464|FG000|Overall Treatment Period|Physician Decision|0|||
170602524|NCT00704288|616551465|FG001|Overall Treatment Period|Physician Decision|2|||
170602525|NCT00704288|616551466|FG002|Overall Treatment Period|Physician Decision|0|||
170602526|NCT00704288|616551464|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
170602527|NCT00704288|616551465|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
170602528|NCT00704288|616551466|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
170602529|NCT00704288|616551464|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
170602530|NCT00704288|616551465|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
170602531|NCT00704288|616551466|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
170602532|NCT00704288|616551464|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
170602533|NCT00704288|616551465|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
170602534|NCT00704288|616551466|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
170602535|NCT00704288|616551464|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
170602536|NCT00704288|616551465|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
170602537|NCT00704288|616551466|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
170602538|NCT00704288|616551464|FG000|Overall Treatment Period|Roll-over to another study|1|||
170602539|NCT00704288|616551465|FG001|Overall Treatment Period|Roll-over to another study|0|||
170602540|NCT00704288|616551466|FG002|Overall Treatment Period|Roll-over to another study|4|||
170602541|NCT00704288|616551464|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
170602542|NCT00704288|616551465|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
170602543|NCT00704288|616551466|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
170602544|NCT00704288|616551464|FG000|Extended Post Treatment Follow Up Period|Death|41|||
170602545|NCT00704288|616551465|FG001|Extended Post Treatment Follow Up Period|Death|50|||
170602546|NCT00704288|616551466|FG002|Extended Post Treatment Follow Up Period|Death|93|||
170602547|NCT00704288|616551464|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
170602548|NCT00704288|616551465|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
170602549|NCT00704288|616551466|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
170602550|NCT00704288|616551464|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
170602551|NCT00704288|616551465|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
170602552|NCT00704288|616551466|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
170602553|NCT00704288|616551464|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
170602554|NCT00704288|616551465|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
170602555|NCT00704288|616551466|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
170602556|NCT04395690|616551467|FG000|Overall Study|Lost to Follow-up|1|||
170602557|NCT04395690|616551468|FG001|Overall Study|Lost to Follow-up|1|||
170602558|NCT03909152|616551471|FG000|Overall Study|Adverse Event|14|||
170602559|NCT03909152|616551472|FG001|Overall Study|Adverse Event|5|||
170602560|NCT03909152|616551473|FG002|Overall Study|Adverse Event|1|||
170602561|NCT03909152|616551474|FG003|Overall Study|Adverse Event|14|||
170602562|NCT04541628|616551475|FG000|Overall Study|Study Terminated|1|||
170602563|NCT04541628|616551476|FG001|Overall Study|Study Terminated|1|||
170602564|NCT04541628|616551477|FG002|Overall Study|Study Terminated|1|||
170602565|NCT01452919|616551478|FG000|Open-Label Treatment|Adverse Event|5|||
170602566|NCT01452919|616551479|FG001|Open-Label Treatment|Adverse Event|0|||
170602567|NCT01452919|616551480|FG002|Open-Label Treatment|Adverse Event|0|||
170602568|NCT01452919|616551478|FG000|Open-Label Treatment|Lost to Follow-up|4|||
170602569|NCT01452919|616551479|FG001|Open-Label Treatment|Lost to Follow-up|0|||
170602570|NCT01452919|616551480|FG002|Open-Label Treatment|Lost to Follow-up|0|||
170602571|NCT01452919|616551478|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
170602572|NCT01452919|616551479|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
170602573|NCT01452919|616551480|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
170602574|NCT01452919|616551478|FG000|Open-Label Treatment|Protocol Violation|4|||
170913861|NCT00090285|617687650|FG003|Extension 1|Withdrawal by Subject|1|||
170602575|NCT01452919|616551479|FG001|Open-Label Treatment|Protocol Violation|0|||
170602576|NCT01452919|616551480|FG002|Open-Label Treatment|Protocol Violation|0|||
170602577|NCT01452919|616551478|FG000|Open-Label Treatment|Sponsor Decision|1|||
170602578|NCT01452919|616551479|FG001|Open-Label Treatment|Sponsor Decision|0|||
170602579|NCT01452919|616551480|FG002|Open-Label Treatment|Sponsor Decision|0|||
170602580|NCT01452919|616551478|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
170602581|NCT01452919|616551479|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
170602582|NCT01452919|616551480|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
170602583|NCT01452919|616551478|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
170602584|NCT01452919|616551479|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
170602585|NCT01452919|616551480|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
170602586|NCT01452919|616551478|FG000|Randomization Treatment|Adverse Event|0|||
170602587|NCT01452919|616551479|FG001|Randomization Treatment|Adverse Event|0|||
170602588|NCT01452919|616551480|FG002|Randomization Treatment|Adverse Event|2|||
170602589|NCT01452919|616551478|FG000|Randomization Treatment|Sponsor Decision|0|||
170602590|NCT01452919|616551479|FG001|Randomization Treatment|Sponsor Decision|1|||
170602591|NCT01452919|616551480|FG002|Randomization Treatment|Sponsor Decision|0|||
170602592|NCT01452919|616551478|FG000|Randomization Treatment|Withdrawal by Subject|0|||
170602593|NCT01452919|616551479|FG001|Randomization Treatment|Withdrawal by Subject|1|||
170602594|NCT01452919|616551480|FG002|Randomization Treatment|Withdrawal by Subject|0|||
170602595|NCT01452919|616551478|FG000|Randomization Treatment|Subject is moving or has moved|0|||
170602596|NCT01452919|616551479|FG001|Randomization Treatment|Subject is moving or has moved|1|||
170602597|NCT01452919|616551480|FG002|Randomization Treatment|Subject is moving or has moved|0|||
170602598|NCT00859937|616551481|FG000|Overall Study|Protocol Violation|1|||
170602599|NCT00859937|616551482|FG001|Overall Study|Protocol Violation|0|||
170602600|NCT00151476|616551483|FG000|FAP Identified Subjects|Protocol Violation|0|||
170813312|NCT00307489|617325842|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
170813313|NCT00307489|617325843|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
170813314|NCT00307489|617325842|FG000|Week 48 Through Week 168|Seroconversion|1|||
170602601|NCT00151476|616551484|FG001|FAP Identified Subjects|Protocol Violation|1|||
170602602|NCT00151476|616551483|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
170602603|NCT00151476|616551484|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
170602604|NCT00151476|616551483|FG000|FAP Analyzed Subjects|Other study participation|0|||
170602605|NCT00151476|616551484|FG001|FAP Analyzed Subjects|Other study participation|1|||
170602606|NCT04369950|616551487|FG000|Overall Study|Protocol Violation|2|||
170602607|NCT04369950|616551488|FG001|Overall Study|Protocol Violation|2|||
170602608|NCT00989963|616551489|FG000|Overall Study|Adverse Event|1|||
170602609|NCT00989963|616551490|FG001|Overall Study|Adverse Event|1|||
170602610|NCT00989963|616551491|FG002|Overall Study|Adverse Event|1|||
170602611|NCT01240200|616551499|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
170602612|NCT01240200|616551500|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
170602613|NCT01529034|616551503|FG000|Overall Study|Discontinued prior to study treatment|14|||
170602614|NCT01529034|616551503|FG000|Overall Study|Site closure|62|||
170602615|NCT01529034|616551503|FG000|Overall Study|Study termination|29|||
170602616|NCT01529034|616551503|FG000|Overall Study|Withdrawal by Subject|25|||
170602617|NCT01529034|616551503|FG000|Overall Study|No treated SCs within protocol window|13|||
170602618|NCT01529034|616551503|FG000|Overall Study|Noncompliance|8|||
170602619|NCT01529034|616551503|FG000|Overall Study|Caregiver no longer available|7|||
170602620|NCT01529034|616551503|FG000|Overall Study|Adverse Event|4|||
170602621|NCT01529034|616551503|FG000|Overall Study|Protocol Violation|4|||
170602622|NCT01529034|616551503|FG000|Overall Study|Lack of Efficacy|4|||
170602623|NCT01529034|616551503|FG000|Overall Study|Investigator no longer available|2|||
170602624|NCT01529034|616551503|FG000|Overall Study|Study drug not available|2|||
170813315|NCT00307489|617325843|FG001|Week 48 Through Week 168|Seroconversion|0|||
170813316|NCT01825785|617325844|FG000|Overall Study|Adverse Event|0|||
170602625|NCT00719680|616551507|FG000|Overall Study|Adverse Event|1|||
170602626|NCT00719680|616551507|FG000|Overall Study|Lost to Follow-up|1|||
170602627|NCT00719680|616551507|FG000|Overall Study|Withdrawal by Subject|3|||
170602628|NCT03194438|616551521|FG000|Overall Study|Withdrawal by Subject|2|||
170813317|NCT01825785|617325845|FG001|Overall Study|Adverse Event|0|||
170813318|NCT01825785|617325846|FG002|Overall Study|Adverse Event|0|||
170813319|NCT01825785|617325847|FG003|Overall Study|Adverse Event|0|||
170602629|NCT01286740|616551522|FG000|Overall Study|Enrolled but not treated|1|||
170602630|NCT01286740|616551522|FG000|Overall Study|Protocol Violation|1|||
170602631|NCT03266172|616551523|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
170602632|NCT03266172|616551524|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
170602633|NCT03266172|616551525|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
170602634|NCT03266172|616551523|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
170602635|NCT03266172|616551524|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
170602636|NCT03266172|616551525|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
170602637|NCT03266172|616551523|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
170602638|NCT03266172|616551524|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
170602639|NCT03266172|616551525|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
170813320|NCT01825785|617325848|FG004|Overall Study|Adverse Event|1|||
170813321|NCT01825785|617325849|FG005|Overall Study|Adverse Event|0|||
170813322|NCT01825785|617325850|FG006|Overall Study|Adverse Event|0|||
170813323|NCT01825785|617325844|FG000|Overall Study|Withdrawal by Subject|0|||
170813324|NCT01825785|617325845|FG001|Overall Study|Withdrawal by Subject|0|||
170813325|NCT01825785|617325846|FG002|Overall Study|Withdrawal by Subject|0|||
170813326|NCT01825785|617325847|FG003|Overall Study|Withdrawal by Subject|0|||
170813327|NCT01825785|617325848|FG004|Overall Study|Withdrawal by Subject|1|||
170602640|NCT03266172|616551523|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
170602641|NCT03266172|616551524|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
170602642|NCT03266172|616551525|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
170602643|NCT03266172|616551523|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
170602644|NCT03266172|616551524|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
170602645|NCT03266172|616551525|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
170602646|NCT03266172|616551523|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
170602647|NCT03266172|616551524|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
170602648|NCT03266172|616551525|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
170602649|NCT01581619|616551530|FG000|Overall Study|Withdrawal by Subject|1|||
170602650|NCT01581619|616551530|FG000|Overall Study|Lost to Follow-up|1|||
170602651|NCT01375608|616551533|FG000|Overall Study|Withdrawal by Subject|2|||
170602652|NCT00599638|616551534|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
170602653|NCT00599638|616551535|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
170602654|NCT00599638|616551536|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
170602655|NCT00599638|616551537|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
170602656|NCT00599638|616551534|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
170602657|NCT00599638|616551535|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
170602658|NCT00599638|616551536|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
170602659|NCT00599638|616551537|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
170602660|NCT00599638|616551534|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
170602661|NCT00599638|616551535|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
170602662|NCT00599638|616551536|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
170602663|NCT00599638|616551537|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
170602664|NCT00599638|616551534|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
170602665|NCT00599638|616551535|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
170602666|NCT00599638|616551536|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
170602667|NCT00599638|616551537|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
170602668|NCT00599638|616551534|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
170602669|NCT00599638|616551535|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
170602670|NCT00599638|616551536|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
170602671|NCT00599638|616551537|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
170602672|NCT00599638|616551534|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
170602673|NCT00599638|616551535|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
170602674|NCT00599638|616551536|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
170602675|NCT00599638|616551537|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
170602676|NCT00599638|616551534|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
170602677|NCT00599638|616551535|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
170602678|NCT00599638|616551536|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
170602679|NCT00599638|616551537|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
170602680|NCT00599638|616551534|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
170602681|NCT00599638|616551535|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
170602682|NCT00599638|616551536|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
170813328|NCT01825785|617325849|FG005|Overall Study|Withdrawal by Subject|1|||
170602683|NCT00599638|616551537|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
170602684|NCT00599638|616551534|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
170602685|NCT00599638|616551535|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
170602686|NCT00599638|616551536|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
170602687|NCT00599638|616551537|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
170602688|NCT01953913|616551540|FG000|Overall Study|Disease Progression|349|||
170602689|NCT01953913|616551540|FG000|Overall Study|Worsening of underlying cancer|22|||
170602690|NCT01953913|616551540|FG000|Overall Study|Adverse Event|20|||
170602691|NCT01953913|616551540|FG000|Overall Study|Protocol Violation|6|||
170602692|NCT01953913|616551540|FG000|Overall Study|Lost to Follow-up|4|||
170602693|NCT01953913|616551540|FG000|Overall Study|Withdrawal by Subject|32|||
170602694|NCT01953913|616551540|FG000|Overall Study|Other than listed|108|||
170602695|NCT01953913|616551540|FG000|Overall Study|Not Treated|1|||
170602696|NCT03006887|616551541|FG000|Overall Study|Adverse Event|1|||
170602697|NCT03836677|616551542|FG000|Period 1|Adverse Event|0|||
170602698|NCT03836677|616551543|FG001|Period 1|Adverse Event|1|||
170813329|NCT01825785|617325850|FG006|Overall Study|Withdrawal by Subject|0|||
170813330|NCT04425252|617325851|FG000|Overall Study|Withdrawal by Subject|2|||
170813331|NCT04425252|617325852|FG001|Overall Study|Withdrawal by Subject|1|||
170602699|NCT03836677|616551542|FG000|Period 2|Severe non-compliance to protocol|1|||
170602700|NCT03836677|616551543|FG001|Period 2|Severe non-compliance to protocol|0|||
170602701|NCT02925741|616551544|FG000|Overall Study|Withdrawal by Subject|11|||
170602702|NCT02925741|616551545|FG001|Overall Study|Withdrawal by Subject|0|||
170602703|NCT00295932|616551546|FG000|Overall Study|Not Treated|0|||
170602704|NCT00295932|616551547|FG001|Overall Study|Not Treated|0|||
170602705|NCT00295932|616551548|FG002|Overall Study|Not Treated|0|||
170813332|NCT04425252|617325851|FG000|Overall Study|Lost to Follow-up|1|||
170813333|NCT04425252|617325852|FG001|Overall Study|Lost to Follow-up|0|||
170813334|NCT04425252|617325851|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
170813335|NCT04425252|617325852|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
170813336|NCT03137784|617325853|FG000|Overall Study|Adverse Event|1|||
170813337|NCT03137784|617325854|FG001|Overall Study|Adverse Event|1|||
170813338|NCT03137784|617325855|FG002|Overall Study|Adverse Event|0|||
170813339|NCT03137784|617325856|FG003|Overall Study|Adverse Event|0|||
170813340|NCT03137784|617325857|FG004|Overall Study|Adverse Event|0|||
170813341|NCT03137784|617325858|FG005|Overall Study|Adverse Event|0|||
170813342|NCT03137784|617325853|FG000|Overall Study|Subject/guardian decision|1|||
170813343|NCT03137784|617325854|FG001|Overall Study|Subject/guardian decision|0|||
170813344|NCT03137784|617325855|FG002|Overall Study|Subject/guardian decision|0|||
170813345|NCT03137784|617325856|FG003|Overall Study|Subject/guardian decision|0|||
170813346|NCT03137784|617325857|FG004|Overall Study|Subject/guardian decision|0|||
170813347|NCT03137784|617325858|FG005|Overall Study|Subject/guardian decision|0|||
170813348|NCT03137784|617325853|FG000|Overall Study|Non-compliance with study treatment|0|||
170813349|NCT03137784|617325854|FG001|Overall Study|Non-compliance with study treatment|0|||
170602706|NCT00295932|616551549|FG003|Overall Study|Not Treated|0|||
170602707|NCT00295932|616551550|FG004|Overall Study|Not Treated|0|||
170813350|NCT03137784|617325855|FG002|Overall Study|Non-compliance with study treatment|0|||
170602708|NCT00295932|616551551|FG005|Overall Study|Not Treated|0|||
170602709|NCT00295932|616551552|FG006|Overall Study|Not Treated|0|||
170602710|NCT00295932|616551553|FG007|Overall Study|Not Treated|0|||
170602711|NCT00295932|616551554|FG008|Overall Study|Not Treated|0|||
170602712|NCT00295932|616551555|FG009|Overall Study|Not Treated|0|||
170602713|NCT00295932|616551556|FG010|Overall Study|Not Treated|1|||
170602714|NCT00109577|616551557|FG000|Overall Study|Withdrawal by Subject|3|||
170602715|NCT00109577|616551558|FG001|Overall Study|Withdrawal by Subject|3|||
170602716|NCT01600092|616551559|FG000|Overall Study|Adverse Event|2|||
170602717|NCT01600092|616551560|FG001|Overall Study|Adverse Event|0|||
170602718|NCT01600092|616551559|FG000|Overall Study|Lost to Follow-up|4|||
170602719|NCT01600092|616551560|FG001|Overall Study|Lost to Follow-up|6|||
170602720|NCT01600092|616551559|FG000|Overall Study|Withdrawal by parent/guardian|8|||
170602721|NCT01600092|616551560|FG001|Overall Study|Withdrawal by parent/guardian|6|||
170602722|NCT01600092|616551559|FG000|Overall Study|Physician Decision|1|||
170602723|NCT01600092|616551560|FG001|Overall Study|Physician Decision|1|||
170602724|NCT01600092|616551559|FG000|Overall Study|Randomized but not vaccinated|3|||
170602725|NCT01600092|616551560|FG001|Overall Study|Randomized but not vaccinated|3|||
170602726|NCT00079677|616551561|FG000|Overall Study|Adverse Event|5|||
170602727|NCT00079677|616551562|FG001|Overall Study|Adverse Event|6|||
170602728|NCT00079677|616551561|FG000|Overall Study|Lack of Efficacy|1|||
170602729|NCT00079677|616551562|FG001|Overall Study|Lack of Efficacy|0|||
170602730|NCT00079677|616551561|FG000|Overall Study|Lost to Follow-up|2|||
170602731|NCT00079677|616551562|FG001|Overall Study|Lost to Follow-up|2|||
170602732|NCT00079677|616551561|FG000|Overall Study|Physician Decision|3|||
170602733|NCT00079677|616551562|FG001|Overall Study|Physician Decision|0|||
170602734|NCT00079677|616551561|FG000|Overall Study|Protocol Violation|2|||
170602735|NCT00079677|616551562|FG001|Overall Study|Protocol Violation|3|||
170602736|NCT00079677|616551561|FG000|Overall Study|Withdrawal by Subject|5|||
170602737|NCT00079677|616551562|FG001|Overall Study|Withdrawal by Subject|3|||
170602738|NCT00079677|616551561|FG000|Overall Study|Miscellaneous|2|||
170602739|NCT00079677|616551562|FG001|Overall Study|Miscellaneous|0|||
170602740|NCT02914561|616551563|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
170602741|NCT02914561|616551564|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
170602742|NCT02914561|616551565|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
170602743|NCT02914561|616551566|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
170602744|NCT02914561|616551567|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
170602745|NCT02914561|616551568|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
170602746|NCT02914561|616551569|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
170813351|NCT03137784|617325856|FG003|Overall Study|Non-compliance with study treatment|0|||
170813352|NCT03137784|617325857|FG004|Overall Study|Non-compliance with study treatment|1|||
170602747|NCT02914561|616551570|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
170602748|NCT02914561|616551571|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
170602749|NCT02914561|616551572|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
170602750|NCT02914561|616551573|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
170602751|NCT02914561|616551563|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
170813353|NCT03137784|617325858|FG005|Overall Study|Non-compliance with study treatment|0|||
170602752|NCT02914561|616551564|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
170602753|NCT02914561|616551565|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
170602754|NCT02914561|616551566|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
170602755|NCT02914561|616551567|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
170602756|NCT02914561|616551568|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
170602757|NCT02914561|616551569|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
170602758|NCT02914561|616551570|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
170602759|NCT02914561|616551571|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
170602760|NCT02914561|616551572|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
170602761|NCT02914561|616551573|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
170602762|NCT02914561|616551563|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
170602763|NCT02914561|616551564|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
170602764|NCT02914561|616551565|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
170602765|NCT02914561|616551566|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
170602766|NCT02914561|616551567|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
170602767|NCT02914561|616551568|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
170602768|NCT02914561|616551569|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
170602769|NCT02914561|616551570|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
170602770|NCT02914561|616551571|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
170602771|NCT02914561|616551572|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
170602772|NCT02914561|616551573|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
170602773|NCT02914561|616551563|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
170602774|NCT02914561|616551564|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
170602775|NCT02914561|616551565|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
170602776|NCT02914561|616551566|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
170602777|NCT02914561|616551567|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
170602778|NCT02914561|616551568|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
170602779|NCT02914561|616551569|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
170602780|NCT02914561|616551570|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
170602781|NCT02914561|616551571|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
170602782|NCT02914561|616551572|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
170602783|NCT02914561|616551573|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
170602784|NCT02914561|616551563|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602785|NCT02914561|616551564|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602786|NCT02914561|616551565|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
170602787|NCT02914561|616551566|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602788|NCT02914561|616551567|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602789|NCT02914561|616551568|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
170602790|NCT02914561|616551569|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602791|NCT02914561|616551570|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602792|NCT02914561|616551571|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602793|NCT02914561|616551572|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602794|NCT02914561|616551573|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
170602795|NCT02914561|616551563|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
170602796|NCT02914561|616551564|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602797|NCT02914561|616551565|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602798|NCT02914561|616551566|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602799|NCT02914561|616551567|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602800|NCT02914561|616551568|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602801|NCT02914561|616551569|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602802|NCT02914561|616551570|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602803|NCT02914561|616551571|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602804|NCT02914561|616551572|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602805|NCT02914561|616551573|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
170602806|NCT02914561|616551563|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602807|NCT02914561|616551564|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602808|NCT02914561|616551565|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
170602809|NCT02914561|616551566|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602810|NCT02914561|616551567|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602811|NCT02914561|616551568|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602812|NCT02914561|616551569|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602813|NCT02914561|616551570|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170913862|NCT00090285|617687651|FG004|Extension 1|Withdrawal by Subject|0|||
170913863|NCT00090285|617687652|FG005|Extension 1|Withdrawal by Subject|0|||
170913864|NCT00090285|617687647|FG000|Extension 1|Other|0|||
170913865|NCT00090285|617687648|FG001|Extension 1|Other|0|||
170913866|NCT00090285|617687649|FG002|Extension 1|Other|4|||
170913867|NCT00090285|617687650|FG003|Extension 1|Other|0|||
170602814|NCT02914561|616551571|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602815|NCT02914561|616551572|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602816|NCT02914561|616551573|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
170602817|NCT02914561|616551563|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
170602818|NCT02914561|616551564|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
170602819|NCT02914561|616551565|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
170602820|NCT02914561|616551566|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
170602821|NCT02914561|616551567|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
170602822|NCT02914561|616551568|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
170602823|NCT02914561|616551569|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
170602824|NCT02914561|616551570|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
170602825|NCT02914561|616551571|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
170602826|NCT02914561|616551572|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
170602827|NCT02914561|616551573|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
170602828|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
170602829|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
170602830|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
170602831|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
170602832|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
170602833|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
170602834|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
170602835|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
170602836|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
170602837|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
170602838|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
170602839|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
170602840|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
170602841|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
170602842|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
170602843|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
170602844|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
170602845|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
170602846|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
170602847|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
170602848|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
170602849|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
170602850|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
170602851|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
170602852|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
170602853|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
170602854|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
170602855|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
170602856|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
170602857|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
170602858|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
170602859|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
170602860|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
170602861|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
170602862|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
170602863|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
170602864|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
170602865|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
170602866|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
170602867|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
170602868|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
170602869|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
170602870|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
170602871|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
170602872|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
170602873|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
170602874|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
170602875|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
170602876|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
170602877|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
170602878|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
170602879|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
170602880|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
170602881|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
170602882|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
170602883|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602884|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602885|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602886|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602887|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602888|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602889|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
170602890|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602891|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
170602892|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602893|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
170602894|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602895|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602896|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602897|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602898|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602899|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602900|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602901|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602902|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
170602903|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602904|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
170602905|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602906|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602907|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602908|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602909|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602910|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602911|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
170602912|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602913|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602914|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602915|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
170602916|NCT02914561|616551563|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
170602917|NCT02914561|616551564|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
170602918|NCT02914561|616551565|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
170602919|NCT02914561|616551566|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
170602920|NCT02914561|616551567|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
170602921|NCT02914561|616551568|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
170602922|NCT02914561|616551569|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
170602923|NCT02914561|616551570|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
170602924|NCT02914561|616551571|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
170602925|NCT02914561|616551572|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
170602926|NCT02914561|616551573|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
170602927|NCT01459913|616551574|FG000|Overall Study|Adverse Event|0|||
170602928|NCT01459913|616551575|FG001|Overall Study|Adverse Event|0|||
170602929|NCT01459913|616551576|FG002|Overall Study|Adverse Event|0|||
170602930|NCT01459913|616551577|FG003|Overall Study|Adverse Event|3|||
170602931|NCT01459913|616551574|FG000|Overall Study|Withdrawal by Subject|4|||
170602932|NCT01459913|616551575|FG001|Overall Study|Withdrawal by Subject|0|||
170602933|NCT01459913|616551576|FG002|Overall Study|Withdrawal by Subject|0|||
170602934|NCT01459913|616551577|FG003|Overall Study|Withdrawal by Subject|5|||
170602935|NCT01459913|616551574|FG000|Overall Study|Lost to Follow-up|7|||
170602936|NCT01459913|616551575|FG001|Overall Study|Lost to Follow-up|4|||
170602937|NCT01459913|616551576|FG002|Overall Study|Lost to Follow-up|1|||
170652187|NCT00266877|616740096|FG001|Overall Study|Symptomatic Deterioration|3|||
170652188|NCT00266877|616740097|FG002|Overall Study|Symptomatic Deterioration|1|||
170652189|NCT00266877|616740095|FG000|Overall Study|Hospitalization|1|||
170652190|NCT00266877|616740096|FG001|Overall Study|Hospitalization|0|||
170602938|NCT01459913|616551577|FG003|Overall Study|Lost to Follow-up|8|||
170602939|NCT01459913|616551574|FG000|Overall Study|Death|0|||
170652191|NCT00266877|616740097|FG002|Overall Study|Hospitalization|0|||
170813354|NCT01437540|617325859|FG000|Overall Study|Not listed below|7|||
170813355|NCT01437540|617325860|FG001|Overall Study|Not listed below|6|||
170813356|NCT01437540|617325859|FG000|Overall Study|COPD exacerbation|13|||
170813357|NCT01437540|617325860|FG001|Overall Study|COPD exacerbation|3|||
170602940|NCT01459913|616551575|FG001|Overall Study|Death|0|||
170602941|NCT01459913|616551576|FG002|Overall Study|Death|0|||
170602942|NCT01459913|616551577|FG003|Overall Study|Death|1|||
170602943|NCT01459913|616551574|FG000|Overall Study|Non- Compliance|0|||
170602944|NCT01459913|616551575|FG001|Overall Study|Non- Compliance|0|||
170602945|NCT01459913|616551576|FG002|Overall Study|Non- Compliance|0|||
170602946|NCT01459913|616551577|FG003|Overall Study|Non- Compliance|3|||
170602947|NCT01459913|616551574|FG000|Overall Study|Physician Decision|0|||
170602948|NCT01459913|616551575|FG001|Overall Study|Physician Decision|1|||
170602949|NCT01459913|616551576|FG002|Overall Study|Physician Decision|0|||
170602950|NCT01459913|616551577|FG003|Overall Study|Physician Decision|0|||
170602951|NCT01459913|616551574|FG000|Overall Study|Study Terminated by Sponsor|30|||
170602952|NCT01459913|616551575|FG001|Overall Study|Study Terminated by Sponsor|15|||
170602953|NCT01459913|616551576|FG002|Overall Study|Study Terminated by Sponsor|9|||
170602954|NCT01459913|616551577|FG003|Overall Study|Study Terminated by Sponsor|11|||
170602955|NCT01459913|616551574|FG000|Overall Study|Other|0|||
170602956|NCT01459913|616551575|FG001|Overall Study|Other|0|||
170602957|NCT01459913|616551576|FG002|Overall Study|Other|3|||
170602958|NCT01459913|616551577|FG003|Overall Study|Other|1|||
170602959|NCT01459913|616551574|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
170602960|NCT01459913|616551575|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
170602961|NCT01459913|616551576|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
170602962|NCT01459913|616551577|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
170602963|NCT01075984|616551583|FG000|Treatment Phase|Adverse Event|0|||
170602964|NCT01075984|616551584|FG001|Treatment Phase|Adverse Event|1|||
170602965|NCT01075984|616551585|FG002|Treatment Phase|Adverse Event|3|||
170602966|NCT01075984|616551586|FG003|Treatment Phase|Adverse Event|7|||
170602967|NCT01075984|616551587|FG004|Treatment Phase|Adverse Event|35|||
170602968|NCT01075984|616551583|FG000|Treatment Phase|Protocol Violation|0|||
170602969|NCT01075984|616551584|FG001|Treatment Phase|Protocol Violation|0|||
170602970|NCT01075984|616551585|FG002|Treatment Phase|Protocol Violation|1|||
170602971|NCT01075984|616551586|FG003|Treatment Phase|Protocol Violation|0|||
170602972|NCT01075984|616551587|FG004|Treatment Phase|Protocol Violation|3|||
170602973|NCT01075984|616551583|FG000|Treatment Phase|Withdrawal by Subject|0|||
170602974|NCT01075984|616551584|FG001|Treatment Phase|Withdrawal by Subject|0|||
170602975|NCT01075984|616551585|FG002|Treatment Phase|Withdrawal by Subject|2|||
170602976|NCT01075984|616551586|FG003|Treatment Phase|Withdrawal by Subject|0|||
170602977|NCT01075984|616551587|FG004|Treatment Phase|Withdrawal by Subject|15|||
170602978|NCT01075984|616551583|FG000|Treatment Phase|Treatment Failure|0|||
170602979|NCT01075984|616551584|FG001|Treatment Phase|Treatment Failure|0|||
170602980|NCT01075984|616551585|FG002|Treatment Phase|Treatment Failure|1|||
170602981|NCT01075984|616551586|FG003|Treatment Phase|Treatment Failure|0|||
170602982|NCT01075984|616551587|FG004|Treatment Phase|Treatment Failure|5|||
170602983|NCT01075984|616551583|FG000|Treatment Phase|Progression of disease|0|||
170602984|NCT01075984|616551584|FG001|Treatment Phase|Progression of disease|0|||
170602985|NCT01075984|616551585|FG002|Treatment Phase|Progression of disease|0|||
170602986|NCT01075984|616551586|FG003|Treatment Phase|Progression of disease|0|||
170602987|NCT01075984|616551587|FG004|Treatment Phase|Progression of disease|2|||
170602988|NCT01075984|616551583|FG000|Follow-up Phase|Protocol Violation|0|||
170602989|NCT01075984|616551584|FG001|Follow-up Phase|Protocol Violation|0|||
170602990|NCT01075984|616551585|FG002|Follow-up Phase|Protocol Violation|1|||
170602991|NCT01075984|616551586|FG003|Follow-up Phase|Protocol Violation|0|||
170602992|NCT01075984|616551587|FG004|Follow-up Phase|Protocol Violation|3|||
170602993|NCT01075984|616551583|FG000|Follow-up Phase|Adverse Event|0|||
170602994|NCT01075984|616551584|FG001|Follow-up Phase|Adverse Event|0|||
170602995|NCT01075984|616551585|FG002|Follow-up Phase|Adverse Event|0|||
170602996|NCT01075984|616551586|FG003|Follow-up Phase|Adverse Event|2|||
170602997|NCT01075984|616551587|FG004|Follow-up Phase|Adverse Event|27|||
170602998|NCT01075984|616551583|FG000|Follow-up Phase|Administrative|0|||
170602999|NCT01075984|616551584|FG001|Follow-up Phase|Administrative|0|||
170603000|NCT01075984|616551585|FG002|Follow-up Phase|Administrative|0|||
170603001|NCT01075984|616551586|FG003|Follow-up Phase|Administrative|0|||
170603002|NCT01075984|616551587|FG004|Follow-up Phase|Administrative|1|||
170603003|NCT01075984|616551583|FG000|Follow-up Phase|Withdrawal by Subject|0|||
170603004|NCT01075984|616551584|FG001|Follow-up Phase|Withdrawal by Subject|0|||
170603005|NCT01075984|616551585|FG002|Follow-up Phase|Withdrawal by Subject|0|||
170603006|NCT01075984|616551586|FG003|Follow-up Phase|Withdrawal by Subject|0|||
170603007|NCT01075984|616551587|FG004|Follow-up Phase|Withdrawal by Subject|10|||
170603008|NCT01075984|616551583|FG000|Follow-up Phase|Progression of disease|0|||
170603009|NCT01075984|616551584|FG001|Follow-up Phase|Progression of disease|0|||
170603010|NCT01075984|616551585|FG002|Follow-up Phase|Progression of disease|0|||
170603011|NCT01075984|616551586|FG003|Follow-up Phase|Progression of disease|0|||
170603012|NCT01075984|616551587|FG004|Follow-up Phase|Progression of disease|2|||
170603013|NCT01075984|616551583|FG000|Follow-up Phase|Treatment failure|0|||
170603014|NCT01075984|616551584|FG001|Follow-up Phase|Treatment failure|0|||
170603015|NCT01075984|616551585|FG002|Follow-up Phase|Treatment failure|0|||
170603016|NCT01075984|616551586|FG003|Follow-up Phase|Treatment failure|0|||
170603017|NCT01075984|616551587|FG004|Follow-up Phase|Treatment failure|4|||
170603018|NCT03652675|616551588|FG000|Overall Study|Lost to Follow-up|4|||
170603019|NCT03652675|616551589|FG001|Overall Study|Lost to Follow-up|4|||
170603020|NCT03101085|616551590|FG000|Overall Study|Lost to Follow-up|0|||
170603021|NCT03101085|616551591|FG001|Overall Study|Lost to Follow-up|1|||
170603022|NCT02986854|616551593|FG000|Overall Study|Withdrawal by Subject|0|||
170603023|NCT02986854|616551594|FG001|Overall Study|Withdrawal by Subject|1|||
170603024|NCT02986854|616551595|FG002|Overall Study|Withdrawal by Subject|1|||
170603025|NCT02986854|616551593|FG000|Overall Study|Lost to Follow-up|3|||
170603026|NCT02986854|616551594|FG001|Overall Study|Lost to Follow-up|11|||
170603027|NCT02986854|616551595|FG002|Overall Study|Lost to Follow-up|2|||
170603028|NCT00695864|616551602|FG000|Placebo|Withdrawal by Subject|1|||
170603029|NCT00695864|616551602|FG000|Placebo|Physician Decision|4|||
170603030|NCT01624090|616551606|FG000|Overall Study|DLT, taken off therapy|0|||
170603031|NCT01624090|616551607|FG001|Overall Study|DLT, taken off therapy|1|||
170603032|NCT01624090|616551608|FG002|Overall Study|DLT, taken off therapy|0|||
170603033|NCT01624090|616551609|FG003|Overall Study|DLT, taken off therapy|0|||
170603034|NCT01624090|616551606|FG000|Overall Study|Withdrew prior to treatment|0|||
170603035|NCT01624090|616551607|FG001|Overall Study|Withdrew prior to treatment|1|||
170603036|NCT01624090|616551608|FG002|Overall Study|Withdrew prior to treatment|0|||
170603037|NCT01624090|616551609|FG003|Overall Study|Withdrew prior to treatment|0|||
170652192|NCT00266877|616740095|FG000|Overall Study|Concomitant Radiotherapy|0|||
170652193|NCT00266877|616740096|FG001|Overall Study|Concomitant Radiotherapy|1|||
170652194|NCT00266877|616740097|FG002|Overall Study|Concomitant Radiotherapy|0|||
170652195|NCT01077375|616740098|FG000|Overall Study|Adverse Event|2|||
170652196|NCT01077375|616740099|FG001|Overall Study|Adverse Event|15|||
170652197|NCT01077375|616740098|FG000|Overall Study|Lack of Efficacy|6|||
170652198|NCT01077375|616740099|FG001|Overall Study|Lack of Efficacy|8|||
170652199|NCT01077375|616740098|FG000|Overall Study|Withdrawal by Subject|0|||
170652200|NCT01077375|616740099|FG001|Overall Study|Withdrawal by Subject|6|||
170652201|NCT01077375|616740098|FG000|Overall Study|Lost to Follow-up|2|||
170652202|NCT01077375|616740099|FG001|Overall Study|Lost to Follow-up|5|||
170652203|NCT01077375|616740098|FG000|Overall Study|Other Reason|0|||
170652204|NCT01077375|616740099|FG001|Overall Study|Other Reason|1|||
170652205|NCT01150474|616740102|FG000|Overall Study|Withdrawal by Subject|5|||
170652206|NCT01150474|616740103|FG001|Overall Study|Withdrawal by Subject|2|||
170652207|NCT01150474|616740102|FG000|Overall Study|Cancer found|1|||
170652208|NCT01150474|616740103|FG001|Overall Study|Cancer found|0|||
170652209|NCT01150474|616740102|FG000|Overall Study|Multiple Studies|0|||
170652210|NCT01150474|616740103|FG001|Overall Study|Multiple Studies|1|||
170652211|NCT01150474|616740102|FG000|Overall Study|Rectotomy|1|||
170652212|NCT01150474|616740103|FG001|Overall Study|Rectotomy|0|||
170652213|NCT01150474|616740102|FG000|Overall Study|Drug did not arrive in time|1|||
170652214|NCT01150474|616740103|FG001|Overall Study|Drug did not arrive in time|0|||
170652215|NCT01150474|616740102|FG000|Overall Study|Drug not administered|1|||
170652216|NCT01150474|616740103|FG001|Overall Study|Drug not administered|0|||
170652217|NCT01150474|616740102|FG000|Overall Study|Surgery Changed|1|||
170652218|NCT01150474|616740103|FG001|Overall Study|Surgery Changed|0|||
170652219|NCT02889562|616740104|FG000|Overall Study|Physician Decision|0|||
170652220|NCT02889562|616740105|FG001|Overall Study|Physician Decision|1|||
170652221|NCT02889562|616740104|FG000|Overall Study|Withdrawal by Subject|0|||
170813358|NCT01437540|617325859|FG000|Overall Study|Lost to Follow-up|3|||
170813359|NCT01437540|617325860|FG001|Overall Study|Lost to Follow-up|5|||
170813360|NCT01437540|617325859|FG000|Overall Study|Lack of Efficacy|23|||
170603038|NCT01624090|616551606|FG000|Overall Study|Died on study|0|||
170603039|NCT01624090|616551607|FG001|Overall Study|Died on study|0|||
170652222|NCT02889562|616740105|FG001|Overall Study|Withdrawal by Subject|1|||
170652223|NCT01514370|616740108|FG000|Overall Study|Protocol Violation|2|||
170652224|NCT01514370|616740109|FG001|Overall Study|Protocol Violation|3|||
170652225|NCT01514370|616740108|FG000|Overall Study|Lost to Follow-up|0|||
170652226|NCT01514370|616740109|FG001|Overall Study|Lost to Follow-up|2|||
170813361|NCT01437540|617325860|FG001|Overall Study|Lack of Efficacy|11|||
170603040|NCT01624090|616551608|FG002|Overall Study|Died on study|2|||
170652227|NCT01514370|616740108|FG000|Overall Study|Withdrawal by Subject|2|||
170652228|NCT01514370|616740109|FG001|Overall Study|Withdrawal by Subject|1|||
170813362|NCT01437540|617325859|FG000|Overall Study|Protocol Violation|24|||
170603041|NCT01624090|616551609|FG003|Overall Study|Died on study|0|||
170603042|NCT01624090|616551606|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
170603043|NCT01624090|616551607|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
170652229|NCT01514370|616740108|FG000|Overall Study|Adverse Event|1|||
170652230|NCT01514370|616740109|FG001|Overall Study|Adverse Event|3|||
170652231|NCT01514370|616740108|FG000|Overall Study|Other|6|||
170813363|NCT01437540|617325860|FG001|Overall Study|Protocol Violation|12|||
170603044|NCT01624090|616551608|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
170603045|NCT01624090|616551609|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
170652232|NCT01514370|616740109|FG001|Overall Study|Other|7|||
170652233|NCT01606878|616740110|FG000|Overall Study|Adverse Event|1|||
170603046|NCT01624090|616551606|FG000|Overall Study|Dose escalated|0|||
170603047|NCT01624090|616551607|FG001|Overall Study|Dose escalated|0|||
170603048|NCT01624090|616551608|FG002|Overall Study|Dose escalated|3|||
170603049|NCT01624090|616551609|FG003|Overall Study|Dose escalated|0|||
170603050|NCT00772109|616551610|FG000|Overall Study|Serious adverse event|1|||
170603051|NCT00772109|616551611|FG001|Overall Study|Serious adverse event|0|||
170603052|NCT00772109|616551612|FG002|Overall Study|Serious adverse event|1|||
170603053|NCT00772109|616551613|FG003|Overall Study|Serious adverse event|0|||
170603054|NCT00772109|616551610|FG000|Overall Study|Protocol Violation|5|||
170603055|NCT00772109|616551611|FG001|Overall Study|Protocol Violation|8|||
170603056|NCT00772109|616551612|FG002|Overall Study|Protocol Violation|7|||
170603057|NCT00772109|616551613|FG003|Overall Study|Protocol Violation|6|||
170603058|NCT00772109|616551610|FG000|Overall Study|Lost to Follow-up|7|||
170603059|NCT00772109|616551611|FG001|Overall Study|Lost to Follow-up|3|||
170603060|NCT00772109|616551612|FG002|Overall Study|Lost to Follow-up|5|||
170603061|NCT00772109|616551613|FG003|Overall Study|Lost to Follow-up|9|||
170603062|NCT00772109|616551610|FG000|Overall Study|Withdrawal by Subject|8|||
170603063|NCT00772109|616551611|FG001|Overall Study|Withdrawal by Subject|8|||
170603064|NCT00772109|616551612|FG002|Overall Study|Withdrawal by Subject|6|||
170603065|NCT00772109|616551613|FG003|Overall Study|Withdrawal by Subject|16|||
170603066|NCT01403116|616551614|FG000|Overall Study|Adverse Event|7|||
170603067|NCT01403116|616551615|FG001|Overall Study|Adverse Event|4|||
170603068|NCT01403116|616551614|FG000|Overall Study|Lost to Follow-up|7|||
170603069|NCT01403116|616551615|FG001|Overall Study|Lost to Follow-up|5|||
170603070|NCT01403116|616551614|FG000|Overall Study|Withdrawal by Subject|12|||
170603071|NCT01403116|616551615|FG001|Overall Study|Withdrawal by Subject|15|||
170603072|NCT01403116|616551614|FG000|Overall Study|Non-compliance of study drug|3|||
170603073|NCT01403116|616551615|FG001|Overall Study|Non-compliance of study drug|0|||
170603074|NCT01403116|616551614|FG000|Overall Study|Protocol Violation|0|||
170603075|NCT01403116|616551615|FG001|Overall Study|Protocol Violation|1|||
170652234|NCT01606878|616740111|FG001|Overall Study|Adverse Event|1|||
170652235|NCT01606878|616740112|FG002|Overall Study|Adverse Event|0|||
170652236|NCT01606878|616740113|FG003|Overall Study|Adverse Event|0|||
170652237|NCT01606878|616740114|FG004|Overall Study|Adverse Event|0|||
170652238|NCT01606878|616740115|FG005|Overall Study|Adverse Event|0|||
170652239|NCT01606878|616740116|FG006|Overall Study|Adverse Event|1|||
170652240|NCT01606878|616740117|FG007|Overall Study|Adverse Event|0|||
170652241|NCT01606878|616740118|FG008|Overall Study|Adverse Event|1|||
170652242|NCT01606878|616740119|FG009|Overall Study|Adverse Event|3|||
170652243|NCT01606878|616740120|FG010|Overall Study|Adverse Event|0|||
170652244|NCT01606878|616740110|FG000|Overall Study|Lack of Efficacy|1|||
170652245|NCT01606878|616740111|FG001|Overall Study|Lack of Efficacy|1|||
170652246|NCT01606878|616740112|FG002|Overall Study|Lack of Efficacy|1|||
170652247|NCT01606878|616740113|FG003|Overall Study|Lack of Efficacy|2|||
170652248|NCT01606878|616740114|FG004|Overall Study|Lack of Efficacy|1|||
170652249|NCT01606878|616740115|FG005|Overall Study|Lack of Efficacy|2|||
170652250|NCT01606878|616740116|FG006|Overall Study|Lack of Efficacy|1|||
170652251|NCT01606878|616740117|FG007|Overall Study|Lack of Efficacy|2|||
170652252|NCT01606878|616740118|FG008|Overall Study|Lack of Efficacy|2|||
170652253|NCT01606878|616740119|FG009|Overall Study|Lack of Efficacy|0|||
170652254|NCT01606878|616740120|FG010|Overall Study|Lack of Efficacy|1|||
170652255|NCT01606878|616740110|FG000|Overall Study|Physician Decision|1|||
170813364|NCT01437540|617325859|FG000|Overall Study|Adverse Event|26|||
170813365|NCT01437540|617325860|FG001|Overall Study|Adverse Event|13|||
170813366|NCT01437540|617325859|FG000|Overall Study|Withdrawal by Subject|31|||
170813367|NCT01437540|617325860|FG001|Overall Study|Withdrawal by Subject|15|||
170813368|NCT00990184|617325870|FG000|Overall Study|Physician Decision|1|||
170813369|NCT01975701|617325871|FG000|Overall Study|Lost to Follow-up|1|||
170813370|NCT01975701|617325871|FG000|Overall Study|Death|23|||
170813371|NCT01975701|617325871|FG000|Overall Study|Physician Decision|1|||
170813372|NCT02152384|617325872|FG000|Period 1|Withdrawal by Subject|0|||
170603076|NCT01403116|616551614|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
170603077|NCT01403116|616551615|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
170652256|NCT01606878|616740111|FG001|Overall Study|Physician Decision|0|||
170652257|NCT01606878|616740112|FG002|Overall Study|Physician Decision|2|||
170652258|NCT01606878|616740113|FG003|Overall Study|Physician Decision|1|||
170652259|NCT01606878|616740114|FG004|Overall Study|Physician Decision|1|||
170603078|NCT01403116|616551614|FG000|Overall Study|Hct >54%|2|||
170603079|NCT01403116|616551615|FG001|Overall Study|Hct >54%|0|||
170603080|NCT01403116|616551614|FG000|Overall Study|unable to keep appointments|0|||
170603081|NCT01403116|616551615|FG001|Overall Study|unable to keep appointments|2|||
170652260|NCT01606878|616740115|FG005|Overall Study|Physician Decision|1|||
170652261|NCT01606878|616740116|FG006|Overall Study|Physician Decision|2|||
170652262|NCT01606878|616740117|FG007|Overall Study|Physician Decision|0|||
170652263|NCT01606878|616740118|FG008|Overall Study|Physician Decision|1|||
170813373|NCT02152384|617325873|FG001|Period 1|Withdrawal by Subject|1|||
170603082|NCT00042666|616551616|FG000|Overall Study|Adverse Event|2|||
170652264|NCT01606878|616740119|FG009|Overall Study|Physician Decision|0|||
170813374|NCT02152384|617325872|FG000|Period 1|Adverse Event|1|||
170603083|NCT00042666|616551616|FG000|Overall Study|Death|4|||
170603084|NCT00042666|616551616|FG000|Overall Study|Protocol Violation|1|||
170603085|NCT00042666|616551616|FG000|Overall Study|Participant/Physician Perception|1|||
170603086|NCT00042666|616551616|FG000|Overall Study|Progressive Disease|41|||
170603087|NCT00042666|616551616|FG000|Overall Study|Other|1|||
170603088|NCT00042666|616551616|FG000|Overall Study|Other|4|||
170603089|NCT04232215|616551617|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
170603090|NCT04232215|616551618|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
170603091|NCT04583956|616551619|FG000|Overall Study|Death|9|||
170603092|NCT04583956|616551620|FG001|Overall Study|Death|11|||
170603093|NCT04583956|616551619|FG000|Overall Study|Lost to Follow-up|7|||
170603094|NCT04583956|616551620|FG001|Overall Study|Lost to Follow-up|9|||
170603095|NCT04583956|616551619|FG000|Overall Study|Protocol Violation|2|||
170603096|NCT04583956|616551620|FG001|Overall Study|Protocol Violation|0|||
170603097|NCT04583956|616551619|FG000|Overall Study|Withdrawal by Subject|0|||
170603098|NCT04583956|616551620|FG001|Overall Study|Withdrawal by Subject|2|||
170603099|NCT04583956|616551619|FG000|Overall Study|Randomized but not dosed|2|||
170603100|NCT04583956|616551620|FG001|Overall Study|Randomized but not dosed|3|||
170603101|NCT04583956|616551619|FG000|Overall Study|Withdrawal of consent before product administration|1|||
170603102|NCT04583956|616551620|FG001|Overall Study|Withdrawal of consent before product administration|0|||
170603103|NCT01031979|616553436|FG000|Overall Study|Lost to Follow-up|5|||
170603104|NCT01031979|616553437|FG001|Overall Study|Lost to Follow-up|4|||
170603105|NCT02814175|616553438|FG000|Part 1|Adverse Event|2|||
170603106|NCT02814175|616553439|FG001|Part 1|Adverse Event|3|||
170603107|NCT02814175|616553440|FG002|Part 1|Adverse Event|0|||
170603108|NCT02814175|616553441|FG003|Part 1|Adverse Event|0|||
170603109|NCT02814175|616553442|FG004|Part 1|Adverse Event|0|||
170603110|NCT02814175|616553443|FG005|Part 1|Adverse Event|0|||
170603111|NCT02814175|616553438|FG000|Part 1|Withdrawal Consent|8|||
170603112|NCT02814175|616553439|FG001|Part 1|Withdrawal Consent|1|||
170603113|NCT02814175|616553440|FG002|Part 1|Withdrawal Consent|0|||
170603114|NCT02814175|616553441|FG003|Part 1|Withdrawal Consent|0|||
170603115|NCT02814175|616553442|FG004|Part 1|Withdrawal Consent|0|||
170603116|NCT02814175|616553443|FG005|Part 1|Withdrawal Consent|0|||
170603117|NCT02814175|616553438|FG000|Part 1|Lost to Follow-up|1|||
170603118|NCT02814175|616553439|FG001|Part 1|Lost to Follow-up|0|||
170603119|NCT02814175|616553440|FG002|Part 1|Lost to Follow-up|0|||
170603120|NCT02814175|616553441|FG003|Part 1|Lost to Follow-up|0|||
170603121|NCT02814175|616553442|FG004|Part 1|Lost to Follow-up|0|||
170603122|NCT02814175|616553443|FG005|Part 1|Lost to Follow-up|0|||
170603123|NCT02814175|616553438|FG000|Part 1|Lack of Efficacy|1|||
170603124|NCT02814175|616553439|FG001|Part 1|Lack of Efficacy|2|||
170603125|NCT02814175|616553440|FG002|Part 1|Lack of Efficacy|0|||
170603126|NCT02814175|616553441|FG003|Part 1|Lack of Efficacy|0|||
170603127|NCT02814175|616553442|FG004|Part 1|Lack of Efficacy|0|||
170603128|NCT02814175|616553443|FG005|Part 1|Lack of Efficacy|0|||
170603129|NCT02814175|616553438|FG000|Part 2|Adverse Event|0|||
170603130|NCT02814175|616553439|FG001|Part 2|Adverse Event|0|||
170603131|NCT02814175|616553440|FG002|Part 2|Adverse Event|0|||
170603132|NCT02814175|616553441|FG003|Part 2|Adverse Event|1|||
170603133|NCT02814175|616553442|FG004|Part 2|Adverse Event|1|||
170603134|NCT02814175|616553443|FG005|Part 2|Adverse Event|2|||
170603135|NCT02814175|616553438|FG000|Part 2|Withdrawal Consent|0|||
170603136|NCT02814175|616553439|FG001|Part 2|Withdrawal Consent|0|||
170603137|NCT02814175|616553440|FG002|Part 2|Withdrawal Consent|0|||
170603138|NCT02814175|616553441|FG003|Part 2|Withdrawal Consent|2|||
170603139|NCT02814175|616553442|FG004|Part 2|Withdrawal Consent|1|||
170603140|NCT02814175|616553443|FG005|Part 2|Withdrawal Consent|1|||
170603141|NCT02814175|616553438|FG000|Part 2|Lost to Follow-up|0|||
170603142|NCT02814175|616553439|FG001|Part 2|Lost to Follow-up|0|||
170603143|NCT02814175|616553440|FG002|Part 2|Lost to Follow-up|0|||
170603144|NCT02814175|616553441|FG003|Part 2|Lost to Follow-up|1|||
170603145|NCT02814175|616553442|FG004|Part 2|Lost to Follow-up|0|||
170603146|NCT02814175|616553443|FG005|Part 2|Lost to Follow-up|0|||
170603147|NCT02814175|616553438|FG000|Part 2|Lack of Efficacy|0|||
170603148|NCT02814175|616553439|FG001|Part 2|Lack of Efficacy|0|||
170603149|NCT02814175|616553440|FG002|Part 2|Lack of Efficacy|0|||
170603150|NCT02814175|616553441|FG003|Part 2|Lack of Efficacy|0|||
170603151|NCT02814175|616553442|FG004|Part 2|Lack of Efficacy|0|||
170603152|NCT02814175|616553443|FG005|Part 2|Lack of Efficacy|3|||
170603153|NCT00924508|616553446|FG000|Overall Study|Withdrawal by Subject|3|||
170603154|NCT01610336|616553450|FG000|Overall Study|Progressive Disease|4|||
170603155|NCT01610336|616553451|FG001|Overall Study|Progressive Disease|6|||
170603156|NCT01610336|616553452|FG002|Overall Study|Progressive Disease|6|||
170603157|NCT01610336|616553453|FG003|Overall Study|Progressive Disease|5|||
170603158|NCT01610336|616553454|FG004|Overall Study|Progressive Disease|3|||
170603159|NCT01610336|616553455|FG005|Overall Study|Progressive Disease|10|||
170603160|NCT01610336|616553456|FG006|Overall Study|Progressive Disease|1|||
170603161|NCT01610336|616553457|FG007|Overall Study|Progressive Disease|6|||
170603162|NCT01610336|616553458|FG008|Overall Study|Progressive Disease|6|||
170603163|NCT01610336|616553459|FG009|Overall Study|Progressive Disease|40|||
170603164|NCT01610336|616553460|FG010|Overall Study|Progressive Disease|36|||
170603165|NCT01610336|616553450|FG000|Overall Study|Adverse Event|0|||
170603166|NCT01610336|616553451|FG001|Overall Study|Adverse Event|0|||
170603167|NCT01610336|616553452|FG002|Overall Study|Adverse Event|0|||
170603168|NCT01610336|616553453|FG003|Overall Study|Adverse Event|1|||
170603169|NCT01610336|616553454|FG004|Overall Study|Adverse Event|1|||
170603170|NCT01610336|616553455|FG005|Overall Study|Adverse Event|1|||
170603171|NCT01610336|616553456|FG006|Overall Study|Adverse Event|0|||
170603172|NCT01610336|616553457|FG007|Overall Study|Adverse Event|0|||
170603173|NCT01610336|616553458|FG008|Overall Study|Adverse Event|2|||
170603174|NCT01610336|616553459|FG009|Overall Study|Adverse Event|8|||
170603175|NCT01610336|616553460|FG010|Overall Study|Adverse Event|6|||
170603176|NCT01610336|616553450|FG000|Overall Study|Subject/Guardian decision|1|||
170603177|NCT01610336|616553451|FG001|Overall Study|Subject/Guardian decision|1|||
170603178|NCT01610336|616553452|FG002|Overall Study|Subject/Guardian decision|0|||
170603179|NCT01610336|616553453|FG003|Overall Study|Subject/Guardian decision|1|||
170603180|NCT01610336|616553454|FG004|Overall Study|Subject/Guardian decision|0|||
170603181|NCT01610336|616553455|FG005|Overall Study|Subject/Guardian decision|0|||
170603182|NCT01610336|616553456|FG006|Overall Study|Subject/Guardian decision|0|||
170603183|NCT01610336|616553457|FG007|Overall Study|Subject/Guardian decision|1|||
170603184|NCT01610336|616553458|FG008|Overall Study|Subject/Guardian decision|0|||
170603185|NCT01610336|616553459|FG009|Overall Study|Subject/Guardian decision|2|||
170603186|NCT01610336|616553460|FG010|Overall Study|Subject/Guardian decision|2|||
170603187|NCT01610336|616553450|FG000|Overall Study|Death|0|||
170603188|NCT01610336|616553451|FG001|Overall Study|Death|0|||
170603189|NCT01610336|616553452|FG002|Overall Study|Death|0|||
170603190|NCT01610336|616553453|FG003|Overall Study|Death|0|||
170603191|NCT01610336|616553454|FG004|Overall Study|Death|0|||
170603192|NCT01610336|616553455|FG005|Overall Study|Death|1|||
170603193|NCT01610336|616553456|FG006|Overall Study|Death|3|||
170603194|NCT01610336|616553457|FG007|Overall Study|Death|0|||
170813375|NCT02152384|617325873|FG001|Period 1|Adverse Event|1|||
170813376|NCT04751929|617325874|FG000|Overall Study|Withdrawal by Subject|2|||
170813377|NCT04751929|617325875|FG001|Overall Study|Withdrawal by Subject|0|||
170813378|NCT04751929|617325876|FG002|Overall Study|Withdrawal by Subject|0|||
170813379|NCT04751929|617325877|FG003|Overall Study|Withdrawal by Subject|0|||
170813380|NCT04751929|617325874|FG000|Overall Study|Rising PSA|0|||
170813381|NCT04751929|617325875|FG001|Overall Study|Rising PSA|1|||
170813382|NCT04751929|617325876|FG002|Overall Study|Rising PSA|0|||
170813383|NCT04751929|617325877|FG003|Overall Study|Rising PSA|0|||
170813384|NCT04751929|617325874|FG000|Overall Study|Adverse Event|1|||
170813385|NCT04751929|617325875|FG001|Overall Study|Adverse Event|2|||
170813386|NCT04751929|617325876|FG002|Overall Study|Adverse Event|0|||
170813387|NCT04751929|617325877|FG003|Overall Study|Adverse Event|0|||
170813388|NCT04751929|617325874|FG000|Overall Study|Progressive Disease|3|||
170813389|NCT04751929|617325875|FG001|Overall Study|Progressive Disease|4|||
170813390|NCT04751929|617325876|FG002|Overall Study|Progressive Disease|4|||
170813391|NCT04751929|617325877|FG003|Overall Study|Progressive Disease|0|||
170813392|NCT04751929|617325874|FG000|Overall Study|Death|1|||
170813393|NCT04751929|617325875|FG001|Overall Study|Death|1|||
170813394|NCT04751929|617325876|FG002|Overall Study|Death|0|||
170813395|NCT04751929|617325877|FG003|Overall Study|Death|0|||
170813396|NCT00376259|617325878|FG000|Overall Study|Sponsor request - study termination|21|||
170813397|NCT00376259|617325879|FG001|Overall Study|Sponsor request - study termination|21|||
170813398|NCT00376259|617325878|FG000|Overall Study|Patient request|1|||
170813399|NCT00376259|617325879|FG001|Overall Study|Patient request|0|||
170813400|NCT01877720|617325880|FG000|Overall Study|Adverse Event|1|||
170603195|NCT01610336|616553458|FG008|Overall Study|Death|0|||
170813401|NCT01877720|617325881|FG001|Overall Study|Adverse Event|0|||
170813402|NCT00267956|617325882|FG000|Controlled Period|Adverse Event|4|||
170813403|NCT00267956|617325883|FG001|Controlled Period|Adverse Event|1|||
170813404|NCT00267956|617325884|FG002|Controlled Period|Adverse Event|0|||
170603196|NCT01610336|616553459|FG009|Overall Study|Death|1|||
170603197|NCT01610336|616553460|FG010|Overall Study|Death|2|||
170813405|NCT00267956|617325885|FG003|Controlled Period|Adverse Event|0|||
170813406|NCT00267956|617325882|FG000|Controlled Period|Lack of Efficacy|4|||
170603198|NCT01610336|616553450|FG000|Overall Study|Non-Compliance with study treatment|0|||
170603199|NCT01610336|616553451|FG001|Overall Study|Non-Compliance with study treatment|0|||
170603200|NCT01610336|616553452|FG002|Overall Study|Non-Compliance with study treatment|0|||
170603201|NCT01610336|616553453|FG003|Overall Study|Non-Compliance with study treatment|0|||
170603202|NCT01610336|616553454|FG004|Overall Study|Non-Compliance with study treatment|0|||
170603203|NCT01610336|616553455|FG005|Overall Study|Non-Compliance with study treatment|0|||
170603204|NCT01610336|616553456|FG006|Overall Study|Non-Compliance with study treatment|0|||
170603205|NCT01610336|616553457|FG007|Overall Study|Non-Compliance with study treatment|0|||
170603206|NCT01610336|616553458|FG008|Overall Study|Non-Compliance with study treatment|0|||
170603207|NCT01610336|616553459|FG009|Overall Study|Non-Compliance with study treatment|1|||
170603208|NCT01610336|616553460|FG010|Overall Study|Non-Compliance with study treatment|0|||
170603209|NCT01610336|616553450|FG000|Overall Study|Physician Decision|0|||
170603210|NCT01610336|616553451|FG001|Overall Study|Physician Decision|0|||
170603211|NCT01610336|616553452|FG002|Overall Study|Physician Decision|0|||
170603212|NCT01610336|616553453|FG003|Overall Study|Physician Decision|0|||
170603213|NCT01610336|616553454|FG004|Overall Study|Physician Decision|0|||
170603214|NCT01610336|616553455|FG005|Overall Study|Physician Decision|0|||
170603215|NCT01610336|616553456|FG006|Overall Study|Physician Decision|1|||
170603216|NCT01610336|616553457|FG007|Overall Study|Physician Decision|0|||
170603217|NCT01610336|616553458|FG008|Overall Study|Physician Decision|0|||
170603218|NCT01610336|616553459|FG009|Overall Study|Physician Decision|0|||
170603219|NCT01610336|616553460|FG010|Overall Study|Physician Decision|0|||
170603220|NCT01610336|616553450|FG000|Overall Study|Protocol Deviation|0|||
170603221|NCT01610336|616553451|FG001|Overall Study|Protocol Deviation|0|||
170603222|NCT01610336|616553452|FG002|Overall Study|Protocol Deviation|0|||
170603223|NCT01610336|616553453|FG003|Overall Study|Protocol Deviation|0|||
170603224|NCT01610336|616553454|FG004|Overall Study|Protocol Deviation|0|||
170603225|NCT01610336|616553455|FG005|Overall Study|Protocol Deviation|0|||
170603226|NCT01610336|616553456|FG006|Overall Study|Protocol Deviation|0|||
170603227|NCT01610336|616553457|FG007|Overall Study|Protocol Deviation|0|||
170603228|NCT01610336|616553458|FG008|Overall Study|Protocol Deviation|0|||
170603229|NCT01610336|616553459|FG009|Overall Study|Protocol Deviation|1|||
170603230|NCT01610336|616553460|FG010|Overall Study|Protocol Deviation|0|||
170603231|NCT01610336|616553450|FG000|Overall Study|Transfer to another trial|0|||
170603232|NCT01610336|616553451|FG001|Overall Study|Transfer to another trial|0|||
170603233|NCT01610336|616553452|FG002|Overall Study|Transfer to another trial|0|||
170603234|NCT01610336|616553453|FG003|Overall Study|Transfer to another trial|0|||
170603235|NCT01610336|616553454|FG004|Overall Study|Transfer to another trial|0|||
170603236|NCT01610336|616553455|FG005|Overall Study|Transfer to another trial|0|||
170603237|NCT01610336|616553456|FG006|Overall Study|Transfer to another trial|0|||
170603238|NCT01610336|616553457|FG007|Overall Study|Transfer to another trial|0|||
170603239|NCT01610336|616553458|FG008|Overall Study|Transfer to another trial|0|||
170603240|NCT01610336|616553459|FG009|Overall Study|Transfer to another trial|0|||
170603241|NCT01610336|616553460|FG010|Overall Study|Transfer to another trial|1|||
170603242|NCT02629822|616553461|FG000|Base Study|Lost to Follow-up|2|||
170603243|NCT02629822|616553461|FG000|Base Study|Non-Compliance With Study Drug|1|||
170603244|NCT02629822|616553461|FG000|Extension Study|Adverse Event|1|||
170603245|NCT02629822|616553461|FG000|Extension Study|Lost to Follow-up|1|||
170603246|NCT01912339|616553462|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
170603247|NCT01912339|616553463|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
170603248|NCT01912339|616553464|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
170603249|NCT01912339|616553462|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
170603250|NCT01912339|616553463|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
170603251|NCT01912339|616553464|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
170603252|NCT01912339|616553462|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
170603253|NCT01912339|616553463|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
170603254|NCT01912339|616553464|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
170603255|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
170603256|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
170603257|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
170603258|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
170603259|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
170603260|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
170603261|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
170603262|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
170603263|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
170603264|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
170603265|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
170603266|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
170603267|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
170603268|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
170603269|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
170603270|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
170603271|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
170603272|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
170603273|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
170603274|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
170603275|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
170603276|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
170603277|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
170603278|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
170603279|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
170603280|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
170603281|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
170603282|NCT01912339|616553462|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
170603283|NCT01912339|616553463|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
170603284|NCT01912339|616553464|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
170603285|NCT00741013|616553465|FG000|Overall Study|Adverse Event|1|||
170603286|NCT00741013|616553466|FG001|Overall Study|Adverse Event|0|||
170603287|NCT00741013|616553467|FG002|Overall Study|Adverse Event|0|||
170603288|NCT00741013|616553465|FG000|Overall Study|Withdrawal by Subject|0|||
170603289|NCT00741013|616553466|FG001|Overall Study|Withdrawal by Subject|0|||
170603290|NCT00741013|616553467|FG002|Overall Study|Withdrawal by Subject|1|||
170603291|NCT00741013|616553465|FG000|Overall Study|Discovered failed screen after enrolled|0|||
170603292|NCT00741013|616553466|FG001|Overall Study|Discovered failed screen after enrolled|2|||
170603293|NCT00741013|616553467|FG002|Overall Study|Discovered failed screen after enrolled|0|||
170603294|NCT04481750|616553472|FG000|Period 1 (Fasted)|Adverse Event|0|||
170603295|NCT04481750|616553473|FG001|Period 1 (Fasted)|Adverse Event|0|||
170603296|NCT04481750|616553474|FG002|Period 1 (Fasted)|Adverse Event|1|||
170603297|NCT04481750|616553475|FG003|Period 1 (Fasted)|Adverse Event|0|||
170603298|NCT04481750|616553476|FG004|Period 1 (Fasted)|Adverse Event|0|||
170603299|NCT04481750|616553477|FG005|Period 1 (Fasted)|Adverse Event|0|||
170603300|NCT04481750|616553478|FG006|Period 1 (Fasted)|Adverse Event|0|||
170603301|NCT04481750|616553479|FG007|Period 1 (Fasted)|Adverse Event|0|||
170603302|NCT04481750|616553480|FG008|Period 1 (Fasted)|Adverse Event|0|||
170603303|NCT04481750|616553481|FG009|Period 1 (Fasted)|Adverse Event|0|||
170603304|NCT04481750|616553482|FG010|Period 1 (Fasted)|Adverse Event|0|||
170603305|NCT03439137|616553483|FG000|Overall Study|Adverse Event|16|||
170603306|NCT03439137|616553484|FG001|Overall Study|Adverse Event|12|||
170603307|NCT03439137|616553483|FG000|Overall Study|Physician Decision|0|||
170603308|NCT03439137|616553484|FG001|Overall Study|Physician Decision|5|||
170603309|NCT03439137|616553483|FG000|Overall Study|Withdrawal by Subject|14|||
170603310|NCT03439137|616553484|FG001|Overall Study|Withdrawal by Subject|4|||
170603311|NCT03439137|616553483|FG000|Overall Study|Conducting rescue therapy|2|||
170603312|NCT03439137|616553484|FG001|Overall Study|Conducting rescue therapy|1|||
170603313|NCT03439137|616553483|FG000|Overall Study|Difficult to control Hb|10|||
170603314|NCT03439137|616553484|FG001|Overall Study|Difficult to control Hb|2|||
170603315|NCT03439137|616553483|FG000|Overall Study|Initiation of a renal transplant|0|||
170603316|NCT03439137|616553484|FG001|Overall Study|Initiation of a renal transplant|2|||
170603317|NCT00539305|616553485|FG000|Overall Study|Adverse Event|1|||
170603318|NCT00539305|616553486|FG001|Overall Study|Adverse Event|0|||
170603319|NCT00539305|616553485|FG000|Overall Study|Substance Use|0|||
170603320|NCT00539305|616553486|FG001|Overall Study|Substance Use|1|||
170603321|NCT00539305|616553485|FG000|Overall Study|Withdrawal by Subject|0|||
170603322|NCT00539305|616553486|FG001|Overall Study|Withdrawal by Subject|1|||
170603323|NCT00691028|616553489|FG000|Open-label Period|Adverse Event|0|||
170603324|NCT00691028|616553490|FG001|Open-label Period|Adverse Event|0|||
170603325|NCT00691028|616553491|FG002|Open-label Period|Adverse Event|0|||
170603326|NCT00691028|616553492|FG003|Open-label Period|Adverse Event|16|||
170652265|NCT01606878|616740120|FG010|Overall Study|Physician Decision|0|||
170913868|NCT00090285|617687651|FG004|Extension 1|Other|0|||
170913869|NCT00090285|617687652|FG005|Extension 1|Other|0|||
170913870|NCT00090285|617687647|FG000|Extension 1|Moved|0|||
170913871|NCT00090285|617687648|FG001|Extension 1|Moved|0|||
170913872|NCT00090285|617687649|FG002|Extension 1|Moved|3|||
170913873|NCT00090285|617687650|FG003|Extension 1|Moved|0|||
170913874|NCT00090285|617687651|FG004|Extension 1|Moved|0|||
170913875|NCT00090285|617687652|FG005|Extension 1|Moved|0|||
170913876|NCT00090285|617687647|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
170913877|NCT00090285|617687648|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
170913878|NCT00090285|617687649|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
170913879|NCT00090285|617687650|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
170913880|NCT00090285|617687651|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
170913881|NCT00090285|617687652|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
170913882|NCT00090285|617687647|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
170913883|NCT00090285|617687648|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
170913884|NCT00090285|617687649|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
170913885|NCT00090285|617687650|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
170913886|NCT00090285|617687651|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
170913887|NCT00090285|617687652|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
170913888|NCT00090285|617687647|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
170913889|NCT00090285|617687648|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
170913890|NCT00090285|617687649|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
170913891|NCT00090285|617687650|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
170913892|NCT00090285|617687651|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
170913893|NCT00090285|617687652|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
170913894|NCT00090285|617687647|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
170913895|NCT00090285|617687648|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
170913896|NCT00090285|617687649|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
170913897|NCT00090285|617687650|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
170913898|NCT00090285|617687651|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
170913899|NCT00090285|617687652|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
170913900|NCT02046564|617687655|FG000|Overall Study|Adverse Event|6|||
170913901|NCT02046564|617687656|FG001|Overall Study|Adverse Event|3|||
170913902|NCT02046564|617687655|FG000|Overall Study|Physician Decision|0|||
170913903|NCT02046564|617687656|FG001|Overall Study|Physician Decision|1|||
170913904|NCT02046564|617687655|FG000|Overall Study|Protocol Violation|3|||
170913905|NCT02046564|617687656|FG001|Overall Study|Protocol Violation|1|||
170913906|NCT02046564|617687655|FG000|Overall Study|Withdrawal by Subject|4|||
170913907|NCT02046564|617687656|FG001|Overall Study|Withdrawal by Subject|10|||
170913908|NCT02046564|617687655|FG000|Overall Study|Subject met withdrawal criteria|2|||
170913909|NCT02046564|617687656|FG001|Overall Study|Subject met withdrawal criteria|5|||
170913910|NCT02747043|617687657|FG000|Overall Study|Other|1|||
170913911|NCT02747043|617687658|FG001|Overall Study|Other|1|||
170913912|NCT02747043|617687657|FG000|Overall Study|Adverse Event|3|||
170913913|NCT02747043|617687658|FG001|Overall Study|Adverse Event|1|||
170913914|NCT02747043|617687657|FG000|Overall Study|Withdrawal by Subject|1|||
170913915|NCT02747043|617687658|FG001|Overall Study|Withdrawal by Subject|1|||
170913916|NCT02747043|617687657|FG000|Overall Study|Physician Decision|1|||
170913917|NCT02747043|617687658|FG001|Overall Study|Physician Decision|1|||
170913918|NCT02747043|617687657|FG000|Overall Study|Protocol Violation|0|||
170913919|NCT02747043|617687658|FG001|Overall Study|Protocol Violation|1|||
170603327|NCT00691028|616553489|FG000|Open-label Period|Withdrawal by Subject|0|||
170603328|NCT00691028|616553490|FG001|Open-label Period|Withdrawal by Subject|0|||
170603329|NCT00691028|616553491|FG002|Open-label Period|Withdrawal by Subject|0|||
170603330|NCT00691028|616553492|FG003|Open-label Period|Withdrawal by Subject|3|||
170603331|NCT00691028|616553489|FG000|Open-label Period|not come to a hospital|0|||
170603332|NCT00691028|616553490|FG001|Open-label Period|not come to a hospital|0|||
170603333|NCT00691028|616553491|FG002|Open-label Period|not come to a hospital|0|||
170603334|NCT00691028|616553492|FG003|Open-label Period|not come to a hospital|1|||
170603335|NCT00691028|616553489|FG000|Double-blind Period|Adverse Event|8|||
170603336|NCT00691028|616553490|FG001|Double-blind Period|Adverse Event|9|||
170603337|NCT00691028|616553491|FG002|Double-blind Period|Adverse Event|6|||
170603338|NCT00691028|616553492|FG003|Double-blind Period|Adverse Event|0|||
170603339|NCT00691028|616553489|FG000|Double-blind Period|Lack of Efficacy|4|||
170603340|NCT00691028|616553490|FG001|Double-blind Period|Lack of Efficacy|3|||
170603341|NCT00691028|616553491|FG002|Double-blind Period|Lack of Efficacy|2|||
170603342|NCT00691028|616553492|FG003|Double-blind Period|Lack of Efficacy|0|||
170603343|NCT00691028|616553489|FG000|Double-blind Period|Withdrawal by Subject|1|||
170603344|NCT00691028|616553490|FG001|Double-blind Period|Withdrawal by Subject|0|||
170603345|NCT00691028|616553491|FG002|Double-blind Period|Withdrawal by Subject|1|||
170603346|NCT00691028|616553492|FG003|Double-blind Period|Withdrawal by Subject|0|||
170603347|NCT00691028|616553489|FG000|Double-blind Period|not come to a hospital.|0|||
170603348|NCT00691028|616553490|FG001|Double-blind Period|not come to a hospital.|1|||
170813407|NCT00267956|617325883|FG001|Controlled Period|Lack of Efficacy|2|||
170813408|NCT00267956|617325884|FG002|Controlled Period|Lack of Efficacy|0|||
170813409|NCT00267956|617325885|FG003|Controlled Period|Lack of Efficacy|0|||
170813410|NCT00267956|617325882|FG000|Controlled Period|Lost to Follow-up|2|||
170813411|NCT00267956|617325883|FG001|Controlled Period|Lost to Follow-up|0|||
170813412|NCT00267956|617325884|FG002|Controlled Period|Lost to Follow-up|0|||
170813413|NCT00267956|617325885|FG003|Controlled Period|Lost to Follow-up|0|||
170813414|NCT00267956|617325882|FG000|Controlled Period|Withdrew consent|3|||
170813415|NCT00267956|617325883|FG001|Controlled Period|Withdrew consent|1|||
170813416|NCT00267956|617325884|FG002|Controlled Period|Withdrew consent|0|||
170813417|NCT00267956|617325885|FG003|Controlled Period|Withdrew consent|0|||
170813418|NCT00267956|617325882|FG000|After Controlled Period|Adverse Event|0|||
170813419|NCT00267956|617325883|FG001|After Controlled Period|Adverse Event|0|||
170813420|NCT00267956|617325884|FG002|After Controlled Period|Adverse Event|2|||
170813421|NCT00267956|617325885|FG003|After Controlled Period|Adverse Event|1|||
170813422|NCT00267956|617325882|FG000|After Controlled Period|Lack of Efficacy|0|||
170813423|NCT00267956|617325883|FG001|After Controlled Period|Lack of Efficacy|0|||
170813424|NCT00267956|617325884|FG002|After Controlled Period|Lack of Efficacy|1|||
170813425|NCT00267956|617325885|FG003|After Controlled Period|Lack of Efficacy|1|||
170813426|NCT00267956|617325882|FG000|After Controlled Period|Lost to Follow-up|0|||
170813427|NCT00267956|617325883|FG001|After Controlled Period|Lost to Follow-up|0|||
170813428|NCT00267956|617325884|FG002|After Controlled Period|Lost to Follow-up|1|||
170813429|NCT00267956|617325885|FG003|After Controlled Period|Lost to Follow-up|0|||
170813430|NCT00267956|617325882|FG000|After Controlled Period|Withdrew consent|0|||
170813431|NCT00267956|617325883|FG001|After Controlled Period|Withdrew consent|0|||
170813432|NCT00267956|617325884|FG002|After Controlled Period|Withdrew consent|1|||
170813433|NCT00267956|617325885|FG003|After Controlled Period|Withdrew consent|0|||
170813434|NCT01263223|617325886|FG000|Period 2|Withdrawal by Subject|0|||
170813435|NCT01263223|617325887|FG001|Period 2|Withdrawal by Subject|1|||
170813436|NCT01263223|617325886|FG000|7-day Follow-up|Withdrawal by Subject|0|||
170813437|NCT01263223|617325887|FG001|7-day Follow-up|Withdrawal by Subject|1|||
170813438|NCT01263223|617325886|FG000|7-day Follow-up|Lost to Follow-up|1|||
170813439|NCT01263223|617325887|FG001|7-day Follow-up|Lost to Follow-up|0|||
170813440|NCT02005484|617325889|FG000|Overall Study|Death|1|||
170813441|NCT02005484|617325889|FG000|Overall Study|Disease progression|1|||
170813442|NCT02005484|617325889|FG000|Overall Study|Changed to a Different Study|1|||
170813443|NCT02005484|617325889|FG000|Overall Study|Sponsor decision|1|||
170813444|NCT02246647|617325890|FG000|Overall Study|Withdrawal by Subject|1|||
170813445|NCT02246647|617325891|FG001|Overall Study|Withdrawal by Subject|1|||
170813446|NCT01113541|617325896|FG000|Overall Study|Withdrawal by Subject|1|||
170813447|NCT01113541|617325896|FG000|Overall Study|Protocol Violation|1|||
170603349|NCT00691028|616553491|FG002|Double-blind Period|not come to a hospital.|0|||
170603350|NCT00691028|616553492|FG003|Double-blind Period|not come to a hospital.|0|||
170603351|NCT03387020|616553493|FG000|Overall Study|Adverse Event|0|||
170603352|NCT03387020|616553494|FG001|Overall Study|Adverse Event|2|||
170603353|NCT03387020|616553495|FG002|Overall Study|Adverse Event|0|||
170603354|NCT03387020|616553493|FG000|Overall Study|Withdrawal by Subject|2|||
170813448|NCT01113541|617325896|FG000|Overall Study|Study Terminated by Sponsor|7|||
170813449|NCT01113541|617325896|FG000|Overall Study|Adverse Event|4|||
170813450|NCT01393964|617325897|FG000|Overall Study|Disease Progression|4|||
170813451|NCT01393964|617325898|FG001|Overall Study|Disease Progression|3|||
170813452|NCT01393964|617325899|FG002|Overall Study|Disease Progression|5|||
170603355|NCT03387020|616553494|FG001|Overall Study|Withdrawal by Subject|0|||
170603356|NCT03387020|616553495|FG002|Overall Study|Withdrawal by Subject|0|||
170603357|NCT01425632|616553496|FG000|Overall Study|Adverse Event|0|||
170603358|NCT01425632|616553497|FG001|Overall Study|Adverse Event|1|||
170603359|NCT01425632|616553498|FG002|Overall Study|Adverse Event|1|||
170603360|NCT01425632|616553496|FG000|Overall Study|Physician Decision|1|||
170603361|NCT01425632|616553497|FG001|Overall Study|Physician Decision|0|||
170603362|NCT01425632|616553498|FG002|Overall Study|Physician Decision|0|||
170603363|NCT01425632|616553496|FG000|Overall Study|Protocol Violation|0|||
170603364|NCT01425632|616553497|FG001|Overall Study|Protocol Violation|0|||
170603365|NCT01425632|616553498|FG002|Overall Study|Protocol Violation|2|||
170603366|NCT01425632|616553496|FG000|Overall Study|Withdrawal by Subject|0|||
170603367|NCT01425632|616553497|FG001|Overall Study|Withdrawal by Subject|0|||
170603368|NCT01425632|616553498|FG002|Overall Study|Withdrawal by Subject|1|||
170603369|NCT05249569|616553506|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
170603370|NCT03927144|616553507|FG000|Core Phase|Adverse Event|9|||
170603371|NCT03927144|616553508|FG001|Core Phase|Adverse Event|5|||
170603372|NCT03927144|616553507|FG000|Core Phase|Lost to Follow-up|3|||
170603373|NCT03927144|616553508|FG001|Core Phase|Lost to Follow-up|2|||
170603374|NCT03927144|616553507|FG000|Core Phase|New Therapy for Study Indication|0|||
170603375|NCT03927144|616553508|FG001|Core Phase|New Therapy for Study Indication|1|||
170603376|NCT03927144|616553507|FG000|Core Phase|No Longer Clinically Benefiting|4|||
170603377|NCT03927144|616553508|FG001|Core Phase|No Longer Clinically Benefiting|4|||
170603378|NCT03927144|616553507|FG000|Core Phase|Physician Decision|2|||
170603379|NCT03927144|616553508|FG001|Core Phase|Physician Decision|8|||
170603380|NCT03927144|616553507|FG000|Core Phase|Protocol Violation|2|||
170603381|NCT03927144|616553508|FG001|Core Phase|Protocol Violation|2|||
170603382|NCT03927144|616553507|FG000|Core Phase|Withdrawal by Subject|16|||
170603383|NCT03927144|616553508|FG001|Core Phase|Withdrawal by Subject|40|||
170603384|NCT03927144|616553507|FG000|Extension Phase|Adverse Event|2|||
170603385|NCT03927144|616553508|FG001|Extension Phase|Adverse Event|1|||
170913920|NCT02747043|617687657|FG000|Overall Study|Disease progression|4|||
170913921|NCT02747043|617687658|FG001|Overall Study|Disease progression|0|||
170603386|NCT03927144|616553507|FG000|Extension Phase|No longer clinically benefiting|4|||
170603387|NCT03927144|616553508|FG001|Extension Phase|No longer clinically benefiting|5|||
170603388|NCT03927144|616553507|FG000|Extension Phase|Pregnancy|1|||
170603389|NCT03927144|616553508|FG001|Extension Phase|Pregnancy|0|||
170603390|NCT03927144|616553507|FG000|Extension Phase|Protocol Violation|0|||
170603391|NCT03927144|616553508|FG001|Extension Phase|Protocol Violation|1|||
170603392|NCT03927144|616553507|FG000|Extension Phase|Withdrawal by Subject|8|||
170603393|NCT03927144|616553508|FG001|Extension Phase|Withdrawal by Subject|3|||
170603394|NCT03461146|616553509|FG000|Overall Study|Adverse Event|2|||
170603395|NCT03461146|616553509|FG000|Overall Study|Physician Decision|1|||
170603396|NCT02140047|616553510|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170603397|NCT02140047|616553511|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170603398|NCT02140047|616553512|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170603399|NCT04617496|616553513|FG000|Overall Study|Death|2|||
170603400|NCT04617496|616553514|FG001|Overall Study|Death|1|||
170603401|NCT04617496|616553513|FG000|Overall Study|Lost to Follow-up|3|||
170603402|NCT04617496|616553514|FG001|Overall Study|Lost to Follow-up|3|||
170603403|NCT00200356|616553515|FG000|Overall Study|Lack of Efficacy|3|||
170813453|NCT01393964|617325897|FG000|Overall Study|Study drug toxicity|1|||
170913922|NCT01936649|617687663|FG000|Overall Study|Withdrawal by Subject|4|||
170913923|NCT01936649|617687663|FG000|Overall Study|Physician Decision|2|||
170913924|NCT01936649|617687663|FG000|Overall Study|Protocol Violation|2|||
170913925|NCT01936649|617687663|FG000|Overall Study|Other than specified above|5|||
170913926|NCT01342640|617687671|FG000|Overall Study|Adverse Event|3|||
170913927|NCT01342640|617687671|FG000|Overall Study|Protocol Violation|16|||
170913928|NCT01342640|617687671|FG000|Overall Study|Lost to Follow-up|21|||
170913929|NCT01342640|617687671|FG000|Overall Study|Other|1|||
170603404|NCT00200356|616553516|FG001|Overall Study|Lack of Efficacy|3|||
170603405|NCT00200356|616553515|FG000|Overall Study|Protocol Violation|4|||
170603406|NCT00200356|616553516|FG001|Overall Study|Protocol Violation|4|||
170603407|NCT00200356|616553515|FG000|Overall Study|Nontreatment|1|||
170813454|NCT01393964|617325898|FG001|Overall Study|Study drug toxicity|0|||
170813455|NCT01393964|617325899|FG002|Overall Study|Study drug toxicity|0|||
170813456|NCT01393964|617325897|FG000|Overall Study|Withdrawal by Subject|0|||
170813457|NCT01393964|617325898|FG001|Overall Study|Withdrawal by Subject|0|||
170813458|NCT01393964|617325899|FG002|Overall Study|Withdrawal by Subject|1|||
170813459|NCT01393964|617325897|FG000|Overall Study|Adverse event unrelated to study drug|0|||
170813460|NCT01393964|617325898|FG001|Overall Study|Adverse event unrelated to study drug|3|||
170913930|NCT02240628|617687674|FG000|Overall Study|Physician Decision|6|||
170913931|NCT02240628|617687675|FG001|Overall Study|Physician Decision|5|||
170603408|NCT00200356|616553516|FG001|Overall Study|Nontreatment|0|||
170603409|NCT03703856|616553521|FG000|Enrolled in study|Withdrawal by Subject|23|||
170603410|NCT03703856|616553521|FG000|Titrated to full dose|Withdrawal by Subject|5|||
170603411|NCT03703856|616553521|FG000|16 week assessment|Withdrawal by Subject|1|||
170603412|NCT03703856|616553521|FG000|24 week assessment|Withdrawal by Subject|1|||
170603413|NCT01596335|616553522|FG000|Overall Study|exacerbation of primary disease|5|||
170603414|NCT01596335|616553523|FG001|Overall Study|exacerbation of primary disease|9|||
170603415|NCT03402386|616553524|FG000|Overall Study|Adverse Event|3|||
170603416|NCT03402386|616553524|FG000|Overall Study|Physician Decision|1|||
170603417|NCT03402386|616553524|FG000|Overall Study|Difficult to control Hb|2|||
170603418|NCT02702414|616553525|FG000|Overall Study|Death|96|||
170603419|NCT02702414|616553526|FG001|Overall Study|Death|42|||
170603420|NCT02702414|616553525|FG000|Overall Study|Lost to Follow-up|0|||
170603421|NCT02702414|616553526|FG001|Overall Study|Lost to Follow-up|1|||
170603422|NCT02702414|616553525|FG000|Overall Study|Withdrawal by Subject|0|||
170603423|NCT02702414|616553526|FG001|Overall Study|Withdrawal by Subject|1|||
170652266|NCT01606878|616740110|FG000|Overall Study|Withdrawal by Subject|3|||
170652267|NCT01606878|616740111|FG001|Overall Study|Withdrawal by Subject|2|||
170652268|NCT01606878|616740112|FG002|Overall Study|Withdrawal by Subject|2|||
170652269|NCT01606878|616740113|FG003|Overall Study|Withdrawal by Subject|0|||
170652270|NCT01606878|616740114|FG004|Overall Study|Withdrawal by Subject|1|||
170652271|NCT01606878|616740115|FG005|Overall Study|Withdrawal by Subject|1|||
170652272|NCT01606878|616740116|FG006|Overall Study|Withdrawal by Subject|2|||
170652273|NCT01606878|616740117|FG007|Overall Study|Withdrawal by Subject|1|||
170652274|NCT01606878|616740118|FG008|Overall Study|Withdrawal by Subject|2|||
170652275|NCT01606878|616740119|FG009|Overall Study|Withdrawal by Subject|0|||
170652276|NCT01606878|616740120|FG010|Overall Study|Withdrawal by Subject|2|||
170652277|NCT00278915|616740121|FG000|Overall Study|Disease progression|1|||
170652278|NCT03720652|616740122|FG000|Overall Study|Withdrawal by Subject|2|||
170652279|NCT03720652|616740123|FG001|Overall Study|Withdrawal by Subject|7|||
170813461|NCT01393964|617325899|FG002|Overall Study|Adverse event unrelated to study drug|0|||
170813462|NCT01393964|617325897|FG000|Overall Study|Subject request stop study treatment|0|||
170813463|NCT01393964|617325898|FG001|Overall Study|Subject request stop study treatment|1|||
170813464|NCT01393964|617325899|FG002|Overall Study|Subject request stop study treatment|0|||
170813465|NCT01393964|617325897|FG000|Overall Study|Subject decided to move to transplant|1|||
170813466|NCT01393964|617325898|FG001|Overall Study|Subject decided to move to transplant|0|||
170813467|NCT01393964|617325899|FG002|Overall Study|Subject decided to move to transplant|0|||
170813468|NCT01393964|617325897|FG000|Overall Study|Subject switched to commercial supply|1|||
170813469|NCT01393964|617325898|FG001|Overall Study|Subject switched to commercial supply|0|||
170813470|NCT01393964|617325899|FG002|Overall Study|Subject switched to commercial supply|2|||
170813471|NCT01393964|617325897|FG000|Overall Study|Subject plateaued in terms of effect|1|||
170813472|NCT01393964|617325898|FG001|Overall Study|Subject plateaued in terms of effect|0|||
170813473|NCT01393964|617325899|FG002|Overall Study|Subject plateaued in terms of effect|0|||
170813474|NCT01393964|617325897|FG000|Overall Study|Investigator removed subject from study|0|||
170813475|NCT01393964|617325898|FG001|Overall Study|Investigator removed subject from study|1|||
170813476|NCT01393964|617325899|FG002|Overall Study|Investigator removed subject from study|0|||
170813477|NCT01393964|617325897|FG000|Overall Study|Subject converted to roll-over study|0|||
170813478|NCT01393964|617325898|FG001|Overall Study|Subject converted to roll-over study|1|||
170813479|NCT01393964|617325899|FG002|Overall Study|Subject converted to roll-over study|0|||
170813480|NCT01393964|617325897|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
170813481|NCT01393964|617325898|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
170813482|NCT01393964|617325899|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
170813483|NCT01918033|617325902|FG000|Overall Study|Adverse Event|1|||
170813484|NCT01918033|617325903|FG001|Overall Study|Adverse Event|0|||
170813485|NCT01918033|617325904|FG002|Overall Study|Adverse Event|2|||
170813486|NCT01918033|617325902|FG000|Overall Study|Lost to Follow-up|0|||
170813487|NCT01918033|617325903|FG001|Overall Study|Lost to Follow-up|1|||
170813488|NCT01918033|617325904|FG002|Overall Study|Lost to Follow-up|0|||
170813489|NCT01918033|617325902|FG000|Overall Study|Protocol Violation|2|||
170813490|NCT01918033|617325903|FG001|Overall Study|Protocol Violation|0|||
170813491|NCT01918033|617325904|FG002|Overall Study|Protocol Violation|1|||
170813492|NCT01918033|617325902|FG000|Overall Study|Withdrawal by Subject|2|||
170813493|NCT01918033|617325903|FG001|Overall Study|Withdrawal by Subject|1|||
170813494|NCT01918033|617325904|FG002|Overall Study|Withdrawal by Subject|0|||
170813495|NCT04679675|617325905|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
170813496|NCT04679675|617325906|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
170813497|NCT04679675|617325907|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
170813498|NCT04679675|617325908|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
170813499|NCT04679675|617325905|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
170813500|NCT04679675|617325906|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
170813501|NCT04679675|617325907|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
170813502|NCT04679675|617325908|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
170813503|NCT00687297|617325914|FG000|Randomization|Withdrawal by Subject|2|||
170813504|NCT00687297|617325915|FG001|Randomization|Withdrawal by Subject|0|||
170913932|NCT00552305|617687679|FG000|Overall Study|Adverse Event|43|||
170913933|NCT00552305|617687679|FG000|Overall Study|Lack of Efficacy|120|||
170603424|NCT02702414|616553525|FG000|Overall Study|Protocol Violation|1|||
170603425|NCT02702414|616553526|FG001|Overall Study|Protocol Violation|0|||
170603426|NCT02702414|616553525|FG000|Overall Study|Sponsor Decision|8|||
170603427|NCT02702414|616553526|FG001|Overall Study|Sponsor Decision|7|||
170603428|NCT02455076|616553531|FG000|Inpatient|Withdrawal by Subject|1|||
170603429|NCT02455076|616553532|FG001|Inpatient|Withdrawal by Subject|0|||
170603430|NCT02455076|616553533|FG002|Inpatient|Withdrawal by Subject|0|||
170603431|NCT02455076|616553534|FG003|Inpatient|Withdrawal by Subject|0|||
170603432|NCT02455076|616553535|FG004|Inpatient|Withdrawal by Subject|0|||
170603433|NCT02455076|616553531|FG000|Inpatient|Discharged <24 h after admission|0|||
170603434|NCT02455076|616553532|FG001|Inpatient|Discharged <24 h after admission|1|||
170603435|NCT02455076|616553533|FG002|Inpatient|Discharged <24 h after admission|0|||
170603436|NCT02455076|616553534|FG003|Inpatient|Discharged <24 h after admission|0|||
170603437|NCT02455076|616553535|FG004|Inpatient|Discharged <24 h after admission|0|||
170603438|NCT02455076|616553531|FG000|Inpatient|Adverse Event|3|||
170603439|NCT02455076|616553532|FG001|Inpatient|Adverse Event|0|||
170603440|NCT02455076|616553533|FG002|Inpatient|Adverse Event|0|||
170603441|NCT02455076|616553534|FG003|Inpatient|Adverse Event|0|||
170603442|NCT02455076|616553535|FG004|Inpatient|Adverse Event|0|||
170603443|NCT02455076|616553531|FG000|Outpatient|Adverse Event|0|||
170603444|NCT02455076|616553532|FG001|Outpatient|Adverse Event|0|||
170603445|NCT02455076|616553533|FG002|Outpatient|Adverse Event|0|||
170603446|NCT02455076|616553534|FG003|Outpatient|Adverse Event|5|||
170603447|NCT02455076|616553535|FG004|Outpatient|Adverse Event|0|||
170603448|NCT02455076|616553531|FG000|Outpatient|Lost to Follow-up|0|||
170603449|NCT02455076|616553532|FG001|Outpatient|Lost to Follow-up|0|||
170603450|NCT02455076|616553533|FG002|Outpatient|Lost to Follow-up|0|||
170603451|NCT02455076|616553534|FG003|Outpatient|Lost to Follow-up|1|||
170603452|NCT02455076|616553535|FG004|Outpatient|Lost to Follow-up|12|||
170603453|NCT04071158|616553536|FG000|Overall Study|Lost to Follow-up|1|||
170913934|NCT00552305|617687679|FG000|Overall Study|Lost to Follow-up|4|||
170913935|NCT00552305|617687679|FG000|Overall Study|Protocol Violation|3|||
170913936|NCT00552305|617687679|FG000|Overall Study|Withdrawal by Subject|44|||
170913937|NCT00552305|617687679|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
170913938|NCT00552305|617687679|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
170913939|NCT00552305|617687679|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
170913940|NCT00552305|617687679|FG000|Overall Study|Unsatisfactory compliance|11|||
170913941|NCT00552305|617687679|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
170913942|NCT00552305|617687679|FG000|Overall Study|AE/Other: prohibited drug required|1|||
170913943|NCT00552305|617687679|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
170913944|NCT00552305|617687679|FG000|Overall Study|Other: Site closed|4|||
170913945|NCT00552305|617687679|FG000|Overall Study|Other: Personal problems|1|||
170913946|NCT00552305|617687679|FG000|Overall Study|Other: Unable to attend visits|1|||
170913947|NCT00552305|617687679|FG000|Overall Study|Other: Subject underwent surgery|4|||
170913948|NCT00552305|617687679|FG000|Overall Study|Other: Subject became pregnant|1|||
170913949|NCT00552305|617687679|FG000|Overall Study|Other: Health problems, not drug related|1|||
170913950|NCT00552305|617687679|FG000|Overall Study|Other: Subject moved from area|2|||
170913951|NCT00552305|617687679|FG000|Overall Study|Other: Subject incarcerated|1|||
170913952|NCT00552305|617687679|FG000|Overall Study|Other: Subject went to rehab|1|||
170913953|NCT01703819|617687680|FG000|Overall Study|Adverse Event|0|||
170913954|NCT01703819|617687681|FG001|Overall Study|Adverse Event|1|||
170913955|NCT01703819|617687680|FG000|Overall Study|Withdrawal by Subject|0|||
170913956|NCT01703819|617687681|FG001|Overall Study|Withdrawal by Subject|1|||
170913957|NCT04230486|617687688|FG000|Overall Study|Screen Failure|1|||
170913958|NCT01302041|617687689|FG000|Overall Study|Death|5|||
170913959|NCT01302041|617687689|FG000|Overall Study|Withdrawal by Subject|4|||
170913960|NCT01302041|617687689|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
170913961|NCT01302041|617687689|FG000|Overall Study|Other-Miscellaneous Reason|2|||
170913962|NCT02064439|617687690|FG000|Overall Study|Adverse Event|51|||
170913963|NCT02064439|617687691|FG001|Overall Study|Adverse Event|47|||
170913964|NCT02064439|617687692|FG002|Overall Study|Adverse Event|46|||
170913965|NCT02064439|617687690|FG000|Overall Study|Death|0|||
170913966|NCT02064439|617687691|FG001|Overall Study|Death|2|||
170913967|NCT02064439|617687692|FG002|Overall Study|Death|3|||
170603454|NCT04071158|616553537|FG001|Overall Study|Lost to Follow-up|2|||
170603455|NCT04071158|616553538|FG002|Overall Study|Lost to Follow-up|3|||
170603456|NCT04071158|616553539|FG003|Overall Study|Lost to Follow-up|3|||
170603457|NCT04071158|616553540|FG004|Overall Study|Lost to Follow-up|5|||
170603458|NCT04071158|616553536|FG000|Overall Study|Randomized but not treated|2|||
170603459|NCT04071158|616553537|FG001|Overall Study|Randomized but not treated|2|||
170603460|NCT04071158|616553538|FG002|Overall Study|Randomized but not treated|0|||
170603461|NCT04071158|616553539|FG003|Overall Study|Randomized but not treated|0|||
170603462|NCT04071158|616553540|FG004|Overall Study|Randomized but not treated|0|||
170603463|NCT03245008|616553541|FG000|Overall Study|Adverse Event|15|||
170913968|NCT02064439|617687690|FG000|Overall Study|Withdrawal by Subject|29|||
170913969|NCT02064439|617687691|FG001|Overall Study|Withdrawal by Subject|18|||
170913970|NCT02064439|617687692|FG002|Overall Study|Withdrawal by Subject|26|||
170603464|NCT03245008|616553542|FG001|Overall Study|Adverse Event|18|||
170603465|NCT03245008|616553543|FG002|Overall Study|Adverse Event|15|||
170603466|NCT03245008|616553544|FG003|Overall Study|Adverse Event|0|||
170603467|NCT03245008|616553545|FG004|Overall Study|Adverse Event|1|||
170603468|NCT03245008|616553541|FG000|Overall Study|Lack of Efficacy|0|||
170603469|NCT03245008|616553542|FG001|Overall Study|Lack of Efficacy|1|||
170603470|NCT03245008|616553543|FG002|Overall Study|Lack of Efficacy|0|||
170603471|NCT03245008|616553544|FG003|Overall Study|Lack of Efficacy|0|||
170603472|NCT03245008|616553545|FG004|Overall Study|Lack of Efficacy|0|||
170603473|NCT03245008|616553541|FG000|Overall Study|Lost to Follow-up|4|||
170603474|NCT03245008|616553542|FG001|Overall Study|Lost to Follow-up|1|||
170603475|NCT03245008|616553543|FG002|Overall Study|Lost to Follow-up|0|||
170603476|NCT03245008|616553544|FG003|Overall Study|Lost to Follow-up|0|||
170603477|NCT03245008|616553545|FG004|Overall Study|Lost to Follow-up|1|||
170603478|NCT03245008|616553541|FG000|Overall Study|Physician Decision|1|||
170603479|NCT03245008|616553542|FG001|Overall Study|Physician Decision|3|||
170603480|NCT03245008|616553543|FG002|Overall Study|Physician Decision|4|||
170603481|NCT03245008|616553544|FG003|Overall Study|Physician Decision|0|||
170603482|NCT03245008|616553545|FG004|Overall Study|Physician Decision|0|||
170603483|NCT03245008|616553541|FG000|Overall Study|Protocol Violation|0|||
170603484|NCT03245008|616553542|FG001|Overall Study|Protocol Violation|1|||
170603485|NCT03245008|616553543|FG002|Overall Study|Protocol Violation|0|||
170603486|NCT03245008|616553544|FG003|Overall Study|Protocol Violation|0|||
170603487|NCT03245008|616553545|FG004|Overall Study|Protocol Violation|0|||
170603488|NCT03245008|616553541|FG000|Overall Study|Withdrawal by Subject|20|||
170813505|NCT00687297|617325914|FG000|Randomization|Withdrew before treatment, ineligible|1|||
170813506|NCT00687297|617325915|FG001|Randomization|Withdrew before treatment, ineligible|1|||
170813507|NCT00687297|617325914|FG000|Induction|Withdrawal by Subject|4|||
170813508|NCT00687297|617325915|FG001|Induction|Withdrawal by Subject|4|||
170813509|NCT00687297|617325914|FG000|Induction|Adverse Event|16|||
170813510|NCT00687297|617325915|FG001|Induction|Adverse Event|15|||
170813511|NCT00687297|617325914|FG000|Induction|Death|7|||
170813512|NCT00687297|617325915|FG001|Induction|Death|11|||
170913971|NCT02064439|617687690|FG000|Overall Study|Protocol Violation|3|||
170913972|NCT02064439|617687691|FG001|Overall Study|Protocol Violation|5|||
170913973|NCT02064439|617687692|FG002|Overall Study|Protocol Violation|3|||
170913974|NCT02064439|617687690|FG000|Overall Study|Lost to Follow-up|1|||
170913975|NCT02064439|617687691|FG001|Overall Study|Lost to Follow-up|3|||
170913976|NCT02064439|617687692|FG002|Overall Study|Lost to Follow-up|4|||
170913977|NCT02064439|617687690|FG000|Overall Study|Non-compliance with study medication|21|||
170913978|NCT02064439|617687691|FG001|Overall Study|Non-compliance with study medication|19|||
170913979|NCT02064439|617687692|FG002|Overall Study|Non-compliance with study medication|23|||
170603489|NCT03245008|616553542|FG001|Overall Study|Withdrawal by Subject|19|||
170603490|NCT03245008|616553543|FG002|Overall Study|Withdrawal by Subject|11|||
170603491|NCT03245008|616553544|FG003|Overall Study|Withdrawal by Subject|0|||
170603492|NCT03245008|616553545|FG004|Overall Study|Withdrawal by Subject|0|||
170603493|NCT03245008|616553541|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
170603494|NCT03245008|616553542|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
170603495|NCT03245008|616553543|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
170603496|NCT03245008|616553544|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
170603497|NCT03245008|616553545|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
170603498|NCT03245008|616553541|FG000|Overall Study|Failure to meet randomization criteria|0|||
170603499|NCT03245008|616553542|FG001|Overall Study|Failure to meet randomization criteria|1|||
170603500|NCT03245008|616553543|FG002|Overall Study|Failure to meet randomization criteria|0|||
170603501|NCT03245008|616553544|FG003|Overall Study|Failure to meet randomization criteria|1|||
170603502|NCT03245008|616553545|FG004|Overall Study|Failure to meet randomization criteria|0|||
170603503|NCT02335424|616553553|FG000|Overall Study|Withdrawal by Subject|19|||
170603504|NCT02335424|616553553|FG000|Overall Study|Adverse Event|25|||
170603505|NCT02335424|616553553|FG000|Overall Study|Death|273|||
170652280|NCT03720652|616740122|FG000|Overall Study|Lost to Follow-up|0|||
170652281|NCT03720652|616740123|FG001|Overall Study|Lost to Follow-up|4|||
170813513|NCT00687297|617325914|FG000|Induction|Lack of Efficacy|17|||
170913980|NCT02064439|617687690|FG000|Overall Study|Physician Decision|0|||
170913981|NCT02064439|617687691|FG001|Overall Study|Physician Decision|1|||
170913982|NCT02064439|617687692|FG002|Overall Study|Physician Decision|1|||
170913983|NCT02064439|617687690|FG000|Overall Study|Logistical difficulties|6|||
170603506|NCT02335424|616553553|FG000|Overall Study|Lost to Follow-up|3|||
170603507|NCT02335424|616553553|FG000|Overall Study|Physician Decision|13|||
170603508|NCT02335424|616553553|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
170603509|NCT02335424|616553553|FG000|Overall Study|Protocol Violation|1|||
170603510|NCT02335424|616553553|FG000|Overall Study|Screen failure|1|||
170603511|NCT02712424|616553554|FG000|Overall Study|Lost to Follow-up|34|||
170813514|NCT00687297|617325915|FG001|Induction|Lack of Efficacy|21|||
170913984|NCT02064439|617687691|FG001|Overall Study|Logistical difficulties|5|||
170913985|NCT02064439|617687692|FG002|Overall Study|Logistical difficulties|2|||
170913986|NCT02064439|617687690|FG000|Overall Study|Efficacy outcome reached|18|||
170913987|NCT02064439|617687691|FG001|Overall Study|Efficacy outcome reached|16|||
170603512|NCT02712424|616553555|FG001|Overall Study|Lost to Follow-up|32|||
170603513|NCT01141478|616553559|FG000|Overall Study|Withdrawal by Subject|1|||
170603514|NCT01141478|616553560|FG001|Overall Study|Withdrawal by Subject|1|||
170603515|NCT02613169|616553565|FG000|Overall Study|Withdrawal by Subject|4|||
170603516|NCT02613169|616553566|FG001|Overall Study|Withdrawal by Subject|1|||
170603517|NCT02613169|616553565|FG000|Overall Study|Lost to Follow-up|0|||
170603518|NCT02613169|616553566|FG001|Overall Study|Lost to Follow-up|5|||
170603519|NCT02613169|616553565|FG000|Overall Study|HIV|0|||
170603520|NCT02613169|616553566|FG001|Overall Study|HIV|2|||
170603521|NCT02613169|616553565|FG000|Overall Study|No TB infection endpoint|14|||
170603522|NCT02613169|616553566|FG001|Overall Study|No TB infection endpoint|9|||
170603523|NCT02096263|616553567|FG000|Overall Study|Adverse Event|1|||
170603524|NCT02096263|616553568|FG001|Overall Study|Adverse Event|0|||
170603525|NCT02096263|616553569|FG002|Overall Study|Adverse Event|1|||
170603526|NCT02096263|616553567|FG000|Overall Study|Lost to Follow-up|14|||
170603527|NCT02096263|616553568|FG001|Overall Study|Lost to Follow-up|18|||
170603528|NCT02096263|616553569|FG002|Overall Study|Lost to Follow-up|15|||
170603529|NCT02096263|616553567|FG000|Overall Study|Other|7|||
170603530|NCT02096263|616553568|FG001|Overall Study|Other|9|||
170603531|NCT02096263|616553569|FG002|Overall Study|Other|6|||
170603532|NCT02096263|616553567|FG000|Overall Study|Sponsor study termination|0|||
170603533|NCT02096263|616553568|FG001|Overall Study|Sponsor study termination|0|||
170603534|NCT02096263|616553569|FG002|Overall Study|Sponsor study termination|1|||
170603535|NCT02096263|616553567|FG000|Overall Study|Protocol Violation|7|||
170603536|NCT02096263|616553568|FG001|Overall Study|Protocol Violation|2|||
170603537|NCT02096263|616553569|FG002|Overall Study|Protocol Violation|8|||
170603538|NCT02096263|616553567|FG000|Overall Study|Withdrawal by Subject|5|||
170603539|NCT02096263|616553568|FG001|Overall Study|Withdrawal by Subject|7|||
170603540|NCT02096263|616553569|FG002|Overall Study|Withdrawal by Subject|8|||
170603541|NCT00710385|616553576|FG000|Overall Study|Did not qualify|1|||
170603542|NCT00710385|616553576|FG000|Overall Study|Withdrawal by Subject|1|||
170603543|NCT00710385|616553576|FG000|Overall Study|Undisclosed back pain|1|||
170603544|NCT00710385|616553576|FG000|Overall Study|Physician Decision|1|||
170603545|NCT00710385|616553576|FG000|Overall Study|Undisclosed excessive methadone use|1|||
170603546|NCT01300455|616553577|FG000|Washout|Withdrawal by Subject|1|||
170603547|NCT01300455|616553578|FG001|Washout|Withdrawal by Subject|0|||
170603548|NCT01026220|616553584|FG000|Induction|Death|1|||
170603549|NCT01026220|616553585|FG001|Induction|Death|0|||
170603550|NCT01026220|616553586|FG002|Induction|Death|0|||
170603551|NCT01026220|616553584|FG000|Induction|Lack of Efficacy|2|||
170603552|NCT01026220|616553585|FG001|Induction|Lack of Efficacy|0|||
170603553|NCT01026220|616553586|FG002|Induction|Lack of Efficacy|0|||
170603554|NCT01026220|616553584|FG000|Induction|Physician Decision|12|||
170603555|NCT01026220|616553585|FG001|Induction|Physician Decision|0|||
170603556|NCT01026220|616553586|FG002|Induction|Physician Decision|0|||
170603557|NCT01026220|616553584|FG000|Induction|Withdrawal by Subject|9|||
170603558|NCT01026220|616553585|FG001|Induction|Withdrawal by Subject|0|||
170603559|NCT01026220|616553586|FG002|Induction|Withdrawal by Subject|0|||
170603560|NCT01026220|616553584|FG000|Induction|Ineligible|1|||
170603561|NCT01026220|616553585|FG001|Induction|Ineligible|0|||
170603562|NCT01026220|616553586|FG002|Induction|Ineligible|0|||
170603563|NCT01026220|616553584|FG000|Consolidation Maintenance|Death|0|||
170603564|NCT01026220|616553585|FG001|Consolidation Maintenance|Death|1|||
170603565|NCT01026220|616553586|FG002|Consolidation Maintenance|Death|0|||
170913988|NCT02064439|617687692|FG002|Overall Study|Efficacy outcome reached|57|||
170913989|NCT02064439|617687690|FG000|Overall Study|Safety outcome reached|12|||
170913990|NCT02064439|617687691|FG001|Overall Study|Safety outcome reached|20|||
170913991|NCT02064439|617687692|FG002|Overall Study|Safety outcome reached|10|||
170913992|NCT02064439|617687690|FG000|Overall Study|Other|2|||
170913993|NCT02064439|617687691|FG001|Overall Study|Other|2|||
170913994|NCT02064439|617687692|FG002|Overall Study|Other|7|||
170913995|NCT02234583|617687697|FG000|Overall Study|Adverse Event|172|||
170913996|NCT02234583|617687698|FG001|Overall Study|Adverse Event|156|||
170913997|NCT02234583|617687697|FG000|Overall Study|Withdrawal by Subject|109|||
170913998|NCT02234583|617687698|FG001|Overall Study|Withdrawal by Subject|157|||
170913999|NCT02234583|617687697|FG000|Overall Study|Lost to Follow-up|0|||
170914000|NCT02234583|617687698|FG001|Overall Study|Lost to Follow-up|1|||
170603566|NCT01026220|616553584|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
170603567|NCT01026220|616553585|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
170603568|NCT01026220|616553586|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
170603569|NCT01026220|616553584|FG000|Consolidation Maintenance|Physician Decision|0|||
170603570|NCT01026220|616553585|FG001|Consolidation Maintenance|Physician Decision|2|||
170603571|NCT01026220|616553586|FG002|Consolidation Maintenance|Physician Decision|7|||
170603572|NCT01026220|616553584|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
170603573|NCT01026220|616553585|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
170603574|NCT01026220|616553586|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
170603575|NCT00778895|616553587|FG000|Active Phase|Adverse Event|3|||
170603576|NCT00778895|616553588|FG001|Active Phase|Adverse Event|1|||
170914001|NCT02234583|617687697|FG000|Overall Study|Lack of Efficacy|58|||
170914002|NCT02234583|617687698|FG001|Overall Study|Lack of Efficacy|103|||
170603577|NCT00778895|616553589|FG002|Active Phase|Adverse Event|0|||
170652282|NCT02216812|616740124|FG000|Overall Study|Lost to Follow-up|10|||
170652283|NCT02216812|616740125|FG001|Overall Study|Lost to Follow-up|5|||
170652284|NCT00853970|616740127|FG000|Overall Study|Withdrawal by Subject|2|||
170652285|NCT00853970|616740128|FG001|Overall Study|Withdrawal by Subject|1|||
170652286|NCT00853970|616740127|FG000|Overall Study|Cancelled surgery|4|||
170652287|NCT00853970|616740128|FG001|Overall Study|Cancelled surgery|2|||
170603578|NCT00778895|616553587|FG000|Active Phase|Withdrawal by Subject|1|||
170603579|NCT00778895|616553588|FG001|Active Phase|Withdrawal by Subject|4|||
170603580|NCT00778895|616553589|FG002|Active Phase|Withdrawal by Subject|0|||
170603581|NCT00778895|616553587|FG000|Active Phase|Lost to Follow-up|1|||
170603582|NCT00778895|616553588|FG001|Active Phase|Lost to Follow-up|1|||
170603583|NCT00778895|616553589|FG002|Active Phase|Lost to Follow-up|0|||
170603584|NCT00778895|616553587|FG000|Active Phase|Other|2|||
170603585|NCT00778895|616553588|FG001|Active Phase|Other|0|||
170603586|NCT00778895|616553589|FG002|Active Phase|Other|0|||
170603587|NCT00778895|616553587|FG000|ESFU Phase|Adverse Event|2|||
170603588|NCT00778895|616553588|FG001|ESFU Phase|Adverse Event|1|||
170603589|NCT00778895|616553589|FG002|ESFU Phase|Adverse Event|0|||
170603590|NCT00778895|616553587|FG000|ESFU Phase|Withdrawal by Subject|1|||
170603591|NCT00778895|616553588|FG001|ESFU Phase|Withdrawal by Subject|4|||
170603592|NCT00778895|616553589|FG002|ESFU Phase|Withdrawal by Subject|0|||
170603593|NCT00778895|616553587|FG000|ESFU Phase|Lost to Follow-up|6|||
170603594|NCT00778895|616553588|FG001|ESFU Phase|Lost to Follow-up|7|||
170603595|NCT00778895|616553589|FG002|ESFU Phase|Lost to Follow-up|2|||
170603596|NCT00778895|616553587|FG000|ESFU Phase|Other|2|||
170652288|NCT01395784|616740131|FG000|Overall Study|Lost to Follow-up|7|||
170652289|NCT01395784|616740131|FG000|Overall Study|Withdrawal by Subject|3|||
170652290|NCT01395784|616740131|FG000|Overall Study|Physician Decision|5|||
170652291|NCT02081859|616740132|FG000|Overall Study|No fertilization|2|||
170652292|NCT02081859|616740133|FG001|Overall Study|No fertilization|2|||
170652293|NCT02081859|616740132|FG000|Overall Study|No sperm|1|||
170652294|NCT02081859|616740133|FG001|Overall Study|No sperm|0|||
170652295|NCT02081859|616740132|FG000|Overall Study|Unanticipated freeze all cycle|2|||
170652296|NCT02081859|616740133|FG001|Overall Study|Unanticipated freeze all cycle|6|||
170652297|NCT02081859|616740132|FG000|Overall Study|< 4 embryos|27|||
170652298|NCT02081859|616740133|FG001|Overall Study|< 4 embryos|23|||
170652299|NCT02081859|616740132|FG000|Overall Study|Other reasons|2|||
170652300|NCT02081859|616740133|FG001|Overall Study|Other reasons|0|||
170652301|NCT02233946|616741556|FG000|Baseline|Withdrawal by Subject|2|||
170652302|NCT02233946|616741557|FG001|Baseline|Withdrawal by Subject|0|||
170652303|NCT02233946|616741556|FG000|3-months Follow-up|Lost to Follow-up|53|||
170652304|NCT02233946|616741557|FG001|3-months Follow-up|Lost to Follow-up|29|||
170652305|NCT02233946|616741556|FG000|6-months Follow-up|Lost to Follow-up|21|||
170652306|NCT02233946|616741557|FG001|6-months Follow-up|Lost to Follow-up|2|||
170652307|NCT02233946|616741556|FG000|9-month Follow-up|Lost to Follow-up|20|||
170652308|NCT02233946|616741557|FG001|9-month Follow-up|Lost to Follow-up|11|||
170652309|NCT02233946|616741556|FG000|12-month Follow-up|Lost to Follow-up|28|||
170652310|NCT02233946|616741557|FG001|12-month Follow-up|Lost to Follow-up|11|||
170652311|NCT02927067|616741558|FG000|Overall Study|Withdrawn Consent|20|||
170652312|NCT02927067|616741559|FG001|Overall Study|Withdrawn Consent|12|||
170652313|NCT02927067|616741558|FG000|Overall Study|Death|18|||
170652314|NCT02927067|616741559|FG001|Overall Study|Death|31|||
170652315|NCT02927067|616741558|FG000|Overall Study|Adverse Event|13|||
170652316|NCT02927067|616741559|FG001|Overall Study|Adverse Event|10|||
170652317|NCT02927067|616741558|FG000|Overall Study|Noncompliance|5|||
170652318|NCT02927067|616741559|FG001|Overall Study|Noncompliance|2|||
170652319|NCT02927067|616741558|FG000|Overall Study|Reason not Specified|4|||
170652320|NCT02927067|616741559|FG001|Overall Study|Reason not Specified|6|||
170652321|NCT00134784|616741560|FG000|Overall Study|Withdrawal by Subject|2|||
170652322|NCT00134784|616741561|FG001|Overall Study|Withdrawal by Subject|2|||
170652323|NCT00134784|616741562|FG002|Overall Study|Withdrawal by Subject|2|||
170652324|NCT00134784|616741563|FG003|Overall Study|Withdrawal by Subject|1|||
170914003|NCT02234583|617687697|FG000|Overall Study|Protocol Violation|35|||
170603597|NCT00778895|616553588|FG001|ESFU Phase|Other|0|||
170603598|NCT00778895|616553589|FG002|ESFU Phase|Other|0|||
170603599|NCT04598269|616553590|FG000|Overall Study|Adverse Event|0|||
170603600|NCT04598269|616553591|FG001|Overall Study|Adverse Event|3|||
170603601|NCT04598269|616553590|FG000|Overall Study|Withdrawal by Subject|1|||
170652325|NCT00625742|616741564|FG000|Overall Study|Disease Progression|2|||
170652326|NCT00625742|616741564|FG000|Overall Study|Withdrawal by Subject|1|||
170652327|NCT00625742|616741564|FG000|Overall Study|Adverse Event|4|||
170652328|NCT00625742|616741564|FG000|Overall Study|Lost to Follow-up|4|||
170652329|NCT00625742|616741564|FG000|Overall Study|Ineligible|1|||
170652330|NCT03384693|616741565|FG000|Overall Study|Adverse Event|3|||
170652331|NCT00718081|616741571|FG000|Overall Study|Adverse Event|0|||
170652332|NCT00718081|616741572|FG001|Overall Study|Adverse Event|1|||
170652333|NCT00718081|616741573|FG002|Overall Study|Adverse Event|0|||
170603602|NCT04598269|616553591|FG001|Overall Study|Withdrawal by Subject|4|||
170652334|NCT00718081|616741571|FG000|Overall Study|Lack of Efficacy|7|||
170914004|NCT02234583|617687698|FG001|Overall Study|Protocol Violation|42|||
170603603|NCT04598269|616553590|FG000|Overall Study|Lost to Follow-up|1|||
170603604|NCT04598269|616553591|FG001|Overall Study|Lost to Follow-up|0|||
170603605|NCT04598269|616553590|FG000|Overall Study|Not Treated|2|||
170603606|NCT04598269|616553591|FG001|Overall Study|Not Treated|0|||
170603607|NCT00424190|616553593|FG000|Overall Study|Withdrew consent|3|||
170603608|NCT00424190|616553594|FG001|Overall Study|Withdrew consent|4|||
170603609|NCT00424190|616553593|FG000|Overall Study|Death|3|||
170603610|NCT00424190|616553594|FG001|Overall Study|Death|0|||
170603611|NCT00424190|616553593|FG000|Overall Study|Noncompliance|1|||
170603612|NCT00424190|616553594|FG001|Overall Study|Noncompliance|2|||
170603613|NCT00424190|616553593|FG000|Overall Study|Request of sponsor or investigator|0|||
170603614|NCT00424190|616553594|FG001|Overall Study|Request of sponsor or investigator|2|||
170603615|NCT00424190|616553593|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
170603616|NCT00424190|616553594|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
170603617|NCT00424190|616553593|FG000|Overall Study|Other|15|||
170603618|NCT00424190|616553594|FG001|Overall Study|Other|21|||
170603619|NCT05096312|616553597|FG000|Overall Study|Lost to Follow-up|2|||
170603620|NCT05096312|616553598|FG001|Overall Study|Lost to Follow-up|4|||
170603621|NCT05096312|616553597|FG000|Overall Study|Adverse Event|1|||
170652335|NCT00718081|616741572|FG001|Overall Study|Lack of Efficacy|3|||
170652336|NCT00718081|616741573|FG002|Overall Study|Lack of Efficacy|21|||
170813515|NCT00687297|617325914|FG000|Induction|Ineligible|0|||
170813516|NCT00687297|617325915|FG001|Induction|Ineligible|1|||
170813517|NCT00687297|617325914|FG000|Induction|Patient Noncompliance|1|||
170813518|NCT00687297|617325915|FG001|Induction|Patient Noncompliance|0|||
170813519|NCT00687297|617325914|FG000|Induction|Physician Decision|0|||
170813520|NCT00687297|617325915|FG001|Induction|Physician Decision|2|||
170813521|NCT00687297|617325914|FG000|Induction|Other|0|||
170813522|NCT00687297|617325915|FG001|Induction|Other|1|||
170813523|NCT01494467|617325918|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
170813524|NCT01494467|617325919|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
170813525|NCT01494467|617325918|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
170813526|NCT01494467|617325919|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
170813527|NCT01494467|617325918|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
170813528|NCT01494467|617325919|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
170813529|NCT01494467|617325918|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
170652337|NCT01397825|616741574|FG000|Overall Study|Progressive Disease|10|||
170813530|NCT01494467|617325919|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
170813531|NCT01494467|617325918|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
170813532|NCT01494467|617325919|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
170813533|NCT01494467|617325918|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
170813534|NCT01494467|617325919|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
170813535|NCT01494467|617325918|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
170813536|NCT01494467|617325919|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
170813537|NCT01494467|617325918|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
170813538|NCT01494467|617325919|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
170813539|NCT01494467|617325918|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
170813540|NCT01494467|617325919|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
170813541|NCT01494467|617325918|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
170813542|NCT01494467|617325919|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
170813543|NCT01494467|617325918|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
170813544|NCT01494467|617325919|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
170813545|NCT01494467|617325918|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
170813546|NCT01494467|617325919|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
170813547|NCT01494467|617325918|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
170813548|NCT01494467|617325919|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
170813549|NCT01494467|617325918|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
170813550|NCT01494467|617325919|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
170813551|NCT02410278|617325924|FG000|Run-in Period|Adverse Event|5|||
170813552|NCT02410278|617325925|FG001|Run-in Period|Adverse Event|0|||
170652338|NCT01397825|616741575|FG001|Overall Study|Progressive Disease|3|||
170652339|NCT01397825|616741576|FG002|Overall Study|Progressive Disease|11|||
170813553|NCT02410278|617325926|FG002|Run-in Period|Adverse Event|0|||
170813554|NCT02410278|617325924|FG000|Run-in Period|GSRS Threshold Not Met|30|||
170813555|NCT02410278|617325925|FG001|Run-in Period|GSRS Threshold Not Met|0|||
170813556|NCT02410278|617325926|FG002|Run-in Period|GSRS Threshold Not Met|0|||
170813557|NCT02410278|617325924|FG000|Run-in Period|Lost to Follow-up|1|||
170813558|NCT02410278|617325925|FG001|Run-in Period|Lost to Follow-up|0|||
170813559|NCT02410278|617325926|FG002|Run-in Period|Lost to Follow-up|0|||
170652340|NCT01397825|616741577|FG003|Overall Study|Progressive Disease|1|||
170603622|NCT05096312|616553598|FG001|Overall Study|Adverse Event|0|||
170603623|NCT00637572|616553599|FG000|Overall Study|Adverse Event|1|||
170603624|NCT00637572|616553600|FG001|Overall Study|Adverse Event|2|||
170603625|NCT00637572|616553599|FG000|Overall Study|Death|0|||
170603626|NCT00637572|616553600|FG001|Overall Study|Death|1|||
170603627|NCT00637572|616553599|FG000|Overall Study|Lost to Follow-up|0|||
170603628|NCT00637572|616553600|FG001|Overall Study|Lost to Follow-up|1|||
170603629|NCT00637572|616553599|FG000|Overall Study|Physician Decision|1|||
170603630|NCT00637572|616553600|FG001|Overall Study|Physician Decision|1|||
170603631|NCT00637572|616553599|FG000|Overall Study|Withdrawal by Subject|0|||
170603632|NCT00637572|616553600|FG001|Overall Study|Withdrawal by Subject|2|||
170603633|NCT00637572|616553599|FG000|Overall Study|Illicit Drug Use|1|||
170603634|NCT00637572|616553600|FG001|Overall Study|Illicit Drug Use|0|||
170603635|NCT02102399|616553601|FG000|Overall Study|Withdrawal by Subject|6|||
170603636|NCT02102399|616553602|FG001|Overall Study|Withdrawal by Subject|4|||
170603637|NCT00718770|616553603|FG000|Overall Study|Adverse Event|1|||
170603638|NCT00718770|616553603|FG000|Overall Study|Lack of Efficacy|1|||
170603639|NCT00718770|616553603|FG000|Overall Study|Lack of Efficacy|1|||
170603640|NCT00718770|616553603|FG000|Overall Study|Adverse Event|1|||
170813560|NCT02410278|617325924|FG000|Run-in Period|Withdrawal by Subject|1|||
170813561|NCT02410278|617325925|FG001|Run-in Period|Withdrawal by Subject|0|||
170813562|NCT02410278|617325926|FG002|Run-in Period|Withdrawal by Subject|0|||
170813563|NCT02410278|617325924|FG000|Run-in Period|Pregnancy|1|||
170813564|NCT02410278|617325925|FG001|Run-in Period|Pregnancy|0|||
170813565|NCT02410278|617325926|FG002|Run-in Period|Pregnancy|0|||
170813566|NCT02410278|617325924|FG000|Study Treatment Period|Adverse Event|0|||
170813567|NCT02410278|617325925|FG001|Study Treatment Period|Adverse Event|6|||
170813568|NCT02410278|617325926|FG002|Study Treatment Period|Adverse Event|3|||
170813569|NCT02410278|617325924|FG000|Study Treatment Period|Physician Decision|0|||
170813570|NCT02410278|617325925|FG001|Study Treatment Period|Physician Decision|0|||
170813571|NCT02410278|617325926|FG002|Study Treatment Period|Physician Decision|1|||
170813572|NCT02410278|617325924|FG000|Study Treatment Period|Withdrawal by Subject|0|||
170813573|NCT02410278|617325925|FG001|Study Treatment Period|Withdrawal by Subject|1|||
170813574|NCT02410278|617325926|FG002|Study Treatment Period|Withdrawal by Subject|0|||
170813575|NCT02410278|617325924|FG000|Study Treatment Period|Other|0|||
170813576|NCT02410278|617325925|FG001|Study Treatment Period|Other|3|||
170813577|NCT02410278|617325926|FG002|Study Treatment Period|Other|0|||
170813578|NCT02410278|617325924|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
170813579|NCT02410278|617325925|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
170813580|NCT02410278|617325926|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
170813581|NCT03695185|617325927|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
170813582|NCT03695185|617325927|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
170813583|NCT03695185|617325927|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
170813584|NCT03695185|617325927|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
170813585|NCT03695185|617325927|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
170813586|NCT03695185|617325927|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
170813587|NCT01535261|617325930|FG000|Overall Study|Physician Decision|8|||
170813588|NCT01535261|617325930|FG000|Overall Study|Protocol Violation|3|||
170813589|NCT01535261|617325930|FG000|Overall Study|Death|5|||
170813590|NCT01535261|617325930|FG000|Overall Study|Lost to Follow-up|8|||
170813591|NCT01535261|617325930|FG000|Overall Study|Withdrawal by Subject|14|||
170813592|NCT01535261|617325930|FG000|Overall Study|Adverse Event|12|||
170813593|NCT01137682|617325931|FG000|Overall Study|Adverse Event-CORE|2|||
170813594|NCT01137682|617325932|FG001|Overall Study|Adverse Event-CORE|4|||
170813595|NCT01137682|617325933|FG002|Overall Study|Adverse Event-CORE|0|||
170813596|NCT01137682|617325931|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
170813597|NCT01137682|617325932|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
170813598|NCT01137682|617325933|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
170813599|NCT01137682|617325931|FG000|Overall Study|Administrative problems-CORE|2|||
170813600|NCT01137682|617325932|FG001|Overall Study|Administrative problems-CORE|1|||
170813601|NCT01137682|617325933|FG002|Overall Study|Administrative problems-CORE|0|||
170813602|NCT01137682|617325931|FG000|Overall Study|Protocol Violation-CORE|0|||
170813603|NCT01137682|617325932|FG001|Overall Study|Protocol Violation-CORE|1|||
170813604|NCT01137682|617325933|FG002|Overall Study|Protocol Violation-CORE|1|||
170813605|NCT01137682|617325931|FG000|Overall Study|Adverse Event-Extension|4|||
170813606|NCT01137682|617325932|FG001|Overall Study|Adverse Event-Extension|8|||
170813607|NCT01137682|617325933|FG002|Overall Study|Adverse Event-Extension|7|||
170813608|NCT01137682|617325931|FG000|Overall Study|Lack of Efficacy-Extension|15|||
170813609|NCT01137682|617325932|FG001|Overall Study|Lack of Efficacy-Extension|9|||
170813610|NCT01137682|617325933|FG002|Overall Study|Lack of Efficacy-Extension|13|||
170813611|NCT01137682|617325931|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
170813612|NCT01137682|617325932|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
170813613|NCT01137682|617325933|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
170813614|NCT01137682|617325931|FG000|Overall Study|Lost to Follow Up-Extension|0|||
170813615|NCT01137682|617325932|FG001|Overall Study|Lost to Follow Up-Extension|1|||
170813616|NCT01137682|617325933|FG002|Overall Study|Lost to Follow Up-Extension|0|||
170813617|NCT01137682|617325931|FG000|Overall Study|Administrative problems-Extension|0|||
170813618|NCT01137682|617325932|FG001|Overall Study|Administrative problems-Extension|2|||
170813619|NCT01137682|617325933|FG002|Overall Study|Administrative problems-Extension|0|||
170813620|NCT01137682|617325931|FG000|Overall Study|Death-Extension|2|||
170813621|NCT01137682|617325932|FG001|Overall Study|Death-Extension|0|||
170813622|NCT01137682|617325933|FG002|Overall Study|Death-Extension|0|||
170813623|NCT01137682|617325931|FG000|Overall Study|Protocol Violation-Extension|2|||
170813624|NCT01137682|617325932|FG001|Overall Study|Protocol Violation-Extension|1|||
170813625|NCT01137682|617325933|FG002|Overall Study|Protocol Violation-Extension|0|||
170813626|NCT01137682|617325931|FG000|Overall Study|Did not enter extension|2|||
170603641|NCT00718770|616553603|FG000|Overall Study|Lack of Efficacy|1|||
170603642|NCT00718770|616553603|FG000|Overall Study|Adverse Event|1|||
170603643|NCT00718770|616553603|FG000|Overall Study|Lack of Efficacy|1|||
170603644|NCT00718770|616553603|FG000|Overall Study|Adverse Event|1|||
170603645|NCT02454478|616554691|FG000|Overall Study|Incomplete DLT Evaluation|1|||
170603646|NCT01732770|616554695|FG000|Overall Study|Lost to Follow-up|2|||
170603647|NCT01732770|616554696|FG001|Overall Study|Lost to Follow-up|3|||
170603648|NCT01732770|616554695|FG000|Overall Study|Withdrawal by Subject|5|||
170603649|NCT01732770|616554696|FG001|Overall Study|Withdrawal by Subject|3|||
170603650|NCT01732770|616554695|FG000|Overall Study|Decision by Sponsor|2|||
170603651|NCT01732770|616554696|FG001|Overall Study|Decision by Sponsor|2|||
170813627|NCT01137682|617325932|FG001|Overall Study|Did not enter extension|3|||
170813628|NCT01137682|617325933|FG002|Overall Study|Did not enter extension|2|||
170603652|NCT01732770|616554695|FG000|Overall Study|Death|1|||
170603653|NCT01732770|616554696|FG001|Overall Study|Death|0|||
170603654|NCT01450098|616554705|FG000|Period 3|Protocol Violation|0|||
170603655|NCT01450098|616554706|FG001|Period 3|Protocol Violation|1|||
170603656|NCT01450098|616554705|FG000|Period 3|Withdrawal by Subject|0|||
170603657|NCT01450098|616554706|FG001|Period 3|Withdrawal by Subject|2|||
170603658|NCT03521141|616554710|FG000|Overall Study|Death|1|||
170603659|NCT03521141|616554711|FG001|Overall Study|Death|0|||
170603660|NCT03521141|616554712|FG002|Overall Study|Death|1|||
170603661|NCT03229109|616554715|FG000|Overall Study|Withdrawal by Subject|0|||
170603662|NCT03229109|616554716|FG001|Overall Study|Withdrawal by Subject|0|||
170603663|NCT03229109|616554717|FG002|Overall Study|Withdrawal by Subject|0|||
170603664|NCT03229109|616554718|FG003|Overall Study|Withdrawal by Subject|1|||
170603665|NCT04207749|616554719|FG000|Overall Study|Lost to Follow-up|0|||
170603666|NCT04207749|616554720|FG001|Overall Study|Lost to Follow-up|2|||
170813629|NCT01137682|617325931|FG000|Overall Study|Did not receive treatment in extension|0|||
170813630|NCT01137682|617325932|FG001|Overall Study|Did not receive treatment in extension|0|||
170813631|NCT01137682|617325933|FG002|Overall Study|Did not receive treatment in extension|1|||
170813632|NCT02009332|617325934|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
170813633|NCT02009332|617325935|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
170813634|NCT02009332|617325936|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
170813635|NCT02009332|617325937|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
170813636|NCT02009332|617325938|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
170813637|NCT02009332|617325939|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
170813638|NCT02009332|617325934|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
170813639|NCT02009332|617325935|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
170813640|NCT02009332|617325936|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
170813641|NCT02009332|617325937|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
170813642|NCT02009332|617325938|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
170813643|NCT02009332|617325939|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
170813644|NCT02009332|617325934|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
170813645|NCT02009332|617325935|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
170813646|NCT02009332|617325936|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
170813647|NCT02009332|617325937|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
170813648|NCT02009332|617325938|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
170813649|NCT02009332|617325939|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
170813650|NCT01912599|617325941|FG000|Overall Study|Withdrawal by Subject|0|||
170813651|NCT01912599|617325942|FG001|Overall Study|Withdrawal by Subject|1|||
170813652|NCT01757288|617325943|FG000|Overall Study|Consent withdrawal|0|||
170813653|NCT01757288|617325944|FG001|Overall Study|Consent withdrawal|4|||
170813654|NCT01757288|617325945|FG002|Overall Study|Consent withdrawal|4|||
170813655|NCT01757288|617325943|FG000|Overall Study|Patient off study, IRB hold.|0|||
170813656|NCT01757288|617325944|FG001|Overall Study|Patient off study, IRB hold.|0|||
170813657|NCT01757288|617325945|FG002|Overall Study|Patient off study, IRB hold.|1|||
170813658|NCT01757288|617325943|FG000|Overall Study|Patient death prior to starting treatment|0|||
170813659|NCT01757288|617325944|FG001|Overall Study|Patient death prior to starting treatment|0|||
170914005|NCT02234583|617687697|FG000|Overall Study|Other|39|||
170603667|NCT04207749|616554719|FG000|Overall Study|Protocol Violation|0|||
170603668|NCT04207749|616554720|FG001|Overall Study|Protocol Violation|1|||
170603669|NCT04207749|616554719|FG000|Overall Study|Withdrawal by Subject|3|||
170603670|NCT04207749|616554720|FG001|Overall Study|Withdrawal by Subject|0|||
170603671|NCT04207749|616554719|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
170603672|NCT04207749|616554720|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
170603673|NCT03176771|616554721|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
170603674|NCT03176771|616554722|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
170603675|NCT03176771|616554723|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
170603676|NCT03176771|616554724|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
170603677|NCT03176771|616554725|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
170603678|NCT03176771|616554721|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
170603679|NCT03176771|616554722|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
170603680|NCT03176771|616554723|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
170603681|NCT03176771|616554724|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
170603682|NCT03176771|616554725|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
170603683|NCT03176771|616554721|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
170603684|NCT03176771|616554722|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
170603685|NCT03176771|616554723|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
170603686|NCT03176771|616554724|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
170603687|NCT03176771|616554725|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
170603688|NCT03176771|616554721|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
170603689|NCT03176771|616554722|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
170603690|NCT03176771|616554723|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
170603691|NCT03176771|616554724|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
170603692|NCT03176771|616554725|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
170603693|NCT03176771|616554721|FG000|Double-Blind Extension Period|Adverse Event|0|||
170603694|NCT03176771|616554722|FG001|Double-Blind Extension Period|Adverse Event|0|||
170603695|NCT03176771|616554723|FG002|Double-Blind Extension Period|Adverse Event|0|||
170603696|NCT03176771|616554724|FG003|Double-Blind Extension Period|Adverse Event|15|||
170603697|NCT03176771|616554725|FG004|Double-Blind Extension Period|Adverse Event|18|||
170603698|NCT03176771|616554721|FG000|Double-Blind Extension Period|Death|0|||
170603699|NCT03176771|616554722|FG001|Double-Blind Extension Period|Death|0|||
170603700|NCT03176771|616554723|FG002|Double-Blind Extension Period|Death|0|||
170603701|NCT03176771|616554724|FG003|Double-Blind Extension Period|Death|3|||
170603702|NCT03176771|616554725|FG004|Double-Blind Extension Period|Death|4|||
170603703|NCT03176771|616554721|FG000|Double-Blind Extension Period|Physician Decision|0|||
170603704|NCT03176771|616554722|FG001|Double-Blind Extension Period|Physician Decision|0|||
170603705|NCT03176771|616554723|FG002|Double-Blind Extension Period|Physician Decision|0|||
170603706|NCT03176771|616554724|FG003|Double-Blind Extension Period|Physician Decision|3|||
170603707|NCT03176771|616554725|FG004|Double-Blind Extension Period|Physician Decision|1|||
170603708|NCT03176771|616554721|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
170603709|NCT03176771|616554722|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
170603710|NCT03176771|616554723|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
170603711|NCT03176771|616554724|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
170603712|NCT03176771|616554725|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
170603713|NCT04512976|616554726|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
170603714|NCT04512976|616554727|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
170603715|NCT04512976|616554728|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
170603716|NCT04512976|616554729|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
170603717|NCT04512976|616554730|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
170603718|NCT04512976|616554731|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
170603719|NCT01532570|616554732|FG000|Overall Study|Lack of Efficacy|1|||
170603720|NCT01532570|616554733|FG001|Overall Study|Lack of Efficacy|0|||
170603721|NCT01532570|616554734|FG002|Overall Study|Lack of Efficacy|0|||
170603722|NCT01532570|616554735|FG003|Overall Study|Lack of Efficacy|0|||
170603723|NCT01532570|616554732|FG000|Overall Study|Withdrawal by Subject|0|||
170603724|NCT01532570|616554733|FG001|Overall Study|Withdrawal by Subject|1|||
170603725|NCT01532570|616554734|FG002|Overall Study|Withdrawal by Subject|0|||
170603726|NCT01532570|616554735|FG003|Overall Study|Withdrawal by Subject|0|||
170603727|NCT01585155|616554736|FG000|Overall Study|Adverse Event|1|||
170603728|NCT01585155|616554736|FG000|Overall Study|Lack of Efficacy|2|||
170603729|NCT01585155|616554736|FG000|Overall Study|Worsening ulcerative colitis|2|||
170603730|NCT01192412|616554738|FG000|Overall Study|Lost to Follow-up|2|||
170603731|NCT01192412|616554739|FG001|Overall Study|Lost to Follow-up|1|||
170603732|NCT01192412|616554738|FG000|Overall Study|Withdrawal by Subject|2|||
170603733|NCT01192412|616554739|FG001|Overall Study|Withdrawal by Subject|1|||
170603734|NCT02421588|616554740|FG000|Overall Study|Non-treatment-related AE|8|||
170603735|NCT02421588|616554741|FG001|Overall Study|Non-treatment-related AE|8|||
170603736|NCT02421588|616554740|FG000|Overall Study|Progressive disease|152|||
170603737|NCT02421588|616554741|FG001|Overall Study|Progressive disease|135|||
170603738|NCT02421588|616554740|FG000|Overall Study|Death|11|||
170603739|NCT02421588|616554741|FG001|Overall Study|Death|3|||
170603740|NCT02421588|616554740|FG000|Overall Study|Physician Decision|8|||
170603741|NCT02421588|616554741|FG001|Overall Study|Physician Decision|17|||
170603742|NCT02421588|616554740|FG000|Overall Study|Other reason not specified|3|||
170603743|NCT02421588|616554741|FG001|Overall Study|Other reason not specified|1|||
170603744|NCT02421588|616554740|FG000|Overall Study|Symptomatic deterioration|13|||
170603745|NCT02421588|616554741|FG001|Overall Study|Symptomatic deterioration|19|||
170603746|NCT02421588|616554740|FG000|Overall Study|Treatment-related AE|10|||
170603747|NCT02421588|616554741|FG001|Overall Study|Treatment-related AE|14|||
170603748|NCT02421588|616554740|FG000|Overall Study|Withdrawal by Subject|14|||
170603749|NCT02421588|616554741|FG001|Overall Study|Withdrawal by Subject|16|||
170603750|NCT02421588|616554740|FG000|Overall Study|Not treated|2|||
170603751|NCT02421588|616554741|FG001|Overall Study|Not treated|8|||
170603752|NCT00805766|616554744|FG000|Screening Period|Adverse Event|1|||
170603753|NCT00805766|616554744|FG000|Screening Period|Lack of Efficacy|2|||
170603754|NCT00805766|616554744|FG000|Screening Period|Pregnancy|1|||
170603755|NCT00805766|616554744|FG000|Screening Period|Responder|2|||
170652341|NCT01397825|616741578|FG004|Overall Study|Progressive Disease|0|||
170652342|NCT01397825|616741574|FG000|Overall Study|Symptomatic Deterioration|2|||
170652343|NCT01397825|616741575|FG001|Overall Study|Symptomatic Deterioration|0|||
170813660|NCT01757288|617325945|FG002|Overall Study|Patient death prior to starting treatment|1|||
170813661|NCT01757288|617325943|FG000|Overall Study|Wrong medication administered|0|||
170813662|NCT01757288|617325944|FG001|Overall Study|Wrong medication administered|1|||
170813663|NCT01757288|617325945|FG002|Overall Study|Wrong medication administered|0|||
170813664|NCT01757288|617325943|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
170813665|NCT01757288|617325944|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
170813666|NCT01757288|617325945|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
170813667|NCT01757288|617325943|FG000|Overall Study|Not meeting protocol constraints|0|||
170813668|NCT01757288|617325944|FG001|Overall Study|Not meeting protocol constraints|1|||
170813669|NCT01757288|617325945|FG002|Overall Study|Not meeting protocol constraints|1|||
170813670|NCT01757288|617325943|FG000|Overall Study|Multiple missed appointments|0|||
170813671|NCT01757288|617325944|FG001|Overall Study|Multiple missed appointments|1|||
170813672|NCT01757288|617325945|FG002|Overall Study|Multiple missed appointments|0|||
170813673|NCT01757288|617325943|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
170813674|NCT01757288|617325944|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
170813675|NCT01757288|617325945|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
170813676|NCT01757288|617325943|FG000|Overall Study|>2 weeks treatment break|0|||
170813677|NCT01757288|617325944|FG001|Overall Study|>2 weeks treatment break|0|||
170813678|NCT01757288|617325945|FG002|Overall Study|>2 weeks treatment break|1|||
170813679|NCT02825550|617325946|FG000|Overall Study|Physician Decision|1|||
170813680|NCT03386344|617325947|FG000|Overall Study|Adverse Event|6|||
170813681|NCT03386344|617325948|FG001|Overall Study|Adverse Event|3|||
170813682|NCT03386344|617325949|FG002|Overall Study|Adverse Event|1|||
170813683|NCT03386344|617325947|FG000|Overall Study|Poor Compliance to Protocol|0|||
170813684|NCT03386344|617325948|FG001|Overall Study|Poor Compliance to Protocol|1|||
170813685|NCT03386344|617325949|FG002|Overall Study|Poor Compliance to Protocol|0|||
170813686|NCT03386344|617325947|FG000|Overall Study|Study Terminated by Sponsor|101|||
170813687|NCT03386344|617325948|FG001|Overall Study|Study Terminated by Sponsor|102|||
170813688|NCT03386344|617325949|FG002|Overall Study|Study Terminated by Sponsor|106|||
170813689|NCT03386344|617325947|FG000|Overall Study|Lost to Follow-up|3|||
170813690|NCT03386344|617325948|FG001|Overall Study|Lost to Follow-up|2|||
170813691|NCT03386344|617325949|FG002|Overall Study|Lost to Follow-up|1|||
170813692|NCT03386344|617325947|FG000|Overall Study|At the Participant's own Request|7|||
170813693|NCT03386344|617325948|FG001|Overall Study|At the Participant's own Request|7|||
170813694|NCT03386344|617325949|FG002|Overall Study|At the Participant's own Request|8|||
170813695|NCT03386344|617325947|FG000|Overall Study|Reason not Specified|0|||
170813696|NCT03386344|617325948|FG001|Overall Study|Reason not Specified|1|||
170813697|NCT03386344|617325949|FG002|Overall Study|Reason not Specified|0|||
170813698|NCT01077284|617325950|FG000|Overall Study|Adverse Event|2|||
170813699|NCT01077284|617325951|FG001|Overall Study|Adverse Event|0|||
170813700|NCT01077284|617325952|FG002|Overall Study|Adverse Event|1|||
170813701|NCT01077284|617325950|FG000|Overall Study|Lost to Follow-up|1|||
170813702|NCT01077284|617325951|FG001|Overall Study|Lost to Follow-up|2|||
170813703|NCT01077284|617325952|FG002|Overall Study|Lost to Follow-up|0|||
170813704|NCT01077284|617325950|FG000|Overall Study|Withdrawal by Subject|2|||
170813705|NCT01077284|617325951|FG001|Overall Study|Withdrawal by Subject|3|||
170813706|NCT01077284|617325952|FG002|Overall Study|Withdrawal by Subject|1|||
170813707|NCT01077284|617325950|FG000|Overall Study|Other|0|||
170813708|NCT01077284|617325951|FG001|Overall Study|Other|0|||
170813709|NCT01077284|617325952|FG002|Overall Study|Other|1|||
170813710|NCT01280721|617325956|FG000|Overall Study|Adverse Event|4|||
170813711|NCT01280721|617325956|FG000|Overall Study|Physician Decision|3|||
170603756|NCT00805766|616554744|FG000|Increased Dose Period|Adverse Event|4|||
170603757|NCT00805766|616554744|FG000|Increased Dose Period|Lack of Efficacy|7|||
170603758|NCT00805766|616554744|FG000|Increased Dose Period|Pregnancy|1|||
170813712|NCT01280721|617325956|FG000|Overall Study|Withdrawal by Subject|6|||
170813713|NCT01280721|617325956|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
170914006|NCT02234583|617687698|FG001|Overall Study|Other|97|||
170603759|NCT00805766|616554744|FG000|Increased Dose Period|Withdrawal by Subject|1|||
170603760|NCT04254913|616554745|FG000|Overall Study|Adverse Event|1|||
170603761|NCT01004952|616554746|FG000|Overall Study|Lost to Follow-up|0|||
170603762|NCT01004952|616554747|FG001|Overall Study|Lost to Follow-up|11|||
170603763|NCT01004952|616554746|FG000|Overall Study|Withdrawal by Subject|0|||
170603764|NCT01004952|616554747|FG001|Overall Study|Withdrawal by Subject|5|||
170603765|NCT02354222|616554748|FG000|Overall Study|Adverse Event|0|||
170603766|NCT02354222|616554749|FG001|Overall Study|Adverse Event|3|||
170914007|NCT01849250|617687699|FG000|Overall Study|Withdrawal by Subject|1|||
170914008|NCT01849250|617687700|FG001|Overall Study|Withdrawal by Subject|0|||
170914009|NCT01849250|617687699|FG000|Overall Study|Not Evaluable|5|||
170914010|NCT01849250|617687700|FG001|Overall Study|Not Evaluable|3|||
170914011|NCT01849250|617687699|FG000|Overall Study|Screen Failure|1|||
170914012|NCT01849250|617687700|FG001|Overall Study|Screen Failure|0|||
170914013|NCT00771030|617687701|FG000|Overall Study|Adverse Event|0|||
170914014|NCT00771030|617687702|FG001|Overall Study|Adverse Event|1|||
170914015|NCT00771030|617687703|FG002|Overall Study|Adverse Event|0|||
170914016|NCT00771030|617687704|FG003|Overall Study|Adverse Event|0|||
170914017|NCT00771030|617687705|FG004|Overall Study|Adverse Event|0|||
170914018|NCT00771030|617687706|FG005|Overall Study|Adverse Event|0|||
170914019|NCT00771030|617687707|FG006|Overall Study|Adverse Event|0|||
170914020|NCT01839188|617687708|FG000|Overall Study|Withdrawal by Subject|1|||
170914021|NCT01671488|617687713|FG000|Overall Study|Withdrawal by Subject|1|||
170914022|NCT01022853|617687714|FG000|Overall Study|Progressive disease|2|||
170914023|NCT01022853|617687715|FG001|Overall Study|Progressive disease|3|||
170603767|NCT02354222|616554748|FG000|Overall Study|Physician Decision|1|||
170603768|NCT02354222|616554749|FG001|Overall Study|Physician Decision|1|||
170603769|NCT02354222|616554748|FG000|Overall Study|Pregnancy|1|||
170603770|NCT02354222|616554749|FG001|Overall Study|Pregnancy|0|||
170603771|NCT02354222|616554748|FG000|Overall Study|Withdrawal by Subject|2|||
170603772|NCT02354222|616554749|FG001|Overall Study|Withdrawal by Subject|3|||
170603773|NCT02354222|616554748|FG000|Overall Study|Conflict with the stopping criteria|0|||
170603774|NCT02354222|616554749|FG001|Overall Study|Conflict with the stopping criteria|4|||
170603775|NCT01359943|616554752|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
170603776|NCT01359943|616554753|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
170603777|NCT01359943|616554754|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
170603778|NCT01359943|616554752|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
170603779|NCT01359943|616554753|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
170603780|NCT01359943|616554754|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
170603781|NCT01359943|616554752|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
170603782|NCT01359943|616554753|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
170603783|NCT01359943|616554754|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
170603784|NCT01359943|616554752|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
170603785|NCT01359943|616554753|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
170603786|NCT01359943|616554754|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
170603787|NCT01359943|616554752|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
170603788|NCT01359943|616554753|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
170603789|NCT01359943|616554754|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
170603790|NCT01359943|616554752|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
170652344|NCT01397825|616741576|FG002|Overall Study|Symptomatic Deterioration|4|||
170603791|NCT01359943|616554753|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
170652345|NCT01397825|616741577|FG003|Overall Study|Symptomatic Deterioration|0|||
170652346|NCT01397825|616741578|FG004|Overall Study|Symptomatic Deterioration|0|||
170914024|NCT01022853|617687716|FG002|Overall Study|Progressive disease|11|||
170914025|NCT01022853|617687717|FG003|Overall Study|Progressive disease|7|||
170914026|NCT01022853|617687718|FG004|Overall Study|Progressive disease|1|||
170914027|NCT01022853|617687714|FG000|Overall Study|Dose-limiting toxicity|0|||
170914028|NCT01022853|617687715|FG001|Overall Study|Dose-limiting toxicity|0|||
170603792|NCT01359943|616554754|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
170603793|NCT01359943|616554752|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
170603794|NCT01359943|616554753|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
170603795|NCT01359943|616554754|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
170603796|NCT01359943|616554752|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
170914029|NCT01022853|617687716|FG002|Overall Study|Dose-limiting toxicity|0|||
170914030|NCT01022853|617687717|FG003|Overall Study|Dose-limiting toxicity|0|||
170914031|NCT01022853|617687718|FG004|Overall Study|Dose-limiting toxicity|1|||
170914032|NCT01022853|617687714|FG000|Overall Study|Withdrawal by Subject|0|||
170914033|NCT01022853|617687715|FG001|Overall Study|Withdrawal by Subject|1|||
170914034|NCT01022853|617687716|FG002|Overall Study|Withdrawal by Subject|1|||
170914035|NCT01022853|617687717|FG003|Overall Study|Withdrawal by Subject|1|||
170914036|NCT01022853|617687718|FG004|Overall Study|Withdrawal by Subject|0|||
170914037|NCT01022853|617687714|FG000|Overall Study|Other not stated above|1|||
170914038|NCT01022853|617687715|FG001|Overall Study|Other not stated above|0|||
170914039|NCT01022853|617687716|FG002|Overall Study|Other not stated above|1|||
170914040|NCT01022853|617687717|FG003|Overall Study|Other not stated above|0|||
170914041|NCT01022853|617687718|FG004|Overall Study|Other not stated above|0|||
170914042|NCT01971476|617687719|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
170914043|NCT01971476|617687720|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
170914044|NCT01971476|617687721|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
170914045|NCT01971476|617687719|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
170914046|NCT01971476|617687720|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
170914047|NCT01971476|617687721|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
170914048|NCT01971476|617687719|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
170914049|NCT01971476|617687720|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
170914050|NCT01971476|617687721|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
170914051|NCT01651052|617687722|FG000|Overall Study|Death|21|||
170914052|NCT01651052|617687722|FG000|Overall Study|Explant|1|||
170914053|NCT01651052|617687722|FG000|Overall Study|Withdrawal by Subject|1|||
170914054|NCT01651052|617687722|FG000|Overall Study|Lost to Follow-up|3|||
170914055|NCT01716169|617687726|FG000|Overall Study|Adverse Event|1|||
170914056|NCT01716169|617687726|FG000|Overall Study|Lost to Follow-up|1|||
170914057|NCT01716169|617687726|FG000|Overall Study|Withdrawal by Subject|1|||
170914058|NCT01716169|617687726|FG000|Overall Study|inconsistent dressing application|1|||
170914059|NCT04156646|617687727|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
170914060|NCT04156646|617687728|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
170914061|NCT00942708|617687729|FG000|Overall Study|Withdrawal by Subject|1|||
170914062|NCT01478347|617687730|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
170914063|NCT01478347|617687730|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
170914064|NCT01478347|617687730|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
170914065|NCT01645930|617687731|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
170914066|NCT01645930|617687731|FG000|Overall Study|Progressive Disease|12|||
170914067|NCT01645930|617687731|FG000|Overall Study|Adverse Event|4|||
170914068|NCT01645930|617687731|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
170914069|NCT01645930|617687731|FG000|Overall Study|Withdrawal by Participant|2|||
170914070|NCT01645930|617687731|FG000|Overall Study|Reason not Defined|1|||
170914071|NCT02263365|617687732|FG000|Overall Study|Physician Decision|22|||
170914072|NCT02263365|617687733|FG001|Overall Study|Physician Decision|18|||
170914073|NCT00231478|617687737|FG000|Overall Study|Protocol Violation|3|||
170914074|NCT00231478|617687738|FG001|Overall Study|Protocol Violation|2|||
170914075|NCT00231478|617687737|FG000|Overall Study|Refused Treatment|1|||
170914076|NCT00231478|617687738|FG001|Overall Study|Refused Treatment|1|||
170914077|NCT00231478|617687737|FG000|Overall Study|Withdrawal by Subject|1|||
170914078|NCT00231478|617687738|FG001|Overall Study|Withdrawal by Subject|0|||
170914079|NCT00231478|617687737|FG000|Overall Study|Adverse Event|0|||
170914080|NCT00231478|617687738|FG001|Overall Study|Adverse Event|1|||
170914081|NCT00231478|617687737|FG000|Overall Study|Administrative|3|||
170914082|NCT00231478|617687738|FG001|Overall Study|Administrative|2|||
170914083|NCT01524289|617687739|FG000|Overall Study|Lost to Follow-up|0|||
170914084|NCT01524289|617687740|FG001|Overall Study|Lost to Follow-up|1|||
170914085|NCT01524289|617687739|FG000|Overall Study|Physician Decision|1|||
170603797|NCT01359943|616554753|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
170603798|NCT01359943|616554754|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
170914086|NCT01524289|617687740|FG001|Overall Study|Physician Decision|0|||
170603799|NCT01359943|616554752|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
170914087|NCT01524289|617687739|FG000|Overall Study|Protocol Violation|5|||
170914088|NCT01524289|617687740|FG001|Overall Study|Protocol Violation|1|||
170914089|NCT01524289|617687739|FG000|Overall Study|Withdrawal by Subject|11|||
170914090|NCT01524289|617687740|FG001|Overall Study|Withdrawal by Subject|7|||
170914091|NCT01524289|617687739|FG000|Overall Study|Adverse Event|12|||
170914092|NCT01524289|617687740|FG001|Overall Study|Adverse Event|5|||
170914093|NCT01524289|617687739|FG000|Overall Study|Did not take study medication|1|||
170914094|NCT01524289|617687740|FG001|Overall Study|Did not take study medication|0|||
170603800|NCT01359943|616554753|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
170603801|NCT01359943|616554754|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
170603802|NCT01359943|616554752|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
170603803|NCT01359943|616554753|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
170603804|NCT01359943|616554754|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
170603805|NCT01359943|616554752|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
170603806|NCT01359943|616554753|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
170603807|NCT01359943|616554754|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
170603808|NCT01359943|616554752|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
170603809|NCT01359943|616554753|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
170603810|NCT01359943|616554754|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
170603811|NCT01359943|616554752|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
170603812|NCT01359943|616554753|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
170603813|NCT01359943|616554754|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
170603814|NCT01359943|616554752|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
170603815|NCT01359943|616554753|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
170603816|NCT01359943|616554754|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
170603817|NCT01359943|616554752|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
170603818|NCT01359943|616554753|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
170603819|NCT01359943|616554754|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
170603820|NCT03436693|616554758|FG000|Overall Study|Adverse Event|22|||
170603821|NCT03436693|616554759|FG001|Overall Study|Adverse Event|10|||
170603822|NCT03436693|616554758|FG000|Overall Study|Physician Decision|3|||
170603823|NCT03436693|616554759|FG001|Overall Study|Physician Decision|3|||
170603824|NCT03436693|616554758|FG000|Overall Study|Withdrawal by Subject|4|||
170603825|NCT03436693|616554759|FG001|Overall Study|Withdrawal by Subject|13|||
170603826|NCT03436693|616554758|FG000|Overall Study|Progressive Disease|1|||
170603827|NCT03436693|616554759|FG001|Overall Study|Progressive Disease|1|||
170603828|NCT04655144|616554760|FG000|Overall Study|Consumed THC|1|||
170603829|NCT04655144|616554761|FG001|Overall Study|Consumed THC|0|||
170603830|NCT04655144|616554760|FG000|Overall Study|Unilateral embolization|0|||
170603831|NCT04655144|616554761|FG001|Overall Study|Unilateral embolization|1|||
170603832|NCT03645863|616554762|FG000|Overall Study|Withdrawal by Subject|1|||
170603833|NCT03645863|616554763|FG001|Overall Study|Withdrawal by Subject|0|||
170603834|NCT03645863|616554764|FG002|Overall Study|Withdrawal by Subject|0|||
170603835|NCT01580670|616554767|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
170603836|NCT01580670|616554767|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
170603837|NCT02473367|616554768|FG000|Wait 1|Withdrawal by Subject|1|||
170603838|NCT02473367|616554768|FG000|Period 4|Lost to Follow-up|1|||
170603839|NCT04816721|616554769|FG000|Overall Study|Withdrawal by Subject|0|||
170603840|NCT04816721|616554770|FG001|Overall Study|Withdrawal by Subject|2|||
170603841|NCT04816721|616554771|FG002|Overall Study|Withdrawal by Subject|0|||
170603842|NCT04816721|616554772|FG003|Overall Study|Withdrawal by Subject|1|||
170603843|NCT04816721|616554773|FG004|Overall Study|Withdrawal by Subject|1|||
170603844|NCT04816721|616554774|FG005|Overall Study|Withdrawal by Subject|0|||
170603845|NCT04816721|616554775|FG006|Overall Study|Withdrawal by Subject|0|||
170603846|NCT04816721|616554776|FG007|Overall Study|Withdrawal by Subject|0|||
170603847|NCT04816721|616554769|FG000|Overall Study|Miscellaneous|0|||
170813714|NCT01280721|617325956|FG000|Overall Study|No tolerability for the lowest dose|2|||
170813715|NCT00042939|617325958|FG000|Overall Study|Adverse Event|6|||
170813716|NCT00042939|617325959|FG001|Overall Study|Adverse Event|7|||
170813717|NCT00042939|617325958|FG000|Overall Study|Death|3|||
170813718|NCT00042939|617325959|FG001|Overall Study|Death|2|||
170914095|NCT02519231|617687741|FG000|Overall Study|Lost to Follow-up|2|||
170652347|NCT01397825|616741574|FG000|Overall Study|Adverse Event|0|||
170813719|NCT00042939|617325958|FG000|Overall Study|Withdrawal by Subject|3|||
170813720|NCT00042939|617325959|FG001|Overall Study|Withdrawal by Subject|4|||
170813721|NCT00042939|617325958|FG000|Overall Study|Other disease|1|||
170813722|NCT00042939|617325959|FG001|Overall Study|Other disease|0|||
170813723|NCT00042939|617325958|FG000|Overall Study|Ineligible|2|||
170813724|NCT00042939|617325959|FG001|Overall Study|Ineligible|2|||
170813725|NCT00042939|617325958|FG000|Overall Study|Deterioration of health|3|||
170813726|NCT00042939|617325959|FG001|Overall Study|Deterioration of health|4|||
170813727|NCT00042939|617325958|FG000|Overall Study|QOL diminished|1|||
170813728|NCT00042939|617325959|FG001|Overall Study|QOL diminished|0|||
170813729|NCT00042939|617325958|FG000|Overall Study|Rising ca 19-9|1|||
170813730|NCT00042939|617325959|FG001|Overall Study|Rising ca 19-9|0|||
170813731|NCT00042939|617325958|FG000|Overall Study|Patient non-compliance|1|||
170813732|NCT00042939|617325959|FG001|Overall Study|Patient non-compliance|0|||
170813733|NCT00042939|617325958|FG000|Overall Study|Still on treatment|1|||
170813734|NCT00042939|617325959|FG001|Overall Study|Still on treatment|0|||
170813735|NCT00042939|617325958|FG000|Overall Study|Treatment break > 4 weeks|0|||
170813736|NCT00042939|617325959|FG001|Overall Study|Treatment break > 4 weeks|1|||
170813737|NCT00042939|617325958|FG000|Overall Study|Did not start treatment|2|||
170914096|NCT02519231|617687742|FG001|Overall Study|Lost to Follow-up|5|||
170914097|NCT02519231|617687741|FG000|Overall Study|Withdrawal by Subject|0|||
170603848|NCT04816721|616554770|FG001|Overall Study|Miscellaneous|0|||
170603849|NCT04816721|616554771|FG002|Overall Study|Miscellaneous|0|||
170603850|NCT04816721|616554772|FG003|Overall Study|Miscellaneous|0|||
170603851|NCT04816721|616554773|FG004|Overall Study|Miscellaneous|0|||
170603852|NCT04816721|616554774|FG005|Overall Study|Miscellaneous|1|||
170603853|NCT04816721|616554775|FG006|Overall Study|Miscellaneous|0|||
170603854|NCT04816721|616554776|FG007|Overall Study|Miscellaneous|0|||
170603855|NCT04816721|616554769|FG000|Overall Study|Lost to Follow-up|0|||
170603856|NCT04816721|616554770|FG001|Overall Study|Lost to Follow-up|0|||
170603857|NCT04816721|616554771|FG002|Overall Study|Lost to Follow-up|0|||
170603858|NCT04816721|616554772|FG003|Overall Study|Lost to Follow-up|1|||
170603859|NCT04816721|616554773|FG004|Overall Study|Lost to Follow-up|0|||
170603860|NCT04816721|616554774|FG005|Overall Study|Lost to Follow-up|0|||
170603861|NCT04816721|616554775|FG006|Overall Study|Lost to Follow-up|0|||
170603862|NCT04816721|616554776|FG007|Overall Study|Lost to Follow-up|0|||
170603863|NCT02220907|616554777|FG000|Overall Study|Adverse Event|7|||
170603864|NCT02220907|616554777|FG000|Overall Study|Physician Decision|1|||
170603865|NCT02220907|616554777|FG000|Overall Study|Withdrawal by Subject|2|||
170603866|NCT02220907|616554777|FG000|Overall Study|Conflict with the stopping criteria|1|||
170603867|NCT00542815|616554778|FG000|Overall Study|Adverse Event|19|||
170603868|NCT00542815|616554779|FG001|Overall Study|Adverse Event|6|||
170603869|NCT00542815|616554780|FG002|Overall Study|Adverse Event|9|||
170603870|NCT00542815|616554778|FG000|Overall Study|Death|10|||
170603871|NCT00542815|616554779|FG001|Overall Study|Death|7|||
170603872|NCT00542815|616554780|FG002|Overall Study|Death|3|||
170603873|NCT00542815|616554778|FG000|Overall Study|Lack of Efficacy|9|||
170603874|NCT00542815|616554779|FG001|Overall Study|Lack of Efficacy|2|||
170603875|NCT00542815|616554780|FG002|Overall Study|Lack of Efficacy|0|||
170603876|NCT00542815|616554778|FG000|Overall Study|Physician Decision|2|||
170603877|NCT00542815|616554779|FG001|Overall Study|Physician Decision|1|||
170603878|NCT00542815|616554780|FG002|Overall Study|Physician Decision|0|||
170652348|NCT01397825|616741575|FG001|Overall Study|Adverse Event|1|||
170652349|NCT01397825|616741576|FG002|Overall Study|Adverse Event|5|||
170652350|NCT01397825|616741577|FG003|Overall Study|Adverse Event|1|||
170652351|NCT01397825|616741578|FG004|Overall Study|Adverse Event|0|||
170652352|NCT01397825|616741574|FG000|Overall Study|Withdrawal by Subject|1|||
170603879|NCT00542815|616554778|FG000|Overall Study|Protocol Violation|1|||
170603880|NCT00542815|616554779|FG001|Overall Study|Protocol Violation|1|||
170652353|NCT01397825|616741575|FG001|Overall Study|Withdrawal by Subject|0|||
170603881|NCT00542815|616554780|FG002|Overall Study|Protocol Violation|2|||
170603882|NCT00542815|616554778|FG000|Overall Study|Withdrawal by Subject|41|||
170603883|NCT00542815|616554779|FG001|Overall Study|Withdrawal by Subject|5|||
170603884|NCT00542815|616554780|FG002|Overall Study|Withdrawal by Subject|8|||
170603885|NCT00542815|616554778|FG000|Overall Study|Other reasons|24|||
170652354|NCT01397825|616741576|FG002|Overall Study|Withdrawal by Subject|5|||
170652355|NCT01397825|616741577|FG003|Overall Study|Withdrawal by Subject|1|||
170652356|NCT01397825|616741578|FG004|Overall Study|Withdrawal by Subject|0|||
170652357|NCT00815516|616741579|FG000|Overall Study|Death|3|||
170652358|NCT00815516|616741580|FG001|Overall Study|Death|1|||
170652359|NCT00815516|616741579|FG000|Overall Study|Physician Decision|1|||
170652360|NCT00815516|616741580|FG001|Overall Study|Physician Decision|0|||
170652361|NCT02311582|616741583|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
170652362|NCT02311582|616741584|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
170652363|NCT02311582|616741585|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
170652364|NCT02311582|616741586|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
170652365|NCT02311582|616741587|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
170914098|NCT02519231|617687742|FG001|Overall Study|Withdrawal by Subject|1|||
170914099|NCT00447421|617687743|FG000|Overall Study|Lack of Efficacy|1|||
170914100|NCT00447421|617687743|FG000|Overall Study|Adverse Event|3|||
170914101|NCT00447421|617687743|FG000|Overall Study|Sponsor Decision|2|||
170914102|NCT01707147|617687744|FG000|Overall Study|Administered Trajenta prior to contract|5|||
170914103|NCT01707147|617687744|FG000|Overall Study|Patients who have not taken Trajenta|1|||
170914104|NCT01707147|617687744|FG000|Overall Study|Follow-up failure|17|||
170914105|NCT01707147|617687744|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
170914106|NCT03067311|617687754|FG000|Overall Study|Lost to Follow-up|1|||
170914107|NCT03067311|617687755|FG001|Overall Study|Lost to Follow-up|1|||
170914108|NCT03067311|617687754|FG000|Overall Study|Moved away|1|||
170914109|NCT03067311|617687755|FG001|Overall Study|Moved away|1|||
170914110|NCT05270694|617689539|FG000|Overall Study|Death|1|||
170914111|NCT05270694|617689539|FG000|Overall Study|Medical issues impacted ability to participate|2|||
170914112|NCT05270694|617689539|FG000|Overall Study|Lost to Follow-up|3|||
170914113|NCT05270694|617689539|FG000|Overall Study|Withdrawal by Subject|3|||
170914114|NCT03314519|617689542|FG000|Overall Study|Protocol Violation|3|||
170914115|NCT03314519|617689543|FG001|Overall Study|Protocol Violation|2|||
170914116|NCT01666444|617689546|FG000|Overall Study|Did not initiate treatment|2|||
170914117|NCT01666444|617689547|FG001|Overall Study|Did not initiate treatment|1|||
170914118|NCT02241512|617689548|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
170914119|NCT02241512|617689549|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
170914120|NCT00641043|617689550|FG000|Overall Study|Adverse Event|6|||
170914121|NCT00641043|617689551|FG001|Overall Study|Adverse Event|4|||
170914122|NCT00641043|617689550|FG000|Overall Study|Protocol Violation|2|||
170914123|NCT00641043|617689551|FG001|Overall Study|Protocol Violation|3|||
170914124|NCT00641043|617689550|FG000|Overall Study|Lost to Follow-up|3|||
170914125|NCT00641043|617689551|FG001|Overall Study|Lost to Follow-up|2|||
170914126|NCT00641043|617689550|FG000|Overall Study|Withdrawal by Subject|4|||
170914127|NCT00641043|617689551|FG001|Overall Study|Withdrawal by Subject|4|||
170914128|NCT00641043|617689550|FG000|Overall Study|Other incl. lack of efficacy|4|||
170914129|NCT00641043|617689551|FG001|Overall Study|Other incl. lack of efficacy|2|||
170914130|NCT03567291|617689552|FG000|Period I|Adverse Event|14|||
170914131|NCT03567291|617689553|FG001|Period I|Adverse Event|0|||
170914132|NCT03567291|617689554|FG002|Period I|Adverse Event|0|||
170914133|NCT03567291|617689555|FG003|Period I|Adverse Event|0|||
170914134|NCT03567291|617689552|FG000|Period I|Protocol Violation|1|||
170914135|NCT03567291|617689553|FG001|Period I|Protocol Violation|0|||
170914136|NCT03567291|617689554|FG002|Period I|Protocol Violation|0|||
170914137|NCT03567291|617689555|FG003|Period I|Protocol Violation|0|||
170914138|NCT03567291|617689552|FG000|Period I|Withdrawal by Subject|23|||
170914139|NCT03567291|617689553|FG001|Period I|Withdrawal by Subject|0|||
170914140|NCT03567291|617689554|FG002|Period I|Withdrawal by Subject|0|||
170914141|NCT03567291|617689555|FG003|Period I|Withdrawal by Subject|0|||
170914142|NCT03567291|617689552|FG000|Period I|Lost to Follow-up|2|||
170914143|NCT03567291|617689553|FG001|Period I|Lost to Follow-up|0|||
170914144|NCT03567291|617689554|FG002|Period I|Lost to Follow-up|0|||
170914145|NCT03567291|617689555|FG003|Period I|Lost to Follow-up|0|||
170914146|NCT03567291|617689552|FG000|Period I|Terminated by sponsor|44|||
170914147|NCT03567291|617689553|FG001|Period I|Terminated by sponsor|0|||
170914148|NCT03567291|617689554|FG002|Period I|Terminated by sponsor|0|||
170914149|NCT03567291|617689555|FG003|Period I|Terminated by sponsor|0|||
170914150|NCT03567291|617689552|FG000|Period I|Missing or unknown|7|||
170914151|NCT03567291|617689553|FG001|Period I|Missing or unknown|0|||
170652366|NCT03404960|616741589|FG000|Overall Study|Adverse Event|0|||
170914152|NCT03567291|617689554|FG002|Period I|Missing or unknown|0|||
170914153|NCT03567291|617689555|FG003|Period I|Missing or unknown|0|||
170914154|NCT03567291|617689552|FG000|Period II|Adverse Event|0|||
170914155|NCT03567291|617689553|FG001|Period II|Adverse Event|1|||
170914156|NCT03567291|617689554|FG002|Period II|Adverse Event|0|||
170914157|NCT03567291|617689555|FG003|Period II|Adverse Event|0|||
170914158|NCT03567291|617689552|FG000|Period II|Missing or unknown|0|||
170914159|NCT03567291|617689553|FG001|Period II|Missing or unknown|2|||
170914160|NCT03567291|617689554|FG002|Period II|Missing or unknown|1|||
170914161|NCT03567291|617689555|FG003|Period II|Missing or unknown|0|||
170914162|NCT03567291|617689552|FG000|Period III|Adverse Event|0|||
170914163|NCT03567291|617689553|FG001|Period III|Adverse Event|0|||
170914164|NCT03567291|617689554|FG002|Period III|Adverse Event|0|||
170914165|NCT03567291|617689555|FG003|Period III|Adverse Event|4|||
170914166|NCT03567291|617689552|FG000|Period III|Withdrawal by Subject|0|||
170914167|NCT03567291|617689553|FG001|Period III|Withdrawal by Subject|0|||
170914168|NCT03567291|617689554|FG002|Period III|Withdrawal by Subject|0|||
170914169|NCT03567291|617689555|FG003|Period III|Withdrawal by Subject|4|||
170914170|NCT03567291|617689552|FG000|Period III|Lost to Follow-up|0|||
170914171|NCT03567291|617689553|FG001|Period III|Lost to Follow-up|0|||
170914172|NCT03567291|617689554|FG002|Period III|Lost to Follow-up|0|||
170914173|NCT03567291|617689555|FG003|Period III|Lost to Follow-up|1|||
170914174|NCT03567291|617689552|FG000|Period III|Terminated by sponsor|0|||
170914175|NCT03567291|617689553|FG001|Period III|Terminated by sponsor|0|||
170914176|NCT03567291|617689554|FG002|Period III|Terminated by sponsor|0|||
170914177|NCT03567291|617689555|FG003|Period III|Terminated by sponsor|68|||
170914178|NCT03567291|617689552|FG000|Period III|Missing or unknown|0|||
170914179|NCT03567291|617689553|FG001|Period III|Missing or unknown|0|||
170914180|NCT03567291|617689554|FG002|Period III|Missing or unknown|0|||
170914181|NCT03567291|617689555|FG003|Period III|Missing or unknown|8|||
170914182|NCT03648476|617689560|FG000|Overall Study|Withdrawal by Subject|2|||
170914183|NCT03648476|617689561|FG001|Overall Study|Withdrawal by Subject|1|||
170914184|NCT02639182|617689562|FG000|Overall Study|Disease Progression|50|||
170914185|NCT02639182|617689563|FG001|Overall Study|Disease Progression|49|||
170914186|NCT02639182|617689562|FG000|Overall Study|Adverse Event|7|||
170914187|NCT02639182|617689563|FG001|Overall Study|Adverse Event|5|||
170914188|NCT02639182|617689562|FG000|Overall Study|Physician Decision|3|||
170914189|NCT02639182|617689563|FG001|Overall Study|Physician Decision|3|||
170914190|NCT02639182|617689562|FG000|Overall Study|Withdrew Consent|5|||
170914191|NCT02639182|617689563|FG001|Overall Study|Withdrew Consent|4|||
170914192|NCT02639182|617689562|FG000|Overall Study|Lost to Follow-up|0|||
170914193|NCT02639182|617689563|FG001|Overall Study|Lost to Follow-up|1|||
170914194|NCT02639182|617689562|FG000|Overall Study|Study Closure|1|||
170914195|NCT02639182|617689563|FG001|Overall Study|Study Closure|2|||
170914196|NCT02639182|617689562|FG000|Overall Study|Sponsor Ended Study|0|||
170914197|NCT02639182|617689563|FG001|Overall Study|Sponsor Ended Study|1|||
170914198|NCT02639182|617689562|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
170914199|NCT02639182|617689563|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
170914200|NCT01097616|617689566|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
170914201|NCT01097616|617689567|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
170914202|NCT01097616|617689568|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
170914203|NCT01097616|617689569|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170914204|NCT01097616|617689570|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170914205|NCT01097616|617689571|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170914206|NCT01097616|617689572|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170914207|NCT01097616|617689573|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
170914208|NCT01097616|617689566|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
170914209|NCT01097616|617689567|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
170914210|NCT01097616|617689568|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
170914211|NCT01097616|617689569|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170914212|NCT01097616|617689570|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170914213|NCT01097616|617689571|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170914214|NCT01097616|617689572|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170914215|NCT01097616|617689573|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
170914216|NCT01097616|617689566|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
170914217|NCT01097616|617689567|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
170914218|NCT01097616|617689568|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
170914219|NCT01097616|617689569|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170914220|NCT01097616|617689570|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170914221|NCT01097616|617689571|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170914222|NCT01097616|617689572|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170914223|NCT01097616|617689573|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
170914224|NCT01097616|617689566|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
170914225|NCT01097616|617689567|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
170603886|NCT00542815|616554779|FG001|Overall Study|Other reasons|10|||
170603887|NCT00542815|616554780|FG002|Overall Study|Other reasons|10|||
170603888|NCT02678923|616554788|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
170603889|NCT02678923|616554789|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
170652367|NCT03404960|616741590|FG001|Overall Study|Adverse Event|2|||
170652368|NCT03404960|616741589|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
170652369|NCT03404960|616741590|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
170652370|NCT03404960|616741589|FG000|Overall Study|Bowel obstruction|0|||
170652371|NCT03404960|616741590|FG001|Overall Study|Bowel obstruction|1|||
170652372|NCT03404960|616741589|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
170603890|NCT02678923|616554788|FG000|Overall Study|Withdrawal by Subject|3|||
170603891|NCT02678923|616554789|FG001|Overall Study|Withdrawal by Subject|2|||
170603892|NCT02678923|616554788|FG000|Overall Study|Lost to Follow-up|1|||
170603893|NCT02678923|616554789|FG001|Overall Study|Lost to Follow-up|0|||
170603894|NCT02678923|616554788|FG000|Overall Study|Did Not Return for Study Visits|1|||
170603895|NCT02678923|616554789|FG001|Overall Study|Did Not Return for Study Visits|0|||
170603896|NCT02717130|616554790|FG000|Overall Study|Withdrawal by Subject|1|||
170603897|NCT02717130|616554790|FG000|Overall Study|Adverse Event|1|||
170603898|NCT02717130|616554790|FG000|Overall Study|Physician Decision|1|||
170603899|NCT02717130|616554790|FG000|Overall Study|Study Closure|4|||
170603900|NCT00565136|616554791|FG000|Overall Study|Lost to Follow-up|1|||
170652373|NCT03404960|616741590|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
170652374|NCT05171816|616741593|FG000|Overall Study|Death|18|||
170652375|NCT05171816|616741594|FG001|Overall Study|Death|16|||
170603901|NCT00565136|616554791|FG000|Overall Study|Withdrawal by Subject|1|||
170603902|NCT00565136|616554791|FG000|Overall Study|Protocol Violation|1|||
170603903|NCT03446456|616556538|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
170603904|NCT03446456|616556539|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
170603905|NCT03446456|616556538|FG000|Overall Study|Lost to Follow-up|1|||
170603906|NCT03446456|616556539|FG001|Overall Study|Lost to Follow-up|3|||
170603907|NCT03446456|616556538|FG000|Overall Study|Participant failed the toxicology test|1|||
170603908|NCT03446456|616556539|FG001|Overall Study|Participant failed the toxicology test|0|||
170603909|NCT03446456|616556538|FG000|Overall Study|Break down of the experimental equipment|1|||
170603910|NCT03446456|616556539|FG001|Overall Study|Break down of the experimental equipment|0|||
170603911|NCT04588389|616556548|FG000|Overall Study|Issues with anesthesia during surgery|2|||
170603912|NCT04588389|616556549|FG001|Overall Study|Issues with anesthesia during surgery|0|||
170603913|NCT04588389|616556550|FG002|Overall Study|Issues with anesthesia during surgery|0|||
170603914|NCT00658814|616556553|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
170603915|NCT00658814|616556554|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
170603916|NCT00658814|616556553|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
170603917|NCT00658814|616556554|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
170603918|NCT00658814|616556553|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
170603919|NCT00658814|616556554|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
170603920|NCT00658814|616556553|FG000|Remission Induction Chemotherapy|Death|1|||
170603921|NCT00658814|616556554|FG001|Remission Induction Chemotherapy|Death|4|||
170603922|NCT00658814|616556553|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
170603923|NCT00658814|616556554|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
170603924|NCT00658814|616556553|FG000|Remission Induction Chemotherapy|Not eligible|1|||
170603925|NCT00658814|616556554|FG001|Remission Induction Chemotherapy|Not eligible|2|||
170603926|NCT00658814|616556553|FG000|Consolidation Therapy|Not protocol specified|0|||
170603927|NCT00658814|616556554|FG001|Consolidation Therapy|Not protocol specified|1|||
170603928|NCT00658814|616556553|FG000|Consolidation Therapy|Not eligible|2|||
170603929|NCT00658814|616556554|FG001|Consolidation Therapy|Not eligible|2|||
170603930|NCT00658814|616556553|FG000|Maintenance Therapy|Adverse Event|1|||
170603931|NCT00658814|616556554|FG001|Maintenance Therapy|Adverse Event|1|||
170603932|NCT00658814|616556553|FG000|Maintenance Therapy|Not protocol specified|1|||
170813738|NCT00042939|617325959|FG001|Overall Study|Did not start treatment|1|||
170813739|NCT01182285|617325960|FG000|First Intervention Week 1-10|Disease progression|1|||
170813740|NCT01182285|617325961|FG001|First Intervention Week 1-10|Disease progression|0|||
170813741|NCT01182285|617325962|FG002|First Intervention Week 1-10|Disease progression|0|||
170813742|NCT01182285|617325960|FG000|First Intervention Week 1-10|Adverse Event|1|||
170813743|NCT01182285|617325961|FG001|First Intervention Week 1-10|Adverse Event|0|||
170813744|NCT01182285|617325962|FG002|First Intervention Week 1-10|Adverse Event|0|||
170813745|NCT01182285|617325960|FG000|First Intervention Week 1-10|Non-compliance|1|||
170813746|NCT01182285|617325961|FG001|First Intervention Week 1-10|Non-compliance|0|||
170813747|NCT01182285|617325962|FG002|First Intervention Week 1-10|Non-compliance|0|||
170813748|NCT01182285|617325960|FG000|Third Intervention Week 11-52|Disease Progression|0|||
170813749|NCT01182285|617325961|FG001|Third Intervention Week 11-52|Disease Progression|0|||
170813750|NCT01182285|617325962|FG002|Third Intervention Week 11-52|Disease Progression|6|||
170813751|NCT01182285|617325960|FG000|Third Intervention Week 11-52|Other|0|||
170813752|NCT01182285|617325961|FG001|Third Intervention Week 11-52|Other|0|||
170813753|NCT01182285|617325962|FG002|Third Intervention Week 11-52|Other|2|||
170813754|NCT00248794|617325963|FG000|Overall Study|Lost to Follow-up|6|||
170813755|NCT00248794|617325964|FG001|Overall Study|Lost to Follow-up|8|||
170813756|NCT00248794|617325965|FG002|Overall Study|Lost to Follow-up|3|||
170813757|NCT03449979|617325966|FG000|Overall Study|Technical difficulty|0|||
170813758|NCT03449979|617325967|FG001|Overall Study|Technical difficulty|0|||
170813759|NCT03449979|617325968|FG002|Overall Study|Technical difficulty|0|||
170813760|NCT03449979|617325969|FG003|Overall Study|Technical difficulty|1|||
170813761|NCT02069379|617325970|FG000|Baseline Measurements|Lost to Follow-up|1|||
170813762|NCT02069379|617325971|FG001|Baseline Measurements|Lost to Follow-up|0|||
170813763|NCT02069379|617325972|FG002|Baseline Measurements|Lost to Follow-up|0|||
170813764|NCT02069379|617325973|FG003|Baseline Measurements|Lost to Follow-up|0|||
170813765|NCT02069379|617325970|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
170914226|NCT01097616|617689568|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170914227|NCT01097616|617689569|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170914228|NCT01097616|617689570|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170914229|NCT01097616|617689571|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170914230|NCT01097616|617689572|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170914231|NCT01097616|617689573|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
170914232|NCT01097616|617689566|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
170914233|NCT01097616|617689567|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
170914234|NCT01097616|617689568|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
170914235|NCT01097616|617689569|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170914236|NCT01097616|617689570|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170914237|NCT01097616|617689571|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170914238|NCT01097616|617689572|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170914239|NCT01097616|617689573|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
170914240|NCT01097616|617689566|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
170914241|NCT01097616|617689567|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
170914242|NCT01097616|617689568|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
170914243|NCT01097616|617689569|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
170914244|NCT01097616|617689570|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
170914245|NCT01097616|617689571|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
170914246|NCT01097616|617689572|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
170914247|NCT01097616|617689573|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
170914248|NCT01097616|617689566|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
170914249|NCT01097616|617689567|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
170914250|NCT01097616|617689568|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170914251|NCT01097616|617689569|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170603933|NCT00658814|616556554|FG001|Maintenance Therapy|Not protocol specified|0|||
170813766|NCT02069379|617325971|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
170813767|NCT02069379|617325972|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
170813768|NCT02069379|617325973|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
170914252|NCT01097616|617689570|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170914253|NCT01097616|617689571|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170914254|NCT01097616|617689572|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170914255|NCT01097616|617689573|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
170813769|NCT02069379|617325970|FG000|First Treatment Arm|Lost to Follow-up|0|||
170813770|NCT02069379|617325971|FG001|First Treatment Arm|Lost to Follow-up|1|||
170603934|NCT00658814|616556553|FG000|Maintenance Therapy|Not eligible|1|||
170603935|NCT00658814|616556554|FG001|Maintenance Therapy|Not eligible|0|||
170603936|NCT02911142|616556555|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
170603937|NCT02911142|616556555|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
170603938|NCT02911142|616556555|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
170603939|NCT02911142|616556555|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
170603940|NCT01178099|616556556|FG000|Overall Study|Physician Decision|0|||
170603941|NCT01178099|616556557|FG001|Overall Study|Physician Decision|1|||
170603942|NCT02354235|616556558|FG000|Overall Study|Adverse Event|2|||
170603943|NCT02354235|616556559|FG001|Overall Study|Adverse Event|2|||
170603944|NCT02354235|616556558|FG000|Overall Study|Physician Decision|0|||
170603945|NCT02354235|616556559|FG001|Overall Study|Physician Decision|1|||
170603946|NCT02354235|616556558|FG000|Overall Study|Withdrawal by Subject|1|||
170603947|NCT02354235|616556559|FG001|Overall Study|Withdrawal by Subject|3|||
170603948|NCT02354235|616556558|FG000|Overall Study|Conflict with the stopping criteria|0|||
170603949|NCT02354235|616556559|FG001|Overall Study|Conflict with the stopping criteria|1|||
170603950|NCT04481789|616556560|FG000|Period 1|Withdrawal by Subject|1|||
170603951|NCT04481789|616556561|FG001|Period 1|Withdrawal by Subject|0|||
170603952|NCT04481789|616556562|FG002|Period 1|Withdrawal by Subject|0|||
170603953|NCT04481789|616556563|FG003|Period 1|Withdrawal by Subject|0|||
170603954|NCT04481789|616556564|FG004|Period 1|Withdrawal by Subject|0|||
170603955|NCT04481789|616556565|FG005|Period 1|Withdrawal by Subject|0|||
170603956|NCT05216224|616556566|FG000|Overall Study|Adverse Event|6|||
170603957|NCT05216224|616556567|FG001|Overall Study|Adverse Event|3|||
170603958|NCT05216224|616556566|FG000|Overall Study|Lack of Efficacy|1|||
170603959|NCT05216224|616556567|FG001|Overall Study|Lack of Efficacy|0|||
170603960|NCT05216224|616556566|FG000|Overall Study|Lost to Follow-up|8|||
170603961|NCT05216224|616556567|FG001|Overall Study|Lost to Follow-up|6|||
170603962|NCT05216224|616556566|FG000|Overall Study|Protocol Violation|1|||
170603963|NCT05216224|616556567|FG001|Overall Study|Protocol Violation|1|||
170603964|NCT05216224|616556566|FG000|Overall Study|Withdrawal by Subject|6|||
170603965|NCT05216224|616556567|FG001|Overall Study|Withdrawal by Subject|5|||
170603966|NCT05216224|616556566|FG000|Overall Study|Other than specified|1|||
170813771|NCT02069379|617325972|FG002|First Treatment Arm|Lost to Follow-up|1|||
170813772|NCT02069379|617325973|FG003|First Treatment Arm|Lost to Follow-up|0|||
170813773|NCT02069379|617325970|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
170813774|NCT02069379|617325971|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
170813775|NCT02069379|617325972|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
170813776|NCT02069379|617325973|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
170813777|NCT02069379|617325970|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
170813778|NCT02069379|617325971|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
170914256|NCT01097616|617689566|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170914257|NCT01097616|617689567|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170914258|NCT01097616|617689568|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
170914259|NCT01097616|617689569|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170603967|NCT05216224|616556567|FG001|Overall Study|Other than specified|0|||
170603968|NCT04317742|616556568|FG000|Overall Study|Lost to Follow-up|57|||
170603969|NCT04317742|616556569|FG001|Overall Study|Lost to Follow-up|59|||
170603970|NCT04317742|616556568|FG000|Overall Study|Pregnancy|1|||
170603971|NCT04317742|616556569|FG001|Overall Study|Pregnancy|1|||
170603972|NCT04317742|616556568|FG000|Overall Study|Withdrawal by Subject|46|||
170603973|NCT04317742|616556569|FG001|Overall Study|Withdrawal by Subject|24|||
170603974|NCT00455143|616556570|FG000|Overall Study|Physician Decision|1|||
170603975|NCT00455143|616556570|FG000|Overall Study|Withdrawal by Subject|1|||
170603976|NCT00455143|616556570|FG000|Overall Study|Staff was not avail to follow patient|2|||
170603977|NCT00455143|616556570|FG000|Overall Study|No longer met Inclusion Criteria|1|||
170603978|NCT00455143|616556570|FG000|Overall Study|Surgical time, staff not available|1|||
170603979|NCT01646203|616556571|FG000|Overall Study|Adverse Event|2|||
170603980|NCT01646203|616556572|FG001|Overall Study|Adverse Event|0|||
170603981|NCT01646203|616556573|FG002|Overall Study|Adverse Event|1|||
170603982|NCT01646203|616556571|FG000|Overall Study|Withdrawal by Subject|0|||
170914260|NCT01097616|617689570|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170914261|NCT01097616|617689571|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170603983|NCT01646203|616556572|FG001|Overall Study|Withdrawal by Subject|1|||
170603984|NCT01646203|616556573|FG002|Overall Study|Withdrawal by Subject|0|||
170603985|NCT01646203|616556571|FG000|Overall Study|Physician's Decision|0|||
170603986|NCT01646203|616556572|FG001|Overall Study|Physician's Decision|1|||
170603987|NCT01646203|616556573|FG002|Overall Study|Physician's Decision|0|||
170603988|NCT01554514|616556582|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
170603989|NCT01554514|616556582|FG000|Overall Study|Physician Decision|1|||
170603990|NCT00549770|616556587|FG000|Overall Study|Protocol deviation|1|||
170603991|NCT00549770|616556588|FG001|Overall Study|Protocol deviation|1|||
170603992|NCT00549770|616556589|FG002|Overall Study|Protocol deviation|1|||
170603993|NCT00549770|616556590|FG003|Overall Study|Protocol deviation|2|||
170603994|NCT00549770|616556591|FG004|Overall Study|Protocol deviation|2|||
170603995|NCT00549770|616556592|FG005|Overall Study|Protocol deviation|2|||
170603996|NCT00549770|616556593|FG006|Overall Study|Protocol deviation|1|||
170603997|NCT00549770|616556594|FG007|Overall Study|Protocol deviation|2|||
170603998|NCT00549770|616556587|FG000|Overall Study|Administrative problems|0|||
170603999|NCT00549770|616556588|FG001|Overall Study|Administrative problems|1|||
170604000|NCT00549770|616556589|FG002|Overall Study|Administrative problems|0|||
170604001|NCT00549770|616556590|FG003|Overall Study|Administrative problems|0|||
170604002|NCT00549770|616556591|FG004|Overall Study|Administrative problems|0|||
170604003|NCT00549770|616556592|FG005|Overall Study|Administrative problems|0|||
170604004|NCT00549770|616556593|FG006|Overall Study|Administrative problems|0|||
170604005|NCT00549770|616556594|FG007|Overall Study|Administrative problems|1|||
170604006|NCT00549770|616556587|FG000|Overall Study|Lost to Follow-up|0|||
170604007|NCT00549770|616556588|FG001|Overall Study|Lost to Follow-up|0|||
170604008|NCT00549770|616556589|FG002|Overall Study|Lost to Follow-up|2|||
170604009|NCT00549770|616556590|FG003|Overall Study|Lost to Follow-up|2|||
170604010|NCT00549770|616556591|FG004|Overall Study|Lost to Follow-up|3|||
170813779|NCT02069379|617325972|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
170914262|NCT01097616|617689572|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170914263|NCT01097616|617689573|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
170914264|NCT01097616|617689566|FG000|Optional DB EXT Phase|Adverse Event|0|||
170914265|NCT01097616|617689567|FG001|Optional DB EXT Phase|Adverse Event|7|||
170604011|NCT00549770|616556592|FG005|Overall Study|Lost to Follow-up|2|||
170604012|NCT00549770|616556593|FG006|Overall Study|Lost to Follow-up|0|||
170604013|NCT00549770|616556594|FG007|Overall Study|Lost to Follow-up|0|||
170604014|NCT00549770|616556587|FG000|Overall Study|Withdrawal by Subject|4|||
170604015|NCT00549770|616556588|FG001|Overall Study|Withdrawal by Subject|6|||
170604016|NCT00549770|616556589|FG002|Overall Study|Withdrawal by Subject|4|||
170813780|NCT02069379|617325973|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
170604017|NCT00549770|616556590|FG003|Overall Study|Withdrawal by Subject|5|||
170604018|NCT00549770|616556591|FG004|Overall Study|Withdrawal by Subject|6|||
170604019|NCT00549770|616556592|FG005|Overall Study|Withdrawal by Subject|6|||
170604020|NCT00549770|616556593|FG006|Overall Study|Withdrawal by Subject|4|||
170604021|NCT00549770|616556594|FG007|Overall Study|Withdrawal by Subject|9|||
170604022|NCT00549770|616556587|FG000|Overall Study|Lack of Efficacy|1|||
170604023|NCT00549770|616556588|FG001|Overall Study|Lack of Efficacy|0|||
170604024|NCT00549770|616556589|FG002|Overall Study|Lack of Efficacy|2|||
170604025|NCT00549770|616556590|FG003|Overall Study|Lack of Efficacy|3|||
170604026|NCT00549770|616556591|FG004|Overall Study|Lack of Efficacy|5|||
170604027|NCT00549770|616556592|FG005|Overall Study|Lack of Efficacy|1|||
170604028|NCT00549770|616556593|FG006|Overall Study|Lack of Efficacy|3|||
170604029|NCT00549770|616556594|FG007|Overall Study|Lack of Efficacy|8|||
170604030|NCT00549770|616556587|FG000|Overall Study|Abnormal test procedure results|0|||
170604031|NCT00549770|616556588|FG001|Overall Study|Abnormal test procedure results|0|||
170604032|NCT00549770|616556589|FG002|Overall Study|Abnormal test procedure results|0|||
170604033|NCT00549770|616556590|FG003|Overall Study|Abnormal test procedure results|2|||
170604034|NCT00549770|616556591|FG004|Overall Study|Abnormal test procedure results|0|||
170604035|NCT00549770|616556592|FG005|Overall Study|Abnormal test procedure results|1|||
170604036|NCT00549770|616556593|FG006|Overall Study|Abnormal test procedure results|1|||
170604037|NCT00549770|616556594|FG007|Overall Study|Abnormal test procedure results|1|||
170604038|NCT00549770|616556587|FG000|Overall Study|Abnormal laboratory values|0|||
170604039|NCT00549770|616556588|FG001|Overall Study|Abnormal laboratory values|0|||
170604040|NCT00549770|616556589|FG002|Overall Study|Abnormal laboratory values|0|||
170604041|NCT00549770|616556590|FG003|Overall Study|Abnormal laboratory values|0|||
170604042|NCT00549770|616556591|FG004|Overall Study|Abnormal laboratory values|0|||
170604043|NCT00549770|616556592|FG005|Overall Study|Abnormal laboratory values|1|||
170604044|NCT00549770|616556593|FG006|Overall Study|Abnormal laboratory values|0|||
170604045|NCT00549770|616556594|FG007|Overall Study|Abnormal laboratory values|0|||
170604046|NCT00549770|616556587|FG000|Overall Study|Adverse Event|1|||
170604047|NCT00549770|616556588|FG001|Overall Study|Adverse Event|3|||
170604048|NCT00549770|616556589|FG002|Overall Study|Adverse Event|1|||
170604049|NCT00549770|616556590|FG003|Overall Study|Adverse Event|2|||
170604050|NCT00549770|616556591|FG004|Overall Study|Adverse Event|1|||
170604051|NCT00549770|616556592|FG005|Overall Study|Adverse Event|0|||
170604052|NCT00549770|616556593|FG006|Overall Study|Adverse Event|5|||
170604053|NCT00549770|616556594|FG007|Overall Study|Adverse Event|4|||
170604054|NCT04856904|616556597|FG000|Overall Study|Physician Decision|1|||
170604055|NCT04856904|616556598|FG001|Overall Study|Physician Decision|1|||
170604056|NCT04856904|616556597|FG000|Overall Study|Withdrawal by Subject|13|||
170604057|NCT04856904|616556598|FG001|Overall Study|Withdrawal by Subject|13|||
170604058|NCT04856904|616556597|FG000|Overall Study|Adverse Event|1|||
170604059|NCT04856904|616556598|FG001|Overall Study|Adverse Event|1|||
170604060|NCT04856904|616556597|FG000|Overall Study|Non-compliance with study drug|1|||
170604061|NCT04856904|616556598|FG001|Overall Study|Non-compliance with study drug|1|||
170604062|NCT04856904|616556597|FG000|Overall Study|Lost to Follow-up|4|||
170604063|NCT04856904|616556598|FG001|Overall Study|Lost to Follow-up|4|||
170604064|NCT04856904|616556597|FG000|Overall Study|Withdrawal by Subject|1|||
170604065|NCT04856904|616556598|FG001|Overall Study|Withdrawal by Subject|1|||
170604066|NCT04856904|616556597|FG000|Overall Study|Protocol Violation|1|||
170604067|NCT04856904|616556598|FG001|Overall Study|Protocol Violation|1|||
170604068|NCT01641822|616556599|FG000|Run-in Phase|Noncompliance with study drug|1|||
170604069|NCT01641822|616556600|FG001|Run-in Phase|Noncompliance with study drug|0|||
170604070|NCT01641822|616556601|FG002|Run-in Phase|Noncompliance with study drug|0|||
170604071|NCT01641822|616556599|FG000|Run-in Phase|Adverse Event|3|||
170604072|NCT01641822|616556600|FG001|Run-in Phase|Adverse Event|0|||
170604073|NCT01641822|616556601|FG002|Run-in Phase|Adverse Event|0|||
170604074|NCT01641822|616556599|FG000|Run-in Phase|Withdrew consent|1|||
170604075|NCT01641822|616556600|FG001|Run-in Phase|Withdrew consent|0|||
170604076|NCT01641822|616556601|FG002|Run-in Phase|Withdrew consent|0|||
170604077|NCT01641822|616556599|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
170604078|NCT01641822|616556600|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
170813781|NCT02069379|617325970|FG000|Second Treatment Arm|Lost to Follow-up|0|||
170813782|NCT02069379|617325971|FG001|Second Treatment Arm|Lost to Follow-up|0|||
170813783|NCT02069379|617325972|FG002|Second Treatment Arm|Lost to Follow-up|1|||
170813784|NCT02069379|617325973|FG003|Second Treatment Arm|Lost to Follow-up|0|||
170813785|NCT00274287|617325976|FG000|Overall Study|Withdrawal by Subject|1|||
170813786|NCT00274287|617325976|FG000|Overall Study|subject non-compliance|1|||
170813787|NCT04617847|617325977|FG000|Overall Study|Withdrawal by Subject|1|||
170813788|NCT04617847|617325978|FG001|Overall Study|Withdrawal by Subject|0|||
170813789|NCT04617847|617325977|FG000|Overall Study|Adverse Event|0|||
170813790|NCT04617847|617325978|FG001|Overall Study|Adverse Event|2|||
170813791|NCT04617847|617325977|FG000|Overall Study|Death|0|||
170813792|NCT04617847|617325978|FG001|Overall Study|Death|1|||
170604079|NCT01641822|616556601|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
170604080|NCT01641822|616556599|FG000|Comparative Phase|Noncompliance with study drug|0|||
170604081|NCT01641822|616556600|FG001|Comparative Phase|Noncompliance with study drug|1|||
170652376|NCT03675321|616741595|FG000|Overall Study|Lack of Efficacy|2|||
170813793|NCT04617847|617325977|FG000|Overall Study|Termination of Study by Sponsor|2|||
170813794|NCT04617847|617325978|FG001|Overall Study|Termination of Study by Sponsor|21|||
170914266|NCT01097616|617689568|FG002|Optional DB EXT Phase|Adverse Event|2|||
170604082|NCT01641822|616556601|FG002|Comparative Phase|Noncompliance with study drug|0|||
170604083|NCT01641822|616556599|FG000|Comparative Phase|Investigator's discretion|0|||
170604084|NCT01641822|616556600|FG001|Comparative Phase|Investigator's discretion|0|||
170604085|NCT01641822|616556601|FG002|Comparative Phase|Investigator's discretion|1|||
170604086|NCT01641822|616556599|FG000|Comparative Phase|Pregnancy|0|||
170604087|NCT01641822|616556600|FG001|Comparative Phase|Pregnancy|0|||
170604088|NCT01641822|616556601|FG002|Comparative Phase|Pregnancy|1|||
170604089|NCT01641822|616556599|FG000|Comparative Phase|Adverse event, serious fatal|0|||
170604090|NCT01641822|616556600|FG001|Comparative Phase|Adverse event, serious fatal|1|||
170652377|NCT03675321|616741596|FG001|Overall Study|Lack of Efficacy|2|||
170652378|NCT03675321|616741595|FG000|Overall Study|Withdrawal by Subject|1|||
170652379|NCT03675321|616741596|FG001|Overall Study|Withdrawal by Subject|3|||
170652380|NCT05028361|616741599|FG000|Overall Study|Withdrawal by Subject|1|||
170652381|NCT05028361|616741600|FG001|Overall Study|Withdrawal by Subject|0|||
170652382|NCT02195687|616741601|FG000|Overall Study|Personal Reasons|1|||
170652383|NCT02195687|616741602|FG001|Overall Study|Personal Reasons|1|||
170652384|NCT02195687|616741601|FG000|Overall Study|Lost to Follow-up|4|||
170652385|NCT02195687|616741602|FG001|Overall Study|Lost to Follow-up|1|||
170652386|NCT00779259|616741603|FG000|Quinine Alone|Adverse Event|2|||
170652387|NCT00924781|616741604|FG000|Overall Study|Study terminated by sponsor|12|||
170652388|NCT00924781|616741605|FG001|Overall Study|Study terminated by sponsor|10|||
170652389|NCT01479985|616741606|FG000|Overall Study|Tablet malfunction, no data saved|1|||
170652390|NCT01479985|616741607|FG001|Overall Study|Tablet malfunction, no data saved|1|||
170652391|NCT01479985|616741606|FG000|Overall Study|No decisional conflict scale responses|0|||
170652392|NCT01479985|616741607|FG001|Overall Study|No decisional conflict scale responses|2|||
170652393|NCT01479985|616741606|FG000|Overall Study|No post-visit survey|5|||
170652394|NCT01479985|616741607|FG001|Overall Study|No post-visit survey|3|||
170652395|NCT00761748|616741613|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
170652396|NCT00761748|616741614|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
170652397|NCT00761748|616741613|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
170652398|NCT00761748|616741614|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
170652399|NCT01155479|616741617|FG000|Part I|Adverse Event|13|||
170652400|NCT01155479|616741618|FG001|Part I|Adverse Event|8|||
170652401|NCT01155479|616741619|FG002|Part I|Adverse Event|18|||
170652402|NCT01155479|616741620|FG003|Part I|Adverse Event|7|||
170652403|NCT01155479|616741621|FG004|Part I|Adverse Event|6|||
170652404|NCT01155479|616741617|FG000|Part I|Administrative|2|||
170652405|NCT01155479|616741618|FG001|Part I|Administrative|2|||
170652406|NCT01155479|616741619|FG002|Part I|Administrative|2|||
170652407|NCT01155479|616741620|FG003|Part I|Administrative|0|||
170652408|NCT01155479|616741621|FG004|Part I|Administrative|0|||
170652409|NCT01155479|616741617|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
170652410|NCT01155479|616741618|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
170652411|NCT01155479|616741619|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
170652412|NCT01155479|616741620|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
170652413|NCT01155479|616741621|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
170652414|NCT01155479|616741617|FG000|Part I|Withdrawal by Subject|11|||
170652415|NCT01155479|616741618|FG001|Part I|Withdrawal by Subject|13|||
170652416|NCT01155479|616741619|FG002|Part I|Withdrawal by Subject|8|||
170652417|NCT01155479|616741620|FG003|Part I|Withdrawal by Subject|8|||
170652418|NCT01155479|616741621|FG004|Part I|Withdrawal by Subject|9|||
170652419|NCT01155479|616741617|FG000|Part I|Lost to Follow-up|0|||
170652420|NCT01155479|616741618|FG001|Part I|Lost to Follow-up|0|||
170652421|NCT01155479|616741619|FG002|Part I|Lost to Follow-up|1|||
170652422|NCT01155479|616741620|FG003|Part I|Lost to Follow-up|1|||
170652423|NCT01155479|616741621|FG004|Part I|Lost to Follow-up|0|||
170813795|NCT01525875|617325979|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
170813796|NCT01525875|617325980|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
170813797|NCT01525875|617325979|FG000|Open-label Period|Lost to Follow-up|0|||
170813798|NCT01525875|617325980|FG001|Open-label Period|Lost to Follow-up|2|||
170813799|NCT02379078|617325981|FG000|Overall Study|Lost to Follow-up|33|||
170813800|NCT02379078|617325982|FG001|Overall Study|Lost to Follow-up|30|||
170813801|NCT02379078|617325981|FG000|Overall Study|Withdrawal by Subject|6|||
170813802|NCT02379078|617325982|FG001|Overall Study|Withdrawal by Subject|5|||
170813803|NCT00761267|617325983|FG000|Overall Study|Death|1|||
170604091|NCT01641822|616556601|FG002|Comparative Phase|Adverse event, serious fatal|0|||
170604092|NCT01641822|616556599|FG000|Comparative Phase|Withdrew consent|0|||
170604093|NCT01641822|616556600|FG001|Comparative Phase|Withdrew consent|3|||
170652424|NCT01155479|616741617|FG000|Part I|Treatment Failure|3|||
170652425|NCT01155479|616741618|FG001|Part I|Treatment Failure|0|||
170652426|NCT01155479|616741619|FG002|Part I|Treatment Failure|3|||
170652427|NCT01155479|616741620|FG003|Part I|Treatment Failure|1|||
170652428|NCT01155479|616741621|FG004|Part I|Treatment Failure|2|||
170652429|NCT01155479|616741617|FG000|Part I|Did Not Receive Treatment|4|||
170652430|NCT01155479|616741618|FG001|Part I|Did Not Receive Treatment|2|||
170604094|NCT01641822|616556601|FG002|Comparative Phase|Withdrew consent|7|||
170652431|NCT01155479|616741619|FG002|Part I|Did Not Receive Treatment|2|||
170652432|NCT01155479|616741620|FG003|Part I|Did Not Receive Treatment|6|||
170604095|NCT01641822|616556599|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
170604096|NCT01641822|616556600|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
170604097|NCT01641822|616556601|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
170604098|NCT00454584|616556602|FG000|Controlled Period|Adverse Event|5|||
170604099|NCT00454584|616556603|FG001|Controlled Period|Adverse Event|2|||
170604100|NCT00454584|616556604|FG002|Controlled Period|Adverse Event|1|||
170604101|NCT00454584|616556605|FG003|Controlled Period|Adverse Event|0|||
170604102|NCT00454584|616556606|FG004|Controlled Period|Adverse Event|0|||
170604103|NCT00454584|616556607|FG005|Controlled Period|Adverse Event|0|||
170604104|NCT00454584|616556602|FG000|Controlled Period|Lost to Follow-up|1|||
170604105|NCT00454584|616556603|FG001|Controlled Period|Lost to Follow-up|2|||
170604106|NCT00454584|616556604|FG002|Controlled Period|Lost to Follow-up|2|||
170604107|NCT00454584|616556605|FG003|Controlled Period|Lost to Follow-up|0|||
170604108|NCT00454584|616556606|FG004|Controlled Period|Lost to Follow-up|0|||
170604109|NCT00454584|616556607|FG005|Controlled Period|Lost to Follow-up|0|||
170604110|NCT00454584|616556602|FG000|Controlled Period|Other|5|||
170604111|NCT00454584|616556603|FG001|Controlled Period|Other|4|||
170604112|NCT00454584|616556604|FG002|Controlled Period|Other|2|||
170604113|NCT00454584|616556605|FG003|Controlled Period|Other|0|||
170604114|NCT00454584|616556606|FG004|Controlled Period|Other|0|||
170604115|NCT00454584|616556607|FG005|Controlled Period|Other|0|||
170604116|NCT00454584|616556602|FG000|After Controlled Period|Adverse Event|0|||
170604117|NCT00454584|616556603|FG001|After Controlled Period|Adverse Event|0|||
170604118|NCT00454584|616556604|FG002|After Controlled Period|Adverse Event|0|||
170604119|NCT00454584|616556605|FG003|After Controlled Period|Adverse Event|9|||
170604120|NCT00454584|616556606|FG004|After Controlled Period|Adverse Event|3|||
170604121|NCT00454584|616556607|FG005|After Controlled Period|Adverse Event|9|||
170604122|NCT00454584|616556602|FG000|After Controlled Period|Lack of Efficacy|0|||
170604123|NCT00454584|616556603|FG001|After Controlled Period|Lack of Efficacy|0|||
170604124|NCT00454584|616556604|FG002|After Controlled Period|Lack of Efficacy|0|||
170604125|NCT00454584|616556605|FG003|After Controlled Period|Lack of Efficacy|1|||
170604126|NCT00454584|616556606|FG004|After Controlled Period|Lack of Efficacy|0|||
170604127|NCT00454584|616556607|FG005|After Controlled Period|Lack of Efficacy|0|||
170604128|NCT00454584|616556602|FG000|After Controlled Period|Lost to Follow-up|0|||
170604129|NCT00454584|616556603|FG001|After Controlled Period|Lost to Follow-up|0|||
170604130|NCT00454584|616556604|FG002|After Controlled Period|Lost to Follow-up|0|||
170604131|NCT00454584|616556605|FG003|After Controlled Period|Lost to Follow-up|2|||
170604132|NCT00454584|616556606|FG004|After Controlled Period|Lost to Follow-up|4|||
170604133|NCT00454584|616556607|FG005|After Controlled Period|Lost to Follow-up|6|||
170604134|NCT00454584|616556602|FG000|After Controlled Period|Other|0|||
170604135|NCT00454584|616556603|FG001|After Controlled Period|Other|0|||
170604136|NCT00454584|616556604|FG002|After Controlled Period|Other|0|||
170604137|NCT00454584|616556605|FG003|After Controlled Period|Other|1|||
170604138|NCT00454584|616556606|FG004|After Controlled Period|Other|0|||
170604139|NCT00454584|616556607|FG005|After Controlled Period|Other|0|||
170604140|NCT00454584|616556602|FG000|After Controlled Period|Other|0|||
170604141|NCT00454584|616556603|FG001|After Controlled Period|Other|0|||
170604142|NCT00454584|616556604|FG002|After Controlled Period|Other|0|||
170604143|NCT00454584|616556605|FG003|After Controlled Period|Other|13|||
170604144|NCT00454584|616556606|FG004|After Controlled Period|Other|5|||
170604145|NCT00454584|616556607|FG005|After Controlled Period|Other|17|||
170604146|NCT02421601|616556608|FG000|Overall Study|Adverse Event|4|||
170604147|NCT02421601|616556608|FG000|Overall Study|Lack of Efficacy|5|||
170604148|NCT02421601|616556608|FG000|Overall Study|Physician Decision|1|||
170604149|NCT02421601|616556608|FG000|Overall Study|Withdrawal by Subject|31|||
170604150|NCT02421601|616556608|FG000|Overall Study|Others|41|||
170604151|NCT00290498|616556609|FG000|Overall Study|Death|2|||
170604152|NCT00290498|616556610|FG001|Overall Study|Death|0|||
170604153|NCT00290498|616556609|FG000|Overall Study|Physician Decision|1|||
170604154|NCT00290498|616556610|FG001|Overall Study|Physician Decision|0|||
170604155|NCT00290498|616556609|FG000|Overall Study|Withdrawal by Subject|1|||
170604156|NCT00290498|616556610|FG001|Overall Study|Withdrawal by Subject|0|||
170604157|NCT00290498|616556609|FG000|Overall Study|Ineligible|3|||
170604158|NCT00290498|616556610|FG001|Overall Study|Ineligible|0|||
170604159|NCT00290498|616556609|FG000|Overall Study|Non-Compliance|1|||
170604160|NCT00290498|616556610|FG001|Overall Study|Non-Compliance|0|||
170604161|NCT02250664|616556613|FG000|Overall Study|Lost to Follow-up|18|||
170604162|NCT02250664|616556614|FG001|Overall Study|Lost to Follow-up|28|||
170604163|NCT02250664|616556615|FG002|Overall Study|Lost to Follow-up|33|||
170604164|NCT02250664|616556613|FG000|Overall Study|Personal Reasons|7|||
170604165|NCT02250664|616556614|FG001|Overall Study|Personal Reasons|8|||
170604166|NCT02250664|616556615|FG002|Overall Study|Personal Reasons|14|||
170604167|NCT02250664|616556613|FG000|Overall Study|Adverse Event|6|||
170604168|NCT02250664|616556614|FG001|Overall Study|Adverse Event|3|||
170604169|NCT02250664|616556615|FG002|Overall Study|Adverse Event|8|||
170604170|NCT02250664|616556613|FG000|Overall Study|Incarcerated|2|||
170604171|NCT02250664|616556614|FG001|Overall Study|Incarcerated|1|||
170604172|NCT02250664|616556615|FG002|Overall Study|Incarcerated|2|||
170604173|NCT02250664|616556613|FG000|Overall Study|Withdrawal by Subject|0|||
170604174|NCT02250664|616556614|FG001|Overall Study|Withdrawal by Subject|1|||
170604175|NCT02250664|616556615|FG002|Overall Study|Withdrawal by Subject|2|||
170604176|NCT02250664|616556613|FG000|Overall Study|Death|0|||
170604177|NCT02250664|616556614|FG001|Overall Study|Death|1|||
170604178|NCT02250664|616556615|FG002|Overall Study|Death|1|||
170604179|NCT02250664|616556613|FG000|Overall Study|Physician Decision|1|||
170604180|NCT02250664|616556614|FG001|Overall Study|Physician Decision|3|||
170604181|NCT02250664|616556615|FG002|Overall Study|Physician Decision|1|||
170604182|NCT02250664|616556613|FG000|Overall Study|Protocol Violation|1|||
170604183|NCT02250664|616556614|FG001|Overall Study|Protocol Violation|0|||
170604184|NCT02250664|616556615|FG002|Overall Study|Protocol Violation|1|||
170604185|NCT02250664|616556613|FG000|Overall Study|Reason unknown|1|||
170604186|NCT02250664|616556614|FG001|Overall Study|Reason unknown|0|||
170604187|NCT02250664|616556615|FG002|Overall Study|Reason unknown|0|||
170604188|NCT03847909|616556616|FG000|Overall Study|Withdrawal by Subject|1|||
170604189|NCT03847909|616556617|FG001|Overall Study|Withdrawal by Subject|1|||
170604190|NCT00581360|616556619|FG000|Overall Study|Withdrawal by Subject|1|||
170604191|NCT03129360|616556620|FG000|Overall Study|Did not meet entry criteria|0|||
170604192|NCT03129360|616556621|FG001|Overall Study|Did not meet entry criteria|2|||
170604193|NCT03129360|616556622|FG002|Overall Study|Did not meet entry criteria|1|||
170604194|NCT03129360|616556620|FG000|Overall Study|Excluded due to motion in scanner|1|||
170604195|NCT03129360|616556621|FG001|Overall Study|Excluded due to motion in scanner|0|||
170604196|NCT03129360|616556622|FG002|Overall Study|Excluded due to motion in scanner|0|||
170604197|NCT02895945|616556623|FG000|Overall Study|Physician Decision|2|||
170604198|NCT02895945|616556624|FG001|Overall Study|Physician Decision|1|||
170604199|NCT00462748|616556627|FG000|Overall Study|Adverse Event|7|||
170604200|NCT00462748|616556628|FG001|Overall Study|Adverse Event|5|||
170604201|NCT00462748|616556629|FG002|Overall Study|Adverse Event|9|||
170604202|NCT00462748|616556627|FG000|Overall Study|Protocol Violation|0|||
170604203|NCT00462748|616556628|FG001|Overall Study|Protocol Violation|2|||
170604204|NCT00462748|616556629|FG002|Overall Study|Protocol Violation|1|||
170604205|NCT00462748|616556627|FG000|Overall Study|Withdrew consent|3|||
170604206|NCT00462748|616556628|FG001|Overall Study|Withdrew consent|3|||
170604207|NCT00462748|616556629|FG002|Overall Study|Withdrew consent|0|||
170604208|NCT00462748|616556627|FG000|Overall Study|Lost to Follow-up|1|||
170604209|NCT00462748|616556628|FG001|Overall Study|Lost to Follow-up|1|||
170604210|NCT00462748|616556629|FG002|Overall Study|Lost to Follow-up|1|||
170604211|NCT00462748|616556627|FG000|Overall Study|Discontinued after 41 days Rx|1|||
170604212|NCT00462748|616556628|FG001|Overall Study|Discontinued after 41 days Rx|0|||
170604213|NCT00462748|616556629|FG002|Overall Study|Discontinued after 41 days Rx|0|||
170604214|NCT03429543|616556630|FG000|Overall Study|Adverse Event|1|||
170604215|NCT03429543|616556631|FG001|Overall Study|Adverse Event|1|||
170604216|NCT03429543|616556632|FG002|Overall Study|Adverse Event|0|||
170604217|NCT03429543|616556633|FG003|Overall Study|Adverse Event|0|||
170604218|NCT03429543|616556634|FG004|Overall Study|Adverse Event|0|||
170604219|NCT03429543|616556635|FG005|Overall Study|Adverse Event|2|||
170604220|NCT03429543|616556636|FG006|Overall Study|Adverse Event|0|||
170604221|NCT03429543|616556630|FG000|Overall Study|Lost to Follow-up|1|||
170604222|NCT03429543|616556631|FG001|Overall Study|Lost to Follow-up|0|||
170604223|NCT03429543|616556632|FG002|Overall Study|Lost to Follow-up|0|||
170604224|NCT03429543|616556633|FG003|Overall Study|Lost to Follow-up|0|||
170604225|NCT03429543|616556634|FG004|Overall Study|Lost to Follow-up|1|||
170604226|NCT03429543|616556635|FG005|Overall Study|Lost to Follow-up|0|||
170604227|NCT03429543|616556636|FG006|Overall Study|Lost to Follow-up|0|||
170604228|NCT03429543|616556630|FG000|Overall Study|Withdrawal by Subject|5|||
170652433|NCT01155479|616741621|FG004|Part I|Did Not Receive Treatment|1|||
170652434|NCT01155479|616741617|FG000|Part I|Non-Compliance with Protocol|2|||
170813804|NCT00761267|617325984|FG001|Overall Study|Death|2|||
170813805|NCT00761267|617325985|FG002|Overall Study|Death|5|||
170813806|NCT00761267|617325983|FG000|Overall Study|Lost to Follow-up|0|||
170604229|NCT03429543|616556631|FG001|Overall Study|Withdrawal by Subject|0|||
170652435|NCT01155479|616741618|FG001|Part I|Non-Compliance with Protocol|1|||
170652436|NCT01155479|616741619|FG002|Part I|Non-Compliance with Protocol|3|||
170652437|NCT01155479|616741620|FG003|Part I|Non-Compliance with Protocol|3|||
170652438|NCT01155479|616741621|FG004|Part I|Non-Compliance with Protocol|2|||
170652439|NCT01155479|616741617|FG000|Part II|Adverse Event|7|||
170813807|NCT00761267|617325984|FG001|Overall Study|Lost to Follow-up|0|||
170604230|NCT03429543|616556632|FG002|Overall Study|Withdrawal by Subject|1|||
170604231|NCT03429543|616556633|FG003|Overall Study|Withdrawal by Subject|2|||
170604232|NCT03429543|616556634|FG004|Overall Study|Withdrawal by Subject|6|||
170604233|NCT03429543|616556635|FG005|Overall Study|Withdrawal by Subject|3|||
170604234|NCT03429543|616556636|FG006|Overall Study|Withdrawal by Subject|1|||
170604235|NCT03429543|616556630|FG000|Overall Study|Other reason than listed|0|||
170604236|NCT03429543|616556631|FG001|Overall Study|Other reason than listed|1|||
170604237|NCT03429543|616556632|FG002|Overall Study|Other reason than listed|0|||
170604238|NCT03429543|616556633|FG003|Overall Study|Other reason than listed|0|||
170604239|NCT03429543|616556634|FG004|Overall Study|Other reason than listed|4|||
170604240|NCT03429543|616556635|FG005|Overall Study|Other reason than listed|4|||
170813808|NCT00761267|617325985|FG002|Overall Study|Lost to Follow-up|1|||
170652440|NCT01155479|616741618|FG001|Part II|Adverse Event|6|||
170652441|NCT01155479|616741619|FG002|Part II|Adverse Event|8|||
170652442|NCT01155479|616741620|FG003|Part II|Adverse Event|3|||
170652443|NCT01155479|616741621|FG004|Part II|Adverse Event|4|||
170652444|NCT01155479|616741617|FG000|Part II|Administrative|43|||
170652445|NCT01155479|616741618|FG001|Part II|Administrative|49|||
170652446|NCT01155479|616741619|FG002|Part II|Administrative|36|||
170652447|NCT01155479|616741620|FG003|Part II|Administrative|38|||
170652448|NCT01155479|616741621|FG004|Part II|Administrative|46|||
170652449|NCT01155479|616741617|FG000|Part II|Withdrawal by Subject|8|||
170652450|NCT01155479|616741618|FG001|Part II|Withdrawal by Subject|4|||
170652451|NCT01155479|616741619|FG002|Part II|Withdrawal by Subject|12|||
170652452|NCT01155479|616741620|FG003|Part II|Withdrawal by Subject|7|||
170652453|NCT01155479|616741621|FG004|Part II|Withdrawal by Subject|3|||
170652454|NCT01155479|616741617|FG000|Part II|Lost to Follow-up|1|||
170652455|NCT01155479|616741618|FG001|Part II|Lost to Follow-up|0|||
170652456|NCT01155479|616741619|FG002|Part II|Lost to Follow-up|0|||
170652457|NCT01155479|616741620|FG003|Part II|Lost to Follow-up|0|||
170652458|NCT01155479|616741621|FG004|Part II|Lost to Follow-up|1|||
170652459|NCT01155479|616741617|FG000|Part II|Treatment Failure|0|||
170652460|NCT01155479|616741618|FG001|Part II|Treatment Failure|1|||
170652461|NCT01155479|616741619|FG002|Part II|Treatment Failure|2|||
170652462|NCT01155479|616741620|FG003|Part II|Treatment Failure|0|||
170652463|NCT01155479|616741621|FG004|Part II|Treatment Failure|1|||
170652464|NCT01155479|616741617|FG000|Part II|Non-Compliance with Protocol|0|||
170652465|NCT01155479|616741618|FG001|Part II|Non-Compliance with Protocol|1|||
170652466|NCT01155479|616741619|FG002|Part II|Non-Compliance with Protocol|0|||
170652467|NCT01155479|616741620|FG003|Part II|Non-Compliance with Protocol|2|||
170652468|NCT01155479|616741621|FG004|Part II|Non-Compliance with Protocol|0|||
170652469|NCT02360605|616741622|FG000|Overall Study|Withdrawal by Subject|4|||
170652470|NCT02360605|616741623|FG001|Overall Study|Withdrawal by Subject|9|||
170652471|NCT02360605|616741622|FG000|Overall Study|Lost to Follow-up|7|||
170652472|NCT02360605|616741623|FG001|Overall Study|Lost to Follow-up|8|||
170652473|NCT02360605|616741622|FG000|Overall Study|Death|0|||
170652474|NCT02360605|616741623|FG001|Overall Study|Death|1|||
170652475|NCT00998764|616741624|FG000|Overall Study|Lack of Efficacy|3|||
170813809|NCT00761267|617325983|FG000|Overall Study|Randomized but not treated|1|||
170813810|NCT00761267|617325984|FG001|Overall Study|Randomized but not treated|1|||
170813811|NCT00761267|617325985|FG002|Overall Study|Randomized but not treated|0|||
170813812|NCT00761267|617325983|FG000|Overall Study|Withdrawal by Subject|0|||
170813813|NCT00761267|617325984|FG001|Overall Study|Withdrawal by Subject|1|||
170813814|NCT00761267|617325985|FG002|Overall Study|Withdrawal by Subject|0|||
170813815|NCT01419184|617325986|FG000|Overall Study|Site data not available|3|||
170813816|NCT01419184|617325987|FG001|Overall Study|Site data not available|2|||
170813817|NCT01419184|617325986|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
170813818|NCT01419184|617325987|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
170604241|NCT03429543|616556636|FG006|Overall Study|Other reason than listed|0|||
170604242|NCT03429543|616556630|FG000|Overall Study|Not treated|0|||
170604243|NCT03429543|616556631|FG001|Overall Study|Not treated|0|||
170604244|NCT03429543|616556632|FG002|Overall Study|Not treated|0|||
170604245|NCT03429543|616556633|FG003|Overall Study|Not treated|0|||
170604246|NCT03429543|616556634|FG004|Overall Study|Not treated|1|||
170604247|NCT03429543|616556635|FG005|Overall Study|Not treated|0|||
170604248|NCT03429543|616556636|FG006|Overall Study|Not treated|0|||
170604249|NCT00082381|616556637|FG000|Overall Study|Adverse Event|27|||
170652476|NCT00998764|616741625|FG001|Overall Study|Lack of Efficacy|6|||
170652477|NCT00998764|616741624|FG000|Overall Study|Adverse Event|17|||
170652478|NCT00998764|616741625|FG001|Overall Study|Adverse Event|12|||
170813819|NCT01419184|617325986|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
170813820|NCT01419184|617325987|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
170813821|NCT01419184|617325986|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
170813822|NCT01419184|617325987|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
170813823|NCT01419184|617325986|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
170813824|NCT01419184|617325987|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
170813825|NCT01419184|617325986|FG000|Overall Study|Participant randomized, not treated|1|||
170813826|NCT01419184|617325987|FG001|Overall Study|Participant randomized, not treated|0|||
170813827|NCT03989232|617325988|FG000|Overall Study|Lost to Follow-up|3|||
170652479|NCT00998764|616741624|FG000|Overall Study|Withdrawal by Subject|19|||
170652480|NCT00998764|616741625|FG001|Overall Study|Withdrawal by Subject|25|||
170652481|NCT00998764|616741624|FG000|Overall Study|Physician Decision|3|||
170652482|NCT00998764|616741625|FG001|Overall Study|Physician Decision|3|||
170652483|NCT00998764|616741624|FG000|Overall Study|Death|3|||
170813828|NCT03989232|617325989|FG001|Overall Study|Lost to Follow-up|10|||
170813829|NCT03989232|617325988|FG000|Overall Study|Withdrawal by Subject|6|||
170813830|NCT03989232|617325989|FG001|Overall Study|Withdrawal by Subject|6|||
170604250|NCT00082381|616556638|FG001|Overall Study|Adverse Event|2|||
170652484|NCT00998764|616741625|FG001|Overall Study|Death|1|||
170652485|NCT00998764|616741624|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
170604251|NCT00082381|616556637|FG000|Overall Study|Lost to Follow-up|5|||
170604252|NCT00082381|616556638|FG001|Overall Study|Lost to Follow-up|7|||
170604253|NCT00082381|616556637|FG000|Overall Study|Patient Decision|8|||
170604254|NCT00082381|616556638|FG001|Overall Study|Patient Decision|4|||
170604255|NCT00082381|616556637|FG000|Overall Study|Physician Decision|1|||
170604256|NCT00082381|616556638|FG001|Overall Study|Physician Decision|2|||
170604257|NCT00082381|616556637|FG000|Overall Study|Protocol Violation|10|||
170604258|NCT00082381|616556638|FG001|Overall Study|Protocol Violation|11|||
170604259|NCT00082381|616556637|FG000|Overall Study|Loss of Glucose Control|4|||
170604260|NCT00082381|616556638|FG001|Overall Study|Loss of Glucose Control|0|||
170604261|NCT02428413|616556639|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
170604262|NCT02428413|616556640|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
170604263|NCT02428413|616556639|FG000|Overall Study|Protocol Violation|1|||
170604264|NCT02428413|616556640|FG001|Overall Study|Protocol Violation|2|||
170604265|NCT02428413|616556639|FG000|Overall Study|Case Cancelled|2|||
170604266|NCT02428413|616556640|FG001|Overall Study|Case Cancelled|0|||
170604267|NCT02428413|616556639|FG000|Overall Study|Missed Cases|1|||
170604268|NCT02428413|616556640|FG001|Overall Study|Missed Cases|2|||
170604269|NCT02428413|616556639|FG000|Overall Study|Nurse Refusal|1|||
170604270|NCT02428413|616556640|FG001|Overall Study|Nurse Refusal|0|||
170604271|NCT02345330|616556641|FG000|Overall Study|Death|1|||
170604272|NCT02345330|616556641|FG000|Overall Study|Progressive Disease|2|||
170604273|NCT03178669|616556648|FG000|Overall Study|Adverse Event|4|||
170604274|NCT03178669|616556649|FG001|Overall Study|Adverse Event|1|||
170604275|NCT03178669|616556650|FG002|Overall Study|Adverse Event|4|||
170604276|NCT03178669|616556651|FG003|Overall Study|Adverse Event|2|||
170604277|NCT03178669|616556652|FG004|Overall Study|Adverse Event|2|||
170604278|NCT03178669|616556648|FG000|Overall Study|Lack of Efficacy|0|||
170604279|NCT03178669|616556649|FG001|Overall Study|Lack of Efficacy|0|||
170604280|NCT03178669|616556650|FG002|Overall Study|Lack of Efficacy|2|||
170604281|NCT03178669|616556651|FG003|Overall Study|Lack of Efficacy|0|||
170604282|NCT03178669|616556652|FG004|Overall Study|Lack of Efficacy|1|||
170604283|NCT03178669|616556648|FG000|Overall Study|Physician Decision|0|||
170604284|NCT03178669|616556649|FG001|Overall Study|Physician Decision|0|||
170604285|NCT03178669|616556650|FG002|Overall Study|Physician Decision|0|||
170604286|NCT03178669|616556651|FG003|Overall Study|Physician Decision|0|||
170604287|NCT03178669|616556652|FG004|Overall Study|Physician Decision|1|||
170604288|NCT03178669|616556648|FG000|Overall Study|Withdrawal by Subject|1|||
170604289|NCT03178669|616556649|FG001|Overall Study|Withdrawal by Subject|0|||
170604290|NCT03178669|616556650|FG002|Overall Study|Withdrawal by Subject|1|||
170604291|NCT03178669|616556651|FG003|Overall Study|Withdrawal by Subject|1|||
170604292|NCT03178669|616556652|FG004|Overall Study|Withdrawal by Subject|0|||
170604293|NCT03178669|616556648|FG000|Overall Study|Lost to Follow-up|0|||
170604294|NCT03178669|616556649|FG001|Overall Study|Lost to Follow-up|0|||
170604295|NCT03178669|616556650|FG002|Overall Study|Lost to Follow-up|0|||
170604296|NCT03178669|616556651|FG003|Overall Study|Lost to Follow-up|1|||
170604297|NCT03178669|616556652|FG004|Overall Study|Lost to Follow-up|0|||
170604298|NCT00885482|616556653|FG000|Overall Study|Pregnancy|1|||
170604299|NCT00885482|616556653|FG000|Overall Study|Lack of Efficacy|1|||
170604300|NCT00885482|616556653|FG000|Overall Study|Death|1|||
170604301|NCT00885482|616556653|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
170604302|NCT03332160|616556657|FG000|Overall Study|Withdrawal by Subject|1|||
170604303|NCT03332160|616556658|FG001|Overall Study|Withdrawal by Subject|1|||
170604304|NCT03332160|616556657|FG000|Overall Study|Adverse Event|0|||
170604305|NCT03332160|616556658|FG001|Overall Study|Adverse Event|1|||
170604306|NCT03332160|616556657|FG000|Overall Study|Developed Exclusion Criteria|0|||
170604307|NCT03332160|616556658|FG001|Overall Study|Developed Exclusion Criteria|1|||
170604308|NCT03332160|616556657|FG000|Overall Study|Non-adherence to treatment|0|||
170604309|NCT03332160|616556658|FG001|Overall Study|Non-adherence to treatment|2|||
170604310|NCT00409344|616556659|FG000|Overall Study|no enrollment|0|||
170604311|NCT00409344|616556660|FG001|Overall Study|no enrollment|0|||
170604312|NCT01561963|616556661|FG000|Overall Study|Adverse Event|1|||
170604313|NCT00576576|616556664|FG000|Overall Study|Lost to Follow-up|6|||
170604314|NCT00576576|616556664|FG000|Overall Study|Protocol Violation|1|||
170604315|NCT03135210|616556665|FG000|Overall Study|Death|0|||
170813831|NCT03989232|617325988|FG000|Overall Study|Death|1|||
170813832|NCT03989232|617325989|FG001|Overall Study|Death|2|||
170813833|NCT02574286|617325992|FG000|Overall Study|Adverse Event|3|||
170813834|NCT02574286|617325992|FG000|Overall Study|Withdrawal by Subject|2|||
170813835|NCT02432274|617325996|FG000|Overall Study|Death|2|||
170604316|NCT03135210|616556666|FG001|Overall Study|Death|1|||
170604317|NCT00671437|616556669|FG000|Overall Study|Progressive disease before C1 week 8|8|||
170813836|NCT02432274|617325997|FG001|Overall Study|Death|6|||
170813837|NCT02432274|617325998|FG002|Overall Study|Death|7|||
170604318|NCT00671437|616556669|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
170604319|NCT00671437|616556669|FG000|Overall Study|Adverse Event|3|||
170604320|NCT00671437|616556669|FG000|Overall Study|Ineligible post-hoc|1|||
170604321|NCT00410605|616556673|FG000|Overall Study|Adverse Event|12|||
170604322|NCT00410605|616556673|FG000|Overall Study|Physician Decision|3|||
170604323|NCT00410605|616556673|FG000|Overall Study|Withdrawal by Subject|5|||
170604324|NCT00410605|616556673|FG000|Overall Study|Started Non-Protocol Therapy|3|||
170813838|NCT02432274|617325999|FG003|Overall Study|Death|0|||
170604325|NCT00410605|616556673|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
170604326|NCT00410605|616556673|FG000|Overall Study|Transferred to another Institution|1|||
170604327|NCT01887353|616556678|FG000|Overall Study|Study stopped early|4|||
170604328|NCT01887353|616556679|FG001|Overall Study|Study stopped early|3|||
170604329|NCT00915551|616556680|FG000|Overall Study|Withdrawal by Subject|0|||
170604330|NCT00915551|616556681|FG001|Overall Study|Withdrawal by Subject|1|||
170604331|NCT04390841|616556682|FG000|Overall Study|Withdrawal by Subject|2|||
170604332|NCT02540291|616556683|FG000|Overall Study|Death|7|||
170604333|NCT02540291|616556684|FG001|Overall Study|Death|7|||
170604334|NCT02540291|616556685|FG002|Overall Study|Death|5|||
170604335|NCT02540291|616556686|FG003|Overall Study|Death|7|||
170604336|NCT02540291|616556683|FG000|Overall Study|Lost to Follow-up|0|||
170604337|NCT02540291|616556684|FG001|Overall Study|Lost to Follow-up|0|||
170604338|NCT02540291|616556685|FG002|Overall Study|Lost to Follow-up|1|||
170604339|NCT02540291|616556686|FG003|Overall Study|Lost to Follow-up|0|||
170604340|NCT02540291|616556683|FG000|Overall Study|Withdrawal Of Consent|0|||
170604341|NCT02540291|616556684|FG001|Overall Study|Withdrawal Of Consent|1|||
170604342|NCT02540291|616556685|FG002|Overall Study|Withdrawal Of Consent|0|||
170604343|NCT02540291|616556686|FG003|Overall Study|Withdrawal Of Consent|0|||
170604344|NCT02540291|616556683|FG000|Overall Study|Study Terminated By Sponsor|1|||
170604345|NCT02540291|616556684|FG001|Overall Study|Study Terminated By Sponsor|0|||
170604346|NCT02540291|616556685|FG002|Overall Study|Study Terminated By Sponsor|0|||
170604347|NCT02540291|616556686|FG003|Overall Study|Study Terminated By Sponsor|0|||
170604348|NCT02540291|616556683|FG000|Overall Study|Other|0|||
170604349|NCT02540291|616556684|FG001|Overall Study|Other|0|||
170604350|NCT02540291|616556685|FG002|Overall Study|Other|1|||
170604351|NCT02540291|616556686|FG003|Overall Study|Other|0|||
170604352|NCT02262754|616556700|FG000|Overall Study|Adverse Event|3|||
170604353|NCT02262754|616556701|FG001|Overall Study|Adverse Event|4|||
170604354|NCT02262754|616556702|FG002|Overall Study|Adverse Event|0|||
170604355|NCT02262754|616556700|FG000|Overall Study|Lack of Efficacy|2|||
170604356|NCT02262754|616556701|FG001|Overall Study|Lack of Efficacy|0|||
170604357|NCT02262754|616556702|FG002|Overall Study|Lack of Efficacy|1|||
170604358|NCT02262754|616556700|FG000|Overall Study|Lost to Follow-up|0|||
170604359|NCT02262754|616556701|FG001|Overall Study|Lost to Follow-up|0|||
170604360|NCT02262754|616556702|FG002|Overall Study|Lost to Follow-up|1|||
170604361|NCT02262754|616556700|FG000|Overall Study|No longer meets eligibility criteria|0|||
170604362|NCT02262754|616556701|FG001|Overall Study|No longer meets eligibility criteria|1|||
170604363|NCT02262754|616556702|FG002|Overall Study|No longer meets eligibility criteria|0|||
170604364|NCT02262754|616556700|FG000|Overall Study|Study terminated by sponsor|5|||
170604365|NCT02262754|616556701|FG001|Overall Study|Study terminated by sponsor|4|||
170604366|NCT02262754|616556702|FG002|Overall Study|Study terminated by sponsor|4|||
170604367|NCT02262754|616556700|FG000|Overall Study|Protocol Violation|1|||
170604368|NCT02262754|616556701|FG001|Overall Study|Protocol Violation|0|||
170604369|NCT02262754|616556702|FG002|Overall Study|Protocol Violation|0|||
170604370|NCT02262754|616556700|FG000|Overall Study|Withdrawal by Subject|1|||
170604371|NCT02262754|616556701|FG001|Overall Study|Withdrawal by Subject|0|||
170604372|NCT02262754|616556702|FG002|Overall Study|Withdrawal by Subject|1|||
170604373|NCT02262754|616556700|FG000|Overall Study|Other|4|||
170604374|NCT02262754|616556701|FG001|Overall Study|Other|0|||
170604375|NCT02262754|616556702|FG002|Overall Study|Other|2|||
170604376|NCT01299116|616556704|FG000|Overall Study|Lost to Follow-up|65|||
170604377|NCT01299116|616556705|FG001|Overall Study|Lost to Follow-up|9|||
170604378|NCT01299116|616556706|FG002|Overall Study|Lost to Follow-up|11|||
170604379|NCT01114438|616556709|FG000|Overall Study|Adverse Event|10|||
170604380|NCT01114438|616556709|FG000|Overall Study|concomitant medication|1|||
170604381|NCT01114438|616556709|FG000|Overall Study|Physician Decision|1|||
170604382|NCT01114438|616556709|FG000|Overall Study|Withdrawal by Subject|2|||
170604383|NCT02725866|616556714|FG000|Overall Study|Failure to return|6|||
170604384|NCT02725866|616556714|FG000|Overall Study|Withdrew consent|3|||
170604385|NCT02725866|616556714|FG000|Overall Study|Insufficient virological response|1|||
170604386|NCT02725866|616556714|FG000|Overall Study|Other, not specified|4|||
170604387|NCT01726582|616558240|FG000|Overall Study|Physician Decision|99|||
170604388|NCT01726582|616558240|FG000|Overall Study|Death|85|||
170604389|NCT05138419|616558241|FG000|Overall Study|Study terminated before participant completed.|0|||
170604390|NCT05138419|616558242|FG001|Overall Study|Study terminated before participant completed.|0|||
170604391|NCT05138419|616558243|FG002|Overall Study|Study terminated before participant completed.|1|||
170604392|NCT01048853|616558244|FG000|Overall Study|Death|1|||
170604393|NCT01048853|616558245|FG001|Overall Study|Death|0|||
170604394|NCT01048853|616558246|FG002|Overall Study|Death|0|||
170604395|NCT01048853|616558244|FG000|Overall Study|Lost to Follow-up|1|||
170604396|NCT01048853|616558245|FG001|Overall Study|Lost to Follow-up|4|||
170604397|NCT01048853|616558246|FG002|Overall Study|Lost to Follow-up|0|||
170604398|NCT04099511|616558247|FG000|Overall Study|Lost to Follow-up|2|||
170604399|NCT04099511|616558248|FG001|Overall Study|Lost to Follow-up|2|||
170813839|NCT02432274|617326000|FG004|Overall Study|Death|27|||
170604400|NCT04099511|616558247|FG000|Overall Study|Withdrawal by Subject|8|||
170604401|NCT04099511|616558248|FG001|Overall Study|Withdrawal by Subject|4|||
170604402|NCT05451940|616558252|FG000|Treatment Period|Physician Decision|1|||
170604403|NCT04302545|616558253|FG000|Overall Study|Lost to Follow-up|3|||
170604404|NCT04302545|616558254|FG001|Overall Study|Lost to Follow-up|4|||
170604405|NCT06045507|616558255|FG000|Overall Study|Death|0|||
170604406|NCT06045507|616558256|FG001|Overall Study|Death|0|||
170604407|NCT06045507|616558257|FG002|Overall Study|Death|1|||
170604408|NCT06045507|616558258|FG003|Overall Study|Death|0|||
170604409|NCT06045507|616558255|FG000|Overall Study|Lost to Follow-up|3|||
170604410|NCT06045507|616558256|FG001|Overall Study|Lost to Follow-up|3|||
170604411|NCT06045507|616558257|FG002|Overall Study|Lost to Follow-up|0|||
170604412|NCT06045507|616558258|FG003|Overall Study|Lost to Follow-up|0|||
170604413|NCT06045507|616558255|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
170604414|NCT06045507|616558256|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
170604415|NCT06045507|616558257|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
170604416|NCT06045507|616558258|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
170604417|NCT06045507|616558255|FG000|Overall Study|Withdrawal by Subject|4|||
170604418|NCT06045507|616558256|FG001|Overall Study|Withdrawal by Subject|1|||
170604419|NCT06045507|616558257|FG002|Overall Study|Withdrawal by Subject|0|||
170604420|NCT06045507|616558258|FG003|Overall Study|Withdrawal by Subject|2|||
170604421|NCT06045507|616558255|FG000|Overall Study|Miscellaneous|2|||
170604422|NCT06045507|616558256|FG001|Overall Study|Miscellaneous|0|||
170604423|NCT06045507|616558257|FG002|Overall Study|Miscellaneous|0|||
170604424|NCT06045507|616558258|FG003|Overall Study|Miscellaneous|1|||
170604425|NCT01966445|616558260|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
170604426|NCT01966445|616558261|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
170604427|NCT01966445|616558262|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
170604428|NCT01966445|616558263|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
170604429|NCT01966445|616558264|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
170604430|NCT01966445|616558265|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
170604431|NCT01966445|616558266|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
170604432|NCT01966445|616558260|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
170604433|NCT01966445|616558261|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
170604434|NCT01966445|616558262|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
170604435|NCT01966445|616558263|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
170604436|NCT01966445|616558264|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
170604437|NCT01966445|616558265|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
170604438|NCT01966445|616558266|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
170604439|NCT01966445|616558260|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
170604440|NCT01966445|616558261|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
170604441|NCT01966445|616558262|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
170604442|NCT01966445|616558263|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
170604443|NCT01966445|616558264|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
170604444|NCT01966445|616558265|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
170604445|NCT01966445|616558266|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
170604446|NCT01966445|616558260|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
170604447|NCT01966445|616558261|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
170604448|NCT01966445|616558262|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
170604449|NCT01966445|616558263|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
170604450|NCT01966445|616558264|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
170604451|NCT01966445|616558265|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
170604452|NCT01966445|616558266|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
170604453|NCT01966445|616558260|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
170604454|NCT01966445|616558261|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
170604455|NCT01966445|616558262|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
170604456|NCT01966445|616558263|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
170604457|NCT01966445|616558264|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
170604458|NCT01966445|616558265|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
170604459|NCT01966445|616558266|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
170604460|NCT01374178|616558267|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
170604461|NCT01374178|616558268|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
170604462|NCT01374178|616558267|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
170604463|NCT01374178|616558268|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
170604464|NCT01422824|616558269|FG000|Overall Study|Case record form not evaluated|1|||
170604465|NCT01422824|616558269|FG000|Overall Study|Lost to Follow-up|37|||
170604466|NCT00847015|616558270|FG000|Overall Study|Withdrawal by Subject|1|||
170604467|NCT00847015|616558270|FG000|Overall Study|declined any surgery|1|||
170604468|NCT00847015|616558270|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
170604469|NCT00902174|616558271|FG000|Overall Study|Adverse Event|27|||
170604470|NCT00902174|616558272|FG001|Overall Study|Adverse Event|7|||
170604471|NCT00902174|616558271|FG000|Overall Study|Lack of Efficacy|1|||
170604472|NCT00902174|616558272|FG001|Overall Study|Lack of Efficacy|5|||
170604473|NCT00902174|616558271|FG000|Overall Study|Death|2|||
170604474|NCT00902174|616558272|FG001|Overall Study|Death|2|||
170604475|NCT00902174|616558271|FG000|Overall Study|Withdrawal by Subject|2|||
170604476|NCT00902174|616558272|FG001|Overall Study|Withdrawal by Subject|1|||
170604477|NCT00902174|616558271|FG000|Overall Study|Abnormal labs|1|||
170604478|NCT00902174|616558272|FG001|Overall Study|Abnormal labs|1|||
170604479|NCT00902174|616558271|FG000|Overall Study|Protocol Violation|1|||
170604480|NCT00902174|616558272|FG001|Overall Study|Protocol Violation|1|||
170604481|NCT00902174|616558271|FG000|Overall Study|Administration problem|0|||
170604482|NCT00902174|616558272|FG001|Overall Study|Administration problem|1|||
170604483|NCT02760810|616558273|FG000|Overall Study|Protocol Violation|1|||
170604484|NCT00117793|616558274|FG000|Overall Study|Withdrawal by Subject|12|||
170604485|NCT00490022|616558275|FG000|Overall Study|Adverse Event|0|||
170604486|NCT00490022|616558276|FG001|Overall Study|Adverse Event|2|||
170604487|NCT00490022|616558275|FG000|Overall Study|Withdrawal by Subject|1|||
170604488|NCT00490022|616558276|FG001|Overall Study|Withdrawal by Subject|0|||
170604489|NCT00490022|616558275|FG000|Overall Study|Subject failed to disclose concommitant|0|||
170604490|NCT00490022|616558276|FG001|Overall Study|Subject failed to disclose concommitant|1|||
170604491|NCT00869401|616558281|FG000|Overall Study|Withdrawal by Subject|0|||
170604492|NCT00869401|616558282|FG001|Overall Study|Withdrawal by Subject|0|||
170604493|NCT00869401|616558283|FG002|Overall Study|Withdrawal by Subject|0|||
170604494|NCT00869401|616558284|FG003|Overall Study|Withdrawal by Subject|5|||
170604495|NCT00869401|616558285|FG004|Overall Study|Withdrawal by Subject|3|||
170604496|NCT00975143|616558288|FG000|Overall Study|Adverse Event|19|||
170604497|NCT00975143|616558289|FG001|Overall Study|Adverse Event|15|||
170604498|NCT00975143|616558288|FG000|Overall Study|Withdrawal by Subject|15|||
170604499|NCT00975143|616558289|FG001|Overall Study|Withdrawal by Subject|15|||
170604500|NCT00975143|616558288|FG000|Overall Study|Lost to Follow-up|20|||
170604501|NCT00975143|616558289|FG001|Overall Study|Lost to Follow-up|16|||
170604502|NCT00975143|616558288|FG000|Overall Study|Non-compliance|5|||
170604503|NCT00975143|616558289|FG001|Overall Study|Non-compliance|8|||
170604504|NCT00975143|616558288|FG000|Overall Study|Physician Decision|1|||
170604505|NCT00975143|616558289|FG001|Overall Study|Physician Decision|2|||
170604506|NCT00975143|616558288|FG000|Overall Study|Details not available|10|||
170604507|NCT00975143|616558289|FG001|Overall Study|Details not available|4|||
170604508|NCT01753401|616558290|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
170604509|NCT01753401|616558291|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
170604510|NCT01753401|616558292|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
170604511|NCT01753401|616558293|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
170604512|NCT01753401|616558290|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
170604513|NCT01753401|616558291|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
170604514|NCT01753401|616558292|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
170604515|NCT01753401|616558293|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
170604516|NCT01753401|616558290|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
170604517|NCT01753401|616558291|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
170604518|NCT01753401|616558292|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
170604519|NCT01753401|616558293|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
170604520|NCT01753401|616558290|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
170604521|NCT01753401|616558291|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
170604522|NCT01753401|616558292|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
170604523|NCT01753401|616558293|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
170604524|NCT01753401|616558290|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
170652486|NCT00998764|616741625|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
170652487|NCT00998764|616741624|FG000|Overall Study|Protocol Violation|0|||
170652488|NCT00998764|616741625|FG001|Overall Study|Protocol Violation|1|||
170652489|NCT00998764|616741624|FG000|Overall Study|Failed to Return|1|||
170604525|NCT01753401|616558291|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
170604526|NCT01753401|616558292|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
170604527|NCT01753401|616558293|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
170604528|NCT01753401|616558290|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
170604529|NCT01753401|616558291|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
170604530|NCT01753401|616558292|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
170604531|NCT01753401|616558293|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
170652490|NCT00998764|616741625|FG001|Overall Study|Failed to Return|1|||
170813840|NCT02432274|617326001|FG005|Overall Study|Death|7|||
170813841|NCT02432274|617326002|FG006|Overall Study|Death|9|||
170813842|NCT02432274|617326003|FG007|Overall Study|Death|14|||
170813843|NCT02432274|617325996|FG000|Overall Study|Withdrawal of Consent|0|||
170604532|NCT01753401|616558290|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
170604533|NCT01753401|616558291|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
170604534|NCT01753401|616558292|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
170604535|NCT01753401|616558293|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
170604536|NCT00470418|616558294|FG000|Overall Study|Withdrawal by Subject|1|||
170604537|NCT00470418|616558295|FG001|Overall Study|Withdrawal by Subject|0|||
170604538|NCT03322423|616558297|FG000|Period 1|Subject no longer eligible|0|||
170604539|NCT03322423|616558298|FG001|Period 1|Subject no longer eligible|1|||
170604540|NCT03322423|616558297|FG000|Period 1|Withdrawal by Subject|0|||
170604541|NCT03322423|616558298|FG001|Period 1|Withdrawal by Subject|1|||
170604542|NCT03322423|616558297|FG000|Period 1|Incorrect Lens Dispensed|1|||
170604543|NCT03322423|616558298|FG001|Period 1|Incorrect Lens Dispensed|0|||
170604544|NCT03322423|616558297|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
170604545|NCT03322423|616558298|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
170604546|NCT03322423|616558297|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
170604547|NCT03322423|616558298|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
170604548|NCT03322423|616558297|FG000|Period 2|Protocol Violation|1|||
170604549|NCT03322423|616558298|FG001|Period 2|Protocol Violation|0|||
170604550|NCT03322423|616558297|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
170604551|NCT03322423|616558298|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
170604552|NCT04891107|616558301|FG000|Overall Study|Physician Decision|1|||
170604553|NCT04891107|616558301|FG000|Overall Study|Withdrawal by Subject|1|||
170604554|NCT04891107|616558301|FG000|Overall Study|Screen failure after consent|1|||
170604555|NCT02453555|616558302|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
170604556|NCT02453555|616558303|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
170604557|NCT02453555|616558304|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
170604558|NCT02453555|616558305|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
170604559|NCT02453555|616558306|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
170604560|NCT02453555|616558307|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
170604561|NCT02453555|616558302|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
170604562|NCT02453555|616558303|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
170604563|NCT02453555|616558304|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
170604564|NCT02453555|616558305|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
170604565|NCT02453555|616558306|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
170604566|NCT02453555|616558307|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
170604567|NCT02453555|616558302|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
170604568|NCT02453555|616558303|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
170604569|NCT02453555|616558304|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
170604570|NCT02453555|616558305|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
170604571|NCT02453555|616558306|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
170604572|NCT02453555|616558307|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
170604573|NCT02453555|616558302|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
170604574|NCT02453555|616558303|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
170604575|NCT02453555|616558304|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
170604576|NCT02453555|616558305|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
170604577|NCT02453555|616558306|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
170604578|NCT02453555|616558307|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
170604579|NCT02453555|616558302|FG000|Extension Period|Adverse Event|0|||
170604580|NCT02453555|616558303|FG001|Extension Period|Adverse Event|0|||
170604581|NCT02453555|616558304|FG002|Extension Period|Adverse Event|1|||
170604582|NCT02453555|616558305|FG003|Extension Period|Adverse Event|2|||
170604583|NCT02453555|616558306|FG004|Extension Period|Adverse Event|1|||
170604584|NCT02453555|616558307|FG005|Extension Period|Adverse Event|1|||
170604585|NCT02453555|616558302|FG000|Extension Period|Protocol Violation|0|||
170604586|NCT02453555|616558303|FG001|Extension Period|Protocol Violation|0|||
170604587|NCT02453555|616558304|FG002|Extension Period|Protocol Violation|1|||
170604588|NCT02453555|616558305|FG003|Extension Period|Protocol Violation|0|||
170604589|NCT02453555|616558306|FG004|Extension Period|Protocol Violation|0|||
170604590|NCT02453555|616558307|FG005|Extension Period|Protocol Violation|0|||
170604591|NCT02453555|616558302|FG000|Extension Period|Withdrawal by Subject|0|||
170604592|NCT02453555|616558303|FG001|Extension Period|Withdrawal by Subject|0|||
170604593|NCT02453555|616558304|FG002|Extension Period|Withdrawal by Subject|1|||
170604594|NCT02453555|616558305|FG003|Extension Period|Withdrawal by Subject|0|||
170604595|NCT02453555|616558306|FG004|Extension Period|Withdrawal by Subject|0|||
170652491|NCT00998764|616741624|FG000|Overall Study|Lost to Follow-up|1|||
170652492|NCT00998764|616741625|FG001|Overall Study|Lost to Follow-up|1|||
170652493|NCT00998764|616741624|FG000|Overall Study|Loss of Caregiver|0|||
170652494|NCT00998764|616741625|FG001|Overall Study|Loss of Caregiver|3|||
170652495|NCT00998764|616741624|FG000|Overall Study|Other|4|||
170652496|NCT00998764|616741625|FG001|Overall Study|Other|4|||
170604596|NCT02453555|616558307|FG005|Extension Period|Withdrawal by Subject|0|||
170604597|NCT03689855|616558308|FG000|Overall Study|Adverse Event|3|||
170604598|NCT03689855|616558308|FG000|Overall Study|Withdrawal by Subject|1|||
170604599|NCT02409719|616558312|FG000|Overall Study|Lost to Follow-up|3|||
170604600|NCT02409719|616558313|FG001|Overall Study|Lost to Follow-up|3|||
170604601|NCT02772978|616558315|FG000|Overall Study|Withdrawal by Subject|1|||
170604602|NCT02772978|616558316|FG001|Overall Study|Withdrawal by Subject|1|||
170604603|NCT00498355|616558321|FG000|Overall Study|Lost to Follow-up|1|||
170604604|NCT01069705|616558322|FG000|Overall Study|Adverse Event|1|||
170604605|NCT01069705|616558322|FG000|Overall Study|Withdrawal by Subject|2|||
170604606|NCT03624127|616558323|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
170604607|NCT03624127|616558324|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
170604608|NCT03624127|616558325|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
170604609|NCT03624127|616558323|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
170604610|NCT03624127|616558324|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
170604611|NCT03624127|616558325|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
170604612|NCT03624127|616558323|FG000|Treatment Week 0 - Week 16|Death|0|||
170604613|NCT03624127|616558324|FG001|Treatment Week 0 - Week 16|Death|1|||
170604614|NCT03624127|616558325|FG002|Treatment Week 0 - Week 16|Death|0|||
170604615|NCT03624127|616558323|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
170604616|NCT03624127|616558324|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
170604617|NCT03624127|616558325|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
170604618|NCT03624127|616558323|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
170604619|NCT03624127|616558324|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
170604620|NCT03624127|616558325|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
170604621|NCT03624127|616558323|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
170604622|NCT03624127|616558324|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
170604623|NCT03624127|616558325|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
170604624|NCT03624127|616558323|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
170604625|NCT03624127|616558324|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
170604626|NCT03624127|616558325|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
170604627|NCT03624127|616558323|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
170604628|NCT03624127|616558324|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
170604629|NCT03624127|616558325|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
170604630|NCT03624127|616558323|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
170604631|NCT03624127|616558324|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
170604632|NCT03624127|616558325|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
170604633|NCT03624127|616558323|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
170604634|NCT03624127|616558324|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
170604635|NCT03624127|616558325|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
170604636|NCT03624127|616558323|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
170604637|NCT03624127|616558324|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
170604638|NCT03624127|616558325|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
170604639|NCT03624127|616558323|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
170604640|NCT03624127|616558324|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
170604641|NCT03624127|616558325|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
170604642|NCT03624127|616558323|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
170604643|NCT03624127|616558324|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
170604644|NCT03624127|616558325|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
170604645|NCT03624127|616558323|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
170604646|NCT03624127|616558324|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
170604647|NCT03624127|616558325|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
170604648|NCT03624127|616558323|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
170604649|NCT03624127|616558324|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
170604650|NCT03624127|616558325|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
170604651|NCT03624127|616558323|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
170604652|NCT03624127|616558324|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
170604653|NCT03624127|616558325|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
170604654|NCT03624127|616558323|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
170604655|NCT03624127|616558324|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
170652497|NCT00998764|616741624|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
170652498|NCT00998764|616741625|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
170604656|NCT03624127|616558325|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
170604657|NCT03624127|616558323|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
170604658|NCT03624127|616558324|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
170604659|NCT03624127|616558325|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
170604660|NCT03624127|616558323|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
170652499|NCT00290407|616741630|FG000|Overall Study|Physician Decision|2|||
170652500|NCT01634178|616741631|FG000|Treatment Period 1|Adverse Event|0|||
170652501|NCT01634178|616741632|FG001|Treatment Period 1|Adverse Event|1|||
170604661|NCT03624127|616558324|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
170604662|NCT03624127|616558325|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
170604663|NCT03624127|616558323|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
170604664|NCT03624127|616558324|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
170604665|NCT03624127|616558325|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
170604666|NCT03624127|616558323|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
170604667|NCT03624127|616558324|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
170604668|NCT03624127|616558325|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
170604669|NCT01817959|616558326|FG000|Overall Study|Graft loss|1|||
170604670|NCT01817959|616558327|FG001|Overall Study|Graft loss|1|||
170604671|NCT01817959|616558326|FG000|Overall Study|forbidden medication|1|||
170604672|NCT01817959|616558327|FG001|Overall Study|forbidden medication|1|||
170604673|NCT01817959|616558326|FG000|Overall Study|Adverse Event|1|||
170604674|NCT01817959|616558327|FG001|Overall Study|Adverse Event|0|||
170604675|NCT01817959|616558326|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
170604676|NCT01817959|616558327|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
170604677|NCT03235089|616558328|FG000|Overall Study|Lost to Follow-up|1|||
170604678|NCT03235089|616558329|FG001|Overall Study|Lost to Follow-up|1|||
170604679|NCT03235089|616558328|FG000|Overall Study|Physician Decision|2|||
170604680|NCT03235089|616558329|FG001|Overall Study|Physician Decision|2|||
170604681|NCT03238924|616558332|FG000|Overall Study|Withdrawal by Subject|2|||
170604682|NCT03238924|616558333|FG001|Overall Study|Withdrawal by Subject|2|||
170604683|NCT02891382|616558335|FG000|Overall Study|Lost to Follow-up|3|||
170604684|NCT02891382|616558336|FG001|Overall Study|Lost to Follow-up|4|||
170604685|NCT02891382|616558337|FG002|Overall Study|Lost to Follow-up|5|||
170604686|NCT02891382|616558338|FG003|Overall Study|Lost to Follow-up|3|||
170914267|NCT01097616|617689569|FG003|Optional DB EXT Phase|Adverse Event|0|||
170604687|NCT02891382|616558339|FG004|Overall Study|Lost to Follow-up|4|||
170604688|NCT01455194|616558340|FG000|Overall Study|Screen Failure|20|||
170604689|NCT01455194|616558341|FG001|Overall Study|Screen Failure|0|||
170604690|NCT01455194|616558342|FG002|Overall Study|Screen Failure|0|||
170604691|NCT01455194|616558343|FG003|Overall Study|Screen Failure|0|||
170604692|NCT01455194|616558340|FG000|Overall Study|Randomisation Failure|90|||
170604693|NCT01455194|616558341|FG001|Overall Study|Randomisation Failure|0|||
170604694|NCT01455194|616558342|FG002|Overall Study|Randomisation Failure|0|||
170604695|NCT01455194|616558343|FG003|Overall Study|Randomisation Failure|0|||
170604696|NCT01455194|616558340|FG000|Overall Study|Deterioration in asthma|12|||
170604697|NCT01455194|616558341|FG001|Overall Study|Deterioration in asthma|6|||
170604698|NCT01455194|616558342|FG002|Overall Study|Deterioration in asthma|14|||
170604699|NCT01455194|616558343|FG003|Overall Study|Deterioration in asthma|9|||
170604700|NCT01455194|616558340|FG000|Overall Study|Adverse Event|1|||
170604701|NCT01455194|616558341|FG001|Overall Study|Adverse Event|1|||
170604702|NCT01455194|616558342|FG002|Overall Study|Adverse Event|1|||
170604703|NCT01455194|616558343|FG003|Overall Study|Adverse Event|3|||
170652502|NCT01634178|616741631|FG000|Treatment Period 2|Adverse Event|1|||
170652503|NCT01634178|616741632|FG001|Treatment Period 2|Adverse Event|0|||
170652504|NCT01933789|616741641|FG000|Overall Study|Death|0|||
170652505|NCT01933789|616741642|FG001|Overall Study|Death|0|||
170652506|NCT01933789|616741643|FG002|Overall Study|Death|0|||
170652507|NCT01933789|616741644|FG003|Overall Study|Death|0|||
170652508|NCT01933789|616741645|FG004|Overall Study|Death|21|||
170652509|NCT01933789|616741646|FG005|Overall Study|Death|32|||
170914268|NCT01097616|617689570|FG004|Optional DB EXT Phase|Adverse Event|0|||
170914269|NCT01097616|617689571|FG005|Optional DB EXT Phase|Adverse Event|0|||
170604704|NCT01455194|616558340|FG000|Overall Study|Withdrawal by Subject|21|||
170604705|NCT01455194|616558341|FG001|Overall Study|Withdrawal by Subject|16|||
170604706|NCT01455194|616558342|FG002|Overall Study|Withdrawal by Subject|12|||
170604707|NCT01455194|616558343|FG003|Overall Study|Withdrawal by Subject|9|||
170604708|NCT01455194|616558340|FG000|Overall Study|Lost to Follow-up|2|||
170604709|NCT01455194|616558341|FG001|Overall Study|Lost to Follow-up|0|||
170604710|NCT01455194|616558342|FG002|Overall Study|Lost to Follow-up|1|||
170604711|NCT01455194|616558343|FG003|Overall Study|Lost to Follow-up|1|||
170604712|NCT01455194|616558340|FG000|Overall Study|Pregnancy|0|||
170604713|NCT01455194|616558341|FG001|Overall Study|Pregnancy|1|||
170604714|NCT01455194|616558342|FG002|Overall Study|Pregnancy|1|||
170604715|NCT01455194|616558343|FG003|Overall Study|Pregnancy|0|||
170604716|NCT01455194|616558340|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
170604717|NCT01455194|616558341|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
170604718|NCT01455194|616558342|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
170652510|NCT01933789|616741647|FG006|Overall Study|Death|0|||
170914270|NCT01097616|617689572|FG006|Optional DB EXT Phase|Adverse Event|0|||
170914271|NCT01097616|617689573|FG007|Optional DB EXT Phase|Adverse Event|0|||
170604719|NCT01455194|616558343|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
170604720|NCT01455194|616558340|FG000|Overall Study|Miscellaneous|4|||
170604721|NCT01455194|616558341|FG001|Overall Study|Miscellaneous|5|||
170604722|NCT01455194|616558342|FG002|Overall Study|Miscellaneous|1|||
170604723|NCT01455194|616558343|FG003|Overall Study|Miscellaneous|4|||
170652511|NCT01933789|616741648|FG007|Overall Study|Death|0|||
170604724|NCT03916484|616558344|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
170604725|NCT03916484|616558345|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
170604726|NCT03916484|616558346|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
170604727|NCT03916484|616558347|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
170604728|NCT03916484|616558344|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
170604729|NCT03916484|616558345|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
170604730|NCT03916484|616558346|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
170604731|NCT03916484|616558347|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
170604732|NCT01879072|616558350|FG000|Overall Study|Withdrawal by Subject|121|||
170604733|NCT01879072|616558350|FG000|Overall Study|Not Transplanted|30|||
170604734|NCT01123707|616558351|FG000|Overall Study|Lost to Follow-up|3|||
170604735|NCT01123707|616558352|FG001|Overall Study|Lost to Follow-up|1|||
170604736|NCT01123707|616558353|FG002|Overall Study|Lost to Follow-up|3|||
170604737|NCT01123707|616558354|FG003|Overall Study|Lost to Follow-up|2|||
170604738|NCT01123707|616558351|FG000|Overall Study|Adverse Event|5|||
170604739|NCT01123707|616558352|FG001|Overall Study|Adverse Event|7|||
170604740|NCT01123707|616558353|FG002|Overall Study|Adverse Event|5|||
170604741|NCT01123707|616558354|FG003|Overall Study|Adverse Event|3|||
170604742|NCT01123707|616558351|FG000|Overall Study|Sponsor Discontinued Study|30|||
170604743|NCT01123707|616558352|FG001|Overall Study|Sponsor Discontinued Study|24|||
170604744|NCT01123707|616558353|FG002|Overall Study|Sponsor Discontinued Study|25|||
170604745|NCT01123707|616558354|FG003|Overall Study|Sponsor Discontinued Study|40|||
170604746|NCT01123707|616558351|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
170604747|NCT01123707|616558352|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
170604748|NCT01123707|616558353|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
170604749|NCT01123707|616558354|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
170604750|NCT01123707|616558351|FG000|Overall Study|Investigator Withdrew Participant|0|||
170604751|NCT01123707|616558352|FG001|Overall Study|Investigator Withdrew Participant|1|||
170604752|NCT01123707|616558353|FG002|Overall Study|Investigator Withdrew Participant|1|||
170604753|NCT01123707|616558354|FG003|Overall Study|Investigator Withdrew Participant|1|||
170604754|NCT01123707|616558351|FG000|Overall Study|Subject Withdrew Consent|4|||
170604755|NCT01123707|616558352|FG001|Overall Study|Subject Withdrew Consent|5|||
170604756|NCT01123707|616558353|FG002|Overall Study|Subject Withdrew Consent|1|||
170604757|NCT01123707|616558354|FG003|Overall Study|Subject Withdrew Consent|2|||
170604758|NCT01123707|616558351|FG000|Overall Study|Lack of Efficacy|1|||
170604759|NCT01123707|616558352|FG001|Overall Study|Lack of Efficacy|2|||
170604760|NCT01123707|616558353|FG002|Overall Study|Lack of Efficacy|1|||
170604761|NCT01123707|616558354|FG003|Overall Study|Lack of Efficacy|0|||
170604762|NCT01123707|616558351|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
170604763|NCT01123707|616558352|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
170604764|NCT01123707|616558353|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
170604765|NCT01123707|616558354|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
170604766|NCT04079114|616558360|FG000|Overall Study|Study prematuely terminated.|166|||
170604767|NCT03281304|616558363|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
170604768|NCT03281304|616558364|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
170604769|NCT03281304|616558363|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
170604770|NCT03281304|616558364|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
170604771|NCT03281304|616558363|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
170604772|NCT03281304|616558364|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
170604773|NCT03281304|616558363|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
170604774|NCT03281304|616558364|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
170604775|NCT03281304|616558363|FG000|Treatment Phase (up to 42 Months)|Death|0|||
170604776|NCT03281304|616558364|FG001|Treatment Phase (up to 42 Months)|Death|1|||
170604777|NCT03281304|616558363|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
170604778|NCT03281304|616558364|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
170604779|NCT03281304|616558363|FG000|Treatment Phase (up to 42 Months)|Other|0|||
170604780|NCT03281304|616558364|FG001|Treatment Phase (up to 42 Months)|Other|2|||
170604781|NCT03281304|616558363|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
170604782|NCT03281304|616558364|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
170604783|NCT00858637|616558365|FG000|Active Comparison Phase|Adverse Event|14|||
170604784|NCT00858637|616558366|FG001|Active Comparison Phase|Adverse Event|0|||
170604785|NCT00858637|616558367|FG002|Active Comparison Phase|Adverse Event|0|||
170604786|NCT00858637|616558368|FG003|Active Comparison Phase|Adverse Event|9|||
170604787|NCT00858637|616558369|FG004|Active Comparison Phase|Adverse Event|0|||
170604788|NCT00858637|616558370|FG005|Active Comparison Phase|Adverse Event|0|||
170604789|NCT00858637|616558365|FG000|Active Comparison Phase|Death|1|||
170604790|NCT00858637|616558366|FG001|Active Comparison Phase|Death|0|||
170604791|NCT00858637|616558367|FG002|Active Comparison Phase|Death|0|||
170604792|NCT00858637|616558368|FG003|Active Comparison Phase|Death|1|||
170604793|NCT00858637|616558369|FG004|Active Comparison Phase|Death|0|||
170604794|NCT00858637|616558370|FG005|Active Comparison Phase|Death|0|||
170604795|NCT00858637|616558365|FG000|Active Comparison Phase|Physician Decision|1|||
170604796|NCT00858637|616558366|FG001|Active Comparison Phase|Physician Decision|0|||
170813844|NCT02432274|617325997|FG001|Overall Study|Withdrawal of Consent|0|||
170813845|NCT02432274|617325998|FG002|Overall Study|Withdrawal of Consent|0|||
170813846|NCT02432274|617325999|FG003|Overall Study|Withdrawal of Consent|0|||
170813847|NCT02432274|617326000|FG004|Overall Study|Withdrawal of Consent|2|||
170813848|NCT02432274|617326001|FG005|Overall Study|Withdrawal of Consent|0|||
170813849|NCT02432274|617326002|FG006|Overall Study|Withdrawal of Consent|1|||
170813850|NCT02432274|617326003|FG007|Overall Study|Withdrawal of Consent|2|||
170813851|NCT01529632|617326004|FG000|Overall Study|Administrative problem|2|||
170813852|NCT01529632|617326005|FG001|Overall Study|Administrative problem|1|||
170813853|NCT01529632|617326004|FG000|Overall Study|Protocol Violation|0|||
170813854|NCT01529632|617326005|FG001|Overall Study|Protocol Violation|1|||
170813855|NCT01529632|617326004|FG000|Overall Study|Adverse Event|1|||
170813856|NCT01529632|617326005|FG001|Overall Study|Adverse Event|1|||
170813857|NCT04186247|617326007|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
170813858|NCT04186247|617326008|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
170813859|NCT04186247|617326009|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
170813860|NCT04186247|617326010|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
170813861|NCT04186247|617326011|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
170813862|NCT05487300|617327287|FG000|Overall Study|Withdrawal by Subject|1|||
170813863|NCT05487300|617327288|FG001|Overall Study|Withdrawal by Subject|0|||
170813864|NCT04783389|617327291|FG000|Overall Study|Withdrawal by Subject|2|||
170813865|NCT04783389|617327292|FG001|Overall Study|Withdrawal by Subject|0|||
170813866|NCT04783389|617327293|FG002|Overall Study|Withdrawal by Subject|0|||
170813867|NCT04783389|617327291|FG000|Overall Study|Termination of Study by Sponsor|10|||
170813868|NCT04783389|617327292|FG001|Overall Study|Termination of Study by Sponsor|12|||
170813869|NCT04783389|617327293|FG002|Overall Study|Termination of Study by Sponsor|14|||
170813870|NCT00451906|617327294|FG000|Overall Study|Adverse Event|515|||
170813871|NCT00451906|617327294|FG000|Overall Study|Lost to Follow-up|31|||
170813872|NCT00451906|617327294|FG000|Overall Study|Withdrawal by Subject|111|||
170813873|NCT00451906|617327294|FG000|Overall Study|Protocol Violation|21|||
170813874|NCT00451906|617327294|FG000|Overall Study|Progressive disease|1328|||
170813875|NCT00451906|617327294|FG000|Overall Study|Termination of the study|108|||
170813876|NCT00451906|617327294|FG000|Overall Study|Other Reasons|121|||
170813877|NCT00451906|617327294|FG000|Overall Study|Did not complete final visit|4|||
170813878|NCT01286311|617327299|FG000|Overall Study|Physician did not want outreach sent|14|||
170813879|NCT01286311|617327300|FG001|Overall Study|Physician did not want outreach sent|0|||
170813880|NCT02889900|617327306|FG000|Overall Study|Adverse Event|11|||
170813881|NCT02889900|617327306|FG000|Overall Study|Condition under investigation worsened|32|||
170813882|NCT02889900|617327306|FG000|Overall Study|Other|5|||
170813883|NCT02889900|617327306|FG000|Overall Study|Withdrawal by Subject|7|||
170813884|NCT02889900|617327306|FG000|Overall Study|Not treated|2|||
170813885|NCT01416285|617327313|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
170813886|NCT01416285|617327314|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
170813887|NCT02165202|617327321|FG000|Oral Phase|Refused further participation|5|||
170604797|NCT00858637|616558367|FG002|Active Comparison Phase|Physician Decision|0|||
170604798|NCT00858637|616558368|FG003|Active Comparison Phase|Physician Decision|1|||
170604799|NCT00858637|616558369|FG004|Active Comparison Phase|Physician Decision|0|||
170604800|NCT00858637|616558370|FG005|Active Comparison Phase|Physician Decision|0|||
170604801|NCT00858637|616558365|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
170604802|NCT00858637|616558366|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
170604803|NCT00858637|616558367|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
170604804|NCT00858637|616558368|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
170604805|NCT00858637|616558369|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
170604806|NCT00858637|616558370|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
170604807|NCT00858637|616558365|FG000|Active Comparison Phase|Other Reasons|1|||
170604808|NCT00858637|616558366|FG001|Active Comparison Phase|Other Reasons|0|||
170604809|NCT00858637|616558367|FG002|Active Comparison Phase|Other Reasons|0|||
170604810|NCT00858637|616558368|FG003|Active Comparison Phase|Other Reasons|1|||
170604811|NCT00858637|616558369|FG004|Active Comparison Phase|Other Reasons|0|||
170604812|NCT00858637|616558370|FG005|Active Comparison Phase|Other Reasons|0|||
170813888|NCT02165202|617327322|FG001|Oral Phase|Refused further participation|1|||
170813889|NCT02165202|617327321|FG000|Oral Phase|Study product Related Toxicity|1|||
170813890|NCT02165202|617327322|FG001|Oral Phase|Study product Related Toxicity|0|||
170813891|NCT02165202|617327321|FG000|Oral Phase|Unable to contact Participant|1|||
170813892|NCT02165202|617327322|FG001|Oral Phase|Unable to contact Participant|1|||
170813893|NCT02165202|617327321|FG000|Oral Phase|Clinical reasons|1|||
170813894|NCT02165202|617327322|FG001|Oral Phase|Clinical reasons|0|||
170813895|NCT02165202|617327321|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
170813896|NCT02165202|617327322|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
170813897|NCT02165202|617327321|FG000|Oral Phase|CMC advised termination|1|||
170813898|NCT02165202|617327322|FG001|Oral Phase|CMC advised termination|0|||
170813899|NCT02165202|617327321|FG000|Oral Phase|Relocated, no follow-up planned|1|||
170604813|NCT00858637|616558365|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
170604814|NCT00858637|616558366|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
170604815|NCT00858637|616558367|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
170604816|NCT00858637|616558368|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
170604817|NCT00858637|616558369|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
170604818|NCT00858637|616558370|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
170604819|NCT00858637|616558365|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
170604820|NCT00858637|616558366|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
170604821|NCT00858637|616558367|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
170604822|NCT00858637|616558368|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
170604823|NCT00858637|616558369|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
170604824|NCT00858637|616558370|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
170604825|NCT00629798|616558371|FG000|Overall Study|Not Treated|4|||
170604826|NCT02292706|616558372|FG000|Overall Study|Lost to Follow-up|20|||
170604827|NCT02292706|616558373|FG001|Overall Study|Lost to Follow-up|44|||
170604828|NCT02292706|616558374|FG002|Overall Study|Lost to Follow-up|24|||
170604829|NCT02292706|616558375|FG003|Overall Study|Lost to Follow-up|61|||
170604830|NCT02292706|616558376|FG004|Overall Study|Lost to Follow-up|21|||
170604831|NCT02292706|616558377|FG005|Overall Study|Lost to Follow-up|52|||
170604832|NCT02292706|616558378|FG006|Overall Study|Lost to Follow-up|25|||
170604833|NCT02292706|616558379|FG007|Overall Study|Lost to Follow-up|0|||
170604834|NCT02292706|616558372|FG000|Overall Study|Withdrew consent|15|||
170604835|NCT02292706|616558373|FG001|Overall Study|Withdrew consent|56|||
170604836|NCT02292706|616558374|FG002|Overall Study|Withdrew consent|43|||
170604837|NCT02292706|616558375|FG003|Overall Study|Withdrew consent|36|||
170604838|NCT02292706|616558376|FG004|Overall Study|Withdrew consent|13|||
170604839|NCT02292706|616558377|FG005|Overall Study|Withdrew consent|51|||
170604840|NCT02292706|616558378|FG006|Overall Study|Withdrew consent|20|||
170604841|NCT02292706|616558379|FG007|Overall Study|Withdrew consent|0|||
170604842|NCT02292706|616558372|FG000|Overall Study|Death|3|||
170604843|NCT02292706|616558373|FG001|Overall Study|Death|11|||
170604844|NCT02292706|616558374|FG002|Overall Study|Death|16|||
170604845|NCT02292706|616558375|FG003|Overall Study|Death|22|||
170604846|NCT02292706|616558376|FG004|Overall Study|Death|8|||
170604847|NCT02292706|616558377|FG005|Overall Study|Death|17|||
170604848|NCT02292706|616558378|FG006|Overall Study|Death|3|||
170604849|NCT02292706|616558379|FG007|Overall Study|Death|0|||
170604850|NCT02292706|616558372|FG000|Overall Study|Study terminated by sponsor|0|||
170604851|NCT02292706|616558373|FG001|Overall Study|Study terminated by sponsor|9|||
170604852|NCT02292706|616558374|FG002|Overall Study|Study terminated by sponsor|4|||
170604853|NCT02292706|616558375|FG003|Overall Study|Study terminated by sponsor|21|||
170604854|NCT02292706|616558376|FG004|Overall Study|Study terminated by sponsor|11|||
170604855|NCT02292706|616558377|FG005|Overall Study|Study terminated by sponsor|13|||
170604856|NCT02292706|616558378|FG006|Overall Study|Study terminated by sponsor|3|||
170604857|NCT02292706|616558379|FG007|Overall Study|Study terminated by sponsor|0|||
170604858|NCT02292706|616558372|FG000|Overall Study|Investigator's discretion|4|||
170604859|NCT02292706|616558373|FG001|Overall Study|Investigator's discretion|9|||
170604860|NCT02292706|616558374|FG002|Overall Study|Investigator's discretion|7|||
170604861|NCT02292706|616558375|FG003|Overall Study|Investigator's discretion|11|||
170604862|NCT02292706|616558376|FG004|Overall Study|Investigator's discretion|4|||
170604863|NCT02292706|616558377|FG005|Overall Study|Investigator's discretion|10|||
170604864|NCT02292706|616558378|FG006|Overall Study|Investigator's discretion|1|||
170604865|NCT02292706|616558379|FG007|Overall Study|Investigator's discretion|0|||
170604866|NCT02292706|616558372|FG000|Overall Study|Liver transplant|1|||
170604867|NCT02292706|616558373|FG001|Overall Study|Liver transplant|1|||
170604868|NCT02292706|616558374|FG002|Overall Study|Liver transplant|11|||
170604869|NCT02292706|616558375|FG003|Overall Study|Liver transplant|16|||
170604870|NCT02292706|616558376|FG004|Overall Study|Liver transplant|5|||
170604871|NCT02292706|616558377|FG005|Overall Study|Liver transplant|6|||
170604872|NCT02292706|616558378|FG006|Overall Study|Liver transplant|5|||
170604873|NCT02292706|616558379|FG007|Overall Study|Liver transplant|0|||
170604874|NCT02292706|616558372|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
170604875|NCT02292706|616558373|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
170604876|NCT02292706|616558374|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
170604877|NCT02292706|616558375|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
170604878|NCT02292706|616558376|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
170604879|NCT02292706|616558377|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
170604880|NCT02292706|616558378|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
170604881|NCT02292706|616558379|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
170604882|NCT02292706|616558372|FG000|Overall Study|Subject terminated by sponsor|1|||
170604883|NCT02292706|616558373|FG001|Overall Study|Subject terminated by sponsor|0|||
170604884|NCT02292706|616558374|FG002|Overall Study|Subject terminated by sponsor|0|||
170604885|NCT02292706|616558375|FG003|Overall Study|Subject terminated by sponsor|2|||
170604886|NCT02292706|616558376|FG004|Overall Study|Subject terminated by sponsor|1|||
170604887|NCT02292706|616558377|FG005|Overall Study|Subject terminated by sponsor|0|||
170604888|NCT02292706|616558378|FG006|Overall Study|Subject terminated by sponsor|0|||
170604889|NCT02292706|616558379|FG007|Overall Study|Subject terminated by sponsor|0|||
170604890|NCT02292706|616558372|FG000|Overall Study|Missing|0|||
170604891|NCT02292706|616558373|FG001|Overall Study|Missing|0|||
170604892|NCT02292706|616558374|FG002|Overall Study|Missing|1|||
170604893|NCT02292706|616558375|FG003|Overall Study|Missing|1|||
170604894|NCT02292706|616558376|FG004|Overall Study|Missing|0|||
170604895|NCT02292706|616558377|FG005|Overall Study|Missing|1|||
170604896|NCT02292706|616558378|FG006|Overall Study|Missing|0|||
170604897|NCT02292706|616558379|FG007|Overall Study|Missing|0|||
170604898|NCT02292706|616558372|FG000|Overall Study|Virologic relapse or reinfection|1|||
170604899|NCT02292706|616558373|FG001|Overall Study|Virologic relapse or reinfection|0|||
170604900|NCT02292706|616558374|FG002|Overall Study|Virologic relapse or reinfection|0|||
170604901|NCT02292706|616558375|FG003|Overall Study|Virologic relapse or reinfection|1|||
170604902|NCT02292706|616558376|FG004|Overall Study|Virologic relapse or reinfection|0|||
170604903|NCT02292706|616558377|FG005|Overall Study|Virologic relapse or reinfection|1|||
170604904|NCT02292706|616558378|FG006|Overall Study|Virologic relapse or reinfection|0|||
170604905|NCT02292706|616558379|FG007|Overall Study|Virologic relapse or reinfection|0|||
170604906|NCT01990612|616558380|FG000|Overall Study|Lost to Follow-up|2|||
170604907|NCT01990612|616558381|FG001|Overall Study|Lost to Follow-up|1|||
170604908|NCT01990612|616558380|FG000|Overall Study|Withdrawal by Subject|5|||
170604909|NCT01990612|616558381|FG001|Overall Study|Withdrawal by Subject|2|||
170604910|NCT04667104|616558387|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
170604911|NCT04667104|616558388|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
170604912|NCT04667104|616558389|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
170604913|NCT02188849|616558390|FG000|Overall Study|Lost to Follow-up|3|||
170604914|NCT02188849|616558391|FG001|Overall Study|Lost to Follow-up|8|||
170604915|NCT01078168|616558396|FG000|Overall Study|Physician Decision|0|||
170604916|NCT01078168|616558397|FG001|Overall Study|Physician Decision|1|||
170604917|NCT00666224|616559943|FG000|Double-Blind|Adverse Event|15|||
170604918|NCT00666224|616559944|FG001|Double-Blind|Adverse Event|5|||
170604919|NCT00666224|616559943|FG000|Double-Blind|Lost to Follow-up|2|||
170604920|NCT00666224|616559944|FG001|Double-Blind|Lost to Follow-up|2|||
170604921|NCT00666224|616559943|FG000|Double-Blind|Withdrawal by Subject|18|||
170604922|NCT00666224|616559944|FG001|Double-Blind|Withdrawal by Subject|14|||
170604923|NCT00666224|616559943|FG000|Double-Blind|Physician Decision|0|||
170604924|NCT00666224|616559944|FG001|Double-Blind|Physician Decision|3|||
170604925|NCT00666224|616559943|FG000|Double-Blind|Sponsor decision|1|||
170604926|NCT00666224|616559944|FG001|Double-Blind|Sponsor decision|0|||
170604927|NCT00666224|616559943|FG000|Double-Blind|Pregnancy|3|||
170604928|NCT00666224|616559944|FG001|Double-Blind|Pregnancy|2|||
170604929|NCT00666224|616559943|FG000|Double-Blind|Noncompliance|1|||
170604930|NCT00666224|616559944|FG001|Double-Blind|Noncompliance|0|||
170604931|NCT00666224|616559943|FG000|Double-Blind|Death|1|||
170604932|NCT00666224|616559944|FG001|Double-Blind|Death|0|||
170604933|NCT00666224|616559943|FG000|Double-Blind|Undefined/Unknown|4|||
170604934|NCT00666224|616559944|FG001|Double-Blind|Undefined/Unknown|1|||
170604935|NCT00666224|616559943|FG000|Open-Label|Adverse Event|8|||
170604936|NCT00666224|616559944|FG001|Open-Label|Adverse Event|43|||
170604937|NCT00666224|616559943|FG000|Open-Label|Lost to Follow-up|4|||
170604938|NCT00666224|616559944|FG001|Open-Label|Lost to Follow-up|5|||
170813900|NCT02165202|617327322|FG001|Oral Phase|Relocated, no follow-up planned|0|||
170813901|NCT02165202|617327321|FG000|Oral Phase|Abnormal EKG|0|||
170604939|NCT00666224|616559943|FG000|Open-Label|Withdrawal by Subject|12|||
170604940|NCT00666224|616559944|FG001|Open-Label|Withdrawal by Subject|25|||
170604941|NCT00666224|616559943|FG000|Open-Label|Physician Decision|7|||
170604942|NCT00666224|616559944|FG001|Open-Label|Physician Decision|5|||
170604943|NCT00666224|616559943|FG000|Open-Label|Pregnancy|1|||
170652512|NCT01933789|616741649|FG008|Overall Study|Death|0|||
170813902|NCT02165202|617327322|FG001|Oral Phase|Abnormal EKG|1|||
170813903|NCT02165202|617327321|FG000|Injection Phase|Abnormal Lab Value|5|||
170813904|NCT02165202|617327322|FG001|Injection Phase|Abnormal Lab Value|1|||
170813905|NCT02165202|617327321|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
170813906|NCT02165202|617327322|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
170813907|NCT02165202|617327321|FG000|Injection Phase|Unable to attend within Visit Window|1|||
170914272|NCT01097616|617689566|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
170604944|NCT00666224|616559944|FG001|Open-Label|Pregnancy|5|||
170604945|NCT00666224|616559943|FG000|Open-Label|Noncompliance|2|||
170604946|NCT00666224|616559944|FG001|Open-Label|Noncompliance|1|||
170604947|NCT00666224|616559943|FG000|Open-Label|Undefined/Unknown|1|||
170604948|NCT00666224|616559944|FG001|Open-Label|Undefined/Unknown|1|||
170604949|NCT03828617|616559945|FG000|Overall Study|Lost to Follow-up|22|||
170604950|NCT03828617|616559946|FG001|Overall Study|Lost to Follow-up|12|||
170604951|NCT03828617|616559947|FG002|Overall Study|Lost to Follow-up|23|||
170604952|NCT03828617|616559948|FG003|Overall Study|Lost to Follow-up|7|||
170652513|NCT01933789|616741641|FG000|Overall Study|Lost to Follow-up|0|||
170604953|NCT03828617|616559945|FG000|Overall Study|No longer met eligibility criteria|0|||
170604954|NCT03828617|616559946|FG001|Overall Study|No longer met eligibility criteria|1|||
170604955|NCT03828617|616559947|FG002|Overall Study|No longer met eligibility criteria|1|||
170604956|NCT03828617|616559948|FG003|Overall Study|No longer met eligibility criteria|3|||
170604957|NCT03828617|616559945|FG000|Overall Study|Protocol Violation|0|||
170604958|NCT03828617|616559946|FG001|Overall Study|Protocol Violation|2|||
170604959|NCT03828617|616559947|FG002|Overall Study|Protocol Violation|0|||
170604960|NCT03828617|616559948|FG003|Overall Study|Protocol Violation|0|||
170604961|NCT03828617|616559945|FG000|Overall Study|Withdrawal by Subject|2|||
170604962|NCT03828617|616559946|FG001|Overall Study|Withdrawal by Subject|0|||
170604963|NCT03828617|616559947|FG002|Overall Study|Withdrawal by Subject|2|||
170604964|NCT03828617|616559948|FG003|Overall Study|Withdrawal by Subject|0|||
170604965|NCT00303485|616559951|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
170604966|NCT00303485|616559952|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
170604967|NCT00303485|616559951|FG000|Overall Study|Failure to return|0|||
170604968|NCT00303485|616559952|FG001|Overall Study|Failure to return|1|||
170604969|NCT00303485|616559951|FG000|Overall Study|Withdrawal by Subject|1|||
170604970|NCT00303485|616559952|FG001|Overall Study|Withdrawal by Subject|0|||
170604971|NCT00193180|616559957|FG000|Overall Study|Lack of Efficacy|1|||
170604972|NCT00193180|616559957|FG000|Overall Study|Adverse Event|8|||
170604973|NCT00193180|616559957|FG000|Overall Study|Protocol Violation|1|||
170604974|NCT03329196|616559958|FG000|Overall Study|Adverse Event|10|||
170604975|NCT03329196|616559959|FG001|Overall Study|Adverse Event|5|||
170604976|NCT03329196|616559958|FG000|Overall Study|Physician Decision|2|||
170604977|NCT03329196|616559959|FG001|Overall Study|Physician Decision|2|||
170604978|NCT03329196|616559958|FG000|Overall Study|Withdrawal by Subject|11|||
170604979|NCT03329196|616559959|FG001|Overall Study|Withdrawal by Subject|3|||
170604980|NCT03329196|616559958|FG000|Overall Study|Hepatic function abnormalities|0|||
170604981|NCT03329196|616559959|FG001|Overall Study|Hepatic function abnormalities|1|||
170604982|NCT03329196|616559958|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
170604983|NCT03329196|616559959|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
170604984|NCT03329196|616559958|FG000|Overall Study|Difficult to control Hb|2|||
170604985|NCT03329196|616559959|FG001|Overall Study|Difficult to control Hb|3|||
170604986|NCT03329196|616559958|FG000|Overall Study|Dialysis or renal transplant|13|||
170604987|NCT03329196|616559959|FG001|Overall Study|Dialysis or renal transplant|15|||
170604988|NCT00930553|616559960|FG000|Overall Study|Adverse Event|1|||
170604989|NCT00930553|616559960|FG000|Overall Study|Lack of Efficacy|7|||
170604990|NCT00930553|616559960|FG000|Overall Study|Physician Decision|39|||
170604991|NCT00930553|616559960|FG000|Overall Study|Protocol Violation|1|||
170604992|NCT00930553|616559960|FG000|Overall Study|Pregnancy|1|||
170604993|NCT00930553|616559960|FG000|Overall Study|Withdrawal by Subject|88|||
170604994|NCT00930553|616559960|FG000|Overall Study|Lost to Follow-up|25|||
170604995|NCT00930553|616559960|FG000|Overall Study|Death|9|||
170604996|NCT00930553|616559960|FG000|Overall Study|Study terminated by sponsor|24|||
170604997|NCT00930553|616559960|FG000|Overall Study|Other than specified above|28|||
170604998|NCT02942485|616559961|FG000|Overall Study|Lost to Follow-up|1|||
170604999|NCT02942485|616559962|FG001|Overall Study|Lost to Follow-up|0|||
170605000|NCT01818492|616559964|FG000|Overall Study|Adverse Event|2|||
170605001|NCT01818492|616559964|FG000|Overall Study|Death|3|||
170605002|NCT01818492|616559964|FG000|Overall Study|Withdrawal by Subject|1|||
170605003|NCT01818492|616559964|FG000|Overall Study|Additional therapy when not allowed PP|4|||
170605004|NCT01729208|616559965|FG000|Baseline|Physician Decision|5|||
170605005|NCT01729208|616559966|FG001|Baseline|Physician Decision|4|||
170605006|NCT01729208|616559965|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
170605007|NCT01729208|616559966|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
170605008|NCT01729208|616559965|FG000|12 Months Follow-up|Lost to Follow-up|3|||
170605009|NCT01729208|616559966|FG001|12 Months Follow-up|Lost to Follow-up|3|||
170605010|NCT01729208|616559965|FG000|24 Months Follow-up|Lost to Follow-up|3|||
170605011|NCT01729208|616559966|FG001|24 Months Follow-up|Lost to Follow-up|0|||
170605012|NCT01729208|616559965|FG000|36 Months Follow-up|Physician Decision|1|||
170605013|NCT01729208|616559966|FG001|36 Months Follow-up|Physician Decision|0|||
170605014|NCT01729208|616559965|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
170605015|NCT01729208|616559966|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
170605016|NCT01331291|616559973|FG000|Overall Study|Lack of Efficacy|2|||
170605017|NCT01331291|616559974|FG001|Overall Study|Lack of Efficacy|8|||
170605018|NCT01331291|616559973|FG000|Overall Study|Death|0|||
170605019|NCT01331291|616559974|FG001|Overall Study|Death|1|||
170605020|NCT02438813|616559975|FG000|Overall Study|Patient Decision|59|||
170605021|NCT02438813|616559975|FG000|Overall Study|Patient Lost to Follow-Up|137|||
170605022|NCT02438813|616559975|FG000|Overall Study|Study Ended by Sponsor|80|||
170605023|NCT02438813|616559975|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
170605024|NCT01389323|616559976|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
170605025|NCT01389323|616559976|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
170605026|NCT01389323|616559976|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
170605027|NCT01389323|616559976|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
170605028|NCT01389323|616559976|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
170605029|NCT01389323|616559976|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
170914273|NCT01097616|617689567|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
170914274|NCT01097616|617689568|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
170605030|NCT01389323|616559976|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
170605031|NCT01389323|616559976|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
170605032|NCT01389323|616559976|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
170605033|NCT01389323|616559976|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
170605034|NCT01389323|616559976|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
170605035|NCT01805037|616559979|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
170605036|NCT01805037|616559980|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
170605037|NCT01805037|616559979|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
170605038|NCT01805037|616559980|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
170605039|NCT01805037|616559979|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
170605040|NCT01805037|616559980|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
170605041|NCT01805037|616559979|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
170605042|NCT01805037|616559980|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
170605043|NCT01805037|616559979|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
170605044|NCT01805037|616559980|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
170652514|NCT01933789|616741642|FG001|Overall Study|Lost to Follow-up|0|||
170813908|NCT02165202|617327322|FG001|Injection Phase|Unable to attend within Visit Window|0|||
170813909|NCT02165202|617327321|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
170813910|NCT02165202|617327322|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
170813911|NCT02165202|617327321|FG000|Injection Phase|End of Study|2|||
170813912|NCT02165202|617327322|FG001|Injection Phase|End of Study|1|||
170813913|NCT02165202|617327321|FG000|Injection Phase|Study Product related Toxicity|1|||
170813914|NCT02165202|617327322|FG001|Injection Phase|Study Product related Toxicity|0|||
170813915|NCT02165202|617327321|FG000|Injection Phase|No longer interested|0|||
170813916|NCT02165202|617327322|FG001|Injection Phase|No longer interested|1|||
170813917|NCT02165202|617327321|FG000|Injection Phase|Participant unwilling to comply|1|||
170914275|NCT01097616|617689569|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
170914276|NCT01097616|617689570|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
170914277|NCT01097616|617689571|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
170914278|NCT01097616|617689572|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
170914279|NCT01097616|617689573|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
170914280|NCT01097616|617689566|FG000|Optional DB EXT Phase|Protocol Violation|0|||
170914281|NCT01097616|617689567|FG001|Optional DB EXT Phase|Protocol Violation|2|||
170914282|NCT01097616|617689568|FG002|Optional DB EXT Phase|Protocol Violation|3|||
170914283|NCT01097616|617689569|FG003|Optional DB EXT Phase|Protocol Violation|0|||
170914284|NCT01097616|617689570|FG004|Optional DB EXT Phase|Protocol Violation|0|||
170914285|NCT01097616|617689571|FG005|Optional DB EXT Phase|Protocol Violation|0|||
170914286|NCT01097616|617689572|FG006|Optional DB EXT Phase|Protocol Violation|0|||
170914287|NCT01097616|617689573|FG007|Optional DB EXT Phase|Protocol Violation|0|||
170914288|NCT01097616|617689566|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
170914289|NCT01097616|617689567|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
170914290|NCT01097616|617689568|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
170914291|NCT01097616|617689569|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
170914292|NCT01097616|617689570|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
170914293|NCT01097616|617689571|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
170914294|NCT01097616|617689572|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
170914295|NCT01097616|617689573|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
170914296|NCT01097616|617689566|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
170914297|NCT01097616|617689567|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
170914298|NCT01097616|617689568|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
170914299|NCT01097616|617689569|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
170914300|NCT01097616|617689570|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
170914301|NCT01097616|617689571|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
170914302|NCT01097616|617689572|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
170914303|NCT01097616|617689573|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
170914304|NCT01097616|617689566|FG000|Optional DB EXT Phase|Physician Decision|1|||
170914305|NCT01097616|617689567|FG001|Optional DB EXT Phase|Physician Decision|0|||
170914306|NCT01097616|617689568|FG002|Optional DB EXT Phase|Physician Decision|0|||
170914307|NCT01097616|617689569|FG003|Optional DB EXT Phase|Physician Decision|0|||
170914308|NCT01097616|617689570|FG004|Optional DB EXT Phase|Physician Decision|0|||
170914309|NCT01097616|617689571|FG005|Optional DB EXT Phase|Physician Decision|0|||
170914310|NCT01097616|617689572|FG006|Optional DB EXT Phase|Physician Decision|0|||
170914311|NCT01097616|617689573|FG007|Optional DB EXT Phase|Physician Decision|0|||
170914312|NCT01097616|617689566|FG000|DB RO Phase|Adverse Event|0|||
170914313|NCT01097616|617689567|FG001|DB RO Phase|Adverse Event|0|||
170914314|NCT01097616|617689568|FG002|DB RO Phase|Adverse Event|0|||
170914315|NCT01097616|617689569|FG003|DB RO Phase|Adverse Event|0|||
170914316|NCT01097616|617689570|FG004|DB RO Phase|Adverse Event|0|||
170914317|NCT01097616|617689571|FG005|DB RO Phase|Adverse Event|0|||
170914318|NCT01097616|617689572|FG006|DB RO Phase|Adverse Event|1|||
170914319|NCT01097616|617689573|FG007|DB RO Phase|Adverse Event|0|||
170914320|NCT01097616|617689566|FG000|DB RO Phase|Withdrawal by Subject|0|||
170914321|NCT01097616|617689567|FG001|DB RO Phase|Withdrawal by Subject|0|||
170914322|NCT01097616|617689568|FG002|DB RO Phase|Withdrawal by Subject|0|||
170914323|NCT01097616|617689569|FG003|DB RO Phase|Withdrawal by Subject|0|||
170914324|NCT01097616|617689570|FG004|DB RO Phase|Withdrawal by Subject|0|||
170914325|NCT01097616|617689571|FG005|DB RO Phase|Withdrawal by Subject|1|||
170914326|NCT01097616|617689572|FG006|DB RO Phase|Withdrawal by Subject|0|||
170914327|NCT01097616|617689573|FG007|DB RO Phase|Withdrawal by Subject|0|||
170914328|NCT01097616|617689566|FG000|DB RO Phase|Lost to Follow-up|0|||
170914329|NCT01097616|617689567|FG001|DB RO Phase|Lost to Follow-up|0|||
170914330|NCT01097616|617689568|FG002|DB RO Phase|Lost to Follow-up|0|||
170914331|NCT01097616|617689569|FG003|DB RO Phase|Lost to Follow-up|1|||
170914332|NCT01097616|617689570|FG004|DB RO Phase|Lost to Follow-up|1|||
170914333|NCT01097616|617689571|FG005|DB RO Phase|Lost to Follow-up|0|||
170813918|NCT02165202|617327322|FG001|Injection Phase|Participant unwilling to comply|0|||
170813919|NCT00759681|617327327|FG000|Overall Study|Death|2|||
170813920|NCT00759681|617327328|FG001|Overall Study|Death|5|||
170813921|NCT00759681|617327327|FG000|Overall Study|Lost to Follow-up|8|||
170914334|NCT01097616|617689572|FG006|DB RO Phase|Lost to Follow-up|0|||
170914335|NCT01097616|617689573|FG007|DB RO Phase|Lost to Follow-up|1|||
170914336|NCT01097616|617689566|FG000|DB RO Phase|Not Treated in RO|0|||
170914337|NCT01097616|617689567|FG001|DB RO Phase|Not Treated in RO|0|||
170605045|NCT01805037|616559979|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
170605046|NCT01805037|616559980|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
170605047|NCT01805037|616559979|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
170605048|NCT01805037|616559980|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
170605049|NCT01805037|616559979|FG000|Follow Up (up to 3 Years)|Death|0|||
170605050|NCT01805037|616559980|FG001|Follow Up (up to 3 Years)|Death|2|||
170605051|NCT01805037|616559979|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
170605052|NCT01805037|616559980|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
170813922|NCT00759681|617327328|FG001|Overall Study|Lost to Follow-up|5|||
170813923|NCT00930644|617327329|FG000|Overall Study|Withdrawal by Subject|4|||
170813924|NCT00930644|617327329|FG000|Overall Study|Physician Decision|2|||
170813925|NCT00930644|617327329|FG000|Overall Study|Death|1|||
170813926|NCT00930644|617327329|FG000|Overall Study|Adverse Event|16|||
170605053|NCT01805037|616559979|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
170605054|NCT01805037|616559980|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
170605055|NCT02879578|616559981|FG000|Overall Study|Adverse Event|1|||
170605056|NCT02879578|616559982|FG001|Overall Study|Adverse Event|2|||
170605057|NCT02879578|616559983|FG002|Overall Study|Adverse Event|14|||
170605058|NCT02879578|616559981|FG000|Overall Study|Protocol Violation|0|||
170605059|NCT02879578|616559982|FG001|Overall Study|Protocol Violation|1|||
170605060|NCT02879578|616559983|FG002|Overall Study|Protocol Violation|1|||
170605061|NCT02879578|616559981|FG000|Overall Study|Withdrawal by Subject|8|||
170605062|NCT02879578|616559982|FG001|Overall Study|Withdrawal by Subject|6|||
170605063|NCT02879578|616559983|FG002|Overall Study|Withdrawal by Subject|9|||
170605064|NCT02879578|616559981|FG000|Overall Study|Lost to Follow-up|1|||
170605065|NCT02879578|616559982|FG001|Overall Study|Lost to Follow-up|0|||
170605066|NCT02879578|616559983|FG002|Overall Study|Lost to Follow-up|4|||
170605067|NCT02879578|616559981|FG000|Overall Study|Physician Decision|0|||
170605068|NCT02879578|616559982|FG001|Overall Study|Physician Decision|0|||
170605069|NCT02879578|616559983|FG002|Overall Study|Physician Decision|4|||
170605070|NCT03517566|616559984|FG000|Overall Study|Adverse Event|5|||
170605071|NCT03517566|616559985|FG001|Overall Study|Adverse Event|2|||
170605072|NCT03517566|616559986|FG002|Overall Study|Adverse Event|2|||
170605073|NCT03517566|616559987|FG003|Overall Study|Adverse Event|8|||
170605074|NCT03517566|616559988|FG004|Overall Study|Adverse Event|7|||
170605075|NCT03517566|616559984|FG000|Overall Study|Lack of Efficacy|3|||
170605076|NCT03517566|616559985|FG001|Overall Study|Lack of Efficacy|2|||
170605077|NCT03517566|616559986|FG002|Overall Study|Lack of Efficacy|1|||
170605078|NCT03517566|616559987|FG003|Overall Study|Lack of Efficacy|1|||
170605079|NCT03517566|616559988|FG004|Overall Study|Lack of Efficacy|4|||
170605080|NCT03517566|616559984|FG000|Overall Study|Lost to Follow-up|3|||
170605081|NCT03517566|616559985|FG001|Overall Study|Lost to Follow-up|1|||
170605082|NCT03517566|616559986|FG002|Overall Study|Lost to Follow-up|1|||
170605083|NCT03517566|616559987|FG003|Overall Study|Lost to Follow-up|1|||
170605084|NCT03517566|616559988|FG004|Overall Study|Lost to Follow-up|0|||
170605085|NCT03517566|616559984|FG000|Overall Study|Physician Decision|1|||
170605086|NCT03517566|616559985|FG001|Overall Study|Physician Decision|1|||
170605087|NCT03517566|616559986|FG002|Overall Study|Physician Decision|0|||
170605088|NCT03517566|616559987|FG003|Overall Study|Physician Decision|1|||
170605089|NCT03517566|616559988|FG004|Overall Study|Physician Decision|0|||
170605090|NCT03517566|616559984|FG000|Overall Study|Pregnancy|0|||
170605091|NCT03517566|616559985|FG001|Overall Study|Pregnancy|1|||
170605092|NCT03517566|616559986|FG002|Overall Study|Pregnancy|0|||
170605093|NCT03517566|616559987|FG003|Overall Study|Pregnancy|0|||
170813927|NCT01129011|617327332|FG000|Overall Study|Adverse Event|20|||
170813928|NCT01129011|617327333|FG001|Overall Study|Adverse Event|30|||
170605094|NCT03517566|616559988|FG004|Overall Study|Pregnancy|0|||
170605095|NCT03517566|616559984|FG000|Overall Study|Protocol Deviation|0|||
170605096|NCT03517566|616559985|FG001|Overall Study|Protocol Deviation|1|||
170605097|NCT03517566|616559986|FG002|Overall Study|Protocol Deviation|0|||
170605098|NCT03517566|616559987|FG003|Overall Study|Protocol Deviation|1|||
170605099|NCT03517566|616559988|FG004|Overall Study|Protocol Deviation|1|||
170605100|NCT03517566|616559984|FG000|Overall Study|Study terminated by Sponsor|11|||
170605101|NCT03517566|616559985|FG001|Overall Study|Study terminated by Sponsor|5|||
170605102|NCT03517566|616559986|FG002|Overall Study|Study terminated by Sponsor|6|||
170605103|NCT03517566|616559987|FG003|Overall Study|Study terminated by Sponsor|14|||
170605104|NCT03517566|616559988|FG004|Overall Study|Study terminated by Sponsor|12|||
170605105|NCT03517566|616559984|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
170605106|NCT03517566|616559985|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
170605107|NCT03517566|616559986|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
170605108|NCT03517566|616559987|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
170605109|NCT03517566|616559988|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
170605110|NCT04566692|616559989|FG000|Overall Study|Adverse Event|2|||
170605111|NCT04566692|616559990|FG001|Overall Study|Adverse Event|0|||
170605112|NCT04566692|616559989|FG000|Overall Study|Withdrawal by Subject|1|||
170605113|NCT04566692|616559990|FG001|Overall Study|Withdrawal by Subject|1|||
170605114|NCT01183468|616559991|FG000|Overall Study|Lost to Follow-up|2|||
170605115|NCT01183468|616559992|FG001|Overall Study|Lost to Follow-up|1|||
170813929|NCT01129011|617327332|FG000|Overall Study|Withdrawal by Subject|24|||
170813930|NCT01129011|617327333|FG001|Overall Study|Withdrawal by Subject|8|||
170813931|NCT01129011|617327332|FG000|Overall Study|Lost to Follow-up|6|||
170813932|NCT01129011|617327333|FG001|Overall Study|Lost to Follow-up|7|||
170813933|NCT01129011|617327332|FG000|Overall Study|Duodenal Ulcer|2|||
170813934|NCT01129011|617327333|FG001|Overall Study|Duodenal Ulcer|8|||
170813935|NCT01129011|617327332|FG000|Overall Study|misc|7|||
170813936|NCT01129011|617327333|FG001|Overall Study|misc|4|||
170813937|NCT01012999|617327334|FG000|Overall Study|Protocol Violation|1|||
170813938|NCT03557307|617327335|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
170813939|NCT03557307|617327335|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
170813940|NCT03557307|617327335|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
170813941|NCT03557307|617327335|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
170813942|NCT03557307|617327335|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
170813943|NCT03557307|617327335|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
170914338|NCT01097616|617689568|FG002|DB RO Phase|Not Treated in RO|0|||
170914339|NCT01097616|617689569|FG003|DB RO Phase|Not Treated in RO|0|||
170914340|NCT01097616|617689570|FG004|DB RO Phase|Not Treated in RO|0|||
170914341|NCT01097616|617689571|FG005|DB RO Phase|Not Treated in RO|1|||
170914342|NCT01097616|617689572|FG006|DB RO Phase|Not Treated in RO|0|||
170914343|NCT01097616|617689573|FG007|DB RO Phase|Not Treated in RO|0|||
170914344|NCT00130208|617689574|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
170914345|NCT00130208|617689575|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
170914346|NCT00130208|617689574|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
170914347|NCT00130208|617689575|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
170914348|NCT00130208|617689574|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
170914349|NCT00130208|617689575|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
170914350|NCT00130208|617689574|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
170914351|NCT00130208|617689575|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
170914352|NCT00130208|617689574|FG000|Maintenance Period (26 Weeks)|Other|1|||
170914353|NCT00130208|617689575|FG001|Maintenance Period (26 Weeks)|Other|1|||
170914354|NCT00130208|617689574|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
170914355|NCT00130208|617689575|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
170914356|NCT00130208|617689574|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
170914357|NCT00130208|617689575|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
170914358|NCT00130208|617689574|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
170914359|NCT00130208|617689575|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
170914360|NCT00130208|617689574|FG000|Washout Period (8 Weeks)|Other|1|||
170914361|NCT00130208|617689575|FG001|Washout Period (8 Weeks)|Other|1|||
170914362|NCT01380093|617689576|FG000|Naloxone Challenge Phase|Screen failures|21|||
170914363|NCT01380093|617689577|FG001|Naloxone Challenge Phase|Screen failures|0|||
170914364|NCT01380093|617689578|FG002|Naloxone Challenge Phase|Screen failures|0|||
170914365|NCT01380093|617689579|FG003|Naloxone Challenge Phase|Screen failures|0|||
170914366|NCT01380093|617689580|FG004|Naloxone Challenge Phase|Screen failures|0|||
170914367|NCT01380093|617689581|FG005|Naloxone Challenge Phase|Screen failures|0|||
170914368|NCT01380093|617689582|FG006|Naloxone Challenge Phase|Screen failures|0|||
170914369|NCT01380093|617689583|FG007|Naloxone Challenge Phase|Screen failures|0|||
170914370|NCT01380093|617689584|FG008|Naloxone Challenge Phase|Screen failures|0|||
170914371|NCT01380093|617689576|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
170914372|NCT01380093|617689577|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
170914373|NCT01380093|617689578|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
170914374|NCT01380093|617689579|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
170914375|NCT01380093|617689580|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
170914376|NCT01380093|617689581|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
170914377|NCT01380093|617689582|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
170605116|NCT01183468|616559993|FG002|Overall Study|Lost to Follow-up|0|||
170605117|NCT01183468|616559994|FG003|Overall Study|Lost to Follow-up|0|||
170605118|NCT01183468|616559991|FG000|Overall Study|Physician Decision|1|||
170605119|NCT01183468|616559992|FG001|Overall Study|Physician Decision|0|||
170605120|NCT01183468|616559993|FG002|Overall Study|Physician Decision|0|||
170605121|NCT01183468|616559994|FG003|Overall Study|Physician Decision|0|||
170605122|NCT01183468|616559991|FG000|Overall Study|Withdrawal by Subject|0|||
170605123|NCT01183468|616559992|FG001|Overall Study|Withdrawal by Subject|1|||
170605124|NCT01183468|616559993|FG002|Overall Study|Withdrawal by Subject|0|||
170605125|NCT01183468|616559994|FG003|Overall Study|Withdrawal by Subject|0|||
170605126|NCT01229449|616559995|FG000|Overall Study|Withdrawal by Subject|0|||
170652515|NCT01933789|616741643|FG002|Overall Study|Lost to Follow-up|0|||
170652516|NCT01933789|616741644|FG003|Overall Study|Lost to Follow-up|1|||
170605127|NCT01229449|616559996|FG001|Overall Study|Withdrawal by Subject|3|||
170652517|NCT01933789|616741645|FG004|Overall Study|Lost to Follow-up|8|||
170652518|NCT01933789|616741646|FG005|Overall Study|Lost to Follow-up|9|||
170605128|NCT01229449|616559997|FG002|Overall Study|Withdrawal by Subject|0|||
170605129|NCT01229449|616559998|FG003|Overall Study|Withdrawal by Subject|1|||
170652519|NCT01933789|616741647|FG006|Overall Study|Lost to Follow-up|1|||
170605130|NCT01229449|616559999|FG004|Overall Study|Withdrawal by Subject|1|||
170605131|NCT01229449|616559995|FG000|Overall Study|Lost to Follow-up|1|||
170605132|NCT01229449|616559996|FG001|Overall Study|Lost to Follow-up|1|||
170605133|NCT01229449|616559997|FG002|Overall Study|Lost to Follow-up|1|||
170605134|NCT01229449|616559998|FG003|Overall Study|Lost to Follow-up|0|||
170605135|NCT01229449|616559999|FG004|Overall Study|Lost to Follow-up|0|||
170605136|NCT01229449|616559995|FG000|Overall Study|Physician Decision|0|||
170605137|NCT01229449|616559996|FG001|Overall Study|Physician Decision|0|||
170605138|NCT01229449|616559997|FG002|Overall Study|Physician Decision|1|||
170605139|NCT01229449|616559998|FG003|Overall Study|Physician Decision|0|||
170605140|NCT01229449|616559999|FG004|Overall Study|Physician Decision|0|||
170605141|NCT03203291|616560000|FG000|Overall Study|Withdrawal by Subject|1|||
170605142|NCT01300260|616560001|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
170605143|NCT01300260|616560002|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
170605144|NCT01300260|616560001|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
170605145|NCT01300260|616560002|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
170605146|NCT01300260|616560001|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
170605147|NCT01300260|616560002|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
170605148|NCT05098509|616560005|FG000|Overall Study|Withdrawal by Subject|0|||
170605149|NCT05098509|616560006|FG001|Overall Study|Withdrawal by Subject|0|||
170605150|NCT05098509|616560007|FG002|Overall Study|Withdrawal by Subject|1|||
170605151|NCT05098509|616560008|FG003|Overall Study|Withdrawal by Subject|0|||
170605152|NCT05098509|616560005|FG000|Overall Study|Early study termination|1|||
170605153|NCT05098509|616560006|FG001|Overall Study|Early study termination|1|||
170605154|NCT05098509|616560007|FG002|Overall Study|Early study termination|1|||
170605155|NCT05098509|616560008|FG003|Overall Study|Early study termination|0|||
170605156|NCT01147848|616560009|FG000|Run-in Period|Screen Failure|623|||
170605157|NCT01147848|616560010|FG001|Run-in Period|Screen Failure|0|||
170605158|NCT01147848|616560011|FG002|Run-in Period|Screen Failure|0|||
170813944|NCT03557307|617327335|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
170813945|NCT03557307|617327335|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
170813946|NCT03557307|617327335|FG000|Period 2: Maintenance Phase|Death|3|||
170813947|NCT03557307|617327335|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
170813948|NCT03557307|617327335|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
170813949|NCT03557307|617327335|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
170813950|NCT03557307|617327335|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
170813951|NCT03557307|617327335|FG000|Period 2: Maintenance Phase|other|3|||
170813952|NCT02584257|617327338|FG000|Period 1|Withdrawal by Subject|0|||
170605159|NCT01147848|616560009|FG000|Run-in Period|Run-in Failure|135|||
170605160|NCT01147848|616560010|FG001|Run-in Period|Run-in Failure|0|||
170605161|NCT01147848|616560011|FG002|Run-in Period|Run-in Failure|0|||
170605162|NCT01147848|616560009|FG000|Randomized Phase|Adverse Event|0|||
170605163|NCT01147848|616560010|FG001|Randomized Phase|Adverse Event|6|||
170605164|NCT01147848|616560011|FG002|Randomized Phase|Adverse Event|8|||
170605165|NCT01147848|616560009|FG000|Randomized Phase|Lack of Efficacy|0|||
170605166|NCT01147848|616560010|FG001|Randomized Phase|Lack of Efficacy|20|||
170605167|NCT01147848|616560011|FG002|Randomized Phase|Lack of Efficacy|11|||
170605168|NCT01147848|616560009|FG000|Randomized Phase|Protocol Violation|0|||
170652520|NCT01933789|616741648|FG007|Overall Study|Lost to Follow-up|4|||
170652521|NCT01933789|616741649|FG008|Overall Study|Lost to Follow-up|0|||
170652522|NCT01933789|616741641|FG000|Overall Study|Withdrawal by Subject|2|||
170605169|NCT01147848|616560010|FG001|Randomized Phase|Protocol Violation|7|||
170652523|NCT01933789|616741642|FG001|Overall Study|Withdrawal by Subject|1|||
170652524|NCT01933789|616741643|FG002|Overall Study|Withdrawal by Subject|0|||
170813953|NCT02584257|617327339|FG001|Period 1|Withdrawal by Subject|0|||
170605170|NCT01147848|616560011|FG002|Randomized Phase|Protocol Violation|10|||
170605171|NCT01147848|616560009|FG000|Randomized Phase|Lost to Follow-up|0|||
170605172|NCT01147848|616560010|FG001|Randomized Phase|Lost to Follow-up|5|||
170605173|NCT01147848|616560011|FG002|Randomized Phase|Lost to Follow-up|7|||
170605174|NCT01147848|616560009|FG000|Randomized Phase|Physician Decision|0|||
170605175|NCT01147848|616560010|FG001|Randomized Phase|Physician Decision|0|||
170605176|NCT01147848|616560011|FG002|Randomized Phase|Physician Decision|1|||
170605177|NCT01147848|616560009|FG000|Randomized Phase|Withdrawal by Subject|0|||
170605178|NCT01147848|616560010|FG001|Randomized Phase|Withdrawal by Subject|7|||
170605179|NCT01147848|616560011|FG002|Randomized Phase|Withdrawal by Subject|9|||
170605180|NCT04033068|616560012|FG000|Overall Study|Withdrawal by Subject|0|||
170605181|NCT04033068|616560013|FG001|Overall Study|Withdrawal by Subject|0|||
170605182|NCT04033068|616560014|FG002|Overall Study|Withdrawal by Subject|1|||
170605183|NCT04033068|616560015|FG003|Overall Study|Withdrawal by Subject|0|||
170605184|NCT04033068|616560012|FG000|Overall Study|Lost to Follow-up|0|||
170605185|NCT04033068|616560013|FG001|Overall Study|Lost to Follow-up|1|||
170605186|NCT04033068|616560014|FG002|Overall Study|Lost to Follow-up|0|||
170605187|NCT04033068|616560015|FG003|Overall Study|Lost to Follow-up|0|||
170605188|NCT04033068|616560012|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
170605189|NCT04033068|616560013|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
170605190|NCT04033068|616560014|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
170605191|NCT04033068|616560015|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
170605192|NCT02540265|616560016|FG000|Overall Study|Lost to Follow-up|0|||
170605193|NCT02540265|616560017|FG001|Overall Study|Lost to Follow-up|0|||
170605194|NCT02540265|616560018|FG002|Overall Study|Lost to Follow-up|1|||
170605195|NCT03157037|616560022|FG000|Overall Study|Death|1|||
170605196|NCT04349033|616560023|FG000|Overall Study|Lost to Follow-up|3|||
170605197|NCT04349033|616560024|FG001|Overall Study|Lost to Follow-up|1|||
170605198|NCT04349033|616560025|FG002|Overall Study|Lost to Follow-up|1|||
170605199|NCT00324233|616560028|FG000|First Period|unable to insert catheter|1|||
170605200|NCT00324233|616560029|FG001|First Period|unable to insert catheter|0|||
170605201|NCT00324233|616560028|FG000|Second Period|unable to insert catheter|1|||
170605202|NCT00324233|616560029|FG001|Second Period|unable to insert catheter|1|||
170605203|NCT00324233|616560028|FG000|Second Period|Protocol Violation|4|||
170605204|NCT00324233|616560029|FG001|Second Period|Protocol Violation|6|||
170605205|NCT01972789|616560030|FG000|Overall Study|Adverse Event|11|||
170605206|NCT01972789|616560031|FG001|Overall Study|Adverse Event|4|||
170605207|NCT01972789|616560030|FG000|Overall Study|Subject withdrew consent|14|||
170605208|NCT01972789|616560031|FG001|Overall Study|Subject withdrew consent|12|||
170605209|NCT01972789|616560030|FG000|Overall Study|Lost to Follow-up|4|||
170605210|NCT01972789|616560031|FG001|Overall Study|Lost to Follow-up|7|||
170605211|NCT01972789|616560030|FG000|Overall Study|Death|7|||
170605212|NCT01972789|616560031|FG001|Overall Study|Death|5|||
170605213|NCT01972789|616560030|FG000|Overall Study|Protocol deviation|1|||
170605214|NCT01972789|616560031|FG001|Overall Study|Protocol deviation|0|||
170605215|NCT01972789|616560030|FG000|Overall Study|Physician Decision|3|||
170605216|NCT01972789|616560031|FG001|Overall Study|Physician Decision|2|||
170605217|NCT01704456|616560034|FG000|Overall Study|Lost to Follow-up|8|||
170605218|NCT01704456|616560035|FG001|Overall Study|Lost to Follow-up|14|||
170605219|NCT04496453|616560036|FG000|Overall Study|Lost to Follow-up|6|||
170605220|NCT03262441|616560048|FG000|Overall Study|Withdrawal by Subject|1|||
170605221|NCT01545050|616560049|FG000|Overall Study|Lack of Efficacy|0|||
170605222|NCT01545050|616560050|FG001|Overall Study|Lack of Efficacy|0|||
170605223|NCT01545050|616560051|FG002|Overall Study|Lack of Efficacy|0|||
170605224|NCT01545050|616560052|FG003|Overall Study|Lack of Efficacy|3|||
170605225|NCT01545050|616560053|FG004|Overall Study|Lack of Efficacy|2|||
170605226|NCT01545050|616560049|FG000|Overall Study|Adverse Event|1|||
170605227|NCT01545050|616560050|FG001|Overall Study|Adverse Event|1|||
170605228|NCT01545050|616560051|FG002|Overall Study|Adverse Event|2|||
170605229|NCT01545050|616560052|FG003|Overall Study|Adverse Event|2|||
170813954|NCT02584257|617327340|FG002|Period 1|Withdrawal by Subject|0|||
170813955|NCT02584257|617327341|FG003|Period 1|Withdrawal by Subject|0|||
170813956|NCT02584257|617327342|FG004|Period 1|Withdrawal by Subject|0|||
170813957|NCT02584257|617327343|FG005|Period 1|Withdrawal by Subject|0|||
170813958|NCT02584257|617327344|FG006|Period 1|Withdrawal by Subject|1|||
170813959|NCT02584257|617327345|FG007|Period 1|Withdrawal by Subject|0|||
170652525|NCT01933789|616741644|FG003|Overall Study|Withdrawal by Subject|0|||
170652526|NCT01933789|616741645|FG004|Overall Study|Withdrawal by Subject|17|||
170652527|NCT01933789|616741646|FG005|Overall Study|Withdrawal by Subject|16|||
170652528|NCT01933789|616741647|FG006|Overall Study|Withdrawal by Subject|1|||
170652529|NCT01933789|616741648|FG007|Overall Study|Withdrawal by Subject|4|||
170652530|NCT01933789|616741649|FG008|Overall Study|Withdrawal by Subject|0|||
170652531|NCT01933789|616741641|FG000|Overall Study|Became Ineligible|4|||
170652532|NCT01933789|616741642|FG001|Overall Study|Became Ineligible|0|||
170652533|NCT01933789|616741643|FG002|Overall Study|Became Ineligible|0|||
170652534|NCT01933789|616741644|FG003|Overall Study|Became Ineligible|0|||
170652535|NCT01933789|616741645|FG004|Overall Study|Became Ineligible|13|||
170652536|NCT01933789|616741646|FG005|Overall Study|Became Ineligible|10|||
170652537|NCT01933789|616741647|FG006|Overall Study|Became Ineligible|13|||
170652538|NCT01933789|616741648|FG007|Overall Study|Became Ineligible|6|||
170813960|NCT02584257|617327346|FG008|Period 1|Withdrawal by Subject|0|||
170813961|NCT02584257|617327338|FG000|Period 2|Physician Decision|1|||
170813962|NCT02584257|617327339|FG001|Period 2|Physician Decision|0|||
170813963|NCT02584257|617327340|FG002|Period 2|Physician Decision|0|||
170813964|NCT02584257|617327341|FG003|Period 2|Physician Decision|0|||
170813965|NCT02584257|617327342|FG004|Period 2|Physician Decision|0|||
170813966|NCT02584257|617327343|FG005|Period 2|Physician Decision|0|||
170813967|NCT02584257|617327344|FG006|Period 2|Physician Decision|0|||
170813968|NCT02584257|617327345|FG007|Period 2|Physician Decision|0|||
170813969|NCT02584257|617327346|FG008|Period 2|Physician Decision|0|||
170813970|NCT02584257|617327338|FG000|Period 2|Adverse Event|0|||
170813971|NCT02584257|617327339|FG001|Period 2|Adverse Event|1|||
170914378|NCT01380093|617689583|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
170914379|NCT01380093|617689584|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
170914380|NCT01380093|617689576|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
170914381|NCT01380093|617689577|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
170914382|NCT01380093|617689578|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
170914383|NCT01380093|617689579|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
170914384|NCT01380093|617689580|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
170914385|NCT01380093|617689581|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
170914386|NCT01380093|617689582|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
170914387|NCT01380093|617689583|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
170914388|NCT01380093|617689584|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
170914389|NCT01380093|617689576|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
170914390|NCT01380093|617689577|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
170914391|NCT01380093|617689578|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
170914392|NCT01380093|617689579|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
170914393|NCT01380093|617689580|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
170914394|NCT01380093|617689581|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
170914395|NCT01380093|617689582|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
170914396|NCT01380093|617689583|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
170914397|NCT01380093|617689584|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
170914398|NCT01380093|617689576|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
170914399|NCT01380093|617689577|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
170914400|NCT01380093|617689578|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
170914401|NCT01380093|617689579|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
170914402|NCT01380093|617689580|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
170652539|NCT01933789|616741649|FG008|Overall Study|Became Ineligible|0|||
170813972|NCT02584257|617327340|FG002|Period 2|Adverse Event|0|||
170813973|NCT02584257|617327341|FG003|Period 2|Adverse Event|0|||
170914403|NCT01380093|617689581|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
170914404|NCT01380093|617689582|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
170652540|NCT00723203|616741654|FG000|Overall Study|Withdrawal by Subject|3|||
170813974|NCT02584257|617327342|FG004|Period 2|Adverse Event|0|||
170813975|NCT02584257|617327343|FG005|Period 2|Adverse Event|0|||
170813976|NCT02584257|617327344|FG006|Period 2|Adverse Event|0|||
170813977|NCT02584257|617327345|FG007|Period 2|Adverse Event|0|||
170813978|NCT02584257|617327346|FG008|Period 2|Adverse Event|0|||
170813979|NCT01358175|617327351|FG000|Overall Study|Death|1|||
170813980|NCT01358175|617327352|FG001|Overall Study|Death|0|||
170813981|NCT01358175|617327353|FG002|Overall Study|Death|1|||
170813982|NCT01358175|617327351|FG000|Overall Study|Withdrawal by Subject|9|||
170813983|NCT01358175|617327352|FG001|Overall Study|Withdrawal by Subject|5|||
170813984|NCT01358175|617327353|FG002|Overall Study|Withdrawal by Subject|10|||
170813985|NCT01358175|617327351|FG000|Overall Study|Technical issues|0|||
170813986|NCT01358175|617327352|FG001|Overall Study|Technical issues|1|||
170813987|NCT01358175|617327353|FG002|Overall Study|Technical issues|0|||
170813988|NCT01358175|617327351|FG000|Overall Study|Pregnancy|0|||
170813989|NCT01358175|617327352|FG001|Overall Study|Pregnancy|1|||
170813990|NCT01358175|617327353|FG002|Overall Study|Pregnancy|0|||
170813991|NCT01358175|617327351|FG000|Overall Study|Physician Decision|1|||
170813992|NCT01358175|617327352|FG001|Overall Study|Physician Decision|0|||
170813993|NCT01358175|617327353|FG002|Overall Study|Physician Decision|0|||
170605230|NCT01545050|616560053|FG004|Overall Study|Adverse Event|0|||
170605231|NCT01545050|616560049|FG000|Overall Study|Discontinued study treatment|1|||
170605232|NCT01545050|616560050|FG001|Overall Study|Discontinued study treatment|0|||
170813994|NCT01358175|617327351|FG000|Overall Study|Non Compliance with Study Treatment|0|||
170813995|NCT01358175|617327352|FG001|Overall Study|Non Compliance with Study Treatment|1|||
170813996|NCT01358175|617327353|FG002|Overall Study|Non Compliance with Study Treatment|1|||
170813997|NCT01358175|617327351|FG000|Overall Study|Lost to Follow-up|1|||
170914405|NCT01380093|617689583|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
170914406|NCT01380093|617689584|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
170914407|NCT01380093|617689576|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
170914408|NCT01380093|617689577|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
170914409|NCT01380093|617689578|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
170914410|NCT01380093|617689579|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
170914411|NCT01380093|617689580|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
170914412|NCT01380093|617689581|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
170813998|NCT01358175|617327352|FG001|Overall Study|Lost to Follow-up|1|||
170813999|NCT01358175|617327353|FG002|Overall Study|Lost to Follow-up|3|||
170814000|NCT01358175|617327351|FG000|Overall Study|Lack of Efficacy|3|||
170605233|NCT01545050|616560051|FG002|Overall Study|Discontinued study treatment|0|||
170605234|NCT01545050|616560052|FG003|Overall Study|Discontinued study treatment|0|||
170605235|NCT01545050|616560053|FG004|Overall Study|Discontinued study treatment|0|||
170605236|NCT01545050|616560049|FG000|Overall Study|Withdrawal by Subject|1|||
170814001|NCT01358175|617327352|FG001|Overall Study|Lack of Efficacy|8|||
170814002|NCT01358175|617327353|FG002|Overall Study|Lack of Efficacy|6|||
170814003|NCT01358175|617327351|FG000|Overall Study|Adverse Event|6|||
170814004|NCT01358175|617327352|FG001|Overall Study|Adverse Event|11|||
170814005|NCT01358175|617327353|FG002|Overall Study|Adverse Event|11|||
170814006|NCT01762345|617327354|FG000|Overall Study|Adverse Event|5|||
170814007|NCT01762345|617327354|FG000|Overall Study|Protocol Violation|2|||
170814008|NCT03481725|617327355|FG000|Overall Study|Withdrawal by Subject|1|||
170814009|NCT03481725|617327356|FG001|Overall Study|Withdrawal by Subject|0|||
170814010|NCT04908488|617327357|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
170814011|NCT04908488|617327358|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
170814012|NCT04908488|617327357|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
170814013|NCT04908488|617327358|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
170814014|NCT03444155|617327363|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
170814015|NCT03444155|617327364|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
170814016|NCT02206607|617327365|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
170814017|NCT02206607|617327366|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
170814018|NCT02206607|617327367|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
170814019|NCT02206607|617327368|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
170814020|NCT02206607|617327369|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
170814021|NCT02206607|617327365|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
170814022|NCT02206607|617327366|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
170814023|NCT02206607|617327367|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
170814024|NCT02206607|617327368|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
170814025|NCT02206607|617327369|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
170814026|NCT00879710|617327376|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
170814027|NCT00879710|617327377|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
170814028|NCT00879710|617327378|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
170814029|NCT00879710|617327379|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
170814030|NCT00879710|617327376|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
170814031|NCT00879710|617327377|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
170814032|NCT00879710|617327378|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
170814033|NCT00879710|617327379|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
170814034|NCT01864200|617327380|FG000|Overall Study|Lost to Follow-up|1|||
170814035|NCT01864200|617327381|FG001|Overall Study|Lost to Follow-up|3|||
170814036|NCT01864200|617327380|FG000|Overall Study|Protocol Violation|1|||
170814037|NCT01864200|617327381|FG001|Overall Study|Protocol Violation|0|||
170814038|NCT01777932|617327391|FG000|Overall Study|Disease progression|136|||
170814039|NCT01777932|617327391|FG000|Overall Study|Death|3|||
170814040|NCT01777932|617327391|FG000|Overall Study|Adverse Event|34|||
170814041|NCT01777932|617327391|FG000|Overall Study|Lost to Follow-up|3|||
170814042|NCT01777932|617327391|FG000|Overall Study|Investigator decision|10|||
170605237|NCT01545050|616560050|FG001|Overall Study|Withdrawal by Subject|0|||
170605238|NCT01545050|616560051|FG002|Overall Study|Withdrawal by Subject|0|||
170605239|NCT01545050|616560052|FG003|Overall Study|Withdrawal by Subject|2|||
170605240|NCT01545050|616560053|FG004|Overall Study|Withdrawal by Subject|1|||
170605241|NCT01545050|616560049|FG000|Overall Study|Participant no longer meets study criteria|0|||
170814043|NCT01777932|617327391|FG000|Overall Study|Reimbursement limit|9|||
170814044|NCT01777932|617327391|FG000|Overall Study|Patient refused further treatment|10|||
170814045|NCT00963924|617327395|FG000|Overall Study|Adverse Event|1|||
170814046|NCT00963924|617327396|FG001|Overall Study|Adverse Event|0|||
170814047|NCT00963924|617327395|FG000|Overall Study|Withdrawal by Subject|0|||
170814048|NCT00963924|617327396|FG001|Overall Study|Withdrawal by Subject|1|||
170814049|NCT00963924|617327395|FG000|Overall Study|Changed antipsychotic|0|||
170605242|NCT01545050|616560050|FG001|Overall Study|Participant no longer meets study criteria|2|||
170605243|NCT01545050|616560051|FG002|Overall Study|Participant no longer meets study criteria|0|||
170605244|NCT01545050|616560052|FG003|Overall Study|Participant no longer meets study criteria|0|||
170605245|NCT01545050|616560053|FG004|Overall Study|Participant no longer meets study criteria|1|||
170605246|NCT01545050|616560049|FG000|Overall Study|Administrative reason by sponsor|4|||
170605247|NCT01545050|616560050|FG001|Overall Study|Administrative reason by sponsor|2|||
170605248|NCT01545050|616560051|FG002|Overall Study|Administrative reason by sponsor|3|||
170605249|NCT01545050|616560052|FG003|Overall Study|Administrative reason by sponsor|5|||
170605250|NCT01545050|616560053|FG004|Overall Study|Administrative reason by sponsor|5|||
170914413|NCT01380093|617689582|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
170914414|NCT01380093|617689583|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
170914415|NCT01380093|617689584|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
170914416|NCT01380093|617689576|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
170914417|NCT01380093|617689577|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
170914418|NCT01380093|617689578|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
170914419|NCT01380093|617689579|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
170914420|NCT01380093|617689580|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
170914421|NCT01380093|617689581|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
170914422|NCT01380093|617689582|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
170914423|NCT01380093|617689583|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
170914424|NCT01380093|617689584|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
170914425|NCT01380093|617689576|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
170914426|NCT01380093|617689577|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
170914427|NCT01380093|617689578|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
170914428|NCT01380093|617689579|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
170914429|NCT01380093|617689580|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
170914430|NCT01380093|617689581|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
170914431|NCT01380093|617689582|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
170914432|NCT01380093|617689583|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
170914433|NCT01380093|617689584|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
170914434|NCT01380093|617689576|FG000|Treatment Phase: Second Intervention|Other|0|||
170914435|NCT01380093|617689577|FG001|Treatment Phase: Second Intervention|Other|0|||
170914436|NCT01380093|617689578|FG002|Treatment Phase: Second Intervention|Other|0|||
170914437|NCT01380093|617689579|FG003|Treatment Phase: Second Intervention|Other|1|||
170914438|NCT01380093|617689580|FG004|Treatment Phase: Second Intervention|Other|0|||
170914439|NCT01380093|617689581|FG005|Treatment Phase: Second Intervention|Other|0|||
170914440|NCT01380093|617689582|FG006|Treatment Phase: Second Intervention|Other|0|||
170914441|NCT01380093|617689583|FG007|Treatment Phase: Second Intervention|Other|0|||
170914442|NCT01380093|617689584|FG008|Treatment Phase: Second Intervention|Other|0|||
170914443|NCT01380093|617689576|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
170914444|NCT01380093|617689577|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
170914445|NCT01380093|617689578|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
170914446|NCT01380093|617689579|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
170914447|NCT01380093|617689580|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
170914448|NCT01380093|617689581|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
170914449|NCT01380093|617689582|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
170914450|NCT01380093|617689583|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
170914451|NCT01380093|617689584|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
170914452|NCT01380093|617689576|FG000|Treatment Phase: Third Intervention|Other|0|||
170914453|NCT01380093|617689577|FG001|Treatment Phase: Third Intervention|Other|0|||
170914454|NCT01380093|617689578|FG002|Treatment Phase: Third Intervention|Other|0|||
170914455|NCT01380093|617689579|FG003|Treatment Phase: Third Intervention|Other|0|||
170914456|NCT01380093|617689580|FG004|Treatment Phase: Third Intervention|Other|0|||
170914457|NCT01380093|617689581|FG005|Treatment Phase: Third Intervention|Other|0|||
170914458|NCT01380093|617689582|FG006|Treatment Phase: Third Intervention|Other|0|||
170914459|NCT01380093|617689583|FG007|Treatment Phase: Third Intervention|Other|0|||
170914460|NCT01380093|617689584|FG008|Treatment Phase: Third Intervention|Other|1|||
170605251|NCT02607228|616560054|FG000|Overall Study|Progressive Disease|4|||
170605252|NCT02607228|616560055|FG001|Overall Study|Progressive Disease|3|||
170605253|NCT02607228|616560056|FG002|Overall Study|Progressive Disease|1|||
170605254|NCT02607228|616560057|FG003|Overall Study|Progressive Disease|5|||
170605255|NCT02607228|616560058|FG004|Overall Study|Progressive Disease|4|||
170605256|NCT02607228|616560059|FG005|Overall Study|Progressive Disease|3|||
170605257|NCT02607228|616560060|FG006|Overall Study|Progressive Disease|1|||
170605258|NCT02607228|616560054|FG000|Overall Study|Adverse Event|1|||
170605259|NCT02607228|616560055|FG001|Overall Study|Adverse Event|0|||
170605260|NCT02607228|616560056|FG002|Overall Study|Adverse Event|1|||
170605261|NCT02607228|616560057|FG003|Overall Study|Adverse Event|0|||
170914461|NCT03988751|617689586|FG000|Overall Study|Withdrawal by Subject|1|||
170914462|NCT03988751|617689587|FG001|Overall Study|Withdrawal by Subject|0|||
170914463|NCT03988751|617689586|FG000|Overall Study|Protocol Violation|0|||
170914464|NCT03988751|617689587|FG001|Overall Study|Protocol Violation|1|||
170605262|NCT02607228|616560058|FG004|Overall Study|Adverse Event|1|||
170605263|NCT02607228|616560059|FG005|Overall Study|Adverse Event|1|||
170605264|NCT02607228|616560060|FG006|Overall Study|Adverse Event|1|||
170605265|NCT02607228|616560054|FG000|Overall Study|Investigator's Discretion|0|||
170605266|NCT02607228|616560055|FG001|Overall Study|Investigator's Discretion|0|||
170605267|NCT02607228|616560056|FG002|Overall Study|Investigator's Discretion|1|||
170605268|NCT02607228|616560057|FG003|Overall Study|Investigator's Discretion|0|||
170605269|NCT02607228|616560058|FG004|Overall Study|Investigator's Discretion|0|||
170605270|NCT02607228|616560059|FG005|Overall Study|Investigator's Discretion|1|||
170605271|NCT02607228|616560060|FG006|Overall Study|Investigator's Discretion|0|||
170814050|NCT00963924|617327396|FG001|Overall Study|Changed antipsychotic|1|||
170814051|NCT00963924|617327395|FG000|Overall Study|Lost to Follow-up|0|||
170814052|NCT00963924|617327396|FG001|Overall Study|Lost to Follow-up|1|||
170814053|NCT00068107|617327397|FG000|Overall Study|end-stage renal disease|6|||
170814054|NCT00068107|617327397|FG000|Overall Study|Death|2|||
170814055|NCT00068107|617327397|FG000|Overall Study|Withdrawal by Subject|1|||
170814056|NCT00446095|617327398|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
170814057|NCT00446095|617327399|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
170814058|NCT00446095|617327400|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
170814059|NCT00446095|617327401|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
170814060|NCT00446095|617327402|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
170814061|NCT00446095|617327398|FG000|Phase II (8 Weeks)|Adverse Event|0|||
170814062|NCT00446095|617327399|FG001|Phase II (8 Weeks)|Adverse Event|1|||
170814063|NCT00446095|617327400|FG002|Phase II (8 Weeks)|Adverse Event|1|||
170814064|NCT00446095|617327401|FG003|Phase II (8 Weeks)|Adverse Event|0|||
170814065|NCT00446095|617327402|FG004|Phase II (8 Weeks)|Adverse Event|0|||
170814066|NCT00446095|617327398|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
170814067|NCT00446095|617327399|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
170814068|NCT00446095|617327400|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
170814069|NCT00446095|617327401|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
170814070|NCT00446095|617327402|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
170814071|NCT00446095|617327398|FG000|Phase II (8 Weeks)|Physician Decision|1|||
170814072|NCT00446095|617327399|FG001|Phase II (8 Weeks)|Physician Decision|0|||
170814073|NCT00446095|617327400|FG002|Phase II (8 Weeks)|Physician Decision|0|||
170814074|NCT00446095|617327401|FG003|Phase II (8 Weeks)|Physician Decision|0|||
170814075|NCT00446095|617327402|FG004|Phase II (8 Weeks)|Physician Decision|0|||
170814076|NCT00446095|617327398|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
170814077|NCT00446095|617327399|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
170814078|NCT00446095|617327400|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
170814079|NCT00446095|617327401|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
170814080|NCT00446095|617327402|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
170814081|NCT00446095|617327398|FG000|Phase II (8 Weeks)|Ongoing|0|||
170814082|NCT00446095|617327399|FG001|Phase II (8 Weeks)|Ongoing|0|||
170814083|NCT00446095|617327400|FG002|Phase II (8 Weeks)|Ongoing|1|||
170814084|NCT00446095|617327401|FG003|Phase II (8 Weeks)|Ongoing|0|||
170814085|NCT00446095|617327402|FG004|Phase II (8 Weeks)|Ongoing|0|||
170814086|NCT00446095|617327398|FG000|Phase I (28 Days)|Adverse Event|0|||
170814087|NCT00446095|617327399|FG001|Phase I (28 Days)|Adverse Event|0|||
170814088|NCT00446095|617327400|FG002|Phase I (28 Days)|Adverse Event|0|||
170814089|NCT00446095|617327401|FG003|Phase I (28 Days)|Adverse Event|1|||
170814090|NCT00446095|617327402|FG004|Phase I (28 Days)|Adverse Event|0|||
170814091|NCT00446095|617327398|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
170814092|NCT00446095|617327399|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
170814093|NCT00446095|617327400|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
170814094|NCT00446095|617327401|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
170814095|NCT00446095|617327402|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
170814096|NCT00657709|617327404|FG000|Overall Study|AE or Death|7|||
170814097|NCT00657709|617327405|FG001|Overall Study|AE or Death|7|||
170814098|NCT00657709|617327406|FG002|Overall Study|AE or Death|6|||
170814099|NCT00657709|617327407|FG003|Overall Study|AE or Death|7|||
170814100|NCT00657709|617327408|FG004|Overall Study|AE or Death|1|||
170814101|NCT00657709|617327404|FG000|Overall Study|Withdrawal by Subject|7|||
170814102|NCT00657709|617327405|FG001|Overall Study|Withdrawal by Subject|15|||
170814103|NCT00657709|617327406|FG002|Overall Study|Withdrawal by Subject|15|||
170814104|NCT00657709|617327407|FG003|Overall Study|Withdrawal by Subject|5|||
170814105|NCT00657709|617327408|FG004|Overall Study|Withdrawal by Subject|9|||
170814106|NCT00657709|617327404|FG000|Overall Study|Lost to Follow-up|9|||
170814107|NCT00657709|617327405|FG001|Overall Study|Lost to Follow-up|9|||
170814108|NCT00657709|617327406|FG002|Overall Study|Lost to Follow-up|7|||
170814109|NCT00657709|617327407|FG003|Overall Study|Lost to Follow-up|1|||
170605272|NCT02607228|616560054|FG000|Overall Study|Withdrew Consent|0|||
170605273|NCT02607228|616560055|FG001|Overall Study|Withdrew Consent|1|||
170605274|NCT02607228|616560056|FG002|Overall Study|Withdrew Consent|0|||
170814110|NCT00657709|617327408|FG004|Overall Study|Lost to Follow-up|21|||
170814111|NCT00657709|617327404|FG000|Overall Study|Protocol Violation|0|||
170814112|NCT00657709|617327405|FG001|Overall Study|Protocol Violation|2|||
170814113|NCT00657709|617327406|FG002|Overall Study|Protocol Violation|0|||
170814114|NCT00657709|617327407|FG003|Overall Study|Protocol Violation|1|||
170814115|NCT00657709|617327408|FG004|Overall Study|Protocol Violation|2|||
170814116|NCT03122860|617327409|FG000|Overall Study|Discontinued Before Treatment|1|||
170814117|NCT03122860|617327410|FG001|Overall Study|Discontinued Before Treatment|1|||
170814118|NCT03122860|617327411|FG002|Overall Study|Discontinued Before Treatment|2|||
170814119|NCT03122860|617327412|FG003|Overall Study|Discontinued Before Treatment|0|||
170814120|NCT03122860|617327413|FG004|Overall Study|Discontinued Before Treatment|1|||
170814121|NCT03122860|617327414|FG005|Overall Study|Discontinued Before Treatment|0|||
170814122|NCT03122860|617327409|FG000|Overall Study|Adverse Event|1|||
170814123|NCT03122860|617327410|FG001|Overall Study|Adverse Event|0|||
170814124|NCT03122860|617327411|FG002|Overall Study|Adverse Event|1|||
170814125|NCT03122860|617327412|FG003|Overall Study|Adverse Event|1|||
170814126|NCT03122860|617327413|FG004|Overall Study|Adverse Event|0|||
170814127|NCT03122860|617327414|FG005|Overall Study|Adverse Event|0|||
170814128|NCT03122860|617327409|FG000|Overall Study|Lost to Follow-up|5|||
170814129|NCT03122860|617327410|FG001|Overall Study|Lost to Follow-up|2|||
170814130|NCT03122860|617327411|FG002|Overall Study|Lost to Follow-up|3|||
170814131|NCT03122860|617327412|FG003|Overall Study|Lost to Follow-up|3|||
170814132|NCT03122860|617327413|FG004|Overall Study|Lost to Follow-up|5|||
170814133|NCT03122860|617327414|FG005|Overall Study|Lost to Follow-up|4|||
170814134|NCT03122860|617327409|FG000|Overall Study|Subject Non-Compliance|0|||
170814135|NCT03122860|617327410|FG001|Overall Study|Subject Non-Compliance|0|||
170814136|NCT03122860|617327411|FG002|Overall Study|Subject Non-Compliance|1|||
170814137|NCT03122860|617327412|FG003|Overall Study|Subject Non-Compliance|0|||
170814138|NCT03122860|617327413|FG004|Overall Study|Subject Non-Compliance|0|||
170814139|NCT03122860|617327414|FG005|Overall Study|Subject Non-Compliance|0|||
170814140|NCT03122860|617327409|FG000|Overall Study|Withdrawal by Subject|3|||
170814141|NCT03122860|617327410|FG001|Overall Study|Withdrawal by Subject|2|||
170814142|NCT03122860|617327411|FG002|Overall Study|Withdrawal by Subject|5|||
170814143|NCT03122860|617327412|FG003|Overall Study|Withdrawal by Subject|7|||
170814144|NCT03122860|617327413|FG004|Overall Study|Withdrawal by Subject|9|||
170814145|NCT03122860|617327414|FG005|Overall Study|Withdrawal by Subject|8|||
170814146|NCT00753896|617327419|FG000|Overall Study|Adverse Event|4|||
170814147|NCT00753896|617327419|FG000|Overall Study|Death|1|||
170814148|NCT00753896|617327419|FG000|Overall Study|Lost to Follow-up|2|||
170814149|NCT00753896|617327419|FG000|Overall Study|Protocol Violation|1|||
170814150|NCT00753896|617327419|FG000|Overall Study|Withdrawal by Subject|4|||
170814151|NCT00753896|617327419|FG000|Overall Study|Entry Criteria Not Met|4|||
170814152|NCT00952523|617327420|FG000|Overall Study|Withdrawal by Subject|7|||
170814153|NCT02852824|617327421|FG000|Overall Study|Withdrawal by Subject|1|||
170814154|NCT02852824|617327422|FG001|Overall Study|Withdrawal by Subject|0|||
170914465|NCT04504032|617689590|FG000|Overall Study|Adverse Event|1|||
170914466|NCT04504032|617689591|FG001|Overall Study|Adverse Event|2|||
170914467|NCT04504032|617689590|FG000|Overall Study|Lost to Follow-up|6|||
170914468|NCT04504032|617689591|FG001|Overall Study|Lost to Follow-up|9|||
170914469|NCT04504032|617689590|FG000|Overall Study|Protocol Violation|2|||
170914470|NCT04504032|617689591|FG001|Overall Study|Protocol Violation|0|||
170914471|NCT04504032|617689590|FG000|Overall Study|Study terminated by sponsor|1|||
170914472|NCT04504032|617689591|FG001|Overall Study|Study terminated by sponsor|2|||
170914473|NCT04504032|617689590|FG000|Overall Study|Withdrawal by Subject|9|||
170914474|NCT04504032|617689591|FG001|Overall Study|Withdrawal by Subject|11|||
170914475|NCT04504032|617689590|FG000|Overall Study|Disease progression prior to dosing|15|||
170914476|NCT04504032|617689591|FG001|Overall Study|Disease progression prior to dosing|3|||
170914477|NCT04504032|617689590|FG000|Overall Study|Drug supply issues|1|||
170914478|NCT04504032|617689591|FG001|Overall Study|Drug supply issues|1|||
170914479|NCT04504032|617689590|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
170914480|NCT04504032|617689591|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
170914481|NCT04983901|617689592|FG000|Overall Study|Death|1|||
170914482|NCT04983901|617689593|FG001|Overall Study|Death|4|||
170914483|NCT04983901|617689592|FG000|Overall Study|Lost to Follow-up|3|||
170914484|NCT04983901|617689593|FG001|Overall Study|Lost to Follow-up|0|||
170914485|NCT04983901|617689592|FG000|Overall Study|Protocol Violation|1|||
170914486|NCT04983901|617689593|FG001|Overall Study|Protocol Violation|0|||
170914487|NCT04983901|617689592|FG000|Overall Study|Withdrawal by Subject|1|||
170914488|NCT04983901|617689593|FG001|Overall Study|Withdrawal by Subject|2|||
170914489|NCT01174784|617689594|FG000|Overall Study|Screen fails|4|||
170914490|NCT01873742|617689601|FG000|Overall Study|Lost to Follow-up|68|||
170914491|NCT01873742|617689602|FG001|Overall Study|Lost to Follow-up|76|||
170914492|NCT01214434|617689605|FG000|Overall Study|Withdrawal by Subject|1|||
170914493|NCT01214434|617689606|FG001|Overall Study|Withdrawal by Subject|0|||
170914494|NCT01214434|617689605|FG000|Overall Study|Lost to Follow-up|2|||
170914495|NCT01214434|617689606|FG001|Overall Study|Lost to Follow-up|2|||
170814155|NCT02852824|617327423|FG002|Overall Study|Withdrawal by Subject|0|||
170814156|NCT02852824|617327424|FG003|Overall Study|Withdrawal by Subject|0|||
170914496|NCT01214434|617689605|FG000|Overall Study|Site error|1|||
170814157|NCT02852824|617327425|FG004|Overall Study|Withdrawal by Subject|0|||
170814158|NCT02852824|617327426|FG005|Overall Study|Withdrawal by Subject|0|||
170814159|NCT02852824|617327427|FG006|Overall Study|Withdrawal by Subject|0|||
170914497|NCT01214434|617689606|FG001|Overall Study|Site error|0|||
170914498|NCT03503773|617689607|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
170914499|NCT03503773|617689608|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
170914500|NCT03503773|617689607|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
170914501|NCT03503773|617689608|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
170914502|NCT03503773|617689607|FG000|Overall Study|Not completing the primary ABPM|3|||
170914503|NCT03503773|617689608|FG001|Overall Study|Not completing the primary ABPM|1|||
170914504|NCT03503773|617689607|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
170914505|NCT03503773|617689608|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
170914506|NCT02498821|617689609|FG000|Overall Study|Screen failure|3|||
170914507|NCT02498821|617689610|FG001|Overall Study|Screen failure|5|||
170914508|NCT00532259|617689611|FG000|Overall Study|Withdrawal by Subject|2|||
170914509|NCT00532259|617689611|FG000|Overall Study|Adverse Event|1|||
170914510|NCT00532259|617689611|FG000|Overall Study|Death|1|||
170914511|NCT00532259|617689611|FG000|Overall Study|Lack of Efficacy|21|||
170914512|NCT00532259|617689611|FG000|Overall Study|Lost to Follow-up|3|||
170914513|NCT00532259|617689611|FG000|Overall Study|Physician Decision|3|||
170914514|NCT00532259|617689611|FG000|Overall Study|Protocol Violation|1|||
170914515|NCT00871858|617689612|FG000|Overall Study|Protocol Violation|3|||
170914516|NCT00871858|617689613|FG001|Overall Study|Protocol Violation|4|||
170914517|NCT00871858|617689612|FG000|Overall Study|Adverse Event|1|||
170914518|NCT00871858|617689613|FG001|Overall Study|Adverse Event|1|||
170914519|NCT00871858|617689612|FG000|Overall Study|Withdrawal by Subject|1|||
170914520|NCT00871858|617689613|FG001|Overall Study|Withdrawal by Subject|1|||
170914521|NCT00871858|617689612|FG000|Overall Study|Lost to Follow-up|0|||
170914522|NCT00871858|617689613|FG001|Overall Study|Lost to Follow-up|1|||
170914523|NCT02795767|617689616|FG000|Overall Study|Received Commercial Emicizumab|1|||
170914524|NCT02795767|617689617|FG001|Overall Study|Received Commercial Emicizumab|0|||
170914525|NCT02795767|617689618|FG002|Overall Study|Received Commercial Emicizumab|0|||
170914526|NCT04983940|617689619|FG000|Overall Study|Lost to Follow-up|14|||
170914527|NCT04983940|617689619|FG000|Overall Study|Lack of Efficacy|2|||
170914528|NCT00465738|617689649|FG000|Overall Study|Lost to Follow-up|2|||
170914529|NCT00465738|617689650|FG001|Overall Study|Lost to Follow-up|0|||
170914530|NCT00465738|617689649|FG000|Overall Study|Adverse Event|0|||
170914531|NCT00465738|617689650|FG001|Overall Study|Adverse Event|1|||
170914532|NCT00465738|617689649|FG000|Overall Study|Withdrawal by Subject|2|||
170914533|NCT00465738|617689650|FG001|Overall Study|Withdrawal by Subject|0|||
170914534|NCT00465738|617689649|FG000|Overall Study|Other|2|||
170914535|NCT00465738|617689650|FG001|Overall Study|Other|5|||
170914536|NCT01787591|617689651|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
170914537|NCT01787591|617689652|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
170914538|NCT01787591|617689653|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
170914539|NCT01787591|617689654|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
170914540|NCT02725177|617689655|FG000|Overall Study|Physician Decision|4|||
170914541|NCT02725177|617689655|FG000|Overall Study|Adverse Event|1|||
170914542|NCT02489630|617689656|FG000|Overall Study|Oversedation|1|||
170914543|NCT02489630|617689657|FG001|Overall Study|Oversedation|1|||
170914544|NCT02489630|617689656|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
170914545|NCT02489630|617689657|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
170914546|NCT01326962|617689658|FG000|Overall Study|Adverse Event|1|||
170914547|NCT01326962|617689658|FG000|Overall Study|Withdrawal by Subject|1|||
170914548|NCT01326962|617689658|FG000|Overall Study|Lost to Follow-up|3|||
170914549|NCT01326962|617689658|FG000|Overall Study|Other|2|||
170914550|NCT02795156|617689660|FG000|Overall Study|Progressive Disease|22|||
170914551|NCT02795156|617689661|FG001|Overall Study|Progressive Disease|7|||
170914552|NCT02795156|617689662|FG002|Overall Study|Progressive Disease|34|||
170914553|NCT02795156|617689663|FG003|Overall Study|Progressive Disease|7|||
170914554|NCT02795156|617689660|FG000|Overall Study|Adverse Event|13|||
170914555|NCT02795156|617689661|FG001|Overall Study|Adverse Event|2|||
170914556|NCT02795156|617689662|FG002|Overall Study|Adverse Event|3|||
170914557|NCT02795156|617689663|FG003|Overall Study|Adverse Event|2|||
170914558|NCT02795156|617689660|FG000|Overall Study|Death|1|||
170914559|NCT02795156|617689661|FG001|Overall Study|Death|1|||
170914560|NCT02795156|617689662|FG002|Overall Study|Death|1|||
170914561|NCT02795156|617689663|FG003|Overall Study|Death|0|||
170914562|NCT02795156|617689660|FG000|Overall Study|Physician Decision|1|||
170914563|NCT02795156|617689661|FG001|Overall Study|Physician Decision|0|||
170914564|NCT02795156|617689662|FG002|Overall Study|Physician Decision|1|||
170914565|NCT02795156|617689663|FG003|Overall Study|Physician Decision|0|||
170914566|NCT02795156|617689660|FG000|Overall Study|Withdrawal by Subject|2|||
170914567|NCT02795156|617689661|FG001|Overall Study|Withdrawal by Subject|0|||
170914568|NCT02795156|617689662|FG002|Overall Study|Withdrawal by Subject|3|||
170914569|NCT02795156|617689663|FG003|Overall Study|Withdrawal by Subject|0|||
170914570|NCT00815308|617689664|FG000|Overall Study|Adverse Event|4|||
170914571|NCT00815308|617689664|FG000|Overall Study|Withdrawal by Subject|0|||
170914572|NCT00815308|617689664|FG000|Overall Study|Protocol Violation|6|||
170914573|NCT03429556|617689665|FG000|Overall Study|Lost to Follow-up|0|||
170914574|NCT03429556|617689666|FG001|Overall Study|Lost to Follow-up|1|||
170914575|NCT03429556|617689667|FG002|Overall Study|Lost to Follow-up|0|||
170914576|NCT03429556|617689668|FG003|Overall Study|Lost to Follow-up|0|||
170914577|NCT00377299|617689669|FG000|Overall Study|Lost to Follow-up|14|||
170914578|NCT00377299|617689670|FG001|Overall Study|Lost to Follow-up|19|||
170914579|NCT00377299|617689669|FG000|Overall Study|Adverse Event|0|||
170914580|NCT00377299|617689670|FG001|Overall Study|Adverse Event|1|||
170652541|NCT05442775|616741655|FG000|Overall Study|Trial terminated|61|||
170652542|NCT05442775|616741655|FG000|Overall Study|Lack of Efficacy|4|||
170914581|NCT00377299|617689669|FG000|Overall Study|Withdrawal by Subject|5|||
170914582|NCT00377299|617689670|FG001|Overall Study|Withdrawal by Subject|4|||
170914583|NCT02369510|617689675|FG000|Overall Study|Spilled Medication|1|||
170914584|NCT02369510|617689676|FG001|Overall Study|Spilled Medication|2|||
170914585|NCT02369510|617689677|FG002|Overall Study|Spilled Medication|1|||
170914586|NCT02369510|617689675|FG000|Overall Study|Epidural Activation|1|||
170652543|NCT05442775|616741655|FG000|Overall Study|Withdrawal by Subject|4|||
170652544|NCT05442775|616741655|FG000|Overall Study|Death|1|||
170914587|NCT02369510|617689676|FG001|Overall Study|Epidural Activation|1|||
170914588|NCT02369510|617689677|FG002|Overall Study|Epidural Activation|5|||
170914589|NCT04799782|617689678|FG000|Washout|Physician Decision|2|||
170914590|NCT04799782|617689679|FG001|Washout|Physician Decision|0|||
170914591|NCT04799782|617689678|FG000|Washout|Withdrawal by Subject|0|||
170914592|NCT04799782|617689679|FG001|Washout|Withdrawal by Subject|2|||
170652545|NCT05442775|616741655|FG000|Overall Study|Participant removed at Sponsor request|1|||
170914593|NCT04799782|617689678|FG000|Washout|Lost to Follow-up|0|||
170914594|NCT04799782|617689679|FG001|Washout|Lost to Follow-up|1|||
170914595|NCT02050048|617689683|FG000|Overall Study|Lost to Follow-up|0|||
170914596|NCT02050048|617689684|FG001|Overall Study|Lost to Follow-up|1|||
170914597|NCT02050048|617689683|FG000|Overall Study|Death|1|||
170914598|NCT02050048|617689684|FG001|Overall Study|Death|0|||
170914599|NCT02050048|617689683|FG000|Overall Study|Ineligible after ERCP|4|||
170914600|NCT02050048|617689684|FG001|Overall Study|Ineligible after ERCP|1|||
170814160|NCT02852824|617327421|FG000|Overall Study|Adverse Event|0|||
170814161|NCT02852824|617327422|FG001|Overall Study|Adverse Event|0|||
170814162|NCT02852824|617327423|FG002|Overall Study|Adverse Event|0|||
170814163|NCT02852824|617327424|FG003|Overall Study|Adverse Event|0|||
170914601|NCT02160977|617689685|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
170914602|NCT02160977|617689686|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
170914603|NCT02160977|617689685|FG000|Three Months After Surgery|Lost to Follow-up|0|||
170914604|NCT02160977|617689686|FG001|Three Months After Surgery|Lost to Follow-up|2|||
170914605|NCT02160977|617689685|FG000|Six Months After Surgery|Lost to Follow-up|2|||
170914606|NCT02160977|617689686|FG001|Six Months After Surgery|Lost to Follow-up|1|||
170914607|NCT01318902|617689689|FG000|Overall Study|Symptomatic Deterioration|0|||
170914608|NCT01318902|617689690|FG001|Overall Study|Symptomatic Deterioration|1|||
170914609|NCT01318902|617689691|FG002|Overall Study|Symptomatic Deterioration|1|||
170914610|NCT01318902|617689692|FG003|Overall Study|Symptomatic Deterioration|2|||
170914611|NCT01318902|617689689|FG000|Overall Study|Withdrawal by Patient|0|||
170914612|NCT01318902|617689690|FG001|Overall Study|Withdrawal by Patient|1|||
170914613|NCT01318902|617689691|FG002|Overall Study|Withdrawal by Patient|0|||
170914614|NCT01318902|617689692|FG003|Overall Study|Withdrawal by Patient|3|||
170914615|NCT01318902|617689689|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
170914616|NCT01318902|617689690|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
170914617|NCT01318902|617689691|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
170914618|NCT01318902|617689692|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
170914619|NCT01318902|617689689|FG000|Overall Study|Adverse Event|0|||
170914620|NCT01318902|617689690|FG001|Overall Study|Adverse Event|1|||
170914621|NCT01318902|617689691|FG002|Overall Study|Adverse Event|0|||
170914622|NCT01318902|617689692|FG003|Overall Study|Adverse Event|0|||
170914623|NCT01318902|617689689|FG000|Overall Study|Terminated by Sponsor|0|||
170914624|NCT01318902|617689690|FG001|Overall Study|Terminated by Sponsor|0|||
170814164|NCT02852824|617327425|FG004|Overall Study|Adverse Event|2|||
170814165|NCT02852824|617327426|FG005|Overall Study|Adverse Event|0|||
170814166|NCT02852824|617327427|FG006|Overall Study|Adverse Event|0|||
170814167|NCT02399449|617327428|FG000|Overall Study|Withdrawal by Subject|3|||
170814168|NCT02399449|617327429|FG001|Overall Study|Withdrawal by Subject|9|||
170814169|NCT02399449|617327428|FG000|Overall Study|Physician Decision|0|||
170814170|NCT02399449|617327429|FG001|Overall Study|Physician Decision|1|||
170814171|NCT01020435|617327430|FG000|Overall Study|Lost to Follow-up|0|||
170814172|NCT01020435|617327431|FG001|Overall Study|Lost to Follow-up|1|||
170814173|NCT00337610|617327432|FG000|Overall Study|Adverse Event|2|||
170814174|NCT00337610|617327433|FG001|Overall Study|Adverse Event|2|||
170814175|NCT00337610|617327432|FG000|Overall Study|Death|0|||
170814176|NCT00337610|617327433|FG001|Overall Study|Death|1|||
170814177|NCT00337610|617327432|FG000|Overall Study|Lack of Efficacy|6|||
170914625|NCT01318902|617689691|FG002|Overall Study|Terminated by Sponsor|1|||
170914626|NCT01318902|617689692|FG003|Overall Study|Terminated by Sponsor|0|||
170914627|NCT03032068|617691659|FG000|Overall Study|Adverse Event|1|||
170814178|NCT00337610|617327433|FG001|Overall Study|Lack of Efficacy|3|||
170814179|NCT00337610|617327432|FG000|Overall Study|Lost to Follow-up|3|||
170814180|NCT00337610|617327433|FG001|Overall Study|Lost to Follow-up|3|||
170814181|NCT00337610|617327432|FG000|Overall Study|Withdrawal by Subject|6|||
170814182|NCT00337610|617327433|FG001|Overall Study|Withdrawal by Subject|5|||
170814183|NCT01860079|617327435|FG000|Overall Study|Physician Decision|14|||
170814184|NCT01860079|617327436|FG001|Overall Study|Physician Decision|22|||
170814185|NCT02279732|617327439|FG000|Overall Study|Death|23|||
170814186|NCT02279732|617327440|FG001|Overall Study|Death|20|||
170814187|NCT02279732|617327439|FG000|Overall Study|Disease Progression|13|||
170814188|NCT02279732|617327440|FG001|Overall Study|Disease Progression|3|||
170814189|NCT02279732|617327439|FG000|Overall Study|Withdrawal by Subject|2|||
170814190|NCT02279732|617327440|FG001|Overall Study|Withdrawal by Subject|7|||
170814191|NCT02279732|617327439|FG000|Overall Study|Adverse Event|1|||
170814192|NCT02279732|617327440|FG001|Overall Study|Adverse Event|2|||
170914628|NCT04543955|617691662|FG000|Overall Study|Company cancelled study|1|||
170652546|NCT03459690|616741657|FG000|Overall Study|Lost to Follow-up|0|||
170814193|NCT02279732|617327439|FG000|Overall Study|Administrative Reason By Sponsor|0|||
170814194|NCT02279732|617327440|FG001|Overall Study|Administrative Reason By Sponsor|2|||
170814195|NCT02279732|617327439|FG000|Overall Study|Study Drug Toxicity|2|||
170814196|NCT02279732|617327440|FG001|Overall Study|Study Drug Toxicity|0|||
170814197|NCT02279732|617327439|FG000|Overall Study|Lost to Follow-up|0|||
170814198|NCT02279732|617327440|FG001|Overall Study|Lost to Follow-up|1|||
170814199|NCT02279732|617327439|FG000|Overall Study|Maximum Clinical Benefit|1|||
170814200|NCT02279732|617327440|FG001|Overall Study|Maximum Clinical Benefit|0|||
170814201|NCT02279732|617327439|FG000|Overall Study|Subject Requested to Discontinue|0|||
170914629|NCT04543955|617691663|FG001|Overall Study|Company cancelled study|0|||
170914630|NCT03918642|617691664|FG000|Overall Study|Lost to Follow-up|12|||
170914631|NCT03918642|617691665|FG001|Overall Study|Lost to Follow-up|10|||
170914632|NCT03270085|617691666|FG000|Overall Study|Withdrawal by Subject|1|||
170914633|NCT03270085|617691667|FG001|Overall Study|Withdrawal by Subject|0|||
170914634|NCT04655586|617691670|FG000|Overall Study|Physician Decision|1|||
170914635|NCT04655586|617691671|FG001|Overall Study|Physician Decision|3|||
170914636|NCT04655586|617691672|FG002|Overall Study|Physician Decision|4|||
170605275|NCT02607228|616560057|FG003|Overall Study|Withdrew Consent|0|||
170914637|NCT04655586|617691670|FG000|Overall Study|Withdrawal by Subject|1|||
170914638|NCT04655586|617691671|FG001|Overall Study|Withdrawal by Subject|3|||
170914639|NCT04655586|617691672|FG002|Overall Study|Withdrawal by Subject|1|||
170914640|NCT03268746|617691673|FG000|Overall Study|Withdrawal by Subject|1|||
170914641|NCT00589472|617691674|FG000|Overall Study|Adverse Event|1|||
170914642|NCT06094296|617691675|FG000|Overall Study|Progressive Disease|1|||
170605276|NCT02607228|616560058|FG004|Overall Study|Withdrew Consent|0|||
170605277|NCT02607228|616560059|FG005|Overall Study|Withdrew Consent|1|||
170605278|NCT02607228|616560060|FG006|Overall Study|Withdrew Consent|0|||
170605279|NCT02607228|616560054|FG000|Overall Study|Study Terminated by Sponsor|0|||
170605280|NCT02607228|616560055|FG001|Overall Study|Study Terminated by Sponsor|0|||
170605281|NCT02607228|616560056|FG002|Overall Study|Study Terminated by Sponsor|0|||
170605282|NCT02607228|616560057|FG003|Overall Study|Study Terminated by Sponsor|1|||
170605283|NCT02607228|616560058|FG004|Overall Study|Study Terminated by Sponsor|0|||
170605284|NCT02607228|616560059|FG005|Overall Study|Study Terminated by Sponsor|0|||
170605285|NCT02607228|616560060|FG006|Overall Study|Study Terminated by Sponsor|0|||
170605286|NCT03576716|616560062|FG000|Overall Study|Withdrawal by Subject|0|||
170605287|NCT03576716|616560063|FG001|Overall Study|Withdrawal by Subject|1|||
170605288|NCT00559988|616560064|FG000|Overall Study|Death|147|||
170605289|NCT00559988|616560065|FG001|Overall Study|Death|140|||
170605290|NCT00559988|616560064|FG000|Overall Study|Withdrawal by Subject|152|||
170605291|NCT00559988|616560065|FG001|Overall Study|Withdrawal by Subject|139|||
170605292|NCT00559988|616560064|FG000|Overall Study|Lost to Follow-up|42|||
170914643|NCT06094296|617691676|FG001|Overall Study|Progressive Disease|0|||
170914644|NCT06094296|617691677|FG002|Overall Study|Progressive Disease|0|||
170914645|NCT06094296|617691678|FG003|Overall Study|Progressive Disease|0|||
170914646|NCT00117338|617691679|FG000|Overall Study|Adverse Event|0|||
170914647|NCT00117338|617691680|FG001|Overall Study|Adverse Event|1|||
170914648|NCT00117338|617691679|FG000|Overall Study|Protocol Violation|3|||
170914649|NCT00117338|617691680|FG001|Overall Study|Protocol Violation|2|||
170914650|NCT00117338|617691679|FG000|Overall Study|Withdrawal by Subject|1|||
170914651|NCT00117338|617691680|FG001|Overall Study|Withdrawal by Subject|0|||
170914652|NCT00117338|617691679|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
170914653|NCT00117338|617691680|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
170914654|NCT00117338|617691679|FG000|Overall Study|Lack of Efficacy|0|||
170914655|NCT00117338|617691680|FG001|Overall Study|Lack of Efficacy|1|||
170914656|NCT00609609|617691684|FG000|Overall Study|Withdrawal by Subject|2|||
170914657|NCT00609609|617691685|FG001|Overall Study|Withdrawal by Subject|0|||
170914658|NCT00609609|617691684|FG000|Overall Study|Progression|4|||
170914659|NCT00609609|617691685|FG001|Overall Study|Progression|2|||
170914660|NCT00670111|617691688|FG000|Enrollment to One Month|Testing Failure|0|||
170914661|NCT00670111|617691689|FG001|Enrollment to One Month|Testing Failure|0|||
170914662|NCT00670111|617691690|FG002|Enrollment to One Month|Testing Failure|13|||
170914663|NCT00670111|617691688|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
170914664|NCT00670111|617691689|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
170914665|NCT00670111|617691690|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
170914666|NCT00670111|617691688|FG000|Enrollment to One Month|Physician Decision|1|||
170914667|NCT00670111|617691689|FG001|Enrollment to One Month|Physician Decision|0|||
170914668|NCT00670111|617691690|FG002|Enrollment to One Month|Physician Decision|0|||
170914669|NCT00844883|617691691|FG000|Overall Study|Bridged to liver transplant|3|||
170914670|NCT00844883|617691691|FG000|Overall Study|Bridged to resection|1|||
170914671|NCT02441803|617691693|FG000|Overall Study|Physician Decision|0|||
170914672|NCT02441803|617691694|FG001|Overall Study|Physician Decision|2|||
170914673|NCT02441803|617691695|FG002|Overall Study|Physician Decision|2|||
170914674|NCT03065530|617691699|FG000|Overall Study|Lack of Efficacy|1|||
170914675|NCT03065530|617691700|FG001|Overall Study|Lack of Efficacy|1|||
170914676|NCT03065530|617691701|FG002|Overall Study|Lack of Efficacy|0|||
170914677|NCT03065530|617691702|FG003|Overall Study|Lack of Efficacy|1|||
170914678|NCT03065530|617691699|FG000|Overall Study|Protocol Violation|1|||
170914679|NCT03065530|617691700|FG001|Overall Study|Protocol Violation|0|||
170914680|NCT03065530|617691701|FG002|Overall Study|Protocol Violation|1|||
170914681|NCT03065530|617691702|FG003|Overall Study|Protocol Violation|1|||
170914682|NCT02873221|617691703|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
170914683|NCT02873221|617691704|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
170914684|NCT02873221|617691705|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
170914685|NCT02873221|617691703|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
170605293|NCT00559988|616560065|FG001|Overall Study|Lost to Follow-up|56|||
170605294|NCT00559988|616560064|FG000|Overall Study|ICD device explanted|10|||
170652547|NCT03459690|616741658|FG001|Overall Study|Lost to Follow-up|1|||
170914686|NCT02873221|617691704|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
170914687|NCT02873221|617691705|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
170914688|NCT02873221|617691703|FG000|Treatment Period|Protocol Violation|2|||
170914689|NCT02873221|617691704|FG001|Treatment Period|Protocol Violation|5|||
170605295|NCT00559988|616560065|FG001|Overall Study|ICD device explanted|17|||
170652548|NCT03459690|616741657|FG000|Overall Study|Withdrawal by Subject|1|||
170652549|NCT03459690|616741658|FG001|Overall Study|Withdrawal by Subject|1|||
170652550|NCT02963831|616741659|FG000|Overall Study|Progressive Disease|3|||
170652551|NCT02963831|616741660|FG001|Overall Study|Progressive Disease|3|||
170652552|NCT02963831|616741661|FG002|Overall Study|Progressive Disease|16|||
170652553|NCT02963831|616741662|FG003|Overall Study|Progressive Disease|27|||
170652554|NCT02963831|616741659|FG000|Overall Study|Withdrawal by Subject|1|||
170652555|NCT02963831|616741660|FG001|Overall Study|Withdrawal by Subject|0|||
170652556|NCT02963831|616741661|FG002|Overall Study|Withdrawal by Subject|2|||
170652557|NCT02963831|616741662|FG003|Overall Study|Withdrawal by Subject|4|||
170605296|NCT02516228|616560066|FG000|Overall Study|Lost to Follow-up|1|||
170605297|NCT02516228|616560066|FG000|Overall Study|Withdrawal by Subject|1|||
170605298|NCT02516228|616560066|FG000|Overall Study|Physician Decision|1|||
170605299|NCT00504894|616560067|FG000|Overall Study|fMRI technical problems|1|||
170605300|NCT00504894|616560068|FG001|Overall Study|fMRI technical problems|1|||
170605301|NCT00504894|616560069|FG002|Overall Study|fMRI technical problems|0|||
170605302|NCT00504894|616560067|FG000|Overall Study|Withdrawal by Subject|0|||
170605303|NCT00504894|616560068|FG001|Overall Study|Withdrawal by Subject|1|||
170605304|NCT00504894|616560069|FG002|Overall Study|Withdrawal by Subject|0|||
170605305|NCT00504894|616560067|FG000|Overall Study|Infusion technical problems|0|||
170605306|NCT00504894|616560068|FG001|Overall Study|Infusion technical problems|1|||
170605307|NCT00504894|616560069|FG002|Overall Study|Infusion technical problems|0|||
170605308|NCT00504894|616560067|FG000|Overall Study|poor subject data|2|||
170605309|NCT00504894|616560068|FG001|Overall Study|poor subject data|0|||
170605310|NCT00504894|616560069|FG002|Overall Study|poor subject data|0|||
170605311|NCT05090852|616560070|FG000|Overall Study|Physician Decision|5|||
170605312|NCT01196416|616560071|FG000|Overall Study|Withdrawal by Subject|2|||
170605313|NCT00148941|616560072|FG000|Overall Study|Lost to Follow-up|17|||
170605314|NCT00148941|616560073|FG001|Overall Study|Lost to Follow-up|24|||
170605315|NCT00148941|616560074|FG002|Overall Study|Lost to Follow-up|18|||
170605316|NCT00148941|616560075|FG003|Overall Study|Lost to Follow-up|22|||
170605317|NCT00148941|616560072|FG000|Overall Study|Withdrawal by Subject|1|||
170605318|NCT00148941|616560073|FG001|Overall Study|Withdrawal by Subject|0|||
170605319|NCT00148941|616560074|FG002|Overall Study|Withdrawal by Subject|1|||
170605320|NCT00148941|616560075|FG003|Overall Study|Withdrawal by Subject|0|||
170652558|NCT02963831|616741659|FG000|Overall Study|Adverse Event|0|||
170605321|NCT00148941|616560072|FG000|Overall Study|Other|0|||
170605322|NCT00148941|616560073|FG001|Overall Study|Other|0|||
170652559|NCT02963831|616741660|FG001|Overall Study|Adverse Event|1|||
170652560|NCT02963831|616741661|FG002|Overall Study|Adverse Event|1|||
170914690|NCT02873221|617691705|FG002|Treatment Period|Protocol Violation|8|||
170914691|NCT02873221|617691703|FG000|Treatment Period|Pregnancy|4|||
170914692|NCT02873221|617691704|FG001|Treatment Period|Pregnancy|6|||
170914693|NCT02873221|617691705|FG002|Treatment Period|Pregnancy|3|||
170914694|NCT02873221|617691703|FG000|Treatment Period|Lack of Qualifying Event|0|||
170914695|NCT02873221|617691704|FG001|Treatment Period|Lack of Qualifying Event|3|||
170914696|NCT02873221|617691705|FG002|Treatment Period|Lack of Qualifying Event|1|||
170914697|NCT02873221|617691703|FG000|Treatment Period|Withdrawal of Consent|52|||
170914698|NCT02873221|617691704|FG001|Treatment Period|Withdrawal of Consent|51|||
170914699|NCT02873221|617691705|FG002|Treatment Period|Withdrawal of Consent|41|||
170914700|NCT02873221|617691703|FG000|Treatment Period|Lack of Efficacy|0|||
170914701|NCT02873221|617691704|FG001|Treatment Period|Lack of Efficacy|17|||
170914702|NCT02873221|617691705|FG002|Treatment Period|Lack of Efficacy|12|||
170914703|NCT02873221|617691703|FG000|Treatment Period|Adverse Event|4|||
170914704|NCT02873221|617691704|FG001|Treatment Period|Adverse Event|9|||
170914705|NCT02873221|617691705|FG002|Treatment Period|Adverse Event|11|||
170914706|NCT02873221|617691703|FG000|Treatment Period|Lost to Follow-up|26|||
170914707|NCT02873221|617691704|FG001|Treatment Period|Lost to Follow-up|30|||
170914708|NCT02873221|617691705|FG002|Treatment Period|Lost to Follow-up|26|||
170914709|NCT02873221|617691703|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
170914710|NCT02873221|617691704|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
170914711|NCT02873221|617691705|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
170914712|NCT02873221|617691703|FG000|Safety Follow-up Period|Protocol Violation|0|||
170914713|NCT02873221|617691704|FG001|Safety Follow-up Period|Protocol Violation|0|||
170914714|NCT02873221|617691705|FG002|Safety Follow-up Period|Protocol Violation|1|||
170914715|NCT02873221|617691703|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
170914716|NCT02873221|617691704|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
170914717|NCT02873221|617691705|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
170914718|NCT02873221|617691703|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
170914719|NCT02873221|617691704|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
170914720|NCT02873221|617691705|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
170914721|NCT00479466|617691706|FG000|Overall Study|Adverse Event|5|||
170914722|NCT00479466|617691707|FG001|Overall Study|Adverse Event|1|||
170914723|NCT00479466|617691708|FG002|Overall Study|Adverse Event|0|||
170914724|NCT00479466|617691709|FG003|Overall Study|Adverse Event|1|||
170914725|NCT00479466|617691710|FG004|Overall Study|Adverse Event|2|||
170914726|NCT00479466|617691711|FG005|Overall Study|Adverse Event|0|||
170914727|NCT00479466|617691706|FG000|Overall Study|Hyperglycemia|0|||
170914728|NCT00479466|617691707|FG001|Overall Study|Hyperglycemia|0|||
170914729|NCT00479466|617691708|FG002|Overall Study|Hyperglycemia|0|||
170914730|NCT00479466|617691709|FG003|Overall Study|Hyperglycemia|0|||
170914731|NCT00479466|617691710|FG004|Overall Study|Hyperglycemia|0|||
170914732|NCT00479466|617691711|FG005|Overall Study|Hyperglycemia|1|||
170914733|NCT00479466|617691706|FG000|Overall Study|Lack of Efficacy|2|||
170914734|NCT00479466|617691707|FG001|Overall Study|Lack of Efficacy|0|||
170914735|NCT00479466|617691708|FG002|Overall Study|Lack of Efficacy|1|||
170914736|NCT00479466|617691709|FG003|Overall Study|Lack of Efficacy|0|||
170914737|NCT00479466|617691710|FG004|Overall Study|Lack of Efficacy|0|||
170914738|NCT00479466|617691711|FG005|Overall Study|Lack of Efficacy|0|||
170914739|NCT00479466|617691706|FG000|Overall Study|Lost to Follow-up|0|||
170914740|NCT00479466|617691707|FG001|Overall Study|Lost to Follow-up|1|||
170914741|NCT00479466|617691708|FG002|Overall Study|Lost to Follow-up|1|||
170914742|NCT00479466|617691709|FG003|Overall Study|Lost to Follow-up|0|||
170914743|NCT00479466|617691710|FG004|Overall Study|Lost to Follow-up|2|||
170914744|NCT00479466|617691711|FG005|Overall Study|Lost to Follow-up|2|||
170914745|NCT00479466|617691706|FG000|Overall Study|Physician Decision|2|||
170914746|NCT00479466|617691707|FG001|Overall Study|Physician Decision|1|||
170914747|NCT00479466|617691708|FG002|Overall Study|Physician Decision|1|||
170914748|NCT00479466|617691709|FG003|Overall Study|Physician Decision|0|||
170605323|NCT00148941|616560074|FG002|Overall Study|Other|1|||
170814202|NCT02279732|617327440|FG001|Overall Study|Subject Requested to Discontinue|1|||
170814203|NCT02279732|617327439|FG000|Overall Study|Other|53|||
170814204|NCT02279732|617327440|FG001|Overall Study|Other|67|||
170814205|NCT02279732|617327439|FG000|Overall Study|Other|3|||
170814206|NCT02279732|617327440|FG001|Overall Study|Other|3|||
170814207|NCT02203513|617327445|FG000|Overall Study|Refused further treatment|2|||
170814208|NCT02203513|617327446|FG001|Overall Study|Refused further treatment|0|||
170814209|NCT02203513|617327447|FG002|Overall Study|Refused further treatment|1|||
170814210|NCT02203513|617327448|FG003|Overall Study|Refused further treatment|0|||
170814211|NCT02203513|617327449|FG004|Overall Study|Refused further treatment|0|||
170814212|NCT02203513|617327445|FG000|Overall Study|Switched to alternative treatment|3|||
170814213|NCT02203513|617327446|FG001|Overall Study|Switched to alternative treatment|4|||
170814214|NCT02203513|617327447|FG002|Overall Study|Switched to alternative treatment|0|||
170814215|NCT02203513|617327448|FG003|Overall Study|Switched to alternative treatment|0|||
170814216|NCT02203513|617327449|FG004|Overall Study|Switched to alternative treatment|4|||
170814217|NCT02203513|617327445|FG000|Overall Study|Did not receive investigational product (IP)|0|||
170814218|NCT02203513|617327446|FG001|Overall Study|Did not receive investigational product (IP)|1|||
170814219|NCT02203513|617327447|FG002|Overall Study|Did not receive investigational product (IP)|0|||
170605324|NCT00148941|616560075|FG003|Overall Study|Other|2|||
170605325|NCT02673684|616560076|FG000|Overall Study|Study not completed d/t loss of funding|9|||
170605326|NCT02673684|616560077|FG001|Overall Study|Study not completed d/t loss of funding|8|||
170605327|NCT01092663|616560078|FG000|Overall Study|Withdrawal by Subject|3|||
170605328|NCT01092663|616560079|FG001|Overall Study|Withdrawal by Subject|2|||
170605329|NCT01092663|616560078|FG000|Overall Study|Glucose >300mg/dL|1|||
170605330|NCT01092663|616560079|FG001|Overall Study|Glucose >300mg/dL|0|||
170605331|NCT01092663|616560078|FG000|Overall Study|High fasting triglyceride|2|||
170605332|NCT01092663|616560079|FG001|Overall Study|High fasting triglyceride|0|||
170605333|NCT01092663|616560078|FG000|Overall Study|Adverse Event|1|||
170605334|NCT01092663|616560079|FG001|Overall Study|Adverse Event|1|||
170605335|NCT01092663|616560078|FG000|Overall Study|Protocol Violation|0|||
170605336|NCT01092663|616560079|FG001|Overall Study|Protocol Violation|1|||
170605337|NCT01008904|616560080|FG000|Overall Study|Lost to Follow-up|1|||
170605338|NCT01008904|616560080|FG000|Overall Study|Adverse Event|2|||
170605339|NCT01008904|616560080|FG000|Overall Study|unexpected unrelated surgery|1|||
170605340|NCT00605345|616560091|FG000|Overall Study|Withdrawal by Subject|1|||
170605341|NCT00605345|616560092|FG001|Overall Study|Withdrawal by Subject|0|||
170605342|NCT00605345|616560091|FG000|Overall Study|Adverse Event|0|||
170605343|NCT00605345|616560092|FG001|Overall Study|Adverse Event|1|||
170605344|NCT00605345|616560091|FG000|Overall Study|Protocol Violation|0|||
170605345|NCT00605345|616560092|FG001|Overall Study|Protocol Violation|2|||
170605346|NCT02666105|616560093|FG000|Overall Study|Death|1|||
170605347|NCT02577016|616560094|FG000|Overall Study|Adverse Event|2|||
170605348|NCT02577016|616560095|FG001|Overall Study|Adverse Event|1|||
170605349|NCT02577016|616560094|FG000|Overall Study|Physician Decision|0|||
170605350|NCT02577016|616560095|FG001|Overall Study|Physician Decision|1|||
170605351|NCT00411632|616560096|FG000|Overall Study|Death|1|||
170605352|NCT01264419|616560097|FG000|Overall Study|Lost to Follow-up|3|||
170605353|NCT02277119|616560098|FG000|Overall Study|Lack of Efficacy|1|||
170605354|NCT02277119|616560099|FG001|Overall Study|Lack of Efficacy|1|||
170605355|NCT02277119|616560100|FG002|Overall Study|Lack of Efficacy|1|||
170605356|NCT02277119|616560098|FG000|Overall Study|Protocol Violation|2|||
170605357|NCT02277119|616560099|FG001|Overall Study|Protocol Violation|3|||
170605358|NCT02277119|616560100|FG002|Overall Study|Protocol Violation|7|||
170605359|NCT00761527|616560103|FG000|Overall Study|Adverse Event|3|||
170605360|NCT00761527|616560103|FG000|Overall Study|Poor Compliance|8|||
170605361|NCT00761527|616560103|FG000|Overall Study|Lost to Follow-up|9|||
170605362|NCT00761527|616560103|FG000|Overall Study|Unknown reason|2|||
170605363|NCT02301624|616560106|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
170605364|NCT02301624|616560107|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
170605365|NCT02301624|616560106|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
170605366|NCT02301624|616560107|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
170605367|NCT02301624|616560106|FG000|Open-label Maintenance Phase|Adverse Event|2|||
170605368|NCT02301624|616560107|FG001|Open-label Maintenance Phase|Adverse Event|5|||
170605369|NCT02301624|616560106|FG000|Open-label Maintenance Phase|Physician Decision|3|||
170605370|NCT02301624|616560107|FG001|Open-label Maintenance Phase|Physician Decision|3|||
170605371|NCT02301624|616560106|FG000|Open-label Maintenance Phase|Death|2|||
170605372|NCT02301624|616560107|FG001|Open-label Maintenance Phase|Death|1|||
170605373|NCT02301624|616560106|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
170605374|NCT02301624|616560107|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
170605375|NCT00895310|616560108|FG000|Overall Study|Withdrawal by Subject|1|||
170605376|NCT00659230|616560109|FG000|Overall Study|Lost to Follow-up|2|||
170605377|NCT00659230|616560110|FG001|Overall Study|Lost to Follow-up|5|||
170605378|NCT00659230|616560109|FG000|Overall Study|Lost source documentation|5|||
170605379|NCT00659230|616560110|FG001|Overall Study|Lost source documentation|4|||
170652561|NCT02963831|616741662|FG003|Overall Study|Adverse Event|2|||
170652562|NCT02963831|616741659|FG000|Overall Study|Death|0|||
170652563|NCT02963831|616741660|FG001|Overall Study|Death|0|||
170652564|NCT02963831|616741661|FG002|Overall Study|Death|0|||
170652565|NCT02963831|616741662|FG003|Overall Study|Death|2|||
170652566|NCT02536404|616741663|FG000|Overall Study|Adverse Event|5|||
170652567|NCT02536404|616741664|FG001|Overall Study|Adverse Event|0|||
170814220|NCT02203513|617327448|FG003|Overall Study|Did not receive investigational product (IP)|0|||
170814221|NCT02203513|617327449|FG004|Overall Study|Did not receive investigational product (IP)|0|||
170914749|NCT00479466|617691710|FG004|Overall Study|Physician Decision|0|||
170914750|NCT00479466|617691711|FG005|Overall Study|Physician Decision|0|||
170914751|NCT00479466|617691706|FG000|Overall Study|Pregnancy|0|||
170914752|NCT00479466|617691707|FG001|Overall Study|Pregnancy|0|||
170914753|NCT00479466|617691708|FG002|Overall Study|Pregnancy|0|||
170914754|NCT00479466|617691709|FG003|Overall Study|Pregnancy|0|||
170914755|NCT00479466|617691710|FG004|Overall Study|Pregnancy|1|||
170914756|NCT00479466|617691711|FG005|Overall Study|Pregnancy|0|||
170914757|NCT00479466|617691706|FG000|Overall Study|Protocol Violation|1|||
170914758|NCT00479466|617691707|FG001|Overall Study|Protocol Violation|0|||
170914759|NCT00479466|617691708|FG002|Overall Study|Protocol Violation|0|||
170652568|NCT02536404|616741663|FG000|Overall Study|Withdrawal by Subject|4|||
170652569|NCT02536404|616741664|FG001|Overall Study|Withdrawal by Subject|1|||
170814222|NCT02203513|617327445|FG000|Overall Study|Death (unrelated to study therapy)|1|||
170814223|NCT02203513|617327446|FG001|Overall Study|Death (unrelated to study therapy)|3|||
170814224|NCT02203513|617327447|FG002|Overall Study|Death (unrelated to study therapy)|1|||
170814225|NCT02203513|617327448|FG003|Overall Study|Death (unrelated to study therapy)|0|||
170814226|NCT02203513|617327449|FG004|Overall Study|Death (unrelated to study therapy)|2|||
170814227|NCT02203513|617327445|FG000|Overall Study|Lost to Follow-up|0|||
170814228|NCT02203513|617327446|FG001|Overall Study|Lost to Follow-up|0|||
170814229|NCT02203513|617327447|FG002|Overall Study|Lost to Follow-up|1|||
170814230|NCT02203513|617327448|FG003|Overall Study|Lost to Follow-up|1|||
170814231|NCT02203513|617327449|FG004|Overall Study|Lost to Follow-up|0|||
170814232|NCT01441596|617327450|FG000|Overall Study|Other reason not defined below|0|||
170814233|NCT01441596|617327451|FG001|Overall Study|Other reason not defined below|2|||
170814234|NCT01441596|617327452|FG002|Overall Study|Other reason not defined below|1|||
170814235|NCT01441596|617327450|FG000|Overall Study|Withdrawal by Subject|4|||
170814236|NCT01441596|617327451|FG001|Overall Study|Withdrawal by Subject|0|||
170814237|NCT01441596|617327452|FG002|Overall Study|Withdrawal by Subject|2|||
170814238|NCT01441596|617327450|FG000|Overall Study|Not treated|0|||
170814239|NCT01441596|617327451|FG001|Overall Study|Not treated|1|||
170814240|NCT01441596|617327452|FG002|Overall Study|Not treated|1|||
170814241|NCT03347396|617327453|FG000|Part A (26 Weeks)|Adverse Event|1|||
170814242|NCT03347396|617327454|FG001|Part A (26 Weeks)|Adverse Event|0|||
170814243|NCT03347396|617327453|FG000|Part A (26 Weeks)|Death|0|||
170814244|NCT03347396|617327454|FG001|Part A (26 Weeks)|Death|1|||
170814245|NCT03347396|617327453|FG000|Part B (149 Weeks)|Adverse Event|1|||
170814246|NCT03347396|617327454|FG001|Part B (149 Weeks)|Adverse Event|1|||
170814247|NCT03347396|617327453|FG000|Part B (149 Weeks)|Death|1|||
170814248|NCT03347396|617327454|FG001|Part B (149 Weeks)|Death|0|||
170814249|NCT00452452|617327457|FG000|Overall Study|Protocol Violation|0|||
170814250|NCT00452452|617327458|FG001|Overall Study|Protocol Violation|0|||
170814251|NCT00452452|617327459|FG002|Overall Study|Protocol Violation|1|||
170814252|NCT00452452|617327457|FG000|Overall Study|Withdrawal by Subject|1|||
170814253|NCT00452452|617327458|FG001|Overall Study|Withdrawal by Subject|0|||
170814254|NCT00452452|617327459|FG002|Overall Study|Withdrawal by Subject|0|||
170814255|NCT00452452|617327457|FG000|Overall Study|Lost to Follow-up|1|||
170814256|NCT00452452|617327458|FG001|Overall Study|Lost to Follow-up|0|||
170814257|NCT00452452|617327459|FG002|Overall Study|Lost to Follow-up|0|||
170814258|NCT04914897|617329245|FG000|Overall Study|Withdrawal by Subject|3|||
170814259|NCT04914897|617329246|FG001|Overall Study|Withdrawal by Subject|1|||
170814260|NCT04914897|617329247|FG002|Overall Study|Withdrawal by Subject|1|||
170814261|NCT04914897|617329248|FG003|Overall Study|Withdrawal by Subject|1|||
170814262|NCT04914897|617329245|FG000|Overall Study|Poor compliance to protocol|0|||
170814263|NCT04914897|617329246|FG001|Overall Study|Poor compliance to protocol|0|||
170814264|NCT04914897|617329247|FG002|Overall Study|Poor compliance to protocol|1|||
170814265|NCT04914897|617329248|FG003|Overall Study|Poor compliance to protocol|0|||
170814266|NCT04914897|617329245|FG000|Overall Study|Progressive disease|5|||
170814267|NCT04914897|617329246|FG001|Overall Study|Progressive disease|14|||
170814268|NCT04914897|617329247|FG002|Overall Study|Progressive disease|30|||
170814269|NCT04914897|617329248|FG003|Overall Study|Progressive disease|21|||
170814270|NCT04914897|617329245|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
170814271|NCT04914897|617329246|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
170814272|NCT04914897|617329247|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
170814273|NCT04914897|617329248|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
170814274|NCT04914897|617329245|FG000|Overall Study|Other|1|||
170914760|NCT00479466|617691709|FG003|Overall Study|Protocol Violation|0|||
170914761|NCT00479466|617691710|FG004|Overall Study|Protocol Violation|0|||
170914762|NCT00479466|617691711|FG005|Overall Study|Protocol Violation|0|||
170914763|NCT00479466|617691706|FG000|Overall Study|Withdrawal by Subject|3|||
170914764|NCT00479466|617691707|FG001|Overall Study|Withdrawal by Subject|5|||
170914765|NCT00479466|617691708|FG002|Overall Study|Withdrawal by Subject|0|||
170914766|NCT00479466|617691709|FG003|Overall Study|Withdrawal by Subject|2|||
170914767|NCT00479466|617691710|FG004|Overall Study|Withdrawal by Subject|3|||
170652570|NCT02536404|616741663|FG000|Overall Study|Physician Decision|10|||
170652571|NCT02536404|616741664|FG001|Overall Study|Physician Decision|0|||
170652572|NCT02536404|616741663|FG000|Overall Study|Sponsor decision|1|||
170652573|NCT02536404|616741664|FG001|Overall Study|Sponsor decision|0|||
170652574|NCT02158364|616741665|FG000|Overall Study|Case report forms uncollected|10|||
170652575|NCT02158364|616741665|FG000|Overall Study|Protocol Deviation|50|||
170652576|NCT02514473|616741666|FG000|Overall Study|Adverse Event|0|||
170652577|NCT02514473|616741667|FG001|Overall Study|Adverse Event|2|||
170652578|NCT02514473|616741666|FG000|Overall Study|Withdrawal by Subject|2|||
170652579|NCT02514473|616741667|FG001|Overall Study|Withdrawal by Subject|1|||
170652580|NCT02514473|616741666|FG000|Overall Study|Lost to Follow-up|0|||
170652581|NCT02514473|616741667|FG001|Overall Study|Lost to Follow-up|1|||
170652582|NCT02514473|616741666|FG000|Overall Study|Other|1|||
170652583|NCT02514473|616741667|FG001|Overall Study|Other|1|||
170652584|NCT04381988|616741668|FG000|Overall Study|The study was terminated|4|||
170652585|NCT04381988|616741669|FG001|Overall Study|The study was terminated|0|||
170652586|NCT02106923|616741670|FG000|Overall Study|Protocol Violation|0|||
170652587|NCT02106923|616741671|FG001|Overall Study|Protocol Violation|0|||
170652588|NCT02106923|616741672|FG002|Overall Study|Protocol Violation|0|||
170652589|NCT02106923|616741673|FG003|Overall Study|Protocol Violation|0|||
170652590|NCT02106923|616741674|FG004|Overall Study|Protocol Violation|0|||
170652591|NCT02106923|616741675|FG005|Overall Study|Protocol Violation|1|||
170652592|NCT03915860|616741676|FG000|Overall Study|Adverse Event|3|||
170652593|NCT03915860|616741676|FG000|Overall Study|Withdrawal by Subject|6|||
170652594|NCT03915860|616741676|FG000|Overall Study|Lost to Follow-up|2|||
170652595|NCT03915860|616741676|FG000|Overall Study|Other than specified|3|||
170652596|NCT01107379|616741680|FG000|Overall Study|Withdrawal by Subject|18|||
170652597|NCT01107379|616741680|FG000|Overall Study|Lost to Follow-up|3|||
170652598|NCT05318183|616741683|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
170652599|NCT05318183|616741684|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
170652600|NCT05318183|616741683|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
170652601|NCT05318183|616741684|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
170652602|NCT05318183|616741683|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
170652603|NCT05318183|616741684|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
170652604|NCT05318183|616741683|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
170652605|NCT05318183|616741684|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
170652606|NCT01986933|616741688|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
170652607|NCT01986933|616741689|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
170652608|NCT01986933|616741690|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
170652609|NCT01986933|616741691|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
170652610|NCT01986933|616741692|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
170652611|NCT01986933|616741688|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
170652612|NCT01986933|616741689|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
170652613|NCT01986933|616741690|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
170652614|NCT01986933|616741691|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
170652615|NCT01986933|616741692|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
170914768|NCT00479466|617691711|FG005|Overall Study|Withdrawal by Subject|1|||
170914769|NCT01325493|617691712|FG000|Overall Study|Protocol Violation|0|||
170652616|NCT01986933|616741688|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
170652617|NCT01986933|616741689|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
170652618|NCT01986933|616741690|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
170652619|NCT01986933|616741691|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
170652620|NCT01986933|616741692|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
170652621|NCT01986933|616741688|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
170652622|NCT01986933|616741689|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
170652623|NCT01986933|616741690|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
170652624|NCT01986933|616741691|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
170652625|NCT01986933|616741692|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
170652626|NCT01986933|616741688|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
170652627|NCT01986933|616741689|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
170652628|NCT01986933|616741690|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
170652629|NCT01986933|616741691|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
170914770|NCT01325493|617691713|FG001|Overall Study|Protocol Violation|1|||
170652630|NCT01986933|616741692|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
170652631|NCT01986933|616741688|FG000|Active-to-active (Part B)|Adverse Event|0|||
170652632|NCT01986933|616741689|FG001|Active-to-active (Part B)|Adverse Event|2|||
170652633|NCT01986933|616741690|FG002|Active-to-active (Part B)|Adverse Event|0|||
170914771|NCT01325493|617691712|FG000|Overall Study|loss of neuromonitoring signals|0|||
170914772|NCT01325493|617691713|FG001|Overall Study|loss of neuromonitoring signals|2|||
170914773|NCT01325493|617691712|FG000|Overall Study|Allergy|1|||
170914774|NCT01325493|617691713|FG001|Overall Study|Allergy|0|||
170914775|NCT01035606|617691715|FG000|Overall Study|change in health, job demands,family|3|||
170914776|NCT01035606|617691716|FG001|Overall Study|change in health, job demands,family|3|||
170914777|NCT01035606|617691717|FG002|Overall Study|change in health, job demands,family|4|||
170914778|NCT01070303|617691721|FG000|Overall Study|Adverse Event|39|||
170914779|NCT01070303|617691721|FG000|Overall Study|Withdrawal by Subject|20|||
170914780|NCT01070303|617691721|FG000|Overall Study|Lost to Follow-up|9|||
170914781|NCT01070303|617691721|FG000|Overall Study|Protocol Violation|0|||
170914782|NCT01070303|617691721|FG000|Overall Study|Lack of Efficacy|2|||
170914783|NCT01070303|617691721|FG000|Overall Study|Administrative Reason|1|||
170914784|NCT01070303|617691721|FG000|Overall Study|Other|18|||
170914785|NCT00718861|617691722|FG000|Overall Study|Withdrawal by Subject|15|||
170914786|NCT00718861|617691723|FG001|Overall Study|Withdrawal by Subject|10|||
170914787|NCT00718861|617691722|FG000|Overall Study|Adverse Event|2|||
170914788|NCT00718861|617691723|FG001|Overall Study|Adverse Event|1|||
170914789|NCT00718861|617691722|FG000|Overall Study|Lost to Follow-up|2|||
170914790|NCT00718861|617691723|FG001|Overall Study|Lost to Follow-up|1|||
170914791|NCT00718861|617691722|FG000|Overall Study|Administrative Problems|1|||
170914792|NCT00718861|617691723|FG001|Overall Study|Administrative Problems|1|||
170914793|NCT00718861|617691722|FG000|Overall Study|Death|1|||
170914794|NCT00718861|617691723|FG001|Overall Study|Death|5|||
170914795|NCT02433288|617691726|FG000|Overall Study|Severe non-compliance to protocol|13|||
170914796|NCT02433288|617691727|FG001|Overall Study|Severe non-compliance to protocol|7|||
170914797|NCT02433288|617691726|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
170914798|NCT02433288|617691727|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
170914799|NCT02433288|617691726|FG000|Overall Study|Withdrawal by Subject|101|||
170914800|NCT02433288|617691727|FG001|Overall Study|Withdrawal by Subject|99|||
170914801|NCT02433288|617691726|FG000|Overall Study|Lost to Follow-up|2|||
170914802|NCT02433288|617691727|FG001|Overall Study|Lost to Follow-up|14|||
170914803|NCT02433288|617691726|FG000|Overall Study|Death|0|||
170914804|NCT02433288|617691727|FG001|Overall Study|Death|3|||
170914805|NCT00367640|617691728|FG000|Overall Study|Adverse Event|3|||
170914806|NCT00367640|617691729|FG001|Overall Study|Adverse Event|6|||
170914807|NCT00367640|617691730|FG002|Overall Study|Adverse Event|8|||
170914808|NCT00367640|617691731|FG003|Overall Study|Adverse Event|0|||
170914809|NCT00367640|617691728|FG000|Overall Study|Withdrawal by Subject|8|||
170914810|NCT00367640|617691729|FG001|Overall Study|Withdrawal by Subject|11|||
170914811|NCT00367640|617691730|FG002|Overall Study|Withdrawal by Subject|8|||
170914812|NCT00367640|617691731|FG003|Overall Study|Withdrawal by Subject|6|||
170914813|NCT00367640|617691728|FG000|Overall Study|Any other reason not above-mentioned|7|||
170914814|NCT00367640|617691729|FG001|Overall Study|Any other reason not above-mentioned|5|||
170914815|NCT00367640|617691730|FG002|Overall Study|Any other reason not above-mentioned|3|||
170914816|NCT00367640|617691731|FG003|Overall Study|Any other reason not above-mentioned|4|||
170914817|NCT02417233|617691734|FG000|Overall Study|Death|4|||
170914818|NCT02417233|617691735|FG001|Overall Study|Death|10|||
170914819|NCT02417233|617691736|FG002|Overall Study|Death|14|||
170914820|NCT02417233|617691734|FG000|Overall Study|Lost to Follow-up|27|||
170914821|NCT02417233|617691735|FG001|Overall Study|Lost to Follow-up|39|||
170914822|NCT02417233|617691736|FG002|Overall Study|Lost to Follow-up|34|||
170914823|NCT02417233|617691734|FG000|Overall Study|Protocol Violation|2|||
170914824|NCT02417233|617691735|FG001|Overall Study|Protocol Violation|0|||
170914825|NCT02417233|617691736|FG002|Overall Study|Protocol Violation|2|||
170914826|NCT02417233|617691734|FG000|Overall Study|Withdrawal by Subject|2|||
170914827|NCT02417233|617691735|FG001|Overall Study|Withdrawal by Subject|1|||
170914828|NCT02417233|617691736|FG002|Overall Study|Withdrawal by Subject|8|||
170914829|NCT02417233|617691734|FG000|Overall Study|Relocation out of study area|1|||
170914830|NCT02417233|617691735|FG001|Overall Study|Relocation out of study area|0|||
170914831|NCT02417233|617691736|FG002|Overall Study|Relocation out of study area|1|||
170914832|NCT02417233|617691734|FG000|Overall Study|Mentally unstable|0|||
170914833|NCT02417233|617691735|FG001|Overall Study|Mentally unstable|1|||
170914834|NCT02417233|617691736|FG002|Overall Study|Mentally unstable|0|||
170914835|NCT00790296|617691737|FG000|Overall Study|Did not meet study eligibility criteria|1|||
170914836|NCT00790296|617691738|FG001|Overall Study|Did not meet study eligibility criteria|1|||
170914837|NCT00790296|617691737|FG000|Overall Study|Adverse Event|0|||
170914838|NCT00790296|617691738|FG001|Overall Study|Adverse Event|1|||
170914839|NCT02416908|617691739|FG000|Dose Escalation Phase|Adverse Event|0|||
170914840|NCT02416908|617691740|FG001|Dose Escalation Phase|Adverse Event|0|||
170914841|NCT02416908|617691741|FG002|Dose Escalation Phase|Adverse Event|3|||
170914842|NCT02416908|617691742|FG003|Dose Escalation Phase|Adverse Event|0|||
170914843|NCT02416908|617691739|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
170914844|NCT02416908|617691740|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
170914845|NCT02416908|617691741|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
170914846|NCT02416908|617691742|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
170914847|NCT00532883|617691743|FG000|Overall Study|Adverse Event|1|||
170914848|NCT00532883|617691744|FG001|Overall Study|Adverse Event|0|||
170914849|NCT00532883|617691745|FG002|Overall Study|Adverse Event|0|||
170814275|NCT04914897|617329246|FG001|Overall Study|Other|0|||
170814276|NCT04914897|617329247|FG002|Overall Study|Other|0|||
170814277|NCT04914897|617329248|FG003|Overall Study|Other|1|||
170814278|NCT03020914|617329249|FG000|Overall Study|Surgery Cancelled|1|||
170814279|NCT03020914|617329250|FG001|Overall Study|Surgery Cancelled|0|||
170814280|NCT03976102|617329253|FG000|Overall Study|Withdrawal by Subject|4|||
170814281|NCT03976102|617329254|FG001|Overall Study|Withdrawal by Subject|4|||
170814282|NCT03976102|617329253|FG000|Overall Study|Adverse Event|2|||
170814283|NCT03976102|617329254|FG001|Overall Study|Adverse Event|4|||
170814284|NCT03976102|617329253|FG000|Overall Study|Not related to Covid-19|9|||
170814285|NCT03976102|617329254|FG001|Overall Study|Not related to Covid-19|13|||
170814286|NCT03976102|617329253|FG000|Overall Study|Lost to Follow-up|0|||
170814287|NCT03976102|617329254|FG001|Overall Study|Lost to Follow-up|2|||
170814288|NCT03976102|617329253|FG000|Overall Study|Death|3|||
170814289|NCT03976102|617329254|FG001|Overall Study|Death|2|||
170814290|NCT03976102|617329253|FG000|Overall Study|Physician Decision|1|||
170814291|NCT03976102|617329254|FG001|Overall Study|Physician Decision|1|||
170814292|NCT00092456|617329258|FG000|Overall Study|Adverse Event|0|||
170814293|NCT00092456|617329259|FG001|Overall Study|Adverse Event|0|||
170814294|NCT00092456|617329260|FG002|Overall Study|Adverse Event|1|||
170814295|NCT00092456|617329261|FG003|Overall Study|Adverse Event|1|||
170814296|NCT00092456|617329258|FG000|Overall Study|Lost to Follow-up|2|||
170814297|NCT00092456|617329259|FG001|Overall Study|Lost to Follow-up|2|||
170814298|NCT00092456|617329260|FG002|Overall Study|Lost to Follow-up|1|||
170814299|NCT00092456|617329261|FG003|Overall Study|Lost to Follow-up|2|||
170814300|NCT00092456|617329258|FG000|Overall Study|Protocol Violation|5|||
170814301|NCT00092456|617329259|FG001|Overall Study|Protocol Violation|7|||
170814302|NCT00092456|617329260|FG002|Overall Study|Protocol Violation|8|||
170814303|NCT00092456|617329261|FG003|Overall Study|Protocol Violation|6|||
170814304|NCT00092456|617329258|FG000|Overall Study|Withdrawal by Subject|13|||
170814305|NCT00092456|617329259|FG001|Overall Study|Withdrawal by Subject|5|||
170814306|NCT00092456|617329260|FG002|Overall Study|Withdrawal by Subject|16|||
170814307|NCT00092456|617329261|FG003|Overall Study|Withdrawal by Subject|6|||
170814308|NCT00092456|617329258|FG000|Overall Study|Moved|1|||
170814309|NCT00092456|617329259|FG001|Overall Study|Moved|1|||
170914850|NCT00532883|617691746|FG003|Overall Study|Adverse Event|1|||
170914851|NCT00532883|617691743|FG000|Overall Study|Lost to Follow-up|1|||
170914852|NCT00532883|617691744|FG001|Overall Study|Lost to Follow-up|1|||
170914853|NCT00532883|617691745|FG002|Overall Study|Lost to Follow-up|1|||
170914854|NCT00532883|617691746|FG003|Overall Study|Lost to Follow-up|0|||
170914855|NCT00532883|617691743|FG000|Overall Study|Withdrawal by Subject|0|||
170914856|NCT00532883|617691744|FG001|Overall Study|Withdrawal by Subject|1|||
170914857|NCT00532883|617691745|FG002|Overall Study|Withdrawal by Subject|1|||
170914858|NCT00532883|617691746|FG003|Overall Study|Withdrawal by Subject|0|||
170914859|NCT00532883|617691743|FG000|Overall Study|Subject was Nonadherent|0|||
170914860|NCT00532883|617691744|FG001|Overall Study|Subject was Nonadherent|1|||
170914861|NCT00532883|617691745|FG002|Overall Study|Subject was Nonadherent|1|||
170914862|NCT00532883|617691746|FG003|Overall Study|Subject was Nonadherent|0|||
170814310|NCT00092456|617329260|FG002|Overall Study|Moved|0|||
170814311|NCT00092456|617329261|FG003|Overall Study|Moved|1|||
170814312|NCT00092456|617329258|FG000|Overall Study|Other|4|||
170814313|NCT00092456|617329259|FG001|Overall Study|Other|2|||
170914863|NCT00532883|617691743|FG000|Overall Study|Early Study Termination|4|||
170914864|NCT00532883|617691744|FG001|Overall Study|Early Study Termination|4|||
170914865|NCT00532883|617691745|FG002|Overall Study|Early Study Termination|1|||
170605380|NCT00659230|616560109|FG000|Overall Study|Did not return post-randomization|2|||
170605381|NCT00659230|616560110|FG001|Overall Study|Did not return post-randomization|3|||
170605382|NCT03077919|616562024|FG000|Overall Study|Lost to Follow-up|4|||
170605383|NCT03077919|616562025|FG001|Overall Study|Lost to Follow-up|1|||
170605384|NCT00826618|616562026|FG000|Overall Study|Withdrawal by Subject|1|||
170814314|NCT00092456|617329260|FG002|Overall Study|Other|3|||
170814315|NCT00092456|617329261|FG003|Overall Study|Other|0|||
170814316|NCT01381549|617329262|FG000|Overall Study|Ineligible: No organisms isolated|0|||
170605385|NCT03354273|616562034|FG000|Overall Study|Adverse Event|5|||
170814317|NCT01381549|617329263|FG001|Overall Study|Ineligible: No organisms isolated|0|||
170814318|NCT01381549|617329264|FG002|Overall Study|Ineligible: No organisms isolated|1|||
170814319|NCT02981953|617329265|FG000|Overall Study|Death|9|||
170814320|NCT02981953|617329265|FG000|Overall Study|Withdrawal by Subject|1|||
170814321|NCT02981953|617329265|FG000|Overall Study|Withdrawal to non-compliance|1|||
170814322|NCT00805792|617329266|FG000|Overall Study|Death|3|||
170814323|NCT00805792|617329266|FG000|Overall Study|Lost to Follow-up|2|||
170814324|NCT01345253|617329268|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
170814325|NCT01345253|617329269|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
170814326|NCT01345253|617329268|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
170814327|NCT01345253|617329269|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
170814328|NCT01345253|617329268|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
170814329|NCT01345253|617329269|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
170814330|NCT01345253|617329268|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
170814331|NCT01345253|617329269|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
170814332|NCT01345253|617329268|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
170814333|NCT01345253|617329269|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
170814334|NCT01345253|617329268|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
170814335|NCT01345253|617329269|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
170814336|NCT01345253|617329268|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
170814337|NCT01345253|617329269|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
170814338|NCT01345253|617329268|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
170814339|NCT01345253|617329269|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
170814340|NCT01345253|617329268|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
170914866|NCT00532883|617691746|FG003|Overall Study|Early Study Termination|4|||
170914867|NCT03792750|617691750|FG000|Overall Study|Death|3|||
170914868|NCT02285010|617691753|FG000|Overall Study|not abdominal hysterectomy|2|||
170914869|NCT02285010|617691754|FG001|Overall Study|not abdominal hysterectomy|0|||
170914870|NCT02285010|617691753|FG000|Overall Study|Not spinal anesthesia|3|||
170914871|NCT02285010|617691754|FG001|Overall Study|Not spinal anesthesia|1|||
170914872|NCT03303339|617691757|FG000|Overall Study|Death|2|||
170914873|NCT03303339|617691758|FG001|Overall Study|Death|2|||
170914874|NCT03303339|617691759|FG002|Overall Study|Death|2|||
170914875|NCT03303339|617691760|FG003|Overall Study|Death|1|||
170914876|NCT03303339|617691761|FG004|Overall Study|Death|4|||
170914877|NCT03303339|617691762|FG005|Overall Study|Death|2|||
170914878|NCT03303339|617691763|FG006|Overall Study|Death|2|||
170914879|NCT03303339|617691764|FG007|Overall Study|Death|2|||
170914880|NCT03303339|617691765|FG008|Overall Study|Death|3|||
170914881|NCT03303339|617691766|FG009|Overall Study|Death|3|||
170914882|NCT03303339|617691767|FG010|Overall Study|Death|4|||
170914883|NCT03303339|617691768|FG011|Overall Study|Death|24|||
170914884|NCT03303339|617691757|FG000|Overall Study|Study Terminated by Sponsor|0|||
170914885|NCT03303339|617691758|FG001|Overall Study|Study Terminated by Sponsor|0|||
170914886|NCT03303339|617691759|FG002|Overall Study|Study Terminated by Sponsor|0|||
170914887|NCT03303339|617691760|FG003|Overall Study|Study Terminated by Sponsor|0|||
170914888|NCT03303339|617691761|FG004|Overall Study|Study Terminated by Sponsor|0|||
170914889|NCT03303339|617691762|FG005|Overall Study|Study Terminated by Sponsor|0|||
170914890|NCT03303339|617691763|FG006|Overall Study|Study Terminated by Sponsor|0|||
170605386|NCT03354273|616562034|FG000|Overall Study|Screen Failure|21|||
170814341|NCT01345253|617329269|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
170814342|NCT01345253|617329268|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
170914891|NCT03303339|617691764|FG007|Overall Study|Study Terminated by Sponsor|0|||
170914892|NCT03303339|617691765|FG008|Overall Study|Study Terminated by Sponsor|1|||
170914893|NCT03303339|617691766|FG009|Overall Study|Study Terminated by Sponsor|0|||
170914894|NCT03303339|617691767|FG010|Overall Study|Study Terminated by Sponsor|1|||
170605387|NCT03354273|616562034|FG000|Overall Study|Withdrawal by Subject|34|||
170605388|NCT03354273|616562034|FG000|Overall Study|Technical Problems|30|||
170605389|NCT03354273|616562034|FG000|Overall Study|Lost to Follow-up|4|||
170605390|NCT03354273|616562034|FG000|Overall Study|Investigator Decision|3|||
170605391|NCT03354273|616562034|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
170605392|NCT03354273|616562034|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
170605393|NCT03354273|616562034|FG000|Overall Study|COVID-19 Restrictions|9|||
170605394|NCT03354273|616562034|FG000|Overall Study|Other|5|||
170605395|NCT02950480|616562035|FG000|Overall Study|Withdrawal by Subject|1|||
170605396|NCT02950480|616562036|FG001|Overall Study|Withdrawal by Subject|0|||
170605397|NCT02630472|616562037|FG000|Overall Study|Physician Decision|10|||
170814343|NCT01345253|617329269|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
170814344|NCT01345253|617329268|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
170814345|NCT01345253|617329269|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
170814346|NCT01345253|617329268|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
170814347|NCT01345253|617329269|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
170814348|NCT01345253|617329268|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
170814349|NCT01345253|617329269|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
170814350|NCT01345253|617329268|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
170814351|NCT01345253|617329269|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
170814352|NCT01345253|617329268|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
170814353|NCT01345253|617329269|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
170814354|NCT01670877|617329270|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
170814355|NCT01670877|617329271|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
170814356|NCT01670877|617329272|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
170814357|NCT01670877|617329273|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
170814358|NCT01670877|617329274|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
170814359|NCT01670877|617329275|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
170814360|NCT01670877|617329270|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
170814361|NCT01670877|617329271|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
170814362|NCT01670877|617329272|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
170814363|NCT01670877|617329273|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
170814364|NCT01670877|617329274|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
170814365|NCT01670877|617329275|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
170814366|NCT01670877|617329270|FG000|Part I and Part 2|Grade 2 vomiting|0|||
170814367|NCT01670877|617329271|FG001|Part I and Part 2|Grade 2 vomiting|0|||
170814368|NCT01670877|617329272|FG002|Part I and Part 2|Grade 2 vomiting|0|||
170814369|NCT01670877|617329273|FG003|Part I and Part 2|Grade 2 vomiting|1|||
170814370|NCT01670877|617329274|FG004|Part I and Part 2|Grade 2 vomiting|0|||
170814371|NCT01670877|617329275|FG005|Part I and Part 2|Grade 2 vomiting|0|||
170814372|NCT01670877|617329270|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
170814373|NCT01670877|617329271|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
170814374|NCT01670877|617329272|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
170814375|NCT01670877|617329273|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
170814376|NCT01670877|617329274|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
170814377|NCT01670877|617329275|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
170814378|NCT01670877|617329270|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
170814379|NCT01670877|617329271|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
170814380|NCT01670877|617329272|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
170814381|NCT01670877|617329273|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
170814382|NCT01670877|617329274|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
170814383|NCT01670877|617329275|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
170814384|NCT02309892|617329276|FG000|Overall Study|Physician Decision|1|||
170814385|NCT02309892|617329277|FG001|Overall Study|Physician Decision|0|||
170814386|NCT02309892|617329278|FG002|Overall Study|Physician Decision|0|||
170814387|NCT02309892|617329279|FG003|Overall Study|Physician Decision|0|||
170814388|NCT02309892|617329280|FG004|Overall Study|Physician Decision|0|||
170814389|NCT02309892|617329281|FG005|Overall Study|Physician Decision|0|||
170814390|NCT02309892|617329282|FG006|Overall Study|Physician Decision|0|||
170814391|NCT02309892|617329276|FG000|Overall Study|Adverse Event|1|||
170814392|NCT02309892|617329277|FG001|Overall Study|Adverse Event|0|||
170814393|NCT02309892|617329278|FG002|Overall Study|Adverse Event|1|||
170605398|NCT02630472|616562038|FG001|Overall Study|Physician Decision|0|||
170814394|NCT02309892|617329279|FG003|Overall Study|Adverse Event|0|||
170814395|NCT02309892|617329280|FG004|Overall Study|Adverse Event|0|||
170605399|NCT01483183|616562049|FG000|Overall Study|Physician Decision|0|||
170605400|NCT01483183|616562050|FG001|Overall Study|Physician Decision|0|||
170605401|NCT01483183|616562051|FG002|Overall Study|Physician Decision|0|||
170605402|NCT01483183|616562052|FG003|Overall Study|Physician Decision|0|||
170605403|NCT01483183|616562053|FG004|Overall Study|Physician Decision|0|||
170605404|NCT01483183|616562054|FG005|Overall Study|Physician Decision|0|||
170605405|NCT01483183|616562055|FG006|Overall Study|Physician Decision|2|||
170605406|NCT01483183|616562056|FG007|Overall Study|Physician Decision|0|||
170605407|NCT01483183|616562057|FG008|Overall Study|Physician Decision|0|||
170814396|NCT02309892|617329281|FG005|Overall Study|Adverse Event|0|||
170814397|NCT02309892|617329282|FG006|Overall Study|Adverse Event|0|||
170814398|NCT02309892|617329276|FG000|Overall Study|Progressive Disease|0|||
170814399|NCT02309892|617329277|FG001|Overall Study|Progressive Disease|1|||
170814400|NCT02309892|617329278|FG002|Overall Study|Progressive Disease|0|||
170814401|NCT02309892|617329279|FG003|Overall Study|Progressive Disease|0|||
170814402|NCT02309892|617329280|FG004|Overall Study|Progressive Disease|1|||
170814403|NCT02309892|617329281|FG005|Overall Study|Progressive Disease|0|||
170814404|NCT02309892|617329282|FG006|Overall Study|Progressive Disease|0|||
170814405|NCT02309892|617329276|FG000|Overall Study|Death|0|||
170814406|NCT02309892|617329277|FG001|Overall Study|Death|0|||
170814407|NCT02309892|617329278|FG002|Overall Study|Death|0|||
170814408|NCT02309892|617329279|FG003|Overall Study|Death|0|||
170814409|NCT02309892|617329280|FG004|Overall Study|Death|0|||
170814410|NCT02309892|617329281|FG005|Overall Study|Death|1|||
170814411|NCT02309892|617329282|FG006|Overall Study|Death|0|||
170814412|NCT03693989|617329283|FG000|Overall Study|Protocol Violation|3|||
170814413|NCT03693989|617329284|FG001|Overall Study|Protocol Violation|4|||
170605408|NCT01483183|616562058|FG009|Overall Study|Physician Decision|0|||
170605409|NCT01483183|616562049|FG000|Overall Study|Withdrawal by Subject|0|||
170914895|NCT03303339|617691768|FG011|Overall Study|Study Terminated by Sponsor|1|||
170914896|NCT03303339|617691757|FG000|Overall Study|Withdrawal by Subject|1|||
170914897|NCT03303339|617691758|FG001|Overall Study|Withdrawal by Subject|0|||
170914898|NCT03303339|617691759|FG002|Overall Study|Withdrawal by Subject|0|||
170914899|NCT03303339|617691760|FG003|Overall Study|Withdrawal by Subject|0|||
170914900|NCT03303339|617691761|FG004|Overall Study|Withdrawal by Subject|0|||
170914901|NCT03303339|617691762|FG005|Overall Study|Withdrawal by Subject|1|||
170914902|NCT03303339|617691763|FG006|Overall Study|Withdrawal by Subject|1|||
170914903|NCT03303339|617691764|FG007|Overall Study|Withdrawal by Subject|0|||
170914904|NCT03303339|617691765|FG008|Overall Study|Withdrawal by Subject|0|||
170914905|NCT03303339|617691766|FG009|Overall Study|Withdrawal by Subject|0|||
170914906|NCT03303339|617691767|FG010|Overall Study|Withdrawal by Subject|0|||
170914907|NCT03303339|617691768|FG011|Overall Study|Withdrawal by Subject|2|||
170914908|NCT03303339|617691757|FG000|Overall Study|Physician Decision|0|||
170914909|NCT03303339|617691758|FG001|Overall Study|Physician Decision|0|||
170914910|NCT03303339|617691759|FG002|Overall Study|Physician Decision|0|||
170914911|NCT03303339|617691760|FG003|Overall Study|Physician Decision|0|||
170914912|NCT03303339|617691761|FG004|Overall Study|Physician Decision|1|||
170914913|NCT03303339|617691762|FG005|Overall Study|Physician Decision|0|||
170914914|NCT03303339|617691763|FG006|Overall Study|Physician Decision|0|||
170914915|NCT03303339|617691764|FG007|Overall Study|Physician Decision|0|||
170914916|NCT03303339|617691765|FG008|Overall Study|Physician Decision|0|||
170914917|NCT03303339|617691766|FG009|Overall Study|Physician Decision|0|||
170914918|NCT03303339|617691767|FG010|Overall Study|Physician Decision|0|||
170914919|NCT03303339|617691768|FG011|Overall Study|Physician Decision|0|||
170914920|NCT03303339|617691757|FG000|Overall Study|Safety/Non-compliance|0|||
170914921|NCT03303339|617691758|FG001|Overall Study|Safety/Non-compliance|0|||
170914922|NCT03303339|617691759|FG002|Overall Study|Safety/Non-compliance|0|||
170914923|NCT03303339|617691760|FG003|Overall Study|Safety/Non-compliance|0|||
170914924|NCT03303339|617691761|FG004|Overall Study|Safety/Non-compliance|0|||
170914925|NCT03303339|617691762|FG005|Overall Study|Safety/Non-compliance|0|||
170914926|NCT03303339|617691763|FG006|Overall Study|Safety/Non-compliance|0|||
170914927|NCT03303339|617691764|FG007|Overall Study|Safety/Non-compliance|0|||
170914928|NCT03303339|617691765|FG008|Overall Study|Safety/Non-compliance|0|||
170914929|NCT03303339|617691766|FG009|Overall Study|Safety/Non-compliance|0|||
170914930|NCT03303339|617691767|FG010|Overall Study|Safety/Non-compliance|0|||
170914931|NCT03303339|617691768|FG011|Overall Study|Safety/Non-compliance|1|||
170914932|NCT01096667|617691772|FG000|Overall Study|Lost to Follow-up|1|||
170914933|NCT01096667|617691773|FG001|Overall Study|Lost to Follow-up|1|||
170914934|NCT01096667|617691774|FG002|Overall Study|Lost to Follow-up|1|||
170914935|NCT01096667|617691775|FG003|Overall Study|Lost to Follow-up|0|||
170914936|NCT01096667|617691776|FG004|Overall Study|Lost to Follow-up|0|||
170914937|NCT01096667|617691772|FG000|Overall Study|Withdrawal by Subject|1|||
170914938|NCT01096667|617691773|FG001|Overall Study|Withdrawal by Subject|0|||
170914939|NCT01096667|617691774|FG002|Overall Study|Withdrawal by Subject|0|||
170914940|NCT01096667|617691775|FG003|Overall Study|Withdrawal by Subject|1|||
170914941|NCT01096667|617691776|FG004|Overall Study|Withdrawal by Subject|0|||
170914942|NCT01096667|617691772|FG000|Overall Study|Reason not available|0|||
170914943|NCT01096667|617691773|FG001|Overall Study|Reason not available|1|||
170914944|NCT01096667|617691774|FG002|Overall Study|Reason not available|1|||
170914945|NCT01096667|617691775|FG003|Overall Study|Reason not available|1|||
170914946|NCT01096667|617691776|FG004|Overall Study|Reason not available|0|||
170914947|NCT01096667|617691772|FG000|Overall Study|Protocol Violation|0|||
170914948|NCT01096667|617691773|FG001|Overall Study|Protocol Violation|0|||
170914949|NCT01096667|617691774|FG002|Overall Study|Protocol Violation|0|||
170914950|NCT01096667|617691775|FG003|Overall Study|Protocol Violation|1|||
170914951|NCT01096667|617691776|FG004|Overall Study|Protocol Violation|0|||
170914952|NCT01096667|617691772|FG000|Overall Study|Not treated|1|||
170914953|NCT01096667|617691773|FG001|Overall Study|Not treated|0|||
170914954|NCT01096667|617691774|FG002|Overall Study|Not treated|0|||
170914955|NCT01096667|617691775|FG003|Overall Study|Not treated|0|||
170914956|NCT01096667|617691776|FG004|Overall Study|Not treated|0|||
170914957|NCT00510692|617691777|FG000|Overall Study|Adverse Event|1|||
170914958|NCT00510692|617691778|FG001|Overall Study|Adverse Event|3|||
170914959|NCT00510692|617691777|FG000|Overall Study|Withdrawal by Subject|1|||
170914960|NCT00510692|617691778|FG001|Overall Study|Withdrawal by Subject|0|||
170914961|NCT00206518|617691779|FG000|Overall Study|Lack of Efficacy|6|||
170914962|NCT00206518|617691780|FG001|Overall Study|Lack of Efficacy|4|||
170914963|NCT00206518|617691779|FG000|Overall Study|Adverse Event|2|||
170914964|NCT00206518|617691780|FG001|Overall Study|Adverse Event|1|||
170914965|NCT00206518|617691779|FG000|Overall Study|Physician Decision|1|||
170914966|NCT00206518|617691780|FG001|Overall Study|Physician Decision|0|||
170914967|NCT00206518|617691779|FG000|Overall Study|Protocol Violation|1|||
170914968|NCT00206518|617691780|FG001|Overall Study|Protocol Violation|1|||
170914969|NCT02335450|617691781|FG000|Overall Study|Pregnancy|1|||
170914970|NCT01845077|617691782|FG000|Washout Period|Lost to Follow-up|0|||
170914971|NCT01845077|617691783|FG001|Washout Period|Lost to Follow-up|1|||
170914972|NCT01845077|617691784|FG002|Washout Period|Lost to Follow-up|0|||
170914973|NCT01845077|617691785|FG003|Washout Period|Lost to Follow-up|1|||
170652634|NCT01986933|616741691|FG003|Active-to-active (Part B)|Adverse Event|1|||
170652635|NCT01986933|616741692|FG004|Active-to-active (Part B)|Adverse Event|3|||
170652636|NCT01986933|616741688|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
170652637|NCT01986933|616741689|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
170652638|NCT01986933|616741690|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
170652639|NCT01986933|616741691|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
170652640|NCT01986933|616741692|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
170652641|NCT01986933|616741688|FG000|Active-to-active (Part B)|Pregnancy|0|||
170652642|NCT01986933|616741689|FG001|Active-to-active (Part B)|Pregnancy|0|||
170652643|NCT01986933|616741690|FG002|Active-to-active (Part B)|Pregnancy|0|||
170652644|NCT01986933|616741691|FG003|Active-to-active (Part B)|Pregnancy|0|||
170652645|NCT01986933|616741692|FG004|Active-to-active (Part B)|Pregnancy|1|||
170652646|NCT01986933|616741688|FG000|Active-to-active (Part B)|Physician Decision|0|||
170652647|NCT01986933|616741689|FG001|Active-to-active (Part B)|Physician Decision|0|||
170652648|NCT01986933|616741690|FG002|Active-to-active (Part B)|Physician Decision|1|||
170652649|NCT01986933|616741691|FG003|Active-to-active (Part B)|Physician Decision|1|||
170814414|NCT01190436|617329285|FG000|Overall Study|Lost to Follow-up|35|||
170814415|NCT01190436|617329285|FG000|Overall Study|Other|4|||
170814416|NCT03146845|617329287|FG000|Overall Study|Reference ulcer healed|1|||
170814417|NCT03146845|617329288|FG001|Overall Study|Reference ulcer healed|0|||
170814418|NCT03146845|617329287|FG000|Overall Study|Physician Decision|1|||
170814419|NCT03146845|617329288|FG001|Overall Study|Physician Decision|0|||
170814420|NCT03146845|617329287|FG000|Overall Study|Adverse Event|1|||
170814421|NCT03146845|617329288|FG001|Overall Study|Adverse Event|0|||
170814422|NCT03146845|617329287|FG000|Overall Study|Withdrawal by Subject|2|||
170814423|NCT03146845|617329288|FG001|Overall Study|Withdrawal by Subject|0|||
170814424|NCT03146845|617329287|FG000|Overall Study|Noncompliance|0|||
170814425|NCT03146845|617329288|FG001|Overall Study|Noncompliance|1|||
170814426|NCT03146845|617329287|FG000|Overall Study|Protocol Violation|0|||
170814427|NCT03146845|617329288|FG001|Overall Study|Protocol Violation|2|||
170814428|NCT03146845|617329287|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
170814429|NCT03146845|617329288|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
170814430|NCT02721147|617329289|FG000|Overall Study|Lost to Follow-up|2|||
170814431|NCT02721147|617329290|FG001|Overall Study|Lost to Follow-up|0|||
170814432|NCT02721147|617329291|FG002|Overall Study|Lost to Follow-up|0|||
170814433|NCT01052272|617329294|FG000|Overall Study|Death|0|||
170814434|NCT01052272|617329295|FG001|Overall Study|Death|0|||
170814435|NCT01052272|617329296|FG002|Overall Study|Death|1|||
170814436|NCT01052272|617329297|FG003|Overall Study|Death|1|||
170814437|NCT01052272|617329294|FG000|Overall Study|Physician Decision|0|||
170814438|NCT01052272|617329295|FG001|Overall Study|Physician Decision|1|||
170814439|NCT01052272|617329296|FG002|Overall Study|Physician Decision|0|||
170814440|NCT01052272|617329297|FG003|Overall Study|Physician Decision|0|||
170814441|NCT01052272|617329294|FG000|Overall Study|patient refuses follow-up|5|||
170814442|NCT01052272|617329295|FG001|Overall Study|patient refuses follow-up|4|||
170814443|NCT01052272|617329296|FG002|Overall Study|patient refuses follow-up|2|||
170814444|NCT01052272|617329297|FG003|Overall Study|patient refuses follow-up|4|||
170814445|NCT01052272|617329294|FG000|Overall Study|Withdrawal by Subject|0|||
170814446|NCT01052272|617329295|FG001|Overall Study|Withdrawal by Subject|2|||
170814447|NCT01052272|617329296|FG002|Overall Study|Withdrawal by Subject|3|||
170814448|NCT01052272|617329297|FG003|Overall Study|Withdrawal by Subject|2|||
170814449|NCT01052272|617329294|FG000|Overall Study|placed in long-term care|0|||
170814450|NCT01052272|617329295|FG001|Overall Study|placed in long-term care|0|||
170814451|NCT01052272|617329296|FG002|Overall Study|placed in long-term care|1|||
170814452|NCT01052272|617329297|FG003|Overall Study|placed in long-term care|0|||
170814453|NCT01052272|617329294|FG000|Overall Study|decline in health|0|||
170814454|NCT01052272|617329295|FG001|Overall Study|decline in health|0|||
170814455|NCT01052272|617329296|FG002|Overall Study|decline in health|1|||
170814456|NCT01052272|617329297|FG003|Overall Study|decline in health|0|||
170814457|NCT00113529|617329298|FG000|Overall Study|Adverse Event|4|||
170652650|NCT01986933|616741692|FG004|Active-to-active (Part B)|Physician Decision|0|||
170652651|NCT01986933|616741688|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
170652652|NCT01986933|616741689|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
170814458|NCT00113529|617329298|FG000|Overall Study|Lack of Efficacy|20|||
170814459|NCT00113529|617329298|FG000|Overall Study|Decision of sponsor|6|||
170814460|NCT00113529|617329298|FG000|Overall Study|Withdrawal by Subject|4|||
170814461|NCT01722097|617329299|FG000|Overall Study|Patient sheets not returned|6|||
170814462|NCT01722097|617329300|FG001|Overall Study|Patient sheets not returned|5|||
170814463|NCT00648895|617329305|FG000|Overall Study|Lack of Efficacy|0|||
170814464|NCT00648895|617329306|FG001|Overall Study|Lack of Efficacy|1|||
170814465|NCT01180400|617329310|FG000|Overall Study|Withdrawal by Subject|5|||
170652653|NCT01986933|616741690|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
170652654|NCT01986933|616741691|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
170652655|NCT01986933|616741692|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
170652656|NCT01986933|616741688|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
170652657|NCT01986933|616741689|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
170652658|NCT01986933|616741690|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
170652659|NCT01986933|616741691|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
170814466|NCT01180400|617329311|FG001|Overall Study|Withdrawal by Subject|6|||
170814467|NCT01180400|617329310|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170814468|NCT01180400|617329311|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
170814469|NCT01180400|617329310|FG000|Overall Study|Adverse Event|12|||
170814470|NCT01180400|617329311|FG001|Overall Study|Adverse Event|10|||
170814471|NCT01180400|617329310|FG000|Overall Study|Severe non-compliance to protocol|1|||
170814472|NCT01180400|617329311|FG001|Overall Study|Severe non-compliance to protocol|2|||
170814473|NCT01180400|617329310|FG000|Overall Study|Condition under investigation worsened|2|||
170814474|NCT01180400|617329311|FG001|Overall Study|Condition under investigation worsened|1|||
170814475|NCT01180400|617329310|FG000|Overall Study|Lack of Efficacy|2|||
170814476|NCT01180400|617329311|FG001|Overall Study|Lack of Efficacy|0|||
170814477|NCT01180400|617329310|FG000|Overall Study|Study-specific withdrawal criteria|1|||
170814478|NCT01180400|617329311|FG001|Overall Study|Study-specific withdrawal criteria|2|||
170814479|NCT01180400|617329310|FG000|Overall Study|Lost to Follow-up|2|||
170814480|NCT01180400|617329311|FG001|Overall Study|Lost to Follow-up|3|||
170814481|NCT01180400|617329310|FG000|Overall Study|Other|0|||
170814482|NCT01180400|617329311|FG001|Overall Study|Other|1|||
170814483|NCT03349476|617329312|FG000|Overall Study|Physician Decision|3|||
170814484|NCT00795639|617329313|FG000|Overall Study|Death|1|||
170814485|NCT00795639|617329314|FG001|Overall Study|Death|6|||
170814486|NCT00795639|617329313|FG000|Overall Study|Withdrawal by Subject|1|||
170814487|NCT00795639|617329314|FG001|Overall Study|Withdrawal by Subject|3|||
170814488|NCT00795639|617329313|FG000|Overall Study|Pregnancy|1|||
170814489|NCT00795639|617329314|FG001|Overall Study|Pregnancy|0|||
170814490|NCT00795639|617329313|FG000|Overall Study|Adverse Event|5|||
170814491|NCT00795639|617329314|FG001|Overall Study|Adverse Event|2|||
170814492|NCT00795639|617329313|FG000|Overall Study|Other|0|||
170814493|NCT00795639|617329314|FG001|Overall Study|Other|2|||
170814494|NCT00795639|617329313|FG000|Overall Study|Terminated by sponsor|13|||
170814495|NCT00795639|617329314|FG001|Overall Study|Terminated by sponsor|12|||
170814496|NCT00795639|617329313|FG000|Overall Study|Randomized and not treated|0|||
170814497|NCT00795639|617329314|FG001|Overall Study|Randomized and not treated|1|||
170814498|NCT04626128|617329315|FG000|Overall Study|Withdrawal by Subject|0|||
170814499|NCT04626128|617329316|FG001|Overall Study|Withdrawal by Subject|1|||
170814500|NCT04626128|617329317|FG002|Overall Study|Withdrawal by Subject|0|||
170814501|NCT04626128|617329318|FG003|Overall Study|Withdrawal by Subject|0|||
170814502|NCT02525744|617329319|FG000|Period 1|Physician Decision|0|||
170814503|NCT02525744|617329320|FG001|Period 1|Physician Decision|0|||
170814504|NCT02525744|617329321|FG002|Period 1|Physician Decision|1|||
170814505|NCT02525744|617329322|FG003|Period 1|Physician Decision|0|||
170814506|NCT02525744|617329319|FG000|Period 3|Adverse Event|0|||
170814507|NCT02525744|617329320|FG001|Period 3|Adverse Event|1|||
170814508|NCT02525744|617329321|FG002|Period 3|Adverse Event|0|||
170814509|NCT02525744|617329322|FG003|Period 3|Adverse Event|0|||
170814510|NCT02525744|617329319|FG000|Period 4|Withdrawal by Subject|1|||
170814511|NCT02525744|617329320|FG001|Period 4|Withdrawal by Subject|0|||
170814512|NCT02525744|617329321|FG002|Period 4|Withdrawal by Subject|0|||
170814513|NCT02525744|617329322|FG003|Period 4|Withdrawal by Subject|0|||
170814514|NCT02525744|617329319|FG000|Period 5|Physician Decision|1|||
170814515|NCT02525744|617329320|FG001|Period 5|Physician Decision|0|||
170814516|NCT02525744|617329321|FG002|Period 5|Physician Decision|0|||
170814517|NCT02525744|617329322|FG003|Period 5|Physician Decision|0|||
170814518|NCT00472082|617329329|FG000|Overall Study|Study prematurely terminated|5|||
170814519|NCT01124916|617329334|FG000|Overall Study|Lost to Follow-up|3|||
170814520|NCT01124916|617329335|FG001|Overall Study|Lost to Follow-up|2|||
170814521|NCT00595959|617329340|FG000|Overall Study|Withdrawal by Subject|1|||
170814522|NCT00595959|617329340|FG000|Overall Study|Lost to Follow-up|1|||
170814523|NCT02077374|617329341|FG000|Overall Study|Withdrawal by Subject|0|||
170814524|NCT02077374|617329342|FG001|Overall Study|Withdrawal by Subject|1|||
170814525|NCT02077374|617329341|FG000|Overall Study|Protocol Violation|0|||
170814526|NCT02077374|617329342|FG001|Overall Study|Protocol Violation|1|||
170814527|NCT02644122|617329347|FG000|Overall Study|Withdrawal by Subject|1|||
170814528|NCT01138657|617329348|FG000|Overall Study|Adverse Event|3|||
170814529|NCT01138657|617329349|FG001|Overall Study|Adverse Event|10|||
170914974|NCT01845077|617691786|FG004|Washout Period|Lost to Follow-up|0|||
170914975|NCT01845077|617691787|FG005|Washout Period|Lost to Follow-up|1|||
170914976|NCT01845077|617691782|FG000|Washout Period|Adverse Event|1|||
170914977|NCT01845077|617691783|FG001|Washout Period|Adverse Event|0|||
170914978|NCT01845077|617691784|FG002|Washout Period|Adverse Event|0|||
170914979|NCT01845077|617691785|FG003|Washout Period|Adverse Event|0|||
170914980|NCT01845077|617691786|FG004|Washout Period|Adverse Event|0|||
170914981|NCT01845077|617691787|FG005|Washout Period|Adverse Event|0|||
170914982|NCT01845077|617691782|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
170914983|NCT01845077|617691783|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
170914984|NCT01845077|617691784|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
170914985|NCT01845077|617691785|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
170914986|NCT01845077|617691786|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
170914987|NCT01845077|617691787|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
170914988|NCT01845077|617691782|FG000|Washout Period|Protocol Violation|0|||
170914989|NCT01845077|617691783|FG001|Washout Period|Protocol Violation|0|||
170914990|NCT01845077|617691784|FG002|Washout Period|Protocol Violation|0|||
170914991|NCT01845077|617691785|FG003|Washout Period|Protocol Violation|1|||
170914992|NCT01845077|617691786|FG004|Washout Period|Protocol Violation|1|||
170914993|NCT01845077|617691787|FG005|Washout Period|Protocol Violation|0|||
170914994|NCT01879618|617691790|FG000|Overall Study|Does not meet entrance criteria|1|||
170914995|NCT01879618|617691790|FG000|Overall Study|Withdrawal by Subject|1|||
170914996|NCT01879618|617691790|FG000|Overall Study|Surgery;changed schedule; not available|8|||
170914997|NCT01879618|617691790|FG000|Overall Study|Protocol Violation|6|||
170652660|NCT01986933|616741692|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
170652661|NCT01986933|616741688|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
170652662|NCT01986933|616741689|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
170652663|NCT01986933|616741690|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
170652664|NCT01986933|616741691|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
170652665|NCT01986933|616741692|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
170652666|NCT01986933|616741688|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
170652667|NCT01986933|616741689|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
170652668|NCT01986933|616741690|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
170652669|NCT01986933|616741691|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
170652670|NCT01986933|616741692|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
170652671|NCT01986933|616741688|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
170914998|NCT01879618|617691790|FG000|Overall Study|Adverse Event|5|||
170914999|NCT02613572|617691791|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
170915000|NCT02613572|617691792|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
170915001|NCT02613572|617691793|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
170915002|NCT02613572|617691791|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
170915003|NCT02613572|617691792|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
170652672|NCT01986933|616741689|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
170652673|NCT01986933|616741690|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
170915004|NCT02613572|617691793|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
170915005|NCT00394914|617691794|FG000|Treatment Period|Adverse Event|0|||
170915006|NCT00394914|617691795|FG001|Treatment Period|Adverse Event|3|||
170915007|NCT00394914|617691796|FG002|Treatment Period|Adverse Event|1|||
170915008|NCT00394914|617691794|FG000|Treatment Period|Lost to Follow-up|0|||
170915009|NCT00394914|617691795|FG001|Treatment Period|Lost to Follow-up|1|||
170915010|NCT00394914|617691796|FG002|Treatment Period|Lost to Follow-up|0|||
170915011|NCT00394914|617691794|FG000|Treatment Period|Withdrawal by Subject|0|||
170915012|NCT00394914|617691795|FG001|Treatment Period|Withdrawal by Subject|2|||
170915013|NCT00394914|617691796|FG002|Treatment Period|Withdrawal by Subject|2|||
170915014|NCT00394914|617691794|FG000|Treatment Period|Noncompliance with protocol|0|||
170915015|NCT00394914|617691795|FG001|Treatment Period|Noncompliance with protocol|3|||
170915016|NCT00394914|617691796|FG002|Treatment Period|Noncompliance with protocol|2|||
170915017|NCT00394914|617691794|FG000|Treatment Period|Did not meet protocol eligibility|0|||
170915018|NCT00394914|617691795|FG001|Treatment Period|Did not meet protocol eligibility|1|||
170915019|NCT00394914|617691796|FG002|Treatment Period|Did not meet protocol eligibility|1|||
170915020|NCT01004146|617691801|FG000|Overall Study|Withdrawal by Subject|4|||
170915021|NCT01004146|617691802|FG001|Overall Study|Withdrawal by Subject|5|||
170915022|NCT05258058|617691803|FG000|Overall Study|Withdrawal by Subject|2|||
170915023|NCT01001494|617691808|FG000|Overall Study|Adverse Event|8|||
170915024|NCT01001494|617691809|FG001|Overall Study|Adverse Event|4|||
170915025|NCT01001494|617691810|FG002|Overall Study|Adverse Event|6|||
170915026|NCT01001494|617691808|FG000|Overall Study|Protocol Violation|0|||
170915027|NCT01001494|617691809|FG001|Overall Study|Protocol Violation|1|||
170915028|NCT01001494|617691810|FG002|Overall Study|Protocol Violation|1|||
170915029|NCT01001494|617691808|FG000|Overall Study|Lost to Follow-up|2|||
170915030|NCT01001494|617691809|FG001|Overall Study|Lost to Follow-up|0|||
170915031|NCT01001494|617691810|FG002|Overall Study|Lost to Follow-up|1|||
170915032|NCT01001494|617691808|FG000|Overall Study|Withdrawal by Subject|9|||
170814530|NCT01138657|617329348|FG000|Overall Study|Lack of Efficacy|2|||
170814531|NCT01138657|617329349|FG001|Overall Study|Lack of Efficacy|1|||
170814532|NCT01138657|617329348|FG000|Overall Study|Lost to Follow-up|0|||
170814533|NCT01138657|617329349|FG001|Overall Study|Lost to Follow-up|3|||
170814534|NCT01138657|617329348|FG000|Overall Study|Miscellaneous Reasons|3|||
170814535|NCT01138657|617329349|FG001|Overall Study|Miscellaneous Reasons|4|||
170814536|NCT01280656|617329352|FG000|Overall Study|Adverse Event|1|||
170814537|NCT01280656|617329353|FG001|Overall Study|Adverse Event|14|||
170814538|NCT01280656|617329354|FG002|Overall Study|Adverse Event|13|||
170814539|NCT01280656|617329352|FG000|Overall Study|Lack of Efficacy|1|||
170814540|NCT01280656|617329353|FG001|Overall Study|Lack of Efficacy|22|||
170814541|NCT01280656|617329354|FG002|Overall Study|Lack of Efficacy|38|||
170814542|NCT01280656|617329352|FG000|Overall Study|Treatment shortening (RGT)|0|||
170814543|NCT01280656|617329353|FG001|Overall Study|Treatment shortening (RGT)|4|||
170814544|NCT01280656|617329354|FG002|Overall Study|Treatment shortening (RGT)|5|||
170814545|NCT01280656|617329352|FG000|Overall Study|Other|1|||
170814546|NCT01280656|617329353|FG001|Overall Study|Other|7|||
170814547|NCT01280656|617329354|FG002|Overall Study|Other|7|||
170814548|NCT03150589|617329355|FG000|Overall Study|Withdrawal by Subject|16|||
170814549|NCT03150589|617329356|FG001|Overall Study|Withdrawal by Subject|9|||
170814550|NCT03150589|617329355|FG000|Overall Study|Adverse Event|7|||
170814551|NCT03150589|617329356|FG001|Overall Study|Adverse Event|6|||
170814552|NCT03150589|617329355|FG000|Overall Study|Protocol Violation|4|||
170814553|NCT03150589|617329356|FG001|Overall Study|Protocol Violation|3|||
170814554|NCT03150589|617329355|FG000|Overall Study|Lost to Follow-up|3|||
170814555|NCT03150589|617329356|FG001|Overall Study|Lost to Follow-up|3|||
170814556|NCT03150589|617329355|FG000|Overall Study|Death|2|||
170814557|NCT03150589|617329356|FG001|Overall Study|Death|3|||
170814558|NCT03150589|617329355|FG000|Overall Study|IP non-compliance and other reasons|12|||
170814559|NCT03150589|617329356|FG001|Overall Study|IP non-compliance and other reasons|3|||
170814560|NCT02159352|617329357|FG000|Overall Study|Adverse Event|3|||
170814561|NCT02159352|617329358|FG001|Overall Study|Adverse Event|1|||
170814562|NCT02159352|617329357|FG000|Overall Study|Withdrawal by Subject|0|||
170814563|NCT02159352|617329358|FG001|Overall Study|Withdrawal by Subject|1|||
170814564|NCT00346398|617329359|FG000|Overall Study|Lost to Follow-up|3|||
170814565|NCT00346398|617329360|FG001|Overall Study|Lost to Follow-up|0|||
170814566|NCT00346398|617329359|FG000|Overall Study|Withdrawal by Subject|0|||
170814567|NCT00346398|617329360|FG001|Overall Study|Withdrawal by Subject|2|||
170814568|NCT00103857|617329361|FG000|54-Week Base Study|Adverse Event|12|||
170814569|NCT00103857|617329362|FG001|54-Week Base Study|Adverse Event|9|||
170814570|NCT00103857|617329363|FG002|54-Week Base Study|Adverse Event|11|||
170814571|NCT00103857|617329364|FG003|54-Week Base Study|Adverse Event|6|||
170814572|NCT00103857|617329365|FG004|54-Week Base Study|Adverse Event|5|||
170814573|NCT00103857|617329366|FG005|54-Week Base Study|Adverse Event|11|||
170814574|NCT00103857|617329367|FG006|54-Week Base Study|Adverse Event|3|||
170814575|NCT00103857|617329361|FG000|54-Week Base Study|Death|0|||
170814576|NCT00103857|617329362|FG001|54-Week Base Study|Death|0|||
170814577|NCT00103857|617329363|FG002|54-Week Base Study|Death|0|||
170814578|NCT00103857|617329364|FG003|54-Week Base Study|Death|0|||
170814579|NCT00103857|617329365|FG004|54-Week Base Study|Death|1|||
170814580|NCT00103857|617329366|FG005|54-Week Base Study|Death|1|||
170814581|NCT00103857|617329367|FG006|54-Week Base Study|Death|0|||
170814582|NCT00103857|617329361|FG000|54-Week Base Study|Lack of Efficacy|11|||
170814583|NCT00103857|617329362|FG001|54-Week Base Study|Lack of Efficacy|14|||
170814584|NCT00103857|617329363|FG002|54-Week Base Study|Lack of Efficacy|8|||
170814585|NCT00103857|617329364|FG003|54-Week Base Study|Lack of Efficacy|4|||
170814586|NCT00103857|617329365|FG004|54-Week Base Study|Lack of Efficacy|3|||
170814587|NCT00103857|617329366|FG005|54-Week Base Study|Lack of Efficacy|14|||
170814588|NCT00103857|617329367|FG006|54-Week Base Study|Lack of Efficacy|19|||
170814589|NCT00103857|617329361|FG000|54-Week Base Study|Lost to Follow-up|5|||
170814590|NCT00103857|617329362|FG001|54-Week Base Study|Lost to Follow-up|4|||
170814591|NCT00103857|617329363|FG002|54-Week Base Study|Lost to Follow-up|7|||
170814592|NCT00103857|617329364|FG003|54-Week Base Study|Lost to Follow-up|5|||
170814593|NCT00103857|617329365|FG004|54-Week Base Study|Lost to Follow-up|10|||
170915033|NCT01001494|617691809|FG001|Overall Study|Withdrawal by Subject|7|||
170814594|NCT00103857|617329366|FG005|54-Week Base Study|Lost to Follow-up|9|||
170915034|NCT01001494|617691810|FG002|Overall Study|Withdrawal by Subject|17|||
170915035|NCT01001494|617691808|FG000|Overall Study|COPD exacerbation|3|||
170915036|NCT01001494|617691809|FG001|Overall Study|COPD exacerbation|4|||
170915037|NCT01001494|617691810|FG002|Overall Study|COPD exacerbation|5|||
170915038|NCT01001494|617691808|FG000|Overall Study|Lack of Efficacy|2|||
170915039|NCT01001494|617691809|FG001|Overall Study|Lack of Efficacy|0|||
170915040|NCT01001494|617691810|FG002|Overall Study|Lack of Efficacy|8|||
170915041|NCT01001494|617691808|FG000|Overall Study|Other|0|||
170814595|NCT00103857|617329367|FG006|54-Week Base Study|Lost to Follow-up|3|||
170814596|NCT00103857|617329361|FG000|54-Week Base Study|Physician Decision|1|||
170814597|NCT00103857|617329362|FG001|54-Week Base Study|Physician Decision|1|||
170814598|NCT00103857|617329363|FG002|54-Week Base Study|Physician Decision|0|||
170915042|NCT01001494|617691809|FG001|Overall Study|Other|1|||
170915043|NCT01001494|617691810|FG002|Overall Study|Other|3|||
170605410|NCT01483183|616562050|FG001|Overall Study|Withdrawal by Subject|0|||
170605411|NCT01483183|616562051|FG002|Overall Study|Withdrawal by Subject|0|||
170605412|NCT01483183|616562052|FG003|Overall Study|Withdrawal by Subject|0|||
170814599|NCT00103857|617329364|FG003|54-Week Base Study|Physician Decision|0|||
170814600|NCT00103857|617329365|FG004|54-Week Base Study|Physician Decision|1|||
170814601|NCT00103857|617329366|FG005|54-Week Base Study|Physician Decision|0|||
170814602|NCT00103857|617329367|FG006|54-Week Base Study|Physician Decision|0|||
170814603|NCT00103857|617329361|FG000|54-Week Base Study|Pregnancy|1|||
170814604|NCT00103857|617329362|FG001|54-Week Base Study|Pregnancy|0|||
170814605|NCT00103857|617329363|FG002|54-Week Base Study|Pregnancy|0|||
170814606|NCT00103857|617329364|FG003|54-Week Base Study|Pregnancy|0|||
170814607|NCT00103857|617329365|FG004|54-Week Base Study|Pregnancy|1|||
170814608|NCT00103857|617329366|FG005|54-Week Base Study|Pregnancy|0|||
170814609|NCT00103857|617329367|FG006|54-Week Base Study|Pregnancy|1|||
170814610|NCT00103857|617329361|FG000|54-Week Base Study|Protocol Violation|6|||
170814611|NCT00103857|617329362|FG001|54-Week Base Study|Protocol Violation|4|||
170814612|NCT00103857|617329363|FG002|54-Week Base Study|Protocol Violation|2|||
170814613|NCT00103857|617329364|FG003|54-Week Base Study|Protocol Violation|4|||
170814614|NCT00103857|617329365|FG004|54-Week Base Study|Protocol Violation|0|||
170605413|NCT01483183|616562053|FG004|Overall Study|Withdrawal by Subject|0|||
170605414|NCT01483183|616562054|FG005|Overall Study|Withdrawal by Subject|0|||
170605415|NCT01483183|616562055|FG006|Overall Study|Withdrawal by Subject|0|||
170605416|NCT01483183|616562056|FG007|Overall Study|Withdrawal by Subject|0|||
170605417|NCT01483183|616562057|FG008|Overall Study|Withdrawal by Subject|0|||
170605418|NCT01483183|616562058|FG009|Overall Study|Withdrawal by Subject|1|||
170605419|NCT00239928|616562059|FG000|Overall Study|Lack of Efficacy|1|||
170605420|NCT00239928|616562059|FG000|Overall Study|Adverse Event|4|||
170605421|NCT00239928|616562059|FG000|Overall Study|Not need to continue study|3|||
170605422|NCT00239928|616562059|FG000|Overall Study|Withdrawal by Subject|2|||
170605423|NCT02524158|616562063|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
170605424|NCT02524158|616562064|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
170605425|NCT02524158|616562063|FG000|12-weeks Assessment|Lost to Follow-up|18|||
170605426|NCT02524158|616562064|FG001|12-weeks Assessment|Lost to Follow-up|12|||
170605427|NCT02524158|616562063|FG000|6-month Assessment|Withdrawal by Subject|1|||
170605428|NCT02524158|616562064|FG001|6-month Assessment|Withdrawal by Subject|1|||
170605429|NCT02524158|616562063|FG000|6-month Assessment|Lost to Follow-up|21|||
170605430|NCT02524158|616562064|FG001|6-month Assessment|Lost to Follow-up|20|||
170605431|NCT00971243|616562065|FG000|Double Blind Period|Adverse Event|2|||
170605432|NCT00971243|616562066|FG001|Double Blind Period|Adverse Event|3|||
170605433|NCT00971243|616562067|FG002|Double Blind Period|Adverse Event|2|||
170814615|NCT00103857|617329366|FG005|54-Week Base Study|Protocol Violation|3|||
170814616|NCT00103857|617329367|FG006|54-Week Base Study|Protocol Violation|3|||
170814617|NCT00103857|617329361|FG000|54-Week Base Study|Withdrawal by Subject|17|||
170814618|NCT00103857|617329362|FG001|54-Week Base Study|Withdrawal by Subject|16|||
170814619|NCT00103857|617329363|FG002|54-Week Base Study|Withdrawal by Subject|16|||
170814620|NCT00103857|617329364|FG003|54-Week Base Study|Withdrawal by Subject|15|||
170915044|NCT02179398|617691811|FG000|Overall Study|Lack of obligatory data|3|||
170605434|NCT00971243|616562068|FG003|Double Blind Period|Adverse Event|2|||
170605435|NCT00971243|616562069|FG004|Double Blind Period|Adverse Event|3|||
170605436|NCT00971243|616562065|FG000|Double Blind Period|Lost to Follow-up|0|||
170605437|NCT00971243|616562066|FG001|Double Blind Period|Lost to Follow-up|1|||
170605438|NCT00971243|616562067|FG002|Double Blind Period|Lost to Follow-up|1|||
170605439|NCT00971243|616562068|FG003|Double Blind Period|Lost to Follow-up|0|||
170605440|NCT00971243|616562069|FG004|Double Blind Period|Lost to Follow-up|1|||
170605441|NCT00971243|616562065|FG000|Double Blind Period|Physician Decision|10|||
170605442|NCT00971243|616562066|FG001|Double Blind Period|Physician Decision|6|||
170605443|NCT00971243|616562067|FG002|Double Blind Period|Physician Decision|7|||
170605444|NCT00971243|616562068|FG003|Double Blind Period|Physician Decision|6|||
170605445|NCT00971243|616562069|FG004|Double Blind Period|Physician Decision|7|||
170605446|NCT00971243|616562065|FG000|Double Blind Period|Protocol Violation|2|||
170605447|NCT00971243|616562066|FG001|Double Blind Period|Protocol Violation|0|||
170605448|NCT00971243|616562067|FG002|Double Blind Period|Protocol Violation|3|||
170605449|NCT00971243|616562068|FG003|Double Blind Period|Protocol Violation|2|||
170605450|NCT00971243|616562069|FG004|Double Blind Period|Protocol Violation|2|||
170605451|NCT00971243|616562065|FG000|Double Blind Period|Withdrawal by Subject|4|||
170605452|NCT00971243|616562066|FG001|Double Blind Period|Withdrawal by Subject|1|||
170605453|NCT00971243|616562067|FG002|Double Blind Period|Withdrawal by Subject|4|||
170605454|NCT00971243|616562068|FG003|Double Blind Period|Withdrawal by Subject|4|||
170605455|NCT00971243|616562069|FG004|Double Blind Period|Withdrawal by Subject|4|||
170605456|NCT00971243|616562065|FG000|Double Blind Period|Other reasons|1|||
170814621|NCT00103857|617329365|FG004|54-Week Base Study|Withdrawal by Subject|10|||
170814622|NCT00103857|617329366|FG005|54-Week Base Study|Withdrawal by Subject|15|||
170915045|NCT02179398|617691812|FG001|Overall Study|Lack of obligatory data|3|||
170915046|NCT02179398|617691811|FG000|Overall Study|Lost to Follow-up|0|||
170915047|NCT02179398|617691812|FG001|Overall Study|Lost to Follow-up|1|||
170915048|NCT00408681|617691813|FG000|Overall Study|Lack of Efficacy|2|||
170915049|NCT00408681|617691813|FG000|Overall Study|Adverse Event|7|||
170915050|NCT01589094|617691819|FG000|Overall Study|Did not receive treatment|2|||
170915051|NCT02975349|617691820|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170915052|NCT02975349|617691821|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170915053|NCT02975349|617691822|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170915054|NCT02975349|617691823|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
170915055|NCT02975349|617691824|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
170915056|NCT02975349|617691825|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170915057|NCT02975349|617691826|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170915058|NCT02975349|617691820|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170915059|NCT02975349|617691821|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170915060|NCT02975349|617691822|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170605457|NCT00971243|616562066|FG001|Double Blind Period|Other reasons|0|||
170605458|NCT00971243|616562067|FG002|Double Blind Period|Other reasons|2|||
170605459|NCT00971243|616562068|FG003|Double Blind Period|Other reasons|0|||
170605460|NCT00971243|616562069|FG004|Double Blind Period|Other reasons|1|||
170605461|NCT00971243|616562065|FG000|Open-label Period|Adverse Event|1|||
170605462|NCT00971243|616562066|FG001|Open-label Period|Adverse Event|0|||
170605463|NCT00971243|616562067|FG002|Open-label Period|Adverse Event|1|||
170605464|NCT00971243|616562068|FG003|Open-label Period|Adverse Event|1|||
170605465|NCT00971243|616562069|FG004|Open-label Period|Adverse Event|0|||
170605466|NCT00971243|616562065|FG000|Open-label Period|Physician Decision|5|||
170605467|NCT00971243|616562066|FG001|Open-label Period|Physician Decision|9|||
170605468|NCT00971243|616562067|FG002|Open-label Period|Physician Decision|3|||
170605469|NCT00971243|616562068|FG003|Open-label Period|Physician Decision|7|||
170605470|NCT00971243|616562069|FG004|Open-label Period|Physician Decision|2|||
170605471|NCT00971243|616562065|FG000|Open-label Period|Protocol Violation|1|||
170605472|NCT00971243|616562066|FG001|Open-label Period|Protocol Violation|1|||
170605473|NCT00971243|616562067|FG002|Open-label Period|Protocol Violation|1|||
170605474|NCT00971243|616562068|FG003|Open-label Period|Protocol Violation|0|||
170605475|NCT00971243|616562069|FG004|Open-label Period|Protocol Violation|1|||
170605476|NCT00971243|616562065|FG000|Open-label Period|Withdrawal by Subject|1|||
170605477|NCT00971243|616562066|FG001|Open-label Period|Withdrawal by Subject|0|||
170605478|NCT00971243|616562067|FG002|Open-label Period|Withdrawal by Subject|0|||
170605479|NCT00971243|616562068|FG003|Open-label Period|Withdrawal by Subject|2|||
170605480|NCT00971243|616562069|FG004|Open-label Period|Withdrawal by Subject|1|||
170605481|NCT00971243|616562065|FG000|Open-label Period|Other reason|0|||
170605482|NCT00971243|616562066|FG001|Open-label Period|Other reason|0|||
170605483|NCT00971243|616562067|FG002|Open-label Period|Other reason|0|||
170605484|NCT00971243|616562068|FG003|Open-label Period|Other reason|0|||
170605485|NCT00971243|616562069|FG004|Open-label Period|Other reason|2|||
170605486|NCT04300218|616562073|FG000|Overall Study|Lost to Follow-up|6|||
170605487|NCT04300218|616562074|FG001|Overall Study|Lost to Follow-up|8|||
170652674|NCT01986933|616741691|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
170652675|NCT01986933|616741692|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
170915061|NCT02975349|617691823|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170915062|NCT02975349|617691824|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170652676|NCT01986933|616741688|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
170652677|NCT01986933|616741689|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
170652678|NCT01986933|616741690|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
170652679|NCT01986933|616741691|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
170652680|NCT01986933|616741692|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
170652681|NCT01986933|616741688|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
170652682|NCT01986933|616741689|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
170652683|NCT01986933|616741690|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
170652684|NCT01986933|616741691|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
170652685|NCT01986933|616741692|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
170652686|NCT01986933|616741688|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
170652687|NCT01986933|616741689|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
170652688|NCT01986933|616741690|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
170652689|NCT01986933|616741691|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
170652690|NCT01986933|616741692|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
170652691|NCT01981551|616741693|FG000|Overall Study|Refused further treatment|8|||
170652692|NCT01981551|616741693|FG000|Overall Study|Adverse Event|1|||
170652693|NCT00075270|616743263|FG000|Overall Study|Withdrawal by Subject|28|||
170652694|NCT00075270|616743264|FG001|Overall Study|Withdrawal by Subject|21|||
170652695|NCT00075270|616743263|FG000|Overall Study|Lost to Follow-up|25|||
170915063|NCT02975349|617691825|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170915064|NCT02975349|617691826|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170915065|NCT02975349|617691820|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
170652696|NCT00075270|616743264|FG001|Overall Study|Lost to Follow-up|28|||
170652697|NCT00075270|616743263|FG000|Overall Study|Protocol Violation|0|||
170652698|NCT00075270|616743264|FG001|Overall Study|Protocol Violation|2|||
170652699|NCT00075270|616743263|FG000|Overall Study|Death|198|||
170652700|NCT00075270|616743264|FG001|Overall Study|Death|215|||
170652701|NCT00075270|616743263|FG000|Overall Study|Other/Unknown|9|||
170652702|NCT00075270|616743264|FG001|Overall Study|Other/Unknown|5|||
170652703|NCT00075270|616743263|FG000|Overall Study|Missing|26|||
170652704|NCT00075270|616743264|FG001|Overall Study|Missing|13|||
170652705|NCT00246571|616743265|FG000|Overall Study|Adverse Event|7|||
170915066|NCT02975349|617691821|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
170915067|NCT02975349|617691822|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
170652706|NCT00246571|616743266|FG001|Overall Study|Adverse Event|0|||
170652707|NCT00246571|616743265|FG000|Overall Study|Protocol Violation|0|||
170652708|NCT00246571|616743266|FG001|Overall Study|Protocol Violation|1|||
170652709|NCT00246571|616743265|FG000|Overall Study|Withdrawal by Subject|2|||
170652710|NCT00246571|616743266|FG001|Overall Study|Withdrawal by Subject|3|||
170652711|NCT00246571|616743265|FG000|Overall Study|Lack of Efficacy|84|||
170605488|NCT06581094|616562077|FG000|Overall Study|Lost to Follow-up|1|||
170605489|NCT06581094|616562078|FG001|Overall Study|Lost to Follow-up|1|||
170605490|NCT05740618|616562079|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
170605491|NCT05740618|616562079|FG000|Overall Study|Physician Decision|1|||
170652712|NCT00246571|616743266|FG001|Overall Study|Lack of Efficacy|21|||
170605492|NCT00596830|616562082|FG000|Overall Study|Death|258|||
170605493|NCT00596830|616562083|FG001|Overall Study|Death|247|||
170605494|NCT00596830|616562082|FG000|Overall Study|Lost to Follow-up|7|||
170605495|NCT00596830|616562083|FG001|Overall Study|Lost to Follow-up|11|||
170605496|NCT00596830|616562082|FG000|Overall Study|Withdrawal by Subject|22|||
170605497|NCT00596830|616562083|FG001|Overall Study|Withdrawal by Subject|12|||
170605498|NCT00596830|616562082|FG000|Overall Study|Study terminated by sponsor|51|||
170605499|NCT00596830|616562083|FG001|Overall Study|Study terminated by sponsor|62|||
170605500|NCT00596830|616562082|FG000|Overall Study|Follow-up was discontinued|1|||
170605501|NCT00596830|616562083|FG001|Overall Study|Follow-up was discontinued|0|||
170605502|NCT00596830|616562082|FG000|Overall Study|Randomized but not treated|3|||
170605503|NCT00596830|616562083|FG001|Overall Study|Randomized but not treated|7|||
170605504|NCT00887926|616562084|FG000|Overall Study|Withdrawal by Subject|0|||
170605505|NCT00887926|616562085|FG001|Overall Study|Withdrawal by Subject|1|||
170605506|NCT00887926|616562086|FG002|Overall Study|Withdrawal by Subject|0|||
170605507|NCT00887926|616562087|FG003|Overall Study|Withdrawal by Subject|0|||
170605508|NCT00988091|616562088|FG000|Double-blind Period|Withdrawal by Subject|15|||
170605509|NCT00988091|616562089|FG001|Double-blind Period|Withdrawal by Subject|13|||
170605510|NCT00988091|616562088|FG000|Double-blind Period|Lost to Follow-up|12|||
170605511|NCT00988091|616562089|FG001|Double-blind Period|Lost to Follow-up|14|||
170605512|NCT00988091|616562088|FG000|Double-blind Period|Other|8|||
170605513|NCT00988091|616562089|FG001|Double-blind Period|Other|8|||
170605514|NCT00988091|616562088|FG000|Double-blind Period|Adverse Event|6|||
170605515|NCT00988091|616562089|FG001|Double-blind Period|Adverse Event|9|||
170605516|NCT00988091|616562088|FG000|Double-blind Period|Use of exclusionary medication|2|||
170605517|NCT00988091|616562089|FG001|Double-blind Period|Use of exclusionary medication|3|||
170605518|NCT00988091|616562088|FG000|Open-label Period|Adverse Event|4|||
170605519|NCT00988091|616562089|FG001|Open-label Period|Adverse Event|7|||
170605520|NCT00988091|616562088|FG000|Open-label Period|Use of exclusionary medication|1|||
170605521|NCT00988091|616562089|FG001|Open-label Period|Use of exclusionary medication|1|||
170605522|NCT00988091|616562088|FG000|Open-label Period|Protocol Violation|1|||
170605523|NCT00988091|616562089|FG001|Open-label Period|Protocol Violation|1|||
170605524|NCT00988091|616562088|FG000|Open-label Period|Withdrawal by Subject|10|||
170605525|NCT00988091|616562089|FG001|Open-label Period|Withdrawal by Subject|16|||
170605526|NCT00988091|616562088|FG000|Open-label Period|Lost to Follow-up|3|||
170605527|NCT00988091|616562089|FG001|Open-label Period|Lost to Follow-up|5|||
170605528|NCT00988091|616562088|FG000|Open-label Period|Other|2|||
170605529|NCT00988091|616562089|FG001|Open-label Period|Other|3|||
170605530|NCT04427072|616562092|FG000|Randomized Treatment Phase|Progressive disease|9|||
170605531|NCT04427072|616562093|FG001|Randomized Treatment Phase|Progressive disease|4|||
170605532|NCT04427072|616562092|FG000|Randomized Treatment Phase|Adverse Event|3|||
170605533|NCT04427072|616562093|FG001|Randomized Treatment Phase|Adverse Event|1|||
170605534|NCT04427072|616562092|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
170605535|NCT04427072|616562093|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
170605536|NCT04427072|616562092|FG000|Randomized Treatment Phase|Death|0|||
170605537|NCT04427072|616562093|FG001|Randomized Treatment Phase|Death|1|||
170605538|NCT04427072|616562092|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
170605539|NCT04427072|616562093|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
170605540|NCT04427072|616562092|FG000|Extension Treatment Phase|Progressive disease|0|||
170605541|NCT04427072|616562093|FG001|Extension Treatment Phase|Progressive disease|5|||
170605542|NCT02516592|616562098|FG000|Overall Study|Patient withdrew consent|5|||
170605543|NCT02516592|616562099|FG001|Overall Study|Patient withdrew consent|2|||
170605544|NCT02516592|616562098|FG000|Overall Study|Protocol deviation|4|||
170605545|NCT02516592|616562099|FG001|Overall Study|Protocol deviation|4|||
170605546|NCT02516592|616562098|FG000|Overall Study|Lost to Follow-up|2|||
170605547|NCT02516592|616562099|FG001|Overall Study|Lost to Follow-up|3|||
170605548|NCT02516592|616562098|FG000|Overall Study|Patient/guardian decision|2|||
170605549|NCT02516592|616562099|FG001|Overall Study|Patient/guardian decision|1|||
170915068|NCT02975349|617691823|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
170915069|NCT02975349|617691824|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
170915070|NCT02975349|617691825|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
170605550|NCT02516592|616562098|FG000|Overall Study|Adverse Event|1|||
170915071|NCT02975349|617691826|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
170605551|NCT02516592|616562099|FG001|Overall Study|Adverse Event|2|||
170605552|NCT02516592|616562098|FG000|Overall Study|Abnormal test procedure result|1|||
170605553|NCT02516592|616562099|FG001|Overall Study|Abnormal test procedure result|0|||
170605554|NCT02516592|616562098|FG000|Overall Study|Death|1|||
170605555|NCT02516592|616562099|FG001|Overall Study|Death|1|||
170605556|NCT01716104|616562100|FG000|Overall Study|Do not meet inclusion criteria|6|||
170605557|NCT01716104|616562101|FG001|Overall Study|Do not meet inclusion criteria|7|||
170605558|NCT03688100|616562102|FG000|Overall Study|Lost to Follow-up|21|||
170605559|NCT03688100|616562103|FG001|Overall Study|Lost to Follow-up|15|||
170605560|NCT03688100|616562104|FG002|Overall Study|Lost to Follow-up|15|||
170605561|NCT03688100|616562105|FG003|Overall Study|Lost to Follow-up|18|||
170605562|NCT03688100|616562102|FG000|Overall Study|Withdrawal by Subject|19|||
170605563|NCT03688100|616562103|FG001|Overall Study|Withdrawal by Subject|16|||
170605564|NCT03688100|616562104|FG002|Overall Study|Withdrawal by Subject|0|||
170605565|NCT03688100|616562105|FG003|Overall Study|Withdrawal by Subject|0|||
170605566|NCT03688100|616562102|FG000|Overall Study|Death|36|||
170605567|NCT03688100|616562103|FG001|Overall Study|Death|27|||
170605568|NCT03688100|616562104|FG002|Overall Study|Death|0|||
170605569|NCT03688100|616562105|FG003|Overall Study|Death|0|||
170605570|NCT02479139|616562106|FG000|Overall Study|Lost to Follow-up|2|||
170605571|NCT02479139|616562107|FG001|Overall Study|Lost to Follow-up|4|||
170605572|NCT02479139|616562108|FG002|Overall Study|Lost to Follow-up|4|||
170605573|NCT02479139|616562109|FG003|Overall Study|Lost to Follow-up|2|||
170605574|NCT02479139|616562110|FG004|Overall Study|Lost to Follow-up|3|||
170605575|NCT02479139|616562111|FG005|Overall Study|Lost to Follow-up|5|||
170605576|NCT02479139|616562106|FG000|Overall Study|Withdrew Consent|5|||
170605577|NCT02479139|616562107|FG001|Overall Study|Withdrew Consent|6|||
170605578|NCT02479139|616562108|FG002|Overall Study|Withdrew Consent|1|||
170605579|NCT02479139|616562109|FG003|Overall Study|Withdrew Consent|4|||
170605580|NCT02479139|616562110|FG004|Overall Study|Withdrew Consent|1|||
170605581|NCT02479139|616562111|FG005|Overall Study|Withdrew Consent|1|||
170605582|NCT02479139|616562106|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
170605583|NCT02479139|616562107|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
170605584|NCT02479139|616562108|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
170605585|NCT02479139|616562109|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
170605586|NCT02479139|616562110|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
170605587|NCT02479139|616562111|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
170605588|NCT02479139|616562106|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170605589|NCT02479139|616562107|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170605590|NCT02479139|616562108|FG002|Overall Study|Other Miscellaneous Reasons|1|||
170605591|NCT02479139|616562109|FG003|Overall Study|Other Miscellaneous Reasons|1|||
170605592|NCT02479139|616562110|FG004|Overall Study|Other Miscellaneous Reasons|1|||
170605593|NCT02479139|616562111|FG005|Overall Study|Other Miscellaneous Reasons|0|||
170605594|NCT00764673|616562112|FG000|Overall Study|Death|1|||
170605595|NCT00764673|616562112|FG000|Overall Study|Lost to Follow-up|3|||
170605596|NCT00764673|616562112|FG000|Overall Study|Withdrawal by Subject|6|||
170605597|NCT00764673|616562112|FG000|Overall Study|Revision of Device|2|||
170605598|NCT01438177|616562113|FG000|Overall Study|Withdrawal by Subject|1|||
170605599|NCT01438177|616562113|FG000|Overall Study|Initiation of new therapy|1|||
170605600|NCT03596450|616562128|FG000|Overall Study|Death|9|||
170605601|NCT03596450|616562129|FG001|Overall Study|Death|9|||
170605602|NCT03596450|616562128|FG000|Overall Study|Protocol Violation|18|||
170605603|NCT03596450|616562129|FG001|Overall Study|Protocol Violation|26|||
170605604|NCT03596450|616562128|FG000|Overall Study|Lost to Follow-up|50|||
170605605|NCT03596450|616562129|FG001|Overall Study|Lost to Follow-up|56|||
170605606|NCT03596450|616562128|FG000|Overall Study|Adverse Event|14|||
170605607|NCT03596450|616562129|FG001|Overall Study|Adverse Event|7|||
170652713|NCT00246571|616743265|FG000|Overall Study|Death|17|||
170652714|NCT00246571|616743266|FG001|Overall Study|Death|3|||
170652715|NCT00246571|616743265|FG000|Overall Study|Sponsor|0|||
170652716|NCT00246571|616743266|FG001|Overall Study|Sponsor|1|||
170652717|NCT00246571|616743265|FG000|Overall Study|Did not meet entrance criteria|2|||
170652718|NCT00246571|616743266|FG001|Overall Study|Did not meet entrance criteria|1|||
170652719|NCT00246571|616743265|FG000|Overall Study|Laboratory abnormalities|1|||
170652720|NCT00246571|616743266|FG001|Overall Study|Laboratory abnormalities|0|||
170652721|NCT00246571|616743265|FG000|Overall Study|Crossover participants|0|||
170652722|NCT00246571|616743266|FG001|Overall Study|Crossover participants|74|||
170652723|NCT00775203|616743267|FG000|Overall Study|Adverse Event|25|||
170652724|NCT00775203|616743268|FG001|Overall Study|Adverse Event|6|||
170652725|NCT00775203|616743267|FG000|Overall Study|Lack of Efficacy|8|||
170652726|NCT00775203|616743268|FG001|Overall Study|Lack of Efficacy|9|||
170605608|NCT03596450|616562128|FG000|Overall Study|Withdrawal by Subject|38|||
170605609|NCT03596450|616562129|FG001|Overall Study|Withdrawal by Subject|36|||
170605610|NCT03596450|616562128|FG000|Overall Study|Accidentally Randomized|2|||
170652727|NCT00775203|616743267|FG000|Overall Study|Withdrawal by Subject|11|||
170652728|NCT00775203|616743268|FG001|Overall Study|Withdrawal by Subject|9|||
170652729|NCT00775203|616743267|FG000|Overall Study|Lost to Follow-up|11|||
170652730|NCT00775203|616743268|FG001|Overall Study|Lost to Follow-up|15|||
170605611|NCT03596450|616562129|FG001|Overall Study|Accidentally Randomized|0|||
170605612|NCT03596450|616562128|FG000|Overall Study|Other reasons|48|||
170605613|NCT03596450|616562129|FG001|Overall Study|Other reasons|53|||
170605614|NCT03596450|616562128|FG000|Overall Study|Pregnancy|2|||
170605615|NCT03596450|616562129|FG001|Overall Study|Pregnancy|0|||
170605616|NCT01894022|616562132|FG000|Overall Study|Death|1|||
170605617|NCT01894022|616562133|FG001|Overall Study|Death|0|||
170605618|NCT01894022|616562132|FG000|Overall Study|Adverse Event, non-fatal|1|||
170605619|NCT01894022|616562133|FG001|Overall Study|Adverse Event, non-fatal|0|||
170605620|NCT01894022|616562132|FG000|Overall Study|Study Closed/terminated|7|||
170605621|NCT01894022|616562133|FG001|Overall Study|Study Closed/terminated|10|||
170605622|NCT04038567|616562135|FG000|Overall Study|Lost to Follow-up|6|||
170605623|NCT04038567|616562136|FG001|Overall Study|Lost to Follow-up|4|||
170605624|NCT04038567|616562137|FG002|Overall Study|Lost to Follow-up|5|||
170605625|NCT04038567|616562138|FG003|Overall Study|Lost to Follow-up|4|||
170605626|NCT04038567|616562139|FG004|Overall Study|Lost to Follow-up|6|||
170605627|NCT04038567|616562140|FG005|Overall Study|Lost to Follow-up|4|||
170605628|NCT04038567|616562141|FG006|Overall Study|Lost to Follow-up|4|||
170605629|NCT04038567|616562142|FG007|Overall Study|Lost to Follow-up|1|||
170605630|NCT04038567|616562135|FG000|Overall Study|Withdrawal by Subject|2|||
170605631|NCT04038567|616562136|FG001|Overall Study|Withdrawal by Subject|1|||
170605632|NCT04038567|616562137|FG002|Overall Study|Withdrawal by Subject|1|||
170814623|NCT00103857|617329367|FG006|54-Week Base Study|Withdrawal by Subject|4|||
170814624|NCT00103857|617329361|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
170814625|NCT00103857|617329362|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
170814626|NCT00103857|617329363|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
170814627|NCT00103857|617329364|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
170814628|NCT00103857|617329365|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
170814629|NCT00103857|617329366|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
170814630|NCT00103857|617329367|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
170814631|NCT00103857|617329361|FG000|54-Week Base Study|patient moved|0|||
170814632|NCT00103857|617329362|FG001|54-Week Base Study|patient moved|1|||
170814633|NCT00103857|617329363|FG002|54-Week Base Study|patient moved|1|||
170814634|NCT00103857|617329364|FG003|54-Week Base Study|patient moved|2|||
170814635|NCT00103857|617329365|FG004|54-Week Base Study|patient moved|3|||
170814636|NCT00103857|617329366|FG005|54-Week Base Study|patient moved|1|||
170814637|NCT00103857|617329367|FG006|54-Week Base Study|patient moved|0|||
170605633|NCT04038567|616562138|FG003|Overall Study|Withdrawal by Subject|1|||
170605634|NCT04038567|616562139|FG004|Overall Study|Withdrawal by Subject|4|||
170605635|NCT04038567|616562140|FG005|Overall Study|Withdrawal by Subject|1|||
170605636|NCT04038567|616562141|FG006|Overall Study|Withdrawal by Subject|1|||
170605637|NCT04038567|616562142|FG007|Overall Study|Withdrawal by Subject|1|||
170605638|NCT04038567|616562135|FG000|Overall Study|missed survey window|1|||
170605639|NCT04038567|616562136|FG001|Overall Study|missed survey window|2|||
170605640|NCT04038567|616562137|FG002|Overall Study|missed survey window|0|||
170605641|NCT04038567|616562138|FG003|Overall Study|missed survey window|0|||
170605642|NCT04038567|616562139|FG004|Overall Study|missed survey window|1|||
170605643|NCT04038567|616562140|FG005|Overall Study|missed survey window|1|||
170605644|NCT04038567|616562141|FG006|Overall Study|missed survey window|2|||
170605645|NCT04038567|616562142|FG007|Overall Study|missed survey window|2|||
170605646|NCT04038567|616562135|FG000|Overall Study|technical issues|0|||
170605647|NCT04038567|616562136|FG001|Overall Study|technical issues|0|||
170605648|NCT04038567|616562137|FG002|Overall Study|technical issues|0|||
170605649|NCT04038567|616562138|FG003|Overall Study|technical issues|0|||
170605650|NCT04038567|616562139|FG004|Overall Study|technical issues|0|||
170605651|NCT04038567|616562140|FG005|Overall Study|technical issues|0|||
170605652|NCT04038567|616562141|FG006|Overall Study|technical issues|1|||
170605653|NCT04038567|616562142|FG007|Overall Study|technical issues|0|||
170605654|NCT04038567|616562135|FG000|Overall Study|Medical issues (i.e., illness)|0|||
170605655|NCT04038567|616562136|FG001|Overall Study|Medical issues (i.e., illness)|1|||
170605656|NCT04038567|616562137|FG002|Overall Study|Medical issues (i.e., illness)|2|||
170605657|NCT04038567|616562138|FG003|Overall Study|Medical issues (i.e., illness)|1|||
170605658|NCT04038567|616562139|FG004|Overall Study|Medical issues (i.e., illness)|1|||
170605659|NCT04038567|616562140|FG005|Overall Study|Medical issues (i.e., illness)|1|||
170605660|NCT04038567|616562141|FG006|Overall Study|Medical issues (i.e., illness)|0|||
170605661|NCT04038567|616562142|FG007|Overall Study|Medical issues (i.e., illness)|0|||
170605662|NCT04038567|616562135|FG000|Overall Study|Death|0|||
170605663|NCT04038567|616562136|FG001|Overall Study|Death|0|||
170605664|NCT04038567|616562137|FG002|Overall Study|Death|0|||
170605665|NCT04038567|616562138|FG003|Overall Study|Death|1|||
170605666|NCT04038567|616562139|FG004|Overall Study|Death|1|||
170605667|NCT04038567|616562140|FG005|Overall Study|Death|0|||
170605668|NCT04038567|616562141|FG006|Overall Study|Death|0|||
170814638|NCT00103857|617329361|FG000|54-Week Base Study|non-compliance with study procedures|1|||
170814639|NCT00103857|617329362|FG001|54-Week Base Study|non-compliance with study procedures|2|||
170814640|NCT00103857|617329363|FG002|54-Week Base Study|non-compliance with study procedures|0|||
170605669|NCT04038567|616562142|FG007|Overall Study|Death|1|||
170605670|NCT02726022|616562143|FG000|Overall Study|Adverse Event|14|||
170605671|NCT02726022|616562143|FG000|Overall Study|Treatment Failure|8|||
170605672|NCT02726022|616562143|FG000|Overall Study|Poor Compliance|13|||
170605673|NCT02726022|616562143|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
170605674|NCT00235716|616562144|FG000|Overall Study|Death|26|||
170605675|NCT00235716|616562145|FG001|Overall Study|Death|39|||
170605676|NCT00235716|616562146|FG002|Overall Study|Death|32|||
170605677|NCT00235716|616562147|FG003|Overall Study|Death|31|||
170605678|NCT00235716|616562144|FG000|Overall Study|Withdrawal by Subject|23|||
170605679|NCT00235716|616562145|FG001|Overall Study|Withdrawal by Subject|19|||
170605680|NCT00235716|616562146|FG002|Overall Study|Withdrawal by Subject|17|||
170605681|NCT00235716|616562147|FG003|Overall Study|Withdrawal by Subject|18|||
170605682|NCT00235716|616562144|FG000|Overall Study|Lost to Follow-up|12|||
170915072|NCT02975349|617691820|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
170605683|NCT00235716|616562145|FG001|Overall Study|Lost to Follow-up|7|||
170605684|NCT00235716|616562146|FG002|Overall Study|Lost to Follow-up|14|||
170605685|NCT00235716|616562147|FG003|Overall Study|Lost to Follow-up|10|||
170605686|NCT00235716|616562144|FG000|Overall Study|Adverse Event|1|||
170605687|NCT00235716|616562145|FG001|Overall Study|Adverse Event|1|||
170605688|NCT00235716|616562146|FG002|Overall Study|Adverse Event|1|||
170605689|NCT00235716|616562147|FG003|Overall Study|Adverse Event|0|||
170605690|NCT00235716|616562144|FG000|Overall Study|Physician Decision|0|||
170605691|NCT00235716|616562145|FG001|Overall Study|Physician Decision|1|||
170605692|NCT00235716|616562146|FG002|Overall Study|Physician Decision|1|||
170605693|NCT00235716|616562147|FG003|Overall Study|Physician Decision|3|||
170605694|NCT00788710|616562150|FG000|Overall Study|Adverse Event|1|||
170605695|NCT00788710|616562151|FG001|Overall Study|Adverse Event|3|||
170605696|NCT00788710|616562152|FG002|Overall Study|Adverse Event|4|||
170605697|NCT00788710|616562150|FG000|Overall Study|Lack of Efficacy|0|||
170605698|NCT00788710|616562151|FG001|Overall Study|Lack of Efficacy|0|||
170605699|NCT00788710|616562152|FG002|Overall Study|Lack of Efficacy|1|||
170605700|NCT00788710|616562150|FG000|Overall Study|Lost to Follow-up|0|||
170605701|NCT00788710|616562151|FG001|Overall Study|Lost to Follow-up|1|||
170605702|NCT00788710|616562152|FG002|Overall Study|Lost to Follow-up|0|||
170605703|NCT00788710|616562150|FG000|Overall Study|Physician Decision|2|||
170605704|NCT00788710|616562151|FG001|Overall Study|Physician Decision|1|||
170605705|NCT00788710|616562152|FG002|Overall Study|Physician Decision|0|||
170605706|NCT00788710|616562150|FG000|Overall Study|Protocol Violation|0|||
170605707|NCT00788710|616562151|FG001|Overall Study|Protocol Violation|1|||
170605708|NCT00788710|616562152|FG002|Overall Study|Protocol Violation|1|||
170605709|NCT00788710|616562150|FG000|Overall Study|Withdrawal by Subject|2|||
170605710|NCT00788710|616562151|FG001|Overall Study|Withdrawal by Subject|2|||
170605711|NCT00788710|616562152|FG002|Overall Study|Withdrawal by Subject|0|||
170605712|NCT00727558|616562153|FG000|Overall Study|Lens issue|0|||
170605713|NCT00727558|616562154|FG001|Overall Study|Lens issue|1|||
170605714|NCT00727558|616562153|FG000|Overall Study|Adverse Event|0|||
170605715|NCT00727558|616562154|FG001|Overall Study|Adverse Event|1|||
170605716|NCT00727558|616562153|FG000|Overall Study|Subject unable to return for follow-up|1|||
170605717|NCT00727558|616562154|FG001|Overall Study|Subject unable to return for follow-up|1|||
170605718|NCT00727558|616562153|FG000|Overall Study|Lost to Follow-up|1|||
170605719|NCT00727558|616562154|FG001|Overall Study|Lost to Follow-up|0|||
170605720|NCT01717326|616562162|FG000|Overall Study|Death|0|||
170605721|NCT01717326|616562163|FG001|Overall Study|Death|0|||
170605722|NCT01717326|616562164|FG002|Overall Study|Death|0|||
170605723|NCT01717326|616562165|FG003|Overall Study|Death|0|||
170605724|NCT01717326|616562166|FG004|Overall Study|Death|0|||
170605725|NCT01717326|616562167|FG005|Overall Study|Death|0|||
170605726|NCT01717326|616562168|FG006|Overall Study|Death|0|||
170605727|NCT01717326|616562169|FG007|Overall Study|Death|0|||
170605728|NCT01717326|616562170|FG008|Overall Study|Death|0|||
170605729|NCT01717326|616562171|FG009|Overall Study|Death|0|||
170605730|NCT01717326|616562172|FG010|Overall Study|Death|1|||
170605731|NCT01717326|616562173|FG011|Overall Study|Death|0|||
170605732|NCT01717326|616562174|FG012|Overall Study|Death|0|||
170605733|NCT01717326|616562175|FG013|Overall Study|Death|0|||
170915073|NCT02975349|617691821|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
170915074|NCT02975349|617691822|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
170915075|NCT02975349|617691823|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
170915076|NCT02975349|617691824|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
170915077|NCT02975349|617691825|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
170915078|NCT02975349|617691826|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
170605734|NCT01717326|616562176|FG014|Overall Study|Death|0|||
170605735|NCT01717326|616562177|FG015|Overall Study|Death|0|||
170605736|NCT01717326|616562178|FG016|Overall Study|Death|0|||
170605737|NCT01717326|616562179|FG017|Overall Study|Death|0|||
170605738|NCT01717326|616562180|FG018|Overall Study|Death|0|||
170605739|NCT01717326|616562181|FG019|Overall Study|Death|0|||
170915079|NCT02975349|617691820|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
170915080|NCT02975349|617691821|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
170915081|NCT02975349|617691822|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
170915082|NCT02975349|617691823|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
170605740|NCT01717326|616562162|FG000|Overall Study|Lost to Follow-up|3|||
170605741|NCT01717326|616562163|FG001|Overall Study|Lost to Follow-up|0|||
170605742|NCT01717326|616562164|FG002|Overall Study|Lost to Follow-up|0|||
170605743|NCT01717326|616562165|FG003|Overall Study|Lost to Follow-up|2|||
170605744|NCT01717326|616562166|FG004|Overall Study|Lost to Follow-up|1|||
170605745|NCT01717326|616562167|FG005|Overall Study|Lost to Follow-up|0|||
170605746|NCT01717326|616562168|FG006|Overall Study|Lost to Follow-up|1|||
170605747|NCT01717326|616562169|FG007|Overall Study|Lost to Follow-up|0|||
170605748|NCT01717326|616562170|FG008|Overall Study|Lost to Follow-up|0|||
170605749|NCT01717326|616562171|FG009|Overall Study|Lost to Follow-up|0|||
170605750|NCT01717326|616562172|FG010|Overall Study|Lost to Follow-up|1|||
170605751|NCT01717326|616562173|FG011|Overall Study|Lost to Follow-up|0|||
170652731|NCT00775203|616743267|FG000|Overall Study|Administrative reason|2|||
170652732|NCT00775203|616743268|FG001|Overall Study|Administrative reason|0|||
170652733|NCT00775203|616743267|FG000|Overall Study|Noncompliance|4|||
170652734|NCT00775203|616743268|FG001|Overall Study|Noncompliance|2|||
170652735|NCT00775203|616743267|FG000|Overall Study|Protocol Violation|0|||
170652736|NCT00775203|616743268|FG001|Overall Study|Protocol Violation|1|||
170814641|NCT00103857|617329364|FG003|54-Week Base Study|non-compliance with study procedures|0|||
170814642|NCT00103857|617329365|FG004|54-Week Base Study|non-compliance with study procedures|0|||
170814643|NCT00103857|617329366|FG005|54-Week Base Study|non-compliance with study procedures|2|||
170814644|NCT00103857|617329367|FG006|54-Week Base Study|non-compliance with study procedures|0|||
170814645|NCT00103857|617329361|FG000|54-Week Base Study|patient incarcerated|0|||
170814646|NCT00103857|617329362|FG001|54-Week Base Study|patient incarcerated|0|||
170814647|NCT00103857|617329363|FG002|54-Week Base Study|patient incarcerated|0|||
170814648|NCT00103857|617329364|FG003|54-Week Base Study|patient incarcerated|0|||
170814649|NCT00103857|617329365|FG004|54-Week Base Study|patient incarcerated|1|||
170814650|NCT00103857|617329366|FG005|54-Week Base Study|patient incarcerated|1|||
170814651|NCT00103857|617329367|FG006|54-Week Base Study|patient incarcerated|0|||
170814652|NCT00103857|617329361|FG000|54-Week Base Study|laboratory reporting error|0|||
170814653|NCT00103857|617329362|FG001|54-Week Base Study|laboratory reporting error|0|||
170814654|NCT00103857|617329363|FG002|54-Week Base Study|laboratory reporting error|0|||
170814655|NCT00103857|617329364|FG003|54-Week Base Study|laboratory reporting error|0|||
170814656|NCT00103857|617329365|FG004|54-Week Base Study|laboratory reporting error|1|||
170814657|NCT00103857|617329366|FG005|54-Week Base Study|laboratory reporting error|0|||
170814658|NCT00103857|617329367|FG006|54-Week Base Study|laboratory reporting error|0|||
170814659|NCT00103857|617329361|FG000|54-Week Base Study|site error|0|||
170814660|NCT00103857|617329362|FG001|54-Week Base Study|site error|0|||
170814661|NCT00103857|617329363|FG002|54-Week Base Study|site error|0|||
170814662|NCT00103857|617329364|FG003|54-Week Base Study|site error|0|||
170814663|NCT00103857|617329365|FG004|54-Week Base Study|site error|0|||
170814664|NCT00103857|617329366|FG005|54-Week Base Study|site error|1|||
170814665|NCT00103857|617329367|FG006|54-Week Base Study|site error|0|||
170814666|NCT00103857|617329361|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
170814667|NCT00103857|617329362|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
170814668|NCT00103857|617329363|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
170814669|NCT00103857|617329364|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
170814670|NCT00103857|617329365|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
170814671|NCT00103857|617329366|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
170814672|NCT00103857|617329367|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
170814673|NCT00103857|617329361|FG000|50-Week Extension Study|Adverse Event|2|||
170814674|NCT00103857|617329362|FG001|50-Week Extension Study|Adverse Event|3|||
170814675|NCT00103857|617329363|FG002|50-Week Extension Study|Adverse Event|2|||
170814676|NCT00103857|617329364|FG003|50-Week Extension Study|Adverse Event|0|||
170814677|NCT00103857|617329365|FG004|50-Week Extension Study|Adverse Event|1|||
170814678|NCT00103857|617329366|FG005|50-Week Extension Study|Adverse Event|1|||
170814679|NCT00103857|617329367|FG006|50-Week Extension Study|Adverse Event|0|||
170814680|NCT00103857|617329361|FG000|50-Week Extension Study|Death|0|||
170814681|NCT00103857|617329362|FG001|50-Week Extension Study|Death|0|||
170814682|NCT00103857|617329363|FG002|50-Week Extension Study|Death|0|||
170814683|NCT00103857|617329364|FG003|50-Week Extension Study|Death|1|||
170814684|NCT00103857|617329365|FG004|50-Week Extension Study|Death|0|||
170814685|NCT00103857|617329366|FG005|50-Week Extension Study|Death|1|||
170814686|NCT00103857|617329367|FG006|50-Week Extension Study|Death|0|||
170814687|NCT00103857|617329361|FG000|50-Week Extension Study|Lack of Efficacy|26|||
170814688|NCT00103857|617329362|FG001|50-Week Extension Study|Lack of Efficacy|15|||
170814689|NCT00103857|617329363|FG002|50-Week Extension Study|Lack of Efficacy|13|||
170814690|NCT00103857|617329364|FG003|50-Week Extension Study|Lack of Efficacy|16|||
170814691|NCT00103857|617329365|FG004|50-Week Extension Study|Lack of Efficacy|8|||
170814692|NCT00103857|617329366|FG005|50-Week Extension Study|Lack of Efficacy|8|||
170814693|NCT00103857|617329367|FG006|50-Week Extension Study|Lack of Efficacy|0|||
170814694|NCT00103857|617329361|FG000|50-Week Extension Study|Lost to Follow-up|4|||
170814695|NCT00103857|617329362|FG001|50-Week Extension Study|Lost to Follow-up|0|||
170814696|NCT00103857|617329363|FG002|50-Week Extension Study|Lost to Follow-up|1|||
170814697|NCT00103857|617329364|FG003|50-Week Extension Study|Lost to Follow-up|4|||
170652737|NCT00775203|616743267|FG000|Overall Study|Entered other study|1|||
170652738|NCT00775203|616743268|FG001|Overall Study|Entered other study|0|||
170652739|NCT00775203|616743267|FG000|Overall Study|Physician Decision|0|||
170814698|NCT00103857|617329365|FG004|50-Week Extension Study|Lost to Follow-up|3|||
170814699|NCT00103857|617329366|FG005|50-Week Extension Study|Lost to Follow-up|3|||
170814700|NCT00103857|617329367|FG006|50-Week Extension Study|Lost to Follow-up|0|||
170814701|NCT00103857|617329361|FG000|50-Week Extension Study|Physician Decision|0|||
170814702|NCT00103857|617329362|FG001|50-Week Extension Study|Physician Decision|1|||
170814703|NCT00103857|617329363|FG002|50-Week Extension Study|Physician Decision|1|||
170814704|NCT00103857|617329364|FG003|50-Week Extension Study|Physician Decision|0|||
170814705|NCT00103857|617329365|FG004|50-Week Extension Study|Physician Decision|0|||
170915083|NCT02975349|617691824|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
170915084|NCT02975349|617691825|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
170915085|NCT02975349|617691826|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
170915086|NCT02975349|617691820|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
170915087|NCT02975349|617691821|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
170915088|NCT02975349|617691822|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
170915089|NCT02975349|617691823|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
170915090|NCT02975349|617691824|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
170915091|NCT02975349|617691825|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
170814706|NCT00103857|617329366|FG005|50-Week Extension Study|Physician Decision|0|||
170814707|NCT00103857|617329367|FG006|50-Week Extension Study|Physician Decision|0|||
170814708|NCT00103857|617329361|FG000|50-Week Extension Study|Pregnancy|0|||
170814709|NCT00103857|617329362|FG001|50-Week Extension Study|Pregnancy|0|||
170814710|NCT00103857|617329363|FG002|50-Week Extension Study|Pregnancy|1|||
170814711|NCT00103857|617329364|FG003|50-Week Extension Study|Pregnancy|0|||
170814712|NCT00103857|617329365|FG004|50-Week Extension Study|Pregnancy|1|||
170814713|NCT00103857|617329366|FG005|50-Week Extension Study|Pregnancy|0|||
170814714|NCT00103857|617329367|FG006|50-Week Extension Study|Pregnancy|0|||
170814715|NCT00103857|617329361|FG000|50-Week Extension Study|Protocol Violation|1|||
170814716|NCT00103857|617329362|FG001|50-Week Extension Study|Protocol Violation|1|||
170814717|NCT00103857|617329363|FG002|50-Week Extension Study|Protocol Violation|1|||
170814718|NCT00103857|617329364|FG003|50-Week Extension Study|Protocol Violation|2|||
170814719|NCT00103857|617329365|FG004|50-Week Extension Study|Protocol Violation|0|||
170814720|NCT00103857|617329366|FG005|50-Week Extension Study|Protocol Violation|1|||
170814721|NCT00103857|617329367|FG006|50-Week Extension Study|Protocol Violation|0|||
170814722|NCT00103857|617329361|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
170814723|NCT00103857|617329362|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
170814724|NCT00103857|617329363|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
170814725|NCT00103857|617329364|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
170814726|NCT00103857|617329365|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
170814727|NCT00103857|617329366|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
170814728|NCT00103857|617329367|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
170814729|NCT00103857|617329361|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
170814730|NCT00103857|617329362|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
170814731|NCT00103857|617329363|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
170814732|NCT00103857|617329364|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
170814733|NCT00103857|617329365|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
170814734|NCT00103857|617329366|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
170814735|NCT00103857|617329367|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
170814736|NCT00103857|617329361|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
170814737|NCT00103857|617329362|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
170814738|NCT00103857|617329363|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
170814739|NCT00103857|617329364|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
170814740|NCT00103857|617329365|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
170814741|NCT00103857|617329366|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
170814742|NCT00103857|617329367|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
170814743|NCT00103857|617329361|FG000|50-Week Extension Study|patient moved|0|||
170814744|NCT00103857|617329362|FG001|50-Week Extension Study|patient moved|0|||
170814745|NCT00103857|617329363|FG002|50-Week Extension Study|patient moved|1|||
170814746|NCT00103857|617329364|FG003|50-Week Extension Study|patient moved|2|||
170814747|NCT00103857|617329365|FG004|50-Week Extension Study|patient moved|0|||
170814748|NCT00103857|617329366|FG005|50-Week Extension Study|patient moved|0|||
170814749|NCT00103857|617329367|FG006|50-Week Extension Study|patient moved|0|||
170814750|NCT00103857|617329361|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
170814751|NCT00103857|617329362|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
170814752|NCT00103857|617329363|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
170814753|NCT00103857|617329364|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
170814754|NCT00103857|617329365|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
170814755|NCT00103857|617329366|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
170814756|NCT00103857|617329367|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
170814757|NCT00103857|617329361|FG000|50-Week Extension Study|reason unspecified|0|||
170814758|NCT00103857|617329362|FG001|50-Week Extension Study|reason unspecified|0|||
170814759|NCT00103857|617329363|FG002|50-Week Extension Study|reason unspecified|0|||
170814760|NCT00103857|617329364|FG003|50-Week Extension Study|reason unspecified|0|||
170814761|NCT00103857|617329365|FG004|50-Week Extension Study|reason unspecified|1|||
170814762|NCT00103857|617329366|FG005|50-Week Extension Study|reason unspecified|0|||
170814763|NCT00103857|617329367|FG006|50-Week Extension Study|reason unspecified|0|||
170652740|NCT00775203|616743268|FG001|Overall Study|Physician Decision|1|||
170652741|NCT04214288|616743272|FG000|Overall Study|Ongoing in the study|41|||
170652742|NCT04214288|616743273|FG001|Overall Study|Ongoing in the study|51|||
170652743|NCT04214288|616743274|FG002|Overall Study|Ongoing in the study|12|||
170652744|NCT04214288|616743275|FG003|Overall Study|Ongoing in the study|39|||
170652745|NCT04214288|616743272|FG000|Overall Study|Adverse Event|1|||
170652746|NCT04214288|616743273|FG001|Overall Study|Adverse Event|0|||
170814764|NCT02707952|617329368|FG000|Overall Study|Adverse Event|1|||
170814765|NCT02707952|617329369|FG001|Overall Study|Adverse Event|0|||
170814766|NCT02707952|617329370|FG002|Overall Study|Adverse Event|0|||
170814767|NCT02707952|617329371|FG003|Overall Study|Adverse Event|0|||
170814768|NCT02707952|617329368|FG000|Overall Study|Lost to Follow-up|1|||
170814769|NCT02707952|617329369|FG001|Overall Study|Lost to Follow-up|0|||
170814770|NCT02707952|617329370|FG002|Overall Study|Lost to Follow-up|0|||
170814771|NCT02707952|617329371|FG003|Overall Study|Lost to Follow-up|0|||
170814772|NCT02707952|617329368|FG000|Overall Study|Withdrawal by Subject|0|||
170814773|NCT02707952|617329369|FG001|Overall Study|Withdrawal by Subject|1|||
170814774|NCT02707952|617329370|FG002|Overall Study|Withdrawal by Subject|2|||
170814775|NCT02707952|617329371|FG003|Overall Study|Withdrawal by Subject|0|||
170814776|NCT01670526|617329375|FG000|Overall Study|Withdrawal by Subject|3|||
170814777|NCT01670526|617329376|FG001|Overall Study|Withdrawal by Subject|1|||
170814778|NCT01670526|617329375|FG000|Overall Study|Lost to Follow-up|9|||
170814779|NCT01670526|617329376|FG001|Overall Study|Lost to Follow-up|5|||
170814780|NCT03055988|617329377|FG000|Period 1|Adverse Event|0|||
170814781|NCT03055988|617329378|FG001|Period 1|Adverse Event|1|||
170814782|NCT03055988|617329377|FG000|Period 1|Lost to Follow-up|1|||
170814783|NCT03055988|617329378|FG001|Period 1|Lost to Follow-up|0|||
170814784|NCT03055988|617329377|FG000|Period 1|Withdrawal by Subject|0|||
170814785|NCT03055988|617329378|FG001|Period 1|Withdrawal by Subject|4|||
170814786|NCT03055988|617329377|FG000|Period 2|Adverse Event|0|||
170814787|NCT03055988|617329378|FG001|Period 2|Adverse Event|1|||
170814788|NCT03055988|617329377|FG000|Period 2|Other than listed|1|||
170814789|NCT03055988|617329378|FG001|Period 2|Other than listed|1|||
170814790|NCT00800176|617329382|FG000|Overall Study|Adverse Event|2|||
170814791|NCT00800176|617329383|FG001|Overall Study|Adverse Event|1|||
170814792|NCT00800176|617329384|FG002|Overall Study|Adverse Event|0|||
170814793|NCT00800176|617329385|FG003|Overall Study|Adverse Event|2|||
170814794|NCT00800176|617329386|FG004|Overall Study|Adverse Event|1|||
170814795|NCT00800176|617329387|FG005|Overall Study|Adverse Event|1|||
170814796|NCT00800176|617329382|FG000|Overall Study|Refused treatment|3|||
170814797|NCT00800176|617329383|FG001|Overall Study|Refused treatment|2|||
170814798|NCT00800176|617329384|FG002|Overall Study|Refused treatment|0|||
170814799|NCT00800176|617329385|FG003|Overall Study|Refused treatment|0|||
170814800|NCT00800176|617329386|FG004|Overall Study|Refused treatment|1|||
170814801|NCT00800176|617329387|FG005|Overall Study|Refused treatment|4|||
170814802|NCT00800176|617329382|FG000|Overall Study|Failure to return|3|||
170814803|NCT00800176|617329383|FG001|Overall Study|Failure to return|3|||
170814804|NCT00800176|617329384|FG002|Overall Study|Failure to return|0|||
170814805|NCT00800176|617329385|FG003|Overall Study|Failure to return|2|||
170814806|NCT00800176|617329386|FG004|Overall Study|Failure to return|0|||
170814807|NCT00800176|617329387|FG005|Overall Study|Failure to return|0|||
170814808|NCT00800176|617329382|FG000|Overall Study|Other|1|||
170814809|NCT00800176|617329383|FG001|Overall Study|Other|0|||
170814810|NCT00800176|617329384|FG002|Overall Study|Other|0|||
170814811|NCT00800176|617329385|FG003|Overall Study|Other|0|||
170814812|NCT00800176|617329386|FG004|Overall Study|Other|2|||
170814813|NCT00800176|617329387|FG005|Overall Study|Other|0|||
170814814|NCT02326220|617329392|FG000|Double-blind Treatment Period|Adverse Event|1|||
170814815|NCT02326220|617329393|FG001|Double-blind Treatment Period|Adverse Event|2|||
170814816|NCT02326220|617329394|FG002|Double-blind Treatment Period|Adverse Event|0|||
170814817|NCT02326220|617329392|FG000|Double-blind Treatment Period|Protocol Violation|0|||
170814818|NCT02326220|617329393|FG001|Double-blind Treatment Period|Protocol Violation|1|||
170814819|NCT02326220|617329394|FG002|Double-blind Treatment Period|Protocol Violation|0|||
170652747|NCT04214288|616743274|FG002|Overall Study|Adverse Event|0|||
170814820|NCT02326220|617329392|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
170814821|NCT02326220|617329393|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
170814822|NCT02326220|617329394|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170814823|NCT02326220|617329392|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
170814824|NCT02326220|617329393|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
170814825|NCT02326220|617329394|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
170814826|NCT02326220|617329392|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
170814827|NCT02326220|617329393|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
170814828|NCT02326220|617329394|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
170814829|NCT02699099|617329395|FG000|Overall Study|Adverse Event|1|||
170814830|NCT02699099|617329396|FG001|Overall Study|Adverse Event|0|||
170814831|NCT02699099|617329397|FG002|Overall Study|Adverse Event|2|||
170814832|NCT02699099|617329395|FG000|Overall Study|Lost to Follow-up|0|||
170814833|NCT02699099|617329396|FG001|Overall Study|Lost to Follow-up|1|||
170915092|NCT02975349|617691826|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
170915093|NCT02975349|617691820|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
170915094|NCT02975349|617691821|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
170915095|NCT02975349|617691822|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
170915096|NCT02975349|617691823|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
170915097|NCT02975349|617691824|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
170915098|NCT02975349|617691825|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
170915099|NCT02975349|617691826|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
170915100|NCT02975349|617691820|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
170915101|NCT02975349|617691821|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
170915102|NCT02975349|617691822|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
170915103|NCT02975349|617691823|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
170915104|NCT02975349|617691824|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
170915105|NCT02975349|617691825|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
170915106|NCT02975349|617691826|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
170915107|NCT02975349|617691820|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
170915108|NCT02975349|617691821|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
170915109|NCT02975349|617691822|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
170915110|NCT02975349|617691823|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
170915111|NCT02975349|617691824|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
170915112|NCT02975349|617691825|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
170915113|NCT02975349|617691826|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
170915114|NCT02975349|617691820|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
170915115|NCT02975349|617691821|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
170915116|NCT02975349|617691822|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
170915117|NCT02975349|617691823|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
170915118|NCT02975349|617691824|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
170605752|NCT01717326|616562174|FG012|Overall Study|Lost to Follow-up|0|||
170605753|NCT01717326|616562175|FG013|Overall Study|Lost to Follow-up|0|||
170605754|NCT01717326|616562176|FG014|Overall Study|Lost to Follow-up|0|||
170605755|NCT01717326|616562177|FG015|Overall Study|Lost to Follow-up|2|||
170605756|NCT01717326|616562178|FG016|Overall Study|Lost to Follow-up|1|||
170605757|NCT01717326|616562179|FG017|Overall Study|Lost to Follow-up|0|||
170605758|NCT01717326|616562180|FG018|Overall Study|Lost to Follow-up|2|||
170605759|NCT01717326|616562181|FG019|Overall Study|Lost to Follow-up|3|||
170605760|NCT01717326|616562162|FG000|Overall Study|Physician Decision|0|||
170605761|NCT01717326|616562163|FG001|Overall Study|Physician Decision|0|||
170605762|NCT01717326|616562164|FG002|Overall Study|Physician Decision|0|||
170605763|NCT01717326|616562165|FG003|Overall Study|Physician Decision|0|||
170605764|NCT01717326|616562166|FG004|Overall Study|Physician Decision|0|||
170605765|NCT01717326|616562167|FG005|Overall Study|Physician Decision|0|||
170605766|NCT01717326|616562168|FG006|Overall Study|Physician Decision|0|||
170605767|NCT01717326|616562169|FG007|Overall Study|Physician Decision|0|||
170605768|NCT01717326|616562170|FG008|Overall Study|Physician Decision|0|||
170605769|NCT01717326|616562171|FG009|Overall Study|Physician Decision|1|||
170605770|NCT01717326|616562172|FG010|Overall Study|Physician Decision|0|||
170605771|NCT01717326|616562173|FG011|Overall Study|Physician Decision|0|||
170605772|NCT01717326|616562174|FG012|Overall Study|Physician Decision|0|||
170915119|NCT02975349|617691825|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
170915120|NCT02975349|617691826|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
170605773|NCT01717326|616562175|FG013|Overall Study|Physician Decision|0|||
170605774|NCT01717326|616562176|FG014|Overall Study|Physician Decision|0|||
170605775|NCT01717326|616562177|FG015|Overall Study|Physician Decision|0|||
170605776|NCT01717326|616562178|FG016|Overall Study|Physician Decision|0|||
170605777|NCT01717326|616562179|FG017|Overall Study|Physician Decision|0|||
170605778|NCT01717326|616562180|FG018|Overall Study|Physician Decision|0|||
170605779|NCT01717326|616562181|FG019|Overall Study|Physician Decision|0|||
170605780|NCT01717326|616562162|FG000|Overall Study|Protocol Violation|0|||
170605781|NCT01717326|616562163|FG001|Overall Study|Protocol Violation|0|||
170605782|NCT01717326|616562164|FG002|Overall Study|Protocol Violation|0|||
170605783|NCT01717326|616562165|FG003|Overall Study|Protocol Violation|0|||
170605784|NCT01717326|616562166|FG004|Overall Study|Protocol Violation|1|||
170915121|NCT02975349|617691820|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
170915122|NCT02975349|617691821|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
170605785|NCT01717326|616562167|FG005|Overall Study|Protocol Violation|0|||
170605786|NCT01717326|616562168|FG006|Overall Study|Protocol Violation|0|||
170605787|NCT01717326|616562169|FG007|Overall Study|Protocol Violation|0|||
170605788|NCT01717326|616562170|FG008|Overall Study|Protocol Violation|0|||
170605789|NCT01717326|616562171|FG009|Overall Study|Protocol Violation|0|||
170605790|NCT01717326|616562172|FG010|Overall Study|Protocol Violation|0|||
170605791|NCT01717326|616562173|FG011|Overall Study|Protocol Violation|0|||
170605792|NCT01717326|616562174|FG012|Overall Study|Protocol Violation|0|||
170915123|NCT02975349|617691822|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
170915124|NCT02975349|617691823|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
170915125|NCT02975349|617691824|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
170915126|NCT02975349|617691825|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
170915127|NCT02975349|617691826|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
170915128|NCT02975349|617691820|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
170915129|NCT02975349|617691821|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
170915130|NCT02975349|617691822|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
170915131|NCT02975349|617691823|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
170915132|NCT02975349|617691824|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
170915133|NCT02975349|617691825|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
170915134|NCT02975349|617691826|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
170915135|NCT02975349|617691820|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
170915136|NCT02975349|617691821|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
170915137|NCT02975349|617691822|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
170915138|NCT02975349|617691823|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
170915139|NCT02975349|617691824|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
170915140|NCT02975349|617691825|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
170915141|NCT02975349|617691826|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
170915142|NCT02975349|617691820|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
170915143|NCT02975349|617691821|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
170915144|NCT02975349|617691822|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
170915145|NCT02975349|617691823|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
170915146|NCT02975349|617691824|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
170915147|NCT02975349|617691825|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
170915148|NCT02975349|617691826|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
170915149|NCT02975349|617691820|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
170915150|NCT02975349|617691821|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
170915151|NCT02975349|617691822|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
170915152|NCT02975349|617691823|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
170915153|NCT02975349|617691824|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
170915154|NCT02975349|617691825|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
170915155|NCT02975349|617691826|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
170915156|NCT01663740|617691827|FG000|Overall Study|Lost to Follow-up|1|||
170915157|NCT01663740|617691828|FG001|Overall Study|Lost to Follow-up|4|||
170915158|NCT01663740|617691827|FG000|Overall Study|Other|9|||
170915159|NCT01663740|617691828|FG001|Overall Study|Other|2|||
170915160|NCT01663740|617691827|FG000|Overall Study|Inclusion/Exclusion not met|1|||
170915161|NCT01663740|617691828|FG001|Overall Study|Inclusion/Exclusion not met|0|||
170915162|NCT01663740|617691827|FG000|Overall Study|Death|0|||
170915163|NCT01663740|617691828|FG001|Overall Study|Death|1|||
170915164|NCT01663740|617691827|FG000|Overall Study|Withdrawal by Subject|2|||
170915165|NCT01663740|617691828|FG001|Overall Study|Withdrawal by Subject|1|||
170915166|NCT01663740|617691827|FG000|Overall Study|No end of study status|3|||
170915167|NCT01663740|617691828|FG001|Overall Study|No end of study status|0|||
170915168|NCT00404768|617691829|FG000|Part A and B|Withdrawn due to labor progression|1|||
170915169|NCT00404768|617691830|FG001|Part A and B|Withdrawn due to labor progression|0|||
170915170|NCT00404768|617691831|FG002|Part A and B|Withdrawn due to labor progression|0|||
170915171|NCT00404768|617691832|FG003|Part A and B|Withdrawn due to labor progression|0|||
170915172|NCT00404768|617691829|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
170915173|NCT00404768|617691830|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
170915174|NCT00404768|617691831|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
170915175|NCT00404768|617691832|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
170915176|NCT00404768|617691829|FG000|Part C|Adverse Event|0|||
170915177|NCT00404768|617691830|FG001|Part C|Adverse Event|0|||
170915178|NCT00404768|617691831|FG002|Part C|Adverse Event|0|||
170915179|NCT00404768|617691832|FG003|Part C|Adverse Event|3|||
170915180|NCT00404768|617691829|FG000|Part C|Lost to Follow-up|0|||
170915181|NCT00404768|617691830|FG001|Part C|Lost to Follow-up|0|||
170605793|NCT01717326|616562175|FG013|Overall Study|Protocol Violation|0|||
170605794|NCT01717326|616562176|FG014|Overall Study|Protocol Violation|0|||
170915182|NCT00404768|617691831|FG002|Part C|Lost to Follow-up|3|||
170915183|NCT00404768|617691832|FG003|Part C|Lost to Follow-up|1|||
170915184|NCT00404768|617691829|FG000|Part C|Withdrawal by Subject|0|||
170915185|NCT00404768|617691830|FG001|Part C|Withdrawal by Subject|0|||
170915186|NCT00404768|617691831|FG002|Part C|Withdrawal by Subject|2|||
170915187|NCT00404768|617691832|FG003|Part C|Withdrawal by Subject|1|||
170915188|NCT00404768|617691829|FG000|Part C|Early withdrawal from study medication|0|||
170915189|NCT00404768|617691830|FG001|Part C|Early withdrawal from study medication|0|||
170915190|NCT00404768|617691831|FG002|Part C|Early withdrawal from study medication|1|||
170915191|NCT00404768|617691832|FG003|Part C|Early withdrawal from study medication|0|||
170605795|NCT01717326|616562177|FG015|Overall Study|Protocol Violation|0|||
170605796|NCT01717326|616562178|FG016|Overall Study|Protocol Violation|0|||
170605797|NCT01717326|616562179|FG017|Overall Study|Protocol Violation|0|||
170605798|NCT01717326|616562180|FG018|Overall Study|Protocol Violation|0|||
170605799|NCT01717326|616562181|FG019|Overall Study|Protocol Violation|0|||
170605800|NCT01717326|616562162|FG000|Overall Study|Withdrawal by Subject|0|||
170605801|NCT01717326|616562163|FG001|Overall Study|Withdrawal by Subject|1|||
170605802|NCT01717326|616562164|FG002|Overall Study|Withdrawal by Subject|0|||
170605803|NCT01717326|616562165|FG003|Overall Study|Withdrawal by Subject|0|||
170605804|NCT01717326|616562166|FG004|Overall Study|Withdrawal by Subject|0|||
170605805|NCT01717326|616562167|FG005|Overall Study|Withdrawal by Subject|0|||
170605806|NCT01717326|616562168|FG006|Overall Study|Withdrawal by Subject|0|||
170605807|NCT01717326|616562169|FG007|Overall Study|Withdrawal by Subject|0|||
170605808|NCT01717326|616562170|FG008|Overall Study|Withdrawal by Subject|0|||
170605809|NCT01717326|616562171|FG009|Overall Study|Withdrawal by Subject|1|||
170605810|NCT01717326|616562172|FG010|Overall Study|Withdrawal by Subject|0|||
170605811|NCT01717326|616562173|FG011|Overall Study|Withdrawal by Subject|0|||
170605812|NCT01717326|616562174|FG012|Overall Study|Withdrawal by Subject|1|||
170605813|NCT01717326|616562175|FG013|Overall Study|Withdrawal by Subject|0|||
170605814|NCT01717326|616562176|FG014|Overall Study|Withdrawal by Subject|0|||
170605815|NCT01717326|616562177|FG015|Overall Study|Withdrawal by Subject|1|||
170605816|NCT01717326|616562178|FG016|Overall Study|Withdrawal by Subject|0|||
170605817|NCT01717326|616562179|FG017|Overall Study|Withdrawal by Subject|0|||
170605818|NCT01717326|616562180|FG018|Overall Study|Withdrawal by Subject|2|||
170605819|NCT01717326|616562181|FG019|Overall Study|Withdrawal by Subject|3|||
170605820|NCT00428844|616562182|FG000|Completed Study Drug Treatment|Adverse Event|2|||
170605821|NCT00428844|616562183|FG001|Completed Study Drug Treatment|Adverse Event|4|||
170605822|NCT00428844|616562184|FG002|Completed Study Drug Treatment|Adverse Event|4|||
170605823|NCT00428844|616562182|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
170605824|NCT00428844|616562183|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
170605825|NCT00428844|616562184|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
170605826|NCT00428844|616562182|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
170605827|NCT00428844|616562183|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
170605828|NCT00428844|616562184|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
170605829|NCT00428844|616562182|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
170605830|NCT00428844|616562183|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
170605831|NCT00428844|616562184|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
170605832|NCT00428844|616562182|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
170605833|NCT00428844|616562183|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
170605834|NCT00428844|616562184|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
170915192|NCT00404768|617691829|FG000|Part C|Participant did not respond to therapy|0|||
170915193|NCT00404768|617691830|FG001|Part C|Participant did not respond to therapy|0|||
170915194|NCT00404768|617691831|FG002|Part C|Participant did not respond to therapy|1|||
170915195|NCT00404768|617691832|FG003|Part C|Participant did not respond to therapy|1|||
170915196|NCT00404768|617691829|FG000|Part C|Physician withdrew the study medication|0|||
170915197|NCT00404768|617691830|FG001|Part C|Physician withdrew the study medication|0|||
170915198|NCT00404768|617691831|FG002|Part C|Physician withdrew the study medication|1|||
170915199|NCT00404768|617691832|FG003|Part C|Physician withdrew the study medication|0|||
170915200|NCT00404768|617691829|FG000|Part C|Participant delivered baby|0|||
170915201|NCT00404768|617691830|FG001|Part C|Participant delivered baby|0|||
170915202|NCT00404768|617691831|FG002|Part C|Participant delivered baby|0|||
170915203|NCT00404768|617691832|FG003|Part C|Participant delivered baby|1|||
170915204|NCT00404768|617691829|FG000|Part C|Unsatisfactory uterine response to IP|0|||
170915205|NCT00404768|617691830|FG001|Part C|Unsatisfactory uterine response to IP|0|||
170652748|NCT04214288|616743275|FG003|Overall Study|Adverse Event|0|||
170652749|NCT04214288|616743272|FG000|Overall Study|Death|22|||
170652750|NCT04214288|616743273|FG001|Overall Study|Death|13|||
170652751|NCT04214288|616743274|FG002|Overall Study|Death|7|||
170652752|NCT04214288|616743275|FG003|Overall Study|Death|19|||
170652753|NCT04214288|616743272|FG000|Overall Study|Lost to Follow-up|1|||
170652754|NCT04214288|616743273|FG001|Overall Study|Lost to Follow-up|2|||
170915206|NCT00404768|617691831|FG002|Part C|Unsatisfactory uterine response to IP|0|||
170915207|NCT00404768|617691832|FG003|Part C|Unsatisfactory uterine response to IP|1|||
170915208|NCT00404768|617691829|FG000|Part C|Active labor|0|||
170915209|NCT00404768|617691830|FG001|Part C|Active labor|0|||
170915210|NCT00404768|617691831|FG002|Part C|Active labor|0|||
170605835|NCT00428844|616562182|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
170605836|NCT00428844|616562183|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
170605837|NCT00428844|616562184|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
170605838|NCT00428844|616562182|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
170605839|NCT00428844|616562183|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
170652755|NCT04214288|616743274|FG002|Overall Study|Lost to Follow-up|1|||
170605840|NCT00428844|616562184|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
170605841|NCT00428844|616562182|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
170605842|NCT00428844|616562183|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
170605843|NCT00428844|616562184|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
170605844|NCT00428844|616562182|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
170605845|NCT00428844|616562183|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
170605846|NCT00428844|616562184|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
170605847|NCT00488826|616562185|FG000|Overall Study|Withdrawal by Subject|40|||
170605848|NCT00488826|616562186|FG001|Overall Study|Withdrawal by Subject|35|||
170605849|NCT00488826|616562187|FG002|Overall Study|Withdrawal by Subject|19|||
170605850|NCT00488826|616562185|FG000|Overall Study|Protocol Violation|0|||
170605851|NCT00488826|616562186|FG001|Overall Study|Protocol Violation|0|||
170605852|NCT00488826|616562187|FG002|Overall Study|Protocol Violation|2|||
170605853|NCT00488826|616562185|FG000|Overall Study|Adverse Event|9|||
170605854|NCT00488826|616562186|FG001|Overall Study|Adverse Event|15|||
170605855|NCT00488826|616562187|FG002|Overall Study|Adverse Event|4|||
170605856|NCT00488826|616562185|FG000|Overall Study|Lost to Follow-up|5|||
170605857|NCT00488826|616562186|FG001|Overall Study|Lost to Follow-up|1|||
170605858|NCT00488826|616562187|FG002|Overall Study|Lost to Follow-up|0|||
170605859|NCT00488826|616562185|FG000|Overall Study|Protocol Deviations|2|||
170605860|NCT00488826|616562186|FG001|Overall Study|Protocol Deviations|1|||
170605861|NCT00488826|616562187|FG002|Overall Study|Protocol Deviations|1|||
170605862|NCT03208088|616562193|FG000|Period 2|Withdrawal by Subject|0|||
170605863|NCT03208088|616562194|FG001|Period 2|Withdrawal by Subject|0|||
170605864|NCT03208088|616562195|FG002|Period 2|Withdrawal by Subject|0|||
170605865|NCT03208088|616562196|FG003|Period 2|Withdrawal by Subject|0|||
170605866|NCT03208088|616562197|FG004|Period 2|Withdrawal by Subject|0|||
170605867|NCT03208088|616562198|FG005|Period 2|Withdrawal by Subject|0|||
170605868|NCT03208088|616562199|FG006|Period 2|Withdrawal by Subject|0|||
170605869|NCT03208088|616562200|FG007|Period 2|Withdrawal by Subject|0|||
170605870|NCT03208088|616562201|FG008|Period 2|Withdrawal by Subject|1|||
170605871|NCT03208088|616562202|FG009|Period 2|Withdrawal by Subject|0|||
170605872|NCT03208088|616562193|FG000|Period 3|Unsatisfactory Test Article|0|||
170605873|NCT03208088|616562194|FG001|Period 3|Unsatisfactory Test Article|0|||
170605874|NCT03208088|616562195|FG002|Period 3|Unsatisfactory Test Article|0|||
170605875|NCT03208088|616562196|FG003|Period 3|Unsatisfactory Test Article|1|||
170605876|NCT03208088|616562197|FG004|Period 3|Unsatisfactory Test Article|0|||
170605877|NCT03208088|616562198|FG005|Period 3|Unsatisfactory Test Article|0|||
170605878|NCT03208088|616562199|FG006|Period 3|Unsatisfactory Test Article|0|||
170814834|NCT02699099|617329397|FG002|Overall Study|Lost to Follow-up|0|||
170814835|NCT02699099|617329395|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
170814836|NCT02699099|617329396|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
170814837|NCT02699099|617329397|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
170814838|NCT01240590|617329402|FG000|Phase I|Refused further treatment|0|||
170814839|NCT01240590|617329403|FG001|Phase I|Refused further treatment|0|||
170814840|NCT01240590|617329404|FG002|Phase I|Refused further treatment|3|||
170814841|NCT01240590|617329405|FG003|Phase I|Refused further treatment|0|||
170814842|NCT01240590|617329406|FG004|Phase I|Refused further treatment|0|||
170814843|NCT01240590|617329402|FG000|Phase II|Refused further treatment|0|||
170814844|NCT01240590|617329403|FG001|Phase II|Refused further treatment|0|||
170814845|NCT01240590|617329404|FG002|Phase II|Refused further treatment|0|||
170814846|NCT01240590|617329405|FG003|Phase II|Refused further treatment|2|||
170814847|NCT01240590|617329406|FG004|Phase II|Refused further treatment|1|||
170814848|NCT04197713|617329407|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
170814849|NCT04197713|617329408|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
170814850|NCT03659136|617329413|FG000|Overall Study|Not treated|2|||
170814851|NCT03659136|617329414|FG001|Overall Study|Not treated|0|||
170814852|NCT03659136|617329413|FG000|Overall Study|Covid-19 related|1|||
170814853|NCT03659136|617329414|FG001|Overall Study|Covid-19 related|1|||
170814854|NCT03659136|617329413|FG000|Overall Study|Withdrawal by Subject|1|||
170814855|NCT03659136|617329414|FG001|Overall Study|Withdrawal by Subject|6|||
170814856|NCT03659136|617329413|FG000|Overall Study|Adverse Event|4|||
170814857|NCT03659136|617329414|FG001|Overall Study|Adverse Event|6|||
170814858|NCT03659136|617329413|FG000|Overall Study|Progressive disease|37|||
170605879|NCT03208088|616562200|FG007|Period 3|Unsatisfactory Test Article|0|||
170605880|NCT03208088|616562201|FG008|Period 3|Unsatisfactory Test Article|0|||
170605881|NCT03208088|616562202|FG009|Period 3|Unsatisfactory Test Article|0|||
170605882|NCT03208088|616562193|FG000|Period 4|Unsatisfactory Test Article|0|||
170605883|NCT03208088|616562194|FG001|Period 4|Unsatisfactory Test Article|0|||
170605884|NCT03208088|616562195|FG002|Period 4|Unsatisfactory Test Article|0|||
170605885|NCT03208088|616562196|FG003|Period 4|Unsatisfactory Test Article|1|||
170652756|NCT04214288|616743275|FG003|Overall Study|Lost to Follow-up|0|||
170814859|NCT03659136|617329414|FG001|Overall Study|Progressive disease|31|||
170814860|NCT03659136|617329413|FG000|Overall Study|Study closure|2|||
170652757|NCT04214288|616743272|FG000|Overall Study|Other|1|||
170814861|NCT03659136|617329414|FG001|Overall Study|Study closure|2|||
170605886|NCT03208088|616562197|FG004|Period 4|Unsatisfactory Test Article|0|||
170605887|NCT03208088|616562198|FG005|Period 4|Unsatisfactory Test Article|0|||
170605888|NCT03208088|616562199|FG006|Period 4|Unsatisfactory Test Article|0|||
170605889|NCT03208088|616562200|FG007|Period 4|Unsatisfactory Test Article|0|||
170605890|NCT03208088|616562201|FG008|Period 4|Unsatisfactory Test Article|0|||
170605891|NCT03208088|616562202|FG009|Period 4|Unsatisfactory Test Article|0|||
170605892|NCT00812565|616562203|FG000|Overall Study|Did Not Receive Study Medication|1|||
170605893|NCT00812565|616562204|FG001|Overall Study|Did Not Receive Study Medication|1|||
170605894|NCT00812565|616562205|FG002|Overall Study|Did Not Receive Study Medication|0|||
170605895|NCT00812565|616562206|FG003|Overall Study|Did Not Receive Study Medication|0|||
170605896|NCT00812565|616562207|FG004|Overall Study|Did Not Receive Study Medication|0|||
170605897|NCT00812565|616562208|FG005|Overall Study|Did Not Receive Study Medication|0|||
170605898|NCT00812565|616562209|FG006|Overall Study|Did Not Receive Study Medication|0|||
170605899|NCT00812565|616562210|FG007|Overall Study|Did Not Receive Study Medication|0|||
170605900|NCT00812565|616562203|FG000|Overall Study|Adverse Event|0|||
170605901|NCT00812565|616562204|FG001|Overall Study|Adverse Event|0|||
170605902|NCT00812565|616562205|FG002|Overall Study|Adverse Event|0|||
170605903|NCT00812565|616562206|FG003|Overall Study|Adverse Event|2|||
170605904|NCT00812565|616562207|FG004|Overall Study|Adverse Event|0|||
170605905|NCT00812565|616562208|FG005|Overall Study|Adverse Event|0|||
170605906|NCT00812565|616562209|FG006|Overall Study|Adverse Event|0|||
170605907|NCT00812565|616562210|FG007|Overall Study|Adverse Event|1|||
170605908|NCT00812565|616562203|FG000|Overall Study|Did Not Come to Study Visit|1|||
170605909|NCT00812565|616562204|FG001|Overall Study|Did Not Come to Study Visit|0|||
170605910|NCT00812565|616562205|FG002|Overall Study|Did Not Come to Study Visit|0|||
170814862|NCT03659136|617329413|FG000|Overall Study|Sponsor decision/recommendation|3|||
170814863|NCT03659136|617329414|FG001|Overall Study|Sponsor decision/recommendation|2|||
170814864|NCT03659136|617329413|FG000|Overall Study|Switched to other drug/therapy|2|||
170814865|NCT03659136|617329414|FG001|Overall Study|Switched to other drug/therapy|2|||
170814866|NCT03659136|617329413|FG000|Overall Study|Lack of clinical benefit|0|||
170814867|NCT03659136|617329414|FG001|Overall Study|Lack of clinical benefit|1|||
170814868|NCT01248715|617331388|FG000|Overall Study|Not influenza positive|501|||
170814869|NCT01248715|617331389|FG001|Overall Study|Not influenza positive|510|||
170814870|NCT00813709|617331390|FG000|Double Blind Period|Adverse Event|4|||
170814871|NCT00813709|617331391|FG001|Double Blind Period|Adverse Event|1|||
170814872|NCT00813709|617331392|FG002|Double Blind Period|Adverse Event|4|||
170814873|NCT00813709|617331393|FG003|Double Blind Period|Adverse Event|0|||
170814874|NCT00813709|617331394|FG004|Double Blind Period|Adverse Event|0|||
170814875|NCT00813709|617331395|FG005|Double Blind Period|Adverse Event|0|||
170814876|NCT00813709|617331390|FG000|Double Blind Period|Lost to Follow-up|3|||
170814877|NCT00813709|617331391|FG001|Double Blind Period|Lost to Follow-up|2|||
170814878|NCT00813709|617331392|FG002|Double Blind Period|Lost to Follow-up|2|||
170814879|NCT00813709|617331393|FG003|Double Blind Period|Lost to Follow-up|0|||
170814880|NCT00813709|617331394|FG004|Double Blind Period|Lost to Follow-up|0|||
170814881|NCT00813709|617331395|FG005|Double Blind Period|Lost to Follow-up|0|||
170814882|NCT00813709|617331390|FG000|Double Blind Period|Switched to open label phase|9|||
170814883|NCT00813709|617331391|FG001|Double Blind Period|Switched to open label phase|26|||
170814884|NCT00813709|617331392|FG002|Double Blind Period|Switched to open label phase|18|||
170814885|NCT00813709|617331393|FG003|Double Blind Period|Switched to open label phase|0|||
170814886|NCT00813709|617331394|FG004|Double Blind Period|Switched to open label phase|0|||
170814887|NCT00813709|617331395|FG005|Double Blind Period|Switched to open label phase|0|||
170814888|NCT00813709|617331390|FG000|Double Blind Period|Randomized but not treated|1|||
170814889|NCT00813709|617331391|FG001|Double Blind Period|Randomized but not treated|3|||
170814890|NCT00813709|617331392|FG002|Double Blind Period|Randomized but not treated|1|||
170814891|NCT00813709|617331393|FG003|Double Blind Period|Randomized but not treated|0|||
170814892|NCT00813709|617331394|FG004|Double Blind Period|Randomized but not treated|0|||
170814893|NCT00813709|617331395|FG005|Double Blind Period|Randomized but not treated|0|||
170814894|NCT00813709|617331390|FG000|Double Blind Period|Other|14|||
170814895|NCT00813709|617331391|FG001|Double Blind Period|Other|9|||
170814896|NCT00813709|617331392|FG002|Double Blind Period|Other|6|||
170814897|NCT00813709|617331393|FG003|Double Blind Period|Other|0|||
170814898|NCT00813709|617331394|FG004|Double Blind Period|Other|0|||
170605911|NCT00812565|616562206|FG003|Overall Study|Did Not Come to Study Visit|0|||
170652758|NCT04214288|616743273|FG001|Overall Study|Other|2|||
170652759|NCT04214288|616743274|FG002|Overall Study|Other|0|||
170652760|NCT04214288|616743275|FG003|Overall Study|Other|6|||
170814899|NCT00813709|617331395|FG005|Double Blind Period|Other|0|||
170814900|NCT00813709|617331390|FG000|Open Label Period|Adverse Event|0|||
170814901|NCT00813709|617331391|FG001|Open Label Period|Adverse Event|0|||
170605912|NCT00812565|616562207|FG004|Overall Study|Did Not Come to Study Visit|0|||
170605913|NCT00812565|616562208|FG005|Overall Study|Did Not Come to Study Visit|0|||
170605914|NCT00812565|616562209|FG006|Overall Study|Did Not Come to Study Visit|0|||
170915211|NCT00404768|617691832|FG003|Part C|Active labor|1|||
170915212|NCT00404768|617691829|FG000|Part C|Lack of Efficacy|0|||
170915213|NCT00404768|617691830|FG001|Part C|Lack of Efficacy|0|||
170915214|NCT00404768|617691831|FG002|Part C|Lack of Efficacy|0|||
170915215|NCT00404768|617691832|FG003|Part C|Lack of Efficacy|2|||
170915216|NCT00404768|617691829|FG000|Part C|Treatment failure|0|||
170915217|NCT00404768|617691830|FG001|Part C|Treatment failure|0|||
170915218|NCT00404768|617691831|FG002|Part C|Treatment failure|0|||
170915219|NCT00404768|617691832|FG003|Part C|Treatment failure|1|||
170915220|NCT00404768|617691829|FG000|Part C|Investigator discretion|0|||
170915221|NCT00404768|617691830|FG001|Part C|Investigator discretion|0|||
170915222|NCT00404768|617691831|FG002|Part C|Investigator discretion|0|||
170915223|NCT00404768|617691832|FG003|Part C|Investigator discretion|1|||
170915224|NCT00404768|617691829|FG000|Part C|Researcher suspended study medication|0|||
170915225|NCT00404768|617691830|FG001|Part C|Researcher suspended study medication|0|||
170915226|NCT00404768|617691831|FG002|Part C|Researcher suspended study medication|0|||
170915227|NCT00404768|617691832|FG003|Part C|Researcher suspended study medication|1|||
170915228|NCT00907738|617691833|FG000|Overall Study|Adverse Event|2|||
170915229|NCT00907738|617691834|FG001|Overall Study|Adverse Event|0|||
170915230|NCT00907738|617691835|FG002|Overall Study|Adverse Event|1|||
170915231|NCT00907738|617691836|FG003|Overall Study|Adverse Event|0|||
170915232|NCT00907738|617691837|FG004|Overall Study|Adverse Event|0|||
170915233|NCT00907738|617691833|FG000|Overall Study|not specified or withdrew consent|3|||
170915234|NCT00907738|617691834|FG001|Overall Study|not specified or withdrew consent|0|||
170915235|NCT00907738|617691835|FG002|Overall Study|not specified or withdrew consent|0|||
170915236|NCT00907738|617691836|FG003|Overall Study|not specified or withdrew consent|0|||
170915237|NCT00907738|617691837|FG004|Overall Study|not specified or withdrew consent|0|||
170915238|NCT00907738|617691833|FG000|Overall Study|Disease progression|8|||
170814902|NCT00813709|617331392|FG002|Open Label Period|Adverse Event|0|||
170814903|NCT00813709|617331393|FG003|Open Label Period|Adverse Event|5|||
170814904|NCT00813709|617331394|FG004|Open Label Period|Adverse Event|4|||
170814905|NCT00813709|617331395|FG005|Open Label Period|Adverse Event|3|||
170814906|NCT00813709|617331390|FG000|Open Label Period|Lack of Efficacy|0|||
170915239|NCT00907738|617691834|FG001|Overall Study|Disease progression|1|||
170915240|NCT00907738|617691835|FG002|Overall Study|Disease progression|6|||
170915241|NCT00907738|617691836|FG003|Overall Study|Disease progression|4|||
170915242|NCT00907738|617691837|FG004|Overall Study|Disease progression|2|||
170915243|NCT03625986|617693477|FG000|Randomization Period|Lost to Follow-up|7|||
170915244|NCT03625986|617693478|FG001|Randomization Period|Lost to Follow-up|12|||
170605915|NCT00812565|616562210|FG007|Overall Study|Did Not Come to Study Visit|0|||
170605916|NCT00812565|616562203|FG000|Overall Study|Withdrawal of Consent|1|||
170605917|NCT00812565|616562204|FG001|Overall Study|Withdrawal of Consent|0|||
170605918|NCT00812565|616562205|FG002|Overall Study|Withdrawal of Consent|0|||
170605919|NCT00812565|616562206|FG003|Overall Study|Withdrawal of Consent|0|||
170605920|NCT00812565|616562207|FG004|Overall Study|Withdrawal of Consent|1|||
170605921|NCT00812565|616562208|FG005|Overall Study|Withdrawal of Consent|0|||
170605922|NCT00812565|616562209|FG006|Overall Study|Withdrawal of Consent|0|||
170605923|NCT00812565|616562210|FG007|Overall Study|Withdrawal of Consent|0|||
170605924|NCT00812565|616562203|FG000|Overall Study|Reason Not Specified|0|||
170605925|NCT00812565|616562204|FG001|Overall Study|Reason Not Specified|0|||
170605926|NCT00812565|616562205|FG002|Overall Study|Reason Not Specified|0|||
170605927|NCT00812565|616562206|FG003|Overall Study|Reason Not Specified|0|||
170652761|NCT04214288|616743272|FG000|Overall Study|Protocol Violation|0|||
170814907|NCT00813709|617331391|FG001|Open Label Period|Lack of Efficacy|0|||
170814908|NCT00813709|617331392|FG002|Open Label Period|Lack of Efficacy|0|||
170814909|NCT00813709|617331393|FG003|Open Label Period|Lack of Efficacy|3|||
170814910|NCT00813709|617331394|FG004|Open Label Period|Lack of Efficacy|1|||
170814911|NCT00813709|617331395|FG005|Open Label Period|Lack of Efficacy|1|||
170814912|NCT00813709|617331390|FG000|Open Label Period|Randomized but not treated|0|||
170814913|NCT00813709|617331391|FG001|Open Label Period|Randomized but not treated|0|||
170814914|NCT00813709|617331392|FG002|Open Label Period|Randomized but not treated|0|||
170814915|NCT00813709|617331393|FG003|Open Label Period|Randomized but not treated|1|||
170814916|NCT00813709|617331394|FG004|Open Label Period|Randomized but not treated|0|||
170814917|NCT00813709|617331395|FG005|Open Label Period|Randomized but not treated|1|||
170814918|NCT00813709|617331390|FG000|Open Label Period|Other|0|||
170814919|NCT00813709|617331391|FG001|Open Label Period|Other|0|||
170814920|NCT00813709|617331392|FG002|Open Label Period|Other|0|||
170814921|NCT00813709|617331393|FG003|Open Label Period|Other|11|||
170915245|NCT03625986|617693477|FG000|Randomization Period|Withdrawal by Subject|10|||
170915246|NCT03625986|617693478|FG001|Randomization Period|Withdrawal by Subject|6|||
170915247|NCT00128206|617693481|FG000|Overall Study|Lost to Follow-up|137|||
170915248|NCT00128206|617693482|FG001|Overall Study|Lost to Follow-up|118|||
170605928|NCT00812565|616562207|FG004|Overall Study|Reason Not Specified|0|||
170605929|NCT00812565|616562208|FG005|Overall Study|Reason Not Specified|1|||
170652762|NCT04214288|616743273|FG001|Overall Study|Protocol Violation|1|||
170915249|NCT00128206|617693481|FG000|Overall Study|Adverse Event|0|||
170915250|NCT00128206|617693482|FG001|Overall Study|Adverse Event|2|||
170652763|NCT04214288|616743274|FG002|Overall Study|Protocol Violation|0|||
170652764|NCT04214288|616743275|FG003|Overall Study|Protocol Violation|0|||
170652765|NCT04214288|616743272|FG000|Overall Study|Withdrawal by Subject|8|||
170652766|NCT04214288|616743273|FG001|Overall Study|Withdrawal by Subject|4|||
170652767|NCT04214288|616743274|FG002|Overall Study|Withdrawal by Subject|0|||
170652768|NCT04214288|616743275|FG003|Overall Study|Withdrawal by Subject|9|||
170652769|NCT01487577|616743286|FG000|Overall Study|Became ineligible after signing consent|1|||
170652770|NCT01857310|616743287|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
170652771|NCT01857310|616743288|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
170652772|NCT01117792|616743291|FG000|Overall Study|Death|1|||
170652773|NCT01117792|616743291|FG000|Overall Study|Adverse Event|3|||
170652774|NCT05867342|616743292|FG000|Overall Study|Investigator Decision|3|||
170652775|NCT05867342|616743293|FG001|Overall Study|Investigator Decision|3|||
170652776|NCT01966432|616743297|FG000|Overall Study|Lost to Follow-up|3|||
170652777|NCT01966432|616743298|FG001|Overall Study|Lost to Follow-up|2|||
170652778|NCT01966432|616743299|FG002|Overall Study|Lost to Follow-up|5|||
170652779|NCT01966432|616743297|FG000|Overall Study|Withdrawal by Subject|1|||
170652780|NCT01966432|616743298|FG001|Overall Study|Withdrawal by Subject|3|||
170652781|NCT01966432|616743299|FG002|Overall Study|Withdrawal by Subject|0|||
170652782|NCT01966432|616743297|FG000|Overall Study|Subject Incarcerated|0|||
170652783|NCT01966432|616743298|FG001|Overall Study|Subject Incarcerated|0|||
170652784|NCT01966432|616743299|FG002|Overall Study|Subject Incarcerated|1|||
170652785|NCT01966432|616743297|FG000|Overall Study|SBIRT program ended|1|||
170652786|NCT01966432|616743298|FG001|Overall Study|SBIRT program ended|8|||
170652787|NCT01966432|616743299|FG002|Overall Study|SBIRT program ended|20|||
170652788|NCT01055496|616743300|FG000|Overall Study|Withdrawal by Subject|2|||
170652789|NCT01055496|616743301|FG001|Overall Study|Withdrawal by Subject|4|||
170652790|NCT01055496|616743300|FG000|Overall Study|Death|13|||
170652791|NCT01055496|616743301|FG001|Overall Study|Death|23|||
170652792|NCT01055496|616743300|FG000|Overall Study|Lost to Follow-up|0|||
170652793|NCT01055496|616743301|FG001|Overall Study|Lost to Follow-up|2|||
170652794|NCT01055496|616743300|FG000|Overall Study|Other - Unspecified|0|||
170652795|NCT01055496|616743301|FG001|Overall Study|Other - Unspecified|1|||
170652796|NCT00584740|616743302|FG000|Overall Study|Adverse Event|1|||
170652797|NCT00584740|616743303|FG001|Overall Study|Adverse Event|1|||
170652798|NCT00584740|616743302|FG000|Overall Study|Lack of Efficacy|8|||
170652799|NCT00584740|616743303|FG001|Overall Study|Lack of Efficacy|2|||
170652800|NCT00584740|616743302|FG000|Overall Study|Withdrawal by Subject|3|||
170652801|NCT00584740|616743303|FG001|Overall Study|Withdrawal by Subject|2|||
170652802|NCT00584740|616743302|FG000|Overall Study|Lost to Follow-up|0|||
170652803|NCT00584740|616743303|FG001|Overall Study|Lost to Follow-up|1|||
170652804|NCT04973137|616743312|FG000|Double Blind Phase|Adverse Event|4|||
170652805|NCT04973137|616743313|FG001|Double Blind Phase|Adverse Event|0|||
170652806|NCT04973137|616743312|FG000|Double Blind Phase|Death|25|||
170652807|NCT04973137|616743313|FG001|Double Blind Phase|Death|15|||
170814922|NCT00813709|617331394|FG004|Open Label Period|Other|5|||
170814923|NCT00813709|617331395|FG005|Open Label Period|Other|6|||
170814924|NCT01655498|617331396|FG000|Overall Study|Unrelated health issue|2|||
170814925|NCT01655498|617331396|FG000|Overall Study|Protocol Violation|2|||
170814926|NCT01655498|617331396|FG000|Overall Study|Withdrawal by Subject|1|||
170814927|NCT01540474|617331397|FG000|Vaccination Period|Lost to Follow-up|0|||
170814928|NCT01540474|617331398|FG001|Vaccination Period|Lost to Follow-up|1|||
170814929|NCT01540474|617331399|FG002|Vaccination Period|Lost to Follow-up|0|||
170814930|NCT01540474|617331400|FG003|Vaccination Period|Lost to Follow-up|0|||
170814931|NCT00857311|617331401|FG000|Overall Study|Lost to Follow-up|1|||
170814932|NCT00857311|617331402|FG001|Overall Study|Lost to Follow-up|0|||
170814933|NCT00857311|617331403|FG002|Overall Study|Lost to Follow-up|0|||
170814934|NCT00857311|617331404|FG003|Overall Study|Lost to Follow-up|0|||
170814935|NCT01587703|617331405|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
170814936|NCT01587703|617331406|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814937|NCT01587703|617331407|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814938|NCT01587703|617331408|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814939|NCT01587703|617331409|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814940|NCT01587703|617331410|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814941|NCT01587703|617331411|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814942|NCT01587703|617331412|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814943|NCT01587703|617331413|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814944|NCT01587703|617331414|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170915251|NCT01597622|617693483|FG000|Overall Study|Adverse Event|7|||
170652808|NCT04973137|616743312|FG000|Double Blind Phase|Physician Decision|5|||
170652809|NCT04973137|616743313|FG001|Double Blind Phase|Physician Decision|1|||
170652810|NCT04973137|616743312|FG000|Double Blind Phase|Withdrawal by Subject|6|||
170652811|NCT04973137|616743313|FG001|Double Blind Phase|Withdrawal by Subject|1|||
170652812|NCT04973137|616743312|FG000|Double Blind Phase|Other|2|||
170652813|NCT04973137|616743313|FG001|Double Blind Phase|Other|2|||
170652814|NCT04973137|616743312|FG000|Open Label Extension Phase|Death|3|||
170915252|NCT01597622|617693483|FG000|Overall Study|Lack of Efficacy|3|||
170915253|NCT01597622|617693483|FG000|Overall Study|Protocol Violation|1|||
170915254|NCT01597622|617693483|FG000|Overall Study|Lost to Follow-up|1|||
170915255|NCT01597622|617693483|FG000|Overall Study|Investigator Discretion|5|||
170915256|NCT01597622|617693483|FG000|Overall Study|Withdrawal by Subject|20|||
170915257|NCT01597622|617693483|FG000|Overall Study|Death|1|||
170915258|NCT00521339|617693487|FG000|Treatment Phase|Adverse Event|2|||
170915259|NCT00521339|617693488|FG001|Treatment Phase|Adverse Event|0|||
170915260|NCT00521339|617693489|FG002|Treatment Phase|Adverse Event|0|||
170915261|NCT00521339|617693487|FG000|Treatment Phase|Intolerability to study drug|2|||
170915262|NCT00521339|617693488|FG001|Treatment Phase|Intolerability to study drug|0|||
170915263|NCT00521339|617693489|FG002|Treatment Phase|Intolerability to study drug|0|||
170915264|NCT00521339|617693487|FG000|Treatment Phase|Lack of Efficacy|3|||
170915265|NCT00521339|617693488|FG001|Treatment Phase|Lack of Efficacy|0|||
170915266|NCT00521339|617693489|FG002|Treatment Phase|Lack of Efficacy|0|||
170915267|NCT00521339|617693487|FG000|Treatment Phase|Withdrawal by Subject|3|||
170915268|NCT00521339|617693488|FG001|Treatment Phase|Withdrawal by Subject|0|||
170915269|NCT00521339|617693489|FG002|Treatment Phase|Withdrawal by Subject|0|||
170915270|NCT00521339|617693487|FG000|Treatment Phase|Lost to Follow-up|1|||
170915271|NCT00521339|617693488|FG001|Treatment Phase|Lost to Follow-up|0|||
170915272|NCT00521339|617693489|FG002|Treatment Phase|Lost to Follow-up|0|||
170915273|NCT00521339|617693487|FG000|Treatment Phase|Protocol Violation|1|||
170915274|NCT00521339|617693488|FG001|Treatment Phase|Protocol Violation|0|||
170915275|NCT00521339|617693489|FG002|Treatment Phase|Protocol Violation|0|||
170915276|NCT00521339|617693487|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
170915277|NCT00521339|617693488|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
170915278|NCT00521339|617693489|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
170915279|NCT00521339|617693487|FG000|Treatment Extension Phase|Death|0|||
170915280|NCT00521339|617693488|FG001|Treatment Extension Phase|Death|0|||
170915281|NCT00521339|617693489|FG002|Treatment Extension Phase|Death|1|||
170915282|NCT01988012|617693490|FG000|Overall Study|Adverse Event|5|||
170915283|NCT01988012|617693490|FG000|Overall Study|Insufficient Therapeutic Response|3|||
170915284|NCT01988012|617693490|FG000|Overall Study|Patient Withdrawal of Consent|4|||
170915285|NCT01988012|617693490|FG000|Overall Study|Lost to Follow-up|1|||
170915286|NCT01988012|617693490|FG000|Overall Study|Physician Decision|1|||
170915287|NCT01988012|617693490|FG000|Overall Study|Protocol Violation|1|||
170915288|NCT02115815|617693495|FG000|Overall Study|Withdrawal by Subject|2|||
170915289|NCT02115815|617693496|FG001|Overall Study|Withdrawal by Subject|0|||
170915290|NCT02115815|617693497|FG002|Overall Study|Withdrawal by Subject|0|||
170915291|NCT02115815|617693498|FG003|Overall Study|Withdrawal by Subject|0|||
170915292|NCT02115815|617693499|FG004|Overall Study|Withdrawal by Subject|0|||
170915293|NCT02115815|617693500|FG005|Overall Study|Withdrawal by Subject|0|||
170915294|NCT02115815|617693501|FG006|Overall Study|Withdrawal by Subject|0|||
170915295|NCT02115815|617693495|FG000|Overall Study|Not enough drug to dose participant|0|||
170915296|NCT02115815|617693496|FG001|Overall Study|Not enough drug to dose participant|0|||
170915297|NCT02115815|617693497|FG002|Overall Study|Not enough drug to dose participant|0|||
170915298|NCT02115815|617693498|FG003|Overall Study|Not enough drug to dose participant|0|||
170915299|NCT02115815|617693499|FG004|Overall Study|Not enough drug to dose participant|0|||
170915300|NCT02115815|617693500|FG005|Overall Study|Not enough drug to dose participant|1|||
170605930|NCT00812565|616562209|FG006|Overall Study|Reason Not Specified|0|||
170605931|NCT00812565|616562210|FG007|Overall Study|Reason Not Specified|0|||
170605932|NCT00687531|616562213|FG000|Overall Study|Did not meet protocol eligibility|104|||
170605933|NCT00687531|616562213|FG000|Overall Study|Adverse Event|5|||
170605934|NCT00687531|616562213|FG000|Overall Study|Lost to Follow-up|26|||
170605935|NCT02353728|616562214|FG000|Overall Study|Subject non-compliance|1|||
170605936|NCT00801229|616563627|FG000|Signed Consent|Withdrawal by Subject|2|||
170605937|NCT00801229|616563628|FG001|Signed Consent|Withdrawal by Subject|2|||
170605938|NCT00801229|616563627|FG000|Signed Consent|Found Ineligible|1|||
170605939|NCT00801229|616563628|FG001|Signed Consent|Found Ineligible|1|||
170652815|NCT04973137|616743313|FG001|Open Label Extension Phase|Death|0|||
170652816|NCT04973137|616743312|FG000|Open Label Extension Phase|Physician Decision|0|||
170915301|NCT02115815|617693501|FG006|Overall Study|Not enough drug to dose participant|0|||
170915302|NCT02115815|617693495|FG000|Overall Study|Missed appointment, randomized in error|0|||
170915303|NCT02115815|617693496|FG001|Overall Study|Missed appointment, randomized in error|0|||
170915304|NCT02115815|617693497|FG002|Overall Study|Missed appointment, randomized in error|0|||
170915305|NCT02115815|617693498|FG003|Overall Study|Missed appointment, randomized in error|0|||
170915306|NCT02115815|617693499|FG004|Overall Study|Missed appointment, randomized in error|0|||
170915307|NCT02115815|617693500|FG005|Overall Study|Missed appointment, randomized in error|1|||
170915308|NCT02115815|617693501|FG006|Overall Study|Missed appointment, randomized in error|0|||
170915309|NCT01228071|617693502|FG000|Overall Study|Protocol Violation|1|||
170915310|NCT01228071|617693502|FG000|Overall Study|Withdrawal by Subject|1|||
170605940|NCT00801229|616563627|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
170605941|NCT00801229|616563628|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
170605942|NCT00801229|616563627|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
170605943|NCT00801229|616563628|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
170915311|NCT02819310|617693503|FG000|Overall Study|Withdrawal by Subject|37|||
170915312|NCT02819310|617693503|FG000|Overall Study|Lost to Follow-up|16|||
170915313|NCT02819310|617693503|FG000|Overall Study|Adverse Event|13|||
170915314|NCT02819310|617693503|FG000|Overall Study|Lack of Efficacy|5|||
170915315|NCT02819310|617693503|FG000|Overall Study|Physician Decision|8|||
170915316|NCT02819310|617693503|FG000|Overall Study|Protocol Violation|30|||
170915317|NCT04003155|617693508|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
170915318|NCT04003155|617693509|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
170915319|NCT04003155|617693510|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
170915320|NCT04003155|617693511|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
170915321|NCT04003155|617693512|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
170915322|NCT04003155|617693508|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
170915323|NCT04003155|617693509|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
170915324|NCT04003155|617693510|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
170915325|NCT04003155|617693511|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
170915326|NCT04003155|617693512|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
170915327|NCT04003155|617693508|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
170915328|NCT04003155|617693509|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
170915329|NCT04003155|617693510|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
170915330|NCT04003155|617693511|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
170915331|NCT04003155|617693512|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
170915332|NCT04003155|617693508|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
170915333|NCT04003155|617693509|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
170915334|NCT04003155|617693510|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
170915335|NCT04003155|617693511|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
170915336|NCT04003155|617693512|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
170915337|NCT04003155|617693508|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
170915338|NCT04003155|617693509|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
170915339|NCT04003155|617693510|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
170915340|NCT04003155|617693511|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
170915341|NCT04003155|617693512|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
170915342|NCT04003155|617693508|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
170915343|NCT04003155|617693509|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
170915344|NCT04003155|617693510|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
170915345|NCT04003155|617693511|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
170915346|NCT04003155|617693512|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
170915347|NCT04003155|617693508|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
170915348|NCT04003155|617693509|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
170915349|NCT04003155|617693510|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
170915350|NCT04003155|617693511|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
170915351|NCT04003155|617693512|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
170915352|NCT04003155|617693508|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
170915353|NCT04003155|617693509|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
170915354|NCT04003155|617693510|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
170915355|NCT04003155|617693511|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
170915356|NCT04003155|617693512|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
170915357|NCT04003155|617693508|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
170915358|NCT04003155|617693509|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
170915359|NCT04003155|617693510|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
170915360|NCT04003155|617693511|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
170915361|NCT04003155|617693512|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
170915362|NCT02345161|617693516|FG000|Overall Study|Withdrawal by Subject|25|||
170915363|NCT02345161|617693517|FG001|Overall Study|Withdrawal by Subject|33|||
170915364|NCT02345161|617693516|FG000|Overall Study|Adverse Event|16|||
170915365|NCT02345161|617693517|FG001|Overall Study|Adverse Event|19|||
170915366|NCT02345161|617693516|FG000|Overall Study|Physician Decision|4|||
170915367|NCT02345161|617693517|FG001|Overall Study|Physician Decision|4|||
170915368|NCT02345161|617693516|FG000|Overall Study|Lost to Follow-up|0|||
170915369|NCT02345161|617693517|FG001|Overall Study|Lost to Follow-up|1|||
170915370|NCT02225223|617693519|FG000|Overall Study|Death|10|||
170915371|NCT02225223|617693520|FG001|Overall Study|Death|1|||
170605944|NCT00801229|616563627|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
170605945|NCT00801229|616563628|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
170915372|NCT02225223|617693519|FG000|Overall Study|Lost to Follow-up|5|||
170915373|NCT02225223|617693520|FG001|Overall Study|Lost to Follow-up|0|||
170915374|NCT02225223|617693519|FG000|Overall Study|Other|1|||
170915375|NCT02225223|617693520|FG001|Overall Study|Other|2|||
170915376|NCT02225223|617693519|FG000|Overall Study|Physician Decision|1|||
170915377|NCT02225223|617693520|FG001|Overall Study|Physician Decision|0|||
170915378|NCT02225223|617693519|FG000|Overall Study|Withdrawal by Subject|2|||
170605946|NCT00801229|616563627|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
170915379|NCT02225223|617693520|FG001|Overall Study|Withdrawal by Subject|2|||
170915380|NCT03666143|617693521|FG000|Overall Study|Death|158|||
170915381|NCT03666143|617693521|FG000|Overall Study|Sponsor Decision|31|||
170915382|NCT03666143|617693521|FG000|Overall Study|Withdrawal by Subject|11|||
170915383|NCT03666143|617693521|FG000|Overall Study|Lost to Follow-up|5|||
170915384|NCT03666143|617693521|FG000|Overall Study|Physician Decision|1|||
170915385|NCT03666143|617693521|FG000|Overall Study|Rolled into extension study|9|||
170915386|NCT03666143|617693521|FG000|Overall Study|Progressive Disease|1|||
170915387|NCT03554005|617693522|FG000|Overall Study|Not in participant's best interest|0|||
170915388|NCT03554005|617693523|FG001|Overall Study|Not in participant's best interest|0|||
170915389|NCT03554005|617693524|FG002|Overall Study|Not in participant's best interest|0|||
170915390|NCT03554005|617693525|FG003|Overall Study|Not in participant's best interest|0|||
170915391|NCT03554005|617693526|FG004|Overall Study|Not in participant's best interest|0|||
170915392|NCT03554005|617693527|FG005|Overall Study|Not in participant's best interest|1|||
170915393|NCT03554005|617693522|FG000|Overall Study|Disease Progression|1|||
170915394|NCT03554005|617693523|FG001|Overall Study|Disease Progression|1|||
170915395|NCT03554005|617693524|FG002|Overall Study|Disease Progression|1|||
170915396|NCT03554005|617693525|FG003|Overall Study|Disease Progression|1|||
170915397|NCT03554005|617693526|FG004|Overall Study|Disease Progression|5|||
170915398|NCT03554005|617693527|FG005|Overall Study|Disease Progression|6|||
170915399|NCT03554005|617693522|FG000|Overall Study|Adverse Event|0|||
170915400|NCT03554005|617693523|FG001|Overall Study|Adverse Event|0|||
170915401|NCT03554005|617693524|FG002|Overall Study|Adverse Event|0|||
170915402|NCT03554005|617693525|FG003|Overall Study|Adverse Event|0|||
170605947|NCT00801229|616563628|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
170605948|NCT00801229|616563627|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
170605949|NCT00801229|616563628|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
170605950|NCT00801229|616563627|FG000|Received Study Drug/Placebo|Adverse Event|1|||
170605951|NCT00801229|616563628|FG001|Received Study Drug/Placebo|Adverse Event|1|||
170605952|NCT02300259|616563631|FG000|Period 1|Adverse Event|0|||
170605953|NCT02300259|616563632|FG001|Period 1|Adverse Event|0|||
170915403|NCT03554005|617693526|FG004|Overall Study|Adverse Event|0|||
170915404|NCT03554005|617693527|FG005|Overall Study|Adverse Event|3|||
170915405|NCT03554005|617693522|FG000|Overall Study|Physician Decision|0|||
170915406|NCT03554005|617693523|FG001|Overall Study|Physician Decision|0|||
170915407|NCT03554005|617693524|FG002|Overall Study|Physician Decision|0|||
170915408|NCT03554005|617693525|FG003|Overall Study|Physician Decision|0|||
170915409|NCT03554005|617693526|FG004|Overall Study|Physician Decision|1|||
170915410|NCT03554005|617693527|FG005|Overall Study|Physician Decision|0|||
170915411|NCT03554005|617693522|FG000|Overall Study|Other|0|||
170915412|NCT03554005|617693523|FG001|Overall Study|Other|0|||
170915413|NCT03554005|617693524|FG002|Overall Study|Other|0|||
170915414|NCT03554005|617693525|FG003|Overall Study|Other|0|||
170915415|NCT03554005|617693526|FG004|Overall Study|Other|0|||
170915416|NCT03554005|617693527|FG005|Overall Study|Other|1|||
170915417|NCT00631488|617693531|FG000|Overall Study|Adverse Event|1|||
170915418|NCT00631488|617693532|FG001|Overall Study|Adverse Event|0|||
170915419|NCT00631488|617693533|FG002|Overall Study|Adverse Event|0|||
170915420|NCT00631488|617693531|FG000|Overall Study|Lost to Follow-up|2|||
170915421|NCT00631488|617693532|FG001|Overall Study|Lost to Follow-up|2|||
170915422|NCT00631488|617693533|FG002|Overall Study|Lost to Follow-up|0|||
170605954|NCT02300259|616563633|FG002|Period 1|Adverse Event|1|||
170605955|NCT02300259|616563631|FG000|Period 1|Withdrawal by Subject|0|||
170605956|NCT02300259|616563632|FG001|Period 1|Withdrawal by Subject|0|||
170605957|NCT02300259|616563633|FG002|Period 1|Withdrawal by Subject|1|||
170605958|NCT02300259|616563631|FG000|Period 2|Adverse Event|1|||
170652817|NCT04973137|616743313|FG001|Open Label Extension Phase|Physician Decision|1|||
170915423|NCT00631488|617693531|FG000|Overall Study|Physician Decision|1|||
170915424|NCT00631488|617693532|FG001|Overall Study|Physician Decision|0|||
170915425|NCT00631488|617693533|FG002|Overall Study|Physician Decision|1|||
170915426|NCT00631488|617693531|FG000|Overall Study|Protocol Violation|0|||
170915427|NCT00631488|617693532|FG001|Overall Study|Protocol Violation|0|||
170915428|NCT00631488|617693533|FG002|Overall Study|Protocol Violation|1|||
170915429|NCT00907881|617693535|FG000|Overall Study|Lost to Follow-up|59|||
170915430|NCT00907881|617693535|FG000|Overall Study|Noncompliance|5|||
170915431|NCT00907881|617693535|FG000|Overall Study|Withdrawal by Subject|5|||
170915432|NCT00907881|617693535|FG000|Overall Study|Protocol Violation|1|||
170915433|NCT00907881|617693535|FG000|Overall Study|Missing discontinuation information|15|||
170915434|NCT02546856|617693536|FG000|4 Months Evaluation|Death|2|||
170605959|NCT02300259|616563632|FG001|Period 2|Adverse Event|0|||
170605960|NCT02300259|616563633|FG002|Period 2|Adverse Event|0|||
170605961|NCT02300259|616563631|FG000|Period 2|Withdrawal by Subject|0|||
170605962|NCT02300259|616563632|FG001|Period 2|Withdrawal by Subject|0|||
170605963|NCT02300259|616563633|FG002|Period 2|Withdrawal by Subject|1|||
170605964|NCT01363661|616563634|FG000|Overall Study|Adverse Event|9|||
170915435|NCT02546856|617693537|FG001|4 Months Evaluation|Death|3|||
170915436|NCT02546856|617693536|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
170915437|NCT02546856|617693537|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
170915438|NCT02546856|617693536|FG000|4 Months Evaluation|Lost to Follow-up|3|||
170915439|NCT02546856|617693537|FG001|4 Months Evaluation|Lost to Follow-up|3|||
170915440|NCT02546856|617693536|FG000|4 Months Evaluation|Physician Decision|3|||
170915441|NCT02546856|617693537|FG001|4 Months Evaluation|Physician Decision|0|||
170915442|NCT02546856|617693536|FG000|4 Months Evaluation|Working or living abroad|5|||
170915443|NCT02546856|617693537|FG001|4 Months Evaluation|Working or living abroad|1|||
170915444|NCT02546856|617693536|FG000|4 Months Evaluation|reasons not due to titration|4|||
170915445|NCT02546856|617693537|FG001|4 Months Evaluation|reasons not due to titration|1|||
170915446|NCT02546856|617693536|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
170915447|NCT02546856|617693537|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
170915448|NCT02546856|617693536|FG000|6 Months Evaluation|Death|1|||
170915449|NCT02546856|617693537|FG001|6 Months Evaluation|Death|1|||
170915450|NCT02546856|617693536|FG000|6 Months Evaluation|Lost to Follow-up|1|||
170915451|NCT02546856|617693537|FG001|6 Months Evaluation|Lost to Follow-up|1|||
170915452|NCT02546856|617693536|FG000|6 Months Evaluation|Working or living abroad|6|||
170915453|NCT02546856|617693537|FG001|6 Months Evaluation|Working or living abroad|4|||
170915454|NCT02546856|617693536|FG000|6 Months Evaluation|reasons not due to titration|0|||
170915455|NCT02546856|617693537|FG001|6 Months Evaluation|reasons not due to titration|1|||
170652818|NCT04973137|616743312|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
170652819|NCT04973137|616743313|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
170652820|NCT04973137|616743312|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
170652821|NCT04973137|616743313|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
170652822|NCT04973137|616743312|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
170652823|NCT04973137|616743313|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
170652824|NCT01903252|616743314|FG000|Double-Blind Induction|Adverse Event|20|||
170652825|NCT01903252|616743315|FG001|Double-Blind Induction|Adverse Event|18|||
170652826|NCT01903252|616743316|FG002|Double-Blind Induction|Adverse Event|0|||
170652827|NCT01903252|616743317|FG003|Double-Blind Induction|Adverse Event|0|||
170652828|NCT01903252|616743318|FG004|Double-Blind Induction|Adverse Event|0|||
170915456|NCT00986258|617693539|FG000|Observation Period|Not eligible to be dosed|11|||
170915457|NCT00986258|617693539|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
170915458|NCT00986258|617693539|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
170915459|NCT00986258|617693539|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
170915460|NCT00986258|617693539|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
170915461|NCT00986258|617693539|FG000|Titration and Optimal Dose Period|Other|1|||
170915462|NCT00986258|617693539|FG000|Maintenance Period|Adverse Event|5|||
170915463|NCT00986258|617693539|FG000|Maintenance Period|Lack of Efficacy|2|||
170915464|NCT00986258|617693539|FG000|Maintenance Period|Withdrawal by Subject|2|||
170915465|NCT01372878|617693540|FG000|Overall Study|Withdrawal by Subject|63|||
170915466|NCT01372878|617693540|FG000|Overall Study|Protocol Violation|17|||
170915467|NCT01372878|617693540|FG000|Overall Study|incomplete study procedure|104|||
170915468|NCT03332667|617693541|FG000|Overall Study|Adverse Event|0|||
170915469|NCT03332667|617693542|FG001|Overall Study|Adverse Event|0|||
170915470|NCT03332667|617693543|FG002|Overall Study|Adverse Event|2|||
170915471|NCT03332667|617693544|FG003|Overall Study|Adverse Event|1|||
170915472|NCT03332667|617693541|FG000|Overall Study|Withdrawal by Subject|2|||
170915473|NCT03332667|617693542|FG001|Overall Study|Withdrawal by Subject|1|||
170915474|NCT03332667|617693543|FG002|Overall Study|Withdrawal by Subject|5|||
170915475|NCT03332667|617693544|FG003|Overall Study|Withdrawal by Subject|1|||
170915476|NCT03332667|617693541|FG000|Overall Study|Disease Progression or Relapse|2|||
170652829|NCT01903252|616743319|FG005|Double-Blind Induction|Adverse Event|0|||
170652830|NCT01903252|616743314|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
170652831|NCT01903252|616743315|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
170915477|NCT03332667|617693542|FG001|Overall Study|Disease Progression or Relapse|1|||
170915478|NCT03332667|617693543|FG002|Overall Study|Disease Progression or Relapse|3|||
170915479|NCT03332667|617693544|FG003|Overall Study|Disease Progression or Relapse|0|||
170915480|NCT03332667|617693541|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
170915481|NCT03332667|617693542|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
170915482|NCT03332667|617693543|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
170915483|NCT03332667|617693544|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
170915484|NCT03332667|617693541|FG000|Overall Study|No Treatment Received|0|||
170915485|NCT03332667|617693542|FG001|Overall Study|No Treatment Received|0|||
170915486|NCT03332667|617693543|FG002|Overall Study|No Treatment Received|1|||
170652832|NCT01903252|616743316|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
170652833|NCT01903252|616743317|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
170652834|NCT01903252|616743318|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
170652835|NCT01903252|616743319|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
170915487|NCT03332667|617693544|FG003|Overall Study|No Treatment Received|0|||
170915488|NCT02616029|617693545|FG000|Overall Study|Adverse Event|1|||
170915489|NCT02616029|617693546|FG001|Overall Study|Adverse Event|0|||
170915490|NCT02616029|617693545|FG000|Overall Study|Death|0|||
170915491|NCT02616029|617693546|FG001|Overall Study|Death|1|||
170605965|NCT01363661|616563635|FG001|Overall Study|Adverse Event|2|||
170605966|NCT01363661|616563634|FG000|Overall Study|Withdrawal by Subject|1|||
170605967|NCT01363661|616563635|FG001|Overall Study|Withdrawal by Subject|1|||
170605968|NCT01363661|616563634|FG000|Overall Study|Protocol Violation|1|||
170605969|NCT01363661|616563635|FG001|Overall Study|Protocol Violation|0|||
170605970|NCT01363661|616563634|FG000|Overall Study|Lost to Follow-up|3|||
170605971|NCT01363661|616563635|FG001|Overall Study|Lost to Follow-up|1|||
170605972|NCT00705367|616563642|FG000|Long-term Extension Period|Adverse Event|2|||
170605973|NCT00705367|616563643|FG001|Long-term Extension Period|Adverse Event|0|||
170605974|NCT00705367|616563642|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
170605975|NCT00705367|616563643|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
170605976|NCT00705367|616563642|FG000|Long-term Extension Period|Lack of Efficacy|1|||
170605977|NCT00705367|616563643|FG001|Long-term Extension Period|Lack of Efficacy|0|||
170605978|NCT00705367|616563642|FG000|Long-term Extension Period|No longer met study criteria|1|||
170605979|NCT00705367|616563643|FG001|Long-term Extension Period|No longer met study criteria|0|||
170605980|NCT00705367|616563642|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
170605981|NCT00705367|616563643|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
170605982|NCT01504841|616563644|FG000|Overall Study|Withdrawal by Subject|1|||
170605983|NCT01504841|616563645|FG001|Overall Study|Withdrawal by Subject|1|||
170605984|NCT01504841|616563646|FG002|Overall Study|Withdrawal by Subject|0|||
170605985|NCT01959139|616563647|FG000|Phase II|Disease progression|0|||
170605986|NCT01959139|616563648|FG001|Phase II|Disease progression|0|||
170605987|NCT01959139|616563649|FG002|Phase II|Disease progression|26|||
170605988|NCT01959139|616563650|FG003|Phase II|Disease progression|34|||
170605989|NCT01959139|616563647|FG000|Phase II|Adverse Event|0|||
170605990|NCT01959139|616563648|FG001|Phase II|Adverse Event|0|||
170605991|NCT01959139|616563649|FG002|Phase II|Adverse Event|10|||
170605992|NCT01959139|616563650|FG003|Phase II|Adverse Event|11|||
170605993|NCT01959139|616563647|FG000|Phase II|Patient Refusal|0|||
170605994|NCT01959139|616563648|FG001|Phase II|Patient Refusal|0|||
170605995|NCT01959139|616563649|FG002|Phase II|Patient Refusal|5|||
170605996|NCT01959139|616563650|FG003|Phase II|Patient Refusal|4|||
170605997|NCT01959139|616563647|FG000|Phase II|Death|0|||
170605998|NCT01959139|616563648|FG001|Phase II|Death|0|||
170605999|NCT01959139|616563649|FG002|Phase II|Death|3|||
170606000|NCT01959139|616563650|FG003|Phase II|Death|1|||
170606001|NCT01959139|616563647|FG000|Phase II|Other/Unknown|0|||
170606002|NCT01959139|616563648|FG001|Phase II|Other/Unknown|0|||
170606003|NCT01959139|616563649|FG002|Phase II|Other/Unknown|8|||
170606004|NCT01959139|616563650|FG003|Phase II|Other/Unknown|5|||
170606005|NCT01959139|616563647|FG000|Phase II|On treatment|0|||
170606006|NCT01959139|616563648|FG001|Phase II|On treatment|0|||
170606007|NCT01959139|616563649|FG002|Phase II|On treatment|4|||
170606008|NCT01959139|616563650|FG003|Phase II|On treatment|0|||
170606009|NCT03149055|616563655|FG000|Overall Study|Not treated|4|||
170606010|NCT04440813|616563656|FG000|Overall Study|Lost to Follow-up|5|||
170606011|NCT04440813|616563657|FG001|Overall Study|Lost to Follow-up|5|||
170606012|NCT00891228|616563660|FG000|Overall Study|Adverse Event|0|||
170606013|NCT00891228|616563661|FG001|Overall Study|Adverse Event|2|||
170606014|NCT00891228|616563662|FG002|Overall Study|Adverse Event|3|||
170606015|NCT00891228|616563660|FG000|Overall Study|Withdrawal by Subject|2|||
170606016|NCT00891228|616563661|FG001|Overall Study|Withdrawal by Subject|4|||
170606017|NCT00891228|616563662|FG002|Overall Study|Withdrawal by Subject|5|||
170606018|NCT00891228|616563660|FG000|Overall Study|Protocol Violation|3|||
170606019|NCT00891228|616563661|FG001|Overall Study|Protocol Violation|1|||
170606020|NCT00891228|616563662|FG002|Overall Study|Protocol Violation|2|||
170814945|NCT01587703|617331415|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814946|NCT01587703|617331416|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814947|NCT01587703|617331417|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814948|NCT01587703|617331418|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814949|NCT01587703|617331419|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814950|NCT01587703|617331420|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814951|NCT01587703|617331421|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814952|NCT01587703|617331422|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814953|NCT01587703|617331423|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
170814954|NCT01587703|617331405|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170606021|NCT00891228|616563660|FG000|Overall Study|Physician Decision|2|||
170606022|NCT00891228|616563661|FG001|Overall Study|Physician Decision|1|||
170606023|NCT00891228|616563662|FG002|Overall Study|Physician Decision|0|||
170606024|NCT00891228|616563660|FG000|Overall Study|Lost to Follow-up|4|||
170606025|NCT00891228|616563661|FG001|Overall Study|Lost to Follow-up|4|||
170606026|NCT00891228|616563662|FG002|Overall Study|Lost to Follow-up|5|||
170606027|NCT00891228|616563660|FG000|Overall Study|Pregnancy|0|||
170606028|NCT00891228|616563661|FG001|Overall Study|Pregnancy|1|||
170606029|NCT00891228|616563662|FG002|Overall Study|Pregnancy|0|||
170606030|NCT02688985|616563671|FG000|Overall Study|Adverse Event|1|||
170606031|NCT02688985|616563672|FG001|Overall Study|Adverse Event|2|||
170606032|NCT02688985|616563673|FG002|Overall Study|Adverse Event|2|||
170606033|NCT02688985|616563674|FG003|Overall Study|Adverse Event|0|||
170606034|NCT02688985|616563675|FG004|Overall Study|Adverse Event|0|||
170606035|NCT02688985|616563671|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
170606036|NCT02688985|616563672|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
170606037|NCT02688985|616563673|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
170606038|NCT02688985|616563674|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
170606039|NCT02688985|616563675|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
170606040|NCT02688985|616563671|FG000|Overall Study|Death|0|||
170606041|NCT02688985|616563672|FG001|Overall Study|Death|0|||
170606042|NCT02688985|616563673|FG002|Overall Study|Death|0|||
170606043|NCT02688985|616563674|FG003|Overall Study|Death|0|||
170606044|NCT02688985|616563675|FG004|Overall Study|Death|1|||
170606045|NCT02688985|616563671|FG000|Overall Study|Lack of Efficacy|0|||
170606046|NCT02688985|616563672|FG001|Overall Study|Lack of Efficacy|0|||
170606047|NCT02688985|616563673|FG002|Overall Study|Lack of Efficacy|0|||
170606048|NCT02688985|616563674|FG003|Overall Study|Lack of Efficacy|0|||
170606049|NCT02688985|616563675|FG004|Overall Study|Lack of Efficacy|1|||
170606050|NCT02688985|616563671|FG000|Overall Study|Lost to Follow-up|2|||
170606051|NCT02688985|616563672|FG001|Overall Study|Lost to Follow-up|0|||
170606052|NCT02688985|616563673|FG002|Overall Study|Lost to Follow-up|1|||
170606053|NCT02688985|616563674|FG003|Overall Study|Lost to Follow-up|1|||
170606054|NCT02688985|616563675|FG004|Overall Study|Lost to Follow-up|1|||
170606055|NCT02688985|616563671|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170606056|NCT02688985|616563672|FG001|Overall Study|Non-Compliance With Study Drug|3|||
170606057|NCT02688985|616563673|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170606058|NCT02688985|616563674|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170606059|NCT02688985|616563675|FG004|Overall Study|Non-Compliance With Study Drug|1|||
170606060|NCT02688985|616563671|FG000|Overall Study|Other|3|||
170606061|NCT02688985|616563672|FG001|Overall Study|Other|4|||
170606062|NCT02688985|616563673|FG002|Overall Study|Other|1|||
170606063|NCT02688985|616563674|FG003|Overall Study|Other|0|||
170606064|NCT02688985|616563675|FG004|Overall Study|Other|0|||
170606065|NCT02688985|616563671|FG000|Overall Study|Physician Decision|2|||
170606066|NCT02688985|616563672|FG001|Overall Study|Physician Decision|2|||
170606067|NCT02688985|616563673|FG002|Overall Study|Physician Decision|0|||
170606068|NCT02688985|616563674|FG003|Overall Study|Physician Decision|0|||
170606069|NCT02688985|616563675|FG004|Overall Study|Physician Decision|1|||
170606070|NCT02688985|616563671|FG000|Overall Study|Pregnancy|0|||
170606071|NCT02688985|616563672|FG001|Overall Study|Pregnancy|0|||
170606072|NCT02688985|616563673|FG002|Overall Study|Pregnancy|2|||
170606073|NCT02688985|616563674|FG003|Overall Study|Pregnancy|1|||
170606074|NCT02688985|616563675|FG004|Overall Study|Pregnancy|0|||
170606075|NCT02688985|616563671|FG000|Overall Study|Study Terminated By Sponsor|0|||
170606076|NCT02688985|616563672|FG001|Overall Study|Study Terminated By Sponsor|0|||
170606077|NCT02688985|616563673|FG002|Overall Study|Study Terminated By Sponsor|0|||
170606078|NCT02688985|616563674|FG003|Overall Study|Study Terminated By Sponsor|1|||
170606079|NCT02688985|616563675|FG004|Overall Study|Study Terminated By Sponsor|0|||
170606080|NCT02688985|616563671|FG000|Overall Study|Withdrawal by Subject|2|||
170606081|NCT02688985|616563672|FG001|Overall Study|Withdrawal by Subject|8|||
170606082|NCT02688985|616563673|FG002|Overall Study|Withdrawal by Subject|7|||
170606083|NCT02688985|616563674|FG003|Overall Study|Withdrawal by Subject|1|||
170606084|NCT02688985|616563675|FG004|Overall Study|Withdrawal by Subject|4|||
170606085|NCT01964963|616563678|FG000|Overall Study|Case Report Forms Uncollected|888|||
170606086|NCT01964963|616563678|FG000|Overall Study|Protocol Deviation|50|||
170606087|NCT01964963|616563678|FG000|Overall Study|Data Reliability was not Assured|5|||
170606088|NCT03704688|616563679|FG000|Overall Study|Adverse Event|0|||
170606089|NCT03704688|616563680|FG001|Overall Study|Adverse Event|0|||
170606090|NCT03704688|616563681|FG002|Overall Study|Adverse Event|0|||
170606091|NCT03704688|616563682|FG003|Overall Study|Adverse Event|4|||
170606092|NCT03704688|616563683|FG004|Overall Study|Adverse Event|1|||
170606093|NCT03704688|616563684|FG005|Overall Study|Adverse Event|0|||
170606094|NCT03704688|616563679|FG000|Overall Study|Disease Progression|0|||
170606095|NCT03704688|616563680|FG001|Overall Study|Disease Progression|0|||
170606096|NCT03704688|616563681|FG002|Overall Study|Disease Progression|0|||
170606097|NCT03704688|616563682|FG003|Overall Study|Disease Progression|3|||
170606098|NCT03704688|616563683|FG004|Overall Study|Disease Progression|1|||
170606099|NCT03704688|616563684|FG005|Overall Study|Disease Progression|0|||
170606100|NCT03704688|616563679|FG000|Overall Study|Death|0|||
170606101|NCT03704688|616563680|FG001|Overall Study|Death|0|||
170606102|NCT03704688|616563681|FG002|Overall Study|Death|0|||
170606103|NCT03704688|616563682|FG003|Overall Study|Death|0|||
170606104|NCT03704688|616563683|FG004|Overall Study|Death|3|||
170606105|NCT03704688|616563684|FG005|Overall Study|Death|0|||
170606106|NCT01832155|616563686|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
170606107|NCT01832155|616563687|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
170606108|NCT01832155|616563686|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
170606109|NCT01832155|616563687|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
170606110|NCT00787189|616563688|FG000|Overall Study|Lost to Follow-up|2|||
170915492|NCT02616029|617693545|FG000|Overall Study|Protocol Violation|1|||
170915493|NCT02616029|617693546|FG001|Overall Study|Protocol Violation|0|||
170915494|NCT02616029|617693545|FG000|Overall Study|Withdrew Consent|1|||
170915495|NCT02616029|617693546|FG001|Overall Study|Withdrew Consent|0|||
170606111|NCT00787189|616563689|FG001|Overall Study|Lost to Follow-up|2|||
170606112|NCT00847886|616563690|FG000|Overall Study|Adverse Event|0|||
170915496|NCT02616029|617693545|FG000|Overall Study|Enrolled and Never Treated|1|||
170606113|NCT00847886|616563691|FG001|Overall Study|Adverse Event|1|||
170606114|NCT01279616|616563692|FG000|Overall Study|donor could not be located|5|||
170606115|NCT01279616|616563692|FG000|Overall Study|no signs of sickle cell disease|2|||
170606116|NCT00413036|616563693|FG000|Overall Study|Adverse Event|44|||
170606117|NCT00413036|616563693|FG000|Overall Study|Lack of Efficacy|129|||
170606118|NCT00413036|616563693|FG000|Overall Study|Withdrawal by Subject|7|||
170606119|NCT00413036|616563693|FG000|Overall Study|Death|9|||
170606120|NCT00413036|616563693|FG000|Overall Study|Other|26|||
170606121|NCT00413036|616563693|FG000|Overall Study|Missing|2|||
170606122|NCT01369641|616563694|FG000|Overall Study|Withdrawal by Subject|1|||
170606123|NCT00842543|616563695|FG000|Overall Study|Withdrawal by Subject|2|||
170606124|NCT00842543|616563696|FG001|Overall Study|Withdrawal by Subject|0|||
170606125|NCT00842543|616563697|FG002|Overall Study|Withdrawal by Subject|3|||
170606126|NCT00842543|616563698|FG003|Overall Study|Withdrawal by Subject|4|||
170606127|NCT00619099|616563707|FG000|Overall Study|Progressive Disease|7|||
170606128|NCT00619099|616563708|FG001|Overall Study|Progressive Disease|5|||
170606129|NCT00619099|616563707|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
170606130|NCT00619099|616563708|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
170606131|NCT00619099|616563707|FG000|Overall Study|Adverse Event|4|||
170606132|NCT00619099|616563708|FG001|Overall Study|Adverse Event|3|||
170606133|NCT00619099|616563707|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
170606134|NCT00619099|616563708|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
170606135|NCT00619099|616563707|FG000|Overall Study|Withdrawal by Subject|10|||
170606136|NCT00619099|616563708|FG001|Overall Study|Withdrawal by Subject|2|||
170606137|NCT00619099|616563707|FG000|Overall Study|Physician Decision|9|||
170606138|NCT00619099|616563708|FG001|Overall Study|Physician Decision|6|||
170606139|NCT00084656|616563709|FG000|Overall Study|Other reasons|0|||
170606140|NCT00084656|616563710|FG001|Overall Study|Other reasons|12|||
170606141|NCT00084656|616563711|FG002|Overall Study|Other reasons|11|||
170606142|NCT00084656|616563709|FG000|Overall Study|Withdrawal by Subject|15|||
170606143|NCT00084656|616563710|FG001|Overall Study|Withdrawal by Subject|4|||
170606144|NCT00084656|616563711|FG002|Overall Study|Withdrawal by Subject|4|||
170606145|NCT00084656|616563709|FG000|Overall Study|Disease relapse|0|||
170606146|NCT00084656|616563710|FG001|Overall Study|Disease relapse|9|||
170606147|NCT00084656|616563711|FG002|Overall Study|Disease relapse|10|||
170606148|NCT00084656|616563709|FG000|Overall Study|Disease progression|9|||
170606149|NCT00084656|616563710|FG001|Overall Study|Disease progression|0|||
170606150|NCT00084656|616563711|FG002|Overall Study|Disease progression|0|||
170606151|NCT00084656|616563709|FG000|Overall Study|Lost to Follow-up|1|||
170606152|NCT00084656|616563710|FG001|Overall Study|Lost to Follow-up|0|||
170606153|NCT00084656|616563711|FG002|Overall Study|Lost to Follow-up|1|||
170606154|NCT00989781|616563712|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
170606155|NCT00989781|616563713|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
170606156|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
170606157|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
170606158|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
170606159|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
170606160|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
170606161|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
170606162|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
170606163|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
170606164|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
170606165|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
170606166|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
170606167|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
170606168|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
170915497|NCT02616029|617693546|FG001|Overall Study|Enrolled and Never Treated|1|||
170915498|NCT02385123|617693549|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
170915499|NCT04498910|617693550|FG000|Overall Study|Lost to Follow-up|0|||
170915500|NCT04498910|617693551|FG001|Overall Study|Lost to Follow-up|1|||
170606169|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
170606170|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
170606171|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
170606172|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
170915501|NCT04498910|617693550|FG000|Overall Study|Withdrawal by Subject|2|||
170915502|NCT04498910|617693551|FG001|Overall Study|Withdrawal by Subject|1|||
170606173|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
170606174|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
170606175|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
170606176|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
170606177|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
170915503|NCT04498910|617693550|FG000|Overall Study|Adverse Event|1|||
170915504|NCT04498910|617693551|FG001|Overall Study|Adverse Event|0|||
170915505|NCT01809262|617693552|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915506|NCT01809262|617693553|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915507|NCT01809262|617693554|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915508|NCT01809262|617693555|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915509|NCT01809262|617693556|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
170915510|NCT01809262|617693557|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915511|NCT01809262|617693558|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915512|NCT01809262|617693559|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915513|NCT01809262|617693560|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915514|NCT01809262|617693561|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
170915515|NCT01809262|617693552|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915516|NCT01809262|617693553|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
170915517|NCT01809262|617693554|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915518|NCT01809262|617693555|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915519|NCT01809262|617693556|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915520|NCT01809262|617693557|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915521|NCT01809262|617693558|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915522|NCT01809262|617693559|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915523|NCT01809262|617693560|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915524|NCT01809262|617693561|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
170915525|NCT02345434|617693563|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
170915526|NCT02345434|617693564|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
170915527|NCT00859898|617693565|FG000|Overall Study|Lack of Efficacy|0|||
170915528|NCT00859898|617693566|FG001|Overall Study|Lack of Efficacy|1|||
170915529|NCT00859898|617693567|FG002|Overall Study|Lack of Efficacy|1|||
170915530|NCT00859898|617693565|FG000|Overall Study|Adverse Event|4|||
170915531|NCT00859898|617693566|FG001|Overall Study|Adverse Event|9|||
170915532|NCT00859898|617693567|FG002|Overall Study|Adverse Event|8|||
170915533|NCT00859898|617693565|FG000|Overall Study|Withdrawal by Subject|11|||
170915534|NCT00859898|617693566|FG001|Overall Study|Withdrawal by Subject|8|||
170915535|NCT00859898|617693567|FG002|Overall Study|Withdrawal by Subject|11|||
170915536|NCT00859898|617693565|FG000|Overall Study|Death|0|||
170915537|NCT00859898|617693566|FG001|Overall Study|Death|0|||
170915538|NCT00859898|617693567|FG002|Overall Study|Death|1|||
170915539|NCT00859898|617693565|FG000|Overall Study|Lost to Follow-up|10|||
170915540|NCT00859898|617693566|FG001|Overall Study|Lost to Follow-up|11|||
170915541|NCT00859898|617693567|FG002|Overall Study|Lost to Follow-up|5|||
170915542|NCT00859898|617693565|FG000|Overall Study|poor/non-compliance|2|||
170915543|NCT00859898|617693566|FG001|Overall Study|poor/non-compliance|0|||
170915544|NCT00859898|617693567|FG002|Overall Study|poor/non-compliance|0|||
170915545|NCT00859898|617693565|FG000|Overall Study|No longer meets criteria|0|||
170915546|NCT00859898|617693566|FG001|Overall Study|No longer meets criteria|1|||
170915547|NCT00859898|617693567|FG002|Overall Study|No longer meets criteria|0|||
170915548|NCT00859898|617693565|FG000|Overall Study|non-specified|1|||
170915549|NCT00859898|617693566|FG001|Overall Study|non-specified|1|||
170915550|NCT00859898|617693567|FG002|Overall Study|non-specified|1|||
170915551|NCT02145156|617693568|FG000|Overall Study|No match to vaccination records|60|||
170915552|NCT02145156|617693569|FG001|Overall Study|No match to vaccination records|52|||
170915553|NCT02145156|617693570|FG002|Overall Study|No match to vaccination records|41|||
170915554|NCT00858702|617693573|FG000|Overall Study|Lack of Efficacy|1|||
170915555|NCT00858702|617693574|FG001|Overall Study|Lack of Efficacy|0|||
170915556|NCT00858702|617693573|FG000|Overall Study|Protocol Violation|1|||
170915557|NCT00858702|617693574|FG001|Overall Study|Protocol Violation|1|||
170915558|NCT00858702|617693573|FG000|Overall Study|Other|2|||
170915559|NCT00858702|617693574|FG001|Overall Study|Other|1|||
170606178|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
170915560|NCT00858702|617693573|FG000|Overall Study|Withdrawal by Subject|1|||
170915561|NCT00858702|617693574|FG001|Overall Study|Withdrawal by Subject|0|||
170915562|NCT01740440|617693577|FG000|Overall Study|Lost to Follow-up|3|||
170915563|NCT01063751|617693578|FG000|Overall Study|Censored from analyses|42|||
170915564|NCT01063751|617693578|FG000|Overall Study|Withdrawal by Subject|34|||
170915565|NCT01063751|617693578|FG000|Overall Study|Lost to Follow-up|30|||
170915566|NCT01063751|617693578|FG000|Overall Study|Death|13|||
170915567|NCT01063751|617693578|FG000|Overall Study|Sponsored Terminated Study|60|||
170915568|NCT01063751|617693578|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
170915569|NCT01063751|617693578|FG000|Overall Study|Investigator site closed|10|||
170915570|NCT01063751|617693578|FG000|Overall Study|Revision|6|||
170915571|NCT01063751|617693578|FG000|Overall Study|Physician Decision|4|||
170915572|NCT01264965|617693581|FG000|Overall Study|Withdrawal by Subject|10|||
170915573|NCT03245814|617693582|FG000|Overall Study|Lost to Follow-up|5|||
170915574|NCT03245814|617693583|FG001|Overall Study|Lost to Follow-up|8|||
170915575|NCT03245814|617693582|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
170915576|NCT03245814|617693583|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
170915577|NCT01164501|617693585|FG000|Overall Study|Not treated|2|||
170915578|NCT01164501|617693586|FG001|Overall Study|Not treated|0|||
170915579|NCT01164501|617693587|FG002|Overall Study|Not treated|1|||
170915580|NCT01164501|617693585|FG000|Overall Study|Adverse Event|18|||
170915581|NCT01164501|617693586|FG001|Overall Study|Adverse Event|4|||
170915582|NCT01164501|617693587|FG002|Overall Study|Adverse Event|21|||
170915583|NCT01164501|617693585|FG000|Overall Study|Lack of Efficacy|0|||
170915584|NCT01164501|617693586|FG001|Overall Study|Lack of Efficacy|0|||
170915585|NCT01164501|617693587|FG002|Overall Study|Lack of Efficacy|1|||
170915586|NCT01164501|617693585|FG000|Overall Study|Non compliant with protocol|1|||
170915587|NCT01164501|617693586|FG001|Overall Study|Non compliant with protocol|1|||
170915588|NCT01164501|617693587|FG002|Overall Study|Non compliant with protocol|4|||
170915589|NCT01164501|617693585|FG000|Overall Study|Lost to Follow-up|3|||
170915590|NCT01164501|617693586|FG001|Overall Study|Lost to Follow-up|0|||
170915591|NCT01164501|617693587|FG002|Overall Study|Lost to Follow-up|3|||
170915592|NCT01164501|617693585|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
170915593|NCT01164501|617693586|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
170915594|NCT01164501|617693587|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
170915595|NCT01164501|617693585|FG000|Overall Study|Other reason not defined above|9|||
170915596|NCT01164501|617693586|FG001|Overall Study|Other reason not defined above|1|||
170915597|NCT01164501|617693587|FG002|Overall Study|Other reason not defined above|4|||
170915598|NCT02116972|617693591|FG000|Overall Study|Adverse Event|4|||
170915599|NCT02116972|617693592|FG001|Overall Study|Adverse Event|4|||
170915600|NCT02116972|617693593|FG002|Overall Study|Adverse Event|1|||
170915601|NCT02116972|617693591|FG000|Overall Study|Withdrawal by Subject|1|||
170915602|NCT02116972|617693592|FG001|Overall Study|Withdrawal by Subject|1|||
170915603|NCT02116972|617693593|FG002|Overall Study|Withdrawal by Subject|5|||
170915604|NCT02116972|617693591|FG000|Overall Study|Protocol Violation|1|||
170915605|NCT02116972|617693592|FG001|Overall Study|Protocol Violation|0|||
170915606|NCT02116972|617693593|FG002|Overall Study|Protocol Violation|1|||
170915607|NCT02116972|617693591|FG000|Overall Study|Lost to Follow-up|4|||
170915608|NCT02116972|617693592|FG001|Overall Study|Lost to Follow-up|3|||
170915609|NCT02116972|617693593|FG002|Overall Study|Lost to Follow-up|1|||
170915610|NCT02116972|617693591|FG000|Overall Study|Lack of Efficacy|6|||
170915611|NCT02116972|617693592|FG001|Overall Study|Lack of Efficacy|6|||
170915612|NCT02116972|617693593|FG002|Overall Study|Lack of Efficacy|5|||
170915613|NCT02116972|617693591|FG000|Overall Study|scheduling conflicts and relocation|3|||
170915614|NCT02116972|617693592|FG001|Overall Study|scheduling conflicts and relocation|3|||
170915615|NCT02116972|617693593|FG002|Overall Study|scheduling conflicts and relocation|6|||
170915616|NCT00784784|617693594|FG000|Overall Study|Withdrawal by Subject|2|||
170915617|NCT00784784|617693595|FG001|Overall Study|Withdrawal by Subject|2|||
170915618|NCT00872898|617693596|FG000|Part Two - Double Blind|Adverse Event|4|||
170915619|NCT00872898|617693597|FG001|Part Two - Double Blind|Adverse Event|3|||
170915620|NCT00872898|617693596|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
170915621|NCT00872898|617693597|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
170915622|NCT00872898|617693596|FG000|Part Two - Double Blind|Protocol Violation|1|||
170915623|NCT00872898|617693597|FG001|Part Two - Double Blind|Protocol Violation|0|||
170915624|NCT00872898|617693596|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
170915625|NCT00872898|617693597|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
170915626|NCT00872898|617693596|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
170915627|NCT00872898|617693597|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
170915628|NCT00872898|617693596|FG000|Part Two - Double Blind|Other reasons|2|||
170915629|NCT00872898|617693597|FG001|Part Two - Double Blind|Other reasons|0|||
170915630|NCT02792777|617693598|FG000|Overall Study|Withdrawal by Subject|2|||
170606179|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
170606180|NCT01532869|616563714|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
170606181|NCT01532869|616563715|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
170915631|NCT02792777|617693599|FG001|Overall Study|Withdrawal by Subject|0|||
170915632|NCT02792777|617693598|FG000|Overall Study|Recording malfunction|2|||
170915633|NCT02792777|617693599|FG001|Overall Study|Recording malfunction|0|||
170915634|NCT02792777|617693598|FG000|Overall Study|Later determined to be ineligible|2|||
170915635|NCT02792777|617693599|FG001|Overall Study|Later determined to be ineligible|0|||
170915636|NCT02792777|617693598|FG000|Overall Study|Participant interviewed twice|1|||
170915637|NCT02792777|617693599|FG001|Overall Study|Participant interviewed twice|0|||
170915638|NCT00734929|617693601|FG000|Overall Study|Lost to Follow-up|1|||
170915639|NCT00734929|617693602|FG001|Overall Study|Lost to Follow-up|2|||
170915640|NCT00734929|617693601|FG000|Overall Study|No intervention/ screen fail|5|||
170915641|NCT00734929|617693602|FG001|Overall Study|No intervention/ screen fail|3|||
170915642|NCT04172831|617693603|FG000|Overall Study|Adverse Event|21|||
170915643|NCT04172831|617693604|FG001|Overall Study|Adverse Event|9|||
170915644|NCT04172831|617693603|FG000|Overall Study|Lack of Efficacy|2|||
170606182|NCT01532869|616563714|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
170606183|NCT01532869|616563715|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
170606184|NCT01532869|616563714|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
170606185|NCT01532869|616563715|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
170606186|NCT01532869|616563714|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
170606187|NCT01532869|616563715|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
170606188|NCT01532869|616563714|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
170606189|NCT01532869|616563715|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
170606190|NCT00820222|616563718|FG000|Overall Study|Lost to Follow-up|10|||
170606191|NCT00820222|616563719|FG001|Overall Study|Lost to Follow-up|9|||
170606192|NCT00820222|616563718|FG000|Overall Study|Withdrawal by Subject|19|||
170606193|NCT00820222|616563719|FG001|Overall Study|Withdrawal by Subject|21|||
170606194|NCT00820222|616563718|FG000|Overall Study|Physician Decision|93|||
170606195|NCT00820222|616563719|FG001|Overall Study|Physician Decision|88|||
170606196|NCT00820222|616563718|FG000|Overall Study|Sponsor Terminated Study|43|||
170606197|NCT00820222|616563719|FG001|Overall Study|Sponsor Terminated Study|65|||
170606198|NCT00820222|616563718|FG000|Overall Study|Unkown|11|||
170606199|NCT00820222|616563719|FG001|Overall Study|Unkown|7|||
170606200|NCT00590577|616563720|FG000|Overall Study|Lack of Efficacy|31|||
170606201|NCT00590577|616563721|FG001|Overall Study|Lack of Efficacy|28|||
170606202|NCT00590577|616563722|FG002|Overall Study|Lack of Efficacy|23|||
170606203|NCT00590577|616563723|FG003|Overall Study|Lack of Efficacy|45|||
170606204|NCT00590577|616563720|FG000|Overall Study|Withdrawal by Subject|23|||
170606205|NCT00590577|616563721|FG001|Overall Study|Withdrawal by Subject|28|||
170606206|NCT00590577|616563722|FG002|Overall Study|Withdrawal by Subject|30|||
170606207|NCT00590577|616563723|FG003|Overall Study|Withdrawal by Subject|26|||
170606208|NCT00590577|616563720|FG000|Overall Study|Adverse Event|10|||
170606209|NCT00590577|616563721|FG001|Overall Study|Adverse Event|10|||
170606210|NCT00590577|616563722|FG002|Overall Study|Adverse Event|13|||
170606211|NCT00590577|616563723|FG003|Overall Study|Adverse Event|11|||
170606212|NCT00590577|616563720|FG000|Overall Study|Lost to Follow-up|12|||
170606213|NCT00590577|616563721|FG001|Overall Study|Lost to Follow-up|6|||
170606214|NCT00590577|616563722|FG002|Overall Study|Lost to Follow-up|6|||
170606215|NCT00590577|616563723|FG003|Overall Study|Lost to Follow-up|9|||
170606216|NCT00590577|616563720|FG000|Overall Study|Pregnancy|0|||
170606217|NCT00590577|616563721|FG001|Overall Study|Pregnancy|1|||
170606218|NCT00590577|616563722|FG002|Overall Study|Pregnancy|0|||
170606219|NCT00590577|616563723|FG003|Overall Study|Pregnancy|0|||
170606220|NCT00590577|616563720|FG000|Overall Study|Various reasons|1|||
170606221|NCT00590577|616563721|FG001|Overall Study|Various reasons|3|||
170606222|NCT00590577|616563722|FG002|Overall Study|Various reasons|1|||
170606223|NCT00590577|616563723|FG003|Overall Study|Various reasons|2|||
170814955|NCT01587703|617331406|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814956|NCT01587703|617331407|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814957|NCT01587703|617331408|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814958|NCT01587703|617331409|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814959|NCT01587703|617331410|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
170814960|NCT01587703|617331411|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814961|NCT01587703|617331412|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
170814962|NCT01587703|617331413|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814963|NCT01587703|617331414|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814964|NCT01587703|617331415|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814965|NCT01587703|617331416|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814966|NCT01587703|617331417|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814967|NCT01587703|617331418|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814968|NCT01587703|617331419|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814969|NCT01587703|617331420|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814970|NCT01587703|617331421|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814971|NCT01587703|617331422|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814972|NCT01587703|617331423|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
170814973|NCT01587703|617331405|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814974|NCT01587703|617331406|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814975|NCT01587703|617331407|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814976|NCT01587703|617331408|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814977|NCT01587703|617331409|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814978|NCT01587703|617331410|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814979|NCT01587703|617331411|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
170606224|NCT03927404|616563725|FG000|Overall Study|Withdrawal by Subject|1|||
170606225|NCT02690714|616563728|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
170606226|NCT02690714|616563728|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
170606227|NCT00666965|616563731|FG000|Overall Study|Adverse Event|0|||
170606228|NCT00666965|616563732|FG001|Overall Study|Adverse Event|2|||
170606229|NCT00666965|616563733|FG002|Overall Study|Adverse Event|1|||
170606230|NCT00666965|616563734|FG003|Overall Study|Adverse Event|9|||
170606231|NCT00666965|616563731|FG000|Overall Study|Lack of Efficacy|1|||
170606232|NCT00666965|616563732|FG001|Overall Study|Lack of Efficacy|1|||
170606233|NCT00666965|616563733|FG002|Overall Study|Lack of Efficacy|0|||
170606234|NCT00666965|616563734|FG003|Overall Study|Lack of Efficacy|0|||
170606235|NCT00666965|616563731|FG000|Overall Study|Protocol Violation|0|||
170606236|NCT00666965|616563732|FG001|Overall Study|Protocol Violation|0|||
170606237|NCT00666965|616563733|FG002|Overall Study|Protocol Violation|0|||
170606238|NCT00666965|616563734|FG003|Overall Study|Protocol Violation|2|||
170606239|NCT00666965|616563731|FG000|Overall Study|Discontinuation criteria|2|||
170606240|NCT00666965|616563732|FG001|Overall Study|Discontinuation criteria|1|||
170606241|NCT00666965|616563733|FG002|Overall Study|Discontinuation criteria|1|||
170606242|NCT00666965|616563734|FG003|Overall Study|Discontinuation criteria|2|||
170606243|NCT00666965|616563731|FG000|Overall Study|Withdrawal by Subject|0|||
170606244|NCT00666965|616563732|FG001|Overall Study|Withdrawal by Subject|0|||
170606245|NCT00666965|616563733|FG002|Overall Study|Withdrawal by Subject|0|||
170606246|NCT00666965|616563734|FG003|Overall Study|Withdrawal by Subject|2|||
170606247|NCT02202538|616563735|FG000|Overall Study|Withdrawal by Subject|5|||
170606248|NCT02202538|616563735|FG000|Overall Study|Did not meet all inclusion criteria|2|||
170606249|NCT02202538|616563735|FG000|Overall Study|Investigator Decision|1|||
170606250|NCT04058886|616563738|FG000|Overall Study|Withdrawal by Subject|4|||
170606251|NCT04058886|616563738|FG000|Overall Study|Inadequate deafness interpreter service|1|||
170606252|NCT00699335|616563739|FG000|Overall Study|Combination of multiple reasons|176|||
170606253|NCT00699335|616563739|FG000|Overall Study|Missing data|52|||
170606254|NCT01371305|616563745|FG000|Overall Study|Adverse Event|0|||
170606255|NCT01371305|616563746|FG001|Overall Study|Adverse Event|0|||
170606256|NCT01371305|616563747|FG002|Overall Study|Adverse Event|0|||
170606257|NCT01371305|616563748|FG003|Overall Study|Adverse Event|2|||
170606258|NCT01371305|616563749|FG004|Overall Study|Adverse Event|1|||
170606259|NCT01371305|616563750|FG005|Overall Study|Adverse Event|0|||
170606260|NCT01371305|616563745|FG000|Overall Study|Study terminated by sponsor|0|||
170606261|NCT01371305|616563746|FG001|Overall Study|Study terminated by sponsor|0|||
170606262|NCT01371305|616563747|FG002|Overall Study|Study terminated by sponsor|0|||
170606263|NCT01371305|616563748|FG003|Overall Study|Study terminated by sponsor|0|||
170606264|NCT01371305|616563749|FG004|Overall Study|Study terminated by sponsor|3|||
170606265|NCT01371305|616563750|FG005|Overall Study|Study terminated by sponsor|1|||
170606266|NCT01371305|616563745|FG000|Overall Study|Subject request|0|||
170606267|NCT01371305|616563746|FG001|Overall Study|Subject request|0|||
170606268|NCT01371305|616563747|FG002|Overall Study|Subject request|0|||
170606269|NCT01371305|616563748|FG003|Overall Study|Subject request|0|||
170606270|NCT01371305|616563749|FG004|Overall Study|Subject request|0|||
170606271|NCT01371305|616563750|FG005|Overall Study|Subject request|1|||
170606272|NCT03908970|616563753|FG000|Overall Study|Adverse Event|7|||
170606273|NCT03908970|616563754|FG001|Overall Study|Adverse Event|21|||
170606274|NCT03908970|616563753|FG000|Overall Study|Physician Decision|1|||
170606275|NCT03908970|616563754|FG001|Overall Study|Physician Decision|4|||
170606276|NCT03908970|616563753|FG000|Overall Study|Withdrawal by Subject|9|||
170606277|NCT03908970|616563754|FG001|Overall Study|Withdrawal by Subject|22|||
170606278|NCT04407234|616563755|FG000|Overall Study|Adverse Event|3|||
170606279|NCT04407234|616563756|FG001|Overall Study|Adverse Event|3|||
170606280|NCT02456857|616563757|FG000|Overall Study|Disease Progression|4|||
170606281|NCT01138501|616563758|FG000|Overall Study|Protocol Violation|2|||
170606282|NCT01138501|616563758|FG000|Overall Study|Withdrawal by Subject|3|||
170606283|NCT00348309|616563759|FG000|Overall Study|Adverse Event|56|||
170606284|NCT00348309|616563760|FG001|Overall Study|Adverse Event|28|||
170606285|NCT00348309|616563761|FG002|Overall Study|Adverse Event|63|||
170606286|NCT00348309|616563759|FG000|Overall Study|Lost to Follow-up|6|||
170606287|NCT00348309|616563760|FG001|Overall Study|Lost to Follow-up|7|||
170606288|NCT00348309|616563761|FG002|Overall Study|Lost to Follow-up|4|||
170606289|NCT00348309|616563759|FG000|Overall Study|Protocol Violation|7|||
170606290|NCT00348309|616563760|FG001|Overall Study|Protocol Violation|12|||
170606291|NCT00348309|616563761|FG002|Overall Study|Protocol Violation|7|||
170606292|NCT00348309|616563759|FG000|Overall Study|Withdrawal by Subject|33|||
170606293|NCT00348309|616563760|FG001|Overall Study|Withdrawal by Subject|37|||
170606294|NCT00348309|616563761|FG002|Overall Study|Withdrawal by Subject|40|||
170606295|NCT00348309|616563759|FG000|Overall Study|Non-compliance|8|||
170606296|NCT00348309|616563760|FG001|Overall Study|Non-compliance|6|||
170606297|NCT00348309|616563761|FG002|Overall Study|Non-compliance|8|||
170606298|NCT00348309|616563759|FG000|Overall Study|Death of caregiver|1|||
170606299|NCT00348309|616563760|FG001|Overall Study|Death of caregiver|0|||
170606300|NCT00348309|616563761|FG002|Overall Study|Death of caregiver|1|||
170606301|NCT00348309|616563759|FG000|Overall Study|Lack of insight, dementia|1|||
170606302|NCT00348309|616563760|FG001|Overall Study|Lack of insight, dementia|0|||
170606303|NCT00348309|616563761|FG002|Overall Study|Lack of insight, dementia|0|||
170606304|NCT00348309|616563759|FG000|Overall Study|Wrong bottle allocated|1|||
170606305|NCT00348309|616563760|FG001|Overall Study|Wrong bottle allocated|0|||
170606306|NCT00348309|616563761|FG002|Overall Study|Wrong bottle allocated|0|||
170606307|NCT00348309|616563759|FG000|Overall Study|Caregiver sick|1|||
170606308|NCT00348309|616563760|FG001|Overall Study|Caregiver sick|0|||
170606309|NCT00348309|616563761|FG002|Overall Study|Caregiver sick|0|||
170606310|NCT00348309|616563759|FG000|Overall Study|Use of prohibited medication|5|||
170606311|NCT00348309|616563760|FG001|Overall Study|Use of prohibited medication|2|||
170606312|NCT00348309|616563761|FG002|Overall Study|Use of prohibited medication|2|||
170606313|NCT00348309|616563759|FG000|Overall Study|Caregiver withdrawal|3|||
170606314|NCT00348309|616563760|FG001|Overall Study|Caregiver withdrawal|0|||
170606315|NCT00348309|616563761|FG002|Overall Study|Caregiver withdrawal|7|||
170606316|NCT00348309|616563759|FG000|Overall Study|Unable to complete ET visit|1|||
170606317|NCT00348309|616563760|FG001|Overall Study|Unable to complete ET visit|0|||
170606318|NCT00348309|616563761|FG002|Overall Study|Unable to complete ET visit|0|||
170606319|NCT00348309|616563759|FG000|Overall Study|PI closing medical practice|1|||
170606320|NCT00348309|616563760|FG001|Overall Study|PI closing medical practice|0|||
170606321|NCT00348309|616563761|FG002|Overall Study|PI closing medical practice|0|||
170606322|NCT00348309|616563759|FG000|Overall Study|Principal investigator's decision|1|||
170606323|NCT00348309|616563760|FG001|Overall Study|Principal investigator's decision|0|||
170606324|NCT00348309|616563761|FG002|Overall Study|Principal investigator's decision|0|||
170606325|NCT00348309|616563759|FG000|Overall Study|No disponibility of medication|1|||
170606326|NCT00348309|616563760|FG001|Overall Study|No disponibility of medication|0|||
170606327|NCT00348309|616563761|FG002|Overall Study|No disponibility of medication|0|||
170606328|NCT00348309|616563759|FG000|Overall Study|Worsened neurodegenerative disease|1|||
170606329|NCT00348309|616563760|FG001|Overall Study|Worsened neurodegenerative disease|0|||
170606330|NCT00348309|616563761|FG002|Overall Study|Worsened neurodegenerative disease|0|||
170606331|NCT00348309|616563759|FG000|Overall Study|Cognitive and behaviour worsening|2|||
170606332|NCT00348309|616563760|FG001|Overall Study|Cognitive and behaviour worsening|0|||
170606333|NCT00348309|616563761|FG002|Overall Study|Cognitive and behaviour worsening|0|||
170606334|NCT00348309|616563759|FG000|Overall Study|Worsening of alzheimer|1|||
170606335|NCT00348309|616563760|FG001|Overall Study|Worsening of alzheimer|0|||
170606336|NCT00348309|616563761|FG002|Overall Study|Worsening of alzheimer|1|||
170606337|NCT00348309|616563759|FG000|Overall Study|Did not appear in time for Visit 3|1|||
170606338|NCT00348309|616563760|FG001|Overall Study|Did not appear in time for Visit 3|0|||
170606339|NCT00348309|616563761|FG002|Overall Study|Did not appear in time for Visit 3|0|||
170606340|NCT00348309|616563759|FG000|Overall Study|Participant died|2|||
170606341|NCT00348309|616563760|FG001|Overall Study|Participant died|1|||
170606342|NCT00348309|616563761|FG002|Overall Study|Participant died|1|||
170606343|NCT00348309|616563759|FG000|Overall Study|Decision of sponsor|1|||
170606344|NCT00348309|616563760|FG001|Overall Study|Decision of sponsor|0|||
170606345|NCT00348309|616563761|FG002|Overall Study|Decision of sponsor|0|||
170606346|NCT00348309|616563759|FG000|Overall Study|Ineffectiveness of treatment|0|||
170606347|NCT00348309|616563760|FG001|Overall Study|Ineffectiveness of treatment|1|||
170606348|NCT00348309|616563761|FG002|Overall Study|Ineffectiveness of treatment|0|||
170606349|NCT00348309|616563759|FG000|Overall Study|A foul of exclusion criteria|0|||
170606350|NCT00348309|616563760|FG001|Overall Study|A foul of exclusion criteria|1|||
170606351|NCT00348309|616563761|FG002|Overall Study|A foul of exclusion criteria|0|||
170606352|NCT00348309|616563759|FG000|Overall Study|Participant was hospitalized|0|||
170606353|NCT00348309|616563760|FG001|Overall Study|Participant was hospitalized|1|||
170606354|NCT00348309|616563761|FG002|Overall Study|Participant was hospitalized|0|||
170606355|NCT00348309|616563759|FG000|Overall Study|Sponsor refuseal|0|||
170606356|NCT00348309|616563760|FG001|Overall Study|Sponsor refuseal|1|||
170606357|NCT00348309|616563761|FG002|Overall Study|Sponsor refuseal|1|||
170606358|NCT00348309|616563759|FG000|Overall Study|Forgot often medication|0|||
170606359|NCT00348309|616563760|FG001|Overall Study|Forgot often medication|1|||
170606360|NCT00348309|616563761|FG002|Overall Study|Forgot often medication|0|||
170606361|NCT00348309|616563759|FG000|Overall Study|Medical Monitor decision|0|||
170606362|NCT00348309|616563760|FG001|Overall Study|Medical Monitor decision|0|||
170606363|NCT00348309|616563761|FG002|Overall Study|Medical Monitor decision|1|||
170606364|NCT00348309|616563759|FG000|Overall Study|Increased dose of Aricept|0|||
170606365|NCT00348309|616563760|FG001|Overall Study|Increased dose of Aricept|0|||
170606366|NCT00348309|616563761|FG002|Overall Study|Increased dose of Aricept|1|||
170606367|NCT00348309|616563759|FG000|Overall Study|Site closure|0|||
170606368|NCT00348309|616563760|FG001|Overall Study|Site closure|0|||
170606369|NCT00348309|616563761|FG002|Overall Study|Site closure|1|||
170606370|NCT00348309|616563759|FG000|Overall Study|Adverse event not attended|0|||
170606371|NCT00348309|616563760|FG001|Overall Study|Adverse event not attended|0|||
170606372|NCT00348309|616563761|FG002|Overall Study|Adverse event not attended|1|||
170606373|NCT00348309|616563759|FG000|Overall Study|ECG abnormal|0|||
170606374|NCT00348309|616563760|FG001|Overall Study|ECG abnormal|0|||
170606375|NCT00348309|616563761|FG002|Overall Study|ECG abnormal|2|||
170606376|NCT00348309|616563759|FG000|Overall Study|Cardiologist recommendations|0|||
170915645|NCT04172831|617693604|FG001|Overall Study|Lack of Efficacy|8|||
170606377|NCT00348309|616563760|FG001|Overall Study|Cardiologist recommendations|0|||
170606378|NCT00348309|616563761|FG002|Overall Study|Cardiologist recommendations|1|||
170606379|NCT00348309|616563759|FG000|Overall Study|HCV career|0|||
170606380|NCT00348309|616563760|FG001|Overall Study|HCV career|0|||
170606381|NCT00348309|616563761|FG002|Overall Study|HCV career|1|||
170606382|NCT01364389|616563770|FG000|Overall Study|Withdrawal by Subject|0|||
170606383|NCT01364389|616563771|FG001|Overall Study|Withdrawal by Subject|1|||
170606384|NCT01364389|616563772|FG002|Overall Study|Withdrawal by Subject|0|||
170606385|NCT01364389|616563770|FG000|Overall Study|Protocol deviation|0|||
170606386|NCT01364389|616563771|FG001|Overall Study|Protocol deviation|0|||
170606387|NCT01364389|616563772|FG002|Overall Study|Protocol deviation|1|||
170606388|NCT01364389|616563770|FG000|Overall Study|Administrative problems|1|||
170606389|NCT01364389|616563771|FG001|Overall Study|Administrative problems|0|||
170606390|NCT01364389|616563772|FG002|Overall Study|Administrative problems|0|||
170606391|NCT01364389|616563770|FG000|Overall Study|Adverse Event|1|||
170606392|NCT01364389|616563771|FG001|Overall Study|Adverse Event|0|||
170606393|NCT01364389|616563772|FG002|Overall Study|Adverse Event|0|||
170606394|NCT03043651|616563779|FG000|Overall Study|Death|1|||
170606395|NCT03043651|616563779|FG000|Overall Study|Progressive Disease|2|||
170606396|NCT03043651|616563779|FG000|Overall Study|Adverse Event|2|||
170606397|NCT03043651|616563779|FG000|Overall Study|Withdrawal by Subject|4|||
170606398|NCT03043651|616563779|FG000|Overall Study|Study Terminated by Sponsor|39|||
170606399|NCT02126839|616563780|FG000|Overall Study|Adverse Event|0|||
170606400|NCT02126839|616563781|FG001|Overall Study|Adverse Event|1|||
170606401|NCT02126839|616563780|FG000|Overall Study|Withdrawal by Subject|1|||
170606402|NCT02126839|616563781|FG001|Overall Study|Withdrawal by Subject|0|||
170606403|NCT02126839|616563780|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170606404|NCT02126839|616563781|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170606405|NCT02126839|616563780|FG000|Overall Study|Protocol Violation|2|||
170606406|NCT02126839|616563781|FG001|Overall Study|Protocol Violation|3|||
170606407|NCT02126839|616563780|FG000|Overall Study|Sponsor request|0|||
170606408|NCT02126839|616563781|FG001|Overall Study|Sponsor request|1|||
170606409|NCT02126839|616563780|FG000|Overall Study|Lost to Follow-up|1|||
170606410|NCT02126839|616563781|FG001|Overall Study|Lost to Follow-up|4|||
170606411|NCT02126839|616563780|FG000|Overall Study|Other|5|||
170606412|NCT02126839|616563781|FG001|Overall Study|Other|5|||
170606413|NCT02596945|616563782|FG000|Overall Study|No documentation of study drug dosing|3|||
170606414|NCT02596945|616563782|FG000|Overall Study|Other|32|||
170606415|NCT02596945|616563782|FG000|Overall Study|Change to hemodialysis|15|||
170606416|NCT02596945|616563782|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
170606417|NCT02596945|616563782|FG000|Overall Study|Withdrawal by Subject|1|||
170606418|NCT02596945|616563782|FG000|Overall Study|Missing|1|||
170606419|NCT00566254|616563783|FG000|Overall Study|Adverse Event|3|||
170606420|NCT00566254|616563784|FG001|Overall Study|Adverse Event|1|||
170606421|NCT00566254|616563783|FG000|Overall Study|Protocol Violation|1|||
170606422|NCT00566254|616563784|FG001|Overall Study|Protocol Violation|3|||
170606423|NCT00566254|616563783|FG000|Overall Study|Withdrawal by Subject|1|||
170606424|NCT00566254|616563784|FG001|Overall Study|Withdrawal by Subject|2|||
170606425|NCT00566254|616563783|FG000|Overall Study|Lack of Efficacy|5|||
170606426|NCT00566254|616563784|FG001|Overall Study|Lack of Efficacy|6|||
170606427|NCT00566254|616563783|FG000|Overall Study|Other|0|||
170606428|NCT00566254|616563784|FG001|Overall Study|Other|2|||
170606429|NCT00238238|616563785|FG000|Overall Study|Withdrawal by Subject|0|||
170606430|NCT00238238|616563786|FG001|Overall Study|Withdrawal by Subject|3|||
170606431|NCT00238238|616563787|FG002|Overall Study|Withdrawal by Subject|0|||
170606432|NCT01108523|616563788|FG000|Overall Study|Protocol Violation|4|||
170606433|NCT01007838|616563789|FG000|Overall Study|Withdrawal by Subject|1|||
170606434|NCT01007838|616563790|FG001|Overall Study|Withdrawal by Subject|0|||
170606435|NCT01007838|616563791|FG002|Overall Study|Withdrawal by Subject|0|||
170606436|NCT01007838|616563792|FG003|Overall Study|Withdrawal by Subject|0|||
170606437|NCT01007838|616563789|FG000|Overall Study|Physician Decision|1|||
170606438|NCT01007838|616563790|FG001|Overall Study|Physician Decision|0|||
170606439|NCT01007838|616563791|FG002|Overall Study|Physician Decision|0|||
170606440|NCT01007838|616563792|FG003|Overall Study|Physician Decision|0|||
170606441|NCT01007838|616563789|FG000|Overall Study|Started home haemodialysis|1|||
170606442|NCT01007838|616563790|FG001|Overall Study|Started home haemodialysis|0|||
170606443|NCT01007838|616563791|FG002|Overall Study|Started home haemodialysis|0|||
170606444|NCT01007838|616563792|FG003|Overall Study|Started home haemodialysis|0|||
170606445|NCT01345669|616563793|FG000|Overall Study|Primary tumour recurrence|53|||
170606446|NCT01345669|616563794|FG001|Overall Study|Primary tumour recurrence|32|||
170606447|NCT01345669|616563793|FG000|Overall Study|Second primary tumour|4|||
170606448|NCT01345669|616563794|FG001|Overall Study|Second primary tumour|3|||
170606449|NCT01345669|616563793|FG000|Overall Study|Adverse Event|63|||
170606450|NCT01345669|616563794|FG001|Overall Study|Adverse Event|9|||
170606451|NCT01345669|616563793|FG000|Overall Study|Protocol Violation|3|||
170606452|NCT01345669|616563794|FG001|Overall Study|Protocol Violation|1|||
170606453|NCT01345669|616563793|FG000|Overall Study|Lost to Follow-up|1|||
170606454|NCT01345669|616563794|FG001|Overall Study|Lost to Follow-up|1|||
170606455|NCT01345669|616563793|FG000|Overall Study|Withdrawal by Subject|52|||
170606456|NCT01345669|616563794|FG001|Overall Study|Withdrawal by Subject|13|||
170606457|NCT01345669|616563793|FG000|Overall Study|Other Reasons|111|||
170606458|NCT01345669|616563794|FG001|Overall Study|Other Reasons|60|||
170606459|NCT04699461|616563795|FG000|Overall Study|Withdrawal by Subject|1|||
170606460|NCT04699461|616563796|FG001|Overall Study|Withdrawal by Subject|0|||
170606461|NCT04699461|616563795|FG000|Overall Study|Study termination by sponsor|2|||
170606462|NCT04699461|616563796|FG001|Overall Study|Study termination by sponsor|1|||
170606463|NCT04699461|616563795|FG000|Overall Study|Death|1|||
170606464|NCT04699461|616563796|FG001|Overall Study|Death|0|||
170606465|NCT04699461|616563795|FG000|Overall Study|Radiographic progression|0|||
170606466|NCT04699461|616563796|FG001|Overall Study|Radiographic progression|1|||
170606467|NCT00061633|616563797|FG000|Overall Study|Adverse Event|1|||
170606468|NCT00061633|616563798|FG001|Overall Study|Adverse Event|2|||
170606469|NCT00061633|616563797|FG000|Overall Study|Withdrawal by Subject|2|||
170606470|NCT00061633|616563798|FG001|Overall Study|Withdrawal by Subject|2|||
170606471|NCT00061633|616563797|FG000|Overall Study|Lost to Follow-up|1|||
170606472|NCT00061633|616563798|FG001|Overall Study|Lost to Follow-up|4|||
170606473|NCT00061633|616563797|FG000|Overall Study|Other|1|||
170606474|NCT00061633|616563798|FG001|Overall Study|Other|1|||
170606475|NCT00061633|616563797|FG000|Overall Study|Never received study treatment|0|||
170606476|NCT00061633|616563798|FG001|Overall Study|Never received study treatment|2|||
170606477|NCT03738618|616565892|FG000|Overall Study|Protocol deviation|23|||
170606478|NCT03738618|616565893|FG001|Overall Study|Protocol deviation|0|||
170606479|NCT03738618|616565892|FG000|Overall Study|Adverse Event|4|||
170606480|NCT03738618|616565893|FG001|Overall Study|Adverse Event|0|||
170606481|NCT03738618|616565892|FG000|Overall Study|Lost to Follow-up|2|||
170606482|NCT03738618|616565893|FG001|Overall Study|Lost to Follow-up|0|||
170606483|NCT03738618|616565892|FG000|Overall Study|Randomization failure|1|||
170606484|NCT03738618|616565893|FG001|Overall Study|Randomization failure|0|||
170606485|NCT03738618|616565892|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
170606486|NCT03738618|616565893|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
170606487|NCT03738618|616565892|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
170606488|NCT03738618|616565893|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
170606489|NCT01487265|616565894|FG000|Overall Study|Adverse Event|8|||
170606490|NCT01487265|616565894|FG000|Overall Study|Withdrawal by Subject|5|||
170606491|NCT01487265|616565894|FG000|Overall Study|Disease Progression|21|||
170606492|NCT01487265|616565894|FG000|Overall Study|Death|2|||
170606493|NCT01487265|616565894|FG000|Overall Study|Still on Treatment|1|||
170606494|NCT01016600|616565895|FG000|Overall Study|Did not start treatment|1|||
170606495|NCT01016600|616565896|FG001|Overall Study|Did not start treatment|0|||
170606496|NCT01016600|616565897|FG002|Overall Study|Did not start treatment|0|||
170606497|NCT01016600|616565898|FG003|Overall Study|Did not start treatment|0|||
170606498|NCT00660179|616565903|FG000|Overall Study|Death|44|||
170606499|NCT00660179|616565904|FG001|Overall Study|Death|47|||
170606500|NCT00660179|616565905|FG002|Overall Study|Death|34|||
170606501|NCT00660179|616565903|FG000|Overall Study|Withdrawal of consent|4|||
170606502|NCT00660179|616565904|FG001|Overall Study|Withdrawal of consent|6|||
170606503|NCT00660179|616565905|FG002|Overall Study|Withdrawal of consent|4|||
170606504|NCT00660179|616565903|FG000|Overall Study|Lost to Follow-up|7|||
170606505|NCT00660179|616565904|FG001|Overall Study|Lost to Follow-up|5|||
170606506|NCT00660179|616565905|FG002|Overall Study|Lost to Follow-up|2|||
170606507|NCT00660179|616565903|FG000|Overall Study|Administrative reason|0|||
170606508|NCT00660179|616565904|FG001|Overall Study|Administrative reason|0|||
170606509|NCT00660179|616565905|FG002|Overall Study|Administrative reason|1|||
170606510|NCT00660179|616565903|FG000|Overall Study|Incorrect randomization|1|||
170606511|NCT00660179|616565904|FG001|Overall Study|Incorrect randomization|0|||
170652836|NCT01903252|616743314|FG000|Double-Blind Induction|Physician Decision|2|||
170652837|NCT01903252|616743315|FG001|Double-Blind Induction|Physician Decision|3|||
170814980|NCT01587703|617331412|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170606512|NCT00660179|616565905|FG002|Overall Study|Incorrect randomization|0|||
170606513|NCT02255461|616565908|FG000|Overall Study|Adverse Event|0|||
170606514|NCT02255461|616565909|FG001|Overall Study|Adverse Event|1|||
170606515|NCT02255461|616565910|FG002|Overall Study|Adverse Event|0|||
170606516|NCT02255461|616565911|FG003|Overall Study|Adverse Event|0|||
170606517|NCT02255461|616565912|FG004|Overall Study|Adverse Event|1|||
170606518|NCT02255461|616565908|FG000|Overall Study|Withdrawal by Subject|0|||
170606519|NCT02255461|616565909|FG001|Overall Study|Withdrawal by Subject|0|||
170606520|NCT02255461|616565910|FG002|Overall Study|Withdrawal by Subject|1|||
170606521|NCT02255461|616565911|FG003|Overall Study|Withdrawal by Subject|0|||
170606522|NCT02255461|616565912|FG004|Overall Study|Withdrawal by Subject|1|||
170606523|NCT02255461|616565908|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
170606524|NCT02255461|616565909|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
170606525|NCT02255461|616565910|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
170606526|NCT02255461|616565911|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
170652838|NCT01903252|616743316|FG002|Double-Blind Induction|Physician Decision|0|||
170606527|NCT02255461|616565912|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
170915646|NCT04172831|617693603|FG000|Overall Study|Physician Decision|0|||
170915647|NCT04172831|617693604|FG001|Overall Study|Physician Decision|1|||
170915648|NCT04172831|617693603|FG000|Overall Study|Withdrawal by Subject|12|||
170915649|NCT04172831|617693604|FG001|Overall Study|Withdrawal by Subject|11|||
170915650|NCT04172831|617693603|FG000|Overall Study|Lost to Follow-up|4|||
170915651|NCT04172831|617693604|FG001|Overall Study|Lost to Follow-up|9|||
170606528|NCT01559675|616565915|FG000|Overall Study|Protocol Violation|1|||
170606529|NCT01559675|616565916|FG001|Overall Study|Protocol Violation|2|||
170606530|NCT01559675|616565915|FG000|Overall Study|2nd operation on same patient excluded|14|||
170606531|NCT01559675|616565916|FG001|Overall Study|2nd operation on same patient excluded|12|||
170606532|NCT00711971|616565917|FG000|Overall Study|Lost to Follow-up|3|||
170606533|NCT00711971|616565918|FG001|Overall Study|Lost to Follow-up|4|||
170606534|NCT00711971|616565919|FG002|Overall Study|Lost to Follow-up|1|||
170606535|NCT03668613|616565930|FG000|Overall Study|Adverse Event|1|||
170606536|NCT03668613|616565931|FG001|Overall Study|Adverse Event|2|||
170606537|NCT03668613|616565930|FG000|Overall Study|Lack of Efficacy|5|||
170606538|NCT03668613|616565931|FG001|Overall Study|Lack of Efficacy|1|||
170606539|NCT03668613|616565930|FG000|Overall Study|Pregnancy|0|||
170606540|NCT03668613|616565931|FG001|Overall Study|Pregnancy|2|||
170606541|NCT03668613|616565930|FG000|Overall Study|Protocol Violation|1|||
170606542|NCT03668613|616565931|FG001|Overall Study|Protocol Violation|0|||
170606543|NCT03668613|616565930|FG000|Overall Study|Physician Decision|1|||
170606544|NCT03668613|616565931|FG001|Overall Study|Physician Decision|0|||
170606545|NCT03668613|616565930|FG000|Overall Study|Withdrawal by Subject|2|||
170606546|NCT03668613|616565931|FG001|Overall Study|Withdrawal by Subject|1|||
170606547|NCT03668613|616565930|FG000|Overall Study|Guardian decision|1|||
170606548|NCT03668613|616565931|FG001|Overall Study|Guardian decision|0|||
170606549|NCT01835158|616565933|FG000|Overall Study|Withdrawal by Subject|1|||
170606550|NCT01835158|616565934|FG001|Overall Study|Withdrawal by Subject|6|||
170606551|NCT01677858|616565945|FG000|Overall Study|Adverse Event|0|||
170606552|NCT01677858|616565946|FG001|Overall Study|Adverse Event|0|||
170606553|NCT01677858|616565947|FG002|Overall Study|Adverse Event|2|||
170606554|NCT01677858|616565948|FG003|Overall Study|Adverse Event|3|||
170606555|NCT01677858|616565949|FG004|Overall Study|Adverse Event|13|||
170606556|NCT01677858|616565945|FG000|Overall Study|Death|0|||
170606557|NCT01677858|616565946|FG001|Overall Study|Death|0|||
170606558|NCT01677858|616565947|FG002|Overall Study|Death|0|||
170606559|NCT01677858|616565948|FG003|Overall Study|Death|0|||
170606560|NCT01677858|616565949|FG004|Overall Study|Death|1|||
170606561|NCT01677858|616565945|FG000|Overall Study|Physician Decision|1|||
170606562|NCT01677858|616565946|FG001|Overall Study|Physician Decision|0|||
170606563|NCT01677858|616565947|FG002|Overall Study|Physician Decision|2|||
170606564|NCT01677858|616565948|FG003|Overall Study|Physician Decision|0|||
170606565|NCT01677858|616565949|FG004|Overall Study|Physician Decision|12|||
170606566|NCT01677858|616565945|FG000|Overall Study|Progressive Disease|2|||
170606567|NCT01677858|616565946|FG001|Overall Study|Progressive Disease|1|||
170606568|NCT01677858|616565947|FG002|Overall Study|Progressive Disease|9|||
170606569|NCT01677858|616565948|FG003|Overall Study|Progressive Disease|3|||
170915652|NCT04172831|617693603|FG000|Overall Study|COVID-19 related crisis|3|||
170915653|NCT04172831|617693604|FG001|Overall Study|COVID-19 related crisis|3|||
170915654|NCT04172831|617693603|FG000|Overall Study|Subject non-compliance|1|||
170915655|NCT04172831|617693604|FG001|Overall Study|Subject non-compliance|1|||
170915656|NCT04172831|617693603|FG000|Overall Study|Family emergency|1|||
170606570|NCT01677858|616565949|FG004|Overall Study|Progressive Disease|43|||
170606571|NCT01677858|616565945|FG000|Overall Study|Withdrawal by Subject|0|||
170606572|NCT01677858|616565946|FG001|Overall Study|Withdrawal by Subject|1|||
170606573|NCT01677858|616565947|FG002|Overall Study|Withdrawal by Subject|1|||
170606574|NCT01677858|616565948|FG003|Overall Study|Withdrawal by Subject|0|||
170606575|NCT01677858|616565949|FG004|Overall Study|Withdrawal by Subject|15|||
170606576|NCT01677858|616565945|FG000|Overall Study|Lost to Follow-up|0|||
170606577|NCT01677858|616565946|FG001|Overall Study|Lost to Follow-up|0|||
170606578|NCT01677858|616565947|FG002|Overall Study|Lost to Follow-up|0|||
170606579|NCT01677858|616565948|FG003|Overall Study|Lost to Follow-up|0|||
170606580|NCT01677858|616565949|FG004|Overall Study|Lost to Follow-up|1|||
170606581|NCT00773747|616565950|FG000|Overall Study|Lack of Efficacy|112|||
170606582|NCT00773747|616565951|FG001|Overall Study|Lack of Efficacy|144|||
170606583|NCT00773747|616565950|FG000|Overall Study|Physician Decision|26|||
170606584|NCT00773747|616565951|FG001|Overall Study|Physician Decision|18|||
170652839|NCT01903252|616743317|FG003|Double-Blind Induction|Physician Decision|0|||
170915657|NCT04172831|617693604|FG001|Overall Study|Family emergency|0|||
170915658|NCT01520922|617693605|FG000|Treatment Phase|Physician Decision|2|||
170606585|NCT00773747|616565950|FG000|Overall Study|Lost to Follow-up|0|||
170606586|NCT00773747|616565951|FG001|Overall Study|Lost to Follow-up|1|||
170606587|NCT00773747|616565950|FG000|Overall Study|Protocol Violation|2|||
170606588|NCT00773747|616565951|FG001|Overall Study|Protocol Violation|2|||
170606589|NCT00773747|616565950|FG000|Overall Study|Withdrawal by Subject|89|||
170606590|NCT00773747|616565951|FG001|Overall Study|Withdrawal by Subject|61|||
170606591|NCT00773747|616565950|FG000|Overall Study|Adverse Event|61|||
170606592|NCT00773747|616565951|FG001|Overall Study|Adverse Event|62|||
170606593|NCT00773747|616565950|FG000|Overall Study|Death|5|||
170606594|NCT00773747|616565951|FG001|Overall Study|Death|8|||
170606595|NCT00773747|616565950|FG000|Overall Study|Not Treated|2|||
170606596|NCT00773747|616565951|FG001|Overall Study|Not Treated|0|||
170606597|NCT02669212|616565952|FG000|Overall Study|Lost to Follow-up|1|||
170606598|NCT02669212|616565953|FG001|Overall Study|Lost to Follow-up|0|||
170606599|NCT02669212|616565952|FG000|Overall Study|Medical Condition|3|||
170606600|NCT02669212|616565953|FG001|Overall Study|Medical Condition|4|||
170606601|NCT02669212|616565952|FG000|Overall Study|Withdrawal by Subject|0|||
170606602|NCT02669212|616565953|FG001|Overall Study|Withdrawal by Subject|2|||
170606603|NCT02669212|616565952|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
170606604|NCT02669212|616565953|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
170606605|NCT04869358|616565957|FG000|Overall Study|Wish to have children.|1|||
170606606|NCT04869358|616565958|FG001|Overall Study|Wish to have children.|0|||
170606607|NCT04869358|616565959|FG002|Overall Study|Wish to have children.|0|||
170606608|NCT04869358|616565960|FG003|Overall Study|Wish to have children.|0|||
170606609|NCT00646399|616565961|FG000|Overall Study|Death|63|||
170606610|NCT00646399|616565962|FG001|Overall Study|Death|53|||
170606611|NCT00646399|616565961|FG000|Overall Study|Withdrawal by Subject|9|||
170606612|NCT00646399|616565962|FG001|Overall Study|Withdrawal by Subject|10|||
170606613|NCT00646399|616565961|FG000|Overall Study|Other Reason|11|||
170606614|NCT00646399|616565962|FG001|Overall Study|Other Reason|11|||
170606615|NCT05232864|616565965|FG000|Overall Study|Adverse Event|0|||
170606616|NCT05232864|616565966|FG001|Overall Study|Adverse Event|1|||
170606617|NCT05232864|616565965|FG000|Overall Study|Study terminated by sponsor|16|||
170606618|NCT05232864|616565966|FG001|Overall Study|Study terminated by sponsor|14|||
170606619|NCT04929249|616565970|FG000|Overall Study|Adverse Event|2|||
170606620|NCT04929249|616565971|FG001|Overall Study|Adverse Event|1|||
170606621|NCT04929249|616565970|FG000|Overall Study|Death|2|||
170606622|NCT04929249|616565971|FG001|Overall Study|Death|1|||
170606623|NCT04929249|616565970|FG000|Overall Study|Lost to Follow-up|3|||
170606624|NCT04929249|616565971|FG001|Overall Study|Lost to Follow-up|11|||
170606625|NCT04929249|616565970|FG000|Overall Study|Technical problems|0|||
170606626|NCT04929249|616565971|FG001|Overall Study|Technical problems|1|||
170606627|NCT04929249|616565970|FG000|Overall Study|Subject decision|6|||
170606628|NCT04929249|616565971|FG001|Overall Study|Subject decision|8|||
170606629|NCT04929249|616565970|FG000|Overall Study|Withdrew consent|0|||
170606630|NCT04929249|616565971|FG001|Overall Study|Withdrew consent|8|||
170606631|NCT01727336|616565980|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
170606632|NCT01727336|616565981|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
170606633|NCT01727336|616565982|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
170606634|NCT01727336|616565983|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
170606635|NCT01727336|616565984|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
170606636|NCT01727336|616565985|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
170606637|NCT01727336|616565980|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
170606638|NCT01727336|616565981|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
170606639|NCT01727336|616565982|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
170606640|NCT01727336|616565983|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
170606641|NCT01727336|616565984|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
170606642|NCT01727336|616565985|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
170606643|NCT01727336|616565980|FG000|Part 2 Blinded|Death|0|||
170606644|NCT01727336|616565981|FG001|Part 2 Blinded|Death|0|||
170606645|NCT01727336|616565982|FG002|Part 2 Blinded|Death|0|||
170606646|NCT01727336|616565983|FG003|Part 2 Blinded|Death|0|||
170606647|NCT01727336|616565984|FG004|Part 2 Blinded|Death|20|||
170606648|NCT01727336|616565985|FG005|Part 2 Blinded|Death|16|||
170652840|NCT01903252|616743318|FG004|Double-Blind Induction|Physician Decision|0|||
170652841|NCT01903252|616743319|FG005|Double-Blind Induction|Physician Decision|0|||
170652842|NCT01903252|616743314|FG000|Double-Blind Induction|non-compliance,|7|||
170652843|NCT01903252|616743315|FG001|Double-Blind Induction|non-compliance,|7|||
170652844|NCT01903252|616743316|FG002|Double-Blind Induction|non-compliance,|0|||
170814981|NCT01587703|617331413|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170606649|NCT01727336|616565980|FG000|Part 2 Blinded|Lack of Efficacy|0|||
170606650|NCT01727336|616565981|FG001|Part 2 Blinded|Lack of Efficacy|0|||
170652845|NCT01903252|616743317|FG003|Double-Blind Induction|non-compliance,|0|||
170606651|NCT01727336|616565982|FG002|Part 2 Blinded|Lack of Efficacy|0|||
170606652|NCT01727336|616565983|FG003|Part 2 Blinded|Lack of Efficacy|0|||
170606653|NCT01727336|616565984|FG004|Part 2 Blinded|Lack of Efficacy|42|||
170652846|NCT01903252|616743318|FG004|Double-Blind Induction|non-compliance,|0|||
170652847|NCT01903252|616743319|FG005|Double-Blind Induction|non-compliance,|0|||
170606654|NCT01727336|616565985|FG005|Part 2 Blinded|Lack of Efficacy|44|||
170606655|NCT01727336|616565980|FG000|Part 2 Blinded|Lost to Follow-up|0|||
170606656|NCT01727336|616565981|FG001|Part 2 Blinded|Lost to Follow-up|0|||
170606657|NCT01727336|616565982|FG002|Part 2 Blinded|Lost to Follow-up|0|||
170606658|NCT01727336|616565983|FG003|Part 2 Blinded|Lost to Follow-up|0|||
170606659|NCT01727336|616565984|FG004|Part 2 Blinded|Lost to Follow-up|0|||
170606660|NCT01727336|616565985|FG005|Part 2 Blinded|Lost to Follow-up|1|||
170606661|NCT01727336|616565980|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
170606662|NCT01727336|616565981|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
170606663|NCT01727336|616565982|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
170606664|NCT01727336|616565983|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
170606665|NCT01727336|616565984|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
170606666|NCT01727336|616565985|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
170606667|NCT01727336|616565980|FG000|Part 2 Blinded|use of prohibited medications|0|||
170606668|NCT01727336|616565981|FG001|Part 2 Blinded|use of prohibited medications|0|||
170606669|NCT01727336|616565982|FG002|Part 2 Blinded|use of prohibited medications|0|||
170606670|NCT01727336|616565983|FG003|Part 2 Blinded|use of prohibited medications|0|||
170606671|NCT01727336|616565984|FG004|Part 2 Blinded|use of prohibited medications|1|||
170606672|NCT01727336|616565985|FG005|Part 2 Blinded|use of prohibited medications|3|||
170606673|NCT03550404|616565986|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
170606674|NCT03550404|616565987|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
170606675|NCT03550404|616565988|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
170606676|NCT03550404|616565986|FG000|Phase 2|Vacated position|1|||
170606677|NCT03550404|616565987|FG001|Phase 2|Vacated position|0|||
170606678|NCT03550404|616565988|FG002|Phase 2|Vacated position|0|||
170606679|NCT01270256|616565990|FG000|Overall Study|Withdrawal by Subject|1|||
170606680|NCT01270256|616565991|FG001|Overall Study|Withdrawal by Subject|0|||
170606681|NCT00293020|616565999|FG000|Overall Study|Withdrawal by Subject|34|||
170606682|NCT00293020|616565999|FG000|Overall Study|Adverse Event|30|||
170606683|NCT00293020|616565999|FG000|Overall Study|Death|32|||
170606684|NCT00293020|616565999|FG000|Overall Study|Lack of Efficacy|12|||
170606685|NCT00293020|616565999|FG000|Overall Study|Lost to Follow-up|4|||
170606686|NCT00293020|616565999|FG000|Overall Study|Protocol Violation|6|||
170606687|NCT00293020|616565999|FG000|Overall Study|Physician Decision|21|||
170606688|NCT00293020|616565999|FG000|Overall Study|Other Reason|22|||
170606689|NCT00293020|616565999|FG000|Overall Study|No dose taken|1|||
170606690|NCT01336023|616566000|FG000|Week 0 to Week 26|Adverse Event|8|||
170606691|NCT01336023|616566001|FG001|Week 0 to Week 26|Adverse Event|10|||
170606692|NCT01336023|616566002|FG002|Week 0 to Week 26|Adverse Event|24|||
170606693|NCT01336023|616566000|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
170606694|NCT01336023|616566001|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
170606695|NCT01336023|616566002|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
170606696|NCT01336023|616566000|FG000|Week 0 to Week 26|Protocol Violation|1|||
170606697|NCT01336023|616566001|FG001|Week 0 to Week 26|Protocol Violation|2|||
170606698|NCT01336023|616566002|FG002|Week 0 to Week 26|Protocol Violation|0|||
170606699|NCT01336023|616566000|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
170606700|NCT01336023|616566001|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
170606701|NCT01336023|616566002|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
170606702|NCT01336023|616566000|FG000|Week 0 to Week 26|Unclassified|5|||
170606703|NCT01336023|616566001|FG001|Week 0 to Week 26|Unclassified|16|||
170606704|NCT01336023|616566002|FG002|Week 0 to Week 26|Unclassified|9|||
170606705|NCT01336023|616566000|FG000|Week 27 to 52|Adverse Event|1|||
170606706|NCT01336023|616566001|FG001|Week 27 to 52|Adverse Event|5|||
170606707|NCT01336023|616566002|FG002|Week 27 to 52|Adverse Event|2|||
170606708|NCT01336023|616566000|FG000|Week 27 to 52|Protocol Violation|0|||
170606709|NCT01336023|616566001|FG001|Week 27 to 52|Protocol Violation|2|||
170606710|NCT01336023|616566002|FG002|Week 27 to 52|Protocol Violation|1|||
170606711|NCT01336023|616566000|FG000|Week 27 to 52|Withdrawal Criteria|14|||
170606712|NCT01336023|616566001|FG001|Week 27 to 52|Withdrawal Criteria|19|||
170915659|NCT01520922|617693606|FG001|Treatment Phase|Physician Decision|1|||
170915660|NCT01520922|617693605|FG000|Treatment Phase|Progression|0|||
170606713|NCT01336023|616566002|FG002|Week 27 to 52|Withdrawal Criteria|16|||
170606714|NCT01336023|616566000|FG000|Week 27 to 52|Unclassified|13|||
170606715|NCT01336023|616566001|FG001|Week 27 to 52|Unclassified|18|||
170606716|NCT01336023|616566002|FG002|Week 27 to 52|Unclassified|9|||
170652848|NCT01903252|616743314|FG000|Extended Induction, Open-Label|Adverse Event|0|||
170652849|NCT01903252|616743315|FG001|Extended Induction, Open-Label|Adverse Event|0|||
170652850|NCT01903252|616743316|FG002|Extended Induction, Open-Label|Adverse Event|17|||
170652851|NCT01903252|616743317|FG003|Extended Induction, Open-Label|Adverse Event|0|||
170915661|NCT01520922|617693606|FG001|Treatment Phase|Progression|2|||
170606717|NCT01846741|616566011|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
170606718|NCT01361178|616566012|FG000|Overall Study|Death|13|||
170606719|NCT01361178|616566013|FG001|Overall Study|Death|0|||
170606720|NCT00383162|616566016|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
170606721|NCT00383162|616566017|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
170606722|NCT00383162|616566016|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
170606723|NCT00383162|616566017|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
170915662|NCT01520922|617693605|FG000|Treatment Phase|Adverse Event|3|||
170606724|NCT00383162|616566016|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
170606725|NCT00383162|616566017|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
170915663|NCT01520922|617693606|FG001|Treatment Phase|Adverse Event|5|||
170606726|NCT00383162|616566016|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
170606727|NCT00383162|616566017|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
170606728|NCT00383162|616566016|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
170606729|NCT00383162|616566017|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
170606730|NCT00383162|616566016|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
170606731|NCT00383162|616566017|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
170606732|NCT00383162|616566016|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
170606733|NCT00383162|616566017|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
170606734|NCT00383162|616566016|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
170606735|NCT00383162|616566017|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
170606736|NCT00383162|616566016|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
170606737|NCT00383162|616566017|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
170606738|NCT00767819|616566018|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
170606739|NCT00767819|616566019|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
170606740|NCT00767819|616566020|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170606741|NCT00767819|616566018|FG000|Overall Study|Withdrawal by Subject|1|||
170606742|NCT00767819|616566019|FG001|Overall Study|Withdrawal by Subject|1|||
170606743|NCT00767819|616566020|FG002|Overall Study|Withdrawal by Subject|0|||
170606744|NCT00767819|616566018|FG000|Overall Study|Administrative problems|0|||
170606745|NCT00767819|616566019|FG001|Overall Study|Administrative problems|1|||
170606746|NCT00767819|616566020|FG002|Overall Study|Administrative problems|0|||
170606747|NCT00767819|616566018|FG000|Overall Study|Death|2|||
170606748|NCT00767819|616566019|FG001|Overall Study|Death|3|||
170606749|NCT00767819|616566020|FG002|Overall Study|Death|0|||
170606750|NCT00767819|616566018|FG000|Overall Study|Adverse Event|2|||
170606751|NCT00767819|616566019|FG001|Overall Study|Adverse Event|0|||
170606752|NCT00767819|616566020|FG002|Overall Study|Adverse Event|0|||
170606753|NCT00767819|616566018|FG000|Overall Study|Abnormal lab values|1|||
170606754|NCT00767819|616566019|FG001|Overall Study|Abnormal lab values|0|||
170606755|NCT00767819|616566020|FG002|Overall Study|Abnormal lab values|0|||
170606756|NCT00767819|616566018|FG000|Overall Study|Lost to Follow-up|1|||
170606757|NCT00767819|616566019|FG001|Overall Study|Lost to Follow-up|0|||
170606758|NCT00767819|616566020|FG002|Overall Study|Lost to Follow-up|0|||
170606759|NCT04294147|616566021|FG000|Overall Study|Protocol Violation|2|||
170606760|NCT04294147|616566022|FG001|Overall Study|Protocol Violation|0|||
170606761|NCT03916081|616566027|FG000|Overall Study|Adverse Event|1|||
170606762|NCT03916081|616566028|FG001|Overall Study|Adverse Event|0|||
170606763|NCT03916081|616566029|FG002|Overall Study|Adverse Event|0|||
170606764|NCT03916081|616566027|FG000|Overall Study|Physician Decision|0|||
170606765|NCT03916081|616566028|FG001|Overall Study|Physician Decision|0|||
170606766|NCT03916081|616566029|FG002|Overall Study|Physician Decision|1|||
170606767|NCT03916081|616566027|FG000|Overall Study|Lost to Follow-up|0|||
170606768|NCT03916081|616566028|FG001|Overall Study|Lost to Follow-up|1|||
170606769|NCT03916081|616566029|FG002|Overall Study|Lost to Follow-up|0|||
170606770|NCT03916081|616566027|FG000|Overall Study|Withdrawal by Subject|3|||
170606771|NCT03916081|616566028|FG001|Overall Study|Withdrawal by Subject|0|||
170606772|NCT03916081|616566029|FG002|Overall Study|Withdrawal by Subject|1|||
170606773|NCT03916081|616566027|FG000|Overall Study|Worsening of AD|0|||
170606774|NCT03916081|616566028|FG001|Overall Study|Worsening of AD|0|||
170606775|NCT03916081|616566029|FG002|Overall Study|Worsening of AD|1|||
170606776|NCT02999633|616566033|FG000|Overall Study|Adverse Event|2|||
170606777|NCT02999633|616566033|FG000|Overall Study|Progressive disease|12|||
170606778|NCT02249182|616566034|FG000|Treatment Phase|Lost to Follow-up|4|||
170606779|NCT02249182|616566035|FG001|Treatment Phase|Lost to Follow-up|0|||
170606780|NCT02249182|616566036|FG002|Treatment Phase|Lost to Follow-up|0|||
170606781|NCT02249182|616566037|FG003|Treatment Phase|Lost to Follow-up|0|||
170606782|NCT02249182|616566038|FG004|Treatment Phase|Lost to Follow-up|0|||
170606783|NCT04356040|616566048|FG000|Overall Study|Death|2|||
170606784|NCT04356040|616566049|FG001|Overall Study|Death|0|||
170606785|NCT04356040|616566048|FG000|Overall Study|Lost to Follow-up|1|||
170606786|NCT04356040|616566049|FG001|Overall Study|Lost to Follow-up|0|||
170606787|NCT04356040|616566048|FG000|Overall Study|Physician Decision|0|||
170652852|NCT01903252|616743318|FG004|Extended Induction, Open-Label|Adverse Event|0|||
170652853|NCT01903252|616743319|FG005|Extended Induction, Open-Label|Adverse Event|0|||
170606788|NCT04356040|616566049|FG001|Overall Study|Physician Decision|1|||
170606789|NCT04356040|616566048|FG000|Overall Study|Withdrawal by Subject|13|||
170606790|NCT04356040|616566049|FG001|Overall Study|Withdrawal by Subject|1|||
170606791|NCT04356040|616566048|FG000|Overall Study|Enrollment Pause|10|||
170606792|NCT04356040|616566049|FG001|Overall Study|Enrollment Pause|0|||
170606793|NCT04356040|616566048|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
170606794|NCT04356040|616566049|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
170606795|NCT04356040|616566048|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
170606796|NCT04356040|616566049|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
170606797|NCT04356040|616566048|FG000|Overall Study|PI left institution|3|||
170606798|NCT04356040|616566049|FG001|Overall Study|PI left institution|0|||
170606799|NCT04356352|616566050|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
170606800|NCT04356352|616566051|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
170606801|NCT04356352|616566052|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
170606802|NCT04356352|616566050|FG000|Overall Study|Protocol Violation|0|||
170606803|NCT04356352|616566051|FG001|Overall Study|Protocol Violation|3|||
170606804|NCT04356352|616566052|FG002|Overall Study|Protocol Violation|1|||
170606805|NCT01220180|616566053|FG000|Overall Study|Lost to Follow-up|76|||
170606806|NCT01220180|616566053|FG000|Overall Study|Other|72|||
170606807|NCT01220180|616566053|FG000|Overall Study|Adverse Event|35|||
170606808|NCT01220180|616566053|FG000|Overall Study|Lack of Efficacy|22|||
170606809|NCT01220180|616566053|FG000|Overall Study|Death|1|||
170606810|NCT01220180|616566053|FG000|Overall Study|Randomized but not treated|1|||
170606811|NCT01534195|616566055|FG000|Overall Study|Withdrawal by Subject|1|||
170606812|NCT01534195|616566056|FG001|Overall Study|Withdrawal by Subject|1|||
170606813|NCT02980133|616566061|FG000|Overall Study|Other than specified|1|||
170606814|NCT02980133|616566062|FG001|Overall Study|Other than specified|1|||
170606815|NCT02980133|616566063|FG002|Overall Study|Other than specified|2|||
170606816|NCT02980133|616566064|FG003|Overall Study|Other than specified|2|||
170606817|NCT02980133|616566061|FG000|Overall Study|Lost to Follow-up|0|||
170606818|NCT02980133|616566062|FG001|Overall Study|Lost to Follow-up|0|||
170606819|NCT02980133|616566063|FG002|Overall Study|Lost to Follow-up|1|||
170606820|NCT02980133|616566064|FG003|Overall Study|Lost to Follow-up|3|||
170606821|NCT02980133|616566061|FG000|Overall Study|Protocol Violation|0|||
170606822|NCT02980133|616566062|FG001|Overall Study|Protocol Violation|1|||
170606823|NCT02980133|616566063|FG002|Overall Study|Protocol Violation|0|||
170606824|NCT02980133|616566064|FG003|Overall Study|Protocol Violation|0|||
170606825|NCT02980133|616566061|FG000|Overall Study|Withdrawal by parent/guardian|6|||
170606826|NCT02980133|616566062|FG001|Overall Study|Withdrawal by parent/guardian|3|||
170606827|NCT02980133|616566063|FG002|Overall Study|Withdrawal by parent/guardian|3|||
170606828|NCT02980133|616566064|FG003|Overall Study|Withdrawal by parent/guardian|1|||
170606829|NCT02980133|616566061|FG000|Overall Study|Withdrawal by Subject|0|||
170606830|NCT02980133|616566062|FG001|Overall Study|Withdrawal by Subject|0|||
170606831|NCT02980133|616566063|FG002|Overall Study|Withdrawal by Subject|1|||
170606832|NCT02980133|616566064|FG003|Overall Study|Withdrawal by Subject|0|||
170606833|NCT02974842|616566065|FG000|Overall Study|Withdrawal by Subject|4|||
170606834|NCT02974842|616566065|FG000|Overall Study|Screen failures|4|||
170606835|NCT01300572|616566066|FG000|Overall Study|HAMA + post dosimetry|1|||
170606836|NCT00422383|616566067|FG000|Overall Study|Adverse Event|5|||
170606837|NCT00422383|616566068|FG001|Overall Study|Adverse Event|3|||
170606838|NCT00422383|616566069|FG002|Overall Study|Adverse Event|1|||
170606839|NCT00422383|616566070|FG003|Overall Study|Adverse Event|1|||
170606840|NCT00422383|616566071|FG004|Overall Study|Adverse Event|0|||
170606841|NCT00422383|616566067|FG000|Overall Study|Lack of Efficacy|4|||
170606842|NCT00422383|616566068|FG001|Overall Study|Lack of Efficacy|4|||
170606843|NCT00422383|616566069|FG002|Overall Study|Lack of Efficacy|2|||
170915664|NCT01520922|617693605|FG000|Follow up|Lost to Follow-up|0|||
170915665|NCT01520922|617693606|FG001|Follow up|Lost to Follow-up|1|||
170915666|NCT01520922|617693605|FG000|Survival Follow-up|Withdrawal by Subject|1|||
170915667|NCT01520922|617693606|FG001|Survival Follow-up|Withdrawal by Subject|0|||
170606844|NCT00422383|616566070|FG003|Overall Study|Lack of Efficacy|1|||
170606845|NCT00422383|616566071|FG004|Overall Study|Lack of Efficacy|1|||
170606846|NCT00422383|616566067|FG000|Overall Study|Lost to Follow-up|0|||
170606847|NCT00422383|616566068|FG001|Overall Study|Lost to Follow-up|1|||
170606848|NCT00422383|616566069|FG002|Overall Study|Lost to Follow-up|0|||
170606849|NCT00422383|616566070|FG003|Overall Study|Lost to Follow-up|0|||
170606850|NCT00422383|616566071|FG004|Overall Study|Lost to Follow-up|1|||
170606851|NCT00422383|616566067|FG000|Overall Study|Protocol Violation|1|||
170606852|NCT00422383|616566068|FG001|Overall Study|Protocol Violation|1|||
170606853|NCT00422383|616566069|FG002|Overall Study|Protocol Violation|1|||
170606854|NCT00422383|616566070|FG003|Overall Study|Protocol Violation|0|||
170606855|NCT00422383|616566071|FG004|Overall Study|Protocol Violation|0|||
170606856|NCT00422383|616566067|FG000|Overall Study|Withdrawal by Subject|5|||
170606857|NCT00422383|616566068|FG001|Overall Study|Withdrawal by Subject|5|||
170606858|NCT00422383|616566069|FG002|Overall Study|Withdrawal by Subject|0|||
170606859|NCT00422383|616566070|FG003|Overall Study|Withdrawal by Subject|0|||
170606860|NCT00422383|616566071|FG004|Overall Study|Withdrawal by Subject|1|||
170606861|NCT00872599|616567768|FG000|Second Washout Period|Adverse Event|1|||
170915668|NCT02955186|617693607|FG000|Overall Study|Withdrawal by Subject|6|||
170606862|NCT00872599|616567769|FG001|Second Washout Period|Adverse Event|1|||
170606863|NCT04794270|616567770|FG000|Period 1|Non Compliance|1|||
170606864|NCT04794270|616567771|FG001|Period 1|Non Compliance|0|||
170606865|NCT04794270|616567770|FG000|Period 1|Adverse Event|1|||
170606866|NCT04794270|616567771|FG001|Period 1|Adverse Event|0|||
170606867|NCT04794270|616567770|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
170606868|NCT04794270|616567771|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
170606869|NCT03826186|616567774|FG000|Overall Study|Protocol Violation|2|||
170606870|NCT03826186|616567775|FG001|Overall Study|Protocol Violation|0|||
170606871|NCT03826186|616567774|FG000|Overall Study|Withdrawal by Subject|1|||
170915669|NCT02955186|617693608|FG001|Overall Study|Withdrawal by Subject|2|||
170814982|NCT01587703|617331414|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814983|NCT01587703|617331415|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170606872|NCT03826186|616567775|FG001|Overall Study|Withdrawal by Subject|0|||
170606873|NCT02510001|616567776|FG000|Overall Study|Early disease progression|0|||
170606874|NCT02510001|616567777|FG001|Overall Study|Early disease progression|0|||
170606875|NCT02510001|616567778|FG002|Overall Study|Early disease progression|0|||
170606876|NCT02510001|616567779|FG003|Overall Study|Early disease progression|1|||
170606877|NCT02510001|616567780|FG004|Overall Study|Early disease progression|1|||
170606878|NCT02510001|616567781|FG005|Overall Study|Early disease progression|1|||
170606879|NCT02510001|616567782|FG006|Overall Study|Early disease progression|0|||
170606880|NCT02510001|616567783|FG007|Overall Study|Early disease progression|0|||
170606881|NCT02510001|616567776|FG000|Overall Study|Adverse Event|0|||
170606882|NCT02510001|616567777|FG001|Overall Study|Adverse Event|0|||
170606883|NCT02510001|616567778|FG002|Overall Study|Adverse Event|0|||
170606884|NCT02510001|616567779|FG003|Overall Study|Adverse Event|1|||
170606885|NCT02510001|616567780|FG004|Overall Study|Adverse Event|2|||
170606886|NCT02510001|616567781|FG005|Overall Study|Adverse Event|1|||
170606887|NCT02510001|616567782|FG006|Overall Study|Adverse Event|2|||
170606888|NCT02510001|616567783|FG007|Overall Study|Adverse Event|5|||
170606889|NCT02510001|616567776|FG000|Overall Study|Physician Decision|0|||
170606890|NCT02510001|616567777|FG001|Overall Study|Physician Decision|0|||
170606891|NCT02510001|616567778|FG002|Overall Study|Physician Decision|0|||
170606892|NCT02510001|616567779|FG003|Overall Study|Physician Decision|0|||
170606893|NCT02510001|616567780|FG004|Overall Study|Physician Decision|1|||
170606894|NCT02510001|616567781|FG005|Overall Study|Physician Decision|0|||
170606895|NCT02510001|616567782|FG006|Overall Study|Physician Decision|0|||
170606896|NCT02510001|616567783|FG007|Overall Study|Physician Decision|0|||
170606897|NCT02510001|616567776|FG000|Overall Study|Withdrawal by Subject|0|||
170606898|NCT02510001|616567777|FG001|Overall Study|Withdrawal by Subject|0|||
170606899|NCT02510001|616567778|FG002|Overall Study|Withdrawal by Subject|0|||
170606900|NCT02510001|616567779|FG003|Overall Study|Withdrawal by Subject|0|||
170606901|NCT02510001|616567780|FG004|Overall Study|Withdrawal by Subject|0|||
170606902|NCT02510001|616567781|FG005|Overall Study|Withdrawal by Subject|0|||
170606903|NCT02510001|616567782|FG006|Overall Study|Withdrawal by Subject|0|||
170606904|NCT02510001|616567783|FG007|Overall Study|Withdrawal by Subject|2|||
170606905|NCT01378325|616567791|FG000|Overall Study|Protocol Violation|0|||
170606906|NCT01378325|616567792|FG001|Overall Study|Protocol Violation|1|||
170606907|NCT01357551|616567798|FG000|Overall Study|Withdrawal by Subject|6|||
170606908|NCT01357551|616567799|FG001|Overall Study|Withdrawal by Subject|4|||
170606909|NCT01357551|616567798|FG000|Overall Study|Death|0|||
170606910|NCT01357551|616567799|FG001|Overall Study|Death|1|||
170606911|NCT01357551|616567798|FG000|Overall Study|Lost to Follow-up|16|||
170606912|NCT01357551|616567799|FG001|Overall Study|Lost to Follow-up|6|||
170606913|NCT05362058|616567800|FG000|Treatment Period|Adverse Event|3|||
170606914|NCT05362058|616567801|FG001|Treatment Period|Adverse Event|3|||
170814984|NCT01587703|617331416|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814985|NCT01587703|617331417|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814986|NCT01587703|617331418|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170606915|NCT05362058|616567800|FG000|Treatment Period|Assigned treatment by mistake|3|||
170606916|NCT05362058|616567801|FG001|Treatment Period|Assigned treatment by mistake|4|||
170606917|NCT05362058|616567800|FG000|Treatment Period|Death|1|||
170606918|NCT05362058|616567801|FG001|Treatment Period|Death|1|||
170814987|NCT01587703|617331419|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814988|NCT01587703|617331420|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814989|NCT01587703|617331421|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814990|NCT01587703|617331422|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814991|NCT01587703|617331423|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
170814992|NCT01587703|617331405|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
170814993|NCT01587703|617331406|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
170814994|NCT01587703|617331407|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
170814995|NCT01587703|617331408|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
170814996|NCT01587703|617331409|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
170814997|NCT01587703|617331410|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
170814998|NCT01587703|617331411|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
170814999|NCT01587703|617331412|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
170815000|NCT01587703|617331413|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815001|NCT01587703|617331414|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815002|NCT01587703|617331415|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170915670|NCT02955186|617693607|FG000|Overall Study|Protocol Violation|1|||
170915671|NCT02955186|617693608|FG001|Overall Study|Protocol Violation|0|||
170606919|NCT05362058|616567800|FG000|Treatment Period|Lost to Follow-up|6|||
170606920|NCT05362058|616567801|FG001|Treatment Period|Lost to Follow-up|3|||
170606921|NCT05362058|616567800|FG000|Treatment Period|Non-compliance with study drug|0|||
170606922|NCT05362058|616567801|FG001|Treatment Period|Non-compliance with study drug|1|||
170606923|NCT05362058|616567800|FG000|Treatment Period|Physician Decision|1|||
170606924|NCT05362058|616567801|FG001|Treatment Period|Physician Decision|0|||
170606925|NCT05362058|616567800|FG000|Treatment Period|Protocol deviation|1|||
170606926|NCT05362058|616567801|FG001|Treatment Period|Protocol deviation|0|||
170606927|NCT05362058|616567800|FG000|Treatment Period|Withdrawal by Subject|10|||
170606928|NCT05362058|616567801|FG001|Treatment Period|Withdrawal by Subject|11|||
170606929|NCT05362058|616567800|FG000|Follow-Up Period|Death|1|||
170606930|NCT05362058|616567801|FG001|Follow-Up Period|Death|0|||
170606931|NCT05362058|616567800|FG000|Follow-Up Period|Lost to Follow-up|2|||
170606932|NCT05362058|616567801|FG001|Follow-Up Period|Lost to Follow-up|1|||
170606933|NCT05362058|616567800|FG000|Follow-Up Period|Protocol deviation|1|||
170606934|NCT05362058|616567801|FG001|Follow-Up Period|Protocol deviation|1|||
170606935|NCT05362058|616567800|FG000|Follow-Up Period|Withdrawal by Subject|0|||
170606936|NCT05362058|616567801|FG001|Follow-Up Period|Withdrawal by Subject|3|||
170606937|NCT01235234|616567806|FG000|Overall Study|Adverse Event|2|||
170606938|NCT01235234|616567807|FG001|Overall Study|Adverse Event|2|||
170606939|NCT01235234|616567808|FG002|Overall Study|Adverse Event|1|||
170606940|NCT01363908|616567811|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
170606941|NCT01363908|616567812|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
170606942|NCT01363908|616567811|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
170606943|NCT01363908|616567812|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
170606944|NCT01363908|616567811|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
170606945|NCT01363908|616567812|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
170606946|NCT01363908|616567811|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
170606947|NCT01363908|616567812|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
170606948|NCT05258149|616567813|FG000|Period 1|Protocol Deviation|1|||
170606949|NCT05258149|616567814|FG001|Period 1|Protocol Deviation|0|||
170606950|NCT05258149|616567813|FG000|Period 1|Adverse Event|0|||
170606951|NCT05258149|616567814|FG001|Period 1|Adverse Event|1|||
170606952|NCT05258149|616567813|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
170606953|NCT05258149|616567814|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
170606954|NCT05258149|616567813|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
170606955|NCT05258149|616567814|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
170606956|NCT05258149|616567813|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
170606957|NCT05258149|616567814|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
170606958|NCT04774926|616567817|FG000|Overall Study|Adverse Event|15|||
170606959|NCT04774926|616567817|FG000|Overall Study|Lost to Follow-up|3|||
170606960|NCT04774926|616567817|FG000|Overall Study|Physician Decision|6|||
170606961|NCT04774926|616567817|FG000|Overall Study|Withdrawal by Subject|3|||
170606962|NCT04774926|616567817|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
170606963|NCT01393639|616567818|FG000|Overall Study|Protocol Violation|0|||
170606964|NCT01393639|616567819|FG001|Overall Study|Protocol Violation|0|||
170606965|NCT01393639|616567820|FG002|Overall Study|Protocol Violation|0|||
170606966|NCT01393639|616567821|FG003|Overall Study|Protocol Violation|1|||
170915672|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Adverse Event|37|||
170915673|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Adverse Event|0|||
170915674|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Adverse Event|0|||
170915675|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Adverse Event|0|||
170915676|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Death|2|||
170915677|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Death|0|||
170915678|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Death|0|||
170915679|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Death|0|||
170915680|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
170915681|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
170915682|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
170915683|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
170915684|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
170915685|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
170606967|NCT01393639|616567822|FG004|Overall Study|Protocol Violation|0|||
170606968|NCT01393639|616567823|FG005|Overall Study|Protocol Violation|0|||
170606969|NCT01393639|616567824|FG006|Overall Study|Protocol Violation|0|||
170606970|NCT01393639|616567818|FG000|Overall Study|Other|0|||
170606971|NCT01393639|616567819|FG001|Overall Study|Other|2|||
170606972|NCT01393639|616567820|FG002|Overall Study|Other|0|||
170606973|NCT01393639|616567821|FG003|Overall Study|Other|2|||
170606974|NCT01393639|616567822|FG004|Overall Study|Other|1|||
170606975|NCT01393639|616567823|FG005|Overall Study|Other|0|||
170606976|NCT01393639|616567824|FG006|Overall Study|Other|1|||
170606977|NCT01393639|616567818|FG000|Overall Study|Withdrawal by Subject|1|||
170606978|NCT01393639|616567819|FG001|Overall Study|Withdrawal by Subject|1|||
170915686|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
170915687|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
170606979|NCT01393639|616567820|FG002|Overall Study|Withdrawal by Subject|0|||
170915688|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
170606980|NCT01393639|616567821|FG003|Overall Study|Withdrawal by Subject|0|||
170606981|NCT01393639|616567822|FG004|Overall Study|Withdrawal by Subject|0|||
170915689|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
170606982|NCT01393639|616567823|FG005|Overall Study|Withdrawal by Subject|0|||
170606983|NCT01393639|616567824|FG006|Overall Study|Withdrawal by Subject|1|||
170606984|NCT01393639|616567818|FG000|Overall Study|Medication error without associated AE|0|||
170606985|NCT01393639|616567819|FG001|Overall Study|Medication error without associated AE|0|||
170606986|NCT01393639|616567820|FG002|Overall Study|Medication error without associated AE|0|||
170606987|NCT01393639|616567821|FG003|Overall Study|Medication error without associated AE|0|||
170606988|NCT01393639|616567822|FG004|Overall Study|Medication error without associated AE|0|||
170606989|NCT01393639|616567823|FG005|Overall Study|Medication error without associated AE|0|||
170606990|NCT01393639|616567824|FG006|Overall Study|Medication error without associated AE|1|||
170606991|NCT01393639|616567818|FG000|Overall Study|Lost to Follow-up|0|||
170606992|NCT01393639|616567819|FG001|Overall Study|Lost to Follow-up|1|||
170606993|NCT01393639|616567820|FG002|Overall Study|Lost to Follow-up|0|||
170606994|NCT01393639|616567821|FG003|Overall Study|Lost to Follow-up|0|||
170606995|NCT01393639|616567822|FG004|Overall Study|Lost to Follow-up|0|||
170606996|NCT01393639|616567823|FG005|Overall Study|Lost to Follow-up|0|||
170606997|NCT01393639|616567824|FG006|Overall Study|Lost to Follow-up|1|||
170606998|NCT01393639|616567818|FG000|Overall Study|Lack of Efficacy|0|||
170606999|NCT01393639|616567819|FG001|Overall Study|Lack of Efficacy|0|||
170607000|NCT01393639|616567820|FG002|Overall Study|Lack of Efficacy|0|||
170607001|NCT01393639|616567821|FG003|Overall Study|Lack of Efficacy|0|||
170607002|NCT01393639|616567822|FG004|Overall Study|Lack of Efficacy|0|||
170607003|NCT01393639|616567823|FG005|Overall Study|Lack of Efficacy|0|||
170607004|NCT01393639|616567824|FG006|Overall Study|Lack of Efficacy|1|||
170607005|NCT01393639|616567818|FG000|Overall Study|Adverse Event|2|||
170607006|NCT01393639|616567819|FG001|Overall Study|Adverse Event|3|||
170607007|NCT01393639|616567820|FG002|Overall Study|Adverse Event|1|||
170607008|NCT01393639|616567821|FG003|Overall Study|Adverse Event|2|||
170607009|NCT01393639|616567822|FG004|Overall Study|Adverse Event|0|||
170607010|NCT01393639|616567823|FG005|Overall Study|Adverse Event|2|||
170607011|NCT01393639|616567824|FG006|Overall Study|Adverse Event|3|||
170607012|NCT00793325|616567827|FG000|Overall Study|Protocol Violation|18|||
170607013|NCT00793325|616567827|FG000|Overall Study|Lost to Follow-up|1|||
170607014|NCT00887549|616567830|FG000|Induction Therapy|Adverse Event|8|||
170607015|NCT00887549|616567830|FG000|Induction Therapy|Physician Decision|1|||
170607016|NCT00887549|616567830|FG000|Induction Therapy|Progressive Disease|13|||
170607017|NCT00887549|616567830|FG000|Induction Therapy|Death due to Study Disease|4|||
170607018|NCT00887549|616567830|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
170607019|NCT00887549|616567830|FG000|Maintenance Therapy|Adverse Event|16|||
170607020|NCT00887549|616567830|FG000|Maintenance Therapy|Physician Decision|1|||
170607021|NCT00887549|616567830|FG000|Maintenance Therapy|Progressive Disease|25|||
170607022|NCT00887549|616567830|FG000|Maintenance Therapy|Death due to adverse event|1|||
170607023|NCT00100789|616567831|FG000|Overall Study|Adverse Event|10|||
170607024|NCT00100789|616567831|FG000|Overall Study|Withdrawal by Subject|1|||
170607025|NCT00100789|616567831|FG000|Overall Study|Progression/relapse|42|||
170607026|NCT00100789|616567831|FG000|Overall Study|Death|2|||
170607027|NCT00100789|616567831|FG000|Overall Study|Not protocol specified|5|||
170607028|NCT00100789|616567831|FG000|Overall Study|Ineligible|3|||
170607029|NCT00100789|616567831|FG000|Overall Study|Never received treatment|1|||
170607030|NCT01858740|616567832|FG000|Overall Study|Death|4|||
170607031|NCT03386487|616567834|FG000|Overall Study|Lost to Follow-up|5|||
170607032|NCT03386487|616567835|FG001|Overall Study|Lost to Follow-up|6|||
170607033|NCT03386487|616567834|FG000|Overall Study|Withdrawal by Subject|11|||
170607034|NCT03386487|616567835|FG001|Overall Study|Withdrawal by Subject|7|||
170607035|NCT03386487|616567834|FG000|Overall Study|Physician Decision|11|||
170607036|NCT03386487|616567835|FG001|Overall Study|Physician Decision|8|||
170607037|NCT01068769|616567836|FG000|Overall Study|Ineligible|1|||
170607038|NCT00517361|616567839|FG000|Overall Study|Death|6|||
170607039|NCT00517361|616567839|FG000|Overall Study|The study was terminated|5|||
170607040|NCT00894361|616567840|FG000|Overall Study|deaths and less than 2 years followup|24|||
170607041|NCT00894361|616567841|FG001|Overall Study|deaths and less than 2 years followup|64|||
170607042|NCT02881762|616567842|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
170607043|NCT02881762|616567843|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170607044|NCT01067144|616567847|FG000|Treatment|Did not receive allocated intervention|4|||
170652854|NCT01903252|616743314|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
170652855|NCT01903252|616743315|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
170607045|NCT01067144|616567848|FG001|Treatment|Did not receive allocated intervention|7|||
170607046|NCT01067144|616567847|FG000|Follow-up|Lost to Follow-up|22|||
170607047|NCT01067144|616567848|FG001|Follow-up|Lost to Follow-up|12|||
170607048|NCT01067144|616567847|FG000|Follow-up|Censored owing to second surgery|19|||
170607049|NCT01067144|616567848|FG001|Follow-up|Censored owing to second surgery|28|||
170607050|NCT01067144|616567847|FG000|Follow-up|Withdrawal by Subject|18|||
170607051|NCT01067144|616567848|FG001|Follow-up|Withdrawal by Subject|14|||
170607052|NCT01067144|616567847|FG000|Follow-up|Surgery cancelled|0|||
170607053|NCT01067144|616567848|FG001|Follow-up|Surgery cancelled|1|||
170607054|NCT01067144|616567847|FG000|Follow-up|Death|0|||
170607055|NCT01067144|616567848|FG001|Follow-up|Death|1|||
170607056|NCT00880191|616567855|FG000|Overall Study|Refused further treatment|4|||
170607057|NCT00880191|616567856|FG001|Overall Study|Refused further treatment|1|||
170607058|NCT00880191|616567855|FG000|Overall Study|Adverse Event|8|||
170607059|NCT00880191|616567856|FG001|Overall Study|Adverse Event|6|||
170607060|NCT00880191|616567855|FG000|Overall Study|Hospitalization/efficacy|1|||
170607061|NCT00880191|616567856|FG001|Overall Study|Hospitalization/efficacy|1|||
170607062|NCT02097030|616567858|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
170607063|NCT02097030|616567859|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
170607064|NCT02097030|616567858|FG000|First Intervention (3 Days)|Visual Acuity|0|||
170607065|NCT02097030|616567859|FG001|First Intervention (3 Days)|Visual Acuity|1|||
170607066|NCT01919801|616567860|FG000|Overall Study|Withdrawal by Subject|1|||
170607067|NCT01919801|616567861|FG001|Overall Study|Withdrawal by Subject|0|||
170607068|NCT01919801|616567860|FG000|Overall Study|Physician Decision|0|||
170607069|NCT01919801|616567861|FG001|Overall Study|Physician Decision|1|||
170607070|NCT01919801|616567860|FG000|Overall Study|Lost to Follow-up|0|||
170607071|NCT01919801|616567861|FG001|Overall Study|Lost to Follow-up|1|||
170607072|NCT01919801|616567860|FG000|Overall Study|Other|0|||
170607073|NCT01919801|616567861|FG001|Overall Study|Other|1|||
170607074|NCT01843062|616567862|FG000|Overall Study|Protocol Violation|1|||
170607075|NCT01843062|616567863|FG001|Overall Study|Protocol Violation|0|||
170607076|NCT01843062|616567862|FG000|Overall Study|New treatment following progression|2|||
170607077|NCT01843062|616567863|FG001|Overall Study|New treatment following progression|0|||
170607078|NCT01843062|616567862|FG000|Overall Study|Pregnancy|1|||
170607079|NCT01843062|616567863|FG001|Overall Study|Pregnancy|0|||
170607080|NCT01843062|616567862|FG000|Overall Study|Adverse Event|2|||
170607081|NCT01843062|616567863|FG001|Overall Study|Adverse Event|0|||
170607082|NCT01843062|616567862|FG000|Overall Study|Incorrect randomisation|1|||
170607083|NCT01843062|616567863|FG001|Overall Study|Incorrect randomisation|0|||
170607084|NCT01843062|616567862|FG000|Overall Study|Withdrawal by Subject|12|||
170607085|NCT01843062|616567863|FG001|Overall Study|Withdrawal by Subject|3|||
170607086|NCT01843062|616567862|FG000|Overall Study|Death|1|||
170607087|NCT01843062|616567863|FG001|Overall Study|Death|2|||
170607088|NCT01843062|616567862|FG000|Overall Study|Lost to Follow-up|2|||
170607089|NCT01843062|616567863|FG001|Overall Study|Lost to Follow-up|4|||
170607090|NCT03078855|616567864|FG000|Overall Study|Lack of Efficacy|62|||
170607091|NCT03078855|616567865|FG001|Overall Study|Lack of Efficacy|31|||
170607092|NCT03078855|616567864|FG000|Overall Study|Death|1|||
170607093|NCT03078855|616567865|FG001|Overall Study|Death|0|||
170607094|NCT03078855|616567864|FG000|Overall Study|Withdrawal by Subject|12|||
170607095|NCT03078855|616567865|FG001|Overall Study|Withdrawal by Subject|6|||
170607096|NCT03078855|616567864|FG000|Overall Study|Physician Decision|3|||
170607097|NCT03078855|616567865|FG001|Overall Study|Physician Decision|2|||
170607098|NCT03078855|616567864|FG000|Overall Study|Second Malignancy|4|||
170607099|NCT03078855|616567865|FG001|Overall Study|Second Malignancy|0|||
170607100|NCT03078855|616567864|FG000|Overall Study|Ineligible|2|||
170607101|NCT03078855|616567865|FG001|Overall Study|Ineligible|0|||
170607102|NCT03078855|616567864|FG000|Overall Study|Withdrew before day 1 treatment|2|||
170607103|NCT03078855|616567865|FG001|Overall Study|Withdrew before day 1 treatment|1|||
170607104|NCT00391027|616567866|FG000|Overall Study|Adverse Event|8|||
170607105|NCT00391027|616567867|FG001|Overall Study|Adverse Event|8|||
170652856|NCT01903252|616743316|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
170652857|NCT01903252|616743317|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
170815003|NCT01587703|617331416|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815004|NCT01587703|617331417|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815005|NCT01587703|617331418|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815006|NCT01587703|617331419|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815007|NCT01587703|617331420|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815008|NCT01587703|617331421|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815009|NCT01587703|617331422|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815010|NCT01587703|617331423|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
170815011|NCT01587703|617331405|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815012|NCT01587703|617331406|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815013|NCT01587703|617331407|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170607106|NCT00391027|616567866|FG000|Overall Study|Lack of Efficacy|3|||
170607107|NCT00391027|616567867|FG001|Overall Study|Lack of Efficacy|0|||
170607108|NCT00391027|616567866|FG000|Overall Study|Withdrawal by Subject|10|||
170607109|NCT00391027|616567867|FG001|Overall Study|Withdrawal by Subject|1|||
170607110|NCT00391027|616567866|FG000|Overall Study|Other|4|||
170607111|NCT00391027|616567867|FG001|Overall Study|Other|3|||
170607112|NCT03194646|616567868|FG000|Overall Study|Adverse Event|24|||
170607113|NCT03194646|616567869|FG001|Overall Study|Adverse Event|25|||
170607114|NCT03194646|616567870|FG002|Overall Study|Adverse Event|14|||
170607115|NCT03194646|616567871|FG003|Overall Study|Adverse Event|17|||
170607116|NCT03194646|616567868|FG000|Overall Study|Lack of Efficacy|4|||
170607117|NCT03194646|616567869|FG001|Overall Study|Lack of Efficacy|2|||
170607118|NCT03194646|616567870|FG002|Overall Study|Lack of Efficacy|2|||
170607119|NCT03194646|616567871|FG003|Overall Study|Lack of Efficacy|12|||
170607120|NCT03194646|616567868|FG000|Overall Study|Lost to Follow-up|30|||
170607121|NCT03194646|616567869|FG001|Overall Study|Lost to Follow-up|22|||
170607122|NCT03194646|616567870|FG002|Overall Study|Lost to Follow-up|12|||
170915690|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
170915691|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
170915692|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
170915693|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
170915694|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
170915695|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
170915696|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Physician Decision|4|||
170915697|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Physician Decision|0|||
170915698|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Physician Decision|0|||
170915699|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Physician Decision|0|||
170915700|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Pregnancy|1|||
170915701|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Pregnancy|0|||
170915702|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Pregnancy|0|||
170915703|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Pregnancy|0|||
170915704|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
170915705|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
170915706|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
170915707|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
170915708|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
170915709|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
170915710|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
170915711|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
170915712|NCT01855789|617693609|FG000|1) Baseline up to Week 24|Other|4|||
170915713|NCT01855789|617693610|FG001|1) Baseline up to Week 24|Other|0|||
170915714|NCT01855789|617693611|FG002|1) Baseline up to Week 24|Other|0|||
170915715|NCT01855789|617693612|FG003|1) Baseline up to Week 24|Other|0|||
170915716|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
170915717|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
170915718|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
170915719|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
170607123|NCT03194646|616567871|FG003|Overall Study|Lost to Follow-up|35|||
170607124|NCT03194646|616567868|FG000|Overall Study|Non-compliance with study drug|4|||
170607125|NCT03194646|616567869|FG001|Overall Study|Non-compliance with study drug|0|||
170607126|NCT03194646|616567870|FG002|Overall Study|Non-compliance with study drug|1|||
170607127|NCT03194646|616567871|FG003|Overall Study|Non-compliance with study drug|1|||
170607128|NCT03194646|616567868|FG000|Overall Study|Other|89|||
170607129|NCT03194646|616567869|FG001|Overall Study|Other|68|||
170607130|NCT03194646|616567870|FG002|Overall Study|Other|34|||
170607131|NCT03194646|616567871|FG003|Overall Study|Other|31|||
170607132|NCT03194646|616567868|FG000|Overall Study|Physician Decision|7|||
170607133|NCT03194646|616567869|FG001|Overall Study|Physician Decision|9|||
170607134|NCT03194646|616567870|FG002|Overall Study|Physician Decision|5|||
170607135|NCT03194646|616567871|FG003|Overall Study|Physician Decision|4|||
170607136|NCT03194646|616567868|FG000|Overall Study|Pregnancy|4|||
170607137|NCT03194646|616567869|FG001|Overall Study|Pregnancy|5|||
170607138|NCT03194646|616567870|FG002|Overall Study|Pregnancy|1|||
170607139|NCT03194646|616567871|FG003|Overall Study|Pregnancy|2|||
170607140|NCT03194646|616567868|FG000|Overall Study|Protocol Violation|4|||
170607141|NCT03194646|616567869|FG001|Overall Study|Protocol Violation|2|||
170607142|NCT03194646|616567870|FG002|Overall Study|Protocol Violation|1|||
170607143|NCT03194646|616567871|FG003|Overall Study|Protocol Violation|1|||
170607144|NCT03194646|616567868|FG000|Overall Study|Site terminated by sponsor|0|||
170607145|NCT03194646|616567869|FG001|Overall Study|Site terminated by sponsor|0|||
170607146|NCT03194646|616567870|FG002|Overall Study|Site terminated by sponsor|2|||
170607147|NCT03194646|616567871|FG003|Overall Study|Site terminated by sponsor|0|||
170607148|NCT03194646|616567868|FG000|Overall Study|Study terminated by sponsor|62|||
170607149|NCT03194646|616567869|FG001|Overall Study|Study terminated by sponsor|61|||
170607150|NCT03194646|616567870|FG002|Overall Study|Study terminated by sponsor|30|||
170607151|NCT03194646|616567871|FG003|Overall Study|Study terminated by sponsor|34|||
170607152|NCT03194646|616567868|FG000|Overall Study|Withdrawal by Subject|75|||
170607153|NCT03194646|616567869|FG001|Overall Study|Withdrawal by Subject|74|||
170607154|NCT03194646|616567870|FG002|Overall Study|Withdrawal by Subject|36|||
170607155|NCT03194646|616567871|FG003|Overall Study|Withdrawal by Subject|131|||
170607156|NCT03194646|616567868|FG000|Overall Study|Missing|1|||
170915720|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
170915721|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
170915722|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
170915723|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
170915724|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
170607157|NCT03194646|616567869|FG001|Overall Study|Missing|0|||
170607158|NCT03194646|616567870|FG002|Overall Study|Missing|1|||
170607159|NCT03194646|616567871|FG003|Overall Study|Missing|12|||
170607160|NCT00098306|616567875|FG000|Double Blind|Randomized, not treated|9|||
170607161|NCT00098306|616567876|FG001|Double Blind|Randomized, not treated|5|||
170607162|NCT00098306|616567877|FG002|Double Blind|Randomized, not treated|2|||
170607163|NCT00098306|616567878|FG003|Double Blind|Randomized, not treated|0|||
170607164|NCT00098306|616567879|FG004|Double Blind|Randomized, not treated|0|||
170607165|NCT00098306|616567880|FG005|Double Blind|Randomized, not treated|0|||
170607166|NCT00098306|616567881|FG006|Double Blind|Randomized, not treated|0|||
170607167|NCT00098306|616567875|FG000|Double Blind|Ongoing at cut-off date|151|||
170607168|NCT00098306|616567876|FG001|Double Blind|Ongoing at cut-off date|166|||
170607169|NCT00098306|616567877|FG002|Double Blind|Ongoing at cut-off date|72|||
170607170|NCT00098306|616567878|FG003|Double Blind|Ongoing at cut-off date|0|||
170607171|NCT00098306|616567879|FG004|Double Blind|Ongoing at cut-off date|0|||
170607172|NCT00098306|616567880|FG005|Double Blind|Ongoing at cut-off date|0|||
170607173|NCT00098306|616567881|FG006|Double Blind|Ongoing at cut-off date|0|||
170607174|NCT00098306|616567875|FG000|Double Blind|Adverse Event|11|||
170607175|NCT00098306|616567876|FG001|Double Blind|Adverse Event|10|||
170607176|NCT00098306|616567877|FG002|Double Blind|Adverse Event|6|||
170607177|NCT00098306|616567878|FG003|Double Blind|Adverse Event|0|||
170607178|NCT00098306|616567879|FG004|Double Blind|Adverse Event|0|||
170607179|NCT00098306|616567880|FG005|Double Blind|Adverse Event|0|||
170607180|NCT00098306|616567881|FG006|Double Blind|Adverse Event|0|||
170607181|NCT00098306|616567875|FG000|Double Blind|Lack of Efficacy|43|||
170607182|NCT00098306|616567876|FG001|Double Blind|Lack of Efficacy|34|||
170607183|NCT00098306|616567877|FG002|Double Blind|Lack of Efficacy|17|||
170607184|NCT00098306|616567878|FG003|Double Blind|Lack of Efficacy|0|||
170607185|NCT00098306|616567879|FG004|Double Blind|Lack of Efficacy|0|||
170607186|NCT00098306|616567880|FG005|Double Blind|Lack of Efficacy|0|||
170607187|NCT00098306|616567881|FG006|Double Blind|Lack of Efficacy|0|||
170607188|NCT00098306|616567875|FG000|Double Blind|Death|1|||
170607189|NCT00098306|616567876|FG001|Double Blind|Death|4|||
170607190|NCT00098306|616567877|FG002|Double Blind|Death|1|||
170607191|NCT00098306|616567878|FG003|Double Blind|Death|0|||
170607192|NCT00098306|616567879|FG004|Double Blind|Death|0|||
170607193|NCT00098306|616567880|FG005|Double Blind|Death|0|||
170607194|NCT00098306|616567881|FG006|Double Blind|Death|0|||
170607195|NCT00098306|616567875|FG000|Double Blind|Participant defaulted|19|||
170607196|NCT00098306|616567876|FG001|Double Blind|Participant defaulted|18|||
170607197|NCT00098306|616567877|FG002|Double Blind|Participant defaulted|11|||
170607198|NCT00098306|616567878|FG003|Double Blind|Participant defaulted|0|||
170607199|NCT00098306|616567879|FG004|Double Blind|Participant defaulted|0|||
170607200|NCT00098306|616567880|FG005|Double Blind|Participant defaulted|0|||
170607201|NCT00098306|616567881|FG006|Double Blind|Participant defaulted|0|||
170607202|NCT00098306|616567875|FG000|Double Blind|Un-specified|7|||
170607203|NCT00098306|616567876|FG001|Double Blind|Un-specified|3|||
170607204|NCT00098306|616567877|FG002|Double Blind|Un-specified|11|||
170607205|NCT00098306|616567878|FG003|Double Blind|Un-specified|0|||
170607206|NCT00098306|616567879|FG004|Double Blind|Un-specified|0|||
170607207|NCT00098306|616567880|FG005|Double Blind|Un-specified|0|||
170607208|NCT00098306|616567881|FG006|Double Blind|Un-specified|0|||
170607209|NCT00098306|616567875|FG000|Open Label|Lack of Efficacy|0|||
170607210|NCT00098306|616567876|FG001|Open Label|Lack of Efficacy|0|||
170607211|NCT00098306|616567877|FG002|Open Label|Lack of Efficacy|0|||
170607212|NCT00098306|616567878|FG003|Open Label|Lack of Efficacy|13|||
170607213|NCT00098306|616567879|FG004|Open Label|Lack of Efficacy|0|||
170607214|NCT00098306|616567880|FG005|Open Label|Lack of Efficacy|0|||
170607215|NCT00098306|616567881|FG006|Open Label|Lack of Efficacy|0|||
170607216|NCT00098306|616567875|FG000|Open Label|Adverse Event|0|||
170607217|NCT00098306|616567876|FG001|Open Label|Adverse Event|0|||
170607218|NCT00098306|616567877|FG002|Open Label|Adverse Event|0|||
170607219|NCT00098306|616567878|FG003|Open Label|Adverse Event|2|||
170607220|NCT00098306|616567879|FG004|Open Label|Adverse Event|0|||
170607221|NCT00098306|616567880|FG005|Open Label|Adverse Event|0|||
170607222|NCT00098306|616567881|FG006|Open Label|Adverse Event|0|||
170607223|NCT00098306|616567875|FG000|Open Label|Death|0|||
170607224|NCT00098306|616567876|FG001|Open Label|Death|0|||
170607225|NCT00098306|616567877|FG002|Open Label|Death|0|||
170607226|NCT00098306|616567878|FG003|Open Label|Death|4|||
170607227|NCT00098306|616567879|FG004|Open Label|Death|0|||
170607228|NCT00098306|616567880|FG005|Open Label|Death|0|||
170607229|NCT00098306|616567881|FG006|Open Label|Death|0|||
170607230|NCT00098306|616567875|FG000|Open Label|Participant defaulted|0|||
170607231|NCT00098306|616567876|FG001|Open Label|Participant defaulted|0|||
170815014|NCT01587703|617331408|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815015|NCT01587703|617331409|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815016|NCT01587703|617331410|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170607232|NCT00098306|616567877|FG002|Open Label|Participant defaulted|0|||
170607233|NCT00098306|616567878|FG003|Open Label|Participant defaulted|24|||
170607234|NCT00098306|616567879|FG004|Open Label|Participant defaulted|0|||
170607235|NCT00098306|616567880|FG005|Open Label|Participant defaulted|0|||
170607236|NCT00098306|616567881|FG006|Open Label|Participant defaulted|0|||
170607237|NCT00098306|616567875|FG000|Open Label|Un-specified|0|||
170607238|NCT00098306|616567876|FG001|Open Label|Un-specified|0|||
170607239|NCT00098306|616567877|FG002|Open Label|Un-specified|0|||
170607240|NCT00098306|616567878|FG003|Open Label|Un-specified|15|||
170607241|NCT00098306|616567879|FG004|Open Label|Un-specified|0|||
170607242|NCT00098306|616567880|FG005|Open Label|Un-specified|0|||
170607243|NCT00098306|616567881|FG006|Open Label|Un-specified|0|||
170607244|NCT00098306|616567875|FG000|Open Label|Ongoing at cut-off date|0|||
170607245|NCT00098306|616567876|FG001|Open Label|Ongoing at cut-off date|0|||
170607246|NCT00098306|616567877|FG002|Open Label|Ongoing at cut-off date|0|||
170607247|NCT00098306|616567878|FG003|Open Label|Ongoing at cut-off date|269|||
170607248|NCT00098306|616567879|FG004|Open Label|Ongoing at cut-off date|62|||
170607249|NCT00098306|616567880|FG005|Open Label|Ongoing at cut-off date|0|||
170607250|NCT00098306|616567881|FG006|Open Label|Ongoing at cut-off date|0|||
170607251|NCT00098306|616567875|FG000|Observational Phase|Death|0|||
170607252|NCT00098306|616567876|FG001|Observational Phase|Death|0|||
170607253|NCT00098306|616567877|FG002|Observational Phase|Death|0|||
170607254|NCT00098306|616567878|FG003|Observational Phase|Death|0|||
170607255|NCT00098306|616567879|FG004|Observational Phase|Death|0|||
170607256|NCT00098306|616567880|FG005|Observational Phase|Death|5|||
170607257|NCT00098306|616567881|FG006|Observational Phase|Death|4|||
170607258|NCT00098306|616567875|FG000|Observational Phase|Participant defaulted|0|||
170607259|NCT00098306|616567876|FG001|Observational Phase|Participant defaulted|0|||
170607260|NCT00098306|616567877|FG002|Observational Phase|Participant defaulted|0|||
170607261|NCT00098306|616567878|FG003|Observational Phase|Participant defaulted|0|||
170607262|NCT00098306|616567879|FG004|Observational Phase|Participant defaulted|0|||
170607263|NCT00098306|616567880|FG005|Observational Phase|Participant defaulted|34|||
170607264|NCT00098306|616567881|FG006|Observational Phase|Participant defaulted|18|||
170607265|NCT00098306|616567875|FG000|Observational Phase|Un-specified|0|||
170607266|NCT00098306|616567876|FG001|Observational Phase|Un-specified|0|||
170607267|NCT00098306|616567877|FG002|Observational Phase|Un-specified|0|||
170607268|NCT00098306|616567878|FG003|Observational Phase|Un-specified|0|||
170607269|NCT00098306|616567879|FG004|Observational Phase|Un-specified|0|||
170607270|NCT00098306|616567880|FG005|Observational Phase|Un-specified|7|||
170607271|NCT00098306|616567881|FG006|Observational Phase|Un-specified|4|||
170607272|NCT00300365|616567882|FG000|Overall Study|Lost to Follow-up|1|||
170607273|NCT00300365|616567883|FG001|Overall Study|Lost to Follow-up|0|||
170607274|NCT00300365|616567882|FG000|Overall Study|Physician Decision|2|||
170607275|NCT00300365|616567883|FG001|Overall Study|Physician Decision|0|||
170607276|NCT00300365|616567882|FG000|Overall Study|Withdrawal by Subject|1|||
170607277|NCT00300365|616567883|FG001|Overall Study|Withdrawal by Subject|0|||
170607278|NCT00300365|616567882|FG000|Overall Study|Adverse Event|0|||
170652858|NCT01903252|616743318|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
170652859|NCT01903252|616743319|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
170607279|NCT00300365|616567883|FG001|Overall Study|Adverse Event|2|||
170607280|NCT00077649|616567884|FG000|Overall Study|Adverse Event|5|||
170607281|NCT00077649|616567885|FG001|Overall Study|Adverse Event|1|||
170607282|NCT00077649|616567886|FG002|Overall Study|Adverse Event|7|||
170607283|NCT00077649|616567887|FG003|Overall Study|Adverse Event|9|||
170652860|NCT01903252|616743314|FG000|Extended Induction, Open-Label|Physician Decision|0|||
170607284|NCT00077649|616567884|FG000|Overall Study|Lack of Efficacy|5|||
170607285|NCT00077649|616567885|FG001|Overall Study|Lack of Efficacy|3|||
170607286|NCT00077649|616567886|FG002|Overall Study|Lack of Efficacy|3|||
170607287|NCT00077649|616567887|FG003|Overall Study|Lack of Efficacy|2|||
170652861|NCT01903252|616743315|FG001|Extended Induction, Open-Label|Physician Decision|0|||
170652862|NCT01903252|616743316|FG002|Extended Induction, Open-Label|Physician Decision|1|||
170652863|NCT01903252|616743317|FG003|Extended Induction, Open-Label|Physician Decision|0|||
170652864|NCT01903252|616743318|FG004|Extended Induction, Open-Label|Physician Decision|0|||
170652865|NCT01903252|616743319|FG005|Extended Induction, Open-Label|Physician Decision|0|||
170652866|NCT01903252|616743314|FG000|Maintenance, Open-Label|Adverse Event|0|||
170652867|NCT01903252|616743315|FG001|Maintenance, Open-Label|Adverse Event|0|||
170652868|NCT01903252|616743316|FG002|Maintenance, Open-Label|Adverse Event|0|||
170652869|NCT01903252|616743317|FG003|Maintenance, Open-Label|Adverse Event|3|||
170652870|NCT01903252|616743318|FG004|Maintenance, Open-Label|Adverse Event|9|||
170607288|NCT00077649|616567884|FG000|Overall Study|Withdrawal by Subject|0|||
170607289|NCT00077649|616567885|FG001|Overall Study|Withdrawal by Subject|1|||
170607290|NCT00077649|616567886|FG002|Overall Study|Withdrawal by Subject|1|||
170607291|NCT00077649|616567887|FG003|Overall Study|Withdrawal by Subject|2|||
170607292|NCT00077649|616567884|FG000|Overall Study|Lost to Follow-up|2|||
170607293|NCT00077649|616567885|FG001|Overall Study|Lost to Follow-up|2|||
170607294|NCT00077649|616567886|FG002|Overall Study|Lost to Follow-up|3|||
170607295|NCT00077649|616567887|FG003|Overall Study|Lost to Follow-up|2|||
170607296|NCT00077649|616567884|FG000|Overall Study|Abnormality of Laboratory Test|1|||
170607297|NCT00077649|616567885|FG001|Overall Study|Abnormality of Laboratory Test|2|||
170607298|NCT00077649|616567886|FG002|Overall Study|Abnormality of Laboratory Test|1|||
170607299|NCT00077649|616567887|FG003|Overall Study|Abnormality of Laboratory Test|2|||
170607300|NCT00077649|616567884|FG000|Overall Study|Randomized but never dosed|1|||
170607301|NCT00077649|616567885|FG001|Overall Study|Randomized but never dosed|0|||
170607302|NCT00077649|616567886|FG002|Overall Study|Randomized but never dosed|0|||
170607303|NCT00077649|616567887|FG003|Overall Study|Randomized but never dosed|0|||
170607304|NCT00844558|616567890|FG000|Overall Study|Withdrawal by Subject|9|||
170607305|NCT00844558|616567891|FG001|Overall Study|Withdrawal by Subject|2|||
170607306|NCT00844558|616567890|FG000|Overall Study|Death|1|||
170607307|NCT00844558|616567891|FG001|Overall Study|Death|0|||
170607308|NCT00844558|616567890|FG000|Overall Study|Protocol Violation|1|||
170607309|NCT00844558|616567891|FG001|Overall Study|Protocol Violation|1|||
170607310|NCT00844558|616567890|FG000|Overall Study|Lost to Follow-up|0|||
170607311|NCT00844558|616567891|FG001|Overall Study|Lost to Follow-up|1|||
170607312|NCT00844558|616567890|FG000|Overall Study|Physician Decision|1|||
170607313|NCT00844558|616567891|FG001|Overall Study|Physician Decision|0|||
170607314|NCT00416455|616567897|FG000|Overall Study|PET / CT not done|3|||
170607315|NCT00416455|616567898|FG001|Overall Study|PET / CT not done|5|||
170607316|NCT00416455|616567897|FG000|Overall Study|PET / CT poor quality|2|||
170607317|NCT00416455|616567898|FG001|Overall Study|PET / CT poor quality|1|||
170607318|NCT00416455|616567897|FG000|Overall Study|Inadequate pathology|11|||
170607319|NCT00416455|616567898|FG001|Overall Study|Inadequate pathology|2|||
170607320|NCT00781859|616567899|FG000|Overall Study|Adverse Event|2|||
170607321|NCT00781859|616567900|FG001|Overall Study|Adverse Event|2|||
170607322|NCT00781859|616567899|FG000|Overall Study|Withdrawal by Subject|8|||
170607323|NCT00781859|616567900|FG001|Overall Study|Withdrawal by Subject|4|||
170607324|NCT00781859|616567899|FG000|Overall Study|Lost to Follow-up|6|||
170815017|NCT01587703|617331411|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815018|NCT01587703|617331412|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815019|NCT01587703|617331413|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
170815020|NCT01587703|617331414|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
170815021|NCT01587703|617331415|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
170815022|NCT01587703|617331416|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815023|NCT01587703|617331417|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815024|NCT01587703|617331418|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815025|NCT01587703|617331419|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815026|NCT01587703|617331420|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815027|NCT01587703|617331421|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815028|NCT01587703|617331422|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170915725|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
170915726|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
170915727|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
170915728|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
170915729|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
170915730|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
170915731|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
170915732|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
170915733|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
170915734|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
170915735|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
170915736|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
170915737|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
170915738|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
170915739|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
170915740|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
170915741|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
170915742|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
170915743|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
170607325|NCT00781859|616567900|FG001|Overall Study|Lost to Follow-up|3|||
170607326|NCT00781859|616567899|FG000|Overall Study|Death|3|||
170607327|NCT00781859|616567900|FG001|Overall Study|Death|0|||
170607328|NCT01008449|616567902|FG000|Overall Study|Lost to Follow-up|29|||
170607329|NCT01008449|616567903|FG001|Overall Study|Lost to Follow-up|19|||
170607330|NCT02554981|616567904|FG000|Overall Study|Adverse Event|1|||
170607331|NCT02554981|616567904|FG000|Overall Study|Administrative Reasons|1|||
170607332|NCT02554981|616567904|FG000|Overall Study|Other Miscellaneous Reasons|3|||
170607333|NCT01959243|616567905|FG000|Overall Study|Investigator Decision|3|||
170607334|NCT01959243|616567906|FG001|Overall Study|Investigator Decision|0|||
170607335|NCT01959243|616567905|FG000|Overall Study|Adverse Event|5|||
170607336|NCT01959243|616567906|FG001|Overall Study|Adverse Event|2|||
170607337|NCT01959243|616567905|FG000|Overall Study|Administrative reasons|2|||
170607338|NCT01959243|616567906|FG001|Overall Study|Administrative reasons|1|||
170607339|NCT01959243|616567905|FG000|Overall Study|Lost to Follow-up|3|||
170607340|NCT01959243|616567906|FG001|Overall Study|Lost to Follow-up|1|||
170607341|NCT01793883|616567910|FG000|Overall Study|Withdrawal by Subject|3|||
170607342|NCT01793883|616567911|FG001|Overall Study|Withdrawal by Subject|7|||
170607343|NCT01793883|616567912|FG002|Overall Study|Withdrawal by Subject|3|||
170607344|NCT01793883|616567910|FG000|Overall Study|Subject noncompliance|0|||
170607345|NCT01793883|616567911|FG001|Overall Study|Subject noncompliance|1|||
170607346|NCT01793883|616567912|FG002|Overall Study|Subject noncompliance|1|||
170607347|NCT01793883|616567910|FG000|Overall Study|Lost to Follow-up|5|||
170607348|NCT01793883|616567911|FG001|Overall Study|Lost to Follow-up|1|||
170607349|NCT01793883|616567912|FG002|Overall Study|Lost to Follow-up|3|||
170607350|NCT01793883|616567910|FG000|Overall Study|Randomized in error|1|||
170607351|NCT01793883|616567911|FG001|Overall Study|Randomized in error|0|||
170607352|NCT01793883|616567912|FG002|Overall Study|Randomized in error|0|||
170607353|NCT01793883|616567910|FG000|Overall Study|Unable to complete spriometry|1|||
170607354|NCT01793883|616567911|FG001|Overall Study|Unable to complete spriometry|0|||
170607355|NCT01793883|616567912|FG002|Overall Study|Unable to complete spriometry|0|||
170607356|NCT01793883|616567910|FG000|Overall Study|Unable to complete measurements|1|||
170607357|NCT01793883|616567911|FG001|Overall Study|Unable to complete measurements|0|||
170815029|NCT01587703|617331423|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
170815030|NCT01587703|617331405|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170915744|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
170607358|NCT01793883|616567912|FG002|Overall Study|Unable to complete measurements|0|||
170607359|NCT01793883|616567910|FG000|Overall Study|Met exclusion criteria|1|||
170607360|NCT01793883|616567911|FG001|Overall Study|Met exclusion criteria|0|||
170607361|NCT01793883|616567912|FG002|Overall Study|Met exclusion criteria|0|||
170607362|NCT01793883|616567910|FG000|Overall Study|Dosing error|0|||
170607363|NCT01793883|616567911|FG001|Overall Study|Dosing error|1|||
170652871|NCT01903252|616743319|FG005|Maintenance, Open-Label|Adverse Event|14|||
170652872|NCT01903252|616743314|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
170815031|NCT01587703|617331406|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815032|NCT01587703|617331407|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815033|NCT01587703|617331408|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815034|NCT01587703|617331409|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815035|NCT01587703|617331410|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815036|NCT01587703|617331411|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815037|NCT01587703|617331412|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815038|NCT01587703|617331413|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
170815039|NCT01587703|617331414|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815040|NCT01587703|617331415|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
170815041|NCT01587703|617331416|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815042|NCT01587703|617331417|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815043|NCT01587703|617331418|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815044|NCT01587703|617331419|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815045|NCT01587703|617331420|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815046|NCT01587703|617331421|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815047|NCT01587703|617331422|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815048|NCT01587703|617331423|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
170815049|NCT01587703|617331405|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815050|NCT01587703|617331406|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815051|NCT01587703|617331407|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815052|NCT01587703|617331408|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815053|NCT01587703|617331409|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815054|NCT01587703|617331410|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815055|NCT01587703|617331411|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815056|NCT01587703|617331412|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815057|NCT01587703|617331413|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815058|NCT01587703|617331414|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
170815059|NCT01587703|617331415|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
170815060|NCT01587703|617331416|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815061|NCT01587703|617331417|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815062|NCT01587703|617331418|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815063|NCT01587703|617331419|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815064|NCT01587703|617331420|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815065|NCT01587703|617331421|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815066|NCT01587703|617331422|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815067|NCT01587703|617331423|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
170815068|NCT01587703|617331405|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815069|NCT01587703|617331406|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815070|NCT01587703|617331407|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815071|NCT01587703|617331408|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815072|NCT01587703|617331409|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815073|NCT01587703|617331410|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815074|NCT01587703|617331411|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815075|NCT01587703|617331412|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815076|NCT01587703|617331413|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
170815077|NCT01587703|617331414|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815078|NCT01587703|617331415|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815079|NCT01587703|617331416|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815080|NCT01587703|617331417|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815081|NCT01587703|617331418|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815082|NCT01587703|617331419|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815083|NCT01587703|617331420|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815084|NCT01587703|617331421|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815085|NCT01587703|617331422|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815086|NCT01587703|617331423|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
170815087|NCT01587703|617331405|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815088|NCT01587703|617331406|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815089|NCT01587703|617331407|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170652873|NCT01903252|616743315|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
170652874|NCT01903252|616743316|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
170652875|NCT01903252|616743317|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
170652876|NCT01903252|616743318|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
170652877|NCT01903252|616743319|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
170652878|NCT01903252|616743314|FG000|Maintenance, Open-Label|Other|0|||
170652879|NCT01903252|616743315|FG001|Maintenance, Open-Label|Other|0|||
170652880|NCT01903252|616743316|FG002|Maintenance, Open-Label|Other|0|||
170652881|NCT01903252|616743317|FG003|Maintenance, Open-Label|Other|2|||
170652882|NCT01903252|616743318|FG004|Maintenance, Open-Label|Other|6|||
170652883|NCT01903252|616743319|FG005|Maintenance, Open-Label|Other|2|||
170652884|NCT03562767|616743328|FG000|Overall Study|Physician Decision|2|||
170652885|NCT03562767|616743329|FG001|Overall Study|Physician Decision|0|||
170652886|NCT03562767|616743330|FG002|Overall Study|Physician Decision|0|||
170652887|NCT03562767|616743328|FG000|Overall Study|Logistic Reason|1|||
170652888|NCT03562767|616743329|FG001|Overall Study|Logistic Reason|3|||
170652889|NCT03562767|616743330|FG002|Overall Study|Logistic Reason|0|||
170652890|NCT01589770|616743333|FG000|Overall Study|EGFR <60ml/min|6|||
170652891|NCT01589770|616743334|FG001|Overall Study|EGFR <60ml/min|4|||
170652892|NCT01589770|616743333|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
170652893|NCT01589770|616743334|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
170652894|NCT02518464|616743337|FG000|Overall Study|Adverse Event|2|||
170652895|NCT03761797|616743338|FG000|Overall Study|Changing hospital|11|||
170652896|NCT03761797|616743338|FG000|Overall Study|Improvement/remission|6|||
170815090|NCT01587703|617331408|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815091|NCT01587703|617331409|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170652897|NCT03761797|616743338|FG000|Overall Study|Withdrawal by Subject|19|||
170652898|NCT03761797|616743338|FG000|Overall Study|Lost to Follow-up|33|||
170652899|NCT03761797|616743338|FG000|Overall Study|Adverse Event|37|||
170652900|NCT03761797|616743338|FG000|Overall Study|Case report form (CRF) not collected|5|||
170652901|NCT03761797|616743338|FG000|Overall Study|No patient visit after entry|13|||
170652902|NCT03761797|616743338|FG000|Overall Study|Switch to other diabetes medication|10|||
170652903|NCT03761797|616743338|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
170652904|NCT03761797|616743338|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
170652905|NCT03761797|616743338|FG000|Overall Study|Insufficient effectives|2|||
170815092|NCT01587703|617331410|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170652906|NCT03761797|616743338|FG000|Overall Study|Excessive alcohol intake|1|||
170652907|NCT00645788|616743341|FG000|Overall Study|Did not receive study drug|1|||
170652908|NCT00645788|616743342|FG001|Overall Study|Did not receive study drug|1|||
170652909|NCT00645788|616743343|FG002|Overall Study|Did not receive study drug|0|||
170652910|NCT00645788|616743344|FG003|Overall Study|Did not receive study drug|0|||
170652911|NCT00645788|616743341|FG000|Overall Study|Adverse Event|4|||
170652912|NCT00645788|616743342|FG001|Overall Study|Adverse Event|9|||
170652913|NCT00645788|616743343|FG002|Overall Study|Adverse Event|5|||
170915745|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
170915746|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
170915747|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
170915748|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
170915749|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
170915750|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
170915751|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
170915752|NCT01855789|617693609|FG000|2) Week 24 up to End of Study|Other|0|||
170915753|NCT01855789|617693610|FG001|2) Week 24 up to End of Study|Other|0|||
170915754|NCT01855789|617693611|FG002|2) Week 24 up to End of Study|Other|0|||
170915755|NCT01855789|617693612|FG003|2) Week 24 up to End of Study|Other|1|||
170915756|NCT01863758|617693613|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
170915757|NCT01863758|617693613|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
170915758|NCT01903434|617693619|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
170915759|NCT01903434|617693620|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
170915760|NCT01903434|617693619|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
170915761|NCT01903434|617693620|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
170915762|NCT04882098|617695601|FG000|Overall Study|Adverse Event|7|||
170915763|NCT04882098|617695602|FG001|Overall Study|Adverse Event|2|||
170915764|NCT04882098|617695603|FG002|Overall Study|Adverse Event|1|||
170915765|NCT04882098|617695601|FG000|Overall Study|Death|0|||
170915766|NCT04882098|617695602|FG001|Overall Study|Death|1|||
170915767|NCT04882098|617695603|FG002|Overall Study|Death|0|||
170915768|NCT04882098|617695601|FG000|Overall Study|Lack of Efficacy|2|||
170915769|NCT04882098|617695602|FG001|Overall Study|Lack of Efficacy|3|||
170915770|NCT04882098|617695603|FG002|Overall Study|Lack of Efficacy|3|||
170915771|NCT04882098|617695601|FG000|Overall Study|Lost to Follow-up|0|||
170915772|NCT04882098|617695602|FG001|Overall Study|Lost to Follow-up|1|||
170915773|NCT04882098|617695603|FG002|Overall Study|Lost to Follow-up|0|||
170915774|NCT04882098|617695601|FG000|Overall Study|Withdrawal by Subject|6|||
170915775|NCT04882098|617695602|FG001|Overall Study|Withdrawal by Subject|1|||
170915776|NCT04882098|617695603|FG002|Overall Study|Withdrawal by Subject|9|||
170915777|NCT04882098|617695601|FG000|Overall Study|Subject refused further study treatment|1|||
170915778|NCT04882098|617695602|FG001|Overall Study|Subject refused further study treatment|0|||
170915779|NCT04882098|617695603|FG002|Overall Study|Subject refused further study treatment|0|||
170915780|NCT04882098|617695601|FG000|Overall Study|Other|2|||
170915781|NCT04882098|617695602|FG001|Overall Study|Other|2|||
170915782|NCT04882098|617695603|FG002|Overall Study|Other|1|||
170915783|NCT03106740|617695604|FG000|Overall Study|Lost to Follow-up|2|||
170915784|NCT03106740|617695605|FG001|Overall Study|Lost to Follow-up|2|||
170915785|NCT03106740|617695604|FG000|Overall Study|Withdrawal by Subject|2|||
170915786|NCT03106740|617695605|FG001|Overall Study|Withdrawal by Subject|4|||
170915787|NCT03106740|617695604|FG000|Overall Study|Physician Decision|0|||
170915788|NCT03106740|617695605|FG001|Overall Study|Physician Decision|1|||
170915789|NCT03106740|617695604|FG000|Overall Study|Partial data|1|||
170915790|NCT03106740|617695605|FG001|Overall Study|Partial data|0|||
170915791|NCT05415215|617695606|FG000|Neoadjuvant Phase|Adverse Event|0|||
170915792|NCT05415215|617695607|FG001|Neoadjuvant Phase|Adverse Event|8|||
170915793|NCT05415215|617695608|FG002|Neoadjuvant Phase|Adverse Event|0|||
170915794|NCT05415215|617695609|FG003|Neoadjuvant Phase|Adverse Event|0|||
170915795|NCT05415215|617695610|FG004|Neoadjuvant Phase|Adverse Event|0|||
170915796|NCT05415215|617695611|FG005|Neoadjuvant Phase|Adverse Event|0|||
170915797|NCT05415215|617695612|FG006|Neoadjuvant Phase|Adverse Event|0|||
170915798|NCT05415215|617695613|FG007|Neoadjuvant Phase|Adverse Event|0|||
170915799|NCT05415215|617695606|FG000|Neoadjuvant Phase|Death|0|||
170915800|NCT05415215|617695607|FG001|Neoadjuvant Phase|Death|4|||
170915801|NCT05415215|617695608|FG002|Neoadjuvant Phase|Death|0|||
170915802|NCT05415215|617695609|FG003|Neoadjuvant Phase|Death|0|||
170915803|NCT05415215|617695610|FG004|Neoadjuvant Phase|Death|0|||
170652914|NCT00645788|616743344|FG003|Overall Study|Adverse Event|3|||
170652915|NCT00645788|616743341|FG000|Overall Study|Lost to Follow-up|1|||
170652916|NCT00645788|616743342|FG001|Overall Study|Lost to Follow-up|0|||
170915804|NCT05415215|617695611|FG005|Neoadjuvant Phase|Death|0|||
170915805|NCT05415215|617695612|FG006|Neoadjuvant Phase|Death|0|||
170915806|NCT05415215|617695613|FG007|Neoadjuvant Phase|Death|0|||
170915807|NCT05415215|617695606|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
170915808|NCT05415215|617695607|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
170915809|NCT05415215|617695608|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
170915810|NCT05415215|617695609|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
170652917|NCT00645788|616743343|FG002|Overall Study|Lost to Follow-up|0|||
170915811|NCT05415215|617695610|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
170915812|NCT05415215|617695611|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
170915813|NCT05415215|617695612|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
170915814|NCT05415215|617695613|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
170915815|NCT05415215|617695606|FG000|Neoadjuvant Phase|Progressive Disease|0|||
170915816|NCT05415215|617695607|FG001|Neoadjuvant Phase|Progressive Disease|2|||
170915817|NCT05415215|617695608|FG002|Neoadjuvant Phase|Progressive Disease|0|||
170915818|NCT05415215|617695609|FG003|Neoadjuvant Phase|Progressive Disease|0|||
170915819|NCT05415215|617695610|FG004|Neoadjuvant Phase|Progressive Disease|0|||
170915820|NCT05415215|617695611|FG005|Neoadjuvant Phase|Progressive Disease|0|||
170915821|NCT05415215|617695612|FG006|Neoadjuvant Phase|Progressive Disease|0|||
170915822|NCT05415215|617695613|FG007|Neoadjuvant Phase|Progressive Disease|0|||
170915823|NCT05415215|617695606|FG000|Neoadjuvant Phase|Reason not Specified|1|||
170915824|NCT05415215|617695607|FG001|Neoadjuvant Phase|Reason not Specified|4|||
170915825|NCT05415215|617695608|FG002|Neoadjuvant Phase|Reason not Specified|0|||
170915826|NCT05415215|617695609|FG003|Neoadjuvant Phase|Reason not Specified|0|||
170915827|NCT05415215|617695610|FG004|Neoadjuvant Phase|Reason not Specified|0|||
170915828|NCT05415215|617695611|FG005|Neoadjuvant Phase|Reason not Specified|0|||
170915829|NCT05415215|617695612|FG006|Neoadjuvant Phase|Reason not Specified|0|||
170915830|NCT05415215|617695613|FG007|Neoadjuvant Phase|Reason not Specified|0|||
170915831|NCT05415215|617695606|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
170915832|NCT05415215|617695607|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
170915833|NCT05415215|617695608|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
170915834|NCT05415215|617695609|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
170915835|NCT05415215|617695610|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
170915836|NCT05415215|617695611|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
170915837|NCT05415215|617695612|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
170915838|NCT05415215|617695613|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
170915839|NCT05415215|617695606|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
170915840|NCT05415215|617695607|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
170915841|NCT05415215|617695608|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
170915842|NCT05415215|617695609|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
170915843|NCT05415215|617695610|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
170915844|NCT05415215|617695611|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
170915845|NCT05415215|617695612|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
170915846|NCT05415215|617695613|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
170915847|NCT05415215|617695606|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
170915848|NCT05415215|617695607|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
170915849|NCT05415215|617695608|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
170915850|NCT05415215|617695609|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
170915851|NCT05415215|617695610|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
170915852|NCT05415215|617695611|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
170915853|NCT05415215|617695612|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
170915854|NCT05415215|617695613|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
170915855|NCT05415215|617695606|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
170915856|NCT05415215|617695607|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
170915857|NCT05415215|617695608|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
170915858|NCT05415215|617695609|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
170915859|NCT05415215|617695610|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
170915860|NCT05415215|617695611|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
170915861|NCT05415215|617695612|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
170915862|NCT05415215|617695613|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
170915863|NCT05415215|617695606|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
170915864|NCT05415215|617695607|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
170915865|NCT05415215|617695608|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
170915866|NCT05415215|617695609|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
170915867|NCT05415215|617695610|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
170915868|NCT05415215|617695611|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
170915869|NCT05415215|617695612|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
170915870|NCT05415215|617695613|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
170915871|NCT05415215|617695606|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
170915872|NCT05415215|617695607|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
170915873|NCT05415215|617695608|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
170915874|NCT05415215|617695609|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
170915875|NCT05415215|617695610|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
170915876|NCT05415215|617695611|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
170915877|NCT05415215|617695612|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
170915878|NCT05415215|617695613|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
170915879|NCT05415215|617695606|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
170915880|NCT05415215|617695607|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
170815093|NCT01587703|617331411|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815094|NCT01587703|617331412|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815095|NCT01587703|617331413|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815096|NCT01587703|617331414|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815097|NCT01587703|617331415|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815098|NCT01587703|617331416|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815099|NCT01587703|617331417|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815100|NCT01587703|617331418|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815101|NCT01587703|617331419|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170607364|NCT01793883|616567912|FG002|Overall Study|Dosing error|0|||
170607365|NCT01793883|616567910|FG000|Overall Study|Respiratory distress during spirometry|0|||
170607366|NCT01793883|616567911|FG001|Overall Study|Respiratory distress during spirometry|0|||
170607367|NCT01793883|616567912|FG002|Overall Study|Respiratory distress during spirometry|1|||
170607368|NCT03068767|616567919|FG000|Overall Study|Lost to Follow-up|7|||
170607369|NCT03068767|616567920|FG001|Overall Study|Lost to Follow-up|3|||
170607370|NCT03068767|616567919|FG000|Overall Study|Protocol Violation|3|||
170607371|NCT03068767|616567920|FG001|Overall Study|Protocol Violation|0|||
170815102|NCT01587703|617331420|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815103|NCT01587703|617331421|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815104|NCT01587703|617331422|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
170815105|NCT01587703|617331423|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
170815106|NCT01587703|617331405|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815107|NCT01587703|617331406|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815108|NCT01587703|617331407|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815109|NCT01587703|617331408|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815110|NCT01587703|617331409|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815111|NCT01587703|617331410|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815112|NCT01587703|617331411|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815113|NCT01587703|617331412|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815114|NCT01587703|617331413|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815115|NCT01587703|617331414|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815116|NCT01587703|617331415|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815117|NCT01587703|617331416|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815118|NCT01587703|617331417|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815119|NCT01587703|617331418|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815120|NCT01587703|617331419|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815121|NCT01587703|617331420|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815122|NCT01587703|617331421|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
170815123|NCT01587703|617331422|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
170815124|NCT01587703|617331423|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
170815125|NCT01587703|617331405|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815126|NCT01587703|617331406|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815127|NCT01587703|617331407|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815128|NCT01587703|617331408|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815129|NCT01587703|617331409|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815130|NCT01587703|617331410|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815131|NCT01587703|617331411|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815132|NCT01587703|617331412|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815133|NCT01587703|617331413|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815134|NCT01587703|617331414|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815135|NCT01587703|617331415|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815136|NCT01587703|617331416|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815137|NCT01587703|617331417|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815138|NCT01587703|617331418|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815139|NCT01587703|617331419|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815140|NCT01587703|617331420|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
170815141|NCT01587703|617331421|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815142|NCT01587703|617331422|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815143|NCT01587703|617331423|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
170815144|NCT01587703|617331405|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815145|NCT01587703|617331406|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815146|NCT01587703|617331407|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170607372|NCT01431963|616567923|FG000|Overall Study|Adverse Event|18|||
170607373|NCT01431963|616567923|FG000|Overall Study|Lack of Efficacy|7|||
170652918|NCT00645788|616743344|FG003|Overall Study|Lost to Follow-up|0|||
170652919|NCT00645788|616743341|FG000|Overall Study|Protocol Violation|1|||
170652920|NCT00645788|616743342|FG001|Overall Study|Protocol Violation|0|||
170652921|NCT00645788|616743343|FG002|Overall Study|Protocol Violation|2|||
170652922|NCT00645788|616743344|FG003|Overall Study|Protocol Violation|0|||
170652923|NCT00645788|616743341|FG000|Overall Study|Withdrawal by Subject|0|||
170652924|NCT00645788|616743342|FG001|Overall Study|Withdrawal by Subject|1|||
170652925|NCT00645788|616743343|FG002|Overall Study|Withdrawal by Subject|0|||
170652926|NCT00645788|616743344|FG003|Overall Study|Withdrawal by Subject|2|||
170652927|NCT00645788|616743341|FG000|Overall Study|Pulmonary exacerbation|13|||
170652928|NCT00645788|616743342|FG001|Overall Study|Pulmonary exacerbation|16|||
170652929|NCT00645788|616743343|FG002|Overall Study|Pulmonary exacerbation|11|||
170652930|NCT00645788|616743344|FG003|Overall Study|Pulmonary exacerbation|9|||
170652931|NCT01924429|616743347|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
170652932|NCT01924429|616743348|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
170652933|NCT04231981|616743351|FG000|Overall Study|Adverse Event|1|||
170652934|NCT04231981|616743351|FG000|Overall Study|Death|16|||
170652935|NCT04231981|616743351|FG000|Overall Study|Lost to Follow-up|1|||
170652936|NCT02581943|616743352|FG000|Overall Study|Death|5|||
170652937|NCT02581943|616743353|FG001|Overall Study|Death|2|||
170652938|NCT02581943|616743352|FG000|Overall Study|Disease Progression|12|||
170652939|NCT02581943|616743353|FG001|Overall Study|Disease Progression|15|||
170815147|NCT01587703|617331408|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170652940|NCT02581943|616743352|FG000|Overall Study|Withdrawal by Subject|1|||
170652941|NCT02581943|616743353|FG001|Overall Study|Withdrawal by Subject|2|||
170652942|NCT03021564|616743354|FG000|Overall Study|Death|84|||
170652943|NCT03021564|616743355|FG001|Overall Study|Death|466|||
170815148|NCT01587703|617331409|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170652944|NCT03021564|616743354|FG000|Overall Study|Lost to Follow-up|0|||
170652945|NCT03021564|616743355|FG001|Overall Study|Lost to Follow-up|2|||
170815149|NCT01587703|617331410|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170652946|NCT01233687|616743356|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
170652947|NCT01233687|616743356|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
170652948|NCT01233687|616743356|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
170652949|NCT00821327|616743362|FG000|Overall Study|Adverse Event|13|||
170652950|NCT00821327|616743362|FG000|Overall Study|Patient Request|1|||
170652951|NCT00821327|616743362|FG000|Overall Study|Investigator Request|2|||
170652952|NCT00821327|616743362|FG000|Overall Study|Sponsor Request|1|||
170652953|NCT00821327|616743362|FG000|Overall Study|Disease Progression|13|||
170652954|NCT00821327|616743362|FG000|Overall Study|Other/Unknown|5|||
170652955|NCT02119676|616743363|FG000|Overall Study|Adverse Event|9|||
170652956|NCT02119676|616743364|FG001|Overall Study|Adverse Event|17|||
170652957|NCT02119676|616743365|FG002|Overall Study|Adverse Event|10|||
170815150|NCT01587703|617331411|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815151|NCT01587703|617331412|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815152|NCT01587703|617331413|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815153|NCT01587703|617331414|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815154|NCT01587703|617331415|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170652958|NCT02119676|616743366|FG003|Overall Study|Adverse Event|10|||
170652959|NCT02119676|616743363|FG000|Overall Study|Disease progression|53|||
170652960|NCT02119676|616743364|FG001|Overall Study|Disease progression|55|||
170815155|NCT01587703|617331416|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
170815156|NCT01587703|617331417|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815157|NCT01587703|617331418|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815158|NCT01587703|617331419|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
170815159|NCT01587703|617331420|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815160|NCT01587703|617331421|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815161|NCT01587703|617331422|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815162|NCT01587703|617331423|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
170815163|NCT01587703|617331405|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815164|NCT01587703|617331406|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815165|NCT01587703|617331407|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815166|NCT01587703|617331408|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815167|NCT01587703|617331409|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815168|NCT01587703|617331410|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815169|NCT01587703|617331411|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815170|NCT01587703|617331412|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815171|NCT01587703|617331413|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815172|NCT01587703|617331414|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815173|NCT01587703|617331415|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815174|NCT01587703|617331416|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
170815175|NCT01587703|617331417|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
170815176|NCT01587703|617331418|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
170815177|NCT01587703|617331419|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
170815178|NCT01587703|617331420|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
170815179|NCT01587703|617331421|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
170815180|NCT01587703|617331422|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815181|NCT01587703|617331423|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
170815182|NCT01587703|617331405|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815183|NCT01587703|617331406|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815184|NCT01587703|617331407|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815185|NCT01587703|617331408|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815186|NCT01587703|617331409|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815187|NCT01587703|617331410|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815188|NCT01587703|617331411|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815189|NCT01587703|617331412|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815190|NCT01587703|617331413|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815191|NCT01587703|617331414|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815192|NCT01587703|617331415|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815193|NCT01587703|617331416|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
170815194|NCT01587703|617331417|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
170815195|NCT01587703|617331418|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
170815196|NCT01587703|617331419|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
170815197|NCT01587703|617331420|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
170815198|NCT01587703|617331421|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
170815199|NCT01587703|617331422|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815200|NCT01587703|617331423|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
170815201|NCT01587703|617331405|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815202|NCT01587703|617331406|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815203|NCT01587703|617331407|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170607374|NCT01431963|616567923|FG000|Overall Study|Protocol Violation|1|||
170815204|NCT01587703|617331408|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815205|NCT01587703|617331409|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815206|NCT01587703|617331410|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815207|NCT01587703|617331411|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815208|NCT01587703|617331412|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815209|NCT01587703|617331413|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815210|NCT01587703|617331414|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815211|NCT01587703|617331415|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815212|NCT01587703|617331416|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
170815213|NCT01587703|617331417|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815214|NCT01587703|617331418|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815215|NCT01587703|617331419|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815216|NCT01587703|617331420|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815217|NCT01587703|617331421|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815218|NCT01587703|617331422|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815219|NCT01587703|617331423|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
170815220|NCT01714947|617331424|FG000|Part B|Progressive Disease|3|||
170815221|NCT04271254|617331425|FG000|Overall Study|Withdrawal by Subject|3|||
170815222|NCT04175834|617331428|FG000|Overall Study|Withdrawal by Subject|1|||
170815223|NCT04175834|617331429|FG001|Overall Study|Withdrawal by Subject|0|||
170815224|NCT01193283|617331430|FG000|Overall Study|Death|1|||
170815225|NCT04883541|617331431|FG000|Overall Study|Not attending regular yoga class|16|||
170815226|NCT04883541|617331432|FG001|Overall Study|Not attending regular yoga class|0|||
170815227|NCT04883541|617331431|FG000|Overall Study|Not attending the pregnancy school|0|||
170815228|NCT04883541|617331432|FG001|Overall Study|Not attending the pregnancy school|9|||
170815229|NCT04239911|617331433|FG000|Overall Study|Lost to Follow-up|2|||
170815230|NCT04239911|617331434|FG001|Overall Study|Lost to Follow-up|1|||
170815231|NCT03456856|617331435|FG000|Overall Study|Lost to Follow-up|2|||
170815232|NCT03456856|617331435|FG000|Overall Study|Withdrawal by Subject|1|||
170815233|NCT00417885|617331437|FG000|Overall Study|Adverse Event|1|||
170815234|NCT00417885|617331437|FG000|Overall Study|Objective Progression or Relapse|3|||
170815235|NCT00417885|617331437|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
170815236|NCT00841321|617331444|FG000|Overall Study|Lost to Follow-up|1|||
170815237|NCT00841321|617331445|FG001|Overall Study|Lost to Follow-up|1|||
170815238|NCT00841321|617331444|FG000|Overall Study|Adverse Event|0|||
170815239|NCT00841321|617331445|FG001|Overall Study|Adverse Event|2|||
170815240|NCT02632747|617331448|FG000|Wash-out Period|Adverse Event|1|||
170815241|NCT02632747|617331449|FG001|Wash-out Period|Adverse Event|0|||
170815242|NCT04421456|617331450|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
170815243|NCT04421456|617331451|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
170815244|NCT04421456|617331452|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
170815245|NCT04421456|617331450|FG000|Randomized Treatment Period|Adverse Event|0|||
170815246|NCT04421456|617331451|FG001|Randomized Treatment Period|Adverse Event|1|||
170815247|NCT04421456|617331452|FG002|Randomized Treatment Period|Adverse Event|0|||
170815248|NCT04421456|617331450|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
170815249|NCT04421456|617331451|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
170815250|NCT04421456|617331452|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
170815251|NCT04421456|617331450|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
170815252|NCT04421456|617331451|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
170815253|NCT04421456|617331452|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
170815254|NCT04421456|617331450|FG000|Randomized Treatment Period|Participant non-compliance|1|||
170815255|NCT04421456|617331451|FG001|Randomized Treatment Period|Participant non-compliance|1|||
170815256|NCT04421456|617331452|FG002|Randomized Treatment Period|Participant non-compliance|2|||
170815257|NCT04421456|617331450|FG000|Randomized Treatment Period|Other|0|||
170815258|NCT04421456|617331451|FG001|Randomized Treatment Period|Other|1|||
170815259|NCT04421456|617331452|FG002|Randomized Treatment Period|Other|3|||
170815260|NCT00379210|617331453|FG000|Overall Study|Withdrawal by Subject|10|||
170815261|NCT00379210|617331454|FG001|Overall Study|Withdrawal by Subject|7|||
170815262|NCT03651271|617331455|FG000|Overall Study|Death|4|||
170815263|NCT03651271|617331456|FG001|Overall Study|Death|37|||
170815264|NCT03651271|617331457|FG002|Overall Study|Death|0|||
170607375|NCT01431963|616567923|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
170815265|NCT03651271|617331458|FG003|Overall Study|Death|2|||
170815266|NCT03651271|617331459|FG004|Overall Study|Death|6|||
170815267|NCT03651271|617331455|FG000|Overall Study|Lost to Follow-up|1|||
170815268|NCT03651271|617331456|FG001|Overall Study|Lost to Follow-up|5|||
170652961|NCT02119676|616743365|FG002|Overall Study|Disease progression|68|||
170652962|NCT02119676|616743366|FG003|Overall Study|Disease progression|73|||
170652963|NCT02119676|616743363|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
170652964|NCT02119676|616743364|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
170652965|NCT02119676|616743365|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
170652966|NCT02119676|616743366|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
170652967|NCT02119676|616743363|FG000|Overall Study|Physician Decision|4|||
170652968|NCT02119676|616743364|FG001|Overall Study|Physician Decision|2|||
170652969|NCT02119676|616743365|FG002|Overall Study|Physician Decision|3|||
170652970|NCT02119676|616743366|FG003|Overall Study|Physician Decision|2|||
170652971|NCT02119676|616743363|FG000|Overall Study|Death|9|||
170652972|NCT02119676|616743364|FG001|Overall Study|Death|3|||
170652973|NCT02119676|616743365|FG002|Overall Study|Death|2|||
170652974|NCT02119676|616743366|FG003|Overall Study|Death|1|||
170652975|NCT02119676|616743363|FG000|Overall Study|Noncompliance|0|||
170652976|NCT02119676|616743364|FG001|Overall Study|Noncompliance|1|||
170652977|NCT02119676|616743365|FG002|Overall Study|Noncompliance|0|||
170652978|NCT02119676|616743366|FG003|Overall Study|Noncompliance|0|||
170652979|NCT02119676|616743363|FG000|Overall Study|Lost to Follow-up|0|||
170652980|NCT02119676|616743364|FG001|Overall Study|Lost to Follow-up|0|||
170652981|NCT02119676|616743365|FG002|Overall Study|Lost to Follow-up|1|||
170652982|NCT02119676|616743366|FG003|Overall Study|Lost to Follow-up|0|||
170652983|NCT02119676|616743363|FG000|Overall Study|Protocol deviation|0|||
170652984|NCT02119676|616743364|FG001|Overall Study|Protocol deviation|0|||
170652985|NCT02119676|616743365|FG002|Overall Study|Protocol deviation|1|||
170652986|NCT02119676|616743366|FG003|Overall Study|Protocol deviation|0|||
170652987|NCT02119676|616743363|FG000|Overall Study|Other, unspecified|2|||
170652988|NCT02119676|616743364|FG001|Overall Study|Other, unspecified|1|||
170652989|NCT02119676|616743365|FG002|Overall Study|Other, unspecified|3|||
170652990|NCT02119676|616743366|FG003|Overall Study|Other, unspecified|4|||
170652991|NCT02119676|616743363|FG000|Overall Study|Did not receive study med|2|||
170652992|NCT02119676|616743364|FG001|Overall Study|Did not receive study med|2|||
170652993|NCT02119676|616743365|FG002|Overall Study|Did not receive study med|4|||
170652994|NCT02119676|616743366|FG003|Overall Study|Did not receive study med|5|||
170652995|NCT00217464|616743367|FG000|Overall Study|Progression|15|||
170652996|NCT00217464|616743367|FG000|Overall Study|Other|2|||
170652997|NCT00459979|616743368|FG000|Overall Study|Withdrawal by Subject|1|||
170652998|NCT00459979|616743368|FG000|Overall Study|Protocol Violation|1|||
170652999|NCT04054947|616743369|FG000|Overall Study|Withdrawal by Subject|1|||
170653000|NCT04054947|616743370|FG001|Overall Study|Withdrawal by Subject|0|||
170653001|NCT04054947|616743369|FG000|Overall Study|Lost to Follow-up|2|||
170653002|NCT04054947|616743370|FG001|Overall Study|Lost to Follow-up|5|||
170653003|NCT05214573|616743376|FG000|Overall Study|Physician Decision|5924|||
170653004|NCT05214573|616743377|FG001|Overall Study|Physician Decision|0|||
170653005|NCT01445886|616743378|FG000|Overall Study|Lost to Follow-up|2|||
170653006|NCT01445886|616743378|FG000|Overall Study|Protocol Violation|3|||
170653007|NCT00814801|616743379|FG000|Overall Study|Adverse Event|15|||
170653008|NCT00814801|616743380|FG001|Overall Study|Adverse Event|16|||
170653009|NCT00814801|616743381|FG002|Overall Study|Adverse Event|19|||
170653010|NCT00814801|616743379|FG000|Overall Study|Withdrawal by Subject|9|||
170653011|NCT00814801|616743380|FG001|Overall Study|Withdrawal by Subject|11|||
170653012|NCT00814801|616743381|FG002|Overall Study|Withdrawal by Subject|14|||
170653013|NCT00814801|616743379|FG000|Overall Study|Inappropriate as a subject|1|||
170653014|NCT00814801|616743380|FG001|Overall Study|Inappropriate as a subject|1|||
170653015|NCT00814801|616743381|FG002|Overall Study|Inappropriate as a subject|1|||
170653016|NCT00814801|616743379|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
170653017|NCT00814801|616743380|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
170653018|NCT00814801|616743381|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
170653019|NCT00814801|616743379|FG000|Overall Study|Missing or change of caregiver|6|||
170653020|NCT00814801|616743380|FG001|Overall Study|Missing or change of caregiver|2|||
170653021|NCT00814801|616743381|FG002|Overall Study|Missing or change of caregiver|4|||
170653022|NCT00814801|616743379|FG000|Overall Study|Non-compliance|0|||
170653023|NCT00814801|616743380|FG001|Overall Study|Non-compliance|1|||
170815269|NCT03651271|617331457|FG002|Overall Study|Lost to Follow-up|0|||
170653024|NCT00814801|616743381|FG002|Overall Study|Non-compliance|1|||
170653025|NCT00814801|616743379|FG000|Overall Study|Other|2|||
170653026|NCT00814801|616743380|FG001|Overall Study|Other|6|||
170653027|NCT00814801|616743381|FG002|Overall Study|Other|4|||
170653028|NCT04090411|616743384|FG000|Induction Period|Adverse Event|3|||
170653029|NCT04090411|616743385|FG001|Induction Period|Adverse Event|1|||
170653030|NCT04090411|616743386|FG002|Induction Period|Adverse Event|1|||
170653031|NCT04090411|616743387|FG003|Induction Period|Adverse Event|1|||
170653032|NCT04090411|616743388|FG004|Induction Period|Adverse Event|0|||
170653033|NCT04090411|616743389|FG005|Induction Period|Adverse Event|0|||
170653034|NCT04090411|616743390|FG006|Induction Period|Adverse Event|0|||
170653035|NCT04090411|616743391|FG007|Induction Period|Adverse Event|0|||
170653036|NCT04090411|616743392|FG008|Induction Period|Adverse Event|0|||
170653037|NCT04090411|616743393|FG009|Induction Period|Adverse Event|0|||
170653038|NCT04090411|616743394|FG010|Induction Period|Adverse Event|0|||
170815270|NCT03651271|617331458|FG003|Overall Study|Lost to Follow-up|1|||
170815271|NCT03651271|617331459|FG004|Overall Study|Lost to Follow-up|0|||
170815272|NCT03651271|617331455|FG000|Overall Study|Physician Decision|0|||
170815273|NCT03651271|617331456|FG001|Overall Study|Physician Decision|2|||
170815274|NCT03651271|617331457|FG002|Overall Study|Physician Decision|0|||
170815275|NCT03651271|617331458|FG003|Overall Study|Physician Decision|0|||
170815276|NCT03651271|617331459|FG004|Overall Study|Physician Decision|0|||
170815277|NCT03651271|617331455|FG000|Overall Study|Withdrawal by Subject|1|||
170815278|NCT03651271|617331456|FG001|Overall Study|Withdrawal by Subject|15|||
170915881|NCT05415215|617695608|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
170915882|NCT05415215|617695609|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
170915883|NCT05415215|617695610|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
170915884|NCT05415215|617695611|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
170915885|NCT05415215|617695612|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
170915886|NCT05415215|617695613|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
170915887|NCT05415215|617695606|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
170915888|NCT05415215|617695607|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
170915889|NCT05415215|617695608|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
170915890|NCT05415215|617695609|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
170915891|NCT05415215|617695610|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
170915892|NCT05415215|617695611|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
170915893|NCT05415215|617695612|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
170915894|NCT05415215|617695613|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
170915895|NCT05415215|617695606|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
170915896|NCT05415215|617695607|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
170915897|NCT05415215|617695608|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
170915898|NCT05415215|617695609|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
170915899|NCT05415215|617695610|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
170915900|NCT05415215|617695611|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
170915901|NCT05415215|617695612|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
170915902|NCT05415215|617695613|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
170915903|NCT05415215|617695606|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
170915904|NCT05415215|617695607|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
170915905|NCT05415215|617695608|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
170915906|NCT05415215|617695609|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
170915907|NCT05415215|617695610|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
170915908|NCT05415215|617695611|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
170915909|NCT05415215|617695612|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
170915910|NCT05415215|617695613|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
170915911|NCT05415215|617695606|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
170915912|NCT05415215|617695607|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
170915913|NCT05415215|617695608|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
170915914|NCT05415215|617695609|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
170915915|NCT05415215|617695610|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
170915916|NCT05415215|617695611|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
170915917|NCT05415215|617695612|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
170915918|NCT05415215|617695613|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
170915919|NCT05415215|617695606|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
170915920|NCT05415215|617695607|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
170915921|NCT05415215|617695608|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
170915922|NCT05415215|617695609|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
170915923|NCT05415215|617695610|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
170915924|NCT05415215|617695611|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
170915925|NCT05415215|617695612|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
170915926|NCT05415215|617695613|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
170915927|NCT05415215|617695606|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
170915928|NCT05415215|617695607|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
170915929|NCT05415215|617695608|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
170915930|NCT05415215|617695609|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
170915931|NCT05415215|617695610|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
170915932|NCT05415215|617695611|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
170915933|NCT05415215|617695612|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
170915934|NCT05415215|617695613|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
170915935|NCT05415215|617695606|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
170915936|NCT05415215|617695607|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
170915937|NCT05415215|617695608|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
170915938|NCT05415215|617695609|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
170915939|NCT05415215|617695610|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
170915940|NCT05415215|617695611|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
170915941|NCT05415215|617695612|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
170915942|NCT05415215|617695613|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
170915943|NCT05415215|617695606|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
170607376|NCT01431963|616567923|FG000|Overall Study|Physician Decision|4|||
170915944|NCT05415215|617695607|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
170915945|NCT05415215|617695608|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
170915946|NCT05415215|617695609|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
170915947|NCT05415215|617695610|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
170915948|NCT05415215|617695611|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
170915949|NCT05415215|617695612|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
170915950|NCT05415215|617695613|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
170915951|NCT05415215|617695606|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
170915952|NCT05415215|617695607|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
170915953|NCT05415215|617695608|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
170915954|NCT05415215|617695609|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
170915955|NCT05415215|617695610|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
170915956|NCT05415215|617695611|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
170915957|NCT05415215|617695612|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
170915958|NCT05415215|617695613|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
170915959|NCT05415215|617695606|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
170915960|NCT05415215|617695607|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
170915961|NCT05415215|617695608|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
170915962|NCT05415215|617695609|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
170915963|NCT05415215|617695610|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
170915964|NCT05415215|617695611|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
170915965|NCT05415215|617695612|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
170915966|NCT05415215|617695613|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
170915967|NCT05415215|617695606|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
170915968|NCT05415215|617695607|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
170915969|NCT05415215|617695608|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
170915970|NCT05415215|617695609|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
170915971|NCT05415215|617695610|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
170915972|NCT05415215|617695611|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
170915973|NCT05415215|617695612|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
170915974|NCT05415215|617695613|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
170915975|NCT05415215|617695606|FG000|Follow-up Period|Ongoing in Follow-up|0|||
170915976|NCT05415215|617695607|FG001|Follow-up Period|Ongoing in Follow-up|0|||
170915977|NCT05415215|617695608|FG002|Follow-up Period|Ongoing in Follow-up|0|||
170915978|NCT05415215|617695609|FG003|Follow-up Period|Ongoing in Follow-up|0|||
170915979|NCT05415215|617695610|FG004|Follow-up Period|Ongoing in Follow-up|0|||
170915980|NCT05415215|617695611|FG005|Follow-up Period|Ongoing in Follow-up|44|||
170915981|NCT05415215|617695612|FG006|Follow-up Period|Ongoing in Follow-up|45|||
170915982|NCT05415215|617695613|FG007|Follow-up Period|Ongoing in Follow-up|51|||
170915983|NCT05415215|617695606|FG000|Follow-up Period|Adverse Event|0|||
170915984|NCT05415215|617695607|FG001|Follow-up Period|Adverse Event|0|||
170915985|NCT05415215|617695608|FG002|Follow-up Period|Adverse Event|0|||
170915986|NCT05415215|617695609|FG003|Follow-up Period|Adverse Event|0|||
170915987|NCT05415215|617695610|FG004|Follow-up Period|Adverse Event|0|||
170915988|NCT05415215|617695611|FG005|Follow-up Period|Adverse Event|0|||
170915989|NCT05415215|617695612|FG006|Follow-up Period|Adverse Event|1|||
170915990|NCT05415215|617695613|FG007|Follow-up Period|Adverse Event|0|||
170915991|NCT05415215|617695606|FG000|Follow-up Period|Lost to Follow-up|0|||
170915992|NCT05415215|617695607|FG001|Follow-up Period|Lost to Follow-up|0|||
170915993|NCT05415215|617695608|FG002|Follow-up Period|Lost to Follow-up|0|||
170915994|NCT05415215|617695609|FG003|Follow-up Period|Lost to Follow-up|0|||
170915995|NCT05415215|617695610|FG004|Follow-up Period|Lost to Follow-up|0|||
170915996|NCT05415215|617695611|FG005|Follow-up Period|Lost to Follow-up|1|||
170915997|NCT05415215|617695612|FG006|Follow-up Period|Lost to Follow-up|1|||
170915998|NCT05415215|617695613|FG007|Follow-up Period|Lost to Follow-up|0|||
170915999|NCT05415215|617695606|FG000|Follow-up Period|Withdrawal by Subject|0|||
170916000|NCT05415215|617695607|FG001|Follow-up Period|Withdrawal by Subject|0|||
170916001|NCT05415215|617695608|FG002|Follow-up Period|Withdrawal by Subject|0|||
170916002|NCT05415215|617695609|FG003|Follow-up Period|Withdrawal by Subject|0|||
170916003|NCT05415215|617695610|FG004|Follow-up Period|Withdrawal by Subject|0|||
170916004|NCT05415215|617695611|FG005|Follow-up Period|Withdrawal by Subject|0|||
170916005|NCT05415215|617695612|FG006|Follow-up Period|Withdrawal by Subject|0|||
170916006|NCT05415215|617695613|FG007|Follow-up Period|Withdrawal by Subject|2|||
170916007|NCT05116085|617695614|FG000|Overall Study|Study Completed by Sponsor|30|||
170916008|NCT05116085|617695614|FG000|Overall Study|Withdrawal by Subject|2|||
170916009|NCT05116085|617695614|FG000|Overall Study|Death|1|||
170916010|NCT04104321|617695616|FG000|Overall Study|didn't take the study drug|3|||
170916011|NCT02274779|617695621|FG000|Overall Study|Lost to Follow-up|1|||
170815279|NCT03651271|617331457|FG002|Overall Study|Withdrawal by Subject|0|||
170815280|NCT03651271|617331458|FG003|Overall Study|Withdrawal by Subject|0|||
170815281|NCT03651271|617331459|FG004|Overall Study|Withdrawal by Subject|1|||
170815282|NCT03651271|617331455|FG000|Overall Study|Patient medically unable to continue|0|||
170815283|NCT03651271|617331456|FG001|Overall Study|Patient medically unable to continue|0|||
170815284|NCT03651271|617331457|FG002|Overall Study|Patient medically unable to continue|0|||
170815285|NCT03651271|617331458|FG003|Overall Study|Patient medically unable to continue|1|||
170815286|NCT03651271|617331459|FG004|Overall Study|Patient medically unable to continue|0|||
170815287|NCT01894620|617331460|FG000|Overall Study|Withdrawal by Subject|0|||
170815288|NCT01894620|617331461|FG001|Overall Study|Withdrawal by Subject|1|||
170815289|NCT00424476|617331467|FG000|Overall Study|Withdrawal by Subject|7|||
170815290|NCT00424476|617331468|FG001|Overall Study|Withdrawal by Subject|6|||
170815291|NCT00424476|617331469|FG002|Overall Study|Withdrawal by Subject|3|||
170815292|NCT00424476|617331467|FG000|Overall Study|Adverse Event|19|||
170815293|NCT00424476|617331468|FG001|Overall Study|Adverse Event|16|||
170815294|NCT00424476|617331469|FG002|Overall Study|Adverse Event|15|||
170815295|NCT00424476|617331467|FG000|Overall Study|Lack of Efficacy|16|||
170815296|NCT00424476|617331468|FG001|Overall Study|Lack of Efficacy|12|||
170815297|NCT00424476|617331469|FG002|Overall Study|Lack of Efficacy|12|||
170815298|NCT00424476|617331467|FG000|Overall Study|Lack of Compliance|1|||
170815299|NCT00424476|617331468|FG001|Overall Study|Lack of Compliance|1|||
170815300|NCT00424476|617331469|FG002|Overall Study|Lack of Compliance|1|||
170815301|NCT00424476|617331467|FG000|Overall Study|Lost to Follow-up|4|||
170815302|NCT00424476|617331468|FG001|Overall Study|Lost to Follow-up|6|||
170815303|NCT00424476|617331469|FG002|Overall Study|Lost to Follow-up|3|||
170815304|NCT00424476|617331467|FG000|Overall Study|Protocol Violation|7|||
170815305|NCT00424476|617331468|FG001|Overall Study|Protocol Violation|2|||
170815306|NCT00424476|617331469|FG002|Overall Study|Protocol Violation|3|||
170815307|NCT00424476|617331467|FG000|Overall Study|Physician Decision|3|||
170815308|NCT00424476|617331468|FG001|Overall Study|Physician Decision|2|||
170815309|NCT00424476|617331469|FG002|Overall Study|Physician Decision|3|||
170815310|NCT00424476|617331467|FG000|Overall Study|Other|4|||
170815311|NCT00424476|617331468|FG001|Overall Study|Other|3|||
170815312|NCT00424476|617331469|FG002|Overall Study|Other|9|||
170815313|NCT02514824|617331470|FG000|Overall Study|Withdrawal by Subject|1|||
170815314|NCT02514824|617331471|FG001|Overall Study|Withdrawal by Subject|0|||
170815315|NCT02514824|617331472|FG002|Overall Study|Withdrawal by Subject|0|||
170815316|NCT02514824|617331473|FG003|Overall Study|Withdrawal by Subject|0|||
170815317|NCT02514824|617331470|FG000|Overall Study|Dose-Limiting Toxicity|0|||
170815318|NCT02514824|617331471|FG001|Overall Study|Dose-Limiting Toxicity|1|||
170815319|NCT02514824|617331472|FG002|Overall Study|Dose-Limiting Toxicity|0|||
170815320|NCT02514824|617331473|FG003|Overall Study|Dose-Limiting Toxicity|0|||
170815321|NCT00886834|617331474|FG000|Overall Study|Protocol Violation|0|||
170815322|NCT00886834|617331475|FG001|Overall Study|Protocol Violation|3|||
170815323|NCT00476957|617331476|FG000|Overall Study|Lost to Follow-up|176|||
170815324|NCT00476957|617331477|FG001|Overall Study|Lost to Follow-up|193|||
170815325|NCT00529529|617331478|FG000|Overall Study|Adverse Event|12|||
170815326|NCT00529529|617331479|FG001|Overall Study|Adverse Event|17|||
170815327|NCT00529529|617331480|FG002|Overall Study|Adverse Event|8|||
170815328|NCT00529529|617331478|FG000|Overall Study|Subject withdrew consent|12|||
170815329|NCT00529529|617331479|FG001|Overall Study|Subject withdrew consent|9|||
170815330|NCT00529529|617331480|FG002|Overall Study|Subject withdrew consent|12|||
170815331|NCT00529529|617331478|FG000|Overall Study|Protocol deviation|8|||
170815332|NCT00529529|617331479|FG001|Overall Study|Protocol deviation|12|||
170815333|NCT00529529|617331480|FG002|Overall Study|Protocol deviation|5|||
170815334|NCT00529529|617331478|FG000|Overall Study|Lost to Follow-up|5|||
170815335|NCT00529529|617331479|FG001|Overall Study|Lost to Follow-up|3|||
170815336|NCT00529529|617331480|FG002|Overall Study|Lost to Follow-up|1|||
170815337|NCT00529529|617331478|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170815338|NCT00529529|617331479|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170815339|NCT00529529|617331480|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
170815340|NCT00529529|617331478|FG000|Overall Study|Death|2|||
170815341|NCT00529529|617331479|FG001|Overall Study|Death|0|||
170815342|NCT00529529|617331480|FG002|Overall Study|Death|0|||
170815343|NCT00529529|617331478|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170815344|NCT00529529|617331479|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170815345|NCT00529529|617331480|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170815346|NCT00529529|617331478|FG000|Overall Study|Administrative problems|1|||
170815347|NCT00529529|617331479|FG001|Overall Study|Administrative problems|0|||
170815348|NCT00529529|617331480|FG002|Overall Study|Administrative problems|3|||
170815349|NCT03979040|617331481|FG000|Overall Study|Withdrawal by Subject|24|||
170815350|NCT03979040|617331482|FG001|Overall Study|Withdrawal by Subject|32|||
170815351|NCT03979040|617331481|FG000|Overall Study|randomized but never started treatment|32|||
170815352|NCT03979040|617331482|FG001|Overall Study|randomized but never started treatment|39|||
170815353|NCT03979040|617331481|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
170815354|NCT03979040|617331482|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
170815355|NCT02607956|617331483|FG000|Double-Blinded Phase|Withdrew Consent|17|||
170815356|NCT02607956|617331484|FG001|Double-Blinded Phase|Withdrew Consent|19|||
170815357|NCT02607956|617331485|FG002|Double-Blinded Phase|Withdrew Consent|0|||
170815358|NCT02607956|617331486|FG003|Double-Blinded Phase|Withdrew Consent|0|||
170815359|NCT02607956|617331483|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
170815360|NCT02607956|617331484|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
170815361|NCT02607956|617331485|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
170815362|NCT02607956|617331486|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
170815363|NCT02607956|617331483|FG000|Double-Blinded Phase|Randomized but never treated|7|||
170815364|NCT02607956|617331484|FG001|Double-Blinded Phase|Randomized but never treated|5|||
170815365|NCT02607956|617331485|FG002|Double-Blinded Phase|Randomized but never treated|0|||
170815366|NCT02607956|617331486|FG003|Double-Blinded Phase|Randomized but never treated|0|||
170815367|NCT02607956|617331483|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
170815368|NCT02607956|617331484|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
170815369|NCT02607956|617331485|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
170815370|NCT02607956|617331486|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
170815371|NCT02607956|617331483|FG000|Double-Blinded Phase|Death|4|||
170815372|NCT02607956|617331484|FG001|Double-Blinded Phase|Death|4|||
170815373|NCT02607956|617331485|FG002|Double-Blinded Phase|Death|0|||
170815374|NCT02607956|617331486|FG003|Double-Blinded Phase|Death|0|||
170815375|NCT02607956|617331483|FG000|Double-Blinded Phase|Adverse Event|4|||
170815376|NCT02607956|617331484|FG001|Double-Blinded Phase|Adverse Event|3|||
170815377|NCT02607956|617331485|FG002|Double-Blinded Phase|Adverse Event|0|||
170815378|NCT02607956|617331486|FG003|Double-Blinded Phase|Adverse Event|0|||
170815379|NCT02607956|617331483|FG000|Double-Blinded Phase|Protocol Violation|3|||
170815380|NCT02607956|617331484|FG001|Double-Blinded Phase|Protocol Violation|1|||
170815381|NCT02607956|617331485|FG002|Double-Blinded Phase|Protocol Violation|0|||
170916012|NCT02274779|617695621|FG000|Overall Study|Protocol Violation|6|||
170916013|NCT02562235|617695622|FG000|Overall Study|Adverse Event|3|||
170815382|NCT02607956|617331486|FG003|Double-Blinded Phase|Protocol Violation|0|||
170815383|NCT02607956|617331483|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
170815384|NCT02607956|617331484|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
170815385|NCT02607956|617331485|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
170815386|NCT02607956|617331486|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
170815387|NCT02607956|617331483|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
170815388|NCT02607956|617331484|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
170815389|NCT02607956|617331485|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
170815390|NCT02607956|617331486|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
170815391|NCT02607956|617331483|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
170815392|NCT02607956|617331484|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
170815393|NCT02607956|617331485|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
170815394|NCT02607956|617331486|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
170815395|NCT02607956|617331483|FG000|Open-Label Extension Phase|Death|0|||
170815396|NCT02607956|617331484|FG001|Open-Label Extension Phase|Death|0|||
170815397|NCT02607956|617331485|FG002|Open-Label Extension Phase|Death|1|||
170815398|NCT02607956|617331486|FG003|Open-Label Extension Phase|Death|3|||
170815399|NCT02607956|617331483|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
170815400|NCT02607956|617331484|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
170815401|NCT02607956|617331485|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
170815402|NCT02607956|617331486|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
170815403|NCT02607956|617331483|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
170815404|NCT02607956|617331484|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
170815405|NCT02607956|617331485|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
170815406|NCT02607956|617331486|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
170815407|NCT02607956|617331483|FG000|Open-Label Extension Phase|Protocol Violation|0|||
170815408|NCT02607956|617331484|FG001|Open-Label Extension Phase|Protocol Violation|0|||
170815409|NCT02607956|617331485|FG002|Open-Label Extension Phase|Protocol Violation|0|||
170815410|NCT02607956|617331486|FG003|Open-Label Extension Phase|Protocol Violation|2|||
170815411|NCT02607956|617331483|FG000|Open-Label Extension Phase|Pregnancy|0|||
170815412|NCT02607956|617331484|FG001|Open-Label Extension Phase|Pregnancy|0|||
170815413|NCT02607956|617331485|FG002|Open-Label Extension Phase|Pregnancy|0|||
170815414|NCT02607956|617331486|FG003|Open-Label Extension Phase|Pregnancy|1|||
170815415|NCT01916109|617331487|FG000|Overall Study|Withdrawal by Subject|1|||
170815416|NCT01287832|617331494|FG000|Overall Study|Adverse Event|1|||
170815417|NCT01287832|617331495|FG001|Overall Study|Adverse Event|0|||
170815418|NCT01287832|617331494|FG000|Overall Study|Death|0|||
170815419|NCT01287832|617331495|FG001|Overall Study|Death|1|||
170815420|NCT03015220|617331499|FG000|Overall Study|Withdrawal by Subject|3|||
170916014|NCT06104306|617695623|FG000|Overall Study|Lost to Follow-up|2|||
170607377|NCT01431963|616567923|FG000|Overall Study|Withdrawal by Subject|3|||
170815421|NCT03015220|617331500|FG001|Overall Study|Withdrawal by Subject|2|||
170815422|NCT03015220|617331501|FG002|Overall Study|Withdrawal by Subject|2|||
170815423|NCT03015220|617331502|FG003|Overall Study|Withdrawal by Subject|2|||
170815424|NCT03015220|617331499|FG000|Overall Study|Lost to Follow-up|0|||
170815425|NCT03015220|617331500|FG001|Overall Study|Lost to Follow-up|0|||
170815426|NCT03015220|617331501|FG002|Overall Study|Lost to Follow-up|1|||
170815427|NCT03015220|617331502|FG003|Overall Study|Lost to Follow-up|0|||
170815428|NCT00392197|617331504|FG000|Overall Study|Adverse Event|4|||
170815429|NCT00392197|617331505|FG001|Overall Study|Adverse Event|12|||
170815430|NCT00392197|617331504|FG000|Overall Study|Lack of Efficacy|3|||
170815431|NCT00392197|617331505|FG001|Overall Study|Lack of Efficacy|4|||
170815432|NCT00392197|617331504|FG000|Overall Study|Lost to Follow-up|0|||
170815433|NCT00392197|617331505|FG001|Overall Study|Lost to Follow-up|1|||
170815434|NCT00392197|617331504|FG000|Overall Study|Physician Decision|3|||
170916015|NCT06104306|617695623|FG000|Overall Study|Death|1|||
170916016|NCT06104306|617695623|FG000|Overall Study|Withdrew Consent|1|||
170916017|NCT03899961|617695628|FG000|Overall Study|-delivery prior to|2|||
170815435|NCT00392197|617331505|FG001|Overall Study|Physician Decision|2|||
170815436|NCT00392197|617331504|FG000|Overall Study|Protocol Violation|7|||
170815437|NCT00392197|617331505|FG001|Overall Study|Protocol Violation|5|||
170815438|NCT00392197|617331504|FG000|Overall Study|Withdrawal by Subject|4|||
170815439|NCT00392197|617331505|FG001|Overall Study|Withdrawal by Subject|6|||
170815440|NCT02312258|617331506|FG000|Overall Study|Lost to Follow-up|8|||
170815441|NCT02312258|617331507|FG001|Overall Study|Lost to Follow-up|8|||
170815442|NCT02312258|617331506|FG000|Overall Study|Withdrawal by Patient|49|||
170815443|NCT02312258|617331507|FG001|Overall Study|Withdrawal by Patient|76|||
170815444|NCT02312258|617331506|FG000|Overall Study|Reason not Specified|107|||
170815445|NCT02312258|617331507|FG001|Overall Study|Reason not Specified|159|||
170815446|NCT02312258|617331506|FG000|Overall Study|Missing|2|||
170815447|NCT02312258|617331507|FG001|Overall Study|Missing|1|||
170815448|NCT02312258|617331506|FG000|Overall Study|Death|115|||
170815449|NCT02312258|617331507|FG001|Overall Study|Death|181|||
170815450|NCT01697956|617331508|FG000|Overall Study|Protocol Violation|1|||
170815451|NCT01697956|617331509|FG001|Overall Study|Protocol Violation|1|||
170815452|NCT01528605|617331511|FG000|Overall Study|Lost to Follow-up|1|||
170815453|NCT01528605|617331512|FG001|Overall Study|Lost to Follow-up|0|||
170815454|NCT01528605|617331513|FG002|Overall Study|Lost to Follow-up|1|||
170815455|NCT01528605|617331514|FG003|Overall Study|Lost to Follow-up|1|||
170815456|NCT01528605|617331515|FG004|Overall Study|Lost to Follow-up|0|||
170815457|NCT01528605|617331516|FG005|Overall Study|Lost to Follow-up|0|||
170815458|NCT01528605|617331511|FG000|Overall Study|Death|1|||
170815459|NCT01528605|617331512|FG001|Overall Study|Death|0|||
170815460|NCT01528605|617331513|FG002|Overall Study|Death|0|||
170815461|NCT01528605|617331514|FG003|Overall Study|Death|0|||
170815462|NCT01528605|617331515|FG004|Overall Study|Death|0|||
170815463|NCT01528605|617331516|FG005|Overall Study|Death|0|||
170815464|NCT01681511|617331517|FG000|Overall Study|No Treatment Received|1|||
170815465|NCT01681511|617331518|FG001|Overall Study|No Treatment Received|3|||
170815466|NCT01681511|617331517|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
170815467|NCT01681511|617331518|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
170815468|NCT01681511|617331517|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
170815469|NCT01681511|617331518|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
170815470|NCT01681511|617331517|FG000|Overall Study|No Daily Urine Sample Collected|0|||
170815471|NCT01681511|617331518|FG001|Overall Study|No Daily Urine Sample Collected|1|||
170815472|NCT01681511|617331517|FG000|Overall Study|No post-catheter sample collected|11|||
170815473|NCT01681511|617331518|FG001|Overall Study|No post-catheter sample collected|4|||
170815474|NCT01156675|617331519|FG000|Overall Study|Death|5|||
170815475|NCT01156675|617331520|FG001|Overall Study|Death|3|||
170815476|NCT01156675|617331521|FG002|Overall Study|Death|0|||
170815477|NCT01156675|617331519|FG000|Overall Study|No data|29|||
170815478|NCT01156675|617331520|FG001|Overall Study|No data|22|||
170815479|NCT01156675|617331521|FG002|Overall Study|No data|2|||
170815480|NCT01970527|617331522|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
170815481|NCT01970527|617331523|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
170815482|NCT01970527|617331522|FG000|Treatment|Disease progression|0|||
170815483|NCT01970527|617331523|FG001|Treatment|Disease progression|1|||
170815484|NCT01970527|617331522|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
170815485|NCT01970527|617331523|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
170815486|NCT01970527|617331522|FG000|Treatment|Death|0|||
170815487|NCT01970527|617331523|FG001|Treatment|Death|1|||
170815488|NCT01970527|617331522|FG000|Follow-up Clinic Visit|Disease progression|1|||
170815489|NCT01970527|617331523|FG001|Follow-up Clinic Visit|Disease progression|1|||
170815490|NCT01970527|617331522|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
170815491|NCT01970527|617331523|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
170815492|NCT01970527|617331522|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
170916018|NCT03899961|617695629|FG001|Overall Study|-delivery prior to|7|||
170815493|NCT01970527|617331523|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
170815494|NCT01964547|617331537|FG000|Overall Study|Adverse Event|8|||
170815495|NCT01964547|617331538|FG001|Overall Study|Adverse Event|2|||
170815496|NCT01964547|617331537|FG000|Overall Study|Withdrawal by Subject|4|||
170815497|NCT01964547|617331538|FG001|Overall Study|Withdrawal by Subject|7|||
170815498|NCT01964547|617331537|FG000|Overall Study|Lost to Follow-up|0|||
170815499|NCT01964547|617331538|FG001|Overall Study|Lost to Follow-up|1|||
170815500|NCT01964547|617331537|FG000|Overall Study|Withdrawal by Investigator|0|||
170916019|NCT03899961|617695628|FG000|Overall Study|req general anesth|1|||
170815501|NCT01964547|617331538|FG001|Overall Study|Withdrawal by Investigator|1|||
170815502|NCT01115309|617331539|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
170815503|NCT01115309|617331539|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
170916020|NCT03899961|617695629|FG001|Overall Study|req general anesth|2|||
170916021|NCT03899961|617695628|FG000|Overall Study|capacity|5|||
170916022|NCT03899961|617695629|FG001|Overall Study|capacity|6|||
170916023|NCT03899961|617695628|FG000|Overall Study|Withdrawal by Subject|1|||
170916024|NCT03899961|617695629|FG001|Overall Study|Withdrawal by Subject|1|||
170916025|NCT00400946|617695630|FG000|Overall Study|Ineligible|0|||
170916026|NCT00400946|617695631|FG001|Overall Study|Ineligible|0|||
170916027|NCT00400946|617695632|FG002|Overall Study|Ineligible|0|||
170916028|NCT00400946|617695633|FG003|Overall Study|Ineligible|5|||
170916029|NCT00400946|617695634|FG004|Overall Study|Ineligible|1|||
170916030|NCT00400946|617695630|FG000|Overall Study|Induction Failure|0|||
170916031|NCT00400946|617695631|FG001|Overall Study|Induction Failure|0|||
170916032|NCT00400946|617695632|FG002|Overall Study|Induction Failure|0|||
170916033|NCT00400946|617695633|FG003|Overall Study|Induction Failure|11|||
170916034|NCT00400946|617695634|FG004|Overall Study|Induction Failure|8|||
170916035|NCT00400946|617695630|FG000|Overall Study|Induction Death|0|||
170916036|NCT00400946|617695631|FG001|Overall Study|Induction Death|0|||
170916037|NCT00400946|617695632|FG002|Overall Study|Induction Death|0|||
170916038|NCT00400946|617695633|FG003|Overall Study|Induction Death|13|||
170916039|NCT00400946|617695634|FG004|Overall Study|Induction Death|3|||
170916040|NCT00400946|617695630|FG000|Overall Study|Lost to Follow-up|1|||
170916041|NCT00400946|617695631|FG001|Overall Study|Lost to Follow-up|1|||
170916042|NCT00400946|617695632|FG002|Overall Study|Lost to Follow-up|0|||
170916043|NCT00400946|617695633|FG003|Overall Study|Lost to Follow-up|0|||
170916044|NCT00400946|617695634|FG004|Overall Study|Lost to Follow-up|1|||
170916045|NCT00400946|617695630|FG000|Overall Study|Remission Death|1|||
170916046|NCT00400946|617695631|FG001|Overall Study|Remission Death|1|||
170916047|NCT00400946|617695632|FG002|Overall Study|Remission Death|0|||
170916048|NCT00400946|617695633|FG003|Overall Study|Remission Death|0|||
170916049|NCT00400946|617695634|FG004|Overall Study|Remission Death|1|||
170916050|NCT00400946|617695630|FG000|Overall Study|Relapse|9|||
170916051|NCT00400946|617695631|FG001|Overall Study|Relapse|2|||
170916052|NCT00400946|617695632|FG002|Overall Study|Relapse|1|||
170916053|NCT00400946|617695633|FG003|Overall Study|Relapse|1|||
170916054|NCT00400946|617695634|FG004|Overall Study|Relapse|5|||
170916055|NCT00400946|617695630|FG000|Overall Study|Transplant in CR1|0|||
170916056|NCT00400946|617695631|FG001|Overall Study|Transplant in CR1|0|||
170916057|NCT00400946|617695632|FG002|Overall Study|Transplant in CR1|0|||
170916058|NCT00400946|617695633|FG003|Overall Study|Transplant in CR1|10|||
170916059|NCT00400946|617695634|FG004|Overall Study|Transplant in CR1|1|||
170916060|NCT00400946|617695630|FG000|Overall Study|Withdrawal by Subject|2|||
170916061|NCT00400946|617695631|FG001|Overall Study|Withdrawal by Subject|5|||
170916062|NCT00400946|617695632|FG002|Overall Study|Withdrawal by Subject|1|||
170916063|NCT00400946|617695633|FG003|Overall Study|Withdrawal by Subject|5|||
170916064|NCT00400946|617695634|FG004|Overall Study|Withdrawal by Subject|8|||
170916065|NCT00400946|617695630|FG000|Overall Study|Clinical|1|||
170916066|NCT00400946|617695631|FG001|Overall Study|Clinical|2|||
170916067|NCT00400946|617695632|FG002|Overall Study|Clinical|0|||
170916068|NCT00400946|617695633|FG003|Overall Study|Clinical|2|||
170916069|NCT00400946|617695634|FG004|Overall Study|Clinical|9|||
170916070|NCT00400946|617695630|FG000|Overall Study|Other|0|||
170916071|NCT00400946|617695631|FG001|Overall Study|Other|0|||
170916072|NCT00400946|617695632|FG002|Overall Study|Other|0|||
170916073|NCT00400946|617695633|FG003|Overall Study|Other|0|||
170916074|NCT00400946|617695634|FG004|Overall Study|Other|1|||
170916075|NCT06955923|617695635|FG000|Overall Study|Limited timeline for follow-up restricted total number of participants for the last follow-up interv|3|||
170916076|NCT06955923|617695636|FG001|Overall Study|Limited timeline for follow-up restricted total number of participants for the last follow-up interv|2|||
170916077|NCT03928184|617695637|FG000|Overall Study|Adverse Event|1|||
170916078|NCT03928184|617695638|FG001|Overall Study|Adverse Event|1|||
170916079|NCT03928184|617695637|FG000|Overall Study|Death|1|||
170916080|NCT03928184|617695638|FG001|Overall Study|Death|0|||
170916081|NCT03928184|617695637|FG000|Overall Study|Lack of Efficacy|0|||
170916082|NCT03928184|617695638|FG001|Overall Study|Lack of Efficacy|2|||
170916083|NCT03928184|617695637|FG000|Overall Study|Lost to Follow-up|5|||
170916084|NCT03928184|617695638|FG001|Overall Study|Lost to Follow-up|10|||
170916085|NCT03928184|617695637|FG000|Overall Study|Subject Non-Compliance|1|||
170916086|NCT03928184|617695638|FG001|Overall Study|Subject Non-Compliance|0|||
170916087|NCT03928184|617695637|FG000|Overall Study|Total or Partial Knee Replacement of the Target Knee|1|||
170916088|NCT03928184|617695638|FG001|Overall Study|Total or Partial Knee Replacement of the Target Knee|1|||
170916089|NCT03928184|617695637|FG000|Overall Study|Withdrawal by Subject|15|||
170916090|NCT03928184|617695638|FG001|Overall Study|Withdrawal by Subject|16|||
170916091|NCT05139914|617695651|FG000|Overall Study|Lost to Follow-up|0|||
170916092|NCT05139914|617695652|FG001|Overall Study|Lost to Follow-up|1|||
170916093|NCT04539964|617695653|FG000|Overall Study|device malfunction|1|||
170916094|NCT04539964|617695654|FG001|Overall Study|device malfunction|0|||
170916095|NCT04539964|617695653|FG000|Overall Study|Withdrawal by Subject|1|||
170653039|NCT04090411|616743395|FG011|Induction Period|Adverse Event|0|||
170916096|NCT04539964|617695654|FG001|Overall Study|Withdrawal by Subject|2|||
170916097|NCT04539964|617695653|FG000|Overall Study|Adverse Event|0|||
170916098|NCT04539964|617695654|FG001|Overall Study|Adverse Event|2|||
170653040|NCT04090411|616743396|FG012|Induction Period|Adverse Event|0|||
170653041|NCT04090411|616743384|FG000|Induction Period|Lack of Efficacy|0|||
170653042|NCT04090411|616743385|FG001|Induction Period|Lack of Efficacy|0|||
170653043|NCT04090411|616743386|FG002|Induction Period|Lack of Efficacy|1|||
170815504|NCT01115309|617331539|FG000|Long-term Follow-up|Lost to Follow-up|6|||
170653044|NCT04090411|616743387|FG003|Induction Period|Lack of Efficacy|1|||
170653045|NCT04090411|616743388|FG004|Induction Period|Lack of Efficacy|0|||
170916099|NCT04001829|617695655|FG000|Overall Study|Never start protocol therapy|5|||
170916100|NCT04001829|617695656|FG001|Overall Study|Never start protocol therapy|5|||
170916101|NCT04001829|617695655|FG000|Overall Study|Adverse Event|11|||
170916102|NCT04001829|617695656|FG001|Overall Study|Adverse Event|7|||
170916103|NCT04001829|617695655|FG000|Overall Study|Alternative therapy|1|||
170916104|NCT04001829|617695656|FG001|Overall Study|Alternative therapy|2|||
170916105|NCT04001829|617695655|FG000|Overall Study|Disease progression/relapse|2|||
170916106|NCT04001829|617695656|FG001|Overall Study|Disease progression/relapse|1|||
170916107|NCT04001829|617695655|FG000|Overall Study|Other complicating disease|1|||
170916108|NCT04001829|617695656|FG001|Overall Study|Other complicating disease|0|||
170916109|NCT04001829|617695655|FG000|Overall Study|Withdrawal by Subject|1|||
170916110|NCT04001829|617695656|FG001|Overall Study|Withdrawal by Subject|4|||
170916111|NCT04001829|617695655|FG000|Overall Study|Ineligible|2|||
170916112|NCT04001829|617695656|FG001|Overall Study|Ineligible|2|||
170916113|NCT04001829|617695655|FG000|Overall Study|Reason missing due to delinquent data|1|||
170916114|NCT04001829|617695656|FG001|Overall Study|Reason missing due to delinquent data|0|||
170916115|NCT03785873|617695657|FG000|Overall Study|Adverse Event|2|||
170916116|NCT03785873|617695658|FG001|Overall Study|Adverse Event|3|||
170916117|NCT03785873|617695657|FG000|Overall Study|Death|1|||
170916118|NCT03785873|617695658|FG001|Overall Study|Death|1|||
170916119|NCT03785873|617695657|FG000|Overall Study|Withdrawal by Subject|0|||
170916120|NCT03785873|617695658|FG001|Overall Study|Withdrawal by Subject|2|||
170916121|NCT05223868|617695659|FG000|Overall Study|Lost to Follow-up|1|||
170916122|NCT05223868|617695660|FG001|Overall Study|Lost to Follow-up|3|||
170916123|NCT05223868|617695661|FG002|Overall Study|Lost to Follow-up|0|||
170916124|NCT05223868|617695662|FG003|Overall Study|Lost to Follow-up|0|||
170916125|NCT05223868|617695663|FG004|Overall Study|Lost to Follow-up|0|||
170916126|NCT05223868|617695664|FG005|Overall Study|Lost to Follow-up|1|||
170916127|NCT05223868|617695659|FG000|Overall Study|Withdrawal by Subject|6|||
170916128|NCT05223868|617695660|FG001|Overall Study|Withdrawal by Subject|2|||
170916129|NCT05223868|617695661|FG002|Overall Study|Withdrawal by Subject|3|||
170916130|NCT05223868|617695662|FG003|Overall Study|Withdrawal by Subject|1|||
170916131|NCT05223868|617695663|FG004|Overall Study|Withdrawal by Subject|1|||
170916132|NCT05223868|617695664|FG005|Overall Study|Withdrawal by Subject|2|||
170916133|NCT05223868|617695659|FG000|Overall Study|Other|0|||
170916134|NCT05223868|617695660|FG001|Overall Study|Other|2|||
170916135|NCT05223868|617695661|FG002|Overall Study|Other|0|||
170916136|NCT05223868|617695662|FG003|Overall Study|Other|0|||
170916137|NCT05223868|617695663|FG004|Overall Study|Other|1|||
170916138|NCT05223868|617695664|FG005|Overall Study|Other|1|||
170916139|NCT04127786|617695665|FG000|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Adverse Event|1|||
170916140|NCT04127786|617695666|FG001|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Adverse Event|0|||
170916141|NCT04127786|617695667|FG002|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Adverse Event|0|||
170916142|NCT04127786|617695668|FG003|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Adverse Event|1|||
170916143|NCT04127786|617695669|FG004|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Adverse Event|0|||
170916144|NCT04127786|617695670|FG005|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Adverse Event|1|||
170916145|NCT04127786|617695665|FG000|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Protocol Violation|5|||
170916146|NCT04127786|617695666|FG001|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Protocol Violation|3|||
170916147|NCT04127786|617695667|FG002|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Protocol Violation|4|||
170916148|NCT04127786|617695668|FG003|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Protocol Violation|3|||
170916149|NCT04127786|617695669|FG004|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Protocol Violation|2|||
170916150|NCT04127786|617695670|FG005|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Protocol Violation|0|||
170916151|NCT04127786|617695665|FG000|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Subject|0|||
170916152|NCT04127786|617695666|FG001|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Subject|0|||
170916153|NCT04127786|617695667|FG002|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Subject|0|||
170916154|NCT04127786|617695668|FG003|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Subject|1|||
170916155|NCT04127786|617695669|FG004|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Subject|0|||
170916156|NCT04127786|617695670|FG005|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Subject|0|||
170916157|NCT04127786|617695665|FG000|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Parent/Guardian|2|||
170916158|NCT04127786|617695666|FG001|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Parent/Guardian|1|||
170916159|NCT04127786|617695667|FG002|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Parent/Guardian|0|||
170916160|NCT04127786|617695668|FG003|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Parent/Guardian|0|||
170916161|NCT04127786|617695669|FG004|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Parent/Guardian|0|||
170916162|NCT04127786|617695670|FG005|Primary: C-1: Day[D]0-D28; C-2:D0-D7|Withdrawal by Parent/Guardian|0|||
170916163|NCT04127786|617695665|FG000|Booster:C-1:At Month(M) 12; C-2:M24-M36|Withdrawal by Subject|2|||
170916164|NCT04127786|617695666|FG001|Booster:C-1:At Month(M) 12; C-2:M24-M36|Withdrawal by Subject|0|||
170916165|NCT04127786|617695667|FG002|Booster:C-1:At Month(M) 12; C-2:M24-M36|Withdrawal by Subject|0|||
170916166|NCT04127786|617695668|FG003|Booster:C-1:At Month(M) 12; C-2:M24-M36|Withdrawal by Subject|1|||
170607378|NCT00547521|616567924|FG000|Short Term Study (4 Months)|Adverse Event|1|||
170916167|NCT04127786|617695669|FG004|Booster:C-1:At Month(M) 12; C-2:M24-M36|Withdrawal by Subject|0|||
170916168|NCT04127786|617695670|FG005|Booster:C-1:At Month(M) 12; C-2:M24-M36|Withdrawal by Subject|0|||
170653046|NCT04090411|616743389|FG005|Induction Period|Lack of Efficacy|0|||
170653047|NCT04090411|616743390|FG006|Induction Period|Lack of Efficacy|0|||
170653048|NCT04090411|616743391|FG007|Induction Period|Lack of Efficacy|0|||
170815505|NCT05700851|617331540|FG000|Overall Study|Received a kidney transplant|1|||
170815506|NCT05700851|617331540|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
170815507|NCT05700851|617331540|FG000|Overall Study|Withdrawal by Subject|1|||
170653049|NCT04090411|616743392|FG008|Induction Period|Lack of Efficacy|0|||
170653050|NCT04090411|616743393|FG009|Induction Period|Lack of Efficacy|0|||
170653051|NCT04090411|616743394|FG010|Induction Period|Lack of Efficacy|0|||
170653052|NCT04090411|616743395|FG011|Induction Period|Lack of Efficacy|0|||
170653053|NCT04090411|616743396|FG012|Induction Period|Lack of Efficacy|0|||
170653054|NCT04090411|616743384|FG000|Induction Period|Physician Decision|0|||
170653055|NCT04090411|616743385|FG001|Induction Period|Physician Decision|0|||
170653056|NCT04090411|616743386|FG002|Induction Period|Physician Decision|1|||
170815508|NCT02147093|617331541|FG000|Period 1|Lost to Follow-up|0|||
170815509|NCT02147093|617331542|FG001|Period 1|Lost to Follow-up|1|||
170815510|NCT02147093|617331541|FG000|Period 2|Protocol Violation|2|||
170815511|NCT02147093|617331542|FG001|Period 2|Protocol Violation|0|||
170815512|NCT00090519|617331543|FG000|Overall Study|Adverse Event|5|||
170815513|NCT00090519|617331544|FG001|Overall Study|Adverse Event|4|||
170815514|NCT00090519|617331543|FG000|Overall Study|Death|9|||
170815515|NCT00090519|617331544|FG001|Overall Study|Death|9|||
170916169|NCT02932410|617695671|FG000|Overall Study|Death|7|||
170916170|NCT02932410|617695672|FG001|Overall Study|Death|6|||
170916171|NCT02932410|617695673|FG002|Overall Study|Death|0|||
170916172|NCT02932410|617695674|FG003|Overall Study|Death|0|||
170916173|NCT02932410|617695671|FG000|Overall Study|Lost to Follow-up|1|||
170916174|NCT02932410|617695672|FG001|Overall Study|Lost to Follow-up|2|||
170916175|NCT02932410|617695673|FG002|Overall Study|Lost to Follow-up|0|||
170916176|NCT02932410|617695674|FG003|Overall Study|Lost to Follow-up|0|||
170916177|NCT02932410|617695671|FG000|Overall Study|Parent/Subjects decision|6|||
170916178|NCT02932410|617695672|FG001|Overall Study|Parent/Subjects decision|6|||
170653057|NCT04090411|616743387|FG003|Induction Period|Physician Decision|0|||
170815516|NCT00090519|617331543|FG000|Overall Study|Lost to Follow-up|26|||
170815517|NCT00090519|617331544|FG001|Overall Study|Lost to Follow-up|29|||
170815518|NCT00090519|617331543|FG000|Overall Study|Withdrawal by Subject|28|||
170815519|NCT00090519|617331544|FG001|Overall Study|Withdrawal by Subject|29|||
170815520|NCT00090519|617331543|FG000|Overall Study|Physician Decision|2|||
170916179|NCT02932410|617695673|FG002|Overall Study|Parent/Subjects decision|1|||
170916180|NCT02932410|617695674|FG003|Overall Study|Parent/Subjects decision|0|||
170916181|NCT02932410|617695671|FG000|Overall Study|Physician Decision|0|||
170916182|NCT02932410|617695672|FG001|Overall Study|Physician Decision|1|||
170916183|NCT02932410|617695673|FG002|Overall Study|Physician Decision|0|||
170653058|NCT04090411|616743388|FG004|Induction Period|Physician Decision|0|||
170815521|NCT00090519|617331544|FG001|Overall Study|Physician Decision|3|||
170607379|NCT00547521|616567925|FG001|Short Term Study (4 Months)|Adverse Event|0|||
170607380|NCT00547521|616567924|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
170607381|NCT00547521|616567925|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
170607382|NCT00547521|616567924|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
170607383|NCT00547521|616567925|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
170607384|NCT00547521|616567924|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
170607385|NCT00547521|616567925|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
170607386|NCT00547521|616567924|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
170607387|NCT00547521|616567925|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
170607388|NCT00547521|616567924|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
170607389|NCT00547521|616567925|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
170607390|NCT00547521|616567924|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
170607391|NCT00547521|616567925|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
170607392|NCT00547521|616567924|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
170607393|NCT00547521|616567925|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
170607394|NCT00547521|616567924|FG000|Long Term Extension (LTE) Study|Other|0|||
170607395|NCT00547521|616567925|FG001|Long Term Extension (LTE) Study|Other|2|||
170607396|NCT00547521|616567924|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
170607397|NCT00547521|616567925|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
170607398|NCT01946152|616571036|FG000|Overall Study|Adverse Event|1|||
170607399|NCT01946152|616571037|FG001|Overall Study|Adverse Event|0|||
170607400|NCT01946152|616571038|FG002|Overall Study|Adverse Event|0|||
170607401|NCT01946152|616571039|FG003|Overall Study|Adverse Event|0|||
170607402|NCT01946152|616571036|FG000|Overall Study|Withdrawal by Subject|0|||
170607403|NCT01946152|616571037|FG001|Overall Study|Withdrawal by Subject|2|||
170607404|NCT01946152|616571038|FG002|Overall Study|Withdrawal by Subject|0|||
170607405|NCT01946152|616571039|FG003|Overall Study|Withdrawal by Subject|0|||
170607406|NCT01946152|616571036|FG000|Overall Study|Progression|0|||
170607407|NCT01946152|616571037|FG001|Overall Study|Progression|1|||
170607408|NCT01946152|616571038|FG002|Overall Study|Progression|4|||
170607409|NCT01946152|616571039|FG003|Overall Study|Progression|7|||
170607410|NCT01946152|616571036|FG000|Overall Study|Physician Decision|0|||
170607411|NCT01946152|616571037|FG001|Overall Study|Physician Decision|0|||
170607412|NCT01946152|616571038|FG002|Overall Study|Physician Decision|1|||
170607413|NCT01946152|616571039|FG003|Overall Study|Physician Decision|0|||
170607414|NCT01946152|616571036|FG000|Overall Study|Second malignancy|0|||
170607415|NCT01946152|616571037|FG001|Overall Study|Second malignancy|0|||
170607416|NCT01946152|616571038|FG002|Overall Study|Second malignancy|1|||
170607417|NCT01946152|616571039|FG003|Overall Study|Second malignancy|0|||
170607418|NCT01946152|616571036|FG000|Overall Study|Adverse Event|0|||
170607419|NCT01946152|616571037|FG001|Overall Study|Adverse Event|0|||
170607420|NCT01946152|616571038|FG002|Overall Study|Adverse Event|0|||
170607421|NCT01946152|616571039|FG003|Overall Study|Adverse Event|1|||
170607422|NCT03712787|616571040|FG000|Overall Study|Adverse Event|2|||
170607423|NCT03712787|616571041|FG001|Overall Study|Adverse Event|3|||
170607424|NCT03712787|616571042|FG002|Overall Study|Adverse Event|0|||
170607425|NCT03712787|616571043|FG003|Overall Study|Adverse Event|4|||
170607426|NCT03712787|616571040|FG000|Overall Study|Withdrawal by Subject|4|||
170607427|NCT03712787|616571041|FG001|Overall Study|Withdrawal by Subject|14|||
170607428|NCT03712787|616571042|FG002|Overall Study|Withdrawal by Subject|12|||
170607429|NCT03712787|616571043|FG003|Overall Study|Withdrawal by Subject|8|||
170607430|NCT03712787|616571040|FG000|Overall Study|Lost to Follow-up|1|||
170607431|NCT03712787|616571041|FG001|Overall Study|Lost to Follow-up|1|||
170607432|NCT03712787|616571042|FG002|Overall Study|Lost to Follow-up|2|||
170607433|NCT03712787|616571043|FG003|Overall Study|Lost to Follow-up|1|||
170607434|NCT03712787|616571040|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
170607435|NCT03712787|616571041|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
170607436|NCT03712787|616571042|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
170607437|NCT03712787|616571043|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
170607438|NCT03712787|616571040|FG000|Overall Study|COVID-19 Infection|0|||
170607439|NCT03712787|616571041|FG001|Overall Study|COVID-19 Infection|1|||
170607440|NCT03712787|616571042|FG002|Overall Study|COVID-19 Infection|0|||
170607441|NCT03712787|616571043|FG003|Overall Study|COVID-19 Infection|0|||
170607442|NCT03712787|616571040|FG000|Overall Study|Other, Not Specified|79|||
170607443|NCT03712787|616571041|FG001|Overall Study|Other, Not Specified|77|||
170607444|NCT03712787|616571042|FG002|Overall Study|Other, Not Specified|74|||
170607445|NCT03712787|616571043|FG003|Overall Study|Other, Not Specified|78|||
170607446|NCT01865448|616571044|FG000|Overall Study|Adverse Event|1|||
170607447|NCT01865448|616571045|FG001|Overall Study|Adverse Event|1|||
170607448|NCT01865448|616571044|FG000|Overall Study|Pregnancy|0|||
170607449|NCT01865448|616571045|FG001|Overall Study|Pregnancy|1|||
170607450|NCT01865448|616571044|FG000|Overall Study|dropout unrelated to study|1|||
170607451|NCT01865448|616571045|FG001|Overall Study|dropout unrelated to study|1|||
170607452|NCT03499314|616571046|FG000|Overall Study|Time Commitment|1|||
170815522|NCT00090519|617331543|FG000|Overall Study|Sponsor Decision|3|||
170607453|NCT03499314|616571047|FG001|Overall Study|Time Commitment|2|||
170607454|NCT03499314|616571046|FG000|Overall Study|Medical issue unrelated to research study|1|||
170607455|NCT03499314|616571047|FG001|Overall Study|Medical issue unrelated to research study|1|||
170607456|NCT01618695|616571048|FG000|Core Phase|Adverse Event|4|||
170607457|NCT01618695|616571049|FG001|Core Phase|Adverse Event|5|||
170607458|NCT01618695|616571050|FG002|Core Phase|Adverse Event|15|||
170607459|NCT01618695|616571051|FG003|Core Phase|Adverse Event|20|||
170607460|NCT01618695|616571048|FG000|Core Phase|Lost to Follow-up|0|||
170607461|NCT01618695|616571049|FG001|Core Phase|Lost to Follow-up|0|||
170607462|NCT01618695|616571050|FG002|Core Phase|Lost to Follow-up|1|||
170607463|NCT01618695|616571051|FG003|Core Phase|Lost to Follow-up|0|||
170607464|NCT01618695|616571048|FG000|Core Phase|Withdrawal by Subject|16|||
170607465|NCT01618695|616571049|FG001|Core Phase|Withdrawal by Subject|11|||
170607466|NCT01618695|616571050|FG002|Core Phase|Withdrawal by Subject|9|||
170607467|NCT01618695|616571051|FG003|Core Phase|Withdrawal by Subject|13|||
170607468|NCT01618695|616571048|FG000|Core Phase|Pregnancy|2|||
170607469|NCT01618695|616571049|FG001|Core Phase|Pregnancy|0|||
170607470|NCT01618695|616571050|FG002|Core Phase|Pregnancy|0|||
170607471|NCT01618695|616571051|FG003|Core Phase|Pregnancy|0|||
170607472|NCT01618695|616571048|FG000|Core Phase|Lack of Efficacy|1|||
170607473|NCT01618695|616571049|FG001|Core Phase|Lack of Efficacy|2|||
170607474|NCT01618695|616571050|FG002|Core Phase|Lack of Efficacy|1|||
170607475|NCT01618695|616571051|FG003|Core Phase|Lack of Efficacy|1|||
170607476|NCT01618695|616571048|FG000|Core Phase|Other than specified|1|||
170607477|NCT01618695|616571049|FG001|Core Phase|Other than specified|2|||
170607478|NCT01618695|616571050|FG002|Core Phase|Other than specified|2|||
170607479|NCT01618695|616571051|FG003|Core Phase|Other than specified|2|||
170607480|NCT01618695|616571048|FG000|Core Phase|Not treated|1|||
170607481|NCT01618695|616571049|FG001|Core Phase|Not treated|0|||
170607482|NCT01618695|616571050|FG002|Core Phase|Not treated|2|||
170607483|NCT01618695|616571051|FG003|Core Phase|Not treated|0|||
170607484|NCT01618695|616571048|FG000|Extension Phase|Lack of Efficacy|17|||
170607485|NCT01618695|616571049|FG001|Extension Phase|Lack of Efficacy|33|||
170607486|NCT01618695|616571050|FG002|Extension Phase|Lack of Efficacy|26|||
170607487|NCT01618695|616571051|FG003|Extension Phase|Lack of Efficacy|24|||
170607488|NCT01618695|616571048|FG000|Extension Phase|Pregnancy|2|||
170607489|NCT01618695|616571049|FG001|Extension Phase|Pregnancy|0|||
170607490|NCT01618695|616571050|FG002|Extension Phase|Pregnancy|1|||
170607491|NCT01618695|616571051|FG003|Extension Phase|Pregnancy|1|||
170607492|NCT01618695|616571048|FG000|Extension Phase|Withdrawal by Subject|43|||
170607493|NCT01618695|616571049|FG001|Extension Phase|Withdrawal by Subject|48|||
170607494|NCT01618695|616571050|FG002|Extension Phase|Withdrawal by Subject|42|||
170607495|NCT01618695|616571051|FG003|Extension Phase|Withdrawal by Subject|33|||
170607496|NCT01618695|616571048|FG000|Extension Phase|Adverse Event|18|||
170607497|NCT01618695|616571049|FG001|Extension Phase|Adverse Event|16|||
170607498|NCT01618695|616571050|FG002|Extension Phase|Adverse Event|9|||
170607499|NCT01618695|616571051|FG003|Extension Phase|Adverse Event|20|||
170607500|NCT01618695|616571048|FG000|Extension Phase|Lost to Follow-up|2|||
170607501|NCT01618695|616571049|FG001|Extension Phase|Lost to Follow-up|1|||
170607502|NCT01618695|616571050|FG002|Extension Phase|Lost to Follow-up|1|||
170607503|NCT01618695|616571051|FG003|Extension Phase|Lost to Follow-up|1|||
170607504|NCT01618695|616571048|FG000|Extension Phase|Other than specified|13|||
170607505|NCT01618695|616571049|FG001|Extension Phase|Other than specified|18|||
170607506|NCT01618695|616571050|FG002|Extension Phase|Other than specified|13|||
170607507|NCT01618695|616571051|FG003|Extension Phase|Other than specified|18|||
170607508|NCT02813889|616571053|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
170607509|NCT02813889|616571054|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
170815523|NCT00090519|617331544|FG001|Overall Study|Sponsor Decision|1|||
170815524|NCT01662505|617331547|FG000|Overall Study|Progressive disease|6|||
170815525|NCT01662505|617331548|FG001|Overall Study|Progressive disease|1|||
170815526|NCT01662505|617331549|FG002|Overall Study|Progressive disease|5|||
170815527|NCT01662505|617331547|FG000|Overall Study|Refused cont. medication|0|||
170815528|NCT01662505|617331548|FG001|Overall Study|Refused cont. medication|0|||
170815529|NCT01662505|617331549|FG002|Overall Study|Refused cont. medication|1|||
170916184|NCT02932410|617695674|FG003|Overall Study|Physician Decision|0|||
170916185|NCT01932697|617695675|FG000|Overall Study|Received a different amount of tx|1|||
170607510|NCT05128578|616571055|FG000|Overall Study|Withdrawal by Subject|9|||
170607511|NCT05128578|616571055|FG000|Overall Study|Lost to Follow-up|5|||
170607512|NCT00871338|616571057|FG000|Prior to Booster|Withdrawal by Subject|1|||
170607513|NCT00871338|616571058|FG001|Prior to Booster|Withdrawal by Subject|3|||
170607514|NCT00871338|616571057|FG000|Prior to Booster|Lost to Follow-up|1|||
170815530|NCT01662505|617331547|FG000|Overall Study|Not specified above|1|||
170815531|NCT01662505|617331548|FG001|Overall Study|Not specified above|3|||
170815532|NCT01662505|617331549|FG002|Overall Study|Not specified above|2|||
170815533|NCT02548585|617331550|FG000|Overall Study|Withdrawal by Subject|0|||
170607515|NCT00871338|616571058|FG001|Prior to Booster|Lost to Follow-up|0|||
170607516|NCT02391363|616571059|FG000|Overall Study|Lost to Follow-up|5|||
170607517|NCT02391363|616571060|FG001|Overall Study|Lost to Follow-up|5|||
170607518|NCT02391363|616571059|FG000|Overall Study|Withdrawal by Subject|6|||
170815534|NCT02548585|617331551|FG001|Overall Study|Withdrawal by Subject|0|||
170607519|NCT02391363|616571060|FG001|Overall Study|Withdrawal by Subject|3|||
170607520|NCT00799266|616571061|FG000|Overall Study|Adverse Event|0|||
170607521|NCT00799266|616571062|FG001|Overall Study|Adverse Event|1|||
170607522|NCT00799266|616571061|FG000|Overall Study|Subject withdrew consent|3|||
170607523|NCT00799266|616571062|FG001|Overall Study|Subject withdrew consent|0|||
170607524|NCT01271725|616571064|FG000|Part A|Progressive disease according to RECIST|8|||
170607525|NCT01271725|616571065|FG001|Part A|Progressive disease according to RECIST|0|||
170607526|NCT01271725|616571064|FG000|Part A|Clinical signs/symptoms of progression|2|||
170607527|NCT01271725|616571065|FG001|Part A|Clinical signs/symptoms of progression|0|||
170607528|NCT01271725|616571064|FG000|Part A|Other Adverse Event|8|||
170607529|NCT01271725|616571065|FG001|Part A|Other Adverse Event|0|||
170607530|NCT01271725|616571064|FG000|Part A|Lost to Follow-up|1|||
170607531|NCT01271725|616571065|FG001|Part A|Lost to Follow-up|0|||
170607532|NCT01271725|616571064|FG000|Part A|Withdrawal by Subject|12|||
170607533|NCT01271725|616571065|FG001|Part A|Withdrawal by Subject|0|||
170607534|NCT01271725|616571064|FG000|Part A|Other than specified|3|||
170607535|NCT01271725|616571065|FG001|Part A|Other than specified|0|||
170607536|NCT01271725|616571064|FG000|Part A|Protocol Violation|1|||
170607537|NCT01271725|616571065|FG001|Part A|Protocol Violation|0|||
170607538|NCT01271725|616571064|FG000|Part B|Other than specified|0|||
170607539|NCT01271725|616571065|FG001|Part B|Other than specified|2|||
170607540|NCT01271725|616571064|FG000|Part B|Clinical signs/symptoms of progression|0|||
170607541|NCT01271725|616571065|FG001|Part B|Clinical signs/symptoms of progression|2|||
170607542|NCT01271725|616571064|FG000|Part B|Other Adverse Event|0|||
170607543|NCT01271725|616571065|FG001|Part B|Other Adverse Event|1|||
170607544|NCT01271725|616571064|FG000|Part B|Protocol Violation|0|||
170607545|NCT01271725|616571065|FG001|Part B|Protocol Violation|1|||
170607546|NCT01271725|616571064|FG000|Part B|Withdrawal by Subject|0|||
170607547|NCT01271725|616571065|FG001|Part B|Withdrawal by Subject|6|||
170607548|NCT00265317|616571066|FG000|Lead-In|Objective progression or relapse|6|||
170607549|NCT00265317|616571067|FG001|Lead-In|Objective progression or relapse|11|||
170607550|NCT00265317|616571068|FG002|Lead-In|Objective progression or relapse|0|||
170607551|NCT00265317|616571069|FG003|Lead-In|Objective progression or relapse|0|||
170607552|NCT00265317|616571066|FG000|Lead-In|Adverse Event|2|||
170607553|NCT00265317|616571067|FG001|Lead-In|Adverse Event|1|||
170607554|NCT00265317|616571068|FG002|Lead-In|Adverse Event|0|||
170607555|NCT00265317|616571069|FG003|Lead-In|Adverse Event|0|||
170607556|NCT00265317|616571066|FG000|Lead-In|Death|3|||
170607557|NCT00265317|616571067|FG001|Lead-In|Death|5|||
170607558|NCT00265317|616571068|FG002|Lead-In|Death|0|||
170607559|NCT00265317|616571069|FG003|Lead-In|Death|0|||
170607560|NCT00265317|616571066|FG000|Lead-In|Withdrawal/other than adverse event|1|||
170607561|NCT00265317|616571067|FG001|Lead-In|Withdrawal/other than adverse event|0|||
170607562|NCT00265317|616571068|FG002|Lead-In|Withdrawal/other than adverse event|0|||
170607563|NCT00265317|616571069|FG003|Lead-In|Withdrawal/other than adverse event|0|||
170607564|NCT00265317|616571066|FG000|Phase 2|Objective progression or relapse|0|||
170607565|NCT00265317|616571067|FG001|Phase 2|Objective progression or relapse|0|||
170607566|NCT00265317|616571068|FG002|Phase 2|Objective progression or relapse|37|||
170607567|NCT00265317|616571069|FG003|Phase 2|Objective progression or relapse|38|||
170607568|NCT00265317|616571066|FG000|Phase 2|Global deterioration of health status|0|||
170607569|NCT00265317|616571067|FG001|Phase 2|Global deterioration of health status|0|||
170607570|NCT00265317|616571068|FG002|Phase 2|Global deterioration of health status|3|||
170607571|NCT00265317|616571069|FG003|Phase 2|Global deterioration of health status|0|||
170607572|NCT00265317|616571066|FG000|Phase 2|Adverse Event|0|||
170607573|NCT00265317|616571067|FG001|Phase 2|Adverse Event|0|||
170607574|NCT00265317|616571068|FG002|Phase 2|Adverse Event|7|||
170815535|NCT02548585|617331552|FG002|Overall Study|Withdrawal by Subject|0|||
170815536|NCT02548585|617331553|FG003|Overall Study|Withdrawal by Subject|0|||
170815537|NCT02548585|617331554|FG004|Overall Study|Withdrawal by Subject|0|||
170815538|NCT02548585|617331555|FG005|Overall Study|Withdrawal by Subject|1|||
170815539|NCT02548585|617331556|FG006|Overall Study|Withdrawal by Subject|0|||
170815540|NCT02548585|617331550|FG000|Overall Study|Lost to Follow-up|1|||
170607575|NCT00265317|616571069|FG003|Phase 2|Adverse Event|5|||
170607576|NCT00265317|616571066|FG000|Phase 2|Death|0|||
170607577|NCT00265317|616571067|FG001|Phase 2|Death|0|||
170607578|NCT00265317|616571068|FG002|Phase 2|Death|12|||
170607579|NCT00265317|616571069|FG003|Phase 2|Death|15|||
170815541|NCT02548585|617331551|FG001|Overall Study|Lost to Follow-up|0|||
170607580|NCT00265317|616571066|FG000|Phase 2|Protocol Violation|0|||
170607581|NCT00265317|616571067|FG001|Phase 2|Protocol Violation|0|||
170607582|NCT00265317|616571068|FG002|Phase 2|Protocol Violation|1|||
170607583|NCT00265317|616571069|FG003|Phase 2|Protocol Violation|4|||
170607584|NCT00265317|616571066|FG000|Phase 2|Lost to Follow-up|0|||
170607585|NCT00265317|616571067|FG001|Phase 2|Lost to Follow-up|0|||
170607586|NCT00265317|616571068|FG002|Phase 2|Lost to Follow-up|0|||
170607587|NCT00265317|616571069|FG003|Phase 2|Lost to Follow-up|1|||
170607588|NCT00265317|616571066|FG000|Phase 2|Withdrawal/other than adverse event|0|||
170607589|NCT00265317|616571067|FG001|Phase 2|Withdrawal/other than adverse event|0|||
170607590|NCT00265317|616571068|FG002|Phase 2|Withdrawal/other than adverse event|2|||
170607591|NCT00265317|616571069|FG003|Phase 2|Withdrawal/other than adverse event|1|||
170607592|NCT00265317|616571066|FG000|Phase 2|Study terminated by sponsor|0|||
170607593|NCT00265317|616571067|FG001|Phase 2|Study terminated by sponsor|0|||
170607594|NCT00265317|616571068|FG002|Phase 2|Study terminated by sponsor|1|||
170607595|NCT00265317|616571069|FG003|Phase 2|Study terminated by sponsor|0|||
170607596|NCT00265317|616571066|FG000|Phase 2|Other|0|||
170607597|NCT00265317|616571067|FG001|Phase 2|Other|0|||
170607598|NCT00265317|616571068|FG002|Phase 2|Other|1|||
170607599|NCT00265317|616571069|FG003|Phase 2|Other|1|||
170607600|NCT00732875|616571070|FG000|Overall Study|Adverse Event|16|||
170607601|NCT00732875|616571070|FG000|Overall Study|Withdrawal by Subject|6|||
170607602|NCT00732875|616571070|FG000|Overall Study|Lack of Efficacy|13|||
170607603|NCT02737475|616571071|FG000|Overall Study|Other reasons|0|||
170607604|NCT02737475|616571072|FG001|Overall Study|Other reasons|0|||
170607605|NCT02737475|616571073|FG002|Overall Study|Other reasons|0|||
170607606|NCT02737475|616571074|FG003|Overall Study|Other reasons|0|||
170607607|NCT02737475|616571075|FG004|Overall Study|Other reasons|1|||
170607608|NCT02737475|616571076|FG005|Overall Study|Other reasons|1|||
170607609|NCT02737475|616571077|FG006|Overall Study|Other reasons|0|||
170607610|NCT02737475|616571078|FG007|Overall Study|Other reasons|0|||
170607611|NCT02737475|616571079|FG008|Overall Study|Other reasons|1|||
170607612|NCT02737475|616571080|FG009|Overall Study|Other reasons|0|||
170607613|NCT02737475|616571081|FG010|Overall Study|Other reasons|1|||
170607614|NCT02737475|616571082|FG011|Overall Study|Other reasons|0|||
170607615|NCT02737475|616571083|FG012|Overall Study|Other reasons|0|||
170607616|NCT02737475|616571084|FG013|Overall Study|Other reasons|0|||
170607617|NCT02737475|616571085|FG014|Overall Study|Other reasons|0|||
170607618|NCT02737475|616571086|FG015|Overall Study|Other reasons|0|||
170607619|NCT02737475|616571087|FG016|Overall Study|Other reasons|0|||
170607620|NCT02737475|616571088|FG017|Overall Study|Other reasons|0|||
170607621|NCT02737475|616571089|FG018|Overall Study|Other reasons|0|||
170607622|NCT02737475|616571090|FG019|Overall Study|Other reasons|0|||
170607623|NCT02737475|616571091|FG020|Overall Study|Other reasons|0|||
170607624|NCT02737475|616571092|FG021|Overall Study|Other reasons|1|||
170607625|NCT02737475|616571093|FG022|Overall Study|Other reasons|0|||
170607626|NCT02737475|616571094|FG023|Overall Study|Other reasons|1|||
170607627|NCT02737475|616571095|FG024|Overall Study|Other reasons|1|||
170607628|NCT02737475|616571096|FG025|Overall Study|Other reasons|1|||
170607629|NCT02737475|616571097|FG026|Overall Study|Other reasons|0|||
170607630|NCT02737475|616571071|FG000|Overall Study|Death|1|||
170607631|NCT02737475|616571072|FG001|Overall Study|Death|0|||
170607632|NCT02737475|616571073|FG002|Overall Study|Death|0|||
170607633|NCT02737475|616571074|FG003|Overall Study|Death|1|||
170607634|NCT02737475|616571075|FG004|Overall Study|Death|0|||
170607635|NCT02737475|616571076|FG005|Overall Study|Death|0|||
170607636|NCT02737475|616571077|FG006|Overall Study|Death|0|||
170607637|NCT02737475|616571078|FG007|Overall Study|Death|2|||
170607638|NCT02737475|616571079|FG008|Overall Study|Death|0|||
170607639|NCT02737475|616571080|FG009|Overall Study|Death|0|||
170607640|NCT02737475|616571081|FG010|Overall Study|Death|0|||
170607641|NCT02737475|616571082|FG011|Overall Study|Death|4|||
170607642|NCT02737475|616571083|FG012|Overall Study|Death|2|||
170607643|NCT02737475|616571084|FG013|Overall Study|Death|2|||
170607644|NCT02737475|616571085|FG014|Overall Study|Death|0|||
170607645|NCT02737475|616571086|FG015|Overall Study|Death|2|||
170815542|NCT02548585|617331552|FG002|Overall Study|Lost to Follow-up|0|||
170815543|NCT02548585|617331553|FG003|Overall Study|Lost to Follow-up|0|||
170815544|NCT02548585|617331554|FG004|Overall Study|Lost to Follow-up|0|||
170815545|NCT02548585|617331555|FG005|Overall Study|Lost to Follow-up|0|||
170815546|NCT02548585|617331556|FG006|Overall Study|Lost to Follow-up|0|||
170815547|NCT02548585|617331550|FG000|Overall Study|Other|1|||
170815548|NCT02548585|617331551|FG001|Overall Study|Other|0|||
170815549|NCT02548585|617331552|FG002|Overall Study|Other|0|||
170815550|NCT02548585|617331553|FG003|Overall Study|Other|2|||
170607646|NCT02737475|616571087|FG016|Overall Study|Death|2|||
170815551|NCT02548585|617331554|FG004|Overall Study|Other|3|||
170815552|NCT02548585|617331555|FG005|Overall Study|Other|0|||
170815553|NCT02548585|617331556|FG006|Overall Study|Other|1|||
170815554|NCT02548585|617331550|FG000|Overall Study|Randomized but not treated|0|||
170815555|NCT02548585|617331551|FG001|Overall Study|Randomized but not treated|0|||
170607647|NCT02737475|616571088|FG017|Overall Study|Death|2|||
170607648|NCT02737475|616571089|FG018|Overall Study|Death|1|||
170607649|NCT02737475|616571090|FG019|Overall Study|Death|0|||
170607650|NCT02737475|616571091|FG020|Overall Study|Death|0|||
170607651|NCT02737475|616571092|FG021|Overall Study|Death|0|||
170607652|NCT02737475|616571093|FG022|Overall Study|Death|0|||
170607653|NCT02737475|616571094|FG023|Overall Study|Death|0|||
170607654|NCT02737475|616571095|FG024|Overall Study|Death|0|||
170607655|NCT02737475|616571096|FG025|Overall Study|Death|0|||
170607656|NCT02737475|616571097|FG026|Overall Study|Death|0|||
170607657|NCT02737475|616571071|FG000|Overall Study|Participant withdrew consent|0|||
170607658|NCT02737475|616571072|FG001|Overall Study|Participant withdrew consent|0|||
170815556|NCT02548585|617331552|FG002|Overall Study|Randomized but not treated|0|||
170815557|NCT02548585|617331553|FG003|Overall Study|Randomized but not treated|0|||
170607659|NCT02737475|616571073|FG002|Overall Study|Participant withdrew consent|0|||
170607660|NCT02737475|616571074|FG003|Overall Study|Participant withdrew consent|0|||
170607661|NCT02737475|616571075|FG004|Overall Study|Participant withdrew consent|0|||
170607662|NCT02737475|616571076|FG005|Overall Study|Participant withdrew consent|2|||
170607663|NCT02737475|616571077|FG006|Overall Study|Participant withdrew consent|0|||
170607664|NCT02737475|616571078|FG007|Overall Study|Participant withdrew consent|0|||
170607665|NCT02737475|616571079|FG008|Overall Study|Participant withdrew consent|0|||
170607666|NCT02737475|616571080|FG009|Overall Study|Participant withdrew consent|0|||
170607667|NCT02737475|616571081|FG010|Overall Study|Participant withdrew consent|0|||
170607668|NCT02737475|616571082|FG011|Overall Study|Participant withdrew consent|0|||
170607669|NCT02737475|616571083|FG012|Overall Study|Participant withdrew consent|0|||
170607670|NCT02737475|616571084|FG013|Overall Study|Participant withdrew consent|0|||
170607671|NCT02737475|616571085|FG014|Overall Study|Participant withdrew consent|1|||
170607672|NCT02737475|616571086|FG015|Overall Study|Participant withdrew consent|0|||
170607673|NCT02737475|616571087|FG016|Overall Study|Participant withdrew consent|0|||
170607674|NCT02737475|616571088|FG017|Overall Study|Participant withdrew consent|2|||
170607675|NCT02737475|616571089|FG018|Overall Study|Participant withdrew consent|1|||
170607676|NCT02737475|616571090|FG019|Overall Study|Participant withdrew consent|0|||
170607677|NCT02737475|616571091|FG020|Overall Study|Participant withdrew consent|2|||
170607678|NCT02737475|616571092|FG021|Overall Study|Participant withdrew consent|0|||
170607679|NCT02737475|616571093|FG022|Overall Study|Participant withdrew consent|0|||
170607680|NCT02737475|616571094|FG023|Overall Study|Participant withdrew consent|0|||
170607681|NCT02737475|616571095|FG024|Overall Study|Participant withdrew consent|0|||
170607682|NCT02737475|616571096|FG025|Overall Study|Participant withdrew consent|0|||
170607683|NCT02737475|616571097|FG026|Overall Study|Participant withdrew consent|0|||
170607684|NCT02737475|616571071|FG000|Overall Study|Lost to Follow-up|0|||
170607685|NCT02737475|616571072|FG001|Overall Study|Lost to Follow-up|0|||
170607686|NCT02737475|616571073|FG002|Overall Study|Lost to Follow-up|0|||
170607687|NCT02737475|616571074|FG003|Overall Study|Lost to Follow-up|0|||
170607688|NCT02737475|616571075|FG004|Overall Study|Lost to Follow-up|0|||
170607689|NCT02737475|616571076|FG005|Overall Study|Lost to Follow-up|0|||
170607690|NCT02737475|616571077|FG006|Overall Study|Lost to Follow-up|0|||
170607691|NCT02737475|616571078|FG007|Overall Study|Lost to Follow-up|0|||
170607692|NCT02737475|616571079|FG008|Overall Study|Lost to Follow-up|0|||
170607693|NCT02737475|616571080|FG009|Overall Study|Lost to Follow-up|0|||
170607694|NCT02737475|616571081|FG010|Overall Study|Lost to Follow-up|0|||
170607695|NCT02737475|616571082|FG011|Overall Study|Lost to Follow-up|0|||
170607696|NCT02737475|616571083|FG012|Overall Study|Lost to Follow-up|0|||
170607697|NCT02737475|616571084|FG013|Overall Study|Lost to Follow-up|0|||
170607698|NCT02737475|616571085|FG014|Overall Study|Lost to Follow-up|0|||
170607699|NCT02737475|616571086|FG015|Overall Study|Lost to Follow-up|1|||
170607700|NCT02737475|616571087|FG016|Overall Study|Lost to Follow-up|0|||
170607701|NCT02737475|616571088|FG017|Overall Study|Lost to Follow-up|0|||
170607702|NCT02737475|616571089|FG018|Overall Study|Lost to Follow-up|0|||
170607703|NCT02737475|616571090|FG019|Overall Study|Lost to Follow-up|0|||
170607704|NCT02737475|616571091|FG020|Overall Study|Lost to Follow-up|0|||
170607705|NCT02737475|616571092|FG021|Overall Study|Lost to Follow-up|0|||
170607706|NCT02737475|616571093|FG022|Overall Study|Lost to Follow-up|0|||
170607707|NCT02737475|616571094|FG023|Overall Study|Lost to Follow-up|0|||
170607708|NCT02737475|616571095|FG024|Overall Study|Lost to Follow-up|0|||
170607709|NCT02737475|616571096|FG025|Overall Study|Lost to Follow-up|0|||
170607710|NCT02737475|616571097|FG026|Overall Study|Lost to Follow-up|0|||
170607711|NCT02737475|616571071|FG000|Overall Study|Disease Progression|0|||
170607712|NCT02737475|616571072|FG001|Overall Study|Disease Progression|0|||
170607713|NCT02737475|616571073|FG002|Overall Study|Disease Progression|0|||
170607714|NCT02737475|616571074|FG003|Overall Study|Disease Progression|0|||
170607715|NCT02737475|616571075|FG004|Overall Study|Disease Progression|0|||
170607716|NCT02737475|616571076|FG005|Overall Study|Disease Progression|0|||
170815558|NCT02548585|617331554|FG004|Overall Study|Randomized but not treated|0|||
170815559|NCT02548585|617331555|FG005|Overall Study|Randomized but not treated|1|||
170815560|NCT02548585|617331556|FG006|Overall Study|Randomized but not treated|0|||
170815561|NCT01075152|617331559|FG000|Overall Study|Withdrawal by Subject|1|||
170815562|NCT01075152|617331560|FG001|Overall Study|Withdrawal by Subject|0|||
170607717|NCT02737475|616571077|FG006|Overall Study|Disease Progression|0|||
170607718|NCT02737475|616571078|FG007|Overall Study|Disease Progression|0|||
170607719|NCT02737475|616571079|FG008|Overall Study|Disease Progression|0|||
170607720|NCT02737475|616571080|FG009|Overall Study|Disease Progression|0|||
170607721|NCT02737475|616571081|FG010|Overall Study|Disease Progression|0|||
170607722|NCT02737475|616571082|FG011|Overall Study|Disease Progression|0|||
170607723|NCT02737475|616571083|FG012|Overall Study|Disease Progression|0|||
170607724|NCT02737475|616571084|FG013|Overall Study|Disease Progression|0|||
170607725|NCT02737475|616571085|FG014|Overall Study|Disease Progression|0|||
170607726|NCT02737475|616571086|FG015|Overall Study|Disease Progression|0|||
170607727|NCT02737475|616571087|FG016|Overall Study|Disease Progression|0|||
170653059|NCT04090411|616743389|FG005|Induction Period|Physician Decision|0|||
170607728|NCT02737475|616571088|FG017|Overall Study|Disease Progression|0|||
170607729|NCT02737475|616571089|FG018|Overall Study|Disease Progression|0|||
170607730|NCT02737475|616571090|FG019|Overall Study|Disease Progression|0|||
170607731|NCT02737475|616571091|FG020|Overall Study|Disease Progression|0|||
170607732|NCT02737475|616571092|FG021|Overall Study|Disease Progression|0|||
170607733|NCT02737475|616571093|FG022|Overall Study|Disease Progression|0|||
170607734|NCT02737475|616571094|FG023|Overall Study|Disease Progression|0|||
170607735|NCT02737475|616571095|FG024|Overall Study|Disease Progression|0|||
170607736|NCT02737475|616571096|FG025|Overall Study|Disease Progression|0|||
170607737|NCT02737475|616571097|FG026|Overall Study|Disease Progression|1|||
170607738|NCT01496469|616571102|FG000|Overall Study|Adverse Event|1|||
170607739|NCT01496469|616571103|FG001|Overall Study|Adverse Event|0|||
170607740|NCT01496469|616571102|FG000|Overall Study|Protocol Violation|2|||
170607741|NCT01496469|616571103|FG001|Overall Study|Protocol Violation|0|||
170607742|NCT01496469|616571102|FG000|Overall Study|Lost to Follow-up|1|||
170607743|NCT01496469|616571103|FG001|Overall Study|Lost to Follow-up|1|||
170607744|NCT01496469|616571102|FG000|Overall Study|Withdrawal by Subject|4|||
170607745|NCT01496469|616571103|FG001|Overall Study|Withdrawal by Subject|4|||
170607746|NCT01496469|616571102|FG000|Overall Study|BP exceeds protocol limits|1|||
170607747|NCT01496469|616571103|FG001|Overall Study|BP exceeds protocol limits|2|||
170607748|NCT01496469|616571102|FG000|Overall Study|Other|1|||
170607749|NCT01496469|616571103|FG001|Overall Study|Other|1|||
170607750|NCT00291018|616571104|FG000|Overall Study|Not Consented or Declined PAS|12|||
170607751|NCT00291018|616571105|FG001|Overall Study|Not Consented or Declined PAS|15|||
170607752|NCT00291018|616571106|FG002|Overall Study|Not Consented or Declined PAS|15|||
170607753|NCT00291018|616571104|FG000|Overall Study|Death|3|||
170607754|NCT00291018|616571105|FG001|Overall Study|Death|3|||
170607755|NCT00291018|616571106|FG002|Overall Study|Death|4|||
170607756|NCT00291018|616571104|FG000|Overall Study|Withdrawal by Subject|2|||
170607757|NCT00291018|616571105|FG001|Overall Study|Withdrawal by Subject|8|||
170607758|NCT00291018|616571106|FG002|Overall Study|Withdrawal by Subject|1|||
170607759|NCT00291018|616571104|FG000|Overall Study|Failures|5|||
170607760|NCT00291018|616571105|FG001|Overall Study|Failures|12|||
170607761|NCT00291018|616571106|FG002|Overall Study|Failures|5|||
170607762|NCT00291018|616571104|FG000|Overall Study|Lost to Follow-up|3|||
170607763|NCT00291018|616571105|FG001|Overall Study|Lost to Follow-up|4|||
170607764|NCT00291018|616571106|FG002|Overall Study|Lost to Follow-up|18|||
170607765|NCT01504412|616571107|FG000|Overall Study|Adverse Event|1|||
170607766|NCT01504412|616571108|FG001|Overall Study|Adverse Event|8|||
170607767|NCT01504412|616571109|FG002|Overall Study|Adverse Event|1|||
170607768|NCT01504412|616571110|FG003|Overall Study|Adverse Event|7|||
170607769|NCT01504412|616571111|FG004|Overall Study|Adverse Event|10|||
170607770|NCT01504412|616571107|FG000|Overall Study|Withdrawal by Subject|2|||
170607771|NCT01504412|616571108|FG001|Overall Study|Withdrawal by Subject|1|||
170607772|NCT01504412|616571109|FG002|Overall Study|Withdrawal by Subject|1|||
170607773|NCT01504412|616571110|FG003|Overall Study|Withdrawal by Subject|5|||
170607774|NCT01504412|616571111|FG004|Overall Study|Withdrawal by Subject|1|||
170607775|NCT01504412|616571107|FG000|Overall Study|Other|2|||
170607776|NCT01504412|616571108|FG001|Overall Study|Other|1|||
170607777|NCT01504412|616571109|FG002|Overall Study|Other|1|||
170607778|NCT01504412|616571110|FG003|Overall Study|Other|6|||
170607779|NCT01504412|616571111|FG004|Overall Study|Other|1|||
170653060|NCT04090411|616743390|FG006|Induction Period|Physician Decision|0|||
170653061|NCT04090411|616743391|FG007|Induction Period|Physician Decision|0|||
170653062|NCT04090411|616743392|FG008|Induction Period|Physician Decision|0|||
170653063|NCT04090411|616743393|FG009|Induction Period|Physician Decision|0|||
170815563|NCT01079949|617331563|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
170815564|NCT01079949|617331564|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
170815565|NCT01079949|617331563|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
170607780|NCT01504412|616571107|FG000|Overall Study|Lost to Follow-up|0|||
170607781|NCT01504412|616571108|FG001|Overall Study|Lost to Follow-up|2|||
170607782|NCT01504412|616571109|FG002|Overall Study|Lost to Follow-up|0|||
170607783|NCT01504412|616571110|FG003|Overall Study|Lost to Follow-up|0|||
170607784|NCT01504412|616571111|FG004|Overall Study|Lost to Follow-up|0|||
170607785|NCT01504412|616571107|FG000|Overall Study|Lack of Efficacy|0|||
170607786|NCT01504412|616571108|FG001|Overall Study|Lack of Efficacy|0|||
170607787|NCT01504412|616571109|FG002|Overall Study|Lack of Efficacy|1|||
170607788|NCT01504412|616571110|FG003|Overall Study|Lack of Efficacy|0|||
170607789|NCT01504412|616571111|FG004|Overall Study|Lack of Efficacy|1|||
170607790|NCT01504412|616571107|FG000|Overall Study|Death|0|||
170653064|NCT04090411|616743394|FG010|Induction Period|Physician Decision|0|||
170653065|NCT04090411|616743395|FG011|Induction Period|Physician Decision|0|||
170607791|NCT01504412|616571108|FG001|Overall Study|Death|0|||
170607792|NCT01504412|616571109|FG002|Overall Study|Death|0|||
170607793|NCT01504412|616571110|FG003|Overall Study|Death|1|||
170607794|NCT01504412|616571111|FG004|Overall Study|Death|0|||
170607795|NCT04273893|616571116|FG000|Overall Study|Withdrawal by Subject|0|||
170607796|NCT04273893|616571117|FG001|Overall Study|Withdrawal by Subject|2|||
170607797|NCT04273893|616571116|FG000|Overall Study|Treatment of Disease Progression|0|||
170607798|NCT04273893|616571117|FG001|Overall Study|Treatment of Disease Progression|2|||
170607799|NCT04273893|616571116|FG000|Overall Study|Death|1|||
170607800|NCT04273893|616571117|FG001|Overall Study|Death|2|||
170607801|NCT04273893|616571116|FG000|Overall Study|Lost to Follow-up|0|||
170607802|NCT04273893|616571117|FG001|Overall Study|Lost to Follow-up|2|||
170607803|NCT04273893|616571116|FG000|Overall Study|Physician Decision|1|||
170607804|NCT04273893|616571117|FG001|Overall Study|Physician Decision|0|||
170607805|NCT03626545|616571118|FG000|Overall Study|Progressive disease|3|||
170607806|NCT03626545|616571119|FG001|Overall Study|Progressive disease|82|||
170607807|NCT03626545|616571120|FG002|Overall Study|Progressive disease|85|||
170607808|NCT03626545|616571118|FG000|Overall Study|Adverse Event|3|||
170607809|NCT03626545|616571119|FG001|Overall Study|Adverse Event|13|||
170607810|NCT03626545|616571120|FG002|Overall Study|Adverse Event|10|||
170607811|NCT03626545|616571118|FG000|Overall Study|Physician Decision|1|||
170607812|NCT03626545|616571119|FG001|Overall Study|Physician Decision|18|||
170607813|NCT03626545|616571120|FG002|Overall Study|Physician Decision|14|||
170607814|NCT03626545|616571118|FG000|Overall Study|Subject Decision|0|||
170607815|NCT03626545|616571119|FG001|Overall Study|Subject Decision|5|||
170607816|NCT03626545|616571120|FG002|Overall Study|Subject Decision|5|||
170607817|NCT03626545|616571118|FG000|Overall Study|Death|1|||
170607818|NCT03626545|616571119|FG001|Overall Study|Death|1|||
170607819|NCT03626545|616571120|FG002|Overall Study|Death|1|||
170607820|NCT03626545|616571118|FG000|Overall Study|Protocol Deviation|0|||
170607821|NCT03626545|616571119|FG001|Overall Study|Protocol Deviation|1|||
170607822|NCT03626545|616571120|FG002|Overall Study|Protocol Deviation|1|||
170607823|NCT03626545|616571118|FG000|Overall Study|Guardian Decision|0|||
170607824|NCT03626545|616571119|FG001|Overall Study|Guardian Decision|0|||
170607825|NCT03626545|616571120|FG002|Overall Study|Guardian Decision|1|||
170607826|NCT02462720|616571124|FG000|Part 2|Withdrawal by Subject|1|||
170607827|NCT02462720|616571125|FG001|Part 2|Withdrawal by Subject|0|||
170607828|NCT02462720|616571124|FG000|Part 2|Protocol Violation|0|||
170607829|NCT02462720|616571125|FG001|Part 2|Protocol Violation|1|||
170607830|NCT05173012|616571130|FG000|Overall Study|Adverse Event|2|||
170607831|NCT05173012|616571131|FG001|Overall Study|Adverse Event|3|||
170607832|NCT05173012|616571132|FG002|Overall Study|Adverse Event|4|||
170607833|NCT05173012|616571133|FG003|Overall Study|Adverse Event|13|||
170607834|NCT05173012|616571134|FG004|Overall Study|Adverse Event|0|||
170607835|NCT05173012|616571135|FG005|Overall Study|Adverse Event|0|||
170607836|NCT05173012|616571136|FG006|Overall Study|Adverse Event|2|||
170607837|NCT05173012|616571137|FG007|Overall Study|Adverse Event|4|||
170815566|NCT01079949|617331564|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
170815567|NCT01079949|617331563|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
170815568|NCT01079949|617331564|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
170607838|NCT05173012|616571130|FG000|Overall Study|Lost to Follow-up|0|||
170607839|NCT05173012|616571131|FG001|Overall Study|Lost to Follow-up|0|||
170607840|NCT05173012|616571132|FG002|Overall Study|Lost to Follow-up|0|||
170607841|NCT05173012|616571133|FG003|Overall Study|Lost to Follow-up|1|||
170607842|NCT05173012|616571134|FG004|Overall Study|Lost to Follow-up|0|||
170607843|NCT05173012|616571135|FG005|Overall Study|Lost to Follow-up|0|||
170607844|NCT05173012|616571136|FG006|Overall Study|Lost to Follow-up|0|||
170607845|NCT05173012|616571137|FG007|Overall Study|Lost to Follow-up|0|||
170607846|NCT05173012|616571130|FG000|Overall Study|Withdrawal by Subject|1|||
170607847|NCT05173012|616571131|FG001|Overall Study|Withdrawal by Subject|0|||
170607848|NCT05173012|616571132|FG002|Overall Study|Withdrawal by Subject|1|||
170607849|NCT05173012|616571133|FG003|Overall Study|Withdrawal by Subject|3|||
170607850|NCT05173012|616571134|FG004|Overall Study|Withdrawal by Subject|1|||
170607851|NCT05173012|616571135|FG005|Overall Study|Withdrawal by Subject|0|||
170607852|NCT05173012|616571136|FG006|Overall Study|Withdrawal by Subject|1|||
170607853|NCT05173012|616571137|FG007|Overall Study|Withdrawal by Subject|0|||
170607854|NCT05173012|616571130|FG000|Overall Study|Protocol Deviation|0|||
170607855|NCT05173012|616571131|FG001|Overall Study|Protocol Deviation|0|||
170607856|NCT05173012|616571132|FG002|Overall Study|Protocol Deviation|0|||
170607857|NCT05173012|616571133|FG003|Overall Study|Protocol Deviation|1|||
170607858|NCT05173012|616571134|FG004|Overall Study|Protocol Deviation|0|||
170815569|NCT01079949|617331563|FG000|Overall Study|Randomized but not treated|1|||
170815570|NCT01079949|617331564|FG001|Overall Study|Randomized but not treated|0|||
170607859|NCT05173012|616571135|FG005|Overall Study|Protocol Deviation|0|||
170815571|NCT04620733|617332781|FG000|Overall Study|Adverse Event|4|||
170607860|NCT05173012|616571136|FG006|Overall Study|Protocol Deviation|0|||
170815572|NCT04620733|617332782|FG001|Overall Study|Adverse Event|3|||
170815573|NCT04620733|617332781|FG000|Overall Study|Withdrawal by Subject|2|||
170815574|NCT04620733|617332782|FG001|Overall Study|Withdrawal by Subject|5|||
170607861|NCT05173012|616571137|FG007|Overall Study|Protocol Deviation|0|||
170607862|NCT05173012|616571130|FG000|Overall Study|Other|0|||
170607863|NCT05173012|616571131|FG001|Overall Study|Other|0|||
170607864|NCT05173012|616571132|FG002|Overall Study|Other|0|||
170607865|NCT05173012|616571133|FG003|Overall Study|Other|2|||
170607866|NCT05173012|616571134|FG004|Overall Study|Other|0|||
170607867|NCT05173012|616571135|FG005|Overall Study|Other|0|||
170607868|NCT05173012|616571136|FG006|Overall Study|Other|0|||
170607869|NCT05173012|616571137|FG007|Overall Study|Other|0|||
170607870|NCT02936843|616571138|FG000|Overall Study|Lost to Follow-up|3|||
170607871|NCT02936843|616571139|FG001|Overall Study|Lost to Follow-up|1|||
170607872|NCT02936843|616571138|FG000|Overall Study|Withdrawal by Subject|1|||
170607873|NCT02936843|616571139|FG001|Overall Study|Withdrawal by Subject|1|||
170607874|NCT01393821|616571140|FG000|Overall Study|Cancel|1|||
170607875|NCT01393821|616571141|FG001|Overall Study|Cancel|1|||
170607876|NCT01393821|616571140|FG000|Overall Study|not evaluable for primary endpoint|4|||
170607877|NCT01393821|616571141|FG001|Overall Study|not evaluable for primary endpoint|2|||
170607878|NCT01858766|616571144|FG000|Overall Study|Randomized but Never Treated|0|||
170607879|NCT01858766|616571145|FG001|Overall Study|Randomized but Never Treated|0|||
170607880|NCT01858766|616571146|FG002|Overall Study|Randomized but Never Treated|0|||
170607881|NCT01858766|616571147|FG003|Overall Study|Randomized but Never Treated|0|||
170607882|NCT01858766|616571148|FG004|Overall Study|Randomized but Never Treated|0|||
170607883|NCT01858766|616571149|FG005|Overall Study|Randomized but Never Treated|1|||
170607884|NCT01858766|616571150|FG006|Overall Study|Randomized but Never Treated|0|||
170607885|NCT01858766|616571151|FG007|Overall Study|Randomized but Never Treated|0|||
170607886|NCT01858766|616571152|FG008|Overall Study|Randomized but Never Treated|0|||
170607887|NCT01858766|616571153|FG009|Overall Study|Randomized but Never Treated|0|||
170607888|NCT01858766|616571154|FG010|Overall Study|Randomized but Never Treated|0|||
170607889|NCT01858766|616571155|FG011|Overall Study|Randomized but Never Treated|0|||
170607890|NCT01858766|616571156|FG012|Overall Study|Randomized but Never Treated|0|||
170607891|NCT01858766|616571157|FG013|Overall Study|Randomized but Never Treated|0|||
170607892|NCT01858766|616571158|FG014|Overall Study|Randomized but Never Treated|0|||
170607893|NCT01858766|616571159|FG015|Overall Study|Randomized but Never Treated|0|||
170607894|NCT01858766|616571160|FG016|Overall Study|Randomized but Never Treated|0|||
170607895|NCT01858766|616571161|FG017|Overall Study|Randomized but Never Treated|1|||
170607896|NCT01858766|616571162|FG018|Overall Study|Randomized but Never Treated|0|||
170607897|NCT01858766|616571144|FG000|Overall Study|Death|0|||
170607898|NCT01858766|616571145|FG001|Overall Study|Death|0|||
170607899|NCT01858766|616571146|FG002|Overall Study|Death|1|||
170607900|NCT01858766|616571147|FG003|Overall Study|Death|0|||
170607901|NCT01858766|616571148|FG004|Overall Study|Death|0|||
170607902|NCT01858766|616571149|FG005|Overall Study|Death|0|||
170607903|NCT01858766|616571150|FG006|Overall Study|Death|0|||
170607904|NCT01858766|616571151|FG007|Overall Study|Death|0|||
170607905|NCT01858766|616571152|FG008|Overall Study|Death|0|||
170607906|NCT01858766|616571153|FG009|Overall Study|Death|0|||
170607907|NCT01858766|616571154|FG010|Overall Study|Death|0|||
170607908|NCT01858766|616571155|FG011|Overall Study|Death|0|||
170607909|NCT01858766|616571156|FG012|Overall Study|Death|0|||
170607910|NCT01858766|616571157|FG013|Overall Study|Death|0|||
170607911|NCT01858766|616571158|FG014|Overall Study|Death|0|||
170916186|NCT01932697|617695676|FG001|Overall Study|Received a different amount of tx|0|||
170916187|NCT01932697|617695675|FG000|Overall Study|Ineligible|1|||
170916188|NCT01932697|617695676|FG001|Overall Study|Ineligible|0|||
170607912|NCT01858766|616571159|FG015|Overall Study|Death|0|||
170607913|NCT01858766|616571160|FG016|Overall Study|Death|0|||
170607914|NCT01858766|616571161|FG017|Overall Study|Death|0|||
170607915|NCT01858766|616571162|FG018|Overall Study|Death|0|||
170607916|NCT01858766|616571144|FG000|Overall Study|Lack of Efficacy|1|||
170607917|NCT01858766|616571145|FG001|Overall Study|Lack of Efficacy|0|||
170607918|NCT01858766|616571146|FG002|Overall Study|Lack of Efficacy|0|||
170607919|NCT01858766|616571147|FG003|Overall Study|Lack of Efficacy|0|||
170607920|NCT01858766|616571148|FG004|Overall Study|Lack of Efficacy|1|||
170607921|NCT01858766|616571149|FG005|Overall Study|Lack of Efficacy|2|||
170607922|NCT01858766|616571150|FG006|Overall Study|Lack of Efficacy|0|||
170607923|NCT01858766|616571151|FG007|Overall Study|Lack of Efficacy|0|||
170607924|NCT01858766|616571152|FG008|Overall Study|Lack of Efficacy|0|||
170607925|NCT01858766|616571153|FG009|Overall Study|Lack of Efficacy|0|||
170607926|NCT01858766|616571154|FG010|Overall Study|Lack of Efficacy|0|||
170607927|NCT01858766|616571155|FG011|Overall Study|Lack of Efficacy|3|||
170607928|NCT01858766|616571156|FG012|Overall Study|Lack of Efficacy|5|||
170607929|NCT01858766|616571157|FG013|Overall Study|Lack of Efficacy|3|||
170607930|NCT01858766|616571158|FG014|Overall Study|Lack of Efficacy|5|||
170607931|NCT01858766|616571159|FG015|Overall Study|Lack of Efficacy|5|||
170607932|NCT01858766|616571160|FG016|Overall Study|Lack of Efficacy|2|||
170607933|NCT01858766|616571161|FG017|Overall Study|Lack of Efficacy|3|||
170607934|NCT01858766|616571162|FG018|Overall Study|Lack of Efficacy|3|||
170607935|NCT01858766|616571144|FG000|Overall Study|Lost to Follow-up|0|||
170607936|NCT01858766|616571145|FG001|Overall Study|Lost to Follow-up|0|||
170607937|NCT01858766|616571146|FG002|Overall Study|Lost to Follow-up|0|||
170607938|NCT01858766|616571147|FG003|Overall Study|Lost to Follow-up|0|||
170607939|NCT01858766|616571148|FG004|Overall Study|Lost to Follow-up|0|||
170607940|NCT01858766|616571149|FG005|Overall Study|Lost to Follow-up|1|||
170607941|NCT01858766|616571150|FG006|Overall Study|Lost to Follow-up|0|||
170916189|NCT02744261|617695677|FG000|Overall Study|Withdrawal by Subject|1|||
170607942|NCT01858766|616571151|FG007|Overall Study|Lost to Follow-up|2|||
170607943|NCT01858766|616571152|FG008|Overall Study|Lost to Follow-up|0|||
170607944|NCT01858766|616571153|FG009|Overall Study|Lost to Follow-up|0|||
170607945|NCT01858766|616571154|FG010|Overall Study|Lost to Follow-up|0|||
170607946|NCT01858766|616571155|FG011|Overall Study|Lost to Follow-up|1|||
170607947|NCT01858766|616571156|FG012|Overall Study|Lost to Follow-up|0|||
170607948|NCT01858766|616571157|FG013|Overall Study|Lost to Follow-up|0|||
170607949|NCT01858766|616571158|FG014|Overall Study|Lost to Follow-up|3|||
170607950|NCT01858766|616571159|FG015|Overall Study|Lost to Follow-up|1|||
170607951|NCT01858766|616571160|FG016|Overall Study|Lost to Follow-up|1|||
170607952|NCT01858766|616571161|FG017|Overall Study|Lost to Follow-up|0|||
170607953|NCT01858766|616571162|FG018|Overall Study|Lost to Follow-up|1|||
170607954|NCT01858766|616571144|FG000|Overall Study|Withdrew Consent|0|||
170607955|NCT01858766|616571145|FG001|Overall Study|Withdrew Consent|0|||
170607956|NCT01858766|616571146|FG002|Overall Study|Withdrew Consent|0|||
170607957|NCT01858766|616571147|FG003|Overall Study|Withdrew Consent|0|||
170607958|NCT01858766|616571148|FG004|Overall Study|Withdrew Consent|0|||
170607959|NCT01858766|616571149|FG005|Overall Study|Withdrew Consent|0|||
170607960|NCT01858766|616571150|FG006|Overall Study|Withdrew Consent|0|||
170607961|NCT01858766|616571151|FG007|Overall Study|Withdrew Consent|0|||
170607962|NCT01858766|616571152|FG008|Overall Study|Withdrew Consent|0|||
170607963|NCT01858766|616571153|FG009|Overall Study|Withdrew Consent|0|||
170607964|NCT01858766|616571154|FG010|Overall Study|Withdrew Consent|0|||
170607965|NCT01858766|616571155|FG011|Overall Study|Withdrew Consent|1|||
170607966|NCT01858766|616571156|FG012|Overall Study|Withdrew Consent|0|||
170607967|NCT01858766|616571157|FG013|Overall Study|Withdrew Consent|0|||
170607968|NCT01858766|616571158|FG014|Overall Study|Withdrew Consent|0|||
170607969|NCT01858766|616571159|FG015|Overall Study|Withdrew Consent|0|||
170607970|NCT01858766|616571160|FG016|Overall Study|Withdrew Consent|0|||
170607971|NCT01858766|616571161|FG017|Overall Study|Withdrew Consent|0|||
170607972|NCT01858766|616571162|FG018|Overall Study|Withdrew Consent|0|||
170607973|NCT00286494|616571171|FG000|Overall Study|Hyperglycemic rescue|12|||
170607974|NCT00286494|616571172|FG001|Overall Study|Hyperglycemic rescue|19|||
170607975|NCT00286494|616571173|FG002|Overall Study|Hyperglycemic rescue|18|||
170607976|NCT00286494|616571171|FG000|Overall Study|Withdrawal by Subject|2|||
170607977|NCT00286494|616571172|FG001|Overall Study|Withdrawal by Subject|10|||
170607978|NCT00286494|616571173|FG002|Overall Study|Withdrawal by Subject|9|||
170607979|NCT00286494|616571171|FG000|Overall Study|Adverse Event|3|||
170607980|NCT00286494|616571172|FG001|Overall Study|Adverse Event|8|||
170607981|NCT00286494|616571173|FG002|Overall Study|Adverse Event|6|||
170607982|NCT00286494|616571171|FG000|Overall Study|Physician Decision|5|||
170607983|NCT00286494|616571172|FG001|Overall Study|Physician Decision|5|||
170607984|NCT00286494|616571173|FG002|Overall Study|Physician Decision|1|||
170607985|NCT00286494|616571171|FG000|Overall Study|Lost to Follow-up|3|||
170607986|NCT00286494|616571172|FG001|Overall Study|Lost to Follow-up|1|||
170607987|NCT00286494|616571173|FG002|Overall Study|Lost to Follow-up|3|||
170607988|NCT00286494|616571171|FG000|Overall Study|Protocol Violation|1|||
170607989|NCT00286494|616571172|FG001|Overall Study|Protocol Violation|1|||
170607990|NCT00286494|616571173|FG002|Overall Study|Protocol Violation|2|||
170607991|NCT04776317|616571174|FG000|Overall Study|Physician Decision|0|||
170607992|NCT04776317|616571175|FG001|Overall Study|Physician Decision|1|||
170607993|NCT04776317|616571176|FG002|Overall Study|Physician Decision|0|||
170607994|NCT04776317|616571177|FG003|Overall Study|Physician Decision|0|||
170607995|NCT04776317|616571178|FG004|Overall Study|Physician Decision|0|||
170607996|NCT04776317|616571179|FG005|Overall Study|Physician Decision|0|||
170607997|NCT04776317|616571180|FG006|Overall Study|Physician Decision|0|||
170607998|NCT04776317|616571181|FG007|Overall Study|Physician Decision|0|||
170607999|NCT04776317|616571182|FG008|Overall Study|Physician Decision|0|||
170608000|NCT04776317|616571183|FG009|Overall Study|Physician Decision|0|||
170608001|NCT04776317|616571184|FG010|Overall Study|Physician Decision|0|||
170608002|NCT04776317|616571185|FG011|Overall Study|Physician Decision|0|||
170608003|NCT04776317|616571186|FG012|Overall Study|Physician Decision|0|||
170608004|NCT04776317|616571187|FG013|Overall Study|Physician Decision|0|||
170608005|NCT04776317|616571188|FG014|Overall Study|Physician Decision|0|||
170653066|NCT04090411|616743396|FG012|Induction Period|Physician Decision|0|||
170815575|NCT04620733|617332781|FG000|Overall Study|Lost to Follow-up|1|||
170815576|NCT04620733|617332782|FG001|Overall Study|Lost to Follow-up|1|||
170815577|NCT04620733|617332781|FG000|Overall Study|Protocol Deviation|1|||
170815578|NCT04620733|617332782|FG001|Overall Study|Protocol Deviation|1|||
170815579|NCT04620733|617332781|FG000|Overall Study|Reason Not Specified|0|||
170815580|NCT04620733|617332782|FG001|Overall Study|Reason Not Specified|1|||
170608006|NCT04776317|616571174|FG000|Overall Study|Protocol Violation|0|||
170608007|NCT04776317|616571175|FG001|Overall Study|Protocol Violation|0|||
170608008|NCT04776317|616571176|FG002|Overall Study|Protocol Violation|1|||
170608009|NCT04776317|616571177|FG003|Overall Study|Protocol Violation|0|||
170608010|NCT04776317|616571178|FG004|Overall Study|Protocol Violation|0|||
170608011|NCT04776317|616571179|FG005|Overall Study|Protocol Violation|0|||
170608012|NCT04776317|616571180|FG006|Overall Study|Protocol Violation|0|||
170608013|NCT04776317|616571181|FG007|Overall Study|Protocol Violation|0|||
170608014|NCT04776317|616571182|FG008|Overall Study|Protocol Violation|0|||
170608015|NCT04776317|616571183|FG009|Overall Study|Protocol Violation|0|||
170608016|NCT04776317|616571184|FG010|Overall Study|Protocol Violation|0|||
170608017|NCT04776317|616571185|FG011|Overall Study|Protocol Violation|0|||
170608018|NCT04776317|616571186|FG012|Overall Study|Protocol Violation|0|||
170608019|NCT04776317|616571187|FG013|Overall Study|Protocol Violation|0|||
170815581|NCT03072238|617332787|FG000|Overall Study|Withdrawal by Subject|44|||
170815582|NCT03072238|617332788|FG001|Overall Study|Withdrawal by Subject|64|||
170815583|NCT03072238|617332787|FG000|Overall Study|Lost to Follow-up|14|||
170815584|NCT03072238|617332788|FG001|Overall Study|Lost to Follow-up|5|||
170815585|NCT03072238|617332787|FG000|Overall Study|Physician Decision|4|||
170608020|NCT04776317|616571188|FG014|Overall Study|Protocol Violation|0|||
170608021|NCT04776317|616571174|FG000|Overall Study|Withdrawal by Subject|0|||
170608022|NCT04776317|616571175|FG001|Overall Study|Withdrawal by Subject|0|||
170608023|NCT04776317|616571176|FG002|Overall Study|Withdrawal by Subject|0|||
170608024|NCT04776317|616571177|FG003|Overall Study|Withdrawal by Subject|0|||
170608025|NCT04776317|616571178|FG004|Overall Study|Withdrawal by Subject|1|||
170608026|NCT04776317|616571179|FG005|Overall Study|Withdrawal by Subject|0|||
170608027|NCT04776317|616571180|FG006|Overall Study|Withdrawal by Subject|0|||
170608028|NCT04776317|616571181|FG007|Overall Study|Withdrawal by Subject|0|||
170608029|NCT04776317|616571182|FG008|Overall Study|Withdrawal by Subject|0|||
170608030|NCT04776317|616571183|FG009|Overall Study|Withdrawal by Subject|0|||
170608031|NCT04776317|616571184|FG010|Overall Study|Withdrawal by Subject|0|||
170608032|NCT04776317|616571185|FG011|Overall Study|Withdrawal by Subject|0|||
170608033|NCT04776317|616571186|FG012|Overall Study|Withdrawal by Subject|0|||
170608034|NCT04776317|616571187|FG013|Overall Study|Withdrawal by Subject|0|||
170608035|NCT04776317|616571188|FG014|Overall Study|Withdrawal by Subject|0|||
170608036|NCT04207060|616571189|FG000|Overall Study|Lost to Follow-up|2|||
170608037|NCT04207060|616571190|FG001|Overall Study|Lost to Follow-up|0|||
170608038|NCT02718716|616571192|FG000|Overall Study|Lack of Efficacy|1|||
170608039|NCT02718716|616571193|FG001|Overall Study|Lack of Efficacy|0|||
170608040|NCT02718716|616571194|FG002|Overall Study|Lack of Efficacy|0|||
170608041|NCT02718716|616571195|FG003|Overall Study|Lack of Efficacy|0|||
170608042|NCT02718716|616571196|FG004|Overall Study|Lack of Efficacy|0|||
170608043|NCT00296140|616571197|FG000|Overall Study|Lost to Follow-up|1|||
170608044|NCT00296140|616571198|FG001|Overall Study|Lost to Follow-up|0|||
170608045|NCT00296140|616571197|FG000|Overall Study|Withdrawal by Subject|1|||
170608046|NCT00296140|616571198|FG001|Overall Study|Withdrawal by Subject|0|||
170608047|NCT00296140|616571197|FG000|Overall Study|Discharge to Nursing Home|1|||
170608048|NCT00296140|616571198|FG001|Overall Study|Discharge to Nursing Home|0|||
170608049|NCT00774800|616571199|FG000|Intervention 4|Withdrawal by Subject|1|||
170608050|NCT00994422|616571203|FG000|Overall Study|Lost to Follow-up|7|||
170608051|NCT00994422|616571204|FG001|Overall Study|Lost to Follow-up|1|||
170608052|NCT04765202|616571207|FG000|Overall Study|Lost to Follow-up|1|||
170608053|NCT04765202|616571208|FG001|Overall Study|Lost to Follow-up|1|||
170815586|NCT03072238|617332788|FG001|Overall Study|Physician Decision|6|||
170815587|NCT03072238|617332787|FG000|Overall Study|Death|351|||
170815588|NCT03072238|617332788|FG001|Overall Study|Death|318|||
170815589|NCT03072238|617332787|FG000|Overall Study|Progressive Disease|3|||
170815590|NCT03072238|617332788|FG001|Overall Study|Progressive Disease|4|||
170608054|NCT04765202|616571209|FG002|Overall Study|Lost to Follow-up|2|||
170608055|NCT04765202|616571210|FG003|Overall Study|Lost to Follow-up|2|||
170608056|NCT04765202|616571207|FG000|Overall Study|Physician Decision|0|||
170608057|NCT04765202|616571208|FG001|Overall Study|Physician Decision|0|||
170608058|NCT04765202|616571209|FG002|Overall Study|Physician Decision|1|||
170608059|NCT04765202|616571210|FG003|Overall Study|Physician Decision|1|||
170608060|NCT03068754|616571213|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
170608061|NCT03068754|616571214|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
170608062|NCT03068754|616571215|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
170608063|NCT03068754|616571216|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
170608064|NCT03068754|616571213|FG000|Randomized Treatment Period (RTP)|Death|2|||
170608065|NCT03068754|616571214|FG001|Randomized Treatment Period (RTP)|Death|2|||
170608066|NCT03068754|616571215|FG002|Randomized Treatment Period (RTP)|Death|0|||
170608067|NCT03068754|616571216|FG003|Randomized Treatment Period (RTP)|Death|0|||
170608068|NCT03068754|616571213|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
170608069|NCT03068754|616571214|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
170608070|NCT03068754|616571215|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
170608071|NCT03068754|616571216|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
170608072|NCT03068754|616571213|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
170608073|NCT03068754|616571214|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
170608074|NCT03068754|616571215|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
170608075|NCT03068754|616571216|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
170608076|NCT03068754|616571213|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
170608077|NCT03068754|616571214|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
170608078|NCT03068754|616571215|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
170608079|NCT03068754|616571216|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
170608080|NCT03068754|616571213|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
170815591|NCT03072238|617332787|FG000|Overall Study|Reason Not Specified|138|||
170916190|NCT02744261|617695678|FG001|Overall Study|Withdrawal by Subject|0|||
170916191|NCT05734508|617695679|FG000|Overall Study|Pregnancy|4|||
170916192|NCT05734508|617695679|FG000|Overall Study|Withdrawal by Subject|2|||
170916193|NCT02355002|617695687|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
170608081|NCT03068754|616571214|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
170608082|NCT03068754|616571215|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
170608083|NCT03068754|616571216|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
170608084|NCT03068754|616571213|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
170608085|NCT03068754|616571214|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
170608086|NCT03068754|616571215|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
170608087|NCT03068754|616571216|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
170608088|NCT03068754|616571213|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
170608089|NCT03068754|616571214|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
170608090|NCT03068754|616571215|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
170608091|NCT03068754|616571216|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
170608092|NCT03068754|616571213|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
170608093|NCT03068754|616571214|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
170608094|NCT03068754|616571215|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
170608095|NCT03068754|616571216|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
170608096|NCT03068754|616571213|FG000|Open Label Extension Period (OLE)|Death|0|||
170608097|NCT03068754|616571214|FG001|Open Label Extension Period (OLE)|Death|0|||
170608098|NCT03068754|616571215|FG002|Open Label Extension Period (OLE)|Death|0|||
170608099|NCT03068754|616571216|FG003|Open Label Extension Period (OLE)|Death|1|||
170608100|NCT03068754|616571213|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
170608101|NCT03068754|616571214|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
170608102|NCT03068754|616571215|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
170608103|NCT03068754|616571216|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
170608104|NCT03068754|616571213|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
170608105|NCT03068754|616571214|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
170608106|NCT03068754|616571215|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
170608107|NCT03068754|616571216|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
170608108|NCT03068754|616571213|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
170608109|NCT03068754|616571214|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
170608110|NCT03068754|616571215|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
170608111|NCT03068754|616571216|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
170608112|NCT03068754|616571213|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
170608113|NCT03068754|616571214|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
170608114|NCT03068754|616571215|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
170608115|NCT03068754|616571216|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
170608116|NCT01110382|616571217|FG000|Overall Study|Withdrawal by Subject|0|||
170608117|NCT01110382|616571218|FG001|Overall Study|Withdrawal by Subject|1|||
170608118|NCT01110382|616571217|FG000|Overall Study|Protocol Violation|0|||
170608119|NCT01110382|616571218|FG001|Overall Study|Protocol Violation|1|||
170608120|NCT01009086|616571219|FG000|Overall Study|Lack of Efficacy|16|||
170608121|NCT01009086|616571220|FG001|Overall Study|Lack of Efficacy|15|||
170608122|NCT01009086|616571221|FG002|Overall Study|Lack of Efficacy|9|||
170608123|NCT01009086|616571219|FG000|Overall Study|Lost to Follow-up|4|||
170608124|NCT01009086|616571220|FG001|Overall Study|Lost to Follow-up|5|||
170608125|NCT01009086|616571221|FG002|Overall Study|Lost to Follow-up|3|||
170608126|NCT01009086|616571219|FG000|Overall Study|Adverse Event|12|||
170608127|NCT01009086|616571220|FG001|Overall Study|Adverse Event|11|||
170608128|NCT01009086|616571221|FG002|Overall Study|Adverse Event|8|||
170608129|NCT01009086|616571219|FG000|Overall Study|Withdrawal by Subject|9|||
170608130|NCT01009086|616571220|FG001|Overall Study|Withdrawal by Subject|11|||
170608131|NCT01009086|616571221|FG002|Overall Study|Withdrawal by Subject|13|||
170608132|NCT01009086|616571219|FG000|Overall Study|Other|3|||
170608133|NCT01009086|616571220|FG001|Overall Study|Other|5|||
170608134|NCT01009086|616571221|FG002|Overall Study|Other|1|||
170608135|NCT01424228|616571222|FG000|Overall Study|Withdrawal by Subject|27|||
170608136|NCT01424228|616571223|FG001|Overall Study|Withdrawal by Subject|11|||
170916194|NCT02355002|617695688|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
170916195|NCT02355002|617695687|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
170916196|NCT02355002|617695688|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
170608137|NCT01424228|616571222|FG000|Overall Study|Adverse Event|10|||
170608138|NCT01424228|616571223|FG001|Overall Study|Adverse Event|14|||
170608139|NCT01424228|616571222|FG000|Overall Study|Sponsor's decision|9|||
170653067|NCT04090411|616743384|FG000|Induction Period|Protocol Violation|0|||
170608140|NCT01424228|616571223|FG001|Overall Study|Sponsor's decision|12|||
170608141|NCT01424228|616571222|FG000|Overall Study|Lack of Efficacy|5|||
170608142|NCT01424228|616571223|FG001|Overall Study|Lack of Efficacy|7|||
170608143|NCT01424228|616571222|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
170608144|NCT01424228|616571223|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
170608145|NCT01424228|616571222|FG000|Overall Study|Non-compliance|2|||
170608146|NCT01424228|616571223|FG001|Overall Study|Non-compliance|0|||
170815592|NCT03072238|617332788|FG001|Overall Study|Reason Not Specified|150|||
170815593|NCT01945593|617332789|FG000|Overall Study|Adverse Event|0|||
170815594|NCT01945593|617332790|FG001|Overall Study|Adverse Event|0|||
170815595|NCT01945593|617332791|FG002|Overall Study|Adverse Event|0|||
170815596|NCT01945593|617332792|FG003|Overall Study|Adverse Event|5|||
170815597|NCT01945593|617332789|FG000|Overall Study|Physician Decision|0|||
170815598|NCT01945593|617332790|FG001|Overall Study|Physician Decision|0|||
170815599|NCT01945593|617332791|FG002|Overall Study|Physician Decision|1|||
170815600|NCT01945593|617332792|FG003|Overall Study|Physician Decision|1|||
170815601|NCT01945593|617332789|FG000|Overall Study|Withdrawal by Subject|0|||
170815602|NCT01945593|617332790|FG001|Overall Study|Withdrawal by Subject|2|||
170815603|NCT01945593|617332791|FG002|Overall Study|Withdrawal by Subject|0|||
170815604|NCT01945593|617332792|FG003|Overall Study|Withdrawal by Subject|4|||
170815605|NCT01945593|617332789|FG000|Overall Study|Protocol Violation|0|||
170815606|NCT01945593|617332790|FG001|Overall Study|Protocol Violation|2|||
170815607|NCT01945593|617332791|FG002|Overall Study|Protocol Violation|1|||
170815608|NCT01945593|617332792|FG003|Overall Study|Protocol Violation|3|||
170815609|NCT01945593|617332789|FG000|Overall Study|Death|0|||
170815610|NCT01945593|617332790|FG001|Overall Study|Death|0|||
170815611|NCT01945593|617332791|FG002|Overall Study|Death|1|||
170815612|NCT01945593|617332792|FG003|Overall Study|Death|0|||
170815613|NCT01945593|617332789|FG000|Overall Study|Other: Terminated|0|||
170815614|NCT01945593|617332790|FG001|Overall Study|Other: Terminated|0|||
170815615|NCT01945593|617332791|FG002|Overall Study|Other: Terminated|0|||
170815616|NCT01945593|617332792|FG003|Overall Study|Other: Terminated|1|||
170815617|NCT01945593|617332789|FG000|Overall Study|Other: Surgical Procedure|0|||
170815618|NCT01945593|617332790|FG001|Overall Study|Other: Surgical Procedure|2|||
170815619|NCT01945593|617332791|FG002|Overall Study|Other: Surgical Procedure|0|||
170916197|NCT02355002|617695687|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
170608147|NCT01424228|616571222|FG000|Overall Study|Worsening of symptoms|1|||
170608148|NCT01424228|616571223|FG001|Overall Study|Worsening of symptoms|0|||
170608149|NCT01424228|616571222|FG000|Overall Study|Unplanned journey|0|||
170608150|NCT01424228|616571223|FG001|Overall Study|Unplanned journey|1|||
170608151|NCT00932165|616571225|FG000|Overall Study|Lost to Follow-up|1|||
170608152|NCT00588094|616571226|FG000|Overall Study|Adverse Event|3|||
170608153|NCT00588094|616571226|FG000|Overall Study|Progression of Disease|2|||
170608154|NCT02951429|616571227|FG000|Overall Study|Adverse Event|3|||
170608155|NCT02951429|616571228|FG001|Overall Study|Adverse Event|7|||
170608156|NCT02951429|616571227|FG000|Overall Study|Death|28|||
170608157|NCT02951429|616571228|FG001|Overall Study|Death|36|||
170608158|NCT02951429|616571227|FG000|Overall Study|Lack of Efficacy|0|||
170608159|NCT02951429|616571228|FG001|Overall Study|Lack of Efficacy|1|||
170608160|NCT02951429|616571227|FG000|Overall Study|Lost to Follow-up|0|||
170608161|NCT02951429|616571228|FG001|Overall Study|Lost to Follow-up|1|||
170608162|NCT02951429|616571227|FG000|Overall Study|Lung Transplantation|9|||
170608163|NCT02951429|616571228|FG001|Overall Study|Lung Transplantation|6|||
170608164|NCT02951429|616571227|FG000|Overall Study|Other|1|||
170608165|NCT02951429|616571228|FG001|Overall Study|Other|3|||
170608166|NCT02951429|616571227|FG000|Overall Study|Progressive Disease|1|||
170608167|NCT02951429|616571228|FG001|Overall Study|Progressive Disease|1|||
170608168|NCT02951429|616571227|FG000|Overall Study|Withdrawal by Subject|7|||
170608169|NCT02951429|616571228|FG001|Overall Study|Withdrawal by Subject|11|||
170608170|NCT02951429|616571227|FG000|Overall Study|Participant ongoing in the study|23|||
170608171|NCT02951429|616571228|FG001|Overall Study|Participant ongoing in the study|17|||
170608172|NCT01853878|616571231|FG000|Overall Study|Recurrence|2|||
170608173|NCT01853878|616571232|FG001|Overall Study|Recurrence|0|||
170608174|NCT01853878|616571231|FG000|Overall Study|Adverse Event|2|||
170608175|NCT01853878|616571232|FG001|Overall Study|Adverse Event|0|||
170916198|NCT02355002|617695688|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
170608176|NCT01853878|616571231|FG000|Overall Study|Withdrawal by Subject|3|||
170608177|NCT01853878|616571232|FG001|Overall Study|Withdrawal by Subject|1|||
170653068|NCT04090411|616743385|FG001|Induction Period|Protocol Violation|0|||
170653069|NCT04090411|616743386|FG002|Induction Period|Protocol Violation|0|||
170815620|NCT01945593|617332792|FG003|Overall Study|Other: Surgical Procedure|6|||
170815621|NCT01945593|617332789|FG000|Overall Study|Other: Screen Failure|0|||
170815622|NCT01945593|617332790|FG001|Overall Study|Other: Screen Failure|2|||
170815623|NCT01945593|617332791|FG002|Overall Study|Other: Screen Failure|0|||
170815624|NCT01945593|617332792|FG003|Overall Study|Other: Screen Failure|0|||
170815625|NCT00228813|617332793|FG000|Overall Study|Death|4|||
170608178|NCT01853878|616571231|FG000|Overall Study|Migrated/moved from the study area|1|||
170608179|NCT01853878|616571232|FG001|Overall Study|Migrated/moved from the study area|0|||
170608180|NCT01853878|616571231|FG000|Overall Study|Other|55|||
170815626|NCT00608959|617332794|FG000|Part 1|Did not meet eligibility criteria|1|||
170916199|NCT02355002|617695687|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
170916200|NCT02355002|617695688|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
170916201|NCT02355002|617695687|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
170916202|NCT02355002|617695688|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
170608181|NCT01853878|616571232|FG001|Overall Study|Other|43|||
170608182|NCT03997825|616571233|FG000|Overall Study|Death|3|||
170608183|NCT03997825|616571233|FG000|Overall Study|Lost to Follow-up|10|||
170608184|NCT03997825|616571233|FG000|Overall Study|Withdrawal by Subject|3|||
170608185|NCT03997825|616571233|FG000|Overall Study|Refused participation|1|||
170608186|NCT03244826|616571235|FG000|Overall Study|Withdrawal by Subject|2|||
170608187|NCT03244826|616571236|FG001|Overall Study|Withdrawal by Subject|0|||
170608188|NCT03244826|616571235|FG000|Overall Study|Transplant delayed or withdrawn|12|||
170608189|NCT03244826|616571236|FG001|Overall Study|Transplant delayed or withdrawn|10|||
170608190|NCT01983774|616571240|FG000|Overall Study|Lung Transplant|0|||
170608191|NCT01983774|616571241|FG001|Overall Study|Lung Transplant|1|||
170608192|NCT01983774|616571240|FG000|Overall Study|Lost to Follow-up|1|||
170608193|NCT01983774|616571241|FG001|Overall Study|Lost to Follow-up|0|||
170608194|NCT00527904|616571242|FG000|Overall Study|Adverse Event|45|||
170608195|NCT00527904|616571242|FG000|Overall Study|Withdrawal by Subject|21|||
170608196|NCT00527904|616571242|FG000|Overall Study|Lost to Follow-up|8|||
170608197|NCT00527904|616571242|FG000|Overall Study|misc|22|||
170608198|NCT00360568|616571243|FG000|Overall Study|Adverse Event|1|||
170608199|NCT00360568|616571244|FG001|Overall Study|Adverse Event|2|||
170608200|NCT00360568|616571243|FG000|Overall Study|Lack of Efficacy|1|||
170608201|NCT00360568|616571244|FG001|Overall Study|Lack of Efficacy|0|||
170608202|NCT00360568|616571243|FG000|Overall Study|Withdrawal by Subject|0|||
170608203|NCT00360568|616571244|FG001|Overall Study|Withdrawal by Subject|3|||
170608204|NCT02611817|616573512|FG000|Open-label Induction Phase|Reason not Specified|9|||
170608205|NCT02611817|616573513|FG001|Open-label Induction Phase|Reason not Specified|0|||
170608206|NCT02611817|616573514|FG002|Open-label Induction Phase|Reason not Specified|0|||
170608207|NCT02611817|616573512|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
170608208|NCT02611817|616573513|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
170608209|NCT02611817|616573514|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
170608210|NCT02611817|616573512|FG000|Open-label Induction Phase|Pregnancy|1|||
170608211|NCT02611817|616573513|FG001|Open-label Induction Phase|Pregnancy|0|||
170608212|NCT02611817|616573514|FG002|Open-label Induction Phase|Pregnancy|0|||
170608213|NCT02611817|616573512|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
170608214|NCT02611817|616573513|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
170608215|NCT02611817|616573514|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
170608216|NCT02611817|616573512|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
170608217|NCT02611817|616573513|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
170608218|NCT02611817|616573514|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
170608219|NCT02611817|616573512|FG000|Open-label Induction Phase|Protocol Violation|5|||
170608220|NCT02611817|616573513|FG001|Open-label Induction Phase|Protocol Violation|0|||
170608221|NCT02611817|616573514|FG002|Open-label Induction Phase|Protocol Violation|0|||
170608222|NCT02611817|616573512|FG000|Open-label Induction Phase|Adverse Event|16|||
170608223|NCT02611817|616573513|FG001|Open-label Induction Phase|Adverse Event|0|||
170608224|NCT02611817|616573514|FG002|Open-label Induction Phase|Adverse Event|0|||
170608225|NCT02611817|616573512|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
170608226|NCT02611817|616573513|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
170608227|NCT02611817|616573514|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
170608228|NCT02611817|616573512|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
170608229|NCT02611817|616573513|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
170608230|NCT02611817|616573514|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
170608231|NCT02611817|616573512|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
170608232|NCT02611817|616573513|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
170608233|NCT02611817|616573514|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
170608234|NCT02611817|616573512|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
170608235|NCT02611817|616573513|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
170608236|NCT02611817|616573514|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
170608237|NCT02611817|616573512|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
170608238|NCT02611817|616573513|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
170608239|NCT02611817|616573514|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
170916203|NCT02355002|617695687|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
170608240|NCT02611817|616573512|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
170608241|NCT02611817|616573513|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
170608242|NCT02611817|616573514|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
170608243|NCT02611817|616573512|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
170608244|NCT02611817|616573513|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
170608245|NCT02611817|616573514|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
170916204|NCT02355002|617695688|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
170916205|NCT02355002|617695687|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
170608246|NCT02475278|616573522|FG000|Overall Study|Lost to Follow-up|1|||
170608247|NCT02475278|616573522|FG000|Overall Study|Reason Not Specified|1|||
170608248|NCT02291419|616573525|FG000|Overall Study|Early study termination|1|||
170608249|NCT02291419|616573526|FG001|Overall Study|Early study termination|5|||
170608250|NCT00931606|616573527|FG000|Overall Study|Death|1|||
170608251|NCT00931606|616573528|FG001|Overall Study|Death|3|||
170608252|NCT00931606|616573529|FG002|Overall Study|Death|2|||
170608253|NCT00931606|616573530|FG003|Overall Study|Death|0|||
170608254|NCT00931606|616573527|FG000|Overall Study|Lost to Follow-up|0|||
170608255|NCT00931606|616573528|FG001|Overall Study|Lost to Follow-up|1|||
170608256|NCT00931606|616573529|FG002|Overall Study|Lost to Follow-up|0|||
170608257|NCT00931606|616573530|FG003|Overall Study|Lost to Follow-up|0|||
170608258|NCT00931606|616573527|FG000|Overall Study|Physician Decision|0|||
170608259|NCT00931606|616573528|FG001|Overall Study|Physician Decision|0|||
170608260|NCT00931606|616573529|FG002|Overall Study|Physician Decision|3|||
170608261|NCT00931606|616573530|FG003|Overall Study|Physician Decision|0|||
170608262|NCT00931606|616573527|FG000|Overall Study|Sponsor Decision|1|||
170608263|NCT00931606|616573528|FG001|Overall Study|Sponsor Decision|4|||
170608264|NCT00931606|616573529|FG002|Overall Study|Sponsor Decision|0|||
170608265|NCT00931606|616573530|FG003|Overall Study|Sponsor Decision|2|||
170608266|NCT00931606|616573527|FG000|Overall Study|Withdrawal by Subject|3|||
170608267|NCT00931606|616573528|FG001|Overall Study|Withdrawal by Subject|1|||
170608268|NCT00931606|616573529|FG002|Overall Study|Withdrawal by Subject|1|||
170608269|NCT00931606|616573530|FG003|Overall Study|Withdrawal by Subject|1|||
170608270|NCT05111249|616573535|FG000|Overall Study|Lost to Follow-up|0|||
170608271|NCT05111249|616573536|FG001|Overall Study|Lost to Follow-up|2|||
170608272|NCT05111249|616573535|FG000|Overall Study|Physician Decision|0|||
170608273|NCT05111249|616573536|FG001|Overall Study|Physician Decision|1|||
170608274|NCT05111249|616573535|FG000|Overall Study|Participant decision|1|||
170608275|NCT05111249|616573536|FG001|Overall Study|Participant decision|5|||
170608276|NCT02679755|616573539|FG000|Overall Study|Death|0|||
170608277|NCT02679755|616573540|FG001|Overall Study|Death|3|||
170608278|NCT02679755|616573539|FG000|Overall Study|Global deterioration of health status|1|||
170608279|NCT02679755|616573540|FG001|Overall Study|Global deterioration of health status|8|||
170608280|NCT02679755|616573539|FG000|Overall Study|Lost to Follow-up|1|||
170608281|NCT02679755|616573540|FG001|Overall Study|Lost to Follow-up|0|||
170608282|NCT02679755|616573539|FG000|Overall Study|Objective progression or relapse|24|||
170608283|NCT02679755|616573540|FG001|Overall Study|Objective progression or relapse|83|||
170608284|NCT02679755|616573539|FG000|Overall Study|Not defined|0|||
170608285|NCT02679755|616573540|FG001|Overall Study|Not defined|2|||
170608286|NCT02679755|616573539|FG000|Overall Study|Withdrawal by participant|6|||
170608287|NCT02679755|616573540|FG001|Overall Study|Withdrawal by participant|3|||
170608288|NCT02679755|616573539|FG000|Overall Study|Adverse Event|1|||
170608289|NCT02679755|616573540|FG001|Overall Study|Adverse Event|4|||
170608290|NCT02679755|616573539|FG000|Overall Study|Adverse events not related to study drug|1|||
170608291|NCT02679755|616573540|FG001|Overall Study|Adverse events not related to study drug|2|||
170608292|NCT01061359|616573541|FG000|Overall Study|Death|32|||
170608293|NCT01061359|616573541|FG000|Overall Study|Lost to Follow-up|1072|||
170608294|NCT01061359|616573541|FG000|Overall Study|Relapse|187|||
170608295|NCT01061359|616573541|FG000|Overall Study|Secondary neoplasm|11|||
170608296|NCT03038126|616573543|FG000|Overall Study|Death|1|||
170608297|NCT03038126|616573544|FG001|Overall Study|Death|1|||
170608298|NCT03038126|616573543|FG000|Overall Study|Withdrawal by Subject|5|||
170608299|NCT03038126|616573544|FG001|Overall Study|Withdrawal by Subject|0|||
170608300|NCT03038126|616573543|FG000|Overall Study|Lost to Follow-up|0|||
170608301|NCT03038126|616573544|FG001|Overall Study|Lost to Follow-up|1|||
170608302|NCT03038126|616573543|FG000|Overall Study|Long Term Hospitalization|2|||
170608303|NCT03038126|616573544|FG001|Overall Study|Long Term Hospitalization|0|||
170608304|NCT03038126|616573543|FG000|Overall Study|Too Ill to Participate|1|||
170608305|NCT03038126|616573544|FG001|Overall Study|Too Ill to Participate|2|||
170815627|NCT00668746|617332798|FG000|Overall Study|Lost to Follow-up|2|||
170815628|NCT00668746|617332799|FG001|Overall Study|Lost to Follow-up|1|||
170815629|NCT02109172|617332800|FG000|Overall Study|Withdrawal by Subject|1|||
170815630|NCT02109172|617332801|FG001|Overall Study|Withdrawal by Subject|0|||
170608306|NCT00630344|616573545|FG000|Overall Study|Adverse Event|5|||
170608307|NCT00630344|616573545|FG000|Overall Study|Progressive Disease|19|||
170608308|NCT00630344|616573545|FG000|Overall Study|Physician Decision|9|||
170608309|NCT00630344|616573545|FG000|Overall Study|Withdrawal by Subject|1|||
170608310|NCT00630344|616573545|FG000|Overall Study|Intercurrent Illness|1|||
170608311|NCT00630344|616573545|FG000|Overall Study|Other|1|||
170608312|NCT02219334|616573546|FG000|Overall Study|Withdrawal by Subject|1|||
170608313|NCT02219334|616573547|FG001|Overall Study|Withdrawal by Subject|0|||
170608314|NCT02219334|616573546|FG000|Overall Study|Protocol Violation|7|||
170608315|NCT02219334|616573547|FG001|Overall Study|Protocol Violation|3|||
170608316|NCT02837029|616573555|FG000|Screening|Failed to meet screening requirements.|7|||
170608317|NCT02837029|616573556|FG001|Screening|Failed to meet screening requirements.|3|||
170608318|NCT02837029|616573557|FG002|Screening|Failed to meet screening requirements.|0|||
170608319|NCT02837029|616573555|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
170608320|NCT02837029|616573556|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
170608321|NCT02837029|616573557|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
170608322|NCT02837029|616573555|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
170608323|NCT02837029|616573556|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
170608324|NCT02837029|616573557|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
170608325|NCT02837029|616573555|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
170608326|NCT02837029|616573556|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
170608327|NCT02837029|616573557|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
170608328|NCT02837029|616573555|FG000|Cycle 2 and Beyond|Adverse Event|1|||
170608329|NCT02837029|616573556|FG001|Cycle 2 and Beyond|Adverse Event|0|||
170608330|NCT02837029|616573557|FG002|Cycle 2 and Beyond|Adverse Event|0|||
170608331|NCT02837029|616573555|FG000|2 Year Follow-up|Death|6|||
170608332|NCT02837029|616573556|FG001|2 Year Follow-up|Death|7|||
170608333|NCT02837029|616573557|FG002|2 Year Follow-up|Death|0|||
170608334|NCT00398567|616573558|FG000|Overall Study|Disease Progression|3|||
170608335|NCT00398567|616573559|FG001|Overall Study|Disease Progression|4|||
170608336|NCT00398567|616573560|FG002|Overall Study|Disease Progression|27|||
170608337|NCT00398567|616573558|FG000|Overall Study|Withdrawal by Subject|1|||
170608338|NCT00398567|616573559|FG001|Overall Study|Withdrawal by Subject|0|||
170608339|NCT00398567|616573560|FG002|Overall Study|Withdrawal by Subject|4|||
170608340|NCT00398567|616573558|FG000|Overall Study|Adverse Event|0|||
170608341|NCT00398567|616573559|FG001|Overall Study|Adverse Event|0|||
170608342|NCT00398567|616573560|FG002|Overall Study|Adverse Event|2|||
170608343|NCT00398567|616573558|FG000|Overall Study|Protocol Violation|0|||
170608344|NCT00398567|616573559|FG001|Overall Study|Protocol Violation|0|||
170608345|NCT00398567|616573560|FG002|Overall Study|Protocol Violation|1|||
170608346|NCT02644343|616573561|FG000|Overall Study|Withdrawal by Subject|1|||
170608347|NCT03437577|616573564|FG000|Pre-Randomization|Withdrawal by Subject|0|||
170608348|NCT03437577|616573565|FG001|Pre-Randomization|Withdrawal by Subject|0|||
170608349|NCT03437577|616573566|FG002|Pre-Randomization|Withdrawal by Subject|10|||
170608350|NCT03437577|616573564|FG000|Post-Randomization|Physician Decision|0|||
170608351|NCT03437577|616573565|FG001|Post-Randomization|Physician Decision|2|||
170608352|NCT03437577|616573566|FG002|Post-Randomization|Physician Decision|0|||
170608353|NCT00536471|616573569|FG000|Overall Study|Lost to Follow-up|48|||
170608354|NCT00536471|616573570|FG001|Overall Study|Lost to Follow-up|23|||
170608355|NCT00536471|616573571|FG002|Overall Study|Lost to Follow-up|48|||
170608356|NCT00536471|616573572|FG003|Overall Study|Lost to Follow-up|22|||
170608357|NCT00536471|616573569|FG000|Overall Study|Adverse Event|32|||
170608358|NCT00536471|616573570|FG001|Overall Study|Adverse Event|16|||
170608359|NCT00536471|616573571|FG002|Overall Study|Adverse Event|28|||
170608360|NCT00536471|616573572|FG003|Overall Study|Adverse Event|13|||
170608361|NCT00536471|616573569|FG000|Overall Study|Withdrawal by Subject|40|||
170608362|NCT00536471|616573570|FG001|Overall Study|Withdrawal by Subject|24|||
170608363|NCT00536471|616573571|FG002|Overall Study|Withdrawal by Subject|43|||
170608364|NCT00536471|616573572|FG003|Overall Study|Withdrawal by Subject|21|||
170608365|NCT00536471|616573569|FG000|Overall Study|Lack of Efficacy|17|||
170608366|NCT00536471|616573570|FG001|Overall Study|Lack of Efficacy|18|||
170608367|NCT00536471|616573571|FG002|Overall Study|Lack of Efficacy|11|||
170608368|NCT00536471|616573572|FG003|Overall Study|Lack of Efficacy|9|||
170608369|NCT00536471|616573569|FG000|Overall Study|Protocol Violation|8|||
170608370|NCT00536471|616573570|FG001|Overall Study|Protocol Violation|1|||
170608371|NCT00536471|616573571|FG002|Overall Study|Protocol Violation|2|||
170608372|NCT00536471|616573572|FG003|Overall Study|Protocol Violation|3|||
170608373|NCT00536471|616573569|FG000|Overall Study|Physician Decision|11|||
170608374|NCT00536471|616573570|FG001|Overall Study|Physician Decision|1|||
170608375|NCT00536471|616573571|FG002|Overall Study|Physician Decision|3|||
170608376|NCT00536471|616573572|FG003|Overall Study|Physician Decision|2|||
170608377|NCT00536471|616573569|FG000|Overall Study|Death|0|||
170608378|NCT00536471|616573570|FG001|Overall Study|Death|0|||
170608379|NCT00536471|616573571|FG002|Overall Study|Death|1|||
170608380|NCT00536471|616573572|FG003|Overall Study|Death|2|||
170815631|NCT02109172|617332802|FG002|Overall Study|Withdrawal by Subject|0|||
170608381|NCT00536471|616573569|FG000|Overall Study|Sponsor Decision|0|||
170608382|NCT00536471|616573570|FG001|Overall Study|Sponsor Decision|1|||
170608383|NCT00536471|616573571|FG002|Overall Study|Sponsor Decision|3|||
170815632|NCT02109172|617332803|FG003|Overall Study|Withdrawal by Subject|1|||
170815633|NCT02109172|617332804|FG004|Overall Study|Withdrawal by Subject|0|||
170815634|NCT02109172|617332805|FG005|Overall Study|Withdrawal by Subject|0|||
170608384|NCT00536471|616573572|FG003|Overall Study|Sponsor Decision|2|||
170608385|NCT01442714|616573573|FG000|Overall Study|Death|11|||
170608386|NCT01442714|616573573|FG000|Overall Study|Withdrawal by Subject|1|||
170608387|NCT01440816|616573579|FG000|Overall Study|Disease Progression|0|||
170608388|NCT01440816|616573580|FG001|Overall Study|Disease Progression|9|||
170608389|NCT01440816|616573579|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
170608390|NCT01440816|616573580|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
170608391|NCT05438576|616573586|FG000|Overall Study|Death|1|||
170608392|NCT05438576|616573587|FG001|Overall Study|Death|1|||
170608393|NCT05438576|616573586|FG000|Overall Study|Withdrawal by Subject|4|||
170608394|NCT05438576|616573587|FG001|Overall Study|Withdrawal by Subject|2|||
170608395|NCT05438576|616573586|FG000|Overall Study|Not Eligible|2|||
170608396|NCT05438576|616573587|FG001|Overall Study|Not Eligible|1|||
170608397|NCT05438576|616573586|FG000|Overall Study|Did not complete baseline testing|22|||
170608398|NCT05438576|616573587|FG001|Overall Study|Did not complete baseline testing|4|||
170608399|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
170608400|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
170608401|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
170608402|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
170608403|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
170608404|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
170608405|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
170608406|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
170608407|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
170608408|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
170916206|NCT02355002|617695688|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
170916207|NCT04848337|617695691|FG000|Overall Study|Adverse Event|8|||
170916208|NCT04848337|617695691|FG000|Overall Study|Death|2|||
170608409|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
170608410|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
170608411|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
170608412|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
170608413|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
170608414|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
170608415|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
170608416|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
170608417|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
170608418|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
170608419|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
170608420|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
170608421|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
170608422|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
170608423|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
170608424|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
170608425|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608426|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
170608427|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
170608428|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608429|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608430|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
170608431|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
170608432|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608433|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608434|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608435|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608436|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608437|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
170608438|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170608439|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
170608440|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
170608441|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170916209|NCT04848337|617695691|FG000|Overall Study|Withdrawal by Subject|2|||
170916210|NCT04848337|617695691|FG000|Overall Study|Symptomatic Deterioration|2|||
170916211|NCT04848337|617695691|FG000|Overall Study|Travel limitations due to natural disaster|1|||
170916212|NCT02213926|617695694|FG000|Overall Study|Death|59|||
170916213|NCT02213926|617695694|FG000|Overall Study|Withdrawal by Subject|10|||
170916214|NCT02213926|617695694|FG000|Overall Study|study terminated by sponsor|51|||
170916215|NCT02213926|617695694|FG000|Overall Study|Lost to Follow-up|3|||
170916216|NCT02213926|617695694|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
170916217|NCT03993353|617695696|FG000|Overall Study|Screen Failure|1|||
170916218|NCT02000622|617695697|FG000|Overall Study|Withdrawal by Subject|5|||
170916219|NCT02000622|617695698|FG001|Overall Study|Withdrawal by Subject|7|||
170916220|NCT02000622|617695697|FG000|Overall Study|Lost to Follow-up|4|||
170916221|NCT02000622|617695698|FG001|Overall Study|Lost to Follow-up|0|||
170916222|NCT02000622|617695697|FG000|Overall Study|Death|159|||
170916223|NCT02000622|617695698|FG001|Overall Study|Death|73|||
170916224|NCT02000622|617695697|FG000|Overall Study|Withdrawn due to site closure|1|||
170608442|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170608443|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170608444|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
170608445|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170608446|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
170608447|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170608448|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170608449|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170608450|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
170608451|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608452|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608453|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608454|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
170608455|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608456|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608457|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608458|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
170608459|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608460|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608461|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608462|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608463|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
170608464|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608465|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608466|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608467|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
170608468|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608469|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608470|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
170608471|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608472|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608473|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608474|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608475|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608476|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
170608477|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608478|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
170608479|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608480|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608481|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608482|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608483|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608484|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608485|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608486|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608487|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608488|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608489|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
170608490|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
170608491|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608492|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608493|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608494|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608495|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608496|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608497|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608498|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608499|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608500|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608501|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608502|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
170608503|NCT03100058|616573588|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608504|NCT03100058|616573589|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608505|NCT03100058|616573590|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608506|NCT03100058|616573591|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608507|NCT03100058|616573592|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170653070|NCT04090411|616743387|FG003|Induction Period|Protocol Violation|1|||
170653071|NCT04090411|616743388|FG004|Induction Period|Protocol Violation|0|||
170608508|NCT03100058|616573593|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608509|NCT03100058|616573594|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
170608510|NCT03100058|616573595|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608511|NCT03100058|616573596|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608512|NCT03100058|616573597|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608513|NCT03100058|616573598|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608514|NCT03100058|616573599|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608515|NCT03100058|616573600|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
170608516|NCT03100058|616573588|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608517|NCT03100058|616573589|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608518|NCT03100058|616573590|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608519|NCT03100058|616573591|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608520|NCT03100058|616573592|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608521|NCT03100058|616573593|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608522|NCT03100058|616573594|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608523|NCT03100058|616573595|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608524|NCT03100058|616573596|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608525|NCT03100058|616573597|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
170608526|NCT03100058|616573598|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
170608527|NCT03100058|616573599|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
170608528|NCT03100058|616573600|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
170608529|NCT03100058|616573588|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608530|NCT03100058|616573589|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608531|NCT03100058|616573590|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608532|NCT03100058|616573591|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608533|NCT03100058|616573592|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608534|NCT03100058|616573593|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608535|NCT03100058|616573594|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608536|NCT03100058|616573595|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608537|NCT03100058|616573596|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608538|NCT03100058|616573597|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608539|NCT03100058|616573598|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
170608540|NCT03100058|616573599|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
170608541|NCT03100058|616573600|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
170608542|NCT03100058|616573588|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608543|NCT03100058|616573589|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608544|NCT03100058|616573590|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608545|NCT03100058|616573591|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608546|NCT03100058|616573592|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608547|NCT03100058|616573593|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608548|NCT03100058|616573594|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608549|NCT03100058|616573595|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608550|NCT03100058|616573596|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608551|NCT03100058|616573597|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
170608552|NCT03100058|616573598|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
170608553|NCT03100058|616573599|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
170608554|NCT03100058|616573600|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
170608555|NCT03100058|616573588|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608556|NCT03100058|616573589|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608557|NCT03100058|616573590|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608558|NCT03100058|616573591|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608559|NCT03100058|616573592|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608560|NCT03100058|616573593|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608561|NCT03100058|616573594|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608562|NCT03100058|616573595|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608563|NCT03100058|616573596|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608564|NCT03100058|616573597|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170815635|NCT02109172|617332800|FG000|Overall Study|Adverse Event|0|||
170815636|NCT02109172|617332801|FG001|Overall Study|Adverse Event|0|||
170815637|NCT02109172|617332802|FG002|Overall Study|Adverse Event|1|||
170815638|NCT02109172|617332803|FG003|Overall Study|Adverse Event|0|||
170815639|NCT02109172|617332804|FG004|Overall Study|Adverse Event|0|||
170815640|NCT02109172|617332805|FG005|Overall Study|Adverse Event|1|||
170815641|NCT02109172|617332800|FG000|Overall Study|Death|0|||
170815642|NCT02109172|617332801|FG001|Overall Study|Death|0|||
170815643|NCT02109172|617332802|FG002|Overall Study|Death|0|||
170815644|NCT02109172|617332803|FG003|Overall Study|Death|0|||
170608565|NCT03100058|616573598|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
170608566|NCT03100058|616573599|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608567|NCT03100058|616573600|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
170608568|NCT03100058|616573588|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170815645|NCT02109172|617332804|FG004|Overall Study|Death|1|||
170815646|NCT02109172|617332805|FG005|Overall Study|Death|0|||
170815647|NCT01279447|617332810|FG000|Overall Study|Lost to Follow-up|3|||
170815648|NCT01279447|617332811|FG001|Overall Study|Lost to Follow-up|1|||
170608569|NCT03100058|616573589|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608570|NCT03100058|616573590|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608571|NCT03100058|616573591|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608572|NCT03100058|616573592|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608573|NCT03100058|616573593|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608574|NCT03100058|616573594|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608575|NCT03100058|616573595|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608576|NCT03100058|616573596|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608577|NCT03100058|616573597|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608578|NCT03100058|616573598|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608579|NCT03100058|616573599|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
170608580|NCT03100058|616573600|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
170608581|NCT03100058|616573588|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608582|NCT03100058|616573589|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608583|NCT03100058|616573590|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608584|NCT03100058|616573591|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608585|NCT03100058|616573592|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608586|NCT03100058|616573593|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608587|NCT03100058|616573594|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608588|NCT03100058|616573595|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608589|NCT03100058|616573596|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608590|NCT03100058|616573597|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
170608591|NCT03100058|616573598|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608592|NCT03100058|616573599|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608593|NCT03100058|616573600|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
170608594|NCT01824355|616573601|FG000|Overall Study|Adverse Event|2|||
170608595|NCT01824355|616573601|FG000|Overall Study|unevaluable reference method results per|1|||
170608596|NCT01331109|616573602|FG000|Overall Study|Adverse Event|6|||
170608597|NCT01331109|616573602|FG000|Overall Study|Lack of Efficacy|2|||
170608598|NCT01331109|616573602|FG000|Overall Study|Protocol Violation|3|||
170608599|NCT01331109|616573602|FG000|Overall Study|Withdrawal by Subject|7|||
170608600|NCT01331109|616573602|FG000|Overall Study|Lost to Follow-up|1|||
170608601|NCT01331109|616573602|FG000|Overall Study|Study Terminated by Sponsor|38|||
170608602|NCT03549104|616573605|FG000|Overall Study|Withdrawal by Subject|5|||
170608603|NCT03549104|616573606|FG001|Overall Study|Withdrawal by Subject|2|||
170608604|NCT03549104|616573605|FG000|Overall Study|Covid shelter in place|1|||
170608605|NCT03549104|616573606|FG001|Overall Study|Covid shelter in place|2|||
170608606|NCT00836186|616573607|FG000|Overall Study|Blood could not be drawn|1|||
170608607|NCT04079816|616573608|FG000|Overall Study|Request of Subject|2|||
170608608|NCT04079816|616573608|FG000|Overall Study|Unable to draw samples|1|||
170608609|NCT00532298|616573609|FG000|Overall Study|Adverse Event|1|||
170608610|NCT00532298|616573610|FG001|Overall Study|Adverse Event|0|||
170608611|NCT00532298|616573611|FG002|Overall Study|Adverse Event|0|||
170608612|NCT00532298|616573612|FG003|Overall Study|Adverse Event|0|||
170608613|NCT00532298|616573613|FG004|Overall Study|Adverse Event|1|||
170608614|NCT00532298|616573614|FG005|Overall Study|Adverse Event|1|||
170608615|NCT00532298|616573609|FG000|Overall Study|Lost to Follow-up|1|||
170608616|NCT00532298|616573610|FG001|Overall Study|Lost to Follow-up|1|||
170608617|NCT00532298|616573611|FG002|Overall Study|Lost to Follow-up|1|||
170608618|NCT00532298|616573612|FG003|Overall Study|Lost to Follow-up|0|||
170608619|NCT00532298|616573613|FG004|Overall Study|Lost to Follow-up|0|||
170608620|NCT00532298|616573614|FG005|Overall Study|Lost to Follow-up|1|||
170608621|NCT00479856|616573615|FG000|Overall Study|Adverse Event|1|||
170608622|NCT00479856|616573615|FG000|Overall Study|Withdrawal by Subject|1|||
170608623|NCT00479856|616573615|FG000|Overall Study|Physician Decision|1|||
170608624|NCT01973998|616573616|FG000|Overall Study|Death|2|||
170608625|NCT01973998|616573617|FG001|Overall Study|Death|2|||
170608626|NCT02332291|616573622|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
170608627|NCT02332291|616573623|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
170815649|NCT01919489|617332812|FG000|Overall Study|Rejected the need of injections|4|||
170608628|NCT02332291|616573622|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
170608629|NCT02332291|616573623|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
170608630|NCT02332291|616573622|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
170608631|NCT02332291|616573623|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
170608632|NCT02332291|616573622|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
170608633|NCT02332291|616573623|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
170608634|NCT02332291|616573622|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
170608635|NCT02332291|616573623|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
170608636|NCT02332291|616573622|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
170608637|NCT02332291|616573623|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
170608638|NCT00395850|616573624|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
170608639|NCT00395850|616573625|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
170608640|NCT00395850|616573626|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
170608641|NCT00395850|616573627|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
170608642|NCT00395850|616573624|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
170608643|NCT00395850|616573625|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
170608644|NCT00395850|616573626|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
170608645|NCT00395850|616573627|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
170608646|NCT00395850|616573624|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
170608647|NCT00395850|616573625|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
170608648|NCT00395850|616573626|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
170608649|NCT00395850|616573627|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
170608650|NCT00395850|616573624|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
170608651|NCT00395850|616573625|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
170608652|NCT00395850|616573626|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
170608653|NCT00395850|616573627|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
170815650|NCT01919489|617332813|FG001|Overall Study|Rejected the need of injections|7|||
170608654|NCT00395850|616573624|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
170608655|NCT00395850|616573625|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
170608656|NCT00395850|616573626|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
170608657|NCT00395850|616573627|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
170608658|NCT00395850|616573624|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
170608659|NCT00395850|616573625|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
170608660|NCT00395850|616573626|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
170608661|NCT00395850|616573627|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
170608662|NCT00395850|616573624|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
170608663|NCT00395850|616573625|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
170608664|NCT00395850|616573626|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
170608665|NCT00395850|616573627|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
170608666|NCT01620528|616573634|FG000|Treatment Period|Did Not Receive Study Drug|0|||
170608667|NCT01620528|616573635|FG001|Treatment Period|Did Not Receive Study Drug|0|||
170608668|NCT01620528|616573636|FG002|Treatment Period|Did Not Receive Study Drug|1|||
170608669|NCT01620528|616573634|FG000|Treatment Period|Withdrawal by Subject|35|||
170608670|NCT01620528|616573635|FG001|Treatment Period|Withdrawal by Subject|21|||
170608671|NCT01620528|616573636|FG002|Treatment Period|Withdrawal by Subject|16|||
170608672|NCT01620528|616573634|FG000|Treatment Period|Adverse Event|17|||
170608673|NCT01620528|616573635|FG001|Treatment Period|Adverse Event|13|||
170608674|NCT01620528|616573636|FG002|Treatment Period|Adverse Event|21|||
170608675|NCT01620528|616573634|FG000|Treatment Period|Lost to Follow-up|16|||
170815651|NCT01919489|617332812|FG000|Overall Study|Adverse Event|10|||
170815652|NCT01919489|617332813|FG001|Overall Study|Adverse Event|0|||
170815653|NCT01919489|617332812|FG000|Overall Study|Hospital readmission|2|||
170815654|NCT01919489|617332813|FG001|Overall Study|Hospital readmission|9|||
170815655|NCT01919489|617332812|FG000|Overall Study|Death|2|||
170815656|NCT01919489|617332813|FG001|Overall Study|Death|1|||
170815657|NCT01919489|617332812|FG000|Overall Study|Lost to Follow-up|38|||
170815658|NCT01919489|617332813|FG001|Overall Study|Lost to Follow-up|27|||
170815659|NCT01131325|617332814|FG000|Overall Study|Adverse Event|1|||
170815660|NCT01131325|617332814|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
170815661|NCT03884478|617332815|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
170815662|NCT03884478|617332816|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
170815663|NCT03884478|617332817|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
170815664|NCT03884478|617332815|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
170815665|NCT03884478|617332816|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
170815666|NCT03884478|617332817|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
170815667|NCT03884478|617332815|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
170608676|NCT01620528|616573635|FG001|Treatment Period|Lost to Follow-up|8|||
170608677|NCT01620528|616573636|FG002|Treatment Period|Lost to Follow-up|14|||
170608678|NCT01620528|616573634|FG000|Treatment Period|Other|9|||
170608679|NCT01620528|616573635|FG001|Treatment Period|Other|5|||
170608680|NCT01620528|616573636|FG002|Treatment Period|Other|7|||
170608681|NCT01620528|616573634|FG000|Treatment Period|Subject Noncompliant|11|||
170608682|NCT01620528|616573635|FG001|Treatment Period|Subject Noncompliant|2|||
170608683|NCT01620528|616573636|FG002|Treatment Period|Subject Noncompliant|2|||
170608684|NCT01620528|616573634|FG000|Treatment Period|Pregnancy|7|||
170608685|NCT01620528|616573635|FG001|Treatment Period|Pregnancy|2|||
170608686|NCT01620528|616573636|FG002|Treatment Period|Pregnancy|2|||
170608687|NCT01620528|616573634|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
170608688|NCT01620528|616573635|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
170608689|NCT01620528|616573636|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
170608690|NCT01620528|616573634|FG000|Treatment Period|Exclusionary Medication Received|0|||
170608691|NCT01620528|616573635|FG001|Treatment Period|Exclusionary Medication Received|1|||
170608692|NCT01620528|616573636|FG002|Treatment Period|Exclusionary Medication Received|0|||
170608693|NCT01620528|616573634|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
170608694|NCT01620528|616573635|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
170608695|NCT01620528|616573636|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
170608696|NCT01620528|616573634|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
170608697|NCT01620528|616573635|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
170608698|NCT01620528|616573636|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
170608699|NCT01620528|616573634|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
170608700|NCT01620528|616573635|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
170608701|NCT01620528|616573636|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
170608702|NCT01620528|616573634|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
170608703|NCT01620528|616573635|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
170608704|NCT01620528|616573636|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
170608705|NCT01620528|616573634|FG000|Post-Treatment Follow-Up Period|Other|6|||
170608706|NCT01620528|616573635|FG001|Post-Treatment Follow-Up Period|Other|4|||
170608707|NCT01620528|616573636|FG002|Post-Treatment Follow-Up Period|Other|2|||
170608708|NCT01457846|616573639|FG000|Overall Study|Death before treatment|1|||
170608709|NCT01457846|616573640|FG001|Overall Study|Death before treatment|2|||
170608710|NCT01457846|616573639|FG000|Overall Study|Did not receive treatment|0|||
170608711|NCT01457846|616573640|FG001|Overall Study|Did not receive treatment|1|||
170608712|NCT01457846|616573639|FG000|Overall Study|Death|27|||
170608713|NCT01457846|616573640|FG001|Overall Study|Death|16|||
170608714|NCT01457846|616573639|FG000|Overall Study|Unclassified reason for not completed|11|||
170608715|NCT01457846|616573640|FG001|Overall Study|Unclassified reason for not completed|10|||
170608716|NCT01457846|616573639|FG000|Overall Study|Withdrawal by Subject|1|||
170608717|NCT01457846|616573640|FG001|Overall Study|Withdrawal by Subject|1|||
170608718|NCT01457846|616573639|FG000|Overall Study|Lost to Follow-up|1|||
170608719|NCT01457846|616573640|FG001|Overall Study|Lost to Follow-up|0|||
170608720|NCT01153698|616573641|FG000|Overall Study|Adverse Event|12|||
170608721|NCT01153698|616573641|FG000|Overall Study|Lost to Follow-up|4|||
170608722|NCT01153698|616573641|FG000|Overall Study|Withdrawal by Subject|2|||
170608723|NCT01153698|616573641|FG000|Overall Study|Switch to other anticoagulants|4|||
170608724|NCT01153698|616573641|FG000|Overall Study|Other|2|||
170608725|NCT01153698|616573641|FG000|Overall Study|Not treated with Pradaxa|5|||
170608726|NCT00465647|616573645|FG000|Overall Study|Administrative|2|||
170608727|NCT00465647|616573646|FG001|Overall Study|Administrative|2|||
170608728|NCT00465647|616573647|FG002|Overall Study|Administrative|3|||
170608729|NCT00465647|616573648|FG003|Overall Study|Administrative|2|||
170608730|NCT00465647|616573645|FG000|Overall Study|Adverse Event|2|||
170608731|NCT00465647|616573646|FG001|Overall Study|Adverse Event|0|||
170608732|NCT00465647|616573647|FG002|Overall Study|Adverse Event|3|||
170608733|NCT00465647|616573648|FG003|Overall Study|Adverse Event|2|||
170608734|NCT00465647|616573645|FG000|Overall Study|Withdrawal by Subject|1|||
170608735|NCT00465647|616573646|FG001|Overall Study|Withdrawal by Subject|2|||
170608736|NCT00465647|616573647|FG002|Overall Study|Withdrawal by Subject|2|||
170608737|NCT00465647|616573648|FG003|Overall Study|Withdrawal by Subject|7|||
170608738|NCT00465647|616573645|FG000|Overall Study|"The other reasons included loss of IV"|8|||
170608739|NCT00465647|616573646|FG001|Overall Study|"The other reasons included loss of IV"|4|||
170608740|NCT00465647|616573647|FG002|Overall Study|"The other reasons included loss of IV"|3|||
170608741|NCT00465647|616573648|FG003|Overall Study|"The other reasons included loss of IV"|2|||
170608742|NCT02220712|616573649|FG000|Overall Study|Adverse Event|1|||
170608743|NCT02220712|616573649|FG000|Overall Study|Withdrawal by Subject|2|||
170608744|NCT02220712|616573649|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
170608745|NCT00760838|616573653|FG000|Overall Study|Adverse Event|1|||
170608746|NCT00760838|616573654|FG001|Overall Study|Adverse Event|1|||
170608747|NCT00760838|616573653|FG000|Overall Study|Lack of Efficacy|1|||
170608748|NCT00760838|616573654|FG001|Overall Study|Lack of Efficacy|0|||
170608749|NCT00760838|616573653|FG000|Overall Study|Lost to Follow-up|2|||
170815668|NCT03884478|617332816|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
170815669|NCT03884478|617332817|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
170815670|NCT03884478|617332815|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
170815671|NCT03884478|617332816|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
170608750|NCT00760838|616573654|FG001|Overall Study|Lost to Follow-up|0|||
170608751|NCT00760838|616573653|FG000|Overall Study|Withdrawal by Subject|1|||
170608752|NCT00760838|616573654|FG001|Overall Study|Withdrawal by Subject|1|||
170608753|NCT01628965|616573655|FG000|Overall Study|Adverse Event|30|||
170608754|NCT01628965|616573655|FG000|Overall Study|Lack of Efficacy|7|||
170608755|NCT01628965|616573655|FG000|Overall Study|Withdrawal by Subject|3|||
170608756|NCT01628965|616573655|FG000|Overall Study|Lost to Follow-up|1|||
170608757|NCT01628965|616573655|FG000|Overall Study|Discontinuation criteria|8|||
170608758|NCT01339897|616573661|FG000|Overall Study|Adverse Event|1|||
170608759|NCT01339897|616573662|FG001|Overall Study|Adverse Event|0|||
170608760|NCT01339897|616573663|FG002|Overall Study|Adverse Event|0|||
170608761|NCT01339897|616573664|FG003|Overall Study|Adverse Event|1|||
170608762|NCT00847197|616573665|FG000|Overall Study|Adverse Event|21|||
170608763|NCT00847197|616573666|FG001|Overall Study|Adverse Event|3|||
170608764|NCT00847197|616573665|FG000|Overall Study|Protocol Violation|0|||
170608765|NCT00847197|616573666|FG001|Overall Study|Protocol Violation|1|||
170608766|NCT00847197|616573665|FG000|Overall Study|Withdrawal by Subject|3|||
170608767|NCT00847197|616573666|FG001|Overall Study|Withdrawal by Subject|1|||
170608768|NCT01990859|616573667|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
170608769|NCT01990859|616573667|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
170608770|NCT00622388|616573670|FG000|Overall Study|Disease Progression|47|||
170608771|NCT00622388|616573670|FG000|Overall Study|Adverse Event|6|||
170608772|NCT00622388|616573670|FG000|Overall Study|Protocol Violation|3|||
170608773|NCT00622388|616573670|FG000|Overall Study|Participant Refusal|1|||
170608774|NCT00622388|616573670|FG000|Overall Study|Death|3|||
170608775|NCT00622388|616573670|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
170608776|NCT00622388|616573670|FG000|Overall Study|Took Prohibited Medication|2|||
170608777|NCT00622388|616573670|FG000|Overall Study|Withdrew Consent|1|||
170608778|NCT00622388|616573670|FG000|Overall Study|Insurance Expired|1|||
170608779|NCT01832532|616573672|FG000|Overall Study|Withdrawal by Subject|5|||
170608780|NCT01832532|616573673|FG001|Overall Study|Withdrawal by Subject|2|||
170608781|NCT01630889|616573676|FG000|Overall Study|Death|2|||
170608782|NCT01630889|616573676|FG000|Overall Study|Withdrawal by Subject|1|||
170608783|NCT01630889|616573676|FG000|Overall Study|Other than Specified|2|||
170608784|NCT01630889|616573676|FG000|Overall Study|Lost to Follow-up|4|||
170608785|NCT01630889|616573676|FG000|Overall Study|Other|1|||
170815672|NCT03884478|617332817|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
170608786|NCT01068158|616573677|FG000|Overall Study|Withdrawal by Subject|1|||
170608787|NCT01068158|616573678|FG001|Overall Study|Withdrawal by Subject|2|||
170608788|NCT01068158|616573677|FG000|Overall Study|Lost to Follow-up|7|||
170608789|NCT01068158|616573678|FG001|Overall Study|Lost to Follow-up|0|||
170608790|NCT01068158|616573677|FG000|Overall Study|Protocol Violation|0|||
170608791|NCT01068158|616573678|FG001|Overall Study|Protocol Violation|2|||
170608792|NCT00991406|616573686|FG000|Overall Study|One participant did not respond to FES.|1|||
170608793|NCT03824587|616573687|FG000|Run-in Period|Screen Failure|0|||
170608794|NCT03824587|616573688|FG001|Run-in Period|Screen Failure|275|||
170608795|NCT03824587|616573687|FG000|Treatment Period|Adverse Event|4|||
170608796|NCT03824587|616573688|FG001|Treatment Period|Adverse Event|1|||
170608797|NCT03824587|616573687|FG000|Treatment Period|Withdrawal by Subject|0|||
170608798|NCT03824587|616573688|FG001|Treatment Period|Withdrawal by Subject|1|||
170608799|NCT03824587|616573687|FG000|Treatment Period|Kidney Transplant|1|||
170608800|NCT03824587|616573688|FG001|Treatment Period|Kidney Transplant|1|||
170608801|NCT00368641|616575217|FG000|Overall Study|Adverse Event|2|||
170608802|NCT00368641|616575218|FG001|Overall Study|Adverse Event|1|||
170608803|NCT00368641|616575217|FG000|Overall Study|Death|1|||
170815673|NCT02213094|617332818|FG000|Overall Study|Adverse Event|1|||
170815674|NCT02213094|617332819|FG001|Overall Study|Adverse Event|0|||
170815675|NCT01807234|617332820|FG000|Overall Study|Lost to Follow-up|2|||
170815676|NCT01807234|617332821|FG001|Overall Study|Lost to Follow-up|5|||
170815677|NCT01807234|617332822|FG002|Overall Study|Lost to Follow-up|1|||
170608804|NCT00368641|616575218|FG001|Overall Study|Death|0|||
170608805|NCT00368641|616575217|FG000|Overall Study|Withdrawal by Subject|1|||
170608806|NCT00368641|616575218|FG001|Overall Study|Withdrawal by Subject|0|||
170608807|NCT00368641|616575217|FG000|Overall Study|Sponsor decision to terminate study|2|||
170815678|NCT01807234|617332823|FG003|Overall Study|Lost to Follow-up|1|||
170815679|NCT01807234|617332824|FG004|Overall Study|Lost to Follow-up|1|||
170815680|NCT01807234|617332825|FG005|Overall Study|Lost to Follow-up|2|||
170608808|NCT00368641|616575218|FG001|Overall Study|Sponsor decision to terminate study|5|||
170608809|NCT01702025|616575219|FG000|Overall Study|Equipment failure|1|||
170608810|NCT01702025|616575220|FG001|Overall Study|Equipment failure|0|||
170608811|NCT01702025|616575221|FG002|Overall Study|Equipment failure|0|||
170608812|NCT01702025|616575222|FG003|Overall Study|Equipment failure|0|||
170608813|NCT01702025|616575219|FG000|Overall Study|Adverse Event|1|||
170608814|NCT01702025|616575220|FG001|Overall Study|Adverse Event|1|||
170608815|NCT01702025|616575221|FG002|Overall Study|Adverse Event|1|||
170608816|NCT01702025|616575222|FG003|Overall Study|Adverse Event|0|||
170608817|NCT02610777|616575223|FG000|Overall Study|Lost to Follow-up|1|||
170608818|NCT02610777|616575224|FG001|Overall Study|Lost to Follow-up|0|||
170608819|NCT02610777|616575223|FG000|Overall Study|Site Terminated by Sponsor|9|||
170608820|NCT02610777|616575224|FG001|Overall Study|Site Terminated by Sponsor|8|||
170608821|NCT02610777|616575223|FG000|Overall Study|Withdrawal by Subject|2|||
170608822|NCT02610777|616575224|FG001|Overall Study|Withdrawal by Subject|2|||
170608823|NCT02610777|616575223|FG000|Overall Study|Reason not Specified|0|||
170608824|NCT02610777|616575224|FG001|Overall Study|Reason not Specified|1|||
170608825|NCT02610777|616575223|FG000|Overall Study|Death|50|||
170608826|NCT02610777|616575224|FG001|Overall Study|Death|47|||
170608827|NCT01724866|616575225|FG000|Overall Study|Adverse Event|0|||
170608828|NCT01724866|616575226|FG001|Overall Study|Adverse Event|0|||
170608829|NCT01724866|616575227|FG002|Overall Study|Adverse Event|1|||
170608830|NCT01724866|616575228|FG003|Overall Study|Adverse Event|1|||
170608831|NCT01724866|616575225|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
170608832|NCT01724866|616575226|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
170608833|NCT01724866|616575227|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
170608834|NCT01724866|616575228|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
170608835|NCT01724866|616575225|FG000|Overall Study|Investigator's Discretion|0|||
170608836|NCT01724866|616575226|FG001|Overall Study|Investigator's Discretion|1|||
170608837|NCT01724866|616575227|FG002|Overall Study|Investigator's Discretion|1|||
170608838|NCT01724866|616575228|FG003|Overall Study|Investigator's Discretion|0|||
170608839|NCT01724866|616575225|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
170608840|NCT01724866|616575226|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
170608841|NCT01724866|616575227|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
170608842|NCT01724866|616575228|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
170608843|NCT01724866|616575225|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
170608844|NCT01724866|616575226|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
170608845|NCT01724866|616575227|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
170608846|NCT01724866|616575228|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
170608847|NCT00411671|616575233|FG000|Overall Study|Adverse Event|15|||
170608848|NCT00411671|616575233|FG000|Overall Study|Death|2|||
170608849|NCT00411671|616575233|FG000|Overall Study|Lost to Follow-up|3|||
170608850|NCT01173601|616575234|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
170608851|NCT01173601|616575235|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170608852|NCT01173601|616575236|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170608853|NCT01173601|616575237|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170608854|NCT01173601|616575238|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170608855|NCT01173601|616575234|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
170608856|NCT01173601|616575235|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170608857|NCT01173601|616575236|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170608858|NCT01173601|616575237|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170608859|NCT01173601|616575238|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170608860|NCT01173601|616575234|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
170608861|NCT01173601|616575235|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170608862|NCT01173601|616575236|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170608863|NCT01173601|616575237|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170608864|NCT01173601|616575238|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170608865|NCT01173601|616575234|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
170608866|NCT01173601|616575235|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170608867|NCT01173601|616575236|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170653072|NCT04090411|616743389|FG005|Induction Period|Protocol Violation|0|||
170653073|NCT04090411|616743390|FG006|Induction Period|Protocol Violation|0|||
170608868|NCT01173601|616575237|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170608869|NCT01173601|616575238|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170608870|NCT01173601|616575234|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
170608871|NCT01173601|616575235|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170608872|NCT01173601|616575236|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170608873|NCT01173601|616575237|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170608874|NCT01173601|616575238|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170608875|NCT01173601|616575234|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
170608876|NCT01173601|616575235|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170608877|NCT01173601|616575236|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170608878|NCT01173601|616575237|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170608879|NCT01173601|616575238|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170608880|NCT01173601|616575234|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
170608881|NCT01173601|616575235|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170608882|NCT01173601|616575236|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170608883|NCT01173601|616575237|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170608884|NCT01173601|616575238|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170608885|NCT01173601|616575234|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
170608886|NCT01173601|616575235|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
170608887|NCT01173601|616575236|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
170608888|NCT01173601|616575237|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
170608889|NCT01173601|616575238|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
170608890|NCT01173601|616575234|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
170608891|NCT01173601|616575235|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
170608892|NCT01173601|616575236|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
170608893|NCT01173601|616575237|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
170608894|NCT01173601|616575238|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
170608895|NCT01173601|616575234|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
170608896|NCT01173601|616575235|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
170608897|NCT01173601|616575236|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
170608898|NCT01173601|616575237|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
170608899|NCT01173601|616575238|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
170608900|NCT01173601|616575234|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
170608901|NCT01173601|616575235|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
170608902|NCT01173601|616575236|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
170608903|NCT01173601|616575237|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
170608904|NCT01173601|616575238|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
170608905|NCT01173601|616575234|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
170608906|NCT01173601|616575235|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
170608907|NCT01173601|616575236|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
170608908|NCT01173601|616575237|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
170608909|NCT01173601|616575238|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
170608910|NCT01173601|616575234|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
170608911|NCT01173601|616575235|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
170608912|NCT01173601|616575236|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
170608913|NCT01173601|616575237|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
170608914|NCT01173601|616575238|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
170608915|NCT01173601|616575234|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
170608916|NCT01173601|616575235|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
170608917|NCT01173601|616575236|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
170608918|NCT01173601|616575237|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
170608919|NCT01173601|616575238|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
170608920|NCT04737278|616575239|FG000|Overall Study|Lost to Follow-up|1|||
170608921|NCT04737278|616575240|FG001|Overall Study|Lost to Follow-up|1|||
170608922|NCT04737278|616575239|FG000|Overall Study|Withdrawal by Subject|1|||
170608923|NCT04737278|616575240|FG001|Overall Study|Withdrawal by Subject|0|||
170608924|NCT04737278|616575239|FG000|Overall Study|Protocol Violation|1|||
170608925|NCT04737278|616575240|FG001|Overall Study|Protocol Violation|1|||
170608926|NCT04737278|616575239|FG000|Overall Study|failure to complete questionnaire|1|||
170608927|NCT04737278|616575240|FG001|Overall Study|failure to complete questionnaire|1|||
170608928|NCT00546000|616575246|FG000|Overall Study|Adverse Event|1|||
170608929|NCT00546000|616575246|FG000|Overall Study|Lost to Follow-up|1|||
170916225|NCT02000622|617695698|FG001|Overall Study|Withdrawn due to site closure|0|||
170916226|NCT04162210|617695699|FG000|Overall Study|Lost to Follow-up|4|||
170916227|NCT04162210|617695700|FG001|Overall Study|Lost to Follow-up|1|||
170916228|NCT04162210|617695699|FG000|Overall Study|Withdrawal by Subject|17|||
170916229|NCT04162210|617695700|FG001|Overall Study|Withdrawal by Subject|9|||
170608930|NCT00546000|616575246|FG000|Overall Study|Baseline HPA Axis Supression|2|||
170608931|NCT03688074|616575247|FG000|Overall Study|Adverse Event|0|||
170608932|NCT03688074|616575248|FG001|Overall Study|Adverse Event|1|||
170608933|NCT03688074|616575247|FG000|Overall Study|Other|1|||
170608934|NCT03688074|616575248|FG001|Overall Study|Other|0|||
170608935|NCT01362608|616575249|FG000|Overall Study|Protocol Violation|0|||
170608936|NCT01362608|616575250|FG001|Overall Study|Protocol Violation|1|||
170608937|NCT01362608|616575249|FG000|Overall Study|Lost to Follow-up|3|||
170608938|NCT01362608|616575250|FG001|Overall Study|Lost to Follow-up|1|||
170608939|NCT01362608|616575249|FG000|Overall Study|Withdrawal by Subject|1|||
170608940|NCT01362608|616575250|FG001|Overall Study|Withdrawal by Subject|2|||
170608941|NCT01362608|616575249|FG000|Overall Study|Lack of Efficacy|0|||
170608942|NCT01362608|616575250|FG001|Overall Study|Lack of Efficacy|2|||
170608943|NCT01362608|616575249|FG000|Overall Study|Adverse Event|0|||
170608944|NCT01362608|616575250|FG001|Overall Study|Adverse Event|2|||
170608945|NCT03056339|616575254|FG000|Overall Study|Failed Requirements|0|||
170608946|NCT03056339|616575255|FG001|Overall Study|Failed Requirements|2|||
170608947|NCT03056339|616575256|FG002|Overall Study|Failed Requirements|7|||
170608948|NCT03056339|616575257|FG003|Overall Study|Failed Requirements|1|||
170608949|NCT01128244|616575260|FG000|Overall Study|Adverse Event|1|||
170608950|NCT01128244|616575260|FG000|Overall Study|Scheduling conflict|2|||
170608951|NCT03472950|616575276|FG000|Overall Study|Lost to Follow-up|0|||
170608952|NCT03472950|616575277|FG001|Overall Study|Lost to Follow-up|1|||
170608953|NCT03472950|616575276|FG000|Overall Study|Adverse Event|0|||
170608954|NCT03472950|616575277|FG001|Overall Study|Adverse Event|3|||
170608955|NCT01948063|616575280|FG000|Overall Study|Boston MCI halted research protocol|0|||
170608956|NCT01948063|616575281|FG001|Overall Study|Boston MCI halted research protocol|1|||
170608957|NCT01948063|616575280|FG000|Overall Study|Discovered an enrollment in other study|0|||
170608958|NCT01948063|616575281|FG001|Overall Study|Discovered an enrollment in other study|1|||
170608959|NCT01948063|616575280|FG000|Overall Study|Blood samples were accidentally thawed|1|||
170608960|NCT01948063|616575281|FG001|Overall Study|Blood samples were accidentally thawed|0|||
170608961|NCT01979952|616575286|FG000|Overall Study|Adverse Event|4|||
170608962|NCT01979952|616575287|FG001|Overall Study|Adverse Event|5|||
170608963|NCT01979952|616575286|FG000|Overall Study|Protocol Violation|1|||
170608964|NCT01979952|616575287|FG001|Overall Study|Protocol Violation|0|||
170608965|NCT01979952|616575286|FG000|Overall Study|Withdrawal by Subject|2|||
170608966|NCT01979952|616575287|FG001|Overall Study|Withdrawal by Subject|1|||
170608967|NCT01979952|616575286|FG000|Overall Study|Other than specified above|1|||
170608968|NCT01979952|616575287|FG001|Overall Study|Other than specified above|0|||
170608969|NCT00245037|616575290|FG000|Overall Study|Death|17|||
170608970|NCT03671304|616575292|FG000|Overall Study|study terminated|7|||
170608971|NCT01053988|616575293|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
170608972|NCT01053988|616575294|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170608973|NCT01053988|616575295|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170608974|NCT01053988|616575296|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170608975|NCT01053988|616575297|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170608976|NCT01053988|616575298|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170608977|NCT01053988|616575293|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
170608978|NCT01053988|616575294|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170608979|NCT01053988|616575295|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170608980|NCT01053988|616575296|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170608981|NCT01053988|616575297|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170608982|NCT01053988|616575298|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170608983|NCT01053988|616575293|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
170608984|NCT01053988|616575294|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170608985|NCT01053988|616575295|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170608986|NCT01053988|616575296|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170608987|NCT01053988|616575297|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170608988|NCT01053988|616575298|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170608989|NCT01053988|616575293|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
170608990|NCT01053988|616575294|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
170608991|NCT01053988|616575295|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
170608992|NCT01053988|616575296|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
170608993|NCT01053988|616575297|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
170608994|NCT01053988|616575298|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
170608995|NCT01053988|616575293|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
170608996|NCT01053988|616575294|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
170608997|NCT01053988|616575295|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
170608998|NCT01053988|616575296|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
170608999|NCT01053988|616575297|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
170609000|NCT01053988|616575298|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
170609001|NCT01053988|616575293|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
170609002|NCT01053988|616575294|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170609003|NCT01053988|616575295|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170609004|NCT01053988|616575296|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170609005|NCT01053988|616575297|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170609006|NCT01053988|616575298|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170609007|NCT01053988|616575293|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
170609008|NCT01053988|616575294|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
170609009|NCT01053988|616575295|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
170609010|NCT01053988|616575296|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
170609011|NCT01053988|616575297|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
170609012|NCT01053988|616575298|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
170609013|NCT01053988|616575293|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170609014|NCT01053988|616575294|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
170609015|NCT01053988|616575295|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
170609016|NCT01053988|616575296|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
170609017|NCT01053988|616575297|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
170609018|NCT01053988|616575298|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170609019|NCT01053988|616575293|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
170609020|NCT01053988|616575294|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
170609021|NCT01053988|616575295|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
170609022|NCT01053988|616575296|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
170609023|NCT01053988|616575297|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
170609024|NCT01053988|616575298|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
170609025|NCT01053988|616575293|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
170609026|NCT01053988|616575294|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
170609027|NCT01053988|616575295|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
170609028|NCT01053988|616575296|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
170609029|NCT01053988|616575297|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
170609030|NCT01053988|616575298|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
170916230|NCT04162210|617695699|FG000|Overall Study|Ongoing|113|||
170916231|NCT04162210|617695700|FG001|Overall Study|Ongoing|59|||
170916232|NCT03907891|617695701|FG000|Overall Study|Death|1|||
170916233|NCT03907891|617695702|FG001|Overall Study|Death|0|||
170916234|NCT03907891|617695703|FG002|Overall Study|Death|0|||
170916235|NCT03907891|617695701|FG000|Overall Study|Withdrawal by Subject|20|||
170916236|NCT03907891|617695702|FG001|Overall Study|Withdrawal by Subject|27|||
170916237|NCT03907891|617695703|FG002|Overall Study|Withdrawal by Subject|23|||
170916238|NCT03907891|617695701|FG000|Overall Study|Lost to Follow-up|8|||
170916239|NCT03907891|617695702|FG001|Overall Study|Lost to Follow-up|5|||
170916240|NCT03907891|617695703|FG002|Overall Study|Lost to Follow-up|4|||
170916241|NCT03907891|617695701|FG000|Overall Study|Patient could no longer identify significant other|0|||
170916242|NCT03907891|617695702|FG001|Overall Study|Patient could no longer identify significant other|3|||
170916243|NCT03907891|617695703|FG002|Overall Study|Patient could no longer identify significant other|0|||
170916244|NCT03907891|617695701|FG000|Overall Study|Decline in health|0|||
170916245|NCT03907891|617695702|FG001|Overall Study|Decline in health|2|||
170916246|NCT03907891|617695703|FG002|Overall Study|Decline in health|0|||
170916247|NCT03036930|617695706|FG000|Overall Study|Lost to Follow-up|7|||
170916248|NCT03036930|617695706|FG000|Overall Study|Withdrawal by Subject|3|||
170916249|NCT03036930|617695706|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
170916250|NCT04527549|617695707|FG000|Overall Study|Withdrawal by Subject|1|||
170916251|NCT04527549|617695708|FG001|Overall Study|Withdrawal by Subject|1|||
170916252|NCT01385176|617695710|FG000|Randomization Phase|Death|1|||
170916253|NCT01385176|617695711|FG001|Randomization Phase|Death|2|||
170916254|NCT01385176|617695710|FG000|6-18 Month All VNS Active|Death|1|||
170916255|NCT01385176|617695711|FG001|6-18 Month All VNS Active|Death|2|||
170916256|NCT01385176|617695710|FG000|6-18 Month All VNS Active|Physician Decision|0|||
170916257|NCT01385176|617695711|FG001|6-18 Month All VNS Active|Physician Decision|1|||
170916258|NCT01385176|617695710|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
170916259|NCT01385176|617695711|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
170916260|NCT01385176|617695710|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
170916261|NCT01385176|617695711|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
170916262|NCT03901963|617695712|FG000|Overall Study|Lost to Follow-up|1|||
170916263|NCT03901963|617695713|FG001|Overall Study|Lost to Follow-up|1|||
170916264|NCT03901963|617695712|FG000|Overall Study|Physician Decision|1|||
170916265|NCT03901963|617695713|FG001|Overall Study|Physician Decision|2|||
170916266|NCT03901963|617695712|FG000|Overall Study|Protocol Violation|1|||
170916267|NCT03901963|617695713|FG001|Overall Study|Protocol Violation|1|||
170815681|NCT01807234|617332820|FG000|Overall Study|Withdrawal by Subject|3|||
170815682|NCT01807234|617332821|FG001|Overall Study|Withdrawal by Subject|1|||
170815683|NCT01807234|617332822|FG002|Overall Study|Withdrawal by Subject|1|||
170815684|NCT01807234|617332823|FG003|Overall Study|Withdrawal by Subject|1|||
170815685|NCT01807234|617332824|FG004|Overall Study|Withdrawal by Subject|2|||
170815686|NCT01807234|617332825|FG005|Overall Study|Withdrawal by Subject|1|||
170609031|NCT01053988|616575293|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
170609032|NCT01053988|616575294|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
170609033|NCT01053988|616575295|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
170609034|NCT01053988|616575296|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
170609035|NCT01053988|616575297|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
170609036|NCT01053988|616575298|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
170609037|NCT01053988|616575293|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170609038|NCT01053988|616575294|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
170609039|NCT01053988|616575295|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170609040|NCT01053988|616575296|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
170609041|NCT01053988|616575297|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
170609042|NCT01053988|616575298|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
170609043|NCT01053988|616575293|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
170609044|NCT01053988|616575294|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
170609045|NCT01053988|616575295|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
170609046|NCT01053988|616575296|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
170609047|NCT01053988|616575297|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
170609048|NCT01053988|616575298|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
170609049|NCT01053988|616575293|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
170609050|NCT01053988|616575294|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
170609051|NCT01053988|616575295|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
170609052|NCT01053988|616575296|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
170609053|NCT01053988|616575297|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
170609054|NCT01053988|616575298|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
170609055|NCT04124705|616575303|FG000|Titration Period|Adverse Event|9|||
170609056|NCT04124705|616575304|FG001|Titration Period|Adverse Event|5|||
170609057|NCT04124705|616575303|FG000|Titration Period|Withdrawal by Subject|6|||
170609058|NCT04124705|616575304|FG001|Titration Period|Withdrawal by Subject|3|||
170609059|NCT04124705|616575303|FG000|Titration Period|Lost to Follow-up|0|||
170609060|NCT04124705|616575304|FG001|Titration Period|Lost to Follow-up|1|||
170609061|NCT04124705|616575303|FG000|Titration Period|Death|1|||
170609062|NCT04124705|616575304|FG001|Titration Period|Death|1|||
170609063|NCT04124705|616575303|FG000|Titration Period|Lack of Efficacy|2|||
170609064|NCT04124705|616575304|FG001|Titration Period|Lack of Efficacy|0|||
170609065|NCT04124705|616575303|FG000|Titration Period|Physician Decision|2|||
170609066|NCT04124705|616575304|FG001|Titration Period|Physician Decision|0|||
170609067|NCT04124705|616575303|FG000|Titration Period|Non-compliance with Study Drug|2|||
170609068|NCT04124705|616575304|FG001|Titration Period|Non-compliance with Study Drug|0|||
170609069|NCT04124705|616575303|FG000|Titration Period|Other|4|||
170609070|NCT04124705|616575304|FG001|Titration Period|Other|9|||
170609071|NCT04124705|616575303|FG000|Stabilization Period|Adverse Event|4|||
170609072|NCT04124705|616575304|FG001|Stabilization Period|Adverse Event|2|||
170609073|NCT04124705|616575303|FG000|Stabilization Period|Withdrawal by Subject|1|||
170609074|NCT04124705|616575304|FG001|Stabilization Period|Withdrawal by Subject|1|||
170609075|NCT04124705|616575303|FG000|Stabilization Period|Lost to Follow-up|0|||
170609076|NCT04124705|616575304|FG001|Stabilization Period|Lost to Follow-up|1|||
170609077|NCT04124705|616575303|FG000|Stabilization Period|Lack of Efficacy|4|||
170609078|NCT04124705|616575304|FG001|Stabilization Period|Lack of Efficacy|2|||
170609079|NCT04124705|616575303|FG000|Stabilization Period|Protocol Deviation|0|||
170609080|NCT04124705|616575304|FG001|Stabilization Period|Protocol Deviation|2|||
170609081|NCT04124705|616575303|FG000|Stabilization Period|Other|2|||
170609082|NCT04124705|616575304|FG001|Stabilization Period|Other|2|||
170609083|NCT04164732|616575306|FG000|Treatment run-in Period|Adverse Event|4|||
170609084|NCT04164732|616575307|FG001|Treatment run-in Period|Adverse Event|0|||
170815687|NCT01807234|617332820|FG000|Overall Study|Lack of Efficacy|0|||
170815688|NCT01807234|617332821|FG001|Overall Study|Lack of Efficacy|0|||
170815689|NCT01807234|617332822|FG002|Overall Study|Lack of Efficacy|0|||
170815690|NCT01807234|617332823|FG003|Overall Study|Lack of Efficacy|0|||
170815691|NCT01807234|617332824|FG004|Overall Study|Lack of Efficacy|1|||
170815692|NCT01807234|617332825|FG005|Overall Study|Lack of Efficacy|1|||
170815693|NCT00538629|617332826|FG000|Overall Study|At subject's request|1|||
170815694|NCT00538629|617332826|FG000|Overall Study|Adverse Event|2|||
170815695|NCT00538629|617332826|FG000|Overall Study|Lack of Efficacy|12|||
170916268|NCT03901963|617695712|FG000|Overall Study|Withdrawal by Subject|4|||
170815696|NCT00538629|617332826|FG000|Overall Study|Lost to Follow-up|6|||
170916269|NCT03901963|617695713|FG001|Overall Study|Withdrawal by Subject|11|||
170609085|NCT04164732|616575308|FG002|Treatment run-in Period|Adverse Event|0|||
170609086|NCT04164732|616575306|FG000|Treatment run-in Period|Physician Decision|1|||
170609087|NCT04164732|616575307|FG001|Treatment run-in Period|Physician Decision|0|||
170609088|NCT04164732|616575308|FG002|Treatment run-in Period|Physician Decision|0|||
170609089|NCT04164732|616575306|FG000|Treatment run-in Period|Screen Failure|1|||
170609090|NCT04164732|616575307|FG001|Treatment run-in Period|Screen Failure|0|||
170609091|NCT04164732|616575308|FG002|Treatment run-in Period|Screen Failure|0|||
170609092|NCT04164732|616575306|FG000|Randomized Treatment Period|Adverse Event|0|||
170609093|NCT04164732|616575307|FG001|Randomized Treatment Period|Adverse Event|1|||
170609094|NCT04164732|616575308|FG002|Randomized Treatment Period|Adverse Event|0|||
170609095|NCT04164732|616575306|FG000|Randomized Treatment Period|Protocol Deviation|0|||
170609096|NCT04164732|616575307|FG001|Randomized Treatment Period|Protocol Deviation|1|||
170609097|NCT04164732|616575308|FG002|Randomized Treatment Period|Protocol Deviation|1|||
170609098|NCT04164732|616575306|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
170609099|NCT04164732|616575307|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
170609100|NCT04164732|616575308|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
170609101|NCT02141360|616575309|FG000|Overall Study|Withdrawal by Subject|6|||
170609102|NCT02141360|616575310|FG001|Overall Study|Withdrawal by Subject|0|||
170609103|NCT02141360|616575311|FG002|Overall Study|Withdrawal by Subject|0|||
170609104|NCT02141360|616575309|FG000|Overall Study|Study Terminated before Visit|1|||
170609105|NCT02141360|616575310|FG001|Overall Study|Study Terminated before Visit|0|||
170609106|NCT02141360|616575311|FG002|Overall Study|Study Terminated before Visit|0|||
170609107|NCT00661622|616575312|FG000|Overall Study|Protocol Violation|1|||
170609108|NCT00661622|616575313|FG001|Overall Study|Protocol Violation|0|||
170609109|NCT01636986|616575314|FG000|Overall Study|Withdrawal by Subject|0|||
170609110|NCT01636986|616575315|FG001|Overall Study|Withdrawal by Subject|1|||
170609111|NCT01636986|616575314|FG000|Overall Study|Corneal Staining|0|||
170609112|NCT01636986|616575315|FG001|Overall Study|Corneal Staining|1|||
170609113|NCT02160145|616575316|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
170609114|NCT02160145|616575317|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
170609115|NCT02160145|616575318|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
170609116|NCT02160145|616575316|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
170609117|NCT02160145|616575317|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
170609118|NCT02160145|616575318|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
170609119|NCT02160145|616575316|FG000|Randomized Double-blind Period|Subject decision|0|||
170609120|NCT02160145|616575317|FG001|Randomized Double-blind Period|Subject decision|21|||
170609121|NCT02160145|616575318|FG002|Randomized Double-blind Period|Subject decision|20|||
170609122|NCT02160145|616575316|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
170609123|NCT02160145|616575317|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
170609124|NCT02160145|616575318|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
170609125|NCT02160145|616575316|FG000|Randomized Double-blind Period|Physician Decision|0|||
170609126|NCT02160145|616575317|FG001|Randomized Double-blind Period|Physician Decision|7|||
170609127|NCT02160145|616575318|FG002|Randomized Double-blind Period|Physician Decision|5|||
170609128|NCT00129467|616575324|FG000|Received Intervention|Death|1|||
170609129|NCT00129467|616575325|FG001|Received Intervention|Death|1|||
170609130|NCT00129467|616575324|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
170609131|NCT00129467|616575325|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
170609132|NCT00129467|616575324|FG000|Received Intervention|Delirium|2|||
170609133|NCT00129467|616575325|FG001|Received Intervention|Delirium|0|||
170609134|NCT00129467|616575324|FG000|Received Intervention|Withdrawal by Subject|1|||
170609135|NCT00129467|616575325|FG001|Received Intervention|Withdrawal by Subject|0|||
170609136|NCT00129467|616575324|FG000|Received Intervention|Nausea|1|||
170609137|NCT00129467|616575325|FG001|Received Intervention|Nausea|0|||
170609138|NCT00129467|616575324|FG000|Received Intervention|Intolerance to citalopram|0|||
170609139|NCT00129467|616575325|FG001|Received Intervention|Intolerance to citalopram|1|||
170609140|NCT00129467|616575324|FG000|Received Intervention|Dizzyness, fatigue|0|||
170609141|NCT00129467|616575325|FG001|Received Intervention|Dizzyness, fatigue|1|||
170609142|NCT00129467|616575324|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
170609143|NCT00129467|616575325|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
170609144|NCT00129467|616575324|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
170609145|NCT00129467|616575325|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
170609146|NCT02540993|616575326|FG000|Overall Study|Lost to Follow-up|5|||
170609147|NCT02540993|616575327|FG001|Overall Study|Lost to Follow-up|3|||
170609148|NCT02540993|616575326|FG000|Overall Study|Withdrawal by Subject|4|||
170609149|NCT02540993|616575327|FG001|Overall Study|Withdrawal by Subject|6|||
170609150|NCT02540993|616575326|FG000|Overall Study|GCP violations|33|||
170916270|NCT03901963|617695712|FG000|Overall Study|Ongoing|84|||
170609151|NCT02540993|616575327|FG001|Overall Study|GCP violations|27|||
170609152|NCT02578186|616575328|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
170609153|NCT02578186|616575329|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
170916271|NCT03901963|617695713|FG001|Overall Study|Ongoing|73|||
170609154|NCT02578186|616575328|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
170609155|NCT02578186|616575329|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
170609156|NCT03657095|616575330|FG000|Overall Study|Withdrawal by Subject|1|||
170609157|NCT03657095|616575331|FG001|Overall Study|Withdrawal by Subject|1|||
170609158|NCT03657095|616575330|FG000|Overall Study|Adverse Event|0|||
170609159|NCT03657095|616575331|FG001|Overall Study|Adverse Event|3|||
170609160|NCT03657095|616575330|FG000|Overall Study|Study Terminated by Sponsor|58|||
170609161|NCT03657095|616575331|FG001|Overall Study|Study Terminated by Sponsor|49|||
170609162|NCT01743040|616575332|FG000|Overall Study|Death|1|||
170609163|NCT01743040|616575332|FG000|Overall Study|Lost to Follow-up|66|||
170609164|NCT01743040|616575332|FG000|Overall Study|Physician Decision|40|||
170609165|NCT01743040|616575332|FG000|Overall Study|Protocol Violation|1|||
170609166|NCT01743040|616575332|FG000|Overall Study|Withdrawal by Subject|121|||
170609167|NCT04006392|616575335|FG000|Overall Study|Lost to Follow-up|0|||
170609168|NCT04006392|616575336|FG001|Overall Study|Lost to Follow-up|1|||
170609169|NCT01067469|616575337|FG000|Overall Study|Withdrawal by Subject|0|||
170609170|NCT01067469|616575338|FG001|Overall Study|Withdrawal by Subject|1|||
170609171|NCT01067469|616575337|FG000|Overall Study|Disease Progression|0|||
170609172|NCT01067469|616575338|FG001|Overall Study|Disease Progression|1|||
170609173|NCT00766051|616575339|FG000|Overall Study|Withdrawal by Subject|2|||
170609174|NCT00766051|616575340|FG001|Overall Study|Withdrawal by Subject|0|||
170609175|NCT01368081|616575341|FG000|Overall Study|Adverse Event|4|||
170609176|NCT01368081|616575342|FG001|Overall Study|Adverse Event|4|||
170609177|NCT01368081|616575343|FG002|Overall Study|Adverse Event|3|||
170609178|NCT01368081|616575344|FG003|Overall Study|Adverse Event|2|||
170609179|NCT01368081|616575345|FG004|Overall Study|Adverse Event|2|||
170609180|NCT01368081|616575346|FG005|Overall Study|Adverse Event|5|||
170609181|NCT01368081|616575347|FG006|Overall Study|Adverse Event|6|||
170609182|NCT01368081|616575348|FG007|Overall Study|Adverse Event|2|||
170609183|NCT01368081|616575349|FG008|Overall Study|Adverse Event|3|||
170609184|NCT01368081|616575350|FG009|Overall Study|Adverse Event|5|||
170609185|NCT01368081|616575351|FG010|Overall Study|Adverse Event|6|||
170609186|NCT01368081|616575352|FG011|Overall Study|Adverse Event|1|||
170609187|NCT01368081|616575353|FG012|Overall Study|Adverse Event|3|||
170609188|NCT01368081|616575341|FG000|Overall Study|Lack of Efficacy|0|||
170609189|NCT01368081|616575342|FG001|Overall Study|Lack of Efficacy|1|||
170609190|NCT01368081|616575343|FG002|Overall Study|Lack of Efficacy|0|||
170609191|NCT01368081|616575344|FG003|Overall Study|Lack of Efficacy|1|||
170609192|NCT01368081|616575345|FG004|Overall Study|Lack of Efficacy|0|||
170609193|NCT01368081|616575346|FG005|Overall Study|Lack of Efficacy|0|||
170609194|NCT01368081|616575347|FG006|Overall Study|Lack of Efficacy|0|||
170609195|NCT01368081|616575348|FG007|Overall Study|Lack of Efficacy|2|||
170609196|NCT01368081|616575349|FG008|Overall Study|Lack of Efficacy|0|||
170609197|NCT01368081|616575350|FG009|Overall Study|Lack of Efficacy|0|||
170609198|NCT01368081|616575351|FG010|Overall Study|Lack of Efficacy|0|||
170609199|NCT01368081|616575352|FG011|Overall Study|Lack of Efficacy|0|||
170609200|NCT01368081|616575353|FG012|Overall Study|Lack of Efficacy|0|||
170609201|NCT01368081|616575341|FG000|Overall Study|Protocol Violation|0|||
170609202|NCT01368081|616575342|FG001|Overall Study|Protocol Violation|0|||
170609203|NCT01368081|616575343|FG002|Overall Study|Protocol Violation|0|||
170609204|NCT01368081|616575344|FG003|Overall Study|Protocol Violation|0|||
170609205|NCT01368081|616575345|FG004|Overall Study|Protocol Violation|0|||
170609206|NCT01368081|616575346|FG005|Overall Study|Protocol Violation|1|||
170609207|NCT01368081|616575347|FG006|Overall Study|Protocol Violation|0|||
170609208|NCT01368081|616575348|FG007|Overall Study|Protocol Violation|1|||
170609209|NCT01368081|616575349|FG008|Overall Study|Protocol Violation|0|||
170609210|NCT01368081|616575350|FG009|Overall Study|Protocol Violation|0|||
170609211|NCT01368081|616575351|FG010|Overall Study|Protocol Violation|0|||
170609212|NCT01368081|616575352|FG011|Overall Study|Protocol Violation|0|||
170609213|NCT01368081|616575353|FG012|Overall Study|Protocol Violation|0|||
170609214|NCT01368081|616575341|FG000|Overall Study|Lost to Follow-up|0|||
170609215|NCT01368081|616575342|FG001|Overall Study|Lost to Follow-up|0|||
170609216|NCT01368081|616575343|FG002|Overall Study|Lost to Follow-up|0|||
170609217|NCT01368081|616575344|FG003|Overall Study|Lost to Follow-up|0|||
170609218|NCT01368081|616575345|FG004|Overall Study|Lost to Follow-up|0|||
170609219|NCT01368081|616575346|FG005|Overall Study|Lost to Follow-up|0|||
170609220|NCT01368081|616575347|FG006|Overall Study|Lost to Follow-up|0|||
170609221|NCT01368081|616575348|FG007|Overall Study|Lost to Follow-up|0|||
170609222|NCT01368081|616575349|FG008|Overall Study|Lost to Follow-up|0|||
170609223|NCT01368081|616575350|FG009|Overall Study|Lost to Follow-up|0|||
170609224|NCT01368081|616575351|FG010|Overall Study|Lost to Follow-up|0|||
170609225|NCT01368081|616575352|FG011|Overall Study|Lost to Follow-up|0|||
170609226|NCT01368081|616575353|FG012|Overall Study|Lost to Follow-up|1|||
170609227|NCT01368081|616575341|FG000|Overall Study|Withdrawal by Subject|4|||
170609228|NCT01368081|616575342|FG001|Overall Study|Withdrawal by Subject|4|||
170609229|NCT01368081|616575343|FG002|Overall Study|Withdrawal by Subject|1|||
170609230|NCT01368081|616575344|FG003|Overall Study|Withdrawal by Subject|1|||
170609231|NCT01368081|616575345|FG004|Overall Study|Withdrawal by Subject|0|||
170609232|NCT01368081|616575346|FG005|Overall Study|Withdrawal by Subject|3|||
170609233|NCT01368081|616575347|FG006|Overall Study|Withdrawal by Subject|4|||
170815697|NCT00538629|617332826|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
170609234|NCT01368081|616575348|FG007|Overall Study|Withdrawal by Subject|2|||
170609235|NCT01368081|616575349|FG008|Overall Study|Withdrawal by Subject|5|||
170609236|NCT01368081|616575350|FG009|Overall Study|Withdrawal by Subject|4|||
170609237|NCT01368081|616575351|FG010|Overall Study|Withdrawal by Subject|3|||
170609238|NCT01368081|616575352|FG011|Overall Study|Withdrawal by Subject|2|||
170609239|NCT01368081|616575353|FG012|Overall Study|Withdrawal by Subject|0|||
170609240|NCT01368081|616575341|FG000|Overall Study|Other reason not defined above|2|||
170609241|NCT01368081|616575342|FG001|Overall Study|Other reason not defined above|0|||
170609242|NCT01368081|616575343|FG002|Overall Study|Other reason not defined above|0|||
170609243|NCT01368081|616575344|FG003|Overall Study|Other reason not defined above|1|||
170609244|NCT01368081|616575345|FG004|Overall Study|Other reason not defined above|0|||
170609245|NCT01368081|616575346|FG005|Overall Study|Other reason not defined above|1|||
170609246|NCT01368081|616575347|FG006|Overall Study|Other reason not defined above|2|||
170609247|NCT01368081|616575348|FG007|Overall Study|Other reason not defined above|0|||
170609248|NCT01368081|616575349|FG008|Overall Study|Other reason not defined above|0|||
170609249|NCT01368081|616575350|FG009|Overall Study|Other reason not defined above|1|||
170609250|NCT01368081|616575351|FG010|Overall Study|Other reason not defined above|0|||
170609251|NCT01368081|616575352|FG011|Overall Study|Other reason not defined above|0|||
170609252|NCT01368081|616575353|FG012|Overall Study|Other reason not defined above|3|||
170609253|NCT03755661|616575355|FG000|Overall Study|Lost to Follow-up|1|||
170609254|NCT03755661|616575356|FG001|Overall Study|Lost to Follow-up|0|||
170609255|NCT02038075|616575357|FG000|Overall Study|Withdrawal by Subject|3|||
170609256|NCT02038075|616575358|FG001|Overall Study|Withdrawal by Subject|0|||
170609257|NCT04000581|616575359|FG000|Overall Study|Withdrawal by Subject|0|||
170609258|NCT04000581|616575360|FG001|Overall Study|Withdrawal by Subject|1|||
170609259|NCT00895453|616575361|FG000|Overall Study|Lost to Follow-up|25|||
170609260|NCT00895453|616575362|FG001|Overall Study|Lost to Follow-up|25|||
170609261|NCT00895453|616575363|FG002|Overall Study|Lost to Follow-up|23|||
170609262|NCT02478255|616575367|FG000|Overall Study|Physician Decision|6|||
170609263|NCT02478255|616575368|FG001|Overall Study|Physician Decision|0|||
170609264|NCT02478255|616575367|FG000|Overall Study|Withdrawal by Subject|2|||
170609265|NCT02478255|616575368|FG001|Overall Study|Withdrawal by Subject|0|||
170609266|NCT02519595|616575369|FG000|Overall Study|Protocol Violation|8|||
170609267|NCT02519595|616575370|FG001|Overall Study|Protocol Violation|22|||
170609268|NCT02519595|616575371|FG002|Overall Study|Protocol Violation|16|||
170609269|NCT03188510|616575374|FG000|Overall Study|Inappropriate behavior with site staff|0|||
170609270|NCT03188510|616575375|FG001|Overall Study|Inappropriate behavior with site staff|1|||
170609271|NCT03188510|616575376|FG002|Overall Study|Inappropriate behavior with site staff|0|||
170609272|NCT01736618|616575379|FG000|Overall Study|Death|294|||
170609273|NCT01736618|616575379|FG000|Overall Study|Lost to Follow-up|193|||
170609274|NCT01736618|616575379|FG000|Overall Study|Withdrawal by Subject|54|||
170609275|NCT01736618|616575379|FG000|Overall Study|Subject unable to be followed at study location|223|||
170815698|NCT02163499|617332829|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
170609276|NCT01736618|616575379|FG000|Overall Study|Physician Decision|33|||
170609277|NCT01736618|616575379|FG000|Overall Study|Transplant or removal of target organ|19|||
170609278|NCT01736618|616575379|FG000|Overall Study|Change in indication or condition|78|||
170609279|NCT01736618|616575379|FG000|Overall Study|Study device explant|103|||
170609280|NCT01736618|616575379|FG000|Overall Study|Unable to complete implant|2|||
170609281|NCT04167137|616575381|FG000|Overall Study|Disease progression|1|||
170609282|NCT04167137|616575382|FG001|Overall Study|Disease progression|1|||
170609283|NCT04167137|616575383|FG002|Overall Study|Disease progression|3|||
170609284|NCT04167137|616575384|FG003|Overall Study|Disease progression|3|||
170609285|NCT04167137|616575385|FG004|Overall Study|Disease progression|2|||
170609286|NCT04167137|616575386|FG005|Overall Study|Disease progression|3|||
170609287|NCT04167137|616575387|FG006|Overall Study|Disease progression|2|||
170609288|NCT04167137|616575388|FG007|Overall Study|Disease progression|2|||
170609289|NCT04167137|616575381|FG000|Overall Study|Withdrawal by Subject|1|||
170609290|NCT04167137|616575382|FG001|Overall Study|Withdrawal by Subject|0|||
170609291|NCT04167137|616575383|FG002|Overall Study|Withdrawal by Subject|0|||
170609292|NCT04167137|616575384|FG003|Overall Study|Withdrawal by Subject|1|||
170609293|NCT04167137|616575385|FG004|Overall Study|Withdrawal by Subject|0|||
170609294|NCT04167137|616575386|FG005|Overall Study|Withdrawal by Subject|2|||
170609295|NCT04167137|616575387|FG006|Overall Study|Withdrawal by Subject|1|||
170609296|NCT04167137|616575388|FG007|Overall Study|Withdrawal by Subject|0|||
170609297|NCT04167137|616575381|FG000|Overall Study|Adverse Event|0|||
170609298|NCT04167137|616575382|FG001|Overall Study|Adverse Event|0|||
170609299|NCT04167137|616575383|FG002|Overall Study|Adverse Event|0|||
170609300|NCT04167137|616575384|FG003|Overall Study|Adverse Event|0|||
170609301|NCT04167137|616575385|FG004|Overall Study|Adverse Event|0|||
170609302|NCT04167137|616575386|FG005|Overall Study|Adverse Event|1|||
170609303|NCT04167137|616575387|FG006|Overall Study|Adverse Event|0|||
170609304|NCT04167137|616575388|FG007|Overall Study|Adverse Event|1|||
170609305|NCT04167137|616575381|FG000|Overall Study|Physician Decision|0|||
170609306|NCT04167137|616575382|FG001|Overall Study|Physician Decision|0|||
170609307|NCT04167137|616575383|FG002|Overall Study|Physician Decision|0|||
170609308|NCT04167137|616575384|FG003|Overall Study|Physician Decision|1|||
170609309|NCT04167137|616575385|FG004|Overall Study|Physician Decision|0|||
170609310|NCT04167137|616575386|FG005|Overall Study|Physician Decision|0|||
170609311|NCT04167137|616575387|FG006|Overall Study|Physician Decision|1|||
170609312|NCT04167137|616575388|FG007|Overall Study|Physician Decision|0|||
170609313|NCT04167137|616575381|FG000|Overall Study|Death|0|||
170609314|NCT04167137|616575382|FG001|Overall Study|Death|1|||
170609315|NCT04167137|616575383|FG002|Overall Study|Death|0|||
170609316|NCT04167137|616575384|FG003|Overall Study|Death|0|||
170609317|NCT04167137|616575385|FG004|Overall Study|Death|0|||
170609318|NCT04167137|616575386|FG005|Overall Study|Death|0|||
170609319|NCT04167137|616575387|FG006|Overall Study|Death|0|||
170609320|NCT04167137|616575388|FG007|Overall Study|Death|0|||
170609321|NCT04167137|616575381|FG000|Overall Study|Study terminated by Sponsor|0|||
170609322|NCT04167137|616575382|FG001|Overall Study|Study terminated by Sponsor|0|||
170609323|NCT04167137|616575383|FG002|Overall Study|Study terminated by Sponsor|0|||
170609324|NCT04167137|616575384|FG003|Overall Study|Study terminated by Sponsor|0|||
170609325|NCT04167137|616575385|FG004|Overall Study|Study terminated by Sponsor|0|||
170609326|NCT04167137|616575386|FG005|Overall Study|Study terminated by Sponsor|0|||
170609327|NCT04167137|616575387|FG006|Overall Study|Study terminated by Sponsor|0|||
170609328|NCT04167137|616575388|FG007|Overall Study|Study terminated by Sponsor|1|||
170609329|NCT01088399|616575391|FG000|Overall Study|Adverse Event|211|||
170609330|NCT01088399|616575392|FG001|Overall Study|Adverse Event|16|||
170609331|NCT01088399|616575393|FG002|Overall Study|Adverse Event|0|||
170609332|NCT01088399|616575391|FG000|Overall Study|Death|204|||
170609333|NCT01088399|616575392|FG001|Overall Study|Death|45|||
170609334|NCT01088399|616575393|FG002|Overall Study|Death|0|||
170609335|NCT01088399|616575391|FG000|Overall Study|Lack of Efficacy|298|||
170609336|NCT01088399|616575392|FG001|Overall Study|Lack of Efficacy|7|||
170609337|NCT01088399|616575393|FG002|Overall Study|Lack of Efficacy|5|||
170609338|NCT01088399|616575391|FG000|Overall Study|Lost to Follow-up|1070|||
170609339|NCT01088399|616575392|FG001|Overall Study|Lost to Follow-up|278|||
170609340|NCT01088399|616575393|FG002|Overall Study|Lost to Follow-up|58|||
170609341|NCT01088399|616575391|FG000|Overall Study|Physician Decision|531|||
170609342|NCT01088399|616575392|FG001|Overall Study|Physician Decision|88|||
170609343|NCT01088399|616575393|FG002|Overall Study|Physician Decision|16|||
170609344|NCT01088399|616575391|FG000|Overall Study|Withdrawal by Subject|544|||
170609345|NCT01088399|616575392|FG001|Overall Study|Withdrawal by Subject|195|||
170609346|NCT01088399|616575393|FG002|Overall Study|Withdrawal by Subject|33|||
170609347|NCT01088399|616575391|FG000|Overall Study|Change to or start of somatropin therapy|234|||
170609348|NCT01088399|616575392|FG001|Overall Study|Change to or start of somatropin therapy|17|||
170609349|NCT01088399|616575393|FG002|Overall Study|Change to or start of somatropin therapy|12|||
170609350|NCT01088399|616575391|FG000|Overall Study|Sponsor decision|1573|||
170609351|NCT01088399|616575392|FG001|Overall Study|Sponsor decision|298|||
170609352|NCT01088399|616575393|FG002|Overall Study|Sponsor decision|7|||
170609353|NCT01088399|616575391|FG000|Overall Study|Protocol Violation|10|||
170609354|NCT01088399|616575392|FG001|Overall Study|Protocol Violation|1|||
170609355|NCT01088399|616575393|FG002|Overall Study|Protocol Violation|0|||
170609356|NCT01088399|616575391|FG000|Overall Study|Enrollment criteria not met|48|||
170609357|NCT01088399|616575392|FG001|Overall Study|Enrollment criteria not met|119|||
170609358|NCT01088399|616575393|FG002|Overall Study|Enrollment criteria not met|70|||
170609359|NCT01088399|616575391|FG000|Overall Study|Study summary visit not completed|2398|||
170609360|NCT01088399|616575392|FG001|Overall Study|Study summary visit not completed|283|||
170609361|NCT01088399|616575393|FG002|Overall Study|Study summary visit not completed|80|||
170609362|NCT01748825|616575394|FG000|Dose Escalation|Refused further treatment|2|||
170609363|NCT01748825|616575395|FG001|Dose Escalation|Refused further treatment|2|||
170609364|NCT01748825|616575396|FG002|Dose Escalation|Refused further treatment|0|||
170609365|NCT01748825|616575397|FG003|Dose Escalation|Refused further treatment|0|||
170609366|NCT01748825|616575398|FG004|Dose Escalation|Refused further treatment|1|||
170609367|NCT01748825|616575399|FG005|Dose Escalation|Refused further treatment|2|||
170609368|NCT01748825|616575400|FG006|Dose Escalation|Refused further treatment|0|||
170609369|NCT01748825|616575401|FG007|Dose Escalation|Refused further treatment|0|||
170609370|NCT01748825|616575402|FG008|Dose Escalation|Refused further treatment|0|||
170609371|NCT01748825|616575403|FG009|Dose Escalation|Refused further treatment|0|||
170609372|NCT01748825|616575394|FG000|Dose Escalation|Switched to alternative treatment|0|||
170609373|NCT01748825|616575395|FG001|Dose Escalation|Switched to alternative treatment|0|||
170609374|NCT01748825|616575396|FG002|Dose Escalation|Switched to alternative treatment|0|||
170815699|NCT02163499|617332829|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
170815700|NCT02163499|617332829|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
170815701|NCT02163499|617332829|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
170609375|NCT01748825|616575397|FG003|Dose Escalation|Switched to alternative treatment|1|||
170609376|NCT01748825|616575398|FG004|Dose Escalation|Switched to alternative treatment|0|||
170609377|NCT01748825|616575399|FG005|Dose Escalation|Switched to alternative treatment|0|||
170609378|NCT01748825|616575400|FG006|Dose Escalation|Switched to alternative treatment|0|||
170609379|NCT01748825|616575401|FG007|Dose Escalation|Switched to alternative treatment|0|||
170609380|NCT01748825|616575402|FG008|Dose Escalation|Switched to alternative treatment|0|||
170609381|NCT01748825|616575403|FG009|Dose Escalation|Switched to alternative treatment|0|||
170609382|NCT01748825|616575394|FG000|Dose Escalation|Adverse Event|0|||
170609383|NCT01748825|616575395|FG001|Dose Escalation|Adverse Event|0|||
170609384|NCT01748825|616575396|FG002|Dose Escalation|Adverse Event|0|||
170609385|NCT01748825|616575397|FG003|Dose Escalation|Adverse Event|0|||
170609386|NCT01748825|616575398|FG004|Dose Escalation|Adverse Event|0|||
170609387|NCT01748825|616575399|FG005|Dose Escalation|Adverse Event|0|||
170609388|NCT01748825|616575400|FG006|Dose Escalation|Adverse Event|1|||
170609389|NCT01748825|616575401|FG007|Dose Escalation|Adverse Event|0|||
170815702|NCT02163499|617332829|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
170815703|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
170815704|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
170815705|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
170815706|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
170815707|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
170815708|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
170815709|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
170815710|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
170815711|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
170815712|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Death|8|||
170815713|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
170815714|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
170815715|NCT02163499|617332829|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
170815716|NCT04454125|617332832|FG000|Overall Study|Lost to Follow-up|0|||
170815717|NCT04454125|617332833|FG001|Overall Study|Lost to Follow-up|1|||
170815718|NCT00828139|617332835|FG000|Overall Study|Adverse Event|8|||
170815719|NCT00828139|617332836|FG001|Overall Study|Adverse Event|1|||
170815720|NCT00828139|617332837|FG002|Overall Study|Adverse Event|10|||
170815721|NCT00828139|617332838|FG003|Overall Study|Adverse Event|5|||
170815722|NCT00828139|617332835|FG000|Overall Study|Death|2|||
170815723|NCT00828139|617332836|FG001|Overall Study|Death|1|||
170815724|NCT00828139|617332837|FG002|Overall Study|Death|0|||
170815725|NCT00828139|617332838|FG003|Overall Study|Death|2|||
170815726|NCT00828139|617332835|FG000|Overall Study|Refusal unrelated to toxicity|3|||
170609390|NCT01748825|616575402|FG008|Dose Escalation|Adverse Event|0|||
170609391|NCT01748825|616575403|FG009|Dose Escalation|Adverse Event|0|||
170609392|NCT01748825|616575394|FG000|Dose Expansion|Refused further treatment|0|||
170609393|NCT01748825|616575395|FG001|Dose Expansion|Refused further treatment|0|||
170609394|NCT01748825|616575396|FG002|Dose Expansion|Refused further treatment|0|||
170609395|NCT01748825|616575397|FG003|Dose Expansion|Refused further treatment|0|||
170609396|NCT01748825|616575398|FG004|Dose Expansion|Refused further treatment|0|||
170609397|NCT01748825|616575399|FG005|Dose Expansion|Refused further treatment|0|||
170609398|NCT01748825|616575400|FG006|Dose Expansion|Refused further treatment|0|||
170609399|NCT01748825|616575401|FG007|Dose Expansion|Refused further treatment|0|||
170609400|NCT01748825|616575402|FG008|Dose Expansion|Refused further treatment|1|||
170609401|NCT01748825|616575403|FG009|Dose Expansion|Refused further treatment|1|||
170609402|NCT01748825|616575394|FG000|Dose Expansion|Switched to alternative treatment|0|||
170609403|NCT01748825|616575395|FG001|Dose Expansion|Switched to alternative treatment|0|||
170609404|NCT01748825|616575396|FG002|Dose Expansion|Switched to alternative treatment|0|||
170609405|NCT01748825|616575397|FG003|Dose Expansion|Switched to alternative treatment|0|||
170609406|NCT01748825|616575398|FG004|Dose Expansion|Switched to alternative treatment|0|||
170609407|NCT01748825|616575399|FG005|Dose Expansion|Switched to alternative treatment|0|||
170609408|NCT01748825|616575400|FG006|Dose Expansion|Switched to alternative treatment|0|||
170609409|NCT01748825|616575401|FG007|Dose Expansion|Switched to alternative treatment|0|||
170609410|NCT01748825|616575402|FG008|Dose Expansion|Switched to alternative treatment|0|||
170609411|NCT01748825|616575403|FG009|Dose Expansion|Switched to alternative treatment|1|||
170609412|NCT01748825|616575394|FG000|Dose Expansion|Adverse Event|0|||
170609413|NCT01748825|616575395|FG001|Dose Expansion|Adverse Event|0|||
170609414|NCT01748825|616575396|FG002|Dose Expansion|Adverse Event|0|||
170609415|NCT01748825|616575397|FG003|Dose Expansion|Adverse Event|0|||
170609416|NCT01748825|616575398|FG004|Dose Expansion|Adverse Event|0|||
170815727|NCT00828139|617332836|FG001|Overall Study|Refusal unrelated to toxicity|4|||
170815728|NCT00828139|617332837|FG002|Overall Study|Refusal unrelated to toxicity|5|||
170815729|NCT00828139|617332838|FG003|Overall Study|Refusal unrelated to toxicity|3|||
170815730|NCT00828139|617332835|FG000|Overall Study|Disease Progression|24|||
170815731|NCT00828139|617332836|FG001|Overall Study|Disease Progression|33|||
170815732|NCT00828139|617332837|FG002|Overall Study|Disease Progression|35|||
170815733|NCT00828139|617332838|FG003|Overall Study|Disease Progression|39|||
170815734|NCT00828139|617332835|FG000|Overall Study|Other|4|||
170815735|NCT00828139|617332836|FG001|Overall Study|Other|2|||
170815736|NCT00828139|617332837|FG002|Overall Study|Other|5|||
170815737|NCT00828139|617332838|FG003|Overall Study|Other|2|||
170815738|NCT00473512|617332845|FG000|Period 1 (Phase 1)|Adverse Event|0|||
170815739|NCT00473512|617332846|FG001|Period 1 (Phase 1)|Adverse Event|0|||
170815740|NCT00473512|617332847|FG002|Period 1 (Phase 1)|Adverse Event|0|||
170815741|NCT00473512|617332848|FG003|Period 1 (Phase 1)|Adverse Event|5|||
170815742|NCT00473512|617332849|FG004|Period 1 (Phase 1)|Adverse Event|0|||
170815743|NCT00473512|617332845|FG000|Period 1 (Phase 1)|Death|0|||
170815744|NCT00473512|617332846|FG001|Period 1 (Phase 1)|Death|0|||
170815745|NCT00473512|617332847|FG002|Period 1 (Phase 1)|Death|0|||
170815746|NCT00473512|617332848|FG003|Period 1 (Phase 1)|Death|1|||
170609417|NCT01748825|616575399|FG005|Dose Expansion|Adverse Event|0|||
170916272|NCT03901963|617695712|FG000|Overall Study|Randomized but not treated|3|||
170916273|NCT03901963|617695713|FG001|Overall Study|Randomized but not treated|3|||
170916274|NCT05197049|617695714|FG000|Overall Study|Death|0|||
170916275|NCT05197049|617695715|FG001|Overall Study|Death|1|||
170916276|NCT05197049|617695716|FG002|Overall Study|Death|0|||
170916277|NCT05197049|617695714|FG000|Overall Study|Lost to Follow-up|3|||
170609418|NCT01748825|616575400|FG006|Dose Expansion|Adverse Event|0|||
170609419|NCT01748825|616575401|FG007|Dose Expansion|Adverse Event|0|||
170609420|NCT01748825|616575402|FG008|Dose Expansion|Adverse Event|0|||
170609421|NCT01748825|616575403|FG009|Dose Expansion|Adverse Event|3|||
170609422|NCT01748825|616575394|FG000|Dose Expansion|Physician Decision|0|||
170609423|NCT01748825|616575395|FG001|Dose Expansion|Physician Decision|0|||
170609424|NCT01748825|616575396|FG002|Dose Expansion|Physician Decision|0|||
170609425|NCT01748825|616575397|FG003|Dose Expansion|Physician Decision|0|||
170609426|NCT01748825|616575398|FG004|Dose Expansion|Physician Decision|0|||
170609427|NCT01748825|616575399|FG005|Dose Expansion|Physician Decision|0|||
170609428|NCT01748825|616575400|FG006|Dose Expansion|Physician Decision|0|||
170609429|NCT01748825|616575401|FG007|Dose Expansion|Physician Decision|0|||
170609430|NCT01748825|616575402|FG008|Dose Expansion|Physician Decision|1|||
170609431|NCT01748825|616575403|FG009|Dose Expansion|Physician Decision|0|||
170609432|NCT01730586|616575407|FG000|Overall Study|Progressive Disease|2|||
170609433|NCT01730586|616575407|FG000|Overall Study|Inadequate Trial|8|||
170609434|NCT01730586|616575407|FG000|Overall Study|Adverse Event|2|||
170609435|NCT01730586|616575407|FG000|Overall Study|Hospice|1|||
170609436|NCT02461745|616575408|FG000|Overall Study|Lack of Efficacy|9|||
170609437|NCT02461745|616575409|FG001|Overall Study|Lack of Efficacy|1|||
170609438|NCT02461745|616575408|FG000|Overall Study|Lost to Follow-up|2|||
170609439|NCT02461745|616575409|FG001|Overall Study|Lost to Follow-up|2|||
170609440|NCT02461745|616575408|FG000|Overall Study|Withdrawal by Subject|3|||
170609441|NCT02461745|616575409|FG001|Overall Study|Withdrawal by Subject|1|||
170609442|NCT02921087|616575410|FG000|Overall Study|Withdrawal by Subject|0|||
170609443|NCT02921087|616575411|FG001|Overall Study|Withdrawal by Subject|1|||
170609444|NCT00211887|616575412|FG000|Overall Study|Adverse Event|8|||
170609445|NCT00211887|616575413|FG001|Overall Study|Adverse Event|4|||
170609446|NCT00211887|616575414|FG002|Overall Study|Adverse Event|6|||
170609447|NCT00211887|616575412|FG000|Overall Study|Death|1|||
170609448|NCT00211887|616575413|FG001|Overall Study|Death|1|||
170609449|NCT00211887|616575414|FG002|Overall Study|Death|1|||
170609450|NCT00211887|616575412|FG000|Overall Study|Lost to Follow-up|28|||
170609451|NCT00211887|616575413|FG001|Overall Study|Lost to Follow-up|13|||
170609452|NCT00211887|616575414|FG002|Overall Study|Lost to Follow-up|9|||
170609453|NCT00211887|616575412|FG000|Overall Study|Non-medical reason|31|||
170609454|NCT00211887|616575413|FG001|Overall Study|Non-medical reason|14|||
170609455|NCT00211887|616575414|FG002|Overall Study|Non-medical reason|8|||
170609456|NCT00211887|616575412|FG000|Overall Study|Other medical reason|15|||
170609457|NCT00211887|616575413|FG001|Overall Study|Other medical reason|11|||
170609458|NCT00211887|616575414|FG002|Overall Study|Other medical reason|7|||
170609459|NCT00211887|616575412|FG000|Overall Study|Side effects|19|||
170609460|NCT00211887|616575413|FG001|Overall Study|Side effects|13|||
170609461|NCT00211887|616575414|FG002|Overall Study|Side effects|5|||
170609462|NCT03193736|616575415|FG000|Overall Study|Death|2|||
170609463|NCT03193736|616575415|FG000|Overall Study|Withdrawal by Subject|1|||
170609464|NCT03193736|616575415|FG000|Overall Study|Lost to Follow-up|1|||
170609465|NCT03193736|616575415|FG000|Overall Study|implant not received|1|||
170609466|NCT02697435|616575416|FG000|Overall Study|Withdrawal by Subject|1|||
170609467|NCT02697435|616575417|FG001|Overall Study|Withdrawal by Subject|0|||
170609468|NCT02697435|616575416|FG000|Overall Study|Physician Decision|0|||
170609469|NCT02697435|616575417|FG001|Overall Study|Physician Decision|4|||
170609470|NCT03058692|616577473|FG000|Overall Study|Lost to Follow-up|2|||
170609471|NCT03058692|616577474|FG001|Overall Study|Lost to Follow-up|1|||
170609472|NCT03058692|616577473|FG000|Overall Study|Withdrawal by Subject|1|||
170609473|NCT03058692|616577474|FG001|Overall Study|Withdrawal by Subject|1|||
170916278|NCT05197049|617695715|FG001|Overall Study|Lost to Follow-up|1|||
170609474|NCT00806988|616577475|FG000|Overall Study|Death|15|||
170609475|NCT00806988|616577476|FG001|Overall Study|Death|16|||
170609476|NCT00806988|616577475|FG000|Overall Study|Withdrawal by Subject|8|||
170609477|NCT00806988|616577476|FG001|Overall Study|Withdrawal by Subject|8|||
170609478|NCT00806988|616577475|FG000|Overall Study|Lost to Follow-up|4|||
170609479|NCT00806988|616577476|FG001|Overall Study|Lost to Follow-up|19|||
170916279|NCT05197049|617695716|FG002|Overall Study|Lost to Follow-up|0|||
170609480|NCT04775953|616577479|FG000|Overall Study|Lost to Follow-up|6|||
170609481|NCT04775953|616577480|FG001|Overall Study|Lost to Follow-up|11|||
170609482|NCT04775953|616577479|FG000|Overall Study|Death|5|||
170609483|NCT04775953|616577480|FG001|Overall Study|Death|4|||
170609484|NCT04775953|616577479|FG000|Overall Study|Withdrawal by Subject|3|||
170609485|NCT04775953|616577480|FG001|Overall Study|Withdrawal by Subject|3|||
170609486|NCT04775953|616577479|FG000|Overall Study|Protocol Violation|2|||
170609487|NCT04775953|616577480|FG001|Overall Study|Protocol Violation|0|||
170609488|NCT04775953|616577479|FG000|Overall Study|Participant non-compliance|0|||
170916280|NCT05197049|617695714|FG000|Overall Study|Withdrawal by Subject|15|||
170815747|NCT00473512|617332849|FG004|Period 1 (Phase 1)|Death|0|||
170815748|NCT00473512|617332845|FG000|Period 1 (Phase 1)|Disease Progression|1|||
170815749|NCT00473512|617332846|FG001|Period 1 (Phase 1)|Disease Progression|1|||
170815750|NCT00473512|617332847|FG002|Period 1 (Phase 1)|Disease Progression|0|||
170609489|NCT04775953|616577480|FG001|Overall Study|Participant non-compliance|1|||
170609490|NCT01698814|616577481|FG000|Overall Study|Adverse Event|0|||
170609491|NCT01698814|616577482|FG001|Overall Study|Adverse Event|2|||
170609492|NCT01698814|616577481|FG000|Overall Study|Lost to Follow-up|0|||
170609493|NCT01698814|616577482|FG001|Overall Study|Lost to Follow-up|1|||
170609494|NCT01698814|616577481|FG000|Overall Study|Pregnancy|1|||
170609495|NCT01698814|616577482|FG001|Overall Study|Pregnancy|0|||
170609496|NCT01698814|616577481|FG000|Overall Study|Randomized in error|1|||
170609497|NCT01698814|616577482|FG001|Overall Study|Randomized in error|0|||
170609498|NCT03777059|616577483|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
170609499|NCT03777059|616577484|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
170609500|NCT03777059|616577485|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
170609501|NCT03777059|616577486|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
170609502|NCT03777059|616577483|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
170609503|NCT03777059|616577484|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
170609504|NCT03777059|616577485|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
170609505|NCT03777059|616577486|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
170609506|NCT03777059|616577483|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
170609507|NCT03777059|616577484|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
170609508|NCT03777059|616577485|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
170609509|NCT03777059|616577486|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
170609510|NCT03777059|616577483|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
170609511|NCT03777059|616577484|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
170609512|NCT03777059|616577485|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
170609513|NCT03777059|616577486|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
170609514|NCT03777059|616577483|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
170609515|NCT03777059|616577484|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
170609516|NCT03777059|616577485|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
170609517|NCT03777059|616577486|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
170609518|NCT03777059|616577483|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
170609519|NCT03777059|616577484|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
170609520|NCT03777059|616577485|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
170609521|NCT03777059|616577486|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
170609522|NCT03777059|616577483|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
170609523|NCT03777059|616577484|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
170609524|NCT03777059|616577485|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
170609525|NCT03777059|616577486|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
170609526|NCT03777059|616577483|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
170609527|NCT03777059|616577484|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
170609528|NCT03777059|616577485|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
170609529|NCT03777059|616577486|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
170609530|NCT03777059|616577483|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
170609531|NCT03777059|616577484|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
170609532|NCT03777059|616577485|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
170609533|NCT03777059|616577486|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
170609534|NCT03777059|616577483|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
170609535|NCT03777059|616577484|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
170609536|NCT03777059|616577485|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
170609537|NCT03777059|616577486|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
170609538|NCT03777059|616577483|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
170609539|NCT03777059|616577484|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
170609540|NCT03777059|616577485|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
170609541|NCT03777059|616577486|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
170609542|NCT00855959|616577487|FG000|Overall Study|Adverse Event|2|||
170609543|NCT00855959|616577487|FG000|Overall Study|Lost to Follow-up|2|||
170609544|NCT00855959|616577487|FG000|Overall Study|Withdrawal by Subject|3|||
170609545|NCT00855959|616577487|FG000|Overall Study|Pregnancy|1|||
170609546|NCT00855959|616577487|FG000|Overall Study|Incorrect enrolment|1|||
170609547|NCT04014062|616577495|FG000|Period I: Dosing|Medical Grounds|4|||
170815751|NCT00473512|617332848|FG003|Period 1 (Phase 1)|Disease Progression|10|||
170609548|NCT04014062|616577496|FG001|Period I: Dosing|Medical Grounds|5|||
170609549|NCT04014062|616577495|FG000|Period I: Dosing|Withdrawal by Subject|3|||
170815752|NCT00473512|617332849|FG004|Period 1 (Phase 1)|Disease Progression|1|||
170815753|NCT00473512|617332845|FG000|Period 1 (Phase 1)|Other|0|||
170815754|NCT00473512|617332846|FG001|Period 1 (Phase 1)|Other|0|||
170815755|NCT00473512|617332847|FG002|Period 1 (Phase 1)|Other|0|||
170916281|NCT05197049|617695715|FG001|Overall Study|Withdrawal by Subject|3|||
170609550|NCT04014062|616577496|FG001|Period I: Dosing|Withdrawal by Subject|1|||
170609551|NCT01424501|616577497|FG000|Overall Study|Withdrawal by Subject|1|||
170609552|NCT01424501|616577498|FG001|Overall Study|Withdrawal by Subject|0|||
170609553|NCT01424501|616577499|FG002|Overall Study|Withdrawal by Subject|1|||
170609554|NCT01424501|616577500|FG003|Overall Study|Withdrawal by Subject|0|||
170609555|NCT01424501|616577501|FG004|Overall Study|Withdrawal by Subject|0|||
170609556|NCT01424501|616577502|FG005|Overall Study|Withdrawal by Subject|0|||
170609557|NCT01424501|616577497|FG000|Overall Study|Lost to Follow-up|0|||
170609558|NCT01424501|616577498|FG001|Overall Study|Lost to Follow-up|1|||
170609559|NCT01424501|616577499|FG002|Overall Study|Lost to Follow-up|1|||
170609560|NCT01424501|616577500|FG003|Overall Study|Lost to Follow-up|0|||
170609561|NCT01424501|616577501|FG004|Overall Study|Lost to Follow-up|0|||
170609562|NCT01424501|616577502|FG005|Overall Study|Lost to Follow-up|0|||
170609563|NCT02974257|616577512|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
170609564|NCT02974257|616577513|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
170609565|NCT02974257|616577512|FG000|Overall Study|Clinical indication for thiamine|1|||
170609566|NCT02974257|616577513|FG001|Overall Study|Clinical indication for thiamine|0|||
170609567|NCT02974257|616577512|FG000|Overall Study|Already on thiamine|1|||
170609568|NCT02974257|616577513|FG001|Overall Study|Already on thiamine|0|||
170609569|NCT02974257|616577512|FG000|Overall Study|Extubated prior to study drug|0|||
170609570|NCT02974257|616577513|FG001|Overall Study|Extubated prior to study drug|1|||
170609571|NCT02974257|616577512|FG000|Overall Study|Death|0|||
170609572|NCT02974257|616577513|FG001|Overall Study|Death|1|||
170609573|NCT01449006|616577514|FG000|Overall Study|Lost to Follow-up|1|||
170609574|NCT01449006|616577515|FG001|Overall Study|Lost to Follow-up|0|||
170609575|NCT01449006|616577514|FG000|Overall Study|Withdrawal by Subject|1|||
170609576|NCT01449006|616577515|FG001|Overall Study|Withdrawal by Subject|0|||
170609577|NCT01449006|616577514|FG000|Overall Study|Protocol Violation|1|||
170609578|NCT01449006|616577515|FG001|Overall Study|Protocol Violation|0|||
170609579|NCT03574779|616577525|FG000|Overall Study|Screening failure|13|||
170609580|NCT03574779|616577526|FG001|Overall Study|Screening failure|83|||
170609581|NCT00394706|616577529|FG000|Overall Study|Withdrawal by Subject|2|||
170609582|NCT00394706|616577530|FG001|Overall Study|Withdrawal by Subject|0|||
170609583|NCT00394706|616577531|FG002|Overall Study|Withdrawal by Subject|1|||
170609584|NCT00394706|616577532|FG003|Overall Study|Withdrawal by Subject|0|||
170815756|NCT00473512|617332848|FG003|Period 1 (Phase 1)|Other|1|||
170815757|NCT00473512|617332849|FG004|Period 1 (Phase 1)|Other|0|||
170815758|NCT00473512|617332845|FG000|Period 2 (Phase 2)|Adverse Event|0|||
170815759|NCT00473512|617332846|FG001|Period 2 (Phase 2)|Adverse Event|0|||
170815760|NCT00473512|617332847|FG002|Period 2 (Phase 2)|Adverse Event|0|||
170815761|NCT00473512|617332848|FG003|Period 2 (Phase 2)|Adverse Event|1|||
170815762|NCT00473512|617332849|FG004|Period 2 (Phase 2)|Adverse Event|0|||
170815763|NCT00473512|617332845|FG000|Period 2 (Phase 2)|Death|0|||
170815764|NCT00473512|617332846|FG001|Period 2 (Phase 2)|Death|0|||
170815765|NCT00473512|617332847|FG002|Period 2 (Phase 2)|Death|0|||
170815766|NCT00473512|617332848|FG003|Period 2 (Phase 2)|Death|1|||
170815767|NCT00473512|617332849|FG004|Period 2 (Phase 2)|Death|1|||
170815768|NCT00473512|617332845|FG000|Period 2 (Phase 2)|Disease Progression|0|||
170815769|NCT00473512|617332846|FG001|Period 2 (Phase 2)|Disease Progression|2|||
170815770|NCT00473512|617332847|FG002|Period 2 (Phase 2)|Disease Progression|2|||
170815771|NCT00473512|617332848|FG003|Period 2 (Phase 2)|Disease Progression|17|||
170815772|NCT00473512|617332849|FG004|Period 2 (Phase 2)|Disease Progression|1|||
170815773|NCT00473512|617332845|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
170815774|NCT00473512|617332846|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
170815775|NCT00473512|617332847|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
170815776|NCT00473512|617332848|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
170815777|NCT00473512|617332849|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
170815778|NCT00473512|617332845|FG000|Period 2 (Phase 2)|Other|1|||
170815779|NCT00473512|617332846|FG001|Period 2 (Phase 2)|Other|0|||
170815780|NCT00473512|617332847|FG002|Period 2 (Phase 2)|Other|0|||
170815781|NCT00473512|617332848|FG003|Period 2 (Phase 2)|Other|3|||
170815782|NCT00473512|617332849|FG004|Period 2 (Phase 2)|Other|0|||
170815783|NCT00946088|617332850|FG000|Overall Study|Withdrawal by Subject|0|||
170815784|NCT00946088|617332851|FG001|Overall Study|Withdrawal by Subject|1|||
170815785|NCT01322347|617332855|FG000|Overall Study|Adverse Event|7|||
170815786|NCT01322347|617332856|FG001|Overall Study|Adverse Event|2|||
170815787|NCT01322347|617332855|FG000|Overall Study|Death|5|||
170815788|NCT01322347|617332856|FG001|Overall Study|Death|3|||
170815789|NCT01322347|617332855|FG000|Overall Study|Physician Decision|2|||
170815790|NCT01322347|617332856|FG001|Overall Study|Physician Decision|1|||
170815791|NCT01322347|617332855|FG000|Overall Study|Protocol Violation|5|||
170609585|NCT00394706|616577533|FG004|Overall Study|Withdrawal by Subject|0|||
170609586|NCT00394706|616577534|FG005|Overall Study|Withdrawal by Subject|2|||
170609587|NCT00394706|616577535|FG006|Overall Study|Withdrawal by Subject|1|||
170815792|NCT01322347|617332856|FG001|Overall Study|Protocol Violation|2|||
170815793|NCT01322347|617332855|FG000|Overall Study|Withdrawal by Subject|1|||
170815794|NCT01322347|617332856|FG001|Overall Study|Withdrawal by Subject|4|||
170609588|NCT00394706|616577536|FG007|Overall Study|Withdrawal by Subject|0|||
170609589|NCT00394706|616577529|FG000|Overall Study|Lost to Follow-up|2|||
170609590|NCT00394706|616577530|FG001|Overall Study|Lost to Follow-up|2|||
170609591|NCT00394706|616577531|FG002|Overall Study|Lost to Follow-up|8|||
170609592|NCT00394706|616577532|FG003|Overall Study|Lost to Follow-up|1|||
170609593|NCT00394706|616577533|FG004|Overall Study|Lost to Follow-up|2|||
170609594|NCT00394706|616577534|FG005|Overall Study|Lost to Follow-up|5|||
170609595|NCT00394706|616577535|FG006|Overall Study|Lost to Follow-up|2|||
170609596|NCT00394706|616577536|FG007|Overall Study|Lost to Follow-up|0|||
170609597|NCT02003534|616577541|FG000|Overall Study|Lost to Follow-up|47|||
170609598|NCT03250182|616577542|FG000|Overall Study|Withdrawal by Subject|1|||
170609599|NCT03040674|616577543|FG000|Overall Study|Lost to Follow-up|225|||
170609600|NCT03040674|616577543|FG000|Overall Study|Death|23|||
170609601|NCT02206035|616577545|FG000|Overall Study|Physician Decision|10|||
170609602|NCT02206035|616577546|FG001|Overall Study|Physician Decision|0|||
170609603|NCT02206035|616577547|FG002|Overall Study|Physician Decision|175|||
170609604|NCT01934010|616577548|FG000|Overall Study|Adverse Event|1|||
170609605|NCT01934010|616577549|FG001|Overall Study|Adverse Event|1|||
170609606|NCT01934010|616577550|FG002|Overall Study|Adverse Event|0|||
170609607|NCT01934010|616577548|FG000|Overall Study|Withdrawal by Subject|15|||
170609608|NCT01934010|616577549|FG001|Overall Study|Withdrawal by Subject|6|||
170609609|NCT01934010|616577550|FG002|Overall Study|Withdrawal by Subject|2|||
170609610|NCT01934010|616577548|FG000|Overall Study|Lost to Follow-up|7|||
170609611|NCT01934010|616577549|FG001|Overall Study|Lost to Follow-up|4|||
170609612|NCT01934010|616577550|FG002|Overall Study|Lost to Follow-up|0|||
170609613|NCT04112303|616577551|FG000|Overall Study|Death|1|||
170609614|NCT02703324|616577558|FG000|Period Two|Withdrawal by Subject|0|||
170609615|NCT02703324|616577559|FG001|Period Two|Withdrawal by Subject|0|||
170609616|NCT02703324|616577560|FG002|Period Two|Withdrawal by Subject|1|||
170609617|NCT02703324|616577561|FG003|Period Two|Withdrawal by Subject|0|||
170609618|NCT02703324|616577562|FG004|Period Two|Withdrawal by Subject|0|||
170609619|NCT02703324|616577563|FG005|Period Two|Withdrawal by Subject|0|||
170609620|NCT03517228|616577566|FG000|Overall Study|Withdrawal by Subject|2|||
170609621|NCT03517228|616577566|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
170609622|NCT03517228|616577566|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
170609623|NCT03517228|616577566|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
170609624|NCT03517228|616577566|FG000|Overall Study|Canceled due to device being updated|1|||
170609625|NCT03517228|616577566|FG000|Overall Study|No V Cares in stock|1|||
170609626|NCT03517228|616577566|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
170609627|NCT03781414|616577571|FG000|Overall Study|Study terminated by sponsor|39|||
170609628|NCT03781414|616577572|FG001|Overall Study|Study terminated by sponsor|34|||
170609629|NCT03781414|616577573|FG002|Overall Study|Study terminated by sponsor|25|||
170609630|NCT03781414|616577571|FG000|Overall Study|Adverse Event|3|||
170609631|NCT03781414|616577572|FG001|Overall Study|Adverse Event|6|||
170609632|NCT03781414|616577573|FG002|Overall Study|Adverse Event|3|||
170609633|NCT03781414|616577571|FG000|Overall Study|Physician Decision|2|||
170609634|NCT03781414|616577572|FG001|Overall Study|Physician Decision|0|||
170609635|NCT03781414|616577573|FG002|Overall Study|Physician Decision|1|||
170609636|NCT03781414|616577571|FG000|Overall Study|Withdrawal by Subject|2|||
170609637|NCT03781414|616577572|FG001|Overall Study|Withdrawal by Subject|3|||
170609638|NCT03781414|616577573|FG002|Overall Study|Withdrawal by Subject|3|||
170609639|NCT03781414|616577571|FG000|Overall Study|Death|1|||
170609640|NCT03781414|616577572|FG001|Overall Study|Death|4|||
170609641|NCT03781414|616577573|FG002|Overall Study|Death|0|||
170609642|NCT03781414|616577571|FG000|Overall Study|Lost to Follow-up|1|||
170609643|NCT03781414|616577572|FG001|Overall Study|Lost to Follow-up|1|||
170609644|NCT03781414|616577573|FG002|Overall Study|Lost to Follow-up|0|||
170609645|NCT01620762|616577574|FG000|Overall Study|Protocol Violation|1|||
170609646|NCT01620762|616577575|FG001|Overall Study|Protocol Violation|1|||
170609647|NCT01620762|616577576|FG002|Overall Study|Protocol Violation|1|||
170609648|NCT01620762|616577574|FG000|Overall Study|Adverse Event|9|||
170609649|NCT01620762|616577575|FG001|Overall Study|Adverse Event|5|||
170916282|NCT05197049|617695716|FG002|Overall Study|Withdrawal by Subject|1|||
170916283|NCT05197049|617695714|FG000|Overall Study|GCP non-compliance|1|||
170609650|NCT01620762|616577576|FG002|Overall Study|Adverse Event|2|||
170609651|NCT01620762|616577574|FG000|Overall Study|Withdrawal by Subject|23|||
170609652|NCT01620762|616577575|FG001|Overall Study|Withdrawal by Subject|26|||
170609653|NCT01620762|616577576|FG002|Overall Study|Withdrawal by Subject|27|||
170609654|NCT01620762|616577574|FG000|Overall Study|Lost to Follow-up|11|||
170916284|NCT05197049|617695715|FG001|Overall Study|GCP non-compliance|2|||
170916285|NCT05197049|617695716|FG002|Overall Study|GCP non-compliance|0|||
170916286|NCT05488847|617695717|FG000|Overall Study|Lost to Follow-up|3|||
170609655|NCT01620762|616577575|FG001|Overall Study|Lost to Follow-up|17|||
170609656|NCT01620762|616577576|FG002|Overall Study|Lost to Follow-up|10|||
170609657|NCT01620762|616577574|FG000|Overall Study|Protocol deviation|1|||
170609658|NCT01620762|616577575|FG001|Overall Study|Protocol deviation|1|||
170609659|NCT01620762|616577576|FG002|Overall Study|Protocol deviation|6|||
170609660|NCT01620762|616577574|FG000|Overall Study|Subject deterioration|0|||
170916287|NCT05488847|617695718|FG001|Overall Study|Lost to Follow-up|2|||
170609661|NCT01620762|616577575|FG001|Overall Study|Subject deterioration|1|||
170609662|NCT01620762|616577576|FG002|Overall Study|Subject deterioration|1|||
170609663|NCT01620762|616577574|FG000|Overall Study|Non-specified|3|||
170609664|NCT01620762|616577575|FG001|Overall Study|Non-specified|6|||
170609665|NCT01620762|616577576|FG002|Overall Study|Non-specified|5|||
170609666|NCT01620762|616577574|FG000|Overall Study|Use of prohibted therapies|0|||
170609667|NCT01620762|616577575|FG001|Overall Study|Use of prohibted therapies|1|||
170609668|NCT01620762|616577576|FG002|Overall Study|Use of prohibted therapies|1|||
170609669|NCT00705146|616577577|FG000|Overall Study|Lost to Follow-up|1|||
170609670|NCT00705146|616577578|FG001|Overall Study|Lost to Follow-up|1|||
170609671|NCT03664765|616577581|FG000|Overall Study|Withdrawal by Subject|4|||
170609672|NCT03664765|616577582|FG001|Overall Study|Withdrawal by Subject|1|||
170609673|NCT03664765|616577581|FG000|Overall Study|Lost to Follow-up|0|||
170609674|NCT03664765|616577582|FG001|Overall Study|Lost to Follow-up|1|||
170609675|NCT05392803|616577583|FG000|Overall Study|Lost to Follow-up|0|||
170609676|NCT05392803|616577584|FG001|Overall Study|Lost to Follow-up|2|||
170609677|NCT01240135|616577585|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
170609678|NCT01240135|616577586|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
170609679|NCT01240135|616577585|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
170609680|NCT01240135|616577586|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
170609681|NCT01772576|616577587|FG000|Overall Study|Death|15|||
170609682|NCT01772576|616577587|FG000|Overall Study|Protocol Violation|1|||
170609683|NCT01772576|616577587|FG000|Overall Study|Lost to Follow-up|3|||
170609684|NCT01772576|616577587|FG000|Overall Study|Study device not used|3|||
170609685|NCT01772576|616577587|FG000|Overall Study|Adverse Event|6|||
170609686|NCT01772576|616577587|FG000|Overall Study|Withdrawal by Subject|6|||
170609687|NCT00923845|616577590|FG000|Induction Therapy|Poor performance status|0|||
170609688|NCT00923845|616577591|FG001|Induction Therapy|Poor performance status|2|||
170609689|NCT03688620|616577596|FG000|Overall Study|Other|0|||
170609690|NCT03688620|616577597|FG001|Overall Study|Other|0|||
170609691|NCT03688620|616577598|FG002|Overall Study|Other|1|||
170609692|NCT03688620|616577596|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
170609693|NCT03688620|616577597|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
170609694|NCT03688620|616577598|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
170609695|NCT03688620|616577596|FG000|Overall Study|Lost to Follow-up|16|||
170609696|NCT03688620|616577597|FG001|Overall Study|Lost to Follow-up|0|||
170609697|NCT03688620|616577598|FG002|Overall Study|Lost to Follow-up|1|||
170609698|NCT03688620|616577596|FG000|Overall Study|Withdrawal by Subject|0|||
170609699|NCT03688620|616577597|FG001|Overall Study|Withdrawal by Subject|0|||
170609700|NCT03688620|616577598|FG002|Overall Study|Withdrawal by Subject|6|||
170609701|NCT00428389|616577601|FG000|Core Phase|Adverse Event|6|||
170609702|NCT00428389|616577602|FG001|Core Phase|Adverse Event|4|||
170609703|NCT00428389|616577601|FG000|Core Phase|Lack of Efficacy|2|||
170609704|NCT00428389|616577602|FG001|Core Phase|Lack of Efficacy|0|||
170609705|NCT00428389|616577601|FG000|Core Phase|Abnormal test procedure result(s)|0|||
170609706|NCT00428389|616577602|FG001|Core Phase|Abnormal test procedure result(s)|1|||
170609707|NCT00428389|616577601|FG000|Core Phase|Withdrawal by Subject|3|||
170609708|NCT00428389|616577602|FG001|Core Phase|Withdrawal by Subject|4|||
170609709|NCT00428389|616577601|FG000|Core Phase|Protocol deviation|0|||
170609710|NCT00428389|616577602|FG001|Core Phase|Protocol deviation|2|||
170609711|NCT00428389|616577601|FG000|Extension Phase|Adverse Event|17|||
170609712|NCT00428389|616577602|FG001|Extension Phase|Adverse Event|11|||
170609713|NCT00428389|616577601|FG000|Extension Phase|Lack of Efficacy|4|||
170609714|NCT00428389|616577602|FG001|Extension Phase|Lack of Efficacy|3|||
170609715|NCT00428389|616577601|FG000|Extension Phase|Withdrawal by Subject|6|||
170609716|NCT00428389|616577602|FG001|Extension Phase|Withdrawal by Subject|6|||
170609717|NCT00428389|616577601|FG000|Extension Phase|Lost to Follow-up|0|||
170609718|NCT00428389|616577602|FG001|Extension Phase|Lost to Follow-up|3|||
170609719|NCT00428389|616577601|FG000|Extension Phase|Death|1|||
170609720|NCT00428389|616577602|FG001|Extension Phase|Death|0|||
170916288|NCT04109924|617695719|FG000|Overall Study|Withdrawal by Subject|3|||
170916289|NCT04109924|617695719|FG000|Overall Study|Physician Decision|1|||
170916290|NCT04109924|617695719|FG000|Overall Study|Incomplete baseline imaging|2|||
170609721|NCT00428389|616577601|FG000|Extension Phase|Protocol Violation|3|||
170609722|NCT00428389|616577602|FG001|Extension Phase|Protocol Violation|2|||
170609723|NCT00428389|616577601|FG000|Extension Phase|Administrative problems|1|||
170609724|NCT00428389|616577602|FG001|Extension Phase|Administrative problems|1|||
170609725|NCT04378114|616577603|FG000|Overall Study|Withdrawal by Subject|5|||
170916291|NCT04109924|617695719|FG000|Overall Study|Death|1|||
170609726|NCT00830180|616577604|FG000|Overall Study|Adverse Event|6|||
170609727|NCT00830180|616577604|FG000|Overall Study|Death|11|||
170609728|NCT00830180|616577604|FG000|Overall Study|Insufficient clinical response|1|||
170609729|NCT00830180|616577604|FG000|Overall Study|Withdrawal by Subject|5|||
170609730|NCT00830180|616577604|FG000|Overall Study|Progressive disease|2|||
170609731|NCT00830180|616577604|FG000|Overall Study|Other - Unspecified|1|||
170609732|NCT02669121|616577605|FG000|Overall Study|Adverse Event|4|||
170916292|NCT06352840|617695720|FG000|Overall Study|Lost to Follow-up|16|||
170916293|NCT06352840|617695721|FG001|Overall Study|Lost to Follow-up|18|||
170916294|NCT04711135|617695729|FG000|Overall Study|Physician Decision|0|||
170916295|NCT04711135|617695730|FG001|Overall Study|Physician Decision|1|||
170916296|NCT04711135|617695729|FG000|Overall Study|Ongoing treatment|0|||
170916297|NCT04711135|617695730|FG001|Overall Study|Ongoing treatment|1|||
170916298|NCT06036108|617695731|FG000|Overall Study|Adverse Event|4|||
170916299|NCT06036108|617695732|FG001|Overall Study|Adverse Event|4|||
170916300|NCT06036108|617695731|FG000|Overall Study|Protocol Violation|1|||
170916301|NCT06036108|617695732|FG001|Overall Study|Protocol Violation|0|||
170916302|NCT06036108|617695731|FG000|Overall Study|Withdrawal by Subject|1|||
170916303|NCT06036108|617695732|FG001|Overall Study|Withdrawal by Subject|2|||
170916304|NCT06036108|617695731|FG000|Overall Study|Meets Study-Specific Discontinuation Criteria|1|||
170609733|NCT02669121|616577606|FG001|Overall Study|Adverse Event|5|||
170609734|NCT02669121|616577605|FG000|Overall Study|Lost to Follow-up|15|||
170609735|NCT02669121|616577606|FG001|Overall Study|Lost to Follow-up|27|||
170609736|NCT02669121|616577605|FG000|Overall Study|Withdrawal by Subject|132|||
170609737|NCT02669121|616577606|FG001|Overall Study|Withdrawal by Subject|140|||
170609738|NCT02669121|616577605|FG000|Overall Study|Pregnancy|0|||
170609739|NCT02669121|616577606|FG001|Overall Study|Pregnancy|1|||
170609740|NCT02669121|616577605|FG000|Overall Study|Discharged from US Military Active Service|117|||
170609741|NCT02669121|616577606|FG001|Overall Study|Discharged from US Military Active Service|91|||
170609742|NCT02669121|616577605|FG000|Overall Study|Reason not Specified|22|||
170609743|NCT02669121|616577606|FG001|Overall Study|Reason not Specified|18|||
170609744|NCT03216746|616577607|FG000|Overall Study|Lost to Follow-up|6|||
170609745|NCT03216746|616577608|FG001|Overall Study|Lost to Follow-up|8|||
170609746|NCT03216746|616577609|FG002|Overall Study|Lost to Follow-up|5|||
170609747|NCT03216746|616577610|FG003|Overall Study|Lost to Follow-up|6|||
170609748|NCT04384523|616577611|FG000|Overall Study|Lost to Follow-up|0|||
170609749|NCT04384523|616577612|FG001|Overall Study|Lost to Follow-up|0|||
170609750|NCT04384523|616577613|FG002|Overall Study|Lost to Follow-up|0|||
170609751|NCT04384523|616577614|FG003|Overall Study|Lost to Follow-up|0|||
170609752|NCT04384523|616577615|FG004|Overall Study|Lost to Follow-up|0|||
170609753|NCT04384523|616577616|FG005|Overall Study|Lost to Follow-up|1|||
170609754|NCT04384523|616577611|FG000|Overall Study|Protocol Violation|0|||
170609755|NCT04384523|616577612|FG001|Overall Study|Protocol Violation|1|||
170609756|NCT04384523|616577613|FG002|Overall Study|Protocol Violation|0|||
170609757|NCT04384523|616577614|FG003|Overall Study|Protocol Violation|0|||
170609758|NCT04384523|616577615|FG004|Overall Study|Protocol Violation|0|||
170609759|NCT04384523|616577616|FG005|Overall Study|Protocol Violation|0|||
170609760|NCT04384523|616577611|FG000|Overall Study|Withdrawal by Subject|1|||
170609761|NCT04384523|616577612|FG001|Overall Study|Withdrawal by Subject|0|||
170609762|NCT04384523|616577613|FG002|Overall Study|Withdrawal by Subject|0|||
170609763|NCT04384523|616577614|FG003|Overall Study|Withdrawal by Subject|0|||
170609764|NCT04384523|616577615|FG004|Overall Study|Withdrawal by Subject|0|||
170609765|NCT04384523|616577616|FG005|Overall Study|Withdrawal by Subject|0|||
170609766|NCT01320202|616577617|FG000|Overall Study|Adverse Event|5|||
170609767|NCT01320202|616577618|FG001|Overall Study|Adverse Event|5|||
170609768|NCT01320202|616577617|FG000|Overall Study|Death|5|||
170609769|NCT01320202|616577618|FG001|Overall Study|Death|3|||
170609770|NCT01320202|616577617|FG000|Overall Study|Lost to Follow-up|1|||
170609771|NCT01320202|616577618|FG001|Overall Study|Lost to Follow-up|0|||
170609772|NCT01320202|616577617|FG000|Overall Study|Physician Decision|3|||
170609773|NCT01320202|616577618|FG001|Overall Study|Physician Decision|1|||
170609774|NCT01320202|616577617|FG000|Overall Study|Protocol Violation|2|||
170609775|NCT01320202|616577618|FG001|Overall Study|Protocol Violation|1|||
170609776|NCT01320202|616577617|FG000|Overall Study|Withdrawal by Subject|10|||
170609777|NCT01320202|616577618|FG001|Overall Study|Withdrawal by Subject|3|||
170609778|NCT01320202|616577617|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
170609779|NCT01320202|616577618|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
170609780|NCT01320202|616577617|FG000|Overall Study|kidney transplant|1|||
170609781|NCT01320202|616577618|FG001|Overall Study|kidney transplant|2|||
170609782|NCT01320202|616577617|FG000|Overall Study|blood transfusion|1|||
170609783|NCT01320202|616577618|FG001|Overall Study|blood transfusion|7|||
170609784|NCT01320202|616577617|FG000|Overall Study|moved/changed dialysis|5|||
170609785|NCT01320202|616577618|FG001|Overall Study|moved/changed dialysis|2|||
170609786|NCT01320202|616577617|FG000|Overall Study|sponsor request|2|||
170609787|NCT01320202|616577618|FG001|Overall Study|sponsor request|0|||
170609788|NCT01320202|616577617|FG000|Overall Study|ineligible|3|||
170609789|NCT01320202|616577618|FG001|Overall Study|ineligible|0|||
170609790|NCT01320202|616577617|FG000|Overall Study|regained renal function|1|||
170609791|NCT01320202|616577618|FG001|Overall Study|regained renal function|0|||
170609792|NCT00635882|616577619|FG000|Overall Study|Protocol Violation|1|||
170609793|NCT00635882|616577620|FG001|Overall Study|Protocol Violation|0|||
170609794|NCT00635882|616577621|FG002|Overall Study|Protocol Violation|0|||
170916305|NCT06036108|617695732|FG001|Overall Study|Meets Study-Specific Discontinuation Criteria|0|||
170609795|NCT00635882|616577622|FG003|Overall Study|Protocol Violation|0|||
170916306|NCT06036108|617695731|FG000|Overall Study|Other|0|||
170609796|NCT00635882|616577623|FG004|Overall Study|Protocol Violation|0|||
170609797|NCT00635882|616577624|FG005|Overall Study|Protocol Violation|0|||
170609798|NCT00392990|616577625|FG000|Treatment on Study|Adverse Event|3|||
170916307|NCT06036108|617695732|FG001|Overall Study|Other|1|||
170916308|NCT03766009|617695734|FG000|Usual Care|Death|0|||
170916309|NCT03766009|617695735|FG001|Usual Care|Death|0|||
170916310|NCT03766009|617695736|FG002|Usual Care|Death|0|||
170916311|NCT03766009|617695737|FG003|Usual Care|Death|1|||
170916312|NCT03766009|617695738|FG004|Usual Care|Death|0|||
170916313|NCT03766009|617695739|FG005|Usual Care|Death|0|||
170916314|NCT03766009|617695734|FG000|Usual Care|Lost to Follow-up|0|||
170916315|NCT03766009|617695735|FG001|Usual Care|Lost to Follow-up|0|||
170916316|NCT03766009|617695736|FG002|Usual Care|Lost to Follow-up|0|||
170815795|NCT01322347|617332855|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
170609799|NCT00392990|616577626|FG001|Treatment on Study|Adverse Event|1|||
170609800|NCT00392990|616577625|FG000|Follow up for 2 Years|Death|4|||
170609801|NCT00392990|616577626|FG001|Follow up for 2 Years|Death|0|||
170609802|NCT00986362|616577627|FG000|Overall Study|Death|2|||
170609803|NCT00986362|616577628|FG001|Overall Study|Death|0|||
170609804|NCT00986362|616577627|FG000|Overall Study|Lost to Follow-up|0|||
170609805|NCT00986362|616577628|FG001|Overall Study|Lost to Follow-up|1|||
170609806|NCT02006979|616577629|FG000|Overall Study|Withdrawal by Subject|1|||
170609807|NCT02006979|616577630|FG001|Overall Study|Withdrawal by Subject|1|||
170609808|NCT02006979|616577629|FG000|Overall Study|Protocol Violation|0|||
170609809|NCT02006979|616577630|FG001|Overall Study|Protocol Violation|1|||
170609810|NCT01771250|616577631|FG000|Period 1|Met exclusion criteria|1|||
170609811|NCT01771250|616577632|FG001|Period 1|Met exclusion criteria|0|||
170609812|NCT00850538|616577633|FG000|Overall Study|unable/unwilling to complete MRI|13|||
170609813|NCT00850538|616577633|FG000|Overall Study|specimen missed due to scheduling error|14|||
170609814|NCT00850538|616577633|FG000|Overall Study|specimen unusable|7|||
170609815|NCT00850538|616577633|FG000|Overall Study|Withdrawal by Subject|3|||
170609816|NCT00850538|616577633|FG000|Overall Study|radiology error|2|||
170609817|NCT00850538|616577633|FG000|Overall Study|Protocol Violation|2|||
170609818|NCT00852241|616577642|FG000|Overall Study|Physician Decision|18|||
170609819|NCT04171219|616579407|FG000|Overall Study|Adverse Event|1|||
170609820|NCT04171219|616579408|FG001|Overall Study|Adverse Event|0|||
170609821|NCT04171219|616579407|FG000|Overall Study|Death|0|||
170609822|NCT04171219|616579408|FG001|Overall Study|Death|1|||
170609823|NCT04171219|616579407|FG000|Overall Study|Lack of Efficacy|9|||
170609824|NCT04171219|616579408|FG001|Overall Study|Lack of Efficacy|13|||
170609825|NCT04171219|616579407|FG000|Overall Study|Withdrawal by Subject|1|||
170609826|NCT04171219|616579408|FG001|Overall Study|Withdrawal by Subject|2|||
170609827|NCT04171219|616579407|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
170609828|NCT04171219|616579408|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
170609829|NCT04171219|616579407|FG000|Overall Study|Clinical PD/Patient choice|1|||
170609830|NCT04171219|616579408|FG001|Overall Study|Clinical PD/Patient choice|0|||
170609831|NCT04171219|616579407|FG000|Overall Study|Toxicity/ Patient choice|1|||
170609832|NCT04171219|616579408|FG001|Overall Study|Toxicity/ Patient choice|0|||
170609833|NCT04809285|616579409|FG000|Phase 1|Lost to Follow-up|6|||
170609834|NCT04809285|616579409|FG000|Phase 1|Protocol Violation|2|||
170609835|NCT04809285|616579409|FG000|Phase 1|Physician Decision|3|||
170609836|NCT04809285|616579409|FG000|Phase 1|Withdrawal by Subject|29|||
170609837|NCT04809285|616579409|FG000|Phase 2|Protocol Violation|3|||
170609838|NCT04809285|616579409|FG000|Phase 2|Withdrawal by Subject|4|||
170609839|NCT04506502|616579411|FG000|Overall Study|Withdrawal by Subject|1|||
170609840|NCT04506502|616579411|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
170609841|NCT03350815|616579412|FG000|Period 1|Adverse Event|10|||
170609842|NCT03350815|616579413|FG001|Period 1|Adverse Event|0|||
170609843|NCT03350815|616579414|FG002|Period 1|Adverse Event|0|||
170815796|NCT01322347|617332856|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
170815797|NCT01322347|617332855|FG000|Overall Study|blood transfusion|5|||
170815798|NCT01322347|617332856|FG001|Overall Study|blood transfusion|5|||
170609844|NCT03350815|616579415|FG003|Period 1|Adverse Event|0|||
170609845|NCT03350815|616579412|FG000|Period 1|Technical problems|1|||
170609846|NCT03350815|616579413|FG001|Period 1|Technical problems|0|||
170609847|NCT03350815|616579414|FG002|Period 1|Technical problems|0|||
170609848|NCT03350815|616579415|FG003|Period 1|Technical problems|0|||
170609849|NCT03350815|616579412|FG000|Period 1|Lost to Follow-up|3|||
170815799|NCT01322347|617332855|FG000|Overall Study|sponsor decision|1|||
170815800|NCT01322347|617332856|FG001|Overall Study|sponsor decision|3|||
170815801|NCT01322347|617332855|FG000|Overall Study|ineligible|6|||
170815802|NCT01322347|617332856|FG001|Overall Study|ineligible|3|||
170815803|NCT01322347|617332855|FG000|Overall Study|kidney transplant|3|||
170815804|NCT01322347|617332856|FG001|Overall Study|kidney transplant|1|||
170815805|NCT01322347|617332855|FG000|Overall Study|study drug withheld > 12 wks|0|||
170815806|NCT01322347|617332856|FG001|Overall Study|study drug withheld > 12 wks|1|||
170815807|NCT01322347|617332855|FG000|Overall Study|moved/changed dialysis|2|||
170815808|NCT01322347|617332856|FG001|Overall Study|moved/changed dialysis|4|||
170815809|NCT01369147|617332857|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
170815810|NCT01369147|617332858|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
170815811|NCT01369147|617332859|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
170815812|NCT02137785|617332860|FG000|Overall Study|Lost to Follow-up|1|||
170815813|NCT02137785|617332861|FG001|Overall Study|Lost to Follow-up|0|||
170653074|NCT04090411|616743391|FG007|Induction Period|Protocol Violation|0|||
170815814|NCT02137785|617332860|FG000|Overall Study|Withdrawal by Subject|1|||
170815815|NCT02137785|617332861|FG001|Overall Study|Withdrawal by Subject|4|||
170815816|NCT02137785|617332860|FG000|Overall Study|subject moved out of state|1|||
170815817|NCT02137785|617332861|FG001|Overall Study|subject moved out of state|0|||
170609850|NCT03350815|616579413|FG001|Period 1|Lost to Follow-up|0|||
170609851|NCT03350815|616579414|FG002|Period 1|Lost to Follow-up|0|||
170609852|NCT03350815|616579415|FG003|Period 1|Lost to Follow-up|0|||
170609853|NCT03350815|616579412|FG000|Period 1|Physician Decision|1|||
170609854|NCT03350815|616579413|FG001|Period 1|Physician Decision|0|||
170609855|NCT03350815|616579414|FG002|Period 1|Physician Decision|0|||
170609856|NCT03350815|616579415|FG003|Period 1|Physician Decision|0|||
170609857|NCT03350815|616579412|FG000|Period 1|Withdrawal by Subject|8|||
170609858|NCT03350815|616579413|FG001|Period 1|Withdrawal by Subject|0|||
170609859|NCT03350815|616579414|FG002|Period 1|Withdrawal by Subject|0|||
170609860|NCT03350815|616579415|FG003|Period 1|Withdrawal by Subject|0|||
170609861|NCT03350815|616579412|FG000|Period 1|Lack of Efficacy|15|||
170609862|NCT03350815|616579413|FG001|Period 1|Lack of Efficacy|0|||
170609863|NCT03350815|616579414|FG002|Period 1|Lack of Efficacy|0|||
170609864|NCT03350815|616579415|FG003|Period 1|Lack of Efficacy|0|||
170609865|NCT03350815|616579412|FG000|Period 1|Non-compliance with study treatment|2|||
170609866|NCT03350815|616579413|FG001|Period 1|Non-compliance with study treatment|0|||
170609867|NCT03350815|616579414|FG002|Period 1|Non-compliance with study treatment|0|||
170609868|NCT03350815|616579415|FG003|Period 1|Non-compliance with study treatment|0|||
170609869|NCT03350815|616579412|FG000|Period 1|Protocol Violation|3|||
170609870|NCT03350815|616579413|FG001|Period 1|Protocol Violation|0|||
170609871|NCT03350815|616579414|FG002|Period 1|Protocol Violation|0|||
170609872|NCT03350815|616579415|FG003|Period 1|Protocol Violation|0|||
170609873|NCT03350815|616579412|FG000|Period 2|Adverse Event|0|||
170609874|NCT03350815|616579413|FG001|Period 2|Adverse Event|3|||
170609875|NCT03350815|616579414|FG002|Period 2|Adverse Event|5|||
170609876|NCT03350815|616579415|FG003|Period 2|Adverse Event|0|||
170609877|NCT03350815|616579412|FG000|Period 2|Technical problem|0|||
170609878|NCT03350815|616579413|FG001|Period 2|Technical problem|1|||
170609879|NCT03350815|616579414|FG002|Period 2|Technical problem|0|||
170609880|NCT03350815|616579415|FG003|Period 2|Technical problem|0|||
170609881|NCT03350815|616579412|FG000|Period 2|Lost to Follow-up|0|||
170609882|NCT03350815|616579413|FG001|Period 2|Lost to Follow-up|3|||
170609883|NCT03350815|616579414|FG002|Period 2|Lost to Follow-up|3|||
170609884|NCT03350815|616579415|FG003|Period 2|Lost to Follow-up|0|||
170609885|NCT03350815|616579412|FG000|Period 2|Physician Decision|0|||
170609886|NCT03350815|616579413|FG001|Period 2|Physician Decision|0|||
170609887|NCT03350815|616579414|FG002|Period 2|Physician Decision|1|||
170609888|NCT03350815|616579415|FG003|Period 2|Physician Decision|0|||
170609889|NCT03350815|616579412|FG000|Period 2|Withdrawal by Subject|0|||
170609890|NCT03350815|616579413|FG001|Period 2|Withdrawal by Subject|3|||
170609891|NCT03350815|616579414|FG002|Period 2|Withdrawal by Subject|4|||
170609892|NCT03350815|616579415|FG003|Period 2|Withdrawal by Subject|0|||
170609893|NCT03350815|616579412|FG000|Period 2|Lack of Efficacy|0|||
170609894|NCT03350815|616579413|FG001|Period 2|Lack of Efficacy|6|||
170609895|NCT03350815|616579414|FG002|Period 2|Lack of Efficacy|2|||
170609896|NCT03350815|616579415|FG003|Period 2|Lack of Efficacy|0|||
170609897|NCT03350815|616579412|FG000|Period 2|Protocol Violation|0|||
170609898|NCT03350815|616579413|FG001|Period 2|Protocol Violation|0|||
170609899|NCT03350815|616579414|FG002|Period 2|Protocol Violation|1|||
170609900|NCT03350815|616579415|FG003|Period 2|Protocol Violation|0|||
170609901|NCT03350815|616579412|FG000|Period 2|New therapy for study indication|0|||
170609902|NCT03350815|616579413|FG001|Period 2|New therapy for study indication|0|||
170609903|NCT03350815|616579414|FG002|Period 2|New therapy for study indication|1|||
170609904|NCT03350815|616579415|FG003|Period 2|New therapy for study indication|0|||
170609905|NCT03526146|616579416|FG000|Overall Study|Lost to Follow-up|5|||
170609906|NCT03526146|616579416|FG000|Overall Study|Withdrawal by Subject|6|||
170609907|NCT03526146|616579416|FG000|Overall Study|class canceled due to COVID-19|4|||
170609908|NCT02517541|616579421|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
170609909|NCT02517541|616579421|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
170609910|NCT02517541|616579421|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
170609911|NCT02517541|616579421|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
170609912|NCT02517541|616579421|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
170609913|NCT02517541|616579421|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
170609914|NCT02828436|616579422|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
170609915|NCT02828436|616579423|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
170609916|NCT02828436|616579422|FG000|Period 1|Lost to Follow-up|0|||
170609917|NCT02828436|616579423|FG001|Period 1|Lost to Follow-up|1|||
170609918|NCT02828436|616579422|FG000|Period 2|Withdrawal by Subject|4|||
170609919|NCT02828436|616579423|FG001|Period 2|Withdrawal by Subject|0|||
170609920|NCT02828436|616579422|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
170609921|NCT02828436|616579423|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
170609922|NCT02828436|616579422|FG000|Period 2|Lost to Follow-up|1|||
170609923|NCT02828436|616579423|FG001|Period 2|Lost to Follow-up|0|||
170609924|NCT02034877|616579427|FG000|Overall Study|Lost to Follow-up|0|||
170609925|NCT02034877|616579428|FG001|Overall Study|Lost to Follow-up|3|||
170609926|NCT02034877|616579427|FG000|Overall Study|No Longer Willing to Participate|0|||
170609927|NCT02034877|616579428|FG001|Overall Study|No Longer Willing to Participate|3|||
170609928|NCT04306510|616579431|FG000|Overall Study|Voluntarily withdrawal|1|||
170609929|NCT04306510|616579431|FG000|Overall Study|Enrolled but Not Treated|1|||
170609930|NCT04878211|616579432|FG000|Overall Study|Lost to Follow-up|0|||
170609931|NCT04878211|616579433|FG001|Overall Study|Lost to Follow-up|0|||
170609932|NCT04878211|616579434|FG002|Overall Study|Lost to Follow-up|0|||
170609933|NCT04878211|616579435|FG003|Overall Study|Lost to Follow-up|1|||
170609934|NCT04878211|616579436|FG004|Overall Study|Lost to Follow-up|0|||
170609935|NCT04878211|616579437|FG005|Overall Study|Lost to Follow-up|1|||
170609936|NCT04878211|616579432|FG000|Overall Study|Protocol deviation|1|||
170609937|NCT04878211|616579433|FG001|Overall Study|Protocol deviation|0|||
170609938|NCT04878211|616579434|FG002|Overall Study|Protocol deviation|0|||
170609939|NCT04878211|616579435|FG003|Overall Study|Protocol deviation|0|||
170609940|NCT04878211|616579436|FG004|Overall Study|Protocol deviation|0|||
170609941|NCT04878211|616579437|FG005|Overall Study|Protocol deviation|0|||
170609942|NCT04878211|616579432|FG000|Overall Study|Study terminated by sponsor|0|||
170609943|NCT04878211|616579433|FG001|Overall Study|Study terminated by sponsor|0|||
170609944|NCT04878211|616579434|FG002|Overall Study|Study terminated by sponsor|0|||
170815818|NCT03262389|617332862|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
170815819|NCT03262389|617332862|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
170815820|NCT03262389|617332862|FG000|Overall Study|opted out of PET/MR|1|||
170815821|NCT05376397|617332863|FG000|Overall Study|Lost to Follow-up|1|||
170815822|NCT03209492|617332864|FG000|Overall Study|Case Report Forms Uncollected|5|||
170815823|NCT00821093|617332865|FG000|Overall Study|Adverse Event|20|||
170815824|NCT00821093|617332866|FG001|Overall Study|Adverse Event|12|||
170815825|NCT00821093|617332865|FG000|Overall Study|Withdrawal by Subject|9|||
170815826|NCT00821093|617332866|FG001|Overall Study|Withdrawal by Subject|13|||
170916317|NCT03766009|617695737|FG003|Usual Care|Lost to Follow-up|1|||
170916318|NCT03766009|617695738|FG004|Usual Care|Lost to Follow-up|0|||
170916319|NCT03766009|617695739|FG005|Usual Care|Lost to Follow-up|0|||
170916320|NCT03766009|617695734|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
170916321|NCT03766009|617695735|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
170916322|NCT03766009|617695736|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
170916323|NCT03766009|617695737|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
170916324|NCT03766009|617695738|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
170916325|NCT03766009|617695739|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
170916326|NCT03766009|617695734|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
170916327|NCT03766009|617695735|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
170916328|NCT03766009|617695736|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
170916329|NCT03766009|617695737|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
170916330|NCT03766009|617695738|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
170916331|NCT03766009|617695739|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
170916332|NCT03766009|617695734|FG000|Usual Care|No treatment or declined surgery|0|||
170916333|NCT03766009|617695735|FG001|Usual Care|No treatment or declined surgery|0|||
170916334|NCT03766009|617695736|FG002|Usual Care|No treatment or declined surgery|0|||
170916335|NCT03766009|617695737|FG003|Usual Care|No treatment or declined surgery|2|||
170916336|NCT03766009|617695738|FG004|Usual Care|No treatment or declined surgery|0|||
170916337|NCT03766009|617695739|FG005|Usual Care|No treatment or declined surgery|0|||
170916338|NCT03766009|617695734|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
170916339|NCT03766009|617695735|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
170916340|NCT03766009|617695736|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
170916341|NCT03766009|617695737|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
170916342|NCT03766009|617695738|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
170916343|NCT03766009|617695739|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
170916344|NCT03766009|617695734|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
170916345|NCT03766009|617695735|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
170916346|NCT03766009|617695736|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
170916347|NCT03766009|617695737|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
170916348|NCT03766009|617695738|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
170916349|NCT03766009|617695739|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
170916350|NCT03766009|617695734|FG000|Usual Care|Ineligible|0|||
170916351|NCT03766009|617695735|FG001|Usual Care|Ineligible|1|||
170916352|NCT03766009|617695736|FG002|Usual Care|Ineligible|0|||
170916353|NCT03766009|617695737|FG003|Usual Care|Ineligible|0|||
170916354|NCT03766009|617695738|FG004|Usual Care|Ineligible|0|||
170916355|NCT03766009|617695739|FG005|Usual Care|Ineligible|0|||
170916356|NCT03766009|617695734|FG000|Usual Care|Other: Staff turnover|0|||
170916357|NCT03766009|617695735|FG001|Usual Care|Other: Staff turnover|0|||
170916358|NCT03766009|617695736|FG002|Usual Care|Other: Staff turnover|0|||
170916359|NCT03766009|617695737|FG003|Usual Care|Other: Staff turnover|0|||
170916360|NCT03766009|617695738|FG004|Usual Care|Other: Staff turnover|0|||
170916361|NCT03766009|617695739|FG005|Usual Care|Other: Staff turnover|2|||
170916362|NCT04404036|617695740|FG000|Overall Study|Withdrawal by Subject|1|||
170916363|NCT04552223|617695741|FG000|Overall Study|Withdrawal by Subject|1|||
170916364|NCT04530552|617695742|FG000|Overall Study|Physician Decision|0|||
170916365|NCT04530552|617695743|FG001|Overall Study|Physician Decision|1|||
170916366|NCT04530552|617695742|FG000|Overall Study|Withdrawal by Subject|0|||
170916367|NCT04530552|617695743|FG001|Overall Study|Withdrawal by Subject|1|||
170916368|NCT04530552|617695742|FG000|Overall Study|Adverse Event|0|||
170916369|NCT04530552|617695743|FG001|Overall Study|Adverse Event|1|||
170916370|NCT04530552|617695742|FG000|Overall Study|No surgery|0|||
170916371|NCT04530552|617695743|FG001|Overall Study|No surgery|1|||
170916372|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
170916373|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
170916374|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170916375|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170916376|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170916377|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
170916378|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
170916379|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170916380|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170916381|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170916382|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170916383|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170609945|NCT04878211|616579435|FG003|Overall Study|Study terminated by sponsor|0|||
170609946|NCT04878211|616579436|FG004|Overall Study|Study terminated by sponsor|9|||
170609947|NCT04878211|616579437|FG005|Overall Study|Study terminated by sponsor|4|||
170609948|NCT04878211|616579432|FG000|Overall Study|Subject decision|0|||
170609949|NCT04878211|616579433|FG001|Overall Study|Subject decision|0|||
170609950|NCT04878211|616579434|FG002|Overall Study|Subject decision|0|||
170609951|NCT04878211|616579435|FG003|Overall Study|Subject decision|0|||
170815827|NCT00821093|617332865|FG000|Overall Study|Lost to Follow-up|9|||
170815828|NCT00821093|617332866|FG001|Overall Study|Lost to Follow-up|3|||
170815829|NCT00821093|617332865|FG000|Overall Study|Protocol deviation|3|||
170815830|NCT00821093|617332866|FG001|Overall Study|Protocol deviation|6|||
170815831|NCT00821093|617332865|FG000|Overall Study|Abnormal laboratory value(s)|2|||
170815832|NCT00821093|617332866|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170815833|NCT00821093|617332865|FG000|Overall Study|Lack of Efficacy|2|||
170815834|NCT00821093|617332866|FG001|Overall Study|Lack of Efficacy|2|||
170815835|NCT00821093|617332865|FG000|Overall Study|Death|2|||
170815836|NCT00821093|617332866|FG001|Overall Study|Death|1|||
170815837|NCT00821093|617332865|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170815838|NCT00821093|617332866|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170815839|NCT00821093|617332865|FG000|Overall Study|Administrative problems|1|||
170815840|NCT00821093|617332866|FG001|Overall Study|Administrative problems|2|||
170609952|NCT04878211|616579436|FG004|Overall Study|Subject decision|1|||
170609953|NCT04878211|616579437|FG005|Overall Study|Subject decision|0|||
170609954|NCT00856544|616579441|FG000|Overall Study|Randomized but not treated|3|||
170609955|NCT00856544|616579442|FG001|Overall Study|Randomized but not treated|0|||
170609956|NCT00856544|616579443|FG002|Overall Study|Randomized but not treated|0|||
170609957|NCT00856544|616579444|FG003|Overall Study|Randomized but not treated|0|||
170609958|NCT00856544|616579441|FG000|Overall Study|Death|0|||
170609959|NCT00856544|616579442|FG001|Overall Study|Death|2|||
170609960|NCT00856544|616579443|FG002|Overall Study|Death|0|||
170609961|NCT00856544|616579444|FG003|Overall Study|Death|0|||
170609962|NCT00856544|616579441|FG000|Overall Study|Adverse Event|20|||
170609963|NCT00856544|616579442|FG001|Overall Study|Adverse Event|29|||
170609964|NCT00856544|616579443|FG002|Overall Study|Adverse Event|2|||
170609965|NCT00856544|616579444|FG003|Overall Study|Adverse Event|3|||
170609966|NCT00856544|616579441|FG000|Overall Study|Lack of Efficacy|16|||
170609967|NCT00856544|616579442|FG001|Overall Study|Lack of Efficacy|12|||
170609968|NCT00856544|616579443|FG002|Overall Study|Lack of Efficacy|3|||
170609969|NCT00856544|616579444|FG003|Overall Study|Lack of Efficacy|3|||
170609970|NCT00856544|616579441|FG000|Overall Study|Other|9|||
170609971|NCT00856544|616579442|FG001|Overall Study|Other|16|||
170609972|NCT00856544|616579443|FG002|Overall Study|Other|1|||
170609973|NCT00856544|616579444|FG003|Overall Study|Other|6|||
170609974|NCT00856544|616579441|FG000|Overall Study|Lost to Follow-up|1|||
170609975|NCT00856544|616579442|FG001|Overall Study|Lost to Follow-up|2|||
170609976|NCT00856544|616579443|FG002|Overall Study|Lost to Follow-up|2|||
170609977|NCT00856544|616579444|FG003|Overall Study|Lost to Follow-up|0|||
170609978|NCT00856544|616579441|FG000|Overall Study|Withdrawal by Subject|8|||
170609979|NCT00856544|616579442|FG001|Overall Study|Withdrawal by Subject|5|||
170609980|NCT00856544|616579443|FG002|Overall Study|Withdrawal by Subject|0|||
170609981|NCT00856544|616579444|FG003|Overall Study|Withdrawal by Subject|1|||
170609982|NCT01036321|616579445|FG000|Overall Study|Ineligible after randomization|0|||
170609983|NCT01036321|616579446|FG001|Overall Study|Ineligible after randomization|1|||
170609984|NCT01036321|616579445|FG000|Overall Study|Withdrawal by Subject|3|||
170609985|NCT01036321|616579446|FG001|Overall Study|Withdrawal by Subject|2|||
170815841|NCT03875729|617332870|FG000|Overall Study|Adverse Event|0|||
170815842|NCT03875729|617332871|FG001|Overall Study|Adverse Event|5|||
170609986|NCT01036321|616579445|FG000|Overall Study|Adverse Event|2|||
170609987|NCT01036321|616579446|FG001|Overall Study|Adverse Event|1|||
170609988|NCT02598297|616579449|FG000|Overall Study|Study terminated by Sponsor|21|||
170609989|NCT02598297|616579450|FG001|Overall Study|Study terminated by Sponsor|23|||
170916384|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170916385|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
170609990|NCT02598297|616579449|FG000|Overall Study|Adverse Event|1|||
170609991|NCT02598297|616579450|FG001|Overall Study|Adverse Event|1|||
170609992|NCT02598297|616579449|FG000|Overall Study|Physician Decision|1|||
170609993|NCT02598297|616579450|FG001|Overall Study|Physician Decision|0|||
170609994|NCT02598297|616579449|FG000|Overall Study|Subject/guardian decision|1|||
170609995|NCT02598297|616579450|FG001|Overall Study|Subject/guardian decision|0|||
170609996|NCT02598297|616579449|FG000|Overall Study|Followed for survival|1|||
170609997|NCT02598297|616579450|FG001|Overall Study|Followed for survival|0|||
170609998|NCT05274269|616579451|FG000|Overall Study|Adverse Event|0|||
170609999|NCT05274269|616579452|FG001|Overall Study|Adverse Event|3|||
170610000|NCT05274269|616579451|FG000|Overall Study|Death|0|||
170610001|NCT05274269|616579452|FG001|Overall Study|Death|1|||
170610002|NCT05274269|616579451|FG000|Overall Study|Other|0|||
170610003|NCT05274269|616579452|FG001|Overall Study|Other|2|||
170610004|NCT05274269|616579451|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
170610005|NCT05274269|616579452|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
170610006|NCT04303572|616579455|FG000|Overall Study|Study closed due to poor enrollment|1|||
170610007|NCT03785405|616579456|FG000|Overall Study|Adverse Event|16|||
170610008|NCT03785405|616579457|FG001|Overall Study|Adverse Event|1|||
170610009|NCT03785405|616579456|FG000|Overall Study|Death|6|||
170610010|NCT03785405|616579457|FG001|Overall Study|Death|4|||
170610011|NCT03785405|616579456|FG000|Overall Study|Guardian decision|4|||
170610012|NCT03785405|616579457|FG001|Overall Study|Guardian decision|1|||
170610013|NCT03785405|616579456|FG000|Overall Study|Lost to Follow-up|1|||
170610014|NCT03785405|616579457|FG001|Overall Study|Lost to Follow-up|0|||
170610015|NCT03785405|616579456|FG000|Overall Study|Physician Decision|8|||
170610016|NCT03785405|616579457|FG001|Overall Study|Physician Decision|5|||
170610017|NCT03785405|616579456|FG000|Overall Study|Participant decision|2|||
170610018|NCT03785405|616579457|FG001|Overall Study|Participant decision|0|||
170610019|NCT03785405|616579456|FG000|Overall Study|Other|1|||
170610020|NCT03785405|616579457|FG001|Overall Study|Other|0|||
170610021|NCT03785405|616579456|FG000|Overall Study|No treatment was received|0|||
170610022|NCT03785405|616579457|FG001|Overall Study|No treatment was received|1|||
170610023|NCT03705559|616579458|FG000|Overall Study|COVID Shut down|1|||
170610024|NCT00203424|616579465|FG000|Treatment Period|Withdrawal by Subject|4|||
170610025|NCT00203424|616579465|FG000|Treatment Period|Adverse Event|5|||
170610026|NCT00203424|616579465|FG000|Treatment Period|progressive disease|2|||
170610027|NCT00203424|616579465|FG000|Follow-up Period|Withdrawal by Subject|1|||
170610028|NCT00203424|616579465|FG000|Follow-up Period|progressive disease|4|||
170610029|NCT00203424|616579465|FG000|Follow-up Period|Lost to Follow-up|1|||
170610030|NCT01922271|616579466|FG000|WASHOUT Period|Withdrawal by Subject|1|||
170610031|NCT01922271|616579467|FG001|WASHOUT Period|Withdrawal by Subject|0|||
170610032|NCT06041919|616579468|FG000|Overall Study|Lost to Follow-up|1|||
170610033|NCT06041919|616579469|FG001|Overall Study|Lost to Follow-up|0|||
170610034|NCT06041919|616579470|FG002|Overall Study|Lost to Follow-up|0|||
170610035|NCT06041919|616579471|FG003|Overall Study|Lost to Follow-up|0|||
170610036|NCT06041919|616579472|FG004|Overall Study|Lost to Follow-up|0|||
170610037|NCT06041919|616579468|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
170610038|NCT06041919|616579469|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
170610039|NCT06041919|616579470|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
170610040|NCT06041919|616579471|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
170610041|NCT06041919|616579472|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
170610042|NCT00719355|616579477|FG000|Overall Study|Death|0|||
170610043|NCT00719355|616579478|FG001|Overall Study|Death|1|||
170610044|NCT00719355|616579477|FG000|Overall Study|Medical|14|||
170610045|NCT00719355|616579478|FG001|Overall Study|Medical|5|||
170610046|NCT00719355|616579477|FG000|Overall Study|Compliance|4|||
170610047|NCT00719355|616579478|FG001|Overall Study|Compliance|6|||
170610048|NCT00719355|616579477|FG000|Overall Study|Moved|0|||
170610049|NCT00719355|616579478|FG001|Overall Study|Moved|1|||
170610050|NCT01856582|616579480|FG000|Overall Study|Died prior to Boost infusion|1|||
170610051|NCT01415401|616579481|FG000|Overall Study|Adverse Event|5|||
170610052|NCT01415401|616579481|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
170610053|NCT01415401|616579481|FG000|Overall Study|Terminated by Sponsor|1|||
170916386|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170610054|NCT03422536|616579484|FG000|Randomized|Physician Decision|1|||
170610055|NCT03422536|616579485|FG001|Randomized|Physician Decision|1|||
170916387|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916388|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916389|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170610056|NCT03422536|616579484|FG000|Allocation - Received Intervention|Disease progression|19|||
170610057|NCT03422536|616579485|FG001|Allocation - Received Intervention|Disease progression|25|||
170610058|NCT03422536|616579484|FG000|Allocation - Received Intervention|Death|1|||
170610059|NCT03422536|616579485|FG001|Allocation - Received Intervention|Death|3|||
170610060|NCT03422536|616579484|FG000|Allocation - Received Intervention|Adverse Event|1|||
170815843|NCT03875729|617332870|FG000|Overall Study|Withdrawal by Subject|8|||
170815844|NCT03875729|617332871|FG001|Overall Study|Withdrawal by Subject|11|||
170815845|NCT03875729|617332870|FG000|Overall Study|Pregnancy|0|||
170815846|NCT03875729|617332871|FG001|Overall Study|Pregnancy|1|||
170815847|NCT03875729|617332870|FG000|Overall Study|Lost to Follow-up|0|||
170815848|NCT03875729|617332871|FG001|Overall Study|Lost to Follow-up|5|||
170815849|NCT03875729|617332870|FG000|Overall Study|Personal reasons|2|||
170815850|NCT03875729|617332871|FG001|Overall Study|Personal reasons|0|||
170815851|NCT04529941|617332874|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
170815852|NCT04529941|617332875|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
170815853|NCT03065400|617332876|FG000|Overall Study|Adverse Event|1|||
170916390|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916391|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
170916392|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
170916393|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916394|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916395|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916396|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916397|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916398|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916399|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
170916400|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
170916401|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916402|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916403|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916404|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916405|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916406|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
170916407|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916408|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916409|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916410|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916411|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916412|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916413|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
170916414|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916415|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916416|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916417|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916418|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916419|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
170916420|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
170916421|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916422|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916423|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916424|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916425|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916426|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916427|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
170916428|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916429|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916430|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916431|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916432|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916433|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916434|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
170916435|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916436|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916437|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916438|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916439|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916440|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916441|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
170916442|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
170916443|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
170916444|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
170916445|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170916446|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170815854|NCT03065400|617332876|FG000|Overall Study|Physician Decision|3|||
170815855|NCT03065400|617332876|FG000|Overall Study|Withdrawal by Subject|1|||
170815856|NCT03065400|617332876|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
170815857|NCT03072862|617332877|FG000|Overall Study|Withdrawal by Subject|4|||
170815858|NCT03072862|617332877|FG000|Overall Study|Lost to Follow-up|6|||
170815859|NCT03072862|617332877|FG000|Overall Study|Protocol Violation|4|||
170815860|NCT03072862|617332877|FG000|Overall Study|Physician Decision|2|||
170815861|NCT03072862|617332877|FG000|Overall Study|Death|1|||
170815862|NCT03072862|617332877|FG000|Overall Study|Adverse Event|1|||
170815863|NCT00632736|617332878|FG000|Overall Study|Adverse Event|104|||
170815864|NCT00632736|617332878|FG000|Overall Study|Lost to Follow-up|15|||
170916447|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
170916448|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
170916449|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170916450|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170916451|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170916452|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170916453|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170916454|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170916455|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
170916456|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916457|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
170916458|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916459|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916460|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916461|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
170916462|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916463|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916464|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916465|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916466|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916467|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916468|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916469|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
170916470|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
170916471|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916472|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916473|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916474|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916475|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
170916476|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916477|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916478|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916479|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916480|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916481|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916482|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916483|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
170916484|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916485|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916486|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916487|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
170916488|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
170916489|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916490|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916491|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
170916492|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
170916493|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170610061|NCT03422536|616579485|FG001|Allocation - Received Intervention|Adverse Event|0|||
170610062|NCT03422536|616579484|FG000|Allocation - Received Intervention|Physician Decision|1|||
170610063|NCT03422536|616579485|FG001|Allocation - Received Intervention|Physician Decision|1|||
170610064|NCT03422536|616579484|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
170610065|NCT03422536|616579485|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
170610066|NCT03422536|616579484|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
170610067|NCT03422536|616579485|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
170610068|NCT02576795|616579489|FG000|Overall Study|Lost to Follow-up|0|||
170610069|NCT02576795|616579490|FG001|Overall Study|Lost to Follow-up|0|||
170610070|NCT02576795|616579491|FG002|Overall Study|Lost to Follow-up|1|||
170610071|NCT02576795|616579492|FG003|Overall Study|Lost to Follow-up|0|||
170610072|NCT03724890|616579493|FG000|Overall Study|Death|2|||
170610073|NCT03724890|616579494|FG001|Overall Study|Death|6|||
170610074|NCT03724890|616579495|FG002|Overall Study|Death|3|||
170610075|NCT03724890|616579496|FG003|Overall Study|Death|5|||
170610076|NCT03724890|616579497|FG004|Overall Study|Death|2|||
170610077|NCT03724890|616579498|FG005|Overall Study|Death|0|||
170610078|NCT03724890|616579499|FG006|Overall Study|Death|2|||
170610079|NCT03724890|616579500|FG007|Overall Study|Death|3|||
170610080|NCT03724890|616579501|FG008|Overall Study|Death|4|||
170610081|NCT03724890|616579502|FG009|Overall Study|Death|2|||
170610082|NCT03724890|616579503|FG010|Overall Study|Death|2|||
170610083|NCT03724890|616579493|FG000|Overall Study|Lost to Follow-up|0|||
170610084|NCT03724890|616579494|FG001|Overall Study|Lost to Follow-up|3|||
170610085|NCT03724890|616579495|FG002|Overall Study|Lost to Follow-up|0|||
170610086|NCT03724890|616579496|FG003|Overall Study|Lost to Follow-up|1|||
170610087|NCT03724890|616579497|FG004|Overall Study|Lost to Follow-up|2|||
170610088|NCT03724890|616579498|FG005|Overall Study|Lost to Follow-up|2|||
170610089|NCT03724890|616579499|FG006|Overall Study|Lost to Follow-up|1|||
170610090|NCT03724890|616579500|FG007|Overall Study|Lost to Follow-up|0|||
170610091|NCT03724890|616579501|FG008|Overall Study|Lost to Follow-up|2|||
170610092|NCT03724890|616579502|FG009|Overall Study|Lost to Follow-up|0|||
170610093|NCT03724890|616579503|FG010|Overall Study|Lost to Follow-up|0|||
170610094|NCT03724890|616579493|FG000|Overall Study|Withdrawal by Subject|1|||
170610095|NCT03724890|616579494|FG001|Overall Study|Withdrawal by Subject|2|||
170610096|NCT03724890|616579495|FG002|Overall Study|Withdrawal by Subject|1|||
170610097|NCT03724890|616579496|FG003|Overall Study|Withdrawal by Subject|0|||
170610098|NCT03724890|616579497|FG004|Overall Study|Withdrawal by Subject|0|||
170610099|NCT03724890|616579498|FG005|Overall Study|Withdrawal by Subject|1|||
170610100|NCT03724890|616579499|FG006|Overall Study|Withdrawal by Subject|0|||
170610101|NCT03724890|616579500|FG007|Overall Study|Withdrawal by Subject|0|||
170610102|NCT03724890|616579501|FG008|Overall Study|Withdrawal by Subject|2|||
170610103|NCT03724890|616579502|FG009|Overall Study|Withdrawal by Subject|2|||
170610104|NCT03724890|616579503|FG010|Overall Study|Withdrawal by Subject|1|||
170610105|NCT03724890|616579493|FG000|Overall Study|Other|1|||
170610106|NCT03724890|616579494|FG001|Overall Study|Other|0|||
170610107|NCT03724890|616579495|FG002|Overall Study|Other|0|||
170610108|NCT03724890|616579496|FG003|Overall Study|Other|0|||
170610109|NCT03724890|616579497|FG004|Overall Study|Other|0|||
170610110|NCT03724890|616579498|FG005|Overall Study|Other|0|||
170610111|NCT03724890|616579499|FG006|Overall Study|Other|0|||
170610112|NCT03724890|616579500|FG007|Overall Study|Other|1|||
170610113|NCT03724890|616579501|FG008|Overall Study|Other|1|||
170610114|NCT03724890|616579502|FG009|Overall Study|Other|0|||
170610115|NCT03724890|616579503|FG010|Overall Study|Other|2|||
170610116|NCT01635855|616579537|FG000|Overall Study|Withdrawal by Subject|4|||
170610117|NCT01844778|616579540|FG000|Overall Study|Protocol deviation|0|||
170610118|NCT01844778|616579541|FG001|Overall Study|Protocol deviation|1|||
170610119|NCT01844778|616579542|FG002|Overall Study|Protocol deviation|2|||
170610120|NCT01844778|616579540|FG000|Overall Study|Withdrawal by Subject|2|||
170610121|NCT01844778|616579541|FG001|Overall Study|Withdrawal by Subject|0|||
170610122|NCT01844778|616579542|FG002|Overall Study|Withdrawal by Subject|0|||
170610123|NCT01844778|616579540|FG000|Overall Study|Adverse Event|0|||
170815865|NCT00632736|617332878|FG000|Overall Study|Protocol Violation|14|||
170610124|NCT01844778|616579541|FG001|Overall Study|Adverse Event|2|||
170815866|NCT00632736|617332878|FG000|Overall Study|Withdrawal by Subject|99|||
170815867|NCT00632736|617332878|FG000|Overall Study|Lack of Efficacy|5|||
170815868|NCT00632736|617332878|FG000|Overall Study|Sponsor terminated study|5|||
170610125|NCT01844778|616579542|FG002|Overall Study|Adverse Event|2|||
170610126|NCT02828020|616579545|FG000|Treatment Period|Adverse Event|3|||
170610127|NCT02828020|616579546|FG001|Treatment Period|Adverse Event|1|||
170610128|NCT02828020|616579547|FG002|Treatment Period|Adverse Event|1|||
170610129|NCT02828020|616579545|FG000|Treatment Period|Withdrawal of Consent|10|||
170610130|NCT02828020|616579546|FG001|Treatment Period|Withdrawal of Consent|14|||
170610131|NCT02828020|616579547|FG002|Treatment Period|Withdrawal of Consent|9|||
170610132|NCT02828020|616579545|FG000|Treatment Period|Lost to Follow-up|21|||
170610133|NCT02828020|616579546|FG001|Treatment Period|Lost to Follow-up|24|||
170610134|NCT02828020|616579547|FG002|Treatment Period|Lost to Follow-up|18|||
170610135|NCT02828020|616579545|FG000|Treatment Period|Lack of Qualifying Event|44|||
170815869|NCT00632736|617332878|FG000|Overall Study|Non-compliance|10|||
170815870|NCT00632736|617332878|FG000|Overall Study|Other|16|||
170815871|NCT01794689|617332879|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
170815872|NCT01794689|617332880|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
170815873|NCT01794689|617332881|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
170815874|NCT01794689|617332882|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
170815875|NCT01794689|617332879|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
170610136|NCT02828020|616579546|FG001|Treatment Period|Lack of Qualifying Event|53|||
170653075|NCT04090411|616743392|FG008|Induction Period|Protocol Violation|0|||
170653076|NCT04090411|616743393|FG009|Induction Period|Protocol Violation|0|||
170610137|NCT02828020|616579547|FG002|Treatment Period|Lack of Qualifying Event|43|||
170610138|NCT02828020|616579545|FG000|Treatment Period|Pregnancy|0|||
170610139|NCT02828020|616579546|FG001|Treatment Period|Pregnancy|2|||
170610140|NCT02828020|616579547|FG002|Treatment Period|Pregnancy|0|||
170610141|NCT02828020|616579545|FG000|Treatment Period|Protocol Violation|2|||
170610142|NCT02828020|616579546|FG001|Treatment Period|Protocol Violation|4|||
170610143|NCT02828020|616579547|FG002|Treatment Period|Protocol Violation|7|||
170610144|NCT02828020|616579545|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
170610145|NCT02828020|616579546|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
170610146|NCT02828020|616579547|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
170610147|NCT02828020|616579545|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
170610148|NCT02828020|616579546|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
170610149|NCT02828020|616579547|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
170610150|NCT02828020|616579545|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
170610151|NCT02828020|616579546|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
170610152|NCT02828020|616579547|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
170610153|NCT02828020|616579545|FG000|Safety Follow-up Period|Protocol Violation|0|||
170610154|NCT02828020|616579546|FG001|Safety Follow-up Period|Protocol Violation|2|||
170610155|NCT02828020|616579547|FG002|Safety Follow-up Period|Protocol Violation|1|||
170610156|NCT02828020|616579545|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
170610157|NCT02828020|616579546|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
170610158|NCT02828020|616579547|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
170815876|NCT01794689|617332880|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
170815877|NCT01794689|617332881|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
170815878|NCT01794689|617332882|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
170815879|NCT01794689|617332879|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
170610159|NCT00145574|616579550|FG000|Double Blind|Adverse Event|0|||
170610160|NCT00145574|616579551|FG001|Double Blind|Adverse Event|3|||
170610161|NCT00145574|616579552|FG002|Double Blind|Adverse Event|1|||
170610162|NCT00145574|616579550|FG000|Double Blind|Withdrawal by Subject|1|||
170610163|NCT00145574|616579551|FG001|Double Blind|Withdrawal by Subject|1|||
170610164|NCT00145574|616579552|FG002|Double Blind|Withdrawal by Subject|1|||
170610165|NCT00145574|616579550|FG000|Double Blind|required restricted medicine|0|||
170610166|NCT00145574|616579551|FG001|Double Blind|required restricted medicine|1|||
170610167|NCT00145574|616579552|FG002|Double Blind|required restricted medicine|0|||
170610168|NCT00145574|616579550|FG000|Open Label Long-term Extension|Adverse Event|0|||
170610169|NCT00145574|616579551|FG001|Open Label Long-term Extension|Adverse Event|0|||
170610170|NCT00145574|616579552|FG002|Open Label Long-term Extension|Adverse Event|5|||
170610171|NCT00145574|616579550|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
170610172|NCT00145574|616579551|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
170610173|NCT00145574|616579552|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
170610174|NCT00145574|616579550|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
170610175|NCT00145574|616579551|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
170610176|NCT00145574|616579552|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
170610177|NCT00145574|616579550|FG000|Open Label Long-term Extension|required restricted medicine|0|||
170610178|NCT00145574|616579551|FG001|Open Label Long-term Extension|required restricted medicine|0|||
170610179|NCT00145574|616579552|FG002|Open Label Long-term Extension|required restricted medicine|1|||
170610180|NCT01140061|616579553|FG000|Part I|Adverse Event|1|||
170610181|NCT01140061|616579554|FG001|Part I|Adverse Event|0|||
170610182|NCT01140061|616579555|FG002|Part I|Adverse Event|0|||
170610183|NCT01140061|616579556|FG003|Part I|Adverse Event|0|||
170610184|NCT01140061|616579557|FG004|Part I|Adverse Event|0|||
170610185|NCT01140061|616579558|FG005|Part I|Adverse Event|0|||
170610186|NCT01140061|616579559|FG006|Part I|Adverse Event|0|||
170610187|NCT01140061|616579560|FG007|Part I|Adverse Event|0|||
170610188|NCT01140061|616579561|FG008|Part I|Adverse Event|0|||
170610189|NCT01140061|616579562|FG009|Part I|Adverse Event|0|||
170610190|NCT01140061|616579553|FG000|Extension|Laboratory Adverse Event|0|||
170610191|NCT01140061|616579554|FG001|Extension|Laboratory Adverse Event|0|||
170610192|NCT01140061|616579555|FG002|Extension|Laboratory Adverse Event|0|||
170610193|NCT01140061|616579556|FG003|Extension|Laboratory Adverse Event|0|||
170610194|NCT01140061|616579557|FG004|Extension|Laboratory Adverse Event|0|||
170610195|NCT01140061|616579558|FG005|Extension|Laboratory Adverse Event|0|||
170610196|NCT01140061|616579559|FG006|Extension|Laboratory Adverse Event|0|||
170610197|NCT01140061|616579560|FG007|Extension|Laboratory Adverse Event|0|||
170610198|NCT01140061|616579561|FG008|Extension|Laboratory Adverse Event|0|||
170610199|NCT01140061|616579562|FG009|Extension|Laboratory Adverse Event|1|||
170610200|NCT00828750|616579563|FG000|Overall Study|Lack of Efficacy|3|||
170610201|NCT00828750|616579563|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
170610202|NCT00835341|616579564|FG000|Overall Study|Lost to Follow-up|3|||
170610203|NCT00835341|616579565|FG001|Overall Study|Lost to Follow-up|12|||
170610204|NCT01711645|616579566|FG000|Overall Study|Withdrawal by Subject|8|||
170610205|NCT01711645|616579566|FG000|Overall Study|Lost to Follow-up|6|||
170610206|NCT01711645|616579566|FG000|Overall Study|Physician Decision|5|||
170610207|NCT00825812|616579568|FG000|Overall Study|Never entered follow up|0|||
170610208|NCT00825812|616579569|FG001|Overall Study|Never entered follow up|0|||
170610209|NCT00825812|616579570|FG002|Overall Study|Never entered follow up|0|||
170610210|NCT00825812|616579571|FG003|Overall Study|Never entered follow up|1|||
170610211|NCT00825812|616579568|FG000|Overall Study|Adverse Event|0|||
170610212|NCT00825812|616579569|FG001|Overall Study|Adverse Event|0|||
170610213|NCT00825812|616579570|FG002|Overall Study|Adverse Event|0|||
170815880|NCT01794689|617332880|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
170815881|NCT01794689|617332881|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
170815882|NCT01794689|617332882|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
170815883|NCT01794689|617332879|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
170815884|NCT01794689|617332880|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
170610214|NCT00825812|616579571|FG003|Overall Study|Adverse Event|1|||
170610215|NCT00825812|616579568|FG000|Overall Study|Subject withdrew consent|0|||
170610216|NCT00825812|616579569|FG001|Overall Study|Subject withdrew consent|0|||
170610217|NCT00825812|616579570|FG002|Overall Study|Subject withdrew consent|3|||
170610218|NCT00825812|616579571|FG003|Overall Study|Subject withdrew consent|2|||
170610219|NCT00825812|616579568|FG000|Overall Study|Non-compliance with protocol|0|||
170610220|NCT00825812|616579569|FG001|Overall Study|Non-compliance with protocol|0|||
170610221|NCT00825812|616579570|FG002|Overall Study|Non-compliance with protocol|0|||
170610222|NCT00825812|616579571|FG003|Overall Study|Non-compliance with protocol|1|||
170610223|NCT00825812|616579568|FG000|Overall Study|Administrative|0|||
170610224|NCT00825812|616579569|FG001|Overall Study|Administrative|1|||
170610225|NCT00825812|616579570|FG002|Overall Study|Administrative|3|||
170916494|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916495|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916496|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916497|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
170916498|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916499|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916500|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916501|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916502|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916503|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916504|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916505|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
170916506|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
170916507|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916508|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916509|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916510|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916511|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
170916512|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170610226|NCT00825812|616579571|FG003|Overall Study|Administrative|5|||
170610227|NCT03170193|616579574|FG000|Overall Study|Withdrawal by Subject|0|||
170610228|NCT03170193|616579575|FG001|Overall Study|Withdrawal by Subject|0|||
170610229|NCT03170193|616579576|FG002|Overall Study|Withdrawal by Subject|0|||
170610230|NCT03170193|616579577|FG003|Overall Study|Withdrawal by Subject|1|||
170610231|NCT03170193|616579578|FG004|Overall Study|Withdrawal by Subject|0|||
170610232|NCT03170193|616579579|FG005|Overall Study|Withdrawal by Subject|0|||
170610233|NCT03170193|616579580|FG006|Overall Study|Withdrawal by Subject|0|||
170610234|NCT03170193|616579574|FG000|Overall Study|Lost to Follow-up|1|||
170610235|NCT03170193|616579575|FG001|Overall Study|Lost to Follow-up|1|||
170610236|NCT03170193|616579576|FG002|Overall Study|Lost to Follow-up|0|||
170916513|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916514|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170653077|NCT04090411|616743394|FG010|Induction Period|Protocol Violation|0|||
170653078|NCT04090411|616743395|FG011|Induction Period|Protocol Violation|0|||
170653079|NCT04090411|616743396|FG012|Induction Period|Protocol Violation|0|||
170653080|NCT04090411|616743384|FG000|Induction Period|Withdrawal by Subject|2|||
170610237|NCT03170193|616579577|FG003|Overall Study|Lost to Follow-up|0|||
170610238|NCT03170193|616579578|FG004|Overall Study|Lost to Follow-up|0|||
170610239|NCT03170193|616579579|FG005|Overall Study|Lost to Follow-up|0|||
170610240|NCT03170193|616579580|FG006|Overall Study|Lost to Follow-up|0|||
170610241|NCT03477838|616579587|FG000|Overall Study|Lost to Follow-up|14|||
170610242|NCT00447226|616581271|FG000|12-Week Open-label Phase|Adverse Event|0|||
170610243|NCT00447226|616581272|FG001|12-Week Open-label Phase|Adverse Event|3|||
170610244|NCT00447226|616581271|FG000|12-Week Open-label Phase|Protocol Violation|0|||
170610245|NCT00447226|616581272|FG001|12-Week Open-label Phase|Protocol Violation|1|||
170610246|NCT00447226|616581271|FG000|12-Week Open-label Phase|Disease Progression|0|||
170610247|NCT00447226|616581272|FG001|12-Week Open-label Phase|Disease Progression|20|||
170610248|NCT00447226|616581271|FG000|12-Week Open-label Phase|Physician Decision|0|||
170610249|NCT00447226|616581272|FG001|12-Week Open-label Phase|Physician Decision|1|||
170610250|NCT00447226|616581271|FG000|Double-blind Phase|Disease Progression|4|||
170610251|NCT00447226|616581272|FG001|Double-blind Phase|Disease Progression|3|||
170610252|NCT00615017|616581273|FG000|Overall Study|Adverse Event|0|||
170610253|NCT00615017|616581274|FG001|Overall Study|Adverse Event|1|||
170610254|NCT00615017|616581275|FG002|Overall Study|Adverse Event|2|||
170610255|NCT00615017|616581276|FG003|Overall Study|Adverse Event|0|||
170610256|NCT00615017|616581277|FG004|Overall Study|Adverse Event|0|||
170610257|NCT00615017|616581278|FG005|Overall Study|Adverse Event|1|||
170610258|NCT00615017|616581273|FG000|Overall Study|Death|0|||
170610259|NCT00615017|616581274|FG001|Overall Study|Death|0|||
170610260|NCT00615017|616581275|FG002|Overall Study|Death|2|||
170610261|NCT00615017|616581276|FG003|Overall Study|Death|0|||
170610262|NCT00615017|616581277|FG004|Overall Study|Death|1|||
170610263|NCT00615017|616581278|FG005|Overall Study|Death|1|||
170610264|NCT00615017|616581273|FG000|Overall Study|Sepsis resolved|0|||
170610265|NCT00615017|616581274|FG001|Overall Study|Sepsis resolved|0|||
170610266|NCT00615017|616581275|FG002|Overall Study|Sepsis resolved|1|||
170610267|NCT00615017|616581276|FG003|Overall Study|Sepsis resolved|0|||
170610268|NCT00615017|616581277|FG004|Overall Study|Sepsis resolved|0|||
170610269|NCT00615017|616581278|FG005|Overall Study|Sepsis resolved|0|||
170610270|NCT00615017|616581273|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
170610271|NCT00615017|616581274|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
170610272|NCT00615017|616581275|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
170610273|NCT00615017|616581276|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
170610274|NCT00615017|616581277|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
170610275|NCT00615017|616581278|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
170610276|NCT00615017|616581273|FG000|Overall Study|Physician discontinued drug|0|||
170610277|NCT00615017|616581274|FG001|Overall Study|Physician discontinued drug|0|||
170610278|NCT00615017|616581275|FG002|Overall Study|Physician discontinued drug|0|||
170610279|NCT00615017|616581276|FG003|Overall Study|Physician discontinued drug|0|||
170610280|NCT00615017|616581277|FG004|Overall Study|Physician discontinued drug|0|||
170610281|NCT00615017|616581278|FG005|Overall Study|Physician discontinued drug|1|||
170610282|NCT01980095|616581284|FG000|Overall Study|Lost to Follow-up|6|||
170610283|NCT01980095|616581285|FG001|Overall Study|Lost to Follow-up|7|||
170610284|NCT01980095|616581284|FG000|Overall Study|Withdrawal by Subject|2|||
170610285|NCT01980095|616581285|FG001|Overall Study|Withdrawal by Subject|3|||
170610286|NCT01980095|616581284|FG000|Overall Study|Poor compliance|5|||
170610287|NCT01980095|616581285|FG001|Overall Study|Poor compliance|0|||
170815885|NCT01794689|617332881|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
170815886|NCT01794689|617332882|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
170815887|NCT00116649|617332883|FG000|Overall Study|Adverse Event|20|||
170815888|NCT00116649|617332883|FG000|Overall Study|Lack of Efficacy|1|||
170815889|NCT00116649|617332883|FG000|Overall Study|Lost to Follow-up|32|||
170815890|NCT00116649|617332883|FG000|Overall Study|Withdrawal by Subject|68|||
170815891|NCT00116649|617332883|FG000|Overall Study|Local Skin Reaction|9|||
170815892|NCT00116649|617332883|FG000|Overall Study|Various Reasons|18|||
170815893|NCT00116649|617332883|FG000|Overall Study|Protocol Specified|7|||
170815894|NCT02161146|617332884|FG000|Overall Study|Adverse Event|1|||
170815895|NCT02161146|617332885|FG001|Overall Study|Adverse Event|1|||
170815896|NCT02161146|617332886|FG002|Overall Study|Adverse Event|0|||
170815897|NCT02161146|617332887|FG003|Overall Study|Adverse Event|1|||
170815898|NCT02161146|617332888|FG004|Overall Study|Adverse Event|0|||
170815899|NCT02161146|617332884|FG000|Overall Study|Lost to Follow-up|0|||
170815900|NCT02161146|617332885|FG001|Overall Study|Lost to Follow-up|1|||
170815901|NCT02161146|617332886|FG002|Overall Study|Lost to Follow-up|0|||
170815902|NCT02161146|617332887|FG003|Overall Study|Lost to Follow-up|0|||
170815903|NCT02161146|617332888|FG004|Overall Study|Lost to Follow-up|0|||
170815904|NCT02161146|617332884|FG000|Overall Study|Personal Reasons|0|||
170916515|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916516|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170815905|NCT02161146|617332885|FG001|Overall Study|Personal Reasons|1|||
170815906|NCT02161146|617332886|FG002|Overall Study|Personal Reasons|0|||
170916517|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916518|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170610288|NCT01980095|616581284|FG000|Overall Study|Safety issue|0|||
170610289|NCT01980095|616581285|FG001|Overall Study|Safety issue|1|||
170610290|NCT01980095|616581284|FG000|Overall Study|Study drug discontinued|1|||
170610291|NCT01980095|616581285|FG001|Overall Study|Study drug discontinued|0|||
170610292|NCT01980095|616581284|FG000|Overall Study|Randomized by mistake|1|||
170610293|NCT01980095|616581285|FG001|Overall Study|Randomized by mistake|0|||
170610294|NCT00699608|616581286|FG000|First Intervention|Withdrawal by Subject|0|||
170610295|NCT00699608|616581287|FG001|First Intervention|Withdrawal by Subject|0|||
170610296|NCT00699608|616581288|FG002|First Intervention|Withdrawal by Subject|1|||
170610297|NCT00699608|616581289|FG003|First Intervention|Withdrawal by Subject|0|||
170610298|NCT00699608|616581290|FG004|First Intervention|Withdrawal by Subject|0|||
170610299|NCT00699608|616581291|FG005|First Intervention|Withdrawal by Subject|0|||
170610300|NCT00699608|616581286|FG000|First Intervention|Protocol Violation|0|||
170610301|NCT00699608|616581287|FG001|First Intervention|Protocol Violation|0|||
170610302|NCT00699608|616581288|FG002|First Intervention|Protocol Violation|0|||
170610303|NCT00699608|616581289|FG003|First Intervention|Protocol Violation|0|||
170610304|NCT00699608|616581290|FG004|First Intervention|Protocol Violation|1|||
170610305|NCT00699608|616581291|FG005|First Intervention|Protocol Violation|0|||
170610306|NCT00699608|616581286|FG000|Second Intervention|Adverse Event|0|||
170610307|NCT00699608|616581287|FG001|Second Intervention|Adverse Event|0|||
170610308|NCT00699608|616581288|FG002|Second Intervention|Adverse Event|1|||
170610309|NCT00699608|616581289|FG003|Second Intervention|Adverse Event|0|||
170610310|NCT00699608|616581290|FG004|Second Intervention|Adverse Event|0|||
170610311|NCT00699608|616581291|FG005|Second Intervention|Adverse Event|0|||
170610312|NCT00699608|616581286|FG000|Second Intervention|Withdrawal by Subject|0|||
170610313|NCT00699608|616581287|FG001|Second Intervention|Withdrawal by Subject|0|||
170610314|NCT00699608|616581288|FG002|Second Intervention|Withdrawal by Subject|0|||
170610315|NCT00699608|616581289|FG003|Second Intervention|Withdrawal by Subject|1|||
170610316|NCT00699608|616581290|FG004|Second Intervention|Withdrawal by Subject|0|||
170610317|NCT00699608|616581291|FG005|Second Intervention|Withdrawal by Subject|0|||
170610318|NCT04720417|616581294|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
170610319|NCT04426318|616581295|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
170610320|NCT04426318|616581296|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
170610321|NCT02751580|616581297|FG000|Overall Study|Lost to Follow-up|4|||
170610322|NCT02751580|616581297|FG000|Overall Study|Death|2|||
170610323|NCT02588261|616581298|FG000|Overall Study|Study Terminated by Sponsor|157|||
170610324|NCT02588261|616581299|FG001|Overall Study|Study Terminated by Sponsor|142|||
170610325|NCT02588261|616581298|FG000|Overall Study|Protocol Deviation|1|||
170610326|NCT02588261|616581299|FG001|Overall Study|Protocol Deviation|0|||
170610327|NCT02588261|616581298|FG000|Overall Study|Death|1|||
170610328|NCT02588261|616581299|FG001|Overall Study|Death|2|||
170610329|NCT02588261|616581298|FG000|Overall Study|Withdrawal by Subject|12|||
170610330|NCT02588261|616581299|FG001|Overall Study|Withdrawal by Subject|8|||
170610331|NCT02588261|616581298|FG000|Overall Study|Noncompliance with Study Drug|0|||
170610332|NCT02588261|616581299|FG001|Overall Study|Noncompliance with Study Drug|1|||
170610333|NCT02588261|616581298|FG000|Overall Study|Miscellaneous|5|||
170610334|NCT02588261|616581299|FG001|Overall Study|Miscellaneous|4|||
170610335|NCT02588261|616581298|FG000|Overall Study|Progressive Disease|61|||
170610336|NCT02588261|616581299|FG001|Overall Study|Progressive Disease|82|||
170610337|NCT02588261|616581298|FG000|Overall Study|Adverse Event|29|||
170610338|NCT02588261|616581299|FG001|Overall Study|Adverse Event|24|||
170610339|NCT02588261|616581298|FG000|Overall Study|Lost to Follow-up|1|||
170610340|NCT02588261|616581299|FG001|Overall Study|Lost to Follow-up|0|||
170610341|NCT02783599|616581300|FG000|Overall Study|Progressive disease|23|||
170610342|NCT02783599|616581300|FG000|Overall Study|Surgical Resection|10|||
170610343|NCT02783599|616581300|FG000|Overall Study|Adverse Event|4|||
170610344|NCT02783599|616581300|FG000|Overall Study|Physician Decision|2|||
170610345|NCT02783599|616581300|FG000|Overall Study|Death|1|||
170610346|NCT02287467|616581302|FG000|Overall Study|Protocol Violation|12|||
170610347|NCT02287467|616581303|FG001|Overall Study|Protocol Violation|9|||
170610348|NCT01564732|616581308|FG000|Overall Study|Early termination by the study sponsor|6|||
170610349|NCT01564732|616581309|FG001|Overall Study|Early termination by the study sponsor|5|||
170610350|NCT03755882|616581310|FG000|Period 1|Protocol Violation|1|||
170610351|NCT03755882|616581311|FG001|Period 1|Protocol Violation|0|||
170610352|NCT03755882|616581310|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
170610353|NCT03755882|616581311|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
170610354|NCT01456169|616581312|FG000|Overall Study|Adverse Event|1|||
170610355|NCT01456169|616581313|FG001|Overall Study|Adverse Event|2|||
170610356|NCT01456169|616581314|FG002|Overall Study|Adverse Event|7|||
170610357|NCT01456169|616581312|FG000|Overall Study|Major Protocol Deviation|3|||
170610358|NCT01456169|616581313|FG001|Overall Study|Major Protocol Deviation|2|||
170610359|NCT01456169|616581314|FG002|Overall Study|Major Protocol Deviation|3|||
170610360|NCT01456169|616581312|FG000|Overall Study|Voluntary Withdrawal|3|||
170610361|NCT01456169|616581313|FG001|Overall Study|Voluntary Withdrawal|0|||
170610362|NCT01456169|616581314|FG002|Overall Study|Voluntary Withdrawal|2|||
170610363|NCT01456169|616581312|FG000|Overall Study|Lack of Efficacy|2|||
170610364|NCT01456169|616581313|FG001|Overall Study|Lack of Efficacy|0|||
170610365|NCT01456169|616581314|FG002|Overall Study|Lack of Efficacy|0|||
170610366|NCT01456169|616581312|FG000|Overall Study|Other|1|||
170610367|NCT01456169|616581313|FG001|Overall Study|Other|1|||
170610368|NCT01456169|616581314|FG002|Overall Study|Other|0|||
170610369|NCT00381693|616581315|FG000|Overall Study|Death|1|||
170610370|NCT00381693|616581315|FG000|Overall Study|Adverse Event|4|||
170610371|NCT00381693|616581315|FG000|Overall Study|Patient Choice|1|||
170610372|NCT00381693|616581315|FG000|Overall Study|Progression|2|||
170610373|NCT01687101|616581316|FG000|Overall Study|Lost to Follow-up|7|||
170610374|NCT00108862|616581320|FG000|Overall Study|Death|31|||
170610375|NCT00108862|616581321|FG001|Overall Study|Death|37|||
170610376|NCT00108862|616581320|FG000|Overall Study|Withdrawal by Subject|10|||
170610377|NCT00108862|616581321|FG001|Overall Study|Withdrawal by Subject|6|||
170610378|NCT00108862|616581320|FG000|Overall Study|Lost to Follow-up|27|||
170610379|NCT00108862|616581321|FG001|Overall Study|Lost to Follow-up|19|||
170610380|NCT02631551|616581322|FG000|Overall Study|Adverse Event|1|||
170610381|NCT02631551|616581323|FG001|Overall Study|Adverse Event|2|||
170610382|NCT02631551|616581324|FG002|Overall Study|Adverse Event|4|||
170610383|NCT02631551|616581325|FG003|Overall Study|Adverse Event|0|||
170610384|NCT02631551|616581322|FG000|Overall Study|Lack of Efficacy|0|||
170610385|NCT02631551|616581323|FG001|Overall Study|Lack of Efficacy|0|||
170610386|NCT02631551|616581324|FG002|Overall Study|Lack of Efficacy|1|||
170610387|NCT02631551|616581325|FG003|Overall Study|Lack of Efficacy|0|||
170610388|NCT02631551|616581322|FG000|Overall Study|Lost to Follow-up|1|||
170610389|NCT02631551|616581323|FG001|Overall Study|Lost to Follow-up|2|||
170610390|NCT02631551|616581324|FG002|Overall Study|Lost to Follow-up|0|||
170610391|NCT02631551|616581325|FG003|Overall Study|Lost to Follow-up|3|||
170610392|NCT02631551|616581322|FG000|Overall Study|Withdrawal by Subject|2|||
170610393|NCT02631551|616581323|FG001|Overall Study|Withdrawal by Subject|2|||
170610394|NCT02631551|616581324|FG002|Overall Study|Withdrawal by Subject|0|||
170610395|NCT02631551|616581325|FG003|Overall Study|Withdrawal by Subject|5|||
170610396|NCT02631551|616581322|FG000|Overall Study|Protocol deviation|3|||
170610397|NCT02631551|616581323|FG001|Overall Study|Protocol deviation|6|||
170610398|NCT02631551|616581324|FG002|Overall Study|Protocol deviation|3|||
170610399|NCT02631551|616581325|FG003|Overall Study|Protocol deviation|0|||
170610400|NCT02631551|616581322|FG000|Overall Study|Non-compliance with study procedures|0|||
170610401|NCT02631551|616581323|FG001|Overall Study|Non-compliance with study procedures|0|||
170610402|NCT02631551|616581324|FG002|Overall Study|Non-compliance with study procedures|1|||
170610403|NCT02631551|616581325|FG003|Overall Study|Non-compliance with study procedures|1|||
170610404|NCT02631551|616581322|FG000|Overall Study|Non-compliance with study drug|1|||
170610405|NCT02631551|616581323|FG001|Overall Study|Non-compliance with study drug|0|||
170610406|NCT02631551|616581324|FG002|Overall Study|Non-compliance with study drug|0|||
170610407|NCT02631551|616581325|FG003|Overall Study|Non-compliance with study drug|0|||
170610408|NCT02631551|616581322|FG000|Overall Study|Other, specific reasons not collected|5|||
170610409|NCT02631551|616581323|FG001|Overall Study|Other, specific reasons not collected|7|||
170610410|NCT02631551|616581324|FG002|Overall Study|Other, specific reasons not collected|2|||
170610411|NCT02631551|616581325|FG003|Overall Study|Other, specific reasons not collected|2|||
170610412|NCT00377858|616581327|FG000|Overall Study|Withdrawal by Subject|12|||
170610413|NCT00377858|616581328|FG001|Overall Study|Withdrawal by Subject|11|||
170610414|NCT00377858|616581327|FG000|Overall Study|Lost to Follow-up|6|||
170610415|NCT00377858|616581328|FG001|Overall Study|Lost to Follow-up|1|||
170610416|NCT00377858|616581327|FG000|Overall Study|Physician Decision|5|||
170610417|NCT00377858|616581328|FG001|Overall Study|Physician Decision|5|||
170610418|NCT00377858|616581327|FG000|Overall Study|Protocol Violation|3|||
170610419|NCT00377858|616581328|FG001|Overall Study|Protocol Violation|4|||
170610420|NCT00377858|616581327|FG000|Overall Study|Adverse Event|2|||
170610421|NCT00377858|616581328|FG001|Overall Study|Adverse Event|1|||
170815907|NCT02161146|617332887|FG003|Overall Study|Personal Reasons|2|||
170815908|NCT02161146|617332888|FG004|Overall Study|Personal Reasons|1|||
170815909|NCT02161146|617332884|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170815910|NCT02161146|617332885|FG001|Overall Study|Other Miscellaneous Reasons|1|||
170815911|NCT02161146|617332886|FG002|Overall Study|Other Miscellaneous Reasons|0|||
170815912|NCT02161146|617332887|FG003|Overall Study|Other Miscellaneous Reasons|0|||
170815913|NCT02161146|617332888|FG004|Overall Study|Other Miscellaneous Reasons|0|||
170815914|NCT02189759|617332889|FG000|Overall Study|Lost to Follow-up|0|||
170610422|NCT00377858|616581327|FG000|Overall Study|Entry Criteria Not Met|2|||
170815915|NCT02189759|617332890|FG001|Overall Study|Lost to Follow-up|0|||
170815916|NCT02189759|617332891|FG002|Overall Study|Lost to Follow-up|2|||
170610423|NCT00377858|616581328|FG001|Overall Study|Entry Criteria Not Met|0|||
170610424|NCT00377858|616581327|FG000|Overall Study|Sponsor Decision|1|||
170815917|NCT02189759|617332892|FG003|Overall Study|Lost to Follow-up|5|||
170815918|NCT02470806|617332893|FG000|Overall Study|Lost to Follow-up|1|||
170916519|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916520|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
170916521|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916522|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916523|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916524|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916525|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
170916526|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916527|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916528|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916529|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
170916530|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916531|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916532|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916533|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916534|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916535|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916536|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170610425|NCT00377858|616581328|FG001|Overall Study|Sponsor Decision|2|||
170610426|NCT00377858|616581327|FG000|Overall Study|Death|0|||
170610427|NCT00377858|616581328|FG001|Overall Study|Death|3|||
170610428|NCT03534141|616581329|FG000|Overall Study|Enrolled in other clinical trial|1|||
170610429|NCT03534141|616581330|FG001|Overall Study|Enrolled in other clinical trial|0|||
170610430|NCT03534141|616581329|FG000|Overall Study|Liver transplant aborted after randomization|0|||
170610431|NCT03534141|616581330|FG001|Overall Study|Liver transplant aborted after randomization|2|||
170610432|NCT03534141|616581329|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
170610433|NCT03534141|616581330|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
170610434|NCT00709618|616581331|FG000|Overall Study|Withdrawal by Subject|4|||
170610435|NCT00709618|616581331|FG000|Overall Study|Lost to Follow-up|1|||
170610436|NCT00709618|616581331|FG000|Overall Study|Study Closed/Terminated|25|||
170610437|NCT01685697|616581332|FG000|Overall Study|Protocol Violation|3|||
170610438|NCT01685697|616581333|FG001|Overall Study|Protocol Violation|3|||
170610439|NCT01345188|616581334|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
170610440|NCT01345188|616581334|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
170610441|NCT00475709|616581338|FG000|Overall Study|Did not meet eligibility criteria|8|||
170610442|NCT00475709|616581338|FG000|Overall Study|Death|41|||
170610443|NCT00475709|616581338|FG000|Overall Study|Device Explant|6|||
170610444|NCT00475709|616581338|FG000|Overall Study|Lost to Follow-up|21|||
170610445|NCT04526145|616581341|FG000|Overall Study|Withdrawal by Subject|5|||
170610446|NCT02123823|616581342|FG000|Overall Study|Lack of Efficacy|0|||
170610447|NCT02123823|616581343|FG001|Overall Study|Lack of Efficacy|2|||
170610448|NCT02123823|616581344|FG002|Overall Study|Lack of Efficacy|8|||
170610449|NCT02123823|616581345|FG003|Overall Study|Lack of Efficacy|10|||
170610450|NCT02123823|616581342|FG000|Overall Study|Progressive disease|3|||
170610451|NCT02123823|616581343|FG001|Overall Study|Progressive disease|19|||
170610452|NCT02123823|616581344|FG002|Overall Study|Progressive disease|52|||
170610453|NCT02123823|616581345|FG003|Overall Study|Progressive disease|53|||
170610454|NCT02123823|616581342|FG000|Overall Study|Withdrawal by Subject|0|||
170610455|NCT02123823|616581343|FG001|Overall Study|Withdrawal by Subject|0|||
170610456|NCT02123823|616581344|FG002|Overall Study|Withdrawal by Subject|7|||
170610457|NCT02123823|616581345|FG003|Overall Study|Withdrawal by Subject|2|||
170610458|NCT02123823|616581342|FG000|Overall Study|Adverse Event|0|||
170610459|NCT02123823|616581343|FG001|Overall Study|Adverse Event|0|||
170610460|NCT02123823|616581344|FG002|Overall Study|Adverse Event|3|||
170610461|NCT02123823|616581345|FG003|Overall Study|Adverse Event|5|||
170610462|NCT02161757|616581350|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
170610463|NCT02161757|616581351|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
170610464|NCT02161757|616581352|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
170610465|NCT02161757|616581350|FG000|Treatment Through Study Completion|Adverse Event|1|||
170610466|NCT02161757|616581351|FG001|Treatment Through Study Completion|Adverse Event|1|||
170610467|NCT02161757|616581352|FG002|Treatment Through Study Completion|Adverse Event|0|||
170610468|NCT02161757|616581350|FG000|Treatment Through Study Completion|Protocol Violation|0|||
170610469|NCT02161757|616581351|FG001|Treatment Through Study Completion|Protocol Violation|1|||
170916537|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170610470|NCT02161757|616581352|FG002|Treatment Through Study Completion|Protocol Violation|2|||
170610471|NCT02161757|616581350|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
170610472|NCT02161757|616581351|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
170610473|NCT02161757|616581352|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
170610474|NCT02161757|616581350|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
170610475|NCT02161757|616581351|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
170916538|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170815919|NCT02470806|617332894|FG001|Overall Study|Lost to Follow-up|1|||
170815920|NCT02470806|617332893|FG000|Overall Study|Adverse Event|5|||
170815921|NCT02470806|617332894|FG001|Overall Study|Adverse Event|2|||
170815922|NCT02470806|617332893|FG000|Overall Study|Protocol Violation|4|||
170815923|NCT02470806|617332894|FG001|Overall Study|Protocol Violation|11|||
170815924|NCT02470806|617332893|FG000|Overall Study|Physician Decision|0|||
170815925|NCT02470806|617332894|FG001|Overall Study|Physician Decision|3|||
170815926|NCT02470806|617332893|FG000|Overall Study|Withdrawal by Subject|3|||
170815927|NCT02470806|617332894|FG001|Overall Study|Withdrawal by Subject|10|||
170815928|NCT02470806|617332893|FG000|Overall Study|Lack of Efficacy|5|||
170815929|NCT02470806|617332894|FG001|Overall Study|Lack of Efficacy|15|||
170815930|NCT01147471|617332895|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
170815931|NCT01147471|617332896|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
170815932|NCT01147471|617332895|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
170815933|NCT01147471|617332896|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
170815934|NCT01147471|617332895|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
170815935|NCT01147471|617332896|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
170815936|NCT01147471|617332895|FG000|3 Month Follow Up|Lost to Follow-up|1|||
170815937|NCT01147471|617332896|FG001|3 Month Follow Up|Lost to Follow-up|1|||
170815938|NCT01147471|617332895|FG000|3 Month Follow Up|Physician Decision|0|||
170815939|NCT01147471|617332896|FG001|3 Month Follow Up|Physician Decision|1|||
170815940|NCT01147471|617332895|FG000|6 Month Follow Up|Lost to Follow-up|4|||
170815941|NCT01147471|617332896|FG001|6 Month Follow Up|Lost to Follow-up|2|||
170815942|NCT02659540|617332897|FG000|Overall Study|Adverse Event|3|||
170815943|NCT02659540|617332898|FG001|Overall Study|Adverse Event|2|||
170815944|NCT02659540|617332897|FG000|Overall Study|Death|1|||
170815945|NCT02659540|617332898|FG001|Overall Study|Death|0|||
170815946|NCT02659540|617332897|FG000|Overall Study|Progressive disease|2|||
170815947|NCT02659540|617332898|FG001|Overall Study|Progressive disease|6|||
170610476|NCT02161757|616581352|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
170610477|NCT02161757|616581350|FG000|Treatment Through Study Completion|Other|20|||
170610478|NCT02161757|616581351|FG001|Treatment Through Study Completion|Other|19|||
170610479|NCT02161757|616581352|FG002|Treatment Through Study Completion|Other|12|||
170610480|NCT02161757|616581350|FG000|Treatment Through Study Completion|Death|2|||
170610481|NCT02161757|616581351|FG001|Treatment Through Study Completion|Death|1|||
170815948|NCT00824850|617332899|FG000|Overall Study|Withdrawal by Subject|0|||
170815949|NCT00824850|617332900|FG001|Overall Study|Withdrawal by Subject|1|||
170610482|NCT02161757|616581352|FG002|Treatment Through Study Completion|Death|1|||
170610483|NCT00391625|616581353|FG000|Month 14|Withdrawal by Subject|1|||
170610484|NCT00391625|616581353|FG000|Month 50|Physician Decision|1|||
170610485|NCT02106403|616581360|FG000|Follow-Up Visit 3|Other Reason|0|||
170610486|NCT02106403|616581361|FG001|Follow-Up Visit 3|Other Reason|0|||
170815950|NCT00882050|617332901|FG000|Overall Study|Physician Decision|1|||
170815951|NCT00882050|617332902|FG001|Overall Study|Physician Decision|0|||
170815952|NCT00882050|617332903|FG002|Overall Study|Physician Decision|0|||
170815953|NCT04820491|617332906|FG000|Overall Study|Withdrawal by Subject|1|||
170610487|NCT02106403|616581362|FG002|Follow-Up Visit 3|Other Reason|0|||
170815954|NCT04820491|617332907|FG001|Overall Study|Withdrawal by Subject|0|||
170815955|NCT00946998|617335359|FG000|Overall Study|Exited prior to first outcome assessment|5|||
170815956|NCT00946998|617335360|FG001|Overall Study|Exited prior to first outcome assessment|3|||
170815957|NCT04820023|617335361|FG000|Overall Study|Death|0|||
170815958|NCT04820023|617335362|FG001|Overall Study|Death|0|||
170815959|NCT04820023|617335363|FG002|Overall Study|Death|0|||
170815960|NCT04820023|617335364|FG003|Overall Study|Death|0|||
170815961|NCT04820023|617335365|FG004|Overall Study|Death|0|||
170815962|NCT04820023|617335366|FG005|Overall Study|Death|0|||
170916539|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
170916540|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170610488|NCT02106403|616581363|FG003|Follow-Up Visit 3|Other Reason|0|||
170610489|NCT02106403|616581364|FG004|Follow-Up Visit 3|Other Reason|0|||
170610490|NCT02106403|616581365|FG005|Follow-Up Visit 3|Other Reason|1|||
170610491|NCT00874848|616581366|FG000|Overall Study|Adverse Event|13|||
170610492|NCT00874848|616581367|FG001|Overall Study|Adverse Event|2|||
170610493|NCT00874848|616581366|FG000|Overall Study|Progressive neoplastic disease|38|||
170610494|NCT00874848|616581367|FG001|Overall Study|Progressive neoplastic disease|18|||
170610495|NCT00874848|616581366|FG000|Overall Study|Withdrawal by Subject|7|||
170610496|NCT00874848|616581367|FG001|Overall Study|Withdrawal by Subject|4|||
170610497|NCT00874848|616581366|FG000|Overall Study|Noncompliance|1|||
170610498|NCT00874848|616581367|FG001|Overall Study|Noncompliance|1|||
170610499|NCT00874848|616581366|FG000|Overall Study|Failure to comply with protocol|0|||
170610500|NCT00874848|616581367|FG001|Overall Study|Failure to comply with protocol|1|||
170610501|NCT00874848|616581366|FG000|Overall Study|Physician Decision|0|||
170610502|NCT00874848|616581367|FG001|Overall Study|Physician Decision|2|||
170610503|NCT01496846|616581368|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
170610504|NCT01496846|616581369|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
170610505|NCT01496846|616581370|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
170610506|NCT01496846|616581371|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
170610507|NCT01496846|616581372|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
170610508|NCT01496846|616581373|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
170610509|NCT01183065|616581385|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
170610510|NCT01128946|616581386|FG000|Period I|Protocol Violation|0|||
170610511|NCT01128946|616581387|FG001|Period I|Protocol Violation|1|||
170610512|NCT01128946|616581388|FG002|Period I|Protocol Violation|0|||
170610513|NCT01128946|616581389|FG003|Period I|Protocol Violation|0|||
170610514|NCT01128946|616581386|FG000|Period I|Withdrawal by Subject|0|||
170610515|NCT01128946|616581387|FG001|Period I|Withdrawal by Subject|0|||
170610516|NCT01128946|616581388|FG002|Period I|Withdrawal by Subject|1|||
170610517|NCT01128946|616581389|FG003|Period I|Withdrawal by Subject|1|||
170610518|NCT01128946|616581386|FG000|Period II|Protocol Violation|0|||
170610519|NCT01128946|616581387|FG001|Period II|Protocol Violation|1|||
170610520|NCT01128946|616581388|FG002|Period II|Protocol Violation|0|||
170610521|NCT01128946|616581389|FG003|Period II|Protocol Violation|0|||
170610522|NCT01128946|616581386|FG000|Period II|Withdrawal by Subject|0|||
170610523|NCT01128946|616581387|FG001|Period II|Withdrawal by Subject|0|||
170610524|NCT01128946|616581388|FG002|Period II|Withdrawal by Subject|0|||
170610525|NCT01128946|616581389|FG003|Period II|Withdrawal by Subject|1|||
170610526|NCT01128946|616581386|FG000|Period III|Protocol Violation|1|||
170610527|NCT01128946|616581387|FG001|Period III|Protocol Violation|0|||
170610528|NCT01128946|616581388|FG002|Period III|Protocol Violation|0|||
170610529|NCT01128946|616581389|FG003|Period III|Protocol Violation|0|||
170610530|NCT04698993|616581390|FG000|Overall Study|PCR results not accessible|2|||
170610531|NCT04698993|616581391|FG001|Overall Study|PCR results not accessible|7|||
170610532|NCT04698993|616581390|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
170610533|NCT04698993|616581391|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
170610534|NCT00379912|616581392|FG000|Overall Study|Lack of Efficacy|1|||
170610535|NCT00379912|616581393|FG001|Overall Study|Lack of Efficacy|0|||
170610536|NCT00206440|616581394|FG000|Overall Study|Protocol Violation|1|||
170610537|NCT00206440|616581395|FG001|Overall Study|Protocol Violation|2|||
170610538|NCT00206440|616581394|FG000|Overall Study|Adverse Event|4|||
170610539|NCT00206440|616581395|FG001|Overall Study|Adverse Event|2|||
170610540|NCT01746225|616581396|FG000|Overall Study|Death|1|||
170610541|NCT01746225|616581397|FG001|Overall Study|Death|0|||
170610542|NCT01746225|616581398|FG002|Overall Study|Death|1|||
170610543|NCT01746225|616581396|FG000|Overall Study|Withdrawal by Subject|5|||
170610544|NCT01746225|616581397|FG001|Overall Study|Withdrawal by Subject|15|||
170610545|NCT01746225|616581398|FG002|Overall Study|Withdrawal by Subject|19|||
170610546|NCT01746225|616581396|FG000|Overall Study|Physician Decision|14|||
170610547|NCT01746225|616581397|FG001|Overall Study|Physician Decision|11|||
170610548|NCT01746225|616581398|FG002|Overall Study|Physician Decision|3|||
170610549|NCT01746225|616581396|FG000|Overall Study|Adverse Event|15|||
170610550|NCT01746225|616581397|FG001|Overall Study|Adverse Event|12|||
170653081|NCT04090411|616743385|FG001|Induction Period|Withdrawal by Subject|0|||
170653082|NCT04090411|616743386|FG002|Induction Period|Withdrawal by Subject|1|||
170653083|NCT04090411|616743387|FG003|Induction Period|Withdrawal by Subject|5|||
170653084|NCT04090411|616743388|FG004|Induction Period|Withdrawal by Subject|0|||
170653085|NCT04090411|616743389|FG005|Induction Period|Withdrawal by Subject|0|||
170653086|NCT04090411|616743390|FG006|Induction Period|Withdrawal by Subject|0|||
170653087|NCT04090411|616743391|FG007|Induction Period|Withdrawal by Subject|0|||
170653088|NCT04090411|616743392|FG008|Induction Period|Withdrawal by Subject|0|||
170653089|NCT04090411|616743393|FG009|Induction Period|Withdrawal by Subject|0|||
170653090|NCT04090411|616743394|FG010|Induction Period|Withdrawal by Subject|0|||
170653091|NCT04090411|616743395|FG011|Induction Period|Withdrawal by Subject|0|||
170653092|NCT04090411|616743396|FG012|Induction Period|Withdrawal by Subject|0|||
170815963|NCT04820023|617335367|FG006|Overall Study|Death|1|||
170815964|NCT04820023|617335368|FG007|Overall Study|Death|0|||
170815965|NCT04820023|617335369|FG008|Overall Study|Death|1|||
170815966|NCT04820023|617335361|FG000|Overall Study|Withdrawal by Subject|1|||
170653093|NCT04090411|616743384|FG000|Chronic Period|Adverse Event|0|||
170653094|NCT04090411|616743385|FG001|Chronic Period|Adverse Event|0|||
170653095|NCT04090411|616743386|FG002|Chronic Period|Adverse Event|0|||
170653096|NCT04090411|616743387|FG003|Chronic Period|Adverse Event|0|||
170653097|NCT04090411|616743388|FG004|Chronic Period|Adverse Event|0|||
170653098|NCT04090411|616743389|FG005|Chronic Period|Adverse Event|1|||
170653099|NCT04090411|616743390|FG006|Chronic Period|Adverse Event|0|||
170653100|NCT04090411|616743391|FG007|Chronic Period|Adverse Event|3|||
170815967|NCT04820023|617335362|FG001|Overall Study|Withdrawal by Subject|2|||
170610551|NCT01746225|616581398|FG002|Overall Study|Adverse Event|17|||
170610552|NCT01746225|616581396|FG000|Overall Study|Continuing Treatment|5|||
170610553|NCT01746225|616581397|FG001|Overall Study|Continuing Treatment|8|||
170610554|NCT01746225|616581398|FG002|Overall Study|Continuing Treatment|3|||
170610555|NCT01298765|616581400|FG000|Titration Period|Adverse Event|26|||
170610556|NCT01298765|616581400|FG000|Titration Period|Death|1|||
170610557|NCT01298765|616581400|FG000|Titration Period|Lack of Efficacy|21|||
170610558|NCT01298765|616581400|FG000|Titration Period|Lost to Follow-up|9|||
170610559|NCT01298765|616581400|FG000|Titration Period|Physician Decision|1|||
170610560|NCT01298765|616581400|FG000|Titration Period|Withdrawal by Subject|10|||
170610561|NCT01298765|616581400|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
170610562|NCT01298765|616581400|FG000|Long-Term Treatment Period|Adverse Event|19|||
170610563|NCT01298765|616581400|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
170610564|NCT01298765|616581400|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
170610565|NCT01298765|616581400|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
170610566|NCT01298765|616581400|FG000|Long-Term Treatment Period|Physician Decision|1|||
170610567|NCT01298765|616581400|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
170610568|NCT03565237|616581401|FG000|Overall Study|Non-compliance of Investigational Product|1|||
170610569|NCT03565237|616581401|FG000|Overall Study|Physician Decision|1|||
170610570|NCT02873338|616581405|FG000|Overall Study|Adverse Event|0|||
170610571|NCT02873338|616581406|FG001|Overall Study|Adverse Event|2|||
170610572|NCT02873338|616581407|FG002|Overall Study|Adverse Event|1|||
170610573|NCT02873338|616581405|FG000|Overall Study|Death|2|||
170610574|NCT02873338|616581406|FG001|Overall Study|Death|1|||
170610575|NCT02873338|616581407|FG002|Overall Study|Death|1|||
170610576|NCT02873338|616581405|FG000|Overall Study|Withdrawal by Subject|2|||
170610577|NCT02873338|616581406|FG001|Overall Study|Withdrawal by Subject|1|||
170610578|NCT02873338|616581407|FG002|Overall Study|Withdrawal by Subject|3|||
170610579|NCT02873338|616581405|FG000|Overall Study|Lack of Efficacy|0|||
170610580|NCT02873338|616581406|FG001|Overall Study|Lack of Efficacy|2|||
170610581|NCT02873338|616581407|FG002|Overall Study|Lack of Efficacy|0|||
170610582|NCT02873338|616581405|FG000|Overall Study|Other or Missing|14|||
170610583|NCT02873338|616581406|FG001|Overall Study|Other or Missing|15|||
170610584|NCT02873338|616581407|FG002|Overall Study|Other or Missing|13|||
170610585|NCT01894243|616581411|FG000|Overall Study|Adverse Event|0|||
170610586|NCT01894243|616581412|FG001|Overall Study|Adverse Event|1|||
170610587|NCT01894243|616581413|FG002|Overall Study|Adverse Event|2|||
170610588|NCT01894243|616581411|FG000|Overall Study|Death|0|||
170610589|NCT01894243|616581412|FG001|Overall Study|Death|0|||
170610590|NCT01894243|616581413|FG002|Overall Study|Death|3|||
170610591|NCT01894243|616581411|FG000|Overall Study|Lack of Efficacy|3|||
170610592|NCT01894243|616581412|FG001|Overall Study|Lack of Efficacy|3|||
170610593|NCT01894243|616581413|FG002|Overall Study|Lack of Efficacy|1|||
170610594|NCT01894243|616581411|FG000|Overall Study|Condition under investigation worsened|8|||
170610595|NCT01894243|616581412|FG001|Overall Study|Condition under investigation worsened|6|||
170610596|NCT01894243|616581413|FG002|Overall Study|Condition under investigation worsened|2|||
170610597|NCT01894243|616581411|FG000|Overall Study|Subject decision|1|||
170610598|NCT01894243|616581412|FG001|Overall Study|Subject decision|0|||
170610599|NCT01894243|616581413|FG002|Overall Study|Subject decision|0|||
170610600|NCT01894243|616581411|FG000|Overall Study|Other|1|||
170610601|NCT01894243|616581412|FG001|Overall Study|Other|0|||
170610602|NCT01894243|616581413|FG002|Overall Study|Other|0|||
170610603|NCT02713828|616581414|FG000|Overall Study|Death|2|||
170610604|NCT02713828|616581415|FG001|Overall Study|Death|0|||
170610605|NCT02713828|616581414|FG000|Overall Study|Withdrawal by Subject|1|||
170610606|NCT02713828|616581415|FG001|Overall Study|Withdrawal by Subject|0|||
170610607|NCT02713828|616581414|FG000|Overall Study|study terminated but patient allowed to|2|||
170610608|NCT02713828|616581415|FG001|Overall Study|study terminated but patient allowed to|0|||
170610609|NCT03302247|616581416|FG000|Overall Study|the study has closed prematurely|2|||
170610610|NCT03302247|616581416|FG000|Overall Study|Death|1|||
170610611|NCT02708355|616581417|FG000|Overall Study|Adverse Event|1|||
170610612|NCT02708355|616581418|FG001|Overall Study|Adverse Event|0|||
170610613|NCT02708355|616581419|FG002|Overall Study|Adverse Event|0|||
170610614|NCT02687581|616581420|FG000|Overall Study|Withdrawal by Subject|1|||
170610615|NCT02687581|616581421|FG001|Overall Study|Withdrawal by Subject|0|||
170610616|NCT02687581|616581422|FG002|Overall Study|Withdrawal by Subject|0|||
170610617|NCT02687581|616581423|FG003|Overall Study|Withdrawal by Subject|1|||
170610618|NCT02687581|616581420|FG000|Overall Study|Lost to Follow-up|2|||
170610619|NCT02687581|616581421|FG001|Overall Study|Lost to Follow-up|2|||
170610620|NCT02687581|616581422|FG002|Overall Study|Lost to Follow-up|0|||
170610621|NCT02687581|616581423|FG003|Overall Study|Lost to Follow-up|0|||
170610622|NCT02687581|616581420|FG000|Overall Study|the device is too small for the patient.|1|||
170610623|NCT02687581|616581421|FG001|Overall Study|the device is too small for the patient.|0|||
170610624|NCT02687581|616581422|FG002|Overall Study|the device is too small for the patient.|0|||
170610625|NCT02687581|616581423|FG003|Overall Study|the device is too small for the patient.|0|||
170610626|NCT03182907|616581424|FG000|Overall Study|Death|3|||
170610627|NCT03182907|616581425|FG001|Overall Study|Death|0|||
170610628|NCT03182907|616581424|FG000|Overall Study|Protocol Violation|4|||
170610629|NCT03182907|616581425|FG001|Overall Study|Protocol Violation|0|||
170610630|NCT03182907|616581424|FG000|Overall Study|Lost to Follow-up|1|||
170610631|NCT03182907|616581425|FG001|Overall Study|Lost to Follow-up|0|||
170610632|NCT03182907|616581424|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170610633|NCT03182907|616581425|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
170610634|NCT00384332|616581430|FG000|Overall Study|Lost to Follow-up|4|||
170610635|NCT00384332|616581431|FG001|Overall Study|Lost to Follow-up|0|||
170610636|NCT04522141|616581434|FG000|Overall Study|Withdrawal by Subject|1|||
170610637|NCT04522141|616581435|FG001|Overall Study|Withdrawal by Subject|0|||
170610638|NCT03508609|616581436|FG000|Overall Study|Withdrawal by Subject|1|||
170610639|NCT01868477|616581438|FG000|Overall Study|Adverse Event|2|||
170610640|NCT01868477|616581439|FG001|Overall Study|Adverse Event|4|||
170610641|NCT01868477|616581438|FG000|Overall Study|Disease progression|1|||
170610642|NCT01868477|616581439|FG001|Overall Study|Disease progression|1|||
170610643|NCT01868477|616581438|FG000|Overall Study|Withdrawal by Subject|1|||
170610644|NCT01868477|616581439|FG001|Overall Study|Withdrawal by Subject|0|||
170610645|NCT04230213|616581440|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
170610646|NCT04230213|616581441|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
170610647|NCT04230213|616581442|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
170610648|NCT04230213|616581440|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
170610649|NCT04230213|616581441|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
170610650|NCT04230213|616581442|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
170610651|NCT04230213|616581440|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
170610652|NCT04230213|616581441|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
170610653|NCT04230213|616581442|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
170610654|NCT04230213|616581440|FG000|TP2: Week 10 to Week 16|Other|0|||
170610655|NCT04230213|616581441|FG001|TP2: Week 10 to Week 16|Other|2|||
170610656|NCT04230213|616581442|FG002|TP2: Week 10 to Week 16|Other|1|||
170610657|NCT04230213|616581440|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
170610658|NCT04230213|616581441|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
170610659|NCT04230213|616581442|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
170610660|NCT04230213|616581440|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
170610661|NCT04230213|616581441|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
170610662|NCT04230213|616581442|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
170610663|NCT04230213|616581440|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
170610664|NCT04230213|616581441|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
170610665|NCT04230213|616581442|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
170610666|NCT04230213|616581440|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
170610667|NCT04230213|616581441|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
170610668|NCT04230213|616581442|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
170610669|NCT04230213|616581440|FG000|TP3: Week 16 to Week 22|Other|0|||
170610670|NCT04230213|616581441|FG001|TP3: Week 16 to Week 22|Other|1|||
170610671|NCT04230213|616581442|FG002|TP3: Week 16 to Week 22|Other|3|||
170610672|NCT04230213|616581440|FG000|TP4: Week 22 to Week 32|Other|0|||
170610673|NCT04230213|616581441|FG001|TP4: Week 22 to Week 32|Other|5|||
170610674|NCT04230213|616581442|FG002|TP4: Week 22 to Week 32|Other|5|||
170610675|NCT04230213|616581440|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
170610676|NCT04230213|616581441|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
170610677|NCT04230213|616581442|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
170610678|NCT04230213|616581440|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
170610679|NCT04230213|616581441|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
170610680|NCT04230213|616581442|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
170610681|NCT04230213|616581440|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
170610682|NCT04230213|616581441|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
170610683|NCT04230213|616581442|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
170610684|NCT04230213|616581440|FG000|Follow up: Week 32 to Week 36|Other|0|||
170610685|NCT04230213|616581441|FG001|Follow up: Week 32 to Week 36|Other|1|||
170610686|NCT04230213|616581442|FG002|Follow up: Week 32 to Week 36|Other|1|||
170610687|NCT00619307|616581449|FG000|Overall Study|Adverse Event|0|||
170610688|NCT00619307|616581450|FG001|Overall Study|Adverse Event|1|||
170610689|NCT00619307|616581449|FG000|Overall Study|Lost to Follow-up|0|||
170610690|NCT00619307|616581450|FG001|Overall Study|Lost to Follow-up|1|||
170653101|NCT04090411|616743392|FG008|Chronic Period|Adverse Event|0|||
170653102|NCT04090411|616743393|FG009|Chronic Period|Adverse Event|0|||
170653103|NCT04090411|616743394|FG010|Chronic Period|Adverse Event|5|||
170610691|NCT00619307|616581449|FG000|Overall Study|Protocol Violation|3|||
170610692|NCT00619307|616581450|FG001|Overall Study|Protocol Violation|0|||
170610693|NCT00619307|616581449|FG000|Overall Study|Withdrew consent|1|||
170610694|NCT00619307|616581450|FG001|Overall Study|Withdrew consent|0|||
170610695|NCT00619307|616581449|FG000|Overall Study|Severe migraine|0|||
170610696|NCT00619307|616581450|FG001|Overall Study|Severe migraine|1|||
170653104|NCT04090411|616743395|FG011|Chronic Period|Adverse Event|1|||
170653105|NCT04090411|616743396|FG012|Chronic Period|Adverse Event|1|||
170916541|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170916542|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170916543|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170916544|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170916545|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170916546|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170916547|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
170610697|NCT00619307|616581449|FG000|Overall Study|MS attack plus steroids|0|||
170610698|NCT00619307|616581450|FG001|Overall Study|MS attack plus steroids|1|||
170610699|NCT02069392|616581453|FG000|Overall Study|Withdrawal by Subject|4|||
170610700|NCT02069392|616581454|FG001|Overall Study|Withdrawal by Subject|2|||
170610701|NCT00269633|616581455|FG000|Overall Study|Withdrawal by Subject|1|||
170610702|NCT00269633|616581456|FG001|Overall Study|Withdrawal by Subject|0|||
170610703|NCT01574651|616581457|FG000|Overall Study|Lost to Follow-up|2|||
170610704|NCT01574651|616581458|FG001|Overall Study|Lost to Follow-up|4|||
170610705|NCT01574651|616581457|FG000|Overall Study|Administrative problems|0|||
170610706|NCT01574651|616581458|FG001|Overall Study|Administrative problems|1|||
170610707|NCT01574651|616581457|FG000|Overall Study|Death|3|||
170610708|NCT01574651|616581458|FG001|Overall Study|Death|3|||
170610709|NCT01574651|616581457|FG000|Overall Study|Patient's inability to use the device|0|||
170610710|NCT01574651|616581458|FG001|Overall Study|Patient's inability to use the device|1|||
170610711|NCT01574651|616581457|FG000|Overall Study|Adverse Event|36|||
170610712|NCT01574651|616581458|FG001|Overall Study|Adverse Event|27|||
170610713|NCT01574651|616581457|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170610714|NCT01574651|616581458|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170610715|NCT01574651|616581457|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170610716|NCT01574651|616581458|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170610717|NCT01574651|616581457|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
170610718|NCT01574651|616581458|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170610719|NCT01574651|616581457|FG000|Overall Study|Protocol Violation|3|||
170610720|NCT01574651|616581458|FG001|Overall Study|Protocol Violation|5|||
170610721|NCT01574651|616581457|FG000|Overall Study|Withdrawal by Subject|9|||
170610722|NCT01574651|616581458|FG001|Overall Study|Withdrawal by Subject|10|||
170610723|NCT03449758|616583542|FG000|Overall Study|Major protocol deviation|1|||
170610724|NCT03449758|616583542|FG000|Overall Study|Treatment inefficacy|5|||
170610725|NCT03449758|616583542|FG000|Overall Study|Adverse Event|9|||
170610726|NCT03449758|616583542|FG000|Overall Study|Consent withdrawal|1|||
170610727|NCT03449758|616583542|FG000|Overall Study|Other unspecified reason|3|||
170610728|NCT00584012|616583546|FG000|Overall Study|Withdrawal by Subject|1|||
170610729|NCT03937713|616583547|FG000|Overall Study|Withdrawal by Subject|3|||
170610730|NCT03937713|616583548|FG001|Overall Study|Withdrawal by Subject|6|||
170610731|NCT03937713|616583547|FG000|Overall Study|Lost to Follow-up|1|||
170610732|NCT03937713|616583548|FG001|Overall Study|Lost to Follow-up|0|||
170610733|NCT02420379|616583549|FG000|Overall Study|Withdrawal by Subject|0|||
170610734|NCT02420379|616583550|FG001|Overall Study|Withdrawal by Subject|3|||
170610735|NCT02420379|616583549|FG000|Overall Study|Unable to complete due to schooling|0|||
170610736|NCT02420379|616583550|FG001|Overall Study|Unable to complete due to schooling|1|||
170610737|NCT02420379|616583549|FG000|Overall Study|Transitioned to commercial drug|1|||
170610738|NCT02420379|616583550|FG001|Overall Study|Transitioned to commercial drug|0|||
170610739|NCT01410890|616583551|FG000|Overall Study|Withdrawal by Subject|0|||
170610740|NCT01410890|616583552|FG001|Overall Study|Withdrawal by Subject|1|||
170610741|NCT03951077|616583553|FG000|Overall Study|Adverse Event|1|||
170610742|NCT03951077|616583554|FG001|Overall Study|Adverse Event|0|||
170610743|NCT03951077|616583555|FG002|Overall Study|Adverse Event|0|||
170610744|NCT03951077|616583556|FG003|Overall Study|Adverse Event|0|||
170610745|NCT03951077|616583557|FG004|Overall Study|Adverse Event|0|||
170610746|NCT03951077|616583558|FG005|Overall Study|Adverse Event|0|||
170610747|NCT03951077|616583553|FG000|Overall Study|Withdrawal by Subject|3|||
170610748|NCT03951077|616583554|FG001|Overall Study|Withdrawal by Subject|3|||
170610749|NCT03951077|616583555|FG002|Overall Study|Withdrawal by Subject|0|||
170610750|NCT03951077|616583556|FG003|Overall Study|Withdrawal by Subject|3|||
170610751|NCT03951077|616583557|FG004|Overall Study|Withdrawal by Subject|3|||
170916548|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
170916549|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170610752|NCT03951077|616583558|FG005|Overall Study|Withdrawal by Subject|2|||
170610753|NCT03951077|616583553|FG000|Overall Study|Lost to Follow-up|1|||
170610754|NCT03951077|616583554|FG001|Overall Study|Lost to Follow-up|1|||
170610755|NCT03951077|616583555|FG002|Overall Study|Lost to Follow-up|2|||
170610756|NCT03951077|616583556|FG003|Overall Study|Lost to Follow-up|3|||
170610757|NCT03951077|616583557|FG004|Overall Study|Lost to Follow-up|2|||
170610758|NCT03951077|616583558|FG005|Overall Study|Lost to Follow-up|3|||
170610759|NCT03951077|616583553|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
170610760|NCT03951077|616583554|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
170653106|NCT04090411|616743384|FG000|Chronic Period|Lack of Efficacy|0|||
170610761|NCT03951077|616583555|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
170610762|NCT03951077|616583556|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
170610763|NCT03951077|616583557|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
170610764|NCT03951077|616583558|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
170610765|NCT03951077|616583553|FG000|Overall Study|Other, Not Specified|12|||
170610766|NCT03951077|616583554|FG001|Overall Study|Other, Not Specified|10|||
170610767|NCT03951077|616583555|FG002|Overall Study|Other, Not Specified|10|||
170610768|NCT03951077|616583556|FG003|Overall Study|Other, Not Specified|5|||
170610769|NCT03951077|616583557|FG004|Overall Study|Other, Not Specified|9|||
170610770|NCT03951077|616583558|FG005|Overall Study|Other, Not Specified|6|||
170610771|NCT03951077|616583553|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
170610772|NCT03951077|616583554|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
170610773|NCT03951077|616583555|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
170610774|NCT03951077|616583556|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
170610775|NCT03951077|616583557|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
170610776|NCT03951077|616583558|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
170610777|NCT00086047|616583559|FG000|Overall Study|Lost to Follow-up|7|||
170610778|NCT00086047|616583560|FG001|Overall Study|Lost to Follow-up|6|||
170610779|NCT00086047|616583559|FG000|Overall Study|Physician Decision|0|||
170610780|NCT00086047|616583560|FG001|Overall Study|Physician Decision|1|||
170610781|NCT03579940|616583561|FG000|Period 2|Withdrawal by Subject|0|||
170610782|NCT03579940|616583562|FG001|Period 2|Withdrawal by Subject|0|||
170610783|NCT03579940|616583563|FG002|Period 2|Withdrawal by Subject|1|||
170610784|NCT03579940|616583564|FG003|Period 2|Withdrawal by Subject|0|||
170610785|NCT03579940|616583565|FG004|Period 2|Withdrawal by Subject|0|||
170610786|NCT03579940|616583566|FG005|Period 2|Withdrawal by Subject|0|||
170610787|NCT03579940|616583567|FG006|Period 2|Withdrawal by Subject|0|||
170610788|NCT03579940|616583568|FG007|Period 2|Withdrawal by Subject|0|||
170610789|NCT03579940|616583569|FG008|Period 2|Withdrawal by Subject|0|||
170610790|NCT03579940|616583570|FG009|Period 2|Withdrawal by Subject|0|||
170610791|NCT03579940|616583571|FG010|Period 2|Withdrawal by Subject|0|||
170610792|NCT01217944|616583572|FG000|Overall Study|Protocol Violation|1|||
170610793|NCT01217944|616583573|FG001|Overall Study|Protocol Violation|1|||
170610794|NCT01217944|616583574|FG002|Overall Study|Protocol Violation|0|||
170610795|NCT01217944|616583572|FG000|Overall Study|Lost to Follow-up|3|||
170610796|NCT01217944|616583573|FG001|Overall Study|Lost to Follow-up|1|||
170610797|NCT01217944|616583574|FG002|Overall Study|Lost to Follow-up|0|||
170610798|NCT01217944|616583572|FG000|Overall Study|Withdrawal by Subject|1|||
170610799|NCT01217944|616583573|FG001|Overall Study|Withdrawal by Subject|2|||
170610800|NCT01217944|616583574|FG002|Overall Study|Withdrawal by Subject|0|||
170610801|NCT01217944|616583572|FG000|Overall Study|Lack of Efficacy|1|||
170610802|NCT01217944|616583573|FG001|Overall Study|Lack of Efficacy|0|||
170610803|NCT01217944|616583574|FG002|Overall Study|Lack of Efficacy|0|||
170610804|NCT00587158|616583575|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
170610805|NCT00587158|616583576|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
170610806|NCT00587158|616583575|FG000|Overall Study|Physician Decision|0|||
170610807|NCT00587158|616583576|FG001|Overall Study|Physician Decision|1|||
170610808|NCT00587158|616583575|FG000|Overall Study|Lost to Follow-up|1|||
170610809|NCT00587158|616583576|FG001|Overall Study|Lost to Follow-up|2|||
170610810|NCT00587158|616583575|FG000|Overall Study|Death|0|||
170610811|NCT00587158|616583576|FG001|Overall Study|Death|1|||
170610812|NCT00587158|616583575|FG000|Overall Study|Subject did not want to take study med|0|||
170610813|NCT00587158|616583576|FG001|Overall Study|Subject did not want to take study med|1|||
170610814|NCT01136408|616583577|FG000|Overall Study|Adverse Event|4|||
170610815|NCT01136408|616583578|FG001|Overall Study|Adverse Event|8|||
170610816|NCT01136408|616583579|FG002|Overall Study|Adverse Event|4|||
170610817|NCT01136408|616583577|FG000|Overall Study|Protocol Violation|1|||
170610818|NCT01136408|616583578|FG001|Overall Study|Protocol Violation|1|||
170610819|NCT01136408|616583579|FG002|Overall Study|Protocol Violation|1|||
170610820|NCT02274792|616583580|FG000|Overall Study|Withdrawal by Subject|13|||
170610821|NCT02274792|616583580|FG000|Overall Study|Lost to Follow-up|8|||
170916550|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170610822|NCT02274792|616583580|FG000|Overall Study|Protocol Specified Criteria|2|||
170610823|NCT02274792|616583580|FG000|Overall Study|Sponsor Decision|2|||
170610824|NCT01510158|616583581|FG000|Overall Study|Adverse Event|7|||
170610825|NCT01510158|616583582|FG001|Overall Study|Adverse Event|8|||
170610826|NCT01510158|616583583|FG002|Overall Study|Adverse Event|5|||
170610827|NCT01510158|616583581|FG000|Overall Study|Gout flare|1|||
170610828|NCT01510158|616583582|FG001|Overall Study|Gout flare|0|||
170610829|NCT01510158|616583583|FG002|Overall Study|Gout flare|0|||
170610830|NCT01510158|616583581|FG000|Overall Study|Protocol Violation|17|||
170653107|NCT04090411|616743385|FG001|Chronic Period|Lack of Efficacy|0|||
170916551|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170916552|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170610831|NCT01510158|616583582|FG001|Overall Study|Protocol Violation|16|||
170610832|NCT01510158|616583583|FG002|Overall Study|Protocol Violation|24|||
170653108|NCT04090411|616743386|FG002|Chronic Period|Lack of Efficacy|0|||
170653109|NCT04090411|616743387|FG003|Chronic Period|Lack of Efficacy|0|||
170653110|NCT04090411|616743388|FG004|Chronic Period|Lack of Efficacy|0|||
170653111|NCT04090411|616743389|FG005|Chronic Period|Lack of Efficacy|0|||
170653112|NCT04090411|616743390|FG006|Chronic Period|Lack of Efficacy|1|||
170653113|NCT04090411|616743391|FG007|Chronic Period|Lack of Efficacy|4|||
170653114|NCT04090411|616743392|FG008|Chronic Period|Lack of Efficacy|2|||
170653115|NCT04090411|616743393|FG009|Chronic Period|Lack of Efficacy|2|||
170653116|NCT04090411|616743394|FG010|Chronic Period|Lack of Efficacy|2|||
170653117|NCT04090411|616743395|FG011|Chronic Period|Lack of Efficacy|1|||
170653118|NCT04090411|616743396|FG012|Chronic Period|Lack of Efficacy|2|||
170653119|NCT04090411|616743384|FG000|Chronic Period|Relocation|0|||
170653120|NCT04090411|616743385|FG001|Chronic Period|Relocation|0|||
170653121|NCT04090411|616743386|FG002|Chronic Period|Relocation|0|||
170653122|NCT04090411|616743387|FG003|Chronic Period|Relocation|0|||
170653123|NCT04090411|616743388|FG004|Chronic Period|Relocation|0|||
170653124|NCT04090411|616743389|FG005|Chronic Period|Relocation|0|||
170653125|NCT04090411|616743390|FG006|Chronic Period|Relocation|0|||
170653126|NCT04090411|616743391|FG007|Chronic Period|Relocation|1|||
170653127|NCT04090411|616743392|FG008|Chronic Period|Relocation|0|||
170653128|NCT04090411|616743393|FG009|Chronic Period|Relocation|0|||
170653129|NCT04090411|616743394|FG010|Chronic Period|Relocation|0|||
170653130|NCT04090411|616743395|FG011|Chronic Period|Relocation|0|||
170653131|NCT04090411|616743396|FG012|Chronic Period|Relocation|0|||
170653132|NCT04090411|616743384|FG000|Chronic Period|Physician Decision|0|||
170653133|NCT04090411|616743385|FG001|Chronic Period|Physician Decision|0|||
170653134|NCT04090411|616743386|FG002|Chronic Period|Physician Decision|0|||
170653135|NCT04090411|616743387|FG003|Chronic Period|Physician Decision|0|||
170653136|NCT04090411|616743388|FG004|Chronic Period|Physician Decision|1|||
170653137|NCT04090411|616743389|FG005|Chronic Period|Physician Decision|0|||
170653138|NCT04090411|616743390|FG006|Chronic Period|Physician Decision|0|||
170653139|NCT04090411|616743391|FG007|Chronic Period|Physician Decision|1|||
170653140|NCT04090411|616743392|FG008|Chronic Period|Physician Decision|0|||
170653141|NCT04090411|616743393|FG009|Chronic Period|Physician Decision|0|||
170653142|NCT04090411|616743394|FG010|Chronic Period|Physician Decision|0|||
170653143|NCT04090411|616743395|FG011|Chronic Period|Physician Decision|1|||
170653144|NCT04090411|616743396|FG012|Chronic Period|Physician Decision|1|||
170653145|NCT04090411|616743384|FG000|Chronic Period|Protocol Violation|0|||
170653146|NCT04090411|616743385|FG001|Chronic Period|Protocol Violation|0|||
170653147|NCT04090411|616743386|FG002|Chronic Period|Protocol Violation|0|||
170653148|NCT04090411|616743387|FG003|Chronic Period|Protocol Violation|0|||
170653149|NCT04090411|616743388|FG004|Chronic Period|Protocol Violation|0|||
170653150|NCT04090411|616743389|FG005|Chronic Period|Protocol Violation|0|||
170653151|NCT04090411|616743390|FG006|Chronic Period|Protocol Violation|0|||
170653152|NCT04090411|616743391|FG007|Chronic Period|Protocol Violation|0|||
170653153|NCT04090411|616743392|FG008|Chronic Period|Protocol Violation|0|||
170653154|NCT04090411|616743393|FG009|Chronic Period|Protocol Violation|0|||
170653155|NCT04090411|616743394|FG010|Chronic Period|Protocol Violation|0|||
170653156|NCT04090411|616743395|FG011|Chronic Period|Protocol Violation|0|||
170653157|NCT04090411|616743396|FG012|Chronic Period|Protocol Violation|1|||
170653158|NCT04090411|616743384|FG000|Chronic Period|Withdrawal by Subject|0|||
170653159|NCT04090411|616743385|FG001|Chronic Period|Withdrawal by Subject|0|||
170653160|NCT04090411|616743386|FG002|Chronic Period|Withdrawal by Subject|0|||
170653161|NCT04090411|616743387|FG003|Chronic Period|Withdrawal by Subject|0|||
170653162|NCT04090411|616743388|FG004|Chronic Period|Withdrawal by Subject|0|||
170653163|NCT04090411|616743389|FG005|Chronic Period|Withdrawal by Subject|1|||
170653164|NCT04090411|616743390|FG006|Chronic Period|Withdrawal by Subject|1|||
170653165|NCT04090411|616743391|FG007|Chronic Period|Withdrawal by Subject|3|||
170653166|NCT04090411|616743392|FG008|Chronic Period|Withdrawal by Subject|3|||
170653167|NCT04090411|616743393|FG009|Chronic Period|Withdrawal by Subject|3|||
170653168|NCT04090411|616743394|FG010|Chronic Period|Withdrawal by Subject|1|||
170653169|NCT04090411|616743395|FG011|Chronic Period|Withdrawal by Subject|3|||
170653170|NCT04090411|616743396|FG012|Chronic Period|Withdrawal by Subject|0|||
170610833|NCT01510158|616583581|FG000|Overall Study|Sponsor terminated study.|2|||
170610834|NCT01510158|616583582|FG001|Overall Study|Sponsor terminated study.|0|||
170610835|NCT01510158|616583583|FG002|Overall Study|Sponsor terminated study.|2|||
170610836|NCT01510158|616583581|FG000|Overall Study|Lost to Follow-up|13|||
170610837|NCT01510158|616583582|FG001|Overall Study|Lost to Follow-up|16|||
170610838|NCT01510158|616583583|FG002|Overall Study|Lost to Follow-up|9|||
170610839|NCT01510158|616583581|FG000|Overall Study|Withdrawal by Subject|10|||
170610840|NCT01510158|616583582|FG001|Overall Study|Withdrawal by Subject|13|||
170610841|NCT01510158|616583583|FG002|Overall Study|Withdrawal by Subject|10|||
170610842|NCT01510158|616583581|FG000|Overall Study|Death|1|||
170610843|NCT01510158|616583582|FG001|Overall Study|Death|0|||
170610844|NCT01510158|616583583|FG002|Overall Study|Death|0|||
170610845|NCT03078556|616583584|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
170610846|NCT03078556|616583585|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
170610847|NCT03078556|616583586|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
170610848|NCT03078556|616583587|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
170610849|NCT03078556|616583584|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
170610850|NCT03078556|616583585|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
170610851|NCT03078556|616583586|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
170610852|NCT03078556|616583587|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
170610853|NCT03078556|616583584|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
170610854|NCT03078556|616583585|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
170610855|NCT03078556|616583586|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
170610856|NCT03078556|616583587|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
170610857|NCT03078556|616583584|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
170610858|NCT03078556|616583585|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
170610859|NCT03078556|616583586|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
170610860|NCT03078556|616583587|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
170610861|NCT00832416|616583588|FG000|Overall Study|Lack of Efficacy|17|||
170610862|NCT00832416|616583589|FG001|Overall Study|Lack of Efficacy|15|||
170610863|NCT00832416|616583590|FG002|Overall Study|Lack of Efficacy|13|||
170610864|NCT00832416|616583591|FG003|Overall Study|Lack of Efficacy|52|||
170610865|NCT00832416|616583588|FG000|Overall Study|Withdrawal by Subject|5|||
170610866|NCT00832416|616583589|FG001|Overall Study|Withdrawal by Subject|7|||
170610867|NCT00832416|616583590|FG002|Overall Study|Withdrawal by Subject|2|||
170610868|NCT00832416|616583591|FG003|Overall Study|Withdrawal by Subject|10|||
170610869|NCT00832416|616583588|FG000|Overall Study|Physician Decision|2|||
170610870|NCT00832416|616583589|FG001|Overall Study|Physician Decision|12|||
170610871|NCT00832416|616583590|FG002|Overall Study|Physician Decision|5|||
170610872|NCT00832416|616583591|FG003|Overall Study|Physician Decision|10|||
170610873|NCT00832416|616583588|FG000|Overall Study|Administrative|0|||
170610874|NCT00832416|616583589|FG001|Overall Study|Administrative|0|||
170610875|NCT00832416|616583590|FG002|Overall Study|Administrative|0|||
170610876|NCT00832416|616583591|FG003|Overall Study|Administrative|1|||
170610877|NCT00832416|616583588|FG000|Overall Study|Adverse Event|21|||
170610878|NCT00832416|616583589|FG001|Overall Study|Adverse Event|19|||
170610879|NCT00832416|616583590|FG002|Overall Study|Adverse Event|41|||
170610880|NCT00832416|616583591|FG003|Overall Study|Adverse Event|10|||
170610881|NCT00832416|616583588|FG000|Overall Study|Death|1|||
170610882|NCT00832416|616583589|FG001|Overall Study|Death|0|||
170610883|NCT00832416|616583590|FG002|Overall Study|Death|0|||
170610884|NCT00832416|616583591|FG003|Overall Study|Death|0|||
170610885|NCT04421482|616583598|FG000|Overall Study|Physician Decision|1|||
170610886|NCT03010319|616583601|FG000|Overall Study|Adverse Event|15|||
170610887|NCT03010319|616583602|FG001|Overall Study|Adverse Event|9|||
170610888|NCT03010319|616583601|FG000|Overall Study|Withdrawal by Subject|1|||
170610889|NCT03010319|616583602|FG001|Overall Study|Withdrawal by Subject|6|||
170610890|NCT03010319|616583601|FG000|Overall Study|Physician Decision|2|||
170610891|NCT03010319|616583602|FG001|Overall Study|Physician Decision|4|||
170610892|NCT03010319|616583601|FG000|Overall Study|Sponsor requested withdrawal|2|||
170610893|NCT03010319|616583602|FG001|Overall Study|Sponsor requested withdrawal|2|||
170610894|NCT03010319|616583601|FG000|Overall Study|Death|1|||
170610895|NCT03010319|616583602|FG001|Overall Study|Death|0|||
170610896|NCT03010319|616583601|FG000|Overall Study|Lost to Follow-up|0|||
170610897|NCT03010319|616583602|FG001|Overall Study|Lost to Follow-up|1|||
170610898|NCT03010319|616583601|FG000|Overall Study|Other Reason|5|||
170610899|NCT03010319|616583602|FG001|Overall Study|Other Reason|7|||
170610900|NCT03781778|616583603|FG000|Overall Study|Withdrawal by Subject|2|||
170610901|NCT03781778|616583604|FG001|Overall Study|Withdrawal by Subject|2|||
170610902|NCT04343755|616583608|FG000|Overall Study|Death|11|||
170610903|NCT04343755|616583608|FG000|Overall Study|Screen Failure|1|||
170610904|NCT02292446|616583609|FG000|Overall Study|Adverse Event|12|||
170610905|NCT02292446|616583609|FG000|Overall Study|Death|1|||
170610906|NCT02292446|616583609|FG000|Overall Study|Disease progression|2|||
170610907|NCT02292446|616583609|FG000|Overall Study|Subject/guardian decision|2|||
170610908|NCT02292446|616583609|FG000|Overall Study|Withdrawal by Subject|3|||
170610909|NCT03920254|616583615|FG000|Overall Study|Adverse Event|1|||
170610910|NCT03920254|616583616|FG001|Overall Study|Adverse Event|0|||
170610911|NCT03920254|616583617|FG002|Overall Study|Adverse Event|0|||
170653171|NCT02520089|616743398|FG000|Overall Study|Lost to Follow-up|3|||
170653172|NCT02520089|616743399|FG001|Overall Study|Lost to Follow-up|4|||
170653173|NCT01037088|616743402|FG000|Overall Study|Withdrawal by Subject|3|||
170653174|NCT04030026|616743405|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
170653175|NCT04030026|616743406|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
170653176|NCT04030026|616743405|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
170653177|NCT04030026|616743406|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
170653178|NCT04030026|616743405|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
170653179|NCT04030026|616743406|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
170653180|NCT04030026|616743405|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
170815968|NCT04820023|617335363|FG002|Overall Study|Withdrawal by Subject|2|||
170815969|NCT04820023|617335364|FG003|Overall Study|Withdrawal by Subject|1|||
170815970|NCT04820023|617335365|FG004|Overall Study|Withdrawal by Subject|4|||
170815971|NCT04820023|617335366|FG005|Overall Study|Withdrawal by Subject|3|||
170815972|NCT04820023|617335367|FG006|Overall Study|Withdrawal by Subject|3|||
170653181|NCT04030026|616743406|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
170815973|NCT04820023|617335368|FG007|Overall Study|Withdrawal by Subject|6|||
170815974|NCT04820023|617335369|FG008|Overall Study|Withdrawal by Subject|5|||
170815975|NCT04820023|617335361|FG000|Overall Study|Progressive Disease|3|||
170815976|NCT04820023|617335362|FG001|Overall Study|Progressive Disease|0|||
170815977|NCT04820023|617335363|FG002|Overall Study|Progressive Disease|2|||
170815978|NCT04820023|617335364|FG003|Overall Study|Progressive Disease|2|||
170815979|NCT04820023|617335365|FG004|Overall Study|Progressive Disease|2|||
170815980|NCT04820023|617335366|FG005|Overall Study|Progressive Disease|0|||
170815981|NCT04820023|617335367|FG006|Overall Study|Progressive Disease|1|||
170815982|NCT04820023|617335368|FG007|Overall Study|Progressive Disease|1|||
170610912|NCT03920254|616583615|FG000|Overall Study|Physician Decision|0|||
170610913|NCT03920254|616583616|FG001|Overall Study|Physician Decision|1|||
170610914|NCT03920254|616583617|FG002|Overall Study|Physician Decision|2|||
170610915|NCT03920254|616583615|FG000|Overall Study|Study Terminated By Sponsor|12|||
170610916|NCT03920254|616583616|FG001|Overall Study|Study Terminated By Sponsor|17|||
170610917|NCT03920254|616583617|FG002|Overall Study|Study Terminated By Sponsor|12|||
170610918|NCT03920254|616583615|FG000|Overall Study|Withdrawal by Subject|0|||
170610919|NCT03920254|616583616|FG001|Overall Study|Withdrawal by Subject|0|||
170610920|NCT03920254|616583617|FG002|Overall Study|Withdrawal by Subject|1|||
170610921|NCT02652156|616583618|FG000|Overall Study|Physician Decision|1|||
170610922|NCT02652156|616583619|FG001|Overall Study|Physician Decision|0|||
170610923|NCT02652156|616583620|FG002|Overall Study|Physician Decision|0|||
170610924|NCT03594773|616583621|FG000|Overall Study|Withdrawal by Subject|3|||
170916553|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
170916554|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916555|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916556|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916557|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916558|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916559|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916560|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916561|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
170916562|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916563|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916564|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916565|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916566|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916567|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
170916568|NCT04033445|617695744|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916569|NCT04033445|617695745|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916570|NCT04033445|617695746|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916571|NCT04033445|617695747|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916572|NCT04033445|617695748|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916573|NCT04033445|617695749|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916574|NCT04033445|617695750|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916575|NCT04033445|617695751|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
170916576|NCT04033445|617695752|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916577|NCT04033445|617695753|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916578|NCT04033445|617695754|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916579|NCT04033445|617695755|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916580|NCT04033445|617695756|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916581|NCT04033445|617695757|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
170916582|NCT04033445|617695744|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916583|NCT04033445|617695745|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916584|NCT04033445|617695746|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916585|NCT04033445|617695747|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916586|NCT04033445|617695748|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916587|NCT04033445|617695749|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916588|NCT04033445|617695750|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916589|NCT04033445|617695751|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916590|NCT04033445|617695752|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
170916591|NCT04033445|617695753|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
170916592|NCT04033445|617695754|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
170916593|NCT04033445|617695755|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
170916594|NCT04033445|617695756|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
170916595|NCT04033445|617695757|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
170916596|NCT04033445|617695744|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916597|NCT04033445|617695745|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916598|NCT04033445|617695746|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916599|NCT04033445|617695747|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916600|NCT04033445|617695748|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916601|NCT04033445|617695749|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916602|NCT04033445|617695750|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916603|NCT04033445|617695751|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916604|NCT04033445|617695752|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
170916605|NCT04033445|617695753|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
170916606|NCT04033445|617695754|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
170916607|NCT04033445|617695755|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
170916608|NCT04033445|617695756|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
170916609|NCT04033445|617695757|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
170916610|NCT04033445|617695744|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916611|NCT04033445|617695745|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916612|NCT04033445|617695746|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916613|NCT04033445|617695747|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916614|NCT04033445|617695748|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916615|NCT04033445|617695749|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916616|NCT04033445|617695750|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916617|NCT04033445|617695751|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916618|NCT04033445|617695752|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170653182|NCT04030026|616743405|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
170653183|NCT04030026|616743406|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
170916619|NCT04033445|617695753|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916620|NCT04033445|617695754|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
170916621|NCT04033445|617695755|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
170916622|NCT04033445|617695756|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
170916623|NCT04033445|617695757|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
170916624|NCT04033445|617695744|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916625|NCT04033445|617695745|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916626|NCT04033445|617695746|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916627|NCT04033445|617695747|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170653184|NCT04030026|616743405|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
170815983|NCT04820023|617335369|FG008|Overall Study|Progressive Disease|0|||
170815984|NCT04820023|617335361|FG000|Overall Study|New anti-cancer therapy|0|||
170815985|NCT04820023|617335362|FG001|Overall Study|New anti-cancer therapy|0|||
170815986|NCT04820023|617335363|FG002|Overall Study|New anti-cancer therapy|0|||
170815987|NCT04820023|617335364|FG003|Overall Study|New anti-cancer therapy|0|||
170815988|NCT04820023|617335365|FG004|Overall Study|New anti-cancer therapy|2|||
170815989|NCT04820023|617335366|FG005|Overall Study|New anti-cancer therapy|0|||
170815990|NCT04820023|617335367|FG006|Overall Study|New anti-cancer therapy|0|||
170815991|NCT04820023|617335368|FG007|Overall Study|New anti-cancer therapy|0|||
170815992|NCT04820023|617335369|FG008|Overall Study|New anti-cancer therapy|0|||
170815993|NCT04820023|617335361|FG000|Overall Study|Other|0|||
170815994|NCT04820023|617335362|FG001|Overall Study|Other|1|||
170815995|NCT04820023|617335363|FG002|Overall Study|Other|0|||
170815996|NCT04820023|617335364|FG003|Overall Study|Other|0|||
170815997|NCT04820023|617335365|FG004|Overall Study|Other|0|||
170815998|NCT04820023|617335366|FG005|Overall Study|Other|0|||
170815999|NCT04820023|617335367|FG006|Overall Study|Other|0|||
170816000|NCT04820023|617335368|FG007|Overall Study|Other|2|||
170816001|NCT04820023|617335369|FG008|Overall Study|Other|0|||
170816002|NCT01005602|617335371|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
170816003|NCT01005602|617335372|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
170816004|NCT03409276|617335378|FG000|Overall Study|Withdrawal by Subject|0|||
170816005|NCT03409276|617335379|FG001|Overall Study|Withdrawal by Subject|0|||
170816006|NCT03409276|617335380|FG002|Overall Study|Withdrawal by Subject|0|||
170816007|NCT03409276|617335381|FG003|Overall Study|Withdrawal by Subject|0|||
170816008|NCT03409276|617335382|FG004|Overall Study|Withdrawal by Subject|1|||
170816009|NCT03409276|617335378|FG000|Overall Study|Lost to Follow-up|0|||
170816010|NCT03409276|617335379|FG001|Overall Study|Lost to Follow-up|0|||
170816011|NCT03409276|617335380|FG002|Overall Study|Lost to Follow-up|0|||
170816012|NCT03409276|617335381|FG003|Overall Study|Lost to Follow-up|2|||
170816013|NCT03409276|617335382|FG004|Overall Study|Lost to Follow-up|2|||
170816014|NCT03761849|617335387|FG000|Overall Study|transferred to OpenLabelExtension|35|||
170816015|NCT03761849|617335388|FG001|Overall Study|transferred to OpenLabelExtension|34|||
170816016|NCT03761849|617335389|FG002|Overall Study|transferred to OpenLabelExtension|36|||
170816017|NCT03761849|617335390|FG003|Overall Study|transferred to OpenLabelExtension|0|||
170816018|NCT03761849|617335391|FG004|Overall Study|transferred to OpenLabelExtension|0|||
170816019|NCT03761849|617335392|FG005|Overall Study|transferred to OpenLabelExtension|0|||
170816020|NCT03761849|617335387|FG000|Overall Study|Adverse Event|1|||
170816021|NCT03761849|617335388|FG001|Overall Study|Adverse Event|0|||
170816022|NCT03761849|617335389|FG002|Overall Study|Adverse Event|0|||
170816023|NCT03761849|617335390|FG003|Overall Study|Adverse Event|0|||
170816024|NCT03761849|617335391|FG004|Overall Study|Adverse Event|2|||
170816025|NCT03761849|617335392|FG005|Overall Study|Adverse Event|3|||
170816026|NCT03761849|617335387|FG000|Overall Study|Withdrawal by Subject|0|||
170816027|NCT03761849|617335388|FG001|Overall Study|Withdrawal by Subject|0|||
170816028|NCT03761849|617335389|FG002|Overall Study|Withdrawal by Subject|0|||
170816029|NCT03761849|617335390|FG003|Overall Study|Withdrawal by Subject|41|||
170816030|NCT03761849|617335391|FG004|Overall Study|Withdrawal by Subject|43|||
170816031|NCT03761849|617335392|FG005|Overall Study|Withdrawal by Subject|35|||
170816032|NCT03761849|617335387|FG000|Overall Study|Lost to Follow-up|0|||
170816033|NCT03761849|617335388|FG001|Overall Study|Lost to Follow-up|1|||
170816034|NCT03761849|617335389|FG002|Overall Study|Lost to Follow-up|0|||
170816035|NCT03761849|617335390|FG003|Overall Study|Lost to Follow-up|2|||
170816036|NCT03761849|617335391|FG004|Overall Study|Lost to Follow-up|4|||
170653185|NCT04030026|616743406|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
170653186|NCT04030026|616743405|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
170653187|NCT04030026|616743406|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
170653188|NCT00811642|616743407|FG000|Overall Study|Adverse Event|3|||
170916628|NCT04033445|617695748|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916629|NCT04033445|617695749|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916630|NCT04033445|617695750|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916631|NCT04033445|617695751|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916632|NCT04033445|617695752|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916633|NCT04033445|617695753|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
170916634|NCT04033445|617695754|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
170916635|NCT04033445|617695755|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
170916636|NCT04033445|617695756|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
170916637|NCT04033445|617695757|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
170916638|NCT04033445|617695744|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916639|NCT04033445|617695745|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916640|NCT04033445|617695746|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916641|NCT04033445|617695747|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916642|NCT04033445|617695748|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916643|NCT04033445|617695749|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916644|NCT04033445|617695750|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916645|NCT04033445|617695751|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916646|NCT04033445|617695752|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
170916647|NCT04033445|617695753|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
170916648|NCT04033445|617695754|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
170916649|NCT04033445|617695755|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
170916650|NCT04033445|617695756|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
170916651|NCT04033445|617695757|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
170916652|NCT04033445|617695744|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916653|NCT04033445|617695745|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916654|NCT04033445|617695746|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916655|NCT04033445|617695747|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916656|NCT04033445|617695748|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916657|NCT04033445|617695749|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916658|NCT04033445|617695750|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916659|NCT04033445|617695751|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916660|NCT04033445|617695752|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916661|NCT04033445|617695753|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916662|NCT04033445|617695754|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916663|NCT04033445|617695755|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916664|NCT04033445|617695756|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
170916665|NCT04033445|617695757|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
170916666|NCT04033445|617695744|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916667|NCT04033445|617695745|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916668|NCT04033445|617695746|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916669|NCT04033445|617695747|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916670|NCT04033445|617695748|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916671|NCT04033445|617695749|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916672|NCT04033445|617695750|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916673|NCT04033445|617695751|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916674|NCT04033445|617695752|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
170916675|NCT04033445|617695753|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
170916676|NCT04033445|617695754|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
170916677|NCT04033445|617695755|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
170916678|NCT04033445|617695756|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
170916679|NCT04033445|617695757|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
170916680|NCT04033445|617695744|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916681|NCT04033445|617695745|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916682|NCT04033445|617695746|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916683|NCT04033445|617695747|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916684|NCT04033445|617695748|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916685|NCT04033445|617695749|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916686|NCT04033445|617695750|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170653189|NCT00811642|616743407|FG000|Overall Study|Protocol Violation|1|||
170653190|NCT00811642|616743407|FG000|Overall Study|Death|2|||
170653191|NCT00811642|616743407|FG000|Overall Study|Withdrawal by Subject|7|||
170653192|NCT00811642|616743407|FG000|Overall Study|Cumulative use of antifungal agent|2|||
170653193|NCT02829944|616743411|FG000|Overall Study|Physician Decision|0|||
170653194|NCT02829944|616743412|FG001|Overall Study|Physician Decision|1|||
170653195|NCT02829944|616743411|FG000|Overall Study|Screen Failure|2|||
170653196|NCT02829944|616743412|FG001|Overall Study|Screen Failure|2|||
170653197|NCT02829944|616743411|FG000|Overall Study|Inadequate Neuraxial Block|1|||
170653198|NCT02829944|616743412|FG001|Overall Study|Inadequate Neuraxial Block|1|||
170653199|NCT02829944|616743411|FG000|Overall Study|Withdrawal by Subject|2|||
170653200|NCT02829944|616743412|FG001|Overall Study|Withdrawal by Subject|1|||
170653201|NCT02829944|616743411|FG000|Overall Study|Catheter Displacement|1|||
170653202|NCT02829944|616743412|FG001|Overall Study|Catheter Displacement|0|||
170653203|NCT02829944|616743411|FG000|Overall Study|Catheter broke|0|||
170653204|NCT02829944|616743412|FG001|Overall Study|Catheter broke|1|||
170653205|NCT02829944|616743411|FG000|Overall Study|Staff unavailable|0|||
170653206|NCT02829944|616743412|FG001|Overall Study|Staff unavailable|1|||
170653207|NCT05856760|616743416|FG000|Overall Study|Adverse Event|2|||
170653208|NCT05856760|616743416|FG000|Overall Study|Physician Decision|1|||
170653209|NCT05856760|616743416|FG000|Overall Study|Protocol Violation|1|||
170653210|NCT05856760|616743416|FG000|Overall Study|Withdrawal by Subject|3|||
170653211|NCT00960570|616743417|FG000|21 Day Washout Period|Adverse Event|1|||
170653212|NCT00960570|616743417|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
170653213|NCT00960570|616743417|FG000|1 Day Period Between Dosing|Adverse Event|2|||
170653214|NCT00960570|616743417|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
170653215|NCT01879579|616744623|FG000|Overall Study|Phone incompatible with texting platform|3|||
170653216|NCT01879579|616744624|FG001|Overall Study|Phone incompatible with texting platform|0|||
170653217|NCT01879579|616744623|FG000|Overall Study|Did not enroll in texting platform|1|||
170916687|NCT04033445|617695751|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916688|NCT04033445|617695752|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916689|NCT04033445|617695753|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
170916690|NCT04033445|617695754|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170916691|NCT04033445|617695755|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
170916692|NCT04033445|617695756|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
170916693|NCT04033445|617695757|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
170653218|NCT01879579|616744624|FG001|Overall Study|Did not enroll in texting platform|0|||
170653219|NCT01879579|616744623|FG000|Overall Study|Did not initiate insulin treatment|1|||
170653220|NCT01879579|616744624|FG001|Overall Study|Did not initiate insulin treatment|0|||
170653221|NCT01879579|616744623|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
170653222|NCT01879579|616744624|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
170653223|NCT01879579|616744623|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
170653224|NCT01879579|616744624|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
170653225|NCT00562627|616744625|FG000|Overall Study|Protocol Violation|1|||
170653226|NCT00562627|616744626|FG001|Overall Study|Protocol Violation|1|||
170653227|NCT00562627|616744627|FG002|Overall Study|Protocol Violation|1|||
170653228|NCT05710185|616744629|FG000|Overall Study|Adverse Event|1|||
170653229|NCT05710185|616744629|FG000|Overall Study|Lack of Efficacy|1|||
170610925|NCT03594773|616583622|FG001|Overall Study|Withdrawal by Subject|2|||
170610926|NCT03594773|616583621|FG000|Overall Study|Lost to Follow-up|3|||
170610927|NCT03594773|616583622|FG001|Overall Study|Lost to Follow-up|4|||
170610928|NCT00496080|616583625|FG000|Overall Study|Lost to Follow-up|9|||
170610929|NCT00496080|616583625|FG000|Overall Study|Surgical re-intervention|7|||
170610930|NCT00496080|616583625|FG000|Overall Study|Withdrawal by Subject|5|||
170610931|NCT00496080|616583625|FG000|Overall Study|Physician Decision|6|||
170610932|NCT00479336|616583626|FG000|Overall Study|Adverse Event|1|||
170610933|NCT00479336|616583627|FG001|Overall Study|Adverse Event|1|||
170653230|NCT03468543|616744632|FG000|Overall Study|Protocol stopping rules met|3|||
170653231|NCT06460493|616744633|FG000|Overall Study|Withdrawal by Subject|2|||
170653232|NCT02987660|616744636|FG000|Overall Study|Study terminated by sponsor|10|||
170653233|NCT02987660|616744637|FG001|Overall Study|Study terminated by sponsor|10|||
170610934|NCT00479336|616583628|FG002|Overall Study|Adverse Event|1|||
170610935|NCT00479336|616583629|FG003|Overall Study|Adverse Event|3|||
170610936|NCT00479336|616583626|FG000|Overall Study|Lack of Efficacy|1|||
170610937|NCT00479336|616583627|FG001|Overall Study|Lack of Efficacy|0|||
170610938|NCT00479336|616583628|FG002|Overall Study|Lack of Efficacy|0|||
170610939|NCT00479336|616583629|FG003|Overall Study|Lack of Efficacy|0|||
170610940|NCT00479336|616583626|FG000|Overall Study|Protocol Violation|0|||
170610941|NCT00479336|616583627|FG001|Overall Study|Protocol Violation|1|||
170610942|NCT00479336|616583628|FG002|Overall Study|Protocol Violation|0|||
170610943|NCT00479336|616583629|FG003|Overall Study|Protocol Violation|0|||
170610944|NCT00479336|616583626|FG000|Overall Study|Withdrawal by Subject|1|||
170610945|NCT00479336|616583627|FG001|Overall Study|Withdrawal by Subject|2|||
170610946|NCT00479336|616583628|FG002|Overall Study|Withdrawal by Subject|0|||
170610947|NCT00479336|616583629|FG003|Overall Study|Withdrawal by Subject|0|||
170610948|NCT00479336|616583626|FG000|Overall Study|Physician Decision|0|||
170610949|NCT00479336|616583627|FG001|Overall Study|Physician Decision|1|||
170610950|NCT00479336|616583628|FG002|Overall Study|Physician Decision|0|||
170610951|NCT00479336|616583629|FG003|Overall Study|Physician Decision|2|||
170610952|NCT00479336|616583626|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
170610953|NCT00479336|616583627|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
170610954|NCT00479336|616583628|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
170610955|NCT00479336|616583629|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
170816037|NCT03761849|617335392|FG005|Overall Study|Lost to Follow-up|5|||
170816038|NCT03761849|617335387|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
170610956|NCT02741596|616583630|FG000|Overall Study|Adverse Event|1|||
170610957|NCT02741596|616583631|FG001|Overall Study|Adverse Event|5|||
170610958|NCT02741596|616583630|FG000|Overall Study|Lost to Follow-up|1|||
170816039|NCT03761849|617335388|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
170816040|NCT03761849|617335389|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
170816041|NCT03761849|617335390|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
170816042|NCT03761849|617335391|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
170610959|NCT02741596|616583631|FG001|Overall Study|Lost to Follow-up|1|||
170610960|NCT02741596|616583630|FG000|Overall Study|Physician Decision|2|||
170610961|NCT02741596|616583631|FG001|Overall Study|Physician Decision|1|||
170610962|NCT02741596|616583630|FG000|Overall Study|Pregnancy|3|||
170610963|NCT02741596|616583631|FG001|Overall Study|Pregnancy|1|||
170610964|NCT02741596|616583630|FG000|Overall Study|Other (Unspecified)|0|||
170610965|NCT02741596|616583631|FG001|Overall Study|Other (Unspecified)|3|||
170610966|NCT02741596|616583630|FG000|Overall Study|Subject withdrawn-Other|17|||
170610967|NCT02741596|616583631|FG001|Overall Study|Subject withdrawn-Other|4|||
170610968|NCT02741596|616583630|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
170610969|NCT02741596|616583631|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
170610970|NCT02021643|616583632|FG000|Overall Study|Enrolled but Never Treated|1|||
170610971|NCT02021643|616583633|FG001|Overall Study|Enrolled but Never Treated|0|||
170610972|NCT02021643|616583634|FG002|Overall Study|Enrolled but Never Treated|0|||
170816043|NCT03761849|617335392|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
170816044|NCT03761849|617335387|FG000|Overall Study|Physician Decision|0|||
170816045|NCT03761849|617335388|FG001|Overall Study|Physician Decision|0|||
170916694|NCT03960476|617695758|FG000|1 month Assessment|Unable to Contact|4|||
170916695|NCT03960476|617695758|FG000|1 month Assessment|Subject Declined Assessment|2|||
170916696|NCT03960476|617695758|FG000|6 Month Assessment|Death|1|||
170916697|NCT03960476|617695758|FG000|6 Month Assessment|Unable to Contact|4|||
170916698|NCT03960476|617695758|FG000|6 Month Assessment|Subject declined Assessment|3|||
170916699|NCT03960476|617695758|FG000|12 Month Assessment|Death|1|||
170916700|NCT03960476|617695758|FG000|12 Month Assessment|Withdrawal by Subject|1|||
170916701|NCT03960476|617695758|FG000|12 Month Assessment|Unable to Contact|8|||
170916702|NCT03960476|617695758|FG000|12 Month Assessment|Subject Declined Assessment|4|||
170916703|NCT03960476|617695758|FG000|18 Month Assessment|Death|2|||
170916704|NCT03960476|617695758|FG000|18 Month Assessment|Withdrawal by Subject|1|||
170916705|NCT03960476|617695758|FG000|18 Month Assessment|Unable to Contact|19|||
170916706|NCT03960476|617695758|FG000|18 Month Assessment|Subject Declined Assessment|3|||
170916707|NCT03960476|617695758|FG000|24 Month Assessment|Death|2|||
170916708|NCT03960476|617695758|FG000|24 Month Assessment|Withdrawal by Subject|4|||
170916709|NCT03960476|617695758|FG000|24 Month Assessment|Unable to Contact|10|||
170916710|NCT03960476|617695758|FG000|24 Month Assessment|Subject Declined Assessment|7|||
170916711|NCT03960476|617695758|FG000|30 month assessment|Withdrawal by Subject|1|||
170916712|NCT03960476|617695758|FG000|30 month assessment|Unable to contact|22|||
170916713|NCT03960476|617695758|FG000|30 month assessment|Subject declined Assessment|12|||
170916714|NCT03960476|617695758|FG000|36 Month Assessment|Death|1|||
170916715|NCT03960476|617695758|FG000|36 Month Assessment|Withdrawal by Subject|2|||
170916716|NCT03960476|617695758|FG000|36 Month Assessment|Unable to Contact|17|||
170916717|NCT03960476|617695758|FG000|36 Month Assessment|Subject Declined Assessment|17|||
170916718|NCT03960476|617695758|FG000|36 Month Assessment|Participant Failed Pre-Assessment Cognition Testing|3|||
170916719|NCT05921760|617695759|FG000|Overall Study|Withdrawal by Subject|0|||
170916720|NCT05921760|617695760|FG001|Overall Study|Withdrawal by Subject|1|||
170916721|NCT05921760|617695759|FG000|Overall Study|Death|3|||
170916722|NCT05921760|617695760|FG001|Overall Study|Death|2|||
170916723|NCT05921760|617695759|FG000|Overall Study|Sponsor Terminated the Study|1|||
170916724|NCT05921760|617695760|FG001|Overall Study|Sponsor Terminated the Study|0|||
170916725|NCT03434652|617695761|FG000|Overall Study|Lost to Follow-up|2|||
170916726|NCT03434652|617695762|FG001|Overall Study|Lost to Follow-up|2|||
170916727|NCT03434652|617695763|FG002|Overall Study|Lost to Follow-up|1|||
170916728|NCT03434652|617695761|FG000|Overall Study|Physician Decision|1|||
170916729|NCT03434652|617695762|FG001|Overall Study|Physician Decision|0|||
170916730|NCT03434652|617695763|FG002|Overall Study|Physician Decision|1|||
170916731|NCT03748641|617695767|FG000|Overall Study|Ongoing|155|||
170653234|NCT02937571|616744638|FG000|Overall Study|Adverse Event|0|||
170653235|NCT02937571|616744639|FG001|Overall Study|Adverse Event|0|||
170653236|NCT02937571|616744640|FG002|Overall Study|Adverse Event|4|||
170653237|NCT02937571|616744638|FG000|Overall Study|Withdrawal by Subject|0|||
170653238|NCT02937571|616744639|FG001|Overall Study|Withdrawal by Subject|0|||
170816046|NCT03761849|617335389|FG002|Overall Study|Physician Decision|0|||
170816047|NCT03761849|617335390|FG003|Overall Study|Physician Decision|1|||
170816048|NCT03761849|617335391|FG004|Overall Study|Physician Decision|4|||
170816049|NCT03761849|617335392|FG005|Overall Study|Physician Decision|4|||
170816050|NCT03761849|617335387|FG000|Overall Study|Death|0|||
170816051|NCT03761849|617335388|FG001|Overall Study|Death|0|||
170816052|NCT03761849|617335389|FG002|Overall Study|Death|0|||
170816053|NCT03761849|617335390|FG003|Overall Study|Death|1|||
170816054|NCT03761849|617335391|FG004|Overall Study|Death|1|||
170816055|NCT03761849|617335392|FG005|Overall Study|Death|3|||
170816056|NCT03761849|617335387|FG000|Overall Study|Protocol Violation|0|||
170816057|NCT03761849|617335388|FG001|Overall Study|Protocol Violation|0|||
170816058|NCT03761849|617335389|FG002|Overall Study|Protocol Violation|0|||
170816059|NCT03761849|617335390|FG003|Overall Study|Protocol Violation|2|||
170816060|NCT03761849|617335391|FG004|Overall Study|Protocol Violation|2|||
170816061|NCT03761849|617335392|FG005|Overall Study|Protocol Violation|1|||
170816062|NCT03761849|617335387|FG000|Overall Study|Participant could not come to site|0|||
170816063|NCT03761849|617335388|FG001|Overall Study|Participant could not come to site|0|||
170816064|NCT03761849|617335389|FG002|Overall Study|Participant could not come to site|0|||
170816065|NCT03761849|617335390|FG003|Overall Study|Participant could not come to site|0|||
170816066|NCT03761849|617335391|FG004|Overall Study|Participant could not come to site|1|||
170816067|NCT03761849|617335392|FG005|Overall Study|Participant could not come to site|0|||
170816068|NCT03761849|617335387|FG000|Overall Study|SF- safety Finding|0|||
170816069|NCT03761849|617335388|FG001|Overall Study|SF- safety Finding|0|||
170816070|NCT03761849|617335389|FG002|Overall Study|SF- safety Finding|0|||
170816071|NCT03761849|617335390|FG003|Overall Study|SF- safety Finding|0|||
170816072|NCT03761849|617335391|FG004|Overall Study|SF- safety Finding|0|||
170816073|NCT03761849|617335392|FG005|Overall Study|SF- safety Finding|1|||
170816074|NCT03761849|617335387|FG000|Overall Study|Patient did not attend visit|0|||
170816075|NCT03761849|617335388|FG001|Overall Study|Patient did not attend visit|0|||
170816076|NCT03761849|617335389|FG002|Overall Study|Patient did not attend visit|0|||
170816077|NCT03761849|617335390|FG003|Overall Study|Patient did not attend visit|0|||
170816078|NCT03761849|617335391|FG004|Overall Study|Patient did not attend visit|0|||
170816079|NCT03761849|617335392|FG005|Overall Study|Patient did not attend visit|1|||
170816080|NCT00555620|617335400|FG000|Overall Study|Death|0|||
170816081|NCT00555620|617335401|FG001|Overall Study|Death|1|||
170816082|NCT00555620|617335402|FG002|Overall Study|Death|0|||
170816083|NCT00555620|617335403|FG003|Overall Study|Death|0|||
170816084|NCT00555620|617335404|FG004|Overall Study|Death|0|||
170816085|NCT00555620|617335405|FG005|Overall Study|Death|1|||
170816086|NCT00555620|617335400|FG000|Overall Study|Study terminated by sponsor|0|||
170816087|NCT00555620|617335401|FG001|Overall Study|Study terminated by sponsor|0|||
170816088|NCT00555620|617335402|FG002|Overall Study|Study terminated by sponsor|1|||
170816089|NCT00555620|617335403|FG003|Overall Study|Study terminated by sponsor|0|||
170816090|NCT00555620|617335404|FG004|Overall Study|Study terminated by sponsor|0|||
170816091|NCT00555620|617335405|FG005|Overall Study|Study terminated by sponsor|0|||
170816092|NCT00555620|617335400|FG000|Overall Study|Adverse Event|0|||
170816093|NCT00555620|617335401|FG001|Overall Study|Adverse Event|0|||
170816094|NCT00555620|617335402|FG002|Overall Study|Adverse Event|1|||
170816095|NCT00555620|617335403|FG003|Overall Study|Adverse Event|5|||
170816096|NCT00555620|617335404|FG004|Overall Study|Adverse Event|0|||
170816097|NCT00555620|617335405|FG005|Overall Study|Adverse Event|1|||
170816098|NCT00555620|617335400|FG000|Overall Study|Objective progression or relapse|6|||
170816099|NCT00555620|617335401|FG001|Overall Study|Objective progression or relapse|5|||
170816100|NCT00555620|617335402|FG002|Overall Study|Objective progression or relapse|12|||
170816101|NCT00555620|617335403|FG003|Overall Study|Objective progression or relapse|17|||
170816102|NCT00555620|617335404|FG004|Overall Study|Objective progression or relapse|3|||
170816103|NCT00555620|617335405|FG005|Overall Study|Objective progression or relapse|16|||
170816104|NCT00555620|617335400|FG000|Overall Study|Participant refused treatment|0|||
170816105|NCT00555620|617335401|FG001|Overall Study|Participant refused treatment|1|||
170816106|NCT00555620|617335402|FG002|Overall Study|Participant refused treatment|1|||
170816107|NCT00555620|617335403|FG003|Overall Study|Participant refused treatment|0|||
170816108|NCT00555620|617335404|FG004|Overall Study|Participant refused treatment|0|||
170816109|NCT00555620|617335405|FG005|Overall Study|Participant refused treatment|1|||
170816110|NCT00555620|617335400|FG000|Overall Study|Other|0|||
170816111|NCT00555620|617335401|FG001|Overall Study|Other|0|||
170816112|NCT00555620|617335402|FG002|Overall Study|Other|0|||
170816113|NCT00555620|617335403|FG003|Overall Study|Other|1|||
170816114|NCT00555620|617335404|FG004|Overall Study|Other|0|||
170653239|NCT02937571|616744640|FG002|Overall Study|Withdrawal by Subject|3|||
170653240|NCT02455557|616744641|FG000|Overall Study|Withdrawal by Subject|2|||
170816115|NCT00555620|617335405|FG005|Overall Study|Other|3|||
170916732|NCT03748641|617695768|FG001|Overall Study|Ongoing|148|||
170653241|NCT02278341|616744643|FG000|Overall Study|Randomized but never received study drug|1|||
170653242|NCT02278341|616744644|FG001|Overall Study|Randomized but never received study drug|1|||
170653243|NCT02278341|616744643|FG000|Overall Study|Adverse Event|3|||
170653244|NCT02278341|616744644|FG001|Overall Study|Adverse Event|0|||
170653245|NCT02278341|616744643|FG000|Overall Study|Death|68|||
170653246|NCT02278341|616744644|FG001|Overall Study|Death|56|||
170653247|NCT02278341|616744643|FG000|Overall Study|Withdrawal by Subject|30|||
170653248|NCT02278341|616744644|FG001|Overall Study|Withdrawal by Subject|19|||
170653249|NCT02278341|616744643|FG000|Overall Study|Lost to Follow-up|0|||
170653250|NCT02278341|616744644|FG001|Overall Study|Lost to Follow-up|1|||
170816116|NCT05361304|617335406|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
170816117|NCT05361304|617335407|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
170653251|NCT02278341|616744643|FG000|Overall Study|Physician Decision|1|||
170653252|NCT02278341|616744644|FG001|Overall Study|Physician Decision|1|||
170653253|NCT02278341|616744643|FG000|Overall Study|Miscellaneous|15|||
170653254|NCT02278341|616744644|FG001|Overall Study|Miscellaneous|14|||
170653255|NCT04902326|616744645|FG000|Overall Study|Withdrawal by Subject|1|||
170653256|NCT04902326|616744646|FG001|Overall Study|Withdrawal by Subject|3|||
170653257|NCT04902326|616744647|FG002|Overall Study|Withdrawal by Subject|0|||
170653258|NCT04902326|616744648|FG003|Overall Study|Withdrawal by Subject|1|||
170653259|NCT04902326|616744645|FG000|Overall Study|Lost to Follow-up|14|||
170653260|NCT04902326|616744646|FG001|Overall Study|Lost to Follow-up|14|||
170653261|NCT04902326|616744647|FG002|Overall Study|Lost to Follow-up|14|||
170653262|NCT04902326|616744648|FG003|Overall Study|Lost to Follow-up|6|||
170653263|NCT00934648|616744649|FG000|Overall Study|Failure to return|8|||
170653264|NCT00934648|616744649|FG000|Overall Study|Withdrawal by Subject|1|||
170653265|NCT02361580|616744652|FG000|Overall Study|Lost to Follow-up|6|||
170653266|NCT02361580|616744653|FG001|Overall Study|Lost to Follow-up|3|||
170653267|NCT02047318|616744654|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
170653268|NCT02047318|616744654|FG000|Core Study Period|Adverse Event|1|||
170653269|NCT02047318|616744654|FG000|Core Study Period|Withdrawal by caregiver|3|||
170653270|NCT02047318|616744654|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
170653271|NCT02032823|616744655|FG000|Overall Study|Death|75|||
170653272|NCT02032823|616744656|FG001|Overall Study|Death|109|||
170653273|NCT02032823|616744655|FG000|Overall Study|Lost to Follow-up|18|||
170653274|NCT02032823|616744656|FG001|Overall Study|Lost to Follow-up|17|||
170653275|NCT02032823|616744655|FG000|Overall Study|Withdrawal by Subject|70|||
170653276|NCT02032823|616744656|FG001|Overall Study|Withdrawal by Subject|53|||
170653277|NCT02032823|616744655|FG000|Overall Study|Ongoing study at data cut-off|755|||
170653278|NCT02032823|616744656|FG001|Overall Study|Ongoing study at data cut-off|731|||
170653279|NCT02032823|616744655|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
170653280|NCT02032823|616744656|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
170653281|NCT02411448|616744673|FG000|Overall Study|Withdrawal by Subject|1|||
170653282|NCT02411448|616744674|FG001|Overall Study|Withdrawal by Subject|14|||
170653283|NCT02411448|616744675|FG002|Overall Study|Withdrawal by Subject|9|||
170653284|NCT02411448|616744673|FG000|Overall Study|Other|0|||
170653285|NCT02411448|616744674|FG001|Overall Study|Other|2|||
170653286|NCT02411448|616744675|FG002|Overall Study|Other|0|||
170653287|NCT02411448|616744673|FG000|Overall Study|Did not receive study treatment|0|||
170653288|NCT02411448|616744674|FG001|Overall Study|Did not receive study treatment|3|||
170653289|NCT02411448|616744675|FG002|Overall Study|Did not receive study treatment|0|||
170653290|NCT02411448|616744673|FG000|Overall Study|Alive on study treatment|3|||
170653291|NCT02411448|616744674|FG001|Overall Study|Alive on study treatment|64|||
170653292|NCT02411448|616744675|FG002|Overall Study|Alive on study treatment|43|||
170653293|NCT03044574|616744682|FG000|Overall Study|Lost to Follow-up|37|||
170653294|NCT03044574|616744683|FG001|Overall Study|Lost to Follow-up|45|||
170653295|NCT04779216|616744684|FG000|Overall Study|Lost to Follow-up|1|||
170653296|NCT04779216|616744685|FG001|Overall Study|Lost to Follow-up|0|||
170653297|NCT04779216|616744684|FG000|Overall Study|Withdrawal by Subject|1|||
170653298|NCT04779216|616744685|FG001|Overall Study|Withdrawal by Subject|0|||
170653299|NCT03783702|616744690|FG000|Overall Study|Lost to Follow-up|6|||
170653300|NCT03783702|616744691|FG001|Overall Study|Lost to Follow-up|8|||
170653301|NCT03783702|616744690|FG000|Overall Study|Protocol Violation|1|||
170653302|NCT03783702|616744691|FG001|Overall Study|Protocol Violation|3|||
170653303|NCT00219544|616744692|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
170816118|NCT05361304|617335406|FG000|Overall Study|COVID-19 Related|1|||
170816119|NCT05361304|617335407|FG001|Overall Study|COVID-19 Related|2|||
170816120|NCT05361304|617335406|FG000|Overall Study|Withdrawal by Subject|1|||
170816121|NCT05361304|617335407|FG001|Overall Study|Withdrawal by Subject|0|||
170816122|NCT01816165|617335408|FG000|Overall Study|Adverse Event|1|||
170816123|NCT01816165|617335409|FG001|Overall Study|Adverse Event|0|||
170816124|NCT01816165|617335410|FG002|Overall Study|Adverse Event|0|||
170816125|NCT01816165|617335411|FG003|Overall Study|Adverse Event|0|||
170816126|NCT00476151|617335412|FG000|Overall Study|Adverse Event|0|||
170816127|NCT00476151|617335413|FG001|Overall Study|Adverse Event|2|||
170816128|NCT00476151|617335412|FG000|Overall Study|Protocol Violation|1|||
170816129|NCT00476151|617335413|FG001|Overall Study|Protocol Violation|3|||
170816130|NCT00476151|617335412|FG000|Overall Study|Withdrawal by Subject|2|||
170816131|NCT00476151|617335413|FG001|Overall Study|Withdrawal by Subject|0|||
170816132|NCT00476151|617335412|FG000|Overall Study|Physician Decision|0|||
170816133|NCT00476151|617335413|FG001|Overall Study|Physician Decision|2|||
170816134|NCT00447499|617335416|FG000|Overall Study|Adverse Event|1|||
170816135|NCT00447499|617335416|FG000|Overall Study|Patient Decision|4|||
170816136|NCT00447499|617335416|FG000|Overall Study|Sponsor Decision|1|||
170816137|NCT00447499|617335416|FG000|Overall Study|Physician Decision|1|||
170816138|NCT02068352|617335417|FG000|Overall Study|Lost to Follow-up|0|||
170816139|NCT02068352|617335418|FG001|Overall Study|Lost to Follow-up|2|||
170816140|NCT02068352|617335419|FG002|Overall Study|Lost to Follow-up|0|||
170816141|NCT02068352|617335417|FG000|Overall Study|Adverse Event|4|||
170816142|NCT02068352|617335418|FG001|Overall Study|Adverse Event|2|||
170816143|NCT02068352|617335419|FG002|Overall Study|Adverse Event|7|||
170816144|NCT02068352|617335417|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
170816145|NCT02068352|617335418|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
170916733|NCT03748641|617695769|FG002|Overall Study|Ongoing|66|||
170916734|NCT03748641|617695770|FG003|Overall Study|Ongoing|79|||
170916735|NCT03748641|617695771|FG004|Overall Study|Ongoing|84|||
170610973|NCT02021643|616583635|FG003|Overall Study|Enrolled but Never Treated|0|||
170610974|NCT02021643|616583632|FG000|Overall Study|Adverse Event|0|||
170610975|NCT02021643|616583633|FG001|Overall Study|Adverse Event|1|||
170610976|NCT02021643|616583634|FG002|Overall Study|Adverse Event|0|||
170610977|NCT02021643|616583635|FG003|Overall Study|Adverse Event|0|||
170610978|NCT02021643|616583632|FG000|Overall Study|Death|0|||
170610979|NCT02021643|616583633|FG001|Overall Study|Death|1|||
170610980|NCT02021643|616583634|FG002|Overall Study|Death|0|||
170610981|NCT02021643|616583635|FG003|Overall Study|Death|0|||
170610982|NCT02021643|616583632|FG000|Overall Study|Investigator's Discretion|1|||
170610983|NCT02021643|616583633|FG001|Overall Study|Investigator's Discretion|0|||
170610984|NCT02021643|616583634|FG002|Overall Study|Investigator's Discretion|0|||
170610985|NCT02021643|616583635|FG003|Overall Study|Investigator's Discretion|0|||
170610986|NCT02021643|616583632|FG000|Overall Study|Lack of Efficacy|7|||
170610987|NCT02021643|616583633|FG001|Overall Study|Lack of Efficacy|6|||
170610988|NCT02021643|616583634|FG002|Overall Study|Lack of Efficacy|0|||
170610989|NCT02021643|616583635|FG003|Overall Study|Lack of Efficacy|12|||
170610990|NCT02021643|616583632|FG000|Overall Study|Lost to Follow-up|0|||
170610991|NCT02021643|616583633|FG001|Overall Study|Lost to Follow-up|1|||
170610992|NCT02021643|616583634|FG002|Overall Study|Lost to Follow-up|0|||
170610993|NCT02021643|616583635|FG003|Overall Study|Lost to Follow-up|0|||
170610994|NCT02021643|616583632|FG000|Overall Study|Withdrew Consent|0|||
170610995|NCT02021643|616583633|FG001|Overall Study|Withdrew Consent|1|||
170610996|NCT02021643|616583634|FG002|Overall Study|Withdrew Consent|0|||
170610997|NCT02021643|616583635|FG003|Overall Study|Withdrew Consent|0|||
170610998|NCT01746368|616583638|FG000|Overall Study|Lost to Follow-up|2|||
170610999|NCT01746368|616583639|FG001|Overall Study|Lost to Follow-up|0|||
170611000|NCT01746368|616583638|FG000|Overall Study|Withdrawal by Subject|0|||
170611001|NCT01746368|616583639|FG001|Overall Study|Withdrawal by Subject|1|||
170611002|NCT05636852|616583640|FG000|Overall Study|Withdrawal by Subject|1|||
170611003|NCT05636852|616583640|FG000|Overall Study|Other than specified|1|||
170611004|NCT02506192|616583641|FG000|Overall Study|Withdrawal by Subject|1|||
170611005|NCT02506192|616583642|FG001|Overall Study|Withdrawal by Subject|1|||
170611006|NCT00555672|616583650|FG000|Overall Study|Death|0|||
170611007|NCT00555672|616583651|FG001|Overall Study|Death|2|||
170611008|NCT00555672|616583650|FG000|Overall Study|Adverse Event|8|||
170611009|NCT00555672|616583651|FG001|Overall Study|Adverse Event|2|||
170611010|NCT00555672|616583650|FG000|Overall Study|Objective progression or relapse|11|||
170611011|NCT00555672|616583651|FG001|Overall Study|Objective progression or relapse|5|||
170611012|NCT00555672|616583650|FG000|Overall Study|Other|3|||
170611013|NCT00555672|616583651|FG001|Overall Study|Other|1|||
170611014|NCT00555672|616583650|FG000|Overall Study|Participant refused|2|||
170611015|NCT00555672|616583651|FG001|Overall Study|Participant refused|0|||
170611016|NCT01147055|616583654|FG000|First Intervention Period|Lost to Follow-up|1|||
170611017|NCT01147055|616583655|FG001|First Intervention Period|Lost to Follow-up|0|||
170611018|NCT02362464|616583656|FG000|Overall Study|Switched to alternative therapy|1|||
170611019|NCT02362464|616583656|FG000|Overall Study|Refused further treatment|1|||
170611020|NCT02362464|616583656|FG000|Overall Study|Physician Decision|4|||
170611021|NCT00095173|616583661|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
170611022|NCT00095173|616583662|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
170611023|NCT00095173|616583663|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
170611024|NCT00095173|616583664|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
170611025|NCT00095173|616583665|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
170611026|NCT00095173|616583666|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
170611027|NCT00095173|616583661|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
170611028|NCT00095173|616583662|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
170611029|NCT00095173|616583663|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
170611030|NCT00095173|616583664|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
170611031|NCT00095173|616583665|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
170611032|NCT00095173|616583666|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
170611033|NCT00095173|616583661|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
170611034|NCT00095173|616583662|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
170611035|NCT00095173|616583663|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
170611036|NCT00095173|616583664|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
170611037|NCT00095173|616583665|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
170611038|NCT00095173|616583666|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
170611039|NCT00095173|616583661|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
170611040|NCT00095173|616583662|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
170611041|NCT00095173|616583663|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
170916736|NCT03748641|617695767|FG000|Overall Study|Death|54|||
170611042|NCT00095173|616583664|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
170916737|NCT03748641|617695768|FG001|Overall Study|Death|59|||
170916738|NCT03748641|617695769|FG002|Overall Study|Death|51|||
170816146|NCT02068352|617335419|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
170816147|NCT02068352|617335417|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
170816148|NCT02068352|617335418|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
170816149|NCT02068352|617335419|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
170816150|NCT02068352|617335417|FG000|Overall Study|Protocol Deviation|0|||
170816151|NCT02068352|617335418|FG001|Overall Study|Protocol Deviation|0|||
170816152|NCT02068352|617335419|FG002|Overall Study|Protocol Deviation|1|||
170816153|NCT01767376|617335423|FG000|Overall Study|Lost to Follow-up|3|||
170816154|NCT01767376|617335424|FG001|Overall Study|Lost to Follow-up|2|||
170816155|NCT01767376|617335425|FG002|Overall Study|Lost to Follow-up|0|||
170816156|NCT01767376|617335423|FG000|Overall Study|Withdrawal by Subject|1|||
170816157|NCT01767376|617335424|FG001|Overall Study|Withdrawal by Subject|1|||
170816158|NCT01767376|617335425|FG002|Overall Study|Withdrawal by Subject|0|||
170816159|NCT03745651|617335428|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
170816160|NCT03745651|617335429|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
170816161|NCT03745651|617335430|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170816162|NCT03745651|617335431|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170816163|NCT03745651|617335432|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170816164|NCT03745651|617335433|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170816165|NCT03745651|617335434|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
170816166|NCT03745651|617335428|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
170816167|NCT03745651|617335429|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
170816168|NCT03745651|617335430|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
170816169|NCT03745651|617335431|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170816170|NCT03745651|617335432|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170816171|NCT03745651|617335433|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170816172|NCT03745651|617335434|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170816173|NCT03745651|617335428|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
170816174|NCT03745651|617335429|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170816175|NCT03745651|617335430|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
170816176|NCT03745651|617335431|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170816177|NCT03745651|617335432|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170816178|NCT03745651|617335433|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170816179|NCT03745651|617335434|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
170816180|NCT03745651|617335428|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170816181|NCT03745651|617335429|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
170816182|NCT03745651|617335430|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170816183|NCT03745651|617335431|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170816184|NCT03745651|617335432|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170816185|NCT03745651|617335433|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170816186|NCT03745651|617335434|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
170816187|NCT03745651|617335428|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
170816188|NCT03745651|617335429|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
170816189|NCT03745651|617335430|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
170816190|NCT03745651|617335431|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170816191|NCT03745651|617335432|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170816192|NCT03745651|617335433|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170816193|NCT03745651|617335434|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170816194|NCT03745651|617335428|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
170816195|NCT03745651|617335429|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
170816196|NCT03745651|617335430|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
170816197|NCT03745651|617335431|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
170816198|NCT03745651|617335432|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
170816199|NCT03745651|617335433|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
170816200|NCT03745651|617335434|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
170816201|NCT03745651|617335428|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170816202|NCT03745651|617335429|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170816203|NCT03745651|617335430|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170816204|NCT03745651|617335431|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170816205|NCT03745651|617335432|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170816206|NCT03745651|617335433|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
170816207|NCT03745651|617335434|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
170916739|NCT03748641|617695770|FG003|Overall Study|Death|42|||
170916740|NCT03748641|617695771|FG004|Overall Study|Death|9|||
170916741|NCT03748641|617695767|FG000|Overall Study|Lost to Follow-up|0|||
170611043|NCT00095173|616583665|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
170611044|NCT00095173|616583666|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
170611045|NCT00095173|616583661|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
170611046|NCT00095173|616583662|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
170611047|NCT00095173|616583663|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
170611048|NCT00095173|616583664|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
170611049|NCT00095173|616583665|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
170611050|NCT00095173|616583666|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
170611051|NCT00095173|616583661|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
170611052|NCT00095173|616583662|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
170611053|NCT00095173|616583663|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
170611054|NCT00095173|616583664|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
170611055|NCT00095173|616583665|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
170611056|NCT00095173|616583666|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
170611057|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|Death|0|||
170611058|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|Death|0|||
170611059|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|Death|0|||
170611060|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|Death|0|||
170611061|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|Death|0|||
170611062|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|Death|1|||
170611063|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
170611064|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
170611065|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
170611066|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
170611067|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
170611068|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
170611069|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
170611070|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
170611071|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
170611072|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
170611073|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
170611074|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
170611075|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
170611076|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
170611077|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
170611078|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
170611079|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
170611080|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
170611081|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
170611082|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
170611083|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
170611084|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
170611085|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
170611086|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
170611087|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
170611088|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
170611089|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
170611090|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
170611091|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
170611092|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
170611093|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
170611094|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
170611095|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
170611096|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
170816208|NCT03745651|617335428|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170816209|NCT03745651|617335429|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170816210|NCT03745651|617335430|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170816211|NCT03745651|617335431|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
170816212|NCT03745651|617335432|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170816213|NCT03745651|617335433|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
170816214|NCT03745651|617335434|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
170816215|NCT03745651|617335428|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170653304|NCT00219544|616744693|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
170653305|NCT00219544|616744692|FG000|Single Blind Treatment Period|Adverse Event|9|||
170653306|NCT00219544|616744693|FG001|Single Blind Treatment Period|Adverse Event|0|||
170653307|NCT00219544|616744692|FG000|Single Blind Treatment Period|Protocol Violation|4|||
170916742|NCT03748641|617695768|FG001|Overall Study|Lost to Follow-up|2|||
170916743|NCT03748641|617695769|FG002|Overall Study|Lost to Follow-up|1|||
170916744|NCT03748641|617695770|FG003|Overall Study|Lost to Follow-up|0|||
170916745|NCT03748641|617695771|FG004|Overall Study|Lost to Follow-up|0|||
170916746|NCT03748641|617695767|FG000|Overall Study|Withdrawal by Subject|3|||
170916747|NCT03748641|617695768|FG001|Overall Study|Withdrawal by Subject|2|||
170916748|NCT03748641|617695769|FG002|Overall Study|Withdrawal by Subject|5|||
170916749|NCT03748641|617695770|FG003|Overall Study|Withdrawal by Subject|3|||
170916750|NCT03748641|617695771|FG004|Overall Study|Withdrawal by Subject|2|||
170916751|NCT05014412|617695772|FG000|Overall Study|Death|11|||
170916752|NCT05014412|617695773|FG001|Overall Study|Death|7|||
170916753|NCT05014412|617695774|FG002|Overall Study|Death|4|||
170916754|NCT05014412|617695775|FG003|Overall Study|Death|7|||
170916755|NCT05014412|617695772|FG000|Overall Study|Withdrawal by Subject|1|||
170916756|NCT05014412|617695773|FG001|Overall Study|Withdrawal by Subject|1|||
170916757|NCT05014412|617695774|FG002|Overall Study|Withdrawal by Subject|1|||
170916758|NCT05014412|617695775|FG003|Overall Study|Withdrawal by Subject|2|||
170916759|NCT05014412|617695772|FG000|Overall Study|Ongoing|21|||
170916760|NCT05014412|617695773|FG001|Overall Study|Ongoing|4|||
170916761|NCT05014412|617695774|FG002|Overall Study|Ongoing|6|||
170916762|NCT05014412|617695775|FG003|Overall Study|Ongoing|20|||
170916763|NCT04654468|617695776|FG000|Overall Study|Death|1|||
170916764|NCT04654468|617695776|FG000|Overall Study|Ongoing in the Study|50|||
170916765|NCT03031730|617695778|FG000|60 mg|Adverse Event|2|||
170916766|NCT03031730|617695779|FG001|60 mg|Adverse Event|0|||
170916767|NCT03031730|617695780|FG002|60 mg|Adverse Event|0|||
170916768|NCT03031730|617695781|FG003|60 mg|Adverse Event|0|||
170916769|NCT03031730|617695782|FG004|60 mg|Adverse Event|0|||
170916770|NCT03031730|617695783|FG005|60 mg|Adverse Event|0|||
170916771|NCT03031730|617695778|FG000|60 mg|Alternative Treatment|1|||
170916772|NCT03031730|617695779|FG001|60 mg|Alternative Treatment|0|||
170916773|NCT03031730|617695780|FG002|60 mg|Alternative Treatment|0|||
170916774|NCT03031730|617695781|FG003|60 mg|Alternative Treatment|0|||
170916775|NCT03031730|617695782|FG004|60 mg|Alternative Treatment|0|||
170916776|NCT03031730|617695783|FG005|60 mg|Alternative Treatment|0|||
170916777|NCT03031730|617695778|FG000|90mg|Death|0|||
170916778|NCT03031730|617695779|FG001|90mg|Death|1|||
170916779|NCT03031730|617695780|FG002|90mg|Death|0|||
170916780|NCT03031730|617695781|FG003|90mg|Death|0|||
170916781|NCT03031730|617695782|FG004|90mg|Death|0|||
170916782|NCT03031730|617695783|FG005|90mg|Death|0|||
170916783|NCT03031730|617695778|FG000|90mg|Physician Decision|0|||
170916784|NCT03031730|617695779|FG001|90mg|Physician Decision|1|||
170916785|NCT03031730|617695780|FG002|90mg|Physician Decision|0|||
170916786|NCT03031730|617695781|FG003|90mg|Physician Decision|0|||
170916787|NCT03031730|617695782|FG004|90mg|Physician Decision|0|||
170916788|NCT03031730|617695783|FG005|90mg|Physician Decision|0|||
170916789|NCT03031730|617695778|FG000|90mg|Withdrawal by Subject|0|||
170916790|NCT03031730|617695779|FG001|90mg|Withdrawal by Subject|2|||
170916791|NCT03031730|617695780|FG002|90mg|Withdrawal by Subject|0|||
170916792|NCT03031730|617695781|FG003|90mg|Withdrawal by Subject|0|||
170916793|NCT03031730|617695782|FG004|90mg|Withdrawal by Subject|0|||
170916794|NCT03031730|617695783|FG005|90mg|Withdrawal by Subject|0|||
170916795|NCT03031730|617695778|FG000|90mg|Alternative Treatment|0|||
170916796|NCT03031730|617695779|FG001|90mg|Alternative Treatment|1|||
170916797|NCT03031730|617695780|FG002|90mg|Alternative Treatment|0|||
170916798|NCT03031730|617695781|FG003|90mg|Alternative Treatment|0|||
170916799|NCT03031730|617695782|FG004|90mg|Alternative Treatment|0|||
170916800|NCT03031730|617695783|FG005|90mg|Alternative Treatment|0|||
170916801|NCT03031730|617695778|FG000|90mg|TP53 mutation or indeterminate TP53 mutation status|0|||
170916802|NCT03031730|617695779|FG001|90mg|TP53 mutation or indeterminate TP53 mutation status|2|||
170916803|NCT03031730|617695780|FG002|90mg|TP53 mutation or indeterminate TP53 mutation status|0|||
170916804|NCT03031730|617695781|FG003|90mg|TP53 mutation or indeterminate TP53 mutation status|0|||
170916805|NCT03031730|617695782|FG004|90mg|TP53 mutation or indeterminate TP53 mutation status|0|||
170916806|NCT03031730|617695783|FG005|90mg|TP53 mutation or indeterminate TP53 mutation status|0|||
170653308|NCT00219544|616744693|FG001|Single Blind Treatment Period|Protocol Violation|0|||
170653309|NCT00219544|616744692|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
170653310|NCT00219544|616744693|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
170653311|NCT00219544|616744692|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
170653312|NCT00219544|616744693|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
170653313|NCT00219544|616744692|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
170653314|NCT00219544|616744693|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
170653315|NCT00989573|616744694|FG000|Overall Study|Adverse Event|8|||
170653316|NCT00989573|616744695|FG001|Overall Study|Adverse Event|12|||
170653317|NCT00989573|616744696|FG002|Overall Study|Adverse Event|4|||
170653318|NCT00989573|616744694|FG000|Overall Study|Physician Decision|0|||
170653319|NCT00989573|616744695|FG001|Overall Study|Physician Decision|2|||
170653320|NCT00989573|616744696|FG002|Overall Study|Physician Decision|0|||
170653321|NCT00989573|616744694|FG000|Overall Study|Protocol Violation|1|||
170653322|NCT00989573|616744695|FG001|Overall Study|Protocol Violation|1|||
170653323|NCT00989573|616744696|FG002|Overall Study|Protocol Violation|1|||
170653324|NCT00989573|616744694|FG000|Overall Study|Withdrawal by Subject|4|||
170653325|NCT00989573|616744695|FG001|Overall Study|Withdrawal by Subject|7|||
170653326|NCT00989573|616744696|FG002|Overall Study|Withdrawal by Subject|3|||
170653327|NCT01163032|616744698|FG000|Randomization Phase|Withdrawal by Subject|2|||
170653328|NCT01163032|616744699|FG001|Randomization Phase|Withdrawal by Subject|3|||
170653329|NCT01163032|616744700|FG002|Randomization Phase|Withdrawal by Subject|0|||
170653330|NCT01163032|616744698|FG000|Randomization Phase|Adverse Event|3|||
170653331|NCT01163032|616744699|FG001|Randomization Phase|Adverse Event|3|||
170653332|NCT01163032|616744700|FG002|Randomization Phase|Adverse Event|0|||
170653333|NCT01163032|616744698|FG000|Randomization Phase|Protocol Violation|0|||
170653334|NCT01163032|616744699|FG001|Randomization Phase|Protocol Violation|1|||
170653335|NCT01163032|616744700|FG002|Randomization Phase|Protocol Violation|0|||
170653336|NCT01163032|616744698|FG000|Randomization Phase|Various*|5|||
170653337|NCT01163032|616744699|FG001|Randomization Phase|Various*|4|||
170653338|NCT01163032|616744700|FG002|Randomization Phase|Various*|0|||
170653339|NCT01163032|616744698|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
170653340|NCT01163032|616744699|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
170653341|NCT01163032|616744700|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
170653342|NCT01163032|616744698|FG000|Open Label Extension Phase|Adverse Event|0|||
170653343|NCT01163032|616744699|FG001|Open Label Extension Phase|Adverse Event|0|||
170653344|NCT01163032|616744700|FG002|Open Label Extension Phase|Adverse Event|3|||
170653345|NCT01163032|616744698|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
170653346|NCT01163032|616744699|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
170653347|NCT01163032|616744700|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
170653348|NCT01163032|616744698|FG000|Open Label Extension Phase|Protocol Violation|0|||
170653349|NCT01163032|616744699|FG001|Open Label Extension Phase|Protocol Violation|0|||
170653350|NCT01163032|616744700|FG002|Open Label Extension Phase|Protocol Violation|1|||
170653351|NCT01163032|616744698|FG000|Open Label Extension Phase|Study Termination|0|||
170653352|NCT01163032|616744699|FG001|Open Label Extension Phase|Study Termination|0|||
170653353|NCT01163032|616744700|FG002|Open Label Extension Phase|Study Termination|7|||
170653354|NCT01163032|616744698|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
170653355|NCT01163032|616744699|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
170653356|NCT01163032|616744700|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
170653357|NCT03473548|616744703|FG000|Overall Study|Did not attempt HST testing|3|||
170653358|NCT03473548|616744704|FG001|Overall Study|Did not attempt HST testing|0|||
170653359|NCT00527488|616744715|FG000|Overall Study|Withdrawn prior to dosing|0|||
170653360|NCT00527488|616744716|FG001|Overall Study|Withdrawn prior to dosing|1|||
170653361|NCT00527488|616744717|FG002|Overall Study|Withdrawn prior to dosing|1|||
170653362|NCT00527488|616744718|FG003|Overall Study|Withdrawn prior to dosing|0|||
170653363|NCT00604214|616744723|FG000|Baseline to Day 28|Death|223|||
170653364|NCT00604214|616744724|FG001|Baseline to Day 28|Death|202|||
170653365|NCT00604214|616744723|FG000|Baseline to Day 28|Lost to Follow-up|2|||
170653366|NCT00604214|616744724|FG001|Baseline to Day 28|Lost to Follow-up|4|||
170653367|NCT00604214|616744723|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
170916807|NCT04767373|617695784|FG000|Overall Study|Death|6|||
170653368|NCT00604214|616744724|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
170653369|NCT00604214|616744723|FG000|Day 29 to Day 90|Death|64|||
170653370|NCT00604214|616744724|FG001|Day 29 to Day 90|Death|67|||
170653371|NCT00604214|616744723|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
170653372|NCT00604214|616744724|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
170653373|NCT00604214|616744723|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
170653374|NCT00604214|616744724|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
170653375|NCT00604214|616744723|FG000|Day 91 to Day 180|Death|19|||
170653376|NCT00604214|616744724|FG001|Day 91 to Day 180|Death|23|||
170653377|NCT00604214|616744723|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
170653378|NCT00604214|616744724|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
170653379|NCT00604214|616744723|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
170653380|NCT00604214|616744724|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
170653381|NCT00534599|616744727|FG000|Overall Study|Adverse Event|25|||
170653382|NCT00534599|616744728|FG001|Overall Study|Adverse Event|4|||
170653383|NCT00534599|616744727|FG000|Overall Study|Incorrect enrollment|2|||
170653384|NCT00534599|616744728|FG001|Overall Study|Incorrect enrollment|1|||
170653385|NCT00534599|616744727|FG000|Overall Study|Mis-randomization|2|||
170653386|NCT00534599|616744728|FG001|Overall Study|Mis-randomization|2|||
170653387|NCT00534599|616744727|FG000|Overall Study|Developed study-specific d/c criteria|5|||
170653388|NCT00534599|616744728|FG001|Overall Study|Developed study-specific d/c criteria|0|||
170653389|NCT00534599|616744727|FG000|Overall Study|Lack of Efficacy|0|||
170653390|NCT00534599|616744728|FG001|Overall Study|Lack of Efficacy|1|||
170653391|NCT00534599|616744727|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
170653392|NCT00534599|616744728|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
170653393|NCT00534599|616744727|FG000|Overall Study|Protocol Violation|1|||
170653394|NCT00534599|616744728|FG001|Overall Study|Protocol Violation|3|||
170653395|NCT00534599|616744727|FG000|Overall Study|Lost to Follow-up|11|||
170653396|NCT00534599|616744728|FG001|Overall Study|Lost to Follow-up|14|||
170653397|NCT00534599|616744727|FG000|Overall Study|Withdrawal by Subject|4|||
170653398|NCT00534599|616744728|FG001|Overall Study|Withdrawal by Subject|6|||
170653399|NCT00534599|616744727|FG000|Overall Study|Other|7|||
170653400|NCT00534599|616744728|FG001|Overall Study|Other|0|||
170653401|NCT02207946|616744729|FG000|Overall Study|Lost to Follow-up|1|||
170653402|NCT02207946|616744730|FG001|Overall Study|Lost to Follow-up|0|||
170653403|NCT02207946|616744729|FG000|Overall Study|Adverse Event|0|||
170653404|NCT02207946|616744730|FG001|Overall Study|Adverse Event|1|||
170653405|NCT02545543|616744731|FG000|Overall Study|Lost to Follow-up|67|||
170653406|NCT02545543|616744732|FG001|Overall Study|Lost to Follow-up|25|||
170653407|NCT02545543|616744731|FG000|Overall Study|Physician Decision|3|||
170653408|NCT02545543|616744732|FG001|Overall Study|Physician Decision|0|||
170653409|NCT02545543|616744731|FG000|Overall Study|Withdrawal by Subject|9|||
170653410|NCT02545543|616744732|FG001|Overall Study|Withdrawal by Subject|8|||
170653411|NCT02545543|616744731|FG000|Overall Study|Noncomplaince|1|||
170653412|NCT02545543|616744732|FG001|Overall Study|Noncomplaince|0|||
170653413|NCT02545543|616744731|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
170653414|NCT02545543|616744732|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
170653415|NCT03764033|616744733|FG000|Treatment Phase|Withdrawal by Subject|8|||
170653416|NCT03764033|616744734|FG001|Treatment Phase|Withdrawal by Subject|3|||
170653417|NCT03764033|616744733|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
170653418|NCT03764033|616744734|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
170653419|NCT03764033|616744733|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
170653420|NCT03764033|616744734|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
170653421|NCT04594369|616744735|FG000|Overall Study|Adverse Event|10|||
170653422|NCT04594369|616744736|FG001|Overall Study|Adverse Event|10|||
170653423|NCT04594369|616744737|FG002|Overall Study|Adverse Event|9|||
170653424|NCT04594369|616744735|FG000|Overall Study|Death|2|||
170653425|NCT04594369|616744736|FG001|Overall Study|Death|4|||
170653426|NCT04594369|616744737|FG002|Overall Study|Death|8|||
170653427|NCT04594369|616744735|FG000|Overall Study|Lost to Follow-up|10|||
170653428|NCT04594369|616744736|FG001|Overall Study|Lost to Follow-up|2|||
170653429|NCT04594369|616744737|FG002|Overall Study|Lost to Follow-up|4|||
170653430|NCT04594369|616744735|FG000|Overall Study|Physician Decision|2|||
170653431|NCT04594369|616744736|FG001|Overall Study|Physician Decision|2|||
170653432|NCT04594369|616744737|FG002|Overall Study|Physician Decision|3|||
170653433|NCT04594369|616744735|FG000|Overall Study|Protocol deviation|1|||
170653434|NCT04594369|616744736|FG001|Overall Study|Protocol deviation|3|||
170653435|NCT04594369|616744737|FG002|Overall Study|Protocol deviation|2|||
170653436|NCT04594369|616744735|FG000|Overall Study|Withdrawal by Subject|40|||
170653437|NCT04594369|616744736|FG001|Overall Study|Withdrawal by Subject|32|||
170653438|NCT04594369|616744737|FG002|Overall Study|Withdrawal by Subject|37|||
170653439|NCT04594369|616744735|FG000|Overall Study|Reason not specified|60|||
170653440|NCT04594369|616744736|FG001|Overall Study|Reason not specified|56|||
170653441|NCT04594369|616744737|FG002|Overall Study|Reason not specified|43|||
170653442|NCT04675151|616744738|FG000|Overall Study|Protocol Violation|1|||
170653443|NCT04675151|616744739|FG001|Overall Study|Protocol Violation|0|||
170653444|NCT04675151|616744740|FG002|Overall Study|Protocol Violation|0|||
170653445|NCT04675151|616744741|FG003|Overall Study|Protocol Violation|1|||
170653446|NCT04035486|616744742|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
170653447|NCT04035486|616744743|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
170653448|NCT04035486|616744744|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
170653449|NCT04035486|616744745|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
170653450|NCT04035486|616744742|FG000|Overall Study|Death|6|||
170653451|NCT04035486|616744743|FG001|Overall Study|Death|3|||
170653452|NCT04035486|616744744|FG002|Overall Study|Death|70|||
170653453|NCT04035486|616744745|FG003|Overall Study|Death|77|||
170653454|NCT04035486|616744742|FG000|Overall Study|Screen Failure|0|||
170653455|NCT04035486|616744743|FG001|Overall Study|Screen Failure|0|||
170653456|NCT04035486|616744744|FG002|Overall Study|Screen Failure|1|||
170653457|NCT04035486|616744745|FG003|Overall Study|Screen Failure|1|||
170653458|NCT04035486|616744742|FG000|Overall Study|Withdrawal by Subject|1|||
170611097|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
170611098|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
170611099|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
170611100|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
170611101|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
170653459|NCT04035486|616744743|FG001|Overall Study|Withdrawal by Subject|1|||
170653460|NCT04035486|616744744|FG002|Overall Study|Withdrawal by Subject|11|||
170653461|NCT04035486|616744745|FG003|Overall Study|Withdrawal by Subject|9|||
170653462|NCT04268823|616744749|FG000|Overall Study|Adverse Event|1|||
170653463|NCT04268823|616744750|FG001|Overall Study|Adverse Event|0|||
170653464|NCT04268823|616744749|FG000|Overall Study|Participant Decision|1|||
170653465|NCT04268823|616744750|FG001|Overall Study|Participant Decision|0|||
170653466|NCT04285580|616745996|FG000|Overall Study|Protocol Violation|0|||
170653467|NCT04285580|616745997|FG001|Overall Study|Protocol Violation|1|||
170653468|NCT01107418|616746000|FG000|Overall Study|Disease Progression|45|||
170611102|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
170611103|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
170611104|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
170611105|NCT00095173|616583661|FG000|Open-Label Extension Phase (Period C)|Other|0|||
170611106|NCT00095173|616583662|FG001|Open-Label Extension Phase (Period C)|Other|0|||
170611107|NCT00095173|616583663|FG002|Open-Label Extension Phase (Period C)|Other|0|||
170653469|NCT01107418|616746000|FG000|Overall Study|Adverse Event|3|||
170611108|NCT00095173|616583664|FG003|Open-Label Extension Phase (Period C)|Other|4|||
170611109|NCT00095173|616583665|FG004|Open-Label Extension Phase (Period C)|Other|6|||
170611110|NCT00095173|616583666|FG005|Open-Label Extension Phase (Period C)|Other|8|||
170611111|NCT02343406|616583667|FG000|Overall Study|Progressive disease|72|||
170611112|NCT02343406|616583668|FG001|Overall Study|Progressive disease|70|||
170611113|NCT02343406|616583669|FG002|Overall Study|Progressive disease|43|||
170611114|NCT02343406|616583670|FG003|Overall Study|Progressive disease|15|||
170611115|NCT02343406|616583671|FG004|Overall Study|Progressive disease|5|||
170611116|NCT02343406|616583667|FG000|Overall Study|Adverse Event|6|||
170611117|NCT02343406|616583668|FG001|Overall Study|Adverse Event|8|||
170611118|NCT02343406|616583669|FG002|Overall Study|Adverse Event|6|||
170611119|NCT02343406|616583670|FG003|Overall Study|Adverse Event|3|||
170611120|NCT02343406|616583671|FG004|Overall Study|Adverse Event|0|||
170611121|NCT02343406|616583667|FG000|Overall Study|Withdrawal by Subject|6|||
170611122|NCT02343406|616583668|FG001|Overall Study|Withdrawal by Subject|4|||
170611123|NCT02343406|616583669|FG002|Overall Study|Withdrawal by Subject|8|||
170611124|NCT02343406|616583670|FG003|Overall Study|Withdrawal by Subject|3|||
170611125|NCT02343406|616583671|FG004|Overall Study|Withdrawal by Subject|0|||
170611126|NCT02343406|616583667|FG000|Overall Study|Death|2|||
170611127|NCT02343406|616583668|FG001|Overall Study|Death|1|||
170611128|NCT02343406|616583669|FG002|Overall Study|Death|0|||
170611129|NCT02343406|616583670|FG003|Overall Study|Death|0|||
170611130|NCT02343406|616583671|FG004|Overall Study|Death|0|||
170611131|NCT02343406|616583667|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
170611132|NCT02343406|616583668|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
170611133|NCT02343406|616583669|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
170653470|NCT01107418|616746000|FG000|Overall Study|Withdrawal by Subject|1|||
170653471|NCT01107418|616746000|FG000|Overall Study|Study Closing|1|||
170653472|NCT01107418|616746000|FG000|Overall Study|Started Other Therapy|1|||
170653473|NCT01107418|616746000|FG000|Overall Study|Entered Extension Study|1|||
170653474|NCT02316548|616746003|FG000|Overall Study|Protocol Violation|0|||
170653475|NCT02316548|616746004|FG001|Overall Study|Protocol Violation|1|||
170653476|NCT05313009|616746005|FG000|Overall Study|Death|1|||
170653477|NCT05313009|616746006|FG001|Overall Study|Death|0|||
170653478|NCT02186301|616746009|FG000|Overall Study|Progressive Disease|7|||
170653479|NCT02186301|616746010|FG001|Overall Study|Progressive Disease|22|||
170653480|NCT02186301|616746011|FG002|Overall Study|Progressive Disease|27|||
170653481|NCT02186301|616746009|FG000|Overall Study|Adverse Event|5|||
170653482|NCT02186301|616746010|FG001|Overall Study|Adverse Event|5|||
170653483|NCT02186301|616746011|FG002|Overall Study|Adverse Event|5|||
170653484|NCT02186301|616746009|FG000|Overall Study|Death|1|||
170653485|NCT02186301|616746010|FG001|Overall Study|Death|0|||
170611134|NCT02343406|616583670|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
170611135|NCT02343406|616583671|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
170611136|NCT02343406|616583667|FG000|Overall Study|Other primary malignancy|0|||
170611137|NCT02343406|616583668|FG001|Overall Study|Other primary malignancy|1|||
170611138|NCT02343406|616583669|FG002|Overall Study|Other primary malignancy|0|||
170611139|NCT02343406|616583670|FG003|Overall Study|Other primary malignancy|0|||
170653486|NCT02186301|616746011|FG002|Overall Study|Death|0|||
170653487|NCT02186301|616746009|FG000|Overall Study|Withdrawal by Subject|5|||
170653488|NCT02186301|616746010|FG001|Overall Study|Withdrawal by Subject|1|||
170653489|NCT02186301|616746011|FG002|Overall Study|Withdrawal by Subject|3|||
170653490|NCT02186301|616746009|FG000|Overall Study|Physician Decision|1|||
170653491|NCT02186301|616746010|FG001|Overall Study|Physician Decision|0|||
170653492|NCT02186301|616746011|FG002|Overall Study|Physician Decision|1|||
170653493|NCT02186301|616746009|FG000|Overall Study|Study Terminated by Sponsor|1|||
170653494|NCT02186301|616746010|FG001|Overall Study|Study Terminated by Sponsor|0|||
170653495|NCT02186301|616746011|FG002|Overall Study|Study Terminated by Sponsor|11|||
170653496|NCT02186301|616746009|FG000|Overall Study|Protocol Deviation|0|||
170653497|NCT02186301|616746010|FG001|Overall Study|Protocol Deviation|2|||
170653498|NCT02186301|616746011|FG002|Overall Study|Protocol Deviation|0|||
170653499|NCT02186301|616746009|FG000|Overall Study|Missing|0|||
170653500|NCT02186301|616746010|FG001|Overall Study|Missing|0|||
170653501|NCT02186301|616746011|FG002|Overall Study|Missing|2|||
170653502|NCT02186301|616746009|FG000|Overall Study|Other|0|||
170653503|NCT02186301|616746010|FG001|Overall Study|Other|0|||
170653504|NCT02186301|616746011|FG002|Overall Study|Other|1|||
170653505|NCT01343823|616746012|FG000|Overall Study|Study Terminated|1|||
170653506|NCT01343823|616746013|FG001|Overall Study|Study Terminated|0|||
170653507|NCT01343823|616746014|FG002|Overall Study|Study Terminated|0|||
170653508|NCT01343823|616746015|FG003|Overall Study|Study Terminated|1|||
170653509|NCT01343823|616746012|FG000|Overall Study|Withdrawal by Subject|1|||
170653510|NCT01343823|616746013|FG001|Overall Study|Withdrawal by Subject|0|||
170653511|NCT01343823|616746014|FG002|Overall Study|Withdrawal by Subject|0|||
170653512|NCT01343823|616746015|FG003|Overall Study|Withdrawal by Subject|0|||
170653513|NCT03505671|616746018|FG000|Overall Study|Withdrawal by Subject|2|||
170653514|NCT03505671|616746019|FG001|Overall Study|Withdrawal by Subject|1|||
170653515|NCT03505671|616746018|FG000|Overall Study|Lost to Follow-up|1|||
170653516|NCT03505671|616746019|FG001|Overall Study|Lost to Follow-up|0|||
170653517|NCT02038829|616746020|FG000|Washout Period 1|Death|0|||
170653518|NCT02038829|616746021|FG001|Washout Period 1|Death|0|||
170653519|NCT02038829|616746022|FG002|Washout Period 1|Death|0|||
170653520|NCT02038829|616746023|FG003|Washout Period 1|Death|0|||
170653521|NCT02038829|616746024|FG004|Washout Period 1|Death|1|||
170653522|NCT02038829|616746025|FG005|Washout Period 1|Death|0|||
170653523|NCT02038829|616746026|FG006|Washout Period 1|Death|0|||
170653524|NCT02038829|616746027|FG007|Washout Period 1|Death|0|||
170653525|NCT02038829|616746028|FG008|Washout Period 1|Death|0|||
170653526|NCT02038829|616746029|FG009|Washout Period 1|Death|0|||
170653527|NCT02038829|616746030|FG010|Washout Period 1|Death|0|||
170653528|NCT02038829|616746031|FG011|Washout Period 1|Death|0|||
170653529|NCT02038829|616746020|FG000|Treatment Period 2|Adverse Event|0|||
170653530|NCT02038829|616746021|FG001|Treatment Period 2|Adverse Event|0|||
170653531|NCT02038829|616746022|FG002|Treatment Period 2|Adverse Event|0|||
170653532|NCT02038829|616746023|FG003|Treatment Period 2|Adverse Event|0|||
170653533|NCT02038829|616746024|FG004|Treatment Period 2|Adverse Event|0|||
170653534|NCT02038829|616746025|FG005|Treatment Period 2|Adverse Event|0|||
170653535|NCT02038829|616746026|FG006|Treatment Period 2|Adverse Event|0|||
170653536|NCT02038829|616746027|FG007|Treatment Period 2|Adverse Event|0|||
170653537|NCT02038829|616746028|FG008|Treatment Period 2|Adverse Event|0|||
170653538|NCT02038829|616746029|FG009|Treatment Period 2|Adverse Event|0|||
170653539|NCT02038829|616746030|FG010|Treatment Period 2|Adverse Event|1|||
170653540|NCT02038829|616746031|FG011|Treatment Period 2|Adverse Event|0|||
170653541|NCT02038829|616746020|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170653542|NCT02038829|616746021|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170653543|NCT02038829|616746022|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170653544|NCT02038829|616746023|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170653545|NCT02038829|616746024|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170653546|NCT02038829|616746025|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170653547|NCT02038829|616746026|FG006|Treatment Period 2|Withdrawal by Subject|0|||
170653548|NCT02038829|616746027|FG007|Treatment Period 2|Withdrawal by Subject|0|||
170653549|NCT02038829|616746028|FG008|Treatment Period 2|Withdrawal by Subject|0|||
170653550|NCT02038829|616746029|FG009|Treatment Period 2|Withdrawal by Subject|0|||
170653551|NCT02038829|616746030|FG010|Treatment Period 2|Withdrawal by Subject|0|||
170653552|NCT02038829|616746031|FG011|Treatment Period 2|Withdrawal by Subject|0|||
170653553|NCT02038829|616746020|FG000|Washout Period 2|Adverse Event|0|||
170653554|NCT02038829|616746021|FG001|Washout Period 2|Adverse Event|0|||
170653555|NCT02038829|616746022|FG002|Washout Period 2|Adverse Event|0|||
170653556|NCT02038829|616746023|FG003|Washout Period 2|Adverse Event|0|||
170653557|NCT02038829|616746024|FG004|Washout Period 2|Adverse Event|0|||
170653558|NCT02038829|616746025|FG005|Washout Period 2|Adverse Event|0|||
170653559|NCT02038829|616746026|FG006|Washout Period 2|Adverse Event|0|||
170653560|NCT02038829|616746027|FG007|Washout Period 2|Adverse Event|0|||
170653561|NCT02038829|616746028|FG008|Washout Period 2|Adverse Event|1|||
170653562|NCT02038829|616746029|FG009|Washout Period 2|Adverse Event|0|||
170653563|NCT02038829|616746030|FG010|Washout Period 2|Adverse Event|0|||
170653564|NCT02038829|616746031|FG011|Washout Period 2|Adverse Event|0|||
170653565|NCT02038829|616746020|FG000|Washout Period 2|Withdrawal by Subject|0|||
170653566|NCT02038829|616746021|FG001|Washout Period 2|Withdrawal by Subject|0|||
170653567|NCT02038829|616746022|FG002|Washout Period 2|Withdrawal by Subject|0|||
170653568|NCT02038829|616746023|FG003|Washout Period 2|Withdrawal by Subject|0|||
170653569|NCT02038829|616746024|FG004|Washout Period 2|Withdrawal by Subject|0|||
170653570|NCT02038829|616746025|FG005|Washout Period 2|Withdrawal by Subject|1|||
170653571|NCT02038829|616746026|FG006|Washout Period 2|Withdrawal by Subject|0|||
170611140|NCT02343406|616583671|FG004|Overall Study|Other primary malignancy|0|||
170611141|NCT02343406|616583667|FG000|Overall Study|Other, not specified|2|||
170611142|NCT02343406|616583668|FG001|Overall Study|Other, not specified|1|||
170611143|NCT02343406|616583669|FG002|Overall Study|Other, not specified|1|||
170611144|NCT02343406|616583670|FG003|Overall Study|Other, not specified|4|||
170611145|NCT02343406|616583671|FG004|Overall Study|Other, not specified|0|||
170653572|NCT02038829|616746027|FG007|Washout Period 2|Withdrawal by Subject|0|||
170611146|NCT00548145|616583672|FG000|Overall Study|Death|0|||
170611147|NCT00548145|616583673|FG001|Overall Study|Death|1|||
170611148|NCT00548145|616583672|FG000|Overall Study|Withdrawal by Subject|0|||
170611149|NCT00548145|616583673|FG001|Overall Study|Withdrawal by Subject|2|||
170611150|NCT00548145|616583672|FG000|Overall Study|Physician Decision|1|||
170611151|NCT00548145|616583673|FG001|Overall Study|Physician Decision|1|||
170611152|NCT00595478|616583675|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
170611153|NCT00595478|616583676|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
170611154|NCT00595478|616583675|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
170611155|NCT00595478|616583676|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
170611156|NCT01620944|616583677|FG000|Overall Study|Early termination of Study|2|||
170611157|NCT01620944|616583678|FG001|Overall Study|Early termination of Study|1|||
170611158|NCT04405076|616583680|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
170611159|NCT04405076|616583681|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
170611160|NCT04405076|616583682|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
170653573|NCT02038829|616746028|FG008|Washout Period 2|Withdrawal by Subject|0|||
170653574|NCT02038829|616746029|FG009|Washout Period 2|Withdrawal by Subject|0|||
170653575|NCT02038829|616746030|FG010|Washout Period 2|Withdrawal by Subject|0|||
170653576|NCT02038829|616746031|FG011|Washout Period 2|Withdrawal by Subject|0|||
170653577|NCT02038829|616746020|FG000|Treatment Period 4|Adverse Event|0|||
170611161|NCT04405076|616583683|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
170653578|NCT02038829|616746021|FG001|Treatment Period 4|Adverse Event|1|||
170653579|NCT02038829|616746022|FG002|Treatment Period 4|Adverse Event|0|||
170653580|NCT02038829|616746023|FG003|Treatment Period 4|Adverse Event|0|||
170653581|NCT02038829|616746024|FG004|Treatment Period 4|Adverse Event|0|||
170653582|NCT02038829|616746025|FG005|Treatment Period 4|Adverse Event|0|||
170653583|NCT02038829|616746026|FG006|Treatment Period 4|Adverse Event|0|||
170653584|NCT02038829|616746027|FG007|Treatment Period 4|Adverse Event|0|||
170653585|NCT02038829|616746028|FG008|Treatment Period 4|Adverse Event|0|||
170653586|NCT02038829|616746029|FG009|Treatment Period 4|Adverse Event|0|||
170653587|NCT02038829|616746030|FG010|Treatment Period 4|Adverse Event|0|||
170653588|NCT02038829|616746031|FG011|Treatment Period 4|Adverse Event|0|||
170653589|NCT02038829|616746020|FG000|Washout Period 4|Adverse Event|0|||
170653590|NCT02038829|616746021|FG001|Washout Period 4|Adverse Event|0|||
170653591|NCT02038829|616746022|FG002|Washout Period 4|Adverse Event|0|||
170653592|NCT02038829|616746023|FG003|Washout Period 4|Adverse Event|0|||
170653593|NCT02038829|616746024|FG004|Washout Period 4|Adverse Event|0|||
170653594|NCT02038829|616746025|FG005|Washout Period 4|Adverse Event|0|||
170653595|NCT02038829|616746026|FG006|Washout Period 4|Adverse Event|1|||
170653596|NCT02038829|616746027|FG007|Washout Period 4|Adverse Event|0|||
170653597|NCT02038829|616746028|FG008|Washout Period 4|Adverse Event|0|||
170653598|NCT02038829|616746029|FG009|Washout Period 4|Adverse Event|0|||
170653599|NCT02038829|616746030|FG010|Washout Period 4|Adverse Event|0|||
170653600|NCT02038829|616746031|FG011|Washout Period 4|Adverse Event|0|||
170653601|NCT02038829|616746020|FG000|Treatment Period 6|Adverse Event|0|||
170653602|NCT02038829|616746021|FG001|Treatment Period 6|Adverse Event|0|||
170653603|NCT02038829|616746022|FG002|Treatment Period 6|Adverse Event|1|||
170653604|NCT02038829|616746023|FG003|Treatment Period 6|Adverse Event|0|||
170653605|NCT02038829|616746024|FG004|Treatment Period 6|Adverse Event|0|||
170653606|NCT02038829|616746025|FG005|Treatment Period 6|Adverse Event|0|||
170653607|NCT02038829|616746026|FG006|Treatment Period 6|Adverse Event|0|||
170653608|NCT02038829|616746027|FG007|Treatment Period 6|Adverse Event|0|||
170653609|NCT02038829|616746028|FG008|Treatment Period 6|Adverse Event|0|||
170653610|NCT02038829|616746029|FG009|Treatment Period 6|Adverse Event|0|||
170653611|NCT02038829|616746030|FG010|Treatment Period 6|Adverse Event|0|||
170653612|NCT02038829|616746031|FG011|Treatment Period 6|Adverse Event|0|||
170816216|NCT03745651|617335429|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170816217|NCT03745651|617335430|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170816218|NCT03745651|617335431|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
170611162|NCT04405076|616583684|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
170611163|NCT04405076|616583685|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
170611164|NCT04405076|616583686|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
170611165|NCT04405076|616583687|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
170611166|NCT04405076|616583688|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
170611167|NCT04405076|616583680|FG000|Part A (Blinded Phase)|Physician Decision|1|||
170611168|NCT04405076|616583681|FG001|Part A (Blinded Phase)|Physician Decision|2|||
170611169|NCT04405076|616583682|FG002|Part A (Blinded Phase)|Physician Decision|0|||
170611170|NCT04405076|616583683|FG003|Part A (Blinded Phase)|Physician Decision|0|||
170611171|NCT04405076|616583684|FG004|Part A (Blinded Phase)|Physician Decision|0|||
170611172|NCT04405076|616583685|FG005|Part A (Blinded Phase)|Physician Decision|0|||
170611173|NCT04405076|616583686|FG006|Part A (Blinded Phase)|Physician Decision|0|||
170611174|NCT04405076|616583687|FG007|Part A (Blinded Phase)|Physician Decision|0|||
170611175|NCT04405076|616583688|FG008|Part A (Blinded Phase)|Physician Decision|0|||
170611176|NCT04405076|616583680|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
170611177|NCT04405076|616583681|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
170611178|NCT04405076|616583682|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
170611179|NCT04405076|616583683|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
170611180|NCT04405076|616583684|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
170611181|NCT04405076|616583685|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
170611182|NCT04405076|616583686|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
170611183|NCT04405076|616583687|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
170611184|NCT04405076|616583688|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
170611185|NCT04405076|616583680|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
170611186|NCT04405076|616583681|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
170611187|NCT04405076|616583682|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
170611188|NCT04405076|616583683|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
170611189|NCT04405076|616583684|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
170653613|NCT00749580|616746032|FG000|Overall Study|Lost to Follow-up|4|||
170653614|NCT00749580|616746033|FG001|Overall Study|Lost to Follow-up|8|||
170653615|NCT00749580|616746032|FG000|Overall Study|Adverse Event|0|||
170653616|NCT00749580|616746033|FG001|Overall Study|Adverse Event|1|||
170653617|NCT04393298|616746034|FG000|Overall Study|Adverse Event|0|||
170653618|NCT04393298|616746035|FG001|Overall Study|Adverse Event|0|||
170653619|NCT04393298|616746036|FG002|Overall Study|Adverse Event|0|||
170653620|NCT04393298|616746037|FG003|Overall Study|Adverse Event|0|||
170653621|NCT04393298|616746038|FG004|Overall Study|Adverse Event|1|||
170816219|NCT03745651|617335432|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
170653622|NCT04393298|616746039|FG005|Overall Study|Adverse Event|0|||
170653623|NCT04393298|616746040|FG006|Overall Study|Adverse Event|0|||
170653624|NCT04393298|616746041|FG007|Overall Study|Adverse Event|0|||
170653625|NCT04393298|616746042|FG008|Overall Study|Adverse Event|2|||
170653626|NCT04393298|616746043|FG009|Overall Study|Adverse Event|0|||
170653627|NCT04393298|616746044|FG010|Overall Study|Adverse Event|0|||
170653628|NCT04393298|616746045|FG011|Overall Study|Adverse Event|0|||
170653629|NCT04393298|616746046|FG012|Overall Study|Adverse Event|1|||
170653630|NCT04393298|616746047|FG013|Overall Study|Adverse Event|1|||
170653631|NCT04393298|616746048|FG014|Overall Study|Adverse Event|0|||
170653632|NCT04393298|616746034|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653633|NCT04393298|616746035|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653634|NCT04393298|616746036|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
170653635|NCT04393298|616746037|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653636|NCT04393298|616746038|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653637|NCT04393298|616746039|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653638|NCT04393298|616746040|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653639|NCT04393298|616746041|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653640|NCT04393298|616746042|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653641|NCT04393298|616746043|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653642|NCT04393298|616746044|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653643|NCT04393298|616746045|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653644|NCT04393298|616746046|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653645|NCT04393298|616746047|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
170653646|NCT04393298|616746048|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
170653647|NCT04393298|616746034|FG000|Overall Study|Lack of Efficacy|0|||
170653648|NCT04393298|616746035|FG001|Overall Study|Lack of Efficacy|0|||
170653649|NCT04393298|616746036|FG002|Overall Study|Lack of Efficacy|0|||
170653650|NCT04393298|616746037|FG003|Overall Study|Lack of Efficacy|0|||
170653651|NCT04393298|616746038|FG004|Overall Study|Lack of Efficacy|0|||
170653652|NCT04393298|616746039|FG005|Overall Study|Lack of Efficacy|0|||
170653653|NCT04393298|616746040|FG006|Overall Study|Lack of Efficacy|0|||
170653654|NCT04393298|616746041|FG007|Overall Study|Lack of Efficacy|0|||
170653655|NCT04393298|616746042|FG008|Overall Study|Lack of Efficacy|0|||
170653656|NCT04393298|616746043|FG009|Overall Study|Lack of Efficacy|0|||
170653657|NCT04393298|616746044|FG010|Overall Study|Lack of Efficacy|0|||
170653658|NCT04393298|616746045|FG011|Overall Study|Lack of Efficacy|0|||
170653659|NCT04393298|616746046|FG012|Overall Study|Lack of Efficacy|0|||
170653660|NCT04393298|616746047|FG013|Overall Study|Lack of Efficacy|0|||
170653661|NCT04393298|616746048|FG014|Overall Study|Lack of Efficacy|1|||
170653662|NCT04393298|616746034|FG000|Overall Study|Progression|1|||
170653663|NCT04393298|616746035|FG001|Overall Study|Progression|0|||
170653664|NCT04393298|616746036|FG002|Overall Study|Progression|0|||
170653665|NCT04393298|616746037|FG003|Overall Study|Progression|0|||
170653666|NCT04393298|616746038|FG004|Overall Study|Progression|0|||
170653667|NCT04393298|616746039|FG005|Overall Study|Progression|0|||
170653668|NCT04393298|616746040|FG006|Overall Study|Progression|0|||
170653669|NCT04393298|616746041|FG007|Overall Study|Progression|0|||
170653670|NCT04393298|616746042|FG008|Overall Study|Progression|0|||
170653671|NCT04393298|616746043|FG009|Overall Study|Progression|0|||
170653672|NCT04393298|616746044|FG010|Overall Study|Progression|1|||
170653673|NCT04393298|616746045|FG011|Overall Study|Progression|1|||
170653674|NCT04393298|616746046|FG012|Overall Study|Progression|0|||
170653675|NCT04393298|616746047|FG013|Overall Study|Progression|0|||
170653676|NCT04393298|616746048|FG014|Overall Study|Progression|0|||
170653677|NCT04393298|616746034|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
170653678|NCT04393298|616746035|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653679|NCT04393298|616746036|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653680|NCT04393298|616746037|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653681|NCT04393298|616746038|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653682|NCT04393298|616746039|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653683|NCT04393298|616746040|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653684|NCT04393298|616746041|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653685|NCT04393298|616746042|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653686|NCT04393298|616746043|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653687|NCT04393298|616746044|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653688|NCT04393298|616746045|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653689|NCT04393298|616746046|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653690|NCT04393298|616746047|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653691|NCT04393298|616746048|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
170653692|NCT04393298|616746034|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653693|NCT04393298|616746035|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
170653694|NCT04393298|616746036|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653695|NCT04393298|616746037|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170816220|NCT03745651|617335433|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
170611190|NCT04405076|616583685|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
170611191|NCT04405076|616583686|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
170611192|NCT04405076|616583687|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
170611193|NCT04405076|616583688|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
170611194|NCT04405076|616583680|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
170611195|NCT04405076|616583681|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
170611196|NCT04405076|616583682|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
170611197|NCT04405076|616583683|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
170611198|NCT04405076|616583684|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
170611199|NCT04405076|616583685|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
170611200|NCT04405076|616583686|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
170611201|NCT04405076|616583687|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
170611202|NCT04405076|616583688|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
170611203|NCT04405076|616583680|FG000|Part A (Blinded Phase)|Other than Specified|0|||
170611204|NCT04405076|616583681|FG001|Part A (Blinded Phase)|Other than Specified|0|||
170611205|NCT04405076|616583682|FG002|Part A (Blinded Phase)|Other than Specified|3|||
170611206|NCT04405076|616583683|FG003|Part A (Blinded Phase)|Other than Specified|0|||
170611207|NCT04405076|616583684|FG004|Part A (Blinded Phase)|Other than Specified|0|||
170611208|NCT04405076|616583685|FG005|Part A (Blinded Phase)|Other than Specified|0|||
170611209|NCT04405076|616583686|FG006|Part A (Blinded Phase)|Other than Specified|0|||
170611210|NCT04405076|616583687|FG007|Part A (Blinded Phase)|Other than Specified|0|||
170611211|NCT04405076|616583688|FG008|Part A (Blinded Phase)|Other than Specified|0|||
170611212|NCT04405076|616583680|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
170611213|NCT04405076|616583681|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
170611214|NCT04405076|616583682|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
170611215|NCT04405076|616583683|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
170611216|NCT04405076|616583684|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
170611217|NCT04405076|616583685|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
170611218|NCT04405076|616583686|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
170611219|NCT04405076|616583687|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
170611220|NCT04405076|616583688|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
170611221|NCT04405076|616583680|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
170611222|NCT04405076|616583681|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
170611223|NCT04405076|616583682|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
170611224|NCT04405076|616583683|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
170611225|NCT04405076|616583684|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
170611226|NCT04405076|616583685|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
170611227|NCT04405076|616583686|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
170611228|NCT04405076|616583687|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
170611229|NCT04405076|616583688|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
170611230|NCT04405076|616583680|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
170611231|NCT04405076|616583681|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
170611232|NCT04405076|616583682|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
170611233|NCT04405076|616583683|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
170611234|NCT04405076|616583684|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
170611235|NCT04405076|616583685|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
170611236|NCT04405076|616583686|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
170611237|NCT04405076|616583687|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
170611238|NCT04405076|616583688|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
170611239|NCT04405076|616583680|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
170611240|NCT04405076|616583681|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
170611241|NCT04405076|616583682|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
170611242|NCT04405076|616583683|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
170611243|NCT04405076|616583684|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
170611244|NCT04405076|616583685|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
170611245|NCT04405076|616583686|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
170611246|NCT04405076|616583687|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
170611247|NCT04405076|616583688|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
170611248|NCT04405076|616583680|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
170611249|NCT04405076|616583681|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
170611250|NCT04405076|616583682|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
170611251|NCT04405076|616583683|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
170611252|NCT04405076|616583684|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
170653696|NCT04393298|616746038|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653697|NCT04393298|616746039|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653698|NCT04393298|616746040|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653699|NCT04393298|616746041|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170611253|NCT04405076|616583685|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
170611254|NCT04405076|616583686|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
170611255|NCT04405076|616583687|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
170611256|NCT04405076|616583688|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
170611257|NCT02513472|616583689|FG000|Overall Study|Radiological Disease Progression|45|||
170611258|NCT02513472|616583690|FG001|Overall Study|Radiological Disease Progression|57|||
170611259|NCT02513472|616583689|FG000|Overall Study|Clinical Disease Progression|5|||
170611260|NCT02513472|616583690|FG001|Overall Study|Clinical Disease Progression|13|||
170611261|NCT02513472|616583689|FG000|Overall Study|Adverse Event|8|||
170611262|NCT02513472|616583690|FG001|Overall Study|Adverse Event|11|||
170611263|NCT02513472|616583689|FG000|Overall Study|Withdrawal by Subject|0|||
170611264|NCT02513472|616583690|FG001|Overall Study|Withdrawal by Subject|4|||
170611265|NCT02513472|616583689|FG000|Overall Study|Subject Choice|2|||
170611266|NCT02513472|616583690|FG001|Overall Study|Subject Choice|7|||
170611267|NCT02513472|616583689|FG000|Overall Study|Treatment Completed as per Protocol|3|||
170611268|NCT02513472|616583690|FG001|Overall Study|Treatment Completed as per Protocol|3|||
170611269|NCT02513472|616583689|FG000|Overall Study|Other|3|||
170611270|NCT02513472|616583690|FG001|Overall Study|Other|6|||
170611271|NCT01019369|616583691|FG000|Overall Study|Lost to Follow-up|10|||
170611272|NCT01019369|616583692|FG001|Overall Study|Lost to Follow-up|6|||
170611273|NCT01019369|616583691|FG000|Overall Study|Withdrawal by Subject|0|||
170611274|NCT01019369|616583692|FG001|Overall Study|Withdrawal by Subject|1|||
170611275|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
170611276|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
170611277|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
170611278|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Death|0|||
170611279|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Death|2|||
170611280|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Death|0|||
170611281|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
170611282|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
170611283|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
170611284|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
170611285|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
170611286|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
170611287|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
170611288|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
170611289|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
170611290|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
170611291|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
170611292|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
170611293|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
170611294|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
170611295|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
170611296|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Recovery|1|||
170611297|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Recovery|0|||
170611298|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Recovery|1|||
170611299|NCT00195663|616583693|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
170611300|NCT00195663|616583694|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
170611301|NCT00195663|616583695|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
170611302|NCT00195663|616583693|FG000|Open-Label Extension Period|Adverse Event|21|||
170611303|NCT00195663|616583694|FG001|Open-Label Extension Period|Adverse Event|32|||
170611304|NCT00195663|616583695|FG002|Open-Label Extension Period|Adverse Event|36|||
170611305|NCT00195663|616583693|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
170611306|NCT00195663|616583694|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
170611307|NCT00195663|616583695|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
170611308|NCT00195663|616583693|FG000|Open-Label Extension Period|Recovery|0|||
170611309|NCT00195663|616583694|FG001|Open-Label Extension Period|Recovery|2|||
170611310|NCT00195663|616583695|FG002|Open-Label Extension Period|Recovery|2|||
170611311|NCT00195663|616583693|FG000|Open-Label Extension Period|Protocol Violation|3|||
170611312|NCT00195663|616583694|FG001|Open-Label Extension Period|Protocol Violation|4|||
170611313|NCT00195663|616583695|FG002|Open-Label Extension Period|Protocol Violation|4|||
170611314|NCT00195663|616583693|FG000|Open-Label Extension Period|Death|2|||
170611315|NCT00195663|616583694|FG001|Open-Label Extension Period|Death|2|||
170611316|NCT00195663|616583695|FG002|Open-Label Extension Period|Death|2|||
170611317|NCT00195663|616583693|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
170916808|NCT04767373|617695785|FG001|Overall Study|Death|3|||
170653700|NCT04393298|616746042|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653701|NCT04393298|616746043|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653702|NCT04393298|616746044|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653703|NCT04393298|616746045|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653704|NCT04393298|616746046|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170611318|NCT00195663|616583694|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
170611319|NCT00195663|616583695|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
170611320|NCT00195663|616583693|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
170611321|NCT00195663|616583694|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
170611322|NCT00195663|616583695|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
170611323|NCT00195663|616583693|FG000|Open-Label Extension Period|Administrative reasons|11|||
170611324|NCT00195663|616583694|FG001|Open-Label Extension Period|Administrative reasons|11|||
170611325|NCT00195663|616583695|FG002|Open-Label Extension Period|Administrative reasons|13|||
170611326|NCT01098305|616583696|FG000|Overall Study|Lost to Follow-up|31|||
170611327|NCT01098305|616583697|FG001|Overall Study|Lost to Follow-up|33|||
170611328|NCT04677504|616583701|FG000|Overall Study|Death|51|||
170611329|NCT04677504|616583702|FG001|Overall Study|Death|49|||
170611330|NCT04677504|616583701|FG000|Overall Study|Progressive Disease|1|||
170611331|NCT04677504|616583702|FG001|Overall Study|Progressive Disease|0|||
170611332|NCT04677504|616583701|FG000|Overall Study|Symptomatic Deterioration|1|||
170611333|NCT04677504|616583702|FG001|Overall Study|Symptomatic Deterioration|0|||
170611334|NCT04677504|616583701|FG000|Overall Study|Withdrawal by Subject|2|||
170611335|NCT04677504|616583702|FG001|Overall Study|Withdrawal by Subject|5|||
170611336|NCT04677504|616583701|FG000|Overall Study|Study Terminated By Sponsor|28|||
170611337|NCT04677504|616583702|FG001|Overall Study|Study Terminated By Sponsor|24|||
170611338|NCT04677504|616583701|FG000|Overall Study|Adverse Event|0|||
170611339|NCT04677504|616583702|FG001|Overall Study|Adverse Event|1|||
170611340|NCT03597061|616583710|FG000|Overall Study|Lost to Follow-up|1|||
170611341|NCT03597061|616583711|FG001|Overall Study|Lost to Follow-up|0|||
170611342|NCT03597061|616583710|FG000|Overall Study|Protocol Violation|0|||
170611343|NCT03597061|616583711|FG001|Overall Study|Protocol Violation|1|||
170611344|NCT02058563|616583712|FG000|Overall Study|Lost to Follow-up|26|||
170611345|NCT02058563|616583713|FG001|Overall Study|Lost to Follow-up|22|||
170611346|NCT02058563|616583712|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
170611347|NCT02058563|616583713|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
170611348|NCT02058563|616583712|FG000|Overall Study|Consent Withdrawal|1|||
170611349|NCT02058563|616583713|FG001|Overall Study|Consent Withdrawal|1|||
170611350|NCT02058563|616583712|FG000|Overall Study|Other (patient incarcerated)|0|||
170611351|NCT02058563|616583713|FG001|Overall Study|Other (patient incarcerated)|1|||
170611352|NCT00166439|616583714|FG000|Overall Study|Ineligible|5|||
170611353|NCT02560012|616583715|FG000|Overall Study|Study Terminated|2|||
170611354|NCT00483938|616583716|FG000|Overall Study|Protocol Violation|0|||
170611355|NCT00483938|616583717|FG001|Overall Study|Protocol Violation|0|||
170611356|NCT00483938|616583718|FG002|Overall Study|Protocol Violation|0|||
170611357|NCT00483938|616583719|FG003|Overall Study|Protocol Violation|0|||
170611358|NCT00483938|616583720|FG004|Overall Study|Protocol Violation|0|||
170611359|NCT00483938|616583721|FG005|Overall Study|Protocol Violation|0|||
170611360|NCT00483938|616583722|FG006|Overall Study|Protocol Violation|3|||
170611361|NCT00483938|616583716|FG000|Overall Study|Withdrawal by Subject|1|||
170611362|NCT00483938|616583717|FG001|Overall Study|Withdrawal by Subject|6|||
170611363|NCT00483938|616583718|FG002|Overall Study|Withdrawal by Subject|0|||
170611364|NCT00483938|616583719|FG003|Overall Study|Withdrawal by Subject|0|||
170611365|NCT00483938|616583720|FG004|Overall Study|Withdrawal by Subject|1|||
170611366|NCT00483938|616583721|FG005|Overall Study|Withdrawal by Subject|3|||
170611367|NCT00483938|616583722|FG006|Overall Study|Withdrawal by Subject|2|||
170611368|NCT00483938|616583716|FG000|Overall Study|Lost to Follow-up|1|||
170611369|NCT00483938|616583717|FG001|Overall Study|Lost to Follow-up|2|||
170611370|NCT00483938|616583718|FG002|Overall Study|Lost to Follow-up|0|||
170653705|NCT04393298|616746047|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653706|NCT04393298|616746048|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
170653707|NCT04393298|616746034|FG000|Overall Study|Clinical Progression|0|||
170653708|NCT04393298|616746035|FG001|Overall Study|Clinical Progression|2|||
170653709|NCT04393298|616746036|FG002|Overall Study|Clinical Progression|0|||
170611371|NCT00483938|616583719|FG003|Overall Study|Lost to Follow-up|2|||
170611372|NCT00483938|616583720|FG004|Overall Study|Lost to Follow-up|1|||
170611373|NCT00483938|616583721|FG005|Overall Study|Lost to Follow-up|1|||
170611374|NCT00483938|616583722|FG006|Overall Study|Lost to Follow-up|3|||
170611375|NCT00483938|616583716|FG000|Overall Study|Death|0|||
170611376|NCT00483938|616583717|FG001|Overall Study|Death|2|||
170611377|NCT00483938|616583718|FG002|Overall Study|Death|0|||
170611378|NCT00483938|616583719|FG003|Overall Study|Death|0|||
170611379|NCT00483938|616583720|FG004|Overall Study|Death|0|||
170611380|NCT00483938|616583721|FG005|Overall Study|Death|0|||
170611381|NCT00483938|616583722|FG006|Overall Study|Death|0|||
170611382|NCT00483938|616583716|FG000|Overall Study|Other|3|||
170611383|NCT00483938|616583717|FG001|Overall Study|Other|9|||
170611384|NCT00483938|616583718|FG002|Overall Study|Other|0|||
170611385|NCT00483938|616583719|FG003|Overall Study|Other|4|||
170611386|NCT00483938|616583720|FG004|Overall Study|Other|0|||
170611387|NCT00483938|616583721|FG005|Overall Study|Other|4|||
170611388|NCT00483938|616583722|FG006|Overall Study|Other|32|||
170611389|NCT03052816|616583723|FG000|Overall Study|Withdrawal by Subject|1|||
170611390|NCT03052816|616583724|FG001|Overall Study|Withdrawal by Subject|0|||
170611391|NCT03052816|616583723|FG000|Overall Study|Desired opioids|2|||
170611392|NCT03052816|616583724|FG001|Overall Study|Desired opioids|0|||
170611393|NCT00106353|616583725|FG000|Part 1|Disease progression|3|||
170611394|NCT00106353|616583726|FG001|Part 1|Disease progression|4|||
170611395|NCT00106353|616583727|FG002|Part 1|Disease progression|1|||
170611396|NCT00106353|616583728|FG003|Part 1|Disease progression|3|||
170611397|NCT00106353|616583729|FG004|Part 1|Disease progression|0|||
170611398|NCT00106353|616583730|FG005|Part 1|Disease progression|0|||
170611399|NCT00106353|616583731|FG006|Part 1|Disease progression|0|||
170611400|NCT00106353|616583725|FG000|Part 1|Withdrawal by Subject|0|||
170611401|NCT00106353|616583726|FG001|Part 1|Withdrawal by Subject|0|||
170611402|NCT00106353|616583727|FG002|Part 1|Withdrawal by Subject|1|||
170611403|NCT00106353|616583728|FG003|Part 1|Withdrawal by Subject|2|||
170611404|NCT00106353|616583729|FG004|Part 1|Withdrawal by Subject|0|||
170611405|NCT00106353|616583730|FG005|Part 1|Withdrawal by Subject|0|||
170611406|NCT00106353|616583731|FG006|Part 1|Withdrawal by Subject|0|||
170611407|NCT00106353|616583725|FG000|Part 1|Symptomatic deterioration|0|||
170611408|NCT00106353|616583726|FG001|Part 1|Symptomatic deterioration|0|||
170611409|NCT00106353|616583727|FG002|Part 1|Symptomatic deterioration|1|||
170611410|NCT00106353|616583728|FG003|Part 1|Symptomatic deterioration|0|||
170611411|NCT00106353|616583729|FG004|Part 1|Symptomatic deterioration|0|||
170611412|NCT00106353|616583730|FG005|Part 1|Symptomatic deterioration|0|||
170611413|NCT00106353|616583731|FG006|Part 1|Symptomatic deterioration|0|||
170611414|NCT00106353|616583725|FG000|Part 1|Entered follow-up phase|1|||
170611415|NCT00106353|616583726|FG001|Part 1|Entered follow-up phase|1|||
170611416|NCT00106353|616583727|FG002|Part 1|Entered follow-up phase|0|||
170611417|NCT00106353|616583728|FG003|Part 1|Entered follow-up phase|1|||
170611418|NCT00106353|616583729|FG004|Part 1|Entered follow-up phase|0|||
170611419|NCT00106353|616583730|FG005|Part 1|Entered follow-up phase|0|||
170611420|NCT00106353|616583731|FG006|Part 1|Entered follow-up phase|0|||
170611421|NCT00106353|616583725|FG000|Part 1|Adverse Event|0|||
170611422|NCT00106353|616583726|FG001|Part 1|Adverse Event|0|||
170611423|NCT00106353|616583727|FG002|Part 1|Adverse Event|0|||
170611424|NCT00106353|616583728|FG003|Part 1|Adverse Event|1|||
170611425|NCT00106353|616583729|FG004|Part 1|Adverse Event|0|||
170611426|NCT00106353|616583730|FG005|Part 1|Adverse Event|0|||
170611427|NCT00106353|616583731|FG006|Part 1|Adverse Event|0|||
170611428|NCT00106353|616583725|FG000|Part 2|Disease progression|0|||
170611429|NCT00106353|616583726|FG001|Part 2|Disease progression|0|||
170611430|NCT00106353|616583727|FG002|Part 2|Disease progression|0|||
170611431|NCT00106353|616583728|FG003|Part 2|Disease progression|0|||
170611432|NCT00106353|616583729|FG004|Part 2|Disease progression|8|||
170611433|NCT00106353|616583730|FG005|Part 2|Disease progression|14|||
170611434|NCT00106353|616583731|FG006|Part 2|Disease progression|13|||
170611435|NCT00106353|616583725|FG000|Part 2|Death|0|||
170611436|NCT00106353|616583726|FG001|Part 2|Death|0|||
170611437|NCT00106353|616583727|FG002|Part 2|Death|0|||
170611438|NCT00106353|616583728|FG003|Part 2|Death|0|||
170611439|NCT00106353|616583729|FG004|Part 2|Death|3|||
170611440|NCT00106353|616583730|FG005|Part 2|Death|0|||
170611441|NCT00106353|616583731|FG006|Part 2|Death|1|||
170611442|NCT00106353|616583725|FG000|Part 2|Symptomatic deterioration|0|||
170611443|NCT00106353|616583726|FG001|Part 2|Symptomatic deterioration|0|||
170611444|NCT00106353|616583727|FG002|Part 2|Symptomatic deterioration|0|||
170611445|NCT00106353|616583728|FG003|Part 2|Symptomatic deterioration|0|||
170611446|NCT00106353|616583729|FG004|Part 2|Symptomatic deterioration|3|||
170611447|NCT00106353|616583730|FG005|Part 2|Symptomatic deterioration|0|||
170611448|NCT00106353|616583731|FG006|Part 2|Symptomatic deterioration|0|||
170611449|NCT00106353|616583725|FG000|Part 2|Adverse Event|0|||
170611450|NCT00106353|616583726|FG001|Part 2|Adverse Event|0|||
170611451|NCT00106353|616583727|FG002|Part 2|Adverse Event|0|||
170611452|NCT00106353|616583728|FG003|Part 2|Adverse Event|0|||
170611453|NCT00106353|616583729|FG004|Part 2|Adverse Event|0|||
170611454|NCT00106353|616583730|FG005|Part 2|Adverse Event|2|||
170611455|NCT00106353|616583731|FG006|Part 2|Adverse Event|1|||
170611456|NCT00106353|616583725|FG000|Part 2|Other|0|||
170611457|NCT00106353|616583726|FG001|Part 2|Other|0|||
170611458|NCT00106353|616583727|FG002|Part 2|Other|0|||
170611459|NCT00106353|616583728|FG003|Part 2|Other|0|||
170611460|NCT00106353|616583729|FG004|Part 2|Other|1|||
170611461|NCT00106353|616583730|FG005|Part 2|Other|1|||
170611462|NCT00106353|616583731|FG006|Part 2|Other|1|||
170611463|NCT00106353|616583725|FG000|Part 2|Withdrawal by Subject|0|||
170611464|NCT00106353|616583726|FG001|Part 2|Withdrawal by Subject|0|||
170611465|NCT00106353|616583727|FG002|Part 2|Withdrawal by Subject|0|||
170611466|NCT00106353|616583728|FG003|Part 2|Withdrawal by Subject|0|||
170611467|NCT00106353|616583729|FG004|Part 2|Withdrawal by Subject|1|||
170611468|NCT00106353|616583730|FG005|Part 2|Withdrawal by Subject|0|||
170653710|NCT04393298|616746037|FG003|Overall Study|Clinical Progression|0|||
170653711|NCT04393298|616746038|FG004|Overall Study|Clinical Progression|0|||
170653712|NCT04393298|616746039|FG005|Overall Study|Clinical Progression|0|||
170653713|NCT04393298|616746040|FG006|Overall Study|Clinical Progression|0|||
170653714|NCT04393298|616746041|FG007|Overall Study|Clinical Progression|0|||
170653715|NCT04393298|616746042|FG008|Overall Study|Clinical Progression|0|||
170653716|NCT04393298|616746043|FG009|Overall Study|Clinical Progression|0|||
170653717|NCT04393298|616746044|FG010|Overall Study|Clinical Progression|0|||
170653718|NCT04393298|616746045|FG011|Overall Study|Clinical Progression|0|||
170653719|NCT04393298|616746046|FG012|Overall Study|Clinical Progression|0|||
170653720|NCT04393298|616746047|FG013|Overall Study|Clinical Progression|0|||
170653721|NCT04393298|616746048|FG014|Overall Study|Clinical Progression|0|||
170653722|NCT04393298|616746034|FG000|Overall Study|Disease Progression|0|||
170653723|NCT04393298|616746035|FG001|Overall Study|Disease Progression|1|||
170653724|NCT04393298|616746036|FG002|Overall Study|Disease Progression|0|||
170653725|NCT04393298|616746037|FG003|Overall Study|Disease Progression|0|||
170653726|NCT04393298|616746038|FG004|Overall Study|Disease Progression|0|||
170653727|NCT04393298|616746039|FG005|Overall Study|Disease Progression|3|||
170653728|NCT04393298|616746040|FG006|Overall Study|Disease Progression|2|||
170653729|NCT04393298|616746041|FG007|Overall Study|Disease Progression|1|||
170653730|NCT04393298|616746042|FG008|Overall Study|Disease Progression|2|||
170653731|NCT04393298|616746043|FG009|Overall Study|Disease Progression|1|||
170653732|NCT04393298|616746044|FG010|Overall Study|Disease Progression|0|||
170653733|NCT04393298|616746045|FG011|Overall Study|Disease Progression|3|||
170653734|NCT04393298|616746046|FG012|Overall Study|Disease Progression|0|||
170653735|NCT04393298|616746047|FG013|Overall Study|Disease Progression|0|||
170653736|NCT04393298|616746048|FG014|Overall Study|Disease Progression|1|||
170653737|NCT04393298|616746034|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653738|NCT04393298|616746035|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653739|NCT04393298|616746036|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
170653740|NCT04393298|616746037|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653741|NCT04393298|616746038|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653742|NCT04393298|616746039|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653743|NCT04393298|616746040|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653744|NCT04393298|616746041|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653745|NCT04393298|616746042|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653746|NCT04393298|616746043|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653747|NCT04393298|616746044|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653748|NCT04393298|616746045|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653749|NCT04393298|616746046|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653750|NCT04393298|616746047|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653751|NCT04393298|616746048|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
170653752|NCT04393298|616746034|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653753|NCT04393298|616746035|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653754|NCT04393298|616746036|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
170653755|NCT04393298|616746037|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653756|NCT04393298|616746038|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653757|NCT04393298|616746039|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653758|NCT04393298|616746040|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653759|NCT04393298|616746041|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653760|NCT04393298|616746042|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653761|NCT04393298|616746043|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653762|NCT04393298|616746044|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653763|NCT04393298|616746045|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653764|NCT04393298|616746046|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653765|NCT04393298|616746047|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653766|NCT04393298|616746048|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
170653767|NCT04393298|616746034|FG000|Overall Study|Progressive Disease (PD)|0|||
170653768|NCT04393298|616746035|FG001|Overall Study|Progressive Disease (PD)|0|||
170653769|NCT04393298|616746036|FG002|Overall Study|Progressive Disease (PD)|0|||
170653770|NCT04393298|616746037|FG003|Overall Study|Progressive Disease (PD)|3|||
170653771|NCT04393298|616746038|FG004|Overall Study|Progressive Disease (PD)|0|||
170653772|NCT04393298|616746039|FG005|Overall Study|Progressive Disease (PD)|0|||
170653773|NCT04393298|616746040|FG006|Overall Study|Progressive Disease (PD)|0|||
170653774|NCT04393298|616746041|FG007|Overall Study|Progressive Disease (PD)|0|||
170653775|NCT04393298|616746042|FG008|Overall Study|Progressive Disease (PD)|0|||
170653776|NCT04393298|616746043|FG009|Overall Study|Progressive Disease (PD)|0|||
170653777|NCT04393298|616746044|FG010|Overall Study|Progressive Disease (PD)|0|||
170653778|NCT04393298|616746045|FG011|Overall Study|Progressive Disease (PD)|0|||
170653779|NCT04393298|616746046|FG012|Overall Study|Progressive Disease (PD)|0|||
170653780|NCT04393298|616746047|FG013|Overall Study|Progressive Disease (PD)|0|||
170653781|NCT04393298|616746048|FG014|Overall Study|Progressive Disease (PD)|0|||
170653782|NCT04393298|616746034|FG000|Overall Study|Started a New Cancer Treatment|0|||
170653783|NCT04393298|616746035|FG001|Overall Study|Started a New Cancer Treatment|0|||
170653784|NCT04393298|616746036|FG002|Overall Study|Started a New Cancer Treatment|0|||
170653785|NCT04393298|616746037|FG003|Overall Study|Started a New Cancer Treatment|0|||
170653786|NCT04393298|616746038|FG004|Overall Study|Started a New Cancer Treatment|1|||
170653787|NCT04393298|616746039|FG005|Overall Study|Started a New Cancer Treatment|0|||
170653788|NCT04393298|616746040|FG006|Overall Study|Started a New Cancer Treatment|0|||
170653789|NCT04393298|616746041|FG007|Overall Study|Started a New Cancer Treatment|0|||
170653790|NCT04393298|616746042|FG008|Overall Study|Started a New Cancer Treatment|0|||
170653791|NCT04393298|616746043|FG009|Overall Study|Started a New Cancer Treatment|0|||
170653792|NCT04393298|616746044|FG010|Overall Study|Started a New Cancer Treatment|0|||
170653793|NCT04393298|616746045|FG011|Overall Study|Started a New Cancer Treatment|0|||
170653794|NCT04393298|616746046|FG012|Overall Study|Started a New Cancer Treatment|0|||
170653795|NCT04393298|616746047|FG013|Overall Study|Started a New Cancer Treatment|0|||
170653796|NCT04393298|616746048|FG014|Overall Study|Started a New Cancer Treatment|0|||
170653797|NCT04393298|616746034|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653798|NCT04393298|616746035|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653799|NCT04393298|616746036|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653800|NCT04393298|616746037|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653801|NCT04393298|616746038|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
170653802|NCT04393298|616746039|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653803|NCT04393298|616746040|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653804|NCT04393298|616746041|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653805|NCT04393298|616746042|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653806|NCT04393298|616746043|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653807|NCT04393298|616746044|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653808|NCT04393298|616746045|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653809|NCT04393298|616746046|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653810|NCT04393298|616746047|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653811|NCT04393298|616746048|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
170653812|NCT04393298|616746034|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653813|NCT04393298|616746035|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653814|NCT04393298|616746036|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653815|NCT04393298|616746037|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653816|NCT04393298|616746038|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653817|NCT04393298|616746039|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
170653818|NCT04393298|616746040|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653819|NCT04393298|616746041|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653820|NCT04393298|616746042|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653821|NCT04393298|616746043|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653822|NCT04393298|616746044|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653823|NCT04393298|616746045|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653824|NCT04393298|616746046|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653825|NCT04393298|616746047|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653826|NCT04393298|616746048|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
170653827|NCT04393298|616746034|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653828|NCT04393298|616746035|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653829|NCT04393298|616746036|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653830|NCT04393298|616746037|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653831|NCT04393298|616746038|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653832|NCT04393298|616746039|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
170653833|NCT04393298|616746040|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653834|NCT04393298|616746041|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653835|NCT04393298|616746042|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653836|NCT04393298|616746043|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653837|NCT04393298|616746044|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653838|NCT04393298|616746045|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653839|NCT04393298|616746046|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653840|NCT04393298|616746047|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
170653841|NCT04393298|616746048|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
170653842|NCT04393298|616746034|FG000|Overall Study|Death|0|||
170653843|NCT04393298|616746035|FG001|Overall Study|Death|0|||
170653844|NCT04393298|616746036|FG002|Overall Study|Death|0|||
170653845|NCT04393298|616746037|FG003|Overall Study|Death|0|||
170653846|NCT04393298|616746038|FG004|Overall Study|Death|0|||
170653847|NCT04393298|616746039|FG005|Overall Study|Death|1|||
170653848|NCT04393298|616746040|FG006|Overall Study|Death|1|||
170653849|NCT04393298|616746041|FG007|Overall Study|Death|0|||
170653850|NCT04393298|616746042|FG008|Overall Study|Death|1|||
170653851|NCT04393298|616746043|FG009|Overall Study|Death|1|||
170653852|NCT04393298|616746044|FG010|Overall Study|Death|0|||
170653853|NCT04393298|616746045|FG011|Overall Study|Death|1|||
170653854|NCT04393298|616746046|FG012|Overall Study|Death|1|||
170653855|NCT04393298|616746047|FG013|Overall Study|Death|0|||
170653856|NCT04393298|616746048|FG014|Overall Study|Death|1|||
170653857|NCT04393298|616746034|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653858|NCT04393298|616746035|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653859|NCT04393298|616746036|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653860|NCT04393298|616746037|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653861|NCT04393298|616746038|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653862|NCT04393298|616746039|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
170653863|NCT04393298|616746040|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653864|NCT04393298|616746041|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653865|NCT04393298|616746042|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653866|NCT04393298|616746043|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653867|NCT04393298|616746044|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653868|NCT04393298|616746045|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653869|NCT04393298|616746046|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653870|NCT04393298|616746047|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653871|NCT04393298|616746048|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
170653872|NCT04393298|616746034|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
170653873|NCT04393298|616746035|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
170653874|NCT04393298|616746036|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
170653875|NCT04393298|616746037|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
170653876|NCT04393298|616746038|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
170653877|NCT04393298|616746039|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
170653878|NCT04393298|616746040|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
170653879|NCT04393298|616746041|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
170653880|NCT04393298|616746042|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
170653881|NCT04393298|616746043|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
170653882|NCT04393298|616746044|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
170653883|NCT04393298|616746045|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
170653884|NCT04393298|616746046|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
170653885|NCT04393298|616746047|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
170653886|NCT04393298|616746048|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
170653887|NCT04393298|616746034|FG000|Overall Study|Patient Passed Away|0|||
170653888|NCT04393298|616746035|FG001|Overall Study|Patient Passed Away|0|||
170653889|NCT04393298|616746036|FG002|Overall Study|Patient Passed Away|0|||
170653890|NCT04393298|616746037|FG003|Overall Study|Patient Passed Away|0|||
170653891|NCT04393298|616746038|FG004|Overall Study|Patient Passed Away|0|||
170653892|NCT04393298|616746039|FG005|Overall Study|Patient Passed Away|0|||
170653893|NCT04393298|616746040|FG006|Overall Study|Patient Passed Away|0|||
170653894|NCT04393298|616746041|FG007|Overall Study|Patient Passed Away|1|||
170653895|NCT04393298|616746042|FG008|Overall Study|Patient Passed Away|0|||
170653896|NCT04393298|616746043|FG009|Overall Study|Patient Passed Away|0|||
170653897|NCT04393298|616746044|FG010|Overall Study|Patient Passed Away|0|||
170653898|NCT04393298|616746045|FG011|Overall Study|Patient Passed Away|0|||
170653899|NCT04393298|616746046|FG012|Overall Study|Patient Passed Away|0|||
170653900|NCT04393298|616746047|FG013|Overall Study|Patient Passed Away|0|||
170653901|NCT04393298|616746048|FG014|Overall Study|Patient Passed Away|0|||
170653902|NCT04393298|616746034|FG000|Overall Study|Patient Deceased|0|||
170653903|NCT04393298|616746035|FG001|Overall Study|Patient Deceased|0|||
170653904|NCT04393298|616746036|FG002|Overall Study|Patient Deceased|0|||
170653905|NCT04393298|616746037|FG003|Overall Study|Patient Deceased|0|||
170611469|NCT00106353|616583731|FG006|Part 2|Withdrawal by Subject|0|||
170611470|NCT00106353|616583725|FG000|Part 2|Physician Decision|0|||
170611471|NCT00106353|616583726|FG001|Part 2|Physician Decision|0|||
170611472|NCT00106353|616583727|FG002|Part 2|Physician Decision|0|||
170611473|NCT00106353|616583728|FG003|Part 2|Physician Decision|0|||
170611474|NCT00106353|616583729|FG004|Part 2|Physician Decision|0|||
170611475|NCT00106353|616583730|FG005|Part 2|Physician Decision|1|||
170611476|NCT00106353|616583731|FG006|Part 2|Physician Decision|0|||
170611477|NCT00167310|616583732|FG000|Overall Study|Protocol Violation|5|||
170611478|NCT00167310|616583733|FG001|Overall Study|Protocol Violation|3|||
170611479|NCT00167310|616583732|FG000|Overall Study|Withdrawal by Subject|3|||
170611480|NCT00167310|616583733|FG001|Overall Study|Withdrawal by Subject|7|||
170611481|NCT02328027|616583735|FG000|Overall Study|Withdrawal by Subject|0|||
170611482|NCT02328027|616583736|FG001|Overall Study|Withdrawal by Subject|1|||
170611483|NCT03304873|616583737|FG000|Overall Study|Lost to Follow-up|1|||
170653906|NCT04393298|616746038|FG004|Overall Study|Patient Deceased|0|||
170653907|NCT04393298|616746039|FG005|Overall Study|Patient Deceased|0|||
170653908|NCT04393298|616746040|FG006|Overall Study|Patient Deceased|0|||
170653909|NCT04393298|616746041|FG007|Overall Study|Patient Deceased|1|||
170653910|NCT04393298|616746042|FG008|Overall Study|Patient Deceased|0|||
170653911|NCT04393298|616746043|FG009|Overall Study|Patient Deceased|0|||
170653912|NCT04393298|616746044|FG010|Overall Study|Patient Deceased|0|||
170653913|NCT04393298|616746045|FG011|Overall Study|Patient Deceased|0|||
170653914|NCT04393298|616746046|FG012|Overall Study|Patient Deceased|0|||
170653915|NCT04393298|616746047|FG013|Overall Study|Patient Deceased|0|||
170653916|NCT04393298|616746048|FG014|Overall Study|Patient Deceased|0|||
170653917|NCT04393298|616746034|FG000|Overall Study|Patient Discharged to Hospice|0|||
170653918|NCT04393298|616746035|FG001|Overall Study|Patient Discharged to Hospice|0|||
170653919|NCT04393298|616746036|FG002|Overall Study|Patient Discharged to Hospice|0|||
170653920|NCT04393298|616746037|FG003|Overall Study|Patient Discharged to Hospice|0|||
170653921|NCT04393298|616746038|FG004|Overall Study|Patient Discharged to Hospice|0|||
170653922|NCT04393298|616746039|FG005|Overall Study|Patient Discharged to Hospice|0|||
170653923|NCT04393298|616746040|FG006|Overall Study|Patient Discharged to Hospice|0|||
170653924|NCT04393298|616746041|FG007|Overall Study|Patient Discharged to Hospice|0|||
170653925|NCT04393298|616746042|FG008|Overall Study|Patient Discharged to Hospice|1|||
170653926|NCT04393298|616746043|FG009|Overall Study|Patient Discharged to Hospice|0|||
170653927|NCT04393298|616746044|FG010|Overall Study|Patient Discharged to Hospice|0|||
170653928|NCT04393298|616746045|FG011|Overall Study|Patient Discharged to Hospice|0|||
170653929|NCT04393298|616746046|FG012|Overall Study|Patient Discharged to Hospice|0|||
170653930|NCT04393298|616746047|FG013|Overall Study|Patient Discharged to Hospice|0|||
170653931|NCT04393298|616746048|FG014|Overall Study|Patient Discharged to Hospice|0|||
170653932|NCT04393298|616746034|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653933|NCT04393298|616746035|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653934|NCT04393298|616746036|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653935|NCT04393298|616746037|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653936|NCT04393298|616746038|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653937|NCT04393298|616746039|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653938|NCT04393298|616746040|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653939|NCT04393298|616746041|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653940|NCT04393298|616746042|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653941|NCT04393298|616746043|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
170653942|NCT04393298|616746044|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653943|NCT04393298|616746045|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653944|NCT04393298|616746046|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653945|NCT04393298|616746047|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653946|NCT04393298|616746048|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
170653947|NCT04393298|616746034|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
170653948|NCT04393298|616746035|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
170653949|NCT04393298|616746036|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
170653950|NCT04393298|616746037|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
170653951|NCT04393298|616746038|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
170653952|NCT04393298|616746039|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
170653953|NCT04393298|616746040|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
170653954|NCT04393298|616746041|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
170653955|NCT04393298|616746042|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
170653956|NCT04393298|616746043|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
170653957|NCT04393298|616746044|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
170653958|NCT04393298|616746045|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
170653959|NCT04393298|616746046|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
170653960|NCT04393298|616746047|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
170653961|NCT04393298|616746048|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
170653962|NCT04972630|616746056|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
170653963|NCT04972630|616746057|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
170653964|NCT04972630|616746058|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
170653965|NCT05247398|616746061|FG000|Overall Study|Withdrawal by Subject|1|||
170653966|NCT03553836|616746062|FG000|Overall Study|Ongoing in Study|460|||
170653967|NCT03553836|616746063|FG001|Overall Study|Ongoing in Study|459|||
170653968|NCT03553836|616746062|FG000|Overall Study|Withdrawal by Subject|9|||
170653969|NCT03553836|616746063|FG001|Overall Study|Withdrawal by Subject|10|||
170653970|NCT03553836|616746062|FG000|Overall Study|Lost to Follow-up|1|||
170653971|NCT03553836|616746063|FG001|Overall Study|Lost to Follow-up|3|||
170653972|NCT03553836|616746062|FG000|Overall Study|Death|17|||
170653973|NCT03553836|616746063|FG001|Overall Study|Death|17|||
170653974|NCT00807027|616746064|FG000|Overall Study|Withdrawal by Subject|13|||
170653975|NCT00807027|616746065|FG001|Overall Study|Withdrawal by Subject|14|||
170816221|NCT03745651|617335434|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
170816222|NCT03745651|617335428|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170816223|NCT03745651|617335429|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170816224|NCT03745651|617335430|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170816225|NCT03745651|617335431|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
170816226|NCT03745651|617335432|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
170816227|NCT03745651|617335433|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
170816228|NCT03745651|617335434|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
170816229|NCT03745651|617335428|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
170816230|NCT03745651|617335429|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
170816231|NCT03745651|617335430|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
170816232|NCT03745651|617335431|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
170816233|NCT03745651|617335432|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
170816234|NCT03745651|617335433|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
170816235|NCT03745651|617335434|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
170816236|NCT03745651|617335428|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170816237|NCT03745651|617335429|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170816238|NCT03745651|617335430|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170816239|NCT03745651|617335431|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170816240|NCT03745651|617335432|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170816241|NCT03745651|617335433|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
170816242|NCT03745651|617335434|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
170816243|NCT03745651|617335428|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170816244|NCT03745651|617335429|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170816245|NCT03745651|617335430|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170816246|NCT03745651|617335431|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
170611484|NCT03304873|616583738|FG001|Overall Study|Lost to Follow-up|8|||
170611485|NCT03319212|616583739|FG000|Overall Study|Discontinued as moving out of local area|0|||
170611486|NCT03319212|616583740|FG001|Overall Study|Discontinued as moving out of local area|1|||
170611487|NCT03319212|616583739|FG000|Overall Study|Adverse Event|2|||
170611488|NCT03319212|616583740|FG001|Overall Study|Adverse Event|2|||
170611489|NCT03319212|616583739|FG000|Overall Study|Withdrawal by Subject|0|||
170611490|NCT03319212|616583740|FG001|Overall Study|Withdrawal by Subject|1|||
170611491|NCT03319212|616583739|FG000|Overall Study|Lost to Follow-up|0|||
170611492|NCT03319212|616583740|FG001|Overall Study|Lost to Follow-up|1|||
170611493|NCT03319212|616583739|FG000|Overall Study|Physician Decision|1|||
170611494|NCT03319212|616583740|FG001|Overall Study|Physician Decision|0|||
170611495|NCT03848949|616583741|FG000|Overall Study|Lost to Follow-up|5|||
170611496|NCT03848949|616583742|FG001|Overall Study|Lost to Follow-up|7|||
170611497|NCT00118430|616583747|FG000|Overall Study|Withdrawal by Subject|6|||
170611498|NCT00118430|616583748|FG001|Overall Study|Withdrawal by Subject|2|||
170611499|NCT00118430|616583749|FG002|Overall Study|Withdrawal by Subject|0|||
170611500|NCT00118430|616583747|FG000|Overall Study|Lost to Follow-up|15|||
170611501|NCT00118430|616583748|FG001|Overall Study|Lost to Follow-up|22|||
170611502|NCT00118430|616583749|FG002|Overall Study|Lost to Follow-up|28|||
170611503|NCT02147288|616583750|FG000|Overall Study|post-operative hematoma|1|||
170611504|NCT02147288|616583751|FG001|Overall Study|post-operative hematoma|1|||
170611505|NCT02147288|616583752|FG002|Overall Study|post-operative hematoma|0|||
170611506|NCT02147288|616583753|FG003|Overall Study|post-operative hematoma|0|||
170611507|NCT02147288|616583754|FG004|Overall Study|post-operative hematoma|0|||
170611508|NCT02147288|616583755|FG005|Overall Study|post-operative hematoma|0|||
170611509|NCT02147288|616583756|FG006|Overall Study|post-operative hematoma|0|||
170611510|NCT02147288|616583757|FG007|Overall Study|post-operative hematoma|0|||
170611511|NCT02147288|616583758|FG008|Overall Study|post-operative hematoma|0|||
170611512|NCT02147288|616583759|FG009|Overall Study|post-operative hematoma|0|||
170611513|NCT02147288|616583750|FG000|Overall Study|complications from concurrent hernia rep|0|||
170611514|NCT02147288|616583751|FG001|Overall Study|complications from concurrent hernia rep|1|||
170611515|NCT02147288|616583752|FG002|Overall Study|complications from concurrent hernia rep|0|||
170611516|NCT02147288|616583753|FG003|Overall Study|complications from concurrent hernia rep|0|||
170611517|NCT02147288|616583754|FG004|Overall Study|complications from concurrent hernia rep|0|||
170611518|NCT02147288|616583755|FG005|Overall Study|complications from concurrent hernia rep|0|||
170611519|NCT02147288|616583756|FG006|Overall Study|complications from concurrent hernia rep|0|||
170611520|NCT02147288|616583757|FG007|Overall Study|complications from concurrent hernia rep|0|||
170816247|NCT03745651|617335432|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
170916809|NCT04767373|617695784|FG000|Overall Study|Lost to Follow-up|67|||
170611521|NCT02147288|616583758|FG008|Overall Study|complications from concurrent hernia rep|0|||
170611522|NCT02147288|616583759|FG009|Overall Study|complications from concurrent hernia rep|0|||
170611523|NCT00264537|616583760|FG000|Overall Study|Death|0|||
170611524|NCT00264537|616583761|FG001|Overall Study|Death|3|||
170611525|NCT00264537|616583762|FG002|Overall Study|Death|3|||
170653976|NCT00807027|616746064|FG000|Overall Study|Protocol Violation|1|||
170653977|NCT00807027|616746065|FG001|Overall Study|Protocol Violation|1|||
170653978|NCT00807027|616746064|FG000|Overall Study|Adverse Event|2|||
170653979|NCT00807027|616746065|FG001|Overall Study|Adverse Event|2|||
170653980|NCT05660850|616746069|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
170653981|NCT05660850|616746070|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
170653982|NCT05660850|616746071|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
170611526|NCT00264537|616583763|FG003|Overall Study|Death|2|||
170611527|NCT00264537|616583760|FG000|Overall Study|Lost to Follow-up|3|||
170611528|NCT00264537|616583761|FG001|Overall Study|Lost to Follow-up|4|||
170611529|NCT00264537|616583762|FG002|Overall Study|Lost to Follow-up|7|||
170611530|NCT00264537|616583763|FG003|Overall Study|Lost to Follow-up|6|||
170611531|NCT00264537|616583760|FG000|Overall Study|Adverse Event|21|||
170611532|NCT00264537|616583761|FG001|Overall Study|Adverse Event|32|||
170611533|NCT00264537|616583762|FG002|Overall Study|Adverse Event|24|||
170611534|NCT00264537|616583763|FG003|Overall Study|Adverse Event|34|||
170611535|NCT00264537|616583760|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
170611536|NCT00264537|616583761|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
170611537|NCT00264537|616583762|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
170611538|NCT00264537|616583763|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
170611539|NCT00264537|616583760|FG000|Overall Study|Other|21|||
170611540|NCT00264537|616583761|FG001|Overall Study|Other|11|||
170611541|NCT00264537|616583762|FG002|Overall Study|Other|10|||
170611542|NCT00264537|616583763|FG003|Overall Study|Other|11|||
170611543|NCT00264537|616583760|FG000|Overall Study|Not treated|0|||
170611544|NCT00264537|616583761|FG001|Overall Study|Not treated|2|||
170611545|NCT00264537|616583762|FG002|Overall Study|Not treated|1|||
170611546|NCT00264537|616583763|FG003|Overall Study|Not treated|0|||
170611547|NCT01478971|616585494|FG000|Standard of Care Period|Adverse Event|1|||
170611548|NCT01478971|616585494|FG000|Standard of Care Period|Withdrawal by Subject|3|||
170611549|NCT01478971|616585494|FG000|Standard of Care Period|Death|8|||
170611550|NCT01478971|616585494|FG000|Standard of Care Period|Lost to Follow-up|9|||
170611551|NCT01478971|616585494|FG000|Standard of Care Period|Other|4|||
170611552|NCT01478971|616585494|FG000|Peginesatide Treatment Period|Adverse Event|1|||
170611553|NCT01478971|616585494|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
170611554|NCT01478971|616585494|FG000|Peginesatide Treatment Period|Death|4|||
170611555|NCT01478971|616585494|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
170611556|NCT01478971|616585494|FG000|Peginesatide Treatment Period|Other|4|||
170611557|NCT02451943|616585497|FG000|Overall Study|Withdrawal by Subject|13|||
170611558|NCT02451943|616585498|FG001|Overall Study|Withdrawal by Subject|16|||
170611559|NCT02451943|616585497|FG000|Overall Study|Lost to Follow-up|3|||
170611560|NCT02451943|616585498|FG001|Overall Study|Lost to Follow-up|4|||
170611561|NCT02451943|616585497|FG000|Overall Study|Sponsor Decision|0|||
170611562|NCT02451943|616585498|FG001|Overall Study|Sponsor Decision|4|||
170611563|NCT00763386|616585503|FG000|Overall Study|Adverse Event|43|||
170611564|NCT00763386|616585504|FG001|Overall Study|Adverse Event|33|||
170611565|NCT00763386|616585503|FG000|Overall Study|Death|1|||
170611566|NCT00763386|616585504|FG001|Overall Study|Death|2|||
170611567|NCT00763386|616585503|FG000|Overall Study|Lost to Follow-up|3|||
170611568|NCT00763386|616585504|FG001|Overall Study|Lost to Follow-up|3|||
170611569|NCT00763386|616585503|FG000|Overall Study|Withdrawal by Subject|0|||
170611570|NCT00763386|616585504|FG001|Overall Study|Withdrawal by Subject|1|||
170611571|NCT00763386|616585503|FG000|Overall Study|CRF missing|0|||
170611572|NCT00763386|616585504|FG001|Overall Study|CRF missing|1|||
170611573|NCT00763386|616585503|FG000|Overall Study|Study Prosthesis Removed|1|||
170611574|NCT00763386|616585504|FG001|Overall Study|Study Prosthesis Removed|0|||
170611575|NCT02451917|616585505|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
170611576|NCT02451917|616585506|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
170611577|NCT02451917|616585505|FG000|First Intervention (24 Weeks)|Death|0|||
170653983|NCT05660850|616746072|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
170611578|NCT02451917|616585506|FG001|First Intervention (24 Weeks)|Death|1|||
170611579|NCT02451917|616585505|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
170653984|NCT01129024|616746073|FG000|Overall Study|Physician Decision|5|||
170653985|NCT01129024|616746073|FG000|Overall Study|Study Terminated by Sponsor|8|||
170653986|NCT01129024|616746073|FG000|Overall Study|Withdrawal by Subject|2|||
170611580|NCT02451917|616585506|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
170611581|NCT02871635|616585507|FG000|Overall Study|Primary lack of efficacy|4|||
170611582|NCT02871635|616585508|FG001|Overall Study|Primary lack of efficacy|4|||
170611583|NCT02871635|616585507|FG000|Overall Study|Protocol Violation|3|||
170611584|NCT02871635|616585508|FG001|Overall Study|Protocol Violation|1|||
170611585|NCT02871635|616585507|FG000|Overall Study|Lost to Follow-up|1|||
170611586|NCT02871635|616585508|FG001|Overall Study|Lost to Follow-up|2|||
170611587|NCT02871635|616585507|FG000|Overall Study|Pregnancy|0|||
170611588|NCT02871635|616585508|FG001|Overall Study|Pregnancy|2|||
170653987|NCT01129024|616746073|FG000|Overall Study|Lack of Efficacy|3|||
170611589|NCT02871635|616585507|FG000|Overall Study|Physician Decision|1|||
170611590|NCT02871635|616585508|FG001|Overall Study|Physician Decision|1|||
170611591|NCT02871635|616585507|FG000|Overall Study|Withdrawal by Subject|3|||
170653988|NCT01129024|616746073|FG000|Overall Study|Needed a Platelet Transfusion|1|||
170653989|NCT01315236|616746075|FG000|Double-blind Phase|Death|1|||
170653990|NCT01315236|616746076|FG001|Double-blind Phase|Death|0|||
170653991|NCT01315236|616746075|FG000|Double-blind Phase|Adverse Event|1|||
170653992|NCT01315236|616746076|FG001|Double-blind Phase|Adverse Event|0|||
170653993|NCT01315236|616746075|FG000|Double-blind Phase|Withdrawal of Consent|1|||
170653994|NCT01315236|616746076|FG001|Double-blind Phase|Withdrawal of Consent|0|||
170653995|NCT01315236|616746075|FG000|Double-blind Phase|Lost to Follow-up|1|||
170653996|NCT01315236|616746076|FG001|Double-blind Phase|Lost to Follow-up|0|||
170653997|NCT01315236|616746075|FG000|Open-label Phase|Death|1|||
170653998|NCT01315236|616746076|FG001|Open-label Phase|Death|0|||
170653999|NCT01315236|616746075|FG000|Open-label Phase|Adverse Event|0|||
170654000|NCT01315236|616746076|FG001|Open-label Phase|Adverse Event|1|||
170654001|NCT01315236|616746075|FG000|Open-label Phase|Other|0|||
170654002|NCT01315236|616746076|FG001|Open-label Phase|Other|1|||
170654003|NCT01315236|616746075|FG000|12-Month Follow-up Period|Death|0|||
170654004|NCT01315236|616746076|FG001|12-Month Follow-up Period|Death|1|||
170654005|NCT01315236|616746075|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
170654006|NCT01315236|616746076|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
170654007|NCT04761627|616746077|FG000|Run-in Period|Death|1|||
170654008|NCT04761627|616746078|FG001|Run-in Period|Death|0|||
170654009|NCT04761627|616746079|FG002|Run-in Period|Death|0|||
170654010|NCT04761627|616746077|FG000|Run-in Period|Required alternative therapy|2|||
170654011|NCT04761627|616746078|FG001|Run-in Period|Required alternative therapy|0|||
170654012|NCT04761627|616746079|FG002|Run-in Period|Required alternative therapy|0|||
170654013|NCT04761627|616746077|FG000|Run-in Period|Lost to Follow-up|2|||
170654014|NCT04761627|616746078|FG001|Run-in Period|Lost to Follow-up|0|||
170654015|NCT04761627|616746079|FG002|Run-in Period|Lost to Follow-up|0|||
170816248|NCT03745651|617335433|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
170816249|NCT03745651|617335434|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
170816250|NCT03745651|617335428|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
170816251|NCT03745651|617335429|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
170816252|NCT03745651|617335430|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
170816253|NCT03745651|617335431|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
170816254|NCT03745651|617335432|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
170816255|NCT03745651|617335433|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
170816256|NCT03745651|617335434|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
170816257|NCT03360071|617335435|FG000|Overall Study|Lost to Follow-up|1|||
170816258|NCT03360071|617335436|FG001|Overall Study|Lost to Follow-up|0|||
170816259|NCT02542696|617335443|FG000|Overall Study|Adverse Event|167|||
170816260|NCT02542696|617335443|FG000|Overall Study|Lack of Efficacy|26|||
170816261|NCT02542696|617335443|FG000|Overall Study|Lost to Follow-up|6|||
170816262|NCT02542696|617335443|FG000|Overall Study|Withdrawal by Subject|104|||
170816263|NCT02542696|617335443|FG000|Overall Study|Protocol Violation|5|||
170816264|NCT02542696|617335443|FG000|Overall Study|Death|8|||
170816265|NCT02542696|617335443|FG000|Overall Study|DECREASED OFF TIME|1|||
170816266|NCT02542696|617335443|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
170816267|NCT02542696|617335443|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
170816268|NCT02542696|617335443|FG000|Overall Study|MEDICAL HISTORY|1|||
170816269|NCT02542696|617335443|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
170816270|NCT02542696|617335443|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
170816271|NCT02542696|617335443|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
170816272|NCT02542696|617335443|FG000|Overall Study|SPONSOR DECISION|3|||
170816273|NCT02542696|617335443|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
170816274|NCT02542696|617335443|FG000|Overall Study|SUBJECT DECISION|2|||
170816275|NCT03345407|617335445|FG000|Overall Study|Withdrawal by Subject|11|||
170816276|NCT03345407|617335446|FG001|Overall Study|Withdrawal by Subject|1|||
170654016|NCT04761627|616746077|FG000|Run-in Period|Protocol Violation|3|||
170654017|NCT04761627|616746078|FG001|Run-in Period|Protocol Violation|0|||
170654018|NCT04761627|616746079|FG002|Run-in Period|Protocol Violation|0|||
170654019|NCT04761627|616746077|FG000|Run-in Period|Abnormal liver function|1|||
170654020|NCT04761627|616746078|FG001|Run-in Period|Abnormal liver function|0|||
170654021|NCT04761627|616746079|FG002|Run-in Period|Abnormal liver function|0|||
170654022|NCT04761627|616746077|FG000|Run-in Period|Adverse Event|6|||
170654023|NCT04761627|616746078|FG001|Run-in Period|Adverse Event|0|||
170816277|NCT03345407|617335447|FG002|Overall Study|Withdrawal by Subject|5|||
170816278|NCT03345407|617335448|FG003|Overall Study|Withdrawal by Subject|6|||
170816279|NCT03345407|617335449|FG004|Overall Study|Withdrawal by Subject|3|||
170816280|NCT03345407|617335450|FG005|Overall Study|Withdrawal by Subject|6|||
170816281|NCT03345407|617335451|FG006|Overall Study|Withdrawal by Subject|16|||
170654024|NCT04761627|616746079|FG002|Run-in Period|Adverse Event|0|||
170654025|NCT04761627|616746077|FG000|Run-in Period|Withdrawal by Subject|7|||
170654026|NCT04761627|616746078|FG001|Run-in Period|Withdrawal by Subject|0|||
170654027|NCT04761627|616746079|FG002|Run-in Period|Withdrawal by Subject|0|||
170654028|NCT04761627|616746077|FG000|Run-in Period|Did not meet PASI 50|15|||
170611592|NCT02871635|616585508|FG001|Overall Study|Withdrawal by Subject|4|||
170611593|NCT02871635|616585507|FG000|Overall Study|Adverse Event|4|||
170611594|NCT02871635|616585508|FG001|Overall Study|Adverse Event|4|||
170611595|NCT02871635|616585507|FG000|Overall Study|Secondary lack of efficacy|2|||
170611596|NCT02871635|616585508|FG001|Overall Study|Secondary lack of efficacy|1|||
170611597|NCT01402817|616585509|FG000|Overall Study|Withdrawal by Subject|3|||
170654029|NCT04761627|616746078|FG001|Run-in Period|Did not meet PASI 50|0|||
170654030|NCT04761627|616746079|FG002|Run-in Period|Did not meet PASI 50|0|||
170654031|NCT04761627|616746077|FG000|Run-in Period|Study site closure|2|||
170654032|NCT04761627|616746078|FG001|Run-in Period|Study site closure|0|||
170654033|NCT04761627|616746079|FG002|Run-in Period|Study site closure|0|||
170654034|NCT04761627|616746077|FG000|Run-in Period|Pregnancy|2|||
170654035|NCT04761627|616746078|FG001|Run-in Period|Pregnancy|0|||
170654036|NCT04761627|616746079|FG002|Run-in Period|Pregnancy|0|||
170654037|NCT04761627|616746077|FG000|Post-randomization Period|Military service|0|||
170654038|NCT04761627|616746078|FG001|Post-randomization Period|Military service|1|||
170654039|NCT04761627|616746079|FG002|Post-randomization Period|Military service|0|||
170654040|NCT04761627|616746077|FG000|Post-randomization Period|Adverse Event|0|||
170654041|NCT04761627|616746078|FG001|Post-randomization Period|Adverse Event|4|||
170654042|NCT04761627|616746079|FG002|Post-randomization Period|Adverse Event|2|||
170654043|NCT04761627|616746077|FG000|Post-randomization Period|Lost to Follow-up|0|||
170654044|NCT04761627|616746078|FG001|Post-randomization Period|Lost to Follow-up|6|||
170654045|NCT04761627|616746079|FG002|Post-randomization Period|Lost to Follow-up|6|||
170654046|NCT04761627|616746077|FG000|Post-randomization Period|Withdrawal by Subject|0|||
170654047|NCT04761627|616746078|FG001|Post-randomization Period|Withdrawal by Subject|7|||
170654048|NCT04761627|616746079|FG002|Post-randomization Period|Withdrawal by Subject|6|||
170654049|NCT04761627|616746077|FG000|Post-randomization Period|Pregnancy|0|||
170654050|NCT04761627|616746078|FG001|Post-randomization Period|Pregnancy|0|||
170654051|NCT04761627|616746079|FG002|Post-randomization Period|Pregnancy|1|||
170654052|NCT04761627|616746077|FG000|Post-randomization Period|Study site closure|0|||
170654053|NCT04761627|616746078|FG001|Post-randomization Period|Study site closure|0|||
170654054|NCT04761627|616746079|FG002|Post-randomization Period|Study site closure|1|||
170654055|NCT04761627|616746077|FG000|Post-randomization Period|Family planning|0|||
170654056|NCT04761627|616746078|FG001|Post-randomization Period|Family planning|1|||
170654057|NCT04761627|616746079|FG002|Post-randomization Period|Family planning|0|||
170654058|NCT02497976|616746082|FG000|Overall Study|Withdrawal by Subject|2|||
170654059|NCT02497976|616746083|FG001|Overall Study|Withdrawal by Subject|0|||
170654060|NCT02497976|616746082|FG000|Overall Study|Moved out of area|0|||
170654061|NCT02497976|616746083|FG001|Overall Study|Moved out of area|1|||
170654062|NCT00058539|616746085|FG000|Overall Study|Disease progression|24|||
170654063|NCT00058539|616746085|FG000|Overall Study|Adverse Event|3|||
170654064|NCT00058539|616746085|FG000|Overall Study|Withdrawal by Subject|5|||
170654065|NCT00058539|616746085|FG000|Overall Study|Physician Decision|9|||
170654066|NCT00058539|616746085|FG000|Overall Study|Death|1|||
170654067|NCT00274924|616746086|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
170654068|NCT00274924|616746087|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
170654069|NCT00274924|616746088|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
170654070|NCT00274924|616746086|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
170654071|NCT00274924|616746087|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
170654072|NCT00274924|616746088|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
170654073|NCT00274924|616746086|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
170654074|NCT00274924|616746087|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
170611598|NCT01402817|616585509|FG000|Overall Study|Study Suspended by FDA|8|||
170611599|NCT00502671|616585510|FG000|Overall Study|Disease Progression|13|||
170611600|NCT00502671|616585510|FG000|Overall Study|Personal Reasons|22|||
170611601|NCT00502671|616585510|FG000|Overall Study|Lost to Follow-up|7|||
170611602|NCT00502671|616585510|FG000|Overall Study|Protocol Violation|16|||
170611603|NCT00502671|616585510|FG000|Overall Study|Adverse Event|19|||
170654075|NCT00274924|616746088|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
170654076|NCT00274924|616746086|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
170654077|NCT00274924|616746087|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
170654078|NCT00274924|616746088|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
170654079|NCT00274924|616746086|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
170654080|NCT00274924|616746087|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
170654081|NCT00274924|616746088|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
170654082|NCT00274924|616746086|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
170654083|NCT00274924|616746087|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
170654084|NCT00274924|616746088|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
170654085|NCT00274924|616746086|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
170654086|NCT00274924|616746087|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
170611604|NCT00681629|616585517|FG000|Overall Study|Study termination|4|||
170611605|NCT00681629|616585518|FG001|Overall Study|Study termination|2|||
170611606|NCT00681629|616585517|FG000|Overall Study|Adverse Event|1|||
170654087|NCT00274924|616746088|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
170654088|NCT00274924|616746086|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
170654089|NCT00274924|616746087|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
170654090|NCT00274924|616746088|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
170654091|NCT00274924|616746086|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
170654092|NCT00274924|616746087|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
170654093|NCT00274924|616746088|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
170654094|NCT00274924|616746086|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
170654095|NCT00274924|616746087|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
170654096|NCT00274924|616746088|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
170611607|NCT00681629|616585518|FG001|Overall Study|Adverse Event|0|||
170611608|NCT01395901|616585521|FG000|Overall Study|Lost to Follow-up|4|||
170611609|NCT01395901|616585522|FG001|Overall Study|Lost to Follow-up|0|||
170611610|NCT01395901|616585521|FG000|Overall Study|Randomized but not received study drug|5|||
170611611|NCT01395901|616585522|FG001|Overall Study|Randomized but not received study drug|4|||
170611612|NCT01395901|616585521|FG000|Overall Study|Adverse Event|0|||
170611613|NCT01395901|616585522|FG001|Overall Study|Adverse Event|1|||
170611614|NCT01395901|616585521|FG000|Overall Study|Withdrawal of consent|1|||
170611615|NCT01395901|616585522|FG001|Overall Study|Withdrawal of consent|0|||
170611616|NCT00853151|616585529|FG000|Overall Study|Adverse Event|1|||
170611617|NCT00853151|616585530|FG001|Overall Study|Adverse Event|4|||
170611618|NCT00853151|616585531|FG002|Overall Study|Adverse Event|2|||
170611619|NCT00853151|616585532|FG003|Overall Study|Adverse Event|0|||
170611620|NCT00853151|616585529|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
170611621|NCT00853151|616585530|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170611622|NCT00853151|616585531|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170611623|NCT00853151|616585532|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170611624|NCT00853151|616585529|FG000|Overall Study|Lost to Follow-up|2|||
170611625|NCT00853151|616585530|FG001|Overall Study|Lost to Follow-up|0|||
170611626|NCT00853151|616585531|FG002|Overall Study|Lost to Follow-up|3|||
170611627|NCT00853151|616585532|FG003|Overall Study|Lost to Follow-up|0|||
170611628|NCT00853151|616585529|FG000|Overall Study|Death|1|||
170611629|NCT00853151|616585530|FG001|Overall Study|Death|0|||
170611630|NCT00853151|616585531|FG002|Overall Study|Death|0|||
170611631|NCT00853151|616585532|FG003|Overall Study|Death|1|||
170611632|NCT00853151|616585529|FG000|Overall Study|Protocol Violation|0|||
170611633|NCT00853151|616585530|FG001|Overall Study|Protocol Violation|0|||
170611634|NCT00853151|616585531|FG002|Overall Study|Protocol Violation|0|||
170611635|NCT00853151|616585532|FG003|Overall Study|Protocol Violation|1|||
170611636|NCT00853151|616585529|FG000|Overall Study|Withdrawal by Subject|5|||
170611637|NCT00853151|616585530|FG001|Overall Study|Withdrawal by Subject|4|||
170611638|NCT00853151|616585531|FG002|Overall Study|Withdrawal by Subject|2|||
170611639|NCT00853151|616585532|FG003|Overall Study|Withdrawal by Subject|1|||
170611640|NCT00853151|616585529|FG000|Overall Study|Physician Decision|0|||
170611641|NCT00853151|616585530|FG001|Overall Study|Physician Decision|2|||
170611642|NCT00853151|616585531|FG002|Overall Study|Physician Decision|1|||
170611643|NCT00853151|616585532|FG003|Overall Study|Physician Decision|0|||
170611644|NCT00853151|616585529|FG000|Overall Study|Sponsor Decision|0|||
170611645|NCT00853151|616585530|FG001|Overall Study|Sponsor Decision|3|||
170611646|NCT00853151|616585531|FG002|Overall Study|Sponsor Decision|0|||
170611647|NCT00853151|616585532|FG003|Overall Study|Sponsor Decision|0|||
170611648|NCT01751984|616585533|FG000|Overall Study|Adverse Event|5|||
170611649|NCT01751984|616585534|FG001|Overall Study|Adverse Event|3|||
170611650|NCT01751984|616585533|FG000|Overall Study|Withdrawal by Subject|0|||
170611651|NCT01751984|616585534|FG001|Overall Study|Withdrawal by Subject|1|||
170611652|NCT01751984|616585533|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
170611653|NCT01751984|616585534|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
170611654|NCT00571038|616585535|FG000|Overall Study|Lost to Follow-up|1|||
170611655|NCT00571038|616585536|FG001|Overall Study|Lost to Follow-up|4|||
170611656|NCT00571038|616585535|FG000|Overall Study|Death|7|||
170611657|NCT00571038|616585536|FG001|Overall Study|Death|5|||
170611658|NCT00571038|616585535|FG000|Overall Study|Withdrawal by Subject|1|||
170611659|NCT00571038|616585536|FG001|Overall Study|Withdrawal by Subject|3|||
170611660|NCT00571038|616585535|FG000|Overall Study|Moved out of state|2|||
170611661|NCT00571038|616585536|FG001|Overall Study|Moved out of state|2|||
170611662|NCT03329092|616585538|FG000|Overall Study|Other|2|||
170611663|NCT03329092|616585539|FG001|Overall Study|Other|2|||
170611664|NCT03329092|616585538|FG000|Overall Study|Withdrawal by Subject|16|||
170611665|NCT03329092|616585539|FG001|Overall Study|Withdrawal by Subject|3|||
170611666|NCT03329092|616585538|FG000|Overall Study|Physician Decision|1|||
170611667|NCT03329092|616585539|FG001|Overall Study|Physician Decision|0|||
170611668|NCT03329092|616585538|FG000|Overall Study|Death|17|||
170611669|NCT03329092|616585539|FG001|Overall Study|Death|11|||
170611670|NCT03329092|616585538|FG000|Overall Study|Adverse Event|3|||
170611671|NCT03329092|616585539|FG001|Overall Study|Adverse Event|1|||
170611672|NCT03329092|616585538|FG000|Overall Study|Lost to Follow-up|1|||
170611673|NCT03329092|616585539|FG001|Overall Study|Lost to Follow-up|1|||
170654097|NCT00274924|616746086|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
170654098|NCT00274924|616746087|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
170654099|NCT00274924|616746088|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
170654100|NCT00274924|616746086|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
170654101|NCT00274924|616746087|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
170654102|NCT00274924|616746088|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
170654103|NCT00274924|616746086|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
170654104|NCT00274924|616746087|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
170654105|NCT00274924|616746088|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
170654106|NCT01903525|616746091|FG000|Overall Study|Lost to Follow-up|5|||
170654107|NCT01903525|616746092|FG001|Overall Study|Lost to Follow-up|9|||
170654108|NCT01903525|616746091|FG000|Overall Study|Adverse Event|0|||
170654109|NCT01903525|616746092|FG001|Overall Study|Adverse Event|1|||
170654110|NCT02129777|616746100|FG000|Double-Blind Period|Adverse Event|0|||
170654111|NCT02129777|616746101|FG001|Double-Blind Period|Adverse Event|0|||
170654112|NCT02129777|616746102|FG002|Double-Blind Period|Adverse Event|0|||
170654113|NCT02129777|616746103|FG003|Double-Blind Period|Adverse Event|0|||
170654114|NCT02129777|616746104|FG004|Double-Blind Period|Adverse Event|1|||
170654115|NCT02129777|616746105|FG005|Double-Blind Period|Adverse Event|0|||
170654116|NCT02129777|616746106|FG006|Double-Blind Period|Adverse Event|0|||
170654117|NCT02129777|616746100|FG000|Double-Blind Period|Lost to Follow-up|1|||
170654118|NCT02129777|616746101|FG001|Double-Blind Period|Lost to Follow-up|1|||
170654119|NCT02129777|616746102|FG002|Double-Blind Period|Lost to Follow-up|1|||
170654120|NCT02129777|616746103|FG003|Double-Blind Period|Lost to Follow-up|2|||
170654121|NCT02129777|616746104|FG004|Double-Blind Period|Lost to Follow-up|0|||
170654122|NCT02129777|616746105|FG005|Double-Blind Period|Lost to Follow-up|0|||
170654123|NCT02129777|616746106|FG006|Double-Blind Period|Lost to Follow-up|0|||
170654124|NCT02129777|616746100|FG000|Double-Blind Period|Withdrawal by Subject|2|||
170654125|NCT02129777|616746101|FG001|Double-Blind Period|Withdrawal by Subject|4|||
170654126|NCT02129777|616746102|FG002|Double-Blind Period|Withdrawal by Subject|3|||
170654127|NCT02129777|616746103|FG003|Double-Blind Period|Withdrawal by Subject|2|||
170654128|NCT02129777|616746104|FG004|Double-Blind Period|Withdrawal by Subject|3|||
170654129|NCT02129777|616746105|FG005|Double-Blind Period|Withdrawal by Subject|0|||
170654130|NCT02129777|616746106|FG006|Double-Blind Period|Withdrawal by Subject|0|||
170654131|NCT02129777|616746100|FG000|Double-Blind Period|Pregnancy|0|||
170654132|NCT02129777|616746101|FG001|Double-Blind Period|Pregnancy|0|||
170654133|NCT02129777|616746102|FG002|Double-Blind Period|Pregnancy|0|||
170654134|NCT02129777|616746103|FG003|Double-Blind Period|Pregnancy|0|||
170654135|NCT02129777|616746104|FG004|Double-Blind Period|Pregnancy|1|||
170654136|NCT02129777|616746105|FG005|Double-Blind Period|Pregnancy|0|||
170654137|NCT02129777|616746106|FG006|Double-Blind Period|Pregnancy|0|||
170654138|NCT02129777|616746100|FG000|Double-Blind Period|Lack of Efficacy|3|||
170654139|NCT02129777|616746101|FG001|Double-Blind Period|Lack of Efficacy|1|||
170654140|NCT02129777|616746102|FG002|Double-Blind Period|Lack of Efficacy|0|||
170654141|NCT02129777|616746103|FG003|Double-Blind Period|Lack of Efficacy|3|||
170654142|NCT02129777|616746104|FG004|Double-Blind Period|Lack of Efficacy|2|||
170654143|NCT02129777|616746105|FG005|Double-Blind Period|Lack of Efficacy|0|||
170654144|NCT02129777|616746106|FG006|Double-Blind Period|Lack of Efficacy|0|||
170654145|NCT02129777|616746100|FG000|Double-Blind Period|Other|1|||
170654146|NCT02129777|616746101|FG001|Double-Blind Period|Other|2|||
170654147|NCT02129777|616746102|FG002|Double-Blind Period|Other|0|||
170654148|NCT02129777|616746103|FG003|Double-Blind Period|Other|0|||
170654149|NCT02129777|616746104|FG004|Double-Blind Period|Other|0|||
170654150|NCT02129777|616746105|FG005|Double-Blind Period|Other|0|||
170654151|NCT02129777|616746106|FG006|Double-Blind Period|Other|0|||
170816282|NCT03345407|617335445|FG000|Overall Study|Physician Decision|3|||
170816283|NCT03345407|617335446|FG001|Overall Study|Physician Decision|1|||
170816284|NCT03345407|617335447|FG002|Overall Study|Physician Decision|0|||
170816285|NCT03345407|617335448|FG003|Overall Study|Physician Decision|0|||
170816286|NCT03345407|617335449|FG004|Overall Study|Physician Decision|1|||
170816287|NCT03345407|617335450|FG005|Overall Study|Physician Decision|2|||
170816288|NCT03345407|617335451|FG006|Overall Study|Physician Decision|3|||
170816289|NCT03345407|617335445|FG000|Overall Study|Lost to Follow-up|2|||
170816290|NCT03345407|617335446|FG001|Overall Study|Lost to Follow-up|0|||
170816291|NCT03345407|617335447|FG002|Overall Study|Lost to Follow-up|1|||
170816292|NCT03345407|617335448|FG003|Overall Study|Lost to Follow-up|0|||
170816293|NCT03345407|617335449|FG004|Overall Study|Lost to Follow-up|1|||
170816294|NCT03345407|617335450|FG005|Overall Study|Lost to Follow-up|2|||
170654152|NCT02129777|616746100|FG000|Open-Label Period|Lack of Efficacy|0|||
170654153|NCT02129777|616746101|FG001|Open-Label Period|Lack of Efficacy|0|||
170816295|NCT03345407|617335451|FG006|Overall Study|Lost to Follow-up|3|||
170816296|NCT03345407|617335445|FG000|Overall Study|Protocol-defined stopping criteria|9|||
170654154|NCT02129777|616746102|FG002|Open-Label Period|Lack of Efficacy|0|||
170654155|NCT02129777|616746103|FG003|Open-Label Period|Lack of Efficacy|0|||
170654156|NCT02129777|616746104|FG004|Open-Label Period|Lack of Efficacy|0|||
170654157|NCT02129777|616746105|FG005|Open-Label Period|Lack of Efficacy|0|||
170816297|NCT03345407|617335446|FG001|Overall Study|Protocol-defined stopping criteria|0|||
170654158|NCT02129777|616746106|FG006|Open-Label Period|Lack of Efficacy|5|||
170654159|NCT02129777|616746100|FG000|Open-Label Period|Lost to Follow-up|0|||
170654160|NCT02129777|616746101|FG001|Open-Label Period|Lost to Follow-up|0|||
170654161|NCT02129777|616746102|FG002|Open-Label Period|Lost to Follow-up|0|||
170654162|NCT02129777|616746103|FG003|Open-Label Period|Lost to Follow-up|0|||
170654163|NCT02129777|616746104|FG004|Open-Label Period|Lost to Follow-up|0|||
170654164|NCT02129777|616746105|FG005|Open-Label Period|Lost to Follow-up|1|||
170654165|NCT02129777|616746106|FG006|Open-Label Period|Lost to Follow-up|1|||
170654166|NCT02129777|616746100|FG000|Open-Label Period|Withdrawal by Subject|0|||
170654167|NCT02129777|616746101|FG001|Open-Label Period|Withdrawal by Subject|0|||
170654168|NCT02129777|616746102|FG002|Open-Label Period|Withdrawal by Subject|0|||
170654169|NCT02129777|616746103|FG003|Open-Label Period|Withdrawal by Subject|0|||
170654170|NCT02129777|616746104|FG004|Open-Label Period|Withdrawal by Subject|0|||
170654171|NCT02129777|616746105|FG005|Open-Label Period|Withdrawal by Subject|1|||
170654172|NCT02129777|616746106|FG006|Open-Label Period|Withdrawal by Subject|3|||
170654173|NCT02129777|616746100|FG000|Open-Label Period|Study Termination|0|||
170654174|NCT02129777|616746101|FG001|Open-Label Period|Study Termination|0|||
170654175|NCT02129777|616746102|FG002|Open-Label Period|Study Termination|0|||
170654176|NCT02129777|616746103|FG003|Open-Label Period|Study Termination|0|||
170654177|NCT02129777|616746104|FG004|Open-Label Period|Study Termination|0|||
170654178|NCT02129777|616746105|FG005|Open-Label Period|Study Termination|10|||
170654179|NCT02129777|616746106|FG006|Open-Label Period|Study Termination|39|||
170654180|NCT01609478|616746107|FG000|Overall Study|Adverse Event|3|||
170654181|NCT01609478|616746108|FG001|Overall Study|Adverse Event|1|||
170654182|NCT01609478|616746109|FG002|Overall Study|Adverse Event|5|||
170654183|NCT01609478|616746107|FG000|Overall Study|Protocol Deviation|0|||
170654184|NCT01609478|616746108|FG001|Overall Study|Protocol Deviation|1|||
170654185|NCT01609478|616746109|FG002|Overall Study|Protocol Deviation|1|||
170654186|NCT01609478|616746107|FG000|Overall Study|Non-Compliance with study treatment|1|||
170654187|NCT01609478|616746108|FG001|Overall Study|Non-Compliance with study treatment|0|||
170654188|NCT01609478|616746109|FG002|Overall Study|Non-Compliance with study treatment|0|||
170654189|NCT01609478|616746107|FG000|Overall Study|Physician Decision|1|||
170654190|NCT01609478|616746108|FG001|Overall Study|Physician Decision|0|||
170654191|NCT01609478|616746109|FG002|Overall Study|Physician Decision|1|||
170654192|NCT01609478|616746107|FG000|Overall Study|Withdrawal by Subject|2|||
170654193|NCT01609478|616746108|FG001|Overall Study|Withdrawal by Subject|0|||
170654194|NCT01609478|616746109|FG002|Overall Study|Withdrawal by Subject|2|||
170654195|NCT04391569|616746112|FG000|Overall Study|Death|15|||
170654196|NCT04391569|616746113|FG001|Overall Study|Death|10|||
170654197|NCT04391569|616746112|FG000|Overall Study|Withdrawal by Subject|1|||
170654198|NCT04391569|616746113|FG001|Overall Study|Withdrawal by Subject|0|||
170654199|NCT04391569|616746112|FG000|Overall Study|Lost to Follow-up|3|||
170654200|NCT04391569|616746113|FG001|Overall Study|Lost to Follow-up|2|||
170654201|NCT04391569|616746112|FG000|Overall Study|Lack of Efficacy|0|||
170654202|NCT04391569|616746113|FG001|Overall Study|Lack of Efficacy|1|||
170654203|NCT04391569|616746112|FG000|Overall Study|Participant discharged to hospice facility|0|||
170654204|NCT04391569|616746113|FG001|Overall Study|Participant discharged to hospice facility|1|||
170654205|NCT04391569|616746112|FG000|Overall Study|Participant family decision|1|||
170654206|NCT04391569|616746113|FG001|Overall Study|Participant family decision|0|||
170654207|NCT04391569|616746112|FG000|Overall Study|Participant discharged prematurely|1|||
170654208|NCT04391569|616746113|FG001|Overall Study|Participant discharged prematurely|0|||
170654209|NCT06066697|616746114|FG000|Overall Study|Lost to Follow-up|5|||
170654210|NCT06066697|616746115|FG001|Overall Study|Lost to Follow-up|0|||
170654211|NCT00938886|616746117|FG000|Overall Study|Death|0|||
170654212|NCT00938886|616746118|FG001|Overall Study|Death|1|||
170654213|NCT00938886|616746117|FG000|Overall Study|Withdrawal by Subject|4|||
170654214|NCT00938886|616746118|FG001|Overall Study|Withdrawal by Subject|7|||
170654215|NCT00938886|616746117|FG000|Overall Study|Lost to Follow-up|3|||
170654216|NCT00938886|616746118|FG001|Overall Study|Lost to Follow-up|2|||
170654217|NCT02283177|616746119|FG000|Overall Study|Withdrawal by Subject|1|||
170654218|NCT02283177|616746120|FG001|Overall Study|Withdrawal by Subject|1|||
170654219|NCT01101191|616746121|FG000|Period 1|Withdrawal by Subject|1|||
170654220|NCT01101191|616746122|FG001|Period 1|Withdrawal by Subject|0|||
170654221|NCT01101191|616746121|FG000|Period 1|Adverse Event|1|||
170654222|NCT01101191|616746122|FG001|Period 1|Adverse Event|2|||
170654223|NCT01146860|616746123|FG000|Overall Study|Withdrawal by Subject|0|||
170654224|NCT01146860|616746124|FG001|Overall Study|Withdrawal by Subject|1|||
170654225|NCT00327470|616746127|FG000|Overall Study|Randomized, but not treated|0|||
170654226|NCT00327470|616746128|FG001|Overall Study|Randomized, but not treated|2|||
170654227|NCT00327470|616746127|FG000|Overall Study|Adverse Event|9|||
170654228|NCT00327470|616746128|FG001|Overall Study|Adverse Event|14|||
170654229|NCT00327470|616746127|FG000|Overall Study|Lack of Efficacy|7|||
170654230|NCT00327470|616746128|FG001|Overall Study|Lack of Efficacy|19|||
170654231|NCT00327470|616746127|FG000|Overall Study|Other|5|||
170654232|NCT00327470|616746128|FG001|Overall Study|Other|9|||
170654233|NCT00327470|616746127|FG000|Overall Study|Lost to Follow-up|1|||
170654234|NCT00327470|616746128|FG001|Overall Study|Lost to Follow-up|3|||
170654235|NCT00327470|616746127|FG000|Overall Study|Withdrawal by Subject|6|||
170654236|NCT00327470|616746128|FG001|Overall Study|Withdrawal by Subject|12|||
170654237|NCT00327470|616746127|FG000|Overall Study|Death|1|||
170654238|NCT00327470|616746128|FG001|Overall Study|Death|4|||
170654239|NCT01470989|616746129|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
170654240|NCT01470989|616746130|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
170611674|NCT05786508|616585540|FG000|Overall Study|Withdrawal by Subject|2|||
170611675|NCT05786508|616585541|FG001|Overall Study|Withdrawal by Subject|0|||
170611676|NCT04829916|616585544|FG000|Overall Study|Withdrawal by Subject|1|||
170611677|NCT04829916|616585545|FG001|Overall Study|Withdrawal by Subject|0|||
170611678|NCT03329846|616585546|FG000|Overall Study|Disease progression|4|||
170611679|NCT03329846|616585547|FG001|Overall Study|Disease progression|6|||
170611680|NCT03329846|616585546|FG000|Overall Study|Study drug toxicity|1|||
170611681|NCT03329846|616585547|FG001|Overall Study|Study drug toxicity|0|||
170611682|NCT03329846|616585546|FG000|Overall Study|Participant request to discontinue treatment|0|||
170611683|NCT03329846|616585547|FG001|Overall Study|Participant request to discontinue treatment|1|||
170611684|NCT03329846|616585546|FG000|Overall Study|Participant withdrew consent|1|||
170611685|NCT03329846|616585547|FG001|Overall Study|Participant withdrew consent|0|||
170611686|NCT03329846|616585546|FG000|Overall Study|Other reasons|2|||
170611687|NCT03329846|616585547|FG001|Overall Study|Other reasons|2|||
170611688|NCT03400176|616585550|FG000|Dose Escalation|Progressive disease|1|||
170611689|NCT03400176|616585551|FG001|Dose Escalation|Progressive disease|1|||
170611690|NCT03400176|616585552|FG002|Dose Escalation|Progressive disease|0|||
170611691|NCT03400176|616585553|FG003|Dose Escalation|Progressive disease|0|||
170611692|NCT03400176|616585554|FG004|Dose Escalation|Progressive disease|1|||
170611693|NCT03400176|616585550|FG000|Dose Escalation|Patient decision|0|||
170611694|NCT03400176|616585551|FG001|Dose Escalation|Patient decision|0|||
170611695|NCT03400176|616585552|FG002|Dose Escalation|Patient decision|0|||
170611696|NCT03400176|616585553|FG003|Dose Escalation|Patient decision|0|||
170611697|NCT03400176|616585554|FG004|Dose Escalation|Patient decision|1|||
170611698|NCT03400176|616585550|FG000|Dose Expansion|Patient decision|0|||
170611699|NCT03400176|616585551|FG001|Dose Expansion|Patient decision|0|||
170611700|NCT03400176|616585552|FG002|Dose Expansion|Patient decision|0|||
170611701|NCT03400176|616585553|FG003|Dose Expansion|Patient decision|1|||
170611702|NCT03400176|616585554|FG004|Dose Expansion|Patient decision|0|||
170611703|NCT03400176|616585550|FG000|Dose Expansion|Adverse Event|0|||
170611704|NCT03400176|616585551|FG001|Dose Expansion|Adverse Event|0|||
170611705|NCT03400176|616585552|FG002|Dose Expansion|Adverse Event|0|||
170611706|NCT03400176|616585553|FG003|Dose Expansion|Adverse Event|1|||
170611707|NCT03400176|616585554|FG004|Dose Expansion|Adverse Event|0|||
170611708|NCT03400176|616585550|FG000|Dose Expansion|Physician Decision|0|||
170611709|NCT03400176|616585551|FG001|Dose Expansion|Physician Decision|0|||
170611710|NCT03400176|616585552|FG002|Dose Expansion|Physician Decision|0|||
170611711|NCT03400176|616585553|FG003|Dose Expansion|Physician Decision|1|||
170611712|NCT03400176|616585554|FG004|Dose Expansion|Physician Decision|0|||
170611713|NCT03400176|616585550|FG000|Dose Expansion|Progressive disease|0|||
170611714|NCT03400176|616585551|FG001|Dose Expansion|Progressive disease|0|||
170611715|NCT03400176|616585552|FG002|Dose Expansion|Progressive disease|1|||
170611716|NCT03400176|616585553|FG003|Dose Expansion|Progressive disease|1|||
170611717|NCT03400176|616585554|FG004|Dose Expansion|Progressive disease|0|||
170611718|NCT01371734|616585557|FG000|Overall Study|Other|2|||
170611719|NCT01371734|616585558|FG001|Overall Study|Other|1|||
170611720|NCT01371734|616585559|FG002|Overall Study|Other|2|||
170611721|NCT01371734|616585557|FG000|Overall Study|Withdrawal by Subject|3|||
170611722|NCT01371734|616585558|FG001|Overall Study|Withdrawal by Subject|4|||
170611723|NCT01371734|616585559|FG002|Overall Study|Withdrawal by Subject|9|||
170611724|NCT01371734|616585557|FG000|Overall Study|Lost to Follow-up|5|||
170611725|NCT01371734|616585558|FG001|Overall Study|Lost to Follow-up|3|||
170611726|NCT01371734|616585559|FG002|Overall Study|Lost to Follow-up|1|||
170611727|NCT01371734|616585557|FG000|Overall Study|Protocol Violation|3|||
170611728|NCT01371734|616585558|FG001|Overall Study|Protocol Violation|1|||
170611729|NCT01371734|616585559|FG002|Overall Study|Protocol Violation|2|||
170611730|NCT01371734|616585557|FG000|Overall Study|Adverse Event|8|||
170611731|NCT01371734|616585558|FG001|Overall Study|Adverse Event|8|||
170611732|NCT01371734|616585559|FG002|Overall Study|Adverse Event|3|||
170654241|NCT01470989|616746129|FG000|Overall Study|Adverse Event|2|||
170654242|NCT01470989|616746130|FG001|Overall Study|Adverse Event|5|||
170654243|NCT01470989|616746129|FG000|Overall Study|Abnormal laboratory value|1|||
170654244|NCT01470989|616746130|FG001|Overall Study|Abnormal laboratory value|1|||
170611733|NCT01371734|616585557|FG000|Overall Study|Lack of Efficacy|2|||
170611734|NCT01371734|616585558|FG001|Overall Study|Lack of Efficacy|2|||
170611735|NCT01371734|616585559|FG002|Overall Study|Lack of Efficacy|0|||
170611736|NCT00621140|616585560|FG000|Overall Study|Adverse Event|4|||
170611737|NCT00621140|616585561|FG001|Overall Study|Adverse Event|5|||
170611738|NCT00621140|616585560|FG000|Overall Study|Lost to Follow-up|1|||
170611739|NCT00621140|616585561|FG001|Overall Study|Lost to Follow-up|2|||
170611740|NCT00621140|616585560|FG000|Overall Study|Withdrawal by Subject|4|||
170611741|NCT00621140|616585561|FG001|Overall Study|Withdrawal by Subject|6|||
170654245|NCT01470989|616746129|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170611742|NCT00621140|616585560|FG000|Overall Study|Other incl. lack of efficacy|6|||
170611743|NCT00621140|616585561|FG001|Overall Study|Other incl. lack of efficacy|5|||
170611744|NCT04090242|616585564|FG000|Overall Study|Withdrawal by Subject|1|||
170611745|NCT04090242|616585565|FG001|Overall Study|Withdrawal by Subject|0|||
170611746|NCT02305238|616585566|FG000|Overall Study|Death|2|||
170611747|NCT02305238|616585567|FG001|Overall Study|Death|1|||
170611748|NCT02305238|616585568|FG002|Overall Study|Death|0|||
170611749|NCT02305238|616585566|FG000|Overall Study|Progressive disease|4|||
170611750|NCT02305238|616585567|FG001|Overall Study|Progressive disease|4|||
170611751|NCT02305238|616585568|FG002|Overall Study|Progressive disease|0|||
170611752|NCT02305238|616585566|FG000|Overall Study|Logistical difficulties|1|||
170611753|NCT02305238|616585567|FG001|Overall Study|Logistical difficulties|3|||
170611754|NCT02305238|616585568|FG002|Overall Study|Logistical difficulties|0|||
170611755|NCT02305238|616585566|FG000|Overall Study|Protocol Violation|0|||
170611756|NCT02305238|616585567|FG001|Overall Study|Protocol Violation|3|||
170611757|NCT02305238|616585568|FG002|Overall Study|Protocol Violation|0|||
170611758|NCT02305238|616585566|FG000|Overall Study|Physician Decision|2|||
170611759|NCT02305238|616585567|FG001|Overall Study|Physician Decision|1|||
170611760|NCT02305238|616585568|FG002|Overall Study|Physician Decision|0|||
170611761|NCT02305238|616585566|FG000|Overall Study|Adverse Event|4|||
170611762|NCT02305238|616585567|FG001|Overall Study|Adverse Event|2|||
170611763|NCT02305238|616585568|FG002|Overall Study|Adverse Event|0|||
170611764|NCT02305238|616585566|FG000|Overall Study|Withdrawal by Subject|3|||
170611765|NCT02305238|616585567|FG001|Overall Study|Withdrawal by Subject|4|||
170611766|NCT02305238|616585568|FG002|Overall Study|Withdrawal by Subject|0|||
170611767|NCT02305238|616585566|FG000|Overall Study|Randomized failure|0|||
170611768|NCT02305238|616585567|FG001|Overall Study|Randomized failure|0|||
170611769|NCT02305238|616585568|FG002|Overall Study|Randomized failure|8|||
170611770|NCT02305238|616585566|FG000|Overall Study|Required procedure failed|0|||
170611771|NCT02305238|616585567|FG001|Overall Study|Required procedure failed|1|||
170611772|NCT02305238|616585568|FG002|Overall Study|Required procedure failed|0|||
170611773|NCT01380834|616585569|FG000|Overall Study|Physician Decision|1|||
170611774|NCT01380834|616585570|FG001|Overall Study|Physician Decision|0|||
170611775|NCT03214406|616585571|FG000|Overall Study|did not meet enrollment criteria|9|||
170611776|NCT03214406|616585572|FG001|Overall Study|did not meet enrollment criteria|13|||
170611777|NCT03214406|616585571|FG000|Overall Study|Withdrawal by Subject|1|||
170611778|NCT03214406|616585572|FG001|Overall Study|Withdrawal by Subject|0|||
170611779|NCT03214406|616585571|FG000|Overall Study|Lost to Follow-up|0|||
170611780|NCT03214406|616585572|FG001|Overall Study|Lost to Follow-up|2|||
170611781|NCT00604695|616585573|FG000|Overall Study|Did not receive first bolus.|0|||
170611782|NCT00604695|616585574|FG001|Overall Study|Did not receive first bolus.|4|||
170611783|NCT01746173|616585582|FG000|Overall Study|Disease Progression|2|||
170611784|NCT00172042|616585586|FG000|Overall Study|Adverse Event|27|||
170611785|NCT00172042|616585587|FG001|Overall Study|Adverse Event|13|||
170611786|NCT00172042|616585586|FG000|Overall Study|Abnormal laboratory value(s)|5|||
170611787|NCT00172042|616585587|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170611788|NCT00172042|616585586|FG000|Overall Study|Abnormal test procedure(s)|0|||
170611789|NCT00172042|616585587|FG001|Overall Study|Abnormal test procedure(s)|3|||
170611790|NCT00172042|616585586|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
170611791|NCT00172042|616585587|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
170611792|NCT00172042|616585586|FG000|Overall Study|Patient no longer requires study drug|10|||
170611793|NCT00172042|616585587|FG001|Overall Study|Patient no longer requires study drug|8|||
170611794|NCT00172042|616585586|FG000|Overall Study|Protocol Violation|8|||
170611795|NCT00172042|616585587|FG001|Overall Study|Protocol Violation|7|||
170611796|NCT00172042|616585586|FG000|Overall Study|Withdrawal by Subject|37|||
170611797|NCT00172042|616585587|FG001|Overall Study|Withdrawal by Subject|25|||
170611798|NCT00172042|616585586|FG000|Overall Study|Lost to Follow-up|3|||
170611799|NCT00172042|616585587|FG001|Overall Study|Lost to Follow-up|5|||
170611800|NCT00172042|616585586|FG000|Overall Study|Administrative problems|13|||
170611801|NCT00172042|616585587|FG001|Overall Study|Administrative problems|10|||
170611802|NCT00172042|616585586|FG000|Overall Study|Death|42|||
170611803|NCT00172042|616585587|FG001|Overall Study|Death|42|||
170611804|NCT00375518|616585588|FG000|Overall Study|Withdrawal by Subject|2|||
170611805|NCT00375518|616585589|FG001|Overall Study|Withdrawal by Subject|10|||
170611806|NCT00375518|616585588|FG000|Overall Study|Patient Not Treated|6|||
170611807|NCT00375518|616585589|FG001|Overall Study|Patient Not Treated|6|||
170611808|NCT00375518|616585588|FG000|Overall Study|Death|0|||
170611809|NCT00375518|616585589|FG001|Overall Study|Death|1|||
170611810|NCT01180296|616585590|FG000|Overall Study|Protocol Violation|1|||
170611811|NCT01180296|616585591|FG001|Overall Study|Protocol Violation|2|||
170611812|NCT04039217|616585594|FG000|Overall Study|Lost to Follow-up|1|||
170611813|NCT00408434|616585595|FG000|Overall Study|Adverse Event|0|||
170611814|NCT00408434|616585596|FG001|Overall Study|Adverse Event|0|||
170611815|NCT00408434|616585597|FG002|Overall Study|Adverse Event|1|||
170611816|NCT00408434|616585598|FG003|Overall Study|Adverse Event|0|||
170611817|NCT00408434|616585599|FG004|Overall Study|Adverse Event|0|||
170611818|NCT00408434|616585600|FG005|Overall Study|Adverse Event|0|||
170611819|NCT00408434|616585601|FG006|Overall Study|Adverse Event|0|||
170654246|NCT01470989|616746130|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
170654247|NCT01470989|616746129|FG000|Overall Study|Withdrawal by Subject|19|||
170654248|NCT01470989|616746130|FG001|Overall Study|Withdrawal by Subject|17|||
170654249|NCT01470989|616746129|FG000|Overall Study|Lost to Follow-up|18|||
170654250|NCT01470989|616746130|FG001|Overall Study|Lost to Follow-up|13|||
170654251|NCT01470989|616746129|FG000|Overall Study|Administrative problems|2|||
170654252|NCT01470989|616746130|FG001|Overall Study|Administrative problems|4|||
170654253|NCT01470989|616746129|FG000|Overall Study|Death|2|||
170654254|NCT01470989|616746130|FG001|Overall Study|Death|2|||
170654255|NCT01470989|616746129|FG000|Overall Study|Protocol deviation|1|||
170654256|NCT01470989|616746130|FG001|Overall Study|Protocol deviation|2|||
170654257|NCT02197234|616746133|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
170654258|NCT02197234|616746133|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
170654259|NCT02197234|616746133|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
170654260|NCT02197234|616746133|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
170654261|NCT02197234|616746133|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
170654262|NCT02197234|616746133|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
170654263|NCT03326206|616746136|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
170654264|NCT03326206|616746137|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
170654265|NCT03326206|616746136|FG000|Overall Study - 24 months|Death|8|||
170654266|NCT03326206|616746137|FG001|Overall Study - 24 months|Death|92|||
170654267|NCT03326206|616746136|FG000|Overall Study - 24 months|Observational data not available|43|||
170654268|NCT03326206|616746137|FG001|Overall Study - 24 months|Observational data not available|2879|||
170654269|NCT03326206|616746136|FG000|12 months|Unable to match cases with controls|17|||
170654270|NCT03326206|616746137|FG001|12 months|Unable to match cases with controls|22721|||
170654271|NCT03326206|616746136|FG000|12 months|Death|2|||
170654272|NCT03326206|616746137|FG001|12 months|Death|50|||
170654273|NCT03326206|616746136|FG000|12 months|Observational data not available|49|||
170654274|NCT03326206|616746137|FG001|12 months|Observational data not available|2921|||
170654275|NCT02003365|616747251|FG000|Overall Study|Lost to Follow-up|0|||
170654276|NCT02003365|616747252|FG001|Overall Study|Lost to Follow-up|0|||
170654277|NCT02003365|616747253|FG002|Overall Study|Lost to Follow-up|1|||
170654278|NCT01709578|616747258|FG000|Overall Study|Rescued and entered in long term safety|63|||
170654279|NCT01709578|616747259|FG001|Overall Study|Rescued and entered in long term safety|25|||
170654280|NCT01709578|616747260|FG002|Overall Study|Rescued and entered in long term safety|26|||
170654281|NCT01709578|616747258|FG000|Overall Study|Adverse Event|9|||
170654282|NCT01709578|616747259|FG001|Overall Study|Adverse Event|18|||
170654283|NCT01709578|616747260|FG002|Overall Study|Adverse Event|17|||
170654284|NCT01709578|616747258|FG000|Overall Study|Lack of Efficacy|5|||
170654285|NCT01709578|616747259|FG001|Overall Study|Lack of Efficacy|4|||
170654286|NCT01709578|616747260|FG002|Overall Study|Lack of Efficacy|2|||
170654287|NCT01709578|616747258|FG000|Overall Study|Poor compliance to protocol|1|||
170654288|NCT01709578|616747259|FG001|Overall Study|Poor compliance to protocol|2|||
170654289|NCT01709578|616747260|FG002|Overall Study|Poor compliance to protocol|1|||
170654290|NCT01709578|616747258|FG000|Overall Study|Other, not related to safety or efficacy|2|||
170654291|NCT01709578|616747259|FG001|Overall Study|Other, not related to safety or efficacy|7|||
170654292|NCT01709578|616747260|FG002|Overall Study|Other, not related to safety or efficacy|5|||
170654293|NCT04050371|616747261|FG000|Overall Study|Withdrawal by Subject|1|||
170654294|NCT04050371|616747262|FG001|Overall Study|Withdrawal by Subject|0|||
170654295|NCT00597701|616747263|FG000|Overall Study|Withdrawal by Subject|5|||
170654296|NCT00597701|616747264|FG001|Overall Study|Withdrawal by Subject|5|||
170654297|NCT00597701|616747263|FG000|Overall Study|Death|0|||
170654298|NCT00597701|616747264|FG001|Overall Study|Death|1|||
170654299|NCT00597701|616747263|FG000|Overall Study|Physician Decision|2|||
170654300|NCT00597701|616747264|FG001|Overall Study|Physician Decision|0|||
170654301|NCT00597701|616747263|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
170654302|NCT00597701|616747264|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
170654303|NCT04078178|616747269|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
170654304|NCT04078178|616747270|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
170654305|NCT04078178|616747269|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
170654306|NCT04078178|616747270|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
170654307|NCT04078178|616747269|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
170654308|NCT04078178|616747270|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
170654309|NCT04078178|616747269|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
170654310|NCT04078178|616747270|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
170654311|NCT04078178|616747269|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
170654312|NCT04078178|616747270|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
170654313|NCT04617795|616747272|FG000|Main Study|Lost to Follow-up|1|||
170654314|NCT04617795|616747273|FG001|Main Study|Lost to Follow-up|0|||
170654315|NCT04850313|616747274|FG000|Overall Study|Withdrawal by Subject|0|||
170654316|NCT04850313|616747275|FG001|Overall Study|Withdrawal by Subject|1|||
170654317|NCT03269552|616747278|FG000|Overall Study|Adverse Event|2|||
170654318|NCT05859698|616747279|FG000|Overall Study|Adverse Event|1|||
170654319|NCT05859698|616747279|FG000|Overall Study|Death|1|||
170654320|NCT05859698|616747279|FG000|Overall Study|Physician Decision|1|||
170654321|NCT05859698|616747279|FG000|Overall Study|Lost to Follow-up|2|||
170654322|NCT05859698|616747279|FG000|Overall Study|Other Than Specified|2|||
170654323|NCT05859698|616747279|FG000|Overall Study|Withdrawal by Subject|1|||
170654324|NCT05128929|616747280|FG000|Overall Study|Adverse Event|0|||
170916810|NCT04767373|617695785|FG001|Overall Study|Lost to Follow-up|35|||
170916811|NCT04767373|617695784|FG000|Overall Study|Physician Decision|15|||
170654325|NCT05128929|616747281|FG001|Overall Study|Adverse Event|1|||
170654326|NCT03422627|616747284|FG000|Overall Study|Protocol-specified Criteria|1|||
170654327|NCT03422627|616747285|FG001|Overall Study|Protocol-specified Criteria|1|||
170654328|NCT03422627|616747286|FG002|Overall Study|Protocol-specified Criteria|0|||
170654329|NCT03422627|616747287|FG003|Overall Study|Protocol-specified Criteria|0|||
170654330|NCT03422627|616747288|FG004|Overall Study|Protocol-specified Criteria|2|||
170654331|NCT03422627|616747284|FG000|Overall Study|Requirement for Alternative Therapy|1|||
170654332|NCT03422627|616747285|FG001|Overall Study|Requirement for Alternative Therapy|1|||
170654333|NCT03422627|616747286|FG002|Overall Study|Requirement for Alternative Therapy|2|||
170654334|NCT03422627|616747287|FG003|Overall Study|Requirement for Alternative Therapy|0|||
170654335|NCT03422627|616747288|FG004|Overall Study|Requirement for Alternative Therapy|0|||
170654336|NCT03422627|616747284|FG000|Overall Study|Disease Progression|1|||
170654337|NCT03422627|616747285|FG001|Overall Study|Disease Progression|0|||
170654338|NCT03422627|616747286|FG002|Overall Study|Disease Progression|1|||
170654339|NCT03422627|616747287|FG003|Overall Study|Disease Progression|2|||
170654340|NCT03422627|616747288|FG004|Overall Study|Disease Progression|0|||
170654341|NCT03422627|616747284|FG000|Overall Study|Adverse Event|2|||
170654342|NCT03422627|616747285|FG001|Overall Study|Adverse Event|1|||
170654343|NCT03422627|616747286|FG002|Overall Study|Adverse Event|0|||
170654344|NCT03422627|616747287|FG003|Overall Study|Adverse Event|0|||
170654345|NCT03422627|616747288|FG004|Overall Study|Adverse Event|2|||
170654346|NCT03422627|616747284|FG000|Overall Study|Ineligibility Determined|0|||
170654347|NCT03422627|616747285|FG001|Overall Study|Ineligibility Determined|1|||
170654348|NCT03422627|616747286|FG002|Overall Study|Ineligibility Determined|0|||
170654349|NCT03422627|616747287|FG003|Overall Study|Ineligibility Determined|0|||
170654350|NCT03422627|616747288|FG004|Overall Study|Ineligibility Determined|0|||
170654351|NCT03422627|616747284|FG000|Overall Study|Death|0|||
170654352|NCT03422627|616747285|FG001|Overall Study|Death|1|||
170654353|NCT03422627|616747286|FG002|Overall Study|Death|1|||
170654354|NCT03422627|616747287|FG003|Overall Study|Death|0|||
170654355|NCT03422627|616747288|FG004|Overall Study|Death|0|||
170654356|NCT03422627|616747284|FG000|Overall Study|Withdrawal by Subject|0|||
170654357|NCT03422627|616747285|FG001|Overall Study|Withdrawal by Subject|0|||
170654358|NCT03422627|616747286|FG002|Overall Study|Withdrawal by Subject|0|||
170654359|NCT03422627|616747287|FG003|Overall Study|Withdrawal by Subject|1|||
170654360|NCT03422627|616747288|FG004|Overall Study|Withdrawal by Subject|0|||
170654361|NCT05900999|616747289|FG000|Overall Study|Withdrawal by Subject|9|||
170654362|NCT05900999|616747289|FG000|Overall Study|transfer to another facility; too complex of a therapy schedule; physician withdrawal|3|||
170654363|NCT02604017|616747292|FG000|Overall Study|Withdrew Consent|0|||
170654364|NCT02604017|616747293|FG001|Overall Study|Withdrew Consent|2|||
170654365|NCT02604017|616747292|FG000|Overall Study|Lost to Follow-up|5|||
170654366|NCT02604017|616747293|FG001|Overall Study|Lost to Follow-up|6|||
170654367|NCT02604017|616747292|FG000|Overall Study|Other|1|||
170654368|NCT02604017|616747293|FG001|Overall Study|Other|0|||
170654369|NCT01653782|616747299|FG000|Overall Study|Withdrawal by Subject|9|||
170654370|NCT01653782|616747300|FG001|Overall Study|Withdrawal by Subject|15|||
170654371|NCT01653782|616747301|FG002|Overall Study|Withdrawal by Subject|4|||
170654372|NCT01653782|616747299|FG000|Overall Study|Lost to Follow-up|7|||
170654373|NCT01653782|616747300|FG001|Overall Study|Lost to Follow-up|3|||
170654374|NCT01653782|616747301|FG002|Overall Study|Lost to Follow-up|2|||
170916812|NCT04767373|617695785|FG001|Overall Study|Physician Decision|4|||
170916813|NCT04767373|617695784|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170916814|NCT04767373|617695785|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170916815|NCT04767373|617695784|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
170916816|NCT04767373|617695785|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
170916817|NCT04767373|617695784|FG000|Overall Study|Other|1|||
170916818|NCT04767373|617695785|FG001|Overall Study|Other|2|||
170916819|NCT01517451|617695791|FG000|Overall Study|Lost to Follow-up|1|||
170916820|NCT03549325|617695792|FG000|Overall Study|Withdrawal by Subject|1|||
170654375|NCT02554279|616747305|FG000|Overall Study|Adverse Event|2|||
170654376|NCT02554279|616747306|FG001|Overall Study|Adverse Event|5|||
170654377|NCT02554279|616747305|FG000|Overall Study|Lost to Follow-up|3|||
170654378|NCT02554279|616747306|FG001|Overall Study|Lost to Follow-up|2|||
170654379|NCT02554279|616747305|FG000|Overall Study|Withdrawal by Subject|6|||
170654380|NCT02554279|616747306|FG001|Overall Study|Withdrawal by Subject|4|||
170654381|NCT02554279|616747305|FG000|Overall Study|Protocol Violation|2|||
170654382|NCT02554279|616747306|FG001|Overall Study|Protocol Violation|1|||
170654383|NCT02554279|616747305|FG000|Overall Study|Other reason|19|||
170916821|NCT03549325|617695793|FG001|Overall Study|Withdrawal by Subject|1|||
170654384|NCT02554279|616747306|FG001|Overall Study|Other reason|6|||
170654385|NCT01673282|616747307|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
170654386|NCT01673282|616747308|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
170654387|NCT01673282|616747307|FG000|Overall Study|Lack of Efficacy|9|||
170654388|NCT01673282|616747308|FG001|Overall Study|Lack of Efficacy|2|||
170654389|NCT01673282|616747307|FG000|Overall Study|Lost to Follow-up|11|||
170654390|NCT01673282|616747308|FG001|Overall Study|Lost to Follow-up|10|||
170654391|NCT01673282|616747307|FG000|Overall Study|Withdrawal by Subject|3|||
170654392|NCT01673282|616747308|FG001|Overall Study|Withdrawal by Subject|3|||
170654393|NCT01673282|616747307|FG000|Overall Study|Other|1|||
170654394|NCT01673282|616747308|FG001|Overall Study|Other|6|||
170654395|NCT02483533|616747309|FG000|Overall Study|Lack of Efficacy|50|||
170654396|NCT02483533|616747310|FG001|Overall Study|Lack of Efficacy|50|||
170654397|NCT04365257|616747311|FG000|Overall Study|Physician Decision|1|||
170654398|NCT04365257|616747312|FG001|Overall Study|Physician Decision|0|||
170654399|NCT04365257|616747311|FG000|Overall Study|Patient Noncompliance|1|||
170654400|NCT04365257|616747312|FG001|Overall Study|Patient Noncompliance|0|||
170654401|NCT04365257|616747311|FG000|Overall Study|Withdrawal by Subject|0|||
170654402|NCT04365257|616747312|FG001|Overall Study|Withdrawal by Subject|1|||
170654403|NCT01323920|616747313|FG000|Overall Study|Death|5|||
170654404|NCT01323920|616747313|FG000|Overall Study|Withdrawal by Subject|1|||
170654405|NCT00768469|616747319|FG000|Overall Study|Adverse Event|0|||
170654406|NCT00768469|616747320|FG001|Overall Study|Adverse Event|2|||
170654407|NCT00768469|616747319|FG000|Overall Study|Disease Progression|3|||
170654408|NCT00768469|616747320|FG001|Overall Study|Disease Progression|4|||
170654409|NCT00768469|616747319|FG000|Overall Study|Withdrawal by Subject|0|||
170654410|NCT00768469|616747320|FG001|Overall Study|Withdrawal by Subject|1|||
170654411|NCT03470441|616747321|FG000|Overall Study|Death|0|||
170654412|NCT03470441|616747322|FG001|Overall Study|Death|1|||
170654413|NCT03470441|616747323|FG002|Overall Study|Death|1|||
170654414|NCT03470441|616747324|FG003|Overall Study|Death|0|||
170654415|NCT03470441|616747321|FG000|Overall Study|Adverse Event|0|||
170654416|NCT03470441|616747322|FG001|Overall Study|Adverse Event|0|||
170654417|NCT03470441|616747323|FG002|Overall Study|Adverse Event|0|||
170654418|NCT03470441|616747324|FG003|Overall Study|Adverse Event|1|||
170654419|NCT03470441|616747321|FG000|Overall Study|Withdrawal by Subject|1|||
170654420|NCT03470441|616747322|FG001|Overall Study|Withdrawal by Subject|4|||
170654421|NCT03470441|616747323|FG002|Overall Study|Withdrawal by Subject|1|||
170654422|NCT03470441|616747324|FG003|Overall Study|Withdrawal by Subject|3|||
170654423|NCT05411367|616747328|FG000|Overall Study|Adverse Event|9|||
170654424|NCT05411367|616747329|FG001|Overall Study|Adverse Event|3|||
170654425|NCT05411367|616747328|FG000|Overall Study|Protocol Violation|0|||
170654426|NCT05411367|616747329|FG001|Overall Study|Protocol Violation|2|||
170654427|NCT05411367|616747328|FG000|Overall Study|Administrative Reasons|2|||
170654428|NCT05411367|616747329|FG001|Overall Study|Administrative Reasons|1|||
170654429|NCT05411367|616747328|FG000|Overall Study|Withdrawal by Subject|3|||
170654430|NCT05411367|616747329|FG001|Overall Study|Withdrawal by Subject|4|||
170654431|NCT05411367|616747328|FG000|Overall Study|Inclusion Criteria Not Met|0|||
170654432|NCT05411367|616747329|FG001|Overall Study|Inclusion Criteria Not Met|1|||
170654433|NCT02674854|616747332|FG000|Overall Study|Adverse Event|17|||
170654434|NCT02674854|616747333|FG001|Overall Study|Adverse Event|15|||
170654435|NCT02674854|616747334|FG002|Overall Study|Adverse Event|5|||
170654436|NCT02674854|616747332|FG000|Overall Study|Withdrawal by Subject|1|||
170654437|NCT02674854|616747333|FG001|Overall Study|Withdrawal by Subject|5|||
170916822|NCT00646906|617695799|FG000|Crossover Period 1|Withdrawal by Subject|1|||
170916823|NCT00646906|617695800|FG001|Crossover Period 1|Withdrawal by Subject|0|||
170916824|NCT00646906|617695801|FG002|Crossover Period 1|Withdrawal by Subject|0|||
170916825|NCT00646906|617695802|FG003|Crossover Period 1|Withdrawal by Subject|0|||
170916826|NCT00646906|617695803|FG004|Crossover Period 1|Withdrawal by Subject|0|||
170916827|NCT00646906|617695804|FG005|Crossover Period 1|Withdrawal by Subject|1|||
170916828|NCT00646906|617695805|FG006|Crossover Period 1|Withdrawal by Subject|0|||
170654438|NCT02674854|616747334|FG002|Overall Study|Withdrawal by Subject|4|||
170654439|NCT02674854|616747332|FG000|Overall Study|No-compliant subject|1|||
170654440|NCT02674854|616747333|FG001|Overall Study|No-compliant subject|0|||
170654441|NCT02674854|616747334|FG002|Overall Study|No-compliant subject|1|||
170654442|NCT02674854|616747332|FG000|Overall Study|Lost to Follow-up|1|||
170654443|NCT02674854|616747333|FG001|Overall Study|Lost to Follow-up|0|||
170654444|NCT02674854|616747334|FG002|Overall Study|Lost to Follow-up|2|||
170654445|NCT02674854|616747332|FG000|Overall Study|Lack of Efficacy|0|||
170654446|NCT02674854|616747333|FG001|Overall Study|Lack of Efficacy|3|||
170654447|NCT02674854|616747334|FG002|Overall Study|Lack of Efficacy|0|||
170654448|NCT02674854|616747332|FG000|Overall Study|Disallowed Concurrent Medication|2|||
170654449|NCT02674854|616747333|FG001|Overall Study|Disallowed Concurrent Medication|2|||
170654450|NCT02674854|616747334|FG002|Overall Study|Disallowed Concurrent Medication|0|||
170654451|NCT02674854|616747332|FG000|Overall Study|Protocol Violation|1|||
170654452|NCT02674854|616747333|FG001|Overall Study|Protocol Violation|1|||
170654453|NCT02674854|616747334|FG002|Overall Study|Protocol Violation|2|||
170916829|NCT00646906|617695799|FG000|Crossover Period 2|Withdrawal by Subject|0|||
170916830|NCT00646906|617695800|FG001|Crossover Period 2|Withdrawal by Subject|1|||
170916831|NCT00646906|617695801|FG002|Crossover Period 2|Withdrawal by Subject|2|||
170916832|NCT00646906|617695802|FG003|Crossover Period 2|Withdrawal by Subject|1|||
170916833|NCT00646906|617695803|FG004|Crossover Period 2|Withdrawal by Subject|0|||
170916834|NCT00646906|617695804|FG005|Crossover Period 2|Withdrawal by Subject|0|||
170916835|NCT00646906|617695805|FG006|Crossover Period 2|Withdrawal by Subject|0|||
170916836|NCT00646906|617695799|FG000|Crossover Period 2|Physician Decision|0|||
170916837|NCT00646906|617695800|FG001|Crossover Period 2|Physician Decision|0|||
170916838|NCT00646906|617695801|FG002|Crossover Period 2|Physician Decision|0|||
170916839|NCT00646906|617695802|FG003|Crossover Period 2|Physician Decision|0|||
170916840|NCT00646906|617695803|FG004|Crossover Period 2|Physician Decision|0|||
170916841|NCT00646906|617695804|FG005|Crossover Period 2|Physician Decision|0|||
170916842|NCT00646906|617695805|FG006|Crossover Period 2|Physician Decision|1|||
170916843|NCT03656926|617695806|FG000|Overall Study|Adverse Event|5|||
170916844|NCT03656926|617695807|FG001|Overall Study|Adverse Event|4|||
170916845|NCT03656926|617695806|FG000|Overall Study|Withdrawal by Subject|7|||
170916846|NCT03656926|617695807|FG001|Overall Study|Withdrawal by Subject|2|||
170916847|NCT03656926|617695806|FG000|Overall Study|Screen fail after randomization|1|||
170611820|NCT00408434|616585595|FG000|Overall Study|Progressive disease|6|||
170611821|NCT00408434|616585596|FG001|Overall Study|Progressive disease|3|||
170611822|NCT00408434|616585597|FG002|Overall Study|Progressive disease|4|||
170611823|NCT00408434|616585598|FG003|Overall Study|Progressive disease|3|||
170611824|NCT00408434|616585599|FG004|Overall Study|Progressive disease|3|||
170611825|NCT00408434|616585600|FG005|Overall Study|Progressive disease|1|||
170611826|NCT00408434|616585601|FG006|Overall Study|Progressive disease|4|||
170611827|NCT00408434|616585595|FG000|Overall Study|Other|0|||
170611828|NCT00408434|616585596|FG001|Overall Study|Other|0|||
170611829|NCT00408434|616585597|FG002|Overall Study|Other|1|||
170611830|NCT00408434|616585598|FG003|Overall Study|Other|0|||
170611831|NCT00408434|616585599|FG004|Overall Study|Other|2|||
170611832|NCT00408434|616585600|FG005|Overall Study|Other|1|||
170611833|NCT00408434|616585601|FG006|Overall Study|Other|0|||
170611834|NCT00408434|616585595|FG000|Overall Study|Terminated by Investigator|0|||
170611835|NCT00408434|616585596|FG001|Overall Study|Terminated by Investigator|0|||
170611836|NCT00408434|616585597|FG002|Overall Study|Terminated by Investigator|0|||
170611837|NCT00408434|616585598|FG003|Overall Study|Terminated by Investigator|0|||
170611838|NCT00408434|616585599|FG004|Overall Study|Terminated by Investigator|1|||
170611839|NCT00408434|616585600|FG005|Overall Study|Terminated by Investigator|1|||
170611840|NCT00408434|616585601|FG006|Overall Study|Terminated by Investigator|0|||
170611841|NCT00588354|616585602|FG000|Baseline to 2 Weeks|Adverse Event|1|||
170611842|NCT00588354|616585603|FG001|Baseline to 2 Weeks|Adverse Event|0|||
170611843|NCT00588354|616585602|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
170611844|NCT00588354|616585603|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
170611845|NCT00588354|616585602|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
170611846|NCT00588354|616585603|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
170611847|NCT00042991|616585606|FG000|Overall Study|Adverse Event|1|||
170611848|NCT00042991|616585607|FG001|Overall Study|Adverse Event|4|||
170611849|NCT00042991|616585608|FG002|Overall Study|Adverse Event|2|||
170611850|NCT00042991|616585609|FG003|Overall Study|Adverse Event|0|||
170611851|NCT00042991|616585610|FG004|Overall Study|Adverse Event|0|||
170611852|NCT00042991|616585611|FG005|Overall Study|Adverse Event|1|||
170611853|NCT00042991|616585612|FG006|Overall Study|Adverse Event|0|||
170611854|NCT00042991|616585606|FG000|Overall Study|Withdrawal by Subject|0|||
170611855|NCT00042991|616585607|FG001|Overall Study|Withdrawal by Subject|7|||
170611856|NCT00042991|616585608|FG002|Overall Study|Withdrawal by Subject|2|||
170611857|NCT00042991|616585609|FG003|Overall Study|Withdrawal by Subject|0|||
170611858|NCT00042991|616585610|FG004|Overall Study|Withdrawal by Subject|1|||
170611859|NCT00042991|616585611|FG005|Overall Study|Withdrawal by Subject|0|||
170611860|NCT00042991|616585612|FG006|Overall Study|Withdrawal by Subject|0|||
170611861|NCT00042991|616585606|FG000|Overall Study|Disease Progression|5|||
170611862|NCT00042991|616585607|FG001|Overall Study|Disease Progression|29|||
170611863|NCT00042991|616585608|FG002|Overall Study|Disease Progression|2|||
170611864|NCT00042991|616585609|FG003|Overall Study|Disease Progression|2|||
170611865|NCT00042991|616585610|FG004|Overall Study|Disease Progression|1|||
170611866|NCT00042991|616585611|FG005|Overall Study|Disease Progression|4|||
170611867|NCT00042991|616585612|FG006|Overall Study|Disease Progression|2|||
170611868|NCT00042991|616585606|FG000|Overall Study|Alternative Therapy|0|||
170654454|NCT02674854|616747332|FG000|Overall Study|Death|0|||
170611869|NCT00042991|616585607|FG001|Overall Study|Alternative Therapy|0|||
170611870|NCT00042991|616585608|FG002|Overall Study|Alternative Therapy|0|||
170611871|NCT00042991|616585609|FG003|Overall Study|Alternative Therapy|0|||
170611872|NCT00042991|616585610|FG004|Overall Study|Alternative Therapy|1|||
170611873|NCT00042991|616585611|FG005|Overall Study|Alternative Therapy|0|||
170611874|NCT00042991|616585612|FG006|Overall Study|Alternative Therapy|0|||
170611875|NCT01153724|616585618|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170611876|NCT01153724|616585618|FG000|Treatment Period 2|Adverse Event|1|||
170916848|NCT03656926|617695807|FG001|Overall Study|Screen fail after randomization|0|||
170916849|NCT03656926|617695806|FG000|Overall Study|PI decision due to patient condition|1|||
170816298|NCT03345407|617335447|FG002|Overall Study|Protocol-defined stopping criteria|0|||
170611877|NCT01153724|616585618|FG000|Treatment Period 2|Other reason not defined above|1|||
170611878|NCT02508428|616585619|FG000|Overall Study|Death|32|||
170611879|NCT02508428|616585620|FG001|Overall Study|Death|33|||
170611880|NCT02508428|616585619|FG000|Overall Study|Liner revised|3|||
170611881|NCT02508428|616585620|FG001|Overall Study|Liner revised|19|||
170611882|NCT02508428|616585619|FG000|Overall Study|Incomplete follow-up|17|||
170611883|NCT02508428|616585620|FG001|Overall Study|Incomplete follow-up|15|||
170611884|NCT00534976|616585628|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
170611885|NCT00534976|616585629|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
170611886|NCT00534976|616585628|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
170611887|NCT00534976|616585629|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
170611888|NCT00534976|616585628|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
170611889|NCT00534976|616585629|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
170611890|NCT00861471|616585630|FG000|Overall Study|Withdrawal by Subject|1|||
170611891|NCT00861471|616585630|FG000|Overall Study|Adverse Event|2|||
170611892|NCT00861471|616585630|FG000|Overall Study|Lack of Efficacy|3|||
170611893|NCT00861471|616585630|FG000|Overall Study|treatment for lumbar laminectomy|1|||
170611894|NCT00861471|616585630|FG000|Overall Study|Physician Decision|2|||
170611895|NCT04412707|616585633|FG000|Cycle 1|Death|0|||
170611896|NCT04412707|616585634|FG001|Cycle 1|Death|3|||
170611897|NCT04412707|616585633|FG000|Cycle 1|Disease progression|1|||
170611898|NCT04412707|616585634|FG001|Cycle 1|Disease progression|2|||
170611899|NCT04412707|616585633|FG000|Cycle 2|Death|0|||
170611900|NCT04412707|616585634|FG001|Cycle 2|Death|1|||
170611901|NCT04412707|616585633|FG000|Cycle 2|Disease progression|3|||
170611902|NCT04412707|616585634|FG001|Cycle 2|Disease progression|0|||
170611903|NCT04412707|616585633|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
170611904|NCT04412707|616585634|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
170611905|NCT04412707|616585633|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
170611906|NCT04412707|616585634|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
170611907|NCT04412707|616585633|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
170611908|NCT04412707|616585634|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
170611909|NCT04412707|616585633|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
170611910|NCT04412707|616585634|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
170611911|NCT02407223|616587210|FG000|Overall Study|Adverse Event|1|||
170611912|NCT02407223|616587211|FG001|Overall Study|Adverse Event|0|||
170611913|NCT02407223|616587212|FG002|Overall Study|Adverse Event|1|||
170611914|NCT02407223|616587210|FG000|Overall Study|Lack of Efficacy|6|||
170611915|NCT02407223|616587211|FG001|Overall Study|Lack of Efficacy|6|||
170611916|NCT02407223|616587212|FG002|Overall Study|Lack of Efficacy|4|||
170611917|NCT02407223|616587210|FG000|Overall Study|Lost to Follow-up|1|||
170611918|NCT02407223|616587211|FG001|Overall Study|Lost to Follow-up|0|||
170611919|NCT02407223|616587212|FG002|Overall Study|Lost to Follow-up|2|||
170611920|NCT02407223|616587210|FG000|Overall Study|Withdrawal by Subject|2|||
170611921|NCT02407223|616587211|FG001|Overall Study|Withdrawal by Subject|4|||
170611922|NCT02407223|616587212|FG002|Overall Study|Withdrawal by Subject|4|||
170611923|NCT02407223|616587210|FG000|Overall Study|Study Terminated by Sponsor|77|||
170611924|NCT02407223|616587211|FG001|Overall Study|Study Terminated by Sponsor|80|||
170611925|NCT02407223|616587212|FG002|Overall Study|Study Terminated by Sponsor|86|||
170611926|NCT02407223|616587210|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
170611927|NCT02407223|616587211|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
170611928|NCT02407223|616587212|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
170611929|NCT02407223|616587210|FG000|Overall Study|Other|29|||
170611930|NCT02407223|616587211|FG001|Overall Study|Other|27|||
170611931|NCT02407223|616587212|FG002|Overall Study|Other|25|||
170611932|NCT00922623|616587213|FG000|Overall Study|Other|4|||
170611933|NCT00922623|616587213|FG000|Overall Study|Lost to Follow-up|1|||
170611934|NCT00412893|616587215|FG000|Overall Study|Adverse Event|31|||
170611935|NCT00412893|616587216|FG001|Overall Study|Adverse Event|53|||
170611936|NCT00412893|616587215|FG000|Overall Study|Death|17|||
170611937|NCT00412893|616587216|FG001|Overall Study|Death|21|||
170611938|NCT00412893|616587215|FG000|Overall Study|Insufficient Therapeutic Response|39|||
170611939|NCT00412893|616587216|FG001|Overall Study|Insufficient Therapeutic Response|23|||
170611940|NCT00412893|616587215|FG000|Overall Study|Lost to Follow-up|2|||
170611941|NCT00412893|616587216|FG001|Overall Study|Lost to Follow-up|1|||
170654455|NCT02674854|616747333|FG001|Overall Study|Death|1|||
170816299|NCT03345407|617335448|FG003|Overall Study|Protocol-defined stopping criteria|0|||
170611942|NCT00412893|616587215|FG000|Overall Study|Violation of Selection at Entry|17|||
170611943|NCT00412893|616587216|FG001|Overall Study|Violation of Selection at Entry|10|||
170611944|NCT00412893|616587215|FG000|Overall Study|Other Protocol Violation|10|||
170611945|NCT00412893|616587216|FG001|Overall Study|Other Protocol Violation|6|||
170816300|NCT03345407|617335449|FG004|Overall Study|Protocol-defined stopping criteria|2|||
170816301|NCT03345407|617335450|FG005|Overall Study|Protocol-defined stopping criteria|1|||
170611946|NCT00412893|616587215|FG000|Overall Study|Did Not Cooperate|12|||
170611947|NCT00412893|616587216|FG001|Overall Study|Did Not Cooperate|9|||
170611948|NCT00412893|616587215|FG000|Overall Study|Administrative Reason|12|||
170611949|NCT00412893|616587216|FG001|Overall Study|Administrative Reason|15|||
170611950|NCT00412893|616587215|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
170611951|NCT00412893|616587216|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
170611952|NCT00950846|616587217|FG000|Overall Study|Death|6|||
170611953|NCT00950846|616587217|FG000|Overall Study|Lost to Follow-up|3|||
170611954|NCT00950846|616587217|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
170611955|NCT01799226|616587218|FG000|Overall Study|Withdrawal by Subject|1|||
170611956|NCT01799226|616587219|FG001|Overall Study|Withdrawal by Subject|0|||
170611957|NCT01799226|616587218|FG000|Overall Study|Disqualified at Day 14|1|||
170611958|NCT01799226|616587219|FG001|Overall Study|Disqualified at Day 14|0|||
170611959|NCT02114606|616587221|FG000|Overall Study|Unable to swallow Cytosponge|6|||
170611960|NCT00981461|616587222|FG000|Overall Study|Lost to Follow-up|5|||
170611961|NCT00981461|616587223|FG001|Overall Study|Lost to Follow-up|2|||
170611962|NCT03361293|616587224|FG000|Overall Study|Lost to Follow-up|0|||
170611963|NCT03361293|616587225|FG001|Overall Study|Lost to Follow-up|2|||
170611964|NCT03361293|616587224|FG000|Overall Study|Withdrawal by Subject|1|||
170611965|NCT03361293|616587225|FG001|Overall Study|Withdrawal by Subject|3|||
170611966|NCT01957202|616587226|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611967|NCT01957202|616587227|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
170611968|NCT01957202|616587228|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611969|NCT01957202|616587229|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611970|NCT01957202|616587230|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611971|NCT01957202|616587231|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611972|NCT01957202|616587232|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611973|NCT01957202|616587233|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611974|NCT01957202|616587234|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611975|NCT01957202|616587235|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611976|NCT01957202|616587236|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611977|NCT01957202|616587237|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611978|NCT01957202|616587238|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611979|NCT01957202|616587239|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611980|NCT01957202|616587240|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611981|NCT01957202|616587241|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611982|NCT01957202|616587242|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
170611983|NCT01957202|616587243|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
170611984|NCT01957202|616587226|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611985|NCT01957202|616587227|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611986|NCT01957202|616587228|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611987|NCT01957202|616587229|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611988|NCT01957202|616587230|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611989|NCT01957202|616587231|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611990|NCT01957202|616587232|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611991|NCT01957202|616587233|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611992|NCT01957202|616587234|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611993|NCT01957202|616587235|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611994|NCT01957202|616587236|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611995|NCT01957202|616587237|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611996|NCT01957202|616587238|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611997|NCT01957202|616587239|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611998|NCT01957202|616587240|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
170611999|NCT01957202|616587241|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
170612000|NCT01957202|616587242|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
170612001|NCT01957202|616587243|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
170612002|NCT00181766|616587253|FG000|Overall Study|Lost to Follow-up|6|||
170612003|NCT00181766|616587253|FG000|Overall Study|Adverse Event|4|||
170612004|NCT00181766|616587253|FG000|Overall Study|non-compliance|2|||
170612005|NCT01076036|616587254|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
170612006|NCT00687804|616587255|FG000|Core Study|Adverse Event|5|||
170612007|NCT00687804|616587256|FG001|Core Study|Adverse Event|3|||
170612008|NCT00687804|616587257|FG002|Core Study|Adverse Event|3|||
170612009|NCT00687804|616587255|FG000|Core Study|Abnormal laboratory value(s)|1|||
170612010|NCT00687804|616587256|FG001|Core Study|Abnormal laboratory value(s)|0|||
170612011|NCT00687804|616587257|FG002|Core Study|Abnormal laboratory value(s)|0|||
170612012|NCT00687804|616587255|FG000|Core Study|Lack of Efficacy|1|||
170612013|NCT00687804|616587256|FG001|Core Study|Lack of Efficacy|1|||
170612014|NCT00687804|616587257|FG002|Core Study|Lack of Efficacy|1|||
170612015|NCT00687804|616587255|FG000|Core Study|Withdrawal by Subject|4|||
170612016|NCT00687804|616587256|FG001|Core Study|Withdrawal by Subject|7|||
170612017|NCT00687804|616587257|FG002|Core Study|Withdrawal by Subject|7|||
170612018|NCT00687804|616587255|FG000|Core Study|Lost to Follow-up|0|||
170612019|NCT00687804|616587256|FG001|Core Study|Lost to Follow-up|1|||
170612020|NCT00687804|616587257|FG002|Core Study|Lost to Follow-up|0|||
170612021|NCT00687804|616587255|FG000|Core Study|Death|2|||
170612022|NCT00687804|616587256|FG001|Core Study|Death|2|||
170612023|NCT00687804|616587257|FG002|Core Study|Death|2|||
170612024|NCT00687804|616587255|FG000|Core Study|Protocol Violation|1|||
170612025|NCT00687804|616587256|FG001|Core Study|Protocol Violation|1|||
170612026|NCT00687804|616587257|FG002|Core Study|Protocol Violation|0|||
170612027|NCT00687804|616587255|FG000|Open-Label Extension Study|Adverse Event|2|||
170612028|NCT00687804|616587256|FG001|Open-Label Extension Study|Adverse Event|2|||
170612029|NCT00687804|616587257|FG002|Open-Label Extension Study|Adverse Event|2|||
170612030|NCT00687804|616587255|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
170612031|NCT00687804|616587256|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
170612032|NCT00687804|616587257|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
170612033|NCT00687804|616587255|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
170612034|NCT00687804|616587256|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
170612035|NCT00687804|616587257|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
170612036|NCT00687804|616587255|FG000|Open-Label Extension Study|Administrative problems|1|||
170612037|NCT00687804|616587256|FG001|Open-Label Extension Study|Administrative problems|1|||
170612038|NCT00687804|616587257|FG002|Open-Label Extension Study|Administrative problems|0|||
170612039|NCT00687804|616587255|FG000|Open-Label Extension Study|Death|2|||
170612040|NCT00687804|616587256|FG001|Open-Label Extension Study|Death|3|||
170612041|NCT00687804|616587257|FG002|Open-Label Extension Study|Death|3|||
170612042|NCT04390243|616587258|FG000|Overall Study|Death|1|||
170612043|NCT04390243|616587258|FG000|Overall Study|Disease Progression|4|||
170612044|NCT04390243|616587258|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
170612045|NCT02221674|616587259|FG000|Overall Study|Lost to Follow-up|1|||
170612046|NCT02221674|616587260|FG001|Overall Study|Lost to Follow-up|0|||
170612047|NCT02221674|616587261|FG002|Overall Study|Lost to Follow-up|0|||
170612048|NCT04042909|616587262|FG000|Overall Study|Withdrawal by Subject|1|||
170612049|NCT04042909|616587263|FG001|Overall Study|Withdrawal by Subject|0|||
170612050|NCT04042909|616587264|FG002|Overall Study|Withdrawal by Subject|0|||
170612051|NCT04042909|616587262|FG000|Overall Study|duplicate cases|2|||
170612052|NCT04042909|616587263|FG001|Overall Study|duplicate cases|0|||
170612053|NCT04042909|616587264|FG002|Overall Study|duplicate cases|0|||
170612054|NCT04042909|616587262|FG000|Overall Study|technical problem|0|||
170612055|NCT04042909|616587263|FG001|Overall Study|technical problem|1|||
170612056|NCT04042909|616587264|FG002|Overall Study|technical problem|0|||
170612057|NCT01521507|616587265|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
170612058|NCT01521507|616587266|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
170612059|NCT01521507|616587265|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
170612060|NCT01521507|616587266|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
170612061|NCT01521507|616587265|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
170612062|NCT01521507|616587266|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
170612063|NCT01521507|616587265|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
170612064|NCT01521507|616587266|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
170612065|NCT01521507|616587265|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
170612066|NCT01521507|616587266|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
170612067|NCT01521507|616587265|FG000|Stage 2: Observational Design|Physician Decision|1|||
170612068|NCT01521507|616587266|FG001|Stage 2: Observational Design|Physician Decision|0|||
170612069|NCT06312592|616587267|FG000|Overall Study|Lost to Follow-up|29|||
170612070|NCT06312592|616587268|FG001|Overall Study|Lost to Follow-up|13|||
170612071|NCT00195091|616587269|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
170612072|NCT04034004|616587270|FG000|Overall Study|Withdrawal by Subject|1|||
170612073|NCT04034004|616587271|FG001|Overall Study|Withdrawal by Subject|2|||
170612074|NCT04034004|616587272|FG002|Overall Study|Withdrawal by Subject|2|||
170612075|NCT04034004|616587273|FG003|Overall Study|Withdrawal by Subject|3|||
170612076|NCT04034004|616587270|FG000|Overall Study|could not find vein to administer IV|2|||
170612077|NCT04034004|616587271|FG001|Overall Study|could not find vein to administer IV|1|||
170612078|NCT04034004|616587272|FG002|Overall Study|could not find vein to administer IV|0|||
170612079|NCT04034004|616587273|FG003|Overall Study|could not find vein to administer IV|0|||
170612080|NCT04034004|616587270|FG000|Overall Study|nurse accidentally unblinded subject|0|||
170612081|NCT04034004|616587271|FG001|Overall Study|nurse accidentally unblinded subject|0|||
170612082|NCT04034004|616587272|FG002|Overall Study|nurse accidentally unblinded subject|0|||
170612083|NCT04034004|616587273|FG003|Overall Study|nurse accidentally unblinded subject|1|||
170612084|NCT04317040|616587274|FG000|Overall Study|Lost to Follow-up|2|||
170612085|NCT04317040|616587275|FG001|Overall Study|Lost to Follow-up|0|||
170612086|NCT04317040|616587274|FG000|Overall Study|Death|16|||
170612087|NCT04317040|616587275|FG001|Overall Study|Death|18|||
170612088|NCT04317040|616587274|FG000|Overall Study|Withdrawal by Subject|0|||
170612089|NCT04317040|616587275|FG001|Overall Study|Withdrawal by Subject|1|||
170612090|NCT04317040|616587274|FG000|Overall Study|Incomplete assessments|0|||
170612091|NCT04317040|616587275|FG001|Overall Study|Incomplete assessments|1|||
170612092|NCT03672292|616587276|FG000|Overall Study|Adverse Event|3|||
170612093|NCT03672292|616587277|FG001|Overall Study|Adverse Event|1|||
170612094|NCT03672292|616587276|FG000|Overall Study|Physician Decision|0|||
170612095|NCT03672292|616587277|FG001|Overall Study|Physician Decision|1|||
170612096|NCT03672292|616587276|FG000|Overall Study|Withdrawal by Subject|1|||
170654456|NCT02674854|616747334|FG002|Overall Study|Death|0|||
170654457|NCT02674854|616747332|FG000|Overall Study|Subject missed V6.2|1|||
170654458|NCT02674854|616747333|FG001|Overall Study|Subject missed V6.2|0|||
170654459|NCT02674854|616747334|FG002|Overall Study|Subject missed V6.2|0|||
170654460|NCT02635646|616747335|FG000|Overall Study|Lost to Follow-up|24|||
170654461|NCT02635646|616747336|FG001|Overall Study|Lost to Follow-up|25|||
170654462|NCT02635646|616747335|FG000|Overall Study|Pregnancy|1|||
170654463|NCT02635646|616747336|FG001|Overall Study|Pregnancy|1|||
170654464|NCT00745615|616747339|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
170654465|NCT00745615|616747340|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
170654466|NCT00745615|616747341|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
170654467|NCT00745615|616747342|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
170654468|NCT00745615|616747343|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
170654469|NCT00745615|616747344|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
170612097|NCT03672292|616587277|FG001|Overall Study|Withdrawal by Subject|2|||
170654470|NCT00745615|616747339|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
170654471|NCT00745615|616747340|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
170654472|NCT00745615|616747341|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
170654473|NCT00745615|616747342|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
170916850|NCT03656926|617695807|FG001|Overall Study|PI decision due to patient condition|0|||
170916851|NCT03656926|617695806|FG000|Overall Study|Patient unresponsiveness|1|||
170916852|NCT03656926|617695807|FG001|Overall Study|Patient unresponsiveness|0|||
170916853|NCT04723719|617695808|FG000|Intervention (SIESTA)|Withdrawal by Subject|1|||
170612098|NCT00799903|616587278|FG000|Overall Study|Investigator Site Closed|25|||
170612099|NCT00799903|616587279|FG001|Overall Study|Investigator Site Closed|23|||
170612100|NCT00799903|616587278|FG000|Overall Study|Withdrawal by Subject|179|||
170612101|NCT00799903|616587279|FG001|Overall Study|Withdrawal by Subject|175|||
170612102|NCT00799903|616587278|FG000|Overall Study|Lost to Follow-up|69|||
170612103|NCT00799903|616587279|FG001|Overall Study|Lost to Follow-up|80|||
170612104|NCT02518971|616587280|FG000|Overall Study|Lost to Follow-up|0|||
170612105|NCT02518971|616587281|FG001|Overall Study|Lost to Follow-up|1|||
170612106|NCT02518971|616587280|FG000|Overall Study|Physician Decision|6|||
170612107|NCT02518971|616587281|FG001|Overall Study|Physician Decision|6|||
170612108|NCT02518971|616587280|FG000|Overall Study|Protocol Violation|6|||
170612109|NCT02518971|616587281|FG001|Overall Study|Protocol Violation|4|||
170612110|NCT02518971|616587280|FG000|Overall Study|Withdrawal by Subject|4|||
170612111|NCT02518971|616587281|FG001|Overall Study|Withdrawal by Subject|5|||
170612112|NCT02518971|616587280|FG000|Overall Study|Side effects|1|||
170612113|NCT02518971|616587281|FG001|Overall Study|Side effects|0|||
170612114|NCT02518971|616587280|FG000|Overall Study|medication lost in mail|0|||
170612115|NCT02518971|616587281|FG001|Overall Study|medication lost in mail|1|||
170612116|NCT02518971|616587280|FG000|Overall Study|eligibility criteria no longer met|6|||
170612117|NCT02518971|616587281|FG001|Overall Study|eligibility criteria no longer met|3|||
170612118|NCT00757237|616587282|FG000|Overall Study|Lost to Follow-up|0|||
170612119|NCT00757237|616587283|FG001|Overall Study|Lost to Follow-up|1|||
170612120|NCT00757237|616587282|FG000|Overall Study|Protocol Violation|0|||
170612121|NCT00757237|616587283|FG001|Overall Study|Protocol Violation|2|||
170612122|NCT00757237|616587282|FG000|Overall Study|Physician Decision|2|||
170612123|NCT00757237|616587283|FG001|Overall Study|Physician Decision|3|||
170612124|NCT00757237|616587282|FG000|Overall Study|Withdrawal by Subject|8|||
170612125|NCT00757237|616587283|FG001|Overall Study|Withdrawal by Subject|12|||
170612126|NCT00757237|616587282|FG000|Overall Study|Safety or Tolerability|3|||
170612127|NCT00757237|616587283|FG001|Overall Study|Safety or Tolerability|5|||
170612128|NCT00757237|616587282|FG000|Overall Study|Other|0|||
170612129|NCT00757237|616587283|FG001|Overall Study|Other|2|||
170612130|NCT01843023|616587284|FG000|Overall Study|Death|1|||
170612131|NCT01843023|616587285|FG001|Overall Study|Death|0|||
170612132|NCT01843023|616587284|FG000|Overall Study|Lost to Follow-up|24|||
170612133|NCT01843023|616587285|FG001|Overall Study|Lost to Follow-up|29|||
170612134|NCT01843023|616587284|FG000|Overall Study|Withdrawal by Subject|8|||
170612135|NCT01843023|616587285|FG001|Overall Study|Withdrawal by Subject|6|||
170612136|NCT04752358|616587286|FG000|Overall Study|Death|2|||
170612137|NCT04752358|616587287|FG001|Overall Study|Death|1|||
170654474|NCT00745615|616747343|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
170654475|NCT00745615|616747344|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
170654476|NCT00745615|616747339|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
170654477|NCT00745615|616747340|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
170612138|NCT01397461|616587289|FG000|Overall Study|Withdrawal by Subject|2|||
170612139|NCT01397461|616587290|FG001|Overall Study|Withdrawal by Subject|1|||
170612140|NCT01397461|616587291|FG002|Overall Study|Withdrawal by Subject|0|||
170612141|NCT01397461|616587289|FG000|Overall Study|Lost to Follow-up|0|||
170654478|NCT00745615|616747341|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
170916854|NCT04723719|617695809|FG001|Intervention (SIESTA)|Withdrawal by Subject|0|||
170916855|NCT04723719|617695808|FG000|Post-test|Lost to Follow-up|2|||
170612142|NCT01397461|616587290|FG001|Overall Study|Lost to Follow-up|2|||
170612143|NCT01397461|616587291|FG002|Overall Study|Lost to Follow-up|1|||
170654479|NCT00745615|616747342|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
170654480|NCT00745615|616747343|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
170654481|NCT00745615|616747344|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
170654482|NCT00745615|616747339|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
170654483|NCT00745615|616747340|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
170654484|NCT00745615|616747341|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
170654485|NCT00745615|616747342|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
170654486|NCT00745615|616747343|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
170654487|NCT00745615|616747344|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
170654488|NCT00745615|616747339|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
170654489|NCT00745615|616747340|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
170654490|NCT00745615|616747341|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
170654491|NCT00745615|616747342|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
170654492|NCT00745615|616747343|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
170654493|NCT00745615|616747344|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
170654494|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
170654495|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
170654496|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
170654497|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
170654498|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
170654499|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
170654500|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
170654501|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
170654502|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
170654503|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
170654504|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
170654505|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
170654506|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
170654507|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
170654508|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
170654509|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
170654510|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
170654511|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
170654512|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
170654513|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
170654514|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
170654515|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
170654516|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
170654517|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
170654518|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
170654519|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
170654520|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
170654521|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
170654522|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
170654523|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
170654524|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
170654525|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
170654526|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
170654527|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
170654528|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
170654529|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
170654530|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
170654531|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
170654532|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
170654533|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
170654534|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
170654535|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
170654536|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
170654537|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
170654538|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
170654539|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
170654540|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
170654541|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
170654542|NCT00745615|616747339|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
170654543|NCT00745615|616747340|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
170654544|NCT00745615|616747341|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
170654545|NCT00745615|616747342|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
170654546|NCT00745615|616747343|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
170654547|NCT00745615|616747344|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
170654548|NCT02751931|616747345|FG000|Overall Study|Adverse Event|3|||
170654549|NCT02751931|616747346|FG001|Overall Study|Adverse Event|0|||
170654550|NCT02751931|616747345|FG000|Overall Study|Other: Miscelleneous|10|||
170654551|NCT02751931|616747346|FG001|Overall Study|Other: Miscelleneous|8|||
170654552|NCT01006603|616747348|FG000|Overall Study|Withdrawal by Subject|17|||
170654553|NCT01006603|616747349|FG001|Overall Study|Withdrawal by Subject|19|||
170654554|NCT01006603|616747348|FG000|Overall Study|Lost to Follow-up|0|||
170654555|NCT01006603|616747349|FG001|Overall Study|Lost to Follow-up|1|||
170654556|NCT01006603|616747348|FG000|Overall Study|Safety reason|1|||
170654557|NCT01006603|616747349|FG001|Overall Study|Safety reason|1|||
170654558|NCT01006603|616747348|FG000|Overall Study|Protocol Violation|1|||
170654559|NCT01006603|616747349|FG001|Overall Study|Protocol Violation|3|||
170654560|NCT01006603|616747348|FG000|Overall Study|Incorrect enrolment|0|||
170654561|NCT01006603|616747349|FG001|Overall Study|Incorrect enrolment|2|||
170654562|NCT01006603|616747348|FG000|Overall Study|Adverse Event|15|||
170654563|NCT01006603|616747349|FG001|Overall Study|Adverse Event|7|||
170654564|NCT01006603|616747348|FG000|Overall Study|Death|1|||
170654565|NCT01006603|616747349|FG001|Overall Study|Death|1|||
170654566|NCT01006603|616747348|FG000|Overall Study|Study specific discontinuation criteria|33|||
170654567|NCT01006603|616747349|FG001|Overall Study|Study specific discontinuation criteria|34|||
170654568|NCT01006603|616747348|FG000|Overall Study|Other|3|||
170654569|NCT01006603|616747349|FG001|Overall Study|Other|7|||
170654570|NCT03875235|616747350|FG000|Overall Study|Ongoing study treatment|63|||
170654571|NCT03875235|616747351|FG001|Overall Study|Ongoing study treatment|20|||
170654572|NCT03875235|616747350|FG000|Overall Study|Off treatment|77|||
170654573|NCT03875235|616747351|FG001|Overall Study|Off treatment|91|||
170654574|NCT03875235|616747350|FG000|Overall Study|Withdrawal by Subject|3|||
170654575|NCT03875235|616747351|FG001|Overall Study|Withdrawal by Subject|10|||
170654576|NCT03875235|616747350|FG000|Overall Study|Death|198|||
170654577|NCT03875235|616747351|FG001|Overall Study|Death|223|||
170654578|NCT03587727|616747352|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
170654579|NCT03587727|616747352|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
170654580|NCT05772702|616747353|FG000|Overall Study|Adverse Event|1|||
170654581|NCT02582255|616748231|FG000|Overall Study|Protocol Violation|0|||
170654582|NCT02582255|616748232|FG001|Overall Study|Protocol Violation|3|||
170654583|NCT03052764|616748233|FG000|Double-Blind Treatment Period|Adverse Event|2|||
170654584|NCT03052764|616748234|FG001|Double-Blind Treatment Period|Adverse Event|0|||
170654585|NCT03052764|616748233|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
170816302|NCT03345407|617335451|FG006|Overall Study|Protocol-defined stopping criteria|1|||
170816303|NCT03345407|617335445|FG000|Overall Study|Protocol Violation|2|||
170816304|NCT03345407|617335446|FG001|Overall Study|Protocol Violation|0|||
170816305|NCT03345407|617335447|FG002|Overall Study|Protocol Violation|0|||
170816306|NCT03345407|617335448|FG003|Overall Study|Protocol Violation|0|||
170612144|NCT01397461|616587289|FG000|Overall Study|Lack of Efficacy|0|||
170612145|NCT01397461|616587290|FG001|Overall Study|Lack of Efficacy|3|||
170612146|NCT01397461|616587291|FG002|Overall Study|Lack of Efficacy|0|||
170612147|NCT01397461|616587289|FG000|Overall Study|Not treated|0|||
170612148|NCT01397461|616587290|FG001|Overall Study|Not treated|0|||
170612149|NCT01397461|616587291|FG002|Overall Study|Not treated|1|||
170612150|NCT02735343|616587299|FG000|Overall Study|screen fail|0|||
170612151|NCT02735343|616587300|FG001|Overall Study|screen fail|2|||
170612152|NCT00637416|616587301|FG000|Overall Study|Lost to Follow-up|1|||
170612153|NCT00637416|616587302|FG001|Overall Study|Lost to Follow-up|1|||
170612154|NCT00637416|616587301|FG000|Overall Study|Unable to take study drug|0|||
170612155|NCT00637416|616587302|FG001|Overall Study|Unable to take study drug|1|||
170612156|NCT00566852|616587311|FG000|Overall Study|Protocol Violation|22|||
170654586|NCT03052764|616748234|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
170654587|NCT03052764|616748233|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
170654588|NCT03052764|616748234|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
170654589|NCT03052764|616748233|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
170654590|NCT03052764|616748234|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170654591|NCT03052764|616748233|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
170816307|NCT03345407|617335449|FG004|Overall Study|Protocol Violation|1|||
170612157|NCT00566852|616587312|FG001|Overall Study|Protocol Violation|24|||
170654592|NCT03052764|616748234|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
170654593|NCT01314911|616748235|FG000|Overall Study|Lost to Follow-up|3|||
170654594|NCT01314911|616748236|FG001|Overall Study|Lost to Follow-up|2|||
170654595|NCT01314911|616748235|FG000|Overall Study|Withdrawal by Subject|1|||
170654596|NCT01314911|616748236|FG001|Overall Study|Withdrawal by Subject|3|||
170654597|NCT01314911|616748235|FG000|Overall Study|Received Non-randomized Study Drug|0|||
170612158|NCT00566852|616587311|FG000|Overall Study|Death|95|||
170654598|NCT01314911|616748236|FG001|Overall Study|Received Non-randomized Study Drug|1|||
170654599|NCT01314911|616748235|FG000|Overall Study|Never Started Treatment|1|||
170816308|NCT03345407|617335450|FG005|Overall Study|Protocol Violation|0|||
170654600|NCT01314911|616748236|FG001|Overall Study|Never Started Treatment|0|||
170654601|NCT01695005|616748237|FG000|Overall Study|Lost to Follow-up|0|||
170654602|NCT01695005|616748238|FG001|Overall Study|Lost to Follow-up|1|||
170654603|NCT01695005|616748239|FG002|Overall Study|Lost to Follow-up|1|||
170654604|NCT01695005|616748240|FG003|Overall Study|Lost to Follow-up|0|||
170654605|NCT01695005|616748241|FG004|Overall Study|Lost to Follow-up|0|||
170654606|NCT01695005|616748242|FG005|Overall Study|Lost to Follow-up|1|||
170654607|NCT01695005|616748243|FG006|Overall Study|Lost to Follow-up|1|||
170654608|NCT01695005|616748244|FG007|Overall Study|Lost to Follow-up|1|||
170654609|NCT01695005|616748245|FG008|Overall Study|Lost to Follow-up|3|||
170654610|NCT01695005|616748246|FG009|Overall Study|Lost to Follow-up|3|||
170654611|NCT01695005|616748247|FG010|Overall Study|Lost to Follow-up|8|||
170654612|NCT01695005|616748248|FG011|Overall Study|Lost to Follow-up|5|||
170654613|NCT01695005|616748249|FG012|Overall Study|Lost to Follow-up|2|||
170654614|NCT01695005|616748250|FG013|Overall Study|Lost to Follow-up|5|||
170654615|NCT01695005|616748251|FG014|Overall Study|Lost to Follow-up|0|||
170654616|NCT01695005|616748252|FG015|Overall Study|Lost to Follow-up|4|||
170654617|NCT01695005|616748253|FG016|Overall Study|Lost to Follow-up|0|||
170654618|NCT01695005|616748254|FG017|Overall Study|Lost to Follow-up|0|||
170654619|NCT01695005|616748255|FG018|Overall Study|Lost to Follow-up|0|||
170654620|NCT01695005|616748256|FG019|Overall Study|Lost to Follow-up|1|||
170654621|NCT01695005|616748257|FG020|Overall Study|Lost to Follow-up|1|||
170654622|NCT01695005|616748258|FG021|Overall Study|Lost to Follow-up|0|||
170654623|NCT01695005|616748259|FG022|Overall Study|Lost to Follow-up|2|||
170654624|NCT01695005|616748260|FG023|Overall Study|Lost to Follow-up|4|||
170654625|NCT01695005|616748261|FG024|Overall Study|Lost to Follow-up|2|||
170654626|NCT01695005|616748262|FG025|Overall Study|Lost to Follow-up|0|||
170654627|NCT01695005|616748263|FG026|Overall Study|Lost to Follow-up|0|||
170654628|NCT01695005|616748264|FG027|Overall Study|Lost to Follow-up|0|||
170654629|NCT01695005|616748265|FG028|Overall Study|Lost to Follow-up|1|||
170654630|NCT01695005|616748237|FG000|Overall Study|Withdrawal by Subject|0|||
170654631|NCT01695005|616748238|FG001|Overall Study|Withdrawal by Subject|0|||
170654632|NCT01695005|616748239|FG002|Overall Study|Withdrawal by Subject|0|||
170654633|NCT01695005|616748240|FG003|Overall Study|Withdrawal by Subject|2|||
170654634|NCT01695005|616748241|FG004|Overall Study|Withdrawal by Subject|0|||
170654635|NCT01695005|616748242|FG005|Overall Study|Withdrawal by Subject|1|||
170654636|NCT01695005|616748243|FG006|Overall Study|Withdrawal by Subject|0|||
170654637|NCT01695005|616748244|FG007|Overall Study|Withdrawal by Subject|1|||
170654638|NCT01695005|616748245|FG008|Overall Study|Withdrawal by Subject|0|||
170654639|NCT01695005|616748246|FG009|Overall Study|Withdrawal by Subject|1|||
170654640|NCT01695005|616748247|FG010|Overall Study|Withdrawal by Subject|2|||
170654641|NCT01695005|616748248|FG011|Overall Study|Withdrawal by Subject|1|||
170654642|NCT01695005|616748249|FG012|Overall Study|Withdrawal by Subject|1|||
170654643|NCT01695005|616748250|FG013|Overall Study|Withdrawal by Subject|0|||
170654644|NCT01695005|616748251|FG014|Overall Study|Withdrawal by Subject|0|||
170654645|NCT01695005|616748252|FG015|Overall Study|Withdrawal by Subject|0|||
170654646|NCT01695005|616748253|FG016|Overall Study|Withdrawal by Subject|0|||
170654647|NCT01695005|616748254|FG017|Overall Study|Withdrawal by Subject|0|||
170654648|NCT01695005|616748255|FG018|Overall Study|Withdrawal by Subject|2|||
170654649|NCT01695005|616748256|FG019|Overall Study|Withdrawal by Subject|0|||
170654650|NCT01695005|616748257|FG020|Overall Study|Withdrawal by Subject|1|||
170654651|NCT01695005|616748258|FG021|Overall Study|Withdrawal by Subject|0|||
170654652|NCT01695005|616748259|FG022|Overall Study|Withdrawal by Subject|0|||
170654653|NCT01695005|616748260|FG023|Overall Study|Withdrawal by Subject|0|||
170654654|NCT01695005|616748261|FG024|Overall Study|Withdrawal by Subject|1|||
170654655|NCT01695005|616748262|FG025|Overall Study|Withdrawal by Subject|0|||
170654656|NCT01695005|616748263|FG026|Overall Study|Withdrawal by Subject|0|||
170916856|NCT04723719|617695809|FG001|Post-test|Lost to Follow-up|1|||
170916857|NCT04723719|617695808|FG000|Follow-up|Lost to Follow-up|0|||
170916858|NCT04723719|617695809|FG001|Follow-up|Lost to Follow-up|1|||
170916859|NCT06244316|617695810|FG000|Overall Study|Adverse Event|0|||
170916860|NCT06244316|617695811|FG001|Overall Study|Adverse Event|3|||
170654657|NCT01695005|616748264|FG027|Overall Study|Withdrawal by Subject|1|||
170654658|NCT01695005|616748265|FG028|Overall Study|Withdrawal by Subject|0|||
170654659|NCT00472459|616748266|FG000|Overall Study|Adverse Event|13|||
170654660|NCT00472459|616748267|FG001|Overall Study|Adverse Event|13|||
170654661|NCT00472459|616748266|FG000|Overall Study|Withdrawal by Subject|5|||
170654662|NCT00472459|616748267|FG001|Overall Study|Withdrawal by Subject|5|||
170654663|NCT00472459|616748266|FG000|Overall Study|Protocol Violation|3|||
170654664|NCT00472459|616748267|FG001|Overall Study|Protocol Violation|3|||
170654665|NCT00472459|616748266|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
170654666|NCT00472459|616748267|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
170654667|NCT00472459|616748266|FG000|Overall Study|Lost to Follow-up|1|||
170654668|NCT00472459|616748267|FG001|Overall Study|Lost to Follow-up|1|||
170654669|NCT04478123|616748268|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
170654670|NCT04478123|616748268|FG000|Overall Study|NE|1|||
170654671|NCT04831216|616748273|FG000|Overall Study|Lost to Follow-up|32|||
170916861|NCT06244316|617695812|FG002|Overall Study|Adverse Event|1|||
170654672|NCT00708201|616748275|FG000|Overall Study|Adverse Event|4|||
170654673|NCT00708201|616748276|FG001|Overall Study|Adverse Event|4|||
170654674|NCT00708201|616748275|FG000|Overall Study|Withdrawal by Subject|1|||
170654675|NCT00708201|616748276|FG001|Overall Study|Withdrawal by Subject|1|||
170654676|NCT00708201|616748275|FG000|Overall Study|Lost to Follow-up|2|||
170654677|NCT00708201|616748276|FG001|Overall Study|Lost to Follow-up|0|||
170654678|NCT00708201|616748275|FG000|Overall Study|Protocol Violation|0|||
170654679|NCT00708201|616748276|FG001|Overall Study|Protocol Violation|1|||
170654680|NCT00812487|616748277|FG000|Overall Study|Lost to Follow-up|2|||
170654681|NCT00812487|616748278|FG001|Overall Study|Lost to Follow-up|0|||
170654682|NCT00812487|616748277|FG000|Overall Study|Withdrawal by Subject|3|||
170612159|NCT00566852|616587312|FG001|Overall Study|Death|78|||
170612160|NCT00566852|616587311|FG000|Overall Study|Withdrawal by Subject|30|||
170612161|NCT00566852|616587312|FG001|Overall Study|Withdrawal by Subject|25|||
170612162|NCT00566852|616587311|FG000|Overall Study|Patient refusal|37|||
170612163|NCT00566852|616587312|FG001|Overall Study|Patient refusal|37|||
170654683|NCT00812487|616748278|FG001|Overall Study|Withdrawal by Subject|2|||
170654684|NCT00812487|616748277|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
170654685|NCT00812487|616748278|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
170654686|NCT00812487|616748277|FG000|Overall Study|Protocol Violation|0|||
170654687|NCT00812487|616748278|FG001|Overall Study|Protocol Violation|1|||
170612164|NCT00566852|616587311|FG000|Overall Study|Not tested due to disability|6|||
170612165|NCT00566852|616587312|FG001|Overall Study|Not tested due to disability|12|||
170612166|NCT00566852|616587311|FG000|Overall Study|Missing reason not specified|1|||
170612167|NCT00566852|616587312|FG001|Overall Study|Missing reason not specified|2|||
170612168|NCT00566852|616587311|FG000|Overall Study|Missing reason not reported|16|||
170612169|NCT00566852|616587312|FG001|Overall Study|Missing reason not reported|20|||
170612170|NCT04531241|616587315|FG000|Period 1|Withdrawal by Subject|2|||
170612171|NCT04531241|616587316|FG001|Period 1|Withdrawal by Subject|0|||
170612172|NCT04531241|616587315|FG000|Period 1|Dispesed incorrect lens power|1|||
170612173|NCT04531241|616587316|FG001|Period 1|Dispesed incorrect lens power|0|||
170612174|NCT04531241|616587315|FG000|Period 1|Protocol Violation|1|||
170612175|NCT04531241|616587316|FG001|Period 1|Protocol Violation|0|||
170612176|NCT04531241|616587315|FG000|Period 1|No longer eligible|0|||
170612177|NCT04531241|616587316|FG001|Period 1|No longer eligible|1|||
170612178|NCT04531241|616587315|FG000|Period 1|Lens Discomfort|0|||
170612179|NCT04531241|616587316|FG001|Period 1|Lens Discomfort|1|||
170612180|NCT04531241|616587315|FG000|Period 2|Covid-19 Related|1|||
170612181|NCT04531241|616587316|FG001|Period 2|Covid-19 Related|1|||
170612182|NCT05236257|616587317|FG000|Overall Study|Ongoing with study treatment|29|||
170612183|NCT05236257|616587318|FG001|Overall Study|Ongoing with study treatment|1|||
170612184|NCT05236257|616587317|FG000|Overall Study|Discontinued study treatment|22|||
170612185|NCT05236257|616587318|FG001|Overall Study|Discontinued study treatment|41|||
170612186|NCT05870865|616587319|FG000|Randomized|Did not receive study treatment|2|||
170612187|NCT05870865|616587320|FG001|Randomized|Did not receive study treatment|4|||
170612188|NCT05870865|616587321|FG002|Randomized|Did not receive study treatment|4|||
170612189|NCT05870865|616587322|FG003|Randomized|Did not receive study treatment|3|||
170612190|NCT05870865|616587319|FG000|Treatment Period|Adverse Event|1|||
170612191|NCT05870865|616587320|FG001|Treatment Period|Adverse Event|1|||
170612192|NCT05870865|616587321|FG002|Treatment Period|Adverse Event|1|||
170612193|NCT05870865|616587322|FG003|Treatment Period|Adverse Event|1|||
170612194|NCT05870865|616587319|FG000|Treatment Period|Lost to Follow-up|0|||
170612195|NCT05870865|616587320|FG001|Treatment Period|Lost to Follow-up|1|||
170612196|NCT05870865|616587321|FG002|Treatment Period|Lost to Follow-up|2|||
170916862|NCT06244316|617695810|FG000|Overall Study|Lost to Follow-up|1|||
170916863|NCT06244316|617695811|FG001|Overall Study|Lost to Follow-up|0|||
170916864|NCT06244316|617695812|FG002|Overall Study|Lost to Follow-up|0|||
170916865|NCT06244316|617695810|FG000|Overall Study|Protocol Violation|0|||
170612197|NCT05870865|616587322|FG003|Treatment Period|Lost to Follow-up|0|||
170612198|NCT05870865|616587319|FG000|Treatment Period|Protocol Violation|0|||
170612199|NCT05870865|616587320|FG001|Treatment Period|Protocol Violation|0|||
170612200|NCT05870865|616587321|FG002|Treatment Period|Protocol Violation|0|||
170612201|NCT05870865|616587322|FG003|Treatment Period|Protocol Violation|1|||
170612202|NCT05870865|616587319|FG000|Treatment Period|Withdrawal by Subject|0|||
170612203|NCT05870865|616587320|FG001|Treatment Period|Withdrawal by Subject|1|||
170612204|NCT05870865|616587321|FG002|Treatment Period|Withdrawal by Subject|1|||
170612205|NCT05870865|616587322|FG003|Treatment Period|Withdrawal by Subject|1|||
170612206|NCT05715242|616587325|FG000|Overall Study|Lost to Follow-up|0|||
170612207|NCT05715242|616587326|FG001|Overall Study|Lost to Follow-up|0|||
170654688|NCT02915874|616748279|FG000|Overall Study|Lost to Follow-up|5|||
170654689|NCT02915874|616748280|FG001|Overall Study|Lost to Follow-up|4|||
170654690|NCT02915874|616748279|FG000|Overall Study|Withdrawal by Subject|1|||
170654691|NCT02915874|616748280|FG001|Overall Study|Withdrawal by Subject|1|||
170654692|NCT02915874|616748279|FG000|Overall Study|Started New Anxiety Medication|0|||
170916866|NCT06244316|617695811|FG001|Overall Study|Protocol Violation|0|||
170612208|NCT05715242|616587327|FG002|Overall Study|Lost to Follow-up|1|||
170916867|NCT06244316|617695812|FG002|Overall Study|Protocol Violation|1|||
170654693|NCT02915874|616748280|FG001|Overall Study|Started New Anxiety Medication|1|||
170654694|NCT01293799|616748285|FG000|Overall Study|Kidney transplantation|109|||
170654695|NCT01293799|616748286|FG001|Overall Study|Kidney transplantation|96|||
170654696|NCT01293799|616748285|FG000|Overall Study|Transfer to hemodialysis|70|||
170654697|NCT01293799|616748286|FG001|Overall Study|Transfer to hemodialysis|90|||
170654698|NCT01293799|616748285|FG000|Overall Study|Death|27|||
170654699|NCT01293799|616748286|FG001|Overall Study|Death|29|||
170654700|NCT01293799|616748285|FG000|Overall Study|Transfer to assisted PD|24|||
170654701|NCT01293799|616748286|FG001|Overall Study|Transfer to assisted PD|18|||
170654702|NCT01293799|616748285|FG000|Overall Study|Withdrawal by Subject|26|||
170654703|NCT01293799|616748286|FG001|Overall Study|Withdrawal by Subject|0|||
170654704|NCT01293799|616748285|FG000|Overall Study|Investigator decision|5|||
170654705|NCT01293799|616748286|FG001|Overall Study|Investigator decision|2|||
170654706|NCT01293799|616748285|FG000|Overall Study|Kidney function improved|6|||
170654707|NCT01293799|616748286|FG001|Overall Study|Kidney function improved|7|||
170654708|NCT01293799|616748285|FG000|Overall Study|Other causes|6|||
170654709|NCT01293799|616748286|FG001|Overall Study|Other causes|3|||
170654710|NCT00879879|616748292|FG000|Overall Study|Death|1|||
170654711|NCT00879879|616748292|FG000|Overall Study|Withdrawal by Subject|1|||
170654712|NCT00879879|616748292|FG000|Overall Study|Physician Decision|1|||
170654713|NCT00570232|616748293|FG000|Overall Study|Adverse Event|10|||
170654714|NCT00570232|616748293|FG000|Overall Study|discontinued due to medical condition|3|||
170654715|NCT00570232|616748293|FG000|Overall Study|discontinued due to recurrence|8|||
170654716|NCT00570232|616748293|FG000|Overall Study|discontinued due to noncompliance|2|||
170654717|NCT01076075|616748294|FG000|Overall Study|Adverse Event|3|||
170654718|NCT01076075|616748295|FG001|Overall Study|Adverse Event|9|||
170654719|NCT01076075|616748294|FG000|Overall Study|Lack of Efficacy|5|||
170654720|NCT01076075|616748295|FG001|Overall Study|Lack of Efficacy|4|||
170654721|NCT01076075|616748294|FG000|Overall Study|Lost to Follow-up|6|||
170654722|NCT01076075|616748295|FG001|Overall Study|Lost to Follow-up|5|||
170654723|NCT01076075|616748294|FG000|Overall Study|other|19|||
170654724|NCT01076075|616748295|FG001|Overall Study|other|9|||
170654725|NCT01076075|616748294|FG000|Overall Study|Protocol Violation|0|||
170654726|NCT01076075|616748295|FG001|Overall Study|Protocol Violation|1|||
170654727|NCT01076075|616748294|FG000|Overall Study|Withdrawal by Subject|8|||
170654728|NCT01076075|616748295|FG001|Overall Study|Withdrawal by Subject|19|||
170654729|NCT01163318|616748298|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
170654730|NCT01163318|616748298|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
170654731|NCT01163318|616748298|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
170654732|NCT01163318|616748298|FG000|Overall Study|Participants Without Case Report Form|7|||
170654733|NCT01163318|616748298|FG000|Overall Study|Multiple Reasons Per Participant|224|||
170654734|NCT06596005|616748299|FG000|Overall Study|Withdrawal by Subject|2|||
170654735|NCT06596005|616748300|FG001|Overall Study|Withdrawal by Subject|2|||
170654736|NCT06596005|616748301|FG002|Overall Study|Withdrawal by Subject|1|||
170654737|NCT06596005|616748299|FG000|Overall Study|Other|0|||
170654738|NCT06596005|616748300|FG001|Overall Study|Other|2|||
170654739|NCT06596005|616748301|FG002|Overall Study|Other|0|||
170654740|NCT05222555|616748307|FG000|Overall Study|Ongoing|2|||
170654741|NCT05222555|616748308|FG001|Overall Study|Ongoing|18|||
170654742|NCT05222555|616748307|FG000|Overall Study|Adverse Event|1|||
170654743|NCT05222555|616748308|FG001|Overall Study|Adverse Event|1|||
170654744|NCT05222555|616748307|FG000|Overall Study|Death|0|||
170654745|NCT05222555|616748308|FG001|Overall Study|Death|6|||
170654746|NCT05222555|616748307|FG000|Overall Study|Withdrawal by Subject|0|||
170654747|NCT05222555|616748308|FG001|Overall Study|Withdrawal by Subject|11|||
170654748|NCT04193410|616748945|FG000|Overall Study|Lost to Follow-up|7|||
170654749|NCT04193410|616748946|FG001|Overall Study|Lost to Follow-up|6|||
170654750|NCT04738318|616748950|FG000|Overall Study|Protocol Violation|1|||
170654751|NCT04738318|616748951|FG001|Overall Study|Protocol Violation|0|||
170654752|NCT00378079|616748952|FG000|Overall Study|Lost to Follow-up|6|||
170816309|NCT03345407|617335451|FG006|Overall Study|Protocol Violation|3|||
170654753|NCT00378079|616748953|FG001|Overall Study|Lost to Follow-up|1|||
170654754|NCT00378079|616748954|FG002|Overall Study|Lost to Follow-up|0|||
170654755|NCT02616562|616748955|FG000|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654756|NCT02616562|616748956|FG001|Main Period (26 Weeks)|Withdrawal by parent/guardian|1|||
170654757|NCT02616562|616748957|FG002|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654758|NCT02616562|616748958|FG003|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654759|NCT02616562|616748959|FG004|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654760|NCT02616562|616748960|FG005|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654761|NCT02616562|616748961|FG006|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654762|NCT02616562|616748962|FG007|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654763|NCT02616562|616748963|FG008|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654764|NCT02616562|616748964|FG009|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654765|NCT02616562|616748965|FG010|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654766|NCT02616562|616748966|FG011|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654767|NCT02616562|616748967|FG012|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654768|NCT02616562|616748968|FG013|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654769|NCT02616562|616748969|FG014|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654770|NCT02616562|616748970|FG015|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654771|NCT02616562|616748971|FG016|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
170654772|NCT02616562|616748955|FG000|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654773|NCT02616562|616748956|FG001|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654774|NCT02616562|616748957|FG002|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654775|NCT02616562|616748958|FG003|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654776|NCT02616562|616748959|FG004|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654777|NCT02616562|616748960|FG005|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654778|NCT02616562|616748961|FG006|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654779|NCT02616562|616748962|FG007|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654780|NCT02616562|616748963|FG008|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654781|NCT02616562|616748964|FG009|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|1|||
170654782|NCT02616562|616748965|FG010|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654783|NCT02616562|616748966|FG011|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654784|NCT02616562|616748967|FG012|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654785|NCT02616562|616748968|FG013|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654786|NCT02616562|616748969|FG014|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654787|NCT02616562|616748970|FG015|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654788|NCT02616562|616748971|FG016|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
170654789|NCT02616562|616748955|FG000|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654790|NCT02616562|616748956|FG001|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654791|NCT02616562|616748957|FG002|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654792|NCT02616562|616748958|FG003|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654793|NCT02616562|616748959|FG004|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654794|NCT02616562|616748960|FG005|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654795|NCT02616562|616748961|FG006|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654796|NCT02616562|616748962|FG007|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654797|NCT02616562|616748963|FG008|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
170654798|NCT02616562|616748964|FG009|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
170654799|NCT02616562|616748965|FG010|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654800|NCT02616562|616748966|FG011|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654801|NCT02616562|616748967|FG012|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654802|NCT02616562|616748968|FG013|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654803|NCT02616562|616748969|FG014|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654804|NCT02616562|616748970|FG015|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654805|NCT02616562|616748971|FG016|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
170654806|NCT02616562|616748955|FG000|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654807|NCT02616562|616748956|FG001|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654808|NCT02616562|616748957|FG002|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654809|NCT02616562|616748958|FG003|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654810|NCT02616562|616748959|FG004|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654811|NCT02616562|616748960|FG005|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654812|NCT02616562|616748961|FG006|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654813|NCT02616562|616748962|FG007|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654814|NCT02616562|616748963|FG008|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654815|NCT02616562|616748964|FG009|Safety Extension Period (104 Weeks)|Lost to Follow-up|1|||
170654816|NCT02616562|616748965|FG010|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654817|NCT02616562|616748966|FG011|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654818|NCT02616562|616748967|FG012|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654819|NCT02616562|616748968|FG013|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654820|NCT02616562|616748969|FG014|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170816310|NCT03345407|617335445|FG000|Overall Study|Lack of Efficacy|1|||
170816311|NCT03345407|617335446|FG001|Overall Study|Lack of Efficacy|1|||
170816312|NCT03345407|617335447|FG002|Overall Study|Lack of Efficacy|1|||
170816313|NCT03345407|617335448|FG003|Overall Study|Lack of Efficacy|1|||
170816314|NCT03345407|617335449|FG004|Overall Study|Lack of Efficacy|1|||
170816315|NCT03345407|617335450|FG005|Overall Study|Lack of Efficacy|0|||
170816316|NCT03345407|617335451|FG006|Overall Study|Lack of Efficacy|3|||
170816317|NCT03345407|617335445|FG000|Overall Study|Adverse Event|4|||
170816318|NCT03345407|617335446|FG001|Overall Study|Adverse Event|0|||
170816319|NCT03345407|617335447|FG002|Overall Study|Adverse Event|5|||
170816320|NCT03345407|617335448|FG003|Overall Study|Adverse Event|4|||
170654821|NCT02616562|616748970|FG015|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654822|NCT02616562|616748971|FG016|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
170654823|NCT02616562|616748955|FG000|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654824|NCT02616562|616748956|FG001|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654825|NCT02616562|616748957|FG002|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654826|NCT02616562|616748958|FG003|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654827|NCT02616562|616748959|FG004|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654828|NCT02616562|616748960|FG005|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654829|NCT02616562|616748961|FG006|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654830|NCT02616562|616748962|FG007|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654831|NCT02616562|616748963|FG008|Safety Extension Period (104 Weeks)|Protocol Violation|1|||
170654832|NCT02616562|616748964|FG009|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654833|NCT02616562|616748965|FG010|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654834|NCT02616562|616748966|FG011|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654835|NCT02616562|616748967|FG012|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654836|NCT02616562|616748968|FG013|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654837|NCT02616562|616748969|FG014|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654838|NCT02616562|616748970|FG015|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654839|NCT02616562|616748971|FG016|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
170654840|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654841|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654842|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654843|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654844|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654845|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654846|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654847|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654848|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654849|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654850|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654851|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|4|||
170654852|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654853|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654854|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|1|||
170654855|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170816321|NCT03345407|617335449|FG004|Overall Study|Adverse Event|6|||
170612209|NCT05715242|616587328|FG003|Overall Study|Lost to Follow-up|0|||
170612210|NCT05715242|616587329|FG004|Overall Study|Lost to Follow-up|0|||
170612211|NCT05715242|616587330|FG005|Overall Study|Lost to Follow-up|1|||
170612212|NCT05715242|616587331|FG006|Overall Study|Lost to Follow-up|0|||
170612213|NCT05715242|616587332|FG007|Overall Study|Lost to Follow-up|0|||
170612214|NCT05715242|616587333|FG008|Overall Study|Lost to Follow-up|0|||
170612215|NCT05715242|616587334|FG009|Overall Study|Lost to Follow-up|0|||
170612216|NCT05715242|616587335|FG010|Overall Study|Lost to Follow-up|0|||
170612217|NCT05715242|616587336|FG011|Overall Study|Lost to Follow-up|0|||
170612218|NCT05715242|616587337|FG012|Overall Study|Lost to Follow-up|0|||
170612219|NCT05715242|616587338|FG013|Overall Study|Lost to Follow-up|0|||
170612220|NCT05715242|616587339|FG014|Overall Study|Lost to Follow-up|0|||
170612221|NCT05715242|616587340|FG015|Overall Study|Lost to Follow-up|0|||
170612222|NCT02104947|616587341|FG000|Overall Study|Withdrawal by Subject|10|||
170612223|NCT02104947|616587342|FG001|Overall Study|Withdrawal by Subject|3|||
170612224|NCT02104947|616587341|FG000|Overall Study|Lost to Follow-up|4|||
170612225|NCT02104947|616587342|FG001|Overall Study|Lost to Follow-up|4|||
170612226|NCT02104947|616587341|FG000|Overall Study|Protocol Violation|6|||
170612227|NCT02104947|616587342|FG001|Overall Study|Protocol Violation|8|||
170612228|NCT02104947|616587341|FG000|Overall Study|Adverse Event|57|||
170612229|NCT02104947|616587342|FG001|Overall Study|Adverse Event|38|||
170612230|NCT02104947|616587341|FG000|Overall Study|Other than stated above|2|||
170612231|NCT02104947|616587342|FG001|Overall Study|Other than stated above|3|||
170612232|NCT01090063|616587349|FG000|Screen|Screen Failed|4|||
170612233|NCT01090063|616587349|FG000|Treatment|Withdrawal by Subject|4|||
170612234|NCT00048347|616587350|FG000|Overall Study|Screen failure|2|||
170612235|NCT00958165|616587352|FG000|Overall Study|Lost to Follow-up|5|||
170612236|NCT00958165|616587352|FG000|Overall Study|Not eligible|9|||
170612237|NCT04310566|616587353|FG000|Period 1|Study Termination due to COVID-19|15|||
170612238|NCT04310566|616587354|FG001|Period 1|Study Termination due to COVID-19|17|||
170612239|NCT04310566|616587353|FG000|Period 1|Protocol Violation|0|||
170612240|NCT04310566|616587354|FG001|Period 1|Protocol Violation|1|||
170612241|NCT04310566|616587353|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
170654856|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
170654857|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654858|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654859|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654860|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654861|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654862|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654863|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654864|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654865|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654866|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654867|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654868|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Protocol Violation|1|||
170654869|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654870|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654871|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654872|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654873|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
170654874|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654875|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654876|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654877|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654878|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654879|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654880|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654881|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654882|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654883|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654884|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654885|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Adverse Event|1|||
170654886|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654887|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654888|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654889|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654890|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
170654891|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654892|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654893|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654894|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654895|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654896|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654897|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654898|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654899|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654900|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654901|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
170654902|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654903|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654904|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
170654905|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
170654906|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654907|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
170654908|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654909|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654910|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654911|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654912|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654913|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654914|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654915|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654916|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654917|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654918|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|1|||
170654919|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654920|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654921|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654922|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654923|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654924|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
170654925|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654926|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654927|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654928|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654929|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654930|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654931|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654932|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654933|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654934|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654935|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654936|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|1|||
170654937|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654938|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654939|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654940|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654941|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
170654942|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654943|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654944|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654945|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654946|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654947|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654948|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654949|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654950|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654951|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654952|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654953|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|1|||
170654954|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654955|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654956|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654957|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170816322|NCT03345407|617335450|FG005|Overall Study|Adverse Event|5|||
170816323|NCT03345407|617335451|FG006|Overall Study|Adverse Event|16|||
170816324|NCT01584648|617335452|FG000|Overall Study|Death|136|||
170816325|NCT01584648|617335453|FG001|Overall Study|Death|146|||
170816326|NCT01584648|617335452|FG000|Overall Study|Lost to Follow-up|9|||
170816327|NCT01584648|617335453|FG001|Overall Study|Lost to Follow-up|9|||
170816328|NCT01584648|617335452|FG000|Overall Study|Investigator discretion|3|||
170816329|NCT01584648|617335453|FG001|Overall Study|Investigator discretion|2|||
170816330|NCT01584648|617335452|FG000|Overall Study|Withdrew consent|13|||
170816331|NCT01584648|617335453|FG001|Overall Study|Withdrew consent|4|||
170816332|NCT01584648|617335452|FG000|Overall Study|Study closed/terminated|50|||
170816333|NCT01584648|617335453|FG001|Overall Study|Study closed/terminated|23|||
170916868|NCT06244316|617695810|FG000|Overall Study|Withdrawal by Subject|3|||
170916869|NCT06244316|617695811|FG001|Overall Study|Withdrawal by Subject|4|||
170916870|NCT06244316|617695812|FG002|Overall Study|Withdrawal by Subject|0|||
170916871|NCT05280184|617695813|FG000|Overall Study|Lost to Follow-up|6|||
170916872|NCT05280184|617695814|FG001|Overall Study|Lost to Follow-up|10|||
170916873|NCT05042362|617697765|FG000|Overall Study|Adverse Event|7|||
170916874|NCT05042362|617697766|FG001|Overall Study|Adverse Event|9|||
170916875|NCT05042362|617697765|FG000|Overall Study|Lack of Efficacy|0|||
170916876|NCT05042362|617697766|FG001|Overall Study|Lack of Efficacy|2|||
170916877|NCT05042362|617697765|FG000|Overall Study|Lost to Follow-up|7|||
170654958|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
170654959|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654960|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654961|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654962|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654963|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654964|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654965|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654966|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654967|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654968|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654969|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654970|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654971|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654972|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|1|||
170654973|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654974|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654975|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
170654976|NCT02616562|616748955|FG000|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654977|NCT02616562|616748956|FG001|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654978|NCT02616562|616748957|FG002|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654979|NCT02616562|616748958|FG003|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654980|NCT02616562|616748959|FG004|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654981|NCT02616562|616748960|FG005|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654982|NCT02616562|616748961|FG006|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654983|NCT02616562|616748962|FG007|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654984|NCT02616562|616748963|FG008|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654985|NCT02616562|616748964|FG009|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654986|NCT02616562|616748965|FG010|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654987|NCT02616562|616748966|FG011|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654988|NCT02616562|616748967|FG012|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654989|NCT02616562|616748968|FG013|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654990|NCT02616562|616748969|FG014|Long Term Safety Extension (208 Weeks)|Adult height reached|1|||
170654991|NCT02616562|616748970|FG015|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654992|NCT02616562|616748971|FG016|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
170654993|NCT02616562|616748955|FG000|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170654994|NCT02616562|616748956|FG001|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170654995|NCT02616562|616748957|FG002|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170654996|NCT02616562|616748958|FG003|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170654997|NCT02616562|616748959|FG004|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170654998|NCT02616562|616748960|FG005|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170654999|NCT02616562|616748961|FG006|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655000|NCT02616562|616748962|FG007|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655001|NCT02616562|616748963|FG008|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655002|NCT02616562|616748964|FG009|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655003|NCT02616562|616748965|FG010|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655004|NCT02616562|616748966|FG011|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655005|NCT02616562|616748967|FG012|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655006|NCT02616562|616748968|FG013|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655007|NCT02616562|616748969|FG014|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
170655008|NCT02616562|616748970|FG015|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|5|||
170655009|NCT02616562|616748971|FG016|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|16|||
170655010|NCT00586664|616748976|FG000|Overall Study|Withdrawal by Subject|3|||
170816334|NCT01584648|617335452|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
170816335|NCT01584648|617335453|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
170816336|NCT02256553|617335454|FG000|Period I|Adverse Event|5|||
170816337|NCT02256553|617335454|FG000|Period I|Protocol Violation|1|||
170816338|NCT02256553|617335454|FG000|Period II|Adverse Event|1|||
170816339|NCT02256553|617335454|FG000|Period II|Subject Moved|1|||
170816340|NCT02256553|617335454|FG000|Period III|Adverse Event|3|||
170816341|NCT02092909|617335455|FG000|Overall Study|Adverse Event|0|||
170816342|NCT02092909|617335456|FG001|Overall Study|Adverse Event|0|||
170816343|NCT02092909|617335457|FG002|Overall Study|Adverse Event|4|||
170612242|NCT04310566|616587354|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
170612243|NCT04310566|616587353|FG000|Period 1|Lost to Follow-up|1|||
170612244|NCT04310566|616587354|FG001|Period 1|Lost to Follow-up|0|||
170612245|NCT04310566|616587353|FG000|Period 1|Withdrawal by Subject|0|||
170612246|NCT04310566|616587354|FG001|Period 1|Withdrawal by Subject|1|||
170612247|NCT04310566|616587353|FG000|Period 2|Study Termination|7|||
170612248|NCT04310566|616587354|FG001|Period 2|Study Termination|5|||
170612249|NCT02218008|616587358|FG000|Stage 1 (S1)|Adverse Event|6|||
170612250|NCT02218008|616587359|FG001|Stage 1 (S1)|Adverse Event|5|||
170612251|NCT02218008|616587360|FG002|Stage 1 (S1)|Adverse Event|11|||
170612252|NCT02218008|616587361|FG003|Stage 1 (S1)|Adverse Event|0|||
170612253|NCT02218008|616587362|FG004|Stage 1 (S1)|Adverse Event|0|||
170612254|NCT02218008|616587363|FG005|Stage 1 (S1)|Adverse Event|0|||
170612255|NCT02218008|616587358|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
170612256|NCT02218008|616587359|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
170612257|NCT02218008|616587360|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
170612258|NCT02218008|616587361|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
170612259|NCT02218008|616587362|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
170612260|NCT02218008|616587363|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
170612261|NCT02218008|616587358|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
170612262|NCT02218008|616587359|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
170612263|NCT02218008|616587360|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
170612264|NCT02218008|616587361|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
170612265|NCT02218008|616587362|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
170612266|NCT02218008|616587363|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
170612267|NCT02218008|616587358|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
170612268|NCT02218008|616587359|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
170612269|NCT02218008|616587360|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
170612270|NCT02218008|616587361|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
170612271|NCT02218008|616587362|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
170612272|NCT02218008|616587363|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
170612273|NCT02218008|616587358|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
170612274|NCT02218008|616587359|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
170612275|NCT02218008|616587360|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
170612276|NCT02218008|616587361|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
170612277|NCT02218008|616587362|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
170612278|NCT02218008|616587363|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
170612279|NCT02218008|616587358|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
170612280|NCT02218008|616587359|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
170612281|NCT02218008|616587360|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
170612282|NCT02218008|616587361|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
170612283|NCT02218008|616587362|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
170612284|NCT02218008|616587363|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
170612285|NCT02218008|616587358|FG000|Stage 1 (S1)|Pregnancy|0|||
170612286|NCT02218008|616587359|FG001|Stage 1 (S1)|Pregnancy|0|||
170612287|NCT02218008|616587360|FG002|Stage 1 (S1)|Pregnancy|1|||
170612288|NCT02218008|616587361|FG003|Stage 1 (S1)|Pregnancy|0|||
170612289|NCT02218008|616587362|FG004|Stage 1 (S1)|Pregnancy|0|||
170612290|NCT02218008|616587363|FG005|Stage 1 (S1)|Pregnancy|0|||
170612291|NCT02218008|616587358|FG000|Stage 1 (S1)|Protocol Violation|0|||
170612292|NCT02218008|616587359|FG001|Stage 1 (S1)|Protocol Violation|0|||
170612293|NCT02218008|616587360|FG002|Stage 1 (S1)|Protocol Violation|1|||
170612294|NCT02218008|616587361|FG003|Stage 1 (S1)|Protocol Violation|0|||
170612295|NCT02218008|616587362|FG004|Stage 1 (S1)|Protocol Violation|0|||
170612296|NCT02218008|616587363|FG005|Stage 1 (S1)|Protocol Violation|0|||
170612297|NCT02218008|616587358|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
170612298|NCT02218008|616587359|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
170612299|NCT02218008|616587360|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
170612300|NCT02218008|616587361|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
170612301|NCT02218008|616587362|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
170612302|NCT02218008|616587363|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
170612303|NCT02218008|616587358|FG000|Stage 2 (S2)|Adverse Event|0|||
170612304|NCT02218008|616587359|FG001|Stage 2 (S2)|Adverse Event|0|||
170612305|NCT02218008|616587360|FG002|Stage 2 (S2)|Adverse Event|0|||
170612306|NCT02218008|616587361|FG003|Stage 2 (S2)|Adverse Event|2|||
170612307|NCT02218008|616587362|FG004|Stage 2 (S2)|Adverse Event|3|||
170612308|NCT02218008|616587363|FG005|Stage 2 (S2)|Adverse Event|3|||
170612309|NCT02218008|616587358|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
170612310|NCT02218008|616587359|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
170612311|NCT02218008|616587360|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
170612312|NCT02218008|616587361|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
170612313|NCT02218008|616587362|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
170612314|NCT02218008|616587363|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
170612315|NCT02218008|616587358|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
170612316|NCT02218008|616587359|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
170612317|NCT02218008|616587360|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
170612318|NCT02218008|616587361|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
170612319|NCT02218008|616587362|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
170655011|NCT00586664|616748977|FG001|Overall Study|Withdrawal by Subject|7|||
170655012|NCT00586664|616748978|FG002|Overall Study|Withdrawal by Subject|1|||
170655013|NCT00586664|616748976|FG000|Overall Study|Exclusion criteria met|2|||
170655014|NCT00586664|616748977|FG001|Overall Study|Exclusion criteria met|0|||
170655015|NCT00586664|616748978|FG002|Overall Study|Exclusion criteria met|0|||
170655016|NCT01958827|616748986|FG000|Overall Study|Adverse Event|3|||
170655017|NCT01958827|616748986|FG000|Overall Study|Lack of Efficacy|6|||
170655018|NCT01958827|616748986|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
170655019|NCT02656706|616748990|FG000|Overall Study|Insurance Denial|1|||
170655020|NCT01602666|616748991|FG000|Induction Chemotherapy|Death|2|||
170655021|NCT01602666|616748992|FG001|Induction Chemotherapy|Death|1|||
170655022|NCT01602666|616748991|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
170655023|NCT01602666|616748992|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
170655024|NCT01602666|616748991|FG000|Induction Chemotherapy|Physician Decision|12|||
170655025|NCT01602666|616748992|FG001|Induction Chemotherapy|Physician Decision|5|||
170655026|NCT01602666|616748991|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
170655027|NCT01602666|616748992|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
170655028|NCT01602666|616748991|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
170655029|NCT01602666|616748992|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
170655030|NCT01602666|616748991|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
170655031|NCT01602666|616748992|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
170655032|NCT01602666|616748991|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
170655033|NCT01602666|616748992|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
170655034|NCT01602666|616748991|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
170655035|NCT01602666|616748992|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
170655036|NCT01602666|616748991|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
170655037|NCT01602666|616748992|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
170655038|NCT01602666|616748991|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
170655039|NCT01602666|616748992|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
170655040|NCT01602666|616748991|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
170655041|NCT01602666|616748992|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
170655042|NCT05169567|616748993|FG000|Overall Study|On study treatment|116|||
170612320|NCT02218008|616587363|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
170612321|NCT02218008|616587358|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
170612322|NCT02218008|616587359|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
170612323|NCT02218008|616587360|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
170612324|NCT02218008|616587361|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
170612325|NCT02218008|616587362|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
170612326|NCT02218008|616587363|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
170612327|NCT02218008|616587358|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
170612328|NCT02218008|616587359|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
170612329|NCT02218008|616587360|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
170612330|NCT02218008|616587361|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
170612331|NCT02218008|616587362|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
170612332|NCT02218008|616587363|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
170655043|NCT05169567|616748994|FG001|Overall Study|On study treatment|128|||
170655044|NCT05169567|616748993|FG000|Overall Study|Lost to Follow-up|1|||
170655045|NCT05169567|616748994|FG001|Overall Study|Lost to Follow-up|0|||
170816344|NCT02092909|617335458|FG003|Overall Study|Adverse Event|2|||
170816345|NCT02092909|617335455|FG000|Overall Study|Lack of Efficacy|0|||
170816346|NCT02092909|617335456|FG001|Overall Study|Lack of Efficacy|2|||
170816347|NCT02092909|617335457|FG002|Overall Study|Lack of Efficacy|1|||
170816348|NCT02092909|617335458|FG003|Overall Study|Lack of Efficacy|0|||
170816349|NCT02092909|617335455|FG000|Overall Study|Withdrawal by Subject|0|||
170816350|NCT02092909|617335456|FG001|Overall Study|Withdrawal by Subject|0|||
170816351|NCT02092909|617335457|FG002|Overall Study|Withdrawal by Subject|2|||
170816352|NCT02092909|617335458|FG003|Overall Study|Withdrawal by Subject|1|||
170816353|NCT02092909|617335455|FG000|Overall Study|Study terminated by Sponsor|0|||
170816354|NCT02092909|617335456|FG001|Overall Study|Study terminated by Sponsor|0|||
170816355|NCT02092909|617335457|FG002|Overall Study|Study terminated by Sponsor|0|||
170816356|NCT02092909|617335458|FG003|Overall Study|Study terminated by Sponsor|2|||
170816357|NCT02092909|617335455|FG000|Overall Study|Miscellaneous|1|||
170816358|NCT02092909|617335456|FG001|Overall Study|Miscellaneous|1|||
170816359|NCT02092909|617335457|FG002|Overall Study|Miscellaneous|2|||
170816360|NCT02092909|617335458|FG003|Overall Study|Miscellaneous|1|||
170816361|NCT02865083|617335459|FG000|Overall Study|Early Termination|3|||
170816362|NCT02865083|617335460|FG001|Overall Study|Early Termination|1|||
170816363|NCT00096278|617335461|FG000|Overall Study|No follow-up data|15|||
170816364|NCT00096278|617335462|FG001|Overall Study|No follow-up data|18|||
170612333|NCT01278797|616587366|FG000|Period 1|Adverse Event|0|||
170612334|NCT01278797|616587367|FG001|Period 1|Adverse Event|1|||
170816365|NCT00096278|617335461|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
170816366|NCT00096278|617335462|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
170816367|NCT02105688|617335463|FG000|Part A: Double-Blind|Adverse Event|1|||
170612335|NCT01278797|616587366|FG000|Period 1|Protocol Violation|1|||
170612336|NCT01278797|616587367|FG001|Period 1|Protocol Violation|0|||
170612337|NCT03364309|616587368|FG000|Induction Period|Adverse Event|4|||
170612338|NCT03364309|616587369|FG001|Induction Period|Adverse Event|0|||
170612339|NCT03364309|616587370|FG002|Induction Period|Adverse Event|1|||
170612340|NCT03364309|616587371|FG003|Induction Period|Adverse Event|0|||
170612341|NCT03364309|616587372|FG004|Induction Period|Adverse Event|0|||
170612342|NCT03364309|616587373|FG005|Induction Period|Adverse Event|0|||
170612343|NCT03364309|616587374|FG006|Induction Period|Adverse Event|0|||
170612344|NCT03364309|616587375|FG007|Induction Period|Adverse Event|0|||
170612345|NCT03364309|616587376|FG008|Induction Period|Adverse Event|0|||
170612346|NCT03364309|616587377|FG009|Induction Period|Adverse Event|0|||
170612347|NCT03364309|616587378|FG010|Induction Period|Adverse Event|0|||
170612348|NCT03364309|616587379|FG011|Induction Period|Adverse Event|0|||
170612349|NCT03364309|616587380|FG012|Induction Period|Adverse Event|0|||
170612350|NCT03364309|616587381|FG013|Induction Period|Adverse Event|0|||
170612351|NCT03364309|616587382|FG014|Induction Period|Adverse Event|0|||
170612352|NCT03364309|616587383|FG015|Induction Period|Adverse Event|0|||
170612353|NCT03364309|616587384|FG016|Induction Period|Adverse Event|0|||
170612354|NCT03364309|616587385|FG017|Induction Period|Adverse Event|0|||
170612355|NCT03364309|616587386|FG018|Induction Period|Adverse Event|0|||
170612356|NCT03364309|616587368|FG000|Induction Period|Withdrawal by Subject|1|||
170612357|NCT03364309|616587369|FG001|Induction Period|Withdrawal by Subject|3|||
170612358|NCT03364309|616587370|FG002|Induction Period|Withdrawal by Subject|0|||
170612359|NCT03364309|616587371|FG003|Induction Period|Withdrawal by Subject|0|||
170612360|NCT03364309|616587372|FG004|Induction Period|Withdrawal by Subject|0|||
170612361|NCT03364309|616587373|FG005|Induction Period|Withdrawal by Subject|0|||
170612362|NCT03364309|616587374|FG006|Induction Period|Withdrawal by Subject|0|||
170612363|NCT03364309|616587375|FG007|Induction Period|Withdrawal by Subject|0|||
170612364|NCT03364309|616587376|FG008|Induction Period|Withdrawal by Subject|0|||
170612365|NCT03364309|616587377|FG009|Induction Period|Withdrawal by Subject|0|||
170612366|NCT03364309|616587378|FG010|Induction Period|Withdrawal by Subject|0|||
170612367|NCT03364309|616587379|FG011|Induction Period|Withdrawal by Subject|0|||
170612368|NCT03364309|616587380|FG012|Induction Period|Withdrawal by Subject|0|||
170612369|NCT03364309|616587381|FG013|Induction Period|Withdrawal by Subject|0|||
170612370|NCT03364309|616587382|FG014|Induction Period|Withdrawal by Subject|0|||
170612371|NCT03364309|616587383|FG015|Induction Period|Withdrawal by Subject|0|||
170612372|NCT03364309|616587384|FG016|Induction Period|Withdrawal by Subject|0|||
170612373|NCT03364309|616587385|FG017|Induction Period|Withdrawal by Subject|0|||
170612374|NCT03364309|616587386|FG018|Induction Period|Withdrawal by Subject|0|||
170612375|NCT03364309|616587368|FG000|Induction Period|Lost to Follow-up|1|||
170612376|NCT03364309|616587369|FG001|Induction Period|Lost to Follow-up|0|||
170612377|NCT03364309|616587370|FG002|Induction Period|Lost to Follow-up|0|||
170612378|NCT03364309|616587371|FG003|Induction Period|Lost to Follow-up|0|||
170612379|NCT03364309|616587372|FG004|Induction Period|Lost to Follow-up|0|||
170612380|NCT03364309|616587373|FG005|Induction Period|Lost to Follow-up|0|||
170612381|NCT03364309|616587374|FG006|Induction Period|Lost to Follow-up|0|||
170612382|NCT03364309|616587375|FG007|Induction Period|Lost to Follow-up|0|||
170612383|NCT03364309|616587376|FG008|Induction Period|Lost to Follow-up|0|||
170612384|NCT03364309|616587377|FG009|Induction Period|Lost to Follow-up|0|||
170612385|NCT03364309|616587378|FG010|Induction Period|Lost to Follow-up|0|||
170612386|NCT03364309|616587379|FG011|Induction Period|Lost to Follow-up|0|||
170612387|NCT03364309|616587380|FG012|Induction Period|Lost to Follow-up|0|||
170612388|NCT03364309|616587381|FG013|Induction Period|Lost to Follow-up|0|||
170612389|NCT03364309|616587382|FG014|Induction Period|Lost to Follow-up|0|||
170612390|NCT03364309|616587383|FG015|Induction Period|Lost to Follow-up|0|||
170612391|NCT03364309|616587384|FG016|Induction Period|Lost to Follow-up|0|||
170612392|NCT03364309|616587385|FG017|Induction Period|Lost to Follow-up|0|||
170612393|NCT03364309|616587386|FG018|Induction Period|Lost to Follow-up|0|||
170612394|NCT03364309|616587368|FG000|Induction Period|Physician Decision|0|||
170612395|NCT03364309|616587369|FG001|Induction Period|Physician Decision|1|||
170612396|NCT03364309|616587370|FG002|Induction Period|Physician Decision|0|||
170612397|NCT03364309|616587371|FG003|Induction Period|Physician Decision|0|||
170612398|NCT03364309|616587372|FG004|Induction Period|Physician Decision|0|||
170612399|NCT03364309|616587373|FG005|Induction Period|Physician Decision|0|||
170612400|NCT03364309|616587374|FG006|Induction Period|Physician Decision|0|||
170612401|NCT03364309|616587375|FG007|Induction Period|Physician Decision|0|||
170612402|NCT03364309|616587376|FG008|Induction Period|Physician Decision|0|||
170816368|NCT02105688|617335464|FG001|Part A: Double-Blind|Adverse Event|0|||
170816369|NCT02105688|617335463|FG000|Part A: Double-Blind|Death|0|||
170612403|NCT03364309|616587377|FG009|Induction Period|Physician Decision|0|||
170612404|NCT03364309|616587378|FG010|Induction Period|Physician Decision|0|||
170612405|NCT03364309|616587379|FG011|Induction Period|Physician Decision|0|||
170612406|NCT03364309|616587380|FG012|Induction Period|Physician Decision|0|||
170612407|NCT03364309|616587381|FG013|Induction Period|Physician Decision|0|||
170612408|NCT03364309|616587382|FG014|Induction Period|Physician Decision|0|||
170612409|NCT03364309|616587383|FG015|Induction Period|Physician Decision|0|||
170916878|NCT05042362|617697766|FG001|Overall Study|Lost to Follow-up|4|||
170916879|NCT05042362|617697765|FG000|Overall Study|Missing|4|||
170916880|NCT05042362|617697766|FG001|Overall Study|Missing|2|||
170916881|NCT05042362|617697765|FG000|Overall Study|Withdrawal by Subject|5|||
170916882|NCT05042362|617697766|FG001|Overall Study|Withdrawal by Subject|9|||
170916883|NCT05042362|617697765|FG000|Overall Study|Randomized by Mistake|1|||
170916884|NCT05042362|617697766|FG001|Overall Study|Randomized by Mistake|2|||
170916885|NCT05042362|617697765|FG000|Overall Study|Physician Decision|3|||
170916886|NCT05042362|617697766|FG001|Overall Study|Physician Decision|0|||
170655046|NCT05169567|616748993|FG000|Overall Study|Withdrawal by Subject|25|||
170612410|NCT03364309|616587384|FG016|Induction Period|Physician Decision|0|||
170612411|NCT03364309|616587385|FG017|Induction Period|Physician Decision|0|||
170612412|NCT03364309|616587386|FG018|Induction Period|Physician Decision|0|||
170612413|NCT03364309|616587368|FG000|Maintenance Period|Withdrawal by Subject|0|||
170612414|NCT03364309|616587369|FG001|Maintenance Period|Withdrawal by Subject|0|||
170612415|NCT03364309|616587370|FG002|Maintenance Period|Withdrawal by Subject|0|||
170612416|NCT03364309|616587371|FG003|Maintenance Period|Withdrawal by Subject|1|||
170612417|NCT03364309|616587372|FG004|Maintenance Period|Withdrawal by Subject|3|||
170612418|NCT03364309|616587373|FG005|Maintenance Period|Withdrawal by Subject|1|||
170612419|NCT03364309|616587374|FG006|Maintenance Period|Withdrawal by Subject|3|||
170612420|NCT03364309|616587375|FG007|Maintenance Period|Withdrawal by Subject|0|||
170612421|NCT03364309|616587376|FG008|Maintenance Period|Withdrawal by Subject|1|||
170612422|NCT03364309|616587377|FG009|Maintenance Period|Withdrawal by Subject|1|||
170612423|NCT03364309|616587378|FG010|Maintenance Period|Withdrawal by Subject|2|||
170612424|NCT03364309|616587379|FG011|Maintenance Period|Withdrawal by Subject|0|||
170612425|NCT03364309|616587380|FG012|Maintenance Period|Withdrawal by Subject|0|||
170612426|NCT03364309|616587381|FG013|Maintenance Period|Withdrawal by Subject|0|||
170612427|NCT03364309|616587382|FG014|Maintenance Period|Withdrawal by Subject|0|||
170612428|NCT03364309|616587383|FG015|Maintenance Period|Withdrawal by Subject|0|||
170612429|NCT03364309|616587384|FG016|Maintenance Period|Withdrawal by Subject|0|||
170612430|NCT03364309|616587385|FG017|Maintenance Period|Withdrawal by Subject|0|||
170612431|NCT03364309|616587386|FG018|Maintenance Period|Withdrawal by Subject|0|||
170612432|NCT03364309|616587368|FG000|Maintenance Period|Adverse Event|0|||
170612433|NCT03364309|616587369|FG001|Maintenance Period|Adverse Event|0|||
170612434|NCT03364309|616587370|FG002|Maintenance Period|Adverse Event|0|||
170612435|NCT03364309|616587371|FG003|Maintenance Period|Adverse Event|0|||
170612436|NCT03364309|616587372|FG004|Maintenance Period|Adverse Event|2|||
170612437|NCT03364309|616587373|FG005|Maintenance Period|Adverse Event|0|||
170612438|NCT03364309|616587374|FG006|Maintenance Period|Adverse Event|3|||
170612439|NCT03364309|616587375|FG007|Maintenance Period|Adverse Event|0|||
170612440|NCT03364309|616587376|FG008|Maintenance Period|Adverse Event|1|||
170612441|NCT03364309|616587377|FG009|Maintenance Period|Adverse Event|0|||
170612442|NCT03364309|616587378|FG010|Maintenance Period|Adverse Event|2|||
170612443|NCT03364309|616587379|FG011|Maintenance Period|Adverse Event|0|||
170612444|NCT03364309|616587380|FG012|Maintenance Period|Adverse Event|0|||
170612445|NCT03364309|616587381|FG013|Maintenance Period|Adverse Event|0|||
170612446|NCT03364309|616587382|FG014|Maintenance Period|Adverse Event|0|||
170612447|NCT03364309|616587383|FG015|Maintenance Period|Adverse Event|0|||
170612448|NCT03364309|616587384|FG016|Maintenance Period|Adverse Event|0|||
170612449|NCT03364309|616587385|FG017|Maintenance Period|Adverse Event|0|||
170612450|NCT03364309|616587386|FG018|Maintenance Period|Adverse Event|0|||
170612451|NCT03364309|616587368|FG000|Maintenance Period|Relapsed|0|||
170612452|NCT03364309|616587369|FG001|Maintenance Period|Relapsed|0|||
170612453|NCT03364309|616587370|FG002|Maintenance Period|Relapsed|0|||
170612454|NCT03364309|616587371|FG003|Maintenance Period|Relapsed|43|||
170612455|NCT03364309|616587372|FG004|Maintenance Period|Relapsed|7|||
170612456|NCT03364309|616587373|FG005|Maintenance Period|Relapsed|45|||
170612457|NCT03364309|616587374|FG006|Maintenance Period|Relapsed|10|||
170612458|NCT03364309|616587375|FG007|Maintenance Period|Relapsed|2|||
170612459|NCT03364309|616587376|FG008|Maintenance Period|Relapsed|0|||
170612460|NCT03364309|616587377|FG009|Maintenance Period|Relapsed|0|||
170612461|NCT03364309|616587378|FG010|Maintenance Period|Relapsed|0|||
170612462|NCT03364309|616587379|FG011|Maintenance Period|Relapsed|0|||
170612463|NCT03364309|616587380|FG012|Maintenance Period|Relapsed|0|||
170612464|NCT03364309|616587381|FG013|Maintenance Period|Relapsed|0|||
170612465|NCT03364309|616587382|FG014|Maintenance Period|Relapsed|0|||
170612466|NCT03364309|616587383|FG015|Maintenance Period|Relapsed|0|||
170612467|NCT03364309|616587384|FG016|Maintenance Period|Relapsed|0|||
170612468|NCT03364309|616587385|FG017|Maintenance Period|Relapsed|0|||
170612469|NCT03364309|616587386|FG018|Maintenance Period|Relapsed|0|||
170612470|NCT03364309|616587368|FG000|Maintenance Period|Lack of Efficacy|0|||
170612471|NCT03364309|616587369|FG001|Maintenance Period|Lack of Efficacy|0|||
170612472|NCT03364309|616587370|FG002|Maintenance Period|Lack of Efficacy|0|||
170612473|NCT03364309|616587371|FG003|Maintenance Period|Lack of Efficacy|0|||
170612474|NCT03364309|616587372|FG004|Maintenance Period|Lack of Efficacy|0|||
170612475|NCT03364309|616587373|FG005|Maintenance Period|Lack of Efficacy|0|||
170612476|NCT03364309|616587374|FG006|Maintenance Period|Lack of Efficacy|0|||
170916887|NCT05042362|617697765|FG000|Overall Study|Other|0|||
170916888|NCT05042362|617697766|FG001|Overall Study|Other|1|||
170655047|NCT05169567|616748994|FG001|Overall Study|Withdrawal by Subject|21|||
170655048|NCT03610555|616748998|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
170655049|NCT03610555|616748999|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
170655050|NCT03610555|616749000|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
170655051|NCT03610555|616749001|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
170655052|NCT04576455|616749004|FG000|Overall Study|Ongoing in the Study|48|||
170655053|NCT04576455|616749005|FG001|Overall Study|Ongoing in the Study|58|||
170655054|NCT04576455|616749004|FG000|Overall Study|Death|83|||
170655055|NCT04576455|616749005|FG001|Overall Study|Death|77|||
170655056|NCT04576455|616749004|FG000|Overall Study|Lost to Follow-up|4|||
170655057|NCT04576455|616749005|FG001|Overall Study|Lost to Follow-up|5|||
170655058|NCT04576455|616749004|FG000|Overall Study|Withdrawal by Subject|16|||
170655059|NCT04576455|616749005|FG001|Overall Study|Withdrawal by Subject|12|||
170655060|NCT04449055|616749006|FG000|Overall Study|Lost to Follow-up|2|||
170655061|NCT04449055|616749007|FG001|Overall Study|Lost to Follow-up|1|||
170655062|NCT04449055|616749006|FG000|Overall Study|Missed 4 treatments--removed by PI|1|||
170655063|NCT04449055|616749007|FG001|Overall Study|Missed 4 treatments--removed by PI|1|||
170655064|NCT04449055|616749006|FG000|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|1|||
170655065|NCT04449055|616749007|FG001|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|0|||
170816370|NCT02105688|617335464|FG001|Part A: Double-Blind|Death|1|||
170816371|NCT02105688|617335463|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
170816372|NCT02105688|617335464|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
170816373|NCT02105688|617335463|FG000|Part A: Double-Blind|Physician Decision|0|||
170655066|NCT04449055|616749006|FG000|Overall Study|Incarcerated|1|||
170655067|NCT04449055|616749007|FG001|Overall Study|Incarcerated|0|||
170655068|NCT02477696|616749008|FG000|Overall Study|Death|89|||
170655069|NCT02477696|616749009|FG001|Overall Study|Death|106|||
170655070|NCT02477696|616749008|FG000|Overall Study|Lost to Follow-up|7|||
170816374|NCT02105688|617335464|FG001|Part A: Double-Blind|Physician Decision|1|||
170816375|NCT02105688|617335463|FG000|Part A: Double-Blind|Status Unknown|0|||
170816376|NCT02105688|617335464|FG001|Part A: Double-Blind|Status Unknown|2|||
170816377|NCT02105688|617335463|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
170816378|NCT02105688|617335464|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
170816379|NCT02105688|617335463|FG000|Part B: Observational Follow-up|Death|2|||
170816380|NCT02105688|617335464|FG001|Part B: Observational Follow-up|Death|1|||
170816381|NCT02105688|617335463|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
170816382|NCT02105688|617335464|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
170816383|NCT02105688|617335463|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
170816384|NCT02105688|617335464|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
170816385|NCT02105688|617335463|FG000|Part B: Observational Follow-up|Physician Decision|3|||
170816386|NCT02105688|617335464|FG001|Part B: Observational Follow-up|Physician Decision|1|||
170816387|NCT01107912|617335465|FG000|Period 1|Adverse Event|0|||
170816388|NCT01107912|617335466|FG001|Period 1|Adverse Event|0|||
170816389|NCT01107912|617335467|FG002|Period 1|Adverse Event|0|||
170816390|NCT01107912|617335468|FG003|Period 1|Adverse Event|0|||
170816391|NCT01107912|617335469|FG004|Period 1|Adverse Event|2|||
170816392|NCT01107912|617335470|FG005|Period 1|Adverse Event|0|||
170816393|NCT01107912|617335465|FG000|Period 1|Physician Decision|0|||
170816394|NCT01107912|617335466|FG001|Period 1|Physician Decision|0|||
170816395|NCT01107912|617335467|FG002|Period 1|Physician Decision|0|||
170816396|NCT01107912|617335468|FG003|Period 1|Physician Decision|0|||
170816397|NCT01107912|617335469|FG004|Period 1|Physician Decision|1|||
170816398|NCT01107912|617335470|FG005|Period 1|Physician Decision|0|||
170816399|NCT01107912|617335465|FG000|Period 1|Withdrawal by Subject|1|||
170816400|NCT01107912|617335466|FG001|Period 1|Withdrawal by Subject|0|||
170816401|NCT01107912|617335467|FG002|Period 1|Withdrawal by Subject|0|||
170816402|NCT01107912|617335468|FG003|Period 1|Withdrawal by Subject|0|||
170816403|NCT01107912|617335469|FG004|Period 1|Withdrawal by Subject|0|||
170816404|NCT01107912|617335470|FG005|Period 1|Withdrawal by Subject|0|||
170816405|NCT01107912|617335465|FG000|Period 2|Physician Decision|0|||
170816406|NCT01107912|617335466|FG001|Period 2|Physician Decision|0|||
170816407|NCT01107912|617335467|FG002|Period 2|Physician Decision|1|||
170816408|NCT01107912|617335468|FG003|Period 2|Physician Decision|0|||
170816409|NCT01107912|617335469|FG004|Period 2|Physician Decision|0|||
170816410|NCT01107912|617335470|FG005|Period 2|Physician Decision|0|||
170816411|NCT01107912|617335465|FG000|Period 3|Adverse Event|0|||
170655071|NCT02477696|616749009|FG001|Overall Study|Lost to Follow-up|5|||
170655072|NCT02477696|616749008|FG000|Overall Study|Withdrawal by Subject|37|||
170655073|NCT02477696|616749009|FG001|Overall Study|Withdrawal by Subject|34|||
170816412|NCT01107912|617335466|FG001|Period 3|Adverse Event|1|||
170816413|NCT01107912|617335467|FG002|Period 3|Adverse Event|1|||
170816414|NCT01107912|617335468|FG003|Period 3|Adverse Event|0|||
170816415|NCT01107912|617335469|FG004|Period 3|Adverse Event|0|||
170816416|NCT01107912|617335470|FG005|Period 3|Adverse Event|0|||
170816417|NCT01107912|617335465|FG000|Period 3|Withdrawal by Subject|0|||
170816418|NCT01107912|617335466|FG001|Period 3|Withdrawal by Subject|0|||
170816419|NCT01107912|617335467|FG002|Period 3|Withdrawal by Subject|0|||
170655074|NCT02477696|616749008|FG000|Overall Study|Physician Decision|7|||
170655075|NCT02477696|616749009|FG001|Overall Study|Physician Decision|9|||
170655076|NCT02477696|616749008|FG000|Overall Study|Study terminated by sponsor|103|||
170655077|NCT02477696|616749009|FG001|Overall Study|Study terminated by sponsor|99|||
170655078|NCT02477696|616749008|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
170655079|NCT02477696|616749009|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
170655080|NCT02477696|616749008|FG000|Overall Study|Missing/Unknown|2|||
170655081|NCT02477696|616749009|FG001|Overall Study|Missing/Unknown|0|||
170655082|NCT03961555|616749010|FG000|Overall Study|Lost to Follow-up|0|||
170655083|NCT03961555|616749011|FG001|Overall Study|Lost to Follow-up|0|||
170655084|NCT03961555|616749012|FG002|Overall Study|Lost to Follow-up|1|||
170655085|NCT03961555|616749013|FG003|Overall Study|Lost to Follow-up|0|||
170655086|NCT03961555|616749010|FG000|Overall Study|Withdrawal by Subject|0|||
170655087|NCT03961555|616749011|FG001|Overall Study|Withdrawal by Subject|0|||
170655088|NCT03961555|616749012|FG002|Overall Study|Withdrawal by Subject|2|||
170655089|NCT03961555|616749013|FG003|Overall Study|Withdrawal by Subject|4|||
170655090|NCT03961555|616749010|FG000|Overall Study|Death|0|||
170655091|NCT03961555|616749011|FG001|Overall Study|Death|1|||
170655092|NCT03961555|616749012|FG002|Overall Study|Death|0|||
170655093|NCT03961555|616749013|FG003|Overall Study|Death|0|||
170655094|NCT03961555|616749010|FG000|Overall Study|Other|0|||
170655095|NCT03961555|616749011|FG001|Overall Study|Other|0|||
170655096|NCT03961555|616749012|FG002|Overall Study|Other|2|||
170655097|NCT03961555|616749013|FG003|Overall Study|Other|2|||
170655098|NCT03961555|616749010|FG000|Overall Study|No treatment received|0|||
170655099|NCT03961555|616749011|FG001|Overall Study|No treatment received|0|||
170655100|NCT03961555|616749012|FG002|Overall Study|No treatment received|1|||
170655101|NCT03961555|616749013|FG003|Overall Study|No treatment received|0|||
170655102|NCT04369053|616750001|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
170655103|NCT04369053|616750001|FG000|Overall Study|Withdrawal by Subject|773|||
170655104|NCT04369053|616750001|FG000|Overall Study|Lost to Follow-up|182|||
170655105|NCT04369053|616750001|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
170655106|NCT00076024|616750003|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
170655107|NCT00076024|616750004|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
170655108|NCT00076024|616750005|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
170655109|NCT00076024|616750006|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
170655110|NCT00076024|616750003|FG000|Phase 1, Lead-in|Adverse Event|1|||
170655111|NCT00076024|616750004|FG001|Phase 1, Lead-in|Adverse Event|0|||
170655112|NCT00076024|616750005|FG002|Phase 1, Lead-in|Adverse Event|0|||
170655113|NCT00076024|616750006|FG003|Phase 1, Lead-in|Adverse Event|0|||
170655114|NCT00076024|616750003|FG000|Phase 1, Lead-in|Clinical progression|1|||
170655115|NCT00076024|616750004|FG001|Phase 1, Lead-in|Clinical progression|0|||
170655116|NCT00076024|616750005|FG002|Phase 1, Lead-in|Clinical progression|0|||
170655117|NCT00076024|616750006|FG003|Phase 1, Lead-in|Clinical progression|0|||
170655118|NCT00076024|616750003|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
170655119|NCT00076024|616750004|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
170655120|NCT00076024|616750005|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
170655121|NCT00076024|616750006|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
170655122|NCT00076024|616750003|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
170655123|NCT00076024|616750004|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
170655124|NCT00076024|616750005|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
170655125|NCT00076024|616750006|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
170655126|NCT00076024|616750003|FG000|Phase 2, Double-blind|Adverse Event|0|||
170655127|NCT00076024|616750004|FG001|Phase 2, Double-blind|Adverse Event|25|||
170655128|NCT00076024|616750005|FG002|Phase 2, Double-blind|Adverse Event|6|||
170655129|NCT00076024|616750006|FG003|Phase 2, Double-blind|Adverse Event|0|||
170655130|NCT00076024|616750003|FG000|Phase 2, Double-blind|Un-specified|0|||
170655131|NCT00076024|616750004|FG001|Phase 2, Double-blind|Un-specified|14|||
170655132|NCT00076024|616750005|FG002|Phase 2, Double-blind|Un-specified|6|||
170655133|NCT00076024|616750006|FG003|Phase 2, Double-blind|Un-specified|0|||
170655134|NCT00076024|616750003|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
170655135|NCT00076024|616750004|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
170655136|NCT00076024|616750005|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
170655137|NCT00076024|616750006|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
170655138|NCT00076024|616750003|FG000|Phase 2, Open-label|Adverse Event|0|||
170655139|NCT00076024|616750004|FG001|Phase 2, Open-label|Adverse Event|0|||
170655140|NCT00076024|616750005|FG002|Phase 2, Open-label|Adverse Event|0|||
170655141|NCT00076024|616750006|FG003|Phase 2, Open-label|Adverse Event|2|||
170655142|NCT00076024|616750003|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
170655143|NCT00076024|616750004|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
170655144|NCT00076024|616750005|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
170655145|NCT00076024|616750006|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
170655146|NCT00076024|616750003|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
170655147|NCT00076024|616750004|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
170655148|NCT00076024|616750005|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
170655149|NCT00076024|616750006|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
170655150|NCT00076024|616750003|FG000|Phase 2, Open-label|Other|0|||
170655151|NCT00076024|616750004|FG001|Phase 2, Open-label|Other|0|||
170655152|NCT00076024|616750005|FG002|Phase 2, Open-label|Other|0|||
170655153|NCT00076024|616750006|FG003|Phase 2, Open-label|Other|2|||
170655154|NCT01155219|616750010|FG000|Overall Study|Adverse Event|3|||
170655155|NCT01155219|616750011|FG001|Overall Study|Adverse Event|1|||
170655156|NCT01155219|616750010|FG000|Overall Study|non-medical reason|1|||
170655157|NCT01155219|616750011|FG001|Overall Study|non-medical reason|2|||
170655158|NCT03150485|616750012|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
170655159|NCT03150485|616750013|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
170655160|NCT03150485|616750014|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
170655161|NCT03150485|616750015|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
170655162|NCT03150485|616750016|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
170655163|NCT03150485|616750017|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
170655164|NCT01394718|616750018|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
170655165|NCT01394718|616750019|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
170655166|NCT01547780|616750020|FG000|Baseline PET Scan|Physician Decision|1|||
170655167|NCT01547780|616750021|FG001|Baseline PET Scan|Physician Decision|0|||
170655168|NCT01547780|616750022|FG002|Baseline PET Scan|Physician Decision|1|||
170655169|NCT01547780|616750023|FG003|Baseline PET Scan|Physician Decision|0|||
170655170|NCT01547780|616750020|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
170655171|NCT01547780|616750021|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
170655172|NCT01547780|616750022|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
170655173|NCT01547780|616750023|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
170655174|NCT01362595|616750025|FG000|Overall Study|Screen failure|10|||
170655175|NCT01362595|616750025|FG000|Overall Study|Withdrawal by Subject|2|||
170655176|NCT00642473|616750026|FG000|Overall Study|Withdrawal by Subject|0|||
170655177|NCT00642473|616750027|FG001|Overall Study|Withdrawal by Subject|5|||
170655178|NCT00642473|616750026|FG000|Overall Study|Progression or death|2|||
170655179|NCT00642473|616750027|FG001|Overall Study|Progression or death|4|||
170655180|NCT00642473|616750026|FG000|Overall Study|Other|2|||
170655181|NCT00642473|616750027|FG001|Overall Study|Other|2|||
170655182|NCT01711879|616750028|FG000|Overall Study|Death|1|||
170655183|NCT01711879|616750029|FG001|Overall Study|Death|0|||
170655184|NCT04950608|616750033|FG000|Overall Study|Withdrawal by Subject|2|||
170655185|NCT04950608|616750033|FG000|Overall Study|Physician Decision|3|||
170655186|NCT03220438|616750034|FG000|Overall Study|Lost to Follow-up|0|||
170655187|NCT03220438|616750035|FG001|Overall Study|Lost to Follow-up|0|||
170655188|NCT03220438|616750036|FG002|Overall Study|Lost to Follow-up|1|||
170655189|NCT03220438|616750037|FG003|Overall Study|Lost to Follow-up|0|||
170655190|NCT01850602|616750040|FG000|Overall Study|Adverse Event|7|||
170655191|NCT01850602|616750041|FG001|Overall Study|Adverse Event|10|||
170655192|NCT01850602|616750040|FG000|Overall Study|Physician Decision|2|||
170655193|NCT01850602|616750041|FG001|Overall Study|Physician Decision|1|||
170655194|NCT01850602|616750040|FG000|Overall Study|Withdrawal by Subject|2|||
170655195|NCT01850602|616750041|FG001|Overall Study|Withdrawal by Subject|4|||
170655196|NCT01850602|616750040|FG000|Overall Study|Decrease in serum calcium|2|||
170655197|NCT01850602|616750041|FG001|Overall Study|Decrease in serum calcium|3|||
170655198|NCT01850602|616750040|FG000|Overall Study|Increase in serum ferritin|1|||
170655199|NCT01850602|616750041|FG001|Overall Study|Increase in serum ferritin|0|||
170655200|NCT01282203|616750044|FG000|Overall Study|Adverse Event|1|||
170655201|NCT00740051|616750045|FG000|Overall Study|Lack of Efficacy|2|||
170655202|NCT00740051|616750046|FG001|Overall Study|Lack of Efficacy|5|||
170655203|NCT00740051|616750045|FG000|Overall Study|Adverse Event|1|||
170655204|NCT00740051|616750046|FG001|Overall Study|Adverse Event|4|||
170655205|NCT00740051|616750045|FG000|Overall Study|Protocol Violation|2|||
170655206|NCT00740051|616750046|FG001|Overall Study|Protocol Violation|6|||
170655207|NCT00740051|616750045|FG000|Overall Study|Lost to Follow-up|3|||
170655208|NCT00740051|616750046|FG001|Overall Study|Lost to Follow-up|8|||
170655209|NCT00740051|616750045|FG000|Overall Study|Withdrawal by Subject|6|||
170655210|NCT00740051|616750046|FG001|Overall Study|Withdrawal by Subject|8|||
170655211|NCT00740051|616750045|FG000|Overall Study|Other reason (not specified)|4|||
170655212|NCT00740051|616750046|FG001|Overall Study|Other reason (not specified)|1|||
170655213|NCT04966741|616750047|FG000|Overall Study|Lost to Follow-up|1|||
170655214|NCT04966741|616750048|FG001|Overall Study|Lost to Follow-up|0|||
170655215|NCT02241889|616750053|FG000|Overall Study|device issues|0|||
170655216|NCT02241889|616750054|FG001|Overall Study|device issues|0|||
170655217|NCT02241889|616750055|FG002|Overall Study|device issues|1|||
170655218|NCT02241889|616750056|FG003|Overall Study|device issues|0|||
170655219|NCT02241889|616750057|FG004|Overall Study|device issues|0|||
170655220|NCT02241889|616750058|FG005|Overall Study|device issues|0|||
170816420|NCT01107912|617335468|FG003|Period 3|Withdrawal by Subject|1|||
170655221|NCT02241889|616750053|FG000|Overall Study|Withdrawal by Subject|0|||
170655222|NCT02241889|616750054|FG001|Overall Study|Withdrawal by Subject|0|||
170655223|NCT02241889|616750055|FG002|Overall Study|Withdrawal by Subject|0|||
170655224|NCT02241889|616750056|FG003|Overall Study|Withdrawal by Subject|0|||
170655225|NCT02241889|616750057|FG004|Overall Study|Withdrawal by Subject|0|||
170655226|NCT02241889|616750058|FG005|Overall Study|Withdrawal by Subject|1|||
170612477|NCT03364309|616587375|FG007|Maintenance Period|Lack of Efficacy|0|||
170612478|NCT03364309|616587376|FG008|Maintenance Period|Lack of Efficacy|1|||
170612479|NCT03364309|616587377|FG009|Maintenance Period|Lack of Efficacy|3|||
170612480|NCT03364309|616587378|FG010|Maintenance Period|Lack of Efficacy|2|||
170612481|NCT03364309|616587379|FG011|Maintenance Period|Lack of Efficacy|0|||
170612482|NCT03364309|616587380|FG012|Maintenance Period|Lack of Efficacy|0|||
170612483|NCT03364309|616587381|FG013|Maintenance Period|Lack of Efficacy|0|||
170612484|NCT03364309|616587382|FG014|Maintenance Period|Lack of Efficacy|0|||
170612485|NCT03364309|616587383|FG015|Maintenance Period|Lack of Efficacy|0|||
170612486|NCT03364309|616587384|FG016|Maintenance Period|Lack of Efficacy|0|||
170612487|NCT03364309|616587385|FG017|Maintenance Period|Lack of Efficacy|0|||
170612488|NCT03364309|616587386|FG018|Maintenance Period|Lack of Efficacy|0|||
170612489|NCT03364309|616587368|FG000|Maintenance Period|Death|0|||
170612490|NCT03364309|616587369|FG001|Maintenance Period|Death|0|||
170612491|NCT03364309|616587370|FG002|Maintenance Period|Death|0|||
170612492|NCT03364309|616587371|FG003|Maintenance Period|Death|0|||
170612493|NCT03364309|616587372|FG004|Maintenance Period|Death|0|||
170612494|NCT03364309|616587373|FG005|Maintenance Period|Death|0|||
170612495|NCT03364309|616587374|FG006|Maintenance Period|Death|0|||
170612496|NCT03364309|616587375|FG007|Maintenance Period|Death|0|||
170612497|NCT03364309|616587376|FG008|Maintenance Period|Death|1|||
170612498|NCT03364309|616587377|FG009|Maintenance Period|Death|0|||
170612499|NCT03364309|616587378|FG010|Maintenance Period|Death|0|||
170612500|NCT03364309|616587379|FG011|Maintenance Period|Death|0|||
170612501|NCT03364309|616587380|FG012|Maintenance Period|Death|0|||
170612502|NCT03364309|616587381|FG013|Maintenance Period|Death|0|||
170612503|NCT03364309|616587382|FG014|Maintenance Period|Death|0|||
170612504|NCT03364309|616587383|FG015|Maintenance Period|Death|0|||
170612505|NCT03364309|616587384|FG016|Maintenance Period|Death|0|||
170612506|NCT03364309|616587385|FG017|Maintenance Period|Death|0|||
170612507|NCT03364309|616587386|FG018|Maintenance Period|Death|0|||
170612508|NCT03364309|616587368|FG000|Maintenance Period|Lost to Follow-up|0|||
170612509|NCT03364309|616587369|FG001|Maintenance Period|Lost to Follow-up|0|||
170612510|NCT03364309|616587370|FG002|Maintenance Period|Lost to Follow-up|0|||
170612511|NCT03364309|616587371|FG003|Maintenance Period|Lost to Follow-up|0|||
170612512|NCT03364309|616587372|FG004|Maintenance Period|Lost to Follow-up|0|||
170612513|NCT03364309|616587373|FG005|Maintenance Period|Lost to Follow-up|0|||
170612514|NCT03364309|616587374|FG006|Maintenance Period|Lost to Follow-up|0|||
170612515|NCT03364309|616587375|FG007|Maintenance Period|Lost to Follow-up|0|||
170612516|NCT03364309|616587376|FG008|Maintenance Period|Lost to Follow-up|1|||
170612517|NCT03364309|616587377|FG009|Maintenance Period|Lost to Follow-up|0|||
170612518|NCT03364309|616587378|FG010|Maintenance Period|Lost to Follow-up|0|||
170612519|NCT03364309|616587379|FG011|Maintenance Period|Lost to Follow-up|0|||
170612520|NCT03364309|616587380|FG012|Maintenance Period|Lost to Follow-up|0|||
170612521|NCT03364309|616587381|FG013|Maintenance Period|Lost to Follow-up|0|||
170612522|NCT03364309|616587382|FG014|Maintenance Period|Lost to Follow-up|0|||
170612523|NCT03364309|616587383|FG015|Maintenance Period|Lost to Follow-up|0|||
170612524|NCT03364309|616587384|FG016|Maintenance Period|Lost to Follow-up|0|||
170612525|NCT03364309|616587385|FG017|Maintenance Period|Lost to Follow-up|0|||
170612526|NCT03364309|616587386|FG018|Maintenance Period|Lost to Follow-up|0|||
170612527|NCT03364309|616587368|FG000|Maintenance Period|Miscellaneous|0|||
170612528|NCT03364309|616587369|FG001|Maintenance Period|Miscellaneous|0|||
170612529|NCT03364309|616587370|FG002|Maintenance Period|Miscellaneous|0|||
170612530|NCT03364309|616587371|FG003|Maintenance Period|Miscellaneous|0|||
170612531|NCT03364309|616587372|FG004|Maintenance Period|Miscellaneous|0|||
170612532|NCT03364309|616587373|FG005|Maintenance Period|Miscellaneous|0|||
170612533|NCT03364309|616587374|FG006|Maintenance Period|Miscellaneous|0|||
170612534|NCT03364309|616587375|FG007|Maintenance Period|Miscellaneous|0|||
170612535|NCT03364309|616587376|FG008|Maintenance Period|Miscellaneous|1|||
170612536|NCT03364309|616587377|FG009|Maintenance Period|Miscellaneous|0|||
170612537|NCT03364309|616587378|FG010|Maintenance Period|Miscellaneous|0|||
170612538|NCT03364309|616587379|FG011|Maintenance Period|Miscellaneous|0|||
170612539|NCT03364309|616587380|FG012|Maintenance Period|Miscellaneous|0|||
170612540|NCT03364309|616587381|FG013|Maintenance Period|Miscellaneous|0|||
170612541|NCT03364309|616587382|FG014|Maintenance Period|Miscellaneous|0|||
170612542|NCT03364309|616587383|FG015|Maintenance Period|Miscellaneous|0|||
170612543|NCT03364309|616587384|FG016|Maintenance Period|Miscellaneous|0|||
170612544|NCT03364309|616587385|FG017|Maintenance Period|Miscellaneous|0|||
170612545|NCT03364309|616587386|FG018|Maintenance Period|Miscellaneous|0|||
170612546|NCT03364309|616587368|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612547|NCT03364309|616587369|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612548|NCT03364309|616587370|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612549|NCT03364309|616587371|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612550|NCT03364309|616587372|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612551|NCT03364309|616587373|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612552|NCT03364309|616587374|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612553|NCT03364309|616587375|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612554|NCT03364309|616587376|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612555|NCT03364309|616587377|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170655227|NCT00773838|616750059|FG000|Overall Study|Adverse Event|29|||
170655228|NCT00773838|616750059|FG000|Overall Study|Lost to Follow-up|1|||
170655229|NCT00773838|616750059|FG000|Overall Study|Physician Decision|8|||
170655230|NCT00773838|616750059|FG000|Overall Study|Progressive Disease|82|||
170655231|NCT00773838|616750059|FG000|Overall Study|Protocol Violation|2|||
170655232|NCT00773838|616750059|FG000|Overall Study|Withdrawal by Subject|21|||
170655233|NCT00459056|616750063|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
170655234|NCT00459056|616750064|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
170655235|NCT02522871|616750065|FG000|Overall Study|Protocol Violation|1|||
170655236|NCT02522871|616750066|FG001|Overall Study|Protocol Violation|4|||
170655237|NCT02522871|616750065|FG000|Overall Study|Treated without randomization|1|||
170655238|NCT02522871|616750066|FG001|Overall Study|Treated without randomization|0|||
170655239|NCT02522871|616750065|FG000|Overall Study|Death|9|||
170655240|NCT02522871|616750066|FG001|Overall Study|Death|9|||
170816421|NCT01107912|617335469|FG004|Period 3|Withdrawal by Subject|0|||
170816422|NCT01107912|617335470|FG005|Period 3|Withdrawal by Subject|0|||
170612556|NCT03364309|616587378|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612557|NCT03364309|616587379|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612558|NCT03364309|616587380|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612559|NCT03364309|616587381|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
170612560|NCT03364309|616587382|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
170612561|NCT03364309|616587383|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
170612562|NCT03364309|616587384|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612563|NCT03364309|616587385|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612564|NCT03364309|616587386|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
170612565|NCT03364309|616587368|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612566|NCT03364309|616587369|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612567|NCT03364309|616587370|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612568|NCT03364309|616587371|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612569|NCT03364309|616587372|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612570|NCT03364309|616587373|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612571|NCT03364309|616587374|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612572|NCT03364309|616587375|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612573|NCT03364309|616587376|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612574|NCT03364309|616587377|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612575|NCT03364309|616587378|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612576|NCT03364309|616587379|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612577|NCT03364309|616587380|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612578|NCT03364309|616587381|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612579|NCT03364309|616587382|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
170612580|NCT03364309|616587383|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612581|NCT03364309|616587384|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612582|NCT03364309|616587385|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612583|NCT03364309|616587386|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
170612584|NCT03364309|616587368|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
170612585|NCT03364309|616587369|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
170612586|NCT03364309|616587370|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
170655241|NCT02522871|616750065|FG000|Overall Study|Died in operating room prior to transplant|0|||
170655242|NCT02522871|616750066|FG001|Overall Study|Died in operating room prior to transplant|1|||
170655243|NCT02398227|616750067|FG000|Overall Study|Lost to Follow-up|21|||
170655244|NCT02398227|616750068|FG001|Overall Study|Lost to Follow-up|12|||
170816423|NCT05104242|617335474|FG000|Overall Study|Withdrawal by Subject|1|||
170816424|NCT05104242|617335475|FG001|Overall Study|Withdrawal by Subject|5|||
170816425|NCT05104242|617335474|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
170816426|NCT05104242|617335475|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
170816427|NCT02469155|617335476|FG000|Overall Study|Adverse Event|6|||
170816428|NCT02469155|617335477|FG001|Overall Study|Adverse Event|0|||
170816429|NCT02469155|617335478|FG002|Overall Study|Adverse Event|1|||
170816430|NCT02469155|617335479|FG003|Overall Study|Adverse Event|10|||
170816431|NCT02469155|617335476|FG000|Overall Study|Lack of Efficacy|13|||
170816432|NCT02469155|617335477|FG001|Overall Study|Lack of Efficacy|10|||
170816433|NCT02469155|617335478|FG002|Overall Study|Lack of Efficacy|10|||
170816434|NCT02469155|617335479|FG003|Overall Study|Lack of Efficacy|8|||
170816435|NCT02469155|617335476|FG000|Overall Study|Death|0|||
170816436|NCT02469155|617335477|FG001|Overall Study|Death|0|||
170816437|NCT02469155|617335478|FG002|Overall Study|Death|0|||
170816438|NCT02469155|617335479|FG003|Overall Study|Death|1|||
170816439|NCT02469155|617335476|FG000|Overall Study|Lost to Follow-up|5|||
170816440|NCT02469155|617335477|FG001|Overall Study|Lost to Follow-up|2|||
170816441|NCT02469155|617335478|FG002|Overall Study|Lost to Follow-up|7|||
170816442|NCT02469155|617335479|FG003|Overall Study|Lost to Follow-up|2|||
170816443|NCT02469155|617335476|FG000|Overall Study|Physician Decision|0|||
170655245|NCT02398227|616750067|FG000|Overall Study|Withdrawal by Subject|5|||
170655246|NCT02398227|616750068|FG001|Overall Study|Withdrawal by Subject|6|||
170655247|NCT02398227|616750067|FG000|Overall Study|Removed from treatment and dropped out|1|||
170655248|NCT02398227|616750068|FG001|Overall Study|Removed from treatment and dropped out|0|||
170655249|NCT01715129|616750069|FG000|Overall Study|Adverse Event, fatal|1|||
170655250|NCT01715129|616750069|FG000|Overall Study|Lack of Efficacy|3|||
170655251|NCT01715129|616750069|FG000|Overall Study|Protocol Violation|1|||
170655252|NCT01715129|616750069|FG000|Overall Study|Consent Withdrawn|2|||
170655253|NCT01715129|616750069|FG000|Overall Study|Lost to Follow-up|1|||
170655254|NCT01715129|616750069|FG000|Overall Study|Other|1|||
170655255|NCT02793622|616750070|FG000|Overall Study|Lost to Follow-up|31|||
170655256|NCT02793622|616750071|FG001|Overall Study|Lost to Follow-up|19|||
170655257|NCT02793622|616750070|FG000|Overall Study|Withdrawal by Subject|21|||
170655258|NCT02793622|616750071|FG001|Overall Study|Withdrawal by Subject|17|||
170655259|NCT02793622|616750070|FG000|Overall Study|Adverse Event|0|||
170655260|NCT02793622|616750071|FG001|Overall Study|Adverse Event|1|||
170655261|NCT02793622|616750070|FG000|Overall Study|Protocol Violation|1|||
170655262|NCT02793622|616750071|FG001|Overall Study|Protocol Violation|5|||
170655263|NCT04777331|616750072|FG000|DBT Period|Death|2|||
170655264|NCT04777331|616750073|FG001|DBT Period|Death|1|||
170655265|NCT04777331|616750074|FG002|DBT Period|Death|0|||
170655266|NCT04777331|616750072|FG000|DBT Period|Reason not Specified|1|||
170655267|NCT04777331|616750073|FG001|DBT Period|Reason not Specified|1|||
170655268|NCT04777331|616750074|FG002|DBT Period|Reason not Specified|0|||
170655269|NCT04777331|616750072|FG000|DBT Period|Physician Decision|4|||
170655270|NCT04777331|616750073|FG001|DBT Period|Physician Decision|0|||
170655271|NCT04777331|616750074|FG002|DBT Period|Physician Decision|0|||
170655272|NCT04777331|616750072|FG000|DBT Period|Withdrawal by Subject|12|||
170655273|NCT04777331|616750073|FG001|DBT Period|Withdrawal by Subject|11|||
170655274|NCT04777331|616750074|FG002|DBT Period|Withdrawal by Subject|0|||
170655275|NCT04777331|616750072|FG000|DBT Period|Randomized but not Treated|1|||
170655276|NCT04777331|616750073|FG001|DBT Period|Randomized but not Treated|3|||
170612587|NCT03364309|616587371|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
170612588|NCT03364309|616587372|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
170612589|NCT03364309|616587373|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
170612590|NCT03364309|616587374|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
170612591|NCT03364309|616587375|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
170612592|NCT03364309|616587376|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
170612593|NCT03364309|616587377|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
170612594|NCT03364309|616587378|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
170612595|NCT03364309|616587379|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
170612596|NCT03364309|616587380|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
170612597|NCT03364309|616587381|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
170612598|NCT03364309|616587382|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
170612599|NCT03364309|616587383|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
170612600|NCT03364309|616587384|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
170612601|NCT03364309|616587385|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
170612602|NCT03364309|616587386|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
170612603|NCT03364309|616587368|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612604|NCT03364309|616587369|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612605|NCT03364309|616587370|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612606|NCT03364309|616587371|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612607|NCT03364309|616587372|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612608|NCT03364309|616587373|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612609|NCT03364309|616587374|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612610|NCT03364309|616587375|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612611|NCT03364309|616587376|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612612|NCT03364309|616587377|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612613|NCT03364309|616587378|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612614|NCT03364309|616587379|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612615|NCT03364309|616587380|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612616|NCT03364309|616587381|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612617|NCT03364309|616587382|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612618|NCT03364309|616587383|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
170612619|NCT03364309|616587384|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
170612620|NCT03364309|616587385|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
170612621|NCT03364309|616587386|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
170612622|NCT03364309|616587368|FG000|Post-Treatment Followup Period|Adverse Event|0|||
170612623|NCT03364309|616587369|FG001|Post-Treatment Followup Period|Adverse Event|0|||
170612624|NCT03364309|616587370|FG002|Post-Treatment Followup Period|Adverse Event|0|||
170612625|NCT03364309|616587371|FG003|Post-Treatment Followup Period|Adverse Event|0|||
170612626|NCT03364309|616587372|FG004|Post-Treatment Followup Period|Adverse Event|0|||
170612627|NCT03364309|616587373|FG005|Post-Treatment Followup Period|Adverse Event|0|||
170655277|NCT04777331|616750074|FG002|DBT Period|Randomized but not Treated|0|||
170655278|NCT04777331|616750072|FG000|OLE Period|Ongoing in OLE|0|||
170655279|NCT04777331|616750073|FG001|OLE Period|Ongoing in OLE|0|||
170655280|NCT04777331|616750074|FG002|OLE Period|Ongoing in OLE|534|||
170655281|NCT01401959|616750075|FG000|Enrolled|Withdrawal by Subject|1|||
170655282|NCT01401959|616750076|FG001|Enrolled|Withdrawal by Subject|0|||
170655283|NCT01401959|616750077|FG002|Enrolled|Withdrawal by Subject|0|||
170655284|NCT01401959|616750075|FG000|Treated|Disease Progression|2|||
170655285|NCT01401959|616750076|FG001|Treated|Disease Progression|2|||
170655286|NCT01401959|616750077|FG002|Treated|Disease Progression|1|||
170655287|NCT01401959|616750075|FG000|Treated|Adverse Event|4|||
170655288|NCT01401959|616750076|FG001|Treated|Adverse Event|3|||
170655289|NCT01401959|616750077|FG002|Treated|Adverse Event|2|||
170655290|NCT01401959|616750075|FG000|Treated|Withdrawal by Subject|1|||
170816444|NCT02469155|617335477|FG001|Overall Study|Physician Decision|0|||
170816445|NCT02469155|617335478|FG002|Overall Study|Physician Decision|1|||
170816446|NCT02469155|617335479|FG003|Overall Study|Physician Decision|0|||
170816447|NCT02469155|617335476|FG000|Overall Study|Withdrawal by Subject|34|||
170816448|NCT02469155|617335477|FG001|Overall Study|Withdrawal by Subject|30|||
170655291|NCT01401959|616750076|FG001|Treated|Withdrawal by Subject|2|||
170655292|NCT01401959|616750077|FG002|Treated|Withdrawal by Subject|2|||
170655293|NCT01401959|616750075|FG000|Treated|Protocol Violation|0|||
170655294|NCT01401959|616750076|FG001|Treated|Protocol Violation|1|||
170816449|NCT02469155|617335478|FG002|Overall Study|Withdrawal by Subject|20|||
170816450|NCT02469155|617335479|FG003|Overall Study|Withdrawal by Subject|37|||
170816451|NCT02469155|617335476|FG000|Overall Study|Other|3|||
170816452|NCT02469155|617335477|FG001|Overall Study|Other|3|||
170816453|NCT02469155|617335478|FG002|Overall Study|Other|2|||
170816454|NCT02469155|617335479|FG003|Overall Study|Other|10|||
170816455|NCT02469155|617335476|FG000|Overall Study|Protocol Violation|0|||
170816456|NCT02469155|617335477|FG001|Overall Study|Protocol Violation|1|||
170816457|NCT02469155|617335478|FG002|Overall Study|Protocol Violation|0|||
170816458|NCT02469155|617335479|FG003|Overall Study|Protocol Violation|1|||
170816459|NCT02991118|617335480|FG000|Overall Study|Death|3|||
170816460|NCT02991118|617335481|FG001|Overall Study|Death|8|||
170816461|NCT02991118|617335480|FG000|Overall Study|Protocol Violation|0|||
170816462|NCT02991118|617335481|FG001|Overall Study|Protocol Violation|3|||
170816463|NCT02991118|617335480|FG000|Overall Study|Physician Decision|0|||
170816464|NCT02991118|617335481|FG001|Overall Study|Physician Decision|1|||
170816465|NCT02991118|617335480|FG000|Overall Study|Moved out of the country|0|||
170816466|NCT02991118|617335481|FG001|Overall Study|Moved out of the country|1|||
170816467|NCT02991118|617335480|FG000|Overall Study|Adverse Event|2|||
170612628|NCT03364309|616587374|FG006|Post-Treatment Followup Period|Adverse Event|0|||
170612629|NCT03364309|616587375|FG007|Post-Treatment Followup Period|Adverse Event|0|||
170612630|NCT03364309|616587376|FG008|Post-Treatment Followup Period|Adverse Event|0|||
170612631|NCT03364309|616587377|FG009|Post-Treatment Followup Period|Adverse Event|0|||
170612632|NCT03364309|616587378|FG010|Post-Treatment Followup Period|Adverse Event|0|||
170612633|NCT03364309|616587379|FG011|Post-Treatment Followup Period|Adverse Event|0|||
170655295|NCT01401959|616750077|FG002|Treated|Protocol Violation|0|||
170612634|NCT03364309|616587380|FG012|Post-Treatment Followup Period|Adverse Event|0|||
170655296|NCT03149848|616750078|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
170655297|NCT03149848|616750078|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
170655298|NCT02274038|616750080|FG000|Overall Study|Death|1|||
170655299|NCT01585584|616750081|FG000|Overall Study|Lack of Efficacy|1|||
170612635|NCT03364309|616587381|FG013|Post-Treatment Followup Period|Adverse Event|0|||
170612636|NCT03364309|616587382|FG014|Post-Treatment Followup Period|Adverse Event|0|||
170612637|NCT03364309|616587383|FG015|Post-Treatment Followup Period|Adverse Event|0|||
170612638|NCT03364309|616587384|FG016|Post-Treatment Followup Period|Adverse Event|2|||
170655300|NCT01585584|616750081|FG000|Overall Study|Withdrawal by Subject|1|||
170655301|NCT01585584|616750081|FG000|Overall Study|Physician Decision|2|||
170655302|NCT01892722|616750082|FG000|Overall Study|Protocol deviation|0|||
170655303|NCT01892722|616750083|FG001|Overall Study|Protocol deviation|1|||
170655304|NCT01892722|616750082|FG000|Overall Study|Administrative problems|0|||
170655305|NCT01892722|616750083|FG001|Overall Study|Administrative problems|1|||
170655306|NCT01892722|616750082|FG000|Overall Study|Patient/guardian decision|0|||
170655307|NCT01892722|616750083|FG001|Overall Study|Patient/guardian decision|2|||
170655308|NCT01892722|616750082|FG000|Overall Study|Physician Decision|1|||
170655309|NCT01892722|616750083|FG001|Overall Study|Physician Decision|2|||
170655310|NCT01892722|616750082|FG000|Overall Study|Adverse Event|3|||
170655311|NCT01892722|616750083|FG001|Overall Study|Adverse Event|2|||
170655312|NCT01892722|616750082|FG000|Overall Study|Lack of Efficacy|0|||
170655313|NCT01892722|616750083|FG001|Overall Study|Lack of Efficacy|7|||
170655314|NCT01892722|616750082|FG000|Overall Study|Withdrawal by Subject|3|||
170655315|NCT01892722|616750083|FG001|Overall Study|Withdrawal by Subject|5|||
170655316|NCT02275910|616750084|FG000|Overall Study|Subject Choice|0|||
170655317|NCT02275910|616750085|FG001|Overall Study|Subject Choice|0|||
170655318|NCT02275910|616750086|FG002|Overall Study|Subject Choice|0|||
170655319|NCT02275910|616750087|FG003|Overall Study|Subject Choice|0|||
170816468|NCT02991118|617335481|FG001|Overall Study|Adverse Event|2|||
170816469|NCT02991118|617335480|FG000|Overall Study|Withdrawal by Subject|1|||
170655320|NCT02275910|616750088|FG004|Overall Study|Subject Choice|0|||
170655321|NCT02275910|616750089|FG005|Overall Study|Subject Choice|0|||
170655322|NCT02275910|616750090|FG006|Overall Study|Subject Choice|0|||
170655323|NCT02275910|616750091|FG007|Overall Study|Subject Choice|0|||
170655324|NCT02275910|616750092|FG008|Overall Study|Subject Choice|1|||
170655325|NCT02275910|616750093|FG009|Overall Study|Subject Choice|0|||
170655326|NCT02275910|616750094|FG010|Overall Study|Subject Choice|0|||
170655327|NCT02275910|616750095|FG011|Overall Study|Subject Choice|0|||
170655328|NCT02275910|616750084|FG000|Overall Study|Radiological Disease Progression|0|||
170655329|NCT02275910|616750085|FG001|Overall Study|Radiological Disease Progression|0|||
170655330|NCT02275910|616750086|FG002|Overall Study|Radiological Disease Progression|0|||
170655331|NCT02275910|616750087|FG003|Overall Study|Radiological Disease Progression|0|||
170655332|NCT02275910|616750088|FG004|Overall Study|Radiological Disease Progression|0|||
170655333|NCT02275910|616750089|FG005|Overall Study|Radiological Disease Progression|0|||
170655334|NCT02275910|616750090|FG006|Overall Study|Radiological Disease Progression|1|||
170655335|NCT02275910|616750091|FG007|Overall Study|Radiological Disease Progression|1|||
170655336|NCT02275910|616750092|FG008|Overall Study|Radiological Disease Progression|0|||
170655337|NCT02275910|616750093|FG009|Overall Study|Radiological Disease Progression|1|||
170655338|NCT02275910|616750094|FG010|Overall Study|Radiological Disease Progression|0|||
170655339|NCT02275910|616750095|FG011|Overall Study|Radiological Disease Progression|0|||
170655340|NCT05217927|616750104|FG000|DBT Phase|Adverse Event|7|||
170655341|NCT05217927|616750105|FG001|DBT Phase|Adverse Event|2|||
170655342|NCT05217927|616750106|FG002|DBT Phase|Adverse Event|5|||
170655343|NCT05217927|616750104|FG000|DBT Phase|Lack of Efficacy|1|||
170655344|NCT05217927|616750105|FG001|DBT Phase|Lack of Efficacy|0|||
170655345|NCT05217927|616750106|FG002|DBT Phase|Lack of Efficacy|0|||
170655346|NCT05217927|616750104|FG000|DBT Phase|Lost to Follow-up|0|||
170655347|NCT05217927|616750105|FG001|DBT Phase|Lost to Follow-up|2|||
170655348|NCT05217927|616750106|FG002|DBT Phase|Lost to Follow-up|0|||
170655349|NCT05217927|616750104|FG000|DBT Phase|Non-compliance|1|||
170655350|NCT05217927|616750105|FG001|DBT Phase|Non-compliance|0|||
170655351|NCT05217927|616750106|FG002|DBT Phase|Non-compliance|0|||
170655352|NCT05217927|616750104|FG000|DBT Phase|Pregnancy|0|||
170655353|NCT05217927|616750105|FG001|DBT Phase|Pregnancy|0|||
170655354|NCT05217927|616750106|FG002|DBT Phase|Pregnancy|1|||
170655355|NCT05217927|616750104|FG000|DBT Phase|Protocol Violation|0|||
170655356|NCT05217927|616750105|FG001|DBT Phase|Protocol Violation|2|||
170655357|NCT05217927|616750106|FG002|DBT Phase|Protocol Violation|1|||
170655358|NCT05217927|616750104|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
170655359|NCT05217927|616750105|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
170655360|NCT05217927|616750106|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
170655361|NCT05217927|616750104|FG000|DBT Phase|Withdrawal of consent|8|||
170655362|NCT05217927|616750105|FG001|DBT Phase|Withdrawal of consent|5|||
170655363|NCT05217927|616750106|FG002|DBT Phase|Withdrawal of consent|7|||
170655364|NCT05217927|616750104|FG000|DBT Phase|Other|7|||
170655365|NCT05217927|616750105|FG001|DBT Phase|Other|3|||
170655366|NCT05217927|616750106|FG002|DBT Phase|Other|4|||
170655367|NCT05217927|616750104|FG000|DBT Phase|Randomized, not treated|2|||
170655368|NCT05217927|616750105|FG001|DBT Phase|Randomized, not treated|3|||
170655369|NCT05217927|616750106|FG002|DBT Phase|Randomized, not treated|2|||
170655370|NCT05217927|616750104|FG000|OLE Phase|Adverse Event|4|||
170655371|NCT05217927|616750105|FG001|OLE Phase|Adverse Event|1|||
170655372|NCT05217927|616750106|FG002|OLE Phase|Adverse Event|1|||
170655373|NCT05217927|616750104|FG000|OLE Phase|Extension phase eligibility failure|1|||
170655374|NCT05217927|616750105|FG001|OLE Phase|Extension phase eligibility failure|0|||
170655375|NCT05217927|616750106|FG002|OLE Phase|Extension phase eligibility failure|0|||
170655376|NCT05217927|616750104|FG000|OLE Phase|Lost to Follow-up|1|||
170655377|NCT05217927|616750105|FG001|OLE Phase|Lost to Follow-up|2|||
170816470|NCT02991118|617335481|FG001|Overall Study|Withdrawal by Subject|7|||
170816471|NCT02991118|617335480|FG000|Overall Study|Could not attend study visits|0|||
170816472|NCT02991118|617335481|FG001|Overall Study|Could not attend study visits|1|||
170816473|NCT02991118|617335480|FG000|Overall Study|Lost to Follow-up|1|||
170816474|NCT02991118|617335481|FG001|Overall Study|Lost to Follow-up|9|||
170655378|NCT05217927|616750106|FG002|OLE Phase|Lost to Follow-up|1|||
170655379|NCT05217927|616750104|FG000|OLE Phase|Non-compliance|0|||
170655380|NCT05217927|616750105|FG001|OLE Phase|Non-compliance|0|||
170655381|NCT05217927|616750106|FG002|OLE Phase|Non-compliance|1|||
170655382|NCT05217927|616750104|FG000|OLE Phase|Other|3|||
170816475|NCT02764320|617335488|FG000|Overall Study|Withdrawal by Subject|35|||
170816476|NCT02764320|617335489|FG001|Overall Study|Withdrawal by Subject|38|||
170816477|NCT02764320|617335488|FG000|Overall Study|Protocol Violation|11|||
170816478|NCT02764320|617335489|FG001|Overall Study|Protocol Violation|6|||
170816479|NCT02764320|617335488|FG000|Overall Study|Adverse Event|2|||
170816480|NCT02764320|617335489|FG001|Overall Study|Adverse Event|0|||
170655383|NCT05217927|616750105|FG001|OLE Phase|Other|5|||
170655384|NCT05217927|616750106|FG002|OLE Phase|Other|4|||
170655385|NCT05217927|616750104|FG000|OLE Phase|Withdrawal of consent|3|||
170655386|NCT05217927|616750105|FG001|OLE Phase|Withdrawal of consent|1|||
170655387|NCT05217927|616750106|FG002|OLE Phase|Withdrawal of consent|5|||
170655388|NCT00543855|616750841|FG000|Overall Study|Adverse Event|3|||
170655389|NCT00543855|616750842|FG001|Overall Study|Adverse Event|1|||
170655390|NCT00543855|616750843|FG002|Overall Study|Adverse Event|3|||
170655391|NCT00543855|616750844|FG003|Overall Study|Adverse Event|4|||
170655392|NCT00543855|616750841|FG000|Overall Study|Lost to Follow-up|0|||
170655393|NCT00543855|616750842|FG001|Overall Study|Lost to Follow-up|0|||
170655394|NCT00543855|616750843|FG002|Overall Study|Lost to Follow-up|1|||
170655395|NCT00543855|616750844|FG003|Overall Study|Lost to Follow-up|0|||
170655396|NCT00543855|616750841|FG000|Overall Study|Withdrawal by Subject|0|||
170655397|NCT00543855|616750842|FG001|Overall Study|Withdrawal by Subject|1|||
170655398|NCT00543855|616750843|FG002|Overall Study|Withdrawal by Subject|2|||
170655399|NCT00543855|616750844|FG003|Overall Study|Withdrawal by Subject|0|||
170655400|NCT00543855|616750841|FG000|Overall Study|Protocol Violation|1|||
170655401|NCT00543855|616750842|FG001|Overall Study|Protocol Violation|0|||
170655402|NCT00543855|616750843|FG002|Overall Study|Protocol Violation|0|||
170655403|NCT00543855|616750844|FG003|Overall Study|Protocol Violation|0|||
170655404|NCT02395016|616750850|FG000|Overall Study|Adverse Event|4|||
170655405|NCT02395016|616750851|FG001|Overall Study|Adverse Event|3|||
170655406|NCT02395016|616750850|FG000|Overall Study|Withdrawal by Subject|9|||
170655407|NCT02395016|616750851|FG001|Overall Study|Withdrawal by Subject|6|||
170655408|NCT02395016|616750850|FG000|Overall Study|Protocol Violation|2|||
170655409|NCT02395016|616750851|FG001|Overall Study|Protocol Violation|3|||
170655410|NCT01741012|616750853|FG000|Overall Study|Lost to Follow-up|1|||
170655411|NCT01741012|616750853|FG000|Overall Study|Withdrawal by Subject|2|||
170655412|NCT04123665|616750854|FG000|Overall Study|Withdrawal by Subject|7|||
170655413|NCT04123665|616750855|FG001|Overall Study|Withdrawal by Subject|0|||
170655414|NCT04123665|616750854|FG000|Overall Study|Lost to Follow-up|1|||
170655415|NCT04123665|616750855|FG001|Overall Study|Lost to Follow-up|0|||
170655416|NCT03228420|616750861|FG000|Overall Study|Lost to Follow-up|5|||
170655417|NCT03228420|616750862|FG001|Overall Study|Lost to Follow-up|3|||
170655418|NCT03228420|616750861|FG000|Overall Study|Withdrawal by Subject|10|||
170655419|NCT03228420|616750862|FG001|Overall Study|Withdrawal by Subject|0|||
170655420|NCT03228420|616750861|FG000|Overall Study|Adverse Event|5|||
170655421|NCT03228420|616750862|FG001|Overall Study|Adverse Event|2|||
170655422|NCT01083173|616750863|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
170655423|NCT01083173|616750864|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
170655424|NCT01083173|616750863|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
170655425|NCT01083173|616750864|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
170655426|NCT01083173|616750863|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
170655427|NCT01083173|616750864|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
170655428|NCT01083173|616750863|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
170655429|NCT01083173|616750864|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
170816481|NCT02764320|617335488|FG000|Overall Study|Health Issues unable to continue|2|||
170816482|NCT02764320|617335489|FG001|Overall Study|Health Issues unable to continue|0|||
170816483|NCT02764320|617335488|FG000|Overall Study|Did not meet inclusion criteria|1|||
170816484|NCT02764320|617335489|FG001|Overall Study|Did not meet inclusion criteria|0|||
170816485|NCT02764320|617335488|FG000|Overall Study|Subject moved|0|||
170816486|NCT02764320|617335489|FG001|Overall Study|Subject moved|2|||
170816487|NCT02764320|617335488|FG000|Overall Study|Overused medication unavailable|0|||
170816488|NCT02764320|617335489|FG001|Overall Study|Overused medication unavailable|1|||
170816489|NCT02764320|617335488|FG000|Overall Study|Seeking care outside site|0|||
170816490|NCT02764320|617335489|FG001|Overall Study|Seeking care outside site|1|||
170816491|NCT02764320|617335488|FG000|Overall Study|Technology barriers|0|||
170612639|NCT03364309|616587385|FG017|Post-Treatment Followup Period|Adverse Event|6|||
170655430|NCT01083173|616750863|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
170655431|NCT01083173|616750864|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
170655432|NCT01083173|616750863|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
170655433|NCT01083173|616750864|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
170612640|NCT03364309|616587386|FG018|Post-Treatment Followup Period|Adverse Event|1|||
170612641|NCT03364309|616587368|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612642|NCT03364309|616587369|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612643|NCT03364309|616587370|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612644|NCT03364309|616587371|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612645|NCT03364309|616587372|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612646|NCT03364309|616587373|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612647|NCT03364309|616587374|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612648|NCT03364309|616587375|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612649|NCT03364309|616587376|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612650|NCT03364309|616587377|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612651|NCT03364309|616587378|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612652|NCT03364309|616587379|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
170655434|NCT01083173|616750863|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
170655435|NCT01083173|616750864|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
170655436|NCT01083173|616750863|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
170655437|NCT01083173|616750864|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
170655438|NCT01083173|616750863|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
170655439|NCT01083173|616750864|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
170655440|NCT01083173|616750863|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
170655441|NCT01083173|616750864|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
170655442|NCT01083173|616750863|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
170655443|NCT01083173|616750864|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
170655444|NCT03707184|616750870|FG000|Overall Study|Withdrawal by Subject|2|||
170655445|NCT04704154|616750871|FG000|Overall Study|Adverse Event|3|||
170655446|NCT04704154|616750872|FG001|Overall Study|Adverse Event|2|||
170655447|NCT04704154|616750873|FG002|Overall Study|Adverse Event|4|||
170655448|NCT04704154|616750874|FG003|Overall Study|Adverse Event|2|||
170655449|NCT04704154|616750875|FG004|Overall Study|Adverse Event|3|||
170655450|NCT04704154|616750876|FG005|Overall Study|Adverse Event|0|||
170655451|NCT04704154|616750871|FG000|Overall Study|Death|3|||
170655452|NCT04704154|616750872|FG001|Overall Study|Death|0|||
170655453|NCT04704154|616750873|FG002|Overall Study|Death|0|||
170655454|NCT04704154|616750874|FG003|Overall Study|Death|0|||
170655455|NCT04704154|616750875|FG004|Overall Study|Death|3|||
170655456|NCT04704154|616750876|FG005|Overall Study|Death|0|||
170655457|NCT04704154|616750871|FG000|Overall Study|Physician Decision|1|||
170655458|NCT04704154|616750872|FG001|Overall Study|Physician Decision|0|||
170655459|NCT04704154|616750873|FG002|Overall Study|Physician Decision|1|||
170655460|NCT04704154|616750874|FG003|Overall Study|Physician Decision|0|||
170655461|NCT04704154|616750875|FG004|Overall Study|Physician Decision|2|||
170916889|NCT05042362|617697765|FG000|Overall Study|Non-Compliance with Study Drug|2|||
170916890|NCT05042362|617697766|FG001|Overall Study|Non-Compliance with Study Drug|3|||
170916891|NCT05042362|617697765|FG000|Overall Study|incompleted treatment; finished follow-up|16|||
170655462|NCT04704154|616750876|FG005|Overall Study|Physician Decision|0|||
170655463|NCT04704154|616750871|FG000|Overall Study|Participant Decision|1|||
170655464|NCT04704154|616750872|FG001|Overall Study|Participant Decision|1|||
170655465|NCT04704154|616750873|FG002|Overall Study|Participant Decision|0|||
170655466|NCT04704154|616750874|FG003|Overall Study|Participant Decision|0|||
170655467|NCT04704154|616750875|FG004|Overall Study|Participant Decision|0|||
170655468|NCT04704154|616750876|FG005|Overall Study|Participant Decision|0|||
170655469|NCT04704154|616750871|FG000|Overall Study|Progressive Disease|19|||
170655470|NCT04704154|616750872|FG001|Overall Study|Progressive Disease|17|||
170655471|NCT04704154|616750873|FG002|Overall Study|Progressive Disease|20|||
170655472|NCT04704154|616750874|FG003|Overall Study|Progressive Disease|18|||
170655473|NCT04704154|616750875|FG004|Overall Study|Progressive Disease|36|||
170655474|NCT04704154|616750876|FG005|Overall Study|Progressive Disease|30|||
170655475|NCT04704154|616750871|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
170655476|NCT04704154|616750872|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
170655477|NCT04704154|616750873|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
170916892|NCT05042362|617697766|FG001|Overall Study|incompleted treatment; finished follow-up|10|||
170916893|NCT05214729|617697767|FG000|Wash-out Period (24 to 48h)|Cardiac index > 4 L/min/m2|0|||
170916894|NCT05214729|617697768|FG001|Wash-out Period (24 to 48h)|Cardiac index > 4 L/min/m2|2|||
170916895|NCT05214729|617697767|FG000|Wash-out Period (24 to 48h)|Preload dependent prior to 2nd challenge|0|||
170916896|NCT05214729|617697768|FG001|Wash-out Period (24 to 48h)|Preload dependent prior to 2nd challenge|1|||
170612653|NCT03364309|616587380|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612654|NCT03364309|616587381|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612655|NCT03364309|616587382|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612656|NCT03364309|616587383|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612657|NCT03364309|616587384|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612658|NCT03364309|616587385|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
170612659|NCT03364309|616587386|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
170612660|NCT03364309|616587368|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
170612661|NCT03364309|616587369|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
170612662|NCT03364309|616587370|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
170612663|NCT03364309|616587371|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
170612664|NCT03364309|616587372|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
170612665|NCT03364309|616587373|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
170612666|NCT03364309|616587374|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
170612667|NCT03364309|616587375|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
170612668|NCT03364309|616587376|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
170612669|NCT03364309|616587377|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
170655478|NCT04704154|616750874|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
170655479|NCT04704154|616750875|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
170655480|NCT04704154|616750876|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
170655481|NCT04704154|616750871|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
170655482|NCT04704154|616750872|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
170655483|NCT04704154|616750873|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
170655484|NCT04704154|616750874|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
170655485|NCT04704154|616750875|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
170655486|NCT04704154|616750876|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
170655487|NCT05388058|616750877|FG000|Initial Treatment|Withdrawal by Subject|0|||
170655488|NCT05388058|616750878|FG001|Initial Treatment|Withdrawal by Subject|1|||
170655489|NCT05388058|616750877|FG000|Initial Treatment|Ineligible|0|||
170655490|NCT05388058|616750878|FG001|Initial Treatment|Ineligible|1|||
170655491|NCT04062123|616750879|FG000|Overall Study|Withdrawal by Subject|0|||
170655492|NCT04062123|616750880|FG001|Overall Study|Withdrawal by Subject|1|||
170655493|NCT04062123|616750881|FG002|Overall Study|Withdrawal by Subject|0|||
170655494|NCT04190680|616750884|FG000|Overall Study|Not meeting criteria for data analysis|1|||
170655495|NCT04190680|616750885|FG001|Overall Study|Not meeting criteria for data analysis|15|||
170655496|NCT04190680|616750884|FG000|Overall Study|Administrative error|0|||
170655497|NCT04190680|616750885|FG001|Overall Study|Administrative error|18|||
170655498|NCT04626310|616750888|FG000|Overall Study|4-miss from treatment|6|||
170655499|NCT04626310|616750889|FG001|Overall Study|4-miss from treatment|5|||
170655500|NCT04626310|616750890|FG002|Overall Study|4-miss from treatment|5|||
170655501|NCT04626310|616750888|FG000|Overall Study|Withdrawal by Subject|1|||
170655502|NCT04626310|616750889|FG001|Overall Study|Withdrawal by Subject|0|||
170655503|NCT04626310|616750890|FG002|Overall Study|Withdrawal by Subject|3|||
170655504|NCT03780400|616750891|FG000|Overall Study|Lost to Follow-up|5|||
170655505|NCT03780400|616750891|FG000|Overall Study|Withdrawal by Subject|2|||
170655506|NCT03282565|616750892|FG000|Overall Study|COVID-19 Research Shutdown|0|||
170655507|NCT03282565|616750893|FG001|Overall Study|COVID-19 Research Shutdown|2|||
170655508|NCT03282565|616750894|FG002|Overall Study|COVID-19 Research Shutdown|2|||
170655509|NCT03977454|616750895|FG000|Overall Study|immediate postoperative revision|2|||
170655510|NCT03977454|616750896|FG001|Overall Study|immediate postoperative revision|2|||
170655511|NCT00930982|616750897|FG000|Overall Study|Adverse Event|19|||
170655512|NCT00930982|616750898|FG001|Overall Study|Adverse Event|23|||
170655513|NCT00930982|616750897|FG000|Overall Study|Protocol Violation|1|||
170655514|NCT00930982|616750898|FG001|Overall Study|Protocol Violation|5|||
170655515|NCT00930982|616750897|FG000|Overall Study|Withdrawal by Subject|1|||
170655516|NCT00930982|616750898|FG001|Overall Study|Withdrawal by Subject|1|||
170655517|NCT00518973|616750899|FG000|Overall Study|Withdrawal by Subject|3|||
170655518|NCT00518973|616750900|FG001|Overall Study|Withdrawal by Subject|2|||
170655519|NCT00582816|616750901|FG000|Overall Study|Engraftment Failure|3|||
170655520|NCT01565499|616750902|FG000|Overall Study|Physician Decision|1|||
170655521|NCT01565499|616750902|FG000|Overall Study|Adverse Event|5|||
170655522|NCT01565499|616750902|FG000|Overall Study|Withdrawal by Subject|2|||
170655523|NCT01923168|616750903|FG000|Overall Study|Protocol Violation|1|||
170655524|NCT01923168|616750904|FG001|Overall Study|Protocol Violation|1|||
170655525|NCT01923168|616750905|FG002|Overall Study|Protocol Violation|0|||
170655526|NCT01923168|616750903|FG000|Overall Study|Subject/guardian decision|14|||
170655527|NCT01923168|616750904|FG001|Overall Study|Subject/guardian decision|14|||
170655528|NCT01923168|616750905|FG002|Overall Study|Subject/guardian decision|4|||
170655529|NCT01923168|616750903|FG000|Overall Study|Adverse Event|12|||
170655530|NCT01923168|616750904|FG001|Overall Study|Adverse Event|12|||
170655531|NCT01923168|616750905|FG002|Overall Study|Adverse Event|0|||
170655532|NCT01923168|616750903|FG000|Overall Study|Physician Decision|6|||
170655533|NCT01923168|616750904|FG001|Overall Study|Physician Decision|9|||
170655534|NCT01923168|616750905|FG002|Overall Study|Physician Decision|5|||
170655535|NCT01923168|616750903|FG000|Overall Study|Progressive disease|4|||
170655536|NCT01923168|616750904|FG001|Overall Study|Progressive disease|3|||
170655537|NCT01923168|616750905|FG002|Overall Study|Progressive disease|7|||
170655538|NCT01923168|616750903|FG000|Overall Study|Death|0|||
170655539|NCT01923168|616750904|FG001|Overall Study|Death|0|||
170655540|NCT01923168|616750905|FG002|Overall Study|Death|1|||
170655541|NCT03116347|616750906|FG000|Overall Study|Withdrawal by Subject|1|||
170655542|NCT03116347|616750907|FG001|Overall Study|Withdrawal by Subject|2|||
170655543|NCT00476047|616750908|FG000|Overall Study|Lost to Follow-up|1|||
170655544|NCT01092832|616750911|FG000|Overall Study|Other|1|||
170655545|NCT01092832|616750912|FG001|Overall Study|Other|0|||
170655546|NCT05458648|616750914|FG000|Overall Study|Physician Decision|1|||
170655547|NCT05458648|616750914|FG000|Overall Study|Patient presented in atrial flutter|1|||
170655548|NCT05952401|616750928|FG000|Overall Study|Lost to Follow-up|4|||
170655549|NCT05952401|616750929|FG001|Overall Study|Lost to Follow-up|1|||
170655550|NCT00719264|616752321|FG000|Overall Study|Adverse Event|41|||
170655551|NCT00719264|616752322|FG001|Overall Study|Adverse Event|49|||
170655552|NCT00719264|616752321|FG000|Overall Study|Death|13|||
170655553|NCT00719264|616752322|FG001|Overall Study|Death|10|||
170655554|NCT00719264|616752321|FG000|Overall Study|Administrative Problems|6|||
170655555|NCT00719264|616752322|FG001|Overall Study|Administrative Problems|4|||
170916897|NCT05214729|617697767|FG000|Wash-out Period (24 to 48h)|Expected death in the following 24h|1|||
170916898|NCT05214729|617697768|FG001|Wash-out Period (24 to 48h)|Expected death in the following 24h|0|||
170916899|NCT04221438|617697773|FG000|Overall Study|Adverse Event|1|||
170916900|NCT04221438|617697773|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
170916901|NCT03519997|617697776|FG000|Overall Study|Adverse Event|4|||
170916902|NCT03519997|617697776|FG000|Overall Study|Withdrawal by Subject|2|||
170916903|NCT03519997|617697776|FG000|Overall Study|Protocol Violation|1|||
170655556|NCT00719264|616752321|FG000|Overall Study|Lost to Follow-up|1|||
170655557|NCT00719264|616752322|FG001|Overall Study|Lost to Follow-up|1|||
170655558|NCT00719264|616752321|FG000|Overall Study|Withdrawal by Subject|12|||
170916904|NCT03504397|617697779|FG000|Overall Study|Progressive Disease|151|||
170655559|NCT00719264|616752322|FG001|Overall Study|Withdrawal by Subject|7|||
170655560|NCT00719264|616752321|FG000|Overall Study|Protocol Deviation|1|||
170655561|NCT00719264|616752322|FG001|Overall Study|Protocol Deviation|3|||
170655562|NCT00719264|616752321|FG000|Overall Study|New Cancer Therapy|4|||
170655563|NCT00719264|616752322|FG001|Overall Study|New Cancer Therapy|2|||
170655564|NCT00719264|616752321|FG000|Overall Study|Disease Progression|104|||
170655565|NCT00719264|616752322|FG001|Overall Study|Disease Progression|107|||
170655566|NCT01277042|616752323|FG000|Overall Study|Adverse Event|4|||
170655567|NCT01277042|616752324|FG001|Overall Study|Adverse Event|3|||
170655568|NCT01277042|616752323|FG000|Overall Study|Lost to Follow-up|2|||
170655569|NCT01277042|616752324|FG001|Overall Study|Lost to Follow-up|2|||
170655570|NCT01277042|616752323|FG000|Overall Study|Withdrawal by Subject|2|||
170655571|NCT01277042|616752324|FG001|Overall Study|Withdrawal by Subject|0|||
170655572|NCT00588952|616752325|FG000|Overall Study|Adverse Event|0|||
170655573|NCT00588952|616752326|FG001|Overall Study|Adverse Event|2|||
170655574|NCT00588952|616752325|FG000|Overall Study|Withdrawal by Subject|3|||
170916905|NCT03504397|617697780|FG001|Overall Study|Progressive Disease|199|||
170916906|NCT03504397|617697779|FG000|Overall Study|Withdrawal by Subject|29|||
170916907|NCT03504397|617697780|FG001|Overall Study|Withdrawal by Subject|17|||
170916908|NCT03504397|617697779|FG000|Overall Study|Lost to Follow-up|1|||
170916909|NCT03504397|617697780|FG001|Overall Study|Lost to Follow-up|0|||
170612670|NCT03364309|616587378|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
170612671|NCT03364309|616587379|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
170612672|NCT03364309|616587380|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
170612673|NCT03364309|616587381|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
170612674|NCT03364309|616587382|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
170612675|NCT03364309|616587383|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
170612676|NCT03364309|616587384|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
170612677|NCT03364309|616587385|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
170612678|NCT03364309|616587386|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
170612679|NCT00615992|616587387|FG000|Overall Study|Protocol Violation|67|||
170612680|NCT03052049|616587388|FG000|Overall Study|Withdrawal by Subject|2|||
170612681|NCT00999518|616587389|FG000|Overall Study|Adverse Event|1|||
170612682|NCT00999518|616587390|FG001|Overall Study|Adverse Event|6|||
170612683|NCT00999518|616587391|FG002|Overall Study|Adverse Event|3|||
170612684|NCT00999518|616587392|FG003|Overall Study|Adverse Event|1|||
170612685|NCT00999518|616587393|FG004|Overall Study|Adverse Event|2|||
170612686|NCT00999518|616587389|FG000|Overall Study|Lack of Efficacy|2|||
170612687|NCT00999518|616587390|FG001|Overall Study|Lack of Efficacy|0|||
170612688|NCT00999518|616587391|FG002|Overall Study|Lack of Efficacy|0|||
170612689|NCT00999518|616587392|FG003|Overall Study|Lack of Efficacy|2|||
170612690|NCT00999518|616587393|FG004|Overall Study|Lack of Efficacy|2|||
170655575|NCT00588952|616752326|FG001|Overall Study|Withdrawal by Subject|5|||
170655576|NCT01461057|616752327|FG000|Overall Study|Death|10|||
170612691|NCT00999518|616587389|FG000|Overall Study|Lost to Follow-up|0|||
170612692|NCT00999518|616587390|FG001|Overall Study|Lost to Follow-up|0|||
170655577|NCT01461057|616752328|FG001|Overall Study|Death|9|||
170655578|NCT01461057|616752327|FG000|Overall Study|Withdrawal by Subject|2|||
170655579|NCT01461057|616752328|FG001|Overall Study|Withdrawal by Subject|3|||
170655580|NCT01461057|616752327|FG000|Overall Study|Physician Decision|0|||
170655581|NCT01461057|616752328|FG001|Overall Study|Physician Decision|2|||
170655582|NCT01461057|616752327|FG000|Overall Study|Adverse Event|0|||
170916910|NCT03504397|617697779|FG000|Overall Study|Death|14|||
170612693|NCT00999518|616587391|FG002|Overall Study|Lost to Follow-up|0|||
170612694|NCT00999518|616587392|FG003|Overall Study|Lost to Follow-up|4|||
170612695|NCT00999518|616587393|FG004|Overall Study|Lost to Follow-up|1|||
170655583|NCT01461057|616752328|FG001|Overall Study|Adverse Event|1|||
170655584|NCT01461057|616752327|FG000|Overall Study|Progression of Disease|1|||
170655585|NCT01461057|616752328|FG001|Overall Study|Progression of Disease|0|||
170655586|NCT01461057|616752327|FG000|Overall Study|Study Terminated by Sponsor|2|||
170655587|NCT01461057|616752328|FG001|Overall Study|Study Terminated by Sponsor|0|||
170655588|NCT01288976|616752329|FG000|Overall Study|Withdrawal by Subject|58|||
170655589|NCT01288976|616752330|FG001|Overall Study|Withdrawal by Subject|12|||
170655590|NCT01288976|616752331|FG002|Overall Study|Withdrawal by Subject|9|||
170655591|NCT01288976|616752329|FG000|Overall Study|Death|98|||
170655592|NCT01288976|616752330|FG001|Overall Study|Death|6|||
170655593|NCT01288976|616752331|FG002|Overall Study|Death|4|||
170655594|NCT01288976|616752329|FG000|Overall Study|Data unavailable|22|||
170655595|NCT01288976|616752330|FG001|Overall Study|Data unavailable|9|||
170655596|NCT01288976|616752331|FG002|Overall Study|Data unavailable|7|||
170655597|NCT03560739|616752337|FG000|Overall Study|Adverse Event|0|||
170655598|NCT03560739|616752338|FG001|Overall Study|Adverse Event|1|||
170655599|NCT03560739|616752339|FG002|Overall Study|Adverse Event|0|||
170655600|NCT03560739|616752340|FG003|Overall Study|Adverse Event|0|||
170655601|NCT00959374|616752341|FG000|Overall Study|Withdrawal by Subject|2|||
170655602|NCT00959374|616752341|FG000|Overall Study|Lost to Follow-up|14|||
170655603|NCT00959374|616752341|FG000|Overall Study|Death|1|||
170655604|NCT00959374|616752341|FG000|Overall Study|Protocol Violation|1|||
170655605|NCT00959374|616752341|FG000|Overall Study|Implant Removed/Not Replaced|4|||
170655606|NCT00959374|616752341|FG000|Overall Study|Physician Decision|1|||
170655607|NCT02469038|616752342|FG000|Overall Study|Physician Decision|4|||
170655608|NCT02469038|616752343|FG001|Overall Study|Physician Decision|5|||
170655609|NCT02448680|616752344|FG000|Overall Study|Physician Decision|1|||
170655610|NCT02448680|616752345|FG001|Overall Study|Physician Decision|1|||
170655611|NCT02448680|616752344|FG000|Overall Study|Withdrawal by Subject|0|||
170655612|NCT02448680|616752345|FG001|Overall Study|Withdrawal by Subject|2|||
170655613|NCT03435640|616752346|FG000|Overall Study|Withdrawal by Subject|0|||
170655614|NCT03435640|616752347|FG001|Overall Study|Withdrawal by Subject|1|||
170655615|NCT03435640|616752348|FG002|Overall Study|Withdrawal by Subject|0|||
170655616|NCT03435640|616752349|FG003|Overall Study|Withdrawal by Subject|2|||
170655617|NCT03435640|616752350|FG004|Overall Study|Withdrawal by Subject|0|||
170655618|NCT03435640|616752351|FG005|Overall Study|Withdrawal by Subject|0|||
170655619|NCT03435640|616752352|FG006|Overall Study|Withdrawal by Subject|3|||
170655620|NCT03435640|616752353|FG007|Overall Study|Withdrawal by Subject|0|||
170655621|NCT03435640|616752354|FG008|Overall Study|Withdrawal by Subject|0|||
170655622|NCT03435640|616752355|FG009|Overall Study|Withdrawal by Subject|2|||
170655623|NCT03435640|616752356|FG010|Overall Study|Withdrawal by Subject|3|||
170655624|NCT03435640|616752346|FG000|Overall Study|Lost to Follow-up|0|||
170655625|NCT03435640|616752347|FG001|Overall Study|Lost to Follow-up|0|||
170655626|NCT03435640|616752348|FG002|Overall Study|Lost to Follow-up|1|||
170655627|NCT03435640|616752349|FG003|Overall Study|Lost to Follow-up|0|||
170655628|NCT03435640|616752350|FG004|Overall Study|Lost to Follow-up|0|||
170655629|NCT03435640|616752351|FG005|Overall Study|Lost to Follow-up|0|||
170655630|NCT03435640|616752352|FG006|Overall Study|Lost to Follow-up|0|||
170655631|NCT03435640|616752353|FG007|Overall Study|Lost to Follow-up|0|||
170655632|NCT03435640|616752354|FG008|Overall Study|Lost to Follow-up|0|||
170655633|NCT03435640|616752355|FG009|Overall Study|Lost to Follow-up|0|||
170655634|NCT03435640|616752356|FG010|Overall Study|Lost to Follow-up|0|||
170655635|NCT00636987|616752357|FG000|Overall Study|Death|44|||
170655636|NCT00636987|616752357|FG000|Overall Study|Explanted|13|||
170655637|NCT00636987|616752357|FG000|Overall Study|Lost to Follow-up|63|||
170655638|NCT00636987|616752357|FG000|Overall Study|5 year visit window not complete|69|||
170655639|NCT01739400|616752358|FG000|Overall Study|Physician Decision|3|||
170655640|NCT01739400|616752359|FG001|Overall Study|Physician Decision|0|||
170655641|NCT01739400|616752358|FG000|Overall Study|Lost to Follow-up|2|||
170655642|NCT01739400|616752359|FG001|Overall Study|Lost to Follow-up|0|||
170655643|NCT01739400|616752358|FG000|Overall Study|Death|5|||
170655644|NCT01739400|616752359|FG001|Overall Study|Death|2|||
170655645|NCT01739400|616752358|FG000|Overall Study|Withdrawal by Subject|7|||
170655646|NCT01739400|616752359|FG001|Overall Study|Withdrawal by Subject|7|||
170655647|NCT01736657|616752360|FG000|Overall Study|insufficient vascular access|1|||
170655648|NCT03350984|616752361|FG000|Overall Study|Death|1|||
170655649|NCT03350984|616752362|FG001|Overall Study|Death|0|||
170655650|NCT03350984|616752361|FG000|Overall Study|Lost to Follow-up|5|||
170655651|NCT03350984|616752362|FG001|Overall Study|Lost to Follow-up|6|||
170816492|NCT02764320|617335489|FG001|Overall Study|Technology barriers|1|||
170816493|NCT04765046|617335490|FG000|Overall Study|Screen Failure|2|||
170816494|NCT04765046|617335490|FG000|Overall Study|Withdrawal by Subject|4|||
170816495|NCT04765046|617335490|FG000|Overall Study|Physician Decision|4|||
170816496|NCT04765046|617335490|FG000|Overall Study|Surgery Cancelled|8|||
170816497|NCT04085614|617335494|FG000|Overall Study|Protocol Violation|9|||
170816498|NCT04085614|617335495|FG001|Overall Study|Protocol Violation|6|||
170655652|NCT03350984|616752361|FG000|Overall Study|Protocol Violation|1|||
170816499|NCT05265247|617335496|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
170816500|NCT05265247|617335497|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
170655653|NCT03350984|616752362|FG001|Overall Study|Protocol Violation|2|||
170655654|NCT03350984|616752361|FG000|Overall Study|Physician Decision|1|||
170655655|NCT03350984|616752362|FG001|Overall Study|Physician Decision|0|||
170655656|NCT04533880|616752371|FG000|Overall Study|Lost to Follow-up|0|||
170655657|NCT04533880|616752372|FG001|Overall Study|Lost to Follow-up|1|||
170655658|NCT04533880|616752373|FG002|Overall Study|Lost to Follow-up|1|||
170655659|NCT02284178|616752374|FG000|Overall Study|Met exclusion criteria|49|||
170655660|NCT02284178|616752375|FG001|Overall Study|Met exclusion criteria|54|||
170655661|NCT00958789|616752382|FG000|Overall Study|Death|5|||
170655662|NCT00958789|616752382|FG000|Overall Study|Lost to Follow-up|14|||
170655663|NCT00958789|616752382|FG000|Overall Study|Withdrawal by Subject|17|||
170655664|NCT00958789|616752382|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
170655665|NCT00958789|616752382|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
170655666|NCT00958789|616752382|FG000|Overall Study|Subject terminated|2|||
170655667|NCT00958789|616752382|FG000|Overall Study|Revision|7|||
170655668|NCT02239224|616752387|FG000|Overall Study|Administrative|0|||
170655669|NCT02239224|616752388|FG001|Overall Study|Administrative|0|||
170655670|NCT02239224|616752389|FG002|Overall Study|Administrative|3|||
170655671|NCT02239224|616752390|FG003|Overall Study|Administrative|1|||
170655672|NCT00478881|616752391|FG000|Overall Study|Adverse Event|31|||
170655673|NCT00478881|616752392|FG001|Overall Study|Adverse Event|12|||
170655674|NCT00478881|616752391|FG000|Overall Study|Lack of Efficacy|0|||
170655675|NCT00478881|616752392|FG001|Overall Study|Lack of Efficacy|3|||
170655676|NCT00478881|616752391|FG000|Overall Study|Lost to Follow-up|0|||
170655677|NCT00478881|616752392|FG001|Overall Study|Lost to Follow-up|1|||
170655678|NCT00478881|616752391|FG000|Overall Study|Protocol Violation|2|||
170655679|NCT00478881|616752392|FG001|Overall Study|Protocol Violation|2|||
170655680|NCT00478881|616752391|FG000|Overall Study|Withdrawal by Subject|6|||
170655681|NCT00478881|616752392|FG001|Overall Study|Withdrawal by Subject|2|||
170655682|NCT00478881|616752391|FG000|Overall Study|Non-Compliance with Study Medication|0|||
170655683|NCT00478881|616752392|FG001|Overall Study|Non-Compliance with Study Medication|2|||
170655684|NCT03183778|616752393|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
170655685|NCT01466179|616752395|FG000|Overall Study|Ongoing in core study|2|||
170655686|NCT01466179|616752395|FG000|Overall Study|Physician Decision|46|||
170655687|NCT01466179|616752395|FG000|Overall Study|Progressive disease|43|||
170655688|NCT01466179|616752395|FG000|Overall Study|Adverse Event|32|||
170655689|NCT01466179|616752395|FG000|Overall Study|Disease relapse|23|||
170655690|NCT01466179|616752395|FG000|Overall Study|Lack of Efficacy|14|||
170655691|NCT01466179|616752395|FG000|Overall Study|Death|7|||
170655692|NCT01466179|616752395|FG000|Overall Study|Withdrawal by Subject|7|||
170655693|NCT01466179|616752395|FG000|Overall Study|Protocol Violation|2|||
170655694|NCT01466179|616752395|FG000|Overall Study|Other|3|||
170655695|NCT03410823|616752402|FG000|Overall Study|Death|1|||
170655696|NCT03410823|616752402|FG000|Overall Study|Withdrawal by Subject|2|||
170655697|NCT03410823|616752402|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
170655698|NCT00740246|616752405|FG000|Overall Study|Received Blood Transfusion|0|||
170655699|NCT00740246|616752406|FG001|Overall Study|Received Blood Transfusion|1|||
170655700|NCT00740246|616752405|FG000|Overall Study|Adverse Event|1|||
170655701|NCT00740246|616752406|FG001|Overall Study|Adverse Event|2|||
170655702|NCT00740246|616752405|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
170655703|NCT00740246|616752406|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
170655704|NCT00740246|616752405|FG000|Overall Study|Lost to Follow-up|2|||
170655705|NCT00740246|616752406|FG001|Overall Study|Lost to Follow-up|2|||
170816501|NCT05265247|617335496|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
170816502|NCT05265247|617335497|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
170816503|NCT05265247|617335496|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
170816504|NCT05265247|617335497|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
170816505|NCT01029925|617335498|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
170816506|NCT01029925|617335498|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
170816507|NCT01029925|617335498|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
170816508|NCT02516202|617335503|FG000|Overall Study|Withdrawal by Subject|1|||
170816509|NCT02516202|617335504|FG001|Overall Study|Withdrawal by Subject|0|||
170816510|NCT02516202|617335505|FG002|Overall Study|Withdrawal by Subject|1|||
170655706|NCT00740246|616752405|FG000|Overall Study|Withdrawal by Subject|4|||
170655707|NCT00740246|616752406|FG001|Overall Study|Withdrawal by Subject|3|||
170655708|NCT00740246|616752405|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
170655709|NCT00740246|616752406|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
170655710|NCT00740246|616752405|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
170655711|NCT00740246|616752406|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
170655712|NCT00740246|616752405|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
170655713|NCT00740246|616752406|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
170655714|NCT00740246|616752405|FG000|Overall Study|Unable To Comply With Study Visits|2|||
170655715|NCT00740246|616752406|FG001|Overall Study|Unable To Comply With Study Visits|0|||
170655716|NCT00740246|616752405|FG000|Overall Study|Unable to Access Vein|0|||
170655717|NCT00740246|616752406|FG001|Overall Study|Unable to Access Vein|2|||
170655718|NCT00740246|616752405|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
170655719|NCT00740246|616752406|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
170655720|NCT02953509|616752407|FG000|Overall Study|Death|1|||
170655721|NCT02953509|616752408|FG001|Overall Study|Death|3|||
170655722|NCT02953509|616752409|FG002|Overall Study|Death|3|||
170655723|NCT02953509|616752410|FG003|Overall Study|Death|4|||
170655724|NCT02953509|616752411|FG004|Overall Study|Death|12|||
170655725|NCT02953509|616752412|FG005|Overall Study|Death|3|||
170655726|NCT02953509|616752413|FG006|Overall Study|Death|25|||
170655727|NCT02953509|616752414|FG007|Overall Study|Death|10|||
170655728|NCT02953509|616752415|FG008|Overall Study|Death|21|||
170655729|NCT02953509|616752416|FG009|Overall Study|Death|20|||
170655730|NCT02953509|616752407|FG000|Overall Study|Reason Not Specified|0|||
170655731|NCT02953509|616752408|FG001|Overall Study|Reason Not Specified|2|||
170655732|NCT02953509|616752409|FG002|Overall Study|Reason Not Specified|8|||
170655733|NCT02953509|616752410|FG003|Overall Study|Reason Not Specified|2|||
170655734|NCT02953509|616752411|FG004|Overall Study|Reason Not Specified|11|||
170816511|NCT02516202|617335503|FG000|Overall Study|Lost to Follow-up|1|||
170612696|NCT00999518|616587389|FG000|Overall Study|Did not meet entrance criteria|0|||
170612697|NCT00999518|616587390|FG001|Overall Study|Did not meet entrance criteria|0|||
170612698|NCT00999518|616587391|FG002|Overall Study|Did not meet entrance criteria|0|||
170612699|NCT00999518|616587392|FG003|Overall Study|Did not meet entrance criteria|0|||
170612700|NCT00999518|616587393|FG004|Overall Study|Did not meet entrance criteria|1|||
170612701|NCT00999518|616587389|FG000|Overall Study|Study terminated by sponsor|10|||
170612702|NCT00999518|616587390|FG001|Overall Study|Study terminated by sponsor|6|||
170612703|NCT00999518|616587391|FG002|Overall Study|Study terminated by sponsor|5|||
170612704|NCT00999518|616587392|FG003|Overall Study|Study terminated by sponsor|5|||
170612705|NCT00999518|616587393|FG004|Overall Study|Study terminated by sponsor|9|||
170612706|NCT00999518|616587389|FG000|Overall Study|Pregnancy|0|||
170612707|NCT00999518|616587390|FG001|Overall Study|Pregnancy|0|||
170612708|NCT00999518|616587391|FG002|Overall Study|Pregnancy|1|||
170612709|NCT00999518|616587392|FG003|Overall Study|Pregnancy|0|||
170612710|NCT00999518|616587393|FG004|Overall Study|Pregnancy|0|||
170612711|NCT00999518|616587389|FG000|Overall Study|Protocol Violation|0|||
170612712|NCT00999518|616587390|FG001|Overall Study|Protocol Violation|1|||
170612713|NCT00999518|616587391|FG002|Overall Study|Protocol Violation|0|||
170612714|NCT00999518|616587392|FG003|Overall Study|Protocol Violation|0|||
170612715|NCT00999518|616587393|FG004|Overall Study|Protocol Violation|2|||
170612716|NCT00999518|616587389|FG000|Overall Study|Withdrawal by Subject|5|||
170612717|NCT00999518|616587390|FG001|Overall Study|Withdrawal by Subject|4|||
170612718|NCT00999518|616587391|FG002|Overall Study|Withdrawal by Subject|10|||
170612719|NCT00999518|616587392|FG003|Overall Study|Withdrawal by Subject|6|||
170612720|NCT00999518|616587393|FG004|Overall Study|Withdrawal by Subject|1|||
170612721|NCT00999518|616587389|FG000|Overall Study|Other|5|||
170612722|NCT00999518|616587390|FG001|Overall Study|Other|7|||
170612723|NCT00999518|616587391|FG002|Overall Study|Other|1|||
170612724|NCT00999518|616587392|FG003|Overall Study|Other|4|||
170612725|NCT00999518|616587393|FG004|Overall Study|Other|5|||
170612726|NCT00999518|616587389|FG000|Overall Study|Randomized but not Treated|1|||
170612727|NCT00999518|616587390|FG001|Overall Study|Randomized but not Treated|1|||
170612728|NCT00999518|616587391|FG002|Overall Study|Randomized but not Treated|2|||
170612729|NCT00999518|616587392|FG003|Overall Study|Randomized but not Treated|0|||
170612730|NCT00999518|616587393|FG004|Overall Study|Randomized but not Treated|1|||
170612731|NCT00400569|616587394|FG000|Overall Study|Death|1|||
170612732|NCT04072887|616587396|FG000|Overall Study|Withdrawal by Subject|3|||
170612733|NCT04072887|616587397|FG001|Overall Study|Withdrawal by Subject|8|||
170612734|NCT04072887|616587398|FG002|Overall Study|Withdrawal by Subject|1|||
170612735|NCT04072887|616587399|FG003|Overall Study|Withdrawal by Subject|3|||
170816512|NCT02516202|617335504|FG001|Overall Study|Lost to Follow-up|1|||
170816513|NCT02516202|617335505|FG002|Overall Study|Lost to Follow-up|1|||
170816514|NCT02516202|617335503|FG000|Overall Study|Stopped Follow-up|0|||
170612736|NCT04072887|616587400|FG004|Overall Study|Withdrawal by Subject|3|||
170612737|NCT04072887|616587401|FG005|Overall Study|Withdrawal by Subject|13|||
170612738|NCT04072887|616587396|FG000|Overall Study|Adverse Event|2|||
170612739|NCT04072887|616587397|FG001|Overall Study|Adverse Event|4|||
170612740|NCT04072887|616587398|FG002|Overall Study|Adverse Event|1|||
170612741|NCT04072887|616587399|FG003|Overall Study|Adverse Event|4|||
170612742|NCT04072887|616587400|FG004|Overall Study|Adverse Event|0|||
170612743|NCT04072887|616587401|FG005|Overall Study|Adverse Event|1|||
170612744|NCT04072887|616587396|FG000|Overall Study|Physician Decision|2|||
170655735|NCT02953509|616752412|FG005|Overall Study|Reason Not Specified|4|||
170655736|NCT02953509|616752413|FG006|Overall Study|Reason Not Specified|12|||
170612745|NCT04072887|616587397|FG001|Overall Study|Physician Decision|0|||
170612746|NCT04072887|616587398|FG002|Overall Study|Physician Decision|0|||
170612747|NCT04072887|616587399|FG003|Overall Study|Physician Decision|0|||
170612748|NCT04072887|616587400|FG004|Overall Study|Physician Decision|0|||
170612749|NCT04072887|616587401|FG005|Overall Study|Physician Decision|1|||
170655737|NCT02953509|616752414|FG007|Overall Study|Reason Not Specified|2|||
170655738|NCT02953509|616752415|FG008|Overall Study|Reason Not Specified|7|||
170655739|NCT02953509|616752416|FG009|Overall Study|Reason Not Specified|2|||
170655740|NCT02953509|616752407|FG000|Overall Study|Consent Withdrawn|1|||
170655741|NCT02953509|616752408|FG001|Overall Study|Consent Withdrawn|1|||
170655742|NCT02953509|616752409|FG002|Overall Study|Consent Withdrawn|2|||
170655743|NCT02953509|616752410|FG003|Overall Study|Consent Withdrawn|1|||
170655744|NCT02953509|616752411|FG004|Overall Study|Consent Withdrawn|3|||
170655745|NCT02953509|616752412|FG005|Overall Study|Consent Withdrawn|0|||
170655746|NCT02953509|616752413|FG006|Overall Study|Consent Withdrawn|4|||
170655747|NCT02953509|616752414|FG007|Overall Study|Consent Withdrawn|1|||
170655748|NCT02953509|616752415|FG008|Overall Study|Consent Withdrawn|1|||
170655749|NCT02953509|616752416|FG009|Overall Study|Consent Withdrawn|4|||
170655750|NCT02953509|616752407|FG000|Overall Study|Lost to Follow-up|0|||
170655751|NCT02953509|616752408|FG001|Overall Study|Lost to Follow-up|0|||
170655752|NCT02953509|616752409|FG002|Overall Study|Lost to Follow-up|0|||
170655753|NCT02953509|616752410|FG003|Overall Study|Lost to Follow-up|0|||
170655754|NCT02953509|616752411|FG004|Overall Study|Lost to Follow-up|0|||
170655755|NCT02953509|616752412|FG005|Overall Study|Lost to Follow-up|0|||
170655756|NCT02953509|616752413|FG006|Overall Study|Lost to Follow-up|1|||
170655757|NCT02953509|616752414|FG007|Overall Study|Lost to Follow-up|1|||
170655758|NCT02953509|616752415|FG008|Overall Study|Lost to Follow-up|1|||
170655759|NCT02953509|616752416|FG009|Overall Study|Lost to Follow-up|1|||
170655760|NCT02953509|616752407|FG000|Overall Study|Study terminated by sponsor|1|||
170655761|NCT02953509|616752408|FG001|Overall Study|Study terminated by sponsor|0|||
170655762|NCT02953509|616752409|FG002|Overall Study|Study terminated by sponsor|0|||
170612750|NCT04072887|616587396|FG000|Overall Study|Lost to Follow-up|1|||
170612751|NCT04072887|616587397|FG001|Overall Study|Lost to Follow-up|3|||
170612752|NCT04072887|616587398|FG002|Overall Study|Lost to Follow-up|0|||
170612753|NCT04072887|616587399|FG003|Overall Study|Lost to Follow-up|0|||
170612754|NCT04072887|616587400|FG004|Overall Study|Lost to Follow-up|0|||
170612755|NCT04072887|616587401|FG005|Overall Study|Lost to Follow-up|0|||
170612756|NCT04072887|616587396|FG000|Overall Study|Death|0|||
170612757|NCT04072887|616587397|FG001|Overall Study|Death|2|||
170612758|NCT04072887|616587398|FG002|Overall Study|Death|0|||
170612759|NCT04072887|616587399|FG003|Overall Study|Death|2|||
170612760|NCT04072887|616587400|FG004|Overall Study|Death|3|||
170612761|NCT04072887|616587401|FG005|Overall Study|Death|0|||
170612762|NCT03369236|616587402|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
170612763|NCT03369236|616587403|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
170612764|NCT03369236|616587402|FG000|Open-label Extension Period|Lack of Efficacy|2|||
170612765|NCT03369236|616587403|FG001|Open-label Extension Period|Lack of Efficacy|1|||
170612766|NCT03369236|616587402|FG000|Open-label Extension Period|Adverse Event|0|||
170612767|NCT03369236|616587403|FG001|Open-label Extension Period|Adverse Event|1|||
170612768|NCT03369236|616587402|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
170612769|NCT03369236|616587403|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
170612770|NCT00423449|616587408|FG000|Overall Study|Clinical Adverse Event|1|||
170612771|NCT00423449|616587409|FG001|Overall Study|Clinical Adverse Event|0|||
170612772|NCT00423449|616587410|FG002|Overall Study|Clinical Adverse Event|1|||
170612773|NCT00423449|616587411|FG003|Overall Study|Clinical Adverse Event|8|||
170612774|NCT00423449|616587412|FG004|Overall Study|Clinical Adverse Event|2|||
170612775|NCT00423449|616587408|FG000|Overall Study|Death|1|||
170612776|NCT00423449|616587409|FG001|Overall Study|Death|0|||
170612777|NCT00423449|616587410|FG002|Overall Study|Death|2|||
170612778|NCT00423449|616587411|FG003|Overall Study|Death|1|||
170612779|NCT00423449|616587412|FG004|Overall Study|Death|1|||
170612780|NCT00423449|616587408|FG000|Overall Study|Progressive Disease|1|||
170612781|NCT00423449|616587409|FG001|Overall Study|Progressive Disease|3|||
170612782|NCT00423449|616587410|FG002|Overall Study|Progressive Disease|8|||
170612783|NCT00423449|616587411|FG003|Overall Study|Progressive Disease|11|||
170612784|NCT00423449|616587412|FG004|Overall Study|Progressive Disease|4|||
170655763|NCT02953509|616752410|FG003|Overall Study|Study terminated by sponsor|0|||
170655764|NCT02953509|616752411|FG004|Overall Study|Study terminated by sponsor|0|||
170655765|NCT02953509|616752412|FG005|Overall Study|Study terminated by sponsor|0|||
170655766|NCT02953509|616752413|FG006|Overall Study|Study terminated by sponsor|1|||
170655767|NCT02953509|616752414|FG007|Overall Study|Study terminated by sponsor|0|||
170655768|NCT02953509|616752415|FG008|Overall Study|Study terminated by sponsor|1|||
170612785|NCT00423449|616587408|FG000|Overall Study|Laboratory Adverse Event|0|||
170612786|NCT00423449|616587409|FG001|Overall Study|Laboratory Adverse Event|1|||
170612787|NCT00423449|616587410|FG002|Overall Study|Laboratory Adverse Event|2|||
170612788|NCT00423449|616587411|FG003|Overall Study|Laboratory Adverse Event|0|||
170612789|NCT00423449|616587412|FG004|Overall Study|Laboratory Adverse Event|0|||
170612790|NCT00423449|616587408|FG000|Overall Study|Other|0|||
170612791|NCT00423449|616587409|FG001|Overall Study|Other|0|||
170612792|NCT00423449|616587410|FG002|Overall Study|Other|0|||
170612793|NCT00423449|616587411|FG003|Overall Study|Other|1|||
170655769|NCT02953509|616752416|FG009|Overall Study|Study terminated by sponsor|1|||
170655770|NCT00509262|616752417|FG000|Overall Study|Adverse Event|16|||
170655771|NCT00509262|616752418|FG001|Overall Study|Adverse Event|18|||
170655772|NCT00509262|616752417|FG000|Overall Study|Other|2|||
170816515|NCT02516202|617335504|FG001|Overall Study|Stopped Follow-up|0|||
170816516|NCT02516202|617335505|FG002|Overall Study|Stopped Follow-up|1|||
170816517|NCT03060525|617335508|FG000|Overall Study|moved out of state|1|||
170816518|NCT03060525|617335509|FG001|Overall Study|moved out of state|1|||
170816519|NCT03060525|617335510|FG002|Overall Study|moved out of state|1|||
170655773|NCT00509262|616752418|FG001|Overall Study|Other|2|||
170655774|NCT00509262|616752417|FG000|Overall Study|Lack of Efficacy|1|||
170655775|NCT00509262|616752418|FG001|Overall Study|Lack of Efficacy|0|||
170655776|NCT00509262|616752417|FG000|Overall Study|Lost to Follow-up|1|||
170655777|NCT00509262|616752418|FG001|Overall Study|Lost to Follow-up|6|||
170655778|NCT00509262|616752417|FG000|Overall Study|Physician Decision|1|||
170655779|NCT00509262|616752418|FG001|Overall Study|Physician Decision|3|||
170655780|NCT00509262|616752417|FG000|Overall Study|Protocol Violation|2|||
170655781|NCT00509262|616752418|FG001|Overall Study|Protocol Violation|2|||
170655782|NCT00509262|616752417|FG000|Overall Study|Withdrawal by Subject|24|||
170655783|NCT00509262|616752418|FG001|Overall Study|Withdrawal by Subject|11|||
170655784|NCT01853618|616752419|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
170655785|NCT01853618|616752420|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
170655786|NCT01853618|616752421|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
170655787|NCT01853618|616752422|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
170655788|NCT01853618|616752423|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
170655789|NCT01853618|616752419|FG000|Overall Study|Progressive disease|1|||
170655790|NCT01853618|616752420|FG001|Overall Study|Progressive disease|1|||
170655791|NCT01853618|616752421|FG002|Overall Study|Progressive disease|1|||
170655792|NCT01853618|616752422|FG003|Overall Study|Progressive disease|1|||
170655793|NCT01853618|616752423|FG004|Overall Study|Progressive disease|2|||
170655794|NCT01853618|616752419|FG000|Overall Study|Physician Decision|0|||
170655795|NCT01853618|616752420|FG001|Overall Study|Physician Decision|1|||
170655796|NCT01853618|616752421|FG002|Overall Study|Physician Decision|1|||
170655797|NCT01853618|616752422|FG003|Overall Study|Physician Decision|0|||
170655798|NCT01853618|616752423|FG004|Overall Study|Physician Decision|0|||
170655799|NCT01853618|616752419|FG000|Overall Study|Refused further treatment|0|||
170655800|NCT01853618|616752420|FG001|Overall Study|Refused further treatment|0|||
170655801|NCT01853618|616752421|FG002|Overall Study|Refused further treatment|0|||
170655802|NCT01853618|616752422|FG003|Overall Study|Refused further treatment|0|||
170655803|NCT01853618|616752423|FG004|Overall Study|Refused further treatment|1|||
170655804|NCT01658813|616752424|FG000|Overall Study|Disease progression|3|||
170655805|NCT01075191|616752425|FG000|Overall Study|Death|1|||
170655806|NCT01075191|616752425|FG000|Overall Study|Intensification|3|||
170655807|NCT01075191|616752425|FG000|Overall Study|Co-morbidities|1|||
170655808|NCT01075191|616752425|FG000|Overall Study|Adverse Event|4|||
170655809|NCT01075191|616752425|FG000|Overall Study|Noncompliance|3|||
170655810|NCT01075191|616752425|FG000|Overall Study|Therapy Break|3|||
170655811|NCT01075191|616752425|FG000|Overall Study|Patient's Wish|2|||
170655812|NCT01075191|616752425|FG000|Overall Study|Unknown Reasons|1|||
170655813|NCT00400153|616752430|FG000|Overall Study|AE due to study disease worsening|14|||
170655814|NCT00400153|616752431|FG001|Overall Study|AE due to study disease worsening|19|||
170655815|NCT00400153|616752432|FG002|Overall Study|AE due to study disease worsening|20|||
170816520|NCT03060525|617335511|FG003|Overall Study|moved out of state|1|||
170816521|NCT03060525|617335508|FG000|Overall Study|unable to meet time commitment required of study|2|||
170816522|NCT03060525|617335509|FG001|Overall Study|unable to meet time commitment required of study|3|||
170916911|NCT03504397|617697780|FG001|Overall Study|Death|16|||
170612794|NCT00423449|616587412|FG004|Overall Study|Other|0|||
170612795|NCT00423449|616587408|FG000|Overall Study|Protocol Violation|0|||
170612796|NCT00423449|616587409|FG001|Overall Study|Protocol Violation|0|||
170612797|NCT00423449|616587410|FG002|Overall Study|Protocol Violation|2|||
170612798|NCT00423449|616587411|FG003|Overall Study|Protocol Violation|1|||
170612799|NCT00423449|616587412|FG004|Overall Study|Protocol Violation|0|||
170612800|NCT00445770|616587416|FG000|Overall Study|Adverse Event|9|||
170612801|NCT00445770|616587417|FG001|Overall Study|Adverse Event|15|||
170612802|NCT00445770|616587418|FG002|Overall Study|Adverse Event|19|||
170655816|NCT00400153|616752430|FG000|Overall Study|AE due to other disease worsening|2|||
170655817|NCT00400153|616752431|FG001|Overall Study|AE due to other disease worsening|1|||
170655818|NCT00400153|616752432|FG002|Overall Study|AE due to other disease worsening|0|||
170655819|NCT00400153|616752430|FG000|Overall Study|AE due to other condition|3|||
170816523|NCT03060525|617335510|FG002|Overall Study|unable to meet time commitment required of study|3|||
170916912|NCT03504397|617697779|FG000|Overall Study|Adverse Event|40|||
170612803|NCT00445770|616587416|FG000|Overall Study|Lack of Efficacy|38|||
170612804|NCT00445770|616587417|FG001|Overall Study|Lack of Efficacy|13|||
170612805|NCT00445770|616587418|FG002|Overall Study|Lack of Efficacy|6|||
170612806|NCT00445770|616587416|FG000|Overall Study|Lost to Follow-up|0|||
170612807|NCT00445770|616587417|FG001|Overall Study|Lost to Follow-up|2|||
170655820|NCT00400153|616752431|FG001|Overall Study|AE due to other condition|14|||
170655821|NCT00400153|616752432|FG002|Overall Study|AE due to other condition|15|||
170655822|NCT00400153|616752430|FG000|Overall Study|Protocol Violation|7|||
170655823|NCT00400153|616752431|FG001|Overall Study|Protocol Violation|4|||
170655824|NCT00400153|616752432|FG002|Overall Study|Protocol Violation|9|||
170655825|NCT00400153|616752430|FG000|Overall Study|Lost to Follow-up|2|||
170655826|NCT00400153|616752431|FG001|Overall Study|Lost to Follow-up|1|||
170655827|NCT00400153|616752432|FG002|Overall Study|Lost to Follow-up|4|||
170655828|NCT00400153|616752430|FG000|Overall Study|Withdrawal by Subject|12|||
170655829|NCT00400153|616752431|FG001|Overall Study|Withdrawal by Subject|11|||
170655830|NCT00400153|616752432|FG002|Overall Study|Withdrawal by Subject|10|||
170655831|NCT00400153|616752430|FG000|Overall Study|Other reasons - not mentioned above|8|||
170655832|NCT00400153|616752431|FG001|Overall Study|Other reasons - not mentioned above|5|||
170655833|NCT00400153|616752432|FG002|Overall Study|Other reasons - not mentioned above|3|||
170655834|NCT00772070|616752433|FG000|Overall Study|Lost to Follow-up|0|||
170655835|NCT00772070|616752434|FG001|Overall Study|Lost to Follow-up|8|||
170655836|NCT00772070|616752433|FG000|Overall Study|Withdrawal by Subject|0|||
170655837|NCT00772070|616752434|FG001|Overall Study|Withdrawal by Subject|2|||
170655838|NCT00772070|616752433|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
170655839|NCT00772070|616752434|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
170655840|NCT00096954|616753418|FG000|Overall Study|Adverse Event|3|||
170655841|NCT00096954|616753419|FG001|Overall Study|Adverse Event|1|||
170655842|NCT00096954|616753418|FG000|Overall Study|Withdrawal by Subject|9|||
170655843|NCT00096954|616753419|FG001|Overall Study|Withdrawal by Subject|8|||
170655844|NCT00096954|616753418|FG000|Overall Study|Physician Decision|1|||
170655845|NCT00096954|616753419|FG001|Overall Study|Physician Decision|1|||
170655846|NCT00096954|616753418|FG000|Overall Study|Sponsors Decision|1|||
170655847|NCT00096954|616753419|FG001|Overall Study|Sponsors Decision|1|||
170655848|NCT00096954|616753418|FG000|Overall Study|Pregnancy|1|||
170655849|NCT00096954|616753419|FG001|Overall Study|Pregnancy|1|||
170655850|NCT00096954|616753418|FG000|Overall Study|Initiation of immunotherapy|1|||
170655851|NCT00096954|616753419|FG001|Overall Study|Initiation of immunotherapy|0|||
170655852|NCT00096954|616753418|FG000|Overall Study|Non-compliance|0|||
170655853|NCT00096954|616753419|FG001|Overall Study|Non-compliance|3|||
170655854|NCT00096954|616753418|FG000|Overall Study|Lost to Follow-up|8|||
170655855|NCT00096954|616753419|FG001|Overall Study|Lost to Follow-up|5|||
170655856|NCT00814879|616753420|FG000|By Week 24|Cancer Diagnosis|1|||
170655857|NCT00814879|616753421|FG001|By Week 24|Cancer Diagnosis|0|||
170655858|NCT00814879|616753420|FG000|By Week 24|Incarceration|0|||
170655859|NCT00814879|616753421|FG001|By Week 24|Incarceration|1|||
170655860|NCT00814879|616753420|FG000|By Week 48|Lost to Follow-up|2|||
170655861|NCT00814879|616753421|FG001|By Week 48|Lost to Follow-up|2|||
170655862|NCT00814879|616753420|FG000|By Week 48|Death|0|||
170655863|NCT00814879|616753421|FG001|By Week 48|Death|1|||
170655864|NCT03581786|616753422|FG000|Overall Study|Death|67|||
170655865|NCT03581786|616753423|FG001|Overall Study|Death|47|||
170655866|NCT03581786|616753422|FG000|Overall Study|Withdrawal by Subject|2|||
170655867|NCT03581786|616753423|FG001|Overall Study|Withdrawal by Subject|5|||
170655868|NCT03581786|616753422|FG000|Overall Study|Lost to Follow-up|7|||
170655869|NCT03581786|616753423|FG001|Overall Study|Lost to Follow-up|4|||
170655870|NCT03581786|616753422|FG000|Overall Study|reason other than specified above|0|||
170655871|NCT03581786|616753423|FG001|Overall Study|reason other than specified above|1|||
170655872|NCT03954041|616753426|FG000|Overall Study|Lost to Follow-up|3|||
170655873|NCT03954041|616753427|FG001|Overall Study|Lost to Follow-up|3|||
170655874|NCT03954041|616753428|FG002|Overall Study|Lost to Follow-up|6|||
170655875|NCT03954041|616753426|FG000|Overall Study|Death|4|||
170655876|NCT03954041|616753427|FG001|Overall Study|Death|0|||
170655877|NCT03954041|616753428|FG002|Overall Study|Death|1|||
170655878|NCT03954041|616753426|FG000|Overall Study|Death by neurologic criteria|0|||
170916913|NCT03504397|617697780|FG001|Overall Study|Adverse Event|14|||
170655879|NCT03954041|616753427|FG001|Overall Study|Death by neurologic criteria|0|||
170655880|NCT03954041|616753428|FG002|Overall Study|Death by neurologic criteria|1|||
170655881|NCT03954041|616753426|FG000|Overall Study|Reason not specified|7|||
170655882|NCT03954041|616753427|FG001|Overall Study|Reason not specified|4|||
170655883|NCT03954041|616753428|FG002|Overall Study|Reason not specified|2|||
170655884|NCT03954041|616753426|FG000|Overall Study|Withdrew prior to dosing|4|||
170655885|NCT03954041|616753427|FG001|Overall Study|Withdrew prior to dosing|2|||
170655886|NCT03954041|616753428|FG002|Overall Study|Withdrew prior to dosing|0|||
170655887|NCT01041495|616753429|FG000|Overall Study|Withdrawal by Subject|2|||
170655888|NCT01041495|616753430|FG001|Overall Study|Withdrawal by Subject|5|||
170655889|NCT01041495|616753429|FG000|Overall Study|Adverse Event|2|||
170655890|NCT01041495|616753430|FG001|Overall Study|Adverse Event|1|||
170655891|NCT01041495|616753429|FG000|Overall Study|Lost to Follow-up|0|||
170655892|NCT01041495|616753430|FG001|Overall Study|Lost to Follow-up|1|||
170655893|NCT04104438|616753431|FG000|Overall Study|Death|2|||
170655894|NCT04104438|616753432|FG001|Overall Study|Death|1|||
170655895|NCT04104438|616753433|FG002|Overall Study|Death|2|||
170655896|NCT04104438|616753431|FG000|Overall Study|Adverse Event|0|||
170655897|NCT04104438|616753432|FG001|Overall Study|Adverse Event|3|||
170655898|NCT04104438|616753433|FG002|Overall Study|Adverse Event|0|||
170655899|NCT04104438|616753431|FG000|Overall Study|Withdrawal by Subject|0|||
170655900|NCT04104438|616753432|FG001|Overall Study|Withdrawal by Subject|1|||
170655901|NCT04104438|616753433|FG002|Overall Study|Withdrawal by Subject|0|||
170655902|NCT04104438|616753431|FG000|Overall Study|Disenrolled due to noncompliance|0|||
170655903|NCT04104438|616753432|FG001|Overall Study|Disenrolled due to noncompliance|1|||
170816524|NCT03060525|617335511|FG003|Overall Study|unable to meet time commitment required of study|1|||
170612808|NCT00445770|616587418|FG002|Overall Study|Lost to Follow-up|0|||
170612809|NCT00445770|616587416|FG000|Overall Study|Other|6|||
170612810|NCT00445770|616587417|FG001|Overall Study|Other|5|||
170612811|NCT00445770|616587418|FG002|Overall Study|Other|6|||
170612812|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Adverse Event|33|||
170612813|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
170612814|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
170612815|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
170612816|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Physician Decision|6|||
170612817|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
170612818|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
170612819|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
170612820|NCT00965419|616587419|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
170612821|NCT00965419|616587419|FG000|Follow-up Phase|Adverse Event|9|||
170612822|NCT00965419|616587419|FG000|Follow-up Phase|Protocol Violation|4|||
170612823|NCT00965419|616587419|FG000|Follow-up Phase|Withdrawal by Subject|8|||
170612824|NCT00965419|616587419|FG000|Follow-up Phase|Physician Decision|4|||
170612825|NCT00965419|616587419|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
170612826|NCT00965419|616587419|FG000|Follow-up Phase|Lack of Efficacy|28|||
170612827|NCT02476006|616587426|FG000|Overall Study|Death|4|||
170612828|NCT02476006|616587426|FG000|Overall Study|Lack of treatment efficacy|2|||
170612829|NCT02476006|616587426|FG000|Overall Study|Pregnancy|1|||
170612830|NCT02476006|616587426|FG000|Overall Study|Participant did not wish to continue|39|||
170612831|NCT02476006|616587426|FG000|Overall Study|Adverse Event|41|||
170612832|NCT02476006|616587426|FG000|Overall Study|Poor compliance to study protocol|3|||
170612833|NCT02476006|616587426|FG000|Overall Study|Sponsor decision|6|||
170612834|NCT02476006|616587426|FG000|Overall Study|Lost to Follow-up|5|||
170612835|NCT02476006|616587426|FG000|Overall Study|Physician Decision|5|||
170612836|NCT02476006|616587426|FG000|Overall Study|Study ended treatment not available|4|||
170612837|NCT02476006|616587426|FG000|Overall Study|Switched to commercial drug|4|||
170612838|NCT02476006|616587426|FG000|Overall Study|Excluded from study|1|||
170612839|NCT02476006|616587426|FG000|Overall Study|Protocol Violation|1|||
170612840|NCT02476006|616587426|FG000|Overall Study|Enrolled but not treated|4|||
170612841|NCT01101035|616588744|FG000|Overall Study|Adverse Event|191|||
170612842|NCT01101035|616588745|FG001|Overall Study|Adverse Event|172|||
170612843|NCT01101035|616588744|FG000|Overall Study|Major Protocol Deviation|52|||
170612844|NCT01101035|616588745|FG001|Overall Study|Major Protocol Deviation|46|||
170612845|NCT01101035|616588744|FG000|Overall Study|Lost to Follow-up|226|||
170612846|NCT01101035|616588745|FG001|Overall Study|Lost to Follow-up|223|||
170612847|NCT01101035|616588744|FG000|Overall Study|Voluntary Withdrawal|595|||
170612848|NCT01101035|616588745|FG001|Overall Study|Voluntary Withdrawal|587|||
170612849|NCT01101035|616588744|FG000|Overall Study|Reason not Specified|333|||
170612850|NCT01101035|616588745|FG001|Overall Study|Reason not Specified|363|||
170612851|NCT00713544|616588752|FG000|Overall Study|Adverse Event|5|||
170612852|NCT00713544|616588753|FG001|Overall Study|Adverse Event|3|||
170612853|NCT00713544|616588754|FG002|Overall Study|Adverse Event|7|||
170612854|NCT00713544|616588755|FG003|Overall Study|Adverse Event|7|||
170612855|NCT00713544|616588756|FG004|Overall Study|Adverse Event|3|||
170612856|NCT00713544|616588757|FG005|Overall Study|Adverse Event|5|||
170612857|NCT00713544|616588752|FG000|Overall Study|Withdrawal by Subject|2|||
170612858|NCT00713544|616588753|FG001|Overall Study|Withdrawal by Subject|0|||
170612859|NCT00713544|616588754|FG002|Overall Study|Withdrawal by Subject|3|||
170612860|NCT00713544|616588755|FG003|Overall Study|Withdrawal by Subject|2|||
170612861|NCT00713544|616588756|FG004|Overall Study|Withdrawal by Subject|3|||
170612862|NCT00713544|616588757|FG005|Overall Study|Withdrawal by Subject|1|||
170612863|NCT00713544|616588752|FG000|Overall Study|Protocol Violation|0|||
170612864|NCT00713544|616588753|FG001|Overall Study|Protocol Violation|0|||
170612865|NCT00713544|616588754|FG002|Overall Study|Protocol Violation|0|||
170655904|NCT04104438|616753433|FG002|Overall Study|Disenrolled due to noncompliance|0|||
170655905|NCT04104438|616753431|FG000|Overall Study|stopped due to possible operation|0|||
170612866|NCT00713544|616588755|FG003|Overall Study|Protocol Violation|0|||
170612867|NCT00713544|616588756|FG004|Overall Study|Protocol Violation|0|||
170612868|NCT00713544|616588757|FG005|Overall Study|Protocol Violation|1|||
170612869|NCT00713544|616588752|FG000|Overall Study|Physician Decision|0|||
170612870|NCT00713544|616588753|FG001|Overall Study|Physician Decision|0|||
170612871|NCT00713544|616588754|FG002|Overall Study|Physician Decision|0|||
170612872|NCT00713544|616588755|FG003|Overall Study|Physician Decision|0|||
170612873|NCT00713544|616588756|FG004|Overall Study|Physician Decision|0|||
170612874|NCT00713544|616588757|FG005|Overall Study|Physician Decision|2|||
170612875|NCT00713544|616588752|FG000|Overall Study|Lack of Efficacy|0|||
170612876|NCT00713544|616588753|FG001|Overall Study|Lack of Efficacy|1|||
170612877|NCT00713544|616588754|FG002|Overall Study|Lack of Efficacy|0|||
170612878|NCT00713544|616588755|FG003|Overall Study|Lack of Efficacy|1|||
170612879|NCT00713544|616588756|FG004|Overall Study|Lack of Efficacy|1|||
170655906|NCT04104438|616753432|FG001|Overall Study|stopped due to possible operation|1|||
170655907|NCT04104438|616753433|FG002|Overall Study|stopped due to possible operation|0|||
170655908|NCT04104438|616753431|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
170655909|NCT04104438|616753432|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
170655910|NCT04104438|616753433|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
170655911|NCT03584373|616753434|FG000|Overall Study|Lost to Follow-up|7|||
170655912|NCT03584373|616753435|FG001|Overall Study|Lost to Follow-up|8|||
170655913|NCT00662532|616753437|FG000|Overall Study|Adverse Event|0|||
170655914|NCT00662532|616753438|FG001|Overall Study|Adverse Event|1|||
170655915|NCT00662532|616753437|FG000|Overall Study|Lost to Follow-up|0|||
170655916|NCT00662532|616753438|FG001|Overall Study|Lost to Follow-up|1|||
170655917|NCT00366340|616753439|FG000|Infant Series|Protocol Violation|3|||
170655918|NCT00366340|616753440|FG001|Infant Series|Protocol Violation|4|||
170655919|NCT00366340|616753439|FG000|Infant Series|Withdrawal by Subject|3|||
170655920|NCT00366340|616753440|FG001|Infant Series|Withdrawal by Subject|3|||
170655921|NCT00366340|616753439|FG000|Infant Series|Adverse Event|0|||
170655922|NCT00366340|616753440|FG001|Infant Series|Adverse Event|2|||
170655923|NCT00366340|616753439|FG000|Infant Series|Lost to Follow-up|1|||
170655924|NCT00366340|616753440|FG001|Infant Series|Lost to Follow-up|1|||
170655925|NCT00366340|616753439|FG000|Infant Series|Failure to return|1|||
170655926|NCT00366340|616753440|FG001|Infant Series|Failure to return|0|||
170655927|NCT00366340|616753439|FG000|After the Infant Series|Parent/legal guardian request|1|||
170655928|NCT00366340|616753440|FG001|After the Infant Series|Parent/legal guardian request|1|||
170655929|NCT00366340|616753439|FG000|After the Infant Series|Failed to return|0|||
170655930|NCT00366340|616753440|FG001|After the Infant Series|Failed to return|1|||
170655931|NCT00366340|616753439|FG000|After the Infant Series|Protocol Violation|2|||
170655932|NCT00366340|616753440|FG001|After the Infant Series|Protocol Violation|2|||
170655933|NCT00366340|616753439|FG000|After the Infant Series|Adverse Event|0|||
170655934|NCT00366340|616753440|FG001|After the Infant Series|Adverse Event|1|||
170655935|NCT00366340|616753439|FG000|After the Infant Series|Lost to Follow-up|0|||
170655936|NCT00366340|616753440|FG001|After the Infant Series|Lost to Follow-up|1|||
170655937|NCT00366340|616753439|FG000|Toddler Dose|Failed to return|1|||
170655938|NCT00366340|616753440|FG001|Toddler Dose|Failed to return|0|||
170655939|NCT00366340|616753439|FG000|Toddler Dose|Parent/legal guardian request|0|||
170655940|NCT00366340|616753440|FG001|Toddler Dose|Parent/legal guardian request|1|||
170655941|NCT00442468|616753444|FG000|Overall Study|Adverse Event|4|||
170655942|NCT00442468|616753444|FG000|Overall Study|Withdrawal by Subject|91|||
170655943|NCT00442468|616753444|FG000|Overall Study|Did not complete all study procedures|88|||
170655944|NCT00521001|616753446|FG000|Overall Study|Ineligible|1|||
170655945|NCT00287079|616753447|FG000|Overall Study|Qualifying relapse|12|||
170655946|NCT00287079|616753448|FG001|Overall Study|Qualifying relapse|1|||
170655947|NCT00287079|616753447|FG000|Overall Study|Non-qualifying relapse|1|||
170655948|NCT00287079|616753448|FG001|Overall Study|Non-qualifying relapse|0|||
170655949|NCT00287079|616753447|FG000|Overall Study|Adverse Event|5|||
170655950|NCT00287079|616753448|FG001|Overall Study|Adverse Event|0|||
170655951|NCT00287079|616753447|FG000|Overall Study|Protocol Violation|1|||
170655952|NCT00287079|616753448|FG001|Overall Study|Protocol Violation|0|||
170655953|NCT00287079|616753447|FG000|Overall Study|Other|3|||
170655954|NCT00287079|616753448|FG001|Overall Study|Other|0|||
170655955|NCT00470184|616753449|FG000|Overall Study|Not Treated(became ineligible)|4|||
170655956|NCT00470184|616753449|FG000|Overall Study|Not treated (other)|1|||
170655957|NCT00470184|616753449|FG000|Overall Study|disease Progression|4|||
170655958|NCT00470184|616753449|FG000|Overall Study|Adverse Event|3|||
170655959|NCT00470184|616753449|FG000|Overall Study|Withdrawal by Subject|4|||
170655960|NCT00470184|616753449|FG000|Overall Study|other|5|||
170655961|NCT00470184|616753449|FG000|Overall Study|recurrence|1|||
170655962|NCT02011893|616753462|FG000|Enrollment to Randomization|Adverse Event|2|||
170655963|NCT02011893|616753463|FG001|Enrollment to Randomization|Adverse Event|0|||
170655964|NCT02011893|616753464|FG002|Enrollment to Randomization|Adverse Event|0|||
170655965|NCT02011893|616753462|FG000|Enrollment to Randomization|Physician Decision|10|||
170655966|NCT02011893|616753463|FG001|Enrollment to Randomization|Physician Decision|0|||
170655967|NCT02011893|616753464|FG002|Enrollment to Randomization|Physician Decision|0|||
170655968|NCT02011893|616753462|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
170655969|NCT02011893|616753463|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
170655970|NCT02011893|616753464|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
170655971|NCT02011893|616753462|FG000|Enrollment to Randomization|Screening Failure|29|||
170655972|NCT02011893|616753463|FG001|Enrollment to Randomization|Screening Failure|0|||
170655973|NCT02011893|616753464|FG002|Enrollment to Randomization|Screening Failure|0|||
170655974|NCT02011893|616753462|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
170655975|NCT02011893|616753463|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
170655976|NCT02011893|616753464|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
170655977|NCT02011893|616753462|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
170655978|NCT02011893|616753463|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
170655979|NCT02011893|616753464|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
170655980|NCT02011893|616753462|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
170655981|NCT02011893|616753463|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
170655982|NCT02011893|616753464|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
170655983|NCT02011893|616753462|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
170655984|NCT02011893|616753463|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
170655985|NCT02011893|616753464|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
170655986|NCT02011893|616753462|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
170655987|NCT02011893|616753463|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
170655988|NCT02011893|616753464|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
170655989|NCT04543409|616753465|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170655990|NCT04543409|616753466|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170655991|NCT04543409|616753465|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
170655992|NCT04543409|616753466|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
170655993|NCT04543409|616753465|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
170655994|NCT04543409|616753466|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
170655995|NCT04543409|616753465|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
170655996|NCT04543409|616753466|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
170655997|NCT04543409|616753465|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
170655998|NCT04543409|616753466|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
170655999|NCT04543409|616753465|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
170656000|NCT04543409|616753466|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
170656001|NCT04543409|616753465|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
170656002|NCT04543409|616753466|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
170656003|NCT04543409|616753465|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
170656004|NCT04543409|616753466|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
170656005|NCT04543409|616753465|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
170656006|NCT04543409|616753466|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
170656007|NCT04543409|616753465|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
170656008|NCT04543409|616753466|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
170656009|NCT04543409|616753465|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
170656010|NCT04543409|616753466|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
170656011|NCT01052844|616753467|FG000|Overall Study|Adverse Event|0|||
170656012|NCT01052844|616753468|FG001|Overall Study|Adverse Event|1|||
170656013|NCT00991952|616753469|FG000|Overall Study|Adverse Event|0|||
170656014|NCT00991952|616753470|FG001|Overall Study|Adverse Event|1|||
170656015|NCT02093026|616753471|FG000|Overall Study|Adverse Event|26|||
170656016|NCT02093026|616753471|FG000|Overall Study|Death|10|||
170656017|NCT02093026|616753471|FG000|Overall Study|Other|157|||
170656018|NCT03452527|616753475|FG000|Overall Study|Withdrawal by Subject|1|||
170656019|NCT03452527|616753476|FG001|Overall Study|Withdrawal by Subject|1|||
170656020|NCT03452527|616753475|FG000|Overall Study|Study Terminated|2|||
170656021|NCT03452527|616753476|FG001|Overall Study|Study Terminated|3|||
170656022|NCT01001299|616753480|FG000|Overall Study|Insufficient Therapeutic Response|20|||
170656023|NCT01001299|616753480|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
170656024|NCT01001299|616753480|FG000|Overall Study|Death|1|||
170656025|NCT01001299|616753480|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
170656026|NCT01001299|616753480|FG000|Overall Study|Withdrew Consent|1|||
170656027|NCT00450112|616753481|FG000|Overall Study|Other Treatment Required|5|||
170656028|NCT00450112|616753482|FG001|Overall Study|Other Treatment Required|1|||
170656029|NCT00450112|616753481|FG000|Overall Study|Withdrawal by Subject|4|||
170656030|NCT00450112|616753482|FG001|Overall Study|Withdrawal by Subject|1|||
170656031|NCT00450112|616753481|FG000|Overall Study|Lost to Follow-up|2|||
170656032|NCT00450112|616753482|FG001|Overall Study|Lost to Follow-up|1|||
170656033|NCT00450112|616753481|FG000|Overall Study|Others|2|||
170656034|NCT00450112|616753482|FG001|Overall Study|Others|3|||
170656035|NCT01255787|616753483|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
170656036|NCT01255787|616753484|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
170656037|NCT01255787|616753485|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
170816525|NCT03060525|617335508|FG000|Overall Study|no longer interested in doing intervention|0|||
170656038|NCT01255787|616753486|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
170656039|NCT01255787|616753483|FG000|Overall Study|Major Protocol Deviation|1|||
170656040|NCT01255787|616753484|FG001|Overall Study|Major Protocol Deviation|1|||
170816526|NCT03060525|617335509|FG001|Overall Study|no longer interested in doing intervention|0|||
170816527|NCT03060525|617335510|FG002|Overall Study|no longer interested in doing intervention|0|||
170656041|NCT01255787|616753485|FG002|Overall Study|Major Protocol Deviation|0|||
170816528|NCT03060525|617335511|FG003|Overall Study|no longer interested in doing intervention|1|||
170816529|NCT04447287|617335512|FG000|Period 1: Run-in Period|Adverse Event|3|||
170612880|NCT00713544|616588757|FG005|Overall Study|Lack of Efficacy|0|||
170612881|NCT00713544|616588752|FG000|Overall Study|Lost to Follow-up|0|||
170612882|NCT00713544|616588753|FG001|Overall Study|Lost to Follow-up|0|||
170612883|NCT00713544|616588754|FG002|Overall Study|Lost to Follow-up|1|||
170612884|NCT00713544|616588755|FG003|Overall Study|Lost to Follow-up|0|||
170612885|NCT00713544|616588756|FG004|Overall Study|Lost to Follow-up|0|||
170612886|NCT00713544|616588757|FG005|Overall Study|Lost to Follow-up|0|||
170612887|NCT00713544|616588752|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
170612888|NCT00713544|616588753|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
170612889|NCT00713544|616588754|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
170612890|NCT00713544|616588755|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
170612891|NCT00713544|616588756|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
170612892|NCT00713544|616588757|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
170612893|NCT00713544|616588752|FG000|Overall Study|Incorrect enrollment|0|||
170612894|NCT00713544|616588753|FG001|Overall Study|Incorrect enrollment|1|||
170612895|NCT00713544|616588754|FG002|Overall Study|Incorrect enrollment|0|||
170612896|NCT00713544|616588755|FG003|Overall Study|Incorrect enrollment|0|||
170612897|NCT00713544|616588756|FG004|Overall Study|Incorrect enrollment|0|||
170612898|NCT00713544|616588757|FG005|Overall Study|Incorrect enrollment|0|||
170612899|NCT00713544|616588752|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
170612900|NCT00713544|616588753|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
170612901|NCT00713544|616588754|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
170612902|NCT00713544|616588755|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
170612903|NCT00713544|616588756|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
170612904|NCT00713544|616588757|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
170612905|NCT00786799|616588758|FG000|Overall Study|Lost to Follow-up|1|||
170612906|NCT00786799|616588759|FG001|Overall Study|Lost to Follow-up|1|||
170612907|NCT02544503|616588760|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
170612908|NCT02544503|616588761|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
170612909|NCT02544503|616588760|FG000|Overall Study|Lost to Follow-up|9|||
170612910|NCT02544503|616588761|FG001|Overall Study|Lost to Follow-up|0|||
170612911|NCT02544503|616588760|FG000|Overall Study|Withdrawal by Subject|1|||
170612912|NCT02544503|616588761|FG001|Overall Study|Withdrawal by Subject|0|||
170612913|NCT01641601|616588762|FG000|Overall Study|Study discontinued.|3|||
170612914|NCT01641601|616588763|FG001|Overall Study|Study discontinued.|5|||
170612915|NCT02178995|616588764|FG000|Double Blind|Adverse Event|0|||
170612916|NCT02178995|616588765|FG001|Double Blind|Adverse Event|0|||
170612917|NCT02178995|616588766|FG002|Double Blind|Adverse Event|0|||
170612918|NCT02178995|616588767|FG003|Double Blind|Adverse Event|0|||
170612919|NCT02178995|616588768|FG004|Double Blind|Adverse Event|0|||
170612920|NCT02178995|616588769|FG005|Double Blind|Adverse Event|1|||
170612921|NCT02178995|616588770|FG006|Double Blind|Adverse Event|0|||
170612922|NCT02178995|616588771|FG007|Double Blind|Adverse Event|1|||
170612923|NCT02178995|616588772|FG008|Double Blind|Adverse Event|1|||
170612924|NCT02178995|616588764|FG000|Double Blind|Lost to Follow-up|0|||
170612925|NCT02178995|616588765|FG001|Double Blind|Lost to Follow-up|1|||
170612926|NCT02178995|616588766|FG002|Double Blind|Lost to Follow-up|0|||
170612927|NCT02178995|616588767|FG003|Double Blind|Lost to Follow-up|0|||
170612928|NCT02178995|616588768|FG004|Double Blind|Lost to Follow-up|0|||
170612929|NCT02178995|616588769|FG005|Double Blind|Lost to Follow-up|0|||
170612930|NCT02178995|616588770|FG006|Double Blind|Lost to Follow-up|0|||
170612931|NCT02178995|616588771|FG007|Double Blind|Lost to Follow-up|1|||
170612932|NCT02178995|616588772|FG008|Double Blind|Lost to Follow-up|0|||
170612933|NCT02178995|616588764|FG000|Open Label|Adverse Event|2|||
170612934|NCT02178995|616588765|FG001|Open Label|Adverse Event|0|||
170612935|NCT02178995|616588766|FG002|Open Label|Adverse Event|0|||
170612936|NCT02178995|616588767|FG003|Open Label|Adverse Event|0|||
170612937|NCT02178995|616588768|FG004|Open Label|Adverse Event|0|||
170612938|NCT02178995|616588769|FG005|Open Label|Adverse Event|0|||
170612939|NCT02178995|616588770|FG006|Open Label|Adverse Event|0|||
170612940|NCT02178995|616588771|FG007|Open Label|Adverse Event|0|||
170612941|NCT02178995|616588772|FG008|Open Label|Adverse Event|0|||
170612942|NCT05292131|616588781|FG000|Overall Study|Lost to Follow-up|1|||
170612943|NCT05292131|616588782|FG001|Overall Study|Lost to Follow-up|1|||
170612944|NCT05292131|616588781|FG000|Overall Study|Withdrawal by Subject|0|||
170612945|NCT05292131|616588782|FG001|Overall Study|Withdrawal by Subject|1|||
170612946|NCT02557542|616588784|FG000|Overall Study|Poor recruitment|3|||
170612947|NCT02557542|616588785|FG001|Overall Study|Poor recruitment|0|||
170612948|NCT04390880|616588786|FG000|Overall Study|Withdrawal by Subject|1|||
170612949|NCT01695135|616588789|FG000|Double-blind Treatment Phase|Progressive disease|50|||
170612950|NCT01695135|616588790|FG001|Double-blind Treatment Phase|Progressive disease|110|||
170612951|NCT01695135|616588791|FG002|Double-blind Treatment Phase|Progressive disease|0|||
170612952|NCT01695135|616588792|FG003|Double-blind Treatment Phase|Progressive disease|0|||
170612953|NCT01695135|616588789|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
170612954|NCT01695135|616588790|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
170916914|NCT03504397|617697779|FG000|Overall Study|miscellaneous|17|||
170612955|NCT01695135|616588791|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170656042|NCT01255787|616753486|FG003|Overall Study|Major Protocol Deviation|4|||
170656043|NCT01255787|616753483|FG000|Overall Study|Lost to Follow-up|1|||
170656044|NCT01255787|616753484|FG001|Overall Study|Lost to Follow-up|2|||
170656045|NCT01255787|616753485|FG002|Overall Study|Lost to Follow-up|4|||
170656046|NCT01255787|616753486|FG003|Overall Study|Lost to Follow-up|2|||
170656047|NCT01255787|616753483|FG000|Overall Study|Withdrawal of Consent|3|||
170656048|NCT01255787|616753484|FG001|Overall Study|Withdrawal of Consent|9|||
170656049|NCT01255787|616753485|FG002|Overall Study|Withdrawal of Consent|3|||
170656050|NCT01255787|616753486|FG003|Overall Study|Withdrawal of Consent|4|||
170656051|NCT01255787|616753483|FG000|Overall Study|Pregnancy|0|||
170656052|NCT01255787|616753484|FG001|Overall Study|Pregnancy|0|||
170656053|NCT01255787|616753485|FG002|Overall Study|Pregnancy|0|||
170656054|NCT01255787|616753486|FG003|Overall Study|Pregnancy|1|||
170656055|NCT01255787|616753483|FG000|Overall Study|Lack of Efficacy|2|||
170656056|NCT01255787|616753484|FG001|Overall Study|Lack of Efficacy|2|||
170656057|NCT01255787|616753485|FG002|Overall Study|Lack of Efficacy|2|||
170656058|NCT01255787|616753486|FG003|Overall Study|Lack of Efficacy|2|||
170656059|NCT01255787|616753483|FG000|Overall Study|Noncompliance with Study Drug|3|||
170656060|NCT01255787|616753484|FG001|Overall Study|Noncompliance with Study Drug|1|||
170656061|NCT01255787|616753485|FG002|Overall Study|Noncompliance with Study Drug|0|||
170656062|NCT01255787|616753486|FG003|Overall Study|Noncompliance with Study Drug|0|||
170656063|NCT00586326|616753487|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
170656064|NCT00586326|616753487|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
170656065|NCT00586326|616753487|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
170656066|NCT00586326|616753487|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
170656067|NCT00586326|616753487|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
170656068|NCT00586326|616753487|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
170656069|NCT00586326|616753487|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
170656070|NCT00586326|616753487|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
170656071|NCT00586326|616753487|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
170656072|NCT00586326|616753487|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
170656073|NCT00586326|616753487|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
170656074|NCT00586326|616753487|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
170656075|NCT00586326|616753487|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
170656076|NCT00586326|616753487|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
170656077|NCT00586326|616753487|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
170656078|NCT00586326|616753487|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
170656079|NCT00586326|616753487|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
170656080|NCT00725842|616753492|FG000|Overall Study|Lost to Follow-up|19|||
170656081|NCT00725842|616753492|FG000|Overall Study|Death|1|||
170656082|NCT00725842|616753492|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
170656083|NCT00725842|616753492|FG000|Overall Study|Consent date prior to study start date|5|||
170656084|NCT00725842|616753492|FG000|Overall Study|Inclusion criterion not met|1|||
170656085|NCT00725842|616753492|FG000|Overall Study|No Visit 1 data|1|||
170656086|NCT02325791|616753497|FG000|Overall Study|Adverse Event|0|||
170656087|NCT02325791|616753498|FG001|Overall Study|Adverse Event|1|||
170656088|NCT02325791|616753499|FG002|Overall Study|Adverse Event|1|||
170656089|NCT02325791|616753500|FG003|Overall Study|Adverse Event|0|||
170656090|NCT02325791|616753497|FG000|Overall Study|Death|0|||
170656091|NCT02325791|616753498|FG001|Overall Study|Death|3|||
170656092|NCT02325791|616753499|FG002|Overall Study|Death|0|||
170656093|NCT02325791|616753500|FG003|Overall Study|Death|1|||
170656094|NCT02325791|616753497|FG000|Overall Study|Lost to Follow-up|0|||
170656095|NCT02325791|616753498|FG001|Overall Study|Lost to Follow-up|15|||
170656096|NCT02325791|616753499|FG002|Overall Study|Lost to Follow-up|14|||
170656097|NCT02325791|616753500|FG003|Overall Study|Lost to Follow-up|9|||
170656098|NCT02325791|616753497|FG000|Overall Study|Physician Decision|0|||
170656099|NCT02325791|616753498|FG001|Overall Study|Physician Decision|1|||
170656100|NCT02325791|616753499|FG002|Overall Study|Physician Decision|1|||
170656101|NCT02325791|616753500|FG003|Overall Study|Physician Decision|0|||
170656102|NCT02325791|616753497|FG000|Overall Study|Protocol Violation|0|||
170656103|NCT02325791|616753498|FG001|Overall Study|Protocol Violation|0|||
170656104|NCT02325791|616753499|FG002|Overall Study|Protocol Violation|1|||
170656105|NCT02325791|616753500|FG003|Overall Study|Protocol Violation|0|||
170656106|NCT02325791|616753497|FG000|Overall Study|Withdrawal by Subject|0|||
170656107|NCT02325791|616753498|FG001|Overall Study|Withdrawal by Subject|5|||
170656108|NCT02325791|616753499|FG002|Overall Study|Withdrawal by Subject|8|||
170656109|NCT02325791|616753500|FG003|Overall Study|Withdrawal by Subject|16|||
170656110|NCT02009384|616753504|FG000|Overall Study|Death|2|||
170656111|NCT01423604|616753505|FG000|Safety Run-In|Adverse Event|3|||
170656112|NCT01423604|616753506|FG001|Safety Run-In|Adverse Event|0|||
170656113|NCT01423604|616753505|FG000|Safety Run-In|Death|1|||
170656114|NCT01423604|616753506|FG001|Safety Run-In|Death|0|||
170656115|NCT01423604|616753505|FG000|Safety Run-In|Physician Decision|1|||
170656116|NCT01423604|616753506|FG001|Safety Run-In|Physician Decision|0|||
170656117|NCT01423604|616753505|FG000|Safety Run-In|Disease progression|3|||
170656118|NCT01423604|616753506|FG001|Safety Run-In|Disease progression|0|||
170656119|NCT01423604|616753505|FG000|Safety Run-In|Patient decision|1|||
170656120|NCT01423604|616753506|FG001|Safety Run-In|Patient decision|0|||
170656121|NCT01423604|616753505|FG000|Randomized|Adverse Event|4|||
170656122|NCT01423604|616753506|FG001|Randomized|Adverse Event|10|||
170656123|NCT01423604|616753505|FG000|Randomized|Death|1|||
170656124|NCT01423604|616753506|FG001|Randomized|Death|0|||
170656125|NCT01423604|616753505|FG000|Randomized|Physician Decision|16|||
170656126|NCT01423604|616753506|FG001|Randomized|Physician Decision|13|||
170656127|NCT01423604|616753505|FG000|Randomized|Other - unspecified|37|||
170656128|NCT01423604|616753506|FG001|Randomized|Other - unspecified|31|||
170656129|NCT01423604|616753505|FG000|Randomized|Patient decision|5|||
170656130|NCT01423604|616753506|FG001|Randomized|Patient decision|9|||
170656131|NCT06374394|616753511|FG000|Overall Study|Adverse Event|0|||
170656132|NCT06374394|616753512|FG001|Overall Study|Adverse Event|2|||
170656133|NCT06374394|616753511|FG000|Overall Study|Lost to Follow-up|6|||
170656134|NCT06374394|616753512|FG001|Overall Study|Lost to Follow-up|9|||
170656135|NCT06374394|616753511|FG000|Overall Study|Withdrawal by Subject|1|||
170656136|NCT06374394|616753512|FG001|Overall Study|Withdrawal by Subject|7|||
170656137|NCT06374394|616753511|FG000|Overall Study|Other|1|||
170656138|NCT06374394|616753512|FG001|Overall Study|Other|0|||
170656139|NCT00356122|616753513|FG000|TREATMENT|Lack of Efficacy|26|||
170656140|NCT00356122|616753513|FG000|TREATMENT|Adverse Event|10|||
170656141|NCT00356122|616753513|FG000|TREATMENT|Subject's request|4|||
170656142|NCT00356122|616753513|FG000|TREATMENT|Other|4|||
170656143|NCT00356122|616753513|FG000|TREATMENT|Did not receive study medication|1|||
170656144|NCT00356122|616753513|FG000|FOLLOW-UP|Death|37|||
170612956|NCT01695135|616588792|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170612957|NCT01695135|616588789|FG000|Double-blind Treatment Phase|Adverse Event|7|||
170612958|NCT01695135|616588790|FG001|Double-blind Treatment Phase|Adverse Event|7|||
170612959|NCT01695135|616588791|FG002|Double-blind Treatment Phase|Adverse Event|0|||
170612960|NCT01695135|616588792|FG003|Double-blind Treatment Phase|Adverse Event|0|||
170612961|NCT01695135|616588789|FG000|Double-blind Treatment Phase|Other|1|||
170612962|NCT01695135|616588790|FG001|Double-blind Treatment Phase|Other|3|||
170612963|NCT01695135|616588791|FG002|Double-blind Treatment Phase|Other|0|||
170612964|NCT01695135|616588792|FG003|Double-blind Treatment Phase|Other|0|||
170612965|NCT01695135|616588789|FG000|Double-blind Treatment Phase|Physician Decision|6|||
170612966|NCT01695135|616588790|FG001|Double-blind Treatment Phase|Physician Decision|3|||
170612967|NCT01695135|616588791|FG002|Double-blind Treatment Phase|Physician Decision|0|||
170612968|NCT01695135|616588792|FG003|Double-blind Treatment Phase|Physician Decision|0|||
170612969|NCT01695135|616588789|FG000|Double-blind Treatment Phase|Death|1|||
170612970|NCT01695135|616588790|FG001|Double-blind Treatment Phase|Death|1|||
170612971|NCT01695135|616588791|FG002|Double-blind Treatment Phase|Death|0|||
170612972|NCT01695135|616588792|FG003|Double-blind Treatment Phase|Death|0|||
170612973|NCT01695135|616588789|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
170612974|NCT01695135|616588790|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
170612975|NCT01695135|616588791|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
170612976|NCT01695135|616588792|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
170612977|NCT01695135|616588789|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
170612978|NCT01695135|616588790|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
170612979|NCT01695135|616588791|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
170612980|NCT01695135|616588792|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
170612981|NCT01695135|616588789|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
170612982|NCT01695135|616588790|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
170612983|NCT01695135|616588791|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
170612984|NCT01695135|616588792|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
170612985|NCT01695135|616588789|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
170612986|NCT01695135|616588790|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
170612987|NCT01695135|616588791|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
170612988|NCT01695135|616588792|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
170612989|NCT01695135|616588789|FG000|Open Label Extension Treatment Phase|Other|0|||
170612990|NCT01695135|616588790|FG001|Open Label Extension Treatment Phase|Other|0|||
170612991|NCT01695135|616588791|FG002|Open Label Extension Treatment Phase|Other|4|||
170612992|NCT01695135|616588792|FG003|Open Label Extension Treatment Phase|Other|7|||
170612993|NCT01695135|616588789|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
170612994|NCT01695135|616588790|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
170612995|NCT01695135|616588791|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
170612996|NCT01695135|616588792|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
170612997|NCT01695135|616588789|FG000|Open Label Extension Treatment Phase|Death|0|||
170612998|NCT01695135|616588790|FG001|Open Label Extension Treatment Phase|Death|0|||
170656145|NCT00356122|616753513|FG000|FOLLOW-UP|Lost to Follow-up|2|||
170656146|NCT00356122|616753513|FG000|FOLLOW-UP|Other|2|||
170656147|NCT02483429|616753514|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
170656148|NCT02483429|616753515|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
170656149|NCT06785857|616753516|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
170656150|NCT06785857|616753517|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
170656151|NCT01683019|616754658|FG000|Overall Study|Withdrawal by Subject|2|||
170656152|NCT01683019|616754659|FG001|Overall Study|Withdrawal by Subject|1|||
170656153|NCT01683019|616754660|FG002|Overall Study|Withdrawal by Subject|4|||
170656154|NCT03437512|616754661|FG000|Randomized|Withdrawal by Subject|0|||
170656155|NCT03437512|616754662|FG001|Randomized|Withdrawal by Subject|2|||
170656156|NCT03437512|616754661|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
170656157|NCT03437512|616754662|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
170656158|NCT01897714|616754663|FG000|Phase I (Dose Escalation)|Disease progression|3|||
170656159|NCT01897714|616754664|FG001|Phase I (Dose Escalation)|Disease progression|5|||
170656160|NCT01897714|616754665|FG002|Phase I (Dose Escalation)|Disease progression|1|||
170656161|NCT01897714|616754666|FG003|Phase I (Dose Escalation)|Disease progression|3|||
170656162|NCT01897714|616754667|FG004|Phase I (Dose Escalation)|Disease progression|0|||
170656163|NCT01897714|616754668|FG005|Phase I (Dose Escalation)|Disease progression|0|||
170656164|NCT01897714|616754663|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
170656165|NCT01897714|616754664|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
170656166|NCT01897714|616754665|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
170656167|NCT01897714|616754666|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
170656168|NCT01897714|616754667|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
170656169|NCT01897714|616754668|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
170656170|NCT01897714|616754663|FG000|Phase I (Dose Escalation)|Other|0|||
170656171|NCT01897714|616754664|FG001|Phase I (Dose Escalation)|Other|1|||
170656172|NCT01897714|616754665|FG002|Phase I (Dose Escalation)|Other|0|||
170656173|NCT01897714|616754666|FG003|Phase I (Dose Escalation)|Other|0|||
170656174|NCT01897714|616754667|FG004|Phase I (Dose Escalation)|Other|0|||
170656175|NCT01897714|616754668|FG005|Phase I (Dose Escalation)|Other|0|||
170656176|NCT01897714|616754663|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
170656177|NCT01897714|616754664|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
170656178|NCT01897714|616754665|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
170656179|NCT01897714|616754666|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
170656180|NCT01897714|616754667|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
170656181|NCT01897714|616754668|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
170656182|NCT01897714|616754663|FG000|Phase II (MTD)|Lost to Follow-up|0|||
170656183|NCT01897714|616754664|FG001|Phase II (MTD)|Lost to Follow-up|0|||
170656184|NCT01897714|616754665|FG002|Phase II (MTD)|Lost to Follow-up|0|||
170656185|NCT01897714|616754666|FG003|Phase II (MTD)|Lost to Follow-up|0|||
170656186|NCT01897714|616754667|FG004|Phase II (MTD)|Lost to Follow-up|1|||
170656187|NCT01897714|616754668|FG005|Phase II (MTD)|Lost to Follow-up|0|||
170656188|NCT01897714|616754663|FG000|Phase II (MTD)|Death|0|||
170656189|NCT01897714|616754664|FG001|Phase II (MTD)|Death|0|||
170656190|NCT01897714|616754665|FG002|Phase II (MTD)|Death|0|||
170656191|NCT01897714|616754666|FG003|Phase II (MTD)|Death|0|||
170656192|NCT01897714|616754667|FG004|Phase II (MTD)|Death|25|||
170656193|NCT01897714|616754668|FG005|Phase II (MTD)|Death|10|||
170656194|NCT01897714|616754663|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
170656195|NCT01897714|616754664|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
170656196|NCT01897714|616754665|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
170656197|NCT01897714|616754666|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
170656198|NCT01897714|616754667|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
170656199|NCT01897714|616754668|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
170656200|NCT01897714|616754663|FG000|Phase II (MTD)|Other|0|||
170656201|NCT01897714|616754664|FG001|Phase II (MTD)|Other|0|||
170656202|NCT01897714|616754665|FG002|Phase II (MTD)|Other|0|||
170656203|NCT01897714|616754666|FG003|Phase II (MTD)|Other|0|||
170656204|NCT01897714|616754667|FG004|Phase II (MTD)|Other|3|||
170656205|NCT01897714|616754668|FG005|Phase II (MTD)|Other|0|||
170816530|NCT04447287|617335513|FG001|Period 1: Run-in Period|Adverse Event|0|||
170816531|NCT04447287|617335514|FG002|Period 1: Run-in Period|Adverse Event|0|||
170816532|NCT04447287|617335512|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
170816533|NCT04447287|617335513|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
170816534|NCT04447287|617335514|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
170816535|NCT04447287|617335512|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
170816536|NCT04447287|617335513|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
170656206|NCT00301821|616754670|FG000|Overall Study|Ineligible|25|||
170656207|NCT00301821|616754670|FG000|Overall Study|Cancel|1|||
170656208|NCT02294773|616754671|FG000|Overall Study|Withdrawal by Subject|0|||
170656209|NCT02294773|616754672|FG001|Overall Study|Withdrawal by Subject|2|||
170656210|NCT01865084|616754673|FG000|Double Blind Period (DB)|Adverse Event|2|||
170656211|NCT01865084|616754674|FG001|Double Blind Period (DB)|Adverse Event|2|||
170656212|NCT01865084|616754675|FG002|Double Blind Period (DB)|Adverse Event|1|||
170656213|NCT01865084|616754673|FG000|Double Blind Period (DB)|Protocol Violation|0|||
170656214|NCT01865084|616754674|FG001|Double Blind Period (DB)|Protocol Violation|0|||
170656215|NCT01865084|616754675|FG002|Double Blind Period (DB)|Protocol Violation|1|||
170656216|NCT01865084|616754673|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
170656217|NCT01865084|616754674|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
170656218|NCT01865084|616754675|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
170656219|NCT01865084|616754673|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
170656220|NCT01865084|616754674|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
170612999|NCT01695135|616588791|FG002|Open Label Extension Treatment Phase|Death|2|||
170613000|NCT01695135|616588792|FG003|Open Label Extension Treatment Phase|Death|7|||
170613001|NCT01695135|616588789|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
170613002|NCT01695135|616588790|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
170613003|NCT01695135|616588791|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
170613004|NCT01695135|616588792|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
170613005|NCT05150990|616588798|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
170613006|NCT05150990|616588799|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
170613007|NCT05150990|616588798|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
170613008|NCT05150990|616588799|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
170613009|NCT05150990|616588798|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
170613010|NCT05150990|616588799|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
170613011|NCT05150990|616588798|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
170613012|NCT05150990|616588799|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
170613013|NCT05150990|616588798|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
170613014|NCT05150990|616588799|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
170613015|NCT05150990|616588798|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
170613016|NCT05150990|616588799|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
170613017|NCT05150990|616588798|FG000|Overall Study|Death (unrelated to the intervention)|1|||
170613018|NCT05150990|616588799|FG001|Overall Study|Death (unrelated to the intervention)|2|||
170613019|NCT01970306|616588803|FG000|Overall Study|Not eligible|3|||
170613020|NCT01970306|616588803|FG000|Overall Study|Not able to be treated|9|||
170613021|NCT00226811|616588804|FG000|Overall Study|Death|8|||
170613022|NCT00226811|616588804|FG000|Overall Study|Adverse Event|11|||
170613023|NCT00226811|616588804|FG000|Overall Study|Lack of Efficacy|55|||
170613024|NCT00226811|616588804|FG000|Overall Study|Withdrawal by Subject|2|||
170613025|NCT02741635|616588805|FG000|Overall Study|Withdrawal by Subject|1|||
170613026|NCT05730387|616588807|FG000|Overall Study|Stillbirth|0|||
170613027|NCT05730387|616588808|FG001|Overall Study|Stillbirth|262|||
170613028|NCT05730387|616588807|FG000|Overall Study|Died during or after delivery|2|||
170613029|NCT05730387|616588808|FG001|Overall Study|Died during or after delivery|85|||
170613030|NCT05730387|616588807|FG000|Overall Study|Died after being admitted|0|||
170613031|NCT05730387|616588808|FG001|Overall Study|Died after being admitted|44|||
170613032|NCT05730387|616588807|FG000|Overall Study|Lost to Follow-up|69|||
170613033|NCT05730387|616588808|FG001|Overall Study|Lost to Follow-up|77|||
170613034|NCT01514201|616588813|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
170613035|NCT01514201|616588814|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
170613036|NCT01514201|616588815|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
170613037|NCT01514201|616588816|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
170613038|NCT01514201|616588813|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
170613039|NCT01514201|616588814|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
170613040|NCT01514201|616588815|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
170613041|NCT01514201|616588816|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
170613042|NCT01514201|616588813|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
170613043|NCT01514201|616588814|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
170613044|NCT01514201|616588815|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
170613045|NCT01514201|616588816|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
170613046|NCT01514201|616588813|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
170613047|NCT01514201|616588814|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
170613048|NCT01514201|616588815|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
170613049|NCT01514201|616588816|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
170613050|NCT01514201|616588813|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
170613051|NCT01514201|616588814|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
170613052|NCT01514201|616588815|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
170613053|NCT01514201|616588816|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
170613054|NCT01514201|616588813|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
170613055|NCT01514201|616588814|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
170613056|NCT01514201|616588815|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
170613057|NCT01514201|616588816|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
170656221|NCT01865084|616754675|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
170656222|NCT01865084|616754673|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
170656223|NCT01865084|616754674|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
170656224|NCT01865084|616754675|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
170656225|NCT01865084|616754673|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
170656226|NCT01865084|616754674|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
170656227|NCT01865084|616754675|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
170656228|NCT01865084|616754673|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
170656229|NCT01865084|616754674|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
170656230|NCT01865084|616754675|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
170656231|NCT01865084|616754673|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
170656232|NCT01865084|616754674|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
170656233|NCT01865084|616754675|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
170656234|NCT01865084|616754673|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
170656235|NCT01865084|616754674|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
170656236|NCT01865084|616754675|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
170656237|NCT03206073|616754676|FG000|Overall Study|Participant Noncompliance|0|||
170656238|NCT03206073|616754677|FG001|Overall Study|Participant Noncompliance|1|||
170656239|NCT03206073|616754678|FG002|Overall Study|Participant Noncompliance|0|||
170656240|NCT03206073|616754679|FG003|Overall Study|Participant Noncompliance|0|||
170656241|NCT03206073|616754676|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
170656242|NCT03206073|616754677|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
170656243|NCT03206073|616754678|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
170656244|NCT03206073|616754679|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
170656245|NCT03206073|616754676|FG000|Overall Study|Death|0|||
170656246|NCT03206073|616754677|FG001|Overall Study|Death|0|||
170656247|NCT03206073|616754678|FG002|Overall Study|Death|1|||
170656248|NCT03206073|616754679|FG003|Overall Study|Death|0|||
170656249|NCT03206073|616754676|FG000|Overall Study|Taken off active treatment|0|||
170656250|NCT03206073|616754677|FG001|Overall Study|Taken off active treatment|0|||
170656251|NCT03206073|616754678|FG002|Overall Study|Taken off active treatment|3|||
170656252|NCT03206073|616754679|FG003|Overall Study|Taken off active treatment|0|||
170656253|NCT01347307|616754680|FG000|Overall Study|Death|0|||
170656254|NCT01347307|616754681|FG001|Overall Study|Death|4|||
170656255|NCT01347307|616754680|FG000|Overall Study|Physician Decision|0|||
170656256|NCT01347307|616754681|FG001|Overall Study|Physician Decision|1|||
170656257|NCT01483690|616754682|FG000|Overall Study|Adverse Event|1|||
170656258|NCT01483690|616754683|FG001|Overall Study|Adverse Event|2|||
170656259|NCT01483690|616754682|FG000|Overall Study|clinical deterioration|1|||
170656260|NCT01483690|616754683|FG001|Overall Study|clinical deterioration|0|||
170656261|NCT01483690|616754682|FG000|Overall Study|Physician Decision|0|||
170656262|NCT01483690|616754683|FG001|Overall Study|Physician Decision|2|||
170656263|NCT01483690|616754682|FG000|Overall Study|exclusionary procedure|0|||
170656264|NCT01483690|616754683|FG001|Overall Study|exclusionary procedure|1|||
170656265|NCT00174291|616754689|FG000|Overall Study|Lost to Follow-up|1|||
170656266|NCT00174291|616754690|FG001|Overall Study|Lost to Follow-up|1|||
170816537|NCT04447287|617335514|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
170816538|NCT03246724|617335515|FG000|Overall Study|Withdrawal by Subject|5|||
170816539|NCT03246724|617335516|FG001|Overall Study|Withdrawal by Subject|2|||
170816540|NCT03246724|617335517|FG002|Overall Study|Withdrawal by Subject|4|||
170816541|NCT03246724|617335518|FG003|Overall Study|Withdrawal by Subject|2|||
170816542|NCT03246724|617335515|FG000|Overall Study|Ineligible on day of surgery|7|||
170816543|NCT03246724|617335516|FG001|Overall Study|Ineligible on day of surgery|2|||
170816544|NCT03246724|617335517|FG002|Overall Study|Ineligible on day of surgery|0|||
170816545|NCT03246724|617335518|FG003|Overall Study|Ineligible on day of surgery|3|||
170816546|NCT03246724|617335515|FG000|Overall Study|Study completed before surgical date|2|||
170816547|NCT03246724|617335516|FG001|Overall Study|Study completed before surgical date|1|||
170816548|NCT03246724|617335517|FG002|Overall Study|Study completed before surgical date|8|||
170816549|NCT03246724|617335518|FG003|Overall Study|Study completed before surgical date|1|||
170816550|NCT03246724|617335515|FG000|Overall Study|Transferred to other arm|0|||
170816551|NCT03246724|617335516|FG001|Overall Study|Transferred to other arm|0|||
170656267|NCT00174291|616754689|FG000|Overall Study|Protocol Violation|0|||
170656268|NCT00174291|616754690|FG001|Overall Study|Protocol Violation|2|||
170656269|NCT00174291|616754689|FG000|Overall Study|Study terminated by sponsor|1|||
170656270|NCT00174291|616754690|FG001|Overall Study|Study terminated by sponsor|0|||
170656271|NCT00174291|616754689|FG000|Overall Study|Withdrawal by Subject|3|||
170656272|NCT00174291|616754690|FG001|Overall Study|Withdrawal by Subject|3|||
170656273|NCT01466595|616754691|FG000|Overall Study|Withdrawal by Subject|0|||
170656274|NCT01466595|616754692|FG001|Overall Study|Withdrawal by Subject|1|||
170656275|NCT03595774|616754695|FG000|Overall Study|Adverse Event|1|||
170656276|NCT03595774|616754696|FG001|Overall Study|Adverse Event|0|||
170816552|NCT03246724|617335517|FG002|Overall Study|Transferred to other arm|1|||
170656277|NCT03595774|616754697|FG002|Overall Study|Adverse Event|1|||
170656278|NCT03595774|616754698|FG003|Overall Study|Adverse Event|0|||
170656279|NCT03595774|616754695|FG000|Overall Study|screen failure|0|||
170656280|NCT03595774|616754696|FG001|Overall Study|screen failure|1|||
170656281|NCT03595774|616754697|FG002|Overall Study|screen failure|0|||
170656282|NCT03595774|616754698|FG003|Overall Study|screen failure|1|||
170656283|NCT03882008|616754699|FG000|Overall Study|Withdrawal by Subject|1|||
170656284|NCT03882008|616754699|FG000|Overall Study|Lost to Follow-up|1|||
170656285|NCT00722371|616754700|FG000|Overall Study|Adverse Event|6|||
170656286|NCT00722371|616754701|FG001|Overall Study|Adverse Event|13|||
170656287|NCT00722371|616754702|FG002|Overall Study|Adverse Event|9|||
170656288|NCT00722371|616754703|FG003|Overall Study|Adverse Event|10|||
170656289|NCT00722371|616754704|FG004|Overall Study|Adverse Event|6|||
170656290|NCT00722371|616754705|FG005|Overall Study|Adverse Event|8|||
170656291|NCT00722371|616754706|FG006|Overall Study|Adverse Event|4|||
170656292|NCT00722371|616754700|FG000|Overall Study|Contraindication|0|||
170656293|NCT00722371|616754701|FG001|Overall Study|Contraindication|0|||
170656294|NCT00722371|616754702|FG002|Overall Study|Contraindication|1|||
170656295|NCT00722371|616754703|FG003|Overall Study|Contraindication|0|||
170656296|NCT00722371|616754704|FG004|Overall Study|Contraindication|0|||
170656297|NCT00722371|616754705|FG005|Overall Study|Contraindication|0|||
170656298|NCT00722371|616754706|FG006|Overall Study|Contraindication|0|||
170656299|NCT00722371|616754700|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
170656300|NCT00722371|616754701|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
170656301|NCT00722371|616754702|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
170656302|NCT00722371|616754703|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
170656303|NCT00722371|616754704|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
170656304|NCT00722371|616754705|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
170656305|NCT00722371|616754706|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
170656306|NCT00722371|616754700|FG000|Overall Study|Excluded medication|0|||
170656307|NCT00722371|616754701|FG001|Overall Study|Excluded medication|1|||
170656308|NCT00722371|616754702|FG002|Overall Study|Excluded medication|1|||
170656309|NCT00722371|616754703|FG003|Overall Study|Excluded medication|0|||
170656310|NCT00722371|616754704|FG004|Overall Study|Excluded medication|0|||
170656311|NCT00722371|616754705|FG005|Overall Study|Excluded medication|0|||
170656312|NCT00722371|616754706|FG006|Overall Study|Excluded medication|1|||
170656313|NCT00722371|616754700|FG000|Overall Study|Hyperglycemia|2|||
170656314|NCT00722371|616754701|FG001|Overall Study|Hyperglycemia|6|||
170656315|NCT00722371|616754702|FG002|Overall Study|Hyperglycemia|4|||
170656316|NCT00722371|616754703|FG003|Overall Study|Hyperglycemia|2|||
170656317|NCT00722371|616754704|FG004|Overall Study|Hyperglycemia|5|||
170656318|NCT00722371|616754705|FG005|Overall Study|Hyperglycemia|1|||
170656319|NCT00722371|616754706|FG006|Overall Study|Hyperglycemia|1|||
170656320|NCT00722371|616754700|FG000|Overall Study|Hypoglycemia|1|||
170656321|NCT00722371|616754701|FG001|Overall Study|Hypoglycemia|0|||
170656322|NCT00722371|616754702|FG002|Overall Study|Hypoglycemia|0|||
170656323|NCT00722371|616754703|FG003|Overall Study|Hypoglycemia|0|||
170656324|NCT00722371|616754704|FG004|Overall Study|Hypoglycemia|0|||
170656325|NCT00722371|616754705|FG005|Overall Study|Hypoglycemia|0|||
170656326|NCT00722371|616754706|FG006|Overall Study|Hypoglycemia|0|||
170656327|NCT00722371|616754700|FG000|Overall Study|Lack of Efficacy|4|||
170656328|NCT00722371|616754701|FG001|Overall Study|Lack of Efficacy|6|||
170656329|NCT00722371|616754702|FG002|Overall Study|Lack of Efficacy|6|||
170656330|NCT00722371|616754703|FG003|Overall Study|Lack of Efficacy|6|||
170656331|NCT00722371|616754704|FG004|Overall Study|Lack of Efficacy|2|||
170656332|NCT00722371|616754705|FG005|Overall Study|Lack of Efficacy|3|||
170656333|NCT00722371|616754706|FG006|Overall Study|Lack of Efficacy|0|||
170656334|NCT00722371|616754700|FG000|Overall Study|Lost to Follow-up|11|||
170656335|NCT00722371|616754701|FG001|Overall Study|Lost to Follow-up|14|||
170656336|NCT00722371|616754702|FG002|Overall Study|Lost to Follow-up|21|||
170656337|NCT00722371|616754703|FG003|Overall Study|Lost to Follow-up|13|||
170656338|NCT00722371|616754704|FG004|Overall Study|Lost to Follow-up|8|||
170656339|NCT00722371|616754705|FG005|Overall Study|Lost to Follow-up|16|||
170656340|NCT00722371|616754706|FG006|Overall Study|Lost to Follow-up|13|||
170656341|NCT00722371|616754700|FG000|Overall Study|Physician Decision|5|||
170656342|NCT00722371|616754701|FG001|Overall Study|Physician Decision|2|||
170656343|NCT00722371|616754702|FG002|Overall Study|Physician Decision|2|||
170656344|NCT00722371|616754703|FG003|Overall Study|Physician Decision|5|||
170656345|NCT00722371|616754704|FG004|Overall Study|Physician Decision|2|||
170656346|NCT00722371|616754705|FG005|Overall Study|Physician Decision|3|||
170656347|NCT00722371|616754706|FG006|Overall Study|Physician Decision|4|||
170656348|NCT00722371|616754700|FG000|Overall Study|Pregnancy|1|||
170656349|NCT00722371|616754701|FG001|Overall Study|Pregnancy|1|||
170656350|NCT00722371|616754702|FG002|Overall Study|Pregnancy|0|||
170656351|NCT00722371|616754703|FG003|Overall Study|Pregnancy|0|||
170656352|NCT00722371|616754704|FG004|Overall Study|Pregnancy|0|||
170656353|NCT00722371|616754705|FG005|Overall Study|Pregnancy|1|||
170656354|NCT00722371|616754706|FG006|Overall Study|Pregnancy|0|||
170656355|NCT00722371|616754700|FG000|Overall Study|Protocol Violation|6|||
170656356|NCT00722371|616754701|FG001|Overall Study|Protocol Violation|1|||
170656357|NCT00722371|616754702|FG002|Overall Study|Protocol Violation|0|||
170613058|NCT01514201|616588813|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
170613059|NCT01514201|616588814|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
170613060|NCT01514201|616588815|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
170613061|NCT01514201|616588816|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
170613062|NCT01514201|616588813|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
170613063|NCT01514201|616588814|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
170613064|NCT01514201|616588815|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
170613065|NCT01514201|616588816|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
170613066|NCT01514201|616588813|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
170613067|NCT01514201|616588814|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
170613068|NCT01514201|616588815|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
170613069|NCT01514201|616588816|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
170613070|NCT01514201|616588813|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
170613071|NCT01514201|616588814|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
170613072|NCT01514201|616588815|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
170613073|NCT01514201|616588816|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
170613074|NCT01514201|616588813|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
170613075|NCT01514201|616588814|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
170613076|NCT01514201|616588815|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
170613077|NCT01514201|616588816|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
170613078|NCT01514201|616588813|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
170613079|NCT01514201|616588814|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
170613080|NCT01514201|616588815|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
170613081|NCT01514201|616588816|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
170613082|NCT04137731|616588819|FG000|Overall Study|Surgery Cancellation|1|||
170613083|NCT04137731|616588820|FG001|Overall Study|Surgery Cancellation|2|||
170613084|NCT04137731|616588819|FG000|Overall Study|Withdrawal by Subject|2|||
170613085|NCT04137731|616588820|FG001|Overall Study|Withdrawal by Subject|0|||
170613086|NCT04137731|616588819|FG000|Overall Study|Protocol Violation|0|||
170613087|NCT04137731|616588820|FG001|Overall Study|Protocol Violation|1|||
170613088|NCT04607837|616588828|FG000|Overall Study|Adverse Event|8|||
170613089|NCT04607837|616588829|FG001|Overall Study|Adverse Event|2|||
170613090|NCT04607837|616588828|FG000|Overall Study|Withdrawal by Subject|8|||
170613091|NCT04607837|616588829|FG001|Overall Study|Withdrawal by Subject|7|||
170613092|NCT04607837|616588828|FG000|Overall Study|Physician Decision|2|||
170613093|NCT04607837|616588829|FG001|Overall Study|Physician Decision|0|||
170613094|NCT04607837|616588828|FG000|Overall Study|Lack of Efficacy|2|||
170613095|NCT04607837|616588829|FG001|Overall Study|Lack of Efficacy|0|||
170613096|NCT04607837|616588828|FG000|Overall Study|Participant terminated by sponsor|1|||
170613097|NCT04607837|616588829|FG001|Overall Study|Participant terminated by sponsor|0|||
170613098|NCT04607837|616588828|FG000|Overall Study|Disease worsening|36|||
170613099|NCT04607837|616588829|FG001|Overall Study|Disease worsening|36|||
170613100|NCT04607837|616588828|FG000|Overall Study|Other|1|||
170613101|NCT04607837|616588829|FG001|Overall Study|Other|0|||
170613102|NCT00367835|616588839|FG000|Overall Study|Adverse Event|14|||
170613103|NCT00367835|616588840|FG001|Overall Study|Adverse Event|1|||
170613104|NCT00367835|616588839|FG000|Overall Study|Protocol Violation|1|||
170613105|NCT00367835|616588840|FG001|Overall Study|Protocol Violation|7|||
170613106|NCT00367835|616588839|FG000|Overall Study|Withdrawal by Subject|7|||
170613107|NCT00367835|616588840|FG001|Overall Study|Withdrawal by Subject|6|||
170613108|NCT00367835|616588839|FG000|Overall Study|Lost to Follow-up|1|||
170613109|NCT00367835|616588840|FG001|Overall Study|Lost to Follow-up|4|||
170613110|NCT00367835|616588839|FG000|Overall Study|Lack of Efficacy|3|||
170613111|NCT00367835|616588840|FG001|Overall Study|Lack of Efficacy|12|||
170613112|NCT00367835|616588839|FG000|Overall Study|Subject in juvenile detention center|1|||
170613113|NCT00367835|616588840|FG001|Overall Study|Subject in juvenile detention center|0|||
170613114|NCT00367835|616588839|FG000|Overall Study|refused blood collection|1|||
170613115|NCT00367835|616588840|FG001|Overall Study|refused blood collection|0|||
170613116|NCT00367835|616588839|FG000|Overall Study|Did not respond to calls|1|||
170613117|NCT00367835|616588840|FG001|Overall Study|Did not respond to calls|0|||
170613118|NCT00367835|616588839|FG000|Overall Study|History of lead poisoning|0|||
170613119|NCT00367835|616588840|FG001|Overall Study|History of lead poisoning|1|||
170613120|NCT02023996|616588841|FG000|Overall Study|Protocol Violation|6|||
170613121|NCT04346654|616588843|FG000|Overall Study|Adverse Event|2|||
170613122|NCT04346654|616588844|FG001|Overall Study|Adverse Event|0|||
170613123|NCT04346654|616588843|FG000|Overall Study|Non-response|1|||
170613124|NCT04346654|616588844|FG001|Overall Study|Non-response|1|||
170613125|NCT04346654|616588843|FG000|Overall Study|Withdrawal by Subject|2|||
170613126|NCT04346654|616588844|FG001|Overall Study|Withdrawal by Subject|0|||
170613127|NCT04346654|616588843|FG000|Overall Study|Lost to Follow-up|0|||
170613128|NCT04346654|616588844|FG001|Overall Study|Lost to Follow-up|1|||
170656358|NCT00722371|616754703|FG003|Overall Study|Protocol Violation|1|||
170656359|NCT00722371|616754704|FG004|Overall Study|Protocol Violation|4|||
170656360|NCT00722371|616754705|FG005|Overall Study|Protocol Violation|2|||
170656361|NCT00722371|616754706|FG006|Overall Study|Protocol Violation|1|||
170656362|NCT00722371|616754700|FG000|Overall Study|Withdrawal by Subject|18|||
170656363|NCT00722371|616754701|FG001|Overall Study|Withdrawal by Subject|27|||
170656364|NCT00722371|616754702|FG002|Overall Study|Withdrawal by Subject|19|||
170656365|NCT00722371|616754703|FG003|Overall Study|Withdrawal by Subject|23|||
170656366|NCT00722371|616754704|FG004|Overall Study|Withdrawal by Subject|19|||
170656367|NCT00722371|616754705|FG005|Overall Study|Withdrawal by Subject|18|||
170656368|NCT00722371|616754706|FG006|Overall Study|Withdrawal by Subject|26|||
170656369|NCT02068768|616754707|FG000|Overall Study|Lost to Follow-up|5|||
170656370|NCT02068768|616754707|FG000|Overall Study|Early Termination by Sponsor|2|||
170656371|NCT00555425|616754708|FG000|Overall Study|Missed Medication > 1 wk|34|||
170656372|NCT00555425|616754709|FG001|Overall Study|Missed Medication > 1 wk|15|||
170656373|NCT00555425|616754708|FG000|Overall Study|Missed 3 physician management visits|1|||
170656374|NCT00555425|616754709|FG001|Overall Study|Missed 3 physician management visits|0|||
170656375|NCT00555425|616754708|FG000|Overall Study|Met criteria for protective transfer|16|||
170656376|NCT00555425|616754709|FG001|Overall Study|Met criteria for protective transfer|3|||
170656377|NCT00555425|616754708|FG000|Overall Study|Became pregnant and transferred care|0|||
170656378|NCT00555425|616754709|FG001|Overall Study|Became pregnant and transferred care|1|||
170656379|NCT01262352|616754710|FG000|Period 1|Illness after randomization|1|||
170656380|NCT01262352|616754711|FG001|Period 1|Illness after randomization|0|||
170656381|NCT01262352|616754710|FG000|Washout|Adverse Event|1|||
170656382|NCT01262352|616754711|FG001|Washout|Adverse Event|1|||
170656383|NCT01262352|616754710|FG000|Washout|Extended Washout|0|||
170656384|NCT01262352|616754711|FG001|Washout|Extended Washout|1|||
170656385|NCT01185834|616754712|FG000|Overall Study|Lost to Follow-up|2|||
170656386|NCT01185834|616754712|FG000|Overall Study|Discomfort|4|||
170656387|NCT01185834|616754712|FG000|Overall Study|Biomicroscopy|4|||
170656388|NCT01185834|616754712|FG000|Overall Study|Time/Job Conflict|2|||
170656389|NCT01185834|616754712|FG000|Overall Study|Early exit - Site error|2|||
170656390|NCT02694718|616754714|FG000|Overall Study|Death|1|||
170656391|NCT02694718|616754714|FG000|Overall Study|Withdrawal by Subject|1|||
170656392|NCT02925793|616754715|FG000|Overall Study|Adverse Event|3|||
170656393|NCT02925793|616754716|FG001|Overall Study|Adverse Event|3|||
170656394|NCT02925793|616754717|FG002|Overall Study|Adverse Event|6|||
170656395|NCT02925793|616754715|FG000|Overall Study|Withdrawal by Subject|16|||
170656396|NCT02925793|616754716|FG001|Overall Study|Withdrawal by Subject|15|||
170656397|NCT02925793|616754717|FG002|Overall Study|Withdrawal by Subject|13|||
170656398|NCT02925793|616754715|FG000|Overall Study|Investigator Discretion|0|||
170656399|NCT02925793|616754716|FG001|Overall Study|Investigator Discretion|1|||
170656400|NCT02925793|616754717|FG002|Overall Study|Investigator Discretion|1|||
170656401|NCT02925793|616754715|FG000|Overall Study|Lost to Follow-up|2|||
170656402|NCT02925793|616754716|FG001|Overall Study|Lost to Follow-up|3|||
170656403|NCT02925793|616754717|FG002|Overall Study|Lost to Follow-up|1|||
170656404|NCT02925793|616754715|FG000|Overall Study|Lack of Efficacy|2|||
170656405|NCT02925793|616754716|FG001|Overall Study|Lack of Efficacy|6|||
170656406|NCT02925793|616754717|FG002|Overall Study|Lack of Efficacy|4|||
170656407|NCT02925793|616754715|FG000|Overall Study|Other:|2|||
170656408|NCT02925793|616754716|FG001|Overall Study|Other:|1|||
170656409|NCT02925793|616754717|FG002|Overall Study|Other:|3|||
170656410|NCT01244490|616754718|FG000|Overall Study|Lack of Efficacy|14|||
170656411|NCT01244490|616754719|FG001|Overall Study|Lack of Efficacy|5|||
170656412|NCT01244490|616754720|FG002|Overall Study|Lack of Efficacy|5|||
170656413|NCT01244490|616754718|FG000|Overall Study|Withdrawal by Subject|4|||
170656414|NCT01244490|616754719|FG001|Overall Study|Withdrawal by Subject|4|||
170656415|NCT01244490|616754720|FG002|Overall Study|Withdrawal by Subject|9|||
170656416|NCT01244490|616754718|FG000|Overall Study|Adverse Event|1|||
170656417|NCT01244490|616754719|FG001|Overall Study|Adverse Event|9|||
170656418|NCT01244490|616754720|FG002|Overall Study|Adverse Event|5|||
170656419|NCT01244490|616754718|FG000|Overall Study|Lost to Follow-up|0|||
170656420|NCT01244490|616754719|FG001|Overall Study|Lost to Follow-up|6|||
170656421|NCT01244490|616754720|FG002|Overall Study|Lost to Follow-up|3|||
170656422|NCT01244490|616754718|FG000|Overall Study|Other|0|||
170656423|NCT01244490|616754719|FG001|Overall Study|Other|0|||
170656424|NCT01244490|616754720|FG002|Overall Study|Other|1|||
170656425|NCT00393042|616754723|FG000|First Intervention|Withdrawal by Subject|1|||
170656426|NCT00393042|616754724|FG001|First Intervention|Withdrawal by Subject|2|||
170656427|NCT00393042|616754723|FG000|First Intervention|Lost to Follow-up|3|||
170656428|NCT00393042|616754724|FG001|First Intervention|Lost to Follow-up|3|||
170656429|NCT00393042|616754723|FG000|First Intervention|Protocol Violation|1|||
170656430|NCT00393042|616754724|FG001|First Intervention|Protocol Violation|0|||
170656431|NCT00393042|616754723|FG000|First Intervention|Adverse Event|0|||
170656432|NCT00393042|616754724|FG001|First Intervention|Adverse Event|1|||
170656433|NCT00393042|616754723|FG000|Second Intervetion|Adverse Event|0|||
170656434|NCT00393042|616754724|FG001|Second Intervetion|Adverse Event|3|||
170656435|NCT00393042|616754723|FG000|Second Intervetion|Withdrawal by Subject|0|||
170656436|NCT00393042|616754724|FG001|Second Intervetion|Withdrawal by Subject|2|||
170656437|NCT00393042|616754723|FG000|Second Intervetion|Lack of Efficacy|1|||
170656438|NCT00393042|616754724|FG001|Second Intervetion|Lack of Efficacy|0|||
170656439|NCT00393042|616754723|FG000|Second Intervetion|Lost to Follow-up|0|||
170656440|NCT00393042|616754724|FG001|Second Intervetion|Lost to Follow-up|2|||
170656441|NCT00393042|616754723|FG000|Second Intervetion|Protocol Violation|1|||
170656442|NCT00393042|616754724|FG001|Second Intervetion|Protocol Violation|1|||
170656443|NCT03475875|616754725|FG000|Period 1|Lost to Follow-up|1|||
170656444|NCT03475875|616754726|FG001|Period 1|Lost to Follow-up|0|||
170656445|NCT03475875|616754725|FG000|Period 1|Adverse Event|2|||
170656446|NCT03475875|616754726|FG001|Period 1|Adverse Event|1|||
170656447|NCT03475875|616754725|FG000|Period 2|Adverse Event|3|||
170656448|NCT03475875|616754726|FG001|Period 2|Adverse Event|0|||
170656449|NCT03475875|616754725|FG000|Period 2|Protocol Violation|0|||
170656450|NCT03475875|616754726|FG001|Period 2|Protocol Violation|1|||
170656451|NCT01226121|616754731|FG000|Overall Study|Lost to Follow-up|2|||
170656452|NCT01226121|616754732|FG001|Overall Study|Lost to Follow-up|0|||
170656453|NCT01226121|616754733|FG002|Overall Study|Lost to Follow-up|1|||
170656454|NCT03945175|616754734|FG000|Overall Study|Did not meet inclusion criteria|31|||
170656455|NCT03945175|616754734|FG000|Overall Study|Withdrew consent|2|||
170656456|NCT03945175|616754734|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
170656457|NCT03945175|616754734|FG000|Overall Study|Early termination during Mydayis treatment|1|||
170656458|NCT03324581|616754736|FG000|Overall Study|Adverse Event|18|||
170656459|NCT03324581|616754737|FG001|Overall Study|Adverse Event|11|||
170656460|NCT03324581|616754738|FG002|Overall Study|Adverse Event|7|||
170656461|NCT03324581|616754736|FG000|Overall Study|Lack of Efficacy|0|||
170656462|NCT03324581|616754737|FG001|Overall Study|Lack of Efficacy|1|||
170656463|NCT03324581|616754738|FG002|Overall Study|Lack of Efficacy|0|||
170656464|NCT03324581|616754736|FG000|Overall Study|Lost to Follow-up|5|||
170656465|NCT03324581|616754737|FG001|Overall Study|Lost to Follow-up|3|||
170656466|NCT03324581|616754738|FG002|Overall Study|Lost to Follow-up|6|||
170656467|NCT03324581|616754736|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
170656468|NCT03324581|616754737|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
170656469|NCT03324581|616754738|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
170656470|NCT03324581|616754736|FG000|Overall Study|Physician Decision|0|||
170656471|NCT03324581|616754737|FG001|Overall Study|Physician Decision|1|||
170656472|NCT03324581|616754738|FG002|Overall Study|Physician Decision|2|||
170656473|NCT03324581|616754736|FG000|Overall Study|Protocol Deviation|8|||
170656474|NCT03324581|616754737|FG001|Overall Study|Protocol Deviation|9|||
170656475|NCT03324581|616754738|FG002|Overall Study|Protocol Deviation|4|||
170656476|NCT03324581|616754736|FG000|Overall Study|Withdrawal by Subject|6|||
170656477|NCT03324581|616754737|FG001|Overall Study|Withdrawal by Subject|8|||
170656478|NCT03324581|616754738|FG002|Overall Study|Withdrawal by Subject|6|||
170656479|NCT03324581|616754736|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
170656480|NCT03324581|616754737|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
170656481|NCT03324581|616754738|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
170656482|NCT04473482|616754739|FG000|Overall Study|Death|0|||
170656483|NCT04473482|616754740|FG001|Overall Study|Death|3|||
170656484|NCT04473482|616754739|FG000|Overall Study|Lost to Follow-up|9|||
170656485|NCT04473482|616754740|FG001|Overall Study|Lost to Follow-up|7|||
170656486|NCT04473482|616754739|FG000|Overall Study|Withdrawal by Subject|2|||
170656487|NCT04473482|616754740|FG001|Overall Study|Withdrawal by Subject|1|||
170656488|NCT02380690|616754746|FG000|Overall Study|Lost to Follow-up|14|||
170656489|NCT02380690|616754747|FG001|Overall Study|Lost to Follow-up|4|||
170656490|NCT02380690|616754746|FG000|Overall Study|Withdrawal by Subject|20|||
170656491|NCT02380690|616754747|FG001|Overall Study|Withdrawal by Subject|8|||
170656492|NCT03687970|616754748|FG000|Overall Study|visit scheduling conflicts|2|||
170656493|NCT03687970|616754749|FG001|Overall Study|visit scheduling conflicts|0|||
170656494|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
170656495|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
170656496|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
170656497|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
170656498|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
170656499|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
170656500|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
170656501|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
170656502|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
170656503|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
170656504|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
170656505|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
170656506|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
170816553|NCT03246724|617335518|FG003|Overall Study|Transferred to other arm|0|||
170656507|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
170816554|NCT03246724|617335515|FG000|Overall Study|Unable to obtain medication timely|0|||
170816555|NCT03246724|617335516|FG001|Overall Study|Unable to obtain medication timely|2|||
170816556|NCT03246724|617335517|FG002|Overall Study|Unable to obtain medication timely|2|||
170816557|NCT03246724|617335518|FG003|Overall Study|Unable to obtain medication timely|1|||
170613129|NCT04346654|616588843|FG000|Overall Study|Pregnancy|0|||
170613130|NCT04346654|616588844|FG001|Overall Study|Pregnancy|1|||
170613131|NCT00465452|616588845|FG000|Overall Study|Adverse Event|1|||
170613132|NCT04209205|616588851|FG000|Overall Study|Adverse Event|2|||
170613133|NCT04209205|616588852|FG001|Overall Study|Adverse Event|3|||
170613134|NCT04209205|616588851|FG000|Overall Study|Lost to Follow-up|3|||
170613135|NCT04209205|616588852|FG001|Overall Study|Lost to Follow-up|1|||
170613136|NCT04209205|616588851|FG000|Overall Study|Physician Decision|1|||
170613137|NCT04209205|616588852|FG001|Overall Study|Physician Decision|1|||
170613138|NCT04209205|616588851|FG000|Overall Study|Subject decision|10|||
170613139|NCT04209205|616588852|FG001|Overall Study|Subject decision|10|||
170613140|NCT04209205|616588851|FG000|Overall Study|Progressive disease|1|||
170613141|NCT04209205|616588852|FG001|Overall Study|Progressive disease|0|||
170613142|NCT04209205|616588851|FG000|Overall Study|Protocol deviation|0|||
170613143|NCT04209205|616588852|FG001|Overall Study|Protocol deviation|1|||
170613144|NCT04209205|616588851|FG000|Overall Study|New therapy for study indication|1|||
170613145|NCT04209205|616588852|FG001|Overall Study|New therapy for study indication|0|||
170613146|NCT04209205|616588851|FG000|Overall Study|Adverse event - placebo not switched|0|||
170613147|NCT04209205|616588852|FG001|Overall Study|Adverse event - placebo not switched|1|||
170613148|NCT04209205|616588851|FG000|Overall Study|Subject decision - placebo not switched|0|||
170613149|NCT04209205|616588852|FG001|Overall Study|Subject decision - placebo not switched|5|||
170613150|NCT04209205|616588851|FG000|Overall Study|Death - placebo not switched|0|||
170613151|NCT04209205|616588852|FG001|Overall Study|Death - placebo not switched|1|||
170613152|NCT03828019|616588853|FG000|Overall Study|Withdrawal by Subject|3|||
170613153|NCT03828019|616588854|FG001|Overall Study|Withdrawal by Subject|8|||
170613154|NCT03828019|616588853|FG000|Overall Study|Lost to Follow-up|1|||
170613155|NCT03828019|616588854|FG001|Overall Study|Lost to Follow-up|6|||
170613156|NCT03828019|616588853|FG000|Overall Study|Incarcerated|1|||
170613157|NCT03828019|616588854|FG001|Overall Study|Incarcerated|0|||
170613158|NCT03828019|616588853|FG000|Overall Study|Adverse Event|0|||
170613159|NCT03828019|616588854|FG001|Overall Study|Adverse Event|1|||
170613160|NCT04752332|616588861|FG000|Overall Study|Adverse Event|3|||
170613161|NCT04752332|616588862|FG001|Overall Study|Adverse Event|1|||
170613162|NCT04752332|616588861|FG000|Overall Study|Disease Relapse|1|||
170613163|NCT04752332|616588862|FG001|Overall Study|Disease Relapse|0|||
170613164|NCT04752332|616588861|FG000|Overall Study|Non-compliance With Study Drug|2|||
170613165|NCT04752332|616588862|FG001|Overall Study|Non-compliance With Study Drug|0|||
170613166|NCT04752332|616588861|FG000|Overall Study|Physician Decision|2|||
170613167|NCT04752332|616588862|FG001|Overall Study|Physician Decision|1|||
170613168|NCT04752332|616588861|FG000|Overall Study|Protocol Violation|1|||
170613169|NCT04752332|616588862|FG001|Overall Study|Protocol Violation|1|||
170613170|NCT04752332|616588861|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
170613171|NCT04752332|616588862|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
170613172|NCT04752332|616588861|FG000|Overall Study|Study Terminated by Sponsor|10|||
170613173|NCT04752332|616588862|FG001|Overall Study|Study Terminated by Sponsor|48|||
170613174|NCT04752332|616588861|FG000|Overall Study|Withdrawal by Subject|11|||
170613175|NCT04752332|616588862|FG001|Overall Study|Withdrawal by Subject|3|||
170613176|NCT01371552|616588865|FG000|Part 1, First 3 Days|Inconvenience|0|||
170613177|NCT01371552|616588866|FG001|Part 1, First 3 Days|Inconvenience|0|||
170613178|NCT01371552|616588867|FG002|Part 1, First 3 Days|Inconvenience|1|||
170613179|NCT01371552|616588868|FG003|Part 1, First 3 Days|Inconvenience|0|||
170613180|NCT01371552|616588869|FG004|Part 1, First 3 Days|Inconvenience|0|||
170613181|NCT01371552|616588870|FG005|Part 1, First 3 Days|Inconvenience|0|||
170613182|NCT00856297|616588871|FG000|Overall Study|Unable to classify|2|||
170613183|NCT00856297|616588872|FG001|Overall Study|Unable to classify|0|||
170613184|NCT00856297|616588873|FG002|Overall Study|Unable to classify|0|||
170613185|NCT00856297|616588874|FG003|Overall Study|Unable to classify|0|||
170613186|NCT00856297|616588875|FG004|Overall Study|Unable to classify|0|||
170613187|NCT04371666|616588876|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
170613188|NCT04371666|616588877|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
170613189|NCT04371666|616588876|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
170613190|NCT04371666|616588877|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
170613191|NCT04371666|616588876|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
170613192|NCT04371666|616588877|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
170613193|NCT04371666|616588876|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
170613194|NCT04371666|616588877|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
170613195|NCT04371666|616588876|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
170613196|NCT04371666|616588877|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
170613197|NCT04371666|616588876|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
170613198|NCT04371666|616588877|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
170656508|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
170656509|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
170656510|NCT00491556|616754750|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
170656511|NCT00491556|616754751|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
170656512|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
170656513|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
170656514|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
170656515|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
170656516|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
170656517|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
170656518|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
170656519|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
170656520|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
170656521|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
170656522|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
170656523|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
170656524|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
170656525|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
170656526|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
170656527|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
170656528|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
170656529|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
170656530|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
170656531|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
170656532|NCT00491556|616754750|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
170656533|NCT00491556|616754751|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
170656534|NCT00734747|616754752|FG000|SRS Procedure|No staples placed|3|||
170656535|NCT00734747|616754752|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
170656536|NCT03576274|616754759|FG000|Overall Study|Lost to Follow-up|3|||
170656537|NCT03576274|616754760|FG001|Overall Study|Lost to Follow-up|2|||
170656538|NCT03576274|616754761|FG002|Overall Study|Lost to Follow-up|3|||
170656539|NCT03576274|616754762|FG003|Overall Study|Lost to Follow-up|1|||
170656540|NCT03576274|616754763|FG004|Overall Study|Lost to Follow-up|3|||
170656541|NCT03576274|616754759|FG000|Overall Study|Withdrawal by Subject|5|||
170656542|NCT03576274|616754760|FG001|Overall Study|Withdrawal by Subject|3|||
170656543|NCT03576274|616754761|FG002|Overall Study|Withdrawal by Subject|2|||
170656544|NCT03576274|616754762|FG003|Overall Study|Withdrawal by Subject|8|||
170656545|NCT03576274|616754763|FG004|Overall Study|Withdrawal by Subject|6|||
170656546|NCT04854642|616756422|FG000|Overall Study|Adverse Event|1|||
170656547|NCT04854642|616756423|FG001|Overall Study|Adverse Event|2|||
170656548|NCT04854642|616756422|FG000|Overall Study|Withdrawal by Subject|0|||
170656549|NCT04854642|616756423|FG001|Overall Study|Withdrawal by Subject|1|||
170656550|NCT05828095|616756426|FG000|Overall Study|Lost to Follow-up|1|||
170656551|NCT05828095|616756427|FG001|Overall Study|Lost to Follow-up|0|||
170656552|NCT05828095|616756426|FG000|Overall Study|Reactogenicity symptom|0|||
170656553|NCT05828095|616756427|FG001|Overall Study|Reactogenicity symptom|1|||
170656554|NCT01994590|616756430|FG000|Overall Study|Adverse Event|1|||
170656555|NCT01994590|616756430|FG000|Overall Study|Trial Terminated|1|||
170656556|NCT03332771|616756431|FG000|Overall Study|Adverse Event|6|||
170656557|NCT03332771|616756432|FG001|Overall Study|Adverse Event|4|||
170656558|NCT03332771|616756433|FG002|Overall Study|Adverse Event|1|||
170656559|NCT03332771|616756434|FG003|Overall Study|Adverse Event|3|||
170656560|NCT03332771|616756431|FG000|Overall Study|Poor Compliance to Protocol|0|||
170656561|NCT03332771|616756432|FG001|Overall Study|Poor Compliance to Protocol|1|||
170656562|NCT03332771|616756433|FG002|Overall Study|Poor Compliance to Protocol|0|||
170656563|NCT03332771|616756434|FG003|Overall Study|Poor Compliance to Protocol|1|||
170656564|NCT03332771|616756431|FG000|Overall Study|Lost to Follow-up|2|||
170656565|NCT03332771|616756432|FG001|Overall Study|Lost to Follow-up|2|||
170656566|NCT03332771|616756433|FG002|Overall Study|Lost to Follow-up|1|||
170656567|NCT03332771|616756434|FG003|Overall Study|Lost to Follow-up|2|||
170656568|NCT03332771|616756431|FG000|Overall Study|At the Participant's own request|20|||
170656569|NCT03332771|616756432|FG001|Overall Study|At the Participant's own request|26|||
170656570|NCT03332771|616756433|FG002|Overall Study|At the Participant's own request|14|||
170656571|NCT03332771|616756434|FG003|Overall Study|At the Participant's own request|23|||
170656572|NCT03332771|616756431|FG000|Overall Study|Reason Not Specified|6|||
170656573|NCT03332771|616756432|FG001|Overall Study|Reason Not Specified|18|||
170656574|NCT03332771|616756433|FG002|Overall Study|Reason Not Specified|16|||
170656575|NCT03332771|616756434|FG003|Overall Study|Reason Not Specified|19|||
170656576|NCT03442764|616756435|FG000|Overall Study|Adverse Event|1|||
170656577|NCT03442764|616756436|FG001|Overall Study|Adverse Event|0|||
170656578|NCT03442764|616756437|FG002|Overall Study|Adverse Event|0|||
170656579|NCT01801072|616756438|FG000|Overall Study|Lost to Follow-up|17|||
170656580|NCT01801072|616756439|FG001|Overall Study|Lost to Follow-up|14|||
170656581|NCT01801072|616756438|FG000|Overall Study|Physician Decision|2|||
170656582|NCT01801072|616756439|FG001|Overall Study|Physician Decision|3|||
170656583|NCT01801072|616756438|FG000|Overall Study|Withdrawal by Subject|1|||
170656584|NCT01801072|616756439|FG001|Overall Study|Withdrawal by Subject|0|||
170656585|NCT01801072|616756438|FG000|Overall Study|Protocol Violation|2|||
170656586|NCT01801072|616756439|FG001|Overall Study|Protocol Violation|0|||
170656587|NCT01801072|616756438|FG000|Overall Study|Death|7|||
170656588|NCT01801072|616756439|FG001|Overall Study|Death|8|||
170656589|NCT03693170|616756440|FG000|Overall Study|Disease Progression|48|||
170656590|NCT03693170|616756440|FG000|Overall Study|Adverse Event|16|||
170656591|NCT03693170|616756440|FG000|Overall Study|Physician Decision|6|||
170656592|NCT03693170|616756440|FG000|Overall Study|Protocol Violation|2|||
170656593|NCT03693170|616756440|FG000|Overall Study|Death|1|||
170656594|NCT03693170|616756440|FG000|Overall Study|Non compliance with study drug|1|||
170656595|NCT03693170|616756440|FG000|Overall Study|Withdrawal by Subject|1|||
170656596|NCT04444895|616756441|FG000|Overall Study|Adverse Event|2|||
170656597|NCT04444895|616756441|FG000|Overall Study|Lost to Follow-up|2|||
170656598|NCT04444895|616756441|FG000|Overall Study|Withdrawal by Subject|5|||
170656599|NCT03034200|616756442|FG000|Overall Study|Disease progression|8|||
170656600|NCT03034200|616756443|FG001|Overall Study|Disease progression|10|||
170656601|NCT03034200|616756444|FG002|Overall Study|Disease progression|4|||
170656602|NCT03034200|616756442|FG000|Overall Study|Physician Decision|2|||
170656603|NCT03034200|616756443|FG001|Overall Study|Physician Decision|0|||
170656604|NCT03034200|616756444|FG002|Overall Study|Physician Decision|3|||
170656605|NCT03034200|616756442|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
170656606|NCT03034200|616756443|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
170656607|NCT03034200|616756444|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
170656608|NCT03034200|616756442|FG000|Overall Study|Adjuvant Therapy|0|||
170656609|NCT03034200|616756443|FG001|Overall Study|Adjuvant Therapy|0|||
170656610|NCT03034200|616756444|FG002|Overall Study|Adjuvant Therapy|1|||
170656611|NCT05523323|616756445|FG000|Overall Study|Death|26|||
170656612|NCT05523323|616756446|FG001|Overall Study|Death|21|||
170656613|NCT05523323|616756445|FG000|Overall Study|Ongoing participants|35|||
170656614|NCT05523323|616756446|FG001|Overall Study|Ongoing participants|30|||
170656615|NCT00510874|616756447|FG000|Overall Study|Withdrawal by Subject|1|||
170656616|NCT00510874|616756448|FG001|Overall Study|Withdrawal by Subject|1|||
170656617|NCT00510874|616756449|FG002|Overall Study|Withdrawal by Subject|0|||
170656618|NCT00510874|616756450|FG003|Overall Study|Withdrawal by Subject|0|||
170656619|NCT00510874|616756451|FG004|Overall Study|Withdrawal by Subject|3|||
170656620|NCT00510874|616756452|FG005|Overall Study|Withdrawal by Subject|0|||
170656621|NCT00510874|616756453|FG006|Overall Study|Withdrawal by Subject|0|||
170656622|NCT00510874|616756447|FG000|Overall Study|Lost to Follow-up|2|||
170656623|NCT00510874|616756448|FG001|Overall Study|Lost to Follow-up|3|||
170656624|NCT00510874|616756449|FG002|Overall Study|Lost to Follow-up|1|||
170656625|NCT00510874|616756450|FG003|Overall Study|Lost to Follow-up|3|||
170656626|NCT00510874|616756451|FG004|Overall Study|Lost to Follow-up|4|||
170613199|NCT02927938|616588878|FG000|Overall Study|Death|0|||
170613200|NCT02927938|616588879|FG001|Overall Study|Death|1|||
170613201|NCT02927938|616588880|FG002|Overall Study|Death|0|||
170613202|NCT02927938|616588881|FG003|Overall Study|Death|4|||
170613203|NCT02927938|616588878|FG000|Overall Study|Early Study Termination|1|||
170613204|NCT02927938|616588879|FG001|Overall Study|Early Study Termination|5|||
170613205|NCT02927938|616588880|FG002|Overall Study|Early Study Termination|4|||
170613206|NCT02927938|616588881|FG003|Overall Study|Early Study Termination|3|||
170613207|NCT00934128|616588884|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
170613208|NCT00934128|616588885|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
170613209|NCT00934128|616588884|FG000|First Intervention (2 Hours)|Adverse Event|4|||
170613210|NCT00934128|616588885|FG001|First Intervention (2 Hours)|Adverse Event|1|||
170613211|NCT00934128|616588884|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
170613212|NCT00934128|616588885|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
170613213|NCT00934128|616588884|FG000|Washout Period (1 Hour)|Patient preference|1|||
170613214|NCT00934128|616588885|FG001|Washout Period (1 Hour)|Patient preference|3|||
170613215|NCT00934128|616588884|FG000|Washout Period (1 Hour)|Pain|1|||
170613216|NCT00934128|616588885|FG001|Washout Period (1 Hour)|Pain|0|||
170613217|NCT00934128|616588884|FG000|Washout Period (1 Hour)|Too tired|1|||
170613218|NCT00934128|616588885|FG001|Washout Period (1 Hour)|Too tired|0|||
170613219|NCT00934128|616588884|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
170656627|NCT00510874|616756452|FG005|Overall Study|Lost to Follow-up|0|||
170656628|NCT00510874|616756453|FG006|Overall Study|Lost to Follow-up|1|||
170656629|NCT01251146|616756454|FG000|Overall Study|Lost to Follow-up|3|||
170656630|NCT01251146|616756455|FG001|Overall Study|Lost to Follow-up|10|||
170656631|NCT00920829|616756461|FG000|Allocation|No post randomization data|3|||
170656632|NCT00920829|616756462|FG001|Allocation|No post randomization data|1|||
170656633|NCT00920829|616756463|FG002|Allocation|No post randomization data|0|||
170656634|NCT00920829|616756464|FG003|Allocation|No post randomization data|2|||
170656635|NCT00920829|616756461|FG000|Available for Analysis|Withdrawal by Subject|6|||
170656636|NCT00920829|616756462|FG001|Available for Analysis|Withdrawal by Subject|6|||
170656637|NCT00920829|616756463|FG002|Available for Analysis|Withdrawal by Subject|6|||
170656638|NCT00920829|616756464|FG003|Available for Analysis|Withdrawal by Subject|10|||
170656639|NCT00920829|616756461|FG000|Available for Analysis|Required Medical Treatment|0|||
170656640|NCT00920829|616756462|FG001|Available for Analysis|Required Medical Treatment|1|||
170656641|NCT00920829|616756463|FG002|Available for Analysis|Required Medical Treatment|2|||
170656642|NCT00920829|616756464|FG003|Available for Analysis|Required Medical Treatment|0|||
170656643|NCT00920829|616756461|FG000|Available for Analysis|Adverse Event|1|||
170656644|NCT00920829|616756462|FG001|Available for Analysis|Adverse Event|2|||
170656645|NCT00920829|616756463|FG002|Available for Analysis|Adverse Event|1|||
170656646|NCT00920829|616756464|FG003|Available for Analysis|Adverse Event|0|||
170656647|NCT00920829|616756461|FG000|Available for Analysis|Death|1|||
170613220|NCT00934128|616588885|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
170613221|NCT00934128|616588884|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
170613222|NCT00934128|616588885|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
170613223|NCT03228212|616588886|FG000|Period 1|Adverse Event|1|||
170613224|NCT03228212|616588887|FG001|Period 1|Adverse Event|0|||
170613225|NCT03228212|616588886|FG000|Period 1|no longer meets eligibility criteria|0|||
170613226|NCT03228212|616588887|FG001|Period 1|no longer meets eligibility criteria|1|||
170613227|NCT03228212|616588886|FG000|Period 2|Lost to Follow-up|1|||
170613228|NCT03228212|616588887|FG001|Period 2|Lost to Follow-up|0|||
170613229|NCT00811174|616588891|FG000|Overall Study|Protocol Violation|2|||
170613230|NCT00811174|616588891|FG000|Overall Study|Sponsors Decision|1|||
170613231|NCT04404556|616591441|FG000|Intervention|Withdrawal by Subject|15|||
170613232|NCT04404556|616591442|FG001|Intervention|Withdrawal by Subject|3|||
170613233|NCT04404556|616591441|FG000|Intervention|Did not complete all intervention sessions|2|||
170613234|NCT04404556|616591442|FG001|Intervention|Did not complete all intervention sessions|1|||
170613235|NCT04404556|616591441|FG000|Post-Intervention|Missing Data|1|||
170613236|NCT04404556|616591442|FG001|Post-Intervention|Missing Data|2|||
170613237|NCT04404556|616591441|FG000|Follow-up 1|Withdrawal by Subject|5|||
170613238|NCT04404556|616591442|FG001|Follow-up 1|Withdrawal by Subject|1|||
170613239|NCT04404556|616591441|FG000|Follow-up 1|Missing Data|4|||
170613240|NCT04404556|616591442|FG001|Follow-up 1|Missing Data|7|||
170613241|NCT04404556|616591441|FG000|Follow-up 2|Withdrawal by Subject|1|||
170613242|NCT04404556|616591442|FG001|Follow-up 2|Withdrawal by Subject|1|||
170613243|NCT04404556|616591441|FG000|Follow-up 2|Missing Data|6|||
170613244|NCT04404556|616591442|FG001|Follow-up 2|Missing Data|5|||
170613245|NCT00859547|616591445|FG000|Overall Study|Lost to Follow-up|1|||
170613246|NCT00859547|616591445|FG000|Overall Study|Parent withdrew consent|1|||
170613247|NCT00269919|616591448|FG000|Overall Study|Other|26|||
170613248|NCT00269919|616591448|FG000|Overall Study|Started but not treated|1|||
170613249|NCT01388907|616591449|FG000|Overall Study|Adverse Event|2|||
170613250|NCT01388907|616591450|FG001|Overall Study|Adverse Event|0|||
170613251|NCT02128724|616591451|FG000|Overall Study|Death|1|||
170613252|NCT02128724|616591452|FG001|Overall Study|Death|0|||
170613253|NCT02128724|616591453|FG002|Overall Study|Death|0|||
170613254|NCT02128724|616591454|FG003|Overall Study|Death|0|||
170613255|NCT02128724|616591451|FG000|Overall Study|Adverse Event|0|||
170613256|NCT02128724|616591452|FG001|Overall Study|Adverse Event|1|||
170613257|NCT02128724|616591453|FG002|Overall Study|Adverse Event|0|||
170613258|NCT02128724|616591454|FG003|Overall Study|Adverse Event|0|||
170613259|NCT02128724|616591451|FG000|Overall Study|Physician Decision|0|||
170613260|NCT02128724|616591452|FG001|Overall Study|Physician Decision|0|||
170613261|NCT02128724|616591453|FG002|Overall Study|Physician Decision|0|||
170613262|NCT02128724|616591454|FG003|Overall Study|Physician Decision|2|||
170613263|NCT02128724|616591451|FG000|Overall Study|Withdrawal by Subject|0|||
170613264|NCT02128724|616591452|FG001|Overall Study|Withdrawal by Subject|0|||
170613265|NCT02128724|616591453|FG002|Overall Study|Withdrawal by Subject|0|||
170613266|NCT02128724|616591454|FG003|Overall Study|Withdrawal by Subject|1|||
170613267|NCT00193206|616591457|FG000|Preoperative Therapy|Lack of Efficacy|2|||
170613268|NCT00193206|616591457|FG000|Preoperative Therapy|Adverse Event|2|||
170613269|NCT00193206|616591457|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
170613270|NCT00193206|616591457|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
170613271|NCT00193206|616591457|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
170613272|NCT00193206|616591457|FG000|Postoperative Therapy|Physician Decision|3|||
170613273|NCT00193206|616591457|FG000|Postoperative Therapy|Intercurrent Illness|2|||
170916915|NCT03504397|617697780|FG001|Overall Study|miscellaneous|15|||
170613274|NCT00193206|616591457|FG000|Postoperative Therapy|Lack of Efficacy|1|||
170613275|NCT00193206|616591457|FG000|Postoperative Therapy|Protocol Violation|1|||
170613276|NCT00570310|616591459|FG000|Overall Study|Adverse Event|1|||
170613277|NCT00570310|616591460|FG001|Overall Study|Adverse Event|2|||
170613278|NCT00570310|616591459|FG000|Overall Study|Lack of Efficacy|1|||
170613279|NCT00570310|616591460|FG001|Overall Study|Lack of Efficacy|4|||
170613280|NCT03088917|616591464|FG000|Overall Study|In care/cured elsewhere|15|||
170613281|NCT03088917|616591464|FG000|Overall Study|Refuse re-evaluation|13|||
170613282|NCT03088917|616591464|FG000|Overall Study|Contact not established|13|||
170656648|NCT00920829|616756462|FG001|Available for Analysis|Death|0|||
170656649|NCT00920829|616756463|FG002|Available for Analysis|Death|0|||
170656650|NCT00920829|616756464|FG003|Available for Analysis|Death|0|||
170656651|NCT00920829|616756461|FG000|Available for Analysis|Protocol Violation|0|||
170656652|NCT00920829|616756462|FG001|Available for Analysis|Protocol Violation|0|||
170656653|NCT00920829|616756463|FG002|Available for Analysis|Protocol Violation|1|||
170656654|NCT00920829|616756464|FG003|Available for Analysis|Protocol Violation|0|||
170656655|NCT00920829|616756461|FG000|Available for Analysis|Required more treatment|0|||
170656656|NCT00920829|616756462|FG001|Available for Analysis|Required more treatment|2|||
170656657|NCT00920829|616756463|FG002|Available for Analysis|Required more treatment|0|||
170656658|NCT00920829|616756464|FG003|Available for Analysis|Required more treatment|1|||
170656659|NCT02237911|616756465|FG000|Overall Study|Withdrawal by Subject|4|||
170656660|NCT02237911|616756466|FG001|Overall Study|Withdrawal by Subject|7|||
170656661|NCT02237911|616756467|FG002|Overall Study|Withdrawal by Subject|2|||
170656662|NCT02237911|616756465|FG000|Overall Study|Lost to Follow-up|3|||
170656663|NCT02237911|616756466|FG001|Overall Study|Lost to Follow-up|1|||
170656664|NCT02237911|616756467|FG002|Overall Study|Lost to Follow-up|1|||
170656665|NCT00053365|616756468|FG000|Overall Study|Incorrect cell type|1|||
170656666|NCT00053365|616756468|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
170656667|NCT00053365|616756468|FG000|Overall Study|Never treated|4|||
170656668|NCT00737464|616756477|FG000|Overall Study|Adverse Event|1|||
170656669|NCT00737464|616756477|FG000|Overall Study|Death|6|||
170656670|NCT00737464|616756477|FG000|Overall Study|Other - Failure to Return|1|||
170656671|NCT00737464|616756477|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
170656672|NCT00737464|616756477|FG000|Overall Study|Other reasons|4|||
170656673|NCT02423109|616756481|FG000|Lens 1|Adverse Event|1|||
170656674|NCT02423109|616756482|FG001|Lens 1|Adverse Event|0|||
170656675|NCT03347188|616756483|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
170656676|NCT03347188|616756484|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
170656677|NCT03347188|616756483|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
170656678|NCT03347188|616756484|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
170656679|NCT03347188|616756483|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
170656680|NCT03347188|616756484|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
170656681|NCT03347188|616756483|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
170656682|NCT03347188|616756484|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
170656683|NCT03347188|616756483|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
170656684|NCT03347188|616756484|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
170656685|NCT03347188|616756483|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
170656686|NCT03347188|616756484|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
170656687|NCT03347188|616756483|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
170656688|NCT03347188|616756484|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
170656689|NCT03347188|616756483|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
170656690|NCT03347188|616756484|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
170656691|NCT02742246|616756485|FG000|Overall Study|Never initiated treatment|5|||
170656692|NCT02742246|616756486|FG001|Overall Study|Never initiated treatment|3|||
170656693|NCT02742246|616756487|FG002|Overall Study|Never initiated treatment|1|||
170656694|NCT02742246|616756485|FG000|Overall Study|dropped out during treatment|7|||
170656695|NCT02742246|616756486|FG001|Overall Study|dropped out during treatment|13|||
170656696|NCT02742246|616756487|FG002|Overall Study|dropped out during treatment|10|||
170656697|NCT02742246|616756485|FG000|Overall Study|Death|1|||
170656698|NCT02742246|616756486|FG001|Overall Study|Death|0|||
170656699|NCT02742246|616756487|FG002|Overall Study|Death|0|||
170656700|NCT00367770|616756490|FG000|Overall Study|Adverse Event|1|||
170656701|NCT00367770|616756490|FG000|Overall Study|Withdrawal by Subject|1|||
170656702|NCT03190369|616756493|FG000|Overall Study|Poor compliance to protocol|0|||
170656703|NCT03190369|616756494|FG001|Overall Study|Poor compliance to protocol|1|||
170656704|NCT03190369|616756493|FG000|Overall Study|Withdraw before treatment|1|||
170656705|NCT03190369|616756494|FG001|Overall Study|Withdraw before treatment|5|||
170656706|NCT03190369|616756493|FG000|Overall Study|Randomized but not treated|0|||
170656707|NCT03190369|616756494|FG001|Overall Study|Randomized but not treated|2|||
170656708|NCT01606254|616756495|FG000|Overall Study|Withdrawal by Subject|1|||
170656709|NCT01606254|616756496|FG001|Overall Study|Withdrawal by Subject|3|||
170656710|NCT01606254|616756497|FG002|Overall Study|Withdrawal by Subject|0|||
170656711|NCT01606254|616756498|FG003|Overall Study|Withdrawal by Subject|2|||
170656712|NCT01606254|616756495|FG000|Overall Study|Adverse Event|1|||
170656713|NCT01606254|616756496|FG001|Overall Study|Adverse Event|1|||
170656714|NCT01606254|616756497|FG002|Overall Study|Adverse Event|0|||
170656715|NCT01606254|616756498|FG003|Overall Study|Adverse Event|1|||
170656716|NCT02195011|616756500|FG000|Overall Study|Adverse Event|4|||
170656717|NCT02195011|616756501|FG001|Overall Study|Adverse Event|0|||
170656718|NCT02195011|616756500|FG000|Overall Study|Progressive Disease|18|||
170656719|NCT02195011|616756501|FG001|Overall Study|Progressive Disease|1|||
170656720|NCT02195011|616756500|FG000|Overall Study|Withdrawal by Subject|3|||
170656721|NCT02195011|616756501|FG001|Overall Study|Withdrawal by Subject|0|||
170656722|NCT03418571|616756502|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
170656723|NCT03418571|616756503|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
170656724|NCT00559754|616756504|FG000|Overall Study|Disease progression|1|||
170656725|NCT00559754|616756504|FG000|Overall Study|Adverse Event|5|||
170656726|NCT00559754|616756504|FG000|Overall Study|Protocol Violation|1|||
170656727|NCT00559754|616756504|FG000|Overall Study|Investigator criteria|2|||
170656728|NCT00559754|616756504|FG000|Overall Study|Withdrawal by Subject|2|||
170656729|NCT01439347|616756505|FG000|Overall Study|Death|10|||
170656730|NCT01439347|616756506|FG001|Overall Study|Death|9|||
170656731|NCT01439347|616756505|FG000|Overall Study|Withdrawal by Subject|0|||
170656732|NCT01439347|616756506|FG001|Overall Study|Withdrawal by Subject|1|||
170656733|NCT01439347|616756505|FG000|Overall Study|Physician Decision|1|||
170656734|NCT01439347|616756506|FG001|Overall Study|Physician Decision|0|||
170656735|NCT01439347|616756505|FG000|Overall Study|Sponsor Terminated Study|2|||
170656736|NCT01439347|616756506|FG001|Overall Study|Sponsor Terminated Study|3|||
170656737|NCT00913692|616756508|FG000|Screening (4 Months)|Physician Decision|3|||
170656738|NCT00913692|616756508|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
170656739|NCT00913692|616756508|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
170656740|NCT00829283|616756509|FG000|Overall Study|Lost to Follow-up|7|||
170656741|NCT00829283|616756510|FG001|Overall Study|Lost to Follow-up|25|||
170656742|NCT02414139|616756511|FG000|Treatment Period|Adverse Event|11|||
170656743|NCT02414139|616756512|FG001|Treatment Period|Adverse Event|6|||
170656744|NCT02414139|616756513|FG002|Treatment Period|Adverse Event|8|||
170656745|NCT02414139|616756514|FG003|Treatment Period|Adverse Event|5|||
170656746|NCT02414139|616756515|FG004|Treatment Period|Adverse Event|14|||
170656747|NCT02414139|616756516|FG005|Treatment Period|Adverse Event|3|||
170656748|NCT02414139|616756517|FG006|Treatment Period|Adverse Event|6|||
170656749|NCT02414139|616756518|FG007|Treatment Period|Adverse Event|1|||
170656750|NCT02414139|616756519|FG008|Treatment Period|Adverse Event|6|||
170656751|NCT02414139|616756520|FG009|Treatment Period|Adverse Event|8|||
170656752|NCT02414139|616756511|FG000|Treatment Period|Death|0|||
170656753|NCT02414139|616756512|FG001|Treatment Period|Death|0|||
170656754|NCT02414139|616756513|FG002|Treatment Period|Death|1|||
170656755|NCT02414139|616756514|FG003|Treatment Period|Death|1|||
170656756|NCT02414139|616756515|FG004|Treatment Period|Death|0|||
170656757|NCT02414139|616756516|FG005|Treatment Period|Death|0|||
170656758|NCT02414139|616756517|FG006|Treatment Period|Death|0|||
170656759|NCT02414139|616756518|FG007|Treatment Period|Death|0|||
170656760|NCT02414139|616756519|FG008|Treatment Period|Death|0|||
170656761|NCT02414139|616756520|FG009|Treatment Period|Death|1|||
170656762|NCT02414139|616756511|FG000|Treatment Period|Physician Decision|5|||
170656763|NCT02414139|616756512|FG001|Treatment Period|Physician Decision|4|||
170656764|NCT02414139|616756513|FG002|Treatment Period|Physician Decision|6|||
170656765|NCT02414139|616756514|FG003|Treatment Period|Physician Decision|1|||
170656766|NCT02414139|616756515|FG004|Treatment Period|Physician Decision|4|||
170656767|NCT02414139|616756516|FG005|Treatment Period|Physician Decision|0|||
170656768|NCT02414139|616756517|FG006|Treatment Period|Physician Decision|2|||
170656769|NCT02414139|616756518|FG007|Treatment Period|Physician Decision|0|||
170656770|NCT02414139|616756519|FG008|Treatment Period|Physician Decision|1|||
170656771|NCT02414139|616756520|FG009|Treatment Period|Physician Decision|4|||
170656772|NCT02414139|616756511|FG000|Treatment Period|Progressive disease|48|||
170656773|NCT02414139|616756512|FG001|Treatment Period|Progressive disease|31|||
170656774|NCT02414139|616756513|FG002|Treatment Period|Progressive disease|37|||
170656775|NCT02414139|616756514|FG003|Treatment Period|Progressive disease|21|||
170656776|NCT02414139|616756515|FG004|Treatment Period|Progressive disease|43|||
170656777|NCT02414139|616756516|FG005|Treatment Period|Progressive disease|12|||
170656778|NCT02414139|616756517|FG006|Treatment Period|Progressive disease|16|||
170656779|NCT02414139|616756518|FG007|Treatment Period|Progressive disease|2|||
170656780|NCT02414139|616756519|FG008|Treatment Period|Progressive disease|20|||
170656781|NCT02414139|616756520|FG009|Treatment Period|Progressive disease|14|||
170656782|NCT02414139|616756511|FG000|Treatment Period|Protocol deviation|0|||
170656783|NCT02414139|616756512|FG001|Treatment Period|Protocol deviation|0|||
170656784|NCT02414139|616756513|FG002|Treatment Period|Protocol deviation|1|||
170656785|NCT02414139|616756514|FG003|Treatment Period|Protocol deviation|0|||
170656786|NCT02414139|616756515|FG004|Treatment Period|Protocol deviation|0|||
170656787|NCT02414139|616756516|FG005|Treatment Period|Protocol deviation|0|||
170816558|NCT03246724|617335515|FG000|Overall Study|Re-consented to participate|0|||
170816559|NCT03246724|617335516|FG001|Overall Study|Re-consented to participate|0|||
170656788|NCT02414139|616756517|FG006|Treatment Period|Protocol deviation|0|||
170656789|NCT02414139|616756518|FG007|Treatment Period|Protocol deviation|0|||
170656790|NCT02414139|616756519|FG008|Treatment Period|Protocol deviation|0|||
170656791|NCT02414139|616756520|FG009|Treatment Period|Protocol deviation|0|||
170656792|NCT02414139|616756511|FG000|Treatment Period|Subject/Guardian decision|5|||
170656793|NCT02414139|616756512|FG001|Treatment Period|Subject/Guardian decision|1|||
170656794|NCT02414139|616756513|FG002|Treatment Period|Subject/Guardian decision|1|||
170656795|NCT02414139|616756514|FG003|Treatment Period|Subject/Guardian decision|2|||
170656796|NCT02414139|616756515|FG004|Treatment Period|Subject/Guardian decision|5|||
170656797|NCT02414139|616756516|FG005|Treatment Period|Subject/Guardian decision|0|||
170656798|NCT02414139|616756517|FG006|Treatment Period|Subject/Guardian decision|2|||
170916916|NCT03504397|617697779|FG000|Overall Study|Protocol deviation|1|||
170656799|NCT02414139|616756518|FG007|Treatment Period|Subject/Guardian decision|0|||
170656800|NCT02414139|616756519|FG008|Treatment Period|Subject/Guardian decision|1|||
170656801|NCT02414139|616756520|FG009|Treatment Period|Subject/Guardian decision|1|||
170656802|NCT02414139|616756511|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
170656803|NCT02414139|616756512|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
170656804|NCT02414139|616756513|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
170656805|NCT02414139|616756514|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
170656806|NCT02414139|616756515|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
170656807|NCT02414139|616756516|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
170656808|NCT02414139|616756517|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
170656809|NCT02414139|616756518|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
170656810|NCT02414139|616756519|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
170656811|NCT02414139|616756520|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
170656812|NCT02414139|616756511|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
170656813|NCT02414139|616756512|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170656814|NCT02414139|616756513|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170656815|NCT02414139|616756514|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170656816|NCT02414139|616756515|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
170656817|NCT02414139|616756516|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170656818|NCT02414139|616756517|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170656819|NCT02414139|616756518|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170656820|NCT02414139|616756519|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170656821|NCT02414139|616756520|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
170656822|NCT02414139|616756511|FG000|Post-treatment Efficacy Follow-up|Death|0|||
170656823|NCT02414139|616756512|FG001|Post-treatment Efficacy Follow-up|Death|1|||
170656824|NCT02414139|616756513|FG002|Post-treatment Efficacy Follow-up|Death|0|||
170656825|NCT02414139|616756514|FG003|Post-treatment Efficacy Follow-up|Death|0|||
170656826|NCT02414139|616756515|FG004|Post-treatment Efficacy Follow-up|Death|1|||
170656827|NCT02414139|616756516|FG005|Post-treatment Efficacy Follow-up|Death|0|||
170656828|NCT02414139|616756517|FG006|Post-treatment Efficacy Follow-up|Death|0|||
170656829|NCT02414139|616756518|FG007|Post-treatment Efficacy Follow-up|Death|0|||
170656830|NCT02414139|616756519|FG008|Post-treatment Efficacy Follow-up|Death|0|||
170656831|NCT02414139|616756520|FG009|Post-treatment Efficacy Follow-up|Death|1|||
170656832|NCT02414139|616756511|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
170656833|NCT02414139|616756512|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656834|NCT02414139|616756513|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656835|NCT02414139|616756514|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656836|NCT02414139|616756515|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656837|NCT02414139|616756516|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656838|NCT02414139|616756517|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656839|NCT02414139|616756518|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656840|NCT02414139|616756519|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656841|NCT02414139|616756520|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
170656842|NCT02414139|616756511|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
170656843|NCT02414139|616756512|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
170656844|NCT02414139|616756513|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
170656845|NCT02414139|616756514|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
170656846|NCT02414139|616756515|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
170656847|NCT02414139|616756516|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
170656848|NCT02414139|616756517|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
170656849|NCT02414139|616756518|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
170656850|NCT02414139|616756519|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
170656851|NCT02414139|616756520|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
170656852|NCT02414139|616756511|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
170656853|NCT02414139|616756512|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
170656854|NCT02414139|616756513|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
170656855|NCT02414139|616756514|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
170656856|NCT02414139|616756515|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
170656857|NCT02414139|616756516|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
170656858|NCT02414139|616756517|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
170656859|NCT02414139|616756518|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
170656860|NCT02414139|616756519|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
170656861|NCT02414139|616756520|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
170656862|NCT02414139|616756511|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
170656863|NCT02414139|616756512|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
170656864|NCT02414139|616756513|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
170656865|NCT02414139|616756514|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
170656866|NCT02414139|616756515|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
170656867|NCT02414139|616756516|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
170656868|NCT02414139|616756517|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
170656869|NCT02414139|616756518|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
170816560|NCT03246724|617335517|FG002|Overall Study|Re-consented to participate|0|||
170816561|NCT03246724|617335518|FG003|Overall Study|Re-consented to participate|1|||
170816562|NCT02978716|617335519|FG000|Overall Study|Death|25|||
170816563|NCT02978716|617335520|FG001|Overall Study|Death|13|||
170816564|NCT02978716|617335521|FG002|Overall Study|Death|20|||
170656870|NCT02414139|616756519|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
170656871|NCT02414139|616756520|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
170656872|NCT02414139|616756511|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
170656873|NCT02414139|616756512|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
170656874|NCT02414139|616756513|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
170656875|NCT02414139|616756514|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
170656876|NCT02414139|616756515|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
170656877|NCT02414139|616756516|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
170656878|NCT02414139|616756517|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
170656879|NCT02414139|616756518|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
170656880|NCT02414139|616756519|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
170656881|NCT02414139|616756520|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
170656882|NCT00591578|616756521|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
170656883|NCT00591578|616756522|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
170656884|NCT00591578|616756523|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
170656885|NCT00591578|616756521|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
170656886|NCT00591578|616756522|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
170656887|NCT00591578|616756523|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
170656888|NCT00591578|616756521|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
170656889|NCT00591578|616756522|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
170656890|NCT00591578|616756523|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
170656891|NCT00591578|616756521|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
170656892|NCT00591578|616756522|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
170656893|NCT00591578|616756523|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
170656894|NCT00591578|616756521|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
170656895|NCT00591578|616756522|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
170656896|NCT00591578|616756523|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
170656897|NCT00591578|616756521|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
170656898|NCT00591578|616756522|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
170656899|NCT00591578|616756523|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
170656900|NCT00591578|616756521|FG000|Double-Blind Treatment Phase|Other|4|||
170656901|NCT00591578|616756522|FG001|Double-Blind Treatment Phase|Other|9|||
170656902|NCT00591578|616756523|FG002|Double-Blind Treatment Phase|Other|4|||
170656903|NCT00591578|616756521|FG000|Open-Label Extension Phase|Adverse Event|3|||
170656904|NCT00591578|616756522|FG001|Open-Label Extension Phase|Adverse Event|5|||
170656905|NCT00591578|616756523|FG002|Open-Label Extension Phase|Adverse Event|0|||
170656906|NCT00591578|616756521|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
170656907|NCT00591578|616756522|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
170656908|NCT00591578|616756523|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
170656909|NCT00591578|616756521|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
170656910|NCT00591578|616756522|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
170656911|NCT00591578|616756523|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
170656912|NCT00591578|616756521|FG000|Open-Label Extension Phase|Other|1|||
170656913|NCT00591578|616756522|FG001|Open-Label Extension Phase|Other|0|||
170656914|NCT00591578|616756523|FG002|Open-Label Extension Phase|Other|0|||
170656915|NCT03631355|616756524|FG000|Overall Study|Lost to Follow-up|1|||
170656916|NCT03631355|616756525|FG001|Overall Study|Lost to Follow-up|2|||
170656917|NCT00870233|616756528|FG000|Overall Study|Withdrawal by Subject|18|||
170656918|NCT00870233|616756528|FG000|Overall Study|Did not undergo laparotomy|3|||
170656919|NCT00870233|616756528|FG000|Overall Study|Incompatible internet browser|2|||
170656920|NCT00870233|616756528|FG000|Overall Study|Death|1|||
170656921|NCT02290431|616756529|FG000|Overall Study|Adverse Event|20|||
170816565|NCT02978716|617335519|FG000|Overall Study|Lost to Follow-up|0|||
170656922|NCT02290431|616756529|FG000|Overall Study|Progressive disease|4|||
170656923|NCT02290431|616756529|FG000|Overall Study|Study terminated by Sponsor|1|||
170656924|NCT02290431|616756529|FG000|Overall Study|Physician Decision|2|||
170656925|NCT02942576|616756531|FG000|Overall Study|Adverse Event|28|||
170656926|NCT02942576|616756532|FG001|Overall Study|Adverse Event|6|||
170816566|NCT02978716|617335520|FG001|Overall Study|Lost to Follow-up|0|||
170816567|NCT02978716|617335521|FG002|Overall Study|Lost to Follow-up|1|||
170816568|NCT02978716|617335519|FG000|Overall Study|Withdrawal by Subject|6|||
170816569|NCT02978716|617335520|FG001|Overall Study|Withdrawal by Subject|4|||
170656927|NCT02942576|616756531|FG000|Overall Study|Withdrawal by Subject|7|||
170656928|NCT02942576|616756532|FG001|Overall Study|Withdrawal by Subject|5|||
170656929|NCT02942576|616756531|FG000|Overall Study|Physician Decision|1|||
170656930|NCT02942576|616756532|FG001|Overall Study|Physician Decision|4|||
170656931|NCT02942576|616756531|FG000|Overall Study|Other|10|||
170656932|NCT02942576|616756532|FG001|Overall Study|Other|8|||
170656933|NCT00321893|616756533|FG000|Overall Study|Non-Compliance/Refusal|16|||
170656934|NCT00321893|616756534|FG001|Overall Study|Non-Compliance/Refusal|10|||
170656935|NCT00321893|616756533|FG000|Overall Study|Lost to Follow-up|2|||
170656936|NCT00321893|616756534|FG001|Overall Study|Lost to Follow-up|1|||
170656937|NCT00321893|616756533|FG000|Overall Study|Adverse Event|6|||
170656938|NCT00321893|616756534|FG001|Overall Study|Adverse Event|3|||
170656939|NCT00769483|616756535|FG000|Overall Study|Withdrawal by Subject|0|||
170656940|NCT00769483|616756536|FG001|Overall Study|Withdrawal by Subject|1|||
170656941|NCT00769483|616756537|FG002|Overall Study|Withdrawal by Subject|0|||
170656942|NCT00769483|616756538|FG003|Overall Study|Withdrawal by Subject|0|||
170656943|NCT00769483|616756539|FG004|Overall Study|Withdrawal by Subject|1|||
170656944|NCT00769483|616756540|FG005|Overall Study|Withdrawal by Subject|0|||
170656945|NCT03455764|616756541|FG000|Overall Study|Adverse Event|1|||
170656946|NCT03455764|616756542|FG001|Overall Study|Adverse Event|0|||
170656947|NCT03455764|616756543|FG002|Overall Study|Adverse Event|0|||
170656948|NCT03455764|616756544|FG003|Overall Study|Adverse Event|0|||
170656949|NCT03455764|616756545|FG004|Overall Study|Adverse Event|0|||
170656950|NCT03455764|616756541|FG000|Overall Study|Disease Progression|4|||
170656951|NCT03455764|616756542|FG001|Overall Study|Disease Progression|0|||
170656952|NCT03455764|616756543|FG002|Overall Study|Disease Progression|0|||
170656953|NCT03455764|616756544|FG003|Overall Study|Disease Progression|0|||
170656954|NCT03455764|616756545|FG004|Overall Study|Disease Progression|0|||
170656955|NCT03455764|616756541|FG000|Overall Study|On Treatment|1|||
170656956|NCT03455764|616756542|FG001|Overall Study|On Treatment|0|||
170656957|NCT03455764|616756543|FG002|Overall Study|On Treatment|0|||
170656958|NCT03455764|616756544|FG003|Overall Study|On Treatment|0|||
170656959|NCT03455764|616756545|FG004|Overall Study|On Treatment|0|||
170656960|NCT01306877|616756546|FG000|Overall Study|Lost to Follow-up|3|||
170656961|NCT01306877|616756547|FG001|Overall Study|Lost to Follow-up|3|||
170656962|NCT01306877|616756546|FG000|Overall Study|Physician Decision|0|||
170656963|NCT01306877|616756547|FG001|Overall Study|Physician Decision|1|||
170656964|NCT03523000|616756548|FG000|Overall Study|Withdrawal by Subject|3|||
170656965|NCT03523000|616756549|FG001|Overall Study|Withdrawal by Subject|0|||
170656966|NCT03523000|616756548|FG000|Overall Study|Unsuccessful trial|2|||
170656967|NCT03523000|616756549|FG001|Overall Study|Unsuccessful trial|0|||
170656968|NCT01285960|616756553|FG000|Overall Study|Withdrawal by Subject|2|||
170656969|NCT01285960|616756553|FG000|Overall Study|Lost to Follow-up|2|||
170656970|NCT01285960|616756553|FG000|Overall Study|2 subjects received less 10 sonications|2|||
170656971|NCT00266864|616756556|FG000|Overall Study|Lost to Follow-up|4|||
170656972|NCT00266864|616756557|FG001|Overall Study|Lost to Follow-up|1|||
170656973|NCT00266864|616756556|FG000|Overall Study|Withdrawal by Subject|1|||
170656974|NCT00266864|616756557|FG001|Overall Study|Withdrawal by Subject|1|||
170656975|NCT00829933|616756558|FG000|Overall Study|Adverse Event|2|||
170656976|NCT00829933|616756559|FG001|Overall Study|Adverse Event|3|||
170656977|NCT00829933|616756560|FG002|Overall Study|Adverse Event|2|||
170656978|NCT00829933|616756561|FG003|Overall Study|Adverse Event|1|||
170656979|NCT00829933|616756558|FG000|Overall Study|Death|0|||
170656980|NCT00829933|616756559|FG001|Overall Study|Death|0|||
170656981|NCT00829933|616756560|FG002|Overall Study|Death|1|||
170656982|NCT00829933|616756561|FG003|Overall Study|Death|1|||
170656983|NCT00829933|616756558|FG000|Overall Study|Lack of Efficacy|0|||
170656984|NCT00829933|616756559|FG001|Overall Study|Lack of Efficacy|1|||
170656985|NCT00829933|616756560|FG002|Overall Study|Lack of Efficacy|0|||
170656986|NCT00829933|616756561|FG003|Overall Study|Lack of Efficacy|0|||
170816570|NCT02978716|617335521|FG002|Overall Study|Withdrawal by Subject|5|||
170816571|NCT02978716|617335519|FG000|Overall Study|Sponsor terminated|2|||
170816572|NCT02978716|617335520|FG001|Overall Study|Sponsor terminated|13|||
170816573|NCT02978716|617335521|FG002|Overall Study|Sponsor terminated|9|||
170816574|NCT02978716|617335519|FG000|Overall Study|Other|1|||
170656987|NCT00829933|616756558|FG000|Overall Study|Physician Decision|5|||
170816575|NCT02978716|617335520|FG001|Overall Study|Other|3|||
170656988|NCT00829933|616756559|FG001|Overall Study|Physician Decision|7|||
170656989|NCT00829933|616756560|FG002|Overall Study|Physician Decision|8|||
170656990|NCT00829933|616756561|FG003|Overall Study|Physician Decision|1|||
170656991|NCT00829933|616756558|FG000|Overall Study|Pregnancy|0|||
170656992|NCT00829933|616756559|FG001|Overall Study|Pregnancy|0|||
170656993|NCT00829933|616756560|FG002|Overall Study|Pregnancy|0|||
170656994|NCT00829933|616756561|FG003|Overall Study|Pregnancy|2|||
170656995|NCT00829933|616756558|FG000|Overall Study|Protocol Violation|2|||
170656996|NCT00829933|616756559|FG001|Overall Study|Protocol Violation|1|||
170656997|NCT00829933|616756560|FG002|Overall Study|Protocol Violation|0|||
170656998|NCT00829933|616756561|FG003|Overall Study|Protocol Violation|0|||
170816576|NCT02978716|617335521|FG002|Overall Study|Other|0|||
170656999|NCT00829933|616756558|FG000|Overall Study|withdrew before treatment started|5|||
170816577|NCT00589628|617335522|FG000|Overall Study|Lost to Follow-up|0|||
170657000|NCT00829933|616756559|FG001|Overall Study|withdrew before treatment started|1|||
170657001|NCT00829933|616756560|FG002|Overall Study|withdrew before treatment started|2|||
170657002|NCT00829933|616756561|FG003|Overall Study|withdrew before treatment started|9|||
170657003|NCT02359851|616756571|FG000|Overall Study|Death|1|||
170657004|NCT02359851|616756571|FG000|Overall Study|Disease progression|1|||
170657005|NCT02125604|616756572|FG000|Overall Study|Other|4|||
170657006|NCT02125604|616756572|FG000|Overall Study|Investigator Decision|1|||
170657007|NCT02125604|616756572|FG000|Overall Study|Lost to Follow-up|2|||
170657008|NCT02125604|616756572|FG000|Overall Study|Consent Withdrawn|4|||
170657009|NCT02125604|616756572|FG000|Overall Study|Adverse Event|20|||
170657010|NCT02361346|616756575|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
170657011|NCT02361346|616756576|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
170657012|NCT02361346|616756577|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
170657013|NCT02361346|616756578|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
170657014|NCT02361346|616756579|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
170657015|NCT02361346|616756580|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
170657016|NCT02361346|616756581|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
170657017|NCT02361346|616756582|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
170657018|NCT02361346|616756583|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
170657019|NCT02361346|616756575|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
170657020|NCT02361346|616756576|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
170657021|NCT02361346|616756577|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
170657022|NCT02361346|616756578|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
170657023|NCT02361346|616756579|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
170657024|NCT02361346|616756580|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
170657025|NCT02361346|616756581|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
170657026|NCT02361346|616756582|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
170816578|NCT00589628|617335523|FG001|Overall Study|Lost to Follow-up|1|||
170816579|NCT00845520|617335527|FG000|Overall Study|Death|1|||
170816580|NCT00845520|617335528|FG001|Overall Study|Death|2|||
170816581|NCT00845520|617335529|FG002|Overall Study|Death|0|||
170816582|NCT00845520|617335527|FG000|Overall Study|Lost to Follow-up|1|||
170613283|NCT03088917|616591464|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
170613284|NCT03088917|616591464|FG000|Overall Study|Moved outside study region|50|||
170613285|NCT00580723|616591465|FG000|Overall Study|Did not want to participate in extension|3|||
170613286|NCT00580723|616591465|FG000|Overall Study|Lost to Follow-up|5|||
170613287|NCT02562716|616591466|FG000|Overall Study|Adverse Event|7|||
170613288|NCT02562716|616591467|FG001|Overall Study|Adverse Event|14|||
170613289|NCT02562716|616591466|FG000|Overall Study|Withdrawal unrelated to AE|7|||
170613290|NCT02562716|616591467|FG001|Overall Study|Withdrawal unrelated to AE|1|||
170613291|NCT02562716|616591466|FG000|Overall Study|Progression|8|||
170613292|NCT02562716|616591467|FG001|Overall Study|Progression|10|||
170613293|NCT02562716|616591466|FG000|Overall Study|Death|2|||
170613294|NCT02562716|616591467|FG001|Overall Study|Death|1|||
170613295|NCT02562716|616591466|FG000|Overall Study|Not protocol specified|4|||
170613296|NCT02562716|616591467|FG001|Overall Study|Not protocol specified|2|||
170613297|NCT02753946|616591468|FG000|Overall Study|Adverse Event|7|||
170613298|NCT02753946|616591469|FG001|Overall Study|Adverse Event|6|||
170613299|NCT02753946|616591468|FG000|Overall Study|Withdrawal by Subject|6|||
170613300|NCT02753946|616591469|FG001|Overall Study|Withdrawal by Subject|1|||
170613301|NCT02753946|616591468|FG000|Overall Study|Lack of Efficacy|1|||
170613302|NCT02753946|616591469|FG001|Overall Study|Lack of Efficacy|0|||
170657027|NCT02361346|616756583|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
170657028|NCT02361346|616756575|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
170657029|NCT02361346|616756576|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
170657030|NCT02361346|616756577|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
170657031|NCT02361346|616756578|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
170657032|NCT02361346|616756579|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
170657033|NCT02361346|616756580|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
170657034|NCT02361346|616756581|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
170657035|NCT02361346|616756582|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
170657036|NCT02361346|616756583|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
170657037|NCT02361346|616756575|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
170657038|NCT02361346|616756576|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
170816583|NCT00845520|617335528|FG001|Overall Study|Lost to Follow-up|0|||
170816584|NCT00845520|617335529|FG002|Overall Study|Lost to Follow-up|0|||
170816585|NCT00845520|617335527|FG000|Overall Study|Adverse Event|0|||
170816586|NCT00845520|617335528|FG001|Overall Study|Adverse Event|0|||
170613303|NCT02753946|616591468|FG000|Overall Study|Physician Decision|0|||
170613304|NCT02753946|616591469|FG001|Overall Study|Physician Decision|2|||
170613305|NCT02519439|616591470|FG000|Overall Study|Study Termination|19|||
170657039|NCT02361346|616756577|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
170657040|NCT02361346|616756578|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
170816587|NCT00845520|617335529|FG002|Overall Study|Adverse Event|1|||
170816588|NCT02613403|617335538|FG000|Overall Study|Lost to Follow-up|0|||
170816589|NCT02613403|617335539|FG001|Overall Study|Lost to Follow-up|1|||
170613306|NCT02519439|616591470|FG000|Overall Study|Withdrawal by Subject|1|||
170657041|NCT02361346|616756579|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
170657042|NCT02361346|616756580|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
170657043|NCT02361346|616756581|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
170657044|NCT02361346|616756582|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
170657045|NCT02361346|616756583|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
170657046|NCT02361346|616756575|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
170657047|NCT02361346|616756576|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
170657048|NCT02361346|616756577|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
170657049|NCT02361346|616756578|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
170657050|NCT02361346|616756579|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
170657051|NCT02361346|616756580|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
170657052|NCT02361346|616756581|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
170657053|NCT02361346|616756582|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
170657054|NCT02361346|616756583|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
170657055|NCT02361346|616756575|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
170657056|NCT02361346|616756576|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
170657057|NCT02361346|616756577|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
170657058|NCT02361346|616756578|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
170657059|NCT02361346|616756579|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
170657060|NCT02361346|616756580|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
170657061|NCT02361346|616756581|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
170657062|NCT02361346|616756582|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
170657063|NCT02361346|616756583|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
170657064|NCT00782795|616756584|FG000|Overall Study|Withdrawal by Subject|1|||
170657065|NCT00782795|616756585|FG001|Overall Study|Withdrawal by Subject|2|||
170657066|NCT04480424|616756586|FG000|Overall Study|Withdrawal by Subject|0|||
170657067|NCT04480424|616756587|FG001|Overall Study|Withdrawal by Subject|2|||
170657068|NCT04480424|616756586|FG000|Overall Study|Lost to Follow-up|3|||
170657069|NCT04480424|616756587|FG001|Overall Study|Lost to Follow-up|3|||
170657070|NCT04480424|616756586|FG000|Overall Study|Death|14|||
170657071|NCT04480424|616756587|FG001|Overall Study|Death|16|||
170657072|NCT04480424|616756586|FG000|Overall Study|Reason not Specified|5|||
170657073|NCT04480424|616756587|FG001|Overall Study|Reason not Specified|5|||
170657074|NCT00993044|616756588|FG000|Irinotecan 50 mg|Physician Decision|1|||
170657075|NCT03875118|616758252|FG000|Overall Study|Withdrawal by Subject|4|||
170657076|NCT03875118|616758253|FG001|Overall Study|Withdrawal by Subject|4|||
170657077|NCT00721123|616758254|FG000|Overall Study|Adverse Event|96|||
170657078|NCT00721123|616758254|FG000|Overall Study|Death|10|||
170657079|NCT00721123|616758254|FG000|Overall Study|Insufficient Therapeutic Response|21|||
170657080|NCT00721123|616758254|FG000|Overall Study|Protocol Violation|1|||
170657081|NCT00721123|616758254|FG000|Overall Study|Refused Treatment|41|||
170657082|NCT00721123|616758254|FG000|Overall Study|Failure to Return|9|||
170657083|NCT00721123|616758254|FG000|Overall Study|Withdrawal by Subject|5|||
170657084|NCT02428608|616758258|FG000|Overall Study|Pregnancy|2|||
170657085|NCT02428608|616758258|FG000|Overall Study|Lost to Follow-up|37|||
170657086|NCT02428608|616758258|FG000|Overall Study|Withdrawal by Subject|2|||
170657087|NCT02428608|616758258|FG000|Overall Study|scheduling conflicts|15|||
170657088|NCT02428608|616758258|FG000|Overall Study|moved away|10|||
170657089|NCT02428608|616758258|FG000|Overall Study|Death|1|||
170657090|NCT02428608|616758258|FG000|Overall Study|various|16|||
170657091|NCT03468985|616758259|FG000|Overall Study|Adverse Event|0|||
170657092|NCT03468985|616758260|FG001|Overall Study|Adverse Event|2|||
170657093|NCT03468985|616758261|FG002|Overall Study|Adverse Event|0|||
170657094|NCT03468985|616758262|FG003|Overall Study|Adverse Event|0|||
170657095|NCT03468985|616758259|FG000|Overall Study|Withdrawal by Subject|0|||
170657096|NCT03468985|616758260|FG001|Overall Study|Withdrawal by Subject|0|||
170657097|NCT03468985|616758261|FG002|Overall Study|Withdrawal by Subject|0|||
170657098|NCT03468985|616758262|FG003|Overall Study|Withdrawal by Subject|1|||
170657099|NCT03868124|616758263|FG000|Overall Study|Withdrawal by Subject|4|||
170657100|NCT03868124|616758264|FG001|Overall Study|Withdrawal by Subject|0|||
170657101|NCT03868124|616758265|FG002|Overall Study|Withdrawal by Subject|1|||
170657102|NCT03868124|616758263|FG000|Overall Study|Physician Decision|1|||
170657103|NCT03868124|616758264|FG001|Overall Study|Physician Decision|0|||
170657104|NCT03868124|616758265|FG002|Overall Study|Physician Decision|1|||
170657105|NCT03868124|616758263|FG000|Overall Study|Lost to Follow-up|1|||
170657106|NCT03868124|616758264|FG001|Overall Study|Lost to Follow-up|1|||
170657107|NCT03868124|616758265|FG002|Overall Study|Lost to Follow-up|2|||
170657108|NCT03868124|616758263|FG000|Overall Study|Death|1|||
170657109|NCT03868124|616758264|FG001|Overall Study|Death|1|||
170657110|NCT03868124|616758265|FG002|Overall Study|Death|2|||
170657111|NCT03868124|616758263|FG000|Overall Study|Adverse Event|0|||
170657112|NCT03868124|616758264|FG001|Overall Study|Adverse Event|0|||
170657113|NCT03868124|616758265|FG002|Overall Study|Adverse Event|3|||
170657114|NCT03868124|616758263|FG000|Overall Study|Explanted|2|||
170613307|NCT02519439|616591470|FG000|Overall Study|Adverse Event|1|||
170613308|NCT03030417|616591479|FG000|Dose Expansion|Disease progression before treatment|0|||
170613309|NCT03030417|616591480|FG001|Dose Expansion|Disease progression before treatment|0|||
170613310|NCT03030417|616591481|FG002|Dose Expansion|Disease progression before treatment|0|||
170613311|NCT03030417|616591482|FG003|Dose Expansion|Disease progression before treatment|0|||
170613312|NCT03030417|616591483|FG004|Dose Expansion|Disease progression before treatment|0|||
170613313|NCT03030417|616591484|FG005|Dose Expansion|Disease progression before treatment|0|||
170613314|NCT03030417|616591485|FG006|Dose Expansion|Disease progression before treatment|0|||
170613315|NCT03030417|616591486|FG007|Dose Expansion|Disease progression before treatment|0|||
170613316|NCT03030417|616591487|FG008|Dose Expansion|Disease progression before treatment|0|||
170613317|NCT03030417|616591488|FG009|Dose Expansion|Disease progression before treatment|0|||
170613318|NCT03030417|616591489|FG010|Dose Expansion|Disease progression before treatment|0|||
170613319|NCT03030417|616591490|FG011|Dose Expansion|Disease progression before treatment|0|||
170613320|NCT03030417|616591491|FG012|Dose Expansion|Disease progression before treatment|1|||
170613321|NCT02868554|616591492|FG000|Overall Study|Lost to Follow-up|3|||
170613322|NCT02868554|616591493|FG001|Overall Study|Lost to Follow-up|0|||
170613323|NCT02868554|616591494|FG002|Overall Study|Lost to Follow-up|1|||
170613324|NCT02175017|616591495|FG000|Overall Study|Did not receive the investigational product|1|||
170613325|NCT02175017|616591496|FG001|Overall Study|Did not receive the investigational product|2|||
170613326|NCT02175017|616591495|FG000|Overall Study|Withdrawal by Subject|6|||
170613327|NCT02175017|616591496|FG001|Overall Study|Withdrawal by Subject|3|||
170613328|NCT02175017|616591495|FG000|Overall Study|Met an exclusion criteria|0|||
170613329|NCT02175017|616591496|FG001|Overall Study|Met an exclusion criteria|1|||
170613330|NCT02175017|616591495|FG000|Overall Study|Adverse Event|3|||
170613331|NCT02175017|616591496|FG001|Overall Study|Adverse Event|10|||
170613332|NCT02175017|616591495|FG000|Overall Study|Disease progression|20|||
170613333|NCT02175017|616591496|FG001|Overall Study|Disease progression|27|||
170613334|NCT02175017|616591495|FG000|Overall Study|Other than above reasons|3|||
170613335|NCT02175017|616591496|FG001|Overall Study|Other than above reasons|0|||
170613336|NCT04915729|616591497|FG000|Overall Study|Lost to Follow-up|20|||
170613337|NCT04915729|616591498|FG001|Overall Study|Lost to Follow-up|10|||
170613338|NCT04915729|616591497|FG000|Overall Study|Withdrawal by Subject|12|||
170613339|NCT04915729|616591498|FG001|Overall Study|Withdrawal by Subject|5|||
170613340|NCT04915729|616591497|FG000|Overall Study|Death|34|||
170613341|NCT04915729|616591498|FG001|Overall Study|Death|44|||
170613342|NCT04915729|616591497|FG000|Overall Study|not treated|3|||
170613343|NCT04915729|616591498|FG001|Overall Study|not treated|6|||
170613344|NCT04915729|616591497|FG000|Overall Study|Investigator removed subject|1|||
170613345|NCT04915729|616591498|FG001|Overall Study|Investigator removed subject|2|||
170613346|NCT04915729|616591497|FG000|Overall Study|questionnaire result not evaluated|1|||
170613347|NCT04915729|616591498|FG001|Overall Study|questionnaire result not evaluated|0|||
170613348|NCT04915729|616591497|FG000|Overall Study|refuse of hospital visit|1|||
170613349|NCT04915729|616591498|FG001|Overall Study|refuse of hospital visit|3|||
170613350|NCT04915729|616591497|FG000|Overall Study|Subject withdrew|1|||
170613351|NCT04915729|616591498|FG001|Overall Study|Subject withdrew|0|||
170613352|NCT04961541|616591499|FG000|Overall Study|Adverse Event|0|||
170613353|NCT04961541|616591500|FG001|Overall Study|Adverse Event|0|||
170613354|NCT04961541|616591501|FG002|Overall Study|Adverse Event|0|||
170613355|NCT04961541|616591502|FG003|Overall Study|Adverse Event|0|||
170613356|NCT04961541|616591503|FG004|Overall Study|Adverse Event|0|||
170613357|NCT04961541|616591504|FG005|Overall Study|Adverse Event|1|||
170613358|NCT04961541|616591505|FG006|Overall Study|Adverse Event|0|||
170613359|NCT04961541|616591506|FG007|Overall Study|Adverse Event|0|||
170613360|NCT04961541|616591507|FG008|Overall Study|Adverse Event|0|||
170613361|NCT04961541|616591508|FG009|Overall Study|Adverse Event|0|||
170613362|NCT04961541|616591509|FG010|Overall Study|Adverse Event|0|||
170613363|NCT04961541|616591510|FG011|Overall Study|Adverse Event|0|||
170613364|NCT04961541|616591511|FG012|Overall Study|Adverse Event|0|||
170613365|NCT04961541|616591512|FG013|Overall Study|Adverse Event|0|||
170613366|NCT04961541|616591499|FG000|Overall Study|Lost to Follow-up|0|||
170613367|NCT04961541|616591500|FG001|Overall Study|Lost to Follow-up|0|||
170613368|NCT04961541|616591501|FG002|Overall Study|Lost to Follow-up|3|||
170613369|NCT04961541|616591502|FG003|Overall Study|Lost to Follow-up|0|||
170613370|NCT04961541|616591503|FG004|Overall Study|Lost to Follow-up|0|||
170613371|NCT04961541|616591504|FG005|Overall Study|Lost to Follow-up|0|||
170613372|NCT04961541|616591505|FG006|Overall Study|Lost to Follow-up|1|||
170613373|NCT04961541|616591506|FG007|Overall Study|Lost to Follow-up|1|||
170613374|NCT04961541|616591507|FG008|Overall Study|Lost to Follow-up|0|||
170613375|NCT04961541|616591508|FG009|Overall Study|Lost to Follow-up|1|||
170613376|NCT04961541|616591509|FG010|Overall Study|Lost to Follow-up|0|||
170613377|NCT04961541|616591510|FG011|Overall Study|Lost to Follow-up|0|||
170613378|NCT04961541|616591511|FG012|Overall Study|Lost to Follow-up|1|||
170613379|NCT04961541|616591512|FG013|Overall Study|Lost to Follow-up|0|||
170816590|NCT02613403|617335540|FG002|Overall Study|Lost to Follow-up|0|||
170613380|NCT04961541|616591499|FG000|Overall Study|Withdrawal by Subject|0|||
170613381|NCT04961541|616591500|FG001|Overall Study|Withdrawal by Subject|0|||
170657115|NCT03868124|616758264|FG001|Overall Study|Explanted|1|||
170613382|NCT04961541|616591501|FG002|Overall Study|Withdrawal by Subject|1|||
170613383|NCT04961541|616591502|FG003|Overall Study|Withdrawal by Subject|1|||
170613384|NCT04961541|616591503|FG004|Overall Study|Withdrawal by Subject|0|||
170613385|NCT04961541|616591504|FG005|Overall Study|Withdrawal by Subject|0|||
170613386|NCT04961541|616591505|FG006|Overall Study|Withdrawal by Subject|0|||
170613387|NCT04961541|616591506|FG007|Overall Study|Withdrawal by Subject|0|||
170613388|NCT04961541|616591507|FG008|Overall Study|Withdrawal by Subject|0|||
170613389|NCT04961541|616591508|FG009|Overall Study|Withdrawal by Subject|1|||
170613390|NCT04961541|616591509|FG010|Overall Study|Withdrawal by Subject|0|||
170613391|NCT04961541|616591510|FG011|Overall Study|Withdrawal by Subject|0|||
170613392|NCT04961541|616591511|FG012|Overall Study|Withdrawal by Subject|0|||
170613393|NCT04961541|616591512|FG013|Overall Study|Withdrawal by Subject|0|||
170613394|NCT01684202|616591513|FG000|Dose-escalation Period|Adverse Event|0|||
170613395|NCT01684202|616591514|FG001|Dose-escalation Period|Adverse Event|1|||
170613396|NCT01684202|616591515|FG002|Dose-escalation Period|Adverse Event|0|||
170613397|NCT01684202|616591516|FG003|Dose-escalation Period|Adverse Event|0|||
170613398|NCT01684202|616591513|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
170613399|NCT01684202|616591514|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
170613400|NCT01684202|616591515|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
170613401|NCT01684202|616591516|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
170613402|NCT01684202|616591513|FG000|Maintenance Period|Adverse Event|1|||
170613403|NCT01684202|616591514|FG001|Maintenance Period|Adverse Event|1|||
170613404|NCT01684202|616591515|FG002|Maintenance Period|Adverse Event|1|||
170613405|NCT01684202|616591516|FG003|Maintenance Period|Adverse Event|1|||
170613406|NCT01684202|616591513|FG000|Maintenance Period|Physician Decision|0|||
170613407|NCT01684202|616591514|FG001|Maintenance Period|Physician Decision|1|||
170613408|NCT01684202|616591515|FG002|Maintenance Period|Physician Decision|0|||
170613409|NCT01684202|616591516|FG003|Maintenance Period|Physician Decision|0|||
170613410|NCT01684202|616591513|FG000|Maintenance Period|Withdrawal by Subject|0|||
170613411|NCT01684202|616591514|FG001|Maintenance Period|Withdrawal by Subject|1|||
170613412|NCT01684202|616591515|FG002|Maintenance Period|Withdrawal by Subject|0|||
170613413|NCT01684202|616591516|FG003|Maintenance Period|Withdrawal by Subject|0|||
170613414|NCT00191308|616591517|FG000|Overall Study|Adverse Event|1|||
170613415|NCT03305770|616591518|FG000|Overall Study|Physician Decision - prior to dispense|0|||
170613416|NCT03305770|616591519|FG001|Overall Study|Physician Decision - prior to dispense|1|||
170613417|NCT03305770|616591518|FG000|Overall Study|Subject moved|1|||
170613418|NCT03305770|616591519|FG001|Overall Study|Subject moved|0|||
170613419|NCT01427933|616591525|FG000|Overall Study|Withdrawal by Subject|5|||
170613420|NCT01427933|616591526|FG001|Overall Study|Withdrawal by Subject|8|||
170613421|NCT01427933|616591525|FG000|Overall Study|Lost to Follow-up|1|||
170613422|NCT01427933|616591526|FG001|Overall Study|Lost to Follow-up|5|||
170613423|NCT01427933|616591525|FG000|Overall Study|Other|1|||
170613424|NCT01427933|616591526|FG001|Overall Study|Other|0|||
170613425|NCT01427933|616591525|FG000|Overall Study|Investigator's Decision|1|||
170613426|NCT01427933|616591526|FG001|Overall Study|Investigator's Decision|0|||
170613427|NCT01633541|616591527|FG000|Overall Study|Death|1|||
170613428|NCT01633541|616591528|FG001|Overall Study|Death|0|||
170613429|NCT03472326|616591531|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
170613430|NCT03472326|616591532|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
170613431|NCT03472326|616591533|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
170613432|NCT03472326|616591534|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
170613433|NCT03472326|616591531|FG000|Part 2: Combination Therapy|Pregnancy|0|||
170613434|NCT03472326|616591532|FG001|Part 2: Combination Therapy|Pregnancy|0|||
170613435|NCT03472326|616591533|FG002|Part 2: Combination Therapy|Pregnancy|0|||
170613436|NCT03472326|616591534|FG003|Part 2: Combination Therapy|Pregnancy|1|||
170613437|NCT05447663|616591535|FG000|Overall Study|Study terminated by Sponsor|5|||
170613438|NCT05447663|616591535|FG000|Overall Study|Death|2|||
170613439|NCT05447663|616591535|FG000|Overall Study|Withdrawal by Subject|1|||
170613440|NCT01100320|616591552|FG000|Period 1|Withdrawal by Subject|2|||
170613441|NCT01100320|616591553|FG001|Period 1|Withdrawal by Subject|4|||
170613442|NCT01100320|616591552|FG000|Period 1|Positive Drug Screen|1|||
170613443|NCT01100320|616591553|FG001|Period 1|Positive Drug Screen|1|||
170613444|NCT01100320|616591552|FG000|Period 1|Adverse Event|2|||
170613445|NCT01100320|616591553|FG001|Period 1|Adverse Event|2|||
170613446|NCT01100320|616591552|FG000|Period 2|Withdrawal by Subject|1|||
170613447|NCT01100320|616591553|FG001|Period 2|Withdrawal by Subject|1|||
170613448|NCT05729568|616591554|FG000|Overall Study|Still on Study|52|||
170613449|NCT05729568|616591555|FG001|Overall Study|Still on Study|26|||
170613450|NCT05729568|616591554|FG000|Overall Study|Randomized but Never Treated|3|||
170613451|NCT05729568|616591555|FG001|Overall Study|Randomized but Never Treated|0|||
170613452|NCT05729568|616591554|FG000|Overall Study|Adverse Event|0|||
170613453|NCT05729568|616591555|FG001|Overall Study|Adverse Event|1|||
170613454|NCT05729568|616591554|FG000|Overall Study|Investigator's Discretion|1|||
170613455|NCT05729568|616591555|FG001|Overall Study|Investigator's Discretion|0|||
170613456|NCT00550953|616591556|FG000|Overall Study|Adverse Event|4|||
170657116|NCT03868124|616758265|FG002|Overall Study|Explanted|0|||
170657117|NCT03868124|616758263|FG000|Overall Study|Ongoing in study|176|||
170657118|NCT03868124|616758264|FG001|Overall Study|Ongoing in study|180|||
170657119|NCT03868124|616758265|FG002|Overall Study|Ongoing in study|183|||
170657120|NCT04177355|616758266|FG000|Overall Study|Lost to Follow-up|0|||
170657121|NCT04177355|616758267|FG001|Overall Study|Lost to Follow-up|2|||
170657122|NCT04177355|616758268|FG002|Overall Study|Lost to Follow-up|0|||
170657123|NCT04177355|616758269|FG003|Overall Study|Lost to Follow-up|1|||
170657124|NCT04177355|616758270|FG004|Overall Study|Lost to Follow-up|2|||
170657125|NCT04177355|616758271|FG005|Overall Study|Lost to Follow-up|0|||
170657126|NCT04177355|616758272|FG006|Overall Study|Lost to Follow-up|1|||
170657127|NCT04177355|616758273|FG007|Overall Study|Lost to Follow-up|0|||
170657128|NCT04177355|616758274|FG008|Overall Study|Lost to Follow-up|0|||
170657129|NCT04177355|616758275|FG009|Overall Study|Lost to Follow-up|0|||
170657130|NCT04177355|616758276|FG010|Overall Study|Lost to Follow-up|0|||
170657131|NCT04177355|616758266|FG000|Overall Study|Withdrawal by Subject|0|||
170657132|NCT04177355|616758267|FG001|Overall Study|Withdrawal by Subject|0|||
170613457|NCT00550953|616591557|FG001|Overall Study|Adverse Event|3|||
170613458|NCT00550953|616591556|FG000|Overall Study|Not able to visit the site|2|||
170613459|NCT00550953|616591557|FG001|Overall Study|Not able to visit the site|3|||
170613460|NCT04181762|616591558|FG000|Overall Study|Adverse Event|1|||
170613461|NCT04181762|616591559|FG001|Overall Study|Adverse Event|3|||
170613462|NCT04181762|616591558|FG000|Overall Study|Lost to Follow-up|1|||
170613463|NCT04181762|616591559|FG001|Overall Study|Lost to Follow-up|1|||
170613464|NCT04181762|616591558|FG000|Overall Study|Physician Decision|1|||
170613465|NCT04181762|616591559|FG001|Overall Study|Physician Decision|3|||
170613466|NCT04181762|616591558|FG000|Overall Study|Pregnancy|0|||
170613467|NCT04181762|616591559|FG001|Overall Study|Pregnancy|1|||
170613468|NCT04181762|616591558|FG000|Overall Study|Lack of Efficacy|2|||
170613469|NCT04181762|616591559|FG001|Overall Study|Lack of Efficacy|2|||
170613470|NCT04181762|616591558|FG000|Overall Study|Study terminated by sponsor|95|||
170613471|NCT04181762|616591559|FG001|Overall Study|Study terminated by sponsor|97|||
170613472|NCT04181762|616591558|FG000|Overall Study|Subject decision|11|||
170613473|NCT04181762|616591559|FG001|Overall Study|Subject decision|4|||
170613474|NCT04181762|616591558|FG000|Overall Study|Death|1|||
170613475|NCT04181762|616591559|FG001|Overall Study|Death|1|||
170613476|NCT04181762|616591558|FG000|Overall Study|Protocol deviation|1|||
170613477|NCT04181762|616591559|FG001|Overall Study|Protocol deviation|0|||
170613478|NCT04181762|616591558|FG000|Overall Study|Withdrawal of informed consent|1|||
170613479|NCT04181762|616591559|FG001|Overall Study|Withdrawal of informed consent|3|||
170613480|NCT04980612|616591560|FG000|Overall Study|Withdrawal by Subject|7|||
170613481|NCT04980612|616591561|FG001|Overall Study|Withdrawal by Subject|5|||
170613482|NCT02864901|616591562|FG000|Overall Study|Withdrawal by Subject|1|||
170613483|NCT02864901|616591563|FG001|Overall Study|Withdrawal by Subject|0|||
170613484|NCT01502228|616591564|FG000|Overall Study|Death|1|||
170613485|NCT00596752|616591565|FG000|Overall Study|Other Reason|44|||
170613486|NCT00596752|616591566|FG001|Overall Study|Other Reason|49|||
170613487|NCT00596752|616591565|FG000|Overall Study|Adverse Event|34|||
170613488|NCT00596752|616591566|FG001|Overall Study|Adverse Event|34|||
170613489|NCT00596752|616591565|FG000|Overall Study|Lost to Follow-up|22|||
170613490|NCT00596752|616591566|FG001|Overall Study|Lost to Follow-up|38|||
170613491|NCT00596752|616591565|FG000|Overall Study|Withdrawal by Subject|12|||
170613492|NCT00596752|616591566|FG001|Overall Study|Withdrawal by Subject|9|||
170613493|NCT00596752|616591565|FG000|Overall Study|Unsatisfactory Compliance|9|||
170613494|NCT00596752|616591566|FG001|Overall Study|Unsatisfactory Compliance|6|||
170613495|NCT00596752|616591565|FG000|Overall Study|Lack of Efficacy|4|||
170613496|NCT00596752|616591566|FG001|Overall Study|Lack of Efficacy|7|||
170613497|NCT00596752|616591565|FG000|Overall Study|Protocol Violation|1|||
170613498|NCT00596752|616591566|FG001|Overall Study|Protocol Violation|0|||
170613499|NCT02534909|616591571|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
170613500|NCT00132808|616591572|FG000|Stratum I|Adverse Event|2|||
170613501|NCT00132808|616591573|FG001|Stratum I|Adverse Event|1|||
170613502|NCT00132808|616591574|FG002|Stratum I|Adverse Event|0|||
170613503|NCT00132808|616591572|FG000|Stratum I|Lost to Follow-up|3|||
170613504|NCT00132808|616591573|FG001|Stratum I|Lost to Follow-up|4|||
170613505|NCT00132808|616591574|FG002|Stratum I|Lost to Follow-up|1|||
170613506|NCT00132808|616591572|FG000|Stratum I|Withdrawal by Subject|4|||
170613507|NCT00132808|616591573|FG001|Stratum I|Withdrawal by Subject|7|||
170613508|NCT00132808|616591574|FG002|Stratum I|Withdrawal by Subject|3|||
170613509|NCT00132808|616591572|FG000|Stratum I|Abnormal test procedure result (s)|0|||
170657133|NCT04177355|616758268|FG002|Overall Study|Withdrawal by Subject|0|||
170657134|NCT04177355|616758269|FG003|Overall Study|Withdrawal by Subject|1|||
170657135|NCT04177355|616758270|FG004|Overall Study|Withdrawal by Subject|1|||
170613510|NCT00132808|616591573|FG001|Stratum I|Abnormal test procedure result (s)|0|||
170613511|NCT00132808|616591574|FG002|Stratum I|Abnormal test procedure result (s)|1|||
170613512|NCT00132808|616591572|FG000|Stratum II|Adverse Event|1|||
170613513|NCT00132808|616591573|FG001|Stratum II|Adverse Event|2|||
170816591|NCT02613403|617335541|FG003|Overall Study|Lost to Follow-up|0|||
170816592|NCT02613403|617335542|FG004|Overall Study|Lost to Follow-up|0|||
170816593|NCT02613403|617335538|FG000|Overall Study|Withdrawal by Subject|2|||
170657136|NCT04177355|616758271|FG005|Overall Study|Withdrawal by Subject|0|||
170657137|NCT04177355|616758272|FG006|Overall Study|Withdrawal by Subject|0|||
170657138|NCT04177355|616758273|FG007|Overall Study|Withdrawal by Subject|0|||
170657139|NCT04177355|616758274|FG008|Overall Study|Withdrawal by Subject|1|||
170657140|NCT04177355|616758275|FG009|Overall Study|Withdrawal by Subject|0|||
170657141|NCT04177355|616758276|FG010|Overall Study|Withdrawal by Subject|0|||
170657142|NCT03981822|616758277|FG000|Overall Study|Lost to Follow-up|0|||
170657143|NCT03981822|616758278|FG001|Overall Study|Lost to Follow-up|1|||
170657144|NCT03981822|616758279|FG002|Overall Study|Lost to Follow-up|1|||
170657145|NCT03981822|616758280|FG003|Overall Study|Lost to Follow-up|0|||
170657146|NCT03981822|616758281|FG004|Overall Study|Lost to Follow-up|6|||
170657147|NCT03981822|616758282|FG005|Overall Study|Lost to Follow-up|4|||
170657148|NCT03981822|616758283|FG006|Overall Study|Lost to Follow-up|4|||
170657149|NCT03981822|616758284|FG007|Overall Study|Lost to Follow-up|2|||
170657150|NCT03981822|616758277|FG000|Overall Study|Withdrawal by Subject|0|||
170657151|NCT03981822|616758278|FG001|Overall Study|Withdrawal by Subject|1|||
170657152|NCT03981822|616758279|FG002|Overall Study|Withdrawal by Subject|0|||
170657153|NCT03981822|616758280|FG003|Overall Study|Withdrawal by Subject|0|||
170657154|NCT03981822|616758281|FG004|Overall Study|Withdrawal by Subject|0|||
170657155|NCT03981822|616758282|FG005|Overall Study|Withdrawal by Subject|1|||
170657156|NCT03981822|616758283|FG006|Overall Study|Withdrawal by Subject|0|||
170657157|NCT03981822|616758284|FG007|Overall Study|Withdrawal by Subject|2|||
170657158|NCT03981822|616758277|FG000|Overall Study|COVID-19 Related|0|||
170657159|NCT03981822|616758278|FG001|Overall Study|COVID-19 Related|0|||
170657160|NCT03981822|616758279|FG002|Overall Study|COVID-19 Related|0|||
170657161|NCT03981822|616758280|FG003|Overall Study|COVID-19 Related|0|||
170657162|NCT03981822|616758281|FG004|Overall Study|COVID-19 Related|2|||
170657163|NCT03981822|616758282|FG005|Overall Study|COVID-19 Related|1|||
170657164|NCT03981822|616758283|FG006|Overall Study|COVID-19 Related|2|||
170657165|NCT03981822|616758284|FG007|Overall Study|COVID-19 Related|1|||
170657166|NCT00397943|616758285|FG000|Overall Study|Unspecified reasons|12|||
170657167|NCT00397943|616758286|FG001|Overall Study|Unspecified reasons|9|||
170657168|NCT00397943|616758287|FG002|Overall Study|Unspecified reasons|0|||
170657169|NCT00397943|616758288|FG003|Overall Study|Unspecified reasons|0|||
170657170|NCT00397943|616758289|FG004|Overall Study|Unspecified reasons|0|||
170657171|NCT03489551|616758290|FG000|Overall Study|Withdrawal by Subject|2|||
170657172|NCT04521777|616758292|FG000|Overall Study|Death|2|||
170657173|NCT04521777|616758292|FG000|Overall Study|Withdrawal by Subject|2|||
170657174|NCT00054717|616758293|FG000|Overall Study|Randomized but not treated|2|||
170657175|NCT00054717|616758294|FG001|Overall Study|Randomized but not treated|8|||
170657176|NCT00054717|616758293|FG000|Overall Study|Adverse Event|70|||
170657177|NCT00054717|616758294|FG001|Overall Study|Adverse Event|22|||
170657178|NCT00054717|616758293|FG000|Overall Study|Protocol Violation|18|||
170657179|NCT00054717|616758294|FG001|Overall Study|Protocol Violation|19|||
170657180|NCT00054717|616758293|FG000|Overall Study|Lost to Follow-up|23|||
170657181|NCT00054717|616758294|FG001|Overall Study|Lost to Follow-up|13|||
170657182|NCT00054717|616758293|FG000|Overall Study|Withdrawal by Subject|32|||
170657183|NCT00054717|616758294|FG001|Overall Study|Withdrawal by Subject|20|||
170657184|NCT00054717|616758293|FG000|Overall Study|Other reason not defined above|117|||
170657185|NCT00054717|616758294|FG001|Overall Study|Other reason not defined above|217|||
170657186|NCT04148911|616758295|FG000|Overall Study|Death|104|||
170657187|NCT04148911|616758295|FG000|Overall Study|Lost to Follow-up|5|||
170657188|NCT04148911|616758295|FG000|Overall Study|Withdrawal by Subject|17|||
170657189|NCT04148911|616758295|FG000|Overall Study|Study Ended by Sponsor|56|||
170657190|NCT02821910|616758297|FG000|Overall Study|Withdrawal by Subject|0|||
170657191|NCT02821910|616758298|FG001|Overall Study|Withdrawal by Subject|0|||
170657192|NCT02821910|616758299|FG002|Overall Study|Withdrawal by Subject|1|||
170657193|NCT02821910|616758300|FG003|Overall Study|Withdrawal by Subject|0|||
170657194|NCT02821910|616758301|FG004|Overall Study|Withdrawal by Subject|0|||
170657195|NCT02821910|616758302|FG005|Overall Study|Withdrawal by Subject|1|||
170916917|NCT03504397|617697780|FG001|Overall Study|Protocol deviation|0|||
170916918|NCT03504397|617697779|FG000|Overall Study|Participants who did not take the study drug|4|||
170916919|NCT03504397|617697780|FG001|Overall Study|Participants who did not take the study drug|4|||
170657196|NCT02821910|616758297|FG000|Overall Study|Other than specified|1|||
170657197|NCT02821910|616758298|FG001|Overall Study|Other than specified|0|||
170657198|NCT02821910|616758299|FG002|Overall Study|Other than specified|1|||
170657199|NCT02821910|616758300|FG003|Overall Study|Other than specified|0|||
170657200|NCT02821910|616758301|FG004|Overall Study|Other than specified|0|||
170657201|NCT02821910|616758302|FG005|Overall Study|Other than specified|0|||
170657202|NCT00423670|616758305|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
170657203|NCT00423670|616758306|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
170657204|NCT00423670|616758307|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
170657205|NCT00423670|616758308|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
170657206|NCT00423670|616758309|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
170657207|NCT00423670|616758310|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
170657208|NCT00423670|616758311|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
170916920|NCT03251495|617697781|FG000|Overall Study|Lost to Follow-up|4|||
170657209|NCT00423670|616758312|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
170657210|NCT00423670|616758305|FG000|Treatment Period|Adverse Event|8|||
170657211|NCT00423670|616758306|FG001|Treatment Period|Adverse Event|12|||
170657212|NCT00423670|616758307|FG002|Treatment Period|Adverse Event|15|||
170657213|NCT00423670|616758308|FG003|Treatment Period|Adverse Event|20|||
170657214|NCT00423670|616758309|FG004|Treatment Period|Adverse Event|9|||
170657215|NCT00423670|616758310|FG005|Treatment Period|Adverse Event|4|||
170657216|NCT00423670|616758311|FG006|Treatment Period|Adverse Event|7|||
170657217|NCT00423670|616758312|FG007|Treatment Period|Adverse Event|2|||
170657218|NCT00423670|616758305|FG000|Treatment Period|Protocol-defined clinical event|0|||
170657219|NCT00423670|616758306|FG001|Treatment Period|Protocol-defined clinical event|7|||
170657220|NCT00423670|616758307|FG002|Treatment Period|Protocol-defined clinical event|4|||
170657221|NCT00423670|616758308|FG003|Treatment Period|Protocol-defined clinical event|12|||
170657222|NCT00423670|616758309|FG004|Treatment Period|Protocol-defined clinical event|5|||
170657223|NCT00423670|616758310|FG005|Treatment Period|Protocol-defined clinical event|4|||
170657224|NCT00423670|616758311|FG006|Treatment Period|Protocol-defined clinical event|16|||
170657225|NCT00423670|616758312|FG007|Treatment Period|Protocol-defined clinical event|15|||
170657226|NCT00423670|616758305|FG000|Treatment Period|Lost to Follow-up|2|||
170657227|NCT00423670|616758306|FG001|Treatment Period|Lost to Follow-up|1|||
170657228|NCT00423670|616758307|FG002|Treatment Period|Lost to Follow-up|3|||
170657229|NCT00423670|616758308|FG003|Treatment Period|Lost to Follow-up|1|||
170657230|NCT00423670|616758309|FG004|Treatment Period|Lost to Follow-up|6|||
170657231|NCT00423670|616758310|FG005|Treatment Period|Lost to Follow-up|0|||
170657232|NCT00423670|616758311|FG006|Treatment Period|Lost to Follow-up|3|||
170657233|NCT00423670|616758312|FG007|Treatment Period|Lost to Follow-up|1|||
170657234|NCT00423670|616758305|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
170657235|NCT00423670|616758306|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
170657236|NCT00423670|616758307|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
170657237|NCT00423670|616758308|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
170657238|NCT00423670|616758309|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
170657239|NCT00423670|616758310|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
170657240|NCT00423670|616758311|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
170657241|NCT00423670|616758312|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
170657242|NCT00423670|616758305|FG000|Treatment Period|Investigator decision|0|||
170657243|NCT00423670|616758306|FG001|Treatment Period|Investigator decision|0|||
170657244|NCT00423670|616758307|FG002|Treatment Period|Investigator decision|0|||
170657245|NCT00423670|616758308|FG003|Treatment Period|Investigator decision|0|||
170657246|NCT00423670|616758309|FG004|Treatment Period|Investigator decision|0|||
170657247|NCT00423670|616758310|FG005|Treatment Period|Investigator decision|0|||
170657248|NCT00423670|616758311|FG006|Treatment Period|Investigator decision|0|||
170657249|NCT00423670|616758312|FG007|Treatment Period|Investigator decision|1|||
170657250|NCT00423670|616758305|FG000|Treatment Period|Non-compliance with protocol|3|||
170657251|NCT00423670|616758306|FG001|Treatment Period|Non-compliance with protocol|1|||
170657252|NCT00423670|616758307|FG002|Treatment Period|Non-compliance with protocol|1|||
170657253|NCT00423670|616758308|FG003|Treatment Period|Non-compliance with protocol|3|||
170657254|NCT00423670|616758309|FG004|Treatment Period|Non-compliance with protocol|2|||
170657255|NCT00423670|616758310|FG005|Treatment Period|Non-compliance with protocol|0|||
170657256|NCT00423670|616758311|FG006|Treatment Period|Non-compliance with protocol|2|||
170657257|NCT00423670|616758312|FG007|Treatment Period|Non-compliance with protocol|2|||
170657258|NCT00423670|616758305|FG000|Follow-up Period|Lost to Follow-up|0|||
170657259|NCT00423670|616758306|FG001|Follow-up Period|Lost to Follow-up|12|||
170657260|NCT00423670|616758307|FG002|Follow-up Period|Lost to Follow-up|8|||
170657261|NCT00423670|616758308|FG003|Follow-up Period|Lost to Follow-up|3|||
170657262|NCT00423670|616758309|FG004|Follow-up Period|Lost to Follow-up|1|||
170657263|NCT00423670|616758310|FG005|Follow-up Period|Lost to Follow-up|0|||
170657264|NCT00423670|616758311|FG006|Follow-up Period|Lost to Follow-up|5|||
170657265|NCT00423670|616758312|FG007|Follow-up Period|Lost to Follow-up|0|||
170657266|NCT00423670|616758305|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
170657267|NCT00423670|616758306|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
170657268|NCT00423670|616758307|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
170657269|NCT00423670|616758308|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
170916921|NCT03251495|617697781|FG000|Overall Study|Withdrawal by Subject|2|||
170657270|NCT00423670|616758309|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
170657271|NCT00423670|616758310|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
170657272|NCT00423670|616758311|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
170657273|NCT00423670|616758312|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
170657274|NCT00423670|616758305|FG000|Follow-up Period|Non-compliance with protocol|2|||
170657275|NCT00423670|616758306|FG001|Follow-up Period|Non-compliance with protocol|0|||
170657276|NCT00423670|616758307|FG002|Follow-up Period|Non-compliance with protocol|1|||
170657277|NCT00423670|616758308|FG003|Follow-up Period|Non-compliance with protocol|1|||
170657278|NCT00423670|616758309|FG004|Follow-up Period|Non-compliance with protocol|0|||
170916922|NCT03778229|617697784|FG000|Overall Study|Death|163|||
170657279|NCT00423670|616758310|FG005|Follow-up Period|Non-compliance with protocol|0|||
170657280|NCT00423670|616758311|FG006|Follow-up Period|Non-compliance with protocol|3|||
170657281|NCT00423670|616758312|FG007|Follow-up Period|Non-compliance with protocol|2|||
170657282|NCT00900601|616758313|FG000|Overall Study|Physician Decision|1|||
170657283|NCT01082640|616758315|FG000|Overall Study|Adverse Event|9|||
170657284|NCT01082640|616758316|FG001|Overall Study|Adverse Event|5|||
170657285|NCT01082640|616758317|FG002|Overall Study|Adverse Event|3|||
170657286|NCT01082640|616758315|FG000|Overall Study|Withdrawal by Subject|3|||
170657287|NCT01082640|616758316|FG001|Overall Study|Withdrawal by Subject|3|||
170657288|NCT01082640|616758317|FG002|Overall Study|Withdrawal by Subject|2|||
170657289|NCT01082640|616758315|FG000|Overall Study|Major protocol deviation|3|||
170657290|NCT01082640|616758316|FG001|Overall Study|Major protocol deviation|3|||
170657291|NCT01082640|616758317|FG002|Overall Study|Major protocol deviation|0|||
170657292|NCT01082640|616758315|FG000|Overall Study|Lost to Follow-up|0|||
170657293|NCT01082640|616758316|FG001|Overall Study|Lost to Follow-up|3|||
170657294|NCT01082640|616758317|FG002|Overall Study|Lost to Follow-up|0|||
170657295|NCT01082640|616758315|FG000|Overall Study|Other|2|||
170657296|NCT01082640|616758316|FG001|Overall Study|Other|1|||
170657297|NCT01082640|616758317|FG002|Overall Study|Other|3|||
170657298|NCT01869725|616758319|FG000|Overall Study|ineligible after registration|1|||
170657299|NCT01869725|616758319|FG000|Overall Study|Death|1|||
170657300|NCT01869725|616758319|FG000|Overall Study|Lost to Follow-up|2|||
170657301|NCT03416374|616758322|FG000|Between Treatment Period I and II|Other|0|||
170657302|NCT03416374|616758323|FG001|Between Treatment Period I and II|Other|9|||
170657303|NCT03416374|616758322|FG000|Treatment Period II|Lack of Efficacy|3|||
170657304|NCT03416374|616758323|FG001|Treatment Period II|Lack of Efficacy|11|||
170657305|NCT03416374|616758322|FG000|Treatment Period II|Adverse Event|1|||
170657306|NCT03416374|616758323|FG001|Treatment Period II|Adverse Event|4|||
170657307|NCT03416374|616758322|FG000|Treatment Period II|Death|0|||
170657308|NCT03416374|616758323|FG001|Treatment Period II|Death|1|||
170657309|NCT03416374|616758322|FG000|Treatment Period II|Other|0|||
170657310|NCT03416374|616758323|FG001|Treatment Period II|Other|2|||
170657311|NCT03463031|616758326|FG000|Overall Study|Withdrawal by Subject|4|||
170657312|NCT03463031|616758327|FG001|Overall Study|Withdrawal by Subject|2|||
170657313|NCT03463031|616758326|FG000|Overall Study|Investigator/Sponsor Decision|0|||
170657314|NCT03463031|616758327|FG001|Overall Study|Investigator/Sponsor Decision|1|||
170657315|NCT03463031|616758326|FG000|Overall Study|Lost to Follow-up|1|||
170657316|NCT03463031|616758327|FG001|Overall Study|Lost to Follow-up|1|||
170657317|NCT03463031|616758326|FG000|Overall Study|Adverse Event|4|||
170657318|NCT03463031|616758327|FG001|Overall Study|Adverse Event|1|||
170657319|NCT03463031|616758326|FG000|Overall Study|Use of prohibited medication by subject|1|||
170657320|NCT03463031|616758327|FG001|Overall Study|Use of prohibited medication by subject|0|||
170657321|NCT02131532|616758328|FG000|Overall Study|Withdrawal by Subject|1|||
170657322|NCT02131532|616758328|FG000|Overall Study|Physician Decision|1|||
170657323|NCT02131532|616758328|FG000|Overall Study|Other health conditions|2|||
170657324|NCT01241240|616758329|FG000|Overall Study|Adverse Event|5|||
170657325|NCT01241240|616758330|FG001|Overall Study|Adverse Event|4|||
170657326|NCT01241240|616758329|FG000|Overall Study|Lost to Follow-up|2|||
170657327|NCT01241240|616758330|FG001|Overall Study|Lost to Follow-up|4|||
170657328|NCT01241240|616758329|FG000|Overall Study|Personal Reasons|1|||
170657329|NCT01241240|616758330|FG001|Overall Study|Personal Reasons|1|||
170657330|NCT01025154|616758331|FG000|Overall Study|Lost to Follow-up|1|||
170657331|NCT01025154|616758331|FG000|Overall Study|Withdrawal by Subject|1|||
170657332|NCT00718237|616758343|FG000|Overall Study|Adverse Event|1|||
170657333|NCT00718237|616758344|FG001|Overall Study|Adverse Event|3|||
170657334|NCT00718237|616758343|FG000|Overall Study|Lost to Follow-up|2|||
170657335|NCT00718237|616758344|FG001|Overall Study|Lost to Follow-up|2|||
170657336|NCT00718237|616758343|FG000|Overall Study|Physician Decision|1|||
170657337|NCT00718237|616758344|FG001|Overall Study|Physician Decision|0|||
170657338|NCT00718237|616758343|FG000|Overall Study|Withdrawal by Subject|9|||
170657339|NCT00718237|616758344|FG001|Overall Study|Withdrawal by Subject|10|||
170657340|NCT01298193|616758345|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
170657341|NCT01298193|616758345|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
170657342|NCT01298193|616758345|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
170816594|NCT02613403|617335539|FG001|Overall Study|Withdrawal by Subject|0|||
170816595|NCT02613403|617335540|FG002|Overall Study|Withdrawal by Subject|0|||
170657343|NCT01298193|616758345|FG000|Efficacy Phase (Second Cycle)|Death|1|||
170657344|NCT00107952|616758346|FG000|Overall Study|Death|75|||
170657345|NCT00107952|616758347|FG001|Overall Study|Death|61|||
170657346|NCT00107952|616758346|FG000|Overall Study|Lost to Follow-up|0|||
170657347|NCT00107952|616758347|FG001|Overall Study|Lost to Follow-up|3|||
170657348|NCT00107952|616758346|FG000|Overall Study|Withdrawal by Subject|9|||
170657349|NCT00107952|616758347|FG001|Overall Study|Withdrawal by Subject|6|||
170657350|NCT00107952|616758346|FG000|Overall Study|Other|2|||
170657351|NCT00107952|616758347|FG001|Overall Study|Other|5|||
170657352|NCT00107952|616758346|FG000|Overall Study|Never received study treatment|9|||
170657353|NCT00107952|616758347|FG001|Overall Study|Never received study treatment|6|||
170657354|NCT01975831|616758348|FG000|Overall Study|Adverse Event|1|||
170916923|NCT03778229|617697785|FG001|Overall Study|Death|68|||
170657355|NCT01975831|616758349|FG001|Overall Study|Adverse Event|2|||
170657356|NCT01975831|616758350|FG002|Overall Study|Adverse Event|2|||
170916924|NCT03778229|617697786|FG002|Overall Study|Death|36|||
170916925|NCT03778229|617697787|FG003|Overall Study|Death|9|||
170916926|NCT03778229|617697784|FG000|Overall Study|Withdrawal by Subject|19|||
170916927|NCT03778229|617697785|FG001|Overall Study|Withdrawal by Subject|1|||
170916928|NCT03778229|617697786|FG002|Overall Study|Withdrawal by Subject|5|||
170613514|NCT00132808|616591574|FG002|Stratum II|Adverse Event|1|||
170613515|NCT00132808|616591572|FG000|Stratum II|Death|1|||
170613516|NCT00132808|616591573|FG001|Stratum II|Death|0|||
170613517|NCT00132808|616591574|FG002|Stratum II|Death|0|||
170613518|NCT00132808|616591572|FG000|Stratum II|Lost to Follow-up|2|||
170613519|NCT00132808|616591573|FG001|Stratum II|Lost to Follow-up|2|||
170613520|NCT00132808|616591574|FG002|Stratum II|Lost to Follow-up|1|||
170613521|NCT00132808|616591572|FG000|Stratum II|Protocol Violation|0|||
170613522|NCT00132808|616591573|FG001|Stratum II|Protocol Violation|2|||
170613523|NCT00132808|616591574|FG002|Stratum II|Protocol Violation|1|||
170613524|NCT00132808|616591572|FG000|Stratum II|Withdrawal by Subject|4|||
170613525|NCT00132808|616591573|FG001|Stratum II|Withdrawal by Subject|9|||
170613526|NCT00132808|616591574|FG002|Stratum II|Withdrawal by Subject|6|||
170613527|NCT02715609|616591582|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
170613528|NCT02715609|616591583|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
170613529|NCT02715609|616591584|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
170613530|NCT02715609|616591582|FG000|Overall Study|Withdrawal by Subject|0|||
170613531|NCT02715609|616591583|FG001|Overall Study|Withdrawal by Subject|0|||
170613532|NCT02715609|616591584|FG002|Overall Study|Withdrawal by Subject|1|||
170613533|NCT00362648|616591585|FG000|Overall Study|Adverse Event|12|||
170613534|NCT00362648|616591586|FG001|Overall Study|Adverse Event|21|||
170613535|NCT00362648|616591587|FG002|Overall Study|Adverse Event|1|||
170613536|NCT00362648|616591588|FG003|Overall Study|Adverse Event|0|||
170613537|NCT00362648|616591585|FG000|Overall Study|Lost to Follow-up|62|||
170613538|NCT00362648|616591586|FG001|Overall Study|Lost to Follow-up|69|||
170613539|NCT00362648|616591587|FG002|Overall Study|Lost to Follow-up|4|||
170613540|NCT00362648|616591588|FG003|Overall Study|Lost to Follow-up|3|||
170613541|NCT00362648|616591585|FG000|Overall Study|Protocol Violation|4|||
170613542|NCT00362648|616591586|FG001|Overall Study|Protocol Violation|2|||
170613543|NCT00362648|616591587|FG002|Overall Study|Protocol Violation|2|||
170613544|NCT00362648|616591588|FG003|Overall Study|Protocol Violation|2|||
170613545|NCT00362648|616591585|FG000|Overall Study|Withdrawal by Subject|48|||
170613546|NCT00362648|616591586|FG001|Overall Study|Withdrawal by Subject|42|||
170613547|NCT00362648|616591587|FG002|Overall Study|Withdrawal by Subject|2|||
170613548|NCT00362648|616591588|FG003|Overall Study|Withdrawal by Subject|6|||
170613549|NCT03983304|616591589|FG000|Overall Study|Withdrawal by Subject|5|||
170613550|NCT03983304|616591589|FG000|Overall Study|Lost to Follow-up|2|||
170613551|NCT01702246|616591590|FG000|Overall Study|Lost to Follow-up|2|||
170613552|NCT01702246|616591590|FG000|Overall Study|Withdrawal by Subject|2|||
170613553|NCT01702246|616591590|FG000|Overall Study|Physician Decision|1|||
170613554|NCT01587040|616591594|FG000|Overall Study|Protocol Violation|0|||
170613555|NCT01587040|616591595|FG001|Overall Study|Protocol Violation|0|||
170613556|NCT01587040|616591596|FG002|Overall Study|Protocol Violation|1|||
170613557|NCT01587040|616591597|FG003|Overall Study|Protocol Violation|0|||
170613558|NCT01587040|616591594|FG000|Overall Study|Adverse Event|0|||
170613559|NCT01587040|616591595|FG001|Overall Study|Adverse Event|1|||
170613560|NCT01587040|616591596|FG002|Overall Study|Adverse Event|10|||
170613561|NCT01587040|616591597|FG003|Overall Study|Adverse Event|0|||
170613562|NCT01587040|616591594|FG000|Overall Study|Disease progression|12|||
170613563|NCT01587040|616591595|FG001|Overall Study|Disease progression|1|||
170613564|NCT01587040|616591596|FG002|Overall Study|Disease progression|15|||
170613565|NCT01587040|616591597|FG003|Overall Study|Disease progression|3|||
170613566|NCT01587040|616591594|FG000|Overall Study|Other than specified|5|||
170613567|NCT01587040|616591595|FG001|Overall Study|Other than specified|1|||
170613568|NCT01587040|616591596|FG002|Overall Study|Other than specified|11|||
170613569|NCT01587040|616591597|FG003|Overall Study|Other than specified|1|||
170613570|NCT01518374|616591600|FG000|Overall Study|Withdrawal by Subject|2|||
170613571|NCT01518374|616591600|FG000|Overall Study|Protocol Violation|3|||
170613572|NCT01518374|616591600|FG000|Overall Study|Lost to Follow-up|2|||
170613573|NCT03197376|616591601|FG000|Primary and Booster Phase|Adverse Event|0|||
170613574|NCT03197376|616591602|FG001|Primary and Booster Phase|Adverse Event|0|||
170613575|NCT03197376|616591603|FG002|Primary and Booster Phase|Adverse Event|0|||
170613576|NCT03197376|616591604|FG003|Primary and Booster Phase|Adverse Event|1|||
170613577|NCT03197376|616591601|FG000|Primary and Booster Phase|Death|1|||
170613578|NCT03197376|616591602|FG001|Primary and Booster Phase|Death|0|||
170613579|NCT03197376|616591603|FG002|Primary and Booster Phase|Death|0|||
170613580|NCT03197376|616591604|FG003|Primary and Booster Phase|Death|2|||
170613581|NCT03197376|616591601|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
170613582|NCT03197376|616591602|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
170657357|NCT01975831|616758351|FG003|Overall Study|Adverse Event|0|||
170916929|NCT03778229|617697787|FG003|Overall Study|Withdrawal by Subject|2|||
170657358|NCT01975831|616758352|FG004|Overall Study|Adverse Event|1|||
170657359|NCT01975831|616758353|FG005|Overall Study|Adverse Event|1|||
170657360|NCT01975831|616758354|FG006|Overall Study|Adverse Event|3|||
170657361|NCT01975831|616758355|FG007|Overall Study|Adverse Event|4|||
170657362|NCT01975831|616758356|FG008|Overall Study|Adverse Event|1|||
170657363|NCT01975831|616758348|FG000|Overall Study|Death|1|||
170657364|NCT01975831|616758349|FG001|Overall Study|Death|1|||
170657365|NCT01975831|616758350|FG002|Overall Study|Death|0|||
170657366|NCT01975831|616758351|FG003|Overall Study|Death|0|||
170657367|NCT01975831|616758352|FG004|Overall Study|Death|1|||
170657368|NCT01975831|616758353|FG005|Overall Study|Death|0|||
170657369|NCT01975831|616758354|FG006|Overall Study|Death|1|||
170657370|NCT01975831|616758355|FG007|Overall Study|Death|0|||
170657371|NCT01975831|616758356|FG008|Overall Study|Death|0|||
170657372|NCT01975831|616758348|FG000|Overall Study|Progressive Disease|1|||
170657373|NCT01975831|616758349|FG001|Overall Study|Progressive Disease|3|||
170657374|NCT01975831|616758350|FG002|Overall Study|Progressive Disease|2|||
170657375|NCT01975831|616758351|FG003|Overall Study|Progressive Disease|4|||
170657376|NCT01975831|616758352|FG004|Overall Study|Progressive Disease|13|||
170657377|NCT01975831|616758353|FG005|Overall Study|Progressive Disease|9|||
170657378|NCT01975831|616758354|FG006|Overall Study|Progressive Disease|10|||
170657379|NCT01975831|616758355|FG007|Overall Study|Progressive Disease|8|||
170657380|NCT01975831|616758356|FG008|Overall Study|Progressive Disease|10|||
170657381|NCT01975831|616758348|FG000|Overall Study|Withdrawal by Subject|0|||
170657382|NCT01975831|616758349|FG001|Overall Study|Withdrawal by Subject|3|||
170657383|NCT01975831|616758350|FG002|Overall Study|Withdrawal by Subject|0|||
170657384|NCT01975831|616758351|FG003|Overall Study|Withdrawal by Subject|0|||
170657385|NCT01975831|616758352|FG004|Overall Study|Withdrawal by Subject|3|||
170657386|NCT01975831|616758353|FG005|Overall Study|Withdrawal by Subject|1|||
170657387|NCT01975831|616758354|FG006|Overall Study|Withdrawal by Subject|1|||
170657388|NCT01975831|616758355|FG007|Overall Study|Withdrawal by Subject|0|||
170657389|NCT01975831|616758356|FG008|Overall Study|Withdrawal by Subject|0|||
170657390|NCT01975831|616758348|FG000|Overall Study|Physician Decision|0|||
170657391|NCT01975831|616758349|FG001|Overall Study|Physician Decision|0|||
170657392|NCT01975831|616758350|FG002|Overall Study|Physician Decision|0|||
170657393|NCT01975831|616758351|FG003|Overall Study|Physician Decision|0|||
170657394|NCT01975831|616758352|FG004|Overall Study|Physician Decision|0|||
170657395|NCT01975831|616758353|FG005|Overall Study|Physician Decision|1|||
170657396|NCT01975831|616758354|FG006|Overall Study|Physician Decision|0|||
170657397|NCT01975831|616758355|FG007|Overall Study|Physician Decision|1|||
170657398|NCT01975831|616758356|FG008|Overall Study|Physician Decision|0|||
170657399|NCT01975831|616758348|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
170657400|NCT01975831|616758349|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
170657401|NCT01975831|616758350|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
170657402|NCT01975831|616758351|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
170657403|NCT01975831|616758352|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
170657404|NCT01975831|616758353|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
170657405|NCT01975831|616758354|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
170657406|NCT01975831|616758355|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
170657407|NCT01975831|616758356|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
170816596|NCT02613403|617335541|FG003|Overall Study|Withdrawal by Subject|0|||
170816597|NCT02613403|617335542|FG004|Overall Study|Withdrawal by Subject|0|||
170816598|NCT00866619|617335543|FG000|Overall Study|Adverse Event|112|||
170816599|NCT00866619|617335544|FG001|Overall Study|Adverse Event|106|||
170816600|NCT00866619|617335545|FG002|Overall Study|Adverse Event|47|||
170816601|NCT00866619|617335546|FG003|Overall Study|Adverse Event|44|||
170816602|NCT00866619|617335543|FG000|Overall Study|Protocol Violation|2|||
170816603|NCT00866619|617335544|FG001|Overall Study|Protocol Violation|39|||
170816604|NCT00866619|617335545|FG002|Overall Study|Protocol Violation|2|||
170816605|NCT00866619|617335546|FG003|Overall Study|Protocol Violation|17|||
170816606|NCT00866619|617335543|FG000|Overall Study|Withdrawal by Subject|587|||
170816607|NCT00866619|617335544|FG001|Overall Study|Withdrawal by Subject|295|||
170816608|NCT00866619|617335545|FG002|Overall Study|Withdrawal by Subject|272|||
170816609|NCT00866619|617335546|FG003|Overall Study|Withdrawal by Subject|144|||
170816610|NCT00866619|617335543|FG000|Overall Study|Lost to Follow-up|1145|||
170816611|NCT00866619|617335544|FG001|Overall Study|Lost to Follow-up|830|||
170816612|NCT00866619|617335545|FG002|Overall Study|Lost to Follow-up|568|||
170657408|NCT01975831|616758348|FG000|Overall Study|Entered Hospice|0|||
170816613|NCT00866619|617335546|FG003|Overall Study|Lost to Follow-up|425|||
170816614|NCT00689351|617335547|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
170816615|NCT00689351|617335548|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
170657409|NCT01975831|616758349|FG001|Overall Study|Entered Hospice|0|||
170657410|NCT01975831|616758350|FG002|Overall Study|Entered Hospice|0|||
170657411|NCT01975831|616758351|FG003|Overall Study|Entered Hospice|0|||
170657412|NCT01975831|616758352|FG004|Overall Study|Entered Hospice|0|||
170657413|NCT01975831|616758353|FG005|Overall Study|Entered Hospice|1|||
170657414|NCT01975831|616758354|FG006|Overall Study|Entered Hospice|0|||
170657415|NCT01975831|616758355|FG007|Overall Study|Entered Hospice|0|||
170657416|NCT01975831|616758356|FG008|Overall Study|Entered Hospice|0|||
170657417|NCT01975831|616758348|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
170657418|NCT01975831|616758349|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
170657419|NCT01975831|616758350|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
170657420|NCT01975831|616758351|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
170657421|NCT01975831|616758352|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
170657422|NCT01975831|616758353|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
170657423|NCT01975831|616758354|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
170657424|NCT01975831|616758355|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
170657425|NCT01975831|616758356|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
170657426|NCT00887744|616758357|FG000|Overall Study|Adverse Event|3|||
170657427|NCT00887744|616758357|FG000|Overall Study|Death|1|||
170657428|NCT00887744|616758357|FG000|Overall Study|Lost to Follow-up|3|||
170657429|NCT00887744|616758357|FG000|Overall Study|Withdrawal by Subject|18|||
170657430|NCT00887744|616758357|FG000|Overall Study|Various reasons|9|||
170657431|NCT00667446|616758368|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
170657432|NCT00667446|616758369|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
170657433|NCT00667446|616758368|FG000|Treatment Period (36 Months)|Other|2|||
170657434|NCT00667446|616758369|FG001|Treatment Period (36 Months)|Other|2|||
170657435|NCT00667446|616758368|FG000|Treatment Period (36 Months)|Personal reasons|2|||
170657436|NCT00667446|616758369|FG001|Treatment Period (36 Months)|Personal reasons|2|||
170657437|NCT00667446|616758368|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
170657438|NCT00667446|616758369|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
170657439|NCT00667446|616758368|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
170657440|NCT00667446|616758369|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
170657441|NCT00667446|616758368|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
170657442|NCT00667446|616758369|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
170657443|NCT00667446|616758368|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
170657444|NCT00667446|616758369|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
170657445|NCT00667446|616758368|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
170657446|NCT00667446|616758369|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
170657447|NCT00667446|616758368|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
170657448|NCT00667446|616758369|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
170657449|NCT02810340|616758370|FG000|Overall Study|Withdrawal by Subject|1|||
170657450|NCT02810340|616758371|FG001|Overall Study|Withdrawal by Subject|0|||
170657451|NCT02810340|616758372|FG002|Overall Study|Withdrawal by Subject|0|||
170657452|NCT02810340|616758370|FG000|Overall Study|Incarceration|0|||
170657453|NCT02810340|616758371|FG001|Overall Study|Incarceration|1|||
170657454|NCT02810340|616758372|FG002|Overall Study|Incarceration|0|||
170657455|NCT02810340|616758370|FG000|Overall Study|Lost to Follow-up|0|||
170657456|NCT02810340|616758371|FG001|Overall Study|Lost to Follow-up|0|||
170657457|NCT02810340|616758372|FG002|Overall Study|Lost to Follow-up|1|||
170657458|NCT03993379|616758379|FG000|Overall Study|The study was terminated early due to business decision.|0|||
170657459|NCT03993379|616758380|FG001|Overall Study|The study was terminated early due to business decision.|2|||
170657460|NCT03993379|616758381|FG002|Overall Study|The study was terminated early due to business decision.|0|||
170657461|NCT03993379|616758382|FG003|Overall Study|The study was terminated early due to business decision.|0|||
170657462|NCT03993379|616758379|FG000|Overall Study|Withdrawal by Subject|0|||
170657463|NCT03993379|616758380|FG001|Overall Study|Withdrawal by Subject|1|||
170657464|NCT03993379|616758381|FG002|Overall Study|Withdrawal by Subject|0|||
170657465|NCT03993379|616758382|FG003|Overall Study|Withdrawal by Subject|0|||
170657466|NCT00727532|616758385|FG000|Overall Study|Adverse Event|1|||
170657467|NCT00727532|616758385|FG000|Overall Study|Withdrawal by Subject|1|||
170657468|NCT00686998|616758386|FG000|Overall Study|Adverse Event|3|||
170657469|NCT00686998|616758387|FG001|Overall Study|Adverse Event|2|||
170657470|NCT00686998|616758388|FG002|Overall Study|Adverse Event|1|||
170657471|NCT00686998|616758386|FG000|Overall Study|Withdrawal by Subject|2|||
170657472|NCT00686998|616758387|FG001|Overall Study|Withdrawal by Subject|1|||
170657473|NCT00686998|616758388|FG002|Overall Study|Withdrawal by Subject|2|||
170657474|NCT00686998|616758386|FG000|Overall Study|Lack of Efficacy|7|||
170657475|NCT00686998|616758387|FG001|Overall Study|Lack of Efficacy|5|||
170657476|NCT00686998|616758388|FG002|Overall Study|Lack of Efficacy|0|||
170657477|NCT00686998|616758386|FG000|Overall Study|Other|0|||
170657478|NCT00686998|616758387|FG001|Overall Study|Other|0|||
170657479|NCT00686998|616758388|FG002|Overall Study|Other|1|||
170657480|NCT00686998|616758386|FG000|Overall Study|Safety Reasons|1|||
170657481|NCT00686998|616758387|FG001|Overall Study|Safety Reasons|0|||
170657482|NCT00686998|616758388|FG002|Overall Study|Safety Reasons|0|||
170657483|NCT04879225|616759763|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
170657484|NCT04879225|616759763|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
170657485|NCT03139604|616759764|FG000|Overall Study|Other|7|||
170657486|NCT03139604|616759765|FG001|Overall Study|Other|3|||
170657487|NCT03139604|616759764|FG000|Overall Study|Withdrawal by Subject|16|||
170657488|NCT03139604|616759765|FG001|Overall Study|Withdrawal by Subject|17|||
170657489|NCT03139604|616759764|FG000|Overall Study|Physician Decision|1|||
170657490|NCT03139604|616759765|FG001|Overall Study|Physician Decision|2|||
170657491|NCT03139604|616759764|FG000|Overall Study|Lost to Follow-up|3|||
170657492|NCT03139604|616759765|FG001|Overall Study|Lost to Follow-up|1|||
170657493|NCT03139604|616759764|FG000|Overall Study|Death|65|||
170657494|NCT03139604|616759765|FG001|Overall Study|Death|67|||
170657495|NCT03139604|616759764|FG000|Overall Study|Study Terminated by Sponsor|122|||
170657496|NCT03139604|616759765|FG001|Overall Study|Study Terminated by Sponsor|127|||
170657497|NCT03139604|616759764|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
170657498|NCT03139604|616759765|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
170657499|NCT04565236|616759767|FG000|Overall Study|Patient/Guardian Decision|0|||
170657500|NCT04565236|616759768|FG001|Overall Study|Patient/Guardian Decision|0|||
170657501|NCT04565236|616759769|FG002|Overall Study|Patient/Guardian Decision|1|||
170657502|NCT04565236|616759770|FG003|Overall Study|Patient/Guardian Decision|0|||
170657503|NCT00427960|616759773|FG000|Overall Study|Adverse Event|2|||
170657504|NCT00427960|616759774|FG001|Overall Study|Adverse Event|0|||
170657505|NCT00427960|616759773|FG000|Overall Study|Withdrawal by Subject|0|||
170657506|NCT00427960|616759774|FG001|Overall Study|Withdrawal by Subject|3|||
170657507|NCT00427960|616759773|FG000|Overall Study|Other|0|||
170657508|NCT00427960|616759774|FG001|Overall Study|Other|1|||
170657509|NCT01142128|616759775|FG000|Overall Study|Physician Decision|1|||
170657510|NCT01142128|616759775|FG000|Overall Study|Lost to Follow-up|1|||
170657511|NCT01142128|616759775|FG000|Overall Study|Withdrawal by Subject|2|||
170657512|NCT00589784|616759777|FG000|Overall Study|Withdrawal by Subject|0|||
170657513|NCT00589784|616759778|FG001|Overall Study|Withdrawal by Subject|6|||
170657514|NCT00589784|616759777|FG000|Overall Study|Patient inevaluable|1|||
170657515|NCT00589784|616759778|FG001|Overall Study|Patient inevaluable|0|||
170657516|NCT00589784|616759777|FG000|Overall Study|Adverse Event|0|||
170657517|NCT00589784|616759778|FG001|Overall Study|Adverse Event|4|||
170657518|NCT00608543|616759779|FG000|Overall Study|Adverse Event|4|||
170657519|NCT01289782|616759780|FG000|Overall Study|Lost to Follow-up|14|||
170657520|NCT01289782|616759781|FG001|Overall Study|Lost to Follow-up|7|||
170657521|NCT01289782|616759780|FG000|Overall Study|Protocol Violation|1|||
170657522|NCT01289782|616759781|FG001|Overall Study|Protocol Violation|1|||
170657523|NCT01289782|616759780|FG000|Overall Study|Withdrawal by Subject|8|||
170657524|NCT01289782|616759781|FG001|Overall Study|Withdrawal by Subject|2|||
170657525|NCT01289782|616759780|FG000|Overall Study|Sponsor's Decision|1|||
170657526|NCT01289782|616759781|FG001|Overall Study|Sponsor's Decision|0|||
170657527|NCT01289782|616759780|FG000|Overall Study|Reason not specified|1|||
170657528|NCT01289782|616759781|FG001|Overall Study|Reason not specified|2|||
170657529|NCT02376829|616759782|FG000|Overall Study|Withdrawal by Subject|27|||
170657530|NCT02376829|616759783|FG001|Overall Study|Withdrawal by Subject|44|||
170657531|NCT00057954|616759784|FG000|Overall Study|Death|1|||
170657532|NCT00057954|616759784|FG000|Overall Study|Disease progression|1|||
170657533|NCT01251744|616759785|FG000|Overall Study|Lost to Follow-up|1|||
170657534|NCT01251744|616759786|FG001|Overall Study|Lost to Follow-up|0|||
170657535|NCT01264016|616759787|FG000|Overall Study|Withdrawal by Subject|1|||
170657536|NCT01264016|616759787|FG000|Overall Study|Felt faint at sight of blood|1|||
170657537|NCT01068652|616759788|FG000|Overall Study|Adverse Event|4|||
170657538|NCT01068652|616759789|FG001|Overall Study|Adverse Event|0|||
170657539|NCT01068652|616759788|FG000|Overall Study|Lack of Efficacy|0|||
170657540|NCT01068652|616759789|FG001|Overall Study|Lack of Efficacy|2|||
170657541|NCT01068652|616759788|FG000|Overall Study|Lost to Follow-up|2|||
170657542|NCT01068652|616759789|FG001|Overall Study|Lost to Follow-up|1|||
170657543|NCT01068652|616759788|FG000|Overall Study|Protocol Violation|3|||
170657544|NCT01068652|616759789|FG001|Overall Study|Protocol Violation|6|||
170657545|NCT01068652|616759788|FG000|Overall Study|Withdrawal criteria|1|||
170657546|NCT01068652|616759789|FG001|Overall Study|Withdrawal criteria|2|||
170657547|NCT01068652|616759788|FG000|Overall Study|Patient was not eligible|1|||
170657548|NCT01068652|616759789|FG001|Overall Study|Patient was not eligible|0|||
170657549|NCT01068652|616759788|FG000|Overall Study|Unclassified|7|||
170657550|NCT01068652|616759789|FG001|Overall Study|Unclassified|4|||
170657551|NCT00214500|616759790|FG000|Treatment Period|Adverse Event|1|||
170657552|NCT00214500|616759790|FG000|Extension Period|Withdrawal by Subject|2|||
170657553|NCT01056380|616759791|FG000|Overall Study|Lost to Follow-up|2|||
170657554|NCT01056380|616759792|FG001|Overall Study|Lost to Follow-up|3|||
170916930|NCT03778229|617697784|FG000|Overall Study|Ongoing on-study|14|||
170916931|NCT03778229|617697785|FG001|Overall Study|Ongoing on-study|32|||
170657555|NCT00147251|616759793|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
170657556|NCT00147251|616759794|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
170657557|NCT02147184|616759795|FG000|Overall Study|Lost to Follow-up|28|||
170657558|NCT02147184|616759796|FG001|Overall Study|Lost to Follow-up|15|||
170657559|NCT02147184|616759795|FG000|Overall Study|Study Burden|11|||
170657560|NCT02147184|616759796|FG001|Overall Study|Study Burden|7|||
170916932|NCT03778229|617697786|FG002|Overall Study|Ongoing on-study|3|||
170916933|NCT03778229|617697787|FG003|Overall Study|Ongoing on-study|13|||
170657561|NCT02147184|616759795|FG000|Overall Study|Pregnancy|6|||
170916934|NCT03778229|617697784|FG000|Overall Study|Incorrectly Randomized|0|||
170657562|NCT02147184|616759796|FG001|Overall Study|Pregnancy|0|||
170657563|NCT02147184|616759795|FG000|Overall Study|Moved out of state|3|||
170657564|NCT02147184|616759796|FG001|Overall Study|Moved out of state|3|||
170657565|NCT02147184|616759795|FG000|Overall Study|Physician Decision|0|||
170657566|NCT02147184|616759796|FG001|Overall Study|Physician Decision|2|||
170657567|NCT02147184|616759795|FG000|Overall Study|Other|1|||
170657568|NCT02147184|616759796|FG001|Overall Study|Other|0|||
170657569|NCT02117414|616759797|FG000|Overall Study|Death|5|||
170657570|NCT02117414|616759798|FG001|Overall Study|Death|2|||
170657571|NCT02117414|616759797|FG000|Overall Study|Withdrawal by Subject|10|||
170613583|NCT03197376|616591603|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
170613584|NCT03197376|616591604|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
170613585|NCT03197376|616591601|FG000|Primary and Booster Phase|Physician Decision|1|||
170613586|NCT03197376|616591602|FG001|Primary and Booster Phase|Physician Decision|0|||
170613587|NCT03197376|616591603|FG002|Primary and Booster Phase|Physician Decision|1|||
170613588|NCT03197376|616591604|FG003|Primary and Booster Phase|Physician Decision|3|||
170613589|NCT03197376|616591601|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
170613590|NCT03197376|616591602|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
170613591|NCT03197376|616591603|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
170613592|NCT03197376|616591604|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
170613593|NCT03197376|616591601|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
170613594|NCT03197376|616591602|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
170613595|NCT03197376|616591603|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
170613596|NCT03197376|616591604|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
170613597|NCT03197376|616591601|FG000|Primary and Booster Phase|Not vaccine related|1|||
170613598|NCT03197376|616591602|FG001|Primary and Booster Phase|Not vaccine related|2|||
170613599|NCT03197376|616591603|FG002|Primary and Booster Phase|Not vaccine related|0|||
170613600|NCT03197376|616591604|FG003|Primary and Booster Phase|Not vaccine related|6|||
170613601|NCT03197376|616591601|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
170613602|NCT03197376|616591602|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
170613603|NCT03197376|616591603|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
170613604|NCT03197376|616591604|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
170613605|NCT03197376|616591601|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
170613606|NCT03197376|616591602|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
170613607|NCT03197376|616591603|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
170613608|NCT03197376|616591604|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
170613609|NCT03197376|616591601|FG000|Immune Persistence Phase|Not vaccine related|1|||
170613610|NCT03197376|616591602|FG001|Immune Persistence Phase|Not vaccine related|0|||
170613611|NCT03197376|616591603|FG002|Immune Persistence Phase|Not vaccine related|1|||
170613612|NCT03197376|616591604|FG003|Immune Persistence Phase|Not vaccine related|1|||
170613613|NCT04565951|616591605|FG000|Overall Study|Lost to Follow-up|66|||
170613614|NCT04565951|616591606|FG001|Overall Study|Lost to Follow-up|38|||
170613615|NCT04565951|616591605|FG000|Overall Study|Withdrawal by Subject|14|||
170613616|NCT04565951|616591606|FG001|Overall Study|Withdrawal by Subject|7|||
170613617|NCT04565951|616591605|FG000|Overall Study|Death|0|||
170613618|NCT04565951|616591606|FG001|Overall Study|Death|1|||
170613619|NCT02978833|616591608|FG000|Overall Study|Study terminated|1|||
170613620|NCT02978833|616591609|FG001|Overall Study|Study terminated|1|||
170613621|NCT02465203|616591610|FG000|Overall Study|Protocol Violation|1|||
170613622|NCT02465203|616591611|FG001|Overall Study|Protocol Violation|1|||
170613623|NCT02465203|616591612|FG002|Overall Study|Protocol Violation|1|||
170613624|NCT02465203|616591610|FG000|Overall Study|Study terminated by sponsor|50|||
170613625|NCT02465203|616591611|FG001|Overall Study|Study terminated by sponsor|34|||
170613626|NCT02465203|616591612|FG002|Overall Study|Study terminated by sponsor|11|||
170613627|NCT02465203|616591610|FG000|Overall Study|New therapy for study indication|4|||
170613628|NCT02465203|616591611|FG001|Overall Study|New therapy for study indication|0|||
170613629|NCT02465203|616591612|FG002|Overall Study|New therapy for study indication|0|||
170613630|NCT02465203|616591610|FG000|Overall Study|Patient/guardian decision|1|||
170613631|NCT02465203|616591611|FG001|Overall Study|Patient/guardian decision|1|||
170613632|NCT02465203|616591612|FG002|Overall Study|Patient/guardian decision|1|||
170613633|NCT00620113|616591613|FG000|Overall Study|Adverse Event|3|||
170613634|NCT00620113|616591614|FG001|Overall Study|Adverse Event|2|||
170613635|NCT00620113|616591615|FG002|Overall Study|Adverse Event|2|||
170613636|NCT00620113|616591616|FG003|Overall Study|Adverse Event|1|||
170613637|NCT00620113|616591613|FG000|Overall Study|Lack of Efficacy|2|||
170613638|NCT00620113|616591614|FG001|Overall Study|Lack of Efficacy|3|||
170613639|NCT00620113|616591615|FG002|Overall Study|Lack of Efficacy|0|||
170613640|NCT00620113|616591616|FG003|Overall Study|Lack of Efficacy|2|||
170657572|NCT02117414|616759798|FG001|Overall Study|Withdrawal by Subject|4|||
170657573|NCT03519386|616759803|FG000|Overall Study|Withdrawal by Subject|4|||
170657574|NCT03519386|616759804|FG001|Overall Study|Withdrawal by Subject|1|||
170613641|NCT00620113|616591613|FG000|Overall Study|Physician Decision|1|||
170613642|NCT00620113|616591614|FG001|Overall Study|Physician Decision|0|||
170613643|NCT00620113|616591615|FG002|Overall Study|Physician Decision|0|||
170613644|NCT00620113|616591616|FG003|Overall Study|Physician Decision|2|||
170657575|NCT03519386|616759805|FG002|Overall Study|Withdrawal by Subject|2|||
170657576|NCT03519386|616759803|FG000|Overall Study|Physician Decision|1|||
170657577|NCT03519386|616759804|FG001|Overall Study|Physician Decision|1|||
170657578|NCT03519386|616759805|FG002|Overall Study|Physician Decision|1|||
170657579|NCT03519386|616759803|FG000|Overall Study|Lost to Follow-up|0|||
170657580|NCT03519386|616759804|FG001|Overall Study|Lost to Follow-up|1|||
170657581|NCT03519386|616759805|FG002|Overall Study|Lost to Follow-up|1|||
170657582|NCT03519386|616759803|FG000|Overall Study|Death|1|||
170657583|NCT03519386|616759804|FG001|Overall Study|Death|0|||
170657584|NCT03519386|616759805|FG002|Overall Study|Death|4|||
170657585|NCT03519386|616759803|FG000|Overall Study|Adverse Event|2|||
170657586|NCT03519386|616759804|FG001|Overall Study|Adverse Event|1|||
170657587|NCT03519386|616759805|FG002|Overall Study|Adverse Event|2|||
170657588|NCT03519386|616759803|FG000|Overall Study|Explanted|2|||
170657589|NCT03519386|616759804|FG001|Overall Study|Explanted|1|||
170657590|NCT03519386|616759805|FG002|Overall Study|Explanted|0|||
170657591|NCT03519386|616759803|FG000|Overall Study|Ongoing in study|190|||
170657592|NCT03519386|616759804|FG001|Overall Study|Ongoing in study|192|||
170657593|NCT03519386|616759805|FG002|Overall Study|Ongoing in study|183|||
170657594|NCT03583073|616759806|FG000|Overall Study|Lost to Follow-up|8|||
170657595|NCT03583073|616759807|FG001|Overall Study|Lost to Follow-up|12|||
170657596|NCT01582854|616759811|FG000|Overall Study|Death|8|||
170657597|NCT01582854|616759812|FG001|Overall Study|Death|5|||
170657598|NCT01582854|616759811|FG000|Overall Study|Adverse Event|2|||
170657599|NCT01582854|616759812|FG001|Overall Study|Adverse Event|3|||
170657600|NCT01582854|616759811|FG000|Overall Study|Withdrawal by Participant|8|||
170657601|NCT01582854|616759812|FG001|Overall Study|Withdrawal by Participant|11|||
170657602|NCT01582854|616759811|FG000|Overall Study|Lost to Follow-up|1|||
170657603|NCT01582854|616759812|FG001|Overall Study|Lost to Follow-up|2|||
170657604|NCT01582854|616759811|FG000|Overall Study|Physician Decision|0|||
170657605|NCT01582854|616759812|FG001|Overall Study|Physician Decision|1|||
170657606|NCT01582854|616759811|FG000|Overall Study|Recurrent Stroke|13|||
170657607|NCT01582854|616759812|FG001|Overall Study|Recurrent Stroke|8|||
170657608|NCT01582854|616759811|FG000|Overall Study|Disallowed Concomitant Medication|3|||
170657609|NCT01582854|616759812|FG001|Overall Study|Disallowed Concomitant Medication|2|||
170657610|NCT01582854|616759811|FG000|Overall Study|Carotid or Neurosurgery|0|||
170657611|NCT01582854|616759812|FG001|Overall Study|Carotid or Neurosurgery|1|||
170657612|NCT01582854|616759811|FG000|Overall Study|General Anaesthesia|0|||
170657613|NCT01582854|616759812|FG001|Overall Study|General Anaesthesia|1|||
170657614|NCT01582854|616759811|FG000|Overall Study|Other Miscellaneous Reason|1|||
170657615|NCT01582854|616759812|FG001|Overall Study|Other Miscellaneous Reason|0|||
170657616|NCT03101267|616759813|FG000|Primary Study Period|Withdrawal by Subject|1|||
170657617|NCT03101267|616759814|FG001|Primary Study Period|Withdrawal by Subject|2|||
170657618|NCT03101267|616759815|FG002|Primary Study Period|Withdrawal by Subject|3|||
170657619|NCT03101267|616759813|FG000|Primary Study Period|Miscellaneous|2|||
170657620|NCT03101267|616759814|FG001|Primary Study Period|Miscellaneous|0|||
170657621|NCT03101267|616759815|FG002|Primary Study Period|Miscellaneous|0|||
170657622|NCT04068896|616759816|FG000|Overall Study|Adverse Event|2|||
170657623|NCT04068896|616759817|FG001|Overall Study|Adverse Event|0|||
170816616|NCT00689351|617335547|FG000|Infant Series of Dosing|Adverse Event|1|||
170816617|NCT00689351|617335548|FG001|Infant Series of Dosing|Adverse Event|0|||
170816618|NCT00689351|617335547|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
170816619|NCT00689351|617335548|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
170816620|NCT00689351|617335547|FG000|After Infant Series|Parent/legal guardian request|1|||
170816621|NCT00689351|617335548|FG001|After Infant Series|Parent/legal guardian request|0|||
170816622|NCT01766206|617335549|FG000|Overall Study|Withdrawal by Subject|22|||
170816623|NCT01766206|617335549|FG000|Overall Study|Lost to Follow-up|10|||
170816624|NCT01766206|617335549|FG000|Overall Study|Inappropriate enrollment|18|||
170816625|NCT01766206|617335549|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
170816626|NCT01229176|617335550|FG000|Overall Study|Withdrawal by Subject|0|||
170657624|NCT04068896|616759818|FG002|Overall Study|Adverse Event|1|||
170657625|NCT04068896|616759819|FG003|Overall Study|Adverse Event|0|||
170657626|NCT04068896|616759820|FG004|Overall Study|Adverse Event|0|||
170657627|NCT04068896|616759821|FG005|Overall Study|Adverse Event|0|||
170816627|NCT01229176|617335551|FG001|Overall Study|Withdrawal by Subject|0|||
170657628|NCT04068896|616759816|FG000|Overall Study|Death|3|||
170657629|NCT04068896|616759817|FG001|Overall Study|Death|1|||
170657630|NCT04068896|616759818|FG002|Overall Study|Death|3|||
170657631|NCT04068896|616759819|FG003|Overall Study|Death|19|||
170657632|NCT04068896|616759820|FG004|Overall Study|Death|17|||
170657633|NCT04068896|616759821|FG005|Overall Study|Death|0|||
170657634|NCT04068896|616759816|FG000|Overall Study|Physician Decision|0|||
170657635|NCT04068896|616759817|FG001|Overall Study|Physician Decision|0|||
170657636|NCT04068896|616759818|FG002|Overall Study|Physician Decision|0|||
170657637|NCT04068896|616759819|FG003|Overall Study|Physician Decision|1|||
170657638|NCT04068896|616759820|FG004|Overall Study|Physician Decision|0|||
170657639|NCT04068896|616759821|FG005|Overall Study|Physician Decision|0|||
170816628|NCT01229176|617335552|FG002|Overall Study|Withdrawal by Subject|0|||
170657640|NCT04068896|616759816|FG000|Overall Study|progressive disease|3|||
170657641|NCT04068896|616759817|FG001|Overall Study|progressive disease|5|||
170613645|NCT00620113|616591613|FG000|Overall Study|Protocol Violation|2|||
170613646|NCT00620113|616591614|FG001|Overall Study|Protocol Violation|1|||
170613647|NCT00620113|616591615|FG002|Overall Study|Protocol Violation|0|||
170613648|NCT00620113|616591616|FG003|Overall Study|Protocol Violation|0|||
170613649|NCT00620113|616591613|FG000|Overall Study|Withdrawal by Subject|5|||
170613650|NCT00620113|616591614|FG001|Overall Study|Withdrawal by Subject|1|||
170613651|NCT00620113|616591615|FG002|Overall Study|Withdrawal by Subject|3|||
170613652|NCT00620113|616591616|FG003|Overall Study|Withdrawal by Subject|5|||
170613653|NCT00947115|616591619|FG000|Overall Study|Missed reporting interval|3|||
170613654|NCT00947115|616591620|FG001|Overall Study|Missed reporting interval|4|||
170613655|NCT00947115|616591621|FG002|Overall Study|Missed reporting interval|2|||
170613656|NCT00947115|616591619|FG000|Overall Study|Physician Decision|0|||
170613657|NCT00947115|616591620|FG001|Overall Study|Physician Decision|2|||
170613658|NCT00947115|616591621|FG002|Overall Study|Physician Decision|0|||
170613659|NCT00947115|616591619|FG000|Overall Study|Death|0|||
170613660|NCT00947115|616591620|FG001|Overall Study|Death|1|||
170613661|NCT00947115|616591621|FG002|Overall Study|Death|1|||
170613662|NCT00947115|616591619|FG000|Overall Study|Migrated from study area|2|||
170613663|NCT00947115|616591620|FG001|Overall Study|Migrated from study area|0|||
170613664|NCT00947115|616591621|FG002|Overall Study|Migrated from study area|0|||
170613665|NCT00947115|616591619|FG000|Overall Study|Withdrawal by Subject|1|||
170613666|NCT00947115|616591620|FG001|Overall Study|Withdrawal by Subject|3|||
170613667|NCT00947115|616591621|FG002|Overall Study|Withdrawal by Subject|4|||
170613668|NCT00947115|616591619|FG000|Overall Study|Lost to Follow-up|11|||
170613669|NCT00947115|616591620|FG001|Overall Study|Lost to Follow-up|12|||
170613670|NCT00947115|616591621|FG002|Overall Study|Lost to Follow-up|8|||
170613671|NCT02092025|616591622|FG000|Overall Study|Case Report Forms Uncollected|44|||
170613672|NCT02092025|616591622|FG000|Overall Study|Protocol Deviation|24|||
170613673|NCT02834247|616591623|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
170613674|NCT02834247|616591624|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
170613675|NCT02834247|616591625|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
170613676|NCT02834247|616591626|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
170613677|NCT02834247|616591623|FG000|Dose Escalation Phase|Death|5|||
170613678|NCT02834247|616591624|FG001|Dose Escalation Phase|Death|6|||
170613679|NCT02834247|616591625|FG002|Dose Escalation Phase|Death|5|||
170613680|NCT02834247|616591626|FG003|Dose Escalation Phase|Death|0|||
170613681|NCT02834247|616591623|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
170613682|NCT02834247|616591624|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
170613683|NCT02834247|616591625|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
170613684|NCT02834247|616591626|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
170613685|NCT02834247|616591623|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
170613686|NCT02834247|616591624|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
170613687|NCT02834247|616591625|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
170613688|NCT02834247|616591626|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
170613689|NCT02834247|616591623|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
170613690|NCT02834247|616591624|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
170613691|NCT02834247|616591625|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
170613692|NCT02834247|616591626|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
170613693|NCT02834247|616591623|FG000|Dose Expansion Phase|Death|0|||
170613694|NCT02834247|616591624|FG001|Dose Expansion Phase|Death|0|||
170613695|NCT02834247|616591625|FG002|Dose Expansion Phase|Death|0|||
170613696|NCT02834247|616591626|FG003|Dose Expansion Phase|Death|8|||
170613697|NCT02834247|616591623|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
170613698|NCT02834247|616591624|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
170613699|NCT02834247|616591625|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
170613700|NCT02834247|616591626|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
170613701|NCT02834247|616591623|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
170613702|NCT02834247|616591624|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
170613703|NCT02834247|616591625|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
170613704|NCT02834247|616591626|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
170613705|NCT01807299|616591627|FG000|Overall Study|Protocol Violation|3|||
170613706|NCT01807299|616591628|FG001|Overall Study|Protocol Violation|1|||
170613707|NCT01807299|616591629|FG002|Overall Study|Protocol Violation|0|||
170613708|NCT01807299|616591630|FG003|Overall Study|Protocol Violation|2|||
170613709|NCT00999544|616593440|FG000|Overall Study|Withdrawal by Subject|1|||
170613710|NCT01392547|616593441|FG000|Overall Study|Adverse Event|2|||
170613711|NCT01392547|616593441|FG000|Overall Study|Non-compliance|2|||
170613712|NCT01392547|616593441|FG000|Overall Study|Withdrawal criteria|3|||
170613713|NCT01392547|616593441|FG000|Overall Study|Unclassified|1|||
170613714|NCT02936635|616593443|FG000|Overall Study|Adverse Event|43|||
170613715|NCT02936635|616593444|FG001|Overall Study|Adverse Event|25|||
170613716|NCT02936635|616593443|FG000|Overall Study|Progressive Disease|10|||
170613717|NCT02936635|616593444|FG001|Overall Study|Progressive Disease|18|||
170613718|NCT02936635|616593443|FG000|Overall Study|Sponsor Discretion|10|||
170613719|NCT02936635|616593444|FG001|Overall Study|Sponsor Discretion|16|||
170613720|NCT02936635|616593443|FG000|Overall Study|Death|9|||
170613721|NCT02936635|616593444|FG001|Overall Study|Death|15|||
170657642|NCT04068896|616759818|FG002|Overall Study|progressive disease|3|||
170657643|NCT04068896|616759819|FG003|Overall Study|progressive disease|2|||
170657644|NCT04068896|616759820|FG004|Overall Study|progressive disease|1|||
170657645|NCT04068896|616759821|FG005|Overall Study|progressive disease|2|||
170657646|NCT04068896|616759816|FG000|Overall Study|Study terminated by sponsor|0|||
170657647|NCT04068896|616759817|FG001|Overall Study|Study terminated by sponsor|0|||
170657648|NCT04068896|616759818|FG002|Overall Study|Study terminated by sponsor|1|||
170657649|NCT04068896|616759819|FG003|Overall Study|Study terminated by sponsor|2|||
170657650|NCT04068896|616759820|FG004|Overall Study|Study terminated by sponsor|1|||
170657651|NCT04068896|616759821|FG005|Overall Study|Study terminated by sponsor|4|||
170657652|NCT04068896|616759816|FG000|Overall Study|Protocol Violation|0|||
170657653|NCT04068896|616759817|FG001|Overall Study|Protocol Violation|0|||
170657654|NCT04068896|616759818|FG002|Overall Study|Protocol Violation|0|||
170657655|NCT04068896|616759819|FG003|Overall Study|Protocol Violation|1|||
170657656|NCT04068896|616759820|FG004|Overall Study|Protocol Violation|0|||
170657657|NCT04068896|616759821|FG005|Overall Study|Protocol Violation|0|||
170657658|NCT04068896|616759816|FG000|Overall Study|Withdrawal by Subject|0|||
170657659|NCT04068896|616759817|FG001|Overall Study|Withdrawal by Subject|3|||
170657660|NCT04068896|616759818|FG002|Overall Study|Withdrawal by Subject|0|||
170657661|NCT04068896|616759819|FG003|Overall Study|Withdrawal by Subject|2|||
170657662|NCT04068896|616759820|FG004|Overall Study|Withdrawal by Subject|1|||
170657663|NCT04068896|616759821|FG005|Overall Study|Withdrawal by Subject|0|||
170657664|NCT04068896|616759816|FG000|Overall Study|Symptomatic deterioration|2|||
170657665|NCT04068896|616759817|FG001|Overall Study|Symptomatic deterioration|0|||
170657666|NCT04068896|616759818|FG002|Overall Study|Symptomatic deterioration|0|||
170657667|NCT04068896|616759819|FG003|Overall Study|Symptomatic deterioration|0|||
170657668|NCT04068896|616759820|FG004|Overall Study|Symptomatic deterioration|0|||
170657669|NCT04068896|616759821|FG005|Overall Study|Symptomatic deterioration|0|||
170657670|NCT00484185|616759822|FG000|Overall Study|Lost to Follow-up|44|||
170657671|NCT00484185|616759822|FG000|Overall Study|Other|20|||
170657672|NCT00484185|616759822|FG000|Overall Study|Randomized but not treated|5|||
170657673|NCT00484185|616759822|FG000|Overall Study|Death|2|||
170657674|NCT01222403|616759823|FG000|Overall Study|Inappropriate enrollment|0|||
170657675|NCT01222403|616759824|FG001|Overall Study|Inappropriate enrollment|2|||
170657676|NCT03189381|616759825|FG000|Overall Study|Death|1|||
170657677|NCT03189381|616759826|FG001|Overall Study|Death|0|||
170657678|NCT02045303|616759827|FG000|Overall Study|Protocol Violation|2|||
170657679|NCT02045303|616759828|FG001|Overall Study|Protocol Violation|1|||
170657680|NCT02045303|616759829|FG002|Overall Study|Protocol Violation|0|||
170657681|NCT02045303|616759827|FG000|Overall Study|Withdrawal by Subject|0|||
170657682|NCT02045303|616759828|FG001|Overall Study|Withdrawal by Subject|2|||
170657683|NCT02045303|616759829|FG002|Overall Study|Withdrawal by Subject|0|||
170657684|NCT01642407|616759830|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
170657685|NCT01642407|616759830|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
170657686|NCT01642407|616759830|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
170657687|NCT01856023|616759831|FG000|Overall Study|Death|1|||
170657688|NCT01856023|616759832|FG001|Overall Study|Death|2|||
170657689|NCT01856023|616759831|FG000|Overall Study|Adverse Event|2|||
170657690|NCT01856023|616759832|FG001|Overall Study|Adverse Event|1|||
170657691|NCT01856023|616759831|FG000|Overall Study|Lack of Efficacy|5|||
170657692|NCT01856023|616759832|FG001|Overall Study|Lack of Efficacy|5|||
170657693|NCT01856023|616759831|FG000|Overall Study|non compliance, study closure|1|||
170657694|NCT01856023|616759832|FG001|Overall Study|non compliance, study closure|3|||
170657695|NCT01856023|616759831|FG000|Overall Study|Withdrawal by Subject|1|||
170657696|NCT01856023|616759832|FG001|Overall Study|Withdrawal by Subject|1|||
170657697|NCT00424255|616759833|FG000|Overall Study|Death|115|||
170657698|NCT00424255|616759834|FG001|Overall Study|Death|111|||
170657699|NCT00424255|616759833|FG000|Overall Study|Lost to Follow-up|26|||
170657700|NCT00424255|616759834|FG001|Overall Study|Lost to Follow-up|20|||
170657701|NCT00424255|616759833|FG000|Overall Study|Protocol Violation|0|||
170657702|NCT00424255|616759834|FG001|Overall Study|Protocol Violation|1|||
170816629|NCT01229176|617335553|FG003|Overall Study|Withdrawal by Subject|1|||
170657703|NCT00424255|616759833|FG000|Overall Study|Withdrawal by Subject|34|||
170657704|NCT00424255|616759834|FG001|Overall Study|Withdrawal by Subject|38|||
170657705|NCT00424255|616759833|FG000|Overall Study|Physician Decision|3|||
170657706|NCT00424255|616759834|FG001|Overall Study|Physician Decision|7|||
170816630|NCT01229176|617335554|FG004|Overall Study|Withdrawal by Subject|1|||
170657707|NCT00424255|616759833|FG000|Overall Study|Cognitive Disturbance|1|||
170657708|NCT00424255|616759834|FG001|Overall Study|Cognitive Disturbance|0|||
170657709|NCT00424255|616759833|FG000|Overall Study|Non-compliance by Participants|1|||
170657710|NCT00424255|616759834|FG001|Overall Study|Non-compliance by Participants|0|||
170657711|NCT00424255|616759833|FG000|Overall Study|Fatigue|1|||
170657712|NCT00424255|616759834|FG001|Overall Study|Fatigue|0|||
170657713|NCT00424255|616759833|FG000|Overall Study|Disease Progression|0|||
170657714|NCT00424255|616759834|FG001|Overall Study|Disease Progression|2|||
170657715|NCT00424255|616759833|FG000|Overall Study|Sponsor Terminated Study|161|||
170613722|NCT02936635|616593443|FG000|Overall Study|Withdrawal by Subject|8|||
170613723|NCT02936635|616593444|FG001|Overall Study|Withdrawal by Subject|15|||
170613724|NCT02936635|616593443|FG000|Overall Study|Physician Decision|2|||
170613725|NCT02936635|616593444|FG001|Overall Study|Physician Decision|9|||
170613726|NCT02936635|616593443|FG000|Overall Study|Lost to Follow-up|1|||
170613727|NCT02936635|616593444|FG001|Overall Study|Lost to Follow-up|2|||
170613728|NCT02936635|616593443|FG000|Overall Study|Protocol Violation|1|||
170613729|NCT02936635|616593444|FG001|Overall Study|Protocol Violation|0|||
170613730|NCT02936635|616593443|FG000|Overall Study|Lack of effect/Entry into other study|31|||
170613731|NCT02936635|616593444|FG001|Overall Study|Lack of effect/Entry into other study|65|||
170613732|NCT04050618|616593445|FG000|First Intervention|Withdrawal by Subject|2|||
170613733|NCT04050618|616593446|FG001|First Intervention|Withdrawal by Subject|0|||
170613734|NCT04050618|616593445|FG000|Second Intervention|Withdrawal by Subject|1|||
170613735|NCT04050618|616593446|FG001|Second Intervention|Withdrawal by Subject|0|||
170613736|NCT01473732|616593447|FG000|Overall Study|Adverse Event|1|||
170613737|NCT01473732|616593448|FG001|Overall Study|Adverse Event|0|||
170613738|NCT01473732|616593447|FG000|Overall Study|Death|1|||
170613739|NCT01473732|616593448|FG001|Overall Study|Death|0|||
170613740|NCT00671034|616593449|FG000|Overall Study|Adverse Event|5|||
170613741|NCT00671034|616593450|FG001|Overall Study|Adverse Event|7|||
170613742|NCT00671034|616593451|FG002|Overall Study|Adverse Event|1|||
170613743|NCT00671034|616593449|FG000|Overall Study|Death|3|||
170613744|NCT00671034|616593450|FG001|Overall Study|Death|2|||
170613745|NCT00671034|616593451|FG002|Overall Study|Death|1|||
170613746|NCT00671034|616593449|FG000|Overall Study|Physician Decision|12|||
170613747|NCT00671034|616593450|FG001|Overall Study|Physician Decision|4|||
170613748|NCT00671034|616593451|FG002|Overall Study|Physician Decision|5|||
170613749|NCT00671034|616593449|FG000|Overall Study|VHR ALL feature|8|||
170613750|NCT00671034|616593450|FG001|Overall Study|VHR ALL feature|3|||
170613751|NCT00671034|616593451|FG002|Overall Study|VHR ALL feature|5|||
170613752|NCT00671034|616593449|FG000|Overall Study|Refusal|5|||
170613753|NCT00671034|616593450|FG001|Overall Study|Refusal|3|||
170613754|NCT00671034|616593451|FG002|Overall Study|Refusal|5|||
170613755|NCT00671034|616593449|FG000|Overall Study|includes Alternative therapy, etc.|6|||
170613756|NCT00671034|616593450|FG001|Overall Study|includes Alternative therapy, etc.|1|||
170613757|NCT00671034|616593451|FG002|Overall Study|includes Alternative therapy, etc.|7|||
170613758|NCT04473963|616593468|FG000|Overall Study|Withdrawal by Subject|1|||
170613759|NCT04473963|616593469|FG001|Overall Study|Withdrawal by Subject|1|||
170613760|NCT04473963|616593470|FG002|Overall Study|Withdrawal by Subject|0|||
170613761|NCT04473963|616593468|FG000|Overall Study|Not inducible in AF|0|||
170613762|NCT04473963|616593469|FG001|Overall Study|Not inducible in AF|0|||
170613763|NCT04473963|616593470|FG002|Overall Study|Not inducible in AF|2|||
170613764|NCT04685798|616593471|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
170613765|NCT02322281|616593481|FG000|Overall Study|Progressive Disease|42|||
170613766|NCT02322281|616593482|FG001|Overall Study|Progressive Disease|14|||
170613767|NCT02322281|616593483|FG002|Overall Study|Progressive Disease|49|||
170613768|NCT02322281|616593481|FG000|Overall Study|Adverse Event|3|||
170613769|NCT02322281|616593482|FG001|Overall Study|Adverse Event|4|||
170613770|NCT02322281|616593483|FG002|Overall Study|Adverse Event|6|||
170613771|NCT02322281|616593481|FG000|Overall Study|Death|3|||
170916935|NCT03778229|617697785|FG001|Overall Study|Incorrectly Randomized|0|||
170916936|NCT03778229|617697786|FG002|Overall Study|Incorrectly Randomized|0|||
170916937|NCT03778229|617697787|FG003|Overall Study|Incorrectly Randomized|1|||
170916938|NCT02542293|617697789|FG000|Overall Study|Death|367|||
170613772|NCT02322281|616593482|FG001|Overall Study|Death|3|||
170613773|NCT02322281|616593483|FG002|Overall Study|Death|3|||
170613774|NCT02322281|616593481|FG000|Overall Study|Withdrawal by Subject|1|||
170613775|NCT02322281|616593482|FG001|Overall Study|Withdrawal by Subject|1|||
170613776|NCT02322281|616593483|FG002|Overall Study|Withdrawal by Subject|6|||
170613777|NCT02322281|616593481|FG000|Overall Study|Physician Decision|2|||
170613778|NCT02322281|616593482|FG001|Overall Study|Physician Decision|0|||
170613779|NCT02322281|616593483|FG002|Overall Study|Physician Decision|5|||
170613780|NCT02322281|616593481|FG000|Overall Study|Study Terminated by Sponsor|2|||
170613781|NCT02322281|616593482|FG001|Overall Study|Study Terminated by Sponsor|0|||
170613782|NCT02322281|616593483|FG002|Overall Study|Study Terminated by Sponsor|0|||
170613783|NCT02322281|616593481|FG000|Overall Study|Missing|0|||
170613784|NCT02322281|616593482|FG001|Overall Study|Missing|0|||
170613785|NCT02322281|616593483|FG002|Overall Study|Missing|1|||
170613786|NCT02322281|616593481|FG000|Overall Study|Miscellaneous|0|||
170613787|NCT02322281|616593482|FG001|Overall Study|Miscellaneous|0|||
170613788|NCT02322281|616593483|FG002|Overall Study|Miscellaneous|4|||
170613789|NCT00592904|616593484|FG000|Overall Study|Adverse Event|15|||
170613790|NCT00592904|616593485|FG001|Overall Study|Adverse Event|25|||
170613791|NCT00592904|616593486|FG002|Overall Study|Adverse Event|13|||
170613792|NCT00592904|616593487|FG003|Overall Study|Adverse Event|5|||
170613793|NCT00592904|616593484|FG000|Overall Study|Protocol Violation|1|||
170613794|NCT00592904|616593485|FG001|Overall Study|Protocol Violation|1|||
170613795|NCT00592904|616593486|FG002|Overall Study|Protocol Violation|0|||
170613796|NCT00592904|616593487|FG003|Overall Study|Protocol Violation|1|||
170916939|NCT02542293|617697790|FG001|Overall Study|Death|377|||
170657716|NCT00424255|616759834|FG001|Overall Study|Sponsor Terminated Study|167|||
170657717|NCT00256282|616759835|FG000|Overall Study|Disease progression, relapse during acti|12|||
170657718|NCT00256282|616759835|FG000|Overall Study|Adverse Event|3|||
170657719|NCT00256282|616759835|FG000|Overall Study|Physician Decision|1|||
170657720|NCT02431247|616759836|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
170657721|NCT02431247|616759837|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
170657722|NCT02431247|616759838|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
170657723|NCT02431247|616759836|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
170657724|NCT02431247|616759837|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
170657725|NCT02431247|616759838|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
170657726|NCT02431247|616759836|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
170657727|NCT02431247|616759837|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
170657728|NCT02431247|616759838|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
170657729|NCT02431247|616759836|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
170657730|NCT02431247|616759837|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
170657731|NCT02431247|616759838|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
170657732|NCT02431247|616759836|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
170657733|NCT02431247|616759837|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
170657734|NCT02431247|616759838|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
170657735|NCT02431247|616759836|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
170657736|NCT02431247|616759837|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
170657737|NCT02431247|616759838|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
170657738|NCT02431247|616759836|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
170657739|NCT02431247|616759837|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
170657740|NCT02431247|616759838|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
170657741|NCT02431247|616759836|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
170657742|NCT02431247|616759837|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
170657743|NCT02431247|616759838|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
170657744|NCT02431247|616759836|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
170657745|NCT02431247|616759837|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
170657746|NCT02431247|616759838|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
170657747|NCT02431247|616759836|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
170657748|NCT02431247|616759837|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
170657749|NCT02431247|616759838|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
170657750|NCT02431247|616759836|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
170657751|NCT02431247|616759837|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
170657752|NCT02431247|616759838|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
170657753|NCT02431247|616759836|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
170657754|NCT02431247|616759837|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
170657755|NCT02431247|616759838|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
170657756|NCT02431247|616759836|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
170657757|NCT02431247|616759837|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
170657758|NCT02431247|616759838|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
170657759|NCT02431247|616759836|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
170657760|NCT02431247|616759837|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
170657761|NCT02431247|616759838|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
170657762|NCT00322153|616759839|FG000|Overall Study|Adverse Event|21|||
170657763|NCT00322153|616759840|FG001|Overall Study|Adverse Event|34|||
170657764|NCT00322153|616759839|FG000|Overall Study|Protocol Violation|6|||
170657765|NCT00322153|616759840|FG001|Overall Study|Protocol Violation|14|||
170657766|NCT00322153|616759839|FG000|Overall Study|Withdrawal by Subject|18|||
170657767|NCT00322153|616759840|FG001|Overall Study|Withdrawal by Subject|10|||
170657768|NCT00322153|616759839|FG000|Overall Study|Lack of Efficacy|8|||
170657769|NCT00322153|616759840|FG001|Overall Study|Lack of Efficacy|3|||
170657770|NCT00322153|616759839|FG000|Overall Study|Lost to Follow-up|5|||
170657771|NCT00322153|616759840|FG001|Overall Study|Lost to Follow-up|4|||
170816631|NCT01229176|617335555|FG005|Overall Study|Withdrawal by Subject|1|||
170816632|NCT01229176|617335556|FG006|Overall Study|Withdrawal by Subject|0|||
170816633|NCT01229176|617335557|FG007|Overall Study|Withdrawal by Subject|1|||
170816634|NCT01229176|617335550|FG000|Overall Study|Lost to Follow-up|0|||
170816635|NCT01229176|617335551|FG001|Overall Study|Lost to Follow-up|3|||
170816636|NCT01229176|617335552|FG002|Overall Study|Lost to Follow-up|0|||
170816637|NCT01229176|617335553|FG003|Overall Study|Lost to Follow-up|0|||
170657772|NCT00322153|616759839|FG000|Overall Study|Withdrawn for other reasons|5|||
170657773|NCT00322153|616759840|FG001|Overall Study|Withdrawn for other reasons|4|||
170657774|NCT02632838|616759841|FG000|Overall Study|Withdrawal by Subject|3|||
170816638|NCT01229176|617335554|FG004|Overall Study|Lost to Follow-up|1|||
170816639|NCT01229176|617335555|FG005|Overall Study|Lost to Follow-up|1|||
170816640|NCT01229176|617335556|FG006|Overall Study|Lost to Follow-up|0|||
170816641|NCT01229176|617335557|FG007|Overall Study|Lost to Follow-up|2|||
170816642|NCT03890484|617335558|FG000|Overall Study|Lost to Follow-up|1|||
170657775|NCT02632838|616759842|FG001|Overall Study|Withdrawal by Subject|0|||
170657776|NCT02632838|616759841|FG000|Overall Study|Lost to Follow-up|0|||
170657777|NCT02632838|616759842|FG001|Overall Study|Lost to Follow-up|2|||
170657778|NCT01562873|616759843|FG000|Overall Study|Disease Progression per RECIST|10|||
170657779|NCT01562873|616759844|FG001|Overall Study|Disease Progression per RECIST|0|||
170657780|NCT01562873|616759843|FG000|Overall Study|Adverse Event|1|||
170657781|NCT01562873|616759844|FG001|Overall Study|Adverse Event|0|||
170657782|NCT01562873|616759843|FG000|Overall Study|Clinical Disease Progression|9|||
170657783|NCT01562873|616759844|FG001|Overall Study|Clinical Disease Progression|0|||
170657784|NCT01562873|616759843|FG000|Overall Study|Clinical PD and adverse event|1|||
170657785|NCT01562873|616759844|FG001|Overall Study|Clinical PD and adverse event|0|||
170657786|NCT01369485|616759845|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
170657787|NCT01369485|616759846|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
170657788|NCT01369485|616759845|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
170657789|NCT01369485|616759846|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
170657790|NCT01369485|616759845|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
170657791|NCT01369485|616759846|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
170657792|NCT01369485|616759845|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
170657793|NCT01369485|616759846|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
170657794|NCT01369485|616759845|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
170657795|NCT01369485|616759846|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
170657796|NCT01369485|616759845|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
170657797|NCT01369485|616759846|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
170657798|NCT01369485|616759845|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
170657799|NCT01369485|616759846|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
170657800|NCT01369485|616759845|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
170657801|NCT01369485|616759846|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
170657802|NCT01369485|616759845|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
170657803|NCT01369485|616759846|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
170657804|NCT01369485|616759845|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
170657805|NCT01369485|616759846|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
170657806|NCT01017575|616759852|FG000|Overall Study|Lack of Efficacy|0|||
170657807|NCT01017575|616759853|FG001|Overall Study|Lack of Efficacy|1|||
170657808|NCT01017575|616759854|FG002|Overall Study|Lack of Efficacy|0|||
170657809|NCT01017575|616759855|FG003|Overall Study|Lack of Efficacy|1|||
170657810|NCT01017575|616759856|FG004|Overall Study|Lack of Efficacy|1|||
170657811|NCT01017575|616759852|FG000|Overall Study|Adverse Event|0|||
170657812|NCT01017575|616759853|FG001|Overall Study|Adverse Event|1|||
170657813|NCT01017575|616759854|FG002|Overall Study|Adverse Event|0|||
170657814|NCT01017575|616759855|FG003|Overall Study|Adverse Event|0|||
170657815|NCT01017575|616759856|FG004|Overall Study|Adverse Event|2|||
170657816|NCT01017575|616759852|FG000|Overall Study|Withdrawal by Subject|1|||
170657817|NCT01017575|616759853|FG001|Overall Study|Withdrawal by Subject|0|||
170657818|NCT01017575|616759854|FG002|Overall Study|Withdrawal by Subject|0|||
170657819|NCT01017575|616759855|FG003|Overall Study|Withdrawal by Subject|0|||
170657820|NCT01017575|616759856|FG004|Overall Study|Withdrawal by Subject|0|||
170657821|NCT00995865|616759866|FG000|Overall Study|Protocol Violation|2|||
170657822|NCT00995865|616759867|FG001|Overall Study|Protocol Violation|0|||
170657823|NCT00995865|616759868|FG002|Overall Study|Protocol Violation|0|||
170657824|NCT00995865|616759866|FG000|Overall Study|Lost to Follow-up|0|||
170657825|NCT00995865|616759867|FG001|Overall Study|Lost to Follow-up|0|||
170657826|NCT00995865|616759868|FG002|Overall Study|Lost to Follow-up|1|||
170657827|NCT01307020|616759874|FG000|Overall Study|Lost to Follow-up|0|||
170657828|NCT01307020|616759875|FG001|Overall Study|Lost to Follow-up|0|||
170657829|NCT01307020|616759876|FG002|Overall Study|Lost to Follow-up|1|||
170657830|NCT01307020|616759877|FG003|Overall Study|Lost to Follow-up|1|||
170657831|NCT01307020|616759878|FG004|Overall Study|Lost to Follow-up|0|||
170657832|NCT01307020|616759879|FG005|Overall Study|Lost to Follow-up|0|||
170657833|NCT01307020|616759880|FG006|Overall Study|Lost to Follow-up|1|||
170657834|NCT01307020|616759881|FG007|Overall Study|Lost to Follow-up|0|||
170657835|NCT01307020|616759882|FG008|Overall Study|Lost to Follow-up|0|||
170916940|NCT02542293|617697789|FG000|Overall Study|Withdrawal by Subject|8|||
170916941|NCT02542293|617697790|FG001|Overall Study|Withdrawal by Subject|19|||
170916942|NCT06067009|617697791|FG000|Overall Study|Lost to Follow-up|0|||
170916943|NCT06067009|617697792|FG001|Overall Study|Lost to Follow-up|2|||
170657836|NCT01307020|616759883|FG009|Overall Study|Lost to Follow-up|0|||
170657837|NCT01307020|616759874|FG000|Overall Study|Electronic data capture failure|0|||
170657838|NCT01307020|616759875|FG001|Overall Study|Electronic data capture failure|1|||
170657839|NCT01307020|616759876|FG002|Overall Study|Electronic data capture failure|0|||
170657840|NCT01307020|616759877|FG003|Overall Study|Electronic data capture failure|0|||
170916944|NCT06067009|617697793|FG002|Overall Study|Lost to Follow-up|2|||
170657841|NCT01307020|616759878|FG004|Overall Study|Electronic data capture failure|0|||
170916945|NCT06067009|617697794|FG003|Overall Study|Lost to Follow-up|0|||
170916946|NCT04662281|617697795|FG000|Overall Study|Adverse Event|4|||
170916947|NCT04662281|617697796|FG001|Overall Study|Adverse Event|13|||
170916948|NCT04662281|617697795|FG000|Overall Study|Withdrawal by Subject|1|||
170916949|NCT04662281|617697796|FG001|Overall Study|Withdrawal by Subject|2|||
170916950|NCT04662281|617697795|FG000|Overall Study|Lack of Efficacy|1|||
170916951|NCT04662281|617697796|FG001|Overall Study|Lack of Efficacy|0|||
170916952|NCT04662281|617697795|FG000|Overall Study|Reason not Specified|1|||
170916953|NCT04662281|617697796|FG001|Overall Study|Reason not Specified|2|||
170916954|NCT03466411|617697799|FG000|Overall Study|Lost to Follow-up|0|||
170657842|NCT01307020|616759879|FG005|Overall Study|Electronic data capture failure|0|||
170657843|NCT01307020|616759880|FG006|Overall Study|Electronic data capture failure|0|||
170657844|NCT01307020|616759881|FG007|Overall Study|Electronic data capture failure|0|||
170657845|NCT01307020|616759882|FG008|Overall Study|Electronic data capture failure|0|||
170657846|NCT01307020|616759883|FG009|Overall Study|Electronic data capture failure|0|||
170657847|NCT02021656|616759884|FG000|Overall Study|Adverse Event|1|||
170657848|NCT02021656|616759884|FG000|Overall Study|Lack of Efficacy|2|||
170657849|NCT02021656|616759884|FG000|Overall Study|Lost to Follow-up|1|||
170657850|NCT02021656|616759884|FG000|Overall Study|Withdrew Consent|2|||
170657851|NCT02247531|616761501|FG000|Overall Study|Adverse Event|3|||
170657852|NCT02247531|616761502|FG001|Overall Study|Adverse Event|4|||
170657853|NCT02247531|616761503|FG002|Overall Study|Adverse Event|9|||
170657854|NCT02247531|616761501|FG000|Overall Study|Death|8|||
170657855|NCT02247531|616761502|FG001|Overall Study|Death|9|||
170657856|NCT02247531|616761503|FG002|Overall Study|Death|5|||
170657857|NCT02247531|616761501|FG000|Overall Study|Lost to Follow-up|1|||
170657858|NCT02247531|616761502|FG001|Overall Study|Lost to Follow-up|8|||
170657859|NCT02247531|616761503|FG002|Overall Study|Lost to Follow-up|3|||
170657860|NCT02247531|616761501|FG000|Overall Study|Non-compliance|2|||
170657861|NCT02247531|616761502|FG001|Overall Study|Non-compliance|2|||
170657862|NCT02247531|616761503|FG002|Overall Study|Non-compliance|0|||
170657863|NCT02247531|616761501|FG000|Overall Study|Withdrawal by Subject|26|||
170657864|NCT02247531|616761502|FG001|Overall Study|Withdrawal by Subject|31|||
170657865|NCT02247531|616761503|FG002|Overall Study|Withdrawal by Subject|25|||
170657866|NCT02247531|616761501|FG000|Overall Study|Study Terminated by Sponsor|64|||
170657867|NCT02247531|616761502|FG001|Overall Study|Study Terminated by Sponsor|66|||
170657868|NCT02247531|616761503|FG002|Overall Study|Study Terminated by Sponsor|62|||
170657869|NCT02247531|616761501|FG000|Overall Study|Physician Decision|0|||
170657870|NCT02247531|616761502|FG001|Overall Study|Physician Decision|2|||
170657871|NCT02247531|616761503|FG002|Overall Study|Physician Decision|2|||
170657872|NCT02247531|616761501|FG000|Overall Study|Unspecified Reason|2|||
170657873|NCT02247531|616761502|FG001|Overall Study|Unspecified Reason|3|||
170657874|NCT02247531|616761503|FG002|Overall Study|Unspecified Reason|4|||
170657875|NCT05007717|616761504|FG000|Overall Study|Death|3|||
170657876|NCT05007717|616761505|FG001|Overall Study|Death|2|||
170657877|NCT01117051|616761516|FG000|Overall Study|Withdrawal by Subject|5|||
170657878|NCT01117051|616761517|FG001|Overall Study|Withdrawal by Subject|3|||
170657879|NCT01117051|616761516|FG000|Overall Study|Adverse Event|4|||
170657880|NCT01117051|616761517|FG001|Overall Study|Adverse Event|3|||
170657881|NCT01117051|616761516|FG000|Overall Study|Lost to Follow-up|0|||
170657882|NCT01117051|616761517|FG001|Overall Study|Lost to Follow-up|1|||
170657883|NCT01117051|616761516|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
170657884|NCT01117051|616761517|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
170657885|NCT01117051|616761516|FG000|Overall Study|Sponsor's decision|3|||
170657886|NCT01117051|616761517|FG001|Overall Study|Sponsor's decision|1|||
170916955|NCT03466411|617697800|FG001|Overall Study|Lost to Follow-up|1|||
170657887|NCT01117051|616761516|FG000|Overall Study|Surgical procedure|0|||
170657888|NCT01117051|616761517|FG001|Overall Study|Surgical procedure|1|||
170657889|NCT01117051|616761516|FG000|Overall Study|Randomized by mistake|0|||
170657890|NCT01117051|616761517|FG001|Overall Study|Randomized by mistake|1|||
170657891|NCT01117051|616761516|FG000|Overall Study|Convenience issue|1|||
170657892|NCT01117051|616761517|FG001|Overall Study|Convenience issue|0|||
170657893|NCT00206076|616761519|FG000|Overall Study|Physician Decision|2|||
170657894|NCT00206076|616761520|FG001|Overall Study|Physician Decision|0|||
170657895|NCT00206076|616761519|FG000|Overall Study|Withdrawal by Subject|1|||
170657896|NCT00206076|616761520|FG001|Overall Study|Withdrawal by Subject|1|||
170657897|NCT03355664|616761521|FG000|Overall Study|Adverse Event|1|||
170657898|NCT03355664|616761522|FG001|Overall Study|Adverse Event|2|||
170657899|NCT03355664|616761521|FG000|Overall Study|Lost to Follow-up|11|||
170657900|NCT03355664|616761522|FG001|Overall Study|Lost to Follow-up|7|||
170657901|NCT03355664|616761521|FG000|Overall Study|Protocol Violation|1|||
170657902|NCT03355664|616761522|FG001|Overall Study|Protocol Violation|2|||
170657903|NCT03355664|616761521|FG000|Overall Study|Withdrawal by Subject|2|||
170916956|NCT03466411|617697801|FG002|Overall Study|Lost to Follow-up|1|||
170916957|NCT03466411|617697802|FG003|Overall Study|Lost to Follow-up|0|||
170657904|NCT03355664|616761522|FG001|Overall Study|Withdrawal by Subject|1|||
170657905|NCT03823378|616761524|FG000|Overall Study|Adverse Event|2|||
170657906|NCT03823378|616761525|FG001|Overall Study|Adverse Event|2|||
170657907|NCT03823378|616761526|FG002|Overall Study|Adverse Event|0|||
170916958|NCT03466411|617697803|FG004|Overall Study|Lost to Follow-up|0|||
170916959|NCT03466411|617697804|FG005|Overall Study|Lost to Follow-up|0|||
170657908|NCT03823378|616761527|FG003|Overall Study|Adverse Event|0|||
170657909|NCT03823378|616761528|FG004|Overall Study|Adverse Event|0|||
170657910|NCT03823378|616761529|FG005|Overall Study|Adverse Event|0|||
170657911|NCT03823378|616761524|FG000|Overall Study|Lost to Follow-up|0|||
170657912|NCT03823378|616761525|FG001|Overall Study|Lost to Follow-up|1|||
170657913|NCT03823378|616761526|FG002|Overall Study|Lost to Follow-up|0|||
170657914|NCT03823378|616761527|FG003|Overall Study|Lost to Follow-up|0|||
170657915|NCT03823378|616761528|FG004|Overall Study|Lost to Follow-up|1|||
170657916|NCT03823378|616761529|FG005|Overall Study|Lost to Follow-up|0|||
170657917|NCT03823378|616761524|FG000|Overall Study|Withdrawal by Subject|0|||
170657918|NCT03823378|616761525|FG001|Overall Study|Withdrawal by Subject|1|||
170657919|NCT03823378|616761526|FG002|Overall Study|Withdrawal by Subject|4|||
170657920|NCT03823378|616761527|FG003|Overall Study|Withdrawal by Subject|2|||
170657921|NCT03823378|616761528|FG004|Overall Study|Withdrawal by Subject|0|||
170657922|NCT03823378|616761529|FG005|Overall Study|Withdrawal by Subject|1|||
170657923|NCT03823378|616761524|FG000|Overall Study|Other, not specified|19|||
170657924|NCT03823378|616761525|FG001|Overall Study|Other, not specified|12|||
170657925|NCT03823378|616761526|FG002|Overall Study|Other, not specified|6|||
170657926|NCT03823378|616761527|FG003|Overall Study|Other, not specified|8|||
170657927|NCT03823378|616761528|FG004|Overall Study|Other, not specified|17|||
170657928|NCT03823378|616761529|FG005|Overall Study|Other, not specified|7|||
170657929|NCT01143207|616761530|FG000|Overall Study|Lost to Follow-up|2|||
170657930|NCT03170232|616761532|FG000|Overall Study|Adverse Event|0|||
170657931|NCT03170232|616761533|FG001|Overall Study|Adverse Event|1|||
170657932|NCT03170232|616761532|FG000|Overall Study|Protocol Violation|0|||
170657933|NCT03170232|616761533|FG001|Overall Study|Protocol Violation|1|||
170657934|NCT03170232|616761532|FG000|Overall Study|Lack of Efficacy|0|||
170657935|NCT03170232|616761533|FG001|Overall Study|Lack of Efficacy|1|||
170657936|NCT03170232|616761532|FG000|Overall Study|Study closed/terminated|26|||
170657937|NCT03170232|616761533|FG001|Overall Study|Study closed/terminated|23|||
170657938|NCT03170232|616761532|FG000|Overall Study|Lost to Follow-up|1|||
170657939|NCT03170232|616761533|FG001|Overall Study|Lost to Follow-up|0|||
170657940|NCT03170232|616761532|FG000|Overall Study|Withdrawal by Subject|0|||
170657941|NCT03170232|616761533|FG001|Overall Study|Withdrawal by Subject|1|||
170657942|NCT01629706|616761534|FG000|Phase 1 PureVision|Screen Failure|4|||
170657943|NCT01629706|616761534|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
170657944|NCT01629706|616761534|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
170657945|NCT01629706|616761534|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
170657946|NCT01629706|616761534|FG000|Phase 2 Habitual|Screen Failure|6|||
170657947|NCT01629706|616761534|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
170657948|NCT01629706|616761534|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
170657949|NCT01629706|616761534|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
170657950|NCT01629706|616761534|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
170657951|NCT02537574|616761535|FG000|Overall Study|Adverse Event|1|||
170657952|NCT02537574|616761536|FG001|Overall Study|Adverse Event|3|||
170657953|NCT02537574|616761537|FG002|Overall Study|Adverse Event|2|||
170657954|NCT02537574|616761535|FG000|Overall Study|Lost to Follow-up|40|||
170657955|NCT02537574|616761536|FG001|Overall Study|Lost to Follow-up|51|||
170657956|NCT02537574|616761537|FG002|Overall Study|Lost to Follow-up|55|||
170657957|NCT02537574|616761535|FG000|Overall Study|Noncompliance with study drug|0|||
170657958|NCT02537574|616761536|FG001|Overall Study|Noncompliance with study drug|1|||
170657959|NCT02537574|616761537|FG002|Overall Study|Noncompliance with study drug|1|||
170657960|NCT02537574|616761535|FG000|Overall Study|Physician Decision|2|||
170657961|NCT02537574|616761536|FG001|Overall Study|Physician Decision|0|||
170816643|NCT03890484|617335559|FG001|Overall Study|Lost to Follow-up|1|||
170816644|NCT00518206|617335560|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
170816645|NCT00518206|617335561|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
170816646|NCT00518206|617335560|FG000|Overall Study|Withdrawal by Subject|2|||
170816647|NCT00518206|617335561|FG001|Overall Study|Withdrawal by Subject|0|||
170816648|NCT00518206|617335560|FG000|Overall Study|Drug Supply Issue|1|||
170816649|NCT00518206|617335561|FG001|Overall Study|Drug Supply Issue|0|||
170657962|NCT02537574|616761537|FG002|Overall Study|Physician Decision|0|||
170657963|NCT02537574|616761535|FG000|Overall Study|Protocol Violation|4|||
170657964|NCT02537574|616761536|FG001|Overall Study|Protocol Violation|2|||
170657965|NCT02537574|616761537|FG002|Overall Study|Protocol Violation|3|||
170657966|NCT02537574|616761535|FG000|Overall Study|Withdrawal by Subject|37|||
170657967|NCT02537574|616761536|FG001|Overall Study|Withdrawal by Subject|27|||
170657968|NCT02537574|616761537|FG002|Overall Study|Withdrawal by Subject|29|||
170657969|NCT02537574|616761535|FG000|Overall Study|Lack of Efficacy|14|||
170657970|NCT02537574|616761536|FG001|Overall Study|Lack of Efficacy|16|||
170657971|NCT02537574|616761537|FG002|Overall Study|Lack of Efficacy|15|||
170657972|NCT02537574|616761535|FG000|Overall Study|Duplicate Patient|1|||
170816650|NCT00518206|617335560|FG000|Overall Study|Reason Unknown|1|||
170816651|NCT00518206|617335561|FG001|Overall Study|Reason Unknown|0|||
170657973|NCT02537574|616761536|FG001|Overall Study|Duplicate Patient|0|||
170657974|NCT02537574|616761537|FG002|Overall Study|Duplicate Patient|0|||
170816652|NCT00518206|617335560|FG000|Overall Study|Completion Status Unknown|1|||
170916960|NCT03466411|617697805|FG006|Overall Study|Lost to Follow-up|1|||
170916961|NCT03466411|617697806|FG007|Overall Study|Lost to Follow-up|1|||
170916962|NCT03466411|617697807|FG008|Overall Study|Lost to Follow-up|0|||
170916963|NCT03466411|617697808|FG009|Overall Study|Lost to Follow-up|1|||
170916964|NCT03466411|617697809|FG010|Overall Study|Lost to Follow-up|1|||
170916965|NCT03466411|617697810|FG011|Overall Study|Lost to Follow-up|1|||
170916966|NCT03466411|617697811|FG012|Overall Study|Lost to Follow-up|0|||
170916967|NCT03466411|617697799|FG000|Overall Study|Withdrawal by Subject|14|||
170613797|NCT00592904|616593484|FG000|Overall Study|Withdrawal by Subject|4|||
170613798|NCT00592904|616593485|FG001|Overall Study|Withdrawal by Subject|16|||
170613799|NCT00592904|616593486|FG002|Overall Study|Withdrawal by Subject|1|||
170613800|NCT00592904|616593487|FG003|Overall Study|Withdrawal by Subject|2|||
170613801|NCT00592904|616593484|FG000|Overall Study|Lack of Efficacy|2|||
170613802|NCT00592904|616593485|FG001|Overall Study|Lack of Efficacy|7|||
170613803|NCT00592904|616593486|FG002|Overall Study|Lack of Efficacy|2|||
170613804|NCT00592904|616593487|FG003|Overall Study|Lack of Efficacy|3|||
170613805|NCT00592904|616593484|FG000|Overall Study|Physician Decision|0|||
170613806|NCT00592904|616593485|FG001|Overall Study|Physician Decision|3|||
170613807|NCT00592904|616593486|FG002|Overall Study|Physician Decision|1|||
170613808|NCT00592904|616593487|FG003|Overall Study|Physician Decision|0|||
170613809|NCT00592904|616593484|FG000|Overall Study|Other|3|||
170613810|NCT00592904|616593485|FG001|Overall Study|Other|3|||
170613811|NCT00592904|616593486|FG002|Overall Study|Other|0|||
170613812|NCT00592904|616593487|FG003|Overall Study|Other|0|||
170613813|NCT01910402|616593490|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
170613814|NCT01910402|616593491|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
170613815|NCT01910402|616593492|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
170613816|NCT01910402|616593490|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
170613817|NCT01910402|616593491|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
170613818|NCT01910402|616593492|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
170613819|NCT01910402|616593490|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
170613820|NCT01910402|616593491|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
170613821|NCT01910402|616593492|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
170613822|NCT01910402|616593490|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
170613823|NCT01910402|616593491|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
170613824|NCT01910402|616593492|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
170613825|NCT01910402|616593490|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
170613826|NCT01910402|616593491|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
170613827|NCT01910402|616593492|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
170613828|NCT01910402|616593490|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
170613829|NCT01910402|616593491|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
170613830|NCT01910402|616593492|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
170613831|NCT01910402|616593490|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
170613832|NCT01910402|616593491|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
170613833|NCT01910402|616593492|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
170613834|NCT01910402|616593490|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
170613835|NCT01910402|616593491|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
170613836|NCT01910402|616593492|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
170613837|NCT01910402|616593490|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
170613838|NCT01910402|616593491|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
170613839|NCT01910402|616593492|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
170613840|NCT01910402|616593490|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
170613841|NCT01910402|616593491|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
170613842|NCT01910402|616593492|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
170613843|NCT01910402|616593490|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
170613844|NCT01910402|616593491|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
170613845|NCT01910402|616593492|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
170613846|NCT01910402|616593490|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
170613847|NCT01910402|616593491|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
170613848|NCT01910402|616593492|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
170613849|NCT01910402|616593490|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
170613850|NCT01910402|616593491|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
170916968|NCT03466411|617697800|FG001|Overall Study|Withdrawal by Subject|7|||
170916969|NCT03466411|617697801|FG002|Overall Study|Withdrawal by Subject|8|||
170613851|NCT01910402|616593492|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
170613852|NCT00483405|616593493|FG000|Overall Study|Adverse Event|8|||
170613853|NCT00483405|616593493|FG000|Overall Study|Lack of Efficacy|14|||
170916970|NCT03466411|617697802|FG003|Overall Study|Withdrawal by Subject|4|||
170916971|NCT03466411|617697803|FG004|Overall Study|Withdrawal by Subject|6|||
170916972|NCT03466411|617697804|FG005|Overall Study|Withdrawal by Subject|3|||
170816653|NCT00518206|617335561|FG001|Overall Study|Completion Status Unknown|0|||
170816654|NCT02935894|617335562|FG000|Overall Study|Subject dismissed|1|||
170816655|NCT01159600|617335563|FG000|Overall Study|Not treated|0|||
170816656|NCT01159600|617335564|FG001|Overall Study|Not treated|0|||
170613854|NCT00483405|616593493|FG000|Overall Study|Death|3|||
170613855|NCT00483405|616593493|FG000|Overall Study|Withdrawal by Subject|2|||
170613856|NCT00483405|616593493|FG000|Overall Study|Other complicating disease|1|||
170613857|NCT00936702|616593494|FG000|Overall Study|Disease progression|34|||
170613858|NCT00936702|616593494|FG000|Overall Study|Adverse Event|8|||
170613859|NCT00936702|616593494|FG000|Overall Study|Withdrawal by Subject|2|||
170613860|NCT00936702|616593494|FG000|Overall Study|Alternative Treatment|1|||
170613861|NCT00936702|616593494|FG000|Overall Study|Other|1|||
170613862|NCT03906071|616593495|FG000|Overall Study|Death|180|||
170613863|NCT03906071|616593496|FG001|Overall Study|Death|185|||
170613864|NCT03906071|616593495|FG000|Overall Study|Lost to Follow-up|3|||
170613865|NCT03906071|616593496|FG001|Overall Study|Lost to Follow-up|3|||
170613866|NCT03906071|616593495|FG000|Overall Study|Withdrawal by Subject|15|||
170613867|NCT03906071|616593496|FG001|Overall Study|Withdrawal by Subject|27|||
170613868|NCT03906071|616593495|FG000|Overall Study|Other|2|||
170613869|NCT03906071|616593496|FG001|Overall Study|Other|1|||
170613870|NCT02152761|616593497|FG000|Epoch: Treatment Epoch|Technical problems|0|||
170613871|NCT02152761|616593498|FG001|Epoch: Treatment Epoch|Technical problems|0|||
170613872|NCT02152761|616593499|FG002|Epoch: Treatment Epoch|Technical problems|0|||
170613873|NCT02152761|616593500|FG003|Epoch: Treatment Epoch|Technical problems|1|||
170613874|NCT02152761|616593497|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
170613875|NCT02152761|616593498|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
170613876|NCT02152761|616593499|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
170613877|NCT02152761|616593500|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
170613878|NCT02152761|616593497|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
170613879|NCT02152761|616593498|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
170613880|NCT02152761|616593499|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
170613881|NCT02152761|616593500|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
170613882|NCT02152761|616593497|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
170613883|NCT02152761|616593498|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
170613884|NCT02152761|616593499|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
170613885|NCT02152761|616593500|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
170613886|NCT02152761|616593497|FG000|Epoch: Treatment Epoch|Death|0|||
170613887|NCT02152761|616593498|FG001|Epoch: Treatment Epoch|Death|3|||
170613888|NCT02152761|616593499|FG002|Epoch: Treatment Epoch|Death|1|||
170613889|NCT02152761|616593500|FG003|Epoch: Treatment Epoch|Death|0|||
170613890|NCT02152761|616593497|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
170613891|NCT02152761|616593498|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
170613892|NCT02152761|616593499|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
170613893|NCT02152761|616593500|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
170613894|NCT02152761|616593497|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
170613895|NCT02152761|616593498|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
170613896|NCT02152761|616593499|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
170613897|NCT02152761|616593500|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
170613898|NCT02152761|616593497|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
170613899|NCT02152761|616593498|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
170613900|NCT02152761|616593499|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
170613901|NCT02152761|616593500|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
170613902|NCT02152761|616593497|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
170613903|NCT02152761|616593498|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
170613904|NCT02152761|616593499|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
170613905|NCT02152761|616593500|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
170613906|NCT02152761|616593497|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
170613907|NCT02152761|616593498|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
170613908|NCT02152761|616593499|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
170613909|NCT02152761|616593500|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
170613910|NCT01797263|616593503|FG000|Overall Study|Withdrawal by Subject|21|||
170613911|NCT01797263|616593504|FG001|Overall Study|Withdrawal by Subject|25|||
170613912|NCT01797263|616593503|FG000|Overall Study|Death|1|||
170613913|NCT01797263|616593504|FG001|Overall Study|Death|0|||
170613914|NCT01797263|616593503|FG000|Overall Study|Lost to Follow-up|15|||
170613915|NCT01797263|616593504|FG001|Overall Study|Lost to Follow-up|15|||
170613916|NCT02640547|616593505|FG000|Overall Study|Failure to Return|1|||
170613917|NCT02640547|616593505|FG000|Overall Study|Withdrawal by Subject|1|||
170613918|NCT02640547|616593505|FG000|Overall Study|Death|6|||
170613919|NCT02640547|616593505|FG000|Overall Study|Miscellaneous|3|||
170816657|NCT01159600|617335565|FG002|Overall Study|Not treated|1|||
170613920|NCT02525588|616593506|FG000|Overall Study|Death|3|||
170613921|NCT02525588|616593507|FG001|Overall Study|Death|1|||
170613922|NCT02525588|616593506|FG000|Overall Study|Lost to Follow-up|2|||
170816658|NCT01159600|617335566|FG003|Overall Study|Not treated|0|||
170657975|NCT02537574|616761535|FG000|Overall Study|Patient not Stable|0|||
170657976|NCT02537574|616761536|FG001|Overall Study|Patient not Stable|1|||
170657977|NCT02537574|616761537|FG002|Overall Study|Patient not Stable|0|||
170657978|NCT02537574|616761535|FG000|Overall Study|Incarceration|0|||
170657979|NCT02537574|616761536|FG001|Overall Study|Incarceration|1|||
170657980|NCT02537574|616761537|FG002|Overall Study|Incarceration|0|||
170657981|NCT02537574|616761535|FG000|Overall Study|Failed Naloxone Challenge|0|||
170657982|NCT02537574|616761536|FG001|Overall Study|Failed Naloxone Challenge|1|||
170657983|NCT02537574|616761537|FG002|Overall Study|Failed Naloxone Challenge|0|||
170657984|NCT02537574|616761535|FG000|Overall Study|Transportation Issues|0|||
170657985|NCT02537574|616761536|FG001|Overall Study|Transportation Issues|0|||
170657986|NCT02537574|616761537|FG002|Overall Study|Transportation Issues|1|||
170657987|NCT02537574|616761535|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
170657988|NCT02537574|616761536|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
170657989|NCT02537574|616761537|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
170657990|NCT02537574|616761535|FG000|Overall Study|Noncompliance with Protocol|0|||
170657991|NCT02537574|616761536|FG001|Overall Study|Noncompliance with Protocol|0|||
170657992|NCT02537574|616761537|FG002|Overall Study|Noncompliance with Protocol|1|||
170657993|NCT01323946|616761540|FG000|Overall Study|Lost to Follow-up|0|||
170657994|NCT01323946|616761541|FG001|Overall Study|Lost to Follow-up|1|||
170657995|NCT01323946|616761542|FG002|Overall Study|Lost to Follow-up|0|||
170657996|NCT01323946|616761540|FG000|Overall Study|Parents refused the last blood draw|1|||
170657997|NCT01323946|616761541|FG001|Overall Study|Parents refused the last blood draw|0|||
170657998|NCT01323946|616761542|FG002|Overall Study|Parents refused the last blood draw|0|||
170657999|NCT01323946|616761540|FG000|Overall Study|Withdrawal by Subject|2|||
170658000|NCT01323946|616761541|FG001|Overall Study|Withdrawal by Subject|2|||
170658001|NCT01323946|616761542|FG002|Overall Study|Withdrawal by Subject|0|||
170658002|NCT04025710|616761545|FG000|Overall Study|Death|3|||
170658003|NCT04025710|616761545|FG000|Overall Study|Lost to Follow-up|5|||
170658004|NCT04025710|616761545|FG000|Overall Study|Withdrawal by Subject|1|||
170658005|NCT04025710|616761545|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
170658006|NCT04025710|616761545|FG000|Overall Study|Drop-out according to protocol|34|||
170658007|NCT03533686|616761548|FG000|Overall Study|Withdrawal by Subject|1|||
170658008|NCT03533686|616761549|FG001|Overall Study|Withdrawal by Subject|0|||
170658009|NCT03533686|616761550|FG002|Overall Study|Withdrawal by Subject|0|||
170658010|NCT03533686|616761551|FG003|Overall Study|Withdrawal by Subject|3|||
170658011|NCT03533686|616761552|FG004|Overall Study|Withdrawal by Subject|5|||
170658012|NCT03533686|616761553|FG005|Overall Study|Withdrawal by Subject|1|||
170658013|NCT03533686|616761548|FG000|Overall Study|Lost to Follow-up|0|||
170658014|NCT03533686|616761549|FG001|Overall Study|Lost to Follow-up|1|||
170658015|NCT03533686|616761550|FG002|Overall Study|Lost to Follow-up|0|||
170658016|NCT03533686|616761551|FG003|Overall Study|Lost to Follow-up|0|||
170658017|NCT03533686|616761552|FG004|Overall Study|Lost to Follow-up|2|||
170658018|NCT03533686|616761553|FG005|Overall Study|Lost to Follow-up|0|||
170658019|NCT03533686|616761548|FG000|Overall Study|Screen Failure|0|||
170658020|NCT03533686|616761549|FG001|Overall Study|Screen Failure|0|||
170658021|NCT03533686|616761550|FG002|Overall Study|Screen Failure|0|||
170658022|NCT03533686|616761551|FG003|Overall Study|Screen Failure|2|||
170658023|NCT03533686|616761552|FG004|Overall Study|Screen Failure|0|||
170658024|NCT03533686|616761553|FG005|Overall Study|Screen Failure|0|||
170658025|NCT01343901|616761554|FG000|Overall Study|Death|85|||
170658026|NCT01343901|616761554|FG000|Overall Study|Physician Decision|4|||
170658027|NCT01343901|616761554|FG000|Overall Study|Lost to Follow-up|12|||
170658028|NCT01343901|616761554|FG000|Overall Study|Management by another medical team|11|||
170658029|NCT01343901|616761554|FG000|Overall Study|Participant decision|1|||
170658030|NCT03370289|616761562|FG000|Overall Study|Screen Failure|1|||
170658031|NCT03370289|616761562|FG000|Overall Study|Sample Size Sufficient|4|||
170658032|NCT02140775|616761563|FG000|Overall Study|Withdrawal by Subject|30|||
170658033|NCT02140775|616761564|FG001|Overall Study|Withdrawal by Subject|7|||
170658034|NCT00006389|616761567|FG000|Overall Study|Adverse Event|1|||
170658035|NCT05308290|616761593|FG000|Overall Study|Death|1|||
170658036|NCT05308290|616761594|FG001|Overall Study|Death|0|||
170658037|NCT05308290|616761593|FG000|Overall Study|Lost to Follow-up|2|||
170658038|NCT05308290|616761594|FG001|Overall Study|Lost to Follow-up|1|||
170658039|NCT05308290|616761593|FG000|Overall Study|still in study followup|0|||
170658040|NCT05308290|616761594|FG001|Overall Study|still in study followup|1|||
170816659|NCT01159600|617335567|FG004|Overall Study|Not treated|0|||
170658041|NCT01309308|616761595|FG000|Overall Study|Lost to Follow-up|6|||
170658042|NCT01309308|616761596|FG001|Overall Study|Lost to Follow-up|4|||
170658043|NCT00473746|616761597|FG000|Period 1 (Phase 1)|Adverse Event|1|||
170658044|NCT00473746|616761598|FG001|Period 1 (Phase 1)|Adverse Event|0|||
170658045|NCT00473746|616761599|FG002|Period 1 (Phase 1)|Adverse Event|0|||
170658046|NCT00473746|616761600|FG003|Period 1 (Phase 1)|Adverse Event|0|||
170658047|NCT00473746|616761601|FG004|Period 1 (Phase 1)|Adverse Event|0|||
170658048|NCT00473746|616761597|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
170658049|NCT00473746|616761598|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
170658050|NCT00473746|616761599|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
170816660|NCT01159600|617335568|FG005|Overall Study|Not treated|1|||
170658051|NCT00473746|616761600|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
170658052|NCT00473746|616761601|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
170658053|NCT00473746|616761597|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
170658054|NCT00473746|616761598|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
170658055|NCT00473746|616761599|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
170658056|NCT00473746|616761600|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
170658057|NCT00473746|616761601|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
170658058|NCT00473746|616761597|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
170658059|NCT00473746|616761598|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
170658060|NCT00473746|616761599|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
170658061|NCT00473746|616761600|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
170658062|NCT00473746|616761601|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
170658063|NCT00473746|616761597|FG000|Period 1 (Phase 1)|Reason not specified|0|||
170658064|NCT00473746|616761598|FG001|Period 1 (Phase 1)|Reason not specified|1|||
170658065|NCT00473746|616761599|FG002|Period 1 (Phase 1)|Reason not specified|0|||
170658066|NCT00473746|616761600|FG003|Period 1 (Phase 1)|Reason not specified|0|||
170658067|NCT00473746|616761601|FG004|Period 1 (Phase 1)|Reason not specified|0|||
170658068|NCT00473746|616761597|FG000|Period 2 (Phase 2)|Adverse Event|0|||
170658069|NCT00473746|616761598|FG001|Period 2 (Phase 2)|Adverse Event|0|||
170658070|NCT00473746|616761599|FG002|Period 2 (Phase 2)|Adverse Event|0|||
170658071|NCT00473746|616761600|FG003|Period 2 (Phase 2)|Adverse Event|0|||
170658072|NCT00473746|616761601|FG004|Period 2 (Phase 2)|Adverse Event|3|||
170658073|NCT00473746|616761597|FG000|Period 2 (Phase 2)|Death|0|||
170658074|NCT00473746|616761598|FG001|Period 2 (Phase 2)|Death|0|||
170658075|NCT00473746|616761599|FG002|Period 2 (Phase 2)|Death|0|||
170658076|NCT00473746|616761600|FG003|Period 2 (Phase 2)|Death|0|||
170658077|NCT00473746|616761601|FG004|Period 2 (Phase 2)|Death|1|||
170658078|NCT00473746|616761597|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
170658079|NCT00473746|616761598|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
170658080|NCT00473746|616761599|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
170658081|NCT00473746|616761600|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
170658082|NCT00473746|616761601|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
170658083|NCT00473746|616761597|FG000|Period 2 (Phase 2)|Reason not specified|0|||
170658084|NCT00473746|616761598|FG001|Period 2 (Phase 2)|Reason not specified|0|||
170658085|NCT00473746|616761599|FG002|Period 2 (Phase 2)|Reason not specified|0|||
170658086|NCT00473746|616761600|FG003|Period 2 (Phase 2)|Reason not specified|0|||
170658087|NCT00473746|616761601|FG004|Period 2 (Phase 2)|Reason not specified|3|||
170658088|NCT01982331|616761602|FG000|Received Vaccination 2|Adverse Event|1|||
170658089|NCT01982331|616761603|FG001|Received Vaccination 2|Adverse Event|2|||
170658090|NCT01982331|616761602|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
170658091|NCT01982331|616761603|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
170658092|NCT01982331|616761602|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
170658093|NCT01982331|616761603|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
170658094|NCT01962922|616761604|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
170658095|NCT01962922|616761605|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
170658096|NCT01962922|616761604|FG000|PK Portion Day 7|non-compliance|1|||
170658097|NCT01962922|616761605|FG001|PK Portion Day 7|non-compliance|0|||
170658098|NCT01962922|616761604|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
170658099|NCT01962922|616761605|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
170658100|NCT01962922|616761604|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
170658101|NCT01962922|616761605|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
170658102|NCT00976573|616761609|FG000|Overall Study|Ineligible|0|||
170658103|NCT00976573|616761610|FG001|Overall Study|Ineligible|1|||
170658104|NCT00976573|616761609|FG000|Overall Study|Cancel prior to receiving treatment|4|||
170658105|NCT00976573|616761610|FG001|Overall Study|Cancel prior to receiving treatment|2|||
170658106|NCT02730208|616761611|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
170658107|NCT02730208|616761612|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
170658108|NCT01226043|616761613|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
170658109|NCT01226043|616761614|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
170658110|NCT01226043|616761615|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
170658111|NCT01226043|616761616|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
170658112|NCT01226043|616761613|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
170658113|NCT01226043|616761614|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
170658114|NCT01226043|616761615|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
170658115|NCT01226043|616761616|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
170658116|NCT01226043|616761613|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
170658117|NCT01226043|616761614|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
170658118|NCT01226043|616761615|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
170658119|NCT01226043|616761616|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
170658120|NCT01226043|616761613|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
170658121|NCT01226043|616761614|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
170658122|NCT01226043|616761615|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
170613923|NCT02525588|616593507|FG001|Overall Study|Lost to Follow-up|0|||
170613924|NCT02525588|616593506|FG000|Overall Study|Withdrawal by Subject|1|||
170613925|NCT02525588|616593507|FG001|Overall Study|Withdrawal by Subject|1|||
170613926|NCT02525588|616593506|FG000|Overall Study|Adverse Event|0|||
170613927|NCT02525588|616593507|FG001|Overall Study|Adverse Event|1|||
170613928|NCT04098809|616593508|FG000|Overall Study|Withdrawal by Subject|1|||
170613929|NCT04098809|616593509|FG001|Overall Study|Withdrawal by Subject|3|||
170613930|NCT04098809|616593508|FG000|Overall Study|Physician Decision|2|||
170613931|NCT04098809|616593509|FG001|Overall Study|Physician Decision|1|||
170613932|NCT01200368|616593514|FG000|Infant Series|Adverse Event|2|||
170613933|NCT01200368|616593515|FG001|Infant Series|Adverse Event|2|||
170613934|NCT01200368|616593516|FG002|Infant Series|Adverse Event|3|||
170613935|NCT01200368|616593514|FG000|Infant Series|Withdrawal by Subject|0|||
170613936|NCT01200368|616593515|FG001|Infant Series|Withdrawal by Subject|2|||
170613937|NCT01200368|616593516|FG002|Infant Series|Withdrawal by Subject|2|||
170613938|NCT01200368|616593514|FG000|Infant Series|Did not meet entrance criteria|0|||
170613939|NCT01200368|616593515|FG001|Infant Series|Did not meet entrance criteria|1|||
170613940|NCT01200368|616593516|FG002|Infant Series|Did not meet entrance criteria|0|||
170613941|NCT01200368|616593514|FG000|Infant Series|Randomized, not vaccinated|0|||
170613942|NCT01200368|616593515|FG001|Infant Series|Randomized, not vaccinated|1|||
170613943|NCT01200368|616593516|FG002|Infant Series|Randomized, not vaccinated|1|||
170613944|NCT01200368|616593514|FG000|Infant Series|Other|1|||
170613945|NCT01200368|616593515|FG001|Infant Series|Other|0|||
170613946|NCT01200368|616593516|FG002|Infant Series|Other|0|||
170613947|NCT01200368|616593514|FG000|After Infant Series|Adverse Event|6|||
170613948|NCT01200368|616593515|FG001|After Infant Series|Adverse Event|6|||
170613949|NCT01200368|616593516|FG002|After Infant Series|Adverse Event|3|||
170613950|NCT01200368|616593514|FG000|After Infant Series|Withdrawal by Subject|10|||
170613951|NCT01200368|616593515|FG001|After Infant Series|Withdrawal by Subject|8|||
170613952|NCT01200368|616593516|FG002|After Infant Series|Withdrawal by Subject|4|||
170613953|NCT01200368|616593514|FG000|After Infant Series|Lost to Follow-up|1|||
170613954|NCT01200368|616593515|FG001|After Infant Series|Lost to Follow-up|0|||
170613955|NCT01200368|616593516|FG002|After Infant Series|Lost to Follow-up|0|||
170613956|NCT01200368|616593514|FG000|After Infant Series|Other|1|||
170613957|NCT01200368|616593515|FG001|After Infant Series|Other|2|||
170613958|NCT01200368|616593516|FG002|After Infant Series|Other|2|||
170613959|NCT01200368|616593514|FG000|Toddler Dose|Adverse Event|0|||
170613960|NCT01200368|616593515|FG001|Toddler Dose|Adverse Event|3|||
170613961|NCT01200368|616593516|FG002|Toddler Dose|Adverse Event|1|||
170613962|NCT01290757|616593517|FG000|Overall Study|Adverse Event|1|||
170613963|NCT01290757|616593518|FG001|Overall Study|Adverse Event|0|||
170613964|NCT01290757|616593517|FG000|Overall Study|Protocol Violation|1|||
170613965|NCT01290757|616593518|FG001|Overall Study|Protocol Violation|1|||
170613966|NCT01290757|616593517|FG000|Overall Study|Other|0|||
170613967|NCT01290757|616593518|FG001|Overall Study|Other|1|||
170613968|NCT01485094|616593519|FG000|Overall Study|Adverse Event|1|||
170613969|NCT01485094|616593520|FG001|Overall Study|Adverse Event|1|||
170613970|NCT01485094|616593521|FG002|Overall Study|Adverse Event|1|||
170613971|NCT01485094|616593519|FG000|Overall Study|Lost to Follow-up|1|||
170613972|NCT01485094|616593520|FG001|Overall Study|Lost to Follow-up|0|||
170613973|NCT01485094|616593521|FG002|Overall Study|Lost to Follow-up|0|||
170613974|NCT01485094|616593519|FG000|Overall Study|Withdrawal by Subject|1|||
170613975|NCT01485094|616593520|FG001|Overall Study|Withdrawal by Subject|1|||
170613976|NCT01485094|616593521|FG002|Overall Study|Withdrawal by Subject|0|||
170613977|NCT03066193|616593522|FG000|Overall Study|Withdrawal by Subject|1|||
170613978|NCT01426958|616593523|FG000|Overall Study|Adverse Event|2|||
170613979|NCT04854551|616593527|FG000|Overall Study|Withdrawal by Subject|1|||
170613980|NCT04854551|616593528|FG001|Overall Study|Withdrawal by Subject|1|||
170613981|NCT01172535|616593533|FG000|Overall Study|Death|3|||
170613982|NCT01172535|616593533|FG000|Overall Study|Withdrawal by Subject|2|||
170658123|NCT01226043|616761616|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
170658124|NCT01226043|616761613|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
170658125|NCT01226043|616761614|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
170658126|NCT01226043|616761615|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
170613983|NCT01172535|616593533|FG000|Overall Study|Lost to Follow-up|1|||
170613984|NCT01172535|616593533|FG000|Overall Study|Ineligible at study entry|1|||
170613985|NCT01172535|616593533|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
170613986|NCT05280717|616593535|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
170613987|NCT05280717|616593536|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
170613988|NCT05280717|616593537|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
170613989|NCT05280717|616593538|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
170658127|NCT01226043|616761616|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
170658128|NCT01226043|616761613|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
170613990|NCT05280717|616593539|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
170613991|NCT05280717|616593540|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
170613992|NCT05280717|616593541|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
170658129|NCT01226043|616761614|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
170658130|NCT01226043|616761615|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
170658131|NCT01226043|616761616|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
170658132|NCT01226043|616761613|FG000|6-week Re-randomization Phase|Adverse Event|0|||
170658133|NCT01226043|616761614|FG001|6-week Re-randomization Phase|Adverse Event|0|||
170658134|NCT01226043|616761615|FG002|6-week Re-randomization Phase|Adverse Event|1|||
170658135|NCT01226043|616761616|FG003|6-week Re-randomization Phase|Adverse Event|1|||
170658136|NCT01226043|616761613|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
170658137|NCT01226043|616761614|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
170613993|NCT05280717|616593535|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
170613994|NCT05280717|616593536|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
170613995|NCT05280717|616593537|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
170613996|NCT05280717|616593538|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
170613997|NCT05280717|616593539|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
170613998|NCT05280717|616593540|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
170613999|NCT05280717|616593541|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
170614000|NCT05280717|616593535|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
170614001|NCT05280717|616593536|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
170614002|NCT05280717|616593537|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
170614003|NCT05280717|616593538|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
170614004|NCT05280717|616593539|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
170614005|NCT05280717|616593540|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
170614006|NCT05280717|616593541|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
170614007|NCT05280717|616593535|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
170614008|NCT05280717|616593536|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
170614009|NCT05280717|616593537|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
170614010|NCT05280717|616593538|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
170614011|NCT05280717|616593539|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
170614012|NCT05280717|616593540|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
170614013|NCT05280717|616593541|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
170614014|NCT05280717|616593535|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
170614015|NCT05280717|616593536|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
170614016|NCT05280717|616593537|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
170614017|NCT05280717|616593538|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
170614018|NCT05280717|616593539|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
170614019|NCT05280717|616593540|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
170614020|NCT05280717|616593541|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
170614021|NCT05280717|616593535|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
170614022|NCT05280717|616593536|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
170614023|NCT05280717|616593537|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
170614024|NCT05280717|616593538|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
170614025|NCT05280717|616593539|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
170614026|NCT05280717|616593540|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
170614027|NCT05280717|616593541|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
170614028|NCT00080301|616593542|FG000|Overall Study|Randomized but Never Treated|5|||
170614029|NCT00080301|616593543|FG001|Overall Study|Randomized but Never Treated|10|||
170614030|NCT00080301|616593542|FG000|Overall Study|Still on Treatment as of CSR date|0|||
170614031|NCT00080301|616593543|FG001|Overall Study|Still on Treatment as of CSR date|1|||
170614032|NCT00991939|616593544|FG000|Overall Study|Lost to Follow-up|0|||
170614033|NCT00991939|616593545|FG001|Overall Study|Lost to Follow-up|1|||
170614034|NCT00991939|616593544|FG000|Overall Study|Withdrawal by Subject|1|||
170614035|NCT00991939|616593545|FG001|Overall Study|Withdrawal by Subject|0|||
170614036|NCT00991939|616593544|FG000|Overall Study|Entire study terminated|4|||
170614037|NCT00991939|616593545|FG001|Overall Study|Entire study terminated|1|||
170614038|NCT00855816|616593546|FG000|Overall Study|Withdrawal by Subject|22|||
170614039|NCT00855816|616593547|FG001|Overall Study|Withdrawal by Subject|15|||
170614040|NCT00855816|616593546|FG000|Overall Study|Lost to Follow-up|3|||
170614041|NCT00855816|616593547|FG001|Overall Study|Lost to Follow-up|5|||
170614042|NCT00855816|616593546|FG000|Overall Study|Death|1|||
170658138|NCT01226043|616761615|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
170658139|NCT01226043|616761616|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
170658140|NCT01226043|616761613|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
170658141|NCT01226043|616761614|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
170658142|NCT01226043|616761615|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
170658143|NCT01226043|616761616|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
170916973|NCT03466411|617697805|FG006|Overall Study|Withdrawal by Subject|6|||
170916974|NCT03466411|617697806|FG007|Overall Study|Withdrawal by Subject|9|||
170916975|NCT03466411|617697807|FG008|Overall Study|Withdrawal by Subject|6|||
170916976|NCT03466411|617697808|FG009|Overall Study|Withdrawal by Subject|11|||
170916977|NCT03466411|617697809|FG010|Overall Study|Withdrawal by Subject|14|||
170916978|NCT03466411|617697810|FG011|Overall Study|Withdrawal by Subject|12|||
170916979|NCT03466411|617697811|FG012|Overall Study|Withdrawal by Subject|7|||
170916980|NCT03466411|617697799|FG000|Overall Study|Other|1|||
170916981|NCT03466411|617697800|FG001|Overall Study|Other|1|||
170916982|NCT03466411|617697801|FG002|Overall Study|Other|0|||
170916983|NCT03466411|617697802|FG003|Overall Study|Other|1|||
170916984|NCT03466411|617697803|FG004|Overall Study|Other|2|||
170916985|NCT03466411|617697804|FG005|Overall Study|Other|0|||
170916986|NCT03466411|617697805|FG006|Overall Study|Other|0|||
170916987|NCT03466411|617697806|FG007|Overall Study|Other|0|||
170916988|NCT03466411|617697807|FG008|Overall Study|Other|0|||
170916989|NCT03466411|617697808|FG009|Overall Study|Other|1|||
170916990|NCT03466411|617697809|FG010|Overall Study|Other|2|||
170916991|NCT03466411|617697810|FG011|Overall Study|Other|0|||
170916992|NCT03466411|617697811|FG012|Overall Study|Other|0|||
170614043|NCT00855816|616593547|FG001|Overall Study|Death|0|||
170614044|NCT00855816|616593546|FG000|Overall Study|Became ineligible|0|||
170614045|NCT00855816|616593547|FG001|Overall Study|Became ineligible|1|||
170614046|NCT01965704|616593548|FG000|Overall Study|Withdrawal by Subject|2|||
170614047|NCT01965704|616593549|FG001|Overall Study|Withdrawal by Subject|2|||
170614048|NCT01965704|616593550|FG002|Overall Study|Withdrawal by Subject|1|||
170614049|NCT01965704|616593551|FG003|Overall Study|Withdrawal by Subject|1|||
170614050|NCT01965704|616593548|FG000|Overall Study|Delivered at home|1|||
170614051|NCT01965704|616593549|FG001|Overall Study|Delivered at home|1|||
170614052|NCT01965704|616593550|FG002|Overall Study|Delivered at home|0|||
170614053|NCT01965704|616593551|FG003|Overall Study|Delivered at home|0|||
170614054|NCT01965704|616593548|FG000|Overall Study|Experienced complications|0|||
170614055|NCT01965704|616593549|FG001|Overall Study|Experienced complications|0|||
170614056|NCT01965704|616593550|FG002|Overall Study|Experienced complications|2|||
170614057|NCT01965704|616593551|FG003|Overall Study|Experienced complications|2|||
170614058|NCT01965704|616593548|FG000|Overall Study|Adverse Event|0|||
170614059|NCT01965704|616593549|FG001|Overall Study|Adverse Event|0|||
170614060|NCT01965704|616593550|FG002|Overall Study|Adverse Event|1|||
170614061|NCT01965704|616593551|FG003|Overall Study|Adverse Event|1|||
170614062|NCT01965704|616593548|FG000|Overall Study|Did not meet inclusion criteria|0|||
170614063|NCT01965704|616593549|FG001|Overall Study|Did not meet inclusion criteria|0|||
170614064|NCT01965704|616593550|FG002|Overall Study|Did not meet inclusion criteria|1|||
170614065|NCT01965704|616593551|FG003|Overall Study|Did not meet inclusion criteria|1|||
170614066|NCT00337207|616593558|FG000|Overall Study|Withdrawal by Subject|3|||
170614067|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
170614068|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
170614069|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
170614070|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
170916993|NCT03466411|617697799|FG000|Overall Study|Randomized but not Treated|0|||
170614071|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
170614072|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
170614073|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
170614074|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
170614075|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
170614076|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
170614077|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
170614078|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
170614079|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
170614080|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
170614081|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
170614082|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
170614083|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
170614084|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
170614085|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
170614086|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
170614087|NCT03573323|616593559|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
170614088|NCT03573323|616593560|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
170614089|NCT03573323|616593559|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
170658144|NCT01226043|616761613|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
170658145|NCT01226043|616761614|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
170658146|NCT01226043|616761615|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
170658147|NCT01226043|616761616|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
170658148|NCT01226043|616761613|FG000|6-week Re-randomization Phase|Physician Decision|0|||
170658149|NCT01226043|616761614|FG001|6-week Re-randomization Phase|Physician Decision|0|||
170658150|NCT01226043|616761615|FG002|6-week Re-randomization Phase|Physician Decision|3|||
170658151|NCT01226043|616761616|FG003|6-week Re-randomization Phase|Physician Decision|2|||
170658152|NCT01226043|616761613|FG000|6-week Re-randomization Phase|completed in error|0|||
170658153|NCT01226043|616761614|FG001|6-week Re-randomization Phase|completed in error|0|||
170658154|NCT01226043|616761615|FG002|6-week Re-randomization Phase|completed in error|0|||
170658155|NCT01226043|616761616|FG003|6-week Re-randomization Phase|completed in error|1|||
170658156|NCT01226043|616761613|FG000|30-week Observational Phase|Adverse Event|0|||
170658157|NCT01226043|616761614|FG001|30-week Observational Phase|Adverse Event|0|||
170658158|NCT01226043|616761615|FG002|30-week Observational Phase|Adverse Event|1|||
170658159|NCT01226043|616761616|FG003|30-week Observational Phase|Adverse Event|1|||
170658160|NCT01226043|616761613|FG000|30-week Observational Phase|Protocol Violation|0|||
170658161|NCT01226043|616761614|FG001|30-week Observational Phase|Protocol Violation|0|||
170658162|NCT01226043|616761615|FG002|30-week Observational Phase|Protocol Violation|0|||
170658163|NCT01226043|616761616|FG003|30-week Observational Phase|Protocol Violation|1|||
170658164|NCT01226043|616761613|FG000|30-week Observational Phase|Lost to Follow-up|0|||
170658165|NCT01226043|616761614|FG001|30-week Observational Phase|Lost to Follow-up|0|||
170658166|NCT01226043|616761615|FG002|30-week Observational Phase|Lost to Follow-up|2|||
170816661|NCT01159600|617335569|FG006|Overall Study|Not treated|2|||
170816662|NCT01159600|617335570|FG007|Overall Study|Not treated|2|||
170816663|NCT01159600|617335563|FG000|Overall Study|Adverse Event|7|||
170816664|NCT01159600|617335564|FG001|Overall Study|Adverse Event|2|||
170816665|NCT01159600|617335565|FG002|Overall Study|Adverse Event|5|||
170614090|NCT03573323|616593560|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
170614091|NCT03573323|616593559|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
170614092|NCT03573323|616593560|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
170614093|NCT03573323|616593559|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
170614094|NCT03573323|616593560|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
170614095|NCT03573323|616593559|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
170614096|NCT03573323|616593560|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
170614097|NCT03573323|616593559|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
170614098|NCT03573323|616593560|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
170614099|NCT03573323|616593559|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
170614100|NCT03573323|616593560|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
170614101|NCT03573323|616593559|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
170614102|NCT03573323|616593560|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
170614103|NCT03573323|616593559|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
170614104|NCT03573323|616593560|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
170614105|NCT03188432|616593561|FG000|Overall Study|Death|3|||
170614106|NCT03188432|616593561|FG000|Overall Study|Withdrawal by Subject|15|||
170614107|NCT03188432|616593561|FG000|Overall Study|Did not complete protocol treatment|9|||
170614108|NCT00466921|616593565|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
170614109|NCT00466921|616593565|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
170614110|NCT00466921|616593565|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
170614111|NCT00466921|616593565|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
170614112|NCT00466921|616593565|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
170614113|NCT00466921|616593565|FG000|Follow up for a Minimum of 1 Year|Death|6|||
170614114|NCT00779025|616593566|FG000|Overall Study|Withdrawal by Subject|1|||
170614115|NCT03539601|616593567|FG000|Overall Study|Withdraw by parent/guardian|1|||
170614116|NCT03539601|616593568|FG001|Overall Study|Withdraw by parent/guardian|0|||
170614117|NCT03539601|616593569|FG002|Overall Study|Withdraw by parent/guardian|1|||
170614118|NCT03539601|616593570|FG003|Overall Study|Withdraw by parent/guardian|0|||
170614119|NCT03539601|616593567|FG000|Overall Study|Adverse Event|0|||
170614120|NCT03539601|616593568|FG001|Overall Study|Adverse Event|2|||
170614121|NCT03539601|616593569|FG002|Overall Study|Adverse Event|0|||
170614122|NCT03539601|616593570|FG003|Overall Study|Adverse Event|0|||
170816666|NCT01159600|617335566|FG003|Overall Study|Adverse Event|1|||
170614123|NCT03539601|616593567|FG000|Overall Study|Lost to Follow-up|2|||
170614124|NCT03539601|616593568|FG001|Overall Study|Lost to Follow-up|4|||
170614125|NCT03539601|616593569|FG002|Overall Study|Lost to Follow-up|5|||
170614126|NCT03539601|616593570|FG003|Overall Study|Lost to Follow-up|0|||
170614127|NCT03539601|616593567|FG000|Overall Study|Withdrawal by Subject|2|||
170614128|NCT03539601|616593568|FG001|Overall Study|Withdrawal by Subject|0|||
170816667|NCT01159600|617335567|FG004|Overall Study|Adverse Event|8|||
170658167|NCT01226043|616761616|FG003|30-week Observational Phase|Lost to Follow-up|2|||
170658168|NCT01226043|616761613|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
170658169|NCT01226043|616761614|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
170658170|NCT01226043|616761615|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
170658171|NCT01226043|616761616|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
170658172|NCT01226043|616761613|FG000|30-week Observational Phase|Physician Decision|0|||
170916994|NCT03466411|617697800|FG001|Overall Study|Randomized but not Treated|0|||
170916995|NCT03466411|617697801|FG002|Overall Study|Randomized but not Treated|0|||
170916996|NCT03466411|617697802|FG003|Overall Study|Randomized but not Treated|0|||
170916997|NCT03466411|617697803|FG004|Overall Study|Randomized but not Treated|0|||
170658173|NCT01226043|616761614|FG001|30-week Observational Phase|Physician Decision|0|||
170658174|NCT01226043|616761615|FG002|30-week Observational Phase|Physician Decision|2|||
170658175|NCT01226043|616761616|FG003|30-week Observational Phase|Physician Decision|2|||
170658176|NCT00510952|616761627|FG000|Overall Study|Adverse Event|1|||
170658177|NCT00510952|616761628|FG001|Overall Study|Adverse Event|0|||
170658178|NCT00510952|616761627|FG000|Overall Study|Entry Criteria Not Met|3|||
170658179|NCT00510952|616761628|FG001|Overall Study|Entry Criteria Not Met|1|||
170658180|NCT00510952|616761627|FG000|Overall Study|Lost to Follow-up|5|||
170658181|NCT00510952|616761628|FG001|Overall Study|Lost to Follow-up|3|||
170658182|NCT00510952|616761627|FG000|Overall Study|Physician Decision|1|||
170658183|NCT00510952|616761628|FG001|Overall Study|Physician Decision|1|||
170658184|NCT00510952|616761627|FG000|Overall Study|Protocol Violation|7|||
170658185|NCT00510952|616761628|FG001|Overall Study|Protocol Violation|4|||
170658186|NCT00510952|616761627|FG000|Overall Study|Sponsor Decision|1|||
170658187|NCT00510952|616761628|FG001|Overall Study|Sponsor Decision|0|||
170658188|NCT00510952|616761627|FG000|Overall Study|Withdrawal by Subject|6|||
170658189|NCT00510952|616761628|FG001|Overall Study|Withdrawal by Subject|7|||
170658190|NCT00510952|616761627|FG000|Overall Study|Did Not Receive Study Drug|2|||
170658191|NCT00510952|616761628|FG001|Overall Study|Did Not Receive Study Drug|0|||
170658192|NCT00596362|616761633|FG000|Overall Study|Progressive Disease|1|||
170658193|NCT00817479|616761634|FG000|Overall Study|Physician Decision|1|||
170658194|NCT00817479|616761635|FG001|Overall Study|Physician Decision|1|||
170658195|NCT05985980|616761636|FG000|Overall Study|Withdrawal by Subject|1|||
170658196|NCT05985980|616761636|FG000|Overall Study|Withdrawal by Subject|1|||
170658197|NCT05985980|616761636|FG000|Overall Study|Withdrawal by Subject|1|||
170658198|NCT05985980|616761636|FG000|Overall Study|Withdrawal by Subject|1|||
170658199|NCT00523367|616761637|FG000|Overall Study|19 screen failures|19|||
170658200|NCT00523367|616761637|FG000|Overall Study|4 Withdrawn by PI|4|||
170658201|NCT00055471|616761638|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
170658202|NCT00055471|616761639|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
170658203|NCT00055471|616761640|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
170658204|NCT00055471|616761638|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
170658205|NCT00055471|616761639|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
170658206|NCT00055471|616761640|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
170658207|NCT00055471|616761638|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
170658208|NCT00055471|616761639|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
170658209|NCT00055471|616761640|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
170658210|NCT01854944|616761641|FG000|Overall Study|Withdrawal by Subject|0|||
170658211|NCT01854944|616761642|FG001|Overall Study|Withdrawal by Subject|0|||
170658212|NCT01854944|616761643|FG002|Overall Study|Withdrawal by Subject|1|||
170658213|NCT00282347|616761646|FG000|Treatment Period|Death|2|||
170658214|NCT00282347|616761647|FG001|Treatment Period|Death|0|||
170658215|NCT00282347|616761646|FG000|Treatment Period|Lost to Follow-up|2|||
170658216|NCT00282347|616761647|FG001|Treatment Period|Lost to Follow-up|5|||
170916998|NCT03466411|617697804|FG005|Overall Study|Randomized but not Treated|0|||
170916999|NCT03466411|617697805|FG006|Overall Study|Randomized but not Treated|1|||
170658217|NCT00282347|616761646|FG000|Treatment Period|Withdrawal by Subject|1|||
170658218|NCT00282347|616761647|FG001|Treatment Period|Withdrawal by Subject|3|||
170658219|NCT00282347|616761646|FG000|Treatment Period|Physician Decision|0|||
170917000|NCT03466411|617697806|FG007|Overall Study|Randomized but not Treated|0|||
170917001|NCT03466411|617697807|FG008|Overall Study|Randomized but not Treated|0|||
170917002|NCT03466411|617697808|FG009|Overall Study|Randomized but not Treated|0|||
170658220|NCT00282347|616761647|FG001|Treatment Period|Physician Decision|1|||
170658221|NCT00282347|616761646|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
170658222|NCT00282347|616761647|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
170658223|NCT00282347|616761646|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
170658224|NCT00282347|616761647|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
170658225|NCT00282347|616761646|FG000|Safety Follow-up Period|Physician Decision|1|||
170917003|NCT03466411|617697809|FG010|Overall Study|Randomized but not Treated|0|||
170917004|NCT03466411|617697810|FG011|Overall Study|Randomized but not Treated|0|||
170658226|NCT00282347|616761647|FG001|Safety Follow-up Period|Physician Decision|1|||
170658227|NCT00282347|616761646|FG000|Safety Follow-up Period|Protocol Deviation|0|||
170917005|NCT03466411|617697811|FG012|Overall Study|Randomized but not Treated|0|||
170917006|NCT04251533|617697813|FG000|Overall Study|Progressive disease|33|||
170917007|NCT04251533|617697814|FG001|Overall Study|Progressive disease|29|||
170658228|NCT00282347|616761647|FG001|Safety Follow-up Period|Protocol Deviation|2|||
170658229|NCT00282347|616761646|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
170658230|NCT00282347|616761647|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
170658231|NCT00282347|616761646|FG000|B Cell Follow-up Period|Physician Decision|1|||
170658232|NCT00282347|616761647|FG001|B Cell Follow-up Period|Physician Decision|0|||
170658233|NCT00282347|616761646|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
170658234|NCT00282347|616761647|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
170917008|NCT04251533|617697815|FG002|Overall Study|Progressive disease|22|||
170917009|NCT04251533|617697813|FG000|Overall Study|Death|5|||
170917010|NCT04251533|617697814|FG001|Overall Study|Death|1|||
170917011|NCT04251533|617697815|FG002|Overall Study|Death|3|||
170917012|NCT04251533|617697813|FG000|Overall Study|Physician Decision|3|||
170917013|NCT04251533|617697814|FG001|Overall Study|Physician Decision|2|||
170917014|NCT04251533|617697815|FG002|Overall Study|Physician Decision|4|||
170917015|NCT04251533|617697813|FG000|Overall Study|Participant decision|1|||
170917016|NCT04251533|617697814|FG001|Overall Study|Participant decision|3|||
170917017|NCT04251533|617697815|FG002|Overall Study|Participant decision|1|||
170917018|NCT04251533|617697813|FG000|Overall Study|Adverse Event|2|||
170917019|NCT04251533|617697814|FG001|Overall Study|Adverse Event|1|||
170917020|NCT04251533|617697815|FG002|Overall Study|Adverse Event|1|||
170917021|NCT03462719|617697816|FG000|Overall Study|Withdrawal by Subject|4|||
170917022|NCT03462719|617697817|FG001|Overall Study|Withdrawal by Subject|3|||
170917023|NCT03462719|617697816|FG000|Overall Study|Ongoing|87|||
170917024|NCT03462719|617697817|FG001|Overall Study|Ongoing|72|||
170917025|NCT03710603|617697819|FG000|Overall Study|Adverse Event|1|||
170658235|NCT02101112|616761648|FG000|Overall Study|Adverse Event|0|||
170658236|NCT02101112|616761649|FG001|Overall Study|Adverse Event|0|||
170658237|NCT02101112|616761650|FG002|Overall Study|Adverse Event|1|||
170658238|NCT02101112|616761651|FG003|Overall Study|Adverse Event|0|||
170658239|NCT02101112|616761652|FG004|Overall Study|Adverse Event|0|||
170614129|NCT03539601|616593569|FG002|Overall Study|Withdrawal by Subject|0|||
170614130|NCT03539601|616593570|FG003|Overall Study|Withdrawal by Subject|1|||
170614131|NCT03539601|616593567|FG000|Overall Study|Randomized but not treated|1|||
170614132|NCT03539601|616593568|FG001|Overall Study|Randomized but not treated|1|||
170614133|NCT03539601|616593569|FG002|Overall Study|Randomized but not treated|0|||
170614134|NCT03539601|616593570|FG003|Overall Study|Randomized but not treated|0|||
170614135|NCT03710642|616593571|FG000|Overall Study|Adverse Event|5|||
170614136|NCT03710642|616593572|FG001|Overall Study|Adverse Event|1|||
170614137|NCT03710642|616593571|FG000|Overall Study|non-site physician recommendation|1|||
170614138|NCT03710642|616593572|FG001|Overall Study|non-site physician recommendation|0|||
170614139|NCT03710642|616593571|FG000|Overall Study|Participant unwilling or unable to participate|1|||
170614140|NCT03710642|616593572|FG001|Overall Study|Participant unwilling or unable to participate|1|||
170614141|NCT03710642|616593571|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
170614142|NCT03710642|616593572|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
170614143|NCT03710642|616593571|FG000|Overall Study|NA-no code provided|1|||
170614144|NCT03710642|616593572|FG001|Overall Study|NA-no code provided|0|||
170614145|NCT03710642|616593571|FG000|Overall Study|Withdrawal by Subject|1|||
170614146|NCT03710642|616593572|FG001|Overall Study|Withdrawal by Subject|0|||
170614147|NCT04445662|616593573|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
170614148|NCT04445662|616593574|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
170614149|NCT04445662|616593573|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
170614150|NCT04445662|616593574|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
170614151|NCT04445662|616593573|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
170614152|NCT04445662|616593574|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
170614153|NCT04445662|616593573|FG000|Post-treatment (12-24 weeks)|Death|1|||
170614154|NCT04445662|616593574|FG001|Post-treatment (12-24 weeks)|Death|0|||
170614155|NCT04669301|616593575|FG000|Overall Study|Lost to Follow-up|0|||
170614156|NCT04669301|616593576|FG001|Overall Study|Lost to Follow-up|1|||
170614157|NCT04669301|616593577|FG002|Overall Study|Lost to Follow-up|0|||
170614158|NCT04669301|616593575|FG000|Overall Study|Withdrawal by Subject|3|||
170614159|NCT04669301|616593576|FG001|Overall Study|Withdrawal by Subject|2|||
170614160|NCT04669301|616593577|FG002|Overall Study|Withdrawal by Subject|0|||
170614161|NCT03364738|616593578|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
170614162|NCT03364738|616593578|FG000|Overall Study|Withdrawal by Subject|1|||
170614163|NCT03364738|616593578|FG000|Overall Study|Adverse Event|1|||
170658240|NCT02101112|616761653|FG005|Overall Study|Adverse Event|0|||
170658241|NCT02101112|616761648|FG000|Overall Study|Withdrawal by Subject|0|||
170658242|NCT02101112|616761649|FG001|Overall Study|Withdrawal by Subject|0|||
170658243|NCT02101112|616761650|FG002|Overall Study|Withdrawal by Subject|0|||
170658244|NCT02101112|616761651|FG003|Overall Study|Withdrawal by Subject|0|||
170658245|NCT02101112|616761652|FG004|Overall Study|Withdrawal by Subject|1|||
170917026|NCT03710603|617697820|FG001|Overall Study|Adverse Event|0|||
170917027|NCT03710603|617697819|FG000|Overall Study|Death|44|||
170658246|NCT02101112|616761653|FG005|Overall Study|Withdrawal by Subject|0|||
170658247|NCT04340063|616761654|FG000|Overall Study|Withdrawal by Subject|1|||
170658248|NCT04340063|616761655|FG001|Overall Study|Withdrawal by Subject|2|||
170658249|NCT04340063|616761654|FG000|Overall Study|Lost to Follow-up|3|||
170658250|NCT04340063|616761655|FG001|Overall Study|Lost to Follow-up|1|||
170658251|NCT04340063|616761654|FG000|Overall Study|Protocol Violation|0|||
170658252|NCT04340063|616761655|FG001|Overall Study|Protocol Violation|1|||
170658253|NCT02782923|616761656|FG000|Overall Study|Lost to Follow-up|15|||
170658254|NCT02418156|616761657|FG000|Overall Study|Lost to Follow-up|12|||
170658255|NCT02418156|616761657|FG000|Overall Study|Death|2|||
170658256|NCT02418156|616761657|FG000|Overall Study|Physician Decision|1|||
170658257|NCT02418156|616761657|FG000|Overall Study|Withdrawal by Subject|1|||
170658258|NCT02418156|616761657|FG000|Overall Study|Subject refused to return|1|||
170658259|NCT05063318|616761663|FG000|Overall Study|Progressive disease|2|||
170658260|NCT05063318|616761664|FG001|Overall Study|Progressive disease|0|||
170658261|NCT05063318|616761665|FG002|Overall Study|Progressive disease|3|||
170658262|NCT05063318|616761663|FG000|Overall Study|Compassionate use|1|||
170658263|NCT05063318|616761664|FG001|Overall Study|Compassionate use|3|||
170658264|NCT05063318|616761665|FG002|Overall Study|Compassionate use|3|||
170658265|NCT05063318|616761663|FG000|Overall Study|Adverse Event|0|||
170658266|NCT05063318|616761664|FG001|Overall Study|Adverse Event|1|||
170658267|NCT05063318|616761665|FG002|Overall Study|Adverse Event|0|||
170658268|NCT05063318|616761663|FG000|Overall Study|Withdrawal by Subject|0|||
170658269|NCT05063318|616761664|FG001|Overall Study|Withdrawal by Subject|1|||
170658270|NCT05063318|616761665|FG002|Overall Study|Withdrawal by Subject|0|||
170658271|NCT03287635|616761666|FG000|Overall Study|Lost to Follow-up|5|||
170658272|NCT03287635|616761666|FG000|Overall Study|Withdrawal by Subject|1|||
170658273|NCT03287635|616761666|FG000|Overall Study|Physician Decision|1|||
170658274|NCT00323869|616761669|FG000|Overall Study|Death|1|||
170658275|NCT04090957|616761670|FG000|Overall Study|Lost to Follow-up|22|||
170658276|NCT04090957|616761671|FG001|Overall Study|Lost to Follow-up|25|||
170658277|NCT04090957|616761672|FG002|Overall Study|Lost to Follow-up|25|||
170658278|NCT04090957|616761673|FG003|Overall Study|Lost to Follow-up|36|||
170658279|NCT04090957|616761670|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
170658280|NCT04090957|616761671|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
170658281|NCT04090957|616761672|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
170658282|NCT04090957|616761673|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
170658283|NCT04090957|616761670|FG000|Overall Study|Adverse Event|19|||
170658284|NCT04090957|616761671|FG001|Overall Study|Adverse Event|25|||
170658285|NCT04090957|616761672|FG002|Overall Study|Adverse Event|8|||
170658286|NCT04090957|616761673|FG003|Overall Study|Adverse Event|104|||
170658287|NCT04090957|616761670|FG000|Overall Study|Other|10|||
170658288|NCT04090957|616761671|FG001|Overall Study|Other|6|||
170658289|NCT04090957|616761672|FG002|Overall Study|Other|5|||
170658290|NCT04090957|616761673|FG003|Overall Study|Other|12|||
170658291|NCT04090957|616761670|FG000|Overall Study|Serious Adverse Event|7|||
170658292|NCT04090957|616761671|FG001|Overall Study|Serious Adverse Event|11|||
170658293|NCT04090957|616761672|FG002|Overall Study|Serious Adverse Event|1|||
170658294|NCT04090957|616761673|FG003|Overall Study|Serious Adverse Event|32|||
170658295|NCT04090957|616761670|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
170658296|NCT04090957|616761671|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
170658297|NCT04090957|616761672|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
170658298|NCT04090957|616761673|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
170658299|NCT04090957|616761670|FG000|Overall Study|Lack of Efficacy|1|||
170658300|NCT04090957|616761671|FG001|Overall Study|Lack of Efficacy|1|||
170658301|NCT04090957|616761672|FG002|Overall Study|Lack of Efficacy|9|||
170816668|NCT01159600|617335568|FG005|Overall Study|Adverse Event|6|||
170816669|NCT01159600|617335569|FG006|Overall Study|Adverse Event|7|||
170816670|NCT01159600|617335570|FG007|Overall Study|Adverse Event|5|||
170816671|NCT01159600|617335563|FG000|Overall Study|Lack of Efficacy|0|||
170816672|NCT01159600|617335564|FG001|Overall Study|Lack of Efficacy|0|||
170816673|NCT01159600|617335565|FG002|Overall Study|Lack of Efficacy|0|||
170816674|NCT01159600|617335566|FG003|Overall Study|Lack of Efficacy|0|||
170816675|NCT01159600|617335567|FG004|Overall Study|Lack of Efficacy|2|||
170816676|NCT01159600|617335568|FG005|Overall Study|Lack of Efficacy|0|||
170816677|NCT01159600|617335569|FG006|Overall Study|Lack of Efficacy|0|||
170816678|NCT01159600|617335570|FG007|Overall Study|Lack of Efficacy|1|||
170816679|NCT01159600|617335563|FG000|Overall Study|Non compliant with protocol|2|||
170816680|NCT01159600|617335564|FG001|Overall Study|Non compliant with protocol|1|||
170816681|NCT01159600|617335565|FG002|Overall Study|Non compliant with protocol|0|||
170816682|NCT01159600|617335566|FG003|Overall Study|Non compliant with protocol|0|||
170816683|NCT01159600|617335567|FG004|Overall Study|Non compliant with protocol|2|||
170658302|NCT04090957|616761673|FG003|Overall Study|Lack of Efficacy|0|||
170658303|NCT04090957|616761670|FG000|Overall Study|Protocol Violation|3|||
170658304|NCT04090957|616761671|FG001|Overall Study|Protocol Violation|5|||
170816684|NCT01159600|617335568|FG005|Overall Study|Non compliant with protocol|0|||
170658305|NCT04090957|616761672|FG002|Overall Study|Protocol Violation|2|||
170658306|NCT04090957|616761673|FG003|Overall Study|Protocol Violation|1|||
170658307|NCT04090957|616761670|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
170658308|NCT04090957|616761671|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
170658309|NCT04090957|616761672|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
170658310|NCT04090957|616761673|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
170658311|NCT04090957|616761670|FG000|Overall Study|COVID-19|2|||
170658312|NCT04090957|616761671|FG001|Overall Study|COVID-19|2|||
170658313|NCT04090957|616761672|FG002|Overall Study|COVID-19|3|||
170658314|NCT04090957|616761673|FG003|Overall Study|COVID-19|7|||
170658315|NCT04090957|616761670|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
170658316|NCT04090957|616761671|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
170658317|NCT04090957|616761672|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
170658318|NCT04090957|616761673|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
170658319|NCT04090957|616761670|FG000|Overall Study|Physician Decision|2|||
170658320|NCT04090957|616761671|FG001|Overall Study|Physician Decision|1|||
170658321|NCT04090957|616761672|FG002|Overall Study|Physician Decision|1|||
170658322|NCT04090957|616761673|FG003|Overall Study|Physician Decision|5|||
170658323|NCT04090957|616761670|FG000|Overall Study|Sponsor Decision|1|||
170658324|NCT04090957|616761671|FG001|Overall Study|Sponsor Decision|1|||
170658325|NCT04090957|616761672|FG002|Overall Study|Sponsor Decision|1|||
170658326|NCT04090957|616761673|FG003|Overall Study|Sponsor Decision|3|||
170658327|NCT04090957|616761670|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
170658328|NCT04090957|616761671|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
170658329|NCT04090957|616761672|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
170658330|NCT04090957|616761673|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
170658331|NCT04090957|616761670|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
170658332|NCT04090957|616761671|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
170658333|NCT04090957|616761672|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
170658334|NCT04090957|616761673|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
170658335|NCT04090957|616761670|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
170658336|NCT04090957|616761671|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
170658337|NCT04090957|616761672|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
170658338|NCT04090957|616761673|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
170658339|NCT04090957|616761670|FG000|Overall Study|Death|1|||
170658340|NCT04090957|616761671|FG001|Overall Study|Death|0|||
170658341|NCT04090957|616761672|FG002|Overall Study|Death|0|||
170658342|NCT04090957|616761673|FG003|Overall Study|Death|0|||
170658343|NCT04090957|616761670|FG000|Overall Study|No Treatment Administered|2|||
170658344|NCT04090957|616761671|FG001|Overall Study|No Treatment Administered|1|||
170658345|NCT04090957|616761672|FG002|Overall Study|No Treatment Administered|2|||
170658346|NCT04090957|616761673|FG003|Overall Study|No Treatment Administered|1|||
170658347|NCT03172910|616763473|FG000|Overall Study|Adverse Event|0|||
170658348|NCT03172910|616763474|FG001|Overall Study|Adverse Event|0|||
170658349|NCT03172910|616763475|FG002|Overall Study|Adverse Event|0|||
170658350|NCT03172910|616763476|FG003|Overall Study|Adverse Event|0|||
170658351|NCT03172910|616763477|FG004|Overall Study|Adverse Event|1|||
170658352|NCT01397201|616763478|FG000|Overall Study|Not treated|0|||
170658353|NCT01397201|616763479|FG001|Overall Study|Not treated|0|||
170658354|NCT01397201|616763480|FG002|Overall Study|Not treated|1|||
170658355|NCT01397201|616763481|FG003|Overall Study|Not treated|0|||
170658356|NCT01397201|616763482|FG004|Overall Study|Not treated|0|||
170658357|NCT01397201|616763478|FG000|Overall Study|Not yet defined|3|||
170658358|NCT01397201|616763479|FG001|Overall Study|Not yet defined|6|||
170658359|NCT01397201|616763480|FG002|Overall Study|Not yet defined|5|||
170658360|NCT01397201|616763481|FG003|Overall Study|Not yet defined|5|||
170658361|NCT01397201|616763482|FG004|Overall Study|Not yet defined|4|||
170658362|NCT01397201|616763478|FG000|Overall Study|Adverse Event|2|||
170658363|NCT01397201|616763479|FG001|Overall Study|Adverse Event|0|||
170658364|NCT01397201|616763480|FG002|Overall Study|Adverse Event|0|||
170658365|NCT01397201|616763481|FG003|Overall Study|Adverse Event|0|||
170658366|NCT01397201|616763482|FG004|Overall Study|Adverse Event|0|||
170658367|NCT00398411|616763483|FG000|Overall Study|Death|0|||
170658368|NCT00398411|616763484|FG001|Overall Study|Death|1|||
170658369|NCT00401531|616763485|FG000|Overall Study|Adverse Event|2|||
170658370|NCT00401531|616763486|FG001|Overall Study|Adverse Event|0|||
170658371|NCT00401531|616763485|FG000|Overall Study|Protocol Violation|3|||
170658372|NCT00401531|616763486|FG001|Overall Study|Protocol Violation|7|||
170658373|NCT00401531|616763485|FG000|Overall Study|Lost to Follow-up|1|||
170658374|NCT00401531|616763486|FG001|Overall Study|Lost to Follow-up|1|||
170658375|NCT00401531|616763485|FG000|Overall Study|Withdrawal by Subject|3|||
170658376|NCT00401531|616763486|FG001|Overall Study|Withdrawal by Subject|2|||
170658377|NCT02395666|616763495|FG000|Overall Study|Physician Decision|3|||
170658378|NCT02395666|616763496|FG001|Overall Study|Physician Decision|0|||
170658379|NCT02395666|616763495|FG000|Overall Study|Lost to Follow-up|1|||
170658380|NCT02395666|616763496|FG001|Overall Study|Lost to Follow-up|0|||
170658381|NCT02395666|616763495|FG000|Overall Study|Withdrawal by Subject|2|||
170658382|NCT02395666|616763496|FG001|Overall Study|Withdrawal by Subject|1|||
170658383|NCT04060862|616763497|FG000|Overall Study|Symptomatic Deterioration|1|||
170658384|NCT04060862|616763497|FG000|Overall Study|Un-specified|6|||
170658385|NCT04060862|616763497|FG000|Overall Study|Progressive disease|12|||
170658386|NCT04060862|616763497|FG000|Overall Study|Physician Decision|1|||
170658387|NCT01751802|616763503|FG000|Overall Study|Adverse Event|4|||
170658388|NCT01751802|616763504|FG001|Overall Study|Adverse Event|2|||
170658389|NCT01229397|616763505|FG000|Overall Study|Withdrawal by Subject|3|||
170658390|NCT01229397|616763506|FG001|Overall Study|Withdrawal by Subject|3|||
170658391|NCT01229397|616763505|FG000|Overall Study|Lost to Follow-up|7|||
170658392|NCT01229397|616763506|FG001|Overall Study|Lost to Follow-up|6|||
170658393|NCT01229397|616763505|FG000|Overall Study|Migrated/moved from study area|1|||
170658394|NCT01229397|616763506|FG001|Overall Study|Migrated/moved from study area|0|||
170658395|NCT01031381|616763511|FG000|Overall Study|Physician Decision|3|||
170658396|NCT01031381|616763511|FG000|Overall Study|Withdrawal by Subject|6|||
170658397|NCT02663687|616763512|FG000|Overall Study|Adverse Event|1|||
170658398|NCT02663687|616763513|FG001|Overall Study|Adverse Event|0|||
170658399|NCT02663687|616763514|FG002|Overall Study|Adverse Event|0|||
170658400|NCT02663687|616763515|FG003|Overall Study|Adverse Event|0|||
170658401|NCT02663687|616763516|FG004|Overall Study|Adverse Event|0|||
170658402|NCT02663687|616763512|FG000|Overall Study|Other|1|||
170658403|NCT02663687|616763513|FG001|Overall Study|Other|0|||
170658404|NCT02663687|616763514|FG002|Overall Study|Other|1|||
170658405|NCT02663687|616763515|FG003|Overall Study|Other|0|||
170658406|NCT02663687|616763516|FG004|Overall Study|Other|0|||
170658407|NCT01151098|616763517|FG000|Overall Study|Adverse Event|82|||
170658408|NCT01151098|616763517|FG000|Overall Study|Lost to Follow-up|6|||
170658409|NCT01151098|616763517|FG000|Overall Study|Lack of Efficacy|15|||
170658410|NCT01151098|616763517|FG000|Overall Study|Protocol Violation|1|||
170658411|NCT01151098|616763517|FG000|Overall Study|Miscellaneous|13|||
170658412|NCT00417482|616763518|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
170658413|NCT00417482|616763519|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
170658414|NCT00417482|616763520|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
170658415|NCT00417482|616763518|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
170658416|NCT00417482|616763519|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
170658417|NCT00417482|616763520|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
170658418|NCT00417482|616763518|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
170658419|NCT00417482|616763519|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
170658420|NCT00417482|616763520|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
170658421|NCT00417482|616763518|FG000|Phase B 1st 16 Weeks|Death|1|||
170658422|NCT00417482|616763519|FG001|Phase B 1st 16 Weeks|Death|0|||
170658423|NCT00417482|616763520|FG002|Phase B 1st 16 Weeks|Death|0|||
170658424|NCT00417482|616763518|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
170658425|NCT00417482|616763519|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
170658426|NCT00417482|616763520|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
170658427|NCT00417482|616763518|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
170658428|NCT00417482|616763519|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
170658429|NCT00417482|616763520|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
170658430|NCT00417482|616763518|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
170658431|NCT00417482|616763519|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
170658432|NCT00417482|616763520|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
170658433|NCT00417482|616763518|FG000|Phase B 2nd 16 Weeks|Death|1|||
170658434|NCT00417482|616763519|FG001|Phase B 2nd 16 Weeks|Death|1|||
170658435|NCT00417482|616763520|FG002|Phase B 2nd 16 Weeks|Death|0|||
170658436|NCT03343067|616763523|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
170658437|NCT03343067|616763524|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
170658438|NCT03343067|616763525|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
170658439|NCT00542451|616763526|FG000|Overall Study|Adverse Event|31|||
170658440|NCT00542451|616763526|FG000|Overall Study|Withdrawal by Subject|30|||
170658441|NCT00542451|616763526|FG000|Overall Study|Physician Decision|4|||
170658442|NCT00542451|616763526|FG000|Overall Study|Recurrent disease|1|||
170816685|NCT01159600|617335569|FG006|Overall Study|Non compliant with protocol|2|||
170658443|NCT00542451|616763526|FG000|Overall Study|unknown reason|1|||
170658444|NCT00542451|616763526|FG000|Overall Study|Death|2|||
170816686|NCT01159600|617335570|FG007|Overall Study|Non compliant with protocol|0|||
170816687|NCT01159600|617335563|FG000|Overall Study|Lost to Follow-up|2|||
170816688|NCT01159600|617335564|FG001|Overall Study|Lost to Follow-up|3|||
170816689|NCT01159600|617335565|FG002|Overall Study|Lost to Follow-up|4|||
170658445|NCT00542451|616763526|FG000|Overall Study|Lost to Follow-up|10|||
170658446|NCT05153473|616763529|FG000|Overall Study|Death|46|||
170658447|NCT05153473|616763529|FG000|Overall Study|Lost to Follow-up|3|||
170658448|NCT02788474|616763530|FG000|Double Blind Treatment Period|Not treated|1|||
170658449|NCT02788474|616763531|FG001|Double Blind Treatment Period|Not treated|0|||
170658450|NCT02788474|616763530|FG000|Double Blind Treatment Period|Patient's refusal|3|||
170658451|NCT02788474|616763531|FG001|Double Blind Treatment Period|Patient's refusal|0|||
170816690|NCT01159600|617335566|FG003|Overall Study|Lost to Follow-up|3|||
170658452|NCT02788474|616763530|FG000|Double Blind Treatment Period|Adverse Event|6|||
170658453|NCT02788474|616763531|FG001|Double Blind Treatment Period|Adverse Event|4|||
170658454|NCT02788474|616763530|FG000|Open Label Treatment Period|Adverse Event|29|||
170658455|NCT02788474|616763531|FG001|Open Label Treatment Period|Adverse Event|9|||
170658456|NCT02788474|616763530|FG000|Open Label Treatment Period|Other than reason specified|1|||
170658457|NCT02788474|616763531|FG001|Open Label Treatment Period|Other than reason specified|0|||
170658458|NCT02788474|616763530|FG000|Open Label Treatment Period|Patient's refusal|1|||
170658459|NCT02788474|616763531|FG001|Open Label Treatment Period|Patient's refusal|3|||
170658460|NCT02788474|616763530|FG000|Open Label Treatment Period|Non-compliance|1|||
170658461|NCT02788474|616763531|FG001|Open Label Treatment Period|Non-compliance|0|||
170658462|NCT00048061|616763532|FG000|Overall Study|Adverse Event|41|||
170658463|NCT00048061|616763533|FG001|Overall Study|Adverse Event|32|||
170658464|NCT00048061|616763534|FG002|Overall Study|Adverse Event|44|||
170658465|NCT00048061|616763535|FG003|Overall Study|Adverse Event|37|||
170658466|NCT00048061|616763532|FG000|Overall Study|Lost to Follow-up|3|||
170658467|NCT00048061|616763533|FG001|Overall Study|Lost to Follow-up|2|||
170658468|NCT00048061|616763534|FG002|Overall Study|Lost to Follow-up|4|||
170658469|NCT00048061|616763535|FG003|Overall Study|Lost to Follow-up|5|||
170658470|NCT00048061|616763532|FG000|Overall Study|Withdrawal by Subject|20|||
170658471|NCT00048061|616763533|FG001|Overall Study|Withdrawal by Subject|29|||
170658472|NCT00048061|616763534|FG002|Overall Study|Withdrawal by Subject|29|||
170658473|NCT00048061|616763535|FG003|Overall Study|Withdrawal by Subject|32|||
170658474|NCT00048061|616763532|FG000|Overall Study|Did not follow-up|5|||
170658475|NCT00048061|616763533|FG001|Overall Study|Did not follow-up|5|||
170658476|NCT00048061|616763534|FG002|Overall Study|Did not follow-up|4|||
170816691|NCT01159600|617335567|FG004|Overall Study|Lost to Follow-up|3|||
170816692|NCT01159600|617335568|FG005|Overall Study|Lost to Follow-up|0|||
170816693|NCT01159600|617335569|FG006|Overall Study|Lost to Follow-up|3|||
170658477|NCT00048061|616763535|FG003|Overall Study|Did not follow-up|5|||
170658478|NCT00048061|616763532|FG000|Overall Study|Early improvement|6|||
170658479|NCT00048061|616763533|FG001|Overall Study|Early improvement|5|||
170658480|NCT00048061|616763534|FG002|Overall Study|Early improvement|3|||
170658481|NCT00048061|616763535|FG003|Overall Study|Early improvement|0|||
170658482|NCT03555435|616763536|FG000|Overall Study|Lost to Follow-up|17|||
170658483|NCT03555435|616763537|FG001|Overall Study|Lost to Follow-up|19|||
170816694|NCT01159600|617335570|FG007|Overall Study|Lost to Follow-up|2|||
170816695|NCT01159600|617335563|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
170658484|NCT03555435|616763538|FG002|Overall Study|Lost to Follow-up|8|||
170658485|NCT00251004|616763540|FG000|Overall Study|Withdrawal by Subject|23|||
170658486|NCT00251004|616763541|FG001|Overall Study|Withdrawal by Subject|16|||
170658487|NCT00251004|616763542|FG002|Overall Study|Withdrawal by Subject|14|||
170658488|NCT00251004|616763540|FG000|Overall Study|Death|9|||
170658489|NCT00251004|616763541|FG001|Overall Study|Death|10|||
170658490|NCT00251004|616763542|FG002|Overall Study|Death|8|||
170658491|NCT00251004|616763540|FG000|Overall Study|Lost to Follow-up|1|||
170658492|NCT00251004|616763541|FG001|Overall Study|Lost to Follow-up|2|||
170658493|NCT00251004|616763542|FG002|Overall Study|Lost to Follow-up|1|||
170658494|NCT00251004|616763540|FG000|Overall Study|Graft Loss|12|||
170658495|NCT00251004|616763541|FG001|Overall Study|Graft Loss|13|||
170658496|NCT00251004|616763542|FG002|Overall Study|Graft Loss|8|||
170658497|NCT01569464|616763543|FG000|Overall Study|Adverse Event|4|||
170658498|NCT01569464|616763544|FG001|Overall Study|Adverse Event|0|||
170658499|NCT01569464|616763543|FG000|Overall Study|Lack of Efficacy|1|||
170658500|NCT01569464|616763544|FG001|Overall Study|Lack of Efficacy|0|||
170658501|NCT01569464|616763543|FG000|Overall Study|Protocol Violation|1|||
170658502|NCT01569464|616763544|FG001|Overall Study|Protocol Violation|0|||
170658503|NCT01569464|616763543|FG000|Overall Study|Lost to Follow-up|2|||
170658504|NCT01569464|616763544|FG001|Overall Study|Lost to Follow-up|3|||
170816696|NCT01159600|617335564|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
170816697|NCT01159600|617335565|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
170816698|NCT01159600|617335566|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
170816699|NCT01159600|617335567|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
170816700|NCT01159600|617335568|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
170816701|NCT01159600|617335569|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
170816702|NCT01159600|617335570|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
170816703|NCT01159600|617335563|FG000|Overall Study|Other reason not defined above|3|||
170816704|NCT01159600|617335564|FG001|Overall Study|Other reason not defined above|0|||
170816705|NCT01159600|617335565|FG002|Overall Study|Other reason not defined above|4|||
170816706|NCT01159600|617335566|FG003|Overall Study|Other reason not defined above|2|||
170816707|NCT01159600|617335567|FG004|Overall Study|Other reason not defined above|5|||
170816708|NCT01159600|617335568|FG005|Overall Study|Other reason not defined above|7|||
170816709|NCT01159600|617335569|FG006|Overall Study|Other reason not defined above|3|||
170658505|NCT01569464|616763543|FG000|Overall Study|Withdrawal by Subject|1|||
170658506|NCT01569464|616763544|FG001|Overall Study|Withdrawal by Subject|1|||
170658507|NCT01569464|616763543|FG000|Overall Study|Other|1|||
170658508|NCT01569464|616763544|FG001|Overall Study|Other|1|||
170658509|NCT02220998|616763545|FG000|Overall Study|Randomized but Never Treated|1|||
170658510|NCT02220998|616763546|FG001|Overall Study|Randomized but Never Treated|2|||
170658511|NCT02220998|616763545|FG000|Overall Study|Death|2|||
170658512|NCT02220998|616763546|FG001|Overall Study|Death|0|||
170658513|NCT02220998|616763545|FG000|Overall Study|Lack of Efficacy|0|||
170658514|NCT02220998|616763546|FG001|Overall Study|Lack of Efficacy|5|||
170658515|NCT02220998|616763545|FG000|Overall Study|Lost to Follow-up|4|||
170658516|NCT02220998|616763546|FG001|Overall Study|Lost to Follow-up|4|||
170658517|NCT03309046|616763547|FG000|Overall Study|Withdrawal by Subject|4|||
170658518|NCT03309046|616763548|FG001|Overall Study|Withdrawal by Subject|17|||
170658519|NCT00873860|616763549|FG000|Overall Study|Lost to Follow-up|1|||
170658520|NCT00873860|616763550|FG001|Overall Study|Lost to Follow-up|0|||
170658521|NCT00873860|616763551|FG002|Overall Study|Lost to Follow-up|0|||
170658522|NCT00873860|616763552|FG003|Overall Study|Lost to Follow-up|1|||
170658523|NCT00873860|616763549|FG000|Overall Study|Withdrawal by Subject|1|||
170658524|NCT00873860|616763550|FG001|Overall Study|Withdrawal by Subject|0|||
170658525|NCT00873860|616763551|FG002|Overall Study|Withdrawal by Subject|2|||
170658526|NCT00873860|616763552|FG003|Overall Study|Withdrawal by Subject|0|||
170658527|NCT00873860|616763549|FG000|Overall Study|Death|1|||
170658528|NCT00873860|616763550|FG001|Overall Study|Death|0|||
170658529|NCT00873860|616763551|FG002|Overall Study|Death|0|||
170658530|NCT00873860|616763552|FG003|Overall Study|Death|0|||
170816710|NCT01159600|617335570|FG007|Overall Study|Other reason not defined above|3|||
170816711|NCT04413149|617337230|FG000|Overall Study|Death|10|||
170816712|NCT04413149|617337231|FG001|Overall Study|Death|5|||
170816713|NCT04413149|617337230|FG000|Overall Study|Lung transplantation|1|||
170816714|NCT04413149|617337231|FG001|Overall Study|Lung transplantation|0|||
170816715|NCT05379400|617337234|FG000|Overall Study|Lost to Follow-up|1|||
170816716|NCT05379400|617337235|FG001|Overall Study|Lost to Follow-up|1|||
170816717|NCT03978130|617337236|FG000|Overall Study|Lost to Follow-up|13|||
170816718|NCT03978130|617337237|FG001|Overall Study|Lost to Follow-up|14|||
170816719|NCT03978130|617337236|FG000|Overall Study|Withdrawal by Subject|12|||
170816720|NCT03978130|617337237|FG001|Overall Study|Withdrawal by Subject|2|||
170816721|NCT03978130|617337236|FG000|Overall Study|Adverse Event|2|||
170816722|NCT03978130|617337237|FG001|Overall Study|Adverse Event|1|||
170816723|NCT05356130|617337238|FG000|Overall Study|Withdrawal by Subject|0|||
170816724|NCT05356130|617337239|FG001|Overall Study|Withdrawal by Subject|0|||
170816725|NCT05356130|617337240|FG002|Overall Study|Withdrawal by Subject|3|||
170816726|NCT04851587|617337241|FG000|Overall Study|Lost to Follow-up|18|||
170816727|NCT01020487|617337248|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
170816728|NCT01020487|617337249|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
170816729|NCT01020487|617337250|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
170816730|NCT01020487|617337248|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
170816731|NCT01020487|617337249|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
170816732|NCT01020487|617337250|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
170816733|NCT01020487|617337248|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
170816734|NCT01020487|617337249|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
170816735|NCT01020487|617337250|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
170816736|NCT01020487|617337248|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
170816737|NCT01020487|617337249|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
170816738|NCT01020487|617337250|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
170816739|NCT01020487|617337248|FG000|Part 2 Open-label Period|Adverse Event|0|||
170816740|NCT01020487|617337249|FG001|Part 2 Open-label Period|Adverse Event|4|||
170816741|NCT01020487|617337250|FG002|Part 2 Open-label Period|Adverse Event|1|||
170816742|NCT01922102|617337257|FG000|Overall Study|Withdrawal by Subject|7|||
170816743|NCT01922102|617337258|FG001|Overall Study|Withdrawal by Subject|3|||
170816744|NCT01922102|617337259|FG002|Overall Study|Withdrawal by Subject|7|||
170816745|NCT01922102|617337257|FG000|Overall Study|Physician Decision|0|||
170816746|NCT01922102|617337258|FG001|Overall Study|Physician Decision|2|||
170816747|NCT01922102|617337259|FG002|Overall Study|Physician Decision|1|||
170658531|NCT00873860|616763549|FG000|Overall Study|Other|1|||
170658532|NCT00873860|616763550|FG001|Overall Study|Other|0|||
170658533|NCT00873860|616763551|FG002|Overall Study|Other|1|||
170816748|NCT01922102|617337257|FG000|Overall Study|Adverse Event|1|||
170816749|NCT01922102|617337258|FG001|Overall Study|Adverse Event|2|||
170658534|NCT00873860|616763552|FG003|Overall Study|Other|0|||
170658535|NCT00938964|616763553|FG000|Overall Study|Death|3|||
170658536|NCT00938964|616763554|FG001|Overall Study|Death|3|||
170658537|NCT00938964|616763553|FG000|Overall Study|Lost to Follow-up|2|||
170816750|NCT01922102|617337259|FG002|Overall Study|Adverse Event|0|||
170816751|NCT01922102|617337257|FG000|Overall Study|Lost to Follow-up|1|||
170816752|NCT01922102|617337258|FG001|Overall Study|Lost to Follow-up|0|||
170816753|NCT01922102|617337259|FG002|Overall Study|Lost to Follow-up|0|||
170816754|NCT01922102|617337257|FG000|Overall Study|Administrative problems|0|||
170816755|NCT01922102|617337258|FG001|Overall Study|Administrative problems|2|||
170658538|NCT00938964|616763554|FG001|Overall Study|Lost to Follow-up|3|||
170658539|NCT00938964|616763553|FG000|Overall Study|Withdrawal by Subject|22|||
170658540|NCT00938964|616763554|FG001|Overall Study|Withdrawal by Subject|18|||
170658541|NCT00938964|616763553|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
170658542|NCT00938964|616763554|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
170658543|NCT01858636|616763555|FG000|Overall Study|No Device Deployment Attempted|24|||
170658544|NCT01858636|616763555|FG000|Overall Study|Physician Decision|1|||
170658545|NCT01858636|616763555|FG000|Overall Study|Death|1|||
170658546|NCT01858636|616763555|FG000|Overall Study|Lost to Follow-up|1|||
170658547|NCT01858636|616763555|FG000|Overall Study|Withdrawal by Subject|1|||
170658548|NCT01172275|616763556|FG000|Overall Study|Lost to Follow-up|1|||
170658549|NCT01172275|616763557|FG001|Overall Study|Lost to Follow-up|0|||
170658550|NCT01172275|616763556|FG000|Overall Study|Protocol Violation|1|||
170658551|NCT01172275|616763557|FG001|Overall Study|Protocol Violation|0|||
170658552|NCT01227564|616763559|FG000|Overall Study|No Longer Willing to Participate|4|||
170658553|NCT01227564|616763560|FG001|Overall Study|No Longer Willing to Participate|2|||
170658554|NCT01227564|616763561|FG002|Overall Study|No Longer Willing to Participate|5|||
170658555|NCT01227564|616763559|FG000|Overall Study|Participant moved to another town|0|||
170658556|NCT01227564|616763560|FG001|Overall Study|Participant moved to another town|0|||
170658557|NCT01227564|616763561|FG002|Overall Study|Participant moved to another town|1|||
170658558|NCT00194675|616763564|FG000|Overall Study|Lost to Follow-up|1|||
170658559|NCT00194675|616763565|FG001|Overall Study|Lost to Follow-up|1|||
170658560|NCT00194675|616763564|FG000|Overall Study|lack of interest|1|||
170658561|NCT00194675|616763565|FG001|Overall Study|lack of interest|1|||
170658562|NCT00194675|616763564|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
170658563|NCT00194675|616763565|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
170658564|NCT00194675|616763564|FG000|Overall Study|Protocol Violation|1|||
170658565|NCT00194675|616763565|FG001|Overall Study|Protocol Violation|0|||
170658566|NCT00194675|616763564|FG000|Overall Study|Death|1|||
170658567|NCT00194675|616763565|FG001|Overall Study|Death|0|||
170658568|NCT00667420|616763567|FG000|Overall Study|Adverse Event|2|||
170658569|NCT00667420|616763567|FG000|Overall Study|Lack of Efficacy|5|||
170658570|NCT00667420|616763567|FG000|Overall Study|Physician Decision|1|||
170658571|NCT00667420|616763567|FG000|Overall Study|Withdrawal by Subject|2|||
170658572|NCT00744471|616763571|FG000|Overall Study|Randomized but not treated|1|||
170658573|NCT00744471|616763572|FG001|Overall Study|Randomized but not treated|1|||
170658574|NCT00744471|616763573|FG002|Overall Study|Randomized but not treated|4|||
170658575|NCT00744471|616763574|FG003|Overall Study|Randomized but not treated|0|||
170658576|NCT00744471|616763571|FG000|Overall Study|Death|0|||
170658577|NCT00744471|616763572|FG001|Overall Study|Death|0|||
170658578|NCT00744471|616763573|FG002|Overall Study|Death|0|||
170658579|NCT00744471|616763574|FG003|Overall Study|Death|1|||
170658580|NCT00744471|616763571|FG000|Overall Study|Adverse Event|6|||
170658581|NCT00744471|616763572|FG001|Overall Study|Adverse Event|7|||
170658582|NCT00744471|616763573|FG002|Overall Study|Adverse Event|5|||
170658583|NCT00744471|616763574|FG003|Overall Study|Adverse Event|9|||
170658584|NCT00744471|616763571|FG000|Overall Study|Withdrawal by Subject|9|||
170658585|NCT00744471|616763572|FG001|Overall Study|Withdrawal by Subject|9|||
170658586|NCT00744471|616763573|FG002|Overall Study|Withdrawal by Subject|15|||
170658587|NCT00744471|616763574|FG003|Overall Study|Withdrawal by Subject|12|||
170658588|NCT00744471|616763571|FG000|Overall Study|Protocol Violation|1|||
170658589|NCT00744471|616763572|FG001|Overall Study|Protocol Violation|4|||
170658590|NCT00744471|616763573|FG002|Overall Study|Protocol Violation|1|||
170658591|NCT00744471|616763574|FG003|Overall Study|Protocol Violation|2|||
170658592|NCT00744471|616763571|FG000|Overall Study|Entered extension study|41|||
170658593|NCT00744471|616763572|FG001|Overall Study|Entered extension study|84|||
170658594|NCT00744471|616763573|FG002|Overall Study|Entered extension study|100|||
170658595|NCT00744471|616763574|FG003|Overall Study|Entered extension study|91|||
170658596|NCT00744471|616763571|FG000|Overall Study|Other|2|||
170658597|NCT00744471|616763572|FG001|Overall Study|Other|3|||
170658598|NCT00744471|616763573|FG002|Overall Study|Other|6|||
170658599|NCT00744471|616763574|FG003|Overall Study|Other|2|||
170658600|NCT00744471|616763571|FG000|Overall Study|Lack of Efficacy|83|||
170658601|NCT00744471|616763572|FG001|Overall Study|Lack of Efficacy|37|||
170658602|NCT00744471|616763573|FG002|Overall Study|Lack of Efficacy|19|||
170658603|NCT00744471|616763574|FG003|Overall Study|Lack of Efficacy|31|||
170658604|NCT00744471|616763571|FG000|Overall Study|Lost to Follow-up|0|||
170658605|NCT00744471|616763572|FG001|Overall Study|Lost to Follow-up|0|||
170658606|NCT00744471|616763573|FG002|Overall Study|Lost to Follow-up|2|||
170658607|NCT00744471|616763574|FG003|Overall Study|Lost to Follow-up|0|||
170816756|NCT01922102|617337259|FG002|Overall Study|Administrative problems|0|||
170816757|NCT01951105|617337263|FG000|Overall Study|Adverse Event|0|||
170658608|NCT04706416|616763575|FG000|Overall Study|Lost to Follow-up|2|||
170658609|NCT04706416|616763576|FG001|Overall Study|Lost to Follow-up|0|||
170658610|NCT01280955|616763577|FG000|Overall Study|Death|2|||
170658611|NCT01280955|616763577|FG000|Overall Study|Withdrawal by Subject|1|||
170658612|NCT05281601|616763582|FG000|Overall Study|Physician Decision|2|||
170816758|NCT01951105|617337264|FG001|Overall Study|Adverse Event|5|||
170658613|NCT05281601|616763583|FG001|Overall Study|Physician Decision|0|||
170658614|NCT05281601|616763582|FG000|Overall Study|Lost to Follow-up|2|||
170658615|NCT05281601|616763583|FG001|Overall Study|Lost to Follow-up|0|||
170658616|NCT05281601|616763582|FG000|Overall Study|Death|1|||
170816759|NCT01951105|617337265|FG002|Overall Study|Adverse Event|0|||
170816760|NCT01951105|617337263|FG000|Overall Study|Lost to Follow-up|0|||
170658617|NCT05281601|616763583|FG001|Overall Study|Death|0|||
170658618|NCT05281601|616763582|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170658619|NCT05281601|616763583|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170658620|NCT00901927|616763584|FG000|Overall Study|Lack of Efficacy|1|||
170658621|NCT00901927|616763584|FG000|Overall Study|Protocol Violation|3|||
170658622|NCT00901927|616763584|FG000|Overall Study|Withdrawal by Subject|2|||
170816761|NCT01951105|617337264|FG001|Overall Study|Lost to Follow-up|1|||
170816762|NCT01951105|617337265|FG002|Overall Study|Lost to Follow-up|0|||
170816763|NCT01951105|617337263|FG000|Overall Study|Protocol Violation|1|||
170816764|NCT01951105|617337264|FG001|Overall Study|Protocol Violation|1|||
170816765|NCT01951105|617337265|FG002|Overall Study|Protocol Violation|1|||
170816766|NCT01951105|617337263|FG000|Overall Study|Withdrawal by Subject|0|||
170816767|NCT01951105|617337264|FG001|Overall Study|Withdrawal by Subject|3|||
170816768|NCT01951105|617337265|FG002|Overall Study|Withdrawal by Subject|1|||
170816769|NCT01901302|617337268|FG000|Overall Study|Adverse Event|2|||
170816770|NCT01901302|617337269|FG001|Overall Study|Adverse Event|1|||
170816771|NCT01901302|617337268|FG000|Overall Study|Lack of Efficacy|0|||
170816772|NCT01901302|617337269|FG001|Overall Study|Lack of Efficacy|2|||
170816773|NCT01901302|617337268|FG000|Overall Study|Study Terminated by Sponsor|23|||
170816774|NCT01901302|617337269|FG001|Overall Study|Study Terminated by Sponsor|20|||
170816775|NCT01901302|617337268|FG000|Overall Study|Withdrawal by Subject|2|||
170816776|NCT01901302|617337269|FG001|Overall Study|Withdrawal by Subject|0|||
170816777|NCT05274906|617337271|FG000|Overall Study|Withdrawal by Subject|2|||
170816778|NCT05274906|617337272|FG001|Overall Study|Withdrawal by Subject|1|||
170816779|NCT00848198|617337273|FG000|Overall Study|Incomplete Case Report Forms|15|||
170816780|NCT01405508|617337274|FG000|Overall Study|AE, non-serious non-fatal|1|||
170816781|NCT01405508|617337275|FG001|Overall Study|AE, non-serious non-fatal|1|||
170816782|NCT01405508|617337276|FG002|Overall Study|AE, non-serious non-fatal|0|||
170816783|NCT01405508|617337277|FG003|Overall Study|AE, non-serious non-fatal|0|||
170917028|NCT03710603|617697820|FG001|Overall Study|Death|34|||
170917029|NCT03710603|617697819|FG000|Overall Study|Lost to Follow-up|3|||
170917030|NCT03710603|617697820|FG001|Overall Study|Lost to Follow-up|5|||
170614164|NCT02586727|616593579|FG000|Overall Study|Lost to Follow-up|1|||
170614165|NCT02586727|616593580|FG001|Overall Study|Lost to Follow-up|0|||
170614166|NCT03245398|616593583|FG000|Overall Study|Travelled to another island|1|||
170614167|NCT03245398|616593584|FG001|Overall Study|Travelled to another island|0|||
170614168|NCT04739436|616593588|FG000|Overall Study|Lost to Follow-up|21|||
170614169|NCT04739436|616593589|FG001|Overall Study|Lost to Follow-up|23|||
170614170|NCT04739436|616593588|FG000|Overall Study|Withdrawal by Subject|4|||
170614171|NCT04739436|616593589|FG001|Overall Study|Withdrawal by Subject|6|||
170614172|NCT04739436|616593588|FG000|Overall Study|not randomized properly|1|||
170614173|NCT04739436|616593589|FG001|Overall Study|not randomized properly|0|||
170614174|NCT00428948|616593590|FG000|Overall Study|Lost to Follow-up|15|||
170614175|NCT00428948|616593591|FG001|Overall Study|Lost to Follow-up|8|||
170614176|NCT00428948|616593590|FG000|Overall Study|Adverse Event|148|||
170614177|NCT00428948|616593591|FG001|Overall Study|Adverse Event|24|||
170614178|NCT00428948|616593590|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
170614179|NCT00428948|616593591|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
170614180|NCT00428948|616593590|FG000|Overall Study|Investigator Withdrew Subject|3|||
170614181|NCT00428948|616593591|FG001|Overall Study|Investigator Withdrew Subject|4|||
170614182|NCT00428948|616593590|FG000|Overall Study|Subject Withdrew Consent|50|||
170614183|NCT00428948|616593591|FG001|Overall Study|Subject Withdrew Consent|30|||
170614184|NCT00428948|616593590|FG000|Overall Study|Protocol Deviation|1|||
170614185|NCT00428948|616593591|FG001|Overall Study|Protocol Deviation|1|||
170614186|NCT00577824|616593594|FG000|Overall Study|Adverse Event|6|||
170614187|NCT00577824|616593595|FG001|Overall Study|Adverse Event|18|||
170614188|NCT00577824|616593596|FG002|Overall Study|Adverse Event|1|||
170614189|NCT00577824|616593594|FG000|Overall Study|Patient decision|0|||
170614190|NCT00577824|616593595|FG001|Overall Study|Patient decision|1|||
170614191|NCT00577824|616593596|FG002|Overall Study|Patient decision|1|||
170614192|NCT00577824|616593594|FG000|Overall Study|Protocol Violation|1|||
170614193|NCT00577824|616593595|FG001|Overall Study|Protocol Violation|1|||
170614194|NCT00577824|616593596|FG002|Overall Study|Protocol Violation|0|||
170614195|NCT00429169|616593601|FG000|Overall Study|Lost to Follow-up|0|||
170614196|NCT00429169|616593602|FG001|Overall Study|Lost to Follow-up|1|||
170614197|NCT00429169|616593601|FG000|Overall Study|Ineligibility discovered after entry|2|||
170614198|NCT00429169|616593602|FG001|Overall Study|Ineligibility discovered after entry|1|||
170614199|NCT01811186|616593603|FG000|Overall Study|Adverse Event|54|||
170816784|NCT03529942|617337278|FG000|Overall Study|Withdrawal by Subject|13|||
170816785|NCT03529942|617337278|FG000|Overall Study|Physician Decision|1|||
170816786|NCT03529942|617337278|FG000|Overall Study|Lost to Follow-up|7|||
170816787|NCT03529942|617337278|FG000|Overall Study|Needle inserted but no drug administered|1|||
170816788|NCT03529942|617337278|FG000|Overall Study|Personal reasons|1|||
170816789|NCT00409747|617337289|FG000|Overall Study|Withdrawal by Subject|1|||
170917031|NCT03710603|617697819|FG000|Overall Study|Withdrawal by Subject|11|||
170658623|NCT00410202|616763585|FG000|On-Treatment|Continuing treatment|69|||
170658624|NCT00410202|616763586|FG001|On-Treatment|Continuing treatment|71|||
170658625|NCT00410202|616763587|FG002|On-Treatment|Continuing treatment|66|||
170658626|NCT00410202|616763585|FG000|On-Treatment|Adverse Event|1|||
170658627|NCT00410202|616763586|FG001|On-Treatment|Adverse Event|3|||
170658628|NCT00410202|616763587|FG002|On-Treatment|Adverse Event|2|||
170658629|NCT00410202|616763585|FG000|On-Treatment|Death|1|||
170658630|NCT00410202|616763586|FG001|On-Treatment|Death|0|||
170658631|NCT00410202|616763587|FG002|On-Treatment|Death|0|||
170658632|NCT00410202|616763585|FG000|On-Treatment|Lost to Follow-up|1|||
170658633|NCT00410202|616763586|FG001|On-Treatment|Lost to Follow-up|0|||
170658634|NCT00410202|616763587|FG002|On-Treatment|Lost to Follow-up|1|||
170658635|NCT00410202|616763585|FG000|On-Treatment|Lack of Efficacy|1|||
170658636|NCT00410202|616763586|FG001|On-Treatment|Lack of Efficacy|4|||
170658637|NCT00410202|616763587|FG002|On-Treatment|Lack of Efficacy|0|||
170658638|NCT00410202|616763585|FG000|On-Treatment|Withdrawal by Subject|2|||
170658639|NCT00410202|616763586|FG001|On-Treatment|Withdrawal by Subject|1|||
170658640|NCT00410202|616763587|FG002|On-Treatment|Withdrawal by Subject|1|||
170658641|NCT00410202|616763585|FG000|On-Treatment|Other Reason|0|||
170658642|NCT00410202|616763586|FG001|On-Treatment|Other Reason|0|||
170658643|NCT00410202|616763587|FG002|On-Treatment|Other Reason|1|||
170658644|NCT00410202|616763585|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
170658645|NCT00410202|616763586|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
170658646|NCT00410202|616763587|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
170658647|NCT00410202|616763585|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
170658648|NCT00410202|616763586|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
170658649|NCT00410202|616763587|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
170658650|NCT00410202|616763585|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
170658651|NCT00410202|616763586|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
170658652|NCT00410202|616763587|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
170658653|NCT01178073|616763590|FG000|Overall Study|Adverse Event|34|||
170658654|NCT01178073|616763591|FG001|Overall Study|Adverse Event|27|||
170658655|NCT01178073|616763592|FG002|Overall Study|Adverse Event|24|||
170658656|NCT01178073|616763590|FG000|Overall Study|Protocol Violation|1|||
170658657|NCT01178073|616763591|FG001|Overall Study|Protocol Violation|1|||
170658658|NCT01178073|616763592|FG002|Overall Study|Protocol Violation|1|||
170658659|NCT01178073|616763590|FG000|Overall Study|Lost to Follow-up|2|||
170658660|NCT01178073|616763591|FG001|Overall Study|Lost to Follow-up|0|||
170658661|NCT01178073|616763592|FG002|Overall Study|Lost to Follow-up|3|||
170658662|NCT01178073|616763590|FG000|Overall Study|Physician Decision|14|||
170658663|NCT01178073|616763591|FG001|Overall Study|Physician Decision|10|||
170658664|NCT01178073|616763592|FG002|Overall Study|Physician Decision|10|||
170658665|NCT01178073|616763590|FG000|Overall Study|Withdrawal by Subject|10|||
170658666|NCT01178073|616763591|FG001|Overall Study|Withdrawal by Subject|6|||
170658667|NCT01178073|616763592|FG002|Overall Study|Withdrawal by Subject|8|||
170658668|NCT01178073|616763590|FG000|Overall Study|Missing Completion Status|1|||
170658669|NCT01178073|616763591|FG001|Overall Study|Missing Completion Status|0|||
170658670|NCT01178073|616763592|FG002|Overall Study|Missing Completion Status|0|||
170658671|NCT01702571|616763613|FG000|Overall Study|Death|1067|||
170658672|NCT01702571|616763614|FG001|Overall Study|Death|76|||
170658673|NCT01702571|616763613|FG000|Overall Study|Lost to Follow-up|144|||
170658674|NCT01702571|616763614|FG001|Overall Study|Lost to Follow-up|10|||
170658675|NCT01702571|616763613|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
170658676|NCT01702571|616763614|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
170658677|NCT01702571|616763613|FG000|Overall Study|Investigator Decision|5|||
170658678|NCT01702571|616763614|FG001|Overall Study|Investigator Decision|0|||
170658679|NCT01702571|616763613|FG000|Overall Study|Not Classifiable|1|||
170658680|NCT01702571|616763614|FG001|Overall Study|Not Classifiable|0|||
170658681|NCT01702571|616763613|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
170658682|NCT01702571|616763614|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
170658683|NCT01702571|616763613|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
170658684|NCT01702571|616763614|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
170658685|NCT01702571|616763613|FG000|Overall Study|Progressive Disease|3|||
170658686|NCT01702571|616763614|FG001|Overall Study|Progressive Disease|0|||
170658687|NCT01702571|616763613|FG000|Overall Study|Protocol Violation|2|||
170658688|NCT01702571|616763614|FG001|Overall Study|Protocol Violation|0|||
170658689|NCT01702571|616763613|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
170658690|NCT01702571|616763614|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
170658691|NCT01702571|616763613|FG000|Overall Study|Termination By Sponsor|4|||
170658692|NCT01702571|616763614|FG001|Overall Study|Termination By Sponsor|0|||
170658693|NCT01702571|616763613|FG000|Overall Study|Withdrawal by Subject|177|||
170658694|NCT01702571|616763614|FG001|Overall Study|Withdrawal by Subject|29|||
170658695|NCT00828854|616763615|FG000|Overall Study|Disease Progression|17|||
170658696|NCT00828854|616763615|FG000|Overall Study|Adverse Event|9|||
170658697|NCT00828854|616763615|FG000|Overall Study|Reason not Specified|1|||
170658698|NCT04221230|616763616|FG000|Overall Study|Lost to Follow-up|12|||
170658699|NCT04221230|616763617|FG001|Overall Study|Lost to Follow-up|12|||
170917032|NCT03710603|617697820|FG001|Overall Study|Withdrawal by Subject|10|||
170614200|NCT01811186|616593604|FG001|Overall Study|Adverse Event|38|||
170614201|NCT01811186|616593603|FG000|Overall Study|Protocol Violation|5|||
170614202|NCT01811186|616593604|FG001|Overall Study|Protocol Violation|6|||
170614203|NCT01811186|616593603|FG000|Overall Study|Withdrawal by Subject|5|||
170614204|NCT01811186|616593604|FG001|Overall Study|Withdrawal by Subject|10|||
170614205|NCT01811186|616593603|FG000|Overall Study|Lack of Efficacy|3|||
170614206|NCT01811186|616593604|FG001|Overall Study|Lack of Efficacy|6|||
170614207|NCT01811186|616593603|FG000|Overall Study|Lost to Follow-up|4|||
170614208|NCT01811186|616593604|FG001|Overall Study|Lost to Follow-up|2|||
170614209|NCT02587819|616593609|FG000|Overall Study|Adverse Event|1|||
170614210|NCT02587819|616593609|FG000|Overall Study|Lost to Follow-up|1|||
170614211|NCT01594931|616595438|FG000|Overall Study|Adverse Event|3|||
170614212|NCT01594931|616595439|FG001|Overall Study|Adverse Event|1|||
170614213|NCT01594931|616595440|FG002|Overall Study|Adverse Event|1|||
170614214|NCT01594931|616595438|FG000|Overall Study|Withdrawal by Subject|2|||
170614215|NCT01594931|616595439|FG001|Overall Study|Withdrawal by Subject|1|||
170614216|NCT01594931|616595440|FG002|Overall Study|Withdrawal by Subject|1|||
170614217|NCT01594931|616595438|FG000|Overall Study|Lack of Efficacy|7|||
170614218|NCT01594931|616595439|FG001|Overall Study|Lack of Efficacy|2|||
170614219|NCT01594931|616595440|FG002|Overall Study|Lack of Efficacy|2|||
170614220|NCT01594931|616595438|FG000|Overall Study|Lost to Follow-up|4|||
170614221|NCT01594931|616595439|FG001|Overall Study|Lost to Follow-up|3|||
170614222|NCT01594931|616595440|FG002|Overall Study|Lost to Follow-up|3|||
170614223|NCT01594931|616595438|FG000|Overall Study|Protocol Violation|2|||
170614224|NCT01594931|616595439|FG001|Overall Study|Protocol Violation|1|||
170614225|NCT01594931|616595440|FG002|Overall Study|Protocol Violation|0|||
170614226|NCT01594931|616595438|FG000|Overall Study|No defiined|11|||
170614227|NCT01594931|616595439|FG001|Overall Study|No defiined|4|||
170614228|NCT01594931|616595440|FG002|Overall Study|No defiined|7|||
170614229|NCT04864639|616595441|FG000|Overall Study|Death|1|||
170614230|NCT04864639|616595441|FG000|Overall Study|Lost to Follow-up|1|||
170614231|NCT01525615|616595444|FG000|Overall Study|Adverse Event|11|||
170614232|NCT01525615|616595445|FG001|Overall Study|Adverse Event|7|||
170614233|NCT01525615|616595446|FG002|Overall Study|Adverse Event|5|||
170614234|NCT01525615|616595444|FG000|Overall Study|Lost to Follow-up|1|||
170614235|NCT01525615|616595445|FG001|Overall Study|Lost to Follow-up|0|||
170614236|NCT01525615|616595446|FG002|Overall Study|Lost to Follow-up|0|||
170614237|NCT01525615|616595444|FG000|Overall Study|Withdrawal by Subject|1|||
170614238|NCT01525615|616595445|FG001|Overall Study|Withdrawal by Subject|0|||
170614239|NCT01525615|616595446|FG002|Overall Study|Withdrawal by Subject|0|||
170614240|NCT01525615|616595444|FG000|Overall Study|Other reason not described above|1|||
170614241|NCT01525615|616595445|FG001|Overall Study|Other reason not described above|0|||
170614242|NCT01525615|616595446|FG002|Overall Study|Other reason not described above|1|||
170614243|NCT03310723|616595454|FG000|Overall Study|Withdrawal by Subject|0|||
170614244|NCT03310723|616595455|FG001|Overall Study|Withdrawal by Subject|1|||
170614245|NCT03310723|616595454|FG000|Overall Study|Protocol Violation|0|||
170614246|NCT03310723|616595455|FG001|Overall Study|Protocol Violation|2|||
170614247|NCT02098746|616595456|FG000|Overall Study|Changes of Investigator|2|||
170614248|NCT02098746|616595456|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170614249|NCT02098746|616595456|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
170614250|NCT02098746|616595456|FG000|Overall Study|Data Not Available After Treatment|1|||
170614251|NCT00217425|616595460|FG000|Overall Study|Never started treatment|2|||
170614252|NCT00217425|616595460|FG000|Overall Study|Patient ineligible|5|||
170614253|NCT00217425|616595460|FG000|Overall Study|Lack of Efficacy|13|||
170614254|NCT00217425|616595460|FG000|Overall Study|Adverse Event|8|||
170614255|NCT00217425|616595460|FG000|Overall Study|Withdrawal by Subject|4|||
170614256|NCT00217425|616595460|FG000|Overall Study|Other complicating disease|1|||
170614257|NCT00217425|616595460|FG000|Overall Study|Other|4|||
170614258|NCT00330759|616595465|FG000|Overall Study|Death|316|||
170614259|NCT00330759|616595466|FG001|Overall Study|Death|310|||
170614260|NCT00330759|616595465|FG000|Overall Study|Disease progression|104|||
170614261|NCT00330759|616595466|FG001|Overall Study|Disease progression|126|||
170614262|NCT00330759|616595465|FG000|Overall Study|Withdrawal by Subject|143|||
170614263|NCT00330759|616595466|FG001|Overall Study|Withdrawal by Subject|124|||
170614264|NCT00330759|616595465|FG000|Overall Study|Adverse Event|48|||
170614265|NCT00330759|616595466|FG001|Overall Study|Adverse Event|36|||
170614266|NCT00330759|616595465|FG000|Overall Study|Participant request|31|||
170614267|NCT00330759|616595466|FG001|Overall Study|Participant request|22|||
170614268|NCT00330759|616595465|FG000|Overall Study|Lost to Follow-up|16|||
170614269|NCT00330759|616595466|FG001|Overall Study|Lost to Follow-up|22|||
170614270|NCT00330759|616595465|FG000|Overall Study|Noncompliance|15|||
170614271|NCT00330759|616595466|FG001|Overall Study|Noncompliance|17|||
170614272|NCT00330759|616595465|FG000|Overall Study|Physician Decision|1|||
170614273|NCT00330759|616595466|FG001|Overall Study|Physician Decision|2|||
170614274|NCT00330759|616595465|FG000|Overall Study|Protocol deviation|0|||
170614275|NCT00330759|616595466|FG001|Overall Study|Protocol deviation|2|||
170614276|NCT00330759|616595465|FG000|Overall Study|Ineligibility determined|2|||
170614277|NCT00330759|616595466|FG001|Overall Study|Ineligibility determined|1|||
170658700|NCT04221230|616763616|FG000|Overall Study|Protocol Violation|2|||
170658701|NCT04221230|616763617|FG001|Overall Study|Protocol Violation|2|||
170658702|NCT04221230|616763616|FG000|Overall Study|Adverse Event|0|||
170658703|NCT04221230|616763617|FG001|Overall Study|Adverse Event|8|||
170658704|NCT04221230|616763616|FG000|Overall Study|Physician Decision|1|||
170658705|NCT04221230|616763617|FG001|Overall Study|Physician Decision|0|||
170658706|NCT04221230|616763616|FG000|Overall Study|Withdrawal by Subject|13|||
170658707|NCT04221230|616763617|FG001|Overall Study|Withdrawal by Subject|11|||
170658708|NCT04221230|616763616|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170658709|NCT04221230|616763617|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170658710|NCT04221230|616763616|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170658711|NCT04221230|616763617|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
170658712|NCT04221230|616763616|FG000|Overall Study|Pregnancy|0|||
170658713|NCT04221230|616763617|FG001|Overall Study|Pregnancy|1|||
170658714|NCT04221230|616763616|FG000|Overall Study|Other|1|||
170658715|NCT04221230|616763617|FG001|Overall Study|Other|2|||
170658716|NCT00915356|616763618|FG000|Overall Study|Withdrawal by Subject|1|||
170658717|NCT00915356|616763619|FG001|Overall Study|Withdrawal by Subject|0|||
170658718|NCT00915356|616763620|FG002|Overall Study|Withdrawal by Subject|0|||
170658719|NCT00915356|616763621|FG003|Overall Study|Withdrawal by Subject|0|||
170658720|NCT00915356|616763622|FG004|Overall Study|Withdrawal by Subject|0|||
170658721|NCT02793128|616763627|FG000|Overall Study|Death|4|||
170658722|NCT02793128|616763627|FG000|Overall Study|Withdrawal by Subject|2|||
170658723|NCT02793128|616763627|FG000|Overall Study|Physician Decision|1|||
170658724|NCT02793128|616763627|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
170658725|NCT02793128|616763627|FG000|Overall Study|Patient elected nephroureterectomy|1|||
170658726|NCT00674973|616765164|FG000|Overall Study|Insufficient Therapeutic Response|77|||
170658727|NCT00674973|616765165|FG001|Overall Study|Insufficient Therapeutic Response|72|||
170658728|NCT00674973|616765164|FG000|Overall Study|Refused Treatment|1|||
170658729|NCT00674973|616765165|FG001|Overall Study|Refused Treatment|5|||
170816790|NCT01000649|617337293|FG000|Overall Study|Adverse Event|5|||
170816791|NCT01000649|617337294|FG001|Overall Study|Adverse Event|1|||
170816792|NCT01000649|617337295|FG002|Overall Study|Adverse Event|2|||
170816793|NCT01000649|617337296|FG003|Overall Study|Adverse Event|4|||
170816794|NCT01000649|617337293|FG000|Overall Study|Lost to Follow-up|0|||
170816795|NCT01000649|617337294|FG001|Overall Study|Lost to Follow-up|2|||
170816796|NCT01000649|617337295|FG002|Overall Study|Lost to Follow-up|0|||
170816797|NCT01000649|617337296|FG003|Overall Study|Lost to Follow-up|2|||
170816798|NCT01989156|617337297|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
170816799|NCT01989156|617337298|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
170816800|NCT01989156|617337299|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
170816801|NCT01989156|617337297|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
170816802|NCT01989156|617337298|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
170816803|NCT01989156|617337299|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
170816804|NCT01989156|617337297|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
170816805|NCT01989156|617337298|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
170658730|NCT00674973|616765164|FG000|Overall Study|Failure to Return|1|||
170658731|NCT00674973|616765165|FG001|Overall Study|Failure to Return|0|||
170658732|NCT00674973|616765164|FG000|Overall Study|Adverse Event|2|||
170614278|NCT00330759|616595465|FG000|Overall Study|Other|36|||
170614279|NCT00330759|616595466|FG001|Overall Study|Other|44|||
170614280|NCT02471014|616595470|FG000|Overall Study|Lost to Follow-up|2|||
170614281|NCT02471014|616595471|FG001|Overall Study|Lost to Follow-up|2|||
170614282|NCT02380287|616595472|FG000|Overall Study|Adverse Event|0|||
170614283|NCT02380287|616595473|FG001|Overall Study|Adverse Event|0|||
170614284|NCT02380287|616595474|FG002|Overall Study|Adverse Event|1|||
170614285|NCT02380287|616595475|FG003|Overall Study|Adverse Event|0|||
170614286|NCT02380287|616595476|FG004|Overall Study|Adverse Event|0|||
170614287|NCT02380287|616595477|FG005|Overall Study|Adverse Event|0|||
170614288|NCT02380287|616595478|FG006|Overall Study|Adverse Event|0|||
170614289|NCT02380287|616595479|FG007|Overall Study|Adverse Event|0|||
170614290|NCT04640311|616595480|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
170614291|NCT04640311|616595481|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614292|NCT04640311|616595482|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614293|NCT04640311|616595483|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170658733|NCT00674973|616765165|FG001|Overall Study|Adverse Event|9|||
170658734|NCT00674973|616765164|FG000|Overall Study|Death|19|||
170658735|NCT00674973|616765165|FG001|Overall Study|Death|15|||
170658736|NCT00674973|616765164|FG000|Overall Study|Protocol Violation|0|||
170658737|NCT00674973|616765165|FG001|Overall Study|Protocol Violation|1|||
170816806|NCT01989156|617337299|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
170816807|NCT01989156|617337297|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
170816808|NCT01989156|617337298|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
170658738|NCT00451451|616765166|FG000|Overall Study|Adverse Event|11|||
170658739|NCT00451451|616765167|FG001|Overall Study|Adverse Event|21|||
170658740|NCT00451451|616765168|FG002|Overall Study|Adverse Event|26|||
170658741|NCT00451451|616765169|FG003|Overall Study|Adverse Event|10|||
170658742|NCT00451451|616765166|FG000|Overall Study|Lost to Follow-up|11|||
170658743|NCT00451451|616765167|FG001|Overall Study|Lost to Follow-up|9|||
170658744|NCT00451451|616765168|FG002|Overall Study|Lost to Follow-up|8|||
170658745|NCT00451451|616765169|FG003|Overall Study|Lost to Follow-up|11|||
170658746|NCT00451451|616765166|FG000|Overall Study|Consent Withdrawn|14|||
170658747|NCT00451451|616765167|FG001|Overall Study|Consent Withdrawn|9|||
170658748|NCT00451451|616765168|FG002|Overall Study|Consent Withdrawn|17|||
170658749|NCT00451451|616765169|FG003|Overall Study|Consent Withdrawn|17|||
170658750|NCT00451451|616765166|FG000|Overall Study|Investigator Decision|6|||
170658751|NCT00451451|616765167|FG001|Overall Study|Investigator Decision|2|||
170658752|NCT00451451|616765168|FG002|Overall Study|Investigator Decision|1|||
170658753|NCT00451451|616765169|FG003|Overall Study|Investigator Decision|2|||
170658754|NCT00451451|616765166|FG000|Overall Study|Subject Non-Compliance|8|||
170658755|NCT00451451|616765167|FG001|Overall Study|Subject Non-Compliance|4|||
170658756|NCT00451451|616765168|FG002|Overall Study|Subject Non-Compliance|3|||
170658757|NCT00451451|616765169|FG003|Overall Study|Subject Non-Compliance|3|||
170658758|NCT00451451|616765166|FG000|Overall Study|Death|1|||
170658759|NCT00451451|616765167|FG001|Overall Study|Death|0|||
170658760|NCT00451451|616765168|FG002|Overall Study|Death|0|||
170658761|NCT00451451|616765169|FG003|Overall Study|Death|1|||
170658762|NCT00451451|616765166|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
170658763|NCT00451451|616765167|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
170658764|NCT00451451|616765168|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
170658765|NCT00451451|616765169|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
170658766|NCT00518687|616765170|FG000|Overall Study|Adverse Event|201|||
170658767|NCT00518687|616765171|FG001|Overall Study|Adverse Event|177|||
170658768|NCT00518687|616765170|FG000|Overall Study|Lost to Follow-up|144|||
170658769|NCT00518687|616765171|FG001|Overall Study|Lost to Follow-up|155|||
170658770|NCT00518687|616765170|FG000|Overall Study|Physician Decision|42|||
170658771|NCT00518687|616765171|FG001|Overall Study|Physician Decision|48|||
170658772|NCT00518687|616765170|FG000|Overall Study|Progressive disease|2|||
170658773|NCT00518687|616765171|FG001|Overall Study|Progressive disease|2|||
170658774|NCT00518687|616765170|FG000|Overall Study|Protocol Violation|8|||
170658775|NCT00518687|616765171|FG001|Overall Study|Protocol Violation|10|||
170658776|NCT00518687|616765170|FG000|Overall Study|Study terminated by sponsor|930|||
170658777|NCT00518687|616765171|FG001|Overall Study|Study terminated by sponsor|918|||
170658778|NCT00518687|616765170|FG000|Overall Study|Withdrawal by Subject|110|||
170658779|NCT00518687|616765171|FG001|Overall Study|Withdrawal by Subject|110|||
170658780|NCT00122278|616765172|FG000|Overall Study|Lost to Follow-up|2|||
170658781|NCT00122278|616765173|FG001|Overall Study|Lost to Follow-up|0|||
170658782|NCT02964507|616765174|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
170658783|NCT02964507|616765175|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
170658784|NCT02964507|616765176|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
170658785|NCT02964507|616765177|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
170658786|NCT02964507|616765178|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
170658787|NCT02964507|616765179|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
170658788|NCT02964507|616765180|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
170658789|NCT02964507|616765181|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
170658790|NCT02964507|616765174|FG000|Overall Study|Study terminated by Sponsor|9|||
170658791|NCT02964507|616765175|FG001|Overall Study|Study terminated by Sponsor|1|||
170658792|NCT02964507|616765176|FG002|Overall Study|Study terminated by Sponsor|9|||
170658793|NCT02964507|616765177|FG003|Overall Study|Study terminated by Sponsor|3|||
170658794|NCT02964507|616765178|FG004|Overall Study|Study terminated by Sponsor|3|||
170658795|NCT02964507|616765179|FG005|Overall Study|Study terminated by Sponsor|2|||
170658796|NCT02964507|616765180|FG006|Overall Study|Study terminated by Sponsor|0|||
170658797|NCT02964507|616765181|FG007|Overall Study|Study terminated by Sponsor|0|||
170658798|NCT02964507|616765174|FG000|Overall Study|Other|3|||
170658799|NCT02964507|616765175|FG001|Overall Study|Other|0|||
170658800|NCT02964507|616765176|FG002|Overall Study|Other|0|||
170658801|NCT02964507|616765177|FG003|Overall Study|Other|0|||
170658802|NCT02964507|616765178|FG004|Overall Study|Other|1|||
170658803|NCT02964507|616765179|FG005|Overall Study|Other|0|||
170658804|NCT02964507|616765180|FG006|Overall Study|Other|0|||
170658805|NCT02964507|616765181|FG007|Overall Study|Other|0|||
170658806|NCT02964507|616765174|FG000|Overall Study|Death|11|||
170658807|NCT02964507|616765175|FG001|Overall Study|Death|9|||
170658808|NCT02964507|616765176|FG002|Overall Study|Death|12|||
170658809|NCT02964507|616765177|FG003|Overall Study|Death|2|||
170658810|NCT02964507|616765178|FG004|Overall Study|Death|10|||
170658811|NCT02964507|616765179|FG005|Overall Study|Death|5|||
170658812|NCT02964507|616765180|FG006|Overall Study|Death|0|||
170658813|NCT02964507|616765181|FG007|Overall Study|Death|0|||
170658814|NCT02964507|616765174|FG000|Overall Study|Withdrawal by Subject|1|||
170658815|NCT02964507|616765175|FG001|Overall Study|Withdrawal by Subject|0|||
170658816|NCT02964507|616765176|FG002|Overall Study|Withdrawal by Subject|1|||
170658817|NCT02964507|616765177|FG003|Overall Study|Withdrawal by Subject|1|||
170658818|NCT02964507|616765178|FG004|Overall Study|Withdrawal by Subject|0|||
170816809|NCT01989156|617337299|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
170816810|NCT01989156|617337297|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
170816811|NCT01989156|617337298|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
170816812|NCT01989156|617337299|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
170816813|NCT01989156|617337297|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
170816814|NCT01989156|617337298|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
170816815|NCT01989156|617337299|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
170816816|NCT01989156|617337297|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
170816817|NCT01989156|617337298|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
170816818|NCT01989156|617337299|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
170816819|NCT01989156|617337297|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
170816820|NCT01989156|617337298|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
170816821|NCT01989156|617337299|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
170816822|NCT03839355|617337300|FG000|Overall Study|Withdrawal by Subject|1|||
170816823|NCT03839355|617337301|FG001|Overall Study|Withdrawal by Subject|0|||
170816824|NCT01622088|617337302|FG000|Overall Study|Adverse Event|20|||
170816825|NCT01622088|617337302|FG000|Overall Study|Lost to Follow-up|1|||
170816826|NCT01622088|617337302|FG000|Overall Study|Withdrawal by Subject|20|||
170816827|NCT01622088|617337302|FG000|Overall Study|Investigator Decision|1|||
170816828|NCT01622088|617337302|FG000|Overall Study|Death|53|||
170816829|NCT01622088|617337302|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
170816830|NCT00636168|617337303|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
170816831|NCT00636168|617337304|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
170816832|NCT00636168|617337303|FG000|Randomized to Study Drug|Adverse Event|1|||
170816833|NCT00636168|617337304|FG001|Randomized to Study Drug|Adverse Event|0|||
170816834|NCT00636168|617337303|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
170816835|NCT00636168|617337304|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
170816836|NCT00636168|617337303|FG000|Treated With Study Drug|Recurrence of disease|135|||
170816837|NCT00636168|617337304|FG001|Treated With Study Drug|Recurrence of disease|282|||
170816838|NCT00636168|617337303|FG000|Treated With Study Drug|Adverse Event|250|||
170816839|NCT00636168|617337304|FG001|Treated With Study Drug|Adverse Event|22|||
170816840|NCT00636168|617337303|FG000|Treated With Study Drug|Participant withdrew consent|16|||
170816841|NCT00636168|617337304|FG001|Treated With Study Drug|Participant withdrew consent|21|||
170614294|NCT04640311|616595484|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614295|NCT04640311|616595485|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614296|NCT04640311|616595486|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614297|NCT04640311|616595487|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614298|NCT04640311|616595488|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614299|NCT04640311|616595489|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614300|NCT04640311|616595490|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614301|NCT04640311|616595491|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614302|NCT04640311|616595492|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614303|NCT04640311|616595480|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614304|NCT04640311|616595481|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
170614305|NCT04640311|616595482|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614306|NCT04640311|616595483|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614307|NCT04640311|616595484|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614308|NCT04640311|616595485|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614309|NCT04640311|616595486|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614310|NCT04640311|616595487|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614311|NCT04640311|616595488|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614312|NCT04640311|616595489|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614313|NCT04640311|616595490|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614314|NCT04640311|616595491|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614315|NCT04640311|616595492|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
170614316|NCT04640311|616595480|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614317|NCT04640311|616595481|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
170614318|NCT04640311|616595482|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614319|NCT04640311|616595483|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614320|NCT04640311|616595484|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614321|NCT04640311|616595485|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170658819|NCT02964507|616765179|FG005|Overall Study|Withdrawal by Subject|1|||
170816842|NCT00636168|617337303|FG000|Treated With Study Drug|Poor/non-compliance|1|||
170658820|NCT02964507|616765180|FG006|Overall Study|Withdrawal by Subject|0|||
170658821|NCT02964507|616765181|FG007|Overall Study|Withdrawal by Subject|0|||
170658822|NCT02964507|616765174|FG000|Overall Study|Physician Decision|2|||
170658823|NCT02964507|616765175|FG001|Overall Study|Physician Decision|0|||
170658824|NCT02964507|616765176|FG002|Overall Study|Physician Decision|3|||
170658825|NCT02964507|616765177|FG003|Overall Study|Physician Decision|0|||
170658826|NCT02964507|616765178|FG004|Overall Study|Physician Decision|1|||
170658827|NCT02964507|616765179|FG005|Overall Study|Physician Decision|0|||
170658828|NCT02964507|616765180|FG006|Overall Study|Physician Decision|0|||
170658829|NCT02964507|616765181|FG007|Overall Study|Physician Decision|0|||
170658830|NCT04341662|616765182|FG000|Overall Study|Did not have source-verified blood loss data|423|||
170658831|NCT04341662|616765183|FG001|Overall Study|Did not have source-verified blood loss data|514|||
170658832|NCT05323656|616765184|FG000|Overall Study|Still On-Treatment|6|||
170658833|NCT05323656|616765185|FG001|Overall Study|Still On-Treatment|6|||
170658834|NCT05323656|616765184|FG000|Overall Study|Progressive Disease|15|||
170658835|NCT05323656|616765185|FG001|Overall Study|Progressive Disease|14|||
170658836|NCT05323656|616765184|FG000|Overall Study|Adverse Event|2|||
170658837|NCT05323656|616765185|FG001|Overall Study|Adverse Event|3|||
170658838|NCT05323656|616765184|FG000|Overall Study|Death|1|||
170658839|NCT05323656|616765185|FG001|Overall Study|Death|2|||
170658840|NCT05323656|616765184|FG000|Overall Study|Withdrawal by Subject|1|||
170658841|NCT05323656|616765185|FG001|Overall Study|Withdrawal by Subject|0|||
170658842|NCT05323656|616765184|FG000|Overall Study|Clinical disease progression|0|||
170658843|NCT05323656|616765185|FG001|Overall Study|Clinical disease progression|1|||
170658844|NCT05323656|616765184|FG000|Overall Study|Patient and Investigator decision|1|||
170658845|NCT05323656|616765185|FG001|Overall Study|Patient and Investigator decision|0|||
170658846|NCT05323656|616765184|FG000|Overall Study|Physician Decision|0|||
170658847|NCT05323656|616765185|FG001|Overall Study|Physician Decision|1|||
170658848|NCT03880461|616765186|FG000|Overall Study|Determined ineligible after enrollment|45|||
170658849|NCT03880461|616765187|FG001|Overall Study|Determined ineligible after enrollment|44|||
170658850|NCT03880461|616765186|FG000|Overall Study|No weight measurement after enrollment|24|||
170658851|NCT03880461|616765187|FG001|Overall Study|No weight measurement after enrollment|17|||
170658852|NCT00064298|616765189|FG000|Overall Study|Withdrawal by Subject|2|||
170658853|NCT00064298|616765190|FG001|Overall Study|Withdrawal by Subject|1|||
170658854|NCT00064298|616765189|FG000|Overall Study|Lost to Follow-up|2|||
170658855|NCT00064298|616765190|FG001|Overall Study|Lost to Follow-up|2|||
170658856|NCT00064298|616765189|FG000|Overall Study|Death|0|||
170658857|NCT00064298|616765190|FG001|Overall Study|Death|1|||
170658858|NCT00064298|616765189|FG000|Overall Study|Disease Progression|2|||
170658859|NCT00064298|616765190|FG001|Overall Study|Disease Progression|1|||
170658860|NCT01309893|616765191|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
170658861|NCT01309893|616765192|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
170658862|NCT01309893|616765191|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
170658863|NCT01309893|616765192|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
170658864|NCT02017171|616765193|FG000|Overall Study|Death|10|||
170658865|NCT02017171|616765194|FG001|Overall Study|Death|4|||
170658866|NCT02017171|616765193|FG000|Overall Study|Withdrawal by Subject|23|||
170658867|NCT02017171|616765194|FG001|Overall Study|Withdrawal by Subject|17|||
170658868|NCT02017171|616765193|FG000|Overall Study|Lost to Follow-up|21|||
170658869|NCT02017171|616765194|FG001|Overall Study|Lost to Follow-up|20|||
170658870|NCT02017171|616765193|FG000|Overall Study|ESKD|6|||
170658871|NCT02017171|616765194|FG001|Overall Study|ESKD|2|||
170658872|NCT02017171|616765193|FG000|Overall Study|Miscellaneous|2|||
170658873|NCT02017171|616765194|FG001|Overall Study|Miscellaneous|3|||
170658874|NCT02764190|616765195|FG000|Overall Study|Lost to Follow-up|17|||
170658875|NCT02764190|616765196|FG001|Overall Study|Lost to Follow-up|13|||
170658876|NCT01484938|616765197|FG000|Overall Study|Adverse Event|2|||
170658877|NCT01484938|616765197|FG000|Overall Study|Lost to Follow-up|1|||
170658878|NCT01484938|616765197|FG000|Overall Study|Noncompliance|1|||
170658879|NCT00999921|616765204|FG000|Overall Study|Lost to Follow-up|10|||
170658880|NCT00999921|616765205|FG001|Overall Study|Lost to Follow-up|19|||
170658881|NCT02862600|616765206|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
170658882|NCT02862600|616765206|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
170658883|NCT02862600|616765206|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
170658884|NCT02862600|616765206|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
170658885|NCT04650854|616765207|FG000|Overall Study|Adverse Event|1|||
170658886|NCT04650854|616765208|FG001|Overall Study|Adverse Event|12|||
170658887|NCT04650854|616765209|FG002|Overall Study|Adverse Event|14|||
170658888|NCT04650854|616765207|FG000|Overall Study|Lack of Efficacy|1|||
170658889|NCT04650854|616765208|FG001|Overall Study|Lack of Efficacy|3|||
170658890|NCT04650854|616765209|FG002|Overall Study|Lack of Efficacy|6|||
170658891|NCT04650854|616765207|FG000|Overall Study|Lost to Follow-up|1|||
170658892|NCT04650854|616765208|FG001|Overall Study|Lost to Follow-up|1|||
170658893|NCT04650854|616765209|FG002|Overall Study|Lost to Follow-up|0|||
170658894|NCT04650854|616765207|FG000|Overall Study|Withdrawal by Subject|2|||
170658895|NCT04650854|616765208|FG001|Overall Study|Withdrawal by Subject|17|||
170658896|NCT04650854|616765209|FG002|Overall Study|Withdrawal by Subject|9|||
170658897|NCT04650854|616765207|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
170658898|NCT04650854|616765208|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
170658899|NCT04650854|616765209|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
170658900|NCT04650854|616765207|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
170658901|NCT04650854|616765208|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
170658902|NCT04650854|616765209|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
170658903|NCT04650854|616765207|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
170658904|NCT04650854|616765208|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
170658905|NCT04650854|616765209|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
170658906|NCT04650854|616765207|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
170658907|NCT04650854|616765208|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
170658908|NCT04650854|616765209|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
170658909|NCT04650854|616765207|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
170658910|NCT04650854|616765208|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
170658911|NCT04650854|616765209|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
170658912|NCT04650854|616765207|FG000|Overall Study|Use of Rescue Medication|0|||
170658913|NCT04650854|616765208|FG001|Overall Study|Use of Rescue Medication|0|||
170658914|NCT04650854|616765209|FG002|Overall Study|Use of Rescue Medication|1|||
170658915|NCT04650854|616765207|FG000|Overall Study|Last Treatment Per Sponsor|0|||
170658916|NCT04650854|616765208|FG001|Overall Study|Last Treatment Per Sponsor|0|||
170658917|NCT04650854|616765209|FG002|Overall Study|Last Treatment Per Sponsor|2|||
170658918|NCT04650854|616765207|FG000|Overall Study|Rescue Medication|0|||
170658919|NCT04650854|616765208|FG001|Overall Study|Rescue Medication|0|||
170658920|NCT04650854|616765209|FG002|Overall Study|Rescue Medication|1|||
170658921|NCT04650854|616765207|FG000|Overall Study|Participant Want to Start a Family|0|||
170658922|NCT04650854|616765208|FG001|Overall Study|Participant Want to Start a Family|0|||
170658923|NCT04650854|616765209|FG002|Overall Study|Participant Want to Start a Family|1|||
170658924|NCT04650854|616765207|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
170658925|NCT04650854|616765208|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
170658926|NCT04650854|616765209|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
170658927|NCT04650854|616765207|FG000|Overall Study|Participant Screened For MG0020|0|||
170658928|NCT04650854|616765208|FG001|Overall Study|Participant Screened For MG0020|2|||
170658929|NCT04650854|616765209|FG002|Overall Study|Participant Screened For MG0020|3|||
170658930|NCT04650854|616765207|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
170658931|NCT04650854|616765208|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
170658932|NCT04650854|616765209|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
170658933|NCT04650854|616765207|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
170658934|NCT04650854|616765208|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
170658935|NCT04650854|616765209|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
170658936|NCT04650854|616765207|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
170658937|NCT04650854|616765208|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
170658938|NCT04650854|616765209|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
170658939|NCT04650854|616765207|FG000|Overall Study|End Of Study|0|||
170658940|NCT04650854|616765208|FG001|Overall Study|End Of Study|2|||
170658941|NCT04650854|616765209|FG002|Overall Study|End Of Study|1|||
170658942|NCT04650854|616765207|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
170658943|NCT04650854|616765208|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
170658944|NCT04650854|616765209|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
170658945|NCT04650854|616765207|FG000|Overall Study|Participant Received Rescue Medication|0|||
170658946|NCT04650854|616765208|FG001|Overall Study|Participant Received Rescue Medication|1|||
170658947|NCT04650854|616765209|FG002|Overall Study|Participant Received Rescue Medication|0|||
170658948|NCT04650854|616765207|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
170658949|NCT04650854|616765208|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
170658950|NCT04650854|616765209|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
170658951|NCT04650854|616765207|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
170658952|NCT04650854|616765208|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
170816843|NCT00636168|617337304|FG001|Treated With Study Drug|Poor/non-compliance|3|||
170816844|NCT00636168|617337303|FG000|Treated With Study Drug|Death|3|||
170816845|NCT00636168|617337304|FG001|Treated With Study Drug|Death|0|||
170816846|NCT00636168|617337303|FG000|Treated With Study Drug|Pregnancy|1|||
170816847|NCT00636168|617337304|FG001|Treated With Study Drug|Pregnancy|0|||
170816848|NCT00636168|617337303|FG000|Treated With Study Drug|No longer meets study criteria|1|||
170816849|NCT00636168|617337304|FG001|Treated With Study Drug|No longer meets study criteria|0|||
170816850|NCT00636168|617337303|FG000|Treated With Study Drug|Other reason|1|||
170816851|NCT00636168|617337304|FG001|Treated With Study Drug|Other reason|3|||
170816852|NCT00636168|617337303|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
170816853|NCT00636168|617337304|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
170658953|NCT04650854|616765209|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
170658954|NCT04650854|616765207|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
170658955|NCT04650854|616765208|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
170658956|NCT04650854|616765209|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
170658957|NCT04650854|616765207|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
170658958|NCT04650854|616765208|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
170658959|NCT04650854|616765209|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
170658960|NCT04650854|616765207|FG000|Overall Study|Enrollment Cup|0|||
170658961|NCT04650854|616765208|FG001|Overall Study|Enrollment Cup|0|||
170658962|NCT04650854|616765209|FG002|Overall Study|Enrollment Cup|1|||
170658963|NCT00704808|616765218|FG000|Overall Study|Discontinued prior to starting treatment|14|||
170658964|NCT00704808|616765218|FG000|Overall Study|Death|7|||
170658965|NCT00704808|616765218|FG000|Overall Study|Tumor progression|80|||
170658966|NCT00704808|616765218|FG000|Overall Study|Patient's decision|11|||
170658967|NCT00704808|616765218|FG000|Overall Study|Early therapy discontinuation|16|||
170658968|NCT00704808|616765218|FG000|Overall Study|Adverse Event|1|||
170658969|NCT00704808|616765218|FG000|Overall Study|Lost to Follow-up|1|||
170658970|NCT00704808|616765218|FG000|Overall Study|Treatment change|1|||
170658971|NCT03500679|616765224|FG000|Overall Study|Lost to Follow-up|6|||
170658972|NCT03500679|616765225|FG001|Overall Study|Lost to Follow-up|3|||
170658973|NCT03500679|616765224|FG000|Overall Study|Withdrawal by Subject|3|||
170658974|NCT03500679|616765225|FG001|Overall Study|Withdrawal by Subject|0|||
170658975|NCT00095628|616765227|FG000|Overall Study|Disease progression prior to treatment|1|||
170658976|NCT04271280|616765228|FG000|Overall Study|Lost to Follow-up|300|||
170658977|NCT04271280|616765228|FG000|Overall Study|Death|153|||
170658978|NCT04271280|616765228|FG000|Overall Study|Withdrawal of consent by patient|59|||
170658979|NCT04271280|616765228|FG000|Overall Study|Other|51|||
170658980|NCT04271280|616765228|FG000|Overall Study|No end of study information|42|||
170658981|NCT01484054|616765233|FG000|Period 1|Withdrawal by Subject|0|||
170658982|NCT01484054|616765234|FG001|Period 1|Withdrawal by Subject|1|||
170658983|NCT02117427|616765237|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
170658984|NCT02117427|616765238|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
170658985|NCT02117427|616765239|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
170658986|NCT02117427|616765237|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
170658987|NCT02117427|616765238|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
170658988|NCT02117427|616765239|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
170658989|NCT02117427|616765237|FG000|Overall Study|Physician Decision|0|||
170658990|NCT02117427|616765238|FG001|Overall Study|Physician Decision|2|||
170658991|NCT02117427|616765239|FG002|Overall Study|Physician Decision|0|||
170658992|NCT02117427|616765237|FG000|Overall Study|No longer meets inclusion criteria|0|||
170658993|NCT02117427|616765238|FG001|Overall Study|No longer meets inclusion criteria|1|||
170658994|NCT02117427|616765239|FG002|Overall Study|No longer meets inclusion criteria|0|||
170658995|NCT02117427|616765237|FG000|Overall Study|Death|0|||
170658996|NCT02117427|616765238|FG001|Overall Study|Death|1|||
170658997|NCT02117427|616765239|FG002|Overall Study|Death|0|||
170658998|NCT04223232|616765240|FG000|Overall Study|Withdrawal by Subject|1|||
170658999|NCT00591266|616765243|FG000|Overall Study|Adverse Event|2|||
170659000|NCT00591266|616765244|FG001|Overall Study|Adverse Event|2|||
170659001|NCT00591266|616765245|FG002|Overall Study|Adverse Event|3|||
170659002|NCT00591266|616765243|FG000|Overall Study|Lost to Follow-up|0|||
170659003|NCT00591266|616765244|FG001|Overall Study|Lost to Follow-up|1|||
170659004|NCT00591266|616765245|FG002|Overall Study|Lost to Follow-up|0|||
170659005|NCT00591266|616765243|FG000|Overall Study|Protocol Violation|0|||
170659006|NCT00591266|616765244|FG001|Overall Study|Protocol Violation|0|||
170659007|NCT00591266|616765245|FG002|Overall Study|Protocol Violation|1|||
170659008|NCT00591266|616765243|FG000|Overall Study|Withdrawal by Subject|6|||
170659009|NCT00591266|616765244|FG001|Overall Study|Withdrawal by Subject|2|||
170659010|NCT00591266|616765245|FG002|Overall Study|Withdrawal by Subject|5|||
170659011|NCT00591266|616765243|FG000|Overall Study|Lack of Efficacy|0|||
170659012|NCT00591266|616765244|FG001|Overall Study|Lack of Efficacy|2|||
170659013|NCT00591266|616765245|FG002|Overall Study|Lack of Efficacy|0|||
170659014|NCT00591266|616765243|FG000|Overall Study|Other|1|||
170659015|NCT00591266|616765244|FG001|Overall Study|Other|4|||
170659016|NCT00591266|616765245|FG002|Overall Study|Other|5|||
170659017|NCT03488927|616765246|FG000|Overall Study|Withdrawal by Subject|44|||
170659018|NCT03488927|616765247|FG001|Overall Study|Withdrawal by Subject|118|||
170659019|NCT03488927|616765248|FG002|Overall Study|Withdrawal by Subject|217|||
170659020|NCT01674634|616765256|FG000|Overall Study|Withdrawal by Subject|3|||
170659021|NCT01674634|616765256|FG000|Overall Study|Lost to Follow-up|3|||
170659022|NCT03004443|616765257|FG000|Overall Study|Pregnancy|0|||
170659023|NCT03004443|616765258|FG001|Overall Study|Pregnancy|1|||
170659024|NCT00191646|616765263|FG000|Overall Study|Toxicity|26|||
170659025|NCT00191646|616765264|FG001|Overall Study|Toxicity|37|||
170659026|NCT00191646|616765263|FG000|Overall Study|Disease Progression|5|||
170659027|NCT00191646|616765264|FG001|Overall Study|Disease Progression|6|||
170659028|NCT00191646|616765263|FG000|Overall Study|Physician Decision|20|||
170659029|NCT00191646|616765264|FG001|Overall Study|Physician Decision|11|||
170659030|NCT00191646|616765263|FG000|Overall Study|Withdrawal by Subject|58|||
170659031|NCT00191646|616765264|FG001|Overall Study|Withdrawal by Subject|39|||
170659032|NCT00191646|616765263|FG000|Overall Study|Protocol Violation|5|||
170659033|NCT00191646|616765264|FG001|Overall Study|Protocol Violation|7|||
170659034|NCT00191646|616765263|FG000|Overall Study|Death|6|||
170659035|NCT00191646|616765264|FG001|Overall Study|Death|8|||
170659036|NCT00191646|616765263|FG000|Overall Study|Other|33|||
170614322|NCT04640311|616595486|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614323|NCT04640311|616595487|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614324|NCT04640311|616595488|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614325|NCT04640311|616595489|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614326|NCT04640311|616595490|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614327|NCT04640311|616595491|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614328|NCT04640311|616595492|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614329|NCT04640311|616595480|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
170614330|NCT04640311|616595481|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
170614331|NCT04640311|616595482|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
170614332|NCT04640311|616595483|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614333|NCT04640311|616595484|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614334|NCT04640311|616595485|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614335|NCT04640311|616595486|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614336|NCT04640311|616595487|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614337|NCT04640311|616595488|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614338|NCT04640311|616595489|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614339|NCT04640311|616595490|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614340|NCT04640311|616595491|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614341|NCT04640311|616595492|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
170614342|NCT04640311|616595480|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614343|NCT04640311|616595481|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614344|NCT04640311|616595482|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
170614345|NCT04640311|616595483|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614346|NCT04640311|616595484|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614347|NCT04640311|616595485|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614348|NCT04640311|616595486|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614349|NCT04640311|616595487|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614350|NCT04640311|616595488|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614351|NCT04640311|616595489|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614352|NCT04640311|616595490|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614353|NCT04640311|616595491|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614354|NCT04640311|616595492|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
170614355|NCT04640311|616595480|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614356|NCT04640311|616595481|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614357|NCT04640311|616595482|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614358|NCT04640311|616595483|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
170614359|NCT04640311|616595484|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614360|NCT04640311|616595485|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614361|NCT04640311|616595486|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
170614362|NCT04640311|616595487|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614363|NCT04640311|616595488|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614364|NCT04640311|616595489|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614365|NCT04640311|616595490|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614366|NCT04640311|616595491|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614367|NCT04640311|616595492|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
170614368|NCT04640311|616595480|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614369|NCT04640311|616595481|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170659037|NCT00191646|616765264|FG001|Overall Study|Other|34|||
170659038|NCT00191646|616765263|FG000|Overall Study|Missing Data|18|||
170659039|NCT00191646|616765264|FG001|Overall Study|Missing Data|11|||
170659040|NCT05211284|616765266|FG000|Overall Study|Study Terminated|3|||
170659041|NCT05211284|616765267|FG001|Overall Study|Study Terminated|1|||
170659042|NCT00406718|616765281|FG000|Overall Study|Withdrawal by Subject|2|||
170659043|NCT00406718|616765282|FG001|Overall Study|Withdrawal by Subject|9|||
170816854|NCT00636168|617337303|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
170816855|NCT00636168|617337304|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
170816856|NCT00636168|617337303|FG000|Long Term Follow-Up|Death|8|||
170816857|NCT00636168|617337304|FG001|Long Term Follow-Up|Death|9|||
170816858|NCT03541369|617337309|FG000|Overall Study|Death|0|||
170816859|NCT03541369|617337310|FG001|Overall Study|Death|0|||
170816860|NCT03541369|617337311|FG002|Overall Study|Death|0|||
170816861|NCT03541369|617337312|FG003|Overall Study|Death|0|||
170816862|NCT03541369|617337313|FG004|Overall Study|Death|1|||
170816863|NCT03541369|617337314|FG005|Overall Study|Death|1|||
170816864|NCT03541369|617337315|FG006|Overall Study|Death|0|||
170816865|NCT03541369|617337316|FG007|Overall Study|Death|2|||
170659044|NCT00406718|616765283|FG002|Overall Study|Withdrawal by Subject|4|||
170659045|NCT00406718|616765281|FG000|Overall Study|Lost to Follow-up|2|||
170659046|NCT00406718|616765282|FG001|Overall Study|Lost to Follow-up|5|||
170659047|NCT00406718|616765283|FG002|Overall Study|Lost to Follow-up|4|||
170659048|NCT01888003|616765286|FG000|Overall Study|Study Terminated|5|||
170659049|NCT01888003|616765287|FG001|Overall Study|Study Terminated|6|||
170816866|NCT03541369|617337317|FG008|Overall Study|Death|1|||
170816867|NCT03541369|617337318|FG009|Overall Study|Death|2|||
170816868|NCT03541369|617337319|FG010|Overall Study|Death|1|||
170816869|NCT03541369|617337320|FG011|Overall Study|Death|0|||
170816870|NCT03541369|617337321|FG012|Overall Study|Death|2|||
170816871|NCT03541369|617337322|FG013|Overall Study|Death|1|||
170816872|NCT03541369|617337323|FG014|Overall Study|Death|1|||
170816873|NCT03541369|617337324|FG015|Overall Study|Death|1|||
170816874|NCT03541369|617337325|FG016|Overall Study|Death|0|||
170816875|NCT03541369|617337326|FG017|Overall Study|Death|1|||
170816876|NCT03541369|617337309|FG000|Overall Study|Decision by sponsor|0|||
170816877|NCT03541369|617337310|FG001|Overall Study|Decision by sponsor|0|||
170816878|NCT03541369|617337311|FG002|Overall Study|Decision by sponsor|0|||
170816879|NCT03541369|617337312|FG003|Overall Study|Decision by sponsor|1|||
170816880|NCT03541369|617337313|FG004|Overall Study|Decision by sponsor|0|||
170816881|NCT03541369|617337314|FG005|Overall Study|Decision by sponsor|2|||
170816882|NCT03541369|617337315|FG006|Overall Study|Decision by sponsor|0|||
170816883|NCT03541369|617337316|FG007|Overall Study|Decision by sponsor|1|||
170816884|NCT03541369|617337317|FG008|Overall Study|Decision by sponsor|2|||
170816885|NCT03541369|617337318|FG009|Overall Study|Decision by sponsor|0|||
170816886|NCT03541369|617337319|FG010|Overall Study|Decision by sponsor|0|||
170816887|NCT03541369|617337320|FG011|Overall Study|Decision by sponsor|0|||
170816888|NCT03541369|617337321|FG012|Overall Study|Decision by sponsor|2|||
170816889|NCT03541369|617337322|FG013|Overall Study|Decision by sponsor|2|||
170816890|NCT03541369|617337323|FG014|Overall Study|Decision by sponsor|0|||
170816891|NCT03541369|617337324|FG015|Overall Study|Decision by sponsor|1|||
170816892|NCT03541369|617337325|FG016|Overall Study|Decision by sponsor|1|||
170816893|NCT03541369|617337326|FG017|Overall Study|Decision by sponsor|1|||
170816894|NCT03541369|617337309|FG000|Overall Study|Withdrawal by Subject|0|||
170816895|NCT03541369|617337310|FG001|Overall Study|Withdrawal by Subject|0|||
170816896|NCT03541369|617337311|FG002|Overall Study|Withdrawal by Subject|0|||
170816897|NCT03541369|617337312|FG003|Overall Study|Withdrawal by Subject|0|||
170816898|NCT03541369|617337313|FG004|Overall Study|Withdrawal by Subject|0|||
170816899|NCT03541369|617337314|FG005|Overall Study|Withdrawal by Subject|0|||
170816900|NCT03541369|617337315|FG006|Overall Study|Withdrawal by Subject|1|||
170816901|NCT03541369|617337316|FG007|Overall Study|Withdrawal by Subject|0|||
170816902|NCT03541369|617337317|FG008|Overall Study|Withdrawal by Subject|0|||
170816903|NCT03541369|617337318|FG009|Overall Study|Withdrawal by Subject|0|||
170816904|NCT03541369|617337319|FG010|Overall Study|Withdrawal by Subject|0|||
170816905|NCT03541369|617337320|FG011|Overall Study|Withdrawal by Subject|1|||
170816906|NCT03541369|617337321|FG012|Overall Study|Withdrawal by Subject|0|||
170816907|NCT03541369|617337322|FG013|Overall Study|Withdrawal by Subject|0|||
170816908|NCT03541369|617337323|FG014|Overall Study|Withdrawal by Subject|3|||
170816909|NCT03541369|617337324|FG015|Overall Study|Withdrawal by Subject|0|||
170816910|NCT03541369|617337325|FG016|Overall Study|Withdrawal by Subject|4|||
170816911|NCT03541369|617337326|FG017|Overall Study|Withdrawal by Subject|2|||
170816912|NCT03541369|617337309|FG000|Overall Study|Lost to Follow-up|0|||
170816913|NCT03541369|617337310|FG001|Overall Study|Lost to Follow-up|0|||
170816914|NCT03541369|617337311|FG002|Overall Study|Lost to Follow-up|0|||
170816915|NCT03541369|617337312|FG003|Overall Study|Lost to Follow-up|0|||
170816916|NCT03541369|617337313|FG004|Overall Study|Lost to Follow-up|1|||
170816917|NCT03541369|617337314|FG005|Overall Study|Lost to Follow-up|0|||
170816918|NCT03541369|617337315|FG006|Overall Study|Lost to Follow-up|0|||
170816919|NCT03541369|617337316|FG007|Overall Study|Lost to Follow-up|0|||
170816920|NCT03541369|617337317|FG008|Overall Study|Lost to Follow-up|1|||
170659050|NCT01888003|616765288|FG002|Overall Study|Study Terminated|40|||
170659051|NCT03187756|616765289|FG000|Overall Study|Termination of study|4|||
170659052|NCT02211638|616765290|FG000|Overall Study|Case Report Forms Uncollected|291|||
170816921|NCT03541369|617337318|FG009|Overall Study|Lost to Follow-up|0|||
170816922|NCT03541369|617337319|FG010|Overall Study|Lost to Follow-up|0|||
170659053|NCT02211638|616765290|FG000|Overall Study|Protocol Violation|692|||
170659054|NCT04041700|616765291|FG000|Overall Study|Pregnancy|1|||
170659055|NCT04041700|616765291|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
170659056|NCT05140382|616765293|FG000|Overall Study|Death|3|||
170659057|NCT05140382|616765294|FG001|Overall Study|Death|0|||
170659058|NCT05140382|616765295|FG002|Overall Study|Death|0|||
170659059|NCT05140382|616765293|FG000|Overall Study|Investigator decision|1|||
170659060|NCT05140382|616765294|FG001|Overall Study|Investigator decision|0|||
170659061|NCT05140382|616765295|FG002|Overall Study|Investigator decision|0|||
170659062|NCT05140382|616765293|FG000|Overall Study|Other|4|||
170659063|NCT05140382|616765294|FG001|Overall Study|Other|0|||
170659064|NCT05140382|616765295|FG002|Overall Study|Other|1|||
170659065|NCT05140382|616765293|FG000|Overall Study|Progressive disease|20|||
170659066|NCT05140382|616765294|FG001|Overall Study|Progressive disease|1|||
170659067|NCT05140382|616765295|FG002|Overall Study|Progressive disease|12|||
170659068|NCT05140382|616765293|FG000|Overall Study|Subjective disease progression|2|||
170659069|NCT05140382|616765294|FG001|Overall Study|Subjective disease progression|1|||
170659070|NCT05140382|616765295|FG002|Overall Study|Subjective disease progression|0|||
170659071|NCT05140382|616765293|FG000|Overall Study|Unknown at data cut-off|0|||
170659072|NCT05140382|616765294|FG001|Overall Study|Unknown at data cut-off|0|||
170659073|NCT05140382|616765295|FG002|Overall Study|Unknown at data cut-off|1|||
170659074|NCT05140382|616765293|FG000|Overall Study|Withdrawal by Subject|1|||
170659075|NCT05140382|616765294|FG001|Overall Study|Withdrawal by Subject|0|||
170659076|NCT05140382|616765295|FG002|Overall Study|Withdrawal by Subject|4|||
170659077|NCT05140382|616765293|FG000|Overall Study|Withdrawal of consent|0|||
170659078|NCT05140382|616765294|FG001|Overall Study|Withdrawal of consent|0|||
170659079|NCT05140382|616765295|FG002|Overall Study|Withdrawal of consent|1|||
170659080|NCT05419908|616765297|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
170659081|NCT05419908|616765298|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
170659082|NCT05419908|616765297|FG000|Overall Study|Serious Adverse Event|0|||
170659083|NCT05419908|616765298|FG001|Overall Study|Serious Adverse Event|2|||
170659084|NCT05419908|616765297|FG000|Overall Study|Withdrawal by Subject|2|||
170659085|NCT05419908|616765298|FG001|Overall Study|Withdrawal by Subject|0|||
170659086|NCT05419908|616765297|FG000|Overall Study|Miscellaneous|1|||
170659087|NCT05419908|616765298|FG001|Overall Study|Miscellaneous|1|||
170659088|NCT01002482|616766569|FG000|Overall Study|Withdrawal by Subject|14|||
170659089|NCT01002482|616766570|FG001|Overall Study|Withdrawal by Subject|21|||
170659090|NCT01002482|616766569|FG000|Overall Study|Included twice|1|||
170659091|NCT01002482|616766570|FG001|Overall Study|Included twice|0|||
170659092|NCT02598960|616766574|FG000|Treatment Period|Disease Progression|4|||
170659093|NCT02598960|616766575|FG001|Treatment Period|Disease Progression|4|||
170659094|NCT02598960|616766576|FG002|Treatment Period|Disease Progression|4|||
170659095|NCT02598960|616766577|FG003|Treatment Period|Disease Progression|6|||
170659096|NCT02598960|616766578|FG004|Treatment Period|Disease Progression|8|||
170659097|NCT02598960|616766579|FG005|Treatment Period|Disease Progression|2|||
170659098|NCT02598960|616766580|FG006|Treatment Period|Disease Progression|2|||
170659099|NCT02598960|616766581|FG007|Treatment Period|Disease Progression|3|||
170659100|NCT02598960|616766582|FG008|Treatment Period|Disease Progression|7|||
170816923|NCT03541369|617337320|FG011|Overall Study|Lost to Follow-up|0|||
170816924|NCT03541369|617337321|FG012|Overall Study|Lost to Follow-up|1|||
170816925|NCT03541369|617337322|FG013|Overall Study|Lost to Follow-up|0|||
170816926|NCT03541369|617337323|FG014|Overall Study|Lost to Follow-up|0|||
170816927|NCT03541369|617337324|FG015|Overall Study|Lost to Follow-up|0|||
170816928|NCT03541369|617337325|FG016|Overall Study|Lost to Follow-up|0|||
170659101|NCT02598960|616766583|FG009|Treatment Period|Disease Progression|9|||
170659102|NCT02598960|616766584|FG010|Treatment Period|Disease Progression|7|||
170659103|NCT02598960|616766585|FG011|Treatment Period|Disease Progression|143|||
170816929|NCT03541369|617337326|FG017|Overall Study|Lost to Follow-up|0|||
170816930|NCT02555397|617337327|FG000|Overall Study|Withdrawal by Subject|1|||
170816931|NCT02555397|617337328|FG001|Overall Study|Withdrawal by Subject|0|||
170816932|NCT02555397|617337329|FG002|Overall Study|Withdrawal by Subject|0|||
170816933|NCT02555397|617337330|FG003|Overall Study|Withdrawal by Subject|0|||
170816934|NCT02555397|617337331|FG004|Overall Study|Withdrawal by Subject|0|||
170816935|NCT02971683|617337333|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
170816936|NCT02971683|617337334|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
170659104|NCT02598960|616766586|FG012|Treatment Period|Disease Progression|23|||
170659105|NCT02598960|616766574|FG000|Treatment Period|Study drug toxicity|0|||
170659106|NCT02598960|616766575|FG001|Treatment Period|Study drug toxicity|0|||
170659107|NCT02598960|616766576|FG002|Treatment Period|Study drug toxicity|0|||
170659108|NCT02598960|616766577|FG003|Treatment Period|Study drug toxicity|0|||
170659109|NCT02598960|616766578|FG004|Treatment Period|Study drug toxicity|0|||
170659110|NCT02598960|616766579|FG005|Treatment Period|Study drug toxicity|0|||
170659111|NCT02598960|616766580|FG006|Treatment Period|Study drug toxicity|0|||
170816937|NCT02971683|617337333|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
170659112|NCT02598960|616766581|FG007|Treatment Period|Study drug toxicity|0|||
170659113|NCT02598960|616766582|FG008|Treatment Period|Study drug toxicity|0|||
170659114|NCT02598960|616766583|FG009|Treatment Period|Study drug toxicity|1|||
170659115|NCT02598960|616766584|FG010|Treatment Period|Study drug toxicity|0|||
170659116|NCT02598960|616766585|FG011|Treatment Period|Study drug toxicity|3|||
170659117|NCT02598960|616766586|FG012|Treatment Period|Study drug toxicity|0|||
170659118|NCT02598960|616766574|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
170659119|NCT02598960|616766575|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
170659120|NCT02598960|616766576|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
170614370|NCT04640311|616595482|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614371|NCT04640311|616595483|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614372|NCT04640311|616595484|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614373|NCT04640311|616595485|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
170614374|NCT04640311|616595486|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614375|NCT04640311|616595487|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614376|NCT04640311|616595488|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
170614377|NCT04640311|616595489|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614378|NCT04640311|616595490|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614379|NCT04640311|616595491|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614380|NCT04640311|616595492|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
170614381|NCT04640311|616595480|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614382|NCT04640311|616595481|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614383|NCT04640311|616595482|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614384|NCT04640311|616595483|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614385|NCT04640311|616595484|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614386|NCT04640311|616595485|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614387|NCT04640311|616595486|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
170614388|NCT04640311|616595487|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614389|NCT04640311|616595488|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614390|NCT04640311|616595489|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614391|NCT04640311|616595490|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
170614392|NCT04640311|616595491|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614393|NCT04640311|616595492|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
170614394|NCT04640311|616595480|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614395|NCT04640311|616595481|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614396|NCT04640311|616595482|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614397|NCT04640311|616595483|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614398|NCT04640311|616595484|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614399|NCT04640311|616595485|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614400|NCT04640311|616595486|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614401|NCT04640311|616595487|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614402|NCT04640311|616595488|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614403|NCT04640311|616595489|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614404|NCT04640311|616595490|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614405|NCT04640311|616595491|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
170614406|NCT04640311|616595492|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
170614407|NCT01508312|616595493|FG000|Overall Study|Lost to Follow-up|1|||
170614408|NCT01508312|616595494|FG001|Overall Study|Lost to Follow-up|0|||
170614409|NCT01508312|616595495|FG002|Overall Study|Lost to Follow-up|0|||
170614410|NCT01508312|616595496|FG003|Overall Study|Lost to Follow-up|0|||
170614411|NCT01508312|616595493|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
170614412|NCT01508312|616595494|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
170614413|NCT01508312|616595495|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
170614414|NCT01508312|616595496|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
170614415|NCT01508312|616595493|FG000|Overall Study|Adverse Event|0|||
170614416|NCT01508312|616595494|FG001|Overall Study|Adverse Event|0|||
170614417|NCT01508312|616595495|FG002|Overall Study|Adverse Event|2|||
170614418|NCT01508312|616595496|FG003|Overall Study|Adverse Event|0|||
170614419|NCT01508312|616595493|FG000|Overall Study|Lack of Efficacy|0|||
170614420|NCT01508312|616595494|FG001|Overall Study|Lack of Efficacy|0|||
170614421|NCT01508312|616595495|FG002|Overall Study|Lack of Efficacy|1|||
170614422|NCT01508312|616595496|FG003|Overall Study|Lack of Efficacy|0|||
170614423|NCT01508312|616595493|FG000|Overall Study|Withdrawal by Subject|0|||
170614424|NCT01508312|616595494|FG001|Overall Study|Withdrawal by Subject|0|||
170659121|NCT02598960|616766577|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
170659122|NCT02598960|616766578|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
170659123|NCT02598960|616766579|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
170659124|NCT02598960|616766580|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
170659125|NCT02598960|616766581|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
170659126|NCT02598960|616766582|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
170659127|NCT02598960|616766583|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
170659128|NCT02598960|616766584|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
170659129|NCT02598960|616766585|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
170659130|NCT02598960|616766586|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
170659131|NCT02598960|616766574|FG000|Treatment Period|participant request to discontinue|0|||
170659132|NCT02598960|616766575|FG001|Treatment Period|participant request to discontinue|1|||
170659133|NCT02598960|616766576|FG002|Treatment Period|participant request to discontinue|0|||
170659134|NCT02598960|616766577|FG003|Treatment Period|participant request to discontinue|0|||
170659135|NCT02598960|616766578|FG004|Treatment Period|participant request to discontinue|1|||
170659136|NCT02598960|616766579|FG005|Treatment Period|participant request to discontinue|0|||
170659137|NCT02598960|616766580|FG006|Treatment Period|participant request to discontinue|0|||
170659138|NCT02598960|616766581|FG007|Treatment Period|participant request to discontinue|0|||
170659139|NCT02598960|616766582|FG008|Treatment Period|participant request to discontinue|0|||
170917033|NCT04108208|617697821|FG000|Overall Study|Withdrawal by Subject|2|||
170659140|NCT02598960|616766583|FG009|Treatment Period|participant request to discontinue|0|||
170659141|NCT02598960|616766584|FG010|Treatment Period|participant request to discontinue|1|||
170659142|NCT02598960|616766585|FG011|Treatment Period|participant request to discontinue|4|||
170659143|NCT02598960|616766586|FG012|Treatment Period|participant request to discontinue|0|||
170659144|NCT02598960|616766574|FG000|Treatment Period|participant withdrew consent|0|||
170659145|NCT02598960|616766575|FG001|Treatment Period|participant withdrew consent|0|||
170659146|NCT02598960|616766576|FG002|Treatment Period|participant withdrew consent|0|||
170659147|NCT02598960|616766577|FG003|Treatment Period|participant withdrew consent|0|||
170659148|NCT02598960|616766578|FG004|Treatment Period|participant withdrew consent|0|||
170659149|NCT02598960|616766579|FG005|Treatment Period|participant withdrew consent|0|||
170659150|NCT02598960|616766580|FG006|Treatment Period|participant withdrew consent|0|||
170659151|NCT02598960|616766581|FG007|Treatment Period|participant withdrew consent|0|||
170659152|NCT02598960|616766582|FG008|Treatment Period|participant withdrew consent|0|||
170659153|NCT02598960|616766583|FG009|Treatment Period|participant withdrew consent|0|||
170659154|NCT02598960|616766584|FG010|Treatment Period|participant withdrew consent|0|||
170659155|NCT02598960|616766585|FG011|Treatment Period|participant withdrew consent|3|||
170659156|NCT02598960|616766586|FG012|Treatment Period|participant withdrew consent|0|||
170659157|NCT02598960|616766574|FG000|Treatment Period|No longer meets study criteria|0|||
170659158|NCT02598960|616766575|FG001|Treatment Period|No longer meets study criteria|0|||
170659159|NCT02598960|616766576|FG002|Treatment Period|No longer meets study criteria|0|||
170659160|NCT02598960|616766577|FG003|Treatment Period|No longer meets study criteria|0|||
170659161|NCT02598960|616766578|FG004|Treatment Period|No longer meets study criteria|0|||
170659162|NCT02598960|616766579|FG005|Treatment Period|No longer meets study criteria|0|||
170659163|NCT02598960|616766580|FG006|Treatment Period|No longer meets study criteria|0|||
170659164|NCT02598960|616766581|FG007|Treatment Period|No longer meets study criteria|0|||
170659165|NCT02598960|616766582|FG008|Treatment Period|No longer meets study criteria|0|||
170659166|NCT02598960|616766583|FG009|Treatment Period|No longer meets study criteria|0|||
170659167|NCT02598960|616766584|FG010|Treatment Period|No longer meets study criteria|0|||
170659168|NCT02598960|616766585|FG011|Treatment Period|No longer meets study criteria|1|||
170659169|NCT02598960|616766586|FG012|Treatment Period|No longer meets study criteria|0|||
170917034|NCT04108208|617697822|FG001|Overall Study|Withdrawal by Subject|6|||
170917035|NCT04108208|617697821|FG000|Overall Study|other-ongoing|20|||
170917036|NCT04108208|617697822|FG001|Overall Study|other-ongoing|40|||
170917037|NCT04108208|617697821|FG000|Overall Study|Death|1|||
170917038|NCT04108208|617697822|FG001|Overall Study|Death|4|||
170917039|NCT04108208|617697821|FG000|Overall Study|Lost to Follow-up|2|||
170917040|NCT04108208|617697822|FG001|Overall Study|Lost to Follow-up|0|||
170917041|NCT04936308|617697823|FG000|Overall Study|Death|0|||
170659170|NCT02598960|616766574|FG000|Treatment Period|Other Reasons|0|||
170659171|NCT02598960|616766575|FG001|Treatment Period|Other Reasons|0|||
170659172|NCT02598960|616766576|FG002|Treatment Period|Other Reasons|0|||
170659173|NCT02598960|616766577|FG003|Treatment Period|Other Reasons|0|||
170659174|NCT02598960|616766578|FG004|Treatment Period|Other Reasons|0|||
170659175|NCT02598960|616766579|FG005|Treatment Period|Other Reasons|0|||
170659176|NCT02598960|616766580|FG006|Treatment Period|Other Reasons|0|||
170659177|NCT02598960|616766581|FG007|Treatment Period|Other Reasons|0|||
170917042|NCT04936308|617697824|FG001|Overall Study|Death|0|||
170917043|NCT04936308|617697825|FG002|Overall Study|Death|1|||
170917044|NCT04936308|617697823|FG000|Overall Study|Withdrawal by Subject|6|||
170917045|NCT04936308|617697824|FG001|Overall Study|Withdrawal by Subject|3|||
170917046|NCT04936308|617697825|FG002|Overall Study|Withdrawal by Subject|0|||
170917047|NCT04936308|617697823|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
170917048|NCT04936308|617697824|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
170659178|NCT02598960|616766582|FG008|Treatment Period|Other Reasons|0|||
170659179|NCT02598960|616766583|FG009|Treatment Period|Other Reasons|0|||
170659180|NCT02598960|616766584|FG010|Treatment Period|Other Reasons|0|||
170659181|NCT02598960|616766585|FG011|Treatment Period|Other Reasons|0|||
170659182|NCT02598960|616766586|FG012|Treatment Period|Other Reasons|1|||
170659183|NCT02598960|616766574|FG000|Participants Entering Follow Up Period|Death|1|||
170659184|NCT02598960|616766575|FG001|Participants Entering Follow Up Period|Death|0|||
170659185|NCT02598960|616766576|FG002|Participants Entering Follow Up Period|Death|0|||
170659186|NCT02598960|616766577|FG003|Participants Entering Follow Up Period|Death|0|||
170659187|NCT02598960|616766578|FG004|Participants Entering Follow Up Period|Death|0|||
170659188|NCT02598960|616766579|FG005|Participants Entering Follow Up Period|Death|0|||
170659189|NCT02598960|616766580|FG006|Participants Entering Follow Up Period|Death|0|||
170659190|NCT02598960|616766581|FG007|Participants Entering Follow Up Period|Death|0|||
170659191|NCT02598960|616766582|FG008|Participants Entering Follow Up Period|Death|0|||
170659192|NCT02598960|616766583|FG009|Participants Entering Follow Up Period|Death|1|||
170659193|NCT02598960|616766584|FG010|Participants Entering Follow Up Period|Death|0|||
170659194|NCT02598960|616766585|FG011|Participants Entering Follow Up Period|Death|11|||
170659195|NCT02598960|616766586|FG012|Participants Entering Follow Up Period|Death|2|||
170659196|NCT02598960|616766574|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659197|NCT02598960|616766575|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659198|NCT02598960|616766576|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659199|NCT02598960|616766577|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659200|NCT02598960|616766578|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659201|NCT02598960|616766579|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659202|NCT02598960|616766580|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659203|NCT02598960|616766581|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659204|NCT02598960|616766582|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659205|NCT02598960|616766583|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659206|NCT02598960|616766584|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659207|NCT02598960|616766585|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
170659208|NCT02598960|616766586|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
170659209|NCT02598960|616766574|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
170659210|NCT02598960|616766575|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
170659211|NCT02598960|616766576|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
170659212|NCT02598960|616766577|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
170659213|NCT02598960|616766578|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
170659214|NCT02598960|616766579|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
170659215|NCT02598960|616766580|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
170659216|NCT02598960|616766581|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
170659217|NCT02598960|616766582|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
170659218|NCT02598960|616766583|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
170659219|NCT02598960|616766584|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
170659220|NCT02598960|616766585|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
170816938|NCT02971683|617337334|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
170816939|NCT02971683|617337333|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
170816940|NCT02971683|617337334|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
170816941|NCT02971683|617337333|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
170816942|NCT02971683|617337334|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
170816943|NCT02971683|617337333|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
170816944|NCT02971683|617337334|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
170816945|NCT02971683|617337333|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
170816946|NCT02971683|617337334|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
170816947|NCT02971683|617337333|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
170816948|NCT02971683|617337334|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
170816949|NCT02971683|617337333|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
170816950|NCT02971683|617337334|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
170816951|NCT02971683|617337333|FG000|Open-Label|Lost to Follow-up|1|||
170816952|NCT02971683|617337334|FG001|Open-Label|Lost to Follow-up|0|||
170816953|NCT02971683|617337333|FG000|Open-Label|Participants withdrew consent|0|||
170816954|NCT02971683|617337334|FG001|Open-Label|Participants withdrew consent|2|||
170816955|NCT02971683|617337333|FG000|Open-Label|Participant request to discontinue study treatment|1|||
170816956|NCT02971683|617337334|FG001|Open-Label|Participant request to discontinue study treatment|0|||
170816957|NCT02971683|617337333|FG000|Open-Label|Lack of Efficacy|2|||
170816958|NCT02971683|617337334|FG001|Open-Label|Lack of Efficacy|0|||
170816959|NCT02971683|617337333|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
170816960|NCT02971683|617337334|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
170816961|NCT02971683|617337333|FG000|Long-Term Open Label|Participant withdrew consent|1|||
170659221|NCT02598960|616766586|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
170659222|NCT02598960|616766574|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659223|NCT02598960|616766575|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659224|NCT02598960|616766576|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659225|NCT02598960|616766577|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659226|NCT02598960|616766578|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659227|NCT02598960|616766579|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659228|NCT02598960|616766580|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659229|NCT02598960|616766581|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659230|NCT02598960|616766582|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659231|NCT02598960|616766583|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659232|NCT02598960|616766584|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659233|NCT02598960|616766585|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
170659234|NCT02598960|616766586|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
170659235|NCT02598960|616766574|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
170659236|NCT02598960|616766575|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
170659237|NCT02598960|616766576|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
170659238|NCT02598960|616766577|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
170659239|NCT02598960|616766578|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
170659240|NCT02598960|616766579|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
170659241|NCT02598960|616766580|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
170659242|NCT02598960|616766581|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
170659243|NCT02598960|616766582|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
170659244|NCT02598960|616766583|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
170659245|NCT02598960|616766584|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
170659246|NCT02598960|616766585|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
170659247|NCT02598960|616766586|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
170659248|NCT00089284|616766587|FG000|Overall Study|Adverse event before starting treatment|0|||
170659249|NCT00089284|616766588|FG001|Overall Study|Adverse event before starting treatment|0|||
170659250|NCT00089284|616766589|FG002|Overall Study|Adverse event before starting treatment|0|||
170659251|NCT00089284|616766590|FG003|Overall Study|Adverse event before starting treatment|0|||
170659252|NCT00089284|616766591|FG004|Overall Study|Adverse event before starting treatment|0|||
170659253|NCT00089284|616766592|FG005|Overall Study|Adverse event before starting treatment|0|||
170659254|NCT00089284|616766593|FG006|Overall Study|Adverse event before starting treatment|1|||
170659255|NCT00736957|616766594|FG000|Overall Study|Adverse Event|43|||
170659256|NCT00736957|616766594|FG000|Overall Study|Withdrawal by Subject|49|||
170659257|NCT00736957|616766594|FG000|Overall Study|violation of eligibility criteria|2|||
170659258|NCT00736957|616766594|FG000|Overall Study|did not attend hospital appointments|1|||
170659259|NCT00736957|616766594|FG000|Overall Study|not eligible for Treatment Period I|22|||
170659260|NCT00736957|616766594|FG000|Overall Study|Physician Decision|5|||
170659261|NCT00085709|616766595|FG000|Overall Study|Adverse Event|8|||
170659262|NCT00085709|616766596|FG001|Overall Study|Adverse Event|0|||
170659263|NCT00085709|616766595|FG000|Overall Study|Death|8|||
170659264|NCT00085709|616766596|FG001|Overall Study|Death|2|||
170659265|NCT00085709|616766595|FG000|Overall Study|Refusal unrelated to adverse events|1|||
170659266|NCT00085709|616766596|FG001|Overall Study|Refusal unrelated to adverse events|2|||
170659267|NCT00085709|616766595|FG000|Overall Study|Progression|3|||
170659268|NCT00085709|616766596|FG001|Overall Study|Progression|4|||
170659269|NCT00085709|616766595|FG000|Overall Study|Not protocol specified|12|||
170659270|NCT00085709|616766596|FG001|Overall Study|Not protocol specified|22|||
170659271|NCT00085709|616766595|FG000|Overall Study|Not eligible|19|||
170659272|NCT00085709|616766596|FG001|Overall Study|Not eligible|19|||
170659273|NCT00085709|616766595|FG000|Overall Study|Withdrawal by Subject|2|||
170816962|NCT02971683|617337334|FG001|Long-Term Open Label|Participant withdrew consent|0|||
170816963|NCT02971683|617337333|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
170816964|NCT02971683|617337334|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
170816965|NCT02971683|617337333|FG000|Long-Term Open Label|Adverse Event|1|||
170816966|NCT02971683|617337334|FG001|Long-Term Open Label|Adverse Event|2|||
170816967|NCT02971683|617337333|FG000|Long-Term Open Label|Lack of Efficacy|1|||
170816968|NCT02971683|617337334|FG001|Long-Term Open Label|Lack of Efficacy|1|||
170816969|NCT01240785|617337335|FG000|Overall Study|Lost to Follow-up|1|||
170816970|NCT01240785|617337336|FG001|Overall Study|Lost to Follow-up|0|||
170816971|NCT01240785|617337335|FG000|Overall Study|Protocol Violation|0|||
170816972|NCT01240785|617337336|FG001|Overall Study|Protocol Violation|3|||
170917049|NCT04936308|617697825|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
170917050|NCT04936308|617697823|FG000|Overall Study|Completed protocol-required follow-up|1|||
170917051|NCT04936308|617697824|FG001|Overall Study|Completed protocol-required follow-up|2|||
170917052|NCT04936308|617697825|FG002|Overall Study|Completed protocol-required follow-up|2|||
170917053|NCT04936308|617697823|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
170917054|NCT04936308|617697824|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
170917055|NCT04936308|617697825|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
170659274|NCT00085709|616766596|FG001|Overall Study|Withdrawal by Subject|1|||
170659275|NCT03646643|616766597|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
170659276|NCT03646643|616766598|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
170659277|NCT03646643|616766597|FG000|Overall Study|Lost to Follow-up|0|||
170659278|NCT03646643|616766598|FG001|Overall Study|Lost to Follow-up|1|||
170659279|NCT02806973|616766599|FG000|Period 1|Withdrawal by Subject|0|||
170659280|NCT02806973|616766600|FG001|Period 1|Withdrawal by Subject|2|||
170659281|NCT02806973|616766601|FG002|Period 1|Withdrawal by Subject|1|||
170659282|NCT02806973|616766602|FG003|Period 1|Withdrawal by Subject|1|||
170659283|NCT02806973|616766599|FG000|Period 1|Adverse Event|0|||
170659284|NCT02806973|616766600|FG001|Period 1|Adverse Event|0|||
170659285|NCT02806973|616766601|FG002|Period 1|Adverse Event|0|||
170659286|NCT02806973|616766602|FG003|Period 1|Adverse Event|1|||
170659287|NCT02806973|616766599|FG000|Period 3|Withdrawal by Subject|0|||
170816973|NCT00237809|617337337|FG000|Overall Study|Lost to Follow-up|11|||
170816974|NCT00237809|617337338|FG001|Overall Study|Lost to Follow-up|10|||
170659288|NCT02806973|616766600|FG001|Period 3|Withdrawal by Subject|0|||
170659289|NCT02806973|616766601|FG002|Period 3|Withdrawal by Subject|0|||
170659290|NCT02806973|616766602|FG003|Period 3|Withdrawal by Subject|3|||
170659291|NCT02806973|616766599|FG000|Period 3|Adverse Event|0|||
170659292|NCT02806973|616766600|FG001|Period 3|Adverse Event|0|||
170659293|NCT02806973|616766601|FG002|Period 3|Adverse Event|1|||
170659294|NCT02806973|616766602|FG003|Period 3|Adverse Event|0|||
170659295|NCT02545075|616766611|FG000|Randomization|Lost to Follow-up|0|||
170659296|NCT02545075|616766612|FG001|Randomization|Lost to Follow-up|1|||
170659297|NCT02545075|616766611|FG000|Randomization|Withdrawal by Subject|0|||
170659298|NCT02545075|616766612|FG001|Randomization|Withdrawal by Subject|6|||
170659299|NCT02545075|616766611|FG000|Treatment|Disease progression|71|||
170659300|NCT02545075|616766612|FG001|Treatment|Disease progression|32|||
170659301|NCT02545075|616766611|FG000|Treatment|Participant dicontinued study treatment|7|||
170659302|NCT02545075|616766612|FG001|Treatment|Participant dicontinued study treatment|9|||
170659303|NCT02545075|616766611|FG000|Treatment|Withdrawal by Subject|1|||
170659304|NCT02545075|616766612|FG001|Treatment|Withdrawal by Subject|0|||
170659305|NCT02545075|616766611|FG000|Treatment|Adverse event not related to study drug|1|||
170659306|NCT02545075|616766612|FG001|Treatment|Adverse event not related to study drug|0|||
170659307|NCT02545075|616766611|FG000|Treatment|Death|1|||
170659308|NCT02545075|616766612|FG001|Treatment|Death|0|||
170659309|NCT02545075|616766611|FG000|Treatment|Participant drug toxicity|1|||
170659310|NCT02545075|616766612|FG001|Treatment|Participant drug toxicity|0|||
170816975|NCT00237809|617337339|FG002|Overall Study|Lost to Follow-up|9|||
170816976|NCT00237809|617337340|FG003|Overall Study|Lost to Follow-up|9|||
170816977|NCT00696241|617337341|FG000|Overall Study|Adverse Event|11|||
170816978|NCT00696241|617337342|FG001|Overall Study|Adverse Event|3|||
170816979|NCT00696241|617337343|FG002|Overall Study|Adverse Event|6|||
170816980|NCT00696241|617337344|FG003|Overall Study|Adverse Event|4|||
170816981|NCT00696241|617337345|FG004|Overall Study|Adverse Event|5|||
170816982|NCT00696241|617337341|FG000|Overall Study|Protocol Violation|1|||
170816983|NCT00696241|617337342|FG001|Overall Study|Protocol Violation|1|||
170816984|NCT00696241|617337343|FG002|Overall Study|Protocol Violation|2|||
170816985|NCT00696241|617337344|FG003|Overall Study|Protocol Violation|0|||
170816986|NCT00696241|617337345|FG004|Overall Study|Protocol Violation|3|||
170816987|NCT00696241|617337341|FG000|Overall Study|Lost to Follow-up|1|||
170816988|NCT00696241|617337342|FG001|Overall Study|Lost to Follow-up|4|||
170816989|NCT00696241|617337343|FG002|Overall Study|Lost to Follow-up|1|||
170816990|NCT00696241|617337344|FG003|Overall Study|Lost to Follow-up|2|||
170816991|NCT00696241|617337345|FG004|Overall Study|Lost to Follow-up|0|||
170816992|NCT00696241|617337341|FG000|Overall Study|Withdrawal by Subject|4|||
170816993|NCT00696241|617337342|FG001|Overall Study|Withdrawal by Subject|8|||
170816994|NCT00696241|617337343|FG002|Overall Study|Withdrawal by Subject|6|||
170816995|NCT00696241|617337344|FG003|Overall Study|Withdrawal by Subject|1|||
170816996|NCT00696241|617337345|FG004|Overall Study|Withdrawal by Subject|0|||
170917056|NCT04936308|617697823|FG000|Overall Study|Other|3|||
170917057|NCT04936308|617697824|FG001|Overall Study|Other|0|||
170659311|NCT02545075|616766611|FG000|Treatment|Completed treatment|40|||
170659312|NCT02545075|616766612|FG001|Treatment|Completed treatment|12|||
170659313|NCT01810432|616766613|FG000|Washout|Protocol Violation|0|||
170659314|NCT01810432|616766614|FG001|Washout|Protocol Violation|1|||
170659315|NCT01810432|616766613|FG000|Washout|Adverse Event|1|||
170816997|NCT00696241|617337341|FG000|Overall Study|Lack of Efficacy|1|||
170816998|NCT00696241|617337342|FG001|Overall Study|Lack of Efficacy|5|||
170816999|NCT00696241|617337343|FG002|Overall Study|Lack of Efficacy|4|||
170817000|NCT00696241|617337344|FG003|Overall Study|Lack of Efficacy|5|||
170659316|NCT01810432|616766614|FG001|Washout|Adverse Event|0|||
170659317|NCT01810432|616766613|FG000|Period 2|Withdrawal by Subject|2|||
170659318|NCT01810432|616766614|FG001|Period 2|Withdrawal by Subject|1|||
170614425|NCT01508312|616595495|FG002|Overall Study|Withdrawal by Subject|1|||
170614426|NCT01508312|616595496|FG003|Overall Study|Withdrawal by Subject|0|||
170614427|NCT03018691|616595497|FG000|Overall Study|Adverse Event|1|||
170614428|NCT03018691|616595498|FG001|Overall Study|Adverse Event|1|||
170614429|NCT03018691|616595499|FG002|Overall Study|Adverse Event|4|||
170614430|NCT03018691|616595497|FG000|Overall Study|Lack of Efficacy|0|||
170614431|NCT03018691|616595498|FG001|Overall Study|Lack of Efficacy|0|||
170614432|NCT03018691|616595499|FG002|Overall Study|Lack of Efficacy|1|||
170614433|NCT03018691|616595497|FG000|Overall Study|Withdrawal by Subject|0|||
170614434|NCT03018691|616595498|FG001|Overall Study|Withdrawal by Subject|0|||
170614435|NCT03018691|616595499|FG002|Overall Study|Withdrawal by Subject|1|||
170614436|NCT03018691|616595497|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170614437|NCT03018691|616595498|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170614438|NCT03018691|616595499|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170614439|NCT03369418|616595500|FG000|Overall Study|Withdrawal by Subject|3|||
170614440|NCT03369418|616595501|FG001|Overall Study|Withdrawal by Subject|3|||
170614441|NCT02859246|616595504|FG000|Overall Study|Screen fails|3|||
170614442|NCT02859246|616595504|FG000|Overall Study|Adverse Event|1|||
170614443|NCT02859246|616595504|FG000|Overall Study|Withdrawal by Subject|1|||
170614444|NCT01461707|616595507|FG000|Overall Study|Withdrawal by Subject|1|||
170614445|NCT01461707|616595508|FG001|Overall Study|Withdrawal by Subject|0|||
170614446|NCT01196026|616595509|FG000|Overall Study|Withdrawal by Subject|1|||
170614447|NCT01196026|616595510|FG001|Overall Study|Withdrawal by Subject|4|||
170614448|NCT01196026|616595511|FG002|Overall Study|Withdrawal by Subject|0|||
170614449|NCT01196026|616595512|FG003|Overall Study|Withdrawal by Subject|0|||
170614450|NCT01196026|616595513|FG004|Overall Study|Withdrawal by Subject|0|||
170614451|NCT01196026|616595514|FG005|Overall Study|Withdrawal by Subject|0|||
170614452|NCT01196026|616595509|FG000|Overall Study|Lost to Follow-up|0|||
170614453|NCT01196026|616595510|FG001|Overall Study|Lost to Follow-up|3|||
170614454|NCT01196026|616595511|FG002|Overall Study|Lost to Follow-up|0|||
170614455|NCT01196026|616595512|FG003|Overall Study|Lost to Follow-up|0|||
170614456|NCT01196026|616595513|FG004|Overall Study|Lost to Follow-up|1|||
170614457|NCT01196026|616595514|FG005|Overall Study|Lost to Follow-up|0|||
170614458|NCT01196026|616595509|FG000|Overall Study|Other|0|||
170614459|NCT01196026|616595510|FG001|Overall Study|Other|1|||
170614460|NCT01196026|616595511|FG002|Overall Study|Other|0|||
170817001|NCT00696241|617337345|FG004|Overall Study|Lack of Efficacy|3|||
170817002|NCT00696241|617337341|FG000|Overall Study|Other|6|||
170817003|NCT00696241|617337342|FG001|Overall Study|Other|1|||
170817004|NCT00696241|617337343|FG002|Overall Study|Other|5|||
170817005|NCT00696241|617337344|FG003|Overall Study|Other|2|||
170817006|NCT00696241|617337345|FG004|Overall Study|Other|1|||
170817007|NCT00321555|617337347|FG000|Overall Study|Developed antibodies|1|||
170817008|NCT00321555|617337347|FG000|Overall Study|Switched to alternative treatment|3|||
170817009|NCT00321555|617337347|FG000|Overall Study|Physician Decision|1|||
170817010|NCT00321555|617337347|FG000|Overall Study|Disease progression on study|1|||
170817011|NCT02066389|617337348|FG000|Overall Study|Adverse Event|1|||
170817012|NCT02066389|617337349|FG001|Overall Study|Adverse Event|1|||
170817013|NCT02066389|617337350|FG002|Overall Study|Adverse Event|1|||
170817014|NCT02066389|617337351|FG003|Overall Study|Adverse Event|1|||
170817015|NCT02066389|617337352|FG004|Overall Study|Adverse Event|5|||
170817016|NCT02066389|617337353|FG005|Overall Study|Adverse Event|1|||
170817017|NCT02066389|617337348|FG000|Overall Study|Withdrawal by Subject|4|||
170817018|NCT02066389|617337349|FG001|Overall Study|Withdrawal by Subject|0|||
170817019|NCT02066389|617337350|FG002|Overall Study|Withdrawal by Subject|5|||
170817020|NCT02066389|617337351|FG003|Overall Study|Withdrawal by Subject|1|||
170817021|NCT02066389|617337352|FG004|Overall Study|Withdrawal by Subject|1|||
170817022|NCT02066389|617337353|FG005|Overall Study|Withdrawal by Subject|2|||
170817023|NCT02066389|617337348|FG000|Overall Study|Lost to Follow-up|0|||
170817024|NCT02066389|617337349|FG001|Overall Study|Lost to Follow-up|0|||
170817025|NCT02066389|617337350|FG002|Overall Study|Lost to Follow-up|0|||
170817026|NCT02066389|617337351|FG003|Overall Study|Lost to Follow-up|1|||
170817027|NCT02066389|617337352|FG004|Overall Study|Lost to Follow-up|1|||
170817028|NCT02066389|617337353|FG005|Overall Study|Lost to Follow-up|1|||
170817029|NCT02066389|617337348|FG000|Overall Study|Randomized in Error|0|||
170817030|NCT02066389|617337349|FG001|Overall Study|Randomized in Error|0|||
170817031|NCT02066389|617337350|FG002|Overall Study|Randomized in Error|0|||
170917058|NCT04936308|617697825|FG002|Overall Study|Other|2|||
170614461|NCT01196026|616595512|FG003|Overall Study|Other|0|||
170614462|NCT01196026|616595513|FG004|Overall Study|Other|0|||
170614463|NCT01196026|616595514|FG005|Overall Study|Other|0|||
170614464|NCT02524171|616595516|FG000|6-month Follow-up|Lost to Follow-up|53|||
170614465|NCT02524171|616595517|FG001|6-month Follow-up|Lost to Follow-up|45|||
170614466|NCT02524171|616595516|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
170817032|NCT02066389|617337351|FG003|Overall Study|Randomized in Error|0|||
170817033|NCT02066389|617337352|FG004|Overall Study|Randomized in Error|0|||
170817034|NCT02066389|617337353|FG005|Overall Study|Randomized in Error|1|||
170817035|NCT04749797|617337354|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
170817036|NCT04749797|617337355|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
170917059|NCT04689828|617697826|FG000|Overall Study|Subject decision|5|||
170917060|NCT04689828|617697827|FG001|Overall Study|Subject decision|5|||
170917061|NCT04689828|617697826|FG000|Overall Study|Adverse Event|12|||
170917062|NCT04689828|617697827|FG001|Overall Study|Adverse Event|12|||
170917063|NCT04689828|617697826|FG000|Overall Study|Physician Decision|24|||
170917064|NCT04689828|617697827|FG001|Overall Study|Physician Decision|32|||
170917065|NCT04689828|617697826|FG000|Overall Study|Progressive disease|54|||
170917066|NCT04689828|617697827|FG001|Overall Study|Progressive disease|173|||
170917067|NCT04689828|617697826|FG000|Overall Study|Death|0|||
170917068|NCT04689828|617697827|FG001|Overall Study|Death|1|||
170917069|NCT04689828|617697826|FG000|Overall Study|Lost to Follow-up|1|||
170917070|NCT04689828|617697827|FG001|Overall Study|Lost to Follow-up|0|||
170614467|NCT02524171|616595517|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
170614468|NCT00684996|616595518|FG000|Overall Study|Adverse Event|1|||
170614469|NCT00684996|616595518|FG000|Overall Study|Refusal unrelated to adverse event|1|||
170614470|NCT00684996|616595518|FG000|Overall Study|Progression/relapse|2|||
170614471|NCT00684996|616595518|FG000|Overall Study|Other reasons not protocol specified|1|||
170614472|NCT01010971|616595519|FG000|Overall Study|Adverse Event|2|||
170614473|NCT01010971|616595520|FG001|Overall Study|Adverse Event|4|||
170614474|NCT01010971|616595521|FG002|Overall Study|Adverse Event|3|||
170614475|NCT01010971|616595519|FG000|Overall Study|Withdrawal by Subject|0|||
170614476|NCT01010971|616595520|FG001|Overall Study|Withdrawal by Subject|2|||
170614477|NCT01010971|616595521|FG002|Overall Study|Withdrawal by Subject|5|||
170614478|NCT01010971|616595519|FG000|Overall Study|Lost to Follow-up|0|||
170614479|NCT01010971|616595520|FG001|Overall Study|Lost to Follow-up|2|||
170614480|NCT01010971|616595521|FG002|Overall Study|Lost to Follow-up|3|||
170614481|NCT01010971|616595519|FG000|Overall Study|Other|1|||
170614482|NCT01010971|616595520|FG001|Overall Study|Other|0|||
170614483|NCT01010971|616595521|FG002|Overall Study|Other|2|||
170614484|NCT01221350|616595525|FG000|Overall Study|Discontinued intervention (GERD)|1|||
170614485|NCT01221350|616595526|FG001|Overall Study|Discontinued intervention (GERD)|0|||
170614486|NCT01221350|616595525|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
170614487|NCT01221350|616595526|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
170614488|NCT01221350|616595525|FG000|Overall Study|Withdrawal by Subject|4|||
170614489|NCT01221350|616595526|FG001|Overall Study|Withdrawal by Subject|2|||
170614490|NCT05888181|616595527|FG000|Overall Study|Lost to Follow-up|1|||
170614491|NCT05888181|616595528|FG001|Overall Study|Lost to Follow-up|1|||
170614492|NCT05888181|616595529|FG002|Overall Study|Lost to Follow-up|0|||
170614493|NCT02326597|616595532|FG000|Overall Study|Lost to Follow-up|42|||
170614494|NCT02326597|616595533|FG001|Overall Study|Lost to Follow-up|32|||
170614495|NCT02204072|616595534|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
170614496|NCT02204072|616595535|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
170614497|NCT02204072|616595536|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
170614498|NCT02204072|616595537|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
170614499|NCT02204072|616595538|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
170614500|NCT02204072|616595534|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
170614501|NCT02204072|616595535|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
170614502|NCT02204072|616595536|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
170614503|NCT02204072|616595537|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
170614504|NCT02204072|616595538|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
170614505|NCT02204072|616595534|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
170614506|NCT02204072|616595535|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
170614507|NCT02204072|616595536|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
170614508|NCT02204072|616595537|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
170614509|NCT02204072|616595538|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
170614510|NCT02204072|616595534|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
170614511|NCT02204072|616595535|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
170614512|NCT02204072|616595536|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
170614513|NCT02204072|616595537|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
170614514|NCT02204072|616595538|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
170614515|NCT00310817|616595539|FG000|Overall Study|AE or Death|3|||
170614516|NCT00310817|616595540|FG001|Overall Study|AE or Death|1|||
170917071|NCT04689828|617697826|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
170917072|NCT04689828|617697827|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
170614517|NCT00310817|616595541|FG002|Overall Study|AE or Death|0|||
170614518|NCT00310817|616595542|FG003|Overall Study|AE or Death|0|||
170614519|NCT00310817|616595539|FG000|Overall Study|Withdrawal by Subject|1|||
170659319|NCT01810432|616766613|FG000|Period 2|Physician Decision|1|||
170659320|NCT01810432|616766614|FG001|Period 2|Physician Decision|0|||
170659321|NCT01810432|616766613|FG000|Period 2|Lost to Follow-up|1|||
170659322|NCT01810432|616766614|FG001|Period 2|Lost to Follow-up|1|||
170614520|NCT00310817|616595540|FG001|Overall Study|Withdrawal by Subject|4|||
170659323|NCT00736879|616766615|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
170659324|NCT00736879|616766616|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
170659325|NCT00736879|616766617|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
170659326|NCT00736879|616766618|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
170659327|NCT00736879|616766615|FG000|Double Blind Treatment Period|Adverse Event|0|||
170659328|NCT00736879|616766616|FG001|Double Blind Treatment Period|Adverse Event|1|||
170659329|NCT00736879|616766617|FG002|Double Blind Treatment Period|Adverse Event|1|||
170659330|NCT00736879|616766618|FG003|Double Blind Treatment Period|Adverse Event|0|||
170659331|NCT00736879|616766615|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
170659332|NCT00736879|616766616|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
170659333|NCT00736879|616766617|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
170659334|NCT00736879|616766618|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
170659335|NCT00736879|616766615|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
170659336|NCT00736879|616766616|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
170659337|NCT00736879|616766617|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
170659338|NCT00736879|616766618|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
170659339|NCT00736879|616766615|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
170659340|NCT00736879|616766616|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
170659341|NCT00736879|616766617|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
170659342|NCT00736879|616766618|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
170659343|NCT00736879|616766615|FG000|Double Blind Treatment Period|No longer met criteria|0|||
170659344|NCT00736879|616766616|FG001|Double Blind Treatment Period|No longer met criteria|1|||
170659345|NCT00736879|616766617|FG002|Double Blind Treatment Period|No longer met criteria|0|||
170659346|NCT00736879|616766618|FG003|Double Blind Treatment Period|No longer met criteria|0|||
170659347|NCT00736879|616766615|FG000|Double Blind Treatment Period|non-specified|0|||
170659348|NCT00736879|616766616|FG001|Double Blind Treatment Period|non-specified|1|||
170659349|NCT00736879|616766617|FG002|Double Blind Treatment Period|non-specified|0|||
170659350|NCT00736879|616766618|FG003|Double Blind Treatment Period|non-specified|0|||
170659351|NCT00736879|616766615|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
170817037|NCT04749797|617337356|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
170614521|NCT00310817|616595541|FG002|Overall Study|Withdrawal by Subject|6|||
170614522|NCT00310817|616595542|FG003|Overall Study|Withdrawal by Subject|7|||
170614523|NCT00310817|616595539|FG000|Overall Study|Lost to Follow-up|2|||
170614524|NCT00310817|616595540|FG001|Overall Study|Lost to Follow-up|1|||
170614525|NCT00310817|616595541|FG002|Overall Study|Lost to Follow-up|0|||
170614526|NCT00310817|616595542|FG003|Overall Study|Lost to Follow-up|0|||
170614527|NCT00310817|616595539|FG000|Overall Study|Inappropriate Enrollment|1|||
170614528|NCT00310817|616595540|FG001|Overall Study|Inappropriate Enrollment|0|||
170614529|NCT00310817|616595541|FG002|Overall Study|Inappropriate Enrollment|1|||
170614530|NCT00310817|616595542|FG003|Overall Study|Inappropriate Enrollment|0|||
170614531|NCT00310817|616595539|FG000|Overall Study|Protocol Violation|1|||
170614532|NCT00310817|616595540|FG001|Overall Study|Protocol Violation|1|||
170614533|NCT00310817|616595541|FG002|Overall Study|Protocol Violation|1|||
170614534|NCT00310817|616595542|FG003|Overall Study|Protocol Violation|1|||
170614535|NCT00310817|616595539|FG000|Overall Study|Unable to classify|3|||
170614536|NCT00310817|616595540|FG001|Overall Study|Unable to classify|1|||
170614537|NCT00310817|616595541|FG002|Overall Study|Unable to classify|0|||
170614538|NCT00310817|616595542|FG003|Overall Study|Unable to classify|0|||
170614539|NCT02863328|616595546|FG000|Overall Study|Lost to Follow-up|4|||
170614540|NCT02863328|616595547|FG001|Overall Study|Lost to Follow-up|10|||
170614541|NCT02863328|616595546|FG000|Overall Study|Withdrawal by Subject|7|||
170614542|NCT02863328|616595547|FG001|Overall Study|Withdrawal by Subject|12|||
170614543|NCT02863328|616595546|FG000|Overall Study|Died|0|||
170614544|NCT02863328|616595547|FG001|Overall Study|Died|1|||
170614545|NCT01248949|616595548|FG000|Overall Study|Lost to Follow-up|2|||
170614546|NCT01248949|616595549|FG001|Overall Study|Lost to Follow-up|2|||
170614547|NCT01248949|616595550|FG002|Overall Study|Lost to Follow-up|2|||
170614548|NCT01248949|616595551|FG003|Overall Study|Lost to Follow-up|1|||
170614549|NCT01248949|616595552|FG004|Overall Study|Lost to Follow-up|0|||
170614550|NCT01248949|616595548|FG000|Overall Study|Withdrawal by Subject|5|||
170614551|NCT01248949|616595549|FG001|Overall Study|Withdrawal by Subject|3|||
170614552|NCT01248949|616595550|FG002|Overall Study|Withdrawal by Subject|11|||
170614553|NCT01248949|616595551|FG003|Overall Study|Withdrawal by Subject|3|||
170614554|NCT01248949|616595552|FG004|Overall Study|Withdrawal by Subject|1|||
170614555|NCT01248949|616595548|FG000|Overall Study|Death|22|||
170614556|NCT01248949|616595549|FG001|Overall Study|Death|7|||
170614557|NCT01248949|616595550|FG002|Overall Study|Death|21|||
170614558|NCT01248949|616595551|FG003|Overall Study|Death|6|||
170614559|NCT01248949|616595552|FG004|Overall Study|Death|2|||
170659352|NCT00736879|616766616|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
170614560|NCT01248949|616595548|FG000|Overall Study|Alternative Therapy|1|||
170614561|NCT01248949|616595549|FG001|Overall Study|Alternative Therapy|0|||
170614562|NCT01248949|616595550|FG002|Overall Study|Alternative Therapy|0|||
170659353|NCT00736879|616766617|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
170659354|NCT00736879|616766618|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
170659355|NCT00736879|616766615|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
170659356|NCT00736879|616766616|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
170659357|NCT00736879|616766617|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
170659358|NCT00736879|616766618|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
170659359|NCT03583164|616766625|FG000|Overall Study|Death in Main Phase|35|||
170659360|NCT03583164|616766625|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
170659361|NCT03583164|616766625|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
170659362|NCT03583164|616766625|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
170659363|NCT03583164|616766625|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
170659364|NCT03583164|616766625|FG000|Overall Study|Physician decision in Main Phase|1|||
170659365|NCT03583164|616766625|FG000|Overall Study|Physician decision in Extended Phase|2|||
170659366|NCT03583164|616766625|FG000|Overall Study|Death in Extended Phase|13|||
170659367|NCT03583164|616766625|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
170659368|NCT03583164|616766625|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
170659369|NCT03583164|616766625|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
170659370|NCT03583164|616766625|FG000|Overall Study|Treatment failure in Main Phase|2|||
170659371|NCT03583164|616766625|FG000|Overall Study|Treatment failure in Extended Phase|4|||
170659372|NCT03583164|616766625|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
170659373|NCT03583164|616766625|FG000|Overall Study|Other not specified reason in Main Phase|2|||
170659374|NCT00735254|616766626|FG000|Overall Study|Protocol Violation|1|||
170659375|NCT00735254|616766627|FG001|Overall Study|Protocol Violation|1|||
170659376|NCT00735254|616766628|FG002|Overall Study|Protocol Violation|1|||
170659377|NCT00735254|616766629|FG003|Overall Study|Protocol Violation|0|||
170659378|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
170659379|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
170659380|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
170659381|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
170659382|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
170659383|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
170659384|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
170659385|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
170659386|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
170659387|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
170659388|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
170659389|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
170659390|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
170659391|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
170659392|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
170659393|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
170659394|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Program Termination|3|||
170659395|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Program Termination|0|||
170659396|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Program Termination|1|||
170659397|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Program Termination|1|||
170659398|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
170659399|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
170659400|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
170659401|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
170659402|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
170659403|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
170659404|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
170659405|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
170659406|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
170659407|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
170659408|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
170659409|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
170817038|NCT00871715|617337365|FG000|Overall Study|Withdrawal by Subject|6|||
170817039|NCT00871715|617337366|FG001|Overall Study|Withdrawal by Subject|10|||
170659410|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
170659411|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
170659412|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
170659413|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
170659414|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
170659415|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
170659416|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
170659417|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
170659418|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
170817040|NCT00871715|617337367|FG002|Overall Study|Withdrawal by Subject|15|||
170659419|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
170659420|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
170659421|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
170659422|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
170659423|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
170614563|NCT01248949|616595551|FG003|Overall Study|Alternative Therapy|0|||
170614564|NCT01248949|616595552|FG004|Overall Study|Alternative Therapy|0|||
170614565|NCT01248949|616595548|FG000|Overall Study|Alternative Therapy.|1|||
170614566|NCT01248949|616595549|FG001|Overall Study|Alternative Therapy.|0|||
170614567|NCT01248949|616595550|FG002|Overall Study|Alternative Therapy.|0|||
170614568|NCT01248949|616595551|FG003|Overall Study|Alternative Therapy.|0|||
170614569|NCT01248949|616595552|FG004|Overall Study|Alternative Therapy.|0|||
170614570|NCT01248949|616595548|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
170614571|NCT01248949|616595549|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
170614572|NCT01248949|616595550|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
170614573|NCT01248949|616595551|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
170614574|NCT01248949|616595552|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
170614575|NCT01248949|616595548|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
170614576|NCT01248949|616595549|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
170614577|NCT01248949|616595550|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
170614578|NCT01248949|616595551|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
170614579|NCT01248949|616595552|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
170614580|NCT01248949|616595548|FG000|Overall Study|Participant Went To Hospice|0|||
170614581|NCT01248949|616595549|FG001|Overall Study|Participant Went To Hospice|0|||
170614582|NCT01248949|616595550|FG002|Overall Study|Participant Went To Hospice|1|||
170614583|NCT01248949|616595551|FG003|Overall Study|Participant Went To Hospice|0|||
170614584|NCT01248949|616595552|FG004|Overall Study|Participant Went To Hospice|0|||
170614585|NCT01248949|616595548|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
170614586|NCT01248949|616595549|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
170614587|NCT01248949|616595550|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
170614588|NCT01248949|616595551|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
170614589|NCT01248949|616595552|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
170614590|NCT01248949|616595548|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
170614591|NCT01248949|616595549|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
170614592|NCT01248949|616595550|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
170614593|NCT01248949|616595551|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
170614594|NCT01248949|616595552|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
170614595|NCT01248949|616595548|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
170614596|NCT01248949|616595549|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
170614597|NCT01248949|616595550|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
170614598|NCT01248949|616595551|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
170614599|NCT01248949|616595552|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
170614600|NCT01248949|616595548|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
170614601|NCT01248949|616595549|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
170614602|NCT01248949|616595550|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
170614603|NCT01248949|616595551|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
170614604|NCT01248949|616595552|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
170614605|NCT00186901|616595562|FG000|Overall Study|Pregnancy|6|||
170614606|NCT00186901|616595563|FG001|Overall Study|Pregnancy|3|||
170614607|NCT00186901|616595564|FG002|Overall Study|Pregnancy|0|||
170614608|NCT00186901|616595562|FG000|Overall Study|Lost to Follow-up|6|||
170614609|NCT00186901|616595563|FG001|Overall Study|Lost to Follow-up|3|||
170614610|NCT00186901|616595564|FG002|Overall Study|Lost to Follow-up|0|||
170614611|NCT00186901|616595562|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
170614612|NCT00186901|616595563|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
170614613|NCT00186901|616595564|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
170614614|NCT00186901|616595562|FG000|Overall Study|ALL relapse or second malignancy|1|||
170614615|NCT00186901|616595563|FG001|Overall Study|ALL relapse or second malignancy|2|||
170614616|NCT00186901|616595564|FG002|Overall Study|ALL relapse or second malignancy|0|||
170614617|NCT00186901|616595562|FG000|Overall Study|Withdrawal by Subject|4|||
170614618|NCT00186901|616595563|FG001|Overall Study|Withdrawal by Subject|5|||
170614619|NCT00186901|616595564|FG002|Overall Study|Withdrawal by Subject|0|||
170614620|NCT00186901|616595562|FG000|Overall Study|Open label|3|||
170659424|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
170614621|NCT00186901|616595563|FG001|Overall Study|Open label|2|||
170614622|NCT00186901|616595564|FG002|Overall Study|Open label|0|||
170614623|NCT00186901|616595562|FG000|Overall Study|Limited adherence to study requirements|20|||
170614624|NCT00186901|616595563|FG001|Overall Study|Limited adherence to study requirements|23|||
170614625|NCT00186901|616595564|FG002|Overall Study|Limited adherence to study requirements|0|||
170614626|NCT00186901|616595562|FG000|Overall Study|Bone Mineral Density > 0|0|||
170659425|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
170659426|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
170659427|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
170659428|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
170917073|NCT04689828|617697826|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
170614627|NCT00186901|616595563|FG001|Overall Study|Bone Mineral Density > 0|0|||
170614628|NCT00186901|616595564|FG002|Overall Study|Bone Mineral Density > 0|149|||
170614629|NCT01052077|616595568|FG000|Phase A|Lost to Follow-up|22|||
170614630|NCT01052077|616595569|FG001|Phase A|Lost to Follow-up|0|||
170614631|NCT01052077|616595570|FG002|Phase A|Lost to Follow-up|0|||
170614632|NCT01052077|616595571|FG003|Phase A|Lost to Follow-up|0|||
170614633|NCT01052077|616595568|FG000|Phase A|Adverse Event|32|||
170614634|NCT01052077|616595569|FG001|Phase A|Adverse Event|0|||
170614635|NCT01052077|616595570|FG002|Phase A|Adverse Event|0|||
170614636|NCT01052077|616595571|FG003|Phase A|Adverse Event|0|||
170614637|NCT01052077|616595568|FG000|Phase A|Met Withdrawal Criteria|26|||
170614638|NCT01052077|616595569|FG001|Phase A|Met Withdrawal Criteria|0|||
170614639|NCT01052077|616595570|FG002|Phase A|Met Withdrawal Criteria|0|||
170614640|NCT01052077|616595571|FG003|Phase A|Met Withdrawal Criteria|0|||
170614641|NCT01052077|616595568|FG000|Phase A|Physician Decision|10|||
170614642|NCT01052077|616595569|FG001|Phase A|Physician Decision|0|||
170614643|NCT01052077|616595570|FG002|Phase A|Physician Decision|0|||
170614644|NCT01052077|616595571|FG003|Phase A|Physician Decision|0|||
170614645|NCT01052077|616595568|FG000|Phase A|Withdrawal by Subject|29|||
170614646|NCT01052077|616595569|FG001|Phase A|Withdrawal by Subject|0|||
170614647|NCT01052077|616595570|FG002|Phase A|Withdrawal by Subject|0|||
170614648|NCT01052077|616595571|FG003|Phase A|Withdrawal by Subject|0|||
170614649|NCT01052077|616595568|FG000|Phase A|Protocol Deviation|27|||
170614650|NCT01052077|616595569|FG001|Phase A|Protocol Deviation|0|||
170614651|NCT01052077|616595570|FG002|Phase A|Protocol Deviation|0|||
170614652|NCT01052077|616595571|FG003|Phase A|Protocol Deviation|0|||
170614653|NCT01052077|616595568|FG000|Phase B|Lost to Follow-up|0|||
170614654|NCT01052077|616595569|FG001|Phase B|Lost to Follow-up|2|||
170614655|NCT01052077|616595570|FG002|Phase B|Lost to Follow-up|3|||
170614656|NCT01052077|616595571|FG003|Phase B|Lost to Follow-up|0|||
170614657|NCT01052077|616595568|FG000|Phase B|Adverse Event|0|||
170614658|NCT01052077|616595569|FG001|Phase B|Adverse Event|9|||
170614659|NCT01052077|616595570|FG002|Phase B|Adverse Event|2|||
170614660|NCT01052077|616595571|FG003|Phase B|Adverse Event|0|||
170614661|NCT01052077|616595568|FG000|Phase B|Met Withdrawal Criteria|0|||
170614662|NCT01052077|616595569|FG001|Phase B|Met Withdrawal Criteria|2|||
170614663|NCT01052077|616595570|FG002|Phase B|Met Withdrawal Criteria|1|||
170614664|NCT01052077|616595571|FG003|Phase B|Met Withdrawal Criteria|0|||
170614665|NCT01052077|616595568|FG000|Phase B|Physician Decision|0|||
170614666|NCT01052077|616595569|FG001|Phase B|Physician Decision|1|||
170614667|NCT01052077|616595570|FG002|Phase B|Physician Decision|1|||
170614668|NCT01052077|616595571|FG003|Phase B|Physician Decision|0|||
170614669|NCT01052077|616595568|FG000|Phase B|Withdrawal by Subject|0|||
170614670|NCT01052077|616595569|FG001|Phase B|Withdrawal by Subject|0|||
170614671|NCT01052077|616595570|FG002|Phase B|Withdrawal by Subject|5|||
170614672|NCT01052077|616595571|FG003|Phase B|Withdrawal by Subject|0|||
170614673|NCT01052077|616595568|FG000|Phase B|Protocol Deviation|0|||
170614674|NCT01052077|616595569|FG001|Phase B|Protocol Deviation|3|||
170614675|NCT01052077|616595570|FG002|Phase B|Protocol Deviation|4|||
170614676|NCT01052077|616595571|FG003|Phase B|Protocol Deviation|0|||
170614677|NCT01052077|616595568|FG000|Phase B|Lack of Efficacy|0|||
170614678|NCT01052077|616595569|FG001|Phase B|Lack of Efficacy|1|||
170614679|NCT01052077|616595570|FG002|Phase B|Lack of Efficacy|0|||
170614680|NCT01052077|616595571|FG003|Phase B|Lack of Efficacy|0|||
170614681|NCT01052077|616595568|FG000|Phase A+|Lost to Follow-up|0|||
170614682|NCT01052077|616595569|FG001|Phase A+|Lost to Follow-up|0|||
170614683|NCT01052077|616595570|FG002|Phase A+|Lost to Follow-up|0|||
170614684|NCT01052077|616595571|FG003|Phase A+|Lost to Follow-up|8|||
170614685|NCT01052077|616595568|FG000|Phase A+|Adverse Event|0|||
170614686|NCT01052077|616595569|FG001|Phase A+|Adverse Event|0|||
170614687|NCT01052077|616595570|FG002|Phase A+|Adverse Event|0|||
170614688|NCT01052077|616595571|FG003|Phase A+|Adverse Event|4|||
170614689|NCT01052077|616595568|FG000|Phase A+|Met Withdrawal Criteria|0|||
170614690|NCT01052077|616595569|FG001|Phase A+|Met Withdrawal Criteria|0|||
170614691|NCT01052077|616595570|FG002|Phase A+|Met Withdrawal Criteria|0|||
170614692|NCT01052077|616595571|FG003|Phase A+|Met Withdrawal Criteria|2|||
170614693|NCT01052077|616595568|FG000|Phase A+|Withdrawal by Subject|0|||
170614694|NCT01052077|616595569|FG001|Phase A+|Withdrawal by Subject|0|||
170614695|NCT01052077|616595570|FG002|Phase A+|Withdrawal by Subject|0|||
170614696|NCT01052077|616595571|FG003|Phase A+|Withdrawal by Subject|7|||
170614697|NCT00950248|616595582|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
170614698|NCT00950248|616595583|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
170614699|NCT00950248|616595584|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
170614700|NCT00950248|616595582|FG000|Year 1: Baseline|worsening of symptoms|2|||
170614701|NCT00950248|616595583|FG001|Year 1: Baseline|worsening of symptoms|0|||
170614702|NCT00950248|616595584|FG002|Year 1: Baseline|worsening of symptoms|0|||
170614703|NCT00950248|616595582|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
170659429|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
170659430|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
170659431|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
170659432|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
170659433|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
170659434|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
170659435|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
170659436|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
170659437|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
170659438|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
170659439|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
170659440|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
170659441|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
170659442|NCT03739840|616766637|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
170659443|NCT03739840|616766638|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
170659444|NCT03739840|616766639|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
170659445|NCT03739840|616766640|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
170659446|NCT03739840|616766637|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
170659447|NCT03739840|616766638|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
170659448|NCT03739840|616766639|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
170659449|NCT03739840|616766640|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
170659450|NCT03739840|616766637|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
170659451|NCT03739840|616766638|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
170659452|NCT03739840|616766639|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
170659453|NCT03739840|616766640|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
170659454|NCT03739840|616766637|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
170659455|NCT03739840|616766638|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
170659456|NCT03739840|616766639|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
170659457|NCT03739840|616766640|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
170659458|NCT03739840|616766637|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
170659459|NCT03739840|616766638|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
170659460|NCT03739840|616766639|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
170659461|NCT03739840|616766640|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
170659462|NCT03739840|616766637|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
170659463|NCT03739840|616766638|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
170659464|NCT03739840|616766639|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
170659465|NCT03739840|616766640|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
170659466|NCT03739840|616766637|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
170659467|NCT03739840|616766638|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
170659468|NCT03739840|616766639|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
170659469|NCT03739840|616766640|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
170659470|NCT03739840|616766637|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
170659471|NCT03739840|616766638|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
170659472|NCT03739840|616766639|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
170659473|NCT03739840|616766640|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
170659474|NCT03739840|616766637|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
170659475|NCT03739840|616766638|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
170659476|NCT03739840|616766639|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
170659477|NCT03739840|616766640|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
170659478|NCT00116168|616766641|FG000|Overall Study|Lost to Follow-up|6|||
170659479|NCT00116168|616766642|FG001|Overall Study|Lost to Follow-up|5|||
170659480|NCT00116168|616766643|FG002|Overall Study|Lost to Follow-up|0|||
170659481|NCT00116168|616766644|FG003|Overall Study|Lost to Follow-up|0|||
170659482|NCT02694523|616766647|FG000|Part A|Adverse Event|7|||
170659483|NCT02694523|616766648|FG001|Part A|Adverse Event|3|||
170659484|NCT02694523|616766649|FG002|Part A|Adverse Event|0|||
170659485|NCT02694523|616766650|FG003|Part A|Adverse Event|0|||
170659486|NCT02694523|616766651|FG004|Part A|Adverse Event|0|||
170659487|NCT02694523|616766652|FG005|Part A|Adverse Event|0|||
170659488|NCT02694523|616766653|FG006|Part A|Adverse Event|0|||
170659489|NCT02694523|616766647|FG000|Part A|Protocol Violation|1|||
170659490|NCT02694523|616766648|FG001|Part A|Protocol Violation|0|||
170659491|NCT02694523|616766649|FG002|Part A|Protocol Violation|0|||
170659492|NCT02694523|616766650|FG003|Part A|Protocol Violation|0|||
170659493|NCT02694523|616766651|FG004|Part A|Protocol Violation|0|||
170659494|NCT02694523|616766652|FG005|Part A|Protocol Violation|0|||
170659495|NCT02694523|616766653|FG006|Part A|Protocol Violation|0|||
170817041|NCT00871715|617337365|FG000|Overall Study|Physician Decision|6|||
170614704|NCT00950248|616595583|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
170614705|NCT00950248|616595584|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
170614706|NCT00950248|616595582|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
170614707|NCT00950248|616595583|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
170614708|NCT00950248|616595584|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
170614709|NCT00950248|616595582|FG000|Year 2&3 Treatment Randomization|Death|0|||
170614710|NCT00950248|616595583|FG001|Year 2&3 Treatment Randomization|Death|0|||
170614711|NCT00950248|616595584|FG002|Year 2&3 Treatment Randomization|Death|1|||
170614712|NCT00950248|616595582|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
170614713|NCT00950248|616595583|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
170614714|NCT00950248|616595584|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
170614715|NCT00003199|616595585|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
170614716|NCT00003199|616595585|FG000|Overall Study|Lack of insurance clearance|2|||
170614717|NCT00003199|616595585|FG000|Overall Study|Screen fail|15|||
170614718|NCT00650845|616595586|FG000|Overall Study|Withdrawal by Subject|5|||
170614719|NCT00650845|616595587|FG001|Overall Study|Withdrawal by Subject|0|||
170614720|NCT00650845|616595586|FG000|Overall Study|Protocol Violation|0|||
170614721|NCT00650845|616595587|FG001|Overall Study|Protocol Violation|13|||
170614722|NCT02487030|616595588|FG000|Overall Study|Lack of Efficacy|2|||
170614723|NCT02487030|616595589|FG001|Overall Study|Lack of Efficacy|4|||
170614724|NCT02487030|616595590|FG002|Overall Study|Lack of Efficacy|1|||
170614725|NCT02487030|616595591|FG003|Overall Study|Lack of Efficacy|0|||
170614726|NCT02487030|616595592|FG004|Overall Study|Lack of Efficacy|1|||
170614727|NCT02487030|616595593|FG005|Overall Study|Lack of Efficacy|0|||
170614728|NCT02487030|616595594|FG006|Overall Study|Lack of Efficacy|0|||
170614729|NCT02487030|616595588|FG000|Overall Study|Lost to Follow-up|0|||
170614730|NCT02487030|616595589|FG001|Overall Study|Lost to Follow-up|0|||
170614731|NCT02487030|616595590|FG002|Overall Study|Lost to Follow-up|1|||
170614732|NCT02487030|616595591|FG003|Overall Study|Lost to Follow-up|1|||
170614733|NCT02487030|616595592|FG004|Overall Study|Lost to Follow-up|0|||
170614734|NCT02487030|616595593|FG005|Overall Study|Lost to Follow-up|1|||
170614735|NCT02487030|616595594|FG006|Overall Study|Lost to Follow-up|0|||
170614736|NCT02487030|616595588|FG000|Overall Study|Adverse Event|0|||
170614737|NCT02487030|616595589|FG001|Overall Study|Adverse Event|0|||
170614738|NCT02487030|616595590|FG002|Overall Study|Adverse Event|0|||
170614739|NCT02487030|616595591|FG003|Overall Study|Adverse Event|1|||
170614740|NCT02487030|616595592|FG004|Overall Study|Adverse Event|0|||
170614741|NCT02487030|616595593|FG005|Overall Study|Adverse Event|0|||
170614742|NCT02487030|616595594|FG006|Overall Study|Adverse Event|0|||
170614743|NCT02487030|616595588|FG000|Overall Study|Death|0|||
170614744|NCT02487030|616595589|FG001|Overall Study|Death|0|||
170614745|NCT02487030|616595590|FG002|Overall Study|Death|0|||
170614746|NCT02487030|616595591|FG003|Overall Study|Death|0|||
170614747|NCT02487030|616595592|FG004|Overall Study|Death|1|||
170614748|NCT02487030|616595593|FG005|Overall Study|Death|0|||
170614749|NCT02487030|616595594|FG006|Overall Study|Death|0|||
170614750|NCT01929226|616597542|FG000|Overall Study|Lost to Follow-up|4|||
170614751|NCT01929226|616597543|FG001|Overall Study|Lost to Follow-up|0|||
170614752|NCT01929226|616597542|FG000|Overall Study|Withdrawal by Subject|1|||
170614753|NCT01929226|616597543|FG001|Overall Study|Withdrawal by Subject|1|||
170614754|NCT01467505|616597545|FG000|Overall Study|Adverse Event|1|||
170614755|NCT01467505|616597546|FG001|Overall Study|Adverse Event|0|||
170614756|NCT01467505|616597545|FG000|Overall Study|Withdrawal by Subject|4|||
170614757|NCT01467505|616597546|FG001|Overall Study|Withdrawal by Subject|0|||
170614758|NCT01467505|616597545|FG000|Overall Study|Study Terminated by Sponsor|28|||
170614759|NCT01467505|616597546|FG001|Overall Study|Study Terminated by Sponsor|3|||
170614760|NCT00824473|616597552|FG000|Overall Study|Adverse Event|4|||
170614761|NCT00824473|616597553|FG001|Overall Study|Adverse Event|5|||
170614762|NCT00824473|616597552|FG000|Overall Study|Lack of Efficacy|2|||
170614763|NCT00824473|616597553|FG001|Overall Study|Lack of Efficacy|2|||
170614764|NCT00824473|616597552|FG000|Overall Study|Protocol Violation|2|||
170614765|NCT00824473|616597553|FG001|Overall Study|Protocol Violation|0|||
170614766|NCT00824473|616597552|FG000|Overall Study|Non-Compliance|4|||
170614767|NCT00824473|616597553|FG001|Overall Study|Non-Compliance|2|||
170614768|NCT00824473|616597552|FG000|Overall Study|Withdrawal by Subject|2|||
170614769|NCT00824473|616597553|FG001|Overall Study|Withdrawal by Subject|3|||
170614770|NCT00824473|616597552|FG000|Overall Study|Other|1|||
170614771|NCT00824473|616597553|FG001|Overall Study|Other|1|||
170614772|NCT00354679|616597554|FG000|Overall Study|Patient Not Treated|1|||
170614773|NCT02045095|616597558|FG000|Overall Study|Other|0|||
170614774|NCT02045095|616597559|FG001|Overall Study|Other|0|||
170614775|NCT02045095|616597560|FG002|Overall Study|Other|1|||
170614776|NCT02045095|616597561|FG003|Overall Study|Other|0|||
170614777|NCT02045095|616597562|FG004|Overall Study|Other|0|||
170614778|NCT02045095|616597563|FG005|Overall Study|Other|2|||
170614779|NCT02045095|616597564|FG006|Overall Study|Other|0|||
170614780|NCT02045095|616597558|FG000|Overall Study|Progressive Disease|3|||
170614781|NCT02045095|616597559|FG001|Overall Study|Progressive Disease|3|||
170659496|NCT02694523|616766647|FG000|Part A|Lost to Follow-up|1|||
170659497|NCT02694523|616766648|FG001|Part A|Lost to Follow-up|2|||
170659498|NCT02694523|616766649|FG002|Part A|Lost to Follow-up|0|||
170659499|NCT02694523|616766650|FG003|Part A|Lost to Follow-up|0|||
170659500|NCT02694523|616766651|FG004|Part A|Lost to Follow-up|0|||
170659501|NCT02694523|616766652|FG005|Part A|Lost to Follow-up|0|||
170659502|NCT02694523|616766653|FG006|Part A|Lost to Follow-up|0|||
170659503|NCT02694523|616766647|FG000|Part A|Withdrawal by Subject|3|||
170659504|NCT02694523|616766648|FG001|Part A|Withdrawal by Subject|1|||
170659505|NCT02694523|616766649|FG002|Part A|Withdrawal by Subject|0|||
170659506|NCT02694523|616766650|FG003|Part A|Withdrawal by Subject|0|||
170659507|NCT02694523|616766651|FG004|Part A|Withdrawal by Subject|0|||
170659508|NCT02694523|616766652|FG005|Part A|Withdrawal by Subject|0|||
170659509|NCT02694523|616766653|FG006|Part A|Withdrawal by Subject|0|||
170659510|NCT02694523|616766647|FG000|Part A|Other|1|||
170659511|NCT02694523|616766648|FG001|Part A|Other|1|||
170659512|NCT02694523|616766649|FG002|Part A|Other|0|||
170659513|NCT02694523|616766650|FG003|Part A|Other|0|||
170659514|NCT02694523|616766651|FG004|Part A|Other|0|||
170659515|NCT02694523|616766652|FG005|Part A|Other|0|||
170659516|NCT02694523|616766653|FG006|Part A|Other|0|||
170659517|NCT02694523|616766647|FG000|Part B|Adverse Event|0|||
170659518|NCT02694523|616766648|FG001|Part B|Adverse Event|0|||
170659519|NCT02694523|616766649|FG002|Part B|Adverse Event|7|||
170659520|NCT02694523|616766650|FG003|Part B|Adverse Event|1|||
170659521|NCT02694523|616766651|FG004|Part B|Adverse Event|1|||
170659522|NCT02694523|616766652|FG005|Part B|Adverse Event|2|||
170659523|NCT02694523|616766653|FG006|Part B|Adverse Event|0|||
170659524|NCT02694523|616766647|FG000|Part B|Protocol Violation|0|||
170659525|NCT02694523|616766648|FG001|Part B|Protocol Violation|0|||
170659526|NCT02694523|616766649|FG002|Part B|Protocol Violation|1|||
170659527|NCT02694523|616766650|FG003|Part B|Protocol Violation|0|||
170659528|NCT02694523|616766651|FG004|Part B|Protocol Violation|0|||
170659529|NCT02694523|616766652|FG005|Part B|Protocol Violation|0|||
170659530|NCT02694523|616766653|FG006|Part B|Protocol Violation|0|||
170659531|NCT02694523|616766647|FG000|Part B|Lost to Follow-up|0|||
170659532|NCT02694523|616766648|FG001|Part B|Lost to Follow-up|0|||
170659533|NCT02694523|616766649|FG002|Part B|Lost to Follow-up|2|||
170659534|NCT02694523|616766650|FG003|Part B|Lost to Follow-up|3|||
170659535|NCT02694523|616766651|FG004|Part B|Lost to Follow-up|2|||
170659536|NCT02694523|616766652|FG005|Part B|Lost to Follow-up|0|||
170659537|NCT02694523|616766653|FG006|Part B|Lost to Follow-up|1|||
170659538|NCT02694523|616766647|FG000|Part B|Withdrawal by Subject|0|||
170659539|NCT02694523|616766648|FG001|Part B|Withdrawal by Subject|0|||
170659540|NCT02694523|616766649|FG002|Part B|Withdrawal by Subject|9|||
170659541|NCT02694523|616766650|FG003|Part B|Withdrawal by Subject|0|||
170659542|NCT02694523|616766651|FG004|Part B|Withdrawal by Subject|1|||
170659543|NCT02694523|616766652|FG005|Part B|Withdrawal by Subject|3|||
170659544|NCT02694523|616766653|FG006|Part B|Withdrawal by Subject|0|||
170659545|NCT02694523|616766647|FG000|Part B|Other|0|||
170659546|NCT02694523|616766648|FG001|Part B|Other|0|||
170659547|NCT02694523|616766649|FG002|Part B|Other|1|||
170659548|NCT02694523|616766650|FG003|Part B|Other|0|||
170659549|NCT02694523|616766651|FG004|Part B|Other|0|||
170659550|NCT02694523|616766652|FG005|Part B|Other|0|||
170659551|NCT02694523|616766653|FG006|Part B|Other|1|||
170817042|NCT00871715|617337366|FG001|Overall Study|Physician Decision|0|||
170817043|NCT00871715|617337367|FG002|Overall Study|Physician Decision|2|||
170817044|NCT00871715|617337365|FG000|Overall Study|Lost to Follow-up|3|||
170817045|NCT00871715|617337366|FG001|Overall Study|Lost to Follow-up|6|||
170817046|NCT00871715|617337367|FG002|Overall Study|Lost to Follow-up|9|||
170817047|NCT03075878|617337370|FG000|Overall Study|Physician Decision|1|||
170817048|NCT02188459|617337371|FG000|Overall Study|Lost to Follow-up|3|||
170659552|NCT01058265|616766655|FG000|Overall Study|Lost to Follow-up|11|||
170659553|NCT01058265|616766656|FG001|Overall Study|Lost to Follow-up|12|||
170659554|NCT01243671|616766657|FG000|Overall Study|Adverse Event|3|||
170659555|NCT01243671|616766657|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
170659556|NCT01243671|616766657|FG000|Overall Study|Other|1|||
170659557|NCT02962765|616766658|FG000|Overall Study|Protocol Violation|9|||
170659558|NCT02962765|616766658|FG000|Overall Study|Withdrawal by Subject|3|||
170659559|NCT02962765|616766658|FG000|Overall Study|Lost to Follow-up|1|||
170659560|NCT02962765|616766658|FG000|Overall Study|Death|1|||
170659561|NCT02962765|616766658|FG000|Overall Study|Limited access to study medication|3|||
170659562|NCT00750880|616766661|FG000|Overall Study|Adverse Event|76|||
170659563|NCT00750880|616766661|FG000|Overall Study|Death|4|||
170659564|NCT00750880|616766661|FG000|Overall Study|Lack of Efficacy|46|||
170659565|NCT00750880|616766661|FG000|Overall Study|Lost to Follow-up|10|||
170659566|NCT00750880|616766661|FG000|Overall Study|Protocol Violation|15|||
170659567|NCT00750880|616766661|FG000|Overall Study|Withdrawal by Subject|33|||
170659568|NCT00750880|616766661|FG000|Overall Study|Physician Decision|20|||
170659569|NCT00750880|616766661|FG000|Overall Study|Administrative|11|||
170659570|NCT02169284|616766662|FG000|Overall Study|Physician Decision|0|||
170659571|NCT02169284|616766663|FG001|Overall Study|Physician Decision|1|||
170659572|NCT03953183|616766668|FG000|Overall Study|Physician Decision|0|||
170817049|NCT02188459|617337372|FG001|Overall Study|Lost to Follow-up|4|||
170659573|NCT03953183|616766669|FG001|Overall Study|Physician Decision|1|||
170659574|NCT03953183|616766668|FG000|Overall Study|Withdrawal by Subject|0|||
170659575|NCT03953183|616766669|FG001|Overall Study|Withdrawal by Subject|1|||
170659576|NCT03063203|616766681|FG000|Overall Study|Chose alternative therapy|3|||
170659577|NCT03063203|616766681|FG000|Overall Study|Death|2|||
170659578|NCT03063203|616766681|FG000|Overall Study|Disease progression|4|||
170659579|NCT03063203|616766681|FG000|Overall Study|Physician Decision|5|||
170659580|NCT00245583|616766682|FG000|Overall Study|Lost to Follow-up|1|||
170659581|NCT00245583|616766683|FG001|Overall Study|Lost to Follow-up|5|||
170659582|NCT00245583|616766682|FG000|Overall Study|Adverse Event|2|||
170659583|NCT00245583|616766683|FG001|Overall Study|Adverse Event|1|||
170659584|NCT00245583|616766682|FG000|Overall Study|Lack of Efficacy|1|||
170659585|NCT00245583|616766683|FG001|Overall Study|Lack of Efficacy|0|||
170659586|NCT00245583|616766682|FG000|Overall Study|Withdrawal by Subject|2|||
170659587|NCT00245583|616766683|FG001|Overall Study|Withdrawal by Subject|3|||
170659588|NCT00937391|616766686|FG000|Stage 2|Withdrawal by Subject|1|||
170659589|NCT03194490|616766690|FG000|Overall Study|Lost to Follow-up|1|||
170659590|NCT03194490|616766691|FG001|Overall Study|Lost to Follow-up|3|||
170659591|NCT03194490|616766690|FG000|Overall Study|participant developed specific neck pain|1|||
170659592|NCT03194490|616766691|FG001|Overall Study|participant developed specific neck pain|0|||
170659593|NCT00880165|616766692|FG000|Overall Study|Withdrawal by Subject|27|||
170659594|NCT00880165|616766693|FG001|Overall Study|Withdrawal by Subject|23|||
170659595|NCT00880165|616766692|FG000|Overall Study|Not diagnosed with OSA|14|||
170659596|NCT00880165|616766693|FG001|Overall Study|Not diagnosed with OSA|8|||
170659597|NCT00880165|616766692|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
170659598|NCT00880165|616766693|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
170659599|NCT00880165|616766692|FG000|Overall Study|Lost to follow|9|||
170659600|NCT00880165|616766693|FG001|Overall Study|Lost to follow|15|||
170659601|NCT03119701|616766694|FG000|6-day Dosing|Death|4|||
170659602|NCT03119701|616766695|FG001|6-day Dosing|Death|1|||
170659603|NCT03119701|616766694|FG000|6-day Dosing|Adverse Event|3|||
170659604|NCT03119701|616766695|FG001|6-day Dosing|Adverse Event|0|||
170659605|NCT03119701|616766694|FG000|6-day Dosing|Physician Decision|0|||
170659606|NCT03119701|616766695|FG001|6-day Dosing|Physician Decision|1|||
170659607|NCT03119701|616766694|FG000|6-day Dosing|Withdrawal by Subject|0|||
170659608|NCT03119701|616766695|FG001|6-day Dosing|Withdrawal by Subject|1|||
170659609|NCT03119701|616766694|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
170659610|NCT03119701|616766695|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
170659611|NCT00395538|616766698|FG000|Overall Study|Did not re-consent to revised protocol|1|||
170659612|NCT00395538|616766699|FG001|Overall Study|Did not re-consent to revised protocol|10|||
170659613|NCT00395538|616766700|FG002|Overall Study|Did not re-consent to revised protocol|0|||
170659614|NCT00395538|616766698|FG000|Overall Study|FDA partial hold on PTH|0|||
170659615|NCT00395538|616766699|FG001|Overall Study|FDA partial hold on PTH|0|||
170659616|NCT00395538|616766700|FG002|Overall Study|FDA partial hold on PTH|11|||
170659617|NCT00395538|616766698|FG000|Overall Study|Failed screening|0|||
170659618|NCT00395538|616766699|FG001|Overall Study|Failed screening|0|||
170659619|NCT00395538|616766700|FG002|Overall Study|Failed screening|4|||
170659620|NCT00395538|616766698|FG000|Overall Study|Switch to Natpara|0|||
170659621|NCT00395538|616766699|FG001|Overall Study|Switch to Natpara|0|||
170659622|NCT00395538|616766700|FG002|Overall Study|Switch to Natpara|3|||
170659623|NCT00395538|616766698|FG000|Overall Study|Adverse Event|1|||
170659624|NCT00395538|616766699|FG001|Overall Study|Adverse Event|0|||
170659625|NCT00395538|616766700|FG002|Overall Study|Adverse Event|2|||
170659626|NCT00395538|616766698|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
170659627|NCT00395538|616766699|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
170659628|NCT00395538|616766700|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
170659629|NCT00395538|616766698|FG000|Overall Study|Non-compliance with study protocol|0|||
170659630|NCT00395538|616766699|FG001|Overall Study|Non-compliance with study protocol|1|||
170659631|NCT00395538|616766700|FG002|Overall Study|Non-compliance with study protocol|0|||
170659632|NCT00395538|616766698|FG000|Overall Study|PTH resistance|0|||
170659633|NCT00395538|616766699|FG001|Overall Study|PTH resistance|0|||
170659634|NCT00395538|616766700|FG002|Overall Study|PTH resistance|1|||
170659635|NCT00395538|616766698|FG000|Overall Study|Pregnancy|1|||
170659636|NCT00395538|616766699|FG001|Overall Study|Pregnancy|0|||
170659637|NCT00395538|616766700|FG002|Overall Study|Pregnancy|0|||
170659638|NCT00395538|616766698|FG000|Overall Study|Partial recovery of parathyroid function|0|||
170659639|NCT00395538|616766699|FG001|Overall Study|Partial recovery of parathyroid function|0|||
170659640|NCT00395538|616766700|FG002|Overall Study|Partial recovery of parathyroid function|1|||
170659641|NCT00395538|616766698|FG000|Overall Study|Participant elected to discontinue|0|||
170659642|NCT00395538|616766699|FG001|Overall Study|Participant elected to discontinue|0|||
170659643|NCT00395538|616766700|FG002|Overall Study|Participant elected to discontinue|1|||
170659644|NCT01074047|616766707|FG000|Treatment Phase|Adverse Event|89|||
170659645|NCT01074047|616766708|FG001|Treatment Phase|Adverse Event|66|||
170659646|NCT01074047|616766707|FG000|Treatment Phase|Disease Progression|16|||
170659647|NCT01074047|616766708|FG001|Treatment Phase|Disease Progression|21|||
170659648|NCT01074047|616766707|FG000|Treatment Phase|Withdrawal by Subject|27|||
170659649|NCT01074047|616766708|FG001|Treatment Phase|Withdrawal by Subject|48|||
170659650|NCT01074047|616766707|FG000|Treatment Phase|Death|53|||
170659651|NCT01074047|616766708|FG001|Treatment Phase|Death|58|||
170659652|NCT01074047|616766707|FG000|Treatment Phase|Lost to Follow-up|0|||
170659653|NCT01074047|616766708|FG001|Treatment Phase|Lost to Follow-up|1|||
170659654|NCT01074047|616766707|FG000|Treatment Phase|Protocol Violation|0|||
170659655|NCT01074047|616766708|FG001|Treatment Phase|Protocol Violation|1|||
170659656|NCT01074047|616766707|FG000|Treatment Phase|Miscellaneous|32|||
170659657|NCT01074047|616766708|FG001|Treatment Phase|Miscellaneous|39|||
170659658|NCT01074047|616766707|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
170659659|NCT01074047|616766708|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
170659660|NCT01074047|616766707|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
170659661|NCT01074047|616766708|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
170659662|NCT01074047|616766707|FG000|Survival Follow-Up Phase|Death|116|||
170659663|NCT01074047|616766708|FG001|Survival Follow-Up Phase|Death|124|||
170659664|NCT01074047|616766707|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
170659665|NCT01074047|616766708|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
170659666|NCT01074047|616766707|FG000|Extension Phase|Physician Decision|1|||
170659667|NCT01074047|616766708|FG001|Extension Phase|Physician Decision|0|||
170659668|NCT01074047|616766707|FG000|Extension Phase|Adverse Event|5|||
170659669|NCT01074047|616766708|FG001|Extension Phase|Adverse Event|0|||
170659670|NCT01074047|616766707|FG000|Extension Phase|Disease Progression|9|||
170659671|NCT01074047|616766708|FG001|Extension Phase|Disease Progression|0|||
170659672|NCT01074047|616766707|FG000|Extension Phase|Withdrawal by Subject|2|||
170659673|NCT01074047|616766708|FG001|Extension Phase|Withdrawal by Subject|0|||
170659674|NCT01074047|616766707|FG000|Extension Phase|Death|5|||
170659675|NCT01074047|616766708|FG001|Extension Phase|Death|0|||
170817050|NCT02188459|617337371|FG000|Overall Study|Early Termination|0|||
170817051|NCT02188459|617337372|FG001|Overall Study|Early Termination|3|||
170817052|NCT01986348|617337373|FG000|Overall Study|Death|8|||
170817053|NCT01986348|617337374|FG001|Overall Study|Death|22|||
170817054|NCT01986348|617337375|FG002|Overall Study|Death|10|||
170817055|NCT01986348|617337376|FG003|Overall Study|Death|21|||
170817056|NCT01986348|617337373|FG000|Overall Study|Lost to Follow-up|0|||
170817057|NCT01986348|617337374|FG001|Overall Study|Lost to Follow-up|0|||
170817058|NCT01986348|617337375|FG002|Overall Study|Lost to Follow-up|0|||
170817059|NCT01986348|617337376|FG003|Overall Study|Lost to Follow-up|2|||
170817060|NCT01986348|617337373|FG000|Overall Study|Physician Decision|0|||
170817061|NCT01986348|617337374|FG001|Overall Study|Physician Decision|0|||
170817062|NCT01986348|617337375|FG002|Overall Study|Physician Decision|0|||
170817063|NCT01986348|617337376|FG003|Overall Study|Physician Decision|1|||
170817064|NCT01986348|617337373|FG000|Overall Study|Progressive Disease|0|||
170817065|NCT01986348|617337374|FG001|Overall Study|Progressive Disease|0|||
170817066|NCT01986348|617337375|FG002|Overall Study|Progressive Disease|2|||
170817067|NCT01986348|617337376|FG003|Overall Study|Progressive Disease|0|||
170817068|NCT01986348|617337373|FG000|Overall Study|Withdrawal by Participant|0|||
170817069|NCT01986348|617337374|FG001|Overall Study|Withdrawal by Participant|1|||
170614782|NCT02045095|616597560|FG002|Overall Study|Progressive Disease|2|||
170614783|NCT02045095|616597561|FG003|Overall Study|Progressive Disease|4|||
170614784|NCT02045095|616597562|FG004|Overall Study|Progressive Disease|2|||
170614785|NCT02045095|616597563|FG005|Overall Study|Progressive Disease|4|||
170614786|NCT02045095|616597564|FG006|Overall Study|Progressive Disease|1|||
170614787|NCT02045095|616597558|FG000|Overall Study|Withdrawal by Subject|0|||
170614788|NCT02045095|616597559|FG001|Overall Study|Withdrawal by Subject|0|||
170614789|NCT02045095|616597560|FG002|Overall Study|Withdrawal by Subject|0|||
170614790|NCT02045095|616597561|FG003|Overall Study|Withdrawal by Subject|0|||
170614791|NCT02045095|616597562|FG004|Overall Study|Withdrawal by Subject|3|||
170614792|NCT02045095|616597563|FG005|Overall Study|Withdrawal by Subject|0|||
170614793|NCT02045095|616597564|FG006|Overall Study|Withdrawal by Subject|0|||
170614794|NCT02045095|616597558|FG000|Overall Study|Adverse Event|0|||
170614795|NCT02045095|616597559|FG001|Overall Study|Adverse Event|1|||
170614796|NCT02045095|616597560|FG002|Overall Study|Adverse Event|1|||
170614797|NCT02045095|616597561|FG003|Overall Study|Adverse Event|0|||
170817070|NCT01986348|617337375|FG002|Overall Study|Withdrawal by Participant|2|||
170817071|NCT01986348|617337376|FG003|Overall Study|Withdrawal by Participant|1|||
170614798|NCT02045095|616597562|FG004|Overall Study|Adverse Event|0|||
170614799|NCT02045095|616597563|FG005|Overall Study|Adverse Event|2|||
170817072|NCT01986348|617337373|FG000|Overall Study|Study Terminated by Sponsor|0|||
170817073|NCT01986348|617337374|FG001|Overall Study|Study Terminated by Sponsor|0|||
170817074|NCT01986348|617337375|FG002|Overall Study|Study Terminated by Sponsor|0|||
170817075|NCT01986348|617337376|FG003|Overall Study|Study Terminated by Sponsor|3|||
170817076|NCT01986348|617337373|FG000|Overall Study|Other-unspecified|0|||
170817077|NCT01986348|617337374|FG001|Overall Study|Other-unspecified|1|||
170817078|NCT01986348|617337375|FG002|Overall Study|Other-unspecified|0|||
170614800|NCT02045095|616597564|FG006|Overall Study|Adverse Event|0|||
170817079|NCT01986348|617337376|FG003|Overall Study|Other-unspecified|2|||
170817080|NCT02612285|617337377|FG000|Overall Study|Withdrawal by Subject|1|||
170817081|NCT01517282|617337378|FG000|Overall Study|Consent withdrawn|0|||
170817082|NCT01517282|617337379|FG001|Overall Study|Consent withdrawn|1|||
170614801|NCT01550757|616597565|FG000|Overall Study|Lost to Follow-up|21|||
170614802|NCT01550757|616597566|FG001|Overall Study|Lost to Follow-up|14|||
170614803|NCT01550757|616597567|FG002|Overall Study|Lost to Follow-up|42|||
170614804|NCT01550757|616597568|FG003|Overall Study|Lost to Follow-up|53|||
170614805|NCT01550757|616597565|FG000|Overall Study|Withdrawal by Subject|2|||
170614806|NCT01550757|616597566|FG001|Overall Study|Withdrawal by Subject|0|||
170614807|NCT01550757|616597567|FG002|Overall Study|Withdrawal by Subject|3|||
170614808|NCT01550757|616597568|FG003|Overall Study|Withdrawal by Subject|1|||
170614809|NCT03191630|616597569|FG000|Overall Study|Lost to Follow-up|7|||
170614810|NCT03191630|616597570|FG001|Overall Study|Lost to Follow-up|7|||
170614811|NCT02342223|616597571|FG000|Overall Study|Lost to Follow-up|1|||
170614812|NCT00837213|616597592|FG000|Overall Study|Lost to Follow-up|3|||
170614813|NCT00837213|616597593|FG001|Overall Study|Lost to Follow-up|2|||
170614814|NCT00837213|616597592|FG000|Overall Study|Withdrawal by Subject|2|||
170614815|NCT00837213|616597593|FG001|Overall Study|Withdrawal by Subject|2|||
170614816|NCT00837213|616597592|FG000|Overall Study|not stated|1|||
170614817|NCT00837213|616597593|FG001|Overall Study|not stated|1|||
170614818|NCT02698826|616597597|FG000|Overall Study|Death|13|||
170614819|NCT02698826|616597597|FG000|Overall Study|Adverse Event|1|||
170614820|NCT02915263|616597598|FG000|Overall Study|Covid|3|||
170614821|NCT02915263|616597599|FG001|Overall Study|Covid|2|||
170614822|NCT03600740|616597606|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
170614823|NCT03259087|616597609|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
170614824|NCT03259087|616597610|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
170614825|NCT03259087|616597611|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
170614826|NCT03259087|616597612|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
170614827|NCT03259087|616597613|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
170614828|NCT03259087|616597609|FG000|Period 2 of Part 2|Adverse Event|0|||
170614829|NCT03259087|616597610|FG001|Period 2 of Part 2|Adverse Event|0|||
170817083|NCT01517282|617337380|FG002|Overall Study|Consent withdrawn|1|||
170817084|NCT01517282|617337381|FG003|Overall Study|Consent withdrawn|1|||
170817085|NCT01517282|617337378|FG000|Overall Study|Physician Decision|1|||
170817086|NCT01517282|617337379|FG001|Overall Study|Physician Decision|0|||
170817087|NCT01517282|617337380|FG002|Overall Study|Physician Decision|0|||
170817088|NCT01517282|617337381|FG003|Overall Study|Physician Decision|0|||
170817089|NCT01884571|617337382|FG000|Overall Study|Adverse Event|1|||
170817090|NCT01884571|617337382|FG000|Overall Study|Death|2|||
170817091|NCT01884571|617337382|FG000|Overall Study|Withdrawal by Subject|2|||
170817092|NCT01884571|617337382|FG000|Overall Study|Disease progression|3|||
170817093|NCT00853957|617337383|FG000|Overall Study|Adverse Event|9|||
170817094|NCT00853957|617337384|FG001|Overall Study|Adverse Event|3|||
170817095|NCT00853957|617337383|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170817096|NCT00853957|617337384|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170817097|NCT00853957|617337383|FG000|Overall Study|Subject withdrew consent|4|||
170817098|NCT00853957|617337384|FG001|Overall Study|Subject withdrew consent|5|||
170817099|NCT00853957|617337383|FG000|Overall Study|Lost to Follow-up|1|||
170817100|NCT00853957|617337384|FG001|Overall Study|Lost to Follow-up|6|||
170817101|NCT00853957|617337383|FG000|Overall Study|Protocol deviation|0|||
170817102|NCT00853957|617337384|FG001|Overall Study|Protocol deviation|3|||
170817103|NCT02942771|617337389|FG000|Overall Study|Adverse Event|1|||
170817104|NCT02942771|617337390|FG001|Overall Study|Adverse Event|0|||
170817105|NCT02942771|617337391|FG002|Overall Study|Adverse Event|0|||
170817106|NCT02942771|617337392|FG003|Overall Study|Adverse Event|0|||
170817107|NCT02942771|617337393|FG004|Overall Study|Adverse Event|2|||
170817108|NCT02942771|617337389|FG000|Overall Study|Lost to Follow-up|1|||
170817109|NCT02942771|617337390|FG001|Overall Study|Lost to Follow-up|0|||
170817110|NCT02942771|617337391|FG002|Overall Study|Lost to Follow-up|0|||
170817111|NCT02942771|617337392|FG003|Overall Study|Lost to Follow-up|0|||
170817112|NCT02942771|617337393|FG004|Overall Study|Lost to Follow-up|0|||
170817113|NCT02942771|617337389|FG000|Overall Study|Withdrawal by Subject|1|||
170817114|NCT02942771|617337390|FG001|Overall Study|Withdrawal by Subject|0|||
170817115|NCT02942771|617337391|FG002|Overall Study|Withdrawal by Subject|0|||
170817116|NCT02942771|617337392|FG003|Overall Study|Withdrawal by Subject|0|||
170817117|NCT02942771|617337393|FG004|Overall Study|Withdrawal by Subject|2|||
170817118|NCT01186809|617337394|FG000|Overall Study|Death|30|||
170817119|NCT04895085|617337395|FG000|Overall Study|Death|1|||
170614830|NCT03259087|616597611|FG002|Period 2 of Part 2|Adverse Event|0|||
170614831|NCT03259087|616597612|FG003|Period 2 of Part 2|Adverse Event|0|||
170659676|NCT01659658|616768354|FG000|Overall Study|Withdrawal by Patient|18|||
170817120|NCT04895085|617337395|FG000|Overall Study|Withdrawal by Subject|1|||
170817121|NCT04895085|617337395|FG000|Overall Study|No longer eligible: Moved from area|1|||
170817122|NCT03605745|617338390|FG000|Overall Study|Study was terminated for business reasons|47|||
170817123|NCT05203822|617338391|FG000|Overall Study|Adverse Event|1|||
170817124|NCT05203822|617338391|FG000|Overall Study|Withdrawal by Subject|1|||
170817125|NCT02823574|617338396|FG000|Randomization|Disease Progression|0|||
170817126|NCT02823574|617338397|FG001|Randomization|Disease Progression|0|||
170817127|NCT02823574|617338398|FG002|Randomization|Disease Progression|1|||
170817128|NCT02823574|617338399|FG003|Randomization|Disease Progression|0|||
170817129|NCT02823574|617338396|FG000|Randomization|AE unrelated to Study Drug|1|||
170614832|NCT03259087|616597613|FG004|Period 2 of Part 2|Adverse Event|1|||
170614833|NCT00556998|616597616|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
170614834|NCT00556998|616597616|FG000|Voriconazole Intravenous (IV)|Other|4|||
170614835|NCT00556998|616597616|FG000|Voriconazole Oral|Adverse Event|1|||
170614836|NCT00556998|616597616|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
170614837|NCT02888106|616597617|FG000|Overall Study|Withdrawal by Subject|1|||
170614838|NCT02888106|616597618|FG001|Overall Study|Withdrawal by Subject|2|||
170614839|NCT02888106|616597619|FG002|Overall Study|Withdrawal by Subject|0|||
170614840|NCT02888106|616597620|FG003|Overall Study|Withdrawal by Subject|1|||
170614841|NCT02888106|616597621|FG004|Overall Study|Withdrawal by Subject|0|||
170614842|NCT02888106|616597622|FG005|Overall Study|Withdrawal by Subject|0|||
170614843|NCT02888106|616597617|FG000|Overall Study|Lost to Follow-up|1|||
170614844|NCT02888106|616597618|FG001|Overall Study|Lost to Follow-up|0|||
170614845|NCT02888106|616597619|FG002|Overall Study|Lost to Follow-up|0|||
170614846|NCT02888106|616597620|FG003|Overall Study|Lost to Follow-up|1|||
170614847|NCT02888106|616597621|FG004|Overall Study|Lost to Follow-up|0|||
170614848|NCT02888106|616597622|FG005|Overall Study|Lost to Follow-up|1|||
170614849|NCT02888106|616597617|FG000|Overall Study|Adverse Event|2|||
170614850|NCT02888106|616597618|FG001|Overall Study|Adverse Event|0|||
170614851|NCT02888106|616597619|FG002|Overall Study|Adverse Event|0|||
170614852|NCT02888106|616597620|FG003|Overall Study|Adverse Event|0|||
170614853|NCT02888106|616597621|FG004|Overall Study|Adverse Event|0|||
170614854|NCT02888106|616597622|FG005|Overall Study|Adverse Event|0|||
170614855|NCT02888106|616597617|FG000|Overall Study|Withdrawal of consent|0|||
170614856|NCT02888106|616597618|FG001|Overall Study|Withdrawal of consent|0|||
170614857|NCT02888106|616597619|FG002|Overall Study|Withdrawal of consent|0|||
170614858|NCT02888106|616597620|FG003|Overall Study|Withdrawal of consent|0|||
170614859|NCT02888106|616597621|FG004|Overall Study|Withdrawal of consent|1|||
170614860|NCT02888106|616597622|FG005|Overall Study|Withdrawal of consent|0|||
170614861|NCT02888106|616597617|FG000|Overall Study|Pregnancy|1|||
170614862|NCT02888106|616597618|FG001|Overall Study|Pregnancy|0|||
170614863|NCT02888106|616597619|FG002|Overall Study|Pregnancy|0|||
170614864|NCT02888106|616597620|FG003|Overall Study|Pregnancy|0|||
170614865|NCT02888106|616597621|FG004|Overall Study|Pregnancy|0|||
170614866|NCT02888106|616597622|FG005|Overall Study|Pregnancy|0|||
170614867|NCT02714569|616597623|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
170614868|NCT02714569|616597624|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
170614869|NCT02714569|616597625|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
170614870|NCT02714569|616597626|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
170614871|NCT02714569|616597627|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
170614872|NCT02714569|616597628|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
170614873|NCT02714569|616597629|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
170614874|NCT02714569|616597630|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
170614875|NCT02714569|616597631|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
170614876|NCT02714569|616597632|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
170614877|NCT02714569|616597633|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
170614878|NCT02714569|616597623|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614879|NCT02714569|616597624|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614880|NCT02714569|616597625|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614881|NCT02714569|616597626|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
170614882|NCT02714569|616597627|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614883|NCT02714569|616597628|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614884|NCT02714569|616597629|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614885|NCT02714569|616597630|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614886|NCT02714569|616597631|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614887|NCT02714569|616597632|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614888|NCT02714569|616597633|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
170614889|NCT02714569|616597623|FG000|Part A Third Intervention|Adverse Event|0|||
170614890|NCT02714569|616597624|FG001|Part A Third Intervention|Adverse Event|0|||
170614891|NCT02714569|616597625|FG002|Part A Third Intervention|Adverse Event|1|||
170614892|NCT02714569|616597626|FG003|Part A Third Intervention|Adverse Event|0|||
170614893|NCT02714569|616597627|FG004|Part A Third Intervention|Adverse Event|0|||
170614894|NCT02714569|616597628|FG005|Part A Third Intervention|Adverse Event|0|||
170614895|NCT02714569|616597629|FG006|Part A Third Intervention|Adverse Event|0|||
170614896|NCT02714569|616597630|FG007|Part A Third Intervention|Adverse Event|0|||
170614897|NCT02714569|616597631|FG008|Part A Third Intervention|Adverse Event|0|||
170614898|NCT02714569|616597632|FG009|Part A Third Intervention|Adverse Event|0|||
170614899|NCT02714569|616597633|FG010|Part A Third Intervention|Adverse Event|0|||
170614900|NCT02714569|616597623|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
170614901|NCT02714569|616597624|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170614902|NCT02714569|616597625|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170659677|NCT01659658|616768355|FG001|Overall Study|Withdrawal by Patient|4|||
170659678|NCT01659658|616768356|FG002|Overall Study|Withdrawal by Patient|2|||
170659679|NCT01659658|616768357|FG003|Overall Study|Withdrawal by Patient|0|||
170659680|NCT01659658|616768358|FG004|Overall Study|Withdrawal by Patient|11|||
170659681|NCT01659658|616768354|FG000|Overall Study|Study Terminated by Sponsor|9|||
170659682|NCT01659658|616768355|FG001|Overall Study|Study Terminated by Sponsor|7|||
170659683|NCT01659658|616768356|FG002|Overall Study|Study Terminated by Sponsor|0|||
170659684|NCT01659658|616768357|FG003|Overall Study|Study Terminated by Sponsor|1|||
170659685|NCT01659658|616768358|FG004|Overall Study|Study Terminated by Sponsor|4|||
170659686|NCT01659658|616768354|FG000|Overall Study|Reason not Specified|61|||
170659687|NCT01659658|616768355|FG001|Overall Study|Reason not Specified|15|||
170659688|NCT01659658|616768356|FG002|Overall Study|Reason not Specified|8|||
170659689|NCT01659658|616768357|FG003|Overall Study|Reason not Specified|1|||
170659690|NCT01659658|616768358|FG004|Overall Study|Reason not Specified|34|||
170659691|NCT01659658|616768354|FG000|Overall Study|Lost to Follow-up|2|||
170659692|NCT01659658|616768355|FG001|Overall Study|Lost to Follow-up|0|||
170659693|NCT01659658|616768356|FG002|Overall Study|Lost to Follow-up|0|||
170659694|NCT01659658|616768357|FG003|Overall Study|Lost to Follow-up|0|||
170659695|NCT01659658|616768358|FG004|Overall Study|Lost to Follow-up|0|||
170659696|NCT01927341|616768361|FG000|Phase 1b|Lost to Follow-up|1|||
170659697|NCT01927341|616768362|FG001|Phase 1b|Lost to Follow-up|0|||
170659698|NCT01927341|616768363|FG002|Phase 1b|Lost to Follow-up|0|||
170659699|NCT01927341|616768364|FG003|Phase 1b|Lost to Follow-up|0|||
170659700|NCT01927341|616768365|FG004|Phase 1b|Lost to Follow-up|0|||
170659701|NCT01927341|616768361|FG000|Phase 1b|Death|2|||
170659702|NCT01927341|616768362|FG001|Phase 1b|Death|0|||
170659703|NCT01927341|616768363|FG002|Phase 1b|Death|0|||
170659704|NCT01927341|616768364|FG003|Phase 1b|Death|0|||
170659705|NCT01927341|616768365|FG004|Phase 1b|Death|0|||
170659706|NCT01927341|616768361|FG000|Phase 1b|Follow-up completed|7|||
170659707|NCT01927341|616768362|FG001|Phase 1b|Follow-up completed|0|||
170659708|NCT01927341|616768363|FG002|Phase 1b|Follow-up completed|0|||
170659709|NCT01927341|616768364|FG003|Phase 1b|Follow-up completed|0|||
170659710|NCT01927341|616768365|FG004|Phase 1b|Follow-up completed|0|||
170659711|NCT01927341|616768361|FG000|Phase 2|Lost to Follow-up|0|||
170659712|NCT01927341|616768362|FG001|Phase 2|Lost to Follow-up|1|||
170659713|NCT01927341|616768363|FG002|Phase 2|Lost to Follow-up|0|||
170659714|NCT01927341|616768364|FG003|Phase 2|Lost to Follow-up|0|||
170659715|NCT01927341|616768365|FG004|Phase 2|Lost to Follow-up|0|||
170659716|NCT01927341|616768361|FG000|Phase 2|Participant withdrew consent|0|||
170659717|NCT01927341|616768362|FG001|Phase 2|Participant withdrew consent|2|||
170659718|NCT01927341|616768363|FG002|Phase 2|Participant withdrew consent|1|||
170659719|NCT01927341|616768364|FG003|Phase 2|Participant withdrew consent|2|||
170659720|NCT01927341|616768365|FG004|Phase 2|Participant withdrew consent|3|||
170659721|NCT01927341|616768361|FG000|Phase 2|Death|0|||
170659722|NCT01927341|616768362|FG001|Phase 2|Death|4|||
170659723|NCT01927341|616768363|FG002|Phase 2|Death|0|||
170659724|NCT01927341|616768364|FG003|Phase 2|Death|3|||
170659725|NCT01927341|616768365|FG004|Phase 2|Death|2|||
170659726|NCT01927341|616768361|FG000|Phase 2|New cancer therapy|0|||
170659727|NCT01927341|616768362|FG001|Phase 2|New cancer therapy|1|||
170659728|NCT01927341|616768363|FG002|Phase 2|New cancer therapy|0|||
170659729|NCT01927341|616768364|FG003|Phase 2|New cancer therapy|4|||
170659730|NCT01927341|616768365|FG004|Phase 2|New cancer therapy|1|||
170659731|NCT01927341|616768361|FG000|Phase 2|Disease progression|0|||
170659732|NCT01927341|616768362|FG001|Phase 2|Disease progression|1|||
170659733|NCT01927341|616768363|FG002|Phase 2|Disease progression|1|||
170659734|NCT01927341|616768364|FG003|Phase 2|Disease progression|1|||
170659735|NCT01927341|616768365|FG004|Phase 2|Disease progression|0|||
170659736|NCT01927341|616768361|FG000|Phase 2|Follow-up completed|0|||
170659737|NCT01927341|616768362|FG001|Phase 2|Follow-up completed|6|||
170659738|NCT01927341|616768363|FG002|Phase 2|Follow-up completed|3|||
170659739|NCT01927341|616768364|FG003|Phase 2|Follow-up completed|5|||
170659740|NCT01927341|616768365|FG004|Phase 2|Follow-up completed|2|||
170659741|NCT01104701|616768366|FG000|Overall Study|Withdrawal by Subject|0|||
170659742|NCT01104701|616768367|FG001|Overall Study|Withdrawal by Subject|1|||
170659743|NCT01104701|616768368|FG002|Overall Study|Withdrawal by Subject|2|||
170659744|NCT01104701|616768369|FG003|Overall Study|Withdrawal by Subject|1|||
170659745|NCT01104701|616768366|FG000|Overall Study|Adverse Event|0|||
170659746|NCT01104701|616768367|FG001|Overall Study|Adverse Event|0|||
170659747|NCT01104701|616768368|FG002|Overall Study|Adverse Event|0|||
170659748|NCT01104701|616768369|FG003|Overall Study|Adverse Event|1|||
170659749|NCT01104701|616768366|FG000|Overall Study|Physician Decision|0|||
170659750|NCT01104701|616768367|FG001|Overall Study|Physician Decision|2|||
170659751|NCT01104701|616768368|FG002|Overall Study|Physician Decision|0|||
170659752|NCT01104701|616768369|FG003|Overall Study|Physician Decision|0|||
170659753|NCT00891462|616768370|FG000|Overall Study|Withdrawal by Subject|9|||
170659754|NCT00891462|616768371|FG001|Overall Study|Withdrawal by Subject|6|||
170659755|NCT00891462|616768372|FG002|Overall Study|Withdrawal by Subject|7|||
170659756|NCT00891462|616768370|FG000|Overall Study|Adverse Event|7|||
170659757|NCT00891462|616768371|FG001|Overall Study|Adverse Event|8|||
170659758|NCT00891462|616768372|FG002|Overall Study|Adverse Event|7|||
170659759|NCT00891462|616768370|FG000|Overall Study|Lack of Efficacy|10|||
170659760|NCT00891462|616768371|FG001|Overall Study|Lack of Efficacy|5|||
170659761|NCT00891462|616768372|FG002|Overall Study|Lack of Efficacy|1|||
170659762|NCT00891462|616768370|FG000|Overall Study|COPD exacerbation|7|||
170659763|NCT00891462|616768371|FG001|Overall Study|COPD exacerbation|4|||
170659764|NCT00891462|616768372|FG002|Overall Study|COPD exacerbation|1|||
170659765|NCT00891462|616768370|FG000|Overall Study|Other Reason|2|||
170659766|NCT00891462|616768371|FG001|Overall Study|Other Reason|5|||
170659767|NCT00891462|616768372|FG002|Overall Study|Other Reason|3|||
170659768|NCT00891462|616768370|FG000|Overall Study|Protocol Violation|2|||
170659769|NCT00891462|616768371|FG001|Overall Study|Protocol Violation|1|||
170659770|NCT00891462|616768372|FG002|Overall Study|Protocol Violation|3|||
170659771|NCT00891462|616768370|FG000|Overall Study|Inclusion/exclusion criteria|0|||
170659772|NCT00891462|616768371|FG001|Overall Study|Inclusion/exclusion criteria|2|||
170659773|NCT00891462|616768372|FG002|Overall Study|Inclusion/exclusion criteria|2|||
170659774|NCT00891462|616768370|FG000|Overall Study|Lost to Follow-up|0|||
170659775|NCT00891462|616768371|FG001|Overall Study|Lost to Follow-up|2|||
170659776|NCT00891462|616768372|FG002|Overall Study|Lost to Follow-up|0|||
170659777|NCT00423722|616768376|FG000|Overall Study|Death|4|||
170659778|NCT00423722|616768377|FG001|Overall Study|Death|4|||
170659779|NCT00423722|616768376|FG000|Overall Study|Declined to participate|2|||
170659780|NCT00423722|616768377|FG001|Overall Study|Declined to participate|3|||
170659781|NCT00423722|616768376|FG000|Overall Study|Unable to complete questionnaires|4|||
170659782|NCT00423722|616768377|FG001|Overall Study|Unable to complete questionnaires|4|||
170659783|NCT00423722|616768376|FG000|Overall Study|Withdrawal by Subject|4|||
170659784|NCT00423722|616768377|FG001|Overall Study|Withdrawal by Subject|2|||
170659785|NCT00215683|616768378|FG000|Overall Study|Adverse Event|15|||
170659786|NCT00215683|616768379|FG001|Overall Study|Adverse Event|16|||
170659787|NCT00215683|616768380|FG002|Overall Study|Adverse Event|15|||
170659788|NCT00215683|616768378|FG000|Overall Study|Lack of Efficacy|5|||
170659789|NCT00215683|616768379|FG001|Overall Study|Lack of Efficacy|1|||
170659790|NCT00215683|616768380|FG002|Overall Study|Lack of Efficacy|2|||
170659791|NCT00215683|616768378|FG000|Overall Study|Lost to Follow-up|0|||
170659792|NCT00215683|616768379|FG001|Overall Study|Lost to Follow-up|2|||
170659793|NCT00215683|616768380|FG002|Overall Study|Lost to Follow-up|1|||
170659794|NCT00215683|616768378|FG000|Overall Study|Withdrawal by Subject|9|||
170659795|NCT00215683|616768379|FG001|Overall Study|Withdrawal by Subject|4|||
170659796|NCT00215683|616768380|FG002|Overall Study|Withdrawal by Subject|13|||
170659797|NCT00215683|616768378|FG000|Overall Study|Physician Decision|0|||
170659798|NCT00215683|616768379|FG001|Overall Study|Physician Decision|0|||
170659799|NCT00215683|616768380|FG002|Overall Study|Physician Decision|1|||
170659800|NCT00215683|616768378|FG000|Overall Study|Difficult to attend visits|0|||
170659801|NCT00215683|616768379|FG001|Overall Study|Difficult to attend visits|1|||
170659802|NCT00215683|616768380|FG002|Overall Study|Difficult to attend visits|0|||
170659803|NCT00215683|616768378|FG000|Overall Study|No study drug available|0|||
170659804|NCT00215683|616768379|FG001|Overall Study|No study drug available|1|||
170659805|NCT00215683|616768380|FG002|Overall Study|No study drug available|0|||
170659806|NCT00215683|616768378|FG000|Overall Study|Intermittent therapy required|0|||
170659807|NCT00215683|616768379|FG001|Overall Study|Intermittent therapy required|1|||
170659808|NCT00215683|616768380|FG002|Overall Study|Intermittent therapy required|0|||
170659809|NCT01614600|616768386|FG000|Overall Study|Unacceptable fit|1|||
170659810|NCT01614600|616768386|FG000|Overall Study|Discomfort|1|||
170659811|NCT01614600|616768386|FG000|Overall Study|Unable to remove lens at the end of day|1|||
170659812|NCT01614600|616768386|FG000|Overall Study|Protocol deviation|1|||
170659813|NCT02437513|616768387|FG000|Overall Study|Withdrawal by Subject|2|||
170659814|NCT03403374|616768388|FG000|Overall Study|Lost to Follow-up|1|||
170659815|NCT00595465|616768390|FG000|Overall Study|Adverse Event|4|||
170659816|NCT00595465|616768391|FG001|Overall Study|Adverse Event|3|||
170659817|NCT00595465|616768392|FG002|Overall Study|Adverse Event|3|||
170659818|NCT00595465|616768390|FG000|Overall Study|Pregnancy|0|||
170659819|NCT00595465|616768391|FG001|Overall Study|Pregnancy|0|||
170659820|NCT00595465|616768392|FG002|Overall Study|Pregnancy|1|||
170659821|NCT00595465|616768390|FG000|Overall Study|Protocol Violation|2|||
170659822|NCT00595465|616768391|FG001|Overall Study|Protocol Violation|1|||
170659823|NCT00595465|616768392|FG002|Overall Study|Protocol Violation|0|||
170659824|NCT00595465|616768390|FG000|Overall Study|Lost to Follow-up|0|||
170659825|NCT00595465|616768391|FG001|Overall Study|Lost to Follow-up|0|||
170659826|NCT00595465|616768392|FG002|Overall Study|Lost to Follow-up|2|||
170659827|NCT00595465|616768390|FG000|Overall Study|administrative reason|0|||
170659828|NCT00595465|616768391|FG001|Overall Study|administrative reason|0|||
170659829|NCT00595465|616768392|FG002|Overall Study|administrative reason|1|||
170659830|NCT01298531|616768393|FG000|Overall Study|Lack of Efficacy|0|||
170659831|NCT01298531|616768394|FG001|Overall Study|Lack of Efficacy|1|||
170659832|NCT01298531|616768393|FG000|Overall Study|Lost to Follow-up|2|||
170659833|NCT01298531|616768394|FG001|Overall Study|Lost to Follow-up|0|||
170614903|NCT02714569|616597626|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170614904|NCT02714569|616597627|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170614905|NCT02714569|616597628|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
170614906|NCT02714569|616597629|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170659834|NCT01298531|616768393|FG000|Overall Study|Protocol Violation|1|||
170659835|NCT01298531|616768394|FG001|Overall Study|Protocol Violation|1|||
170659836|NCT01298531|616768393|FG000|Overall Study|Adverse Event|4|||
170659837|NCT01298531|616768394|FG001|Overall Study|Adverse Event|3|||
170659838|NCT01298531|616768393|FG000|Overall Study|Does not meet entrance criteria|0|||
170659839|NCT01298531|616768394|FG001|Overall Study|Does not meet entrance criteria|1|||
170659840|NCT01298531|616768393|FG000|Overall Study|Other|2|||
170659841|NCT01298531|616768394|FG001|Overall Study|Other|1|||
170659842|NCT04209426|616768397|FG000|Overall Study|Lost to Follow-up|3|||
170659843|NCT04209426|616768398|FG001|Overall Study|Lost to Follow-up|2|||
170659844|NCT04629508|616768399|FG000|Overall Study|Adverse Event|1|||
170659845|NCT04629508|616768399|FG000|Overall Study|Death|2|||
170659846|NCT04629508|616768399|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
170659847|NCT04073368|616768406|FG000|Overall Study|Adverse Event|2|||
170659848|NCT04073368|616768407|FG001|Overall Study|Adverse Event|0|||
170659849|NCT04073368|616768408|FG002|Overall Study|Adverse Event|1|||
170659850|NCT04073368|616768409|FG003|Overall Study|Adverse Event|1|||
170659851|NCT04073368|616768406|FG000|Overall Study|Withdrawal by Subject|2|||
170659852|NCT04073368|616768407|FG001|Overall Study|Withdrawal by Subject|2|||
170659853|NCT04073368|616768408|FG002|Overall Study|Withdrawal by Subject|1|||
170659854|NCT04073368|616768409|FG003|Overall Study|Withdrawal by Subject|1|||
170659855|NCT04073368|616768406|FG000|Overall Study|Lost to Follow-up|1|||
170659856|NCT04073368|616768407|FG001|Overall Study|Lost to Follow-up|1|||
170659857|NCT04073368|616768408|FG002|Overall Study|Lost to Follow-up|1|||
170659858|NCT04073368|616768409|FG003|Overall Study|Lost to Follow-up|0|||
170659859|NCT04073368|616768406|FG000|Overall Study|Protocol Violation|0|||
170659860|NCT04073368|616768407|FG001|Overall Study|Protocol Violation|1|||
170659861|NCT04073368|616768408|FG002|Overall Study|Protocol Violation|0|||
170659862|NCT04073368|616768409|FG003|Overall Study|Protocol Violation|0|||
170659863|NCT04073368|616768406|FG000|Overall Study|Subject noncompliance|7|||
170659864|NCT04073368|616768407|FG001|Overall Study|Subject noncompliance|4|||
170659865|NCT04073368|616768408|FG002|Overall Study|Subject noncompliance|0|||
170659866|NCT04073368|616768409|FG003|Overall Study|Subject noncompliance|0|||
170659867|NCT00145600|616768410|FG000|Overall Study|Death|1|||
170659868|NCT00145600|616768411|FG001|Overall Study|Death|2|||
170659869|NCT00145600|616768412|FG002|Overall Study|Death|2|||
170659870|NCT00145600|616768413|FG003|Overall Study|Death|6|||
170817130|NCT02823574|617338397|FG001|Randomization|AE unrelated to Study Drug|0|||
170817131|NCT02823574|617338398|FG002|Randomization|AE unrelated to Study Drug|0|||
170817132|NCT02823574|617338399|FG003|Randomization|AE unrelated to Study Drug|0|||
170817133|NCT02823574|617338396|FG000|Treatment Period|Poor/Non Compliance|1|||
170817134|NCT02823574|617338397|FG001|Treatment Period|Poor/Non Compliance|0|||
170817135|NCT02823574|617338398|FG002|Treatment Period|Poor/Non Compliance|0|||
170817136|NCT02823574|617338399|FG003|Treatment Period|Poor/Non Compliance|1|||
170817137|NCT02823574|617338396|FG000|Treatment Period|Maximum Clinical Benefit|8|||
170817138|NCT02823574|617338397|FG001|Treatment Period|Maximum Clinical Benefit|4|||
170817139|NCT02823574|617338398|FG002|Treatment Period|Maximum Clinical Benefit|7|||
170817140|NCT02823574|617338399|FG003|Treatment Period|Maximum Clinical Benefit|1|||
170817141|NCT02823574|617338396|FG000|Treatment Period|Lost to Follow-up|1|||
170817142|NCT02823574|617338397|FG001|Treatment Period|Lost to Follow-up|1|||
170614907|NCT02714569|616597630|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170614908|NCT02714569|616597631|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170614909|NCT02714569|616597632|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170614910|NCT02714569|616597633|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
170614911|NCT02714569|616597623|FG000|Part B (Overall)|Lost to Follow-up|0|||
170614912|NCT02714569|616597624|FG001|Part B (Overall)|Lost to Follow-up|0|||
170614913|NCT02714569|616597625|FG002|Part B (Overall)|Lost to Follow-up|0|||
170614914|NCT02714569|616597626|FG003|Part B (Overall)|Lost to Follow-up|0|||
170614915|NCT02714569|616597627|FG004|Part B (Overall)|Lost to Follow-up|0|||
170614916|NCT02714569|616597628|FG005|Part B (Overall)|Lost to Follow-up|0|||
170659871|NCT00145600|616768410|FG000|Overall Study|Ineligible|3|||
170659872|NCT00145600|616768411|FG001|Overall Study|Ineligible|0|||
170659873|NCT00145600|616768412|FG002|Overall Study|Ineligible|1|||
170659874|NCT00145600|616768413|FG003|Overall Study|Ineligible|5|||
170659875|NCT00145600|616768410|FG000|Overall Study|Lost to Follow-up|2|||
170659876|NCT00145600|616768411|FG001|Overall Study|Lost to Follow-up|6|||
170659877|NCT00145600|616768412|FG002|Overall Study|Lost to Follow-up|2|||
170659878|NCT00145600|616768413|FG003|Overall Study|Lost to Follow-up|4|||
170659879|NCT00145600|616768410|FG000|Overall Study|Noncompliance|1|||
170659880|NCT00145600|616768411|FG001|Overall Study|Noncompliance|0|||
170817143|NCT02823574|617338398|FG002|Treatment Period|Lost to Follow-up|0|||
170817144|NCT02823574|617338399|FG003|Treatment Period|Lost to Follow-up|0|||
170659881|NCT00145600|616768412|FG002|Overall Study|Noncompliance|0|||
170659882|NCT00145600|616768413|FG003|Overall Study|Noncompliance|0|||
170659883|NCT00145600|616768410|FG000|Overall Study|Withdrawal by Subject|1|||
170659884|NCT00145600|616768411|FG001|Overall Study|Withdrawal by Subject|2|||
170659885|NCT00145600|616768412|FG002|Overall Study|Withdrawal by Subject|0|||
170659886|NCT00145600|616768413|FG003|Overall Study|Withdrawal by Subject|1|||
170659887|NCT03026088|616768414|FG000|Overall Study|Study termination|20|||
170659888|NCT00761579|616768416|FG000|Overall Study|Adverse Event|10|||
170659889|NCT00761579|616768416|FG000|Overall Study|Death|2|||
170659890|NCT00761579|616768416|FG000|Overall Study|Lack of Efficacy|21|||
170659891|NCT00761579|616768416|FG000|Overall Study|Lost to Follow-up|16|||
170659892|NCT00761579|616768416|FG000|Overall Study|Pregnancy|1|||
170659893|NCT00761579|616768416|FG000|Overall Study|Withdrawal by Subject|34|||
170659894|NCT00761579|616768416|FG000|Overall Study|Lack of compliance|2|||
170659895|NCT00761579|616768416|FG000|Overall Study|Protocol deviation|1|||
170659896|NCT00761579|616768416|FG000|Overall Study|Drug overdose|1|||
170659897|NCT00761579|616768416|FG000|Overall Study|Aggravation of depression|1|||
170659898|NCT00761579|616768416|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
170659899|NCT00761579|616768416|FG000|Overall Study|Lost survey form|1|||
170659900|NCT00761579|616768416|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
170659901|NCT00950911|616768417|FG000|Overall Study|Adverse Event|0|||
170659902|NCT00950911|616768418|FG001|Overall Study|Adverse Event|2|||
170659903|NCT00950911|616768417|FG000|Overall Study|Death|4|||
170659904|NCT00950911|616768418|FG001|Overall Study|Death|6|||
170659905|NCT00950911|616768417|FG000|Overall Study|Disease progression|2|||
170659906|NCT00950911|616768418|FG001|Overall Study|Disease progression|2|||
170659907|NCT00950911|616768417|FG000|Overall Study|Consent withdrawn|1|||
170659908|NCT00950911|616768418|FG001|Overall Study|Consent withdrawn|3|||
170659909|NCT00950911|616768417|FG000|Overall Study|Administrative decision|3|||
170659910|NCT00950911|616768418|FG001|Overall Study|Administrative decision|1|||
170659911|NCT00950911|616768417|FG000|Overall Study|Ineligibility determined|1|||
170659912|NCT00950911|616768418|FG001|Overall Study|Ineligibility determined|0|||
170659913|NCT00950911|616768417|FG000|Overall Study|Noncompliance|1|||
170659914|NCT00950911|616768418|FG001|Overall Study|Noncompliance|0|||
170659915|NCT00950911|616768417|FG000|Overall Study|Poor performance status|0|||
170659916|NCT00950911|616768418|FG001|Overall Study|Poor performance status|1|||
170659917|NCT02063880|616768419|FG000|Overall Study|Death|21|||
170659918|NCT02063880|616768420|FG001|Overall Study|Death|18|||
170659919|NCT02063880|616768419|FG000|Overall Study|Lost to Follow-up|7|||
170659920|NCT02063880|616768420|FG001|Overall Study|Lost to Follow-up|7|||
170659921|NCT02063880|616768419|FG000|Overall Study|Ineligible|0|||
170659922|NCT02063880|616768420|FG001|Overall Study|Ineligible|2|||
170659923|NCT02600351|616768421|FG000|Overall Study|Lack of Efficacy|3|||
170659924|NCT02600351|616768422|FG001|Overall Study|Lack of Efficacy|0|||
170659925|NCT02600351|616768423|FG002|Overall Study|Lack of Efficacy|5|||
170659926|NCT02600351|616768424|FG003|Overall Study|Lack of Efficacy|2|||
170659927|NCT02600351|616768421|FG000|Overall Study|Lost to Follow-up|1|||
170659928|NCT02600351|616768422|FG001|Overall Study|Lost to Follow-up|0|||
170659929|NCT02600351|616768423|FG002|Overall Study|Lost to Follow-up|0|||
170659930|NCT02600351|616768424|FG003|Overall Study|Lost to Follow-up|0|||
170659931|NCT02600351|616768421|FG000|Overall Study|Randomized but Not Treated|1|||
170659932|NCT02600351|616768422|FG001|Overall Study|Randomized but Not Treated|0|||
170659933|NCT02600351|616768423|FG002|Overall Study|Randomized but Not Treated|1|||
170659934|NCT02600351|616768424|FG003|Overall Study|Randomized but Not Treated|3|||
170659935|NCT02106910|616768425|FG000|Overall Study|Lost to Follow-up|1|||
170659936|NCT02106910|616768426|FG001|Overall Study|Lost to Follow-up|1|||
170659937|NCT00567593|616768427|FG000|Overall Study|Adverse Event|1|||
170659938|NCT00567593|616768427|FG000|Overall Study|Physician Decision|1|||
170659939|NCT02476422|616768430|FG000|Overall Study|Subject/guardian decision|0|||
170659940|NCT02476422|616768431|FG001|Overall Study|Subject/guardian decision|1|||
170659941|NCT04087213|616768432|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
170659942|NCT04087213|616768432|FG000|In-Facility Introduction|Adverse Event|1|||
170659943|NCT04087213|616768432|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
170659944|NCT04087213|616768432|FG000|Assisted Evaluable Period|Personal reasons|3|||
170659945|NCT04087213|616768432|FG000|Transition Period B|Renal Transplantation|1|||
170659946|NCT03960554|616768437|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
170659947|NCT03960554|616768438|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
170659948|NCT03923738|616768447|FG000|Period 1|Adverse Event|1|||
170659949|NCT03923738|616768447|FG000|Period 1|Withdrawal by Subject|1|||
170659950|NCT05246397|616768449|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
170659951|NCT02869438|616768451|FG000|Overall Study|Lost to Follow-up|1|||
170659952|NCT02869438|616768452|FG001|Overall Study|Lost to Follow-up|0|||
170659953|NCT02869438|616768451|FG000|Overall Study|Adverse Event|1|||
170659954|NCT02869438|616768452|FG001|Overall Study|Adverse Event|0|||
170659955|NCT02869438|616768451|FG000|Overall Study|Withdrawal by Subject|1|||
170659956|NCT02869438|616768452|FG001|Overall Study|Withdrawal by Subject|2|||
170659957|NCT00573248|616768457|FG000|Overall Study|scheduling conflicts|15|||
170659958|NCT00573248|616768458|FG001|Overall Study|scheduling conflicts|11|||
170659959|NCT01367119|616768459|FG000|Overall Study|Adverse Event|1|||
170659960|NCT01367119|616768460|FG001|Overall Study|Adverse Event|0|||
170659961|NCT01367119|616768459|FG000|Overall Study|Withdrawal by Subject|1|||
170659962|NCT01367119|616768460|FG001|Overall Study|Withdrawal by Subject|1|||
170659963|NCT02675231|616768462|FG000|Overall Study|Withdrawal by Subject|2|||
170659964|NCT02675231|616768463|FG001|Overall Study|Withdrawal by Subject|4|||
170659965|NCT02675231|616768464|FG002|Overall Study|Withdrawal by Subject|2|||
170659966|NCT02675231|616768462|FG000|Overall Study|Lost to Follow-up|3|||
170659967|NCT02675231|616768463|FG001|Overall Study|Lost to Follow-up|4|||
170659968|NCT02675231|616768464|FG002|Overall Study|Lost to Follow-up|3|||
170659969|NCT01758289|616768470|FG000|Overall Study|Premature Study Termination|44|||
170659970|NCT01758289|616768470|FG000|Overall Study|Adverse Event|9|||
170659971|NCT02059005|616768473|FG000|Overall Study|Death|1|||
170659972|NCT02059005|616768474|FG001|Overall Study|Death|3|||
170659973|NCT02059005|616768473|FG000|Overall Study|Lost to Follow-up|19|||
170659974|NCT02059005|616768474|FG001|Overall Study|Lost to Follow-up|19|||
170659975|NCT02059005|616768473|FG000|Overall Study|Incarceration|0|||
170659976|NCT02059005|616768474|FG001|Overall Study|Incarceration|1|||
170659977|NCT02059005|616768473|FG000|Overall Study|Inpatient|0|||
170659978|NCT02059005|616768474|FG001|Overall Study|Inpatient|1|||
170659979|NCT00908011|616768475|FG000|Overall Study|Withdrawal by Subject|2|||
170659980|NCT00908011|616768476|FG001|Overall Study|Withdrawal by Subject|2|||
170659981|NCT00843726|616768477|FG000|Overall Study|Death|1|||
170659982|NCT00843726|616768478|FG001|Overall Study|Death|0|||
170659983|NCT00843726|616768477|FG000|Overall Study|Withdrawal by Subject|0|||
170659984|NCT00843726|616768478|FG001|Overall Study|Withdrawal by Subject|1|||
170659985|NCT02520661|616768479|FG000|Overall Study|Lost to Follow-up|7|||
170659986|NCT02520661|616768480|FG001|Overall Study|Lost to Follow-up|3|||
170659987|NCT02520661|616768479|FG000|Overall Study|Admitted from ED|49|||
170659988|NCT02520661|616768480|FG001|Overall Study|Admitted from ED|48|||
170659989|NCT02520661|616768479|FG000|Overall Study|ED greater than 24 hours|29|||
170659990|NCT02520661|616768480|FG001|Overall Study|ED greater than 24 hours|38|||
170659991|NCT02520661|616768479|FG000|Overall Study|other ineligibility|14|||
170659992|NCT02520661|616768480|FG001|Overall Study|other ineligibility|22|||
170659993|NCT02520661|616768479|FG000|Overall Study|Withdrawal by Subject|7|||
170659994|NCT02520661|616768480|FG001|Overall Study|Withdrawal by Subject|16|||
170659995|NCT02750943|616768481|FG000|Overall Study|Lost to Follow-up|1|||
170659996|NCT02750943|616768482|FG001|Overall Study|Lost to Follow-up|2|||
170659997|NCT02750943|616768481|FG000|Overall Study|Withdrawal by Subject|5|||
170659998|NCT02750943|616768482|FG001|Overall Study|Withdrawal by Subject|7|||
170659999|NCT04597918|616768483|FG000|Overall Study|Withdrawal by Subject|6|||
170660000|NCT04597918|616768483|FG000|Overall Study|Lost to Follow-up|3|||
170660001|NCT04597918|616768483|FG000|Overall Study|Death|1|||
170660002|NCT00171054|616768484|FG000|Overall Study|Protocol Violation|1|||
170660003|NCT00171054|616768485|FG001|Overall Study|Protocol Violation|2|||
170660004|NCT00171054|616768484|FG000|Overall Study|Patient withdrew consent|1|||
170660005|NCT00171054|616768485|FG001|Overall Study|Patient withdrew consent|0|||
170660006|NCT00171054|616768484|FG000|Overall Study|Lost to Follow-up|0|||
170660007|NCT00171054|616768485|FG001|Overall Study|Lost to Follow-up|1|||
170660008|NCT00171054|616768484|FG000|Overall Study|Adverse Event|8|||
170660009|NCT00171054|616768485|FG001|Overall Study|Adverse Event|8|||
170660010|NCT00171054|616768484|FG000|Overall Study|Condition no longer required study drug|0|||
170660011|NCT00171054|616768485|FG001|Overall Study|Condition no longer required study drug|1|||
170660012|NCT04669535|616768486|FG000|Overall Study|Death|1|||
170660013|NCT04669535|616768487|FG001|Overall Study|Death|1|||
170660014|NCT04669535|616768488|FG002|Overall Study|Death|0|||
170660015|NCT04669535|616768489|FG003|Overall Study|Death|0|||
170660016|NCT04382755|616768492|FG000|Overall Study|Withdrawal by Subject|1|||
170660017|NCT04382755|616768493|FG001|Overall Study|Withdrawal by Subject|0|||
170817145|NCT02823574|617338396|FG000|Treatment Period|Participant withdrew consent|4|||
170817146|NCT02823574|617338397|FG001|Treatment Period|Participant withdrew consent|0|||
170660018|NCT04382755|616768492|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
170660019|NCT04382755|616768493|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
170660020|NCT04382755|616768492|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
170660021|NCT04382755|616768493|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
170660022|NCT01909453|616768499|FG000|Overall Study|Ongoing|118|||
170660023|NCT01909453|616768500|FG001|Overall Study|Ongoing|103|||
170660024|NCT01909453|616768501|FG002|Overall Study|Ongoing|83|||
170660025|NCT01909453|616768502|FG003|Overall Study|Ongoing|164|||
170660026|NCT01909453|616768503|FG004|Overall Study|Ongoing|50|||
170660027|NCT01909453|616768499|FG000|Overall Study|Death|69|||
170660028|NCT01909453|616768500|FG001|Overall Study|Death|74|||
170660029|NCT01909453|616768501|FG002|Overall Study|Death|88|||
170660030|NCT01909453|616768502|FG003|Overall Study|Death|86|||
170660031|NCT01909453|616768503|FG004|Overall Study|Death|29|||
170660032|NCT01909453|616768499|FG000|Overall Study|Lost to Follow-up|3|||
170660033|NCT01909453|616768500|FG001|Overall Study|Lost to Follow-up|4|||
170660034|NCT01909453|616768501|FG002|Overall Study|Lost to Follow-up|4|||
170660035|NCT01909453|616768502|FG003|Overall Study|Lost to Follow-up|3|||
170660036|NCT01909453|616768503|FG004|Overall Study|Lost to Follow-up|3|||
170660037|NCT01909453|616768499|FG000|Overall Study|Withdrawal by Subject|2|||
170660038|NCT01909453|616768500|FG001|Overall Study|Withdrawal by Subject|13|||
170660039|NCT01909453|616768501|FG002|Overall Study|Withdrawal by Subject|16|||
170660040|NCT01909453|616768502|FG003|Overall Study|Withdrawal by Subject|5|||
170660041|NCT01909453|616768503|FG004|Overall Study|Withdrawal by Subject|4|||
170660042|NCT00760214|616770150|FG000|Overall Study|Adverse Event|8|||
170660043|NCT00760214|616770151|FG001|Overall Study|Adverse Event|9|||
170660044|NCT00760214|616770152|FG002|Overall Study|Adverse Event|12|||
170660045|NCT00760214|616770150|FG000|Overall Study|Protocol Violation|3|||
170660046|NCT00760214|616770151|FG001|Overall Study|Protocol Violation|0|||
170660047|NCT00760214|616770152|FG002|Overall Study|Protocol Violation|3|||
170660048|NCT00760214|616770150|FG000|Overall Study|Lost to Follow-up|0|||
170660049|NCT00760214|616770151|FG001|Overall Study|Lost to Follow-up|0|||
170660050|NCT00760214|616770152|FG002|Overall Study|Lost to Follow-up|1|||
170660051|NCT00760214|616770150|FG000|Overall Study|Withdrawal by Subject|12|||
170660052|NCT00760214|616770151|FG001|Overall Study|Withdrawal by Subject|14|||
170660053|NCT00760214|616770152|FG002|Overall Study|Withdrawal by Subject|13|||
170660054|NCT00760214|616770150|FG000|Overall Study|Lack of Efficacy|3|||
170660055|NCT00760214|616770151|FG001|Overall Study|Lack of Efficacy|2|||
170660056|NCT00760214|616770152|FG002|Overall Study|Lack of Efficacy|4|||
170660057|NCT00760214|616770150|FG000|Overall Study|Pregnancy|0|||
170660058|NCT00760214|616770151|FG001|Overall Study|Pregnancy|0|||
170660059|NCT00760214|616770152|FG002|Overall Study|Pregnancy|1|||
170660060|NCT00760214|616770150|FG000|Overall Study|Physician Decision|1|||
170660061|NCT00760214|616770151|FG001|Overall Study|Physician Decision|1|||
170660062|NCT00760214|616770152|FG002|Overall Study|Physician Decision|1|||
170660063|NCT00760214|616770150|FG000|Overall Study|Other|3|||
170660064|NCT00760214|616770151|FG001|Overall Study|Other|4|||
170660065|NCT00760214|616770152|FG002|Overall Study|Other|6|||
170660066|NCT00700570|616770153|FG000|Overall Study|Adverse Event|2|||
170817147|NCT02823574|617338398|FG002|Treatment Period|Participant withdrew consent|0|||
170817148|NCT02823574|617338399|FG003|Treatment Period|Participant withdrew consent|1|||
170817149|NCT02823574|617338396|FG000|Treatment Period|Participant request to discontinue|5|||
170817150|NCT02823574|617338397|FG001|Treatment Period|Participant request to discontinue|0|||
170817151|NCT02823574|617338398|FG002|Treatment Period|Participant request to discontinue|3|||
170817152|NCT02823574|617338399|FG003|Treatment Period|Participant request to discontinue|2|||
170817153|NCT02823574|617338396|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
170817154|NCT02823574|617338397|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
170817155|NCT02823574|617338398|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
170817156|NCT02823574|617338399|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
170817157|NCT02823574|617338396|FG000|Treatment Period|Study Drug Toxicity|11|||
170817158|NCT02823574|617338397|FG001|Treatment Period|Study Drug Toxicity|2|||
170817159|NCT02823574|617338398|FG002|Treatment Period|Study Drug Toxicity|14|||
170817160|NCT02823574|617338399|FG003|Treatment Period|Study Drug Toxicity|4|||
170817161|NCT02823574|617338396|FG000|Treatment Period|Disease Progression|113|||
170817162|NCT02823574|617338397|FG001|Treatment Period|Disease Progression|64|||
170817163|NCT02823574|617338398|FG002|Treatment Period|Disease Progression|82|||
170817164|NCT02823574|617338399|FG003|Treatment Period|Disease Progression|43|||
170817165|NCT02823574|617338396|FG000|Treatment Period|Other reasons|5|||
170817166|NCT02823574|617338397|FG001|Treatment Period|Other reasons|9|||
170817167|NCT02823574|617338398|FG002|Treatment Period|Other reasons|3|||
170817168|NCT02823574|617338399|FG003|Treatment Period|Other reasons|6|||
170817169|NCT02823574|617338396|FG000|Treatment Period|Participant no longer meets study criteria|0|||
170817170|NCT02823574|617338397|FG001|Treatment Period|Participant no longer meets study criteria|0|||
170817171|NCT02823574|617338398|FG002|Treatment Period|Participant no longer meets study criteria|1|||
170817172|NCT02823574|617338399|FG003|Treatment Period|Participant no longer meets study criteria|0|||
170660067|NCT00700570|616770154|FG001|Overall Study|Adverse Event|6|||
170660068|NCT00700570|616770153|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
170660069|NCT00700570|616770154|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
170660070|NCT00700570|616770153|FG000|Overall Study|Disease Progression|8|||
170660071|NCT00700570|616770154|FG001|Overall Study|Disease Progression|11|||
170660072|NCT00700570|616770153|FG000|Overall Study|Withdrawal by Subject|1|||
170660073|NCT00700570|616770154|FG001|Overall Study|Withdrawal by Subject|6|||
170660074|NCT00611533|616770155|FG000|First Intervention (6 Weeks)|Never started study|0|||
170660075|NCT00611533|616770156|FG001|First Intervention (6 Weeks)|Never started study|1|||
170660076|NCT00611533|616770155|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
170660077|NCT00611533|616770156|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
170660078|NCT00611533|616770155|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
170660079|NCT00611533|616770156|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
170660080|NCT01933217|616770157|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
170660081|NCT01933217|616770158|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
170660082|NCT01933217|616770157|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
170660083|NCT01933217|616770158|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
170660084|NCT03875768|616770159|FG000|Overall Study|Lost to Follow-up|16|||
170660085|NCT03875768|616770160|FG001|Overall Study|Lost to Follow-up|13|||
170660086|NCT03875768|616770159|FG000|Overall Study|Withdrawal by Subject|10|||
170660087|NCT03875768|616770160|FG001|Overall Study|Withdrawal by Subject|21|||
170660088|NCT03875768|616770159|FG000|Overall Study|Did not complete assessment|21|||
170660089|NCT03875768|616770160|FG001|Overall Study|Did not complete assessment|12|||
170660090|NCT03875768|616770159|FG000|Overall Study|Became ineligible|1|||
170660091|NCT03875768|616770160|FG001|Overall Study|Became ineligible|0|||
170660092|NCT01925274|616770161|FG000|Overall Study|Death|1|||
170660093|NCT01925274|616770162|FG001|Overall Study|Death|0|||
170660094|NCT01925274|616770163|FG002|Overall Study|Death|0|||
170660095|NCT01925274|616770161|FG000|Overall Study|Lost to Follow-up|0|||
170660096|NCT01925274|616770162|FG001|Overall Study|Lost to Follow-up|1|||
170660097|NCT01925274|616770163|FG002|Overall Study|Lost to Follow-up|0|||
170660098|NCT01925274|616770161|FG000|Overall Study|Withdrawal by Subject|1|||
170660099|NCT01925274|616770162|FG001|Overall Study|Withdrawal by Subject|2|||
170660100|NCT01925274|616770163|FG002|Overall Study|Withdrawal by Subject|0|||
170660101|NCT01925274|616770161|FG000|Overall Study|Study terminated by sponsor|4|||
170660102|NCT01925274|616770162|FG001|Overall Study|Study terminated by sponsor|0|||
170660103|NCT01925274|616770163|FG002|Overall Study|Study terminated by sponsor|0|||
170660104|NCT01925274|616770161|FG000|Overall Study|Protocol amendment|1|||
170660105|NCT01925274|616770162|FG001|Overall Study|Protocol amendment|3|||
170660106|NCT01925274|616770163|FG002|Overall Study|Protocol amendment|6|||
170660107|NCT04327674|616770165|FG000|Overall Study|Protocol Violation|19|||
170660108|NCT00723398|616770170|FG000|Overall Study|Withdrawal by Subject|2|||
170660109|NCT00723398|616770171|FG001|Overall Study|Withdrawal by Subject|6|||
170660110|NCT00723398|616770172|FG002|Overall Study|Withdrawal by Subject|4|||
170660111|NCT00723398|616770173|FG003|Overall Study|Withdrawal by Subject|4|||
170660112|NCT00723398|616770174|FG004|Overall Study|Withdrawal by Subject|4|||
170660113|NCT00723398|616770170|FG000|Overall Study|Protocol Violation|2|||
170660114|NCT00723398|616770171|FG001|Overall Study|Protocol Violation|1|||
170660115|NCT00723398|616770172|FG002|Overall Study|Protocol Violation|5|||
170660116|NCT00723398|616770173|FG003|Overall Study|Protocol Violation|0|||
170660117|NCT00723398|616770174|FG004|Overall Study|Protocol Violation|0|||
170660118|NCT00723398|616770170|FG000|Overall Study|Physician Decision|2|||
170660119|NCT00723398|616770171|FG001|Overall Study|Physician Decision|2|||
170660120|NCT00723398|616770172|FG002|Overall Study|Physician Decision|5|||
170660121|NCT00723398|616770173|FG003|Overall Study|Physician Decision|0|||
170660122|NCT00723398|616770174|FG004|Overall Study|Physician Decision|1|||
170660123|NCT00723398|616770170|FG000|Overall Study|Adverse Event|0|||
170660124|NCT00723398|616770171|FG001|Overall Study|Adverse Event|5|||
170660125|NCT00723398|616770172|FG002|Overall Study|Adverse Event|3|||
170660126|NCT00723398|616770173|FG003|Overall Study|Adverse Event|1|||
170660127|NCT00723398|616770174|FG004|Overall Study|Adverse Event|4|||
170817173|NCT02823574|617338396|FG000|Treatment Period|Death|0|||
170817174|NCT02823574|617338397|FG001|Treatment Period|Death|0|||
170817175|NCT02823574|617338398|FG002|Treatment Period|Death|3|||
170817176|NCT02823574|617338399|FG003|Treatment Period|Death|1|||
170817177|NCT01601821|617338409|FG000|Overall Study|Death|2|||
170817178|NCT01601821|617338410|FG001|Overall Study|Death|5|||
170817179|NCT01601821|617338409|FG000|Overall Study|Protocol Violation|2|||
170817180|NCT01601821|617338410|FG001|Overall Study|Protocol Violation|2|||
170817181|NCT01601821|617338409|FG000|Overall Study|Lost to Follow-up|6|||
170817182|NCT01601821|617338410|FG001|Overall Study|Lost to Follow-up|14|||
170660128|NCT00723398|616770170|FG000|Overall Study|Lost to Follow-up|0|||
170660129|NCT00723398|616770171|FG001|Overall Study|Lost to Follow-up|1|||
170660130|NCT00723398|616770172|FG002|Overall Study|Lost to Follow-up|0|||
170660131|NCT00723398|616770173|FG003|Overall Study|Lost to Follow-up|0|||
170660132|NCT00723398|616770174|FG004|Overall Study|Lost to Follow-up|0|||
170660133|NCT00267189|616770175|FG000|Overall Study|Patient withdrew consent|1|||
170660134|NCT00267189|616770176|FG001|Overall Study|Patient withdrew consent|1|||
170660135|NCT00267189|616770175|FG000|Overall Study|Death|1|||
170660136|NCT00267189|616770176|FG001|Overall Study|Death|0|||
170660137|NCT00267189|616770175|FG000|Overall Study|Missing|3|||
170660138|NCT00267189|616770176|FG001|Overall Study|Missing|0|||
170660139|NCT00751621|616770177|FG000|Overall Study|Adverse Event|1|||
170660140|NCT00751621|616770177|FG000|Overall Study|Withdrawal by Subject|1|||
170660141|NCT00751621|616770177|FG000|Overall Study|Subject moved to another country|1|||
170660142|NCT00751621|616770177|FG000|Overall Study|Poor adherence to asthma treatment|1|||
170817183|NCT01601821|617338409|FG000|Overall Study|Withdrawal by Subject|1|||
170660143|NCT06400979|616770180|FG000|Overall Study|Lost to Follow-up|29|||
170660144|NCT06400979|616770180|FG000|Overall Study|Withdrawal by Subject|1|||
170660145|NCT01272661|616770184|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
170660146|NCT01272661|616770185|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
170660147|NCT01272661|616770186|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
170660148|NCT01086423|616770187|FG000|Overall Study|Protocol Violation|0|||
170660149|NCT01086423|616770188|FG001|Overall Study|Protocol Violation|0|||
170660150|NCT01086423|616770189|FG002|Overall Study|Protocol Violation|1|||
170660151|NCT01086423|616770187|FG000|Overall Study|Migrated/moved from study area|2|||
170660152|NCT01086423|616770188|FG001|Overall Study|Migrated/moved from study area|0|||
170660153|NCT01086423|616770189|FG002|Overall Study|Migrated/moved from study area|4|||
170660154|NCT01086423|616770187|FG000|Overall Study|Adverse event, fatal|1|||
170660155|NCT01086423|616770188|FG001|Overall Study|Adverse event, fatal|1|||
170660156|NCT01086423|616770189|FG002|Overall Study|Adverse event, fatal|0|||
170660157|NCT01086423|616770187|FG000|Overall Study|Adverse event, non-fatal|2|||
170660158|NCT01086423|616770188|FG001|Overall Study|Adverse event, non-fatal|1|||
170660159|NCT01086423|616770189|FG002|Overall Study|Adverse event, non-fatal|0|||
170660160|NCT01086423|616770187|FG000|Overall Study|Withdrawal by Subject|5|||
170660161|NCT01086423|616770188|FG001|Overall Study|Withdrawal by Subject|1|||
170660162|NCT01086423|616770189|FG002|Overall Study|Withdrawal by Subject|3|||
170660163|NCT01086423|616770187|FG000|Overall Study|Lost to Follow-up|0|||
170660164|NCT01086423|616770188|FG001|Overall Study|Lost to Follow-up|0|||
170660165|NCT01086423|616770189|FG002|Overall Study|Lost to Follow-up|1|||
170660166|NCT01225887|616770191|FG000|Overall Study|Ineligible:required test not done|2|||
170660167|NCT01225887|616770191|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
170660168|NCT01225887|616770191|FG000|Overall Study|Ineligible:inadequate pathology|2|||
170660169|NCT00925990|616770195|FG000|Overall Study|Adverse Event|1|||
170660170|NCT00925990|616770196|FG001|Overall Study|Adverse Event|3|||
170660171|NCT00925990|616770195|FG000|Overall Study|Withdrawal by Subject|2|||
170660172|NCT00925990|616770196|FG001|Overall Study|Withdrawal by Subject|2|||
170660173|NCT00925990|616770195|FG000|Overall Study|Lost to Follow-up|1|||
170660174|NCT00925990|616770196|FG001|Overall Study|Lost to Follow-up|3|||
170660175|NCT00925990|616770195|FG000|Overall Study|Physician Decision|1|||
170660176|NCT00925990|616770196|FG001|Overall Study|Physician Decision|1|||
170660177|NCT00925990|616770195|FG000|Overall Study|moved out of state, missed medication|0|||
170660178|NCT00925990|616770196|FG001|Overall Study|moved out of state, missed medication|2|||
170660179|NCT05342532|616770199|FG000|Overall Study|Adverse Event|5|||
170660180|NCT05342532|616770200|FG001|Overall Study|Adverse Event|20|||
170660181|NCT05342532|616770199|FG000|Overall Study|Lost to Follow-up|10|||
170660182|NCT05342532|616770200|FG001|Overall Study|Lost to Follow-up|15|||
170660183|NCT02057393|616770205|FG000|Overall Study|Withdrawal by Subject|1|||
170660184|NCT02057393|616770205|FG000|Overall Study|Patient did not meet criteria|1|||
170660185|NCT03180684|616770206|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
170660186|NCT03180684|616770207|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
170660187|NCT03180684|616770206|FG000|Overall Study|Physician Decision|1|||
170660188|NCT03180684|616770207|FG001|Overall Study|Physician Decision|0|||
170660189|NCT03180684|616770206|FG000|Overall Study|Lost to Follow-up|1|||
170660190|NCT03180684|616770207|FG001|Overall Study|Lost to Follow-up|0|||
170660191|NCT03180684|616770206|FG000|Overall Study|Progressive Disease|1|||
170660192|NCT03180684|616770207|FG001|Overall Study|Progressive Disease|0|||
170660193|NCT02495233|616770211|FG000|Overall Study|Miscellaneous|0|||
170660194|NCT02495233|616770212|FG001|Overall Study|Miscellaneous|1|||
170660195|NCT02652767|616770213|FG000|Overall Study|Death|2|||
170660196|NCT02652767|616770213|FG000|Overall Study|Lost to Follow-up|1|||
170660197|NCT02652767|616770213|FG000|Overall Study|Withdrawal by Subject|1|||
170660198|NCT01115803|616770214|FG000|Overall Study|Withdrawal by Subject|0|||
170660199|NCT01115803|616770215|FG001|Overall Study|Withdrawal by Subject|0|||
170660200|NCT01115803|616770216|FG002|Overall Study|Withdrawal by Subject|0|||
170660201|NCT01115803|616770217|FG003|Overall Study|Withdrawal by Subject|0|||
170660202|NCT01115803|616770218|FG004|Overall Study|Withdrawal by Subject|0|||
170660203|NCT01115803|616770219|FG005|Overall Study|Withdrawal by Subject|0|||
170660204|NCT01115803|616770220|FG006|Overall Study|Withdrawal by Subject|1|||
170660205|NCT01115803|616770214|FG000|Overall Study|Lost to Follow-up|0|||
170660206|NCT01115803|616770215|FG001|Overall Study|Lost to Follow-up|0|||
170660207|NCT01115803|616770216|FG002|Overall Study|Lost to Follow-up|1|||
170660208|NCT01115803|616770217|FG003|Overall Study|Lost to Follow-up|0|||
170660209|NCT01115803|616770218|FG004|Overall Study|Lost to Follow-up|0|||
170660210|NCT01115803|616770219|FG005|Overall Study|Lost to Follow-up|0|||
170660211|NCT01115803|616770220|FG006|Overall Study|Lost to Follow-up|0|||
170660212|NCT01115803|616770214|FG000|Overall Study|Progressive Disease during Cycle1|0|||
170660213|NCT01115803|616770215|FG001|Overall Study|Progressive Disease during Cycle1|0|||
170660214|NCT01115803|616770216|FG002|Overall Study|Progressive Disease during Cycle1|0|||
170660215|NCT01115803|616770217|FG003|Overall Study|Progressive Disease during Cycle1|0|||
170660216|NCT01115803|616770218|FG004|Overall Study|Progressive Disease during Cycle1|0|||
170660217|NCT01115803|616770219|FG005|Overall Study|Progressive Disease during Cycle1|0|||
170660218|NCT01115803|616770220|FG006|Overall Study|Progressive Disease during Cycle1|1|||
170660219|NCT00249288|616770221|FG000|Overall Study|Lost to Follow-up|3|||
170660220|NCT00249288|616770222|FG001|Overall Study|Lost to Follow-up|3|||
170660221|NCT00249288|616770221|FG000|Overall Study|Withdrawal by Subject|2|||
170660222|NCT00249288|616770222|FG001|Overall Study|Withdrawal by Subject|2|||
170660223|NCT04718103|616770223|FG000|Overall Study|Adverse Event|1|||
170660224|NCT04718103|616770224|FG001|Overall Study|Adverse Event|1|||
170660225|NCT04718103|616770223|FG000|Overall Study|Lack of Efficacy|4|||
170660226|NCT04718103|616770224|FG001|Overall Study|Lack of Efficacy|1|||
170660227|NCT04718103|616770223|FG000|Overall Study|Lost to Follow-up|2|||
170660228|NCT04718103|616770224|FG001|Overall Study|Lost to Follow-up|2|||
170660229|NCT04718103|616770223|FG000|Overall Study|Physician Decision|2|||
170817184|NCT01601821|617338410|FG001|Overall Study|Withdrawal by Subject|0|||
170817185|NCT01601821|617338409|FG000|Overall Study|Graft Loss|6|||
170817186|NCT01601821|617338410|FG001|Overall Study|Graft Loss|6|||
170817187|NCT01601821|617338409|FG000|Overall Study|Study Events|7|||
170817188|NCT01601821|617338410|FG001|Overall Study|Study Events|1|||
170817189|NCT01601821|617338409|FG000|Overall Study|Other|5|||
170817190|NCT01601821|617338410|FG001|Overall Study|Other|1|||
170817191|NCT02959866|617338414|FG000|Overall Study|Withdrawal by Subject|1|||
170817192|NCT03708744|617338415|FG000|Overall Study|Withdrawal by Subject|0|||
170817193|NCT03708744|617338416|FG001|Overall Study|Withdrawal by Subject|0|||
170817194|NCT03708744|617338417|FG002|Overall Study|Withdrawal by Subject|1|||
170817195|NCT03708744|617338418|FG003|Overall Study|Withdrawal by Subject|0|||
170817196|NCT02812706|617338419|FG000|Phase 1|Adverse Event|0|||
170817197|NCT02812706|617338420|FG001|Phase 1|Adverse Event|2|||
170817198|NCT02812706|617338421|FG002|Phase 1|Adverse Event|0|||
170817199|NCT02812706|617338419|FG000|Phase 1|Progressive disease|3|||
170817200|NCT02812706|617338420|FG001|Phase 1|Progressive disease|3|||
170817201|NCT02812706|617338421|FG002|Phase 1|Progressive disease|0|||
170817202|NCT02812706|617338419|FG000|Phase 2|Adverse Event|0|||
170817203|NCT02812706|617338420|FG001|Phase 2|Adverse Event|0|||
170817204|NCT02812706|617338421|FG002|Phase 2|Adverse Event|2|||
170817205|NCT02812706|617338419|FG000|Phase 2|Progressive disease|0|||
170660230|NCT04718103|616770224|FG001|Overall Study|Physician Decision|0|||
170660231|NCT04718103|616770223|FG000|Overall Study|Pregnancy|0|||
170660232|NCT04718103|616770224|FG001|Overall Study|Pregnancy|1|||
170660233|NCT04718103|616770223|FG000|Overall Study|Withdrawal by Subject|10|||
170660234|NCT04718103|616770224|FG001|Overall Study|Withdrawal by Subject|6|||
170660235|NCT04718103|616770223|FG000|Overall Study|Randomized, not treated|4|||
170660236|NCT04718103|616770224|FG001|Overall Study|Randomized, not treated|1|||
170660237|NCT04718103|616770223|FG000|Overall Study|GCP violations|7|||
170660238|NCT04718103|616770224|FG001|Overall Study|GCP violations|5|||
170660239|NCT02536833|616770225|FG000|Overall Study|Discontinued Before Treatment|0|||
170660240|NCT02536833|616770226|FG001|Overall Study|Discontinued Before Treatment|0|||
170660241|NCT02536833|616770227|FG002|Overall Study|Discontinued Before Treatment|1|||
170660242|NCT02536833|616770228|FG003|Overall Study|Discontinued Before Treatment|2|||
170660243|NCT02536833|616770225|FG000|Overall Study|Adverse Event|1|||
170660244|NCT02536833|616770226|FG001|Overall Study|Adverse Event|3|||
170660245|NCT02536833|616770227|FG002|Overall Study|Adverse Event|4|||
170660246|NCT02536833|616770228|FG003|Overall Study|Adverse Event|1|||
170660247|NCT02536833|616770225|FG000|Overall Study|Lost to Follow-up|2|||
170660248|NCT02536833|616770226|FG001|Overall Study|Lost to Follow-up|1|||
170660249|NCT02536833|616770227|FG002|Overall Study|Lost to Follow-up|2|||
170660250|NCT02536833|616770228|FG003|Overall Study|Lost to Follow-up|2|||
170660251|NCT02536833|616770225|FG000|Overall Study|Physician Decision|0|||
170917074|NCT04689828|617697827|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
170917075|NCT04689828|617697826|FG000|Overall Study|Participants not treated|7|||
170917076|NCT04689828|617697827|FG001|Overall Study|Participants not treated|2|||
170917077|NCT02158091|617697832|FG000|Overall Study|DLT|2|||
170917078|NCT02158091|617697833|FG001|Overall Study|DLT|1|||
170660252|NCT02536833|616770226|FG001|Overall Study|Physician Decision|0|||
170660253|NCT02536833|616770227|FG002|Overall Study|Physician Decision|0|||
170660254|NCT02536833|616770228|FG003|Overall Study|Physician Decision|1|||
170660255|NCT02536833|616770225|FG000|Overall Study|Site Terminated by Sponsor|2|||
170817206|NCT02812706|617338420|FG001|Phase 2|Progressive disease|0|||
170917079|NCT02158091|617697834|FG002|Overall Study|DLT|0|||
170660256|NCT02536833|616770226|FG001|Overall Study|Site Terminated by Sponsor|2|||
170660257|NCT02536833|616770227|FG002|Overall Study|Site Terminated by Sponsor|2|||
170660258|NCT02536833|616770228|FG003|Overall Study|Site Terminated by Sponsor|2|||
170917080|NCT04181827|617697835|FG000|Overall Study|Ongoing|124|||
170917081|NCT04181827|617697836|FG001|Overall Study|Ongoing|157|||
170917082|NCT04181827|617697835|FG000|Overall Study|Death|82|||
170917083|NCT04181827|617697836|FG001|Overall Study|Death|50|||
170660259|NCT02536833|616770225|FG000|Overall Study|Subject Non-Compliance|0|||
170817207|NCT02812706|617338421|FG002|Phase 2|Progressive disease|22|||
170817208|NCT02812706|617338419|FG000|Phase 2|Other-Unspecified|0|||
170817209|NCT02812706|617338420|FG001|Phase 2|Other-Unspecified|0|||
170817210|NCT02812706|617338421|FG002|Phase 2|Other-Unspecified|4|||
170817211|NCT00910871|617338427|FG000|Overall Study|Adverse Event|5|||
170917084|NCT04181827|617697835|FG000|Overall Study|Lost to Follow-up|0|||
170917085|NCT04181827|617697836|FG001|Overall Study|Lost to Follow-up|1|||
170817212|NCT00910871|617338427|FG000|Overall Study|Death|12|||
170817213|NCT00910871|617338427|FG000|Overall Study|Lost to Follow-up|8|||
170817214|NCT00910871|617338427|FG000|Overall Study|Protocol Violation|11|||
170817215|NCT00910871|617338427|FG000|Overall Study|Withdrawal by Subject|12|||
170817216|NCT00910871|617338427|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
170817217|NCT00910871|617338427|FG000|Overall Study|Undefined|1|||
170614917|NCT02714569|616597629|FG006|Part B (Overall)|Lost to Follow-up|1|||
170614918|NCT02714569|616597630|FG007|Part B (Overall)|Lost to Follow-up|0|||
170614919|NCT02714569|616597631|FG008|Part B (Overall)|Lost to Follow-up|0|||
170614920|NCT02714569|616597632|FG009|Part B (Overall)|Lost to Follow-up|0|||
170614921|NCT02714569|616597633|FG010|Part B (Overall)|Lost to Follow-up|0|||
170614922|NCT02714569|616597623|FG000|Part B (Overall)|Withdrawal by Subject|0|||
170614923|NCT02714569|616597624|FG001|Part B (Overall)|Withdrawal by Subject|0|||
170614924|NCT02714569|616597625|FG002|Part B (Overall)|Withdrawal by Subject|0|||
170614925|NCT02714569|616597626|FG003|Part B (Overall)|Withdrawal by Subject|0|||
170614926|NCT02714569|616597627|FG004|Part B (Overall)|Withdrawal by Subject|0|||
170614927|NCT02714569|616597628|FG005|Part B (Overall)|Withdrawal by Subject|0|||
170614928|NCT02714569|616597629|FG006|Part B (Overall)|Withdrawal by Subject|0|||
170614929|NCT02714569|616597630|FG007|Part B (Overall)|Withdrawal by Subject|1|||
170614930|NCT02714569|616597631|FG008|Part B (Overall)|Withdrawal by Subject|0|||
170614931|NCT02714569|616597632|FG009|Part B (Overall)|Withdrawal by Subject|1|||
170614932|NCT02714569|616597633|FG010|Part B (Overall)|Withdrawal by Subject|0|||
170614933|NCT02714569|616597623|FG000|Part B (Overall)|Adverse Event|0|||
170614934|NCT02714569|616597624|FG001|Part B (Overall)|Adverse Event|0|||
170614935|NCT02714569|616597625|FG002|Part B (Overall)|Adverse Event|0|||
170614936|NCT02714569|616597626|FG003|Part B (Overall)|Adverse Event|0|||
170614937|NCT02714569|616597627|FG004|Part B (Overall)|Adverse Event|0|||
170614938|NCT02714569|616597628|FG005|Part B (Overall)|Adverse Event|0|||
170614939|NCT02714569|616597629|FG006|Part B (Overall)|Adverse Event|0|||
170614940|NCT02714569|616597630|FG007|Part B (Overall)|Adverse Event|0|||
170614941|NCT02714569|616597631|FG008|Part B (Overall)|Adverse Event|0|||
170614942|NCT02714569|616597632|FG009|Part B (Overall)|Adverse Event|1|||
170614943|NCT02714569|616597633|FG010|Part B (Overall)|Adverse Event|0|||
170614944|NCT02915978|616597634|FG000|Overall Study|Adverse Event|2|||
170614945|NCT02915978|616597635|FG001|Overall Study|Adverse Event|1|||
170614946|NCT02915978|616597636|FG002|Overall Study|Adverse Event|0|||
170614947|NCT02451124|616597641|FG000|Overall Study|Withdrawal by Subject|1|||
170614948|NCT02119663|616597642|FG000|Overall Study|Disease progression|26|||
170614949|NCT02119663|616597643|FG001|Overall Study|Disease progression|27|||
170614950|NCT02119663|616597642|FG000|Overall Study|Adverse Event|5|||
170614951|NCT02119663|616597643|FG001|Overall Study|Adverse Event|5|||
170614952|NCT02119663|616597642|FG000|Overall Study|Death|3|||
170614953|NCT02119663|616597643|FG001|Overall Study|Death|2|||
170614954|NCT02119663|616597642|FG000|Overall Study|Physician Decision|1|||
170614955|NCT02119663|616597643|FG001|Overall Study|Physician Decision|2|||
170614956|NCT02119663|616597642|FG000|Overall Study|Other unspecified|2|||
170614957|NCT02119663|616597643|FG001|Overall Study|Other unspecified|0|||
170614958|NCT02119663|616597642|FG000|Overall Study|Subject decision|0|||
170614959|NCT02119663|616597643|FG001|Overall Study|Subject decision|1|||
170614960|NCT02119663|616597642|FG000|Overall Study|Study Terminated by the Sponsor|3|||
170614961|NCT02119663|616597643|FG001|Overall Study|Study Terminated by the Sponsor|4|||
170614962|NCT00892775|616597644|FG000|Overall Study|Protocol Violation|1|||
170614963|NCT00892775|616597645|FG001|Overall Study|Protocol Violation|0|||
170614964|NCT00892775|616597644|FG000|Overall Study|Subject difficulties with blood drawing|1|||
170614965|NCT00892775|616597645|FG001|Overall Study|Subject difficulties with blood drawing|0|||
170614966|NCT00892775|616597644|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
170614967|NCT00892775|616597645|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
170614968|NCT00892775|616597644|FG000|Overall Study|Migrated/ moved from study area|1|||
170614969|NCT00892775|616597645|FG001|Overall Study|Migrated/ moved from study area|0|||
170614970|NCT00892775|616597644|FG000|Overall Study|Withdrawal by Subject|0|||
170614971|NCT00892775|616597645|FG001|Overall Study|Withdrawal by Subject|1|||
170614972|NCT00892775|616597644|FG000|Overall Study|Lost to Follow-up|1|||
170614973|NCT00892775|616597645|FG001|Overall Study|Lost to Follow-up|0|||
170614974|NCT01870726|616597646|FG000|Overall Study|Withdrawal of informed consent|0|||
170614975|NCT01870726|616597647|FG001|Overall Study|Withdrawal of informed consent|0|||
170660260|NCT02536833|616770226|FG001|Overall Study|Subject Non-Compliance|1|||
170614976|NCT01870726|616597648|FG002|Overall Study|Withdrawal of informed consent|0|||
170614977|NCT01870726|616597649|FG003|Overall Study|Withdrawal of informed consent|1|||
170614978|NCT01870726|616597650|FG004|Overall Study|Withdrawal of informed consent|0|||
170614979|NCT01870726|616597651|FG005|Overall Study|Withdrawal of informed consent|0|||
170614980|NCT01870726|616597652|FG006|Overall Study|Withdrawal of informed consent|0|||
170614981|NCT01870726|616597646|FG000|Overall Study|Withdrawal by Subject|0|||
170614982|NCT01870726|616597647|FG001|Overall Study|Withdrawal by Subject|1|||
170614983|NCT01870726|616597648|FG002|Overall Study|Withdrawal by Subject|0|||
170660261|NCT02536833|616770227|FG002|Overall Study|Subject Non-Compliance|1|||
170817218|NCT00850993|617338428|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
170917086|NCT04181827|617697835|FG000|Overall Study|Withdrawal by Subject|5|||
170917087|NCT04181827|617697836|FG001|Overall Study|Withdrawal by Subject|0|||
170660262|NCT02536833|616770228|FG003|Overall Study|Subject Non-Compliance|0|||
170660263|NCT02536833|616770225|FG000|Overall Study|Withdrawal by Subject|4|||
170660264|NCT02536833|616770226|FG001|Overall Study|Withdrawal by Subject|3|||
170660265|NCT02536833|616770227|FG002|Overall Study|Withdrawal by Subject|5|||
170660266|NCT02536833|616770228|FG003|Overall Study|Withdrawal by Subject|11|||
170660267|NCT01437878|616770229|FG000|Overall Study|Withdrawal by Subject|1|||
170660268|NCT01437878|616770230|FG001|Overall Study|Withdrawal by Subject|0|||
170660269|NCT01476644|616770237|FG000|Overall Study|Death|5|||
170660270|NCT01476644|616770237|FG000|Overall Study|moved to another state|2|||
170660271|NCT01476644|616770237|FG000|Overall Study|Lost to Follow-up|19|||
170660272|NCT01476644|616770237|FG000|Overall Study|Withdrawal by Subject|13|||
170660273|NCT00495131|616770238|FG000|Overall Study|Adverse Event|6|||
170660274|NCT00495131|616770239|FG001|Overall Study|Adverse Event|2|||
170660275|NCT00495131|616770238|FG000|Overall Study|Lack of Efficacy|0|||
170660276|NCT00495131|616770239|FG001|Overall Study|Lack of Efficacy|2|||
170660277|NCT00495131|616770238|FG000|Overall Study|Lost to Follow-up|0|||
170660278|NCT00495131|616770239|FG001|Overall Study|Lost to Follow-up|2|||
170660279|NCT00495131|616770238|FG000|Overall Study|Withdrawal by Subject|1|||
170660280|NCT00495131|616770239|FG001|Overall Study|Withdrawal by Subject|0|||
170660281|NCT03224546|616770240|FG000|Overall Study|Lost to Follow-up|9|||
170660282|NCT03224546|616770241|FG001|Overall Study|Lost to Follow-up|8|||
170660283|NCT03224546|616770242|FG002|Overall Study|Lost to Follow-up|3|||
170660284|NCT03224546|616770240|FG000|Overall Study|Withdrawal by Subject|7|||
170660285|NCT03224546|616770241|FG001|Overall Study|Withdrawal by Subject|14|||
170660286|NCT03224546|616770242|FG002|Overall Study|Withdrawal by Subject|12|||
170660287|NCT01539317|616770243|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
170660288|NCT01539317|616770244|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
170660289|NCT01462227|616770246|FG000|Second Assignment|Lost to Follow-up|1|||
170660290|NCT01462227|616770247|FG001|Second Assignment|Lost to Follow-up|0|||
170660291|NCT01462227|616770248|FG002|Second Assignment|Lost to Follow-up|0|||
170660292|NCT01462227|616770249|FG003|Second Assignment|Lost to Follow-up|0|||
170660293|NCT01462227|616770246|FG000|Second Assignment|Protocol Violation|0|||
170660294|NCT01462227|616770247|FG001|Second Assignment|Protocol Violation|1|||
170660295|NCT01462227|616770248|FG002|Second Assignment|Protocol Violation|1|||
170660296|NCT01462227|616770249|FG003|Second Assignment|Protocol Violation|0|||
170660297|NCT02393690|616770250|FG000|Overall Study|Ineligible|0|||
170660298|NCT02393690|616770251|FG001|Overall Study|Ineligible|1|||
170660299|NCT05298306|616770252|FG000|Overall Study|Physician Decision|0|||
170660300|NCT05298306|616770253|FG001|Overall Study|Physician Decision|0|||
170660301|NCT05298306|616770254|FG002|Overall Study|Physician Decision|0|||
170660302|NCT05298306|616770255|FG003|Overall Study|Physician Decision|1|||
170660303|NCT05298306|616770256|FG004|Overall Study|Physician Decision|0|||
170660304|NCT05298306|616770257|FG005|Overall Study|Physician Decision|0|||
170660305|NCT00471146|616770258|FG000|Overall Study|Adverse Event|32|||
170660306|NCT00471146|616770259|FG001|Overall Study|Adverse Event|33|||
170660307|NCT00471146|616770258|FG000|Overall Study|Withdrawal by Subject|14|||
170660308|NCT00471146|616770259|FG001|Overall Study|Withdrawal by Subject|11|||
170660309|NCT00471146|616770258|FG000|Overall Study|Death|11|||
170660310|NCT00471146|616770259|FG001|Overall Study|Death|12|||
170660311|NCT00471146|616770258|FG000|Overall Study|Lost to Follow-up|4|||
170660312|NCT00471146|616770259|FG001|Overall Study|Lost to Follow-up|2|||
170660313|NCT00471146|616770258|FG000|Overall Study|Protocol Violation|2|||
170660314|NCT00471146|616770259|FG001|Overall Study|Protocol Violation|2|||
170660315|NCT00471146|616770258|FG000|Overall Study|Objective progression or relapse|84|||
170660316|NCT00471146|616770259|FG001|Overall Study|Objective progression or relapse|87|||
170660317|NCT00471146|616770258|FG000|Overall Study|Global deterioration of health status|12|||
170660318|NCT00471146|616770259|FG001|Overall Study|Global deterioration of health status|14|||
170660319|NCT00471146|616770258|FG000|Overall Study|Randomized but not treated|9|||
170660320|NCT00471146|616770259|FG001|Overall Study|Randomized but not treated|8|||
170660321|NCT00471146|616770258|FG000|Overall Study|Other|4|||
170660322|NCT00471146|616770259|FG001|Overall Study|Other|5|||
170917088|NCT05923099|617697837|FG000|Overall Study|Adverse Event|0|||
170660323|NCT00237185|616770261|FG000|Core|Adverse Event|3|||
170660324|NCT00237185|616770262|FG001|Core|Adverse Event|4|||
170660325|NCT00237185|616770261|FG000|Core|Abnormal laboratory value|0|||
170660326|NCT00237185|616770262|FG001|Core|Abnormal laboratory value|4|||
170660327|NCT00237185|616770261|FG000|Core|Abnormal test procedure results|1|||
170917089|NCT05923099|617697838|FG001|Overall Study|Adverse Event|0|||
170660328|NCT00237185|616770262|FG001|Core|Abnormal test procedure results|0|||
170660329|NCT00237185|616770261|FG000|Core|Lack of Efficacy|30|||
170660330|NCT00237185|616770262|FG001|Core|Lack of Efficacy|23|||
170660331|NCT00237185|616770261|FG000|Core|Protocol Violation|1|||
170660332|NCT00237185|616770262|FG001|Core|Protocol Violation|1|||
170660333|NCT00237185|616770261|FG000|Core|Withdrawal by Subject|4|||
170660334|NCT00237185|616770262|FG001|Core|Withdrawal by Subject|4|||
170660335|NCT00237185|616770261|FG000|Core|Administrative problems|0|||
170917090|NCT05923099|617697839|FG002|Overall Study|Adverse Event|1|||
170817219|NCT00850993|617338429|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
170817220|NCT00850993|617338430|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
170817221|NCT00850993|617338431|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
170817222|NCT04501614|617338437|FG000|Overall Study|Study Terminated by Sponsor|6|||
170817223|NCT04501614|617338438|FG001|Overall Study|Study Terminated by Sponsor|3|||
170817224|NCT04501614|617338437|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
170817225|NCT04501614|617338438|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
170614984|NCT01870726|616597649|FG003|Overall Study|Withdrawal by Subject|0|||
170614985|NCT01870726|616597650|FG004|Overall Study|Withdrawal by Subject|0|||
170614986|NCT01870726|616597651|FG005|Overall Study|Withdrawal by Subject|0|||
170614987|NCT01870726|616597652|FG006|Overall Study|Withdrawal by Subject|0|||
170614988|NCT01870726|616597646|FG000|Overall Study|Adverse Event|0|||
170614989|NCT01870726|616597647|FG001|Overall Study|Adverse Event|0|||
170614990|NCT01870726|616597648|FG002|Overall Study|Adverse Event|0|||
170614991|NCT01870726|616597649|FG003|Overall Study|Adverse Event|0|||
170614992|NCT01870726|616597650|FG004|Overall Study|Adverse Event|1|||
170614993|NCT01870726|616597651|FG005|Overall Study|Adverse Event|1|||
170614994|NCT01870726|616597652|FG006|Overall Study|Adverse Event|0|||
170614995|NCT01870726|616597646|FG000|Overall Study|Progressive disease|5|||
170614996|NCT01870726|616597647|FG001|Overall Study|Progressive disease|5|||
170614997|NCT01870726|616597648|FG002|Overall Study|Progressive disease|4|||
170614998|NCT01870726|616597649|FG003|Overall Study|Progressive disease|5|||
170614999|NCT01870726|616597650|FG004|Overall Study|Progressive disease|6|||
170615000|NCT01870726|616597651|FG005|Overall Study|Progressive disease|4|||
170615001|NCT01870726|616597652|FG006|Overall Study|Progressive disease|10|||
170615002|NCT00286429|616597653|FG000|Overall Study|Adverse Event|4|||
170615003|NCT00286429|616597654|FG001|Overall Study|Adverse Event|1|||
170615004|NCT00286429|616597655|FG002|Overall Study|Adverse Event|6|||
170615005|NCT00286429|616597653|FG000|Overall Study|Lack of Efficacy|52|||
170615006|NCT00286429|616597654|FG001|Overall Study|Lack of Efficacy|27|||
170615007|NCT00286429|616597655|FG002|Overall Study|Lack of Efficacy|25|||
170615008|NCT00286429|616597653|FG000|Overall Study|Lost to Follow-up|2|||
170615009|NCT00286429|616597654|FG001|Overall Study|Lost to Follow-up|4|||
170615010|NCT00286429|616597655|FG002|Overall Study|Lost to Follow-up|3|||
170615011|NCT00286429|616597653|FG000|Overall Study|Physician Decision|10|||
170615012|NCT00286429|616597654|FG001|Overall Study|Physician Decision|7|||
170615013|NCT00286429|616597655|FG002|Overall Study|Physician Decision|7|||
170615014|NCT00286429|616597653|FG000|Overall Study|Protocol Violation|3|||
170615015|NCT00286429|616597654|FG001|Overall Study|Protocol Violation|5|||
170615016|NCT00286429|616597655|FG002|Overall Study|Protocol Violation|4|||
170615017|NCT00286429|616597653|FG000|Overall Study|Withdrawal by Subject|3|||
170615018|NCT00286429|616597654|FG001|Overall Study|Withdrawal by Subject|2|||
170615019|NCT00286429|616597655|FG002|Overall Study|Withdrawal by Subject|6|||
170615020|NCT00286429|616597653|FG000|Overall Study|Administrative Error|1|||
170615021|NCT00286429|616597654|FG001|Overall Study|Administrative Error|1|||
170615022|NCT00286429|616597655|FG002|Overall Study|Administrative Error|1|||
170615023|NCT00286429|616597653|FG000|Overall Study|Administrative Decision|0|||
170615024|NCT00286429|616597654|FG001|Overall Study|Administrative Decision|1|||
170615025|NCT00286429|616597655|FG002|Overall Study|Administrative Decision|0|||
170615026|NCT01123395|616597659|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
170615027|NCT01123395|616597660|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
170615028|NCT00250276|616597664|FG000|Overall Study|Serious Adverse Event|0|||
170615029|NCT00250276|616597665|FG001|Overall Study|Serious Adverse Event|0|||
170615030|NCT00250276|616597666|FG002|Overall Study|Serious Adverse Event|1|||
170615031|NCT00250276|616597667|FG003|Overall Study|Serious Adverse Event|0|||
170615032|NCT00250276|616597664|FG000|Overall Study|Non-serious Adverse Event|2|||
170615033|NCT00250276|616597665|FG001|Overall Study|Non-serious Adverse Event|0|||
170615034|NCT00250276|616597666|FG002|Overall Study|Non-serious Adverse Event|0|||
170615035|NCT00250276|616597667|FG003|Overall Study|Non-serious Adverse Event|2|||
170615036|NCT00250276|616597664|FG000|Overall Study|Protocol Violation|0|||
170615037|NCT00250276|616597665|FG001|Overall Study|Protocol Violation|1|||
170615038|NCT00250276|616597666|FG002|Overall Study|Protocol Violation|0|||
170615039|NCT00250276|616597667|FG003|Overall Study|Protocol Violation|0|||
170615040|NCT00250276|616597664|FG000|Overall Study|Withdrawal by Subject|1|||
170615041|NCT00250276|616597665|FG001|Overall Study|Withdrawal by Subject|2|||
170615042|NCT00250276|616597666|FG002|Overall Study|Withdrawal by Subject|3|||
170615043|NCT00250276|616597667|FG003|Overall Study|Withdrawal by Subject|2|||
170615044|NCT00250276|616597664|FG000|Overall Study|Migrated/moved from study area|3|||
170615045|NCT00250276|616597665|FG001|Overall Study|Migrated/moved from study area|0|||
170615046|NCT00250276|616597666|FG002|Overall Study|Migrated/moved from study area|2|||
170615047|NCT00250276|616597667|FG003|Overall Study|Migrated/moved from study area|7|||
170615048|NCT00250276|616597664|FG000|Overall Study|Lost to Follow-up|11|||
170615049|NCT00250276|616597665|FG001|Overall Study|Lost to Follow-up|18|||
170615050|NCT00250276|616597666|FG002|Overall Study|Lost to Follow-up|13|||
170817226|NCT01856569|617338442|FG000|Overall Study|Other|1|||
170615051|NCT00250276|616597667|FG003|Overall Study|Lost to Follow-up|8|||
170615052|NCT00555217|616597668|FG000|Overall Study|Withdrawal by Subject|35|||
170660336|NCT00237185|616770262|FG001|Core|Administrative problems|1|||
170660337|NCT00237185|616770261|FG000|Core|Death|4|||
170660338|NCT00237185|616770262|FG001|Core|Death|0|||
170660339|NCT00237185|616770261|FG000|Core|Determined ineligible post randomization|1|||
170660340|NCT00237185|616770262|FG001|Core|Determined ineligible post randomization|0|||
170660341|NCT00237185|616770261|FG000|Extension|Adverse Event|1|||
170660342|NCT00237185|616770262|FG001|Extension|Adverse Event|0|||
170660343|NCT00237185|616770261|FG000|Extension|Abnormal laboratory value|0|||
170660344|NCT00237185|616770262|FG001|Extension|Abnormal laboratory value|1|||
170660345|NCT00237185|616770261|FG000|Extension|Lack of Efficacy|9|||
170660346|NCT00237185|616770262|FG001|Extension|Lack of Efficacy|14|||
170660347|NCT00237185|616770261|FG000|Extension|Condition no longer required study drug|0|||
170660348|NCT00237185|616770262|FG001|Extension|Condition no longer required study drug|1|||
170660349|NCT00237185|616770261|FG000|Extension|Withdrawal by Subject|3|||
170660350|NCT00237185|616770262|FG001|Extension|Withdrawal by Subject|2|||
170660351|NCT00237185|616770261|FG000|Extension|Lost to Follow-up|1|||
170660352|NCT00237185|616770262|FG001|Extension|Lost to Follow-up|0|||
170660353|NCT00237185|616770261|FG000|Extension|Administrative problems|1|||
170660354|NCT00237185|616770262|FG001|Extension|Administrative problems|0|||
170660355|NCT00237185|616770261|FG000|Extension|Death|1|||
170660356|NCT00237185|616770262|FG001|Extension|Death|1|||
170660357|NCT02204007|616770263|FG000|Overall Study|Surgery Canceled|1|||
170660358|NCT02204007|616770264|FG001|Overall Study|Surgery Canceled|1|||
170660359|NCT02047227|616770265|FG000|Overall Study|Adverse Event|2|||
170660360|NCT02047227|616770266|FG001|Overall Study|Adverse Event|4|||
170660361|NCT02047227|616770265|FG000|Overall Study|Lost to Follow-up|0|||
170660362|NCT02047227|616770266|FG001|Overall Study|Lost to Follow-up|3|||
170660363|NCT02047227|616770265|FG000|Overall Study|Protocol Violation|1|||
170660364|NCT02047227|616770266|FG001|Overall Study|Protocol Violation|0|||
170660365|NCT02047227|616770265|FG000|Overall Study|Spontaneous pregnancy|1|||
170660366|NCT02047227|616770266|FG001|Overall Study|Spontaneous pregnancy|0|||
170660367|NCT02047227|616770265|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
170660368|NCT02047227|616770266|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
170660369|NCT02047227|616770265|FG000|Overall Study|No oocytes retrieved|21|||
170660370|NCT02047227|616770266|FG001|Overall Study|No oocytes retrieved|20|||
170660371|NCT02047227|616770265|FG000|Overall Study|No fertilization|61|||
170660372|NCT02047227|616770266|FG001|Overall Study|No fertilization|51|||
170660373|NCT02047227|616770265|FG000|Overall Study|Intention to freeze all embryos|1|||
170660374|NCT02047227|616770266|FG001|Overall Study|Intention to freeze all embryos|0|||
170660375|NCT02047227|616770265|FG000|Overall Study|All embryos discarded|12|||
170660376|NCT02047227|616770266|FG001|Overall Study|All embryos discarded|11|||
170660377|NCT02047227|616770265|FG000|Overall Study|Other|10|||
170660378|NCT02047227|616770266|FG001|Overall Study|Other|9|||
170660379|NCT01977937|616770267|FG000|Overall Study|Withdrawal by Subject|2|||
170660380|NCT01977937|616770268|FG001|Overall Study|Withdrawal by Subject|1|||
170660381|NCT01977937|616770267|FG000|Overall Study|Adverse Event|1|||
170660382|NCT01977937|616770268|FG001|Overall Study|Adverse Event|0|||
170660383|NCT01977937|616770267|FG000|Overall Study|Physician Decision|0|||
170660384|NCT01977937|616770268|FG001|Overall Study|Physician Decision|1|||
170660385|NCT02001181|616770271|FG000|Overall Study|Adverse Event|0|||
170660386|NCT02001181|616770272|FG001|Overall Study|Adverse Event|2|||
170660387|NCT02001181|616770271|FG000|Overall Study|Lost to Follow-up|1|||
170660388|NCT02001181|616770272|FG001|Overall Study|Lost to Follow-up|0|||
170660389|NCT02001181|616770271|FG000|Overall Study|Withdrawal by Subject|0|||
170660390|NCT02001181|616770272|FG001|Overall Study|Withdrawal by Subject|1|||
170660391|NCT03911843|616770274|FG000|Overall Study|Adverse Event|2|||
170660392|NCT03911843|616770275|FG001|Overall Study|Adverse Event|0|||
170817227|NCT01856569|617338442|FG000|Overall Study|Changed Site/Structure|1|||
170660393|NCT03911843|616770274|FG000|Overall Study|Protocol Violation|2|||
170660394|NCT03911843|616770275|FG001|Overall Study|Protocol Violation|0|||
170660395|NCT03911843|616770274|FG000|Overall Study|Lost to Follow-up|0|||
170660396|NCT03911843|616770275|FG001|Overall Study|Lost to Follow-up|1|||
170660397|NCT02819518|616770276|FG000|Overall Study|Death|9|||
170660398|NCT02819518|616770277|FG001|Overall Study|Death|12|||
170660399|NCT02819518|616770278|FG002|Overall Study|Death|9|||
170660400|NCT02819518|616770279|FG003|Overall Study|Death|475|||
170660401|NCT02819518|616770280|FG004|Overall Study|Death|244|||
170660402|NCT02819518|616770276|FG000|Overall Study|Withdrawal by Subject|0|||
170660403|NCT02819518|616770277|FG001|Overall Study|Withdrawal by Subject|0|||
170660404|NCT02819518|616770278|FG002|Overall Study|Withdrawal by Subject|0|||
170660405|NCT02819518|616770279|FG003|Overall Study|Withdrawal by Subject|25|||
170660406|NCT02819518|616770280|FG004|Overall Study|Withdrawal by Subject|8|||
170660407|NCT02819518|616770276|FG000|Overall Study|Lost to Follow-up|0|||
170817228|NCT01856569|617338442|FG000|Overall Study|Lost to Follow-up|3|||
170660408|NCT02819518|616770277|FG001|Overall Study|Lost to Follow-up|0|||
170660409|NCT02819518|616770278|FG002|Overall Study|Lost to Follow-up|0|||
170660410|NCT02819518|616770279|FG003|Overall Study|Lost to Follow-up|0|||
170660411|NCT02819518|616770280|FG004|Overall Study|Lost to Follow-up|1|||
170660412|NCT02819518|616770276|FG000|Overall Study|Sponsor Decision|1|||
170660413|NCT02819518|616770277|FG001|Overall Study|Sponsor Decision|1|||
170817229|NCT01856569|617338442|FG000|Overall Study|Did not met inclusion criteria|8|||
170615053|NCT00555217|616597669|FG001|Overall Study|Withdrawal by Subject|31|||
170615054|NCT00555217|616597668|FG000|Overall Study|Lost to Follow-up|19|||
170615055|NCT00555217|616597669|FG001|Overall Study|Lost to Follow-up|20|||
170615056|NCT00555217|616597668|FG000|Overall Study|close out sites|21|||
170615057|NCT00555217|616597669|FG001|Overall Study|close out sites|17|||
170615058|NCT01546688|616597670|FG000|Overall Study|Adverse Event|0|||
170615059|NCT01546688|616597671|FG001|Overall Study|Adverse Event|4|||
170615060|NCT01546688|616597670|FG000|Overall Study|Withdrawal by Subject|2|||
170615061|NCT01546688|616597671|FG001|Overall Study|Withdrawal by Subject|1|||
170615062|NCT01546688|616597670|FG000|Overall Study|Lack of Efficacy|1|||
170615063|NCT01546688|616597671|FG001|Overall Study|Lack of Efficacy|0|||
170615064|NCT00782483|616597673|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
170615065|NCT03543137|616597674|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
170615066|NCT03543137|616597675|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
170615067|NCT03543137|616597674|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
170615068|NCT03543137|616597675|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
170615069|NCT03543137|616597674|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
170615070|NCT03543137|616597675|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
170615071|NCT01045694|616597677|FG000|Overall Study|Withdrawal by Subject|2|||
170615072|NCT01099397|616597684|FG000|Overall Study|Lost to Follow-up|4|||
170615073|NCT01099397|616597684|FG000|Overall Study|Protocol Violation|4|||
170615074|NCT01099397|616597684|FG000|Overall Study|Withdrawal by Subject|5|||
170615075|NCT02363959|616597685|FG000|Overall Study|Medical instability|1|||
170615076|NCT02363959|616597686|FG001|Overall Study|Medical instability|0|||
170615077|NCT01445080|616597694|FG000|Overall Study|Adverse Event|5|||
170615078|NCT01445080|616597695|FG001|Overall Study|Adverse Event|3|||
170615079|NCT01445080|616597696|FG002|Overall Study|Adverse Event|11|||
170615080|NCT01445080|616597697|FG003|Overall Study|Adverse Event|6|||
170615081|NCT01445080|616597698|FG004|Overall Study|Adverse Event|2|||
170615082|NCT01445080|616597699|FG005|Overall Study|Adverse Event|3|||
170615083|NCT01445080|616597700|FG006|Overall Study|Adverse Event|0|||
170615084|NCT01445080|616597701|FG007|Overall Study|Adverse Event|3|||
170615085|NCT01445080|616597702|FG008|Overall Study|Adverse Event|10|||
170615086|NCT01445080|616597694|FG000|Overall Study|Physician Decision|0|||
170615087|NCT01445080|616597695|FG001|Overall Study|Physician Decision|0|||
170615088|NCT01445080|616597696|FG002|Overall Study|Physician Decision|1|||
170615089|NCT01445080|616597697|FG003|Overall Study|Physician Decision|0|||
170615090|NCT01445080|616597698|FG004|Overall Study|Physician Decision|0|||
170615091|NCT01445080|616597699|FG005|Overall Study|Physician Decision|3|||
170615092|NCT01445080|616597700|FG006|Overall Study|Physician Decision|2|||
170615093|NCT01445080|616597701|FG007|Overall Study|Physician Decision|2|||
170615094|NCT01445080|616597702|FG008|Overall Study|Physician Decision|0|||
170615095|NCT01445080|616597694|FG000|Overall Study|Withdrawal by Subject|1|||
170615096|NCT01445080|616597695|FG001|Overall Study|Withdrawal by Subject|0|||
170615097|NCT01445080|616597696|FG002|Overall Study|Withdrawal by Subject|0|||
170615098|NCT01445080|616597697|FG003|Overall Study|Withdrawal by Subject|1|||
170615099|NCT01445080|616597698|FG004|Overall Study|Withdrawal by Subject|0|||
170615100|NCT01445080|616597699|FG005|Overall Study|Withdrawal by Subject|0|||
170615101|NCT01445080|616597700|FG006|Overall Study|Withdrawal by Subject|0|||
170615102|NCT01445080|616597701|FG007|Overall Study|Withdrawal by Subject|0|||
170615103|NCT01445080|616597702|FG008|Overall Study|Withdrawal by Subject|2|||
170615104|NCT01445080|616597694|FG000|Overall Study|Ineligible/Inevaluable|1|||
170615105|NCT01445080|616597695|FG001|Overall Study|Ineligible/Inevaluable|2|||
170615106|NCT01445080|616597696|FG002|Overall Study|Ineligible/Inevaluable|0|||
170615107|NCT01445080|616597697|FG003|Overall Study|Ineligible/Inevaluable|1|||
170615108|NCT01445080|616597698|FG004|Overall Study|Ineligible/Inevaluable|2|||
170615109|NCT01445080|616597699|FG005|Overall Study|Ineligible/Inevaluable|3|||
170615110|NCT01445080|616597700|FG006|Overall Study|Ineligible/Inevaluable|0|||
170615111|NCT01445080|616597701|FG007|Overall Study|Ineligible/Inevaluable|0|||
170615112|NCT01445080|616597702|FG008|Overall Study|Ineligible/Inevaluable|6|||
170615113|NCT03887221|616597703|FG000|Overall Study|Protocol Violation|1|||
170615114|NCT03887221|616597704|FG001|Overall Study|Protocol Violation|0|||
170615115|NCT00983385|616597705|FG000|Observation Period|Not eligible to be dosed|20|||
170615116|NCT00983385|616597705|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
170615117|NCT03857542|616597706|FG000|Overall Study|Adverse Event|1|||
170615118|NCT03857542|616597707|FG001|Overall Study|Adverse Event|3|||
170615119|NCT03857542|616597706|FG000|Overall Study|Withdrawal by Subject|2|||
170615120|NCT03857542|616597707|FG001|Overall Study|Withdrawal by Subject|1|||
170615121|NCT03857542|616597706|FG000|Overall Study|Lost to Follow-up|2|||
170615122|NCT03857542|616597707|FG001|Overall Study|Lost to Follow-up|1|||
170615123|NCT03857542|616597706|FG000|Overall Study|Reason not Specified|1|||
170817230|NCT01005914|617338443|FG000|Overall Study|Adverse Event|4|||
170615124|NCT03857542|616597707|FG001|Overall Study|Reason not Specified|0|||
170615125|NCT02123576|616597708|FG000|Overall Study|Adverse Event|1|||
170615126|NCT02123576|616597709|FG001|Overall Study|Adverse Event|0|||
170615127|NCT00900029|616597711|FG000|Overall Study|Lost to Follow-up|0|||
170817231|NCT01005914|617338443|FG000|Overall Study|Death|4|||
170917091|NCT05923099|617697840|FG003|Overall Study|Adverse Event|2|||
170917092|NCT05923099|617697841|FG004|Overall Study|Adverse Event|1|||
170917093|NCT05923099|617697837|FG000|Overall Study|Lack of Efficacy|1|||
170917094|NCT05923099|617697838|FG001|Overall Study|Lack of Efficacy|2|||
170917095|NCT05923099|617697839|FG002|Overall Study|Lack of Efficacy|1|||
170917096|NCT05923099|617697840|FG003|Overall Study|Lack of Efficacy|1|||
170917097|NCT05923099|617697841|FG004|Overall Study|Lack of Efficacy|6|||
170917098|NCT05923099|617697837|FG000|Overall Study|Withdrawal by Subject|8|||
170917099|NCT05923099|617697838|FG001|Overall Study|Withdrawal by Subject|4|||
170917100|NCT05923099|617697839|FG002|Overall Study|Withdrawal by Subject|8|||
170917101|NCT05923099|617697840|FG003|Overall Study|Withdrawal by Subject|10|||
170917102|NCT05923099|617697841|FG004|Overall Study|Withdrawal by Subject|8|||
170917103|NCT05923099|617697837|FG000|Overall Study|Lost to Follow-up|2|||
170917104|NCT05923099|617697838|FG001|Overall Study|Lost to Follow-up|1|||
170917105|NCT05923099|617697839|FG002|Overall Study|Lost to Follow-up|1|||
170917106|NCT05923099|617697840|FG003|Overall Study|Lost to Follow-up|1|||
170917107|NCT05923099|617697841|FG004|Overall Study|Lost to Follow-up|1|||
170917108|NCT05923099|617697837|FG000|Overall Study|Protocol-specified withdrawal criteria, withdrawal by investigator, prohibited medication used|1|||
170917109|NCT05923099|617697838|FG001|Overall Study|Protocol-specified withdrawal criteria, withdrawal by investigator, prohibited medication used|1|||
170917110|NCT05923099|617697839|FG002|Overall Study|Protocol-specified withdrawal criteria, withdrawal by investigator, prohibited medication used|1|||
170917111|NCT05923099|617697840|FG003|Overall Study|Protocol-specified withdrawal criteria, withdrawal by investigator, prohibited medication used|1|||
170917112|NCT05923099|617697841|FG004|Overall Study|Protocol-specified withdrawal criteria, withdrawal by investigator, prohibited medication used|1|||
170917113|NCT05369832|617697842|FG000|Overall Study|Adverse Event|6|||
170917114|NCT05369832|617697843|FG001|Overall Study|Adverse Event|3|||
170917115|NCT05369832|617697842|FG000|Overall Study|Lost to Follow-up|1|||
170917116|NCT05369832|617697843|FG001|Overall Study|Lost to Follow-up|0|||
170917117|NCT05369832|617697842|FG000|Overall Study|Physician Decision|17|||
170917118|NCT05369832|617697843|FG001|Overall Study|Physician Decision|6|||
170917119|NCT05369832|617697842|FG000|Overall Study|Study terminated by sponsor|57|||
170615128|NCT00900029|616597712|FG001|Overall Study|Lost to Follow-up|2|||
170615129|NCT00900029|616597713|FG002|Overall Study|Lost to Follow-up|1|||
170615130|NCT00900029|616597714|FG003|Overall Study|Lost to Follow-up|4|||
170615131|NCT00900029|616597715|FG004|Overall Study|Lost to Follow-up|4|||
170615132|NCT00900029|616597711|FG000|Overall Study|Withdrawal by Subject|2|||
170615133|NCT00900029|616597712|FG001|Overall Study|Withdrawal by Subject|2|||
170615134|NCT00900029|616597713|FG002|Overall Study|Withdrawal by Subject|1|||
170615135|NCT00900029|616597714|FG003|Overall Study|Withdrawal by Subject|1|||
170615136|NCT00900029|616597715|FG004|Overall Study|Withdrawal by Subject|1|||
170615137|NCT00900029|616597711|FG000|Overall Study|Adverse Event|0|||
170615138|NCT00900029|616597712|FG001|Overall Study|Adverse Event|0|||
170615139|NCT00900029|616597713|FG002|Overall Study|Adverse Event|1|||
170615140|NCT00900029|616597714|FG003|Overall Study|Adverse Event|1|||
170615141|NCT00900029|616597715|FG004|Overall Study|Adverse Event|1|||
170615142|NCT00900029|616597711|FG000|Overall Study|Death|1|||
170615143|NCT00900029|616597712|FG001|Overall Study|Death|0|||
170615144|NCT00900029|616597713|FG002|Overall Study|Death|0|||
170615145|NCT00900029|616597714|FG003|Overall Study|Death|1|||
170615146|NCT00900029|616597715|FG004|Overall Study|Death|0|||
170615147|NCT02709330|616597716|FG000|Overall Study|Death|5|||
170615148|NCT02709330|616597717|FG001|Overall Study|Death|0|||
170615149|NCT02709330|616597716|FG000|Overall Study|Lost to Follow-up|2|||
170615150|NCT02709330|616597717|FG001|Overall Study|Lost to Follow-up|0|||
170615151|NCT02709330|616597716|FG000|Overall Study|Physician Decision|2|||
170615152|NCT02709330|616597717|FG001|Overall Study|Physician Decision|0|||
170615153|NCT02709330|616597716|FG000|Overall Study|Withdrawal by Subject|4|||
170615154|NCT02709330|616597717|FG001|Overall Study|Withdrawal by Subject|0|||
170615155|NCT02219464|616599019|FG000|Overall Study|Withdrawal by Subject|1|||
170615156|NCT02219464|616599020|FG001|Overall Study|Withdrawal by Subject|0|||
170615157|NCT02219464|616599019|FG000|Overall Study|case cancelled|1|||
170615158|NCT02219464|616599020|FG001|Overall Study|case cancelled|0|||
170615159|NCT02219464|616599019|FG000|Overall Study|catheter malfunction|1|||
170615160|NCT02219464|616599020|FG001|Overall Study|catheter malfunction|0|||
170917120|NCT05369832|617697843|FG001|Overall Study|Study terminated by sponsor|24|||
170917121|NCT05369832|617697842|FG000|Overall Study|Withdrawal by Subject|15|||
170917122|NCT05369832|617697843|FG001|Overall Study|Withdrawal by Subject|6|||
170917123|NCT05369832|617697842|FG000|Overall Study|Site is closing, site decided to early terminate participant|1|||
170917124|NCT05369832|617697843|FG001|Overall Study|Site is closing, site decided to early terminate participant|0|||
170917125|NCT05369832|617697842|FG000|Overall Study|Missing|2|||
170615161|NCT01121146|616599027|FG000|Overall Study|Death|17|||
170615162|NCT01121146|616599028|FG001|Overall Study|Death|15|||
170615163|NCT01121146|616599027|FG000|Overall Study|Adverse Event|2|||
170615164|NCT01121146|616599028|FG001|Overall Study|Adverse Event|11|||
170615165|NCT01121146|616599027|FG000|Overall Study|Lost to Follow-up|7|||
170615166|NCT01121146|616599028|FG001|Overall Study|Lost to Follow-up|16|||
170615167|NCT00997035|616599032|FG000|3-week Followup Visit|Lost to Follow-up|9|||
170660414|NCT02819518|616770278|FG002|Overall Study|Sponsor Decision|0|||
170660415|NCT02819518|616770279|FG003|Overall Study|Sponsor Decision|34|||
170660416|NCT02819518|616770280|FG004|Overall Study|Sponsor Decision|17|||
170660417|NCT02819518|616770276|FG000|Overall Study|Transferred to extension study|1|||
170660418|NCT02819518|616770277|FG001|Overall Study|Transferred to extension study|1|||
170660419|NCT02819518|616770278|FG002|Overall Study|Transferred to extension study|1|||
170660420|NCT02819518|616770279|FG003|Overall Study|Transferred to extension study|32|||
170660421|NCT02819518|616770280|FG004|Overall Study|Transferred to extension study|11|||
170660422|NCT02766465|616770281|FG000|Overall Study|Withdrawal by Subject|0|||
170660423|NCT02766465|616770282|FG001|Overall Study|Withdrawal by Subject|10|||
170660424|NCT01505647|616770283|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
170660425|NCT01505647|616770284|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
170660426|NCT01505647|616770283|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
170660427|NCT01505647|616770284|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
170660428|NCT01505647|616770283|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
170660429|NCT01505647|616770284|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
170660430|NCT01505647|616770283|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
170660431|NCT01505647|616770284|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
170660432|NCT01505647|616770283|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
170660433|NCT01505647|616770284|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
170660434|NCT01907100|616770285|FG000|Overall Study|PD based on modified RECIST criteria|31|||
170660435|NCT01907100|616770286|FG001|Overall Study|PD based on modified RECIST criteria|32|||
170660436|NCT01907100|616770287|FG002|Overall Study|PD based on modified RECIST criteria|95|||
170660437|NCT01907100|616770288|FG003|Overall Study|PD based on modified RECIST criteria|92|||
170660438|NCT01907100|616770285|FG000|Overall Study|Withdrawal by Subject|2|||
170660439|NCT01907100|616770286|FG001|Overall Study|Withdrawal by Subject|5|||
170660440|NCT01907100|616770287|FG002|Overall Study|Withdrawal by Subject|10|||
170660441|NCT01907100|616770288|FG003|Overall Study|Withdrawal by Subject|13|||
170660442|NCT01907100|616770285|FG000|Overall Study|Protocol Violation|0|||
170660443|NCT01907100|616770286|FG001|Overall Study|Protocol Violation|0|||
170660444|NCT01907100|616770287|FG002|Overall Study|Protocol Violation|1|||
170660445|NCT01907100|616770288|FG003|Overall Study|Protocol Violation|1|||
170660446|NCT01907100|616770285|FG000|Overall Study|Lost to Follow-up|0|||
170660447|NCT01907100|616770286|FG001|Overall Study|Lost to Follow-up|0|||
170660448|NCT01907100|616770287|FG002|Overall Study|Lost to Follow-up|0|||
170660449|NCT01907100|616770288|FG003|Overall Study|Lost to Follow-up|1|||
170660450|NCT01907100|616770285|FG000|Overall Study|Not treated|2|||
170660451|NCT01907100|616770286|FG001|Overall Study|Not treated|0|||
170660452|NCT01907100|616770287|FG002|Overall Study|Not treated|1|||
170660453|NCT01907100|616770288|FG003|Overall Study|Not treated|2|||
170660454|NCT01907100|616770285|FG000|Overall Study|Other than reasons specified|1|||
170660455|NCT01907100|616770286|FG001|Overall Study|Other than reasons specified|0|||
170660456|NCT01907100|616770287|FG002|Overall Study|Other than reasons specified|10|||
170660457|NCT01907100|616770288|FG003|Overall Study|Other than reasons specified|6|||
170660458|NCT01907100|616770285|FG000|Overall Study|Adverse event (AE)|6|||
170660459|NCT01907100|616770286|FG001|Overall Study|Adverse event (AE)|3|||
170660460|NCT01907100|616770287|FG002|Overall Study|Adverse event (AE)|22|||
170660461|NCT01907100|616770288|FG003|Overall Study|Adverse event (AE)|23|||
170660462|NCT01907100|616770285|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
170660463|NCT01907100|616770286|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
170660464|NCT01907100|616770287|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
170660465|NCT01907100|616770288|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
170660466|NCT00739596|616770289|FG000|Overall Study|Adverse Event|12|||
170660467|NCT00739596|616770290|FG001|Overall Study|Adverse Event|6|||
170660468|NCT00739596|616770289|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
170660469|NCT00739596|616770290|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170660470|NCT00739596|616770289|FG000|Overall Study|Patient Withdrew Consent|8|||
170660471|NCT00739596|616770290|FG001|Overall Study|Patient Withdrew Consent|8|||
170660472|NCT00739596|616770289|FG000|Overall Study|Lost to Follow-up|0|||
170660473|NCT00739596|616770290|FG001|Overall Study|Lost to Follow-up|2|||
170660474|NCT00739596|616770289|FG000|Overall Study|Protocol Deviation|1|||
170817232|NCT01005914|617338443|FG000|Overall Study|Lack of Efficacy|1|||
170660475|NCT00739596|616770290|FG001|Overall Study|Protocol Deviation|1|||
170660476|NCT01414608|616770291|FG000|Overall Study|Ineligible|5|||
170817233|NCT01005914|617338443|FG000|Overall Study|Withdrawal by Subject|1|||
170817234|NCT01613599|617338446|FG000|Overall Study|Death|9|||
170660477|NCT01414608|616770292|FG001|Overall Study|Ineligible|2|||
170660478|NCT03640559|616770293|FG000|Overall Study|Physician Decision|1|||
170660479|NCT03640559|616770294|FG001|Overall Study|Physician Decision|1|||
170660480|NCT03640559|616770293|FG000|Overall Study|Withdrawal by Subject|1|||
170660481|NCT03640559|616770294|FG001|Overall Study|Withdrawal by Subject|0|||
170660482|NCT02301988|616770295|FG000|Overall Study|Withdrawal by Subject|2|||
170660483|NCT02301988|616770296|FG001|Overall Study|Withdrawal by Subject|1|||
170660484|NCT02301988|616770295|FG000|Overall Study|Physician Decision|2|||
170660485|NCT02301988|616770296|FG001|Overall Study|Physician Decision|2|||
170660486|NCT02301988|616770295|FG000|Overall Study|Unknown Reason|1|||
170660487|NCT02301988|616770296|FG001|Overall Study|Unknown Reason|3|||
170660488|NCT02301988|616770295|FG000|Overall Study|Lack of Efficacy|3|||
170660489|NCT02301988|616770296|FG001|Overall Study|Lack of Efficacy|2|||
170660490|NCT02301988|616770295|FG000|Overall Study|Death|1|||
170660491|NCT02301988|616770296|FG001|Overall Study|Death|0|||
170660492|NCT02301988|616770295|FG000|Overall Study|Adverse Event|1|||
170660493|NCT02301988|616770296|FG001|Overall Study|Adverse Event|1|||
170660494|NCT01931202|616770299|FG000|Overall Study|Withdrawal by Subject|0|||
170660495|NCT01931202|616770300|FG001|Overall Study|Withdrawal by Subject|0|||
170660496|NCT01931202|616770301|FG002|Overall Study|Withdrawal by Subject|2|||
170660497|NCT01931202|616770299|FG000|Overall Study|Lost to Follow-up|0|||
170660498|NCT01931202|616770300|FG001|Overall Study|Lost to Follow-up|5|||
170660499|NCT01931202|616770301|FG002|Overall Study|Lost to Follow-up|2|||
170660500|NCT00285207|616770308|FG000|Overall Study|Lost to Follow-up|3|||
170660501|NCT00285207|616770309|FG001|Overall Study|Lost to Follow-up|2|||
170660502|NCT00285207|616770308|FG000|Overall Study|Withdrawal by Subject|5|||
170660503|NCT00285207|616770309|FG001|Overall Study|Withdrawal by Subject|2|||
170817235|NCT01613599|617338446|FG000|Overall Study|Lost to Follow-up|5|||
170615168|NCT00997035|616599033|FG001|3-week Followup Visit|Lost to Follow-up|6|||
170615169|NCT00997035|616599032|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
170615170|NCT00997035|616599033|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
170615171|NCT03922581|616599036|FG000|Overall Study|Lost to Follow-up|20|||
170615172|NCT03922581|616599037|FG001|Overall Study|Lost to Follow-up|9|||
170615173|NCT03922581|616599036|FG000|Overall Study|Physician Decision|1|||
170615174|NCT03922581|616599037|FG001|Overall Study|Physician Decision|1|||
170615175|NCT03922581|616599036|FG000|Overall Study|Withdrawal by Subject|1|||
170615176|NCT03922581|616599037|FG001|Overall Study|Withdrawal by Subject|0|||
170615177|NCT02223715|616599043|FG000|Overall Study|Death|31|||
170615178|NCT02223715|616599043|FG000|Overall Study|Lost to Follow-up|73|||
170615179|NCT02222558|616599044|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
170615180|NCT02222558|616599045|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
170615181|NCT02222558|616599046|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
170615182|NCT02222558|616599047|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
170615183|NCT02222558|616599048|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
170615184|NCT02222558|616599049|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
170615185|NCT02222558|616599044|FG000|Period 3|Withdrawal by Subject|0|||
170615186|NCT02222558|616599045|FG001|Period 3|Withdrawal by Subject|0|||
170615187|NCT02222558|616599046|FG002|Period 3|Withdrawal by Subject|0|||
170615188|NCT02222558|616599047|FG003|Period 3|Withdrawal by Subject|0|||
170615189|NCT02222558|616599048|FG004|Period 3|Withdrawal by Subject|0|||
170615190|NCT02222558|616599049|FG005|Period 3|Withdrawal by Subject|1|||
170615191|NCT02107703|616599051|FG000|Overall Study|Withdrawal by Subject|46|||
170615192|NCT02107703|616599052|FG001|Overall Study|Withdrawal by Subject|21|||
170615193|NCT02107703|616599051|FG000|Overall Study|Lost to Follow-up|20|||
170615194|NCT02107703|616599052|FG001|Overall Study|Lost to Follow-up|9|||
170615195|NCT02107703|616599051|FG000|Overall Study|On study treatment/follow up|48|||
170615196|NCT02107703|616599052|FG001|Overall Study|On study treatment/follow up|5|||
170615197|NCT02532465|616599053|FG000|Overall Study|Protocol Violation|1|||
170615198|NCT02532465|616599054|FG001|Overall Study|Protocol Violation|0|||
170615199|NCT02532465|616599053|FG000|Overall Study|Lack of Efficacy|0|||
170615200|NCT02532465|616599054|FG001|Overall Study|Lack of Efficacy|1|||
170615201|NCT01359904|616599059|FG000|Overall Study|Withdrawal by Subject|1|||
170615202|NCT01359904|616599060|FG001|Overall Study|Withdrawal by Subject|0|||
170615203|NCT00466440|616599061|FG000|Overall Study|Adverse Event|0|||
170615204|NCT00466440|616599062|FG001|Overall Study|Adverse Event|3|||
170615205|NCT00466440|616599063|FG002|Overall Study|Adverse Event|1|||
170615206|NCT00466440|616599061|FG000|Overall Study|Death|1|||
170615207|NCT00466440|616599062|FG001|Overall Study|Death|1|||
170615208|NCT00466440|616599063|FG002|Overall Study|Death|0|||
170615209|NCT00466440|616599061|FG000|Overall Study|Progressive disease|13|||
170615210|NCT00466440|616599062|FG001|Overall Study|Progressive disease|5|||
170615211|NCT00466440|616599063|FG002|Overall Study|Progressive disease|4|||
170615212|NCT00466440|616599061|FG000|Overall Study|Lost to Follow-up|0|||
170660504|NCT00285207|616770308|FG000|Overall Study|Pregnancy|1|||
170660505|NCT00285207|616770309|FG001|Overall Study|Pregnancy|1|||
170660506|NCT00285207|616770308|FG000|Overall Study|non-compliance|0|||
170660507|NCT00285207|616770309|FG001|Overall Study|non-compliance|1|||
170615213|NCT00466440|616599062|FG001|Overall Study|Lost to Follow-up|1|||
170660508|NCT02160782|616772613|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
170660509|NCT02160782|616772614|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
170615214|NCT00466440|616599063|FG002|Overall Study|Lost to Follow-up|0|||
170615215|NCT00466440|616599061|FG000|Overall Study|Physician Decision|0|||
170660510|NCT02160782|616772615|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
170660511|NCT02160782|616772616|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
170917126|NCT05369832|617697843|FG001|Overall Study|Missing|1|||
170615216|NCT00466440|616599062|FG001|Overall Study|Physician Decision|1|||
170615217|NCT00466440|616599063|FG002|Overall Study|Physician Decision|2|||
170615218|NCT00466440|616599061|FG000|Overall Study|Protocol entry criteria not met|0|||
170615219|NCT00466440|616599062|FG001|Overall Study|Protocol entry criteria not met|0|||
170615220|NCT00466440|616599063|FG002|Overall Study|Protocol entry criteria not met|4|||
170615221|NCT00466440|616599061|FG000|Overall Study|Withdrawal by Subject|0|||
170615222|NCT00466440|616599062|FG001|Overall Study|Withdrawal by Subject|1|||
170615223|NCT00466440|616599063|FG002|Overall Study|Withdrawal by Subject|0|||
170615224|NCT00466440|616599061|FG000|Overall Study|Sponsor decision|0|||
170615225|NCT00466440|616599062|FG001|Overall Study|Sponsor decision|0|||
170615226|NCT00466440|616599063|FG002|Overall Study|Sponsor decision|1|||
170615227|NCT03187132|616599064|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
170615228|NCT03187132|616599065|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
170615229|NCT03187132|616599064|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
170615230|NCT03187132|616599065|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
170615231|NCT03187132|616599064|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
170615232|NCT03187132|616599065|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
170615233|NCT03187132|616599064|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
170615234|NCT03187132|616599065|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
170615235|NCT03187132|616599064|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
170615236|NCT03187132|616599065|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
170615237|NCT03187132|616599064|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
170615238|NCT03187132|616599065|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
170615239|NCT03187132|616599064|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
170615240|NCT03187132|616599065|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
170615241|NCT03187132|616599064|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
170615242|NCT03187132|616599065|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
170615243|NCT03187132|616599064|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
170615244|NCT03187132|616599065|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
170615245|NCT03187132|616599064|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
170615246|NCT03187132|616599065|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
170615247|NCT03187132|616599064|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
170615248|NCT03187132|616599065|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
170615249|NCT02396212|616599071|FG000|Overall Study|Adverse Event|1|||
170615250|NCT02396212|616599071|FG000|Overall Study|Lack of Efficacy|2|||
170615251|NCT01623115|616599072|FG000|Overall Study|Randomized but not treated|0|||
170615252|NCT01623115|616599073|FG001|Overall Study|Randomized but not treated|1|||
170615253|NCT01623115|616599072|FG000|Overall Study|Physician Decision|1|||
170615254|NCT01623115|616599073|FG001|Overall Study|Physician Decision|0|||
170615255|NCT01623115|616599072|FG000|Overall Study|Participants moved|1|||
170615256|NCT01623115|616599073|FG001|Overall Study|Participants moved|5|||
170615257|NCT01623115|616599072|FG000|Overall Study|Adverse Event|10|||
170615258|NCT01623115|616599073|FG001|Overall Study|Adverse Event|13|||
170615259|NCT01623115|616599072|FG000|Overall Study|Poor compliance to protocol|4|||
170615260|NCT01623115|616599073|FG001|Overall Study|Poor compliance to protocol|10|||
170615261|NCT01623115|616599072|FG000|Overall Study|Consent withdrawn by participant|2|||
170615262|NCT01623115|616599073|FG001|Overall Study|Consent withdrawn by participant|6|||
170615263|NCT01623115|616599072|FG000|Overall Study|Related to study drug administration|0|||
170615264|NCT01623115|616599073|FG001|Overall Study|Related to study drug administration|2|||
170615265|NCT01623115|616599072|FG000|Overall Study|Last visit outside protocol visit window|14|||
170615266|NCT01623115|616599073|FG001|Overall Study|Last visit outside protocol visit window|26|||
170615267|NCT01623115|616599072|FG000|Overall Study|Site closure|1|||
170615268|NCT01623115|616599073|FG001|Overall Study|Site closure|7|||
170615269|NCT01623115|616599072|FG000|Overall Study|Death|0|||
170615270|NCT01623115|616599073|FG001|Overall Study|Death|4|||
170615271|NCT01623115|616599072|FG000|Overall Study|Other than specified above|0|||
170615272|NCT01623115|616599073|FG001|Overall Study|Other than specified above|3|||
170615273|NCT02336230|616599078|FG000|Overall Study|Adverse Event|1|||
170615274|NCT02336230|616599078|FG000|Overall Study|Withdrawal of consent|1|||
170615275|NCT02336230|616599078|FG000|Overall Study|Death|9|||
170615276|NCT02336230|616599078|FG000|Overall Study|Dose not received due to shipping delay|1|||
170615277|NCT02336230|616599078|FG000|Overall Study|Discontinuation of MSC infusion|1|||
170615278|NCT01788566|616599089|FG000|Overall Study|Death|4|||
170917127|NCT04002362|617697846|FG000|Overall Study|Lost to Follow-up|1|||
170615279|NCT01788566|616599089|FG000|Overall Study|Adverse Event|1|||
170615280|NCT01788566|616599089|FG000|Overall Study|Clinical Progressive Disease|3|||
170615281|NCT01620086|616599090|FG000|Overall Study|Withdrawal by Subject|3|||
170615282|NCT01620086|616599091|FG001|Overall Study|Withdrawal by Subject|3|||
170615283|NCT01620086|616599092|FG002|Overall Study|Withdrawal by Subject|0|||
170615284|NCT01620086|616599090|FG000|Overall Study|failed study criteria|1|||
170615285|NCT01620086|616599091|FG001|Overall Study|failed study criteria|4|||
170615286|NCT01620086|616599092|FG002|Overall Study|failed study criteria|0|||
170615287|NCT01620086|616599090|FG000|Overall Study|Physician Decision|1|||
170817236|NCT01613599|617338446|FG000|Overall Study|Withdrawal by Subject|8|||
170817237|NCT01613599|617338446|FG000|Overall Study|Reason not specified|3|||
170817238|NCT02132195|617338447|FG000|Initial Assignment|Relapsed|14|||
170817239|NCT02132195|617338448|FG001|Initial Assignment|Relapsed|0|||
170817240|NCT02132195|617338449|FG002|Initial Assignment|Relapsed|0|||
170817241|NCT02132195|617338447|FG000|Rescue Therapy|Relapsed|0|||
170817242|NCT02132195|617338448|FG001|Rescue Therapy|Relapsed|0|||
170817243|NCT02132195|617338449|FG002|Rescue Therapy|Relapsed|7|||
170817244|NCT02132195|617338447|FG000|Rescue Therapy|Physician Decision|0|||
170817245|NCT02132195|617338448|FG001|Rescue Therapy|Physician Decision|0|||
170817246|NCT02132195|617338449|FG002|Rescue Therapy|Physician Decision|1|||
170817247|NCT02132195|617338447|FG000|Rescue Therapy|Withdrawal by Subject|0|||
170817248|NCT02132195|617338448|FG001|Rescue Therapy|Withdrawal by Subject|0|||
170817249|NCT02132195|617338449|FG002|Rescue Therapy|Withdrawal by Subject|1|||
170817250|NCT02132195|617338447|FG000|Rescue Therapy|Adverse Event|0|||
170817251|NCT02132195|617338448|FG001|Rescue Therapy|Adverse Event|0|||
170817252|NCT02132195|617338449|FG002|Rescue Therapy|Adverse Event|2|||
170817253|NCT03503188|617338450|FG000|Overall Study|Non eligible in the sub study|0|||
170817254|NCT03503188|617338451|FG001|Overall Study|Non eligible in the sub study|1|||
170817255|NCT02513667|617338457|FG000|Overall Study|Withdrawal by Subject|0|||
170817256|NCT02513667|617338458|FG001|Overall Study|Withdrawal by Subject|1|||
170817257|NCT00655824|617338463|FG000|Overall Study|Adverse Event|3|||
170817258|NCT00655824|617338463|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
170817259|NCT00655824|617338463|FG000|Overall Study|Protocol Violation|1|||
170817260|NCT00655824|617338463|FG000|Overall Study|Withdrawal by Subject|4|||
170817261|NCT00655824|617338463|FG000|Overall Study|Deterioration of Trial Disease|2|||
170817262|NCT03032198|617338465|FG000|Overall Study|Screen Fail|1|||
170817263|NCT02367794|617338474|FG000|Overall Study|Death|252|||
170817264|NCT02367794|617338475|FG001|Overall Study|Death|245|||
170817265|NCT02367794|617338476|FG002|Overall Study|Death|243|||
170817266|NCT02367794|617338474|FG000|Overall Study|Lost to Follow-up|1|||
170817267|NCT02367794|617338475|FG001|Overall Study|Lost to Follow-up|2|||
170817268|NCT02367794|617338476|FG002|Overall Study|Lost to Follow-up|2|||
170817269|NCT02367794|617338474|FG000|Overall Study|Physician Decision|0|||
170817270|NCT02367794|617338475|FG001|Overall Study|Physician Decision|5|||
170817271|NCT02367794|617338476|FG002|Overall Study|Physician Decision|3|||
170817272|NCT02367794|617338474|FG000|Overall Study|Protocol Violation|1|||
170817273|NCT02367794|617338475|FG001|Overall Study|Protocol Violation|0|||
170817274|NCT02367794|617338476|FG002|Overall Study|Protocol Violation|1|||
170817275|NCT02367794|617338474|FG000|Overall Study|Withdrawal by Subject|25|||
170817276|NCT02367794|617338475|FG001|Overall Study|Withdrawal by Subject|12|||
170817277|NCT02367794|617338476|FG002|Overall Study|Withdrawal by Subject|20|||
170817278|NCT02367794|617338474|FG000|Overall Study|Brain metastasis|1|||
170817279|NCT02367794|617338475|FG001|Overall Study|Brain metastasis|0|||
170817280|NCT02367794|617338476|FG002|Overall Study|Brain metastasis|0|||
170817281|NCT02367794|617338474|FG000|Overall Study|Randomized in error|0|||
170817282|NCT02367794|617338475|FG001|Overall Study|Randomized in error|0|||
170817283|NCT02367794|617338476|FG002|Overall Study|Randomized in error|1|||
170817284|NCT02367794|617338474|FG000|Overall Study|Patient unable to receive carboplatin|0|||
170817285|NCT02367794|617338475|FG001|Overall Study|Patient unable to receive carboplatin|0|||
170817286|NCT02367794|617338476|FG002|Overall Study|Patient unable to receive carboplatin|1|||
170817287|NCT02367794|617338474|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
170817288|NCT02367794|617338475|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
170817289|NCT02367794|617338476|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
170817290|NCT02367794|617338474|FG000|Overall Study|Adverse Event|0|||
170817291|NCT02367794|617338475|FG001|Overall Study|Adverse Event|0|||
170817292|NCT02367794|617338476|FG002|Overall Study|Adverse Event|2|||
170817293|NCT02367794|617338474|FG000|Overall Study|Study Terminated By Sponsor|0|||
170817294|NCT02367794|617338475|FG001|Overall Study|Study Terminated By Sponsor|1|||
170817295|NCT02367794|617338476|FG002|Overall Study|Study Terminated By Sponsor|1|||
170817296|NCT02367794|617338474|FG000|Overall Study|Moved to Roll-Over Study|0|||
170817297|NCT02367794|617338475|FG001|Overall Study|Moved to Roll-Over Study|15|||
170615288|NCT01620086|616599091|FG001|Overall Study|Physician Decision|0|||
170615289|NCT01620086|616599092|FG002|Overall Study|Physician Decision|0|||
170615290|NCT02721875|616599095|FG000|Overall Study|Progressive disease/relapse|1|||
170615291|NCT02721875|616599096|FG001|Overall Study|Progressive disease/relapse|0|||
170615292|NCT00857285|616599099|FG000|Overall Study|Adverse Event|4|||
170615293|NCT00857285|616599100|FG001|Overall Study|Adverse Event|2|||
170615294|NCT00857285|616599099|FG000|Overall Study|Lack of Efficacy|0|||
170615295|NCT00857285|616599100|FG001|Overall Study|Lack of Efficacy|2|||
170615296|NCT00857285|616599099|FG000|Overall Study|Protocol Violation|3|||
170615297|NCT00857285|616599100|FG001|Overall Study|Protocol Violation|1|||
170615298|NCT00857285|616599099|FG000|Overall Study|Withdrawal by Subject|4|||
170615299|NCT00857285|616599100|FG001|Overall Study|Withdrawal by Subject|0|||
170615300|NCT00857285|616599099|FG000|Overall Study|Randomization criteria not met|1|||
170615301|NCT00857285|616599100|FG001|Overall Study|Randomization criteria not met|1|||
170615302|NCT01539759|616599108|FG000|Overall Study|Lost to Follow-up|6|||
170615303|NCT01539759|616599109|FG001|Overall Study|Lost to Follow-up|8|||
170660512|NCT02160782|616772617|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
170660513|NCT02160782|616772613|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
170660514|NCT02160782|616772614|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
170660515|NCT02160782|616772615|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
170660516|NCT02160782|616772616|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
170660517|NCT02160782|616772617|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
170660518|NCT02160782|616772613|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
170660519|NCT02160782|616772614|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
170660520|NCT02160782|616772615|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
170660521|NCT02160782|616772616|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
170660522|NCT02160782|616772617|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
170660523|NCT02160782|616772613|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
170660524|NCT02160782|616772614|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
170660525|NCT02160782|616772615|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
170660526|NCT02160782|616772616|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
170660527|NCT02160782|616772617|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
170660528|NCT02160782|616772613|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
170660529|NCT02160782|616772614|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
170660530|NCT02160782|616772615|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
170660531|NCT02160782|616772616|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
170660532|NCT02160782|616772617|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
170660533|NCT02160782|616772613|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
170660534|NCT02160782|616772614|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
170660535|NCT02160782|616772615|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
170660536|NCT02160782|616772616|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
170660537|NCT02160782|616772617|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
170660538|NCT02160782|616772613|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
170660539|NCT02160782|616772614|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
170660540|NCT02160782|616772615|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
170660541|NCT02160782|616772616|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
170660542|NCT02160782|616772617|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
170660543|NCT01083485|616772620|FG000|Overall Study|Adverse Event|0|||
170660544|NCT01083485|616772621|FG001|Overall Study|Adverse Event|1|||
170660545|NCT01083485|616772620|FG000|Overall Study|Protocol Violation|1|||
170660546|NCT01083485|616772621|FG001|Overall Study|Protocol Violation|0|||
170660547|NCT01083485|616772620|FG000|Overall Study|Withdrawal by Subject|5|||
170660548|NCT01083485|616772621|FG001|Overall Study|Withdrawal by Subject|2|||
170660549|NCT01083485|616772620|FG000|Overall Study|Other|1|||
170660550|NCT01083485|616772621|FG001|Overall Study|Other|0|||
170660551|NCT00084838|616772624|FG000|Overall Study|Death|1|||
170660552|NCT00084838|616772624|FG000|Overall Study|Adverse Event|2|||
170660553|NCT00084838|616772624|FG000|Overall Study|Withdrawal by Subject|1|||
170660554|NCT00084838|616772624|FG000|Overall Study|Progressive Disease|4|||
170660555|NCT00084838|616772624|FG000|Overall Study|Pt Non-Compliance|1|||
170660556|NCT00084838|616772624|FG000|Overall Study|Ineligible|4|||
170660557|NCT05036369|616772626|FG000|Overall Study|Run In non compliance|1|||
170660558|NCT05036369|616772627|FG001|Overall Study|Run In non compliance|2|||
170660559|NCT05036369|616772626|FG000|Overall Study|Change in eligibility criteria|0|||
170660560|NCT05036369|616772627|FG001|Overall Study|Change in eligibility criteria|1|||
170660561|NCT01846104|616772628|FG000|Overall Study|Withdrawal by Subject|1|||
170660562|NCT00851630|616772632|FG000|Overall Study|Death|2|||
170660563|NCT00851630|616772633|FG001|Overall Study|Death|1|||
170660564|NCT00851630|616772632|FG000|Overall Study|Clinical failure|0|||
170660565|NCT00851630|616772633|FG001|Overall Study|Clinical failure|1|||
170660566|NCT01854658|616772640|FG000|Overall Study|Protocol Violation|6|||
170660567|NCT01854658|616772641|FG001|Overall Study|Protocol Violation|2|||
170660568|NCT01854658|616772642|FG002|Overall Study|Protocol Violation|2|||
170660569|NCT01854658|616772643|FG003|Overall Study|Protocol Violation|1|||
170660570|NCT01854658|616772640|FG000|Overall Study|Physician Decision|7|||
170660571|NCT01854658|616772641|FG001|Overall Study|Physician Decision|5|||
170660572|NCT01854658|616772642|FG002|Overall Study|Physician Decision|2|||
170660573|NCT01854658|616772643|FG003|Overall Study|Physician Decision|4|||
170660574|NCT01854658|616772640|FG000|Overall Study|Lost to Follow-up|8|||
170817298|NCT02367794|617338476|FG002|Overall Study|Moved to Roll-Over Study|13|||
170817299|NCT02367794|617338474|FG000|Overall Study|Sponsor Request|60|||
170817300|NCT02367794|617338475|FG001|Overall Study|Sponsor Request|57|||
170817301|NCT02367794|617338476|FG002|Overall Study|Sponsor Request|45|||
170817302|NCT02367794|617338474|FG000|Overall Study|Moved into PTAP Study|0|||
170817303|NCT02367794|617338475|FG001|Overall Study|Moved into PTAP Study|2|||
170817304|NCT02367794|617338476|FG002|Overall Study|Moved into PTAP Study|3|||
170817305|NCT02367794|617338474|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
170817306|NCT02367794|617338475|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
170817307|NCT02367794|617338476|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
170817308|NCT02367794|617338474|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
170817309|NCT02367794|617338475|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
170817310|NCT02367794|617338476|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
170817311|NCT02367794|617338474|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
170817312|NCT02367794|617338475|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
170817313|NCT02367794|617338476|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
170817314|NCT02367794|617338474|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
170817315|NCT02367794|617338475|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
170817316|NCT02367794|617338476|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
170817317|NCT02158806|617338487|FG000|Overall Study|Death|2|||
170817318|NCT02158806|617338488|FG001|Overall Study|Death|0|||
170817319|NCT02158806|617338487|FG000|Overall Study|Withdrawal by Subject|2|||
170817320|NCT02158806|617338488|FG001|Overall Study|Withdrawal by Subject|0|||
170615304|NCT03386721|616599110|FG000|Overall Study|Death|12|||
170615305|NCT03386721|616599111|FG001|Overall Study|Death|21|||
170615306|NCT03386721|616599112|FG002|Overall Study|Death|2|||
170615307|NCT03386721|616599113|FG003|Overall Study|Death|5|||
170615308|NCT03386721|616599114|FG004|Overall Study|Death|1|||
170615309|NCT03386721|616599115|FG005|Overall Study|Death|12|||
170615310|NCT03386721|616599116|FG006|Overall Study|Death|1|||
170615311|NCT03386721|616599117|FG007|Overall Study|Death|1|||
170615312|NCT03386721|616599118|FG008|Overall Study|Death|12|||
170615313|NCT03386721|616599119|FG009|Overall Study|Death|20|||
170615314|NCT03386721|616599120|FG010|Overall Study|Death|21|||
170615315|NCT03386721|616599121|FG011|Overall Study|Death|21|||
170615316|NCT03386721|616599122|FG012|Overall Study|Death|14|||
170615317|NCT03386721|616599123|FG013|Overall Study|Death|2|||
170615318|NCT03386721|616599124|FG014|Overall Study|Death|1|||
170615319|NCT03386721|616599110|FG000|Overall Study|Lost to Follow-up|1|||
170615320|NCT03386721|616599111|FG001|Overall Study|Lost to Follow-up|3|||
170615321|NCT03386721|616599112|FG002|Overall Study|Lost to Follow-up|0|||
170615322|NCT03386721|616599113|FG003|Overall Study|Lost to Follow-up|0|||
170615323|NCT03386721|616599114|FG004|Overall Study|Lost to Follow-up|0|||
170615324|NCT03386721|616599115|FG005|Overall Study|Lost to Follow-up|2|||
170615325|NCT03386721|616599116|FG006|Overall Study|Lost to Follow-up|1|||
170615326|NCT03386721|616599117|FG007|Overall Study|Lost to Follow-up|0|||
170615327|NCT03386721|616599118|FG008|Overall Study|Lost to Follow-up|1|||
170615328|NCT03386721|616599119|FG009|Overall Study|Lost to Follow-up|2|||
170615329|NCT03386721|616599120|FG010|Overall Study|Lost to Follow-up|1|||
170615330|NCT03386721|616599121|FG011|Overall Study|Lost to Follow-up|0|||
170615331|NCT03386721|616599122|FG012|Overall Study|Lost to Follow-up|0|||
170615332|NCT03386721|616599123|FG013|Overall Study|Lost to Follow-up|0|||
170615333|NCT03386721|616599124|FG014|Overall Study|Lost to Follow-up|0|||
170615334|NCT03386721|616599110|FG000|Overall Study|Reason not specified|3|||
170615335|NCT03386721|616599111|FG001|Overall Study|Reason not specified|0|||
170615336|NCT03386721|616599112|FG002|Overall Study|Reason not specified|0|||
170615337|NCT03386721|616599113|FG003|Overall Study|Reason not specified|0|||
170615338|NCT03386721|616599114|FG004|Overall Study|Reason not specified|0|||
170615339|NCT03386721|616599115|FG005|Overall Study|Reason not specified|3|||
170615340|NCT03386721|616599116|FG006|Overall Study|Reason not specified|1|||
170615341|NCT03386721|616599117|FG007|Overall Study|Reason not specified|0|||
170615342|NCT03386721|616599118|FG008|Overall Study|Reason not specified|0|||
170615343|NCT03386721|616599119|FG009|Overall Study|Reason not specified|1|||
170615344|NCT03386721|616599120|FG010|Overall Study|Reason not specified|2|||
170615345|NCT03386721|616599121|FG011|Overall Study|Reason not specified|6|||
170615346|NCT03386721|616599122|FG012|Overall Study|Reason not specified|1|||
170615347|NCT03386721|616599123|FG013|Overall Study|Reason not specified|0|||
170615348|NCT03386721|616599124|FG014|Overall Study|Reason not specified|0|||
170615349|NCT03386721|616599110|FG000|Overall Study|Progressive Disease|0|||
170615350|NCT03386721|616599111|FG001|Overall Study|Progressive Disease|0|||
170615351|NCT03386721|616599112|FG002|Overall Study|Progressive Disease|1|||
170615352|NCT03386721|616599113|FG003|Overall Study|Progressive Disease|0|||
170615353|NCT03386721|616599114|FG004|Overall Study|Progressive Disease|0|||
170615354|NCT03386721|616599115|FG005|Overall Study|Progressive Disease|1|||
170615355|NCT03386721|616599116|FG006|Overall Study|Progressive Disease|0|||
170615356|NCT03386721|616599117|FG007|Overall Study|Progressive Disease|0|||
170615357|NCT03386721|616599118|FG008|Overall Study|Progressive Disease|2|||
170615358|NCT03386721|616599119|FG009|Overall Study|Progressive Disease|1|||
170615359|NCT03386721|616599120|FG010|Overall Study|Progressive Disease|1|||
170615360|NCT03386721|616599121|FG011|Overall Study|Progressive Disease|0|||
170615361|NCT03386721|616599122|FG012|Overall Study|Progressive Disease|1|||
170615362|NCT03386721|616599123|FG013|Overall Study|Progressive Disease|0|||
170615363|NCT03386721|616599124|FG014|Overall Study|Progressive Disease|0|||
170660575|NCT01854658|616772641|FG001|Overall Study|Lost to Follow-up|9|||
170660576|NCT01854658|616772642|FG002|Overall Study|Lost to Follow-up|8|||
170660577|NCT01854658|616772643|FG003|Overall Study|Lost to Follow-up|4|||
170660578|NCT01854658|616772640|FG000|Overall Study|Withdrawal by Subject|28|||
170660579|NCT01854658|616772641|FG001|Overall Study|Withdrawal by Subject|21|||
170660580|NCT01854658|616772642|FG002|Overall Study|Withdrawal by Subject|29|||
170660581|NCT01854658|616772643|FG003|Overall Study|Withdrawal by Subject|15|||
170660582|NCT01854658|616772640|FG000|Overall Study|Protocol-specified criteria|15|||
170660583|NCT01854658|616772641|FG001|Overall Study|Protocol-specified criteria|15|||
170660584|NCT01854658|616772642|FG002|Overall Study|Protocol-specified criteria|10|||
170660585|NCT01854658|616772643|FG003|Overall Study|Protocol-specified criteria|7|||
170660586|NCT01854658|616772640|FG000|Overall Study|Lack of Efficacy|3|||
170660587|NCT01854658|616772641|FG001|Overall Study|Lack of Efficacy|8|||
170660588|NCT01854658|616772642|FG002|Overall Study|Lack of Efficacy|4|||
170660589|NCT01854658|616772643|FG003|Overall Study|Lack of Efficacy|7|||
170660590|NCT01854658|616772640|FG000|Overall Study|Adverse Event|21|||
170660591|NCT01854658|616772641|FG001|Overall Study|Adverse Event|14|||
170660592|NCT01854658|616772642|FG002|Overall Study|Adverse Event|23|||
170660593|NCT01854658|616772643|FG003|Overall Study|Adverse Event|19|||
170660594|NCT01854658|616772640|FG000|Overall Study|Administrative reasons|5|||
170660595|NCT01854658|616772641|FG001|Overall Study|Administrative reasons|1|||
170660596|NCT01854658|616772642|FG002|Overall Study|Administrative reasons|2|||
170660597|NCT01854658|616772643|FG003|Overall Study|Administrative reasons|2|||
170660598|NCT03906461|616772644|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
170660599|NCT03906461|616772644|FG000|Completed 12-month Follow-up|Missed Visit|6|||
170660600|NCT01442038|616772645|FG000|Overall Study|Death|35|||
170660601|NCT01442038|616772646|FG001|Overall Study|Death|29|||
170660602|NCT01442038|616772645|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
170660603|NCT01442038|616772646|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
170660604|NCT01442038|616772645|FG000|Overall Study|Participant Withdrew Consent|137|||
170660605|NCT01442038|616772646|FG001|Overall Study|Participant Withdrew Consent|102|||
170660606|NCT01442038|616772645|FG000|Overall Study|Lost to Follow-up|37|||
170660607|NCT01442038|616772646|FG001|Overall Study|Lost to Follow-up|51|||
170660608|NCT01442038|616772645|FG000|Overall Study|Adverse Event|26|||
170660609|NCT01442038|616772646|FG001|Overall Study|Adverse Event|15|||
170660610|NCT01442038|616772645|FG000|Overall Study|Protocol Deviation|9|||
170660611|NCT01442038|616772646|FG001|Overall Study|Protocol Deviation|20|||
170660612|NCT01442038|616772645|FG000|Overall Study|Investigator's Discretion|13|||
170660613|NCT01442038|616772646|FG001|Overall Study|Investigator's Discretion|16|||
170660614|NCT01442038|616772645|FG000|Overall Study|Study Terminated By Sponsor|2|||
170660615|NCT01442038|616772646|FG001|Overall Study|Study Terminated By Sponsor|3|||
170660616|NCT03061097|616772647|FG000|Overall Study|Withdrawal by Subject|0|||
170660617|NCT03061097|616772648|FG001|Overall Study|Withdrawal by Subject|3|||
170660618|NCT03956056|616772655|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
170660619|NCT03956056|616772655|FG000|Overall Study|Lack of Efficacy|1|||
170660620|NCT00422097|616772656|FG000|Dose Level 2|Still on treatment|0|||
170660621|NCT00422097|616772657|FG001|Dose Level 2|Still on treatment|1|||
170660622|NCT00422097|616772658|FG002|Dose Level 2|Still on treatment|0|||
170660623|NCT00422097|616772659|FG003|Dose Level 2|Still on treatment|0|||
170660624|NCT00422097|616772660|FG004|Dose Level 2|Still on treatment|0|||
170660625|NCT00422097|616772661|FG005|Dose Level 2|Still on treatment|0|||
170660626|NCT00422097|616772662|FG006|Dose Level 2|Still on treatment|0|||
170660627|NCT00422097|616772663|FG007|Dose Level 2|Still on treatment|0|||
170660628|NCT02360995|616772664|FG000|Overall Study|Lost to Follow-up|2|||
170660629|NCT02360995|616772665|FG001|Overall Study|Lost to Follow-up|0|||
170660630|NCT02360995|616772666|FG002|Overall Study|Lost to Follow-up|2|||
170660631|NCT02360995|616772664|FG000|Overall Study|Withdrawal by Subject|0|||
170660632|NCT02360995|616772665|FG001|Overall Study|Withdrawal by Subject|1|||
170660633|NCT02360995|616772666|FG002|Overall Study|Withdrawal by Subject|0|||
170660634|NCT00331864|616772675|FG000|Overall Study|Adverse Event|30|||
170660635|NCT00331864|616772676|FG001|Overall Study|Adverse Event|1|||
170660636|NCT00331864|616772675|FG000|Overall Study|Lack of Efficacy|4|||
170660637|NCT00331864|616772676|FG001|Overall Study|Lack of Efficacy|0|||
170660638|NCT00331864|616772675|FG000|Overall Study|Protocol Violation|3|||
170660639|NCT00331864|616772676|FG001|Overall Study|Protocol Violation|0|||
170660640|NCT00331864|616772675|FG000|Overall Study|Withdrawal by Subject|10|||
170660641|NCT00331864|616772676|FG001|Overall Study|Withdrawal by Subject|0|||
170660642|NCT00331864|616772675|FG000|Overall Study|Lost to Follow-up|4|||
170660643|NCT00331864|616772676|FG001|Overall Study|Lost to Follow-up|3|||
170660644|NCT00331864|616772675|FG000|Overall Study|Administrative Problems|1|||
170660645|NCT00331864|616772676|FG001|Overall Study|Administrative Problems|0|||
170660646|NCT00331864|616772675|FG000|Overall Study|Death|6|||
170660647|NCT00331864|616772676|FG001|Overall Study|Death|0|||
170660648|NCT00137631|616772677|FG000|Overall Study|Lost to Follow-up|37|||
170660649|NCT00137631|616772678|FG001|Overall Study|Lost to Follow-up|41|||
170660650|NCT01092507|616772679|FG000|Overall Study|Withdrawal by Subject|2|||
170660651|NCT01092507|616772680|FG001|Overall Study|Withdrawal by Subject|0|||
170660652|NCT01409434|616772682|FG000|Overall Study|Protocol Violation|4|||
170660653|NCT00293215|616772683|FG000|Overall Study|Progressive disease|3|||
170660654|NCT00293215|616772684|FG001|Overall Study|Progressive disease|1|||
170660655|NCT00293215|616772683|FG000|Overall Study|Adverse Event|2|||
170660656|NCT00293215|616772684|FG001|Overall Study|Adverse Event|2|||
170660657|NCT04131556|616772689|FG000|Overall Study|Adverse Event|1|||
170660658|NCT04131556|616772689|FG000|Overall Study|Withdrawal by Subject|1|||
170660659|NCT01229371|616772690|FG000|Overall Study|Withdrawal by Subject|0|||
170660660|NCT01229371|616772691|FG001|Overall Study|Withdrawal by Subject|1|||
170660661|NCT01229371|616772692|FG002|Overall Study|Withdrawal by Subject|0|||
170660662|NCT01229371|616772693|FG003|Overall Study|Withdrawal by Subject|0|||
170660663|NCT02213042|616772694|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
170660664|NCT02213042|616772695|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
170660665|NCT02213042|616772696|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
170660666|NCT02213042|616772694|FG000|Overall Study|Adverse Event|2|||
170660667|NCT02213042|616772695|FG001|Overall Study|Adverse Event|1|||
170660668|NCT02213042|616772696|FG002|Overall Study|Adverse Event|0|||
170660669|NCT02213042|616772694|FG000|Overall Study|Withdrawal by Subject|0|||
170660670|NCT02213042|616772695|FG001|Overall Study|Withdrawal by Subject|1|||
170660671|NCT02213042|616772696|FG002|Overall Study|Withdrawal by Subject|1|||
170615364|NCT03386721|616599110|FG000|Overall Study|Site Terminated by Sponsor|5|||
170615365|NCT03386721|616599111|FG001|Overall Study|Site Terminated by Sponsor|5|||
170615366|NCT03386721|616599112|FG002|Overall Study|Site Terminated by Sponsor|0|||
170615367|NCT03386721|616599113|FG003|Overall Study|Site Terminated by Sponsor|0|||
170615368|NCT03386721|616599114|FG004|Overall Study|Site Terminated by Sponsor|1|||
170615369|NCT03386721|616599115|FG005|Overall Study|Site Terminated by Sponsor|3|||
170615370|NCT03386721|616599116|FG006|Overall Study|Site Terminated by Sponsor|0|||
170615371|NCT03386721|616599117|FG007|Overall Study|Site Terminated by Sponsor|1|||
170615372|NCT03386721|616599118|FG008|Overall Study|Site Terminated by Sponsor|4|||
170615373|NCT03386721|616599119|FG009|Overall Study|Site Terminated by Sponsor|5|||
170615374|NCT03386721|616599120|FG010|Overall Study|Site Terminated by Sponsor|3|||
170615375|NCT03386721|616599121|FG011|Overall Study|Site Terminated by Sponsor|11|||
170615376|NCT03386721|616599122|FG012|Overall Study|Site Terminated by Sponsor|6|||
170615377|NCT03386721|616599123|FG013|Overall Study|Site Terminated by Sponsor|0|||
170615378|NCT03386721|616599124|FG014|Overall Study|Site Terminated by Sponsor|0|||
170615379|NCT03386721|616599110|FG000|Overall Study|Symptomatic Deterioration|0|||
170615380|NCT03386721|616599111|FG001|Overall Study|Symptomatic Deterioration|0|||
170615381|NCT03386721|616599112|FG002|Overall Study|Symptomatic Deterioration|0|||
170615382|NCT03386721|616599113|FG003|Overall Study|Symptomatic Deterioration|0|||
170615383|NCT03386721|616599114|FG004|Overall Study|Symptomatic Deterioration|0|||
170615384|NCT03386721|616599115|FG005|Overall Study|Symptomatic Deterioration|0|||
170615385|NCT03386721|616599116|FG006|Overall Study|Symptomatic Deterioration|0|||
170615386|NCT03386721|616599117|FG007|Overall Study|Symptomatic Deterioration|0|||
170615387|NCT03386721|616599118|FG008|Overall Study|Symptomatic Deterioration|1|||
170615388|NCT03386721|616599119|FG009|Overall Study|Symptomatic Deterioration|0|||
170615389|NCT03386721|616599120|FG010|Overall Study|Symptomatic Deterioration|0|||
170615390|NCT03386721|616599121|FG011|Overall Study|Symptomatic Deterioration|1|||
170615391|NCT03386721|616599122|FG012|Overall Study|Symptomatic Deterioration|0|||
170615392|NCT03386721|616599123|FG013|Overall Study|Symptomatic Deterioration|0|||
170615393|NCT03386721|616599124|FG014|Overall Study|Symptomatic Deterioration|0|||
170615394|NCT03386721|616599110|FG000|Overall Study|Withdrawal by Subject|1|||
170615395|NCT03386721|616599111|FG001|Overall Study|Withdrawal by Subject|2|||
170615396|NCT03386721|616599112|FG002|Overall Study|Withdrawal by Subject|0|||
170615397|NCT03386721|616599113|FG003|Overall Study|Withdrawal by Subject|0|||
170615398|NCT03386721|616599114|FG004|Overall Study|Withdrawal by Subject|0|||
170615399|NCT03386721|616599115|FG005|Overall Study|Withdrawal by Subject|0|||
170615400|NCT03386721|616599116|FG006|Overall Study|Withdrawal by Subject|0|||
170615401|NCT03386721|616599117|FG007|Overall Study|Withdrawal by Subject|0|||
170615402|NCT03386721|616599118|FG008|Overall Study|Withdrawal by Subject|2|||
170615403|NCT03386721|616599119|FG009|Overall Study|Withdrawal by Subject|1|||
170615404|NCT03386721|616599120|FG010|Overall Study|Withdrawal by Subject|3|||
170615405|NCT03386721|616599121|FG011|Overall Study|Withdrawal by Subject|2|||
170615406|NCT03386721|616599122|FG012|Overall Study|Withdrawal by Subject|3|||
170615407|NCT03386721|616599123|FG013|Overall Study|Withdrawal by Subject|0|||
170615408|NCT03386721|616599124|FG014|Overall Study|Withdrawal by Subject|0|||
170615409|NCT02330055|616599125|FG000|Overall Study|technical issues|2|||
170660672|NCT02213042|616772694|FG000|Overall Study|Protocol Violation|1|||
170615410|NCT02330055|616599126|FG001|Overall Study|technical issues|0|||
170660673|NCT02213042|616772695|FG001|Overall Study|Protocol Violation|0|||
170660674|NCT02213042|616772696|FG002|Overall Study|Protocol Violation|0|||
170660675|NCT02213042|616772694|FG000|Overall Study|Investigator discretion|0|||
170660676|NCT02213042|616772695|FG001|Overall Study|Investigator discretion|0|||
170660677|NCT02213042|616772696|FG002|Overall Study|Investigator discretion|1|||
170660678|NCT04622735|616772699|FG000|Overall Study|Lost to Follow-up|1|||
170660679|NCT04622735|616772700|FG001|Overall Study|Lost to Follow-up|2|||
170660680|NCT04622735|616772701|FG002|Overall Study|Lost to Follow-up|1|||
170660681|NCT04622735|616772699|FG000|Overall Study|Adverse Event|0|||
170660682|NCT04622735|616772700|FG001|Overall Study|Adverse Event|0|||
170660683|NCT04622735|616772701|FG002|Overall Study|Adverse Event|1|||
170660684|NCT04622735|616772699|FG000|Overall Study|Protocol Violation|1|||
170660685|NCT04622735|616772700|FG001|Overall Study|Protocol Violation|0|||
170660686|NCT04622735|616772701|FG002|Overall Study|Protocol Violation|0|||
170660687|NCT05314478|616772702|FG000|Overall Study|Physician Decision|1|||
170660688|NCT02923427|616772704|FG000|Overall Study|convert to laparatomy|2|||
170660689|NCT02923427|616772705|FG001|Overall Study|convert to laparatomy|2|||
170660690|NCT02923427|616772704|FG000|Overall Study|destaturation|1|||
170660691|NCT02923427|616772705|FG001|Overall Study|destaturation|0|||
170660692|NCT02923427|616772704|FG000|Overall Study|can not replace LMA|1|||
170660693|NCT02923427|616772705|FG001|Overall Study|can not replace LMA|0|||
170660694|NCT02360111|616772706|FG000|Overall Study|Death|2|||
170660695|NCT02180165|616772707|FG000|Overall Study|Not Treated|0|||
170660696|NCT02180165|616772708|FG001|Overall Study|Not Treated|0|||
170660697|NCT02180165|616772709|FG002|Overall Study|Not Treated|1|||
170660698|NCT02180165|616772710|FG003|Overall Study|Not Treated|0|||
170660699|NCT02180165|616772707|FG000|Overall Study|Adverse Event|7|||
170660700|NCT02180165|616772708|FG001|Overall Study|Adverse Event|0|||
170660701|NCT02180165|616772709|FG002|Overall Study|Adverse Event|18|||
170660702|NCT02180165|616772710|FG003|Overall Study|Adverse Event|3|||
170660703|NCT02180165|616772707|FG000|Overall Study|Lack of Efficacy|0|||
170660704|NCT02180165|616772708|FG001|Overall Study|Lack of Efficacy|1|||
170660705|NCT02180165|616772709|FG002|Overall Study|Lack of Efficacy|3|||
170660706|NCT02180165|616772710|FG003|Overall Study|Lack of Efficacy|2|||
170660707|NCT02180165|616772707|FG000|Overall Study|Physician Decision|1|||
170660708|NCT02180165|616772708|FG001|Overall Study|Physician Decision|0|||
170660709|NCT02180165|616772709|FG002|Overall Study|Physician Decision|5|||
170660710|NCT02180165|616772710|FG003|Overall Study|Physician Decision|0|||
170660711|NCT02180165|616772707|FG000|Overall Study|Withdrawal by Subject|3|||
170660712|NCT02180165|616772708|FG001|Overall Study|Withdrawal by Subject|0|||
170660713|NCT02180165|616772709|FG002|Overall Study|Withdrawal by Subject|2|||
170660714|NCT02180165|616772710|FG003|Overall Study|Withdrawal by Subject|1|||
170660715|NCT04171765|616772711|FG000|Overall Study|Adverse Event|2|||
170660716|NCT04171765|616772712|FG001|Overall Study|Adverse Event|0|||
170660717|NCT04171765|616772713|FG002|Overall Study|Adverse Event|1|||
170660718|NCT04171765|616772714|FG003|Overall Study|Adverse Event|0|||
170660719|NCT04171765|616772711|FG000|Overall Study|Lost to Follow-up|0|||
170660720|NCT04171765|616772712|FG001|Overall Study|Lost to Follow-up|2|||
170660721|NCT04171765|616772713|FG002|Overall Study|Lost to Follow-up|2|||
170660722|NCT04171765|616772714|FG003|Overall Study|Lost to Follow-up|2|||
170660723|NCT04171765|616772711|FG000|Overall Study|Week 58 visit missed|0|||
170660724|NCT04171765|616772712|FG001|Overall Study|Week 58 visit missed|0|||
170660725|NCT04171765|616772713|FG002|Overall Study|Week 58 visit missed|1|||
170660726|NCT04171765|616772714|FG003|Overall Study|Week 58 visit missed|0|||
170660727|NCT04171765|616772711|FG000|Overall Study|Study terminated by sponsor|2|||
170660728|NCT04171765|616772712|FG001|Overall Study|Study terminated by sponsor|0|||
170660729|NCT04171765|616772713|FG002|Overall Study|Study terminated by sponsor|0|||
170660730|NCT04171765|616772714|FG003|Overall Study|Study terminated by sponsor|0|||
170660731|NCT04171765|616772711|FG000|Overall Study|Withdrawal by Subject|1|||
170660732|NCT04171765|616772712|FG001|Overall Study|Withdrawal by Subject|0|||
170660733|NCT04171765|616772713|FG002|Overall Study|Withdrawal by Subject|0|||
170660734|NCT04171765|616772714|FG003|Overall Study|Withdrawal by Subject|3|||
170660735|NCT00809354|616772715|FG000|Overall Study|Adverse Event|32|||
170660736|NCT00809354|616772716|FG001|Overall Study|Adverse Event|45|||
170660737|NCT00809354|616772717|FG002|Overall Study|Adverse Event|37|||
170660738|NCT00809354|616772718|FG003|Overall Study|Adverse Event|53|||
170660739|NCT00809354|616772719|FG004|Overall Study|Adverse Event|26|||
170660740|NCT00809354|616772720|FG005|Overall Study|Adverse Event|33|||
170660741|NCT00809354|616772721|FG006|Overall Study|Adverse Event|44|||
170817321|NCT02158806|617338487|FG000|Overall Study|Lost to Follow-up|0|||
170817322|NCT02158806|617338488|FG001|Overall Study|Lost to Follow-up|3|||
170660742|NCT00809354|616772722|FG007|Overall Study|Adverse Event|40|||
170660743|NCT00809354|616772723|FG008|Overall Study|Adverse Event|46|||
170660744|NCT00809354|616772724|FG009|Overall Study|Adverse Event|26|||
170660745|NCT00809354|616772715|FG000|Overall Study|Lack of Efficacy|23|||
170660746|NCT00809354|616772716|FG001|Overall Study|Lack of Efficacy|23|||
170660747|NCT00809354|616772717|FG002|Overall Study|Lack of Efficacy|22|||
170660748|NCT00809354|616772718|FG003|Overall Study|Lack of Efficacy|15|||
170660749|NCT00809354|616772719|FG004|Overall Study|Lack of Efficacy|40|||
170660750|NCT00809354|616772720|FG005|Overall Study|Lack of Efficacy|19|||
170660751|NCT00809354|616772721|FG006|Overall Study|Lack of Efficacy|21|||
170660752|NCT00809354|616772722|FG007|Overall Study|Lack of Efficacy|15|||
170660753|NCT00809354|616772723|FG008|Overall Study|Lack of Efficacy|18|||
170660754|NCT00809354|616772724|FG009|Overall Study|Lack of Efficacy|38|||
170660755|NCT00809354|616772715|FG000|Overall Study|Lost to Follow-up|10|||
170660756|NCT00809354|616772716|FG001|Overall Study|Lost to Follow-up|11|||
170660757|NCT00809354|616772717|FG002|Overall Study|Lost to Follow-up|8|||
170660758|NCT00809354|616772718|FG003|Overall Study|Lost to Follow-up|13|||
170660759|NCT00809354|616772719|FG004|Overall Study|Lost to Follow-up|6|||
170660760|NCT00809354|616772720|FG005|Overall Study|Lost to Follow-up|2|||
170660761|NCT00809354|616772721|FG006|Overall Study|Lost to Follow-up|0|||
170660762|NCT00809354|616772722|FG007|Overall Study|Lost to Follow-up|5|||
170660763|NCT00809354|616772723|FG008|Overall Study|Lost to Follow-up|4|||
170660764|NCT00809354|616772724|FG009|Overall Study|Lost to Follow-up|0|||
170660765|NCT00809354|616772715|FG000|Overall Study|Protocol Violation|7|||
170660766|NCT00809354|616772716|FG001|Overall Study|Protocol Violation|14|||
170660767|NCT00809354|616772717|FG002|Overall Study|Protocol Violation|14|||
170660768|NCT00809354|616772718|FG003|Overall Study|Protocol Violation|12|||
170660769|NCT00809354|616772719|FG004|Overall Study|Protocol Violation|14|||
170660770|NCT00809354|616772720|FG005|Overall Study|Protocol Violation|6|||
170660771|NCT00809354|616772721|FG006|Overall Study|Protocol Violation|4|||
170660772|NCT00809354|616772722|FG007|Overall Study|Protocol Violation|6|||
170660773|NCT00809354|616772723|FG008|Overall Study|Protocol Violation|9|||
170660774|NCT00809354|616772724|FG009|Overall Study|Protocol Violation|3|||
170660775|NCT00809354|616772715|FG000|Overall Study|Withdrawal by Subject|32|||
170660776|NCT00809354|616772716|FG001|Overall Study|Withdrawal by Subject|27|||
170660777|NCT00809354|616772717|FG002|Overall Study|Withdrawal by Subject|31|||
170660778|NCT00809354|616772718|FG003|Overall Study|Withdrawal by Subject|33|||
170660779|NCT00809354|616772719|FG004|Overall Study|Withdrawal by Subject|34|||
170660780|NCT00809354|616772720|FG005|Overall Study|Withdrawal by Subject|29|||
170660781|NCT00809354|616772721|FG006|Overall Study|Withdrawal by Subject|27|||
170817323|NCT02158806|617338487|FG000|Overall Study|Moved out of area|0|||
170817324|NCT02158806|617338488|FG001|Overall Study|Moved out of area|1|||
170817325|NCT02158806|617338487|FG000|Overall Study|Transferred to palliative care|0|||
170817326|NCT02158806|617338488|FG001|Overall Study|Transferred to palliative care|1|||
170817327|NCT04433091|617338489|FG000|Overall Study|Lost to Follow-up|1|||
170817328|NCT04433091|617338490|FG001|Overall Study|Lost to Follow-up|0|||
170817329|NCT04433091|617338489|FG000|Overall Study|Withdrawn .|2|||
170817330|NCT04433091|617338490|FG001|Overall Study|Withdrawn .|4|||
170817331|NCT01730118|617339737|FG000|Dose Escalation|Death on study|5|||
170817332|NCT01730118|617339738|FG001|Dose Escalation|Death on study|7|||
170817333|NCT01730118|617339739|FG002|Dose Escalation|Death on study|2|||
170817334|NCT01730118|617339740|FG003|Dose Escalation|Death on study|6|||
170817335|NCT01730118|617339741|FG004|Dose Escalation|Death on study|0|||
170817336|NCT01730118|617339742|FG005|Dose Escalation|Death on study|0|||
170817337|NCT01730118|617339743|FG006|Dose Escalation|Death on study|0|||
170817338|NCT01730118|617339737|FG000|Dose Escalation|Died before treatment|0|||
170817339|NCT01730118|617339738|FG001|Dose Escalation|Died before treatment|0|||
170817340|NCT01730118|617339739|FG002|Dose Escalation|Died before treatment|0|||
170817341|NCT01730118|617339740|FG003|Dose Escalation|Died before treatment|0|||
170817342|NCT01730118|617339741|FG004|Dose Escalation|Died before treatment|0|||
170817343|NCT01730118|617339742|FG005|Dose Escalation|Died before treatment|0|||
170817344|NCT01730118|617339743|FG006|Dose Escalation|Died before treatment|1|||
170817345|NCT01730118|617339737|FG000|Dose Escalation|Chose to start a different treatment|1|||
170817346|NCT01730118|617339738|FG001|Dose Escalation|Chose to start a different treatment|0|||
170817347|NCT01730118|617339739|FG002|Dose Escalation|Chose to start a different treatment|0|||
170817348|NCT01730118|617339740|FG003|Dose Escalation|Chose to start a different treatment|0|||
170817349|NCT01730118|617339741|FG004|Dose Escalation|Chose to start a different treatment|0|||
170817350|NCT01730118|617339742|FG005|Dose Escalation|Chose to start a different treatment|0|||
170817351|NCT01730118|617339743|FG006|Dose Escalation|Chose to start a different treatment|0|||
170817352|NCT01730118|617339737|FG000|Dose Escalation|Withdrawal by Subject|0|||
170817353|NCT01730118|617339738|FG001|Dose Escalation|Withdrawal by Subject|0|||
170817354|NCT01730118|617339739|FG002|Dose Escalation|Withdrawal by Subject|1|||
170817355|NCT01730118|617339740|FG003|Dose Escalation|Withdrawal by Subject|0|||
170817356|NCT01730118|617339741|FG004|Dose Escalation|Withdrawal by Subject|0|||
170817357|NCT01730118|617339742|FG005|Dose Escalation|Withdrawal by Subject|0|||
170817358|NCT01730118|617339743|FG006|Dose Escalation|Withdrawal by Subject|0|||
170817359|NCT01730118|617339737|FG000|Dose Escalation|Disease progression prior to treatment|0|||
170817360|NCT01730118|617339738|FG001|Dose Escalation|Disease progression prior to treatment|0|||
170817361|NCT01730118|617339739|FG002|Dose Escalation|Disease progression prior to treatment|0|||
170817362|NCT01730118|617339740|FG003|Dose Escalation|Disease progression prior to treatment|0|||
170817363|NCT01730118|617339741|FG004|Dose Escalation|Disease progression prior to treatment|0|||
170817364|NCT01730118|617339742|FG005|Dose Escalation|Disease progression prior to treatment|0|||
170817365|NCT01730118|617339743|FG006|Dose Escalation|Disease progression prior to treatment|1|||
170817366|NCT01730118|617339737|FG000|Dose Expansion|Death|0|||
170660782|NCT00809354|616772722|FG007|Overall Study|Withdrawal by Subject|19|||
170817367|NCT01730118|617339738|FG001|Dose Expansion|Death|0|||
170817368|NCT01730118|617339739|FG002|Dose Expansion|Death|0|||
170660783|NCT00809354|616772723|FG008|Overall Study|Withdrawal by Subject|18|||
170660784|NCT00809354|616772724|FG009|Overall Study|Withdrawal by Subject|20|||
170660785|NCT00809354|616772715|FG000|Overall Study|Other|10|||
170660786|NCT00809354|616772716|FG001|Overall Study|Other|2|||
170660787|NCT00809354|616772717|FG002|Overall Study|Other|7|||
170660788|NCT00809354|616772718|FG003|Overall Study|Other|10|||
170660789|NCT00809354|616772719|FG004|Overall Study|Other|5|||
170660790|NCT00809354|616772720|FG005|Overall Study|Other|3|||
170660791|NCT00809354|616772721|FG006|Overall Study|Other|2|||
170660792|NCT00809354|616772722|FG007|Overall Study|Other|3|||
170660793|NCT00809354|616772723|FG008|Overall Study|Other|4|||
170660794|NCT00809354|616772724|FG009|Overall Study|Other|3|||
170660795|NCT00809354|616772715|FG000|Overall Study|Study terminated by sponsor|138|||
170660796|NCT00809354|616772716|FG001|Overall Study|Study terminated by sponsor|134|||
170660797|NCT00809354|616772717|FG002|Overall Study|Study terminated by sponsor|129|||
170660798|NCT00809354|616772718|FG003|Overall Study|Study terminated by sponsor|120|||
170660799|NCT00809354|616772719|FG004|Overall Study|Study terminated by sponsor|126|||
170660800|NCT00809354|616772720|FG005|Overall Study|Study terminated by sponsor|133|||
170660801|NCT00809354|616772721|FG006|Overall Study|Study terminated by sponsor|124|||
170660802|NCT00809354|616772722|FG007|Overall Study|Study terminated by sponsor|148|||
170660803|NCT00809354|616772723|FG008|Overall Study|Study terminated by sponsor|127|||
170660804|NCT00809354|616772724|FG009|Overall Study|Study terminated by sponsor|135|||
170660805|NCT00809354|616772715|FG000|Overall Study|Withdrawn due to pregnancy|0|||
170660806|NCT00809354|616772716|FG001|Overall Study|Withdrawn due to pregnancy|1|||
170660807|NCT00809354|616772717|FG002|Overall Study|Withdrawn due to pregnancy|0|||
170660808|NCT00809354|616772718|FG003|Overall Study|Withdrawn due to pregnancy|0|||
170660809|NCT00809354|616772719|FG004|Overall Study|Withdrawn due to pregnancy|0|||
170660810|NCT00809354|616772720|FG005|Overall Study|Withdrawn due to pregnancy|0|||
170817369|NCT01730118|617339740|FG003|Dose Expansion|Death|0|||
170817370|NCT01730118|617339741|FG004|Dose Expansion|Death|1|||
170817371|NCT01730118|617339742|FG005|Dose Expansion|Death|0|||
170660811|NCT00809354|616772721|FG006|Overall Study|Withdrawn due to pregnancy|0|||
170660812|NCT00809354|616772722|FG007|Overall Study|Withdrawn due to pregnancy|0|||
170660813|NCT00809354|616772723|FG008|Overall Study|Withdrawn due to pregnancy|0|||
170817372|NCT01730118|617339743|FG006|Dose Expansion|Death|0|||
170817373|NCT01730118|617339737|FG000|Dose Expansion|Other medical condition|0|||
170817374|NCT01730118|617339738|FG001|Dose Expansion|Other medical condition|0|||
170817375|NCT01730118|617339739|FG002|Dose Expansion|Other medical condition|0|||
170817376|NCT01730118|617339740|FG003|Dose Expansion|Other medical condition|0|||
170817377|NCT01730118|617339741|FG004|Dose Expansion|Other medical condition|1|||
170817378|NCT01730118|617339742|FG005|Dose Expansion|Other medical condition|0|||
170817379|NCT01730118|617339743|FG006|Dose Expansion|Other medical condition|0|||
170817380|NCT01730118|617339737|FG000|Dose Expansion|Withdrawal by Subject|0|||
170817381|NCT01730118|617339738|FG001|Dose Expansion|Withdrawal by Subject|0|||
170817382|NCT01730118|617339739|FG002|Dose Expansion|Withdrawal by Subject|0|||
170817383|NCT01730118|617339740|FG003|Dose Expansion|Withdrawal by Subject|0|||
170817384|NCT01730118|617339741|FG004|Dose Expansion|Withdrawal by Subject|1|||
170817385|NCT01730118|617339742|FG005|Dose Expansion|Withdrawal by Subject|0|||
170817386|NCT01730118|617339743|FG006|Dose Expansion|Withdrawal by Subject|0|||
170817387|NCT01730118|617339737|FG000|Dose Expansion|Disease progression|0|||
170817388|NCT01730118|617339738|FG001|Dose Expansion|Disease progression|0|||
170817389|NCT01730118|617339739|FG002|Dose Expansion|Disease progression|0|||
170817390|NCT01730118|617339740|FG003|Dose Expansion|Disease progression|0|||
170817391|NCT01730118|617339741|FG004|Dose Expansion|Disease progression|0|||
170817392|NCT01730118|617339742|FG005|Dose Expansion|Disease progression|1|||
170817393|NCT01730118|617339743|FG006|Dose Expansion|Disease progression|0|||
170817394|NCT01730118|617339737|FG000|Dose Expansion|Inability to return|0|||
170817395|NCT01730118|617339738|FG001|Dose Expansion|Inability to return|0|||
170817396|NCT01730118|617339739|FG002|Dose Expansion|Inability to return|0|||
170817397|NCT01730118|617339740|FG003|Dose Expansion|Inability to return|0|||
170817398|NCT01730118|617339741|FG004|Dose Expansion|Inability to return|0|||
170817399|NCT01730118|617339742|FG005|Dose Expansion|Inability to return|1|||
170817400|NCT01730118|617339743|FG006|Dose Expansion|Inability to return|0|||
170817401|NCT01730118|617339737|FG000|Dose Expansion|Physician Decision|0|||
170817402|NCT01730118|617339738|FG001|Dose Expansion|Physician Decision|0|||
170817403|NCT01730118|617339739|FG002|Dose Expansion|Physician Decision|0|||
170817404|NCT01730118|617339740|FG003|Dose Expansion|Physician Decision|0|||
170817405|NCT01730118|617339741|FG004|Dose Expansion|Physician Decision|0|||
170817406|NCT01730118|617339742|FG005|Dose Expansion|Physician Decision|1|||
170817407|NCT01730118|617339743|FG006|Dose Expansion|Physician Decision|0|||
170817408|NCT00961298|617339744|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
170817409|NCT00961298|617339744|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
170660814|NCT00809354|616772724|FG009|Overall Study|Withdrawn due to pregnancy|0|||
170817410|NCT00961298|617339744|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
170817411|NCT02101554|617339748|FG000|Overall Study|Protocol Violation|0|||
170817412|NCT02101554|617339749|FG001|Overall Study|Protocol Violation|1|||
170817413|NCT02101554|617339750|FG002|Overall Study|Protocol Violation|0|||
170817414|NCT02101554|617339748|FG000|Overall Study|Insufficient Clinical Response|0|||
170817415|NCT02101554|617339749|FG001|Overall Study|Insufficient Clinical Response|2|||
170817416|NCT02101554|617339750|FG002|Overall Study|Insufficient Clinical Response|0|||
170660815|NCT00809354|616772715|FG000|Overall Study|Randomized but not Treated|3|||
170660816|NCT00809354|616772716|FG001|Overall Study|Randomized but not Treated|1|||
170660817|NCT00809354|616772717|FG002|Overall Study|Randomized but not Treated|6|||
170917128|NCT06295692|617697847|FG000|Overall Study|Ongoing|8|||
170917129|NCT06295692|617697848|FG001|Overall Study|Ongoing|9|||
170917130|NCT03101748|617697849|FG000|Overall Study|Adverse Event|0|||
170917131|NCT03101748|617697850|FG001|Overall Study|Adverse Event|0|||
170917132|NCT03101748|617697851|FG002|Overall Study|Adverse Event|1|||
170917133|NCT03101748|617697852|FG003|Overall Study|Adverse Event|0|||
170917134|NCT03101748|617697853|FG004|Overall Study|Adverse Event|0|||
170917135|NCT03101748|617697854|FG005|Overall Study|Adverse Event|3|||
170917136|NCT03101748|617697855|FG006|Overall Study|Adverse Event|3|||
170917137|NCT03101748|617697849|FG000|Overall Study|Withdrawal by Subject|0|||
170917138|NCT03101748|617697850|FG001|Overall Study|Withdrawal by Subject|0|||
170917139|NCT03101748|617697851|FG002|Overall Study|Withdrawal by Subject|0|||
170917140|NCT03101748|617697852|FG003|Overall Study|Withdrawal by Subject|0|||
170917141|NCT03101748|617697853|FG004|Overall Study|Withdrawal by Subject|0|||
170917142|NCT03101748|617697854|FG005|Overall Study|Withdrawal by Subject|1|||
170917143|NCT03101748|617697855|FG006|Overall Study|Withdrawal by Subject|0|||
170917144|NCT03101748|617697849|FG000|Overall Study|Disease Progression|0|||
170917145|NCT03101748|617697850|FG001|Overall Study|Disease Progression|1|||
170817417|NCT02101554|617339748|FG000|Overall Study|Adverse Event|2|||
170817418|NCT02101554|617339749|FG001|Overall Study|Adverse Event|1|||
170817419|NCT02101554|617339750|FG002|Overall Study|Adverse Event|1|||
170817420|NCT02101554|617339748|FG000|Overall Study|Lost to Follow-up|0|||
170817421|NCT02101554|617339749|FG001|Overall Study|Lost to Follow-up|1|||
170817422|NCT02101554|617339750|FG002|Overall Study|Lost to Follow-up|0|||
170817423|NCT02101554|617339748|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
170817424|NCT02101554|617339749|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
170817425|NCT02101554|617339750|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
170817426|NCT02011568|617339752|FG000|Overall Study|Withdrawal by Subject|8|||
170817427|NCT02011568|617339753|FG001|Overall Study|Withdrawal by Subject|10|||
170817428|NCT02011568|617339752|FG000|Overall Study|Physician Decision|1|||
170817429|NCT02011568|617339753|FG001|Overall Study|Physician Decision|3|||
170817430|NCT01074229|617339754|FG000|Overall Study|Lost to Follow-up|1|||
170817431|NCT01074229|617339755|FG001|Overall Study|Lost to Follow-up|0|||
170817432|NCT01074229|617339756|FG002|Overall Study|Lost to Follow-up|0|||
170817433|NCT01074229|617339754|FG000|Overall Study|Change to open surgical procedure|1|||
170817434|NCT01074229|617339755|FG001|Overall Study|Change to open surgical procedure|3|||
170817435|NCT01074229|617339756|FG002|Overall Study|Change to open surgical procedure|4|||
170817436|NCT03314233|617339757|FG000|Overall Study|No longer eligible at time of delivery|1|||
170817437|NCT00168805|617339759|FG000|Overall Study|Adverse Event|7|||
170817438|NCT00168805|617339760|FG001|Overall Study|Adverse Event|11|||
170817439|NCT00168805|617339761|FG002|Overall Study|Adverse Event|16|||
170817440|NCT00168805|617339759|FG000|Overall Study|Protocol Violation|12|||
170817441|NCT00168805|617339760|FG001|Overall Study|Protocol Violation|11|||
170817442|NCT00168805|617339761|FG002|Overall Study|Protocol Violation|8|||
170817443|NCT00168805|617339759|FG000|Overall Study|Lost to Follow-up|12|||
170817444|NCT00168805|617339760|FG001|Overall Study|Lost to Follow-up|17|||
170817445|NCT00168805|617339761|FG002|Overall Study|Lost to Follow-up|11|||
170817446|NCT00168805|617339759|FG000|Overall Study|Withdrawal by Subject|16|||
170817447|NCT00168805|617339760|FG001|Overall Study|Withdrawal by Subject|18|||
170817448|NCT00168805|617339761|FG002|Overall Study|Withdrawal by Subject|21|||
170817449|NCT00168805|617339759|FG000|Overall Study|Other|24|||
170817450|NCT00168805|617339760|FG001|Overall Study|Other|21|||
170817451|NCT00168805|617339761|FG002|Overall Study|Other|22|||
170817452|NCT00168805|617339759|FG000|Treatment|Adverse Event|25|||
170817453|NCT00168805|617339760|FG001|Treatment|Adverse Event|26|||
170817454|NCT00168805|617339761|FG002|Treatment|Adverse Event|32|||
170817455|NCT00168805|617339759|FG000|Treatment|Protocol Violation|3|||
170817456|NCT00168805|617339760|FG001|Treatment|Protocol Violation|5|||
170817457|NCT00168805|617339761|FG002|Treatment|Protocol Violation|5|||
170817458|NCT00168805|617339759|FG000|Treatment|Withdrawal by Subject|3|||
170817459|NCT00168805|617339760|FG001|Treatment|Withdrawal by Subject|7|||
170817460|NCT00168805|617339761|FG002|Treatment|Withdrawal by Subject|8|||
170817461|NCT00168805|617339759|FG000|Treatment|Other|18|||
170917146|NCT03101748|617697851|FG002|Overall Study|Disease Progression|0|||
170917147|NCT03101748|617697852|FG003|Overall Study|Disease Progression|0|||
170817462|NCT00168805|617339760|FG001|Treatment|Other|18|||
170817463|NCT00168805|617339761|FG002|Treatment|Other|17|||
170917148|NCT03101748|617697853|FG004|Overall Study|Disease Progression|0|||
170917149|NCT03101748|617697854|FG005|Overall Study|Disease Progression|1|||
170917150|NCT03101748|617697855|FG006|Overall Study|Disease Progression|3|||
170817464|NCT03184519|617339762|FG000|Overall Study|Lost to Follow-up|6|||
170817465|NCT03184519|617339762|FG000|Overall Study|Physician Decision|21|||
170817466|NCT06247488|617339763|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
170817467|NCT06247488|617339764|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
170817468|NCT06247488|617339765|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
170817469|NCT06247488|617339766|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
170817470|NCT06247488|617339767|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
170917151|NCT05775289|617697856|FG000|Overall Study|Study Ongoing|20|||
170917152|NCT05775289|617697857|FG001|Overall Study|Study Ongoing|53|||
170660818|NCT00809354|616772718|FG003|Overall Study|Randomized but not Treated|0|||
170660819|NCT00809354|616772719|FG004|Overall Study|Randomized but not Treated|5|||
170660820|NCT00809354|616772720|FG005|Overall Study|Randomized but not Treated|0|||
170660821|NCT00809354|616772721|FG006|Overall Study|Randomized but not Treated|1|||
170660822|NCT00809354|616772722|FG007|Overall Study|Randomized but not Treated|1|||
170660823|NCT00809354|616772723|FG008|Overall Study|Randomized but not Treated|2|||
170660824|NCT00809354|616772724|FG009|Overall Study|Randomized but not Treated|1|||
170660825|NCT00809354|616772715|FG000|Overall Study|Death|0|||
170660826|NCT00809354|616772716|FG001|Overall Study|Death|0|||
170660827|NCT00809354|616772717|FG002|Overall Study|Death|0|||
170660828|NCT00809354|616772718|FG003|Overall Study|Death|0|||
170660829|NCT00809354|616772719|FG004|Overall Study|Death|0|||
170660830|NCT00809354|616772720|FG005|Overall Study|Death|0|||
170660831|NCT00809354|616772721|FG006|Overall Study|Death|0|||
170660832|NCT00809354|616772722|FG007|Overall Study|Death|1|||
170660833|NCT00809354|616772723|FG008|Overall Study|Death|0|||
170660834|NCT00809354|616772724|FG009|Overall Study|Death|0|||
170660835|NCT04137224|616772725|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
170660836|NCT04137224|616772726|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
170660837|NCT04137224|616772725|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
170660838|NCT04137224|616772726|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
170660839|NCT04137224|616772725|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
170660840|NCT04137224|616772726|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
170660841|NCT04505540|616772734|FG000|Baseline|Protocol Violation|10|||
170660842|NCT04505540|616772734|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
170660843|NCT04505540|616772734|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
170660844|NCT04505540|616772734|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
170660845|NCT04505540|616772734|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
170660846|NCT04505540|616772734|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
170660847|NCT04505540|616772734|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
170660848|NCT04505540|616772734|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
170660849|NCT04505540|616772734|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
170660850|NCT04505540|616772734|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
170660851|NCT04505540|616772734|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
170660852|NCT04505540|616772734|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
170660853|NCT04505540|616772734|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
170660854|NCT01123850|616772735|FG000|Overall Study|Slow enrollment|45|||
170660855|NCT01130103|616772736|FG000|Randomized Treatment|Adverse Event|1|||
170660856|NCT01130103|616772737|FG001|Randomized Treatment|Adverse Event|1|||
170660857|NCT01130103|616772736|FG000|Randomized Treatment|Lost to Follow-up|1|||
170660858|NCT01130103|616772737|FG001|Randomized Treatment|Lost to Follow-up|0|||
170660859|NCT01130103|616772736|FG000|Randomized Treatment|Protocol Violation|3|||
170660860|NCT01130103|616772737|FG001|Randomized Treatment|Protocol Violation|2|||
170660861|NCT01130103|616772736|FG000|Randomized Treatment|Withdrawal by Subject|1|||
170660862|NCT01130103|616772737|FG001|Randomized Treatment|Withdrawal by Subject|2|||
170660863|NCT01130103|616772736|FG000|Maintenance Treatment|Lack of Efficacy|0|||
170660864|NCT01130103|616772737|FG001|Maintenance Treatment|Lack of Efficacy|1|||
170660865|NCT01130103|616772736|FG000|Maintenance Treatment|Lost to Follow-up|1|||
170660866|NCT01130103|616772737|FG001|Maintenance Treatment|Lost to Follow-up|1|||
170660867|NCT01130103|616772736|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
170660868|NCT01130103|616772737|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
170660869|NCT02273739|616772738|FG000|Overall Study|Progression of Disease|3|||
170660870|NCT02273739|616772739|FG001|Overall Study|Progression of Disease|4|||
170660871|NCT02273739|616772740|FG002|Overall Study|Progression of Disease|5|||
170660872|NCT02273739|616772741|FG003|Overall Study|Progression of Disease|2|||
170660873|NCT02273739|616772738|FG000|Overall Study|Death|0|||
170660874|NCT02273739|616772739|FG001|Overall Study|Death|0|||
170660875|NCT02273739|616772740|FG002|Overall Study|Death|0|||
170660876|NCT02273739|616772741|FG003|Overall Study|Death|2|||
170660877|NCT02273739|616772738|FG000|Overall Study|Adverse Event|0|||
170660878|NCT02273739|616772739|FG001|Overall Study|Adverse Event|0|||
170660879|NCT02273739|616772740|FG002|Overall Study|Adverse Event|0|||
170660880|NCT02273739|616772741|FG003|Overall Study|Adverse Event|1|||
170660881|NCT02273739|616772738|FG000|Overall Study|Withdrawal by Subject|0|||
170660882|NCT02273739|616772739|FG001|Overall Study|Withdrawal by Subject|0|||
170660883|NCT02273739|616772740|FG002|Overall Study|Withdrawal by Subject|2|||
170660884|NCT02273739|616772741|FG003|Overall Study|Withdrawal by Subject|1|||
170660885|NCT02273739|616772738|FG000|Overall Study|Physician Decision|0|||
170660886|NCT02273739|616772739|FG001|Overall Study|Physician Decision|0|||
170660887|NCT02273739|616772740|FG002|Overall Study|Physician Decision|0|||
170660888|NCT02273739|616772741|FG003|Overall Study|Physician Decision|1|||
170660889|NCT03091777|616772743|FG000|Overall Study|Pregnancy|2|||
170660890|NCT03091777|616772744|FG001|Overall Study|Pregnancy|1|||
170660891|NCT03091777|616772745|FG002|Overall Study|Pregnancy|0|||
170660892|NCT03091777|616772743|FG000|Overall Study|Adverse Event|2|||
170660893|NCT03091777|616772744|FG001|Overall Study|Adverse Event|1|||
170660894|NCT03091777|616772745|FG002|Overall Study|Adverse Event|4|||
170660895|NCT03091777|616772743|FG000|Overall Study|Withdrawal by Subject|4|||
170660896|NCT03091777|616772744|FG001|Overall Study|Withdrawal by Subject|2|||
170660897|NCT03091777|616772745|FG002|Overall Study|Withdrawal by Subject|6|||
170660898|NCT03091777|616772743|FG000|Overall Study|Protocol Violation|2|||
170660899|NCT03091777|616772744|FG001|Overall Study|Protocol Violation|1|||
170660900|NCT03091777|616772745|FG002|Overall Study|Protocol Violation|1|||
170660901|NCT03091777|616772743|FG000|Overall Study|Lost to Follow-up|12|||
170660902|NCT03091777|616772744|FG001|Overall Study|Lost to Follow-up|14|||
170660903|NCT03091777|616772745|FG002|Overall Study|Lost to Follow-up|7|||
170660904|NCT03091777|616772743|FG000|Overall Study|Lack of Efficacy|0|||
170660905|NCT03091777|616772744|FG001|Overall Study|Lack of Efficacy|0|||
170660906|NCT03091777|616772745|FG002|Overall Study|Lack of Efficacy|5|||
170660907|NCT03091777|616772743|FG000|Overall Study|Noncompliance with study drug|2|||
170660908|NCT03091777|616772744|FG001|Overall Study|Noncompliance with study drug|3|||
170660909|NCT03091777|616772745|FG002|Overall Study|Noncompliance with study drug|1|||
170660910|NCT03091777|616772743|FG000|Overall Study|Physician Decision|1|||
170660911|NCT03091777|616772744|FG001|Overall Study|Physician Decision|0|||
170660912|NCT03091777|616772745|FG002|Overall Study|Physician Decision|1|||
170660913|NCT03091777|616772743|FG000|Overall Study|Abnormal Laboratory Value|7|||
170660914|NCT03091777|616772744|FG001|Overall Study|Abnormal Laboratory Value|11|||
170660915|NCT03091777|616772745|FG002|Overall Study|Abnormal Laboratory Value|12|||
170660916|NCT00089674|616772746|FG000|Overall Study|Physician Decision|4|||
170660917|NCT00089674|616772747|FG001|Overall Study|Physician Decision|2|||
170660918|NCT00089674|616772746|FG000|Overall Study|Adverse Event|23|||
170660919|NCT00089674|616772747|FG001|Overall Study|Adverse Event|29|||
170660920|NCT00089674|616772746|FG000|Overall Study|Withdrawal by Subject|143|||
170660921|NCT00089674|616772747|FG001|Overall Study|Withdrawal by Subject|127|||
170660922|NCT00089674|616772746|FG000|Overall Study|Death|43|||
170660923|NCT00089674|616772747|FG001|Overall Study|Death|43|||
170660924|NCT00089674|616772746|FG000|Overall Study|Disease progression|21|||
170660925|NCT00089674|616772747|FG001|Overall Study|Disease progression|23|||
170660926|NCT00089674|616772746|FG000|Overall Study|Ineligibility determined|8|||
170660927|NCT00089674|616772747|FG001|Overall Study|Ineligibility determined|10|||
170660928|NCT00089674|616772746|FG000|Overall Study|Lost to Follow-up|21|||
170660929|NCT00089674|616772747|FG001|Overall Study|Lost to Follow-up|17|||
170660930|NCT00089674|616772746|FG000|Overall Study|Noncompliance|7|||
170660931|NCT00089674|616772747|FG001|Overall Study|Noncompliance|3|||
170660932|NCT00089674|616772746|FG000|Overall Study|Other|5|||
170660933|NCT00089674|616772747|FG001|Overall Study|Other|9|||
170660934|NCT00089674|616772746|FG000|Overall Study|Requirement for alternative therapy|14|||
170660935|NCT00089674|616772747|FG001|Overall Study|Requirement for alternative therapy|4|||
170660936|NCT03963401|616772748|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
170660937|NCT03963401|616772749|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
170660938|NCT03963401|616772750|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
170660939|NCT03963401|616772751|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
170660940|NCT03963401|616772752|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
170660941|NCT03963401|616772753|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
170660942|NCT03963401|616772748|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
170660943|NCT03963401|616772749|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
170660944|NCT03963401|616772750|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
170660945|NCT03963401|616772751|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
170660946|NCT03963401|616772752|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
170660947|NCT03963401|616772753|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
170660948|NCT03963401|616772748|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
170660949|NCT03963401|616772749|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
170660950|NCT03963401|616772750|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
170660951|NCT03963401|616772751|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
170660952|NCT03963401|616772752|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
170660953|NCT03963401|616772753|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
170817471|NCT06247488|617339768|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
170660954|NCT03963401|616772748|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
170660955|NCT03963401|616772749|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
170660956|NCT03963401|616772750|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
170660957|NCT03963401|616772751|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
170660958|NCT03963401|616772752|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
170660959|NCT03963401|616772753|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
170660960|NCT03963401|616772748|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
170660961|NCT03963401|616772749|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
170660962|NCT03963401|616772750|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
170660963|NCT03963401|616772751|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
170660964|NCT03963401|616772752|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
170660965|NCT03963401|616772753|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
170660966|NCT03963401|616772748|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
170660967|NCT03963401|616772749|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
170660968|NCT03963401|616772750|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
170615411|NCT02330055|616599125|FG000|Overall Study|participant forgot to wear device|5|||
170615412|NCT02330055|616599126|FG001|Overall Study|participant forgot to wear device|5|||
170615413|NCT02330055|616599125|FG000|Overall Study|data for less than 60 minutes|3|||
170615414|NCT02330055|616599126|FG001|Overall Study|data for less than 60 minutes|3|||
170615415|NCT02330055|616599125|FG000|Overall Study|participant did not sleep|0|||
170615416|NCT02330055|616599126|FG001|Overall Study|participant did not sleep|1|||
170615417|NCT03797586|616599127|FG000|Overall Study|Lost to Follow-up|3|||
170615418|NCT03797586|616599128|FG001|Overall Study|Lost to Follow-up|6|||
170615419|NCT03797586|616599127|FG000|Overall Study|Death|1|||
170615420|NCT03797586|616599128|FG001|Overall Study|Death|1|||
170615421|NCT03797586|616599127|FG000|Overall Study|Adverse Event|0|||
170615422|NCT03797586|616599128|FG001|Overall Study|Adverse Event|2|||
170615423|NCT01219985|616599129|FG000|Overall Study|Physician Decision|20|||
170615424|NCT02680665|616599130|FG000|Overall Study|No visit after the first prescription|5|||
170615425|NCT02905266|616599131|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
170615426|NCT02905266|616599132|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
170615427|NCT02905266|616599131|FG000|Treatment Phase Part 1|Disease Progression|6|||
170615428|NCT02905266|616599132|FG001|Treatment Phase Part 1|Disease Progression|7|||
170615429|NCT02905266|616599131|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
170615430|NCT02905266|616599132|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
170615431|NCT02905266|616599131|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
170615432|NCT02905266|616599132|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
170615433|NCT02905266|616599131|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
170615434|NCT02905266|616599132|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
170615435|NCT02905266|616599131|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
170615436|NCT02905266|616599132|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
170615437|NCT02905266|616599131|FG000|Transition From Part 1 to Part 2|Death|0|||
170615438|NCT02905266|616599132|FG001|Transition From Part 1 to Part 2|Death|1|||
170615439|NCT02905266|616599131|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
170615440|NCT02905266|616599132|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
170615441|NCT02905266|616599131|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
170615442|NCT02905266|616599132|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
170615443|NCT02905266|616599131|FG000|Maintenance Phase Part 2|Disease Progression|9|||
170615444|NCT02905266|616599132|FG001|Maintenance Phase Part 2|Disease Progression|2|||
170615445|NCT02905266|616599131|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
170615446|NCT02905266|616599132|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
170615447|NCT02905266|616599131|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
170615448|NCT02905266|616599132|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
170615449|NCT02940496|616599135|FG000|Overall Study|Adverse Event|1|||
170615450|NCT02940496|616599136|FG001|Overall Study|Adverse Event|0|||
170615451|NCT02940496|616599135|FG000|Overall Study|Death|2|||
170615452|NCT02940496|616599136|FG001|Overall Study|Death|0|||
170615453|NCT02940496|616599135|FG000|Overall Study|Hospice Care|1|||
170615454|NCT02940496|616599136|FG001|Overall Study|Hospice Care|0|||
170615455|NCT02940496|616599135|FG000|Overall Study|No MRE Done|1|||
170615456|NCT02940496|616599136|FG001|Overall Study|No MRE Done|0|||
170615457|NCT02940496|616599135|FG000|Overall Study|MRE Failure|1|||
170615458|NCT02940496|616599136|FG001|Overall Study|MRE Failure|0|||
170615459|NCT05973006|616599137|FG000|Overall Study|Early termination|3|||
170615460|NCT05973006|616599138|FG001|Overall Study|Early termination|9|||
170615461|NCT01807598|616599139|FG000|Overall Study|Withdrawal by Subject|4|||
170615462|NCT01807598|616599139|FG000|Overall Study|Adverse Event|1|||
170615463|NCT01807598|616599139|FG000|Overall Study|Other Physician Decision|1|||
170615464|NCT04089761|616599140|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
170615465|NCT04089761|616599140|FG000|"Run In Phase"|Lost to Follow-up|1|||
170615466|NCT04089761|616599140|FG000|"Treatment Phase"|No evaluable data|5|||
170615467|NCT04089761|616599140|FG000|"Treatment Phase"|Lost to Follow-up|1|||
170660969|NCT03963401|616772751|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
170615468|NCT04417361|616599142|FG000|Overall Study|Withdrawal by Subject|1|||
170615469|NCT04417361|616599143|FG001|Overall Study|Withdrawal by Subject|0|||
170615470|NCT04417361|616599142|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
170615471|NCT04417361|616599143|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
170615472|NCT00165672|616599144|FG000|Overall Study|Adverse Event|0|||
170615473|NCT00165672|616599145|FG001|Overall Study|Adverse Event|1|||
170615474|NCT03868943|616599146|FG000|Overall Study|Adverse Event|1|||
170615475|NCT04896593|616599149|FG000|Overall Study|Withdrawal by Subject|2|||
170615476|NCT04896593|616599149|FG000|Overall Study|Lost to Follow-up|1|||
170615477|NCT04896593|616599149|FG000|Overall Study|Did not complete onboarding|2|||
170917153|NCT05775289|617697858|FG002|Overall Study|Study Ongoing|15|||
170660970|NCT03963401|616772752|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
170615478|NCT00924443|616599150|FG000|Overall Study|Physician Decision|2|||
170615479|NCT00924443|616599150|FG000|Overall Study|Protocol Violation|1|||
170615480|NCT00103740|616599153|FG000|Period 1 - Core|Adverse Event|1|||
170615481|NCT00103740|616599154|FG001|Period 1 - Core|Adverse Event|0|||
170615482|NCT00103740|616599153|FG000|Period 1 - Core|Protocol Violation|3|||
170615483|NCT00103740|616599154|FG001|Period 1 - Core|Protocol Violation|2|||
170615484|NCT00103740|616599153|FG000|Period 1 - Core|Patient withdrew consent|3|||
170615485|NCT00103740|616599154|FG001|Period 1 - Core|Patient withdrew consent|2|||
170615486|NCT00103740|616599153|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
170615487|NCT00103740|616599154|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
170615488|NCT00103740|616599153|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
170615489|NCT00103740|616599154|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
170615490|NCT00103740|616599153|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
170615491|NCT00103740|616599154|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
170615492|NCT00103740|616599153|FG000|Period 2 - Extended Observation Period|Death|6|||
170615493|NCT00103740|616599154|FG001|Period 2 - Extended Observation Period|Death|2|||
170615494|NCT00103740|616599153|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
170615495|NCT00103740|616599154|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
170615496|NCT01463306|616599155|FG000|Overall Study|Adverse Event|6|||
170615497|NCT01463306|616599156|FG001|Overall Study|Adverse Event|9|||
170615498|NCT01463306|616599157|FG002|Overall Study|Adverse Event|3|||
170615499|NCT01463306|616599155|FG000|Overall Study|Death|3|||
170615500|NCT01463306|616599156|FG001|Overall Study|Death|3|||
170615501|NCT01463306|616599157|FG002|Overall Study|Death|0|||
170615502|NCT01463306|616599155|FG000|Overall Study|Lack of Efficacy|22|||
170615503|NCT01463306|616599156|FG001|Overall Study|Lack of Efficacy|16|||
170615504|NCT01463306|616599157|FG002|Overall Study|Lack of Efficacy|1|||
170615505|NCT01463306|616599155|FG000|Overall Study|Lost to Follow-up|5|||
170615506|NCT01463306|616599156|FG001|Overall Study|Lost to Follow-up|2|||
170615507|NCT01463306|616599157|FG002|Overall Study|Lost to Follow-up|0|||
170615508|NCT01463306|616599155|FG000|Overall Study|Protocol Violation|4|||
170615509|NCT01463306|616599156|FG001|Overall Study|Protocol Violation|0|||
170615510|NCT01463306|616599157|FG002|Overall Study|Protocol Violation|0|||
170615511|NCT01463306|616599155|FG000|Overall Study|Withdrawal by Subject|19|||
170615512|NCT01463306|616599156|FG001|Overall Study|Withdrawal by Subject|9|||
170615513|NCT01463306|616599157|FG002|Overall Study|Withdrawal by Subject|1|||
170615514|NCT01463306|616599155|FG000|Overall Study|Other|26|||
170615515|NCT01463306|616599156|FG001|Overall Study|Other|13|||
170615516|NCT01463306|616599157|FG002|Overall Study|Other|0|||
170615517|NCT01463306|616599155|FG000|Overall Study|Approval expiry at site|1|||
170615518|NCT01463306|616599156|FG001|Overall Study|Approval expiry at site|0|||
170615519|NCT01463306|616599157|FG002|Overall Study|Approval expiry at site|0|||
170615520|NCT04186871|616599158|FG000|Overall Study|Lack of Efficacy|0|||
170615521|NCT04186871|616599159|FG001|Overall Study|Lack of Efficacy|1|||
170615522|NCT04186871|616599160|FG002|Overall Study|Lack of Efficacy|0|||
170615523|NCT04186871|616599161|FG003|Overall Study|Lack of Efficacy|0|||
170615524|NCT04186871|616599162|FG004|Overall Study|Lack of Efficacy|1|||
170615525|NCT04186871|616599163|FG005|Overall Study|Lack of Efficacy|1|||
170615526|NCT04186871|616599158|FG000|Overall Study|Adverse Event|1|||
170615527|NCT04186871|616599159|FG001|Overall Study|Adverse Event|1|||
170615528|NCT04186871|616599160|FG002|Overall Study|Adverse Event|0|||
170615529|NCT04186871|616599161|FG003|Overall Study|Adverse Event|0|||
170615530|NCT04186871|616599162|FG004|Overall Study|Adverse Event|0|||
170615531|NCT04186871|616599163|FG005|Overall Study|Adverse Event|2|||
170615532|NCT04186871|616599158|FG000|Overall Study|Study terminated by sponsor|1|||
170615533|NCT04186871|616599159|FG001|Overall Study|Study terminated by sponsor|2|||
170615534|NCT04186871|616599160|FG002|Overall Study|Study terminated by sponsor|0|||
170615535|NCT04186871|616599161|FG003|Overall Study|Study terminated by sponsor|1|||
170615536|NCT04186871|616599162|FG004|Overall Study|Study terminated by sponsor|0|||
170615537|NCT04186871|616599163|FG005|Overall Study|Study terminated by sponsor|0|||
170615538|NCT04186871|616599158|FG000|Overall Study|Other reasons|0|||
170615539|NCT04186871|616599159|FG001|Overall Study|Other reasons|0|||
170615540|NCT04186871|616599160|FG002|Overall Study|Other reasons|0|||
170615541|NCT04186871|616599161|FG003|Overall Study|Other reasons|0|||
170615542|NCT04186871|616599162|FG004|Overall Study|Other reasons|0|||
170615543|NCT04186871|616599163|FG005|Overall Study|Other reasons|1|||
170615544|NCT04186871|616599158|FG000|Overall Study|Withdrawal by Subject|0|||
170615545|NCT04186871|616599159|FG001|Overall Study|Withdrawal by Subject|0|||
170615546|NCT04186871|616599160|FG002|Overall Study|Withdrawal by Subject|0|||
170615547|NCT04186871|616599161|FG003|Overall Study|Withdrawal by Subject|0|||
170615548|NCT04186871|616599162|FG004|Overall Study|Withdrawal by Subject|0|||
170917154|NCT05775289|617697859|FG003|Overall Study|Study Ongoing|55|||
170917155|NCT05775289|617697856|FG000|Overall Study|Death|4|||
170917156|NCT05775289|617697857|FG001|Overall Study|Death|11|||
170917157|NCT05775289|617697858|FG002|Overall Study|Death|8|||
170917158|NCT05775289|617697859|FG003|Overall Study|Death|12|||
170615549|NCT04186871|616599163|FG005|Overall Study|Withdrawal by Subject|1|||
170615550|NCT04186871|616599158|FG000|Overall Study|Lost to Follow-up|0|||
170615551|NCT04186871|616599159|FG001|Overall Study|Lost to Follow-up|0|||
170615552|NCT04186871|616599160|FG002|Overall Study|Lost to Follow-up|0|||
170615553|NCT04186871|616599161|FG003|Overall Study|Lost to Follow-up|0|||
170615554|NCT04186871|616599162|FG004|Overall Study|Lost to Follow-up|0|||
170615555|NCT04186871|616599163|FG005|Overall Study|Lost to Follow-up|1|||
170615556|NCT03790111|616601269|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
170615557|NCT04002960|616601270|FG000|Overall Study|Withdrawn prior to Completion|2|||
170615558|NCT01045967|616601271|FG000|Second Intervention|Protocol Violation|0|||
170615559|NCT01045967|616601272|FG001|Second Intervention|Protocol Violation|1|||
170615560|NCT00383786|616601273|FG000|Overall Study|Protocol Violation|2|||
170615561|NCT00383786|616601274|FG001|Overall Study|Protocol Violation|6|||
170615562|NCT00383786|616601273|FG000|Overall Study|Withdrawal by Subject|2|||
170615563|NCT00383786|616601274|FG001|Overall Study|Withdrawal by Subject|5|||
170615564|NCT00383786|616601273|FG000|Overall Study|Physician Decision|0|||
170615565|NCT00383786|616601274|FG001|Overall Study|Physician Decision|1|||
170615566|NCT00985673|616601275|FG000|Overall Study|Lost to Follow-up|6|||
170615567|NCT00985673|616601276|FG001|Overall Study|Lost to Follow-up|7|||
170615568|NCT00985673|616601277|FG002|Overall Study|Lost to Follow-up|6|||
170615569|NCT00985673|616601278|FG003|Overall Study|Lost to Follow-up|10|||
170615570|NCT00985673|616601279|FG004|Overall Study|Lost to Follow-up|5|||
170615571|NCT00985673|616601280|FG005|Overall Study|Lost to Follow-up|3|||
170615572|NCT00985673|616601275|FG000|Overall Study|Withdrawal by Subject|0|||
170615573|NCT00985673|616601276|FG001|Overall Study|Withdrawal by Subject|4|||
170615574|NCT00985673|616601277|FG002|Overall Study|Withdrawal by Subject|5|||
170615575|NCT00985673|616601278|FG003|Overall Study|Withdrawal by Subject|2|||
170615576|NCT00985673|616601279|FG004|Overall Study|Withdrawal by Subject|2|||
170615577|NCT00985673|616601280|FG005|Overall Study|Withdrawal by Subject|3|||
170615578|NCT00985673|616601275|FG000|Overall Study|Other|1|||
170615579|NCT00985673|616601276|FG001|Overall Study|Other|0|||
170615580|NCT00985673|616601277|FG002|Overall Study|Other|1|||
170615581|NCT00985673|616601278|FG003|Overall Study|Other|0|||
170615582|NCT00985673|616601279|FG004|Overall Study|Other|1|||
170615583|NCT00985673|616601280|FG005|Overall Study|Other|0|||
170615584|NCT02252146|616601281|FG000|Overall Study|Lack of Efficacy|4|||
170615585|NCT02252146|616601281|FG000|Overall Study|Entered hospice care|1|||
170615586|NCT02252146|616601281|FG000|Overall Study|Inability to travel to study site|1|||
170615587|NCT00531284|616601284|FG000|Overall Study|Progressive Disease|1|||
170615588|NCT00531284|616601285|FG001|Overall Study|Progressive Disease|3|||
170615589|NCT00531284|616601286|FG002|Overall Study|Progressive Disease|5|||
170615590|NCT00531284|616601287|FG003|Overall Study|Progressive Disease|42|||
170615591|NCT00531284|616601288|FG004|Overall Study|Progressive Disease|4|||
170615592|NCT00531284|616601289|FG005|Overall Study|Progressive Disease|4|||
170615593|NCT00531284|616601290|FG006|Overall Study|Progressive Disease|3|||
170615594|NCT00531284|616601291|FG007|Overall Study|Progressive Disease|8|||
170615595|NCT00531284|616601292|FG008|Overall Study|Progressive Disease|6|||
170615596|NCT00531284|616601293|FG009|Overall Study|Progressive Disease|3|||
170615597|NCT00531284|616601294|FG010|Overall Study|Progressive Disease|3|||
170615598|NCT00531284|616601295|FG011|Overall Study|Progressive Disease|14|||
170615599|NCT00531284|616601296|FG012|Overall Study|Progressive Disease|2|||
170615600|NCT00531284|616601297|FG013|Overall Study|Progressive Disease|1|||
170615601|NCT00531284|616601298|FG014|Overall Study|Progressive Disease|2|||
170615602|NCT00531284|616601299|FG015|Overall Study|Progressive Disease|11|||
170615603|NCT00531284|616601300|FG016|Overall Study|Progressive Disease|5|||
170615604|NCT00531284|616601284|FG000|Overall Study|Adverse Event|0|||
170615605|NCT00531284|616601285|FG001|Overall Study|Adverse Event|1|||
170615606|NCT00531284|616601286|FG002|Overall Study|Adverse Event|1|||
170615607|NCT00531284|616601287|FG003|Overall Study|Adverse Event|7|||
170615608|NCT00531284|616601288|FG004|Overall Study|Adverse Event|0|||
170615609|NCT00531284|616601289|FG005|Overall Study|Adverse Event|2|||
170615610|NCT00531284|616601290|FG006|Overall Study|Adverse Event|3|||
170615611|NCT00531284|616601291|FG007|Overall Study|Adverse Event|2|||
170615612|NCT00531284|616601292|FG008|Overall Study|Adverse Event|3|||
170615613|NCT00531284|616601293|FG009|Overall Study|Adverse Event|0|||
170615614|NCT00531284|616601294|FG010|Overall Study|Adverse Event|0|||
170615615|NCT00531284|616601295|FG011|Overall Study|Adverse Event|5|||
170615616|NCT00531284|616601296|FG012|Overall Study|Adverse Event|0|||
170615617|NCT00531284|616601297|FG013|Overall Study|Adverse Event|1|||
170615618|NCT00531284|616601298|FG014|Overall Study|Adverse Event|1|||
170615619|NCT00531284|616601299|FG015|Overall Study|Adverse Event|0|||
170615620|NCT00531284|616601300|FG016|Overall Study|Adverse Event|2|||
170615621|NCT00531284|616601284|FG000|Overall Study|Withdrawal by Subject|1|||
170615622|NCT00531284|616601285|FG001|Overall Study|Withdrawal by Subject|0|||
170615623|NCT00531284|616601286|FG002|Overall Study|Withdrawal by Subject|0|||
170660971|NCT03963401|616772753|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
170660972|NCT03963401|616772748|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
170660973|NCT03963401|616772749|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
170660974|NCT03963401|616772750|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
170660975|NCT03963401|616772751|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
170660976|NCT03963401|616772752|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
170660977|NCT03963401|616772753|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
170660978|NCT03963401|616772748|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
170660979|NCT03963401|616772749|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
170660980|NCT03963401|616772750|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
170660981|NCT03963401|616772751|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
170660982|NCT03963401|616772752|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
170660983|NCT03963401|616772753|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
170660984|NCT03963401|616772748|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
170660985|NCT03963401|616772749|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
170660986|NCT03963401|616772750|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
170660987|NCT03963401|616772751|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
170660988|NCT03963401|616772752|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
170660989|NCT03963401|616772753|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
170660990|NCT03963401|616772748|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
170660991|NCT03963401|616772749|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
170660992|NCT03963401|616772750|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
170660993|NCT03963401|616772751|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
170660994|NCT03963401|616772752|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
170660995|NCT03963401|616772753|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
170660996|NCT03963401|616772748|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
170660997|NCT03963401|616772749|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
170660998|NCT03963401|616772750|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
170660999|NCT03963401|616772751|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
170661000|NCT03963401|616772752|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
170661001|NCT03963401|616772753|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
170661002|NCT00586846|616772756|FG000|Overall Study|Physician Decision|1|||
170661003|NCT00586846|616772756|FG000|Overall Study|Death|1|||
170661004|NCT00586846|616772756|FG000|Overall Study|Evaluable for Toxicity Only|4|||
170661005|NCT00923936|616772757|FG000|Overall Study|progressive disease on study|2|||
170661006|NCT00923936|616772758|FG001|Overall Study|progressive disease on study|1|||
170661007|NCT00923936|616772757|FG000|Overall Study|Adverse Event|2|||
170661008|NCT00923936|616772758|FG001|Overall Study|Adverse Event|1|||
170661009|NCT00923936|616772757|FG000|Overall Study|Lost to follow up|2|||
170661010|NCT00923936|616772758|FG001|Overall Study|Lost to follow up|0|||
170661011|NCT00923936|616772757|FG000|Overall Study|Continuing in follow up period|2|||
170661012|NCT00923936|616772758|FG001|Overall Study|Continuing in follow up period|1|||
170661013|NCT00586066|616772761|FG000|Overall Study|Lost to Follow-up|6|||
170661014|NCT00586066|616772762|FG001|Overall Study|Lost to Follow-up|3|||
170661015|NCT00586066|616772761|FG000|Overall Study|Lack of Efficacy|5|||
170661016|NCT00586066|616772762|FG001|Overall Study|Lack of Efficacy|3|||
170661017|NCT00586066|616772761|FG000|Overall Study|Adverse Event|2|||
170661018|NCT00586066|616772762|FG001|Overall Study|Adverse Event|2|||
170661019|NCT00586066|616772761|FG000|Overall Study|Physician Decision|1|||
170661020|NCT00586066|616772762|FG001|Overall Study|Physician Decision|0|||
170661021|NCT00586066|616772761|FG000|Overall Study|Withdrawal of consent|4|||
170661022|NCT00586066|616772762|FG001|Overall Study|Withdrawal of consent|2|||
170661023|NCT00144027|616772763|FG000|Overall Study|Lost to Follow-up|1|||
170661024|NCT00144027|616772764|FG001|Overall Study|Lost to Follow-up|3|||
170661025|NCT00144027|616772763|FG000|Overall Study|Withdrawal by Subject|2|||
170661026|NCT00144027|616772764|FG001|Overall Study|Withdrawal by Subject|2|||
170661027|NCT00144027|616772763|FG000|Overall Study|did not complete baseline assessment|0|||
170661028|NCT00144027|616772764|FG001|Overall Study|did not complete baseline assessment|6|||
170817472|NCT06247488|617339763|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
170817473|NCT06247488|617339764|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
170817474|NCT06247488|617339765|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
170817475|NCT06247488|617339766|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
170661029|NCT02676466|616772765|FG000|Overall Study|Death|0|||
170661030|NCT02676466|616772766|FG001|Overall Study|Death|2|||
170661031|NCT02676466|616772767|FG002|Overall Study|Death|1|||
170661032|NCT02676466|616772768|FG003|Overall Study|Death|0|||
170661033|NCT02676466|616772769|FG004|Overall Study|Death|0|||
170817476|NCT06247488|617339767|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
170817477|NCT06247488|617339768|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
170661034|NCT02676466|616772770|FG005|Overall Study|Death|0|||
170661035|NCT02676466|616772771|FG006|Overall Study|Death|0|||
170661036|NCT02676466|616772772|FG007|Overall Study|Death|0|||
170661037|NCT02676466|616772765|FG000|Overall Study|Withdrawal by Subject|4|||
170661038|NCT02676466|616772766|FG001|Overall Study|Withdrawal by Subject|3|||
170661039|NCT02676466|616772767|FG002|Overall Study|Withdrawal by Subject|1|||
170661040|NCT02676466|616772768|FG003|Overall Study|Withdrawal by Subject|0|||
170661041|NCT02676466|616772769|FG004|Overall Study|Withdrawal by Subject|3|||
170661042|NCT02676466|616772770|FG005|Overall Study|Withdrawal by Subject|1|||
170661043|NCT02676466|616772771|FG006|Overall Study|Withdrawal by Subject|1|||
170661044|NCT02676466|616772772|FG007|Overall Study|Withdrawal by Subject|1|||
170661045|NCT05080660|616772774|FG000|Overall Study|Adverse Event|4|||
170661046|NCT05080660|616772775|FG001|Overall Study|Adverse Event|0|||
170661047|NCT05080660|616772774|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
170661048|NCT05080660|616772775|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
170661049|NCT05080660|616772774|FG000|Overall Study|Physician Decision|1|||
170661050|NCT05080660|616772775|FG001|Overall Study|Physician Decision|0|||
170661051|NCT05080660|616772774|FG000|Overall Study|Protocol Deviation|2|||
170661052|NCT05080660|616772775|FG001|Overall Study|Protocol Deviation|0|||
170661053|NCT05080660|616772774|FG000|Overall Study|Withdrawal by Subject|5|||
170661054|NCT05080660|616772775|FG001|Overall Study|Withdrawal by Subject|2|||
170661055|NCT01857583|616772777|FG000|Overall Study|Adverse Event|0|||
170661056|NCT01857583|616772778|FG001|Overall Study|Adverse Event|0|||
170661057|NCT01857583|616772779|FG002|Overall Study|Adverse Event|1|||
170661058|NCT01857583|616772780|FG003|Overall Study|Adverse Event|1|||
170661059|NCT01857583|616772777|FG000|Overall Study|Death|0|||
170661060|NCT01857583|616772778|FG001|Overall Study|Death|1|||
170661061|NCT01857583|616772779|FG002|Overall Study|Death|1|||
170661062|NCT01857583|616772780|FG003|Overall Study|Death|0|||
170661063|NCT01857583|616772777|FG000|Overall Study|Physician Decision|0|||
170661064|NCT01857583|616772778|FG001|Overall Study|Physician Decision|0|||
170661065|NCT01857583|616772779|FG002|Overall Study|Physician Decision|0|||
170661066|NCT01857583|616772780|FG003|Overall Study|Physician Decision|1|||
170661067|NCT01857583|616772777|FG000|Overall Study|Withdrawal by Subject|1|||
170661068|NCT01857583|616772778|FG001|Overall Study|Withdrawal by Subject|0|||
170661069|NCT01857583|616772779|FG002|Overall Study|Withdrawal by Subject|1|||
170661070|NCT01857583|616772780|FG003|Overall Study|Withdrawal by Subject|2|||
170661071|NCT05430022|616772781|FG000|Overall Study|Withdrawal by Subject|4|||
170661072|NCT05430022|616772782|FG001|Overall Study|Withdrawal by Subject|4|||
170661073|NCT05521906|616772783|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
170661074|NCT05521906|616772784|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
170661075|NCT02775903|616772787|FG000|Overall Study|Death|7|||
170661076|NCT02775903|616772788|FG001|Overall Study|Death|11|||
170661077|NCT02775903|616772789|FG002|Overall Study|Death|12|||
170661078|NCT02775903|616772790|FG003|Overall Study|Death|11|||
170661079|NCT02775903|616772787|FG000|Overall Study|Adverse Event|0|||
170661080|NCT02775903|616772788|FG001|Overall Study|Adverse Event|1|||
170661081|NCT02775903|616772789|FG002|Overall Study|Adverse Event|12|||
170661082|NCT02775903|616772790|FG003|Overall Study|Adverse Event|3|||
170661083|NCT02775903|616772787|FG000|Overall Study|Progressive disease|15|||
170661084|NCT02775903|616772788|FG001|Overall Study|Progressive disease|14|||
170661085|NCT02775903|616772789|FG002|Overall Study|Progressive disease|30|||
170661086|NCT02775903|616772790|FG003|Overall Study|Progressive disease|20|||
170661087|NCT02775903|616772787|FG000|Overall Study|Lack of Efficacy|2|||
170661088|NCT02775903|616772788|FG001|Overall Study|Lack of Efficacy|2|||
170661089|NCT02775903|616772789|FG002|Overall Study|Lack of Efficacy|2|||
170661090|NCT02775903|616772790|FG003|Overall Study|Lack of Efficacy|6|||
170661091|NCT02775903|616772787|FG000|Overall Study|Withdrawal by Subject|7|||
170817478|NCT06247488|617339763|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
170817479|NCT06247488|617339764|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
170817480|NCT06247488|617339765|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
170817481|NCT06247488|617339766|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
170817482|NCT06247488|617339767|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
170661092|NCT02775903|616772788|FG001|Overall Study|Withdrawal by Subject|5|||
170661093|NCT02775903|616772789|FG002|Overall Study|Withdrawal by Subject|5|||
170817483|NCT06247488|617339768|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
170661094|NCT02775903|616772790|FG003|Overall Study|Withdrawal by Subject|8|||
170661095|NCT02775903|616772787|FG000|Overall Study|Other reasons|7|||
170661096|NCT02775903|616772788|FG001|Overall Study|Other reasons|8|||
170661097|NCT02775903|616772789|FG002|Overall Study|Other reasons|2|||
170661098|NCT02775903|616772790|FG003|Overall Study|Other reasons|12|||
170661099|NCT05098938|616772793|FG000|Overall Study|Adverse Event|4|||
170661100|NCT05098938|616772794|FG001|Overall Study|Adverse Event|3|||
170661101|NCT05098938|616772793|FG000|Overall Study|inclusion/exclusion criteria change|11|||
170661102|NCT05098938|616772794|FG001|Overall Study|inclusion/exclusion criteria change|5|||
170661103|NCT05098938|616772793|FG000|Overall Study|lack of compliance|26|||
170661104|NCT05098938|616772794|FG001|Overall Study|lack of compliance|19|||
170817484|NCT06247488|617339763|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
170817485|NCT06247488|617339764|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
170817486|NCT06247488|617339765|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
170615624|NCT00531284|616601287|FG003|Overall Study|Withdrawal by Subject|4|||
170615625|NCT00531284|616601288|FG004|Overall Study|Withdrawal by Subject|0|||
170615626|NCT00531284|616601289|FG005|Overall Study|Withdrawal by Subject|0|||
170615627|NCT00531284|616601290|FG006|Overall Study|Withdrawal by Subject|0|||
170615628|NCT00531284|616601291|FG007|Overall Study|Withdrawal by Subject|0|||
170615629|NCT00531284|616601292|FG008|Overall Study|Withdrawal by Subject|0|||
170615630|NCT00531284|616601293|FG009|Overall Study|Withdrawal by Subject|0|||
170615631|NCT00531284|616601294|FG010|Overall Study|Withdrawal by Subject|0|||
170615632|NCT00531284|616601295|FG011|Overall Study|Withdrawal by Subject|3|||
170615633|NCT00531284|616601296|FG012|Overall Study|Withdrawal by Subject|0|||
170615634|NCT00531284|616601297|FG013|Overall Study|Withdrawal by Subject|1|||
170615635|NCT00531284|616601298|FG014|Overall Study|Withdrawal by Subject|0|||
170615636|NCT00531284|616601299|FG015|Overall Study|Withdrawal by Subject|1|||
170615637|NCT00531284|616601300|FG016|Overall Study|Withdrawal by Subject|1|||
170615638|NCT00531284|616601284|FG000|Overall Study|Other|1|||
170615639|NCT00531284|616601285|FG001|Overall Study|Other|0|||
170615640|NCT00531284|616601286|FG002|Overall Study|Other|0|||
170615641|NCT00531284|616601287|FG003|Overall Study|Other|10|||
170615642|NCT00531284|616601288|FG004|Overall Study|Other|2|||
170615643|NCT00531284|616601289|FG005|Overall Study|Other|1|||
170615644|NCT00531284|616601290|FG006|Overall Study|Other|0|||
170615645|NCT00531284|616601291|FG007|Overall Study|Other|0|||
170615646|NCT00531284|616601292|FG008|Overall Study|Other|2|||
170615647|NCT00531284|616601293|FG009|Overall Study|Other|1|||
170615648|NCT00531284|616601294|FG010|Overall Study|Other|0|||
170615649|NCT00531284|616601295|FG011|Overall Study|Other|2|||
170615650|NCT00531284|616601296|FG012|Overall Study|Other|0|||
170615651|NCT00531284|616601297|FG013|Overall Study|Other|0|||
170615652|NCT00531284|616601298|FG014|Overall Study|Other|1|||
170615653|NCT00531284|616601299|FG015|Overall Study|Other|0|||
170615654|NCT00531284|616601300|FG016|Overall Study|Other|0|||
170615655|NCT03057496|616601302|FG000|Overall Study|Withdrawal by Subject|8|||
170615656|NCT03057496|616601302|FG000|Overall Study|Lost to Follow-up|5|||
170615657|NCT03057496|616601302|FG000|Overall Study|Did not use device during home trial|3|||
170615658|NCT03057496|616601302|FG000|Overall Study|Device failure|2|||
170615659|NCT00280917|616601303|FG000|Overall Study|Adverse Event|1|||
170615660|NCT00280917|616601304|FG001|Overall Study|Adverse Event|1|||
170615661|NCT00280917|616601305|FG002|Overall Study|Adverse Event|4|||
170615662|NCT00280917|616601306|FG003|Overall Study|Adverse Event|1|||
170615663|NCT00280917|616601303|FG000|Overall Study|Change Therapy|1|||
170615664|NCT00280917|616601304|FG001|Overall Study|Change Therapy|2|||
170615665|NCT00280917|616601305|FG002|Overall Study|Change Therapy|0|||
170615666|NCT00280917|616601306|FG003|Overall Study|Change Therapy|0|||
170615667|NCT00280917|616601303|FG000|Overall Study|Withdrawal by Subject|0|||
170615668|NCT00280917|616601304|FG001|Overall Study|Withdrawal by Subject|2|||
170615669|NCT00280917|616601305|FG002|Overall Study|Withdrawal by Subject|0|||
170615670|NCT00280917|616601306|FG003|Overall Study|Withdrawal by Subject|1|||
170615671|NCT00280917|616601303|FG000|Overall Study|Noncompliance|0|||
170615672|NCT00280917|616601304|FG001|Overall Study|Noncompliance|1|||
170615673|NCT00280917|616601305|FG002|Overall Study|Noncompliance|2|||
170615674|NCT00280917|616601306|FG003|Overall Study|Noncompliance|0|||
170615675|NCT03493945|616601307|FG000|Phase I Dose Escalation|Ineligible|0|||
170615676|NCT03493945|616601308|FG001|Phase I Dose Escalation|Ineligible|0|||
170615677|NCT03493945|616601309|FG002|Phase I Dose Escalation|Ineligible|1|||
170615678|NCT03493945|616601310|FG003|Phase I Dose Escalation|Ineligible|0|||
170615679|NCT03493945|616601311|FG004|Phase I Dose Escalation|Ineligible|0|||
170615680|NCT03493945|616601312|FG005|Phase I Dose Escalation|Ineligible|0|||
170615681|NCT03493945|616601313|FG006|Phase I Dose Escalation|Ineligible|0|||
170615682|NCT03493945|616601307|FG000|Phase I Dose Escalation|New therapy|0|||
170615683|NCT03493945|616601308|FG001|Phase I Dose Escalation|New therapy|1|||
170615684|NCT03493945|616601309|FG002|Phase I Dose Escalation|New therapy|0|||
170615685|NCT03493945|616601310|FG003|Phase I Dose Escalation|New therapy|0|||
170615686|NCT03493945|616601311|FG004|Phase I Dose Escalation|New therapy|0|||
170615687|NCT03493945|616601312|FG005|Phase I Dose Escalation|New therapy|0|||
170615688|NCT03493945|616601313|FG006|Phase I Dose Escalation|New therapy|0|||
170615689|NCT03493945|616601307|FG000|Phase II Dose Expansion|Refused further treatment|0|||
170615690|NCT03493945|616601308|FG001|Phase II Dose Expansion|Refused further treatment|0|||
170615691|NCT03493945|616601309|FG002|Phase II Dose Expansion|Refused further treatment|0|||
170615692|NCT03493945|616601310|FG003|Phase II Dose Expansion|Refused further treatment|0|||
170615693|NCT03493945|616601311|FG004|Phase II Dose Expansion|Refused further treatment|1|||
170615694|NCT03493945|616601312|FG005|Phase II Dose Expansion|Refused further treatment|1|||
170615695|NCT03493945|616601313|FG006|Phase II Dose Expansion|Refused further treatment|0|||
170615696|NCT03493945|616601307|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
170615697|NCT03493945|616601308|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
170661105|NCT05098938|616772793|FG000|Overall Study|Lost to Follow-up|37|||
170661106|NCT05098938|616772794|FG001|Overall Study|Lost to Follow-up|40|||
170661107|NCT05098938|616772793|FG000|Overall Study|Lost in treatment period|17|||
170661108|NCT05098938|616772794|FG001|Overall Study|Lost in treatment period|13|||
170661109|NCT05098938|616772793|FG000|Overall Study|Met an exclusion criterion|0|||
170661110|NCT05098938|616772794|FG001|Overall Study|Met an exclusion criterion|3|||
170661111|NCT05098938|616772793|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
170661112|NCT05098938|616772794|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
170661113|NCT05098938|616772793|FG000|Overall Study|Physician Decision|25|||
170661114|NCT05098938|616772794|FG001|Overall Study|Physician Decision|32|||
170661115|NCT05098938|616772793|FG000|Overall Study|Run in failure in treatment phase|1|||
170661116|NCT05098938|616772794|FG001|Overall Study|Run in failure in treatment phase|1|||
170661117|NCT05098938|616772793|FG000|Overall Study|Withdrawal by Subject|0|||
170661118|NCT05098938|616772794|FG001|Overall Study|Withdrawal by Subject|3|||
170661119|NCT05098938|616772793|FG000|Overall Study|Run-in Failure in early study|505|||
170661120|NCT05098938|616772794|FG001|Overall Study|Run-in Failure in early study|514|||
170661121|NCT05098938|616772793|FG000|Overall Study|IMP delivery missed|1|||
170661122|NCT05098938|616772794|FG001|Overall Study|IMP delivery missed|5|||
170661123|NCT05098938|616772793|FG000|Overall Study|6 months visit was missed|2|||
170661124|NCT05098938|616772794|FG001|Overall Study|6 months visit was missed|0|||
170661125|NCT05098938|616772793|FG000|Overall Study|fit for use was not completed within window|3|||
170661126|NCT05098938|616772794|FG001|Overall Study|fit for use was not completed within window|0|||
170661127|NCT05098938|616772793|FG000|Overall Study|V2 visit was not completed within window|0|||
170661128|NCT05098938|616772794|FG001|Overall Study|V2 visit was not completed within window|1|||
170661129|NCT05098938|616772793|FG000|Overall Study|exclusionary medication use|1|||
170661130|NCT05098938|616772794|FG001|Overall Study|exclusionary medication use|2|||
170661131|NCT05098938|616772793|FG000|Overall Study|change in medication|1|||
170817487|NCT06247488|617339766|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
170661132|NCT05098938|616772794|FG001|Overall Study|change in medication|0|||
170661133|NCT05098938|616772793|FG000|Overall Study|treatment failure|2|||
170661134|NCT05098938|616772794|FG001|Overall Study|treatment failure|1|||
170661135|NCT02171065|616774307|FG000|Overall Study|Withdrawal by Subject|1|||
170661136|NCT02171065|616774308|FG001|Overall Study|Withdrawal by Subject|0|||
170661137|NCT02171065|616774309|FG002|Overall Study|Withdrawal by Subject|0|||
170661138|NCT02171065|616774307|FG000|Overall Study|Lost to Follow-up|0|||
170661139|NCT02171065|616774308|FG001|Overall Study|Lost to Follow-up|0|||
170661140|NCT02171065|616774309|FG002|Overall Study|Lost to Follow-up|1|||
170661141|NCT05108922|616774310|FG000|Overall Study|Adverse Event|2|||
170661142|NCT05108922|616774311|FG001|Overall Study|Adverse Event|3|||
170661143|NCT05108922|616774310|FG000|Overall Study|Lost to Follow-up|2|||
170661144|NCT05108922|616774311|FG001|Overall Study|Lost to Follow-up|1|||
170661145|NCT05108922|616774310|FG000|Overall Study|Inadvertent enrollment|0|||
170661146|NCT05108922|616774311|FG001|Overall Study|Inadvertent enrollment|1|||
170661147|NCT05108922|616774310|FG000|Overall Study|Physician Decision|2|||
170661148|NCT05108922|616774311|FG001|Overall Study|Physician Decision|3|||
170661149|NCT05108922|616774310|FG000|Overall Study|Protocol deviation|1|||
170661150|NCT05108922|616774311|FG001|Overall Study|Protocol deviation|0|||
170661151|NCT05108922|616774310|FG000|Overall Study|Screen failure|1|||
170661152|NCT05108922|616774311|FG001|Overall Study|Screen failure|0|||
170661153|NCT05108922|616774310|FG000|Overall Study|Withdrawal by Subject|11|||
170661154|NCT05108922|616774311|FG001|Overall Study|Withdrawal by Subject|8|||
170661155|NCT01920555|616774315|FG000|Overall Study|Physician Decision|1|||
170661156|NCT01920555|616774316|FG001|Overall Study|Physician Decision|2|||
170661157|NCT01920555|616774317|FG002|Overall Study|Physician Decision|1|||
170817488|NCT06247488|617339767|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
170817489|NCT06247488|617339768|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
170817490|NCT06247488|617339763|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
170817491|NCT06247488|617339764|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
170817492|NCT06247488|617339765|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
170817493|NCT06247488|617339766|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
170817494|NCT06247488|617339767|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
170817495|NCT06247488|617339768|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
170817496|NCT06247488|617339763|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
170817497|NCT06247488|617339764|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
170661158|NCT01920555|616774318|FG003|Overall Study|Physician Decision|2|||
170661159|NCT01920555|616774319|FG004|Overall Study|Physician Decision|0|||
170661160|NCT01920555|616774315|FG000|Overall Study|Lack of Efficacy|2|||
170661161|NCT01920555|616774316|FG001|Overall Study|Lack of Efficacy|0|||
170661162|NCT01920555|616774317|FG002|Overall Study|Lack of Efficacy|0|||
170661163|NCT01920555|616774318|FG003|Overall Study|Lack of Efficacy|0|||
170661164|NCT01920555|616774319|FG004|Overall Study|Lack of Efficacy|0|||
170661165|NCT01920555|616774315|FG000|Overall Study|Travel Difficulties|1|||
170661166|NCT01920555|616774316|FG001|Overall Study|Travel Difficulties|1|||
170661167|NCT01920555|616774317|FG002|Overall Study|Travel Difficulties|0|||
170661168|NCT01920555|616774318|FG003|Overall Study|Travel Difficulties|0|||
170661169|NCT01920555|616774319|FG004|Overall Study|Travel Difficulties|1|||
170661170|NCT01920555|616774315|FG000|Overall Study|Lost to Follow-up|0|||
170661171|NCT01920555|616774316|FG001|Overall Study|Lost to Follow-up|1|||
170661172|NCT01920555|616774317|FG002|Overall Study|Lost to Follow-up|0|||
170661173|NCT01920555|616774318|FG003|Overall Study|Lost to Follow-up|1|||
170661174|NCT01920555|616774319|FG004|Overall Study|Lost to Follow-up|0|||
170661175|NCT00426231|616774322|FG000|Overall Study|Withdrawal by Subject|9|||
170661176|NCT00426231|616774323|FG001|Overall Study|Withdrawal by Subject|12|||
170661177|NCT01795638|616774324|FG000|Overall Study|Death|0|||
170661178|NCT01795638|616774325|FG001|Overall Study|Death|3|||
170661179|NCT01795638|616774324|FG000|Overall Study|transferred to quaternary hospital|2|||
170661180|NCT01795638|616774325|FG001|Overall Study|transferred to quaternary hospital|3|||
170661181|NCT01795638|616774324|FG000|Overall Study|Protocol Violation|3|||
170661182|NCT01795638|616774325|FG001|Overall Study|Protocol Violation|0|||
170661183|NCT01795638|616774324|FG000|Overall Study|discharged from hospital|7|||
170661184|NCT01795638|616774325|FG001|Overall Study|discharged from hospital|5|||
170661185|NCT01795638|616774324|FG000|Overall Study|Withdrawal by Subject|1|||
170661186|NCT01795638|616774325|FG001|Overall Study|Withdrawal by Subject|0|||
170661187|NCT01193660|616774326|FG000|Overall Study|Withdrawal by Subject|2|||
170661188|NCT01193660|616774327|FG001|Overall Study|Withdrawal by Subject|3|||
170661189|NCT01193660|616774328|FG002|Overall Study|Withdrawal by Subject|1|||
170661190|NCT01193660|616774326|FG000|Overall Study|Death|1|||
170661191|NCT01193660|616774327|FG001|Overall Study|Death|0|||
170661192|NCT01193660|616774328|FG002|Overall Study|Death|0|||
170661193|NCT01193660|616774326|FG000|Overall Study|Physician Decision|1|||
170661194|NCT01193660|616774327|FG001|Overall Study|Physician Decision|0|||
170661195|NCT01193660|616774328|FG002|Overall Study|Physician Decision|1|||
170661196|NCT00195273|616774329|FG000|Overall Study|Adverse Event|9|||
170661197|NCT00195273|616774330|FG001|Overall Study|Adverse Event|9|||
170661198|NCT00195273|616774329|FG000|Overall Study|Protocol deviation|0|||
170661199|NCT00195273|616774330|FG001|Overall Study|Protocol deviation|1|||
170661200|NCT00195273|616774329|FG000|Overall Study|Lack of Efficacy|3|||
170661201|NCT00195273|616774330|FG001|Overall Study|Lack of Efficacy|1|||
170661202|NCT00195273|616774329|FG000|Overall Study|Procedural complications|9|||
170661203|NCT00195273|616774330|FG001|Overall Study|Procedural complications|3|||
170661204|NCT00107783|616774331|FG000|Overall Study|Adverse Event|0|||
170661205|NCT00107783|616774332|FG001|Overall Study|Adverse Event|2|||
170661206|NCT00107783|616774331|FG000|Overall Study|Death|0|||
170661207|NCT00107783|616774332|FG001|Overall Study|Death|1|||
170661208|NCT00107783|616774331|FG000|Overall Study|Withdrawal by Subject|2|||
170661209|NCT00107783|616774332|FG001|Overall Study|Withdrawal by Subject|0|||
170661210|NCT00107783|616774331|FG000|Overall Study|Second hip replacement|1|||
170661211|NCT00107783|616774332|FG001|Overall Study|Second hip replacement|1|||
170661212|NCT02367131|616774333|FG000|Overall Study|Adverse Event|64|||
170661213|NCT02367131|616774333|FG000|Overall Study|No visit since the first visit|3|||
170661214|NCT02367131|616774333|FG000|Overall Study|Request by patient|53|||
170661215|NCT02367131|616774333|FG000|Overall Study|Improvement/remission|2|||
170661216|NCT02367131|616774333|FG000|Overall Study|No change/progressive disease|78|||
170661217|NCT02367131|616774333|FG000|Overall Study|Other than stated above|20|||
170661218|NCT02367131|616774333|FG000|Overall Study|Not treated|2|||
170661219|NCT01051466|616774337|FG000|Overall Study|Adverse Event|1|||
170661220|NCT01051466|616774338|FG001|Overall Study|Adverse Event|0|||
170661221|NCT01051466|616774337|FG000|Overall Study|Lost to Follow-up|1|||
170661222|NCT01051466|616774338|FG001|Overall Study|Lost to Follow-up|1|||
170661223|NCT01051466|616774337|FG000|Overall Study|Withdrawal by Subject|5|||
170661224|NCT01051466|616774338|FG001|Overall Study|Withdrawal by Subject|1|||
170661225|NCT01051466|616774337|FG000|Overall Study|Entry Criteria Not Met|0|||
170661226|NCT01051466|616774338|FG001|Overall Study|Entry Criteria Not Met|3|||
170661227|NCT01051466|616774337|FG000|Overall Study|Physician Decision|1|||
170661228|NCT01051466|616774338|FG001|Overall Study|Physician Decision|0|||
170661229|NCT02231918|616774339|FG000|Overall Study|Withdrawal by Subject|0|||
170661230|NCT02231918|616774340|FG001|Overall Study|Withdrawal by Subject|1|||
170661231|NCT02231918|616774341|FG002|Overall Study|Withdrawal by Subject|0|||
170661232|NCT02231918|616774339|FG000|Overall Study|Adverse Event|0|||
170661233|NCT02231918|616774340|FG001|Overall Study|Adverse Event|0|||
170661234|NCT02231918|616774341|FG002|Overall Study|Adverse Event|1|||
170661235|NCT02611960|616774342|FG000|Overall Study|Adverse Event|7|||
170661236|NCT02611960|616774343|FG001|Overall Study|Adverse Event|8|||
170661237|NCT02611960|616774342|FG000|Overall Study|Death|98|||
170661238|NCT02611960|616774343|FG001|Overall Study|Death|92|||
170661239|NCT02611960|616774342|FG000|Overall Study|Withdrawal by Subject|1|||
170661240|NCT02611960|616774343|FG001|Overall Study|Withdrawal by Subject|5|||
170661241|NCT02611960|616774342|FG000|Overall Study|Sponsor Decision|11|||
170661242|NCT02611960|616774343|FG001|Overall Study|Sponsor Decision|11|||
170661243|NCT03793556|616774355|FG000|Overall Study|Withdrawal by Subject|12|||
170661244|NCT03793556|616774356|FG001|Overall Study|Withdrawal by Subject|1|||
170661245|NCT03793556|616774355|FG000|Overall Study|Lost to Follow-up|1|||
170661246|NCT03793556|616774356|FG001|Overall Study|Lost to Follow-up|1|||
170661247|NCT02007512|616774357|FG000|Double Blind Treatment Period|Adverse Event|4|||
170661248|NCT02007512|616774358|FG001|Double Blind Treatment Period|Adverse Event|6|||
170661249|NCT02007512|616774359|FG002|Double Blind Treatment Period|Adverse Event|2|||
170661250|NCT02007512|616774360|FG003|Double Blind Treatment Period|Adverse Event|2|||
170661251|NCT02007512|616774357|FG000|Double Blind Treatment Period|Death|1|||
170661252|NCT02007512|616774358|FG001|Double Blind Treatment Period|Death|0|||
170661253|NCT02007512|616774359|FG002|Double Blind Treatment Period|Death|0|||
170661254|NCT02007512|616774360|FG003|Double Blind Treatment Period|Death|0|||
170661255|NCT02007512|616774357|FG000|Double Blind Treatment Period|Disease progression|51|||
170615698|NCT03493945|616601309|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
170615699|NCT03493945|616601310|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
170615700|NCT03493945|616601311|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
170615701|NCT03493945|616601312|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
170615702|NCT03493945|616601313|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
170615703|NCT05104450|616601314|FG000|Overall Study|Death|1|||
170615704|NCT05104450|616601315|FG001|Overall Study|Death|2|||
170615705|NCT05104450|616601314|FG000|Overall Study|Withdrawal by Subject|3|||
170615706|NCT05104450|616601315|FG001|Overall Study|Withdrawal by Subject|1|||
170615707|NCT01584232|616601316|FG000|Overall Study|Adverse Event|3|||
170615708|NCT01584232|616601317|FG001|Overall Study|Adverse Event|1|||
170615709|NCT01584232|616601316|FG000|Overall Study|Withdrawal by Subject|2|||
170615710|NCT01584232|616601317|FG001|Overall Study|Withdrawal by Subject|1|||
170615711|NCT01584232|616601316|FG000|Overall Study|Physician Decision|2|||
170615712|NCT01584232|616601317|FG001|Overall Study|Physician Decision|1|||
170615713|NCT01584232|616601316|FG000|Overall Study|Lost to Follow-up|1|||
170615714|NCT01584232|616601317|FG001|Overall Study|Lost to Follow-up|0|||
170615715|NCT01307319|616601318|FG000|Overall Study|Adverse Event|2|||
170615716|NCT01307319|616601319|FG001|Overall Study|Adverse Event|2|||
170615717|NCT01307319|616601320|FG002|Overall Study|Adverse Event|1|||
170615718|NCT01307319|616601318|FG000|Overall Study|Lost to Follow-up|1|||
170615719|NCT01307319|616601319|FG001|Overall Study|Lost to Follow-up|0|||
170615720|NCT01307319|616601320|FG002|Overall Study|Lost to Follow-up|1|||
170615721|NCT01307319|616601318|FG000|Overall Study|Protocol Violation|1|||
170615722|NCT01307319|616601319|FG001|Overall Study|Protocol Violation|1|||
170615723|NCT01307319|616601320|FG002|Overall Study|Protocol Violation|0|||
170615724|NCT01307319|616601318|FG000|Overall Study|Withdrawal by Subject|0|||
170615725|NCT01307319|616601319|FG001|Overall Study|Withdrawal by Subject|1|||
170615726|NCT01307319|616601320|FG002|Overall Study|Withdrawal by Subject|2|||
170615727|NCT01307319|616601318|FG000|Overall Study|Other|0|||
170615728|NCT01307319|616601319|FG001|Overall Study|Other|4|||
170615729|NCT01307319|616601320|FG002|Overall Study|Other|3|||
170615730|NCT02735239|616601322|FG000|Overall Study|Adverse Event|0|||
170615731|NCT02735239|616601323|FG001|Overall Study|Adverse Event|0|||
170615732|NCT02735239|616601324|FG002|Overall Study|Adverse Event|4|||
170615733|NCT02735239|616601325|FG003|Overall Study|Adverse Event|0|||
170615734|NCT02735239|616601326|FG004|Overall Study|Adverse Event|0|||
170615735|NCT02735239|616601327|FG005|Overall Study|Adverse Event|0|||
170615736|NCT02735239|616601322|FG000|Overall Study|Death|1|||
170615737|NCT02735239|616601323|FG001|Overall Study|Death|1|||
170615738|NCT02735239|616601324|FG002|Overall Study|Death|0|||
170615739|NCT02735239|616601325|FG003|Overall Study|Death|0|||
170615740|NCT02735239|616601326|FG004|Overall Study|Death|0|||
170615741|NCT02735239|616601327|FG005|Overall Study|Death|0|||
170615742|NCT02735239|616601322|FG000|Overall Study|Physician Decision|0|||
170615743|NCT02735239|616601323|FG001|Overall Study|Physician Decision|0|||
170615744|NCT02735239|616601324|FG002|Overall Study|Physician Decision|1|||
170615745|NCT02735239|616601325|FG003|Overall Study|Physician Decision|0|||
170615746|NCT02735239|616601326|FG004|Overall Study|Physician Decision|0|||
170615747|NCT02735239|616601327|FG005|Overall Study|Physician Decision|0|||
170615748|NCT02735239|616601322|FG000|Overall Study|Progressive disease|3|||
170615749|NCT02735239|616601323|FG001|Overall Study|Progressive disease|1|||
170615750|NCT02735239|616601324|FG002|Overall Study|Progressive disease|3|||
170661256|NCT02007512|616774358|FG001|Double Blind Treatment Period|Disease progression|50|||
170817498|NCT06247488|617339765|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
170817499|NCT06247488|617339766|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
170817500|NCT06247488|617339767|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
170817501|NCT06247488|617339768|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
170817502|NCT06247488|617339763|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
170817503|NCT06247488|617339764|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
170817504|NCT06247488|617339765|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
170817505|NCT06247488|617339766|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
170817506|NCT06247488|617339767|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
170817507|NCT06247488|617339768|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
170817508|NCT01183013|617339771|FG000|Overall Study|Adverse Event|6|||
170817509|NCT01183013|617339772|FG001|Overall Study|Adverse Event|8|||
170615751|NCT02735239|616601325|FG003|Overall Study|Progressive disease|0|||
170661257|NCT02007512|616774359|FG002|Double Blind Treatment Period|Disease progression|57|||
170615752|NCT02735239|616601326|FG004|Overall Study|Progressive disease|0|||
170661258|NCT02007512|616774360|FG003|Double Blind Treatment Period|Disease progression|52|||
170661259|NCT02007512|616774357|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
170661260|NCT02007512|616774358|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
170661261|NCT02007512|616774359|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
170661262|NCT02007512|616774360|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
170661263|NCT02007512|616774357|FG000|Double Blind Treatment Period|Protocol Violation|1|||
170661264|NCT02007512|616774358|FG001|Double Blind Treatment Period|Protocol Violation|0|||
170661265|NCT02007512|616774359|FG002|Double Blind Treatment Period|Protocol Violation|0|||
170661266|NCT02007512|616774360|FG003|Double Blind Treatment Period|Protocol Violation|1|||
170817510|NCT01183013|617339773|FG002|Overall Study|Adverse Event|5|||
170615753|NCT02735239|616601327|FG005|Overall Study|Progressive disease|2|||
170615754|NCT02735239|616601322|FG000|Overall Study|Withdrawal by Subject|0|||
170615755|NCT02735239|616601323|FG001|Overall Study|Withdrawal by Subject|1|||
170615756|NCT02735239|616601324|FG002|Overall Study|Withdrawal by Subject|0|||
170615757|NCT02735239|616601325|FG003|Overall Study|Withdrawal by Subject|0|||
170615758|NCT02735239|616601326|FG004|Overall Study|Withdrawal by Subject|0|||
170615759|NCT02735239|616601327|FG005|Overall Study|Withdrawal by Subject|0|||
170615760|NCT00527735|616601334|FG000|Overall Study|Disease progression|47|||
170615761|NCT00527735|616601335|FG001|Overall Study|Disease progression|61|||
170615762|NCT00527735|616601336|FG002|Overall Study|Disease progression|53|||
170615763|NCT00527735|616601334|FG000|Overall Study|Death|23|||
170615764|NCT00527735|616601335|FG001|Overall Study|Death|13|||
170615765|NCT00527735|616601336|FG002|Overall Study|Death|15|||
170615766|NCT00527735|616601334|FG000|Overall Study|Completed treatment in treatment phase|14|||
170615767|NCT00527735|616601335|FG001|Overall Study|Completed treatment in treatment phase|13|||
170615768|NCT00527735|616601336|FG002|Overall Study|Completed treatment in treatment phase|18|||
170615769|NCT00527735|616601334|FG000|Overall Study|Adverse Event|10|||
170615770|NCT00527735|616601335|FG001|Overall Study|Adverse Event|6|||
170615771|NCT00527735|616601336|FG002|Overall Study|Adverse Event|7|||
170615772|NCT00527735|616601334|FG000|Overall Study|Not identified|5|||
170615773|NCT00527735|616601335|FG001|Overall Study|Not identified|5|||
170615774|NCT00527735|616601336|FG002|Overall Study|Not identified|5|||
170615775|NCT00527735|616601334|FG000|Overall Study|Withdrawal by Subject|5|||
170615776|NCT00527735|616601335|FG001|Overall Study|Withdrawal by Subject|4|||
170615777|NCT00527735|616601336|FG002|Overall Study|Withdrawal by Subject|3|||
170615778|NCT00527735|616601334|FG000|Overall Study|No longer met study criteria|2|||
170615779|NCT00527735|616601335|FG001|Overall Study|No longer met study criteria|2|||
170615780|NCT00527735|616601336|FG002|Overall Study|No longer met study criteria|1|||
170615781|NCT00527735|616601334|FG000|Overall Study|Lost to Follow-up|0|||
170615782|NCT00527735|616601335|FG001|Overall Study|Lost to Follow-up|0|||
170615783|NCT00527735|616601336|FG002|Overall Study|Lost to Follow-up|3|||
170615784|NCT00527735|616601334|FG000|Overall Study|Poor compliance or noncompliance|0|||
170615785|NCT00527735|616601335|FG001|Overall Study|Poor compliance or noncompliance|1|||
170615786|NCT00527735|616601336|FG002|Overall Study|Poor compliance or noncompliance|1|||
170615787|NCT00527735|616601334|FG000|Overall Study|Completed treatment during maintenance|2|||
170615788|NCT00527735|616601335|FG001|Overall Study|Completed treatment during maintenance|2|||
170615789|NCT00527735|616601336|FG002|Overall Study|Completed treatment during maintenance|1|||
170615790|NCT00404651|616601337|FG000|Overall Study|Serious Adverse Event|0|||
170615791|NCT00404651|616601338|FG001|Overall Study|Serious Adverse Event|0|||
170615792|NCT00404651|616601339|FG002|Overall Study|Serious Adverse Event|2|||
170615793|NCT00404651|616601340|FG003|Overall Study|Serious Adverse Event|0|||
170615794|NCT00404651|616601337|FG000|Overall Study|Protocol Violation|10|||
170615795|NCT00404651|616601338|FG001|Overall Study|Protocol Violation|5|||
170615796|NCT00404651|616601339|FG002|Overall Study|Protocol Violation|14|||
170615797|NCT00404651|616601340|FG003|Overall Study|Protocol Violation|5|||
170615798|NCT00404651|616601337|FG000|Overall Study|Lost to Follow-up|15|||
170615799|NCT00404651|616601338|FG001|Overall Study|Lost to Follow-up|11|||
170615800|NCT00404651|616601339|FG002|Overall Study|Lost to Follow-up|13|||
170615801|NCT00404651|616601340|FG003|Overall Study|Lost to Follow-up|10|||
170615802|NCT00404651|616601337|FG000|Overall Study|Withdrawal by Subject|14|||
170615803|NCT00404651|616601338|FG001|Overall Study|Withdrawal by Subject|12|||
170615804|NCT00404651|616601339|FG002|Overall Study|Withdrawal by Subject|16|||
170615805|NCT00404651|616601340|FG003|Overall Study|Withdrawal by Subject|6|||
170615806|NCT01080807|616601346|FG000|Overall Study|Adverse Event|9|||
170615807|NCT01080807|616601347|FG001|Overall Study|Adverse Event|1|||
170615808|NCT01080807|616601346|FG000|Overall Study|Lack of Efficacy|0|||
170615809|NCT01080807|616601347|FG001|Overall Study|Lack of Efficacy|1|||
170615810|NCT01080807|616601346|FG000|Overall Study|Withdrawal by Subject|7|||
170615811|NCT01080807|616601347|FG001|Overall Study|Withdrawal by Subject|2|||
170615812|NCT01080807|616601346|FG000|Overall Study|Protocol Violation|7|||
170661267|NCT02007512|616774357|FG000|Double Blind Treatment Period|Other|2|||
170661268|NCT02007512|616774358|FG001|Double Blind Treatment Period|Other|1|||
170817511|NCT01183013|617339774|FG003|Overall Study|Adverse Event|5|||
170615813|NCT01080807|616601347|FG001|Overall Study|Protocol Violation|6|||
170615814|NCT01080807|616601346|FG000|Overall Study|Lost to Follow-up|6|||
170615815|NCT01080807|616601347|FG001|Overall Study|Lost to Follow-up|4|||
170615816|NCT01080807|616601346|FG000|Overall Study|Noncompliance with drug administration|1|||
170615817|NCT01080807|616601347|FG001|Overall Study|Noncompliance with drug administration|1|||
170615818|NCT01080807|616601346|FG000|Overall Study|Noncompliance to study procedures|1|||
170615819|NCT01080807|616601347|FG001|Overall Study|Noncompliance to study procedures|1|||
170615820|NCT01080807|616601346|FG000|Overall Study|Began working day shift|0|||
170615821|NCT01080807|616601347|FG001|Overall Study|Began working day shift|2|||
170615822|NCT01080807|616601346|FG000|Overall Study|Laid off or terminated from job|1|||
170615823|NCT01080807|616601347|FG001|Overall Study|Laid off or terminated from job|2|||
170615824|NCT01080807|616601346|FG000|Overall Study|Stopped working consistent night shifts|0|||
170615825|NCT01080807|616601347|FG001|Overall Study|Stopped working consistent night shifts|1|||
170615826|NCT01080807|616601346|FG000|Overall Study|Work schedule changing|1|||
170615827|NCT01080807|616601347|FG001|Overall Study|Work schedule changing|1|||
170615828|NCT01080807|616601346|FG000|Overall Study|Work schedule and travel|0|||
170615829|NCT01080807|616601347|FG001|Overall Study|Work schedule and travel|1|||
170615830|NCT01080807|616601346|FG000|Overall Study|Switched to first shift|1|||
170615831|NCT01080807|616601347|FG001|Overall Study|Switched to first shift|0|||
170615832|NCT01080807|616601346|FG000|Overall Study|Moved away without notifying center|1|||
170615833|NCT01080807|616601347|FG001|Overall Study|Moved away without notifying center|0|||
170615834|NCT00764699|616601350|FG000|Overall Study|PI left and study terminated|3|||
170615835|NCT01020786|616601355|FG000|Induction Period|Entry Criteria Not Met|2|||
170615836|NCT01020786|616601355|FG000|Induction Period|Adverse Event|10|||
170615837|NCT01020786|616601355|FG000|Induction Period|Progressive Disease|31|||
170615838|NCT01020786|616601355|FG000|Induction Period|Investigator Decision|3|||
170615839|NCT01020786|616601355|FG000|Induction Period|Withdrawal by Subject|3|||
170615840|NCT01020786|616601355|FG000|Maintenance Period|Adverse Event|8|||
170615841|NCT01020786|616601355|FG000|Maintenance Period|Progressive Disease|43|||
170615842|NCT01020786|616601355|FG000|Maintenance Period|Withdrawal by Subject|8|||
170615843|NCT01020786|616601355|FG000|Maintenance Period|Sponsor Decision|1|||
170615844|NCT01217463|616601358|FG000|Overall Study|Adverse Event|8|||
170615845|NCT01217463|616601359|FG001|Overall Study|Adverse Event|5|||
170615846|NCT01217463|616601358|FG000|Overall Study|Physician Decision|0|||
170615847|NCT01217463|616601359|FG001|Overall Study|Physician Decision|1|||
170615848|NCT01217463|616601358|FG000|Overall Study|Withdrawal by Subject|3|||
170615849|NCT01217463|616601359|FG001|Overall Study|Withdrawal by Subject|0|||
170615850|NCT01217463|616601358|FG000|Overall Study|Surgery on the Target Limb|0|||
170615851|NCT01217463|616601359|FG001|Overall Study|Surgery on the Target Limb|1|||
170615852|NCT01217463|616601358|FG000|Overall Study|Patient Non-compliant|1|||
170615853|NCT01217463|616601359|FG001|Overall Study|Patient Non-compliant|0|||
170615854|NCT01217463|616601358|FG000|Overall Study|Other|1|||
170615855|NCT01217463|616601359|FG001|Overall Study|Other|1|||
170615856|NCT04497116|616601367|FG000|Overall Study|Lost to Follow-up|1|||
170615857|NCT04497116|616601368|FG001|Overall Study|Lost to Follow-up|0|||
170615858|NCT04497116|616601369|FG002|Overall Study|Lost to Follow-up|0|||
170615859|NCT04497116|616601370|FG003|Overall Study|Lost to Follow-up|0|||
170615860|NCT04497116|616601371|FG004|Overall Study|Lost to Follow-up|0|||
170615861|NCT04497116|616601372|FG005|Overall Study|Lost to Follow-up|0|||
170615862|NCT04497116|616601373|FG006|Overall Study|Lost to Follow-up|0|||
170615863|NCT04497116|616601374|FG007|Overall Study|Lost to Follow-up|3|||
170615864|NCT04497116|616601375|FG008|Overall Study|Lost to Follow-up|3|||
170615865|NCT04497116|616601376|FG009|Overall Study|Lost to Follow-up|0|||
170615866|NCT04497116|616601377|FG010|Overall Study|Lost to Follow-up|0|||
170615867|NCT04497116|616601378|FG011|Overall Study|Lost to Follow-up|0|||
170615868|NCT04497116|616601379|FG012|Overall Study|Lost to Follow-up|0|||
170615869|NCT04497116|616601380|FG013|Overall Study|Lost to Follow-up|0|||
170615870|NCT04497116|616601381|FG014|Overall Study|Lost to Follow-up|0|||
170615871|NCT04497116|616601382|FG015|Overall Study|Lost to Follow-up|0|||
170615872|NCT04497116|616601383|FG016|Overall Study|Lost to Follow-up|0|||
170615873|NCT04497116|616601384|FG017|Overall Study|Lost to Follow-up|0|||
170615874|NCT04497116|616601385|FG018|Overall Study|Lost to Follow-up|0|||
170615875|NCT04497116|616601386|FG019|Overall Study|Lost to Follow-up|0|||
170817512|NCT01183013|617339775|FG004|Overall Study|Adverse Event|10|||
170817513|NCT01183013|617339776|FG005|Overall Study|Adverse Event|10|||
170817514|NCT01183013|617339777|FG006|Overall Study|Adverse Event|6|||
170817515|NCT01183013|617339771|FG000|Overall Study|Lack of Efficacy|3|||
170817516|NCT01183013|617339772|FG001|Overall Study|Lack of Efficacy|2|||
170817517|NCT01183013|617339773|FG002|Overall Study|Lack of Efficacy|1|||
170817518|NCT01183013|617339774|FG003|Overall Study|Lack of Efficacy|2|||
170817519|NCT01183013|617339775|FG004|Overall Study|Lack of Efficacy|1|||
170817520|NCT01183013|617339776|FG005|Overall Study|Lack of Efficacy|2|||
170817521|NCT01183013|617339777|FG006|Overall Study|Lack of Efficacy|0|||
170817522|NCT01183013|617339771|FG000|Overall Study|Protocol Violation|5|||
170817523|NCT01183013|617339772|FG001|Overall Study|Protocol Violation|2|||
170817524|NCT01183013|617339773|FG002|Overall Study|Protocol Violation|4|||
170817525|NCT01183013|617339774|FG003|Overall Study|Protocol Violation|0|||
170817526|NCT01183013|617339775|FG004|Overall Study|Protocol Violation|4|||
170615876|NCT04497116|616601387|FG020|Overall Study|Lost to Follow-up|0|||
170817527|NCT01183013|617339776|FG005|Overall Study|Protocol Violation|3|||
170615877|NCT04497116|616601388|FG021|Overall Study|Lost to Follow-up|0|||
170661269|NCT02007512|616774359|FG002|Double Blind Treatment Period|Other|1|||
170661270|NCT02007512|616774360|FG003|Double Blind Treatment Period|Other|2|||
170661271|NCT02007512|616774357|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
170661272|NCT02007512|616774358|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
170661273|NCT02007512|616774359|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
170661274|NCT02007512|616774360|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
170661275|NCT02007512|616774357|FG000|Open Label Treatment Period|Adverse Event|1|||
170661276|NCT02007512|616774358|FG001|Open Label Treatment Period|Adverse Event|0|||
170661277|NCT02007512|616774359|FG002|Open Label Treatment Period|Adverse Event|0|||
170817528|NCT01183013|617339777|FG006|Overall Study|Protocol Violation|3|||
170817529|NCT01183013|617339771|FG000|Overall Study|Lost to Follow-up|7|||
170817530|NCT01183013|617339772|FG001|Overall Study|Lost to Follow-up|3|||
170817531|NCT01183013|617339773|FG002|Overall Study|Lost to Follow-up|4|||
170817532|NCT01183013|617339774|FG003|Overall Study|Lost to Follow-up|3|||
170817533|NCT01183013|617339775|FG004|Overall Study|Lost to Follow-up|2|||
170817534|NCT01183013|617339776|FG005|Overall Study|Lost to Follow-up|6|||
170817535|NCT01183013|617339777|FG006|Overall Study|Lost to Follow-up|5|||
170817536|NCT01183013|617339771|FG000|Overall Study|Withdrawal by Subject|9|||
170661278|NCT02007512|616774360|FG003|Open Label Treatment Period|Adverse Event|0|||
170661279|NCT02007512|616774357|FG000|Open Label Treatment Period|Other|1|||
170661280|NCT02007512|616774358|FG001|Open Label Treatment Period|Other|1|||
170615878|NCT04497116|616601389|FG022|Overall Study|Lost to Follow-up|1|||
170615879|NCT04497116|616601390|FG023|Overall Study|Lost to Follow-up|0|||
170615880|NCT04497116|616601391|FG024|Overall Study|Lost to Follow-up|0|||
170615881|NCT04497116|616601367|FG000|Overall Study|Sponsor decision to terminate study|0|||
170615882|NCT04497116|616601368|FG001|Overall Study|Sponsor decision to terminate study|0|||
170615883|NCT04497116|616601369|FG002|Overall Study|Sponsor decision to terminate study|0|||
170615884|NCT04497116|616601370|FG003|Overall Study|Sponsor decision to terminate study|0|||
170615885|NCT04497116|616601371|FG004|Overall Study|Sponsor decision to terminate study|0|||
170615886|NCT04497116|616601372|FG005|Overall Study|Sponsor decision to terminate study|0|||
170615887|NCT04497116|616601373|FG006|Overall Study|Sponsor decision to terminate study|1|||
170615888|NCT04497116|616601374|FG007|Overall Study|Sponsor decision to terminate study|0|||
170615889|NCT04497116|616601375|FG008|Overall Study|Sponsor decision to terminate study|0|||
170615890|NCT04497116|616601376|FG009|Overall Study|Sponsor decision to terminate study|1|||
170615891|NCT04497116|616601377|FG010|Overall Study|Sponsor decision to terminate study|0|||
170615892|NCT04497116|616601378|FG011|Overall Study|Sponsor decision to terminate study|0|||
170615893|NCT04497116|616601379|FG012|Overall Study|Sponsor decision to terminate study|0|||
170615894|NCT04497116|616601380|FG013|Overall Study|Sponsor decision to terminate study|0|||
170615895|NCT04497116|616601381|FG014|Overall Study|Sponsor decision to terminate study|0|||
170615896|NCT04497116|616601382|FG015|Overall Study|Sponsor decision to terminate study|0|||
170615897|NCT04497116|616601383|FG016|Overall Study|Sponsor decision to terminate study|0|||
170615898|NCT04497116|616601384|FG017|Overall Study|Sponsor decision to terminate study|0|||
170615899|NCT04497116|616601385|FG018|Overall Study|Sponsor decision to terminate study|0|||
170615900|NCT04497116|616601386|FG019|Overall Study|Sponsor decision to terminate study|1|||
170615901|NCT04497116|616601387|FG020|Overall Study|Sponsor decision to terminate study|0|||
170615902|NCT04497116|616601388|FG021|Overall Study|Sponsor decision to terminate study|0|||
170615903|NCT04497116|616601389|FG022|Overall Study|Sponsor decision to terminate study|0|||
170615904|NCT04497116|616601390|FG023|Overall Study|Sponsor decision to terminate study|0|||
170615905|NCT04497116|616601391|FG024|Overall Study|Sponsor decision to terminate study|0|||
170615906|NCT04497116|616601367|FG000|Overall Study|Death|4|||
170615907|NCT04497116|616601368|FG001|Overall Study|Death|5|||
170615908|NCT04497116|616601369|FG002|Overall Study|Death|2|||
170615909|NCT04497116|616601370|FG003|Overall Study|Death|2|||
170615910|NCT04497116|616601371|FG004|Overall Study|Death|1|||
170615911|NCT04497116|616601372|FG005|Overall Study|Death|1|||
170615912|NCT04497116|616601373|FG006|Overall Study|Death|3|||
170615913|NCT04497116|616601374|FG007|Overall Study|Death|10|||
170615914|NCT04497116|616601375|FG008|Overall Study|Death|37|||
170615915|NCT04497116|616601376|FG009|Overall Study|Death|17|||
170615916|NCT04497116|616601377|FG010|Overall Study|Death|2|||
170615917|NCT04497116|616601378|FG011|Overall Study|Death|1|||
170615918|NCT04497116|616601379|FG012|Overall Study|Death|1|||
170615919|NCT04497116|616601380|FG013|Overall Study|Death|3|||
170615920|NCT04497116|616601381|FG014|Overall Study|Death|18|||
170817537|NCT01183013|617339772|FG001|Overall Study|Withdrawal by Subject|13|||
170661281|NCT02007512|616774359|FG002|Open Label Treatment Period|Other|0|||
170661282|NCT02007512|616774360|FG003|Open Label Treatment Period|Other|0|||
170661283|NCT02007512|616774357|FG000|Open Label Treatment Period|Disease progression|23|||
170661284|NCT02007512|616774358|FG001|Open Label Treatment Period|Disease progression|11|||
170615921|NCT04497116|616601382|FG015|Overall Study|Death|3|||
170615922|NCT04497116|616601383|FG016|Overall Study|Death|2|||
170615923|NCT04497116|616601384|FG017|Overall Study|Death|1|||
170615924|NCT04497116|616601385|FG018|Overall Study|Death|4|||
170615925|NCT04497116|616601386|FG019|Overall Study|Death|17|||
170661285|NCT02007512|616774359|FG002|Open Label Treatment Period|Disease progression|0|||
170817538|NCT01183013|617339773|FG002|Overall Study|Withdrawal by Subject|10|||
170615926|NCT04497116|616601387|FG020|Overall Study|Death|1|||
170661286|NCT02007512|616774360|FG003|Open Label Treatment Period|Disease progression|0|||
170661287|NCT01325623|616774361|FG000|Overall Study|Withdrawal by Subject|3|||
170661288|NCT02413372|616774364|FG000|Treatment|Lost to Follow-up|0|||
170661289|NCT02413372|616774365|FG001|Treatment|Lost to Follow-up|2|||
170661290|NCT02413372|616774366|FG002|Treatment|Lost to Follow-up|1|||
170661291|NCT02413372|616774364|FG000|Treatment|Withdrawal by Subject|1|||
170661292|NCT02413372|616774365|FG001|Treatment|Withdrawal by Subject|0|||
170661293|NCT02413372|616774366|FG002|Treatment|Withdrawal by Subject|0|||
170661294|NCT02413372|616774364|FG000|Follow-up|Lost to Follow-up|1|||
170661295|NCT02413372|616774365|FG001|Follow-up|Lost to Follow-up|1|||
170661296|NCT02413372|616774366|FG002|Follow-up|Lost to Follow-up|0|||
170661297|NCT02413372|616774364|FG000|Follow-up|Subject Withdrew Consent|1|||
170661298|NCT02413372|616774365|FG001|Follow-up|Subject Withdrew Consent|0|||
170661299|NCT02413372|616774366|FG002|Follow-up|Subject Withdrew Consent|1|||
170661300|NCT02413372|616774364|FG000|Follow-up|Subject unable to return for visit|0|||
170661301|NCT02413372|616774365|FG001|Follow-up|Subject unable to return for visit|0|||
170661302|NCT02413372|616774366|FG002|Follow-up|Subject unable to return for visit|1|||
170661303|NCT02556203|616774373|FG000|Overall Study|Withdrawal by Subject|21|||
170661304|NCT02556203|616774374|FG001|Overall Study|Withdrawal by Subject|21|||
170661305|NCT02556203|616774373|FG000|Overall Study|Lost to Follow-up|5|||
170661306|NCT02556203|616774374|FG001|Overall Study|Lost to Follow-up|5|||
170661307|NCT02556203|616774373|FG000|Overall Study|Adverse Event|1|||
170661308|NCT02556203|616774374|FG001|Overall Study|Adverse Event|0|||
170661309|NCT04587271|616774375|FG000|Overall Study|Lost to Follow-up|2|||
170661310|NCT04587271|616774376|FG001|Overall Study|Lost to Follow-up|2|||
170661311|NCT04587271|616774377|FG002|Overall Study|Lost to Follow-up|0|||
170661312|NCT04587271|616774378|FG003|Overall Study|Lost to Follow-up|2|||
170661313|NCT04587271|616774379|FG004|Overall Study|Lost to Follow-up|2|||
170661314|NCT04587271|616774380|FG005|Overall Study|Lost to Follow-up|0|||
170661315|NCT04587271|616774375|FG000|Overall Study|Caregiver brought child to visits|0|||
170661316|NCT04587271|616774376|FG001|Overall Study|Caregiver brought child to visits|0|||
170661317|NCT04587271|616774377|FG002|Overall Study|Caregiver brought child to visits|0|||
170661318|NCT04587271|616774378|FG003|Overall Study|Caregiver brought child to visits|1|||
170661319|NCT04587271|616774379|FG004|Overall Study|Caregiver brought child to visits|0|||
170661320|NCT04587271|616774380|FG005|Overall Study|Caregiver brought child to visits|0|||
170661321|NCT02943460|616774381|FG000|Blinded Study Phase|Adverse Event|3|||
170661322|NCT02943460|616774382|FG001|Blinded Study Phase|Adverse Event|0|||
170661323|NCT02943460|616774383|FG002|Blinded Study Phase|Adverse Event|0|||
170661324|NCT02943460|616774381|FG000|Blinded Study Phase|Withdrew Consent|0|||
170661325|NCT02943460|616774382|FG001|Blinded Study Phase|Withdrew Consent|1|||
170661326|NCT02943460|616774383|FG002|Blinded Study Phase|Withdrew Consent|0|||
170661327|NCT02943460|616774381|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
170661328|NCT02943460|616774382|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
170661329|NCT02943460|616774383|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
170661330|NCT02943460|616774381|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
170661331|NCT02943460|616774382|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
170661332|NCT02943460|616774383|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
170661333|NCT02943460|616774381|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
170661334|NCT02943460|616774382|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
170661335|NCT02943460|616774383|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
170661336|NCT00369122|616774384|FG000|Overall Study|Ineligible|10|||
170661337|NCT00369122|616774384|FG000|Overall Study|No protocol treatment|1|||
170661338|NCT01031706|616774385|FG000|Overall Study|Adverse Event|1|||
170661339|NCT01031706|616774386|FG001|Overall Study|Adverse Event|0|||
170661340|NCT01031706|616774385|FG000|Overall Study|Withdrawal by Subject|1|||
170661341|NCT01031706|616774386|FG001|Overall Study|Withdrawal by Subject|1|||
170661342|NCT03719586|616774390|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
170661343|NCT03719586|616774391|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
170661344|NCT03719586|616774392|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
170661345|NCT03719586|616774393|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
170661346|NCT02791594|616774394|FG000|Overall Study|Physician Decision|2|||
170661347|NCT01822678|616774401|FG000|Overall Study|Withdrawal by Subject|5|||
170661348|NCT01822678|616774402|FG001|Overall Study|Withdrawal by Subject|4|||
170661349|NCT01822678|616774403|FG002|Overall Study|Withdrawal by Subject|4|||
170661350|NCT01822678|616774401|FG000|Overall Study|Adverse Event|4|||
170661351|NCT01822678|616774402|FG001|Overall Study|Adverse Event|3|||
170661352|NCT01822678|616774403|FG002|Overall Study|Adverse Event|1|||
170661353|NCT01822678|616774401|FG000|Overall Study|Lack of Efficacy|3|||
170661354|NCT01822678|616774402|FG001|Overall Study|Lack of Efficacy|6|||
170661355|NCT01822678|616774403|FG002|Overall Study|Lack of Efficacy|5|||
170661356|NCT01822678|616774401|FG000|Overall Study|Lost to Follow-up|0|||
170661357|NCT01822678|616774402|FG001|Overall Study|Lost to Follow-up|2|||
170661358|NCT01822678|616774403|FG002|Overall Study|Lost to Follow-up|1|||
170661359|NCT00764504|616774404|FG000|Overall Study|Death|12|||
170661360|NCT00764504|616774405|FG001|Overall Study|Death|6|||
170661361|NCT00764504|616774406|FG002|Overall Study|Death|13|||
170661362|NCT00764504|616774404|FG000|Overall Study|Revision of Device|12|||
170661363|NCT00764504|616774405|FG001|Overall Study|Revision of Device|23|||
170661364|NCT00764504|616774406|FG002|Overall Study|Revision of Device|14|||
170661365|NCT00764504|616774404|FG000|Overall Study|Physician Decision|1|||
170661366|NCT00764504|616774405|FG001|Overall Study|Physician Decision|0|||
170661367|NCT00764504|616774406|FG002|Overall Study|Physician Decision|0|||
170661368|NCT00764504|616774404|FG000|Overall Study|Withdrawal by Subject|1|||
170661369|NCT00764504|616774405|FG001|Overall Study|Withdrawal by Subject|7|||
170661370|NCT00764504|616774406|FG002|Overall Study|Withdrawal by Subject|4|||
170661371|NCT00764504|616774404|FG000|Overall Study|Lost to Follow-up|40|||
170661372|NCT00764504|616774405|FG001|Overall Study|Lost to Follow-up|34|||
170661373|NCT00764504|616774406|FG002|Overall Study|Lost to Follow-up|72|||
170661374|NCT01028378|616774407|FG000|Overall Study|Lost to Follow-up|12|||
170661375|NCT01028378|616774407|FG000|Overall Study|Withdrawal by Subject|1|||
170661376|NCT01028378|616774407|FG000|Overall Study|Adminstrative Reasons|4|||
170661377|NCT02456103|616774408|FG000|Overall Study|Study Closure|207|||
170661378|NCT02456103|616774408|FG000|Overall Study|Physician Decision|1|||
170661379|NCT02456103|616774408|FG000|Overall Study|Required prohibited medications|5|||
170661380|NCT02456103|616774408|FG000|Overall Study|Protocol Violation|1|||
170661381|NCT02456103|616774408|FG000|Overall Study|Adverse Event|5|||
170661382|NCT02456103|616774408|FG000|Overall Study|Abnormal Laboratory Value|2|||
170661383|NCT02456103|616774408|FG000|Overall Study|Lost to Follow-up|1|||
170661384|NCT02456103|616774408|FG000|Overall Study|Withdrawal by Subject|24|||
170615927|NCT04497116|616601388|FG021|Overall Study|Death|0|||
170615928|NCT04497116|616601389|FG022|Overall Study|Death|3|||
170615929|NCT04497116|616601390|FG023|Overall Study|Death|5|||
170615930|NCT04497116|616601391|FG024|Overall Study|Death|4|||
170615931|NCT04497116|616601367|FG000|Overall Study|Withdrawal by Subject|1|||
170615932|NCT04497116|616601368|FG001|Overall Study|Withdrawal by Subject|0|||
170615933|NCT04497116|616601369|FG002|Overall Study|Withdrawal by Subject|1|||
170615934|NCT04497116|616601370|FG003|Overall Study|Withdrawal by Subject|0|||
170615935|NCT04497116|616601371|FG004|Overall Study|Withdrawal by Subject|0|||
170615936|NCT04497116|616601372|FG005|Overall Study|Withdrawal by Subject|0|||
170615937|NCT04497116|616601373|FG006|Overall Study|Withdrawal by Subject|0|||
170615938|NCT04497116|616601374|FG007|Overall Study|Withdrawal by Subject|7|||
170615939|NCT04497116|616601375|FG008|Overall Study|Withdrawal by Subject|14|||
170615940|NCT04497116|616601376|FG009|Overall Study|Withdrawal by Subject|3|||
170615941|NCT04497116|616601377|FG010|Overall Study|Withdrawal by Subject|3|||
170615942|NCT04497116|616601378|FG011|Overall Study|Withdrawal by Subject|0|||
170615943|NCT04497116|616601379|FG012|Overall Study|Withdrawal by Subject|1|||
170615944|NCT04497116|616601380|FG013|Overall Study|Withdrawal by Subject|0|||
170615945|NCT04497116|616601381|FG014|Overall Study|Withdrawal by Subject|7|||
170615946|NCT04497116|616601382|FG015|Overall Study|Withdrawal by Subject|1|||
170615947|NCT04497116|616601383|FG016|Overall Study|Withdrawal by Subject|3|||
170615948|NCT04497116|616601384|FG017|Overall Study|Withdrawal by Subject|1|||
170615949|NCT04497116|616601385|FG018|Overall Study|Withdrawal by Subject|1|||
170615950|NCT04497116|616601386|FG019|Overall Study|Withdrawal by Subject|5|||
170615951|NCT04497116|616601387|FG020|Overall Study|Withdrawal by Subject|2|||
170615952|NCT04497116|616601388|FG021|Overall Study|Withdrawal by Subject|2|||
170615953|NCT04497116|616601389|FG022|Overall Study|Withdrawal by Subject|2|||
170615954|NCT04497116|616601390|FG023|Overall Study|Withdrawal by Subject|4|||
170615955|NCT04497116|616601391|FG024|Overall Study|Withdrawal by Subject|3|||
170615956|NCT04497116|616601367|FG000|Overall Study|Physician Decision|0|||
170615957|NCT04497116|616601368|FG001|Overall Study|Physician Decision|0|||
170615958|NCT04497116|616601369|FG002|Overall Study|Physician Decision|0|||
170615959|NCT04497116|616601370|FG003|Overall Study|Physician Decision|0|||
170615960|NCT04497116|616601371|FG004|Overall Study|Physician Decision|0|||
170615961|NCT04497116|616601372|FG005|Overall Study|Physician Decision|0|||
170615962|NCT04497116|616601373|FG006|Overall Study|Physician Decision|0|||
170615963|NCT04497116|616601374|FG007|Overall Study|Physician Decision|0|||
170615964|NCT04497116|616601375|FG008|Overall Study|Physician Decision|0|||
170615965|NCT04497116|616601376|FG009|Overall Study|Physician Decision|0|||
170615966|NCT04497116|616601377|FG010|Overall Study|Physician Decision|0|||
170615967|NCT04497116|616601378|FG011|Overall Study|Physician Decision|0|||
170615968|NCT04497116|616601379|FG012|Overall Study|Physician Decision|0|||
170615969|NCT04497116|616601380|FG013|Overall Study|Physician Decision|0|||
170615970|NCT04497116|616601381|FG014|Overall Study|Physician Decision|0|||
170615971|NCT04497116|616601382|FG015|Overall Study|Physician Decision|0|||
170615972|NCT04497116|616601383|FG016|Overall Study|Physician Decision|0|||
170661385|NCT00450385|616774409|FG000|Overall Study|Death|3|||
170661386|NCT00450385|616774409|FG000|Overall Study|Protocol Violation|1|||
170661387|NCT00450385|616774409|FG000|Overall Study|Withdrawal by Subject|2|||
170661388|NCT00450385|616774409|FG000|Overall Study|Lack of Efficacy|2|||
170661389|NCT00450385|616774409|FG000|Overall Study|Adverse Event|1|||
170661390|NCT00450385|616774409|FG000|Overall Study|Physician Decision|1|||
170661391|NCT00450385|616774409|FG000|Overall Study|Other|3|||
170661392|NCT03614975|616774410|FG000|Overall Study|Physician Decision|7|||
170661393|NCT03614975|616774411|FG001|Overall Study|Physician Decision|5|||
170661394|NCT03614975|616774410|FG000|Overall Study|Withdrawal by Subject|2|||
170661395|NCT03614975|616774411|FG001|Overall Study|Withdrawal by Subject|2|||
170661396|NCT03614975|616774410|FG000|Overall Study|Specimens not in lab batch shipment|1|||
170661397|NCT03614975|616774411|FG001|Overall Study|Specimens not in lab batch shipment|1|||
170661398|NCT01390220|616774412|FG000|Test Dose Phase|Adverse Event|17|||
170661399|NCT01390220|616774413|FG001|Test Dose Phase|Adverse Event|0|||
170661400|NCT01390220|616774414|FG002|Test Dose Phase|Adverse Event|0|||
170661401|NCT01390220|616774412|FG000|Test Dose Phase|Withdrawal by Subject|8|||
170661402|NCT01390220|616774413|FG001|Test Dose Phase|Withdrawal by Subject|0|||
170661403|NCT01390220|616774414|FG002|Test Dose Phase|Withdrawal by Subject|0|||
170661404|NCT01390220|616774412|FG000|Test Dose Phase|Lost to Follow-up|2|||
170661405|NCT01390220|616774413|FG001|Test Dose Phase|Lost to Follow-up|0|||
170661406|NCT01390220|616774414|FG002|Test Dose Phase|Lost to Follow-up|0|||
170661407|NCT01390220|616774412|FG000|Test Dose Phase|Protocol Violation|8|||
170661408|NCT01390220|616774413|FG001|Test Dose Phase|Protocol Violation|0|||
170661409|NCT01390220|616774414|FG002|Test Dose Phase|Protocol Violation|0|||
170661410|NCT01390220|616774412|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
170661411|NCT01390220|616774413|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
170661412|NCT01390220|616774414|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
170661413|NCT01390220|616774412|FG000|Test Dose Phase|Study/Site closure|6|||
170661414|NCT01390220|616774413|FG001|Test Dose Phase|Study/Site closure|0|||
170661415|NCT01390220|616774414|FG002|Test Dose Phase|Study/Site closure|0|||
170661416|NCT01390220|616774412|FG000|Test Dose Phase|Caregiver no longer available|5|||
170661417|NCT01390220|616774413|FG001|Test Dose Phase|Caregiver no longer available|0|||
170917159|NCT05775289|617697856|FG000|Overall Study|Lost to Follow-up|0|||
170615973|NCT04497116|616601384|FG017|Overall Study|Physician Decision|0|||
170615974|NCT04497116|616601385|FG018|Overall Study|Physician Decision|0|||
170615975|NCT04497116|616601386|FG019|Overall Study|Physician Decision|0|||
170615976|NCT04497116|616601387|FG020|Overall Study|Physician Decision|0|||
170615977|NCT04497116|616601388|FG021|Overall Study|Physician Decision|0|||
170615978|NCT04497116|616601389|FG022|Overall Study|Physician Decision|0|||
170615979|NCT04497116|616601390|FG023|Overall Study|Physician Decision|1|||
170615980|NCT04497116|616601391|FG024|Overall Study|Physician Decision|0|||
170615981|NCT04497116|616601367|FG000|Overall Study|Clinical Progression Related|0|||
170615982|NCT04497116|616601368|FG001|Overall Study|Clinical Progression Related|0|||
170615983|NCT04497116|616601369|FG002|Overall Study|Clinical Progression Related|0|||
170615984|NCT04497116|616601370|FG003|Overall Study|Clinical Progression Related|0|||
170615985|NCT04497116|616601371|FG004|Overall Study|Clinical Progression Related|0|||
170615986|NCT04497116|616601372|FG005|Overall Study|Clinical Progression Related|0|||
170615987|NCT04497116|616601373|FG006|Overall Study|Clinical Progression Related|0|||
170615988|NCT04497116|616601374|FG007|Overall Study|Clinical Progression Related|0|||
170615989|NCT04497116|616601375|FG008|Overall Study|Clinical Progression Related|0|||
170615990|NCT04497116|616601376|FG009|Overall Study|Clinical Progression Related|1|||
170615991|NCT04497116|616601377|FG010|Overall Study|Clinical Progression Related|0|||
170615992|NCT04497116|616601378|FG011|Overall Study|Clinical Progression Related|0|||
170615993|NCT04497116|616601379|FG012|Overall Study|Clinical Progression Related|0|||
170615994|NCT04497116|616601380|FG013|Overall Study|Clinical Progression Related|0|||
170615995|NCT04497116|616601381|FG014|Overall Study|Clinical Progression Related|0|||
170615996|NCT04497116|616601382|FG015|Overall Study|Clinical Progression Related|0|||
170615997|NCT04497116|616601383|FG016|Overall Study|Clinical Progression Related|0|||
170615998|NCT04497116|616601384|FG017|Overall Study|Clinical Progression Related|0|||
170615999|NCT04497116|616601385|FG018|Overall Study|Clinical Progression Related|0|||
170616000|NCT04497116|616601386|FG019|Overall Study|Clinical Progression Related|0|||
170616001|NCT04497116|616601387|FG020|Overall Study|Clinical Progression Related|0|||
170616002|NCT04497116|616601388|FG021|Overall Study|Clinical Progression Related|0|||
170616003|NCT04497116|616601389|FG022|Overall Study|Clinical Progression Related|0|||
170616004|NCT04497116|616601390|FG023|Overall Study|Clinical Progression Related|0|||
170616005|NCT04497116|616601391|FG024|Overall Study|Clinical Progression Related|0|||
170661418|NCT01390220|616774414|FG002|Test Dose Phase|Caregiver no longer available|0|||
170661419|NCT01390220|616774412|FG000|Test Dose Phase|Noncompliance|2|||
170661420|NCT01390220|616774413|FG001|Test Dose Phase|Noncompliance|0|||
170661421|NCT01390220|616774414|FG002|Test Dose Phase|Noncompliance|0|||
170661422|NCT01390220|616774412|FG000|Test Dose Phase|Logistical|6|||
170661423|NCT01390220|616774413|FG001|Test Dose Phase|Logistical|0|||
170661424|NCT01390220|616774414|FG002|Test Dose Phase|Logistical|0|||
170616006|NCT03089580|616601396|FG000|Overall Study|Lost to Follow-up|2|||
170616007|NCT03087513|616601397|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
170616008|NCT04170543|616601402|FG000|Overall Study|Death|1|||
170616009|NCT04170543|616601403|FG001|Overall Study|Death|1|||
170616010|NCT04170543|616601404|FG002|Overall Study|Death|1|||
170616011|NCT04170543|616601405|FG003|Overall Study|Death|1|||
170616012|NCT04170543|616601406|FG004|Overall Study|Death|1|||
170917160|NCT05775289|617697857|FG001|Overall Study|Lost to Follow-up|1|||
170661425|NCT01390220|616774412|FG000|Comparative Phase|Withdrawal by Subject|0|||
170661426|NCT01390220|616774413|FG001|Comparative Phase|Withdrawal by Subject|1|||
170661427|NCT01390220|616774414|FG002|Comparative Phase|Withdrawal by Subject|0|||
170661428|NCT02448810|616774415|FG000|Overall Study|Adverse Event|0|||
170661429|NCT02448810|616774416|FG001|Overall Study|Adverse Event|0|||
170661430|NCT02448810|616774417|FG002|Overall Study|Adverse Event|1|||
170661431|NCT02448810|616774418|FG003|Overall Study|Adverse Event|0|||
170661432|NCT02448810|616774419|FG004|Overall Study|Adverse Event|0|||
170661433|NCT02448810|616774420|FG005|Overall Study|Adverse Event|0|||
170661434|NCT02448810|616774421|FG006|Overall Study|Adverse Event|0|||
170661435|NCT02448810|616774422|FG007|Overall Study|Adverse Event|0|||
170661436|NCT02448810|616774415|FG000|Overall Study|Withdrawal by Subject|0|||
170661437|NCT02448810|616774416|FG001|Overall Study|Withdrawal by Subject|0|||
170661438|NCT02448810|616774417|FG002|Overall Study|Withdrawal by Subject|1|||
170661439|NCT02448810|616774418|FG003|Overall Study|Withdrawal by Subject|0|||
170661440|NCT02448810|616774419|FG004|Overall Study|Withdrawal by Subject|3|||
170661441|NCT02448810|616774420|FG005|Overall Study|Withdrawal by Subject|5|||
170661442|NCT02448810|616774421|FG006|Overall Study|Withdrawal by Subject|0|||
170661443|NCT02448810|616774422|FG007|Overall Study|Withdrawal by Subject|2|||
170661444|NCT02448810|616774415|FG000|Overall Study|Other (study terminated by sponsor)|0|||
170661445|NCT02448810|616774416|FG001|Overall Study|Other (study terminated by sponsor)|0|||
170661446|NCT02448810|616774417|FG002|Overall Study|Other (study terminated by sponsor)|0|||
170661447|NCT02448810|616774418|FG003|Overall Study|Other (study terminated by sponsor)|0|||
170661448|NCT02448810|616774419|FG004|Overall Study|Other (study terminated by sponsor)|4|||
170661449|NCT02448810|616774420|FG005|Overall Study|Other (study terminated by sponsor)|2|||
170661450|NCT02448810|616774421|FG006|Overall Study|Other (study terminated by sponsor)|2|||
170661451|NCT02448810|616774422|FG007|Overall Study|Other (study terminated by sponsor)|1|||
170661452|NCT02448810|616774415|FG000|Overall Study|Death|1|||
170661453|NCT02448810|616774416|FG001|Overall Study|Death|0|||
170661454|NCT02448810|616774417|FG002|Overall Study|Death|1|||
170661455|NCT02448810|616774418|FG003|Overall Study|Death|0|||
170661456|NCT02448810|616774419|FG004|Overall Study|Death|1|||
170661457|NCT02448810|616774420|FG005|Overall Study|Death|0|||
170661458|NCT02448810|616774421|FG006|Overall Study|Death|0|||
170661459|NCT02448810|616774422|FG007|Overall Study|Death|0|||
170661460|NCT02448810|616774415|FG000|Overall Study|Other (Progressive disease)|2|||
170661461|NCT02448810|616774416|FG001|Overall Study|Other (Progressive disease)|2|||
170661462|NCT02448810|616774417|FG002|Overall Study|Other (Progressive disease)|0|||
170661463|NCT02448810|616774418|FG003|Overall Study|Other (Progressive disease)|3|||
170661464|NCT02448810|616774419|FG004|Overall Study|Other (Progressive disease)|23|||
170661465|NCT02448810|616774420|FG005|Overall Study|Other (Progressive disease)|9|||
170661466|NCT02448810|616774421|FG006|Overall Study|Other (Progressive disease)|14|||
170661467|NCT02448810|616774422|FG007|Overall Study|Other (Progressive disease)|5|||
170661468|NCT02448810|616774415|FG000|Overall Study|Lost to Follow-up|0|||
170661469|NCT02448810|616774416|FG001|Overall Study|Lost to Follow-up|1|||
170661470|NCT02448810|616774417|FG002|Overall Study|Lost to Follow-up|0|||
170661471|NCT02448810|616774418|FG003|Overall Study|Lost to Follow-up|0|||
170661472|NCT02448810|616774419|FG004|Overall Study|Lost to Follow-up|0|||
170661473|NCT02448810|616774420|FG005|Overall Study|Lost to Follow-up|0|||
170661474|NCT02448810|616774421|FG006|Overall Study|Lost to Follow-up|0|||
170661475|NCT02448810|616774422|FG007|Overall Study|Lost to Follow-up|0|||
170661476|NCT02448810|616774415|FG000|Overall Study|Other (unspecified)|0|||
170661477|NCT02448810|616774416|FG001|Overall Study|Other (unspecified)|0|||
170661478|NCT02448810|616774417|FG002|Overall Study|Other (unspecified)|0|||
170661479|NCT02448810|616774418|FG003|Overall Study|Other (unspecified)|0|||
170661480|NCT02448810|616774419|FG004|Overall Study|Other (unspecified)|0|||
170661481|NCT02448810|616774420|FG005|Overall Study|Other (unspecified)|0|||
170661482|NCT02448810|616774421|FG006|Overall Study|Other (unspecified)|2|||
170661483|NCT02448810|616774422|FG007|Overall Study|Other (unspecified)|0|||
170661484|NCT04795622|616774425|FG000|Overall Study|Adverse Event|1|||
170661485|NCT04795622|616774426|FG001|Overall Study|Adverse Event|0|||
170661486|NCT04795622|616774425|FG000|Overall Study|Withdrawal by Subject|3|||
170661487|NCT04795622|616774426|FG001|Overall Study|Withdrawal by Subject|3|||
170661488|NCT04795622|616774425|FG000|Overall Study|Protocol Violation|0|||
170661489|NCT04795622|616774426|FG001|Overall Study|Protocol Violation|2|||
170661490|NCT04795622|616774425|FG000|Overall Study|Lost to Follow-up|2|||
170661491|NCT04795622|616774426|FG001|Overall Study|Lost to Follow-up|3|||
170661492|NCT04795622|616774425|FG000|Overall Study|Other|7|||
170661493|NCT04795622|616774426|FG001|Overall Study|Other|8|||
170661494|NCT00470847|616774427|FG000|Overall Study|Pt still receiving treatment|1|||
170661495|NCT02280473|616774430|FG000|Overall Study|Adverse Event|1|||
170661496|NCT02280473|616774431|FG001|Overall Study|Adverse Event|1|||
170661497|NCT02280473|616774430|FG000|Overall Study|Lack of Efficacy|0|||
170661498|NCT02280473|616774431|FG001|Overall Study|Lack of Efficacy|1|||
170661499|NCT02280473|616774430|FG000|Overall Study|Lost to Follow-up|0|||
170661500|NCT02280473|616774431|FG001|Overall Study|Lost to Follow-up|1|||
170661501|NCT01610271|616774432|FG000|Overall Study|Surgery not complete|0|||
170661502|NCT01610271|616774433|FG001|Overall Study|Surgery not complete|1|||
170616013|NCT04170543|616601402|FG000|Overall Study|Lost to Follow-up|3|||
170616014|NCT04170543|616601403|FG001|Overall Study|Lost to Follow-up|3|||
170616015|NCT04170543|616601404|FG002|Overall Study|Lost to Follow-up|0|||
170616016|NCT04170543|616601405|FG003|Overall Study|Lost to Follow-up|3|||
170616017|NCT04170543|616601406|FG004|Overall Study|Lost to Follow-up|1|||
170616018|NCT04170543|616601402|FG000|Overall Study|Withdrawal by Subject|13|||
170616019|NCT04170543|616601403|FG001|Overall Study|Withdrawal by Subject|6|||
170616020|NCT04170543|616601404|FG002|Overall Study|Withdrawal by Subject|5|||
170616021|NCT04170543|616601405|FG003|Overall Study|Withdrawal by Subject|4|||
170616022|NCT04170543|616601406|FG004|Overall Study|Withdrawal by Subject|9|||
170616023|NCT04170543|616601402|FG000|Overall Study|Not able to transition to phase 2b|8|||
170616024|NCT04170543|616601403|FG001|Overall Study|Not able to transition to phase 2b|0|||
170616025|NCT04170543|616601404|FG002|Overall Study|Not able to transition to phase 2b|10|||
170616026|NCT04170543|616601405|FG003|Overall Study|Not able to transition to phase 2b|0|||
170616027|NCT04170543|616601406|FG004|Overall Study|Not able to transition to phase 2b|6|||
170616028|NCT04170543|616601402|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
170616029|NCT04170543|616601403|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
170616030|NCT04170543|616601404|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
170616031|NCT04170543|616601405|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
170616032|NCT04170543|616601406|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
170616033|NCT04170543|616601402|FG000|Overall Study|Not Treated|0|||
170616034|NCT04170543|616601403|FG001|Overall Study|Not Treated|0|||
170616035|NCT04170543|616601404|FG002|Overall Study|Not Treated|0|||
170616036|NCT04170543|616601405|FG003|Overall Study|Not Treated|0|||
170616037|NCT04170543|616601406|FG004|Overall Study|Not Treated|2|||
170616038|NCT04170543|616601402|FG000|Overall Study|(CRF)|16|||
170616039|NCT04170543|616601403|FG001|Overall Study|(CRF)|15|||
170616040|NCT04170543|616601404|FG002|Overall Study|(CRF)|12|||
170616041|NCT04170543|616601405|FG003|Overall Study|(CRF)|17|||
170616042|NCT04170543|616601406|FG004|Overall Study|(CRF)|17|||
170616043|NCT04170543|616601402|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
170616044|NCT04170543|616601403|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
170616045|NCT04170543|616601404|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
170616046|NCT04170543|616601405|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
170616047|NCT04170543|616601406|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
170616048|NCT00770601|616601407|FG000|Overall Study|Withdrawal by Subject|1|||
170616049|NCT03622814|616601409|FG000|Overall Study|Lost to Follow-up|8|||
170616050|NCT03622814|616601410|FG001|Overall Study|Lost to Follow-up|14|||
170616051|NCT01236521|616601411|FG000|Overall Study|Withdrawal by Subject|12|||
170616052|NCT01236521|616601412|FG001|Overall Study|Withdrawal by Subject|17|||
170616053|NCT01236521|616601411|FG000|Overall Study|Death|2|||
170616054|NCT01236521|616601412|FG001|Overall Study|Death|1|||
170616055|NCT01236521|616601411|FG000|Overall Study|Lost to Follow-up|9|||
170616056|NCT01236521|616601412|FG001|Overall Study|Lost to Follow-up|7|||
170616057|NCT03201419|616601419|FG000|Overall Study|Adverse Event|3|||
170616058|NCT03201419|616601420|FG001|Overall Study|Adverse Event|1|||
170616059|NCT03201419|616601421|FG002|Overall Study|Adverse Event|0|||
170616060|NCT03201419|616601422|FG003|Overall Study|Adverse Event|0|||
170616061|NCT03201419|616601423|FG004|Overall Study|Adverse Event|1|||
170616062|NCT03201419|616601424|FG005|Overall Study|Adverse Event|1|||
170616063|NCT03201419|616601425|FG006|Overall Study|Adverse Event|5|||
170616064|NCT03201419|616601426|FG007|Overall Study|Adverse Event|0|||
170616065|NCT03201419|616601427|FG008|Overall Study|Adverse Event|0|||
170616066|NCT03201419|616601419|FG000|Overall Study|Lost to Follow-up|1|||
170616067|NCT03201419|616601420|FG001|Overall Study|Lost to Follow-up|0|||
170616068|NCT03201419|616601421|FG002|Overall Study|Lost to Follow-up|0|||
170616069|NCT03201419|616601422|FG003|Overall Study|Lost to Follow-up|0|||
170616070|NCT03201419|616601423|FG004|Overall Study|Lost to Follow-up|0|||
170616071|NCT03201419|616601424|FG005|Overall Study|Lost to Follow-up|0|||
170616072|NCT03201419|616601425|FG006|Overall Study|Lost to Follow-up|0|||
170616073|NCT03201419|616601426|FG007|Overall Study|Lost to Follow-up|0|||
170616074|NCT03201419|616601427|FG008|Overall Study|Lost to Follow-up|0|||
170616075|NCT03201419|616601419|FG000|Overall Study|Protocol Deviation|0|||
170616076|NCT03201419|616601420|FG001|Overall Study|Protocol Deviation|0|||
170616077|NCT03201419|616601421|FG002|Overall Study|Protocol Deviation|0|||
170616078|NCT03201419|616601422|FG003|Overall Study|Protocol Deviation|0|||
170616079|NCT03201419|616601423|FG004|Overall Study|Protocol Deviation|0|||
170616080|NCT03201419|616601424|FG005|Overall Study|Protocol Deviation|0|||
170616081|NCT03201419|616601425|FG006|Overall Study|Protocol Deviation|1|||
170661503|NCT01610271|616774432|FG000|Overall Study|Prosthesis not implanted|2|||
170616082|NCT03201419|616601426|FG007|Overall Study|Protocol Deviation|0|||
170616083|NCT03201419|616601427|FG008|Overall Study|Protocol Deviation|0|||
170616084|NCT03201419|616601419|FG000|Overall Study|Withdrawal by Subject|4|||
170616085|NCT03201419|616601420|FG001|Overall Study|Withdrawal by Subject|2|||
170616086|NCT03201419|616601421|FG002|Overall Study|Withdrawal by Subject|1|||
170616087|NCT03201419|616601422|FG003|Overall Study|Withdrawal by Subject|0|||
170661504|NCT01610271|616774433|FG001|Overall Study|Prosthesis not implanted|3|||
170661505|NCT00364130|616774434|FG000|Intervention Period|Lost to Follow-up|4|||
170661506|NCT00364130|616774435|FG001|Intervention Period|Lost to Follow-up|3|||
170661507|NCT00364130|616774434|FG000|Intervention Period|Pregnancy|1|||
170661508|NCT00364130|616774435|FG001|Intervention Period|Pregnancy|0|||
170661509|NCT00364130|616774434|FG000|Intervention Period|Withdrawal by Subject|4|||
170661510|NCT00364130|616774435|FG001|Intervention Period|Withdrawal by Subject|5|||
170661511|NCT00364130|616774434|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
170661512|NCT00364130|616774435|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
170661513|NCT01638819|616774441|FG000|Overall Study|Lost to Follow-up|1|||
170661514|NCT01638819|616774442|FG001|Overall Study|Lost to Follow-up|0|||
170661515|NCT01231347|616774445|FG000|Overall Study|Full Consent withdrawn|19|||
170661516|NCT01231347|616774446|FG001|Overall Study|Full Consent withdrawn|19|||
170661517|NCT01231347|616774447|FG002|Overall Study|Full Consent withdrawn|11|||
170661518|NCT01231347|616774445|FG000|Overall Study|Lost to Follow-up|4|||
170661519|NCT01231347|616774446|FG001|Overall Study|Lost to Follow-up|2|||
170661520|NCT01231347|616774447|FG002|Overall Study|Lost to Follow-up|2|||
170661521|NCT01231347|616774445|FG000|Overall Study|Death|202|||
170661522|NCT01231347|616774446|FG001|Overall Study|Death|210|||
170917161|NCT05775289|617697858|FG002|Overall Study|Lost to Follow-up|0|||
170917162|NCT05775289|617697859|FG003|Overall Study|Lost to Follow-up|0|||
170917163|NCT05775289|617697856|FG000|Overall Study|Progressive Disease|0|||
170917164|NCT05775289|617697857|FG001|Overall Study|Progressive Disease|0|||
170661523|NCT01231347|616774447|FG002|Overall Study|Death|101|||
170661524|NCT01231347|616774445|FG000|Overall Study|other event|7|||
170661525|NCT01231347|616774446|FG001|Overall Study|other event|9|||
170661526|NCT01231347|616774447|FG002|Overall Study|other event|3|||
170661527|NCT01460368|616774448|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
170661528|NCT01460368|616774449|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
170661529|NCT01460368|616774450|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
170661530|NCT01460368|616774451|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
170661531|NCT01460368|616774452|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
170661532|NCT01460368|616774453|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
170661533|NCT01460368|616774454|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
170661534|NCT01460368|616774448|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
170661535|NCT01460368|616774449|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
170661536|NCT01460368|616774450|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
170661537|NCT01460368|616774451|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
170661538|NCT01460368|616774452|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
170661539|NCT01460368|616774453|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
170661540|NCT01460368|616774454|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
170661541|NCT01460368|616774448|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
170661542|NCT01460368|616774449|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
170661543|NCT01460368|616774450|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
170661544|NCT01460368|616774451|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
170661545|NCT01460368|616774452|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
170661546|NCT01460368|616774453|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
170661547|NCT01460368|616774454|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
170661548|NCT01460368|616774448|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
170661549|NCT01460368|616774449|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
170661550|NCT01460368|616774450|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
170661551|NCT01460368|616774451|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
170661552|NCT01460368|616774452|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
170661553|NCT01460368|616774453|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
170661554|NCT01460368|616774454|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
170661555|NCT01460368|616774448|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
170661556|NCT01460368|616774449|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
170661557|NCT01460368|616774450|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
170661558|NCT01460368|616774451|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
170661559|NCT01460368|616774452|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
170661560|NCT01460368|616774453|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
170661561|NCT01460368|616774454|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
170661562|NCT00910988|616774455|FG000|Overall Study|Lost to Follow-up|2|||
170661563|NCT00910988|616774456|FG001|Overall Study|Lost to Follow-up|4|||
170661564|NCT00910988|616774457|FG002|Overall Study|Lost to Follow-up|3|||
170661565|NCT00910988|616774458|FG003|Overall Study|Lost to Follow-up|0|||
170917165|NCT05775289|617697858|FG002|Overall Study|Progressive Disease|1|||
170917166|NCT05775289|617697859|FG003|Overall Study|Progressive Disease|0|||
170917167|NCT05775289|617697856|FG000|Overall Study|Withdrawal by Subject|1|||
170917168|NCT05775289|617697857|FG001|Overall Study|Withdrawal by Subject|1|||
170917169|NCT05775289|617697858|FG002|Overall Study|Withdrawal by Subject|0|||
170817539|NCT01183013|617339774|FG003|Overall Study|Withdrawal by Subject|8|||
170817540|NCT01183013|617339775|FG004|Overall Study|Withdrawal by Subject|7|||
170661566|NCT01385371|616774471|FG000|Overall Study|Adverse Event|54|||
170661567|NCT01385371|616774472|FG001|Overall Study|Adverse Event|19|||
170661568|NCT01385371|616774471|FG000|Overall Study|Lost to Follow-up|16|||
170661569|NCT01385371|616774472|FG001|Overall Study|Lost to Follow-up|16|||
170661570|NCT01385371|616774471|FG000|Overall Study|Withdrawal by Subject|52|||
170661571|NCT01385371|616774472|FG001|Overall Study|Withdrawal by Subject|39|||
170661572|NCT01385371|616774471|FG000|Overall Study|Protocol Violation|25|||
170661573|NCT01385371|616774472|FG001|Overall Study|Protocol Violation|21|||
170661574|NCT01385371|616774471|FG000|Overall Study|Administrative|2|||
170661575|NCT01385371|616774472|FG001|Overall Study|Administrative|2|||
170661576|NCT01626495|616774473|FG000|Overall Study|Adverse Event|3|||
170661577|NCT01626495|616774473|FG000|Overall Study|Disease progression|27|||
170661578|NCT01626495|616774473|FG000|Overall Study|Withdrawal by Subject|1|||
170661579|NCT01626495|616774473|FG000|Overall Study|Administrative problem|1|||
170661580|NCT01626495|616774473|FG000|Overall Study|Death|2|||
170661581|NCT01626495|616774473|FG000|Overall Study|Physician Decision|1|||
170661582|NCT01626495|616774473|FG000|Overall Study|New cancer therapy|16|||
170661583|NCT01626495|616774473|FG000|Overall Study|Manufacturing failure|1|||
170661584|NCT03635788|616774479|FG000|Step 1|Death|1|||
170661585|NCT03635788|616774480|FG001|Step 1|Death|0|||
170661586|NCT03635788|616774481|FG002|Step 1|Death|0|||
170661587|NCT03635788|616774479|FG000|Step 1|Lost to Follow-up|31|||
170661588|NCT03635788|616774480|FG001|Step 1|Lost to Follow-up|0|||
170661589|NCT03635788|616774481|FG002|Step 1|Lost to Follow-up|0|||
170661590|NCT03635788|616774479|FG000|Step 1|Pregnancy|1|||
170661591|NCT03635788|616774480|FG001|Step 1|Pregnancy|0|||
170661592|NCT03635788|616774481|FG002|Step 1|Pregnancy|0|||
170661593|NCT03635788|616774479|FG000|Step 1|Protocol Violation|8|||
170661594|NCT03635788|616774480|FG001|Step 1|Protocol Violation|0|||
170661595|NCT03635788|616774481|FG002|Step 1|Protocol Violation|0|||
170661596|NCT03635788|616774479|FG000|Step 1|Withdrawal by Subject|13|||
170661597|NCT03635788|616774480|FG001|Step 1|Withdrawal by Subject|0|||
170661598|NCT03635788|616774481|FG002|Step 1|Withdrawal by Subject|0|||
170661599|NCT03635788|616774479|FG000|Step 1|Other reasons|12|||
170661600|NCT03635788|616774480|FG001|Step 1|Other reasons|0|||
170661601|NCT03635788|616774481|FG002|Step 1|Other reasons|0|||
170661602|NCT03635788|616774479|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
170661603|NCT03635788|616774480|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
170661604|NCT03635788|616774481|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
170661605|NCT03635788|616774479|FG000|Step 2|Lost to Follow-up|0|||
170817541|NCT01183013|617339776|FG005|Overall Study|Withdrawal by Subject|9|||
170817542|NCT01183013|617339777|FG006|Overall Study|Withdrawal by Subject|10|||
170817543|NCT01183013|617339771|FG000|Overall Study|Reasons other than stated above|15|||
170817544|NCT01183013|617339772|FG001|Overall Study|Reasons other than stated above|11|||
170817545|NCT01183013|617339773|FG002|Overall Study|Reasons other than stated above|17|||
170817546|NCT01183013|617339774|FG003|Overall Study|Reasons other than stated above|12|||
170661606|NCT03635788|616774480|FG001|Step 2|Lost to Follow-up|8|||
170661607|NCT03635788|616774481|FG002|Step 2|Lost to Follow-up|15|||
170661608|NCT03635788|616774479|FG000|Step 2|Withdrawal by Subject|0|||
170661609|NCT03635788|616774480|FG001|Step 2|Withdrawal by Subject|6|||
170661610|NCT03635788|616774481|FG002|Step 2|Withdrawal by Subject|6|||
170661611|NCT03635788|616774479|FG000|Step 2|Death|0|||
170661612|NCT03635788|616774480|FG001|Step 2|Death|2|||
170661613|NCT03635788|616774481|FG002|Step 2|Death|0|||
170661614|NCT03635788|616774479|FG000|Step 2|Incarceration|0|||
170661615|NCT03635788|616774480|FG001|Step 2|Incarceration|2|||
170661616|NCT03635788|616774481|FG002|Step 2|Incarceration|0|||
170661617|NCT03635788|616774479|FG000|Step 2|Non-Compliance With Study Requirements|0|||
170661618|NCT03635788|616774480|FG001|Step 2|Non-Compliance With Study Requirements|1|||
170661619|NCT03635788|616774481|FG002|Step 2|Non-Compliance With Study Requirements|1|||
170661620|NCT03635788|616774479|FG000|Step 2|Confounding Medical Condition|0|||
170661621|NCT03635788|616774480|FG001|Step 2|Confounding Medical Condition|0|||
170661622|NCT03635788|616774481|FG002|Step 2|Confounding Medical Condition|1|||
170661623|NCT03635788|616774479|FG000|Step 2|Out Of State With No Plan To Return|0|||
170661624|NCT03635788|616774480|FG001|Step 2|Out Of State With No Plan To Return|1|||
170661625|NCT03635788|616774481|FG002|Step 2|Out Of State With No Plan To Return|0|||
170661626|NCT03635788|616774479|FG000|Step 2|Switched To Injectables|0|||
170661627|NCT03635788|616774480|FG001|Step 2|Switched To Injectables|0|||
170661628|NCT03635788|616774481|FG002|Step 2|Switched To Injectables|1|||
170661629|NCT03635788|616774479|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
170661630|NCT03635788|616774480|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
170661631|NCT03635788|616774481|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
170661632|NCT01876810|616774482|FG000|Overall Study|Physician Decision|0|||
170661633|NCT01876810|616774483|FG001|Overall Study|Physician Decision|1|||
170661634|NCT00866788|616776031|FG000|Overall Study|Adverse Event|0|||
170661635|NCT00866788|616776032|FG001|Overall Study|Adverse Event|2|||
170661636|NCT00866788|616776033|FG002|Overall Study|Adverse Event|0|||
170661637|NCT00866788|616776034|FG003|Overall Study|Adverse Event|1|||
170661638|NCT00866788|616776031|FG000|Overall Study|Lost to Follow-up|1|||
170661639|NCT00866788|616776032|FG001|Overall Study|Lost to Follow-up|1|||
170661640|NCT00866788|616776033|FG002|Overall Study|Lost to Follow-up|0|||
170661641|NCT00866788|616776034|FG003|Overall Study|Lost to Follow-up|2|||
170661642|NCT00866788|616776031|FG000|Overall Study|Withdrawal by Subject|2|||
170661643|NCT00866788|616776032|FG001|Overall Study|Withdrawal by Subject|1|||
170661644|NCT00866788|616776033|FG002|Overall Study|Withdrawal by Subject|0|||
170661645|NCT00866788|616776034|FG003|Overall Study|Withdrawal by Subject|1|||
170661646|NCT00866788|616776031|FG000|Overall Study|Pregnancy|0|||
170661647|NCT00866788|616776032|FG001|Overall Study|Pregnancy|1|||
170661648|NCT00866788|616776033|FG002|Overall Study|Pregnancy|0|||
170661649|NCT00866788|616776034|FG003|Overall Study|Pregnancy|0|||
170661650|NCT00866788|616776031|FG000|Overall Study|Disease progression|3|||
170661651|NCT00866788|616776032|FG001|Overall Study|Disease progression|1|||
170661652|NCT00866788|616776033|FG002|Overall Study|Disease progression|1|||
170661653|NCT00866788|616776034|FG003|Overall Study|Disease progression|0|||
170661654|NCT00866788|616776031|FG000|Overall Study|Physician Decision|0|||
170661655|NCT00866788|616776032|FG001|Overall Study|Physician Decision|0|||
170661656|NCT00866788|616776033|FG002|Overall Study|Physician Decision|1|||
170661657|NCT00866788|616776034|FG003|Overall Study|Physician Decision|1|||
170661658|NCT02349061|616776035|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
170661659|NCT02349061|616776036|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
170661660|NCT02349061|616776037|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
170661661|NCT02349061|616776035|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
170661662|NCT02349061|616776036|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
170661663|NCT02349061|616776037|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
170661664|NCT02349061|616776035|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
170661665|NCT02349061|616776036|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
170661666|NCT02349061|616776037|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
170661667|NCT02349061|616776035|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
170661668|NCT02349061|616776036|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
170661669|NCT02349061|616776037|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
170661670|NCT02349061|616776035|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
170661671|NCT02349061|616776036|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
170661672|NCT02349061|616776037|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
170661673|NCT02349061|616776035|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
170661674|NCT02349061|616776036|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
170661675|NCT02349061|616776037|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
170661676|NCT02349061|616776035|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
170661677|NCT02349061|616776036|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
170661678|NCT02349061|616776037|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
170661679|NCT02349061|616776035|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
170661680|NCT02349061|616776036|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
170661681|NCT02349061|616776037|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
170661682|NCT02349061|616776035|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
170661683|NCT02349061|616776036|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
170661684|NCT02349061|616776037|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
170661685|NCT02349061|616776035|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
170661686|NCT02349061|616776036|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
170661687|NCT02349061|616776037|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
170661688|NCT02349061|616776035|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
170661689|NCT02349061|616776036|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
170661690|NCT02349061|616776037|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
170661691|NCT02349061|616776035|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
170661692|NCT02349061|616776036|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
170661693|NCT02349061|616776037|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
170817547|NCT01183013|617339775|FG004|Overall Study|Reasons other than stated above|12|||
170817548|NCT01183013|617339776|FG005|Overall Study|Reasons other than stated above|15|||
170817549|NCT01183013|617339777|FG006|Overall Study|Reasons other than stated above|13|||
170817550|NCT01469819|617339778|FG000|Overall Study|Withdrawal by Subject|1|||
170817551|NCT01469819|617339778|FG000|Overall Study|Did not meet inclusionary criteria|2|||
170661694|NCT02349061|616776035|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
170661695|NCT02349061|616776036|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
170661696|NCT02349061|616776037|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
170661697|NCT00598702|616776043|FG000|Overall Study|Other|0|||
170661698|NCT00598702|616776044|FG001|Overall Study|Other|2|||
170661699|NCT00598702|616776045|FG002|Overall Study|Other|0|||
170661700|NCT00598702|616776046|FG003|Overall Study|Other|0|||
170661701|NCT00598702|616776047|FG004|Overall Study|Other|0|||
170661702|NCT00598702|616776048|FG005|Overall Study|Other|1|||
170616088|NCT03201419|616601423|FG004|Overall Study|Withdrawal by Subject|0|||
170661703|NCT00598702|616776049|FG006|Overall Study|Other|0|||
170661704|NCT00598702|616776050|FG007|Overall Study|Other|0|||
170661705|NCT00598702|616776043|FG000|Overall Study|Early discharge from hospital|0|||
170661706|NCT00598702|616776044|FG001|Overall Study|Early discharge from hospital|0|||
170661707|NCT00598702|616776045|FG002|Overall Study|Early discharge from hospital|2|||
170661708|NCT00598702|616776046|FG003|Overall Study|Early discharge from hospital|5|||
170661709|NCT00598702|616776047|FG004|Overall Study|Early discharge from hospital|0|||
170661710|NCT00598702|616776048|FG005|Overall Study|Early discharge from hospital|10|||
170616089|NCT03201419|616601424|FG005|Overall Study|Withdrawal by Subject|0|||
170616090|NCT03201419|616601425|FG006|Overall Study|Withdrawal by Subject|0|||
170616091|NCT03201419|616601426|FG007|Overall Study|Withdrawal by Subject|1|||
170616092|NCT03201419|616601427|FG008|Overall Study|Withdrawal by Subject|2|||
170616093|NCT03201419|616601419|FG000|Overall Study|Other|0|||
170616094|NCT03201419|616601420|FG001|Overall Study|Other|0|||
170616095|NCT03201419|616601421|FG002|Overall Study|Other|1|||
170616096|NCT03201419|616601422|FG003|Overall Study|Other|0|||
170616097|NCT03201419|616601423|FG004|Overall Study|Other|0|||
170616098|NCT03201419|616601424|FG005|Overall Study|Other|0|||
170616099|NCT03201419|616601425|FG006|Overall Study|Other|0|||
170616100|NCT03201419|616601426|FG007|Overall Study|Other|0|||
170616101|NCT03201419|616601427|FG008|Overall Study|Other|0|||
170616102|NCT03635424|616601428|FG000|Overall Study|Adverse Event|1|||
170616103|NCT03635424|616601428|FG000|Overall Study|Death|1|||
170616104|NCT03635424|616601428|FG000|Overall Study|Device not implanted|1|||
170616105|NCT04544956|616601429|FG000|Overall Study|Withdrawal by Subject|1|||
170616106|NCT03915470|616601432|FG000|Overall Study|Death|3|||
170616107|NCT03915470|616601433|FG001|Overall Study|Death|1|||
170616108|NCT03915470|616601432|FG000|Overall Study|Adverse Event|1|||
170616109|NCT03915470|616601433|FG001|Overall Study|Adverse Event|0|||
170616110|NCT03915470|616601432|FG000|Overall Study|Physician Decision|1|||
170616111|NCT03915470|616601433|FG001|Overall Study|Physician Decision|0|||
170616112|NCT03915470|616601432|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
170616113|NCT03915470|616601433|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
170616114|NCT03245775|616601434|FG000|Overall Study|Lost to Follow-up|25|||
170616115|NCT03245775|616601435|FG001|Overall Study|Lost to Follow-up|26|||
170616116|NCT03245775|616601436|FG002|Overall Study|Lost to Follow-up|16|||
170616117|NCT03245775|616601437|FG003|Overall Study|Lost to Follow-up|16|||
170616118|NCT03405818|616601438|FG000|Overall Study|Withdrawal by Subject|4|||
170616119|NCT03405818|616601438|FG000|Overall Study|Lost to Follow-up|4|||
170616120|NCT03691571|616601439|FG000|Overall Study|Withdrawal by Subject|9|||
170616121|NCT03691571|616601440|FG001|Overall Study|Withdrawal by Subject|2|||
170616122|NCT00940498|616601442|FG000|Overall Study|Death|2|||
170616123|NCT00940498|616601443|FG001|Overall Study|Death|0|||
170616124|NCT00940498|616601444|FG002|Overall Study|Death|0|||
170616125|NCT00940498|616601445|FG003|Overall Study|Death|1|||
170616126|NCT00940498|616601446|FG004|Overall Study|Death|5|||
170616127|NCT00940498|616601447|FG005|Overall Study|Death|0|||
170616128|NCT00940498|616601448|FG006|Overall Study|Death|1|||
170616129|NCT00940498|616601449|FG007|Overall Study|Death|0|||
170616130|NCT00940498|616601442|FG000|Overall Study|Lost to Follow-up|1|||
170616131|NCT00940498|616601443|FG001|Overall Study|Lost to Follow-up|1|||
170616132|NCT00940498|616601444|FG002|Overall Study|Lost to Follow-up|2|||
170616133|NCT00940498|616601445|FG003|Overall Study|Lost to Follow-up|0|||
170616134|NCT00940498|616601446|FG004|Overall Study|Lost to Follow-up|1|||
170616135|NCT00940498|616601447|FG005|Overall Study|Lost to Follow-up|0|||
170616136|NCT00940498|616601448|FG006|Overall Study|Lost to Follow-up|0|||
170616137|NCT00940498|616601449|FG007|Overall Study|Lost to Follow-up|1|||
170616138|NCT00940498|616601442|FG000|Overall Study|Disease Progression|0|||
170616139|NCT00940498|616601443|FG001|Overall Study|Disease Progression|0|||
170616140|NCT00940498|616601444|FG002|Overall Study|Disease Progression|1|||
170616141|NCT00940498|616601445|FG003|Overall Study|Disease Progression|1|||
170616142|NCT00940498|616601446|FG004|Overall Study|Disease Progression|0|||
170661711|NCT00598702|616776049|FG006|Overall Study|Early discharge from hospital|1|||
170661712|NCT00598702|616776050|FG007|Overall Study|Early discharge from hospital|0|||
170661713|NCT00598702|616776043|FG000|Overall Study|Adverse Event|0|||
170616143|NCT00940498|616601447|FG005|Overall Study|Disease Progression|1|||
170616144|NCT00940498|616601448|FG006|Overall Study|Disease Progression|0|||
170616145|NCT00940498|616601449|FG007|Overall Study|Disease Progression|0|||
170616146|NCT00940498|616601442|FG000|Overall Study|Physician Decision|0|||
170616147|NCT00940498|616601443|FG001|Overall Study|Physician Decision|0|||
170616148|NCT00940498|616601444|FG002|Overall Study|Physician Decision|0|||
170616149|NCT00940498|616601445|FG003|Overall Study|Physician Decision|0|||
170616150|NCT00940498|616601446|FG004|Overall Study|Physician Decision|2|||
170616151|NCT00940498|616601447|FG005|Overall Study|Physician Decision|0|||
170616152|NCT00940498|616601448|FG006|Overall Study|Physician Decision|0|||
170616153|NCT00940498|616601449|FG007|Overall Study|Physician Decision|0|||
170616154|NCT00940498|616601442|FG000|Overall Study|Not treated due to disease related pain|0|||
170616155|NCT00940498|616601443|FG001|Overall Study|Not treated due to disease related pain|0|||
170616156|NCT00940498|616601444|FG002|Overall Study|Not treated due to disease related pain|0|||
170616157|NCT00940498|616601445|FG003|Overall Study|Not treated due to disease related pain|0|||
170616158|NCT00940498|616601446|FG004|Overall Study|Not treated due to disease related pain|1|||
170616159|NCT00940498|616601447|FG005|Overall Study|Not treated due to disease related pain|0|||
170616160|NCT00940498|616601448|FG006|Overall Study|Not treated due to disease related pain|0|||
170817552|NCT01469819|617339778|FG000|Overall Study|Could not swallow SmartPill|2|||
170817553|NCT01469819|617339778|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
170817554|NCT02727998|617339779|FG000|Overall Study|Lost to Follow-up|3|||
170817555|NCT02727998|617339780|FG001|Overall Study|Lost to Follow-up|3|||
170616161|NCT00940498|616601449|FG007|Overall Study|Not treated due to disease related pain|0|||
170616162|NCT01657292|616601450|FG000|Overall Study|Adverse Event|6|||
170616163|NCT01657292|616601450|FG000|Overall Study|Withdrawal by Subject|2|||
170616164|NCT01657292|616601450|FG000|Overall Study|Violation of eligibility criteria|1|||
170616165|NCT01657292|616601450|FG000|Overall Study|Change of therapy|1|||
170616166|NCT00549445|616601451|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
170616167|NCT00549445|616601452|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
170616168|NCT01900652|616601453|FG000|Overall Study|Progressive Disease|1|||
170616169|NCT01900652|616601454|FG001|Overall Study|Progressive Disease|0|||
170616170|NCT01900652|616601453|FG000|Overall Study|Consent withdrawn by subject|1|||
170616171|NCT01900652|616601454|FG001|Overall Study|Consent withdrawn by subject|1|||
170616172|NCT01900652|616601453|FG000|Overall Study|Death|3|||
170616173|NCT01900652|616601454|FG001|Overall Study|Death|0|||
170616174|NCT01900652|616601453|FG000|Overall Study|Adverse Event|2|||
170616175|NCT01900652|616601454|FG001|Overall Study|Adverse Event|1|||
170616176|NCT01900652|616601453|FG000|Overall Study|Physician Decision|1|||
170616177|NCT01900652|616601454|FG001|Overall Study|Physician Decision|1|||
170616178|NCT03761810|616601455|FG000|Overall Study|Adverse Event|12|||
170616179|NCT03761810|616601456|FG001|Overall Study|Adverse Event|0|||
170616180|NCT03761810|616601455|FG000|Overall Study|Lost to Follow-up|15|||
170616181|NCT03761810|616601456|FG001|Overall Study|Lost to Follow-up|7|||
170616182|NCT03761810|616601455|FG000|Overall Study|Pregnancy|1|||
170616183|NCT03761810|616601456|FG001|Overall Study|Pregnancy|0|||
170616184|NCT03761810|616601455|FG000|Overall Study|Withdrawal by Subject|14|||
170616185|NCT03761810|616601456|FG001|Overall Study|Withdrawal by Subject|5|||
170616186|NCT03761810|616601455|FG000|Overall Study|Physician Decision|1|||
170616187|NCT03761810|616601456|FG001|Overall Study|Physician Decision|0|||
170616188|NCT03761810|616601455|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
170616189|NCT03761810|616601456|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170616190|NCT03761810|616601455|FG000|Overall Study|Other Than Specified|1|||
170616191|NCT03761810|616601456|FG001|Overall Study|Other Than Specified|0|||
170616192|NCT04178720|616601457|FG000|Overall Study|Withdrawal by Subject|2|||
170616193|NCT04178720|616601458|FG001|Overall Study|Withdrawal by Subject|0|||
170616194|NCT04178720|616601457|FG000|Overall Study|Relocation|0|||
170616195|NCT04178720|616601458|FG001|Overall Study|Relocation|1|||
170616196|NCT01633788|616603632|FG000|Overall Study|Adverse Event|1|||
170616197|NCT01633788|616603633|FG001|Overall Study|Adverse Event|3|||
170616198|NCT01633788|616603634|FG002|Overall Study|Adverse Event|3|||
170616199|NCT01633788|616603635|FG003|Overall Study|Adverse Event|3|||
170616200|NCT01633788|616603632|FG000|Overall Study|Lost to Follow-up|2|||
170616201|NCT01633788|616603633|FG001|Overall Study|Lost to Follow-up|2|||
170616202|NCT01633788|616603634|FG002|Overall Study|Lost to Follow-up|2|||
170616203|NCT01633788|616603635|FG003|Overall Study|Lost to Follow-up|0|||
170616204|NCT01633788|616603632|FG000|Overall Study|Personal Reasons|3|||
170616205|NCT01633788|616603633|FG001|Overall Study|Personal Reasons|1|||
170616206|NCT01633788|616603634|FG002|Overall Study|Personal Reasons|1|||
170616207|NCT01633788|616603635|FG003|Overall Study|Personal Reasons|3|||
170616208|NCT01633788|616603632|FG000|Overall Study|Protocol Violation|1|||
170616209|NCT01633788|616603633|FG001|Overall Study|Protocol Violation|0|||
170616210|NCT01633788|616603634|FG002|Overall Study|Protocol Violation|1|||
170616211|NCT01633788|616603635|FG003|Overall Study|Protocol Violation|0|||
170616212|NCT01633788|616603632|FG000|Overall Study|Other Reasons|0|||
170616213|NCT01633788|616603633|FG001|Overall Study|Other Reasons|2|||
170616214|NCT01633788|616603634|FG002|Overall Study|Other Reasons|3|||
170817556|NCT02727998|617339779|FG000|Overall Study|Withdrawal by Subject|0|||
170817557|NCT02727998|617339780|FG001|Overall Study|Withdrawal by Subject|1|||
170817558|NCT00561678|617339781|FG000|Overall Study|Withdrawal by Subject|4|||
170817559|NCT00561678|617339782|FG001|Overall Study|Withdrawal by Subject|3|||
170817560|NCT00561678|617339781|FG000|Overall Study|surgery cancelled|1|||
170817561|NCT00561678|617339782|FG001|Overall Study|surgery cancelled|1|||
170616215|NCT01633788|616603635|FG003|Overall Study|Other Reasons|7|||
170616216|NCT03553758|616603636|FG000|Overall Study|Lost to Follow-up|1|||
170616217|NCT02719171|616603639|FG000|Overall Study|Adverse Event|1|||
170616218|NCT02719171|616603640|FG001|Overall Study|Adverse Event|2|||
170616219|NCT02719171|616603641|FG002|Overall Study|Adverse Event|0|||
170616220|NCT02719171|616603642|FG003|Overall Study|Adverse Event|0|||
170817562|NCT00561678|617339781|FG000|Overall Study|surgery rescheduled to different site|2|||
170817563|NCT00561678|617339782|FG001|Overall Study|surgery rescheduled to different site|2|||
170661714|NCT00598702|616776044|FG001|Overall Study|Adverse Event|0|||
170661715|NCT00598702|616776045|FG002|Overall Study|Adverse Event|0|||
170661716|NCT00598702|616776046|FG003|Overall Study|Adverse Event|1|||
170661717|NCT00598702|616776047|FG004|Overall Study|Adverse Event|0|||
170661718|NCT00598702|616776048|FG005|Overall Study|Adverse Event|0|||
170616221|NCT02719171|616603643|FG004|Overall Study|Adverse Event|2|||
170616222|NCT02719171|616603639|FG000|Overall Study|Lost to Follow-up|0|||
170616223|NCT02719171|616603640|FG001|Overall Study|Lost to Follow-up|0|||
170616224|NCT02719171|616603641|FG002|Overall Study|Lost to Follow-up|1|||
170616225|NCT02719171|616603642|FG003|Overall Study|Lost to Follow-up|0|||
170616226|NCT02719171|616603643|FG004|Overall Study|Lost to Follow-up|0|||
170616227|NCT02719171|616603639|FG000|Overall Study|Subject Withdrawal|0|||
170616228|NCT02719171|616603640|FG001|Overall Study|Subject Withdrawal|2|||
170616229|NCT02719171|616603641|FG002|Overall Study|Subject Withdrawal|2|||
170616230|NCT02719171|616603642|FG003|Overall Study|Subject Withdrawal|1|||
170616231|NCT02719171|616603643|FG004|Overall Study|Subject Withdrawal|0|||
170616232|NCT02719171|616603639|FG000|Overall Study|Other|0|||
170616233|NCT02719171|616603640|FG001|Overall Study|Other|0|||
170616234|NCT02719171|616603641|FG002|Overall Study|Other|0|||
170616235|NCT02719171|616603642|FG003|Overall Study|Other|1|||
170616236|NCT02719171|616603643|FG004|Overall Study|Other|0|||
170616237|NCT03212326|616603646|FG000|Overall Study|Physician Decision|4|||
170616238|NCT02544321|616603654|FG000|Overall Study|Withdrawal by Subject|1|||
170616239|NCT02544321|616603655|FG001|Overall Study|Withdrawal by Subject|2|||
170616240|NCT02544321|616603654|FG000|Overall Study|Adverse Event|1|||
170616241|NCT02544321|616603655|FG001|Overall Study|Adverse Event|1|||
170616242|NCT02544321|616603654|FG000|Overall Study|Protocol Violation|0|||
170616243|NCT02544321|616603655|FG001|Overall Study|Protocol Violation|1|||
170616244|NCT01131507|616603656|FG000|Overall Study|Adverse Event|1|||
170616245|NCT01131507|616603656|FG000|Overall Study|Lost to Follow-up|1|||
170616246|NCT01131507|616603656|FG000|Overall Study|Withdrawal by Subject|1|||
170616247|NCT01517750|616603657|FG000|Overall Study|Lost to Follow-up|1|||
170616248|NCT01517750|616603658|FG001|Overall Study|Lost to Follow-up|2|||
170616249|NCT01517750|616603659|FG002|Overall Study|Lost to Follow-up|4|||
170616250|NCT01517750|616603660|FG003|Overall Study|Lost to Follow-up|1|||
170616251|NCT01276639|616603664|FG000|Week 0 to 16|Death|1|||
170616252|NCT01276639|616603665|FG001|Week 0 to 16|Death|0|||
170616253|NCT01276639|616603666|FG002|Week 0 to 16|Death|0|||
170616254|NCT01276639|616603667|FG003|Week 0 to 16|Death|0|||
170616255|NCT01276639|616603668|FG004|Week 0 to 16|Death|0|||
170616256|NCT01276639|616603664|FG000|Week 0 to 16|Adverse Event|11|||
170616257|NCT01276639|616603665|FG001|Week 0 to 16|Adverse Event|8|||
170616258|NCT01276639|616603666|FG002|Week 0 to 16|Adverse Event|11|||
170616259|NCT01276639|616603667|FG003|Week 0 to 16|Adverse Event|0|||
170616260|NCT01276639|616603668|FG004|Week 0 to 16|Adverse Event|0|||
170616261|NCT01276639|616603664|FG000|Week 0 to 16|Lack of Efficacy|20|||
170616262|NCT01276639|616603665|FG001|Week 0 to 16|Lack of Efficacy|15|||
170616263|NCT01276639|616603666|FG002|Week 0 to 16|Lack of Efficacy|25|||
170616264|NCT01276639|616603667|FG003|Week 0 to 16|Lack of Efficacy|0|||
170616265|NCT01276639|616603668|FG004|Week 0 to 16|Lack of Efficacy|0|||
170616266|NCT01276639|616603664|FG000|Week 0 to 16|Lost to Follow-up|3|||
170616267|NCT01276639|616603665|FG001|Week 0 to 16|Lost to Follow-up|5|||
170616268|NCT01276639|616603666|FG002|Week 0 to 16|Lost to Follow-up|3|||
170616269|NCT01276639|616603667|FG003|Week 0 to 16|Lost to Follow-up|0|||
170616270|NCT01276639|616603668|FG004|Week 0 to 16|Lost to Follow-up|0|||
170616271|NCT01276639|616603664|FG000|Week 0 to 16|Withdrawal by Subject|8|||
170616272|NCT01276639|616603665|FG001|Week 0 to 16|Withdrawal by Subject|5|||
170616273|NCT01276639|616603666|FG002|Week 0 to 16|Withdrawal by Subject|4|||
170616274|NCT01276639|616603667|FG003|Week 0 to 16|Withdrawal by Subject|0|||
170616275|NCT01276639|616603668|FG004|Week 0 to 16|Withdrawal by Subject|0|||
170616276|NCT01276639|616603664|FG000|Week 0 to 16|Other|7|||
170616277|NCT01276639|616603665|FG001|Week 0 to 16|Other|7|||
170616278|NCT01276639|616603666|FG002|Week 0 to 16|Other|2|||
170616279|NCT01276639|616603667|FG003|Week 0 to 16|Other|0|||
170616280|NCT01276639|616603668|FG004|Week 0 to 16|Other|0|||
170616281|NCT01276639|616603664|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
170616282|NCT01276639|616603665|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
170616283|NCT01276639|616603666|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
170616284|NCT01276639|616603667|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
170616285|NCT01276639|616603668|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
170616286|NCT01276639|616603664|FG000|Week 16 to 52|Death|1|||
170616287|NCT01276639|616603665|FG001|Week 16 to 52|Death|0|||
170616288|NCT01276639|616603666|FG002|Week 16 to 52|Death|0|||
170616289|NCT01276639|616603667|FG003|Week 16 to 52|Death|0|||
170616290|NCT01276639|616603668|FG004|Week 16 to 52|Death|0|||
170616291|NCT01276639|616603664|FG000|Week 16 to 52|Adverse Event|10|||
170616292|NCT01276639|616603665|FG001|Week 16 to 52|Adverse Event|13|||
170616293|NCT01276639|616603666|FG002|Week 16 to 52|Adverse Event|0|||
170616294|NCT01276639|616603667|FG003|Week 16 to 52|Adverse Event|1|||
170616295|NCT01276639|616603668|FG004|Week 16 to 52|Adverse Event|3|||
170616296|NCT01276639|616603664|FG000|Week 16 to 52|Lack of Efficacy|99|||
170661719|NCT00598702|616776049|FG006|Overall Study|Adverse Event|0|||
170661720|NCT00598702|616776050|FG007|Overall Study|Adverse Event|0|||
170661721|NCT00598702|616776043|FG000|Overall Study|Withdrawal by Subject|0|||
170661722|NCT00598702|616776044|FG001|Overall Study|Withdrawal by Subject|0|||
170661723|NCT00598702|616776045|FG002|Overall Study|Withdrawal by Subject|0|||
170661724|NCT00598702|616776046|FG003|Overall Study|Withdrawal by Subject|1|||
170661725|NCT00598702|616776047|FG004|Overall Study|Withdrawal by Subject|1|||
170661726|NCT00598702|616776048|FG005|Overall Study|Withdrawal by Subject|0|||
170661727|NCT00598702|616776049|FG006|Overall Study|Withdrawal by Subject|0|||
170661728|NCT00598702|616776050|FG007|Overall Study|Withdrawal by Subject|0|||
170661729|NCT00598702|616776043|FG000|Overall Study|Physician Decision|0|||
170661730|NCT00598702|616776044|FG001|Overall Study|Physician Decision|0|||
170661731|NCT00598702|616776045|FG002|Overall Study|Physician Decision|0|||
170661732|NCT00598702|616776046|FG003|Overall Study|Physician Decision|0|||
170661733|NCT00598702|616776047|FG004|Overall Study|Physician Decision|1|||
170661734|NCT00598702|616776048|FG005|Overall Study|Physician Decision|0|||
170661735|NCT00598702|616776049|FG006|Overall Study|Physician Decision|0|||
170661736|NCT00598702|616776050|FG007|Overall Study|Physician Decision|0|||
170661737|NCT00598702|616776043|FG000|Overall Study|Dose limiting toxicity|0|||
170661738|NCT00598702|616776044|FG001|Overall Study|Dose limiting toxicity|0|||
170661739|NCT00598702|616776045|FG002|Overall Study|Dose limiting toxicity|0|||
170661740|NCT00598702|616776046|FG003|Overall Study|Dose limiting toxicity|1|||
170661741|NCT00598702|616776047|FG004|Overall Study|Dose limiting toxicity|1|||
170661742|NCT00598702|616776048|FG005|Overall Study|Dose limiting toxicity|1|||
170661743|NCT00598702|616776049|FG006|Overall Study|Dose limiting toxicity|0|||
170661744|NCT00598702|616776050|FG007|Overall Study|Dose limiting toxicity|0|||
170661745|NCT01859143|616776051|FG000|Overall Study|Lost to Follow-up|2|||
170661746|NCT01859143|616776052|FG001|Overall Study|Lost to Follow-up|0|||
170661747|NCT01134315|616776056|FG000|Overall Study|Adverse Event|1|||
170661748|NCT01134315|616776057|FG001|Overall Study|Adverse Event|2|||
170661749|NCT01134315|616776056|FG000|Overall Study|Other Reason|8|||
170661750|NCT01134315|616776057|FG001|Overall Study|Other Reason|17|||
170661751|NCT03633617|616776064|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
170661752|NCT03633617|616776065|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
170661753|NCT03633617|616776066|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661754|NCT03633617|616776067|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661755|NCT03633617|616776068|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661756|NCT03633617|616776069|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661757|NCT03633617|616776070|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661758|NCT03633617|616776071|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661759|NCT03633617|616776072|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661760|NCT03633617|616776073|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661761|NCT03633617|616776074|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
170661762|NCT03633617|616776064|FG000|Part A|Unconfirmed early termination visit|1|||
170661763|NCT03633617|616776065|FG001|Part A|Unconfirmed early termination visit|0|||
170661764|NCT03633617|616776066|FG002|Part A|Unconfirmed early termination visit|0|||
170661765|NCT03633617|616776067|FG003|Part A|Unconfirmed early termination visit|0|||
170661766|NCT03633617|616776068|FG004|Part A|Unconfirmed early termination visit|0|||
170661767|NCT03633617|616776069|FG005|Part A|Unconfirmed early termination visit|0|||
170661768|NCT03633617|616776070|FG006|Part A|Unconfirmed early termination visit|0|||
170661769|NCT03633617|616776071|FG007|Part A|Unconfirmed early termination visit|0|||
170661770|NCT03633617|616776072|FG008|Part A|Unconfirmed early termination visit|0|||
170661771|NCT03633617|616776073|FG009|Part A|Unconfirmed early termination visit|0|||
170661772|NCT03633617|616776074|FG010|Part A|Unconfirmed early termination visit|0|||
170661773|NCT03633617|616776064|FG000|Part A|Adverse Event|0|||
170661774|NCT03633617|616776065|FG001|Part A|Adverse Event|1|||
170661775|NCT03633617|616776066|FG002|Part A|Adverse Event|0|||
170661776|NCT03633617|616776067|FG003|Part A|Adverse Event|0|||
170661777|NCT03633617|616776068|FG004|Part A|Adverse Event|0|||
170661778|NCT03633617|616776069|FG005|Part A|Adverse Event|0|||
170661779|NCT03633617|616776070|FG006|Part A|Adverse Event|0|||
170661780|NCT03633617|616776071|FG007|Part A|Adverse Event|0|||
170661781|NCT03633617|616776072|FG008|Part A|Adverse Event|0|||
170661782|NCT03633617|616776073|FG009|Part A|Adverse Event|0|||
170661783|NCT03633617|616776074|FG010|Part A|Adverse Event|0|||
170661784|NCT03633617|616776064|FG000|Part A|Pregnancy|1|||
170661785|NCT03633617|616776065|FG001|Part A|Pregnancy|0|||
170661786|NCT03633617|616776066|FG002|Part A|Pregnancy|0|||
170661787|NCT03633617|616776067|FG003|Part A|Pregnancy|0|||
170661788|NCT03633617|616776068|FG004|Part A|Pregnancy|0|||
170661789|NCT03633617|616776069|FG005|Part A|Pregnancy|0|||
170661790|NCT03633617|616776070|FG006|Part A|Pregnancy|0|||
170661791|NCT03633617|616776071|FG007|Part A|Pregnancy|0|||
170661792|NCT03633617|616776072|FG008|Part A|Pregnancy|0|||
170661793|NCT03633617|616776073|FG009|Part A|Pregnancy|0|||
170661794|NCT03633617|616776074|FG010|Part A|Pregnancy|0|||
170661795|NCT03633617|616776064|FG000|Part A|Withdrawal by Subject|0|||
170661796|NCT03633617|616776065|FG001|Part A|Withdrawal by Subject|1|||
170661797|NCT03633617|616776066|FG002|Part A|Withdrawal by Subject|0|||
170661798|NCT03633617|616776067|FG003|Part A|Withdrawal by Subject|0|||
170661799|NCT03633617|616776068|FG004|Part A|Withdrawal by Subject|0|||
170661800|NCT03633617|616776069|FG005|Part A|Withdrawal by Subject|0|||
170661801|NCT03633617|616776070|FG006|Part A|Withdrawal by Subject|0|||
170661802|NCT03633617|616776071|FG007|Part A|Withdrawal by Subject|0|||
170661803|NCT03633617|616776072|FG008|Part A|Withdrawal by Subject|0|||
170661804|NCT03633617|616776073|FG009|Part A|Withdrawal by Subject|0|||
170661805|NCT03633617|616776074|FG010|Part A|Withdrawal by Subject|0|||
170661806|NCT03633617|616776064|FG000|Part B|Adverse Event|0|||
170661807|NCT03633617|616776065|FG001|Part B|Adverse Event|0|||
170661808|NCT03633617|616776066|FG002|Part B|Adverse Event|2|||
170661809|NCT03633617|616776067|FG003|Part B|Adverse Event|2|||
170661810|NCT03633617|616776068|FG004|Part B|Adverse Event|1|||
170661811|NCT03633617|616776069|FG005|Part B|Adverse Event|0|||
170661812|NCT03633617|616776070|FG006|Part B|Adverse Event|0|||
170661813|NCT03633617|616776071|FG007|Part B|Adverse Event|0|||
170661814|NCT03633617|616776072|FG008|Part B|Adverse Event|0|||
170661815|NCT03633617|616776073|FG009|Part B|Adverse Event|0|||
170661816|NCT03633617|616776074|FG010|Part B|Adverse Event|0|||
170661817|NCT03633617|616776064|FG000|Part B|Withdrawal by Subject|0|||
170661818|NCT03633617|616776065|FG001|Part B|Withdrawal by Subject|0|||
170661819|NCT03633617|616776066|FG002|Part B|Withdrawal by Subject|1|||
170661820|NCT03633617|616776067|FG003|Part B|Withdrawal by Subject|0|||
170661821|NCT03633617|616776068|FG004|Part B|Withdrawal by Subject|2|||
170661822|NCT03633617|616776069|FG005|Part B|Withdrawal by Subject|0|||
170661823|NCT03633617|616776070|FG006|Part B|Withdrawal by Subject|0|||
170661824|NCT03633617|616776071|FG007|Part B|Withdrawal by Subject|0|||
170661825|NCT03633617|616776072|FG008|Part B|Withdrawal by Subject|0|||
170661826|NCT03633617|616776073|FG009|Part B|Withdrawal by Subject|0|||
170661827|NCT03633617|616776074|FG010|Part B|Withdrawal by Subject|0|||
170661828|NCT03633617|616776064|FG000|Part B|Lost to Follow-up|0|||
170661829|NCT03633617|616776065|FG001|Part B|Lost to Follow-up|0|||
170661830|NCT03633617|616776066|FG002|Part B|Lost to Follow-up|0|||
170661831|NCT03633617|616776067|FG003|Part B|Lost to Follow-up|0|||
170661832|NCT03633617|616776068|FG004|Part B|Lost to Follow-up|1|||
170661833|NCT03633617|616776069|FG005|Part B|Lost to Follow-up|0|||
170661834|NCT03633617|616776070|FG006|Part B|Lost to Follow-up|0|||
170661835|NCT03633617|616776071|FG007|Part B|Lost to Follow-up|0|||
170661836|NCT03633617|616776072|FG008|Part B|Lost to Follow-up|0|||
170661837|NCT03633617|616776073|FG009|Part B|Lost to Follow-up|0|||
170661838|NCT03633617|616776074|FG010|Part B|Lost to Follow-up|0|||
170661839|NCT03633617|616776064|FG000|Part B|Physician Decision|0|||
170661840|NCT03633617|616776065|FG001|Part B|Physician Decision|0|||
170661841|NCT03633617|616776066|FG002|Part B|Physician Decision|0|||
170661842|NCT03633617|616776067|FG003|Part B|Physician Decision|0|||
170661843|NCT03633617|616776068|FG004|Part B|Physician Decision|1|||
170661844|NCT03633617|616776069|FG005|Part B|Physician Decision|0|||
170661845|NCT03633617|616776070|FG006|Part B|Physician Decision|0|||
170661846|NCT03633617|616776071|FG007|Part B|Physician Decision|0|||
170661847|NCT03633617|616776072|FG008|Part B|Physician Decision|0|||
170661848|NCT03633617|616776073|FG009|Part B|Physician Decision|0|||
170661849|NCT03633617|616776074|FG010|Part B|Physician Decision|0|||
170661850|NCT03633617|616776064|FG000|Part B|COVID-19 Restrictions|0|||
170661851|NCT03633617|616776065|FG001|Part B|COVID-19 Restrictions|0|||
170661852|NCT03633617|616776066|FG002|Part B|COVID-19 Restrictions|1|||
170661853|NCT03633617|616776067|FG003|Part B|COVID-19 Restrictions|0|||
170661854|NCT03633617|616776068|FG004|Part B|COVID-19 Restrictions|0|||
170661855|NCT03633617|616776069|FG005|Part B|COVID-19 Restrictions|0|||
170661856|NCT03633617|616776070|FG006|Part B|COVID-19 Restrictions|0|||
170661857|NCT03633617|616776071|FG007|Part B|COVID-19 Restrictions|0|||
170661858|NCT03633617|616776072|FG008|Part B|COVID-19 Restrictions|0|||
170661859|NCT03633617|616776073|FG009|Part B|COVID-19 Restrictions|0|||
170661860|NCT03633617|616776074|FG010|Part B|COVID-19 Restrictions|0|||
170661861|NCT03633617|616776064|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661862|NCT03633617|616776065|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661863|NCT03633617|616776066|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
170661864|NCT03633617|616776067|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661865|NCT03633617|616776068|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661866|NCT03633617|616776069|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661867|NCT03633617|616776070|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661868|NCT03633617|616776071|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661869|NCT03633617|616776072|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661870|NCT03633617|616776073|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661871|NCT03633617|616776074|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
170661872|NCT03633617|616776064|FG000|Part C (& Follow-up)|Adverse Event|0|||
170661873|NCT03633617|616776065|FG001|Part C (& Follow-up)|Adverse Event|0|||
170661874|NCT03633617|616776066|FG002|Part C (& Follow-up)|Adverse Event|0|||
170616297|NCT01276639|616603665|FG001|Week 16 to 52|Lack of Efficacy|71|||
170616298|NCT01276639|616603666|FG002|Week 16 to 52|Lack of Efficacy|0|||
170616299|NCT01276639|616603667|FG003|Week 16 to 52|Lack of Efficacy|14|||
170616300|NCT01276639|616603668|FG004|Week 16 to 52|Lack of Efficacy|13|||
170616301|NCT01276639|616603664|FG000|Week 16 to 52|Lost to Follow-up|3|||
170616302|NCT01276639|616603665|FG001|Week 16 to 52|Lost to Follow-up|1|||
170616303|NCT01276639|616603666|FG002|Week 16 to 52|Lost to Follow-up|0|||
170616304|NCT01276639|616603667|FG003|Week 16 to 52|Lost to Follow-up|0|||
170616305|NCT01276639|616603668|FG004|Week 16 to 52|Lost to Follow-up|1|||
170616306|NCT01276639|616603664|FG000|Week 16 to 52|Withdrawal by Subject|4|||
170616307|NCT01276639|616603665|FG001|Week 16 to 52|Withdrawal by Subject|4|||
170616308|NCT01276639|616603666|FG002|Week 16 to 52|Withdrawal by Subject|0|||
170616309|NCT01276639|616603667|FG003|Week 16 to 52|Withdrawal by Subject|0|||
170616310|NCT01276639|616603668|FG004|Week 16 to 52|Withdrawal by Subject|1|||
170616311|NCT01276639|616603664|FG000|Week 16 to 52|Other|10|||
170616312|NCT01276639|616603665|FG001|Week 16 to 52|Other|12|||
170616313|NCT01276639|616603666|FG002|Week 16 to 52|Other|0|||
170616314|NCT01276639|616603667|FG003|Week 16 to 52|Other|1|||
170616315|NCT01276639|616603668|FG004|Week 16 to 52|Other|3|||
170616316|NCT01132807|616603672|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
170616317|NCT01132807|616603673|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
170616318|NCT01132807|616603674|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
170616319|NCT01132807|616603672|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
170616320|NCT01132807|616603673|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
170616321|NCT01132807|616603674|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
170616322|NCT01380769|616603675|FG000|Overall Study|Withdrawal by Subject|7|||
170616323|NCT01380769|616603676|FG001|Overall Study|Withdrawal by Subject|11|||
170616324|NCT01380769|616603675|FG000|Overall Study|Physician Decision|1|||
170616325|NCT01380769|616603676|FG001|Overall Study|Physician Decision|1|||
170616326|NCT01380769|616603675|FG000|Overall Study|Adverse Event|1|||
170616327|NCT01380769|616603676|FG001|Overall Study|Adverse Event|1|||
170616328|NCT01380769|616603675|FG000|Overall Study|Protocol Violation|0|||
170616329|NCT01380769|616603676|FG001|Overall Study|Protocol Violation|1|||
170616330|NCT01745367|616603680|FG000|Overall Study|Death|1|||
170616331|NCT01745367|616603681|FG001|Overall Study|Death|0|||
170616332|NCT01745367|616603680|FG000|Overall Study|Withdrawal by Subject|1|||
170616333|NCT01745367|616603681|FG001|Overall Study|Withdrawal by Subject|2|||
170616334|NCT01745367|616603680|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
170616335|NCT01745367|616603681|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
170616336|NCT01745367|616603680|FG000|Overall Study|Other Reasons Unspecified|0|||
170616337|NCT01745367|616603681|FG001|Overall Study|Other Reasons Unspecified|2|||
170616338|NCT02366312|616603684|FG000|Overall Study|Lost to Follow-up|0|||
170616339|NCT02366312|616603685|FG001|Overall Study|Lost to Follow-up|1|||
170616340|NCT00965081|616603686|FG000|Overall Study|Adverse Event|14|||
170616341|NCT00965081|616603687|FG001|Overall Study|Adverse Event|9|||
170616342|NCT00965081|616603686|FG000|Overall Study|Lack of Efficacy|2|||
170616343|NCT00965081|616603687|FG001|Overall Study|Lack of Efficacy|5|||
170616344|NCT00965081|616603686|FG000|Overall Study|Lost to Follow-up|4|||
170616345|NCT00965081|616603687|FG001|Overall Study|Lost to Follow-up|5|||
170616346|NCT00965081|616603686|FG000|Overall Study|Physician Decision|2|||
170616347|NCT00965081|616603687|FG001|Overall Study|Physician Decision|0|||
170616348|NCT00965081|616603686|FG000|Overall Study|Protocol Violation|2|||
170616349|NCT00965081|616603687|FG001|Overall Study|Protocol Violation|5|||
170616350|NCT00965081|616603686|FG000|Overall Study|Sponsor Decision|1|||
170616351|NCT00965081|616603687|FG001|Overall Study|Sponsor Decision|0|||
170616352|NCT00965081|616603686|FG000|Overall Study|Withdrawal by Subject|4|||
170616353|NCT00965081|616603687|FG001|Overall Study|Withdrawal by Subject|7|||
170616354|NCT00965081|616603686|FG000|Overall Study|Switched to Rescue Arm|5|||
170616355|NCT00965081|616603687|FG001|Overall Study|Switched to Rescue Arm|12|||
170616356|NCT00714415|616603690|FG000|Overall Study|Lack of Efficacy|1|||
170616357|NCT00714415|616603691|FG001|Overall Study|Lack of Efficacy|0|||
170616358|NCT00714415|616603690|FG000|Overall Study|Death|1|||
170661875|NCT03633617|616776067|FG003|Part C (& Follow-up)|Adverse Event|0|||
170616359|NCT00714415|616603691|FG001|Overall Study|Death|0|||
170616360|NCT00740584|616603694|FG000|Overall Study|Withdrawal by Subject|1|||
170616361|NCT01818596|616603701|FG000|Overall Study|Enrolled but Not Treated|4|||
170616362|NCT01818596|616603702|FG001|Overall Study|Enrolled but Not Treated|0|||
170616363|NCT01818596|616603701|FG000|Overall Study|Adverse Event|7|||
170616364|NCT01818596|616603702|FG001|Overall Study|Adverse Event|0|||
170616365|NCT01818596|616603701|FG000|Overall Study|Death|3|||
170616366|NCT01818596|616603702|FG001|Overall Study|Death|0|||
170616367|NCT01818596|616603701|FG000|Overall Study|Investigator's Discretion|4|||
170616368|NCT01818596|616603702|FG001|Overall Study|Investigator's Discretion|0|||
170616369|NCT01818596|616603701|FG000|Overall Study|Protocol Violation|1|||
170616370|NCT01818596|616603702|FG001|Overall Study|Protocol Violation|0|||
170616371|NCT01818596|616603701|FG000|Overall Study|Withdrew Consent|5|||
170817564|NCT00561678|617339781|FG000|Overall Study|anesthesia provider refusal|1|||
170817565|NCT00561678|617339782|FG001|Overall Study|anesthesia provider refusal|0|||
170817566|NCT01103141|617339785|FG000|Overall Study|Death|0|||
170817567|NCT01103141|617339786|FG001|Overall Study|Death|1|||
170817568|NCT01103141|617339785|FG000|Overall Study|Lost to Follow-up|2|||
170817569|NCT01103141|617339786|FG001|Overall Study|Lost to Follow-up|1|||
170817570|NCT05072795|617339787|FG000|Overall Study|Lost to Follow-up|5|||
170817571|NCT00901459|617339788|FG000|Overall Study|Withdrawal by Subject|6|||
170817572|NCT02062827|617339793|FG000|Overall Study|Death|1|||
170616372|NCT01818596|616603702|FG001|Overall Study|Withdrew Consent|0|||
170616373|NCT01818596|616603701|FG000|Overall Study|Lost to Follow-up|7|||
170616374|NCT01818596|616603702|FG001|Overall Study|Lost to Follow-up|0|||
170616375|NCT02073682|616603705|FG000|Overall Study|Low Creatinine Clearance|1|||
170616376|NCT02073682|616603706|FG001|Overall Study|Low Creatinine Clearance|2|||
170616377|NCT02073682|616603705|FG000|Overall Study|Death|86|||
170616378|NCT02073682|616603706|FG001|Overall Study|Death|100|||
170616379|NCT02073682|616603705|FG000|Overall Study|Cancer Cured|10|||
170616380|NCT02073682|616603706|FG001|Overall Study|Cancer Cured|15|||
170616381|NCT02073682|616603705|FG000|Overall Study|ID: Patient Noncompliance|1|||
170616382|NCT02073682|616603706|FG001|Overall Study|ID: Patient Noncompliance|2|||
170616383|NCT02073682|616603705|FG000|Overall Study|ID: Palliative Treatment Only|10|||
170616384|NCT02073682|616603706|FG001|Overall Study|ID: Palliative Treatment Only|7|||
170616385|NCT02073682|616603705|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
170616386|NCT02073682|616603706|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
170616387|NCT02073682|616603705|FG000|Overall Study|Platelet Count <50,000/mL|1|||
170616388|NCT02073682|616603706|FG001|Overall Study|Platelet Count <50,000/mL|2|||
170616389|NCT02073682|616603705|FG000|Overall Study|Surgery/Medical Procedure|3|||
170616390|NCT02073682|616603706|FG001|Overall Study|Surgery/Medical Procedure|1|||
170616391|NCT02073682|616603705|FG000|Overall Study|Withdrawal by Subject|6|||
170616392|NCT02073682|616603706|FG001|Overall Study|Withdrawal by Subject|8|||
170616393|NCT02073682|616603705|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
170616394|NCT02073682|616603706|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
170616395|NCT02073682|616603705|FG000|Overall Study|Cancer Progression|53|||
170616396|NCT02073682|616603706|FG001|Overall Study|Cancer Progression|33|||
170616397|NCT02073682|616603705|FG000|Overall Study|Protocol Violation|1|||
170616398|NCT02073682|616603706|FG001|Overall Study|Protocol Violation|0|||
170616399|NCT02073682|616603705|FG000|Overall Study|Adverse Event|79|||
170616400|NCT02073682|616603706|FG001|Overall Study|Adverse Event|62|||
170616401|NCT02073682|616603705|FG000|Overall Study|No reason provided|11|||
170616402|NCT02073682|616603706|FG001|Overall Study|No reason provided|9|||
170616403|NCT02073682|616603705|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
170616404|NCT02073682|616603706|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
170616405|NCT02073682|616603705|FG000|Overall Study|Lost to Follow-up|1|||
170616406|NCT02073682|616603706|FG001|Overall Study|Lost to Follow-up|1|||
170616407|NCT02073682|616603705|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
170616408|NCT02073682|616603706|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
170616409|NCT01176058|616603707|FG000|Overall Study|Adverse Event|1|||
170616410|NCT01176058|616603708|FG001|Overall Study|Adverse Event|0|||
170616411|NCT01176058|616603707|FG000|Overall Study|Insufficient clinical response|2|||
170616412|NCT01176058|616603708|FG001|Overall Study|Insufficient clinical response|2|||
170616413|NCT01176058|616603707|FG000|Overall Study|Insufficient mycological response|0|||
170616414|NCT01176058|616603708|FG001|Overall Study|Insufficient mycological response|1|||
170616415|NCT01176058|616603707|FG000|Overall Study|Withdrawal by Subject|1|||
170616416|NCT01176058|616603708|FG001|Overall Study|Withdrawal by Subject|0|||
170616417|NCT00256724|616603711|FG000|Overall Study|Physician Decision|2|||
170616418|NCT00256724|616603712|FG001|Overall Study|Physician Decision|5|||
170616419|NCT00256724|616603711|FG000|Overall Study|Protocol Violation|3|||
170616420|NCT00256724|616603712|FG001|Overall Study|Protocol Violation|3|||
170616421|NCT05963022|616603716|FG000|Overall Study|Adverse Event|0|||
170616422|NCT05963022|616603717|FG001|Overall Study|Adverse Event|1|||
170616423|NCT05963022|616603718|FG002|Overall Study|Adverse Event|1|||
170616424|NCT05963022|616603719|FG003|Overall Study|Adverse Event|0|||
170616425|NCT05963022|616603716|FG000|Overall Study|Protocol Violation|0|||
170817573|NCT02062827|617339794|FG001|Overall Study|Death|0|||
170817574|NCT02062827|617339795|FG002|Overall Study|Death|0|||
170817575|NCT02062827|617339796|FG003|Overall Study|Death|0|||
170817576|NCT02062827|617339797|FG004|Overall Study|Death|0|||
170616426|NCT05963022|616603717|FG001|Overall Study|Protocol Violation|3|||
170616427|NCT05963022|616603718|FG002|Overall Study|Protocol Violation|0|||
170616428|NCT05963022|616603719|FG003|Overall Study|Protocol Violation|0|||
170616429|NCT05963022|616603716|FG000|Overall Study|Pregnancy|0|||
170616430|NCT05963022|616603717|FG001|Overall Study|Pregnancy|1|||
170616431|NCT05963022|616603718|FG002|Overall Study|Pregnancy|1|||
170616432|NCT05963022|616603719|FG003|Overall Study|Pregnancy|1|||
170616433|NCT05963022|616603716|FG000|Overall Study|Withdrawal by Subject|0|||
170616434|NCT05963022|616603717|FG001|Overall Study|Withdrawal by Subject|0|||
170616435|NCT05963022|616603718|FG002|Overall Study|Withdrawal by Subject|2|||
170817577|NCT02062827|617339798|FG005|Overall Study|Death|0|||
170661876|NCT03633617|616776068|FG004|Part C (& Follow-up)|Adverse Event|0|||
170661877|NCT03633617|616776069|FG005|Part C (& Follow-up)|Adverse Event|1|||
170661878|NCT03633617|616776070|FG006|Part C (& Follow-up)|Adverse Event|0|||
170661879|NCT03633617|616776071|FG007|Part C (& Follow-up)|Adverse Event|1|||
170661880|NCT03633617|616776072|FG008|Part C (& Follow-up)|Adverse Event|0|||
170661881|NCT03633617|616776073|FG009|Part C (& Follow-up)|Adverse Event|0|||
170661882|NCT03633617|616776074|FG010|Part C (& Follow-up)|Adverse Event|0|||
170661883|NCT03633617|616776064|FG000|Part C (& Follow-up)|Pregnancy|0|||
170661884|NCT03633617|616776065|FG001|Part C (& Follow-up)|Pregnancy|0|||
170661885|NCT03633617|616776066|FG002|Part C (& Follow-up)|Pregnancy|0|||
170661886|NCT03633617|616776067|FG003|Part C (& Follow-up)|Pregnancy|0|||
170661887|NCT03633617|616776068|FG004|Part C (& Follow-up)|Pregnancy|0|||
170661888|NCT03633617|616776069|FG005|Part C (& Follow-up)|Pregnancy|0|||
170661889|NCT03633617|616776070|FG006|Part C (& Follow-up)|Pregnancy|0|||
170661890|NCT03633617|616776071|FG007|Part C (& Follow-up)|Pregnancy|0|||
170661891|NCT03633617|616776072|FG008|Part C (& Follow-up)|Pregnancy|0|||
170661892|NCT03633617|616776073|FG009|Part C (& Follow-up)|Pregnancy|1|||
170661893|NCT03633617|616776074|FG010|Part C (& Follow-up)|Pregnancy|0|||
170661894|NCT03633617|616776064|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
170661895|NCT03633617|616776065|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
170661896|NCT03633617|616776066|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
170661897|NCT03633617|616776067|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
170661898|NCT03633617|616776068|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
170661899|NCT03633617|616776069|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
170661900|NCT03633617|616776070|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
170661901|NCT03633617|616776071|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
170661902|NCT03633617|616776072|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
170661903|NCT03633617|616776073|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
170661904|NCT03633617|616776074|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
170661905|NCT03633617|616776064|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
170661906|NCT03633617|616776065|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
170661907|NCT03633617|616776066|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
170661908|NCT03633617|616776067|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
170661909|NCT03633617|616776068|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
170661910|NCT03633617|616776069|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
170661911|NCT03633617|616776070|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
170661912|NCT03633617|616776071|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
170661913|NCT03633617|616776072|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
170661914|NCT03633617|616776073|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
170661915|NCT03633617|616776074|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
170661916|NCT03633617|616776064|FG000|Part C (& Follow-up)|Physician Decision|0|||
170661917|NCT03633617|616776065|FG001|Part C (& Follow-up)|Physician Decision|0|||
170661918|NCT03633617|616776066|FG002|Part C (& Follow-up)|Physician Decision|0|||
170661919|NCT03633617|616776067|FG003|Part C (& Follow-up)|Physician Decision|0|||
170661920|NCT03633617|616776068|FG004|Part C (& Follow-up)|Physician Decision|0|||
170661921|NCT03633617|616776069|FG005|Part C (& Follow-up)|Physician Decision|0|||
170661922|NCT03633617|616776070|FG006|Part C (& Follow-up)|Physician Decision|0|||
170661923|NCT03633617|616776071|FG007|Part C (& Follow-up)|Physician Decision|1|||
170661924|NCT03633617|616776072|FG008|Part C (& Follow-up)|Physician Decision|0|||
170661925|NCT03633617|616776073|FG009|Part C (& Follow-up)|Physician Decision|0|||
170661926|NCT03633617|616776074|FG010|Part C (& Follow-up)|Physician Decision|1|||
170661927|NCT03633617|616776064|FG000|Part C (& Follow-up)|COVID-19 related|0|||
170616436|NCT05963022|616603719|FG003|Overall Study|Withdrawal by Subject|1|||
170616437|NCT05963022|616603716|FG000|Overall Study|Lost to Follow-up|0|||
170616438|NCT05963022|616603717|FG001|Overall Study|Lost to Follow-up|0|||
170616439|NCT05963022|616603718|FG002|Overall Study|Lost to Follow-up|0|||
170616440|NCT05963022|616603719|FG003|Overall Study|Lost to Follow-up|1|||
170616441|NCT05963022|616603716|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
170616442|NCT05963022|616603717|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
170616443|NCT05963022|616603718|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
170616444|NCT05963022|616603719|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
170616445|NCT02478463|616603724|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
170616446|NCT02478463|616603724|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
170616447|NCT02478463|616603724|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
170616448|NCT01358825|616603725|FG000|Overall Study|Blood sample not drawn|0|||
170616449|NCT01358825|616603726|FG001|Overall Study|Blood sample not drawn|1|||
170661928|NCT03633617|616776065|FG001|Part C (& Follow-up)|COVID-19 related|0|||
170661929|NCT03633617|616776066|FG002|Part C (& Follow-up)|COVID-19 related|0|||
170661930|NCT03633617|616776067|FG003|Part C (& Follow-up)|COVID-19 related|0|||
170661931|NCT03633617|616776068|FG004|Part C (& Follow-up)|COVID-19 related|0|||
170661932|NCT03633617|616776069|FG005|Part C (& Follow-up)|COVID-19 related|1|||
170661933|NCT03633617|616776070|FG006|Part C (& Follow-up)|COVID-19 related|0|||
170661934|NCT03633617|616776071|FG007|Part C (& Follow-up)|COVID-19 related|0|||
170661935|NCT03633617|616776072|FG008|Part C (& Follow-up)|COVID-19 related|0|||
170661936|NCT03633617|616776073|FG009|Part C (& Follow-up)|COVID-19 related|0|||
170661937|NCT03633617|616776074|FG010|Part C (& Follow-up)|COVID-19 related|0|||
170661938|NCT03633617|616776064|FG000|Part C (& Follow-up)|Protocol Violation|0|||
170661939|NCT03633617|616776065|FG001|Part C (& Follow-up)|Protocol Violation|0|||
170661940|NCT03633617|616776066|FG002|Part C (& Follow-up)|Protocol Violation|0|||
170661941|NCT03633617|616776067|FG003|Part C (& Follow-up)|Protocol Violation|0|||
170661942|NCT03633617|616776068|FG004|Part C (& Follow-up)|Protocol Violation|0|||
170661943|NCT03633617|616776069|FG005|Part C (& Follow-up)|Protocol Violation|0|||
170661944|NCT03633617|616776070|FG006|Part C (& Follow-up)|Protocol Violation|0|||
170661945|NCT03633617|616776071|FG007|Part C (& Follow-up)|Protocol Violation|0|||
170661946|NCT03633617|616776072|FG008|Part C (& Follow-up)|Protocol Violation|0|||
170661947|NCT03633617|616776073|FG009|Part C (& Follow-up)|Protocol Violation|3|||
170661948|NCT03633617|616776074|FG010|Part C (& Follow-up)|Protocol Violation|1|||
170661949|NCT03633617|616776064|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
170661950|NCT03633617|616776065|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
170661951|NCT03633617|616776066|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
170661952|NCT03633617|616776067|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
170661953|NCT03633617|616776068|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
170661954|NCT03633617|616776069|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
170661955|NCT03633617|616776070|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
170661956|NCT03633617|616776071|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
170661957|NCT03633617|616776072|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
170661958|NCT03633617|616776073|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
170661959|NCT03633617|616776074|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
170661960|NCT03059446|616776097|FG000|Overall Study|Adverse Event|11|||
170661961|NCT03059446|616776097|FG000|Overall Study|Withdrawal of Consent|16|||
170661962|NCT03059446|616776097|FG000|Overall Study|Lost to Follow-up|3|||
170661963|NCT03059446|616776097|FG000|Overall Study|Protocol Violation|1|||
170661964|NCT03059446|616776097|FG000|Overall Study|Study Terminated by Sponsor|131|||
170661965|NCT03059446|616776097|FG000|Overall Study|Reason not Specified|5|||
170661966|NCT02992132|616776098|FG000|Overall Study|Adverse Event|4|||
170661967|NCT02992132|616776099|FG001|Overall Study|Adverse Event|1|||
170661968|NCT02992132|616776100|FG002|Overall Study|Adverse Event|3|||
170661969|NCT02992132|616776098|FG000|Overall Study|Lack of Efficacy|2|||
170661970|NCT02992132|616776099|FG001|Overall Study|Lack of Efficacy|0|||
170661971|NCT02992132|616776100|FG002|Overall Study|Lack of Efficacy|0|||
170661972|NCT02992132|616776098|FG000|Overall Study|Non-compliance with study drug|2|||
170661973|NCT02992132|616776099|FG001|Overall Study|Non-compliance with study drug|0|||
170661974|NCT02992132|616776100|FG002|Overall Study|Non-compliance with study drug|0|||
170661975|NCT02992132|616776098|FG000|Overall Study|Progressive disease|1|||
170661976|NCT02992132|616776099|FG001|Overall Study|Progressive disease|0|||
170661977|NCT02992132|616776100|FG002|Overall Study|Progressive disease|0|||
170661978|NCT02992132|616776098|FG000|Overall Study|Protocol Violation|2|||
170661979|NCT02992132|616776099|FG001|Overall Study|Protocol Violation|2|||
170661980|NCT02992132|616776100|FG002|Overall Study|Protocol Violation|0|||
170661981|NCT02992132|616776098|FG000|Overall Study|Caregiver withdrew consent|2|||
170661982|NCT02992132|616776099|FG001|Overall Study|Caregiver withdrew consent|3|||
170661983|NCT02992132|616776100|FG002|Overall Study|Caregiver withdrew consent|2|||
170661984|NCT02992132|616776098|FG000|Overall Study|Withdrawal by Subject|0|||
170661985|NCT02992132|616776099|FG001|Overall Study|Withdrawal by Subject|2|||
170661986|NCT02992132|616776100|FG002|Overall Study|Withdrawal by Subject|1|||
170661987|NCT02992132|616776098|FG000|Overall Study|Physician Decision|0|||
170661988|NCT02992132|616776099|FG001|Overall Study|Physician Decision|0|||
170661989|NCT02992132|616776100|FG002|Overall Study|Physician Decision|1|||
170661990|NCT02028871|616776101|FG000|Overall Study|Positive urine drug screen|1|||
170817578|NCT02062827|617339799|FG006|Overall Study|Death|0|||
170817579|NCT02062827|617339800|FG007|Overall Study|Death|0|||
170817580|NCT02062827|617339793|FG000|Overall Study|Withdrawal by Subject|3|||
170817581|NCT02062827|617339794|FG001|Overall Study|Withdrawal by Subject|1|||
170817582|NCT02062827|617339795|FG002|Overall Study|Withdrawal by Subject|1|||
170817583|NCT02062827|617339796|FG003|Overall Study|Withdrawal by Subject|2|||
170817584|NCT02062827|617339797|FG004|Overall Study|Withdrawal by Subject|6|||
170817585|NCT02062827|617339798|FG005|Overall Study|Withdrawal by Subject|0|||
170817586|NCT02062827|617339799|FG006|Overall Study|Withdrawal by Subject|5|||
170817587|NCT02062827|617339800|FG007|Overall Study|Withdrawal by Subject|0|||
170661991|NCT02028871|616776102|FG001|Overall Study|Positive urine drug screen|1|||
170661992|NCT02028871|616776101|FG000|Overall Study|Withdrawal by Subject|1|||
170661993|NCT02028871|616776102|FG001|Overall Study|Withdrawal by Subject|2|||
170661994|NCT02028871|616776101|FG000|Overall Study|IV placement difficulty|1|||
170661995|NCT02028871|616776102|FG001|Overall Study|IV placement difficulty|0|||
170661996|NCT02028871|616776101|FG000|Overall Study|Current Illness|1|||
170661997|NCT02028871|616776102|FG001|Overall Study|Current Illness|0|||
170661998|NCT00568685|616776103|FG000|Overall Study|Adverse Event|2|||
170661999|NCT00568685|616776104|FG001|Overall Study|Adverse Event|3|||
170817588|NCT02062827|617339793|FG000|Overall Study|Screen Fail|0|||
170817589|NCT02062827|617339794|FG001|Overall Study|Screen Fail|0|||
170817590|NCT02062827|617339795|FG002|Overall Study|Screen Fail|0|||
170817591|NCT02062827|617339796|FG003|Overall Study|Screen Fail|0|||
170817592|NCT02062827|617339797|FG004|Overall Study|Screen Fail|0|||
170817593|NCT02062827|617339798|FG005|Overall Study|Screen Fail|0|||
170817594|NCT02062827|617339799|FG006|Overall Study|Screen Fail|0|||
170817595|NCT02062827|617339800|FG007|Overall Study|Screen Fail|8|||
170817596|NCT04930263|617339801|FG000|Overall Study|Withdrawal by Subject|3|||
170817597|NCT04930263|617339802|FG001|Overall Study|Withdrawal by Subject|5|||
170817598|NCT04043806|617339803|FG000|Overall Study|Commercial drug is available for participants|13|||
170662000|NCT00568685|616776105|FG002|Overall Study|Adverse Event|3|||
170662001|NCT00568685|616776103|FG000|Overall Study|Withdrawal by Subject|7|||
170662002|NCT00568685|616776104|FG001|Overall Study|Withdrawal by Subject|2|||
170662003|NCT00568685|616776105|FG002|Overall Study|Withdrawal by Subject|2|||
170662004|NCT00568685|616776103|FG000|Overall Study|Protocol Violation|1|||
170662005|NCT00568685|616776104|FG001|Overall Study|Protocol Violation|0|||
170662006|NCT00568685|616776105|FG002|Overall Study|Protocol Violation|0|||
170662007|NCT02038452|616776107|FG000|Overall Study|Withdrawal by Subject|7|||
170662008|NCT02038452|616776108|FG001|Overall Study|Withdrawal by Subject|9|||
170662009|NCT02038452|616776107|FG000|Overall Study|Lost to Follow-up|31|||
170662010|NCT02038452|616776108|FG001|Overall Study|Lost to Follow-up|28|||
170662011|NCT01336569|616776111|FG000|Overall Study|Lost to Follow-up|4|||
170662012|NCT00467610|616776112|FG000|Overall Study|Withdrawal by Subject|1|||
170662013|NCT01369615|616776113|FG000|Overall Study|Withdrawal by Subject|0|||
170662014|NCT01369615|616776114|FG001|Overall Study|Withdrawal by Subject|1|||
170662015|NCT01369615|616776113|FG000|Overall Study|Lost to Follow-up|0|||
170662016|NCT01369615|616776114|FG001|Overall Study|Lost to Follow-up|1|||
170662017|NCT04263454|616776115|FG000|Overall Study|Adverse Event|0|||
170662018|NCT04263454|616776116|FG001|Overall Study|Adverse Event|2|||
170662019|NCT04263454|616776115|FG000|Overall Study|Physician Decision|3|||
170662020|NCT04263454|616776116|FG001|Overall Study|Physician Decision|5|||
170662021|NCT04263454|616776115|FG000|Overall Study|Poor Data Quality|0|||
170662022|NCT04263454|616776116|FG001|Overall Study|Poor Data Quality|1|||
170662023|NCT02337738|616776117|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
170662024|NCT02337738|616776118|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
170662025|NCT02337738|616776119|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
170662026|NCT02337738|616776117|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
170662027|NCT02337738|616776118|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
170662028|NCT02337738|616776119|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
170662029|NCT02337738|616776117|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
170662030|NCT02337738|616776118|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
170662031|NCT02337738|616776119|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
170662032|NCT02337738|616776117|FG000|Overall Study|Voluntary Withdrawal|10|||
170662033|NCT02337738|616776118|FG001|Overall Study|Voluntary Withdrawal|5|||
170662034|NCT02337738|616776119|FG002|Overall Study|Voluntary Withdrawal|2|||
170662035|NCT02337738|616776117|FG000|Overall Study|Lack of Efficacy|2|||
170662036|NCT02337738|616776118|FG001|Overall Study|Lack of Efficacy|4|||
170662037|NCT02337738|616776119|FG002|Overall Study|Lack of Efficacy|0|||
170662038|NCT02337738|616776117|FG000|Overall Study|Investigator's Judgment|1|||
170662039|NCT02337738|616776118|FG001|Overall Study|Investigator's Judgment|1|||
170817599|NCT04043806|617339803|FG000|Overall Study|Physician Decision|2|||
170817600|NCT04043806|617339803|FG000|Overall Study|Other|12|||
170817601|NCT04043806|617339803|FG000|Overall Study|Adverse Event|2|||
170817602|NCT04043806|617339803|FG000|Overall Study|Lost to Follow-up|6|||
170817603|NCT04043806|617339803|FG000|Overall Study|Other non-compliance|2|||
170817604|NCT04043806|617339803|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
170817605|NCT04043806|617339803|FG000|Overall Study|Never Dosed|1|||
170817606|NCT04362176|617339806|FG000|Overall Study|Lost to Follow-up|5|||
170817607|NCT04362176|617339807|FG001|Overall Study|Lost to Follow-up|8|||
170817608|NCT04362176|617339806|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
170817609|NCT04362176|617339807|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
170817610|NCT04985604|617339808|FG000|Overall Study|Death|4|||
170662040|NCT02337738|616776119|FG002|Overall Study|Investigator's Judgment|3|||
170662041|NCT00986479|616776120|FG000|Period 1|Improved mood|1|||
170662042|NCT00986479|616776121|FG001|Period 1|Improved mood|0|||
170662043|NCT00986479|616776120|FG000|Period 1|Administrative reasons|1|||
170662044|NCT00986479|616776121|FG001|Period 1|Administrative reasons|0|||
170662045|NCT01721070|616776122|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
170662046|NCT02035475|616776123|FG000|Overall Study|Withdrawal by Subject|4|||
170662047|NCT02035475|616776123|FG000|Overall Study|Physician Decision|1|||
170662048|NCT02035475|616776123|FG000|Overall Study|Equipment Error|1|||
170817611|NCT04985604|617339809|FG001|Overall Study|Death|6|||
170817612|NCT04985604|617339808|FG000|Overall Study|Withdrawal by Subject|0|||
170817613|NCT04985604|617339809|FG001|Overall Study|Withdrawal by Subject|1|||
170817614|NCT04598776|617339810|FG000|Overall Study|Protocol Violation|5|||
170817615|NCT04598776|617339810|FG000|Overall Study|Physician Decision|4|||
170616450|NCT01479868|616603727|FG000|Overall Study|Adverse Event|1|||
170616451|NCT01479868|616603727|FG000|Overall Study|Lost to Follow-up|4|||
170616452|NCT01479868|616603727|FG000|Overall Study|Protocol Violation|1|||
170616453|NCT01479868|616603727|FG000|Overall Study|Withdrawal by Subject|1|||
170616454|NCT01479868|616603727|FG000|Overall Study|Sponsor's Decision|1|||
170616455|NCT01479868|616603727|FG000|Overall Study|Initiation of new HCV Therapy|1|||
170616456|NCT01177007|616603733|FG000|Overall Study|Lost to Follow-up|2|||
170616457|NCT01177007|616603733|FG000|Overall Study|Death|4|||
170616458|NCT01177007|616603733|FG000|Overall Study|Entered hospice care|5|||
170616459|NCT01177007|616603733|FG000|Overall Study|Required additional Y90 treatment|6|||
170616460|NCT01177007|616603733|FG000|Overall Study|Change in treatment modality|21|||
170616461|NCT01702558|616603734|FG000|Overall Study|Withdrawal by Subject|0|||
170616462|NCT01702558|616603735|FG001|Overall Study|Withdrawal by Subject|0|||
170616463|NCT01702558|616603736|FG002|Overall Study|Withdrawal by Subject|0|||
170616464|NCT01702558|616603737|FG003|Overall Study|Withdrawal by Subject|12|||
170616465|NCT01702558|616603738|FG004|Overall Study|Withdrawal by Subject|4|||
170616466|NCT01702558|616603734|FG000|Overall Study|Lost to Follow-up|0|||
170616467|NCT01702558|616603735|FG001|Overall Study|Lost to Follow-up|0|||
170616468|NCT01702558|616603736|FG002|Overall Study|Lost to Follow-up|0|||
170616469|NCT01702558|616603737|FG003|Overall Study|Lost to Follow-up|3|||
170616470|NCT01702558|616603738|FG004|Overall Study|Lost to Follow-up|0|||
170616471|NCT01702558|616603734|FG000|Overall Study|Death|4|||
170616472|NCT01702558|616603735|FG001|Overall Study|Death|3|||
170616473|NCT01702558|616603736|FG002|Overall Study|Death|3|||
170616474|NCT01702558|616603737|FG003|Overall Study|Death|16|||
170616475|NCT01702558|616603738|FG004|Overall Study|Death|20|||
170616476|NCT01702558|616603734|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
170616477|NCT01702558|616603735|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
170616478|NCT01702558|616603736|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
170616479|NCT01702558|616603737|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
170616480|NCT01702558|616603738|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
170616481|NCT01702558|616603734|FG000|Overall Study|Study Terminated by Sponsor|0|||
170616482|NCT01702558|616603735|FG001|Overall Study|Study Terminated by Sponsor|1|||
170616483|NCT01702558|616603736|FG002|Overall Study|Study Terminated by Sponsor|0|||
170616484|NCT01702558|616603737|FG003|Overall Study|Study Terminated by Sponsor|0|||
170616485|NCT01702558|616603738|FG004|Overall Study|Study Terminated by Sponsor|1|||
170616486|NCT01702558|616603734|FG000|Overall Study|Other|0|||
170616487|NCT01702558|616603735|FG001|Overall Study|Other|0|||
170616488|NCT01702558|616603736|FG002|Overall Study|Other|0|||
170616489|NCT01702558|616603737|FG003|Overall Study|Other|16|||
170616490|NCT01702558|616603738|FG004|Overall Study|Other|17|||
170616491|NCT04524858|616603741|FG000|Overall Study|Adverse Event|1|||
170616492|NCT04950465|616603742|FG000|Overall Study|Lost to Follow-up|1|||
170616493|NCT04950465|616603743|FG001|Overall Study|Lost to Follow-up|0|||
170616494|NCT04950465|616603744|FG002|Overall Study|Lost to Follow-up|0|||
170616495|NCT01078441|616603745|FG000|Overall Study|Withdrawal by Subject|1|||
170616496|NCT01425801|616603746|FG000|Period 1|Withdrawal by Subject|0|||
170616497|NCT01425801|616603747|FG001|Period 1|Withdrawal by Subject|0|||
170616498|NCT01425801|616603748|FG002|Period 1|Withdrawal by Subject|0|||
170616499|NCT01425801|616603749|FG003|Period 1|Withdrawal by Subject|0|||
170616500|NCT01425801|616603750|FG004|Period 1|Withdrawal by Subject|1|||
170616501|NCT01425801|616603751|FG005|Period 1|Withdrawal by Subject|0|||
170616502|NCT01425801|616603746|FG000|Period 2|Withdrawal by Subject|0|||
170616503|NCT01425801|616603747|FG001|Period 2|Withdrawal by Subject|0|||
170616504|NCT01425801|616603748|FG002|Period 2|Withdrawal by Subject|0|||
170616505|NCT01425801|616603749|FG003|Period 2|Withdrawal by Subject|0|||
170616506|NCT01425801|616603750|FG004|Period 2|Withdrawal by Subject|1|||
170616507|NCT01425801|616603751|FG005|Period 2|Withdrawal by Subject|0|||
170616508|NCT01425801|616603746|FG000|Period 3|Stability criteria not fullfilled|0|||
170616509|NCT01425801|616603747|FG001|Period 3|Stability criteria not fullfilled|0|||
170616510|NCT01425801|616603748|FG002|Period 3|Stability criteria not fullfilled|1|||
170616511|NCT01425801|616603749|FG003|Period 3|Stability criteria not fullfilled|0|||
170616512|NCT01425801|616603750|FG004|Period 3|Stability criteria not fullfilled|0|||
170616513|NCT01425801|616603751|FG005|Period 3|Stability criteria not fullfilled|0|||
170616514|NCT01425801|616603746|FG000|Period 4|Not able to maintain visit schedule|0|||
170616515|NCT01425801|616603747|FG001|Period 4|Not able to maintain visit schedule|0|||
170616516|NCT01425801|616603748|FG002|Period 4|Not able to maintain visit schedule|1|||
170616517|NCT01425801|616603749|FG003|Period 4|Not able to maintain visit schedule|0|||
170616518|NCT01425801|616603750|FG004|Period 4|Not able to maintain visit schedule|0|||
170616519|NCT01425801|616603751|FG005|Period 4|Not able to maintain visit schedule|0|||
170616520|NCT00216671|616603752|FG000|Overall Study|Adverse Event|4|||
170616521|NCT00216671|616603753|FG001|Overall Study|Adverse Event|9|||
170616522|NCT00216671|616603752|FG000|Overall Study|Pregnancy|0|||
170616523|NCT00216671|616603753|FG001|Overall Study|Pregnancy|1|||
170616524|NCT00216671|616603752|FG000|Overall Study|Withdrawal by Subject|4|||
170662049|NCT00445978|616776130|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
170662050|NCT00445978|616776130|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
170662051|NCT00445978|616776130|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
170662052|NCT00445978|616776130|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
170662053|NCT00445978|616776130|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
170662054|NCT00445978|616776130|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
170662055|NCT00445978|616776130|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
170662056|NCT00445978|616776130|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
170662057|NCT00445978|616776130|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
170662058|NCT02436681|616776131|FG000|Overall Study|Lost to Follow-up|10|||
170662059|NCT02436681|616776131|FG000|Overall Study|Withdrawal by Subject|2|||
170662060|NCT02436681|616776131|FG000|Overall Study|Death|2|||
170662061|NCT01574079|616776132|FG000|Overall Study|Physician Decision|0|||
170662062|NCT01574079|616776133|FG001|Overall Study|Physician Decision|2|||
170662063|NCT01574079|616776132|FG000|Overall Study|Lost to Follow-up|1|||
170662064|NCT01574079|616776133|FG001|Overall Study|Lost to Follow-up|0|||
170662065|NCT00667602|616776138|FG000|Overall Study|Withdrawal by Subject|4|||
170662066|NCT00667602|616776139|FG001|Overall Study|Withdrawal by Subject|9|||
170662067|NCT00667602|616776140|FG002|Overall Study|Withdrawal by Subject|10|||
170662068|NCT00667602|616776138|FG000|Overall Study|Lost to Follow-up|4|||
170662069|NCT00667602|616776139|FG001|Overall Study|Lost to Follow-up|5|||
170662070|NCT00667602|616776140|FG002|Overall Study|Lost to Follow-up|6|||
170662071|NCT00667602|616776138|FG000|Overall Study|Administrative reason|0|||
170662072|NCT00667602|616776139|FG001|Overall Study|Administrative reason|0|||
170662073|NCT00667602|616776140|FG002|Overall Study|Administrative reason|2|||
170662074|NCT00667602|616776138|FG000|Overall Study|Protocol Violation|0|||
170662075|NCT00667602|616776139|FG001|Overall Study|Protocol Violation|1|||
170662076|NCT00667602|616776140|FG002|Overall Study|Protocol Violation|0|||
170662077|NCT01436162|616776146|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
170662078|NCT01436162|616776147|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
170662079|NCT01436162|616776148|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
170662080|NCT01436162|616776146|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
170662081|NCT01436162|616776147|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
170662082|NCT01436162|616776148|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
170662083|NCT01436162|616776146|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
170662084|NCT01436162|616776147|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
170662085|NCT01436162|616776148|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
170662086|NCT01436162|616776146|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
170662087|NCT01436162|616776147|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
170662088|NCT01436162|616776148|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
170662089|NCT01436162|616776146|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
170662090|NCT01436162|616776147|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
170817616|NCT00348283|617339811|FG000|Induction|Adverse Event|0|||
170616525|NCT00216671|616603753|FG001|Overall Study|Withdrawal by Subject|2|||
170616526|NCT00216671|616603752|FG000|Overall Study|Refused Injections|3|||
170616527|NCT00216671|616603753|FG001|Overall Study|Refused Injections|13|||
170616528|NCT00216671|616603752|FG000|Overall Study|No Need to Continue Medication|1|||
170616529|NCT00216671|616603753|FG001|Overall Study|No Need to Continue Medication|1|||
170616530|NCT00216671|616603752|FG000|Overall Study|Insufficient Response|9|||
170616531|NCT00216671|616603753|FG001|Overall Study|Insufficient Response|4|||
170616532|NCT00216671|616603752|FG000|Overall Study|Lost to Follow-up|3|||
170616533|NCT00216671|616603753|FG001|Overall Study|Lost to Follow-up|5|||
170616534|NCT00216671|616603752|FG000|Overall Study|Non compliant|2|||
170616535|NCT00216671|616603753|FG001|Overall Study|Non compliant|2|||
170616536|NCT00216671|616603752|FG000|Overall Study|Ineligible|0|||
170616537|NCT00216671|616603753|FG001|Overall Study|Ineligible|2|||
170616538|NCT00216671|616603752|FG000|Overall Study|Physician Decision|1|||
170616539|NCT00216671|616603753|FG001|Overall Study|Physician Decision|1|||
170616540|NCT00216671|616603752|FG000|Overall Study|Protocol Violation|3|||
170616541|NCT00216671|616603753|FG001|Overall Study|Protocol Violation|5|||
170616542|NCT00216671|616603752|FG000|Overall Study|Relapse|1|||
170616543|NCT00216671|616603753|FG001|Overall Study|Relapse|0|||
170616544|NCT00216671|616603752|FG000|Overall Study|Investigator Illness|0|||
170616545|NCT00216671|616603753|FG001|Overall Study|Investigator Illness|1|||
170616546|NCT00216671|616603752|FG000|Overall Study|Patient Moved|0|||
170616547|NCT00216671|616603753|FG001|Overall Study|Patient Moved|1|||
170616548|NCT00216671|616603752|FG000|Overall Study|Ineligible, no efficacy data|2|||
170616549|NCT00216671|616603753|FG001|Overall Study|Ineligible, no efficacy data|2|||
170616550|NCT00216671|616603752|FG000|Overall Study|Insufficient Response Adverse Event|2|||
170616551|NCT00216671|616603753|FG001|Overall Study|Insufficient Response Adverse Event|1|||
170616552|NCT03066596|616603754|FG000|Overall Study|Withdrawal by Subject|4|||
170616553|NCT03066596|616603755|FG001|Overall Study|Withdrawal by Subject|2|||
170616554|NCT03066596|616603754|FG000|Overall Study|Lost to Follow-up|14|||
170616555|NCT03066596|616603755|FG001|Overall Study|Lost to Follow-up|10|||
170616556|NCT00773513|616603756|FG000|Overall Study|Renal Transplant|254|||
170817617|NCT00348283|617339812|FG001|Induction|Adverse Event|2|||
170662091|NCT01436162|616776148|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
170662092|NCT01436162|616776146|FG000|Single-blind Lead-in Phase|Other|107|||
170662093|NCT01436162|616776147|FG001|Single-blind Lead-in Phase|Other|0|||
170662094|NCT01436162|616776148|FG002|Single-blind Lead-in Phase|Other|0|||
170662095|NCT01436162|616776146|FG000|Randomized Phase|Adverse Event|1|||
170662096|NCT01436162|616776147|FG001|Randomized Phase|Adverse Event|5|||
170662097|NCT01436162|616776148|FG002|Randomized Phase|Adverse Event|6|||
170662098|NCT01436162|616776146|FG000|Randomized Phase|Protocol Violation|4|||
170662099|NCT01436162|616776147|FG001|Randomized Phase|Protocol Violation|4|||
170662100|NCT01436162|616776148|FG002|Randomized Phase|Protocol Violation|2|||
170662101|NCT01436162|616776146|FG000|Randomized Phase|Withdrawal by Subject|16|||
170662102|NCT01436162|616776147|FG001|Randomized Phase|Withdrawal by Subject|9|||
170662103|NCT01436162|616776148|FG002|Randomized Phase|Withdrawal by Subject|8|||
170662104|NCT01436162|616776146|FG000|Randomized Phase|Lost to Follow-up|17|||
170662105|NCT01436162|616776147|FG001|Randomized Phase|Lost to Follow-up|5|||
170662106|NCT01436162|616776148|FG002|Randomized Phase|Lost to Follow-up|4|||
170662107|NCT01436162|616776146|FG000|Randomized Phase|Lack of Efficacy|0|||
170662108|NCT01436162|616776147|FG001|Randomized Phase|Lack of Efficacy|1|||
170662109|NCT01436162|616776148|FG002|Randomized Phase|Lack of Efficacy|1|||
170662110|NCT01436162|616776146|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
170662111|NCT01436162|616776147|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
170662112|NCT01436162|616776148|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
170662113|NCT01436162|616776146|FG000|Randomized Phase|Other|2|||
170662114|NCT01436162|616776147|FG001|Randomized Phase|Other|5|||
170662115|NCT01436162|616776148|FG002|Randomized Phase|Other|4|||
170662116|NCT00760084|616776150|FG000|Overall Study|Physician Decision|5|||
170662117|NCT00760084|616776150|FG000|Overall Study|Withdrawal by Subject|2|||
170662118|NCT00760084|616776150|FG000|Overall Study|Progressive Disease|3|||
170662119|NCT02567552|616776151|FG000|Overall Study|Adverse Event|0|||
170662120|NCT02567552|616776152|FG001|Overall Study|Adverse Event|1|||
170662121|NCT02891161|616776163|FG000|Study Treatment|Disease Progression|2|||
170662122|NCT02891161|616776164|FG001|Study Treatment|Disease Progression|4|||
170662123|NCT02891161|616776163|FG000|Study Treatment|AE/Side Effects/Complications|1|||
170662124|NCT02891161|616776164|FG001|Study Treatment|AE/Side Effects/Complications|5|||
170662125|NCT02891161|616776163|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
170662126|NCT02891161|616776164|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
170662127|NCT02891161|616776163|FG000|Follow up|Death|4|||
170662128|NCT02891161|616776164|FG001|Follow up|Death|8|||
170662129|NCT02891161|616776163|FG000|Follow up|Refused to Follow up|0|||
170662130|NCT02891161|616776164|FG001|Follow up|Refused to Follow up|2|||
170662131|NCT02891161|616776163|FG000|Follow up|Symptomatic deterioration|0|||
170662132|NCT02891161|616776164|FG001|Follow up|Symptomatic deterioration|1|||
170662133|NCT02891161|616776163|FG000|Follow up|Study terminated|0|||
170662134|NCT02891161|616776164|FG001|Follow up|Study terminated|6|||
170662135|NCT03552965|616776169|FG000|Overall Study|Death|1|||
170662136|NCT03552965|616776170|FG001|Overall Study|Death|1|||
170662137|NCT03552965|616776169|FG000|Overall Study|Lost to Follow-up|1|||
170662138|NCT03552965|616776170|FG001|Overall Study|Lost to Follow-up|1|||
170662139|NCT03552965|616776169|FG000|Overall Study|Physician Decision|1|||
170662140|NCT03552965|616776170|FG001|Overall Study|Physician Decision|1|||
170662141|NCT03552965|616776169|FG000|Overall Study|Withdrawal by Subject|0|||
170662142|NCT03552965|616776170|FG001|Overall Study|Withdrawal by Subject|2|||
170662143|NCT03552965|616776169|FG000|Overall Study|Continuation not in patient best interest|1|||
170662144|NCT03552965|616776170|FG001|Overall Study|Continuation not in patient best interest|0|||
170662145|NCT03552965|616776169|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
170662146|NCT03552965|616776170|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
170662147|NCT04571515|616776174|FG000|Overall Study|Physician Decision|0|||
170662148|NCT04571515|616776175|FG001|Overall Study|Physician Decision|0|||
170662149|NCT04571515|616776176|FG002|Overall Study|Physician Decision|0|||
170662150|NCT04571515|616776177|FG003|Overall Study|Physician Decision|0|||
170662151|NCT04571515|616776178|FG004|Overall Study|Physician Decision|1|||
170662152|NCT04571515|616776174|FG000|Overall Study|Withdrawal by Subject|0|||
170662153|NCT04571515|616776175|FG001|Overall Study|Withdrawal by Subject|0|||
170662154|NCT04571515|616776176|FG002|Overall Study|Withdrawal by Subject|0|||
170662155|NCT04571515|616776177|FG003|Overall Study|Withdrawal by Subject|0|||
170817618|NCT00348283|617339811|FG000|Induction|Protocol Violation|0|||
170662156|NCT04571515|616776178|FG004|Overall Study|Withdrawal by Subject|1|||
170662157|NCT04571515|616776174|FG000|Overall Study|insufficient pain|1|||
170662158|NCT04571515|616776175|FG001|Overall Study|insufficient pain|0|||
170662159|NCT04571515|616776176|FG002|Overall Study|insufficient pain|0|||
170662160|NCT04571515|616776177|FG003|Overall Study|insufficient pain|0|||
170662161|NCT04571515|616776178|FG004|Overall Study|insufficient pain|1|||
170662162|NCT03148275|616776190|FG000|Overall Study|Death|6|||
170662163|NCT03148275|616776190|FG000|Overall Study|Adverse Event|3|||
170662164|NCT03148275|616776190|FG000|Overall Study|Liver transplant|2|||
170662165|NCT03148275|616776190|FG000|Overall Study|Patient decision|5|||
170662166|NCT03148275|616776190|FG000|Overall Study|transition to commercial drug|1|||
170817619|NCT00348283|617339812|FG001|Induction|Protocol Violation|4|||
170616557|NCT00773513|616603757|FG001|Overall Study|Renal Transplant|263|||
170616558|NCT00773513|616603756|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
170616559|NCT00773513|616603757|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
170616560|NCT00773513|616603756|FG000|Overall Study|Withdrew Consent|68|||
170616561|NCT00773513|616603757|FG001|Overall Study|Withdrew Consent|69|||
170616562|NCT00773513|616603756|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
170616563|NCT00773513|616603757|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
170616564|NCT00773513|616603756|FG000|Overall Study|Failure to Return|22|||
170616565|NCT00773513|616603757|FG001|Overall Study|Failure to Return|8|||
170616566|NCT00773513|616603756|FG000|Overall Study|Insufficient Therapeutic Response|1|||
170616567|NCT00773513|616603757|FG001|Overall Study|Insufficient Therapeutic Response|18|||
170616568|NCT00773513|616603756|FG000|Overall Study|Reason Not Specified|159|||
170616569|NCT00773513|616603757|FG001|Overall Study|Reason Not Specified|126|||
170616570|NCT00773513|616603756|FG000|Overall Study|Death|531|||
170616571|NCT00773513|616603757|FG001|Overall Study|Death|545|||
170616572|NCT00700713|616603758|FG000|Overall Study|Protocol Violation|1|||
170616573|NCT00700713|616603759|FG001|Overall Study|Protocol Violation|0|||
170616574|NCT00700713|616603760|FG002|Overall Study|Protocol Violation|1|||
170616575|NCT00700713|616603758|FG000|Overall Study|Withdrawal by Subject|0|||
170616576|NCT00700713|616603759|FG001|Overall Study|Withdrawal by Subject|0|||
170616577|NCT00700713|616603760|FG002|Overall Study|Withdrawal by Subject|1|||
170616578|NCT02959437|616603762|FG000|Overall Study|Death|33|||
170616579|NCT02959437|616603763|FG001|Overall Study|Death|3|||
170616580|NCT02959437|616603764|FG002|Overall Study|Death|0|||
170616581|NCT02959437|616603765|FG003|Overall Study|Death|0|||
170616582|NCT02959437|616603762|FG000|Overall Study|Lost to Follow-up|3|||
170616583|NCT02959437|616603763|FG001|Overall Study|Lost to Follow-up|1|||
170616584|NCT02959437|616603764|FG002|Overall Study|Lost to Follow-up|0|||
170616585|NCT02959437|616603765|FG003|Overall Study|Lost to Follow-up|0|||
170616586|NCT02959437|616603762|FG000|Overall Study|Withdrawal by Subject|11|||
170616587|NCT02959437|616603763|FG001|Overall Study|Withdrawal by Subject|3|||
170616588|NCT02959437|616603764|FG002|Overall Study|Withdrawal by Subject|0|||
170616589|NCT02959437|616603765|FG003|Overall Study|Withdrawal by Subject|0|||
170616590|NCT02959437|616603762|FG000|Overall Study|Progressive Disease|9|||
170616591|NCT02959437|616603763|FG001|Overall Study|Progressive Disease|1|||
170616592|NCT02959437|616603764|FG002|Overall Study|Progressive Disease|0|||
170616593|NCT02959437|616603765|FG003|Overall Study|Progressive Disease|0|||
170616594|NCT02959437|616603762|FG000|Overall Study|Study Terminated by Sponsor|4|||
170616595|NCT02959437|616603763|FG001|Overall Study|Study Terminated by Sponsor|0|||
170616596|NCT02959437|616603764|FG002|Overall Study|Study Terminated by Sponsor|0|||
170616597|NCT02959437|616603765|FG003|Overall Study|Study Terminated by Sponsor|0|||
170616598|NCT02959437|616603762|FG000|Overall Study|Other Unspecified|2|||
170616599|NCT02959437|616603763|FG001|Overall Study|Other Unspecified|0|||
170616600|NCT02959437|616603764|FG002|Overall Study|Other Unspecified|0|||
170616601|NCT02959437|616603765|FG003|Overall Study|Other Unspecified|0|||
170616602|NCT02728089|616603768|FG000|Overall Study|Physician Decision|2|||
170616603|NCT02728089|616603768|FG000|Overall Study|Withdrawal by Subject|1|||
170616604|NCT01369784|616603773|FG000|Overall Study|Protocol Violation|12|||
170616605|NCT03359174|616603774|FG000|Overall Study|Adverse Event|1|||
170616606|NCT02292719|616603775|FG000|Overall Study|Withdrawal by Subject|0|||
170616607|NCT02292719|616603776|FG001|Overall Study|Withdrawal by Subject|0|||
170616608|NCT02292719|616603777|FG002|Overall Study|Withdrawal by Subject|0|||
170616609|NCT02292719|616603778|FG003|Overall Study|Withdrawal by Subject|1|||
170616610|NCT02292719|616603779|FG004|Overall Study|Withdrawal by Subject|1|||
170616611|NCT02292719|616603780|FG005|Overall Study|Withdrawal by Subject|0|||
170616612|NCT02292719|616603775|FG000|Overall Study|Subject enrolled in new study.|0|||
170616613|NCT02292719|616603776|FG001|Overall Study|Subject enrolled in new study.|0|||
170616614|NCT02292719|616603777|FG002|Overall Study|Subject enrolled in new study.|1|||
170616615|NCT02292719|616603778|FG003|Overall Study|Subject enrolled in new study.|0|||
170616616|NCT02292719|616603779|FG004|Overall Study|Subject enrolled in new study.|0|||
170616617|NCT02292719|616603780|FG005|Overall Study|Subject enrolled in new study.|0|||
170616618|NCT01332994|616603785|FG000|Overall Study|Adverse Event|34|||
170616619|NCT01332994|616603785|FG000|Overall Study|Death|1|||
170616620|NCT01332994|616603785|FG000|Overall Study|Lack of Efficacy|1|||
170616621|NCT01332994|616603785|FG000|Overall Study|Lost to Follow-up|4|||
170616622|NCT01332994|616603785|FG000|Overall Study|Protocol Violation|6|||
170616623|NCT01332994|616603785|FG000|Overall Study|Withdrawal by Subject|15|||
170616624|NCT01332994|616603785|FG000|Overall Study|Administrative Problem|2|||
170616625|NCT01332994|616603785|FG000|Overall Study|Other|8|||
170616626|NCT00731679|616603787|FG000|Overall Study|Adverse Event|7|||
170616627|NCT00731679|616603788|FG001|Overall Study|Adverse Event|8|||
170616628|NCT00731679|616603787|FG000|Overall Study|Withdrawal by Subject|8|||
170616629|NCT00731679|616603788|FG001|Overall Study|Withdrawal by Subject|8|||
170616630|NCT00731679|616603787|FG000|Overall Study|Lost to Follow-up|7|||
170616631|NCT00731679|616603788|FG001|Overall Study|Lost to Follow-up|8|||
170616632|NCT00731679|616603787|FG000|Overall Study|Noncompliance|0|||
170616633|NCT00731679|616603788|FG001|Overall Study|Noncompliance|1|||
170917170|NCT05775289|617697859|FG003|Overall Study|Withdrawal by Subject|0|||
170616634|NCT00731679|616603787|FG000|Overall Study|Pregnancy|0|||
170616635|NCT00731679|616603788|FG001|Overall Study|Pregnancy|1|||
170616636|NCT00869518|616603789|FG000|Overall Study|Lost to Follow-up|1|||
170616637|NCT00869518|616603790|FG001|Overall Study|Lost to Follow-up|1|||
170616638|NCT03566082|616603791|FG000|Overall Study|Death|7|||
170616639|NCT03566082|616603791|FG000|Overall Study|Failures (revision required)|2|||
170616640|NCT03566082|616603791|FG000|Overall Study|Lost to Follow-up|8|||
170616641|NCT03922620|616603792|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
170616642|NCT03922620|616603793|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
170616643|NCT02663622|616603794|FG000|Overall Study|Death|3|||
170616644|NCT02663622|616603795|FG001|Overall Study|Death|1|||
170616645|NCT02663622|616603796|FG002|Overall Study|Death|1|||
170616646|NCT02663622|616603797|FG003|Overall Study|Death|8|||
170616647|NCT02663622|616603794|FG000|Overall Study|Protocol Violation|0|||
170616648|NCT02663622|616603795|FG001|Overall Study|Protocol Violation|0|||
170616649|NCT02663622|616603796|FG002|Overall Study|Protocol Violation|0|||
170616650|NCT02663622|616603797|FG003|Overall Study|Protocol Violation|1|||
170616651|NCT00163020|616603801|FG000|Overall Study|Lost to Follow-up|0|||
170616652|NCT00163020|616603802|FG001|Overall Study|Lost to Follow-up|2|||
170616653|NCT02807623|616605142|FG000|Overall Study|Lost to Follow-up|23|||
170616654|NCT02807623|616605143|FG001|Overall Study|Lost to Follow-up|18|||
170616655|NCT02807623|616605144|FG002|Overall Study|Lost to Follow-up|22|||
170616656|NCT02807623|616605142|FG000|Overall Study|Drug intolerance|0|||
170616657|NCT02807623|616605143|FG001|Overall Study|Drug intolerance|1|||
170616658|NCT02807623|616605144|FG002|Overall Study|Drug intolerance|0|||
170616659|NCT02807623|616605142|FG000|Overall Study|incomplete blood draw|0|||
170616660|NCT02807623|616605143|FG001|Overall Study|incomplete blood draw|2|||
170616661|NCT02807623|616605144|FG002|Overall Study|incomplete blood draw|1|||
170616662|NCT02614729|616605145|FG000|Overall Study|Withdrawal by Subject|1|||
170616663|NCT02614729|616605146|FG001|Overall Study|Withdrawal by Subject|0|||
170616664|NCT00227721|616605147|FG000|Overall Study|On study, but never treated.|1|||
170616665|NCT01389882|616605150|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
170616666|NCT01389882|616605151|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
170616667|NCT01389882|616605150|FG000|Overall Study|Withdrawal by Subject|0|||
170616668|NCT01389882|616605151|FG001|Overall Study|Withdrawal by Subject|1|||
170616669|NCT03811340|616605152|FG000|Overall Study|subjects did not complete the survey.|90|||
170616670|NCT00984256|616605153|FG000|Overall Study|Withdrawal by Subject|0|||
170616671|NCT00984256|616605154|FG001|Overall Study|Withdrawal by Subject|1|||
170616672|NCT03529110|616605155|FG000|Overall Study|Progressive Disease|66|||
170616673|NCT03529110|616605156|FG001|Overall Study|Progressive Disease|158|||
170616674|NCT03529110|616605155|FG000|Overall Study|Clinical Progression|4|||
170616675|NCT03529110|616605156|FG001|Overall Study|Clinical Progression|12|||
170616676|NCT03529110|616605155|FG000|Overall Study|Adverse Event|35|||
170616677|NCT03529110|616605156|FG001|Overall Study|Adverse Event|17|||
170616678|NCT03529110|616605155|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
170616679|NCT03529110|616605156|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
170616680|NCT03529110|616605155|FG000|Overall Study|Lack of Efficacy|3|||
170616681|NCT03529110|616605156|FG001|Overall Study|Lack of Efficacy|3|||
170616682|NCT03529110|616605155|FG000|Overall Study|Physician Decision|2|||
170616683|NCT03529110|616605156|FG001|Overall Study|Physician Decision|8|||
170616684|NCT03529110|616605155|FG000|Overall Study|Miscellaneous|2|||
170616685|NCT03529110|616605156|FG001|Overall Study|Miscellaneous|5|||
170616686|NCT03654690|616605163|FG000|Overall Study|Withdrawal by Subject|1|||
170616687|NCT03654690|616605164|FG001|Overall Study|Withdrawal by Subject|0|||
170616688|NCT03654690|616605165|FG002|Overall Study|Withdrawal by Subject|0|||
170616689|NCT03367858|616605183|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
170616690|NCT03367858|616605184|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
170616691|NCT03367858|616605183|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
170616692|NCT03367858|616605184|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
170616693|NCT03367858|616605183|FG000|3 Month Follow Up|Lost to Follow-up|8|||
170616694|NCT03367858|616605184|FG001|3 Month Follow Up|Lost to Follow-up|3|||
170616695|NCT03367858|616605183|FG000|3 Month Follow Up|Moved out of study area|2|||
170616696|NCT03367858|616605184|FG001|3 Month Follow Up|Moved out of study area|6|||
170616697|NCT03367858|616605183|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
170616698|NCT03367858|616605184|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
170616699|NCT03367858|616605183|FG000|3 Month Follow Up|MRI contraindication|2|||
170616700|NCT03367858|616605184|FG001|3 Month Follow Up|MRI contraindication|1|||
170616701|NCT03367858|616605183|FG000|3 Month Follow Up|Incarcerated|0|||
170616702|NCT03367858|616605184|FG001|3 Month Follow Up|Incarcerated|1|||
170616703|NCT03367858|616605183|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
170616704|NCT03367858|616605184|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
170616705|NCT03367858|616605183|FG000|6 Month Follow Up|Lost to Follow-up|5|||
170616706|NCT03367858|616605184|FG001|6 Month Follow Up|Lost to Follow-up|2|||
170616707|NCT03367858|616605183|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
170917171|NCT03954236|617697860|FG000|Overall Study|Death|1|||
170662167|NCT03148275|616776190|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
170662168|NCT01828320|616776191|FG000|Overall Study|Lost to Follow-up|1|||
170662169|NCT01828320|616776192|FG001|Overall Study|Lost to Follow-up|3|||
170662170|NCT01828320|616776191|FG000|Overall Study|Withdrawal by Subject|7|||
170662171|NCT01828320|616776192|FG001|Overall Study|Withdrawal by Subject|2|||
170662172|NCT02925923|616777961|FG000|Overall Study|blood samples hemolyzed|0|||
170662173|NCT02925923|616777962|FG001|Overall Study|blood samples hemolyzed|2|||
170662174|NCT02095223|616777963|FG000|Overall Study|Withdrawal by Subject|1|||
170662175|NCT02095223|616777964|FG001|Overall Study|Withdrawal by Subject|0|||
170662176|NCT00282412|616777967|FG000|Overall Study|Death|2|||
170662177|NCT00697073|616777968|FG000|Overall Study|Withdrawal by Subject|2|||
170662178|NCT00697073|616777968|FG000|Overall Study|Pregnancy|1|||
170662179|NCT00697073|616777968|FG000|Overall Study|non compliance and other|6|||
170662180|NCT03911713|616777969|FG000|Overall Study|Lost to Follow-up|0|||
170662181|NCT03911713|616777970|FG001|Overall Study|Lost to Follow-up|2|||
170662182|NCT03911713|616777971|FG002|Overall Study|Lost to Follow-up|0|||
170662183|NCT03911713|616777972|FG003|Overall Study|Lost to Follow-up|0|||
170662184|NCT03911713|616777973|FG004|Overall Study|Lost to Follow-up|0|||
170662185|NCT03911713|616777969|FG000|Overall Study|Other|0|||
170662186|NCT03911713|616777970|FG001|Overall Study|Other|0|||
170662187|NCT03911713|616777971|FG002|Overall Study|Other|0|||
170662188|NCT03911713|616777972|FG003|Overall Study|Other|1|||
170662189|NCT03911713|616777973|FG004|Overall Study|Other|0|||
170662190|NCT03911713|616777969|FG000|Overall Study|Randomized, Never Dosed|1|||
170662191|NCT03911713|616777970|FG001|Overall Study|Randomized, Never Dosed|0|||
170662192|NCT03911713|616777971|FG002|Overall Study|Randomized, Never Dosed|0|||
170662193|NCT03911713|616777972|FG003|Overall Study|Randomized, Never Dosed|1|||
170662194|NCT03911713|616777973|FG004|Overall Study|Randomized, Never Dosed|0|||
170662195|NCT03265665|616777974|FG000|24-week Data Collection|Withdrawal by Subject|2|||
170662196|NCT03265665|616777975|FG001|24-week Data Collection|Withdrawal by Subject|2|||
170662197|NCT03265665|616777974|FG000|24-week Data Collection|Lost to Follow-up|4|||
170662198|NCT03265665|616777975|FG001|24-week Data Collection|Lost to Follow-up|5|||
170662199|NCT03265665|616777974|FG000|36-week Data Collection|Lost to Follow-up|6|||
170662200|NCT03265665|616777975|FG001|36-week Data Collection|Lost to Follow-up|8|||
170662201|NCT00108433|616777976|FG000|Overall Study|Lack of Efficacy|1|||
170662202|NCT00108433|616777977|FG001|Overall Study|Lack of Efficacy|2|||
170662203|NCT00108433|616777976|FG000|Overall Study|Death|3|||
170662204|NCT00108433|616777977|FG001|Overall Study|Death|0|||
170662205|NCT00108433|616777976|FG000|Overall Study|Adverse Event|3|||
170662206|NCT00108433|616777977|FG001|Overall Study|Adverse Event|1|||
170662207|NCT00108433|616777976|FG000|Overall Study|Other|14|||
170662208|NCT00108433|616777977|FG001|Overall Study|Other|14|||
170662209|NCT01845818|616777978|FG000|Overall Study|Withdrawal by Subject|0|||
170662210|NCT01845818|616777979|FG001|Overall Study|Withdrawal by Subject|1|||
170662211|NCT01845818|616777978|FG000|Overall Study|Lost to Follow-up|7|||
170662212|NCT01845818|616777979|FG001|Overall Study|Lost to Follow-up|5|||
170662213|NCT01845818|616777978|FG000|Overall Study|Administrative Reasons|3|||
170662214|NCT01845818|616777979|FG001|Overall Study|Administrative Reasons|1|||
170662215|NCT01845818|616777978|FG000|Overall Study|Serious Adverse Event|1|||
170662216|NCT01845818|616777979|FG001|Overall Study|Serious Adverse Event|1|||
170662217|NCT01845818|616777978|FG000|Overall Study|Other|25|||
170662218|NCT01845818|616777979|FG001|Overall Study|Other|8|||
170662219|NCT01845818|616777978|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
170662220|NCT01845818|616777979|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
170662221|NCT01845818|616777978|FG000|Overall Study|No Follow-Up Data Available|4|||
170662222|NCT01845818|616777979|FG001|Overall Study|No Follow-Up Data Available|1|||
170662223|NCT01886716|616777980|FG000|Week 1|Lost to Follow-up|0|||
170662224|NCT01886716|616777981|FG001|Week 1|Lost to Follow-up|0|||
170662225|NCT01886716|616777982|FG002|Week 1|Lost to Follow-up|2|||
170662226|NCT01886716|616777983|FG003|Week 1|Lost to Follow-up|2|||
170662227|NCT01886716|616777980|FG000|Week 2|Lost to Follow-up|3|||
170662228|NCT01886716|616777981|FG001|Week 2|Lost to Follow-up|2|||
170662229|NCT01886716|616777982|FG002|Week 2|Lost to Follow-up|1|||
170662230|NCT01886716|616777983|FG003|Week 2|Lost to Follow-up|3|||
170662231|NCT01886716|616777980|FG000|Week 3|Lost to Follow-up|1|||
170662232|NCT01886716|616777981|FG001|Week 3|Lost to Follow-up|1|||
170817620|NCT00348283|617339811|FG000|Double Blind|Adverse Event|2|||
170662233|NCT01886716|616777982|FG002|Week 3|Lost to Follow-up|0|||
170662234|NCT01886716|616777983|FG003|Week 3|Lost to Follow-up|1|||
170662235|NCT02572388|616777987|FG000|Overall Study|Withdrawal by Subject|1|||
170662236|NCT02572388|616777988|FG001|Overall Study|Withdrawal by Subject|1|||
170662237|NCT02572388|616777989|FG002|Overall Study|Withdrawal by Subject|2|||
170662238|NCT02572388|616777990|FG003|Overall Study|Withdrawal by Subject|2|||
170662239|NCT00810108|616777991|FG000|Overall Study|Withdrawal by Subject|1|||
170662240|NCT00810108|616777992|FG001|Overall Study|Withdrawal by Subject|0|||
170662241|NCT04806503|616777997|FG000|Overall Study|Lost to Follow-up|0|||
170662242|NCT04806503|616777998|FG001|Overall Study|Lost to Follow-up|0|||
170662243|NCT04806503|616777999|FG002|Overall Study|Lost to Follow-up|1|||
170662244|NCT04806503|616778000|FG003|Overall Study|Lost to Follow-up|0|||
170662245|NCT04806503|616778001|FG004|Overall Study|Lost to Follow-up|0|||
170662246|NCT04806503|616777997|FG000|Overall Study|Withdrawal by Subject|1|||
170662247|NCT04806503|616777998|FG001|Overall Study|Withdrawal by Subject|0|||
170662248|NCT04806503|616777999|FG002|Overall Study|Withdrawal by Subject|1|||
170662249|NCT04806503|616778000|FG003|Overall Study|Withdrawal by Subject|1|||
170662250|NCT04806503|616778001|FG004|Overall Study|Withdrawal by Subject|1|||
170662251|NCT04806503|616777997|FG000|Overall Study|Adverse Event|1|||
170662252|NCT04806503|616777998|FG001|Overall Study|Adverse Event|1|||
170662253|NCT04806503|616777999|FG002|Overall Study|Adverse Event|0|||
170662254|NCT04806503|616778000|FG003|Overall Study|Adverse Event|1|||
170662255|NCT04806503|616778001|FG004|Overall Study|Adverse Event|0|||
170662256|NCT03589469|616778002|FG000|Overall Study|Withdrawal by Subject|8|||
170662257|NCT03589469|616778002|FG000|Overall Study|Physician Decision|20|||
170662258|NCT03589469|616778002|FG000|Overall Study|Death|97|||
170662259|NCT03589469|616778002|FG000|Overall Study|Lost to Follow-up|8|||
170662260|NCT03589469|616778002|FG000|Overall Study|Miscellaneous|1|||
170662261|NCT05274815|616778007|FG000|Overall Study|Adverse Event|1|||
170662262|NCT05274815|616778007|FG000|Overall Study|Death|2|||
170662263|NCT05274815|616778007|FG000|Overall Study|Lost to Follow-up|4|||
170662264|NCT05274815|616778007|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
170662265|NCT05274815|616778007|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
170662266|NCT05274815|616778007|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
170662267|NCT05274815|616778007|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
170662268|NCT05274815|616778007|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
170662269|NCT05274815|616778007|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
170662270|NCT05274815|616778007|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
170662271|NCT05274815|616778007|FG000|Overall Study|Withdrawal by Subject|11|||
170662272|NCT03914326|616778008|FG000|Overall Study|Withdrawal by Subject|27|||
170662273|NCT03914326|616778009|FG001|Overall Study|Withdrawal by Subject|34|||
170662274|NCT03914326|616778008|FG000|Overall Study|Lost to Follow-up|43|||
170662275|NCT03914326|616778009|FG001|Overall Study|Lost to Follow-up|51|||
170662276|NCT03914326|616778008|FG000|Overall Study|Randomised more than once|0|||
170662277|NCT03914326|616778009|FG001|Overall Study|Randomised more than once|1|||
170662278|NCT03053271|616778012|FG000|Overall Study|Did not meet randomization criteria|3|||
170662279|NCT03053271|616778012|FG000|Overall Study|Withdrawal by Subject|1|||
170662280|NCT00580970|616778013|FG000|Pre-treatment|Non-compliance|1|||
170662281|NCT00580970|616778013|FG000|Treatment (Lovastatin)|Non-compliance|6|||
170662282|NCT00580970|616778013|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
170662283|NCT00580970|616778013|FG000|Treatment (Lovastatin)|Physician Decision|4|||
170662284|NCT00580970|616778013|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
170662285|NCT00580970|616778013|FG000|Treatment (Lovastatin)|Death|1|||
170662286|NCT00570765|616778016|FG000|DB Phase|Withdrawal by Subject|1|||
170662287|NCT00570765|616778017|FG001|DB Phase|Withdrawal by Subject|0|||
170662288|NCT00570765|616778018|FG002|DB Phase|Withdrawal by Subject|0|||
170662289|NCT00570765|616778019|FG003|DB Phase|Withdrawal by Subject|0|||
170662290|NCT00570765|616778016|FG000|DB Phase|Protocol Violation|0|||
170662291|NCT00570765|616778017|FG001|DB Phase|Protocol Violation|1|||
170662292|NCT00570765|616778018|FG002|DB Phase|Protocol Violation|0|||
170662293|NCT00570765|616778019|FG003|DB Phase|Protocol Violation|0|||
170662294|NCT00570765|616778016|FG000|DB Phase|Adverse Event|3|||
170662295|NCT00570765|616778017|FG001|DB Phase|Adverse Event|6|||
170662296|NCT00570765|616778018|FG002|DB Phase|Adverse Event|0|||
170662297|NCT00570765|616778019|FG003|DB Phase|Adverse Event|0|||
170662298|NCT00570765|616778016|FG000|DB Phase|Did Not Receive Study Drug|0|||
170662299|NCT00570765|616778017|FG001|DB Phase|Did Not Receive Study Drug|0|||
170662300|NCT00570765|616778018|FG002|DB Phase|Did Not Receive Study Drug|1|||
170662301|NCT00570765|616778019|FG003|DB Phase|Did Not Receive Study Drug|0|||
170662302|NCT00570765|616778016|FG000|LTSE Phase|Withdrawal by Subject|0|||
170662303|NCT00570765|616778017|FG001|LTSE Phase|Withdrawal by Subject|0|||
170662304|NCT00570765|616778018|FG002|LTSE Phase|Withdrawal by Subject|0|||
170662305|NCT00570765|616778019|FG003|LTSE Phase|Withdrawal by Subject|1|||
170662306|NCT00570765|616778016|FG000|LTSE Phase|Adverse Event|0|||
170662307|NCT00570765|616778017|FG001|LTSE Phase|Adverse Event|0|||
170662308|NCT00570765|616778018|FG002|LTSE Phase|Adverse Event|0|||
170662309|NCT00570765|616778019|FG003|LTSE Phase|Adverse Event|7|||
170662310|NCT00570765|616778016|FG000|LTSE Phase|Physician Decision|0|||
170662311|NCT00570765|616778017|FG001|LTSE Phase|Physician Decision|0|||
170662312|NCT00570765|616778018|FG002|LTSE Phase|Physician Decision|0|||
170662313|NCT00570765|616778019|FG003|LTSE Phase|Physician Decision|4|||
170662314|NCT02124161|616778020|FG000|Overall Study|Other unspecified|0|||
170662315|NCT02124161|616778021|FG001|Overall Study|Other unspecified|1|||
170662316|NCT02124161|616778020|FG000|Overall Study|Death|1|||
170662317|NCT02124161|616778021|FG001|Overall Study|Death|0|||
170662318|NCT02124161|616778020|FG000|Overall Study|Protocol Violation|2|||
170662319|NCT02124161|616778021|FG001|Overall Study|Protocol Violation|1|||
170662320|NCT02124161|616778020|FG000|Overall Study|Withdrawal by Subject|1|||
170662321|NCT02124161|616778021|FG001|Overall Study|Withdrawal by Subject|2|||
170662322|NCT02124161|616778020|FG000|Overall Study|Adverse Event|2|||
170662323|NCT02124161|616778021|FG001|Overall Study|Adverse Event|0|||
170662324|NCT02124161|616778020|FG000|Overall Study|Does not meet entrance criteria|2|||
170662325|NCT02124161|616778021|FG001|Overall Study|Does not meet entrance criteria|3|||
170662326|NCT02124161|616778020|FG000|Overall Study|No longer meets eligibility criteria|5|||
170662327|NCT02124161|616778021|FG001|Overall Study|No longer meets eligibility criteria|4|||
170662328|NCT02124161|616778020|FG000|Overall Study|Lost to Follow-up|3|||
170662329|NCT02124161|616778021|FG001|Overall Study|Lost to Follow-up|4|||
170662330|NCT01669928|616778022|FG000|First Intervention|Withdrawal by Subject|3|||
170662331|NCT01669928|616778023|FG001|First Intervention|Withdrawal by Subject|5|||
170662332|NCT01954342|616778026|FG000|Overall Study|Missing data from 13-16week study visit|0|||
170662333|NCT01954342|616778027|FG001|Overall Study|Missing data from 13-16week study visit|0|||
170662334|NCT01954342|616778028|FG002|Overall Study|Missing data from 13-16week study visit|0|||
170662335|NCT01954342|616778029|FG003|Overall Study|Missing data from 13-16week study visit|1|||
170662336|NCT01954342|616778026|FG000|Overall Study|Miscarriage|0|||
170662337|NCT01954342|616778027|FG001|Overall Study|Miscarriage|0|||
170662338|NCT01954342|616778028|FG002|Overall Study|Miscarriage|0|||
170662339|NCT01954342|616778029|FG003|Overall Study|Miscarriage|3|||
170662340|NCT01954342|616778026|FG000|Overall Study|Lost to Follow-up|0|||
170662341|NCT01954342|616778027|FG001|Overall Study|Lost to Follow-up|0|||
170662342|NCT01954342|616778028|FG002|Overall Study|Lost to Follow-up|0|||
170662343|NCT01954342|616778029|FG003|Overall Study|Lost to Follow-up|5|||
170662344|NCT01954342|616778026|FG000|Overall Study|Preterm delivery|0|||
170662345|NCT01954342|616778027|FG001|Overall Study|Preterm delivery|0|||
170662346|NCT01954342|616778028|FG002|Overall Study|Preterm delivery|0|||
170662347|NCT01954342|616778029|FG003|Overall Study|Preterm delivery|3|||
170662348|NCT01954342|616778026|FG000|Overall Study|Pre-eclampsia|0|||
170662349|NCT01954342|616778027|FG001|Overall Study|Pre-eclampsia|0|||
170662350|NCT01954342|616778028|FG002|Overall Study|Pre-eclampsia|0|||
170662351|NCT01954342|616778029|FG003|Overall Study|Pre-eclampsia|4|||
170662352|NCT01954342|616778026|FG000|Overall Study|Unreliable Data|0|||
170662353|NCT01954342|616778027|FG001|Overall Study|Unreliable Data|0|||
170662354|NCT01954342|616778028|FG002|Overall Study|Unreliable Data|0|||
170662355|NCT01954342|616778029|FG003|Overall Study|Unreliable Data|2|||
170662356|NCT05095454|616778030|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
170662357|NCT05095454|616778031|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
170662358|NCT01368432|616778032|FG000|Overall Study|Lost to Follow-up|0|||
170662359|NCT01368432|616778033|FG001|Overall Study|Lost to Follow-up|1|||
170662360|NCT02310321|616778040|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
170662361|NCT02310321|616778041|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
170662362|NCT02310321|616778042|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
170662363|NCT02310321|616778040|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
170662364|NCT02310321|616778041|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
170662365|NCT02310321|616778042|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
170662366|NCT02310321|616778040|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
170662367|NCT02310321|616778041|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
170662368|NCT02310321|616778042|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
170662369|NCT02310321|616778040|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
170662370|NCT02310321|616778041|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
170662371|NCT02310321|616778042|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
170662372|NCT02310321|616778040|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
170817621|NCT00348283|617339812|FG001|Double Blind|Adverse Event|5|||
170817622|NCT00348283|617339811|FG000|Double Blind|Withdrawal by Subject|1|||
170817623|NCT00348283|617339812|FG001|Double Blind|Withdrawal by Subject|1|||
170817624|NCT00348283|617339811|FG000|Double Blind|Protocol Violation|0|||
170817625|NCT00348283|617339812|FG001|Double Blind|Protocol Violation|1|||
170817626|NCT00348283|617339811|FG000|Double Blind|Lack of Efficacy|2|||
170817627|NCT00348283|617339812|FG001|Double Blind|Lack of Efficacy|2|||
170817628|NCT00348283|617339811|FG000|Double Blind|Pregnancy|0|||
170662373|NCT02310321|616778041|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
170662374|NCT02310321|616778042|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
170662375|NCT02310321|616778040|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
170662376|NCT02310321|616778041|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
170662377|NCT02310321|616778042|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
170662378|NCT02310321|616778040|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
170662379|NCT02310321|616778041|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
170817629|NCT00348283|617339812|FG001|Double Blind|Pregnancy|1|||
170817630|NCT00348283|617339811|FG000|Open Label|Adverse Event|0|||
170662380|NCT02310321|616778042|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
170662381|NCT02310321|616778040|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
170662382|NCT02310321|616778041|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
170662383|NCT02310321|616778042|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
170662384|NCT02310321|616778040|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
170662385|NCT02310321|616778041|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
170662386|NCT02310321|616778042|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
170662387|NCT02310321|616778040|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
170662388|NCT02310321|616778041|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
170662389|NCT02310321|616778042|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
170662390|NCT02310321|616778040|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
170662391|NCT02310321|616778041|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
170662392|NCT02310321|616778042|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
170662393|NCT02310321|616778040|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
170662394|NCT02310321|616778041|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
170662395|NCT02310321|616778042|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
170662396|NCT02310321|616778040|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
170662397|NCT02310321|616778041|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
170662398|NCT02310321|616778042|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
170662399|NCT02310321|616778040|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
170662400|NCT02310321|616778041|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
170662401|NCT02310321|616778042|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
170662402|NCT02310321|616778040|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
170662403|NCT02310321|616778041|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
170662404|NCT02310321|616778042|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
170662405|NCT02310321|616778040|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
170662406|NCT02310321|616778041|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
170662407|NCT02310321|616778042|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
170662408|NCT02310321|616778040|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
170662409|NCT02310321|616778041|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
170662410|NCT02310321|616778042|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
170662411|NCT02310321|616778040|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
170662412|NCT02310321|616778041|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
170662413|NCT02310321|616778042|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
170662414|NCT02310321|616778040|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
170662415|NCT02310321|616778041|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
170662416|NCT02310321|616778042|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
170662417|NCT02310321|616778040|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
170662418|NCT02310321|616778041|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
170662419|NCT02310321|616778042|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
170662420|NCT02310321|616778040|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
170662421|NCT02310321|616778041|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
170662422|NCT02310321|616778042|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
170662423|NCT02310321|616778040|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
170662424|NCT02310321|616778041|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
170662425|NCT02310321|616778042|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
170662426|NCT02310321|616778040|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
170662427|NCT02310321|616778041|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
170662428|NCT02310321|616778042|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
170662429|NCT04950166|616778043|FG000|Overall Study|Withdrawal by Subject|1|||
170662430|NCT01698905|616778044|FG000|Overall Study|Adverse Event|4|||
170662431|NCT01698905|616778044|FG000|Overall Study|Physician Decision|2|||
170662432|NCT01698905|616778044|FG000|Overall Study|Pregnancy|1|||
170662433|NCT01698905|616778044|FG000|Overall Study|Protocol Violation|1|||
170616708|NCT03367858|616605184|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
170616709|NCT03367858|616605183|FG000|12 Month Follow Up|Lost to Follow-up|3|||
170616710|NCT03367858|616605184|FG001|12 Month Follow Up|Lost to Follow-up|3|||
170616711|NCT03367858|616605183|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
170616712|NCT03367858|616605184|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
170616713|NCT01450761|616605188|FG000|Randomization|Subject no longer meets study criteria|1|||
170616714|NCT01450761|616605189|FG001|Randomization|Subject no longer meets study criteria|2|||
170616715|NCT01450761|616605188|FG000|Randomization|Withdrawal by Subject|2|||
170616716|NCT01450761|616605189|FG001|Randomization|Withdrawal by Subject|0|||
170616717|NCT01450761|616605188|FG000|Randomization|Disease progression|0|||
170616718|NCT01450761|616605189|FG001|Randomization|Disease progression|2|||
170616719|NCT01450761|616605188|FG000|Randomization|Adverse Event unrelated to study drug|1|||
170616720|NCT01450761|616605189|FG001|Randomization|Adverse Event unrelated to study drug|0|||
170662434|NCT01698905|616778044|FG000|Overall Study|Subject/guardian decision|2|||
170662435|NCT01698905|616778044|FG000|Overall Study|Death|1|||
170662436|NCT05896748|616778045|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
170662437|NCT05896748|616778045|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
170662438|NCT05896748|616778045|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
170662439|NCT05896748|616778045|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
170662440|NCT05896748|616778045|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
170662441|NCT04508140|616778051|FG000|Overall Study|Adverse Event|2|||
170662442|NCT04508140|616778052|FG001|Overall Study|Adverse Event|2|||
170662443|NCT04508140|616778051|FG000|Overall Study|Withdrawal by Subject|0|||
170662444|NCT04508140|616778052|FG001|Overall Study|Withdrawal by Subject|2|||
170662445|NCT04508140|616778051|FG000|Overall Study|progressive disease|9|||
170662446|NCT04508140|616778052|FG001|Overall Study|progressive disease|3|||
170662447|NCT01199731|616778053|FG000|Overall Study|Adverse Event|0|||
170662448|NCT01199731|616778054|FG001|Overall Study|Adverse Event|1|||
170662449|NCT01199731|616778055|FG002|Overall Study|Adverse Event|0|||
170662450|NCT01199731|616778053|FG000|Overall Study|Study closed/terminated|7|||
170662451|NCT01199731|616778054|FG001|Overall Study|Study closed/terminated|9|||
170662452|NCT01199731|616778055|FG002|Overall Study|Study closed/terminated|7|||
170662453|NCT01199731|616778053|FG000|Overall Study|Lost to Follow-up|0|||
170662454|NCT01199731|616778054|FG001|Overall Study|Lost to Follow-up|0|||
170662455|NCT01199731|616778055|FG002|Overall Study|Lost to Follow-up|2|||
170662456|NCT01199731|616778053|FG000|Overall Study|Physician Decision|0|||
170662457|NCT01199731|616778054|FG001|Overall Study|Physician Decision|1|||
170662458|NCT01199731|616778055|FG002|Overall Study|Physician Decision|1|||
170662459|NCT01199731|616778053|FG000|Overall Study|Withdrawal by Subject|2|||
170662460|NCT01199731|616778054|FG001|Overall Study|Withdrawal by Subject|0|||
170662461|NCT01199731|616778055|FG002|Overall Study|Withdrawal by Subject|0|||
170662462|NCT01465191|616778056|FG000|Overall Study|Protocol Violation|6|||
170817631|NCT00348283|617339812|FG001|Open Label|Adverse Event|8|||
170817632|NCT00348283|617339811|FG000|Open Label|Withdrawal by Subject|0|||
170817633|NCT00348283|617339812|FG001|Open Label|Withdrawal by Subject|4|||
170817634|NCT00348283|617339811|FG000|Open Label|Lost to Follow-up|0|||
170817635|NCT00348283|617339812|FG001|Open Label|Lost to Follow-up|1|||
170817636|NCT00348283|617339811|FG000|Open Label|Lack of Efficacy|0|||
170817637|NCT00348283|617339812|FG001|Open Label|Lack of Efficacy|13|||
170817638|NCT00348283|617339811|FG000|Open Label|Administrative reasons|0|||
170817639|NCT00348283|617339812|FG001|Open Label|Administrative reasons|5|||
170817640|NCT00348283|617339811|FG000|Open Label|Subject moved to the United States|0|||
170817641|NCT00348283|617339812|FG001|Open Label|Subject moved to the United States|1|||
170817642|NCT00348283|617339811|FG000|Open Label|Pregnancy|0|||
170817643|NCT00348283|617339812|FG001|Open Label|Pregnancy|1|||
170817644|NCT00348283|617339811|FG000|Open Label|Sponsor decision|0|||
170817645|NCT00348283|617339812|FG001|Open Label|Sponsor decision|1|||
170817646|NCT02282761|617339813|FG000|Overall Study|Death|0|||
170817647|NCT02282761|617339814|FG001|Overall Study|Death|0|||
170817648|NCT02282761|617339815|FG002|Overall Study|Death|1|||
170662463|NCT01465191|616778057|FG001|Overall Study|Protocol Violation|3|||
170662464|NCT01465191|616778058|FG002|Overall Study|Protocol Violation|3|||
170662465|NCT01465191|616778056|FG000|Overall Study|Lost to Follow-up|3|||
170662466|NCT01465191|616778057|FG001|Overall Study|Lost to Follow-up|6|||
170662467|NCT01465191|616778058|FG002|Overall Study|Lost to Follow-up|4|||
170662468|NCT00943124|616778059|FG000|Period 1|Withdrawal by Subject|1|||
170662469|NCT00943124|616778060|FG001|Period 1|Withdrawal by Subject|1|||
170662470|NCT00943124|616778059|FG000|Period 1|Did Not Follow Study Procedures|1|||
170662471|NCT00943124|616778060|FG001|Period 1|Did Not Follow Study Procedures|0|||
170662472|NCT00943124|616778059|FG000|Period 1|Personal Reasons|0|||
170662473|NCT00943124|616778060|FG001|Period 1|Personal Reasons|1|||
170662474|NCT04010539|616778061|FG000|Overall Study|Withdrawal by Subject|4|||
170662475|NCT04010539|616778062|FG001|Overall Study|Withdrawal by Subject|1|||
170662476|NCT04010539|616778061|FG000|Overall Study|Physician Decision|0|||
170662477|NCT04010539|616778062|FG001|Overall Study|Physician Decision|2|||
170662478|NCT04010539|616778061|FG000|Overall Study|Lost to Follow-up|10|||
170817649|NCT02282761|617339813|FG000|Overall Study|Adverse Event|6|||
170817650|NCT02282761|617339814|FG001|Overall Study|Adverse Event|2|||
170817651|NCT02282761|617339815|FG002|Overall Study|Adverse Event|0|||
170662479|NCT04010539|616778062|FG001|Overall Study|Lost to Follow-up|14|||
170662480|NCT04010539|616778061|FG000|Overall Study|Adverse Event|3|||
170662481|NCT04010539|616778062|FG001|Overall Study|Adverse Event|0|||
170662482|NCT04010539|616778061|FG000|Overall Study|Participant Did Not Receive IP|0|||
170662483|NCT04010539|616778062|FG001|Overall Study|Participant Did Not Receive IP|1|||
170662484|NCT04010539|616778061|FG000|Overall Study|Protocol Deviation|0|||
170662485|NCT04010539|616778062|FG001|Overall Study|Protocol Deviation|1|||
170662486|NCT04010539|616778061|FG000|Overall Study|Randomized in Error/ Mistake|2|||
170817652|NCT02282761|617339813|FG000|Overall Study|Lack of Efficacy|11|||
170662487|NCT04010539|616778062|FG001|Overall Study|Randomized in Error/ Mistake|0|||
170817653|NCT02282761|617339814|FG001|Overall Study|Lack of Efficacy|6|||
170817654|NCT02282761|617339815|FG002|Overall Study|Lack of Efficacy|17|||
170662488|NCT04010539|616778061|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
170662489|NCT04010539|616778062|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
170662490|NCT00136604|616778063|FG000|Overall Study|Lost to Follow-up|1|||
170662491|NCT00136604|616778064|FG001|Overall Study|Lost to Follow-up|0|||
170662492|NCT00136604|616778065|FG002|Overall Study|Lost to Follow-up|0|||
170662493|NCT00136604|616778066|FG003|Overall Study|Lost to Follow-up|0|||
170662494|NCT00136604|616778067|FG004|Overall Study|Lost to Follow-up|1|||
170662495|NCT00136604|616778063|FG000|Overall Study|Migrated/moved from study area|0|||
170662496|NCT00136604|616778064|FG001|Overall Study|Migrated/moved from study area|1|||
170662497|NCT00136604|616778065|FG002|Overall Study|Migrated/moved from study area|0|||
170662498|NCT00136604|616778066|FG003|Overall Study|Migrated/moved from study area|0|||
170662499|NCT00136604|616778067|FG004|Overall Study|Migrated/moved from study area|0|||
170662500|NCT01070043|616778068|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
170662501|NCT01070043|616778069|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
170662502|NCT01070043|616778070|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
170662503|NCT01070043|616778068|FG000|Double-Blind Treatment|Adverse Event|0|||
170662504|NCT01070043|616778069|FG001|Double-Blind Treatment|Adverse Event|0|||
170662505|NCT01070043|616778070|FG002|Double-Blind Treatment|Adverse Event|2|||
170662506|NCT02322021|616778071|FG000|Core Phase|Adverse Event|1|||
170662507|NCT02322021|616778072|FG001|Core Phase|Adverse Event|3|||
170662508|NCT02322021|616778073|FG002|Core Phase|Adverse Event|4|||
170662509|NCT02322021|616778074|FG003|Core Phase|Adverse Event|2|||
170662510|NCT02322021|616778075|FG004|Core Phase|Adverse Event|0|||
170662511|NCT02322021|616778071|FG000|Core Phase|Participant Choice|4|||
170662512|NCT02322021|616778072|FG001|Core Phase|Participant Choice|5|||
170662513|NCT02322021|616778073|FG002|Core Phase|Participant Choice|4|||
170662514|NCT02322021|616778074|FG003|Core Phase|Participant Choice|2|||
170662515|NCT02322021|616778075|FG004|Core Phase|Participant Choice|0|||
170662516|NCT02322021|616778071|FG000|Core Phase|Lost to Follow-up|0|||
170662517|NCT02322021|616778072|FG001|Core Phase|Lost to Follow-up|0|||
170662518|NCT02322021|616778073|FG002|Core Phase|Lost to Follow-up|0|||
170662519|NCT02322021|616778074|FG003|Core Phase|Lost to Follow-up|1|||
170662520|NCT02322021|616778075|FG004|Core Phase|Lost to Follow-up|0|||
170662521|NCT02322021|616778071|FG000|Core Phase|Other|0|||
170662522|NCT02322021|616778072|FG001|Core Phase|Other|0|||
170662523|NCT02322021|616778073|FG002|Core Phase|Other|1|||
170662524|NCT02322021|616778074|FG003|Core Phase|Other|0|||
170662525|NCT02322021|616778075|FG004|Core Phase|Other|0|||
170662526|NCT02322021|616778071|FG000|Extension Phase|Adverse Event|0|||
170662527|NCT02322021|616778072|FG001|Extension Phase|Adverse Event|0|||
170662528|NCT02322021|616778073|FG002|Extension Phase|Adverse Event|0|||
170662529|NCT02322021|616778074|FG003|Extension Phase|Adverse Event|0|||
170662530|NCT02322021|616778075|FG004|Extension Phase|Adverse Event|3|||
170662531|NCT02322021|616778071|FG000|Extension Phase|Participant Choice|0|||
170662532|NCT02322021|616778072|FG001|Extension Phase|Participant Choice|0|||
170817655|NCT02282761|617339813|FG000|Overall Study|Lost to Follow-up|2|||
170817656|NCT02282761|617339814|FG001|Overall Study|Lost to Follow-up|2|||
170817657|NCT02282761|617339815|FG002|Overall Study|Lost to Follow-up|1|||
170817658|NCT02282761|617339813|FG000|Overall Study|Physician Decision|0|||
170817659|NCT02282761|617339814|FG001|Overall Study|Physician Decision|0|||
170817660|NCT02282761|617339815|FG002|Overall Study|Physician Decision|2|||
170817661|NCT02282761|617339813|FG000|Overall Study|Withdrawal by Subject|8|||
170817662|NCT02282761|617339814|FG001|Overall Study|Withdrawal by Subject|10|||
170817663|NCT02282761|617339815|FG002|Overall Study|Withdrawal by Subject|16|||
170817664|NCT02282761|617339813|FG000|Overall Study|Other|3|||
170817665|NCT02282761|617339814|FG001|Overall Study|Other|2|||
170817666|NCT02282761|617339815|FG002|Overall Study|Other|1|||
170817667|NCT00658632|617339816|FG000|Overall Study|Adverse Event|13|||
170817668|NCT00658632|617339817|FG001|Overall Study|Adverse Event|11|||
170817669|NCT00658632|617339816|FG000|Overall Study|Lost to Follow-up|25|||
170817670|NCT00658632|617339817|FG001|Overall Study|Lost to Follow-up|23|||
170817671|NCT00658632|617339816|FG000|Overall Study|Withdrawal by Subject|10|||
170817672|NCT00658632|617339817|FG001|Overall Study|Withdrawal by Subject|7|||
170817673|NCT00658632|617339816|FG000|Overall Study|Lack of Efficacy|0|||
170662533|NCT02322021|616778073|FG002|Extension Phase|Participant Choice|0|||
170662534|NCT02322021|616778074|FG003|Extension Phase|Participant Choice|0|||
170817674|NCT00658632|617339817|FG001|Overall Study|Lack of Efficacy|1|||
170817675|NCT00658632|617339816|FG000|Overall Study|Withdrawal of consent|8|||
170817676|NCT00658632|617339817|FG001|Overall Study|Withdrawal of consent|14|||
170817677|NCT00658632|617339816|FG000|Overall Study|Pregnancy|1|||
170662535|NCT02322021|616778075|FG004|Extension Phase|Participant Choice|6|||
170662536|NCT02322021|616778071|FG000|Extension Phase|Other|0|||
170662537|NCT02322021|616778072|FG001|Extension Phase|Other|0|||
170662538|NCT02322021|616778073|FG002|Extension Phase|Other|0|||
170662539|NCT02322021|616778074|FG003|Extension Phase|Other|0|||
170817678|NCT00658632|617339817|FG001|Overall Study|Pregnancy|1|||
170662540|NCT02322021|616778075|FG004|Extension Phase|Other|3|||
170662541|NCT02322021|616778071|FG000|Extension Phase|Lost to Follow-up|0|||
170662542|NCT02322021|616778072|FG001|Extension Phase|Lost to Follow-up|0|||
170662543|NCT02322021|616778073|FG002|Extension Phase|Lost to Follow-up|0|||
170662544|NCT02322021|616778074|FG003|Extension Phase|Lost to Follow-up|0|||
170662545|NCT02322021|616778075|FG004|Extension Phase|Lost to Follow-up|1|||
170616721|NCT01450761|616605188|FG000|Randomization|Other|0|||
170616722|NCT01450761|616605189|FG001|Randomization|Other|1|||
170616723|NCT01450761|616605188|FG000|Lead-in Chemotherapy|Disease progression|33|||
170616724|NCT01450761|616605189|FG001|Lead-in Chemotherapy|Disease progression|32|||
170616725|NCT01450761|616605188|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
170616726|NCT01450761|616605189|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
170616727|NCT01450761|616605188|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
170616728|NCT01450761|616605189|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
170616729|NCT01450761|616605188|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
170662546|NCT02322021|616778071|FG000|Extension Phase|Study terminated by sponsor|0|||
170662547|NCT02322021|616778072|FG001|Extension Phase|Study terminated by sponsor|0|||
170662548|NCT02322021|616778073|FG002|Extension Phase|Study terminated by sponsor|0|||
170662549|NCT02322021|616778074|FG003|Extension Phase|Study terminated by sponsor|0|||
170662550|NCT02322021|616778075|FG004|Extension Phase|Study terminated by sponsor|28|||
170662551|NCT03112590|616778078|FG000|Overall Study|Adverse Event|0|||
170662552|NCT03112590|616778079|FG001|Overall Study|Adverse Event|1|||
170662553|NCT03112590|616778080|FG002|Overall Study|Adverse Event|0|||
170662554|NCT02949700|616778081|FG000|Phase I|Withdrawal by Subject|1|||
170662555|NCT02949700|616778082|FG001|Phase I|Withdrawal by Subject|1|||
170662556|NCT02949700|616778083|FG002|Phase I|Withdrawal by Subject|0|||
170662557|NCT02949700|616778084|FG003|Phase I|Withdrawal by Subject|0|||
170662558|NCT02949700|616778081|FG000|Phase I|Protocol Violation|1|||
170662559|NCT02949700|616778082|FG001|Phase I|Protocol Violation|0|||
170662560|NCT02949700|616778083|FG002|Phase I|Protocol Violation|0|||
170662561|NCT02949700|616778084|FG003|Phase I|Protocol Violation|0|||
170662562|NCT02949700|616778081|FG000|Phase II|Withdrawal by Subject|0|||
170662563|NCT02949700|616778082|FG001|Phase II|Withdrawal by Subject|0|||
170662564|NCT02949700|616778083|FG002|Phase II|Withdrawal by Subject|0|||
170662565|NCT02949700|616778084|FG003|Phase II|Withdrawal by Subject|2|||
170662566|NCT02949700|616778081|FG000|Phase II|Protocol Violation|0|||
170662567|NCT02949700|616778082|FG001|Phase II|Protocol Violation|0|||
170662568|NCT02949700|616778083|FG002|Phase II|Protocol Violation|1|||
170662569|NCT02949700|616778084|FG003|Phase II|Protocol Violation|3|||
170662570|NCT02887859|616778087|FG000|Overall Study|Ongoing|6|||
170662571|NCT02887859|616778087|FG000|Overall Study|Adverse Event|7|||
170662572|NCT02887859|616778087|FG000|Overall Study|Death|1|||
170662573|NCT02887859|616778087|FG000|Overall Study|Physician Decision|1|||
170662574|NCT01554397|616778088|FG000|Overall Study|Withdrawal by Subject|1|||
170662575|NCT01554397|616778089|FG001|Overall Study|Withdrawal by Subject|0|||
170662576|NCT01554397|616778088|FG000|Overall Study|Ineligible|7|||
170662577|NCT01554397|616778089|FG001|Overall Study|Ineligible|0|||
170662578|NCT03670836|616778090|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
170662579|NCT03670836|616778091|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
170662580|NCT03670836|616778090|FG000|Per Protocol Population (PP)|Physician Decision|9|||
170662581|NCT03670836|616778091|FG001|Per Protocol Population (PP)|Physician Decision|10|||
170662582|NCT03670836|616778090|FG000|Per Protocol Population (PP)|Physician Decision|4|||
170662583|NCT03670836|616778091|FG001|Per Protocol Population (PP)|Physician Decision|6|||
170662584|NCT03670836|616778090|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
170662585|NCT03670836|616778091|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
170662586|NCT03803683|616778093|FG000|Overall Study|Lost to Follow-up|41|||
170662587|NCT03803683|616778094|FG001|Overall Study|Lost to Follow-up|18|||
170662588|NCT03803683|616778095|FG002|Overall Study|Lost to Follow-up|12|||
170662589|NCT03803683|616778093|FG000|Overall Study|Withdrawal by Subject|9|||
170662590|NCT03803683|616778094|FG001|Overall Study|Withdrawal by Subject|1|||
170662591|NCT03803683|616778095|FG002|Overall Study|Withdrawal by Subject|4|||
170662592|NCT00492050|616778096|FG000|Overall Study|Adverse Event|1|||
170662593|NCT00492050|616778096|FG000|Overall Study|Lack of Efficacy|1|||
170662594|NCT00492050|616778096|FG000|Overall Study|Withdrawal by Subject|3|||
170662595|NCT00492050|616778096|FG000|Overall Study|Unable to collect SCT|2|||
170662596|NCT00492050|616778096|FG000|Overall Study|Progressive Disease|2|||
170662597|NCT04493333|616779845|FG000|Overall Study|Withdrawal by Subject|1|||
170662598|NCT04493333|616779846|FG001|Overall Study|Withdrawal by Subject|1|||
170662599|NCT04493333|616779845|FG000|Overall Study|Ineligible|0|||
170662600|NCT04493333|616779846|FG001|Overall Study|Ineligible|1|||
170662601|NCT04493333|616779845|FG000|Overall Study|Noncompliance|2|||
170662602|NCT04493333|616779846|FG001|Overall Study|Noncompliance|1|||
170662603|NCT01896050|616779849|FG000|Overall Study|Adverse Event|37|||
170662604|NCT01896050|616779850|FG001|Overall Study|Adverse Event|2|||
170662605|NCT01896050|616779849|FG000|Overall Study|Death|1|||
170662606|NCT01896050|616779850|FG001|Overall Study|Death|0|||
170662607|NCT00392015|616779851|FG000|Overall Study|Lost to Follow-up|2|||
170662608|NCT00392015|616779852|FG001|Overall Study|Lost to Follow-up|0|||
170662609|NCT00392015|616779853|FG002|Overall Study|Lost to Follow-up|2|||
170662610|NCT00392015|616779854|FG003|Overall Study|Lost to Follow-up|1|||
170662611|NCT00392015|616779855|FG004|Overall Study|Lost to Follow-up|1|||
170662612|NCT00392015|616779856|FG005|Overall Study|Lost to Follow-up|0|||
170662613|NCT00392015|616779851|FG000|Overall Study|Withdrawal by Subject|0|||
170662614|NCT00392015|616779852|FG001|Overall Study|Withdrawal by Subject|0|||
170662615|NCT00392015|616779853|FG002|Overall Study|Withdrawal by Subject|2|||
170662616|NCT00392015|616779854|FG003|Overall Study|Withdrawal by Subject|0|||
170662617|NCT00392015|616779855|FG004|Overall Study|Withdrawal by Subject|0|||
170662618|NCT00392015|616779856|FG005|Overall Study|Withdrawal by Subject|0|||
170662619|NCT00392015|616779851|FG000|Overall Study|Adverse Event|0|||
170662620|NCT00392015|616779852|FG001|Overall Study|Adverse Event|0|||
170662621|NCT00392015|616779853|FG002|Overall Study|Adverse Event|0|||
170662622|NCT00392015|616779854|FG003|Overall Study|Adverse Event|0|||
170662623|NCT00392015|616779855|FG004|Overall Study|Adverse Event|1|||
170662624|NCT00392015|616779856|FG005|Overall Study|Adverse Event|0|||
170662625|NCT00392015|616779851|FG000|Overall Study|Previous trial recipient|0|||
170662626|NCT00392015|616779852|FG001|Overall Study|Previous trial recipient|0|||
170662627|NCT00392015|616779853|FG002|Overall Study|Previous trial recipient|0|||
170662628|NCT00392015|616779854|FG003|Overall Study|Previous trial recipient|0|||
170662629|NCT00392015|616779855|FG004|Overall Study|Previous trial recipient|1|||
170662630|NCT00392015|616779856|FG005|Overall Study|Previous trial recipient|0|||
170662631|NCT02206048|616779857|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
170662632|NCT01397162|616779858|FG000|Overall Study|Adverse Event|4|||
170662633|NCT01397162|616779859|FG001|Overall Study|Adverse Event|0|||
170662634|NCT01397162|616779860|FG002|Overall Study|Adverse Event|0|||
170662635|NCT01397162|616779861|FG003|Overall Study|Adverse Event|0|||
170662636|NCT01397162|616779862|FG004|Overall Study|Adverse Event|0|||
170662637|NCT01397162|616779858|FG000|Overall Study|Not yet defined|3|||
170662638|NCT01397162|616779859|FG001|Overall Study|Not yet defined|4|||
170662639|NCT01397162|616779860|FG002|Overall Study|Not yet defined|3|||
170662640|NCT01397162|616779861|FG003|Overall Study|Not yet defined|5|||
170662641|NCT01397162|616779862|FG004|Overall Study|Not yet defined|3|||
170662642|NCT02339285|616779863|FG000|Overall Study|Withdrawal by Subject|0|||
170662643|NCT02339285|616779864|FG001|Overall Study|Withdrawal by Subject|1|||
170662644|NCT02339285|616779865|FG002|Overall Study|Withdrawal by Subject|1|||
170662645|NCT02339285|616779863|FG000|Overall Study|Lost to Follow-up|1|||
170662646|NCT02339285|616779864|FG001|Overall Study|Lost to Follow-up|1|||
170662647|NCT02339285|616779865|FG002|Overall Study|Lost to Follow-up|1|||
170662648|NCT02339285|616779863|FG000|Overall Study|Protocol Deviation|0|||
170662649|NCT02339285|616779864|FG001|Overall Study|Protocol Deviation|1|||
170662650|NCT02339285|616779865|FG002|Overall Study|Protocol Deviation|0|||
170662651|NCT01858376|616779868|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
170662652|NCT02203071|616779872|FG000|Overall Study|Lost to Follow-up|3|||
170662653|NCT02203071|616779873|FG001|Overall Study|Lost to Follow-up|1|||
170662654|NCT03611010|616779886|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
170662655|NCT03611010|616779887|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
170662656|NCT03611010|616779888|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
170662657|NCT03611010|616779889|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
170662658|NCT01675427|616779893|FG000|Overall Study|Withdrawal by Subject|7|||
170662659|NCT01675427|616779893|FG000|Overall Study|Participant Refused Sample Collection|18|||
170662660|NCT01675427|616779893|FG000|Overall Study|Sample not Collected by Mistake|2|||
170662661|NCT01675427|616779893|FG000|Overall Study|Lost to Follow-up|5|||
170662662|NCT01675427|616779893|FG000|Overall Study|Other|2|||
170817679|NCT00658632|617339816|FG000|Overall Study|Other|7|||
170817680|NCT00658632|617339817|FG001|Overall Study|Other|8|||
170817681|NCT06312566|617339818|FG000|Overall Study|Protocol Violation|0|||
170662663|NCT00902668|616779894|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
170662664|NCT05021081|616779895|FG000|Phase 2|Subject enrolled in error|1|||
170662665|NCT05021081|616779896|FG001|Phase 2|Subject enrolled in error|1|||
170662666|NCT05021081|616779897|FG002|Phase 2|Subject enrolled in error|0|||
170662667|NCT01461980|616779898|FG000|Overall Study|Other|9|||
170662668|NCT01461980|616779899|FG001|Overall Study|Other|8|||
170662669|NCT01461980|616779900|FG002|Overall Study|Other|6|||
170817682|NCT06312566|617339819|FG001|Overall Study|Protocol Violation|1|||
170662670|NCT01461980|616779898|FG000|Overall Study|Medication error|7|||
170662671|NCT01461980|616779899|FG001|Overall Study|Medication error|5|||
170662672|NCT01461980|616779900|FG002|Overall Study|Medication error|6|||
170662673|NCT01461980|616779898|FG000|Overall Study|Adverse Event|12|||
170817683|NCT02632045|617339820|FG000|Overall Study|Withdrawal by Subject|1|||
170662674|NCT01461980|616779899|FG001|Overall Study|Adverse Event|5|||
170662675|NCT01461980|616779900|FG002|Overall Study|Adverse Event|6|||
170662676|NCT01461980|616779898|FG000|Overall Study|Protocol Violation|12|||
170662677|NCT01461980|616779899|FG001|Overall Study|Protocol Violation|19|||
170662678|NCT01461980|616779900|FG002|Overall Study|Protocol Violation|16|||
170662679|NCT01461980|616779898|FG000|Overall Study|No longer meets eligibility criteria|18|||
170662680|NCT01461980|616779899|FG001|Overall Study|No longer meets eligibility criteria|9|||
170662681|NCT01461980|616779900|FG002|Overall Study|No longer meets eligibility criteria|19|||
170662682|NCT01461980|616779898|FG000|Overall Study|Lost to Follow-up|52|||
170662683|NCT01461980|616779899|FG001|Overall Study|Lost to Follow-up|53|||
170662684|NCT01461980|616779900|FG002|Overall Study|Lost to Follow-up|51|||
170662685|NCT01461980|616779898|FG000|Overall Study|No longer willing to participate|52|||
170662686|NCT01461980|616779899|FG001|Overall Study|No longer willing to participate|38|||
170662687|NCT01461980|616779900|FG002|Overall Study|No longer willing to participate|54|||
170662688|NCT01461980|616779898|FG000|Overall Study|Randomized but not vaccinated|4|||
170662689|NCT01461980|616779899|FG001|Overall Study|Randomized but not vaccinated|8|||
170662690|NCT01461980|616779900|FG002|Overall Study|Randomized but not vaccinated|7|||
170662691|NCT03161093|616779905|FG000|Overall Study|Protocol Violation|11|||
170662692|NCT03161093|616779906|FG001|Overall Study|Protocol Violation|14|||
170662693|NCT03161093|616779907|FG002|Overall Study|Protocol Violation|6|||
170662694|NCT03161093|616779908|FG003|Overall Study|Protocol Violation|13|||
170662695|NCT03161093|616779909|FG004|Overall Study|Protocol Violation|1|||
170662696|NCT03161093|616779910|FG005|Overall Study|Protocol Violation|0|||
170662697|NCT03161093|616779905|FG000|Overall Study|Adverse Event|5|||
170662698|NCT03161093|616779906|FG001|Overall Study|Adverse Event|21|||
170662699|NCT03161093|616779907|FG002|Overall Study|Adverse Event|16|||
170662700|NCT03161093|616779908|FG003|Overall Study|Adverse Event|35|||
170662701|NCT03161093|616779909|FG004|Overall Study|Adverse Event|2|||
170662702|NCT03161093|616779910|FG005|Overall Study|Adverse Event|1|||
170662703|NCT03161093|616779905|FG000|Overall Study|Lack of Efficacy|9|||
170662704|NCT03161093|616779906|FG001|Overall Study|Lack of Efficacy|13|||
170662705|NCT03161093|616779907|FG002|Overall Study|Lack of Efficacy|9|||
170662706|NCT03161093|616779908|FG003|Overall Study|Lack of Efficacy|24|||
170662707|NCT03161093|616779909|FG004|Overall Study|Lack of Efficacy|4|||
170662708|NCT03161093|616779910|FG005|Overall Study|Lack of Efficacy|1|||
170662709|NCT03161093|616779905|FG000|Overall Study|Physician Decision|0|||
170662710|NCT03161093|616779906|FG001|Overall Study|Physician Decision|1|||
170662711|NCT03161093|616779907|FG002|Overall Study|Physician Decision|0|||
170662712|NCT03161093|616779908|FG003|Overall Study|Physician Decision|2|||
170662713|NCT03161093|616779909|FG004|Overall Study|Physician Decision|17|||
170662714|NCT03161093|616779910|FG005|Overall Study|Physician Decision|15|||
170662715|NCT03161093|616779905|FG000|Overall Study|Withdrawal by Subject|24|||
170662716|NCT03161093|616779906|FG001|Overall Study|Withdrawal by Subject|73|||
170662717|NCT03161093|616779907|FG002|Overall Study|Withdrawal by Subject|44|||
170662718|NCT03161093|616779908|FG003|Overall Study|Withdrawal by Subject|97|||
170662719|NCT03161093|616779909|FG004|Overall Study|Withdrawal by Subject|11|||
170662720|NCT03161093|616779910|FG005|Overall Study|Withdrawal by Subject|10|||
170662721|NCT03161093|616779905|FG000|Overall Study|Lost to Follow-up|3|||
170662722|NCT03161093|616779906|FG001|Overall Study|Lost to Follow-up|12|||
170662723|NCT03161093|616779907|FG002|Overall Study|Lost to Follow-up|4|||
170662724|NCT03161093|616779908|FG003|Overall Study|Lost to Follow-up|7|||
170662725|NCT03161093|616779909|FG004|Overall Study|Lost to Follow-up|8|||
170662726|NCT03161093|616779910|FG005|Overall Study|Lost to Follow-up|13|||
170662727|NCT03161093|616779905|FG000|Overall Study|Death|3|||
170662728|NCT03161093|616779906|FG001|Overall Study|Death|9|||
170662729|NCT03161093|616779907|FG002|Overall Study|Death|7|||
170662730|NCT03161093|616779908|FG003|Overall Study|Death|9|||
170662731|NCT03161093|616779909|FG004|Overall Study|Death|0|||
170662732|NCT03161093|616779910|FG005|Overall Study|Death|0|||
170662733|NCT03161093|616779905|FG000|Overall Study|Unknown - Not reported|0|||
170662734|NCT03161093|616779906|FG001|Overall Study|Unknown - Not reported|1|||
170662735|NCT03161093|616779907|FG002|Overall Study|Unknown - Not reported|0|||
170662736|NCT03161093|616779908|FG003|Overall Study|Unknown - Not reported|0|||
170662737|NCT03161093|616779909|FG004|Overall Study|Unknown - Not reported|0|||
170662738|NCT03161093|616779910|FG005|Overall Study|Unknown - Not reported|1|||
170662739|NCT02517866|616779911|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
170662740|NCT02517866|616779912|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
170817684|NCT02632045|617339821|FG001|Overall Study|Withdrawal by Subject|2|||
170817685|NCT02291549|617339824|FG000|Overall Study|Lost to Follow-up|1|||
170662741|NCT02517866|616779913|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
170662742|NCT02517866|616779911|FG000|Overall Study|Significant Protocol Deviation|4|||
170817686|NCT02291549|617339825|FG001|Overall Study|Lost to Follow-up|0|||
170817687|NCT02291549|617339824|FG000|Overall Study|Withdrawal by Subject|0|||
170817688|NCT02291549|617339825|FG001|Overall Study|Withdrawal by Subject|1|||
170817689|NCT00537914|617339826|FG000|Overall Study|Death|1|||
170817690|NCT00537914|617339826|FG000|Overall Study|Adverse Event|7|||
170662743|NCT02517866|616779912|FG001|Overall Study|Significant Protocol Deviation|1|||
170662744|NCT02517866|616779913|FG002|Overall Study|Significant Protocol Deviation|0|||
170662745|NCT02517866|616779911|FG000|Overall Study|Lost to Follow-up|1|||
170662746|NCT02517866|616779912|FG001|Overall Study|Lost to Follow-up|0|||
170662747|NCT02517866|616779913|FG002|Overall Study|Lost to Follow-up|0|||
170662748|NCT02517866|616779911|FG000|Overall Study|Voluntary Withdrawal|2|||
170662749|NCT02517866|616779912|FG001|Overall Study|Voluntary Withdrawal|2|||
170662750|NCT02517866|616779913|FG002|Overall Study|Voluntary Withdrawal|0|||
170662751|NCT02517866|616779911|FG000|Overall Study|Investigator Decision|2|||
170662752|NCT02517866|616779912|FG001|Overall Study|Investigator Decision|1|||
170662753|NCT02517866|616779913|FG002|Overall Study|Investigator Decision|0|||
170662754|NCT02517866|616779911|FG000|Overall Study|Reason not specified|2|||
170662755|NCT02517866|616779912|FG001|Overall Study|Reason not specified|0|||
170662756|NCT02517866|616779913|FG002|Overall Study|Reason not specified|0|||
170662757|NCT03387683|616779914|FG000|Overall Study|In receipt of disallowed medication|1|||
170662758|NCT03387683|616779915|FG001|Overall Study|In receipt of disallowed medication|0|||
170662759|NCT03387683|616779914|FG000|Overall Study|Did not receive treatment|1|||
170662760|NCT03387683|616779915|FG001|Overall Study|Did not receive treatment|0|||
170662761|NCT00566501|616779916|FG000|Overall Study|Adverse Event|68|||
170662762|NCT00566501|616779917|FG001|Overall Study|Adverse Event|59|||
170662763|NCT00566501|616779916|FG000|Overall Study|Medication Non-compliance|5|||
170662764|NCT00566501|616779917|FG001|Overall Study|Medication Non-compliance|0|||
170662765|NCT00566501|616779916|FG000|Overall Study|Protocol Violation|2|||
170662766|NCT00566501|616779917|FG001|Overall Study|Protocol Violation|2|||
170662767|NCT00566501|616779916|FG000|Overall Study|Request of Investigator or Sponsor|6|||
170662768|NCT00566501|616779917|FG001|Overall Study|Request of Investigator or Sponsor|7|||
170662769|NCT00566501|616779916|FG000|Overall Study|Withdrawal by Subject|33|||
170662770|NCT00566501|616779917|FG001|Overall Study|Withdrawal by Subject|30|||
170662771|NCT00566501|616779916|FG000|Overall Study|Lack of Efficacy|8|||
170662772|NCT00566501|616779917|FG001|Overall Study|Lack of Efficacy|3|||
170662773|NCT00566501|616779916|FG000|Overall Study|Other|25|||
170662774|NCT00566501|616779917|FG001|Overall Study|Other|21|||
170662775|NCT00629772|616779918|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
170662776|NCT00629772|616779919|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
170662777|NCT00629772|616779918|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
170662778|NCT00629772|616779919|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
170662779|NCT02758171|616779920|FG000|Wash-out|Withdrawal by Subject|1|||
170662780|NCT02758171|616779921|FG001|Wash-out|Withdrawal by Subject|0|||
170662781|NCT02758171|616779920|FG000|Wash-out|Other reason|1|||
170662782|NCT02758171|616779921|FG001|Wash-out|Other reason|0|||
170662783|NCT01999114|616779924|FG000|Overall Study|Adverse Event|8|||
170662784|NCT01999114|616779925|FG001|Overall Study|Adverse Event|7|||
170662785|NCT01999114|616779926|FG002|Overall Study|Adverse Event|2|||
170662786|NCT01999114|616779927|FG003|Overall Study|Adverse Event|2|||
170662787|NCT01999114|616779928|FG004|Overall Study|Adverse Event|1|||
170662788|NCT01999114|616779924|FG000|Overall Study|Withdrawal by Subject|0|||
170662789|NCT01999114|616779925|FG001|Overall Study|Withdrawal by Subject|0|||
170662790|NCT01999114|616779926|FG002|Overall Study|Withdrawal by Subject|1|||
170662791|NCT01999114|616779927|FG003|Overall Study|Withdrawal by Subject|0|||
170662792|NCT01999114|616779928|FG004|Overall Study|Withdrawal by Subject|1|||
170662793|NCT01999114|616779924|FG000|Overall Study|Lost to Follow-up|0|||
170662794|NCT01999114|616779925|FG001|Overall Study|Lost to Follow-up|0|||
170662795|NCT01999114|616779926|FG002|Overall Study|Lost to Follow-up|1|||
170662796|NCT01999114|616779927|FG003|Overall Study|Lost to Follow-up|0|||
170662797|NCT01999114|616779928|FG004|Overall Study|Lost to Follow-up|0|||
170662798|NCT01999114|616779924|FG000|Overall Study|Administrative|0|||
170662799|NCT01999114|616779925|FG001|Overall Study|Administrative|0|||
170662800|NCT01999114|616779926|FG002|Overall Study|Administrative|1|||
170662801|NCT01999114|616779927|FG003|Overall Study|Administrative|1|||
170662802|NCT01999114|616779928|FG004|Overall Study|Administrative|2|||
170662803|NCT03840174|616779929|FG000|Overall Study|Withdrawal by Subject|1|||
170662804|NCT03840174|616779930|FG001|Overall Study|Withdrawal by Subject|0|||
170662805|NCT03840174|616779931|FG002|Overall Study|Withdrawal by Subject|0|||
170662806|NCT03840174|616779932|FG003|Overall Study|Withdrawal by Subject|0|||
170662807|NCT01008150|616779933|FG000|Overall Study|did not receive study drug|1|||
170662808|NCT01008150|616779934|FG001|Overall Study|did not receive study drug|1|||
170662809|NCT01008150|616779935|FG002|Overall Study|did not receive study drug|1|||
170662810|NCT01008150|616779936|FG003|Overall Study|did not receive study drug|0|||
170662811|NCT00984568|616779937|FG000|Overall Study|Withdrawal by Subject|1|||
170662812|NCT00984568|616779938|FG001|Overall Study|Withdrawal by Subject|2|||
170662813|NCT00984568|616779937|FG000|Overall Study|Lack of Efficacy|2|||
170662814|NCT00984568|616779938|FG001|Overall Study|Lack of Efficacy|0|||
170662815|NCT00984568|616779937|FG000|Overall Study|Adverse Event|2|||
170662816|NCT00984568|616779938|FG001|Overall Study|Adverse Event|0|||
170662817|NCT00984568|616779937|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
170662818|NCT00984568|616779938|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
170662819|NCT00984568|616779937|FG000|Overall Study|Lost to Follow-up|0|||
170662820|NCT00984568|616779938|FG001|Overall Study|Lost to Follow-up|1|||
170662821|NCT00984568|616779937|FG000|Overall Study|Opportunistic Infection|1|||
170662822|NCT00984568|616779938|FG001|Overall Study|Opportunistic Infection|0|||
170662823|NCT00984568|616779937|FG000|Overall Study|Unknown Reason|1|||
170662824|NCT00984568|616779938|FG001|Overall Study|Unknown Reason|3|||
170662825|NCT01309165|616779939|FG000|Overall Study|Lost to Follow-up|4|||
170662826|NCT01309165|616779940|FG001|Overall Study|Lost to Follow-up|3|||
170662827|NCT01309165|616779939|FG000|Overall Study|Return to work|1|||
170662828|NCT01309165|616779940|FG001|Overall Study|Return to work|2|||
170917172|NCT03954236|617697861|FG001|Overall Study|Death|0|||
170917173|NCT03954236|617697860|FG000|Overall Study|Lost to Follow-up|0|||
170917174|NCT03954236|617697861|FG001|Overall Study|Lost to Follow-up|2|||
170917175|NCT03954236|617697860|FG000|Overall Study|Withdrawal by Subject|1|||
170917176|NCT03954236|617697861|FG001|Overall Study|Withdrawal by Subject|0|||
170917177|NCT04665856|617697862|FG000|Overall Study|Site Terminated by Sponsor|1|||
170917178|NCT04665856|617697863|FG001|Overall Study|Site Terminated by Sponsor|0|||
170917179|NCT04665856|617697862|FG000|Overall Study|Withdrawal by Subject|2|||
170917180|NCT04665856|617697863|FG001|Overall Study|Withdrawal by Subject|0|||
170917181|NCT04665856|617697862|FG000|Overall Study|Lost to Follow-up|3|||
170917182|NCT04665856|617697863|FG001|Overall Study|Lost to Follow-up|2|||
170917183|NCT04665856|617697862|FG000|Overall Study|Death|39|||
170917184|NCT04665856|617697863|FG001|Overall Study|Death|44|||
170917185|NCT04665856|617697862|FG000|Overall Study|Ongoing in study|17|||
170917186|NCT04665856|617697863|FG001|Overall Study|Ongoing in study|15|||
170917187|NCT05353283|617697864|FG000|Overall Study|Lost to Follow-up|1|||
170917188|NCT05353283|617697865|FG001|Overall Study|Lost to Follow-up|0|||
170917189|NCT05027074|617697868|FG000|Overall Study|Death|47|||
170917190|NCT05027074|617697869|FG001|Overall Study|Death|42|||
170917191|NCT05027074|617697870|FG002|Overall Study|Death|39|||
170917192|NCT05027074|617697868|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170917193|NCT05027074|617697869|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170917194|NCT05027074|617697870|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170917195|NCT05027074|617697868|FG000|Overall Study|Site Terminated By Sponsor|3|||
170917196|NCT05027074|617697869|FG001|Overall Study|Site Terminated By Sponsor|0|||
170616730|NCT01450761|616605189|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
170616731|NCT01450761|616605188|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
170616732|NCT01450761|616605189|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
170616733|NCT01450761|616605188|FG000|Lead-in Chemotherapy|Death|3|||
170616734|NCT01450761|616605189|FG001|Lead-in Chemotherapy|Death|3|||
170616735|NCT01450761|616605188|FG000|Lead-in Chemotherapy|Other|2|||
170616736|NCT01450761|616605189|FG001|Lead-in Chemotherapy|Other|2|||
170616737|NCT01450761|616605188|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
170616738|NCT01450761|616605189|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
170616739|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
170616740|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
170616741|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
170616742|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
170616743|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
170616744|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
170616745|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
170616746|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
170616747|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
170616748|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
170616749|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Death|5|||
170616750|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Death|6|||
170616751|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
170616752|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
170616753|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
170616754|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
170616755|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
170616756|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
170616757|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
170616758|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
170616759|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
170616760|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
170616761|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
170616762|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
170616763|NCT01450761|616605188|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
170616764|NCT01450761|616605189|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
170616765|NCT03801174|616605190|FG000|Overall Study|Withdrawal by Subject|14|||
170616766|NCT03801174|616605191|FG001|Overall Study|Withdrawal by Subject|15|||
170616767|NCT03801174|616605190|FG000|Overall Study|Death|1|||
170616768|NCT03801174|616605191|FG001|Overall Study|Death|0|||
170616769|NCT03801174|616605190|FG000|Overall Study|Pregnancy|2|||
170616770|NCT03801174|616605191|FG001|Overall Study|Pregnancy|2|||
170917197|NCT05027074|617697870|FG002|Overall Study|Site Terminated By Sponsor|2|||
170917198|NCT05027074|617697868|FG000|Overall Study|Withdrawal by Subject|13|||
170917199|NCT05027074|617697869|FG001|Overall Study|Withdrawal by Subject|8|||
170917200|NCT05027074|617697870|FG002|Overall Study|Withdrawal by Subject|10|||
170917201|NCT05027074|617697868|FG000|Overall Study|Lost to Follow-up|2|||
170917202|NCT05027074|617697869|FG001|Overall Study|Lost to Follow-up|4|||
170662829|NCT01309165|616779939|FG000|Overall Study|Left country|0|||
170662830|NCT01309165|616779940|FG001|Overall Study|Left country|1|||
170662831|NCT01309165|616779939|FG000|Overall Study|No transportation|0|||
170662832|NCT01309165|616779940|FG001|Overall Study|No transportation|1|||
170662833|NCT01309165|616779939|FG000|Overall Study|Admitted to hospital for second stroke|1|||
170662834|NCT01309165|616779940|FG001|Overall Study|Admitted to hospital for second stroke|0|||
170662835|NCT01739309|616779944|FG000|Overall Study|Adverse Event|1|||
170662836|NCT01739309|616779944|FG000|Overall Study|Withdrawal by Subject|1|||
170662837|NCT05085730|616779946|FG000|Overall Study|Withdrawal by Subject|4|||
170662838|NCT05085730|616779946|FG000|Overall Study|Physician Decision|1|||
170662839|NCT05447897|616779947|FG000|Overall Study|Did not participate in survey|2|||
170662840|NCT00178633|616779948|FG000|Overall Study|Lost to Follow-up|6|||
170662841|NCT03845543|616779949|FG000|Overall Study|Death|25|||
170662842|NCT03845543|616779949|FG000|Overall Study|Withdrawal by Subject|2|||
170662843|NCT03845543|616779949|FG000|Overall Study|Lost to Follow-up|12|||
170662844|NCT03845543|616779949|FG000|Overall Study|Adverse Event|17|||
170662845|NCT00857415|616779951|FG000|Overall Study|Image acquisition failure|2|||
170662846|NCT00857415|616779952|FG001|Overall Study|Image acquisition failure|0|||
170662847|NCT00857415|616779951|FG000|Overall Study|Invalid image or not imaged|3|||
170662848|NCT00857415|616779952|FG001|Overall Study|Invalid image or not imaged|0|||
170662849|NCT00857415|616779951|FG000|Overall Study|Subject still living at end of study|110|||
170662850|NCT00857415|616779952|FG001|Overall Study|Subject still living at end of study|0|||
170662851|NCT00857415|616779951|FG000|Overall Study|Deceased with no autopsy|2|||
170662852|NCT00857415|616779952|FG001|Overall Study|Deceased with no autopsy|0|||
170662853|NCT02314143|616779953|FG000|Overall Study|Adverse Event|0|||
170662854|NCT02314143|616779954|FG001|Overall Study|Adverse Event|6|||
170662855|NCT02314143|616779955|FG002|Overall Study|Adverse Event|4|||
170662856|NCT02314143|616779953|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
170662857|NCT02314143|616779954|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
170662858|NCT02314143|616779955|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
170662859|NCT02314143|616779953|FG000|Overall Study|Physician Decision|2|||
170662860|NCT02314143|616779954|FG001|Overall Study|Physician Decision|1|||
170662861|NCT02314143|616779955|FG002|Overall Study|Physician Decision|0|||
170662862|NCT02314143|616779953|FG000|Overall Study|Withdrawal by Subject|1|||
170662863|NCT02314143|616779954|FG001|Overall Study|Withdrawal by Subject|0|||
170662864|NCT02314143|616779955|FG002|Overall Study|Withdrawal by Subject|1|||
170662865|NCT01916967|616779962|FG000|Overall Study|Adverse Event|0|||
170662866|NCT01916967|616779963|FG001|Overall Study|Adverse Event|0|||
170662867|NCT01916967|616779964|FG002|Overall Study|Adverse Event|2|||
170662868|NCT01916967|616779962|FG000|Overall Study|Lack of Efficacy|0|||
170662869|NCT01916967|616779963|FG001|Overall Study|Lack of Efficacy|0|||
170662870|NCT01916967|616779964|FG002|Overall Study|Lack of Efficacy|6|||
170662871|NCT01916967|616779962|FG000|Overall Study|Physician Decision|0|||
170662872|NCT01916967|616779963|FG001|Overall Study|Physician Decision|0|||
170662873|NCT01916967|616779964|FG002|Overall Study|Physician Decision|1|||
170662874|NCT01916967|616779962|FG000|Overall Study|Protocol Violation|0|||
170662875|NCT01916967|616779963|FG001|Overall Study|Protocol Violation|1|||
170662876|NCT01916967|616779964|FG002|Overall Study|Protocol Violation|0|||
170662877|NCT03538431|616779966|FG000|Overall Study|Physician Decision|0|||
170662878|NCT03538431|616779967|FG001|Overall Study|Physician Decision|1|||
170662879|NCT03538431|616779966|FG000|Overall Study|Withdrawal by Subject|1|||
170662880|NCT03538431|616779967|FG001|Overall Study|Withdrawal by Subject|0|||
170662881|NCT03139279|616779968|FG000|Overall Study|Physician Decision|2|||
170662882|NCT03139279|616779969|FG001|Overall Study|Physician Decision|0|||
170662883|NCT03139279|616779968|FG000|Overall Study|Protocol Violation|5|||
170917203|NCT05027074|617697870|FG002|Overall Study|Lost to Follow-up|3|||
170917204|NCT05027074|617697868|FG000|Overall Study|Status Not Recorded|0|||
170917205|NCT05027074|617697869|FG001|Overall Study|Status Not Recorded|0|||
170917206|NCT05027074|617697870|FG002|Overall Study|Status Not Recorded|1|||
170917207|NCT04954313|617697874|FG000|Overall Study|Lost to Follow-up|6|||
170917208|NCT04954313|617697875|FG001|Overall Study|Lost to Follow-up|12|||
170917209|NCT04954313|617697874|FG000|Overall Study|Protocol Violation|1|||
170917210|NCT04954313|617697875|FG001|Overall Study|Protocol Violation|2|||
170662884|NCT03139279|616779969|FG001|Overall Study|Protocol Violation|4|||
170662885|NCT03139279|616779968|FG000|Overall Study|Withdrawal by Subject|0|||
170662886|NCT03139279|616779969|FG001|Overall Study|Withdrawal by Subject|2|||
170662887|NCT00406354|616779970|FG000|All Randomized Patients|Protocol Violation|0|||
170662888|NCT00406354|616779971|FG001|All Randomized Patients|Protocol Violation|0|||
170662889|NCT00406354|616779972|FG002|All Randomized Patients|Protocol Violation|1|||
170662890|NCT00406354|616779970|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
170662891|NCT00406354|616779971|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
170917211|NCT04954313|617697874|FG000|Overall Study|Withdrawal by Subject|11|||
170662892|NCT00406354|616779972|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
170662893|NCT00406354|616779970|FG000|All Randomized and Treated Patients|Adverse Event|6|||
170662894|NCT00406354|616779971|FG001|All Randomized and Treated Patients|Adverse Event|2|||
170662895|NCT00406354|616779972|FG002|All Randomized and Treated Patients|Adverse Event|1|||
170917212|NCT04954313|617697875|FG001|Overall Study|Withdrawal by Subject|13|||
170662896|NCT00406354|616779970|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
170662897|NCT00406354|616779971|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
170662898|NCT00406354|616779972|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
170662899|NCT00406354|616779970|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
170662900|NCT00406354|616779971|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
170662901|NCT00406354|616779972|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
170662902|NCT00406354|616779970|FG000|All Randomized and Treated Patients|Physician Decision|0|||
170662903|NCT00406354|616779971|FG001|All Randomized and Treated Patients|Physician Decision|0|||
170662904|NCT00406354|616779972|FG002|All Randomized and Treated Patients|Physician Decision|1|||
170662905|NCT01090973|616779984|FG000|Overall Study|Disease progression|1|||
170662906|NCT01565642|616779985|FG000|Overall Study|Withdrawal by Subject|2|||
170662907|NCT01565642|616779986|FG001|Overall Study|Withdrawal by Subject|1|||
170662908|NCT00304239|616779991|FG000|Overall Study|Protocol Deviations/Violations|15|||
170662909|NCT00304239|616779992|FG001|Overall Study|Protocol Deviations/Violations|0|||
170662910|NCT00304239|616779991|FG000|Overall Study|Adverse Event|2|||
170662911|NCT00304239|616779992|FG001|Overall Study|Adverse Event|0|||
170662912|NCT02979197|616779993|FG000|Overall Study|Adverse Event|4|||
170662913|NCT02979197|616779994|FG001|Overall Study|Adverse Event|2|||
170662914|NCT02979197|616779995|FG002|Overall Study|Adverse Event|0|||
170662915|NCT02979197|616779993|FG000|Overall Study|Protocol Violation|0|||
170662916|NCT02979197|616779994|FG001|Overall Study|Protocol Violation|1|||
170662917|NCT02979197|616779995|FG002|Overall Study|Protocol Violation|0|||
170662918|NCT02979197|616779993|FG000|Overall Study|Subject unable to commit to study dates|0|||
170662919|NCT02979197|616779994|FG001|Overall Study|Subject unable to commit to study dates|1|||
170662920|NCT02979197|616779995|FG002|Overall Study|Subject unable to commit to study dates|0|||
170662921|NCT01528033|616779996|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
170662922|NCT01528033|616779997|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
170662923|NCT01528033|616779996|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
170662924|NCT01528033|616779997|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
170662925|NCT01528033|616779996|FG000|Primary Endpoint Assessment ITT|Death|2|||
170662926|NCT01528033|616779997|FG001|Primary Endpoint Assessment ITT|Death|2|||
170662927|NCT01528033|616779996|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
170662928|NCT01528033|616779997|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
170662929|NCT01528033|616779996|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
170662930|NCT01528033|616779997|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
170662931|NCT01528033|616779996|FG000|Follow Up|No data available|46|||
170662932|NCT01528033|616779997|FG001|Follow Up|No data available|44|||
170662933|NCT05597020|616780001|FG000|Washout|Forbidden medication|2|||
170662934|NCT05597020|616780002|FG001|Washout|Forbidden medication|0|||
170662935|NCT05597020|616780001|FG000|Treatment Period II|Advice from primary care physician|1|||
170662936|NCT05597020|616780002|FG001|Treatment Period II|Advice from primary care physician|0|||
170662937|NCT05597020|616780001|FG000|Treatment Period II|Subject lost investigational product|1|||
170662938|NCT05597020|616780002|FG001|Treatment Period II|Subject lost investigational product|0|||
170662939|NCT05597020|616780001|FG000|Treatment Period II|Private reasons|0|||
170662940|NCT05597020|616780002|FG001|Treatment Period II|Private reasons|1|||
170662941|NCT01015131|616780003|FG000|Overall Study|Physician Decision|1|||
170662942|NCT01015131|616780003|FG000|Overall Study|Protocol Violation|1|||
170662943|NCT01015131|616780003|FG000|Overall Study|Withdrawal by Subject|2|||
170662944|NCT01015131|616780003|FG000|Overall Study|Other Protocol Specified Criteria|4|||
170662945|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
170662946|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
170662947|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
170662948|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
170662949|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
170662950|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
170662951|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
170662952|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
170662953|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
170662954|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
170662955|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
170817691|NCT00537914|617339826|FG000|Overall Study|Treatment failure|10|||
170817692|NCT00537914|617339826|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
170817693|NCT00537914|617339826|FG000|Overall Study|Lost to Follow-up|19|||
170817694|NCT00537914|617339826|FG000|Overall Study|Withdrawal of informed consent|59|||
170817695|NCT01307800|617339829|FG000|Overall Study|Adverse Event|9|||
170817696|NCT01307800|617339830|FG001|Overall Study|Adverse Event|8|||
170662956|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
170662957|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
170662958|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
170662959|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
170662960|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
170662961|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
170662962|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
170662963|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
170662964|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
170662965|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
170662966|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
170662967|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
170662968|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
170662969|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
170662970|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
170662971|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
170662972|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
170662973|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
170662974|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
170662975|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
170662976|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
170662977|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
170662978|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
170662979|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
170662980|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
170662981|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
170662982|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
170662983|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
170662984|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
170662985|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
170662986|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
170662987|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
170662988|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
170662989|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
170662990|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
170662991|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
170662992|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
170817697|NCT01307800|617339831|FG002|Overall Study|Adverse Event|10|||
170817698|NCT01307800|617339832|FG003|Overall Study|Adverse Event|14|||
170817699|NCT01307800|617339829|FG000|Overall Study|Entry Criteria Not Met|0|||
170817700|NCT01307800|617339830|FG001|Overall Study|Entry Criteria Not Met|0|||
170662993|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
170662994|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
170662995|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
170662996|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
170662997|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
170662998|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
170662999|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
170663000|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
170663001|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
170663002|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
170663003|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
170663004|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
170663005|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
170663006|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
170663007|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
170663008|NCT04526509|616780004|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
170663009|NCT04526509|616780005|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
170663010|NCT04526509|616780006|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
170663011|NCT04526509|616780007|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
170663012|NCT04526509|616780008|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
170663013|NCT04526509|616780009|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
170663014|NCT04526509|616780010|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
170663015|NCT04526509|616780004|FG000|Enrolled|Study Terminated by Sponsor|0|||
170663016|NCT04526509|616780005|FG001|Enrolled|Study Terminated by Sponsor|0|||
170663017|NCT04526509|616780006|FG002|Enrolled|Study Terminated by Sponsor|0|||
170663018|NCT04526509|616780007|FG003|Enrolled|Study Terminated by Sponsor|0|||
170663019|NCT04526509|616780008|FG004|Enrolled|Study Terminated by Sponsor|0|||
170663020|NCT04526509|616780009|FG005|Enrolled|Study Terminated by Sponsor|0|||
170663021|NCT04526509|616780010|FG006|Enrolled|Study Terminated by Sponsor|1|||
170663022|NCT04526509|616780004|FG000|Enrolled|Death prior to lymphodepletion|0|||
170663023|NCT04526509|616780005|FG001|Enrolled|Death prior to lymphodepletion|0|||
170663024|NCT04526509|616780006|FG002|Enrolled|Death prior to lymphodepletion|0|||
170663025|NCT04526509|616780007|FG003|Enrolled|Death prior to lymphodepletion|1|||
170663026|NCT04526509|616780008|FG004|Enrolled|Death prior to lymphodepletion|0|||
170663027|NCT04526509|616780009|FG005|Enrolled|Death prior to lymphodepletion|0|||
170663028|NCT04526509|616780010|FG006|Enrolled|Death prior to lymphodepletion|0|||
170663029|NCT04526509|616780004|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
170663030|NCT04526509|616780005|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
170663031|NCT04526509|616780006|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
170663032|NCT04526509|616780007|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
170663033|NCT04526509|616780008|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
170663034|NCT04526509|616780009|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
170663035|NCT04526509|616780010|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
170663036|NCT04526509|616780004|FG000|Enrolled|Physician Decision|0|||
170663037|NCT04526509|616780005|FG001|Enrolled|Physician Decision|1|||
170663038|NCT04526509|616780006|FG002|Enrolled|Physician Decision|0|||
170663039|NCT04526509|616780007|FG003|Enrolled|Physician Decision|0|||
170663040|NCT04526509|616780008|FG004|Enrolled|Physician Decision|0|||
170663041|NCT04526509|616780009|FG005|Enrolled|Physician Decision|0|||
170663042|NCT04526509|616780010|FG006|Enrolled|Physician Decision|0|||
170663043|NCT04246372|616781762|FG000|Overall Study|Adverse Event|1|||
170663044|NCT04246372|616781762|FG000|Overall Study|Withdrawal by Subject|1|||
170663045|NCT04246372|616781762|FG000|Overall Study|Protocol Violation|2|||
170663046|NCT04246372|616781762|FG000|Overall Study|Physician Decision|1|||
170663047|NCT00257608|616781764|FG000|Chemotherapy Phase|Adverse Event|138|||
170663048|NCT00257608|616781765|FG001|Chemotherapy Phase|Adverse Event|0|||
170663049|NCT00257608|616781766|FG002|Chemotherapy Phase|Adverse Event|0|||
170663050|NCT00257608|616781764|FG000|Chemotherapy Phase|Disease progression|139|||
170663051|NCT00257608|616781765|FG001|Chemotherapy Phase|Disease progression|0|||
170663052|NCT00257608|616781766|FG002|Chemotherapy Phase|Disease progression|0|||
170663053|NCT00257608|616781764|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
170663054|NCT00257608|616781765|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
170663055|NCT00257608|616781766|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
170663056|NCT00257608|616781764|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
170663057|NCT00257608|616781765|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
170663058|NCT00257608|616781766|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
170663059|NCT00257608|616781764|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
170663060|NCT00257608|616781765|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
170663061|NCT00257608|616781766|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
170663062|NCT00257608|616781764|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
170663063|NCT00257608|616781765|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
170663064|NCT00257608|616781766|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
170663065|NCT00257608|616781764|FG000|Chemotherapy Phase|Physician Decision|28|||
170663066|NCT00257608|616781765|FG001|Chemotherapy Phase|Physician Decision|0|||
170663067|NCT00257608|616781766|FG002|Chemotherapy Phase|Physician Decision|0|||
170663068|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Adverse Event|0|||
170663069|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Adverse Event|34|||
170663070|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Adverse Event|38|||
170663071|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Disease progression|0|||
170663072|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Disease progression|204|||
170663073|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Disease progression|168|||
170663074|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
170663075|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
170663076|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
170663077|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
170663078|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
170663079|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
170663080|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
170663081|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
170663082|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
170663083|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
170663084|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
170663085|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
170663086|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
170663087|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
170663088|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
170663089|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Physician Decision|0|||
170663090|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Physician Decision|8|||
170663091|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Physician Decision|11|||
170663092|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
170663093|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
170663094|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
170663095|NCT00257608|616781764|FG000|Post Chemotherapy Phase|Not treated|0|||
170663096|NCT00257608|616781765|FG001|Post Chemotherapy Phase|Not treated|4|||
170663097|NCT00257608|616781766|FG002|Post Chemotherapy Phase|Not treated|7|||
170663098|NCT02742441|616781768|FG000|Overall Study|Lost to Follow-up|4|||
170663099|NCT02742441|616781769|FG001|Overall Study|Lost to Follow-up|4|||
170663100|NCT02742441|616781768|FG000|Overall Study|Withdrawal by Subject|2|||
170663101|NCT02742441|616781769|FG001|Overall Study|Withdrawal by Subject|2|||
170663102|NCT02742441|616781768|FG000|Overall Study|Adverse Event|0|||
170663103|NCT02742441|616781769|FG001|Overall Study|Adverse Event|2|||
170663104|NCT02595970|616781770|FG000|Overall Study|Withdrawal by Subject|2|||
170663105|NCT02595970|616781770|FG000|Overall Study|Physician Decision|2|||
170663106|NCT02595970|616781770|FG000|Overall Study|Protocol Violation|4|||
170663107|NCT02595970|616781770|FG000|Overall Study|Adverse Event|5|||
170663108|NCT02595970|616781770|FG000|Overall Study|Lack of Efficacy|7|||
170663109|NCT01824342|616781771|FG000|Overall Study|Withdrawal by Subject|0|||
170663110|NCT01824342|616781772|FG001|Overall Study|Withdrawal by Subject|3|||
170663111|NCT01824342|616781771|FG000|Overall Study|Adverse Event|1|||
170663112|NCT01824342|616781772|FG001|Overall Study|Adverse Event|1|||
170817701|NCT01307800|617339831|FG002|Overall Study|Entry Criteria Not Met|0|||
170817702|NCT01307800|617339832|FG003|Overall Study|Entry Criteria Not Met|2|||
170817703|NCT01307800|617339829|FG000|Overall Study|Lost to Follow-up|5|||
170817704|NCT01307800|617339830|FG001|Overall Study|Lost to Follow-up|6|||
170817705|NCT01307800|617339831|FG002|Overall Study|Lost to Follow-up|2|||
170817706|NCT01307800|617339832|FG003|Overall Study|Lost to Follow-up|8|||
170817707|NCT01307800|617339829|FG000|Overall Study|Perceived Lack of Efficacy|24|||
170663113|NCT01824342|616781771|FG000|Overall Study|Disease Progression|1|||
170817708|NCT01307800|617339830|FG001|Overall Study|Perceived Lack of Efficacy|23|||
170817709|NCT01307800|617339831|FG002|Overall Study|Perceived Lack of Efficacy|20|||
170663114|NCT01824342|616781772|FG001|Overall Study|Disease Progression|1|||
170663115|NCT01824342|616781771|FG000|Overall Study|Physician Decision|5|||
170663116|NCT01824342|616781772|FG001|Overall Study|Physician Decision|0|||
170663117|NCT01824342|616781771|FG000|Overall Study|Death|2|||
170663118|NCT01824342|616781772|FG001|Overall Study|Death|0|||
170663119|NCT02202837|616781773|FG000|Overall Study|Enbrel treatment discontinued|36|||
170663120|NCT02202837|616781774|FG001|Overall Study|Enbrel treatment discontinued|4|||
170663121|NCT02202837|616781773|FG000|Overall Study|Other|10|||
170663122|NCT02202837|616781774|FG001|Overall Study|Other|0|||
170663123|NCT02202837|616781773|FG000|Overall Study|Lost to Follow-up|7|||
170663124|NCT02202837|616781774|FG001|Overall Study|Lost to Follow-up|1|||
170663125|NCT02486302|616781775|FG000|Overall Study|Discontinued prematurely|410|||
170663126|NCT02486302|616781775|FG000|Overall Study|Documentation not completed|255|||
170663127|NCT02486302|616781775|FG000|Overall Study|Excluded due to legal reasons|8|||
170663128|NCT02486302|616781775|FG000|Overall Study|Not treated|3|||
170663129|NCT01871142|616781778|FG000|Overall Study|Adverse Event|1|||
170663130|NCT02104752|616781787|FG000|Overall Study|Withdrawal by Subject|1|||
170663131|NCT02104752|616781788|FG001|Overall Study|Withdrawal by Subject|0|||
170663132|NCT02104752|616781787|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
170663133|NCT02104752|616781788|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
170663134|NCT00231842|616781789|FG000|Overall Study|Withdrawal by Subject|3|||
170663135|NCT00231842|616781789|FG000|Overall Study|Did not complete the last 3 cycle|8|||
170663136|NCT02422303|616781790|FG000|Overall Study|Lost to Follow-up|1|||
170663137|NCT02422303|616781791|FG001|Overall Study|Lost to Follow-up|1|||
170663138|NCT02899299|616781792|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
170663139|NCT02899299|616781793|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
170663140|NCT02899299|616781792|FG000|Pre-treatment|Participant withdrew consent|1|||
170663141|NCT02899299|616781793|FG001|Pre-treatment|Participant withdrew consent|11|||
170663142|NCT02899299|616781792|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
170663143|NCT02899299|616781793|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
170663144|NCT02899299|616781792|FG000|Pre-treatment|Not reported|0|||
170663145|NCT02899299|616781793|FG001|Pre-treatment|Not reported|1|||
170663146|NCT02899299|616781792|FG000|Treatment|Disease Progression|182|||
170663147|NCT02899299|616781793|FG001|Treatment|Disease Progression|43|||
170663148|NCT02899299|616781792|FG000|Treatment|Study Drug Toxicity|60|||
170663149|NCT02899299|616781793|FG001|Treatment|Study Drug Toxicity|24|||
170663150|NCT02899299|616781792|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
170663151|NCT02899299|616781793|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
170663152|NCT02899299|616781792|FG000|Treatment|Participant request to discontinue Study treatment|4|||
170663153|NCT02899299|616781793|FG001|Treatment|Participant request to discontinue Study treatment|10|||
170663154|NCT02899299|616781792|FG000|Treatment|Participant withdrew consent|6|||
170663155|NCT02899299|616781793|FG001|Treatment|Participant withdrew consent|3|||
170663156|NCT02899299|616781792|FG000|Treatment|Lost to Follow-up|0|||
170663157|NCT02899299|616781793|FG001|Treatment|Lost to Follow-up|2|||
170663158|NCT02899299|616781792|FG000|Treatment|Maximum Clinical Benefit|11|||
170663159|NCT02899299|616781793|FG001|Treatment|Maximum Clinical Benefit|2|||
170663160|NCT02899299|616781792|FG000|Treatment|Poor/Non-compliance|1|||
170663161|NCT02899299|616781793|FG001|Treatment|Poor/Non-compliance|0|||
170663162|NCT02899299|616781792|FG000|Treatment|Participant no longer meets Study criteria|4|||
170663163|NCT02899299|616781793|FG001|Treatment|Participant no longer meets Study criteria|0|||
170663164|NCT02899299|616781792|FG000|Treatment|Administrative reason by Sponsor|2|||
170663165|NCT02899299|616781793|FG001|Treatment|Administrative reason by Sponsor|0|||
170663166|NCT02899299|616781792|FG000|Treatment|Other reasons|12|||
170663167|NCT02899299|616781793|FG001|Treatment|Other reasons|2|||
170663168|NCT02899299|616781792|FG000|Treatment|Not reported|7|||
170663169|NCT02899299|616781793|FG001|Treatment|Not reported|0|||
170663170|NCT00313300|616781795|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
170817710|NCT01307800|617339832|FG003|Overall Study|Perceived Lack of Efficacy|33|||
170817711|NCT01307800|617339829|FG000|Overall Study|Protocol Violation|0|||
170817712|NCT01307800|617339830|FG001|Overall Study|Protocol Violation|3|||
170817713|NCT01307800|617339831|FG002|Overall Study|Protocol Violation|4|||
170817714|NCT01307800|617339832|FG003|Overall Study|Protocol Violation|5|||
170817715|NCT01307800|617339829|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
170817716|NCT01307800|617339830|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
170663171|NCT00313300|616781796|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
170663172|NCT00313300|616781797|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
170663173|NCT00313300|616781798|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
170663174|NCT00313300|616781799|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
170663175|NCT00313300|616781795|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
170663176|NCT00313300|616781796|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
170663177|NCT00313300|616781797|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
170663178|NCT00313300|616781798|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
170663179|NCT00313300|616781799|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
170663180|NCT00313300|616781795|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
170663181|NCT00313300|616781796|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
170663182|NCT00313300|616781797|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
170663183|NCT00313300|616781798|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
170663184|NCT00313300|616781799|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
170663185|NCT00313300|616781795|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
170663186|NCT00313300|616781796|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
170663187|NCT00313300|616781797|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
170663188|NCT00313300|616781798|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
170663189|NCT00313300|616781799|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
170663190|NCT00313300|616781795|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
170663191|NCT00313300|616781796|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
170663192|NCT00313300|616781797|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
170663193|NCT00313300|616781798|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
170917213|NCT04954313|617697874|FG000|Overall Study|Physician Decision|0|||
170917214|NCT04954313|617697875|FG001|Overall Study|Physician Decision|1|||
170917215|NCT04954313|617697874|FG000|Overall Study|Death|1|||
170917216|NCT04954313|617697875|FG001|Overall Study|Death|0|||
170663194|NCT00313300|616781799|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
170663195|NCT00313300|616781795|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
170663196|NCT00313300|616781796|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
170663197|NCT00313300|616781797|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
170663198|NCT00313300|616781798|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
170663199|NCT00313300|616781799|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
170663200|NCT00313300|616781795|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
170663201|NCT00313300|616781796|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
170663202|NCT00313300|616781797|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
170663203|NCT00313300|616781798|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
170663204|NCT00313300|616781799|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
170663205|NCT00313300|616781795|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
170663206|NCT00313300|616781796|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
170663207|NCT00313300|616781797|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
170663208|NCT00313300|616781798|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
170663209|NCT00313300|616781799|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
170663210|NCT00313300|616781795|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
170663211|NCT00313300|616781796|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
170663212|NCT00313300|616781797|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
170663213|NCT00313300|616781798|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
170663214|NCT00313300|616781799|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
170663215|NCT00313300|616781795|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
170663216|NCT00313300|616781796|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
170663217|NCT00313300|616781797|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
170663218|NCT00313300|616781798|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
170663219|NCT00313300|616781799|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
170663220|NCT00313300|616781795|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
170663221|NCT00313300|616781796|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
170663222|NCT00313300|616781797|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
170663223|NCT00313300|616781798|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
170663224|NCT00313300|616781799|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
170663225|NCT00313300|616781795|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
170663226|NCT00313300|616781796|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
170663227|NCT00313300|616781797|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
170663228|NCT00313300|616781798|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
170663229|NCT00313300|616781799|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
170663230|NCT00313300|616781795|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
170663231|NCT00313300|616781796|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
170663232|NCT00313300|616781797|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
170663233|NCT00313300|616781798|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
170663234|NCT00313300|616781799|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
170663235|NCT00313300|616781795|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
170663236|NCT00313300|616781796|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
170917217|NCT04954313|617697874|FG000|Overall Study|Adverse Event|1|||
170917218|NCT04954313|617697875|FG001|Overall Study|Adverse Event|0|||
170663237|NCT00313300|616781797|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
170663238|NCT00313300|616781798|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
170663239|NCT00313300|616781799|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
170663240|NCT00313300|616781795|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
170917219|NCT05301894|617697876|FG000|Overall Study|Withdrawal by Subject|2|||
170917220|NCT05301894|617697876|FG000|Overall Study|Study Terminated by Sponsor|15|||
170663241|NCT00313300|616781796|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
170663242|NCT00313300|616781797|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
170663243|NCT00313300|616781798|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
170663244|NCT00313300|616781799|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
170663245|NCT00313300|616781795|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
170663246|NCT00313300|616781796|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
170663247|NCT00313300|616781797|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
170663248|NCT00313300|616781798|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
170663249|NCT00313300|616781799|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
170663250|NCT00313300|616781795|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
170663251|NCT00313300|616781796|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
170663252|NCT00313300|616781797|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
170663253|NCT00313300|616781798|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
170663254|NCT00313300|616781799|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
170663255|NCT00313300|616781795|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
170663256|NCT00313300|616781796|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
170663257|NCT00313300|616781797|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
170663258|NCT00313300|616781798|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
170663259|NCT00313300|616781799|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
170663260|NCT00313300|616781795|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
170663261|NCT00313300|616781796|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
170663262|NCT00313300|616781797|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
170663263|NCT00313300|616781798|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
170663264|NCT00313300|616781799|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
170663265|NCT00313300|616781795|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
170663266|NCT00313300|616781796|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
170663267|NCT00313300|616781797|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
170663268|NCT00313300|616781798|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
170663269|NCT00313300|616781799|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
170663270|NCT00313300|616781795|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
170663271|NCT00313300|616781796|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
170663272|NCT00313300|616781797|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
170663273|NCT00313300|616781798|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
170663274|NCT00313300|616781799|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
170663275|NCT00428792|616781800|FG000|Overall Study|Lack of Efficacy|1|||
170663276|NCT00428792|616781801|FG001|Overall Study|Lack of Efficacy|3|||
170663277|NCT00428792|616781800|FG000|Overall Study|Lost to Follow-up|0|||
170663278|NCT00428792|616781801|FG001|Overall Study|Lost to Follow-up|1|||
170663279|NCT00850343|616781803|FG000|Overall Study|Withdrawal by Subject|11|||
170663280|NCT00850343|616781804|FG001|Overall Study|Withdrawal by Subject|0|||
170663281|NCT00850343|616781805|FG002|Overall Study|Withdrawal by Subject|3|||
170663282|NCT00850343|616781806|FG003|Overall Study|Withdrawal by Subject|2|||
170663283|NCT00850343|616781803|FG000|Overall Study|Adverse Event|15|||
170663284|NCT00850343|616781804|FG001|Overall Study|Adverse Event|2|||
170663285|NCT00850343|616781805|FG002|Overall Study|Adverse Event|6|||
170663286|NCT00850343|616781806|FG003|Overall Study|Adverse Event|6|||
170663287|NCT00850343|616781803|FG000|Overall Study|Pregnancy|0|||
170663288|NCT00850343|616781804|FG001|Overall Study|Pregnancy|0|||
170663289|NCT00850343|616781805|FG002|Overall Study|Pregnancy|0|||
170663290|NCT00850343|616781806|FG003|Overall Study|Pregnancy|1|||
170663291|NCT00850343|616781803|FG000|Overall Study|Lack of Efficacy|17|||
170663292|NCT00850343|616781804|FG001|Overall Study|Lack of Efficacy|0|||
170663293|NCT00850343|616781805|FG002|Overall Study|Lack of Efficacy|3|||
170663294|NCT00850343|616781806|FG003|Overall Study|Lack of Efficacy|2|||
170663295|NCT00850343|616781803|FG000|Overall Study|Non-compliance with Study Procedures|1|||
170663296|NCT00850343|616781804|FG001|Overall Study|Non-compliance with Study Procedures|0|||
170663297|NCT00850343|616781805|FG002|Overall Study|Non-compliance with Study Procedures|1|||
170663298|NCT00850343|616781806|FG003|Overall Study|Non-compliance with Study Procedures|1|||
170663299|NCT00850343|616781803|FG000|Overall Study|Physician Decision|2|||
170663300|NCT00850343|616781804|FG001|Overall Study|Physician Decision|1|||
170663301|NCT00850343|616781805|FG002|Overall Study|Physician Decision|1|||
170663302|NCT00850343|616781806|FG003|Overall Study|Physician Decision|1|||
170663303|NCT02570074|616781807|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
170663304|NCT02570074|616781808|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
170663305|NCT00639678|616781810|FG000|Overall Study|Withdrawal by Subject|3|||
170663306|NCT00639678|616781811|FG001|Overall Study|Withdrawal by Subject|0|||
170663307|NCT00639678|616781812|FG002|Overall Study|Withdrawal by Subject|4|||
170663308|NCT00639678|616781813|FG003|Overall Study|Withdrawal by Subject|0|||
170663309|NCT00639678|616781810|FG000|Overall Study|Lost to Follow-up|1|||
170663310|NCT00639678|616781811|FG001|Overall Study|Lost to Follow-up|0|||
170663311|NCT00639678|616781812|FG002|Overall Study|Lost to Follow-up|6|||
170663312|NCT00639678|616781813|FG003|Overall Study|Lost to Follow-up|0|||
170663313|NCT00639678|616781810|FG000|Overall Study|Adverse Event|0|||
170663314|NCT00639678|616781811|FG001|Overall Study|Adverse Event|1|||
170663315|NCT00639678|616781812|FG002|Overall Study|Adverse Event|0|||
170663316|NCT00639678|616781813|FG003|Overall Study|Adverse Event|0|||
170663317|NCT00639678|616781810|FG000|Overall Study|Lack of Compliance|0|||
170663318|NCT00639678|616781811|FG001|Overall Study|Lack of Compliance|0|||
170663319|NCT00639678|616781812|FG002|Overall Study|Lack of Compliance|1|||
170663320|NCT00639678|616781813|FG003|Overall Study|Lack of Compliance|0|||
170663321|NCT01926015|616781814|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170663322|NCT01926015|616781815|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170663323|NCT01926015|616781814|FG000|Overall Study|Randomized not treated|2|||
170663324|NCT01926015|616781815|FG001|Overall Study|Randomized not treated|0|||
170663325|NCT01364649|616781816|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
170663326|NCT01364649|616781817|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
170663327|NCT01364649|616781816|FG000|Overall Study|Lack of Efficacy|6|||
170663328|NCT01364649|616781817|FG001|Overall Study|Lack of Efficacy|0|||
170663329|NCT01364649|616781816|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
170663330|NCT01364649|616781817|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
170663331|NCT01364649|616781816|FG000|Overall Study|Protocol Deviations|4|||
170663332|NCT01364649|616781817|FG001|Overall Study|Protocol Deviations|8|||
170663333|NCT01364649|616781816|FG000|Overall Study|Withdrawal of Consent|9|||
170663334|NCT01364649|616781817|FG001|Overall Study|Withdrawal of Consent|7|||
170663335|NCT01364649|616781816|FG000|Overall Study|Lost to Follow-up|12|||
170663336|NCT01364649|616781817|FG001|Overall Study|Lost to Follow-up|13|||
170663337|NCT01364649|616781816|FG000|Overall Study|Other|4|||
170663338|NCT01364649|616781817|FG001|Overall Study|Other|1|||
170663339|NCT01826604|616781818|FG000|Overall Study|Lost to Follow-up|8|||
170663340|NCT01826604|616781819|FG001|Overall Study|Lost to Follow-up|9|||
170663341|NCT02436304|616781820|FG000|Overall Study|Lost to Follow-up|0|||
170663342|NCT02436304|616781821|FG001|Overall Study|Lost to Follow-up|1|||
170663343|NCT02436304|616781822|FG002|Overall Study|Lost to Follow-up|0|||
170663344|NCT02436304|616781820|FG000|Overall Study|Withdrawal by Subject|0|||
170663345|NCT02436304|616781821|FG001|Overall Study|Withdrawal by Subject|1|||
170663346|NCT02436304|616781822|FG002|Overall Study|Withdrawal by Subject|0|||
170663347|NCT02436304|616781820|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
170663348|NCT02436304|616781821|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
170663349|NCT02436304|616781822|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
170663350|NCT05061966|616781823|FG000|Overall Study|Lost to Follow-up|13|||
170663351|NCT05061966|616781824|FG001|Overall Study|Lost to Follow-up|13|||
170663352|NCT04540497|616781825|FG000|Overall Study|Adverse Event|0|||
170663353|NCT04540497|616781826|FG001|Overall Study|Adverse Event|2|||
170663354|NCT04540497|616781825|FG000|Overall Study|Lost to Follow-up|1|||
170663355|NCT04540497|616781826|FG001|Overall Study|Lost to Follow-up|0|||
170663356|NCT04540497|616781825|FG000|Overall Study|Withdrawal by Subject|1|||
170663357|NCT04540497|616781826|FG001|Overall Study|Withdrawal by Subject|1|||
170663358|NCT04540497|616781825|FG000|Overall Study|Miscellaneous|2|||
170663359|NCT04540497|616781826|FG001|Overall Study|Miscellaneous|1|||
170663360|NCT04416633|616781827|FG000|Overall Study|Death|1|||
170663361|NCT04416633|616781827|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
170663362|NCT04416633|616781827|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
170663363|NCT04416633|616781827|FG000|Overall Study|Adverse Event|6|||
170663364|NCT04416633|616781827|FG000|Overall Study|Withdrawal by Subject|6|||
170817717|NCT01307800|617339831|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
170817718|NCT01307800|617339832|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
170817719|NCT01307800|617339829|FG000|Overall Study|Sponsor Decision|6|||
170817720|NCT01307800|617339830|FG001|Overall Study|Sponsor Decision|9|||
170817721|NCT01307800|617339831|FG002|Overall Study|Sponsor Decision|12|||
170817722|NCT01307800|617339832|FG003|Overall Study|Sponsor Decision|28|||
170817723|NCT01307800|617339829|FG000|Overall Study|Withdrawal by Subject|10|||
170663365|NCT04612790|616781828|FG000|DB Period (Up to 36 Weeks)|Death|1|||
170663366|NCT04612790|616781829|FG001|DB Period (Up to 36 Weeks)|Death|1|||
170663367|NCT04612790|616781830|FG002|DB Period (Up to 36 Weeks)|Death|0|||
170917221|NCT05301894|617697876|FG000|Overall Study|Lack of Efficacy|2|||
170917222|NCT05433090|617697878|FG000|Overall Study|Patient Discharged Before ACP Intervention|3|||
170663368|NCT04612790|616781831|FG003|DB Period (Up to 36 Weeks)|Death|0|||
170663369|NCT04612790|616781828|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
170663370|NCT04612790|616781829|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
170663371|NCT04612790|616781830|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
170917223|NCT05433090|617697878|FG000|Overall Study|Withdrawal by Subject|1|||
170917224|NCT05433090|617697878|FG000|Overall Study|Death|2|||
170917225|NCT03775486|617697887|FG000|Initial Therapy Phase|Other reason provided|0|||
170663372|NCT04612790|616781831|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
170663373|NCT04612790|616781828|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
170817724|NCT01307800|617339830|FG001|Overall Study|Withdrawal by Subject|11|||
170817725|NCT01307800|617339831|FG002|Overall Study|Withdrawal by Subject|8|||
170817726|NCT01307800|617339832|FG003|Overall Study|Withdrawal by Subject|15|||
170817727|NCT01307800|617339829|FG000|Overall Study|Participant Moved|0|||
170817728|NCT01307800|617339830|FG001|Overall Study|Participant Moved|2|||
170817729|NCT01307800|617339831|FG002|Overall Study|Participant Moved|1|||
170817730|NCT01307800|617339832|FG003|Overall Study|Participant Moved|3|||
170817731|NCT02892019|617339833|FG000|Overall Study|randomized but not treated|0|||
170817732|NCT02892019|617339834|FG001|Overall Study|randomized but not treated|1|||
170817733|NCT02892019|617339833|FG000|Overall Study|Withdrawal by Subject|0|||
170817734|NCT02892019|617339834|FG001|Overall Study|Withdrawal by Subject|1|||
170817735|NCT02892019|617339833|FG000|Overall Study|Adverse Event|1|||
170817736|NCT02892019|617339834|FG001|Overall Study|Adverse Event|1|||
170817737|NCT02674399|617339835|FG000|Overall Study|Lost to Follow-up|2|||
170817738|NCT02674399|617339836|FG001|Overall Study|Lost to Follow-up|0|||
170817739|NCT01313663|617339837|FG000|Overall Study|Study Closed/Terminated|2|||
170817740|NCT01313663|617339838|FG001|Overall Study|Study Closed/Terminated|4|||
170817741|NCT01313663|617339837|FG000|Overall Study|Lost to Follow-up|0|||
170817742|NCT01313663|617339838|FG001|Overall Study|Lost to Follow-up|1|||
170817743|NCT01313663|617339837|FG000|Overall Study|Physician Decision|0|||
170817744|NCT01313663|617339838|FG001|Overall Study|Physician Decision|2|||
170817745|NCT01313663|617339837|FG000|Overall Study|Withdrawal by Subject|2|||
170817746|NCT01313663|617339838|FG001|Overall Study|Withdrawal by Subject|1|||
170817747|NCT01294644|617339844|FG000|Overall Study|Adverse Event|2|||
170817748|NCT01294644|617339845|FG001|Overall Study|Adverse Event|0|||
170817749|NCT01294644|617339846|FG002|Overall Study|Adverse Event|1|||
170817750|NCT01294644|617339844|FG000|Overall Study|Withdrawal by Subject|3|||
170817751|NCT01294644|617339845|FG001|Overall Study|Withdrawal by Subject|7|||
170817752|NCT01294644|617339846|FG002|Overall Study|Withdrawal by Subject|4|||
170817753|NCT01294644|617339844|FG000|Overall Study|Lost to Follow-up|3|||
170817754|NCT01294644|617339845|FG001|Overall Study|Lost to Follow-up|2|||
170817755|NCT01294644|617339846|FG002|Overall Study|Lost to Follow-up|5|||
170616771|NCT03801174|616605190|FG000|Overall Study|Lost to Follow-up|19|||
170616772|NCT03801174|616605191|FG001|Overall Study|Lost to Follow-up|10|||
170616773|NCT03801174|616605190|FG000|Overall Study|Other|4|||
170616774|NCT03801174|616605191|FG001|Overall Study|Other|3|||
170616775|NCT03801174|616605190|FG000|Overall Study|Lack of Efficacy|4|||
170616776|NCT03801174|616605191|FG001|Overall Study|Lack of Efficacy|0|||
170616777|NCT03801174|616605190|FG000|Overall Study|Unwilling to complete activities|5|||
170616778|NCT03801174|616605191|FG001|Overall Study|Unwilling to complete activities|6|||
170616779|NCT03801174|616605190|FG000|Overall Study|Moved out of area|3|||
170616780|NCT03801174|616605191|FG001|Overall Study|Moved out of area|0|||
170616781|NCT01569841|616605194|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
170616782|NCT01569841|616605195|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
170616783|NCT00764361|616605196|FG000|Overall Study|Withdrawal by Subject|2|||
170616784|NCT00764361|616605197|FG001|Overall Study|Withdrawal by Subject|3|||
170616785|NCT00764361|616605196|FG000|Overall Study|Adverse Event|0|||
170616786|NCT00764361|616605197|FG001|Overall Study|Adverse Event|1|||
170616787|NCT04435366|616605198|FG000|Year 1 (12 Months)|Adverse Event|3|||
170616788|NCT04435366|616605199|FG001|Year 1 (12 Months)|Adverse Event|0|||
170616789|NCT04435366|616605200|FG002|Year 1 (12 Months)|Adverse Event|2|||
170616790|NCT04435366|616605198|FG000|Year 1 (12 Months)|Death|2|||
170616791|NCT04435366|616605199|FG001|Year 1 (12 Months)|Death|0|||
170616792|NCT04435366|616605200|FG002|Year 1 (12 Months)|Death|1|||
170616793|NCT04435366|616605198|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
170616794|NCT04435366|616605199|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
170616795|NCT04435366|616605200|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
170616796|NCT04435366|616605198|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
170616797|NCT04435366|616605199|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
170616798|NCT04435366|616605200|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
170616799|NCT04435366|616605198|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
170616800|NCT04435366|616605199|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
170616801|NCT04435366|616605200|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
170616802|NCT04435366|616605198|FG000|Year 1 (12 Months)|Not treated|0|||
170616803|NCT04435366|616605199|FG001|Year 1 (12 Months)|Not treated|0|||
170616804|NCT04435366|616605200|FG002|Year 1 (12 Months)|Not treated|1|||
170616805|NCT04435366|616605198|FG000|Year 2 (12 Months)|Death|1|||
170616806|NCT04435366|616605199|FG001|Year 2 (12 Months)|Death|4|||
170817756|NCT01294644|617339844|FG000|Overall Study|Miscellaneous Reason|2|||
170817757|NCT01294644|617339845|FG001|Overall Study|Miscellaneous Reason|1|||
170616807|NCT04435366|616605200|FG002|Year 2 (12 Months)|Death|6|||
170616808|NCT04435366|616605198|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
170616809|NCT04435366|616605199|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
170616810|NCT04435366|616605200|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
170616811|NCT04435366|616605198|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
170616812|NCT04435366|616605199|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
170616813|NCT04435366|616605200|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
170616814|NCT04435366|616605198|FG000|Year 2 (12 Months)|Adverse Event|2|||
170817758|NCT01294644|617339846|FG002|Overall Study|Miscellaneous Reason|4|||
170616815|NCT04435366|616605199|FG001|Year 2 (12 Months)|Adverse Event|1|||
170616816|NCT04435366|616605200|FG002|Year 2 (12 Months)|Adverse Event|6|||
170616817|NCT00413218|616605201|FG000|Overall Study|Randomized but didn't receive study drug|2|||
170616818|NCT00413218|616605202|FG001|Overall Study|Randomized but didn't receive study drug|8|||
170616819|NCT00413218|616605201|FG000|Overall Study|Death|57|||
170616820|NCT00413218|616605202|FG001|Overall Study|Death|56|||
170616821|NCT00413218|616605201|FG000|Overall Study|Lost to Follow-up|14|||
170616822|NCT00413218|616605202|FG001|Overall Study|Lost to Follow-up|17|||
170616823|NCT00413218|616605201|FG000|Overall Study|Admin|20|||
170616824|NCT00413218|616605202|FG001|Overall Study|Admin|14|||
170616825|NCT00413218|616605201|FG000|Overall Study|Missing|1|||
170616826|NCT00413218|616605202|FG001|Overall Study|Missing|0|||
170616827|NCT00413218|616605201|FG000|Overall Study|Withdrawal by Subject|9|||
170616828|NCT00413218|616605202|FG001|Overall Study|Withdrawal by Subject|1|||
170616829|NCT04112810|616605203|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
170616830|NCT01687296|616605204|FG000|Overall Study|Lack of Efficacy|1|||
170616831|NCT01687296|616605205|FG001|Overall Study|Lack of Efficacy|1|||
170616832|NCT01687296|616605204|FG000|Overall Study|Protocol Violation|0|||
170616833|NCT01687296|616605205|FG001|Overall Study|Protocol Violation|1|||
170616834|NCT01687296|616605204|FG000|Overall Study|Withdrawal by Subject|6|||
170616835|NCT01687296|616605205|FG001|Overall Study|Withdrawal by Subject|3|||
170616836|NCT00101686|616605208|FG000|Overall Study|Progressive Disease|37|||
170616837|NCT00101686|616605209|FG001|Overall Study|Progressive Disease|28|||
170616838|NCT00101686|616605210|FG002|Overall Study|Progressive Disease|37|||
170616839|NCT00101686|616605211|FG003|Overall Study|Progressive Disease|38|||
170616840|NCT00101686|616605212|FG004|Overall Study|Progressive Disease|28|||
170616841|NCT00101686|616605213|FG005|Overall Study|Progressive Disease|25|||
170616842|NCT00101686|616605214|FG006|Overall Study|Progressive Disease|5|||
170616843|NCT00101686|616605215|FG007|Overall Study|Progressive Disease|7|||
170616844|NCT00101686|616605216|FG008|Overall Study|Progressive Disease|10|||
170616845|NCT00101686|616605217|FG009|Overall Study|Progressive Disease|8|||
170616846|NCT00101686|616605208|FG000|Overall Study|initiation other anti-cancer treatment|4|||
170616847|NCT00101686|616605209|FG001|Overall Study|initiation other anti-cancer treatment|3|||
170616848|NCT00101686|616605210|FG002|Overall Study|initiation other anti-cancer treatment|4|||
170616849|NCT00101686|616605211|FG003|Overall Study|initiation other anti-cancer treatment|3|||
170616850|NCT00101686|616605212|FG004|Overall Study|initiation other anti-cancer treatment|1|||
170616851|NCT00101686|616605213|FG005|Overall Study|initiation other anti-cancer treatment|1|||
170616852|NCT00101686|616605214|FG006|Overall Study|initiation other anti-cancer treatment|2|||
170616853|NCT00101686|616605215|FG007|Overall Study|initiation other anti-cancer treatment|2|||
170616854|NCT00101686|616605216|FG008|Overall Study|initiation other anti-cancer treatment|3|||
170616855|NCT00101686|616605217|FG009|Overall Study|initiation other anti-cancer treatment|3|||
170817759|NCT02010684|617339847|FG000|Overall Study|Lost to Follow-up|8|||
170817760|NCT02010684|617339848|FG001|Overall Study|Lost to Follow-up|18|||
170817761|NCT02010684|617339847|FG000|Overall Study|Withdrawal by Subject|4|||
170817762|NCT02010684|617339848|FG001|Overall Study|Withdrawal by Subject|5|||
170817763|NCT00805441|617339849|FG000|Overall Study|Adverse Event|5|||
170817764|NCT00805441|617339850|FG001|Overall Study|Adverse Event|2|||
170817765|NCT00805441|617339849|FG000|Overall Study|Lack of Efficacy|0|||
170817766|NCT00805441|617339850|FG001|Overall Study|Lack of Efficacy|2|||
170817767|NCT00805441|617339849|FG000|Overall Study|Protocol Violation|4|||
170817768|NCT00805441|617339850|FG001|Overall Study|Protocol Violation|8|||
170817769|NCT00805441|617339849|FG000|Overall Study|Lost to Follow-up|10|||
170817770|NCT00805441|617339850|FG001|Overall Study|Lost to Follow-up|13|||
170817771|NCT00805441|617339849|FG000|Overall Study|Withdrawal by Subject|15|||
170817772|NCT00805441|617339850|FG001|Overall Study|Withdrawal by Subject|9|||
170817773|NCT00805441|617339849|FG000|Overall Study|Physician Decision|0|||
170817774|NCT00805441|617339850|FG001|Overall Study|Physician Decision|1|||
170817775|NCT00805441|617339849|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
170817776|NCT00805441|617339850|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
170817777|NCT01898299|617339853|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
170817778|NCT01898299|617339854|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
170817779|NCT02340806|617339861|FG000|Overall Study|Protocol Violation|2|||
170817780|NCT02340806|617339862|FG001|Overall Study|Protocol Violation|0|||
170817781|NCT02340806|617339861|FG000|Overall Study|epidural catheter replaced|2|||
170817782|NCT02340806|617339862|FG001|Overall Study|epidural catheter replaced|1|||
170817783|NCT02340806|617339861|FG000|Overall Study|history of chronic pain medication|1|||
170817784|NCT02340806|617339862|FG001|Overall Study|history of chronic pain medication|0|||
170817785|NCT02340806|617339861|FG000|Overall Study|re-dose < 90 min of CSE|1|||
170817786|NCT02340806|617339862|FG001|Overall Study|re-dose < 90 min of CSE|3|||
170917226|NCT03775486|617697888|FG001|Initial Therapy Phase|Other reason provided|15|||
170616856|NCT00101686|616605208|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
170817787|NCT01634165|617339864|FG000|Period 2|Adverse Event|0|||
170616857|NCT00101686|616605209|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
170616858|NCT00101686|616605210|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
170616859|NCT00101686|616605211|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
170616860|NCT00101686|616605212|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
170917227|NCT03775486|617697887|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
170663374|NCT04612790|616781829|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
170663375|NCT04612790|616781830|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
170663376|NCT04612790|616781831|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
170917228|NCT03775486|617697888|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
170917229|NCT03775486|617697887|FG000|Initial Therapy Phase|Protocol Violation|0|||
170917230|NCT03775486|617697888|FG001|Initial Therapy Phase|Protocol Violation|2|||
170917231|NCT03775486|617697887|FG000|Initial Therapy Phase|Adverse Event|0|||
170917232|NCT03775486|617697888|FG001|Initial Therapy Phase|Adverse Event|34|||
170917233|NCT03775486|617697887|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
170917234|NCT03775486|617697888|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
170917235|NCT03775486|617697887|FG000|Maintenance Phase|Withdrawal by Subject|13|||
170917236|NCT03775486|617697888|FG001|Maintenance Phase|Withdrawal by Subject|12|||
170917237|NCT03775486|617697887|FG000|Maintenance Phase|Death|44|||
170917238|NCT03775486|617697888|FG001|Maintenance Phase|Death|45|||
170917239|NCT02257736|617697889|FG000|Overall Study|Progressive disease|365|||
170917240|NCT02257736|617697890|FG001|Overall Study|Progressive disease|327|||
170917241|NCT02257736|617697889|FG000|Overall Study|Adverse Event|45|||
170917242|NCT02257736|617697890|FG001|Overall Study|Adverse Event|56|||
170917243|NCT02257736|617697889|FG000|Overall Study|Withdrawal by Subject|21|||
170917244|NCT02257736|617697890|FG001|Overall Study|Withdrawal by Subject|38|||
170917245|NCT02257736|617697889|FG000|Overall Study|Death|11|||
170917246|NCT02257736|617697890|FG001|Overall Study|Death|6|||
170917247|NCT02257736|617697889|FG000|Overall Study|Physician Decision|5|||
170917248|NCT02257736|617697890|FG001|Overall Study|Physician Decision|9|||
170917249|NCT02257736|617697889|FG000|Overall Study|Non-Compliance with study drug|1|||
170917250|NCT02257736|617697890|FG001|Overall Study|Non-Compliance with study drug|2|||
170917251|NCT02257736|617697889|FG000|Overall Study|Protocol Violation|1|||
170917252|NCT02257736|617697890|FG001|Overall Study|Protocol Violation|0|||
170917253|NCT02257736|617697889|FG000|Overall Study|Other|1|||
170917254|NCT02257736|617697890|FG001|Overall Study|Other|7|||
170917255|NCT02257736|617697889|FG000|Overall Study|Randomized, not treated|1|||
170917256|NCT02257736|617697890|FG001|Overall Study|Randomized, not treated|2|||
170917257|NCT05550532|617697891|FG000|Overall Study|Withdrawal by Subject|8|||
170917258|NCT05550532|617697892|FG001|Overall Study|Withdrawal by Subject|3|||
170917259|NCT05550532|617697891|FG000|Overall Study|Adverse Event|2|||
170917260|NCT05550532|617697892|FG001|Overall Study|Adverse Event|3|||
170917261|NCT05550532|617697891|FG000|Overall Study|Lost to Follow-up|4|||
170917262|NCT05550532|617697892|FG001|Overall Study|Lost to Follow-up|0|||
170917263|NCT05550532|617697891|FG000|Overall Study|Other|0|||
170917264|NCT05550532|617697892|FG001|Overall Study|Other|4|||
170917265|NCT02499146|617697893|FG000|Overall Study|Global deterioration of health status|1|||
170917266|NCT02499146|617697893|FG000|Overall Study|Objective progression or relapse|20|||
170917267|NCT02499146|617697893|FG000|Overall Study|Other|2|||
170917268|NCT02499146|617697893|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
170917269|NCT06250101|617697894|FG000|Overall Study|Excessive absenteeism|1|||
170917270|NCT06250101|617697895|FG001|Overall Study|Excessive absenteeism|0|||
170616861|NCT00101686|616605213|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
170616862|NCT00101686|616605214|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
170616863|NCT00101686|616605215|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
170616864|NCT00101686|616605216|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
170616865|NCT00101686|616605217|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
170616866|NCT00101686|616605208|FG000|Overall Study|unacceptable toxicity|3|||
170616867|NCT00101686|616605209|FG001|Overall Study|unacceptable toxicity|9|||
170616868|NCT00101686|616605210|FG002|Overall Study|unacceptable toxicity|10|||
170616869|NCT00101686|616605211|FG003|Overall Study|unacceptable toxicity|6|||
170616870|NCT00101686|616605212|FG004|Overall Study|unacceptable toxicity|16|||
170616871|NCT00101686|616605213|FG005|Overall Study|unacceptable toxicity|10|||
170616872|NCT00101686|616605214|FG006|Overall Study|unacceptable toxicity|4|||
170616873|NCT00101686|616605215|FG007|Overall Study|unacceptable toxicity|2|||
170616874|NCT00101686|616605216|FG008|Overall Study|unacceptable toxicity|1|||
170616875|NCT00101686|616605217|FG009|Overall Study|unacceptable toxicity|4|||
170616876|NCT00101686|616605208|FG000|Overall Study|Randomized but did not receive treament|1|||
170616877|NCT00101686|616605209|FG001|Overall Study|Randomized but did not receive treament|6|||
170616878|NCT00101686|616605210|FG002|Overall Study|Randomized but did not receive treament|2|||
170663377|NCT04612790|616781828|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
170663378|NCT04612790|616781829|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
170663379|NCT04612790|616781830|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
170663380|NCT04612790|616781831|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
170663381|NCT04612790|616781828|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
170663382|NCT04612790|616781829|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
170663383|NCT04612790|616781830|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
170917271|NCT04325828|617697898|FG000|Overall Study|Ongoing|26|||
170917272|NCT06001840|617697902|FG000|Overall Study|Lost to Follow-up|4|||
170663384|NCT04612790|616781831|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
170663385|NCT04612790|616781828|FG000|DB Period (Up to 36 Weeks)|Other|1|||
170663386|NCT04612790|616781829|FG001|DB Period (Up to 36 Weeks)|Other|0|||
170663387|NCT04612790|616781830|FG002|DB Period (Up to 36 Weeks)|Other|0|||
170663388|NCT04612790|616781831|FG003|DB Period (Up to 36 Weeks)|Other|0|||
170663389|NCT04612790|616781828|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
170663390|NCT04612790|616781829|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
170663391|NCT04612790|616781830|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
170663392|NCT04612790|616781831|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
170663393|NCT04612790|616781828|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
170663394|NCT04612790|616781829|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
170663395|NCT04612790|616781830|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
170663396|NCT04612790|616781831|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
170663397|NCT04612790|616781828|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
170663398|NCT04612790|616781829|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
170663399|NCT04612790|616781830|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
170663400|NCT04612790|616781831|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
170663401|NCT04612790|616781828|FG000|OLE Period (Up to 1 Year)|Other|0|||
170663402|NCT04612790|616781829|FG001|OLE Period (Up to 1 Year)|Other|0|||
170663403|NCT04612790|616781830|FG002|OLE Period (Up to 1 Year)|Other|0|||
170663404|NCT04612790|616781831|FG003|OLE Period (Up to 1 Year)|Other|1|||
170663405|NCT00785928|616781832|FG000|Treatment Phase|Adverse Event|1|||
170663406|NCT00785928|616781833|FG001|Treatment Phase|Adverse Event|1|||
170663407|NCT00785928|616781834|FG002|Treatment Phase|Adverse Event|2|||
170663408|NCT00785928|616781835|FG003|Treatment Phase|Adverse Event|0|||
170663409|NCT00785928|616781836|FG004|Treatment Phase|Adverse Event|0|||
170663410|NCT00785928|616781837|FG005|Treatment Phase|Adverse Event|0|||
170663411|NCT00785928|616781838|FG006|Treatment Phase|Adverse Event|2|||
170663412|NCT00785928|616781832|FG000|Treatment Phase|Inadequate Response|0|||
170663413|NCT00785928|616781833|FG001|Treatment Phase|Inadequate Response|1|||
170663414|NCT00785928|616781834|FG002|Treatment Phase|Inadequate Response|0|||
170663415|NCT00785928|616781835|FG003|Treatment Phase|Inadequate Response|0|||
170663416|NCT00785928|616781836|FG004|Treatment Phase|Inadequate Response|0|||
170663417|NCT00785928|616781837|FG005|Treatment Phase|Inadequate Response|0|||
170663418|NCT00785928|616781838|FG006|Treatment Phase|Inadequate Response|0|||
170663419|NCT00785928|616781832|FG000|Treatment Phase|Lack of Efficacy|0|||
170663420|NCT00785928|616781833|FG001|Treatment Phase|Lack of Efficacy|1|||
170663421|NCT00785928|616781834|FG002|Treatment Phase|Lack of Efficacy|1|||
170663422|NCT00785928|616781835|FG003|Treatment Phase|Lack of Efficacy|0|||
170663423|NCT00785928|616781836|FG004|Treatment Phase|Lack of Efficacy|0|||
170663424|NCT00785928|616781837|FG005|Treatment Phase|Lack of Efficacy|0|||
170663425|NCT00785928|616781838|FG006|Treatment Phase|Lack of Efficacy|0|||
170663426|NCT00785928|616781832|FG000|Treatment Phase|Physician Decision|0|||
170663427|NCT00785928|616781833|FG001|Treatment Phase|Physician Decision|0|||
170663428|NCT00785928|616781834|FG002|Treatment Phase|Physician Decision|0|||
170663429|NCT00785928|616781835|FG003|Treatment Phase|Physician Decision|0|||
170663430|NCT00785928|616781836|FG004|Treatment Phase|Physician Decision|1|||
170663431|NCT00785928|616781837|FG005|Treatment Phase|Physician Decision|0|||
170663432|NCT00785928|616781838|FG006|Treatment Phase|Physician Decision|0|||
170663433|NCT00785928|616781832|FG000|Treatment Phase|Sponsor Decision|1|||
170663434|NCT00785928|616781833|FG001|Treatment Phase|Sponsor Decision|0|||
170663435|NCT00785928|616781834|FG002|Treatment Phase|Sponsor Decision|0|||
170663436|NCT00785928|616781835|FG003|Treatment Phase|Sponsor Decision|0|||
170663437|NCT00785928|616781836|FG004|Treatment Phase|Sponsor Decision|0|||
170663438|NCT00785928|616781837|FG005|Treatment Phase|Sponsor Decision|0|||
170663439|NCT00785928|616781838|FG006|Treatment Phase|Sponsor Decision|1|||
170663440|NCT00785928|616781832|FG000|Treatment Phase|Withdrawal by Subject|1|||
170663441|NCT00785928|616781833|FG001|Treatment Phase|Withdrawal by Subject|2|||
170663442|NCT00785928|616781834|FG002|Treatment Phase|Withdrawal by Subject|0|||
170663443|NCT00785928|616781835|FG003|Treatment Phase|Withdrawal by Subject|0|||
170663444|NCT00785928|616781836|FG004|Treatment Phase|Withdrawal by Subject|1|||
170663445|NCT00785928|616781837|FG005|Treatment Phase|Withdrawal by Subject|0|||
170663446|NCT00785928|616781838|FG006|Treatment Phase|Withdrawal by Subject|0|||
170663447|NCT03323502|616781842|FG000|Overall Study|Resident could not be linked to CMS data|594|||
170663448|NCT03323502|616781843|FG001|Overall Study|Resident could not be linked to CMS data|435|||
170663449|NCT03323502|616781842|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
170663450|NCT03323502|616781843|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
170663451|NCT03323502|616781842|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
170663452|NCT03323502|616781843|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
170663453|NCT03323502|616781842|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
170663454|NCT03323502|616781843|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
170663455|NCT03323502|616781842|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
170663456|NCT03323502|616781843|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
170663457|NCT03615326|616781844|FG000|Overall Study|Death|266|||
170663458|NCT03615326|616781845|FG001|Overall Study|Death|286|||
170663459|NCT03615326|616781846|FG002|Overall Study|Death|14|||
170663460|NCT03615326|616781847|FG003|Overall Study|Death|17|||
170663461|NCT03615326|616781844|FG000|Overall Study|Lost to Follow-up|0|||
170663462|NCT03615326|616781845|FG001|Overall Study|Lost to Follow-up|1|||
170663463|NCT03615326|616781846|FG002|Overall Study|Lost to Follow-up|0|||
170663464|NCT03615326|616781847|FG003|Overall Study|Lost to Follow-up|0|||
170663465|NCT03615326|616781844|FG000|Overall Study|Withdrawal by Subject|1|||
170663466|NCT03615326|616781845|FG001|Overall Study|Withdrawal by Subject|3|||
170663467|NCT03615326|616781846|FG002|Overall Study|Withdrawal by Subject|0|||
170663468|NCT03615326|616781847|FG003|Overall Study|Withdrawal by Subject|0|||
170663469|NCT03615326|616781844|FG000|Overall Study|Participants Ongoing|83|||
170663470|NCT03615326|616781845|FG001|Overall Study|Participants Ongoing|58|||
170663471|NCT03615326|616781846|FG002|Overall Study|Participants Ongoing|6|||
170663472|NCT03615326|616781847|FG003|Overall Study|Participants Ongoing|3|||
170663473|NCT01539642|616781849|FG000|Overall Study|Lack of Efficacy|20|||
170663474|NCT01539642|616781850|FG001|Overall Study|Lack of Efficacy|18|||
170663475|NCT01539642|616781849|FG000|Overall Study|Patient ready for early discharge|8|||
170663476|NCT01539642|616781850|FG001|Overall Study|Patient ready for early discharge|7|||
170663477|NCT01539642|616781849|FG000|Overall Study|Adverse Event|6|||
170663478|NCT01539642|616781850|FG001|Overall Study|Adverse Event|4|||
170663479|NCT01539642|616781849|FG000|Overall Study|Withdrawal by Subject|2|||
170663480|NCT01539642|616781850|FG001|Overall Study|Withdrawal by Subject|2|||
170663481|NCT02651467|616781851|FG000|Overall Study|Withdrawal by Subject|0|||
170663482|NCT02651467|616781852|FG001|Overall Study|Withdrawal by Subject|0|||
170663483|NCT02651467|616781853|FG002|Overall Study|Withdrawal by Subject|2|||
170663484|NCT02651467|616781851|FG000|Overall Study|Other (Not specified)|1|||
170663485|NCT02651467|616781852|FG001|Overall Study|Other (Not specified)|0|||
170663486|NCT02651467|616781853|FG002|Overall Study|Other (Not specified)|2|||
170663487|NCT00408629|616781856|FG000|Overall Study|Adverse Event|13|||
170663488|NCT00408629|616781857|FG001|Overall Study|Adverse Event|27|||
170663489|NCT00408629|616781856|FG000|Overall Study|Withdrawal by Subject|8|||
170663490|NCT00408629|616781857|FG001|Overall Study|Withdrawal by Subject|4|||
170663491|NCT00408629|616781856|FG000|Overall Study|Lost to Follow-up|1|||
170663492|NCT00408629|616781857|FG001|Overall Study|Lost to Follow-up|1|||
170663493|NCT00408629|616781856|FG000|Overall Study|Lack of Efficacy|63|||
170663494|NCT00408629|616781857|FG001|Overall Study|Lack of Efficacy|73|||
170663495|NCT00408629|616781856|FG000|Overall Study|Protocol Violation|1|||
170663496|NCT00408629|616781857|FG001|Overall Study|Protocol Violation|5|||
170663497|NCT00408629|616781856|FG000|Overall Study|Miscellaneous|11|||
170663498|NCT00408629|616781857|FG001|Overall Study|Miscellaneous|15|||
170663499|NCT00122109|616781858|FG000|Overall Study|Did not meet criteria|6|||
170663500|NCT00122109|616781859|FG001|Overall Study|Did not meet criteria|7|||
170663501|NCT01890746|616781862|FG000|Overall Study|Death|39|||
170663502|NCT01890746|616781863|FG001|Overall Study|Death|30|||
170663503|NCT01890746|616781862|FG000|Overall Study|Adverse Event|1|||
170663504|NCT01890746|616781863|FG001|Overall Study|Adverse Event|0|||
170663505|NCT01890746|616781862|FG000|Overall Study|Lost to Follow-up|4|||
170663506|NCT01890746|616781863|FG001|Overall Study|Lost to Follow-up|1|||
170663507|NCT01890746|616781862|FG000|Overall Study|Physician Decision|3|||
170663508|NCT01890746|616781863|FG001|Overall Study|Physician Decision|2|||
170663509|NCT01890746|616781862|FG000|Overall Study|Withdrawal by Subject|5|||
170663510|NCT01890746|616781863|FG001|Overall Study|Withdrawal by Subject|8|||
170663511|NCT03257371|616781864|FG000|Overall Study|Lost to Follow-up|1|||
170663512|NCT00631696|616781865|FG000|Overall Study|Entered, not randomized to treatment|1|||
170663513|NCT00631696|616781866|FG001|Overall Study|Entered, not randomized to treatment|1|||
170663514|NCT00631696|616781865|FG000|Overall Study|Discontinued after database release date|1|||
170663515|NCT00631696|616781866|FG001|Overall Study|Discontinued after database release date|0|||
170663516|NCT00631696|616781865|FG000|Overall Study|Follow up after database release date|1|||
170663517|NCT00631696|616781866|FG001|Overall Study|Follow up after database release date|0|||
170663518|NCT00631696|616781865|FG000|Overall Study|Lost to Follow-up|7|||
170663519|NCT00631696|616781866|FG001|Overall Study|Lost to Follow-up|10|||
170663520|NCT00631696|616781865|FG000|Overall Study|Withdrawal by Subject|2|||
170663521|NCT00631696|616781866|FG001|Overall Study|Withdrawal by Subject|9|||
170663522|NCT00631696|616781865|FG000|Overall Study|Other|8|||
170663523|NCT00631696|616781866|FG001|Overall Study|Other|8|||
170663524|NCT00631696|616781865|FG000|Overall Study|Protocol Violation|9|||
170663525|NCT00631696|616781866|FG001|Overall Study|Protocol Violation|9|||
170663526|NCT00631696|616781865|FG000|Overall Study|Study terminated by sponsor|3|||
170663527|NCT00631696|616781866|FG001|Overall Study|Study terminated by sponsor|3|||
170663528|NCT00631696|616781865|FG000|Overall Study|Adverse Event|5|||
170663529|NCT00631696|616781866|FG001|Overall Study|Adverse Event|0|||
170663530|NCT03198078|616781867|FG000|Overall Study|Adverse Event|0|||
170663531|NCT03198078|616781868|FG001|Overall Study|Adverse Event|1|||
170663532|NCT03198078|616781869|FG002|Overall Study|Adverse Event|2|||
170663533|NCT03198078|616781867|FG000|Overall Study|Lack of Efficacy|0|||
170663534|NCT03198078|616781868|FG001|Overall Study|Lack of Efficacy|0|||
170663535|NCT03198078|616781869|FG002|Overall Study|Lack of Efficacy|3|||
170663536|NCT03198078|616781867|FG000|Overall Study|Lost to Follow-up|1|||
170663537|NCT03198078|616781868|FG001|Overall Study|Lost to Follow-up|0|||
170663538|NCT03198078|616781869|FG002|Overall Study|Lost to Follow-up|0|||
170663539|NCT03198078|616781867|FG000|Overall Study|Pregnancy|0|||
170663540|NCT03198078|616781868|FG001|Overall Study|Pregnancy|1|||
170663541|NCT03198078|616781869|FG002|Overall Study|Pregnancy|0|||
170663542|NCT03198078|616781867|FG000|Overall Study|Withdrawal by Subject|1|||
170663543|NCT03198078|616781868|FG001|Overall Study|Withdrawal by Subject|0|||
170663544|NCT03198078|616781869|FG002|Overall Study|Withdrawal by Subject|2|||
170663545|NCT03198078|616781867|FG000|Overall Study|Withdrawal by Caregiver|1|||
170663546|NCT03198078|616781868|FG001|Overall Study|Withdrawal by Caregiver|3|||
170663547|NCT03198078|616781869|FG002|Overall Study|Withdrawal by Caregiver|5|||
170663548|NCT03114488|616781871|FG000|Time Period 2|Withdrawal by Subject|1|||
170663549|NCT03114488|616781872|FG001|Time Period 2|Withdrawal by Subject|3|||
170663550|NCT03711266|616781874|FG000|Overall Study|Lost to Follow-up|10|||
170663551|NCT00057876|616781875|FG000|Overall Study|Adverse Event|8|||
170663552|NCT00057876|616781876|FG001|Overall Study|Adverse Event|8|||
170663553|NCT00057876|616781875|FG000|Overall Study|Death|2|||
170663554|NCT00057876|616781876|FG001|Overall Study|Death|1|||
170663555|NCT00057876|616781875|FG000|Overall Study|Withdrawal by Subject|5|||
170663556|NCT00057876|616781876|FG001|Overall Study|Withdrawal by Subject|6|||
170663557|NCT00057876|616781875|FG000|Overall Study|Lack of Efficacy|10|||
170663558|NCT00057876|616781876|FG001|Overall Study|Lack of Efficacy|8|||
170663559|NCT00057876|616781875|FG000|Overall Study|Ineligible|1|||
170663560|NCT00057876|616781876|FG001|Overall Study|Ineligible|2|||
170663561|NCT00057876|616781875|FG000|Overall Study|other reason|2|||
170663562|NCT00057876|616781876|FG001|Overall Study|other reason|2|||
170663563|NCT00057876|616781875|FG000|Overall Study|other complicating disease|1|||
170663564|NCT00057876|616781876|FG001|Overall Study|other complicating disease|0|||
170663565|NCT04553679|616781877|FG000|Overall Study|Withdrawal by Subject|2|||
170663566|NCT04553679|616781878|FG001|Overall Study|Withdrawal by Subject|0|||
170663567|NCT04553679|616781877|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
170663568|NCT04553679|616781878|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
170663569|NCT00381381|616781888|FG000|Overall Study|Adverse Event|3|||
170663570|NCT00381381|616781888|FG000|Overall Study|Lost to Follow-up|52|||
170663571|NCT00381381|616781888|FG000|Overall Study|Withdrawal by Subject|9|||
170663572|NCT01912963|616781891|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
170663573|NCT01912963|616781892|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
170663574|NCT01912963|616781893|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
170663575|NCT01912963|616781891|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
170663576|NCT01912963|616781892|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
170663577|NCT01912963|616781893|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
170663578|NCT01912963|616781891|FG000|Overall Study|Adverse Event|0|||
170663579|NCT01912963|616781892|FG001|Overall Study|Adverse Event|1|||
170663580|NCT01912963|616781893|FG002|Overall Study|Adverse Event|1|||
170663581|NCT01912963|616781891|FG000|Overall Study|Withdrawal by Subject|0|||
170663582|NCT01912963|616781892|FG001|Overall Study|Withdrawal by Subject|1|||
170663583|NCT01912963|616781893|FG002|Overall Study|Withdrawal by Subject|0|||
170663584|NCT01912963|616781891|FG000|Overall Study|Sought treatment locally|0|||
170663585|NCT01912963|616781892|FG001|Overall Study|Sought treatment locally|1|||
170663586|NCT01912963|616781893|FG002|Overall Study|Sought treatment locally|0|||
170663587|NCT01528215|616781895|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
170663588|NCT01528215|616781896|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
170663589|NCT01528215|616781895|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
170663590|NCT01528215|616781896|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
170663591|NCT01528215|616781895|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
170663592|NCT01528215|616781896|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
170663593|NCT01528215|616781895|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
170663594|NCT01528215|616781896|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
170663595|NCT02787551|616781897|FG000|Core Period: 26 Weeks|Adverse Event|10|||
170663596|NCT02787551|616781898|FG001|Core Period: 26 Weeks|Adverse Event|0|||
170663597|NCT02787551|616781897|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
170663598|NCT02787551|616781898|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
170663599|NCT02787551|616781897|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
170663600|NCT02787551|616781898|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
170663601|NCT02787551|616781897|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
170663602|NCT02787551|616781898|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
170663603|NCT02787551|616781897|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
170663604|NCT02787551|616781898|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
170663605|NCT02787551|616781897|FG000|Core Period: 26 Weeks|Other than specified|3|||
170663606|NCT02787551|616781898|FG001|Core Period: 26 Weeks|Other than specified|1|||
170663607|NCT02787551|616781897|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
170663608|NCT02787551|616781898|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
170663609|NCT02787551|616781897|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
170663610|NCT02787551|616781898|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
170663611|NCT02787551|616781897|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
170663612|NCT02787551|616781898|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
170663613|NCT03799211|616781899|FG000|Overall Study|Lost to Follow-up|2|||
170663614|NCT03799211|616781900|FG001|Overall Study|Lost to Follow-up|13|||
170663615|NCT03799211|616781899|FG000|Overall Study|Withdrawal by Subject|2|||
170663616|NCT03799211|616781900|FG001|Overall Study|Withdrawal by Subject|0|||
170663617|NCT05394350|616781902|FG000|Overall Study|Death|2|||
170663618|NCT05394350|616781903|FG001|Overall Study|Death|2|||
170663619|NCT05394350|616781904|FG002|Overall Study|Death|4|||
170663620|NCT05394350|616781905|FG003|Overall Study|Death|0|||
170663621|NCT05394350|616781906|FG004|Overall Study|Death|1|||
170663622|NCT05394350|616781907|FG005|Overall Study|Death|0|||
170663623|NCT05394350|616781902|FG000|Overall Study|Study terminated by sponsor|1|||
170663624|NCT05394350|616781903|FG001|Overall Study|Study terminated by sponsor|1|||
170663625|NCT05394350|616781904|FG002|Overall Study|Study terminated by sponsor|7|||
170663626|NCT05394350|616781905|FG003|Overall Study|Study terminated by sponsor|3|||
170663627|NCT05394350|616781906|FG004|Overall Study|Study terminated by sponsor|2|||
170917273|NCT06001840|617697903|FG001|Overall Study|Lost to Follow-up|4|||
170917274|NCT06001840|617697902|FG000|Overall Study|Withdrawal by Subject|0|||
170917275|NCT06001840|617697903|FG001|Overall Study|Withdrawal by Subject|2|||
170917276|NCT06001840|617697902|FG000|Overall Study|Screen fail|2|||
170917277|NCT06001840|617697903|FG001|Overall Study|Screen fail|0|||
170917278|NCT04865770|617697904|FG000|Overall Study|Withdrawal by Subject|3|||
170917279|NCT04865770|617697905|FG001|Overall Study|Withdrawal by Subject|0|||
170616879|NCT00101686|616605211|FG003|Overall Study|Randomized but did not receive treament|2|||
170616880|NCT00101686|616605212|FG004|Overall Study|Randomized but did not receive treament|2|||
170616881|NCT00101686|616605213|FG005|Overall Study|Randomized but did not receive treament|2|||
170616882|NCT00101686|616605214|FG006|Overall Study|Randomized but did not receive treament|0|||
170616883|NCT00101686|616605215|FG007|Overall Study|Randomized but did not receive treament|1|||
170616884|NCT00101686|616605216|FG008|Overall Study|Randomized but did not receive treament|0|||
170616885|NCT00101686|616605217|FG009|Overall Study|Randomized but did not receive treament|1|||
170616886|NCT00101686|616605208|FG000|Overall Study|intercurrent non-cancer related illness|0|||
170616887|NCT00101686|616605209|FG001|Overall Study|intercurrent non-cancer related illness|0|||
170616888|NCT00101686|616605210|FG002|Overall Study|intercurrent non-cancer related illness|2|||
170616889|NCT00101686|616605211|FG003|Overall Study|intercurrent non-cancer related illness|0|||
170616890|NCT00101686|616605212|FG004|Overall Study|intercurrent non-cancer related illness|1|||
170616891|NCT00101686|616605213|FG005|Overall Study|intercurrent non-cancer related illness|3|||
170616892|NCT00101686|616605214|FG006|Overall Study|intercurrent non-cancer related illness|1|||
170616893|NCT00101686|616605215|FG007|Overall Study|intercurrent non-cancer related illness|0|||
170616894|NCT00101686|616605216|FG008|Overall Study|intercurrent non-cancer related illness|1|||
170616895|NCT00101686|616605217|FG009|Overall Study|intercurrent non-cancer related illness|1|||
170616896|NCT00101686|616605208|FG000|Overall Study|Physician Decision|10|||
170616897|NCT00101686|616605209|FG001|Overall Study|Physician Decision|13|||
170616898|NCT00101686|616605210|FG002|Overall Study|Physician Decision|6|||
170616899|NCT00101686|616605211|FG003|Overall Study|Physician Decision|7|||
170616900|NCT00101686|616605212|FG004|Overall Study|Physician Decision|8|||
170616901|NCT00101686|616605213|FG005|Overall Study|Physician Decision|9|||
170616902|NCT00101686|616605214|FG006|Overall Study|Physician Decision|5|||
170616903|NCT00101686|616605215|FG007|Overall Study|Physician Decision|5|||
170616904|NCT00101686|616605216|FG008|Overall Study|Physician Decision|1|||
170616905|NCT00101686|616605217|FG009|Overall Study|Physician Decision|1|||
170616906|NCT00101686|616605208|FG000|Overall Study|Other|1|||
170616907|NCT00101686|616605209|FG001|Overall Study|Other|4|||
170616908|NCT00101686|616605210|FG002|Overall Study|Other|1|||
170616909|NCT00101686|616605211|FG003|Overall Study|Other|6|||
170616910|NCT00101686|616605212|FG004|Overall Study|Other|2|||
170616911|NCT00101686|616605213|FG005|Overall Study|Other|12|||
170616912|NCT00101686|616605214|FG006|Overall Study|Other|1|||
170616913|NCT00101686|616605215|FG007|Overall Study|Other|5|||
170616914|NCT00101686|616605216|FG008|Overall Study|Other|3|||
170917280|NCT04865770|617697904|FG000|Overall Study|Physician Decision|9|||
170917281|NCT04865770|617697905|FG001|Overall Study|Physician Decision|0|||
170917282|NCT04865770|617697904|FG000|Overall Study|Death|1|||
170917283|NCT04865770|617697905|FG001|Overall Study|Death|1|||
170616915|NCT00101686|616605217|FG009|Overall Study|Other|3|||
170616916|NCT00101686|616605208|FG000|Overall Study|Withdrawal by Subject|9|||
170616917|NCT00101686|616605209|FG001|Overall Study|Withdrawal by Subject|8|||
170616918|NCT00101686|616605210|FG002|Overall Study|Withdrawal by Subject|6|||
170616919|NCT00101686|616605211|FG003|Overall Study|Withdrawal by Subject|8|||
170917284|NCT03362177|617697906|FG000|Overall Study|Lost to Follow-up|2|||
170917285|NCT03362177|617697907|FG001|Overall Study|Lost to Follow-up|0|||
170917286|NCT03362177|617697906|FG000|Overall Study|Withdrawal by Subject|12|||
170917287|NCT03362177|617697907|FG001|Overall Study|Withdrawal by Subject|8|||
170917288|NCT03362177|617697906|FG000|Overall Study|Decision by sponsor|6|||
170917289|NCT03362177|617697907|FG001|Overall Study|Decision by sponsor|0|||
170663628|NCT05394350|616781907|FG005|Overall Study|Study terminated by sponsor|4|||
170663629|NCT02435069|616781914|FG000|Dose Response - First Intervention|Adverse Event|0|||
170663630|NCT02435069|616781915|FG001|Dose Response - First Intervention|Adverse Event|1|||
170663631|NCT02435069|616781916|FG002|Dose Response - First Intervention|Adverse Event|1|||
170663632|NCT02435069|616781917|FG003|Dose Response - First Intervention|Adverse Event|0|||
170663633|NCT02435069|616781918|FG004|Dose Response - First Intervention|Adverse Event|0|||
170663634|NCT02435069|616781914|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
170663635|NCT02435069|616781915|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
170663636|NCT02435069|616781916|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
170663637|NCT02435069|616781917|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
170663638|NCT02435069|616781918|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
170663639|NCT00543543|616781921|FG000|Base Study|Adverse Event|1|||
170663640|NCT00543543|616781922|FG001|Base Study|Adverse Event|11|||
170663641|NCT00543543|616781923|FG002|Base Study|Adverse Event|0|||
170663642|NCT00543543|616781924|FG003|Base Study|Adverse Event|5|||
170663643|NCT00543543|616781921|FG000|Base Study|Lost to Follow-up|12|||
170663644|NCT00543543|616781922|FG001|Base Study|Lost to Follow-up|749|||
170663645|NCT00543543|616781923|FG002|Base Study|Lost to Follow-up|9|||
170663646|NCT00543543|616781924|FG003|Base Study|Lost to Follow-up|701|||
170663647|NCT00543543|616781921|FG000|Base Study|Physician Decision|0|||
170663648|NCT00543543|616781922|FG001|Base Study|Physician Decision|4|||
170663649|NCT00543543|616781923|FG002|Base Study|Physician Decision|0|||
170663650|NCT00543543|616781924|FG003|Base Study|Physician Decision|7|||
170663651|NCT00543543|616781921|FG000|Base Study|Protocol Violation|0|||
170663652|NCT00543543|616781922|FG001|Base Study|Protocol Violation|6|||
170663653|NCT00543543|616781923|FG002|Base Study|Protocol Violation|0|||
170663654|NCT00543543|616781924|FG003|Base Study|Protocol Violation|6|||
170663655|NCT00543543|616781921|FG000|Base Study|Withdrawal by Subject|7|||
170663656|NCT00543543|616781922|FG001|Base Study|Withdrawal by Subject|482|||
170663657|NCT00543543|616781923|FG002|Base Study|Withdrawal by Subject|5|||
170663658|NCT00543543|616781924|FG003|Base Study|Withdrawal by Subject|503|||
170663659|NCT00543543|616781921|FG000|Extension Study|Adverse Event|0|||
170663660|NCT00543543|616781922|FG001|Extension Study|Adverse Event|0|||
170663661|NCT00543543|616781923|FG002|Extension Study|Adverse Event|0|||
170663662|NCT00543543|616781924|FG003|Extension Study|Adverse Event|5|||
170663663|NCT00543543|616781921|FG000|Extension Study|Lost to Follow-up|0|||
170663664|NCT00543543|616781922|FG001|Extension Study|Lost to Follow-up|0|||
170663665|NCT00543543|616781923|FG002|Extension Study|Lost to Follow-up|0|||
170663666|NCT00543543|616781924|FG003|Extension Study|Lost to Follow-up|77|||
170663667|NCT00543543|616781921|FG000|Extension Study|Physician Decision|0|||
170663668|NCT00543543|616781922|FG001|Extension Study|Physician Decision|0|||
170663669|NCT00543543|616781923|FG002|Extension Study|Physician Decision|0|||
170663670|NCT00543543|616781924|FG003|Extension Study|Physician Decision|7|||
170663671|NCT00543543|616781921|FG000|Extension Study|Pregnancy|0|||
170663672|NCT00543543|616781922|FG001|Extension Study|Pregnancy|0|||
170663673|NCT00543543|616781923|FG002|Extension Study|Pregnancy|0|||
170663674|NCT00543543|616781924|FG003|Extension Study|Pregnancy|6|||
170663675|NCT00543543|616781921|FG000|Extension Study|Protocol Violation|0|||
170663676|NCT00543543|616781922|FG001|Extension Study|Protocol Violation|0|||
170663677|NCT00543543|616781923|FG002|Extension Study|Protocol Violation|0|||
170663678|NCT00543543|616781924|FG003|Extension Study|Protocol Violation|11|||
170663679|NCT00543543|616781921|FG000|Extension Study|Withdrawal by Subject|0|||
170663680|NCT00543543|616781922|FG001|Extension Study|Withdrawal by Subject|0|||
170663681|NCT00543543|616781923|FG002|Extension Study|Withdrawal by Subject|0|||
170917290|NCT03362177|617697906|FG000|Overall Study|Death|55|||
170917291|NCT03362177|617697907|FG001|Overall Study|Death|22|||
170663682|NCT00543543|616781924|FG003|Extension Study|Withdrawal by Subject|120|||
170663683|NCT02840721|616781927|FG000|Treatment Period|Adverse Event|1|||
170663684|NCT02840721|616781927|FG000|Follow-Up|Lack of Efficacy|1|||
170663685|NCT02840721|616781927|FG000|Follow-Up|Withdrawal by Subject|4|||
170663686|NCT02840721|616781927|FG000|Follow-Up|Withdrawal of Consent|2|||
170663687|NCT02130024|616781931|FG000|Overall Study|Adverse Event|10|||
170663688|NCT02130024|616781932|FG001|Overall Study|Adverse Event|11|||
170663689|NCT02130024|616781931|FG000|Overall Study|Death|2|||
170663690|NCT02130024|616781932|FG001|Overall Study|Death|2|||
170663691|NCT02130024|616781931|FG000|Overall Study|Lost to Follow-up|1|||
170663692|NCT02130024|616781932|FG001|Overall Study|Lost to Follow-up|1|||
170917292|NCT05445843|617697911|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
170663693|NCT02130024|616781931|FG000|Overall Study|Physician Decision|1|||
170663694|NCT02130024|616781932|FG001|Overall Study|Physician Decision|3|||
170663695|NCT02130024|616781931|FG000|Overall Study|Protocol Deviation|4|||
170663696|NCT02130024|616781932|FG001|Overall Study|Protocol Deviation|0|||
170663697|NCT02130024|616781931|FG000|Overall Study|Site Administration Problems|1|||
170663698|NCT02130024|616781932|FG001|Overall Study|Site Administration Problems|0|||
170917293|NCT05445843|617697912|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
170616920|NCT00101686|616605212|FG004|Overall Study|Withdrawal by Subject|8|||
170616921|NCT00101686|616605213|FG005|Overall Study|Withdrawal by Subject|7|||
170616922|NCT00101686|616605214|FG006|Overall Study|Withdrawal by Subject|7|||
170616923|NCT00101686|616605215|FG007|Overall Study|Withdrawal by Subject|7|||
170616924|NCT00101686|616605216|FG008|Overall Study|Withdrawal by Subject|8|||
170616925|NCT00101686|616605217|FG009|Overall Study|Withdrawal by Subject|9|||
170616926|NCT00296816|616605218|FG000|Overall Study|Disease Progression|37|||
170616927|NCT00296816|616605218|FG000|Overall Study|Adverse Event|18|||
170616928|NCT00296816|616605218|FG000|Overall Study|Investigator/Participant request|5|||
170616929|NCT00296816|616605218|FG000|Overall Study|Non-compliance|1|||
170616930|NCT00296816|616605218|FG000|Overall Study|Missing for end of treatment|4|||
170616931|NCT00296816|616605218|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
170616932|NCT00296816|616605218|FG000|Overall Study|Poor performance status|1|||
170616933|NCT00296816|616605218|FG000|Overall Study|Relocation to Florida|1|||
170616934|NCT00296816|616605218|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
170616935|NCT00296816|616605218|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
170616936|NCT00296816|616605218|FG000|Overall Study|Neuropathy/patient preference|1|||
170616937|NCT00296816|616605218|FG000|Overall Study|Proteinuria|1|||
170616938|NCT00296816|616605218|FG000|Overall Study|ineligibility due to radiation treatment|1|||
170616939|NCT01618669|616605219|FG000|Overall Study|Lost to Follow-up|1|||
170616940|NCT01618669|616605220|FG001|Overall Study|Lost to Follow-up|1|||
170616941|NCT01618669|616605219|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
170616942|NCT01618669|616605220|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
170616943|NCT01618669|616605219|FG000|Overall Study|Adverse Event|16|||
170616944|NCT01618669|616605220|FG001|Overall Study|Adverse Event|7|||
170616945|NCT01618669|616605219|FG000|Overall Study|Protocol Violation|5|||
170616946|NCT01618669|616605220|FG001|Overall Study|Protocol Violation|3|||
170616947|NCT01618669|616605219|FG000|Overall Study|Withdrawal by Subject|9|||
170616948|NCT01618669|616605220|FG001|Overall Study|Withdrawal by Subject|9|||
170616949|NCT01618669|616605219|FG000|Overall Study|Miscellaneous Reason|0|||
170616950|NCT01618669|616605220|FG001|Overall Study|Miscellaneous Reason|1|||
170616951|NCT01879683|616605221|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
170616952|NCT02520726|616605222|FG000|Overall Study|Lost to Follow-up|3|||
170616953|NCT02520726|616605223|FG001|Overall Study|Lost to Follow-up|2|||
170616954|NCT01338818|616605224|FG000|Overall Study|Adverse Event|8|||
170616955|NCT01338818|616605224|FG000|Overall Study|Lack of Efficacy|5|||
170616956|NCT01338818|616605224|FG000|Overall Study|no longer require study drug|1|||
170616957|NCT01338818|616605224|FG000|Overall Study|Withdrawal by Subject|11|||
170616958|NCT01338818|616605224|FG000|Overall Study|Lost to Follow-up|4|||
170616959|NCT01338818|616605224|FG000|Overall Study|Administrative problems|3|||
170616960|NCT01338818|616605224|FG000|Overall Study|Protocol Deviation|4|||
170616961|NCT00430716|616605227|FG000|Double Blind Phase|Death|1|||
170616962|NCT00430716|616605228|FG001|Double Blind Phase|Death|0|||
170616963|NCT00430716|616605229|FG002|Double Blind Phase|Death|0|||
170616964|NCT00430716|616605227|FG000|Double Blind Phase|No longer willing to participate|2|||
170616965|NCT00430716|616605228|FG001|Double Blind Phase|No longer willing to participate|1|||
170616966|NCT00430716|616605229|FG002|Double Blind Phase|No longer willing to participate|1|||
170616967|NCT00430716|616605227|FG000|Double Blind Phase|Other|0|||
170616968|NCT00430716|616605228|FG001|Double Blind Phase|Other|2|||
170616969|NCT00430716|616605229|FG002|Double Blind Phase|Other|0|||
170616970|NCT00430716|616605227|FG000|Double Blind Phase|Study terminated by sponsor|1|||
170616971|NCT00430716|616605228|FG001|Double Blind Phase|Study terminated by sponsor|1|||
170616972|NCT00430716|616605229|FG002|Double Blind Phase|Study terminated by sponsor|2|||
170616973|NCT00430716|616605227|FG000|Double Blind Phase|Adverse Event|1|||
170616974|NCT00430716|616605228|FG001|Double Blind Phase|Adverse Event|1|||
170616975|NCT00430716|616605229|FG002|Double Blind Phase|Adverse Event|3|||
170616976|NCT00430716|616605227|FG000|Double Blind Phase|Not treated|1|||
170616977|NCT00430716|616605228|FG001|Double Blind Phase|Not treated|0|||
170616978|NCT00430716|616605229|FG002|Double Blind Phase|Not treated|0|||
170616979|NCT00430716|616605227|FG000|Open Label Phase|Lost to Follow-up|1|||
170616980|NCT00430716|616605228|FG001|Open Label Phase|Lost to Follow-up|0|||
170616981|NCT00430716|616605229|FG002|Open Label Phase|Lost to Follow-up|1|||
170616982|NCT00430716|616605227|FG000|Open Label Phase|No longer willing to participate|0|||
170616983|NCT00430716|616605228|FG001|Open Label Phase|No longer willing to participate|1|||
170616984|NCT00430716|616605229|FG002|Open Label Phase|No longer willing to participate|1|||
170616985|NCT00430716|616605227|FG000|Open Label Phase|Other|3|||
170616986|NCT00430716|616605228|FG001|Open Label Phase|Other|1|||
170616987|NCT00430716|616605229|FG002|Open Label Phase|Other|1|||
170616988|NCT00430716|616605227|FG000|Open Label Phase|Protocol Violation|1|||
170817788|NCT01634165|617339865|FG001|Period 2|Adverse Event|1|||
170817789|NCT01634165|617339866|FG002|Period 2|Adverse Event|0|||
170817790|NCT01634165|617339867|FG003|Period 2|Adverse Event|0|||
170817791|NCT04097535|617339870|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
170817792|NCT04919499|617339871|FG000|Overall Study|Adverse Event|0|||
170817793|NCT04919499|617339872|FG001|Overall Study|Adverse Event|0|||
170817794|NCT04919499|617339873|FG002|Overall Study|Adverse Event|0|||
170917294|NCT05445843|617697911|FG000|Overall Study|Progressive disease|17|||
170917295|NCT05445843|617697912|FG001|Overall Study|Progressive disease|9|||
170917296|NCT05445843|617697911|FG000|Overall Study|Physician Decision|16|||
170917297|NCT05445843|617697912|FG001|Overall Study|Physician Decision|4|||
170917298|NCT05445843|617697911|FG000|Overall Study|Death|6|||
170917299|NCT05445843|617697912|FG001|Overall Study|Death|3|||
170917300|NCT05445843|617697911|FG000|Overall Study|Subject decision|6|||
170917301|NCT05445843|617697912|FG001|Overall Study|Subject decision|2|||
170663699|NCT02130024|616781931|FG000|Overall Study|Subject Withdrew Consent|6|||
170616989|NCT00430716|616605228|FG001|Open Label Phase|Protocol Violation|0|||
170616990|NCT00430716|616605229|FG002|Open Label Phase|Protocol Violation|0|||
170616991|NCT00430716|616605227|FG000|Open Label Phase|Study terminated by sponsor|4|||
170616992|NCT00430716|616605228|FG001|Open Label Phase|Study terminated by sponsor|5|||
170616993|NCT00430716|616605229|FG002|Open Label Phase|Study terminated by sponsor|4|||
170616994|NCT01076959|616605230|FG000|Overall Study|Adverse Event|767|||
170616995|NCT01076959|616605230|FG000|Overall Study|Lack of Efficacy|849|||
170616996|NCT01076959|616605230|FG000|Overall Study|Non-compliance|274|||
170616997|NCT01076959|616605230|FG000|Overall Study|Lost to Follow-up|241|||
170616998|NCT01076959|616605230|FG000|Overall Study|Other|119|||
170616999|NCT03901144|616605231|FG000|Overall Study|Lost to Follow-up|1|||
170617000|NCT03901144|616605232|FG001|Overall Study|Lost to Follow-up|1|||
170617001|NCT03901144|616605233|FG002|Overall Study|Lost to Follow-up|1|||
170617002|NCT03901144|616605234|FG003|Overall Study|Lost to Follow-up|1|||
170617003|NCT02491983|616605235|FG000|Overall Study|Physician Decision|1|||
170617004|NCT02491983|616605236|FG001|Overall Study|Physician Decision|0|||
170617005|NCT02491983|616605235|FG000|Overall Study|Not meet selection criteria|1|||
170617006|NCT02491983|616605236|FG001|Overall Study|Not meet selection criteria|0|||
170617007|NCT02491983|616605235|FG000|Overall Study|Withdrawal by Subject|0|||
170617008|NCT02491983|616605236|FG001|Overall Study|Withdrawal by Subject|1|||
170617009|NCT02021565|616605237|FG000|Baseline Through Intervention|Death|0|||
170617010|NCT02021565|616605238|FG001|Baseline Through Intervention|Death|1|||
170617011|NCT02021565|616605237|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
170617012|NCT02021565|616605238|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
170617013|NCT02021565|616605237|FG000|Baseline Through Intervention|Protocol Violation|0|||
170617014|NCT02021565|616605238|FG001|Baseline Through Intervention|Protocol Violation|7|||
170617015|NCT02021565|616605237|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
170617016|NCT02021565|616605238|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
170617017|NCT02021565|616605237|FG000|3-month Follow-up|Death|3|||
170617018|NCT02021565|616605238|FG001|3-month Follow-up|Death|0|||
170617019|NCT02021565|616605237|FG000|3-month Follow-up|Withdrawal by Subject|4|||
170617020|NCT02021565|616605238|FG001|3-month Follow-up|Withdrawal by Subject|0|||
170617021|NCT02021565|616605237|FG000|3-month Follow-up|Protocol Violation|3|||
170617022|NCT02021565|616605238|FG001|3-month Follow-up|Protocol Violation|2|||
170617023|NCT03948334|616605244|FG000|Overall Study|Adverse Event|1|||
170617024|NCT03948334|616605245|FG001|Overall Study|Adverse Event|4|||
170617025|NCT03948334|616605244|FG000|Overall Study|Lack of Efficacy|2|||
170617026|NCT03948334|616605245|FG001|Overall Study|Lack of Efficacy|0|||
170617027|NCT03948334|616605244|FG000|Overall Study|Lost to Follow-up|1|||
170617028|NCT03948334|616605245|FG001|Overall Study|Lost to Follow-up|0|||
170617029|NCT03948334|616605244|FG000|Overall Study|Physician Decision|1|||
170617030|NCT03948334|616605245|FG001|Overall Study|Physician Decision|0|||
170617031|NCT03948334|616605244|FG000|Overall Study|Pregnancy|0|||
170617032|NCT03948334|616605245|FG001|Overall Study|Pregnancy|1|||
170617033|NCT03948334|616605244|FG000|Overall Study|Protocol Deviation|1|||
170617034|NCT03948334|616605245|FG001|Overall Study|Protocol Deviation|0|||
170617035|NCT03948334|616605244|FG000|Overall Study|Study terminated by Sponsor|50|||
170617036|NCT03948334|616605245|FG001|Overall Study|Study terminated by Sponsor|51|||
170617037|NCT03948334|616605244|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
170617038|NCT03948334|616605245|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
170617039|NCT05114473|616605246|FG000|Overall Study|Lost to Follow-up|2|||
170617040|NCT05114473|616605247|FG001|Overall Study|Lost to Follow-up|2|||
170617041|NCT05114473|616605248|FG002|Overall Study|Lost to Follow-up|0|||
170617042|NCT00782717|616605253|FG000|Overall Study|Adverse Event|2|||
170617043|NCT00782717|616605254|FG001|Overall Study|Adverse Event|5|||
170617044|NCT00782717|616605253|FG000|Overall Study|Patient decision unrelated to AE|6|||
170617045|NCT00782717|616605254|FG001|Overall Study|Patient decision unrelated to AE|3|||
170617046|NCT00782717|616605253|FG000|Overall Study|Noncompliance|2|||
170617047|NCT00782717|616605254|FG001|Overall Study|Noncompliance|1|||
170617048|NCT00782717|616605253|FG000|Overall Study|Treatment failure|3|||
170617049|NCT00782717|616605254|FG001|Overall Study|Treatment failure|14|||
170617050|NCT00782717|616605253|FG000|Overall Study|Enrollment close prior to surgery|1|||
170617051|NCT00782717|616605254|FG001|Overall Study|Enrollment close prior to surgery|0|||
170617052|NCT00782717|616605253|FG000|Overall Study|Did not meet entrance criteria|1|||
170617053|NCT00782717|616605254|FG001|Overall Study|Did not meet entrance criteria|3|||
170917302|NCT05445843|617697911|FG000|Overall Study|Adverse Event|2|||
170917303|NCT05445843|617697912|FG001|Overall Study|Adverse Event|0|||
170663700|NCT02130024|616781932|FG001|Overall Study|Subject Withdrew Consent|14|||
170663701|NCT02024555|616781933|FG000|Overall Study|Lost to Follow-up|1|||
170663702|NCT02024555|616781934|FG001|Overall Study|Lost to Follow-up|1|||
170663703|NCT02024555|616781933|FG000|Overall Study|Withdrawal by Subject|5|||
170663704|NCT02024555|616781934|FG001|Overall Study|Withdrawal by Subject|1|||
170663705|NCT05736224|616781935|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
170663706|NCT02452697|616781936|FG000|Overall Study|Physician Decision|4|||
170663707|NCT02452697|616781937|FG001|Overall Study|Physician Decision|4|||
170663708|NCT02452697|616781938|FG002|Overall Study|Physician Decision|3|||
170663709|NCT02452697|616781939|FG003|Overall Study|Physician Decision|2|||
170663710|NCT02452697|616781936|FG000|Overall Study|Withdrawal by Subject|1|||
170663711|NCT02452697|616781937|FG001|Overall Study|Withdrawal by Subject|0|||
170663712|NCT02452697|616781938|FG002|Overall Study|Withdrawal by Subject|0|||
170663713|NCT02452697|616781939|FG003|Overall Study|Withdrawal by Subject|0|||
170663714|NCT02452697|616781936|FG000|Overall Study|still in follow-up|2|||
170663715|NCT02452697|616781937|FG001|Overall Study|still in follow-up|2|||
170663716|NCT02452697|616781938|FG002|Overall Study|still in follow-up|1|||
170663717|NCT02452697|616781939|FG003|Overall Study|still in follow-up|3|||
170663718|NCT00560885|616781940|FG000|Overall Study|Death|7|||
170663719|NCT00560885|616781940|FG000|Overall Study|Withdrawal by Subject|1|||
170663720|NCT03673046|616783744|FG000|Overall Study|Adverse Event|1|||
170663721|NCT03673046|616783745|FG001|Overall Study|Adverse Event|1|||
170817795|NCT04919499|617339874|FG003|Overall Study|Adverse Event|0|||
170817796|NCT04919499|617339875|FG004|Overall Study|Adverse Event|2|||
170817797|NCT04919499|617339871|FG000|Overall Study|Not treated|0|||
170817798|NCT04919499|617339872|FG001|Overall Study|Not treated|0|||
170817799|NCT04919499|617339873|FG002|Overall Study|Not treated|0|||
170817800|NCT04919499|617339874|FG003|Overall Study|Not treated|1|||
170817801|NCT04919499|617339875|FG004|Overall Study|Not treated|0|||
170817802|NCT04520256|617339877|FG000|Overall Study|Lost to Follow-up|6|||
170817803|NCT04520256|617339878|FG001|Overall Study|Lost to Follow-up|4|||
170817804|NCT04520256|617339879|FG002|Overall Study|Lost to Follow-up|2|||
170817805|NCT04520256|617339880|FG003|Overall Study|Lost to Follow-up|3|||
170817806|NCT04520256|617339881|FG004|Overall Study|Lost to Follow-up|6|||
170817807|NCT04520256|617339882|FG005|Overall Study|Lost to Follow-up|6|||
170817808|NCT04520256|617339883|FG006|Overall Study|Lost to Follow-up|4|||
170817809|NCT04520256|617339884|FG007|Overall Study|Lost to Follow-up|6|||
170817810|NCT04520256|617339885|FG008|Overall Study|Lost to Follow-up|1|||
170817811|NCT04520256|617339886|FG009|Overall Study|Lost to Follow-up|3|||
170817812|NCT04520256|617339887|FG010|Overall Study|Lost to Follow-up|3|||
170817813|NCT04520256|617339888|FG011|Overall Study|Lost to Follow-up|2|||
170663722|NCT03673046|616783744|FG000|Overall Study|Withdrawal by Subject|8|||
170663723|NCT03673046|616783745|FG001|Overall Study|Withdrawal by Subject|2|||
170663724|NCT03817879|616783746|FG000|Overall Study|Drop out|5|||
170663725|NCT03817879|616783747|FG001|Overall Study|Drop out|12|||
170817814|NCT04520256|617339889|FG012|Overall Study|Lost to Follow-up|5|||
170617054|NCT00782717|616605253|FG000|Overall Study|Exited in error|0|||
170617055|NCT00782717|616605254|FG001|Overall Study|Exited in error|2|||
170617056|NCT02446717|616605255|FG000|Overall Study|Adverse Event|0|||
170617057|NCT02446717|616605256|FG001|Overall Study|Adverse Event|0|||
170617058|NCT02446717|616605257|FG002|Overall Study|Adverse Event|1|||
170617059|NCT02446717|616605258|FG003|Overall Study|Adverse Event|0|||
170617060|NCT02446717|616605259|FG004|Overall Study|Adverse Event|0|||
170617061|NCT02446717|616605255|FG000|Overall Study|Lost to Follow-up|0|||
170617062|NCT02446717|616605256|FG001|Overall Study|Lost to Follow-up|1|||
170617063|NCT02446717|616605257|FG002|Overall Study|Lost to Follow-up|1|||
170617064|NCT02446717|616605258|FG003|Overall Study|Lost to Follow-up|0|||
170617065|NCT02446717|616605259|FG004|Overall Study|Lost to Follow-up|1|||
170617066|NCT02446717|616605255|FG000|Overall Study|Withdrew consent|0|||
170617067|NCT02446717|616605256|FG001|Overall Study|Withdrew consent|0|||
170617068|NCT02446717|616605257|FG002|Overall Study|Withdrew consent|0|||
170617069|NCT02446717|616605258|FG003|Overall Study|Withdrew consent|1|||
170617070|NCT02446717|616605259|FG004|Overall Study|Withdrew consent|0|||
170617071|NCT01987102|616605274|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
170617072|NCT01987102|616605275|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
170617073|NCT01987102|616605274|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
170617074|NCT01987102|616605275|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
170617075|NCT01987102|616605274|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
170617076|NCT01987102|616605275|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
170617077|NCT01987102|616605274|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
170617078|NCT01987102|616605275|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
170617079|NCT01987102|616605274|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
170617080|NCT01987102|616605275|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
170617081|NCT01987102|616605274|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
170617082|NCT01987102|616605275|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
170617083|NCT01288989|616605276|FG000|Overall Study|Death|0|||
170817815|NCT04520256|617339890|FG013|Overall Study|Lost to Follow-up|3|||
170663726|NCT03817879|616783746|FG000|Overall Study|Withdrawal by Subject|0|||
170663727|NCT03817879|616783747|FG001|Overall Study|Withdrawal by Subject|1|||
170663728|NCT03693300|616783751|FG000|Overall Study|Withdrawal by Subject|6|||
170663729|NCT03693300|616783752|FG001|Overall Study|Withdrawal by Subject|0|||
170663730|NCT03693300|616783751|FG000|Overall Study|Death|50|||
170663731|NCT03693300|616783752|FG001|Overall Study|Death|2|||
170663732|NCT03693300|616783751|FG000|Overall Study|Lost to Follow-up|2|||
170663733|NCT03693300|616783752|FG001|Overall Study|Lost to Follow-up|0|||
170663734|NCT04063384|616783753|FG000|Overall Study|placebo manipulation issue|1|||
170663735|NCT04063384|616783754|FG001|Overall Study|placebo manipulation issue|2|||
170663736|NCT04063384|616783755|FG002|Overall Study|placebo manipulation issue|1|||
170663737|NCT04063384|616783756|FG003|Overall Study|placebo manipulation issue|1|||
170663738|NCT01507298|616783757|FG000|Overall Study|Protocol Violation|0|||
170663739|NCT01507298|616783758|FG001|Overall Study|Protocol Violation|6|||
170663740|NCT00537238|616783759|FG000|Overall Study|Death|1|||
170663741|NCT00537238|616783760|FG001|Overall Study|Death|2|||
170663742|NCT00537238|616783759|FG000|Overall Study|Adverse Event|31|||
170663743|NCT00537238|616783760|FG001|Overall Study|Adverse Event|22|||
170663744|NCT00537238|616783759|FG000|Overall Study|Lack of Efficacy|20|||
170663745|NCT00537238|616783760|FG001|Overall Study|Lack of Efficacy|21|||
170663746|NCT00537238|616783759|FG000|Overall Study|Lost to Follow-up|12|||
170663747|NCT00537238|616783760|FG001|Overall Study|Lost to Follow-up|8|||
170663748|NCT00537238|616783759|FG000|Overall Study|Withdrawal by Subject|51|||
170663749|NCT00537238|616783760|FG001|Overall Study|Withdrawal by Subject|47|||
170663750|NCT00537238|616783759|FG000|Overall Study|Protocol Violation|15|||
170663751|NCT00537238|616783760|FG001|Overall Study|Protocol Violation|19|||
170663752|NCT00537238|616783759|FG000|Overall Study|Does not meet entrance criteria|0|||
170663753|NCT00537238|616783760|FG001|Overall Study|Does not meet entrance criteria|2|||
170663754|NCT00537238|616783759|FG000|Overall Study|Other|44|||
170663755|NCT00537238|616783760|FG001|Overall Study|Other|52|||
170663756|NCT01680965|616783766|FG000|Overall Study|Death|0|||
170663757|NCT01680965|616783767|FG001|Overall Study|Death|0|||
170663758|NCT01680965|616783768|FG002|Overall Study|Death|0|||
170663759|NCT01680965|616783769|FG003|Overall Study|Death|6|||
170663760|NCT00734474|616783777|FG000|Overall Study|Entry Criteria Not Met|0|||
170663761|NCT00734474|616783778|FG001|Overall Study|Entry Criteria Not Met|0|||
170663762|NCT00734474|616783779|FG002|Overall Study|Entry Criteria Not Met|5|||
170663763|NCT00734474|616783780|FG003|Overall Study|Entry Criteria Not Met|0|||
170663764|NCT00734474|616783781|FG004|Overall Study|Entry Criteria Not Met|3|||
170663765|NCT00734474|616783782|FG005|Overall Study|Entry Criteria Not Met|1|||
170663766|NCT00734474|616783783|FG006|Overall Study|Entry Criteria Not Met|0|||
170663767|NCT00734474|616783784|FG007|Overall Study|Entry Criteria Not Met|1|||
170663768|NCT00734474|616783785|FG008|Overall Study|Entry Criteria Not Met|1|||
170663769|NCT00734474|616783777|FG000|Overall Study|Lost to Follow-up|1|||
170663770|NCT00734474|616783778|FG001|Overall Study|Lost to Follow-up|0|||
170663771|NCT00734474|616783779|FG002|Overall Study|Lost to Follow-up|13|||
170663772|NCT00734474|616783780|FG003|Overall Study|Lost to Follow-up|0|||
170663773|NCT00734474|616783781|FG004|Overall Study|Lost to Follow-up|11|||
170663774|NCT00734474|616783782|FG005|Overall Study|Lost to Follow-up|1|||
170663775|NCT00734474|616783783|FG006|Overall Study|Lost to Follow-up|0|||
170663776|NCT00734474|616783784|FG007|Overall Study|Lost to Follow-up|9|||
170663777|NCT00734474|616783785|FG008|Overall Study|Lost to Follow-up|4|||
170663778|NCT00734474|616783777|FG000|Overall Study|Withdrawal by Subject|2|||
170663779|NCT00734474|616783778|FG001|Overall Study|Withdrawal by Subject|1|||
170663780|NCT00734474|616783779|FG002|Overall Study|Withdrawal by Subject|18|||
170663781|NCT00734474|616783780|FG003|Overall Study|Withdrawal by Subject|0|||
170663782|NCT00734474|616783781|FG004|Overall Study|Withdrawal by Subject|24|||
170663783|NCT00734474|616783782|FG005|Overall Study|Withdrawal by Subject|2|||
170663784|NCT00734474|616783783|FG006|Overall Study|Withdrawal by Subject|0|||
170663785|NCT00734474|616783784|FG007|Overall Study|Withdrawal by Subject|36|||
170663786|NCT00734474|616783785|FG008|Overall Study|Withdrawal by Subject|21|||
170663787|NCT00734474|616783777|FG000|Overall Study|Physician Decision|0|||
170663788|NCT00734474|616783778|FG001|Overall Study|Physician Decision|0|||
170663789|NCT00734474|616783779|FG002|Overall Study|Physician Decision|4|||
170663790|NCT00734474|616783780|FG003|Overall Study|Physician Decision|1|||
170663791|NCT00734474|616783781|FG004|Overall Study|Physician Decision|11|||
170663792|NCT00734474|616783782|FG005|Overall Study|Physician Decision|0|||
170663793|NCT00734474|616783783|FG006|Overall Study|Physician Decision|0|||
170663794|NCT00734474|616783784|FG007|Overall Study|Physician Decision|9|||
170663795|NCT00734474|616783785|FG008|Overall Study|Physician Decision|9|||
170663796|NCT00734474|616783777|FG000|Overall Study|Adverse Event|4|||
170663797|NCT00734474|616783778|FG001|Overall Study|Adverse Event|4|||
170663798|NCT00734474|616783779|FG002|Overall Study|Adverse Event|63|||
170663799|NCT00734474|616783780|FG003|Overall Study|Adverse Event|1|||
170663800|NCT00734474|616783781|FG004|Overall Study|Adverse Event|64|||
170663801|NCT00734474|616783782|FG005|Overall Study|Adverse Event|0|||
170663802|NCT00734474|616783783|FG006|Overall Study|Adverse Event|1|||
170663803|NCT00734474|616783784|FG007|Overall Study|Adverse Event|65|||
170663804|NCT00734474|616783785|FG008|Overall Study|Adverse Event|39|||
170663805|NCT00734474|616783777|FG000|Overall Study|Protocol Violation|0|||
170663806|NCT00734474|616783778|FG001|Overall Study|Protocol Violation|0|||
170663807|NCT00734474|616783779|FG002|Overall Study|Protocol Violation|4|||
170663808|NCT00734474|616783780|FG003|Overall Study|Protocol Violation|0|||
170663809|NCT00734474|616783781|FG004|Overall Study|Protocol Violation|3|||
170663810|NCT00734474|616783782|FG005|Overall Study|Protocol Violation|0|||
170663811|NCT00734474|616783783|FG006|Overall Study|Protocol Violation|0|||
170663812|NCT00734474|616783784|FG007|Overall Study|Protocol Violation|3|||
170663813|NCT00734474|616783785|FG008|Overall Study|Protocol Violation|1|||
170663814|NCT00734474|616783777|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
170663815|NCT00734474|616783778|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
170663816|NCT00734474|616783779|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
170663817|NCT00734474|616783780|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
170663818|NCT00734474|616783781|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
170663819|NCT00734474|616783782|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
170663820|NCT00734474|616783783|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
170663821|NCT00734474|616783784|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
170663822|NCT00734474|616783785|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
170663823|NCT00734474|616783777|FG000|Overall Study|Sponsor Decision|0|||
170663824|NCT00734474|616783778|FG001|Overall Study|Sponsor Decision|0|||
170917304|NCT04589650|617697924|FG000|Overall Study|Subject decision|6|||
170663825|NCT00734474|616783779|FG002|Overall Study|Sponsor Decision|0|||
170663826|NCT00734474|616783780|FG003|Overall Study|Sponsor Decision|0|||
170663827|NCT00734474|616783781|FG004|Overall Study|Sponsor Decision|2|||
170663828|NCT00734474|616783782|FG005|Overall Study|Sponsor Decision|0|||
170663829|NCT00734474|616783783|FG006|Overall Study|Sponsor Decision|0|||
170663830|NCT00734474|616783784|FG007|Overall Study|Sponsor Decision|0|||
170663831|NCT00734474|616783785|FG008|Overall Study|Sponsor Decision|0|||
170663832|NCT00734474|616783777|FG000|Overall Study|Death|0|||
170663833|NCT00734474|616783778|FG001|Overall Study|Death|0|||
170663834|NCT00734474|616783779|FG002|Overall Study|Death|1|||
170663835|NCT00734474|616783780|FG003|Overall Study|Death|0|||
170663836|NCT00734474|616783781|FG004|Overall Study|Death|0|||
170663837|NCT00734474|616783782|FG005|Overall Study|Death|0|||
170663838|NCT00734474|616783783|FG006|Overall Study|Death|0|||
170663839|NCT00734474|616783784|FG007|Overall Study|Death|2|||
170663840|NCT00734474|616783785|FG008|Overall Study|Death|1|||
170663841|NCT00734474|616783777|FG000|Overall Study|Lack of Efficacy|0|||
170663842|NCT00734474|616783778|FG001|Overall Study|Lack of Efficacy|0|||
170663843|NCT00734474|616783779|FG002|Overall Study|Lack of Efficacy|4|||
170663844|NCT00734474|616783780|FG003|Overall Study|Lack of Efficacy|0|||
170663845|NCT00734474|616783781|FG004|Overall Study|Lack of Efficacy|0|||
170663846|NCT00734474|616783782|FG005|Overall Study|Lack of Efficacy|0|||
170663847|NCT00734474|616783783|FG006|Overall Study|Lack of Efficacy|0|||
170663848|NCT00734474|616783784|FG007|Overall Study|Lack of Efficacy|4|||
170663849|NCT00734474|616783785|FG008|Overall Study|Lack of Efficacy|6|||
170663850|NCT02468232|616783786|FG000|Core Part of Study|Adverse Event|0|||
170663851|NCT02468232|616783787|FG001|Core Part of Study|Adverse Event|1|||
170663852|NCT02468232|616783788|FG002|Core Part of Study|Adverse Event|0|||
170663853|NCT02468232|616783789|FG003|Core Part of Study|Adverse Event|0|||
170663854|NCT02468232|616783786|FG000|Core Part of Study|Death|20|||
170663855|NCT02468232|616783787|FG001|Core Part of Study|Death|17|||
170663856|NCT02468232|616783788|FG002|Core Part of Study|Death|0|||
170663857|NCT02468232|616783789|FG003|Core Part of Study|Death|0|||
170663858|NCT02468232|616783786|FG000|Core Part of Study|Technical Problems|1|||
170663859|NCT02468232|616783787|FG001|Core Part of Study|Technical Problems|1|||
170663860|NCT02468232|616783788|FG002|Core Part of Study|Technical Problems|0|||
170817816|NCT04520256|617339891|FG014|Overall Study|Lost to Follow-up|3|||
170817817|NCT04520256|617339892|FG015|Overall Study|Lost to Follow-up|6|||
170817818|NCT04520256|617339893|FG016|Overall Study|Lost to Follow-up|6|||
170817819|NCT04520256|617339894|FG017|Overall Study|Lost to Follow-up|4|||
170817820|NCT04520256|617339895|FG018|Overall Study|Lost to Follow-up|3|||
170817821|NCT04520256|617339896|FG019|Overall Study|Lost to Follow-up|3|||
170817822|NCT04520256|617339897|FG020|Overall Study|Lost to Follow-up|7|||
170817823|NCT04520256|617339898|FG021|Overall Study|Lost to Follow-up|3|||
170917305|NCT04589650|617697925|FG001|Overall Study|Subject decision|2|||
170917306|NCT04589650|617697926|FG002|Overall Study|Subject decision|2|||
170917307|NCT04589650|617697927|FG003|Overall Study|Subject decision|0|||
170663861|NCT02468232|616783789|FG003|Core Part of Study|Technical Problems|0|||
170663862|NCT02468232|616783786|FG000|OLE Part of Study|Adverse Event|0|||
170663863|NCT02468232|616783787|FG001|OLE Part of Study|Adverse Event|0|||
170663864|NCT02468232|616783788|FG002|OLE Part of Study|Adverse Event|4|||
170663865|NCT02468232|616783789|FG003|OLE Part of Study|Adverse Event|5|||
170817824|NCT04520256|617339899|FG022|Overall Study|Lost to Follow-up|3|||
170817825|NCT04520256|617339900|FG023|Overall Study|Lost to Follow-up|8|||
170817826|NCT04520256|617339901|FG024|Overall Study|Lost to Follow-up|5|||
170663866|NCT02468232|616783786|FG000|OLE Part of Study|Death|0|||
170663867|NCT02468232|616783787|FG001|OLE Part of Study|Death|0|||
170817827|NCT04520256|617339902|FG025|Overall Study|Lost to Follow-up|4|||
170917308|NCT04589650|617697928|FG004|Overall Study|Subject decision|0|||
170917309|NCT04589650|617697929|FG005|Overall Study|Subject decision|0|||
170917310|NCT04589650|617697924|FG000|Overall Study|Adverse Event|3|||
170917311|NCT04589650|617697925|FG001|Overall Study|Adverse Event|1|||
170917312|NCT04589650|617697926|FG002|Overall Study|Adverse Event|1|||
170917313|NCT04589650|617697927|FG003|Overall Study|Adverse Event|1|||
170917314|NCT04589650|617697928|FG004|Overall Study|Adverse Event|0|||
170917315|NCT04589650|617697929|FG005|Overall Study|Adverse Event|1|||
170917316|NCT04589650|617697924|FG000|Overall Study|Physician Decision|1|||
170617084|NCT01288989|616605277|FG001|Overall Study|Death|0|||
170617085|NCT01288989|616605278|FG002|Overall Study|Death|0|||
170617086|NCT01288989|616605279|FG003|Overall Study|Death|1|||
170617087|NCT01288989|616605280|FG004|Overall Study|Death|0|||
170617088|NCT01288989|616605276|FG000|Overall Study|Dose limiting toxicity|1|||
170617089|NCT01288989|616605277|FG001|Overall Study|Dose limiting toxicity|0|||
170617090|NCT01288989|616605278|FG002|Overall Study|Dose limiting toxicity|0|||
170617091|NCT01288989|616605279|FG003|Overall Study|Dose limiting toxicity|0|||
170617092|NCT01288989|616605280|FG004|Overall Study|Dose limiting toxicity|0|||
170617093|NCT01288989|616605276|FG000|Overall Study|Adverse Event|0|||
170617094|NCT01288989|616605277|FG001|Overall Study|Adverse Event|0|||
170617095|NCT01288989|616605278|FG002|Overall Study|Adverse Event|0|||
170617096|NCT01288989|616605279|FG003|Overall Study|Adverse Event|0|||
170617097|NCT01288989|616605280|FG004|Overall Study|Adverse Event|2|||
170617098|NCT01288989|616605276|FG000|Overall Study|Physician Decision|0|||
170617099|NCT01288989|616605277|FG001|Overall Study|Physician Decision|0|||
170617100|NCT01288989|616605278|FG002|Overall Study|Physician Decision|0|||
170617101|NCT01288989|616605279|FG003|Overall Study|Physician Decision|0|||
170617102|NCT01288989|616605280|FG004|Overall Study|Physician Decision|1|||
170617103|NCT01288989|616605276|FG000|Overall Study|Withdrawal by Subject|0|||
170617104|NCT01288989|616605277|FG001|Overall Study|Withdrawal by Subject|0|||
170617105|NCT01288989|616605278|FG002|Overall Study|Withdrawal by Subject|0|||
170617106|NCT01288989|616605279|FG003|Overall Study|Withdrawal by Subject|0|||
170617107|NCT01288989|616605280|FG004|Overall Study|Withdrawal by Subject|3|||
170617108|NCT01156714|616605281|FG000|Overall Study|Withdrawal by Subject|9|||
170617109|NCT01156714|616605282|FG001|Overall Study|Withdrawal by Subject|4|||
170617110|NCT01156714|616605283|FG002|Overall Study|Withdrawal by Subject|3|||
170617111|NCT04965688|616605286|FG000|Overall Study|Withdrawal by Subject|2|||
170617112|NCT03116685|616605287|FG000|Overall Study|Physician Decision|0|||
170617113|NCT03116685|616605288|FG001|Overall Study|Physician Decision|1|||
170617114|NCT04551066|616605289|FG000|Overall Study|Death|5|||
170617115|NCT04551066|616605290|FG001|Overall Study|Death|3|||
170617116|NCT04551066|616605289|FG000|Overall Study|Lost to Follow-up|1|||
170617117|NCT04551066|616605290|FG001|Overall Study|Lost to Follow-up|0|||
170617118|NCT04551066|616605289|FG000|Overall Study|Sponsor Decision|104|||
170617119|NCT04551066|616605290|FG001|Overall Study|Sponsor Decision|117|||
170617120|NCT04551066|616605289|FG000|Overall Study|Withdrawal by Subject|8|||
170617121|NCT04551066|616605290|FG001|Overall Study|Withdrawal by Subject|2|||
170617122|NCT04551066|616605289|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
170617123|NCT04551066|616605290|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
170617124|NCT04551066|616605289|FG000|Overall Study|Adverse Event|2|||
170617125|NCT04551066|616605290|FG001|Overall Study|Adverse Event|0|||
170617126|NCT04551066|616605289|FG000|Overall Study|Physician Decision|2|||
170617127|NCT04551066|616605290|FG001|Overall Study|Physician Decision|0|||
170617128|NCT04551066|616605289|FG000|Overall Study|Protocol Violation|1|||
170617129|NCT04551066|616605290|FG001|Overall Study|Protocol Violation|0|||
170617130|NCT04551066|616605289|FG000|Overall Study|Lack of Efficacy|0|||
170617131|NCT04551066|616605290|FG001|Overall Study|Lack of Efficacy|1|||
170617132|NCT04551066|616605289|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
170617133|NCT04551066|616605290|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
170617134|NCT00369577|616605291|FG000|Overall Study|Withdrawal by Subject|0|||
170617135|NCT00369577|616605292|FG001|Overall Study|Withdrawal by Subject|0|||
170617136|NCT00369577|616605293|FG002|Overall Study|Withdrawal by Subject|1|||
170617137|NCT00699660|616605294|FG000|Overall Study|Lost to Follow-up|4|||
170617138|NCT00699660|616605295|FG001|Overall Study|Lost to Follow-up|2|||
170617139|NCT00699660|616605294|FG000|Overall Study|missing reports and recording failures|10|||
170917317|NCT04589650|617697925|FG001|Overall Study|Physician Decision|1|||
170917318|NCT04589650|617697926|FG002|Overall Study|Physician Decision|0|||
170917319|NCT04589650|617697927|FG003|Overall Study|Physician Decision|0|||
170917320|NCT04589650|617697928|FG004|Overall Study|Physician Decision|0|||
170617140|NCT00699660|616605295|FG001|Overall Study|missing reports and recording failures|6|||
170617141|NCT03160898|616605296|FG000|Overall Study|Adverse Event|4|||
170617142|NCT03160898|616605297|FG001|Overall Study|Adverse Event|8|||
170617143|NCT03160898|616605298|FG002|Overall Study|Adverse Event|7|||
170617144|NCT03160898|616605299|FG003|Overall Study|Adverse Event|10|||
170617145|NCT03160898|616605296|FG000|Overall Study|Death|1|||
170917321|NCT04589650|617697929|FG005|Overall Study|Physician Decision|0|||
170917322|NCT04589650|617697924|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170917323|NCT04589650|617697925|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170663868|NCT02468232|616783788|FG002|OLE Part of Study|Death|4|||
170663869|NCT02468232|616783789|FG003|OLE Part of Study|Death|2|||
170663870|NCT02468232|616783786|FG000|OLE Part of Study|Physician Decision|0|||
170663871|NCT02468232|616783787|FG001|OLE Part of Study|Physician Decision|0|||
170663872|NCT02468232|616783788|FG002|OLE Part of Study|Physician Decision|4|||
170663873|NCT02468232|616783789|FG003|OLE Part of Study|Physician Decision|0|||
170663874|NCT02468232|616783786|FG000|OLE Part of Study|Subject/Guardian decision|0|||
170663875|NCT02468232|616783787|FG001|OLE Part of Study|Subject/Guardian decision|0|||
170663876|NCT02468232|616783788|FG002|OLE Part of Study|Subject/Guardian decision|2|||
170663877|NCT02468232|616783789|FG003|OLE Part of Study|Subject/Guardian decision|5|||
170663878|NCT01973569|616783790|FG000|Overall Study|Adverse Event|9|||
170663879|NCT01973569|616783791|FG001|Overall Study|Adverse Event|2|||
170663880|NCT01973569|616783792|FG002|Overall Study|Adverse Event|4|||
170663881|NCT01973569|616783790|FG000|Overall Study|Protocol Violation|2|||
170663882|NCT01973569|616783791|FG001|Overall Study|Protocol Violation|1|||
170663883|NCT01973569|616783792|FG002|Overall Study|Protocol Violation|3|||
170663884|NCT01973569|616783790|FG000|Overall Study|Withdrawal by Subject|7|||
170663885|NCT01973569|616783791|FG001|Overall Study|Withdrawal by Subject|5|||
170663886|NCT01973569|616783792|FG002|Overall Study|Withdrawal by Subject|2|||
170663887|NCT01973569|616783790|FG000|Overall Study|Invasive dental treatment|3|||
170663888|NCT01973569|616783791|FG001|Overall Study|Invasive dental treatment|5|||
170663889|NCT01973569|616783792|FG002|Overall Study|Invasive dental treatment|6|||
170663890|NCT01973569|616783790|FG000|Overall Study|Prohibited concomitant d|1|||
170663891|NCT01973569|616783791|FG001|Overall Study|Prohibited concomitant d|5|||
170663892|NCT01973569|616783792|FG002|Overall Study|Prohibited concomitant d|0|||
170663893|NCT01973569|616783790|FG000|Overall Study|Disease progression|0|||
170663894|NCT01973569|616783791|FG001|Overall Study|Disease progression|3|||
170663895|NCT01973569|616783792|FG002|Overall Study|Disease progression|0|||
170663896|NCT01973569|616783790|FG000|Overall Study|Other|1|||
170663897|NCT01973569|616783791|FG001|Overall Study|Other|1|||
170663898|NCT01973569|616783792|FG002|Overall Study|Other|0|||
170663899|NCT01973569|616783790|FG000|Overall Study|Did not receive study drug|6|||
170663900|NCT01973569|616783791|FG001|Overall Study|Did not receive study drug|3|||
170663901|NCT01973569|616783792|FG002|Overall Study|Did not receive study drug|3|||
170663902|NCT00371826|616783793|FG000|Core Phase (12 Months)|Adverse Event|15|||
170663903|NCT00371826|616783794|FG001|Core Phase (12 Months)|Adverse Event|4|||
170663904|NCT00371826|616783795|FG002|Core Phase (12 Months)|Adverse Event|9|||
170663905|NCT00371826|616783793|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
170663906|NCT00371826|616783794|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
170663907|NCT00371826|616783795|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
170663908|NCT00371826|616783793|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
170663909|NCT00371826|616783794|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
170663910|NCT00371826|616783795|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
170663911|NCT00371826|616783793|FG000|Core Phase (12 Months)|Protocol Violation|1|||
170663912|NCT00371826|616783794|FG001|Core Phase (12 Months)|Protocol Violation|0|||
170663913|NCT00371826|616783795|FG002|Core Phase (12 Months)|Protocol Violation|1|||
170663914|NCT00371826|616783793|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
170663915|NCT00371826|616783794|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
170663916|NCT00371826|616783795|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
170663917|NCT00371826|616783793|FG000|Core Phase (12 Months)|Administrative problems|1|||
170663918|NCT00371826|616783794|FG001|Core Phase (12 Months)|Administrative problems|0|||
170663919|NCT00371826|616783795|FG002|Core Phase (12 Months)|Administrative problems|8|||
170663920|NCT00371826|616783793|FG000|Core Phase (12 Months)|Graft Loss|0|||
170663921|NCT00371826|616783794|FG001|Core Phase (12 Months)|Graft Loss|1|||
170663922|NCT00371826|616783795|FG002|Core Phase (12 Months)|Graft Loss|0|||
170663923|NCT00371826|616783793|FG000|Extension Phase (24 Months)|Adverse Event|4|||
170663924|NCT00371826|616783794|FG001|Extension Phase (24 Months)|Adverse Event|5|||
170663925|NCT00371826|616783795|FG002|Extension Phase (24 Months)|Adverse Event|0|||
170663926|NCT00371826|616783793|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
170663927|NCT00371826|616783794|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
170817828|NCT04520256|617339903|FG026|Overall Study|Lost to Follow-up|3|||
170817829|NCT04520256|617339904|FG027|Overall Study|Lost to Follow-up|4|||
170663928|NCT00371826|616783795|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
170663929|NCT00371826|616783793|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
170663930|NCT00371826|616783794|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
170663931|NCT00371826|616783795|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
170663932|NCT00371826|616783793|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
170663933|NCT00371826|616783794|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
170663934|NCT00371826|616783795|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
170663935|NCT00371826|616783793|FG000|Extension Phase (24 Months)|Administrative problems|0|||
170817830|NCT04520256|617339905|FG028|Overall Study|Lost to Follow-up|3|||
170663936|NCT00371826|616783794|FG001|Extension Phase (24 Months)|Administrative problems|0|||
170817831|NCT04520256|617339906|FG029|Overall Study|Lost to Follow-up|4|||
170663937|NCT00371826|616783795|FG002|Extension Phase (24 Months)|Administrative problems|2|||
170663938|NCT06132659|616783801|FG000|Overall Study|Lost to Follow-up|0|||
170663939|NCT06132659|616783802|FG001|Overall Study|Lost to Follow-up|1|||
170663940|NCT06132659|616783803|FG002|Overall Study|Lost to Follow-up|0|||
170663941|NCT03794583|616783804|FG000|Overall Study|Death|8|||
170663942|NCT03794583|616783804|FG000|Overall Study|Study Terminated by Sponsor|24|||
170663943|NCT03794583|616783804|FG000|Overall Study|Withdrawal by Subject|9|||
170663944|NCT02497612|616783805|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
170663945|NCT02497612|616783806|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
170663946|NCT02497612|616783807|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
170663947|NCT02497612|616783808|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
170663948|NCT02497612|616783805|FG000|Overall Study|Participant's request|2|||
170663949|NCT02497612|616783806|FG001|Overall Study|Participant's request|3|||
170663950|NCT02497612|616783807|FG002|Overall Study|Participant's request|4|||
170663951|NCT02497612|616783808|FG003|Overall Study|Participant's request|1|||
170663952|NCT02497612|616783805|FG000|Overall Study|Investigator's judgement|1|||
170663953|NCT02497612|616783806|FG001|Overall Study|Investigator's judgement|0|||
170663954|NCT02497612|616783807|FG002|Overall Study|Investigator's judgement|0|||
170663955|NCT02497612|616783808|FG003|Overall Study|Investigator's judgement|2|||
170663956|NCT02497612|616783805|FG000|Overall Study|Adverse Event|3|||
170663957|NCT02497612|616783806|FG001|Overall Study|Adverse Event|1|||
170663958|NCT02497612|616783807|FG002|Overall Study|Adverse Event|4|||
170663959|NCT02497612|616783808|FG003|Overall Study|Adverse Event|1|||
170663960|NCT02497612|616783805|FG000|Overall Study|Lost to Follow-up|1|||
170663961|NCT02497612|616783806|FG001|Overall Study|Lost to Follow-up|1|||
170663962|NCT02497612|616783807|FG002|Overall Study|Lost to Follow-up|0|||
170663963|NCT02497612|616783808|FG003|Overall Study|Lost to Follow-up|1|||
170663964|NCT02497612|616783805|FG000|Overall Study|Other unspecified|1|||
170663965|NCT02497612|616783806|FG001|Overall Study|Other unspecified|1|||
170663966|NCT02497612|616783807|FG002|Overall Study|Other unspecified|2|||
170663967|NCT02497612|616783808|FG003|Overall Study|Other unspecified|0|||
170663968|NCT02497612|616783805|FG000|Overall Study|Not eligible|1|||
170663969|NCT02497612|616783806|FG001|Overall Study|Not eligible|0|||
170663970|NCT02497612|616783807|FG002|Overall Study|Not eligible|0|||
170663971|NCT02497612|616783808|FG003|Overall Study|Not eligible|1|||
170663972|NCT01914757|616783819|FG000|Overall Study|Severe non-compliance to protocol|3|||
170663973|NCT01914757|616783820|FG001|Overall Study|Severe non-compliance to protocol|1|||
170663974|NCT01914757|616783821|FG002|Overall Study|Severe non-compliance to protocol|2|||
170663975|NCT01914757|616783819|FG000|Overall Study|Lost to Follow-up|5|||
170663976|NCT01914757|616783820|FG001|Overall Study|Lost to Follow-up|8|||
170663977|NCT01914757|616783821|FG002|Overall Study|Lost to Follow-up|6|||
170663978|NCT01914757|616783819|FG000|Overall Study|Withdrawal by Subject|15|||
170663979|NCT01914757|616783820|FG001|Overall Study|Withdrawal by Subject|27|||
170663980|NCT01914757|616783821|FG002|Overall Study|Withdrawal by Subject|19|||
170663981|NCT01914757|616783819|FG000|Overall Study|Death|2|||
170663982|NCT01914757|616783820|FG001|Overall Study|Death|2|||
170663983|NCT01914757|616783821|FG002|Overall Study|Death|1|||
170663984|NCT01914757|616783819|FG000|Overall Study|Adverse Event|4|||
170663985|NCT01914757|616783820|FG001|Overall Study|Adverse Event|3|||
170663986|NCT01914757|616783821|FG002|Overall Study|Adverse Event|4|||
170663987|NCT01914757|616783819|FG000|Overall Study|Study specific withdrawal criteria|0|||
170663988|NCT01914757|616783820|FG001|Overall Study|Study specific withdrawal criteria|1|||
170663989|NCT01914757|616783821|FG002|Overall Study|Study specific withdrawal criteria|0|||
170663990|NCT01914757|616783819|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
170917324|NCT04589650|617697926|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170917325|NCT04589650|617697927|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
170917326|NCT04589650|617697928|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
170917327|NCT04589650|617697929|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
170917328|NCT04589650|617697924|FG000|Overall Study|Death|0|||
170917329|NCT04589650|617697925|FG001|Overall Study|Death|0|||
170663991|NCT01914757|616783820|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170917330|NCT04589650|617697926|FG002|Overall Study|Death|0|||
170663992|NCT01914757|616783821|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
170663993|NCT01914757|616783819|FG000|Overall Study|Other reasons|5|||
170663994|NCT01914757|616783820|FG001|Overall Study|Other reasons|9|||
170663995|NCT01914757|616783821|FG002|Overall Study|Other reasons|4|||
170663996|NCT00853073|616783824|FG000|Overall Study|Withdrawal by Subject|3|||
170663997|NCT00853073|616783825|FG001|Overall Study|Withdrawal by Subject|2|||
170663998|NCT05469113|616783827|FG000|Period 2|Adverse Event|0|||
170663999|NCT05469113|616783828|FG001|Period 2|Adverse Event|3|||
170664000|NCT01649804|616783829|FG000|Overall Study|Administrative/Other|8|||
170917331|NCT04589650|617697927|FG003|Overall Study|Death|1|||
170917332|NCT04589650|617697928|FG004|Overall Study|Death|0|||
170664001|NCT01400815|616783830|FG000|Overall Study|Adverse Event|3|||
170664002|NCT01400815|616783831|FG001|Overall Study|Adverse Event|0|||
170664003|NCT01400815|616783830|FG000|Overall Study|Death|0|||
170917333|NCT04589650|617697929|FG005|Overall Study|Death|0|||
170664004|NCT01400815|616783831|FG001|Overall Study|Death|1|||
170664005|NCT01400815|616783830|FG000|Overall Study|Lost to Follow-up|18|||
170664006|NCT01400815|616783831|FG001|Overall Study|Lost to Follow-up|11|||
170664007|NCT01400815|616783830|FG000|Overall Study|Protocol Violation|0|||
170664008|NCT01400815|616783831|FG001|Overall Study|Protocol Violation|1|||
170664009|NCT01400815|616783830|FG000|Overall Study|Physician Decision|1|||
170664010|NCT01400815|616783831|FG001|Overall Study|Physician Decision|0|||
170664011|NCT01400815|616783830|FG000|Overall Study|Withdrawal by Subject|15|||
170664012|NCT01400815|616783831|FG001|Overall Study|Withdrawal by Subject|8|||
170664013|NCT01400815|616783830|FG000|Overall Study|Subject in jail|1|||
170664014|NCT01400815|616783831|FG001|Overall Study|Subject in jail|0|||
170664015|NCT04810481|616783834|FG000|Overall Study|Disqualified data sets|10|||
170664016|NCT04810481|616783835|FG001|Overall Study|Disqualified data sets|28|||
170664017|NCT03277690|616783838|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
170664018|NCT03277690|616783839|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
170664019|NCT03277690|616783838|FG000|Dose Titration and Maintenance|Physician Decision|1|||
170664020|NCT03277690|616783839|FG001|Dose Titration and Maintenance|Physician Decision|0|||
170664021|NCT03277690|616783838|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
170664022|NCT03277690|616783839|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
170664023|NCT03277690|616783838|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
170664024|NCT03277690|616783839|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
170664025|NCT03277690|616783838|FG000|Dose Titration and Maintenance|Adverse Event|15|||
170664026|NCT03277690|616783839|FG001|Dose Titration and Maintenance|Adverse Event|0|||
170664027|NCT03277690|616783838|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
170664028|NCT03277690|616783839|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
170664029|NCT03277690|616783838|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
170664030|NCT03277690|616783839|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
170664031|NCT00747812|616783840|FG000|Overall Study|Research Site Staff Relocation|5|||
170664032|NCT00747812|616783841|FG001|Overall Study|Research Site Staff Relocation|3|||
170664033|NCT01708161|616783842|FG000|Overall Study|Adverse Event|1|||
170664034|NCT01708161|616783843|FG001|Overall Study|Adverse Event|3|||
170664035|NCT01708161|616783844|FG002|Overall Study|Adverse Event|4|||
170664036|NCT01708161|616783845|FG003|Overall Study|Adverse Event|2|||
170664037|NCT01708161|616783846|FG004|Overall Study|Adverse Event|3|||
170664038|NCT01708161|616783847|FG005|Overall Study|Adverse Event|0|||
170664039|NCT01708161|616783842|FG000|Overall Study|Death|0|||
170664040|NCT01708161|616783843|FG001|Overall Study|Death|0|||
170664041|NCT01708161|616783844|FG002|Overall Study|Death|0|||
170664042|NCT01708161|616783845|FG003|Overall Study|Death|1|||
170664043|NCT01708161|616783846|FG004|Overall Study|Death|0|||
170664044|NCT01708161|616783847|FG005|Overall Study|Death|1|||
170664045|NCT01708161|616783842|FG000|Overall Study|Withdrawal by Subject|0|||
170664046|NCT01708161|616783843|FG001|Overall Study|Withdrawal by Subject|1|||
170664047|NCT01708161|616783844|FG002|Overall Study|Withdrawal by Subject|1|||
170664048|NCT01708161|616783845|FG003|Overall Study|Withdrawal by Subject|0|||
170664049|NCT01708161|616783846|FG004|Overall Study|Withdrawal by Subject|0|||
170664050|NCT01708161|616783847|FG005|Overall Study|Withdrawal by Subject|0|||
170664051|NCT01708161|616783842|FG000|Overall Study|Administrative problems|0|||
170664052|NCT01708161|616783843|FG001|Overall Study|Administrative problems|1|||
170664053|NCT01708161|616783844|FG002|Overall Study|Administrative problems|0|||
170664054|NCT01708161|616783845|FG003|Overall Study|Administrative problems|0|||
170664055|NCT01708161|616783846|FG004|Overall Study|Administrative problems|0|||
170664056|NCT01708161|616783847|FG005|Overall Study|Administrative problems|0|||
170664057|NCT01708161|616783842|FG000|Overall Study|Disease progression|3|||
170664058|NCT01708161|616783843|FG001|Overall Study|Disease progression|5|||
170664059|NCT01708161|616783844|FG002|Overall Study|Disease progression|5|||
170664060|NCT01708161|616783845|FG003|Overall Study|Disease progression|13|||
170664061|NCT01708161|616783846|FG004|Overall Study|Disease progression|3|||
170664062|NCT01708161|616783847|FG005|Overall Study|Disease progression|0|||
170664063|NCT03109847|616783848|FG000|Overall Study|Withdrawal by Subject|1|||
170664064|NCT03109847|616783849|FG001|Overall Study|Withdrawal by Subject|0|||
170664065|NCT00764491|616783857|FG000|Overall Study|Lost to Follow-up|35|||
170664066|NCT00764491|616783858|FG001|Overall Study|Lost to Follow-up|17|||
170664067|NCT00620464|616783859|FG000|Overall Study|Adverse Event|15|||
170664068|NCT00620464|616783860|FG001|Overall Study|Adverse Event|17|||
170664069|NCT00620464|616783859|FG000|Overall Study|Lost to Follow-up|1|||
170664070|NCT00620464|616783860|FG001|Overall Study|Lost to Follow-up|1|||
170664071|NCT00620464|616783859|FG000|Overall Study|Planning Pregnancy|1|||
170664072|NCT00620464|616783860|FG001|Overall Study|Planning Pregnancy|4|||
170664073|NCT00620464|616783859|FG000|Overall Study|Personal|2|||
170664074|NCT00620464|616783860|FG001|Overall Study|Personal|2|||
170664075|NCT00620464|616783859|FG000|Overall Study|Used prohibited medication|1|||
170664076|NCT00620464|616783860|FG001|Overall Study|Used prohibited medication|0|||
170917334|NCT04589650|617697924|FG000|Overall Study|Guardian Decision|0|||
170664077|NCT03911154|616783861|FG000|Overall Study|Withdrawal by Subject|1|||
170664078|NCT00771316|616783862|FG000|Overall Study|Adverse Event|0|||
170664079|NCT00771316|616783863|FG001|Overall Study|Adverse Event|1|||
170664080|NCT00771316|616783862|FG000|Overall Study|Patient withdrew consent|1|||
170664081|NCT00771316|616783863|FG001|Overall Study|Patient withdrew consent|0|||
170664082|NCT00771316|616783862|FG000|Overall Study|Discontinued due to early termination|1|||
170664083|NCT00771316|616783863|FG001|Overall Study|Discontinued due to early termination|0|||
170664084|NCT02027376|616783864|FG000|Overall Study|Death|1|||
170664085|NCT02027376|616783865|FG001|Overall Study|Death|0|||
170664086|NCT02027376|616783866|FG002|Overall Study|Death|0|||
170664087|NCT01934972|616783867|FG000|Overall Study|Withdrawal by Subject|9|||
170664088|NCT01934972|616783868|FG001|Overall Study|Withdrawal by Subject|6|||
170664089|NCT01278160|616783869|FG000|Overall Study|Adverse Event|1|||
170664090|NCT01278160|616783870|FG001|Overall Study|Adverse Event|1|||
170664091|NCT01278160|616783869|FG000|Overall Study|Lost to Follow-up|0|||
170664092|NCT01278160|616783870|FG001|Overall Study|Lost to Follow-up|1|||
170664093|NCT01278160|616783869|FG000|Overall Study|Withdrawal by Subject|3|||
170664094|NCT01278160|616783870|FG001|Overall Study|Withdrawal by Subject|2|||
170664095|NCT01278160|616783869|FG000|Overall Study|Unclassified|1|||
170664096|NCT01278160|616783870|FG001|Overall Study|Unclassified|2|||
170664097|NCT01822496|616783872|FG000|Overall Study|Protocol Violation|2|||
170664098|NCT01822496|616783873|FG001|Overall Study|Protocol Violation|2|||
170664099|NCT01822496|616783874|FG002|Overall Study|Protocol Violation|0|||
170664100|NCT01822496|616783875|FG003|Overall Study|Protocol Violation|1|||
170664101|NCT01822496|616783872|FG000|Overall Study|Withdrawal by Subject|0|||
170664102|NCT01822496|616783873|FG001|Overall Study|Withdrawal by Subject|0|||
170664103|NCT01822496|616783874|FG002|Overall Study|Withdrawal by Subject|0|||
170664104|NCT01822496|616783875|FG003|Overall Study|Withdrawal by Subject|3|||
170664105|NCT03438383|616783876|FG000|Overall Study|Protocol Violation|9|||
170664106|NCT03438383|616783877|FG001|Overall Study|Protocol Violation|3|||
170664107|NCT02282358|616783878|FG000|Overall Study|Nonevaluable|1|||
170664108|NCT01631812|616783879|FG000|Overall Study|Adverse Event|25|||
170664109|NCT01631812|616783879|FG000|Overall Study|Lack of Efficacy|5|||
170664110|NCT01631812|616783879|FG000|Overall Study|Withdrawal by Subject|4|||
170664111|NCT01631812|616783879|FG000|Overall Study|Physician Decision|3|||
170664112|NCT03780543|616783880|FG000|Overall Study|Adverse Event|1|||
170664113|NCT03780543|616783881|FG001|Overall Study|Adverse Event|0|||
170664114|NCT03780543|616783882|FG002|Overall Study|Adverse Event|2|||
170664115|NCT03780543|616783880|FG000|Overall Study|Lost to Follow-up|2|||
170664116|NCT03780543|616783881|FG001|Overall Study|Lost to Follow-up|0|||
170664117|NCT03780543|616783882|FG002|Overall Study|Lost to Follow-up|1|||
170664118|NCT03780543|616783880|FG000|Overall Study|Study terminated by Sponsor|8|||
170664119|NCT03780543|616783881|FG001|Overall Study|Study terminated by Sponsor|7|||
170664120|NCT03780543|616783882|FG002|Overall Study|Study terminated by Sponsor|13|||
170664121|NCT03780543|616783880|FG000|Overall Study|Withdrawal by Subject|1|||
170664122|NCT03780543|616783881|FG001|Overall Study|Withdrawal by Subject|8|||
170664123|NCT03780543|616783882|FG002|Overall Study|Withdrawal by Subject|1|||
170664124|NCT03780543|616783880|FG000|Overall Study|Noncompliance with study drug|1|||
170664125|NCT03780543|616783881|FG001|Overall Study|Noncompliance with study drug|0|||
170664126|NCT03780543|616783882|FG002|Overall Study|Noncompliance with study drug|0|||
170664127|NCT02030938|616783883|FG000|Overall Study|Lost to Follow-up|4|||
170664128|NCT02030938|616783883|FG000|Overall Study|Withdrawal by Subject|1|||
170664129|NCT03954132|616783887|FG000|Overall Study|Adverse Event|2|||
170664130|NCT03954132|616783888|FG001|Overall Study|Adverse Event|0|||
170664131|NCT03954132|616783887|FG000|Overall Study|Patient's wish|5|||
170664132|NCT03954132|616783888|FG001|Overall Study|Patient's wish|0|||
170664133|NCT03954132|616783887|FG000|Overall Study|Lost to Follow-up|10|||
170664134|NCT03954132|616783888|FG001|Overall Study|Lost to Follow-up|0|||
170664135|NCT03954132|616783887|FG000|Overall Study|Screening failure|0|||
170664136|NCT03954132|616783888|FG001|Overall Study|Screening failure|1|||
170917335|NCT04589650|617697925|FG001|Overall Study|Guardian Decision|0|||
170917336|NCT04589650|617697926|FG002|Overall Study|Guardian Decision|0|||
170917337|NCT04589650|617697927|FG003|Overall Study|Guardian Decision|1|||
170917338|NCT04589650|617697928|FG004|Overall Study|Guardian Decision|0|||
170664137|NCT03954132|616783887|FG000|Overall Study|No registration after Visit 1|5|||
170664138|NCT03954132|616783888|FG001|Overall Study|No registration after Visit 1|2|||
170664139|NCT03954132|616783887|FG000|Overall Study|Other reason than listed|2|||
170664140|NCT03954132|616783888|FG001|Overall Study|Other reason than listed|2|||
170664141|NCT03954132|616783887|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
170664142|NCT03954132|616783888|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
170664143|NCT03954132|616783887|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
170664144|NCT03954132|616783888|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
170664145|NCT04308304|616783889|FG000|Overall Study|Withdrawal by Subject|4|||
170664146|NCT04308304|616783890|FG001|Overall Study|Withdrawal by Subject|0|||
170664147|NCT04308304|616783889|FG000|Overall Study|Protocol Violation|1|||
170664148|NCT04308304|616783890|FG001|Overall Study|Protocol Violation|0|||
170664149|NCT00945555|616783891|FG000|Overall Study|Referred to another hospital|5|||
170664150|NCT00945555|616783891|FG000|Overall Study|Worsening condition, intensive care unit|1|||
170664151|NCT00945555|616783891|FG000|Overall Study|Withdrawal by Subject|2|||
170664152|NCT00945555|616783891|FG000|Overall Study|Participant continued treatment at home|1|||
170664153|NCT00945555|616783891|FG000|Overall Study|Death|18|||
170664154|NCT00945555|616783891|FG000|Overall Study|Other|1|||
170664155|NCT02906332|616783899|FG000|Overall Study|Withdrawal by Subject|1|||
170664156|NCT03001882|616783900|FG000|Overall Study|Death|1|||
170664157|NCT03001882|616783901|FG001|Overall Study|Death|0|||
170664158|NCT03001882|616783902|FG002|Overall Study|Death|0|||
170664159|NCT03001882|616783903|FG003|Overall Study|Death|3|||
170664160|NCT03001882|616783900|FG000|Overall Study|Participant withdrew consent|0|||
170664161|NCT03001882|616783901|FG001|Overall Study|Participant withdrew consent|1|||
170664162|NCT03001882|616783902|FG002|Overall Study|Participant withdrew consent|0|||
170664163|NCT03001882|616783903|FG003|Overall Study|Participant withdrew consent|5|||
170664164|NCT03001882|616783900|FG000|Overall Study|Other reasons|1|||
170664165|NCT03001882|616783901|FG001|Overall Study|Other reasons|2|||
170664166|NCT03001882|616783902|FG002|Overall Study|Other reasons|0|||
170664167|NCT03001882|616783903|FG003|Overall Study|Other reasons|5|||
170664168|NCT03001882|616783900|FG000|Overall Study|Administrative reason by sponsor|0|||
170664169|NCT03001882|616783901|FG001|Overall Study|Administrative reason by sponsor|0|||
170664170|NCT03001882|616783902|FG002|Overall Study|Administrative reason by sponsor|0|||
170664171|NCT03001882|616783903|FG003|Overall Study|Administrative reason by sponsor|1|||
170664172|NCT03001882|616783900|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
170664173|NCT03001882|616783901|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
170664174|NCT03001882|616783902|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
170664175|NCT03001882|616783903|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
170664176|NCT03001882|616783900|FG000|Overall Study|Not reported|0|||
170664177|NCT03001882|616783901|FG001|Overall Study|Not reported|0|||
170664178|NCT03001882|616783902|FG002|Overall Study|Not reported|0|||
170664179|NCT03001882|616783903|FG003|Overall Study|Not reported|6|||
170664180|NCT03001882|616783900|FG000|Overall Study|Maximum clinical benefit|2|||
170664181|NCT03001882|616783901|FG001|Overall Study|Maximum clinical benefit|3|||
170664182|NCT03001882|616783902|FG002|Overall Study|Maximum clinical benefit|0|||
170664183|NCT03001882|616783903|FG003|Overall Study|Maximum clinical benefit|10|||
170664184|NCT03001882|616783900|FG000|Overall Study|AE unrelated to study drug|3|||
170664185|NCT03001882|616783901|FG001|Overall Study|AE unrelated to study drug|3|||
170664186|NCT03001882|616783902|FG002|Overall Study|AE unrelated to study drug|0|||
170664187|NCT03001882|616783903|FG003|Overall Study|AE unrelated to study drug|11|||
170664188|NCT03001882|616783900|FG000|Overall Study|Study Drug Toxicity|8|||
170664189|NCT03001882|616783901|FG001|Overall Study|Study Drug Toxicity|5|||
170664190|NCT03001882|616783902|FG002|Overall Study|Study Drug Toxicity|0|||
170664191|NCT03001882|616783903|FG003|Overall Study|Study Drug Toxicity|37|||
170664192|NCT03001882|616783900|FG000|Overall Study|Disease progression|16|||
170664193|NCT03001882|616783901|FG001|Overall Study|Disease progression|14|||
170664194|NCT03001882|616783902|FG002|Overall Study|Disease progression|1|||
170664195|NCT03001882|616783903|FG003|Overall Study|Disease progression|90|||
170664196|NCT03894046|616785392|FG000|Overall Study|Protocol Violation|1|||
170664197|NCT03894046|616785393|FG001|Overall Study|Protocol Violation|0|||
170664198|NCT03894046|616785394|FG002|Overall Study|Protocol Violation|0|||
170664199|NCT03894046|616785392|FG000|Overall Study|Adverse Event|0|||
170664200|NCT03894046|616785393|FG001|Overall Study|Adverse Event|1|||
170664201|NCT03894046|616785394|FG002|Overall Study|Adverse Event|0|||
170664202|NCT03894046|616785392|FG000|Overall Study|Withdrawal by Subject|2|||
170664203|NCT03894046|616785393|FG001|Overall Study|Withdrawal by Subject|3|||
170664204|NCT03894046|616785394|FG002|Overall Study|Withdrawal by Subject|1|||
170664205|NCT03894046|616785392|FG000|Overall Study|Death|15|||
170664206|NCT03894046|616785393|FG001|Overall Study|Death|21|||
170664207|NCT03894046|616785394|FG002|Overall Study|Death|4|||
170664208|NCT03894046|616785392|FG000|Overall Study|No growth of ABC|2|||
170664209|NCT03894046|616785393|FG001|Overall Study|No growth of ABC|1|||
170664210|NCT03894046|616785394|FG002|Overall Study|No growth of ABC|0|||
170664211|NCT03894046|616785392|FG000|Overall Study|Physician Decision|1|||
170664212|NCT03894046|616785393|FG001|Overall Study|Physician Decision|1|||
170664213|NCT03894046|616785394|FG002|Overall Study|Physician Decision|1|||
170664214|NCT03894046|616785392|FG000|Overall Study|Prohibited concomitant medication|1|||
170664215|NCT03894046|616785393|FG001|Overall Study|Prohibited concomitant medication|0|||
170664216|NCT03894046|616785394|FG002|Overall Study|Prohibited concomitant medication|0|||
170664217|NCT03894046|616785392|FG000|Overall Study|Transferred to other arm/group|1|||
170664218|NCT03894046|616785393|FG001|Overall Study|Transferred to other arm/group|1|||
170664219|NCT03894046|616785394|FG002|Overall Study|Transferred to other arm/group|0|||
170664220|NCT00100178|616785395|FG000|Overall Study|Lost to Follow-up|0|||
170664221|NCT00100178|616785396|FG001|Overall Study|Lost to Follow-up|6|||
170664222|NCT00100178|616785397|FG002|Overall Study|Lost to Follow-up|5|||
170664223|NCT00100178|616785395|FG000|Overall Study|Adverse Event|2|||
170664224|NCT00100178|616785396|FG001|Overall Study|Adverse Event|2|||
170664225|NCT00100178|616785397|FG002|Overall Study|Adverse Event|1|||
170664226|NCT00100178|616785395|FG000|Overall Study|Withdrawal by Subject|1|||
170664227|NCT00100178|616785396|FG001|Overall Study|Withdrawal by Subject|1|||
170664228|NCT00100178|616785397|FG002|Overall Study|Withdrawal by Subject|1|||
170917339|NCT04589650|617697929|FG005|Overall Study|Guardian Decision|0|||
170917340|NCT03492177|617697930|FG000|Overall Study|Adverse Event|1|||
170917341|NCT03492177|617697931|FG001|Overall Study|Adverse Event|0|||
170917342|NCT03492177|617697932|FG002|Overall Study|Adverse Event|0|||
170664229|NCT00100178|616785395|FG000|Overall Study|Physician Decision|6|||
170664230|NCT00100178|616785396|FG001|Overall Study|Physician Decision|1|||
170664231|NCT00100178|616785397|FG002|Overall Study|Physician Decision|3|||
170917343|NCT03492177|617697930|FG000|Overall Study|Death|3|||
170917344|NCT03492177|617697931|FG001|Overall Study|Death|0|||
170917345|NCT03492177|617697932|FG002|Overall Study|Death|3|||
170917346|NCT03492177|617697930|FG000|Overall Study|Lack of Efficacy|1|||
170917347|NCT03492177|617697931|FG001|Overall Study|Lack of Efficacy|2|||
170917348|NCT03492177|617697932|FG002|Overall Study|Lack of Efficacy|0|||
170917349|NCT03492177|617697930|FG000|Overall Study|Other|1|||
170917350|NCT03492177|617697931|FG001|Overall Study|Other|0|||
170917351|NCT03492177|617697932|FG002|Overall Study|Other|0|||
170917352|NCT03492177|617697930|FG000|Overall Study|Ongoing|16|||
170917353|NCT03492177|617697931|FG001|Overall Study|Ongoing|19|||
170917354|NCT03492177|617697932|FG002|Overall Study|Ongoing|17|||
170917355|NCT02499328|617697933|FG000|Overall Study|Withdrawal by Subject|1|||
170917356|NCT02499328|617697934|FG001|Overall Study|Withdrawal by Subject|1|||
170917357|NCT02499328|617697935|FG002|Overall Study|Withdrawal by Subject|5|||
170917358|NCT02499328|617697936|FG003|Overall Study|Withdrawal by Subject|3|||
170917359|NCT02499328|617697937|FG004|Overall Study|Withdrawal by Subject|5|||
170917360|NCT02499328|617697938|FG005|Overall Study|Withdrawal by Subject|0|||
170917361|NCT02499328|617697939|FG006|Overall Study|Withdrawal by Subject|0|||
170917362|NCT02499328|617697940|FG007|Overall Study|Withdrawal by Subject|0|||
170917363|NCT02499328|617697941|FG008|Overall Study|Withdrawal by Subject|2|||
170917364|NCT02499328|617697942|FG009|Overall Study|Withdrawal by Subject|2|||
170917365|NCT02499328|617697943|FG010|Overall Study|Withdrawal by Subject|0|||
170917366|NCT02499328|617697944|FG011|Overall Study|Withdrawal by Subject|3|||
170917367|NCT02499328|617697945|FG012|Overall Study|Withdrawal by Subject|7|||
170917368|NCT02499328|617697946|FG013|Overall Study|Withdrawal by Subject|3|||
170917369|NCT02499328|617697947|FG014|Overall Study|Withdrawal by Subject|1|||
170917370|NCT02499328|617697948|FG015|Overall Study|Withdrawal by Subject|0|||
170917371|NCT02499328|617697949|FG016|Overall Study|Withdrawal by Subject|0|||
170917372|NCT02499328|617697950|FG017|Overall Study|Withdrawal by Subject|3|||
170917373|NCT02499328|617697951|FG018|Overall Study|Withdrawal by Subject|0|||
170917374|NCT02499328|617697933|FG000|Overall Study|Lost to Follow-up|0|||
170917375|NCT02499328|617697934|FG001|Overall Study|Lost to Follow-up|1|||
170917376|NCT02499328|617697935|FG002|Overall Study|Lost to Follow-up|1|||
170917377|NCT02499328|617697936|FG003|Overall Study|Lost to Follow-up|2|||
170917378|NCT02499328|617697937|FG004|Overall Study|Lost to Follow-up|0|||
170617146|NCT03160898|616605297|FG001|Overall Study|Death|0|||
170617147|NCT03160898|616605298|FG002|Overall Study|Death|0|||
170617148|NCT03160898|616605299|FG003|Overall Study|Death|1|||
170617149|NCT03160898|616605296|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
170617150|NCT03160898|616605297|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
170617151|NCT03160898|616605298|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
170617152|NCT03160898|616605299|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
170617153|NCT03160898|616605296|FG000|Overall Study|Lost to Follow-up|1|||
170617154|NCT03160898|616605297|FG001|Overall Study|Lost to Follow-up|1|||
170617155|NCT03160898|616605298|FG002|Overall Study|Lost to Follow-up|1|||
170617156|NCT03160898|616605299|FG003|Overall Study|Lost to Follow-up|2|||
170617157|NCT03160898|616605296|FG000|Overall Study|Physician Decision|1|||
170617158|NCT03160898|616605297|FG001|Overall Study|Physician Decision|0|||
170617159|NCT03160898|616605298|FG002|Overall Study|Physician Decision|0|||
170617160|NCT03160898|616605299|FG003|Overall Study|Physician Decision|1|||
170617161|NCT03160898|616605296|FG000|Overall Study|Progressive Disease|4|||
170617162|NCT03160898|616605297|FG001|Overall Study|Progressive Disease|1|||
170617163|NCT03160898|616605298|FG002|Overall Study|Progressive Disease|2|||
170617164|NCT03160898|616605299|FG003|Overall Study|Progressive Disease|1|||
170617165|NCT03160898|616605296|FG000|Overall Study|Protocol Violation|1|||
170664232|NCT02477839|616785398|FG000|Overall Study|Adverse Event|0|||
170617166|NCT03160898|616605297|FG001|Overall Study|Protocol Violation|0|||
170617167|NCT03160898|616605298|FG002|Overall Study|Protocol Violation|2|||
170617168|NCT03160898|616605299|FG003|Overall Study|Protocol Violation|0|||
170664233|NCT02477839|616785399|FG001|Overall Study|Adverse Event|1|||
170664234|NCT02477839|616785398|FG000|Overall Study|Protocol Violation|0|||
170917379|NCT02499328|617697938|FG005|Overall Study|Lost to Follow-up|0|||
170917380|NCT02499328|617697939|FG006|Overall Study|Lost to Follow-up|0|||
170917381|NCT02499328|617697940|FG007|Overall Study|Lost to Follow-up|2|||
170917382|NCT02499328|617697941|FG008|Overall Study|Lost to Follow-up|3|||
170917383|NCT02499328|617697942|FG009|Overall Study|Lost to Follow-up|0|||
170617169|NCT03160898|616605296|FG000|Overall Study|Sponsor Discretion|2|||
170617170|NCT03160898|616605297|FG001|Overall Study|Sponsor Discretion|0|||
170917384|NCT02499328|617697943|FG010|Overall Study|Lost to Follow-up|0|||
170917385|NCT02499328|617697944|FG011|Overall Study|Lost to Follow-up|0|||
170917386|NCT02499328|617697945|FG012|Overall Study|Lost to Follow-up|0|||
170917387|NCT02499328|617697946|FG013|Overall Study|Lost to Follow-up|0|||
170664235|NCT02477839|616785399|FG001|Overall Study|Protocol Violation|2|||
170664236|NCT02477839|616785398|FG000|Overall Study|Withdrawal by Subject|3|||
170664237|NCT02477839|616785399|FG001|Overall Study|Withdrawal by Subject|3|||
170664238|NCT02477839|616785398|FG000|Overall Study|Participant had PGS during V6|0|||
170664239|NCT02477839|616785399|FG001|Overall Study|Participant had PGS during V6|1|||
170664240|NCT02477839|616785398|FG000|Overall Study|Parents decided to stop medication|0|||
170664241|NCT02477839|616785399|FG001|Overall Study|Parents decided to stop medication|1|||
170664242|NCT02477839|616785398|FG000|Overall Study|Lack of tolerability|0|||
170664243|NCT02477839|616785399|FG001|Overall Study|Lack of tolerability|1|||
170664244|NCT02477839|616785398|FG000|Overall Study|Exclusion criterion|0|||
170664245|NCT02477839|616785399|FG001|Overall Study|Exclusion criterion|1|||
170664246|NCT01439568|616785403|FG000|Overall Study|Lost to Follow-up|1|||
170664247|NCT01439568|616785404|FG001|Overall Study|Lost to Follow-up|0|||
170664248|NCT01439568|616785403|FG000|Overall Study|Withdrawal by Subject|2|||
170664249|NCT01439568|616785404|FG001|Overall Study|Withdrawal by Subject|2|||
170664250|NCT01676727|616785407|FG000|Overall Study|Death|18|||
170664251|NCT01676727|616785407|FG000|Overall Study|Withdrawal by Subject|6|||
170664252|NCT01676727|616785407|FG000|Overall Study|Screening failure|5|||
170664253|NCT01676727|616785407|FG000|Overall Study|Not willing to attend 1-year visit|2|||
170664254|NCT01676727|616785407|FG000|Overall Study|Valve explanted|1|||
170664255|NCT01578330|616785408|FG000|Overall Study|Adverse Event|2|||
170664256|NCT01578330|616785408|FG000|Overall Study|Protocol Violation|5|||
170664257|NCT01646073|616785411|FG000|Period A (12 Weeks)|Adverse Event|0|||
170664258|NCT01646073|616785412|FG001|Period A (12 Weeks)|Adverse Event|2|||
170664259|NCT01646073|616785411|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
170664260|NCT01646073|616785412|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
170664261|NCT01646073|616785411|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
170664262|NCT01646073|616785412|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
170664263|NCT01646073|616785411|FG000|Period A (12 Weeks)|Protocol Violation|0|||
170664264|NCT01646073|616785412|FG001|Period A (12 Weeks)|Protocol Violation|1|||
170664265|NCT01646073|616785411|FG000|Period A (12 Weeks)|Other|0|||
170664266|NCT01646073|616785412|FG001|Period A (12 Weeks)|Other|1|||
170664267|NCT01646073|616785411|FG000|Period B (12 Weeks)|Adverse Event|0|||
170664268|NCT01646073|616785412|FG001|Period B (12 Weeks)|Adverse Event|7|||
170664269|NCT01646073|616785411|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
170664270|NCT01646073|616785412|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
170664271|NCT01646073|616785411|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
170664272|NCT01646073|616785412|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
170664273|NCT00679055|616785413|FG000|Overall Study|Adverse Event|0|||
170664274|NCT00679055|616785414|FG001|Overall Study|Adverse Event|1|||
170664275|NCT00679055|616785413|FG000|Overall Study|Other|0|||
170664276|NCT00679055|616785414|FG001|Overall Study|Other|3|||
170664277|NCT00679055|616785413|FG000|Overall Study|Study Terminated|2|||
170664278|NCT00679055|616785414|FG001|Overall Study|Study Terminated|1|||
170664279|NCT01393301|616785415|FG000|Overall Study|Lost to Follow-up|5|||
170664280|NCT01393301|616785416|FG001|Overall Study|Lost to Follow-up|3|||
170664281|NCT01393301|616785415|FG000|Overall Study|Withdrawal by Subject|2|||
170664282|NCT01393301|616785416|FG001|Overall Study|Withdrawal by Subject|0|||
170664283|NCT01393301|616785415|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
170664284|NCT01393301|616785416|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
170664285|NCT01497275|616785417|FG000|Overall Study|Death|1|||
170664286|NCT01497275|616785417|FG000|Overall Study|Adverse Event|1|||
170664287|NCT00437320|616785418|FG000|Overall Study|Participant request|2|||
170664288|NCT00437320|616785419|FG001|Overall Study|Participant request|1|||
170664289|NCT00437320|616785420|FG002|Overall Study|Participant request|4|||
170664290|NCT01756053|616785426|FG000|Period 1 (10 Days)|Protocol Violation|1|||
170664291|NCT01756053|616785427|FG001|Period 1 (10 Days)|Protocol Violation|1|||
170664292|NCT01756053|616785426|FG000|Period 2 (10 Days)|Protocol Violation|0|||
170664293|NCT01756053|616785427|FG001|Period 2 (10 Days)|Protocol Violation|2|||
170664294|NCT00285818|616785428|FG000|Overall Study|Withdrawal by Subject|3|||
170664295|NCT00285818|616785429|FG001|Overall Study|Withdrawal by Subject|2|||
170664296|NCT00285818|616785428|FG000|Overall Study|Lost to Follow-up|1|||
170664297|NCT00285818|616785429|FG001|Overall Study|Lost to Follow-up|0|||
170664298|NCT02083081|616785430|FG000|Overall Study|Lost to Follow-up|31|||
170664299|NCT02083081|616785431|FG001|Overall Study|Lost to Follow-up|9|||
170664300|NCT01230710|616785436|FG000|Overall Study|Disease Progression|41|||
170664301|NCT01230710|616785436|FG000|Overall Study|Lost to Follow-up|3|||
170817832|NCT04520256|617339907|FG030|Overall Study|Lost to Follow-up|4|||
170817833|NCT04520256|617339908|FG031|Overall Study|Lost to Follow-up|4|||
170817834|NCT00760877|617341388|FG000|Overall Study|Protocol Violation|1|||
170817835|NCT00760877|617341389|FG001|Overall Study|Protocol Violation|0|||
170817836|NCT00760877|617341388|FG000|Overall Study|Non-compliance with protocol treatment|2|||
170817837|NCT00760877|617341389|FG001|Overall Study|Non-compliance with protocol treatment|1|||
170817838|NCT00760877|617341388|FG000|Overall Study|Pregnancy|1|||
170817839|NCT00760877|617341389|FG001|Overall Study|Pregnancy|4|||
170817840|NCT00760877|617341388|FG000|Overall Study|Death|2|||
170664302|NCT01230710|616785436|FG000|Overall Study|Death|4|||
170817841|NCT00760877|617341389|FG001|Overall Study|Death|1|||
170664303|NCT01230710|616785436|FG000|Overall Study|Withdrawal of Consent|1|||
170664304|NCT02905149|616785437|FG000|Overall Study|Lost to Follow-up|2|||
170664305|NCT02905149|616785438|FG001|Overall Study|Lost to Follow-up|0|||
170664306|NCT01104155|616785446|FG000|Overall Study|Adverse Event|15|||
170664307|NCT01104155|616785447|FG001|Overall Study|Adverse Event|8|||
170664308|NCT01104155|616785446|FG000|Overall Study|Participant choice|6|||
170664309|NCT01104155|616785447|FG001|Overall Study|Participant choice|5|||
170664310|NCT01104155|616785446|FG000|Overall Study|Withdrawal of consent|1|||
170664311|NCT01104155|616785447|FG001|Overall Study|Withdrawal of consent|1|||
170664312|NCT01104155|616785446|FG000|Overall Study|Other|3|||
170664313|NCT01104155|616785447|FG001|Overall Study|Other|4|||
170664314|NCT01484132|616785448|FG000|Overall Study|Lost to Follow-up|8|||
170664315|NCT01484132|616785448|FG000|Overall Study|Difficulty with time commitment|2|||
170664316|NCT01484132|616785448|FG000|Overall Study|Ineligible|1|||
170664317|NCT01484132|616785448|FG000|Overall Study|No pre-treatment urine sample collected|1|||
170664318|NCT01484132|616785448|FG000|Overall Study|No post-treatment urine sample collected|10|||
170664319|NCT01672736|616785455|FG000|Overall Study|Available drug expired on 31 May 16|3|||
170664320|NCT01069627|616785456|FG000|Overall Study|Disease progression|7|||
170664321|NCT01069627|616785456|FG000|Overall Study|Adverse Event|12|||
170664322|NCT01069627|616785456|FG000|Overall Study|Protocol Violation|1|||
170664323|NCT04209348|616785457|FG000|Overall Study|Lost to Follow-up|1|||
170664324|NCT04209348|616785458|FG001|Overall Study|Lost to Follow-up|0|||
170664325|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
170664326|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
170664327|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Death|1|||
170664328|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Death|0|||
170664329|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
170664330|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
170664331|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
170664332|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
170664333|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
170664334|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
170664335|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
170664336|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
170664337|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
170664338|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
170664339|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
170664340|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
170664341|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
170664342|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
170664343|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
170664344|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
170664345|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
170664346|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
170664347|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
170664348|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
170664349|NCT02927262|616785459|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
170664350|NCT02927262|616785460|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
170664351|NCT02927262|616785459|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
170664352|NCT02927262|616785460|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
170664353|NCT02927262|616785459|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
170664354|NCT02927262|616785460|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
170664355|NCT02927262|616785459|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
170664356|NCT02927262|616785460|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
170664357|NCT02963935|616785463|FG000|Overall Study|Adverse Event|12|||
170664358|NCT02963935|616785464|FG001|Overall Study|Adverse Event|6|||
170664359|NCT02963935|616785463|FG000|Overall Study|Protocol Violation|2|||
170664360|NCT02963935|616785464|FG001|Overall Study|Protocol Violation|1|||
170664361|NCT02963935|616785463|FG000|Overall Study|Lack of Efficacy|0|||
170817842|NCT00760877|617341388|FG000|Overall Study|Withdrawal by Subject|7|||
170817843|NCT00760877|617341389|FG001|Overall Study|Withdrawal by Subject|3|||
170817844|NCT00760877|617341388|FG000|Overall Study|Adverse Event|19|||
170817845|NCT00760877|617341389|FG001|Overall Study|Adverse Event|12|||
170817846|NCT00760877|617341388|FG000|Overall Study|Participant diagnosed with AML|0|||
170817847|NCT00760877|617341389|FG001|Overall Study|Participant diagnosed with AML|1|||
170817848|NCT00760877|617341388|FG000|Overall Study|Participant not eligible to cross-over|0|||
170664362|NCT02963935|616785464|FG001|Overall Study|Lack of Efficacy|2|||
170664363|NCT02963935|616785463|FG000|Overall Study|Lost to Follow-up|1|||
170664364|NCT02963935|616785464|FG001|Overall Study|Lost to Follow-up|6|||
170617171|NCT03160898|616605298|FG002|Overall Study|Sponsor Discretion|0|||
170617172|NCT03160898|616605299|FG003|Overall Study|Sponsor Discretion|0|||
170617173|NCT03160898|616605296|FG000|Overall Study|Withdrawal by Subject|1|||
170617174|NCT03160898|616605297|FG001|Overall Study|Withdrawal by Subject|3|||
170617175|NCT03160898|616605298|FG002|Overall Study|Withdrawal by Subject|2|||
170617176|NCT03160898|616605299|FG003|Overall Study|Withdrawal by Subject|1|||
170617177|NCT03160898|616605296|FG000|Overall Study|Other|2|||
170617178|NCT03160898|616605297|FG001|Overall Study|Other|0|||
170617179|NCT03160898|616605298|FG002|Overall Study|Other|2|||
170617180|NCT03160898|616605299|FG003|Overall Study|Other|2|||
170617181|NCT00434109|616605302|FG000|Overall Study|Physician Decision|9|||
170617182|NCT00434109|616605302|FG000|Overall Study|Adverse Event|5|||
170617183|NCT00434109|616605302|FG000|Overall Study|Protocol Violation|1|||
170617184|NCT00434109|616605302|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
170617185|NCT04618744|616605305|FG000|Overall Study|Adverse Event|0|||
170617186|NCT04618744|616605306|FG001|Overall Study|Adverse Event|1|||
170617187|NCT04618744|616605305|FG000|Overall Study|Withdrawal by Subject|0|||
170617188|NCT04618744|616605306|FG001|Overall Study|Withdrawal by Subject|1|||
170617189|NCT00930930|616605307|FG000|Overall Study|Death|1|||
170617190|NCT00930930|616605308|FG001|Overall Study|Death|0|||
170617191|NCT00930930|616605307|FG000|Overall Study|Physician Decision|1|||
170617192|NCT00930930|616605308|FG001|Overall Study|Physician Decision|0|||
170617193|NCT00930930|616605307|FG000|Overall Study|Adverse Event|13|||
170617194|NCT00930930|616605308|FG001|Overall Study|Adverse Event|3|||
170617195|NCT00930930|616605307|FG000|Overall Study|Withdrawal by Subject|3|||
170617196|NCT00930930|616605308|FG001|Overall Study|Withdrawal by Subject|1|||
170617197|NCT00930930|616605307|FG000|Overall Study|Disease progression|2|||
170617198|NCT00930930|616605308|FG001|Overall Study|Disease progression|3|||
170617199|NCT00930930|616605307|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
170617200|NCT00930930|616605308|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
170617201|NCT00930930|616605307|FG000|Overall Study|patients not compliant|1|||
170617202|NCT00930930|616605308|FG001|Overall Study|patients not compliant|1|||
170617203|NCT00511238|616605309|FG000|Overall Study|Adverse Event|13|||
170617204|NCT00511238|616605310|FG001|Overall Study|Adverse Event|33|||
170617205|NCT00511238|616605309|FG000|Overall Study|Withdrawal by Subject|2|||
170617206|NCT00511238|616605310|FG001|Overall Study|Withdrawal by Subject|22|||
170617207|NCT00511238|616605309|FG000|Overall Study|Progressive Disease|23|||
170617208|NCT00511238|616605310|FG001|Overall Study|Progressive Disease|157|||
170617209|NCT00511238|616605309|FG000|Overall Study|various reasons|4|||
170617210|NCT00511238|616605310|FG001|Overall Study|various reasons|14|||
170617211|NCT01855412|616606878|FG000|Overall Study|Death|77|||
170617212|NCT01855412|616606879|FG001|Overall Study|Death|123|||
170617213|NCT01855412|616606880|FG002|Overall Study|Death|30|||
170617214|NCT01855412|616606878|FG000|Overall Study|Lost to Follow-up|28|||
170617215|NCT01855412|616606879|FG001|Overall Study|Lost to Follow-up|46|||
170617216|NCT01855412|616606880|FG002|Overall Study|Lost to Follow-up|15|||
170617217|NCT01855412|616606878|FG000|Overall Study|Withdrawal by Subject|77|||
170617218|NCT01855412|616606879|FG001|Overall Study|Withdrawal by Subject|123|||
170617219|NCT01855412|616606880|FG002|Overall Study|Withdrawal by Subject|24|||
170617220|NCT01855412|616606878|FG000|Overall Study|Physician Decision|25|||
170617221|NCT01855412|616606879|FG001|Overall Study|Physician Decision|31|||
170617222|NCT01855412|616606880|FG002|Overall Study|Physician Decision|3|||
170617223|NCT01855412|616606878|FG000|Overall Study|Site Closure|4|||
170817849|NCT00760877|617341389|FG001|Overall Study|Participant not eligible to cross-over|1|||
170817850|NCT00760877|617341388|FG000|Overall Study|Physician Decision|1|||
170817851|NCT00760877|617341389|FG001|Overall Study|Physician Decision|2|||
170817852|NCT00760877|617341388|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
170817853|NCT00760877|617341389|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
170817854|NCT00760877|617341388|FG000|Overall Study|Treatment failure|1|||
170817855|NCT00760877|617341389|FG001|Overall Study|Treatment failure|0|||
170817856|NCT00705614|617341390|FG000|Initial Intervention|Adverse Event|40|||
170817857|NCT00705614|617341391|FG001|Initial Intervention|Adverse Event|21|||
170817858|NCT00705614|617341390|FG000|Initial Intervention|Lost to Follow-up|310|||
170817859|NCT00705614|617341391|FG001|Initial Intervention|Lost to Follow-up|191|||
170817860|NCT00705614|617341390|FG000|Initial Intervention|Withdrawal by Subject|114|||
170817861|NCT00705614|617341391|FG001|Initial Intervention|Withdrawal by Subject|71|||
170817862|NCT00705614|617341390|FG000|Initial Intervention|Administrative Reason|51|||
170817863|NCT00705614|617341391|FG001|Initial Intervention|Administrative Reason|38|||
170817864|NCT00705614|617341390|FG000|Initial Intervention|Status completion unknown|3|||
170617224|NCT01855412|616606879|FG001|Overall Study|Site Closure|18|||
170617225|NCT01855412|616606880|FG002|Overall Study|Site Closure|1|||
170617226|NCT01855412|616606878|FG000|Overall Study|Reason not Specified|1|||
170817865|NCT00705614|617341391|FG001|Initial Intervention|Status completion unknown|0|||
170817866|NCT00705614|617341390|FG000|Switch to Remicade|Adverse Event|0|||
170817867|NCT00705614|617341391|FG001|Switch to Remicade|Adverse Event|5|||
170817868|NCT00705614|617341390|FG000|Switch to Remicade|Lost to Follow-up|0|||
170617227|NCT01855412|616606879|FG001|Overall Study|Reason not Specified|2|||
170617228|NCT01855412|616606880|FG002|Overall Study|Reason not Specified|3|||
170617229|NCT03347123|616606882|FG000|Overall Study|Death|1|||
170617230|NCT03347123|616606883|FG001|Overall Study|Death|2|||
170617231|NCT03347123|616606884|FG002|Overall Study|Death|0|||
170617232|NCT03347123|616606885|FG003|Overall Study|Death|0|||
170617233|NCT03347123|616606886|FG004|Overall Study|Death|0|||
170617234|NCT03347123|616606887|FG005|Overall Study|Death|0|||
170617235|NCT03347123|616606888|FG006|Overall Study|Death|0|||
170617236|NCT03347123|616606882|FG000|Overall Study|Withdrawal by Subject|1|||
170617237|NCT03347123|616606883|FG001|Overall Study|Withdrawal by Subject|0|||
170617238|NCT03347123|616606884|FG002|Overall Study|Withdrawal by Subject|0|||
170617239|NCT03347123|616606885|FG003|Overall Study|Withdrawal by Subject|0|||
170617240|NCT03347123|616606886|FG004|Overall Study|Withdrawal by Subject|0|||
170617241|NCT03347123|616606887|FG005|Overall Study|Withdrawal by Subject|0|||
170617242|NCT03347123|616606888|FG006|Overall Study|Withdrawal by Subject|0|||
170617243|NCT03347123|616606882|FG000|Overall Study|Reason not Specified|3|||
170617244|NCT03347123|616606883|FG001|Overall Study|Reason not Specified|4|||
170617245|NCT03347123|616606884|FG002|Overall Study|Reason not Specified|0|||
170617246|NCT03347123|616606885|FG003|Overall Study|Reason not Specified|0|||
170617247|NCT03347123|616606886|FG004|Overall Study|Reason not Specified|0|||
170617248|NCT03347123|616606887|FG005|Overall Study|Reason not Specified|0|||
170617249|NCT03347123|616606888|FG006|Overall Study|Reason not Specified|0|||
170617250|NCT05030350|616606903|FG000|Overall Study|Adverse Event|13|||
170617251|NCT05030350|616606903|FG000|Overall Study|Lack of Efficacy|8|||
170617252|NCT05030350|616606903|FG000|Overall Study|Lost to Follow-up|35|||
170617253|NCT05030350|616606903|FG000|Overall Study|Pregnancy|2|||
170617254|NCT05030350|616606903|FG000|Overall Study|Protocol Violation|2|||
170617255|NCT05030350|616606903|FG000|Overall Study|Withdrawal by Subject|60|||
170617256|NCT05030350|616606903|FG000|Overall Study|Study terminated by sponsor|349|||
170617257|NCT05030350|616606903|FG000|Overall Study|Positive Drug Screen|4|||
170617258|NCT05030350|616606903|FG000|Overall Study|Other|8|||
170617259|NCT00742183|616606904|FG000|Overall Study|Adverse Event|2|||
170617260|NCT00742183|616606905|FG001|Overall Study|Adverse Event|2|||
170617261|NCT00742183|616606904|FG000|Overall Study|Death|1|||
170617262|NCT00742183|616606905|FG001|Overall Study|Death|0|||
170617263|NCT00742183|616606904|FG000|Overall Study|Physician Decision|0|||
170617264|NCT00742183|616606905|FG001|Overall Study|Physician Decision|2|||
170617265|NCT00742183|616606904|FG000|Overall Study|Lost to Follow-up|4|||
170617266|NCT00742183|616606905|FG001|Overall Study|Lost to Follow-up|4|||
170617267|NCT00742183|616606904|FG000|Overall Study|Required skin-graft|1|||
170617268|NCT00742183|616606905|FG001|Overall Study|Required skin-graft|1|||
170617269|NCT00742183|616606904|FG000|Overall Study|Withdrawal by Subject|1|||
170617270|NCT00742183|616606905|FG001|Overall Study|Withdrawal by Subject|0|||
170617271|NCT00742183|616606904|FG000|Overall Study|Lack of Efficacy|0|||
170617272|NCT00742183|616606905|FG001|Overall Study|Lack of Efficacy|3|||
170617273|NCT03985761|616606909|FG000|Overall Study|Withdrawal by Subject|2|||
170617274|NCT03985761|616606910|FG001|Overall Study|Withdrawal by Subject|3|||
170617275|NCT01255423|616606913|FG000|Overall Study|Abnormal Laboratory value|3|||
170617276|NCT01255423|616606914|FG001|Overall Study|Abnormal Laboratory value|2|||
170617277|NCT01255423|616606913|FG000|Overall Study|Use of prohibited medications|0|||
170617278|NCT01255423|616606914|FG001|Overall Study|Use of prohibited medications|1|||
170617279|NCT00988598|616606915|FG000|Overall Study|Withdrawal by Subject|2|||
170617280|NCT00988598|616606916|FG001|Overall Study|Withdrawal by Subject|0|||
170817869|NCT00705614|617341391|FG001|Switch to Remicade|Lost to Follow-up|23|||
170817870|NCT00705614|617341390|FG000|Switch to Remicade|Withdrawal by Subject|0|||
170817871|NCT00705614|617341391|FG001|Switch to Remicade|Withdrawal by Subject|12|||
170817872|NCT00705614|617341390|FG000|Switch to Remicade|Administrative Reason|0|||
170817873|NCT00705614|617341391|FG001|Switch to Remicade|Administrative Reason|9|||
170817874|NCT00676195|617341394|FG000|Overall Study|Lost to Follow-up|1|||
170817875|NCT00676195|617341394|FG000|Overall Study|Adverse Event|1|||
170817876|NCT00676195|617341394|FG000|Overall Study|Physician Decision|1|||
170817877|NCT02878590|617341395|FG000|Overall Study|Withdrawal by Subject|2|||
170817878|NCT03322514|617341396|FG000|Overall Study|Withdrawal by Subject|1|||
170817879|NCT03322514|617341397|FG001|Overall Study|Withdrawal by Subject|1|||
170817880|NCT05878990|617341404|FG000|Overall Study|Lost to Follow-up|7|||
170817881|NCT05878990|617341404|FG000|Overall Study|Withdrawal by Subject|1|||
170817882|NCT02889809|617341405|FG000|Overall Study|Withdrawal by Subject|30|||
170817883|NCT02889809|617341406|FG001|Overall Study|Withdrawal by Subject|21|||
170817884|NCT02889809|617341405|FG000|Overall Study|Lost to Follow-up|1|||
170617281|NCT03480152|616606917|FG000|Phase I|Signed consent. Died before treatment.|1|||
170617282|NCT03480152|616606918|FG001|Phase I|Signed consent. Died before treatment.|0|||
170617283|NCT03480152|616606919|FG002|Phase I|Signed consent. Died before treatment.|0|||
170617284|NCT01946139|616606920|FG000|Overall Study|Withdrawal by Subject|8|||
170617285|NCT01946139|616606920|FG000|Overall Study|ineligible|8|||
170617286|NCT01946139|616606920|FG000|Overall Study|Specimens not available|4|||
170617287|NCT01508169|616606927|FG000|Overall Study|Adverse Event|1|||
170617288|NCT01508169|616606928|FG001|Overall Study|Adverse Event|0|||
170617289|NCT01508169|616606927|FG000|Overall Study|Withdrawal by Subject|1|||
170817885|NCT02889809|617341406|FG001|Overall Study|Lost to Follow-up|1|||
170817886|NCT02889809|617341405|FG000|Overall Study|Site Closed|12|||
170817887|NCT02889809|617341406|FG001|Overall Study|Site Closed|11|||
170817888|NCT03696342|617341407|FG000|Overall Study|Lost to Follow-up|1|||
170817889|NCT03696342|617341408|FG001|Overall Study|Lost to Follow-up|0|||
170817890|NCT03320941|617341411|FG000|Overall Study|subject/guardian decision|0|||
170817891|NCT03320941|617341412|FG001|Overall Study|subject/guardian decision|0|||
170817892|NCT03320941|617341413|FG002|Overall Study|subject/guardian decision|0|||
170817893|NCT03320941|617341414|FG003|Overall Study|subject/guardian decision|1|||
170817894|NCT03320941|617341415|FG004|Overall Study|subject/guardian decision|0|||
170817895|NCT02368691|617341416|FG000|Overall Study|Death|13|||
170817896|NCT02368691|617341416|FG000|Overall Study|Lack of Efficacy|15|||
170817897|NCT02368691|617341416|FG000|Overall Study|Physician Decision|4|||
170817898|NCT02069366|617341417|FG000|Overall Study|Lost to Follow-up|0|||
170817899|NCT02069366|617341418|FG001|Overall Study|Lost to Follow-up|0|||
170817900|NCT02069366|617341419|FG002|Overall Study|Lost to Follow-up|1|||
170817901|NCT02069366|617341420|FG003|Overall Study|Lost to Follow-up|0|||
170817902|NCT02069366|617341421|FG004|Overall Study|Lost to Follow-up|0|||
170817903|NCT02069366|617341422|FG005|Overall Study|Lost to Follow-up|2|||
170817904|NCT02069366|617341417|FG000|Overall Study|Protocol Violation|0|||
170817905|NCT02069366|617341418|FG001|Overall Study|Protocol Violation|0|||
170817906|NCT02069366|617341419|FG002|Overall Study|Protocol Violation|1|||
170817907|NCT02069366|617341420|FG003|Overall Study|Protocol Violation|0|||
170817908|NCT02069366|617341421|FG004|Overall Study|Protocol Violation|0|||
170817909|NCT02069366|617341422|FG005|Overall Study|Protocol Violation|0|||
170817910|NCT02069366|617341417|FG000|Overall Study|Withdrawal by Subject|1|||
170817911|NCT02069366|617341418|FG001|Overall Study|Withdrawal by Subject|0|||
170817912|NCT02069366|617341419|FG002|Overall Study|Withdrawal by Subject|1|||
170817913|NCT02069366|617341420|FG003|Overall Study|Withdrawal by Subject|2|||
170817914|NCT02069366|617341421|FG004|Overall Study|Withdrawal by Subject|0|||
170817915|NCT02069366|617341422|FG005|Overall Study|Withdrawal by Subject|0|||
170817916|NCT01797705|617341424|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
170817917|NCT01797705|617341424|FG000|Overall Study|Withdrawal by Subject|1|||
170817918|NCT01838447|617341425|FG000|Overall Study|Change in surgical plan|1|||
170817919|NCT01838447|617341426|FG001|Overall Study|Change in surgical plan|2|||
170817920|NCT01838447|617341425|FG000|Overall Study|Withdrawal by Subject|1|||
170817921|NCT01838447|617341426|FG001|Overall Study|Withdrawal by Subject|1|||
170817922|NCT02030847|617341427|FG000|Overall Study|Death|10|||
170817923|NCT02030847|617341427|FG000|Overall Study|Disease Progression|15|||
170817924|NCT02030847|617341427|FG000|Overall Study|New Cancer Therapy|8|||
170817925|NCT02030847|617341427|FG000|Overall Study|Physician Decision|3|||
170617290|NCT01508169|616606928|FG001|Overall Study|Withdrawal by Subject|0|||
170617291|NCT01508169|616606927|FG000|Overall Study|Lost to Follow-up|1|||
170617292|NCT01508169|616606928|FG001|Overall Study|Lost to Follow-up|2|||
170617293|NCT01292187|616606929|FG000|Overall Study|Adverse Event|10|||
170617294|NCT01292187|616606930|FG001|Overall Study|Adverse Event|5|||
170617295|NCT01292187|616606929|FG000|Overall Study|Withdrawal by Subject|6|||
170617296|NCT01292187|616606930|FG001|Overall Study|Withdrawal by Subject|5|||
170617297|NCT01292187|616606929|FG000|Overall Study|All other reasons|1|||
170617298|NCT01292187|616606930|FG001|Overall Study|All other reasons|3|||
170617299|NCT03571204|616606933|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
170617300|NCT03571204|616606934|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
170617301|NCT03571204|616606935|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
170617302|NCT03571204|616606933|FG000|Overall Study|Physician Decision|0|||
170617303|NCT03571204|616606934|FG001|Overall Study|Physician Decision|1|||
170617304|NCT03571204|616606935|FG002|Overall Study|Physician Decision|0|||
170617305|NCT00687401|616606936|FG000|Overall Study|Protocol Violation|7|||
170617306|NCT00687401|616606936|FG000|Overall Study|Adverse Event|6|||
170617307|NCT00687401|616606936|FG000|Overall Study|Lack of Efficacy|6|||
170617308|NCT00687401|616606936|FG000|Overall Study|Withdrawal by Subject|4|||
170617309|NCT00687401|616606936|FG000|Overall Study|Did not return for visit|3|||
170617310|NCT00687401|616606936|FG000|Overall Study|For reasons different from those above|4|||
170617311|NCT00113841|616606944|FG000|Overall Study|Disease progression|0|||
170617312|NCT00113841|616606945|FG001|Overall Study|Disease progression|2|||
170617313|NCT00113841|616606944|FG000|Overall Study|Non-compliant|1|||
170617314|NCT00113841|616606945|FG001|Overall Study|Non-compliant|0|||
170617315|NCT02366195|616606946|FG000|Overall Study|Protocol-specified criteria|3|||
170617316|NCT02366195|616606946|FG000|Overall Study|Withdrawal by Subject|9|||
170617317|NCT02366195|616606946|FG000|Overall Study|Lost to Follow-up|1|||
170617318|NCT02366195|616606946|FG000|Overall Study|Death|41|||
170617319|NCT00721396|616606948|FG000|Overall Study|Adverse Event|4|||
170817926|NCT02030847|617341427|FG000|Overall Study|Withdrawal by Subject|1|||
170817927|NCT01703988|617341428|FG000|Overall Study|Investigator Judgment|0|||
170817928|NCT01703988|617341429|FG001|Overall Study|Investigator Judgment|0|||
170817929|NCT01703988|617341430|FG002|Overall Study|Investigator Judgment|0|||
170817930|NCT01703988|617341431|FG003|Overall Study|Investigator Judgment|1|||
170817931|NCT02995733|617341432|FG000|Overall Study|Study site closed|9|||
170817932|NCT02995733|617341433|FG001|Overall Study|Study site closed|10|||
170817933|NCT02995733|617341432|FG000|Overall Study|Death|3|||
170817934|NCT02995733|617341433|FG001|Overall Study|Death|4|||
170664365|NCT02963935|616785463|FG000|Overall Study|Unclassified|13|||
170664366|NCT02963935|616785464|FG001|Overall Study|Unclassified|22|||
170664367|NCT00464269|616785465|FG000|Overall Study|Lack of Efficacy|1|||
170664368|NCT00464269|616785466|FG001|Overall Study|Lack of Efficacy|0|||
170664369|NCT00464269|616785467|FG002|Overall Study|Lack of Efficacy|0|||
170664370|NCT00464269|616785468|FG003|Overall Study|Lack of Efficacy|0|||
170664371|NCT00464269|616785465|FG000|Overall Study|Lost to Follow-up|0|||
170664372|NCT00464269|616785466|FG001|Overall Study|Lost to Follow-up|4|||
170664373|NCT00464269|616785467|FG002|Overall Study|Lost to Follow-up|0|||
170664374|NCT00464269|616785468|FG003|Overall Study|Lost to Follow-up|1|||
170664375|NCT00464269|616785465|FG000|Overall Study|Withdrawal by Subject|0|||
170664376|NCT00464269|616785466|FG001|Overall Study|Withdrawal by Subject|2|||
170664377|NCT00464269|616785467|FG002|Overall Study|Withdrawal by Subject|1|||
170664378|NCT00464269|616785468|FG003|Overall Study|Withdrawal by Subject|1|||
170664379|NCT00464269|616785465|FG000|Overall Study|Other reason|3|||
170664380|NCT00464269|616785466|FG001|Overall Study|Other reason|3|||
170664381|NCT00464269|616785467|FG002|Overall Study|Other reason|1|||
170664382|NCT00464269|616785468|FG003|Overall Study|Other reason|1|||
170664383|NCT00464269|616785465|FG000|Overall Study|AE, serious fatal|0|||
170664384|NCT00464269|616785466|FG001|Overall Study|AE, serious fatal|0|||
170664385|NCT00464269|616785467|FG002|Overall Study|AE, serious fatal|1|||
170664386|NCT00464269|616785468|FG003|Overall Study|AE, serious fatal|1|||
170664387|NCT00464269|616785465|FG000|Overall Study|SAE, non-fatal|0|||
170664388|NCT00464269|616785466|FG001|Overall Study|SAE, non-fatal|0|||
170664389|NCT00464269|616785467|FG002|Overall Study|SAE, non-fatal|0|||
170664390|NCT00464269|616785468|FG003|Overall Study|SAE, non-fatal|1|||
170664391|NCT00464269|616785465|FG000|Overall Study|AE, non-serious non-fatal|2|||
170817935|NCT02995733|617341432|FG000|Overall Study|Withdrawal by Subject|6|||
170817936|NCT02995733|617341433|FG001|Overall Study|Withdrawal by Subject|2|||
170817937|NCT02995733|617341432|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
170817938|NCT02995733|617341433|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
170817939|NCT02995733|617341432|FG000|Overall Study|Lost to Follow-up|48|||
170817940|NCT02995733|617341433|FG001|Overall Study|Lost to Follow-up|37|||
170817941|NCT02995733|617341432|FG000|Overall Study|Other|0|||
170817942|NCT02995733|617341433|FG001|Overall Study|Other|1|||
170817943|NCT03785210|617341437|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
170817944|NCT03785210|617341438|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
170617320|NCT00721396|616606949|FG001|Overall Study|Adverse Event|7|||
170617321|NCT00721396|616606950|FG002|Overall Study|Adverse Event|2|||
170617322|NCT00721396|616606951|FG003|Overall Study|Adverse Event|0|||
170617323|NCT00721396|616606948|FG000|Overall Study|Withdrawal by Subject|12|||
170617324|NCT00721396|616606949|FG001|Overall Study|Withdrawal by Subject|15|||
170617325|NCT00721396|616606950|FG002|Overall Study|Withdrawal by Subject|3|||
170617326|NCT00721396|616606951|FG003|Overall Study|Withdrawal by Subject|7|||
170617327|NCT00721396|616606948|FG000|Overall Study|Lost to Follow-up|7|||
170617328|NCT00721396|616606949|FG001|Overall Study|Lost to Follow-up|9|||
170617329|NCT00721396|616606950|FG002|Overall Study|Lost to Follow-up|3|||
170617330|NCT00721396|616606951|FG003|Overall Study|Lost to Follow-up|3|||
170617331|NCT00721396|616606948|FG000|Overall Study|Protocol Violation|4|||
170617332|NCT00721396|616606949|FG001|Overall Study|Protocol Violation|3|||
170617333|NCT00721396|616606950|FG002|Overall Study|Protocol Violation|1|||
170617334|NCT00721396|616606951|FG003|Overall Study|Protocol Violation|0|||
170617335|NCT00721396|616606948|FG000|Overall Study|Inappropriate enrollment|0|||
170617336|NCT00721396|616606949|FG001|Overall Study|Inappropriate enrollment|2|||
170617337|NCT00721396|616606950|FG002|Overall Study|Inappropriate enrollment|0|||
170617338|NCT00721396|616606951|FG003|Overall Study|Inappropriate enrollment|0|||
170617339|NCT00721396|616606948|FG000|Overall Study|Administrative reason|3|||
170617340|NCT00721396|616606949|FG001|Overall Study|Administrative reason|0|||
170617341|NCT00721396|616606950|FG002|Overall Study|Administrative reason|1|||
170617342|NCT00721396|616606951|FG003|Overall Study|Administrative reason|0|||
170617343|NCT00148759|616606952|FG000|Overall Study|Withdrawal by Subject|1|||
170617344|NCT00148759|616606953|FG001|Overall Study|Withdrawal by Subject|1|||
170617345|NCT00148759|616606952|FG000|Overall Study|Lost to Follow-up|1|||
170617346|NCT00148759|616606953|FG001|Overall Study|Lost to Follow-up|0|||
170617347|NCT05202418|616606954|FG000|Overall Study|Withdrawal by Subject|2|||
170617348|NCT05202418|616606955|FG001|Overall Study|Withdrawal by Subject|1|||
170617349|NCT05202418|616606954|FG000|Overall Study|Lost to Follow-up|1|||
170617350|NCT05202418|616606955|FG001|Overall Study|Lost to Follow-up|1|||
170664392|NCT00464269|616785466|FG001|Overall Study|AE, non-serious non-fatal|8|||
170664393|NCT00464269|616785467|FG002|Overall Study|AE, non-serious non-fatal|3|||
170664394|NCT00464269|616785468|FG003|Overall Study|AE, non-serious non-fatal|4|||
170664395|NCT00464269|616785465|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
170617351|NCT03575403|616606962|FG000|Overall Study|Adverse Event|1|||
170617352|NCT03575403|616606963|FG001|Overall Study|Adverse Event|0|||
170617353|NCT03575403|616606964|FG002|Overall Study|Adverse Event|0|||
170617354|NCT03575403|616606962|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
170817945|NCT02720198|617341439|FG000|Overall Study|Withdrawal by Subject|0|||
170664396|NCT00464269|616785466|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
170664397|NCT00464269|616785467|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
170664398|NCT00464269|616785468|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
170664399|NCT02853344|616785469|FG000|Overall Study|Lost to Follow-up|1|||
170664400|NCT02853344|616785470|FG001|Overall Study|Lost to Follow-up|1|||
170664401|NCT02853344|616785469|FG000|Overall Study|Withdrawal by Subject|2|||
170664402|NCT02853344|616785470|FG001|Overall Study|Withdrawal by Subject|4|||
170664403|NCT02853344|616785469|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
170664404|NCT02853344|616785470|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
170664405|NCT02853344|616785469|FG000|Overall Study|Death|70|||
170664406|NCT02853344|616785470|FG001|Overall Study|Death|112|||
170664407|NCT02913612|616785471|FG000|Overall Study|Lost to Follow-up|6|||
170664408|NCT02913612|616785472|FG001|Overall Study|Lost to Follow-up|5|||
170664409|NCT02913612|616785473|FG002|Overall Study|Lost to Follow-up|2|||
170664410|NCT02913612|616785474|FG003|Overall Study|Lost to Follow-up|0|||
170664411|NCT02913612|616785471|FG000|Overall Study|Physician Decision|1|||
170664412|NCT02913612|616785472|FG001|Overall Study|Physician Decision|4|||
170664413|NCT02913612|616785473|FG002|Overall Study|Physician Decision|1|||
170664414|NCT02913612|616785474|FG003|Overall Study|Physician Decision|0|||
170664415|NCT02913612|616785471|FG000|Overall Study|Withdrawal by Subject|2|||
170664416|NCT02913612|616785472|FG001|Overall Study|Withdrawal by Subject|4|||
170817946|NCT02720198|617341440|FG001|Overall Study|Withdrawal by Subject|1|||
170817947|NCT00590759|617341446|FG000|Overall Study|Death|52|||
170817948|NCT00590759|617341446|FG000|Overall Study|Lost to Follow-up|28|||
170817949|NCT04468633|617341447|FG000|Overall Study|Withdrawal by Subject|4|||
170817950|NCT04468633|617341448|FG001|Overall Study|Withdrawal by Subject|0|||
170817951|NCT00584909|617341449|FG000|Overall Study|Adverse Event|4|||
170817952|NCT03436797|617341450|FG000|Main Study|Withdrawal by Subject|2|||
170817953|NCT03436797|617341450|FG000|Main Study|Adverse Event|4|||
170817954|NCT03436797|617341450|FG000|Main Study|Lost to Follow-up|1|||
170817955|NCT03436797|617341450|FG000|Main Study|Death|1|||
170817956|NCT03436797|617341450|FG000|Main Study|Non-Specific|2|||
170817957|NCT03436797|617341450|FG000|Extended Dosing|Patient decision|1|||
170817958|NCT00203502|617341453|FG000|Overall Study|Death|1|||
170817959|NCT00422162|617341454|FG000|Overall Study|Adverse Event|11|||
170817960|NCT00422162|617341455|FG001|Overall Study|Adverse Event|9|||
170817961|NCT00422162|617341454|FG000|Overall Study|Lack of Efficacy|4|||
170817962|NCT00422162|617341455|FG001|Overall Study|Lack of Efficacy|10|||
170817963|NCT00422162|617341454|FG000|Overall Study|Withdrawal by Subject|7|||
170817964|NCT00422162|617341455|FG001|Overall Study|Withdrawal by Subject|6|||
170817965|NCT00422162|617341454|FG000|Overall Study|Lost to Follow-up|1|||
170817966|NCT00422162|617341455|FG001|Overall Study|Lost to Follow-up|2|||
170817967|NCT00422162|617341454|FG000|Overall Study|Non-Compliant with Protocol|1|||
170817968|NCT00422162|617341455|FG001|Overall Study|Non-Compliant with Protocol|1|||
170817969|NCT00422162|617341454|FG000|Overall Study|Other|0|||
170817970|NCT00422162|617341455|FG001|Overall Study|Other|1|||
170817971|NCT00422162|617341454|FG000|Overall Study|Didn't Receive Treatment|0|||
170817972|NCT00422162|617341455|FG001|Overall Study|Didn't Receive Treatment|1|||
170817973|NCT02006641|617341459|FG000|Overall Study|Withdrawal before treatment|2|||
170817974|NCT02006641|617341460|FG001|Overall Study|Withdrawal before treatment|5|||
170817975|NCT02006641|617341461|FG002|Overall Study|Withdrawal before treatment|3|||
170817976|NCT02006641|617341459|FG000|Overall Study|Adverse Event|15|||
170817977|NCT02006641|617341460|FG001|Overall Study|Adverse Event|11|||
170817978|NCT02006641|617341461|FG002|Overall Study|Adverse Event|15|||
170817979|NCT02006641|617341459|FG000|Overall Study|Protocol Violation|0|||
170817980|NCT02006641|617341460|FG001|Overall Study|Protocol Violation|2|||
170817981|NCT02006641|617341461|FG002|Overall Study|Protocol Violation|2|||
170817982|NCT02006641|617341459|FG000|Overall Study|Lost to Follow-up|0|||
170817983|NCT02006641|617341460|FG001|Overall Study|Lost to Follow-up|1|||
170817984|NCT02006641|617341461|FG002|Overall Study|Lost to Follow-up|0|||
170817985|NCT02006641|617341459|FG000|Overall Study|Withdrawal by Subject|7|||
170817986|NCT02006641|617341460|FG001|Overall Study|Withdrawal by Subject|12|||
170664417|NCT02913612|616785473|FG002|Overall Study|Withdrawal by Subject|0|||
170664418|NCT02913612|616785474|FG003|Overall Study|Withdrawal by Subject|0|||
170817987|NCT02006641|617341461|FG002|Overall Study|Withdrawal by Subject|11|||
170817988|NCT02006641|617341459|FG000|Overall Study|Other reason: patient didn't show up|1|||
170664419|NCT02913612|616785471|FG000|Overall Study|Hemangioma resolved|1|||
170664420|NCT02913612|616785472|FG001|Overall Study|Hemangioma resolved|0|||
170664421|NCT02913612|616785473|FG002|Overall Study|Hemangioma resolved|0|||
170817989|NCT02006641|617341460|FG001|Overall Study|Other reason: patient didn't show up|0|||
170817990|NCT02006641|617341461|FG002|Overall Study|Other reason: patient didn't show up|0|||
170817991|NCT02006641|617341459|FG000|Overall Study|Other reason:patient didn't want to come|0|||
170817992|NCT02006641|617341460|FG001|Overall Study|Other reason:patient didn't want to come|0|||
170817993|NCT02006641|617341461|FG002|Overall Study|Other reason:patient didn't want to come|1|||
170817994|NCT02006641|617341459|FG000|Overall Study|Other reason: patient has moved|1|||
170817995|NCT02006641|617341460|FG001|Overall Study|Other reason: patient has moved|0|||
170817996|NCT02006641|617341461|FG002|Overall Study|Other reason: patient has moved|1|||
170664422|NCT02913612|616785474|FG003|Overall Study|Hemangioma resolved|0|||
170664423|NCT02913612|616785471|FG000|Overall Study|Local IRB decision|1|||
170664424|NCT02913612|616785472|FG001|Overall Study|Local IRB decision|0|||
170664425|NCT02913612|616785473|FG002|Overall Study|Local IRB decision|0|||
170664426|NCT02913612|616785474|FG003|Overall Study|Local IRB decision|0|||
170664427|NCT02913612|616785471|FG000|Overall Study|Study drug non-compliance|1|||
170664428|NCT02913612|616785472|FG001|Overall Study|Study drug non-compliance|1|||
170664429|NCT02913612|616785473|FG002|Overall Study|Study drug non-compliance|0|||
170664430|NCT02913612|616785474|FG003|Overall Study|Study drug non-compliance|0|||
170664431|NCT02913612|616785471|FG000|Overall Study|Insurance issues|0|||
170664432|NCT02913612|616785472|FG001|Overall Study|Insurance issues|1|||
170664433|NCT02913612|616785473|FG002|Overall Study|Insurance issues|0|||
170664434|NCT02913612|616785474|FG003|Overall Study|Insurance issues|0|||
170664435|NCT02913612|616785471|FG000|Overall Study|Needed to treat second hemangioma|0|||
170664436|NCT02913612|616785472|FG001|Overall Study|Needed to treat second hemangioma|1|||
170664437|NCT02913612|616785473|FG002|Overall Study|Needed to treat second hemangioma|0|||
170664438|NCT02913612|616785474|FG003|Overall Study|Needed to treat second hemangioma|0|||
170664439|NCT02913612|616785471|FG000|Overall Study|Study completion criteria not met|0|||
170664440|NCT02913612|616785472|FG001|Overall Study|Study completion criteria not met|1|||
170664441|NCT02913612|616785473|FG002|Overall Study|Study completion criteria not met|0|||
170664442|NCT02913612|616785474|FG003|Overall Study|Study completion criteria not met|0|||
170664443|NCT02913612|616785471|FG000|Overall Study|Ineligible|0|||
170664444|NCT02913612|616785472|FG001|Overall Study|Ineligible|1|||
170664445|NCT02913612|616785473|FG002|Overall Study|Ineligible|0|||
170664446|NCT02913612|616785474|FG003|Overall Study|Ineligible|0|||
170664447|NCT03643159|616785478|FG000|Overall Study|Adverse Event|1|||
170664448|NCT03643159|616785478|FG000|Overall Study|Withdrawal by Subject|1|||
170664449|NCT02081183|616785479|FG000|Overall Study|Lost to Follow-up|0|||
170664450|NCT02081183|616785480|FG001|Overall Study|Lost to Follow-up|1|||
170664451|NCT02081183|616785479|FG000|Overall Study|Protocol Violation|1|||
170664452|NCT02081183|616785480|FG001|Overall Study|Protocol Violation|0|||
170664453|NCT02081183|616785479|FG000|Overall Study|Other|3|||
170664454|NCT02081183|616785480|FG001|Overall Study|Other|3|||
170664455|NCT05535972|616785484|FG000|Overall Study|Withdrawal by Subject|31|||
170664456|NCT05535972|616785484|FG000|Overall Study|Lost to Follow-up|5|||
170664457|NCT05535972|616785484|FG000|Overall Study|Adverse Event|6|||
170664458|NCT05535972|616785484|FG000|Overall Study|Protocol Deviation|2|||
170664459|NCT04502979|616785485|FG000|Overall Study|Lost to Follow-up|1|||
170664460|NCT04502979|616785486|FG001|Overall Study|Lost to Follow-up|3|||
170664461|NCT04502979|616785485|FG000|Overall Study|Withdrawal by Subject|2|||
170664462|NCT04502979|616785486|FG001|Overall Study|Withdrawal by Subject|1|||
170664463|NCT00932737|616785489|FG000|Overall Study|Not treated in second episode|1|||
170664464|NCT00932737|616785490|FG001|Overall Study|Not treated in second episode|0|||
170664465|NCT00932737|616785489|FG000|Overall Study|Adverse Event|0|||
170664466|NCT00932737|616785490|FG001|Overall Study|Adverse Event|1|||
170817997|NCT02006641|617341459|FG000|Overall Study|Other reason: caregiver in hospital|0|||
170817998|NCT02006641|617341460|FG001|Overall Study|Other reason: caregiver in hospital|1|||
170817999|NCT02006641|617341461|FG002|Overall Study|Other reason: caregiver in hospital|0|||
170818000|NCT02006641|617341459|FG000|Overall Study|Other reason: patient's wife has died|0|||
170818001|NCT02006641|617341460|FG001|Overall Study|Other reason: patient's wife has died|0|||
170818002|NCT02006641|617341461|FG002|Overall Study|Other reason: patient's wife has died|1|||
170818003|NCT02006641|617341459|FG000|Overall Study|Other reason: hospitalisation|0|||
170818004|NCT02006641|617341460|FG001|Overall Study|Other reason: hospitalisation|1|||
170818005|NCT02006641|617341461|FG002|Overall Study|Other reason: hospitalisation|0|||
170818006|NCT02006641|617341459|FG000|Overall Study|Other reason: caregiver impossibility|0|||
170818007|NCT02006641|617341460|FG001|Overall Study|Other reason: caregiver impossibility|0|||
170818008|NCT02006641|617341461|FG002|Overall Study|Other reason: caregiver impossibility|1|||
170818009|NCT02006641|617341459|FG000|Overall Study|Other reason: protocol non-compliance|0|||
170818010|NCT02006641|617341460|FG001|Overall Study|Other reason: protocol non-compliance|0|||
170818011|NCT02006641|617341461|FG002|Overall Study|Other reason: protocol non-compliance|1|||
170818012|NCT00321672|617341465|FG000|Overall Study|Withdrawal by Subject|5|||
170818013|NCT00321672|617341466|FG001|Overall Study|Withdrawal by Subject|1|||
170818014|NCT00321672|617341467|FG002|Overall Study|Withdrawal by Subject|2|||
170818015|NCT00321672|617341468|FG003|Overall Study|Withdrawal by Subject|0|||
170664467|NCT03945266|616785494|FG000|Overall Study|Withdrawal by Subject|1|||
170664468|NCT03945266|616785495|FG001|Overall Study|Withdrawal by Subject|0|||
170664469|NCT03945266|616785494|FG000|Overall Study|Miscarriage|0|||
170664470|NCT03945266|616785495|FG001|Overall Study|Miscarriage|2|||
170664471|NCT03945266|616785494|FG000|Overall Study|Lost to Follow-up|1|||
170664472|NCT03945266|616785495|FG001|Overall Study|Lost to Follow-up|0|||
170664473|NCT05156073|616785496|FG000|Overall Study|Patient canceled appointment with PCP|1|||
170664474|NCT01686828|616785497|FG000|Overall Study|Physician Decision|1|||
170818016|NCT00321672|617341465|FG000|Overall Study|Noncompliance|1|||
170818017|NCT00321672|617341466|FG001|Overall Study|Noncompliance|2|||
170818018|NCT00321672|617341467|FG002|Overall Study|Noncompliance|1|||
170664475|NCT01686828|616785498|FG001|Overall Study|Physician Decision|0|||
170664476|NCT01686828|616785499|FG002|Overall Study|Physician Decision|0|||
170664477|NCT01686828|616785500|FG003|Overall Study|Physician Decision|0|||
170664478|NCT01686828|616785497|FG000|Overall Study|New Job|0|||
170664479|NCT01686828|616785498|FG001|Overall Study|New Job|1|||
170664480|NCT01686828|616785499|FG002|Overall Study|New Job|0|||
170664481|NCT01686828|616785500|FG003|Overall Study|New Job|0|||
170664482|NCT01686828|616785497|FG000|Overall Study|Weight Loss|0|||
170664483|NCT01686828|616785498|FG001|Overall Study|Weight Loss|0|||
170664484|NCT01686828|616785499|FG002|Overall Study|Weight Loss|1|||
170664485|NCT01686828|616785500|FG003|Overall Study|Weight Loss|0|||
170664486|NCT00973349|616785501|FG000|Overall Study|Adverse Event|0|||
170664487|NCT00973349|616785502|FG001|Overall Study|Adverse Event|0|||
170664488|NCT00973349|616785503|FG002|Overall Study|Adverse Event|0|||
170664489|NCT00973349|616785504|FG003|Overall Study|Adverse Event|0|||
170664490|NCT00973349|616785505|FG004|Overall Study|Adverse Event|1|||
170664491|NCT00973349|616785506|FG005|Overall Study|Adverse Event|0|||
170664492|NCT00973349|616785507|FG006|Overall Study|Adverse Event|0|||
170664493|NCT00973349|616785508|FG007|Overall Study|Adverse Event|0|||
170664494|NCT00973349|616785509|FG008|Overall Study|Adverse Event|1|||
170664495|NCT00973349|616785510|FG009|Overall Study|Adverse Event|0|||
170664496|NCT00973349|616785511|FG010|Overall Study|Adverse Event|0|||
170664497|NCT00973349|616785512|FG011|Overall Study|Adverse Event|0|||
170664498|NCT00973349|616785513|FG012|Overall Study|Adverse Event|0|||
170664499|NCT00973349|616785514|FG013|Overall Study|Adverse Event|0|||
170664500|NCT00973349|616785515|FG014|Overall Study|Adverse Event|1|||
170664501|NCT00973349|616785516|FG015|Overall Study|Adverse Event|0|||
170664502|NCT00973349|616785501|FG000|Overall Study|Withdrawal by Subject|1|||
170664503|NCT00973349|616785502|FG001|Overall Study|Withdrawal by Subject|2|||
170664504|NCT00973349|616785503|FG002|Overall Study|Withdrawal by Subject|2|||
170664505|NCT00973349|616785504|FG003|Overall Study|Withdrawal by Subject|3|||
170664506|NCT00973349|616785505|FG004|Overall Study|Withdrawal by Subject|2|||
170664507|NCT00973349|616785506|FG005|Overall Study|Withdrawal by Subject|0|||
170664508|NCT00973349|616785507|FG006|Overall Study|Withdrawal by Subject|2|||
170664509|NCT00973349|616785508|FG007|Overall Study|Withdrawal by Subject|2|||
170664510|NCT00973349|616785509|FG008|Overall Study|Withdrawal by Subject|0|||
170664511|NCT00973349|616785510|FG009|Overall Study|Withdrawal by Subject|2|||
170664512|NCT00973349|616785511|FG010|Overall Study|Withdrawal by Subject|0|||
170664513|NCT00973349|616785512|FG011|Overall Study|Withdrawal by Subject|1|||
170664514|NCT00973349|616785513|FG012|Overall Study|Withdrawal by Subject|0|||
170664515|NCT00973349|616785514|FG013|Overall Study|Withdrawal by Subject|0|||
170664516|NCT00973349|616785515|FG014|Overall Study|Withdrawal by Subject|0|||
170664517|NCT00973349|616785516|FG015|Overall Study|Withdrawal by Subject|0|||
170664518|NCT00973349|616785501|FG000|Overall Study|Lost to Follow-up|3|||
170664519|NCT00973349|616785502|FG001|Overall Study|Lost to Follow-up|1|||
170664520|NCT00973349|616785503|FG002|Overall Study|Lost to Follow-up|2|||
170664521|NCT00973349|616785504|FG003|Overall Study|Lost to Follow-up|2|||
170664522|NCT00973349|616785505|FG004|Overall Study|Lost to Follow-up|1|||
170664523|NCT00973349|616785506|FG005|Overall Study|Lost to Follow-up|3|||
170664524|NCT00973349|616785507|FG006|Overall Study|Lost to Follow-up|0|||
170664525|NCT00973349|616785508|FG007|Overall Study|Lost to Follow-up|1|||
170664526|NCT00973349|616785509|FG008|Overall Study|Lost to Follow-up|2|||
170664527|NCT00973349|616785510|FG009|Overall Study|Lost to Follow-up|1|||
170664528|NCT00973349|616785511|FG010|Overall Study|Lost to Follow-up|0|||
170664529|NCT00973349|616785512|FG011|Overall Study|Lost to Follow-up|1|||
170664530|NCT00973349|616785513|FG012|Overall Study|Lost to Follow-up|0|||
170664531|NCT00973349|616785514|FG013|Overall Study|Lost to Follow-up|0|||
170664532|NCT00973349|616785515|FG014|Overall Study|Lost to Follow-up|0|||
170664533|NCT00973349|616785516|FG015|Overall Study|Lost to Follow-up|1|||
170664534|NCT00973349|616785501|FG000|Overall Study|Inappropriate enrolment|0|||
170664535|NCT00973349|616785502|FG001|Overall Study|Inappropriate enrolment|0|||
170664536|NCT00973349|616785503|FG002|Overall Study|Inappropriate enrolment|1|||
170664537|NCT00973349|616785504|FG003|Overall Study|Inappropriate enrolment|0|||
170664538|NCT00973349|616785505|FG004|Overall Study|Inappropriate enrolment|0|||
170664539|NCT00973349|616785506|FG005|Overall Study|Inappropriate enrolment|0|||
170664540|NCT00973349|616785507|FG006|Overall Study|Inappropriate enrolment|0|||
170664541|NCT00973349|616785508|FG007|Overall Study|Inappropriate enrolment|0|||
170664542|NCT00973349|616785509|FG008|Overall Study|Inappropriate enrolment|0|||
170664543|NCT00973349|616785510|FG009|Overall Study|Inappropriate enrolment|2|||
170664544|NCT00973349|616785511|FG010|Overall Study|Inappropriate enrolment|0|||
170664545|NCT00973349|616785512|FG011|Overall Study|Inappropriate enrolment|0|||
170664546|NCT00973349|616785513|FG012|Overall Study|Inappropriate enrolment|1|||
170664547|NCT00973349|616785514|FG013|Overall Study|Inappropriate enrolment|0|||
170664548|NCT00973349|616785515|FG014|Overall Study|Inappropriate enrolment|1|||
170664549|NCT00973349|616785516|FG015|Overall Study|Inappropriate enrolment|1|||
170664550|NCT00973349|616785501|FG000|Overall Study|Protocol Violation|0|||
170664551|NCT00973349|616785502|FG001|Overall Study|Protocol Violation|0|||
170664552|NCT00973349|616785503|FG002|Overall Study|Protocol Violation|0|||
170664553|NCT00973349|616785504|FG003|Overall Study|Protocol Violation|0|||
170664554|NCT00973349|616785505|FG004|Overall Study|Protocol Violation|0|||
170664555|NCT00973349|616785506|FG005|Overall Study|Protocol Violation|0|||
170664556|NCT00973349|616785507|FG006|Overall Study|Protocol Violation|0|||
170664557|NCT00973349|616785508|FG007|Overall Study|Protocol Violation|0|||
170664558|NCT00973349|616785509|FG008|Overall Study|Protocol Violation|1|||
170664559|NCT00973349|616785510|FG009|Overall Study|Protocol Violation|0|||
170664560|NCT00973349|616785511|FG010|Overall Study|Protocol Violation|0|||
170664561|NCT00973349|616785512|FG011|Overall Study|Protocol Violation|0|||
170664562|NCT00973349|616785513|FG012|Overall Study|Protocol Violation|0|||
170664563|NCT00973349|616785514|FG013|Overall Study|Protocol Violation|0|||
170664564|NCT00973349|616785515|FG014|Overall Study|Protocol Violation|0|||
170664565|NCT00973349|616785516|FG015|Overall Study|Protocol Violation|0|||
170664566|NCT00973349|616785501|FG000|Overall Study|Unable to classify|0|||
170664567|NCT00973349|616785502|FG001|Overall Study|Unable to classify|0|||
170664568|NCT00973349|616785503|FG002|Overall Study|Unable to classify|0|||
170664569|NCT00973349|616785504|FG003|Overall Study|Unable to classify|0|||
170664570|NCT00973349|616785505|FG004|Overall Study|Unable to classify|1|||
170664571|NCT00973349|616785506|FG005|Overall Study|Unable to classify|1|||
170664572|NCT00973349|616785507|FG006|Overall Study|Unable to classify|0|||
170664573|NCT00973349|616785508|FG007|Overall Study|Unable to classify|0|||
170664574|NCT00973349|616785509|FG008|Overall Study|Unable to classify|0|||
170664575|NCT00973349|616785510|FG009|Overall Study|Unable to classify|1|||
170664576|NCT00973349|616785511|FG010|Overall Study|Unable to classify|0|||
170664577|NCT00973349|616785512|FG011|Overall Study|Unable to classify|0|||
170664578|NCT00973349|616785513|FG012|Overall Study|Unable to classify|0|||
170664579|NCT00973349|616785514|FG013|Overall Study|Unable to classify|0|||
170664580|NCT00973349|616785515|FG014|Overall Study|Unable to classify|0|||
170664581|NCT00973349|616785516|FG015|Overall Study|Unable to classify|0|||
170664582|NCT02898116|616785517|FG000|Overall Study|Adverse Event|1|||
170664583|NCT02898116|616785517|FG000|Overall Study|Progressive disease|1|||
170664584|NCT02734433|616785518|FG000|Overall Study|Disease progression|1|||
170664585|NCT02734433|616785519|FG001|Overall Study|Disease progression|5|||
170664586|NCT02734433|616785518|FG000|Overall Study|Clinical progression|0|||
170664587|NCT02734433|616785519|FG001|Overall Study|Clinical progression|1|||
170664588|NCT02734433|616785518|FG000|Overall Study|Withdrawal by Subject|1|||
170664589|NCT02734433|616785519|FG001|Overall Study|Withdrawal by Subject|2|||
170664590|NCT04941456|616785520|FG000|Overall Study|Withdrawal by Subject|1|||
170664591|NCT04941456|616785521|FG001|Overall Study|Withdrawal by Subject|0|||
170664592|NCT04941456|616785520|FG000|Overall Study|Protocol Violation|1|||
170664593|NCT04941456|616785521|FG001|Overall Study|Protocol Violation|0|||
170664594|NCT04452344|616785523|FG000|Overall Study|Withdrawal by Subject|3|||
170664595|NCT04452344|616785524|FG001|Overall Study|Withdrawal by Subject|6|||
170664596|NCT04452344|616785523|FG000|Overall Study|Adverse Event|1|||
170664597|NCT04452344|616785524|FG001|Overall Study|Adverse Event|2|||
170664598|NCT04452344|616785523|FG000|Overall Study|Lost to Follow-up|2|||
170664599|NCT04452344|616785524|FG001|Overall Study|Lost to Follow-up|2|||
170664600|NCT04452344|616785523|FG000|Overall Study|No Post-Op Visit|6|||
170664601|NCT04452344|616785524|FG001|Overall Study|No Post-Op Visit|7|||
170664602|NCT04340193|616785525|FG000|Overall Study|Other reason|0|||
170664603|NCT04340193|616785526|FG001|Overall Study|Other reason|0|||
170664604|NCT04340193|616785527|FG002|Overall Study|Other reason|1|||
170664605|NCT04340193|616785525|FG000|Overall Study|Disease recurrence|0|||
170664606|NCT04340193|616785526|FG001|Overall Study|Disease recurrence|1|||
170664607|NCT04340193|616785527|FG002|Overall Study|Disease recurrence|0|||
170664608|NCT04340193|616785525|FG000|Overall Study|Study drug toxicity|1|||
170664609|NCT04340193|616785526|FG001|Overall Study|Study drug toxicity|0|||
170664610|NCT04340193|616785527|FG002|Overall Study|Study drug toxicity|0|||
170917388|NCT02499328|617697947|FG014|Overall Study|Lost to Follow-up|0|||
170917389|NCT02499328|617697948|FG015|Overall Study|Lost to Follow-up|0|||
170664611|NCT04340193|616785525|FG000|Overall Study|Disease progression|1|||
170664612|NCT04340193|616785526|FG001|Overall Study|Disease progression|2|||
170664613|NCT04340193|616785527|FG002|Overall Study|Disease progression|3|||
170664614|NCT04340193|616785525|FG000|Overall Study|Administrative reasons by sponsor|0|||
170664615|NCT04340193|616785526|FG001|Overall Study|Administrative reasons by sponsor|1|||
170664616|NCT04340193|616785527|FG002|Overall Study|Administrative reasons by sponsor|0|||
170664617|NCT04340193|616785525|FG000|Overall Study|Adverse Event|1|||
170917390|NCT02499328|617697949|FG016|Overall Study|Lost to Follow-up|0|||
170664618|NCT04340193|616785526|FG001|Overall Study|Adverse Event|1|||
170664619|NCT04340193|616785527|FG002|Overall Study|Adverse Event|0|||
170917391|NCT02499328|617697950|FG017|Overall Study|Lost to Follow-up|0|||
170664620|NCT01950169|616786815|FG000|Overall Study|Withdrawal by Subject|2|||
170664621|NCT01950169|616786816|FG001|Overall Study|Withdrawal by Subject|8|||
170664622|NCT01950169|616786817|FG002|Overall Study|Withdrawal by Subject|1|||
170917392|NCT02499328|617697951|FG018|Overall Study|Lost to Follow-up|1|||
170664623|NCT01950169|616786815|FG000|Overall Study|Death|1|||
170664624|NCT01950169|616786816|FG001|Overall Study|Death|0|||
170664625|NCT01950169|616786817|FG002|Overall Study|Death|0|||
170664626|NCT02410551|616786818|FG000|Overall Study|Adverse Event|1|||
170664627|NCT02410551|616786818|FG000|Overall Study|Withdrawal by Subject|1|||
170664628|NCT02410551|616786818|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
170664629|NCT00808483|616786821|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
170664630|NCT00808483|616786822|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
170664631|NCT00808483|616786821|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
170664632|NCT00808483|616786822|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
170664633|NCT00808483|616786821|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
170664634|NCT00808483|616786822|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
170664635|NCT02038881|616786823|FG000|Overall Study|Withdrawal by Subject|0|||
170664636|NCT02038881|616786824|FG001|Overall Study|Withdrawal by Subject|0|||
170664637|NCT02038881|616786825|FG002|Overall Study|Withdrawal by Subject|1|||
170664638|NCT02038881|616786823|FG000|Overall Study|Lost to Follow-up|2|||
170664639|NCT02038881|616786824|FG001|Overall Study|Lost to Follow-up|0|||
170664640|NCT02038881|616786825|FG002|Overall Study|Lost to Follow-up|0|||
170664641|NCT02038881|616786823|FG000|Overall Study|incarcerated|1|||
170664642|NCT02038881|616786824|FG001|Overall Study|incarcerated|0|||
170664643|NCT02038881|616786825|FG002|Overall Study|incarcerated|0|||
170664644|NCT00333840|616786826|FG000|First-line Treatment Period|Adverse Event|38|||
170664645|NCT00333840|616786827|FG001|First-line Treatment Period|Adverse Event|37|||
170664646|NCT00333840|616786828|FG002|First-line Treatment Period|Adverse Event|0|||
170664647|NCT00333840|616786829|FG003|First-line Treatment Period|Adverse Event|0|||
170664648|NCT00333840|616786826|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
170664649|NCT00333840|616786827|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
170664650|NCT00333840|616786828|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
170664651|NCT00333840|616786829|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
170664652|NCT00333840|616786826|FG000|First-line Treatment Period|Abnormal procedure|2|||
170664653|NCT00333840|616786827|FG001|First-line Treatment Period|Abnormal procedure|0|||
170818019|NCT00321672|617341468|FG003|Overall Study|Noncompliance|0|||
170818020|NCT00321672|617341465|FG000|Overall Study|Adverse Event|1|||
170818021|NCT00321672|617341466|FG001|Overall Study|Adverse Event|1|||
170818022|NCT00321672|617341467|FG002|Overall Study|Adverse Event|0|||
170818023|NCT00321672|617341468|FG003|Overall Study|Adverse Event|0|||
170818024|NCT00321672|617341465|FG000|Overall Study|Lack of Efficacy|1|||
170818025|NCT00321672|617341466|FG001|Overall Study|Lack of Efficacy|1|||
170818026|NCT00321672|617341467|FG002|Overall Study|Lack of Efficacy|0|||
170818027|NCT00321672|617341468|FG003|Overall Study|Lack of Efficacy|0|||
170818028|NCT00321672|617341465|FG000|Overall Study|Lost to Follow-up|2|||
170818029|NCT00321672|617341466|FG001|Overall Study|Lost to Follow-up|0|||
170818030|NCT00321672|617341467|FG002|Overall Study|Lost to Follow-up|4|||
170818031|NCT00321672|617341468|FG003|Overall Study|Lost to Follow-up|2|||
170818032|NCT00321672|617341465|FG000|Overall Study|Death|1|||
170818033|NCT00321672|617341466|FG001|Overall Study|Death|0|||
170818034|NCT00321672|617341467|FG002|Overall Study|Death|0|||
170818035|NCT00321672|617341468|FG003|Overall Study|Death|0|||
170818036|NCT00321672|617341465|FG000|Overall Study|Too far to travel for visits|1|||
170664654|NCT00333840|616786828|FG002|First-line Treatment Period|Abnormal procedure|0|||
170664655|NCT00333840|616786829|FG003|First-line Treatment Period|Abnormal procedure|0|||
170664656|NCT00333840|616786826|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
170664657|NCT00333840|616786827|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
170664658|NCT00333840|616786828|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
170664659|NCT00333840|616786829|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
170664660|NCT00333840|616786826|FG000|First-line Treatment Period|No longer required study drug|21|||
170664661|NCT00333840|616786827|FG001|First-line Treatment Period|No longer required study drug|8|||
170664662|NCT00333840|616786828|FG002|First-line Treatment Period|No longer required study drug|0|||
170664663|NCT00333840|616786829|FG003|First-line Treatment Period|No longer required study drug|0|||
170664664|NCT00333840|616786826|FG000|First-line Treatment Period|Protocol Violation|17|||
170664665|NCT00333840|616786827|FG001|First-line Treatment Period|Protocol Violation|17|||
170664666|NCT00333840|616786828|FG002|First-line Treatment Period|Protocol Violation|0|||
170664667|NCT00333840|616786829|FG003|First-line Treatment Period|Protocol Violation|0|||
170664668|NCT00333840|616786826|FG000|First-line Treatment Period|Subject withdrew consent|57|||
170664669|NCT00333840|616786827|FG001|First-line Treatment Period|Subject withdrew consent|77|||
170664670|NCT00333840|616786828|FG002|First-line Treatment Period|Subject withdrew consent|0|||
170818037|NCT00321672|617341466|FG001|Overall Study|Too far to travel for visits|0|||
170818038|NCT00321672|617341467|FG002|Overall Study|Too far to travel for visits|0|||
170818039|NCT00321672|617341468|FG003|Overall Study|Too far to travel for visits|0|||
170818040|NCT00321672|617341465|FG000|Overall Study|Incarcerated|0|||
170664671|NCT00333840|616786829|FG003|First-line Treatment Period|Subject withdrew consent|0|||
170664672|NCT00333840|616786826|FG000|First-line Treatment Period|Lost to Follow-up|15|||
170664673|NCT00333840|616786827|FG001|First-line Treatment Period|Lost to Follow-up|6|||
170818041|NCT00321672|617341466|FG001|Overall Study|Incarcerated|0|||
170818042|NCT00321672|617341467|FG002|Overall Study|Incarcerated|2|||
170818043|NCT00321672|617341468|FG003|Overall Study|Incarcerated|0|||
170818044|NCT00321672|617341465|FG000|Overall Study|Moved out of state|0|||
170818045|NCT00321672|617341466|FG001|Overall Study|Moved out of state|1|||
170664674|NCT00333840|616786828|FG002|First-line Treatment Period|Lost to Follow-up|0|||
170664675|NCT00333840|616786829|FG003|First-line Treatment Period|Lost to Follow-up|0|||
170664676|NCT00333840|616786826|FG000|First-line Treatment Period|Administrative problems|12|||
170664677|NCT00333840|616786827|FG001|First-line Treatment Period|Administrative problems|6|||
170664678|NCT00333840|616786828|FG002|First-line Treatment Period|Administrative problems|0|||
170664679|NCT00333840|616786829|FG003|First-line Treatment Period|Administrative problems|0|||
170664680|NCT00333840|616786826|FG000|First-line Treatment Period|Death|19|||
170664681|NCT00333840|616786827|FG001|First-line Treatment Period|Death|2|||
170664682|NCT00333840|616786828|FG002|First-line Treatment Period|Death|0|||
170664683|NCT00333840|616786829|FG003|First-line Treatment Period|Death|0|||
170664684|NCT00333840|616786826|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
170664685|NCT00333840|616786827|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
170664686|NCT00333840|616786828|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
170664687|NCT00333840|616786829|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
170664688|NCT00333840|616786826|FG000|Second-line Treatment Period|Adverse Event|0|||
170664689|NCT00333840|616786827|FG001|Second-line Treatment Period|Adverse Event|0|||
170664690|NCT00333840|616786828|FG002|Second-line Treatment Period|Adverse Event|3|||
170818046|NCT00321672|617341467|FG002|Overall Study|Moved out of state|1|||
170818047|NCT00321672|617341468|FG003|Overall Study|Moved out of state|0|||
170818048|NCT00321672|617341465|FG000|Overall Study|Protocol Violation|0|||
170818049|NCT00321672|617341466|FG001|Overall Study|Protocol Violation|0|||
170818050|NCT00321672|617341467|FG002|Overall Study|Protocol Violation|1|||
170818051|NCT00321672|617341468|FG003|Overall Study|Protocol Violation|0|||
170818052|NCT00321672|617341465|FG000|Overall Study|Diagnosis of testicular cancer|0|||
170818053|NCT00321672|617341466|FG001|Overall Study|Diagnosis of testicular cancer|1|||
170818054|NCT00321672|617341467|FG002|Overall Study|Diagnosis of testicular cancer|0|||
170818055|NCT00321672|617341468|FG003|Overall Study|Diagnosis of testicular cancer|0|||
170818056|NCT00321672|617341465|FG000|Overall Study|Extensive travel required for new job|0|||
170818057|NCT00321672|617341466|FG001|Overall Study|Extensive travel required for new job|1|||
170818058|NCT00321672|617341467|FG002|Overall Study|Extensive travel required for new job|0|||
170818059|NCT00321672|617341468|FG003|Overall Study|Extensive travel required for new job|0|||
170818060|NCT01468597|617341470|FG000|Overall Study|Found ineligible|17|||
170818061|NCT01468597|617341470|FG000|Overall Study|concomitant valves|12|||
170818062|NCT01468597|617341470|FG000|Overall Study|off-pump CABG|1|||
170818063|NCT01468597|617341470|FG000|Overall Study|no platelet function data|5|||
170818064|NCT02561195|617341472|FG000|Vaccination 1 to 3|Adverse Event|4|||
170818065|NCT02561195|617341473|FG001|Vaccination 1 to 3|Adverse Event|5|||
170818066|NCT02561195|617341474|FG002|Vaccination 1 to 3|Adverse Event|0|||
170818067|NCT02561195|617341475|FG003|Vaccination 1 to 3|Adverse Event|3|||
170818068|NCT02561195|617341476|FG004|Vaccination 1 to 3|Adverse Event|4|||
170818069|NCT02561195|617341477|FG005|Vaccination 1 to 3|Adverse Event|0|||
170818070|NCT02561195|617341478|FG006|Vaccination 1 to 3|Adverse Event|0|||
170818071|NCT02561195|617341479|FG007|Vaccination 1 to 3|Adverse Event|0|||
170818072|NCT02561195|617341480|FG008|Vaccination 1 to 3|Adverse Event|0|||
170818073|NCT02561195|617341481|FG009|Vaccination 1 to 3|Adverse Event|0|||
170818074|NCT02561195|617341482|FG010|Vaccination 1 to 3|Adverse Event|0|||
170818075|NCT02561195|617341483|FG011|Vaccination 1 to 3|Adverse Event|0|||
170818076|NCT02561195|617341484|FG012|Vaccination 1 to 3|Adverse Event|0|||
170818077|NCT02561195|617341485|FG013|Vaccination 1 to 3|Adverse Event|0|||
170818078|NCT02561195|617341472|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
170818079|NCT02561195|617341473|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
170818080|NCT02561195|617341474|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
170818081|NCT02561195|617341475|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
170818082|NCT02561195|617341476|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
170818083|NCT02561195|617341477|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
170818084|NCT02561195|617341478|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
170818085|NCT02561195|617341479|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
170818086|NCT02561195|617341480|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
170818087|NCT02561195|617341481|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
170664691|NCT00333840|616786829|FG003|Second-line Treatment Period|Adverse Event|34|||
170664692|NCT00333840|616786826|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
170664693|NCT00333840|616786827|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
170818088|NCT02561195|617341482|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
170664694|NCT00333840|616786828|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
170818089|NCT02561195|617341483|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
170818090|NCT02561195|617341484|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
170818091|NCT02561195|617341485|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
170818092|NCT02561195|617341472|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818093|NCT02561195|617341473|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
170818094|NCT02561195|617341474|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818095|NCT02561195|617341475|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
170818096|NCT02561195|617341476|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
170818097|NCT02561195|617341477|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
170818098|NCT02561195|617341478|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818099|NCT02561195|617341479|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818100|NCT02561195|617341480|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818101|NCT02561195|617341481|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818102|NCT02561195|617341482|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818103|NCT02561195|617341483|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818104|NCT02561195|617341484|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818105|NCT02561195|617341485|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
170818106|NCT02561195|617341472|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
170818107|NCT02561195|617341473|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
170818108|NCT02561195|617341474|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
170818109|NCT02561195|617341475|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
170818110|NCT02561195|617341476|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
170818111|NCT02561195|617341477|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
170818112|NCT02561195|617341478|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
170818113|NCT02561195|617341479|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
170818114|NCT02561195|617341480|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
170818115|NCT02561195|617341481|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
170818116|NCT02561195|617341482|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
170818117|NCT02561195|617341483|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
170818118|NCT02561195|617341484|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
170818119|NCT02561195|617341485|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
170818120|NCT02561195|617341472|FG000|Vaccination 1 to 3|Other|7|||
170818121|NCT02561195|617341473|FG001|Vaccination 1 to 3|Other|3|||
170818122|NCT02561195|617341474|FG002|Vaccination 1 to 3|Other|1|||
170818123|NCT02561195|617341475|FG003|Vaccination 1 to 3|Other|7|||
170818124|NCT02561195|617341476|FG004|Vaccination 1 to 3|Other|5|||
170818125|NCT02561195|617341477|FG005|Vaccination 1 to 3|Other|1|||
170818126|NCT02561195|617341478|FG006|Vaccination 1 to 3|Other|0|||
170818127|NCT02561195|617341479|FG007|Vaccination 1 to 3|Other|0|||
170818128|NCT02561195|617341480|FG008|Vaccination 1 to 3|Other|0|||
170818129|NCT02561195|617341481|FG009|Vaccination 1 to 3|Other|0|||
170818130|NCT02561195|617341482|FG010|Vaccination 1 to 3|Other|0|||
170818131|NCT02561195|617341483|FG011|Vaccination 1 to 3|Other|0|||
170818132|NCT02561195|617341484|FG012|Vaccination 1 to 3|Other|0|||
170818133|NCT02561195|617341485|FG013|Vaccination 1 to 3|Other|0|||
170818134|NCT02561195|617341472|FG000|Vaccination 1 to 3|Protocol Violation|1|||
170818135|NCT02561195|617341473|FG001|Vaccination 1 to 3|Protocol Violation|0|||
170818136|NCT02561195|617341474|FG002|Vaccination 1 to 3|Protocol Violation|1|||
170664695|NCT00333840|616786829|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
170664696|NCT00333840|616786826|FG000|Second-line Treatment Period|Abnormal procedure|0|||
170664697|NCT00333840|616786827|FG001|Second-line Treatment Period|Abnormal procedure|0|||
170664698|NCT00333840|616786828|FG002|Second-line Treatment Period|Abnormal procedure|0|||
170664699|NCT00333840|616786829|FG003|Second-line Treatment Period|Abnormal procedure|1|||
170664700|NCT00333840|616786826|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
170664701|NCT00333840|616786827|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
170664702|NCT00333840|616786828|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
170664703|NCT00333840|616786829|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
170664704|NCT00333840|616786826|FG000|Second-line Treatment Period|No longer required study drug|0|||
170664705|NCT00333840|616786827|FG001|Second-line Treatment Period|No longer required study drug|0|||
170664706|NCT00333840|616786828|FG002|Second-line Treatment Period|No longer required study drug|1|||
170664707|NCT00333840|616786829|FG003|Second-line Treatment Period|No longer required study drug|14|||
170664708|NCT00333840|616786826|FG000|Second-line Treatment Period|Protocol Violation|0|||
170664709|NCT00333840|616786827|FG001|Second-line Treatment Period|Protocol Violation|0|||
170664710|NCT00333840|616786828|FG002|Second-line Treatment Period|Protocol Violation|1|||
170664711|NCT00333840|616786829|FG003|Second-line Treatment Period|Protocol Violation|10|||
170664712|NCT00333840|616786826|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
170664713|NCT00333840|616786827|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
170664714|NCT00333840|616786828|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
170917393|NCT02499328|617697933|FG000|Overall Study|Death|0|||
170917394|NCT02499328|617697934|FG001|Overall Study|Death|3|||
170664715|NCT00333840|616786829|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
170664716|NCT00333840|616786826|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
170818137|NCT02561195|617341475|FG003|Vaccination 1 to 3|Protocol Violation|2|||
170818138|NCT02561195|617341476|FG004|Vaccination 1 to 3|Protocol Violation|5|||
170818139|NCT02561195|617341477|FG005|Vaccination 1 to 3|Protocol Violation|2|||
170917395|NCT02499328|617697935|FG002|Overall Study|Death|3|||
170818140|NCT02561195|617341478|FG006|Vaccination 1 to 3|Protocol Violation|0|||
170818141|NCT02561195|617341479|FG007|Vaccination 1 to 3|Protocol Violation|0|||
170818142|NCT02561195|617341480|FG008|Vaccination 1 to 3|Protocol Violation|0|||
170664717|NCT00333840|616786827|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
170664718|NCT00333840|616786828|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
170664719|NCT00333840|616786829|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
170664720|NCT00333840|616786826|FG000|Second-line Treatment Period|Administrative problems|0|||
170664721|NCT00333840|616786827|FG001|Second-line Treatment Period|Administrative problems|0|||
170664722|NCT00333840|616786828|FG002|Second-line Treatment Period|Administrative problems|0|||
170664723|NCT00333840|616786829|FG003|Second-line Treatment Period|Administrative problems|7|||
170664724|NCT00333840|616786826|FG000|Second-line Treatment Period|Death|0|||
170664725|NCT00333840|616786827|FG001|Second-line Treatment Period|Death|0|||
170664726|NCT00333840|616786828|FG002|Second-line Treatment Period|Death|0|||
170664727|NCT00333840|616786829|FG003|Second-line Treatment Period|Death|9|||
170664728|NCT02357979|616786830|FG000|Overall Study|Lost to Follow-up|5|||
170818143|NCT02561195|617341481|FG009|Vaccination 1 to 3|Protocol Violation|0|||
170818144|NCT02561195|617341482|FG010|Vaccination 1 to 3|Protocol Violation|0|||
170818145|NCT02561195|617341483|FG011|Vaccination 1 to 3|Protocol Violation|0|||
170818146|NCT02561195|617341484|FG012|Vaccination 1 to 3|Protocol Violation|0|||
170818147|NCT02561195|617341485|FG013|Vaccination 1 to 3|Protocol Violation|0|||
170818148|NCT02561195|617341472|FG000|Vaccination 1 to 3|Death|2|||
170818149|NCT02561195|617341473|FG001|Vaccination 1 to 3|Death|1|||
170818150|NCT02561195|617341474|FG002|Vaccination 1 to 3|Death|0|||
170818151|NCT02561195|617341475|FG003|Vaccination 1 to 3|Death|2|||
170818152|NCT02561195|617341476|FG004|Vaccination 1 to 3|Death|0|||
170818153|NCT02561195|617341477|FG005|Vaccination 1 to 3|Death|0|||
170818154|NCT02561195|617341478|FG006|Vaccination 1 to 3|Death|0|||
170818155|NCT02561195|617341479|FG007|Vaccination 1 to 3|Death|0|||
170818156|NCT02561195|617341480|FG008|Vaccination 1 to 3|Death|0|||
170818157|NCT02561195|617341481|FG009|Vaccination 1 to 3|Death|0|||
170818158|NCT02561195|617341482|FG010|Vaccination 1 to 3|Death|0|||
170818159|NCT02561195|617341483|FG011|Vaccination 1 to 3|Death|0|||
170818160|NCT02561195|617341484|FG012|Vaccination 1 to 3|Death|0|||
170818161|NCT02561195|617341485|FG013|Vaccination 1 to 3|Death|0|||
170917396|NCT02499328|617697936|FG003|Overall Study|Death|2|||
170917397|NCT02499328|617697937|FG004|Overall Study|Death|4|||
170917398|NCT02499328|617697938|FG005|Overall Study|Death|7|||
170917399|NCT02499328|617697939|FG006|Overall Study|Death|3|||
170917400|NCT02499328|617697940|FG007|Overall Study|Death|0|||
170917401|NCT02499328|617697941|FG008|Overall Study|Death|2|||
170917402|NCT02499328|617697942|FG009|Overall Study|Death|6|||
170617355|NCT03575403|616606963|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
170617356|NCT03575403|616606964|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
170617357|NCT04797780|616606965|FG000|Overall Study|Lost to Follow-up|1|||
170617358|NCT04797780|616606966|FG001|Overall Study|Lost to Follow-up|1|||
170617359|NCT04797780|616606965|FG000|Overall Study|Withdrawal by Subject|14|||
170617360|NCT04797780|616606966|FG001|Overall Study|Withdrawal by Subject|9|||
170617361|NCT04797780|616606965|FG000|Overall Study|Death|49|||
170617362|NCT04797780|616606966|FG001|Overall Study|Death|20|||
170617363|NCT02800863|616606967|FG000|Overall Study|Adverse Event|14|||
170617364|NCT02800863|616606967|FG000|Overall Study|Another Device Implanted|1|||
170617365|NCT02800863|616606967|FG000|Overall Study|Device Explanted|1|||
170617366|NCT02800863|616606967|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
170617367|NCT02800863|616606967|FG000|Overall Study|Health Issues|1|||
170617368|NCT02800863|616606967|FG000|Overall Study|Insurance Denial|8|||
170617369|NCT02800863|616606967|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
170617370|NCT02800863|616606967|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
170617371|NCT02800863|616606967|FG000|Overall Study|Screen Failure|1|||
170617372|NCT02800863|616606967|FG000|Overall Study|Sponsor Request|6|||
170617373|NCT02800863|616606967|FG000|Overall Study|Death|3|||
170617374|NCT02800863|616606967|FG000|Overall Study|Subject Implant at Another Facility|1|||
170617375|NCT02800863|616606967|FG000|Overall Study|Lost to Follow-up|26|||
170617376|NCT02800863|616606967|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
170617377|NCT02800863|616606967|FG000|Overall Study|Subject and/or Family Request|64|||
170664729|NCT02357979|616786831|FG001|Overall Study|Lost to Follow-up|5|||
170818162|NCT02561195|617341472|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
170917403|NCT02499328|617697943|FG010|Overall Study|Death|6|||
170617378|NCT02800863|616606967|FG000|Overall Study|Trial Failure|81|||
170617379|NCT02800863|616606967|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
170617380|NCT00279916|616606968|FG000|Overall Study|Withdrawal by Subject|4|||
170664730|NCT00747461|616786832|FG000|Overall Study|study terminated by sponsor|5|||
170664731|NCT02149875|616786833|FG000|Overall Study|Lost to Follow-up|3|||
170664732|NCT02149875|616786834|FG001|Overall Study|Lost to Follow-up|4|||
170664733|NCT02149875|616786835|FG002|Overall Study|Lost to Follow-up|5|||
170818163|NCT02561195|617341473|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
170818164|NCT02561195|617341474|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
170818165|NCT02561195|617341475|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
170818166|NCT02561195|617341476|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
170818167|NCT02561195|617341477|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
170917404|NCT02499328|617697944|FG011|Overall Study|Death|20|||
170818168|NCT02561195|617341478|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
170818169|NCT02561195|617341479|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
170818170|NCT02561195|617341480|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
170818171|NCT02561195|617341481|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
170818172|NCT02561195|617341482|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
170818173|NCT02561195|617341483|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
170818174|NCT02561195|617341484|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
170818175|NCT02561195|617341485|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
170818176|NCT02561195|617341472|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
170818177|NCT02561195|617341473|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
170818178|NCT02561195|617341474|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
170818179|NCT02561195|617341475|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
170818180|NCT02561195|617341476|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
170818181|NCT02561195|617341477|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
170818182|NCT02561195|617341478|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
170818183|NCT02561195|617341479|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
170818184|NCT02561195|617341480|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
170818185|NCT02561195|617341481|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
170818186|NCT02561195|617341482|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
170818187|NCT02561195|617341483|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
170818188|NCT02561195|617341484|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
170818189|NCT02561195|617341485|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
170818190|NCT02561195|617341472|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818191|NCT02561195|617341473|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818192|NCT02561195|617341474|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818193|NCT02561195|617341475|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818194|NCT02561195|617341476|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818195|NCT02561195|617341477|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818196|NCT02561195|617341478|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818197|NCT02561195|617341479|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818198|NCT02561195|617341480|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
170818199|NCT02561195|617341481|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
170818200|NCT02561195|617341482|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
170818201|NCT02561195|617341483|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
170818202|NCT02561195|617341484|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
170818203|NCT02561195|617341485|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
170818204|NCT02561195|617341472|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818205|NCT02561195|617341473|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
170664734|NCT02149875|616786833|FG000|Overall Study|Withdrawal by Subject|3|||
170664735|NCT02149875|616786834|FG001|Overall Study|Withdrawal by Subject|2|||
170664736|NCT02149875|616786835|FG002|Overall Study|Withdrawal by Subject|2|||
170664737|NCT02149875|616786833|FG000|Overall Study|Physician Decision|1|||
170664738|NCT02149875|616786834|FG001|Overall Study|Physician Decision|2|||
170664739|NCT02149875|616786835|FG002|Overall Study|Physician Decision|2|||
170664740|NCT00299182|616786837|FG000|Overall Study|Withdrawal by Subject|0|||
170664741|NCT00299182|616786838|FG001|Overall Study|Withdrawal by Subject|0|||
170664742|NCT00299182|616786839|FG002|Overall Study|Withdrawal by Subject|1|||
170664743|NCT00299182|616786840|FG003|Overall Study|Withdrawal by Subject|0|||
170664744|NCT00299182|616786841|FG004|Overall Study|Withdrawal by Subject|1|||
170664745|NCT00299182|616786842|FG005|Overall Study|Withdrawal by Subject|2|||
170664746|NCT00299182|616786843|FG006|Overall Study|Withdrawal by Subject|0|||
170664747|NCT00299182|616786837|FG000|Overall Study|Chemotherapy Changed|0|||
170664748|NCT00299182|616786838|FG001|Overall Study|Chemotherapy Changed|0|||
170664749|NCT00299182|616786839|FG002|Overall Study|Chemotherapy Changed|1|||
170664750|NCT00299182|616786840|FG003|Overall Study|Chemotherapy Changed|0|||
170664751|NCT00299182|616786841|FG004|Overall Study|Chemotherapy Changed|1|||
170664752|NCT00299182|616786842|FG005|Overall Study|Chemotherapy Changed|0|||
170664753|NCT00299182|616786843|FG006|Overall Study|Chemotherapy Changed|1|||
170917405|NCT02499328|617697945|FG012|Overall Study|Death|9|||
170664754|NCT00299182|616786837|FG000|Overall Study|Adverse Event|0|||
170664755|NCT00299182|616786838|FG001|Overall Study|Adverse Event|0|||
170664756|NCT00299182|616786839|FG002|Overall Study|Adverse Event|0|||
170664757|NCT00299182|616786840|FG003|Overall Study|Adverse Event|0|||
170664758|NCT00299182|616786841|FG004|Overall Study|Adverse Event|0|||
170664759|NCT00299182|616786842|FG005|Overall Study|Adverse Event|1|||
170664760|NCT00299182|616786843|FG006|Overall Study|Adverse Event|0|||
170664761|NCT00299182|616786837|FG000|Overall Study|Not Eligible|0|||
170664762|NCT00299182|616786838|FG001|Overall Study|Not Eligible|0|||
170818206|NCT02561195|617341474|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818207|NCT02561195|617341475|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818208|NCT02561195|617341476|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818209|NCT02561195|617341477|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818210|NCT02561195|617341478|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
170917406|NCT02499328|617697946|FG013|Overall Study|Death|7|||
170617381|NCT00279916|616606969|FG001|Overall Study|Withdrawal by Subject|3|||
170617382|NCT00279916|616606968|FG000|Overall Study|Lost to Follow-up|3|||
170617383|NCT00279916|616606969|FG001|Overall Study|Lost to Follow-up|2|||
170617384|NCT05167825|616606970|FG000|Overall Study|Ongoing|3|||
170617385|NCT03384940|616606980|FG000|Overall Study|Progressive disease|36|||
170617386|NCT03384940|616606981|FG001|Overall Study|Progressive disease|11|||
170617387|NCT03384940|616606982|FG002|Overall Study|Progressive disease|13|||
170818211|NCT02561195|617341479|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818212|NCT02561195|617341480|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818213|NCT02561195|617341481|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818214|NCT02561195|617341482|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818215|NCT02561195|617341483|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818216|NCT02561195|617341484|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
170818217|NCT02561195|617341485|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
170818218|NCT02561195|617341472|FG000|Extension Stage (Vaccination 4)|Death|0|||
170818219|NCT02561195|617341473|FG001|Extension Stage (Vaccination 4)|Death|0|||
170818220|NCT02561195|617341474|FG002|Extension Stage (Vaccination 4)|Death|0|||
170818221|NCT02561195|617341475|FG003|Extension Stage (Vaccination 4)|Death|0|||
170818222|NCT02561195|617341476|FG004|Extension Stage (Vaccination 4)|Death|0|||
170818223|NCT02561195|617341477|FG005|Extension Stage (Vaccination 4)|Death|0|||
170818224|NCT02561195|617341478|FG006|Extension Stage (Vaccination 4)|Death|0|||
170818225|NCT02561195|617341479|FG007|Extension Stage (Vaccination 4)|Death|0|||
170818226|NCT02561195|617341480|FG008|Extension Stage (Vaccination 4)|Death|0|||
170818227|NCT02561195|617341481|FG009|Extension Stage (Vaccination 4)|Death|1|||
170818228|NCT02561195|617341482|FG010|Extension Stage (Vaccination 4)|Death|0|||
170818229|NCT02561195|617341483|FG011|Extension Stage (Vaccination 4)|Death|0|||
170818230|NCT02561195|617341484|FG012|Extension Stage (Vaccination 4)|Death|0|||
170818231|NCT02561195|617341485|FG013|Extension Stage (Vaccination 4)|Death|0|||
170818232|NCT02561195|617341472|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
170818233|NCT02561195|617341473|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
170818234|NCT02561195|617341474|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
170818235|NCT02561195|617341475|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
170818236|NCT02561195|617341476|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
170818237|NCT02561195|617341477|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
170818238|NCT02561195|617341478|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
170818239|NCT02561195|617341479|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
170818240|NCT02561195|617341480|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
170818241|NCT02561195|617341481|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
170818242|NCT02561195|617341482|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
170818243|NCT02561195|617341483|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
170818244|NCT02561195|617341484|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
170818245|NCT02561195|617341485|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
170818246|NCT02561195|617341472|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818247|NCT02561195|617341473|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818248|NCT02561195|617341474|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818249|NCT02561195|617341475|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818250|NCT02561195|617341476|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818251|NCT02561195|617341477|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818252|NCT02561195|617341478|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818253|NCT02561195|617341479|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818254|NCT02561195|617341480|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818255|NCT02561195|617341481|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818256|NCT02561195|617341482|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
170818257|NCT02561195|617341483|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
170818258|NCT02561195|617341484|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
170818259|NCT02561195|617341485|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
170818260|NCT02561195|617341472|FG000|Extension Stage (Vaccination 4)|Other|0|||
170818261|NCT02561195|617341473|FG001|Extension Stage (Vaccination 4)|Other|0|||
170617388|NCT03384940|616606980|FG000|Overall Study|Clinical progression|4|||
170617389|NCT03384940|616606981|FG001|Overall Study|Clinical progression|0|||
170664763|NCT00299182|616786839|FG002|Overall Study|Not Eligible|0|||
170818262|NCT02561195|617341474|FG002|Extension Stage (Vaccination 4)|Other|0|||
170818263|NCT02561195|617341475|FG003|Extension Stage (Vaccination 4)|Other|0|||
170818264|NCT02561195|617341476|FG004|Extension Stage (Vaccination 4)|Other|0|||
170818265|NCT02561195|617341477|FG005|Extension Stage (Vaccination 4)|Other|0|||
170818266|NCT02561195|617341478|FG006|Extension Stage (Vaccination 4)|Other|0|||
170818267|NCT02561195|617341479|FG007|Extension Stage (Vaccination 4)|Other|0|||
170818268|NCT02561195|617341480|FG008|Extension Stage (Vaccination 4)|Other|0|||
170818269|NCT02561195|617341481|FG009|Extension Stage (Vaccination 4)|Other|0|||
170818270|NCT02561195|617341482|FG010|Extension Stage (Vaccination 4)|Other|2|||
170664764|NCT00299182|616786840|FG003|Overall Study|Not Eligible|0|||
170664765|NCT00299182|616786841|FG004|Overall Study|Not Eligible|1|||
170664766|NCT00299182|616786842|FG005|Overall Study|Not Eligible|0|||
170664767|NCT00299182|616786843|FG006|Overall Study|Not Eligible|0|||
170664768|NCT04251273|616786846|FG000|Overall Study|Lost to Follow-up|331|||
170664769|NCT04251273|616786847|FG001|Overall Study|Lost to Follow-up|290|||
170664770|NCT00292318|616786851|FG000|Overall Study|Study terminated by officials|2|||
170664771|NCT00292318|616786852|FG001|Overall Study|Study terminated by officials|1|||
170664772|NCT00936611|616786853|FG000|Overall Study|Progressive Disease|3|||
170664773|NCT00936611|616786853|FG000|Overall Study|New Systemic Therapy|22|||
170664774|NCT00936611|616786853|FG000|Overall Study|Lost to Follow-up|1|||
170664775|NCT00936611|616786853|FG000|Overall Study|Withdrawal by Subject|2|||
170664776|NCT00936611|616786853|FG000|Overall Study|Still on Follow-up|1|||
170664777|NCT00936611|616786853|FG000|Overall Study|Still on Active Therapy|7|||
170664778|NCT00936611|616786853|FG000|Overall Study|Ineligible for Study Drug|3|||
170664779|NCT02955797|616786854|FG000|Overall Study|Protocol Violation|1|||
170664780|NCT02955797|616786855|FG001|Overall Study|Protocol Violation|0|||
170664781|NCT02955797|616786856|FG002|Overall Study|Protocol Violation|0|||
170664782|NCT02955797|616786857|FG003|Overall Study|Protocol Violation|1|||
170664783|NCT02955797|616786854|FG000|Overall Study|Withdrawal by Subject|2|||
170664784|NCT02955797|616786855|FG001|Overall Study|Withdrawal by Subject|2|||
170664785|NCT02955797|616786856|FG002|Overall Study|Withdrawal by Subject|0|||
170664786|NCT02955797|616786857|FG003|Overall Study|Withdrawal by Subject|1|||
170664787|NCT02955797|616786854|FG000|Overall Study|Lost to Follow-up|0|||
170664788|NCT02955797|616786855|FG001|Overall Study|Lost to Follow-up|1|||
170664789|NCT02955797|616786856|FG002|Overall Study|Lost to Follow-up|0|||
170664790|NCT02955797|616786857|FG003|Overall Study|Lost to Follow-up|0|||
170664791|NCT03131453|616786859|FG000|Overall Study|Study terminated by Sponsor|424|||
170664792|NCT03131453|616786860|FG001|Overall Study|Study terminated by Sponsor|222|||
170664793|NCT03131453|616786861|FG002|Overall Study|Study terminated by Sponsor|438|||
170664794|NCT03131453|616786859|FG000|Overall Study|Withdrawal by Subject|18|||
170664795|NCT03131453|616786860|FG001|Overall Study|Withdrawal by Subject|7|||
170664796|NCT03131453|616786861|FG002|Overall Study|Withdrawal by Subject|13|||
170664797|NCT03131453|616786859|FG000|Overall Study|Adverse Event|10|||
170664798|NCT03131453|616786860|FG001|Overall Study|Adverse Event|3|||
170664799|NCT03131453|616786861|FG002|Overall Study|Adverse Event|3|||
170664800|NCT03131453|616786859|FG000|Overall Study|Lost to Follow-up|1|||
170664801|NCT03131453|616786860|FG001|Overall Study|Lost to Follow-up|0|||
170664802|NCT03131453|616786861|FG002|Overall Study|Lost to Follow-up|1|||
170664803|NCT03131453|616786859|FG000|Overall Study|Physician Decision|1|||
170664804|NCT03131453|616786860|FG001|Overall Study|Physician Decision|0|||
170664805|NCT03131453|616786861|FG002|Overall Study|Physician Decision|1|||
170664806|NCT03131453|616786859|FG000|Overall Study|Non-compliance with study treatment|1|||
170664807|NCT03131453|616786860|FG001|Overall Study|Non-compliance with study treatment|0|||
170664808|NCT03131453|616786861|FG002|Overall Study|Non-compliance with study treatment|0|||
170664809|NCT03131453|616786859|FG000|Overall Study|Technical problems|1|||
170664810|NCT03131453|616786860|FG001|Overall Study|Technical problems|0|||
170664811|NCT03131453|616786861|FG002|Overall Study|Technical problems|0|||
170664812|NCT03131453|616786859|FG000|Overall Study|Protocol deviation|0|||
170664813|NCT03131453|616786860|FG001|Overall Study|Protocol deviation|1|||
170664814|NCT03131453|616786861|FG002|Overall Study|Protocol deviation|0|||
170664815|NCT01898208|616786866|FG000|Overall Study|Positive blood culture|17|||
170664816|NCT01898208|616786867|FG001|Overall Study|Positive blood culture|23|||
170664817|NCT01898208|616786868|FG002|Overall Study|Positive blood culture|15|||
170664818|NCT01898208|616786866|FG000|Overall Study|Death/comfort care within 24 hours|10|||
170664819|NCT01898208|616786867|FG001|Overall Study|Death/comfort care within 24 hours|9|||
170664820|NCT01898208|616786868|FG002|Overall Study|Death/comfort care within 24 hours|8|||
170664821|NCT01898208|616786866|FG000|Overall Study|Negative Gram Stain|6|||
170664822|NCT01898208|616786867|FG001|Overall Study|Negative Gram Stain|9|||
170664823|NCT01898208|616786868|FG002|Overall Study|Negative Gram Stain|6|||
170664824|NCT01898208|616786866|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
170664825|NCT01898208|616786867|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
170664826|NCT01898208|616786868|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
170818271|NCT02561195|617341483|FG011|Extension Stage (Vaccination 4)|Other|2|||
170664827|NCT01898208|616786866|FG000|Overall Study|System/Technical Error|1|||
170664828|NCT01898208|616786867|FG001|Overall Study|System/Technical Error|2|||
170664829|NCT01898208|616786868|FG002|Overall Study|System/Technical Error|3|||
170664830|NCT01898208|616786866|FG000|Overall Study|Lost to Follow-up|3|||
170664831|NCT01898208|616786867|FG001|Overall Study|Lost to Follow-up|1|||
170664832|NCT01898208|616786868|FG002|Overall Study|Lost to Follow-up|1|||
170664833|NCT04043728|616786870|FG000|Overall Study|Lost to Follow-up|1|||
170664834|NCT04043728|616786871|FG001|Overall Study|Lost to Follow-up|2|||
170664835|NCT04043728|616786872|FG002|Overall Study|Lost to Follow-up|0|||
170664836|NCT00072176|616786873|FG000|Overall Study|Withdrawal by Subject|1|||
170664837|NCT00072176|616786874|FG001|Overall Study|Withdrawal by Subject|0|||
170664838|NCT00072176|616786873|FG000|Overall Study|Protocol Violation|0|||
170664839|NCT00072176|616786874|FG001|Overall Study|Protocol Violation|1|||
170818272|NCT02561195|617341484|FG012|Extension Stage (Vaccination 4)|Other|1|||
170617390|NCT03384940|616606982|FG002|Overall Study|Clinical progression|3|||
170617391|NCT03384940|616606980|FG000|Overall Study|Adverse Event|7|||
170617392|NCT03384940|616606981|FG001|Overall Study|Adverse Event|1|||
170617393|NCT03384940|616606982|FG002|Overall Study|Adverse Event|1|||
170617394|NCT03384940|616606980|FG000|Overall Study|Withdrawal by Subject|3|||
170617395|NCT03384940|616606981|FG001|Overall Study|Withdrawal by Subject|1|||
170617396|NCT03384940|616606982|FG002|Overall Study|Withdrawal by Subject|0|||
170617397|NCT03384940|616606980|FG000|Overall Study|Physician Decision|1|||
170617398|NCT03384940|616606981|FG001|Overall Study|Physician Decision|1|||
170617399|NCT03384940|616606982|FG002|Overall Study|Physician Decision|0|||
170617400|NCT03384940|616606980|FG000|Overall Study|Death|2|||
170617401|NCT03384940|616606981|FG001|Overall Study|Death|1|||
170617402|NCT03384940|616606982|FG002|Overall Study|Death|0|||
170617403|NCT03384940|616606980|FG000|Overall Study|Other|0|||
170617404|NCT03384940|616606981|FG001|Overall Study|Other|0|||
170617405|NCT03384940|616606982|FG002|Overall Study|Other|1|||
170617406|NCT04628780|616606988|FG000|Overall Study|Death|0|||
170617407|NCT04628780|616606989|FG001|Overall Study|Death|1|||
170617408|NCT04628780|616606990|FG002|Overall Study|Death|0|||
170617409|NCT04628780|616606991|FG003|Overall Study|Death|0|||
170617410|NCT04628780|616606992|FG004|Overall Study|Death|1|||
170617411|NCT04628780|616606993|FG005|Overall Study|Death|0|||
170617412|NCT04628780|616606988|FG000|Overall Study|Physician Decision|2|||
170617413|NCT04628780|616606989|FG001|Overall Study|Physician Decision|0|||
170617414|NCT04628780|616606990|FG002|Overall Study|Physician Decision|0|||
170617415|NCT04628780|616606991|FG003|Overall Study|Physician Decision|0|||
170617416|NCT04628780|616606992|FG004|Overall Study|Physician Decision|2|||
170617417|NCT04628780|616606993|FG005|Overall Study|Physician Decision|0|||
170617418|NCT04628780|616606988|FG000|Overall Study|Progressive disease|2|||
170617419|NCT04628780|616606989|FG001|Overall Study|Progressive disease|2|||
170617420|NCT04628780|616606990|FG002|Overall Study|Progressive disease|2|||
170617421|NCT04628780|616606991|FG003|Overall Study|Progressive disease|3|||
170617422|NCT04628780|616606992|FG004|Overall Study|Progressive disease|9|||
170617423|NCT04628780|616606993|FG005|Overall Study|Progressive disease|4|||
170617424|NCT04628780|616606988|FG000|Overall Study|Withdrawal by Subject|0|||
170617425|NCT04628780|616606989|FG001|Overall Study|Withdrawal by Subject|1|||
170617426|NCT04628780|616606990|FG002|Overall Study|Withdrawal by Subject|2|||
170617427|NCT04628780|616606991|FG003|Overall Study|Withdrawal by Subject|0|||
170617428|NCT04628780|616606992|FG004|Overall Study|Withdrawal by Subject|3|||
170617429|NCT04628780|616606993|FG005|Overall Study|Withdrawal by Subject|1|||
170617430|NCT04628780|616606988|FG000|Overall Study|Global deterioration of health status|0|||
170617431|NCT04628780|616606989|FG001|Overall Study|Global deterioration of health status|0|||
170617432|NCT04628780|616606990|FG002|Overall Study|Global deterioration of health status|0|||
170617433|NCT04628780|616606991|FG003|Overall Study|Global deterioration of health status|0|||
170617434|NCT04628780|616606992|FG004|Overall Study|Global deterioration of health status|1|||
170617435|NCT04628780|616606993|FG005|Overall Study|Global deterioration of health status|1|||
170617436|NCT03269994|616606994|FG000|Overall Study|Withdrawal by Subject|4|||
170617437|NCT03269994|616606995|FG001|Overall Study|Withdrawal by Subject|5|||
170617438|NCT03269994|616606994|FG000|Overall Study|Unresectable at surgery|39|||
170617439|NCT03269994|616606995|FG001|Overall Study|Unresectable at surgery|58|||
170617440|NCT03269994|616606994|FG000|Overall Study|Patient canceled surgery|5|||
170617441|NCT03269994|616606995|FG001|Overall Study|Patient canceled surgery|14|||
170617442|NCT03269994|616606994|FG000|Overall Study|Preoperative progression|14|||
170617443|NCT03269994|616606995|FG001|Overall Study|Preoperative progression|9|||
170617444|NCT03269994|616606994|FG000|Overall Study|Preoperative infection|10|||
170617445|NCT03269994|616606995|FG001|Overall Study|Preoperative infection|4|||
170617446|NCT03269994|616606994|FG000|Overall Study|Kidney insufficiency|1|||
170617447|NCT03269994|616606995|FG001|Overall Study|Kidney insufficiency|0|||
170617448|NCT03269994|616606994|FG000|Overall Study|Drug allergy|0|||
170617449|NCT03269994|616606995|FG001|Overall Study|Drug allergy|2|||
170617450|NCT03269994|616606994|FG000|Overall Study|Operation changed to different resection|9|||
170617451|NCT03269994|616606995|FG001|Overall Study|Operation changed to different resection|0|||
170617452|NCT03269994|616606994|FG000|Overall Study|Preoperative steroid|0|||
170617453|NCT03269994|616606995|FG001|Overall Study|Preoperative steroid|3|||
170617454|NCT03269994|616606994|FG000|Overall Study|Accrual Closed|2|||
170617455|NCT03269994|616606995|FG001|Overall Study|Accrual Closed|0|||
170617456|NCT03269994|616606994|FG000|Overall Study|Operation changed to different resection|0|||
170617457|NCT03269994|616606995|FG001|Overall Study|Operation changed to different resection|10|||
170617458|NCT00479713|616606997|FG000|Overall Study|Adverse Event|8|||
170617459|NCT00479713|616606998|FG001|Overall Study|Adverse Event|6|||
170617460|NCT00479713|616606997|FG000|Overall Study|Death|1|||
170617461|NCT00479713|616606998|FG001|Overall Study|Death|0|||
170617462|NCT00479713|616606997|FG000|Overall Study|Lost to Follow-up|0|||
170617463|NCT00479713|616606998|FG001|Overall Study|Lost to Follow-up|1|||
170664840|NCT02586064|616786875|FG000|Overall Study|Other Obligations|6|||
170617464|NCT00479713|616606997|FG000|Overall Study|Protocol Violation|0|||
170617465|NCT00479713|616606998|FG001|Overall Study|Protocol Violation|1|||
170917407|NCT02499328|617697947|FG014|Overall Study|Death|3|||
170664841|NCT02586064|616786876|FG001|Overall Study|Other Obligations|6|||
170664842|NCT02586064|616786875|FG000|Overall Study|Other|3|||
170664843|NCT02586064|616786876|FG001|Overall Study|Other|7|||
170664844|NCT02586064|616786875|FG000|Overall Study|Never Started|3|||
170664845|NCT02586064|616786876|FG001|Overall Study|Never Started|3|||
170664846|NCT02586064|616786875|FG000|Overall Study|Lost Interest|1|||
170664847|NCT02586064|616786876|FG001|Overall Study|Lost Interest|4|||
170664848|NCT02586064|616786875|FG000|Overall Study|Miscellaneous Life Issues|0|||
170664849|NCT02586064|616786876|FG001|Overall Study|Miscellaneous Life Issues|5|||
170664850|NCT02586064|616786875|FG000|Overall Study|Infrequent Attendance|2|||
170664851|NCT02586064|616786876|FG001|Overall Study|Infrequent Attendance|1|||
170664852|NCT02586064|616786875|FG000|Overall Study|Timed Out|2|||
170818273|NCT02561195|617341485|FG013|Extension Stage (Vaccination 4)|Other|0|||
170818274|NCT02561195|617341472|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170664853|NCT02586064|616786876|FG001|Overall Study|Timed Out|0|||
170664854|NCT02586064|616786875|FG000|Overall Study|AUD relapse|0|||
170917408|NCT02499328|617697948|FG015|Overall Study|Death|1|||
170917409|NCT02499328|617697949|FG016|Overall Study|Death|1|||
170664855|NCT02586064|616786876|FG001|Overall Study|AUD relapse|2|||
170664856|NCT02586064|616786875|FG000|Overall Study|Legal Issue|1|||
170917410|NCT02499328|617697950|FG017|Overall Study|Death|16|||
170664857|NCT02586064|616786876|FG001|Overall Study|Legal Issue|0|||
170664858|NCT02158975|616786877|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
170664859|NCT00586625|616786878|FG000|Overall Study|Adverse Event|6|||
170664860|NCT00586625|616786879|FG001|Overall Study|Adverse Event|6|||
170664861|NCT00586625|616786878|FG000|Overall Study|Protocol Violation|3|||
170664862|NCT00586625|616786879|FG001|Overall Study|Protocol Violation|0|||
170664863|NCT00586625|616786878|FG000|Overall Study|Withdrawal by Subject|32|||
170917411|NCT02499328|617697951|FG018|Overall Study|Death|5|||
170917412|NCT02499328|617697933|FG000|Overall Study|"Other"|2|||
170917413|NCT02499328|617697934|FG001|Overall Study|"Other"|2|||
170917414|NCT02499328|617697935|FG002|Overall Study|"Other"|1|||
170917415|NCT02499328|617697936|FG003|Overall Study|"Other"|3|||
170917416|NCT02499328|617697937|FG004|Overall Study|"Other"|6|||
170917417|NCT02499328|617697938|FG005|Overall Study|"Other"|2|||
170917418|NCT02499328|617697939|FG006|Overall Study|"Other"|3|||
170917419|NCT02499328|617697940|FG007|Overall Study|"Other"|4|||
170917420|NCT02499328|617697941|FG008|Overall Study|"Other"|6|||
170917421|NCT02499328|617697942|FG009|Overall Study|"Other"|16|||
170917422|NCT02499328|617697943|FG010|Overall Study|"Other"|13|||
170917423|NCT02499328|617697944|FG011|Overall Study|"Other"|31|||
170917424|NCT02499328|617697945|FG012|Overall Study|"Other"|8|||
170917425|NCT02499328|617697946|FG013|Overall Study|"Other"|7|||
170917426|NCT02499328|617697947|FG014|Overall Study|"Other"|6|||
170917427|NCT02499328|617697948|FG015|Overall Study|"Other"|0|||
170917428|NCT02499328|617697949|FG016|Overall Study|"Other"|0|||
170917429|NCT02499328|617697950|FG017|Overall Study|"Other"|34|||
170917430|NCT02499328|617697951|FG018|Overall Study|"Other"|43|||
170917431|NCT02499328|617697933|FG000|Overall Study|Disease Progression|0|||
170917432|NCT02499328|617697934|FG001|Overall Study|Disease Progression|0|||
170917433|NCT02499328|617697935|FG002|Overall Study|Disease Progression|0|||
170917434|NCT02499328|617697936|FG003|Overall Study|Disease Progression|0|||
170917435|NCT02499328|617697937|FG004|Overall Study|Disease Progression|0|||
170917436|NCT02499328|617697938|FG005|Overall Study|Disease Progression|0|||
170917437|NCT02499328|617697939|FG006|Overall Study|Disease Progression|1|||
170917438|NCT02499328|617697940|FG007|Overall Study|Disease Progression|0|||
170917439|NCT02499328|617697941|FG008|Overall Study|Disease Progression|1|||
170818275|NCT02561195|617341473|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170818276|NCT02561195|617341474|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170818277|NCT02561195|617341475|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170818278|NCT02561195|617341476|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170818279|NCT02561195|617341477|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170818280|NCT02561195|617341478|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
170917440|NCT02499328|617697942|FG009|Overall Study|Disease Progression|0|||
170917441|NCT02499328|617697943|FG010|Overall Study|Disease Progression|1|||
170917442|NCT02499328|617697944|FG011|Overall Study|Disease Progression|0|||
170917443|NCT02499328|617697945|FG012|Overall Study|Disease Progression|0|||
170917444|NCT02499328|617697946|FG013|Overall Study|Disease Progression|0|||
170917445|NCT02499328|617697947|FG014|Overall Study|Disease Progression|0|||
170917446|NCT02499328|617697948|FG015|Overall Study|Disease Progression|0|||
170917447|NCT02499328|617697949|FG016|Overall Study|Disease Progression|0|||
170917448|NCT02499328|617697950|FG017|Overall Study|Disease Progression|2|||
170917449|NCT02499328|617697951|FG018|Overall Study|Disease Progression|0|||
170664864|NCT00586625|616786879|FG001|Overall Study|Withdrawal by Subject|10|||
170664865|NCT00586625|616786878|FG000|Overall Study|Subject non-compliance|0|||
170818281|NCT02561195|617341479|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170917450|NCT02499328|617697933|FG000|Overall Study|Adverse Event|1|||
170917451|NCT02499328|617697934|FG001|Overall Study|Adverse Event|0|||
170917452|NCT02499328|617697935|FG002|Overall Study|Adverse Event|0|||
170917453|NCT02499328|617697936|FG003|Overall Study|Adverse Event|1|||
170917454|NCT02499328|617697937|FG004|Overall Study|Adverse Event|0|||
170917455|NCT02499328|617697938|FG005|Overall Study|Adverse Event|0|||
170917456|NCT02499328|617697939|FG006|Overall Study|Adverse Event|0|||
170917457|NCT02499328|617697940|FG007|Overall Study|Adverse Event|0|||
170917458|NCT02499328|617697941|FG008|Overall Study|Adverse Event|0|||
170917459|NCT02499328|617697942|FG009|Overall Study|Adverse Event|0|||
170917460|NCT02499328|617697943|FG010|Overall Study|Adverse Event|0|||
170917461|NCT02499328|617697944|FG011|Overall Study|Adverse Event|0|||
170917462|NCT02499328|617697945|FG012|Overall Study|Adverse Event|1|||
170917463|NCT02499328|617697946|FG013|Overall Study|Adverse Event|0|||
170917464|NCT02499328|617697947|FG014|Overall Study|Adverse Event|0|||
170917465|NCT02499328|617697948|FG015|Overall Study|Adverse Event|0|||
170917466|NCT02499328|617697949|FG016|Overall Study|Adverse Event|0|||
170917467|NCT02499328|617697950|FG017|Overall Study|Adverse Event|0|||
170917468|NCT02499328|617697951|FG018|Overall Study|Adverse Event|0|||
170917469|NCT05197426|617697961|FG000|Treatment|Disease Relapse|2|||
170917470|NCT05197426|617697962|FG001|Treatment|Disease Relapse|2|||
170917471|NCT05197426|617697961|FG000|Treatment|Physician Decision|1|||
170917472|NCT05197426|617697962|FG001|Treatment|Physician Decision|3|||
170917473|NCT05197426|617697961|FG000|Treatment|Transitioned to commercially available treatment|1|||
170917474|NCT05197426|617697962|FG001|Treatment|Transitioned to commercially available treatment|0|||
170664866|NCT00586625|616786879|FG001|Overall Study|Subject non-compliance|1|||
170664867|NCT00586625|616786878|FG000|Overall Study|Subject unable to return for visit|2|||
170664868|NCT00586625|616786879|FG001|Overall Study|Subject unable to return for visit|0|||
170664869|NCT00165984|616786881|FG000|Overall Study|Death|15|||
170664870|NCT02649894|616786882|FG000|Overall Study|Adverse Event|1|||
170664871|NCT02649894|616786883|FG001|Overall Study|Adverse Event|0|||
170664872|NCT02649894|616786882|FG000|Overall Study|Physician Decision|0|||
170664873|NCT02649894|616786883|FG001|Overall Study|Physician Decision|1|||
170664874|NCT02649894|616786882|FG000|Overall Study|Withdrawal by Subject|5|||
170664875|NCT02649894|616786883|FG001|Overall Study|Withdrawal by Subject|2|||
170818282|NCT02561195|617341480|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170818283|NCT02561195|617341481|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170818284|NCT02561195|617341482|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
170818285|NCT02561195|617341483|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
170818286|NCT02561195|617341484|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
170818287|NCT02561195|617341485|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
170818288|NCT03905512|617341486|FG000|Overall Study|Withdrawal by Subject|9|||
170818289|NCT03905512|617341487|FG001|Overall Study|Withdrawal by Subject|8|||
170818290|NCT03905512|617341486|FG000|Overall Study|Adverse Event|1|||
170664876|NCT02649894|616786882|FG000|Overall Study|Lost to Follow-up|2|||
170664877|NCT02649894|616786883|FG001|Overall Study|Lost to Follow-up|1|||
170664878|NCT02649894|616786882|FG000|Overall Study|Death|30|||
170664879|NCT02649894|616786883|FG001|Overall Study|Death|7|||
170664880|NCT02649894|616786882|FG000|Overall Study|Other, not specified|6|||
170664881|NCT02649894|616786883|FG001|Overall Study|Other, not specified|0|||
170664882|NCT03698331|616786893|FG000|Overall Study|Adverse Event|2|||
170664883|NCT03698331|616786894|FG001|Overall Study|Adverse Event|3|||
170664884|NCT03698331|616786893|FG000|Overall Study|Withdrawal by Subject|1|||
170664885|NCT03698331|616786894|FG001|Overall Study|Withdrawal by Subject|1|||
170664886|NCT03698331|616786893|FG000|Overall Study|Lost to Follow-up|0|||
170664887|NCT03698331|616786894|FG001|Overall Study|Lost to Follow-up|2|||
170664888|NCT03698331|616786893|FG000|Overall Study|Non-compliance with study drug|1|||
170664889|NCT03698331|616786894|FG001|Overall Study|Non-compliance with study drug|0|||
170664890|NCT01467583|616786895|FG000|Overall Study|Death|1|||
170664891|NCT01467583|616786896|FG001|Overall Study|Death|1|||
170664892|NCT01467583|616786897|FG002|Overall Study|Death|0|||
170664893|NCT01467583|616786895|FG000|Overall Study|Withdrawal by Subject|1|||
170664894|NCT01467583|616786896|FG001|Overall Study|Withdrawal by Subject|0|||
170664895|NCT01467583|616786897|FG002|Overall Study|Withdrawal by Subject|0|||
170664896|NCT01467583|616786895|FG000|Overall Study|Protocol Violation|0|||
170664897|NCT01467583|616786896|FG001|Overall Study|Protocol Violation|0|||
170664898|NCT01467583|616786897|FG002|Overall Study|Protocol Violation|2|||
170664899|NCT05274165|616786898|FG000|Overall Study|Withdrawal by Subject|3|||
170664900|NCT05274165|616786899|FG001|Overall Study|Withdrawal by Subject|3|||
170664901|NCT04916769|616786900|FG000|Period 1|Physician Decision|0|||
170664902|NCT04916769|616786901|FG001|Period 1|Physician Decision|0|||
170664903|NCT04916769|616786902|FG002|Period 1|Physician Decision|0|||
170664904|NCT04916769|616786903|FG003|Period 1|Physician Decision|0|||
170664905|NCT04916769|616786904|FG004|Period 1|Physician Decision|0|||
170664906|NCT04916769|616786905|FG005|Period 1|Physician Decision|1|||
170664907|NCT04916769|616786900|FG000|Period 2|Physician Decision|0|||
170664908|NCT04916769|616786901|FG001|Period 2|Physician Decision|1|||
170818291|NCT03905512|617341487|FG001|Overall Study|Adverse Event|2|||
170818292|NCT03905512|617341486|FG000|Overall Study|Lost to Follow-up|4|||
170917475|NCT05197426|617697961|FG000|Treatment|Other Reasons|1|||
170917476|NCT05197426|617697962|FG001|Treatment|Other Reasons|1|||
170917477|NCT05197426|617697961|FG000|Follow Up|Death|1|||
170664909|NCT04916769|616786902|FG002|Period 2|Physician Decision|0|||
170664910|NCT04916769|616786903|FG003|Period 2|Physician Decision|0|||
170664911|NCT04916769|616786904|FG004|Period 2|Physician Decision|0|||
170664912|NCT04916769|616786905|FG005|Period 2|Physician Decision|0|||
170664913|NCT03805646|616786918|FG000|Overall Study|Death|40|||
170664914|NCT03805646|616786919|FG001|Overall Study|Death|49|||
170664915|NCT03805646|616786918|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
170664916|NCT03805646|616786919|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
170664917|NCT05171777|616786920|FG000|Treatment Crossover Period|Adverse Event|9|||
170664918|NCT05171777|616786921|FG001|Treatment Crossover Period|Adverse Event|6|||
170664919|NCT05171777|616786922|FG002|Treatment Crossover Period|Adverse Event|0|||
170664920|NCT05171777|616786923|FG003|Treatment Crossover Period|Adverse Event|0|||
170664921|NCT05171777|616786920|FG000|Treatment Crossover Period|Death|5|||
170664922|NCT05171777|616786921|FG001|Treatment Crossover Period|Death|5|||
170664923|NCT05171777|616786922|FG002|Treatment Crossover Period|Death|0|||
170664924|NCT05171777|616786923|FG003|Treatment Crossover Period|Death|0|||
170664925|NCT05171777|616786920|FG000|Treatment Crossover Period|Disease Relapse|1|||
170664926|NCT05171777|616786921|FG001|Treatment Crossover Period|Disease Relapse|0|||
170664927|NCT05171777|616786922|FG002|Treatment Crossover Period|Disease Relapse|0|||
170664928|NCT05171777|616786923|FG003|Treatment Crossover Period|Disease Relapse|0|||
170664929|NCT05171777|616786920|FG000|Treatment Crossover Period|Reason not Specified|1|||
170664930|NCT05171777|616786921|FG001|Treatment Crossover Period|Reason not Specified|1|||
170664931|NCT05171777|616786922|FG002|Treatment Crossover Period|Reason not Specified|0|||
170664932|NCT05171777|616786923|FG003|Treatment Crossover Period|Reason not Specified|0|||
170664933|NCT05171777|616786920|FG000|Treatment Crossover Period|Physician Decision|0|||
170664934|NCT05171777|616786921|FG001|Treatment Crossover Period|Physician Decision|1|||
170664935|NCT05171777|616786922|FG002|Treatment Crossover Period|Physician Decision|0|||
170664936|NCT05171777|616786923|FG003|Treatment Crossover Period|Physician Decision|0|||
170664937|NCT05171777|616786920|FG000|Treatment Crossover Period|Progressive Disease|14|||
170664938|NCT05171777|616786921|FG001|Treatment Crossover Period|Progressive Disease|10|||
170664939|NCT05171777|616786922|FG002|Treatment Crossover Period|Progressive Disease|0|||
170664940|NCT05171777|616786923|FG003|Treatment Crossover Period|Progressive Disease|0|||
170664941|NCT05171777|616786920|FG000|Treatment Crossover Period|Protocol Violation|0|||
170664942|NCT05171777|616786921|FG001|Treatment Crossover Period|Protocol Violation|2|||
170664943|NCT05171777|616786922|FG002|Treatment Crossover Period|Protocol Violation|0|||
170664944|NCT05171777|616786923|FG003|Treatment Crossover Period|Protocol Violation|0|||
170664945|NCT05171777|616786920|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
170664946|NCT05171777|616786921|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
170664947|NCT05171777|616786922|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
170664948|NCT05171777|616786923|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
170664949|NCT05171777|616786920|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
170664950|NCT05171777|616786921|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
170664951|NCT05171777|616786922|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
170664952|NCT05171777|616786923|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
170664953|NCT05171777|616786920|FG000|Treatment Continuation Period|Adverse Event|0|||
170664954|NCT05171777|616786921|FG001|Treatment Continuation Period|Adverse Event|0|||
170664955|NCT05171777|616786922|FG002|Treatment Continuation Period|Adverse Event|3|||
170664956|NCT05171777|616786923|FG003|Treatment Continuation Period|Adverse Event|6|||
170664957|NCT05171777|616786920|FG000|Treatment Continuation Period|Death|0|||
170664958|NCT05171777|616786921|FG001|Treatment Continuation Period|Death|0|||
170664959|NCT05171777|616786922|FG002|Treatment Continuation Period|Death|1|||
170664960|NCT05171777|616786923|FG003|Treatment Continuation Period|Death|3|||
170664961|NCT05171777|616786920|FG000|Treatment Continuation Period|Disease Relapse|0|||
170664962|NCT05171777|616786921|FG001|Treatment Continuation Period|Disease Relapse|0|||
170664963|NCT05171777|616786922|FG002|Treatment Continuation Period|Disease Relapse|1|||
170664964|NCT05171777|616786923|FG003|Treatment Continuation Period|Disease Relapse|0|||
170664965|NCT05171777|616786920|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
170664966|NCT05171777|616786921|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
170664967|NCT05171777|616786922|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
170818293|NCT03905512|617341487|FG001|Overall Study|Lost to Follow-up|3|||
170818294|NCT03905512|617341486|FG000|Overall Study|Other than Specified|7|||
170818295|NCT03905512|617341487|FG001|Overall Study|Other than Specified|4|||
170818296|NCT00070317|617341488|FG000|Overall Study|Inevaluable (Never Treated)|1|||
170664968|NCT05171777|616786923|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
170664969|NCT05171777|616786920|FG000|Treatment Continuation Period|Physician Decision|0|||
170664970|NCT05171777|616786921|FG001|Treatment Continuation Period|Physician Decision|0|||
170664971|NCT05171777|616786922|FG002|Treatment Continuation Period|Physician Decision|0|||
170664972|NCT05171777|616786923|FG003|Treatment Continuation Period|Physician Decision|4|||
170664973|NCT05171777|616786920|FG000|Treatment Continuation Period|Progressive Disease|0|||
170664974|NCT05171777|616786921|FG001|Treatment Continuation Period|Progressive Disease|0|||
170818297|NCT00070317|617341488|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
170818298|NCT00070317|617341488|FG000|Overall Study|Ineligible required test not done|1|||
170664975|NCT05171777|616786922|FG002|Treatment Continuation Period|Progressive Disease|6|||
170664976|NCT05171777|616786923|FG003|Treatment Continuation Period|Progressive Disease|20|||
170664977|NCT05171777|616786920|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
170664978|NCT05171777|616786921|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
170664979|NCT05171777|616786922|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
170664980|NCT05171777|616786923|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
170664981|NCT05171777|616786920|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
170664982|NCT05171777|616786921|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
170664983|NCT05171777|616786922|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
170664984|NCT05171777|616786923|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
170664985|NCT05171777|616786920|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
170664986|NCT05171777|616786921|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
170664987|NCT05171777|616786922|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
170664988|NCT05171777|616786923|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
170664989|NCT02364713|616786924|FG000|Overall Study|Ineligible|2|||
170664990|NCT02364713|616786925|FG001|Overall Study|Ineligible|2|||
170664991|NCT04686786|616786928|FG000|Overall Study|Adverse Event|9|||
170664992|NCT04686786|616786928|FG000|Overall Study|Death|1|||
170664993|NCT04686786|616786928|FG000|Overall Study|Lack of Efficacy|25|||
170664994|NCT04686786|616786928|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
170664995|NCT04686786|616786928|FG000|Overall Study|Study Terminated by Sponsor|14|||
170664996|NCT04686786|616786928|FG000|Overall Study|Withdrawal by Subject|15|||
170664997|NCT04686786|616786928|FG000|Overall Study|Other than specified|1|||
170664998|NCT03924869|616786932|FG000|Overall Study|Death|73|||
170664999|NCT03924869|616786933|FG001|Overall Study|Death|62|||
170665000|NCT03924869|616786932|FG000|Overall Study|Lost to Follow-up|3|||
170665001|NCT03924869|616786933|FG001|Overall Study|Lost to Follow-up|0|||
170665002|NCT03924869|616786932|FG000|Overall Study|Physician Decision|0|||
170665003|NCT03924869|616786933|FG001|Overall Study|Physician Decision|3|||
170665004|NCT03924869|616786932|FG000|Overall Study|Withdrawal by Subject|7|||
170665005|NCT03924869|616786933|FG001|Overall Study|Withdrawal by Subject|3|||
170665006|NCT03924869|616786932|FG000|Overall Study|Study Terminated By Sponsor|144|||
170665007|NCT03924869|616786933|FG001|Overall Study|Study Terminated By Sponsor|153|||
170665008|NCT05741528|616786936|FG000|Overall Study|Withdrawal by Subject|11|||
170665009|NCT05741528|616786936|FG000|Overall Study|Lost to Follow-up|3|||
170665010|NCT05741528|616786936|FG000|Overall Study|Adverse Event|2|||
170665011|NCT05741528|616786936|FG000|Overall Study|Non-Compliance With Study Drug|2|||
170665012|NCT05741528|616786936|FG000|Overall Study|Reason Not Specified|1|||
170665013|NCT04823650|616786937|FG000|Overall Study|Withdrawal by Subject|0|||
170665014|NCT04823650|616786938|FG001|Overall Study|Withdrawal by Subject|0|||
170665015|NCT04823650|616786939|FG002|Overall Study|Withdrawal by Subject|0|||
170665016|NCT04823650|616786940|FG003|Overall Study|Withdrawal by Subject|0|||
170665017|NCT04823650|616786941|FG004|Overall Study|Withdrawal by Subject|1|||
170665018|NCT04823650|616786942|FG005|Overall Study|Withdrawal by Subject|0|||
170665019|NCT00717093|616788466|FG000|Overall Study|Adverse Event|19|||
170665020|NCT00717093|616788467|FG001|Overall Study|Adverse Event|9|||
170665021|NCT00717093|616788466|FG000|Overall Study|Lack of Efficacy|3|||
170665022|NCT00717093|616788467|FG001|Overall Study|Lack of Efficacy|13|||
170665023|NCT00717093|616788466|FG000|Overall Study|Lost to Follow-up|9|||
170665024|NCT00717093|616788467|FG001|Overall Study|Lost to Follow-up|6|||
170665025|NCT00717093|616788466|FG000|Overall Study|Withdrawal by Subject|12|||
170665026|NCT00717093|616788467|FG001|Overall Study|Withdrawal by Subject|19|||
170665027|NCT00717093|616788466|FG000|Overall Study|Other|0|||
170665028|NCT00717093|616788467|FG001|Overall Study|Other|1|||
170665029|NCT00717093|616788466|FG000|Overall Study|Randomized but not treated|1|||
170665030|NCT00717093|616788467|FG001|Overall Study|Randomized but not treated|0|||
170665031|NCT01543698|616788472|FG000|Phase 1b|Disease progression|2|||
170665032|NCT01543698|616788473|FG001|Phase 1b|Disease progression|4|||
170665033|NCT01543698|616788474|FG002|Phase 1b|Disease progression|3|||
170665034|NCT01543698|616788475|FG003|Phase 1b|Disease progression|2|||
170818299|NCT00070317|617341488|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
170665035|NCT01543698|616788476|FG004|Phase 1b|Disease progression|10|||
170665036|NCT01543698|616788477|FG005|Phase 1b|Disease progression|6|||
170665037|NCT01543698|616788478|FG006|Phase 1b|Disease progression|5|||
170665038|NCT01543698|616788479|FG007|Phase 1b|Disease progression|3|||
170665039|NCT01543698|616788480|FG008|Phase 1b|Disease progression|4|||
170665040|NCT01543698|616788481|FG009|Phase 1b|Disease progression|5|||
170665041|NCT01543698|616788482|FG010|Phase 1b|Disease progression|1|||
170665042|NCT01543698|616788483|FG011|Phase 1b|Disease progression|0|||
170665043|NCT01543698|616788484|FG012|Phase 1b|Disease progression|0|||
170665044|NCT01543698|616788485|FG013|Phase 1b|Disease progression|0|||
170665045|NCT01543698|616788486|FG014|Phase 1b|Disease progression|0|||
170665046|NCT01543698|616788472|FG000|Phase 1b|Death|0|||
170665047|NCT01543698|616788473|FG001|Phase 1b|Death|0|||
170665048|NCT01543698|616788474|FG002|Phase 1b|Death|1|||
170665049|NCT01543698|616788475|FG003|Phase 1b|Death|1|||
170665050|NCT01543698|616788476|FG004|Phase 1b|Death|0|||
170665051|NCT01543698|616788477|FG005|Phase 1b|Death|0|||
170665052|NCT01543698|616788478|FG006|Phase 1b|Death|0|||
170665053|NCT01543698|616788479|FG007|Phase 1b|Death|0|||
170665054|NCT01543698|616788480|FG008|Phase 1b|Death|0|||
170665055|NCT01543698|616788481|FG009|Phase 1b|Death|0|||
170665056|NCT01543698|616788482|FG010|Phase 1b|Death|1|||
170665057|NCT01543698|616788483|FG011|Phase 1b|Death|0|||
170665058|NCT01543698|616788484|FG012|Phase 1b|Death|0|||
170665059|NCT01543698|616788485|FG013|Phase 1b|Death|0|||
170665060|NCT01543698|616788486|FG014|Phase 1b|Death|0|||
170665061|NCT01543698|616788472|FG000|Phase 1b|Withdrawal by Subject|0|||
170665062|NCT01543698|616788473|FG001|Phase 1b|Withdrawal by Subject|1|||
170665063|NCT01543698|616788474|FG002|Phase 1b|Withdrawal by Subject|0|||
170665064|NCT01543698|616788475|FG003|Phase 1b|Withdrawal by Subject|1|||
170665065|NCT01543698|616788476|FG004|Phase 1b|Withdrawal by Subject|0|||
170665066|NCT01543698|616788477|FG005|Phase 1b|Withdrawal by Subject|0|||
170665067|NCT01543698|616788478|FG006|Phase 1b|Withdrawal by Subject|1|||
170665068|NCT01543698|616788479|FG007|Phase 1b|Withdrawal by Subject|0|||
170665069|NCT01543698|616788480|FG008|Phase 1b|Withdrawal by Subject|0|||
170665070|NCT01543698|616788481|FG009|Phase 1b|Withdrawal by Subject|0|||
170665071|NCT01543698|616788482|FG010|Phase 1b|Withdrawal by Subject|0|||
170665072|NCT01543698|616788483|FG011|Phase 1b|Withdrawal by Subject|0|||
170665073|NCT01543698|616788484|FG012|Phase 1b|Withdrawal by Subject|0|||
170665074|NCT01543698|616788485|FG013|Phase 1b|Withdrawal by Subject|0|||
170665075|NCT01543698|616788486|FG014|Phase 1b|Withdrawal by Subject|0|||
170665076|NCT01543698|616788472|FG000|Phase 1b|Adverse Event|1|||
170665077|NCT01543698|616788473|FG001|Phase 1b|Adverse Event|0|||
170665078|NCT01543698|616788474|FG002|Phase 1b|Adverse Event|0|||
170665079|NCT01543698|616788475|FG003|Phase 1b|Adverse Event|1|||
170665080|NCT01543698|616788476|FG004|Phase 1b|Adverse Event|2|||
170665081|NCT01543698|616788477|FG005|Phase 1b|Adverse Event|2|||
170665082|NCT01543698|616788478|FG006|Phase 1b|Adverse Event|0|||
170665083|NCT01543698|616788479|FG007|Phase 1b|Adverse Event|0|||
170665084|NCT01543698|616788480|FG008|Phase 1b|Adverse Event|1|||
170665085|NCT01543698|616788481|FG009|Phase 1b|Adverse Event|1|||
170665086|NCT01543698|616788482|FG010|Phase 1b|Adverse Event|2|||
170665087|NCT01543698|616788483|FG011|Phase 1b|Adverse Event|0|||
170665088|NCT01543698|616788484|FG012|Phase 1b|Adverse Event|0|||
170665089|NCT01543698|616788485|FG013|Phase 1b|Adverse Event|0|||
170665090|NCT01543698|616788486|FG014|Phase 1b|Adverse Event|0|||
170665091|NCT01543698|616788472|FG000|Phase 1b|Administrative problems|1|||
170818300|NCT00070317|617341488|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
170818301|NCT00645411|617341489|FG000|Overall Study|Adverse Event|0|||
170818302|NCT00645411|617341490|FG001|Overall Study|Adverse Event|0|||
170818303|NCT00645411|617341491|FG002|Overall Study|Adverse Event|0|||
170818304|NCT00645411|617341492|FG003|Overall Study|Adverse Event|2|||
170818305|NCT00645411|617341489|FG000|Overall Study|Withdrawal by Subject|2|||
170818306|NCT00645411|617341490|FG001|Overall Study|Withdrawal by Subject|1|||
170818307|NCT00645411|617341491|FG002|Overall Study|Withdrawal by Subject|19|||
170818308|NCT00645411|617341492|FG003|Overall Study|Withdrawal by Subject|21|||
170818309|NCT00645411|617341489|FG000|Overall Study|Lost to Follow-up|10|||
170818310|NCT00645411|617341490|FG001|Overall Study|Lost to Follow-up|5|||
170665092|NCT01543698|616788473|FG001|Phase 1b|Administrative problems|0|||
170665093|NCT01543698|616788474|FG002|Phase 1b|Administrative problems|0|||
170665094|NCT01543698|616788475|FG003|Phase 1b|Administrative problems|0|||
170665095|NCT01543698|616788476|FG004|Phase 1b|Administrative problems|1|||
170665096|NCT01543698|616788477|FG005|Phase 1b|Administrative problems|0|||
170665097|NCT01543698|616788478|FG006|Phase 1b|Administrative problems|0|||
170665098|NCT01543698|616788479|FG007|Phase 1b|Administrative problems|1|||
170665099|NCT01543698|616788480|FG008|Phase 1b|Administrative problems|0|||
170665100|NCT01543698|616788481|FG009|Phase 1b|Administrative problems|0|||
170665101|NCT01543698|616788482|FG010|Phase 1b|Administrative problems|2|||
170665102|NCT01543698|616788483|FG011|Phase 1b|Administrative problems|0|||
170665103|NCT01543698|616788484|FG012|Phase 1b|Administrative problems|0|||
170665104|NCT01543698|616788485|FG013|Phase 1b|Administrative problems|0|||
170665105|NCT01543698|616788486|FG014|Phase 1b|Administrative problems|0|||
170665106|NCT01543698|616788472|FG000|Phase 1b|Protocol Violation|2|||
170665107|NCT01543698|616788473|FG001|Phase 1b|Protocol Violation|0|||
170665108|NCT01543698|616788474|FG002|Phase 1b|Protocol Violation|0|||
170665109|NCT01543698|616788475|FG003|Phase 1b|Protocol Violation|0|||
170665110|NCT01543698|616788476|FG004|Phase 1b|Protocol Violation|0|||
170665111|NCT01543698|616788477|FG005|Phase 1b|Protocol Violation|0|||
170665112|NCT01543698|616788478|FG006|Phase 1b|Protocol Violation|0|||
170665113|NCT01543698|616788479|FG007|Phase 1b|Protocol Violation|0|||
170665114|NCT01543698|616788480|FG008|Phase 1b|Protocol Violation|0|||
170665115|NCT01543698|616788481|FG009|Phase 1b|Protocol Violation|0|||
170665116|NCT01543698|616788482|FG010|Phase 1b|Protocol Violation|0|||
170665117|NCT01543698|616788483|FG011|Phase 1b|Protocol Violation|0|||
170665118|NCT01543698|616788484|FG012|Phase 1b|Protocol Violation|0|||
170665119|NCT01543698|616788485|FG013|Phase 1b|Protocol Violation|0|||
170818311|NCT00645411|617341491|FG002|Overall Study|Lost to Follow-up|124|||
170818312|NCT00645411|617341492|FG003|Overall Study|Lost to Follow-up|75|||
170818313|NCT00645411|617341489|FG000|Overall Study|Protocol Violation|1|||
170818314|NCT00645411|617341490|FG001|Overall Study|Protocol Violation|0|||
170665120|NCT01543698|616788486|FG014|Phase 1b|Protocol Violation|0|||
170665121|NCT01543698|616788472|FG000|Phase 2|Protocol Violation|0|||
170665122|NCT01543698|616788473|FG001|Phase 2|Protocol Violation|0|||
170665123|NCT01543698|616788474|FG002|Phase 2|Protocol Violation|0|||
170665124|NCT01543698|616788475|FG003|Phase 2|Protocol Violation|0|||
170665125|NCT01543698|616788476|FG004|Phase 2|Protocol Violation|0|||
170665126|NCT01543698|616788477|FG005|Phase 2|Protocol Violation|0|||
170665127|NCT01543698|616788478|FG006|Phase 2|Protocol Violation|0|||
170665128|NCT01543698|616788479|FG007|Phase 2|Protocol Violation|0|||
170665129|NCT01543698|616788480|FG008|Phase 2|Protocol Violation|0|||
170665130|NCT01543698|616788481|FG009|Phase 2|Protocol Violation|0|||
170665131|NCT01543698|616788482|FG010|Phase 2|Protocol Violation|0|||
170665132|NCT01543698|616788483|FG011|Phase 2|Protocol Violation|0|||
170665133|NCT01543698|616788484|FG012|Phase 2|Protocol Violation|1|||
170665134|NCT01543698|616788485|FG013|Phase 2|Protocol Violation|0|||
170665135|NCT01543698|616788486|FG014|Phase 2|Protocol Violation|0|||
170665136|NCT01543698|616788472|FG000|Phase 2|Disease progression|0|||
170665137|NCT01543698|616788473|FG001|Phase 2|Disease progression|0|||
170665138|NCT01543698|616788474|FG002|Phase 2|Disease progression|0|||
170665139|NCT01543698|616788475|FG003|Phase 2|Disease progression|0|||
170665140|NCT01543698|616788476|FG004|Phase 2|Disease progression|0|||
170665141|NCT01543698|616788477|FG005|Phase 2|Disease progression|0|||
170665142|NCT01543698|616788478|FG006|Phase 2|Disease progression|0|||
170665143|NCT01543698|616788479|FG007|Phase 2|Disease progression|0|||
170665144|NCT01543698|616788480|FG008|Phase 2|Disease progression|0|||
170665145|NCT01543698|616788481|FG009|Phase 2|Disease progression|0|||
170665146|NCT01543698|616788482|FG010|Phase 2|Disease progression|0|||
170665147|NCT01543698|616788483|FG011|Phase 2|Disease progression|10|||
170665148|NCT01543698|616788484|FG012|Phase 2|Disease progression|21|||
170665149|NCT01543698|616788485|FG013|Phase 2|Disease progression|30|||
170665150|NCT01543698|616788486|FG014|Phase 2|Disease progression|25|||
170665151|NCT01543698|616788472|FG000|Phase 2|Death|0|||
170665152|NCT01543698|616788473|FG001|Phase 2|Death|0|||
170665153|NCT01543698|616788474|FG002|Phase 2|Death|0|||
170665154|NCT01543698|616788475|FG003|Phase 2|Death|0|||
170665155|NCT01543698|616788476|FG004|Phase 2|Death|0|||
170665156|NCT01543698|616788477|FG005|Phase 2|Death|0|||
170665157|NCT01543698|616788478|FG006|Phase 2|Death|0|||
170665158|NCT01543698|616788479|FG007|Phase 2|Death|0|||
170665159|NCT01543698|616788480|FG008|Phase 2|Death|0|||
170665160|NCT01543698|616788481|FG009|Phase 2|Death|0|||
170665161|NCT01543698|616788482|FG010|Phase 2|Death|0|||
170665162|NCT01543698|616788483|FG011|Phase 2|Death|0|||
170665163|NCT01543698|616788484|FG012|Phase 2|Death|1|||
170665164|NCT01543698|616788485|FG013|Phase 2|Death|1|||
170665165|NCT01543698|616788486|FG014|Phase 2|Death|1|||
170665166|NCT01543698|616788472|FG000|Phase 2|Administrative problems|0|||
170665167|NCT01543698|616788473|FG001|Phase 2|Administrative problems|0|||
170665168|NCT01543698|616788474|FG002|Phase 2|Administrative problems|0|||
170665169|NCT01543698|616788475|FG003|Phase 2|Administrative problems|0|||
170665170|NCT01543698|616788476|FG004|Phase 2|Administrative problems|0|||
170665171|NCT01543698|616788477|FG005|Phase 2|Administrative problems|0|||
170665172|NCT01543698|616788478|FG006|Phase 2|Administrative problems|0|||
170665173|NCT01543698|616788479|FG007|Phase 2|Administrative problems|0|||
170818315|NCT00645411|617341491|FG002|Overall Study|Protocol Violation|1|||
170818316|NCT00645411|617341492|FG003|Overall Study|Protocol Violation|0|||
170818317|NCT00645411|617341489|FG000|Overall Study|Inappropriate enrollment|0|||
170818318|NCT00645411|617341490|FG001|Overall Study|Inappropriate enrollment|0|||
170818319|NCT00645411|617341491|FG002|Overall Study|Inappropriate enrollment|4|||
170818320|NCT00645411|617341492|FG003|Overall Study|Inappropriate enrollment|1|||
170818321|NCT00645411|617341489|FG000|Overall Study|Unable to classify|0|||
170818322|NCT00645411|617341490|FG001|Overall Study|Unable to classify|0|||
170818323|NCT00645411|617341491|FG002|Overall Study|Unable to classify|3|||
170818324|NCT00645411|617341492|FG003|Overall Study|Unable to classify|4|||
170665174|NCT01543698|616788480|FG008|Phase 2|Administrative problems|0|||
170665175|NCT01543698|616788481|FG009|Phase 2|Administrative problems|0|||
170665176|NCT01543698|616788482|FG010|Phase 2|Administrative problems|0|||
170665177|NCT01543698|616788483|FG011|Phase 2|Administrative problems|0|||
170665178|NCT01543698|616788484|FG012|Phase 2|Administrative problems|0|||
170665179|NCT01543698|616788485|FG013|Phase 2|Administrative problems|3|||
170665180|NCT01543698|616788486|FG014|Phase 2|Administrative problems|1|||
170665181|NCT01543698|616788472|FG000|Phase 2|Withdrawal by Subject|0|||
170665182|NCT01543698|616788473|FG001|Phase 2|Withdrawal by Subject|0|||
170665183|NCT01543698|616788474|FG002|Phase 2|Withdrawal by Subject|0|||
170665184|NCT01543698|616788475|FG003|Phase 2|Withdrawal by Subject|0|||
170665185|NCT01543698|616788476|FG004|Phase 2|Withdrawal by Subject|0|||
170665186|NCT01543698|616788477|FG005|Phase 2|Withdrawal by Subject|0|||
170665187|NCT01543698|616788478|FG006|Phase 2|Withdrawal by Subject|0|||
170665188|NCT01543698|616788479|FG007|Phase 2|Withdrawal by Subject|0|||
170665189|NCT01543698|616788480|FG008|Phase 2|Withdrawal by Subject|0|||
170818325|NCT03987074|617341497|FG000|Overall Study|Withdrew Consent|1|||
170818326|NCT03987074|617341498|FG001|Overall Study|Withdrew Consent|1|||
170818327|NCT03987074|617341499|FG002|Overall Study|Withdrew Consent|0|||
170665190|NCT01543698|616788481|FG009|Phase 2|Withdrawal by Subject|0|||
170665191|NCT01543698|616788482|FG010|Phase 2|Withdrawal by Subject|0|||
170665192|NCT01543698|616788483|FG011|Phase 2|Withdrawal by Subject|0|||
170665193|NCT01543698|616788484|FG012|Phase 2|Withdrawal by Subject|0|||
170665194|NCT01543698|616788485|FG013|Phase 2|Withdrawal by Subject|3|||
170665195|NCT01543698|616788486|FG014|Phase 2|Withdrawal by Subject|1|||
170665196|NCT01543698|616788472|FG000|Phase 2|Adverse Event|0|||
170665197|NCT01543698|616788473|FG001|Phase 2|Adverse Event|0|||
170665198|NCT01543698|616788474|FG002|Phase 2|Adverse Event|0|||
170665199|NCT01543698|616788475|FG003|Phase 2|Adverse Event|0|||
170665200|NCT01543698|616788476|FG004|Phase 2|Adverse Event|0|||
170665201|NCT01543698|616788477|FG005|Phase 2|Adverse Event|0|||
170665202|NCT01543698|616788478|FG006|Phase 2|Adverse Event|0|||
170665203|NCT01543698|616788479|FG007|Phase 2|Adverse Event|0|||
170665204|NCT01543698|616788480|FG008|Phase 2|Adverse Event|0|||
170665205|NCT01543698|616788481|FG009|Phase 2|Adverse Event|0|||
170665206|NCT01543698|616788482|FG010|Phase 2|Adverse Event|0|||
170665207|NCT01543698|616788483|FG011|Phase 2|Adverse Event|1|||
170665208|NCT01543698|616788484|FG012|Phase 2|Adverse Event|3|||
170665209|NCT01543698|616788485|FG013|Phase 2|Adverse Event|5|||
170665210|NCT01543698|616788486|FG014|Phase 2|Adverse Event|14|||
170665211|NCT00217620|616788487|FG000|Overall Study|Adverse Event|2|||
170665212|NCT00217620|616788487|FG000|Overall Study|Progression|31|||
170665213|NCT00217620|616788487|FG000|Overall Study|Not Protocol Specified|4|||
170665214|NCT00217620|616788487|FG000|Overall Study|Ineligible|13|||
170665215|NCT00217620|616788487|FG000|Overall Study|Never received treatment|1|||
170665216|NCT02699697|616788493|FG000|Overall Study|Death|18|||
170665217|NCT02699697|616788494|FG001|Overall Study|Death|15|||
170665218|NCT02699697|616788493|FG000|Overall Study|Physician Decision|0|||
170665219|NCT02699697|616788494|FG001|Overall Study|Physician Decision|1|||
170665220|NCT02699697|616788493|FG000|Overall Study|Lost to Follow-up|2|||
170665221|NCT02699697|616788494|FG001|Overall Study|Lost to Follow-up|3|||
170665222|NCT02699697|616788493|FG000|Overall Study|Refused to follow up|1|||
170665223|NCT02699697|616788494|FG001|Overall Study|Refused to follow up|1|||
170665224|NCT02699697|616788493|FG000|Overall Study|Entered hospice care|5|||
170665225|NCT02699697|616788494|FG001|Overall Study|Entered hospice care|2|||
170665226|NCT02699697|616788493|FG000|Overall Study|Missing reason for discontinuation|6|||
170665227|NCT02699697|616788494|FG001|Overall Study|Missing reason for discontinuation|5|||
170665228|NCT03270644|616788495|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
170665229|NCT03270644|616788495|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
170665230|NCT00354614|616788496|FG000|Overall Study|Lack of Efficacy|28|||
170665231|NCT00573937|616788497|FG000|Overall Study|Study Terminated|0|||
170665232|NCT00573937|616788498|FG001|Overall Study|Study Terminated|1|||
170665233|NCT02476201|616788499|FG000|Overall Study|Unable to program MPP|9|||
170665234|NCT02476201|616788499|FG000|Overall Study|Study echo not performed|5|||
170665235|NCT02476201|616788499|FG000|Overall Study|Adverse Event|4|||
170665236|NCT02476201|616788499|FG000|Overall Study|Death|2|||
170665237|NCT02476201|616788499|FG000|Overall Study|Lost to Follow-up|2|||
170665238|NCT02476201|616788499|FG000|Overall Study|MPP programmed to OFF|2|||
170665239|NCT02476201|616788499|FG000|Overall Study|Withdrawal by Subject|1|||
170665240|NCT02476201|616788499|FG000|Overall Study|Unsuccessful implant|1|||
170665241|NCT01823146|616788500|FG000|Overall Study|Withdrawal by Subject|0|||
170665242|NCT01823146|616788501|FG001|Overall Study|Withdrawal by Subject|1|||
170665243|NCT01823146|616788500|FG000|Overall Study|Lost to Follow-up|2|||
170665244|NCT01823146|616788501|FG001|Overall Study|Lost to Follow-up|1|||
170665245|NCT01797731|616788507|FG000|Overall Study|Didn't have proper radiographs required|3|||
170665246|NCT01797731|616788508|FG001|Overall Study|Didn't have proper radiographs required|3|||
170665247|NCT01604408|616788509|FG000|Treatment Period 1|Protocol Violation|0|||
170665248|NCT01604408|616788510|FG001|Treatment Period 1|Protocol Violation|1|||
170665249|NCT01604408|616788509|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170665250|NCT01604408|616788510|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170665251|NCT01604408|616788509|FG000|Treatment Period 2|Protocol Violation|1|||
170665252|NCT01604408|616788510|FG001|Treatment Period 2|Protocol Violation|0|||
170665253|NCT01604408|616788509|FG000|Treatment Period 2|Adverse Event|0|||
170665254|NCT01604408|616788510|FG001|Treatment Period 2|Adverse Event|1|||
170665255|NCT01604408|616788509|FG000|Treatment Period 3|Protocol Violation|1|||
170665256|NCT01604408|616788510|FG001|Treatment Period 3|Protocol Violation|1|||
170665257|NCT01604408|616788509|FG000|Treatment Period 3|Adverse Event|0|||
170665258|NCT01604408|616788510|FG001|Treatment Period 3|Adverse Event|3|||
170665259|NCT01604408|616788509|FG000|Treatment Period 3|Withdrawal by Subject|3|||
170665260|NCT01604408|616788510|FG001|Treatment Period 3|Withdrawal by Subject|1|||
170665261|NCT01604408|616788509|FG000|Treatment Period 3|Sponsor Decision|1|||
170665262|NCT01604408|616788510|FG001|Treatment Period 3|Sponsor Decision|0|||
170665263|NCT01604408|616788509|FG000|Treatment Period 4|Death|1|||
170665264|NCT01604408|616788510|FG001|Treatment Period 4|Death|0|||
170665265|NCT01604408|616788509|FG000|Treatment Period 4|Withdrawal by Subject|2|||
170665266|NCT01604408|616788510|FG001|Treatment Period 4|Withdrawal by Subject|1|||
170665267|NCT01604408|616788509|FG000|Treatment Period 4|Adverse Event|0|||
170665268|NCT01604408|616788510|FG001|Treatment Period 4|Adverse Event|1|||
170665269|NCT01604408|616788509|FG000|Treatment Period 5|Adverse Event|4|||
170665270|NCT01604408|616788510|FG001|Treatment Period 5|Adverse Event|0|||
170665271|NCT01604408|616788509|FG000|Treatment Period 6|Lost to Follow-up|0|||
170665272|NCT01604408|616788510|FG001|Treatment Period 6|Lost to Follow-up|1|||
170665273|NCT01604408|616788509|FG000|Treatment Period 6|Adverse Event|2|||
170665274|NCT01604408|616788510|FG001|Treatment Period 6|Adverse Event|0|||
170665275|NCT01604408|616788509|FG000|Treatment Period 6|Sponsor decision|0|||
170665276|NCT01604408|616788510|FG001|Treatment Period 6|Sponsor decision|1|||
170665277|NCT01604408|616788509|FG000|Observation Period|Adverse Event|1|||
170665278|NCT01604408|616788510|FG001|Observation Period|Adverse Event|1|||
170665279|NCT01604408|616788509|FG000|Observation Period|Withdrawal by Subject|0|||
170665280|NCT01604408|616788510|FG001|Observation Period|Withdrawal by Subject|2|||
170665281|NCT00075218|616788512|FG000|Double-Blind Treatment|Adverse Event|23|||
170665282|NCT00075218|616788513|FG001|Double-Blind Treatment|Adverse Event|4|||
170665283|NCT00075218|616788514|FG002|Double-Blind Treatment|Adverse Event|0|||
170665284|NCT00075218|616788512|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
170665285|NCT00075218|616788513|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
170665286|NCT00075218|616788514|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
170665287|NCT00075218|616788512|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
170665288|NCT00075218|616788513|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
170665289|NCT00075218|616788514|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
170665290|NCT00075218|616788512|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
170665291|NCT00075218|616788513|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
170665292|NCT00075218|616788514|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
170665293|NCT00075218|616788512|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
170665294|NCT00075218|616788513|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
170665295|NCT00075218|616788514|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
170665296|NCT00075218|616788512|FG000|Double-Blind Treatment|No study medication taken|2|||
170665297|NCT00075218|616788513|FG001|Double-Blind Treatment|No study medication taken|0|||
170665298|NCT00075218|616788514|FG002|Double-Blind Treatment|No study medication taken|0|||
170665299|NCT00075218|616788512|FG000|Open-Label Treatment|Lack of Efficacy|0|||
170665300|NCT00075218|616788513|FG001|Open-Label Treatment|Lack of Efficacy|0|||
170665301|NCT00075218|616788514|FG002|Open-Label Treatment|Lack of Efficacy|174|||
170665302|NCT00075218|616788512|FG000|Open-Label Treatment|Adverse Event|0|||
170665303|NCT00075218|616788513|FG001|Open-Label Treatment|Adverse Event|0|||
170665304|NCT00075218|616788514|FG002|Open-Label Treatment|Adverse Event|51|||
170665305|NCT00075218|616788512|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
170665306|NCT00075218|616788513|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
170665307|NCT00075218|616788514|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
170665308|NCT00075218|616788512|FG000|Open-Label Treatment|Decision of Sponsor|0|||
170665309|NCT00075218|616788513|FG001|Open-Label Treatment|Decision of Sponsor|0|||
170665310|NCT00075218|616788514|FG002|Open-Label Treatment|Decision of Sponsor|8|||
170665311|NCT00075218|616788512|FG000|Open-Label Treatment|Protocol Violation|0|||
170665312|NCT00075218|616788513|FG001|Open-Label Treatment|Protocol Violation|0|||
170665313|NCT00075218|616788514|FG002|Open-Label Treatment|Protocol Violation|1|||
170665314|NCT00075218|616788512|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
170665315|NCT00075218|616788513|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
170818328|NCT03987074|617341500|FG003|Overall Study|Withdrew Consent|2|||
170818329|NCT03987074|617341501|FG004|Overall Study|Withdrew Consent|1|||
170818330|NCT03987074|617341497|FG000|Overall Study|Adverse Event|2|||
170818331|NCT03987074|617341498|FG001|Overall Study|Adverse Event|1|||
170818332|NCT03987074|617341499|FG002|Overall Study|Adverse Event|0|||
170818333|NCT03987074|617341500|FG003|Overall Study|Adverse Event|0|||
170818334|NCT03987074|617341501|FG004|Overall Study|Adverse Event|1|||
170818335|NCT03987074|617341497|FG000|Overall Study|Lost to Follow-up|0|||
170818336|NCT03987074|617341498|FG001|Overall Study|Lost to Follow-up|0|||
170818337|NCT03987074|617341499|FG002|Overall Study|Lost to Follow-up|1|||
170818338|NCT03987074|617341500|FG003|Overall Study|Lost to Follow-up|1|||
170818339|NCT03987074|617341501|FG004|Overall Study|Lost to Follow-up|0|||
170818340|NCT03987074|617341497|FG000|Overall Study|Investigator's Discretion|0|||
170818341|NCT03987074|617341498|FG001|Overall Study|Investigator's Discretion|0|||
170917478|NCT05197426|617697962|FG001|Follow Up|Death|2|||
170917479|NCT05197426|617697961|FG000|Follow Up|Withdrawal by Subject|0|||
170665316|NCT00075218|616788514|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
170665317|NCT00722423|616788517|FG000|Overall Study|Protocol Violation|0|||
170665318|NCT00722423|616788518|FG001|Overall Study|Protocol Violation|1|||
170665319|NCT03643575|616788519|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
170665320|NCT03643575|616788520|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
170665321|NCT03643575|616788521|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
170665322|NCT03643575|616788522|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
170665323|NCT03643575|616788523|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
170818342|NCT03987074|617341499|FG002|Overall Study|Investigator's Discretion|0|||
170818343|NCT03987074|617341500|FG003|Overall Study|Investigator's Discretion|1|||
170818344|NCT03987074|617341501|FG004|Overall Study|Investigator's Discretion|0|||
170818345|NCT03100370|617341502|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170818346|NCT03100370|617341503|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170665324|NCT03643575|616788524|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
170665325|NCT03643575|616788519|FG000|Washout: 7 Days|Adverse Event|1|||
170665326|NCT03643575|616788520|FG001|Washout: 7 Days|Adverse Event|0|||
170665327|NCT03643575|616788521|FG002|Washout: 7 Days|Adverse Event|0|||
170665328|NCT03643575|616788522|FG003|Washout: 7 Days|Adverse Event|0|||
170665329|NCT03643575|616788523|FG004|Washout: 7 Days|Adverse Event|0|||
170665330|NCT03643575|616788524|FG005|Washout: 7 Days|Adverse Event|0|||
170665331|NCT03643575|616788519|FG000|Washout: 7 Days|Non compliance check in|0|||
170665332|NCT03643575|616788520|FG001|Washout: 7 Days|Non compliance check in|1|||
170665333|NCT03643575|616788521|FG002|Washout: 7 Days|Non compliance check in|0|||
170665334|NCT03643575|616788522|FG003|Washout: 7 Days|Non compliance check in|0|||
170665335|NCT03643575|616788523|FG004|Washout: 7 Days|Non compliance check in|0|||
170665336|NCT03643575|616788524|FG005|Washout: 7 Days|Non compliance check in|0|||
170665337|NCT00131508|616788525|FG000|Overall Study|Disease progression|0|||
170665338|NCT00131508|616788526|FG001|Overall Study|Disease progression|2|||
170665339|NCT00131508|616788525|FG000|Overall Study|Non-Compliance|2|||
170665340|NCT00131508|616788526|FG001|Overall Study|Non-Compliance|4|||
170665341|NCT00131508|616788525|FG000|Overall Study|Withdrawal by Subject|1|||
170665342|NCT00131508|616788526|FG001|Overall Study|Withdrawal by Subject|2|||
170665343|NCT01189604|616788528|FG000|Overall Study|Impossible to visit|0|||
170665344|NCT01189604|616788529|FG001|Overall Study|Impossible to visit|0|||
170665345|NCT01189604|616788530|FG002|Overall Study|Impossible to visit|0|||
170665346|NCT01189604|616788531|FG003|Overall Study|Impossible to visit|0|||
170665347|NCT01189604|616788532|FG004|Overall Study|Impossible to visit|0|||
170665348|NCT01189604|616788533|FG005|Overall Study|Impossible to visit|1|||
170665349|NCT01189604|616788534|FG006|Overall Study|Impossible to visit|0|||
170665350|NCT01189604|616788528|FG000|Overall Study|Adverse Event|0|||
170665351|NCT01189604|616788529|FG001|Overall Study|Adverse Event|1|||
170665352|NCT01189604|616788530|FG002|Overall Study|Adverse Event|0|||
170665353|NCT01189604|616788531|FG003|Overall Study|Adverse Event|0|||
170665354|NCT01189604|616788532|FG004|Overall Study|Adverse Event|2|||
170665355|NCT01189604|616788533|FG005|Overall Study|Adverse Event|0|||
170665356|NCT01189604|616788534|FG006|Overall Study|Adverse Event|1|||
170665357|NCT01189604|616788528|FG000|Overall Study|Withdrawal by Subject|1|||
170917480|NCT05197426|617697962|FG001|Follow Up|Withdrawal by Subject|1|||
170917481|NCT06597344|617697965|FG000|Overall Study|Lost to Follow-up|1|||
170917482|NCT02445391|617697967|FG000|Overall Study|No active protocol treatment|3|||
170917483|NCT02445391|617697968|FG001|Overall Study|No active protocol treatment|0|||
170665358|NCT01189604|616788529|FG001|Overall Study|Withdrawal by Subject|0|||
170665359|NCT01189604|616788530|FG002|Overall Study|Withdrawal by Subject|0|||
170665360|NCT01189604|616788531|FG003|Overall Study|Withdrawal by Subject|0|||
170665361|NCT01189604|616788532|FG004|Overall Study|Withdrawal by Subject|0|||
170665362|NCT01189604|616788533|FG005|Overall Study|Withdrawal by Subject|0|||
170665363|NCT01189604|616788534|FG006|Overall Study|Withdrawal by Subject|0|||
170665364|NCT00737438|616788535|FG000|Overall Study|Withdrawal by Subject|2|||
170665365|NCT00737438|616788535|FG000|Overall Study|Patient ineligible|1|||
170665366|NCT00986830|616788536|FG000|Overall Study|Death|1|||
170665367|NCT00986830|616788536|FG000|Overall Study|Lost to Follow-up|1|||
170665368|NCT00986830|616788536|FG000|Overall Study|Lack of Efficacy|1|||
170665369|NCT00986830|616788536|FG000|Overall Study|Unable to access sinus with device|5|||
170665370|NCT01495975|616788537|FG000|Overall Study|Lost to Follow-up|1|||
170665371|NCT01495975|616788538|FG001|Overall Study|Lost to Follow-up|0|||
170665372|NCT00845858|616788539|FG000|Overall Study|Withdrawal by Subject|5|||
170665373|NCT00845858|616788540|FG001|Overall Study|Withdrawal by Subject|1|||
170665374|NCT00845858|616788541|FG002|Overall Study|Withdrawal by Subject|1|||
170665375|NCT00845858|616788539|FG000|Overall Study|Adverse Event|3|||
170665376|NCT00845858|616788540|FG001|Overall Study|Adverse Event|8|||
170665377|NCT00845858|616788541|FG002|Overall Study|Adverse Event|4|||
170665378|NCT00845858|616788539|FG000|Overall Study|Protocol Violation|0|||
170665379|NCT00845858|616788540|FG001|Overall Study|Protocol Violation|0|||
170665380|NCT00845858|616788541|FG002|Overall Study|Protocol Violation|1|||
170665381|NCT00845858|616788539|FG000|Overall Study|not eligible|0|||
170665382|NCT00845858|616788540|FG001|Overall Study|not eligible|3|||
170665383|NCT00845858|616788541|FG002|Overall Study|not eligible|2|||
170665384|NCT03945214|616788542|FG000|Overall Study|Lost to Follow-up|3|||
170665385|NCT03945214|616788543|FG001|Overall Study|Lost to Follow-up|4|||
170665386|NCT03945214|616788544|FG002|Overall Study|Lost to Follow-up|7|||
170665387|NCT03945214|616788545|FG003|Overall Study|Lost to Follow-up|4|||
170665388|NCT01436396|616788557|FG000|Overall Study|Protocol Violation|7|||
170665389|NCT01436396|616788558|FG001|Overall Study|Protocol Violation|5|||
170665390|NCT01436396|616788557|FG000|Overall Study|Adverse Event|1|||
170665391|NCT01436396|616788558|FG001|Overall Study|Adverse Event|2|||
170665392|NCT01436396|616788557|FG000|Overall Study|Withdrawal by Subject|19|||
170665393|NCT01436396|616788558|FG001|Overall Study|Withdrawal by Subject|29|||
170665394|NCT01436396|616788557|FG000|Overall Study|Serious adverse event|2|||
170665395|NCT01436396|616788558|FG001|Overall Study|Serious adverse event|3|||
170665396|NCT01436396|616788557|FG000|Overall Study|Lost to Follow-up|3|||
170665397|NCT01436396|616788558|FG001|Overall Study|Lost to Follow-up|3|||
170917484|NCT02445391|617697969|FG002|Overall Study|No active protocol treatment|0|||
170665398|NCT00875979|616788559|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
170665399|NCT00875979|616788560|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
170665400|NCT00875979|616788559|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
170665401|NCT00875979|616788560|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
170665402|NCT00875979|616788559|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
170665403|NCT00875979|616788560|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
170665404|NCT00875979|616788559|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
170665405|NCT00875979|616788560|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
170665406|NCT00875979|616788559|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
170665407|NCT00875979|616788560|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
170665408|NCT00875979|616788559|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
170665409|NCT00875979|616788560|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
170665410|NCT00875979|616788559|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
170665411|NCT00875979|616788560|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
170665412|NCT00875979|616788559|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
170665413|NCT00875979|616788560|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
170665414|NCT00875979|616788559|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
170665415|NCT00875979|616788560|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
170665416|NCT01696695|616788562|FG000|Overall Study|Disease progression|373|||
170665417|NCT01696695|616788562|FG000|Overall Study|Death|29|||
170665418|NCT01696695|616788562|FG000|Overall Study|Adverse Event|74|||
170665419|NCT01696695|616788562|FG000|Overall Study|Withdrawal by Subject|92|||
170665420|NCT01696695|616788562|FG000|Overall Study|Lost to Follow-up|48|||
170665421|NCT01696695|616788562|FG000|Overall Study|Other|74|||
170665422|NCT01696695|616788562|FG000|Overall Study|Major Protocol Violation|192|||
170665423|NCT01904058|616788567|FG000|Overall Study|Adverse Event|2|||
170665424|NCT01904058|616788568|FG001|Overall Study|Adverse Event|0|||
170665425|NCT01904058|616788569|FG002|Overall Study|Adverse Event|0|||
170665426|NCT01904058|616788570|FG003|Overall Study|Adverse Event|0|||
170665427|NCT01904058|616788567|FG000|Overall Study|Withdrawal by Subject|1|||
170665428|NCT01904058|616788568|FG001|Overall Study|Withdrawal by Subject|0|||
170665429|NCT01904058|616788569|FG002|Overall Study|Withdrawal by Subject|1|||
170665430|NCT01904058|616788570|FG003|Overall Study|Withdrawal by Subject|0|||
170665431|NCT01904058|616788567|FG000|Overall Study|Pregnancy|0|||
170665432|NCT01904058|616788568|FG001|Overall Study|Pregnancy|0|||
170665433|NCT01904058|616788569|FG002|Overall Study|Pregnancy|0|||
170665434|NCT01904058|616788570|FG003|Overall Study|Pregnancy|1|||
170665435|NCT04102098|616788571|FG000|Main Study Period|Ongoing in study|302|||
170665436|NCT04102098|616788572|FG001|Main Study Period|Ongoing in study|291|||
170665437|NCT04102098|616788571|FG000|Main Study Period|Death|20|||
170665438|NCT04102098|616788572|FG001|Main Study Period|Death|27|||
170665439|NCT04102098|616788571|FG000|Main Study Period|Lost to Follow-up|1|||
170818347|NCT03100370|617341504|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170818348|NCT03100370|617341505|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
170818349|NCT03100370|617341506|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170818350|NCT03100370|617341507|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170818351|NCT00508144|617341508|FG000|Overall Study|Not eligible|6|||
170818352|NCT00508144|617341508|FG000|Overall Study|Death|5|||
170818353|NCT01661972|617341509|FG000|Overall Study|Adverse Event|1|||
170818354|NCT01661972|617341510|FG001|Overall Study|Adverse Event|2|||
170818355|NCT01661972|617341509|FG000|Overall Study|Death during Treatment period|1|||
170818356|NCT01661972|617341510|FG001|Overall Study|Death during Treatment period|1|||
170818357|NCT01661972|617341509|FG000|Overall Study|Withdrawal by Subject|0|||
170818358|NCT01661972|617341510|FG001|Overall Study|Withdrawal by Subject|1|||
170818359|NCT02138838|617341511|FG000|Overall Study|Study Closure|7|||
170818360|NCT02138838|617341512|FG001|Overall Study|Study Closure|6|||
170818361|NCT02138838|617341511|FG000|Overall Study|Withdrawal by Subject|1|||
170818362|NCT02138838|617341512|FG001|Overall Study|Withdrawal by Subject|5|||
170818363|NCT01084772|617341515|FG000|Baseline|Withdrawal by Subject|7|||
170665440|NCT04102098|616788572|FG001|Main Study Period|Lost to Follow-up|1|||
170665441|NCT04102098|616788571|FG000|Main Study Period|Physician Decision|0|||
170665442|NCT04102098|616788572|FG001|Main Study Period|Physician Decision|1|||
170665443|NCT04102098|616788571|FG000|Main Study Period|Withdrawal by Subject|11|||
170665444|NCT04102098|616788572|FG001|Main Study Period|Withdrawal by Subject|14|||
170665445|NCT04102098|616788571|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
170665446|NCT04102098|616788572|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
170818364|NCT01084772|617341516|FG001|Baseline|Withdrawal by Subject|6|||
170818365|NCT01084772|617341515|FG000|3 Months|Death|1|||
170818366|NCT01084772|617341516|FG001|3 Months|Death|0|||
170818367|NCT01084772|617341515|FG000|3 Months|Study Termination|2|||
170818368|NCT01084772|617341516|FG001|3 Months|Study Termination|2|||
170818369|NCT01084772|617341515|FG000|1 Year|Withdrawal by Subject|0|||
170617466|NCT00479713|616606997|FG000|Overall Study|Withdrawal by Subject|4|||
170617467|NCT00479713|616606998|FG001|Overall Study|Withdrawal by Subject|1|||
170617468|NCT05907395|616606999|FG000|Period 1|No longer met eligibility criteria|0|||
170818370|NCT01084772|617341516|FG001|1 Year|Withdrawal by Subject|1|||
170818371|NCT01084772|617341515|FG000|1 Year|Lost to Follow-up|3|||
170617469|NCT05907395|616607000|FG001|Period 1|No longer met eligibility criteria|1|||
170617470|NCT05907395|616607001|FG002|Period 1|No longer met eligibility criteria|0|||
170617471|NCT05907395|616607002|FG003|Period 1|No longer met eligibility criteria|0|||
170617472|NCT05907395|616607003|FG004|Period 1|No longer met eligibility criteria|0|||
170617473|NCT05907395|616607004|FG005|Period 1|No longer met eligibility criteria|1|||
170617474|NCT05907395|616607005|FG006|Period 1|No longer met eligibility criteria|1|||
170617475|NCT05907395|616607006|FG007|Period 1|No longer met eligibility criteria|0|||
170617476|NCT05907395|616607007|FG008|Period 1|No longer met eligibility criteria|0|||
170617477|NCT05907395|616607008|FG009|Period 1|No longer met eligibility criteria|0|||
170617478|NCT05907395|616607009|FG010|Period 1|No longer met eligibility criteria|0|||
170617479|NCT05907395|616607010|FG011|Period 1|No longer met eligibility criteria|0|||
170617480|NCT05907395|616606999|FG000|Period 2|Adverse Event|0|||
170617481|NCT05907395|616607000|FG001|Period 2|Adverse Event|0|||
170617482|NCT05907395|616607001|FG002|Period 2|Adverse Event|0|||
170617483|NCT05907395|616607002|FG003|Period 2|Adverse Event|1|||
170617484|NCT05907395|616607003|FG004|Period 2|Adverse Event|0|||
170617485|NCT05907395|616607004|FG005|Period 2|Adverse Event|0|||
170617486|NCT05907395|616607005|FG006|Period 2|Adverse Event|0|||
170617487|NCT05907395|616607006|FG007|Period 2|Adverse Event|1|||
170818372|NCT01084772|617341516|FG001|1 Year|Lost to Follow-up|0|||
170818373|NCT01084772|617341515|FG000|1 Year|Study Termination|0|||
170818374|NCT01084772|617341516|FG001|1 Year|Study Termination|7|||
170818375|NCT01084772|617341515|FG000|2 Years|Withdrawal by Subject|1|||
170818376|NCT01084772|617341516|FG001|2 Years|Withdrawal by Subject|0|||
170818377|NCT01084772|617341515|FG000|2 Years|Lost to Follow-up|5|||
170818378|NCT01084772|617341516|FG001|2 Years|Lost to Follow-up|2|||
170818379|NCT01084772|617341515|FG000|2 Years|Study Termination|3|||
170818380|NCT01084772|617341516|FG001|2 Years|Study Termination|2|||
170818381|NCT01867307|617341517|FG000|Overall Study|Protocol Violation|2|||
170818382|NCT01867307|617341518|FG001|Overall Study|Protocol Violation|0|||
170818383|NCT01867307|617341517|FG000|Overall Study|Other Adverse Event|1|||
170818384|NCT01867307|617341518|FG001|Overall Study|Other Adverse Event|3|||
170818385|NCT02009865|617341525|FG000|Overall Study|Adverse Event|0|||
170818386|NCT02009865|617341526|FG001|Overall Study|Adverse Event|2|||
170818387|NCT02009865|617341525|FG000|Overall Study|Protocol Violation|0|||
170818388|NCT02009865|617341526|FG001|Overall Study|Protocol Violation|2|||
170818389|NCT02009865|617341525|FG000|Overall Study|Withdrawal by Subject|1|||
170818390|NCT02009865|617341526|FG001|Overall Study|Withdrawal by Subject|1|||
170818391|NCT01760876|617341527|FG000|Overall Study|Non-cardiac death (head injury)|1|||
170818392|NCT01760876|617341527|FG000|Overall Study|Carcinoma of prostate|1|||
170818393|NCT01760876|617341527|FG000|Overall Study|Impaired renal function|1|||
170818394|NCT01760876|617341527|FG000|Overall Study|Major depression|1|||
170818395|NCT01760876|617341527|FG000|Overall Study|Very poor baseline OCT quality|2|||
170818396|NCT00267865|617341530|FG000|Induction Treatment|Died before completing.|2|||
170818397|NCT00267865|617341530|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
170818398|NCT03122548|617341536|FG000|Overall Study|Death|2|||
170818399|NCT03122548|617341536|FG000|Overall Study|Progression - subject went into hospice|1|||
170818400|NCT03122548|617341536|FG000|Overall Study|Study Terminated by Sponsor|2|||
170818401|NCT01199302|617341540|FG000|Overall Study|Adverse Event|1|||
170818402|NCT01199302|617341541|FG001|Overall Study|Adverse Event|1|||
170818403|NCT01199302|617341542|FG002|Overall Study|Adverse Event|2|||
170818404|NCT01199302|617341543|FG003|Overall Study|Adverse Event|0|||
170818405|NCT01199302|617341540|FG000|Overall Study|Withdrawal by Subject|2|||
170818406|NCT01199302|617341541|FG001|Overall Study|Withdrawal by Subject|2|||
170818407|NCT01199302|617341542|FG002|Overall Study|Withdrawal by Subject|3|||
170818408|NCT01199302|617341543|FG003|Overall Study|Withdrawal by Subject|0|||
170818409|NCT01199302|617341540|FG000|Overall Study|Disease Progression|3|||
170617488|NCT05907395|616607007|FG008|Period 2|Adverse Event|0|||
170818410|NCT01199302|617341541|FG001|Overall Study|Disease Progression|4|||
170818411|NCT01199302|617341542|FG002|Overall Study|Disease Progression|4|||
170818412|NCT01199302|617341543|FG003|Overall Study|Disease Progression|2|||
170818413|NCT01199302|617341540|FG000|Overall Study|Study Termination|13|||
170818414|NCT01199302|617341541|FG001|Overall Study|Study Termination|8|||
170818415|NCT01199302|617341542|FG002|Overall Study|Study Termination|11|||
170818416|NCT01199302|617341543|FG003|Overall Study|Study Termination|9|||
170818417|NCT01199302|617341540|FG000|Overall Study|Lost to Follow-up|0|||
170818418|NCT01199302|617341541|FG001|Overall Study|Lost to Follow-up|1|||
170818419|NCT01199302|617341542|FG002|Overall Study|Lost to Follow-up|0|||
170818420|NCT01199302|617341543|FG003|Overall Study|Lost to Follow-up|0|||
170818421|NCT01199302|617341540|FG000|Overall Study|Other|1|||
170818422|NCT01199302|617341541|FG001|Overall Study|Other|0|||
170818423|NCT01199302|617341542|FG002|Overall Study|Other|0|||
170818424|NCT01199302|617341543|FG003|Overall Study|Other|0|||
170665447|NCT04102098|616788571|FG000|Crossover: AS Who Crossed Over|Death|11|||
170665448|NCT04102098|616788572|FG001|Crossover: AS Who Crossed Over|Death|0|||
170665449|NCT04102098|616788571|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
170665450|NCT04102098|616788572|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
170665451|NCT01254292|616788576|FG000|Comparative Phase|Adverse Event|25|||
170665452|NCT01254292|616788577|FG001|Comparative Phase|Adverse Event|25|||
170665453|NCT01254292|616788576|FG000|Comparative Phase|Lost to Follow-up|3|||
170665454|NCT01254292|616788577|FG001|Comparative Phase|Lost to Follow-up|21|||
170665455|NCT01254292|616788576|FG000|Comparative Phase|Pregnancy|2|||
170665456|NCT01254292|616788577|FG001|Comparative Phase|Pregnancy|6|||
170665457|NCT01254292|616788576|FG000|Comparative Phase|Withdrawal by Subject|20|||
170665458|NCT01254292|616788577|FG001|Comparative Phase|Withdrawal by Subject|21|||
170665459|NCT01254292|616788576|FG000|Comparative Phase|Protocol Violation|1|||
170665460|NCT01254292|616788577|FG001|Comparative Phase|Protocol Violation|2|||
170665461|NCT01254292|616788576|FG000|Comparative Phase|Wish for pregnancy|4|||
170665462|NCT01254292|616788577|FG001|Comparative Phase|Wish for pregnancy|6|||
170665463|NCT01254292|616788576|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
170665464|NCT01254292|616788577|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
170665465|NCT01254292|616788576|FG000|LCS12 Extension Phase|Adverse Event|9|||
170665466|NCT01254292|616788577|FG001|LCS12 Extension Phase|Adverse Event|0|||
170665467|NCT01254292|616788576|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
170665468|NCT01254292|616788577|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
170665469|NCT01254292|616788576|FG000|LCS12 Extension Phase|Other unknown|4|||
170665470|NCT01254292|616788577|FG001|LCS12 Extension Phase|Other unknown|0|||
170665471|NCT01254292|616788576|FG000|LCS12 Extension Phase|Pregnancy|2|||
170665472|NCT01254292|616788577|FG001|LCS12 Extension Phase|Pregnancy|0|||
170665473|NCT01254292|616788576|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
170665474|NCT01254292|616788577|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
170665475|NCT02633501|616788578|FG000|Overall Study|Adverse Event|0|||
170665476|NCT02633501|616788579|FG001|Overall Study|Adverse Event|0|||
170665477|NCT02633501|616788580|FG002|Overall Study|Adverse Event|1|||
170665478|NCT02633501|616788581|FG003|Overall Study|Adverse Event|0|||
170665479|NCT02633501|616788582|FG004|Overall Study|Adverse Event|1|||
170665480|NCT02633501|616788583|FG005|Overall Study|Adverse Event|1|||
170665481|NCT02633501|616788578|FG000|Overall Study|Withdrawal by Subject|2|||
170665482|NCT02633501|616788579|FG001|Overall Study|Withdrawal by Subject|1|||
170665483|NCT02633501|616788580|FG002|Overall Study|Withdrawal by Subject|2|||
170665484|NCT02633501|616788581|FG003|Overall Study|Withdrawal by Subject|2|||
170665485|NCT02633501|616788582|FG004|Overall Study|Withdrawal by Subject|1|||
170665486|NCT02633501|616788583|FG005|Overall Study|Withdrawal by Subject|3|||
170665487|NCT02633501|616788578|FG000|Overall Study|Various other reasons|0|||
170665488|NCT02633501|616788579|FG001|Overall Study|Various other reasons|2|||
170665489|NCT02633501|616788580|FG002|Overall Study|Various other reasons|4|||
170665490|NCT02633501|616788581|FG003|Overall Study|Various other reasons|1|||
170665491|NCT02633501|616788582|FG004|Overall Study|Various other reasons|7|||
170665492|NCT02633501|616788583|FG005|Overall Study|Various other reasons|11|||
170665493|NCT02633501|616788578|FG000|Overall Study|Lost to Follow-up|0|||
170665494|NCT02633501|616788579|FG001|Overall Study|Lost to Follow-up|0|||
170665495|NCT02633501|616788580|FG002|Overall Study|Lost to Follow-up|0|||
170665496|NCT02633501|616788581|FG003|Overall Study|Lost to Follow-up|1|||
170665497|NCT02633501|616788582|FG004|Overall Study|Lost to Follow-up|2|||
170665498|NCT02633501|616788583|FG005|Overall Study|Lost to Follow-up|0|||
170665499|NCT00395733|616788585|FG000|Period 2|Withdrawal by Subject|1|||
170665500|NCT00395733|616788586|FG001|Period 2|Withdrawal by Subject|2|||
170665501|NCT00395733|616788585|FG000|Period 2|Protocol Violation|0|||
170665502|NCT00395733|616788586|FG001|Period 2|Protocol Violation|1|||
170665503|NCT00395733|616788585|FG000|Period 2|Adverse Event|0|||
170665504|NCT00395733|616788586|FG001|Period 2|Adverse Event|2|||
170665505|NCT00395733|616788585|FG000|Period 2|Technical problems|1|||
170665506|NCT00395733|616788586|FG001|Period 2|Technical problems|0|||
170665507|NCT01986140|616788587|FG000|Overall Study|Withdrawal by Subject|31|||
170665508|NCT01986140|616788588|FG001|Overall Study|Withdrawal by Subject|25|||
170665509|NCT01986140|616788587|FG000|Overall Study|alternative treatment|1|||
170665510|NCT01986140|616788588|FG001|Overall Study|alternative treatment|1|||
170665511|NCT01986140|616788587|FG000|Overall Study|found not eligible|3|||
170665512|NCT01986140|616788588|FG001|Overall Study|found not eligible|0|||
170665513|NCT01986140|616788587|FG000|Overall Study|Adverse Event|0|||
170665514|NCT01986140|616788588|FG001|Overall Study|Adverse Event|1|||
170665515|NCT01986140|616788587|FG000|Overall Study|progression disease|0|||
170665516|NCT01986140|616788588|FG001|Overall Study|progression disease|1|||
170665517|NCT05055128|616788591|FG000|Overall Study|Adverse Event|0|||
170665518|NCT05055128|616788592|FG001|Overall Study|Adverse Event|0|||
170665519|NCT05055128|616788593|FG002|Overall Study|Adverse Event|0|||
170665520|NCT05055128|616788594|FG003|Overall Study|Adverse Event|1|||
170665521|NCT05055128|616788595|FG004|Overall Study|Adverse Event|1|||
170665522|NCT05055128|616788591|FG000|Overall Study|Protocol Violation|0|||
170665523|NCT05055128|616788592|FG001|Overall Study|Protocol Violation|0|||
170665524|NCT05055128|616788593|FG002|Overall Study|Protocol Violation|0|||
170665525|NCT05055128|616788594|FG003|Overall Study|Protocol Violation|1|||
170665526|NCT05055128|616788595|FG004|Overall Study|Protocol Violation|0|||
170665527|NCT05055128|616788591|FG000|Overall Study|Withdrawal by Subject|5|||
170665528|NCT05055128|616788592|FG001|Overall Study|Withdrawal by Subject|2|||
170665529|NCT05055128|616788593|FG002|Overall Study|Withdrawal by Subject|2|||
170665530|NCT05055128|616788594|FG003|Overall Study|Withdrawal by Subject|4|||
170665531|NCT05055128|616788595|FG004|Overall Study|Withdrawal by Subject|2|||
170665532|NCT05055128|616788591|FG000|Overall Study|Randomized By Mistake|0|||
170665533|NCT05055128|616788592|FG001|Overall Study|Randomized By Mistake|1|||
170665534|NCT05055128|616788593|FG002|Overall Study|Randomized By Mistake|0|||
170665535|NCT05055128|616788594|FG003|Overall Study|Randomized By Mistake|0|||
170665536|NCT05055128|616788595|FG004|Overall Study|Randomized By Mistake|0|||
170665537|NCT05055128|616788591|FG000|Overall Study|Other|1|||
170665538|NCT05055128|616788592|FG001|Overall Study|Other|0|||
170665539|NCT05055128|616788593|FG002|Overall Study|Other|0|||
170665540|NCT05055128|616788594|FG003|Overall Study|Other|0|||
170665541|NCT05055128|616788595|FG004|Overall Study|Other|0|||
170665542|NCT04590963|616788596|FG000|Overall Study|Death|118|||
170665543|NCT04590963|616788597|FG001|Overall Study|Death|59|||
170665544|NCT04590963|616788596|FG000|Overall Study|Lost to Follow-up|1|||
170665545|NCT04590963|616788597|FG001|Overall Study|Lost to Follow-up|1|||
170665546|NCT04590963|616788596|FG000|Overall Study|Progressive disease|0|||
170665547|NCT04590963|616788597|FG001|Overall Study|Progressive disease|1|||
170665548|NCT04590963|616788596|FG000|Overall Study|Study terminated by sponsor|103|||
170665549|NCT04590963|616788597|FG001|Overall Study|Study terminated by sponsor|50|||
170665550|NCT04590963|616788596|FG000|Overall Study|Withdrawal by Subject|15|||
170665551|NCT04590963|616788597|FG001|Overall Study|Withdrawal by Subject|8|||
170665552|NCT04590963|616788596|FG000|Overall Study|Ongoing at data cut-off|9|||
170665553|NCT04590963|616788597|FG001|Overall Study|Ongoing at data cut-off|4|||
170665554|NCT04590963|616788596|FG000|Overall Study|Screen failure|1|||
170665555|NCT04590963|616788597|FG001|Overall Study|Screen failure|0|||
170665556|NCT04176705|616788598|FG000|Overall Study|Withdrawal by Subject|4|||
170665557|NCT04176705|616788599|FG001|Overall Study|Withdrawal by Subject|4|||
170665558|NCT04176705|616788598|FG000|Overall Study|Death|1|||
170665559|NCT04176705|616788599|FG001|Overall Study|Death|1|||
170665560|NCT04176705|616788598|FG000|Overall Study|Lost to Follow-up|3|||
170665561|NCT04176705|616788599|FG001|Overall Study|Lost to Follow-up|3|||
170665562|NCT04840888|616788604|FG000|Period 1|Withdrawal by Subject|0|||
170665563|NCT04840888|616788605|FG001|Period 1|Withdrawal by Subject|0|||
170665564|NCT04840888|616788606|FG002|Period 1|Withdrawal by Subject|0|||
170665565|NCT04840888|616788607|FG003|Period 1|Withdrawal by Subject|0|||
170665566|NCT04840888|616788608|FG004|Period 1|Withdrawal by Subject|1|||
170665567|NCT04840888|616788609|FG005|Period 1|Withdrawal by Subject|0|||
170665568|NCT04840888|616788604|FG000|Period 1|Adverse Event|0|||
170665569|NCT04840888|616788605|FG001|Period 1|Adverse Event|0|||
170665570|NCT04840888|616788606|FG002|Period 1|Adverse Event|1|||
170665571|NCT04840888|616788607|FG003|Period 1|Adverse Event|1|||
170665572|NCT04840888|616788608|FG004|Period 1|Adverse Event|10|||
170665573|NCT04840888|616788609|FG005|Period 1|Adverse Event|1|||
170665574|NCT02719327|616788611|FG000|Overall Study|Withdrawal by Subject|11|||
170665575|NCT02719327|616788612|FG001|Overall Study|Withdrawal by Subject|8|||
170665576|NCT02718300|616788613|FG000|Overall Study|Death|4|||
170665577|NCT02718300|616788614|FG001|Overall Study|Death|5|||
170665578|NCT02718300|616788615|FG002|Overall Study|Death|17|||
170665579|NCT02718300|616788613|FG000|Overall Study|Lost to Follow-up|1|||
170665580|NCT02718300|616788614|FG001|Overall Study|Lost to Follow-up|0|||
170665581|NCT02718300|616788615|FG002|Overall Study|Lost to Follow-up|2|||
170665582|NCT02718300|616788613|FG000|Overall Study|Physician Decision|1|||
170665583|NCT02718300|616788614|FG001|Overall Study|Physician Decision|0|||
170665584|NCT02718300|616788615|FG002|Overall Study|Physician Decision|2|||
170665585|NCT02718300|616788613|FG000|Overall Study|Study Terminated by Sponsor|6|||
170665586|NCT02718300|616788614|FG001|Overall Study|Study Terminated by Sponsor|3|||
170665587|NCT02718300|616788615|FG002|Overall Study|Study Terminated by Sponsor|4|||
170665588|NCT02718300|616788613|FG000|Overall Study|Withdrawal by Subject|0|||
170665589|NCT02718300|616788614|FG001|Overall Study|Withdrawal by Subject|4|||
170665590|NCT02718300|616788615|FG002|Overall Study|Withdrawal by Subject|3|||
170665591|NCT02718300|616788613|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
170665592|NCT02718300|616788614|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
170665593|NCT02718300|616788615|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
170665594|NCT05268055|616788617|FG000|Overall Study|Lost to Follow-up|68|||
170665595|NCT05268055|616788618|FG001|Overall Study|Lost to Follow-up|68|||
170665596|NCT05268055|616788617|FG000|Overall Study|Withdrawal by Subject|12|||
170665597|NCT05268055|616788618|FG001|Overall Study|Withdrawal by Subject|8|||
170665598|NCT03507400|616788619|FG000|Overall Study|discontinued|5|||
170665599|NCT03507400|616788620|FG001|Overall Study|discontinued|1|||
170665600|NCT03507400|616788619|FG000|Overall Study|Lost to Follow-up|8|||
170665601|NCT03507400|616788620|FG001|Overall Study|Lost to Follow-up|6|||
170665602|NCT03507400|616788619|FG000|Overall Study|Protocol Violation|0|||
170665603|NCT03507400|616788620|FG001|Overall Study|Protocol Violation|1|||
170665604|NCT01555983|616788621|FG000|Overall Study|Withdrawal by Subject|1|||
170665605|NCT01555983|616788622|FG001|Overall Study|Withdrawal by Subject|0|||
170665606|NCT01555983|616788623|FG002|Overall Study|Withdrawal by Subject|0|||
170665607|NCT01555983|616788624|FG003|Overall Study|Withdrawal by Subject|0|||
170665608|NCT01555983|616788625|FG004|Overall Study|Withdrawal by Subject|1|||
170665609|NCT01555983|616788626|FG005|Overall Study|Withdrawal by Subject|1|||
170665610|NCT04026711|616788627|FG000|Overall Study|Withdrawal by Subject|1|||
170665611|NCT04026711|616788628|FG001|Overall Study|Withdrawal by Subject|0|||
170665612|NCT04026711|616788627|FG000|Overall Study|mental health crisis|1|||
170665613|NCT04026711|616788628|FG001|Overall Study|mental health crisis|0|||
170665614|NCT05985395|616788633|FG000|Overall Study|Physician Decision|2|||
170665615|NCT05985395|616788634|FG001|Overall Study|Physician Decision|1|||
170665616|NCT05985395|616788633|FG000|Overall Study|Withdrawal by Subject|1|||
170665617|NCT05985395|616788634|FG001|Overall Study|Withdrawal by Subject|0|||
170665618|NCT04102189|616788635|FG000|Overall Study|Withdrawal by Subject|1|||
170665619|NCT04102189|616788636|FG001|Overall Study|Withdrawal by Subject|2|||
170665620|NCT04102189|616788635|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170665621|NCT04102189|616788636|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170665622|NCT04102189|616788635|FG000|Overall Study|Lost to Follow-up|1|||
170665623|NCT04102189|616788636|FG001|Overall Study|Lost to Follow-up|0|||
170665624|NCT00316719|616790384|FG000|Overall Study|Adverse Event|0|||
170665625|NCT00316719|616790385|FG001|Overall Study|Adverse Event|6|||
170665626|NCT00316719|616790384|FG000|Overall Study|Consent withdrawn|2|||
170665627|NCT00316719|616790385|FG001|Overall Study|Consent withdrawn|0|||
170665628|NCT01314703|616790390|FG000|Overall Study|screen failure and closed enrollment|8|||
170665629|NCT02975336|616790391|FG000|DBPC (52 Weeks)|Adverse Event|16|||
170665630|NCT02975336|616790392|FG001|DBPC (52 Weeks)|Adverse Event|17|||
170665631|NCT02975336|616790393|FG002|DBPC (52 Weeks)|Adverse Event|13|||
170665632|NCT02975336|616790394|FG003|DBPC (52 Weeks)|Adverse Event|18|||
170665633|NCT02975336|616790395|FG004|DBPC (52 Weeks)|Adverse Event|0|||
170665634|NCT02975336|616790396|FG005|DBPC (52 Weeks)|Adverse Event|0|||
170665635|NCT02975336|616790397|FG006|DBPC (52 Weeks)|Adverse Event|0|||
170665636|NCT02975336|616790398|FG007|DBPC (52 Weeks)|Adverse Event|0|||
170665637|NCT02975336|616790391|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
170665638|NCT02975336|616790392|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
170665639|NCT02975336|616790393|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
170665640|NCT02975336|616790394|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
170665641|NCT02975336|616790395|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
170665642|NCT02975336|616790396|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
170665643|NCT02975336|616790397|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
170665644|NCT02975336|616790398|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
170665645|NCT02975336|616790391|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
170665646|NCT02975336|616790392|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
170665647|NCT02975336|616790393|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
170665648|NCT02975336|616790394|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
170665649|NCT02975336|616790395|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
170665650|NCT02975336|616790396|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
170665651|NCT02975336|616790397|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
170665652|NCT02975336|616790398|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
170665653|NCT02975336|616790391|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
170665654|NCT02975336|616790392|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
170665655|NCT02975336|616790393|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
170665656|NCT02975336|616790394|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
170665657|NCT02975336|616790395|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
170665658|NCT02975336|616790396|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
170665659|NCT02975336|616790397|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
170665660|NCT02975336|616790398|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
170665661|NCT02975336|616790391|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
170665662|NCT02975336|616790392|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
170665663|NCT02975336|616790393|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
170665664|NCT02975336|616790394|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
170665665|NCT02975336|616790395|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
170665666|NCT02975336|616790396|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
170665667|NCT02975336|616790397|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
170665668|NCT02975336|616790398|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
170665669|NCT02975336|616790391|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
170665670|NCT02975336|616790392|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
170665671|NCT02975336|616790393|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
170665672|NCT02975336|616790394|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
170665673|NCT02975336|616790395|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
170665674|NCT02975336|616790396|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
170665675|NCT02975336|616790397|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
170665676|NCT02975336|616790398|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
170665677|NCT02975336|616790391|FG000|LTE (104 Weeks)|Adverse Event|0|||
170665678|NCT02975336|616790392|FG001|LTE (104 Weeks)|Adverse Event|0|||
170665679|NCT02975336|616790393|FG002|LTE (104 Weeks)|Adverse Event|0|||
170665680|NCT02975336|616790394|FG003|LTE (104 Weeks)|Adverse Event|0|||
170665681|NCT02975336|616790395|FG004|LTE (104 Weeks)|Adverse Event|7|||
170665682|NCT02975336|616790396|FG005|LTE (104 Weeks)|Adverse Event|4|||
170665683|NCT02975336|616790397|FG006|LTE (104 Weeks)|Adverse Event|2|||
170665684|NCT02975336|616790398|FG007|LTE (104 Weeks)|Adverse Event|0|||
170665685|NCT02975336|616790391|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
170665686|NCT02975336|616790392|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
170665687|NCT02975336|616790393|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
170665688|NCT02975336|616790394|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
170665689|NCT02975336|616790395|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
170665690|NCT02975336|616790396|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
170665691|NCT02975336|616790397|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
170665692|NCT02975336|616790398|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
170665693|NCT02975336|616790391|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
170665694|NCT02975336|616790392|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
170665695|NCT02975336|616790393|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
170665696|NCT02975336|616790394|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
170665697|NCT02975336|616790395|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
170665698|NCT02975336|616790396|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
170665699|NCT02975336|616790397|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
170665700|NCT02975336|616790398|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
170665701|NCT02975336|616790391|FG000|LTE (104 Weeks)|Other|0|||
170665702|NCT02975336|616790392|FG001|LTE (104 Weeks)|Other|0|||
170665703|NCT02975336|616790393|FG002|LTE (104 Weeks)|Other|0|||
170665704|NCT02975336|616790394|FG003|LTE (104 Weeks)|Other|0|||
170665705|NCT02975336|616790395|FG004|LTE (104 Weeks)|Other|55|||
170665706|NCT02975336|616790396|FG005|LTE (104 Weeks)|Other|63|||
170665707|NCT02975336|616790397|FG006|LTE (104 Weeks)|Other|76|||
170665708|NCT02975336|616790398|FG007|LTE (104 Weeks)|Other|72|||
170665709|NCT01863953|616790399|FG000|Overall Study|Adverse Event|0|||
170665710|NCT01863953|616790400|FG001|Overall Study|Adverse Event|0|||
170665711|NCT01863953|616790401|FG002|Overall Study|Adverse Event|1|||
170665712|NCT00385762|616790402|FG000|Overall Study|Adverse Event|1|||
170665713|NCT00385762|616790402|FG000|Overall Study|Lost to Follow-up|1|||
170665714|NCT00573183|616790403|FG000|Overall Study|Lost to Follow-up|52|||
170665715|NCT00573183|616790404|FG001|Overall Study|Lost to Follow-up|50|||
170665716|NCT00573183|616790403|FG000|Overall Study|Withdrawal by Subject|8|||
170665717|NCT00573183|616790404|FG001|Overall Study|Withdrawal by Subject|2|||
170665718|NCT00573183|616790403|FG000|Overall Study|Death|0|||
170665719|NCT00573183|616790404|FG001|Overall Study|Death|1|||
170665720|NCT00573183|616790403|FG000|Overall Study|Adverse Event|2|||
170665721|NCT00573183|616790404|FG001|Overall Study|Adverse Event|0|||
170665722|NCT00573183|616790403|FG000|Overall Study|Incarceration|5|||
170665723|NCT00573183|616790404|FG001|Overall Study|Incarceration|8|||
170665724|NCT00573183|616790403|FG000|Overall Study|Other|5|||
170665725|NCT00573183|616790404|FG001|Overall Study|Other|2|||
170665726|NCT02362035|616790413|FG000|Overall Study|Death|67|||
170665727|NCT02362035|616790413|FG000|Overall Study|Lost to Follow-up|3|||
170665728|NCT02362035|616790413|FG000|Overall Study|Adverse Event|1|||
170665729|NCT02362035|616790413|FG000|Overall Study|Physician Decision|1|||
170665730|NCT02362035|616790413|FG000|Overall Study|Subject started another cancer therapy|10|||
170665731|NCT02362035|616790413|FG000|Overall Study|Study terminated by sponsor|45|||
170665732|NCT02362035|616790413|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
170665733|NCT02362035|616790413|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
170665734|NCT02362035|616790413|FG000|Overall Study|Disease progression|11|||
170665735|NCT02362035|616790413|FG000|Overall Study|Withdrawal by Subject|20|||
170665736|NCT00615108|616790414|FG000|Overall Study|Adverse Event|122|||
170665737|NCT00615108|616790414|FG000|Overall Study|Other|370|||
170665738|NCT00615108|616790414|FG000|Overall Study|Lost to Follow-up|15|||
170665739|NCT00004635|616790415|FG000|Period One|refused|2|||
170665740|NCT00004635|616790416|FG001|Period One|refused|1|||
170665741|NCT00004635|616790415|FG000|Period One|Withdrawal by Subject|1|||
170665742|NCT00004635|616790416|FG001|Period One|Withdrawal by Subject|1|||
170665743|NCT00004635|616790415|FG000|Period One|Protocol Violation|1|||
170665744|NCT00004635|616790416|FG001|Period One|Protocol Violation|0|||
170665745|NCT00004635|616790415|FG000|Period One|PSA did not go <5 ng/mL|1|||
170665746|NCT00004635|616790416|FG001|Period One|PSA did not go <5 ng/mL|0|||
170665747|NCT00004635|616790415|FG000|Period One|second malignancy|1|||
170665748|NCT00004635|616790416|FG001|Period One|second malignancy|0|||
170665749|NCT00004635|616790415|FG000|Period One|progressed|0|||
170665750|NCT00004635|616790416|FG001|Period One|progressed|2|||
170665751|NCT00004635|616790415|FG000|Period One|health problem|0|||
170665752|NCT00004635|616790416|FG001|Period One|health problem|1|||
170665753|NCT00004635|616790415|FG000|Period One|discrepancy in data entry|0|||
170665754|NCT00004635|616790416|FG001|Period One|discrepancy in data entry|1|||
170665755|NCT00004635|616790415|FG000|Period Two|progression|2|||
170665756|NCT00004635|616790416|FG001|Period Two|progression|3|||
170665757|NCT00004635|616790415|FG000|Period Two|Adverse Event|1|||
170665758|NCT00004635|616790416|FG001|Period Two|Adverse Event|0|||
170665759|NCT00004635|616790415|FG000|Period Two|refused|0|||
170665760|NCT00004635|616790416|FG001|Period Two|refused|2|||
170665761|NCT00004635|616790415|FG000|Period Two|health problem|1|||
170665762|NCT00004635|616790416|FG001|Period Two|health problem|1|||
170665763|NCT00004635|616790415|FG000|Period Two|travel issues|0|||
170665764|NCT00004635|616790416|FG001|Period Two|travel issues|1|||
170665765|NCT00004635|616790415|FG000|Period Two|secondary malignancy|1|||
170665766|NCT00004635|616790416|FG001|Period Two|secondary malignancy|1|||
170665767|NCT00004635|616790415|FG000|Period Two|Lost to Follow-up|1|||
170665768|NCT00004635|616790416|FG001|Period Two|Lost to Follow-up|0|||
170665769|NCT00004635|616790415|FG000|Period Two|discrepancy in data entry|0|||
170665770|NCT00004635|616790416|FG001|Period Two|discrepancy in data entry|1|||
170665771|NCT02024529|616790423|FG000|Overall Study|Withdrawal by Subject|11|||
170665772|NCT02024529|616790424|FG001|Overall Study|Withdrawal by Subject|21|||
170665773|NCT02024529|616790423|FG000|Overall Study|Lost to Follow-up|2|||
170665774|NCT02024529|616790424|FG001|Overall Study|Lost to Follow-up|4|||
170665775|NCT00191906|616790425|FG000|Study Period II|Adverse Event|0|||
170665776|NCT00191906|616790426|FG001|Study Period II|Adverse Event|1|||
170665777|NCT00191906|616790427|FG002|Study Period II|Adverse Event|0|||
170665778|NCT00191906|616790428|FG003|Study Period II|Adverse Event|0|||
170665779|NCT00191906|616790425|FG000|Study Period II|Withdrawal by Subject|0|||
170665780|NCT00191906|616790426|FG001|Study Period II|Withdrawal by Subject|3|||
170665781|NCT00191906|616790427|FG002|Study Period II|Withdrawal by Subject|0|||
170665782|NCT00191906|616790428|FG003|Study Period II|Withdrawal by Subject|0|||
170665783|NCT00191906|616790425|FG000|Study Period II|Parent/Caregiver Decision|0|||
170665784|NCT00191906|616790426|FG001|Study Period II|Parent/Caregiver Decision|1|||
170665785|NCT00191906|616790427|FG002|Study Period II|Parent/Caregiver Decision|0|||
170665786|NCT00191906|616790428|FG003|Study Period II|Parent/Caregiver Decision|0|||
170665787|NCT00191906|616790425|FG000|Study Period II|Entry Criteria Exclusion|0|||
170665788|NCT00191906|616790426|FG001|Study Period II|Entry Criteria Exclusion|0|||
170665789|NCT00191906|616790427|FG002|Study Period II|Entry Criteria Exclusion|1|||
170665790|NCT00191906|616790428|FG003|Study Period II|Entry Criteria Exclusion|0|||
170665791|NCT00191906|616790425|FG000|Study Period III|Adverse Event|1|||
170665792|NCT00191906|616790426|FG001|Study Period III|Adverse Event|0|||
170665793|NCT00191906|616790427|FG002|Study Period III|Adverse Event|0|||
170665794|NCT00191906|616790428|FG003|Study Period III|Adverse Event|0|||
170665795|NCT00191906|616790425|FG000|Study Period III|Lost to Follow-up|0|||
170665796|NCT00191906|616790426|FG001|Study Period III|Lost to Follow-up|1|||
170665797|NCT00191906|616790427|FG002|Study Period III|Lost to Follow-up|0|||
170665798|NCT00191906|616790428|FG003|Study Period III|Lost to Follow-up|0|||
170665799|NCT00191906|616790425|FG000|Study Period III|Parent/Caregiver Decision|1|||
170665800|NCT00191906|616790426|FG001|Study Period III|Parent/Caregiver Decision|0|||
170665801|NCT00191906|616790427|FG002|Study Period III|Parent/Caregiver Decision|0|||
170665802|NCT00191906|616790428|FG003|Study Period III|Parent/Caregiver Decision|0|||
170665803|NCT00191906|616790425|FG000|Study Period III|Lack of Efficacy|3|||
170665804|NCT00191906|616790426|FG001|Study Period III|Lack of Efficacy|3|||
170665805|NCT00191906|616790427|FG002|Study Period III|Lack of Efficacy|0|||
170665806|NCT00191906|616790428|FG003|Study Period III|Lack of Efficacy|0|||
170665807|NCT00333801|616790429|FG000|Overall Study|Moved to another state|5|||
170665808|NCT00333801|616790430|FG001|Overall Study|Moved to another state|3|||
170665809|NCT00333801|616790429|FG000|Overall Study|Lost to Follow-up|2|||
170665810|NCT00333801|616790430|FG001|Overall Study|Lost to Follow-up|0|||
170665811|NCT00333801|616790429|FG000|Overall Study|Incarcerated|1|||
170665812|NCT00333801|616790430|FG001|Overall Study|Incarcerated|2|||
170665813|NCT00333801|616790429|FG000|Overall Study|Withdrawal by Subject|0|||
170665814|NCT00333801|616790430|FG001|Overall Study|Withdrawal by Subject|1|||
170665815|NCT03650556|616790431|FG000|Overall Study|Death|2|||
170665816|NCT03650556|616790431|FG000|Overall Study|Withdrawal by Subject|20|||
170665817|NCT03650556|616790431|FG000|Overall Study|Physician Decision|2|||
170665818|NCT03650556|616790431|FG000|Overall Study|Lost to Follow-up|8|||
170665819|NCT03650556|616790431|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
170665820|NCT03650556|616790431|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
170665821|NCT00691301|616790434|FG000|Overall Study|Adverse Event|10|||
170665822|NCT00691301|616790434|FG000|Overall Study|Death|2|||
170665823|NCT00691301|616790434|FG000|Overall Study|Lack of Efficacy|32|||
170665824|NCT00691301|616790434|FG000|Overall Study|Withdrawal by Subject|4|||
170665825|NCT00691301|616790434|FG000|Overall Study|Concurrent illness|2|||
170665826|NCT00691301|616790434|FG000|Overall Study|other reason|3|||
170665827|NCT00691301|616790434|FG000|Overall Study|Did not initiate study treatment|1|||
170665828|NCT02642029|616790435|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
170665829|NCT02642029|616790436|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
170665830|NCT02642029|616790437|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
170665831|NCT02642029|616790438|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
170665832|NCT02642029|616790439|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
170665833|NCT02642029|616790440|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
170665834|NCT02642029|616790435|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
170665835|NCT02642029|616790436|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
170665836|NCT02642029|616790437|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
170665837|NCT02642029|616790438|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
170665838|NCT02642029|616790439|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
170665839|NCT02642029|616790440|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
170665840|NCT02642029|616790435|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
170665841|NCT02642029|616790436|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
170665842|NCT02642029|616790437|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
170665843|NCT02642029|616790438|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
170665844|NCT02642029|616790439|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
170665845|NCT02642029|616790440|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
170665846|NCT02642029|616790435|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
170665847|NCT02642029|616790436|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
170665848|NCT02642029|616790437|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
170665849|NCT02642029|616790438|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
170665850|NCT02642029|616790439|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
170665851|NCT02642029|616790440|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
170665852|NCT02642029|616790435|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
170665853|NCT02642029|616790436|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
170665854|NCT02642029|616790437|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
170665855|NCT02642029|616790438|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
170665856|NCT02642029|616790439|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
170665857|NCT02642029|616790440|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
170665858|NCT02642029|616790435|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
170665859|NCT02642029|616790436|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
170665860|NCT02642029|616790437|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
170665861|NCT02642029|616790438|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
170665862|NCT02642029|616790439|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
170665863|NCT02642029|616790440|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
170665864|NCT00463580|616790442|FG000|Overall Study|Lost to Follow-up|1|||
170665865|NCT00463580|616790443|FG001|Overall Study|Lost to Follow-up|0|||
170665866|NCT00463580|616790442|FG000|Overall Study|Schedule conflict|2|||
170665867|NCT00463580|616790443|FG001|Overall Study|Schedule conflict|0|||
170665868|NCT00463580|616790442|FG000|Overall Study|Medical/psychiatric complications|0|||
170665869|NCT00463580|616790443|FG001|Overall Study|Medical/psychiatric complications|2|||
170665870|NCT00777205|616790444|FG000|Overall Study|Lost to Follow-up|25|||
170665871|NCT00777205|616790445|FG001|Overall Study|Lost to Follow-up|9|||
170665872|NCT00777205|616790444|FG000|Overall Study|Withdrawal by Subject|6|||
170665873|NCT00777205|616790445|FG001|Overall Study|Withdrawal by Subject|4|||
170665874|NCT00777205|616790444|FG000|Overall Study|Death|0|||
170665875|NCT00777205|616790445|FG001|Overall Study|Death|2|||
170665876|NCT00777205|616790444|FG000|Overall Study|Protocol Violation|0|||
170665877|NCT00777205|616790445|FG001|Overall Study|Protocol Violation|56|||
170665878|NCT00736944|616790446|FG000|Induction|Death|1|||
170665879|NCT00736944|616790446|FG000|Definitive Treatment|Physician Decision|1|||
170665880|NCT01426438|616790448|FG000|Overall Study|Lost to Follow-up|1|||
170665881|NCT01426438|616790449|FG001|Overall Study|Lost to Follow-up|3|||
170665882|NCT01426438|616790448|FG000|Overall Study|Off study Treatment|9|||
170665883|NCT01426438|616790449|FG001|Overall Study|Off study Treatment|3|||
170665884|NCT01426438|616790448|FG000|Overall Study|Poor scan quality|3|||
170665885|NCT01426438|616790449|FG001|Overall Study|Poor scan quality|2|||
170665886|NCT01426438|616790448|FG000|Overall Study|Missed Scan|2|||
170665887|NCT01426438|616790449|FG001|Overall Study|Missed Scan|2|||
170665888|NCT02607930|616790450|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
170665889|NCT02607930|616790451|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
170665890|NCT02607930|616790452|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
170665891|NCT02607930|616790453|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
170665892|NCT02607930|616790450|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
170665893|NCT02607930|616790451|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
170665894|NCT02607930|616790452|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
170665895|NCT02607930|616790453|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
170665896|NCT02607930|616790450|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
170665897|NCT02607930|616790451|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
170665898|NCT02607930|616790452|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
170665899|NCT02607930|616790453|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
170665900|NCT02607930|616790450|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
170665901|NCT02607930|616790451|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
170665902|NCT02607930|616790452|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
170665903|NCT02607930|616790453|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
170665904|NCT02607930|616790450|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
170665905|NCT02607930|616790451|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
170665906|NCT02607930|616790452|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
170617489|NCT05907395|616607008|FG009|Period 2|Adverse Event|0|||
170617490|NCT05907395|616607009|FG010|Period 2|Adverse Event|0|||
170617491|NCT05907395|616607010|FG011|Period 2|Adverse Event|0|||
170617492|NCT05907395|616606999|FG000|Period 2|Personal reason|0|||
170617493|NCT05907395|616607000|FG001|Period 2|Personal reason|0|||
170617494|NCT05907395|616607001|FG002|Period 2|Personal reason|0|||
170617495|NCT05907395|616607002|FG003|Period 2|Personal reason|0|||
170617496|NCT05907395|616607003|FG004|Period 2|Personal reason|0|||
170617497|NCT05907395|616607004|FG005|Period 2|Personal reason|0|||
170617498|NCT05907395|616607005|FG006|Period 2|Personal reason|0|||
170617499|NCT05907395|616607006|FG007|Period 2|Personal reason|0|||
170617500|NCT05907395|616607007|FG008|Period 2|Personal reason|0|||
170617501|NCT05907395|616607008|FG009|Period 2|Personal reason|1|||
170617502|NCT05907395|616607009|FG010|Period 2|Personal reason|0|||
170617503|NCT05907395|616607010|FG011|Period 2|Personal reason|0|||
170617504|NCT05907395|616606999|FG000|Period 3|Adverse Event|0|||
170617505|NCT05907395|616607000|FG001|Period 3|Adverse Event|0|||
170617506|NCT05907395|616607001|FG002|Period 3|Adverse Event|0|||
170617507|NCT05907395|616607002|FG003|Period 3|Adverse Event|0|||
170617508|NCT05907395|616607003|FG004|Period 3|Adverse Event|1|||
170617509|NCT05907395|616607004|FG005|Period 3|Adverse Event|0|||
170617510|NCT05907395|616607005|FG006|Period 3|Adverse Event|0|||
170617511|NCT05907395|616607006|FG007|Period 3|Adverse Event|0|||
170617512|NCT05907395|616607007|FG008|Period 3|Adverse Event|0|||
170617513|NCT05907395|616607008|FG009|Period 3|Adverse Event|0|||
170617514|NCT05907395|616607009|FG010|Period 3|Adverse Event|0|||
170617515|NCT05907395|616607010|FG011|Period 3|Adverse Event|0|||
170617516|NCT05214768|616607011|FG000|Induction Period|Withdrawal by Subject|1|||
170617517|NCT05214768|616607012|FG001|Induction Period|Withdrawal by Subject|0|||
170617518|NCT05214768|616607013|FG002|Induction Period|Withdrawal by Subject|0|||
170617519|NCT05214768|616607014|FG003|Induction Period|Withdrawal by Subject|0|||
170617520|NCT05214768|616607015|FG004|Induction Period|Withdrawal by Subject|0|||
170617521|NCT05214768|616607016|FG005|Induction Period|Withdrawal by Subject|0|||
170617522|NCT05214768|616607011|FG000|Induction Period|Physician Decision|1|||
170617523|NCT05214768|616607012|FG001|Induction Period|Physician Decision|0|||
170617524|NCT05214768|616607013|FG002|Induction Period|Physician Decision|0|||
170617525|NCT05214768|616607014|FG003|Induction Period|Physician Decision|0|||
170617526|NCT05214768|616607015|FG004|Induction Period|Physician Decision|0|||
170617527|NCT05214768|616607016|FG005|Induction Period|Physician Decision|0|||
170617528|NCT05214768|616607011|FG000|Maintenance Period|Other Reasons|0|||
170617529|NCT05214768|616607012|FG001|Maintenance Period|Other Reasons|0|||
170617530|NCT05214768|616607013|FG002|Maintenance Period|Other Reasons|1|||
170617531|NCT05214768|616607014|FG003|Maintenance Period|Other Reasons|1|||
170617532|NCT05214768|616607015|FG004|Maintenance Period|Other Reasons|0|||
170617533|NCT05214768|616607016|FG005|Maintenance Period|Other Reasons|0|||
170617534|NCT05214768|616607011|FG000|Maintenance Period|Withdrawal by Subject|0|||
170617535|NCT05214768|616607012|FG001|Maintenance Period|Withdrawal by Subject|0|||
170617536|NCT05214768|616607013|FG002|Maintenance Period|Withdrawal by Subject|0|||
170617537|NCT05214768|616607014|FG003|Maintenance Period|Withdrawal by Subject|1|||
170617538|NCT05214768|616607015|FG004|Maintenance Period|Withdrawal by Subject|0|||
170617539|NCT05214768|616607016|FG005|Maintenance Period|Withdrawal by Subject|0|||
170617540|NCT05214768|616607011|FG000|Maintenance Period|Lack of Efficacy|0|||
170617541|NCT05214768|616607012|FG001|Maintenance Period|Lack of Efficacy|0|||
170617542|NCT05214768|616607013|FG002|Maintenance Period|Lack of Efficacy|1|||
170617543|NCT05214768|616607014|FG003|Maintenance Period|Lack of Efficacy|0|||
170617544|NCT05214768|616607015|FG004|Maintenance Period|Lack of Efficacy|1|||
170617545|NCT05214768|616607016|FG005|Maintenance Period|Lack of Efficacy|0|||
170617546|NCT05214768|616607011|FG000|Open Label Extension Period|Physician Decision|0|||
170617547|NCT05214768|616607012|FG001|Open Label Extension Period|Physician Decision|0|||
170617548|NCT05214768|616607013|FG002|Open Label Extension Period|Physician Decision|0|||
170617549|NCT05214768|616607014|FG003|Open Label Extension Period|Physician Decision|0|||
170617550|NCT05214768|616607015|FG004|Open Label Extension Period|Physician Decision|0|||
170617551|NCT05214768|616607016|FG005|Open Label Extension Period|Physician Decision|1|||
170617552|NCT05214768|616607011|FG000|Open Label Extension Period|Lack of Efficacy|0|||
170617553|NCT05214768|616607012|FG001|Open Label Extension Period|Lack of Efficacy|0|||
170617554|NCT05214768|616607013|FG002|Open Label Extension Period|Lack of Efficacy|0|||
170617555|NCT05214768|616607014|FG003|Open Label Extension Period|Lack of Efficacy|0|||
170617556|NCT05214768|616607015|FG004|Open Label Extension Period|Lack of Efficacy|0|||
170617557|NCT05214768|616607016|FG005|Open Label Extension Period|Lack of Efficacy|1|||
170617558|NCT05214768|616607011|FG000|Open Label Extension Period|Ongoing Study|0|||
170617559|NCT05214768|616607012|FG001|Open Label Extension Period|Ongoing Study|0|||
170617560|NCT05214768|616607013|FG002|Open Label Extension Period|Ongoing Study|0|||
170617561|NCT05214768|616607014|FG003|Open Label Extension Period|Ongoing Study|0|||
170617562|NCT05214768|616607015|FG004|Open Label Extension Period|Ongoing Study|0|||
170617563|NCT05214768|616607016|FG005|Open Label Extension Period|Ongoing Study|42|||
170617564|NCT05481359|616607017|FG000|Overall Study|Lost to Follow-up|3|||
170617565|NCT05481359|616607017|FG000|Overall Study|Withdrawal by Subject|1|||
170617566|NCT04266795|616607022|FG000|Overall Study|Adverse Event|10|||
170665907|NCT02607930|616790453|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
170665908|NCT02607930|616790450|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
170665909|NCT02607930|616790451|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
170665910|NCT02607930|616790452|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
170665911|NCT02607930|616790453|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
170665912|NCT02607930|616790450|FG000|Double-Blinded Treatment Phase|Death|2|||
170665913|NCT02607930|616790451|FG001|Double-Blinded Treatment Phase|Death|1|||
170665914|NCT02607930|616790452|FG002|Double-Blinded Treatment Phase|Death|0|||
170665915|NCT02607930|616790453|FG003|Double-Blinded Treatment Phase|Death|0|||
170665916|NCT02607930|616790450|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
170665917|NCT02607930|616790451|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
170665918|NCT02607930|616790452|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
170665919|NCT02607930|616790453|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
170665920|NCT02607930|616790450|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
170665921|NCT02607930|616790451|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
170665922|NCT02607930|616790452|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
170665923|NCT02607930|616790453|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
170665924|NCT02607930|616790450|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
170665925|NCT02607930|616790451|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
170665926|NCT02607930|616790452|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
170665927|NCT02607930|616790453|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
170665928|NCT02607930|616790450|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
170665929|NCT02607930|616790451|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
170665930|NCT02607930|616790452|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
170665931|NCT02607930|616790453|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
170665932|NCT02607930|616790450|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
170665933|NCT02607930|616790451|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
170665934|NCT02607930|616790452|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
170665935|NCT02607930|616790453|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
170665936|NCT02607930|616790450|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
170665937|NCT02607930|616790451|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
170665938|NCT02607930|616790452|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
170665939|NCT02607930|616790453|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
170665940|NCT02607930|616790450|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
170665941|NCT02607930|616790451|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
170665942|NCT02607930|616790452|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
170818425|NCT03070301|617341544|FG000|Overall Study|Progression of disease|16|||
170818426|NCT03070301|617341544|FG000|Overall Study|Physician Decision|3|||
170818427|NCT03070301|617341544|FG000|Overall Study|Withdrawal by Subject|1|||
170818428|NCT03820024|617341545|FG000|Overall Study|Physician Decision|1|||
170818429|NCT03820024|617341546|FG001|Overall Study|Physician Decision|2|||
170818430|NCT02661490|617343572|FG000|Overall Study|Lost to Follow-up|0|||
170818431|NCT02661490|617343573|FG001|Overall Study|Lost to Follow-up|1|||
170665943|NCT02607930|616790453|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
170665944|NCT02607930|616790450|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
170665945|NCT02607930|616790451|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
170665946|NCT02607930|616790452|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
170665947|NCT02607930|616790453|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
170665948|NCT02607930|616790450|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
170665949|NCT02607930|616790451|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
170665950|NCT02607930|616790452|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
170665951|NCT02607930|616790453|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
170665952|NCT01134731|616790454|FG000|Overall Study|Adverse Event|3|||
170665953|NCT01134731|616790455|FG001|Overall Study|Adverse Event|2|||
170665954|NCT01134731|616790456|FG002|Overall Study|Adverse Event|1|||
170665955|NCT01134731|616790454|FG000|Overall Study|Physician Decision|2|||
170665956|NCT01134731|616790455|FG001|Overall Study|Physician Decision|2|||
170665957|NCT01134731|616790456|FG002|Overall Study|Physician Decision|2|||
170665958|NCT01134731|616790454|FG000|Overall Study|Lack of Efficacy|0|||
170665959|NCT01134731|616790455|FG001|Overall Study|Lack of Efficacy|0|||
170818432|NCT02661490|617343574|FG002|Overall Study|Lost to Follow-up|0|||
170818433|NCT02661490|617343575|FG003|Overall Study|Lost to Follow-up|0|||
170818434|NCT02661490|617343576|FG004|Overall Study|Lost to Follow-up|2|||
170818435|NCT02661490|617343572|FG000|Overall Study|Withdrawal by Subject|2|||
170818436|NCT02661490|617343573|FG001|Overall Study|Withdrawal by Subject|0|||
170818437|NCT02661490|617343574|FG002|Overall Study|Withdrawal by Subject|2|||
170818438|NCT02661490|617343575|FG003|Overall Study|Withdrawal by Subject|0|||
170818439|NCT02661490|617343576|FG004|Overall Study|Withdrawal by Subject|0|||
170818440|NCT02661490|617343572|FG000|Overall Study|Death|1|||
170818441|NCT02661490|617343573|FG001|Overall Study|Death|1|||
170818442|NCT02661490|617343574|FG002|Overall Study|Death|0|||
170665960|NCT01134731|616790456|FG002|Overall Study|Lack of Efficacy|1|||
170665961|NCT01134731|616790454|FG000|Overall Study|Withdrawal by Subject|3|||
170665962|NCT01134731|616790455|FG001|Overall Study|Withdrawal by Subject|3|||
170665963|NCT01134731|616790456|FG002|Overall Study|Withdrawal by Subject|1|||
170665964|NCT01134731|616790454|FG000|Overall Study|Lost to Follow-up|5|||
170665965|NCT01134731|616790455|FG001|Overall Study|Lost to Follow-up|4|||
170665966|NCT01134731|616790456|FG002|Overall Study|Lost to Follow-up|3|||
170665967|NCT01050543|616790457|FG000|Overall Study|Withdrawal by Subject|0|||
170665968|NCT01050543|616790458|FG001|Overall Study|Withdrawal by Subject|2|||
170665969|NCT01050543|616790457|FG000|Overall Study|Protocol Violation|0|||
170665970|NCT01050543|616790458|FG001|Overall Study|Protocol Violation|1|||
170665971|NCT01050543|616790457|FG000|Overall Study|Administrative|4|||
170665972|NCT01050543|616790458|FG001|Overall Study|Administrative|1|||
170665973|NCT00676338|616790461|FG000|Overall Study|Adverse Event|6|||
170665974|NCT00676338|616790462|FG001|Overall Study|Adverse Event|6|||
170665975|NCT00676338|616790463|FG002|Overall Study|Adverse Event|5|||
170665976|NCT00676338|616790464|FG003|Overall Study|Adverse Event|1|||
170665977|NCT00676338|616790461|FG000|Overall Study|Lost to Follow-up|4|||
170665978|NCT00676338|616790462|FG001|Overall Study|Lost to Follow-up|1|||
170665979|NCT00676338|616790463|FG002|Overall Study|Lost to Follow-up|3|||
170665980|NCT00676338|616790464|FG003|Overall Study|Lost to Follow-up|4|||
170665981|NCT00676338|616790461|FG000|Overall Study|Physician Decision|3|||
170665982|NCT00676338|616790462|FG001|Overall Study|Physician Decision|3|||
170665983|NCT00676338|616790463|FG002|Overall Study|Physician Decision|2|||
170665984|NCT00676338|616790464|FG003|Overall Study|Physician Decision|3|||
170665985|NCT00676338|616790461|FG000|Overall Study|Protocol Violation|5|||
170665986|NCT00676338|616790462|FG001|Overall Study|Protocol Violation|9|||
170665987|NCT00676338|616790463|FG002|Overall Study|Protocol Violation|2|||
170665988|NCT00676338|616790464|FG003|Overall Study|Protocol Violation|5|||
170665989|NCT00676338|616790461|FG000|Overall Study|Withdrawal by Subject|17|||
170665990|NCT00676338|616790462|FG001|Overall Study|Withdrawal by Subject|9|||
170665991|NCT00676338|616790463|FG002|Overall Study|Withdrawal by Subject|12|||
170665992|NCT00676338|616790464|FG003|Overall Study|Withdrawal by Subject|6|||
170665993|NCT00676338|616790461|FG000|Overall Study|Entry Criteria Not Met|0|||
170665994|NCT00676338|616790462|FG001|Overall Study|Entry Criteria Not Met|2|||
170617567|NCT04266795|616607023|FG001|Overall Study|Adverse Event|19|||
170617568|NCT04266795|616607022|FG000|Overall Study|Death|7|||
170617569|NCT04266795|616607023|FG001|Overall Study|Death|8|||
170617570|NCT04266795|616607022|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
170617571|NCT04266795|616607023|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
170617572|NCT04266795|616607022|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
170617573|NCT04266795|616607023|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170617574|NCT04266795|616607022|FG000|Overall Study|Progressive Disease|12|||
170617575|NCT04266795|616607023|FG001|Overall Study|Progressive Disease|9|||
170617576|NCT04266795|616607022|FG000|Overall Study|Withdrawal by Patient|5|||
170617577|NCT04266795|616607023|FG001|Overall Study|Withdrawal by Patient|6|||
170617578|NCT04266795|616607022|FG000|Overall Study|Disease Relapse|3|||
170617579|NCT04266795|616607023|FG001|Overall Study|Disease Relapse|6|||
170617580|NCT04266795|616607022|FG000|Overall Study|Reason not Specified|12|||
170617581|NCT04266795|616607023|FG001|Overall Study|Reason not Specified|10|||
170617582|NCT04266795|616607022|FG000|Overall Study|Participants Ongoing on Treatment|25|||
170617583|NCT04266795|616607023|FG001|Overall Study|Participants Ongoing on Treatment|23|||
170617584|NCT03043872|616607024|FG000|Overall Study|Withdrawal by Subject|6|||
170617585|NCT03043872|616607025|FG001|Overall Study|Withdrawal by Subject|6|||
170617586|NCT03043872|616607026|FG002|Overall Study|Withdrawal by Subject|15|||
170617587|NCT03043872|616607024|FG000|Overall Study|Lost to Follow-up|2|||
170617588|NCT03043872|616607025|FG001|Overall Study|Lost to Follow-up|1|||
170617589|NCT03043872|616607026|FG002|Overall Study|Lost to Follow-up|1|||
170617590|NCT03043872|616607024|FG000|Overall Study|Death|270|||
170617591|NCT03043872|616607025|FG001|Overall Study|Death|269|||
170617592|NCT03043872|616607026|FG002|Overall Study|Death|296|||
170617593|NCT04491136|616607028|FG000|Overall Study|Patient withdraw informed consent|9|||
170617594|NCT04491136|616607028|FG000|Overall Study|Adverse Event|2|||
170617595|NCT04491136|616607028|FG000|Overall Study|Death|3|||
170617596|NCT04491136|616607028|FG000|Overall Study|Lost to Follow-up|3|||
170617597|NCT04491136|616607028|FG000|Overall Study|Physician Decision|45|||
170617598|NCT04491136|616607028|FG000|Overall Study|sponsor terminated the study early|16|||
170665995|NCT00676338|616790463|FG002|Overall Study|Entry Criteria Not Met|1|||
170665996|NCT00676338|616790464|FG003|Overall Study|Entry Criteria Not Met|1|||
170665997|NCT00676338|616790461|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
170665998|NCT00676338|616790462|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
170665999|NCT00676338|616790463|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
170666000|NCT00676338|616790464|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
170666001|NCT02122458|616790465|FG000|Overall Study|Withdrawal by Subject|0|||
170666002|NCT02122458|616790466|FG001|Overall Study|Withdrawal by Subject|0|||
170666003|NCT02122458|616790467|FG002|Overall Study|Withdrawal by Subject|0|||
170666004|NCT02122458|616790468|FG003|Overall Study|Withdrawal by Subject|4|||
170818443|NCT02661490|617343575|FG003|Overall Study|Death|1|||
170818444|NCT02661490|617343576|FG004|Overall Study|Death|0|||
170818445|NCT02661490|617343572|FG000|Overall Study|Reason not Specified|0|||
170818446|NCT02661490|617343573|FG001|Overall Study|Reason not Specified|0|||
170818447|NCT02661490|617343574|FG002|Overall Study|Reason not Specified|0|||
170818448|NCT02661490|617343575|FG003|Overall Study|Reason not Specified|0|||
170818449|NCT02661490|617343576|FG004|Overall Study|Reason not Specified|1|||
170818450|NCT00434577|617343579|FG000|Months 0-3|Serious Adverse Event|0|||
170818451|NCT00434577|617343580|FG001|Months 0-3|Serious Adverse Event|0|||
170666005|NCT02122458|616790469|FG004|Overall Study|Withdrawal by Subject|4|||
170617599|NCT04491136|616607028|FG000|Overall Study|Patient/guardian's decision|1|||
170617600|NCT00319254|616607036|FG000|Overall Study|Withdrawal by Subject|4|||
170617601|NCT00319254|616607036|FG000|Overall Study|Death|46|||
170617602|NCT00319254|616607036|FG000|Overall Study|Lost to Follow-up|2|||
170617603|NCT00319254|616607036|FG000|Overall Study|Enrolled, Not Treated|2|||
170617604|NCT01712204|616607040|FG000|Overall Study|Adverse Event|3|||
170617605|NCT01712204|616607041|FG001|Overall Study|Adverse Event|1|||
170617606|NCT01712204|616607040|FG000|Overall Study|Withdrawal by Subject|3|||
170617607|NCT01712204|616607041|FG001|Overall Study|Withdrawal by Subject|3|||
170617608|NCT01712204|616607040|FG000|Overall Study|Lost to Follow-up|1|||
170617609|NCT01712204|616607041|FG001|Overall Study|Lost to Follow-up|0|||
170617610|NCT01712204|616607040|FG000|Overall Study|Protocol Violation|1|||
170617611|NCT01712204|616607041|FG001|Overall Study|Protocol Violation|1|||
170617612|NCT02452424|616607042|FG000|Overall Study|Death|2|||
170617613|NCT02452424|616607043|FG001|Overall Study|Death|2|||
170617614|NCT02452424|616607044|FG002|Overall Study|Death|2|||
170617615|NCT02452424|616607045|FG003|Overall Study|Death|6|||
170617616|NCT02452424|616607046|FG004|Overall Study|Death|2|||
170617617|NCT02452424|616607047|FG005|Overall Study|Death|0|||
170617618|NCT02452424|616607048|FG006|Overall Study|Death|5|||
170617619|NCT02452424|616607049|FG007|Overall Study|Death|1|||
170617620|NCT02452424|616607050|FG008|Overall Study|Death|3|||
170617621|NCT02452424|616607051|FG009|Overall Study|Death|1|||
170617622|NCT02452424|616607052|FG010|Overall Study|Death|0|||
170617623|NCT02452424|616607042|FG000|Overall Study|Lost to Follow-up|0|||
170617624|NCT02452424|616607043|FG001|Overall Study|Lost to Follow-up|1|||
170617625|NCT02452424|616607044|FG002|Overall Study|Lost to Follow-up|1|||
170617626|NCT02452424|616607045|FG003|Overall Study|Lost to Follow-up|0|||
170617627|NCT02452424|616607046|FG004|Overall Study|Lost to Follow-up|0|||
170617628|NCT02452424|616607047|FG005|Overall Study|Lost to Follow-up|0|||
170617629|NCT02452424|616607048|FG006|Overall Study|Lost to Follow-up|0|||
170617630|NCT02452424|616607049|FG007|Overall Study|Lost to Follow-up|0|||
170617631|NCT02452424|616607050|FG008|Overall Study|Lost to Follow-up|0|||
170617632|NCT02452424|616607051|FG009|Overall Study|Lost to Follow-up|0|||
170617633|NCT02452424|616607052|FG010|Overall Study|Lost to Follow-up|0|||
170617634|NCT02452424|616607042|FG000|Overall Study|Withdrawal by Subject|0|||
170617635|NCT02452424|616607043|FG001|Overall Study|Withdrawal by Subject|0|||
170617636|NCT02452424|616607044|FG002|Overall Study|Withdrawal by Subject|3|||
170617637|NCT02452424|616607045|FG003|Overall Study|Withdrawal by Subject|2|||
170617638|NCT02452424|616607046|FG004|Overall Study|Withdrawal by Subject|0|||
170617639|NCT02452424|616607047|FG005|Overall Study|Withdrawal by Subject|0|||
170617640|NCT02452424|616607048|FG006|Overall Study|Withdrawal by Subject|1|||
170617641|NCT02452424|616607049|FG007|Overall Study|Withdrawal by Subject|0|||
170617642|NCT02452424|616607050|FG008|Overall Study|Withdrawal by Subject|1|||
170617643|NCT02452424|616607051|FG009|Overall Study|Withdrawal by Subject|1|||
170617644|NCT02452424|616607052|FG010|Overall Study|Withdrawal by Subject|0|||
170617645|NCT02452424|616607042|FG000|Overall Study|Other|0|||
170617646|NCT02452424|616607043|FG001|Overall Study|Other|0|||
170617647|NCT02452424|616607044|FG002|Overall Study|Other|1|||
170617648|NCT02452424|616607045|FG003|Overall Study|Other|0|||
170617649|NCT02452424|616607046|FG004|Overall Study|Other|0|||
170617650|NCT02452424|616607047|FG005|Overall Study|Other|1|||
170617651|NCT02452424|616607048|FG006|Overall Study|Other|4|||
170617652|NCT02452424|616607049|FG007|Overall Study|Other|3|||
170617653|NCT02452424|616607050|FG008|Overall Study|Other|0|||
170617654|NCT02452424|616607051|FG009|Overall Study|Other|0|||
170617655|NCT02452424|616607052|FG010|Overall Study|Other|1|||
170818452|NCT00434577|617343581|FG002|Months 0-3|Serious Adverse Event|1|||
170666006|NCT02122458|616790470|FG005|Overall Study|Withdrawal by Subject|4|||
170617656|NCT02452424|616607042|FG000|Overall Study|Progressive disease (per RECIST)|0|||
170617657|NCT02452424|616607043|FG001|Overall Study|Progressive disease (per RECIST)|0|||
170617658|NCT02452424|616607044|FG002|Overall Study|Progressive disease (per RECIST)|0|||
170617659|NCT02452424|616607045|FG003|Overall Study|Progressive disease (per RECIST)|0|||
170617660|NCT02452424|616607046|FG004|Overall Study|Progressive disease (per RECIST)|0|||
170617661|NCT02452424|616607047|FG005|Overall Study|Progressive disease (per RECIST)|0|||
170617662|NCT02452424|616607048|FG006|Overall Study|Progressive disease (per RECIST)|0|||
170617663|NCT02452424|616607049|FG007|Overall Study|Progressive disease (per RECIST)|0|||
170617664|NCT02452424|616607050|FG008|Overall Study|Progressive disease (per RECIST)|2|||
170818453|NCT00434577|617343582|FG003|Months 0-3|Serious Adverse Event|0|||
170818454|NCT00434577|617343583|FG004|Months 0-3|Serious Adverse Event|0|||
170617665|NCT02452424|616607051|FG009|Overall Study|Progressive disease (per RECIST)|0|||
170617666|NCT02452424|616607052|FG010|Overall Study|Progressive disease (per RECIST)|0|||
170617667|NCT02452424|616607042|FG000|Overall Study|Adverse Event|0|||
170617668|NCT02452424|616607043|FG001|Overall Study|Adverse Event|0|||
170617669|NCT02452424|616607044|FG002|Overall Study|Adverse Event|0|||
170617670|NCT02452424|616607045|FG003|Overall Study|Adverse Event|0|||
170617671|NCT02452424|616607046|FG004|Overall Study|Adverse Event|0|||
170617672|NCT02452424|616607047|FG005|Overall Study|Adverse Event|0|||
170617673|NCT02452424|616607048|FG006|Overall Study|Adverse Event|0|||
170617674|NCT02452424|616607049|FG007|Overall Study|Adverse Event|0|||
170617675|NCT02452424|616607050|FG008|Overall Study|Adverse Event|0|||
170617676|NCT02452424|616607051|FG009|Overall Study|Adverse Event|0|||
170617677|NCT02452424|616607052|FG010|Overall Study|Adverse Event|1|||
170617678|NCT01059318|616607053|FG000|Core Study (26 Week)|Adverse Event|3|||
170617679|NCT01059318|616607053|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
170617680|NCT01059318|616607053|FG000|Extension (36 Week)|Adverse Event|3|||
170617681|NCT03790917|616607054|FG000|Overall Study|Death|1|||
170617682|NCT01279681|616607057|FG000|Overall Study|Disease Progression|9|||
170617683|NCT01279681|616607058|FG001|Overall Study|Disease Progression|6|||
170617684|NCT01279681|616607057|FG000|Overall Study|Withdrawal by Subject|3|||
170617685|NCT01279681|616607058|FG001|Overall Study|Withdrawal by Subject|4|||
170617686|NCT01279681|616607057|FG000|Overall Study|Adverse Event|2|||
170617687|NCT01279681|616607058|FG001|Overall Study|Adverse Event|3|||
170617688|NCT01279681|616607057|FG000|Overall Study|Death|0|||
170617689|NCT01279681|616607058|FG001|Overall Study|Death|1|||
170617690|NCT01279681|616607057|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
170617691|NCT01279681|616607058|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
170617692|NCT01279681|616607057|FG000|Overall Study|Physician Decision|1|||
170617693|NCT01279681|616607058|FG001|Overall Study|Physician Decision|0|||
170617694|NCT01279681|616607057|FG000|Overall Study|Other Reason|0|||
170617695|NCT01279681|616607058|FG001|Overall Study|Other Reason|2|||
170617696|NCT01943591|616607059|FG000|Overall Study|Lost to Follow-up|3|||
170617697|NCT01943591|616607060|FG001|Overall Study|Lost to Follow-up|4|||
170617698|NCT01943591|616607059|FG000|Overall Study|Death|2|||
170617699|NCT01943591|616607060|FG001|Overall Study|Death|7|||
170617700|NCT03772665|616607061|FG000|Overall Study|Protocol Violation|1|||
170617701|NCT03772665|616607062|FG001|Overall Study|Protocol Violation|0|||
170617702|NCT01232868|616608769|FG000|Overall Study|Lost to Follow-up|2|||
170617703|NCT01232868|616608770|FG001|Overall Study|Lost to Follow-up|4|||
170617704|NCT04481243|616608773|FG000|Overall Study|Withdrawal by Subject|4|||
170617705|NCT00961181|616608777|FG000|Overall Study|Death|2|||
170617706|NCT00961181|616608777|FG000|Overall Study|Withdrawal by Subject|2|||
170617707|NCT00961181|616608777|FG000|Overall Study|Lost to Follow-up|1|||
170617708|NCT03737123|616608787|FG000|Study Treatment|Adverse Event|2|||
170617709|NCT03737123|616608788|FG001|Study Treatment|Adverse Event|0|||
170617710|NCT03737123|616608787|FG000|Study Treatment|Disease Progression|2|||
170617711|NCT03737123|616608788|FG001|Study Treatment|Disease Progression|0|||
170617712|NCT03737123|616608787|FG000|Study Treatment|Withdrawal by Subject|2|||
170617713|NCT03737123|616608788|FG001|Study Treatment|Withdrawal by Subject|0|||
170617714|NCT03737123|616608787|FG000|Follow up|Death|1|||
170617715|NCT03737123|616608788|FG001|Follow up|Death|0|||
170617716|NCT03737123|616608787|FG000|Follow up|Withdrawal by Subject|1|||
170617717|NCT03737123|616608788|FG001|Follow up|Withdrawal by Subject|0|||
170617718|NCT03737123|616608787|FG000|Follow up|Termination of study|4|||
170617719|NCT03737123|616608788|FG001|Follow up|Termination of study|0|||
170617720|NCT00445549|616608789|FG000|Overall Study|progressive disease|12|||
170617721|NCT03858049|616608795|FG000|Overall Study|Adverse Event|16|||
170617722|NCT03858049|616608796|FG001|Overall Study|Adverse Event|9|||
170617723|NCT03858049|616608795|FG000|Overall Study|Other|1|||
170617724|NCT03858049|616608796|FG001|Overall Study|Other|1|||
170617725|NCT01474317|616608799|FG000|Overall Study|Adverse Event|1|||
170617726|NCT01474317|616608799|FG000|Overall Study|Subject ineligible for study|1|||
170617727|NCT00453154|616608802|FG000|Double BIind Maintenance|Adverse Event|0|||
170617728|NCT00453154|616608803|FG001|Double BIind Maintenance|Adverse Event|0|||
170617729|NCT00453154|616608804|FG002|Double BIind Maintenance|Adverse Event|3|||
170617730|NCT00453154|616608805|FG003|Double BIind Maintenance|Adverse Event|12|||
170617731|NCT00453154|616608802|FG000|Double BIind Maintenance|Death|0|||
170617732|NCT00453154|616608803|FG001|Double BIind Maintenance|Death|0|||
170617733|NCT00453154|616608804|FG002|Double BIind Maintenance|Death|2|||
170617734|NCT00453154|616608805|FG003|Double BIind Maintenance|Death|1|||
170617735|NCT00453154|616608802|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
170617736|NCT00453154|616608803|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
170617737|NCT00453154|616608804|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
170617738|NCT00453154|616608805|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
170617739|NCT00453154|616608802|FG000|Double BIind Maintenance|Progression|0|||
170617740|NCT00453154|616608803|FG001|Double BIind Maintenance|Progression|0|||
170617741|NCT00453154|616608804|FG002|Double BIind Maintenance|Progression|29|||
170617742|NCT00453154|616608805|FG003|Double BIind Maintenance|Progression|26|||
170617743|NCT00453154|616608802|FG000|Double BIind Maintenance|Medical Issues|0|||
170666007|NCT02122458|616790471|FG006|Overall Study|Withdrawal by Subject|0|||
170666008|NCT02122458|616790465|FG000|Overall Study|Lost to Follow-up|1|||
170666009|NCT02122458|616790466|FG001|Overall Study|Lost to Follow-up|3|||
170666010|NCT02122458|616790467|FG002|Overall Study|Lost to Follow-up|0|||
170666011|NCT02122458|616790468|FG003|Overall Study|Lost to Follow-up|7|||
170666012|NCT02122458|616790469|FG004|Overall Study|Lost to Follow-up|5|||
170666013|NCT02122458|616790470|FG005|Overall Study|Lost to Follow-up|15|||
170666014|NCT02122458|616790471|FG006|Overall Study|Lost to Follow-up|1|||
170666015|NCT02122458|616790465|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
170666016|NCT02122458|616790466|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
170666017|NCT02122458|616790467|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
170666018|NCT02122458|616790468|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
170666019|NCT02122458|616790469|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
170666020|NCT02122458|616790470|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
170666021|NCT02122458|616790471|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
170666022|NCT02122458|616790465|FG000|Overall Study|Adverse Event|1|||
170666023|NCT02122458|616790466|FG001|Overall Study|Adverse Event|0|||
170666024|NCT02122458|616790467|FG002|Overall Study|Adverse Event|0|||
170666025|NCT02122458|616790468|FG003|Overall Study|Adverse Event|0|||
170666026|NCT02122458|616790469|FG004|Overall Study|Adverse Event|0|||
170666027|NCT02122458|616790470|FG005|Overall Study|Adverse Event|0|||
170666028|NCT02122458|616790471|FG006|Overall Study|Adverse Event|0|||
170666029|NCT02122458|616790465|FG000|Overall Study|Experimental Error|0|||
170666030|NCT02122458|616790466|FG001|Overall Study|Experimental Error|0|||
170666031|NCT02122458|616790467|FG002|Overall Study|Experimental Error|0|||
170666032|NCT02122458|616790468|FG003|Overall Study|Experimental Error|0|||
170666033|NCT02122458|616790469|FG004|Overall Study|Experimental Error|3|||
170666034|NCT02122458|616790470|FG005|Overall Study|Experimental Error|0|||
170666035|NCT02122458|616790471|FG006|Overall Study|Experimental Error|0|||
170666036|NCT02122458|616790465|FG000|Overall Study|Deployed or Moved|0|||
170666037|NCT02122458|616790466|FG001|Overall Study|Deployed or Moved|0|||
170666038|NCT02122458|616790467|FG002|Overall Study|Deployed or Moved|0|||
170666039|NCT02122458|616790468|FG003|Overall Study|Deployed or Moved|0|||
170666040|NCT02122458|616790469|FG004|Overall Study|Deployed or Moved|1|||
170666041|NCT02122458|616790470|FG005|Overall Study|Deployed or Moved|0|||
170666042|NCT02122458|616790471|FG006|Overall Study|Deployed or Moved|0|||
170666043|NCT02122458|616790465|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
170666044|NCT02122458|616790466|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
170666045|NCT02122458|616790467|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
170666046|NCT02122458|616790468|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
170666047|NCT02122458|616790469|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
170666048|NCT02122458|616790470|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
170666049|NCT02122458|616790471|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
170666050|NCT02122458|616790465|FG000|Overall Study|Noncompliance|0|||
170666051|NCT02122458|616790466|FG001|Overall Study|Noncompliance|1|||
170666052|NCT02122458|616790467|FG002|Overall Study|Noncompliance|0|||
170666053|NCT02122458|616790468|FG003|Overall Study|Noncompliance|0|||
170666054|NCT02122458|616790469|FG004|Overall Study|Noncompliance|0|||
170818455|NCT00434577|617343579|FG000|Months 0-3|Adverse Event|0|||
170818456|NCT00434577|617343580|FG001|Months 0-3|Adverse Event|1|||
170818457|NCT00434577|617343581|FG002|Months 0-3|Adverse Event|1|||
170818458|NCT00434577|617343582|FG003|Months 0-3|Adverse Event|0|||
170818459|NCT00434577|617343583|FG004|Months 0-3|Adverse Event|0|||
170818460|NCT00434577|617343579|FG000|Months 0-3|Lost to Follow-up|0|||
170818461|NCT00434577|617343580|FG001|Months 0-3|Lost to Follow-up|0|||
170818462|NCT00434577|617343581|FG002|Months 0-3|Lost to Follow-up|0|||
170818463|NCT00434577|617343582|FG003|Months 0-3|Lost to Follow-up|0|||
170818464|NCT00434577|617343583|FG004|Months 0-3|Lost to Follow-up|2|||
170818465|NCT00434577|617343579|FG000|Months 0-3|Protocol Violation|1|||
170666055|NCT02122458|616790470|FG005|Overall Study|Noncompliance|0|||
170666056|NCT02122458|616790471|FG006|Overall Study|Noncompliance|0|||
170666057|NCT00412542|616790472|FG000|Overall Study|Withdrawal by Subject|0|||
170666058|NCT00412542|616790473|FG001|Overall Study|Withdrawal by Subject|2|||
170666059|NCT00412542|616790472|FG000|Overall Study|Not Eligible|0|||
170666060|NCT00412542|616790473|FG001|Overall Study|Not Eligible|1|||
170666061|NCT01788046|616790474|FG000|Overall Study|Withdrawal by Subject|12|||
170666062|NCT01788046|616790475|FG001|Overall Study|Withdrawal by Subject|12|||
170666063|NCT01788046|616790474|FG000|Overall Study|Lost to Follow-up|12|||
170666064|NCT01788046|616790475|FG001|Overall Study|Lost to Follow-up|19|||
170666065|NCT01788046|616790474|FG000|Overall Study|Death|7|||
170666066|NCT01788046|616790475|FG001|Overall Study|Death|5|||
170666067|NCT01788046|616790474|FG000|Overall Study|Protocol Specified Criteria|25|||
170666068|NCT01788046|616790475|FG001|Overall Study|Protocol Specified Criteria|1|||
170666069|NCT01500031|616790478|FG000|Overall Study|Death|1|||
170818466|NCT00434577|617343580|FG001|Months 0-3|Protocol Violation|0|||
170818467|NCT00434577|617343581|FG002|Months 0-3|Protocol Violation|1|||
170818468|NCT00434577|617343582|FG003|Months 0-3|Protocol Violation|0|||
170666070|NCT01500031|616790478|FG000|Overall Study|Withdrawal by Subject|4|||
170666071|NCT01938573|616790479|FG000|Overall Study|Lack of Efficacy|1|||
170666072|NCT01938573|616790480|FG001|Overall Study|Lack of Efficacy|0|||
170666073|NCT01938573|616790479|FG000|Overall Study|Operation at other hospital|1|||
170666074|NCT01938573|616790480|FG001|Overall Study|Operation at other hospital|0|||
170666075|NCT03449901|616790483|FG000|Overall Study|Progression|57|||
170666076|NCT03449901|616790484|FG001|Overall Study|Progression|12|||
170666077|NCT03449901|616790483|FG000|Overall Study|Adverse Event|3|||
170666078|NCT03449901|616790484|FG001|Overall Study|Adverse Event|0|||
170666079|NCT03449901|616790483|FG000|Overall Study|Death|6|||
170666080|NCT03449901|616790484|FG001|Overall Study|Death|2|||
170666081|NCT03449901|616790483|FG000|Overall Study|Withdrawal by Subject|12|||
170666082|NCT03449901|616790484|FG001|Overall Study|Withdrawal by Subject|1|||
170666083|NCT03449901|616790483|FG000|Overall Study|Physician Decision|1|||
170666084|NCT03449901|616790484|FG001|Overall Study|Physician Decision|0|||
170666085|NCT03449901|616790483|FG000|Overall Study|Patient elected for surgical intervention|1|||
170666086|NCT03449901|616790484|FG001|Overall Study|Patient elected for surgical intervention|0|||
170666087|NCT03449901|616790483|FG000|Overall Study|Patient off for other complicating disease|1|||
170666088|NCT03449901|616790484|FG001|Overall Study|Patient off for other complicating disease|0|||
170666089|NCT03150173|616790485|FG000|Overall Study|Lost to Follow-up|13|||
170666090|NCT03150173|616790486|FG001|Overall Study|Lost to Follow-up|5|||
170666091|NCT03755791|616790489|FG000|Overall Study|Did not receive any study treatment|3|||
170666092|NCT03755791|616790490|FG001|Overall Study|Did not receive any study treatment|0|||
170666093|NCT03755791|616790491|FG002|Overall Study|Did not receive any study treatment|10|||
170666094|NCT03755791|616790489|FG000|Overall Study|Radiographic progression|204|||
170666095|NCT03755791|616790490|FG001|Overall Study|Radiographic progression|92|||
170666096|NCT03755791|616790491|FG002|Overall Study|Radiographic progression|115|||
170666097|NCT03755791|616790489|FG000|Overall Study|Adverse Event|140|||
170666098|NCT03755791|616790490|FG001|Overall Study|Adverse Event|60|||
170666099|NCT03755791|616790491|FG002|Overall Study|Adverse Event|51|||
170666100|NCT03755791|616790489|FG000|Overall Study|Lack of Efficacy|12|||
170666101|NCT03755791|616790490|FG001|Overall Study|Lack of Efficacy|6|||
170666102|NCT03755791|616790491|FG002|Overall Study|Lack of Efficacy|6|||
170666103|NCT03755791|616790489|FG000|Overall Study|Withdrawal by Subject|26|||
170666104|NCT03755791|616790490|FG001|Overall Study|Withdrawal by Subject|23|||
170666105|NCT03755791|616790491|FG002|Overall Study|Withdrawal by Subject|24|||
170666106|NCT03755791|616790489|FG000|Overall Study|Sponsor decision,|41|||
170666107|NCT03755791|616790490|FG001|Overall Study|Sponsor decision,|5|||
170666108|NCT03755791|616790491|FG002|Overall Study|Sponsor decision,|7|||
170666109|NCT03755791|616790489|FG000|Overall Study|Lost to Follow-up|1|||
170666110|NCT03755791|616790490|FG001|Overall Study|Lost to Follow-up|0|||
170666111|NCT03755791|616790491|FG002|Overall Study|Lost to Follow-up|2|||
170666112|NCT03755791|616790489|FG000|Overall Study|Protocol Violation|0|||
170666113|NCT03755791|616790490|FG001|Overall Study|Protocol Violation|0|||
170666114|NCT03755791|616790491|FG002|Overall Study|Protocol Violation|2|||
170666115|NCT03755791|616790489|FG000|Overall Study|Other than specified|5|||
170666116|NCT03755791|616790490|FG001|Overall Study|Other than specified|2|||
170666117|NCT03755791|616790491|FG002|Overall Study|Other than specified|0|||
170666118|NCT03605212|616790494|FG000|Treatment Period|Adverse Event|1|||
170666119|NCT03605212|616790495|FG001|Treatment Period|Adverse Event|0|||
170666120|NCT03605212|616790496|FG002|Treatment Period|Adverse Event|0|||
170666121|NCT03605212|616790497|FG003|Treatment Period|Adverse Event|0|||
170666122|NCT03605212|616790498|FG004|Treatment Period|Adverse Event|0|||
170666123|NCT03605212|616790494|FG000|Treatment Period|Physician Decision|0|||
170666124|NCT03605212|616790495|FG001|Treatment Period|Physician Decision|0|||
170666125|NCT03605212|616790496|FG002|Treatment Period|Physician Decision|0|||
170666126|NCT03605212|616790497|FG003|Treatment Period|Physician Decision|0|||
170666127|NCT03605212|616790498|FG004|Treatment Period|Physician Decision|1|||
170666128|NCT02404220|616790508|FG000|Overall Study|Adverse Event|0|||
170666129|NCT02404220|616790509|FG001|Overall Study|Adverse Event|0|||
170666130|NCT02404220|616790510|FG002|Overall Study|Adverse Event|1|||
170666131|NCT02404220|616790511|FG003|Overall Study|Adverse Event|0|||
170818469|NCT00434577|617343583|FG004|Months 0-3|Protocol Violation|0|||
170666132|NCT02404220|616790508|FG000|Overall Study|Death|5|||
170666133|NCT02404220|616790509|FG001|Overall Study|Death|5|||
170666134|NCT02404220|616790510|FG002|Overall Study|Death|3|||
170666135|NCT02404220|616790511|FG003|Overall Study|Death|8|||
170666136|NCT02404220|616790508|FG000|Overall Study|Progressive Disease|0|||
170666137|NCT02404220|616790509|FG001|Overall Study|Progressive Disease|0|||
170666138|NCT02404220|616790510|FG002|Overall Study|Progressive Disease|1|||
170666139|NCT02404220|616790511|FG003|Overall Study|Progressive Disease|1|||
170666140|NCT02404220|616790508|FG000|Overall Study|Study Terminated by Sponsor|0|||
170666141|NCT02404220|616790509|FG001|Overall Study|Study Terminated by Sponsor|0|||
170666142|NCT02404220|616790510|FG002|Overall Study|Study Terminated by Sponsor|2|||
170666143|NCT02404220|616790511|FG003|Overall Study|Study Terminated by Sponsor|1|||
170666144|NCT02404220|616790508|FG000|Overall Study|Withdrawal by Subject|0|||
170666145|NCT02404220|616790509|FG001|Overall Study|Withdrawal by Subject|1|||
170617744|NCT00453154|616608803|FG001|Double BIind Maintenance|Medical Issues|0|||
170617745|NCT00453154|616608804|FG002|Double BIind Maintenance|Medical Issues|3|||
170617746|NCT00453154|616608805|FG003|Double BIind Maintenance|Medical Issues|1|||
170617747|NCT00453154|616608802|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
170617748|NCT00453154|616608803|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
170617749|NCT00453154|616608804|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
170617750|NCT00453154|616608805|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
170617751|NCT03629886|616608807|FG000|Overall Study|Migrated / moved from the study area|0|||
170818470|NCT00434577|617343579|FG000|Months 0-3|Withdrawal by Subject|2|||
170818471|NCT00434577|617343580|FG001|Months 0-3|Withdrawal by Subject|1|||
170818472|NCT00434577|617343581|FG002|Months 0-3|Withdrawal by Subject|1|||
170818473|NCT00434577|617343582|FG003|Months 0-3|Withdrawal by Subject|1|||
170818474|NCT00434577|617343583|FG004|Months 0-3|Withdrawal by Subject|1|||
170818475|NCT01232569|617343584|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
170818476|NCT01232569|617343585|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
170617752|NCT03629886|616608808|FG001|Overall Study|Migrated / moved from the study area|55|||
170617753|NCT03629886|616608807|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
170617754|NCT03629886|616608808|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
170617755|NCT03629886|616608807|FG000|Overall Study|Study vaccine not administrated|0|||
170617756|NCT03629886|616608808|FG001|Overall Study|Study vaccine not administrated|3|||
170617757|NCT03629886|616608807|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
170617758|NCT03629886|616608808|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
170617759|NCT03629886|616608807|FG000|Overall Study|Refused vaccination step of the study|0|||
170617760|NCT03629886|616608808|FG001|Overall Study|Refused vaccination step of the study|44|||
170617761|NCT01790594|616608809|FG000|Overall Study|Death|1|||
170617762|NCT01790594|616608810|FG001|Overall Study|Death|0|||
170617763|NCT01790594|616608811|FG002|Overall Study|Death|0|||
170617764|NCT01790594|616608809|FG000|Overall Study|Physician Decision|2|||
170617765|NCT01790594|616608810|FG001|Overall Study|Physician Decision|1|||
170617766|NCT01790594|616608811|FG002|Overall Study|Physician Decision|0|||
170617767|NCT01790594|616608809|FG000|Overall Study|Withdrawal by Subject|2|||
170617768|NCT01790594|616608810|FG001|Overall Study|Withdrawal by Subject|0|||
170617769|NCT01790594|616608811|FG002|Overall Study|Withdrawal by Subject|0|||
170617770|NCT01790594|616608809|FG000|Overall Study|Transplant was not done|0|||
170617771|NCT01790594|616608810|FG001|Overall Study|Transplant was not done|0|||
170617772|NCT01790594|616608811|FG002|Overall Study|Transplant was not done|3|||
170617773|NCT01790594|616608809|FG000|Overall Study|Terminated prior to week 76|0|||
170617774|NCT01790594|616608810|FG001|Overall Study|Terminated prior to week 76|2|||
170617775|NCT01790594|616608811|FG002|Overall Study|Terminated prior to week 76|0|||
170617776|NCT05473026|616608813|FG000|Overall Study|Lost to Follow-up|5|||
170617777|NCT05473026|616608814|FG001|Overall Study|Lost to Follow-up|2|||
170617778|NCT02038153|616608815|FG000|Overall Study|Withdrawal by Subject|1|||
170617779|NCT03683173|616608816|FG000|Completed Follow-up|Unavailable|235|||
170617780|NCT03683173|616608817|FG001|Completed Follow-up|Unavailable|217|||
170617781|NCT03683173|616608816|FG000|Completed Follow-up|Refused|69|||
170617782|NCT03683173|616608817|FG001|Completed Follow-up|Refused|59|||
170617783|NCT03683173|616608816|FG000|Completed Follow-up|Disconnected phone|65|||
170617784|NCT03683173|616608817|FG001|Completed Follow-up|Disconnected phone|95|||
170617785|NCT03683173|616608816|FG000|Completed Follow-up|Health issue/deceased|10|||
170617786|NCT03683173|616608817|FG001|Completed Follow-up|Health issue/deceased|4|||
170617787|NCT03683173|616608816|FG000|Completed Follow-up|Moved away|8|||
170617788|NCT03683173|616608817|FG001|Completed Follow-up|Moved away|1|||
170617789|NCT02647281|616608818|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
170617790|NCT02647281|616608819|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
170617791|NCT02647281|616608820|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
170617792|NCT02647281|616608821|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
170617793|NCT02647281|616608822|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
170617794|NCT02647281|616608823|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
170617795|NCT02647281|616608824|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
170617796|NCT02647281|616608825|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
170617797|NCT02647281|616608826|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
170617798|NCT01050634|616608827|FG000|Overall Study|Enrolled, but Not Treated|56|||
170617799|NCT01050634|616608827|FG000|Overall Study|Death|2|||
170818477|NCT01232569|617343586|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170818478|NCT01232569|617343587|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
170818479|NCT01232569|617343584|FG000|Double-blind Treatment Period|Escape|2|||
170818480|NCT01232569|617343585|FG001|Double-blind Treatment Period|Escape|2|||
170818481|NCT01232569|617343586|FG002|Double-blind Treatment Period|Escape|0|||
170818482|NCT01232569|617343587|FG003|Double-blind Treatment Period|Escape|0|||
170818483|NCT01232569|617343584|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
170818484|NCT01232569|617343585|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
170818485|NCT01232569|617343586|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
170666146|NCT02404220|616790510|FG002|Overall Study|Withdrawal by Subject|0|||
170666147|NCT02404220|616790511|FG003|Overall Study|Withdrawal by Subject|0|||
170666148|NCT02404220|616790508|FG000|Overall Study|Enrolled but Never Treated|0|||
170666149|NCT02404220|616790509|FG001|Overall Study|Enrolled but Never Treated|2|||
170666150|NCT02404220|616790510|FG002|Overall Study|Enrolled but Never Treated|0|||
170666151|NCT02404220|616790511|FG003|Overall Study|Enrolled but Never Treated|0|||
170666152|NCT03469934|616790512|FG000|Overall Study|Withdrawal by Subject|0|||
170666153|NCT03469934|616790513|FG001|Overall Study|Withdrawal by Subject|1|||
170666154|NCT01268150|616790515|FG000|Treatment Phase|Progression of disease|18|||
170666155|NCT01268150|616790515|FG000|Treatment Phase|Adverse Event|3|||
170666156|NCT01268150|616790515|FG000|Treatment Phase|Withdrawal by Subject|3|||
170666157|NCT01268150|616790515|FG000|Treatment Phase|Other|4|||
170617800|NCT01050634|616608827|FG000|Overall Study|Adverse Event|42|||
170617801|NCT01050634|616608827|FG000|Overall Study|Lost to Follow-up|2|||
170617802|NCT01050634|616608827|FG000|Overall Study|Other|21|||
170617803|NCT01050634|616608827|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
170617804|NCT00496015|616608828|FG000|Overall Study|Other|1|||
170617805|NCT00496015|616608829|FG001|Overall Study|Other|0|||
170617806|NCT00496015|616608830|FG002|Overall Study|Other|0|||
170617807|NCT00496015|616608831|FG003|Overall Study|Other|1|||
170617808|NCT00496015|616608832|FG004|Overall Study|Other|0|||
170617809|NCT02730728|616608833|FG000|Overall Study|Withdrawal by Subject|0|||
170617810|NCT02730728|616608834|FG001|Overall Study|Withdrawal by Subject|1|||
170617811|NCT02730728|616608835|FG002|Overall Study|Withdrawal by Subject|0|||
170617812|NCT02730728|616608833|FG000|Overall Study|Lack of Efficacy|0|||
170617813|NCT02730728|616608834|FG001|Overall Study|Lack of Efficacy|1|||
170617814|NCT02730728|616608835|FG002|Overall Study|Lack of Efficacy|1|||
170617815|NCT03400852|616608838|FG000|Blinded Treatment Period|Physician Decision|0|||
170617816|NCT03400852|616608839|FG001|Blinded Treatment Period|Physician Decision|1|||
170617817|NCT03400852|616608840|FG002|Blinded Treatment Period|Physician Decision|0|||
170617818|NCT03400852|616608838|FG000|Blinded Treatment Period|Adverse Event|1|||
170617819|NCT03400852|616608839|FG001|Blinded Treatment Period|Adverse Event|1|||
170617820|NCT03400852|616608840|FG002|Blinded Treatment Period|Adverse Event|0|||
170617821|NCT03400852|616608838|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
170617822|NCT03400852|616608839|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
170617823|NCT03400852|616608840|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
170617824|NCT03400852|616608838|FG000|Open Label Period|Physician Decision|0|||
170617825|NCT03400852|616608839|FG001|Open Label Period|Physician Decision|0|||
170617826|NCT03400852|616608840|FG002|Open Label Period|Physician Decision|1|||
170617827|NCT03400852|616608838|FG000|Open Label Period|Study terminated by sponsor|0|||
170617828|NCT03400852|616608839|FG001|Open Label Period|Study terminated by sponsor|0|||
170617829|NCT03400852|616608840|FG002|Open Label Period|Study terminated by sponsor|21|||
170617830|NCT00248495|616608841|FG000|Overall Study|Withdrawal by Subject|1|||
170617831|NCT01285401|616608842|FG000|Overall Study|Prematurely withdrawn from the study|17|||
170617832|NCT01285401|616608843|FG001|Overall Study|Prematurely withdrawn from the study|29|||
170617833|NCT01794000|616608846|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
170617834|NCT01794000|616608847|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
170617835|NCT01794000|616608846|FG000|Double-Blind Phase (DBP)|Death|1|||
170617836|NCT01794000|616608847|FG001|Double-Blind Phase (DBP)|Death|2|||
170617837|NCT01794000|616608846|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
170617838|NCT01794000|616608847|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
170617839|NCT01794000|616608846|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
170617840|NCT01794000|616608847|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
170617841|NCT01794000|616608846|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
170617842|NCT01794000|616608847|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
170617843|NCT01794000|616608846|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
170617844|NCT01794000|616608847|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
170617845|NCT01794000|616608846|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
170617846|NCT01794000|616608847|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
170617847|NCT01794000|616608846|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
170617848|NCT01794000|616608847|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
170617849|NCT00255190|616608848|FG000|Overall Study|Adverse Event|17|||
170617850|NCT00255190|616608849|FG001|Overall Study|Adverse Event|36|||
170617851|NCT00255190|616608848|FG000|Overall Study|Protocol Violation|2|||
170617852|NCT00255190|616608849|FG001|Overall Study|Protocol Violation|2|||
170617853|NCT00255190|616608848|FG000|Overall Study|Lost to Follow-up|10|||
170617854|NCT00255190|616608849|FG001|Overall Study|Lost to Follow-up|27|||
170617855|NCT00255190|616608848|FG000|Overall Study|Withdrew Consent|17|||
170617856|NCT00255190|616608849|FG001|Overall Study|Withdrew Consent|48|||
170617857|NCT00255190|616608848|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
170617858|NCT00255190|616608849|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
170666158|NCT01268150|616790515|FG000|Extension Phase|Adverse Event|3|||
170666159|NCT01268150|616790515|FG000|Extension Phase|Disease progression|18|||
170666160|NCT01268150|616790515|FG000|Extension Phase|Other|6|||
170666161|NCT02761733|616790518|FG000|Overall Study|Death|3|||
170666162|NCT02761733|616790519|FG001|Overall Study|Death|5|||
170666163|NCT02761733|616790520|FG002|Overall Study|Death|1|||
170666164|NCT02761733|616790521|FG003|Overall Study|Death|1|||
170666165|NCT02761733|616790518|FG000|Overall Study|Lost to Follow-up|6|||
170666166|NCT02761733|616790519|FG001|Overall Study|Lost to Follow-up|7|||
170666167|NCT02761733|616790520|FG002|Overall Study|Lost to Follow-up|0|||
170666168|NCT02761733|616790521|FG003|Overall Study|Lost to Follow-up|3|||
170666169|NCT02761733|616790518|FG000|Overall Study|Physician Decision|4|||
170617859|NCT00255190|616608848|FG000|Overall Study|Erosive esophagitis not healed|0|||
170617860|NCT00255190|616608849|FG001|Overall Study|Erosive esophagitis not healed|20|||
170617861|NCT00255190|616608848|FG000|Overall Study|Various|4|||
170617862|NCT00255190|616608849|FG001|Overall Study|Various|23|||
170617863|NCT04303559|616608850|FG000|Overall Study|Study closed due to poor enrollment.|1|||
170617864|NCT04378270|616608855|FG000|Overall Study|Lack of Efficacy|1|||
170617865|NCT04378270|616608855|FG000|Overall Study|Withdrawal by Subject|1|||
170617866|NCT04378270|616608855|FG000|Overall Study|Screen Failure|1|||
170617867|NCT04378270|616608855|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
170617868|NCT01327599|616608856|FG000|Overall Study|Adverse Event|1|||
170617869|NCT01327599|616608856|FG000|Overall Study|Could Not Attend Visit|1|||
170617870|NCT01327599|616608856|FG000|Overall Study|Withdrawal of Consent|1|||
170617871|NCT01132313|616608857|FG000|Overall Study|Lack of Efficacy|1|||
170617872|NCT01132313|616608858|FG001|Overall Study|Lack of Efficacy|0|||
170617873|NCT01132313|616608859|FG002|Overall Study|Lack of Efficacy|0|||
170617874|NCT01132313|616608860|FG003|Overall Study|Lack of Efficacy|0|||
170617875|NCT01132313|616608861|FG004|Overall Study|Lack of Efficacy|0|||
170617876|NCT01132313|616608862|FG005|Overall Study|Lack of Efficacy|0|||
170617877|NCT01132313|616608863|FG006|Overall Study|Lack of Efficacy|0|||
170617878|NCT01132313|616608864|FG007|Overall Study|Lack of Efficacy|3|||
170617879|NCT01132313|616608865|FG008|Overall Study|Lack of Efficacy|14|||
170617880|NCT01132313|616608866|FG009|Overall Study|Lack of Efficacy|16|||
170617881|NCT01132313|616608867|FG010|Overall Study|Lack of Efficacy|0|||
170617882|NCT01132313|616608868|FG011|Overall Study|Lack of Efficacy|0|||
170617883|NCT01132313|616608857|FG000|Overall Study|Not treated|2|||
170617884|NCT01132313|616608858|FG001|Overall Study|Not treated|0|||
170617885|NCT01132313|616608859|FG002|Overall Study|Not treated|0|||
170617886|NCT01132313|616608860|FG003|Overall Study|Not treated|0|||
170617887|NCT01132313|616608861|FG004|Overall Study|Not treated|2|||
170617888|NCT01132313|616608862|FG005|Overall Study|Not treated|1|||
170617889|NCT01132313|616608863|FG006|Overall Study|Not treated|3|||
170617890|NCT01132313|616608864|FG007|Overall Study|Not treated|0|||
170617891|NCT01132313|616608865|FG008|Overall Study|Not treated|0|||
170617892|NCT01132313|616608866|FG009|Overall Study|Not treated|0|||
170617893|NCT01132313|616608867|FG010|Overall Study|Not treated|0|||
170617894|NCT01132313|616608868|FG011|Overall Study|Not treated|0|||
170617895|NCT01132313|616608857|FG000|Overall Study|Adverse Event|0|||
170617896|NCT01132313|616608858|FG001|Overall Study|Adverse Event|0|||
170617897|NCT01132313|616608859|FG002|Overall Study|Adverse Event|4|||
170617898|NCT01132313|616608860|FG003|Overall Study|Adverse Event|10|||
170617899|NCT01132313|616608861|FG004|Overall Study|Adverse Event|19|||
170617900|NCT01132313|616608862|FG005|Overall Study|Adverse Event|6|||
170617901|NCT01132313|616608863|FG006|Overall Study|Adverse Event|5|||
170617902|NCT01132313|616608864|FG007|Overall Study|Adverse Event|3|||
170617903|NCT01132313|616608865|FG008|Overall Study|Adverse Event|7|||
170617904|NCT01132313|616608866|FG009|Overall Study|Adverse Event|2|||
170617905|NCT01132313|616608867|FG010|Overall Study|Adverse Event|0|||
170617906|NCT01132313|616608868|FG011|Overall Study|Adverse Event|0|||
170617907|NCT01132313|616608857|FG000|Overall Study|Protocol Violation|0|||
170617908|NCT01132313|616608858|FG001|Overall Study|Protocol Violation|0|||
170617909|NCT01132313|616608859|FG002|Overall Study|Protocol Violation|0|||
170617910|NCT01132313|616608860|FG003|Overall Study|Protocol Violation|1|||
170617911|NCT01132313|616608861|FG004|Overall Study|Protocol Violation|0|||
170617912|NCT01132313|616608862|FG005|Overall Study|Protocol Violation|0|||
170617913|NCT01132313|616608863|FG006|Overall Study|Protocol Violation|0|||
170617914|NCT01132313|616608864|FG007|Overall Study|Protocol Violation|0|||
170617915|NCT01132313|616608865|FG008|Overall Study|Protocol Violation|0|||
170617916|NCT01132313|616608866|FG009|Overall Study|Protocol Violation|0|||
170617917|NCT01132313|616608867|FG010|Overall Study|Protocol Violation|0|||
170617918|NCT01132313|616608868|FG011|Overall Study|Protocol Violation|0|||
170617919|NCT01132313|616608857|FG000|Overall Study|Lost to Follow-up|0|||
170617920|NCT01132313|616608858|FG001|Overall Study|Lost to Follow-up|0|||
170617921|NCT01132313|616608859|FG002|Overall Study|Lost to Follow-up|1|||
170617922|NCT01132313|616608860|FG003|Overall Study|Lost to Follow-up|0|||
170617923|NCT01132313|616608861|FG004|Overall Study|Lost to Follow-up|0|||
170617924|NCT01132313|616608862|FG005|Overall Study|Lost to Follow-up|0|||
170617925|NCT01132313|616608863|FG006|Overall Study|Lost to Follow-up|0|||
170617926|NCT01132313|616608864|FG007|Overall Study|Lost to Follow-up|1|||
170666170|NCT02761733|616790519|FG001|Overall Study|Physician Decision|0|||
170617927|NCT01132313|616608865|FG008|Overall Study|Lost to Follow-up|0|||
170617928|NCT01132313|616608866|FG009|Overall Study|Lost to Follow-up|0|||
170617929|NCT01132313|616608867|FG010|Overall Study|Lost to Follow-up|0|||
170617930|NCT01132313|616608868|FG011|Overall Study|Lost to Follow-up|0|||
170617931|NCT01132313|616608857|FG000|Overall Study|Withdrawal by Subject|0|||
170666171|NCT02761733|616790520|FG002|Overall Study|Physician Decision|0|||
170666172|NCT02761733|616790521|FG003|Overall Study|Physician Decision|0|||
170666173|NCT02761733|616790518|FG000|Overall Study|Withdrawal by Subject|2|||
170666174|NCT02761733|616790519|FG001|Overall Study|Withdrawal by Subject|0|||
170666175|NCT02761733|616790520|FG002|Overall Study|Withdrawal by Subject|0|||
170666176|NCT02761733|616790521|FG003|Overall Study|Withdrawal by Subject|0|||
170666177|NCT02761733|616790518|FG000|Overall Study|Discharged from Study Site|10|||
170666178|NCT02761733|616790519|FG001|Overall Study|Discharged from Study Site|9|||
170666179|NCT02761733|616790520|FG002|Overall Study|Discharged from Study Site|25|||
170666180|NCT02761733|616790521|FG003|Overall Study|Discharged from Study Site|11|||
170666181|NCT02761733|616790518|FG000|Overall Study|Cognitive Impairment|5|||
170666182|NCT02761733|616790519|FG001|Overall Study|Cognitive Impairment|0|||
170666183|NCT02761733|616790520|FG002|Overall Study|Cognitive Impairment|1|||
170666184|NCT02761733|616790521|FG003|Overall Study|Cognitive Impairment|0|||
170666185|NCT00669396|616790522|FG000|Overall Study|Lost to Follow-up|10|||
170666186|NCT00669396|616790523|FG001|Overall Study|Lost to Follow-up|12|||
170666187|NCT04402060|616790524|FG000|Overall Study|Death|1|||
170666188|NCT04402060|616790525|FG001|Overall Study|Death|12|||
170666189|NCT04402060|616790526|FG002|Overall Study|Death|7|||
170666190|NCT04402060|616790524|FG000|Overall Study|Adverse Event|0|||
170666191|NCT04402060|616790525|FG001|Overall Study|Adverse Event|0|||
170666192|NCT04402060|616790526|FG002|Overall Study|Adverse Event|1|||
170666193|NCT04402060|616790524|FG000|Overall Study|Withdrawal by Subject|0|||
170666194|NCT04402060|616790525|FG001|Overall Study|Withdrawal by Subject|1|||
170666195|NCT04402060|616790526|FG002|Overall Study|Withdrawal by Subject|2|||
170666196|NCT04402060|616790524|FG000|Overall Study|Sponsor Request|0|||
170666197|NCT04402060|616790525|FG001|Overall Study|Sponsor Request|2|||
170666198|NCT04402060|616790526|FG002|Overall Study|Sponsor Request|0|||
170666199|NCT04402060|616790524|FG000|Overall Study|Physician Decision|0|||
170666200|NCT04402060|616790525|FG001|Overall Study|Physician Decision|0|||
170666201|NCT04402060|616790526|FG002|Overall Study|Physician Decision|1|||
170666202|NCT04402060|616790524|FG000|Overall Study|Other|0|||
170666203|NCT04402060|616790525|FG001|Overall Study|Other|1|||
170666204|NCT04402060|616790526|FG002|Overall Study|Other|0|||
170666205|NCT01297920|616790527|FG000|Overall Study|Adverse Event|42|||
170666206|NCT01297920|616790528|FG001|Overall Study|Adverse Event|10|||
170666207|NCT01297920|616790529|FG002|Overall Study|Adverse Event|38|||
170666208|NCT01297920|616790527|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
170666209|NCT01297920|616790528|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
170666210|NCT01297920|616790529|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
170666211|NCT01297920|616790527|FG000|Overall Study|Noncompliance|1|||
170666212|NCT01297920|616790528|FG001|Overall Study|Noncompliance|0|||
170666213|NCT01297920|616790529|FG002|Overall Study|Noncompliance|0|||
170666214|NCT01297920|616790527|FG000|Overall Study|Protocol Violation|1|||
170666215|NCT01297920|616790528|FG001|Overall Study|Protocol Violation|3|||
170666216|NCT01297920|616790529|FG002|Overall Study|Protocol Violation|0|||
170666217|NCT01297920|616790527|FG000|Overall Study|Inadequate Control of IOP|7|||
170666218|NCT01297920|616790528|FG001|Overall Study|Inadequate Control of IOP|9|||
170666219|NCT01297920|616790529|FG002|Overall Study|Inadequate Control of IOP|17|||
170666220|NCT01297920|616790527|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
170666221|NCT01297920|616790528|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
170666222|NCT01297920|616790529|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
170666223|NCT04068610|616790533|FG000|Overall Study|Death|4|||
170666224|NCT04068610|616790534|FG001|Overall Study|Death|8|||
170666225|NCT04068610|616790535|FG002|Overall Study|Death|13|||
170666226|NCT04068610|616790533|FG000|Overall Study|Lost to Follow-up|0|||
170666227|NCT04068610|616790534|FG001|Overall Study|Lost to Follow-up|2|||
170666228|NCT04068610|616790535|FG002|Overall Study|Lost to Follow-up|0|||
170666229|NCT04068610|616790533|FG000|Overall Study|Withdrawal by Subject|0|||
170666230|NCT04068610|616790534|FG001|Overall Study|Withdrawal by Subject|4|||
170666231|NCT04068610|616790535|FG002|Overall Study|Withdrawal by Subject|2|||
170666232|NCT04068610|616790533|FG000|Overall Study|Other|3|||
170666233|NCT04068610|616790534|FG001|Overall Study|Other|12|||
170666234|NCT04068610|616790535|FG002|Overall Study|Other|11|||
170666235|NCT03308786|616790540|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
170666236|NCT01999868|616790541|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
170666237|NCT01999868|616790542|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
170666238|NCT01999868|616790543|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
170666239|NCT01999868|616790541|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
170666240|NCT01999868|616790542|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
170666241|NCT01999868|616790543|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
170666242|NCT01999868|616790541|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
170666243|NCT01999868|616790542|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
170666244|NCT01999868|616790543|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
170666245|NCT01999868|616790541|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
170666246|NCT01999868|616790542|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
170917485|NCT02445391|617697967|FG000|Overall Study|Adverse Event|0|||
170666247|NCT01999868|616790543|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
170666248|NCT01999868|616790541|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
170666249|NCT01999868|616790542|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
170666250|NCT01999868|616790543|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
170666251|NCT01999868|616790541|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
170666252|NCT01999868|616790542|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
170666253|NCT01999868|616790543|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
170666254|NCT01999868|616790541|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
170666255|NCT01999868|616790542|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
170666256|NCT01999868|616790543|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
170666257|NCT01999868|616790541|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
170666258|NCT01999868|616790542|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
170666259|NCT01999868|616790543|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
170666260|NCT01999868|616790541|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
170666261|NCT01999868|616790542|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
170666262|NCT01999868|616790543|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
170666263|NCT01999868|616790541|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
170666264|NCT01999868|616790542|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
170666265|NCT01999868|616790543|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
170666266|NCT01999868|616790541|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
170666267|NCT01999868|616790542|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
170666268|NCT01999868|616790543|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
170666269|NCT01999868|616790541|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
170666270|NCT01999868|616790542|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
170666271|NCT01999868|616790543|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
170666272|NCT01999868|616790541|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
170666273|NCT01999868|616790542|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
170666274|NCT01999868|616790543|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
170666275|NCT01999868|616790541|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
170666276|NCT01999868|616790542|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
170666277|NCT01999868|616790543|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
170666278|NCT01999868|616790541|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
170666279|NCT01999868|616790542|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
170666280|NCT01999868|616790543|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
170666281|NCT05628103|616790544|FG000|Overall Study|Adverse Event|7|||
170666282|NCT05628103|616790544|FG000|Overall Study|Withdrawal by Subject|3|||
170666283|NCT05628103|616790544|FG000|Overall Study|Lost to Follow-up|3|||
170666284|NCT05628103|616790544|FG000|Overall Study|Lack of Efficacy|1|||
170666285|NCT05628103|616790544|FG000|Overall Study|Non-Compliance With Study Drug|4|||
170666286|NCT04195906|616792070|FG000|Part 1|Adverse Event|3|||
170666287|NCT04195906|616792071|FG001|Part 1|Adverse Event|7|||
170666288|NCT04195906|616792070|FG000|Part 1|Withdrawal by Subject|0|||
170666289|NCT04195906|616792071|FG001|Part 1|Withdrawal by Subject|1|||
170666290|NCT04195906|616792070|FG000|Part 2|Adverse Event|1|||
170666291|NCT04195906|616792071|FG001|Part 2|Adverse Event|1|||
170666292|NCT04195906|616792070|FG000|Part 2|Withdrawal by Subject|0|||
170666293|NCT04195906|616792071|FG001|Part 2|Withdrawal by Subject|3|||
170666294|NCT04195906|616792070|FG000|Part 2|Other|1|||
170666295|NCT04195906|616792071|FG001|Part 2|Other|3|||
170666296|NCT02008318|616792074|FG000|Overall Study|Adverse Event|4|||
170666297|NCT02008318|616792075|FG001|Overall Study|Adverse Event|0|||
170666298|NCT02008318|616792074|FG000|Overall Study|Physician Decision|2|||
170666299|NCT02008318|616792075|FG001|Overall Study|Physician Decision|0|||
170666300|NCT02008318|616792074|FG000|Overall Study|Progressive Disease|2|||
170666301|NCT02008318|616792075|FG001|Overall Study|Progressive Disease|0|||
170666302|NCT02008318|616792074|FG000|Overall Study|Protocol Violation|1|||
170666303|NCT02008318|616792075|FG001|Overall Study|Protocol Violation|1|||
170666304|NCT02008318|616792074|FG000|Overall Study|Withdrawal by Subject|3|||
170666305|NCT02008318|616792075|FG001|Overall Study|Withdrawal by Subject|0|||
170666306|NCT02281773|616792076|FG000|Overall Study|Adverse Event|6|||
170666307|NCT02281773|616792077|FG001|Overall Study|Adverse Event|1|||
170666308|NCT02281773|616792078|FG002|Overall Study|Adverse Event|4|||
170818486|NCT01232569|617343587|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
170818487|NCT01232569|617343584|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
170818488|NCT01232569|617343585|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
170818489|NCT01232569|617343586|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
170666309|NCT02281773|616792079|FG003|Overall Study|Adverse Event|8|||
170666310|NCT02281773|616792080|FG004|Overall Study|Adverse Event|9|||
170818490|NCT01232569|617343587|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
170666311|NCT02281773|616792076|FG000|Overall Study|Protocol Violation|1|||
170666312|NCT02281773|616792077|FG001|Overall Study|Protocol Violation|0|||
170666313|NCT02281773|616792078|FG002|Overall Study|Protocol Violation|0|||
170666314|NCT02281773|616792079|FG003|Overall Study|Protocol Violation|2|||
170666315|NCT02281773|616792080|FG004|Overall Study|Protocol Violation|2|||
170666316|NCT02281773|616792076|FG000|Overall Study|Lost to Follow-up|2|||
170666317|NCT02281773|616792077|FG001|Overall Study|Lost to Follow-up|2|||
170666318|NCT02281773|616792078|FG002|Overall Study|Lost to Follow-up|6|||
170666319|NCT02281773|616792079|FG003|Overall Study|Lost to Follow-up|2|||
170666320|NCT02281773|616792080|FG004|Overall Study|Lost to Follow-up|10|||
170666321|NCT02281773|616792076|FG000|Overall Study|Withdrawal by Subject|2|||
170666322|NCT02281773|616792077|FG001|Overall Study|Withdrawal by Subject|8|||
170666323|NCT02281773|616792078|FG002|Overall Study|Withdrawal by Subject|6|||
170666324|NCT02281773|616792079|FG003|Overall Study|Withdrawal by Subject|6|||
170666325|NCT02281773|616792080|FG004|Overall Study|Withdrawal by Subject|8|||
170666326|NCT02281773|616792076|FG000|Overall Study|Other Reason|0|||
170666327|NCT02281773|616792077|FG001|Overall Study|Other Reason|4|||
170666328|NCT02281773|616792078|FG002|Overall Study|Other Reason|2|||
170666329|NCT02281773|616792079|FG003|Overall Study|Other Reason|3|||
170666330|NCT02281773|616792080|FG004|Overall Study|Other Reason|1|||
170666331|NCT05439941|616792081|FG000|Overall Study|Lack of Efficacy|8|||
170666332|NCT05439941|616792082|FG001|Overall Study|Lack of Efficacy|5|||
170666333|NCT05439941|616792083|FG002|Overall Study|Lack of Efficacy|3|||
170666334|NCT05439941|616792081|FG000|Overall Study|Treatment Failure|0|||
170666335|NCT05439941|616792082|FG001|Overall Study|Treatment Failure|1|||
170666336|NCT05439941|616792083|FG002|Overall Study|Treatment Failure|0|||
170666337|NCT05439941|616792081|FG000|Overall Study|Adverse Event|1|||
170666338|NCT05439941|616792082|FG001|Overall Study|Adverse Event|3|||
170666339|NCT05439941|616792083|FG002|Overall Study|Adverse Event|0|||
170666340|NCT05439941|616792081|FG000|Overall Study|Adverse Event - Parent Study|1|||
170666341|NCT05439941|616792082|FG001|Overall Study|Adverse Event - Parent Study|0|||
170666342|NCT05439941|616792083|FG002|Overall Study|Adverse Event - Parent Study|0|||
170666343|NCT05439941|616792081|FG000|Overall Study|Pregnancy|1|||
170666344|NCT05439941|616792082|FG001|Overall Study|Pregnancy|0|||
170666345|NCT05439941|616792083|FG002|Overall Study|Pregnancy|0|||
170666346|NCT05439941|616792081|FG000|Overall Study|Withdrawal by Subject|9|||
170666347|NCT05439941|616792082|FG001|Overall Study|Withdrawal by Subject|6|||
170666348|NCT05439941|616792083|FG002|Overall Study|Withdrawal by Subject|10|||
170666349|NCT05439941|616792081|FG000|Overall Study|Non-Compliance|1|||
170666350|NCT05439941|616792082|FG001|Overall Study|Non-Compliance|1|||
170666351|NCT05439941|616792083|FG002|Overall Study|Non-Compliance|1|||
170666352|NCT05439941|616792081|FG000|Overall Study|Lost to Follow-up|2|||
170666353|NCT05439941|616792082|FG001|Overall Study|Lost to Follow-up|2|||
170666354|NCT05439941|616792083|FG002|Overall Study|Lost to Follow-up|0|||
170666355|NCT05439941|616792081|FG000|Overall Study|Physician Decision|1|||
170666356|NCT05439941|616792082|FG001|Overall Study|Physician Decision|0|||
170666357|NCT05439941|616792083|FG002|Overall Study|Physician Decision|0|||
170666358|NCT05439941|616792081|FG000|Overall Study|Trial Termination by Sponsor|78|||
170666359|NCT05439941|616792082|FG001|Overall Study|Trial Termination by Sponsor|83|||
170666360|NCT05439941|616792083|FG002|Overall Study|Trial Termination by Sponsor|65|||
170666361|NCT05439941|616792081|FG000|Overall Study|Other than Reasons Listed|2|||
170666362|NCT05439941|616792082|FG001|Overall Study|Other than Reasons Listed|1|||
170666363|NCT05439941|616792083|FG002|Overall Study|Other than Reasons Listed|0|||
170666364|NCT02336373|616792086|FG000|Overall Study|Protocol closed early|4|||
170666365|NCT02336373|616792086|FG000|Overall Study|Physician Decision|14|||
170666366|NCT01816074|616792090|FG000|Phase 1|Time commitment issues|0|||
170666367|NCT01816074|616792091|FG001|Phase 1|Time commitment issues|0|||
170666368|NCT01816074|616792092|FG002|Phase 1|Time commitment issues|1|||
170666369|NCT01816074|616792093|FG003|Phase 1|Time commitment issues|0|||
170666370|NCT01816074|616792090|FG000|Phase 2|Time commitment Issues|0|||
170666371|NCT01816074|616792091|FG001|Phase 2|Time commitment Issues|2|||
170666372|NCT01816074|616792092|FG002|Phase 2|Time commitment Issues|0|||
170666373|NCT01816074|616792093|FG003|Phase 2|Time commitment Issues|0|||
170666374|NCT01816074|616792090|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
170666375|NCT01816074|616792091|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
170818491|NCT01232569|617343584|FG000|Double-blind Treatment Period|Physician Decision|1|||
170818492|NCT01232569|617343585|FG001|Double-blind Treatment Period|Physician Decision|0|||
170818493|NCT01232569|617343586|FG002|Double-blind Treatment Period|Physician Decision|0|||
170818494|NCT01232569|617343587|FG003|Double-blind Treatment Period|Physician Decision|0|||
170818495|NCT01232569|617343584|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
170818496|NCT01232569|617343585|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
170917486|NCT02445391|617697968|FG001|Overall Study|Adverse Event|21|||
170666376|NCT01816074|616792092|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
170666377|NCT01816074|616792093|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
170666378|NCT01816074|616792090|FG000|Phase 2|Physician Decision|0|||
170666379|NCT01816074|616792091|FG001|Phase 2|Physician Decision|0|||
170666380|NCT01816074|616792092|FG002|Phase 2|Physician Decision|0|||
170666381|NCT01816074|616792093|FG003|Phase 2|Physician Decision|1|||
170666382|NCT01816074|616792090|FG000|Phase 2|Withdrawal by Subject|1|||
170666383|NCT01816074|616792091|FG001|Phase 2|Withdrawal by Subject|0|||
170666384|NCT01816074|616792092|FG002|Phase 2|Withdrawal by Subject|0|||
170666385|NCT01816074|616792093|FG003|Phase 2|Withdrawal by Subject|0|||
170666386|NCT04798781|616792097|FG000|Overall Study|Withdrawal by Subject|1|||
170666387|NCT01303861|616792103|FG000|Overall Study|Lost to Follow-up|34|||
170666388|NCT01303861|616792104|FG001|Overall Study|Lost to Follow-up|14|||
170666389|NCT01303861|616792105|FG002|Overall Study|Lost to Follow-up|27|||
170666390|NCT01303861|616792106|FG003|Overall Study|Lost to Follow-up|31|||
170666391|NCT01303861|616792103|FG000|Overall Study|Lack of Efficacy|3|||
170666392|NCT01303861|616792104|FG001|Overall Study|Lack of Efficacy|2|||
170666393|NCT01303861|616792105|FG002|Overall Study|Lack of Efficacy|1|||
170666394|NCT01303861|616792106|FG003|Overall Study|Lack of Efficacy|0|||
170666395|NCT01303861|616792103|FG000|Overall Study|Withdrawal by Subject|16|||
170666396|NCT01303861|616792104|FG001|Overall Study|Withdrawal by Subject|8|||
170666397|NCT01303861|616792105|FG002|Overall Study|Withdrawal by Subject|8|||
170666398|NCT01303861|616792106|FG003|Overall Study|Withdrawal by Subject|23|||
170666399|NCT01303861|616792103|FG000|Overall Study|Adverse Event|4|||
170666400|NCT01303861|616792104|FG001|Overall Study|Adverse Event|1|||
170666401|NCT01303861|616792105|FG002|Overall Study|Adverse Event|0|||
170666402|NCT01303861|616792106|FG003|Overall Study|Adverse Event|5|||
170666403|NCT01303861|616792103|FG000|Overall Study|Pregnancy|1|||
170666404|NCT01303861|616792104|FG001|Overall Study|Pregnancy|0|||
170666405|NCT01303861|616792105|FG002|Overall Study|Pregnancy|0|||
170666406|NCT01303861|616792106|FG003|Overall Study|Pregnancy|0|||
170666407|NCT03917459|616792109|FG000|Overall Study|Adverse Event|1|||
170666408|NCT03917459|616792110|FG001|Overall Study|Adverse Event|0|||
170666409|NCT03917459|616792109|FG000|Overall Study|Withdrawal by Subject|0|||
170666410|NCT03917459|616792110|FG001|Overall Study|Withdrawal by Subject|1|||
170666411|NCT00894166|616792111|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
170666412|NCT00894166|616792112|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
170666413|NCT00894166|616792113|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
170666414|NCT00894166|616792114|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
170666415|NCT00894166|616792115|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
170666416|NCT00894166|616792116|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
170666417|NCT00894166|616792117|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
170666418|NCT00894166|616792118|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
170666419|NCT00894166|616792111|FG000|Overall Study|Death|0|||
170666420|NCT00894166|616792112|FG001|Overall Study|Death|0|||
170666421|NCT00894166|616792113|FG002|Overall Study|Death|0|||
170666422|NCT00894166|616792114|FG003|Overall Study|Death|1|||
170666423|NCT00894166|616792115|FG004|Overall Study|Death|0|||
170666424|NCT00894166|616792116|FG005|Overall Study|Death|0|||
170666425|NCT00894166|616792117|FG006|Overall Study|Death|0|||
170666426|NCT00894166|616792118|FG007|Overall Study|Death|0|||
170666427|NCT02833350|616792119|FG000|Overall Study|Adverse Event|0|||
170666428|NCT02833350|616792120|FG001|Overall Study|Adverse Event|3|||
170666429|NCT02833350|616792121|FG002|Overall Study|Adverse Event|4|||
170666430|NCT02833350|616792122|FG003|Overall Study|Adverse Event|4|||
170666431|NCT02833350|616792123|FG004|Overall Study|Adverse Event|1|||
170666432|NCT02833350|616792124|FG005|Overall Study|Adverse Event|0|||
170666433|NCT02833350|616792125|FG006|Overall Study|Adverse Event|1|||
170666434|NCT02833350|616792119|FG000|Overall Study|Death|0|||
170666435|NCT02833350|616792120|FG001|Overall Study|Death|0|||
170666436|NCT02833350|616792121|FG002|Overall Study|Death|1|||
170666437|NCT02833350|616792122|FG003|Overall Study|Death|0|||
170666438|NCT02833350|616792123|FG004|Overall Study|Death|0|||
170666439|NCT02833350|616792124|FG005|Overall Study|Death|0|||
170666440|NCT02833350|616792125|FG006|Overall Study|Death|0|||
170666441|NCT02833350|616792119|FG000|Overall Study|Lack of Efficacy|0|||
170666442|NCT02833350|616792120|FG001|Overall Study|Lack of Efficacy|2|||
170666443|NCT02833350|616792121|FG002|Overall Study|Lack of Efficacy|1|||
170666444|NCT02833350|616792122|FG003|Overall Study|Lack of Efficacy|4|||
170666445|NCT02833350|616792123|FG004|Overall Study|Lack of Efficacy|0|||
170666446|NCT02833350|616792124|FG005|Overall Study|Lack of Efficacy|1|||
170666447|NCT02833350|616792125|FG006|Overall Study|Lack of Efficacy|1|||
170666448|NCT02833350|616792119|FG000|Overall Study|Lost to Follow-up|0|||
170666449|NCT02833350|616792120|FG001|Overall Study|Lost to Follow-up|1|||
170666450|NCT02833350|616792121|FG002|Overall Study|Lost to Follow-up|0|||
170666451|NCT02833350|616792122|FG003|Overall Study|Lost to Follow-up|0|||
170666452|NCT02833350|616792123|FG004|Overall Study|Lost to Follow-up|0|||
170666453|NCT02833350|616792124|FG005|Overall Study|Lost to Follow-up|0|||
170666454|NCT02833350|616792125|FG006|Overall Study|Lost to Follow-up|1|||
170666455|NCT02833350|616792119|FG000|Overall Study|Withdrawal by Subject|3|||
170666456|NCT02833350|616792120|FG001|Overall Study|Withdrawal by Subject|3|||
170666457|NCT02833350|616792121|FG002|Overall Study|Withdrawal by Subject|2|||
170666458|NCT02833350|616792122|FG003|Overall Study|Withdrawal by Subject|0|||
170666459|NCT02833350|616792123|FG004|Overall Study|Withdrawal by Subject|2|||
170666460|NCT02833350|616792124|FG005|Overall Study|Withdrawal by Subject|0|||
170666461|NCT02833350|616792125|FG006|Overall Study|Withdrawal by Subject|2|||
170666462|NCT01453725|616792126|FG000|Overall Study|Adverse Event|3|||
170666463|NCT01453725|616792127|FG001|Overall Study|Adverse Event|3|||
170666464|NCT01453725|616792126|FG000|Overall Study|Lost to Follow-up|4|||
170666465|NCT01453725|616792127|FG001|Overall Study|Lost to Follow-up|0|||
170666466|NCT01453725|616792126|FG000|Overall Study|Non-compliance With Protocol|1|||
170666467|NCT01453725|616792127|FG001|Overall Study|Non-compliance With Protocol|2|||
170666468|NCT01453725|616792126|FG000|Overall Study|Protocol Violation|1|||
170666469|NCT01453725|616792127|FG001|Overall Study|Protocol Violation|0|||
170666470|NCT01453725|616792126|FG000|Overall Study|Withdrawal by Subject|2|||
170666471|NCT01453725|616792127|FG001|Overall Study|Withdrawal by Subject|3|||
170666472|NCT01453725|616792126|FG000|Overall Study|Pregnancy Wish|0|||
170666473|NCT01453725|616792127|FG001|Overall Study|Pregnancy Wish|2|||
170666474|NCT01453725|616792126|FG000|Overall Study|Pregnancy|1|||
170666475|NCT01453725|616792127|FG001|Overall Study|Pregnancy|0|||
170666476|NCT01453725|616792126|FG000|Overall Study|Physician Decision|1|||
170666477|NCT01453725|616792127|FG001|Overall Study|Physician Decision|1|||
170666478|NCT04674644|616792136|FG000|Overall Study|with missing data|37|||
170666479|NCT01024231|616792137|FG000|Overall Study|Other Reasons|1|||
170666480|NCT01024231|616792138|FG001|Overall Study|Other Reasons|2|||
170666481|NCT01024231|616792139|FG002|Overall Study|Other Reasons|0|||
170666482|NCT01024231|616792140|FG003|Overall Study|Other Reasons|0|||
170666483|NCT01024231|616792141|FG004|Overall Study|Other Reasons|2|||
170818497|NCT01232569|617343586|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
170818498|NCT01232569|617343587|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
170818499|NCT01232569|617343584|FG000|Double-blind Treatment Period|Death|2|||
170818500|NCT01232569|617343585|FG001|Double-blind Treatment Period|Death|0|||
170818501|NCT01232569|617343586|FG002|Double-blind Treatment Period|Death|0|||
170818502|NCT01232569|617343587|FG003|Double-blind Treatment Period|Death|0|||
170818503|NCT04044352|617343588|FG000|Overall Study|Lost to Follow-up|9|||
170818504|NCT04044352|617343588|FG000|Overall Study|Withdrawal by Subject|2|||
170818505|NCT00489489|617343603|FG000|Overall Study|Not treated due to protocol violation|0|||
170818506|NCT00489489|617343604|FG001|Overall Study|Not treated due to protocol violation|1|||
170818507|NCT00489489|617343605|FG002|Overall Study|Not treated due to protocol violation|1|||
170818508|NCT00489489|617343603|FG000|Overall Study|Adverse Event|1|||
170818509|NCT00489489|617343604|FG001|Overall Study|Adverse Event|1|||
170818510|NCT00489489|617343605|FG002|Overall Study|Adverse Event|1|||
170818511|NCT00489489|617343603|FG000|Overall Study|Protocol Violation|1|||
170818512|NCT00489489|617343604|FG001|Overall Study|Protocol Violation|0|||
170818513|NCT00489489|617343605|FG002|Overall Study|Protocol Violation|1|||
170818514|NCT00489489|617343603|FG000|Overall Study|Progressive disease|0|||
170818515|NCT00489489|617343604|FG001|Overall Study|Progressive disease|1|||
170818516|NCT00489489|617343605|FG002|Overall Study|Progressive disease|0|||
170818517|NCT00489489|617343603|FG000|Overall Study|Participant did not wish to continue|1|||
170818518|NCT00489489|617343604|FG001|Overall Study|Participant did not wish to continue|1|||
170818519|NCT00489489|617343605|FG002|Overall Study|Participant did not wish to continue|0|||
170818520|NCT00489489|617343603|FG000|Overall Study|Other than above|0|||
170818521|NCT00489489|617343604|FG001|Overall Study|Other than above|1|||
170818522|NCT00489489|617343605|FG002|Overall Study|Other than above|0|||
170818523|NCT02388932|617343608|FG000|Overall Study|Death|1|||
170818524|NCT02880293|617343609|FG000|Overall Study|Inevaluable|5|||
170818525|NCT05335005|617343610|FG000|Overall Study|Lost to Follow-up|1|||
170818526|NCT05927753|617343611|FG000|Overall Study|Withdrawal by Subject|0|||
170818527|NCT05927753|617343612|FG001|Overall Study|Withdrawal by Subject|2|||
170818528|NCT05927753|617343611|FG000|Overall Study|Physician Decision|0|||
170818529|NCT05927753|617343612|FG001|Overall Study|Physician Decision|1|||
170818530|NCT02136797|617343613|FG000|Overall Study|Not Treated|8|||
170818531|NCT01375777|617343614|FG000|Overall Study|Withdrawal by Subject|0|||
170818532|NCT01375777|617343615|FG001|Overall Study|Withdrawal by Subject|2|||
170818533|NCT01375777|617343616|FG002|Overall Study|Withdrawal by Subject|1|||
170818534|NCT01375777|617343617|FG003|Overall Study|Withdrawal by Subject|0|||
170818535|NCT01375777|617343618|FG004|Overall Study|Withdrawal by Subject|1|||
170818536|NCT01375777|617343619|FG005|Overall Study|Withdrawal by Subject|1|||
170818537|NCT01375777|617343620|FG006|Overall Study|Withdrawal by Subject|1|||
170818538|NCT01375777|617343621|FG007|Overall Study|Withdrawal by Subject|2|||
170666484|NCT01024231|616792142|FG005|Overall Study|Other Reasons|0|||
170666485|NCT01024231|616792143|FG006|Overall Study|Other Reasons|1|||
170666486|NCT01024231|616792137|FG000|Overall Study|Maximum Clinical Benefit|1|||
170666487|NCT01024231|616792138|FG001|Overall Study|Maximum Clinical Benefit|2|||
170666488|NCT01024231|616792139|FG002|Overall Study|Maximum Clinical Benefit|0|||
170818539|NCT01375777|617343622|FG008|Overall Study|Withdrawal by Subject|1|||
170818540|NCT01375777|617343614|FG000|Overall Study|Lost to Follow-up|1|||
170818541|NCT01375777|617343615|FG001|Overall Study|Lost to Follow-up|0|||
170818542|NCT01375777|617343616|FG002|Overall Study|Lost to Follow-up|0|||
170818543|NCT01375777|617343617|FG003|Overall Study|Lost to Follow-up|0|||
170818544|NCT01375777|617343618|FG004|Overall Study|Lost to Follow-up|0|||
170818545|NCT01375777|617343619|FG005|Overall Study|Lost to Follow-up|0|||
170818546|NCT01375777|617343620|FG006|Overall Study|Lost to Follow-up|1|||
170818547|NCT01375777|617343621|FG007|Overall Study|Lost to Follow-up|0|||
170666489|NCT01024231|616792140|FG003|Overall Study|Maximum Clinical Benefit|1|||
170666490|NCT01024231|616792141|FG004|Overall Study|Maximum Clinical Benefit|1|||
170666491|NCT01024231|616792142|FG005|Overall Study|Maximum Clinical Benefit|0|||
170666492|NCT01024231|616792143|FG006|Overall Study|Maximum Clinical Benefit|0|||
170666493|NCT01024231|616792137|FG000|Overall Study|Disease Progression|3|||
170666494|NCT01024231|616792138|FG001|Overall Study|Disease Progression|1|||
170666495|NCT01024231|616792139|FG002|Overall Study|Disease Progression|3|||
170666496|NCT01024231|616792140|FG003|Overall Study|Disease Progression|0|||
170917487|NCT02445391|617697969|FG002|Overall Study|Adverse Event|12|||
170917488|NCT02445391|617697967|FG000|Overall Study|Alternative therapy|0|||
170917489|NCT02445391|617697968|FG001|Overall Study|Alternative therapy|0|||
170917490|NCT02445391|617697969|FG002|Overall Study|Alternative therapy|1|||
170917491|NCT02445391|617697967|FG000|Overall Study|Disease progression|0|||
170917492|NCT02445391|617697968|FG001|Overall Study|Disease progression|7|||
170917493|NCT02445391|617697969|FG002|Overall Study|Disease progression|22|||
170917494|NCT02445391|617697967|FG000|Overall Study|Complicating disease|0|||
170917495|NCT02445391|617697968|FG001|Overall Study|Complicating disease|2|||
170917496|NCT02445391|617697969|FG002|Overall Study|Complicating disease|1|||
170917497|NCT02445391|617697967|FG000|Overall Study|Withdrawal by Subject|0|||
170917498|NCT02445391|617697968|FG001|Overall Study|Withdrawal by Subject|4|||
170917499|NCT02445391|617697969|FG002|Overall Study|Withdrawal by Subject|9|||
170917500|NCT02445391|617697967|FG000|Overall Study|Financial issue|0|||
170917501|NCT02445391|617697968|FG001|Overall Study|Financial issue|0|||
170917502|NCT02445391|617697969|FG002|Overall Study|Financial issue|2|||
170917503|NCT02445391|617697967|FG000|Overall Study|Still on treatment|0|||
170917504|NCT02445391|617697968|FG001|Overall Study|Still on treatment|7|||
170917505|NCT02445391|617697969|FG002|Overall Study|Still on treatment|16|||
170917506|NCT02445391|617697967|FG000|Overall Study|Not start protocol therapy|0|||
170917507|NCT02445391|617697968|FG001|Overall Study|Not start protocol therapy|12|||
170917508|NCT02445391|617697969|FG002|Overall Study|Not start protocol therapy|9|||
170617932|NCT01132313|616608858|FG001|Overall Study|Withdrawal by Subject|0|||
170617933|NCT01132313|616608859|FG002|Overall Study|Withdrawal by Subject|3|||
170617934|NCT01132313|616608860|FG003|Overall Study|Withdrawal by Subject|3|||
170617935|NCT01132313|616608861|FG004|Overall Study|Withdrawal by Subject|6|||
170617936|NCT01132313|616608862|FG005|Overall Study|Withdrawal by Subject|0|||
170666497|NCT01024231|616792141|FG004|Overall Study|Disease Progression|4|||
170666498|NCT01024231|616792142|FG005|Overall Study|Disease Progression|11|||
170666499|NCT01024231|616792143|FG006|Overall Study|Disease Progression|6|||
170666500|NCT01024231|616792137|FG000|Overall Study|AE unrelated to Study Drug|0|||
170666501|NCT01024231|616792138|FG001|Overall Study|AE unrelated to Study Drug|1|||
170666502|NCT01024231|616792139|FG002|Overall Study|AE unrelated to Study Drug|0|||
170666503|NCT01024231|616792140|FG003|Overall Study|AE unrelated to Study Drug|0|||
170666504|NCT01024231|616792141|FG004|Overall Study|AE unrelated to Study Drug|0|||
170666505|NCT01024231|616792142|FG005|Overall Study|AE unrelated to Study Drug|0|||
170666506|NCT01024231|616792143|FG006|Overall Study|AE unrelated to Study Drug|0|||
170666507|NCT01024231|616792137|FG000|Overall Study|No longer meets criteria|0|||
170666508|NCT01024231|616792138|FG001|Overall Study|No longer meets criteria|0|||
170666509|NCT01024231|616792139|FG002|Overall Study|No longer meets criteria|0|||
170666510|NCT01024231|616792140|FG003|Overall Study|No longer meets criteria|0|||
170666511|NCT01024231|616792141|FG004|Overall Study|No longer meets criteria|1|||
170666512|NCT01024231|616792142|FG005|Overall Study|No longer meets criteria|0|||
170666513|NCT01024231|616792143|FG006|Overall Study|No longer meets criteria|1|||
170666514|NCT01024231|616792137|FG000|Overall Study|Study Drug Toxicity|1|||
170666515|NCT01024231|616792138|FG001|Overall Study|Study Drug Toxicity|6|||
170666516|NCT01024231|616792139|FG002|Overall Study|Study Drug Toxicity|6|||
170666517|NCT01024231|616792140|FG003|Overall Study|Study Drug Toxicity|4|||
170666518|NCT01024231|616792141|FG004|Overall Study|Study Drug Toxicity|2|||
170666519|NCT01024231|616792142|FG005|Overall Study|Study Drug Toxicity|0|||
170666520|NCT01024231|616792143|FG006|Overall Study|Study Drug Toxicity|7|||
170666521|NCT01024231|616792137|FG000|Overall Study|Death|6|||
170666522|NCT01024231|616792138|FG001|Overall Study|Death|2|||
170617937|NCT01132313|616608863|FG006|Overall Study|Withdrawal by Subject|1|||
170666523|NCT01024231|616792139|FG002|Overall Study|Death|1|||
170666524|NCT01024231|616792140|FG003|Overall Study|Death|0|||
170666525|NCT01024231|616792141|FG004|Overall Study|Death|4|||
170666526|NCT01024231|616792142|FG005|Overall Study|Death|3|||
170617938|NCT01132313|616608864|FG007|Overall Study|Withdrawal by Subject|0|||
170617939|NCT01132313|616608865|FG008|Overall Study|Withdrawal by Subject|0|||
170617940|NCT01132313|616608866|FG009|Overall Study|Withdrawal by Subject|2|||
170617941|NCT01132313|616608867|FG010|Overall Study|Withdrawal by Subject|0|||
170666527|NCT01024231|616792143|FG006|Overall Study|Death|5|||
170666528|NCT01024231|616792137|FG000|Overall Study|Lost to Follow-up|0|||
170666529|NCT01024231|616792138|FG001|Overall Study|Lost to Follow-up|0|||
170666530|NCT01024231|616792139|FG002|Overall Study|Lost to Follow-up|0|||
170666531|NCT01024231|616792140|FG003|Overall Study|Lost to Follow-up|0|||
170666532|NCT01024231|616792141|FG004|Overall Study|Lost to Follow-up|0|||
170917509|NCT00585039|617698447|FG000|Overall Study|medication spilled|2|||
170917510|NCT00585039|617698448|FG001|Overall Study|medication spilled|0|||
170917511|NCT01949662|617698456|FG000|Overall Study|Death|9|||
170666533|NCT01024231|616792142|FG005|Overall Study|Lost to Follow-up|0|||
170666534|NCT01024231|616792143|FG006|Overall Study|Lost to Follow-up|1|||
170666535|NCT01024231|616792137|FG000|Overall Study|Withdrew Consent|0|||
170666536|NCT01024231|616792138|FG001|Overall Study|Withdrew Consent|1|||
170666537|NCT01024231|616792139|FG002|Overall Study|Withdrew Consent|0|||
170666538|NCT01024231|616792140|FG003|Overall Study|Withdrew Consent|0|||
170666539|NCT01024231|616792141|FG004|Overall Study|Withdrew Consent|0|||
170666540|NCT01024231|616792142|FG005|Overall Study|Withdrew Consent|0|||
170666541|NCT01024231|616792143|FG006|Overall Study|Withdrew Consent|0|||
170666542|NCT01024231|616792137|FG000|Overall Study|Continuing on Treatment|0|||
170666543|NCT01024231|616792138|FG001|Overall Study|Continuing on Treatment|0|||
170666544|NCT01024231|616792139|FG002|Overall Study|Continuing on Treatment|0|||
170666545|NCT01024231|616792140|FG003|Overall Study|Continuing on Treatment|0|||
170666546|NCT01024231|616792141|FG004|Overall Study|Continuing on Treatment|3|||
170666547|NCT01024231|616792142|FG005|Overall Study|Continuing on Treatment|2|||
170666548|NCT01024231|616792143|FG006|Overall Study|Continuing on Treatment|0|||
170666549|NCT01147172|616792148|FG000|Overall Study|Withdrawal by Subject|2|||
170666550|NCT01147172|616792148|FG000|Overall Study|Lost to Follow-up|2|||
170666551|NCT01262573|616792149|FG000|Overall Study|Withdrawal by Subject|0|||
170666552|NCT01262573|616792150|FG001|Overall Study|Withdrawal by Subject|1|||
170666553|NCT02507973|616792151|FG000|Overall Study|Adverse Event|1|||
170666554|NCT03386474|616792154|FG000|Overall Study|Death|1|||
170666555|NCT03386474|616792155|FG001|Overall Study|Death|0|||
170666556|NCT03386474|616792154|FG000|Overall Study|Adverse Event|0|||
170666557|NCT03386474|616792155|FG001|Overall Study|Adverse Event|1|||
170666558|NCT02155881|616792156|FG000|Overall Study|Withdrawal by Subject|0|||
170666559|NCT02155881|616792157|FG001|Overall Study|Withdrawal by Subject|2|||
170666560|NCT02155881|616792156|FG000|Overall Study|Inappropriately randomized|2|||
170666561|NCT02155881|616792157|FG001|Overall Study|Inappropriately randomized|2|||
170666562|NCT04357782|616792158|FG000|Overall Study|Discharged from hospital|1|||
170666563|NCT04357782|616792159|FG001|Overall Study|Discharged from hospital|0|||
170666564|NCT04357782|616792158|FG000|Overall Study|Death|0|||
170666565|NCT04357782|616792159|FG001|Overall Study|Death|2|||
170666566|NCT00338104|616792162|FG000|Overall Study|Protocol Violation|2|||
170666567|NCT00338104|616792163|FG001|Overall Study|Protocol Violation|1|||
170666568|NCT00338104|616792164|FG002|Overall Study|Protocol Violation|3|||
170666569|NCT02919696|616792165|FG000|Overall Study|Adverse Event|1|||
170666570|NCT02919696|616792166|FG001|Overall Study|Adverse Event|2|||
170666571|NCT02919696|616792165|FG000|Overall Study|Withdrawal by Subject|2|||
170666572|NCT02919696|616792166|FG001|Overall Study|Withdrawal by Subject|1|||
170666573|NCT02919696|616792165|FG000|Overall Study|Sponsor Decision|1|||
170666574|NCT02919696|616792166|FG001|Overall Study|Sponsor Decision|1|||
170666575|NCT02919696|616792165|FG000|Overall Study|Never Treated|0|||
170666576|NCT02919696|616792166|FG001|Overall Study|Never Treated|1|||
170666577|NCT04128371|616792167|FG000|Overall Study|Lack of Efficacy|1|||
170666578|NCT01361568|616792170|FG000|Overall Study|Adverse Event|0|||
170666579|NCT01361568|616792171|FG001|Overall Study|Adverse Event|0|||
170666580|NCT01361568|616792172|FG002|Overall Study|Adverse Event|0|||
170666581|NCT01361568|616792173|FG003|Overall Study|Adverse Event|0|||
170666582|NCT01361568|616792174|FG004|Overall Study|Adverse Event|1|||
170666583|NCT01361568|616792175|FG005|Overall Study|Adverse Event|0|||
170666584|NCT01361568|616792170|FG000|Overall Study|Physician Decision|0|||
170666585|NCT01361568|616792171|FG001|Overall Study|Physician Decision|0|||
170666586|NCT01361568|616792172|FG002|Overall Study|Physician Decision|0|||
170666587|NCT01361568|616792173|FG003|Overall Study|Physician Decision|0|||
170666588|NCT01361568|616792174|FG004|Overall Study|Physician Decision|0|||
170666589|NCT01361568|616792175|FG005|Overall Study|Physician Decision|1|||
170666590|NCT01361568|616792170|FG000|Overall Study|Withdrawal by Subject|2|||
170666591|NCT01361568|616792171|FG001|Overall Study|Withdrawal by Subject|1|||
170666592|NCT01361568|616792172|FG002|Overall Study|Withdrawal by Subject|0|||
170666593|NCT01361568|616792173|FG003|Overall Study|Withdrawal by Subject|0|||
170666594|NCT01361568|616792174|FG004|Overall Study|Withdrawal by Subject|0|||
170666595|NCT01361568|616792175|FG005|Overall Study|Withdrawal by Subject|1|||
170666596|NCT00484094|616792176|FG000|Overall Study|Discontinued|39|||
170818548|NCT01375777|617343622|FG008|Overall Study|Lost to Follow-up|0|||
170818549|NCT01375777|617343614|FG000|Overall Study|Other|1|||
170818550|NCT01375777|617343615|FG001|Overall Study|Other|1|||
170818551|NCT01375777|617343616|FG002|Overall Study|Other|0|||
170818552|NCT01375777|617343617|FG003|Overall Study|Other|0|||
170666597|NCT00484094|616792176|FG000|Overall Study|Other|3|||
170666598|NCT02728596|616792177|FG000|Overall Study|Refusal unrelated to adverse event|3|||
170666599|NCT02728596|616792178|FG001|Overall Study|Refusal unrelated to adverse event|6|||
170666600|NCT02728596|616792179|FG002|Overall Study|Refusal unrelated to adverse event|7|||
170666601|NCT02728596|616792180|FG003|Overall Study|Refusal unrelated to adverse event|7|||
170666602|NCT02728596|616792177|FG000|Overall Study|Death|44|||
170666603|NCT02728596|616792178|FG001|Overall Study|Death|42|||
170666604|NCT02728596|616792179|FG002|Overall Study|Death|123|||
170666605|NCT02728596|616792180|FG003|Overall Study|Death|68|||
170818553|NCT01375777|617343618|FG004|Overall Study|Other|0|||
170818554|NCT01375777|617343619|FG005|Overall Study|Other|0|||
170617942|NCT01132313|616608868|FG011|Overall Study|Withdrawal by Subject|0|||
170617943|NCT01132313|616608857|FG000|Overall Study|Lack of antiviral response|0|||
170617944|NCT01132313|616608858|FG001|Overall Study|Lack of antiviral response|0|||
170617945|NCT01132313|616608859|FG002|Overall Study|Lack of antiviral response|12|||
170617946|NCT01132313|616608860|FG003|Overall Study|Lack of antiviral response|18|||
170617947|NCT01132313|616608861|FG004|Overall Study|Lack of antiviral response|18|||
170617948|NCT01132313|616608862|FG005|Overall Study|Lack of antiviral response|18|||
170617949|NCT01132313|616608863|FG006|Overall Study|Lack of antiviral response|21|||
170617950|NCT01132313|616608864|FG007|Overall Study|Lack of antiviral response|0|||
170617951|NCT01132313|616608865|FG008|Overall Study|Lack of antiviral response|0|||
170617952|NCT01132313|616608866|FG009|Overall Study|Lack of antiviral response|0|||
170617953|NCT01132313|616608867|FG010|Overall Study|Lack of antiviral response|1|||
170617954|NCT01132313|616608868|FG011|Overall Study|Lack of antiviral response|0|||
170617955|NCT01132313|616608857|FG000|Overall Study|Other reason not defined above|0|||
170617956|NCT01132313|616608858|FG001|Overall Study|Other reason not defined above|0|||
170617957|NCT01132313|616608859|FG002|Overall Study|Other reason not defined above|0|||
170617958|NCT01132313|616608860|FG003|Overall Study|Other reason not defined above|0|||
170617959|NCT01132313|616608861|FG004|Overall Study|Other reason not defined above|0|||
170617960|NCT01132313|616608862|FG005|Overall Study|Other reason not defined above|0|||
170617961|NCT01132313|616608863|FG006|Overall Study|Other reason not defined above|0|||
170617962|NCT01132313|616608864|FG007|Overall Study|Other reason not defined above|1|||
170617963|NCT01132313|616608865|FG008|Overall Study|Other reason not defined above|0|||
170617964|NCT01132313|616608866|FG009|Overall Study|Other reason not defined above|0|||
170617965|NCT01132313|616608867|FG010|Overall Study|Other reason not defined above|0|||
170617966|NCT01132313|616608868|FG011|Overall Study|Other reason not defined above|0|||
170617967|NCT04332107|616608869|FG000|Day 3|Lost to Follow-up|23|||
170617968|NCT04332107|616608870|FG001|Day 3|Lost to Follow-up|14|||
170617969|NCT04332107|616608869|FG000|Day 3|Missing outcome data|3|||
170617970|NCT04332107|616608870|FG001|Day 3|Missing outcome data|6|||
170617971|NCT04332107|616608869|FG000|Day 14|Lost to Follow-up|13|||
170617972|NCT04332107|616608870|FG001|Day 14|Lost to Follow-up|4|||
170617973|NCT04332107|616608869|FG000|Day 14|Missing outcome data|4|||
170617974|NCT04332107|616608870|FG001|Day 14|Missing outcome data|4|||
170617975|NCT04332107|616608869|FG000|Day 21|Lost to Follow-up|10|||
170617976|NCT04332107|616608870|FG001|Day 21|Lost to Follow-up|2|||
170617977|NCT01670721|616608876|FG000|Overall Study|Participant's decision|15|||
170617978|NCT01670721|616608876|FG000|Overall Study|Other than specified above|38|||
170617979|NCT00141102|616608877|FG000|Overall Study|Adverse Event|233|||
170617980|NCT00141102|616608878|FG001|Overall Study|Adverse Event|305|||
170617981|NCT00141102|616608877|FG000|Overall Study|Laboratory Abnormality|9|||
170617982|NCT00141102|616608878|FG001|Overall Study|Laboratory Abnormality|33|||
170617983|NCT00141102|616608877|FG000|Overall Study|Lack of Efficacy|21|||
170617984|NCT00141102|616608878|FG001|Overall Study|Lack of Efficacy|26|||
170617985|NCT00141102|616608877|FG000|Overall Study|Lost to Follow-up|29|||
170617986|NCT00141102|616608878|FG001|Overall Study|Lost to Follow-up|32|||
170617987|NCT00141102|616608877|FG000|Overall Study|Other|87|||
170617988|NCT00141102|616608878|FG001|Overall Study|Other|76|||
170617989|NCT00141102|616608877|FG000|Overall Study|Withdrawal by Subject|112|||
170617990|NCT00141102|616608878|FG001|Overall Study|Withdrawal by Subject|142|||
170617991|NCT00141102|616608877|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
170617992|NCT00141102|616608878|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
170617993|NCT00141102|616608877|FG000|Overall Study|Death|2|||
170617994|NCT00141102|616608878|FG001|Overall Study|Death|2|||
170617995|NCT03061201|616608888|FG000|Overall Study|Participants Terminated at Month 36|0|||
170617996|NCT03061201|616608889|FG001|Overall Study|Participants Terminated at Month 36|1|||
170617997|NCT03061201|616608890|FG002|Overall Study|Participants Terminated at Month 36|0|||
170617998|NCT03061201|616608891|FG003|Overall Study|Participants Terminated at Month 36|1|||
170617999|NCT03061201|616608888|FG000|Overall Study|Lost to Follow-up|1|||
170618000|NCT03061201|616608889|FG001|Overall Study|Lost to Follow-up|0|||
170618001|NCT03061201|616608890|FG002|Overall Study|Lost to Follow-up|0|||
170618002|NCT03061201|616608891|FG003|Overall Study|Lost to Follow-up|0|||
170618003|NCT05864586|616608892|FG000|Overall Study|Ineligible|4|||
170618004|NCT05864586|616608893|FG001|Overall Study|Ineligible|12|||
170618005|NCT05864586|616608892|FG000|Overall Study|Pregnancy|0|||
170618006|NCT05864586|616608893|FG001|Overall Study|Pregnancy|1|||
170618007|NCT05864586|616608892|FG000|Overall Study|Withdrawal by Subject|0|||
170618008|NCT05864586|616608893|FG001|Overall Study|Withdrawal by Subject|1|||
170618009|NCT01572480|616608894|FG000|Participants Enrolled|Withdrawal by Subject|1|||
170618010|NCT01572480|616608894|FG000|Drug Administration|Discontinued drug/Off Study|1|||
170618011|NCT01572480|616608894|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
170618012|NCT01572480|616608894|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
170618013|NCT05081219|616608895|FG000|Overall Study|Withdrawal by Subject|4|||
170618014|NCT05081219|616608896|FG001|Overall Study|Withdrawal by Subject|0|||
170618015|NCT05081219|616608897|FG002|Overall Study|Withdrawal by Subject|0|||
170618016|NCT05081219|616608898|FG003|Overall Study|Withdrawal by Subject|1|||
170618017|NCT03446313|616608899|FG000|Overall Study|Lost to Follow-up|1|||
170618018|NCT03446313|616608900|FG001|Overall Study|Lost to Follow-up|2|||
170618019|NCT03446313|616608899|FG000|Overall Study|Failed primary screening|3|||
170618020|NCT03446313|616608900|FG001|Overall Study|Failed primary screening|0|||
170618021|NCT03446313|616608899|FG000|Overall Study|Diagnosed with terminal cancer|1|||
170618022|NCT03446313|616608900|FG001|Overall Study|Diagnosed with terminal cancer|0|||
170618023|NCT03446313|616608899|FG000|Overall Study|Excluded from analysis|1|||
170618024|NCT03446313|616608900|FG001|Overall Study|Excluded from analysis|1|||
170618025|NCT00801216|616608901|FG000|Overall Study|Screening Failure|2|||
170618026|NCT02701283|616608902|FG000|Overall Study|Death|25|||
170818555|NCT01375777|617343620|FG006|Overall Study|Other|0|||
170818556|NCT01375777|617343621|FG007|Overall Study|Other|0|||
170818557|NCT01375777|617343622|FG008|Overall Study|Other|1|||
170818558|NCT01038128|617343623|FG000|Overall Study|Lack of Efficacy|1|||
170818559|NCT01038128|617343623|FG000|Overall Study|Lost to Follow-up|1|||
170818560|NCT01038128|617343623|FG000|Overall Study|Withdrawal by Subject|2|||
170818561|NCT01234675|617343624|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
170818562|NCT01234675|617343625|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
170818563|NCT01234675|617343624|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
170618027|NCT02701283|616608903|FG001|Overall Study|Death|29|||
170618028|NCT02701283|616608904|FG002|Overall Study|Death|19|||
170618029|NCT02701283|616608902|FG000|Overall Study|Lost to Follow-up|3|||
170618030|NCT02701283|616608903|FG001|Overall Study|Lost to Follow-up|8|||
170618031|NCT02701283|616608904|FG002|Overall Study|Lost to Follow-up|1|||
170618032|NCT02701283|616608902|FG000|Overall Study|Withdrawal by Subject|12|||
170618033|NCT02701283|616608903|FG001|Overall Study|Withdrawal by Subject|41|||
170618034|NCT02701283|616608904|FG002|Overall Study|Withdrawal by Subject|1|||
170618035|NCT02701283|616608902|FG000|Overall Study|Missed 2-year visit|22|||
170618036|NCT02701283|616608903|FG001|Overall Study|Missed 2-year visit|27|||
170618037|NCT02701283|616608904|FG002|Overall Study|Missed 2-year visit|0|||
170618038|NCT02701283|616608902|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
170618039|NCT02701283|616608903|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
170618040|NCT02701283|616608904|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
170618041|NCT00866814|616608905|FG000|Overall Study|Lost to Follow-up|12|||
170618042|NCT00866814|616608905|FG000|Overall Study|Adverse Event|2|||
170618043|NCT00866814|616608905|FG000|Overall Study|Physician Decision|1|||
170618044|NCT00866814|616608905|FG000|Overall Study|Death|1|||
170618045|NCT00866814|616608905|FG000|Overall Study|No longer wished to participate|1|||
170618046|NCT00866814|616608905|FG000|Overall Study|Unable to meet follow-up requirements|2|||
170618047|NCT00866814|616608905|FG000|Overall Study|Moved to area without study site|1|||
170618048|NCT01150097|616608907|FG000|Months 24 to 36 Post-transplantation|Death|2|||
170618049|NCT01150097|616608908|FG001|Months 24 to 36 Post-transplantation|Death|0|||
170618050|NCT01150097|616608909|FG002|Months 24 to 36 Post-transplantation|Death|0|||
170618051|NCT01150097|616608907|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
170618052|NCT01150097|616608908|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
170618053|NCT01150097|616608909|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
170618054|NCT01150097|616608907|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
170618055|NCT01150097|616608908|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
170618056|NCT01150097|616608909|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
170618057|NCT01150097|616608907|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
170618058|NCT01150097|616608908|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
170618059|NCT01150097|616608909|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
170618060|NCT01150097|616608907|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
170618061|NCT01150097|616608908|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
170618062|NCT01150097|616608909|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
170618063|NCT01150097|616608907|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
170618064|NCT01150097|616608908|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
170618065|NCT01150097|616608909|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
170618066|NCT01150097|616608907|FG000|Months 24 to 48 Post-transplantation|Death|2|||
170618067|NCT01150097|616608908|FG001|Months 24 to 48 Post-transplantation|Death|0|||
170618068|NCT01150097|616608909|FG002|Months 24 to 48 Post-transplantation|Death|0|||
170618069|NCT01408459|616608910|FG000|Overall Study|Withdrawal by Subject|1|||
170618070|NCT01408459|616608911|FG001|Overall Study|Withdrawal by Subject|1|||
170618071|NCT00543387|616608912|FG000|Panel 1 + Panel 2|Adverse Event|0|||
170618072|NCT00543387|616608913|FG001|Panel 1 + Panel 2|Adverse Event|1|||
170618073|NCT00543387|616608914|FG002|Panel 1 + Panel 2|Adverse Event|0|||
170618074|NCT00543387|616608915|FG003|Panel 1 + Panel 2|Adverse Event|0|||
170618075|NCT00543387|616608916|FG004|Panel 1 + Panel 2|Adverse Event|0|||
170618076|NCT00543387|616608917|FG005|Panel 1 + Panel 2|Adverse Event|0|||
170618077|NCT00543387|616608918|FG006|Panel 1 + Panel 2|Adverse Event|0|||
170818564|NCT01234675|617343625|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
170818565|NCT00396409|617343626|FG000|Period 1 - 2007|Adverse Event|0|||
170818566|NCT00396409|617343627|FG001|Period 1 - 2007|Adverse Event|1|||
170618078|NCT00543387|616608919|FG007|Panel 1 + Panel 2|Adverse Event|1|||
170618079|NCT00543387|616608920|FG008|Panel 1 + Panel 2|Adverse Event|1|||
170618080|NCT00543387|616608921|FG009|Panel 1 + Panel 2|Adverse Event|0|||
170618081|NCT00543387|616608922|FG010|Panel 1 + Panel 2|Adverse Event|0|||
170618082|NCT00543387|616608912|FG000|Panel 1 + Panel 2|Physician Decision|0|||
170618083|NCT00543387|616608913|FG001|Panel 1 + Panel 2|Physician Decision|0|||
170618084|NCT00543387|616608914|FG002|Panel 1 + Panel 2|Physician Decision|1|||
170618085|NCT00543387|616608915|FG003|Panel 1 + Panel 2|Physician Decision|0|||
170618086|NCT00543387|616608916|FG004|Panel 1 + Panel 2|Physician Decision|0|||
170618087|NCT00543387|616608917|FG005|Panel 1 + Panel 2|Physician Decision|0|||
170618088|NCT00543387|616608918|FG006|Panel 1 + Panel 2|Physician Decision|0|||
170618089|NCT00543387|616608919|FG007|Panel 1 + Panel 2|Physician Decision|1|||
170618090|NCT00543387|616608920|FG008|Panel 1 + Panel 2|Physician Decision|0|||
170618091|NCT00543387|616608921|FG009|Panel 1 + Panel 2|Physician Decision|0|||
170618092|NCT00543387|616608922|FG010|Panel 1 + Panel 2|Physician Decision|0|||
170618093|NCT00543387|616608912|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
170618094|NCT00543387|616608913|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
170618095|NCT00543387|616608914|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
170618096|NCT00543387|616608915|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
170618097|NCT00543387|616608916|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
170618098|NCT00543387|616608917|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
170618099|NCT00543387|616608918|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
170618100|NCT00543387|616608919|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
170618101|NCT00543387|616608920|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
170618102|NCT00543387|616608921|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
170618103|NCT00543387|616608922|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
170618104|NCT00543387|616608912|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618105|NCT00543387|616608913|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618106|NCT00543387|616608914|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618107|NCT00543387|616608915|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618108|NCT00543387|616608916|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618109|NCT00543387|616608917|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618110|NCT00543387|616608918|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
170618111|NCT00543387|616608919|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618112|NCT00543387|616608920|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618113|NCT00543387|616608921|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618114|NCT00543387|616608922|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
170618115|NCT00543387|616608912|FG000|Crossover Participants|Progressive Disease|0|||
170618116|NCT00543387|616608913|FG001|Crossover Participants|Progressive Disease|0|||
170618117|NCT00543387|616608914|FG002|Crossover Participants|Progressive Disease|0|||
170618118|NCT00543387|616608915|FG003|Crossover Participants|Progressive Disease|0|||
170618119|NCT00543387|616608916|FG004|Crossover Participants|Progressive Disease|0|||
170618120|NCT00543387|616608917|FG005|Crossover Participants|Progressive Disease|0|||
170618121|NCT00543387|616608918|FG006|Crossover Participants|Progressive Disease|0|||
170618122|NCT00543387|616608919|FG007|Crossover Participants|Progressive Disease|0|||
170618123|NCT00543387|616608920|FG008|Crossover Participants|Progressive Disease|0|||
170618124|NCT00543387|616608921|FG009|Crossover Participants|Progressive Disease|1|||
170618125|NCT00543387|616608922|FG010|Crossover Participants|Progressive Disease|2|||
170618126|NCT00543387|616608912|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
170618127|NCT00543387|616608913|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
170618128|NCT00543387|616608914|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
170618129|NCT00543387|616608915|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
170618130|NCT00543387|616608916|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
170618131|NCT00543387|616608917|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
170618132|NCT00543387|616608918|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
170618133|NCT00543387|616608919|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
170618134|NCT00543387|616608920|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
170618135|NCT00543387|616608921|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
170618136|NCT00543387|616608922|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
170618137|NCT03932760|616608923|FG000|Overall Study|Became Ineligible|2|||
170618138|NCT03932760|616608924|FG001|Overall Study|Became Ineligible|5|||
170618139|NCT03932760|616608923|FG000|Overall Study|Withdrawal by Subject|6|||
170618140|NCT03932760|616608924|FG001|Overall Study|Withdrawal by Subject|6|||
170618141|NCT04725500|616608928|FG000|Screening|Screen Failure|26|||
170618142|NCT04725500|616608928|FG000|Screening|Withdrawal by Subject|1|||
170618143|NCT04725500|616608928|FG000|2 Week Take Home|Screen Fail|5|||
170618144|NCT02831764|616611282|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
170618145|NCT02831764|616611283|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
170618146|NCT02831764|616611284|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
170618147|NCT02831764|616611285|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
170618148|NCT02831764|616611286|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
170818567|NCT00396409|617343626|FG000|Period 1 - 2007|Lack of Efficacy|0|||
170818568|NCT00396409|617343627|FG001|Period 1 - 2007|Lack of Efficacy|1|||
170618149|NCT02831764|616611282|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
170618150|NCT02831764|616611283|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
170618151|NCT02831764|616611284|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
170618152|NCT02831764|616611285|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
170618153|NCT02831764|616611286|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
170618154|NCT02831764|616611282|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
170618155|NCT02831764|616611283|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
170618156|NCT02831764|616611284|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
170618157|NCT02831764|616611285|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
170618158|NCT02831764|616611286|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
170618159|NCT02831764|616611282|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
170618160|NCT02831764|616611283|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
170618161|NCT02831764|616611284|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
170618162|NCT02831764|616611285|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
170618163|NCT02831764|616611286|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
170618164|NCT02831764|616611282|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
170618165|NCT02831764|616611283|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
170618166|NCT02831764|616611284|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
170618167|NCT02831764|616611285|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
170618168|NCT02831764|616611286|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
170618169|NCT02831764|616611282|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
170618170|NCT02831764|616611283|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
170618171|NCT02831764|616611284|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
170618172|NCT02831764|616611285|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
170618173|NCT02831764|616611286|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
170618174|NCT02831764|616611282|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
170618175|NCT02831764|616611283|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
170618176|NCT02831764|616611284|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
170618177|NCT02831764|616611285|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
170618178|NCT02831764|616611286|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
170618179|NCT02831764|616611282|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
170618180|NCT02831764|616611283|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
170618181|NCT02831764|616611284|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
170618182|NCT02831764|616611285|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
170618183|NCT02831764|616611286|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
170618184|NCT02831764|616611282|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
170618185|NCT02831764|616611283|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
170618186|NCT02831764|616611284|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
170618187|NCT02831764|616611285|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
170618188|NCT02831764|616611286|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
170618189|NCT02831764|616611282|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
170618190|NCT02831764|616611283|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
170618191|NCT02831764|616611284|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
170618192|NCT02831764|616611285|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
170618193|NCT02831764|616611286|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
170618194|NCT02831764|616611282|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
170618195|NCT02831764|616611283|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
170618196|NCT02831764|616611284|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
170618197|NCT02831764|616611285|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
170618198|NCT02831764|616611286|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
170618199|NCT02831764|616611282|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
170618200|NCT02831764|616611283|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
170618201|NCT02831764|616611284|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
170618202|NCT02831764|616611285|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
170618203|NCT02831764|616611286|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
170618204|NCT02831764|616611282|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
170618205|NCT02831764|616611283|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
170618206|NCT02831764|616611284|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
170618207|NCT02831764|616611285|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
170618208|NCT02831764|616611286|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
170818569|NCT00396409|617343626|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
170818570|NCT00396409|617343627|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
170666606|NCT00370071|616792181|FG000|Overall Study|Withdrawal by Subject|2|||
170666607|NCT01787331|616792182|FG000|Overall Study|Physician Decision|1|||
170666608|NCT01787331|616792182|FG000|Overall Study|Withdrawal by Subject|1|||
170666609|NCT00761631|616792183|FG000|Overall Study|Parent/legal guardian request|8|||
170666610|NCT00761631|616792184|FG001|Overall Study|Parent/legal guardian request|3|||
170666611|NCT00761631|616792185|FG002|Overall Study|Parent/legal guardian request|8|||
170666612|NCT00761631|616792186|FG003|Overall Study|Parent/legal guardian request|0|||
170666613|NCT00761631|616792187|FG004|Overall Study|Parent/legal guardian request|5|||
170666614|NCT00761631|616792188|FG005|Overall Study|Parent/legal guardian request|0|||
170666615|NCT00761631|616792183|FG000|Overall Study|Lost to Follow-up|2|||
170666616|NCT00761631|616792184|FG001|Overall Study|Lost to Follow-up|4|||
170666617|NCT00761631|616792185|FG002|Overall Study|Lost to Follow-up|7|||
170666618|NCT00761631|616792186|FG003|Overall Study|Lost to Follow-up|1|||
170666619|NCT00761631|616792187|FG004|Overall Study|Lost to Follow-up|6|||
170666620|NCT00761631|616792188|FG005|Overall Study|Lost to Follow-up|1|||
170666621|NCT00761631|616792183|FG000|Overall Study|Protocol Violation|2|||
170666622|NCT00761631|616792184|FG001|Overall Study|Protocol Violation|0|||
170666623|NCT00761631|616792185|FG002|Overall Study|Protocol Violation|0|||
170666624|NCT00761631|616792186|FG003|Overall Study|Protocol Violation|1|||
170666625|NCT00761631|616792187|FG004|Overall Study|Protocol Violation|5|||
170666626|NCT00761631|616792188|FG005|Overall Study|Protocol Violation|1|||
170666627|NCT00761631|616792183|FG000|Overall Study|Randomized, not treated|1|||
170666628|NCT00761631|616792184|FG001|Overall Study|Randomized, not treated|0|||
170666629|NCT00761631|616792185|FG002|Overall Study|Randomized, not treated|0|||
170666630|NCT00761631|616792186|FG003|Overall Study|Randomized, not treated|0|||
170666631|NCT00761631|616792187|FG004|Overall Study|Randomized, not treated|0|||
170666632|NCT00761631|616792188|FG005|Overall Study|Randomized, not treated|0|||
170666633|NCT00761631|616792183|FG000|Overall Study|Failed to return|1|||
170666634|NCT00761631|616792184|FG001|Overall Study|Failed to return|0|||
170818571|NCT00396409|617343626|FG000|Period 1 - 2007|Lost to Follow-up|2|||
170818572|NCT00396409|617343627|FG001|Period 1 - 2007|Lost to Follow-up|3|||
170666635|NCT00761631|616792185|FG002|Overall Study|Failed to return|1|||
170666636|NCT00761631|616792186|FG003|Overall Study|Failed to return|1|||
170666637|NCT00761631|616792187|FG004|Overall Study|Failed to return|5|||
170818573|NCT00396409|617343626|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
170818574|NCT00396409|617343627|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
170818575|NCT00396409|617343626|FG000|Period 2 - 2008|Protocol Violation|1|||
170818576|NCT00396409|617343627|FG001|Period 2 - 2008|Protocol Violation|0|||
170818577|NCT00396409|617343626|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
170818578|NCT00396409|617343627|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
170818579|NCT00396409|617343626|FG000|Period 2 - 2008|Lost to Follow-up|3|||
170818580|NCT00396409|617343627|FG001|Period 2 - 2008|Lost to Follow-up|1|||
170818581|NCT00331799|617343628|FG000|Overall Study|Withdrawal by Subject|2|||
170818582|NCT00331799|617343628|FG000|Overall Study|Sedation|1|||
170818583|NCT03997409|617343629|FG000|Overall Study|Protocol Violation|1|||
170818584|NCT03997409|617343630|FG001|Overall Study|Protocol Violation|1|||
170818585|NCT03997409|617343631|FG002|Overall Study|Protocol Violation|0|||
170818586|NCT03997409|617343629|FG000|Overall Study|Withdrawal by Subject|3|||
170818587|NCT03997409|617343630|FG001|Overall Study|Withdrawal by Subject|0|||
170818588|NCT03997409|617343631|FG002|Overall Study|Withdrawal by Subject|0|||
170818589|NCT03997409|617343629|FG000|Overall Study|Lost to Follow-up|0|||
170818590|NCT03997409|617343630|FG001|Overall Study|Lost to Follow-up|0|||
170818591|NCT03997409|617343631|FG002|Overall Study|Lost to Follow-up|1|||
170818592|NCT04203199|617343636|FG000|First Intervention Period|Lost to Follow-up|0|||
170818593|NCT04203199|617343637|FG001|First Intervention Period|Lost to Follow-up|1|||
170818594|NCT04203199|617343636|FG000|Second Intervention Period|Medication change|1|||
170818595|NCT04203199|617343637|FG001|Second Intervention Period|Medication change|0|||
170818596|NCT02409732|617343638|FG000|Overall Study|Withdrawal by Subject|4|||
170818597|NCT02409732|617343638|FG000|Overall Study|Lost to Follow-up|2|||
170818598|NCT03960437|617343639|FG000|Overall Study|Removed by PI|4|||
170818599|NCT03960437|617343639|FG000|Overall Study|Lost to Follow-up|2|||
170818600|NCT03960437|617343639|FG000|Overall Study|Withdrawal by Subject|1|||
170818601|NCT03960437|617343639|FG000|Overall Study|Death|2|||
170818602|NCT01636258|617343645|FG000|Overall Study|Lost to Follow-up|1|||
170666638|NCT00761631|616792188|FG005|Overall Study|Failed to return|2|||
170666639|NCT00761631|616792183|FG000|Overall Study|Physician Decision|1|||
170666640|NCT00761631|616792184|FG001|Overall Study|Physician Decision|0|||
170818603|NCT01636258|617343646|FG001|Overall Study|Lost to Follow-up|0|||
170818604|NCT01838499|617343647|FG000|Overall Study|Protocol Violation|0|||
170818605|NCT01838499|617343648|FG001|Overall Study|Protocol Violation|1|||
170818606|NCT01838499|617343647|FG000|Overall Study|Lost to Follow-up|2|||
170818607|NCT01838499|617343648|FG001|Overall Study|Lost to Follow-up|4|||
170818608|NCT01838499|617343647|FG000|Overall Study|Lack of Efficacy|1|||
170818609|NCT01838499|617343648|FG001|Overall Study|Lack of Efficacy|2|||
170818610|NCT01838499|617343647|FG000|Overall Study|Adverse Event|2|||
170666641|NCT00761631|616792185|FG002|Overall Study|Physician Decision|0|||
170666642|NCT00761631|616792186|FG003|Overall Study|Physician Decision|0|||
170666643|NCT00761631|616792187|FG004|Overall Study|Physician Decision|0|||
170666644|NCT00761631|616792188|FG005|Overall Study|Physician Decision|0|||
170666645|NCT00761631|616792183|FG000|Overall Study|Other|0|||
170666646|NCT00761631|616792184|FG001|Overall Study|Other|0|||
170666647|NCT00761631|616792185|FG002|Overall Study|Other|0|||
170666648|NCT00761631|616792186|FG003|Overall Study|Other|0|||
170666649|NCT00761631|616792187|FG004|Overall Study|Other|1|||
170666650|NCT00761631|616792188|FG005|Overall Study|Other|1|||
170666651|NCT00289016|616792189|FG000|Overall Study|Disease Progression|29|||
170666652|NCT00289016|616792189|FG000|Overall Study|Death|2|||
170818611|NCT01838499|617343648|FG001|Overall Study|Adverse Event|1|||
170818612|NCT01838499|617343647|FG000|Overall Study|Withdrawal by Subject|19|||
170818613|NCT01838499|617343648|FG001|Overall Study|Withdrawal by Subject|9|||
170818614|NCT03614923|617343649|FG000|Overall Study|Withdrawal by Subject|2|||
170818615|NCT03614923|617343650|FG001|Overall Study|Withdrawal by Subject|1|||
170818616|NCT03614923|617343651|FG002|Overall Study|Withdrawal by Subject|1|||
170618209|NCT02831764|616611282|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
170618210|NCT02831764|616611283|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
170618211|NCT02831764|616611284|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
170618212|NCT02831764|616611285|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
170618213|NCT02831764|616611286|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
170618214|NCT02831764|616611282|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
170618215|NCT02831764|616611283|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
170618216|NCT02831764|616611284|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
170618217|NCT02831764|616611285|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
170618218|NCT02831764|616611286|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
170618219|NCT02831764|616611282|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
170618220|NCT02831764|616611283|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
170618221|NCT02831764|616611284|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
170618222|NCT02831764|616611285|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
170618223|NCT02831764|616611286|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
170618224|NCT02831764|616611282|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
170618225|NCT02831764|616611283|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
170618226|NCT02831764|616611284|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
170618227|NCT02831764|616611285|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
170618228|NCT02831764|616611286|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
170618229|NCT02831764|616611282|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
170618230|NCT02831764|616611283|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
170618231|NCT02831764|616611284|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
170618232|NCT02831764|616611285|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
170618233|NCT02831764|616611286|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
170618234|NCT02831764|616611282|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
170618235|NCT02831764|616611283|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
170618236|NCT02831764|616611284|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
170618237|NCT02831764|616611285|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
170618238|NCT02831764|616611286|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
170618239|NCT02796677|616611289|FG000|Overall Study|Adverse Event|11|||
170618240|NCT02796677|616611290|FG001|Overall Study|Adverse Event|22|||
170618241|NCT02796677|616611291|FG002|Overall Study|Adverse Event|14|||
170618242|NCT02796677|616611292|FG003|Overall Study|Adverse Event|14|||
170618243|NCT02796677|616611289|FG000|Overall Study|Protocol Violation|7|||
170618244|NCT02796677|616611290|FG001|Overall Study|Protocol Violation|5|||
170618245|NCT02796677|616611291|FG002|Overall Study|Protocol Violation|4|||
170618246|NCT02796677|616611292|FG003|Overall Study|Protocol Violation|8|||
170618247|NCT02796677|616611289|FG000|Overall Study|Lost to Follow-up|1|||
170618248|NCT02796677|616611290|FG001|Overall Study|Lost to Follow-up|5|||
170618249|NCT02796677|616611291|FG002|Overall Study|Lost to Follow-up|2|||
170618250|NCT02796677|616611292|FG003|Overall Study|Lost to Follow-up|2|||
170618251|NCT02796677|616611289|FG000|Overall Study|Lack of Efficacy|7|||
170618252|NCT02796677|616611290|FG001|Overall Study|Lack of Efficacy|9|||
170618253|NCT02796677|616611291|FG002|Overall Study|Lack of Efficacy|14|||
170618254|NCT02796677|616611292|FG003|Overall Study|Lack of Efficacy|20|||
170618255|NCT02796677|616611289|FG000|Overall Study|Withdrawal by Subject|4|||
170618256|NCT02796677|616611290|FG001|Overall Study|Withdrawal by Subject|14|||
170618257|NCT02796677|616611291|FG002|Overall Study|Withdrawal by Subject|6|||
170618258|NCT02796677|616611292|FG003|Overall Study|Withdrawal by Subject|7|||
170666653|NCT00289016|616792189|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
170666654|NCT00289016|616792189|FG000|Overall Study|Withdrawal by Subject|2|||
170818617|NCT03614923|617343649|FG000|Overall Study|Adverse Event|0|||
170818618|NCT03614923|617343650|FG001|Overall Study|Adverse Event|2|||
170666655|NCT00289016|616792189|FG000|Overall Study|Adverse Event|1|||
170666656|NCT00289016|616792189|FG000|Overall Study|Other|1|||
170666657|NCT00667875|616792190|FG000|Overall Study|Adverse Event|0|||
170666658|NCT00667875|616792191|FG001|Overall Study|Adverse Event|2|||
170666659|NCT00667875|616792192|FG002|Overall Study|Adverse Event|6|||
170666660|NCT00667875|616792190|FG000|Overall Study|Withdrawal by Subject|10|||
170666661|NCT00667875|616792191|FG001|Overall Study|Withdrawal by Subject|9|||
170666662|NCT00667875|616792192|FG002|Overall Study|Withdrawal by Subject|7|||
170666663|NCT00450255|616792193|FG000|Overall Study|Prior RFA ablation of liver|1|||
170666664|NCT04430738|616792194|FG000|Phase 1: Dose Escalation|Death|1|||
170666665|NCT04430738|616792195|FG001|Phase 1: Dose Escalation|Death|4|||
170666666|NCT04430738|616792196|FG002|Phase 1: Dose Escalation|Death|4|||
170666667|NCT04430738|616792197|FG003|Phase 1: Dose Escalation|Death|1|||
170666668|NCT04430738|616792198|FG004|Phase 1: Dose Escalation|Death|6|||
170666669|NCT04430738|616792199|FG005|Phase 1: Dose Escalation|Death|0|||
170666670|NCT04430738|616792194|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
170666671|NCT04430738|616792195|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
170666672|NCT04430738|616792196|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
170666673|NCT04430738|616792197|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
170666674|NCT04430738|616792198|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
170666675|NCT04430738|616792199|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
170666676|NCT04430738|616792194|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
170666677|NCT04430738|616792195|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
170666678|NCT04430738|616792196|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
170666679|NCT04430738|616792197|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
170666680|NCT04430738|616792198|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
170666681|NCT04430738|616792199|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
170666682|NCT04430738|616792194|FG000|Phase 1: Dose Escalation|Other|1|||
170666683|NCT04430738|616792195|FG001|Phase 1: Dose Escalation|Other|0|||
170666684|NCT04430738|616792196|FG002|Phase 1: Dose Escalation|Other|0|||
170666685|NCT04430738|616792197|FG003|Phase 1: Dose Escalation|Other|0|||
170666686|NCT04430738|616792198|FG004|Phase 1: Dose Escalation|Other|0|||
170666687|NCT04430738|616792199|FG005|Phase 1: Dose Escalation|Other|0|||
170666688|NCT04430738|616792194|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
170666689|NCT04430738|616792195|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
170666690|NCT04430738|616792196|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
170666691|NCT04430738|616792197|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
170666692|NCT04430738|616792198|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
170666693|NCT04430738|616792199|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
170666694|NCT04430738|616792194|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
170666695|NCT04430738|616792195|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
170666696|NCT04430738|616792196|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
170818619|NCT03614923|617343651|FG002|Overall Study|Adverse Event|1|||
170818620|NCT03614923|617343649|FG000|Overall Study|Lost to Follow-up|1|||
170818621|NCT03614923|617343650|FG001|Overall Study|Lost to Follow-up|0|||
170818622|NCT03614923|617343651|FG002|Overall Study|Lost to Follow-up|1|||
170818623|NCT03614923|617343649|FG000|Overall Study|Lack of Efficacy|2|||
170818624|NCT03614923|617343650|FG001|Overall Study|Lack of Efficacy|0|||
170666697|NCT04430738|616792197|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
170666698|NCT04430738|616792198|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
170666699|NCT04430738|616792199|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
170666700|NCT01736124|616792200|FG000|Post-intervention Assessment|Death|2|||
170666701|NCT01736124|616792201|FG001|Post-intervention Assessment|Death|2|||
170666702|NCT01736124|616792200|FG000|Post-intervention Assessment|lost computer access|1|||
170666703|NCT01736124|616792201|FG001|Post-intervention Assessment|lost computer access|1|||
170666704|NCT01736124|616792200|FG000|Post-intervention Assessment|Moved away|3|||
170666705|NCT01736124|616792201|FG001|Post-intervention Assessment|Moved away|1|||
170666706|NCT01736124|616792200|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
170666707|NCT01736124|616792201|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
170666708|NCT01736124|616792200|FG000|Post-intervention Assessment|Illness|3|||
170666709|NCT01736124|616792201|FG001|Post-intervention Assessment|Illness|2|||
170666710|NCT01736124|616792200|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
170666711|NCT01736124|616792201|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
170666712|NCT01736124|616792200|FG000|Post-intervention Assessment|Temporarily away|3|||
170666713|NCT01736124|616792201|FG001|Post-intervention Assessment|Temporarily away|1|||
170666714|NCT01736124|616792200|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
170666715|NCT01736124|616792201|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
170666716|NCT01736124|616792200|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
170818625|NCT03614923|617343651|FG002|Overall Study|Lack of Efficacy|1|||
170818626|NCT03614923|617343649|FG000|Overall Study|Non-compliance|0|||
170818627|NCT03614923|617343650|FG001|Overall Study|Non-compliance|1|||
170666717|NCT01736124|616792201|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
170666718|NCT01736124|616792200|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
170666719|NCT01736124|616792201|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
170666720|NCT01736124|616792200|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
170666721|NCT01736124|616792201|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
170666722|NCT01736124|616792200|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
170666723|NCT01736124|616792201|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
170666724|NCT01736124|616792200|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
170666725|NCT01736124|616792201|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
170666726|NCT01736124|616792200|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
170666727|NCT01736124|616792201|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
170666728|NCT01736124|616792200|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
170666729|NCT01736124|616792201|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
170666730|NCT01736124|616792200|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
170666731|NCT01736124|616792201|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
170666732|NCT00309985|616792202|FG000|Overall Study|Disease progression|12|||
170666733|NCT00309985|616792203|FG001|Overall Study|Disease progression|0|||
170666734|NCT00309985|616792202|FG000|Overall Study|Adverse Event|30|||
170666735|NCT00309985|616792203|FG001|Overall Study|Adverse Event|0|||
170666736|NCT00309985|616792202|FG000|Overall Study|Death|2|||
170666737|NCT00309985|616792203|FG001|Overall Study|Death|0|||
170666738|NCT00309985|616792202|FG000|Overall Study|Withdrawal by Subject|5|||
170666739|NCT00309985|616792203|FG001|Overall Study|Withdrawal by Subject|1|||
170666740|NCT00309985|616792202|FG000|Overall Study|Physician Decision|3|||
170666741|NCT00309985|616792203|FG001|Overall Study|Physician Decision|0|||
170666742|NCT00309985|616792202|FG000|Overall Study|Never started treatment|7|||
170666743|NCT00309985|616792203|FG001|Overall Study|Never started treatment|0|||
170666744|NCT00309985|616792202|FG000|Overall Study|Complicating disease|1|||
170666745|NCT00309985|616792203|FG001|Overall Study|Complicating disease|0|||
170666746|NCT00309985|616792202|FG000|Overall Study|Non-compliance|1|||
170666747|NCT00309985|616792203|FG001|Overall Study|Non-compliance|0|||
170666748|NCT00309985|616792202|FG000|Overall Study|Chemotherapy discontinued only|1|||
170666749|NCT00309985|616792203|FG001|Overall Study|Chemotherapy discontinued only|0|||
170666750|NCT01950390|616792204|FG000|Overall Study|Never started treatment|3|||
170666751|NCT01950390|616792205|FG001|Overall Study|Never started treatment|2|||
170666752|NCT01950390|616792204|FG000|Overall Study|Disease progression|45|||
170666753|NCT01950390|616792205|FG001|Overall Study|Disease progression|52|||
170666754|NCT01950390|616792204|FG000|Overall Study|Adverse Event|22|||
170666755|NCT01950390|616792205|FG001|Overall Study|Adverse Event|16|||
170666756|NCT01950390|616792204|FG000|Overall Study|Death|5|||
170666757|NCT01950390|616792205|FG001|Overall Study|Death|3|||
170666758|NCT01950390|616792204|FG000|Overall Study|Withdrawal by Subject|5|||
170666759|NCT01950390|616792205|FG001|Overall Study|Withdrawal by Subject|1|||
170666760|NCT01950390|616792204|FG000|Overall Study|Alternative therapy|0|||
170666761|NCT01950390|616792205|FG001|Overall Study|Alternative therapy|3|||
170666762|NCT01950390|616792204|FG000|Overall Study|Complicating disease|1|||
170666763|NCT01950390|616792205|FG001|Overall Study|Complicating disease|0|||
170666764|NCT01950390|616792204|FG000|Overall Study|On treatment|1|||
170666765|NCT01950390|616792205|FG001|Overall Study|On treatment|0|||
170666766|NCT01950390|616792204|FG000|Overall Study|Symptomatic deterioration|2|||
170666767|NCT01950390|616792205|FG001|Overall Study|Symptomatic deterioration|1|||
170666768|NCT01950390|616792204|FG000|Overall Study|Physician Decision|0|||
170666769|NCT01950390|616792205|FG001|Overall Study|Physician Decision|4|||
170666770|NCT01950390|616792204|FG000|Overall Study|Lack of clinical benefit|0|||
170666771|NCT01950390|616792205|FG001|Overall Study|Lack of clinical benefit|1|||
170666772|NCT01950390|616792204|FG000|Overall Study|Maintained PR and moved to observation only|0|||
170666773|NCT01950390|616792205|FG001|Overall Study|Maintained PR and moved to observation only|1|||
170666774|NCT01251861|616792206|FG000|Overall Study|Disease progression|6|||
170666775|NCT01251861|616792207|FG001|Overall Study|Disease progression|6|||
170666776|NCT01251861|616792206|FG000|Overall Study|Adverse Event|2|||
170666777|NCT01251861|616792207|FG001|Overall Study|Adverse Event|17|||
170917512|NCT01949662|617698457|FG001|Overall Study|Death|7|||
170917513|NCT01949662|617698456|FG000|Overall Study|Discharged before an agitation event|8|||
170666778|NCT01251861|616792206|FG000|Overall Study|Withdrawal by Subject|2|||
170666779|NCT01251861|616792207|FG001|Overall Study|Withdrawal by Subject|2|||
170666780|NCT01251861|616792206|FG000|Overall Study|Alternative therapy|1|||
170666781|NCT01251861|616792207|FG001|Overall Study|Alternative therapy|0|||
170666782|NCT01251861|616792206|FG000|Overall Study|Other complicating disease|0|||
170666783|NCT01251861|616792207|FG001|Overall Study|Other complicating disease|1|||
170666784|NCT01251861|616792206|FG000|Overall Study|Physician Decision|1|||
170666785|NCT01251861|616792207|FG001|Overall Study|Physician Decision|0|||
170666786|NCT01251861|616792206|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
170666787|NCT01251861|616792207|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
170666788|NCT01251861|616792206|FG000|Overall Study|Other|1|||
170666789|NCT01251861|616792207|FG001|Overall Study|Other|0|||
170917514|NCT01949662|617698457|FG001|Overall Study|Discharged before an agitation event|3|||
170618259|NCT02796677|616611289|FG000|Overall Study|Progressive disease|6|||
170618260|NCT02796677|616611290|FG001|Overall Study|Progressive disease|15|||
170618261|NCT02796677|616611291|FG002|Overall Study|Progressive disease|13|||
170618262|NCT02796677|616611292|FG003|Overall Study|Progressive disease|18|||
170618263|NCT02796677|616611289|FG000|Overall Study|Reason not mentioned|2|||
170618264|NCT02796677|616611290|FG001|Overall Study|Reason not mentioned|3|||
170618265|NCT02796677|616611291|FG002|Overall Study|Reason not mentioned|0|||
170618266|NCT02796677|616611292|FG003|Overall Study|Reason not mentioned|5|||
170618267|NCT01777308|616611297|FG000|Overall Study|Withdrawal by Subject|5|||
170618268|NCT01777308|616611298|FG001|Overall Study|Withdrawal by Subject|1|||
170618269|NCT01777308|616611297|FG000|Overall Study|Migrated/moved from study area|1|||
170618270|NCT01777308|616611298|FG001|Overall Study|Migrated/moved from study area|0|||
170618271|NCT01777308|616611297|FG000|Overall Study|Lost to Follow-up|7|||
170618272|NCT01777308|616611298|FG001|Overall Study|Lost to Follow-up|2|||
170618273|NCT01777308|616611297|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
170618274|NCT01777308|616611298|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
170618275|NCT00346216|616611304|FG000|Overall Study|Other|181|||
170618276|NCT00346216|616611305|FG001|Overall Study|Other|231|||
170618277|NCT00346216|616611306|FG002|Overall Study|Other|205|||
170618278|NCT00346216|616611304|FG000|Overall Study|No longer willing to participate|600|||
170618279|NCT00346216|616611305|FG001|Overall Study|No longer willing to participate|606|||
170618280|NCT00346216|616611306|FG002|Overall Study|No longer willing to participate|585|||
170618281|NCT00346216|616611304|FG000|Overall Study|Withdrawal by Subject|661|||
170618282|NCT00346216|616611305|FG001|Overall Study|Withdrawal by Subject|692|||
170618283|NCT00346216|616611306|FG002|Overall Study|Withdrawal by Subject|651|||
170618284|NCT00346216|616611304|FG000|Overall Study|Lost to Follow-up|611|||
170618285|NCT00346216|616611305|FG001|Overall Study|Lost to Follow-up|588|||
170618286|NCT00346216|616611306|FG002|Overall Study|Lost to Follow-up|542|||
170618287|NCT00346216|616611304|FG000|Overall Study|Physician Decision|80|||
170618288|NCT00346216|616611305|FG001|Overall Study|Physician Decision|76|||
170618289|NCT00346216|616611306|FG002|Overall Study|Physician Decision|59|||
170618290|NCT00346216|616611304|FG000|Overall Study|Does not meet entrance criteria|13|||
170618291|NCT00346216|616611305|FG001|Overall Study|Does not meet entrance criteria|10|||
170618292|NCT00346216|616611306|FG002|Overall Study|Does not meet entrance criteria|8|||
170618293|NCT00346216|616611304|FG000|Overall Study|Death|189|||
170618294|NCT00346216|616611305|FG001|Overall Study|Death|192|||
170618295|NCT00346216|616611306|FG002|Overall Study|Death|228|||
170618296|NCT00346216|616611304|FG000|Overall Study|Study terminated by sponsor|11|||
170618297|NCT00346216|616611305|FG001|Overall Study|Study terminated by sponsor|4|||
170618298|NCT00346216|616611306|FG002|Overall Study|Study terminated by sponsor|8|||
170618299|NCT00346216|616611304|FG000|Overall Study|Missing Subject Summary Status|62|||
170618300|NCT00346216|616611305|FG001|Overall Study|Missing Subject Summary Status|61|||
170618301|NCT00346216|616611306|FG002|Overall Study|Missing Subject Summary Status|62|||
170618302|NCT03431441|616611307|FG000|Overall Study|Withdrawal by Subject|2|||
170618303|NCT03431441|616611307|FG000|Overall Study|Adverse Event|2|||
170618304|NCT03431441|616611307|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
170618305|NCT01272232|616611317|FG000|Weeks 0-56|Adverse Event|39|||
170618306|NCT01272232|616611318|FG001|Weeks 0-56|Adverse Event|18|||
170618307|NCT01272232|616611319|FG002|Weeks 0-56|Adverse Event|7|||
170618308|NCT01272232|616611317|FG000|Weeks 0-56|Lack of Efficacy|0|||
170618309|NCT01272232|616611318|FG001|Weeks 0-56|Lack of Efficacy|0|||
170618310|NCT01272232|616611319|FG002|Weeks 0-56|Lack of Efficacy|3|||
170618311|NCT01272232|616611317|FG000|Weeks 0-56|Protocol Violation|12|||
170618312|NCT01272232|616611318|FG001|Weeks 0-56|Protocol Violation|8|||
170618313|NCT01272232|616611319|FG002|Weeks 0-56|Protocol Violation|13|||
170618314|NCT01272232|616611317|FG000|Weeks 0-56|Withdrawal criteria|32|||
170618315|NCT01272232|616611318|FG001|Weeks 0-56|Withdrawal criteria|14|||
170618316|NCT01272232|616611319|FG002|Weeks 0-56|Withdrawal criteria|37|||
170618317|NCT01272232|616611317|FG000|Weeks 0-56|Unclassified|16|||
170618318|NCT01272232|616611318|FG001|Weeks 0-56|Unclassified|7|||
170618319|NCT01272232|616611319|FG002|Weeks 0-56|Unclassified|12|||
170618320|NCT01272232|616611317|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
170618321|NCT01272232|616611318|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
170618322|NCT01272232|616611319|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
170618323|NCT01272232|616611317|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
170618324|NCT01272232|616611318|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
170618325|NCT01272232|616611319|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
170618326|NCT01272232|616611317|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
170618327|NCT01272232|616611318|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
170618328|NCT01272232|616611319|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
170618329|NCT01272232|616611317|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
170618330|NCT01272232|616611318|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
170618331|NCT01272232|616611319|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
170618332|NCT01272232|616611317|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
170666790|NCT01251861|616792206|FG000|Overall Study|Never started therapy|4|||
170666791|NCT01251861|616792207|FG001|Overall Study|Never started therapy|1|||
170666792|NCT01251861|616792206|FG000|Overall Study|Potential interaction of drugs|0|||
170666793|NCT01251861|616792207|FG001|Overall Study|Potential interaction of drugs|1|||
170666794|NCT03355365|616793362|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
170666795|NCT03355365|616793363|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
170666796|NCT03355365|616793362|FG000|Year 1, First Intervention|Protocol Violation|1|||
170666797|NCT03355365|616793363|FG001|Year 1, First Intervention|Protocol Violation|0|||
170666798|NCT03355365|616793362|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
170666799|NCT03355365|616793363|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
170666800|NCT03355365|616793362|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
170666801|NCT03355365|616793363|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
170666802|NCT03355365|616793362|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
170666803|NCT03355365|616793363|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
170666804|NCT03355365|616793362|FG000|Year 2, Crossover Intervention|severe COVID|0|||
170666805|NCT03355365|616793363|FG001|Year 2, Crossover Intervention|severe COVID|1|||
170666806|NCT03355365|616793362|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
170666807|NCT03355365|616793363|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
170666808|NCT01601132|616793375|FG000|Overall Study|Patient withdrew consent|1|||
170666809|NCT01601132|616793375|FG000|Overall Study|Protocol deviation|1|||
170666810|NCT02110238|616793376|FG000|12 Week Pivotal Phase|Adverse Event|3|||
170666811|NCT02110238|616793377|FG001|12 Week Pivotal Phase|Adverse Event|0|||
170666812|NCT02110238|616793376|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
170666813|NCT02110238|616793377|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
170666814|NCT02110238|616793376|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
170666815|NCT02110238|616793377|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
170666816|NCT02110238|616793376|FG000|12 Week Pivotal Phase|Physician Decision|0|||
170666817|NCT02110238|616793377|FG001|12 Week Pivotal Phase|Physician Decision|2|||
170666818|NCT02110238|616793376|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
170666819|NCT02110238|616793377|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
170666820|NCT02110238|616793376|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
170666821|NCT02110238|616793377|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
170666822|NCT02110238|616793376|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
170666823|NCT02110238|616793377|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
170666824|NCT02110238|616793376|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
170666825|NCT02110238|616793377|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
170666826|NCT02110238|616793376|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
170666827|NCT02110238|616793377|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
170666828|NCT02110238|616793376|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
170666829|NCT02110238|616793377|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
170666830|NCT02110238|616793376|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
170666831|NCT02110238|616793377|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
170666832|NCT03228433|616793380|FG000|Overall Study|Lost to Follow-up|1|||
170666833|NCT03228433|616793381|FG001|Overall Study|Lost to Follow-up|0|||
170666834|NCT03228433|616793382|FG002|Overall Study|Lost to Follow-up|0|||
170666835|NCT03228433|616793383|FG003|Overall Study|Lost to Follow-up|0|||
170666836|NCT03228433|616793384|FG004|Overall Study|Lost to Follow-up|0|||
170666837|NCT03228433|616793385|FG005|Overall Study|Lost to Follow-up|0|||
170666838|NCT03228433|616793380|FG000|Overall Study|Positive alcohol test|0|||
170666839|NCT03228433|616793381|FG001|Overall Study|Positive alcohol test|0|||
170666840|NCT03228433|616793382|FG002|Overall Study|Positive alcohol test|0|||
170666841|NCT03228433|616793383|FG003|Overall Study|Positive alcohol test|1|||
170666842|NCT03228433|616793384|FG004|Overall Study|Positive alcohol test|0|||
170818628|NCT03614923|617343651|FG002|Overall Study|Non-compliance|0|||
170818629|NCT03614923|617343649|FG000|Overall Study|Other|0|||
170818630|NCT03614923|617343650|FG001|Overall Study|Other|1|||
170818631|NCT03614923|617343651|FG002|Overall Study|Other|1|||
170818632|NCT00116584|617343662|FG000|Overall Study|Withdrawal by Subject|1|||
170818633|NCT00116584|617343663|FG001|Overall Study|Withdrawal by Subject|0|||
170666843|NCT03228433|616793385|FG005|Overall Study|Positive alcohol test|0|||
170666844|NCT01147640|616793386|FG000|Overall Study|Adverse Event|2|||
170666845|NCT01147640|616793387|FG001|Overall Study|Adverse Event|0|||
170666846|NCT01147640|616793386|FG000|Overall Study|Physician Decision|1|||
170818634|NCT00116584|617343662|FG000|Overall Study|Protocol Violation|1|||
170818635|NCT00116584|617343663|FG001|Overall Study|Protocol Violation|1|||
170666847|NCT01147640|616793387|FG001|Overall Study|Physician Decision|0|||
170666848|NCT01147640|616793386|FG000|Overall Study|Withdrawal by Subject|1|||
170666849|NCT01147640|616793387|FG001|Overall Study|Withdrawal by Subject|0|||
170666850|NCT01147640|616793386|FG000|Overall Study|Lost to Follow-up|0|||
170917515|NCT01949662|617698456|FG000|Overall Study|Dropped out|1|||
170917516|NCT01949662|617698457|FG001|Overall Study|Dropped out|3|||
170818636|NCT03034772|617343664|FG000|Overall Study|Adverse Event|0|||
170818637|NCT03034772|617343665|FG001|Overall Study|Adverse Event|1|||
170917517|NCT01949662|617698456|FG000|Overall Study|Ineligible|0|||
170666851|NCT01147640|616793387|FG001|Overall Study|Lost to Follow-up|1|||
170666852|NCT01147640|616793386|FG000|Overall Study|Didn't meet eligibility criteria|1|||
170666853|NCT01147640|616793387|FG001|Overall Study|Didn't meet eligibility criteria|0|||
170666854|NCT01856907|616793388|FG000|Overall Study|Pregnancy|0|||
170666855|NCT01856907|616793389|FG001|Overall Study|Pregnancy|1|||
170666856|NCT01856907|616793390|FG002|Overall Study|Pregnancy|0|||
170666857|NCT01856907|616793388|FG000|Overall Study|Pregnancy|0|||
170666858|NCT01856907|616793389|FG001|Overall Study|Pregnancy|1|||
170666859|NCT01856907|616793390|FG002|Overall Study|Pregnancy|0|||
170666860|NCT01856907|616793388|FG000|Overall Study|Withdrawal by Subject|0|||
170666861|NCT01856907|616793389|FG001|Overall Study|Withdrawal by Subject|1|||
170666862|NCT01856907|616793390|FG002|Overall Study|Withdrawal by Subject|0|||
170666863|NCT00091442|616793393|FG000|Overall Study|Progressive Disease|220|||
170666864|NCT00091442|616793394|FG001|Overall Study|Progressive Disease|189|||
170666865|NCT00091442|616793393|FG000|Overall Study|Physician Decision|61|||
170666866|NCT00091442|616793394|FG001|Overall Study|Physician Decision|58|||
170666867|NCT00091442|616793393|FG000|Overall Study|Withdrawal by Subject|38|||
170666868|NCT00091442|616793394|FG001|Overall Study|Withdrawal by Subject|46|||
170666869|NCT00091442|616793393|FG000|Overall Study|Adverse Event|29|||
170666870|NCT00091442|616793394|FG001|Overall Study|Adverse Event|48|||
170666871|NCT00091442|616793393|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
170666872|NCT00091442|616793394|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
170666873|NCT00091442|616793393|FG000|Overall Study|Death|9|||
170666874|NCT00091442|616793394|FG001|Overall Study|Death|7|||
170666875|NCT00091442|616793393|FG000|Overall Study|Lost to Follow-up|1|||
170666876|NCT00091442|616793394|FG001|Overall Study|Lost to Follow-up|3|||
170666877|NCT00091442|616793393|FG000|Overall Study|Other|2|||
170666878|NCT00091442|616793394|FG001|Overall Study|Other|6|||
170666879|NCT00917501|616793395|FG000|Overall Study|Lost to Follow-up|4|||
170666880|NCT00917501|616793396|FG001|Overall Study|Lost to Follow-up|1|||
170666881|NCT00917501|616793395|FG000|Overall Study|Withdrawal by Subject|3|||
170666882|NCT00917501|616793396|FG001|Overall Study|Withdrawal by Subject|1|||
170666883|NCT00917501|616793395|FG000|Overall Study|Lack of Efficacy|1|||
170666884|NCT00917501|616793396|FG001|Overall Study|Lack of Efficacy|2|||
170666885|NCT00917501|616793395|FG000|Overall Study|trouble swollowing capsules|0|||
170666886|NCT00917501|616793396|FG001|Overall Study|trouble swollowing capsules|1|||
170666887|NCT03342963|616793397|FG000|Overall Study|Adverse Event|1|||
170666888|NCT03342963|616793398|FG001|Overall Study|Adverse Event|2|||
170666889|NCT03342963|616793399|FG002|Overall Study|Adverse Event|0|||
170666890|NCT03342963|616793400|FG003|Overall Study|Adverse Event|0|||
170666891|NCT03342963|616793397|FG000|Overall Study|Withdrawal by Subject|1|||
170666892|NCT03342963|616793398|FG001|Overall Study|Withdrawal by Subject|0|||
170666893|NCT03342963|616793399|FG002|Overall Study|Withdrawal by Subject|0|||
170666894|NCT03342963|616793400|FG003|Overall Study|Withdrawal by Subject|0|||
170666895|NCT04041375|616793407|FG000|Intervention Phase|Withdrawal by Subject|2|||
170666896|NCT04041375|616793408|FG001|Intervention Phase|Withdrawal by Subject|2|||
170666897|NCT04041375|616793407|FG000|Follow-up Phase|Death|2|||
170666898|NCT04041375|616793408|FG001|Follow-up Phase|Death|0|||
170666899|NCT04041375|616793407|FG000|Follow-up Phase|Lost to Follow-up|2|||
170666900|NCT04041375|616793408|FG001|Follow-up Phase|Lost to Follow-up|1|||
170666901|NCT04041375|616793407|FG000|Follow-up Phase|Too ill|3|||
170666902|NCT04041375|616793408|FG001|Follow-up Phase|Too ill|0|||
170666903|NCT04515394|616793409|FG000|Overall Study|Participant did not receive treatment|1|||
170666904|NCT00199875|616793410|FG000|Overall Study|Withdrawal by Subject|0|||
170666905|NCT00199875|616793411|FG001|Overall Study|Withdrawal by Subject|0|||
170666906|NCT00199875|616793412|FG002|Overall Study|Withdrawal by Subject|0|||
170666907|NCT00199875|616793413|FG003|Overall Study|Withdrawal by Subject|0|||
170666908|NCT00199875|616793414|FG004|Overall Study|Withdrawal by Subject|1|||
170666909|NCT01013350|616793417|FG000|Overall Study|Lost to Follow-up|15|||
170666910|NCT01013350|616793418|FG001|Overall Study|Lost to Follow-up|95|||
170666911|NCT01013350|616793417|FG000|Overall Study|Adverse Event|0|||
170666912|NCT01013350|616793418|FG001|Overall Study|Adverse Event|1|||
170666913|NCT01013350|616793417|FG000|Overall Study|Physician Decision|4|||
170666914|NCT01013350|616793418|FG001|Overall Study|Physician Decision|20|||
170666915|NCT01013350|616793417|FG000|Overall Study|Withdrawal by Subject|15|||
170666916|NCT01013350|616793418|FG001|Overall Study|Withdrawal by Subject|38|||
170666917|NCT01013350|616793417|FG000|Overall Study|Death|3|||
170666918|NCT01013350|616793418|FG001|Overall Study|Death|5|||
170666919|NCT01013350|616793417|FG000|Overall Study|Participant entered interventional study|0|||
170666920|NCT01013350|616793418|FG001|Overall Study|Participant entered interventional study|8|||
170666921|NCT01013350|616793417|FG000|Overall Study|Other|1|||
170666922|NCT01013350|616793418|FG001|Overall Study|Other|25|||
170666923|NCT02019277|616793419|FG000|Overall Study|Withdrawal by Subject|3|||
170666924|NCT02019277|616793419|FG000|Overall Study|Death|7|||
170666925|NCT02019277|616793419|FG000|Overall Study|Did no Cooperate|1|||
170666926|NCT02019277|616793419|FG000|Overall Study|Adverse Event|1|||
170666927|NCT04738734|616793421|FG000|Overall Study|Withdrawal by Subject|2|||
170666928|NCT04738734|616793422|FG001|Overall Study|Withdrawal by Subject|4|||
170666929|NCT04738734|616793421|FG000|Overall Study|Lost to Follow-up|5|||
170666930|NCT04738734|616793422|FG001|Overall Study|Lost to Follow-up|2|||
170666931|NCT04738734|616793421|FG000|Overall Study|Physician Decision|0|||
170666932|NCT04738734|616793422|FG001|Overall Study|Physician Decision|1|||
170666933|NCT04738734|616793421|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
170666934|NCT04738734|616793422|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
170666935|NCT04889222|616793427|FG000|Overall Study|Did not meet eligibility criteria|8|||
170666936|NCT04889222|616793427|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
170666937|NCT04889222|616793427|FG000|Overall Study|Did not proceed due to time constraints|5|||
170666938|NCT01697358|616793428|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
170666939|NCT01697358|616793429|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
170666940|NCT01697358|616793428|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
170666941|NCT01697358|616793429|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
170666942|NCT01697358|616793428|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
170666943|NCT01697358|616793429|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
170666944|NCT01697358|616793428|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
170666945|NCT01697358|616793429|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
170666946|NCT01697358|616793428|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
170666947|NCT01697358|616793429|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
170666948|NCT01697358|616793428|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
170666949|NCT01697358|616793429|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
170666950|NCT01697358|616793428|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
170666951|NCT01697358|616793429|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
170666952|NCT01697358|616793428|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
170666953|NCT01697358|616793429|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
170666954|NCT01697358|616793428|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
170666955|NCT01697358|616793429|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
170666956|NCT01697358|616793428|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
170666957|NCT01697358|616793429|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
170666958|NCT00810693|616793436|FG000|Treatment Period|Adverse Event|8|||
170666959|NCT00810693|616793437|FG001|Treatment Period|Adverse Event|1|||
170666960|NCT00810693|616793438|FG002|Treatment Period|Adverse Event|7|||
170666961|NCT00810693|616793436|FG000|Treatment Period|Death|0|||
170666962|NCT00810693|616793437|FG001|Treatment Period|Death|1|||
170666963|NCT00810693|616793438|FG002|Treatment Period|Death|2|||
170666964|NCT00810693|616793436|FG000|Treatment Period|Lack of Efficacy|0|||
170666965|NCT00810693|616793437|FG001|Treatment Period|Lack of Efficacy|0|||
170666966|NCT00810693|616793438|FG002|Treatment Period|Lack of Efficacy|1|||
170666967|NCT00810693|616793436|FG000|Treatment Period|Lost to Follow-up|1|||
170666968|NCT00810693|616793437|FG001|Treatment Period|Lost to Follow-up|0|||
170666969|NCT00810693|616793438|FG002|Treatment Period|Lost to Follow-up|0|||
170666970|NCT00810693|616793436|FG000|Treatment Period|Non-compliance|1|||
170666971|NCT00810693|616793437|FG001|Treatment Period|Non-compliance|0|||
170666972|NCT00810693|616793438|FG002|Treatment Period|Non-compliance|0|||
170666973|NCT00810693|616793436|FG000|Treatment Period|Protocol Violation|1|||
170666974|NCT00810693|616793437|FG001|Treatment Period|Protocol Violation|2|||
170666975|NCT00810693|616793438|FG002|Treatment Period|Protocol Violation|2|||
170666976|NCT00810693|616793436|FG000|Treatment Period|Withdrawal by Subject|6|||
170666977|NCT00810693|616793437|FG001|Treatment Period|Withdrawal by Subject|2|||
170666978|NCT00810693|616793438|FG002|Treatment Period|Withdrawal by Subject|3|||
170666979|NCT00810693|616793436|FG000|Treatment Period|Not treated|0|||
170666980|NCT00810693|616793437|FG001|Treatment Period|Not treated|1|||
170666981|NCT00810693|616793438|FG002|Treatment Period|Not treated|1|||
170666982|NCT00810693|616793436|FG000|Follow-up Period (FUP)|Adverse Event|3|||
170666983|NCT00810693|616793437|FG001|Follow-up Period (FUP)|Adverse Event|1|||
170666984|NCT00810693|616793438|FG002|Follow-up Period (FUP)|Adverse Event|1|||
170666985|NCT00810693|616793436|FG000|Follow-up Period (FUP)|Death|2|||
170666986|NCT00810693|616793437|FG001|Follow-up Period (FUP)|Death|0|||
170666987|NCT00810693|616793438|FG002|Follow-up Period (FUP)|Death|1|||
170666988|NCT00810693|616793436|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
170666989|NCT00810693|616793437|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
170666990|NCT00810693|616793438|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
170666991|NCT00810693|616793436|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
170666992|NCT00810693|616793437|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
170666993|NCT00810693|616793438|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
170666994|NCT00810693|616793436|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
170666995|NCT00810693|616793437|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
170666996|NCT00810693|616793438|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
170666997|NCT03208127|616793449|FG000|Overall Study|Death|1|||
170917518|NCT01949662|617698457|FG001|Overall Study|Ineligible|1|||
170666998|NCT00961649|616793450|FG000|Overall Study|Adverse Event|4|||
170666999|NCT00961649|616793451|FG001|Overall Study|Adverse Event|0|||
170667000|NCT00961649|616793452|FG002|Overall Study|Adverse Event|0|||
170667001|NCT00961649|616793453|FG003|Overall Study|Adverse Event|2|||
170667002|NCT00961649|616793450|FG000|Overall Study|Inadequate control of IOP|0|||
170667003|NCT00961649|616793451|FG001|Overall Study|Inadequate control of IOP|0|||
170667004|NCT00961649|616793452|FG002|Overall Study|Inadequate control of IOP|0|||
170667005|NCT00961649|616793453|FG003|Overall Study|Inadequate control of IOP|1|||
170667006|NCT00961649|616793450|FG000|Overall Study|Patient has travel plans during holidays|0|||
170667007|NCT00961649|616793451|FG001|Overall Study|Patient has travel plans during holidays|0|||
170667008|NCT00961649|616793452|FG002|Overall Study|Patient has travel plans during holidays|1|||
170667009|NCT00961649|616793453|FG003|Overall Study|Patient has travel plans during holidays|0|||
170667010|NCT00961649|616793450|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
170667011|NCT00961649|616793451|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
170667012|NCT00961649|616793452|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
170667013|NCT00961649|616793453|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
170667014|NCT00961649|616793450|FG000|Overall Study|Study terminated by sponsor|4|||
170667015|NCT00961649|616793451|FG001|Overall Study|Study terminated by sponsor|4|||
170667016|NCT00961649|616793452|FG002|Overall Study|Study terminated by sponsor|4|||
170667017|NCT00961649|616793453|FG003|Overall Study|Study terminated by sponsor|1|||
170667018|NCT01786148|616793454|FG000|Overall Study|Lost to Follow-up|21|||
170667019|NCT01786148|616793455|FG001|Overall Study|Lost to Follow-up|13|||
170667020|NCT01786148|616793454|FG000|Overall Study|Death|0|||
170667021|NCT01786148|616793455|FG001|Overall Study|Death|1|||
170667022|NCT01786148|616793454|FG000|Overall Study|Withdrawal by Subject|0|||
170667023|NCT01786148|616793455|FG001|Overall Study|Withdrawal by Subject|7|||
170667024|NCT01786148|616793454|FG000|Overall Study|Incarceration|1|||
170667025|NCT01786148|616793455|FG001|Overall Study|Incarceration|1|||
170667026|NCT03594994|616793458|FG000|Overall Study|Adverse Event|1|||
170667027|NCT03594994|616793459|FG001|Overall Study|Adverse Event|0|||
170667028|NCT03594994|616793458|FG000|Overall Study|Withdrawal by Subject|0|||
170667029|NCT03594994|616793459|FG001|Overall Study|Withdrawal by Subject|1|||
170667030|NCT02764697|616793461|FG000|Overall Study|Lack of Efficacy|3|||
170667031|NCT00302107|616793464|FG000|Overall Study|Lost to Follow-up|6|||
170667032|NCT00302107|616793465|FG001|Overall Study|Lost to Follow-up|5|||
170667033|NCT00302107|616793464|FG000|Overall Study|Protocol Violation|1|||
170667034|NCT00302107|616793465|FG001|Overall Study|Protocol Violation|0|||
170667035|NCT00302107|616793464|FG000|Overall Study|Relocation|0|||
170667036|NCT00302107|616793465|FG001|Overall Study|Relocation|1|||
170667037|NCT00302107|616793464|FG000|Overall Study|Withdrawal by Subject|0|||
170667038|NCT00302107|616793465|FG001|Overall Study|Withdrawal by Subject|3|||
170667039|NCT00302107|616793464|FG000|Overall Study|Adverse Event|1|||
170667040|NCT00302107|616793465|FG001|Overall Study|Adverse Event|0|||
170667041|NCT01790932|616793468|FG000|Overall Study|Disease Progression|41|||
170667042|NCT01790932|616793468|FG000|Overall Study|Adverse Event|7|||
170667043|NCT01790932|616793468|FG000|Overall Study|Physician Decision|1|||
170667044|NCT01790932|616793468|FG000|Overall Study|Withdrawal by Subject|1|||
170667045|NCT03553927|616793469|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
170667046|NCT03553927|616793470|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
170667047|NCT03553927|616793469|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
170667048|NCT03553927|616793470|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
170667049|NCT02628769|616793477|FG000|First Intervention|Adverse Event|1|||
170667050|NCT02628769|616793478|FG001|First Intervention|Adverse Event|0|||
170667051|NCT02628769|616793477|FG000|First Intervention|Withdrawal by Subject|0|||
170667052|NCT02628769|616793478|FG001|First Intervention|Withdrawal by Subject|1|||
170667053|NCT02628769|616793477|FG000|Second Intervention|Adverse Event|2|||
170667054|NCT02628769|616793478|FG001|Second Intervention|Adverse Event|0|||
170667055|NCT02628769|616793477|FG000|Second Intervention|Physician Decision|0|||
170667056|NCT02628769|616793478|FG001|Second Intervention|Physician Decision|1|||
170667057|NCT03672643|616793481|FG000|Overall Study|Adverse Event|3|||
170667058|NCT03672643|616793481|FG000|Overall Study|Death|2|||
170667059|NCT03672643|616793481|FG000|Overall Study|Withdrawal by Subject|1|||
170667060|NCT03672643|616793481|FG000|Overall Study|Progressive disease|11|||
170667061|NCT03672643|616793481|FG000|Overall Study|Global deterioration of health status|1|||
170667062|NCT03672643|616793481|FG000|Overall Study|Refused further treatment|7|||
170667063|NCT03672643|616793481|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
170667064|NCT03350620|616793483|FG000|Stage 2|Adverse Event|0|||
170667065|NCT03350620|616793484|FG001|Stage 2|Adverse Event|1|||
170667066|NCT03350620|616793485|FG002|Stage 2|Adverse Event|1|||
170667067|NCT03350620|616793483|FG000|Stage 2|Lack of Efficacy|0|||
170667068|NCT03350620|616793484|FG001|Stage 2|Lack of Efficacy|2|||
170667069|NCT03350620|616793485|FG002|Stage 2|Lack of Efficacy|0|||
170667070|NCT03350620|616793483|FG000|Stage 2|Lost to Follow-up|1|||
170667071|NCT03350620|616793484|FG001|Stage 2|Lost to Follow-up|2|||
170667072|NCT03350620|616793485|FG002|Stage 2|Lost to Follow-up|2|||
170667073|NCT03350620|616793483|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
170917519|NCT05630014|617698463|FG000|Overall Study|Lost to Follow-up|1|||
170917520|NCT05630014|617698463|FG000|Overall Study|Withdrawal by Subject|3|||
170917521|NCT05630014|617698463|FG000|Overall Study|Physician Decision|2|||
170917522|NCT07041333|617698464|FG000|Overall Study|Lost to Follow-up|7|||
170667074|NCT03350620|616793484|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
170667075|NCT03350620|616793485|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
170667076|NCT00531934|616795593|FG000|Overall Study|Adverse Event|4|||
170667077|NCT00531934|616795594|FG001|Overall Study|Adverse Event|8|||
170667078|NCT00531934|616795593|FG000|Overall Study|Progression|52|||
170667079|NCT00531934|616795594|FG001|Overall Study|Progression|42|||
170667080|NCT00531934|616795593|FG000|Overall Study|Death|7|||
170667081|NCT00531934|616795594|FG001|Overall Study|Death|10|||
170667082|NCT00531934|616795593|FG000|Overall Study|Withdrawal by Subject|1|||
170667083|NCT00531934|616795594|FG001|Overall Study|Withdrawal by Subject|1|||
170667084|NCT00531934|616795593|FG000|Overall Study|Other|2|||
170667085|NCT00531934|616795594|FG001|Overall Study|Other|2|||
170667086|NCT00150709|616795595|FG000|Overall Study|Protocol Violation|7|||
170667087|NCT00150709|616795596|FG001|Overall Study|Protocol Violation|8|||
170667088|NCT00150709|616795597|FG002|Overall Study|Protocol Violation|3|||
170667089|NCT00150709|616795598|FG003|Overall Study|Protocol Violation|1|||
170667090|NCT00150709|616795595|FG000|Overall Study|Adverse Event|8|||
170667091|NCT00150709|616795596|FG001|Overall Study|Adverse Event|2|||
170667092|NCT00150709|616795597|FG002|Overall Study|Adverse Event|2|||
170667093|NCT00150709|616795598|FG003|Overall Study|Adverse Event|3|||
170667094|NCT00150709|616795595|FG000|Overall Study|Lack of Efficacy|6|||
170667095|NCT00150709|616795596|FG001|Overall Study|Lack of Efficacy|11|||
170667096|NCT00150709|616795597|FG002|Overall Study|Lack of Efficacy|9|||
170667097|NCT00150709|616795598|FG003|Overall Study|Lack of Efficacy|0|||
170667098|NCT00150709|616795595|FG000|Overall Study|Withdrawal by Subject|7|||
170667099|NCT00150709|616795596|FG001|Overall Study|Withdrawal by Subject|10|||
170667100|NCT00150709|616795597|FG002|Overall Study|Withdrawal by Subject|5|||
170667101|NCT00150709|616795598|FG003|Overall Study|Withdrawal by Subject|0|||
170667102|NCT00150709|616795595|FG000|Overall Study|Lost to Follow-up|3|||
170667103|NCT00150709|616795596|FG001|Overall Study|Lost to Follow-up|2|||
170667104|NCT00150709|616795597|FG002|Overall Study|Lost to Follow-up|0|||
170667105|NCT00150709|616795598|FG003|Overall Study|Lost to Follow-up|0|||
170667106|NCT00150709|616795595|FG000|Overall Study|Sponsor decision|0|||
170667107|NCT00150709|616795596|FG001|Overall Study|Sponsor decision|0|||
170667108|NCT00150709|616795597|FG002|Overall Study|Sponsor decision|0|||
170667109|NCT00150709|616795598|FG003|Overall Study|Sponsor decision|1|||
170667110|NCT00150709|616795595|FG000|Overall Study|Site/Investigator discontinued the study|5|||
170667111|NCT00150709|616795596|FG001|Overall Study|Site/Investigator discontinued the study|5|||
170667112|NCT00150709|616795597|FG002|Overall Study|Site/Investigator discontinued the study|2|||
170667113|NCT00150709|616795598|FG003|Overall Study|Site/Investigator discontinued the study|0|||
170667114|NCT00150709|616795595|FG000|Overall Study|Decision of parent(s)|1|||
170667115|NCT00150709|616795596|FG001|Overall Study|Decision of parent(s)|2|||
170667116|NCT00150709|616795597|FG002|Overall Study|Decision of parent(s)|0|||
170667117|NCT00150709|616795598|FG003|Overall Study|Decision of parent(s)|0|||
170667118|NCT00150709|616795595|FG000|Overall Study|Decision of parent(s) and investigator|3|||
170667119|NCT00150709|616795596|FG001|Overall Study|Decision of parent(s) and investigator|0|||
170667120|NCT00150709|616795597|FG002|Overall Study|Decision of parent(s) and investigator|0|||
170667121|NCT00150709|616795598|FG003|Overall Study|Decision of parent(s) and investigator|0|||
170667122|NCT00150709|616795595|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
170667123|NCT00150709|616795596|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
170667124|NCT00150709|616795597|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
170667125|NCT00150709|616795598|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
170667126|NCT00150709|616795595|FG000|Overall Study|Investigator decision|1|||
170667127|NCT00150709|616795596|FG001|Overall Study|Investigator decision|0|||
170667128|NCT00150709|616795597|FG002|Overall Study|Investigator decision|0|||
170667129|NCT00150709|616795598|FG003|Overall Study|Investigator decision|1|||
170917523|NCT07041333|617698464|FG000|Overall Study|Side effect|3|||
170917524|NCT07041333|617698464|FG000|Overall Study|Medication refusal by the child.|3|||
170667130|NCT00150709|616795595|FG000|Overall Study|Subject relocated|2|||
170667131|NCT00150709|616795596|FG001|Overall Study|Subject relocated|2|||
170667132|NCT00150709|616795597|FG002|Overall Study|Subject relocated|1|||
170667133|NCT00150709|616795598|FG003|Overall Study|Subject relocated|0|||
170917525|NCT07041333|617698464|FG000|Overall Study|Medication refusal by the family.|1|||
170917526|NCT07041333|617698464|FG000|Overall Study|The family's request to obtain a second medical opinion.|1|||
170917527|NCT06560177|617698465|FG000|Overall Study|One (1) eligible subject did not complete device application due to an unanticipated scheduling conf|1|||
170667134|NCT00150709|616795595|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
170667135|NCT00150709|616795596|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
170667136|NCT00150709|616795597|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
170667137|NCT00150709|616795598|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
170667138|NCT00150709|616795595|FG000|Overall Study|Convenience|0|||
170667139|NCT00150709|616795596|FG001|Overall Study|Convenience|1|||
170667140|NCT00150709|616795597|FG002|Overall Study|Convenience|0|||
170667141|NCT00150709|616795598|FG003|Overall Study|Convenience|0|||
170667142|NCT00150709|616795595|FG000|Overall Study|Subject entered new drug study|0|||
170667143|NCT00150709|616795596|FG001|Overall Study|Subject entered new drug study|1|||
170667144|NCT00150709|616795597|FG002|Overall Study|Subject entered new drug study|0|||
170667145|NCT00150709|616795598|FG003|Overall Study|Subject entered new drug study|0|||
170667146|NCT00150709|616795595|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
170667147|NCT00150709|616795596|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
170667148|NCT00150709|616795597|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
170667149|NCT00150709|616795598|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
170667150|NCT00150709|616795595|FG000|Overall Study|Lack of ease of swallowing|0|||
170667151|NCT00150709|616795596|FG001|Overall Study|Lack of ease of swallowing|1|||
170667152|NCT00150709|616795597|FG002|Overall Study|Lack of ease of swallowing|0|||
170667153|NCT00150709|616795598|FG003|Overall Study|Lack of ease of swallowing|0|||
170667154|NCT04092582|616795599|FG000|Overall Study|Death|1|||
170667155|NCT04092582|616795600|FG001|Overall Study|Death|1|||
170667156|NCT04092582|616795599|FG000|Overall Study|Withdrawal by Subject|4|||
170667157|NCT04092582|616795600|FG001|Overall Study|Withdrawal by Subject|1|||
170667158|NCT04092582|616795599|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
170667159|NCT04092582|616795600|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
170667160|NCT02808650|616795605|FG000|Overall Study|Death|0|||
170667161|NCT02808650|616795606|FG001|Overall Study|Death|0|||
170667162|NCT02808650|616795607|FG002|Overall Study|Death|0|||
170667163|NCT02808650|616795608|FG003|Overall Study|Death|0|||
170667164|NCT02808650|616795609|FG004|Overall Study|Death|1|||
170667165|NCT02808650|616795605|FG000|Overall Study|Lack of Efficacy|5|||
170667166|NCT02808650|616795606|FG001|Overall Study|Lack of Efficacy|5|||
170667167|NCT02808650|616795607|FG002|Overall Study|Lack of Efficacy|6|||
170667168|NCT02808650|616795608|FG003|Overall Study|Lack of Efficacy|5|||
170667169|NCT02808650|616795609|FG004|Overall Study|Lack of Efficacy|4|||
170667170|NCT02808650|616795605|FG000|Overall Study|Physician Decision|1|||
170667171|NCT02808650|616795606|FG001|Overall Study|Physician Decision|1|||
170667172|NCT02808650|616795607|FG002|Overall Study|Physician Decision|0|||
170667173|NCT02808650|616795608|FG003|Overall Study|Physician Decision|0|||
170667174|NCT02808650|616795609|FG004|Overall Study|Physician Decision|0|||
170667175|NCT02808650|616795605|FG000|Overall Study|Withdrawal by Subject|0|||
170667176|NCT02808650|616795606|FG001|Overall Study|Withdrawal by Subject|0|||
170667177|NCT02808650|616795607|FG002|Overall Study|Withdrawal by Subject|0|||
170667178|NCT02808650|616795608|FG003|Overall Study|Withdrawal by Subject|1|||
170667179|NCT02808650|616795609|FG004|Overall Study|Withdrawal by Subject|1|||
170667180|NCT00071396|616795610|FG000|Overall Study|Withdrawal by Subject|1|||
170667181|NCT00071396|616795610|FG000|Overall Study|Physician Decision|2|||
170667182|NCT04545554|616795611|FG000|Overall Study|Withdrawal by Subject|0|||
170667183|NCT04545554|616795612|FG001|Overall Study|Withdrawal by Subject|0|||
170667184|NCT04545554|616795613|FG002|Overall Study|Withdrawal by Subject|0|||
170667185|NCT04545554|616795614|FG003|Overall Study|Withdrawal by Subject|1|||
170667186|NCT04545554|616795615|FG004|Overall Study|Withdrawal by Subject|0|||
170667187|NCT04545554|616795616|FG005|Overall Study|Withdrawal by Subject|0|||
170667188|NCT02639546|616795617|FG000|Overall Study|Death|2|||
170667189|NCT02639546|616795618|FG001|Overall Study|Death|2|||
170667190|NCT02639546|616795619|FG002|Overall Study|Death|1|||
170667191|NCT02639546|616795620|FG003|Overall Study|Death|2|||
170667192|NCT02639546|616795621|FG004|Overall Study|Death|2|||
170667193|NCT02639546|616795622|FG005|Overall Study|Death|2|||
170667194|NCT02639546|616795623|FG006|Overall Study|Death|0|||
170667195|NCT02639546|616795624|FG007|Overall Study|Death|0|||
170667196|NCT02639546|616795617|FG000|Overall Study|Lost to Follow-up|0|||
170667197|NCT02639546|616795618|FG001|Overall Study|Lost to Follow-up|0|||
170667198|NCT02639546|616795619|FG002|Overall Study|Lost to Follow-up|1|||
170667199|NCT02639546|616795620|FG003|Overall Study|Lost to Follow-up|0|||
170667200|NCT02639546|616795621|FG004|Overall Study|Lost to Follow-up|1|||
170818638|NCT03034772|617343664|FG000|Overall Study|Withdrawal by Subject|0|||
170818639|NCT03034772|617343665|FG001|Overall Study|Withdrawal by Subject|1|||
170818640|NCT01136733|617343666|FG000|Phase 1b|Adverse Event|0|||
170667201|NCT02639546|616795622|FG005|Overall Study|Lost to Follow-up|1|||
170667202|NCT02639546|616795623|FG006|Overall Study|Lost to Follow-up|0|||
170667203|NCT02639546|616795624|FG007|Overall Study|Lost to Follow-up|1|||
170667204|NCT02639546|616795617|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
170667205|NCT02639546|616795618|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
170667206|NCT02639546|616795619|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
170667207|NCT02639546|616795620|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
170667208|NCT02639546|616795621|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
170667209|NCT02639546|616795622|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
170667210|NCT02639546|616795623|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
170667211|NCT02639546|616795624|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
170667212|NCT02639546|616795617|FG000|Overall Study|Study Terminated By Sponsor|0|||
170667213|NCT02639546|616795618|FG001|Overall Study|Study Terminated By Sponsor|2|||
170667214|NCT02639546|616795619|FG002|Overall Study|Study Terminated By Sponsor|3|||
170818641|NCT01136733|617343667|FG001|Phase 1b|Adverse Event|3|||
170917528|NCT04739761|617698466|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
170917529|NCT04739761|617698467|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
170667215|NCT02639546|616795620|FG003|Overall Study|Study Terminated By Sponsor|4|||
170667216|NCT02639546|616795621|FG004|Overall Study|Study Terminated By Sponsor|4|||
170667217|NCT02639546|616795622|FG005|Overall Study|Study Terminated By Sponsor|3|||
170667218|NCT02639546|616795623|FG006|Overall Study|Study Terminated By Sponsor|3|||
170667219|NCT02639546|616795624|FG007|Overall Study|Study Terminated By Sponsor|9|||
170667220|NCT02639546|616795617|FG000|Overall Study|Withdrawal by Subject|2|||
170667221|NCT02639546|616795618|FG001|Overall Study|Withdrawal by Subject|2|||
170667222|NCT02639546|616795619|FG002|Overall Study|Withdrawal by Subject|1|||
170667223|NCT02639546|616795620|FG003|Overall Study|Withdrawal by Subject|0|||
170667224|NCT02639546|616795621|FG004|Overall Study|Withdrawal by Subject|0|||
170667225|NCT02639546|616795622|FG005|Overall Study|Withdrawal by Subject|1|||
170667226|NCT02639546|616795623|FG006|Overall Study|Withdrawal by Subject|2|||
170667227|NCT02639546|616795624|FG007|Overall Study|Withdrawal by Subject|1|||
170667228|NCT02478372|616795625|FG000|Overall Study|Protocol Violation|12|||
170667229|NCT02478372|616795626|FG001|Overall Study|Protocol Violation|8|||
170667230|NCT02478372|616795625|FG000|Overall Study|Lost to Follow-up|1|||
170667231|NCT02478372|616795626|FG001|Overall Study|Lost to Follow-up|4|||
170667232|NCT02478372|616795625|FG000|Overall Study|Death|0|||
170667233|NCT02478372|616795626|FG001|Overall Study|Death|2|||
170667234|NCT00116428|616795627|FG000|Overall Study|Withdrawal by Subject|2|||
170667235|NCT00116428|616795628|FG001|Overall Study|Withdrawal by Subject|5|||
170667236|NCT00116428|616795627|FG000|Overall Study|Did not meet inclusion criteria|1|||
170667237|NCT00116428|616795628|FG001|Overall Study|Did not meet inclusion criteria|0|||
170667238|NCT01032174|616795629|FG000|Overall Study|Adverse Event|0|||
170667239|NCT01032174|616795630|FG001|Overall Study|Adverse Event|1|||
170667240|NCT01281137|616795631|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
170667241|NCT01281137|616795632|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
170667242|NCT01281137|616795631|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
170667243|NCT01281137|616795632|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
170667244|NCT01281137|616795631|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
170667245|NCT01281137|616795632|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
170667246|NCT01281137|616795631|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
170667247|NCT01281137|616795632|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
170667248|NCT01281137|616795631|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
170667249|NCT01281137|616795632|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
170667250|NCT03212690|616795635|FG000|Overall Study|Protocol Violation|1|||
170667251|NCT00474760|616795637|FG000|Overall Study|Death|0|||
170667252|NCT00474760|616795638|FG001|Overall Study|Death|0|||
170667253|NCT00474760|616795639|FG002|Overall Study|Death|0|||
170667254|NCT00474760|616795640|FG003|Overall Study|Death|0|||
170667255|NCT00474760|616795641|FG004|Overall Study|Death|2|||
170667256|NCT00474760|616795642|FG005|Overall Study|Death|0|||
170667257|NCT00474760|616795643|FG006|Overall Study|Death|0|||
170667258|NCT00474760|616795637|FG000|Overall Study|Adverse Event|0|||
170667259|NCT00474760|616795638|FG001|Overall Study|Adverse Event|0|||
170667260|NCT00474760|616795639|FG002|Overall Study|Adverse Event|0|||
170667261|NCT00474760|616795640|FG003|Overall Study|Adverse Event|0|||
170667262|NCT00474760|616795641|FG004|Overall Study|Adverse Event|1|||
170667263|NCT00474760|616795642|FG005|Overall Study|Adverse Event|7|||
170667264|NCT00474760|616795643|FG006|Overall Study|Adverse Event|0|||
170667265|NCT00474760|616795637|FG000|Overall Study|Laboratory abnormality|0|||
170667266|NCT00474760|616795638|FG001|Overall Study|Laboratory abnormality|0|||
170667267|NCT00474760|616795639|FG002|Overall Study|Laboratory abnormality|0|||
170667268|NCT00474760|616795640|FG003|Overall Study|Laboratory abnormality|0|||
170667269|NCT00474760|616795641|FG004|Overall Study|Laboratory abnormality|0|||
170917530|NCT04739761|617698466|FG000|Overall Study|By complete response from the participant|1|||
170917531|NCT04739761|617698467|FG001|Overall Study|By complete response from the participant|0|||
170917532|NCT04739761|617698466|FG000|Overall Study|Lost to Follow-up|3|||
170917533|NCT04739761|617698467|FG001|Overall Study|Lost to Follow-up|3|||
170917534|NCT04739761|617698466|FG000|Overall Study|Death|13|||
170917535|NCT04739761|617698467|FG001|Overall Study|Death|13|||
170667270|NCT00474760|616795642|FG005|Overall Study|Laboratory abnormality|1|||
170667271|NCT00474760|616795643|FG006|Overall Study|Laboratory abnormality|0|||
170667272|NCT00474760|616795637|FG000|Overall Study|Withdrawal by Subject|0|||
170667273|NCT00474760|616795638|FG001|Overall Study|Withdrawal by Subject|0|||
170667274|NCT00474760|616795639|FG002|Overall Study|Withdrawal by Subject|0|||
170667275|NCT00474760|616795640|FG003|Overall Study|Withdrawal by Subject|1|||
170667276|NCT00474760|616795641|FG004|Overall Study|Withdrawal by Subject|0|||
170667277|NCT00474760|616795642|FG005|Overall Study|Withdrawal by Subject|1|||
170667278|NCT00474760|616795643|FG006|Overall Study|Withdrawal by Subject|1|||
170667279|NCT00474760|616795637|FG000|Overall Study|Other|0|||
170667280|NCT00474760|616795638|FG001|Overall Study|Other|1|||
170667281|NCT00474760|616795639|FG002|Overall Study|Other|0|||
170667282|NCT00474760|616795640|FG003|Overall Study|Other|0|||
170667283|NCT00474760|616795641|FG004|Overall Study|Other|1|||
170667284|NCT00474760|616795642|FG005|Overall Study|Other|0|||
170667285|NCT00474760|616795643|FG006|Overall Study|Other|0|||
170667286|NCT00474760|616795637|FG000|Overall Study|Progressive disease|3|||
170667287|NCT00474760|616795638|FG001|Overall Study|Progressive disease|2|||
170667288|NCT00474760|616795639|FG002|Overall Study|Progressive disease|3|||
170667289|NCT00474760|616795640|FG003|Overall Study|Progressive disease|2|||
170667290|NCT00474760|616795641|FG004|Overall Study|Progressive disease|8|||
170667291|NCT00474760|616795642|FG005|Overall Study|Progressive disease|20|||
170667292|NCT00474760|616795643|FG006|Overall Study|Progressive disease|7|||
170667293|NCT00474760|616795637|FG000|Overall Study|Terminated by sponsor|0|||
170667294|NCT00474760|616795638|FG001|Overall Study|Terminated by sponsor|0|||
170667295|NCT00474760|616795639|FG002|Overall Study|Terminated by sponsor|0|||
170667296|NCT00474760|616795640|FG003|Overall Study|Terminated by sponsor|0|||
170667297|NCT00474760|616795641|FG004|Overall Study|Terminated by sponsor|0|||
170667298|NCT00474760|616795642|FG005|Overall Study|Terminated by sponsor|0|||
170667299|NCT00474760|616795643|FG006|Overall Study|Terminated by sponsor|2|||
170667300|NCT04295772|616795646|FG000|Overall Study|Protocol Violation|1|||
170667301|NCT04295772|616795647|FG001|Overall Study|Protocol Violation|0|||
170667302|NCT04295772|616795646|FG000|Overall Study|Ongoing for safety monitoring|14|||
170667303|NCT04295772|616795647|FG001|Overall Study|Ongoing for safety monitoring|1|||
170667304|NCT04295772|616795646|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
170667305|NCT04295772|616795647|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
170667306|NCT00331422|616795648|FG000|Overall Study|Did not receive entire study regimen|5|||
170667307|NCT02345226|616795649|FG000|Double-Blind Phase|Adverse Event|5|||
170667308|NCT02345226|616795650|FG001|Double-Blind Phase|Adverse Event|6|||
170667309|NCT02345226|616795649|FG000|Double-Blind Phase|Death|3|||
170667310|NCT02345226|616795650|FG001|Double-Blind Phase|Death|0|||
170667311|NCT02345226|616795649|FG000|Double-Blind Phase|Pregnancy|0|||
170667312|NCT02345226|616795650|FG001|Double-Blind Phase|Pregnancy|1|||
170667313|NCT02345226|616795649|FG000|Double-Blind Phase|Lack of Efficacy|1|||
170667314|NCT02345226|616795650|FG001|Double-Blind Phase|Lack of Efficacy|0|||
170667315|NCT02345226|616795649|FG000|Double-Blind Phase|Investigator's Discretion|4|||
170667316|NCT02345226|616795650|FG001|Double-Blind Phase|Investigator's Discretion|3|||
170667317|NCT02345226|616795649|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
170667318|NCT02345226|616795650|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
170667319|NCT02345226|616795649|FG000|Double-Blind Phase|Withdrew Consent|41|||
170667320|NCT02345226|616795650|FG001|Double-Blind Phase|Withdrew Consent|39|||
170667321|NCT02345226|616795649|FG000|Double-Blind Phase|Lost to Follow-up|12|||
170667322|NCT02345226|616795650|FG001|Double-Blind Phase|Lost to Follow-up|16|||
170667323|NCT02345226|616795649|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
170667324|NCT02345226|616795650|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
170667325|NCT02345226|616795649|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
170667326|NCT02345226|616795650|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
170667327|NCT01927627|616795651|FG000|Overall Study|Adverse Event|3|||
170667328|NCT01927627|616795651|FG000|Overall Study|Lack of Efficacy|1|||
170667329|NCT01927627|616795651|FG000|Overall Study|Financial Concerns|1|||
170667330|NCT01710046|616795652|FG000|Overall Study|Lost to Follow-up|1|||
170667331|NCT01710046|616795653|FG001|Overall Study|Lost to Follow-up|0|||
170667332|NCT00910273|616795658|FG000|Overall Study|Lack of Efficacy|6|||
170667333|NCT00910273|616795659|FG001|Overall Study|Lack of Efficacy|9|||
170667334|NCT00910273|616795658|FG000|Overall Study|Adverse Event|1|||
170667335|NCT00910273|616795659|FG001|Overall Study|Adverse Event|1|||
170667336|NCT00910273|616795658|FG000|Overall Study|Withdrawal by Subject|1|||
170667337|NCT00910273|616795659|FG001|Overall Study|Withdrawal by Subject|0|||
170667338|NCT00910273|616795658|FG000|Overall Study|Discontinuation of study by sponsor|8|||
170667339|NCT00910273|616795659|FG001|Overall Study|Discontinuation of study by sponsor|2|||
170667340|NCT00910273|616795658|FG000|Overall Study|Protocol Violation|1|||
170667341|NCT00910273|616795659|FG001|Overall Study|Protocol Violation|0|||
170667342|NCT00910273|616795658|FG000|Overall Study|Lost to Follow-up|1|||
170667343|NCT00910273|616795659|FG001|Overall Study|Lost to Follow-up|1|||
170667344|NCT01033851|616795660|FG000|Overall Study|Withdrawal by Subject|3|||
170667345|NCT01033851|616795661|FG001|Overall Study|Withdrawal by Subject|7|||
170667346|NCT00066729|616795662|FG000|Overall Study|Lost to Follow-up|1|||
170667347|NCT00066729|616795662|FG000|Overall Study|Disease progression|1|||
170667348|NCT02362269|616795663|FG000|Overall Study|Moved|1|||
170667349|NCT02362269|616795664|FG001|Overall Study|Moved|0|||
170667350|NCT02362269|616795663|FG000|Overall Study|Lost to Follow-up|0|||
170667351|NCT02362269|616795664|FG001|Overall Study|Lost to Follow-up|6|||
170667352|NCT02349542|616795665|FG000|Overall Study|Withdrawal by Subject|5|||
170667353|NCT02215096|616795666|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
170667354|NCT02215096|616795667|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
170667355|NCT02215096|616795668|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
170667356|NCT02215096|616795669|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
170667357|NCT02215096|616795670|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
170667358|NCT02215096|616795666|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
170667359|NCT02215096|616795667|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
170667360|NCT02215096|616795668|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
170667361|NCT02215096|616795669|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
170667362|NCT02215096|616795670|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
170667363|NCT02215096|616795666|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
170667364|NCT02215096|616795667|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
170667365|NCT02215096|616795668|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
170667366|NCT02215096|616795669|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
170667367|NCT02215096|616795670|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
170667368|NCT02215096|616795666|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
170667369|NCT02215096|616795667|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
170667370|NCT02215096|616795668|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
170667371|NCT02215096|616795669|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
170667372|NCT02215096|616795670|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
170667373|NCT01011738|616795671|FG000|Overall Study|Death|12|||
170667374|NCT01011738|616795672|FG001|Overall Study|Death|3|||
170667375|NCT01011738|616795673|FG002|Overall Study|Death|0|||
170667376|NCT01011738|616795671|FG000|Overall Study|Unknown reasons|312|||
170667377|NCT01011738|616795672|FG001|Overall Study|Unknown reasons|291|||
170667378|NCT01011738|616795673|FG002|Overall Study|Unknown reasons|17|||
170667379|NCT01903031|616795674|FG000|Overall Study|Not Able to Attend Clinic|1|||
170667380|NCT01903031|616795675|FG001|Overall Study|Not Able to Attend Clinic|1|||
170667381|NCT01903031|616795676|FG002|Overall Study|Not Able to Attend Clinic|0|||
170667382|NCT01903031|616795674|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
170667383|NCT01903031|616795675|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
170667384|NCT01903031|616795676|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
170667385|NCT01903031|616795674|FG000|Overall Study|Adverse Event|0|||
170667386|NCT01903031|616795675|FG001|Overall Study|Adverse Event|1|||
170667387|NCT01903031|616795676|FG002|Overall Study|Adverse Event|0|||
170667388|NCT01903031|616795674|FG000|Overall Study|Withdrawal by Subject|0|||
170667389|NCT01903031|616795675|FG001|Overall Study|Withdrawal by Subject|1|||
170667390|NCT01903031|616795676|FG002|Overall Study|Withdrawal by Subject|1|||
170667391|NCT01903031|616795674|FG000|Overall Study|Protocol Violation|0|||
170667392|NCT01903031|616795675|FG001|Overall Study|Protocol Violation|0|||
170667393|NCT01903031|616795676|FG002|Overall Study|Protocol Violation|2|||
170667394|NCT01903031|616795674|FG000|Overall Study|Lost to Follow-up|0|||
170667395|NCT01903031|616795675|FG001|Overall Study|Lost to Follow-up|0|||
170667396|NCT01903031|616795676|FG002|Overall Study|Lost to Follow-up|1|||
170667397|NCT01903031|616795674|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
170667398|NCT01903031|616795675|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
170667399|NCT01903031|616795676|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
170667400|NCT03841448|616795679|FG000|Double-blind Treatment (DBT) Period|Death|1|||
170667401|NCT03841448|616795680|FG001|Double-blind Treatment (DBT) Period|Death|1|||
170667402|NCT03841448|616795681|FG002|Double-blind Treatment (DBT) Period|Death|0|||
170667403|NCT03841448|616795682|FG003|Double-blind Treatment (DBT) Period|Death|0|||
170667404|NCT03841448|616795679|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
170667405|NCT03841448|616795680|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
170667406|NCT03841448|616795681|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
170667407|NCT03841448|616795682|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
170667408|NCT03841448|616795679|FG000|Open-Label Extension (OLE) Period|Death|0|||
170667409|NCT03841448|616795680|FG001|Open-Label Extension (OLE) Period|Death|0|||
170667410|NCT03841448|616795681|FG002|Open-Label Extension (OLE) Period|Death|0|||
170667411|NCT03841448|616795682|FG003|Open-Label Extension (OLE) Period|Death|1|||
170667412|NCT03841448|616795679|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
170667413|NCT03841448|616795680|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
170667414|NCT03841448|616795681|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
170667415|NCT03841448|616795682|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
170667416|NCT03841448|616795679|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
170667417|NCT03841448|616795680|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
170667418|NCT03841448|616795681|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
170667419|NCT03841448|616795682|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
170667420|NCT03841448|616795679|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
170667421|NCT03841448|616795680|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
170667422|NCT03841448|616795681|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
170818642|NCT01136733|617343668|FG002|Phase 1b|Adverse Event|1|||
170818643|NCT01136733|617343669|FG003|Phase 1b|Adverse Event|0|||
170667423|NCT03841448|616795682|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
170667424|NCT03896165|616795683|FG000|Overall Study|Withdrawal by Subject|2|||
170667425|NCT01163266|616795684|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
170667426|NCT01163266|616795685|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
170667427|NCT01163266|616795686|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
170667428|NCT01163266|616795684|FG000|Overall Study|Lack of Efficacy|1|||
170667429|NCT01163266|616795685|FG001|Overall Study|Lack of Efficacy|3|||
170667430|NCT01163266|616795686|FG002|Overall Study|Lack of Efficacy|1|||
170667431|NCT01163266|616795684|FG000|Overall Study|Noncompliance with Study Drug|0|||
170667432|NCT01163266|616795685|FG001|Overall Study|Noncompliance with Study Drug|2|||
170667433|NCT01163266|616795686|FG002|Overall Study|Noncompliance with Study Drug|0|||
170667434|NCT01163266|616795684|FG000|Overall Study|Protocol Deviations|2|||
170667435|NCT01163266|616795685|FG001|Overall Study|Protocol Deviations|2|||
170667436|NCT01163266|616795686|FG002|Overall Study|Protocol Deviations|5|||
170667437|NCT01163266|616795684|FG000|Overall Study|Withdrawal of Consent|5|||
170667438|NCT01163266|616795685|FG001|Overall Study|Withdrawal of Consent|7|||
170667439|NCT01163266|616795686|FG002|Overall Study|Withdrawal of Consent|3|||
170667440|NCT01163266|616795684|FG000|Overall Study|Lost to Follow-up|7|||
170667441|NCT01163266|616795685|FG001|Overall Study|Lost to Follow-up|7|||
170667442|NCT01163266|616795686|FG002|Overall Study|Lost to Follow-up|10|||
170667443|NCT01163266|616795684|FG000|Overall Study|Other|1|||
170667444|NCT01163266|616795685|FG001|Overall Study|Other|1|||
170667445|NCT01163266|616795686|FG002|Overall Study|Other|2|||
170667446|NCT03181893|616795687|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667447|NCT03181893|616795688|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
170667448|NCT03181893|616795689|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667449|NCT03181893|616795690|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667450|NCT03181893|616795691|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667451|NCT03181893|616795692|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667452|NCT03181893|616795693|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667453|NCT03181893|616795694|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667454|NCT03181893|616795695|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667455|NCT03181893|616795696|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667456|NCT03181893|616795697|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
170667457|NCT03181893|616795687|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
170667458|NCT03181893|616795688|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
170667459|NCT03181893|616795689|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667460|NCT03181893|616795690|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667461|NCT03181893|616795691|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667462|NCT03181893|616795692|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667463|NCT03181893|616795693|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667464|NCT03181893|616795694|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667465|NCT03181893|616795695|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667466|NCT03181893|616795696|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667467|NCT03181893|616795697|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
170667468|NCT03181893|616795687|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170667469|NCT03181893|616795688|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170667470|NCT03181893|616795689|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170667471|NCT03181893|616795690|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170667472|NCT03181893|616795691|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170667473|NCT03181893|616795692|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170667474|NCT03181893|616795693|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170667475|NCT03181893|616795694|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
170667476|NCT03181893|616795695|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
170667477|NCT03181893|616795696|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170818644|NCT01136733|617343670|FG004|Phase 1b|Adverse Event|0|||
170818645|NCT01136733|617343671|FG005|Phase 1b|Adverse Event|0|||
170818646|NCT01136733|617343672|FG006|Phase 1b|Adverse Event|0|||
170818647|NCT01136733|617343666|FG000|Phase 1b|Participant Choice|0|||
170818648|NCT01136733|617343667|FG001|Phase 1b|Participant Choice|0|||
170818649|NCT01136733|617343668|FG002|Phase 1b|Participant Choice|1|||
170818650|NCT01136733|617343669|FG003|Phase 1b|Participant Choice|0|||
170667478|NCT03181893|616795697|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
170667479|NCT03181893|616795687|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667480|NCT03181893|616795688|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667481|NCT03181893|616795689|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667482|NCT03181893|616795690|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170818651|NCT01136733|617343670|FG004|Phase 1b|Participant Choice|0|||
170818652|NCT01136733|617343671|FG005|Phase 1b|Participant Choice|0|||
170818653|NCT01136733|617343672|FG006|Phase 1b|Participant Choice|0|||
170818654|NCT01136733|617343666|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
170618333|NCT01272232|616611318|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
170618334|NCT01272232|616611319|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
170618335|NCT02159066|616611320|FG000|Part I|Adverse Event|7|||
170618336|NCT02159066|616611321|FG001|Part I|Adverse Event|5|||
170618337|NCT02159066|616611322|FG002|Part I|Adverse Event|0|||
170618338|NCT02159066|616611323|FG003|Part I|Adverse Event|0|||
170618339|NCT02159066|616611324|FG004|Part I|Adverse Event|0|||
170618340|NCT02159066|616611325|FG005|Part I|Adverse Event|0|||
170618341|NCT02159066|616611320|FG000|Part I|Death|11|||
170618342|NCT02159066|616611321|FG001|Part I|Death|9|||
170618343|NCT02159066|616611322|FG002|Part I|Death|0|||
170618344|NCT02159066|616611323|FG003|Part I|Death|0|||
170618345|NCT02159066|616611324|FG004|Part I|Death|0|||
170618346|NCT02159066|616611325|FG005|Part I|Death|0|||
170618347|NCT02159066|616611320|FG000|Part I|Progressive Disease|37|||
170618348|NCT02159066|616611321|FG001|Part I|Progressive Disease|46|||
170618349|NCT02159066|616611322|FG002|Part I|Progressive Disease|0|||
170618350|NCT02159066|616611323|FG003|Part I|Progressive Disease|0|||
170618351|NCT02159066|616611324|FG004|Part I|Progressive Disease|0|||
170618352|NCT02159066|616611325|FG005|Part I|Progressive Disease|0|||
170618353|NCT02159066|616611320|FG000|Part I|New Therapy for Study Indication|5|||
170618354|NCT02159066|616611321|FG001|Part I|New Therapy for Study Indication|4|||
170618355|NCT02159066|616611322|FG002|Part I|New Therapy for Study Indication|0|||
170618356|NCT02159066|616611323|FG003|Part I|New Therapy for Study Indication|0|||
170618357|NCT02159066|616611324|FG004|Part I|New Therapy for Study Indication|0|||
170618358|NCT02159066|616611325|FG005|Part I|New Therapy for Study Indication|0|||
170618359|NCT02159066|616611320|FG000|Part I|Termination of participants from the study|3|||
170618360|NCT02159066|616611321|FG001|Part I|Termination of participants from the study|3|||
170618361|NCT02159066|616611322|FG002|Part I|Termination of participants from the study|0|||
170618362|NCT02159066|616611323|FG003|Part I|Termination of participants from the study|0|||
170618363|NCT02159066|616611324|FG004|Part I|Termination of participants from the study|0|||
170618364|NCT02159066|616611325|FG005|Part I|Termination of participants from the study|0|||
170618365|NCT02159066|616611320|FG000|Part I|Physician Decision|2|||
170618366|NCT02159066|616611321|FG001|Part I|Physician Decision|9|||
170618367|NCT02159066|616611322|FG002|Part I|Physician Decision|0|||
170618368|NCT02159066|616611323|FG003|Part I|Physician Decision|0|||
170618369|NCT02159066|616611324|FG004|Part I|Physician Decision|0|||
170618370|NCT02159066|616611325|FG005|Part I|Physician Decision|0|||
170618371|NCT02159066|616611320|FG000|Part I|Participant/Guardian Decision|9|||
170618372|NCT02159066|616611321|FG001|Part I|Participant/Guardian Decision|3|||
170618373|NCT02159066|616611322|FG002|Part I|Participant/Guardian Decision|0|||
170618374|NCT02159066|616611323|FG003|Part I|Participant/Guardian Decision|0|||
170618375|NCT02159066|616611324|FG004|Part I|Participant/Guardian Decision|0|||
170618376|NCT02159066|616611325|FG005|Part I|Participant/Guardian Decision|0|||
170618377|NCT02159066|616611320|FG000|Part I|Missing Data|1|||
170618378|NCT02159066|616611321|FG001|Part I|Missing Data|0|||
170618379|NCT02159066|616611322|FG002|Part I|Missing Data|0|||
170618380|NCT02159066|616611323|FG003|Part I|Missing Data|0|||
170618381|NCT02159066|616611324|FG004|Part I|Missing Data|0|||
170618382|NCT02159066|616611325|FG005|Part I|Missing Data|0|||
170618383|NCT02159066|616611320|FG000|Part II|Adverse Event|0|||
170618384|NCT02159066|616611321|FG001|Part II|Adverse Event|0|||
170618385|NCT02159066|616611322|FG002|Part II|Adverse Event|1|||
170618386|NCT02159066|616611323|FG003|Part II|Adverse Event|0|||
170618387|NCT02159066|616611324|FG004|Part II|Adverse Event|1|||
170618388|NCT02159066|616611325|FG005|Part II|Adverse Event|1|||
170618389|NCT02159066|616611320|FG000|Part II|Death|0|||
170618390|NCT02159066|616611321|FG001|Part II|Death|0|||
170618391|NCT02159066|616611322|FG002|Part II|Death|1|||
170618392|NCT02159066|616611323|FG003|Part II|Death|0|||
170618393|NCT02159066|616611324|FG004|Part II|Death|2|||
170618394|NCT02159066|616611325|FG005|Part II|Death|1|||
170618395|NCT02159066|616611320|FG000|Part II|Progressive Disease|0|||
170618396|NCT02159066|616611321|FG001|Part II|Progressive Disease|0|||
170618397|NCT02159066|616611322|FG002|Part II|Progressive Disease|35|||
170618398|NCT02159066|616611323|FG003|Part II|Progressive Disease|1|||
170618399|NCT02159066|616611324|FG004|Part II|Progressive Disease|7|||
170618400|NCT02159066|616611325|FG005|Part II|Progressive Disease|4|||
170618401|NCT02159066|616611320|FG000|Part II|New Therapy for Study Indication|0|||
170618402|NCT02159066|616611321|FG001|Part II|New Therapy for Study Indication|0|||
170618403|NCT02159066|616611322|FG002|Part II|New Therapy for Study Indication|0|||
170667483|NCT03181893|616795691|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667484|NCT03181893|616795692|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667485|NCT03181893|616795693|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667486|NCT03181893|616795694|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667487|NCT03181893|616795695|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667488|NCT03181893|616795696|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
170667489|NCT03181893|616795697|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
170667490|NCT03181893|616795687|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667491|NCT03181893|616795688|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667492|NCT03181893|616795689|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667493|NCT03181893|616795690|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667494|NCT03181893|616795691|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667495|NCT03181893|616795692|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667496|NCT03181893|616795693|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667497|NCT03181893|616795694|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667498|NCT03181893|616795695|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667499|NCT03181893|616795696|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
170667500|NCT03181893|616795697|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
170667501|NCT00287365|616795698|FG000|Overall Study|sample not acquired|13|||
170667502|NCT03000569|616795699|FG000|Overall Study|Withdrawal by Subject|1|||
170667503|NCT03000569|616795700|FG001|Overall Study|Withdrawal by Subject|0|||
170667504|NCT03021304|616795702|FG000|Overall Study|Lack of Efficacy|1|||
170667505|NCT04815031|616795703|FG000|Overall Study|No adverse event information (missing information)|33|||
170667506|NCT02925117|616795706|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
170667507|NCT02925117|616795707|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
170667508|NCT02925117|616795708|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
170667509|NCT02925117|616795709|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
170667510|NCT02925117|616795710|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
170667511|NCT02925117|616795711|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
170667512|NCT02925117|616795712|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
170667513|NCT02925117|616795713|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
170667514|NCT02925117|616795714|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
170667515|NCT02925117|616795715|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
170667516|NCT02925117|616795716|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
170667517|NCT02925117|616795717|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
170667518|NCT02925117|616795706|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
170667519|NCT02925117|616795707|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
170667520|NCT02925117|616795708|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
170667521|NCT02925117|616795709|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667522|NCT02925117|616795710|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667523|NCT02925117|616795711|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667524|NCT02925117|616795712|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667525|NCT02925117|616795713|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667526|NCT02925117|616795714|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667527|NCT02925117|616795715|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667528|NCT02925117|616795716|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667529|NCT02925117|616795717|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
170667530|NCT02925117|616795706|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
170667531|NCT02925117|616795707|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
170667532|NCT02925117|616795708|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667533|NCT02925117|616795709|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667534|NCT02925117|616795710|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667535|NCT02925117|616795711|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667536|NCT02925117|616795712|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667537|NCT02925117|616795713|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667538|NCT02925117|616795714|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667539|NCT02925117|616795715|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667540|NCT02925117|616795716|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667541|NCT02925117|616795717|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
170667542|NCT02925117|616795706|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
170667543|NCT02925117|616795707|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
170667544|NCT02925117|616795708|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
170667545|NCT02925117|616795709|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
170667546|NCT02925117|616795710|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
170667547|NCT02925117|616795711|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
170667548|NCT02925117|616795712|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
170667549|NCT02925117|616795713|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
170667550|NCT02925117|616795714|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
170667551|NCT02925117|616795715|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
170667552|NCT02925117|616795716|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
170818655|NCT01136733|617343667|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
170818656|NCT01136733|617343668|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
170667553|NCT02925117|616795717|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
170667554|NCT02925117|616795706|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170667555|NCT02925117|616795707|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170667556|NCT02925117|616795708|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170667557|NCT02925117|616795709|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170667558|NCT02925117|616795710|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170667559|NCT02925117|616795711|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
170667560|NCT02925117|616795712|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170667561|NCT02925117|616795713|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170818657|NCT01136733|617343669|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
170818658|NCT01136733|617343670|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
170667562|NCT02925117|616795714|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170667563|NCT02925117|616795715|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
170667564|NCT02925117|616795716|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
170667565|NCT02925117|616795717|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
170667566|NCT02925117|616795706|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
170667567|NCT02925117|616795707|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
170667568|NCT02925117|616795708|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
170667569|NCT02925117|616795709|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
170667570|NCT02925117|616795710|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
170667571|NCT02925117|616795711|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
170667572|NCT02925117|616795712|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
170667573|NCT02925117|616795713|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
170667574|NCT02925117|616795714|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
170667575|NCT02925117|616795715|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
170667576|NCT02925117|616795716|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
170667577|NCT02925117|616795717|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
170667578|NCT02925117|616795706|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
170667579|NCT02925117|616795707|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
170667580|NCT02925117|616795708|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
170667581|NCT02925117|616795709|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
170667582|NCT02925117|616795710|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
170667583|NCT02925117|616795711|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
170667584|NCT02925117|616795712|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
170667585|NCT02925117|616795713|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
170667586|NCT02925117|616795714|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
170667587|NCT02925117|616795715|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
170667588|NCT02925117|616795716|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
170667589|NCT02925117|616795717|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
170667590|NCT02925117|616795706|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
170667591|NCT02925117|616795707|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
170667592|NCT02925117|616795708|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
170667593|NCT02925117|616795709|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
170667594|NCT02925117|616795710|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
170667595|NCT02925117|616795711|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
170667596|NCT02925117|616795712|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
170667597|NCT02925117|616795713|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
170667598|NCT02925117|616795714|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
170667599|NCT02925117|616795715|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
170667600|NCT02925117|616795716|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
170667601|NCT02925117|616795717|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
170667602|NCT02004522|616795718|FG000|Overall Study|Adverse Event|55|||
170667603|NCT02004522|616795719|FG001|Overall Study|Adverse Event|6|||
170667604|NCT02004522|616795718|FG000|Overall Study|Withdrawal by Subject|13|||
170667605|NCT02004522|616795719|FG001|Overall Study|Withdrawal by Subject|7|||
170667606|NCT02004522|616795718|FG000|Overall Study|Death|12|||
170667607|NCT02004522|616795719|FG001|Overall Study|Death|3|||
170667608|NCT02004522|616795718|FG000|Overall Study|Physician Decision|3|||
170667609|NCT02004522|616795719|FG001|Overall Study|Physician Decision|4|||
170667610|NCT02004522|616795718|FG000|Overall Study|Protocol Violation|1|||
170667611|NCT02004522|616795719|FG001|Overall Study|Protocol Violation|0|||
170667612|NCT02004522|616795718|FG000|Overall Study|Other is reason listed by PI|4|||
170667613|NCT02004522|616795719|FG001|Overall Study|Other is reason listed by PI|1|||
170667614|NCT02004522|616795718|FG000|Overall Study|Never Dosed|2|||
170667615|NCT02004522|616795719|FG001|Overall Study|Never Dosed|4|||
170667616|NCT02004522|616795718|FG000|Overall Study|Disease Progression|35|||
170667617|NCT02004522|616795719|FG001|Overall Study|Disease Progression|31|||
170667618|NCT02004522|616795718|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
170667619|NCT02004522|616795719|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
170667620|NCT00319501|616795726|FG000|Double-blind Period|Withdrawal by Subject|0|||
170667621|NCT00319501|616795727|FG001|Double-blind Period|Withdrawal by Subject|3|||
170667622|NCT00319501|616795726|FG000|Double-blind Period|Sponsor Request|1|||
170667623|NCT00319501|616795727|FG001|Double-blind Period|Sponsor Request|0|||
170667624|NCT00319501|616795726|FG000|Double-blind Period|Did not receive treatment|42|||
170667625|NCT00319501|616795727|FG001|Double-blind Period|Did not receive treatment|29|||
170667626|NCT00319501|616795726|FG000|Open-label Period|Adverse Event|5|||
170667627|NCT00319501|616795727|FG001|Open-label Period|Adverse Event|0|||
170667628|NCT00319501|616795726|FG000|Open-label Period|Protocol Violation|6|||
170667629|NCT00319501|616795727|FG001|Open-label Period|Protocol Violation|0|||
170667630|NCT00319501|616795726|FG000|Open-label Period|Withdrawal by Subject|38|||
170667631|NCT00319501|616795727|FG001|Open-label Period|Withdrawal by Subject|0|||
170667632|NCT00319501|616795726|FG000|Open-label Period|Principal Investigator decision|6|||
170667633|NCT00319501|616795727|FG001|Open-label Period|Principal Investigator decision|0|||
170667634|NCT00319501|616795726|FG000|Open-label Period|Sponsor request|12|||
170667635|NCT00319501|616795727|FG001|Open-label Period|Sponsor request|0|||
170667636|NCT00319501|616795726|FG000|Open-label Period|Lost to Follow-up|5|||
170667637|NCT00319501|616795727|FG001|Open-label Period|Lost to Follow-up|0|||
170667638|NCT00319501|616795726|FG000|Open-label Period|Did not receive treatment|33|||
170667639|NCT00319501|616795727|FG001|Open-label Period|Did not receive treatment|0|||
170667640|NCT00319501|616795726|FG000|Open-label Period|Other|11|||
170667641|NCT00319501|616795727|FG001|Open-label Period|Other|0|||
170667642|NCT00319501|616795726|FG000|Open-label Extension Period|Adverse Event|2|||
170667643|NCT00319501|616795727|FG001|Open-label Extension Period|Adverse Event|0|||
170667644|NCT00319501|616795726|FG000|Open-label Extension Period|Did not receive treatment|18|||
170667645|NCT00319501|616795727|FG001|Open-label Extension Period|Did not receive treatment|0|||
170667646|NCT00319501|616795726|FG000|Open-label Extension Period|Other|1|||
170667647|NCT00319501|616795727|FG001|Open-label Extension Period|Other|0|||
170667648|NCT00319501|616795726|FG000|Open-label Extension Period|Principal investigator decision|2|||
170667649|NCT00319501|616795727|FG001|Open-label Extension Period|Principal investigator decision|0|||
170667650|NCT00319501|616795726|FG000|Open-label Extension Period|Sponsor request|26|||
170667651|NCT00319501|616795727|FG001|Open-label Extension Period|Sponsor request|0|||
170667652|NCT00319501|616795726|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
170667653|NCT00319501|616795727|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
170667654|NCT01402011|616795729|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
170667655|NCT01402011|616795730|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
170667656|NCT01402011|616795731|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
170667657|NCT01402011|616795729|FG000|Active Treatment Period|Withdrawal by Subject|1|||
170667658|NCT01402011|616795730|FG001|Active Treatment Period|Withdrawal by Subject|3|||
170667659|NCT01402011|616795731|FG002|Active Treatment Period|Withdrawal by Subject|0|||
170667660|NCT01402011|616795729|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
170667661|NCT01402011|616795730|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
170667662|NCT01402011|616795731|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
170667663|NCT00594659|616795732|FG000|Overall Study|Lost to Follow-up|13|||
170667664|NCT00594659|616795733|FG001|Overall Study|Lost to Follow-up|9|||
170667665|NCT00594659|616795734|FG002|Overall Study|Lost to Follow-up|7|||
170667666|NCT02612129|616795736|FG000|Single Dose Treatment Period|Screening Failure|1|||
170667667|NCT02612129|616795737|FG001|Single Dose Treatment Period|Screening Failure|0|||
170667668|NCT02612129|616795738|FG002|Single Dose Treatment Period|Screening Failure|0|||
170667669|NCT02612129|616795736|FG000|Continuous Treatment Period|Early Escape|0|||
170667670|NCT02612129|616795737|FG001|Continuous Treatment Period|Early Escape|2|||
170667671|NCT02612129|616795738|FG002|Continuous Treatment Period|Early Escape|0|||
170667672|NCT02612129|616795736|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
170667673|NCT02612129|616795737|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
170667674|NCT02612129|616795738|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
170667675|NCT02612129|616795736|FG000|Continuous Treatment Period|Safety Reasons|0|||
170667676|NCT02612129|616795737|FG001|Continuous Treatment Period|Safety Reasons|3|||
170667677|NCT02612129|616795738|FG002|Continuous Treatment Period|Safety Reasons|0|||
170667678|NCT02612129|616795736|FG000|Continuous Treatment Period|Death|0|||
170667679|NCT02612129|616795737|FG001|Continuous Treatment Period|Death|1|||
170667680|NCT02612129|616795738|FG002|Continuous Treatment Period|Death|0|||
170667681|NCT02612129|616795736|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
170667682|NCT02612129|616795737|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
170667683|NCT02612129|616795738|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
170667684|NCT02557295|616795739|FG000|Overall Study|Withdrawal by Subject|9|||
170667685|NCT02557295|616795740|FG001|Overall Study|Withdrawal by Subject|2|||
170667686|NCT02557295|616795741|FG002|Overall Study|Withdrawal by Subject|4|||
170667687|NCT02557295|616795742|FG003|Overall Study|Withdrawal by Subject|0|||
170667688|NCT02557295|616795743|FG004|Overall Study|Withdrawal by Subject|0|||
170667689|NCT02557295|616795744|FG005|Overall Study|Withdrawal by Subject|0|||
170667690|NCT02557295|616795745|FG006|Overall Study|Withdrawal by Subject|15|||
170667691|NCT02557295|616795746|FG007|Overall Study|Withdrawal by Subject|1|||
170667692|NCT02557295|616795747|FG008|Overall Study|Withdrawal by Subject|3|||
170667693|NCT02557295|616795739|FG000|Overall Study|Disease Progression|0|||
170667694|NCT02557295|616795740|FG001|Overall Study|Disease Progression|0|||
170667695|NCT02557295|616795741|FG002|Overall Study|Disease Progression|0|||
170667696|NCT02557295|616795742|FG003|Overall Study|Disease Progression|0|||
170667697|NCT02557295|616795743|FG004|Overall Study|Disease Progression|0|||
170667698|NCT02557295|616795744|FG005|Overall Study|Disease Progression|0|||
170667699|NCT02557295|616795745|FG006|Overall Study|Disease Progression|1|||
170667700|NCT02557295|616795746|FG007|Overall Study|Disease Progression|0|||
170667701|NCT02557295|616795747|FG008|Overall Study|Disease Progression|0|||
170667702|NCT02557295|616795739|FG000|Overall Study|Lack of Efficacy|24|||
170667703|NCT02557295|616795740|FG001|Overall Study|Lack of Efficacy|1|||
170667704|NCT02557295|616795741|FG002|Overall Study|Lack of Efficacy|3|||
170667705|NCT02557295|616795742|FG003|Overall Study|Lack of Efficacy|0|||
170667706|NCT02557295|616795743|FG004|Overall Study|Lack of Efficacy|0|||
170667707|NCT02557295|616795744|FG005|Overall Study|Lack of Efficacy|0|||
170667708|NCT02557295|616795745|FG006|Overall Study|Lack of Efficacy|12|||
170667709|NCT02557295|616795746|FG007|Overall Study|Lack of Efficacy|1|||
170667710|NCT02557295|616795747|FG008|Overall Study|Lack of Efficacy|0|||
170667711|NCT02557295|616795739|FG000|Overall Study|Adverse Event|16|||
170667712|NCT02557295|616795740|FG001|Overall Study|Adverse Event|2|||
170667713|NCT02557295|616795741|FG002|Overall Study|Adverse Event|3|||
170667714|NCT02557295|616795742|FG003|Overall Study|Adverse Event|0|||
170667715|NCT02557295|616795743|FG004|Overall Study|Adverse Event|0|||
170667716|NCT02557295|616795744|FG005|Overall Study|Adverse Event|0|||
170667717|NCT02557295|616795745|FG006|Overall Study|Adverse Event|2|||
170667718|NCT02557295|616795746|FG007|Overall Study|Adverse Event|1|||
170667719|NCT02557295|616795747|FG008|Overall Study|Adverse Event|1|||
170667720|NCT02557295|616795739|FG000|Overall Study|Lost to Follow-up|4|||
170667721|NCT02557295|616795740|FG001|Overall Study|Lost to Follow-up|0|||
170667722|NCT02557295|616795741|FG002|Overall Study|Lost to Follow-up|0|||
170667723|NCT02557295|616795742|FG003|Overall Study|Lost to Follow-up|0|||
170667724|NCT02557295|616795743|FG004|Overall Study|Lost to Follow-up|0|||
170667725|NCT02557295|616795744|FG005|Overall Study|Lost to Follow-up|0|||
170667726|NCT02557295|616795745|FG006|Overall Study|Lost to Follow-up|9|||
170667727|NCT02557295|616795746|FG007|Overall Study|Lost to Follow-up|0|||
170667728|NCT02557295|616795747|FG008|Overall Study|Lost to Follow-up|0|||
170667729|NCT02557295|616795739|FG000|Overall Study|Study Close|54|||
170667730|NCT02557295|616795740|FG001|Overall Study|Study Close|3|||
170667731|NCT02557295|616795741|FG002|Overall Study|Study Close|5|||
170667732|NCT02557295|616795742|FG003|Overall Study|Study Close|3|||
170667733|NCT02557295|616795743|FG004|Overall Study|Study Close|0|||
170667734|NCT02557295|616795744|FG005|Overall Study|Study Close|0|||
170667735|NCT02557295|616795745|FG006|Overall Study|Study Close|37|||
170667736|NCT02557295|616795746|FG007|Overall Study|Study Close|3|||
170667737|NCT02557295|616795747|FG008|Overall Study|Study Close|19|||
170667738|NCT02557295|616795739|FG000|Overall Study|except for study close|4|||
170667739|NCT02557295|616795740|FG001|Overall Study|except for study close|0|||
170667740|NCT02557295|616795741|FG002|Overall Study|except for study close|0|||
170667741|NCT02557295|616795742|FG003|Overall Study|except for study close|0|||
170667742|NCT02557295|616795743|FG004|Overall Study|except for study close|0|||
170667743|NCT02557295|616795744|FG005|Overall Study|except for study close|0|||
170667744|NCT02557295|616795745|FG006|Overall Study|except for study close|5|||
170667745|NCT02557295|616795746|FG007|Overall Study|except for study close|1|||
170667746|NCT02557295|616795747|FG008|Overall Study|except for study close|0|||
170667747|NCT00566111|616795748|FG000|Overall Study|Adverse Event|0|||
170667748|NCT00566111|616795749|FG001|Overall Study|Adverse Event|2|||
170667749|NCT03774082|616795753|FG000|Overall Study|Death|6|||
170667750|NCT03774082|616795754|FG001|Overall Study|Death|3|||
170667751|NCT03774082|616795755|FG002|Overall Study|Death|2|||
170667752|NCT03774082|616795753|FG000|Overall Study|Subject decision|0|||
170667753|NCT03774082|616795754|FG001|Overall Study|Subject decision|3|||
170667754|NCT03774082|616795755|FG002|Overall Study|Subject decision|0|||
170667755|NCT03774082|616795753|FG000|Overall Study|Lost to Follow-up|2|||
170667756|NCT03774082|616795754|FG001|Overall Study|Lost to Follow-up|0|||
170667757|NCT03774082|616795755|FG002|Overall Study|Lost to Follow-up|0|||
170667758|NCT03774082|616795753|FG000|Overall Study|Guardian decision|0|||
170667759|NCT03774082|616795754|FG001|Overall Study|Guardian decision|0|||
170667760|NCT03774082|616795755|FG002|Overall Study|Guardian decision|1|||
170667761|NCT03774082|616795753|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
170667762|NCT03774082|616795754|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
170667763|NCT03774082|616795755|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
170667764|NCT01546207|616797483|FG000|Overall Study|Death|1|||
170667765|NCT04015336|616797484|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
170917536|NCT04739761|617698466|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
170917537|NCT04739761|617698467|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
170917538|NCT04739761|617698466|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
170917539|NCT04739761|617698467|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
170667766|NCT00246753|616797485|FG000|Overall Study|Withdrawal by Subject|2|||
170667767|NCT00246753|616797485|FG000|Overall Study|Physician Decision|2|||
170667768|NCT00246753|616797485|FG000|Overall Study|Adverse Event|2|||
170667769|NCT00246753|616797485|FG000|Overall Study|Unacceptable toxicity|2|||
170667770|NCT00880542|616797489|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
170667771|NCT00880542|616797489|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
170667772|NCT00880542|616797489|FG000|REP: Surgical Resection|progressive disease|1|||
170667773|NCT00216476|616797492|FG000|Overall Study|Withdrawal by Subject|59|||
170667774|NCT00216476|616797493|FG001|Overall Study|Withdrawal by Subject|72|||
170667775|NCT00216476|616797494|FG002|Overall Study|Withdrawal by Subject|9|||
170667776|NCT00216476|616797492|FG000|Overall Study|Lost to Follow-up|10|||
170667777|NCT00216476|616797493|FG001|Overall Study|Lost to Follow-up|9|||
170667778|NCT00216476|616797494|FG002|Overall Study|Lost to Follow-up|1|||
170667779|NCT00216476|616797492|FG000|Overall Study|Adverse Event|6|||
170667780|NCT00216476|616797493|FG001|Overall Study|Adverse Event|10|||
170667781|NCT00216476|616797494|FG002|Overall Study|Adverse Event|1|||
170667782|NCT00216476|616797492|FG000|Overall Study|Lack of Efficacy|4|||
170667783|NCT00216476|616797493|FG001|Overall Study|Lack of Efficacy|3|||
170667784|NCT00216476|616797494|FG002|Overall Study|Lack of Efficacy|0|||
170667785|NCT00216476|616797492|FG000|Overall Study|Death|2|||
170667786|NCT00216476|616797493|FG001|Overall Study|Death|0|||
170667787|NCT00216476|616797494|FG002|Overall Study|Death|0|||
170667788|NCT00216476|616797492|FG000|Overall Study|Pregnancy|0|||
170667789|NCT00216476|616797493|FG001|Overall Study|Pregnancy|1|||
170667790|NCT00216476|616797494|FG002|Overall Study|Pregnancy|1|||
170667791|NCT00216476|616797492|FG000|Overall Study|Other|0|||
170667792|NCT00216476|616797493|FG001|Overall Study|Other|0|||
170667793|NCT00216476|616797494|FG002|Overall Study|Other|1|||
170667794|NCT00216476|616797492|FG000|Overall Study|Refuses Injection|11|||
170667795|NCT00216476|616797493|FG001|Overall Study|Refuses Injection|0|||
170667796|NCT00216476|616797494|FG002|Overall Study|Refuses Injection|0|||
170667797|NCT00216476|616797492|FG000|Overall Study|No Further Need for Treatment|3|||
170667798|NCT00216476|616797493|FG001|Overall Study|No Further Need for Treatment|4|||
170667799|NCT00216476|616797494|FG002|Overall Study|No Further Need for Treatment|1|||
170667800|NCT00216476|616797492|FG000|Overall Study|Non-compliance|0|||
170667801|NCT00216476|616797493|FG001|Overall Study|Non-compliance|4|||
170667802|NCT00216476|616797494|FG002|Overall Study|Non-compliance|1|||
170667803|NCT00216476|616797492|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
170667804|NCT00216476|616797493|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
170667805|NCT00216476|616797494|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
170667806|NCT00216476|616797492|FG000|Overall Study|Administrative Reasons|1|||
170667807|NCT00216476|616797493|FG001|Overall Study|Administrative Reasons|1|||
170667808|NCT00216476|616797494|FG002|Overall Study|Administrative Reasons|0|||
170667809|NCT00216476|616797492|FG000|Overall Study|Protocol Deviation|5|||
170667810|NCT00216476|616797493|FG001|Overall Study|Protocol Deviation|1|||
170667811|NCT00216476|616797494|FG002|Overall Study|Protocol Deviation|0|||
170667812|NCT00216476|616797492|FG000|Overall Study|Patient Moved|2|||
170667813|NCT00216476|616797493|FG001|Overall Study|Patient Moved|2|||
170667814|NCT00216476|616797494|FG002|Overall Study|Patient Moved|0|||
170667815|NCT01952145|616797495|FG000|Overall Study|Protocol Violation|2|||
170667816|NCT01952145|616797496|FG001|Overall Study|Protocol Violation|1|||
170667817|NCT01952145|616797495|FG000|Overall Study|Death|0|||
170667818|NCT01952145|616797496|FG001|Overall Study|Death|1|||
170667819|NCT01952145|616797495|FG000|Overall Study|Adverse Event|9|||
170667820|NCT01952145|616797496|FG001|Overall Study|Adverse Event|0|||
170667821|NCT01952145|616797495|FG000|Overall Study|Withdrawal Criteria|16|||
170667822|NCT01952145|616797496|FG001|Overall Study|Withdrawal Criteria|11|||
170667823|NCT01952145|616797495|FG000|Overall Study|Unclassified|1|||
170667824|NCT01952145|616797496|FG001|Overall Study|Unclassified|1|||
170667825|NCT01522248|616797497|FG000|Overall Study|Lost to Follow-up|1|||
170667826|NCT01522248|616797498|FG001|Overall Study|Lost to Follow-up|0|||
170667827|NCT02191137|616797500|FG000|Treatment|Death|4|||
170667828|NCT02191137|616797500|FG000|Treatment|Withdrawal by Subject|3|||
170667829|NCT02191137|616797500|FG000|Treatment|Adverse Event|2|||
170667830|NCT02191137|616797500|FG000|Treatment|Other|1|||
170667831|NCT02191137|616797500|FG000|Follow-up|Lost to Follow-up|2|||
170667832|NCT02191137|616797500|FG000|Follow-up|Ongoing/unknown|2|||
170667833|NCT02191137|616797500|FG000|Follow-up|Adverse Event|1|||
170667834|NCT01332331|616797501|FG000|Overall Study|Lost to Follow-up|0|||
170667835|NCT01332331|616797502|FG001|Overall Study|Lost to Follow-up|1|||
170667836|NCT01332331|616797501|FG000|Overall Study|Adverse Event|1|||
170667837|NCT01332331|616797502|FG001|Overall Study|Adverse Event|1|||
170667838|NCT01332331|616797501|FG000|Overall Study|Physician Decision|1|||
170667839|NCT01332331|616797502|FG001|Overall Study|Physician Decision|0|||
170667840|NCT00538291|616797503|FG000|Overall Study|Adverse Event|2|||
170667841|NCT00538291|616797503|FG000|Overall Study|Withdrawal by Subject|1|||
170667842|NCT00694707|616797504|FG000|Overall Study|Did Not Receive Treatment|0|||
170667843|NCT00694707|616797505|FG001|Overall Study|Did Not Receive Treatment|0|||
170917540|NCT04739761|617698466|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
170917541|NCT04739761|617698467|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
170667844|NCT00694707|616797506|FG002|Overall Study|Did Not Receive Treatment|1|||
170667845|NCT00694707|616797507|FG003|Overall Study|Did Not Receive Treatment|1|||
170667846|NCT00694707|616797508|FG004|Overall Study|Did Not Receive Treatment|1|||
170667847|NCT00694707|616797504|FG000|Overall Study|Adverse Event|22|||
170667848|NCT00694707|616797505|FG001|Overall Study|Adverse Event|14|||
170667849|NCT00694707|616797506|FG002|Overall Study|Adverse Event|8|||
170667850|NCT00694707|616797507|FG003|Overall Study|Adverse Event|12|||
170667851|NCT00694707|616797508|FG004|Overall Study|Adverse Event|13|||
170667852|NCT00694707|616797504|FG000|Overall Study|Insufficient Therapeutic Response|33|||
170667853|NCT00694707|616797505|FG001|Overall Study|Insufficient Therapeutic Response|18|||
170667854|NCT00694707|616797506|FG002|Overall Study|Insufficient Therapeutic Response|17|||
170667855|NCT00694707|616797507|FG003|Overall Study|Insufficient Therapeutic Response|15|||
170667856|NCT00694707|616797508|FG004|Overall Study|Insufficient Therapeutic Response|10|||
170667857|NCT00694707|616797504|FG000|Overall Study|Protocol Violation|1|||
170667858|NCT00694707|616797505|FG001|Overall Study|Protocol Violation|2|||
170667859|NCT00694707|616797506|FG002|Overall Study|Protocol Violation|1|||
170667860|NCT00694707|616797507|FG003|Overall Study|Protocol Violation|3|||
170667861|NCT00694707|616797508|FG004|Overall Study|Protocol Violation|1|||
170667862|NCT00694707|616797504|FG000|Overall Study|Withdrawal of Consent|14|||
170667863|NCT00694707|616797505|FG001|Overall Study|Withdrawal of Consent|18|||
170667864|NCT00694707|616797506|FG002|Overall Study|Withdrawal of Consent|22|||
170667865|NCT00694707|616797507|FG003|Overall Study|Withdrawal of Consent|16|||
170667866|NCT00694707|616797508|FG004|Overall Study|Withdrawal of Consent|15|||
170667867|NCT00694707|616797504|FG000|Overall Study|Lost to Follow-up|0|||
170667868|NCT00694707|616797505|FG001|Overall Study|Lost to Follow-up|1|||
170667869|NCT00694707|616797506|FG002|Overall Study|Lost to Follow-up|2|||
170818659|NCT01136733|617343671|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
170818660|NCT01136733|617343672|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
170818661|NCT01136733|617343666|FG000|Phase 1b|Clinical Progression|1|||
170818662|NCT01136733|617343667|FG001|Phase 1b|Clinical Progression|1|||
170818663|NCT01136733|617343668|FG002|Phase 1b|Clinical Progression|0|||
170818664|NCT01136733|617343669|FG003|Phase 1b|Clinical Progression|0|||
170818665|NCT01136733|617343670|FG004|Phase 1b|Clinical Progression|0|||
170818666|NCT01136733|617343671|FG005|Phase 1b|Clinical Progression|0|||
170818667|NCT01136733|617343672|FG006|Phase 1b|Clinical Progression|0|||
170818668|NCT01136733|617343666|FG000|Phase 2|Disease Progression|0|||
170818669|NCT01136733|617343667|FG001|Phase 2|Disease Progression|0|||
170818670|NCT01136733|617343668|FG002|Phase 2|Disease Progression|0|||
170818671|NCT01136733|617343669|FG003|Phase 2|Disease Progression|0|||
170818672|NCT01136733|617343670|FG004|Phase 2|Disease Progression|30|||
170818673|NCT01136733|617343671|FG005|Phase 2|Disease Progression|32|||
170818674|NCT01136733|617343672|FG006|Phase 2|Disease Progression|38|||
170818675|NCT01136733|617343666|FG000|Phase 2|Adverse Event|0|||
170818676|NCT01136733|617343667|FG001|Phase 2|Adverse Event|0|||
170818677|NCT01136733|617343668|FG002|Phase 2|Adverse Event|0|||
170818678|NCT01136733|617343669|FG003|Phase 2|Adverse Event|0|||
170818679|NCT01136733|617343670|FG004|Phase 2|Adverse Event|11|||
170818680|NCT01136733|617343671|FG005|Phase 2|Adverse Event|13|||
170818681|NCT01136733|617343672|FG006|Phase 2|Adverse Event|5|||
170818682|NCT01136733|617343666|FG000|Phase 2|Participant Choice|0|||
170818683|NCT01136733|617343667|FG001|Phase 2|Participant Choice|0|||
170818684|NCT01136733|617343668|FG002|Phase 2|Participant Choice|0|||
170818685|NCT01136733|617343669|FG003|Phase 2|Participant Choice|0|||
170818686|NCT01136733|617343670|FG004|Phase 2|Participant Choice|3|||
170818687|NCT01136733|617343671|FG005|Phase 2|Participant Choice|0|||
170818688|NCT01136733|617343672|FG006|Phase 2|Participant Choice|1|||
170818689|NCT01136733|617343666|FG000|Phase 2|Administrative-Withdrew Consent|0|||
170818690|NCT01136733|617343667|FG001|Phase 2|Administrative-Withdrew Consent|0|||
170818691|NCT01136733|617343668|FG002|Phase 2|Administrative-Withdrew Consent|0|||
170818692|NCT01136733|617343669|FG003|Phase 2|Administrative-Withdrew Consent|0|||
170818693|NCT01136733|617343670|FG004|Phase 2|Administrative-Withdrew Consent|1|||
170818694|NCT01136733|617343671|FG005|Phase 2|Administrative-Withdrew Consent|0|||
170818695|NCT01136733|617343672|FG006|Phase 2|Administrative-Withdrew Consent|0|||
170818696|NCT01136733|617343666|FG000|Phase 2|Other|0|||
170818697|NCT01136733|617343667|FG001|Phase 2|Other|0|||
170818698|NCT01136733|617343668|FG002|Phase 2|Other|0|||
170818699|NCT01136733|617343669|FG003|Phase 2|Other|0|||
170818700|NCT01136733|617343670|FG004|Phase 2|Other|6|||
170818701|NCT01136733|617343671|FG005|Phase 2|Other|7|||
170818702|NCT01136733|617343672|FG006|Phase 2|Other|6|||
170818703|NCT01837719|617343673|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
170818704|NCT01837719|617343673|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
170818705|NCT00460434|617343676|FG000|Overall Study|Lost to Follow-up|3|||
170818706|NCT00460434|617343677|FG001|Overall Study|Lost to Follow-up|7|||
170818707|NCT01498445|617343678|FG000|Overall Study|Lack of Efficacy|0|||
170818708|NCT01498445|617343679|FG001|Overall Study|Lack of Efficacy|0|||
170818709|NCT01498445|617343680|FG002|Overall Study|Lack of Efficacy|1|||
170818710|NCT01498445|617343681|FG003|Overall Study|Lack of Efficacy|2|||
170667870|NCT00694707|616797507|FG003|Overall Study|Lost to Follow-up|0|||
170667871|NCT00694707|616797508|FG004|Overall Study|Lost to Follow-up|0|||
170667872|NCT00694707|616797504|FG000|Overall Study|Jeopardizing Parole Status|1|||
170667873|NCT00694707|616797505|FG001|Overall Study|Jeopardizing Parole Status|0|||
170667874|NCT00694707|616797506|FG002|Overall Study|Jeopardizing Parole Status|0|||
170667875|NCT00694707|616797507|FG003|Overall Study|Jeopardizing Parole Status|0|||
170818711|NCT01498445|617343682|FG004|Overall Study|Lack of Efficacy|0|||
170818712|NCT01498445|617343683|FG005|Overall Study|Lack of Efficacy|0|||
170818713|NCT01498445|617343678|FG000|Overall Study|Screen Failure|0|||
170818714|NCT01498445|617343679|FG001|Overall Study|Screen Failure|0|||
170818715|NCT01498445|617343680|FG002|Overall Study|Screen Failure|0|||
170818716|NCT01498445|617343681|FG003|Overall Study|Screen Failure|0|||
170818717|NCT01498445|617343682|FG004|Overall Study|Screen Failure|1|||
170818718|NCT01498445|617343683|FG005|Overall Study|Screen Failure|1|||
170818719|NCT04739306|617343684|FG000|Main Study Period|Adverse Event|6|||
170818720|NCT04739306|617343685|FG001|Main Study Period|Adverse Event|7|||
170618404|NCT02159066|616611323|FG003|Part II|New Therapy for Study Indication|0|||
170618405|NCT02159066|616611324|FG004|Part II|New Therapy for Study Indication|1|||
170618406|NCT02159066|616611325|FG005|Part II|New Therapy for Study Indication|0|||
170618407|NCT02159066|616611320|FG000|Part II|Physician Decision|0|||
170618408|NCT02159066|616611321|FG001|Part II|Physician Decision|0|||
170618409|NCT02159066|616611322|FG002|Part II|Physician Decision|1|||
170618410|NCT02159066|616611323|FG003|Part II|Physician Decision|0|||
170618411|NCT02159066|616611324|FG004|Part II|Physician Decision|0|||
170618412|NCT02159066|616611325|FG005|Part II|Physician Decision|0|||
170618413|NCT02159066|616611320|FG000|Part II|Participant/Guardian Decision|0|||
170618414|NCT02159066|616611321|FG001|Part II|Participant/Guardian Decision|0|||
170618415|NCT02159066|616611322|FG002|Part II|Participant/Guardian Decision|0|||
170618416|NCT02159066|616611323|FG003|Part II|Participant/Guardian Decision|0|||
170618417|NCT02159066|616611324|FG004|Part II|Participant/Guardian Decision|2|||
170618418|NCT02159066|616611325|FG005|Part II|Participant/Guardian Decision|0|||
170618419|NCT00796666|616611326|FG000|Overall Study|Death|2|||
170618420|NCT00796666|616611327|FG001|Overall Study|Death|4|||
170618421|NCT00796666|616611326|FG000|Overall Study|Withdrawal by Subject|2|||
170618422|NCT00796666|616611327|FG001|Overall Study|Withdrawal by Subject|0|||
170618423|NCT00796666|616611326|FG000|Overall Study|Adverse Event|7|||
170618424|NCT00796666|616611327|FG001|Overall Study|Adverse Event|5|||
170618425|NCT00796666|616611326|FG000|Overall Study|Protocol Violation|1|||
170618426|NCT00796666|616611327|FG001|Overall Study|Protocol Violation|0|||
170618427|NCT00796666|616611326|FG000|Overall Study|Other|1|||
170618428|NCT00796666|616611327|FG001|Overall Study|Other|0|||
170618429|NCT00796666|616611326|FG000|Overall Study|Terminated by sponsor|53|||
170618430|NCT00796666|616611327|FG001|Overall Study|Terminated by sponsor|55|||
170618431|NCT00796666|616611326|FG000|Overall Study|Randomized and not treated|1|||
170618432|NCT00796666|616611327|FG001|Overall Study|Randomized and not treated|0|||
170618433|NCT02748863|616611328|FG000|Treatment Period 1|Adverse Event|0|||
170618434|NCT02748863|616611329|FG001|Treatment Period 1|Adverse Event|1|||
170618435|NCT02748863|616611330|FG002|Treatment Period 1|Adverse Event|0|||
170618436|NCT02748863|616611331|FG003|Treatment Period 1|Adverse Event|0|||
170618437|NCT02748863|616611332|FG004|Treatment Period 1|Adverse Event|0|||
170618438|NCT02748863|616611328|FG000|Treatment Period 1|Lack of Efficacy|0|||
170618439|NCT02748863|616611329|FG001|Treatment Period 1|Lack of Efficacy|0|||
170618440|NCT02748863|616611330|FG002|Treatment Period 1|Lack of Efficacy|1|||
170618441|NCT02748863|616611331|FG003|Treatment Period 1|Lack of Efficacy|0|||
170618442|NCT02748863|616611332|FG004|Treatment Period 1|Lack of Efficacy|0|||
170618443|NCT02748863|616611328|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170618444|NCT02748863|616611329|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170618445|NCT02748863|616611330|FG002|Treatment Period 1|Withdrawal by Subject|1|||
170618446|NCT02748863|616611331|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170618447|NCT02748863|616611332|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170618448|NCT02748863|616611328|FG000|Treatment Period 2|Lost to Follow-up|2|||
170618449|NCT02748863|616611329|FG001|Treatment Period 2|Lost to Follow-up|0|||
170618450|NCT02748863|616611330|FG002|Treatment Period 2|Lost to Follow-up|0|||
170618451|NCT02748863|616611331|FG003|Treatment Period 2|Lost to Follow-up|0|||
170618452|NCT02748863|616611332|FG004|Treatment Period 2|Lost to Follow-up|0|||
170618453|NCT02748863|616611328|FG000|Treatment Period 2|Adverse Event|3|||
170618454|NCT02748863|616611329|FG001|Treatment Period 2|Adverse Event|2|||
170618455|NCT02748863|616611330|FG002|Treatment Period 2|Adverse Event|0|||
170618456|NCT02748863|616611331|FG003|Treatment Period 2|Adverse Event|2|||
170618457|NCT02748863|616611332|FG004|Treatment Period 2|Adverse Event|0|||
170618458|NCT02748863|616611328|FG000|Treatment Period 2|Lack of Efficacy|0|||
170618459|NCT02748863|616611329|FG001|Treatment Period 2|Lack of Efficacy|1|||
170618460|NCT02748863|616611330|FG002|Treatment Period 2|Lack of Efficacy|0|||
170618461|NCT02748863|616611331|FG003|Treatment Period 2|Lack of Efficacy|0|||
170618462|NCT02748863|616611332|FG004|Treatment Period 2|Lack of Efficacy|0|||
170618463|NCT02748863|616611328|FG000|Treatment Period 2|Pregnancy|0|||
170618464|NCT02748863|616611329|FG001|Treatment Period 2|Pregnancy|0|||
170818721|NCT04739306|617343684|FG000|Main Study Period|Lost to Follow-up|4|||
170818722|NCT04739306|617343685|FG001|Main Study Period|Lost to Follow-up|6|||
170818723|NCT04739306|617343684|FG000|Main Study Period|Physician Decision|1|||
170818724|NCT04739306|617343685|FG001|Main Study Period|Physician Decision|1|||
170818725|NCT04739306|617343684|FG000|Main Study Period|Withdrawal by Subject|8|||
170818726|NCT04739306|617343685|FG001|Main Study Period|Withdrawal by Subject|6|||
170818727|NCT04739306|617343684|FG000|Main Study Period|Protocol Violation|0|||
170818728|NCT04739306|617343685|FG001|Main Study Period|Protocol Violation|1|||
170818729|NCT04739306|617343684|FG000|Main Study Period|War in Ukraine|1|||
170818730|NCT04739306|617343685|FG001|Main Study Period|War in Ukraine|1|||
170818731|NCT02722278|617343686|FG000|Overall Study|Withdrawal by Subject|5|||
170818732|NCT02722278|617343687|FG001|Overall Study|Withdrawal by Subject|3|||
170818733|NCT02722278|617343686|FG000|Overall Study|Adverse Event|4|||
170818734|NCT02722278|617343687|FG001|Overall Study|Adverse Event|1|||
170818735|NCT02722278|617343686|FG000|Overall Study|Lost to Follow-up|2|||
170818736|NCT02722278|617343687|FG001|Overall Study|Lost to Follow-up|0|||
170818737|NCT02722278|617343686|FG000|Overall Study|Protocol Violation|1|||
170667876|NCT00694707|616797508|FG004|Overall Study|Jeopardizing Parole Status|0|||
170667877|NCT00694707|616797504|FG000|Overall Study|Death in the Family|1|||
170667878|NCT00694707|616797505|FG001|Overall Study|Death in the Family|0|||
170667879|NCT00694707|616797506|FG002|Overall Study|Death in the Family|0|||
170667880|NCT00694707|616797507|FG003|Overall Study|Death in the Family|0|||
170667881|NCT00694707|616797508|FG004|Overall Study|Death in the Family|0|||
170667882|NCT00694707|616797504|FG000|Overall Study|Arrest by Police|0|||
170667883|NCT00694707|616797505|FG001|Overall Study|Arrest by Police|1|||
170667884|NCT00694707|616797506|FG002|Overall Study|Arrest by Police|0|||
170667885|NCT00694707|616797507|FG003|Overall Study|Arrest by Police|0|||
170667886|NCT00694707|616797508|FG004|Overall Study|Arrest by Police|0|||
170667887|NCT00694707|616797504|FG000|Overall Study|Administrative Reasons|0|||
170667888|NCT00694707|616797505|FG001|Overall Study|Administrative Reasons|1|||
170667889|NCT00694707|616797506|FG002|Overall Study|Administrative Reasons|0|||
170667890|NCT00694707|616797507|FG003|Overall Study|Administrative Reasons|2|||
170667891|NCT00694707|616797508|FG004|Overall Study|Administrative Reasons|0|||
170667892|NCT00694707|616797504|FG000|Overall Study|Notification of Past Head Injury|0|||
170667893|NCT00694707|616797505|FG001|Overall Study|Notification of Past Head Injury|0|||
170667894|NCT00694707|616797506|FG002|Overall Study|Notification of Past Head Injury|0|||
170667895|NCT00694707|616797507|FG003|Overall Study|Notification of Past Head Injury|1|||
170667896|NCT00694707|616797508|FG004|Overall Study|Notification of Past Head Injury|0|||
170667897|NCT03096483|616797509|FG000|Overall Study|Withdrawal by site|1|||
170667898|NCT00369707|616797511|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
170667899|NCT00369707|616797511|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
170667900|NCT00369707|616797511|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
170667901|NCT00369707|616797511|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
170667902|NCT00369707|616797511|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
170667903|NCT00369707|616797511|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
170667904|NCT00369707|616797511|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
170667905|NCT00369707|616797511|FG000|Follow up for 2 Years After Treatment|Death|1|||
170667906|NCT00369707|616797511|FG000|Follow up for 2 Years After Treatment|Other|2|||
170667907|NCT05224141|616797518|FG000|Overall Study|Ongoing|75|||
170667908|NCT05224141|616797519|FG001|Overall Study|Ongoing|88|||
170667909|NCT05224141|616797518|FG000|Overall Study|Withdrawal by Subject|2|||
170667910|NCT05224141|616797519|FG001|Overall Study|Withdrawal by Subject|4|||
170667911|NCT05224141|616797518|FG000|Overall Study|Death|153|||
170667912|NCT05224141|616797519|FG001|Overall Study|Death|138|||
170667913|NCT02046733|616797522|FG000|Overall Study|never initiated 'treatment visits'|6|||
170667914|NCT02046733|616797523|FG001|Overall Study|never initiated 'treatment visits'|0|||
170667915|NCT01691898|616797531|FG000|Overall Study|Death|34|||
170667916|NCT01691898|616797532|FG001|Overall Study|Death|32|||
170667917|NCT01691898|616797533|FG002|Overall Study|Death|6|||
170667918|NCT01691898|616797534|FG003|Overall Study|Death|3|||
170667919|NCT01691898|616797535|FG004|Overall Study|Death|8|||
170667920|NCT01691898|616797536|FG005|Overall Study|Death|31|||
170667921|NCT01691898|616797531|FG000|Overall Study|Adverse Event|0|||
170667922|NCT01691898|616797532|FG001|Overall Study|Adverse Event|1|||
170667923|NCT01691898|616797533|FG002|Overall Study|Adverse Event|0|||
170667924|NCT01691898|616797534|FG003|Overall Study|Adverse Event|1|||
170667925|NCT01691898|616797535|FG004|Overall Study|Adverse Event|1|||
170667926|NCT01691898|616797536|FG005|Overall Study|Adverse Event|0|||
170667927|NCT01691898|616797531|FG000|Overall Study|Progression of Disease|1|||
170667928|NCT01691898|616797532|FG001|Overall Study|Progression of Disease|2|||
170667929|NCT01691898|616797533|FG002|Overall Study|Progression of Disease|1|||
170667930|NCT01691898|616797534|FG003|Overall Study|Progression of Disease|0|||
170667931|NCT01691898|616797535|FG004|Overall Study|Progression of Disease|0|||
170667932|NCT01691898|616797536|FG005|Overall Study|Progression of Disease|1|||
170667933|NCT01691898|616797531|FG000|Overall Study|Lost to Follow-up|3|||
170667934|NCT01691898|616797532|FG001|Overall Study|Lost to Follow-up|1|||
170667935|NCT01691898|616797533|FG002|Overall Study|Lost to Follow-up|0|||
170667936|NCT01691898|616797534|FG003|Overall Study|Lost to Follow-up|0|||
170667937|NCT01691898|616797535|FG004|Overall Study|Lost to Follow-up|1|||
170667938|NCT01691898|616797536|FG005|Overall Study|Lost to Follow-up|0|||
170667939|NCT01691898|616797531|FG000|Overall Study|Withdrawal by Subject|9|||
170818738|NCT02722278|617343687|FG001|Overall Study|Protocol Violation|0|||
170818739|NCT02722278|617343686|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
170818740|NCT02722278|617343687|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
170818741|NCT02722278|617343686|FG000|Overall Study|Subject declined after tx assignment|0|||
170818742|NCT02722278|617343687|FG001|Overall Study|Subject declined after tx assignment|1|||
170818743|NCT02722278|617343686|FG000|Overall Study|Site closure not study related|0|||
170818744|NCT02722278|617343687|FG001|Overall Study|Site closure not study related|1|||
170667940|NCT01691898|616797532|FG001|Overall Study|Withdrawal by Subject|8|||
170667941|NCT01691898|616797533|FG002|Overall Study|Withdrawal by Subject|2|||
170667942|NCT01691898|616797534|FG003|Overall Study|Withdrawal by Subject|1|||
170667943|NCT01691898|616797535|FG004|Overall Study|Withdrawal by Subject|3|||
170667944|NCT01691898|616797536|FG005|Overall Study|Withdrawal by Subject|3|||
170667945|NCT01691898|616797531|FG000|Overall Study|Non-Compliance|0|||
170667946|NCT01691898|616797532|FG001|Overall Study|Non-Compliance|0|||
170667947|NCT01691898|616797533|FG002|Overall Study|Non-Compliance|0|||
170667948|NCT01691898|616797534|FG003|Overall Study|Non-Compliance|0|||
170667949|NCT01691898|616797535|FG004|Overall Study|Non-Compliance|1|||
170667950|NCT01691898|616797536|FG005|Overall Study|Non-Compliance|0|||
170667951|NCT03725852|616797543|FG000|Overall Study|Death|1|||
170667952|NCT03725852|616797544|FG001|Overall Study|Death|0|||
170667953|NCT03725852|616797543|FG000|Overall Study|Withdrawal by Subject|1|||
170667954|NCT03725852|616797544|FG001|Overall Study|Withdrawal by Subject|0|||
170667955|NCT03725852|616797543|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
170667956|NCT03725852|616797544|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
170667957|NCT04093414|616797548|FG000|3 Month Follow up|Physician Decision|0|||
170667958|NCT04093414|616797549|FG001|3 Month Follow up|Physician Decision|1|||
170667959|NCT04093414|616797548|FG000|6month Follow up|Physician Decision|1|||
170667960|NCT04093414|616797549|FG001|6month Follow up|Physician Decision|3|||
170667961|NCT01180647|616797550|FG000|Overall Study|Lost to Follow-up|5|||
170667962|NCT01180647|616797551|FG001|Overall Study|Lost to Follow-up|6|||
170667963|NCT00494299|616797556|FG000|Overall Study|Adverse Event|93|||
170667964|NCT00494299|616797557|FG001|Overall Study|Adverse Event|13|||
170667965|NCT00494299|616797556|FG000|Overall Study|Lost to Follow-up|1|||
170667966|NCT00494299|616797557|FG001|Overall Study|Lost to Follow-up|0|||
170667967|NCT00494299|616797556|FG000|Overall Study|Physician Decision|0|||
170667968|NCT00494299|616797557|FG001|Overall Study|Physician Decision|2|||
170667969|NCT00494299|616797556|FG000|Overall Study|Protocol Violation|1|||
170667970|NCT00494299|616797557|FG001|Overall Study|Protocol Violation|2|||
170667971|NCT00494299|616797556|FG000|Overall Study|Withdrawal by Subject|8|||
170667972|NCT00494299|616797557|FG001|Overall Study|Withdrawal by Subject|3|||
170667973|NCT00494299|616797556|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
170667974|NCT00494299|616797557|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
170667975|NCT00494299|616797556|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
170667976|NCT00494299|616797557|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
170667977|NCT00494299|616797556|FG000|Overall Study|Site Closed by Sponsor|6|||
170667978|NCT00494299|616797557|FG001|Overall Study|Site Closed by Sponsor|0|||
170667979|NCT00494299|616797556|FG000|Overall Study|Protocol Driven Decision Point|11|||
170667980|NCT00494299|616797557|FG001|Overall Study|Protocol Driven Decision Point|22|||
170667981|NCT00113087|616797558|FG000|Overall Study|Death or Transplant|14|||
170667982|NCT00113087|616797559|FG001|Overall Study|Death or Transplant|16|||
170667983|NCT00113087|616797558|FG000|Overall Study|Family or MD withdrew subject|10|||
170667984|NCT00113087|616797559|FG001|Overall Study|Family or MD withdrew subject|5|||
170667985|NCT03452228|616797560|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
170667986|NCT03452228|616797561|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
170667987|NCT03452228|616797562|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
170667988|NCT03452228|616797560|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
170667989|NCT03452228|616797561|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
170667990|NCT03452228|616797562|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170667991|NCT03452228|616797560|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
170667992|NCT03452228|616797561|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
170667993|NCT03452228|616797562|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
170667994|NCT03452228|616797560|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170667995|NCT03452228|616797561|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
170667996|NCT03452228|616797562|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
170667997|NCT02635776|616797564|FG000|Overall Study|Physician Decision|1|||
170667998|NCT02635776|616797565|FG001|Overall Study|Physician Decision|0|||
170667999|NCT02635776|616797564|FG000|Overall Study|Adverse Event|51|||
170668000|NCT02635776|616797565|FG001|Overall Study|Adverse Event|3|||
170668001|NCT02635776|616797564|FG000|Overall Study|Withdrawal by Subject|41|||
170668002|NCT02635776|616797565|FG001|Overall Study|Withdrawal by Subject|7|||
170668003|NCT02635776|616797564|FG000|Overall Study|Lost to Follow-up|4|||
170668004|NCT02635776|616797565|FG001|Overall Study|Lost to Follow-up|0|||
170668005|NCT02635776|616797564|FG000|Overall Study|Other reasons|5|||
170668006|NCT02635776|616797565|FG001|Overall Study|Other reasons|1|||
170668007|NCT00788073|616797566|FG000|STX209 Then Placebo|Adverse Event|1|||
170668008|NCT00788073|616797567|FG001|STX209 Then Placebo|Adverse Event|0|||
170668009|NCT00788073|616797566|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
170668010|NCT00788073|616797567|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
170668011|NCT00788073|616797566|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
170668012|NCT00788073|616797567|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
170668013|NCT00788073|616797566|FG000|STX209 Then Placebo|unable to return due to travel|0|||
170668014|NCT00788073|616797567|FG001|STX209 Then Placebo|unable to return due to travel|1|||
170668015|NCT00788073|616797566|FG000|Placebo Then STX209|Adverse Event|2|||
170668016|NCT00788073|616797567|FG001|Placebo Then STX209|Adverse Event|0|||
170668017|NCT00788073|616797566|FG000|Placebo Then STX209|Protocol Violation|0|||
170668018|NCT00788073|616797567|FG001|Placebo Then STX209|Protocol Violation|1|||
170818745|NCT02465866|617343688|FG000|Period 3|Withdrawal by Subject|0|||
170818746|NCT02465866|617343689|FG001|Period 3|Withdrawal by Subject|1|||
170818747|NCT02465866|617343690|FG002|Period 3|Withdrawal by Subject|0|||
170818748|NCT02465866|617343691|FG003|Period 3|Withdrawal by Subject|0|||
170818749|NCT02023099|617343692|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
170818750|NCT02023099|617343693|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
170618465|NCT02748863|616611330|FG002|Treatment Period 2|Pregnancy|0|||
170618466|NCT02748863|616611331|FG003|Treatment Period 2|Pregnancy|0|||
170618467|NCT02748863|616611332|FG004|Treatment Period 2|Pregnancy|1|||
170618468|NCT01367834|616611334|FG000|Overall Study|Withdrawal by Subject|2|||
170618469|NCT01367834|616611335|FG001|Overall Study|Withdrawal by Subject|2|||
170618470|NCT01367834|616611334|FG000|Overall Study|Study was ended.|0|||
170618471|NCT01367834|616611335|FG001|Overall Study|Study was ended.|1|||
170618472|NCT01156480|616611339|FG000|Overall Study|change in diagnosis|0|||
170618473|NCT01156480|616611340|FG001|Overall Study|change in diagnosis|1|||
170618474|NCT04537793|616611341|FG000|Part B (24 Weeks)|Adverse Event|0|||
170618475|NCT04537793|616611342|FG001|Part B (24 Weeks)|Adverse Event|1|||
170618476|NCT00057863|616611351|FG000|Overall Study|Death|1|||
170618477|NCT00057863|616611351|FG000|Overall Study|Withdrawal by Subject|2|||
170618478|NCT02090426|616611352|FG000|Overall Study|Lost to Follow-up|12|||
170618479|NCT02090426|616611353|FG001|Overall Study|Lost to Follow-up|6|||
170618480|NCT01141712|616611355|FG000|Overall Study|Disease progression|3|||
170618481|NCT01308736|616611362|FG000|Overall Study|Did not attend a single session|6|||
170618482|NCT01308736|616611363|FG001|Overall Study|Did not attend a single session|5|||
170618483|NCT04701333|616611366|FG000|Overall Study|Lost to Follow-up|3|||
170618484|NCT04701333|616611367|FG001|Overall Study|Lost to Follow-up|7|||
170618485|NCT04701333|616611366|FG000|Overall Study|Withdrawal by Subject|0|||
170618486|NCT04701333|616611367|FG001|Overall Study|Withdrawal by Subject|1|||
170618487|NCT01894607|616611371|FG000|Overall Study|Ineligible|1|||
170618488|NCT01917747|616611372|FG000|Overall Study|Withdrawal by Subject|1|||
170618489|NCT01917747|616611373|FG001|Overall Study|Withdrawal by Subject|2|||
170618490|NCT01917747|616611372|FG000|Overall Study|Lost to Follow-up|18|||
170618491|NCT01917747|616611373|FG001|Overall Study|Lost to Follow-up|9|||
170618492|NCT02741245|616611383|FG000|Overall Study|Adverse Event|0|||
170618493|NCT02741245|616611384|FG001|Overall Study|Adverse Event|0|||
170618494|NCT02741245|616611385|FG002|Overall Study|Adverse Event|0|||
170618495|NCT02741245|616611386|FG003|Overall Study|Adverse Event|2|||
170618496|NCT02741245|616611387|FG004|Overall Study|Adverse Event|2|||
170618497|NCT02741245|616611383|FG000|Overall Study|Protocol Violation|0|||
170618498|NCT02741245|616611384|FG001|Overall Study|Protocol Violation|1|||
170618499|NCT02741245|616611385|FG002|Overall Study|Protocol Violation|0|||
170618500|NCT02741245|616611386|FG003|Overall Study|Protocol Violation|1|||
170618501|NCT02741245|616611387|FG004|Overall Study|Protocol Violation|0|||
170618502|NCT02741245|616611383|FG000|Overall Study|Withdrawal by Subject|0|||
170618503|NCT02741245|616611384|FG001|Overall Study|Withdrawal by Subject|0|||
170618504|NCT02741245|616611385|FG002|Overall Study|Withdrawal by Subject|0|||
170618505|NCT02741245|616611386|FG003|Overall Study|Withdrawal by Subject|1|||
170618506|NCT02741245|616611387|FG004|Overall Study|Withdrawal by Subject|0|||
170618507|NCT01787461|616611393|FG000|Overall Study|Adverse Event|4|||
170618508|NCT01787461|616611394|FG001|Overall Study|Adverse Event|3|||
170618509|NCT01787461|616611393|FG000|Overall Study|Lost to Follow-up|3|||
170618510|NCT01787461|616611394|FG001|Overall Study|Lost to Follow-up|2|||
170618511|NCT01787461|616611393|FG000|Overall Study|No longer met eligibility criteria|1|||
170618512|NCT01787461|616611394|FG001|Overall Study|No longer met eligibility criteria|0|||
170618513|NCT01787461|616611393|FG000|Overall Study|Withdrawal by Subject|3|||
170618514|NCT01787461|616611394|FG001|Overall Study|Withdrawal by Subject|4|||
170618515|NCT01787461|616611393|FG000|Overall Study|Protocol Violation|3|||
170618516|NCT01787461|616611394|FG001|Overall Study|Protocol Violation|0|||
170618517|NCT00152503|616611395|FG000|Overall Study|Adverse Event|4|||
170618518|NCT00607087|616611396|FG000|Overall Study|Withdrawal by Subject|9|||
170618519|NCT00607087|616611397|FG001|Overall Study|Withdrawal by Subject|4|||
170618520|NCT00607087|616611398|FG002|Overall Study|Withdrawal by Subject|4|||
170618521|NCT00607087|616611396|FG000|Overall Study|Adverse Event|3|||
170818751|NCT02023099|617343694|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
170818752|NCT02023099|617343692|FG000|Overall Study|Withdrawn Consent|3|||
170618522|NCT00607087|616611397|FG001|Overall Study|Adverse Event|2|||
170618523|NCT00607087|616611398|FG002|Overall Study|Adverse Event|3|||
170618524|NCT00607087|616611396|FG000|Overall Study|Other reason|1|||
170618525|NCT00607087|616611397|FG001|Overall Study|Other reason|5|||
170618526|NCT00607087|616611398|FG002|Overall Study|Other reason|2|||
170618527|NCT00607087|616611396|FG000|Overall Study|Poor compliance to protocol|1|||
170618528|NCT00607087|616611397|FG001|Overall Study|Poor compliance to protocol|0|||
170618529|NCT00607087|616611398|FG002|Overall Study|Poor compliance to protocol|1|||
170618530|NCT00607087|616611396|FG000|Overall Study|Lost to Follow-up|1|||
170618531|NCT00607087|616611397|FG001|Overall Study|Lost to Follow-up|0|||
170618532|NCT00607087|616611398|FG002|Overall Study|Lost to Follow-up|0|||
170618533|NCT00607087|616611396|FG000|Period 1|Withdrawal by Subject|7|||
170618534|NCT00607087|616611397|FG001|Period 1|Withdrawal by Subject|2|||
170618535|NCT00607087|616611398|FG002|Period 1|Withdrawal by Subject|3|||
170668019|NCT03608254|616797568|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
170668020|NCT03608254|616797568|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
170668021|NCT02711345|616797569|FG000|Overall Study|Adverse Event|0|||
170668022|NCT02711345|616797570|FG001|Overall Study|Adverse Event|0|||
170668023|NCT02711345|616797571|FG002|Overall Study|Adverse Event|0|||
170668024|NCT02711345|616797572|FG003|Overall Study|Adverse Event|1|||
170668025|NCT02711345|616797573|FG004|Overall Study|Adverse Event|1|||
170668026|NCT02711345|616797574|FG005|Overall Study|Adverse Event|2|||
170668027|NCT02711345|616797575|FG006|Overall Study|Adverse Event|1|||
170668028|NCT02711345|616797576|FG007|Overall Study|Adverse Event|0|||
170668029|NCT02711345|616797577|FG008|Overall Study|Adverse Event|0|||
170668030|NCT02711345|616797578|FG009|Overall Study|Adverse Event|2|||
170668031|NCT02711345|616797569|FG000|Overall Study|Physician Decision|0|||
170668032|NCT02711345|616797570|FG001|Overall Study|Physician Decision|0|||
170668033|NCT02711345|616797571|FG002|Overall Study|Physician Decision|1|||
170668034|NCT02711345|616797572|FG003|Overall Study|Physician Decision|0|||
170668035|NCT02711345|616797573|FG004|Overall Study|Physician Decision|0|||
170668036|NCT02711345|616797574|FG005|Overall Study|Physician Decision|0|||
170668037|NCT02711345|616797575|FG006|Overall Study|Physician Decision|0|||
170668038|NCT02711345|616797576|FG007|Overall Study|Physician Decision|0|||
170668039|NCT02711345|616797577|FG008|Overall Study|Physician Decision|1|||
170668040|NCT02711345|616797578|FG009|Overall Study|Physician Decision|0|||
170668041|NCT02711345|616797569|FG000|Overall Study|Progressive disease|1|||
170668042|NCT02711345|616797570|FG001|Overall Study|Progressive disease|3|||
170668043|NCT02711345|616797571|FG002|Overall Study|Progressive disease|5|||
170668044|NCT02711345|616797572|FG003|Overall Study|Progressive disease|3|||
170668045|NCT02711345|616797573|FG004|Overall Study|Progressive disease|7|||
170668046|NCT02711345|616797574|FG005|Overall Study|Progressive disease|2|||
170668047|NCT02711345|616797575|FG006|Overall Study|Progressive disease|8|||
170668048|NCT02711345|616797576|FG007|Overall Study|Progressive disease|4|||
170668049|NCT02711345|616797577|FG008|Overall Study|Progressive disease|5|||
170668050|NCT02711345|616797578|FG009|Overall Study|Progressive disease|6|||
170668051|NCT02711345|616797569|FG000|Overall Study|Subject/guardian decision|0|||
170668052|NCT02711345|616797570|FG001|Overall Study|Subject/guardian decision|0|||
170668053|NCT02711345|616797571|FG002|Overall Study|Subject/guardian decision|0|||
170668054|NCT02711345|616797572|FG003|Overall Study|Subject/guardian decision|0|||
170668055|NCT02711345|616797573|FG004|Overall Study|Subject/guardian decision|0|||
170668056|NCT02711345|616797574|FG005|Overall Study|Subject/guardian decision|2|||
170668057|NCT02711345|616797575|FG006|Overall Study|Subject/guardian decision|3|||
170668058|NCT02711345|616797576|FG007|Overall Study|Subject/guardian decision|1|||
170668059|NCT02711345|616797577|FG008|Overall Study|Subject/guardian decision|0|||
170668060|NCT02711345|616797578|FG009|Overall Study|Subject/guardian decision|4|||
170668061|NCT02711345|616797569|FG000|Overall Study|Death|1|||
170668062|NCT02711345|616797570|FG001|Overall Study|Death|0|||
170668063|NCT02711345|616797571|FG002|Overall Study|Death|0|||
170668064|NCT02711345|616797572|FG003|Overall Study|Death|0|||
170668065|NCT02711345|616797573|FG004|Overall Study|Death|0|||
170668066|NCT02711345|616797574|FG005|Overall Study|Death|0|||
170668067|NCT02711345|616797575|FG006|Overall Study|Death|0|||
170668068|NCT02711345|616797576|FG007|Overall Study|Death|1|||
170668069|NCT02711345|616797577|FG008|Overall Study|Death|0|||
170668070|NCT02711345|616797578|FG009|Overall Study|Death|0|||
170668071|NCT01254331|616797583|FG000|Initial Phase|Adverse Event|3|||
170668072|NCT01254331|616797583|FG000|Initial Phase|Withdrawal by Subject|1|||
170668073|NCT01254331|616797583|FG000|Initial Phase|Pregnancy|1|||
170668074|NCT01254331|616797583|FG000|Extension Phase|Lack of Efficacy|1|||
170668075|NCT01254331|616797583|FG000|Extension Phase|Lost to Follow-up|3|||
170668076|NCT00516074|616797585|FG000|Overall Study|Adverse Event|0|||
170668077|NCT00516074|616797586|FG001|Overall Study|Adverse Event|1|||
170668078|NCT00516074|616797585|FG000|Overall Study|Subject Decision|4|||
170668079|NCT00516074|616797586|FG001|Overall Study|Subject Decision|2|||
170668080|NCT00516074|616797585|FG000|Overall Study|Loss of Glucose Control|2|||
170668081|NCT00516074|616797586|FG001|Overall Study|Loss of Glucose Control|0|||
170668082|NCT00633750|616797588|FG000|Overall Study|Adverse Event|2|||
170818753|NCT02023099|617343693|FG001|Overall Study|Withdrawn Consent|0|||
170818754|NCT02023099|617343694|FG002|Overall Study|Withdrawn Consent|1|||
170818755|NCT02023099|617343692|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
170818756|NCT02023099|617343693|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
170818757|NCT02023099|617343694|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
170818758|NCT04175392|617343695|FG000|Overall Study|Withdrawal by Subject|3|||
170668083|NCT00633750|616797588|FG000|Overall Study|Withdrawal by Subject|3|||
170668084|NCT01811225|616797589|FG000|Treatment Period 1|Adverse Event|2|||
170668085|NCT01811225|616797590|FG001|Treatment Period 1|Adverse Event|3|||
170818759|NCT04175392|617343696|FG001|Overall Study|Withdrawal by Subject|2|||
170668086|NCT01811225|616797589|FG000|Treatment Period 1|Lost to Follow-up|12|||
170668087|NCT01811225|616797590|FG001|Treatment Period 1|Lost to Follow-up|8|||
170668088|NCT01811225|616797589|FG000|Treatment Period 1|transporation|1|||
170668089|NCT01811225|616797590|FG001|Treatment Period 1|transporation|0|||
170668090|NCT01811225|616797589|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
170668091|NCT01811225|616797590|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
170668092|NCT01811225|616797589|FG000|Treatment Period 2|Lost to Follow-up|1|||
170668093|NCT01811225|616797590|FG001|Treatment Period 2|Lost to Follow-up|2|||
170668094|NCT01811225|616797589|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
170668095|NCT01811225|616797590|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
170668096|NCT02298023|616797591|FG000|Overall Study|Withdrawal by Subject|1|||
170668097|NCT02298023|616797592|FG001|Overall Study|Withdrawal by Subject|0|||
170668098|NCT02298023|616797593|FG002|Overall Study|Withdrawal by Subject|0|||
170668099|NCT00968864|616797594|FG000|Overall Study|Protocol exception/ not evaluable|1|||
170668100|NCT01967173|616797595|FG000|Overall Study|Lost to Follow-up|5|||
170668101|NCT01967173|616797596|FG001|Overall Study|Lost to Follow-up|3|||
170668102|NCT01967173|616797597|FG002|Overall Study|Lost to Follow-up|2|||
170668103|NCT01967173|616797598|FG003|Overall Study|Lost to Follow-up|4|||
170668104|NCT01967173|616797599|FG004|Overall Study|Lost to Follow-up|8|||
170668105|NCT01967173|616797600|FG005|Overall Study|Lost to Follow-up|12|||
170668106|NCT01967173|616797601|FG006|Overall Study|Lost to Follow-up|6|||
170668107|NCT01967173|616797602|FG007|Overall Study|Lost to Follow-up|8|||
170668108|NCT01967173|616797595|FG000|Overall Study|Physician Decision|2|||
170668109|NCT01967173|616797596|FG001|Overall Study|Physician Decision|0|||
170668110|NCT01967173|616797597|FG002|Overall Study|Physician Decision|2|||
170668111|NCT01967173|616797598|FG003|Overall Study|Physician Decision|1|||
170668112|NCT01967173|616797599|FG004|Overall Study|Physician Decision|1|||
170668113|NCT01967173|616797600|FG005|Overall Study|Physician Decision|1|||
170668114|NCT01967173|616797601|FG006|Overall Study|Physician Decision|1|||
170668115|NCT01967173|616797602|FG007|Overall Study|Physician Decision|0|||
170668116|NCT01967173|616797595|FG000|Overall Study|Lack of Efficacy|2|||
170668117|NCT01967173|616797596|FG001|Overall Study|Lack of Efficacy|0|||
170668118|NCT01967173|616797597|FG002|Overall Study|Lack of Efficacy|2|||
170668119|NCT01967173|616797598|FG003|Overall Study|Lack of Efficacy|2|||
170668120|NCT01967173|616797599|FG004|Overall Study|Lack of Efficacy|0|||
170668121|NCT01967173|616797600|FG005|Overall Study|Lack of Efficacy|1|||
170668122|NCT01967173|616797601|FG006|Overall Study|Lack of Efficacy|0|||
170668123|NCT01967173|616797602|FG007|Overall Study|Lack of Efficacy|2|||
170668124|NCT01967173|616797595|FG000|Overall Study|Pregnancy|0|||
170668125|NCT01967173|616797596|FG001|Overall Study|Pregnancy|0|||
170668126|NCT01967173|616797597|FG002|Overall Study|Pregnancy|0|||
170668127|NCT01967173|616797598|FG003|Overall Study|Pregnancy|0|||
170668128|NCT01967173|616797599|FG004|Overall Study|Pregnancy|0|||
170668129|NCT01967173|616797600|FG005|Overall Study|Pregnancy|0|||
170668130|NCT01967173|616797601|FG006|Overall Study|Pregnancy|1|||
170668131|NCT01967173|616797602|FG007|Overall Study|Pregnancy|1|||
170668132|NCT01967173|616797595|FG000|Overall Study|Adverse Event|0|||
170668133|NCT01967173|616797596|FG001|Overall Study|Adverse Event|0|||
170668134|NCT01967173|616797597|FG002|Overall Study|Adverse Event|0|||
170668135|NCT01967173|616797598|FG003|Overall Study|Adverse Event|0|||
170668136|NCT01967173|616797599|FG004|Overall Study|Adverse Event|0|||
170668137|NCT01967173|616797600|FG005|Overall Study|Adverse Event|0|||
170668138|NCT01967173|616797601|FG006|Overall Study|Adverse Event|0|||
170668139|NCT01967173|616797602|FG007|Overall Study|Adverse Event|1|||
170668140|NCT01967173|616797595|FG000|Overall Study|Withdrawal by Subject|15|||
170668141|NCT01967173|616797596|FG001|Overall Study|Withdrawal by Subject|14|||
170668142|NCT01967173|616797597|FG002|Overall Study|Withdrawal by Subject|10|||
170668143|NCT01967173|616797598|FG003|Overall Study|Withdrawal by Subject|7|||
170668144|NCT01967173|616797599|FG004|Overall Study|Withdrawal by Subject|8|||
170668145|NCT01967173|616797600|FG005|Overall Study|Withdrawal by Subject|9|||
170668146|NCT01967173|616797601|FG006|Overall Study|Withdrawal by Subject|10|||
170668147|NCT01967173|616797602|FG007|Overall Study|Withdrawal by Subject|12|||
170668148|NCT01346969|616797603|FG000|Overall Study|Withdrawal by Subject|0|||
170668149|NCT01346969|616797604|FG001|Overall Study|Withdrawal by Subject|0|||
170668150|NCT01346969|616797605|FG002|Overall Study|Withdrawal by Subject|1|||
170668151|NCT01346969|616797606|FG003|Overall Study|Withdrawal by Subject|0|||
170668152|NCT01346969|616797603|FG000|Overall Study|Lost to Follow-up|1|||
170668153|NCT01346969|616797604|FG001|Overall Study|Lost to Follow-up|0|||
170668154|NCT01346969|616797605|FG002|Overall Study|Lost to Follow-up|2|||
170668155|NCT01346969|616797606|FG003|Overall Study|Lost to Follow-up|0|||
170668156|NCT01346969|616797603|FG000|Overall Study|Physician Decision|0|||
170668157|NCT01346969|616797604|FG001|Overall Study|Physician Decision|0|||
170668158|NCT01346969|616797605|FG002|Overall Study|Physician Decision|0|||
170668159|NCT01346969|616797606|FG003|Overall Study|Physician Decision|1|||
170668160|NCT01346969|616797603|FG000|Overall Study|Randomized but not treated|1|||
170668161|NCT01346969|616797604|FG001|Overall Study|Randomized but not treated|0|||
170668162|NCT01346969|616797605|FG002|Overall Study|Randomized but not treated|0|||
170668163|NCT01346969|616797606|FG003|Overall Study|Randomized but not treated|0|||
170668164|NCT03540030|616797610|FG000|Overall Study|Withdrawal by Subject|2|||
170668165|NCT03540030|616797611|FG001|Overall Study|Withdrawal by Subject|1|||
170668166|NCT03540030|616797610|FG000|Overall Study|screen fail|7|||
170668167|NCT03540030|616797611|FG001|Overall Study|screen fail|1|||
170668168|NCT03540030|616797610|FG000|Overall Study|never had surgery after signing consent|9|||
170668169|NCT03540030|616797611|FG001|Overall Study|never had surgery after signing consent|1|||
170668170|NCT03666624|616797616|FG000|Overall Study|participant grieving over recent death of parent|1|||
170668171|NCT03666624|616797617|FG001|Overall Study|participant grieving over recent death of parent|0|||
170668172|NCT05213481|616797619|FG000|Overall Study|Adverse Event|3|||
170668173|NCT05213481|616797619|FG000|Overall Study|Lost to Follow-up|1|||
170668174|NCT00569270|616797620|FG000|Period: First Intervention|Protocol Violation|0|||
170668175|NCT00569270|616797621|FG001|Period: First Intervention|Protocol Violation|1|||
170668176|NCT00447005|616797623|FG000|Overall Study|Adverse Event|1|||
170668177|NCT00447005|616797623|FG000|Overall Study|Lack of Efficacy|11|||
170668178|NCT00492531|616797624|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
170668179|NCT00492531|616797625|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
170668180|NCT04122534|616797626|FG000|Overall Study|Lost to Follow-up|4|||
170668181|NCT00423514|616797632|FG000|Overall Study|Ineligible|1|||
170668182|NCT00423514|616797633|FG001|Overall Study|Ineligible|0|||
170668183|NCT02128932|616797634|FG000|Overall Study|Withdrawal by Subject|11|||
170668184|NCT02128932|616797635|FG001|Overall Study|Withdrawal by Subject|7|||
170668185|NCT02128932|616797636|FG002|Overall Study|Withdrawal by Subject|8|||
170668186|NCT02128932|616797634|FG000|Overall Study|Death|2|||
170668187|NCT02128932|616797635|FG001|Overall Study|Death|0|||
170668188|NCT02128932|616797636|FG002|Overall Study|Death|2|||
170668189|NCT02128932|616797634|FG000|Overall Study|Lost to Follow-up|2|||
170668190|NCT02128932|616797635|FG001|Overall Study|Lost to Follow-up|1|||
170668191|NCT02128932|616797636|FG002|Overall Study|Lost to Follow-up|1|||
170668192|NCT02128932|616797634|FG000|Overall Study|No reason for withdrawal|12|||
170668193|NCT02128932|616797635|FG001|Overall Study|No reason for withdrawal|11|||
170668194|NCT02128932|616797636|FG002|Overall Study|No reason for withdrawal|7|||
170668195|NCT01254630|616797637|FG000|Overall Study|Adverse Event|36|||
170668196|NCT01254630|616797638|FG001|Overall Study|Adverse Event|15|||
170668197|NCT01254630|616797639|FG002|Overall Study|Adverse Event|40|||
170668198|NCT01254630|616797640|FG003|Overall Study|Adverse Event|8|||
170668199|NCT01254630|616797637|FG000|Overall Study|Death|461|||
170668200|NCT01254630|616797638|FG001|Overall Study|Death|151|||
170668201|NCT01254630|616797639|FG002|Overall Study|Death|478|||
170668202|NCT01254630|616797640|FG003|Overall Study|Death|139|||
170668203|NCT01254630|616797637|FG000|Overall Study|Lost to Follow-up|80|||
170668204|NCT01254630|616797638|FG001|Overall Study|Lost to Follow-up|26|||
170668205|NCT01254630|616797639|FG002|Overall Study|Lost to Follow-up|89|||
170668206|NCT01254630|616797640|FG003|Overall Study|Lost to Follow-up|32|||
170668207|NCT01254630|616797637|FG000|Overall Study|Physician Decision|24|||
170668208|NCT01254630|616797638|FG001|Overall Study|Physician Decision|8|||
170668209|NCT01254630|616797639|FG002|Overall Study|Physician Decision|16|||
170668210|NCT01254630|616797640|FG003|Overall Study|Physician Decision|7|||
170668211|NCT01254630|616797637|FG000|Overall Study|Withdrawal by Subject|201|||
170668212|NCT01254630|616797638|FG001|Overall Study|Withdrawal by Subject|94|||
170668213|NCT01254630|616797639|FG002|Overall Study|Withdrawal by Subject|188|||
170668214|NCT01254630|616797640|FG003|Overall Study|Withdrawal by Subject|89|||
170668215|NCT01254630|616797637|FG000|Overall Study|Study terminated by sponsor|0|||
170668216|NCT01254630|616797638|FG001|Overall Study|Study terminated by sponsor|994|||
170668217|NCT01254630|616797639|FG002|Overall Study|Study terminated by sponsor|0|||
170668218|NCT01254630|616797640|FG003|Overall Study|Study terminated by sponsor|1010|||
170668219|NCT01254630|616797637|FG000|Overall Study|Status not recorded|0|||
170668220|NCT01254630|616797638|FG001|Overall Study|Status not recorded|0|||
170668221|NCT01254630|616797639|FG002|Overall Study|Status not recorded|1|||
170668222|NCT01254630|616797640|FG003|Overall Study|Status not recorded|0|||
170668223|NCT03685123|616797641|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
170668224|NCT03685123|616797642|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
170668225|NCT03685123|616797643|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
170668226|NCT03685123|616797641|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
170917542|NCT04739761|617698466|FG000|Overall Study|Adverse Event|0|||
170917543|NCT04739761|617698467|FG001|Overall Study|Adverse Event|3|||
170668227|NCT03685123|616797642|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
170668228|NCT03685123|616797643|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
170668229|NCT03685123|616797641|FG000|Weight Loss Phase|Lost to Follow-up|1|||
170668230|NCT03685123|616797642|FG001|Weight Loss Phase|Lost to Follow-up|0|||
170668231|NCT03685123|616797643|FG002|Weight Loss Phase|Lost to Follow-up|0|||
170668232|NCT03685123|616797641|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
170668233|NCT03685123|616797642|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
170668234|NCT03685123|616797643|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
170668235|NCT03685123|616797641|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
170668236|NCT03685123|616797642|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
170668237|NCT03685123|616797643|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
170668238|NCT03685123|616797641|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
170668239|NCT03685123|616797642|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
170668240|NCT03685123|616797643|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
170668241|NCT03439657|616797649|FG000|Overall Study|Adverse Event|2|||
170668242|NCT03439657|616797650|FG001|Overall Study|Adverse Event|3|||
170668243|NCT03439657|616797649|FG000|Overall Study|Lost to Follow-up|1|||
170668244|NCT03439657|616797650|FG001|Overall Study|Lost to Follow-up|0|||
170668245|NCT03439657|616797649|FG000|Overall Study|Protocol Violation|1|||
170668246|NCT03439657|616797650|FG001|Overall Study|Protocol Violation|1|||
170668247|NCT03439657|616797649|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
170668248|NCT03439657|616797650|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
170668249|NCT04032652|616797652|FG000|Overall Study|The study was terminated and the PI has|1|||
170668250|NCT04032652|616797653|FG001|Overall Study|The study was terminated and the PI has|1|||
170668251|NCT02663908|616797654|FG000|Overall Study|Withdrawal by Subject|8|||
170668252|NCT02663908|616797655|FG001|Overall Study|Withdrawal by Subject|5|||
170668253|NCT02663908|616797654|FG000|Overall Study|Lost to Follow-up|1|||
170668254|NCT02663908|616797655|FG001|Overall Study|Lost to Follow-up|5|||
170668255|NCT02663908|616797654|FG000|Overall Study|Adverse Event|13|||
170668256|NCT02663908|616797655|FG001|Overall Study|Adverse Event|11|||
170668257|NCT02663908|616797654|FG000|Overall Study|Protocol Violation|1|||
170668258|NCT02663908|616797655|FG001|Overall Study|Protocol Violation|2|||
170668259|NCT02663908|616797654|FG000|Overall Study|Lack of therapeutic response|2|||
170668260|NCT02663908|616797655|FG001|Overall Study|Lack of therapeutic response|0|||
170668261|NCT02663908|616797654|FG000|Overall Study|COVID-19|1|||
170668262|NCT02663908|616797655|FG001|Overall Study|COVID-19|0|||
170668263|NCT02663908|616797654|FG000|Overall Study|Site closed|1|||
170668264|NCT02663908|616797655|FG001|Overall Study|Site closed|0|||
170668265|NCT02663908|616797654|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
170668266|NCT02663908|616797655|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
170668267|NCT02663908|616797654|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
170668268|NCT02663908|616797655|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
170668269|NCT02663908|616797654|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
170668270|NCT02663908|616797655|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
170668271|NCT02663908|616797654|FG000|Overall Study|Death|1|||
170668272|NCT02663908|616797655|FG001|Overall Study|Death|0|||
170668273|NCT02663908|616797654|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
170668274|NCT02663908|616797655|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
170668275|NCT02663908|616797654|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
170668276|NCT02663908|616797655|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
170668277|NCT00437983|616797656|FG000|Overall Study|Adverse Event|6|||
170668278|NCT00437983|616797657|FG001|Overall Study|Adverse Event|6|||
170668279|NCT00437983|616797656|FG000|Overall Study|Protocol Violation|2|||
170668280|NCT00437983|616797657|FG001|Overall Study|Protocol Violation|1|||
170668281|NCT00437983|616797656|FG000|Overall Study|Withdrawal by Subject|5|||
170668282|NCT00437983|616797657|FG001|Overall Study|Withdrawal by Subject|6|||
170668283|NCT04223973|616797658|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
170668284|NCT04223973|616797659|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
170668285|NCT04223973|616797658|FG000|Overall Study|Adverse Event|4|||
170668286|NCT04223973|616797659|FG001|Overall Study|Adverse Event|0|||
170668287|NCT04223973|616797658|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
170668288|NCT04223973|616797659|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
170668289|NCT04223973|616797658|FG000|Overall Study|Physician Decision|1|||
170668290|NCT04223973|616797659|FG001|Overall Study|Physician Decision|1|||
170668291|NCT04223973|616797658|FG000|Overall Study|Withdrawal by Subject|0|||
170668292|NCT04223973|616797659|FG001|Overall Study|Withdrawal by Subject|1|||
170668293|NCT05938920|616797660|FG000|Overall Study|Adverse Event|1|||
170668294|NCT05938920|616797661|FG001|Overall Study|Adverse Event|3|||
170668295|NCT05938920|616797662|FG002|Overall Study|Adverse Event|2|||
170668296|NCT05938920|616797663|FG003|Overall Study|Adverse Event|1|||
170668297|NCT05938920|616797660|FG000|Overall Study|Death|0|||
170668298|NCT05938920|616797661|FG001|Overall Study|Death|1|||
170668299|NCT05938920|616797662|FG002|Overall Study|Death|0|||
170668300|NCT05938920|616797663|FG003|Overall Study|Death|0|||
170668301|NCT05938920|616797660|FG000|Overall Study|Lost to Follow-up|0|||
170668302|NCT05938920|616797661|FG001|Overall Study|Lost to Follow-up|0|||
170668303|NCT05938920|616797662|FG002|Overall Study|Lost to Follow-up|1|||
170668304|NCT05938920|616797663|FG003|Overall Study|Lost to Follow-up|0|||
170668305|NCT05938920|616797660|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
170668306|NCT05938920|616797661|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
170668307|NCT05938920|616797662|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
170668308|NCT05938920|616797663|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
170668309|NCT05938920|616797660|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
170668310|NCT05938920|616797661|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
170668311|NCT05938920|616797662|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
170668312|NCT05938920|616797663|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
170668313|NCT05938920|616797660|FG000|Overall Study|Participant Refused to Come In|0|||
170668314|NCT05938920|616797661|FG001|Overall Study|Participant Refused to Come In|0|||
170668315|NCT05938920|616797662|FG002|Overall Study|Participant Refused to Come In|1|||
170668316|NCT05938920|616797663|FG003|Overall Study|Participant Refused to Come In|0|||
170917544|NCT04739761|617698466|FG000|Overall Study|Participant decision|1|||
170917545|NCT04739761|617698467|FG001|Overall Study|Participant decision|0|||
170917546|NCT04739761|617698466|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
170917547|NCT04739761|617698467|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
170917548|NCT04739761|617698466|FG000|Overall Study|Participant immediately started next line of treatment|1|||
170917549|NCT04739761|617698467|FG001|Overall Study|Participant immediately started next line of treatment|0|||
170917550|NCT04739761|617698466|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
170917551|NCT04739761|617698467|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
170917552|NCT04739761|617698466|FG000|Overall Study|Lack of clinical benefit|1|||
170917553|NCT04739761|617698467|FG001|Overall Study|Lack of clinical benefit|0|||
170917554|NCT04739761|617698466|FG000|Overall Study|Disease progression|5|||
170917555|NCT04739761|617698467|FG001|Overall Study|Disease progression|5|||
170917556|NCT04739761|617698466|FG000|Overall Study|Withdrawal by Subject|14|||
170917557|NCT04739761|617698467|FG001|Overall Study|Withdrawal by Subject|13|||
170917558|NCT04739761|617698466|FG000|Overall Study|Protocol Violation|1|||
170917559|NCT04739761|617698467|FG001|Overall Study|Protocol Violation|0|||
170917560|NCT04739761|617698466|FG000|Overall Study|Physician Decision|2|||
170917561|NCT04739761|617698467|FG001|Overall Study|Physician Decision|0|||
170917562|NCT06756113|617698470|FG000|Overall Study|Lost to Follow-up|3|||
170917563|NCT06756113|617698471|FG001|Overall Study|Lost to Follow-up|17|||
170917564|NCT03404245|617698472|FG000|Baseline|Erroneously randomized|1|||
170917565|NCT03404245|617698473|FG001|Baseline|Erroneously randomized|0|||
170917566|NCT03404245|617698472|FG000|Week 27 - Primary Endpoint|Withdrawal by Subject|4|||
170917567|NCT03404245|617698473|FG001|Week 27 - Primary Endpoint|Withdrawal by Subject|3|||
170917568|NCT03404245|617698472|FG000|Week 27 - Primary Endpoint|Lost to Follow-up|2|||
170917569|NCT03404245|617698473|FG001|Week 27 - Primary Endpoint|Lost to Follow-up|0|||
170668317|NCT03320057|616799359|FG000|Overall Study|Lost to Follow-up|4|||
170668318|NCT03320057|616799360|FG001|Overall Study|Lost to Follow-up|17|||
170668319|NCT03320057|616799359|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
170668320|NCT03320057|616799360|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
170668321|NCT06956170|616799361|FG000|Overall Study|Death|2|||
170668322|NCT06956170|616799362|FG001|Overall Study|Death|1|||
170668323|NCT06956170|616799361|FG000|Overall Study|Withdrawal by Subject|1|||
170668324|NCT06956170|616799362|FG001|Overall Study|Withdrawal by Subject|0|||
170668325|NCT06956170|616799361|FG000|Overall Study|Ongoing|7|||
170668326|NCT06956170|616799362|FG001|Overall Study|Ongoing|10|||
170668327|NCT02323113|616799363|FG000|Overall Study|Adverse Event|3|||
170668328|NCT02323113|616799364|FG001|Overall Study|Adverse Event|3|||
170668329|NCT02323113|616799365|FG002|Overall Study|Adverse Event|2|||
170668330|NCT02323113|616799366|FG003|Overall Study|Adverse Event|5|||
170668331|NCT02323113|616799367|FG004|Overall Study|Adverse Event|8|||
170668332|NCT02323113|616799368|FG005|Overall Study|Adverse Event|3|||
170668333|NCT02323113|616799369|FG006|Overall Study|Adverse Event|6|||
170668334|NCT02323113|616799370|FG007|Overall Study|Adverse Event|0|||
170668335|NCT02323113|616799363|FG000|Overall Study|Progressive Disease|0|||
170668336|NCT02323113|616799364|FG001|Overall Study|Progressive Disease|1|||
170668337|NCT02323113|616799365|FG002|Overall Study|Progressive Disease|1|||
170668338|NCT02323113|616799366|FG003|Overall Study|Progressive Disease|0|||
170668339|NCT02323113|616799367|FG004|Overall Study|Progressive Disease|0|||
170668340|NCT02323113|616799368|FG005|Overall Study|Progressive Disease|3|||
170668341|NCT02323113|616799369|FG006|Overall Study|Progressive Disease|0|||
170668342|NCT02323113|616799370|FG007|Overall Study|Progressive Disease|0|||
170668343|NCT02323113|616799363|FG000|Overall Study|Symptomatic Deterioration|0|||
170668344|NCT02323113|616799364|FG001|Overall Study|Symptomatic Deterioration|0|||
170668345|NCT02323113|616799365|FG002|Overall Study|Symptomatic Deterioration|1|||
170668346|NCT02323113|616799366|FG003|Overall Study|Symptomatic Deterioration|0|||
170668347|NCT02323113|616799367|FG004|Overall Study|Symptomatic Deterioration|1|||
170668348|NCT02323113|616799368|FG005|Overall Study|Symptomatic Deterioration|0|||
170668349|NCT02323113|616799369|FG006|Overall Study|Symptomatic Deterioration|0|||
170668350|NCT02323113|616799370|FG007|Overall Study|Symptomatic Deterioration|0|||
170818760|NCT00472199|617343697|FG000|Overall Study|Adverse Event|19|||
170818761|NCT00472199|617343698|FG001|Overall Study|Adverse Event|23|||
170818762|NCT00472199|617343697|FG000|Overall Study|Lack of Efficacy|4|||
170818763|NCT00472199|617343698|FG001|Overall Study|Lack of Efficacy|25|||
170818764|NCT00472199|617343697|FG000|Overall Study|Lost to Follow-up|2|||
170818765|NCT00472199|617343698|FG001|Overall Study|Lost to Follow-up|4|||
170818766|NCT00472199|617343697|FG000|Overall Study|Protocol Violation|3|||
170818767|NCT00472199|617343698|FG001|Overall Study|Protocol Violation|2|||
170818768|NCT00472199|617343697|FG000|Overall Study|Withdrawal by Subject|6|||
170668351|NCT02323113|616799363|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
170818769|NCT00472199|617343698|FG001|Overall Study|Withdrawal by Subject|5|||
170818770|NCT00472199|617343697|FG000|Overall Study|personal reason|0|||
170668352|NCT02323113|616799364|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
170668353|NCT02323113|616799365|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
170668354|NCT02323113|616799366|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
170668355|NCT02323113|616799367|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
170668356|NCT02323113|616799368|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
170668357|NCT02323113|616799369|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
170668358|NCT02323113|616799370|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
170668359|NCT02323113|616799363|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
170668360|NCT02323113|616799364|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
170668361|NCT02323113|616799365|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
170668362|NCT02323113|616799366|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
170668363|NCT02323113|616799367|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
170668364|NCT02323113|616799368|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
170668365|NCT02323113|616799369|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
170668366|NCT02323113|616799370|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
170668367|NCT01977794|616799372|FG000|Overall Study|Adverse Event|2|||
170668368|NCT01977794|616799373|FG001|Overall Study|Adverse Event|2|||
170668369|NCT01977794|616799372|FG000|Overall Study|Lost to Follow-up|2|||
170668370|NCT01977794|616799373|FG001|Overall Study|Lost to Follow-up|1|||
170668371|NCT01977794|616799372|FG000|Overall Study|Protocol Violation|1|||
170668372|NCT01977794|616799373|FG001|Overall Study|Protocol Violation|0|||
170668373|NCT01977794|616799372|FG000|Overall Study|Death|1|||
170668374|NCT01977794|616799373|FG001|Overall Study|Death|1|||
170668375|NCT01977794|616799372|FG000|Overall Study|Withdrew consent|2|||
170668376|NCT01977794|616799373|FG001|Overall Study|Withdrew consent|1|||
170668377|NCT01977794|616799372|FG000|Overall Study|Other|0|||
170668378|NCT01977794|616799373|FG001|Overall Study|Other|1|||
170668379|NCT00533897|616799374|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
170668380|NCT00533897|616799375|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
170668381|NCT00533897|616799376|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
170668382|NCT00533897|616799377|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
170668383|NCT00533897|616799378|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
170668384|NCT00533897|616799379|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
170668385|NCT00533897|616799380|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
170668386|NCT00533897|616799381|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
170668387|NCT00533897|616799374|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
170668388|NCT00533897|616799375|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
170668389|NCT00533897|616799376|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
170668390|NCT00533897|616799377|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
170668391|NCT00533897|616799378|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
170668392|NCT00533897|616799379|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
170668393|NCT00533897|616799380|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
170668394|NCT00533897|616799381|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
170668395|NCT00533897|616799374|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
170668396|NCT00533897|616799375|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
170668397|NCT00533897|616799376|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
170668398|NCT00533897|616799377|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
170668399|NCT00533897|616799378|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
170668400|NCT00533897|616799379|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
170668401|NCT00533897|616799380|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
170668402|NCT00533897|616799381|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
170668403|NCT00533897|616799374|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
170668404|NCT00533897|616799375|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
170668405|NCT00533897|616799376|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
170668406|NCT00533897|616799377|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
170668407|NCT00533897|616799378|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
170668408|NCT00533897|616799379|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
170668409|NCT00533897|616799380|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
170668410|NCT00533897|616799381|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
170668411|NCT00533897|616799374|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
170668412|NCT00533897|616799375|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
170668413|NCT00533897|616799376|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
170668414|NCT00533897|616799377|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
170668415|NCT00533897|616799378|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
170668416|NCT00533897|616799379|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
170668417|NCT00533897|616799380|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
170668418|NCT00533897|616799381|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
170668419|NCT00533897|616799374|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
170668420|NCT00533897|616799375|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
170668421|NCT00533897|616799376|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
170668422|NCT00533897|616799377|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
170668423|NCT00533897|616799378|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
170668424|NCT00533897|616799379|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
170668425|NCT00533897|616799380|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
170668426|NCT00533897|616799381|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
170668427|NCT00533897|616799374|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
170668428|NCT00533897|616799375|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
170668429|NCT00533897|616799376|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
170668430|NCT00533897|616799377|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
170668431|NCT00533897|616799378|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
170668432|NCT00533897|616799379|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
170668433|NCT00533897|616799380|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
170668434|NCT00533897|616799381|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
170668435|NCT00533897|616799374|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
170668436|NCT00533897|616799375|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
170668437|NCT00533897|616799376|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
170668438|NCT00533897|616799377|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
170668439|NCT00533897|616799378|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
170668440|NCT00533897|616799379|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
170668441|NCT00533897|616799380|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
170668442|NCT00533897|616799381|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
170668443|NCT00533897|616799374|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
170668444|NCT00533897|616799375|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
170668445|NCT00533897|616799376|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
170668446|NCT00533897|616799377|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
170668447|NCT00533897|616799378|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
170668448|NCT00533897|616799379|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
170668449|NCT00533897|616799380|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
170668450|NCT00533897|616799381|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
170668451|NCT00533897|616799374|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
170668452|NCT00533897|616799375|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
170668453|NCT00533897|616799376|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
170668454|NCT00533897|616799377|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
170668455|NCT00533897|616799378|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
170668456|NCT00533897|616799379|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
170668457|NCT00533897|616799380|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
170668458|NCT00533897|616799381|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
170668459|NCT00533897|616799374|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
170668460|NCT00533897|616799375|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
170668461|NCT00533897|616799376|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
170668462|NCT00533897|616799377|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
170668463|NCT00533897|616799378|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
170668464|NCT00533897|616799379|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
170668465|NCT00533897|616799380|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
170668466|NCT00533897|616799381|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
170668467|NCT00533897|616799374|FG000|Long Term Extension (LTE)|Death|0|||
170668468|NCT00533897|616799375|FG001|Long Term Extension (LTE)|Death|0|||
170668469|NCT00533897|616799376|FG002|Long Term Extension (LTE)|Death|0|||
170668470|NCT00533897|616799377|FG003|Long Term Extension (LTE)|Death|0|||
170668471|NCT00533897|616799378|FG004|Long Term Extension (LTE)|Death|0|||
170668472|NCT00533897|616799379|FG005|Long Term Extension (LTE)|Death|0|||
170668473|NCT00533897|616799380|FG006|Long Term Extension (LTE)|Death|1|||
170668474|NCT00533897|616799381|FG007|Long Term Extension (LTE)|Death|3|||
170668475|NCT00533897|616799374|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
170668476|NCT00533897|616799375|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
170818771|NCT00472199|617343698|FG001|Overall Study|personal reason|1|||
170818772|NCT00472199|617343697|FG000|Overall Study|patient was asymptomatic|1|||
170818773|NCT00472199|617343698|FG001|Overall Study|patient was asymptomatic|0|||
170818774|NCT00147745|617343699|FG000|Overall Study|Withdrawal by Subject|1|||
170668477|NCT00533897|616799376|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
170668478|NCT00533897|616799377|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
170818775|NCT00147745|617343700|FG001|Overall Study|Withdrawal by Subject|0|||
170818776|NCT00147745|617343701|FG002|Overall Study|Withdrawal by Subject|0|||
170818777|NCT01757171|617343702|FG000|Overall Study|Adverse Event|5|||
170668479|NCT00533897|616799378|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
170668480|NCT00533897|616799379|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
170668481|NCT00533897|616799380|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
170668482|NCT00533897|616799381|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
170668483|NCT00533897|616799374|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
170668484|NCT00533897|616799375|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
170668485|NCT00533897|616799376|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
170668486|NCT00533897|616799377|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
170668487|NCT00533897|616799378|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
170668488|NCT00533897|616799379|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
170668489|NCT00533897|616799380|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
170668490|NCT00533897|616799381|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
170668491|NCT00533897|616799374|FG000|Long Term Extension (LTE)|Adverse Event|0|||
170668492|NCT00533897|616799375|FG001|Long Term Extension (LTE)|Adverse Event|0|||
170668493|NCT00533897|616799376|FG002|Long Term Extension (LTE)|Adverse Event|0|||
170668494|NCT00533897|616799377|FG003|Long Term Extension (LTE)|Adverse Event|0|||
170668495|NCT00533897|616799378|FG004|Long Term Extension (LTE)|Adverse Event|0|||
170668496|NCT00533897|616799379|FG005|Long Term Extension (LTE)|Adverse Event|0|||
170668497|NCT00533897|616799380|FG006|Long Term Extension (LTE)|Adverse Event|2|||
170668498|NCT00533897|616799381|FG007|Long Term Extension (LTE)|Adverse Event|5|||
170668499|NCT00533897|616799374|FG000|Long Term Extension (LTE)|Pregnancy|0|||
170668500|NCT00533897|616799375|FG001|Long Term Extension (LTE)|Pregnancy|0|||
170668501|NCT00533897|616799376|FG002|Long Term Extension (LTE)|Pregnancy|0|||
170668502|NCT00533897|616799377|FG003|Long Term Extension (LTE)|Pregnancy|0|||
170668503|NCT00533897|616799378|FG004|Long Term Extension (LTE)|Pregnancy|0|||
170668504|NCT00533897|616799379|FG005|Long Term Extension (LTE)|Pregnancy|0|||
170668505|NCT00533897|616799380|FG006|Long Term Extension (LTE)|Pregnancy|0|||
170668506|NCT00533897|616799381|FG007|Long Term Extension (LTE)|Pregnancy|2|||
170818778|NCT01757171|617343703|FG001|Overall Study|Adverse Event|1|||
170818779|NCT01757171|617343702|FG000|Overall Study|Disease Progression|1|||
170818780|NCT01757171|617343703|FG001|Overall Study|Disease Progression|0|||
170818781|NCT01757171|617343702|FG000|Overall Study|Hospitalization|1|||
170818782|NCT01757171|617343703|FG001|Overall Study|Hospitalization|0|||
170818783|NCT01757171|617343702|FG000|Overall Study|ECOG decline|1|||
170818784|NCT01757171|617343703|FG001|Overall Study|ECOG decline|0|||
170818785|NCT00105521|617343705|FG000|Overall Study|Other|1|||
170818786|NCT00105521|617343706|FG001|Overall Study|Other|1|||
170818787|NCT00105521|617343707|FG002|Overall Study|Other|2|||
170818788|NCT00105521|617343708|FG003|Overall Study|Other|0|||
170818789|NCT00105521|617343705|FG000|Overall Study|Adverse Event|10|||
170818790|NCT00105521|617343706|FG001|Overall Study|Adverse Event|4|||
170818791|NCT00105521|617343707|FG002|Overall Study|Adverse Event|10|||
170818792|NCT00105521|617343708|FG003|Overall Study|Adverse Event|8|||
170818793|NCT00105521|617343705|FG000|Overall Study|Withdrawal by Subject|1|||
170818794|NCT00105521|617343706|FG001|Overall Study|Withdrawal by Subject|0|||
170818795|NCT00105521|617343707|FG002|Overall Study|Withdrawal by Subject|1|||
170818796|NCT00105521|617343708|FG003|Overall Study|Withdrawal by Subject|4|||
170818797|NCT00105521|617343705|FG000|Overall Study|Lack of Efficacy|0|||
170818798|NCT00105521|617343706|FG001|Overall Study|Lack of Efficacy|0|||
170818799|NCT00105521|617343707|FG002|Overall Study|Lack of Efficacy|0|||
170818800|NCT00105521|617343708|FG003|Overall Study|Lack of Efficacy|1|||
170818801|NCT00105521|617343705|FG000|Overall Study|Protocol Violation|3|||
170818802|NCT00105521|617343706|FG001|Overall Study|Protocol Violation|5|||
170818803|NCT00105521|617343707|FG002|Overall Study|Protocol Violation|4|||
170818804|NCT00105521|617343708|FG003|Overall Study|Protocol Violation|4|||
170818805|NCT00105521|617343705|FG000|Overall Study|Lost to Follow-up|0|||
170818806|NCT00105521|617343706|FG001|Overall Study|Lost to Follow-up|1|||
170818807|NCT00105521|617343707|FG002|Overall Study|Lost to Follow-up|0|||
170818808|NCT00105521|617343708|FG003|Overall Study|Lost to Follow-up|0|||
170818809|NCT00385697|617343710|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
170818810|NCT00385697|617343711|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
170818811|NCT00385697|617343712|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
170818812|NCT00385697|617343713|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
170818813|NCT00385697|617343714|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
170818814|NCT00385697|617343710|FG000|Open-label Segment 1|Lost to Follow-up|1|||
170818815|NCT00385697|617343711|FG001|Open-label Segment 1|Lost to Follow-up|0|||
170818816|NCT00385697|617343712|FG002|Open-label Segment 1|Lost to Follow-up|0|||
170818817|NCT00385697|617343713|FG003|Open-label Segment 1|Lost to Follow-up|0|||
170818818|NCT00385697|617343714|FG004|Open-label Segment 1|Lost to Follow-up|0|||
170818819|NCT00385697|617343710|FG000|Double-blind Segment 2|Adverse Event|0|||
170668507|NCT00533897|616799374|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
170668508|NCT00533897|616799375|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
170818820|NCT00385697|617343711|FG001|Double-blind Segment 2|Adverse Event|3|||
170818821|NCT00385697|617343712|FG002|Double-blind Segment 2|Adverse Event|1|||
170818822|NCT00385697|617343713|FG003|Double-blind Segment 2|Adverse Event|0|||
170818823|NCT00385697|617343714|FG004|Double-blind Segment 2|Adverse Event|0|||
170668509|NCT00533897|616799376|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
170668510|NCT00533897|616799377|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
170668511|NCT00533897|616799378|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
170668512|NCT00533897|616799379|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
170668513|NCT00533897|616799380|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
170668514|NCT00533897|616799381|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
170668515|NCT00533897|616799374|FG000|Long Term Extension (LTE)|Other|0|||
170668516|NCT00533897|616799375|FG001|Long Term Extension (LTE)|Other|0|||
170668517|NCT00533897|616799376|FG002|Long Term Extension (LTE)|Other|0|||
170668518|NCT00533897|616799377|FG003|Long Term Extension (LTE)|Other|0|||
170668519|NCT00533897|616799378|FG004|Long Term Extension (LTE)|Other|0|||
170668520|NCT00533897|616799379|FG005|Long Term Extension (LTE)|Other|0|||
170668521|NCT00533897|616799380|FG006|Long Term Extension (LTE)|Other|1|||
170668522|NCT00533897|616799381|FG007|Long Term Extension (LTE)|Other|6|||
170668523|NCT00541931|616799382|FG000|Overall Study|Adverse Event|1|||
170668524|NCT00541931|616799383|FG001|Overall Study|Adverse Event|0|||
170668525|NCT00541931|616799382|FG000|Overall Study|Lost to Follow-up|3|||
170668526|NCT00541931|616799383|FG001|Overall Study|Lost to Follow-up|3|||
170668527|NCT00541931|616799382|FG000|Overall Study|Withdrawal by Subject|1|||
170668528|NCT00541931|616799383|FG001|Overall Study|Withdrawal by Subject|0|||
170668529|NCT00541931|616799382|FG000|Overall Study|Transportation Issue|0|||
170668530|NCT00541931|616799383|FG001|Overall Study|Transportation Issue|1|||
170668531|NCT00713323|616799393|FG000|Overall Study|Adverse Event|75|||
170668532|NCT00713323|616799393|FG000|Overall Study|Withdrawal by Subject|15|||
170668533|NCT00713323|616799393|FG000|Overall Study|Lost to Follow-up|11|||
170668534|NCT00713323|616799393|FG000|Overall Study|Lack of Efficacy|36|||
170668535|NCT00713323|616799393|FG000|Overall Study|Low creatine clearance at screening|1|||
170668536|NCT00713323|616799393|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
170668537|NCT00713323|616799393|FG000|Overall Study|Surgery cured allodynic pain|1|||
170668538|NCT00713323|616799393|FG000|Overall Study|Pain free|1|||
170668539|NCT00713323|616799393|FG000|Overall Study|Non-compliance|1|||
170668540|NCT00713323|616799393|FG000|Overall Study|Pain resolved|1|||
170668541|NCT00713323|616799393|FG000|Overall Study|Subject travelling to USA|1|||
170668542|NCT00713323|616799393|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
170668543|NCT00713323|616799393|FG000|Overall Study|Treatment that may interact with Sativex|1|||
170668544|NCT00506662|616799394|FG000|Overall Study|Adverse Event|0|||
170668545|NCT00506662|616799395|FG001|Overall Study|Adverse Event|2|||
170668546|NCT00506662|616799394|FG000|Overall Study|Lack of Efficacy|1|||
170668547|NCT00506662|616799395|FG001|Overall Study|Lack of Efficacy|0|||
170668548|NCT00506662|616799394|FG000|Overall Study|Protocol Violation|2|||
170668549|NCT00506662|616799395|FG001|Overall Study|Protocol Violation|4|||
170668550|NCT00506662|616799394|FG000|Overall Study|Trial terminated|10|||
170668551|NCT00506662|616799395|FG001|Overall Study|Trial terminated|16|||
170668552|NCT00506662|616799394|FG000|Overall Study|Not recorded|4|||
170668553|NCT00506662|616799395|FG001|Overall Study|Not recorded|6|||
170668554|NCT00491075|616799397|FG000|Overall Study|Withdrawal by Subject|1|||
170668555|NCT00491075|616799397|FG000|Overall Study|Physician Decision|1|||
170668556|NCT01603355|616799398|FG000|Overall Study|Lack of Efficacy|2|||
170668557|NCT03019185|616799400|FG000|Overall Study|Lost to Follow-up|3|||
170668558|NCT03019185|616799401|FG001|Overall Study|Lost to Follow-up|0|||
170668559|NCT03019185|616799402|FG002|Overall Study|Lost to Follow-up|2|||
170668560|NCT03019185|616799400|FG000|Overall Study|Withdrawal by Subject|1|||
170668561|NCT03019185|616799401|FG001|Overall Study|Withdrawal by Subject|1|||
170668562|NCT03019185|616799402|FG002|Overall Study|Withdrawal by Subject|0|||
170668563|NCT03019185|616799400|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
170668564|NCT03019185|616799401|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
170668565|NCT03019185|616799402|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
170818824|NCT00385697|617343710|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
170668566|NCT03019185|616799400|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
170668567|NCT03019185|616799401|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
170668568|NCT03019185|616799402|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
170668569|NCT05154578|616799403|FG000|Overall Study|Withdrawal by Subject|2|||
170668570|NCT05154578|616799404|FG001|Overall Study|Withdrawal by Subject|3|||
170668571|NCT05154578|616799405|FG002|Overall Study|Withdrawal by Subject|2|||
170668572|NCT05154578|616799406|FG003|Overall Study|Withdrawal by Subject|4|||
170668573|NCT05154578|616799407|FG004|Overall Study|Withdrawal by Subject|0|||
170668574|NCT05154578|616799403|FG000|Overall Study|Lost to Follow-up|0|||
170668575|NCT05154578|616799404|FG001|Overall Study|Lost to Follow-up|1|||
170668576|NCT05154578|616799405|FG002|Overall Study|Lost to Follow-up|0|||
170668577|NCT05154578|616799406|FG003|Overall Study|Lost to Follow-up|3|||
170668578|NCT05154578|616799407|FG004|Overall Study|Lost to Follow-up|0|||
170668579|NCT05154578|616799403|FG000|Overall Study|Adverse Event|0|||
170668580|NCT05154578|616799404|FG001|Overall Study|Adverse Event|0|||
170668581|NCT05154578|616799405|FG002|Overall Study|Adverse Event|0|||
170668582|NCT05154578|616799406|FG003|Overall Study|Adverse Event|1|||
170668583|NCT05154578|616799407|FG004|Overall Study|Adverse Event|0|||
170668584|NCT05154578|616799403|FG000|Overall Study|Relocated to another province|0|||
170668585|NCT05154578|616799404|FG001|Overall Study|Relocated to another province|0|||
170668586|NCT05154578|616799405|FG002|Overall Study|Relocated to another province|1|||
170668587|NCT05154578|616799406|FG003|Overall Study|Relocated to another province|0|||
170668588|NCT05154578|616799407|FG004|Overall Study|Relocated to another province|1|||
170668589|NCT05154578|616799403|FG000|Overall Study|Baby loss|0|||
170668590|NCT05154578|616799404|FG001|Overall Study|Baby loss|1|||
170668591|NCT05154578|616799405|FG002|Overall Study|Baby loss|0|||
170668592|NCT05154578|616799406|FG003|Overall Study|Baby loss|0|||
170668593|NCT05154578|616799407|FG004|Overall Study|Baby loss|0|||
170668594|NCT02764333|616799408|FG000|Overall Study|Ineligible|1|||
170668595|NCT03094169|616799409|FG000|Overall Study|Lack of Efficacy|0|||
170668596|NCT03094169|616799410|FG001|Overall Study|Lack of Efficacy|0|||
170668597|NCT03094169|616799411|FG002|Overall Study|Lack of Efficacy|0|||
170668598|NCT03094169|616799412|FG003|Overall Study|Lack of Efficacy|0|||
170668599|NCT03094169|616799413|FG004|Overall Study|Lack of Efficacy|0|||
170668600|NCT03094169|616799414|FG005|Overall Study|Lack of Efficacy|0|||
170668601|NCT03094169|616799415|FG006|Overall Study|Lack of Efficacy|0|||
170668602|NCT03094169|616799416|FG007|Overall Study|Lack of Efficacy|21|||
170668603|NCT03094169|616799409|FG000|Overall Study|Adverse Event|0|||
170668604|NCT03094169|616799410|FG001|Overall Study|Adverse Event|0|||
170668605|NCT03094169|616799411|FG002|Overall Study|Adverse Event|0|||
170668606|NCT03094169|616799412|FG003|Overall Study|Adverse Event|0|||
170668607|NCT03094169|616799413|FG004|Overall Study|Adverse Event|0|||
170668608|NCT03094169|616799414|FG005|Overall Study|Adverse Event|0|||
170668609|NCT03094169|616799415|FG006|Overall Study|Adverse Event|0|||
170668610|NCT03094169|616799416|FG007|Overall Study|Adverse Event|2|||
170668611|NCT03094169|616799409|FG000|Overall Study|Withdrawal by Subject|0|||
170668612|NCT03094169|616799410|FG001|Overall Study|Withdrawal by Subject|0|||
170668613|NCT03094169|616799411|FG002|Overall Study|Withdrawal by Subject|0|||
170668614|NCT03094169|616799412|FG003|Overall Study|Withdrawal by Subject|0|||
170668615|NCT03094169|616799413|FG004|Overall Study|Withdrawal by Subject|0|||
170668616|NCT03094169|616799414|FG005|Overall Study|Withdrawal by Subject|0|||
170668617|NCT03094169|616799415|FG006|Overall Study|Withdrawal by Subject|1|||
170668618|NCT03094169|616799416|FG007|Overall Study|Withdrawal by Subject|1|||
170668619|NCT03094169|616799409|FG000|Overall Study|Trial Termination|0|||
170668620|NCT03094169|616799410|FG001|Overall Study|Trial Termination|0|||
170668621|NCT03094169|616799411|FG002|Overall Study|Trial Termination|0|||
170668622|NCT03094169|616799412|FG003|Overall Study|Trial Termination|0|||
170668623|NCT03094169|616799413|FG004|Overall Study|Trial Termination|0|||
170668624|NCT03094169|616799414|FG005|Overall Study|Trial Termination|0|||
170668625|NCT03094169|616799415|FG006|Overall Study|Trial Termination|0|||
170668626|NCT03094169|616799416|FG007|Overall Study|Trial Termination|1|||
170668627|NCT00617851|616799417|FG000|Overall Study|Death|0|||
170668628|NCT00617851|616799418|FG001|Overall Study|Death|0|||
170668629|NCT00617851|616799419|FG002|Overall Study|Death|0|||
170668630|NCT00617851|616799420|FG003|Overall Study|Death|1|||
170668631|NCT00617851|616799417|FG000|Overall Study|Withdrawal by Subject|14|||
170668632|NCT00617851|616799418|FG001|Overall Study|Withdrawal by Subject|7|||
170668633|NCT00617851|616799419|FG002|Overall Study|Withdrawal by Subject|12|||
170668634|NCT00617851|616799420|FG003|Overall Study|Withdrawal by Subject|4|||
170668635|NCT00617851|616799417|FG000|Overall Study|Lost to Follow-up|27|||
170668636|NCT00617851|616799418|FG001|Overall Study|Lost to Follow-up|29|||
170668637|NCT00617851|616799419|FG002|Overall Study|Lost to Follow-up|31|||
170668638|NCT00617851|616799420|FG003|Overall Study|Lost to Follow-up|19|||
170668639|NCT00617851|616799417|FG000|Overall Study|Inappropriate Enrollment|5|||
170668640|NCT00617851|616799418|FG001|Overall Study|Inappropriate Enrollment|4|||
170668641|NCT00617851|616799419|FG002|Overall Study|Inappropriate Enrollment|1|||
170668642|NCT00617851|616799420|FG003|Overall Study|Inappropriate Enrollment|1|||
170668643|NCT00617851|616799417|FG000|Overall Study|Unable to classify|1|||
170668644|NCT00617851|616799418|FG001|Overall Study|Unable to classify|0|||
170668645|NCT00617851|616799419|FG002|Overall Study|Unable to classify|1|||
170668646|NCT00617851|616799420|FG003|Overall Study|Unable to classify|0|||
170818825|NCT00385697|617343711|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
170818826|NCT00385697|617343712|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
170668647|NCT01200524|616799421|FG000|Overall Study|Withdrawal by Subject|1|||
170668648|NCT01200524|616799422|FG001|Overall Study|Withdrawal by Subject|1|||
170668649|NCT01200524|616799423|FG002|Overall Study|Withdrawal by Subject|3|||
170668650|NCT01200524|616799421|FG000|Overall Study|Adverse Event|1|||
170668651|NCT01200524|616799422|FG001|Overall Study|Adverse Event|0|||
170668652|NCT01200524|616799423|FG002|Overall Study|Adverse Event|0|||
170818827|NCT00385697|617343713|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
170668653|NCT01200524|616799421|FG000|Overall Study|Non availability of study nurse|0|||
170668654|NCT01200524|616799422|FG001|Overall Study|Non availability of study nurse|0|||
170668655|NCT01200524|616799423|FG002|Overall Study|Non availability of study nurse|1|||
170668656|NCT00491764|616799426|FG000|Overall Study|Adverse Event|1|||
170668657|NCT00491764|616799427|FG001|Overall Study|Adverse Event|2|||
170668658|NCT00491764|616799428|FG002|Overall Study|Adverse Event|4|||
170668659|NCT00491764|616799429|FG003|Overall Study|Adverse Event|4|||
170668660|NCT00491764|616799430|FG004|Overall Study|Adverse Event|0|||
170668661|NCT00491764|616799431|FG005|Overall Study|Adverse Event|1|||
170668662|NCT00491764|616799426|FG000|Overall Study|Lost to Follow-up|0|||
170668663|NCT00491764|616799427|FG001|Overall Study|Lost to Follow-up|1|||
170668664|NCT00491764|616799428|FG002|Overall Study|Lost to Follow-up|0|||
170668665|NCT00491764|616799429|FG003|Overall Study|Lost to Follow-up|1|||
170668666|NCT00491764|616799430|FG004|Overall Study|Lost to Follow-up|0|||
170668667|NCT00491764|616799431|FG005|Overall Study|Lost to Follow-up|3|||
170668668|NCT00491764|616799426|FG000|Overall Study|Withdrawal by Subject|2|||
170668669|NCT00491764|616799427|FG001|Overall Study|Withdrawal by Subject|3|||
170668670|NCT00491764|616799428|FG002|Overall Study|Withdrawal by Subject|1|||
170668671|NCT00491764|616799429|FG003|Overall Study|Withdrawal by Subject|2|||
170668672|NCT00491764|616799430|FG004|Overall Study|Withdrawal by Subject|2|||
170668673|NCT00491764|616799431|FG005|Overall Study|Withdrawal by Subject|4|||
170668674|NCT00491764|616799426|FG000|Overall Study|Non Compliance with the Protocol|1|||
170668675|NCT00491764|616799427|FG001|Overall Study|Non Compliance with the Protocol|0|||
170668676|NCT00491764|616799428|FG002|Overall Study|Non Compliance with the Protocol|0|||
170668677|NCT00491764|616799429|FG003|Overall Study|Non Compliance with the Protocol|0|||
170668678|NCT00491764|616799430|FG004|Overall Study|Non Compliance with the Protocol|0|||
170668679|NCT00491764|616799431|FG005|Overall Study|Non Compliance with the Protocol|0|||
170668680|NCT00491764|616799426|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
170668681|NCT00491764|616799427|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
170668682|NCT00491764|616799428|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
170668683|NCT00491764|616799429|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
170668684|NCT00491764|616799430|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
170668685|NCT00491764|616799431|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
170668686|NCT00491764|616799426|FG000|Overall Study|Administrative|1|||
170668687|NCT00491764|616799427|FG001|Overall Study|Administrative|0|||
170668688|NCT00491764|616799428|FG002|Overall Study|Administrative|2|||
170818828|NCT00385697|617343714|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
170818829|NCT00385697|617343710|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
170668689|NCT00491764|616799429|FG003|Overall Study|Administrative|1|||
170668690|NCT00491764|616799430|FG004|Overall Study|Administrative|0|||
170668691|NCT00491764|616799431|FG005|Overall Study|Administrative|0|||
170668692|NCT01180985|616799434|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
170668693|NCT01180985|616799435|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
170668694|NCT00705289|616799436|FG000|Overall Study|Subject or treating physician's choice|131|||
170668695|NCT03345914|616799443|FG000|Overall Study|Transition to another study at week 16|80|||
170668696|NCT03345914|616799444|FG001|Overall Study|Transition to another study at week 16|86|||
170668697|NCT03345914|616799445|FG002|Overall Study|Transition to another study at week 16|78|||
170668698|NCT03345914|616799443|FG000|Overall Study|Transition to OLE during follow-up|37|||
170668699|NCT03345914|616799444|FG001|Overall Study|Transition to OLE during follow-up|33|||
170668700|NCT03345914|616799445|FG002|Overall Study|Transition to OLE during follow-up|39|||
170668701|NCT03345914|616799443|FG000|Overall Study|Physician Decision|0|||
170668702|NCT03345914|616799444|FG001|Overall Study|Physician Decision|1|||
170668703|NCT03345914|616799445|FG002|Overall Study|Physician Decision|1|||
170668704|NCT03345914|616799443|FG000|Overall Study|Withdrawal by Subject|5|||
170668705|NCT03345914|616799444|FG001|Overall Study|Withdrawal by Subject|1|||
170818830|NCT00385697|617343711|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
170818831|NCT00385697|617343712|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
170818832|NCT00385697|617343713|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
170818833|NCT00385697|617343714|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
170818834|NCT00385697|617343710|FG000|Double-blind Segment 2|Other|0|||
170818835|NCT00385697|617343711|FG001|Double-blind Segment 2|Other|2|||
170818836|NCT00385697|617343712|FG002|Double-blind Segment 2|Other|0|||
170818837|NCT00385697|617343713|FG003|Double-blind Segment 2|Other|0|||
170818838|NCT00385697|617343714|FG004|Double-blind Segment 2|Other|0|||
170818839|NCT02213458|617343723|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
170818840|NCT02213458|617343724|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
170818841|NCT02213458|617343723|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
170818842|NCT02213458|617343724|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
170818843|NCT02213458|617343723|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
170818844|NCT02213458|617343724|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
170818845|NCT02213458|617343723|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
170668706|NCT03345914|616799445|FG002|Overall Study|Withdrawal by Subject|2|||
170668707|NCT03345914|616799443|FG000|Overall Study|Other|1|||
170668708|NCT03345914|616799444|FG001|Overall Study|Other|1|||
170668709|NCT03345914|616799445|FG002|Overall Study|Other|1|||
170668710|NCT03345914|616799443|FG000|Overall Study|Ongoing|0|||
170668711|NCT03345914|616799444|FG001|Overall Study|Ongoing|0|||
170668712|NCT03345914|616799445|FG002|Overall Study|Ongoing|1|||
170668713|NCT01330030|616799446|FG000|Overall Study|Lost to Follow-up|16|||
170668714|NCT01330030|616799447|FG001|Overall Study|Lost to Follow-up|17|||
170668715|NCT03626168|616799448|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170668716|NCT03626168|616799449|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
170668717|NCT03626168|616799448|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
170668718|NCT03626168|616799449|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
170668719|NCT03626168|616799448|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
170668720|NCT03626168|616799449|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
170668721|NCT01419626|616799450|FG000|Overall Study|Protocol Violation|3|||
170668722|NCT01419626|616799451|FG001|Overall Study|Protocol Violation|2|||
170668723|NCT01419626|616799452|FG002|Overall Study|Protocol Violation|2|||
170668724|NCT01419626|616799450|FG000|Overall Study|Withdrawal by Subject|1|||
170668725|NCT01419626|616799451|FG001|Overall Study|Withdrawal by Subject|0|||
170668726|NCT01419626|616799452|FG002|Overall Study|Withdrawal by Subject|0|||
170668727|NCT01419626|616799450|FG000|Overall Study|Lost to Follow-up|0|||
170668728|NCT01419626|616799451|FG001|Overall Study|Lost to Follow-up|1|||
170668729|NCT01419626|616799452|FG002|Overall Study|Lost to Follow-up|1|||
170668730|NCT01146912|616799453|FG000|Overall Study|Already received influenza vaccination|817|||
170668731|NCT01146912|616799454|FG001|Overall Study|Already received influenza vaccination|822|||
170668732|NCT01146912|616799455|FG002|Overall Study|Already received influenza vaccination|13|||
170668733|NCT01146912|616799456|FG003|Overall Study|Already received influenza vaccination|15|||
170668734|NCT01146912|616799457|FG004|Overall Study|Already received influenza vaccination|41|||
170668735|NCT01146912|616799458|FG005|Overall Study|Already received influenza vaccination|61|||
170668736|NCT01146912|616799459|FG006|Overall Study|Already received influenza vaccination|56|||
170668737|NCT01146912|616799460|FG007|Overall Study|Already received influenza vaccination|0|||
170668738|NCT01146912|616799453|FG000|Overall Study|< 14 weeks gestational age|0|||
170668739|NCT01146912|616799454|FG001|Overall Study|< 14 weeks gestational age|0|||
170668740|NCT01146912|616799455|FG002|Overall Study|< 14 weeks gestational age|3|||
170668741|NCT01146912|616799456|FG003|Overall Study|< 14 weeks gestational age|2|||
170668742|NCT01146912|616799457|FG004|Overall Study|< 14 weeks gestational age|0|||
170668743|NCT01146912|616799458|FG005|Overall Study|< 14 weeks gestational age|0|||
170668744|NCT01146912|616799459|FG006|Overall Study|< 14 weeks gestational age|0|||
170668745|NCT01146912|616799460|FG007|Overall Study|< 14 weeks gestational age|0|||
170668746|NCT01146912|616799453|FG000|Overall Study|Duplicate patient|0|||
170668747|NCT01146912|616799454|FG001|Overall Study|Duplicate patient|0|||
170668748|NCT01146912|616799455|FG002|Overall Study|Duplicate patient|1|||
170668749|NCT01146912|616799456|FG003|Overall Study|Duplicate patient|0|||
170668750|NCT01146912|616799457|FG004|Overall Study|Duplicate patient|0|||
170668751|NCT01146912|616799458|FG005|Overall Study|Duplicate patient|0|||
170668752|NCT01146912|616799459|FG006|Overall Study|Duplicate patient|0|||
170668753|NCT01146912|616799460|FG007|Overall Study|Duplicate patient|0|||
170668754|NCT02980783|616799461|FG000|Overall Study|Lost to Follow-up|1|||
170668755|NCT00850070|616799462|FG000|Overall Study|Lack of Efficacy|1|||
170668756|NCT00850070|616799463|FG001|Overall Study|Lack of Efficacy|1|||
170668757|NCT00850070|616799462|FG000|Overall Study|Adverse Event|2|||
170668758|NCT00850070|616799463|FG001|Overall Study|Adverse Event|0|||
170668759|NCT05047770|616799464|FG000|Overall Study|Withdrawal by Subject|15|||
170668760|NCT05047770|616799465|FG001|Overall Study|Withdrawal by Subject|10|||
170668761|NCT05047770|616799466|FG002|Overall Study|Withdrawal by Subject|6|||
170668762|NCT05047770|616799467|FG003|Overall Study|Withdrawal by Subject|12|||
170668763|NCT05047770|616799464|FG000|Overall Study|Lost to Follow-up|7|||
170668764|NCT05047770|616799465|FG001|Overall Study|Lost to Follow-up|5|||
170668765|NCT05047770|616799466|FG002|Overall Study|Lost to Follow-up|12|||
170668766|NCT05047770|616799467|FG003|Overall Study|Lost to Follow-up|13|||
170668767|NCT05047770|616799464|FG000|Overall Study|Other|1|||
170668768|NCT05047770|616799465|FG001|Overall Study|Other|0|||
170668769|NCT05047770|616799466|FG002|Overall Study|Other|1|||
170668770|NCT05047770|616799467|FG003|Overall Study|Other|0|||
170668771|NCT01772160|616799471|FG000|Overall Study|Death|3|||
170668772|NCT01772160|616799471|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
170668773|NCT01772160|616799471|FG000|Overall Study|Consent withdrawal|3|||
170668774|NCT01772160|616799471|FG000|Overall Study|Migrated / moved from the study area|4|||
170668775|NCT01772160|616799471|FG000|Overall Study|Lost to Follow-up|30|||
170668776|NCT01772160|616799471|FG000|Overall Study|Other|5|||
170668777|NCT02202980|616799472|FG000|Overall Study|Lack of Efficacy|1|||
170668778|NCT02202980|616799473|FG001|Overall Study|Lack of Efficacy|0|||
170668779|NCT02202980|616799474|FG002|Overall Study|Lack of Efficacy|7|||
170818846|NCT02213458|617343724|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
170668780|NCT02202980|616799475|FG003|Overall Study|Lack of Efficacy|0|||
170668781|NCT02202980|616799476|FG004|Overall Study|Lack of Efficacy|3|||
170668782|NCT02202980|616799477|FG005|Overall Study|Lack of Efficacy|1|||
170668783|NCT02202980|616799478|FG006|Overall Study|Lack of Efficacy|11|||
170668784|NCT02202980|616799479|FG007|Overall Study|Lack of Efficacy|2|||
170668785|NCT02202980|616799480|FG008|Overall Study|Lack of Efficacy|2|||
170668786|NCT02202980|616799481|FG009|Overall Study|Lack of Efficacy|0|||
170668787|NCT02202980|616799482|FG010|Overall Study|Lack of Efficacy|0|||
170668788|NCT02202980|616799483|FG011|Overall Study|Lack of Efficacy|3|||
170668789|NCT02202980|616799484|FG012|Overall Study|Lack of Efficacy|10|||
170668790|NCT02202980|616799485|FG013|Overall Study|Lack of Efficacy|0|||
170668791|NCT02202980|616799472|FG000|Overall Study|Protocol Violation|0|||
170668792|NCT02202980|616799473|FG001|Overall Study|Protocol Violation|0|||
170668793|NCT02202980|616799474|FG002|Overall Study|Protocol Violation|0|||
170668794|NCT02202980|616799475|FG003|Overall Study|Protocol Violation|3|||
170668795|NCT02202980|616799476|FG004|Overall Study|Protocol Violation|3|||
170668796|NCT02202980|616799477|FG005|Overall Study|Protocol Violation|0|||
170668797|NCT02202980|616799478|FG006|Overall Study|Protocol Violation|0|||
170668798|NCT02202980|616799479|FG007|Overall Study|Protocol Violation|0|||
170668799|NCT02202980|616799480|FG008|Overall Study|Protocol Violation|0|||
170668800|NCT02202980|616799481|FG009|Overall Study|Protocol Violation|0|||
170668801|NCT02202980|616799482|FG010|Overall Study|Protocol Violation|0|||
170668802|NCT02202980|616799483|FG011|Overall Study|Protocol Violation|0|||
170668803|NCT02202980|616799484|FG012|Overall Study|Protocol Violation|0|||
170668804|NCT02202980|616799485|FG013|Overall Study|Protocol Violation|0|||
170668805|NCT02202980|616799472|FG000|Overall Study|Lost to Follow-up|0|||
170668806|NCT02202980|616799473|FG001|Overall Study|Lost to Follow-up|1|||
170668807|NCT02202980|616799474|FG002|Overall Study|Lost to Follow-up|1|||
170668808|NCT02202980|616799475|FG003|Overall Study|Lost to Follow-up|1|||
170668809|NCT02202980|616799476|FG004|Overall Study|Lost to Follow-up|0|||
170668810|NCT02202980|616799477|FG005|Overall Study|Lost to Follow-up|0|||
170668811|NCT02202980|616799478|FG006|Overall Study|Lost to Follow-up|0|||
170668812|NCT02202980|616799479|FG007|Overall Study|Lost to Follow-up|1|||
170668813|NCT02202980|616799480|FG008|Overall Study|Lost to Follow-up|1|||
170668814|NCT02202980|616799481|FG009|Overall Study|Lost to Follow-up|0|||
170668815|NCT02202980|616799482|FG010|Overall Study|Lost to Follow-up|0|||
170668816|NCT02202980|616799483|FG011|Overall Study|Lost to Follow-up|0|||
170668817|NCT02202980|616799484|FG012|Overall Study|Lost to Follow-up|1|||
170668818|NCT02202980|616799485|FG013|Overall Study|Lost to Follow-up|0|||
170668819|NCT02202980|616799472|FG000|Overall Study|Withdrew Consent|0|||
170668820|NCT02202980|616799473|FG001|Overall Study|Withdrew Consent|1|||
170668821|NCT02202980|616799474|FG002|Overall Study|Withdrew Consent|2|||
170668822|NCT02202980|616799475|FG003|Overall Study|Withdrew Consent|0|||
170668823|NCT02202980|616799476|FG004|Overall Study|Withdrew Consent|0|||
170668824|NCT02202980|616799477|FG005|Overall Study|Withdrew Consent|0|||
170668825|NCT02202980|616799478|FG006|Overall Study|Withdrew Consent|0|||
170668826|NCT02202980|616799479|FG007|Overall Study|Withdrew Consent|0|||
170668827|NCT02202980|616799480|FG008|Overall Study|Withdrew Consent|1|||
170668828|NCT02202980|616799481|FG009|Overall Study|Withdrew Consent|0|||
170668829|NCT02202980|616799482|FG010|Overall Study|Withdrew Consent|0|||
170668830|NCT02202980|616799483|FG011|Overall Study|Withdrew Consent|0|||
170668831|NCT02202980|616799484|FG012|Overall Study|Withdrew Consent|0|||
170668832|NCT02202980|616799485|FG013|Overall Study|Withdrew Consent|0|||
170668833|NCT01540838|616799488|FG000|Overall Study|Open nasogastric tube|9|||
170668834|NCT01540838|616799489|FG001|Overall Study|Open nasogastric tube|7|||
170668835|NCT01540838|616799488|FG000|Overall Study|Treatment doses missing|8|||
170668836|NCT01540838|616799489|FG001|Overall Study|Treatment doses missing|12|||
170668837|NCT01540838|616799488|FG000|Overall Study|Additional antibiotic treatment|1|||
170668838|NCT01540838|616799489|FG001|Overall Study|Additional antibiotic treatment|2|||
170668839|NCT01540838|616799488|FG000|Overall Study|Died before treatment initiation|1|||
170668840|NCT01540838|616799489|FG001|Overall Study|Died before treatment initiation|1|||
170668841|NCT01540838|616799488|FG000|Overall Study|Not BM. Other treatment|3|||
170668842|NCT01540838|616799489|FG001|Overall Study|Not BM. Other treatment|1|||
170668843|NCT02130570|616799490|FG000|Overall Study|Death|3|||
170668844|NCT02130570|616799491|FG001|Overall Study|Death|5|||
170668845|NCT02130570|616799490|FG000|Overall Study|Withdrawal by Subject|6|||
170668846|NCT02130570|616799491|FG001|Overall Study|Withdrawal by Subject|3|||
170818847|NCT02213458|617343723|FG000|Overall Study|Refused re-consent|6|||
170818848|NCT02213458|617343724|FG001|Overall Study|Refused re-consent|0|||
170818849|NCT02213458|617343723|FG000|Overall Study|Lost to Follow-up|2|||
170818850|NCT02213458|617343724|FG001|Overall Study|Lost to Follow-up|2|||
170668847|NCT02130570|616799490|FG000|Overall Study|Part of practice that discontinued study|0|||
170668848|NCT02130570|616799491|FG001|Overall Study|Part of practice that discontinued study|5|||
170668849|NCT00591344|616799492|FG000|Overall Study|Transportation issues|1|||
170668850|NCT00591344|616799493|FG001|Overall Study|Transportation issues|0|||
170668851|NCT00591344|616799492|FG000|Overall Study|Moved out of state|1|||
170668852|NCT00591344|616799493|FG001|Overall Study|Moved out of state|0|||
170668853|NCT00591344|616799492|FG000|Overall Study|Medical complications|1|||
170668854|NCT00591344|616799493|FG001|Overall Study|Medical complications|3|||
170668855|NCT00591344|616799492|FG000|Overall Study|Underwent DBS|2|||
170668856|NCT00591344|616799493|FG001|Overall Study|Underwent DBS|2|||
170668857|NCT00591344|616799492|FG000|Overall Study|Death|0|||
170668858|NCT00591344|616799493|FG001|Overall Study|Death|1|||
170668859|NCT00591344|616799492|FG000|Overall Study|Lost to Follow-up|0|||
170668860|NCT00591344|616799493|FG001|Overall Study|Lost to Follow-up|1|||
170668861|NCT00591344|616799492|FG000|Overall Study|Did not want to come off medication|0|||
170668862|NCT00591344|616799493|FG001|Overall Study|Did not want to come off medication|1|||
170917570|NCT03404245|617698472|FG000|Week 27 - Primary Endpoint|COVID related reasons|0|||
170917571|NCT03404245|617698473|FG001|Week 27 - Primary Endpoint|COVID related reasons|1|||
170917572|NCT03404245|617698472|FG000|Week 27 - Primary Endpoint|Natural disaster evacuation|1|||
170917573|NCT03404245|617698473|FG001|Week 27 - Primary Endpoint|Natural disaster evacuation|0|||
170917574|NCT03404245|617698472|FG000|Week 53 - Follow-up|Withdrawal by Subject|1|||
170917575|NCT03404245|617698473|FG001|Week 53 - Follow-up|Withdrawal by Subject|7|||
170917576|NCT03404245|617698472|FG000|Week 53 - Follow-up|Moved out of province|1|||
170917577|NCT03404245|617698473|FG001|Week 53 - Follow-up|Moved out of province|0|||
170917578|NCT03404245|617698472|FG000|Week 53 - Follow-up|Health reason|1|||
170917579|NCT03404245|617698473|FG001|Week 53 - Follow-up|Health reason|0|||
170917580|NCT06874361|617698794|FG000|Overall Study|Physician Decision|1|||
170917581|NCT06874361|617698795|FG001|Overall Study|Physician Decision|0|||
170917582|NCT06874361|617698794|FG000|Overall Study|Did not treat|13|||
170917583|NCT06874361|617698795|FG001|Overall Study|Did not treat|12|||
170917584|NCT06874361|617698794|FG000|Overall Study|Subject noncompliance|1|||
170917585|NCT06874361|617698795|FG001|Overall Study|Subject noncompliance|3|||
170917586|NCT06874361|617698794|FG000|Overall Study|Technical issue|1|||
170917587|NCT06874361|617698795|FG001|Overall Study|Technical issue|0|||
170917588|NCT03621670|617698798|FG000|Overall Study|Adverse Event|3|||
170917589|NCT03621670|617698799|FG001|Overall Study|Adverse Event|1|||
170917590|NCT03621670|617698798|FG000|Overall Study|Lost to Follow-up|32|||
170917591|NCT03621670|617698799|FG001|Overall Study|Lost to Follow-up|25|||
170917592|NCT03621670|617698798|FG000|Overall Study|Consent withdrawal not due to AEs|54|||
170917593|NCT03621670|617698799|FG001|Overall Study|Consent withdrawal not due to AEs|18|||
170917594|NCT03621670|617698798|FG000|Overall Study|Migrated / Moved from the study area|21|||
170917595|NCT03621670|617698799|FG001|Overall Study|Migrated / Moved from the study area|12|||
170917596|NCT03621670|617698798|FG000|Overall Study|Not willing / Not able to be contacted|9|||
170917597|NCT03621670|617698799|FG001|Overall Study|Not willing / Not able to be contacted|13|||
170917598|NCT03621670|617698798|FG000|Overall Study|Other|13|||
170917599|NCT03621670|617698799|FG001|Overall Study|Other|5|||
170917600|NCT03621670|617698798|FG000|Overall Study|Protocol Deviation|7|||
170917601|NCT03621670|617698799|FG001|Overall Study|Protocol Deviation|3|||
170917602|NCT02513394|617698800|FG000|Overall Study|Withdrawal by Subject|11|||
170917603|NCT02513394|617698801|FG001|Overall Study|Withdrawal by Subject|23|||
170917604|NCT02513394|617698800|FG000|Overall Study|Ineligible|1|||
170668863|NCT01781975|616799498|FG000|Overall Study|Death|1|||
170668864|NCT01781975|616799499|FG001|Overall Study|Death|0|||
170668865|NCT01781975|616799498|FG000|Overall Study|Withdrawal by Subject|1|||
170668866|NCT01781975|616799499|FG001|Overall Study|Withdrawal by Subject|1|||
170668867|NCT02939079|616799500|FG000|Overall Study|Adverse Event|2|||
170668868|NCT02939079|616799501|FG001|Overall Study|Adverse Event|1|||
170668869|NCT02939079|616799500|FG000|Overall Study|Lost to Follow-up|0|||
170668870|NCT02939079|616799501|FG001|Overall Study|Lost to Follow-up|2|||
170668871|NCT02939079|616799500|FG000|Overall Study|Protocol Violation|1|||
170668872|NCT02939079|616799501|FG001|Overall Study|Protocol Violation|0|||
170668873|NCT02939079|616799500|FG000|Overall Study|Withdrawal by Subject|0|||
170668874|NCT02939079|616799501|FG001|Overall Study|Withdrawal by Subject|1|||
170668875|NCT02939079|616799500|FG000|Overall Study|relapse during the study|1|||
170668876|NCT02939079|616799501|FG001|Overall Study|relapse during the study|1|||
170668877|NCT00386607|616799509|FG000|Core|Adverse Event|40|||
170668878|NCT00386607|616799510|FG001|Core|Adverse Event|0|||
170668879|NCT00386607|616799509|FG000|Core|Abnormal laboratory value(s)|3|||
170668880|NCT00386607|616799510|FG001|Core|Abnormal laboratory value(s)|0|||
170668881|NCT00386607|616799509|FG000|Core|Unsatisfactory therapeutic effect|23|||
170668882|NCT00386607|616799510|FG001|Core|Unsatisfactory therapeutic effect|0|||
170668883|NCT00386607|616799509|FG000|Core|Condition no longer requires study drug|4|||
170668884|NCT00386607|616799510|FG001|Core|Condition no longer requires study drug|0|||
170668885|NCT00386607|616799509|FG000|Core|Patient withdrew consent|15|||
170668886|NCT00386607|616799510|FG001|Core|Patient withdrew consent|0|||
170668887|NCT00386607|616799509|FG000|Core|Lost to Follow-up|23|||
170917605|NCT02513394|617698801|FG001|Overall Study|Ineligible|0|||
170917606|NCT03365882|617698804|FG000|Randomization|Still Receiving Protocol Treatment|2|||
170668888|NCT00386607|616799510|FG001|Core|Lost to Follow-up|0|||
170668889|NCT00386607|616799509|FG000|Core|Administrative problems|1|||
170917607|NCT03365882|617698805|FG001|Randomization|Still Receiving Protocol Treatment|0|||
170668890|NCT00386607|616799510|FG001|Core|Administrative problems|0|||
170668891|NCT00386607|616799509|FG000|Core|Protocol Deviation|6|||
170668892|NCT00386607|616799510|FG001|Core|Protocol Deviation|0|||
170668893|NCT00386607|616799509|FG000|Extension|Adverse Event|0|||
170668894|NCT00386607|616799510|FG001|Extension|Adverse Event|6|||
170917608|NCT03365882|617698804|FG000|Randomization|Adverse Event|1|||
170917609|NCT03365882|617698805|FG001|Randomization|Adverse Event|2|||
170917610|NCT03365882|617698804|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
170917611|NCT03365882|617698805|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
170917612|NCT03365882|617698804|FG000|Randomization|Progression/Relapse|21|||
170917613|NCT03365882|617698805|FG001|Randomization|Progression/Relapse|3|||
170917614|NCT03365882|617698804|FG000|Randomization|Death|1|||
170917615|NCT03365882|617698805|FG001|Randomization|Death|0|||
170668895|NCT00386607|616799509|FG000|Extension|Abnormal laboratory value(s)|0|||
170668896|NCT00386607|616799510|FG001|Extension|Abnormal laboratory value(s)|1|||
170668897|NCT00386607|616799509|FG000|Extension|Administrative problems|0|||
170668898|NCT00386607|616799510|FG001|Extension|Administrative problems|1|||
170668899|NCT00386607|616799509|FG000|Extension|Lost to Follow-up|0|||
170668900|NCT00386607|616799510|FG001|Extension|Lost to Follow-up|3|||
170668901|NCT00386607|616799509|FG000|Extension|Patient withdrew consent|0|||
170668902|NCT00386607|616799510|FG001|Extension|Patient withdrew consent|5|||
170668903|NCT00386607|616799509|FG000|Extension|Unsatisfactory therapeutic effect|0|||
170668904|NCT00386607|616799510|FG001|Extension|Unsatisfactory therapeutic effect|1|||
170668905|NCT02713204|616799511|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
170668906|NCT02713204|616799512|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
170668907|NCT02713204|616799513|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
170668908|NCT02713204|616799514|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
170668909|NCT02713204|616799515|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
170668910|NCT02713204|616799516|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
170668911|NCT02713204|616799517|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
170668912|NCT02713204|616799518|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
170668913|NCT02713204|616799511|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170668914|NCT02713204|616799512|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170668915|NCT02713204|616799513|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
170668916|NCT02713204|616799514|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170668917|NCT02713204|616799515|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170668918|NCT02713204|616799516|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170668919|NCT02713204|616799517|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170668920|NCT02713204|616799518|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170668921|NCT02713204|616799511|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170668922|NCT02713204|616799512|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
170668923|NCT02713204|616799513|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170668924|NCT02713204|616799514|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170668925|NCT02713204|616799515|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170668926|NCT02713204|616799516|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170668927|NCT02713204|616799517|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170668928|NCT02713204|616799518|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170668929|NCT02713204|616799511|FG000|From Week 12 up to Week 36|Adverse Event|1|||
170668930|NCT02713204|616799512|FG001|From Week 12 up to Week 36|Adverse Event|0|||
170668931|NCT02713204|616799513|FG002|From Week 12 up to Week 36|Adverse Event|0|||
170818851|NCT02213458|617343723|FG000|Overall Study|Withdrawal by Subject|26|||
170818852|NCT02213458|617343724|FG001|Overall Study|Withdrawal by Subject|8|||
170818853|NCT02267746|617343725|FG000|Overall Study|Adverse Event|0|||
170818854|NCT02267746|617343726|FG001|Overall Study|Adverse Event|2|||
170818855|NCT02267746|617343727|FG002|Overall Study|Adverse Event|1|||
170818856|NCT02267746|617343725|FG000|Overall Study|Protocol Violation|8|||
170818857|NCT02267746|617343726|FG001|Overall Study|Protocol Violation|7|||
170818858|NCT02267746|617343727|FG002|Overall Study|Protocol Violation|3|||
170818859|NCT02267746|617343725|FG000|Overall Study|Lack of Efficacy|11|||
170818860|NCT02267746|617343726|FG001|Overall Study|Lack of Efficacy|11|||
170818861|NCT02267746|617343727|FG002|Overall Study|Lack of Efficacy|15|||
170818862|NCT02267746|617343725|FG000|Overall Study|Protocol Violation|1|||
170818863|NCT02267746|617343726|FG001|Overall Study|Protocol Violation|2|||
170818864|NCT02267746|617343727|FG002|Overall Study|Protocol Violation|1|||
170818865|NCT02267746|617343725|FG000|Overall Study|Miscellaneous|1|||
170818866|NCT02267746|617343726|FG001|Overall Study|Miscellaneous|0|||
170818867|NCT02267746|617343727|FG002|Overall Study|Miscellaneous|1|||
170818868|NCT03861078|617343730|FG000|Overall Study|COVID-19 shut down|4|||
170818869|NCT03861078|617343730|FG000|Overall Study|Lost to Follow-up|1|||
170818870|NCT03861078|617343730|FG000|Overall Study|Protocol Violation|2|||
170818871|NCT03861078|617343730|FG000|Overall Study|lack of venous access|1|||
170818872|NCT02058992|617343732|FG000|Overall Study|Lost to Follow-up|4|||
170818873|NCT02058992|617343732|FG000|Overall Study|Protocol Violation|92|||
170818874|NCT02058992|617343732|FG000|Overall Study|CRF Uncollected|20|||
170818875|NCT01699178|617343733|FG000|Overall Study|Adverse Event|1|||
170818876|NCT01699178|617343734|FG001|Overall Study|Adverse Event|5|||
170818877|NCT01699178|617343733|FG000|Overall Study|Lost to Follow-up|1|||
170818878|NCT01699178|617343734|FG001|Overall Study|Lost to Follow-up|6|||
170818879|NCT01699178|617343733|FG000|Overall Study|Non-compliance with Study Drug|3|||
170818880|NCT01699178|617343734|FG001|Overall Study|Non-compliance with Study Drug|1|||
170818881|NCT01699178|617343733|FG000|Overall Study|Physician Decision|1|||
170818882|NCT01699178|617343734|FG001|Overall Study|Physician Decision|0|||
170668932|NCT02713204|616799514|FG003|From Week 12 up to Week 36|Adverse Event|1|||
170668933|NCT02713204|616799515|FG004|From Week 12 up to Week 36|Adverse Event|1|||
170668934|NCT02713204|616799516|FG005|From Week 12 up to Week 36|Adverse Event|0|||
170668935|NCT02713204|616799517|FG006|From Week 12 up to Week 36|Adverse Event|2|||
170668936|NCT02713204|616799518|FG007|From Week 12 up to Week 36|Adverse Event|1|||
170818883|NCT01699178|617343733|FG000|Overall Study|Withdrawal by Subject|4|||
170818884|NCT01699178|617343734|FG001|Overall Study|Withdrawal by Subject|12|||
170818885|NCT01699178|617343733|FG000|Overall Study|Hematocrit >54%|1|||
170818886|NCT01699178|617343734|FG001|Overall Study|Hematocrit >54%|1|||
170818887|NCT01699178|617343733|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
170818888|NCT01699178|617343734|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
170818889|NCT01699178|617343733|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
170818890|NCT01699178|617343734|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
170818891|NCT00912964|617343735|FG000|Overall Study|Eligibility criterion not met|1|||
170818892|NCT00912964|617343736|FG001|Overall Study|Eligibility criterion not met|1|||
170818893|NCT00912964|617343737|FG002|Overall Study|Eligibility criterion not met|0|||
170818894|NCT00912964|617343735|FG000|Overall Study|Adverse Event|15|||
170818895|NCT00912964|617343736|FG001|Overall Study|Adverse Event|18|||
170818896|NCT00912964|617343737|FG002|Overall Study|Adverse Event|12|||
170818897|NCT00912964|617343735|FG000|Overall Study|Lack of Efficacy|11|||
170818898|NCT00912964|617343736|FG001|Overall Study|Lack of Efficacy|4|||
170818899|NCT00912964|617343737|FG002|Overall Study|Lack of Efficacy|3|||
170818900|NCT00912964|617343735|FG000|Overall Study|Withdrawal by Subject|20|||
170618536|NCT00607087|616611396|FG000|Period 1|Adverse Event|3|||
170618537|NCT00607087|616611397|FG001|Period 1|Adverse Event|0|||
170618538|NCT00607087|616611398|FG002|Period 1|Adverse Event|0|||
170618539|NCT00607087|616611396|FG000|Period 1|Poor compliance to protocol|1|||
170618540|NCT00607087|616611397|FG001|Period 1|Poor compliance to protocol|0|||
170618541|NCT00607087|616611398|FG002|Period 1|Poor compliance to protocol|0|||
170618542|NCT00607087|616611396|FG000|Period 1|Lost to Follow-up|1|||
170618543|NCT00607087|616611397|FG001|Period 1|Lost to Follow-up|0|||
170618544|NCT00607087|616611398|FG002|Period 1|Lost to Follow-up|0|||
170618545|NCT00607087|616611396|FG000|Period 1|Other reason|0|||
170618546|NCT00607087|616611397|FG001|Period 1|Other reason|4|||
170618547|NCT00607087|616611398|FG002|Period 1|Other reason|2|||
170618548|NCT00607087|616611396|FG000|Period 2|Withdrawal by Subject|0|||
170618549|NCT00607087|616611397|FG001|Period 2|Withdrawal by Subject|1|||
170618550|NCT00607087|616611398|FG002|Period 2|Withdrawal by Subject|1|||
170618551|NCT00607087|616611396|FG000|Period 2|Other reason|1|||
170618552|NCT00607087|616611397|FG001|Period 2|Other reason|1|||
170618553|NCT00607087|616611398|FG002|Period 2|Other reason|0|||
170618554|NCT00607087|616611396|FG000|Period 2|Adverse Event|0|||
170618555|NCT00607087|616611397|FG001|Period 2|Adverse Event|1|||
170618556|NCT00607087|616611398|FG002|Period 2|Adverse Event|3|||
170618557|NCT00607087|616611396|FG000|Period 2|Poor compliance to protocol|0|||
170618558|NCT00607087|616611397|FG001|Period 2|Poor compliance to protocol|0|||
170618559|NCT00607087|616611398|FG002|Period 2|Poor compliance to protocol|1|||
170618560|NCT00607087|616611396|FG000|Period 3|Withdrawal by Subject|2|||
170618561|NCT00607087|616611397|FG001|Period 3|Withdrawal by Subject|1|||
170618562|NCT00607087|616611398|FG002|Period 3|Withdrawal by Subject|0|||
170618563|NCT00607087|616611396|FG000|Period 3|Adverse Event|0|||
170618564|NCT00607087|616611397|FG001|Period 3|Adverse Event|1|||
170618565|NCT00607087|616611398|FG002|Period 3|Adverse Event|0|||
170618566|NCT02488005|616611403|FG000|Overall Study|Lost to Follow-up|2|||
170618567|NCT00154297|616611404|FG000|Overall Study|Death|5|||
170618568|NCT00154297|616611405|FG001|Overall Study|Death|2|||
170618569|NCT00154297|616611404|FG000|Overall Study|Withdrawal by Subject|0|||
170618570|NCT00154297|616611405|FG001|Overall Study|Withdrawal by Subject|5|||
170618571|NCT00154297|616611404|FG000|Overall Study|Lost to Follow-up|3|||
170618572|NCT00154297|616611405|FG001|Overall Study|Lost to Follow-up|0|||
170618573|NCT00650767|616611406|FG000|Overall Study|Adverse Event|0|||
170618574|NCT00650767|616611407|FG001|Overall Study|Adverse Event|3|||
170618575|NCT00650767|616611408|FG002|Overall Study|Adverse Event|10|||
170618576|NCT00650767|616611409|FG003|Overall Study|Adverse Event|8|||
170618577|NCT00650767|616611406|FG000|Overall Study|Death|1|||
170618578|NCT00650767|616611407|FG001|Overall Study|Death|0|||
170618579|NCT00650767|616611408|FG002|Overall Study|Death|0|||
170618580|NCT00650767|616611409|FG003|Overall Study|Death|0|||
170618581|NCT00650767|616611406|FG000|Overall Study|Withdrawal by Subject|2|||
170618582|NCT00650767|616611407|FG001|Overall Study|Withdrawal by Subject|4|||
170618583|NCT00650767|616611408|FG002|Overall Study|Withdrawal by Subject|3|||
170618584|NCT00650767|616611409|FG003|Overall Study|Withdrawal by Subject|3|||
170618585|NCT00650767|616611406|FG000|Overall Study|Lost to Follow-up|1|||
170618586|NCT00650767|616611407|FG001|Overall Study|Lost to Follow-up|1|||
170618587|NCT00650767|616611408|FG002|Overall Study|Lost to Follow-up|1|||
170618588|NCT00650767|616611409|FG003|Overall Study|Lost to Follow-up|0|||
170618589|NCT00650767|616611406|FG000|Overall Study|Other|1|||
170668937|NCT02713204|616799511|FG000|From Week 12 up to Week 36|Death|0|||
170668938|NCT02713204|616799512|FG001|From Week 12 up to Week 36|Death|0|||
170668939|NCT02713204|616799513|FG002|From Week 12 up to Week 36|Death|0|||
170668940|NCT02713204|616799514|FG003|From Week 12 up to Week 36|Death|1|||
170668941|NCT02713204|616799515|FG004|From Week 12 up to Week 36|Death|0|||
170668942|NCT02713204|616799516|FG005|From Week 12 up to Week 36|Death|1|||
170668943|NCT02713204|616799517|FG006|From Week 12 up to Week 36|Death|0|||
170668944|NCT02713204|616799518|FG007|From Week 12 up to Week 36|Death|3|||
170668945|NCT02713204|616799511|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
170668946|NCT02713204|616799512|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
170668947|NCT02713204|616799513|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
170668948|NCT02713204|616799514|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
170668949|NCT02713204|616799515|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
170668950|NCT02713204|616799516|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
170668951|NCT02713204|616799517|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
170668952|NCT02713204|616799518|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
170668953|NCT02713204|616799511|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
170668954|NCT02713204|616799512|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
170668955|NCT02713204|616799513|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
170668956|NCT02713204|616799514|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
170668957|NCT02713204|616799515|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
170668958|NCT02713204|616799516|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
170668959|NCT02713204|616799517|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
170668960|NCT02713204|616799518|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
170668961|NCT02846324|616799519|FG000|Overall Study|Other|1|||
170668962|NCT02846324|616799520|FG001|Overall Study|Other|0|||
170668963|NCT02846324|616799521|FG002|Overall Study|Other|0|||
170668964|NCT02846324|616799522|FG003|Overall Study|Other|0|||
170668965|NCT02846324|616799519|FG000|Overall Study|Withdrawal by Subject|1|||
170668966|NCT02846324|616799520|FG001|Overall Study|Withdrawal by Subject|0|||
170668967|NCT02846324|616799521|FG002|Overall Study|Withdrawal by Subject|4|||
170668968|NCT02846324|616799522|FG003|Overall Study|Withdrawal by Subject|0|||
170668969|NCT02959983|616799525|FG000|Overall Study|Protocol Violation|0|||
170668970|NCT02959983|616799526|FG001|Overall Study|Protocol Violation|1|||
170668971|NCT02959983|616799525|FG000|Overall Study|Lack of Efficacy|0|||
170668972|NCT02959983|616799526|FG001|Overall Study|Lack of Efficacy|1|||
170668973|NCT02959983|616799525|FG000|Overall Study|Lost to Follow-up|12|||
170668974|NCT02959983|616799526|FG001|Overall Study|Lost to Follow-up|9|||
170668975|NCT02959983|616799525|FG000|Overall Study|Other|1|||
170668976|NCT02959983|616799526|FG001|Overall Study|Other|1|||
170668977|NCT02959983|616799525|FG000|Overall Study|Physician Decision|1|||
170668978|NCT02959983|616799526|FG001|Overall Study|Physician Decision|0|||
170668979|NCT02959983|616799525|FG000|Overall Study|Adverse Event|5|||
170668980|NCT02959983|616799526|FG001|Overall Study|Adverse Event|1|||
170668981|NCT02959983|616799525|FG000|Overall Study|Withdrawal by Subject|7|||
170668982|NCT02959983|616799526|FG001|Overall Study|Withdrawal by Subject|12|||
170668983|NCT01441180|616799529|FG000|Overall Study|Lost to Follow-up|1|||
170668984|NCT01441180|616799530|FG001|Overall Study|Lost to Follow-up|1|||
170668985|NCT01441180|616799531|FG002|Overall Study|Lost to Follow-up|1|||
170668986|NCT01441180|616799529|FG000|Overall Study|Discontinued|0|||
170668987|NCT01441180|616799530|FG001|Overall Study|Discontinued|0|||
170668988|NCT01441180|616799531|FG002|Overall Study|Discontinued|2|||
170668989|NCT01558739|616799534|FG000|Overall Study|Adverse Event|7|||
170668990|NCT01558739|616799534|FG000|Overall Study|Withdrawal by Subject|2|||
170668991|NCT01558739|616799534|FG000|Overall Study|Death|3|||
170668992|NCT01558739|616799534|FG000|Overall Study|Disease Progression|4|||
170668993|NCT01558739|616799534|FG000|Overall Study|Protocol Violation|1|||
170668994|NCT00142298|616799539|FG000|Overall Study|Adverse Event|10|||
170668995|NCT00142298|616799540|FG001|Overall Study|Adverse Event|10|||
170668996|NCT00142298|616799541|FG002|Overall Study|Adverse Event|1|||
170668997|NCT00142298|616799542|FG003|Overall Study|Adverse Event|5|||
170668998|NCT00142298|616799543|FG004|Overall Study|Adverse Event|2|||
170668999|NCT00142298|616799544|FG005|Overall Study|Adverse Event|2|||
170669000|NCT00142298|616799545|FG006|Overall Study|Adverse Event|0|||
170669001|NCT00142298|616799546|FG007|Overall Study|Adverse Event|0|||
170669002|NCT00142298|616799547|FG008|Overall Study|Adverse Event|0|||
170669003|NCT00142298|616799548|FG009|Overall Study|Adverse Event|0|||
170669004|NCT00142298|616799539|FG000|Overall Study|Clinical disease progression|1|||
170669005|NCT00142298|616799540|FG001|Overall Study|Clinical disease progression|0|||
170669006|NCT00142298|616799541|FG002|Overall Study|Clinical disease progression|0|||
170669007|NCT00142298|616799542|FG003|Overall Study|Clinical disease progression|0|||
170669008|NCT00142298|616799543|FG004|Overall Study|Clinical disease progression|0|||
170669009|NCT00142298|616799544|FG005|Overall Study|Clinical disease progression|0|||
170669010|NCT00142298|616799545|FG006|Overall Study|Clinical disease progression|0|||
170669011|NCT00142298|616799546|FG007|Overall Study|Clinical disease progression|0|||
170669012|NCT00142298|616799547|FG008|Overall Study|Clinical disease progression|0|||
170669013|NCT00142298|616799548|FG009|Overall Study|Clinical disease progression|0|||
170669014|NCT00142298|616799539|FG000|Overall Study|Death|1|||
170618590|NCT00650767|616611407|FG001|Overall Study|Other|1|||
170618591|NCT00650767|616611408|FG002|Overall Study|Other|0|||
170618592|NCT00650767|616611409|FG003|Overall Study|Other|0|||
170618593|NCT03649074|616611410|FG000|Overall Study|Lost to Follow-up|2|||
170618594|NCT03649074|616611411|FG001|Overall Study|Lost to Follow-up|1|||
170618595|NCT03649074|616611410|FG000|Overall Study|Adverse Event|1|||
170618596|NCT03649074|616611411|FG001|Overall Study|Adverse Event|0|||
170618597|NCT03649074|616611410|FG000|Overall Study|Physician Decision|1|||
170618598|NCT03649074|616611411|FG001|Overall Study|Physician Decision|0|||
170618599|NCT03649074|616611410|FG000|Overall Study|Withdrawal by Subject|0|||
170618600|NCT03649074|616611411|FG001|Overall Study|Withdrawal by Subject|2|||
170618601|NCT03649074|616611410|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
170618602|NCT03649074|616611411|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
170618603|NCT03649074|616611410|FG000|Overall Study|Other|1|||
170618604|NCT03649074|616611411|FG001|Overall Study|Other|0|||
170618605|NCT04393493|616611412|FG000|First 4 Days of Intervention|Early improvement|5|||
170618606|NCT04393493|616611413|FG001|First 4 Days of Intervention|Early improvement|7|||
170618607|NCT01125800|616611414|FG000|Phase I|Protocol Violation|0|||
170618608|NCT01125800|616611415|FG001|Phase I|Protocol Violation|3|||
170618609|NCT01125800|616611416|FG002|Phase I|Protocol Violation|1|||
170618610|NCT01125800|616611417|FG003|Phase I|Protocol Violation|1|||
170618611|NCT01125800|616611418|FG004|Phase I|Protocol Violation|0|||
170618612|NCT01125800|616611414|FG000|Phase I|Adverse Event|2|||
170618613|NCT01125800|616611415|FG001|Phase I|Adverse Event|2|||
170618614|NCT01125800|616611416|FG002|Phase I|Adverse Event|1|||
170618615|NCT01125800|616611417|FG003|Phase I|Adverse Event|7|||
170618616|NCT01125800|616611418|FG004|Phase I|Adverse Event|0|||
170618617|NCT01125800|616611414|FG000|Phase I|Administrative problems|1|||
170618618|NCT01125800|616611415|FG001|Phase I|Administrative problems|0|||
170618619|NCT01125800|616611416|FG002|Phase I|Administrative problems|0|||
170618620|NCT01125800|616611417|FG003|Phase I|Administrative problems|0|||
170618621|NCT01125800|616611418|FG004|Phase I|Administrative problems|0|||
170618622|NCT01125800|616611414|FG000|Phase I|Withdrawal by Subject|0|||
170618623|NCT01125800|616611415|FG001|Phase I|Withdrawal by Subject|0|||
170618624|NCT01125800|616611416|FG002|Phase I|Withdrawal by Subject|1|||
170618625|NCT01125800|616611417|FG003|Phase I|Withdrawal by Subject|0|||
170618626|NCT01125800|616611418|FG004|Phase I|Withdrawal by Subject|0|||
170618627|NCT01125800|616611414|FG000|Phase I|Disease progression|5|||
170618628|NCT01125800|616611415|FG001|Phase I|Disease progression|4|||
170618629|NCT01125800|616611416|FG002|Phase I|Disease progression|1|||
170618630|NCT01125800|616611417|FG003|Phase I|Disease progression|3|||
170618631|NCT01125800|616611418|FG004|Phase I|Disease progression|0|||
170618632|NCT01125800|616611414|FG000|Phase II|Protocol Violation|0|||
170618633|NCT01125800|616611415|FG001|Phase II|Protocol Violation|0|||
170618634|NCT01125800|616611416|FG002|Phase II|Protocol Violation|0|||
170618635|NCT01125800|616611417|FG003|Phase II|Protocol Violation|0|||
170618636|NCT01125800|616611418|FG004|Phase II|Protocol Violation|1|||
170618637|NCT01125800|616611414|FG000|Phase II|Adverse Event|0|||
170618638|NCT01125800|616611415|FG001|Phase II|Adverse Event|0|||
170618639|NCT01125800|616611416|FG002|Phase II|Adverse Event|0|||
170618640|NCT01125800|616611417|FG003|Phase II|Adverse Event|0|||
170618641|NCT01125800|616611418|FG004|Phase II|Adverse Event|2|||
170618642|NCT01125800|616611414|FG000|Phase II|Disease progression|0|||
170618643|NCT01125800|616611415|FG001|Phase II|Disease progression|0|||
170917616|NCT03365882|617698804|FG000|Randomization|Other - Not Protocol Specified|1|||
170618644|NCT01125800|616611416|FG002|Phase II|Disease progression|0|||
170618645|NCT01125800|616611417|FG003|Phase II|Disease progression|1|||
170669015|NCT00142298|616799540|FG001|Overall Study|Death|1|||
170669016|NCT00142298|616799541|FG002|Overall Study|Death|1|||
170669017|NCT00142298|616799542|FG003|Overall Study|Death|0|||
170669018|NCT00142298|616799543|FG004|Overall Study|Death|0|||
170917617|NCT03365882|617698805|FG001|Randomization|Other - Not Protocol Specified|1|||
170917618|NCT03365882|617698804|FG000|Randomization|Major Protocol Deviation|0|||
170669019|NCT00142298|616799544|FG005|Overall Study|Death|6|||
170618646|NCT01125800|616611418|FG004|Phase II|Disease progression|8|||
170618647|NCT00717249|616611421|FG000|Overall Study|Lens Discomfort|4|||
170618648|NCT00717249|616611422|FG001|Overall Study|Lens Discomfort|1|||
170618649|NCT00717249|616611421|FG000|Overall Study|Unsatisfactory visual Response|0|||
170618650|NCT00717249|616611422|FG001|Overall Study|Unsatisfactory visual Response|2|||
170618651|NCT00717249|616611421|FG000|Overall Study|Adverse Event|4|||
170618652|NCT00717249|616611422|FG001|Overall Study|Adverse Event|2|||
170618653|NCT00717249|616611421|FG000|Overall Study|Lost to Follow-up|2|||
170618654|NCT00717249|616611422|FG001|Overall Study|Lost to Follow-up|0|||
170618655|NCT00717249|616611421|FG000|Overall Study|Withdrawal by Subject|1|||
170618656|NCT00717249|616611422|FG001|Overall Study|Withdrawal by Subject|2|||
170618657|NCT00717249|616611421|FG000|Overall Study|Pregnancy|6|||
170618658|NCT00717249|616611422|FG001|Overall Study|Pregnancy|3|||
170618659|NCT00717249|616611421|FG000|Overall Study|Protocol Violation|0|||
170618660|NCT00717249|616611422|FG001|Overall Study|Protocol Violation|2|||
170669020|NCT00142298|616799545|FG006|Overall Study|Death|0|||
170618661|NCT00717249|616611421|FG000|Overall Study|Subject became Ineligible|1|||
170618662|NCT00717249|616611422|FG001|Overall Study|Subject became Ineligible|1|||
170618663|NCT00717249|616611421|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
170618664|NCT00717249|616611422|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
170618665|NCT00717249|616611421|FG000|Overall Study|Gastric Surgery|0|||
170618666|NCT00717249|616611422|FG001|Overall Study|Gastric Surgery|1|||
170618667|NCT00717249|616611421|FG000|Overall Study|Diagnosed with Diabetes|1|||
170618668|NCT00717249|616611422|FG001|Overall Study|Diagnosed with Diabetes|0|||
170618669|NCT00717249|616611421|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
170618670|NCT00717249|616611422|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
170618671|NCT00717249|616611421|FG000|Overall Study|Subject relocated|1|||
170618672|NCT00717249|616611422|FG001|Overall Study|Subject relocated|0|||
170618673|NCT00717249|616611421|FG000|Overall Study|Headaches|1|||
170618674|NCT00717249|616611422|FG001|Overall Study|Headaches|0|||
170618675|NCT01808196|616611426|FG000|Overall Study|Lost to Follow-up|1|||
170618676|NCT03370718|616611427|FG000|Overall Study|Withdrawal by Subject|1|||
170618677|NCT05477485|616611430|FG000|Overall Study|Lost to Follow-up|0|||
170618678|NCT05477485|616611431|FG001|Overall Study|Lost to Follow-up|4|||
170618679|NCT02777827|616611432|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
170618680|NCT02777827|616611433|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
170618681|NCT02777827|616611434|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
170618682|NCT02777827|616611435|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
170618683|NCT02777827|616611436|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
170618684|NCT02777827|616611437|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
170618685|NCT00064792|616611438|FG000|Overall Study|Withdrawal by Subject|2|||
170618686|NCT00064792|616611439|FG001|Overall Study|Withdrawal by Subject|0|||
170618687|NCT00064792|616611438|FG000|Overall Study|Adverse Event|3|||
170618688|NCT00064792|616611439|FG001|Overall Study|Adverse Event|0|||
170618689|NCT00992459|616611443|FG000|Overall Study|Withdrawal by Subject|0|||
170618690|NCT00992459|616611444|FG001|Overall Study|Withdrawal by Subject|1|||
170818901|NCT00912964|617343736|FG001|Overall Study|Withdrawal by Subject|12|||
170818902|NCT00912964|617343737|FG002|Overall Study|Withdrawal by Subject|18|||
170818903|NCT00912964|617343735|FG000|Overall Study|Lost to Follow-up|4|||
170618691|NCT00992459|616611443|FG000|Overall Study|Adverse Event|1|||
170618692|NCT00992459|616611444|FG001|Overall Study|Adverse Event|0|||
170618693|NCT03096834|616612731|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
170618694|NCT03096834|616612732|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
170618695|NCT03096834|616612733|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
170618696|NCT03096834|616612734|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
170618697|NCT03096834|616612731|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
170618698|NCT03096834|616612732|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
170618699|NCT03096834|616612733|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
170618700|NCT03096834|616612734|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
170618701|NCT03096834|616612731|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
170618702|NCT03096834|616612732|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
170618703|NCT03096834|616612733|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
170618704|NCT03096834|616612734|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
170618705|NCT03096834|616612731|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
170618706|NCT03096834|616612732|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
170618707|NCT03096834|616612733|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
170618708|NCT03096834|616612734|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
170618709|NCT03096834|616612731|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
170618710|NCT03096834|616612732|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
170618711|NCT03096834|616612733|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
170618712|NCT03096834|616612734|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
170618713|NCT03096834|616612731|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
170618714|NCT03096834|616612732|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
170618715|NCT03096834|616612733|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
170618716|NCT03096834|616612734|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
170618717|NCT03096834|616612731|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
170618718|NCT03096834|616612732|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
170618719|NCT03096834|616612733|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
170618720|NCT03096834|616612734|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
170618721|NCT03096834|616612731|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
170818904|NCT00912964|617343736|FG001|Overall Study|Lost to Follow-up|3|||
170618722|NCT03096834|616612732|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
170618723|NCT03096834|616612733|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
170618724|NCT03096834|616612734|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
170618725|NCT03096834|616612731|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
170618726|NCT03096834|616612732|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
170618727|NCT03096834|616612733|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
170669021|NCT00142298|616799546|FG007|Overall Study|Death|0|||
170618728|NCT03096834|616612734|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
170618729|NCT03096834|616612731|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
170618730|NCT03096834|616612732|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
170618731|NCT03096834|616612733|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
170618732|NCT03096834|616612734|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
170618733|NCT03096834|616612731|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
170618734|NCT03096834|616612732|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
170618735|NCT03096834|616612733|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
170618736|NCT03096834|616612734|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
170618737|NCT03096834|616612731|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
170618738|NCT03096834|616612732|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
170618739|NCT03096834|616612733|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
170618740|NCT03096834|616612734|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
170618741|NCT00882440|616612737|FG000|Overall Study|Adverse Event|2|||
170618742|NCT00882440|616612738|FG001|Overall Study|Adverse Event|2|||
170618743|NCT00882440|616612739|FG002|Overall Study|Adverse Event|2|||
170618744|NCT00882440|616612740|FG003|Overall Study|Adverse Event|1|||
170618745|NCT00882440|616612741|FG004|Overall Study|Adverse Event|1|||
170618746|NCT00882440|616612742|FG005|Overall Study|Adverse Event|4|||
170618747|NCT00882440|616612743|FG006|Overall Study|Adverse Event|2|||
170618748|NCT00882440|616612737|FG000|Overall Study|Lack of Efficacy|3|||
170618749|NCT00882440|616612738|FG001|Overall Study|Lack of Efficacy|5|||
170618750|NCT00882440|616612739|FG002|Overall Study|Lack of Efficacy|2|||
170618751|NCT00882440|616612740|FG003|Overall Study|Lack of Efficacy|0|||
170618752|NCT00882440|616612741|FG004|Overall Study|Lack of Efficacy|0|||
170618753|NCT00882440|616612742|FG005|Overall Study|Lack of Efficacy|3|||
170618754|NCT00882440|616612743|FG006|Overall Study|Lack of Efficacy|0|||
170618755|NCT00882440|616612737|FG000|Overall Study|Lost to Follow-up|2|||
170618756|NCT00882440|616612738|FG001|Overall Study|Lost to Follow-up|0|||
170618757|NCT00882440|616612739|FG002|Overall Study|Lost to Follow-up|1|||
170618758|NCT00882440|616612740|FG003|Overall Study|Lost to Follow-up|1|||
170618759|NCT00882440|616612741|FG004|Overall Study|Lost to Follow-up|1|||
170618760|NCT00882440|616612742|FG005|Overall Study|Lost to Follow-up|0|||
170618761|NCT00882440|616612743|FG006|Overall Study|Lost to Follow-up|1|||
170618762|NCT00882440|616612737|FG000|Overall Study|Protocol Violation|0|||
170618763|NCT00882440|616612738|FG001|Overall Study|Protocol Violation|0|||
170618764|NCT00882440|616612739|FG002|Overall Study|Protocol Violation|1|||
170618765|NCT00882440|616612740|FG003|Overall Study|Protocol Violation|1|||
170618766|NCT00882440|616612741|FG004|Overall Study|Protocol Violation|1|||
170618767|NCT00882440|616612742|FG005|Overall Study|Protocol Violation|0|||
170618768|NCT00882440|616612743|FG006|Overall Study|Protocol Violation|0|||
170618769|NCT00882440|616612737|FG000|Overall Study|Withdrawal by Subject|2|||
170818905|NCT00912964|617343737|FG002|Overall Study|Lost to Follow-up|3|||
170818906|NCT00912964|617343735|FG000|Overall Study|Protocol Violation|5|||
170818907|NCT00912964|617343736|FG001|Overall Study|Protocol Violation|3|||
170818908|NCT00912964|617343737|FG002|Overall Study|Protocol Violation|8|||
170818909|NCT00912964|617343735|FG000|Overall Study|Taking exclusionary medications|7|||
170818910|NCT00912964|617343736|FG001|Overall Study|Taking exclusionary medications|4|||
170818911|NCT00912964|617343737|FG002|Overall Study|Taking exclusionary medications|8|||
170818912|NCT00912964|617343735|FG000|Overall Study|Medical History|1|||
170818913|NCT00912964|617343736|FG001|Overall Study|Medical History|0|||
170818914|NCT00912964|617343737|FG002|Overall Study|Medical History|0|||
170818915|NCT00912964|617343735|FG000|Overall Study|Non-compliance with study procedures|2|||
170818916|NCT00912964|617343736|FG001|Overall Study|Non-compliance with study procedures|0|||
170818917|NCT00912964|617343737|FG002|Overall Study|Non-compliance with study procedures|0|||
170818918|NCT00912964|617343735|FG000|Overall Study|Violation of exclusion criterion|0|||
170818919|NCT00912964|617343736|FG001|Overall Study|Violation of exclusion criterion|0|||
170818920|NCT00912964|617343737|FG002|Overall Study|Violation of exclusion criterion|2|||
170818921|NCT00912964|617343735|FG000|Overall Study|Randomized but never received study drug|0|||
170818922|NCT00912964|617343736|FG001|Overall Study|Randomized but never received study drug|1|||
170818923|NCT00912964|617343737|FG002|Overall Study|Randomized but never received study drug|0|||
170818924|NCT02260154|617343738|FG000|Overall Study|Screening failure|2|||
170818925|NCT03689452|617343747|FG000|Overall Study|Lost to Follow-up|1|||
170818926|NCT03689452|617343748|FG001|Overall Study|Lost to Follow-up|1|||
170818927|NCT00732498|617343750|FG000|Overall Study|Ineligible|1|||
170818928|NCT00732498|617343750|FG000|Overall Study|Adverse Event|2|||
170818929|NCT00732498|617343750|FG000|Overall Study|Physician Decision|3|||
170818930|NCT00091572|617343754|FG000|Overall Study|Lost to Follow-up|1|||
170818931|NCT00091572|617343755|FG001|Overall Study|Lost to Follow-up|1|||
170618770|NCT00882440|616612738|FG001|Overall Study|Withdrawal by Subject|1|||
170618771|NCT00882440|616612739|FG002|Overall Study|Withdrawal by Subject|1|||
170618772|NCT00882440|616612740|FG003|Overall Study|Withdrawal by Subject|0|||
170618773|NCT00882440|616612741|FG004|Overall Study|Withdrawal by Subject|6|||
170618774|NCT00882440|616612742|FG005|Overall Study|Withdrawal by Subject|0|||
170618775|NCT00882440|616612743|FG006|Overall Study|Withdrawal by Subject|1|||
170669022|NCT00142298|616799547|FG008|Overall Study|Death|0|||
170618776|NCT00882440|616612737|FG000|Overall Study|Patient Uncooperative|2|||
170618777|NCT00882440|616612738|FG001|Overall Study|Patient Uncooperative|0|||
170618778|NCT00882440|616612739|FG002|Overall Study|Patient Uncooperative|0|||
170618779|NCT00882440|616612740|FG003|Overall Study|Patient Uncooperative|0|||
170618780|NCT00882440|616612741|FG004|Overall Study|Patient Uncooperative|1|||
170618781|NCT00882440|616612742|FG005|Overall Study|Patient Uncooperative|0|||
170618782|NCT00882440|616612743|FG006|Overall Study|Patient Uncooperative|0|||
170618783|NCT00833040|616612744|FG000|Overall Study|Adverse Event|0|||
170618784|NCT00833040|616612745|FG001|Overall Study|Adverse Event|0|||
170618785|NCT00833040|616612746|FG002|Overall Study|Adverse Event|0|||
170618786|NCT00833040|616612747|FG003|Overall Study|Adverse Event|0|||
170618787|NCT00833040|616612748|FG004|Overall Study|Adverse Event|0|||
170618788|NCT00833040|616612749|FG005|Overall Study|Adverse Event|1|||
170618789|NCT02313766|616612750|FG000|Overall Study|surgery cancelled|1|||
170618790|NCT02313766|616612751|FG001|Overall Study|surgery cancelled|0|||
170618791|NCT02313766|616612752|FG002|Overall Study|surgery cancelled|0|||
170618792|NCT02313766|616612750|FG000|Overall Study|Lost to Follow-up|0|||
170618793|NCT02313766|616612751|FG001|Overall Study|Lost to Follow-up|2|||
170618794|NCT02313766|616612752|FG002|Overall Study|Lost to Follow-up|0|||
170618795|NCT02313766|616612750|FG000|Overall Study|Adverse Event|0|||
170618796|NCT02313766|616612751|FG001|Overall Study|Adverse Event|1|||
170618797|NCT02313766|616612752|FG002|Overall Study|Adverse Event|0|||
170618798|NCT00416624|616612755|FG000|Overall Study|Withdrawal by Subject|1|||
170618799|NCT00416624|616612756|FG001|Overall Study|Withdrawal by Subject|6|||
170618800|NCT00416624|616612757|FG002|Overall Study|Withdrawal by Subject|4|||
170618801|NCT00416624|616612758|FG003|Overall Study|Withdrawal by Subject|9|||
170618802|NCT00416624|616612755|FG000|Overall Study|Death|4|||
170618803|NCT00416624|616612756|FG001|Overall Study|Death|7|||
170618804|NCT00416624|616612757|FG002|Overall Study|Death|7|||
170618805|NCT00416624|616612758|FG003|Overall Study|Death|1|||
170618806|NCT00416624|616612755|FG000|Overall Study|Adverse Event|8|||
170618807|NCT00416624|616612756|FG001|Overall Study|Adverse Event|3|||
170618808|NCT00416624|616612757|FG002|Overall Study|Adverse Event|2|||
170618809|NCT00416624|616612758|FG003|Overall Study|Adverse Event|2|||
170618810|NCT00416624|616612755|FG000|Overall Study|Other|8|||
170618811|NCT00416624|616612756|FG001|Overall Study|Other|11|||
170618812|NCT00416624|616612757|FG002|Overall Study|Other|5|||
170618813|NCT00416624|616612758|FG003|Overall Study|Other|5|||
170618814|NCT00416624|616612755|FG000|Overall Study|Cancel|1|||
170618815|NCT00416624|616612756|FG001|Overall Study|Cancel|0|||
170618816|NCT00416624|616612757|FG002|Overall Study|Cancel|0|||
170618817|NCT00416624|616612758|FG003|Overall Study|Cancel|0|||
170618818|NCT01005251|616612759|FG000|Overall Study|Withdrawal by Subject|2|||
170618819|NCT01005251|616612760|FG001|Overall Study|Withdrawal by Subject|5|||
170618820|NCT01005251|616612761|FG002|Overall Study|Withdrawal by Subject|3|||
170618821|NCT01005251|616612762|FG003|Overall Study|Withdrawal by Subject|4|||
170618822|NCT01005251|616612763|FG004|Overall Study|Withdrawal by Subject|9|||
170618823|NCT01005251|616612759|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
170618824|NCT01005251|616612760|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170618825|NCT01005251|616612761|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
170618826|NCT01005251|616612762|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
170618827|NCT01005251|616612763|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
170618828|NCT01005251|616612759|FG000|Overall Study|Adverse Event|2|||
170618829|NCT01005251|616612760|FG001|Overall Study|Adverse Event|6|||
170618830|NCT01005251|616612761|FG002|Overall Study|Adverse Event|8|||
170818932|NCT00091572|617343754|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
170818933|NCT00091572|617343755|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
170818934|NCT00091572|617343754|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
170818935|NCT00091572|617343755|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
170818936|NCT00091572|617343754|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
170818937|NCT00091572|617343755|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
170818938|NCT00091572|617343754|FG000|Overall Study|Other Reason|6|||
170818939|NCT00091572|617343755|FG001|Overall Study|Other Reason|13|||
170818940|NCT00091572|617343754|FG000|Overall Study|Ongoing (still on treatment)|8|||
170818941|NCT00091572|617343755|FG001|Overall Study|Ongoing (still on treatment)|12|||
170818942|NCT00091572|617343754|FG000|Overall Study|Major Protocol Violation|2|||
170618831|NCT01005251|616612762|FG003|Overall Study|Adverse Event|5|||
170618832|NCT01005251|616612763|FG004|Overall Study|Adverse Event|4|||
170618833|NCT01005251|616612759|FG000|Overall Study|Protocol Violation|1|||
170618834|NCT01005251|616612760|FG001|Overall Study|Protocol Violation|0|||
170618835|NCT01005251|616612761|FG002|Overall Study|Protocol Violation|0|||
170618836|NCT01005251|616612762|FG003|Overall Study|Protocol Violation|0|||
170618837|NCT01005251|616612763|FG004|Overall Study|Protocol Violation|2|||
170618838|NCT01005251|616612759|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
170618839|NCT01005251|616612760|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
170818943|NCT00091572|617343755|FG001|Overall Study|Major Protocol Violation|0|||
170818944|NCT00091572|617343754|FG000|Overall Study|Toxicity (Related AE)|53|||
170618840|NCT01005251|616612761|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
170618841|NCT01005251|616612762|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
170618842|NCT01005251|616612763|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
170618843|NCT01005251|616612759|FG000|Overall Study|Lost to Follow-up|1|||
170618844|NCT01005251|616612760|FG001|Overall Study|Lost to Follow-up|4|||
170618845|NCT01005251|616612761|FG002|Overall Study|Lost to Follow-up|2|||
170618846|NCT01005251|616612762|FG003|Overall Study|Lost to Follow-up|0|||
170618847|NCT01005251|616612763|FG004|Overall Study|Lost to Follow-up|0|||
170618848|NCT01005251|616612759|FG000|Overall Study|Physician Decision|0|||
170618849|NCT01005251|616612760|FG001|Overall Study|Physician Decision|0|||
170618850|NCT01005251|616612761|FG002|Overall Study|Physician Decision|0|||
170618851|NCT01005251|616612762|FG003|Overall Study|Physician Decision|0|||
170618852|NCT01005251|616612763|FG004|Overall Study|Physician Decision|2|||
170618853|NCT01005251|616612759|FG000|Overall Study|Patient moved|1|||
170618854|NCT01005251|616612760|FG001|Overall Study|Patient moved|0|||
170618855|NCT01005251|616612761|FG002|Overall Study|Patient moved|0|||
170618856|NCT01005251|616612762|FG003|Overall Study|Patient moved|0|||
170618857|NCT01005251|616612763|FG004|Overall Study|Patient moved|0|||
170618858|NCT01005251|616612759|FG000|Overall Study|Wrong drug dispensed|0|||
170618859|NCT01005251|616612760|FG001|Overall Study|Wrong drug dispensed|1|||
170618860|NCT01005251|616612761|FG002|Overall Study|Wrong drug dispensed|0|||
170618861|NCT01005251|616612762|FG003|Overall Study|Wrong drug dispensed|0|||
170618862|NCT01005251|616612763|FG004|Overall Study|Wrong drug dispensed|0|||
170618863|NCT01005251|616612759|FG000|Overall Study|Randomized in error|0|||
170618864|NCT01005251|616612760|FG001|Overall Study|Randomized in error|0|||
170618865|NCT01005251|616612761|FG002|Overall Study|Randomized in error|1|||
170618866|NCT01005251|616612762|FG003|Overall Study|Randomized in error|1|||
170618867|NCT01005251|616612763|FG004|Overall Study|Randomized in error|0|||
170618868|NCT01005251|616612759|FG000|Overall Study|Lack of Efficacy|0|||
170618869|NCT01005251|616612760|FG001|Overall Study|Lack of Efficacy|0|||
170618870|NCT01005251|616612761|FG002|Overall Study|Lack of Efficacy|1|||
170618871|NCT01005251|616612762|FG003|Overall Study|Lack of Efficacy|1|||
170618872|NCT01005251|616612763|FG004|Overall Study|Lack of Efficacy|0|||
170618873|NCT02193776|616612764|FG000|Overall Study|Consent withdrawn|1|||
170618874|NCT02193776|616612765|FG001|Overall Study|Consent withdrawn|0|||
170618875|NCT02193776|616612766|FG002|Overall Study|Consent withdrawn|0|||
170618876|NCT02193776|616612767|FG003|Overall Study|Consent withdrawn|0|||
170618877|NCT02193776|616612764|FG000|Overall Study|Failure to comply with protocol|0|||
170618878|NCT02193776|616612765|FG001|Overall Study|Failure to comply with protocol|1|||
170618879|NCT02193776|616612766|FG002|Overall Study|Failure to comply with protocol|0|||
170618880|NCT02193776|616612767|FG003|Overall Study|Failure to comply with protocol|0|||
170618881|NCT02193776|616612764|FG000|Overall Study|Investigator/Sponsor decision|1|||
170618882|NCT02193776|616612765|FG001|Overall Study|Investigator/Sponsor decision|1|||
170618883|NCT02193776|616612766|FG002|Overall Study|Investigator/Sponsor decision|0|||
170618884|NCT02193776|616612767|FG003|Overall Study|Investigator/Sponsor decision|0|||
170618885|NCT02193776|616612764|FG000|Overall Study|Death|1|||
170618886|NCT02193776|616612765|FG001|Overall Study|Death|0|||
170618887|NCT02193776|616612766|FG002|Overall Study|Death|0|||
170618888|NCT02193776|616612767|FG003|Overall Study|Death|0|||
170618889|NCT02193776|616612764|FG000|Overall Study|Adverse event/Specific toxicity|5|||
170618890|NCT02193776|616612765|FG001|Overall Study|Adverse event/Specific toxicity|5|||
170618891|NCT02193776|616612766|FG002|Overall Study|Adverse event/Specific toxicity|2|||
170618892|NCT02193776|616612767|FG003|Overall Study|Adverse event/Specific toxicity|2|||
170618893|NCT02995980|616612773|FG000|Overall Study|Lost to Follow-up|14|||
170618894|NCT02711137|616612775|FG000|Overall Study|Death|1|||
170618895|NCT02711137|616612776|FG001|Overall Study|Death|4|||
170618896|NCT02711137|616612777|FG002|Overall Study|Death|5|||
170618897|NCT02711137|616612778|FG003|Overall Study|Death|5|||
170618898|NCT02711137|616612779|FG004|Overall Study|Death|3|||
170618899|NCT02711137|616612780|FG005|Overall Study|Death|1|||
170618900|NCT02711137|616612781|FG006|Overall Study|Death|61|||
170618901|NCT02711137|616612782|FG007|Overall Study|Death|3|||
170618902|NCT02711137|616612783|FG008|Overall Study|Death|0|||
170618903|NCT02711137|616612784|FG009|Overall Study|Death|1|||
170618904|NCT02711137|616612785|FG010|Overall Study|Death|1|||
170618905|NCT02711137|616612786|FG011|Overall Study|Death|1|||
170618906|NCT02711137|616612787|FG012|Overall Study|Death|0|||
170818945|NCT00091572|617343755|FG001|Overall Study|Toxicity (Related AE)|9|||
170618907|NCT02711137|616612788|FG013|Overall Study|Death|0|||
170618908|NCT02711137|616612789|FG014|Overall Study|Death|0|||
170618909|NCT02711137|616612775|FG000|Overall Study|Study Terminated by Sponsor|0|||
170618910|NCT02711137|616612776|FG001|Overall Study|Study Terminated by Sponsor|0|||
170618911|NCT02711137|616612777|FG002|Overall Study|Study Terminated by Sponsor|1|||
170618912|NCT02711137|616612778|FG003|Overall Study|Study Terminated by Sponsor|0|||
170618913|NCT02711137|616612779|FG004|Overall Study|Study Terminated by Sponsor|0|||
170618914|NCT02711137|616612780|FG005|Overall Study|Study Terminated by Sponsor|0|||
170618915|NCT02711137|616612781|FG006|Overall Study|Study Terminated by Sponsor|1|||
170618916|NCT02711137|616612782|FG007|Overall Study|Study Terminated by Sponsor|0|||
170917619|NCT03365882|617698805|FG001|Randomization|Major Protocol Deviation|1|||
170917620|NCT03365882|617698804|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
170917621|NCT03365882|617698805|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
170618917|NCT02711137|616612783|FG008|Overall Study|Study Terminated by Sponsor|0|||
170618918|NCT02711137|616612784|FG009|Overall Study|Study Terminated by Sponsor|0|||
170618919|NCT02711137|616612785|FG010|Overall Study|Study Terminated by Sponsor|0|||
170618920|NCT02711137|616612786|FG011|Overall Study|Study Terminated by Sponsor|0|||
170618921|NCT02711137|616612787|FG012|Overall Study|Study Terminated by Sponsor|0|||
170618922|NCT02711137|616612788|FG013|Overall Study|Study Terminated by Sponsor|0|||
170618923|NCT02711137|616612789|FG014|Overall Study|Study Terminated by Sponsor|0|||
170618924|NCT02711137|616612775|FG000|Overall Study|Physician Decision|1|||
170618925|NCT02711137|616612776|FG001|Overall Study|Physician Decision|0|||
170618926|NCT02711137|616612777|FG002|Overall Study|Physician Decision|2|||
170618927|NCT02711137|616612778|FG003|Overall Study|Physician Decision|1|||
170618928|NCT02711137|616612779|FG004|Overall Study|Physician Decision|1|||
170618929|NCT02711137|616612780|FG005|Overall Study|Physician Decision|0|||
170618930|NCT02711137|616612781|FG006|Overall Study|Physician Decision|12|||
170618931|NCT02711137|616612782|FG007|Overall Study|Physician Decision|2|||
170618932|NCT02711137|616612783|FG008|Overall Study|Physician Decision|1|||
170618933|NCT02711137|616612784|FG009|Overall Study|Physician Decision|1|||
170618934|NCT02711137|616612785|FG010|Overall Study|Physician Decision|3|||
170618935|NCT02711137|616612786|FG011|Overall Study|Physician Decision|2|||
170618936|NCT02711137|616612787|FG012|Overall Study|Physician Decision|1|||
170618937|NCT02711137|616612788|FG013|Overall Study|Physician Decision|1|||
170618938|NCT02711137|616612789|FG014|Overall Study|Physician Decision|2|||
170618939|NCT02711137|616612775|FG000|Overall Study|Other|0|||
170618940|NCT02711137|616612776|FG001|Overall Study|Other|1|||
170618941|NCT02711137|616612777|FG002|Overall Study|Other|0|||
170618942|NCT02711137|616612778|FG003|Overall Study|Other|0|||
170618943|NCT02711137|616612779|FG004|Overall Study|Other|0|||
170618944|NCT02711137|616612780|FG005|Overall Study|Other|0|||
170618945|NCT02711137|616612781|FG006|Overall Study|Other|3|||
170618946|NCT02711137|616612782|FG007|Overall Study|Other|0|||
170618947|NCT02711137|616612783|FG008|Overall Study|Other|0|||
170618948|NCT02711137|616612784|FG009|Overall Study|Other|0|||
170618949|NCT02711137|616612785|FG010|Overall Study|Other|0|||
170618950|NCT02711137|616612786|FG011|Overall Study|Other|0|||
170618951|NCT02711137|616612787|FG012|Overall Study|Other|0|||
170618952|NCT02711137|616612788|FG013|Overall Study|Other|0|||
170618953|NCT02711137|616612789|FG014|Overall Study|Other|1|||
170618954|NCT02711137|616612775|FG000|Overall Study|Withdrawal by Subject|1|||
170618955|NCT02711137|616612776|FG001|Overall Study|Withdrawal by Subject|0|||
170618956|NCT02711137|616612777|FG002|Overall Study|Withdrawal by Subject|0|||
170618957|NCT02711137|616612778|FG003|Overall Study|Withdrawal by Subject|1|||
170618958|NCT02711137|616612779|FG004|Overall Study|Withdrawal by Subject|1|||
170618959|NCT02711137|616612780|FG005|Overall Study|Withdrawal by Subject|0|||
170618960|NCT02711137|616612781|FG006|Overall Study|Withdrawal by Subject|7|||
170618961|NCT02711137|616612782|FG007|Overall Study|Withdrawal by Subject|0|||
170618962|NCT02711137|616612783|FG008|Overall Study|Withdrawal by Subject|0|||
170618963|NCT02711137|616612784|FG009|Overall Study|Withdrawal by Subject|0|||
170618964|NCT02711137|616612785|FG010|Overall Study|Withdrawal by Subject|0|||
170618965|NCT02711137|616612786|FG011|Overall Study|Withdrawal by Subject|0|||
170618966|NCT02711137|616612787|FG012|Overall Study|Withdrawal by Subject|0|||
170618967|NCT02711137|616612788|FG013|Overall Study|Withdrawal by Subject|1|||
170618968|NCT02711137|616612789|FG014|Overall Study|Withdrawal by Subject|0|||
170618969|NCT02711137|616612775|FG000|Overall Study|Lost to Follow-up|1|||
170618970|NCT02711137|616612776|FG001|Overall Study|Lost to Follow-up|0|||
170618971|NCT02711137|616612777|FG002|Overall Study|Lost to Follow-up|0|||
170618972|NCT02711137|616612778|FG003|Overall Study|Lost to Follow-up|0|||
170618973|NCT02711137|616612779|FG004|Overall Study|Lost to Follow-up|0|||
170618974|NCT02711137|616612780|FG005|Overall Study|Lost to Follow-up|0|||
170618975|NCT02711137|616612781|FG006|Overall Study|Lost to Follow-up|2|||
170917622|NCT03365882|617698804|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
170618976|NCT02711137|616612782|FG007|Overall Study|Lost to Follow-up|0|||
170618977|NCT02711137|616612783|FG008|Overall Study|Lost to Follow-up|0|||
170618978|NCT02711137|616612784|FG009|Overall Study|Lost to Follow-up|0|||
170618979|NCT02711137|616612785|FG010|Overall Study|Lost to Follow-up|0|||
170618980|NCT02711137|616612786|FG011|Overall Study|Lost to Follow-up|0|||
170618981|NCT02711137|616612787|FG012|Overall Study|Lost to Follow-up|0|||
170618982|NCT02711137|616612788|FG013|Overall Study|Lost to Follow-up|0|||
170917623|NCT03365882|617698805|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
170618983|NCT02711137|616612789|FG014|Overall Study|Lost to Follow-up|0|||
170618984|NCT01858363|616612792|FG000|Overall Study|Death|35|||
170618985|NCT01858363|616612793|FG001|Overall Study|Death|9|||
170618986|NCT01858363|616612792|FG000|Overall Study|Withdrawal by Subject|28|||
170618987|NCT01858363|616612793|FG001|Overall Study|Withdrawal by Subject|14|||
170618988|NCT01858363|616612792|FG000|Overall Study|Lost to Follow-up|13|||
170618989|NCT01858363|616612793|FG001|Overall Study|Lost to Follow-up|3|||
170618990|NCT01859923|616612800|FG000|Overall Study|Adverse Event|0|||
170618991|NCT01859923|616612801|FG001|Overall Study|Adverse Event|0|||
170618992|NCT01859923|616612802|FG002|Overall Study|Adverse Event|1|||
170618993|NCT01859923|616612803|FG003|Overall Study|Adverse Event|1|||
170618994|NCT03634085|616612804|FG000|Overall Study|Adverse Event|1|||
170618995|NCT03634085|616612805|FG001|Overall Study|Adverse Event|0|||
170618996|NCT03634085|616612804|FG000|Overall Study|Withdrawal by Subject|0|||
170618997|NCT03634085|616612805|FG001|Overall Study|Withdrawal by Subject|2|||
170618998|NCT04276233|616612806|FG000|Overall Study|Adverse Event|1|||
170618999|NCT04276233|616612806|FG000|Overall Study|Lost to Follow-up|3|||
170619000|NCT04276233|616612806|FG000|Overall Study|Physician Decision|4|||
170619001|NCT04276233|616612806|FG000|Overall Study|Withdrawal by Subject|2|||
170619002|NCT00985465|616612811|FG000|Overall Study|Withdrawal by Subject|1|||
170619003|NCT00985465|616612812|FG001|Overall Study|Withdrawal by Subject|2|||
170619004|NCT00985465|616612811|FG000|Overall Study|Considered to be part of the other group|0|||
170619005|NCT00985465|616612812|FG001|Overall Study|Considered to be part of the other group|1|||
170619006|NCT01054456|616612813|FG000|Overall Study|Other|1|||
170619007|NCT03259555|616612814|FG000|Overall Study|Adverse Event|6|||
170619008|NCT03259555|616612815|FG001|Overall Study|Adverse Event|4|||
170619009|NCT03259555|616612814|FG000|Overall Study|Lack of Efficacy|6|||
170619010|NCT03259555|616612815|FG001|Overall Study|Lack of Efficacy|4|||
170619011|NCT03259555|616612814|FG000|Overall Study|Lost to Follow-up|0|||
170619012|NCT03259555|616612815|FG001|Overall Study|Lost to Follow-up|2|||
170619013|NCT03259555|616612814|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170619014|NCT03259555|616612815|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170619015|NCT03259555|616612814|FG000|Overall Study|Progressive Disease|0|||
170619016|NCT03259555|616612815|FG001|Overall Study|Progressive Disease|2|||
170619017|NCT03259555|616612814|FG000|Overall Study|Withdrawal by Subject|19|||
170619018|NCT03259555|616612815|FG001|Overall Study|Withdrawal by Subject|16|||
170619019|NCT03259555|616612814|FG000|Overall Study|Physician Decision|1|||
170619020|NCT03259555|616612815|FG001|Overall Study|Physician Decision|2|||
170619021|NCT03259555|616612814|FG000|Overall Study|Other|1|||
170619022|NCT03259555|616612815|FG001|Overall Study|Other|0|||
170619023|NCT02717494|616612816|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
170619024|NCT02717494|616612817|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
170619025|NCT02717494|616612818|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
170619026|NCT02717494|616612816|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
170619027|NCT02717494|616612817|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
170619028|NCT02717494|616612818|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
170619029|NCT02717494|616612816|FG000|First Intervention (Step 1)|Death|0|||
170619030|NCT02717494|616612817|FG001|First Intervention (Step 1)|Death|0|||
170619031|NCT02717494|616612818|FG002|First Intervention (Step 1)|Death|1|||
170619032|NCT02717494|616612816|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
170619033|NCT02717494|616612817|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
170619034|NCT02717494|616612818|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
170619035|NCT01774799|616612821|FG000|Overall Study|Lost to Follow-up|1|||
170619036|NCT01774799|616612822|FG001|Overall Study|Lost to Follow-up|1|||
170619037|NCT01774799|616612823|FG002|Overall Study|Lost to Follow-up|0|||
170619038|NCT01774799|616612824|FG003|Overall Study|Lost to Follow-up|0|||
170619039|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
170619040|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
170619041|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
170619042|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
170619043|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
170619044|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
170619045|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
170619046|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
170619047|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
170619048|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
170619049|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
170619050|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
170619051|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
170619052|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
170619053|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
170619054|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
170619055|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
170619056|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
170619057|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
170619058|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
170619059|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
170619060|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
170619061|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
170619062|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
170619063|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
170619064|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
170619065|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
170619066|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
170619067|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
170619068|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
170619069|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
170619070|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
170619071|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
170619072|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
170619073|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
170619074|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
170619075|NCT02586623|616612825|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
170619076|NCT02586623|616612826|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
170619077|NCT02586623|616612827|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
170619078|NCT02586623|616612825|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
170619079|NCT02586623|616612826|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
170619080|NCT02586623|616612827|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
170619081|NCT02586623|616612825|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
170619082|NCT02586623|616612826|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
170619083|NCT02586623|616612827|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
170619084|NCT02586623|616612825|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
170619085|NCT02586623|616612826|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
170619086|NCT02586623|616612827|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
170619087|NCT02586623|616612825|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
170619088|NCT02586623|616612826|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
170619089|NCT02586623|616612827|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
170619090|NCT02586623|616612825|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
170619091|NCT02586623|616612826|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
170619092|NCT02586623|616612827|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
170619093|NCT02586623|616612825|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
170619094|NCT02586623|616612826|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
170619095|NCT02586623|616612827|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
170619096|NCT02586623|616612825|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
170619097|NCT02586623|616612826|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
170619098|NCT02586623|616612827|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
170619099|NCT02586623|616612825|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
170619100|NCT02586623|616612826|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
170619101|NCT02586623|616612827|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
170619102|NCT02910466|616612830|FG000|Overall Study|Adverse Event|1|||
170619103|NCT02910466|616612830|FG000|Overall Study|Withdrawal by Subject|3|||
170619104|NCT02910466|616612830|FG000|Overall Study|Lost to Follow-up|5|||
170619105|NCT02910466|616612830|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
170619106|NCT02910466|616612830|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
170619107|NCT05051579|616612833|FG000|Overall Study|Withdrawal by Subject|3|||
170619108|NCT05051579|616612834|FG001|Overall Study|Withdrawal by Subject|5|||
170619109|NCT05051579|616612835|FG002|Overall Study|Withdrawal by Subject|2|||
170619110|NCT05051579|616612836|FG003|Overall Study|Withdrawal by Subject|1|||
170619111|NCT05051579|616612837|FG004|Overall Study|Withdrawal by Subject|4|||
170619112|NCT05051579|616612838|FG005|Overall Study|Withdrawal by Subject|0|||
170619113|NCT05051579|616612839|FG006|Overall Study|Withdrawal by Subject|4|||
170619114|NCT05051579|616612833|FG000|Overall Study|Lost to Follow-up|1|||
170619115|NCT05051579|616612834|FG001|Overall Study|Lost to Follow-up|0|||
170619116|NCT05051579|616612835|FG002|Overall Study|Lost to Follow-up|0|||
170619117|NCT05051579|616612836|FG003|Overall Study|Lost to Follow-up|0|||
170619118|NCT05051579|616612837|FG004|Overall Study|Lost to Follow-up|1|||
170619119|NCT05051579|616612838|FG005|Overall Study|Lost to Follow-up|0|||
170619120|NCT05051579|616612839|FG006|Overall Study|Lost to Follow-up|1|||
170669023|NCT00142298|616799548|FG009|Overall Study|Death|0|||
170818946|NCT00088452|617345732|FG000|Overall Study|Did not receive intervention|1|||
170619121|NCT05051579|616612833|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
170619122|NCT05051579|616612834|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
170619123|NCT05051579|616612835|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
170669024|NCT00142298|616799539|FG000|Overall Study|Lack of Efficacy|44|||
170669025|NCT00142298|616799540|FG001|Overall Study|Lack of Efficacy|62|||
170818947|NCT00088452|617345733|FG001|Overall Study|Did not receive intervention|0|||
170818948|NCT00088452|617345734|FG002|Overall Study|Did not receive intervention|1|||
170818949|NCT01184859|617345735|FG000|Period 1: Single Dose|Insufficient urine production|0|||
170818950|NCT01184859|617345736|FG001|Period 1: Single Dose|Insufficient urine production|1|||
170818951|NCT01184859|617345737|FG002|Period 1: Single Dose|Insufficient urine production|0|||
170619124|NCT05051579|616612836|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
170619125|NCT05051579|616612837|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
170619126|NCT05051579|616612838|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
170619127|NCT05051579|616612839|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
170619128|NCT05051579|616612833|FG000|Overall Study|Adverse Event|2|||
170619129|NCT05051579|616612834|FG001|Overall Study|Adverse Event|1|||
170619130|NCT05051579|616612835|FG002|Overall Study|Adverse Event|0|||
170619131|NCT05051579|616612836|FG003|Overall Study|Adverse Event|4|||
170619132|NCT05051579|616612837|FG004|Overall Study|Adverse Event|1|||
170619133|NCT05051579|616612838|FG005|Overall Study|Adverse Event|2|||
170619134|NCT05051579|616612839|FG006|Overall Study|Adverse Event|0|||
170619135|NCT05051579|616612833|FG000|Overall Study|Inadvertent Enrollment|0|||
170619136|NCT05051579|616612834|FG001|Overall Study|Inadvertent Enrollment|0|||
170619137|NCT05051579|616612835|FG002|Overall Study|Inadvertent Enrollment|0|||
170619138|NCT05051579|616612836|FG003|Overall Study|Inadvertent Enrollment|0|||
170619139|NCT05051579|616612837|FG004|Overall Study|Inadvertent Enrollment|0|||
170619140|NCT05051579|616612838|FG005|Overall Study|Inadvertent Enrollment|0|||
170619141|NCT05051579|616612839|FG006|Overall Study|Inadvertent Enrollment|1|||
170619142|NCT05051579|616612833|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
170619143|NCT05051579|616612834|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
170619144|NCT05051579|616612835|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
170619145|NCT05051579|616612836|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
170619146|NCT05051579|616612837|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
170619147|NCT05051579|616612838|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
170619148|NCT05051579|616612839|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
170619149|NCT05051579|616612833|FG000|Overall Study|Sponsor Decision|0|||
170619150|NCT05051579|616612834|FG001|Overall Study|Sponsor Decision|0|||
170619151|NCT05051579|616612835|FG002|Overall Study|Sponsor Decision|0|||
170619152|NCT05051579|616612836|FG003|Overall Study|Sponsor Decision|0|||
170619153|NCT05051579|616612837|FG004|Overall Study|Sponsor Decision|1|||
170619154|NCT05051579|616612838|FG005|Overall Study|Sponsor Decision|0|||
170619155|NCT05051579|616612839|FG006|Overall Study|Sponsor Decision|0|||
170619156|NCT05051579|616612833|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
170619157|NCT05051579|616612834|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
170619158|NCT05051579|616612835|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
170619159|NCT05051579|616612836|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
170619160|NCT05051579|616612837|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
170619161|NCT05051579|616612838|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
170619162|NCT05051579|616612839|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
170619163|NCT01116648|616612842|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
170619164|NCT01116648|616612843|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
170619165|NCT01116648|616612844|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
170619166|NCT01116648|616612845|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
170619167|NCT01116648|616612846|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
170818952|NCT01184859|617345738|FG003|Period 1: Single Dose|Insufficient urine production|0|||
170818953|NCT01184859|617345739|FG004|Period 1: Single Dose|Insufficient urine production|0|||
170818954|NCT01184859|617345735|FG000|Period 1: Single Dose|Protocol Violation|0|||
170818955|NCT01184859|617345736|FG001|Period 1: Single Dose|Protocol Violation|1|||
170818956|NCT01184859|617345737|FG002|Period 1: Single Dose|Protocol Violation|0|||
170818957|NCT01184859|617345738|FG003|Period 1: Single Dose|Protocol Violation|0|||
170818958|NCT01184859|617345739|FG004|Period 1: Single Dose|Protocol Violation|0|||
170818959|NCT01184859|617345735|FG000|Period 1: Single Dose|Adverse Event|0|||
170818960|NCT01184859|617345736|FG001|Period 1: Single Dose|Adverse Event|0|||
170818961|NCT01184859|617345737|FG002|Period 1: Single Dose|Adverse Event|0|||
170818962|NCT01184859|617345738|FG003|Period 1: Single Dose|Adverse Event|0|||
170818963|NCT01184859|617345739|FG004|Period 1: Single Dose|Adverse Event|1|||
170818964|NCT01184859|617345735|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
170818965|NCT01184859|617345736|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
170818966|NCT01184859|617345737|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
170818967|NCT01184859|617345738|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
170818968|NCT01184859|617345739|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
170818969|NCT01184859|617345735|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
170818970|NCT01184859|617345736|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
170818971|NCT01184859|617345737|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
170619168|NCT01116648|616612847|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
170818972|NCT01184859|617345738|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
170619169|NCT01116648|616612848|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
170619170|NCT01116648|616612849|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
170619171|NCT01116648|616612850|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
170619172|NCT01116648|616612851|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
170619173|NCT01116648|616612852|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
170619174|NCT01116648|616612853|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
170619175|NCT01116648|616612854|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
170619176|NCT01116648|616612855|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
170619177|NCT01116648|616612856|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
170619178|NCT04539938|616612857|FG000|Overall Study|Death|30|||
170619179|NCT04539938|616612857|FG000|Overall Study|Withdrawal by Subject|4|||
170619180|NCT04037891|616612858|FG000|Open-label Period|Withdrawal by Subject|1|||
170619181|NCT04037891|616612859|FG001|Open-label Period|Withdrawal by Subject|0|||
170619182|NCT04037891|616612860|FG002|Open-label Period|Withdrawal by Subject|0|||
170619183|NCT04037891|616612858|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
170619184|NCT04037891|616612859|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
170619185|NCT04037891|616612860|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
170619186|NCT00990106|616612861|FG000|Overall Study|"too busy to continue"|1|||
170619187|NCT00990106|616612862|FG001|Overall Study|"too busy to continue"|2|||
170619188|NCT00990106|616612861|FG000|Overall Study|Lost to Follow-up|1|||
170619189|NCT00990106|616612862|FG001|Overall Study|Lost to Follow-up|3|||
170619190|NCT00990106|616612861|FG000|Overall Study|Withdrawal by Subject|2|||
170619191|NCT00990106|616612862|FG001|Overall Study|Withdrawal by Subject|1|||
170619192|NCT00990106|616612861|FG000|Overall Study|opted for open label prazosin|1|||
170619193|NCT00990106|616612862|FG001|Overall Study|opted for open label prazosin|1|||
170619194|NCT00990106|616612861|FG000|Overall Study|relocation/deployment|4|||
170619195|NCT00990106|616612862|FG001|Overall Study|relocation/deployment|1|||
170619196|NCT00990106|616612861|FG000|Overall Study|started exclusionary medication|0|||
170619197|NCT00990106|616612862|FG001|Overall Study|started exclusionary medication|1|||
170619198|NCT00990106|616612861|FG000|Overall Study|planned major surgery|0|||
170619199|NCT00990106|616612862|FG001|Overall Study|planned major surgery|1|||
170619200|NCT00990106|616612861|FG000|Overall Study|scheduling conflicts|0|||
170619201|NCT00990106|616612862|FG001|Overall Study|scheduling conflicts|2|||
170619202|NCT04194944|616612863|FG000|Overall Study|Lost to Follow-up|3|||
170619203|NCT04194944|616612864|FG001|Overall Study|Lost to Follow-up|0|||
170619204|NCT04194944|616612863|FG000|Overall Study|Withdrawal by Subject|2|||
170619205|NCT04194944|616612864|FG001|Overall Study|Withdrawal by Subject|2|||
170619206|NCT04194944|616612863|FG000|Overall Study|On Treatment|93|||
170619207|NCT04194944|616612864|FG001|Overall Study|On Treatment|30|||
170619208|NCT05274958|616612865|FG000|Overall Study|Only completed 1 set of PROMs|22|||
170619209|NCT05274958|616612866|FG001|Overall Study|Only completed 1 set of PROMs|35|||
170619210|NCT02539797|616612869|FG000|Overall Study|Lost to Follow-up|0|||
170619211|NCT02539797|616612870|FG001|Overall Study|Lost to Follow-up|1|||
170619212|NCT02539797|616612871|FG002|Overall Study|Lost to Follow-up|0|||
170619213|NCT06235905|616612872|FG000|Overall Study|Adverse Event|1|||
170619214|NCT06235905|616612872|FG000|Overall Study|Non-compliant with protocol procedures|1|||
170619215|NCT00398320|616612874|FG000|Overall Study|Death|1|||
170619216|NCT00398320|616612874|FG000|Overall Study|Adverse Event|4|||
170619217|NCT00398320|616612874|FG000|Overall Study|Physician Decision|1|||
170619218|NCT00348673|616612875|FG000|Stage 1|Randomized but not Treated|0|||
170619219|NCT00348673|616612876|FG001|Stage 1|Randomized but not Treated|0|||
170619220|NCT00348673|616612877|FG002|Stage 1|Randomized but not Treated|1|||
170619221|NCT00348673|616612878|FG003|Stage 1|Randomized but not Treated|0|||
170619222|NCT00348673|616612879|FG004|Stage 1|Randomized but not Treated|0|||
170619223|NCT00348673|616612880|FG005|Stage 1|Randomized but not Treated|0|||
170619224|NCT00348673|616612881|FG006|Stage 1|Randomized but not Treated|0|||
170619225|NCT00348673|616612882|FG007|Stage 1|Randomized but not Treated|0|||
170619226|NCT00348673|616612883|FG008|Stage 1|Randomized but not Treated|0|||
170619227|NCT00291486|616612887|FG000|Overall Study|Adverse Event|0|||
170619228|NCT00291486|616612888|FG001|Overall Study|Adverse Event|3|||
170818973|NCT01184859|617345739|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
170818974|NCT02514577|617345740|FG000|Overall Study|Lost to Follow-up|6|||
170818975|NCT02514577|617345741|FG001|Overall Study|Lost to Follow-up|6|||
170818976|NCT02514577|617345740|FG000|Overall Study|Protocol Violation|1|||
170818977|NCT02514577|617345741|FG001|Overall Study|Protocol Violation|0|||
170818978|NCT02514577|617345740|FG000|Overall Study|Withdrawal by Subject|6|||
170818979|NCT02514577|617345741|FG001|Overall Study|Withdrawal by Subject|6|||
170818980|NCT02514577|617345740|FG000|Overall Study|Adverse Event|1|||
170619229|NCT00291486|616612889|FG002|Overall Study|Adverse Event|0|||
170818981|NCT02514577|617345741|FG001|Overall Study|Adverse Event|1|||
170818982|NCT00958711|617345742|FG000|Overall Study|Withdrawal by Subject|0|||
170619230|NCT00291486|616612890|FG003|Overall Study|Adverse Event|1|||
170619231|NCT00291486|616612891|FG004|Overall Study|Adverse Event|0|||
170619232|NCT00291486|616612887|FG000|Overall Study|Withdrawal by Subject|0|||
170619233|NCT00291486|616612888|FG001|Overall Study|Withdrawal by Subject|0|||
170619234|NCT00291486|616612889|FG002|Overall Study|Withdrawal by Subject|0|||
170619235|NCT00291486|616612890|FG003|Overall Study|Withdrawal by Subject|0|||
170619236|NCT00291486|616612891|FG004|Overall Study|Withdrawal by Subject|1|||
170619237|NCT00291486|616612887|FG000|Overall Study|Disease progression|1|||
170619238|NCT00291486|616612888|FG001|Overall Study|Disease progression|0|||
170619239|NCT00291486|616612889|FG002|Overall Study|Disease progression|1|||
170619240|NCT00291486|616612890|FG003|Overall Study|Disease progression|0|||
170619241|NCT00291486|616612891|FG004|Overall Study|Disease progression|0|||
170619242|NCT00320515|616612896|FG000|Overall Study|Death|33|||
170619243|NCT00320515|616612896|FG000|Overall Study|Lost to Follow-up|6|||
170619244|NCT00320515|616612896|FG000|Overall Study|Physician Decision|2|||
170619245|NCT00320515|616612896|FG000|Overall Study|Withdrawal by Subject|8|||
170619246|NCT01114828|616612897|FG000|Overall Study|Adverse Event|1|||
170619247|NCT01114828|616612898|FG001|Overall Study|Adverse Event|1|||
170619248|NCT01114828|616612897|FG000|Overall Study|Lack of Efficacy|0|||
170619249|NCT01114828|616612898|FG001|Overall Study|Lack of Efficacy|2|||
170619250|NCT01114828|616612897|FG000|Overall Study|Protocol Violation|2|||
170619251|NCT01114828|616612898|FG001|Overall Study|Protocol Violation|0|||
170619252|NCT01114828|616612897|FG000|Overall Study|Withdrawal by Subject|0|||
170619253|NCT01114828|616612898|FG001|Overall Study|Withdrawal by Subject|1|||
170619254|NCT00794950|616612899|FG000|BCG Induction|Withdrawal by Subject|2|||
170619255|NCT00794950|616612899|FG000|BCG Induction|ineligible|3|||
170619256|NCT00794950|616612899|FG000|BCG Induction|noncompliant w. BCG|1|||
170619257|NCT00794950|616612899|FG000|BCG Induction|Adverse Event|1|||
170619258|NCT00794950|616612899|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
170619259|NCT00794950|616612899|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
170619260|NCT00794950|616612899|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
170619261|NCT00794950|616612899|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
170619262|NCT02485704|616612900|FG000|Overall Study|Lost to Follow-up|4|||
170619263|NCT02485704|616612901|FG001|Overall Study|Lost to Follow-up|5|||
170619264|NCT02485704|616612900|FG000|Overall Study|Withdrawal by Subject|0|||
170619265|NCT02485704|616612901|FG001|Overall Study|Withdrawal by Subject|3|||
170619266|NCT02485704|616612900|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
170619267|NCT02485704|616612901|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
170619268|NCT00851786|616612904|FG000|Overall Study|Withdrawal by Subject|0|||
170619269|NCT00851786|616612905|FG001|Overall Study|Withdrawal by Subject|1|||
170619270|NCT00851786|616612904|FG000|Overall Study|Protocol Violation|0|||
170619271|NCT00851786|616612905|FG001|Overall Study|Protocol Violation|1|||
170619272|NCT00851786|616612904|FG000|Overall Study|Lost to Follow-up|1|||
170619273|NCT00851786|616612905|FG001|Overall Study|Lost to Follow-up|0|||
170619274|NCT00851786|616612904|FG000|Overall Study|Incarceration|1|||
170619275|NCT00851786|616612905|FG001|Overall Study|Incarceration|0|||
170619276|NCT00851786|616612904|FG000|Overall Study|Site Closure|1|||
170619277|NCT00851786|616612905|FG001|Overall Study|Site Closure|0|||
170619278|NCT00851786|616612904|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
170619279|NCT00851786|616612905|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
170619280|NCT01223183|616612912|FG000|Imaging Day 1|Physician Decision|0|||
170619281|NCT01223183|616612913|FG001|Imaging Day 1|Physician Decision|1|||
170619282|NCT01223183|616612912|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
170619283|NCT01223183|616612913|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
170619284|NCT01223183|616612912|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
170619285|NCT01223183|616612913|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
170619286|NCT04177212|616612914|FG000|Overall Study|Withdrawal by Subject|9|||
170619287|NCT04177212|616612915|FG001|Overall Study|Withdrawal by Subject|7|||
170619288|NCT04177212|616612914|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
170619289|NCT04177212|616612915|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
170619290|NCT04177212|616612914|FG000|Overall Study|Physician Decision|1|||
170619291|NCT04177212|616612915|FG001|Overall Study|Physician Decision|0|||
170619292|NCT04177212|616612914|FG000|Overall Study|Lost to Follow-up|0|||
170619293|NCT04177212|616612915|FG001|Overall Study|Lost to Follow-up|3|||
170619294|NCT04177212|616612914|FG000|Overall Study|Adverse Event|0|||
170619295|NCT04177212|616612915|FG001|Overall Study|Adverse Event|1|||
170619296|NCT04177212|616612914|FG000|Overall Study|Other|1|||
170619297|NCT04177212|616612915|FG001|Overall Study|Other|2|||
170619298|NCT01792115|616612916|FG000|Overall Study|Lost to Follow-up|0|||
170619299|NCT01792115|616612917|FG001|Overall Study|Lost to Follow-up|1|||
170619300|NCT01792115|616612918|FG002|Overall Study|Lost to Follow-up|0|||
170619301|NCT03798717|616614870|FG000|Overall Study|Failed Screening|0|||
170818983|NCT00958711|617345743|FG001|Overall Study|Withdrawal by Subject|4|||
170818984|NCT00958711|617345742|FG000|Overall Study|Physician Decision|5|||
170818985|NCT00958711|617345743|FG001|Overall Study|Physician Decision|7|||
170818986|NCT00958711|617345742|FG000|Overall Study|Lost to Follow-up|4|||
170818987|NCT00958711|617345743|FG001|Overall Study|Lost to Follow-up|1|||
170818988|NCT00958711|617345742|FG000|Overall Study|Other|2|||
170818989|NCT00958711|617345743|FG001|Overall Study|Other|5|||
170619302|NCT03798717|616614871|FG001|Overall Study|Failed Screening|0|||
170619303|NCT03798717|616614872|FG002|Overall Study|Failed Screening|0|||
170619304|NCT03798717|616614873|FG003|Overall Study|Failed Screening|0|||
170619305|NCT03798717|616614874|FG004|Overall Study|Failed Screening|0|||
170619306|NCT03798717|616614875|FG005|Overall Study|Failed Screening|1|||
170619307|NCT03798717|616614870|FG000|Overall Study|Physician Decision|1|||
170619308|NCT03798717|616614871|FG001|Overall Study|Physician Decision|0|||
170619309|NCT03798717|616614872|FG002|Overall Study|Physician Decision|1|||
170619310|NCT03798717|616614873|FG003|Overall Study|Physician Decision|0|||
170619311|NCT03798717|616614874|FG004|Overall Study|Physician Decision|0|||
170619312|NCT03798717|616614875|FG005|Overall Study|Physician Decision|0|||
170619313|NCT03798717|616614870|FG000|Overall Study|Withdrawal by Subject|0|||
170619314|NCT03798717|616614871|FG001|Overall Study|Withdrawal by Subject|0|||
170619315|NCT03798717|616614872|FG002|Overall Study|Withdrawal by Subject|0|||
170619316|NCT03798717|616614873|FG003|Overall Study|Withdrawal by Subject|1|||
170619317|NCT03798717|616614874|FG004|Overall Study|Withdrawal by Subject|0|||
170619318|NCT03798717|616614875|FG005|Overall Study|Withdrawal by Subject|0|||
170619319|NCT03798717|616614870|FG000|Overall Study|Lost to Follow-up|1|||
170619320|NCT03798717|616614871|FG001|Overall Study|Lost to Follow-up|0|||
170619321|NCT03798717|616614872|FG002|Overall Study|Lost to Follow-up|0|||
170619322|NCT03798717|616614873|FG003|Overall Study|Lost to Follow-up|1|||
170619323|NCT03798717|616614874|FG004|Overall Study|Lost to Follow-up|0|||
170619324|NCT03798717|616614875|FG005|Overall Study|Lost to Follow-up|0|||
170619325|NCT03798717|616614870|FG000|Overall Study|Adverse Event|0|||
170619326|NCT03798717|616614871|FG001|Overall Study|Adverse Event|1|||
170619327|NCT03798717|616614872|FG002|Overall Study|Adverse Event|0|||
170619328|NCT03798717|616614873|FG003|Overall Study|Adverse Event|0|||
170619329|NCT03798717|616614874|FG004|Overall Study|Adverse Event|0|||
170619330|NCT03798717|616614875|FG005|Overall Study|Adverse Event|0|||
170619331|NCT03798717|616614870|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
170619332|NCT03798717|616614871|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
170619333|NCT03798717|616614872|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
170619334|NCT03798717|616614873|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
170619335|NCT03798717|616614874|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
170619336|NCT03798717|616614875|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
170619337|NCT00865345|616614876|FG000|Overall Study|Withdrawal by Subject|2|||
170619338|NCT01519323|616614877|FG000|Overall Study|Death|3|||
170619339|NCT01519323|616614878|FG001|Overall Study|Death|2|||
170619340|NCT01519323|616614877|FG000|Overall Study|Study terminated by sponsor|0|||
170619341|NCT01519323|616614878|FG001|Overall Study|Study terminated by sponsor|1|||
170619342|NCT00966654|616614886|FG000|Overall Study|Study was terminated,PI left institution|12|||
170818990|NCT00958711|617345742|FG000|Overall Study|Death|1|||
170818991|NCT00958711|617345743|FG001|Overall Study|Death|2|||
170818992|NCT00958711|617345742|FG000|Overall Study|Adverse Event|1|||
170818993|NCT00958711|617345743|FG001|Overall Study|Adverse Event|2|||
170818994|NCT04523571|617345747|FG000|Received 2 Doses|Withdrawal by Subject|0|||
170818995|NCT04523571|617345748|FG001|Received 2 Doses|Withdrawal by Subject|0|||
170818996|NCT04523571|617345749|FG002|Received 2 Doses|Withdrawal by Subject|0|||
170818997|NCT04523571|617345750|FG003|Received 2 Doses|Withdrawal by Subject|1|||
170818998|NCT04523571|617345751|FG004|Received 2 Doses|Withdrawal by Subject|1|||
170818999|NCT04523571|617345752|FG005|Received 2 Doses|Withdrawal by Subject|0|||
170819000|NCT04523571|617345747|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
170819001|NCT04523571|617345748|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
170819002|NCT04523571|617345749|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
170819003|NCT04523571|617345750|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
170819004|NCT04523571|617345751|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
170819005|NCT04523571|617345752|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
170819006|NCT04523571|617345747|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
170819007|NCT04523571|617345748|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
170819008|NCT04523571|617345749|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
170819009|NCT04523571|617345750|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
170819010|NCT04523571|617345751|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
170819011|NCT04523571|617345752|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
170819012|NCT04523571|617345747|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
170819013|NCT04523571|617345748|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
170819014|NCT04523571|617345749|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
170819015|NCT04523571|617345750|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
170819016|NCT04523571|617345751|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
170819017|NCT04523571|617345752|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
170819018|NCT03087851|617345753|FG000|Overall Study|Withdraw on medical grounds|0|||
170819019|NCT03087851|617345754|FG001|Overall Study|Withdraw on medical grounds|1|||
170819020|NCT03087851|617345755|FG002|Overall Study|Withdraw on medical grounds|2|||
170819021|NCT04049578|617345756|FG000|Overall Study|Physician Decision|1|||
170819022|NCT00644332|617345757|FG000|Overall Study|Adverse Event|11|||
170619343|NCT01600326|616614889|FG000|Overall Study|Lost to Follow-up|1|||
170619344|NCT01600326|616614890|FG001|Overall Study|Lost to Follow-up|1|||
170619345|NCT02079740|616614891|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
170619346|NCT02079740|616614892|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
170619347|NCT02079740|616614893|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
170619348|NCT02079740|616614894|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
170619349|NCT02079740|616614895|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
170619350|NCT02079740|616614896|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
170619351|NCT02079740|616614897|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
170619352|NCT02079740|616614898|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
170619353|NCT02079740|616614899|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
170619354|NCT02079740|616614900|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
170619355|NCT02079740|616614901|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
170619356|NCT02079740|616614902|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
170619357|NCT02079740|616614903|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
170619358|NCT02079740|616614891|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
170619359|NCT02079740|616614892|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
170619360|NCT02079740|616614893|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
170619361|NCT02079740|616614894|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
170619362|NCT02079740|616614895|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
170619363|NCT02079740|616614896|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
170619364|NCT02079740|616614897|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
170619365|NCT02079740|616614898|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
170619366|NCT02079740|616614899|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
170619367|NCT02079740|616614900|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
170619368|NCT02079740|616614901|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
170619369|NCT02079740|616614902|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
170619370|NCT02079740|616614903|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
170619371|NCT02079740|616614891|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619372|NCT02079740|616614892|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619373|NCT02079740|616614893|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619374|NCT02079740|616614894|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619375|NCT02079740|616614895|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619376|NCT02079740|616614896|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619377|NCT02079740|616614897|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619378|NCT02079740|616614898|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
170619379|NCT02079740|616614899|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619380|NCT02079740|616614900|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619381|NCT02079740|616614901|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619382|NCT02079740|616614902|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619383|NCT02079740|616614903|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
170619384|NCT02079740|616614891|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619385|NCT02079740|616614892|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619386|NCT02079740|616614893|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619387|NCT02079740|616614894|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619388|NCT02079740|616614895|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619389|NCT02079740|616614896|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619390|NCT02079740|616614897|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619391|NCT02079740|616614898|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
170619392|NCT02079740|616614899|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619393|NCT02079740|616614900|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619394|NCT02079740|616614901|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619395|NCT02079740|616614902|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619396|NCT02079740|616614903|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
170619397|NCT02079740|616614891|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619398|NCT02079740|616614892|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619399|NCT02079740|616614893|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619400|NCT02079740|616614894|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619401|NCT02079740|616614895|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619402|NCT02079740|616614896|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619403|NCT02079740|616614897|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619404|NCT02079740|616614898|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619405|NCT02079740|616614899|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619406|NCT02079740|616614900|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
170619407|NCT02079740|616614901|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
170619408|NCT02079740|616614902|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
170619409|NCT02079740|616614903|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
170619410|NCT04617782|616614904|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
170619411|NCT04617782|616614904|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
170669026|NCT00142298|616799541|FG002|Overall Study|Lack of Efficacy|9|||
170669027|NCT00142298|616799542|FG003|Overall Study|Lack of Efficacy|12|||
170669028|NCT00142298|616799543|FG004|Overall Study|Lack of Efficacy|1|||
170669029|NCT00142298|616799544|FG005|Overall Study|Lack of Efficacy|0|||
170669030|NCT00142298|616799545|FG006|Overall Study|Lack of Efficacy|0|||
170669031|NCT00142298|616799546|FG007|Overall Study|Lack of Efficacy|1|||
170669032|NCT00142298|616799547|FG008|Overall Study|Lack of Efficacy|0|||
170669033|NCT00142298|616799548|FG009|Overall Study|Lack of Efficacy|0|||
170669034|NCT00142298|616799539|FG000|Overall Study|Non-compliance|15|||
170669035|NCT00142298|616799540|FG001|Overall Study|Non-compliance|13|||
170669036|NCT00142298|616799541|FG002|Overall Study|Non-compliance|0|||
170669037|NCT00142298|616799542|FG003|Overall Study|Non-compliance|6|||
170669038|NCT00142298|616799543|FG004|Overall Study|Non-compliance|1|||
170669039|NCT00142298|616799544|FG005|Overall Study|Non-compliance|0|||
170669040|NCT00142298|616799545|FG006|Overall Study|Non-compliance|0|||
170669041|NCT00142298|616799546|FG007|Overall Study|Non-compliance|3|||
170669042|NCT00142298|616799547|FG008|Overall Study|Non-compliance|3|||
170669043|NCT00142298|616799548|FG009|Overall Study|Non-compliance|0|||
170669044|NCT00142298|616799539|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
170669045|NCT00142298|616799540|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
170669046|NCT00142298|616799541|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
170669047|NCT00142298|616799542|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
170669048|NCT00142298|616799543|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
170669049|NCT00142298|616799544|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
170669050|NCT00142298|616799545|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
170669051|NCT00142298|616799546|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
170669052|NCT00142298|616799547|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
170669053|NCT00142298|616799548|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
170619412|NCT04617782|616614904|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
170619413|NCT04617782|616614904|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
170619414|NCT04617782|616614904|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
170619415|NCT04617782|616614904|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
170619416|NCT04388111|616614909|FG000|Overall Study|Lost to Follow-up|5|||
170619417|NCT04388111|616614910|FG001|Overall Study|Lost to Follow-up|3|||
170619418|NCT04388111|616614909|FG000|Overall Study|Adverse Event|1|||
170619419|NCT04388111|616614910|FG001|Overall Study|Adverse Event|1|||
170619420|NCT04388111|616614909|FG000|Overall Study|Protocol Violation|2|||
170619421|NCT04388111|616614910|FG001|Overall Study|Protocol Violation|4|||
170619422|NCT04388111|616614909|FG000|Overall Study|Withdrawal by Subject|1|||
170619423|NCT04388111|616614910|FG001|Overall Study|Withdrawal by Subject|0|||
170619424|NCT00387881|616614913|FG000|Overall Study|Lost to Follow-up|23|||
170619425|NCT00387881|616614914|FG001|Overall Study|Lost to Follow-up|23|||
170619426|NCT00387881|616614913|FG000|Overall Study|Protocol Violation|2|||
170619427|NCT00387881|616614914|FG001|Overall Study|Protocol Violation|12|||
170619428|NCT00387881|616614913|FG000|Overall Study|Withdrawal by Subject|15|||
170619429|NCT00387881|616614914|FG001|Overall Study|Withdrawal by Subject|18|||
170619430|NCT00387881|616614913|FG000|Overall Study|Sponsor terminated Study|0|||
170619431|NCT00387881|616614914|FG001|Overall Study|Sponsor terminated Study|1|||
170619432|NCT00387881|616614913|FG000|Overall Study|Not eligible|6|||
170619433|NCT00387881|616614914|FG001|Overall Study|Not eligible|7|||
170619434|NCT00387881|616614913|FG000|Overall Study|No opportunity to treat headache|32|||
170619435|NCT00387881|616614914|FG001|Overall Study|No opportunity to treat headache|34|||
170619436|NCT00387881|616614913|FG000|Overall Study|Not otherwise specified|11|||
170819023|NCT00644332|617345757|FG000|Overall Study|Withdrawal by Subject|6|||
170819024|NCT00644332|617345757|FG000|Overall Study|Completion Status Unknown|2|||
170819025|NCT00644332|617345757|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
170819026|NCT00644332|617345757|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
170819027|NCT01809691|617345758|FG000|Overall Study|Currently on Treatment|192|||
170819028|NCT01809691|617345759|FG001|Overall Study|Currently on Treatment|100|||
170819029|NCT01809691|617345758|FG000|Overall Study|No Protocol Treatment|10|||
170819030|NCT01809691|617345759|FG001|Overall Study|No Protocol Treatment|11|||
170619437|NCT00387881|616614914|FG001|Overall Study|Not otherwise specified|7|||
170619438|NCT02250326|616614915|FG000|Treatment|Death|1|||
170619439|NCT02250326|616614916|FG001|Treatment|Death|13|||
170619440|NCT02250326|616614917|FG002|Treatment|Death|2|||
170669054|NCT00142298|616799539|FG000|Overall Study|Pregnancy|4|||
170669055|NCT00142298|616799540|FG001|Overall Study|Pregnancy|4|||
170669056|NCT00142298|616799541|FG002|Overall Study|Pregnancy|2|||
170669057|NCT00142298|616799542|FG003|Overall Study|Pregnancy|3|||
170669058|NCT00142298|616799543|FG004|Overall Study|Pregnancy|0|||
170669059|NCT00142298|616799544|FG005|Overall Study|Pregnancy|0|||
170619441|NCT02250326|616614915|FG000|Treatment|Adverse Event|8|||
170619442|NCT02250326|616614916|FG001|Treatment|Adverse Event|8|||
170619443|NCT02250326|616614917|FG002|Treatment|Adverse Event|9|||
170619444|NCT02250326|616614915|FG000|Treatment|Progressive Disease|42|||
170619445|NCT02250326|616614916|FG001|Treatment|Progressive Disease|40|||
170669060|NCT00142298|616799545|FG006|Overall Study|Pregnancy|0|||
170619446|NCT02250326|616614917|FG002|Treatment|Progressive Disease|47|||
170619447|NCT02250326|616614915|FG000|Treatment|Symptomatic Deterioration|9|||
170619448|NCT02250326|616614916|FG001|Treatment|Symptomatic Deterioration|4|||
170619449|NCT02250326|616614917|FG002|Treatment|Symptomatic Deterioration|10|||
170619450|NCT02250326|616614915|FG000|Treatment|Withdrawal by Subject|11|||
170619451|NCT02250326|616614916|FG001|Treatment|Withdrawal by Subject|6|||
170619452|NCT02250326|616614917|FG002|Treatment|Withdrawal by Subject|4|||
170619453|NCT02250326|616614915|FG000|Treatment|Other reasons|8|||
170619454|NCT02250326|616614916|FG001|Treatment|Other reasons|7|||
170619455|NCT02250326|616614917|FG002|Treatment|Other reasons|7|||
170619456|NCT02250326|616614915|FG000|Extension Period|Progressive Disease|0|||
170619457|NCT02250326|616614916|FG001|Extension Period|Progressive Disease|2|||
170619458|NCT02250326|616614917|FG002|Extension Period|Progressive Disease|0|||
170619459|NCT02250326|616614915|FG000|Extension Period|Withdrawal by Subject|0|||
170619460|NCT02250326|616614916|FG001|Extension Period|Withdrawal by Subject|1|||
170619461|NCT02250326|616614917|FG002|Extension Period|Withdrawal by Subject|0|||
170619462|NCT02250326|616614915|FG000|Extension Period|Withdrawal by investigator|0|||
170619463|NCT02250326|616614916|FG001|Extension Period|Withdrawal by investigator|1|||
170619464|NCT02250326|616614917|FG002|Extension Period|Withdrawal by investigator|0|||
170619465|NCT01421017|616614926|FG000|Overall Study|Withdrawal by Subject|2|||
170619466|NCT01421017|616614927|FG001|Overall Study|Withdrawal by Subject|0|||
170619467|NCT01421017|616614928|FG002|Overall Study|Withdrawal by Subject|0|||
170619468|NCT01421017|616614926|FG000|Overall Study|POD|0|||
170619469|NCT01421017|616614927|FG001|Overall Study|POD|6|||
170619470|NCT01421017|616614928|FG002|Overall Study|POD|3|||
170619471|NCT04245111|616614929|FG000|Overall Study|Lost to Follow-up|5|||
170619472|NCT04245111|616614930|FG001|Overall Study|Lost to Follow-up|1|||
170619473|NCT04245111|616614931|FG002|Overall Study|Lost to Follow-up|1|||
170619474|NCT03956550|616614932|FG000|Overall Study|Sponsor decision|65|||
170619475|NCT03956550|616614933|FG001|Overall Study|Sponsor decision|66|||
170619476|NCT03956550|616614934|FG002|Overall Study|Sponsor decision|64|||
170619477|NCT03956550|616614932|FG000|Overall Study|Adverse Event|0|||
170619478|NCT03956550|616614933|FG001|Overall Study|Adverse Event|1|||
170619479|NCT03956550|616614934|FG002|Overall Study|Adverse Event|0|||
170619480|NCT03956550|616614932|FG000|Overall Study|Withdrawal by Subject|5|||
170619481|NCT03956550|616614933|FG001|Overall Study|Withdrawal by Subject|5|||
170619482|NCT03956550|616614934|FG002|Overall Study|Withdrawal by Subject|6|||
170619483|NCT00861705|616614937|FG000|Overall Study|Never Began Treatment|7|||
170619484|NCT00861705|616614938|FG001|Overall Study|Never Began Treatment|3|||
170619485|NCT00861705|616614939|FG002|Overall Study|Never Began Treatment|0|||
170619486|NCT00861705|616614940|FG003|Overall Study|Never Began Treatment|1|||
170619487|NCT04551989|616614943|FG000|Overall Study|Adverse Event|4|||
170619488|NCT04551989|616614943|FG000|Overall Study|Protocol Violation|3|||
170619489|NCT04551989|616614943|FG000|Overall Study|Lost to Follow-up|1|||
170619490|NCT04551989|616614943|FG000|Overall Study|Physician Decision|3|||
170619491|NCT02079038|616614946|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
170619492|NCT02079038|616614947|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
170619493|NCT02079038|616614946|FG000|Modified Intent to Treat Population|Death|1|||
170619494|NCT02079038|616614947|FG001|Modified Intent to Treat Population|Death|0|||
170619495|NCT02079038|616614946|FG000|Completed 6 Months|Lost to Follow-up|2|||
170619496|NCT02079038|616614947|FG001|Completed 6 Months|Lost to Follow-up|1|||
170619497|NCT01012258|616614950|FG000|Overall Study|Death|14|||
170619498|NCT01012258|616614950|FG000|Overall Study|Lost to Follow-up|1|||
170619499|NCT01012258|616614950|FG000|Overall Study|Adverse Event|1|||
170619500|NCT01012258|616614950|FG000|Overall Study|Progressive Disease (PD)|18|||
170619501|NCT01012258|616614950|FG000|Overall Study|Symptomatic Deterioration|1|||
170619502|NCT01012258|616614950|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
170619503|NCT01012258|616614950|FG000|Overall Study|Another Tumor Discovered|1|||
170619504|NCT01012258|616614950|FG000|Overall Study|Ongoing|29|||
170619505|NCT01814527|616614953|FG000|Overall Study|RTP greater than 30 days|6|||
170619506|NCT01814527|616614954|FG001|Overall Study|RTP greater than 30 days|1|||
170619507|NCT01454596|616614957|FG000|Overall Study|Death|0|||
170619508|NCT01454596|616614958|FG001|Overall Study|Death|0|||
170669061|NCT00142298|616799546|FG007|Overall Study|Pregnancy|0|||
170619509|NCT01454596|616614959|FG002|Overall Study|Death|0|||
170619510|NCT01454596|616614960|FG003|Overall Study|Death|0|||
170619511|NCT01454596|616614961|FG004|Overall Study|Death|0|||
170619512|NCT01454596|616614962|FG005|Overall Study|Death|0|||
170619513|NCT01454596|616614963|FG006|Overall Study|Death|0|||
170619514|NCT01454596|616614964|FG007|Overall Study|Death|0|||
170619515|NCT01454596|616614965|FG008|Overall Study|Death|0|||
170619516|NCT01454596|616614966|FG009|Overall Study|Death|1|||
170619517|NCT01454596|616614967|FG010|Overall Study|Death|1|||
170619518|NCT01454596|616614968|FG011|Overall Study|Death|0|||
170669062|NCT00142298|616799547|FG008|Overall Study|Pregnancy|1|||
170619519|NCT01091675|616614975|FG000|Overall Study|Adverse Event|7|||
170619520|NCT01091675|616614975|FG000|Overall Study|Lack of Efficacy|27|||
170619521|NCT01188772|616614986|FG000|Overall Study|Randomized but Not Treated|0|||
170669063|NCT00142298|616799548|FG009|Overall Study|Pregnancy|0|||
170619522|NCT01188772|616614987|FG001|Overall Study|Randomized but Not Treated|1|||
170619523|NCT01188772|616614988|FG002|Overall Study|Randomized but Not Treated|0|||
170619524|NCT01188772|616614989|FG003|Overall Study|Randomized but Not Treated|0|||
170619525|NCT01188772|616614986|FG000|Overall Study|Adverse Event|0|||
170619526|NCT01188772|616614987|FG001|Overall Study|Adverse Event|1|||
170619527|NCT01188772|616614988|FG002|Overall Study|Adverse Event|2|||
170619528|NCT01188772|616614989|FG003|Overall Study|Adverse Event|0|||
170619529|NCT01188772|616614986|FG000|Overall Study|Lost to Follow-up|4|||
170619530|NCT01188772|616614987|FG001|Overall Study|Lost to Follow-up|1|||
170619531|NCT01188772|616614988|FG002|Overall Study|Lost to Follow-up|1|||
170619532|NCT01188772|616614989|FG003|Overall Study|Lost to Follow-up|1|||
170619533|NCT01188772|616614986|FG000|Overall Study|Non-responder|0|||
170619534|NCT01188772|616614987|FG001|Overall Study|Non-responder|0|||
170619535|NCT01188772|616614988|FG002|Overall Study|Non-responder|3|||
170619536|NCT01188772|616614989|FG003|Overall Study|Non-responder|0|||
170619537|NCT01188772|616614986|FG000|Overall Study|Physician Decision|0|||
170619538|NCT01188772|616614987|FG001|Overall Study|Physician Decision|0|||
170619539|NCT01188772|616614988|FG002|Overall Study|Physician Decision|1|||
170619540|NCT01188772|616614989|FG003|Overall Study|Physician Decision|0|||
170619541|NCT01188772|616614986|FG000|Overall Study|Terminated by Sponsor|0|||
170619542|NCT01188772|616614987|FG001|Overall Study|Terminated by Sponsor|0|||
170619543|NCT01188772|616614988|FG002|Overall Study|Terminated by Sponsor|1|||
170619544|NCT01188772|616614989|FG003|Overall Study|Terminated by Sponsor|0|||
170619545|NCT01188772|616614986|FG000|Overall Study|Treatment Failure|0|||
170619546|NCT01188772|616614987|FG001|Overall Study|Treatment Failure|0|||
170619547|NCT01188772|616614988|FG002|Overall Study|Treatment Failure|1|||
170619548|NCT01188772|616614989|FG003|Overall Study|Treatment Failure|0|||
170619549|NCT01188772|616614986|FG000|Overall Study|Virologic Failure|1|||
170619550|NCT01188772|616614987|FG001|Overall Study|Virologic Failure|0|||
170619551|NCT01188772|616614988|FG002|Overall Study|Virologic Failure|0|||
170619552|NCT01188772|616614989|FG003|Overall Study|Virologic Failure|0|||
170619553|NCT01188772|616614986|FG000|Overall Study|Withdrawal by Subject|0|||
170619554|NCT01188772|616614987|FG001|Overall Study|Withdrawal by Subject|0|||
170619555|NCT01188772|616614988|FG002|Overall Study|Withdrawal by Subject|2|||
170619556|NCT01188772|616614989|FG003|Overall Study|Withdrawal by Subject|0|||
170619557|NCT03081884|616614993|FG000|Overall Study|deferred prostate cancer treatment|1|||
170619558|NCT03081884|616614993|FG000|Overall Study|metastasis managed with systemic therapy|3|||
170619559|NCT00920855|616614995|FG000|Overall Study|Adverse Event|1|||
170619560|NCT00920855|616614996|FG001|Overall Study|Adverse Event|1|||
170619561|NCT00920855|616614997|FG002|Overall Study|Adverse Event|4|||
170619562|NCT00920855|616614995|FG000|Overall Study|Withdrawal by Subject|2|||
170619563|NCT00920855|616614996|FG001|Overall Study|Withdrawal by Subject|1|||
170619564|NCT00920855|616614997|FG002|Overall Study|Withdrawal by Subject|6|||
170619565|NCT00920855|616614995|FG000|Overall Study|Disease progression|2|||
170619566|NCT00920855|616614996|FG001|Overall Study|Disease progression|1|||
170619567|NCT00920855|616614997|FG002|Overall Study|Disease progression|10|||
170619568|NCT00920855|616614995|FG000|Overall Study|Noncompliance to study medication|0|||
170619569|NCT00920855|616614996|FG001|Overall Study|Noncompliance to study medication|0|||
170619570|NCT00920855|616614997|FG002|Overall Study|Noncompliance to study medication|1|||
170619571|NCT00920855|616614995|FG000|Overall Study|Response plateau; started maintenance|0|||
170619572|NCT00920855|616614996|FG001|Overall Study|Response plateau; started maintenance|0|||
170619573|NCT00920855|616614997|FG002|Overall Study|Response plateau; started maintenance|1|||
170619574|NCT00510835|616615004|FG000|Overall Study|Withdrawal by Subject|6|||
170619575|NCT00510835|616615005|FG001|Overall Study|Withdrawal by Subject|2|||
170619576|NCT00510835|616615006|FG002|Overall Study|Withdrawal by Subject|2|||
170819031|NCT01809691|617345758|FG000|Overall Study|Adverse Event|80|||
170819032|NCT01809691|617345759|FG001|Overall Study|Adverse Event|21|||
170819033|NCT01809691|617345758|FG000|Overall Study|Disease Progression|226|||
170819034|NCT01809691|617345759|FG001|Overall Study|Disease Progression|372|||
170819035|NCT01809691|617345758|FG000|Overall Study|Death|26|||
170819036|NCT01809691|617345759|FG001|Overall Study|Death|13|||
170819037|NCT01809691|617345758|FG000|Overall Study|Participant Refusal|70|||
170819038|NCT01809691|617345759|FG001|Overall Study|Participant Refusal|72|||
170819039|NCT01809691|617345758|FG000|Overall Study|Other, Not Specified|34|||
170819040|NCT01809691|617345759|FG001|Overall Study|Other, Not Specified|52|||
170619577|NCT03084796|616615007|FG000|Overall Study|Adverse Event|4|||
170619578|NCT03084796|616615008|FG001|Overall Study|Adverse Event|5|||
170619579|NCT03084796|616615009|FG002|Overall Study|Adverse Event|6|||
170619580|NCT03084796|616615010|FG003|Overall Study|Adverse Event|2|||
170619581|NCT03084796|616615011|FG004|Overall Study|Adverse Event|3|||
170619582|NCT03084796|616615012|FG005|Overall Study|Adverse Event|5|||
170619583|NCT03084796|616615007|FG000|Overall Study|Withdrawal by Subject|3|||
170619584|NCT03084796|616615008|FG001|Overall Study|Withdrawal by Subject|5|||
170619585|NCT03084796|616615009|FG002|Overall Study|Withdrawal by Subject|2|||
170619586|NCT03084796|616615010|FG003|Overall Study|Withdrawal by Subject|1|||
170619587|NCT03084796|616615011|FG004|Overall Study|Withdrawal by Subject|3|||
170619588|NCT03084796|616615012|FG005|Overall Study|Withdrawal by Subject|0|||
170819041|NCT00409006|617345762|FG000|Overall Study|Death|15|||
170619589|NCT03084796|616615007|FG000|Overall Study|Protocol Violation|0|||
170619590|NCT03084796|616615008|FG001|Overall Study|Protocol Violation|0|||
170619591|NCT03084796|616615009|FG002|Overall Study|Protocol Violation|1|||
170619592|NCT03084796|616615010|FG003|Overall Study|Protocol Violation|0|||
170619593|NCT03084796|616615011|FG004|Overall Study|Protocol Violation|1|||
170619594|NCT03084796|616615012|FG005|Overall Study|Protocol Violation|1|||
170619595|NCT03084796|616615007|FG000|Overall Study|Lack of Efficacy|0|||
170619596|NCT03084796|616615008|FG001|Overall Study|Lack of Efficacy|0|||
170619597|NCT03084796|616615009|FG002|Overall Study|Lack of Efficacy|1|||
170619598|NCT03084796|616615010|FG003|Overall Study|Lack of Efficacy|0|||
170619599|NCT03084796|616615011|FG004|Overall Study|Lack of Efficacy|1|||
170619600|NCT03084796|616615012|FG005|Overall Study|Lack of Efficacy|0|||
170619601|NCT03084796|616615007|FG000|Overall Study|Lost to Follow-up|0|||
170619602|NCT03084796|616615008|FG001|Overall Study|Lost to Follow-up|0|||
170619603|NCT03084796|616615009|FG002|Overall Study|Lost to Follow-up|1|||
170619604|NCT03084796|616615010|FG003|Overall Study|Lost to Follow-up|1|||
170619605|NCT03084796|616615011|FG004|Overall Study|Lost to Follow-up|3|||
170619606|NCT03084796|616615012|FG005|Overall Study|Lost to Follow-up|1|||
170619607|NCT03084796|616615007|FG000|Overall Study|Randomization error|0|||
170619608|NCT03084796|616615008|FG001|Overall Study|Randomization error|0|||
170619609|NCT03084796|616615009|FG002|Overall Study|Randomization error|1|||
170619610|NCT03084796|616615010|FG003|Overall Study|Randomization error|0|||
170619611|NCT03084796|616615011|FG004|Overall Study|Randomization error|0|||
170619612|NCT03084796|616615012|FG005|Overall Study|Randomization error|0|||
170619613|NCT05470985|616615013|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
170619614|NCT05470985|616615014|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
170619615|NCT05470985|616615013|FG000|Double Blind Treatment Period|Physician Decision|0|||
170619616|NCT05470985|616615014|FG001|Double Blind Treatment Period|Physician Decision|1|||
170619617|NCT05470985|616615013|FG000|Long Term Extension|Adverse Event|0|||
170619618|NCT05470985|616615014|FG001|Long Term Extension|Adverse Event|1|||
170619619|NCT05470985|616615013|FG000|Long Term Extension|Study terminated by sponsor|2|||
170619620|NCT05470985|616615014|FG001|Long Term Extension|Study terminated by sponsor|0|||
170619621|NCT05579977|616615018|FG000|Treatment Phase|Other|0|||
170619622|NCT05579977|616615019|FG001|Treatment Phase|Other|0|||
170619623|NCT05579977|616615020|FG002|Treatment Phase|Other|0|||
170619624|NCT05579977|616615021|FG003|Treatment Phase|Other|2|||
170619625|NCT05579977|616615022|FG004|Treatment Phase|Other|1|||
170619626|NCT05579977|616615023|FG005|Treatment Phase|Other|2|||
170619627|NCT05579977|616615024|FG006|Treatment Phase|Other|1|||
170619628|NCT05579977|616615025|FG007|Treatment Phase|Other|2|||
170619629|NCT05579977|616615026|FG008|Treatment Phase|Other|2|||
170619630|NCT05579977|616615027|FG009|Treatment Phase|Other|1|||
170619631|NCT05579977|616615028|FG010|Treatment Phase|Other|0|||
170619632|NCT05579977|616615029|FG011|Treatment Phase|Other|0|||
170619633|NCT05579977|616615030|FG012|Treatment Phase|Other|3|||
170619634|NCT05579977|616615018|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
170819042|NCT00409006|617345763|FG001|Overall Study|Death|6|||
170819043|NCT00409006|617345762|FG000|Overall Study|Lost to Follow-up|1|||
170819044|NCT00409006|617345763|FG001|Overall Study|Lost to Follow-up|2|||
170819045|NCT00409006|617345762|FG000|Overall Study|Withdrawal by Subject|3|||
170819046|NCT00409006|617345763|FG001|Overall Study|Withdrawal by Subject|2|||
170819047|NCT00409006|617345762|FG000|Overall Study|Physician Decision|1|||
170819048|NCT00409006|617345763|FG001|Overall Study|Physician Decision|2|||
170819049|NCT03694210|617345764|FG000|Overall Study|Death|1|||
170819050|NCT03694210|617345764|FG000|Overall Study|Screen Failure|7|||
170819051|NCT03050372|617345767|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
170819052|NCT03050372|617345768|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
170819053|NCT03050372|617345767|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
170819054|NCT03050372|617345768|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
170819055|NCT02123797|617345771|FG000|Baseline Intervention|Death|9|||
170819056|NCT02123797|617345772|FG001|Baseline Intervention|Death|16|||
170819057|NCT02123797|617345773|FG002|Baseline Intervention|Death|0|||
170819058|NCT02123797|617345774|FG003|Baseline Intervention|Death|0|||
170619635|NCT05579977|616615019|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
170619636|NCT05579977|616615020|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
170619637|NCT05579977|616615021|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
170619638|NCT05579977|616615022|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
170619639|NCT05579977|616615023|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
170619640|NCT05579977|616615024|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
170619641|NCT05579977|616615025|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
170619642|NCT05579977|616615026|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
170619643|NCT05579977|616615027|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
170619644|NCT05579977|616615028|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
170619645|NCT05579977|616615029|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
170619646|NCT05579977|616615030|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
170619647|NCT05579977|616615018|FG000|Treatment Phase|Withdrawal by Subject|2|||
170619648|NCT05579977|616615019|FG001|Treatment Phase|Withdrawal by Subject|0|||
170619649|NCT05579977|616615020|FG002|Treatment Phase|Withdrawal by Subject|0|||
170619650|NCT05579977|616615021|FG003|Treatment Phase|Withdrawal by Subject|1|||
170619651|NCT05579977|616615022|FG004|Treatment Phase|Withdrawal by Subject|2|||
170619652|NCT05579977|616615023|FG005|Treatment Phase|Withdrawal by Subject|0|||
170619653|NCT05579977|616615024|FG006|Treatment Phase|Withdrawal by Subject|1|||
170619654|NCT05579977|616615025|FG007|Treatment Phase|Withdrawal by Subject|8|||
170917624|NCT03365882|617698804|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
170917625|NCT03365882|617698805|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
170917626|NCT03365882|617698804|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
170619655|NCT05579977|616615026|FG008|Treatment Phase|Withdrawal by Subject|3|||
170619656|NCT05579977|616615027|FG009|Treatment Phase|Withdrawal by Subject|3|||
170619657|NCT05579977|616615028|FG010|Treatment Phase|Withdrawal by Subject|5|||
170619658|NCT05579977|616615029|FG011|Treatment Phase|Withdrawal by Subject|1|||
170619659|NCT05579977|616615030|FG012|Treatment Phase|Withdrawal by Subject|3|||
170619660|NCT05579977|616615018|FG000|Treatment Phase|Study terminated by sponsor|70|||
170619661|NCT05579977|616615019|FG001|Treatment Phase|Study terminated by sponsor|70|||
170619662|NCT05579977|616615020|FG002|Treatment Phase|Study terminated by sponsor|61|||
170619663|NCT05579977|616615021|FG003|Treatment Phase|Study terminated by sponsor|59|||
170619664|NCT05579977|616615022|FG004|Treatment Phase|Study terminated by sponsor|63|||
170619665|NCT05579977|616615023|FG005|Treatment Phase|Study terminated by sponsor|53|||
170619666|NCT05579977|616615024|FG006|Treatment Phase|Study terminated by sponsor|66|||
170619667|NCT05579977|616615025|FG007|Treatment Phase|Study terminated by sponsor|48|||
170619668|NCT05579977|616615026|FG008|Treatment Phase|Study terminated by sponsor|47|||
170619669|NCT05579977|616615027|FG009|Treatment Phase|Study terminated by sponsor|37|||
170619670|NCT05579977|616615028|FG010|Treatment Phase|Study terminated by sponsor|44|||
170619671|NCT05579977|616615029|FG011|Treatment Phase|Study terminated by sponsor|36|||
170619672|NCT05579977|616615030|FG012|Treatment Phase|Study terminated by sponsor|32|||
170619673|NCT05579977|616615018|FG000|Treatment Phase|Pregnancy|0|||
170619674|NCT05579977|616615019|FG001|Treatment Phase|Pregnancy|0|||
170917627|NCT03365882|617698805|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
170917628|NCT03559049|617698806|FG000|Overall Study|Adverse Event|6|||
170619675|NCT05579977|616615020|FG002|Treatment Phase|Pregnancy|0|||
170619676|NCT05579977|616615021|FG003|Treatment Phase|Pregnancy|0|||
170619677|NCT05579977|616615022|FG004|Treatment Phase|Pregnancy|0|||
170619678|NCT05579977|616615023|FG005|Treatment Phase|Pregnancy|0|||
170619679|NCT05579977|616615024|FG006|Treatment Phase|Pregnancy|0|||
170619680|NCT05579977|616615025|FG007|Treatment Phase|Pregnancy|0|||
170619681|NCT05579977|616615026|FG008|Treatment Phase|Pregnancy|0|||
170619682|NCT05579977|616615027|FG009|Treatment Phase|Pregnancy|1|||
170619683|NCT05579977|616615028|FG010|Treatment Phase|Pregnancy|0|||
170619684|NCT05579977|616615029|FG011|Treatment Phase|Pregnancy|0|||
170619685|NCT05579977|616615030|FG012|Treatment Phase|Pregnancy|0|||
170619686|NCT05579977|616615018|FG000|Treatment Phase|Physician Decision|0|||
170619687|NCT05579977|616615019|FG001|Treatment Phase|Physician Decision|0|||
170619688|NCT05579977|616615020|FG002|Treatment Phase|Physician Decision|0|||
170619689|NCT05579977|616615021|FG003|Treatment Phase|Physician Decision|0|||
170619690|NCT05579977|616615022|FG004|Treatment Phase|Physician Decision|0|||
170619691|NCT05579977|616615023|FG005|Treatment Phase|Physician Decision|0|||
170619692|NCT05579977|616615024|FG006|Treatment Phase|Physician Decision|0|||
170619693|NCT05579977|616615025|FG007|Treatment Phase|Physician Decision|0|||
170619694|NCT05579977|616615026|FG008|Treatment Phase|Physician Decision|0|||
170619695|NCT05579977|616615027|FG009|Treatment Phase|Physician Decision|0|||
170619696|NCT05579977|616615028|FG010|Treatment Phase|Physician Decision|0|||
170619697|NCT05579977|616615029|FG011|Treatment Phase|Physician Decision|1|||
170619698|NCT05579977|616615030|FG012|Treatment Phase|Physician Decision|0|||
170619699|NCT05579977|616615018|FG000|Treatment Phase|Lost to Follow-up|0|||
170619700|NCT05579977|616615019|FG001|Treatment Phase|Lost to Follow-up|0|||
170619701|NCT05579977|616615020|FG002|Treatment Phase|Lost to Follow-up|0|||
170619702|NCT05579977|616615021|FG003|Treatment Phase|Lost to Follow-up|1|||
170619703|NCT05579977|616615022|FG004|Treatment Phase|Lost to Follow-up|1|||
170917629|NCT03559049|617698806|FG000|Overall Study|Withdrawal by Subject|2|||
170917630|NCT03559049|617698806|FG000|Overall Study|Death|1|||
170619704|NCT05579977|616615023|FG005|Treatment Phase|Lost to Follow-up|1|||
170619705|NCT05579977|616615024|FG006|Treatment Phase|Lost to Follow-up|0|||
170619706|NCT05579977|616615025|FG007|Treatment Phase|Lost to Follow-up|1|||
170619707|NCT05579977|616615026|FG008|Treatment Phase|Lost to Follow-up|2|||
170619708|NCT05579977|616615027|FG009|Treatment Phase|Lost to Follow-up|2|||
170619709|NCT05579977|616615028|FG010|Treatment Phase|Lost to Follow-up|1|||
170619710|NCT05579977|616615029|FG011|Treatment Phase|Lost to Follow-up|4|||
170619711|NCT05579977|616615030|FG012|Treatment Phase|Lost to Follow-up|3|||
170619712|NCT05579977|616615018|FG000|Treatment Phase|Death|1|||
170619713|NCT05579977|616615019|FG001|Treatment Phase|Death|0|||
170619714|NCT05579977|616615020|FG002|Treatment Phase|Death|0|||
170619715|NCT05579977|616615021|FG003|Treatment Phase|Death|0|||
170619716|NCT05579977|616615022|FG004|Treatment Phase|Death|0|||
170619717|NCT05579977|616615023|FG005|Treatment Phase|Death|0|||
170917631|NCT03559049|617698806|FG000|Overall Study|Physician Decision|2|||
170619718|NCT05579977|616615024|FG006|Treatment Phase|Death|0|||
170619719|NCT05579977|616615025|FG007|Treatment Phase|Death|0|||
170619720|NCT05579977|616615026|FG008|Treatment Phase|Death|0|||
170619721|NCT05579977|616615027|FG009|Treatment Phase|Death|0|||
170619722|NCT05579977|616615028|FG010|Treatment Phase|Death|0|||
170619723|NCT05579977|616615029|FG011|Treatment Phase|Death|0|||
170619724|NCT05579977|616615030|FG012|Treatment Phase|Death|0|||
170619725|NCT05579977|616615018|FG000|Treatment Phase|Adverse Event|0|||
170619726|NCT05579977|616615019|FG001|Treatment Phase|Adverse Event|3|||
170619727|NCT05579977|616615020|FG002|Treatment Phase|Adverse Event|11|||
170619728|NCT05579977|616615021|FG003|Treatment Phase|Adverse Event|10|||
170619729|NCT05579977|616615022|FG004|Treatment Phase|Adverse Event|5|||
170619730|NCT05579977|616615023|FG005|Treatment Phase|Adverse Event|17|||
170619731|NCT05579977|616615024|FG006|Treatment Phase|Adverse Event|5|||
170619732|NCT05579977|616615025|FG007|Treatment Phase|Adverse Event|5|||
170619733|NCT05579977|616615026|FG008|Treatment Phase|Adverse Event|12|||
170619734|NCT05579977|616615027|FG009|Treatment Phase|Adverse Event|20|||
170619735|NCT05579977|616615028|FG010|Treatment Phase|Adverse Event|15|||
170619736|NCT05579977|616615029|FG011|Treatment Phase|Adverse Event|24|||
170619737|NCT05579977|616615030|FG012|Treatment Phase|Adverse Event|23|||
170619738|NCT05579977|616615018|FG000|Treatment Phase|Randomized not treated|0|||
170619739|NCT05579977|616615019|FG001|Treatment Phase|Randomized not treated|0|||
170619740|NCT05579977|616615020|FG002|Treatment Phase|Randomized not treated|0|||
170619741|NCT05579977|616615021|FG003|Treatment Phase|Randomized not treated|0|||
170819059|NCT02123797|617345775|FG004|Baseline Intervention|Death|0|||
170819060|NCT02123797|617345771|FG000|Baseline Intervention|Withdrawal by Subject|2|||
170819061|NCT02123797|617345772|FG001|Baseline Intervention|Withdrawal by Subject|8|||
170819062|NCT02123797|617345773|FG002|Baseline Intervention|Withdrawal by Subject|0|||
170819063|NCT02123797|617345774|FG003|Baseline Intervention|Withdrawal by Subject|0|||
170819064|NCT02123797|617345775|FG004|Baseline Intervention|Withdrawal by Subject|0|||
170819065|NCT02123797|617345771|FG000|Baseline Intervention|Relocation|2|||
170819066|NCT02123797|617345772|FG001|Baseline Intervention|Relocation|0|||
170819067|NCT02123797|617345773|FG002|Baseline Intervention|Relocation|0|||
170819068|NCT02123797|617345774|FG003|Baseline Intervention|Relocation|0|||
170819069|NCT02123797|617345775|FG004|Baseline Intervention|Relocation|0|||
170819070|NCT02123797|617345771|FG000|Baseline Intervention|Out of window for initial survey|6|||
170819071|NCT02123797|617345772|FG001|Baseline Intervention|Out of window for initial survey|13|||
170917632|NCT03559049|617698806|FG000|Overall Study|Sponsor termination|3|||
170917633|NCT03516942|617698807|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
170917634|NCT03516942|617698807|FG000|Registration through baseline survey com|Death|8|||
170917635|NCT03516942|617698807|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
170917636|NCT03516942|617698807|FG000|T0: Baseline|LOST|13|||
170917637|NCT03516942|617698807|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
170917638|NCT03516942|617698807|FG000|T1: 3 Months Survey|Death|10|||
170917639|NCT03516942|617698807|FG000|T1: 3 Months Survey|Lost|163|||
170917640|NCT03516942|617698807|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
170917641|NCT03516942|617698807|FG000|T2: 6 Month Survey|Death|14|||
170917642|NCT03516942|617698807|FG000|T2: 6 Month Survey|Lost|180|||
170917643|NCT03516942|617698807|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
170917644|NCT03516942|617698807|FG000|T3: 12 Month Survey|Death|19|||
170917645|NCT03516942|617698807|FG000|T3: 12 Month Survey|Lost|209|||
170917646|NCT05099159|617698808|FG000|Overall Study|Subject Decision|14|||
170917647|NCT05099159|617698809|FG001|Overall Study|Subject Decision|10|||
170917648|NCT05099159|617698808|FG000|Overall Study|Adverse Event|7|||
170917649|NCT05099159|617698809|FG001|Overall Study|Adverse Event|3|||
170917650|NCT05099159|617698808|FG000|Overall Study|Lack of Efficacy|1|||
170917651|NCT05099159|617698809|FG001|Overall Study|Lack of Efficacy|1|||
170917652|NCT05099159|617698808|FG000|Overall Study|Lost to Follow-up|6|||
170917653|NCT05099159|617698809|FG001|Overall Study|Lost to Follow-up|1|||
170917654|NCT05099159|617698808|FG000|Overall Study|Non-compliance with study drug|1|||
170917655|NCT05099159|617698809|FG001|Overall Study|Non-compliance with study drug|4|||
170917656|NCT05099159|617698808|FG000|Overall Study|Other|1|||
170917657|NCT05099159|617698809|FG001|Overall Study|Other|1|||
170917658|NCT05099159|617698808|FG000|Overall Study|Protocol Violation|0|||
170917659|NCT05099159|617698809|FG001|Overall Study|Protocol Violation|1|||
170917660|NCT05099159|617698808|FG000|Overall Study|Did not complete study treatment but completed FU|13|||
170917661|NCT05099159|617698809|FG001|Overall Study|Did not complete study treatment but completed FU|12|||
170917662|NCT04497844|617698810|FG000|Overall Study|Ongoing|231|||
170917663|NCT04497844|617698811|FG001|Overall Study|Ongoing|249|||
170619742|NCT05579977|616615022|FG004|Treatment Phase|Randomized not treated|1|||
170619743|NCT05579977|616615023|FG005|Treatment Phase|Randomized not treated|0|||
170619744|NCT05579977|616615024|FG006|Treatment Phase|Randomized not treated|0|||
170619745|NCT05579977|616615025|FG007|Treatment Phase|Randomized not treated|0|||
170619746|NCT05579977|616615026|FG008|Treatment Phase|Randomized not treated|0|||
170619747|NCT05579977|616615027|FG009|Treatment Phase|Randomized not treated|0|||
170917664|NCT04497844|617698810|FG000|Overall Study|Death|106|||
170917665|NCT04497844|617698811|FG001|Overall Study|Death|84|||
170917666|NCT04497844|617698810|FG000|Overall Study|Lost to Follow-up|2|||
170917667|NCT04497844|617698811|FG001|Overall Study|Lost to Follow-up|0|||
170619748|NCT05579977|616615028|FG010|Treatment Phase|Randomized not treated|0|||
170619749|NCT05579977|616615029|FG011|Treatment Phase|Randomized not treated|0|||
170619750|NCT05579977|616615030|FG012|Treatment Phase|Randomized not treated|0|||
170619751|NCT05579977|616615018|FG000|Follow up|Death|1|||
170619752|NCT05579977|616615019|FG001|Follow up|Death|0|||
170619753|NCT05579977|616615020|FG002|Follow up|Death|0|||
170619754|NCT05579977|616615021|FG003|Follow up|Death|0|||
170619755|NCT05579977|616615022|FG004|Follow up|Death|0|||
170619756|NCT05579977|616615023|FG005|Follow up|Death|0|||
170619757|NCT05579977|616615024|FG006|Follow up|Death|0|||
170619758|NCT05579977|616615025|FG007|Follow up|Death|0|||
170619759|NCT05579977|616615026|FG008|Follow up|Death|0|||
170619760|NCT05579977|616615027|FG009|Follow up|Death|0|||
170619761|NCT05579977|616615028|FG010|Follow up|Death|0|||
170619762|NCT05579977|616615029|FG011|Follow up|Death|0|||
170619763|NCT05579977|616615030|FG012|Follow up|Death|0|||
170619764|NCT05579977|616615018|FG000|Follow up|Lost to Follow-up|0|||
170619765|NCT05579977|616615019|FG001|Follow up|Lost to Follow-up|0|||
170619766|NCT05579977|616615020|FG002|Follow up|Lost to Follow-up|0|||
170619767|NCT05579977|616615021|FG003|Follow up|Lost to Follow-up|1|||
170819072|NCT02123797|617345773|FG002|Baseline Intervention|Out of window for initial survey|0|||
170917668|NCT04497844|617698810|FG000|Overall Study|Withdrawal by Subject|6|||
170917669|NCT04497844|617698811|FG001|Overall Study|Withdrawal by Subject|14|||
170917670|NCT04497844|617698810|FG000|Overall Study|Regional Crisis|3|||
170917671|NCT04497844|617698811|FG001|Overall Study|Regional Crisis|1|||
170917672|NCT03451851|617698812|FG000|PCP: Week 0 -16|Adverse Event|1|||
170917673|NCT03451851|617698813|FG001|PCP: Week 0 -16|Adverse Event|0|||
170917674|NCT03451851|617698814|FG002|PCP: Week 0 -16|Adverse Event|0|||
170819073|NCT02123797|617345774|FG003|Baseline Intervention|Out of window for initial survey|0|||
170819074|NCT02123797|617345775|FG004|Baseline Intervention|Out of window for initial survey|0|||
170819075|NCT02123797|617345771|FG000|Baseline Intervention|Lost to Follow-up|0|||
170819076|NCT02123797|617345772|FG001|Baseline Intervention|Lost to Follow-up|5|||
170819077|NCT02123797|617345773|FG002|Baseline Intervention|Lost to Follow-up|0|||
170819078|NCT02123797|617345774|FG003|Baseline Intervention|Lost to Follow-up|0|||
170819079|NCT02123797|617345775|FG004|Baseline Intervention|Lost to Follow-up|0|||
170819080|NCT02123797|617345771|FG000|Baseline Intervention|Other Disease|3|||
170819081|NCT02123797|617345772|FG001|Baseline Intervention|Other Disease|0|||
170819082|NCT02123797|617345773|FG002|Baseline Intervention|Other Disease|0|||
170819083|NCT02123797|617345774|FG003|Baseline Intervention|Other Disease|0|||
170819084|NCT02123797|617345775|FG004|Baseline Intervention|Other Disease|0|||
170819085|NCT02123797|617345771|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
170819086|NCT02123797|617345772|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
170819087|NCT02123797|617345773|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
170819088|NCT02123797|617345774|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
170819089|NCT02123797|617345775|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
170819090|NCT02123797|617345771|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
170819091|NCT02123797|617345772|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
170819092|NCT02123797|617345773|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
170819093|NCT02123797|617345774|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
170819094|NCT02123797|617345775|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
170819095|NCT02123797|617345771|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
170819096|NCT02123797|617345772|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
170819097|NCT02123797|617345773|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
170819098|NCT02123797|617345774|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
170819099|NCT02123797|617345775|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
170819100|NCT02123797|617345771|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
170819101|NCT02123797|617345772|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
170819102|NCT02123797|617345773|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
170819103|NCT02123797|617345774|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
170819104|NCT02123797|617345775|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
170819105|NCT02123797|617345771|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
170819106|NCT02123797|617345772|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
170819107|NCT02123797|617345773|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
170819108|NCT02123797|617345774|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
170917675|NCT03451851|617698815|FG003|PCP: Week 0 -16|Adverse Event|0|||
170917676|NCT03451851|617698816|FG004|PCP: Week 0 -16|Adverse Event|0|||
170917677|NCT03451851|617698817|FG005|PCP: Week 0 -16|Adverse Event|0|||
170917678|NCT03451851|617698818|FG006|PCP: Week 0 -16|Adverse Event|1|||
170619768|NCT05579977|616615022|FG004|Follow up|Lost to Follow-up|1|||
170619769|NCT05579977|616615023|FG005|Follow up|Lost to Follow-up|2|||
170619770|NCT05579977|616615024|FG006|Follow up|Lost to Follow-up|1|||
170619771|NCT05579977|616615025|FG007|Follow up|Lost to Follow-up|1|||
170619772|NCT05579977|616615026|FG008|Follow up|Lost to Follow-up|3|||
170619773|NCT05579977|616615027|FG009|Follow up|Lost to Follow-up|2|||
170619774|NCT05579977|616615028|FG010|Follow up|Lost to Follow-up|2|||
170619775|NCT05579977|616615029|FG011|Follow up|Lost to Follow-up|4|||
170619776|NCT05579977|616615030|FG012|Follow up|Lost to Follow-up|4|||
170619777|NCT05579977|616615018|FG000|Follow up|Withdrawal by Subject|2|||
170619778|NCT05579977|616615019|FG001|Follow up|Withdrawal by Subject|0|||
170619779|NCT05579977|616615020|FG002|Follow up|Withdrawal by Subject|0|||
170619780|NCT05579977|616615021|FG003|Follow up|Withdrawal by Subject|0|||
170619781|NCT05579977|616615022|FG004|Follow up|Withdrawal by Subject|1|||
170619782|NCT05579977|616615023|FG005|Follow up|Withdrawal by Subject|0|||
170619783|NCT05579977|616615024|FG006|Follow up|Withdrawal by Subject|1|||
170619784|NCT05579977|616615025|FG007|Follow up|Withdrawal by Subject|4|||
170619785|NCT05579977|616615026|FG008|Follow up|Withdrawal by Subject|2|||
170619786|NCT05579977|616615027|FG009|Follow up|Withdrawal by Subject|3|||
170619787|NCT05579977|616615028|FG010|Follow up|Withdrawal by Subject|3|||
170619788|NCT05579977|616615029|FG011|Follow up|Withdrawal by Subject|1|||
170619789|NCT05579977|616615030|FG012|Follow up|Withdrawal by Subject|3|||
170619790|NCT01505374|616615032|FG000|Overall Study|Lost to Follow-up|1|||
170619791|NCT01505374|616615033|FG001|Overall Study|Lost to Follow-up|0|||
170619792|NCT00176462|616615036|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
170619793|NCT00176462|616615037|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
170619794|NCT00176462|616615036|FG000|Induction (4 Weeks)|Death|1|||
170619795|NCT00176462|616615037|FG001|Induction (4 Weeks)|Death|2|||
170619796|NCT00176462|616615036|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
170619797|NCT00176462|616615037|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
170619798|NCT00176462|616615036|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
170619799|NCT00176462|616615037|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
170619800|NCT00176462|616615036|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
170619801|NCT00176462|616615037|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
170619802|NCT00176462|616615036|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
170619803|NCT00176462|616615037|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
170619804|NCT00176462|616615036|FG000|Consolidation (12 Weeks)|Not documented|0|||
170619805|NCT00176462|616615037|FG001|Consolidation (12 Weeks)|Not documented|1|||
170619806|NCT00176462|616615036|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
170619807|NCT00176462|616615037|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
170619808|NCT00176462|616615036|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
170619809|NCT00176462|616615037|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
170619810|NCT02679287|616615038|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
170619811|NCT02679287|616615039|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
170619812|NCT02679287|616615038|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
170619813|NCT02679287|616615039|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
170619814|NCT02679287|616615038|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
170619815|NCT02679287|616615039|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
170619816|NCT02679287|616615038|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
170619817|NCT02679287|616615039|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
170619818|NCT02679287|616615038|FG000|Period 2|Work/Scheduling Conflict|1|||
170619819|NCT02679287|616615039|FG001|Period 2|Work/Scheduling Conflict|0|||
170619820|NCT02679287|616615038|FG000|Period 2|Disliked Mobile System|2|||
170619821|NCT02679287|616615039|FG001|Period 2|Disliked Mobile System|0|||
170619822|NCT02679287|616615038|FG000|Period 3|Work/Scheduling Conflict|0|||
170619823|NCT02679287|616615039|FG001|Period 3|Work/Scheduling Conflict|1|||
170619824|NCT01928927|616615040|FG000|Overall Study|Lost to Follow-up|1|||
170619825|NCT01928927|616615041|FG001|Overall Study|Lost to Follow-up|0|||
170619826|NCT01928927|616615040|FG000|Overall Study|Withdrawal by Subject|1|||
170619827|NCT01928927|616615041|FG001|Overall Study|Withdrawal by Subject|1|||
170619828|NCT00350844|616615042|FG000|Overall Study|Lost to Follow-up|1|||
170619829|NCT01420926|616615043|FG000|Overall Study|Adverse Event|6|||
170917679|NCT03451851|617698819|FG007|PCP: Week 0 -16|Adverse Event|0|||
170619830|NCT01420926|616615044|FG001|Overall Study|Adverse Event|4|||
170619831|NCT01420926|616615043|FG000|Overall Study|Death|18|||
170619832|NCT01420926|616615044|FG001|Overall Study|Death|17|||
170619833|NCT01420926|616615043|FG000|Overall Study|Withdrawal by Subject|11|||
170619834|NCT01420926|616615044|FG001|Overall Study|Withdrawal by Subject|17|||
170619835|NCT01420926|616615043|FG000|Overall Study|Non-protocol treatment|17|||
170619836|NCT01420926|616615044|FG001|Overall Study|Non-protocol treatment|20|||
170619837|NCT01420926|616615043|FG000|Overall Study|Physician Decision|8|||
170619838|NCT01420926|616615044|FG001|Overall Study|Physician Decision|5|||
170619839|NCT01405768|616616866|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
170619840|NCT01405768|616616867|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
170619841|NCT01535807|616616873|FG000|Overall Study|Withdrawal by Subject|1|||
170619842|NCT01535807|616616874|FG001|Overall Study|Withdrawal by Subject|1|||
170619843|NCT01535807|616616873|FG000|Overall Study|Data collection error|1|||
170619844|NCT01535807|616616874|FG001|Overall Study|Data collection error|1|||
170619845|NCT01329263|616616877|FG000|Overall Study|Lost to Follow-up|4|||
170619846|NCT01329263|616616878|FG001|Overall Study|Lost to Follow-up|21|||
170619847|NCT01329263|616616877|FG000|Overall Study|Withdrawal by Subject|1|||
170619848|NCT01329263|616616878|FG001|Overall Study|Withdrawal by Subject|2|||
170619849|NCT06039579|616616884|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
170619850|NCT06039579|616616885|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
170619851|NCT06039579|616616886|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
170619852|NCT06039579|616616887|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
170619853|NCT06039579|616616888|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
170619854|NCT06039579|616616889|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
170619855|NCT06039579|616616890|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
170619856|NCT06039579|616616891|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
170619857|NCT02792231|616616892|FG000|Overall Study|Patient/guardian decision|32|||
170619858|NCT02792231|616616893|FG001|Overall Study|Patient/guardian decision|42|||
170619859|NCT02792231|616616892|FG000|Overall Study|Adverse Event|15|||
170619860|NCT02792231|616616893|FG001|Overall Study|Adverse Event|11|||
170619861|NCT02792231|616616892|FG000|Overall Study|Physician Decision|14|||
170619862|NCT02792231|616616893|FG001|Overall Study|Physician Decision|12|||
170619863|NCT02792231|616616892|FG000|Overall Study|Lack of Efficacy|7|||
170619864|NCT02792231|616616893|FG001|Overall Study|Lack of Efficacy|9|||
170619865|NCT02792231|616616892|FG000|Overall Study|Lost to Follow-up|9|||
170619866|NCT02792231|616616893|FG001|Overall Study|Lost to Follow-up|5|||
170619867|NCT02792231|616616892|FG000|Overall Study|Pregnancy|1|||
170619868|NCT02792231|616616893|FG001|Overall Study|Pregnancy|3|||
170619869|NCT02792231|616616892|FG000|Overall Study|Non-compliance with study treatment|2|||
170619870|NCT02792231|616616893|FG001|Overall Study|Non-compliance with study treatment|1|||
170619871|NCT02792231|616616892|FG000|Overall Study|Protocol deviation|2|||
170619872|NCT02792231|616616893|FG001|Overall Study|Protocol deviation|0|||
170619873|NCT02792231|616616892|FG000|Overall Study|Technical problems|0|||
170619874|NCT02792231|616616893|FG001|Overall Study|Technical problems|1|||
170619875|NCT03309878|616616894|FG000|Overall Study|Adverse Event|1|||
170619876|NCT03309878|616616895|FG001|Overall Study|Adverse Event|0|||
170619877|NCT03309878|616616896|FG002|Overall Study|Adverse Event|0|||
170619878|NCT03309878|616616897|FG003|Overall Study|Adverse Event|0|||
170619879|NCT03309878|616616894|FG000|Overall Study|Did not maintain eligibility|2|||
170619880|NCT03309878|616616895|FG001|Overall Study|Did not maintain eligibility|1|||
170619881|NCT03309878|616616896|FG002|Overall Study|Did not maintain eligibility|0|||
170619882|NCT03309878|616616897|FG003|Overall Study|Did not maintain eligibility|0|||
170619883|NCT03309878|616616894|FG000|Overall Study|Withdrawal by Subject|0|||
170619884|NCT03309878|616616895|FG001|Overall Study|Withdrawal by Subject|1|||
170619885|NCT03309878|616616896|FG002|Overall Study|Withdrawal by Subject|0|||
170619886|NCT03309878|616616897|FG003|Overall Study|Withdrawal by Subject|0|||
170619887|NCT01884077|616616898|FG000|Overall Study|screen fail|0|||
170619888|NCT01884077|616616899|FG001|Overall Study|screen fail|2|||
170619889|NCT01884077|616616898|FG000|Overall Study|canceled surgery|2|||
170619890|NCT01884077|616616899|FG001|Overall Study|canceled surgery|0|||
170619891|NCT01884077|616616898|FG000|Overall Study|Lost to Follow-up|0|||
170619892|NCT01884077|616616899|FG001|Overall Study|Lost to Follow-up|4|||
170619893|NCT01884077|616616898|FG000|Overall Study|study closed|6|||
170619894|NCT01884077|616616899|FG001|Overall Study|study closed|4|||
170619895|NCT01008943|616616903|FG000|Overall Study|Withdrawal by Subject|1|||
170619896|NCT02356159|616616904|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
170619897|NCT02356159|616616905|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
170619898|NCT02356159|616616906|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
170619899|NCT02356159|616616907|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
170619900|NCT02356159|616616908|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
170619901|NCT02356159|616616909|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
170619902|NCT03719131|616616911|FG000|Overall Study|Death|1|||
170917680|NCT03451851|617698812|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
170917681|NCT03451851|617698813|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
170917682|NCT03451851|617698814|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
170619903|NCT03719131|616616912|FG001|Overall Study|Death|2|||
170619904|NCT04244253|616616913|FG000|Overall Study|Adverse Event|2|||
170619905|NCT04244253|616616914|FG001|Overall Study|Adverse Event|2|||
170917683|NCT03451851|617698815|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
170917684|NCT03451851|617698816|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
170619906|NCT04244253|616616915|FG002|Overall Study|Adverse Event|4|||
170619907|NCT04244253|616616913|FG000|Overall Study|Protocol Violation|1|||
170619908|NCT04244253|616616914|FG001|Overall Study|Protocol Violation|2|||
170619909|NCT04244253|616616915|FG002|Overall Study|Protocol Violation|1|||
170619910|NCT04244253|616616913|FG000|Overall Study|Withdrawal by Subject|0|||
170619911|NCT04244253|616616914|FG001|Overall Study|Withdrawal by Subject|1|||
170619912|NCT04244253|616616915|FG002|Overall Study|Withdrawal by Subject|6|||
170917685|NCT03451851|617698817|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
170917686|NCT03451851|617698818|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
170917687|NCT03451851|617698819|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
170917688|NCT03451851|617698812|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
170917689|NCT03451851|617698813|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
170619913|NCT04244253|616616913|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170619914|NCT04244253|616616914|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170619915|NCT04244253|616616915|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170619916|NCT03360682|616616916|FG000|Overall Study|Adverse Event|3|||
170619917|NCT01544920|616616917|FG000|Overall Study|Adverse Event|0|||
170619918|NCT01544920|616616918|FG001|Overall Study|Adverse Event|3|||
170619919|NCT01544920|616616917|FG000|Overall Study|Death|0|||
170619920|NCT01544920|616616918|FG001|Overall Study|Death|1|||
170619921|NCT01544920|616616917|FG000|Overall Study|Lost to Follow-up|11|||
170619922|NCT01544920|616616918|FG001|Overall Study|Lost to Follow-up|12|||
170619923|NCT01544920|616616917|FG000|Overall Study|Protocol Violation|0|||
170619924|NCT01544920|616616918|FG001|Overall Study|Protocol Violation|2|||
170619925|NCT01544920|616616917|FG000|Overall Study|Physician Decision|4|||
170619926|NCT01544920|616616918|FG001|Overall Study|Physician Decision|1|||
170619927|NCT01544920|616616917|FG000|Overall Study|Withdrawal by Subject|4|||
170619928|NCT01544920|616616918|FG001|Overall Study|Withdrawal by Subject|4|||
170619929|NCT00619515|616616919|FG000|Overall Study|Study Termination by IRB|73|||
170619930|NCT02420093|616616920|FG000|Overall Study|Withdrawal by Subject|1|||
170619931|NCT02420093|616616921|FG001|Overall Study|Withdrawal by Subject|1|||
170619932|NCT02634333|616616925|FG000|Overall Study|Completed out of Window|3|||
170619933|NCT02634333|616616926|FG001|Overall Study|Completed out of Window|2|||
170619934|NCT02634333|616616925|FG000|Overall Study|Missed Visit|5|||
170619935|NCT02634333|616616926|FG001|Overall Study|Missed Visit|2|||
170619936|NCT02634333|616616925|FG000|Overall Study|Lost to Follow-up|12|||
170619937|NCT02634333|616616926|FG001|Overall Study|Lost to Follow-up|7|||
170619938|NCT02634333|616616925|FG000|Overall Study|Withdrawal by Subject|9|||
170619939|NCT02634333|616616926|FG001|Overall Study|Withdrawal by Subject|13|||
170619940|NCT02634333|616616925|FG000|Overall Study|Death|11|||
170619941|NCT02634333|616616926|FG001|Overall Study|Death|8|||
170619942|NCT03244917|616616927|FG000|Overall Study|Lost to Follow-up|2|||
170619943|NCT03244917|616616928|FG001|Overall Study|Lost to Follow-up|2|||
170619944|NCT03001557|616616932|FG000|Core Phase|Randomized but not treated|0|||
170619945|NCT03001557|616616933|FG001|Core Phase|Randomized but not treated|0|||
170619946|NCT03001557|616616934|FG002|Core Phase|Randomized but not treated|1|||
170619947|NCT03001557|616616935|FG003|Core Phase|Randomized but not treated|0|||
170619948|NCT03001557|616616936|FG004|Core Phase|Randomized but not treated|0|||
170619949|NCT03001557|616616937|FG005|Core Phase|Randomized but not treated|0|||
170619950|NCT03001557|616616938|FG006|Core Phase|Randomized but not treated|0|||
170619951|NCT03001557|616616939|FG007|Core Phase|Randomized but not treated|0|||
170619952|NCT03001557|616616932|FG000|Extension Phase|Adverse Event|0|||
170619953|NCT03001557|616616933|FG001|Extension Phase|Adverse Event|0|||
170619954|NCT03001557|616616934|FG002|Extension Phase|Adverse Event|0|||
170619955|NCT03001557|616616935|FG003|Extension Phase|Adverse Event|0|||
170619956|NCT03001557|616616936|FG004|Extension Phase|Adverse Event|0|||
170619957|NCT03001557|616616937|FG005|Extension Phase|Adverse Event|2|||
170619958|NCT03001557|616616938|FG006|Extension Phase|Adverse Event|0|||
170619959|NCT03001557|616616939|FG007|Extension Phase|Adverse Event|0|||
170619960|NCT03001557|616616932|FG000|Extension Phase|Withdrawal by Subject|0|||
170619961|NCT03001557|616616933|FG001|Extension Phase|Withdrawal by Subject|0|||
170619962|NCT03001557|616616934|FG002|Extension Phase|Withdrawal by Subject|0|||
170619963|NCT03001557|616616935|FG003|Extension Phase|Withdrawal by Subject|0|||
170619964|NCT03001557|616616936|FG004|Extension Phase|Withdrawal by Subject|0|||
170619965|NCT03001557|616616937|FG005|Extension Phase|Withdrawal by Subject|1|||
170619966|NCT03001557|616616938|FG006|Extension Phase|Withdrawal by Subject|5|||
170819109|NCT02123797|617345775|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
170619967|NCT03001557|616616939|FG007|Extension Phase|Withdrawal by Subject|2|||
170619968|NCT03001557|616616932|FG000|Extension Phase|Lost to Follow-up|0|||
170619969|NCT03001557|616616933|FG001|Extension Phase|Lost to Follow-up|0|||
170819110|NCT02123797|617345771|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
170819111|NCT02123797|617345772|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
170819112|NCT02123797|617345773|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
170819113|NCT02123797|617345774|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
170819114|NCT02123797|617345775|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
170819115|NCT02123797|617345771|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
170819116|NCT02123797|617345772|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
170619970|NCT03001557|616616934|FG002|Extension Phase|Lost to Follow-up|0|||
170619971|NCT03001557|616616935|FG003|Extension Phase|Lost to Follow-up|0|||
170619972|NCT03001557|616616936|FG004|Extension Phase|Lost to Follow-up|0|||
170619973|NCT03001557|616616937|FG005|Extension Phase|Lost to Follow-up|0|||
170619974|NCT03001557|616616938|FG006|Extension Phase|Lost to Follow-up|2|||
170619975|NCT03001557|616616939|FG007|Extension Phase|Lost to Follow-up|1|||
170619976|NCT03001557|616616932|FG000|Extension Phase|Administrative Reason|0|||
170619977|NCT03001557|616616933|FG001|Extension Phase|Administrative Reason|0|||
170619978|NCT03001557|616616934|FG002|Extension Phase|Administrative Reason|0|||
170619979|NCT03001557|616616935|FG003|Extension Phase|Administrative Reason|0|||
170619980|NCT03001557|616616936|FG004|Extension Phase|Administrative Reason|0|||
170619981|NCT03001557|616616937|FG005|Extension Phase|Administrative Reason|1|||
170619982|NCT03001557|616616938|FG006|Extension Phase|Administrative Reason|3|||
170619983|NCT03001557|616616939|FG007|Extension Phase|Administrative Reason|3|||
170619984|NCT03001557|616616932|FG000|Extension Phase|Loss of caregiver|0|||
170619985|NCT03001557|616616933|FG001|Extension Phase|Loss of caregiver|0|||
170619986|NCT03001557|616616934|FG002|Extension Phase|Loss of caregiver|0|||
170619987|NCT03001557|616616935|FG003|Extension Phase|Loss of caregiver|0|||
170619988|NCT03001557|616616936|FG004|Extension Phase|Loss of caregiver|0|||
170619989|NCT03001557|616616937|FG005|Extension Phase|Loss of caregiver|0|||
170619990|NCT03001557|616616938|FG006|Extension Phase|Loss of caregiver|1|||
170619991|NCT03001557|616616939|FG007|Extension Phase|Loss of caregiver|0|||
170619992|NCT03001557|616616932|FG000|Extension Phase|Others|0|||
170619993|NCT03001557|616616933|FG001|Extension Phase|Others|0|||
170619994|NCT03001557|616616934|FG002|Extension Phase|Others|0|||
170619995|NCT03001557|616616935|FG003|Extension Phase|Others|0|||
170619996|NCT03001557|616616936|FG004|Extension Phase|Others|0|||
170619997|NCT03001557|616616937|FG005|Extension Phase|Others|1|||
170619998|NCT03001557|616616938|FG006|Extension Phase|Others|3|||
170619999|NCT03001557|616616939|FG007|Extension Phase|Others|0|||
170620000|NCT00718510|616616942|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
170620001|NCT00718510|616616943|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
170620002|NCT00718510|616616942|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
170620003|NCT00718510|616616943|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
170620004|NCT01147666|616616944|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
170620005|NCT01147666|616616945|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
170620006|NCT01147666|616616946|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
170819117|NCT02123797|617345773|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
170819118|NCT02123797|617345774|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
170819119|NCT02123797|617345775|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
170819120|NCT02123797|617345771|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
170819121|NCT02123797|617345772|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
170819122|NCT02123797|617345773|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
170819123|NCT02123797|617345774|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
170819124|NCT02123797|617345775|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
170819125|NCT02123797|617345771|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
170819126|NCT02123797|617345772|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
170819127|NCT02123797|617345773|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
170819128|NCT02123797|617345774|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
170819129|NCT02123797|617345775|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
170819130|NCT00443755|617345776|FG000|Overall Study|Withdrawal by Subject|2|||
170819131|NCT00443755|617345777|FG001|Overall Study|Withdrawal by Subject|1|||
170819132|NCT02706834|617345779|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
170819133|NCT02706834|617345780|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
170819134|NCT02706834|617345781|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
170819135|NCT02706834|617345782|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
170819136|NCT02706834|617345783|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
170819137|NCT02706834|617345784|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
170819138|NCT02706834|617345785|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
170819139|NCT02706834|617345786|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
170819140|NCT02706834|617345787|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
170819141|NCT02706834|617345788|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
170819142|NCT02706834|617345789|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
170819143|NCT02706834|617345779|FG000|Overall Study|Lost to Follow-up|0|||
170819144|NCT02706834|617345780|FG001|Overall Study|Lost to Follow-up|0|||
170819145|NCT02706834|617345781|FG002|Overall Study|Lost to Follow-up|1|||
170819146|NCT02706834|617345782|FG003|Overall Study|Lost to Follow-up|0|||
170819147|NCT02706834|617345783|FG004|Overall Study|Lost to Follow-up|0|||
170819148|NCT02706834|617345784|FG005|Overall Study|Lost to Follow-up|0|||
170819149|NCT02706834|617345785|FG006|Overall Study|Lost to Follow-up|0|||
170819150|NCT02706834|617345786|FG007|Overall Study|Lost to Follow-up|0|||
170819151|NCT02706834|617345787|FG008|Overall Study|Lost to Follow-up|0|||
170819152|NCT02706834|617345788|FG009|Overall Study|Lost to Follow-up|0|||
170819153|NCT02706834|617345789|FG010|Overall Study|Lost to Follow-up|0|||
170819154|NCT02706834|617345779|FG000|Overall Study|Voluntary Withdrawal|1|||
170819155|NCT02706834|617345780|FG001|Overall Study|Voluntary Withdrawal|0|||
170620007|NCT01147666|616616947|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620008|NCT01147666|616616948|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620009|NCT01147666|616616949|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170819156|NCT02706834|617345781|FG002|Overall Study|Voluntary Withdrawal|0|||
170819157|NCT02706834|617345782|FG003|Overall Study|Voluntary Withdrawal|0|||
170819158|NCT02706834|617345783|FG004|Overall Study|Voluntary Withdrawal|0|||
170620010|NCT01147666|616616950|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620011|NCT01147666|616616951|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620012|NCT01147666|616616952|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620013|NCT01147666|616616953|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170669064|NCT00142298|616799539|FG000|Overall Study|Virologic breakthrough|19|||
170669065|NCT00142298|616799540|FG001|Overall Study|Virologic breakthrough|23|||
170669066|NCT00142298|616799541|FG002|Overall Study|Virologic breakthrough|9|||
170669067|NCT00142298|616799542|FG003|Overall Study|Virologic breakthrough|7|||
170669068|NCT00142298|616799543|FG004|Overall Study|Virologic breakthrough|2|||
170669069|NCT00142298|616799544|FG005|Overall Study|Virologic breakthrough|3|||
170669070|NCT00142298|616799545|FG006|Overall Study|Virologic breakthrough|3|||
170669071|NCT00142298|616799546|FG007|Overall Study|Virologic breakthrough|0|||
170669072|NCT00142298|616799547|FG008|Overall Study|Virologic breakthrough|0|||
170669073|NCT00142298|616799548|FG009|Overall Study|Virologic breakthrough|0|||
170669074|NCT00142298|616799539|FG000|Overall Study|Other- not specified|0|||
170620014|NCT01147666|616616954|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620015|NCT01147666|616616955|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620016|NCT01147666|616616956|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
170620017|NCT01147666|616616957|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620018|NCT01147666|616616958|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
170620019|NCT01147666|616616944|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
170620020|NCT01147666|616616945|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
170620021|NCT01147666|616616946|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
170620022|NCT01147666|616616947|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
170620023|NCT01147666|616616948|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
170620024|NCT01147666|616616949|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
170620025|NCT01147666|616616950|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
170620026|NCT01147666|616616951|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
170620027|NCT01147666|616616952|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
170620028|NCT01147666|616616953|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
170620029|NCT01147666|616616954|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
170620030|NCT01147666|616616955|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
170620031|NCT01147666|616616956|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
170620032|NCT01147666|616616957|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
170620033|NCT01147666|616616958|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
170620034|NCT01147666|616616944|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
170620035|NCT01147666|616616945|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
170620036|NCT01147666|616616946|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
170620037|NCT01147666|616616947|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
170620038|NCT01147666|616616948|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
170620039|NCT01147666|616616949|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
170620040|NCT01147666|616616950|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
170620041|NCT01147666|616616951|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
170620042|NCT01147666|616616952|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
170620043|NCT01147666|616616953|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
170620044|NCT01147666|616616954|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
170620045|NCT01147666|616616955|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
170620046|NCT01147666|616616956|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
170620047|NCT01147666|616616957|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
170620048|NCT01147666|616616958|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
170620049|NCT01147666|616616944|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
170620050|NCT01147666|616616945|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620051|NCT01147666|616616946|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620052|NCT01147666|616616947|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
170620053|NCT01147666|616616948|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620054|NCT01147666|616616949|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620055|NCT01147666|616616950|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620056|NCT01147666|616616951|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620057|NCT01147666|616616952|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170819159|NCT02706834|617345784|FG005|Overall Study|Voluntary Withdrawal|0|||
170819160|NCT02706834|617345785|FG006|Overall Study|Voluntary Withdrawal|0|||
170819161|NCT02706834|617345786|FG007|Overall Study|Voluntary Withdrawal|0|||
170819162|NCT02706834|617345787|FG008|Overall Study|Voluntary Withdrawal|0|||
170819163|NCT02706834|617345788|FG009|Overall Study|Voluntary Withdrawal|1|||
170819164|NCT02706834|617345789|FG010|Overall Study|Voluntary Withdrawal|0|||
170819165|NCT02706834|617345779|FG000|Overall Study|Other Reason Not Specified|1|||
170620058|NCT01147666|616616953|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620059|NCT01147666|616616954|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
170620060|NCT01147666|616616955|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620061|NCT01147666|616616956|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170669075|NCT00142298|616799540|FG001|Overall Study|Other- not specified|3|||
170669076|NCT00142298|616799541|FG002|Overall Study|Other- not specified|0|||
170819166|NCT02706834|617345780|FG001|Overall Study|Other Reason Not Specified|0|||
170819167|NCT02706834|617345781|FG002|Overall Study|Other Reason Not Specified|0|||
170819168|NCT02706834|617345782|FG003|Overall Study|Other Reason Not Specified|0|||
170620062|NCT01147666|616616957|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620063|NCT01147666|616616958|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
170620064|NCT01147666|616616944|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620065|NCT01147666|616616945|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620066|NCT01147666|616616946|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620067|NCT01147666|616616947|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620068|NCT01147666|616616948|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
170620069|NCT01147666|616616949|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
170620070|NCT01147666|616616950|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620071|NCT01147666|616616951|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
170620072|NCT01147666|616616952|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620073|NCT01147666|616616953|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
170620074|NCT01147666|616616954|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620075|NCT01147666|616616955|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
170620076|NCT01147666|616616956|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620077|NCT01147666|616616957|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
170620078|NCT01147666|616616958|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
170620079|NCT01147666|616616944|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620080|NCT01147666|616616945|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620081|NCT01147666|616616946|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620082|NCT01147666|616616947|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
170620083|NCT01147666|616616948|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620084|NCT01147666|616616949|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620085|NCT01147666|616616950|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620086|NCT01147666|616616951|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620087|NCT01147666|616616952|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620088|NCT01147666|616616953|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620089|NCT01147666|616616954|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
170620090|NCT01147666|616616955|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620091|NCT01147666|616616956|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620092|NCT01147666|616616957|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620093|NCT01147666|616616958|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
170620094|NCT01147666|616616944|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620095|NCT01147666|616616945|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620096|NCT01147666|616616946|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620097|NCT01147666|616616947|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620098|NCT01147666|616616948|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620099|NCT01147666|616616949|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620100|NCT01147666|616616950|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620101|NCT01147666|616616951|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620102|NCT01147666|616616952|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620103|NCT01147666|616616953|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620104|NCT01147666|616616954|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620105|NCT01147666|616616955|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
170620106|NCT01147666|616616956|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
170620107|NCT01147666|616616957|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
170620108|NCT01147666|616616958|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
170620109|NCT01147666|616616944|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
170620110|NCT01147666|616616945|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
170620111|NCT01147666|616616946|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
170620112|NCT01147666|616616947|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
170620113|NCT01147666|616616948|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
170620114|NCT01147666|616616949|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
170620115|NCT01147666|616616950|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
170620116|NCT01147666|616616951|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
170620117|NCT01147666|616616952|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
170620118|NCT01147666|616616953|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
170620119|NCT01147666|616616954|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
170819169|NCT02706834|617345783|FG004|Overall Study|Other Reason Not Specified|1|||
170819170|NCT02706834|617345784|FG005|Overall Study|Other Reason Not Specified|0|||
170819171|NCT02706834|617345785|FG006|Overall Study|Other Reason Not Specified|0|||
170819172|NCT02706834|617345786|FG007|Overall Study|Other Reason Not Specified|0|||
170819173|NCT02706834|617345787|FG008|Overall Study|Other Reason Not Specified|0|||
170819174|NCT02706834|617345788|FG009|Overall Study|Other Reason Not Specified|0|||
170819175|NCT02706834|617345789|FG010|Overall Study|Other Reason Not Specified|0|||
170819176|NCT00627523|617345791|FG000|Overall Study|Lack of Efficacy|1|||
170819177|NCT00627523|617345792|FG001|Overall Study|Lack of Efficacy|0|||
170917690|NCT03451851|617698814|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
170917691|NCT03451851|617698815|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
170917692|NCT03451851|617698816|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
170917693|NCT03451851|617698817|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
170917694|NCT03451851|617698818|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
170917695|NCT03451851|617698819|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
170917696|NCT03451851|617698812|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
170917697|NCT03451851|617698813|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
170917698|NCT03451851|617698814|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
170917699|NCT03451851|617698815|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
170917700|NCT03451851|617698816|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
170917701|NCT03451851|617698817|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
170917702|NCT03451851|617698818|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
170620120|NCT01147666|616616955|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
170620121|NCT01147666|616616956|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
170620122|NCT01147666|616616957|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
170917703|NCT03451851|617698819|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
170620123|NCT01147666|616616958|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
170620124|NCT01147666|616616944|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
170620125|NCT01147666|616616945|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
170620126|NCT01147666|616616946|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
170620127|NCT01147666|616616947|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
170620128|NCT01147666|616616948|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
170620129|NCT01147666|616616949|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
170620130|NCT01147666|616616950|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
170620131|NCT01147666|616616951|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
170620132|NCT01147666|616616952|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
170620133|NCT01147666|616616953|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
170620134|NCT01147666|616616954|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
170620135|NCT01147666|616616955|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
170620136|NCT01147666|616616956|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
170620137|NCT01147666|616616957|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
170620138|NCT01147666|616616958|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
170620139|NCT01147666|616616944|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620140|NCT01147666|616616945|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620141|NCT01147666|616616946|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620142|NCT01147666|616616947|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
170620143|NCT01147666|616616948|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620144|NCT01147666|616616949|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620145|NCT01147666|616616950|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620146|NCT01147666|616616951|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620147|NCT01147666|616616952|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620148|NCT01147666|616616953|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620149|NCT01147666|616616954|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620150|NCT01147666|616616955|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620151|NCT01147666|616616956|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620152|NCT01147666|616616957|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620153|NCT01147666|616616958|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
170620154|NCT01147666|616616944|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620155|NCT01147666|616616945|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620156|NCT01147666|616616946|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620157|NCT01147666|616616947|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620158|NCT01147666|616616948|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
170620159|NCT01147666|616616949|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
170620160|NCT01147666|616616950|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620161|NCT01147666|616616951|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
170620162|NCT01147666|616616952|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620163|NCT01147666|616616953|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
170620164|NCT01147666|616616954|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620165|NCT01147666|616616955|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620166|NCT01147666|616616956|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620167|NCT01147666|616616957|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
170917704|NCT03451851|617698812|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
170620168|NCT01147666|616616958|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
170620169|NCT01147666|616616944|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620170|NCT01147666|616616945|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620171|NCT01147666|616616946|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620172|NCT01147666|616616947|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
170620173|NCT01147666|616616948|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620174|NCT01147666|616616949|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620175|NCT01147666|616616950|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620176|NCT01147666|616616951|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620177|NCT01147666|616616952|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620178|NCT01147666|616616953|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620179|NCT01147666|616616954|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
170620180|NCT01147666|616616955|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620181|NCT01147666|616616956|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620182|NCT01147666|616616957|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620183|NCT01147666|616616958|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
170620184|NCT01147666|616616944|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620185|NCT01147666|616616945|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620186|NCT01147666|616616946|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620187|NCT01147666|616616947|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620188|NCT01147666|616616948|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620189|NCT01147666|616616949|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620190|NCT01147666|616616950|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620191|NCT01147666|616616951|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620192|NCT01147666|616616952|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620193|NCT01147666|616616953|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620194|NCT01147666|616616954|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620195|NCT01147666|616616955|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620196|NCT01147666|616616956|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
170620197|NCT01147666|616616957|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620198|NCT01147666|616616958|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
170620199|NCT01147666|616616944|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620200|NCT01147666|616616945|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620201|NCT01147666|616616946|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620202|NCT01147666|616616947|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620203|NCT01147666|616616948|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620204|NCT01147666|616616949|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620205|NCT01147666|616616950|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620206|NCT01147666|616616951|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620207|NCT01147666|616616952|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620208|NCT01147666|616616953|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620209|NCT01147666|616616954|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620210|NCT01147666|616616955|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620211|NCT01147666|616616956|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
170620212|NCT01147666|616616957|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
170620213|NCT01147666|616616958|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
170620214|NCT00423657|616616959|FG000|Overall Study|Withdrew consent|10|||
170620215|NCT00423657|616616960|FG001|Overall Study|Withdrew consent|8|||
170620216|NCT00423657|616616959|FG000|Overall Study|Non-compliance|0|||
170620217|NCT00423657|616616960|FG001|Overall Study|Non-compliance|1|||
170620218|NCT00423657|616616959|FG000|Overall Study|Other|15|||
170669077|NCT00142298|616799542|FG003|Overall Study|Other- not specified|1|||
170669078|NCT00142298|616799543|FG004|Overall Study|Other- not specified|0|||
170669079|NCT00142298|616799544|FG005|Overall Study|Other- not specified|0|||
170669080|NCT00142298|616799545|FG006|Overall Study|Other- not specified|0|||
170669081|NCT00142298|616799546|FG007|Overall Study|Other- not specified|0|||
170669082|NCT00142298|616799547|FG008|Overall Study|Other- not specified|0|||
170669083|NCT00142298|616799548|FG009|Overall Study|Other- not specified|0|||
170917705|NCT03451851|617698813|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
170917706|NCT03451851|617698814|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
170917707|NCT03451851|617698815|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
170917708|NCT03451851|617698816|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
170917709|NCT03451851|617698817|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
170917710|NCT03451851|617698818|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
170917711|NCT03451851|617698819|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
170917712|NCT03451851|617698812|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
170917713|NCT03451851|617698813|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
170917714|NCT03451851|617698814|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
170917715|NCT03451851|617698815|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
170669084|NCT00142298|616799539|FG000|Overall Study|Lost to Follow-up|0|||
170669085|NCT00142298|616799540|FG001|Overall Study|Lost to Follow-up|0|||
170669086|NCT00142298|616799541|FG002|Overall Study|Lost to Follow-up|0|||
170669087|NCT00142298|616799542|FG003|Overall Study|Lost to Follow-up|0|||
170669088|NCT00142298|616799543|FG004|Overall Study|Lost to Follow-up|0|||
170669089|NCT00142298|616799544|FG005|Overall Study|Lost to Follow-up|0|||
170669090|NCT00142298|616799545|FG006|Overall Study|Lost to Follow-up|2|||
170819178|NCT00627523|617345791|FG000|Overall Study|Withdrawal by Subject|0|||
170620219|NCT00423657|616616960|FG001|Overall Study|Other|16|||
170620220|NCT00423657|616616959|FG000|Overall Study|Request of sponsor/investigator|1|||
170620221|NCT00423657|616616960|FG001|Overall Study|Request of sponsor/investigator|0|||
170620222|NCT01135134|616616961|FG000|Overall Study|Adverse Event|1|||
170620223|NCT01135134|616616962|FG001|Overall Study|Adverse Event|1|||
170620224|NCT01135134|616616961|FG000|Overall Study|Did not meet protocol eligibility|1|||
170620225|NCT01135134|616616962|FG001|Overall Study|Did not meet protocol eligibility|0|||
170620226|NCT02576639|616616963|FG000|Overall Study|Withdrawal by Subject|1|||
170620227|NCT02576639|616616964|FG001|Overall Study|Withdrawal by Subject|2|||
170620228|NCT02576639|616616965|FG002|Overall Study|Withdrawal by Subject|1|||
170620229|NCT02576639|616616966|FG003|Overall Study|Withdrawal by Subject|0|||
170620230|NCT02576639|616616967|FG004|Overall Study|Withdrawal by Subject|1|||
170620231|NCT02576639|616616963|FG000|Overall Study|Adverse Event|1|||
170620232|NCT02576639|616616964|FG001|Overall Study|Adverse Event|0|||
170620233|NCT02576639|616616965|FG002|Overall Study|Adverse Event|1|||
170620234|NCT02576639|616616966|FG003|Overall Study|Adverse Event|1|||
170620235|NCT02576639|616616967|FG004|Overall Study|Adverse Event|2|||
170620236|NCT02576639|616616963|FG000|Overall Study|Physician Decision|0|||
170620237|NCT02576639|616616964|FG001|Overall Study|Physician Decision|0|||
170620238|NCT02576639|616616965|FG002|Overall Study|Physician Decision|0|||
170620239|NCT02576639|616616966|FG003|Overall Study|Physician Decision|0|||
170620240|NCT02576639|616616967|FG004|Overall Study|Physician Decision|1|||
170620241|NCT02653326|616616968|FG000|Overall Study|Lost to Follow-up|10|||
170620242|NCT02653326|616616969|FG001|Overall Study|Lost to Follow-up|7|||
170620243|NCT02422498|616616970|FG000|Overall Study|Inevaluable|4|||
170620244|NCT00628030|616616973|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
170620245|NCT00628030|616616974|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
170620246|NCT00628030|616616973|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
170620247|NCT00628030|616616974|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
170620248|NCT00628030|616616973|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
170620249|NCT00628030|616616974|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
170620250|NCT05470387|616616976|FG000|Overall Study|Protocol Violation|0|||
170620251|NCT05470387|616616977|FG001|Overall Study|Protocol Violation|3|||
170620252|NCT01009060|616616980|FG000|Overall Study|Adverse Event|1|||
170620253|NCT01009060|616616981|FG001|Overall Study|Adverse Event|2|||
170620254|NCT01009060|616616980|FG000|Overall Study|Protocol Violation|0|||
170620255|NCT01009060|616616981|FG001|Overall Study|Protocol Violation|1|||
170620256|NCT01009060|616616980|FG000|Overall Study|Lost to Follow-up|1|||
170620257|NCT01009060|616616981|FG001|Overall Study|Lost to Follow-up|0|||
170620258|NCT01009060|616616980|FG000|Overall Study|Physician Decision|1|||
170620259|NCT01009060|616616981|FG001|Overall Study|Physician Decision|1|||
170620260|NCT01009060|616616980|FG000|Overall Study|Withdrawal by Subject|1|||
170620261|NCT01009060|616616981|FG001|Overall Study|Withdrawal by Subject|1|||
170620262|NCT00005906|616616982|FG000|Overall Study|Lack of Efficacy|3|||
170620263|NCT00657046|616616983|FG000|Overall Study|Adverse Event|1|||
170620264|NCT00657046|616616984|FG001|Overall Study|Adverse Event|1|||
170620265|NCT00657046|616616985|FG002|Overall Study|Adverse Event|0|||
170620266|NCT00657046|616616983|FG000|Overall Study|Protocol Violation|2|||
170620267|NCT00657046|616616984|FG001|Overall Study|Protocol Violation|2|||
170620268|NCT00657046|616616985|FG002|Overall Study|Protocol Violation|0|||
170620269|NCT00657046|616616983|FG000|Overall Study|Withdrawal by Subject|1|||
170620270|NCT00657046|616616984|FG001|Overall Study|Withdrawal by Subject|0|||
170620271|NCT00657046|616616985|FG002|Overall Study|Withdrawal by Subject|0|||
170620272|NCT00657046|616616983|FG000|Overall Study|Death|0|||
170620273|NCT00657046|616616984|FG001|Overall Study|Death|0|||
170620274|NCT00657046|616616985|FG002|Overall Study|Death|1|||
170620275|NCT00657046|616616983|FG000|Overall Study|Surgery|0|||
170620276|NCT00657046|616616984|FG001|Overall Study|Surgery|0|||
170620277|NCT00657046|616616985|FG002|Overall Study|Surgery|1|||
170620278|NCT00300755|616616990|FG000|Overall Study|Adverse Event|1|||
170620279|NCT00300755|616616991|FG001|Overall Study|Adverse Event|2|||
170620280|NCT00300755|616616992|FG002|Overall Study|Adverse Event|1|||
170620281|NCT00300755|616616990|FG000|Overall Study|Withdrawal by Subject|0|||
170620282|NCT00300755|616616991|FG001|Overall Study|Withdrawal by Subject|2|||
170620283|NCT00300755|616616992|FG002|Overall Study|Withdrawal by Subject|0|||
170669091|NCT00142298|616799546|FG007|Overall Study|Lost to Follow-up|0|||
170620284|NCT00300755|616616990|FG000|Overall Study|Protocol Violation|0|||
170669092|NCT00142298|616799547|FG008|Overall Study|Lost to Follow-up|0|||
170620285|NCT00300755|616616991|FG001|Overall Study|Protocol Violation|0|||
170620286|NCT00300755|616616992|FG002|Overall Study|Protocol Violation|1|||
170819179|NCT00627523|617345792|FG001|Overall Study|Withdrawal by Subject|2|||
170620287|NCT01506271|616616993|FG000|Overall Study|Progressive disease|0|||
170620288|NCT01506271|616616994|FG001|Overall Study|Progressive disease|1|||
170620289|NCT01506271|616616995|FG002|Overall Study|Progressive disease|0|||
170620290|NCT01506271|616616993|FG000|Overall Study|Protocol Violation|3|||
170620291|NCT01506271|616616994|FG001|Overall Study|Protocol Violation|1|||
170620292|NCT01506271|616616995|FG002|Overall Study|Protocol Violation|0|||
170620293|NCT01506271|616616993|FG000|Overall Study|Death|0|||
170620294|NCT01506271|616616994|FG001|Overall Study|Death|1|||
170620295|NCT01506271|616616995|FG002|Overall Study|Death|0|||
170620296|NCT01506271|616616993|FG000|Overall Study|Adverse Event|0|||
170620297|NCT01506271|616616994|FG001|Overall Study|Adverse Event|2|||
170620298|NCT01506271|616616995|FG002|Overall Study|Adverse Event|0|||
170620299|NCT01506271|616616993|FG000|Overall Study|Insufficient supply of study drug|1|||
170620300|NCT01506271|616616994|FG001|Overall Study|Insufficient supply of study drug|0|||
170620301|NCT01506271|616616995|FG002|Overall Study|Insufficient supply of study drug|0|||
170620302|NCT01506271|616616993|FG000|Overall Study|Withdrawal by Subject|0|||
170620303|NCT01506271|616616994|FG001|Overall Study|Withdrawal by Subject|1|||
170620304|NCT01506271|616616995|FG002|Overall Study|Withdrawal by Subject|1|||
170620305|NCT01506271|616616993|FG000|Overall Study|Lost to Follow-up|0|||
170620306|NCT01506271|616616994|FG001|Overall Study|Lost to Follow-up|1|||
170620307|NCT01506271|616616995|FG002|Overall Study|Lost to Follow-up|2|||
170620308|NCT01391663|616616996|FG000|Overall Study|Withdrawal by Subject|0|||
170620309|NCT01391663|616616997|FG001|Overall Study|Withdrawal by Subject|0|||
170620310|NCT01391663|616616998|FG002|Overall Study|Withdrawal by Subject|1|||
170620311|NCT01391663|616616999|FG003|Overall Study|Withdrawal by Subject|0|||
170620312|NCT02294058|616617000|FG000|Overall Study|Adverse Event|16|||
170620313|NCT02294058|616617001|FG001|Overall Study|Adverse Event|7|||
170620314|NCT02294058|616617002|FG002|Overall Study|Adverse Event|13|||
170620315|NCT02294058|616617000|FG000|Overall Study|Lack of Efficacy|3|||
170620316|NCT02294058|616617001|FG001|Overall Study|Lack of Efficacy|3|||
170620317|NCT02294058|616617002|FG002|Overall Study|Lack of Efficacy|0|||
170620318|NCT02294058|616617000|FG000|Overall Study|Lost to Follow-up|1|||
170620319|NCT02294058|616617001|FG001|Overall Study|Lost to Follow-up|0|||
170620320|NCT02294058|616617002|FG002|Overall Study|Lost to Follow-up|2|||
170620321|NCT02294058|616617000|FG000|Overall Study|Withdrawal by Subject|10|||
170620322|NCT02294058|616617001|FG001|Overall Study|Withdrawal by Subject|14|||
170620323|NCT02294058|616617002|FG002|Overall Study|Withdrawal by Subject|13|||
170620324|NCT02294058|616617000|FG000|Overall Study|Physician Decision|2|||
170620325|NCT02294058|616617001|FG001|Overall Study|Physician Decision|1|||
170620326|NCT02294058|616617002|FG002|Overall Study|Physician Decision|0|||
170620327|NCT02294058|616617000|FG000|Overall Study|Miscellaneous|4|||
170620328|NCT02294058|616617001|FG001|Overall Study|Miscellaneous|1|||
170620329|NCT02294058|616617002|FG002|Overall Study|Miscellaneous|1|||
170620330|NCT03515824|616617003|FG000|Overall Study|Death|3|||
170620331|NCT03515824|616617004|FG001|Overall Study|Death|2|||
170620332|NCT03515824|616617005|FG002|Overall Study|Death|6|||
170620333|NCT03515824|616617006|FG003|Overall Study|Death|0|||
170620334|NCT03515824|616617003|FG000|Overall Study|Lost to Follow-up|0|||
170620335|NCT03515824|616617004|FG001|Overall Study|Lost to Follow-up|1|||
170620336|NCT03515824|616617005|FG002|Overall Study|Lost to Follow-up|1|||
170620337|NCT03515824|616617006|FG003|Overall Study|Lost to Follow-up|0|||
170620338|NCT03515824|616617003|FG000|Overall Study|Study terminated by sponsor|0|||
170620339|NCT03515824|616617004|FG001|Overall Study|Study terminated by sponsor|1|||
170620340|NCT03515824|616617005|FG002|Overall Study|Study terminated by sponsor|6|||
170620341|NCT03515824|616617006|FG003|Overall Study|Study terminated by sponsor|0|||
170620342|NCT03515824|616617003|FG000|Overall Study|Status not recorded|0|||
170620343|NCT03515824|616617004|FG001|Overall Study|Status not recorded|0|||
170620344|NCT03515824|616617005|FG002|Overall Study|Status not recorded|2|||
170620345|NCT03515824|616617006|FG003|Overall Study|Status not recorded|0|||
170620346|NCT06172348|616617010|FG000|Treatment Period 2|Adverse Event|0|||
170819180|NCT00627523|617345791|FG000|Overall Study|Other|1|||
170819181|NCT00627523|617345792|FG001|Overall Study|Other|0|||
170620347|NCT06172348|616617011|FG001|Treatment Period 2|Adverse Event|0|||
170620348|NCT06172348|616617012|FG002|Treatment Period 2|Adverse Event|1|||
170620349|NCT06172348|616617013|FG003|Treatment Period 2|Adverse Event|0|||
170620350|NCT06172348|616617014|FG004|Treatment Period 2|Adverse Event|0|||
170620351|NCT06172348|616617015|FG005|Treatment Period 2|Adverse Event|0|||
170620352|NCT03799341|616617018|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
170620353|NCT03799341|616617019|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
170620354|NCT03799341|616617020|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
170620355|NCT03799341|616617018|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
170620356|NCT03799341|616617019|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
170620357|NCT03799341|616617020|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
170620358|NCT03799341|616617018|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
170620359|NCT03799341|616617019|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
170620360|NCT03799341|616617020|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
170620361|NCT03799341|616617018|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
170620362|NCT03799341|616617019|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
170620363|NCT03799341|616617020|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
170620364|NCT03799341|616617018|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
170620365|NCT03799341|616617019|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
170620366|NCT03799341|616617020|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
170620367|NCT03799341|616617018|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
170620368|NCT03799341|616617019|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
170620369|NCT03799341|616617020|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
170620370|NCT00191334|616617021|FG000|Overall Study|Adverse Event|4|||
170620371|NCT00191334|616617021|FG000|Overall Study|Disease Progression or Relapse|8|||
170620372|NCT00191334|616617021|FG000|Overall Study|Physician Decision|1|||
170620373|NCT00191334|616617021|FG000|Overall Study|Withdrawal by Subject|4|||
170620374|NCT04564846|616618977|FG000|Overall Study|Withdrawal by Subject|2|||
170620375|NCT04564846|616618978|FG001|Overall Study|Withdrawal by Subject|1|||
170620376|NCT04564846|616618977|FG000|Overall Study|Physician Decision|0|||
170620377|NCT04564846|616618978|FG001|Overall Study|Physician Decision|1|||
170620378|NCT04564846|616618977|FG000|Overall Study|Lost to Follow-up|0|||
170620379|NCT04564846|616618978|FG001|Overall Study|Lost to Follow-up|1|||
170620380|NCT04564846|616618977|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
170620381|NCT04564846|616618978|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
170620382|NCT04564846|616618977|FG000|Overall Study|Subject non-compliance|1|||
170620383|NCT04564846|616618978|FG001|Overall Study|Subject non-compliance|0|||
170620384|NCT00179621|616618979|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
170620385|NCT00179621|616618980|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
170620386|NCT00179621|616618981|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
170620387|NCT00179621|616618982|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
170620388|NCT00179621|616618979|FG000|Double-Blind Period|Adverse Event|2|||
170620389|NCT00179621|616618980|FG001|Double-Blind Period|Adverse Event|7|||
170620390|NCT00179621|616618981|FG002|Double-Blind Period|Adverse Event|4|||
170620391|NCT00179621|616618982|FG003|Double-Blind Period|Adverse Event|0|||
170620392|NCT00179621|616618979|FG000|Double-Blind Period|Withdrawal by Subject|2|||
170620393|NCT00179621|616618980|FG001|Double-Blind Period|Withdrawal by Subject|1|||
170620394|NCT00179621|616618981|FG002|Double-Blind Period|Withdrawal by Subject|3|||
170620395|NCT00179621|616618982|FG003|Double-Blind Period|Withdrawal by Subject|0|||
170620396|NCT00179621|616618979|FG000|Double-Blind Period|Death|0|||
170620397|NCT00179621|616618980|FG001|Double-Blind Period|Death|1|||
170620398|NCT00179621|616618981|FG002|Double-Blind Period|Death|2|||
170620399|NCT00179621|616618982|FG003|Double-Blind Period|Death|0|||
170620400|NCT00179621|616618979|FG000|Double-Blind Period|Protocol Violation|1|||
170620401|NCT00179621|616618980|FG001|Double-Blind Period|Protocol Violation|0|||
170620402|NCT00179621|616618981|FG002|Double-Blind Period|Protocol Violation|0|||
170620403|NCT00179621|616618982|FG003|Double-Blind Period|Protocol Violation|0|||
170620404|NCT00179621|616618979|FG000|Double-Blind Period|Other|0|||
170620405|NCT00179621|616618980|FG001|Double-Blind Period|Other|2|||
170620406|NCT00179621|616618981|FG002|Double-Blind Period|Other|2|||
170620407|NCT00179621|616618982|FG003|Double-Blind Period|Other|0|||
170620408|NCT00179621|616618979|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
170620409|NCT00179621|616618980|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
170620410|NCT00179621|616618981|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
170620411|NCT00179621|616618982|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
170620412|NCT00179621|616618979|FG000|Open-Label Period|Adverse Event|0|||
170620413|NCT00179621|616618980|FG001|Open-Label Period|Adverse Event|6|||
170620414|NCT00179621|616618981|FG002|Open-Label Period|Adverse Event|5|||
170620415|NCT00179621|616618982|FG003|Open-Label Period|Adverse Event|6|||
170620416|NCT00179621|616618979|FG000|Open-Label Period|Withdrawal by Subject|0|||
170620417|NCT00179621|616618980|FG001|Open-Label Period|Withdrawal by Subject|2|||
170620418|NCT00179621|616618981|FG002|Open-Label Period|Withdrawal by Subject|2|||
170620419|NCT00179621|616618982|FG003|Open-Label Period|Withdrawal by Subject|2|||
170620420|NCT00179621|616618979|FG000|Open-Label Period|Death|0|||
170620421|NCT00179621|616618980|FG001|Open-Label Period|Death|0|||
170620422|NCT00179621|616618981|FG002|Open-Label Period|Death|1|||
170620423|NCT00179621|616618982|FG003|Open-Label Period|Death|2|||
170620424|NCT00179621|616618979|FG000|Open-Label Period|Other|0|||
170620425|NCT00179621|616618980|FG001|Open-Label Period|Other|1|||
170620426|NCT00179621|616618981|FG002|Open-Label Period|Other|1|||
170620427|NCT00179621|616618982|FG003|Open-Label Period|Other|2|||
170620428|NCT01419236|616618988|FG000|Overall Study|Adverse Event|1|||
170620429|NCT01419236|616618989|FG001|Overall Study|Adverse Event|0|||
170620430|NCT01419236|616618988|FG000|Overall Study|Lack of Efficacy|0|||
170620431|NCT01419236|616618989|FG001|Overall Study|Lack of Efficacy|1|||
170620432|NCT01419236|616618988|FG000|Overall Study|Lost to Follow-up|1|||
170620433|NCT01419236|616618989|FG001|Overall Study|Lost to Follow-up|0|||
170620434|NCT01419236|616618988|FG000|Overall Study|Physician Decision|1|||
170620435|NCT01419236|616618989|FG001|Overall Study|Physician Decision|0|||
170620436|NCT01419236|616618988|FG000|Overall Study|Withdrawal by Subject|1|||
170620437|NCT01419236|616618989|FG001|Overall Study|Withdrawal by Subject|4|||
170620438|NCT01419236|616618988|FG000|Overall Study|Entry Criteria Not Met|1|||
170669093|NCT00142298|616799548|FG009|Overall Study|Lost to Follow-up|0|||
170620439|NCT01419236|616618989|FG001|Overall Study|Entry Criteria Not Met|0|||
170620440|NCT04456504|616618990|FG000|Overall Study|Lost to Follow-up|2|||
170620441|NCT00762359|616618991|FG000|Overall Study|Adverse Event|20|||
170620442|NCT00762359|616618992|FG001|Overall Study|Adverse Event|23|||
170620443|NCT00762359|616618991|FG000|Overall Study|Protocol Violation|21|||
170620444|NCT00762359|616618992|FG001|Overall Study|Protocol Violation|13|||
170620445|NCT00762359|616618991|FG000|Overall Study|Withdrawal by Subject|13|||
170620446|NCT00762359|616618992|FG001|Overall Study|Withdrawal by Subject|10|||
170620447|NCT00762359|616618991|FG000|Overall Study|Lack of Efficacy|0|||
170620448|NCT00762359|616618992|FG001|Overall Study|Lack of Efficacy|4|||
170620449|NCT00762359|616618991|FG000|Overall Study|Institution closed|2|||
170620450|NCT00762359|616618992|FG001|Overall Study|Institution closed|3|||
170620451|NCT00762359|616618991|FG000|Overall Study|Physician Decision|2|||
170620452|NCT00762359|616618992|FG001|Overall Study|Physician Decision|3|||
170620453|NCT00762359|616618991|FG000|Overall Study|Removal|0|||
170620454|NCT00762359|616618992|FG001|Overall Study|Removal|1|||
170620455|NCT00762359|616618991|FG000|Overall Study|Withdrew consent|1|||
170620456|NCT00762359|616618992|FG001|Overall Study|Withdrew consent|0|||
170620457|NCT02891174|616618999|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
170620458|NCT02891174|616619000|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
170620459|NCT02891174|616618999|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
170620460|NCT02891174|616619000|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
170620461|NCT02891174|616618999|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
170620462|NCT02891174|616619000|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
170620463|NCT02891174|616618999|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
170620464|NCT02891174|616619000|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
170620465|NCT02891174|616618999|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
170620466|NCT02891174|616619000|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
170620467|NCT02891174|616618999|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
170620468|NCT02891174|616619000|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
170620469|NCT02891174|616618999|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
170620470|NCT02891174|616619000|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
170620471|NCT04319198|616619001|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
170620472|NCT04319198|616619002|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
170620473|NCT04319198|616619003|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
170620474|NCT04319198|616619001|FG000|Overall Study|Death|0|||
170620475|NCT04319198|616619002|FG001|Overall Study|Death|3|||
170620476|NCT04319198|616619003|FG002|Overall Study|Death|3|||
170620477|NCT04319198|616619001|FG000|Overall Study|Reason Not Specified|0|||
170620478|NCT04319198|616619002|FG001|Overall Study|Reason Not Specified|2|||
170620479|NCT04319198|616619003|FG002|Overall Study|Reason Not Specified|4|||
170620480|NCT04319198|616619001|FG000|Overall Study|Withdrawal of Consent|0|||
170620481|NCT04319198|616619002|FG001|Overall Study|Withdrawal of Consent|0|||
170620482|NCT04319198|616619003|FG002|Overall Study|Withdrawal of Consent|5|||
170620483|NCT04319198|616619001|FG000|Overall Study|Site Terminated by Sponsor|0|||
170620484|NCT04319198|616619002|FG001|Overall Study|Site Terminated by Sponsor|1|||
170620485|NCT04319198|616619003|FG002|Overall Study|Site Terminated by Sponsor|0|||
170620486|NCT01693029|616619004|FG000|Overall Study|Withdrawal by Subject|15|||
170620487|NCT01693029|616619005|FG001|Overall Study|Withdrawal by Subject|22|||
170620488|NCT01693029|616619004|FG000|Overall Study|Kidney transplantation|7|||
170620489|NCT01693029|616619005|FG001|Overall Study|Kidney transplantation|7|||
170620490|NCT01693029|616619004|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
170620491|NCT01693029|616619005|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
170620492|NCT01693029|616619004|FG000|Overall Study|Protocol Violation|6|||
170620493|NCT01693029|616619005|FG001|Overall Study|Protocol Violation|7|||
170620494|NCT01693029|616619004|FG000|Overall Study|Change in dialysis modality|2|||
170620495|NCT01693029|616619005|FG001|Overall Study|Change in dialysis modality|1|||
170620496|NCT01693029|616619004|FG000|Overall Study|Physician Decision|0|||
170620497|NCT01693029|616619005|FG001|Overall Study|Physician Decision|2|||
170819182|NCT04385849|617345797|FG000|Overall Study|Lost to Follow-up|1|||
170819183|NCT04385849|617345798|FG001|Overall Study|Lost to Follow-up|0|||
170819184|NCT00355784|617345801|FG000|Overall Study|Withdrawal by Subject|0|||
170819185|NCT00355784|617345802|FG001|Overall Study|Withdrawal by Subject|0|||
170620498|NCT01693029|616619004|FG000|Overall Study|Lost to Follow-up|0|||
170620499|NCT01693029|616619005|FG001|Overall Study|Lost to Follow-up|1|||
170620500|NCT01693029|616619004|FG000|Overall Study|Adverse Event|1|||
170620501|NCT01693029|616619005|FG001|Overall Study|Adverse Event|6|||
170620502|NCT01693029|616619004|FG000|Overall Study|Death|5|||
170620503|NCT01693029|616619005|FG001|Overall Study|Death|8|||
170620504|NCT01693029|616619004|FG000|Overall Study|Non-compliance|2|||
170620505|NCT01693029|616619005|FG001|Overall Study|Non-compliance|1|||
170620506|NCT01702844|616619006|FG000|Overall Study|Adverse Event|9|||
170620507|NCT01702844|616619006|FG000|Overall Study|Death|1|||
170669094|NCT00142298|616799539|FG000|Overall Study|Treatment Failure|0|||
170620508|NCT01702844|616619006|FG000|Overall Study|Withdrawal by Subject|3|||
170620509|NCT01702844|616619006|FG000|Overall Study|Physician Decision|6|||
170620510|NCT01169103|616619007|FG000|Overall Study|Lost to Follow-up|3|||
170620511|NCT01169103|616619008|FG001|Overall Study|Lost to Follow-up|3|||
170620512|NCT01169103|616619007|FG000|Overall Study|Withdrawal by Subject|3|||
170620513|NCT01169103|616619008|FG001|Overall Study|Withdrawal by Subject|1|||
170620514|NCT00141453|616619009|FG000|Overall Study|Protocol Violation|6|||
170620515|NCT00141453|616619010|FG001|Overall Study|Protocol Violation|5|||
170620516|NCT02043938|616619011|FG000|Overall Study|Withdrawal by Subject|7|||
170620517|NCT02043938|616619011|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
170620518|NCT02043938|616619011|FG000|Overall Study|No show by subject|1|||
170620519|NCT02043938|616619011|FG000|Overall Study|Investigator decision|1|||
170620520|NCT01458639|616619012|FG000|Overall Study|Physician Decision|4|||
170620521|NCT01458639|616619012|FG000|Overall Study|Equipment issue|1|||
170620522|NCT01458639|616619012|FG000|Overall Study|Inability to obtain subject blood sample|1|||
170917716|NCT03451851|617698816|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
170917717|NCT03451851|617698817|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
170917718|NCT03451851|617698818|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
170917719|NCT03451851|617698819|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
170917720|NCT03580928|617699074|FG000|Overall Study|Death|0|||
170917721|NCT03580928|617699075|FG001|Overall Study|Death|3|||
170917722|NCT03580928|617699074|FG000|Overall Study|Withdrawal by Subject|2|||
170917723|NCT03580928|617699075|FG001|Overall Study|Withdrawal by Subject|1|||
170917724|NCT03580928|617699074|FG000|Overall Study|Lost to Follow-up|2|||
170917725|NCT03580928|617699075|FG001|Overall Study|Lost to Follow-up|0|||
170917726|NCT03580928|617699074|FG000|Overall Study|Progressive Disease|0|||
170917727|NCT03580928|617699075|FG001|Overall Study|Progressive Disease|1|||
170917728|NCT05534984|617699077|FG000|Overall Study|Negative for HMPXV|30|||
170917729|NCT05534984|617699078|FG001|Overall Study|Negative for HMPXV|21|||
170917730|NCT05534984|617699079|FG002|Overall Study|Negative for HMPXV|20|||
170917731|NCT05534984|617699077|FG000|Overall Study|Lost to Follow-up|23|||
170917732|NCT05534984|617699078|FG001|Overall Study|Lost to Follow-up|11|||
170917733|NCT05534984|617699079|FG002|Overall Study|Lost to Follow-up|26|||
170917734|NCT05534984|617699077|FG000|Overall Study|Withdrawal by Subject|6|||
170917735|NCT05534984|617699078|FG001|Overall Study|Withdrawal by Subject|3|||
170917736|NCT05534984|617699079|FG002|Overall Study|Withdrawal by Subject|2|||
170917737|NCT05534984|617699077|FG000|Overall Study|Adverse Event|0|||
170917738|NCT05534984|617699078|FG001|Overall Study|Adverse Event|1|||
170917739|NCT05534984|617699079|FG002|Overall Study|Adverse Event|0|||
170917740|NCT03301350|617699080|FG000|Overall Study|Withdrawal by Subject|4|||
170917741|NCT03301350|617699080|FG000|Overall Study|Adverse Event|1|||
170917742|NCT03301350|617699080|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
170917743|NCT03301350|617699080|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
170917744|NCT03301350|617699080|FG000|Overall Study|no detail provided|1|||
170917745|NCT05383755|617699082|FG000|Aim 1 Phase 3: Pilot Clinical Trial|Lost to Follow-up|1|||
170620523|NCT02656017|616619013|FG000|Overall Study|Study burden|3|||
170620524|NCT02656017|616619014|FG001|Overall Study|Study burden|3|||
170620525|NCT02656017|616619013|FG000|Overall Study|Adverse Event|2|||
170620526|NCT02656017|616619014|FG001|Overall Study|Adverse Event|1|||
170669095|NCT00142298|616799540|FG001|Overall Study|Treatment Failure|0|||
170620527|NCT02656017|616619013|FG000|Overall Study|Unable/unwilling to take study medication|2|||
170620528|NCT02656017|616619014|FG001|Overall Study|Unable/unwilling to take study medication|1|||
170620529|NCT02656017|616619013|FG000|Overall Study|Began Tolvaptan|1|||
170620530|NCT02656017|616619014|FG001|Overall Study|Began Tolvaptan|1|||
170620531|NCT02656017|616619013|FG000|Overall Study|Withdrawal by Subject|1|||
170620532|NCT02656017|616619014|FG001|Overall Study|Withdrawal by Subject|0|||
170620533|NCT02314052|616619016|FG000|Cycle One|Adverse Event|0|||
170620534|NCT02314052|616619017|FG001|Cycle One|Adverse Event|0|||
170620535|NCT02314052|616619018|FG002|Cycle One|Adverse Event|0|||
170620536|NCT02314052|616619019|FG003|Cycle One|Adverse Event|1|||
170620537|NCT02314052|616619020|FG004|Cycle One|Adverse Event|0|||
170620538|NCT02314052|616619021|FG005|Cycle One|Adverse Event|0|||
170620539|NCT00474955|616619022|FG000|Overall Study|Adverse Event|2|||
170620540|NCT00474955|616619022|FG000|Overall Study|Drug unavailability|1|||
170620541|NCT00474955|616619022|FG000|Overall Study|Personal reasons|5|||
170620542|NCT03206216|616619023|FG000|Overall Study|Withdrawal by Subject|0|||
170620543|NCT03206216|616619024|FG001|Overall Study|Withdrawal by Subject|1|||
170620544|NCT02694744|616619030|FG000|Overall Study|Adverse Event|2|||
170620545|NCT02694744|616619031|FG001|Overall Study|Adverse Event|1|||
170620546|NCT02694744|616619030|FG000|Overall Study|Withdrawal by Subject|2|||
170620547|NCT02694744|616619031|FG001|Overall Study|Withdrawal by Subject|1|||
170620548|NCT02694744|616619030|FG000|Overall Study|Physician Decision|1|||
170620549|NCT02694744|616619031|FG001|Overall Study|Physician Decision|2|||
170620550|NCT02694744|616619030|FG000|Overall Study|Lost to Follow-up|1|||
170620551|NCT02694744|616619031|FG001|Overall Study|Lost to Follow-up|0|||
170620552|NCT02694744|616619030|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
170620553|NCT02694744|616619031|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
170620554|NCT00883779|616619032|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
170620555|NCT00883779|616619033|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
170620556|NCT00883779|616619032|FG000|Primary Study Treatment Phase|Disease progression|75|||
170620557|NCT00883779|616619033|FG001|Primary Study Treatment Phase|Disease progression|59|||
170620558|NCT00883779|616619032|FG000|Primary Study Treatment Phase|Adverse Event|16|||
170620559|NCT00883779|616619033|FG001|Primary Study Treatment Phase|Adverse Event|16|||
170620560|NCT00883779|616619032|FG000|Primary Study Treatment Phase|Death|2|||
170620561|NCT00883779|616619033|FG001|Primary Study Treatment Phase|Death|3|||
170620562|NCT00883779|616619032|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
170620563|NCT00883779|616619033|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
170620564|NCT00883779|616619032|FG000|Primary Study Treatment Phase|Other|3|||
170620565|NCT00883779|616619033|FG001|Primary Study Treatment Phase|Other|0|||
170620566|NCT00883779|616619032|FG000|Post-Study Treatment Phase|Adverse Event|2|||
170620567|NCT00883779|616619033|FG001|Post-Study Treatment Phase|Adverse Event|3|||
170620568|NCT00883779|616619032|FG000|Post-Study Treatment Phase|Death|1|||
170620569|NCT00883779|616619033|FG001|Post-Study Treatment Phase|Death|3|||
170620570|NCT00883779|616619032|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
170620571|NCT00883779|616619033|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
170620572|NCT00883779|616619032|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
170620573|NCT00883779|616619033|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
170620574|NCT00883779|616619032|FG000|Post-Study Treatment Phase|Disease progression|103|||
170620575|NCT00883779|616619033|FG001|Post-Study Treatment Phase|Disease progression|122|||
170620576|NCT00883779|616619032|FG000|Post-Study Treatment Phase|Other|3|||
170620577|NCT00883779|616619033|FG001|Post-Study Treatment Phase|Other|0|||
170620578|NCT00883779|616619032|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
170620579|NCT00883779|616619033|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
170620580|NCT00883779|616619032|FG000|Off-study Phase|Death|185|||
170620581|NCT00883779|616619033|FG001|Off-study Phase|Death|174|||
170620582|NCT00883779|616619032|FG000|Off-study Phase|Refused treatment|1|||
170620583|NCT00883779|616619033|FG001|Off-study Phase|Refused treatment|1|||
170620584|NCT00883779|616619032|FG000|Off-study Phase|Failure to return|5|||
170620585|NCT00883779|616619033|FG001|Off-study Phase|Failure to return|6|||
170620586|NCT00883779|616619032|FG000|Off-study Phase|Other|18|||
170620587|NCT00883779|616619033|FG001|Off-study Phase|Other|21|||
170620588|NCT00325897|616619034|FG000|Overall Study|Lost to Follow-up|12|||
170620589|NCT00325897|616619035|FG001|Overall Study|Lost to Follow-up|13|||
170620590|NCT04575155|616619036|FG000|2 Month|Withdrawal by Subject|1|||
170620591|NCT04575155|616619037|FG001|2 Month|Withdrawal by Subject|1|||
170620592|NCT04575155|616619036|FG000|2 Month|Lost to Follow-up|5|||
170620593|NCT04575155|616619037|FG001|2 Month|Lost to Follow-up|3|||
170620594|NCT04575155|616619036|FG000|2 Month|Ineligible|1|||
170620595|NCT04575155|616619037|FG001|2 Month|Ineligible|0|||
170620596|NCT03915717|616619038|FG000|Overall Study|EchoMark Not Implanted|6|||
170620597|NCT01239381|616619040|FG000|Overall Study|Protocol Violation|1|||
170620598|NCT01239381|616619040|FG000|Overall Study|Withdrawal by Subject|1|||
170620599|NCT06237049|616619041|FG000|Overall Study|Death|0|||
170620600|NCT06237049|616619042|FG001|Overall Study|Death|0|||
170620601|NCT06237049|616619043|FG002|Overall Study|Death|0|||
170620602|NCT06237049|616619044|FG003|Overall Study|Death|1|||
170620603|NCT06237049|616619041|FG000|Overall Study|Lost to Follow-up|11|||
170620604|NCT06237049|616619042|FG001|Overall Study|Lost to Follow-up|5|||
170620605|NCT06237049|616619043|FG002|Overall Study|Lost to Follow-up|8|||
170620606|NCT06237049|616619044|FG003|Overall Study|Lost to Follow-up|8|||
170620607|NCT06237049|616619041|FG000|Overall Study|Protocol Violation|0|||
170620608|NCT06237049|616619042|FG001|Overall Study|Protocol Violation|1|||
170620609|NCT06237049|616619043|FG002|Overall Study|Protocol Violation|0|||
170620610|NCT06237049|616619044|FG003|Overall Study|Protocol Violation|1|||
170620611|NCT06237049|616619041|FG000|Overall Study|Withdrawal by Subject|4|||
170620612|NCT06237049|616619042|FG001|Overall Study|Withdrawal by Subject|2|||
170620613|NCT06237049|616619043|FG002|Overall Study|Withdrawal by Subject|1|||
170620614|NCT06237049|616619044|FG003|Overall Study|Withdrawal by Subject|0|||
170620615|NCT03748823|616619045|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
170620616|NCT03748823|616619046|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
170620617|NCT03748823|616619045|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
170620618|NCT03748823|616619046|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
170620619|NCT03748823|616619045|FG000|Extension Period|Withdrawal by Subject|9|||
170620620|NCT03748823|616619046|FG001|Extension Period|Withdrawal by Subject|12|||
170620621|NCT03748823|616619045|FG000|Extension Period|Death|2|||
170620622|NCT03748823|616619046|FG001|Extension Period|Death|2|||
170620623|NCT03748823|616619045|FG000|Extension Period|Other than Specified|0|||
170620624|NCT03748823|616619046|FG001|Extension Period|Other than Specified|1|||
170620625|NCT03748823|616619045|FG000|Extension Period|Protocol Violation|1|||
170620626|NCT03748823|616619046|FG001|Extension Period|Protocol Violation|0|||
170620627|NCT03748823|616619045|FG000|Extension Period|Lost to Follow-up|0|||
170620628|NCT03748823|616619046|FG001|Extension Period|Lost to Follow-up|1|||
170620629|NCT03748823|616619045|FG000|Extension Period|Lack of Efficacy|0|||
170620630|NCT03748823|616619046|FG001|Extension Period|Lack of Efficacy|1|||
170669096|NCT00142298|616799541|FG002|Overall Study|Treatment Failure|0|||
170669097|NCT00142298|616799542|FG003|Overall Study|Treatment Failure|0|||
170669098|NCT00142298|616799543|FG004|Overall Study|Treatment Failure|0|||
170669099|NCT00142298|616799544|FG005|Overall Study|Treatment Failure|2|||
170669100|NCT00142298|616799545|FG006|Overall Study|Treatment Failure|2|||
170669101|NCT00142298|616799546|FG007|Overall Study|Treatment Failure|0|||
170669102|NCT00142298|616799547|FG008|Overall Study|Treatment Failure|0|||
170620631|NCT03748823|616619045|FG000|Extension Period|Physician Decision|1|||
170669103|NCT00142298|616799548|FG009|Overall Study|Treatment Failure|0|||
170620632|NCT03748823|616619046|FG001|Extension Period|Physician Decision|2|||
170620633|NCT00867165|616619048|FG000|Overall Study|Adverse Event|3|||
170620634|NCT00867165|616619049|FG001|Overall Study|Adverse Event|0|||
170620635|NCT00867165|616619048|FG000|Overall Study|Withdrawal by Subject|1|||
170620636|NCT00867165|616619049|FG001|Overall Study|Withdrawal by Subject|0|||
170669104|NCT00242216|616799549|FG000|Overall Study|Lost to Follow-up|12|||
170669105|NCT00242216|616799550|FG001|Overall Study|Lost to Follow-up|17|||
170669106|NCT00242216|616799549|FG000|Overall Study|Death|4|||
170669107|NCT00242216|616799550|FG001|Overall Study|Death|2|||
170669108|NCT00242216|616799549|FG000|Overall Study|Lack of Efficacy|1|||
170669109|NCT00242216|616799550|FG001|Overall Study|Lack of Efficacy|2|||
170669110|NCT00242216|616799549|FG000|Overall Study|no medicaiton dispensed|1|||
170669111|NCT00242216|616799550|FG001|Overall Study|no medicaiton dispensed|1|||
170669112|NCT01995825|616801032|FG000|Overall Study|Withdrawal by Subject|1|||
170669113|NCT01995825|616801033|FG001|Overall Study|Withdrawal by Subject|0|||
170669114|NCT01798004|616801034|FG000|Overall Study|Death|2|||
170669115|NCT01798004|616801034|FG000|Overall Study|Lack of Efficacy|8|||
170669116|NCT01798004|616801034|FG000|Overall Study|Physician Decision|25|||
170620637|NCT04678115|616619050|FG000|Overall Study|Lost to Follow-up|1|||
170620638|NCT04678115|616619051|FG001|Overall Study|Lost to Follow-up|0|||
170620639|NCT01363700|616619054|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
170620640|NCT01363700|616619055|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
170620641|NCT01363700|616619056|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
170620642|NCT01363700|616619057|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
170620643|NCT01363700|616619058|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
170620644|NCT03827655|616619059|FG000|Overall Study|Death|0|||
170620645|NCT03827655|616619060|FG001|Overall Study|Death|0|||
170620646|NCT03827655|616619061|FG002|Overall Study|Death|0|||
170620647|NCT03827655|616619062|FG003|Overall Study|Death|0|||
170620648|NCT03827655|616619063|FG004|Overall Study|Death|1|||
170620649|NCT03827655|616619059|FG000|Overall Study|Protocol Deviation|1|||
170620650|NCT03827655|616619060|FG001|Overall Study|Protocol Deviation|0|||
170620651|NCT03827655|616619061|FG002|Overall Study|Protocol Deviation|1|||
170620652|NCT03827655|616619062|FG003|Overall Study|Protocol Deviation|1|||
170620653|NCT03827655|616619063|FG004|Overall Study|Protocol Deviation|0|||
170620654|NCT03827655|616619059|FG000|Overall Study|Withdrawal by Subject|3|||
170620655|NCT03827655|616619060|FG001|Overall Study|Withdrawal by Subject|2|||
170620656|NCT03827655|616619061|FG002|Overall Study|Withdrawal by Subject|2|||
170620657|NCT03827655|616619062|FG003|Overall Study|Withdrawal by Subject|0|||
170620658|NCT03827655|616619063|FG004|Overall Study|Withdrawal by Subject|1|||
170620659|NCT03827655|616619059|FG000|Overall Study|Reason not Specified|3|||
170620660|NCT03827655|616619060|FG001|Overall Study|Reason not Specified|1|||
170620661|NCT03827655|616619061|FG002|Overall Study|Reason not Specified|1|||
170620662|NCT03827655|616619062|FG003|Overall Study|Reason not Specified|1|||
170620663|NCT03827655|616619063|FG004|Overall Study|Reason not Specified|1|||
170620664|NCT01092728|616619064|FG000|Overall Study|Withdrawal by Subject|2|||
170620665|NCT01092728|616619065|FG001|Overall Study|Withdrawal by Subject|0|||
170620666|NCT01092728|616619064|FG000|Overall Study|Adverse Event|0|||
170620667|NCT01092728|616619065|FG001|Overall Study|Adverse Event|1|||
170620668|NCT01092728|616619064|FG000|Overall Study|Disease Progression|1|||
170620669|NCT01092728|616619065|FG001|Overall Study|Disease Progression|13|||
170620670|NCT01092728|616619064|FG000|Overall Study|Prohibited Concomitant Medications|1|||
170620671|NCT01092728|616619065|FG001|Overall Study|Prohibited Concomitant Medications|0|||
170620672|NCT03649217|616619066|FG000|Overall Study|subject had severe ataxia not initially found|1|||
170620673|NCT03649217|616619066|FG000|Overall Study|subject had cognitive issues not initially found|1|||
170620674|NCT02336607|616619067|FG000|Overall Study|Physician Decision|1|||
170620675|NCT02336607|616619068|FG001|Overall Study|Physician Decision|4|||
170620676|NCT02336607|616619069|FG002|Overall Study|Physician Decision|3|||
170620677|NCT02336607|616619070|FG003|Overall Study|Physician Decision|15|||
170620678|NCT02336607|616619067|FG000|Overall Study|Lack of Efficacy|1|||
170620679|NCT02336607|616619068|FG001|Overall Study|Lack of Efficacy|0|||
170620680|NCT02336607|616619069|FG002|Overall Study|Lack of Efficacy|0|||
170620681|NCT02336607|616619070|FG003|Overall Study|Lack of Efficacy|2|||
170620682|NCT02336607|616619067|FG000|Overall Study|Lost to Follow-up|2|||
170620683|NCT02336607|616619068|FG001|Overall Study|Lost to Follow-up|1|||
170620684|NCT02336607|616619069|FG002|Overall Study|Lost to Follow-up|0|||
170620685|NCT02336607|616619070|FG003|Overall Study|Lost to Follow-up|21|||
170819186|NCT00355784|617345803|FG002|Overall Study|Withdrawal by Subject|2|||
170819187|NCT02543294|617345810|FG000|Overall Study|Lost to Follow-up|3|||
170620686|NCT02336607|616619067|FG000|Overall Study|Protocol Violation|0|||
170620687|NCT02336607|616619068|FG001|Overall Study|Protocol Violation|1|||
170620688|NCT02336607|616619069|FG002|Overall Study|Protocol Violation|1|||
170620689|NCT02336607|616619070|FG003|Overall Study|Protocol Violation|3|||
170620690|NCT02336607|616619067|FG000|Overall Study|Adverse Event|0|||
170669117|NCT01798004|616801034|FG000|Overall Study|Withdrawal by Subject|4|||
170819188|NCT02543294|617345810|FG000|Overall Study|Physician Decision|2|||
170819189|NCT02543294|617345810|FG000|Overall Study|Withdrawal by Subject|7|||
170620691|NCT02336607|616619068|FG001|Overall Study|Adverse Event|2|||
170620692|NCT02336607|616619069|FG002|Overall Study|Adverse Event|2|||
170620693|NCT02336607|616619070|FG003|Overall Study|Adverse Event|26|||
170620694|NCT02336607|616619067|FG000|Overall Study|Withdrawal by Subject|0|||
170620695|NCT02336607|616619068|FG001|Overall Study|Withdrawal by Subject|2|||
170620696|NCT02336607|616619069|FG002|Overall Study|Withdrawal by Subject|0|||
170669118|NCT01798004|616801034|FG000|Overall Study|Ineligible|4|||
170669119|NCT01798004|616801034|FG000|Overall Study|Patient/parent refusal|7|||
170819190|NCT03602053|617345812|FG000|Overall Study|Withdrawal by Subject|7|||
170819191|NCT03602053|617345813|FG001|Overall Study|Withdrawal by Subject|9|||
170819192|NCT03602053|617345814|FG002|Overall Study|Withdrawal by Subject|7|||
170819193|NCT03602053|617345812|FG000|Overall Study|Lost to Follow-up|5|||
170819194|NCT03602053|617345813|FG001|Overall Study|Lost to Follow-up|6|||
170819195|NCT03602053|617345814|FG002|Overall Study|Lost to Follow-up|0|||
170819196|NCT03602053|617345812|FG000|Overall Study|Protocol Violation|3|||
170819197|NCT03602053|617345813|FG001|Overall Study|Protocol Violation|0|||
170819198|NCT03602053|617345814|FG002|Overall Study|Protocol Violation|4|||
170819199|NCT03602053|617345812|FG000|Overall Study|Physician Decision|1|||
170819200|NCT03602053|617345813|FG001|Overall Study|Physician Decision|0|||
170819201|NCT03602053|617345814|FG002|Overall Study|Physician Decision|0|||
170819202|NCT03602053|617345812|FG000|Overall Study|migration|2|||
170620697|NCT02336607|616619070|FG003|Overall Study|Withdrawal by Subject|20|||
170620698|NCT02552966|616619073|FG000|Overall Study|Lost to Follow-up|2|||
170620699|NCT02552966|616619073|FG000|Overall Study|Withdrawal by Subject|3|||
170620700|NCT01721161|616619075|FG000|Overall Study|Adverse Event|2|||
170620701|NCT01721161|616619076|FG001|Overall Study|Adverse Event|3|||
170620702|NCT01721161|616619075|FG000|Overall Study|Lost to Follow-up|1|||
170620703|NCT01721161|616619076|FG001|Overall Study|Lost to Follow-up|2|||
170620704|NCT01721161|616619075|FG000|Overall Study|Withdrawal by Subject|1|||
170620705|NCT01721161|616619076|FG001|Overall Study|Withdrawal by Subject|1|||
170620706|NCT01721161|616619075|FG000|Overall Study|Other|0|||
170620707|NCT01721161|616619076|FG001|Overall Study|Other|1|||
170620708|NCT01216202|616619077|FG000|Overall Study|Withdrawal by Subject|8|||
170620709|NCT01216202|616619078|FG001|Overall Study|Withdrawal by Subject|0|||
170620710|NCT01216202|616619077|FG000|Overall Study|Death|0|||
170620711|NCT01216202|616619078|FG001|Overall Study|Death|2|||
170620712|NCT01216202|616619077|FG000|Overall Study|Lost to Follow-up|14|||
170620713|NCT01216202|616619078|FG001|Overall Study|Lost to Follow-up|0|||
170620714|NCT00614380|616619088|FG000|Overall Study|Adverse Event|14|||
170620715|NCT00614380|616619089|FG001|Overall Study|Adverse Event|4|||
170620716|NCT00614380|616619090|FG002|Overall Study|Adverse Event|0|||
170620717|NCT00614380|616619091|FG003|Overall Study|Adverse Event|0|||
170620718|NCT00614380|616619088|FG000|Overall Study|Lost to Follow-up|6|||
170620719|NCT00614380|616619089|FG001|Overall Study|Lost to Follow-up|1|||
170620720|NCT00614380|616619090|FG002|Overall Study|Lost to Follow-up|0|||
170620721|NCT00614380|616619091|FG003|Overall Study|Lost to Follow-up|0|||
170620722|NCT00614380|616619088|FG000|Overall Study|Non compliant with the protocol|12|||
170620723|NCT00614380|616619089|FG001|Overall Study|Non compliant with the protocol|2|||
170620724|NCT00614380|616619090|FG002|Overall Study|Non compliant with the protocol|1|||
170620725|NCT00614380|616619091|FG003|Overall Study|Non compliant with the protocol|2|||
170620726|NCT00614380|616619088|FG000|Overall Study|Consent withdrawn|3|||
170620727|NCT00614380|616619089|FG001|Overall Study|Consent withdrawn|1|||
170620728|NCT00614380|616619090|FG002|Overall Study|Consent withdrawn|0|||
170620729|NCT00614380|616619091|FG003|Overall Study|Consent withdrawn|0|||
170620730|NCT02365649|616619092|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170620731|NCT02365649|616619093|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170620732|NCT02365649|616619094|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170620733|NCT02365649|616619095|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
170620734|NCT02365649|616619096|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170620735|NCT02365649|616619097|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170620736|NCT02365649|616619098|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170620737|NCT02365649|616619099|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170819203|NCT03602053|617345813|FG001|Overall Study|migration|3|||
170819204|NCT03602053|617345814|FG002|Overall Study|migration|0|||
170819205|NCT03602053|617345812|FG000|Overall Study|Other|1|||
170819206|NCT03602053|617345813|FG001|Overall Study|Other|0|||
170819207|NCT03602053|617345814|FG002|Overall Study|Other|0|||
170819208|NCT01533181|617345825|FG000|Overall Study|Disease progression pre-active treatment|0|||
170819209|NCT01533181|617345826|FG001|Overall Study|Disease progression pre-active treatment|1|||
170819210|NCT01533181|617345825|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
170819211|NCT01533181|617345826|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
170819212|NCT01114217|617345827|FG000|Overall Study|Adverse Event|5|||
170620738|NCT02365649|616619100|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170819213|NCT01114217|617345828|FG001|Overall Study|Adverse Event|3|||
170620739|NCT02365649|616619101|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
170620740|NCT02365649|616619092|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
170620741|NCT02365649|616619093|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
170620742|NCT02365649|616619094|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
170620743|NCT02365649|616619095|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
170819214|NCT01114217|617345827|FG000|Overall Study|Lost to Follow-up|17|||
170819215|NCT01114217|617345828|FG001|Overall Study|Lost to Follow-up|33|||
170620744|NCT02365649|616619096|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
170620745|NCT02365649|616619097|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
170620746|NCT02365649|616619098|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
170620747|NCT02365649|616619099|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
170620748|NCT02365649|616619100|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
170620749|NCT02365649|616619101|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
170620750|NCT02365649|616619092|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
170620751|NCT02365649|616619093|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
170620752|NCT02365649|616619094|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
170620753|NCT02365649|616619095|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
170620754|NCT02365649|616619096|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
170620755|NCT02365649|616619097|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
170620756|NCT02365649|616619098|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
170620757|NCT02365649|616619099|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
170620758|NCT02365649|616619100|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
170620759|NCT02365649|616619101|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
170620760|NCT02365649|616619092|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
170620761|NCT02365649|616619093|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
170620762|NCT02365649|616619094|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
170620763|NCT02365649|616619095|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
170620764|NCT02365649|616619096|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
170620765|NCT02365649|616619097|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
170620766|NCT02365649|616619098|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
170620767|NCT02365649|616619099|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
170620768|NCT02365649|616619100|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
170669120|NCT01798004|616801034|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
170669121|NCT01798004|616801034|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
170669122|NCT02280304|616801039|FG000|Overall Study|Lost to Follow-up|7|||
170669123|NCT02280304|616801040|FG001|Overall Study|Lost to Follow-up|8|||
170669124|NCT04805541|616801041|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
170669125|NCT01560403|616801044|FG000|Overall Study|Lost to Follow-up|0|||
170620769|NCT02365649|616619101|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
170620770|NCT02365649|616619092|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
170620771|NCT02365649|616619093|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
170620772|NCT02365649|616619094|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
170620773|NCT02365649|616619095|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
170620774|NCT02365649|616619096|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
170620775|NCT02365649|616619097|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
170620776|NCT02365649|616619098|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
170620777|NCT02365649|616619099|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
170620778|NCT02365649|616619100|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
170620779|NCT02365649|616619101|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
170620780|NCT02365649|616619092|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
170620781|NCT02365649|616619093|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
170620782|NCT02365649|616619094|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
170620783|NCT02365649|616619095|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
170620784|NCT02365649|616619096|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
170620785|NCT02365649|616619097|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
170620786|NCT02365649|616619098|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
170620787|NCT02365649|616619099|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
170620788|NCT02365649|616619100|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
170620789|NCT02365649|616619101|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
170620790|NCT02365649|616619092|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620791|NCT02365649|616619093|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620792|NCT02365649|616619094|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
170620793|NCT02365649|616619095|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620794|NCT02365649|616619096|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620795|NCT02365649|616619097|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620796|NCT02365649|616619098|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620797|NCT02365649|616619099|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620798|NCT02365649|616619100|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620799|NCT02365649|616619101|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
170620800|NCT02365649|616619092|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170620801|NCT02365649|616619093|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170620802|NCT02365649|616619094|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170669126|NCT01560403|616801045|FG001|Overall Study|Lost to Follow-up|1|||
170669127|NCT00354744|616801046|FG000|Overall Study|Adverse Event|2|||
170669128|NCT00354744|616801046|FG000|Overall Study|Death|2|||
170669129|NCT00354744|616801046|FG000|Overall Study|Lack of Efficacy|11|||
170620803|NCT02365649|616619095|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170620804|NCT02365649|616619096|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170620805|NCT02365649|616619097|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170620806|NCT02365649|616619098|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
170620807|NCT02365649|616619099|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170620808|NCT02365649|616619100|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170620809|NCT02365649|616619101|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
170620810|NCT02365649|616619092|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
170620811|NCT02365649|616619093|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
170620812|NCT02365649|616619094|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
170620813|NCT02365649|616619095|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
170620814|NCT02365649|616619096|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
170620815|NCT02365649|616619097|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
170620816|NCT02365649|616619098|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
170620817|NCT02365649|616619099|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
170620818|NCT02365649|616619100|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
170620819|NCT02365649|616619101|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
170620820|NCT02365649|616619092|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
170620821|NCT02365649|616619093|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
170620822|NCT02365649|616619094|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
170620823|NCT02365649|616619095|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
170620824|NCT02365649|616619096|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
170620825|NCT02365649|616619097|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
170620826|NCT02365649|616619098|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
170620827|NCT02365649|616619099|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
170620828|NCT02365649|616619100|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
170620829|NCT02365649|616619101|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
170620830|NCT02365649|616619092|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
170620831|NCT02365649|616619093|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
170620832|NCT02365649|616619094|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
170620833|NCT02365649|616619095|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
170620834|NCT02365649|616619096|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
170620835|NCT02365649|616619097|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
170620836|NCT02365649|616619098|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
170620837|NCT02365649|616619099|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
170620838|NCT02365649|616619100|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
170620839|NCT02365649|616619101|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
170620840|NCT02365649|616619092|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
170620841|NCT02365649|616619093|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
170620842|NCT02365649|616619094|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
170620843|NCT02365649|616619095|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
170620844|NCT02365649|616619096|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
170620845|NCT02365649|616619097|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
170620846|NCT02365649|616619098|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
170620847|NCT02365649|616619099|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
170620848|NCT02365649|616619100|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
170620849|NCT02365649|616619101|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
170620850|NCT01329978|616619102|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
170620851|NCT01329978|616619103|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
170620852|NCT01329978|616619104|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
170620853|NCT01329978|616619105|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
170620854|NCT01329978|616619106|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
170620855|NCT01329978|616619102|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
170620856|NCT01329978|616619103|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
170620857|NCT01329978|616619104|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
170620858|NCT01329978|616619105|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
170620859|NCT01329978|616619106|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
170620860|NCT01329978|616619102|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
170620861|NCT01329978|616619103|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
170620862|NCT01329978|616619104|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
170620863|NCT01329978|616619105|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
170620864|NCT01329978|616619106|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
170620865|NCT01329978|616619102|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
170819216|NCT01114217|617345827|FG000|Overall Study|Withdrawal by Subject|21|||
170620866|NCT01329978|616619103|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
170620867|NCT01329978|616619104|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
170620868|NCT01329978|616619105|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
170620869|NCT01329978|616619106|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
170620870|NCT01329978|616619102|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
170620871|NCT01329978|616619103|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
170620872|NCT01329978|616619104|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
170620873|NCT01329978|616619105|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
170620874|NCT01329978|616619106|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
170620875|NCT01329978|616619102|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
170620876|NCT01329978|616619103|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
170620877|NCT01329978|616619104|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
170620878|NCT01329978|616619105|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
170620879|NCT01329978|616619106|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
170620880|NCT01329978|616619102|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
170620881|NCT01329978|616619103|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
170620882|NCT01329978|616619104|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
170620883|NCT01329978|616619105|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
170620884|NCT01329978|616619106|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
170620885|NCT00689390|616619107|FG000|Overall Study|Adverse Event|19|||
170620886|NCT00689390|616619108|FG001|Overall Study|Adverse Event|0|||
170620887|NCT00689390|616619107|FG000|Overall Study|Lost to Follow-up|179|||
170620888|NCT00689390|616619108|FG001|Overall Study|Lost to Follow-up|7|||
170620889|NCT00689390|616619107|FG000|Overall Study|Withdrawal by Subject|117|||
170620890|NCT00689390|616619108|FG001|Overall Study|Withdrawal by Subject|3|||
170620891|NCT00689390|616619107|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
170620892|NCT00689390|616619108|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
170620893|NCT00689390|616619107|FG000|Overall Study|Non-Compliance With Protocol|21|||
170620894|NCT00689390|616619108|FG001|Overall Study|Non-Compliance With Protocol|0|||
170620895|NCT00689390|616619107|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
170620896|NCT00689390|616619108|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
170620897|NCT00689390|616619107|FG000|Overall Study|Administrative|37|||
170620898|NCT00689390|616619108|FG001|Overall Study|Administrative|0|||
170620899|NCT00104650|616619109|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
170620900|NCT00104650|616619110|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
170620901|NCT00104650|616619111|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
170620902|NCT00104650|616619109|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
170620903|NCT00104650|616619110|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
170620904|NCT00104650|616619111|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
170620905|NCT00104650|616619109|FG000|Treatment Period (25 Weeks)|Death|7|||
170620906|NCT00104650|616619110|FG001|Treatment Period (25 Weeks)|Death|5|||
170620907|NCT00104650|616619111|FG002|Treatment Period (25 Weeks)|Death|6|||
170620908|NCT00104650|616619109|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
170620909|NCT00104650|616619110|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
170620910|NCT00104650|616619111|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
170620911|NCT00104650|616619109|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
170620912|NCT00104650|616619110|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
170620913|NCT00104650|616619111|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
170620914|NCT00104650|616619109|FG000|Treatment Period (25 Weeks)|Other|1|||
170620915|NCT00104650|616619110|FG001|Treatment Period (25 Weeks)|Other|0|||
170620916|NCT00104650|616619111|FG002|Treatment Period (25 Weeks)|Other|0|||
170620917|NCT00104650|616619109|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
170620918|NCT00104650|616619110|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
170620919|NCT00104650|616619111|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
170620920|NCT00104650|616619109|FG000|Follow-up Period|Physician Decision|1|||
170819217|NCT01114217|617345828|FG001|Overall Study|Withdrawal by Subject|28|||
170620921|NCT00104650|616619110|FG001|Follow-up Period|Physician Decision|1|||
170819218|NCT01114217|617345827|FG000|Overall Study|Other-Clerical Error|3|||
170819219|NCT01114217|617345828|FG001|Overall Study|Other-Clerical Error|0|||
170819220|NCT01114217|617345827|FG000|Overall Study|Other-Early termination|6|||
170819221|NCT01114217|617345828|FG001|Overall Study|Other-Early termination|10|||
170819222|NCT01114217|617345827|FG000|Overall Study|Other-Procedure|1|||
170819223|NCT01114217|617345828|FG001|Overall Study|Other-Procedure|1|||
170819224|NCT01114217|617345827|FG000|Overall Study|Other-Pregnancy|2|||
170819225|NCT01114217|617345828|FG001|Overall Study|Other-Pregnancy|4|||
170819226|NCT01114217|617345827|FG000|Overall Study|Other-Protocol Violation|1|||
170620922|NCT00104650|616619111|FG002|Follow-up Period|Physician Decision|0|||
170819227|NCT01114217|617345828|FG001|Overall Study|Other-Protocol Violation|3|||
170620923|NCT00104650|616619109|FG000|Follow-up Period|Adverse Event|1|||
170620924|NCT00104650|616619110|FG001|Follow-up Period|Adverse Event|0|||
170620925|NCT00104650|616619111|FG002|Follow-up Period|Adverse Event|1|||
170620926|NCT00104650|616619109|FG000|Follow-up Period|Withdrawal by Subject|0|||
170620927|NCT00104650|616619110|FG001|Follow-up Period|Withdrawal by Subject|3|||
170620928|NCT00104650|616619111|FG002|Follow-up Period|Withdrawal by Subject|3|||
170620929|NCT00104650|616619109|FG000|Follow-up Period|Death|6|||
170620930|NCT00104650|616619110|FG001|Follow-up Period|Death|6|||
170620931|NCT00104650|616619111|FG002|Follow-up Period|Death|4|||
170620932|NCT00104650|616619109|FG000|Follow-up Period|Disease progression|3|||
170620933|NCT00104650|616619110|FG001|Follow-up Period|Disease progression|1|||
170620934|NCT00104650|616619111|FG002|Follow-up Period|Disease progression|0|||
170620935|NCT00104650|616619109|FG000|Follow-up Period|Lost to Follow-up|0|||
170620936|NCT00104650|616619110|FG001|Follow-up Period|Lost to Follow-up|1|||
170620937|NCT00104650|616619111|FG002|Follow-up Period|Lost to Follow-up|2|||
170620938|NCT00104650|616619109|FG000|Follow-up Period|Other|0|||
170620939|NCT00104650|616619110|FG001|Follow-up Period|Other|1|||
170620940|NCT00104650|616619111|FG002|Follow-up Period|Other|0|||
170620941|NCT00360412|616619116|FG000|Overall Study|Adverse Event|37|||
170620942|NCT00360412|616619117|FG001|Overall Study|Adverse Event|65|||
170620943|NCT00360412|616619116|FG000|Overall Study|Protocol Violation|2|||
170620944|NCT00360412|616619117|FG001|Overall Study|Protocol Violation|5|||
170620945|NCT00360412|616619116|FG000|Overall Study|Patient withdrew consent|27|||
170620946|NCT00360412|616619117|FG001|Overall Study|Patient withdrew consent|52|||
170620947|NCT00360412|616619116|FG000|Overall Study|Lack of therapeutic efficacy|46|||
170620948|NCT00360412|616619117|FG001|Overall Study|Lack of therapeutic efficacy|61|||
170620949|NCT00360412|616619116|FG000|Overall Study|Physician Decision|2|||
170620950|NCT00360412|616619117|FG001|Overall Study|Physician Decision|4|||
170620951|NCT00360412|616619116|FG000|Overall Study|Other|5|||
170620952|NCT00360412|616619117|FG001|Overall Study|Other|6|||
170620953|NCT00360412|616619116|FG000|Overall Study|Study termination by Sponsor|214|||
170620954|NCT00360412|616619117|FG001|Overall Study|Study termination by Sponsor|469|||
170620955|NCT00871871|616619118|FG000|Part I|Adverse Event|0|||
170620956|NCT00871871|616619119|FG001|Part I|Adverse Event|2|||
170620957|NCT00871871|616619120|FG002|Part I|Adverse Event|0|||
170620958|NCT00871871|616619121|FG003|Part I|Adverse Event|0|||
170620959|NCT00871871|616619118|FG000|Part I|Withdrawal by Subject|3|||
170620960|NCT00871871|616619119|FG001|Part I|Withdrawal by Subject|0|||
170620961|NCT00871871|616619120|FG002|Part I|Withdrawal by Subject|0|||
170620962|NCT00871871|616619121|FG003|Part I|Withdrawal by Subject|0|||
170620963|NCT00871871|616619118|FG000|Part I|Laboratory abnormality|0|||
170620964|NCT00871871|616619119|FG001|Part I|Laboratory abnormality|1|||
170620965|NCT00871871|616619120|FG002|Part I|Laboratory abnormality|0|||
170620966|NCT00871871|616619121|FG003|Part I|Laboratory abnormality|0|||
170620967|NCT00871871|616619118|FG000|Part II|Lack of Efficacy|0|||
170620968|NCT00871871|616619119|FG001|Part II|Lack of Efficacy|0|||
170620969|NCT00871871|616619120|FG002|Part II|Lack of Efficacy|1|||
170620970|NCT00871871|616619121|FG003|Part II|Lack of Efficacy|0|||
170620971|NCT00871871|616619118|FG000|Part II|Withdrawal by Subject|0|||
170620972|NCT00871871|616619119|FG001|Part II|Withdrawal by Subject|0|||
170620973|NCT00871871|616619120|FG002|Part II|Withdrawal by Subject|2|||
170819228|NCT01114217|617345827|FG000|Overall Study|Other-Lack of Efficacy|1|||
170819229|NCT01114217|617345828|FG001|Overall Study|Other-Lack of Efficacy|0|||
170819230|NCT01114217|617345827|FG000|Overall Study|Other-Non Compliance|2|||
170819231|NCT01114217|617345828|FG001|Overall Study|Other-Non Compliance|0|||
170819232|NCT01114217|617345827|FG000|Overall Study|Other-Physician Decision|1|||
170819233|NCT01114217|617345828|FG001|Overall Study|Other-Physician Decision|1|||
170819234|NCT01114217|617345827|FG000|Overall Study|Other-Sponsor Decision|10|||
170819235|NCT01114217|617345828|FG001|Overall Study|Other-Sponsor Decision|12|||
170819236|NCT01114217|617345827|FG000|Overall Study|Other-Study Termination|0|||
170819237|NCT01114217|617345828|FG001|Overall Study|Other-Study Termination|1|||
170819238|NCT01114217|617345827|FG000|Overall Study|Other-Study Withdrawn|1|||
170819239|NCT01114217|617345828|FG001|Overall Study|Other-Study Withdrawn|1|||
170819240|NCT01114217|617345827|FG000|Overall Study|Other-Site Stopped Communicating|2|||
170819241|NCT01114217|617345828|FG001|Overall Study|Other-Site Stopped Communicating|0|||
170620974|NCT00871871|616619121|FG003|Part II|Withdrawal by Subject|1|||
170620975|NCT00871871|616619118|FG000|Part II|Adverse Event|0|||
170620976|NCT00871871|616619119|FG001|Part II|Adverse Event|0|||
170620977|NCT00871871|616619120|FG002|Part II|Adverse Event|1|||
170620978|NCT00871871|616619121|FG003|Part II|Adverse Event|2|||
170620979|NCT00871871|616619118|FG000|Part II|Protocol Violation|0|||
170620980|NCT00871871|616619119|FG001|Part II|Protocol Violation|0|||
170620981|NCT00871871|616619120|FG002|Part II|Protocol Violation|0|||
170620982|NCT00871871|616619121|FG003|Part II|Protocol Violation|1|||
170620983|NCT01611194|616619127|FG000|Overall Study|Lost to Follow-up|0|||
170819242|NCT01114217|617345827|FG000|Overall Study|Other-Lost to Follow-up|1|||
170819243|NCT01114217|617345828|FG001|Overall Study|Other-Lost to Follow-up|0|||
170620984|NCT01611194|616619128|FG001|Overall Study|Lost to Follow-up|1|||
170620985|NCT01611194|616619127|FG000|Overall Study|Withdrawal by Subject|0|||
170620986|NCT01611194|616619128|FG001|Overall Study|Withdrawal by Subject|1|||
170620987|NCT01611194|616619127|FG000|Overall Study|drug use|0|||
170620988|NCT01611194|616619128|FG001|Overall Study|drug use|1|||
170620989|NCT00452790|616619131|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
170620990|NCT00452790|616619132|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
170620991|NCT00452790|616619131|FG000|Infant Series|Parent/legal guardian request|8|||
170620992|NCT00452790|616619132|FG001|Infant Series|Parent/legal guardian request|6|||
170620993|NCT00452790|616619131|FG000|Infant Series|Failed to return|4|||
170620994|NCT00452790|616619132|FG001|Infant Series|Failed to return|1|||
170620995|NCT00452790|616619131|FG000|Infant Series|Protocol Violation|1|||
170620996|NCT00452790|616619132|FG001|Infant Series|Protocol Violation|3|||
170620997|NCT00452790|616619131|FG000|Infant Series|Lost to Follow-up|2|||
170620998|NCT00452790|616619132|FG001|Infant Series|Lost to Follow-up|2|||
170620999|NCT00452790|616619131|FG000|Infant Series|Adverse Event|1|||
170621000|NCT00452790|616619132|FG001|Infant Series|Adverse Event|2|||
170621001|NCT00452790|616619131|FG000|Infant Series|Other reasons|1|||
170621002|NCT00452790|616619132|FG001|Infant Series|Other reasons|2|||
170621003|NCT00452790|616619131|FG000|Infant Series|Investigator request|0|||
170621004|NCT00452790|616619132|FG001|Infant Series|Investigator request|1|||
170621005|NCT00452790|616619131|FG000|Infant Series|Death|0|||
170621006|NCT00452790|616619132|FG001|Infant Series|Death|1|||
170621007|NCT00452790|616619131|FG000|After Infant Series|Investigator request|10|||
170621008|NCT00452790|616619132|FG001|After Infant Series|Investigator request|10|||
170621009|NCT00452790|616619131|FG000|After Infant Series|Adverse Event|4|||
170621010|NCT00452790|616619132|FG001|After Infant Series|Adverse Event|1|||
170621011|NCT00452790|616619131|FG000|After Infant Series|Parent/legal guardian request|1|||
170621012|NCT00452790|616619132|FG001|After Infant Series|Parent/legal guardian request|3|||
170621013|NCT00452790|616619131|FG000|After Infant Series|Lost to Follow-up|4|||
170621014|NCT00452790|616619132|FG001|After Infant Series|Lost to Follow-up|0|||
170621015|NCT00452790|616619131|FG000|After Infant Series|Failed to return|1|||
170621016|NCT00452790|616619132|FG001|After Infant Series|Failed to return|0|||
170621017|NCT00452790|616619131|FG000|After Infant Series|Other reasons|1|||
170621018|NCT00452790|616619132|FG001|After Infant Series|Other reasons|0|||
170621019|NCT00452790|616619131|FG000|Toddler Dose|Failed to return|0|||
170621020|NCT00452790|616619132|FG001|Toddler Dose|Failed to return|1|||
170621021|NCT00452790|616619131|FG000|Toddler Dose|Parent/legal guardian request|0|||
170621022|NCT00452790|616619132|FG001|Toddler Dose|Parent/legal guardian request|1|||
170621023|NCT01871519|616619133|FG000|Overall Study|Death|26|||
170621024|NCT01871519|616619133|FG000|Overall Study|Lost to Follow-up|15|||
170621025|NCT01871519|616619133|FG000|Overall Study|Withdrawal by Subject|49|||
170621026|NCT02775916|616619134|FG000|Overall Study|Adverse Event|1|||
170621027|NCT02775916|616619135|FG001|Overall Study|Adverse Event|0|||
170621028|NCT02775916|616619134|FG000|Overall Study|Subject/Guardian Decision|2|||
170819244|NCT01114217|617345827|FG000|Overall Study|Other-Withdrawal by Subject|1|||
170819245|NCT01114217|617345828|FG001|Overall Study|Other-Withdrawal by Subject|1|||
170819246|NCT01106586|617345829|FG000|Overall Study|Adverse Event|9|||
170819247|NCT01106586|617345830|FG001|Overall Study|Adverse Event|15|||
170819248|NCT01106586|617345829|FG000|Overall Study|Death|1|||
170819249|NCT01106586|617345830|FG001|Overall Study|Death|3|||
170819250|NCT01106586|617345829|FG000|Overall Study|Pregnancy|2|||
170819251|NCT01106586|617345830|FG001|Overall Study|Pregnancy|2|||
170819252|NCT01106586|617345829|FG000|Overall Study|Lack of Efficacy|1|||
170819253|NCT01106586|617345830|FG001|Overall Study|Lack of Efficacy|0|||
170819254|NCT01106586|617345829|FG000|Overall Study|Investigator's Discretion|5|||
170819255|NCT01106586|617345830|FG001|Overall Study|Investigator's Discretion|8|||
170819256|NCT01106586|617345829|FG000|Overall Study|Withdrew Consent|18|||
170819257|NCT01106586|617345830|FG001|Overall Study|Withdrew Consent|30|||
170819258|NCT01106586|617345829|FG000|Overall Study|Lost to Follow-up|24|||
170819259|NCT01106586|617345830|FG001|Overall Study|Lost to Follow-up|20|||
170819260|NCT01106586|617345829|FG000|Overall Study|Participant Noncompliance|12|||
170819261|NCT01106586|617345830|FG001|Overall Study|Participant Noncompliance|10|||
170621029|NCT02775916|616619135|FG001|Overall Study|Subject/Guardian Decision|0|||
170621030|NCT01908426|616620775|FG000|Overall Study|Adverse Event|98|||
170621031|NCT01908426|616620776|FG001|Overall Study|Adverse Event|11|||
170621032|NCT01908426|616620775|FG000|Overall Study|Clinical Deterioration|72|||
170621033|NCT01908426|616620776|FG001|Overall Study|Clinical Deterioration|38|||
170621034|NCT01908426|616620775|FG000|Overall Study|Lack of Efficacy|3|||
170621035|NCT01908426|616620776|FG001|Overall Study|Lack of Efficacy|0|||
170621036|NCT01908426|616620775|FG000|Overall Study|Lost to Follow-up|0|||
170621037|NCT01908426|616620776|FG001|Overall Study|Lost to Follow-up|1|||
170621038|NCT01908426|616620775|FG000|Overall Study|Physician Decision|3|||
170621039|NCT01908426|616620776|FG001|Overall Study|Physician Decision|3|||
170819262|NCT01106586|617345829|FG000|Overall Study|Protocol Violation|1|||
170819263|NCT01106586|617345830|FG001|Overall Study|Protocol Violation|0|||
170819264|NCT01106586|617345829|FG000|Overall Study|Participant Transferred to Another Study|212|||
170819265|NCT01106586|617345830|FG001|Overall Study|Participant Transferred to Another Study|197|||
170621040|NCT01908426|616620775|FG000|Overall Study|Withdrawal by Subject|11|||
170621041|NCT01908426|616620776|FG001|Overall Study|Withdrawal by Subject|6|||
170621042|NCT01908426|616620775|FG000|Overall Study|Progressive Disease|206|||
170621043|NCT01908426|616620776|FG001|Overall Study|Progressive Disease|152|||
170621044|NCT01908426|616620775|FG000|Overall Study|Protocol Violation|1|||
170621045|NCT01908426|616620776|FG001|Overall Study|Protocol Violation|0|||
170621046|NCT01908426|616620775|FG000|Overall Study|No Study Treatment Given|3|||
170621047|NCT01908426|616620776|FG001|Overall Study|No Study Treatment Given|0|||
170621048|NCT02973100|616620777|FG000|Overall Study|Adverse Event|1|||
170621049|NCT02973100|616620778|FG001|Overall Study|Adverse Event|2|||
170621050|NCT02973100|616620779|FG002|Overall Study|Adverse Event|1|||
170621051|NCT02973100|616620780|FG003|Overall Study|Adverse Event|2|||
170621052|NCT02973100|616620777|FG000|Overall Study|Lost to Follow-up|3|||
170621053|NCT02973100|616620778|FG001|Overall Study|Lost to Follow-up|1|||
170621054|NCT02973100|616620779|FG002|Overall Study|Lost to Follow-up|1|||
170621055|NCT02973100|616620780|FG003|Overall Study|Lost to Follow-up|0|||
170621056|NCT02973100|616620777|FG000|Overall Study|Withdrawal by Subject|3|||
170621057|NCT02973100|616620778|FG001|Overall Study|Withdrawal by Subject|5|||
170621058|NCT02973100|616620779|FG002|Overall Study|Withdrawal by Subject|1|||
170621059|NCT02973100|616620780|FG003|Overall Study|Withdrawal by Subject|4|||
170621060|NCT02973100|616620777|FG000|Overall Study|Notification of change in address|0|||
170621061|NCT02973100|616620778|FG001|Overall Study|Notification of change in address|0|||
170621062|NCT02973100|616620779|FG002|Overall Study|Notification of change in address|0|||
170819266|NCT03166215|617345835|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
170621063|NCT02973100|616620780|FG003|Overall Study|Notification of change in address|1|||
170621064|NCT02973100|616620777|FG000|Overall Study|Failed to attend Safety followup period|0|||
170621065|NCT02973100|616620778|FG001|Overall Study|Failed to attend Safety followup period|0|||
170621066|NCT02973100|616620779|FG002|Overall Study|Failed to attend Safety followup period|1|||
170621067|NCT02973100|616620780|FG003|Overall Study|Failed to attend Safety followup period|0|||
170621068|NCT00878501|616620789|FG000|Overall Study|Adverse Event|11|||
170621069|NCT00878501|616620790|FG001|Overall Study|Adverse Event|3|||
170621070|NCT00878501|616620791|FG002|Overall Study|Adverse Event|3|||
170819267|NCT03166215|617345836|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
170819268|NCT03166215|617345837|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
170819269|NCT03166215|617345835|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
170819270|NCT03166215|617345836|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
170819271|NCT03166215|617345837|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
170819272|NCT00742560|617345841|FG000|Overall Study|Adverse Event|0|||
170819273|NCT00742560|617345842|FG001|Overall Study|Adverse Event|0|||
170819274|NCT00742560|617345843|FG002|Overall Study|Adverse Event|1|||
170819275|NCT00742560|617345844|FG003|Overall Study|Adverse Event|1|||
170819276|NCT00742560|617345845|FG004|Overall Study|Adverse Event|1|||
170819277|NCT00742560|617345841|FG000|Overall Study|Death|0|||
170819278|NCT00742560|617345842|FG001|Overall Study|Death|2|||
170819279|NCT00742560|617345843|FG002|Overall Study|Death|0|||
170819280|NCT00742560|617345844|FG003|Overall Study|Death|2|||
170819281|NCT00742560|617345845|FG004|Overall Study|Death|3|||
170819282|NCT00742560|617345841|FG000|Overall Study|Subject's Decision|1|||
170819283|NCT00742560|617345842|FG001|Overall Study|Subject's Decision|0|||
170819284|NCT00742560|617345843|FG002|Overall Study|Subject's Decision|2|||
170819285|NCT00742560|617345844|FG003|Overall Study|Subject's Decision|3|||
170819286|NCT00742560|617345845|FG004|Overall Study|Subject's Decision|3|||
170819287|NCT00742560|617345841|FG000|Overall Study|Investigator's Decision|0|||
170819288|NCT00742560|617345842|FG001|Overall Study|Investigator's Decision|0|||
170819289|NCT00742560|617345843|FG002|Overall Study|Investigator's Decision|4|||
170819290|NCT00742560|617345844|FG003|Overall Study|Investigator's Decision|1|||
170819291|NCT00742560|617345845|FG004|Overall Study|Investigator's Decision|0|||
170819292|NCT00742560|617345841|FG000|Overall Study|Disease Progression|1|||
170819293|NCT00742560|617345842|FG001|Overall Study|Disease Progression|0|||
170819294|NCT00742560|617345843|FG002|Overall Study|Disease Progression|5|||
170819295|NCT00742560|617345844|FG003|Overall Study|Disease Progression|17|||
170819296|NCT00742560|617345845|FG004|Overall Study|Disease Progression|16|||
170819297|NCT00742560|617345841|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
170819298|NCT00742560|617345842|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
170819299|NCT00742560|617345843|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
170819300|NCT00742560|617345844|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
170621071|NCT00878501|616620789|FG000|Overall Study|Lack of Efficacy|2|||
170621072|NCT00878501|616620790|FG001|Overall Study|Lack of Efficacy|1|||
170621073|NCT00878501|616620791|FG002|Overall Study|Lack of Efficacy|0|||
170621074|NCT00878501|616620789|FG000|Overall Study|Withdrawal by Subject|2|||
170621075|NCT00878501|616620790|FG001|Overall Study|Withdrawal by Subject|1|||
170621076|NCT00878501|616620791|FG002|Overall Study|Withdrawal by Subject|2|||
170819301|NCT00742560|617345845|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
170819302|NCT00742560|617345841|FG000|Overall Study|Other|0|||
170819303|NCT00742560|617345842|FG001|Overall Study|Other|1|||
170819304|NCT00742560|617345843|FG002|Overall Study|Other|8|||
170819305|NCT00742560|617345844|FG003|Overall Study|Other|9|||
170819306|NCT00742560|617345845|FG004|Overall Study|Other|9|||
170819307|NCT00742560|617345841|FG000|Overall Study|MIssing|0|||
170819308|NCT00742560|617345842|FG001|Overall Study|MIssing|0|||
170819309|NCT00742560|617345843|FG002|Overall Study|MIssing|0|||
170819310|NCT00742560|617345844|FG003|Overall Study|MIssing|0|||
170819311|NCT00742560|617345845|FG004|Overall Study|MIssing|1|||
170819312|NCT01536795|617345846|FG000|Overall Study|Lost to Follow-up|0|||
170621077|NCT00878501|616620789|FG000|Overall Study|Protocol Violation|0|||
170621078|NCT00878501|616620790|FG001|Overall Study|Protocol Violation|0|||
170621079|NCT00878501|616620791|FG002|Overall Study|Protocol Violation|1|||
170621080|NCT00878501|616620789|FG000|Overall Study|Incorrect enrolment|1|||
170621081|NCT00878501|616620790|FG001|Overall Study|Incorrect enrolment|2|||
170621082|NCT00878501|616620791|FG002|Overall Study|Incorrect enrolment|0|||
170621083|NCT00878501|616620789|FG000|Overall Study|Intake of prohibited concom. medication|0|||
170621084|NCT00878501|616620790|FG001|Overall Study|Intake of prohibited concom. medication|0|||
170621085|NCT00878501|616620791|FG002|Overall Study|Intake of prohibited concom. medication|1|||
170621086|NCT00878501|616620789|FG000|Overall Study|Mis-randomisation of patient|1|||
170621087|NCT00878501|616620790|FG001|Overall Study|Mis-randomisation of patient|0|||
170621088|NCT00878501|616620791|FG002|Overall Study|Mis-randomisation of patient|0|||
170621089|NCT00878501|616620789|FG000|Overall Study|Administrative|0|||
170621090|NCT00878501|616620790|FG001|Overall Study|Administrative|0|||
170621091|NCT00878501|616620791|FG002|Overall Study|Administrative|1|||
170621092|NCT03598036|616620800|FG000|Overall Study|Withdrawal by Subject|1|||
170621093|NCT03598036|616620801|FG001|Overall Study|Withdrawal by Subject|0|||
170621094|NCT01096316|616620814|FG000|Overall Study|Lost to Follow-up|15|||
170621095|NCT01096316|616620815|FG001|Overall Study|Lost to Follow-up|9|||
170621096|NCT01755234|616620816|FG000|Overall Study|Lost to Follow-up|11|||
170621097|NCT01755234|616620817|FG001|Overall Study|Lost to Follow-up|6|||
170621098|NCT01755234|616620816|FG000|Overall Study|Change in surgical case|2|||
170621099|NCT01755234|616620817|FG001|Overall Study|Change in surgical case|1|||
170621100|NCT01755234|616620816|FG000|Overall Study|case cancelled|1|||
170621101|NCT01755234|616620817|FG001|Overall Study|case cancelled|0|||
170621102|NCT01755234|616620816|FG000|Overall Study|Withdrawal by Subject|0|||
170621103|NCT01755234|616620817|FG001|Overall Study|Withdrawal by Subject|1|||
170621104|NCT01755234|616620816|FG000|Overall Study|unblinded|1|||
170621105|NCT01755234|616620817|FG001|Overall Study|unblinded|0|||
170621106|NCT00981149|616620818|FG000|Overall Study|Lost to Follow-up|1|||
170621107|NCT00981149|616620819|FG001|Overall Study|Lost to Follow-up|2|||
170621108|NCT00981149|616620818|FG000|Overall Study|Withdrawal by Subject|1|||
170621109|NCT00981149|616620819|FG001|Overall Study|Withdrawal by Subject|1|||
170621110|NCT04663321|616620822|FG000|Overall Study|Study terminated by Sponsor|2|||
170621111|NCT04663321|616620823|FG001|Overall Study|Study terminated by Sponsor|1|||
170621112|NCT04663321|616620824|FG002|Overall Study|Study terminated by Sponsor|2|||
170621113|NCT04663321|616620822|FG000|Overall Study|Withdrawal by Subject|10|||
170621114|NCT04663321|616620823|FG001|Overall Study|Withdrawal by Subject|3|||
170621115|NCT04663321|616620824|FG002|Overall Study|Withdrawal by Subject|2|||
170621116|NCT04663321|616620822|FG000|Overall Study|Not provided|0|||
170621117|NCT04663321|616620823|FG001|Overall Study|Not provided|0|||
170621118|NCT04663321|616620824|FG002|Overall Study|Not provided|1|||
170621119|NCT02529852|616620829|FG000|Overall Study|Withdrawal by Subject|2|||
170621120|NCT00622505|616620830|FG000|Overall Study|Adverse Event|9|||
170621121|NCT00622505|616620831|FG001|Overall Study|Adverse Event|7|||
170621122|NCT00622505|616620830|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
170621123|NCT00622505|616620831|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
170621124|NCT00622505|616620830|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
170621125|NCT00622505|616620831|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
170819313|NCT01536795|617345847|FG001|Overall Study|Lost to Follow-up|2|||
170819314|NCT01536795|617345846|FG000|Overall Study|Lack of Efficacy|1|||
170819315|NCT01536795|617345847|FG001|Overall Study|Lack of Efficacy|0|||
170819316|NCT05008224|617345848|FG000|Overall Study|Death|3|||
170621126|NCT00622505|616620830|FG000|Overall Study|Withdrawal by Subject|12|||
170621127|NCT00622505|616620831|FG001|Overall Study|Withdrawal by Subject|5|||
170621128|NCT00622505|616620830|FG000|Overall Study|Administrative Problems|2|||
170621129|NCT00622505|616620831|FG001|Overall Study|Administrative Problems|4|||
170621130|NCT00622505|616620830|FG000|Overall Study|Death|2|||
170621131|NCT00622505|616620831|FG001|Overall Study|Death|2|||
170819317|NCT05008224|617345848|FG000|Overall Study|Lost to Follow-up|2|||
170819318|NCT05008224|617345848|FG000|Overall Study|Did Not Continue on Extension Study|39|||
170621132|NCT03294590|616620834|FG000|Overall Study|Lost to Follow-up|105|||
170621133|NCT03294590|616620835|FG001|Overall Study|Lost to Follow-up|107|||
170621134|NCT01962441|616620836|FG000|Randomized Period|Randomized but Never Treated|4|||
170621135|NCT01962441|616620837|FG001|Randomized Period|Randomized but Never Treated|2|||
170819319|NCT05008224|617345848|FG000|Overall Study|Transferred to Extension Study|100|||
170621136|NCT01962441|616620838|FG002|Randomized Period|Randomized but Never Treated|3|||
170621137|NCT01962441|616620836|FG000|Randomized Period|Lost to Follow-up|2|||
170621138|NCT01962441|616620837|FG001|Randomized Period|Lost to Follow-up|4|||
170621139|NCT01962441|616620838|FG002|Randomized Period|Lost to Follow-up|4|||
170621140|NCT01962441|616620836|FG000|Randomized Period|Withdrew Consent|3|||
170621141|NCT01962441|616620837|FG001|Randomized Period|Withdrew Consent|3|||
170621142|NCT01962441|616620838|FG002|Randomized Period|Withdrew Consent|2|||
170621143|NCT01962441|616620836|FG000|Randomized Period|Adverse Event|1|||
170621144|NCT01962441|616620837|FG001|Randomized Period|Adverse Event|1|||
170621145|NCT01962441|616620838|FG002|Randomized Period|Adverse Event|0|||
170621146|NCT01962441|616620836|FG000|Randomized Period|Death|0|||
170621147|NCT01962441|616620837|FG001|Randomized Period|Death|0|||
170621148|NCT01962441|616620838|FG002|Randomized Period|Death|2|||
170621149|NCT01962441|616620836|FG000|Randomized Period|Protocol Violation|0|||
170621150|NCT01962441|616620837|FG001|Randomized Period|Protocol Violation|1|||
170621151|NCT01962441|616620838|FG002|Randomized Period|Protocol Violation|0|||
170621152|NCT01962441|616620836|FG000|Retreatment Substudy|Lack of Efficacy|1|||
170621153|NCT01962441|616620837|FG001|Retreatment Substudy|Lack of Efficacy|0|||
170621154|NCT01962441|616620838|FG002|Retreatment Substudy|Lack of Efficacy|0|||
170621155|NCT01962441|616620836|FG000|Retreatment Substudy|Lost to Follow-up|1|||
170621156|NCT01962441|616620837|FG001|Retreatment Substudy|Lost to Follow-up|0|||
170669130|NCT00354744|616801046|FG000|Overall Study|Lost to Follow-up|2|||
170669131|NCT00354744|616801046|FG000|Overall Study|Physician Decision|11|||
170669132|NCT00354744|616801046|FG000|Overall Study|Withdrawal by Subject|14|||
170669133|NCT00094172|616801048|FG000|Overall Study|Adverse Event|0|||
170621157|NCT01962441|616620838|FG002|Retreatment Substudy|Lost to Follow-up|0|||
170621158|NCT01453140|616620839|FG000|Overall Study|Adverse Event|3|||
170621159|NCT02611479|616620840|FG000|Baseline Enrollment|Exited study|13|||
170669134|NCT00094172|616801049|FG001|Overall Study|Adverse Event|1|||
170669135|NCT00094172|616801048|FG000|Overall Study|Lost to Follow-up|2|||
170621160|NCT02611479|616620840|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
170621161|NCT02611479|616620840|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
170621162|NCT02611479|616620840|FG000|Data Cleaning|No baseline function or pain metrics|2|||
170621163|NCT02201524|616620841|FG000|Overall Study|Adverse Event|0|||
170621164|NCT02201524|616620842|FG001|Overall Study|Adverse Event|2|||
170621165|NCT02201524|616620843|FG002|Overall Study|Adverse Event|1|||
170621166|NCT02201524|616620844|FG003|Overall Study|Adverse Event|0|||
170621167|NCT02201524|616620841|FG000|Overall Study|Insufficient clinical response|1|||
170621168|NCT02201524|616620842|FG001|Overall Study|Insufficient clinical response|0|||
170621169|NCT02201524|616620843|FG002|Overall Study|Insufficient clinical response|0|||
170621170|NCT02201524|616620844|FG003|Overall Study|Insufficient clinical response|0|||
170621171|NCT02201524|616620841|FG000|Overall Study|Lost to Follow-up|0|||
170621172|NCT02201524|616620842|FG001|Overall Study|Lost to Follow-up|0|||
170621173|NCT02201524|616620843|FG002|Overall Study|Lost to Follow-up|2|||
170621174|NCT02201524|616620844|FG003|Overall Study|Lost to Follow-up|0|||
170621175|NCT02201524|616620841|FG000|Overall Study|No longer meets eligibility criteria|0|||
170621176|NCT02201524|616620842|FG001|Overall Study|No longer meets eligibility criteria|0|||
170621177|NCT02201524|616620843|FG002|Overall Study|No longer meets eligibility criteria|0|||
170621178|NCT02201524|616620844|FG003|Overall Study|No longer meets eligibility criteria|2|||
170621179|NCT02201524|616620841|FG000|Overall Study|Protocol Violation|0|||
170621180|NCT02201524|616620842|FG001|Overall Study|Protocol Violation|0|||
170621181|NCT02201524|616620843|FG002|Overall Study|Protocol Violation|0|||
170621182|NCT02201524|616620844|FG003|Overall Study|Protocol Violation|1|||
170621183|NCT02201524|616620841|FG000|Overall Study|Withdrawal by Subject|0|||
170621184|NCT02201524|616620842|FG001|Overall Study|Withdrawal by Subject|0|||
170621185|NCT02201524|616620843|FG002|Overall Study|Withdrawal by Subject|1|||
170621186|NCT02201524|616620844|FG003|Overall Study|Withdrawal by Subject|1|||
170621187|NCT02201524|616620841|FG000|Overall Study|Other|1|||
170621188|NCT02201524|616620842|FG001|Overall Study|Other|1|||
170621189|NCT02201524|616620843|FG002|Overall Study|Other|0|||
170621190|NCT02201524|616620844|FG003|Overall Study|Other|0|||
170621191|NCT01620060|616620850|FG000|Overall Study|Adverse Event|9|||
170621192|NCT01620060|616620850|FG000|Overall Study|Protocol Violation|1|||
170621193|NCT01620060|616620850|FG000|Overall Study|Withdrawal by Subject|1|||
170621194|NCT01620060|616620850|FG000|Overall Study|Did not comply with Study Produre|1|||
170621195|NCT01620060|616620850|FG000|Overall Study|Family emergency|1|||
170621196|NCT01620060|616620850|FG000|Overall Study|Per Sponsor Decision|2|||
170621197|NCT02269124|616620852|FG000|Overall Study|Lost to Follow-up|1|||
170621198|NCT02269124|616620853|FG001|Overall Study|Lost to Follow-up|0|||
170621199|NCT02269124|616620852|FG000|Overall Study|Withdrawal by Subject|0|||
170621200|NCT02269124|616620853|FG001|Overall Study|Withdrawal by Subject|2|||
170621201|NCT04201431|616620866|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
170621202|NCT04201431|616620867|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
170621203|NCT04201431|616620868|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
170621204|NCT00686777|616620879|FG000|Overall Study|Adverse Event|2|||
170621205|NCT00686777|616620879|FG000|Overall Study|Pregnancy|1|||
170621206|NCT00686777|616620879|FG000|Overall Study|Withdrawal by Subject|2|||
170621207|NCT00686777|616620879|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
170621208|NCT00686777|616620879|FG000|Overall Study|No Visit|1|||
170621209|NCT00667888|616620880|FG000|Overall Study|Death|1|||
170621210|NCT00667888|616620881|FG001|Overall Study|Death|1|||
170621211|NCT00667888|616620880|FG000|Overall Study|Withdrawal by Subject|6|||
170621212|NCT00667888|616620881|FG001|Overall Study|Withdrawal by Subject|3|||
170621213|NCT00667888|616620880|FG000|Overall Study|Proceed with other treatment|3|||
170621214|NCT00667888|616620881|FG001|Overall Study|Proceed with other treatment|3|||
170621215|NCT00667888|616620880|FG000|Overall Study|Ineligible after SIM|0|||
170621216|NCT00667888|616620881|FG001|Overall Study|Ineligible after SIM|2|||
170621217|NCT00499681|616620882|FG000|Overall Study|toxicity|0|||
170621218|NCT00499681|616620883|FG001|Overall Study|toxicity|1|||
170621219|NCT00499681|616620882|FG000|Overall Study|disease progression|0|||
170621220|NCT00499681|616620883|FG001|Overall Study|disease progression|1|||
170621221|NCT00739401|616620887|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
170621222|NCT00739401|616620887|FG000|Overall Study|Death|3|||
170621223|NCT00739401|616620887|FG000|Overall Study|Withdrawal by Subject|4|||
170621224|NCT00890825|616620891|FG000|Overall Study|Withdrawal by Subject|1|||
170621225|NCT00890825|616620892|FG001|Overall Study|Withdrawal by Subject|0|||
170621226|NCT00890825|616620891|FG000|Overall Study|Alive at data cut off (DCO)|13|||
170621227|NCT00890825|616620892|FG001|Overall Study|Alive at data cut off (DCO)|14|||
170621228|NCT02920892|616620893|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
170621229|NCT02920892|616620894|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
170621230|NCT02920892|616620895|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
170621231|NCT02920892|616620893|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
170621232|NCT02920892|616620894|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
170621233|NCT02920892|616620895|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
170621234|NCT02920892|616620893|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
170621235|NCT02920892|616620894|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
170621236|NCT02920892|616620895|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
170621237|NCT02920892|616620893|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
170621238|NCT02920892|616620894|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
170621239|NCT02920892|616620895|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
170621240|NCT02920892|616620893|FG000|Placebo-Controlled Period|Physician Decision|0|||
170621241|NCT02920892|616620894|FG001|Placebo-Controlled Period|Physician Decision|0|||
170621242|NCT02920892|616620895|FG002|Placebo-Controlled Period|Physician Decision|1|||
170621243|NCT02920892|616620893|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
170621244|NCT02920892|616620894|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
170669136|NCT00094172|616801049|FG001|Overall Study|Lost to Follow-up|0|||
170669137|NCT00094172|616801048|FG000|Overall Study|Protocol Violation|0|||
170669138|NCT00094172|616801049|FG001|Overall Study|Protocol Violation|1|||
170669139|NCT00094172|616801048|FG000|Overall Study|Withdrawal by Subject|10|||
170621245|NCT02920892|616620895|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
170669140|NCT00094172|616801049|FG001|Overall Study|Withdrawal by Subject|5|||
170621246|NCT02920892|616620893|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170621247|NCT02920892|616620894|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
170621248|NCT02920892|616620895|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
170621249|NCT02920892|616620893|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
170621250|NCT02920892|616620894|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
170621251|NCT02920892|616620895|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
170621252|NCT03935126|616620898|FG000|Overall Study|Study termination by sponsor|3|||
170621253|NCT04908397|616620915|FG000|Overall Study|Withdrawal by Subject|2|||
170621254|NCT03318549|616620916|FG000|Overall Study|Withdrawal by Subject|5|||
170621255|NCT03318549|616620917|FG001|Overall Study|Withdrawal by Subject|19|||
170621256|NCT03318549|616620918|FG002|Overall Study|Withdrawal by Subject|2|||
170621257|NCT03318549|616620919|FG003|Overall Study|Withdrawal by Subject|0|||
170621258|NCT03318549|616620920|FG004|Overall Study|Withdrawal by Subject|0|||
170621259|NCT03318549|616620921|FG005|Overall Study|Withdrawal by Subject|0|||
170621260|NCT03318549|616620922|FG006|Overall Study|Withdrawal by Subject|0|||
170621261|NCT03318549|616620916|FG000|Overall Study|Physician Decision|0|||
170621262|NCT03318549|616620917|FG001|Overall Study|Physician Decision|4|||
170621263|NCT03318549|616620918|FG002|Overall Study|Physician Decision|1|||
170621264|NCT03318549|616620919|FG003|Overall Study|Physician Decision|0|||
170621265|NCT03318549|616620920|FG004|Overall Study|Physician Decision|0|||
170621266|NCT03318549|616620921|FG005|Overall Study|Physician Decision|0|||
170621267|NCT03318549|616620922|FG006|Overall Study|Physician Decision|0|||
170621268|NCT03318549|616620916|FG000|Overall Study|Lost to Follow-up|0|||
170621269|NCT03318549|616620917|FG001|Overall Study|Lost to Follow-up|3|||
170621270|NCT03318549|616620918|FG002|Overall Study|Lost to Follow-up|3|||
170621271|NCT03318549|616620919|FG003|Overall Study|Lost to Follow-up|0|||
170621272|NCT03318549|616620920|FG004|Overall Study|Lost to Follow-up|0|||
170621273|NCT03318549|616620921|FG005|Overall Study|Lost to Follow-up|0|||
170621274|NCT03318549|616620922|FG006|Overall Study|Lost to Follow-up|0|||
170621275|NCT01433172|616620923|FG000|Overall Study|Withdrawal by Subject|0|||
170621276|NCT01433172|616620924|FG001|Overall Study|Withdrawal by Subject|1|||
170621277|NCT01433172|616620925|FG002|Overall Study|Withdrawal by Subject|0|||
170621278|NCT01433172|616620923|FG000|Overall Study|Disease Progression|0|||
170621279|NCT01433172|616620924|FG001|Overall Study|Disease Progression|0|||
170621280|NCT01433172|616620925|FG002|Overall Study|Disease Progression|1|||
170621281|NCT01433172|616620923|FG000|Overall Study|Death|0|||
170621282|NCT01433172|616620924|FG001|Overall Study|Death|2|||
170621283|NCT01433172|616620925|FG002|Overall Study|Death|0|||
170621284|NCT00462306|616620926|FG000|Overall Study|insufficient data|0|||
170621285|NCT00462306|616620927|FG001|Overall Study|insufficient data|13|||
170621286|NCT00539994|616620928|FG000|Overall Study|Lost to Follow-up|2|||
170621287|NCT00539994|616620929|FG001|Overall Study|Lost to Follow-up|1|||
170621288|NCT00539994|616620930|FG002|Overall Study|Lost to Follow-up|0|||
170621289|NCT00539994|616620928|FG000|Overall Study|Withdrawal by Subject|1|||
170621290|NCT00539994|616620929|FG001|Overall Study|Withdrawal by Subject|0|||
170621291|NCT00539994|616620930|FG002|Overall Study|Withdrawal by Subject|1|||
170621292|NCT00539994|616620928|FG000|Overall Study|Physician Decision|0|||
170621293|NCT00539994|616620929|FG001|Overall Study|Physician Decision|0|||
170621294|NCT00539994|616620930|FG002|Overall Study|Physician Decision|1|||
170621295|NCT04612725|616620931|FG000|Overall Study|Adverse Event|1|||
170621296|NCT04612725|616620932|FG001|Overall Study|Adverse Event|3|||
170621297|NCT04612725|616620933|FG002|Overall Study|Adverse Event|1|||
170621298|NCT04612725|616620934|FG003|Overall Study|Adverse Event|0|||
170621299|NCT04612725|616620935|FG004|Overall Study|Adverse Event|1|||
170621300|NCT04612725|616620931|FG000|Overall Study|Lost to Follow-up|0|||
170621301|NCT04612725|616620932|FG001|Overall Study|Lost to Follow-up|1|||
170621302|NCT04612725|616620933|FG002|Overall Study|Lost to Follow-up|0|||
170621303|NCT04612725|616620934|FG003|Overall Study|Lost to Follow-up|0|||
170621304|NCT04612725|616620935|FG004|Overall Study|Lost to Follow-up|0|||
170621305|NCT04612725|616620931|FG000|Overall Study|Physician Decision|2|||
170621306|NCT04612725|616620932|FG001|Overall Study|Physician Decision|0|||
170621307|NCT04612725|616620933|FG002|Overall Study|Physician Decision|0|||
170621308|NCT04612725|616620934|FG003|Overall Study|Physician Decision|0|||
170621309|NCT04612725|616620935|FG004|Overall Study|Physician Decision|0|||
170621310|NCT04612725|616620931|FG000|Overall Study|Study terminated by sponsor|3|||
170621311|NCT04612725|616620932|FG001|Overall Study|Study terminated by sponsor|1|||
170621312|NCT04612725|616620933|FG002|Overall Study|Study terminated by sponsor|2|||
170819320|NCT05008224|617345848|FG000|Overall Study|Withdrawal by Subject|2|||
170621313|NCT04612725|616620934|FG003|Overall Study|Study terminated by sponsor|4|||
170621314|NCT04612725|616620935|FG004|Overall Study|Study terminated by sponsor|5|||
170621315|NCT04612725|616620931|FG000|Overall Study|Withdrawal by Subject|8|||
170621316|NCT04612725|616620932|FG001|Overall Study|Withdrawal by Subject|3|||
170621317|NCT04612725|616620933|FG002|Overall Study|Withdrawal by Subject|5|||
170621318|NCT04612725|616620934|FG003|Overall Study|Withdrawal by Subject|1|||
170621319|NCT04612725|616620935|FG004|Overall Study|Withdrawal by Subject|9|||
170621320|NCT04612725|616620931|FG000|Overall Study|Other|0|||
170621321|NCT04612725|616620932|FG001|Overall Study|Other|0|||
170621322|NCT04612725|616620933|FG002|Overall Study|Other|0|||
170819321|NCT05878522|617345852|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819322|NCT05878522|617345853|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819323|NCT05878522|617345854|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819324|NCT05878522|617345855|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819325|NCT05878522|617345856|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819326|NCT05878522|617345857|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819327|NCT05878522|617345858|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819328|NCT05878522|617345859|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819329|NCT05878522|617345860|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
170819330|NCT05878522|617345861|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819331|NCT05878522|617345862|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819332|NCT05878522|617345863|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
170819333|NCT05878522|617345852|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
170819334|NCT05878522|617345853|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819335|NCT05878522|617345854|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819336|NCT05878522|617345855|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819337|NCT05878522|617345856|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819338|NCT05878522|617345857|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819339|NCT05878522|617345858|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819340|NCT05878522|617345859|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819341|NCT05878522|617345860|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819342|NCT05878522|617345861|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
170819343|NCT05878522|617345862|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819344|NCT05878522|617345863|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
170819345|NCT05878522|617345852|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170819346|NCT05878522|617345853|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
170819347|NCT05878522|617345854|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170819348|NCT05878522|617345855|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
170819349|NCT05878522|617345856|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170819350|NCT05878522|617345857|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170819351|NCT05878522|617345858|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170819352|NCT05878522|617345859|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170819353|NCT05878522|617345860|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170669141|NCT00094172|616801048|FG000|Overall Study|Primary endpoint met.|1|||
170669142|NCT00094172|616801049|FG001|Overall Study|Primary endpoint met.|0|||
170669143|NCT00094172|616801048|FG000|Overall Study|Started other MS therapy due to disease|1|||
170669144|NCT00094172|616801049|FG001|Overall Study|Started other MS therapy due to disease|0|||
170669145|NCT01313858|616801051|FG000|Overall Study|Premature Treatment Termination|251|||
170669146|NCT01313858|616801052|FG001|Overall Study|Premature Treatment Termination|219|||
170669147|NCT01313858|616801053|FG002|Overall Study|Premature Treatment Termination|191|||
170669148|NCT01313858|616801051|FG000|Overall Study|Lost to Follow-up|35|||
170669149|NCT01313858|616801052|FG001|Overall Study|Lost to Follow-up|51|||
170669150|NCT01313858|616801053|FG002|Overall Study|Lost to Follow-up|47|||
170669151|NCT03689530|616801054|FG000|Overall Study|Withdrawal by Subject|53|||
170669152|NCT03689530|616801055|FG001|Overall Study|Withdrawal by Subject|16|||
170669153|NCT01392443|616801056|FG000|Overall Study|Disease progression|30|||
170669154|NCT01392443|616801056|FG000|Overall Study|Adverse Event|24|||
170819354|NCT05878522|617345861|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170819355|NCT05878522|617345862|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170669155|NCT01392443|616801056|FG000|Overall Study|Death|7|||
170669156|NCT01392443|616801056|FG000|Overall Study|Withdrawal by Subject|5|||
170669157|NCT01392443|616801056|FG000|Overall Study|Lost to Follow-up|1|||
170669158|NCT01392443|616801056|FG000|Overall Study|Protocol Violation|1|||
170669159|NCT01626456|616801061|FG000|Overall Study|Withdrawal by Subject|21|||
170669160|NCT01626456|616801062|FG001|Overall Study|Withdrawal by Subject|46|||
170669161|NCT01626456|616801061|FG000|Overall Study|Adverse Event|2|||
170669162|NCT01626456|616801062|FG001|Overall Study|Adverse Event|27|||
170669163|NCT01626456|616801061|FG000|Overall Study|Lost to Follow-up|2|||
170819356|NCT05878522|617345863|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
170819357|NCT05878522|617345852|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819358|NCT05878522|617345853|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819359|NCT05878522|617345854|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819360|NCT05878522|617345855|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819361|NCT05878522|617345856|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
170819362|NCT05878522|617345857|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819363|NCT05878522|617345858|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819364|NCT05878522|617345859|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819365|NCT05878522|617345860|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819366|NCT05878522|617345861|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170621323|NCT04612725|616620934|FG003|Overall Study|Other|0|||
170621324|NCT04612725|616620935|FG004|Overall Study|Other|1|||
170621325|NCT03064490|616620936|FG000|Overall Study|Physician Decision|5|||
170621326|NCT02360228|616620948|FG000|Overall Study|Withdrawal by Subject|1|||
170621327|NCT02360228|616620949|FG001|Overall Study|Withdrawal by Subject|0|||
170621328|NCT02360228|616620950|FG002|Overall Study|Withdrawal by Subject|0|||
170621329|NCT02360228|616620948|FG000|Overall Study|Self-discontinued medication|0|||
170621330|NCT02360228|616620949|FG001|Overall Study|Self-discontinued medication|1|||
170621331|NCT02360228|616620950|FG002|Overall Study|Self-discontinued medication|0|||
170621332|NCT02360228|616620948|FG000|Overall Study|Unstable symptoms during screening|0|||
170621333|NCT02360228|616620949|FG001|Overall Study|Unstable symptoms during screening|0|||
170621334|NCT02360228|616620950|FG002|Overall Study|Unstable symptoms during screening|1|||
170621335|NCT02464410|616620951|FG000|Overall Study|Death|3|||
170621336|NCT02464410|616620952|FG001|Overall Study|Death|4|||
170819367|NCT05878522|617345862|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819368|NCT05878522|617345863|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
170819369|NCT05263492|617345864|FG000|Overall Study|Adverse Event|1|||
170819370|NCT05263492|617345864|FG000|Overall Study|Disease progression during active treatment|3|||
170819371|NCT04551053|617345865|FG000|Overall Study|Death|10|||
170819372|NCT04551053|617345866|FG001|Overall Study|Death|9|||
170819373|NCT04551053|617345865|FG000|Overall Study|Lost to Follow-up|0|||
170819374|NCT04551053|617345866|FG001|Overall Study|Lost to Follow-up|2|||
170819375|NCT04551053|617345865|FG000|Overall Study|Study Terminated by Sponsor|57|||
170819376|NCT04551053|617345866|FG001|Overall Study|Study Terminated by Sponsor|65|||
170819377|NCT04551053|617345865|FG000|Overall Study|Withdrawal by Subject|12|||
170819378|NCT04551053|617345866|FG001|Overall Study|Withdrawal by Subject|5|||
170819379|NCT04551053|617345865|FG000|Overall Study|Adverse Event|2|||
170819380|NCT04551053|617345866|FG001|Overall Study|Adverse Event|0|||
170819381|NCT04551053|617345865|FG000|Overall Study|Lack of Efficacy|2|||
170819382|NCT04551053|617345866|FG001|Overall Study|Lack of Efficacy|1|||
170819383|NCT04551053|617345865|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
170819384|NCT04551053|617345866|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
170819385|NCT04551053|617345865|FG000|Overall Study|Splenapendectomi|1|||
170819386|NCT04551053|617345866|FG001|Overall Study|Splenapendectomi|0|||
170819387|NCT04551053|617345865|FG000|Overall Study|Medical Decision|1|||
170819388|NCT04551053|617345866|FG001|Overall Study|Medical Decision|1|||
170819389|NCT00596960|617345868|FG000|Overall Study|Death|1|||
170819390|NCT00596960|617345869|FG001|Overall Study|Death|2|||
170819391|NCT00596960|617345868|FG000|Overall Study|Lost to Follow-up|6|||
170621337|NCT02464410|616620951|FG000|Overall Study|Lost to Follow-up|7|||
170819392|NCT00596960|617345869|FG001|Overall Study|Lost to Follow-up|5|||
170621338|NCT02464410|616620952|FG001|Overall Study|Lost to Follow-up|9|||
170621339|NCT02464410|616620951|FG000|Overall Study|Withdrawal by Subject|12|||
170621340|NCT02464410|616620952|FG001|Overall Study|Withdrawal by Subject|3|||
170621341|NCT01063153|616620958|FG000|Overall Study|Found Ineligible During Screening|2|||
170621342|NCT01063153|616620959|FG001|Overall Study|Found Ineligible During Screening|0|||
170621343|NCT01063153|616620958|FG000|Overall Study|Lost to Follow-up|0|||
170621344|NCT01063153|616620959|FG001|Overall Study|Lost to Follow-up|7|||
170621345|NCT01063153|616620958|FG000|Overall Study|Withdrawal by Subject|0|||
170621346|NCT01063153|616620959|FG001|Overall Study|Withdrawal by Subject|1|||
170621347|NCT01063153|616620958|FG000|Overall Study|Physician Decision|0|||
170621348|NCT01063153|616620959|FG001|Overall Study|Physician Decision|4|||
170621349|NCT01777776|616620960|FG000|Overall Study|Adverse Event|2|||
170621350|NCT01777776|616620961|FG001|Overall Study|Adverse Event|4|||
170819393|NCT00596960|617345868|FG000|Overall Study|Withdrawal by Subject|1|||
170819394|NCT00596960|617345869|FG001|Overall Study|Withdrawal by Subject|0|||
170819395|NCT00596960|617345868|FG000|Overall Study|Incarcerated|2|||
170819396|NCT00596960|617345869|FG001|Overall Study|Incarcerated|0|||
170819397|NCT00596960|617345868|FG000|Overall Study|Physician Decision|1|||
170819398|NCT00596960|617345869|FG001|Overall Study|Physician Decision|0|||
170819399|NCT00596960|617345868|FG000|Overall Study|Protocol Violation|0|||
170819400|NCT00596960|617345869|FG001|Overall Study|Protocol Violation|1|||
170819401|NCT00596960|617345868|FG000|Overall Study|No alcohol use data|0|||
170819402|NCT00596960|617345869|FG001|Overall Study|No alcohol use data|1|||
170819403|NCT02374476|617345870|FG000|VT Induced Ablation|Screening Failures|36|||
170819404|NCT02374476|617345871|FG001|VT Induced Ablation|Screening Failures|0|||
170819405|NCT02374476|617345872|FG002|VT Induced Ablation|Screening Failures|0|||
170819406|NCT02374476|617345870|FG000|Arm Assignment|Withdrawal by Subject|0|||
170819407|NCT02374476|617345871|FG001|Arm Assignment|Withdrawal by Subject|0|||
170819408|NCT02374476|617345872|FG002|Arm Assignment|Withdrawal by Subject|1|||
170819409|NCT02924051|617345875|FG000|Overall Study|Withdrawal by Subject|1|||
170819410|NCT02924051|617345876|FG001|Overall Study|Withdrawal by Subject|9|||
170819411|NCT04016415|617345877|FG000|Overall Study|Adverse Event|2|||
170819412|NCT04016415|617345878|FG001|Overall Study|Adverse Event|1|||
170819413|NCT04016415|617345877|FG000|Overall Study|Lost to Follow-up|6|||
170819414|NCT04016415|617345878|FG001|Overall Study|Lost to Follow-up|2|||
170819415|NCT04016415|617345877|FG000|Overall Study|Physician Decision|5|||
170621351|NCT01777776|616620962|FG002|Overall Study|Adverse Event|0|||
170621352|NCT01777776|616620963|FG003|Overall Study|Adverse Event|0|||
170621353|NCT01777776|616620960|FG000|Overall Study|Disease Progression|4|||
170621354|NCT01777776|616620961|FG001|Overall Study|Disease Progression|8|||
170621355|NCT01777776|616620962|FG002|Overall Study|Disease Progression|6|||
170621356|NCT01777776|616620963|FG003|Overall Study|Disease Progression|3|||
170621357|NCT01777776|616620960|FG000|Overall Study|Withdrawal by Subject|0|||
170621358|NCT01777776|616620961|FG001|Overall Study|Withdrawal by Subject|0|||
170621359|NCT01777776|616620962|FG002|Overall Study|Withdrawal by Subject|0|||
170621360|NCT01777776|616620963|FG003|Overall Study|Withdrawal by Subject|1|||
170621361|NCT00948064|616622596|FG000|Phase I|No treatment received|1|||
170621362|NCT00948064|616622597|FG001|Phase I|No treatment received|0|||
170621363|NCT00948064|616622598|FG002|Phase I|No treatment received|0|||
170621364|NCT00948064|616622596|FG000|Phase II|Physician Decision|0|||
170621365|NCT00948064|616622597|FG001|Phase II|Physician Decision|0|||
170621366|NCT00948064|616622598|FG002|Phase II|Physician Decision|1|||
170621367|NCT00948064|616622596|FG000|Phase II|Withdrawal by Subject|0|||
170621368|NCT00948064|616622597|FG001|Phase II|Withdrawal by Subject|1|||
170669164|NCT01626456|616801062|FG001|Overall Study|Lost to Follow-up|27|||
170669165|NCT01626456|616801061|FG000|Overall Study|Lack of Efficacy|6|||
170669166|NCT01626456|616801062|FG001|Overall Study|Lack of Efficacy|7|||
170669167|NCT01626456|616801061|FG000|Overall Study|Physician Decision|1|||
170669168|NCT01626456|616801062|FG001|Overall Study|Physician Decision|4|||
170669169|NCT01626456|616801061|FG000|Overall Study|Protocol Violation|1|||
170669170|NCT01626456|616801062|FG001|Overall Study|Protocol Violation|1|||
170669171|NCT01626456|616801061|FG000|Overall Study|Site Closure|2|||
170669172|NCT01626456|616801062|FG001|Overall Study|Site Closure|3|||
170669173|NCT01626456|616801061|FG000|Overall Study|Incarceration|0|||
170669174|NCT01626456|616801062|FG001|Overall Study|Incarceration|2|||
170669175|NCT04622306|616801065|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
170669176|NCT04622306|616801066|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
170669177|NCT04622306|616801067|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
170669178|NCT04622306|616801068|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
170669179|NCT04622306|616801069|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
170669180|NCT04622306|616801070|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
170669181|NCT04622306|616801065|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
170669182|NCT04622306|616801066|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
170669183|NCT04622306|616801067|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
170669184|NCT04622306|616801068|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
170669185|NCT04622306|616801069|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
170669186|NCT04622306|616801070|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
170819416|NCT04016415|617345878|FG001|Overall Study|Physician Decision|1|||
170819417|NCT04016415|617345877|FG000|Overall Study|Pregnancy|0|||
170819418|NCT04016415|617345878|FG001|Overall Study|Pregnancy|1|||
170819419|NCT04016415|617345877|FG000|Overall Study|Withdrawal by Subject|24|||
170819420|NCT04016415|617345878|FG001|Overall Study|Withdrawal by Subject|27|||
170819421|NCT04016415|617345877|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
170819422|NCT04016415|617345878|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
170621369|NCT00948064|616622598|FG002|Phase II|Withdrawal by Subject|0|||
170621370|NCT03409796|616622612|FG000|Overall Study|Adverse Event|2|||
170621371|NCT03409796|616622613|FG001|Overall Study|Adverse Event|0|||
170621372|NCT03409796|616622612|FG000|Overall Study|Other|0|||
170621373|NCT03409796|616622613|FG001|Overall Study|Other|1|||
170621374|NCT00740220|616622614|FG000|Overall Study|screen failures (non-COPD patients)|9|||
170621375|NCT00633477|616622615|FG000|Overall Study|Death|1|||
170621376|NCT00633477|616622616|FG001|Overall Study|Death|0|||
170621377|NCT00633477|616622615|FG000|Overall Study|Randomized but not treated|1|||
170621378|NCT00633477|616622616|FG001|Overall Study|Randomized but not treated|0|||
170621379|NCT00770653|616622620|FG000|Overall Study|Adverse Event|13|||
170621380|NCT00770653|616622621|FG001|Overall Study|Adverse Event|5|||
170621381|NCT00770653|616622620|FG000|Overall Study|Protocol Violation|8|||
170621382|NCT00770653|616622621|FG001|Overall Study|Protocol Violation|6|||
170621383|NCT00770653|616622620|FG000|Overall Study|Withdrawal by Subject|4|||
170621384|NCT00770653|616622621|FG001|Overall Study|Withdrawal by Subject|7|||
170621385|NCT00770653|616622620|FG000|Overall Study|Lack of Compliance|1|||
170621386|NCT00770653|616622621|FG001|Overall Study|Lack of Compliance|4|||
170621387|NCT00770653|616622620|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
170621388|NCT00770653|616622621|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
170621389|NCT00770653|616622620|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
170621390|NCT00770653|616622621|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
170621391|NCT00770653|616622620|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
170621392|NCT00770653|616622621|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
170621393|NCT00770653|616622620|FG000|Overall Study|Lost to Follow-up|1|||
170621394|NCT00770653|616622621|FG001|Overall Study|Lost to Follow-up|2|||
170621395|NCT00770653|616622620|FG000|Overall Study|Physician Decision|1|||
170621396|NCT00770653|616622621|FG001|Overall Study|Physician Decision|0|||
170621397|NCT04906499|616622627|FG000|Overall Study|Lack of time|1|||
170669187|NCT01868503|616801071|FG000|Overall Study|Withdrawal by Subject|1|||
170669188|NCT01868503|616801071|FG000|Overall Study|Protocol Violation|1|||
170669189|NCT05350410|616801072|FG000|Overall Study|Withdrawal by Subject|1|||
170669190|NCT00142935|616801085|FG000|Overall Study|Other reason|1|||
170621398|NCT02741128|616622632|FG000|Overall Study|Protocol Violation|4|||
170621399|NCT02741128|616622633|FG001|Overall Study|Protocol Violation|1|||
170621400|NCT02741128|616622632|FG000|Overall Study|Withdrawal by Subject|2|||
170621401|NCT02741128|616622633|FG001|Overall Study|Withdrawal by Subject|0|||
170621402|NCT02741128|616622632|FG000|Overall Study|Lost to Follow-up|1|||
170621403|NCT02741128|616622633|FG001|Overall Study|Lost to Follow-up|0|||
170621404|NCT02426580|616622636|FG000|Overall Study|Death|2|||
170621405|NCT02426580|616622637|FG001|Overall Study|Death|2|||
170621406|NCT02426580|616622636|FG000|Overall Study|Lost to Follow-up|0|||
170621407|NCT02426580|616622637|FG001|Overall Study|Lost to Follow-up|9|||
170621408|NCT02426580|616622636|FG000|Overall Study|transfer to hemodialysis|5|||
170621409|NCT02426580|616622637|FG001|Overall Study|transfer to hemodialysis|5|||
170621410|NCT02426580|616622636|FG000|Overall Study|Kidney transplant|3|||
170621411|NCT02426580|616622637|FG001|Overall Study|Kidney transplant|0|||
170621412|NCT02426580|616622636|FG000|Overall Study|Allergic to egg white|1|||
170621413|NCT02426580|616622637|FG001|Overall Study|Allergic to egg white|0|||
170621414|NCT01419769|616622638|FG000|Overall Study|Did not receive the AXIOS stent|3|||
170621415|NCT01419769|616622638|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
170621416|NCT00383552|616622639|FG000|Overall Study|Adverse Event|7|||
170621417|NCT00383552|616622640|FG001|Overall Study|Adverse Event|6|||
170621418|NCT00383552|616622641|FG002|Overall Study|Adverse Event|9|||
170621419|NCT00383552|616622642|FG003|Overall Study|Adverse Event|6|||
170621420|NCT00383552|616622639|FG000|Overall Study|Lack of Efficacy|4|||
170621421|NCT00383552|616622640|FG001|Overall Study|Lack of Efficacy|13|||
170621422|NCT00383552|616622641|FG002|Overall Study|Lack of Efficacy|29|||
170621423|NCT00383552|616622642|FG003|Overall Study|Lack of Efficacy|42|||
170621424|NCT00383552|616622639|FG000|Overall Study|Lost to Follow-up|0|||
170621425|NCT00383552|616622640|FG001|Overall Study|Lost to Follow-up|1|||
170621426|NCT00383552|616622641|FG002|Overall Study|Lost to Follow-up|5|||
170621427|NCT00383552|616622642|FG003|Overall Study|Lost to Follow-up|1|||
170621428|NCT00383552|616622639|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
170621429|NCT00383552|616622640|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
170621430|NCT00383552|616622641|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
170621431|NCT00383552|616622642|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
170621432|NCT00383552|616622639|FG000|Overall Study|Did not wish to continue (related)|1|||
170621433|NCT00383552|616622640|FG001|Overall Study|Did not wish to continue (related)|0|||
170621434|NCT00383552|616622641|FG002|Overall Study|Did not wish to continue (related)|2|||
170621435|NCT00383552|616622642|FG003|Overall Study|Did not wish to continue (related)|3|||
170621436|NCT00383552|616622639|FG000|Overall Study|Noncompliance with the protocol|11|||
170621437|NCT00383552|616622640|FG001|Overall Study|Noncompliance with the protocol|6|||
170621438|NCT00383552|616622641|FG002|Overall Study|Noncompliance with the protocol|8|||
170621439|NCT00383552|616622642|FG003|Overall Study|Noncompliance with the protocol|10|||
170621440|NCT00383552|616622639|FG000|Overall Study|Did not meet protocol eligibility|8|||
170621441|NCT00383552|616622640|FG001|Overall Study|Did not meet protocol eligibility|6|||
170621442|NCT00383552|616622641|FG002|Overall Study|Did not meet protocol eligibility|2|||
170621443|NCT00383552|616622642|FG003|Overall Study|Did not meet protocol eligibility|3|||
170621444|NCT00383552|616622639|FG000|Overall Study|Administrative|1|||
170621445|NCT00383552|616622640|FG001|Overall Study|Administrative|0|||
170621446|NCT00383552|616622641|FG002|Overall Study|Administrative|1|||
170621447|NCT00383552|616622642|FG003|Overall Study|Administrative|1|||
170621448|NCT01393158|616622649|FG000|Overall Study|Adverse Event|1|||
170621449|NCT01393158|616622650|FG001|Overall Study|Adverse Event|0|||
170621450|NCT02173769|616622651|FG000|Overall Study|Protocol Violation|4|||
170621451|NCT04233801|616622652|FG000|Overall Study|Other than listed|0|||
170621452|NCT04233801|616622653|FG001|Overall Study|Other than listed|0|||
170621453|NCT04233801|616622654|FG002|Overall Study|Other than listed|1|||
170621454|NCT04233801|616622652|FG000|Overall Study|Withdrawal by Subject|0|||
170621455|NCT04233801|616622653|FG001|Overall Study|Withdrawal by Subject|2|||
170621456|NCT04233801|616622654|FG002|Overall Study|Withdrawal by Subject|3|||
170621457|NCT00683878|616622657|FG000|Overall Study|Lack of Efficacy|3|||
170621458|NCT00683878|616622658|FG001|Overall Study|Lack of Efficacy|0|||
170621459|NCT00683878|616622659|FG002|Overall Study|Lack of Efficacy|1|||
170621460|NCT00683878|616622657|FG000|Overall Study|Adverse Event|4|||
170621461|NCT00683878|616622658|FG001|Overall Study|Adverse Event|3|||
170621462|NCT00683878|616622659|FG002|Overall Study|Adverse Event|3|||
170621463|NCT00683878|616622657|FG000|Overall Study|Withdrawal by Subject|9|||
170621464|NCT00683878|616622658|FG001|Overall Study|Withdrawal by Subject|8|||
170621465|NCT00683878|616622659|FG002|Overall Study|Withdrawal by Subject|6|||
170621466|NCT00683878|616622657|FG000|Overall Study|Death|0|||
170621467|NCT00683878|616622658|FG001|Overall Study|Death|1|||
170621468|NCT00683878|616622659|FG002|Overall Study|Death|0|||
170621469|NCT00683878|616622657|FG000|Overall Study|Lost to Follow-up|4|||
170621470|NCT00683878|616622658|FG001|Overall Study|Lost to Follow-up|2|||
170621471|NCT00683878|616622659|FG002|Overall Study|Lost to Follow-up|4|||
170621472|NCT00683878|616622657|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
170621473|NCT00683878|616622658|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
170621474|NCT00683878|616622659|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
170621475|NCT03287791|616622665|FG000|Overall Study|Insufficient Therapeutic Response|0|||
170621476|NCT03287791|616622666|FG001|Overall Study|Insufficient Therapeutic Response|0|||
170621477|NCT03287791|616622667|FG002|Overall Study|Insufficient Therapeutic Response|1|||
170621478|NCT03287791|616622665|FG000|Overall Study|Adverse Event|0|||
170621479|NCT03287791|616622666|FG001|Overall Study|Adverse Event|4|||
170621480|NCT03287791|616622667|FG002|Overall Study|Adverse Event|3|||
170621481|NCT03287791|616622665|FG000|Overall Study|Withdrawal by Subject|12|||
170621482|NCT03287791|616622666|FG001|Overall Study|Withdrawal by Subject|12|||
170621483|NCT03287791|616622667|FG002|Overall Study|Withdrawal by Subject|17|||
170621484|NCT03287791|616622665|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
170621485|NCT03287791|616622666|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
170621486|NCT03287791|616622667|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
170621487|NCT03287791|616622665|FG000|Overall Study|Lost to Follow-up|8|||
170621488|NCT03287791|616622666|FG001|Overall Study|Lost to Follow-up|14|||
170621489|NCT03287791|616622667|FG002|Overall Study|Lost to Follow-up|11|||
170621490|NCT03287791|616622665|FG000|Overall Study|Protocol Violation|7|||
170621491|NCT03287791|616622666|FG001|Overall Study|Protocol Violation|2|||
170621492|NCT03287791|616622667|FG002|Overall Study|Protocol Violation|1|||
170621493|NCT03287791|616622665|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
170621494|NCT03287791|616622666|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
170621495|NCT03287791|616622667|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
170621496|NCT03287791|616622665|FG000|Overall Study|Too much time between 2 visits|0|||
170621497|NCT03287791|616622666|FG001|Overall Study|Too much time between 2 visits|1|||
170621498|NCT03287791|616622667|FG002|Overall Study|Too much time between 2 visits|0|||
170621499|NCT03287791|616622665|FG000|Overall Study|Non-compliance|0|||
170621500|NCT03287791|616622666|FG001|Overall Study|Non-compliance|1|||
170621501|NCT03287791|616622667|FG002|Overall Study|Non-compliance|0|||
170621502|NCT03287791|616622665|FG000|Overall Study|Did not meet inclusion criteria|1|||
170621503|NCT03287791|616622666|FG001|Overall Study|Did not meet inclusion criteria|0|||
170621504|NCT03287791|616622667|FG002|Overall Study|Did not meet inclusion criteria|0|||
170621505|NCT01381016|616622668|FG000|Overall Study|Lost to Follow-up|1|||
170621506|NCT01381016|616622669|FG001|Overall Study|Lost to Follow-up|1|||
170621507|NCT01381016|616622668|FG000|Overall Study|Screen Failure|2|||
170621508|NCT01381016|616622669|FG001|Overall Study|Screen Failure|2|||
170621509|NCT01381016|616622668|FG000|Overall Study|Withdrawal by Subject|0|||
170621510|NCT01381016|616622669|FG001|Overall Study|Withdrawal by Subject|1|||
170621511|NCT01381016|616622668|FG000|Overall Study|Physician Decision|0|||
170621512|NCT01381016|616622669|FG001|Overall Study|Physician Decision|2|||
170621513|NCT05482308|616622670|FG000|Overall Study|Withdrawal by Subject|1|||
170621514|NCT05482308|616622671|FG001|Overall Study|Withdrawal by Subject|0|||
170621515|NCT05482308|616622670|FG000|Overall Study|No longer meets eligibility criteria|0|||
170621516|NCT05482308|616622671|FG001|Overall Study|No longer meets eligibility criteria|1|||
170621517|NCT04124939|616622679|FG000|Overall Study|Lost to Follow-up|1|||
170621518|NCT04124939|616622680|FG001|Overall Study|Lost to Follow-up|3|||
170669191|NCT00142935|616801086|FG001|Overall Study|Other reason|1|||
170669192|NCT00142935|616801087|FG002|Overall Study|Other reason|1|||
170669193|NCT00142935|616801085|FG000|Overall Study|Lost to Follow-up|2|||
170669194|NCT00142935|616801086|FG001|Overall Study|Lost to Follow-up|5|||
170669195|NCT00142935|616801087|FG002|Overall Study|Lost to Follow-up|5|||
170669196|NCT00142935|616801085|FG000|Overall Study|Death|0|||
170669197|NCT00142935|616801086|FG001|Overall Study|Death|2|||
170669198|NCT00142935|616801087|FG002|Overall Study|Death|1|||
170669199|NCT01030536|616801088|FG000|Overall Study|Withdrawal by Subject|0|||
170669200|NCT01030536|616801089|FG001|Overall Study|Withdrawal by Subject|0|||
170669201|NCT01030536|616801090|FG002|Overall Study|Withdrawal by Subject|1|||
170669202|NCT01030536|616801091|FG003|Overall Study|Withdrawal by Subject|0|||
170669203|NCT01030536|616801092|FG004|Overall Study|Withdrawal by Subject|0|||
170669204|NCT01030536|616801088|FG000|Overall Study|undefined|1|||
170669205|NCT01030536|616801089|FG001|Overall Study|undefined|0|||
170669206|NCT01030536|616801090|FG002|Overall Study|undefined|1|||
170621519|NCT04607668|616622681|FG000|Overall Study|Death|49|||
170621520|NCT04607668|616622682|FG001|Overall Study|Death|26|||
170621521|NCT04607668|616622681|FG000|Overall Study|Lost to Follow-up|3|||
170621522|NCT04607668|616622682|FG001|Overall Study|Lost to Follow-up|4|||
170621523|NCT04607668|616622681|FG000|Overall Study|Study terminated by Sponsor|92|||
170669207|NCT01030536|616801091|FG003|Overall Study|undefined|1|||
170669208|NCT01030536|616801092|FG004|Overall Study|undefined|0|||
170669209|NCT01030536|616801088|FG000|Overall Study|Adverse Event|0|||
170669210|NCT01030536|616801089|FG001|Overall Study|Adverse Event|3|||
170669211|NCT01030536|616801090|FG002|Overall Study|Adverse Event|1|||
170621524|NCT04607668|616622682|FG001|Overall Study|Study terminated by Sponsor|114|||
170621525|NCT04607668|616622681|FG000|Overall Study|Withdrawal by Subject|12|||
170621526|NCT04607668|616622682|FG001|Overall Study|Withdrawal by Subject|11|||
170621527|NCT04607668|616622681|FG000|Overall Study|Other, unspecified|8|||
170621528|NCT04607668|616622682|FG001|Overall Study|Other, unspecified|7|||
170621529|NCT05801991|616622683|FG000|Overall Study|Lost to Follow-up|1|||
170621530|NCT05801991|616622684|FG001|Overall Study|Lost to Follow-up|0|||
170621531|NCT01838694|616622685|FG000|Overall Study|Adverse Event|0|||
170621532|NCT01838694|616622686|FG001|Overall Study|Adverse Event|1|||
170621533|NCT04235140|616622687|FG000|Overall Study|Adverse Event|2|||
170621534|NCT04235140|616622687|FG000|Overall Study|Lost to Follow-up|1|||
170621535|NCT04235140|616622687|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
170621536|NCT04235140|616622687|FG000|Overall Study|Commercial drug is available for participants|7|||
170621537|NCT03016312|616622688|FG000|Overall Study|discontinued before the treatment started|0|||
170621538|NCT03016312|616622689|FG001|Overall Study|discontinued before the treatment started|1|||
170621539|NCT03016312|616622688|FG000|Overall Study|Withdrawal by Subject|37|||
170621540|NCT03016312|616622689|FG001|Overall Study|Withdrawal by Subject|44|||
170621541|NCT03016312|616622688|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
170621542|NCT03016312|616622689|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
170621543|NCT03016312|616622688|FG000|Overall Study|Physician Decision|1|||
170621544|NCT03016312|616622689|FG001|Overall Study|Physician Decision|3|||
170621545|NCT03016312|616622688|FG000|Overall Study|Lost to Follow-up|12|||
170621546|NCT03016312|616622689|FG001|Overall Study|Lost to Follow-up|12|||
170621547|NCT03016312|616622688|FG000|Overall Study|Death|210|||
170621548|NCT03016312|616622689|FG001|Overall Study|Death|184|||
170621549|NCT03016312|616622688|FG000|Overall Study|loss to contact|1|||
170621550|NCT03016312|616622689|FG001|Overall Study|loss to contact|0|||
170621551|NCT03016312|616622688|FG000|Overall Study|started a new cancer therapy|1|||
170621552|NCT03016312|616622689|FG001|Overall Study|started a new cancer therapy|0|||
170621553|NCT01451723|616622692|FG000|Overall Study|study halted|6|||
170621554|NCT01451723|616622693|FG001|Overall Study|study halted|5|||
170621555|NCT02210000|616622694|FG000|Overall Study|Study Terminated|11|||
170621556|NCT02210000|616622695|FG001|Overall Study|Study Terminated|12|||
170621557|NCT02210000|616622694|FG000|Overall Study|Withdrawal by Subject|7|||
170621558|NCT02210000|616622695|FG001|Overall Study|Withdrawal by Subject|1|||
170621559|NCT02210000|616622694|FG000|Overall Study|Adverse Event|1|||
170621560|NCT02210000|616622695|FG001|Overall Study|Adverse Event|5|||
170621561|NCT02210000|616622694|FG000|Overall Study|Lost to Follow-up|0|||
170621562|NCT02210000|616622695|FG001|Overall Study|Lost to Follow-up|2|||
170621563|NCT02210000|616622694|FG000|Overall Study|Physician Decision|0|||
170621564|NCT02210000|616622695|FG001|Overall Study|Physician Decision|1|||
170621565|NCT01631435|616622698|FG000|Overall Study|Adverse Event|2|||
170621566|NCT01631435|616622698|FG000|Overall Study|Withdrawal by Subject|2|||
170621567|NCT01631435|616622698|FG000|Overall Study|incomplete study procedure|5|||
170621568|NCT02123134|616622704|FG000|Overall Study|Withdrawal of consent|3|||
170621569|NCT02123134|616622705|FG001|Overall Study|Withdrawal of consent|2|||
170621570|NCT02123134|616622704|FG000|Overall Study|Administrative decision|0|||
170621571|NCT02123134|616622705|FG001|Overall Study|Administrative decision|1|||
170621572|NCT00962208|616622706|FG000|Overall Study|Could not achieve good vision|9|||
170621573|NCT00962208|616622707|FG001|Overall Study|Could not achieve good vision|0|||
170621574|NCT00962208|616622706|FG000|Overall Study|Contraindicated to continue study|5|||
170621575|NCT00962208|616622707|FG001|Overall Study|Contraindicated to continue study|1|||
170621576|NCT00962208|616622706|FG000|Overall Study|Lost to Follow-up|0|||
170621577|NCT00962208|616622707|FG001|Overall Study|Lost to Follow-up|9|||
170621578|NCT00791388|616622708|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
170621579|NCT00791388|616622709|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
170621580|NCT00791388|616622710|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
170621581|NCT00791388|616622711|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
170621582|NCT00791388|616622712|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
170621583|NCT00791388|616622708|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
170621584|NCT00791388|616622709|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
170621585|NCT00791388|616622710|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
170621586|NCT00791388|616622711|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
170621587|NCT00791388|616622712|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
170621588|NCT00791388|616622708|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
170621589|NCT00791388|616622709|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
170621590|NCT00791388|616622710|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
170621591|NCT00791388|616622711|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
170621592|NCT00791388|616622712|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
170819423|NCT00936065|617345879|FG000|Overall Study|Adverse Event|1|||
170819424|NCT00936065|617345880|FG001|Overall Study|Adverse Event|0|||
170621593|NCT00657540|616622719|FG000|Overall Study|Lost to Follow-up|1|||
170621594|NCT00657540|616622720|FG001|Overall Study|Lost to Follow-up|4|||
170621595|NCT00807911|616622721|FG000|Overall Study|Withdrawal by Subject|12|||
170621596|NCT00807911|616622722|FG001|Overall Study|Withdrawal by Subject|10|||
170621597|NCT00807911|616622721|FG000|Overall Study|Ineligible|0|||
170621598|NCT00807911|616622722|FG001|Overall Study|Ineligible|4|||
170621599|NCT02469623|616622723|FG000|Overall Study|Not consented for long-term follow-up|4|||
170621600|NCT02469623|616622723|FG000|Overall Study|Lost to Follow-up|4|||
170621601|NCT02469623|616622723|FG000|Overall Study|Withdrawal by Subject|2|||
170621602|NCT02469623|616622723|FG000|Overall Study|Death|3|||
170621603|NCT01220167|616622727|FG000|Period 3|Urine positive for substance abuse|0|||
170621604|NCT01220167|616622728|FG001|Period 3|Urine positive for substance abuse|1|||
170621605|NCT01220167|616622729|FG002|Period 3|Urine positive for substance abuse|0|||
170621606|NCT03192176|616622730|FG000|Overall Study|Adverse Event|1|||
170621607|NCT03192176|616622731|FG001|Overall Study|Adverse Event|0|||
170621608|NCT03192176|616622732|FG002|Overall Study|Adverse Event|4|||
170621609|NCT03192176|616622733|FG003|Overall Study|Adverse Event|5|||
170621610|NCT03192176|616622734|FG004|Overall Study|Adverse Event|3|||
170621611|NCT03192176|616622735|FG005|Overall Study|Adverse Event|2|||
170621612|NCT03192176|616622736|FG006|Overall Study|Adverse Event|3|||
170621613|NCT03192176|616622737|FG007|Overall Study|Adverse Event|3|||
170621614|NCT03192176|616622730|FG000|Overall Study|Lost to Follow-up|0|||
170621615|NCT03192176|616622731|FG001|Overall Study|Lost to Follow-up|0|||
170621616|NCT03192176|616622732|FG002|Overall Study|Lost to Follow-up|1|||
170621617|NCT03192176|616622733|FG003|Overall Study|Lost to Follow-up|2|||
170621618|NCT03192176|616622734|FG004|Overall Study|Lost to Follow-up|3|||
170621619|NCT03192176|616622735|FG005|Overall Study|Lost to Follow-up|1|||
170621620|NCT03192176|616622736|FG006|Overall Study|Lost to Follow-up|1|||
170621621|NCT03192176|616622737|FG007|Overall Study|Lost to Follow-up|1|||
170621622|NCT03192176|616622730|FG000|Overall Study|Physician Decision|1|||
170621623|NCT03192176|616622731|FG001|Overall Study|Physician Decision|0|||
170621624|NCT03192176|616622732|FG002|Overall Study|Physician Decision|0|||
170621625|NCT03192176|616622733|FG003|Overall Study|Physician Decision|0|||
170621626|NCT03192176|616622734|FG004|Overall Study|Physician Decision|0|||
170621627|NCT03192176|616622735|FG005|Overall Study|Physician Decision|2|||
170621628|NCT03192176|616622736|FG006|Overall Study|Physician Decision|1|||
170621629|NCT03192176|616622737|FG007|Overall Study|Physician Decision|0|||
170621630|NCT03192176|616622730|FG000|Overall Study|Protocol Deviation|1|||
170621631|NCT03192176|616622731|FG001|Overall Study|Protocol Deviation|1|||
170621632|NCT03192176|616622732|FG002|Overall Study|Protocol Deviation|0|||
170621633|NCT03192176|616622733|FG003|Overall Study|Protocol Deviation|0|||
170621634|NCT03192176|616622734|FG004|Overall Study|Protocol Deviation|2|||
170621635|NCT03192176|616622735|FG005|Overall Study|Protocol Deviation|0|||
170621636|NCT03192176|616622736|FG006|Overall Study|Protocol Deviation|0|||
170621637|NCT03192176|616622737|FG007|Overall Study|Protocol Deviation|0|||
170621638|NCT03192176|616622730|FG000|Overall Study|Withdrawal by Subject|3|||
170621639|NCT03192176|616622731|FG001|Overall Study|Withdrawal by Subject|4|||
170621640|NCT03192176|616622732|FG002|Overall Study|Withdrawal by Subject|0|||
170621641|NCT03192176|616622733|FG003|Overall Study|Withdrawal by Subject|4|||
170621642|NCT03192176|616622734|FG004|Overall Study|Withdrawal by Subject|3|||
170621643|NCT03192176|616622735|FG005|Overall Study|Withdrawal by Subject|4|||
170621644|NCT03192176|616622736|FG006|Overall Study|Withdrawal by Subject|4|||
170621645|NCT03192176|616622737|FG007|Overall Study|Withdrawal by Subject|2|||
170621646|NCT03192176|616622730|FG000|Overall Study|Miscellaneous|1|||
170621647|NCT03192176|616622731|FG001|Overall Study|Miscellaneous|0|||
170621648|NCT03192176|616622732|FG002|Overall Study|Miscellaneous|1|||
170621649|NCT03192176|616622733|FG003|Overall Study|Miscellaneous|1|||
170621650|NCT03192176|616622734|FG004|Overall Study|Miscellaneous|1|||
170621651|NCT03192176|616622735|FG005|Overall Study|Miscellaneous|2|||
170621652|NCT03192176|616622736|FG006|Overall Study|Miscellaneous|0|||
170621653|NCT03192176|616622737|FG007|Overall Study|Miscellaneous|1|||
170621654|NCT00743249|616622738|FG000|Overall Study|Adverse Event|0|||
170621655|NCT00743249|616622739|FG001|Overall Study|Adverse Event|4|||
170621656|NCT00743249|616622738|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
170621657|NCT00743249|616622739|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
170621658|NCT00743249|616622738|FG000|Overall Study|Unsuccessful insertion of stent|2|||
170621659|NCT00743249|616622739|FG001|Overall Study|Unsuccessful insertion of stent|1|||
170621660|NCT02914639|616622740|FG000|Overall Study|Withdrawal by Subject|0|||
170621661|NCT02914639|616622741|FG001|Overall Study|Withdrawal by Subject|2|||
170621662|NCT01960140|616622742|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
170621663|NCT01582061|616622743|FG000|Overall Study|Lack of Efficacy|3|||
170621664|NCT01582061|616622744|FG001|Overall Study|Lack of Efficacy|23|||
170621665|NCT01582061|616622743|FG000|Overall Study|Adverse Event|12|||
170621666|NCT01582061|616622744|FG001|Overall Study|Adverse Event|8|||
170621667|NCT01582061|616622743|FG000|Overall Study|Withdrawal by Subject|10|||
170621668|NCT01582061|616622744|FG001|Overall Study|Withdrawal by Subject|4|||
170621669|NCT01582061|616622743|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170621670|NCT01582061|616622744|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170621671|NCT01582061|616622743|FG000|Overall Study|Death|0|||
170621672|NCT01582061|616622744|FG001|Overall Study|Death|1|||
170621673|NCT01582061|616622743|FG000|Overall Study|condition no longer requires study drug|1|||
170621674|NCT01582061|616622744|FG001|Overall Study|condition no longer requires study drug|0|||
170621675|NCT01582061|616622743|FG000|Overall Study|Lost to Follow-up|1|||
170621676|NCT01582061|616622744|FG001|Overall Study|Lost to Follow-up|0|||
170621677|NCT00097500|616622748|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
170621678|NCT00097500|616622749|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
170621679|NCT00097500|616622748|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
170621680|NCT00097500|616622749|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
170621681|NCT00097500|616622748|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
170621682|NCT00097500|616622749|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
170621683|NCT00097500|616622748|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
170621684|NCT00097500|616622749|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
170621685|NCT00097500|616622748|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
170621686|NCT00097500|616622749|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
170621687|NCT00097500|616622748|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
170621688|NCT00097500|616622749|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
170621689|NCT00097500|616622748|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
170621690|NCT00097500|616622749|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
170621691|NCT00524485|616622751|FG000|Overall Study|Withdrawal by Subject|5|||
170621692|NCT01600885|616622752|FG000|First Period|Adverse Event|1|||
170621693|NCT01600885|616622753|FG001|First Period|Adverse Event|1|||
170621694|NCT01600885|616622752|FG000|First Period|moved out of area|1|||
170621695|NCT01600885|616622753|FG001|First Period|moved out of area|0|||
170621696|NCT00436332|616622754|FG000|Overall Study|Adverse Event|9|||
170621697|NCT00436332|616622754|FG000|Overall Study|Withdrawal by Subject|2|||
170621698|NCT00436332|616622754|FG000|Overall Study|Progression|59|||
170621699|NCT00436332|616622754|FG000|Overall Study|Death|2|||
170621700|NCT00436332|616622754|FG000|Overall Study|Not Protocol Specified|6|||
170621701|NCT00436332|616622754|FG000|Overall Study|Ineligible|2|||
170621702|NCT00436332|616622754|FG000|Overall Study|Never Received Treatment|3|||
170621703|NCT02926638|616622756|FG000|Overall Study|Progression|2|||
170621704|NCT02926638|616622757|FG001|Overall Study|Progression|5|||
170621705|NCT02926638|616622756|FG000|Overall Study|Ineligible|1|||
170621706|NCT02926638|616622757|FG001|Overall Study|Ineligible|0|||
170621707|NCT02926638|616622756|FG000|Overall Study|Not protocol specified|1|||
170621708|NCT02926638|616622757|FG001|Overall Study|Not protocol specified|0|||
170621709|NCT01751061|616625358|FG000|Overall Study|Death|1|||
170621710|NCT01751061|616625359|FG001|Overall Study|Death|0|||
170621711|NCT01751061|616625358|FG000|Overall Study|patient death|5|||
170621712|NCT01751061|616625359|FG001|Overall Study|patient death|0|||
170669212|NCT01030536|616801091|FG003|Overall Study|Adverse Event|0|||
170669213|NCT01030536|616801092|FG004|Overall Study|Adverse Event|1|||
170669214|NCT01030536|616801088|FG000|Overall Study|Progressive disease|6|||
170669215|NCT01030536|616801089|FG001|Overall Study|Progressive disease|2|||
170669216|NCT01030536|616801090|FG002|Overall Study|Progressive disease|3|||
170669217|NCT01030536|616801091|FG003|Overall Study|Progressive disease|2|||
170669218|NCT01030536|616801092|FG004|Overall Study|Progressive disease|0|||
170669219|NCT01030536|616801088|FG000|Overall Study|Death|0|||
170669220|NCT01030536|616801089|FG001|Overall Study|Death|1|||
170669221|NCT01030536|616801090|FG002|Overall Study|Death|0|||
170669222|NCT01030536|616801091|FG003|Overall Study|Death|0|||
170669223|NCT01030536|616801092|FG004|Overall Study|Death|0|||
170669224|NCT02601027|616801095|FG000|Registration to Surgery|Withdrawal by Subject|20|||
170669225|NCT02601027|616801096|FG001|Registration to Surgery|Withdrawal by Subject|10|||
170669226|NCT02248701|616801102|FG000|Overall Study|Withdrawal by Subject|2|||
170669227|NCT02248701|616801103|FG001|Overall Study|Withdrawal by Subject|1|||
170669228|NCT02248701|616801102|FG000|Overall Study|Physician Decision|0|||
170669229|NCT02248701|616801103|FG001|Overall Study|Physician Decision|1|||
170669230|NCT02248701|616801102|FG000|Overall Study|Adverse Event|1|||
170669231|NCT02248701|616801103|FG001|Overall Study|Adverse Event|0|||
170669232|NCT02248701|616801102|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
170669233|NCT02248701|616801103|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
170669234|NCT00885846|616801105|FG000|Overall Study|Withdrawal by Subject|2|||
170669235|NCT00885846|616801106|FG001|Overall Study|Withdrawal by Subject|5|||
170669236|NCT00885846|616801107|FG002|Overall Study|Withdrawal by Subject|2|||
170669237|NCT00074984|616801108|FG000|Overall Study|Death|1|||
170669238|NCT00074984|616801109|FG001|Overall Study|Death|2|||
170669239|NCT00074984|616801108|FG000|Overall Study|Withdrawal by Subject|2|||
170669240|NCT00074984|616801109|FG001|Overall Study|Withdrawal by Subject|3|||
170669241|NCT00074984|616801108|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
170669242|NCT00074984|616801109|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
170669243|NCT03758443|616801110|FG000|Induction Period|Adverse Event|2|||
170669244|NCT03758443|616801111|FG001|Induction Period|Adverse Event|4|||
170669245|NCT03758443|616801112|FG002|Induction Period|Adverse Event|2|||
170669246|NCT03758443|616801113|FG003|Induction Period|Adverse Event|3|||
170669247|NCT03758443|616801110|FG000|Induction Period|Physician Decision|1|||
170669248|NCT03758443|616801111|FG001|Induction Period|Physician Decision|1|||
170669249|NCT03758443|616801112|FG002|Induction Period|Physician Decision|3|||
170669250|NCT03758443|616801113|FG003|Induction Period|Physician Decision|0|||
170669251|NCT03758443|616801110|FG000|Induction Period|Protocol Violation|0|||
170669252|NCT03758443|616801111|FG001|Induction Period|Protocol Violation|0|||
170669253|NCT03758443|616801112|FG002|Induction Period|Protocol Violation|0|||
170669254|NCT03758443|616801113|FG003|Induction Period|Protocol Violation|1|||
170669255|NCT03758443|616801110|FG000|Induction Period|Withdrawal by Subject|3|||
170669256|NCT03758443|616801111|FG001|Induction Period|Withdrawal by Subject|2|||
170621713|NCT01751061|616625358|FG000|Overall Study|Lost to Follow-up|40|||
170621714|NCT01751061|616625359|FG001|Overall Study|Lost to Follow-up|25|||
170621715|NCT01751061|616625358|FG000|Overall Study|patient regained decisional capacity|4|||
170621716|NCT01751061|616625359|FG001|Overall Study|patient regained decisional capacity|8|||
170621717|NCT01751061|616625358|FG000|Overall Study|Withdrawal by Subject|4|||
170621718|NCT01751061|616625359|FG001|Overall Study|Withdrawal by Subject|1|||
170621719|NCT01751061|616625358|FG000|Overall Study|Physician Decision|2|||
170621720|NCT01751061|616625359|FG001|Overall Study|Physician Decision|0|||
170621721|NCT01731912|616625360|FG000|Overall Study|noncompliance|2|||
170621722|NCT03010527|616625362|FG000|Overall Study|Death|0|||
170621723|NCT03010527|616625363|FG001|Overall Study|Death|0|||
170621724|NCT03010527|616625364|FG002|Overall Study|Death|1|||
170621725|NCT03010527|616625362|FG000|Overall Study|Adverse Event|0|||
170621726|NCT03010527|616625363|FG001|Overall Study|Adverse Event|4|||
170621727|NCT03010527|616625364|FG002|Overall Study|Adverse Event|2|||
170621728|NCT03010527|616625362|FG000|Overall Study|Protocol Violation|0|||
170621729|NCT03010527|616625363|FG001|Overall Study|Protocol Violation|1|||
170621730|NCT03010527|616625364|FG002|Overall Study|Protocol Violation|0|||
170621731|NCT03010527|616625362|FG000|Overall Study|Lost to Follow-up|0|||
170621732|NCT03010527|616625363|FG001|Overall Study|Lost to Follow-up|2|||
170621733|NCT03010527|616625364|FG002|Overall Study|Lost to Follow-up|1|||
170621734|NCT03010527|616625362|FG000|Overall Study|Withdrawal by Subject|0|||
170621735|NCT03010527|616625363|FG001|Overall Study|Withdrawal by Subject|3|||
170621736|NCT03010527|616625364|FG002|Overall Study|Withdrawal by Subject|4|||
170621737|NCT03010527|616625362|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
170621738|NCT03010527|616625363|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
170621739|NCT03010527|616625364|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
170621740|NCT03010527|616625362|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
170621741|NCT03010527|616625363|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
170621742|NCT03010527|616625364|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
170669257|NCT03758443|616801112|FG002|Induction Period|Withdrawal by Subject|2|||
170669258|NCT03758443|616801113|FG003|Induction Period|Withdrawal by Subject|4|||
170669259|NCT03758443|616801110|FG000|Extended Induction Period|Adverse Event|1|||
170669260|NCT03758443|616801111|FG001|Extended Induction Period|Adverse Event|1|||
170669261|NCT03758443|616801112|FG002|Extended Induction Period|Adverse Event|0|||
170669262|NCT03758443|616801113|FG003|Extended Induction Period|Adverse Event|1|||
170669263|NCT03758443|616801110|FG000|Extended Induction Period|Lost to Follow-up|1|||
170621743|NCT03010527|616625362|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
170669264|NCT03758443|616801111|FG001|Extended Induction Period|Lost to Follow-up|0|||
170621744|NCT03010527|616625363|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
170621745|NCT03010527|616625364|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
170621746|NCT00443040|616625365|FG000|Overall Study|Withdrawal by Subject|1|||
170621747|NCT00443040|616625366|FG001|Overall Study|Withdrawal by Subject|0|||
170621748|NCT00443040|616625367|FG002|Overall Study|Withdrawal by Subject|0|||
170621749|NCT00443040|616625365|FG000|Overall Study|Converted to an open laparotomy|3|||
170621750|NCT00443040|616625366|FG001|Overall Study|Converted to an open laparotomy|0|||
170621751|NCT00443040|616625367|FG002|Overall Study|Converted to an open laparotomy|1|||
170621752|NCT00866177|616625368|FG000|Overall Study|Withdrawal by Subject|1|||
170621753|NCT00866177|616625368|FG000|Overall Study|Not Treated|151|||
170621754|NCT03760029|616625372|FG000|Overall Study|Death|1|||
170621755|NCT03760029|616625373|FG001|Overall Study|Death|0|||
170621756|NCT03760029|616625374|FG002|Overall Study|Death|0|||
170621757|NCT03760029|616625372|FG000|Overall Study|Lost to Follow-up|0|||
170621758|NCT03760029|616625373|FG001|Overall Study|Lost to Follow-up|2|||
170621759|NCT03760029|616625374|FG002|Overall Study|Lost to Follow-up|1|||
170621760|NCT03760029|616625372|FG000|Overall Study|Withdrawal by Subject|1|||
170621761|NCT03760029|616625373|FG001|Overall Study|Withdrawal by Subject|4|||
170621762|NCT03760029|616625374|FG002|Overall Study|Withdrawal by Subject|1|||
170621763|NCT03760029|616625372|FG000|Overall Study|Withdrawal by parent/guardian|4|||
170621764|NCT03760029|616625373|FG001|Overall Study|Withdrawal by parent/guardian|4|||
170621765|NCT03760029|616625374|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170621766|NCT03760029|616625372|FG000|Overall Study|Other|2|||
170621767|NCT03760029|616625373|FG001|Overall Study|Other|1|||
170621768|NCT03760029|616625374|FG002|Overall Study|Other|0|||
170621769|NCT04073186|616625381|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
170621770|NCT04073186|616625381|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
170621771|NCT04073186|616625381|FG000|First Wearing Cycle|Protocol Violation|1|||
170621772|NCT04073186|616625381|FG000|First Wearing Cycle|Lens Discomfort|2|||
170621773|NCT04073186|616625381|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
170621774|NCT04073186|616625381|FG000|Second Wearing Cycle|Adverse Event|1|||
170621775|NCT00473434|616625382|FG000|Overall Study|Physician Decision|3|||
170621776|NCT00473434|616625382|FG000|Overall Study|Withdrawal by Subject|9|||
170621777|NCT00473434|616625382|FG000|Overall Study|Compliance|3|||
170621778|NCT00473434|616625382|FG000|Overall Study|Lack of Efficacy|3|||
170621779|NCT00473434|616625382|FG000|Overall Study|Adverse Event|3|||
170621780|NCT00473434|616625382|FG000|Overall Study|Patient was selling medication to others|1|||
170621781|NCT00473434|616625382|FG000|Overall Study|Safety evaluation|1|||
170621782|NCT00473434|616625382|FG000|Overall Study|Reason not specified|6|||
170621783|NCT00473434|616625382|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
170621784|NCT00473434|616625382|FG000|Overall Study|Switching to trial medication|1|||
170621785|NCT00473434|616625382|FG000|Overall Study|No longer required|1|||
170621786|NCT02836652|616625383|FG000|Overall Study|Death|3|||
170621787|NCT02836652|616625384|FG001|Overall Study|Death|3|||
170621788|NCT02836652|616625383|FG000|Overall Study|Transplant/Explant|3|||
170621789|NCT02836652|616625384|FG001|Overall Study|Transplant/Explant|4|||
170621790|NCT02836652|616625383|FG000|Overall Study|Withdrawn|9|||
170621791|NCT02836652|616625384|FG001|Overall Study|Withdrawn|9|||
170621792|NCT02836652|616625383|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
170621793|NCT02836652|616625384|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
170621794|NCT03812380|616625385|FG000|Overall Study|Protocol Violation|3|||
170621795|NCT03812380|616625386|FG001|Overall Study|Protocol Violation|3|||
170621796|NCT03812380|616625385|FG000|Overall Study|Withdrawal by Subject|5|||
170621797|NCT03812380|616625386|FG001|Overall Study|Withdrawal by Subject|4|||
170621798|NCT03812380|616625385|FG000|Overall Study|Early termination of study|14|||
170621799|NCT03812380|616625386|FG001|Overall Study|Early termination of study|14|||
170669265|NCT03758443|616801112|FG002|Extended Induction Period|Lost to Follow-up|0|||
170621800|NCT02349633|616625388|FG000|Overall Study|Death|0|||
170621801|NCT02349633|616625389|FG001|Overall Study|Death|1|||
170621802|NCT02349633|616625390|FG002|Overall Study|Death|0|||
170621803|NCT02349633|616625391|FG003|Overall Study|Death|0|||
170621804|NCT02349633|616625392|FG004|Overall Study|Death|0|||
170621805|NCT02349633|616625393|FG005|Overall Study|Death|1|||
170621806|NCT02349633|616625394|FG006|Overall Study|Death|1|||
170621807|NCT02349633|616625395|FG007|Overall Study|Death|1|||
170621808|NCT02349633|616625396|FG008|Overall Study|Death|0|||
170621809|NCT02349633|616625397|FG009|Overall Study|Death|1|||
170621810|NCT02349633|616625398|FG010|Overall Study|Death|0|||
170669266|NCT03758443|616801113|FG003|Extended Induction Period|Lost to Follow-up|0|||
170669267|NCT03758443|616801110|FG000|Extended Induction Period|Physician Decision|2|||
170669268|NCT03758443|616801111|FG001|Extended Induction Period|Physician Decision|1|||
170669269|NCT03758443|616801112|FG002|Extended Induction Period|Physician Decision|2|||
170669270|NCT03758443|616801113|FG003|Extended Induction Period|Physician Decision|2|||
170669271|NCT03758443|616801110|FG000|Extended Induction Period|Protocol Violation|0|||
170669272|NCT03758443|616801111|FG001|Extended Induction Period|Protocol Violation|0|||
170669273|NCT03758443|616801112|FG002|Extended Induction Period|Protocol Violation|0|||
170669274|NCT03758443|616801113|FG003|Extended Induction Period|Protocol Violation|1|||
170669275|NCT03758443|616801110|FG000|Extended Induction Period|Withdrawal by Subject|8|||
170669276|NCT03758443|616801111|FG001|Extended Induction Period|Withdrawal by Subject|1|||
170669277|NCT03758443|616801112|FG002|Extended Induction Period|Withdrawal by Subject|7|||
170669278|NCT03758443|616801113|FG003|Extended Induction Period|Withdrawal by Subject|3|||
170669279|NCT03758443|616801110|FG000|Extended Induction Period|Miscellaneous|1|||
170669280|NCT03758443|616801111|FG001|Extended Induction Period|Miscellaneous|0|||
170669281|NCT03758443|616801112|FG002|Extended Induction Period|Miscellaneous|0|||
170669282|NCT03758443|616801113|FG003|Extended Induction Period|Miscellaneous|0|||
170669283|NCT03758443|616801110|FG000|Maintenance Period|Adverse Event|1|||
170669284|NCT03758443|616801111|FG001|Maintenance Period|Adverse Event|2|||
170669285|NCT03758443|616801112|FG002|Maintenance Period|Adverse Event|0|||
170669286|NCT03758443|616801113|FG003|Maintenance Period|Adverse Event|0|||
170669287|NCT03758443|616801110|FG000|Maintenance Period|Lost to Follow-up|0|||
170669288|NCT03758443|616801111|FG001|Maintenance Period|Lost to Follow-up|0|||
170669289|NCT03758443|616801112|FG002|Maintenance Period|Lost to Follow-up|0|||
170669290|NCT03758443|616801113|FG003|Maintenance Period|Lost to Follow-up|1|||
170669291|NCT03758443|616801110|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
170669292|NCT03758443|616801111|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
170669293|NCT03758443|616801112|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
170669294|NCT03758443|616801113|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
170669295|NCT03758443|616801110|FG000|Maintenance Period|Protocol Violation|0|||
170669296|NCT03758443|616801111|FG001|Maintenance Period|Protocol Violation|1|||
170669297|NCT03758443|616801112|FG002|Maintenance Period|Protocol Violation|0|||
170669298|NCT03758443|616801113|FG003|Maintenance Period|Protocol Violation|0|||
170669299|NCT03758443|616801110|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
170669300|NCT03758443|616801111|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
170669301|NCT03758443|616801112|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
170669302|NCT03758443|616801113|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
170669303|NCT03758443|616801110|FG000|Maintenance Period|Withdrawal by Subject|1|||
170669304|NCT03758443|616801111|FG001|Maintenance Period|Withdrawal by Subject|0|||
170669305|NCT03758443|616801112|FG002|Maintenance Period|Withdrawal by Subject|1|||
170669306|NCT03758443|616801113|FG003|Maintenance Period|Withdrawal by Subject|1|||
170669307|NCT03758443|616801110|FG000|Maintenance Period|Miscellaneous|0|||
170669308|NCT03758443|616801111|FG001|Maintenance Period|Miscellaneous|0|||
170669309|NCT03758443|616801112|FG002|Maintenance Period|Miscellaneous|1|||
170669310|NCT03758443|616801113|FG003|Maintenance Period|Miscellaneous|0|||
170669311|NCT03080454|616801114|FG000|Baseline|Adverse Event|2|||
170669312|NCT03080454|616801114|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
170669313|NCT03080454|616801114|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
170669314|NCT00660673|616801119|FG000|Overall Study|Adverse Event|84|||
170669315|NCT00660673|616801119|FG000|Overall Study|Lack of Efficacy|7|||
170669316|NCT00660673|616801119|FG000|Overall Study|Withdrawal by Subject|22|||
170669317|NCT00660673|616801119|FG000|Overall Study|Administrative|2|||
170669318|NCT00660673|616801119|FG000|Overall Study|Protocol Violation|2|||
170669319|NCT00579098|616801120|FG000|Overall Study|Lost to Follow-up|2|||
170669320|NCT00579098|616801121|FG001|Overall Study|Lost to Follow-up|0|||
170669321|NCT00579098|616801120|FG000|Overall Study|Adverse Event|2|||
170669322|NCT00579098|616801121|FG001|Overall Study|Adverse Event|3|||
170669323|NCT00579098|616801120|FG000|Overall Study|Withdrawal by Subject|2|||
170669324|NCT00579098|616801121|FG001|Overall Study|Withdrawal by Subject|3|||
170669325|NCT00579098|616801120|FG000|Overall Study|AF returned after ablation|3|||
170669326|NCT00579098|616801121|FG001|Overall Study|AF returned after ablation|2|||
170669327|NCT00397215|616801131|FG000|Month 0 (Day 0)|Adverse Event|0|||
170669328|NCT00397215|616801132|FG001|Month 0 (Day 0)|Adverse Event|1|||
170669329|NCT00397215|616801133|FG002|Month 0 (Day 0)|Adverse Event|0|||
170669330|NCT00397215|616801134|FG003|Month 0 (Day 0)|Adverse Event|0|||
170669331|NCT00397215|616801131|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
170669332|NCT00397215|616801132|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
170669333|NCT00397215|616801133|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
170669334|NCT00397215|616801134|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
170669335|NCT00397215|616801131|FG000|Month 0 (Day 0)|Other|4|||
170669336|NCT00397215|616801132|FG001|Month 0 (Day 0)|Other|1|||
170669337|NCT00397215|616801133|FG002|Month 0 (Day 0)|Other|3|||
170669338|NCT00397215|616801134|FG003|Month 0 (Day 0)|Other|3|||
170669339|NCT00397215|616801131|FG000|Month 6 (Day 180)|Adverse Event|0|||
170669340|NCT00397215|616801132|FG001|Month 6 (Day 180)|Adverse Event|3|||
170621811|NCT02349633|616625399|FG011|Overall Study|Death|0|||
170621812|NCT02349633|616625400|FG012|Overall Study|Death|0|||
170621813|NCT02349633|616625401|FG013|Overall Study|Death|0|||
170621814|NCT02349633|616625388|FG000|Overall Study|Withdrawal by Subject|0|||
170621815|NCT02349633|616625389|FG001|Overall Study|Withdrawal by Subject|0|||
170621816|NCT02349633|616625390|FG002|Overall Study|Withdrawal by Subject|0|||
170621817|NCT02349633|616625391|FG003|Overall Study|Withdrawal by Subject|1|||
170621818|NCT02349633|616625392|FG004|Overall Study|Withdrawal by Subject|0|||
170621819|NCT02349633|616625393|FG005|Overall Study|Withdrawal by Subject|0|||
170621820|NCT02349633|616625394|FG006|Overall Study|Withdrawal by Subject|0|||
170621821|NCT02349633|616625395|FG007|Overall Study|Withdrawal by Subject|2|||
170621822|NCT02349633|616625396|FG008|Overall Study|Withdrawal by Subject|2|||
170621823|NCT02349633|616625397|FG009|Overall Study|Withdrawal by Subject|1|||
170621824|NCT02349633|616625398|FG010|Overall Study|Withdrawal by Subject|0|||
170621825|NCT02349633|616625399|FG011|Overall Study|Withdrawal by Subject|0|||
170621826|NCT02349633|616625400|FG012|Overall Study|Withdrawal by Subject|0|||
170621827|NCT02349633|616625401|FG013|Overall Study|Withdrawal by Subject|0|||
170621828|NCT02349633|616625388|FG000|Overall Study|Withdrawal of informed consent|0|||
170621829|NCT02349633|616625389|FG001|Overall Study|Withdrawal of informed consent|0|||
170621830|NCT02349633|616625390|FG002|Overall Study|Withdrawal of informed consent|0|||
170621831|NCT02349633|616625391|FG003|Overall Study|Withdrawal of informed consent|1|||
170621832|NCT02349633|616625392|FG004|Overall Study|Withdrawal of informed consent|1|||
170621833|NCT02349633|616625393|FG005|Overall Study|Withdrawal of informed consent|0|||
170621834|NCT02349633|616625394|FG006|Overall Study|Withdrawal of informed consent|0|||
170621835|NCT02349633|616625395|FG007|Overall Study|Withdrawal of informed consent|3|||
170621836|NCT02349633|616625396|FG008|Overall Study|Withdrawal of informed consent|0|||
170621837|NCT02349633|616625397|FG009|Overall Study|Withdrawal of informed consent|0|||
170621838|NCT02349633|616625398|FG010|Overall Study|Withdrawal of informed consent|0|||
170621839|NCT02349633|616625399|FG011|Overall Study|Withdrawal of informed consent|0|||
170621840|NCT02349633|616625400|FG012|Overall Study|Withdrawal of informed consent|0|||
170621841|NCT02349633|616625401|FG013|Overall Study|Withdrawal of informed consent|0|||
170621842|NCT02349633|616625388|FG000|Overall Study|Transition to compassionate use|0|||
170621843|NCT02349633|616625389|FG001|Overall Study|Transition to compassionate use|0|||
170621844|NCT02349633|616625390|FG002|Overall Study|Transition to compassionate use|0|||
170621845|NCT02349633|616625391|FG003|Overall Study|Transition to compassionate use|0|||
170621846|NCT02349633|616625392|FG004|Overall Study|Transition to compassionate use|1|||
170621847|NCT02349633|616625393|FG005|Overall Study|Transition to compassionate use|0|||
170621848|NCT02349633|616625394|FG006|Overall Study|Transition to compassionate use|0|||
170621849|NCT02349633|616625395|FG007|Overall Study|Transition to compassionate use|3|||
170621850|NCT02349633|616625396|FG008|Overall Study|Transition to compassionate use|0|||
170621851|NCT02349633|616625397|FG009|Overall Study|Transition to compassionate use|1|||
170621852|NCT02349633|616625398|FG010|Overall Study|Transition to compassionate use|0|||
170621853|NCT02349633|616625399|FG011|Overall Study|Transition to compassionate use|0|||
170621854|NCT02349633|616625400|FG012|Overall Study|Transition to compassionate use|0|||
170621855|NCT02349633|616625401|FG013|Overall Study|Transition to compassionate use|0|||
170621856|NCT02349633|616625388|FG000|Overall Study|Early termination of survival follow-up|0|||
170621857|NCT02349633|616625389|FG001|Overall Study|Early termination of survival follow-up|0|||
170621858|NCT02349633|616625390|FG002|Overall Study|Early termination of survival follow-up|0|||
170621859|NCT02349633|616625391|FG003|Overall Study|Early termination of survival follow-up|0|||
170669341|NCT00397215|616801133|FG002|Month 6 (Day 180)|Adverse Event|2|||
170621860|NCT02349633|616625392|FG004|Overall Study|Early termination of survival follow-up|0|||
170669342|NCT00397215|616801134|FG003|Month 6 (Day 180)|Adverse Event|0|||
170669343|NCT00397215|616801131|FG000|Month 6 (Day 180)|Other|2|||
170669344|NCT00397215|616801132|FG001|Month 6 (Day 180)|Other|0|||
170669345|NCT00397215|616801133|FG002|Month 6 (Day 180)|Other|3|||
170669346|NCT00397215|616801134|FG003|Month 6 (Day 180)|Other|0|||
170669347|NCT04154930|616801139|FG000|Overall Study|Withdrawal by Subject|15|||
170669348|NCT04154930|616801140|FG001|Overall Study|Withdrawal by Subject|6|||
170669349|NCT04154930|616801139|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
170669350|NCT04154930|616801140|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
170669351|NCT04154930|616801139|FG000|Overall Study|Lost to Follow-up|14|||
170669352|NCT04154930|616801140|FG001|Overall Study|Lost to Follow-up|6|||
170669353|NCT04154930|616801139|FG000|Overall Study|Other|6|||
170669354|NCT04154930|616801140|FG001|Overall Study|Other|0|||
170669355|NCT00400764|616801142|FG000|Phase Ib|Adverse Event|1|||
170669356|NCT00400764|616801143|FG001|Phase Ib|Adverse Event|0|||
170669357|NCT00400764|616801144|FG002|Phase Ib|Adverse Event|0|||
170669358|NCT00400764|616801145|FG003|Phase Ib|Adverse Event|0|||
170669359|NCT00400764|616801146|FG004|Phase Ib|Adverse Event|0|||
170669360|NCT00400764|616801142|FG000|Phase Ib|Death|1|||
170669361|NCT00400764|616801143|FG001|Phase Ib|Death|0|||
170669362|NCT00400764|616801144|FG002|Phase Ib|Death|0|||
170669363|NCT00400764|616801145|FG003|Phase Ib|Death|0|||
170669364|NCT00400764|616801146|FG004|Phase Ib|Death|0|||
170669365|NCT00400764|616801142|FG000|Phase Ib|Disease Progression|4|||
170669366|NCT00400764|616801143|FG001|Phase Ib|Disease Progression|4|||
170621861|NCT02349633|616625393|FG005|Overall Study|Early termination of survival follow-up|0|||
170621862|NCT02349633|616625394|FG006|Overall Study|Early termination of survival follow-up|0|||
170621863|NCT02349633|616625395|FG007|Overall Study|Early termination of survival follow-up|4|||
170621864|NCT02349633|616625396|FG008|Overall Study|Early termination of survival follow-up|0|||
170621865|NCT02349633|616625397|FG009|Overall Study|Early termination of survival follow-up|0|||
170621866|NCT02349633|616625398|FG010|Overall Study|Early termination of survival follow-up|0|||
170621867|NCT02349633|616625399|FG011|Overall Study|Early termination of survival follow-up|0|||
170621868|NCT02349633|616625400|FG012|Overall Study|Early termination of survival follow-up|0|||
170621869|NCT02349633|616625401|FG013|Overall Study|Early termination of survival follow-up|0|||
170621870|NCT02349633|616625388|FG000|Overall Study|Termination by sponsor|0|||
170621871|NCT02349633|616625389|FG001|Overall Study|Termination by sponsor|0|||
170621872|NCT02349633|616625390|FG002|Overall Study|Termination by sponsor|0|||
170621873|NCT02349633|616625391|FG003|Overall Study|Termination by sponsor|0|||
170621874|NCT02349633|616625392|FG004|Overall Study|Termination by sponsor|0|||
170621875|NCT02349633|616625393|FG005|Overall Study|Termination by sponsor|0|||
170621876|NCT02349633|616625394|FG006|Overall Study|Termination by sponsor|0|||
170621877|NCT02349633|616625395|FG007|Overall Study|Termination by sponsor|1|||
170621878|NCT02349633|616625396|FG008|Overall Study|Termination by sponsor|0|||
170621879|NCT02349633|616625397|FG009|Overall Study|Termination by sponsor|2|||
170621880|NCT02349633|616625398|FG010|Overall Study|Termination by sponsor|0|||
170621881|NCT02349633|616625399|FG011|Overall Study|Termination by sponsor|0|||
170621882|NCT02349633|616625400|FG012|Overall Study|Termination by sponsor|0|||
170621883|NCT02349633|616625401|FG013|Overall Study|Termination by sponsor|0|||
170621884|NCT02349633|616625388|FG000|Overall Study|Other|0|||
170621885|NCT02349633|616625389|FG001|Overall Study|Other|0|||
170621886|NCT02349633|616625390|FG002|Overall Study|Other|0|||
170621887|NCT02349633|616625391|FG003|Overall Study|Other|0|||
170621888|NCT02349633|616625392|FG004|Overall Study|Other|0|||
170621889|NCT02349633|616625393|FG005|Overall Study|Other|0|||
170621890|NCT02349633|616625394|FG006|Overall Study|Other|0|||
170621891|NCT02349633|616625395|FG007|Overall Study|Other|2|||
170621892|NCT02349633|616625396|FG008|Overall Study|Other|0|||
170621893|NCT02349633|616625397|FG009|Overall Study|Other|0|||
170621894|NCT02349633|616625398|FG010|Overall Study|Other|0|||
170621895|NCT02349633|616625399|FG011|Overall Study|Other|0|||
170621896|NCT02349633|616625400|FG012|Overall Study|Other|0|||
170621897|NCT02349633|616625401|FG013|Overall Study|Other|0|||
170621898|NCT02648204|616625402|FG000|Overall Study|Withdrawal by Subject|12|||
170621899|NCT02648204|616625403|FG001|Overall Study|Withdrawal by Subject|8|||
170621900|NCT02648204|616625404|FG002|Overall Study|Withdrawal by Subject|2|||
170621901|NCT02648204|616625405|FG003|Overall Study|Withdrawal by Subject|6|||
170621902|NCT02648204|616625402|FG000|Overall Study|Lost to Follow-up|5|||
170621903|NCT02648204|616625403|FG001|Overall Study|Lost to Follow-up|8|||
170621904|NCT02648204|616625404|FG002|Overall Study|Lost to Follow-up|4|||
170621905|NCT02648204|616625405|FG003|Overall Study|Lost to Follow-up|6|||
170621906|NCT02648204|616625402|FG000|Overall Study|Missing follow-up information|4|||
170621907|NCT02648204|616625403|FG001|Overall Study|Missing follow-up information|4|||
170621908|NCT02648204|616625404|FG002|Overall Study|Missing follow-up information|4|||
170621909|NCT02648204|616625405|FG003|Overall Study|Missing follow-up information|2|||
170621910|NCT02648204|616625402|FG000|Overall Study|Death|1|||
170621911|NCT02648204|616625403|FG001|Overall Study|Death|1|||
170621912|NCT02648204|616625404|FG002|Overall Study|Death|2|||
170621913|NCT02648204|616625405|FG003|Overall Study|Death|2|||
170621914|NCT02648204|616625402|FG000|Overall Study|Adverse Event|0|||
170621915|NCT02648204|616625403|FG001|Overall Study|Adverse Event|0|||
170621916|NCT02648204|616625404|FG002|Overall Study|Adverse Event|1|||
170621917|NCT02648204|616625405|FG003|Overall Study|Adverse Event|0|||
170621918|NCT06418152|616625407|FG000|Overall Study|Frequent DBS setting changes|1|||
170621919|NCT06418152|616625407|FG000|Overall Study|Withdrawal by Subject|2|||
170621920|NCT05789745|616625408|FG000|Overall Study|Withdrawal by Subject|0|||
170621921|NCT05789745|616625409|FG001|Overall Study|Withdrawal by Subject|0|||
170621922|NCT05789745|616625410|FG002|Overall Study|Withdrawal by Subject|0|||
170621923|NCT05789745|616625411|FG003|Overall Study|Withdrawal by Subject|0|||
170621924|NCT05789745|616625412|FG004|Overall Study|Withdrawal by Subject|1|||
170621925|NCT04862065|616625413|FG000|Screening|Protocol Violation|54|||
170621926|NCT04862065|616625414|FG001|Screening|Protocol Violation|0|||
170621927|NCT04862065|616625415|FG002|Screening|Protocol Violation|0|||
170621928|NCT04862065|616625413|FG000|Screening|Insufficient Sample|1|||
170621929|NCT04862065|616625414|FG001|Screening|Insufficient Sample|0|||
170621930|NCT04862065|616625415|FG002|Screening|Insufficient Sample|0|||
170621931|NCT04862065|616625413|FG000|Follow-Up|Lost to Follow-up|3|||
170621932|NCT04862065|616625414|FG001|Follow-Up|Lost to Follow-up|0|||
170621933|NCT04862065|616625415|FG002|Follow-Up|Lost to Follow-up|0|||
170621934|NCT00117637|616625416|FG000|First Intervention (Period 1)|Adverse Event|11|||
170621935|NCT00117637|616625417|FG001|First Intervention (Period 1)|Adverse Event|16|||
170621936|NCT00117637|616625416|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
170621937|NCT00117637|616625417|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
170621938|NCT00117637|616625416|FG000|First Intervention (Period 1)|Protocol Violation|1|||
170621939|NCT00117637|616625417|FG001|First Intervention (Period 1)|Protocol Violation|0|||
170621940|NCT00117637|616625416|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
170621941|NCT00117637|616625417|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
170621942|NCT00117637|616625416|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
170621943|NCT00117637|616625417|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
170621944|NCT00117637|616625416|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
170621945|NCT00117637|616625417|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
170621946|NCT00117637|616625416|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
170621947|NCT00117637|616625417|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
170621948|NCT00117637|616625416|FG000|First Intervention (Period 1)|reason not reported|0|||
170621949|NCT00117637|616625417|FG001|First Intervention (Period 1)|reason not reported|1|||
170621950|NCT00117637|616625416|FG000|Second Intervention (Period 2)|Adverse Event|0|||
170621951|NCT00117637|616625417|FG001|Second Intervention (Period 2)|Adverse Event|9|||
170621952|NCT00117637|616625416|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
170621953|NCT00117637|616625417|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
170621954|NCT00117637|616625416|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
170621955|NCT00117637|616625417|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
170621956|NCT00117637|616625416|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
170621957|NCT00117637|616625417|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
170621958|NCT00117637|616625416|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
170621959|NCT00117637|616625417|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
170621960|NCT00117637|616625416|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
170621961|NCT00117637|616625417|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
170621962|NCT00117637|616625416|FG000|Second Intervention (Period 2)|reason not reported|1|||
170621963|NCT00117637|616625417|FG001|Second Intervention (Period 2)|reason not reported|0|||
170621964|NCT00614575|616625419|FG000|Overall Study|Adverse Event|106|||
170621965|NCT00614575|616625419|FG000|Overall Study|Lost to Follow-up|55|||
170621966|NCT00614575|616625419|FG000|Overall Study|Lack of Efficacy|14|||
170621967|NCT00614575|616625419|FG000|Overall Study|Withdrawal by Subject|6|||
170621968|NCT00614575|616625419|FG000|Overall Study|Death|3|||
170621969|NCT00614575|616625419|FG000|Overall Study|Physician Decision|2|||
170621970|NCT00614575|616625419|FG000|Overall Study|No data were collected.|18|||
170621971|NCT00614575|616625419|FG000|Overall Study|Irregularly enrolled patients|23|||
170621972|NCT00614575|616625419|FG000|Overall Study|No treatment|1|||
170621973|NCT03452540|616625420|FG000|Overall Study|Adverse Event|1|||
170621974|NCT03452540|616625420|FG000|Overall Study|Withdrawal by Subject|1|||
170621975|NCT03452540|616625420|FG000|Overall Study|Other SAE and AE|2|||
170621976|NCT04664153|616625421|FG000|Overall Study|Lack of Efficacy|0|||
170621977|NCT04664153|616625422|FG001|Overall Study|Lack of Efficacy|0|||
170621978|NCT04664153|616625423|FG002|Overall Study|Lack of Efficacy|1|||
170621979|NCT04664153|616625424|FG003|Overall Study|Lack of Efficacy|0|||
170621980|NCT04664153|616625421|FG000|Overall Study|Physician Decision|0|||
170621981|NCT04664153|616625422|FG001|Overall Study|Physician Decision|0|||
170621982|NCT04664153|616625423|FG002|Overall Study|Physician Decision|1|||
170621983|NCT04664153|616625424|FG003|Overall Study|Physician Decision|0|||
170621984|NCT04664153|616625421|FG000|Overall Study|Withdrawal by Subject|3|||
170621985|NCT04664153|616625422|FG001|Overall Study|Withdrawal by Subject|2|||
170621986|NCT04664153|616625423|FG002|Overall Study|Withdrawal by Subject|1|||
170621987|NCT04664153|616625424|FG003|Overall Study|Withdrawal by Subject|2|||
170621988|NCT04664153|616625421|FG000|Overall Study|Other|0|||
170621989|NCT04664153|616625422|FG001|Overall Study|Other|1|||
170621990|NCT04664153|616625423|FG002|Overall Study|Other|0|||
170621991|NCT04664153|616625424|FG003|Overall Study|Other|0|||
170621992|NCT04664153|616625421|FG000|Overall Study|Adverse Event|4|||
170621993|NCT04664153|616625422|FG001|Overall Study|Adverse Event|0|||
170621994|NCT04664153|616625423|FG002|Overall Study|Adverse Event|1|||
170621995|NCT04664153|616625424|FG003|Overall Study|Adverse Event|0|||
170621996|NCT00231777|616625425|FG000|Overall Study|Lost to Follow-up|3|||
170621997|NCT00231777|616625426|FG001|Overall Study|Lost to Follow-up|0|||
170621998|NCT00231777|616625425|FG000|Overall Study|Other|3|||
170621999|NCT00231777|616625426|FG001|Overall Study|Other|2|||
170622000|NCT00062439|616625427|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
170622001|NCT00062439|616625427|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
170622002|NCT00062439|616625427|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
170622003|NCT00062439|616625427|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
170622004|NCT00062439|616625427|FG000|Post Chemoradiation Assessment|Death|1|||
170622005|NCT00062439|616625427|FG000|Post Chemoradiation Assessment|Disease progression|2|||
170622006|NCT00062439|616625427|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
170622007|NCT00062439|616625427|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
170622008|NCT00062439|616625427|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
170622009|NCT00062439|616625427|FG000|Surgery|Physician Decision|4|||
170622010|NCT00062439|616625427|FG000|Surgery|Death|1|||
170622011|NCT00062439|616625427|FG000|Surgery|Adverse Event|2|||
170622012|NCT00062439|616625427|FG000|Consolidation Chemotherapy|Adverse Event|2|||
170622013|NCT00642356|616625431|FG000|Overall Study|Adverse Event|1|||
170622014|NCT00642356|616625432|FG001|Overall Study|Adverse Event|0|||
170622015|NCT00642356|616625431|FG000|Overall Study|Protocol Violation|0|||
170622016|NCT00642356|616625432|FG001|Overall Study|Protocol Violation|3|||
170622017|NCT00642356|616625431|FG000|Overall Study|Lack of Efficacy|1|||
170622018|NCT00642356|616625432|FG001|Overall Study|Lack of Efficacy|0|||
170622019|NCT03780452|616625433|FG000|Overall Study|Screening failure|2|||
170622020|NCT02388269|616625434|FG000|Overall Study|Adverse Event|2|||
170622021|NCT02388269|616625435|FG001|Overall Study|Adverse Event|0|||
170622022|NCT02388269|616625436|FG002|Overall Study|Adverse Event|0|||
170622023|NCT02388269|616625434|FG000|Overall Study|Withdrawal by Subject|1|||
170622024|NCT02388269|616625435|FG001|Overall Study|Withdrawal by Subject|2|||
170622025|NCT02388269|616625436|FG002|Overall Study|Withdrawal by Subject|0|||
170622026|NCT02388269|616625434|FG000|Overall Study|less than 50% stimulations|1|||
170622027|NCT02388269|616625435|FG001|Overall Study|less than 50% stimulations|0|||
170622028|NCT02388269|616625436|FG002|Overall Study|less than 50% stimulations|0|||
170622029|NCT02388269|616625434|FG000|Overall Study|no diary data|3|||
170622030|NCT02388269|616625435|FG001|Overall Study|no diary data|0|||
170622031|NCT02388269|616625436|FG002|Overall Study|no diary data|0|||
170622032|NCT02388269|616625434|FG000|Overall Study|Protocol Violation|2|||
170622033|NCT02388269|616625435|FG001|Overall Study|Protocol Violation|0|||
170622034|NCT02388269|616625436|FG002|Overall Study|Protocol Violation|0|||
170622035|NCT02388269|616625434|FG000|Overall Study|Screen Failure|0|||
170622036|NCT02388269|616625435|FG001|Overall Study|Screen Failure|0|||
170622037|NCT02388269|616625436|FG002|Overall Study|Screen Failure|10|||
170622038|NCT01553084|616625441|FG000|Overall Study|Withdrawal by Subject|15|||
170622039|NCT01553084|616625442|FG001|Overall Study|Withdrawal by Subject|13|||
170622040|NCT01553084|616625443|FG002|Overall Study|Withdrawal by Subject|35|||
170622041|NCT04698343|616625444|FG000|Overall Study|Withdrawal by Subject|6|||
170622042|NCT04698343|616625444|FG000|Overall Study|Physician Decision|2|||
170669367|NCT00400764|616801144|FG002|Phase Ib|Disease Progression|0|||
170622043|NCT04698343|616625444|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
170669368|NCT00400764|616801145|FG003|Phase Ib|Disease Progression|0|||
170669369|NCT00400764|616801146|FG004|Phase Ib|Disease Progression|0|||
170669370|NCT00400764|616801142|FG000|Phase II|Death|0|||
170669371|NCT00400764|616801143|FG001|Phase II|Death|0|||
170669372|NCT00400764|616801144|FG002|Phase II|Death|1|||
170669373|NCT00400764|616801145|FG003|Phase II|Death|2|||
170669374|NCT00400764|616801146|FG004|Phase II|Death|0|||
170669375|NCT00400764|616801142|FG000|Phase II|Lost to Follow-up|0|||
170669376|NCT00400764|616801143|FG001|Phase II|Lost to Follow-up|0|||
170669377|NCT00400764|616801144|FG002|Phase II|Lost to Follow-up|1|||
170669378|NCT00400764|616801145|FG003|Phase II|Lost to Follow-up|0|||
170669379|NCT00400764|616801146|FG004|Phase II|Lost to Follow-up|0|||
170669380|NCT00400764|616801142|FG000|Phase II|Physician Decision|0|||
170622044|NCT04698343|616625444|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
170622045|NCT04698343|616625444|FG000|Overall Study|Personal reasons|3|||
170669381|NCT00400764|616801143|FG001|Phase II|Physician Decision|0|||
170669382|NCT00400764|616801144|FG002|Phase II|Physician Decision|1|||
170669383|NCT00400764|616801145|FG003|Phase II|Physician Decision|1|||
170669384|NCT00400764|616801146|FG004|Phase II|Physician Decision|0|||
170669385|NCT00400764|616801142|FG000|Phase II|Sponsor's decision to terminate|0|||
170622046|NCT04698343|616625444|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
170622047|NCT03882021|616625448|FG000|Enrollment|Procedure aborted/cancelled|2|||
170669386|NCT00400764|616801143|FG001|Phase II|Sponsor's decision to terminate|0|||
170669387|NCT00400764|616801144|FG002|Phase II|Sponsor's decision to terminate|18|||
170669388|NCT00400764|616801145|FG003|Phase II|Sponsor's decision to terminate|22|||
170669389|NCT00400764|616801146|FG004|Phase II|Sponsor's decision to terminate|11|||
170669390|NCT00400764|616801142|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
170669391|NCT00400764|616801143|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
170669392|NCT00400764|616801144|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
170669393|NCT00400764|616801145|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
170669394|NCT00400764|616801146|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
170669395|NCT00400764|616801142|FG000|Phase II|Withdrawal by Subject|0|||
170669396|NCT00400764|616801143|FG001|Phase II|Withdrawal by Subject|0|||
170669397|NCT00400764|616801144|FG002|Phase II|Withdrawal by Subject|1|||
170669398|NCT00400764|616801145|FG003|Phase II|Withdrawal by Subject|1|||
170669399|NCT00400764|616801146|FG004|Phase II|Withdrawal by Subject|0|||
170669400|NCT00347360|616801149|FG000|Overall Study|Adverse Event|1|||
170669401|NCT00347360|616801150|FG001|Overall Study|Adverse Event|2|||
170669402|NCT00347360|616801151|FG002|Overall Study|Adverse Event|0|||
170669403|NCT00347360|616801152|FG003|Overall Study|Adverse Event|4|||
170669404|NCT00347360|616801153|FG004|Overall Study|Adverse Event|1|||
170669405|NCT00347360|616801154|FG005|Overall Study|Adverse Event|2|||
170669406|NCT00347360|616801155|FG006|Overall Study|Adverse Event|2|||
170669407|NCT00347360|616801156|FG007|Overall Study|Adverse Event|0|||
170622048|NCT03882021|616625448|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
170622049|NCT03882021|616625448|FG000|Enrollment to 3-Month|Death|1|||
170622050|NCT03882021|616625448|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
170622051|NCT03882021|616625448|FG000|Enrollment to 3-Month|Missed Visit|4|||
170622052|NCT03882021|616625448|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
170622053|NCT03882021|616625448|FG000|6-Month to 12-Month Visit|Death|1|||
170622054|NCT03882021|616625448|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
170622055|NCT00286442|616625449|FG000|Overall Study|Hyperglycemic Rescue|19|||
170622056|NCT00286442|616625450|FG001|Overall Study|Hyperglycemic Rescue|17|||
170622057|NCT00286442|616625451|FG002|Overall Study|Hyperglycemic Rescue|25|||
170622058|NCT00286442|616625449|FG000|Overall Study|Adverse Event|7|||
170622059|NCT00286442|616625450|FG001|Overall Study|Adverse Event|6|||
170622060|NCT00286442|616625451|FG002|Overall Study|Adverse Event|1|||
170622061|NCT00286442|616625449|FG000|Overall Study|Protocol Violation|2|||
170622062|NCT00286442|616625450|FG001|Overall Study|Protocol Violation|4|||
170669408|NCT00347360|616801157|FG008|Overall Study|Adverse Event|2|||
170669409|NCT00347360|616801158|FG009|Overall Study|Adverse Event|3|||
170669410|NCT00347360|616801159|FG010|Overall Study|Adverse Event|3|||
170669411|NCT00347360|616801160|FG011|Overall Study|Adverse Event|1|||
170669412|NCT00347360|616801161|FG012|Overall Study|Adverse Event|3|||
170669413|NCT00347360|616801162|FG013|Overall Study|Adverse Event|2|||
170622063|NCT00286442|616625451|FG002|Overall Study|Protocol Violation|2|||
170669414|NCT00347360|616801163|FG014|Overall Study|Adverse Event|2|||
170669415|NCT00347360|616801149|FG000|Overall Study|Lost to Follow-up|0|||
170669416|NCT00347360|616801150|FG001|Overall Study|Lost to Follow-up|0|||
170669417|NCT00347360|616801151|FG002|Overall Study|Lost to Follow-up|0|||
170669418|NCT00347360|616801152|FG003|Overall Study|Lost to Follow-up|2|||
170669419|NCT00347360|616801153|FG004|Overall Study|Lost to Follow-up|1|||
170669420|NCT00347360|616801154|FG005|Overall Study|Lost to Follow-up|1|||
170669421|NCT00347360|616801155|FG006|Overall Study|Lost to Follow-up|0|||
170669422|NCT00347360|616801156|FG007|Overall Study|Lost to Follow-up|1|||
170669423|NCT00347360|616801157|FG008|Overall Study|Lost to Follow-up|1|||
170669424|NCT00347360|616801158|FG009|Overall Study|Lost to Follow-up|2|||
170669425|NCT00347360|616801159|FG010|Overall Study|Lost to Follow-up|0|||
170669426|NCT00347360|616801160|FG011|Overall Study|Lost to Follow-up|0|||
170669427|NCT00347360|616801161|FG012|Overall Study|Lost to Follow-up|1|||
170669428|NCT00347360|616801162|FG013|Overall Study|Lost to Follow-up|0|||
170669429|NCT00347360|616801163|FG014|Overall Study|Lost to Follow-up|0|||
170669430|NCT00347360|616801149|FG000|Overall Study|Protocol Violation|2|||
170669431|NCT00347360|616801150|FG001|Overall Study|Protocol Violation|3|||
170669432|NCT00347360|616801151|FG002|Overall Study|Protocol Violation|1|||
170669433|NCT00347360|616801152|FG003|Overall Study|Protocol Violation|2|||
170669434|NCT00347360|616801153|FG004|Overall Study|Protocol Violation|1|||
170669435|NCT00347360|616801154|FG005|Overall Study|Protocol Violation|2|||
170622064|NCT00286442|616625449|FG000|Overall Study|Lost to Follow-up|5|||
170622065|NCT00286442|616625450|FG001|Overall Study|Lost to Follow-up|2|||
170622066|NCT00286442|616625451|FG002|Overall Study|Lost to Follow-up|1|||
170622067|NCT00286442|616625449|FG000|Overall Study|Physician Decision|1|||
170622068|NCT00286442|616625450|FG001|Overall Study|Physician Decision|1|||
170622069|NCT00286442|616625451|FG002|Overall Study|Physician Decision|1|||
170622070|NCT00286442|616625449|FG000|Overall Study|Administrative Error|1|||
170622071|NCT00286442|616625450|FG001|Overall Study|Administrative Error|1|||
170622072|NCT00286442|616625451|FG002|Overall Study|Administrative Error|0|||
170622073|NCT00286442|616625449|FG000|Overall Study|Withdrawal by Subject|2|||
170622074|NCT00286442|616625450|FG001|Overall Study|Withdrawal by Subject|14|||
170622075|NCT00286442|616625451|FG002|Overall Study|Withdrawal by Subject|2|||
170622076|NCT00088530|616625454|FG000|Overall Study|Progressive/Relapsed Disease|28|||
170622077|NCT00088530|616625455|FG001|Overall Study|Progressive/Relapsed Disease|39|||
170622078|NCT00088530|616625454|FG000|Overall Study|Adverse Event|15|||
170622079|NCT00088530|616625455|FG001|Overall Study|Adverse Event|9|||
170622080|NCT00088530|616625454|FG000|Overall Study|Withdrawal by Subject|2|||
170622081|NCT00088530|616625455|FG001|Overall Study|Withdrawal by Subject|5|||
170622082|NCT00088530|616625454|FG000|Overall Study|Lost to Follow-up|2|||
170622083|NCT00088530|616625455|FG001|Overall Study|Lost to Follow-up|0|||
170622084|NCT00088530|616625454|FG000|Overall Study|Physician Decision|2|||
170622085|NCT00088530|616625455|FG001|Overall Study|Physician Decision|0|||
170622086|NCT00088530|616625454|FG000|Overall Study|Sponsor decision|0|||
170622087|NCT00088530|616625455|FG001|Overall Study|Sponsor decision|1|||
170622088|NCT00088530|616625454|FG000|Overall Study|Patient never treated|1|||
170622089|NCT00088530|616625455|FG001|Overall Study|Patient never treated|0|||
170622090|NCT01945021|616625458|FG000|Overall Study|Adverse Event|1|||
170622091|NCT01945021|616625458|FG000|Overall Study|Withdrawal of consent|12|||
170622092|NCT01945021|616625458|FG000|Overall Study|Lost to Follow-up|5|||
170622093|NCT01945021|616625458|FG000|Overall Study|Death|65|||
170622094|NCT03582215|616625459|FG000|Overall Study|Adverse Event|1|||
170622095|NCT03582215|616625460|FG001|Overall Study|Adverse Event|0|||
170622096|NCT03582215|616625461|FG002|Overall Study|Adverse Event|0|||
170622097|NCT03582215|616625462|FG003|Overall Study|Adverse Event|0|||
170622098|NCT03582215|616625463|FG004|Overall Study|Adverse Event|0|||
170622099|NCT03582215|616625464|FG005|Overall Study|Adverse Event|0|||
170622100|NCT03582215|616625465|FG006|Overall Study|Adverse Event|2|||
170622101|NCT03582215|616625466|FG007|Overall Study|Adverse Event|2|||
170622102|NCT02174731|616625467|FG000|Overall Study|Participant decision|67|||
170622103|NCT02174731|616625468|FG001|Overall Study|Participant decision|64|||
170622104|NCT02174731|616625467|FG000|Overall Study|Incorrect enrolment before randomization|0|||
170622105|NCT02174731|616625468|FG001|Overall Study|Incorrect enrolment before randomization|1|||
170622106|NCT02174731|616625467|FG000|Overall Study|Missing|2|||
170622107|NCT02174731|616625468|FG001|Overall Study|Missing|0|||
170622108|NCT00079040|616625471|FG000|Overall Study|Withdrew before treatment|1|||
170622109|NCT00079040|616625471|FG000|Overall Study|Ineligible|1|||
170622110|NCT03119259|616625472|FG000|Overall Study|Withdrawn as no longer eligible|1|||
170622111|NCT03119259|616625473|FG001|Overall Study|Withdrawn as no longer eligible|0|||
170622112|NCT03119259|616625472|FG000|Overall Study|Withdrawal by Subject|4|||
170622113|NCT03119259|616625473|FG001|Overall Study|Withdrawal by Subject|2|||
170622114|NCT03119259|616625472|FG000|Overall Study|Lost to Follow-up|0|||
170622115|NCT03119259|616625473|FG001|Overall Study|Lost to Follow-up|1|||
170622116|NCT00844376|616625478|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
170669436|NCT00347360|616801155|FG006|Overall Study|Protocol Violation|0|||
170669437|NCT00347360|616801156|FG007|Overall Study|Protocol Violation|0|||
170622117|NCT00844376|616625479|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
170669438|NCT00347360|616801157|FG008|Overall Study|Protocol Violation|1|||
170622118|NCT00549640|616625481|FG000|Overall Study|Withdrawal by Subject|6|||
170622119|NCT00549640|616625482|FG001|Overall Study|Withdrawal by Subject|12|||
170622120|NCT00549640|616625481|FG000|Overall Study|Adverse Event|5|||
170622121|NCT00549640|616625482|FG001|Overall Study|Adverse Event|0|||
170622122|NCT00549640|616625481|FG000|Overall Study|Lost to Follow-up|7|||
170622123|NCT00549640|616625482|FG001|Overall Study|Lost to Follow-up|4|||
170669439|NCT00347360|616801158|FG009|Overall Study|Protocol Violation|2|||
170622124|NCT03550378|616625483|FG000|Overall Study|Death|0|||
170622125|NCT03550378|616625484|FG001|Overall Study|Death|1|||
170622126|NCT04486235|616625485|FG000|Overall Study|Pregnancy|1|||
170622127|NCT04486235|616625486|FG001|Overall Study|Pregnancy|0|||
170622128|NCT04486235|616625485|FG000|Overall Study|Lost to Follow-up|1|||
170622129|NCT04486235|616625486|FG001|Overall Study|Lost to Follow-up|0|||
170622130|NCT00626275|616625487|FG000|Part A - Treatment Period 1|Adverse Event|1|||
170622131|NCT00626275|616625488|FG001|Part A - Treatment Period 1|Adverse Event|0|||
170622132|NCT00626275|616625489|FG002|Part A - Treatment Period 1|Adverse Event|0|||
170622133|NCT00626275|616625490|FG003|Part A - Treatment Period 1|Adverse Event|0|||
170622134|NCT00626275|616625491|FG004|Part A - Treatment Period 1|Adverse Event|0|||
170622135|NCT00626275|616625492|FG005|Part A - Treatment Period 1|Adverse Event|0|||
170622136|NCT00626275|616625493|FG006|Part A - Treatment Period 1|Adverse Event|0|||
170622137|NCT00626275|616625494|FG007|Part A - Treatment Period 1|Adverse Event|0|||
170622138|NCT00626275|616625487|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
170622139|NCT00626275|616625488|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
170622140|NCT00626275|616625489|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
170622141|NCT00626275|616625490|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
170622142|NCT00626275|616625491|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
170622143|NCT00626275|616625492|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
170622144|NCT00626275|616625493|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
170622145|NCT00626275|616625494|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
170622146|NCT00626275|616625487|FG000|Part B|Lost to Follow-up|0|||
170622147|NCT00626275|616625488|FG001|Part B|Lost to Follow-up|0|||
170622148|NCT00626275|616625489|FG002|Part B|Lost to Follow-up|0|||
170622149|NCT00626275|616625490|FG003|Part B|Lost to Follow-up|0|||
170622150|NCT00626275|616625491|FG004|Part B|Lost to Follow-up|0|||
170622151|NCT00626275|616625492|FG005|Part B|Lost to Follow-up|0|||
170622152|NCT00626275|616625493|FG006|Part B|Lost to Follow-up|1|||
170622153|NCT00626275|616625494|FG007|Part B|Lost to Follow-up|0|||
170622154|NCT00626275|616625487|FG000|Part B|Withdrawal by Subject|0|||
170622155|NCT00626275|616625488|FG001|Part B|Withdrawal by Subject|0|||
170622156|NCT00626275|616625489|FG002|Part B|Withdrawal by Subject|0|||
170622157|NCT00626275|616625490|FG003|Part B|Withdrawal by Subject|0|||
170622158|NCT00626275|616625491|FG004|Part B|Withdrawal by Subject|0|||
170622159|NCT00626275|616625492|FG005|Part B|Withdrawal by Subject|0|||
170622160|NCT00626275|616625493|FG006|Part B|Withdrawal by Subject|0|||
170622161|NCT00626275|616625494|FG007|Part B|Withdrawal by Subject|1|||
170622162|NCT04999839|616625495|FG000|Overall Study|Adverse Event|1|||
170622163|NCT04999839|616625496|FG001|Overall Study|Adverse Event|1|||
170622164|NCT04999839|616625497|FG002|Overall Study|Adverse Event|1|||
170622165|NCT04999839|616625498|FG003|Overall Study|Adverse Event|1|||
170622166|NCT04999839|616625499|FG004|Overall Study|Adverse Event|1|||
170622167|NCT04999839|616625495|FG000|Overall Study|Lost to Follow-up|2|||
170622168|NCT04999839|616625496|FG001|Overall Study|Lost to Follow-up|0|||
170622169|NCT04999839|616625497|FG002|Overall Study|Lost to Follow-up|2|||
170622170|NCT04999839|616625498|FG003|Overall Study|Lost to Follow-up|4|||
170622171|NCT04999839|616625499|FG004|Overall Study|Lost to Follow-up|1|||
170622172|NCT04999839|616625495|FG000|Overall Study|Withdrawal by Subject|6|||
170622173|NCT04999839|616625496|FG001|Overall Study|Withdrawal by Subject|5|||
170622174|NCT04999839|616625497|FG002|Overall Study|Withdrawal by Subject|3|||
170622175|NCT04999839|616625498|FG003|Overall Study|Withdrawal by Subject|2|||
170622176|NCT04999839|616625499|FG004|Overall Study|Withdrawal by Subject|2|||
170622177|NCT04999839|616625495|FG000|Overall Study|Lack of Efficacy|0|||
170622178|NCT04999839|616625496|FG001|Overall Study|Lack of Efficacy|1|||
170622179|NCT04999839|616625497|FG002|Overall Study|Lack of Efficacy|0|||
170622180|NCT04999839|616625498|FG003|Overall Study|Lack of Efficacy|0|||
170622181|NCT04999839|616625499|FG004|Overall Study|Lack of Efficacy|0|||
170622182|NCT04999839|616625495|FG000|Overall Study|Physician Decision|0|||
170622183|NCT04999839|616625496|FG001|Overall Study|Physician Decision|0|||
170622184|NCT04999839|616625497|FG002|Overall Study|Physician Decision|0|||
170622185|NCT04999839|616625498|FG003|Overall Study|Physician Decision|0|||
170622186|NCT04999839|616625499|FG004|Overall Study|Physician Decision|1|||
170622187|NCT04999839|616625495|FG000|Overall Study|Sponsor request|0|||
170622188|NCT04999839|616625496|FG001|Overall Study|Sponsor request|1|||
170622189|NCT04999839|616625497|FG002|Overall Study|Sponsor request|0|||
170622190|NCT04999839|616625498|FG003|Overall Study|Sponsor request|0|||
170622191|NCT04999839|616625499|FG004|Overall Study|Sponsor request|0|||
170622192|NCT04999839|616625495|FG000|Overall Study|Other|0|||
170622193|NCT04999839|616625496|FG001|Overall Study|Other|0|||
170622194|NCT04999839|616625497|FG002|Overall Study|Other|1|||
170622195|NCT04999839|616625498|FG003|Overall Study|Other|0|||
170622196|NCT04999839|616625499|FG004|Overall Study|Other|0|||
170622197|NCT01362348|616625500|FG000|Overall Study|Protocol-defined stopping criteria|9|||
170622198|NCT01362348|616625500|FG000|Overall Study|Study closed/terminated|5|||
170622199|NCT00399516|616625501|FG000|Overall Study|Lost to Follow-up|2|||
170622200|NCT00960063|616625505|FG000|Overall Study|Adverse Event|1|||
170622201|NCT00960063|616625506|FG001|Overall Study|Adverse Event|0|||
170622202|NCT00960063|616625507|FG002|Overall Study|Adverse Event|0|||
170622203|NCT00960063|616625505|FG000|Overall Study|Progression of Disease|0|||
170622204|NCT00960063|616625506|FG001|Overall Study|Progression of Disease|0|||
170622205|NCT00960063|616625507|FG002|Overall Study|Progression of Disease|3|||
170622206|NCT00625131|616625508|FG000|Overall Study|Lost to Follow-up|3|||
170622207|NCT00625131|616625509|FG001|Overall Study|Lost to Follow-up|2|||
170622208|NCT00625131|616625510|FG002|Overall Study|Lost to Follow-up|0|||
170622209|NCT00625131|616625508|FG000|Overall Study|Withdrawal by Subject|1|||
170622210|NCT00625131|616625509|FG001|Overall Study|Withdrawal by Subject|0|||
170622211|NCT00625131|616625510|FG002|Overall Study|Withdrawal by Subject|5|||
170622212|NCT01129622|616625513|FG000|Overall Study|Withdrawal by Subject|2|||
170622213|NCT00647296|616625516|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
170622214|NCT00647296|616625517|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
170622215|NCT00647296|616625518|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
170622216|NCT00647296|616625519|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
170622217|NCT00647296|616625516|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
170622218|NCT00647296|616625517|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
170622219|NCT00647296|616625518|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
170622220|NCT00647296|616625519|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
170622221|NCT00647296|616625516|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
170622222|NCT00647296|616625517|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
170622223|NCT00647296|616625518|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
170622224|NCT00647296|616625519|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
170622225|NCT00647296|616625516|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
170622226|NCT00647296|616625517|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
170622227|NCT00647296|616625518|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
170622228|NCT00647296|616625519|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
170622229|NCT00647296|616625516|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
170622230|NCT00647296|616625517|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
170622231|NCT00647296|616625518|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
170622232|NCT00647296|616625519|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
170622233|NCT00647296|616625516|FG000|Part 2: 4-week Placebo Washout|Death|3|||
170622234|NCT00647296|616625517|FG001|Part 2: 4-week Placebo Washout|Death|0|||
170622235|NCT00647296|616625518|FG002|Part 2: 4-week Placebo Washout|Death|0|||
170622236|NCT00647296|616625519|FG003|Part 2: 4-week Placebo Washout|Death|0|||
170622237|NCT00647296|616625516|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
170622238|NCT00647296|616625517|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
170622239|NCT00647296|616625518|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
170622240|NCT00647296|616625519|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
170622241|NCT00647296|616625516|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
170622242|NCT00647296|616625517|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
170622243|NCT00647296|616625518|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
170622244|NCT00647296|616625519|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
170622245|NCT00647296|616625516|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
170622246|NCT00647296|616625517|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
170622247|NCT00647296|616625518|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
170622248|NCT00647296|616625519|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
170622249|NCT00647296|616625516|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
170622250|NCT00647296|616625517|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
170622251|NCT00647296|616625518|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
170622252|NCT00647296|616625519|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
170622253|NCT00647296|616625516|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
170622254|NCT00647296|616625517|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
170622255|NCT00647296|616625518|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
170622256|NCT00647296|616625519|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
170622257|NCT03353675|616625521|FG000|Overall Study|Adverse Event|4|||
170622258|NCT00402168|616625522|FG000|Randomized|Lost to Follow-up|1|||
170622259|NCT00402168|616625523|FG001|Randomized|Lost to Follow-up|0|||
170622260|NCT00402168|616625522|FG000|Randomized|Withdrawal by Subject|0|||
170622261|NCT00402168|616625523|FG001|Randomized|Withdrawal by Subject|1|||
170622262|NCT00402168|616625522|FG000|Treatment (up to 12 Months)|Death|0|||
170622263|NCT00402168|616625523|FG001|Treatment (up to 12 Months)|Death|1|||
170622264|NCT00402168|616625522|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
170622265|NCT00402168|616625523|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
170622266|NCT00402168|616625522|FG000|Treatment (up to 12 Months)|non-specified|0|||
170622267|NCT00402168|616625523|FG001|Treatment (up to 12 Months)|non-specified|1|||
170622268|NCT00402168|616625522|FG000|Long Term (LT)|Adverse Event|1|||
170622269|NCT00402168|616625523|FG001|Long Term (LT)|Adverse Event|5|||
170622270|NCT00402168|616625522|FG000|Long Term (LT)|Withdrawal by Subject|4|||
170622271|NCT00402168|616625523|FG001|Long Term (LT)|Withdrawal by Subject|7|||
170622272|NCT00402168|616625522|FG000|Long Term (LT)|Pregnancy|0|||
170622273|NCT00402168|616625523|FG001|Long Term (LT)|Pregnancy|1|||
170622274|NCT00402168|616625522|FG000|Long Term (LT)|Lost to Follow-up|1|||
170622275|NCT00402168|616625523|FG001|Long Term (LT)|Lost to Follow-up|0|||
170622276|NCT00402168|616625522|FG000|Long Term (LT)|Death|4|||
170622277|NCT00402168|616625523|FG001|Long Term (LT)|Death|0|||
170622278|NCT00402168|616625522|FG000|Long Term (LT)|Lack of Efficacy|0|||
170622279|NCT00402168|616625523|FG001|Long Term (LT)|Lack of Efficacy|2|||
170622280|NCT00402168|616625522|FG000|Long Term (LT)|non-specified|1|||
170622281|NCT00402168|616625523|FG001|Long Term (LT)|non-specified|2|||
170622282|NCT00402168|616625522|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
170622283|NCT00402168|616625523|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
170622284|NCT00402168|616625522|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
170622285|NCT00402168|616625523|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
170622286|NCT02922725|616625524|FG000|Overall Study|Withdrawal by Subject|1|||
170622287|NCT02922725|616625525|FG001|Overall Study|Withdrawal by Subject|0|||
170622288|NCT02922725|616625526|FG002|Overall Study|Withdrawal by Subject|0|||
170622289|NCT01300234|616625527|FG000|Overall Study|Adverse Event|1|||
170622290|NCT01300234|616625528|FG001|Overall Study|Adverse Event|1|||
170622291|NCT01300234|616625527|FG000|Overall Study|Protocol Violation|2|||
170622292|NCT01300234|616625528|FG001|Overall Study|Protocol Violation|3|||
170622293|NCT01300234|616625527|FG000|Overall Study|Withdrawal by Subject|5|||
170622294|NCT01300234|616625528|FG001|Overall Study|Withdrawal by Subject|9|||
170622295|NCT01300234|616625527|FG000|Overall Study|Lost to Follow-up|14|||
170622296|NCT01300234|616625528|FG001|Overall Study|Lost to Follow-up|12|||
170622297|NCT01300234|616625527|FG000|Overall Study|Pregnancy|2|||
170622298|NCT01300234|616625528|FG001|Overall Study|Pregnancy|1|||
170622299|NCT01300234|616625527|FG000|Overall Study|Participant reached stopping critera|2|||
170622300|NCT01300234|616625528|FG001|Overall Study|Participant reached stopping critera|0|||
170622301|NCT01300234|616625527|FG000|Overall Study|Participant stopped medication|1|||
170622302|NCT01300234|616625528|FG001|Overall Study|Participant stopped medication|1|||
170622303|NCT01300234|616625527|FG000|Overall Study|Participant refused return to hospital|1|||
170622304|NCT01300234|616625528|FG001|Overall Study|Participant refused return to hospital|0|||
170622305|NCT01602224|616627318|FG000|Overall Study|Adverse Event|0|||
170622306|NCT01602224|616627319|FG001|Overall Study|Adverse Event|1|||
170622307|NCT01602224|616627320|FG002|Overall Study|Adverse Event|0|||
170622308|NCT01602224|616627318|FG000|Overall Study|Investigator Decison|1|||
170622309|NCT01602224|616627319|FG001|Overall Study|Investigator Decison|0|||
170622310|NCT01602224|616627320|FG002|Overall Study|Investigator Decison|0|||
170622311|NCT01602224|616627318|FG000|Overall Study|Lost to Follow-up|0|||
170622312|NCT01602224|616627319|FG001|Overall Study|Lost to Follow-up|0|||
170622313|NCT01602224|616627320|FG002|Overall Study|Lost to Follow-up|1|||
170622314|NCT01602224|616627318|FG000|Overall Study|Protocol Violation|0|||
170622315|NCT01602224|616627319|FG001|Overall Study|Protocol Violation|1|||
170622316|NCT01602224|616627320|FG002|Overall Study|Protocol Violation|0|||
170622317|NCT01602224|616627318|FG000|Overall Study|Sponsor Decision|2|||
170622318|NCT01602224|616627319|FG001|Overall Study|Sponsor Decision|3|||
170622319|NCT01602224|616627320|FG002|Overall Study|Sponsor Decision|2|||
170669440|NCT00347360|616801159|FG010|Overall Study|Protocol Violation|0|||
170669441|NCT00347360|616801160|FG011|Overall Study|Protocol Violation|0|||
170622320|NCT01602224|616627318|FG000|Overall Study|Withdrawal by Subject|5|||
170622321|NCT01602224|616627319|FG001|Overall Study|Withdrawal by Subject|3|||
170622322|NCT01602224|616627320|FG002|Overall Study|Withdrawal by Subject|3|||
170622323|NCT01352117|616627321|FG000|Overall Study|Death|15|||
170622324|NCT01352117|616627322|FG001|Overall Study|Death|16|||
170622325|NCT01352117|616627321|FG000|Overall Study|Withdrawal by Subject|1|||
170622326|NCT01352117|616627322|FG001|Overall Study|Withdrawal by Subject|0|||
170622327|NCT01352117|616627321|FG000|Overall Study|Lost to Follow-up|2|||
170622328|NCT01352117|616627322|FG001|Overall Study|Lost to Follow-up|7|||
170622329|NCT01352117|616627321|FG000|Overall Study|Non-adherent to study requirements|1|||
170622330|NCT01352117|616627322|FG001|Overall Study|Non-adherent to study requirements|1|||
170622331|NCT01352117|616627321|FG000|Overall Study|Did not initiate study treatment|1|||
170622332|NCT01352117|616627322|FG001|Overall Study|Did not initiate study treatment|0|||
170622333|NCT01352117|616627321|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
170622334|NCT01352117|616627322|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
170622335|NCT00644423|616627324|FG000|Overall Study|Lost to Follow-up|1|||
170622336|NCT00644423|616627325|FG001|Overall Study|Lost to Follow-up|1|||
170622337|NCT03346434|616627326|FG000|Overall Study|Randomized in Error|0|||
170622338|NCT03346434|616627327|FG001|Overall Study|Randomized in Error|0|||
170622339|NCT03346434|616627328|FG002|Overall Study|Randomized in Error|0|||
170622340|NCT03346434|616627329|FG003|Overall Study|Randomized in Error|0|||
170622341|NCT03346434|616627330|FG004|Overall Study|Randomized in Error|1|||
170622342|NCT03346434|616627331|FG005|Overall Study|Randomized in Error|0|||
170622343|NCT03346434|616627326|FG000|Overall Study|Withdrawal by Subject|0|||
170622344|NCT03346434|616627327|FG001|Overall Study|Withdrawal by Subject|0|||
170622345|NCT03346434|616627328|FG002|Overall Study|Withdrawal by Subject|1|||
170622346|NCT03346434|616627329|FG003|Overall Study|Withdrawal by Subject|0|||
170622347|NCT03346434|616627330|FG004|Overall Study|Withdrawal by Subject|1|||
170622348|NCT03346434|616627331|FG005|Overall Study|Withdrawal by Subject|0|||
170622349|NCT03346434|616627326|FG000|Overall Study|Lost to Follow-up|0|||
170622350|NCT03346434|616627327|FG001|Overall Study|Lost to Follow-up|0|||
170622351|NCT03346434|616627328|FG002|Overall Study|Lost to Follow-up|0|||
170622352|NCT03346434|616627329|FG003|Overall Study|Lost to Follow-up|0|||
170622353|NCT03346434|616627330|FG004|Overall Study|Lost to Follow-up|1|||
170622354|NCT03346434|616627331|FG005|Overall Study|Lost to Follow-up|1|||
170622355|NCT03346434|616627326|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
170622356|NCT03346434|616627327|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
170622357|NCT03346434|616627328|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
170622358|NCT03346434|616627329|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
170622359|NCT03346434|616627330|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
170622360|NCT03346434|616627331|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
170622361|NCT03525444|616627332|FG000|Overall Study|Adverse Event|0|||
170622362|NCT03525444|616627333|FG001|Overall Study|Adverse Event|1|||
170622363|NCT03525444|616627332|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
170622364|NCT03525444|616627333|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
170622365|NCT03525444|616627332|FG000|Overall Study|Other|0|||
170622366|NCT03525444|616627333|FG001|Overall Study|Other|1|||
170622367|NCT00262860|616627337|FG000|Overall Study|Adverse Event|2|||
170622368|NCT02081677|616627338|FG000|Overall Study|Adverse Event|0|||
170622369|NCT02081677|616627339|FG001|Overall Study|Adverse Event|0|||
170622370|NCT02081677|616627340|FG002|Overall Study|Adverse Event|1|||
170622371|NCT02081677|616627341|FG003|Overall Study|Adverse Event|0|||
170622372|NCT02081677|616627338|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
170622373|NCT02081677|616627339|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170622374|NCT02081677|616627340|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
170622375|NCT02081677|616627341|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
170622376|NCT02081677|616627338|FG000|Overall Study|Not comfortable with lens care system|1|||
170622377|NCT02081677|616627339|FG001|Overall Study|Not comfortable with lens care system|0|||
170622378|NCT02081677|616627340|FG002|Overall Study|Not comfortable with lens care system|0|||
170622379|NCT02081677|616627341|FG003|Overall Study|Not comfortable with lens care system|0|||
170669442|NCT00347360|616801161|FG012|Overall Study|Protocol Violation|0|||
170669443|NCT00347360|616801162|FG013|Overall Study|Protocol Violation|1|||
170669444|NCT00347360|616801163|FG014|Overall Study|Protocol Violation|0|||
170819425|NCT00936065|617345881|FG002|Overall Study|Adverse Event|1|||
170819426|NCT00936065|617345879|FG000|Overall Study|Lack of Efficacy|1|||
170819427|NCT00936065|617345880|FG001|Overall Study|Lack of Efficacy|0|||
170819428|NCT00936065|617345881|FG002|Overall Study|Lack of Efficacy|1|||
170819429|NCT00936065|617345879|FG000|Overall Study|Lost to Follow-up|1|||
170819430|NCT00936065|617345880|FG001|Overall Study|Lost to Follow-up|0|||
170819431|NCT00936065|617345881|FG002|Overall Study|Lost to Follow-up|0|||
170622380|NCT02081677|616627338|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
170622381|NCT02081677|616627339|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
170622382|NCT02081677|616627340|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
170622383|NCT02081677|616627341|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
170622384|NCT04416204|616627342|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
170622385|NCT04416204|616627343|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
170622386|NCT04416204|616627344|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
170669445|NCT00347360|616801149|FG000|Overall Study|Withdrawal by Subject|0|||
170622387|NCT04416204|616627345|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
170622388|NCT01959503|616627346|FG000|Overall Study|Death|2|||
170622389|NCT01959503|616627347|FG001|Overall Study|Death|1|||
170622390|NCT01959503|616627346|FG000|Overall Study|Randomized but not treated|1|||
170622391|NCT01959503|616627347|FG001|Overall Study|Randomized but not treated|1|||
170622392|NCT04750824|616627363|FG000|Overall Study|Toxicity/intolerability|3|||
170622393|NCT04750824|616627364|FG001|Overall Study|Toxicity/intolerability|1|||
170622394|NCT04750824|616627363|FG000|Overall Study|Death|1|||
170622395|NCT04750824|616627364|FG001|Overall Study|Death|3|||
170622396|NCT04750824|616627363|FG000|Overall Study|Scheduled duration of therapy complete|1|||
170622397|NCT04750824|616627364|FG001|Overall Study|Scheduled duration of therapy complete|9|||
170622398|NCT04750824|616627363|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
170622399|NCT04750824|616627364|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
170622400|NCT00667628|616627365|FG000|Overall Study|Lost to Follow-up|1|||
170622401|NCT00667628|616627366|FG001|Overall Study|Lost to Follow-up|0|||
170622402|NCT00667628|616627365|FG000|Overall Study|Death|6|||
170622403|NCT00667628|616627366|FG001|Overall Study|Death|6|||
170622404|NCT00667628|616627365|FG000|Overall Study|Investigator Considers in Best Interest|1|||
170622405|NCT00667628|616627366|FG001|Overall Study|Investigator Considers in Best Interest|0|||
170622406|NCT00667628|616627365|FG000|Overall Study|Sponsor Terminated Study|17|||
170622407|NCT00667628|616627366|FG001|Overall Study|Sponsor Terminated Study|21|||
170622408|NCT02055898|616627369|FG000|First Intervention (5 Days)|Physician Decision|2|||
170622409|NCT02055898|616627370|FG001|First Intervention (5 Days)|Physician Decision|0|||
170622410|NCT02055898|616627369|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
170622411|NCT02055898|616627370|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
170622412|NCT01924845|616627371|FG000|Overall Study|Adverse Event|3|||
170622413|NCT01924845|616627371|FG000|Overall Study|Withdrawal by Subject|2|||
170622414|NCT01924845|616627371|FG000|Overall Study|Protocol Violation|1|||
170622415|NCT00265564|616627372|FG000|Overall Study|Lost to Follow-up|5|||
170622416|NCT00265564|616627373|FG001|Overall Study|Lost to Follow-up|7|||
170622417|NCT00265564|616627372|FG000|Overall Study|met exclusion criteria|5|||
170622418|NCT00265564|616627373|FG001|Overall Study|met exclusion criteria|2|||
170622419|NCT04571944|616627374|FG000|Overall Study|Death|1|||
170622420|NCT04571944|616627375|FG001|Overall Study|Death|0|||
170622421|NCT04571944|616627374|FG000|Overall Study|Withdrawal by Subject|3|||
170622422|NCT04571944|616627375|FG001|Overall Study|Withdrawal by Subject|0|||
170622423|NCT04571944|616627374|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
170669446|NCT00347360|616801150|FG001|Overall Study|Withdrawal by Subject|1|||
170622424|NCT04571944|616627375|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
170622425|NCT02163902|616627376|FG000|Overall Study|Subject's Request|3|||
170622426|NCT02163902|616627377|FG001|Overall Study|Subject's Request|4|||
170622427|NCT02163902|616627376|FG000|Overall Study|Lost to Follow-up|6|||
170622428|NCT02163902|616627377|FG001|Overall Study|Lost to Follow-up|7|||
170622429|NCT02163902|616627376|FG000|Overall Study|Administrative Decision|2|||
170622430|NCT02163902|616627377|FG001|Overall Study|Administrative Decision|2|||
170622431|NCT00703014|616627381|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
170622432|NCT00703014|616627382|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
170622433|NCT00703014|616627383|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
170622434|NCT00703014|616627384|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
170622435|NCT00703014|616627381|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
170622436|NCT00703014|616627382|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
170622437|NCT00703014|616627383|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
170622438|NCT00703014|616627384|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
170622439|NCT00988884|616627386|FG000|Overall Study|Adverse Event|0|||
170622440|NCT00988884|616627387|FG001|Overall Study|Adverse Event|1|||
170622441|NCT00988884|616627386|FG000|Overall Study|Lost to Follow-up|20|||
170622442|NCT00988884|616627387|FG001|Overall Study|Lost to Follow-up|16|||
170622443|NCT00988884|616627386|FG000|Overall Study|Protocol Violation|0|||
170622444|NCT00988884|616627387|FG001|Overall Study|Protocol Violation|1|||
170622445|NCT00988884|616627386|FG000|Overall Study|Withdrawal by Subject|15|||
170622446|NCT00988884|616627387|FG001|Overall Study|Withdrawal by Subject|18|||
170622447|NCT05468814|616627388|FG000|Overall Study|Lost to Follow-up|5|||
170622448|NCT05468814|616627389|FG001|Overall Study|Lost to Follow-up|6|||
170622449|NCT04621448|616627390|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
170622450|NCT04621448|616627391|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
170622451|NCT04621448|616627392|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
170622452|NCT04621448|616627393|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
170622453|NCT04621448|616627390|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
170622454|NCT04621448|616627391|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
170622455|NCT04621448|616627392|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
170622456|NCT04621448|616627393|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
170622457|NCT04621448|616627390|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
170622458|NCT04621448|616627391|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
170622459|NCT04621448|616627392|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
170622460|NCT04621448|616627393|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
170622461|NCT04621448|616627390|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
170622462|NCT04621448|616627391|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
170622463|NCT04621448|616627392|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
170622464|NCT04621448|616627393|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
170622465|NCT04590014|616627404|FG000|Overall Study|Withdrawal by Subject|1|||
170622466|NCT04590014|616627405|FG001|Overall Study|Withdrawal by Subject|0|||
170622467|NCT00468299|616627408|FG000|Overall Study|Withdrawal by Subject|0|||
170622468|NCT00468299|616627409|FG001|Overall Study|Withdrawal by Subject|1|||
170622469|NCT01046565|616627412|FG000|Overall Study|Adverse Event|2|||
170622470|NCT01046565|616627412|FG000|Overall Study|Withdrawal by Subject|7|||
170622471|NCT02960217|616627413|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
170622472|NCT02960217|616627414|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
170622473|NCT02960217|616627413|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
170622474|NCT02960217|616627414|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
170622475|NCT02960217|616627413|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
170622476|NCT02960217|616627414|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
170622477|NCT02960217|616627413|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
170669447|NCT00347360|616801151|FG002|Overall Study|Withdrawal by Subject|2|||
170622478|NCT02960217|616627414|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
170622479|NCT02960217|616627413|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
170622480|NCT02960217|616627414|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
170622481|NCT02960217|616627413|FG000|Open-Label Extension Phase|Adverse Event|1|||
170622482|NCT02960217|616627414|FG001|Open-Label Extension Phase|Adverse Event|0|||
170622483|NCT02960217|616627413|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
170622484|NCT02960217|616627414|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
170622485|NCT02960217|616627413|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
170622486|NCT02960217|616627414|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
170622487|NCT02960217|616627413|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
170622488|NCT02960217|616627414|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
170622489|NCT01069484|616627416|FG000|Overall Study|Death-in-near-family|1|||
170622490|NCT01069484|616627417|FG001|Overall Study|Death-in-near-family|0|||
170669448|NCT00347360|616801152|FG003|Overall Study|Withdrawal by Subject|4|||
170669449|NCT00347360|616801153|FG004|Overall Study|Withdrawal by Subject|1|||
170669450|NCT00347360|616801154|FG005|Overall Study|Withdrawal by Subject|2|||
170819432|NCT00936065|617345879|FG000|Overall Study|Protocol Violation|1|||
170819433|NCT00936065|617345880|FG001|Overall Study|Protocol Violation|2|||
170819434|NCT00936065|617345881|FG002|Overall Study|Protocol Violation|1|||
170819435|NCT00936065|617345879|FG000|Overall Study|Withdrawal by Subject|0|||
170819436|NCT00936065|617345880|FG001|Overall Study|Withdrawal by Subject|2|||
170819437|NCT00936065|617345881|FG002|Overall Study|Withdrawal by Subject|4|||
170819438|NCT03547167|617345886|FG000|Overall Study|Withdrawal by Subject|34|||
170819439|NCT03547167|617345887|FG001|Overall Study|Withdrawal by Subject|12|||
170819440|NCT03547167|617345886|FG000|Overall Study|Screen Failure|0|||
170819441|NCT03547167|617345887|FG001|Overall Study|Screen Failure|1|||
170819442|NCT03547167|617345886|FG000|Overall Study|Lost to Follow-up|59|||
170819443|NCT03547167|617345887|FG001|Overall Study|Lost to Follow-up|15|||
170819444|NCT03547167|617345886|FG000|Overall Study|Death|4|||
170819445|NCT03547167|617345887|FG001|Overall Study|Death|2|||
170819446|NCT00736502|617345888|FG000|Overall Study|Adverse Event|22|||
170819447|NCT00736502|617345888|FG000|Overall Study|Lack of Efficacy|16|||
170819448|NCT00736502|617345888|FG000|Overall Study|Lost to Follow-up|27|||
170819449|NCT01885559|617345889|FG000|Overall Study|Lost to Follow-up|15|||
170819450|NCT01885559|617345890|FG001|Overall Study|Lost to Follow-up|16|||
170819451|NCT01885559|617345889|FG000|Overall Study|Less than full participation|9|||
170819452|NCT01885559|617345890|FG001|Overall Study|Less than full participation|19|||
170819453|NCT01885559|617345889|FG000|Overall Study|Protocol Violation|0|||
170819454|NCT01885559|617345890|FG001|Overall Study|Protocol Violation|1|||
170819455|NCT02993926|617345895|FG000|Enantone Treatment Phase|Adverse Event|1|||
170819456|NCT02993926|617345896|FG001|Enantone Treatment Phase|Adverse Event|0|||
170819457|NCT02993926|617345897|FG002|Enantone Treatment Phase|Adverse Event|0|||
170819458|NCT02993926|617345895|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
170819459|NCT02993926|617345896|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
170819460|NCT02993926|617345897|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
170819461|NCT02993926|617345895|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
170819462|NCT02993926|617345896|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
170819463|NCT02993926|617345897|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
170819464|NCT02993926|617345895|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
170819465|NCT02993926|617345896|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
170819466|NCT02993926|617345897|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
170819467|NCT00525915|617345898|FG000|Overall Study|Non-Compliance|0|||
170819468|NCT00525915|617345899|FG001|Overall Study|Non-Compliance|1|||
170819469|NCT00525915|617345898|FG000|Overall Study|Disease Progression|5|||
170819470|NCT00525915|617345899|FG001|Overall Study|Disease Progression|6|||
170819471|NCT00525915|617345898|FG000|Overall Study|Withdrawal by Subject|1|||
170622491|NCT01069484|616627416|FG000|Overall Study|No specific reason|8|||
170622492|NCT01069484|616627417|FG001|Overall Study|No specific reason|2|||
170622493|NCT01069484|616627416|FG000|Overall Study|Illness mother or child|3|||
170622494|NCT01069484|616627417|FG001|Overall Study|Illness mother or child|1|||
170622495|NCT00292942|616627418|FG000|Overall Study|Withdrawal by Subject|0|||
170622496|NCT00292942|616627419|FG001|Overall Study|Withdrawal by Subject|0|||
170622497|NCT00292942|616627420|FG002|Overall Study|Withdrawal by Subject|1|||
170622498|NCT00292942|616627421|FG003|Overall Study|Withdrawal by Subject|0|||
170622499|NCT00292942|616627418|FG000|Overall Study|Adverse Event|0|||
170622500|NCT00292942|616627419|FG001|Overall Study|Adverse Event|0|||
170622501|NCT00292942|616627420|FG002|Overall Study|Adverse Event|0|||
170622502|NCT00292942|616627421|FG003|Overall Study|Adverse Event|1|||
170622503|NCT00644358|616627422|FG000|Overall Study|Adverse Event|124|||
170622504|NCT00644358|616627422|FG000|Overall Study|Lost to Follow-up|105|||
170622505|NCT00644358|616627422|FG000|Overall Study|Consent Withdrawal|64|||
170622506|NCT00644358|616627422|FG000|Overall Study|Lack of Effectiveness|39|||
170622507|NCT00644358|616627422|FG000|Overall Study|Protocol Violation|5|||
170622508|NCT00644358|616627422|FG000|Overall Study|Noncompliance|14|||
170622509|NCT00644358|616627422|FG000|Overall Study|Other Unspecified|11|||
170622510|NCT00651924|616627427|FG000|Overall Study|Withdrawal by PI|0|||
170622511|NCT00651924|616627428|FG001|Overall Study|Withdrawal by PI|2|||
170622512|NCT00651924|616627427|FG000|Overall Study|Withdrawal by Subject|0|||
170622513|NCT00651924|616627428|FG001|Overall Study|Withdrawal by Subject|5|||
170622514|NCT01611792|616627431|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
170622515|NCT01611792|616627432|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
170622516|NCT01611792|616627431|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
170622517|NCT01611792|616627432|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
170622518|NCT01759420|616627433|FG000|Overall Study|Screen failure|5|||
170622519|NCT01759420|616627433|FG000|Overall Study|Inaccurate EKG machine readings|1|||
170622520|NCT02051764|616627434|FG000|Overall Study|Study terminated by sponsor|0|||
170819472|NCT00525915|617345899|FG001|Overall Study|Withdrawal by Subject|0|||
170819473|NCT00525915|617345898|FG000|Overall Study|Refused Surgery|1|||
170819474|NCT00525915|617345899|FG001|Overall Study|Refused Surgery|2|||
170819475|NCT00525915|617345898|FG000|Overall Study|Unrelated illness|1|||
170819476|NCT00525915|617345899|FG001|Overall Study|Unrelated illness|0|||
170819477|NCT04295499|617345900|FG000|Overall Study|moving out of state|1|||
170819478|NCT04295499|617345901|FG001|Overall Study|moving out of state|0|||
170819479|NCT04295499|617345900|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
170819480|NCT04295499|617345901|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
170819481|NCT01755598|617345902|FG000|Overall Study|Other|109|||
170819482|NCT01755598|617345903|FG001|Overall Study|Other|109|||
170819483|NCT01755598|617345902|FG000|Overall Study|Lost to Follow-up|32|||
170819484|NCT01755598|617345903|FG001|Overall Study|Lost to Follow-up|43|||
170819485|NCT01755598|617345902|FG000|Overall Study|Migrated/moved from study area|76|||
170819486|NCT01755598|617345903|FG001|Overall Study|Migrated/moved from study area|65|||
170819487|NCT01755598|617345902|FG000|Overall Study|Withdrawal by Subject|22|||
170819488|NCT01755598|617345903|FG001|Overall Study|Withdrawal by Subject|31|||
170819489|NCT01755598|617345902|FG000|Overall Study|Protocol Violation|7|||
170819490|NCT01755598|617345903|FG001|Overall Study|Protocol Violation|7|||
170819491|NCT01755598|617345902|FG000|Overall Study|Adverse Event|19|||
170819492|NCT01755598|617345903|FG001|Overall Study|Adverse Event|28|||
170819493|NCT02332889|617345904|FG000|Overall Study|Physician Decision|1|||
170819494|NCT02135445|617345905|FG000|Overall Study|Lost to Follow-up|1|||
170819495|NCT02135445|617345906|FG001|Overall Study|Lost to Follow-up|0|||
170819496|NCT02135445|617345905|FG000|Overall Study|Withdrawal by Subject|1|||
170819497|NCT02135445|617345906|FG001|Overall Study|Withdrawal by Subject|0|||
170819498|NCT02081196|617347612|FG000|Overall Study|Lost to Follow-up|1|||
170819499|NCT00814632|617347613|FG000|Overall Study|Lack of Efficacy|2|||
170819500|NCT04198428|617347619|FG000|Overall Study|Withdrawal by Subject|150|||
170819501|NCT04198428|617347620|FG001|Overall Study|Withdrawal by Subject|156|||
170819502|NCT02775214|617347621|FG000|Overall Study|Withdrawal by Subject|2|||
170819503|NCT02775214|617347622|FG001|Overall Study|Withdrawal by Subject|0|||
170819504|NCT00678899|617347625|FG000|Overall Study|Adverse Event|1|||
170819505|NCT03344458|617347626|FG000|Overall Study|Physician Decision|1|||
170819506|NCT03344458|617347626|FG000|Overall Study|Withdrawal by Subject|16|||
170819507|NCT03344458|617347626|FG000|Overall Study|Other reasons|10|||
170819508|NCT03344458|617347626|FG000|Overall Study|Lost to Follow-up|9|||
170819509|NCT03344458|617347626|FG000|Overall Study|Protocol Violation|3|||
170819510|NCT01753323|617347629|FG000|Overall Study|Lack of Efficacy|0|||
170819511|NCT01753323|617347630|FG001|Overall Study|Lack of Efficacy|0|||
170819512|NCT01753323|617347631|FG002|Overall Study|Lack of Efficacy|8|||
170622521|NCT02051764|616627435|FG001|Overall Study|Study terminated by sponsor|7|||
170622522|NCT03253679|616627440|FG000|Overall Study|Screen Failure|1|||
170622523|NCT04816214|616627441|FG000|Overall Study|Progressive Disease|4|||
170622524|NCT04816214|616627442|FG001|Overall Study|Progressive Disease|0|||
170622525|NCT04816214|616627443|FG002|Overall Study|Progressive Disease|0|||
170622526|NCT04816214|616627441|FG000|Overall Study|Death|1|||
170622527|NCT04816214|616627442|FG001|Overall Study|Death|0|||
170622528|NCT04816214|616627443|FG002|Overall Study|Death|0|||
170819513|NCT01753323|617347629|FG000|Overall Study|Protocol deviation|1|||
170819514|NCT01753323|617347630|FG001|Overall Study|Protocol deviation|0|||
170819515|NCT01753323|617347631|FG002|Overall Study|Protocol deviation|0|||
170819516|NCT01753323|617347629|FG000|Overall Study|Adverse Event|0|||
170819517|NCT01753323|617347630|FG001|Overall Study|Adverse Event|0|||
170819518|NCT01753323|617347631|FG002|Overall Study|Adverse Event|1|||
170819519|NCT01870999|617347632|FG000|Overall Study|Adverse Event|0|||
170819520|NCT01870999|617347633|FG001|Overall Study|Adverse Event|4|||
170819521|NCT01870999|617347634|FG002|Overall Study|Adverse Event|1|||
170819522|NCT01870999|617347632|FG000|Overall Study|Subject met withdrawal criteria|3|||
170819523|NCT01870999|617347633|FG001|Overall Study|Subject met withdrawal criteria|2|||
170819524|NCT01870999|617347634|FG002|Overall Study|Subject met withdrawal criteria|0|||
170819525|NCT01870999|617347632|FG000|Overall Study|Subject withdrawn by Investigator|1|||
170819526|NCT01870999|617347633|FG001|Overall Study|Subject withdrawn by Investigator|0|||
170819527|NCT01870999|617347634|FG002|Overall Study|Subject withdrawn by Investigator|0|||
170819528|NCT01870999|617347632|FG000|Overall Study|Withdrawal by Subject|0|||
170819529|NCT01870999|617347633|FG001|Overall Study|Withdrawal by Subject|2|||
170819530|NCT01870999|617347634|FG002|Overall Study|Withdrawal by Subject|5|||
170819531|NCT01870999|617347632|FG000|Overall Study|Protocol Violation|0|||
170819532|NCT01870999|617347633|FG001|Overall Study|Protocol Violation|0|||
170819533|NCT01870999|617347634|FG002|Overall Study|Protocol Violation|1|||
170819534|NCT01745380|617347636|FG000|Overall Study|Lost to Follow-up|1|||
170819535|NCT01745380|617347637|FG001|Overall Study|Lost to Follow-up|0|||
170819536|NCT01745380|617347636|FG000|Overall Study|Lack of Efficacy|0|||
170819537|NCT01745380|617347637|FG001|Overall Study|Lack of Efficacy|1|||
170819538|NCT01882088|617347638|FG000|Overall Study|Intolerance of esophageal manometry|1|||
170819539|NCT01882088|617347638|FG000|Overall Study|no possibility to place the catheter|1|||
170819540|NCT01882088|617347638|FG000|Overall Study|Protocol Violation|1|||
170819541|NCT01882088|617347638|FG000|Overall Study|inadequate pH-impedance tracings|2|||
170819542|NCT02186015|617347639|FG000|Overall Study|Physician Decision|1|||
170819543|NCT02186015|617347640|FG001|Overall Study|Physician Decision|0|||
170819544|NCT01403805|617347644|FG000|Overall Study|Withdrawal by Subject|0|||
170819545|NCT01403805|617347645|FG001|Overall Study|Withdrawal by Subject|4|||
170819546|NCT01403805|617347644|FG000|Overall Study|Lost to Follow-up|0|||
170819547|NCT01403805|617347645|FG001|Overall Study|Lost to Follow-up|2|||
170819548|NCT01403805|617347644|FG000|Overall Study|Death|0|||
170819549|NCT01403805|617347645|FG001|Overall Study|Death|1|||
170819550|NCT01695993|617347646|FG000|Overall Study|Lost to Follow-up|2|||
170819551|NCT01695993|617347647|FG001|Overall Study|Lost to Follow-up|1|||
170819552|NCT01695993|617347648|FG002|Overall Study|Lost to Follow-up|3|||
170819553|NCT01695993|617347646|FG000|Overall Study|Withdrawal by Subject|2|||
170819554|NCT01695993|617347647|FG001|Overall Study|Withdrawal by Subject|2|||
170819555|NCT01695993|617347648|FG002|Overall Study|Withdrawal by Subject|2|||
170819556|NCT01695993|617347646|FG000|Overall Study|To ill to continue|1|||
170819557|NCT01695993|617347647|FG001|Overall Study|To ill to continue|2|||
170819558|NCT01695993|617347648|FG002|Overall Study|To ill to continue|0|||
170819559|NCT01695993|617347646|FG000|Overall Study|Changed Medical Facility|0|||
170819560|NCT01695993|617347647|FG001|Overall Study|Changed Medical Facility|0|||
170819561|NCT01695993|617347648|FG002|Overall Study|Changed Medical Facility|1|||
170819562|NCT01732627|617347649|FG000|Overall Study|Withdrawal by Subject|1|||
170819563|NCT01732627|617347650|FG001|Overall Study|Withdrawal by Subject|0|||
170819564|NCT02137239|617347651|FG000|Overall Study|Discontinued Study Treatment|0|||
170622529|NCT04816214|616627441|FG000|Overall Study|Study Terminated by Sponsor|1|||
170622530|NCT04816214|616627442|FG001|Overall Study|Study Terminated by Sponsor|0|||
170622531|NCT04816214|616627443|FG002|Overall Study|Study Terminated by Sponsor|0|||
170819565|NCT02137239|617347652|FG001|Overall Study|Discontinued Study Treatment|3|||
170819566|NCT02137239|617347651|FG000|Overall Study|Withdrew Consent|1|||
170819567|NCT02137239|617347652|FG001|Overall Study|Withdrew Consent|1|||
170819568|NCT02137239|617347651|FG000|Overall Study|Adverse Event|2|||
170819569|NCT02137239|617347652|FG001|Overall Study|Adverse Event|2|||
170819570|NCT04057937|617347653|FG000|Placebo-controlled Phase|Adverse Event|3|||
170819571|NCT04057937|617347654|FG001|Placebo-controlled Phase|Adverse Event|0|||
170819572|NCT04057937|617347653|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
170819573|NCT04057937|617347654|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
170622532|NCT00584415|616627444|FG000|Overall Study|Adverse Event|7|||
170622533|NCT04879628|616627445|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
170622534|NCT04879628|616627446|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
170622535|NCT04879628|616627447|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
170622536|NCT04879628|616627448|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
170622537|NCT04879628|616627445|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
170622538|NCT04879628|616627446|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
170669451|NCT00347360|616801155|FG006|Overall Study|Withdrawal by Subject|1|||
170669452|NCT00347360|616801156|FG007|Overall Study|Withdrawal by Subject|1|||
170669453|NCT00347360|616801157|FG008|Overall Study|Withdrawal by Subject|1|||
170669454|NCT00347360|616801158|FG009|Overall Study|Withdrawal by Subject|1|||
170819574|NCT04057937|617347653|FG000|Active-treatment Phase|Pregnancy|0|||
170819575|NCT04057937|617347654|FG001|Active-treatment Phase|Pregnancy|1|||
170819576|NCT04057937|617347653|FG000|Active-treatment Phase|Physician Decision|0|||
170819577|NCT04057937|617347654|FG001|Active-treatment Phase|Physician Decision|1|||
170819578|NCT02029521|617347655|FG000|Overall Study|Protocol Violation|1|||
170819579|NCT02029521|617347656|FG001|Overall Study|Protocol Violation|0|||
170819580|NCT02029521|617347655|FG000|Overall Study|Withdrawal by Subject|1|||
170819581|NCT02029521|617347656|FG001|Overall Study|Withdrawal by Subject|1|||
170819582|NCT01072396|617347657|FG000|Period One|Adverse Event|1|||
170819583|NCT01072396|617347658|FG001|Period One|Adverse Event|1|||
170819584|NCT01072396|617347657|FG000|Period One|Protocol Violation|2|||
170819585|NCT01072396|617347658|FG001|Period One|Protocol Violation|1|||
170819586|NCT01072396|617347657|FG000|Period One|Withdrawal by Subject|2|||
170819587|NCT01072396|617347658|FG001|Period One|Withdrawal by Subject|0|||
170819588|NCT01072396|617347657|FG000|Washout Period|Missing termination information|0|||
170819589|NCT01072396|617347658|FG001|Washout Period|Missing termination information|1|||
170819590|NCT01072396|617347657|FG000|Period Two|Adverse Event|0|||
170819591|NCT01072396|617347658|FG001|Period Two|Adverse Event|3|||
170819592|NCT01072396|617347657|FG000|Period Two|Lost to Follow-up|1|||
170819593|NCT01072396|617347658|FG001|Period Two|Lost to Follow-up|0|||
170819594|NCT02446912|617347659|FG000|Overall Study|Adverse Event|3|||
170819595|NCT02446912|617347660|FG001|Overall Study|Adverse Event|13|||
170819596|NCT02446912|617347661|FG002|Overall Study|Adverse Event|5|||
170819597|NCT02446912|617347659|FG000|Overall Study|Condition under investigation worsened|0|||
170819598|NCT02446912|617347660|FG001|Overall Study|Condition under investigation worsened|1|||
170819599|NCT02446912|617347661|FG002|Overall Study|Condition under investigation worsened|1|||
170819600|NCT02446912|617347659|FG000|Overall Study|Study-specific withdrawal criteria|1|||
170819601|NCT02446912|617347660|FG001|Overall Study|Study-specific withdrawal criteria|0|||
170819602|NCT02446912|617347661|FG002|Overall Study|Study-specific withdrawal criteria|0|||
170819603|NCT02446912|617347659|FG000|Overall Study|Lack of Efficacy|1|||
170819604|NCT02446912|617347660|FG001|Overall Study|Lack of Efficacy|4|||
170819605|NCT02446912|617347661|FG002|Overall Study|Lack of Efficacy|7|||
170819606|NCT02446912|617347659|FG000|Overall Study|Lost to Follow-up|0|||
170819607|NCT02446912|617347660|FG001|Overall Study|Lost to Follow-up|0|||
170819608|NCT02446912|617347661|FG002|Overall Study|Lost to Follow-up|2|||
170819609|NCT02446912|617347659|FG000|Overall Study|Severe non-compliance to protocol|1|||
170819610|NCT02446912|617347660|FG001|Overall Study|Severe non-compliance to protocol|0|||
170819611|NCT02446912|617347661|FG002|Overall Study|Severe non-compliance to protocol|1|||
170819612|NCT02446912|617347659|FG000|Overall Study|Withdrawal by Subject|10|||
170819613|NCT02446912|617347660|FG001|Overall Study|Withdrawal by Subject|15|||
170819614|NCT02446912|617347661|FG002|Overall Study|Withdrawal by Subject|15|||
170819615|NCT02446912|617347659|FG000|Overall Study|Miscellaneous|2|||
170819616|NCT02446912|617347660|FG001|Overall Study|Miscellaneous|2|||
170819617|NCT02446912|617347661|FG002|Overall Study|Miscellaneous|4|||
170819618|NCT00510783|617347667|FG000|Overall Study|Lost to Follow-up|29|||
170819619|NCT00510783|617347668|FG001|Overall Study|Lost to Follow-up|25|||
170819620|NCT00510783|617347667|FG000|Overall Study|Withdrawal by Subject|2|||
170819621|NCT00510783|617347668|FG001|Overall Study|Withdrawal by Subject|3|||
170819622|NCT00510783|617347667|FG000|Overall Study|Protocol Violation|0|||
170819623|NCT00510783|617347668|FG001|Overall Study|Protocol Violation|1|||
170819624|NCT03508830|617347672|FG000|Overall Study|Withdrawal by Subject|3|||
170819625|NCT03508830|617347673|FG001|Overall Study|Withdrawal by Subject|4|||
170819626|NCT03508830|617347672|FG000|Overall Study|Physician Decision|2|||
170819627|NCT03508830|617347673|FG001|Overall Study|Physician Decision|2|||
170819628|NCT00296504|617347675|FG000|Interim Analysis|Withdrawal by Subject|8|||
170819629|NCT00296504|617347676|FG001|Interim Analysis|Withdrawal by Subject|0|||
170819630|NCT00296504|617347677|FG002|Interim Analysis|Withdrawal by Subject|12|||
170819631|NCT00296504|617347678|FG003|Interim Analysis|Withdrawal by Subject|0|||
170819632|NCT00296504|617347679|FG004|Interim Analysis|Withdrawal by Subject|5|||
170819633|NCT00296504|617347680|FG005|Interim Analysis|Withdrawal by Subject|5|||
170819634|NCT00296504|617347681|FG006|Interim Analysis|Withdrawal by Subject|9|||
170819635|NCT00296504|617347682|FG007|Interim Analysis|Withdrawal by Subject|3|||
170819636|NCT00296504|617347683|FG008|Interim Analysis|Withdrawal by Subject|0|||
170819637|NCT00296504|617347675|FG000|Interim Analysis|Lost to Follow-up|13|||
170622539|NCT04879628|616627447|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
170622540|NCT04879628|616627448|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
170622541|NCT04879628|616627445|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
170622542|NCT04879628|616627446|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
170622543|NCT04879628|616627447|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
170622544|NCT04879628|616627448|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
170622545|NCT04879628|616627445|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
170622546|NCT04879628|616627446|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
170622547|NCT04879628|616627447|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
170622548|NCT04879628|616627448|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
170622549|NCT03863509|616627450|FG000|Overall Study|COVID-19 shutdown period|0|||
170622550|NCT03863509|616627451|FG001|Overall Study|COVID-19 shutdown period|4|||
170622551|NCT03863509|616627452|FG002|Overall Study|COVID-19 shutdown period|0|||
170622552|NCT03863509|616627450|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
170622553|NCT03863509|616627451|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
170622554|NCT03863509|616627452|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
170622555|NCT03863509|616627450|FG000|Overall Study|Lost to Follow-up|8|||
170622556|NCT03863509|616627451|FG001|Overall Study|Lost to Follow-up|0|||
170622557|NCT03863509|616627452|FG002|Overall Study|Lost to Follow-up|2|||
170622558|NCT03863509|616627450|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
170622559|NCT03863509|616627451|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
170622560|NCT03863509|616627452|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
170622561|NCT03863509|616627450|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
170669455|NCT00347360|616801159|FG010|Overall Study|Withdrawal by Subject|0|||
170622562|NCT03863509|616627451|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
170622563|NCT03863509|616627452|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
170622564|NCT03069352|616627453|FG000|Overall Study|Ongoing|12|||
170622565|NCT03069352|616627454|FG001|Overall Study|Ongoing|40|||
170622566|NCT02621424|616627455|FG000|Overall Study|Withdrawal by Subject|1|||
170622567|NCT02621424|616627456|FG001|Overall Study|Withdrawal by Subject|2|||
170622568|NCT03861273|616627459|FG000|Screening Phase (3 Weeks)|Other|1|||
170622569|NCT03861273|616627459|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
170622570|NCT03861273|616627459|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
170622571|NCT03861273|616627459|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
170622572|NCT03861273|616627459|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
170622573|NCT01400698|616627460|FG000|Overall Study|Lost to Follow-up|2|||
170622574|NCT01400698|616627461|FG001|Overall Study|Lost to Follow-up|5|||
170622575|NCT01400698|616627462|FG002|Overall Study|Lost to Follow-up|2|||
170622576|NCT01400698|616627463|FG003|Overall Study|Lost to Follow-up|1|||
170622577|NCT01400698|616627464|FG004|Overall Study|Lost to Follow-up|4|||
170669456|NCT00347360|616801160|FG011|Overall Study|Withdrawal by Subject|3|||
170669457|NCT00347360|616801161|FG012|Overall Study|Withdrawal by Subject|4|||
170669458|NCT00347360|616801162|FG013|Overall Study|Withdrawal by Subject|2|||
170669459|NCT00347360|616801163|FG014|Overall Study|Withdrawal by Subject|1|||
170669460|NCT00347360|616801149|FG000|Overall Study|Lack of Efficacy|1|||
170669461|NCT00347360|616801150|FG001|Overall Study|Lack of Efficacy|1|||
170669462|NCT00347360|616801151|FG002|Overall Study|Lack of Efficacy|3|||
170669463|NCT00347360|616801152|FG003|Overall Study|Lack of Efficacy|1|||
170669464|NCT00347360|616801153|FG004|Overall Study|Lack of Efficacy|0|||
170669465|NCT00347360|616801154|FG005|Overall Study|Lack of Efficacy|1|||
170669466|NCT00347360|616801155|FG006|Overall Study|Lack of Efficacy|0|||
170669467|NCT00347360|616801156|FG007|Overall Study|Lack of Efficacy|1|||
170622578|NCT01400698|616627465|FG005|Overall Study|Lost to Follow-up|3|||
170622579|NCT01400698|616627460|FG000|Overall Study|Withdrawal by Subject|8|||
170669468|NCT00347360|616801157|FG008|Overall Study|Lack of Efficacy|1|||
170622580|NCT01400698|616627461|FG001|Overall Study|Withdrawal by Subject|2|||
170622581|NCT01400698|616627462|FG002|Overall Study|Withdrawal by Subject|0|||
170622582|NCT01400698|616627463|FG003|Overall Study|Withdrawal by Subject|4|||
170669469|NCT00347360|616801158|FG009|Overall Study|Lack of Efficacy|0|||
170622583|NCT01400698|616627464|FG004|Overall Study|Withdrawal by Subject|1|||
170622584|NCT01400698|616627465|FG005|Overall Study|Withdrawal by Subject|3|||
170622585|NCT01400698|616627460|FG000|Overall Study|Protocol Violation|0|||
170622586|NCT01400698|616627461|FG001|Overall Study|Protocol Violation|1|||
170622587|NCT01400698|616627462|FG002|Overall Study|Protocol Violation|0|||
170622588|NCT01400698|616627463|FG003|Overall Study|Protocol Violation|0|||
170622589|NCT01400698|616627464|FG004|Overall Study|Protocol Violation|1|||
170622590|NCT01400698|616627465|FG005|Overall Study|Protocol Violation|0|||
170622591|NCT01400698|616627460|FG000|Overall Study|Non-compliance|0|||
170622592|NCT01400698|616627461|FG001|Overall Study|Non-compliance|1|||
170622593|NCT01400698|616627462|FG002|Overall Study|Non-compliance|0|||
170622594|NCT01400698|616627463|FG003|Overall Study|Non-compliance|1|||
170622595|NCT01400698|616627464|FG004|Overall Study|Non-compliance|0|||
170622596|NCT01400698|616627465|FG005|Overall Study|Non-compliance|0|||
170622597|NCT01400698|616627460|FG000|Overall Study|Adverse Event|1|||
170622598|NCT01400698|616627461|FG001|Overall Study|Adverse Event|0|||
170622599|NCT01400698|616627462|FG002|Overall Study|Adverse Event|0|||
170622600|NCT01400698|616627463|FG003|Overall Study|Adverse Event|0|||
170622601|NCT01400698|616627464|FG004|Overall Study|Adverse Event|0|||
170622602|NCT01400698|616627465|FG005|Overall Study|Adverse Event|0|||
170622603|NCT01400698|616627460|FG000|Overall Study|Other|4|||
170622604|NCT01400698|616627461|FG001|Overall Study|Other|2|||
170622605|NCT01400698|616627462|FG002|Overall Study|Other|0|||
170622606|NCT01400698|616627463|FG003|Overall Study|Other|2|||
170622607|NCT01400698|616627464|FG004|Overall Study|Other|1|||
170622608|NCT01400698|616627465|FG005|Overall Study|Other|0|||
170622609|NCT04750642|616627466|FG000|Overall Study|Adverse Event|1|||
170622610|NCT04750642|616627467|FG001|Overall Study|Adverse Event|0|||
170622611|NCT04750642|616627466|FG000|Overall Study|Withdrawal by Subject|0|||
170622612|NCT04750642|616627467|FG001|Overall Study|Withdrawal by Subject|1|||
170669470|NCT00347360|616801159|FG010|Overall Study|Lack of Efficacy|0|||
170669471|NCT00347360|616801160|FG011|Overall Study|Lack of Efficacy|0|||
170669472|NCT00347360|616801161|FG012|Overall Study|Lack of Efficacy|0|||
170669473|NCT00347360|616801162|FG013|Overall Study|Lack of Efficacy|0|||
170669474|NCT00347360|616801163|FG014|Overall Study|Lack of Efficacy|0|||
170669475|NCT00347360|616801149|FG000|Overall Study|Reason not listed/blank|1|||
170669476|NCT00347360|616801150|FG001|Overall Study|Reason not listed/blank|0|||
170669477|NCT00347360|616801151|FG002|Overall Study|Reason not listed/blank|0|||
170669478|NCT00347360|616801152|FG003|Overall Study|Reason not listed/blank|0|||
170669479|NCT00347360|616801153|FG004|Overall Study|Reason not listed/blank|0|||
170669480|NCT00347360|616801154|FG005|Overall Study|Reason not listed/blank|0|||
170669481|NCT00347360|616801155|FG006|Overall Study|Reason not listed/blank|1|||
170622613|NCT04750642|616627466|FG000|Overall Study|Protocol Violation|0|||
170622614|NCT04750642|616627467|FG001|Overall Study|Protocol Violation|1|||
170622615|NCT01650194|616627469|FG000|Overall Study|Progressive Disease (PD)|35|||
170622616|NCT01650194|616627469|FG000|Overall Study|Withdrawal by Subject|2|||
170622617|NCT01650194|616627469|FG000|Overall Study|Miscellaneous|10|||
170622618|NCT01690052|616629755|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
170622619|NCT01690052|616629756|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
170622620|NCT01342913|616629757|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
170622621|NCT01342913|616629758|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
170622622|NCT01342913|616629759|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
170622623|NCT01342913|616629757|FG000|2-week Run-in Period|Physician Decision|6|||
170669482|NCT00347360|616801156|FG007|Overall Study|Reason not listed/blank|0|||
170669483|NCT00347360|616801157|FG008|Overall Study|Reason not listed/blank|0|||
170622624|NCT01342913|616629758|FG001|2-week Run-in Period|Physician Decision|0|||
170622625|NCT01342913|616629759|FG002|2-week Run-in Period|Physician Decision|0|||
170622626|NCT01342913|616629757|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
170622627|NCT01342913|616629758|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
170622628|NCT01342913|616629759|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
170669484|NCT00347360|616801158|FG009|Overall Study|Reason not listed/blank|0|||
170622629|NCT01342913|616629757|FG000|2-week Run-in Period|Adverse Event|2|||
170622630|NCT01342913|616629758|FG001|2-week Run-in Period|Adverse Event|0|||
170622631|NCT01342913|616629759|FG002|2-week Run-in Period|Adverse Event|0|||
170622632|NCT01342913|616629757|FG000|2-week Run-in Period|Protocol Violation|5|||
170622633|NCT01342913|616629758|FG001|2-week Run-in Period|Protocol Violation|0|||
170622634|NCT01342913|616629759|FG002|2-week Run-in Period|Protocol Violation|0|||
170622635|NCT01342913|616629757|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
170622636|NCT01342913|616629758|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
170622637|NCT01342913|616629759|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
170622638|NCT01342913|616629757|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170622639|NCT01342913|616629758|FG001|Double-Blind Treatment Period|Adverse Event|3|||
170622640|NCT01342913|616629759|FG002|Double-Blind Treatment Period|Adverse Event|6|||
170622641|NCT01342913|616629757|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
170622642|NCT01342913|616629758|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
170622643|NCT01342913|616629759|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
170622644|NCT01342913|616629757|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
170622645|NCT01342913|616629758|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
170622646|NCT01342913|616629759|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
170622647|NCT01342913|616629757|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170622648|NCT01342913|616629758|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
170622649|NCT01342913|616629759|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
170622650|NCT01342913|616629757|FG000|Double-Blind Treatment Period|Physician Decision|0|||
170622651|NCT01342913|616629758|FG001|Double-Blind Treatment Period|Physician Decision|2|||
170622652|NCT01342913|616629759|FG002|Double-Blind Treatment Period|Physician Decision|0|||
170622653|NCT01342913|616629757|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170622654|NCT01342913|616629758|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
170622655|NCT01342913|616629759|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
170622656|NCT02869633|616629764|FG000|Overall Study|Death|2|||
170622657|NCT02869633|616629765|FG001|Overall Study|Death|1|||
170622658|NCT02869633|616629764|FG000|Overall Study|Patient refused follow-up|1|||
170622659|NCT02869633|616629765|FG001|Overall Study|Patient refused follow-up|0|||
170622660|NCT02869633|616629764|FG000|Overall Study|Provider discretion|1|||
170622661|NCT02869633|616629765|FG001|Overall Study|Provider discretion|0|||
170622662|NCT02869633|616629764|FG000|Overall Study|Investigator decision|1|||
170622663|NCT02869633|616629765|FG001|Overall Study|Investigator decision|0|||
170622664|NCT02869633|616629764|FG000|Overall Study|Lost to Follow-up|0|||
170622665|NCT02869633|616629765|FG001|Overall Study|Lost to Follow-up|1|||
170622666|NCT02869633|616629764|FG000|Overall Study|Not eligible|6|||
170622667|NCT02869633|616629765|FG001|Overall Study|Not eligible|1|||
170622668|NCT02869633|616629764|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
170622669|NCT02869633|616629765|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
170622670|NCT02869633|616629764|FG000|Overall Study|Withdrawal by Subject|0|||
170622671|NCT02869633|616629765|FG001|Overall Study|Withdrawal by Subject|1|||
170622672|NCT04024891|616629766|FG000|Overall Study|Pregnancy|0|||
170622673|NCT04024891|616629767|FG001|Overall Study|Pregnancy|1|||
170622674|NCT03095651|616629771|FG000|Overall Study|Lost to Follow-up|1|||
170622675|NCT03095651|616629772|FG001|Overall Study|Lost to Follow-up|1|||
170622676|NCT03095651|616629773|FG002|Overall Study|Lost to Follow-up|0|||
170622677|NCT03095651|616629774|FG003|Overall Study|Lost to Follow-up|1|||
170622678|NCT03095651|616629775|FG004|Overall Study|Lost to Follow-up|0|||
170622679|NCT03095651|616629776|FG005|Overall Study|Lost to Follow-up|0|||
170622680|NCT03095651|616629777|FG006|Overall Study|Lost to Follow-up|0|||
170622681|NCT03095651|616629778|FG007|Overall Study|Lost to Follow-up|0|||
170622682|NCT03095651|616629771|FG000|Overall Study|Withdrawal by Subject|0|||
170622683|NCT03095651|616629772|FG001|Overall Study|Withdrawal by Subject|0|||
170622684|NCT03095651|616629773|FG002|Overall Study|Withdrawal by Subject|0|||
170622685|NCT03095651|616629774|FG003|Overall Study|Withdrawal by Subject|0|||
170622686|NCT03095651|616629775|FG004|Overall Study|Withdrawal by Subject|0|||
170622687|NCT03095651|616629776|FG005|Overall Study|Withdrawal by Subject|1|||
170622688|NCT03095651|616629777|FG006|Overall Study|Withdrawal by Subject|0|||
170622689|NCT03095651|616629778|FG007|Overall Study|Withdrawal by Subject|0|||
170622690|NCT00308139|616629780|FG000|Overall Study|Adverse Event|20|||
170622691|NCT00308139|616629781|FG001|Overall Study|Adverse Event|14|||
170622692|NCT00308139|616629780|FG000|Overall Study|Lost to Follow-up|13|||
170622693|NCT00308139|616629781|FG001|Overall Study|Lost to Follow-up|8|||
170622694|NCT00308139|616629780|FG000|Overall Study|Protocol Violation|3|||
170622695|NCT00308139|616629781|FG001|Overall Study|Protocol Violation|2|||
170622696|NCT00308139|616629780|FG000|Overall Study|Withdrawal of Consent|40|||
170622697|NCT00308139|616629781|FG001|Overall Study|Withdrawal of Consent|42|||
170622698|NCT00308139|616629780|FG000|Overall Study|Investigator Decision|11|||
170622699|NCT00308139|616629781|FG001|Overall Study|Investigator Decision|10|||
170622700|NCT00308139|616629780|FG000|Overall Study|Loss of Glucose Control|5|||
170622701|NCT00308139|616629781|FG001|Overall Study|Loss of Glucose Control|7|||
170622702|NCT00308139|616629780|FG000|Overall Study|Administrative|1|||
170622703|NCT00308139|616629781|FG001|Overall Study|Administrative|4|||
170622704|NCT00308139|616629780|FG000|Overall Study|Other|1|||
170622705|NCT00308139|616629781|FG001|Overall Study|Other|0|||
170622706|NCT01194830|616629784|FG000|Overall Study|Adverse Event|3|||
170622707|NCT01194830|616629785|FG001|Overall Study|Adverse Event|2|||
170622708|NCT01194830|616629784|FG000|Overall Study|Protocol Violation|5|||
170622709|NCT01194830|616629785|FG001|Overall Study|Protocol Violation|4|||
170622710|NCT01194830|616629784|FG000|Overall Study|Lost to Follow-up|9|||
170622711|NCT01194830|616629785|FG001|Overall Study|Lost to Follow-up|7|||
170622712|NCT01194830|616629784|FG000|Overall Study|Withdrawal by Subject|2|||
170622713|NCT01194830|616629785|FG001|Overall Study|Withdrawal by Subject|1|||
170622714|NCT01194830|616629784|FG000|Overall Study|Lack of Efficacy|1|||
170622715|NCT01194830|616629785|FG001|Overall Study|Lack of Efficacy|1|||
170622716|NCT01194830|616629784|FG000|Overall Study|Non-compliance issues|4|||
170622717|NCT01194830|616629785|FG001|Overall Study|Non-compliance issues|4|||
170622718|NCT01194830|616629784|FG000|Overall Study|Other Reason|12|||
170622719|NCT01194830|616629785|FG001|Overall Study|Other Reason|8|||
170622720|NCT02412306|616629786|FG000|Overall Study|Lost to Follow-up|0|||
170622721|NCT02412306|616629787|FG001|Overall Study|Lost to Follow-up|1|||
170622722|NCT02412306|616629788|FG002|Overall Study|Lost to Follow-up|0|||
170622723|NCT02412306|616629789|FG003|Overall Study|Lost to Follow-up|0|||
170622724|NCT02412306|616629790|FG004|Overall Study|Lost to Follow-up|0|||
170622725|NCT02412306|616629786|FG000|Overall Study|Withdrawal by Subject|0|||
170622726|NCT02412306|616629787|FG001|Overall Study|Withdrawal by Subject|0|||
170622727|NCT02412306|616629788|FG002|Overall Study|Withdrawal by Subject|1|||
170622728|NCT02412306|616629789|FG003|Overall Study|Withdrawal by Subject|0|||
170622729|NCT02412306|616629790|FG004|Overall Study|Withdrawal by Subject|0|||
170622730|NCT02412306|616629786|FG000|Overall Study|Death|5|||
170622731|NCT02412306|616629787|FG001|Overall Study|Death|7|||
170622732|NCT02412306|616629788|FG002|Overall Study|Death|15|||
170622733|NCT02412306|616629789|FG003|Overall Study|Death|0|||
170622734|NCT02412306|616629790|FG004|Overall Study|Death|2|||
170622735|NCT00435409|616629791|FG000|Overall Study|Protocol Violation|1|||
170622736|NCT00435409|616629792|FG001|Overall Study|Protocol Violation|2|||
170622737|NCT00435409|616629793|FG002|Overall Study|Protocol Violation|0|||
170622738|NCT00435409|616629791|FG000|Overall Study|Lost to Follow-up|1|||
170622739|NCT00435409|616629792|FG001|Overall Study|Lost to Follow-up|2|||
170622740|NCT00435409|616629793|FG002|Overall Study|Lost to Follow-up|0|||
170622741|NCT00435409|616629791|FG000|Overall Study|Death|8|||
170622742|NCT00435409|616629792|FG001|Overall Study|Death|6|||
170622743|NCT00435409|616629793|FG002|Overall Study|Death|6|||
170622744|NCT00435409|616629791|FG000|Overall Study|Objective progression or relapse|158|||
170622745|NCT00435409|616629792|FG001|Overall Study|Objective progression or relapse|93|||
170819638|NCT00296504|617347676|FG001|Interim Analysis|Lost to Follow-up|3|||
170819639|NCT00296504|617347677|FG002|Interim Analysis|Lost to Follow-up|26|||
170819640|NCT00296504|617347678|FG003|Interim Analysis|Lost to Follow-up|8|||
170819641|NCT00296504|617347679|FG004|Interim Analysis|Lost to Follow-up|14|||
170819642|NCT00296504|617347680|FG005|Interim Analysis|Lost to Follow-up|4|||
170819643|NCT00296504|617347681|FG006|Interim Analysis|Lost to Follow-up|11|||
170819644|NCT00296504|617347682|FG007|Interim Analysis|Lost to Follow-up|4|||
170819645|NCT00296504|617347683|FG008|Interim Analysis|Lost to Follow-up|0|||
170819646|NCT00296504|617347675|FG000|Interim Analysis|Clinical Progression|1|||
170819647|NCT00296504|617347676|FG001|Interim Analysis|Clinical Progression|0|||
170819648|NCT00296504|617347677|FG002|Interim Analysis|Clinical Progression|1|||
170819649|NCT00296504|617347678|FG003|Interim Analysis|Clinical Progression|1|||
170819650|NCT00296504|617347679|FG004|Interim Analysis|Clinical Progression|0|||
170819651|NCT00296504|617347680|FG005|Interim Analysis|Clinical Progression|2|||
170819652|NCT00296504|617347681|FG006|Interim Analysis|Clinical Progression|1|||
170819653|NCT00296504|617347682|FG007|Interim Analysis|Clinical Progression|2|||
170819654|NCT00296504|617347683|FG008|Interim Analysis|Clinical Progression|0|||
170819655|NCT00296504|617347675|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
170819656|NCT00296504|617347676|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
170819657|NCT00296504|617347677|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
170819658|NCT00296504|617347678|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
170622746|NCT00435409|616629793|FG002|Overall Study|Objective progression or relapse|58|||
170622747|NCT00435409|616629791|FG000|Overall Study|Global deterioration of health status|0|||
170622748|NCT00435409|616629792|FG001|Overall Study|Global deterioration of health status|0|||
170622749|NCT00435409|616629793|FG002|Overall Study|Global deterioration of health status|4|||
170622750|NCT00435409|616629791|FG000|Overall Study|Withdrawal by Subject|8|||
170622751|NCT00435409|616629792|FG001|Overall Study|Withdrawal by Subject|7|||
170669485|NCT00347360|616801159|FG010|Overall Study|Reason not listed/blank|0|||
170819659|NCT00296504|617347679|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
170622752|NCT00435409|616629793|FG002|Overall Study|Withdrawal by Subject|1|||
170622753|NCT00435409|616629791|FG000|Overall Study|Other|45|||
170622754|NCT00435409|616629792|FG001|Overall Study|Other|30|||
170622755|NCT00435409|616629793|FG002|Overall Study|Other|1|||
170622756|NCT00435409|616629791|FG000|Overall Study|Adverse Event|0|||
170622757|NCT00435409|616629792|FG001|Overall Study|Adverse Event|0|||
170622758|NCT00435409|616629793|FG002|Overall Study|Adverse Event|8|||
170622759|NCT00435409|616629791|FG000|Overall Study|Sponsor decision|0|||
170622760|NCT00435409|616629792|FG001|Overall Study|Sponsor decision|3|||
170622761|NCT00435409|616629793|FG002|Overall Study|Sponsor decision|0|||
170622762|NCT05196828|616629796|FG000|Overall Study|Withdrawal by Subject|2|||
170622763|NCT05196828|616629797|FG001|Overall Study|Withdrawal by Subject|0|||
170622764|NCT05196828|616629796|FG000|Overall Study|Lost to Follow-up|0|||
170622765|NCT05196828|616629797|FG001|Overall Study|Lost to Follow-up|4|||
170622766|NCT05196828|616629796|FG000|Overall Study|Adverse Event|1|||
170622767|NCT05196828|616629797|FG001|Overall Study|Adverse Event|0|||
170622768|NCT02763644|616629798|FG000|Overall Study|Patient/guardian decision|1|||
170622769|NCT02763644|616629799|FG001|Overall Study|Patient/guardian decision|0|||
170622770|NCT02763644|616629798|FG000|Overall Study|Death|1|||
170622771|NCT02763644|616629799|FG001|Overall Study|Death|1|||
170622772|NCT02763644|616629798|FG000|Overall Study|Adverse Event|1|||
170622773|NCT02763644|616629799|FG001|Overall Study|Adverse Event|1|||
170622774|NCT01706458|616629800|FG000|Overall Study|Physician Decision|3|||
170622775|NCT01706458|616629801|FG001|Overall Study|Physician Decision|4|||
170622776|NCT02766023|616629802|FG000|Overall Study|Lost to Follow-up|23|||
170622777|NCT02766023|616629803|FG001|Overall Study|Lost to Follow-up|11|||
170622778|NCT02766023|616629802|FG000|Overall Study|Pregnancy|1|||
170622779|NCT02766023|616629803|FG001|Overall Study|Pregnancy|0|||
170622780|NCT02766023|616629802|FG000|Overall Study|Adverse Event|1|||
170622781|NCT02766023|616629803|FG001|Overall Study|Adverse Event|0|||
170622782|NCT02766023|616629802|FG000|Overall Study|Withdrawal by Subject|4|||
170622783|NCT02766023|616629803|FG001|Overall Study|Withdrawal by Subject|5|||
170622784|NCT02766023|616629802|FG000|Overall Study|Physician Decision|1|||
170622785|NCT02766023|616629803|FG001|Overall Study|Physician Decision|0|||
170622786|NCT02766023|616629802|FG000|Overall Study|Not Eligible at Enrollment|0|||
170622787|NCT02766023|616629803|FG001|Overall Study|Not Eligible at Enrollment|1|||
170622788|NCT00286468|616629804|FG000|Overall Study|Hyperglycemic Rescue|28|||
170622789|NCT00286468|616629805|FG001|Overall Study|Hyperglycemic Rescue|30|||
170622790|NCT00286468|616629806|FG002|Overall Study|Hyperglycemic Rescue|31|||
170622791|NCT00286468|616629804|FG000|Overall Study|Adverse Event|2|||
170622792|NCT00286468|616629805|FG001|Overall Study|Adverse Event|6|||
170622793|NCT00286468|616629806|FG002|Overall Study|Adverse Event|4|||
170622794|NCT00286468|616629804|FG000|Overall Study|Protocol Violation|0|||
170622795|NCT00286468|616629805|FG001|Overall Study|Protocol Violation|3|||
170622796|NCT00286468|616629806|FG002|Overall Study|Protocol Violation|1|||
170622797|NCT00286468|616629804|FG000|Overall Study|Lost to Follow-up|1|||
170622798|NCT00286468|616629805|FG001|Overall Study|Lost to Follow-up|1|||
170622799|NCT00286468|616629806|FG002|Overall Study|Lost to Follow-up|2|||
170622800|NCT00286468|616629804|FG000|Overall Study|Withdrawal by Subject|3|||
170622801|NCT00286468|616629805|FG001|Overall Study|Withdrawal by Subject|8|||
170622802|NCT00286468|616629806|FG002|Overall Study|Withdrawal by Subject|11|||
170622803|NCT00286468|616629804|FG000|Overall Study|Physician Decision|3|||
170622804|NCT00286468|616629805|FG001|Overall Study|Physician Decision|2|||
170622805|NCT00286468|616629806|FG002|Overall Study|Physician Decision|1|||
170622806|NCT04349891|616629809|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
170622807|NCT04349891|616629810|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
170622808|NCT04349891|616629809|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
170622809|NCT04349891|616629810|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
170622810|NCT04349891|616629809|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
170622811|NCT04349891|616629810|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
170622812|NCT04349891|616629809|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
170622813|NCT04349891|616629810|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
170622814|NCT00836589|616629823|FG000|Overall Study|Lost to Follow-up|246|||
170622815|NCT00836589|616629823|FG000|Overall Study|Death|429|||
170622816|NCT00836589|616629823|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
170622817|NCT01045460|616629825|FG000|Overall Study|Physician Decision|3|||
170622818|NCT01045460|616629826|FG001|Overall Study|Physician Decision|2|||
170622819|NCT01045460|616629825|FG000|Overall Study|Lost to Follow-up|0|||
170622820|NCT01045460|616629826|FG001|Overall Study|Lost to Follow-up|1|||
170622821|NCT01045460|616629825|FG000|Overall Study|Lack of Efficacy|3|||
170622822|NCT01045460|616629826|FG001|Overall Study|Lack of Efficacy|0|||
170622823|NCT00189540|616629838|FG000|Overall Study|Withdrawal by Subject|3|||
170622824|NCT00189540|616629839|FG001|Overall Study|Withdrawal by Subject|0|||
170622825|NCT00189540|616629838|FG000|Overall Study|Death|4|||
170622826|NCT00189540|616629839|FG001|Overall Study|Death|1|||
170622827|NCT00472108|616629840|FG000|Overall Study|Lost to Follow-up|0|||
170622828|NCT00472108|616629841|FG001|Overall Study|Lost to Follow-up|1|||
170622829|NCT04529083|616629842|FG000|Overall Study|Withdrawal by Subject|3|||
170622830|NCT04196686|616629843|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
170622831|NCT04196686|616629844|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
170622832|NCT02546609|616629845|FG000|Overall Study|Withdrawal by Subject|0|||
170622833|NCT02546609|616629846|FG001|Overall Study|Withdrawal by Subject|1|||
170622834|NCT02546609|616629847|FG002|Overall Study|Withdrawal by Subject|2|||
170622835|NCT02546609|616629845|FG000|Overall Study|Adverse Event|0|||
170622836|NCT02546609|616629846|FG001|Overall Study|Adverse Event|6|||
170622837|NCT02546609|616629847|FG002|Overall Study|Adverse Event|1|||
170622838|NCT02546609|616629845|FG000|Overall Study|Protocol Violation|0|||
170622839|NCT02546609|616629846|FG001|Overall Study|Protocol Violation|1|||
170622840|NCT02546609|616629847|FG002|Overall Study|Protocol Violation|1|||
170622841|NCT02546609|616629845|FG000|Overall Study|Lost to Follow-up|2|||
170622842|NCT02546609|616629846|FG001|Overall Study|Lost to Follow-up|3|||
170622843|NCT02546609|616629847|FG002|Overall Study|Lost to Follow-up|1|||
170622844|NCT02546609|616629845|FG000|Overall Study|travel or work schedule restriction|0|||
170622845|NCT02546609|616629846|FG001|Overall Study|travel or work schedule restriction|0|||
170622846|NCT02546609|616629847|FG002|Overall Study|travel or work schedule restriction|2|||
170622847|NCT01292486|616629852|FG000|Overall Study|Protocol Violation|2|||
170622848|NCT01292486|616629852|FG000|Overall Study|Did not meet screening criteria|2|||
170622849|NCT01292486|616629852|FG000|Overall Study|Adverse Event|1|||
170622850|NCT01292486|616629852|FG000|Overall Study|Physician Decision|1|||
170622851|NCT00087152|616629853|FG000|Overall Study|Ineligible|6|||
170622852|NCT01277744|616629857|FG000|Overall Study|Physician Decision|2|||
170622853|NCT01791244|616629859|FG000|Overall Study|Adverse Event|5|||
170622854|NCT01791244|616629860|FG001|Overall Study|Adverse Event|7|||
170622855|NCT01791244|616629859|FG000|Overall Study|Insufficient clinical response|10|||
170622856|NCT01791244|616629860|FG001|Overall Study|Insufficient clinical response|10|||
170622857|NCT01791244|616629859|FG000|Overall Study|Laboratory Abnormality|0|||
170622858|NCT01791244|616629860|FG001|Overall Study|Laboratory Abnormality|1|||
170622859|NCT02358473|616629861|FG000|Overall Study|Disease Progession|6|||
170622860|NCT02358473|616629861|FG000|Overall Study|Adverse Event|3|||
170622861|NCT02358473|616629861|FG000|Overall Study|Withdrawal by Subject|2|||
170622862|NCT02358473|616629861|FG000|Overall Study|Physician Decision|2|||
170622863|NCT04079296|616629866|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
170622864|NCT04079296|616629867|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
170622865|NCT04079296|616629868|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
170622866|NCT04079296|616629869|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
170622867|NCT04079296|616629870|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
170622868|NCT04079296|616629866|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
170622869|NCT04079296|616629867|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
170622870|NCT04079296|616629868|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
170622871|NCT04079296|616629869|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
170622872|NCT04079296|616629870|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
170622873|NCT04079296|616629866|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
170622874|NCT04079296|616629867|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
170622875|NCT04079296|616629868|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
170622876|NCT04079296|616629869|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
170622877|NCT04079296|616629870|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
170622878|NCT04079296|616629866|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
170622879|NCT04079296|616629867|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
170622880|NCT04079296|616629868|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
170622881|NCT04079296|616629869|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
170622882|NCT04079296|616629870|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
170622883|NCT04079296|616629866|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
170622884|NCT04079296|616629867|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
170622885|NCT04079296|616629868|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
170622886|NCT04079296|616629869|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
170622887|NCT04079296|616629870|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
170622888|NCT04079296|616629866|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
170622889|NCT04079296|616629867|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
170622890|NCT04079296|616629868|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
170622891|NCT04079296|616629869|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
170622892|NCT04079296|616629870|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
170622893|NCT04079296|616629866|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
170622894|NCT04079296|616629867|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
170622895|NCT04079296|616629868|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
170622896|NCT04079296|616629869|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
170622897|NCT04079296|616629870|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
170622898|NCT04079296|616629866|FG000|Dose Expansion Phase (168 Days)|Death|0|||
170622899|NCT04079296|616629867|FG001|Dose Expansion Phase (168 Days)|Death|0|||
170622900|NCT04079296|616629868|FG002|Dose Expansion Phase (168 Days)|Death|0|||
170622901|NCT04079296|616629869|FG003|Dose Expansion Phase (168 Days)|Death|1|||
170622902|NCT04079296|616629870|FG004|Dose Expansion Phase (168 Days)|Death|0|||
170622903|NCT00467740|616629883|FG000|Overall Study|Adverse Event|0|||
170622904|NCT00467740|616629884|FG001|Overall Study|Adverse Event|0|||
170622905|NCT00467740|616629885|FG002|Overall Study|Adverse Event|1|||
170622906|NCT00467740|616629886|FG003|Overall Study|Adverse Event|0|||
170622907|NCT00467740|616629887|FG004|Overall Study|Adverse Event|0|||
170622908|NCT00467740|616629883|FG000|Overall Study|Protocol Violation|0|||
170622909|NCT00467740|616629884|FG001|Overall Study|Protocol Violation|0|||
170622910|NCT00467740|616629885|FG002|Overall Study|Protocol Violation|1|||
170622911|NCT00467740|616629886|FG003|Overall Study|Protocol Violation|0|||
170622912|NCT00467740|616629887|FG004|Overall Study|Protocol Violation|0|||
170622913|NCT00467740|616629883|FG000|Overall Study|Lost to Follow-up|0|||
170622914|NCT00467740|616629884|FG001|Overall Study|Lost to Follow-up|1|||
170622915|NCT00467740|616629885|FG002|Overall Study|Lost to Follow-up|0|||
170622916|NCT00467740|616629886|FG003|Overall Study|Lost to Follow-up|0|||
170622917|NCT00467740|616629887|FG004|Overall Study|Lost to Follow-up|0|||
170622918|NCT00467740|616629883|FG000|Overall Study|Withdrawal by Subject|1|||
170622919|NCT00467740|616629884|FG001|Overall Study|Withdrawal by Subject|1|||
170622920|NCT00467740|616629885|FG002|Overall Study|Withdrawal by Subject|0|||
170622921|NCT00467740|616629886|FG003|Overall Study|Withdrawal by Subject|1|||
170622922|NCT00467740|616629887|FG004|Overall Study|Withdrawal by Subject|0|||
170622923|NCT00467740|616629883|FG000|Overall Study|Lack of Efficacy|0|||
170622924|NCT00467740|616629884|FG001|Overall Study|Lack of Efficacy|1|||
170622925|NCT00467740|616629885|FG002|Overall Study|Lack of Efficacy|0|||
170622926|NCT00467740|616629886|FG003|Overall Study|Lack of Efficacy|0|||
170622927|NCT00467740|616629887|FG004|Overall Study|Lack of Efficacy|0|||
170622928|NCT02903160|616629888|FG000|Overall Study|Adverse Event|2|||
170622929|NCT02903160|616629888|FG000|Overall Study|Death|1|||
170622930|NCT02903160|616629888|FG000|Overall Study|Lost to Follow-up|2|||
170622931|NCT02903160|616629888|FG000|Overall Study|Withdrawal by Subject|1|||
170622932|NCT02903160|616629888|FG000|Overall Study|Medical Insurance Barriers|1|||
170622933|NCT01664910|616629891|FG000|Overall Study|Adverse Event|0|||
170622934|NCT01664910|616629892|FG001|Overall Study|Adverse Event|0|||
170622935|NCT01664910|616629893|FG002|Overall Study|Adverse Event|1|||
170622936|NCT02525471|616629894|FG000|Overall Study|Screen Failure|6|||
170622937|NCT02525471|616629894|FG000|Overall Study|Withdrawal by Subject|4|||
170622938|NCT02525471|616629894|FG000|Overall Study|Death|1|||
170622939|NCT02240485|616629895|FG000|3 Months Post-admission|Lost to Follow-up|1|||
170622940|NCT02240485|616629896|FG001|3 Months Post-admission|Lost to Follow-up|5|||
170622941|NCT02240485|616629895|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
170622942|NCT02240485|616629896|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
170622943|NCT02240485|616629895|FG000|9 Months Post-admission|Lost to Follow-up|3|||
170622944|NCT02240485|616629896|FG001|9 Months Post-admission|Lost to Follow-up|1|||
170622945|NCT02240485|616629895|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
170622946|NCT02240485|616629896|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
170622947|NCT02240485|616629895|FG000|18 Months Post-admission|Lost to Follow-up|1|||
170622948|NCT02240485|616629896|FG001|18 Months Post-admission|Lost to Follow-up|1|||
170622949|NCT02240485|616629895|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
170622950|NCT02240485|616629896|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
170622951|NCT04949191|616629897|FG000|Overall Study|Non-compliance with Study Drug|1|||
170622952|NCT04949191|616629898|FG001|Overall Study|Non-compliance with Study Drug|0|||
170622953|NCT04949191|616629899|FG002|Overall Study|Non-compliance with Study Drug|0|||
170622954|NCT04949191|616629900|FG003|Overall Study|Non-compliance with Study Drug|0|||
170622955|NCT04949191|616629897|FG000|Overall Study|Progressive Disease|0|||
170622956|NCT04949191|616629898|FG001|Overall Study|Progressive Disease|1|||
170622957|NCT04949191|616629899|FG002|Overall Study|Progressive Disease|0|||
170669486|NCT00347360|616801160|FG011|Overall Study|Reason not listed/blank|0|||
170669487|NCT00347360|616801161|FG012|Overall Study|Reason not listed/blank|0|||
170669488|NCT00347360|616801162|FG013|Overall Study|Reason not listed/blank|1|||
170669489|NCT00347360|616801163|FG014|Overall Study|Reason not listed/blank|0|||
170669490|NCT00347360|616801149|FG000|Overall Study|Per sponsors instruction|0|||
170669491|NCT00347360|616801150|FG001|Overall Study|Per sponsors instruction|1|||
170669492|NCT00347360|616801151|FG002|Overall Study|Per sponsors instruction|0|||
170669493|NCT00347360|616801152|FG003|Overall Study|Per sponsors instruction|0|||
170669494|NCT00347360|616801153|FG004|Overall Study|Per sponsors instruction|0|||
170669495|NCT00347360|616801154|FG005|Overall Study|Per sponsors instruction|0|||
170622958|NCT04949191|616629900|FG003|Overall Study|Progressive Disease|0|||
170622959|NCT04949191|616629897|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
170622960|NCT04949191|616629898|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
170622961|NCT04949191|616629899|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
170622962|NCT04949191|616629900|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
170622963|NCT04949191|616629897|FG000|Overall Study|Sponsor Terminated Study|0|||
170622964|NCT04949191|616629898|FG001|Overall Study|Sponsor Terminated Study|0|||
170622965|NCT04949191|616629899|FG002|Overall Study|Sponsor Terminated Study|1|||
170622966|NCT04949191|616629900|FG003|Overall Study|Sponsor Terminated Study|1|||
170622967|NCT00730158|616629901|FG000|Overall Study|Withdrawal by Subject|1|||
170622968|NCT00730158|616629902|FG001|Overall Study|Withdrawal by Subject|1|||
170622969|NCT03546621|616629904|FG000|Overall Study|Withdrawal by Subject|0|||
170622970|NCT03546621|616629905|FG001|Overall Study|Withdrawal by Subject|1|||
170622971|NCT03546621|616629906|FG002|Overall Study|Withdrawal by Subject|2|||
170622972|NCT03546621|616629907|FG003|Overall Study|Withdrawal by Subject|1|||
170622973|NCT03546621|616629904|FG000|Overall Study|Lost to Follow-up|0|||
170622974|NCT03546621|616629905|FG001|Overall Study|Lost to Follow-up|1|||
170622975|NCT03546621|616629906|FG002|Overall Study|Lost to Follow-up|0|||
170622976|NCT03546621|616629907|FG003|Overall Study|Lost to Follow-up|0|||
170622977|NCT03546621|616629904|FG000|Overall Study|Adverse Event|0|||
170622978|NCT03546621|616629905|FG001|Overall Study|Adverse Event|1|||
170622979|NCT03546621|616629906|FG002|Overall Study|Adverse Event|0|||
170622980|NCT03546621|616629907|FG003|Overall Study|Adverse Event|1|||
170622981|NCT03546621|616629904|FG000|Overall Study|Progressive disease|0|||
170669496|NCT00347360|616801155|FG006|Overall Study|Per sponsors instruction|0|||
170622982|NCT03546621|616629905|FG001|Overall Study|Progressive disease|0|||
170622983|NCT03546621|616629906|FG002|Overall Study|Progressive disease|0|||
170622984|NCT03546621|616629907|FG003|Overall Study|Progressive disease|1|||
170622985|NCT05083351|616629911|FG000|Overall Study|Adverse Event|3|||
170622986|NCT05083351|616629911|FG000|Overall Study|Did not meet data inclusion criteria|8|||
170622987|NCT05083351|616629911|FG000|Overall Study|Did not meet eligibility criteria|19|||
170622988|NCT05083351|616629911|FG000|Overall Study|Study Staff Decision|19|||
170622989|NCT00539981|616629912|FG000|Overall Study|Adverse events (AE)|3|||
170622990|NCT00539981|616629913|FG001|Overall Study|Adverse events (AE)|3|||
170622991|NCT00539981|616629912|FG000|Overall Study|Lost to Follow-up|260|||
170622992|NCT00539981|616629913|FG001|Overall Study|Lost to Follow-up|251|||
170622993|NCT00539981|616629912|FG000|Overall Study|Withdrew consent|22|||
170622994|NCT00539981|616629913|FG001|Overall Study|Withdrew consent|14|||
170622995|NCT00539981|616629912|FG000|Overall Study|Death|1|||
170622996|NCT00539981|616629913|FG001|Overall Study|Death|1|||
170622997|NCT00539981|616629912|FG000|Overall Study|Other reason-unspecified|9|||
170622998|NCT00539981|616629913|FG001|Overall Study|Other reason-unspecified|13|||
170622999|NCT00591006|616629919|FG000|Overall Study|Withdrawal by Subject|0|||
170623000|NCT00591006|616629920|FG001|Overall Study|Withdrawal by Subject|0|||
170623001|NCT00591006|616629921|FG002|Overall Study|Withdrawal by Subject|0|||
170623002|NCT00591006|616629922|FG003|Overall Study|Withdrawal by Subject|0|||
170623003|NCT00591006|616629923|FG004|Overall Study|Withdrawal by Subject|0|||
170623004|NCT00591006|616629924|FG005|Overall Study|Withdrawal by Subject|0|||
170623005|NCT00591006|616629925|FG006|Overall Study|Withdrawal by Subject|0|||
170623006|NCT00591006|616629926|FG007|Overall Study|Withdrawal by Subject|0|||
170623007|NCT00591006|616629927|FG008|Overall Study|Withdrawal by Subject|0|||
170623008|NCT00591006|616629928|FG009|Overall Study|Withdrawal by Subject|0|||
170623009|NCT00591006|616629929|FG010|Overall Study|Withdrawal by Subject|0|||
170623010|NCT00591006|616629930|FG011|Overall Study|Withdrawal by Subject|0|||
170623011|NCT00591006|616629931|FG012|Overall Study|Withdrawal by Subject|0|||
170623012|NCT00591006|616629932|FG013|Overall Study|Withdrawal by Subject|0|||
170623013|NCT00591006|616629933|FG014|Overall Study|Withdrawal by Subject|0|||
170623014|NCT00591006|616629934|FG015|Overall Study|Withdrawal by Subject|1|||
170623015|NCT00591006|616629935|FG016|Overall Study|Withdrawal by Subject|0|||
170623016|NCT00591006|616629936|FG017|Overall Study|Withdrawal by Subject|0|||
170623017|NCT00591006|616629937|FG018|Overall Study|Withdrawal by Subject|0|||
170623018|NCT00591006|616629938|FG019|Overall Study|Withdrawal by Subject|0|||
170623019|NCT00591006|616629939|FG020|Overall Study|Withdrawal by Subject|0|||
170623020|NCT00591006|616629940|FG021|Overall Study|Withdrawal by Subject|0|||
170623021|NCT00591006|616629941|FG022|Overall Study|Withdrawal by Subject|0|||
170623022|NCT00591006|616629942|FG023|Overall Study|Withdrawal by Subject|1|||
170623023|NCT00591006|616629919|FG000|Overall Study|Adverse Event|0|||
170623024|NCT00591006|616629920|FG001|Overall Study|Adverse Event|0|||
170623025|NCT00591006|616629921|FG002|Overall Study|Adverse Event|0|||
170623026|NCT00591006|616629922|FG003|Overall Study|Adverse Event|0|||
170623027|NCT00591006|616629923|FG004|Overall Study|Adverse Event|0|||
170623028|NCT00591006|616629924|FG005|Overall Study|Adverse Event|0|||
170623029|NCT00591006|616629925|FG006|Overall Study|Adverse Event|0|||
170623030|NCT00591006|616629926|FG007|Overall Study|Adverse Event|0|||
170623031|NCT00591006|616629927|FG008|Overall Study|Adverse Event|0|||
170623032|NCT00591006|616629928|FG009|Overall Study|Adverse Event|0|||
170623033|NCT00591006|616629929|FG010|Overall Study|Adverse Event|0|||
170623034|NCT00591006|616629930|FG011|Overall Study|Adverse Event|0|||
170623035|NCT00591006|616629931|FG012|Overall Study|Adverse Event|0|||
170623036|NCT00591006|616629932|FG013|Overall Study|Adverse Event|0|||
170623037|NCT00591006|616629933|FG014|Overall Study|Adverse Event|0|||
170623038|NCT00591006|616629934|FG015|Overall Study|Adverse Event|0|||
170623039|NCT00591006|616629935|FG016|Overall Study|Adverse Event|0|||
170623040|NCT00591006|616629936|FG017|Overall Study|Adverse Event|0|||
170623041|NCT00591006|616629937|FG018|Overall Study|Adverse Event|0|||
170623042|NCT00591006|616629938|FG019|Overall Study|Adverse Event|0|||
170623043|NCT00591006|616629939|FG020|Overall Study|Adverse Event|0|||
170623044|NCT00591006|616629940|FG021|Overall Study|Adverse Event|0|||
170623045|NCT00591006|616629941|FG022|Overall Study|Adverse Event|1|||
170623046|NCT00591006|616629942|FG023|Overall Study|Adverse Event|0|||
170623047|NCT02898454|616629943|FG000|Overall Study|Adverse Event|4|||
170623048|NCT02898454|616629944|FG001|Overall Study|Adverse Event|1|||
170623049|NCT02898454|616629945|FG002|Overall Study|Adverse Event|2|||
170623050|NCT02898454|616629943|FG000|Overall Study|Protocol Violation|1|||
170623051|NCT02898454|616629944|FG001|Overall Study|Protocol Violation|0|||
170623052|NCT02898454|616629945|FG002|Overall Study|Protocol Violation|1|||
170623053|NCT02898454|616629943|FG000|Overall Study|Lack of Efficacy|4|||
170623054|NCT02898454|616629944|FG001|Overall Study|Lack of Efficacy|1|||
170623055|NCT02898454|616629945|FG002|Overall Study|Lack of Efficacy|0|||
170623056|NCT02898454|616629943|FG000|Overall Study|Withdrawal by Subject|6|||
170623057|NCT02898454|616629944|FG001|Overall Study|Withdrawal by Subject|3|||
170623058|NCT02898454|616629945|FG002|Overall Study|Withdrawal by Subject|3|||
170623059|NCT02898454|616629943|FG000|Overall Study|Lost to Follow-up|1|||
170623060|NCT02898454|616629944|FG001|Overall Study|Lost to Follow-up|0|||
170623061|NCT02898454|616629945|FG002|Overall Study|Lost to Follow-up|0|||
170623062|NCT02898454|616629943|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
170623063|NCT02898454|616629944|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
170623064|NCT02898454|616629945|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
170623065|NCT01290523|616629946|FG000|Overall Study|Death|3|||
170623066|NCT00556894|616629948|FG000|Overall Study|Adverse Event|2|||
170623067|NCT00556894|616629949|FG001|Overall Study|Adverse Event|3|||
170623068|NCT00556894|616629950|FG002|Overall Study|Adverse Event|3|||
170623069|NCT00556894|616629948|FG000|Overall Study|Death|1|||
170623070|NCT00556894|616629949|FG001|Overall Study|Death|0|||
170623071|NCT00556894|616629950|FG002|Overall Study|Death|0|||
170623072|NCT00556894|616629948|FG000|Overall Study|regulatory decision in Bulgaria|10|||
170623073|NCT00556894|616629949|FG001|Overall Study|regulatory decision in Bulgaria|14|||
170623074|NCT00556894|616629950|FG002|Overall Study|regulatory decision in Bulgaria|13|||
170623075|NCT00556894|616629948|FG000|Overall Study|Change in therapy|2|||
170623076|NCT00556894|616629949|FG001|Overall Study|Change in therapy|1|||
170623077|NCT00556894|616629950|FG002|Overall Study|Change in therapy|2|||
170623078|NCT00556894|616629948|FG000|Overall Study|Withdrawal by Subject|1|||
170623079|NCT00556894|616629949|FG001|Overall Study|Withdrawal by Subject|1|||
170623080|NCT00556894|616629950|FG002|Overall Study|Withdrawal by Subject|1|||
170623081|NCT05190120|616629951|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
170623082|NCT05190120|616629952|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
170623083|NCT05190120|616629953|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
170623084|NCT05190120|616629954|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
170623085|NCT05190120|616629951|FG000|Overall Study|Lost to Follow-up|5|||
170623086|NCT05190120|616629952|FG001|Overall Study|Lost to Follow-up|0|||
170623087|NCT05190120|616629953|FG002|Overall Study|Lost to Follow-up|2|||
170623088|NCT05190120|616629954|FG003|Overall Study|Lost to Follow-up|3|||
170623089|NCT05148234|616629955|FG000|Phase I|Ineligible|0|||
170623090|NCT05148234|616629956|FG001|Phase I|Ineligible|0|||
170623091|NCT05148234|616629957|FG002|Phase I|Ineligible|0|||
170623092|NCT05148234|616629958|FG003|Phase I|Ineligible|0|||
170623093|NCT05148234|616629959|FG004|Phase I|Ineligible|0|||
170623094|NCT05148234|616629960|FG005|Phase I|Ineligible|0|||
170623095|NCT05148234|616629961|FG006|Phase I|Ineligible|0|||
170623096|NCT05148234|616629962|FG007|Phase I|Ineligible|1|||
170623097|NCT05148234|616629955|FG000|Phase I|Company closed the trial.|0|||
170623098|NCT05148234|616629956|FG001|Phase I|Company closed the trial.|1|||
170669497|NCT00347360|616801156|FG007|Overall Study|Per sponsors instruction|0|||
170623099|NCT05148234|616629957|FG002|Phase I|Company closed the trial.|0|||
170623100|NCT05148234|616629958|FG003|Phase I|Company closed the trial.|0|||
170623101|NCT05148234|616629959|FG004|Phase I|Company closed the trial.|0|||
170623102|NCT05148234|616629960|FG005|Phase I|Company closed the trial.|0|||
170623103|NCT05148234|616629961|FG006|Phase I|Company closed the trial.|0|||
170623104|NCT05148234|616629962|FG007|Phase I|Company closed the trial.|0|||
170623105|NCT03062358|616629963|FG000|Overall Study|Death|269|||
170669498|NCT00347360|616801157|FG008|Overall Study|Per sponsors instruction|0|||
170669499|NCT00347360|616801158|FG009|Overall Study|Per sponsors instruction|0|||
170669500|NCT00347360|616801159|FG010|Overall Study|Per sponsors instruction|0|||
170623106|NCT03062358|616629964|FG001|Overall Study|Death|145|||
170623107|NCT03062358|616629963|FG000|Overall Study|Withdrawal by Subject|2|||
170623108|NCT03062358|616629964|FG001|Overall Study|Withdrawal by Subject|1|||
170623109|NCT03062358|616629963|FG000|Overall Study|Sponsor Decision|29|||
170623110|NCT03062358|616629964|FG001|Overall Study|Sponsor Decision|7|||
170623111|NCT02994108|616631683|FG000|Intervention Messages|Withdrawal by Subject|2|||
170623112|NCT02994108|616631684|FG001|Intervention Messages|Withdrawal by Subject|0|||
170623113|NCT02994108|616631683|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
170623114|NCT02994108|616631684|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
170623115|NCT02994108|616631683|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
170623116|NCT02994108|616631684|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
170623117|NCT02994108|616631683|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
170623118|NCT02994108|616631684|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
170623119|NCT03224130|616631690|FG000|Overall Study|consent issue|0|||
170623120|NCT03224130|616631691|FG001|Overall Study|consent issue|1|||
170623121|NCT01453049|616631692|FG000|Overall Study|Protocol Violation|2|||
170623122|NCT01453049|616631693|FG001|Overall Study|Protocol Violation|5|||
170623123|NCT01453049|616631692|FG000|Overall Study|Lost to Follow-up|2|||
170623124|NCT01453049|616631693|FG001|Overall Study|Lost to Follow-up|1|||
170623125|NCT01453049|616631692|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
170623126|NCT01453049|616631693|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
170623127|NCT01453049|616631692|FG000|Overall Study|Withdrawal by Subject|1|||
170623128|NCT01453049|616631693|FG001|Overall Study|Withdrawal by Subject|0|||
170623129|NCT01453049|616631692|FG000|Overall Study|Randomized in Error|1|||
170623130|NCT01453049|616631693|FG001|Overall Study|Randomized in Error|0|||
170623131|NCT00928486|616631694|FG000|Overall Study|Adverse Event|2|||
170623132|NCT00928486|616631694|FG000|Overall Study|Disease Progression|7|||
170623133|NCT00928486|616631694|FG000|Overall Study|Withdrawal by Subject|1|||
170669501|NCT00347360|616801160|FG011|Overall Study|Per sponsors instruction|0|||
170669502|NCT00347360|616801161|FG012|Overall Study|Per sponsors instruction|0|||
170669503|NCT00347360|616801162|FG013|Overall Study|Per sponsors instruction|0|||
170669504|NCT00347360|616801163|FG014|Overall Study|Per sponsors instruction|0|||
170669505|NCT00347360|616801149|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
170623134|NCT01021020|616631696|FG000|Period I|Protocol Violation|1|||
170623135|NCT01021020|616631696|FG000|Period I|Withdrawal by Subject|1|||
170623136|NCT01021020|616631696|FG000|14 Day Washout Period A|Physician Decision|1|||
170623137|NCT02587520|616631701|FG000|Overall Study|Protocol Violation|2|||
170623138|NCT02587520|616631702|FG001|Overall Study|Protocol Violation|0|||
170623139|NCT02587520|616631703|FG002|Overall Study|Protocol Violation|0|||
170623140|NCT02587520|616631704|FG003|Overall Study|Protocol Violation|2|||
170623141|NCT02587520|616631705|FG004|Overall Study|Protocol Violation|0|||
170623142|NCT02587520|616631706|FG005|Overall Study|Protocol Violation|1|||
170623143|NCT02587520|616631707|FG006|Overall Study|Protocol Violation|1|||
170623144|NCT02587520|616631708|FG007|Overall Study|Protocol Violation|1|||
170623145|NCT02587520|616631709|FG008|Overall Study|Protocol Violation|3|||
170623146|NCT02587520|616631710|FG009|Overall Study|Protocol Violation|3|||
170623147|NCT02587520|616631711|FG010|Overall Study|Protocol Violation|1|||
170623148|NCT02587520|616631712|FG011|Overall Study|Protocol Violation|2|||
170623149|NCT02587520|616631713|FG012|Overall Study|Protocol Violation|0|||
170623150|NCT02587520|616631714|FG013|Overall Study|Protocol Violation|0|||
170623151|NCT02587520|616631715|FG014|Overall Study|Protocol Violation|0|||
170623152|NCT02587520|616631716|FG015|Overall Study|Protocol Violation|0|||
170623153|NCT02587520|616631717|FG016|Overall Study|Protocol Violation|0|||
170623154|NCT02587520|616631718|FG017|Overall Study|Protocol Violation|0|||
170623155|NCT02587520|616631701|FG000|Overall Study|Adverse Event|0|||
170623156|NCT02587520|616631702|FG001|Overall Study|Adverse Event|0|||
170623157|NCT02587520|616631703|FG002|Overall Study|Adverse Event|0|||
170623158|NCT02587520|616631704|FG003|Overall Study|Adverse Event|0|||
170623159|NCT02587520|616631705|FG004|Overall Study|Adverse Event|0|||
170623160|NCT02587520|616631706|FG005|Overall Study|Adverse Event|0|||
170669506|NCT00347360|616801150|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
170669507|NCT00347360|616801151|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
170623161|NCT02587520|616631707|FG006|Overall Study|Adverse Event|0|||
170623162|NCT02587520|616631708|FG007|Overall Study|Adverse Event|0|||
170669508|NCT00347360|616801152|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
170623163|NCT02587520|616631709|FG008|Overall Study|Adverse Event|0|||
170623164|NCT02587520|616631710|FG009|Overall Study|Adverse Event|0|||
170623165|NCT02587520|616631711|FG010|Overall Study|Adverse Event|0|||
170623166|NCT02587520|616631712|FG011|Overall Study|Adverse Event|1|||
170623167|NCT02587520|616631713|FG012|Overall Study|Adverse Event|0|||
170623168|NCT02587520|616631714|FG013|Overall Study|Adverse Event|0|||
170623169|NCT02587520|616631715|FG014|Overall Study|Adverse Event|0|||
170623170|NCT02587520|616631716|FG015|Overall Study|Adverse Event|0|||
170623171|NCT02587520|616631717|FG016|Overall Study|Adverse Event|0|||
170623172|NCT02587520|616631718|FG017|Overall Study|Adverse Event|0|||
170623173|NCT02587520|616631701|FG000|Overall Study|Withdrawal by Subject|0|||
170623174|NCT02587520|616631702|FG001|Overall Study|Withdrawal by Subject|0|||
170623175|NCT02587520|616631703|FG002|Overall Study|Withdrawal by Subject|1|||
170623176|NCT02587520|616631704|FG003|Overall Study|Withdrawal by Subject|1|||
170623177|NCT02587520|616631705|FG004|Overall Study|Withdrawal by Subject|0|||
170623178|NCT02587520|616631706|FG005|Overall Study|Withdrawal by Subject|1|||
170623179|NCT02587520|616631707|FG006|Overall Study|Withdrawal by Subject|1|||
170623180|NCT02587520|616631708|FG007|Overall Study|Withdrawal by Subject|0|||
170623181|NCT02587520|616631709|FG008|Overall Study|Withdrawal by Subject|0|||
170623182|NCT02587520|616631710|FG009|Overall Study|Withdrawal by Subject|0|||
170623183|NCT02587520|616631711|FG010|Overall Study|Withdrawal by Subject|0|||
170623184|NCT02587520|616631712|FG011|Overall Study|Withdrawal by Subject|0|||
170623185|NCT02587520|616631713|FG012|Overall Study|Withdrawal by Subject|0|||
170623186|NCT02587520|616631714|FG013|Overall Study|Withdrawal by Subject|1|||
170623187|NCT02587520|616631715|FG014|Overall Study|Withdrawal by Subject|0|||
170669509|NCT00347360|616801153|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
170669510|NCT00347360|616801154|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
170669511|NCT00347360|616801155|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
170669512|NCT00347360|616801156|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
170669513|NCT00347360|616801157|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
170669514|NCT00347360|616801158|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
170669515|NCT00347360|616801159|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
170669516|NCT00347360|616801160|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
170669517|NCT00347360|616801161|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
170669518|NCT00347360|616801162|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
170669519|NCT00347360|616801163|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
170669520|NCT00347360|616801149|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
170669521|NCT00347360|616801150|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
170669522|NCT00347360|616801151|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
170669523|NCT00347360|616801152|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
170669524|NCT00347360|616801153|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
170669525|NCT00347360|616801154|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
170669526|NCT00347360|616801155|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
170669527|NCT00347360|616801156|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
170669528|NCT00347360|616801157|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
170623188|NCT02587520|616631716|FG015|Overall Study|Withdrawal by Subject|0|||
170623189|NCT02587520|616631717|FG016|Overall Study|Withdrawal by Subject|0|||
170623190|NCT02587520|616631718|FG017|Overall Study|Withdrawal by Subject|0|||
170623191|NCT02587520|616631701|FG000|Overall Study|Lost to Follow-up|0|||
170623192|NCT02587520|616631702|FG001|Overall Study|Lost to Follow-up|2|||
170623193|NCT02587520|616631703|FG002|Overall Study|Lost to Follow-up|0|||
170623194|NCT02587520|616631704|FG003|Overall Study|Lost to Follow-up|2|||
170623195|NCT02587520|616631705|FG004|Overall Study|Lost to Follow-up|0|||
170623196|NCT02587520|616631706|FG005|Overall Study|Lost to Follow-up|1|||
170623197|NCT02587520|616631707|FG006|Overall Study|Lost to Follow-up|1|||
170623198|NCT02587520|616631708|FG007|Overall Study|Lost to Follow-up|1|||
170623199|NCT02587520|616631709|FG008|Overall Study|Lost to Follow-up|0|||
170623200|NCT02587520|616631710|FG009|Overall Study|Lost to Follow-up|2|||
170623201|NCT02587520|616631711|FG010|Overall Study|Lost to Follow-up|2|||
170623202|NCT02587520|616631712|FG011|Overall Study|Lost to Follow-up|1|||
170623203|NCT02587520|616631713|FG012|Overall Study|Lost to Follow-up|0|||
170623204|NCT02587520|616631714|FG013|Overall Study|Lost to Follow-up|0|||
170623205|NCT02587520|616631715|FG014|Overall Study|Lost to Follow-up|0|||
170623206|NCT02587520|616631716|FG015|Overall Study|Lost to Follow-up|0|||
170623207|NCT02587520|616631717|FG016|Overall Study|Lost to Follow-up|0|||
170623208|NCT02587520|616631718|FG017|Overall Study|Lost to Follow-up|0|||
170669529|NCT00347360|616801158|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
170669530|NCT00347360|616801159|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
170623209|NCT00672555|616631719|FG000|Overall Study|Lost to Follow-up|4|||
170623210|NCT00672555|616631719|FG000|Overall Study|Did not want to answer questionnaire|2|||
170623211|NCT00768989|616631725|FG000|Prior to Week 24|Withdrawal by Subject|1|||
170623212|NCT00768989|616631726|FG001|Prior to Week 24|Withdrawal by Subject|0|||
170623213|NCT00768989|616631725|FG000|Prior to Week 24|Adverse Event|3|||
170623214|NCT00768989|616631726|FG001|Prior to Week 24|Adverse Event|0|||
170623215|NCT00768989|616631725|FG000|Prior to Week 24|Lost to Follow-up|0|||
170623216|NCT00768989|616631726|FG001|Prior to Week 24|Lost to Follow-up|1|||
170623217|NCT00768989|616631725|FG000|Prior to Week 24|Protocol Violation|0|||
170669531|NCT00347360|616801160|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
170669532|NCT00347360|616801161|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
170623218|NCT00768989|616631726|FG001|Prior to Week 24|Protocol Violation|2|||
170623219|NCT00768989|616631725|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
170623220|NCT00768989|616631726|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
170623221|NCT00768989|616631725|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
170623222|NCT00768989|616631726|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
170623223|NCT00768989|616631725|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
170623224|NCT00768989|616631726|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
170623225|NCT00768989|616631725|FG000|On or After Week 36|Lack of Efficacy|1|||
170623226|NCT00768989|616631726|FG001|On or After Week 36|Lack of Efficacy|0|||
170623227|NCT00768989|616631725|FG000|On or After Week 36|Adverse Event|0|||
170623228|NCT00768989|616631726|FG001|On or After Week 36|Adverse Event|1|||
170623229|NCT00768989|616631725|FG000|On or After Week 36|Lost to Follow-up|1|||
170623230|NCT00768989|616631726|FG001|On or After Week 36|Lost to Follow-up|0|||
170623231|NCT00768989|616631725|FG000|On or After Week 36|Poor Compliance|1|||
170623232|NCT00768989|616631726|FG001|On or After Week 36|Poor Compliance|0|||
170623233|NCT00768989|616631725|FG000|On or After Week 36|Protocol Violation|1|||
170623234|NCT00768989|616631726|FG001|On or After Week 36|Protocol Violation|0|||
170819660|NCT00296504|617347680|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
170819661|NCT00296504|617347681|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
170819662|NCT00296504|617347682|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
170819663|NCT00296504|617347683|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
170819664|NCT00296504|617347675|FG000|Interim Analysis|Adverse Event|0|||
170819665|NCT00296504|617347676|FG001|Interim Analysis|Adverse Event|0|||
170819666|NCT00296504|617347677|FG002|Interim Analysis|Adverse Event|13|||
170819667|NCT00296504|617347678|FG003|Interim Analysis|Adverse Event|4|||
170819668|NCT00296504|617347679|FG004|Interim Analysis|Adverse Event|6|||
170819669|NCT00296504|617347680|FG005|Interim Analysis|Adverse Event|3|||
170819670|NCT00296504|617347681|FG006|Interim Analysis|Adverse Event|4|||
170819671|NCT00296504|617347682|FG007|Interim Analysis|Adverse Event|5|||
170819672|NCT00296504|617347683|FG008|Interim Analysis|Adverse Event|0|||
170819673|NCT00296504|617347675|FG000|Interim Analysis|Protocol Violation|0|||
170819674|NCT00296504|617347676|FG001|Interim Analysis|Protocol Violation|0|||
170819675|NCT00296504|617347677|FG002|Interim Analysis|Protocol Violation|2|||
170819676|NCT00296504|617347678|FG003|Interim Analysis|Protocol Violation|0|||
170819677|NCT00296504|617347679|FG004|Interim Analysis|Protocol Violation|1|||
170819678|NCT00296504|617347680|FG005|Interim Analysis|Protocol Violation|0|||
170819679|NCT00296504|617347681|FG006|Interim Analysis|Protocol Violation|0|||
170819680|NCT00296504|617347682|FG007|Interim Analysis|Protocol Violation|1|||
170819681|NCT00296504|617347683|FG008|Interim Analysis|Protocol Violation|0|||
170819682|NCT00296504|617347675|FG000|Interim Analysis|Insufficient CD4 Response|0|||
170819683|NCT00296504|617347676|FG001|Interim Analysis|Insufficient CD4 Response|0|||
170819684|NCT00296504|617347677|FG002|Interim Analysis|Insufficient CD4 Response|0|||
170819685|NCT00296504|617347678|FG003|Interim Analysis|Insufficient CD4 Response|0|||
170819686|NCT00296504|617347679|FG004|Interim Analysis|Insufficient CD4 Response|1|||
170819687|NCT00296504|617347680|FG005|Interim Analysis|Insufficient CD4 Response|1|||
170819688|NCT00296504|617347681|FG006|Interim Analysis|Insufficient CD4 Response|0|||
170819689|NCT00296504|617347682|FG007|Interim Analysis|Insufficient CD4 Response|0|||
170819690|NCT00296504|617347683|FG008|Interim Analysis|Insufficient CD4 Response|0|||
170819691|NCT00296504|617347675|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
170819692|NCT00296504|617347676|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
170819693|NCT00296504|617347677|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
170819694|NCT00296504|617347678|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
170819695|NCT00296504|617347679|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
170819696|NCT00296504|617347680|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
170819697|NCT00296504|617347681|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
170819698|NCT00296504|617347682|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
170819699|NCT00296504|617347683|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
170819700|NCT00296504|617347675|FG000|Interim Analysis|Pregnancy|4|||
170819701|NCT00296504|617347676|FG001|Interim Analysis|Pregnancy|1|||
170819702|NCT00296504|617347677|FG002|Interim Analysis|Pregnancy|4|||
170819703|NCT00296504|617347678|FG003|Interim Analysis|Pregnancy|2|||
170819704|NCT00296504|617347679|FG004|Interim Analysis|Pregnancy|0|||
170819705|NCT00296504|617347680|FG005|Interim Analysis|Pregnancy|1|||
170819706|NCT00296504|617347681|FG006|Interim Analysis|Pregnancy|1|||
170819707|NCT00296504|617347682|FG007|Interim Analysis|Pregnancy|1|||
170819708|NCT00296504|617347683|FG008|Interim Analysis|Pregnancy|0|||
170819709|NCT00296504|617347675|FG000|Interim Analysis|Death|1|||
170819710|NCT00296504|617347676|FG001|Interim Analysis|Death|0|||
170819711|NCT00296504|617347677|FG002|Interim Analysis|Death|3|||
170819712|NCT00296504|617347678|FG003|Interim Analysis|Death|0|||
170819713|NCT00296504|617347679|FG004|Interim Analysis|Death|0|||
170819714|NCT00296504|617347680|FG005|Interim Analysis|Death|0|||
170819715|NCT00296504|617347681|FG006|Interim Analysis|Death|0|||
170819716|NCT00296504|617347682|FG007|Interim Analysis|Death|0|||
170819717|NCT00296504|617347683|FG008|Interim Analysis|Death|0|||
170819718|NCT00296504|617347675|FG000|Interim Analysis|Participant Non-compliant|0|||
170819719|NCT00296504|617347676|FG001|Interim Analysis|Participant Non-compliant|1|||
170819720|NCT00296504|617347677|FG002|Interim Analysis|Participant Non-compliant|2|||
170819721|NCT00296504|617347678|FG003|Interim Analysis|Participant Non-compliant|1|||
170819722|NCT00296504|617347679|FG004|Interim Analysis|Participant Non-compliant|1|||
170819723|NCT00296504|617347680|FG005|Interim Analysis|Participant Non-compliant|3|||
170819724|NCT00296504|617347681|FG006|Interim Analysis|Participant Non-compliant|6|||
170819725|NCT00296504|617347682|FG007|Interim Analysis|Participant Non-compliant|2|||
170819726|NCT00296504|617347683|FG008|Interim Analysis|Participant Non-compliant|0|||
170623235|NCT00768989|616631725|FG000|On or After Week 36|Did not attend termination visit|2|||
170819727|NCT00296504|617347675|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
170623236|NCT00768989|616631726|FG001|On or After Week 36|Did not attend termination visit|0|||
170623237|NCT00768989|616631725|FG000|On or After Week 36|Sponsor Termination|45|||
170623238|NCT00768989|616631726|FG001|On or After Week 36|Sponsor Termination|26|||
170623239|NCT02153086|616631727|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
170623240|NCT02153086|616631727|FG000|Overall Study|Other|2|||
170623241|NCT00446849|616631730|FG000|Acute Phase|Lack of Efficacy|64|||
170623242|NCT00446849|616631730|FG000|Acute Phase|Protocol Violation|10|||
170623243|NCT00446849|616631730|FG000|Acute Phase|Consent withdrawn|4|||
170623244|NCT00446849|616631730|FG000|Acute Phase|Lost to Follow-up|2|||
170623245|NCT00446849|616631730|FG000|Acute Phase|Physician Decision|1|||
170623246|NCT00446849|616631730|FG000|Acute Phase|noncompliance|1|||
170623247|NCT00446849|616631730|FG000|Maintenance Phase|Lack of Efficacy|40|||
170623248|NCT00446849|616631730|FG000|Maintenance Phase|Protocol Violation|7|||
170623249|NCT00446849|616631730|FG000|Maintenance Phase|Adverse Event|6|||
170623250|NCT00446849|616631730|FG000|Maintenance Phase|Consent withdrawn|5|||
170623251|NCT00446849|616631730|FG000|Maintenance Phase|Lost to Follow-up|3|||
170623252|NCT00446849|616631730|FG000|Maintenance Phase|Pregnancy|1|||
170623253|NCT00446849|616631730|FG000|Maintenance Phase|noncompliance|2|||
170623254|NCT00446849|616631730|FG000|Maintenance Phase|prohibited medication use|2|||
170623255|NCT00446849|616631730|FG000|Maintenance Phase|antibiotic use|1|||
170623256|NCT00446849|616631730|FG000|Maintenance Phase|study closure|1|||
170623257|NCT00446849|616631730|FG000|Maintenance Phase|hydrocodone use|1|||
170623258|NCT00446849|616631730|FG000|Maintenance Phase|concomitant medication use|1|||
170623259|NCT05546476|616631734|FG000|Period 1: Part A|Adverse Event|2|||
170623260|NCT05546476|616631735|FG001|Period 1: Part A|Adverse Event|0|||
170623261|NCT05546476|616631736|FG002|Period 1: Part A|Adverse Event|0|||
170623262|NCT05546476|616631737|FG003|Period 1: Part A|Adverse Event|1|||
170623263|NCT05546476|616631734|FG000|Period 1: Part A|Death|4|||
170623264|NCT05546476|616631735|FG001|Period 1: Part A|Death|4|||
170623265|NCT05546476|616631736|FG002|Period 1: Part A|Death|5|||
170623266|NCT05546476|616631737|FG003|Period 1: Part A|Death|6|||
170623267|NCT05546476|616631734|FG000|Period 1: Part A|Lack of Efficacy|0|||
170623268|NCT05546476|616631735|FG001|Period 1: Part A|Lack of Efficacy|0|||
170623269|NCT05546476|616631736|FG002|Period 1: Part A|Lack of Efficacy|0|||
170623270|NCT05546476|616631737|FG003|Period 1: Part A|Lack of Efficacy|1|||
170623271|NCT05546476|616631734|FG000|Period 1: Part A|Lost to Follow-up|0|||
170623272|NCT05546476|616631735|FG001|Period 1: Part A|Lost to Follow-up|0|||
170623273|NCT05546476|616631736|FG002|Period 1: Part A|Lost to Follow-up|0|||
170623274|NCT05546476|616631737|FG003|Period 1: Part A|Lost to Follow-up|1|||
170623275|NCT05546476|616631734|FG000|Period 1: Part A|Physician Decision|1|||
170623276|NCT05546476|616631735|FG001|Period 1: Part A|Physician Decision|0|||
170623277|NCT05546476|616631736|FG002|Period 1: Part A|Physician Decision|0|||
170623278|NCT05546476|616631737|FG003|Period 1: Part A|Physician Decision|0|||
170623279|NCT05546476|616631734|FG000|Period 1: Part A|Progressive disease|3|||
170623280|NCT05546476|616631735|FG001|Period 1: Part A|Progressive disease|5|||
170623281|NCT05546476|616631736|FG002|Period 1: Part A|Progressive disease|0|||
170623282|NCT05546476|616631737|FG003|Period 1: Part A|Progressive disease|1|||
170623283|NCT05546476|616631734|FG000|Period 1: Part A|Withdrawal by Subject|1|||
170623284|NCT05546476|616631735|FG001|Period 1: Part A|Withdrawal by Subject|1|||
170623285|NCT05546476|616631736|FG002|Period 1: Part A|Withdrawal by Subject|1|||
170623286|NCT05546476|616631737|FG003|Period 1: Part A|Withdrawal by Subject|2|||
170623287|NCT05546476|616631734|FG000|Period 1: Part A|Global deterioration of health status|2|||
170623288|NCT05546476|616631735|FG001|Period 1: Part A|Global deterioration of health status|2|||
170623289|NCT05546476|616631736|FG002|Period 1: Part A|Global deterioration of health status|1|||
170623290|NCT05546476|616631737|FG003|Period 1: Part A|Global deterioration of health status|4|||
170623291|NCT05546476|616631734|FG000|Period 1: Part A|Other: Unspecified|0|||
170623292|NCT05546476|616631735|FG001|Period 1: Part A|Other: Unspecified|2|||
170623293|NCT05546476|616631736|FG002|Period 1: Part A|Other: Unspecified|0|||
170623294|NCT05546476|616631737|FG003|Period 1: Part A|Other: Unspecified|0|||
170623295|NCT05546476|616631734|FG000|Period 2: Part B|Ongoing|26|||
170623296|NCT05546476|616631735|FG001|Period 2: Part B|Ongoing|27|||
170623297|NCT05546476|616631736|FG002|Period 2: Part B|Ongoing|35|||
170623298|NCT05546476|616631737|FG003|Period 2: Part B|Ongoing|29|||
170623299|NCT03585660|616631748|FG000|Overall Study|operator error|1|||
170623300|NCT03585660|616631748|FG000|Overall Study|technical error|2|||
170623301|NCT03585660|616631748|FG000|Overall Study|hip prosthesis|2|||
170623302|NCT03585660|616631748|FG000|Overall Study|did not undergo biopsy|8|||
170819728|NCT00296504|617347676|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
170623303|NCT03585660|616631748|FG000|Overall Study|scanner problem|2|||
170623304|NCT05635461|616631751|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
170623305|NCT05635461|616631752|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
170623306|NCT05635461|616631753|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
170623307|NCT05635461|616631754|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
170623308|NCT05635461|616631755|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
170623309|NCT05635461|616631756|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
170623310|NCT05635461|616631751|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
170623311|NCT05635461|616631752|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
170623312|NCT05635461|616631753|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
170623313|NCT05635461|616631754|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
170623314|NCT05635461|616631755|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
170623315|NCT05635461|616631756|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
170623316|NCT05635461|616631751|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
170623317|NCT05635461|616631752|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
170669533|NCT00347360|616801162|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
170669534|NCT00347360|616801163|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
170669535|NCT00347360|616801149|FG000|Overall Study|Abnormal lab values|0|||
170669536|NCT00347360|616801150|FG001|Overall Study|Abnormal lab values|0|||
170669537|NCT00347360|616801151|FG002|Overall Study|Abnormal lab values|0|||
170669538|NCT00347360|616801152|FG003|Overall Study|Abnormal lab values|0|||
170669539|NCT00347360|616801153|FG004|Overall Study|Abnormal lab values|0|||
170623318|NCT05635461|616631753|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
170623319|NCT05635461|616631754|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
170623320|NCT05635461|616631755|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
170623321|NCT05635461|616631756|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
170623322|NCT03661723|616631763|FG000|Overall Study|Disease Progression|4|||
170623323|NCT03661723|616631764|FG001|Overall Study|Disease Progression|24|||
170623324|NCT03661723|616631765|FG002|Overall Study|Disease Progression|4|||
170623325|NCT03661723|616631766|FG003|Overall Study|Disease Progression|19|||
170623326|NCT03661723|616631763|FG000|Overall Study|Withdrawal by Subject|1|||
170623327|NCT03661723|616631764|FG001|Overall Study|Withdrawal by Subject|0|||
170623328|NCT03661723|616631765|FG002|Overall Study|Withdrawal by Subject|2|||
170623329|NCT03661723|616631766|FG003|Overall Study|Withdrawal by Subject|4|||
170623330|NCT03661723|616631763|FG000|Overall Study|Physician Decision|1|||
170623331|NCT03661723|616631764|FG001|Overall Study|Physician Decision|0|||
170623332|NCT03661723|616631765|FG002|Overall Study|Physician Decision|0|||
170623333|NCT03661723|616631766|FG003|Overall Study|Physician Decision|0|||
170623334|NCT03661723|616631763|FG000|Overall Study|Clinical Deterioration|0|||
170623335|NCT03661723|616631764|FG001|Overall Study|Clinical Deterioration|0|||
170623336|NCT03661723|616631765|FG002|Overall Study|Clinical Deterioration|0|||
170623337|NCT03661723|616631766|FG003|Overall Study|Clinical Deterioration|1|||
170623338|NCT04890652|616631769|FG000|Overall Study|Withdrawal by Subject|2|||
170623339|NCT05543265|616631773|FG000|Overall Study|Lost to Follow-up|3|||
170623340|NCT05543265|616631774|FG001|Overall Study|Lost to Follow-up|3|||
170623341|NCT05543265|616631773|FG000|Overall Study|Withdrawal by Subject|0|||
170623342|NCT05543265|616631774|FG001|Overall Study|Withdrawal by Subject|1|||
170623343|NCT05316597|616631775|FG000|First Session|Withdrawal by Subject|0|||
170623344|NCT05316597|616631776|FG001|First Session|Withdrawal by Subject|1|||
170623345|NCT05316597|616631775|FG000|Washout Period|Lost to Follow-up|1|||
170623346|NCT05316597|616631776|FG001|Washout Period|Lost to Follow-up|2|||
170623347|NCT05316597|616631775|FG000|Washout Period|Physician Decision|1|||
170623348|NCT05316597|616631776|FG001|Washout Period|Physician Decision|1|||
170623349|NCT05316597|616631775|FG000|Washout Period|Excluded before second session|1|||
170623350|NCT05316597|616631776|FG001|Washout Period|Excluded before second session|1|||
170623351|NCT05316597|616631775|FG000|Washout Period|Withdrawal by Subject|0|||
170623352|NCT05316597|616631776|FG001|Washout Period|Withdrawal by Subject|4|||
170623353|NCT02182895|616631779|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
170623354|NCT02182895|616631780|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
170669540|NCT00347360|616801154|FG005|Overall Study|Abnormal lab values|0|||
170623355|NCT03547518|616631781|FG000|Overall Study|Lost to Follow-up|2|||
170623356|NCT03547518|616631782|FG001|Overall Study|Lost to Follow-up|0|||
170623357|NCT03275740|616631789|FG000|Overall Study|Adverse Event|0|||
170623358|NCT03275740|616631790|FG001|Overall Study|Adverse Event|0|||
170623359|NCT03275740|616631791|FG002|Overall Study|Adverse Event|0|||
170623360|NCT03275740|616631792|FG003|Overall Study|Adverse Event|0|||
170623361|NCT03275740|616631793|FG004|Overall Study|Adverse Event|1|||
170623362|NCT03275740|616631794|FG005|Overall Study|Adverse Event|0|||
170623363|NCT03275740|616631795|FG006|Overall Study|Adverse Event|0|||
170623364|NCT03275740|616631796|FG007|Overall Study|Adverse Event|0|||
170623365|NCT03275740|616631797|FG008|Overall Study|Adverse Event|0|||
170623366|NCT03275740|616631798|FG009|Overall Study|Adverse Event|0|||
170623367|NCT03275740|616631799|FG010|Overall Study|Adverse Event|0|||
170623368|NCT03275740|616631800|FG011|Overall Study|Adverse Event|0|||
170623369|NCT03275740|616631789|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623370|NCT03275740|616631790|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623371|NCT03275740|616631791|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623372|NCT03275740|616631792|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623373|NCT03275740|616631793|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623374|NCT03275740|616631794|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
170623375|NCT03275740|616631795|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623376|NCT03275740|616631796|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623377|NCT03275740|616631797|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623378|NCT03275740|616631798|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623379|NCT03275740|616631799|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623380|NCT03275740|616631800|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
170623381|NCT03275740|616631789|FG000|Overall Study|Withdrawal by Subject|0|||
170623382|NCT03275740|616631790|FG001|Overall Study|Withdrawal by Subject|0|||
170623383|NCT03275740|616631791|FG002|Overall Study|Withdrawal by Subject|0|||
170623384|NCT03275740|616631792|FG003|Overall Study|Withdrawal by Subject|0|||
170623385|NCT03275740|616631793|FG004|Overall Study|Withdrawal by Subject|0|||
170623386|NCT03275740|616631794|FG005|Overall Study|Withdrawal by Subject|0|||
170623387|NCT03275740|616631795|FG006|Overall Study|Withdrawal by Subject|0|||
170623388|NCT03275740|616631796|FG007|Overall Study|Withdrawal by Subject|0|||
170623389|NCT03275740|616631797|FG008|Overall Study|Withdrawal by Subject|1|||
170623390|NCT03275740|616631798|FG009|Overall Study|Withdrawal by Subject|1|||
170623391|NCT03275740|616631799|FG010|Overall Study|Withdrawal by Subject|0|||
170623392|NCT03275740|616631800|FG011|Overall Study|Withdrawal by Subject|0|||
170623393|NCT03535974|616631801|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
170623394|NCT03535974|616631802|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
170623395|NCT03535974|616631803|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
170623396|NCT03535974|616631801|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
170623397|NCT03535974|616631802|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
170623398|NCT03535974|616631803|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
170623399|NCT03259230|616631804|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
170623400|NCT03259230|616631805|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
170623401|NCT02913482|616631806|FG000|Overall Study|Death|0|||
170623402|NCT02913482|616631807|FG001|Overall Study|Death|2|||
170623403|NCT02913482|616631808|FG002|Overall Study|Death|2|||
170623404|NCT02913482|616631806|FG000|Overall Study|Progressive Disease|1|||
170623405|NCT02913482|616631807|FG001|Overall Study|Progressive Disease|1|||
170623406|NCT02913482|616631808|FG002|Overall Study|Progressive Disease|1|||
170623407|NCT02913482|616631806|FG000|Overall Study|Reason not specified|0|||
170623408|NCT02913482|616631807|FG001|Overall Study|Reason not specified|0|||
170623409|NCT02913482|616631808|FG002|Overall Study|Reason not specified|1|||
170623410|NCT02913482|616631806|FG000|Overall Study|Withdrawal by Subject|0|||
170623411|NCT02913482|616631807|FG001|Overall Study|Withdrawal by Subject|1|||
170623412|NCT02913482|616631808|FG002|Overall Study|Withdrawal by Subject|1|||
170623413|NCT01011673|616631809|FG000|Randomized|Secondary headache|2|||
170623414|NCT01011673|616631810|FG001|Randomized|Secondary headache|1|||
170623415|NCT01011673|616631809|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
170623416|NCT01011673|616631810|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
170623417|NCT02675907|616631812|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
170623418|NCT02675907|616631813|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
170623419|NCT02675907|616631812|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
170623420|NCT02675907|616631813|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
170623421|NCT02675907|616631812|FG000|Study Overall|Lack of Efficacy|1|||
170623422|NCT02675907|616631813|FG001|Study Overall|Lack of Efficacy|0|||
170623423|NCT02675907|616631812|FG000|Study Overall|Withdrawal by Subject|2|||
170623424|NCT02675907|616631813|FG001|Study Overall|Withdrawal by Subject|2|||
170623425|NCT02675907|616631812|FG000|Study Overall|Lost to Follow-up|0|||
170623426|NCT02675907|616631813|FG001|Study Overall|Lost to Follow-up|2|||
170623427|NCT03040141|616631814|FG000|Overall Study|Death|1|||
170623428|NCT03040141|616631815|FG001|Overall Study|Death|2|||
170623429|NCT03040141|616631816|FG002|Overall Study|Death|3|||
170623430|NCT03040141|616631814|FG000|Overall Study|Withdrawal by Subject|3|||
170623431|NCT03040141|616631815|FG001|Overall Study|Withdrawal by Subject|1|||
170623432|NCT03040141|616631816|FG002|Overall Study|Withdrawal by Subject|1|||
170623433|NCT03040141|616631814|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
170623434|NCT03040141|616631815|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
170623435|NCT03040141|616631816|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
170623436|NCT03040141|616631814|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
170623437|NCT03040141|616631815|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
170623438|NCT03040141|616631816|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
170623439|NCT01384734|616631818|FG000|Overall Study|Adverse Event|0|||
170623440|NCT01384734|616631819|FG001|Overall Study|Adverse Event|3|||
170623441|NCT01384734|616631820|FG002|Overall Study|Adverse Event|0|||
170623442|NCT01384734|616631821|FG003|Overall Study|Adverse Event|2|||
170623443|NCT01384734|616631822|FG004|Overall Study|Adverse Event|7|||
170623444|NCT01384734|616631818|FG000|Overall Study|Death|1|||
170623445|NCT01384734|616631819|FG001|Overall Study|Death|0|||
170623446|NCT01384734|616631820|FG002|Overall Study|Death|1|||
170623447|NCT01384734|616631821|FG003|Overall Study|Death|0|||
170623448|NCT01384734|616631822|FG004|Overall Study|Death|0|||
170623449|NCT01384734|616631818|FG000|Overall Study|Continuation criteria not met|0|||
170623450|NCT01384734|616631819|FG001|Overall Study|Continuation criteria not met|0|||
170623451|NCT01384734|616631820|FG002|Overall Study|Continuation criteria not met|1|||
170623452|NCT01384734|616631821|FG003|Overall Study|Continuation criteria not met|1|||
170623453|NCT01384734|616631822|FG004|Overall Study|Continuation criteria not met|0|||
170623454|NCT01384734|616631818|FG000|Overall Study|Lack of Efficacy|3|||
170623455|NCT01384734|616631819|FG001|Overall Study|Lack of Efficacy|7|||
170623456|NCT01384734|616631820|FG002|Overall Study|Lack of Efficacy|4|||
170623457|NCT01384734|616631821|FG003|Overall Study|Lack of Efficacy|4|||
170623458|NCT01384734|616631822|FG004|Overall Study|Lack of Efficacy|2|||
170623459|NCT01384734|616631818|FG000|Overall Study|Lost to Follow-up|5|||
170623460|NCT01384734|616631819|FG001|Overall Study|Lost to Follow-up|3|||
170623461|NCT01384734|616631820|FG002|Overall Study|Lost to Follow-up|3|||
170623462|NCT01384734|616631821|FG003|Overall Study|Lost to Follow-up|8|||
170623463|NCT01384734|616631822|FG004|Overall Study|Lost to Follow-up|5|||
170623464|NCT01384734|616631818|FG000|Overall Study|Non-compliance with study drug|1|||
170623465|NCT01384734|616631819|FG001|Overall Study|Non-compliance with study drug|2|||
170623466|NCT01384734|616631820|FG002|Overall Study|Non-compliance with study drug|6|||
170623467|NCT01384734|616631821|FG003|Overall Study|Non-compliance with study drug|0|||
170623468|NCT01384734|616631822|FG004|Overall Study|Non-compliance with study drug|2|||
170623469|NCT01384734|616631818|FG000|Overall Study|Pregnancy|0|||
170623470|NCT01384734|616631819|FG001|Overall Study|Pregnancy|1|||
170623471|NCT01384734|616631820|FG002|Overall Study|Pregnancy|0|||
170623472|NCT01384734|616631821|FG003|Overall Study|Pregnancy|0|||
170623473|NCT01384734|616631822|FG004|Overall Study|Pregnancy|1|||
170623474|NCT01384734|616631818|FG000|Overall Study|Sponsor terminated|0|||
170623475|NCT01384734|616631819|FG001|Overall Study|Sponsor terminated|0|||
170623476|NCT01384734|616631820|FG002|Overall Study|Sponsor terminated|0|||
170623477|NCT01384734|616631821|FG003|Overall Study|Sponsor terminated|0|||
170623478|NCT01384734|616631822|FG004|Overall Study|Sponsor terminated|1|||
170623479|NCT01384734|616631818|FG000|Overall Study|Withdrawal by Subject|5|||
170623480|NCT01384734|616631819|FG001|Overall Study|Withdrawal by Subject|5|||
170623481|NCT01384734|616631820|FG002|Overall Study|Withdrawal by Subject|6|||
170623482|NCT01384734|616631821|FG003|Overall Study|Withdrawal by Subject|7|||
170623483|NCT01384734|616631822|FG004|Overall Study|Withdrawal by Subject|9|||
170623484|NCT01384734|616631818|FG000|Overall Study|Investigator relocating|0|||
170623485|NCT01384734|616631819|FG001|Overall Study|Investigator relocating|2|||
170623486|NCT01384734|616631820|FG002|Overall Study|Investigator relocating|0|||
170623487|NCT01384734|616631821|FG003|Overall Study|Investigator relocating|3|||
170623488|NCT01384734|616631822|FG004|Overall Study|Investigator relocating|1|||
170623489|NCT01384734|616631818|FG000|Overall Study|Unable to come back for visit|1|||
170623490|NCT01384734|616631819|FG001|Overall Study|Unable to come back for visit|0|||
170669541|NCT00347360|616801155|FG006|Overall Study|Abnormal lab values|1|||
170669542|NCT00347360|616801156|FG007|Overall Study|Abnormal lab values|0|||
170669543|NCT00347360|616801157|FG008|Overall Study|Abnormal lab values|0|||
170669544|NCT00347360|616801158|FG009|Overall Study|Abnormal lab values|0|||
170669545|NCT00347360|616801159|FG010|Overall Study|Abnormal lab values|0|||
170669546|NCT00347360|616801160|FG011|Overall Study|Abnormal lab values|0|||
170669547|NCT00347360|616801161|FG012|Overall Study|Abnormal lab values|0|||
170669548|NCT00347360|616801162|FG013|Overall Study|Abnormal lab values|0|||
170669549|NCT00347360|616801163|FG014|Overall Study|Abnormal lab values|0|||
170669550|NCT00347360|616801149|FG000|Overall Study|PI recommended early withdrawal|0|||
170623491|NCT01384734|616631820|FG002|Overall Study|Unable to come back for visit|1|||
170669551|NCT00347360|616801150|FG001|Overall Study|PI recommended early withdrawal|0|||
170623492|NCT01384734|616631821|FG003|Overall Study|Unable to come back for visit|1|||
170623493|NCT01384734|616631822|FG004|Overall Study|Unable to come back for visit|0|||
170623494|NCT01384734|616631818|FG000|Overall Study|Prison|0|||
170623495|NCT01384734|616631819|FG001|Overall Study|Prison|0|||
170623496|NCT01384734|616631820|FG002|Overall Study|Prison|1|||
170623497|NCT01384734|616631821|FG003|Overall Study|Prison|0|||
170623498|NCT01384734|616631822|FG004|Overall Study|Prison|0|||
170623499|NCT01384734|616631818|FG000|Overall Study|As per Exclusion criteria|0|||
170623500|NCT01384734|616631819|FG001|Overall Study|As per Exclusion criteria|1|||
170623501|NCT01384734|616631820|FG002|Overall Study|As per Exclusion criteria|0|||
170623502|NCT01384734|616631821|FG003|Overall Study|As per Exclusion criteria|0|||
170623503|NCT01384734|616631822|FG004|Overall Study|As per Exclusion criteria|0|||
170623504|NCT01384734|616631818|FG000|Overall Study|Missed End of treatment visit|0|||
170623505|NCT01384734|616631819|FG001|Overall Study|Missed End of treatment visit|0|||
170623506|NCT01384734|616631820|FG002|Overall Study|Missed End of treatment visit|0|||
170623507|NCT01384734|616631821|FG003|Overall Study|Missed End of treatment visit|1|||
170623508|NCT01384734|616631822|FG004|Overall Study|Missed End of treatment visit|0|||
170623509|NCT01384734|616631818|FG000|Overall Study|Adhesion problem|0|||
170623510|NCT01384734|616631819|FG001|Overall Study|Adhesion problem|0|||
170623511|NCT01384734|616631820|FG002|Overall Study|Adhesion problem|0|||
170623512|NCT01384734|616631821|FG003|Overall Study|Adhesion problem|1|||
170623513|NCT01384734|616631822|FG004|Overall Study|Adhesion problem|0|||
170623514|NCT01384734|616631818|FG000|Overall Study|Early termination|0|||
170623515|NCT01384734|616631819|FG001|Overall Study|Early termination|0|||
170623516|NCT01384734|616631820|FG002|Overall Study|Early termination|0|||
170623517|NCT01384734|616631821|FG003|Overall Study|Early termination|0|||
170623518|NCT01384734|616631822|FG004|Overall Study|Early termination|1|||
170623519|NCT01384734|616631818|FG000|Overall Study|Physician Decision|1|||
170623520|NCT01384734|616631819|FG001|Overall Study|Physician Decision|0|||
170623521|NCT01384734|616631820|FG002|Overall Study|Physician Decision|0|||
170623522|NCT01384734|616631821|FG003|Overall Study|Physician Decision|0|||
170623523|NCT01384734|616631822|FG004|Overall Study|Physician Decision|0|||
170623524|NCT00849940|616631823|FG000|Overall Study|Physician Decision|4|||
170623525|NCT03071263|616631824|FG000|Overall Study|Adverse Event|1|||
170623526|NCT03071263|616631825|FG001|Overall Study|Adverse Event|3|||
170623527|NCT03071263|616631824|FG000|Overall Study|Withdrawal by Subject|1|||
170623528|NCT03071263|616631825|FG001|Overall Study|Withdrawal by Subject|3|||
170623529|NCT03071263|616631824|FG000|Overall Study|Physician Decision|1|||
170623530|NCT03071263|616631825|FG001|Overall Study|Physician Decision|0|||
170623531|NCT03071263|616631824|FG000|Overall Study|Participant moved to another city|0|||
170623532|NCT03071263|616631825|FG001|Overall Study|Participant moved to another city|1|||
170623533|NCT00550407|616631830|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
170623534|NCT00550407|616631831|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
170623535|NCT00550407|616631832|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
170623536|NCT00550407|616631830|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
170623537|NCT00550407|616631831|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
170623538|NCT00550407|616631832|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
170623539|NCT00550407|616631830|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
170623540|NCT00550407|616631831|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
170669552|NCT00347360|616801151|FG002|Overall Study|PI recommended early withdrawal|0|||
170669553|NCT00347360|616801152|FG003|Overall Study|PI recommended early withdrawal|0|||
170669554|NCT00347360|616801153|FG004|Overall Study|PI recommended early withdrawal|0|||
170669555|NCT00347360|616801154|FG005|Overall Study|PI recommended early withdrawal|0|||
170623541|NCT00550407|616631832|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
170623542|NCT00550407|616631830|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
170623543|NCT00550407|616631831|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
170623544|NCT00550407|616631832|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
170623545|NCT00550407|616631830|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
170669556|NCT00347360|616801155|FG006|Overall Study|PI recommended early withdrawal|0|||
170669557|NCT00347360|616801156|FG007|Overall Study|PI recommended early withdrawal|0|||
170669558|NCT00347360|616801157|FG008|Overall Study|PI recommended early withdrawal|0|||
170623546|NCT00550407|616631831|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
170623547|NCT00550407|616631832|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
170623548|NCT00550407|616631830|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
170623549|NCT00550407|616631831|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
170623550|NCT00550407|616631832|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
170623551|NCT00550407|616631830|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
170623552|NCT00550407|616631831|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
170623553|NCT00550407|616631832|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
170623554|NCT00550407|616631830|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
170623555|NCT00550407|616631831|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
170623556|NCT00550407|616631832|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
170623557|NCT00550407|616631830|FG000|26-Week Randomized Phase|Adverse Event|0|||
170623558|NCT00550407|616631831|FG001|26-Week Randomized Phase|Adverse Event|5|||
170623559|NCT00550407|616631832|FG002|26-Week Randomized Phase|Adverse Event|2|||
170623560|NCT00550407|616631830|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
170623561|NCT00550407|616631831|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
170623562|NCT00550407|616631832|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
170623563|NCT00550407|616631830|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
170623564|NCT00550407|616631831|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
170623565|NCT00550407|616631832|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
170623566|NCT00550407|616631830|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
170623567|NCT00550407|616631831|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
170623568|NCT00550407|616631832|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
170623569|NCT03883581|616631833|FG000|Overall Study|Withdrawal by Subject|4|||
170623570|NCT01766050|616633631|FG000|Overall Study|Adverse Event|1|||
170623571|NCT01766050|616633631|FG000|Overall Study|Lost to Follow-up|1|||
170623572|NCT01766050|616633631|FG000|Overall Study|Withdrawal by Subject|2|||
170623573|NCT00089297|616633636|FG000|Overall Study|Adverse Event|9|||
170623574|NCT00089297|616633636|FG000|Overall Study|Death|1|||
170623575|NCT00089297|616633636|FG000|Overall Study|Withdrawal by Subject|12|||
170623576|NCT00089297|616633636|FG000|Overall Study|Disease progression|2|||
170623577|NCT00089297|616633636|FG000|Overall Study|Ineligible|11|||
170623578|NCT00089297|616633636|FG000|Overall Study|Secondary malignancy|1|||
170623579|NCT00089297|616633636|FG000|Overall Study|IRB approval not ready|1|||
170623580|NCT00089297|616633636|FG000|Overall Study|Non-compliance|1|||
170623581|NCT00904969|616633637|FG000|Overall Study|Lost to Follow-up|4|||
170623582|NCT00904969|616633637|FG000|Overall Study|Withdrawal by Subject|3|||
170623583|NCT00904969|616633637|FG000|Overall Study|Additional Treatments|11|||
170623584|NCT00904969|616633637|FG000|Overall Study|Case Aborted; Subject Exited|1|||
170623585|NCT01097668|616633638|FG000|Overall Study|Withdrawal by Subject|1|||
170623586|NCT01097668|616633639|FG001|Overall Study|Withdrawal by Subject|2|||
170623587|NCT01097668|616633638|FG000|Overall Study|Lost to Follow-up|1|||
170623588|NCT01097668|616633639|FG001|Overall Study|Lost to Follow-up|0|||
170623589|NCT01295814|616633650|FG000|Overall Study|Lack of Efficacy|0|||
170623590|NCT01295814|616633651|FG001|Overall Study|Lack of Efficacy|2|||
170623591|NCT01295814|616633650|FG000|Overall Study|Withdrawal by Subject|2|||
170623592|NCT01295814|616633651|FG001|Overall Study|Withdrawal by Subject|0|||
170623593|NCT03414983|616633652|FG000|Pre-Treatment|Other reasons|1|||
170623594|NCT03414983|616633653|FG001|Pre-Treatment|Other reasons|0|||
170623595|NCT03414983|616633652|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
170623596|NCT03414983|616633653|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
170669559|NCT00347360|616801158|FG009|Overall Study|PI recommended early withdrawal|1|||
170669560|NCT00347360|616801159|FG010|Overall Study|PI recommended early withdrawal|0|||
170669561|NCT00347360|616801160|FG011|Overall Study|PI recommended early withdrawal|0|||
170669562|NCT00347360|616801161|FG012|Overall Study|PI recommended early withdrawal|0|||
170669563|NCT00347360|616801162|FG013|Overall Study|PI recommended early withdrawal|0|||
170669564|NCT00347360|616801163|FG014|Overall Study|PI recommended early withdrawal|0|||
170669565|NCT00347360|616801149|FG000|Overall Study|Did not meet criteria before ABPM|0|||
170669566|NCT00347360|616801150|FG001|Overall Study|Did not meet criteria before ABPM|0|||
170669567|NCT00347360|616801151|FG002|Overall Study|Did not meet criteria before ABPM|0|||
170669568|NCT00347360|616801152|FG003|Overall Study|Did not meet criteria before ABPM|0|||
170669569|NCT00347360|616801153|FG004|Overall Study|Did not meet criteria before ABPM|0|||
170669570|NCT00347360|616801154|FG005|Overall Study|Did not meet criteria before ABPM|0|||
170669571|NCT00347360|616801155|FG006|Overall Study|Did not meet criteria before ABPM|0|||
170669572|NCT00347360|616801156|FG007|Overall Study|Did not meet criteria before ABPM|0|||
170669573|NCT00347360|616801157|FG008|Overall Study|Did not meet criteria before ABPM|0|||
170669574|NCT00347360|616801158|FG009|Overall Study|Did not meet criteria before ABPM|0|||
170669575|NCT00347360|616801159|FG010|Overall Study|Did not meet criteria before ABPM|1|||
170669576|NCT00347360|616801160|FG011|Overall Study|Did not meet criteria before ABPM|0|||
170669577|NCT00347360|616801161|FG012|Overall Study|Did not meet criteria before ABPM|0|||
170669578|NCT00347360|616801162|FG013|Overall Study|Did not meet criteria before ABPM|0|||
170669579|NCT00347360|616801163|FG014|Overall Study|Did not meet criteria before ABPM|0|||
170669580|NCT00347360|616801149|FG000|Overall Study|Randomized in error|0|||
170669581|NCT00347360|616801150|FG001|Overall Study|Randomized in error|0|||
170669582|NCT00347360|616801151|FG002|Overall Study|Randomized in error|0|||
170669583|NCT00347360|616801152|FG003|Overall Study|Randomized in error|0|||
170669584|NCT00347360|616801153|FG004|Overall Study|Randomized in error|0|||
170669585|NCT00347360|616801154|FG005|Overall Study|Randomized in error|0|||
170669586|NCT00347360|616801155|FG006|Overall Study|Randomized in error|0|||
170669587|NCT00347360|616801156|FG007|Overall Study|Randomized in error|0|||
170669588|NCT00347360|616801157|FG008|Overall Study|Randomized in error|0|||
170669589|NCT00347360|616801158|FG009|Overall Study|Randomized in error|0|||
170669590|NCT00347360|616801159|FG010|Overall Study|Randomized in error|0|||
170669591|NCT00347360|616801160|FG011|Overall Study|Randomized in error|1|||
170669592|NCT00347360|616801161|FG012|Overall Study|Randomized in error|0|||
170669593|NCT00347360|616801162|FG013|Overall Study|Randomized in error|0|||
170669594|NCT00347360|616801163|FG014|Overall Study|Randomized in error|0|||
170669595|NCT00347360|616801149|FG000|Overall Study|Failed inclusion criteria #4|0|||
170669596|NCT00347360|616801150|FG001|Overall Study|Failed inclusion criteria #4|0|||
170669597|NCT00347360|616801151|FG002|Overall Study|Failed inclusion criteria #4|0|||
170669598|NCT00347360|616801152|FG003|Overall Study|Failed inclusion criteria #4|0|||
170669599|NCT00347360|616801153|FG004|Overall Study|Failed inclusion criteria #4|0|||
170669600|NCT00347360|616801154|FG005|Overall Study|Failed inclusion criteria #4|0|||
170669601|NCT00347360|616801155|FG006|Overall Study|Failed inclusion criteria #4|0|||
170669602|NCT00347360|616801156|FG007|Overall Study|Failed inclusion criteria #4|0|||
170669603|NCT00347360|616801157|FG008|Overall Study|Failed inclusion criteria #4|0|||
170669604|NCT00347360|616801158|FG009|Overall Study|Failed inclusion criteria #4|0|||
170669605|NCT00347360|616801159|FG010|Overall Study|Failed inclusion criteria #4|0|||
170669606|NCT00347360|616801160|FG011|Overall Study|Failed inclusion criteria #4|1|||
170669607|NCT00347360|616801161|FG012|Overall Study|Failed inclusion criteria #4|0|||
170623597|NCT03414983|616633652|FG000|Pre-Treatment|Participant withdrew consent|1|||
170623598|NCT03414983|616633653|FG001|Pre-Treatment|Participant withdrew consent|3|||
170623599|NCT03414983|616633652|FG000|Treatment|Participant withdrew consent|4|||
170623600|NCT03414983|616633653|FG001|Treatment|Participant withdrew consent|3|||
170623601|NCT03414983|616633652|FG000|Treatment|Participant request to discontinue study treatment|8|||
170623602|NCT03414983|616633653|FG001|Treatment|Participant request to discontinue study treatment|10|||
170623603|NCT03414983|616633652|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
170623604|NCT03414983|616633653|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
170623605|NCT03414983|616633652|FG000|Treatment|Death|0|||
170623606|NCT03414983|616633653|FG001|Treatment|Death|1|||
170669608|NCT00347360|616801162|FG013|Overall Study|Failed inclusion criteria #4|0|||
170669609|NCT00347360|616801163|FG014|Overall Study|Failed inclusion criteria #4|0|||
170669610|NCT00347360|616801149|FG000|Overall Study|Prolonged duration between visits|0|||
170669611|NCT00347360|616801150|FG001|Overall Study|Prolonged duration between visits|0|||
170669612|NCT00347360|616801151|FG002|Overall Study|Prolonged duration between visits|0|||
170669613|NCT00347360|616801152|FG003|Overall Study|Prolonged duration between visits|0|||
170669614|NCT00347360|616801153|FG004|Overall Study|Prolonged duration between visits|0|||
170669615|NCT00347360|616801154|FG005|Overall Study|Prolonged duration between visits|0|||
170623607|NCT03414983|616633652|FG000|Treatment|Study Drug Toxicity|10|||
170623608|NCT03414983|616633653|FG001|Treatment|Study Drug Toxicity|5|||
170623609|NCT03414983|616633652|FG000|Treatment|Disease Progression|75|||
170623610|NCT03414983|616633653|FG001|Treatment|Disease Progression|29|||
170623611|NCT03414983|616633652|FG000|Treatment|Not reported|1|||
170623612|NCT03414983|616633653|FG001|Treatment|Not reported|0|||
170623613|NCT03414983|616633652|FG000|Treatment|Other reasons|3|||
170623614|NCT03414983|616633653|FG001|Treatment|Other reasons|2|||
170623615|NCT03414983|616633652|FG000|Treatment|Poor/non-compliance|2|||
170623616|NCT03414983|616633653|FG001|Treatment|Poor/non-compliance|0|||
170623617|NCT03414983|616633652|FG000|Treatment|Maximum clinical benefit|5|||
170623618|NCT03414983|616633653|FG001|Treatment|Maximum clinical benefit|9|||
170623619|NCT03414983|616633652|FG000|Treatment|Lost to Follow-up|0|||
170623620|NCT03414983|616633653|FG001|Treatment|Lost to Follow-up|1|||
170623621|NCT03414983|616633652|FG000|Treatment|Administrative reasons by sponsor|1|||
170623622|NCT03414983|616633653|FG001|Treatment|Administrative reasons by sponsor|0|||
170623623|NCT00812708|616633654|FG000|Overall Study|Device could not be implanted|2|||
170623624|NCT00812708|616633654|FG000|Overall Study|Lack of medical insurance|1|||
170623625|NCT00812708|616633654|FG000|Overall Study|Switched to another study|1|||
170623626|NCT00812708|616633654|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
170623627|NCT00812708|616633654|FG000|Overall Study|Signed consent but later withdrew|3|||
170623628|NCT02608684|616633655|FG000|Overall Study|Physician Decision|2|||
170623629|NCT02608684|616633655|FG000|Overall Study|Withdrawal by Subject|1|||
170819729|NCT00296504|617347677|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
170819730|NCT00296504|617347678|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
170819731|NCT00296504|617347679|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
170819732|NCT00296504|617347680|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
170819733|NCT00296504|617347681|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
170819734|NCT00296504|617347682|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
170819735|NCT00296504|617347683|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
170819736|NCT00296504|617347675|FG000|Interim Analysis|To Simplify Treatment|0|||
170819737|NCT00296504|617347676|FG001|Interim Analysis|To Simplify Treatment|0|||
170819738|NCT00296504|617347677|FG002|Interim Analysis|To Simplify Treatment|1|||
170819739|NCT00296504|617347678|FG003|Interim Analysis|To Simplify Treatment|0|||
170819740|NCT00296504|617347679|FG004|Interim Analysis|To Simplify Treatment|0|||
170819741|NCT00296504|617347680|FG005|Interim Analysis|To Simplify Treatment|0|||
170819742|NCT00296504|617347681|FG006|Interim Analysis|To Simplify Treatment|2|||
170819743|NCT00296504|617347682|FG007|Interim Analysis|To Simplify Treatment|0|||
170623630|NCT00751296|616633657|FG000|Overall Study|Adverse Event|2|||
170623631|NCT01972217|616633658|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
170623632|NCT01972217|616633659|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
170623633|NCT01972217|616633660|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
170623634|NCT01972217|616633661|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
170623635|NCT01972217|616633658|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
170623636|NCT01972217|616633659|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
170623637|NCT01972217|616633660|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
170623638|NCT01972217|616633661|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
170623639|NCT01972217|616633658|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
170623640|NCT01972217|616633659|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
170623641|NCT01972217|616633660|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
170623642|NCT01972217|616633661|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
170623643|NCT01972217|616633658|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
170623644|NCT01972217|616633659|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
170623645|NCT01972217|616633660|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
170623646|NCT01972217|616633661|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
170623647|NCT01972217|616633658|FG000|Part B Double-blind, Randomised Period|Death|0|||
170623648|NCT01972217|616633659|FG001|Part B Double-blind, Randomised Period|Death|0|||
170623649|NCT01972217|616633660|FG002|Part B Double-blind, Randomised Period|Death|43|||
170623650|NCT01972217|616633661|FG003|Part B Double-blind, Randomised Period|Death|44|||
170623651|NCT01972217|616633658|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
170623652|NCT01972217|616633659|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
170623653|NCT01972217|616633660|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
170623654|NCT01972217|616633661|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
170623655|NCT01972217|616633658|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
170623656|NCT01972217|616633659|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
170623657|NCT01972217|616633660|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
170669616|NCT00347360|616801155|FG006|Overall Study|Prolonged duration between visits|0|||
170623658|NCT01972217|616633661|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
170623659|NCT01972217|616633658|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
170623660|NCT01972217|616633659|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
170623661|NCT01972217|616633660|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
170623662|NCT01972217|616633661|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
170623663|NCT01972217|616633658|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
170623664|NCT01972217|616633659|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
170623665|NCT01972217|616633660|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
170623666|NCT01972217|616633661|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
170623667|NCT04515771|616633666|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
170623668|NCT04515771|616633667|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
170623669|NCT04515771|616633666|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
170623670|NCT04515771|616633667|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
170623671|NCT04515771|616633666|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
170623672|NCT04515771|616633667|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
170623673|NCT00755183|616633668|FG000|Overall Study|Adverse Event|5|||
170623674|NCT00755183|616633669|FG001|Overall Study|Adverse Event|2|||
170623675|NCT00755183|616633668|FG000|Overall Study|Protocol Violation|0|||
170623676|NCT00755183|616633669|FG001|Overall Study|Protocol Violation|1|||
170623677|NCT00755183|616633668|FG000|Overall Study|Withdrawal by Subject|0|||
170623678|NCT00755183|616633669|FG001|Overall Study|Withdrawal by Subject|2|||
170623679|NCT00755183|616633668|FG000|Overall Study|Administrative|2|||
170623680|NCT00755183|616633669|FG001|Overall Study|Administrative|1|||
170623681|NCT00313014|616633671|FG000|Overall Study|Withdrawal by Subject|11|||
170623682|NCT00313014|616633672|FG001|Overall Study|Withdrawal by Subject|7|||
170623683|NCT00313014|616633673|FG002|Overall Study|Withdrawal by Subject|5|||
170623684|NCT00313014|616633671|FG000|Overall Study|Adverse Event|14|||
170623685|NCT00313014|616633672|FG001|Overall Study|Adverse Event|29|||
170623686|NCT00313014|616633673|FG002|Overall Study|Adverse Event|16|||
170623687|NCT00313014|616633671|FG000|Overall Study|Lost to Follow-up|7|||
170623688|NCT00313014|616633672|FG001|Overall Study|Lost to Follow-up|6|||
170623689|NCT00313014|616633673|FG002|Overall Study|Lost to Follow-up|10|||
170623690|NCT00313014|616633671|FG000|Overall Study|Administrative|9|||
170623691|NCT00313014|616633672|FG001|Overall Study|Administrative|6|||
170623692|NCT00313014|616633673|FG002|Overall Study|Administrative|14|||
170623693|NCT00313014|616633671|FG000|Overall Study|Lack of Efficacy|52|||
170623694|NCT00313014|616633672|FG001|Overall Study|Lack of Efficacy|25|||
170623695|NCT00313014|616633673|FG002|Overall Study|Lack of Efficacy|16|||
170623696|NCT03623243|616633674|FG000|Overall Study|Adverse Event|15|||
170623697|NCT03623243|616633674|FG000|Overall Study|Guardian Decision|1|||
170623698|NCT03623243|616633674|FG000|Overall Study|New Therapy for Study Indication|1|||
170623699|NCT03623243|616633674|FG000|Overall Study|Protocol Deviation|3|||
170623700|NCT03623243|616633674|FG000|Overall Study|Physician Decision|4|||
170623701|NCT03623243|616633674|FG000|Overall Study|Patient Decision|15|||
170623702|NCT04516746|616633675|FG000|Overall Study|Randomized but not Treated|51|||
170623703|NCT04516746|616633676|FG001|Overall Study|Randomized but not Treated|19|||
170623704|NCT04516746|616633675|FG000|Overall Study|Adverse Event|0|||
170623705|NCT04516746|616633676|FG001|Overall Study|Adverse Event|1|||
170623706|NCT04516746|616633675|FG000|Overall Study|Death|62|||
170623707|NCT04516746|616633676|FG001|Overall Study|Death|32|||
170623708|NCT04516746|616633675|FG000|Overall Study|Lost to Follow-up|3431|||
170623709|NCT04516746|616633676|FG001|Overall Study|Lost to Follow-up|1831|||
170623710|NCT04516746|616633675|FG000|Overall Study|Withdrawal by Subject|1946|||
170623711|NCT04516746|616633676|FG001|Overall Study|Withdrawal by Subject|1696|||
170623712|NCT04516746|616633675|FG000|Overall Study|Physician Decision|10|||
170623713|NCT04516746|616633676|FG001|Overall Study|Physician Decision|8|||
170623714|NCT04516746|616633675|FG000|Overall Study|Other|35|||
170623715|NCT04516746|616633676|FG001|Overall Study|Other|16|||
170623716|NCT03489863|616633677|FG000|Overall Study|Withdrawal by Subject|0|||
170623717|NCT03489863|616633678|FG001|Overall Study|Withdrawal by Subject|1|||
170623718|NCT03115359|616633679|FG000|Overall Study|Withdrawal by Subject|29|||
170623719|NCT03115359|616633680|FG001|Overall Study|Withdrawal by Subject|39|||
170623720|NCT03115359|616633679|FG000|Overall Study|Scheduling conflict|25|||
170623721|NCT03115359|616633680|FG001|Overall Study|Scheduling conflict|23|||
170623722|NCT03115359|616633679|FG000|Overall Study|Personal reasons including health|12|||
170623723|NCT03115359|616633680|FG001|Overall Study|Personal reasons including health|9|||
170623724|NCT03115359|616633679|FG000|Overall Study|Transportation barriers|3|||
170623725|NCT03115359|616633680|FG001|Overall Study|Transportation barriers|0|||
170623726|NCT03115359|616633679|FG000|Overall Study|No longer interested|5|||
170623727|NCT03115359|616633680|FG001|Overall Study|No longer interested|4|||
170623728|NCT03115359|616633679|FG000|Overall Study|No reason provided|45|||
170623729|NCT03115359|616633680|FG001|Overall Study|No reason provided|47|||
170623730|NCT01317472|616633683|FG000|Overall Study|Withdrawal by Subject|1|||
170623731|NCT01317472|616633684|FG001|Overall Study|Withdrawal by Subject|0|||
170623732|NCT01317472|616633683|FG000|Overall Study|Unrelated hospitalization|1|||
170623733|NCT01317472|616633684|FG001|Overall Study|Unrelated hospitalization|0|||
170623734|NCT01815918|616633685|FG000|Overall Study|Patient samples not analyzable|3|||
170623735|NCT01815918|616633686|FG001|Overall Study|Patient samples not analyzable|4|||
170623736|NCT01815918|616633685|FG000|Overall Study|Lack of Efficacy|15|||
170623737|NCT01815918|616633686|FG001|Overall Study|Lack of Efficacy|15|||
170623738|NCT04742556|616633691|FG000|Overall Study|Withdrawal by Subject|0|||
170623739|NCT04742556|616633692|FG001|Overall Study|Withdrawal by Subject|1|||
170623740|NCT04742556|616633693|FG002|Overall Study|Withdrawal by Subject|0|||
170623741|NCT04742556|616633691|FG000|Overall Study|Adverse Event|0|||
170623742|NCT04742556|616633692|FG001|Overall Study|Adverse Event|0|||
170623743|NCT04742556|616633693|FG002|Overall Study|Adverse Event|2|||
170623744|NCT04742556|616633691|FG000|Overall Study|Clinical disease progression|0|||
170623745|NCT04742556|616633692|FG001|Overall Study|Clinical disease progression|1|||
170623746|NCT04742556|616633693|FG002|Overall Study|Clinical disease progression|2|||
170623747|NCT04742556|616633691|FG000|Overall Study|Objective disease progression|3|||
170623748|NCT04742556|616633692|FG001|Overall Study|Objective disease progression|2|||
170623749|NCT04742556|616633693|FG002|Overall Study|Objective disease progression|4|||
170623750|NCT02903771|616633694|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
170623751|NCT02903771|616633695|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
170623752|NCT02903771|616633696|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
170623753|NCT02903771|616633697|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
170623754|NCT02903771|616633698|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
170623755|NCT02903771|616633699|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
170623756|NCT02903771|616633700|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
170623757|NCT02903771|616633694|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
170623758|NCT02903771|616633695|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
170623759|NCT02903771|616633696|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
170623760|NCT02903771|616633697|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
170623761|NCT02903771|616633698|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
170623762|NCT02903771|616633699|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
170623763|NCT02903771|616633700|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
170623764|NCT02903771|616633694|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
170623765|NCT02903771|616633695|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
170623766|NCT02903771|616633696|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
170623767|NCT02903771|616633697|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
170623768|NCT02903771|616633698|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
170623769|NCT02903771|616633699|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
170623770|NCT02903771|616633700|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
170623771|NCT02903771|616633694|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
170623772|NCT02903771|616633695|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
170623773|NCT02903771|616633696|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
170623774|NCT02903771|616633697|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
170623775|NCT02903771|616633698|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
170623776|NCT02903771|616633699|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
170623777|NCT02903771|616633700|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
170623778|NCT02903771|616633694|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
170623779|NCT02903771|616633695|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
170623780|NCT02903771|616633696|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
170623781|NCT02903771|616633697|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
170623782|NCT02903771|616633698|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
170623783|NCT02903771|616633699|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
170623784|NCT02903771|616633700|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
170623785|NCT02903771|616633694|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
170623786|NCT02903771|616633695|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
170623787|NCT02903771|616633696|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
170623788|NCT02903771|616633697|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
170623789|NCT02903771|616633698|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
170623790|NCT02903771|616633699|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
170623791|NCT02903771|616633700|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
170623792|NCT02903771|616633694|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
170623793|NCT02903771|616633695|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
170623794|NCT02903771|616633696|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
170623795|NCT02903771|616633697|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
170623796|NCT02903771|616633698|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
170623797|NCT02903771|616633699|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
170623798|NCT02903771|616633700|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
170623799|NCT02903771|616633694|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
170623800|NCT02903771|616633695|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
170623801|NCT02903771|616633696|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
170623802|NCT02903771|616633697|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
170623803|NCT02903771|616633698|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
170623804|NCT02903771|616633699|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
170623805|NCT02903771|616633700|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
170623806|NCT02903771|616633694|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
170623807|NCT02903771|616633695|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
170623808|NCT02903771|616633696|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
170623809|NCT02903771|616633697|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
170623810|NCT02903771|616633698|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
170623811|NCT02903771|616633699|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
170623812|NCT02903771|616633700|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
170623813|NCT02903771|616633694|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
170623814|NCT02903771|616633695|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
170623815|NCT02903771|616633696|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
170623816|NCT02903771|616633697|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
170623817|NCT02903771|616633698|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
170623818|NCT02903771|616633699|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
170623819|NCT02903771|616633700|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
170623820|NCT02903771|616633694|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
170623821|NCT02903771|616633695|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
170623822|NCT02903771|616633696|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
170623823|NCT02903771|616633697|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
170623824|NCT02903771|616633698|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
170623825|NCT02903771|616633699|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
170623826|NCT02903771|616633700|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
170623827|NCT04247347|616633703|FG000|Overall Study|Withdrawal by Subject|2|||
170623828|NCT04247347|616633704|FG001|Overall Study|Withdrawal by Subject|3|||
170623829|NCT04247347|616633705|FG002|Overall Study|Withdrawal by Subject|3|||
170623830|NCT04247347|616633703|FG000|Overall Study|Lost to Follow-up|1|||
170623831|NCT04247347|616633704|FG001|Overall Study|Lost to Follow-up|1|||
170623832|NCT04247347|616633705|FG002|Overall Study|Lost to Follow-up|1|||
170623833|NCT03035032|616633706|FG000|Overall Study|Adverse Event|2|||
170623834|NCT03035032|616633706|FG000|Overall Study|Death|9|||
170623835|NCT03035032|616633706|FG000|Overall Study|Lost to Follow-up|1|||
170623836|NCT03035032|616633706|FG000|Overall Study|Progressive Disease|22|||
170623837|NCT03035032|616633706|FG000|Overall Study|Protocol Violation|2|||
170623838|NCT03035032|616633706|FG000|Overall Study|Withdrawal by Subject|2|||
170623839|NCT03035032|616633706|FG000|Overall Study|Physician Decision|5|||
170623840|NCT03562195|616633707|FG000|Overall Study|Adverse Event|0|||
170623841|NCT03562195|616633708|FG001|Overall Study|Adverse Event|6|||
170623842|NCT03562195|616633707|FG000|Overall Study|Lack of Efficacy|0|||
170623843|NCT03562195|616633708|FG001|Overall Study|Lack of Efficacy|5|||
170623844|NCT03562195|616633707|FG000|Overall Study|Protocol Violation|0|||
170623845|NCT03562195|616633708|FG001|Overall Study|Protocol Violation|1|||
170623846|NCT03562195|616633707|FG000|Overall Study|Lost to Follow-up|0|||
170623847|NCT03562195|616633708|FG001|Overall Study|Lost to Follow-up|1|||
170623848|NCT03562195|616633707|FG000|Overall Study|Physician Decision|1|||
170623849|NCT03562195|616633708|FG001|Overall Study|Physician Decision|0|||
170623850|NCT03562195|616633707|FG000|Overall Study|Withdrawal by Subject|3|||
170623851|NCT03562195|616633708|FG001|Overall Study|Withdrawal by Subject|0|||
170623852|NCT02218372|616633709|FG000|Overall Study|Adverse Event|1|||
170623853|NCT02218372|616633710|FG001|Overall Study|Adverse Event|1|||
170623854|NCT02218372|616633709|FG000|Overall Study|Miscellaneous|2|||
170623855|NCT02218372|616633710|FG001|Overall Study|Miscellaneous|1|||
170623856|NCT02218372|616633709|FG000|Overall Study|Randomized but did not receive treatment|2|||
170623857|NCT02218372|616633710|FG001|Overall Study|Randomized but did not receive treatment|3|||
170623858|NCT02218372|616633709|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170623859|NCT02218372|616633710|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170623860|NCT00001832|616633711|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
170623861|NCT00001832|616633712|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
170623862|NCT00001832|616633713|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
170623863|NCT00001832|616633714|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
170623864|NCT00001832|616633715|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
170623865|NCT00001832|616633716|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
170623866|NCT00001832|616633717|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
170623867|NCT00001832|616633718|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
170623868|NCT00001832|616633719|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
170623869|NCT00001832|616633720|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
170623870|NCT00001832|616633721|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
170623871|NCT00001832|616633722|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
170623872|NCT00001832|616633723|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
170623873|NCT00001832|616633724|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
170623874|NCT00001832|616633725|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
170623875|NCT00001832|616633711|FG000|Treatment Period|Death during treatment|0|||
170623876|NCT00001832|616633712|FG001|Treatment Period|Death during treatment|0|||
170623877|NCT00001832|616633713|FG002|Treatment Period|Death during treatment|0|||
170623878|NCT00001832|616633714|FG003|Treatment Period|Death during treatment|0|||
170623879|NCT00001832|616633715|FG004|Treatment Period|Death during treatment|0|||
170623880|NCT00001832|616633716|FG005|Treatment Period|Death during treatment|1|||
170623881|NCT00001832|616633717|FG006|Treatment Period|Death during treatment|0|||
170623882|NCT00001832|616633718|FG007|Treatment Period|Death during treatment|0|||
170623883|NCT00001832|616633719|FG008|Treatment Period|Death during treatment|0|||
170623884|NCT00001832|616633720|FG009|Treatment Period|Death during treatment|0|||
170623885|NCT00001832|616633721|FG010|Treatment Period|Death during treatment|0|||
170623886|NCT00001832|616633722|FG011|Treatment Period|Death during treatment|0|||
170623887|NCT00001832|616633723|FG012|Treatment Period|Death during treatment|0|||
170623888|NCT00001832|616633724|FG013|Treatment Period|Death during treatment|0|||
170623889|NCT00001832|616633725|FG014|Treatment Period|Death during treatment|0|||
170623890|NCT00001832|616633711|FG000|Treatment Period|Not treated|0|||
170623891|NCT00001832|616633712|FG001|Treatment Period|Not treated|0|||
170623892|NCT00001832|616633713|FG002|Treatment Period|Not treated|0|||
170623893|NCT00001832|616633714|FG003|Treatment Period|Not treated|0|||
170623894|NCT00001832|616633715|FG004|Treatment Period|Not treated|0|||
170623895|NCT00001832|616633716|FG005|Treatment Period|Not treated|0|||
170623896|NCT00001832|616633717|FG006|Treatment Period|Not treated|0|||
170623897|NCT00001832|616633718|FG007|Treatment Period|Not treated|1|||
170623898|NCT00001832|616633719|FG008|Treatment Period|Not treated|0|||
170623899|NCT00001832|616633720|FG009|Treatment Period|Not treated|0|||
170623900|NCT00001832|616633721|FG010|Treatment Period|Not treated|0|||
170623901|NCT00001832|616633722|FG011|Treatment Period|Not treated|0|||
170623902|NCT00001832|616633723|FG012|Treatment Period|Not treated|0|||
170623903|NCT00001832|616633724|FG013|Treatment Period|Not treated|0|||
170623904|NCT00001832|616633725|FG014|Treatment Period|Not treated|0|||
170623905|NCT05106959|616633726|FG000|Overall Study|Lost to Follow-up|1|||
170623906|NCT03448406|616633727|FG000|Overall Study|Noncompliance of scheduled visits|1|||
170623907|NCT03448406|616633728|FG001|Overall Study|Noncompliance of scheduled visits|2|||
170623908|NCT03448406|616633727|FG000|Overall Study|Withdrawal by Subject|1|||
170623909|NCT03448406|616633728|FG001|Overall Study|Withdrawal by Subject|2|||
170623910|NCT03448406|616633727|FG000|Overall Study|Protocol Violation|1|||
170623911|NCT03448406|616633728|FG001|Overall Study|Protocol Violation|0|||
170623912|NCT03448406|616633727|FG000|Overall Study|Adverse Event|8|||
170623913|NCT03448406|616633728|FG001|Overall Study|Adverse Event|9|||
170623914|NCT02756338|616633731|FG000|Overall Study|Withdrawn by Investigator|1|||
170623915|NCT02756338|616633731|FG000|Overall Study|Device Replaced with Pacemaker|4|||
170623916|NCT03186209|616633732|FG000|Overall Study|Withdrawal by Subject|11|||
170623917|NCT03186209|616633733|FG001|Overall Study|Withdrawal by Subject|22|||
170819744|NCT00296504|617347683|FG008|Interim Analysis|To Simplify Treatment|0|||
170623918|NCT03186209|616633732|FG000|Overall Study|Pregnancy|1|||
170819745|NCT00296504|617347675|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
170819746|NCT00296504|617347676|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
170623919|NCT03186209|616633733|FG001|Overall Study|Pregnancy|0|||
170623920|NCT03186209|616633732|FG000|Overall Study|Adverse Event|4|||
170623921|NCT03186209|616633733|FG001|Overall Study|Adverse Event|0|||
170623922|NCT03186209|616633732|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
170623923|NCT03186209|616633733|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
170623924|NCT03186209|616633732|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
170623925|NCT03186209|616633733|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
170623926|NCT03186209|616633732|FG000|Overall Study|Fail to meet randomization criteria|0|||
170623927|NCT03186209|616633733|FG001|Overall Study|Fail to meet randomization criteria|1|||
170623928|NCT03186209|616633732|FG000|Overall Study|Lost to Follow-up|0|||
170623929|NCT03186209|616633733|FG001|Overall Study|Lost to Follow-up|1|||
170623930|NCT05121766|616633735|FG000|Overall Study|Covid reinfection|3|||
170623931|NCT05121766|616633736|FG001|Overall Study|Covid reinfection|0|||
170623932|NCT05121766|616633735|FG000|Overall Study|Withdrawal by Subject|3|||
170623933|NCT05121766|616633736|FG001|Overall Study|Withdrawal by Subject|1|||
170623934|NCT05121766|616633735|FG000|Overall Study|Adverse Event|2|||
170623935|NCT05121766|616633736|FG001|Overall Study|Adverse Event|4|||
170623936|NCT05121766|616633735|FG000|Overall Study|Lost to Follow-up|0|||
170623937|NCT05121766|616633736|FG001|Overall Study|Lost to Follow-up|1|||
170623938|NCT04059549|616633737|FG000|Overall Study|Withdrawal by Subject|2|||
170623939|NCT04059549|616633738|FG001|Overall Study|Withdrawal by Subject|0|||
170623940|NCT02678351|616633739|FG000|Overall Study|Withdrawal by Subject|1|||
170623941|NCT01919229|616633740|FG000|Overall Study|Subject/guardian decision|0|||
170623942|NCT01919229|616633741|FG001|Overall Study|Subject/guardian decision|0|||
170623943|NCT01919229|616633742|FG002|Overall Study|Subject/guardian decision|1|||
170623944|NCT01632020|616633743|FG000|Overall Study|Withdrawal by Subject|1|||
170623945|NCT01632020|616633744|FG001|Overall Study|Withdrawal by Subject|0|||
170623946|NCT01632020|616633743|FG000|Overall Study|Adverse Event|1|||
170623947|NCT01632020|616633744|FG001|Overall Study|Adverse Event|0|||
170623948|NCT04716426|616633745|FG000|Overall Study|Vaccination|1|||
170623949|NCT04716426|616633746|FG001|Overall Study|Vaccination|1|||
170623950|NCT04716426|616633745|FG000|Overall Study|Contamination|1|||
170623951|NCT04716426|616633746|FG001|Overall Study|Contamination|0|||
170623952|NCT00377520|616633747|FG000|Overall Study|Ineligible (Prior radiation)|1|||
170623953|NCT00982735|616633748|FG000|Overall Study|Lost to Follow-up|6|||
170623954|NCT00982735|616633748|FG000|Overall Study|Patient ineligible for trial|224|||
170623955|NCT02734693|616633749|FG000|Overall Study|Adverse Event|1|||
170623956|NCT02734693|616633750|FG001|Overall Study|Adverse Event|3|||
170623957|NCT02734693|616633751|FG002|Overall Study|Adverse Event|3|||
170623958|NCT02734693|616633749|FG000|Overall Study|Lack of Efficacy|1|||
170623959|NCT02734693|616633750|FG001|Overall Study|Lack of Efficacy|0|||
170623960|NCT02734693|616633751|FG002|Overall Study|Lack of Efficacy|0|||
170623961|NCT02734693|616633749|FG000|Overall Study|Lost to Follow-up|2|||
170623962|NCT02734693|616633750|FG001|Overall Study|Lost to Follow-up|0|||
170623963|NCT02734693|616633751|FG002|Overall Study|Lost to Follow-up|0|||
170623964|NCT02734693|616633749|FG000|Overall Study|Protocol Violation|1|||
170623965|NCT02734693|616633750|FG001|Overall Study|Protocol Violation|0|||
170623966|NCT02734693|616633751|FG002|Overall Study|Protocol Violation|0|||
170623967|NCT02734693|616633749|FG000|Overall Study|Withdrawal by Subject|1|||
170623968|NCT02734693|616633750|FG001|Overall Study|Withdrawal by Subject|0|||
170623969|NCT02734693|616633751|FG002|Overall Study|Withdrawal by Subject|0|||
170623970|NCT03740048|616633752|FG000|Overall Study|Withdrawal by Subject|1|||
170623971|NCT03740048|616633753|FG001|Overall Study|Withdrawal by Subject|1|||
170623972|NCT03740048|616633752|FG000|Overall Study|Death|1|||
170623973|NCT03740048|616633753|FG001|Overall Study|Death|6|||
170623974|NCT03740048|616633752|FG000|Overall Study|Switched to thrice-weekly HD|2|||
170623975|NCT03740048|616633753|FG001|Overall Study|Switched to thrice-weekly HD|0|||
170623976|NCT03740048|616633752|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
170623977|NCT03740048|616633753|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
170623978|NCT03740048|616633752|FG000|Overall Study|Lost to Follow-up|0|||
170623979|NCT03740048|616633753|FG001|Overall Study|Lost to Follow-up|1|||
170623980|NCT03740048|616633752|FG000|Overall Study|Non-compliance with HD|0|||
170623981|NCT03740048|616633753|FG001|Overall Study|Non-compliance with HD|1|||
170623982|NCT03261336|616633754|FG000|Overall Study|Adverse Event|1|||
170623983|NCT03624881|616633760|FG000|Overall Study|Screen Failure|14|||
170623984|NCT03624881|616633761|FG001|Overall Study|Screen Failure|0|||
170623985|NCT03624881|616633760|FG000|Overall Study|No Catheter Inserted|6|||
170623986|NCT03624881|616633761|FG001|Overall Study|No Catheter Inserted|1|||
170623987|NCT03624881|616633760|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
170623988|NCT03624881|616633761|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
170623989|NCT03624881|616633760|FG000|Overall Study|Death|2|||
170623990|NCT03624881|616633761|FG001|Overall Study|Death|0|||
170623991|NCT03624881|616633760|FG000|Overall Study|Lost to Follow-up|10|||
170623992|NCT03624881|616633761|FG001|Overall Study|Lost to Follow-up|4|||
170623993|NCT03624881|616633760|FG000|Overall Study|Withdrawal by Subject|12|||
170623994|NCT03624881|616633761|FG001|Overall Study|Withdrawal by Subject|1|||
170623995|NCT02343263|616633762|FG000|Overall Study|Physician Decision|5|||
170623996|NCT02343263|616633763|FG001|Overall Study|Physician Decision|3|||
170623997|NCT02343263|616633764|FG002|Overall Study|Physician Decision|1|||
170623998|NCT04264442|616633765|FG000|Overall Study|Lack of Efficacy|6|||
170623999|NCT04264442|616633765|FG000|Overall Study|Lost to Follow-up|2|||
170624000|NCT04264442|616633765|FG000|Overall Study|Sponsor Decision|23|||
170624001|NCT04264442|616633765|FG000|Overall Study|Withdrawal by Subject|11|||
170624002|NCT04264442|616633765|FG000|Overall Study|Study Termination|5|||
170624003|NCT03309020|616633768|FG000|Overall Study|Death|1|||
170624004|NCT03309020|616633769|FG001|Overall Study|Death|0|||
170624005|NCT03309020|616633768|FG000|Overall Study|Did not undergo surgery|2|||
170624006|NCT03309020|616633769|FG001|Overall Study|Did not undergo surgery|1|||
170624007|NCT02362724|616633775|FG000|Overall Study|Withdrawal by Subject|3|||
170624008|NCT02362724|616633776|FG001|Overall Study|Withdrawal by Subject|1|||
170624009|NCT02362724|616633775|FG000|Overall Study|Adverse Event|3|||
170624010|NCT02362724|616633776|FG001|Overall Study|Adverse Event|0|||
170624011|NCT02370420|616633777|FG000|Overall Study|Physician Decision|3|||
170624012|NCT02370420|616633778|FG001|Overall Study|Physician Decision|3|||
170624013|NCT02370420|616633777|FG000|Overall Study|Lost to Follow-up|11|||
170624014|NCT02370420|616633778|FG001|Overall Study|Lost to Follow-up|9|||
170624015|NCT05893862|616633779|FG000|Overall Study|Physician Decision|0|||
170624016|NCT05893862|616633780|FG001|Overall Study|Physician Decision|1|||
170624017|NCT05893862|616633781|FG002|Overall Study|Physician Decision|0|||
170624018|NCT05893862|616633782|FG003|Overall Study|Physician Decision|0|||
170624019|NCT05893862|616633783|FG004|Overall Study|Physician Decision|1|||
170624020|NCT05893862|616633784|FG005|Overall Study|Physician Decision|0|||
170624021|NCT05893862|616633779|FG000|Overall Study|Withdrawal by Subject|1|||
170624022|NCT05893862|616633780|FG001|Overall Study|Withdrawal by Subject|7|||
170624023|NCT05893862|616633781|FG002|Overall Study|Withdrawal by Subject|1|||
170624024|NCT05893862|616633782|FG003|Overall Study|Withdrawal by Subject|3|||
170624025|NCT05893862|616633783|FG004|Overall Study|Withdrawal by Subject|3|||
170624026|NCT05893862|616633784|FG005|Overall Study|Withdrawal by Subject|2|||
170624027|NCT05893862|616633779|FG000|Overall Study|Adverse Event|1|||
170624028|NCT05893862|616633780|FG001|Overall Study|Adverse Event|4|||
170624029|NCT05893862|616633781|FG002|Overall Study|Adverse Event|2|||
170624030|NCT05893862|616633782|FG003|Overall Study|Adverse Event|2|||
170624031|NCT05893862|616633783|FG004|Overall Study|Adverse Event|1|||
170624032|NCT05893862|616633784|FG005|Overall Study|Adverse Event|0|||
170624033|NCT04158583|616633785|FG000|Overall Study|Withdrawal by Subject|1|||
170624034|NCT04158583|616633786|FG001|Overall Study|Withdrawal by Subject|1|||
170624035|NCT04158583|616633787|FG002|Overall Study|Withdrawal by Subject|0|||
170624036|NCT04158583|616633788|FG003|Overall Study|Withdrawal by Subject|0|||
170624037|NCT04158583|616633789|FG004|Overall Study|Withdrawal by Subject|1|||
170624038|NCT04158583|616633790|FG005|Overall Study|Withdrawal by Subject|0|||
170624039|NCT04158583|616633791|FG006|Overall Study|Withdrawal by Subject|0|||
170624040|NCT04158583|616633792|FG007|Overall Study|Withdrawal by Subject|0|||
170624041|NCT04158583|616633793|FG008|Overall Study|Withdrawal by Subject|2|||
170624042|NCT04158583|616633794|FG009|Overall Study|Withdrawal by Subject|0|||
170624043|NCT04158583|616633785|FG000|Overall Study|Study Terminated by Sponsor|0|||
170624044|NCT04158583|616633786|FG001|Overall Study|Study Terminated by Sponsor|0|||
170624045|NCT04158583|616633787|FG002|Overall Study|Study Terminated by Sponsor|0|||
170624046|NCT04158583|616633788|FG003|Overall Study|Study Terminated by Sponsor|1|||
170624047|NCT04158583|616633789|FG004|Overall Study|Study Terminated by Sponsor|0|||
170624048|NCT04158583|616633790|FG005|Overall Study|Study Terminated by Sponsor|0|||
170669617|NCT00347360|616801156|FG007|Overall Study|Prolonged duration between visits|0|||
170669618|NCT00347360|616801157|FG008|Overall Study|Prolonged duration between visits|0|||
170669619|NCT00347360|616801158|FG009|Overall Study|Prolonged duration between visits|0|||
170624049|NCT04158583|616633791|FG006|Overall Study|Study Terminated by Sponsor|0|||
170624050|NCT04158583|616633792|FG007|Overall Study|Study Terminated by Sponsor|0|||
170624051|NCT04158583|616633793|FG008|Overall Study|Study Terminated by Sponsor|0|||
170624052|NCT04158583|616633794|FG009|Overall Study|Study Terminated by Sponsor|0|||
170624053|NCT04158583|616633785|FG000|Overall Study|Progressive Disease|1|||
170624054|NCT04158583|616633786|FG001|Overall Study|Progressive Disease|0|||
170624055|NCT04158583|616633787|FG002|Overall Study|Progressive Disease|3|||
170624056|NCT04158583|616633788|FG003|Overall Study|Progressive Disease|5|||
170624057|NCT04158583|616633789|FG004|Overall Study|Progressive Disease|0|||
170624058|NCT04158583|616633790|FG005|Overall Study|Progressive Disease|1|||
170624059|NCT04158583|616633791|FG006|Overall Study|Progressive Disease|6|||
170624060|NCT04158583|616633792|FG007|Overall Study|Progressive Disease|2|||
170624061|NCT04158583|616633793|FG008|Overall Study|Progressive Disease|1|||
170624062|NCT04158583|616633794|FG009|Overall Study|Progressive Disease|2|||
170624063|NCT04158583|616633785|FG000|Overall Study|Lost to Follow-up|0|||
170624064|NCT04158583|616633786|FG001|Overall Study|Lost to Follow-up|0|||
170624065|NCT04158583|616633787|FG002|Overall Study|Lost to Follow-up|1|||
170624066|NCT04158583|616633788|FG003|Overall Study|Lost to Follow-up|1|||
170624067|NCT04158583|616633789|FG004|Overall Study|Lost to Follow-up|1|||
170624068|NCT04158583|616633790|FG005|Overall Study|Lost to Follow-up|0|||
170624069|NCT04158583|616633791|FG006|Overall Study|Lost to Follow-up|0|||
170624070|NCT04158583|616633792|FG007|Overall Study|Lost to Follow-up|0|||
170624071|NCT04158583|616633793|FG008|Overall Study|Lost to Follow-up|0|||
170624072|NCT04158583|616633794|FG009|Overall Study|Lost to Follow-up|0|||
170624073|NCT04158583|616633785|FG000|Overall Study|Due To Patient Status|0|||
170624074|NCT04158583|616633786|FG001|Overall Study|Due To Patient Status|0|||
170624075|NCT04158583|616633787|FG002|Overall Study|Due To Patient Status|0|||
170624076|NCT04158583|616633788|FG003|Overall Study|Due To Patient Status|0|||
170624077|NCT04158583|616633789|FG004|Overall Study|Due To Patient Status|0|||
170624078|NCT04158583|616633790|FG005|Overall Study|Due To Patient Status|0|||
170624079|NCT04158583|616633791|FG006|Overall Study|Due To Patient Status|0|||
170624080|NCT04158583|616633792|FG007|Overall Study|Due To Patient Status|0|||
170624081|NCT04158583|616633793|FG008|Overall Study|Due To Patient Status|1|||
170624082|NCT04158583|616633794|FG009|Overall Study|Due To Patient Status|0|||
170624083|NCT04158583|616633785|FG000|Overall Study|Death|3|||
170624084|NCT04158583|616633786|FG001|Overall Study|Death|4|||
170624085|NCT04158583|616633787|FG002|Overall Study|Death|2|||
170669620|NCT00347360|616801159|FG010|Overall Study|Prolonged duration between visits|0|||
170669621|NCT00347360|616801160|FG011|Overall Study|Prolonged duration between visits|0|||
170669622|NCT00347360|616801161|FG012|Overall Study|Prolonged duration between visits|1|||
170669623|NCT00347360|616801162|FG013|Overall Study|Prolonged duration between visits|0|||
170669624|NCT00347360|616801163|FG014|Overall Study|Prolonged duration between visits|0|||
170669625|NCT00347360|616801149|FG000|Overall Study|Subject left town, ran out of study drug|0|||
170669626|NCT00347360|616801150|FG001|Overall Study|Subject left town, ran out of study drug|0|||
170669627|NCT00347360|616801151|FG002|Overall Study|Subject left town, ran out of study drug|0|||
170669628|NCT00347360|616801152|FG003|Overall Study|Subject left town, ran out of study drug|0|||
170669629|NCT00347360|616801153|FG004|Overall Study|Subject left town, ran out of study drug|0|||
170669630|NCT00347360|616801154|FG005|Overall Study|Subject left town, ran out of study drug|0|||
170669631|NCT00347360|616801155|FG006|Overall Study|Subject left town, ran out of study drug|0|||
170669632|NCT00347360|616801156|FG007|Overall Study|Subject left town, ran out of study drug|0|||
170669633|NCT00347360|616801157|FG008|Overall Study|Subject left town, ran out of study drug|0|||
170669634|NCT00347360|616801158|FG009|Overall Study|Subject left town, ran out of study drug|0|||
170669635|NCT00347360|616801159|FG010|Overall Study|Subject left town, ran out of study drug|0|||
170669636|NCT00347360|616801160|FG011|Overall Study|Subject left town, ran out of study drug|0|||
170669637|NCT00347360|616801161|FG012|Overall Study|Subject left town, ran out of study drug|0|||
170669638|NCT00347360|616801162|FG013|Overall Study|Subject left town, ran out of study drug|1|||
170669639|NCT00347360|616801163|FG014|Overall Study|Subject left town, ran out of study drug|0|||
170669640|NCT00347360|616801149|FG000|Overall Study|Subject refuse to sign updated consent|0|||
170669641|NCT00347360|616801150|FG001|Overall Study|Subject refuse to sign updated consent|0|||
170669642|NCT00347360|616801151|FG002|Overall Study|Subject refuse to sign updated consent|0|||
170669643|NCT00347360|616801152|FG003|Overall Study|Subject refuse to sign updated consent|0|||
170624086|NCT04158583|616633788|FG003|Overall Study|Death|2|||
170624087|NCT04158583|616633789|FG004|Overall Study|Death|4|||
170624088|NCT04158583|616633790|FG005|Overall Study|Death|3|||
170624089|NCT04158583|616633791|FG006|Overall Study|Death|5|||
170624090|NCT04158583|616633792|FG007|Overall Study|Death|2|||
170624091|NCT04158583|616633793|FG008|Overall Study|Death|0|||
170624092|NCT04158583|616633794|FG009|Overall Study|Death|1|||
170624093|NCT04158583|616633785|FG000|Overall Study|Clinical Progression Disease|0|||
170624094|NCT04158583|616633786|FG001|Overall Study|Clinical Progression Disease|0|||
170624095|NCT04158583|616633787|FG002|Overall Study|Clinical Progression Disease|0|||
170624096|NCT04158583|616633788|FG003|Overall Study|Clinical Progression Disease|1|||
170624097|NCT04158583|616633789|FG004|Overall Study|Clinical Progression Disease|0|||
170624098|NCT04158583|616633790|FG005|Overall Study|Clinical Progression Disease|0|||
170624099|NCT04158583|616633791|FG006|Overall Study|Clinical Progression Disease|0|||
170624100|NCT04158583|616633792|FG007|Overall Study|Clinical Progression Disease|0|||
170624101|NCT04158583|616633793|FG008|Overall Study|Clinical Progression Disease|0|||
170624102|NCT04158583|616633794|FG009|Overall Study|Clinical Progression Disease|0|||
170624103|NCT04158583|616633785|FG000|Overall Study|Clinical Progression|0|||
170624104|NCT04158583|616633786|FG001|Overall Study|Clinical Progression|0|||
170624105|NCT04158583|616633787|FG002|Overall Study|Clinical Progression|0|||
170624106|NCT04158583|616633788|FG003|Overall Study|Clinical Progression|0|||
170624107|NCT04158583|616633789|FG004|Overall Study|Clinical Progression|1|||
170624108|NCT04158583|616633790|FG005|Overall Study|Clinical Progression|0|||
170624109|NCT04158583|616633791|FG006|Overall Study|Clinical Progression|2|||
170624110|NCT04158583|616633792|FG007|Overall Study|Clinical Progression|0|||
170624111|NCT04158583|616633793|FG008|Overall Study|Clinical Progression|0|||
170624112|NCT04158583|616633794|FG009|Overall Study|Clinical Progression|0|||
170624113|NCT04158583|616633785|FG000|Overall Study|Clinical Deterioration|0|||
170624114|NCT04158583|616633786|FG001|Overall Study|Clinical Deterioration|0|||
170624115|NCT04158583|616633787|FG002|Overall Study|Clinical Deterioration|0|||
170624116|NCT04158583|616633788|FG003|Overall Study|Clinical Deterioration|1|||
170624117|NCT04158583|616633789|FG004|Overall Study|Clinical Deterioration|0|||
170624118|NCT04158583|616633790|FG005|Overall Study|Clinical Deterioration|0|||
170624119|NCT04158583|616633791|FG006|Overall Study|Clinical Deterioration|0|||
170624120|NCT04158583|616633792|FG007|Overall Study|Clinical Deterioration|0|||
170624121|NCT04158583|616633793|FG008|Overall Study|Clinical Deterioration|0|||
170624122|NCT04158583|616633794|FG009|Overall Study|Clinical Deterioration|1|||
170624123|NCT00979901|616635519|FG000|Overall Study|Adverse Event|1|||
170624124|NCT00979901|616635520|FG001|Overall Study|Adverse Event|3|||
170624125|NCT00979901|616635521|FG002|Overall Study|Adverse Event|9|||
170624126|NCT00979901|616635522|FG003|Overall Study|Adverse Event|2|||
170624127|NCT00979901|616635519|FG000|Overall Study|Lack of Efficacy|8|||
170624128|NCT00979901|616635520|FG001|Overall Study|Lack of Efficacy|4|||
170624129|NCT00979901|616635521|FG002|Overall Study|Lack of Efficacy|9|||
170624130|NCT00979901|616635522|FG003|Overall Study|Lack of Efficacy|0|||
170624131|NCT00979901|616635519|FG000|Overall Study|Lost to Follow-up|1|||
170624132|NCT00979901|616635520|FG001|Overall Study|Lost to Follow-up|1|||
170624133|NCT00979901|616635521|FG002|Overall Study|Lost to Follow-up|2|||
170624134|NCT00979901|616635522|FG003|Overall Study|Lost to Follow-up|0|||
170624135|NCT00979901|616635519|FG000|Overall Study|Protocol Violation|2|||
170624136|NCT00979901|616635520|FG001|Overall Study|Protocol Violation|2|||
170624137|NCT00979901|616635521|FG002|Overall Study|Protocol Violation|7|||
170624138|NCT00979901|616635522|FG003|Overall Study|Protocol Violation|1|||
170624139|NCT00979901|616635519|FG000|Overall Study|Withdrawal by Subject|2|||
170624140|NCT00979901|616635520|FG001|Overall Study|Withdrawal by Subject|1|||
170624141|NCT00979901|616635521|FG002|Overall Study|Withdrawal by Subject|1|||
170624142|NCT00979901|616635522|FG003|Overall Study|Withdrawal by Subject|1|||
170624143|NCT00979901|616635519|FG000|Overall Study|Noncompliance|1|||
170624144|NCT00979901|616635520|FG001|Overall Study|Noncompliance|0|||
170624145|NCT00979901|616635521|FG002|Overall Study|Noncompliance|0|||
170624146|NCT00979901|616635522|FG003|Overall Study|Noncompliance|0|||
170624147|NCT00979901|616635519|FG000|Overall Study|out-of-state|1|||
170624148|NCT00979901|616635520|FG001|Overall Study|out-of-state|0|||
170624149|NCT00979901|616635521|FG002|Overall Study|out-of-state|0|||
170624150|NCT00979901|616635522|FG003|Overall Study|out-of-state|0|||
170624151|NCT00979901|616635519|FG000|Overall Study|vacation|1|||
170624152|NCT00979901|616635520|FG001|Overall Study|vacation|0|||
170624153|NCT00979901|616635521|FG002|Overall Study|vacation|0|||
170624154|NCT00979901|616635522|FG003|Overall Study|vacation|0|||
170624155|NCT00979901|616635519|FG000|Overall Study|elevated lab values pre-randomization|1|||
170669644|NCT00347360|616801153|FG004|Overall Study|Subject refuse to sign updated consent|0|||
170669645|NCT00347360|616801154|FG005|Overall Study|Subject refuse to sign updated consent|0|||
170669646|NCT00347360|616801155|FG006|Overall Study|Subject refuse to sign updated consent|0|||
170669647|NCT00347360|616801156|FG007|Overall Study|Subject refuse to sign updated consent|0|||
170669648|NCT00347360|616801157|FG008|Overall Study|Subject refuse to sign updated consent|0|||
170624156|NCT00979901|616635520|FG001|Overall Study|elevated lab values pre-randomization|0|||
170624157|NCT00979901|616635521|FG002|Overall Study|elevated lab values pre-randomization|0|||
170669649|NCT00347360|616801158|FG009|Overall Study|Subject refuse to sign updated consent|0|||
170624158|NCT00979901|616635522|FG003|Overall Study|elevated lab values pre-randomization|0|||
170624159|NCT00979901|616635519|FG000|Overall Study|Discontinued in Error|0|||
170624160|NCT00979901|616635520|FG001|Overall Study|Discontinued in Error|1|||
170624161|NCT00979901|616635521|FG002|Overall Study|Discontinued in Error|0|||
170624162|NCT00979901|616635522|FG003|Overall Study|Discontinued in Error|0|||
170624163|NCT00979901|616635519|FG000|Overall Study|Left Country|0|||
170624164|NCT00979901|616635520|FG001|Overall Study|Left Country|0|||
170624165|NCT00979901|616635521|FG002|Overall Study|Left Country|1|||
170624166|NCT00979901|616635522|FG003|Overall Study|Left Country|0|||
170624167|NCT00979901|616635519|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
170624168|NCT00979901|616635520|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
170624169|NCT00979901|616635521|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
170624170|NCT00979901|616635522|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
170624171|NCT03924622|616635523|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
170624172|NCT03924622|616635524|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
170624173|NCT03924622|616635525|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
170624174|NCT03924622|616635526|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
170624175|NCT03924622|616635527|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
170624176|NCT03924622|616635528|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
170624177|NCT00248625|616635529|FG000|Overall Study|Withdrawal by Subject|0|||
170624178|NCT00248625|616635530|FG001|Overall Study|Withdrawal by Subject|2|||
170624179|NCT03085095|616635532|FG000|Overall Study|Adverse Event|23|||
170624180|NCT03085095|616635533|FG001|Overall Study|Adverse Event|8|||
170624181|NCT03085095|616635532|FG000|Overall Study|Protocol Violation|0|||
170624182|NCT03085095|616635533|FG001|Overall Study|Protocol Violation|1|||
170624183|NCT03085095|616635532|FG000|Overall Study|Lost to Follow-up|2|||
170624184|NCT03085095|616635533|FG001|Overall Study|Lost to Follow-up|1|||
170624185|NCT03085095|616635532|FG000|Overall Study|Withdrawal by Subject|17|||
170624186|NCT03085095|616635533|FG001|Overall Study|Withdrawal by Subject|6|||
170624187|NCT03085095|616635532|FG000|Overall Study|Physician Decision|9|||
170624188|NCT03085095|616635533|FG001|Overall Study|Physician Decision|3|||
170624189|NCT03085095|616635532|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
170624190|NCT03085095|616635533|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
170624191|NCT03085095|616635532|FG000|Overall Study|Did not Receive Study Drug|2|||
170624192|NCT03085095|616635533|FG001|Overall Study|Did not Receive Study Drug|2|||
170624193|NCT03085095|616635532|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
170624194|NCT03085095|616635533|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
170624195|NCT02814916|616635534|FG000|Overall Study|Withdrawal of consent|0|||
170624196|NCT02814916|616635535|FG001|Overall Study|Withdrawal of consent|2|||
170624197|NCT02814916|616635536|FG002|Overall Study|Withdrawal of consent|0|||
170624198|NCT02814916|616635534|FG000|Overall Study|Lost to Follow-up|0|||
170624199|NCT02814916|616635535|FG001|Overall Study|Lost to Follow-up|1|||
170624200|NCT02814916|616635536|FG002|Overall Study|Lost to Follow-up|0|||
170624201|NCT02814916|616635534|FG000|Overall Study|Other, not specified|0|||
170624202|NCT02814916|616635535|FG001|Overall Study|Other, not specified|1|||
170624203|NCT02814916|616635536|FG002|Overall Study|Other, not specified|0|||
170624204|NCT03103542|616635538|FG000|Overall Study|Physician Decision|2|||
170624205|NCT03103542|616635538|FG000|Overall Study|Adverse Event|2|||
170624206|NCT03103542|616635538|FG000|Overall Study|Other|2|||
170624207|NCT03103542|616635538|FG000|Overall Study|Withdrawal by Subject|1|||
170624208|NCT02953652|616635539|FG000|Overall Study|Adverse Event|18|||
170624209|NCT02953652|616635539|FG000|Overall Study|Withdrawal by Subject|6|||
170624210|NCT02953652|616635539|FG000|Overall Study|Protocol Violation|1|||
170624211|NCT02953652|616635539|FG000|Overall Study|Disease Progression|27|||
170624212|NCT03566511|616635540|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
170624213|NCT03566511|616635541|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
170624214|NCT02384551|616635542|FG000|Overall Study|Lost to Follow-up|13|||
170624215|NCT02384551|616635543|FG001|Overall Study|Lost to Follow-up|14|||
170624216|NCT02384551|616635544|FG002|Overall Study|Lost to Follow-up|14|||
170624217|NCT02384551|616635545|FG003|Overall Study|Lost to Follow-up|14|||
170624218|NCT02939287|616635546|FG000|Overall Study|met exclusion criteria|1|||
170624219|NCT02939287|616635547|FG001|Overall Study|met exclusion criteria|1|||
170624220|NCT02939287|616635548|FG002|Overall Study|met exclusion criteria|1|||
170624221|NCT02939287|616635546|FG000|Overall Study|Did not complete survey|2|||
170624222|NCT02939287|616635547|FG001|Overall Study|Did not complete survey|2|||
170624223|NCT02939287|616635548|FG002|Overall Study|Did not complete survey|0|||
170624224|NCT02939287|616635546|FG000|Overall Study|Withdrawal by Subject|1|||
170624225|NCT02939287|616635547|FG001|Overall Study|Withdrawal by Subject|1|||
170624226|NCT02939287|616635548|FG002|Overall Study|Withdrawal by Subject|0|||
170624227|NCT04026113|616635549|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
170624228|NCT04026113|616635550|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
170624229|NCT04026113|616635551|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
170624230|NCT04026113|616635552|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
170624231|NCT04026113|616635549|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
170624232|NCT04026113|616635550|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
170624233|NCT04026113|616635551|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
170624234|NCT04026113|616635552|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
170624235|NCT04026113|616635549|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
170624236|NCT04026113|616635550|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170624237|NCT04026113|616635551|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
170624238|NCT04026113|616635552|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
170624239|NCT04026113|616635549|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
170624240|NCT04026113|616635550|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
170624241|NCT04026113|616635551|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
170624242|NCT04026113|616635552|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
170624243|NCT04026113|616635549|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
170624244|NCT04026113|616635550|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
170624245|NCT04026113|616635551|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
170624246|NCT04026113|616635552|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
170624247|NCT04026113|616635549|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
170624248|NCT04026113|616635550|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
170624249|NCT04026113|616635551|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
170624250|NCT04026113|616635552|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
170624251|NCT04026113|616635549|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
170624252|NCT04026113|616635550|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
170624253|NCT04026113|616635551|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
170624254|NCT04026113|616635552|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
170624255|NCT04026113|616635549|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
170624256|NCT04026113|616635550|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
170624257|NCT04026113|616635551|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
170624258|NCT04026113|616635552|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
170624259|NCT04026113|616635549|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
170624260|NCT04026113|616635550|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
170624261|NCT04026113|616635551|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
170624262|NCT04026113|616635552|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
170624263|NCT02927301|616635553|FG000|Overall Study|Death|39|||
170624264|NCT02927301|616635553|FG000|Overall Study|Lost to Follow-up|8|||
170624265|NCT02927301|616635553|FG000|Overall Study|Physician Decision|2|||
170624266|NCT02927301|616635553|FG000|Overall Study|Withdrawal by Subject|12|||
170624267|NCT02927301|616635553|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
170624268|NCT02923726|616635554|FG000|Overall Study|Death|196|||
170624269|NCT02923726|616635555|FG001|Overall Study|Death|175|||
170624270|NCT02923726|616635554|FG000|Overall Study|Withdrawal by Subject|337|||
170624271|NCT02923726|616635555|FG001|Overall Study|Withdrawal by Subject|307|||
170624272|NCT03532542|616635556|FG000|Overall Study|Death|1|||
170624273|NCT03532542|616635557|FG001|Overall Study|Death|0|||
170624274|NCT03532542|616635556|FG000|Overall Study|Study Terminated by Sponsor|41|||
170624275|NCT03532542|616635557|FG001|Overall Study|Study Terminated by Sponsor|65|||
170624276|NCT03532542|616635556|FG000|Overall Study|Withdrawal by Subject|6|||
170624277|NCT03532542|616635557|FG001|Overall Study|Withdrawal by Subject|5|||
170624278|NCT03406780|616635562|FG000|Overall Study|Withdrawal by Subject|1|||
170624279|NCT03406780|616635563|FG001|Overall Study|Withdrawal by Subject|1|||
170624280|NCT03406780|616635562|FG000|Overall Study|Other|0|||
170624281|NCT03406780|616635563|FG001|Overall Study|Other|2|||
170624282|NCT01488045|616635568|FG000|Overall Study|Withdrawal by Subject|6|||
170624283|NCT01488045|616635569|FG001|Overall Study|Withdrawal by Subject|11|||
170624284|NCT01488045|616635568|FG000|Overall Study|Failure to present for colonoscopy|3|||
170624285|NCT01488045|616635569|FG001|Overall Study|Failure to present for colonoscopy|6|||
170624286|NCT01488045|616635568|FG000|Overall Study|Failure to report exclusion criteria|0|||
170624287|NCT01488045|616635569|FG001|Overall Study|Failure to report exclusion criteria|1|||
170624288|NCT01018030|616635574|FG000|Overall Study|Adverse Event|10|||
170624289|NCT01018030|616635575|FG001|Overall Study|Adverse Event|5|||
170624290|NCT01018030|616635576|FG002|Overall Study|Adverse Event|5|||
170624291|NCT01018030|616635574|FG000|Overall Study|Withdrawal by Subject|2|||
170624292|NCT01018030|616635575|FG001|Overall Study|Withdrawal by Subject|2|||
170624293|NCT01018030|616635576|FG002|Overall Study|Withdrawal by Subject|4|||
170624294|NCT01018030|616635574|FG000|Overall Study|Lost to Follow-up|2|||
170624295|NCT01018030|616635575|FG001|Overall Study|Lost to Follow-up|0|||
170624296|NCT01018030|616635576|FG002|Overall Study|Lost to Follow-up|3|||
170624297|NCT01018030|616635574|FG000|Overall Study|Protocol Violation|2|||
170624298|NCT01018030|616635575|FG001|Overall Study|Protocol Violation|1|||
170624299|NCT01018030|616635576|FG002|Overall Study|Protocol Violation|0|||
170624300|NCT01018030|616635574|FG000|Overall Study|Physician Decision|1|||
170624301|NCT01018030|616635575|FG001|Overall Study|Physician Decision|0|||
170624302|NCT01018030|616635576|FG002|Overall Study|Physician Decision|1|||
170624303|NCT01018030|616635574|FG000|Overall Study|Lack of Efficacy|1|||
170624304|NCT01018030|616635575|FG001|Overall Study|Lack of Efficacy|0|||
170624305|NCT01018030|616635576|FG002|Overall Study|Lack of Efficacy|0|||
170624306|NCT01018030|616635574|FG000|Overall Study|Did Not Receive Study Drug|1|||
170624307|NCT01018030|616635575|FG001|Overall Study|Did Not Receive Study Drug|3|||
170624308|NCT01018030|616635576|FG002|Overall Study|Did Not Receive Study Drug|0|||
170624309|NCT00671658|616635577|FG000|Overall Study|Physician Decision|5|||
170624310|NCT02399215|616635586|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
170624311|NCT02399215|616635586|FG000|Overall Study|Withdrawal by Subject|1|||
170624312|NCT00772538|616635587|FG000|Overall Study|Adverse Event|6|||
170624313|NCT00772538|616635588|FG001|Overall Study|Adverse Event|6|||
170624314|NCT00772538|616635587|FG000|Overall Study|Protocol Violation|3|||
170624315|NCT00772538|616635588|FG001|Overall Study|Protocol Violation|3|||
170624316|NCT00772538|616635587|FG000|Overall Study|Lost to Follow-up|1|||
170624317|NCT00772538|616635588|FG001|Overall Study|Lost to Follow-up|1|||
170624318|NCT00772538|616635587|FG000|Overall Study|Withdrawal by Subject|3|||
170624319|NCT00772538|616635588|FG001|Overall Study|Withdrawal by Subject|8|||
170624320|NCT00772538|616635587|FG000|Overall Study|Lack of Efficacy|0|||
170624321|NCT00772538|616635588|FG001|Overall Study|Lack of Efficacy|1|||
170624322|NCT00772538|616635587|FG000|Overall Study|Other|7|||
170624323|NCT00772538|616635588|FG001|Overall Study|Other|7|||
170624324|NCT03617172|616635591|FG000|Overall Study|Lost to Follow-up|1|||
170624325|NCT03617172|616635592|FG001|Overall Study|Lost to Follow-up|0|||
170624326|NCT01089504|616635593|FG000|Overall Study|Lost to Follow-up|1|||
170624327|NCT01089504|616635594|FG001|Overall Study|Lost to Follow-up|1|||
170624328|NCT01089504|616635593|FG000|Overall Study|Withdrawal by Subject|2|||
170624329|NCT01089504|616635594|FG001|Overall Study|Withdrawal by Subject|0|||
170624330|NCT00713609|616635595|FG000|Overall Study|Adverse Event|2|||
170624331|NCT00713609|616635596|FG001|Overall Study|Adverse Event|0|||
170624332|NCT00713609|616635597|FG002|Overall Study|Adverse Event|2|||
170624333|NCT00713609|616635598|FG003|Overall Study|Adverse Event|2|||
170624334|NCT00713609|616635599|FG004|Overall Study|Adverse Event|3|||
170624335|NCT00713609|616635600|FG005|Overall Study|Adverse Event|1|||
170624336|NCT00713609|616635595|FG000|Overall Study|Lost to Follow-up|5|||
170624337|NCT00713609|616635596|FG001|Overall Study|Lost to Follow-up|7|||
170624338|NCT00713609|616635597|FG002|Overall Study|Lost to Follow-up|5|||
170624339|NCT00713609|616635598|FG003|Overall Study|Lost to Follow-up|5|||
170624340|NCT00713609|616635599|FG004|Overall Study|Lost to Follow-up|7|||
170624341|NCT00713609|616635600|FG005|Overall Study|Lost to Follow-up|0|||
170624342|NCT00713609|616635595|FG000|Overall Study|Lack of Efficacy|1|||
170624343|NCT00713609|616635596|FG001|Overall Study|Lack of Efficacy|3|||
170624344|NCT00713609|616635597|FG002|Overall Study|Lack of Efficacy|0|||
170624345|NCT00713609|616635598|FG003|Overall Study|Lack of Efficacy|0|||
170624346|NCT00713609|616635599|FG004|Overall Study|Lack of Efficacy|1|||
170624347|NCT00713609|616635600|FG005|Overall Study|Lack of Efficacy|0|||
170624348|NCT00713609|616635595|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
170624349|NCT00713609|616635596|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
170624350|NCT00713609|616635597|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
170624351|NCT00713609|616635598|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
170624352|NCT00713609|616635599|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
170624353|NCT00713609|616635600|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
170624354|NCT00713609|616635595|FG000|Overall Study|Withdrawal by Subject|6|||
170624355|NCT00713609|616635596|FG001|Overall Study|Withdrawal by Subject|1|||
170624356|NCT00713609|616635597|FG002|Overall Study|Withdrawal by Subject|5|||
170624357|NCT00713609|616635598|FG003|Overall Study|Withdrawal by Subject|1|||
170624358|NCT00713609|616635599|FG004|Overall Study|Withdrawal by Subject|5|||
170624359|NCT00713609|616635600|FG005|Overall Study|Withdrawal by Subject|7|||
170624360|NCT00713609|616635595|FG000|Overall Study|Protocol Violation|6|||
170624361|NCT00713609|616635596|FG001|Overall Study|Protocol Violation|3|||
170624362|NCT00713609|616635597|FG002|Overall Study|Protocol Violation|1|||
170624363|NCT00713609|616635598|FG003|Overall Study|Protocol Violation|1|||
170624364|NCT00713609|616635599|FG004|Overall Study|Protocol Violation|2|||
170624365|NCT00713609|616635600|FG005|Overall Study|Protocol Violation|0|||
170624366|NCT03305666|616635605|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
170624367|NCT03305666|616635606|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
170624368|NCT00914849|616635611|FG000|Overall Study|Withdrawal by Subject|1|||
170624369|NCT00914849|616635612|FG001|Overall Study|Withdrawal by Subject|0|||
170624370|NCT00914849|616635611|FG000|Overall Study|Not eligible|0|||
170624371|NCT00914849|616635612|FG001|Overall Study|Not eligible|1|||
170624372|NCT01001221|616635613|FG000|Overall Study|Adverse Event|1|||
170624373|NCT01001221|616635614|FG001|Overall Study|Adverse Event|2|||
170624374|NCT01001221|616635615|FG002|Overall Study|Adverse Event|0|||
170624375|NCT01001221|616635616|FG003|Overall Study|Adverse Event|2|||
170624376|NCT01001221|616635617|FG004|Overall Study|Adverse Event|0|||
170624377|NCT01001221|616635613|FG000|Overall Study|Disease progression|3|||
170624378|NCT01001221|616635614|FG001|Overall Study|Disease progression|2|||
170624379|NCT01001221|616635615|FG002|Overall Study|Disease progression|2|||
170624380|NCT01001221|616635616|FG003|Overall Study|Disease progression|4|||
170624381|NCT01001221|616635617|FG004|Overall Study|Disease progression|0|||
170624382|NCT01001221|616635613|FG000|Overall Study|Other|1|||
170624383|NCT01001221|616635614|FG001|Overall Study|Other|1|||
170624384|NCT01001221|616635615|FG002|Overall Study|Other|0|||
170624385|NCT01001221|616635616|FG003|Overall Study|Other|0|||
170624386|NCT01001221|616635617|FG004|Overall Study|Other|0|||
170624387|NCT01001221|616635613|FG000|Overall Study|Not treated; protocol exclusion|0|||
170624388|NCT01001221|616635614|FG001|Overall Study|Not treated; protocol exclusion|0|||
170624389|NCT01001221|616635615|FG002|Overall Study|Not treated; protocol exclusion|1|||
170624390|NCT01001221|616635616|FG003|Overall Study|Not treated; protocol exclusion|0|||
170624391|NCT01001221|616635617|FG004|Overall Study|Not treated; protocol exclusion|0|||
170624392|NCT04602390|616635619|FG000|Overall Study|Withdrawal by Subject|0|||
170624393|NCT04602390|616635620|FG001|Overall Study|Withdrawal by Subject|0|||
170624394|NCT04602390|616635621|FG002|Overall Study|Withdrawal by Subject|0|||
170624395|NCT04602390|616635622|FG003|Overall Study|Withdrawal by Subject|0|||
170624396|NCT04602390|616635623|FG004|Overall Study|Withdrawal by Subject|1|||
170624397|NCT04602390|616635624|FG005|Overall Study|Withdrawal by Subject|0|||
170624398|NCT04602390|616635619|FG000|Overall Study|Adverse Event|0|||
170624399|NCT04602390|616635620|FG001|Overall Study|Adverse Event|0|||
170624400|NCT04602390|616635621|FG002|Overall Study|Adverse Event|0|||
170624401|NCT04602390|616635622|FG003|Overall Study|Adverse Event|0|||
170624402|NCT04602390|616635623|FG004|Overall Study|Adverse Event|0|||
170624403|NCT04602390|616635624|FG005|Overall Study|Adverse Event|1|||
170624404|NCT03988400|616635625|FG000|Overall Study|Adverse Event|1|||
170624405|NCT03988400|616635626|FG001|Overall Study|Adverse Event|0|||
170624406|NCT03988400|616635625|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
170624407|NCT03988400|616635626|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
170624408|NCT03988400|616635625|FG000|Overall Study|Lost to Follow-up|0|||
170624409|NCT03988400|616635626|FG001|Overall Study|Lost to Follow-up|1|||
170624410|NCT00475670|616635629|FG000|Overall Study|Death|0|||
170624411|NCT00475670|616635630|FG001|Overall Study|Death|1|||
170624412|NCT00475670|616635629|FG000|Overall Study|Lack of Efficacy|3|||
170624413|NCT00475670|616635630|FG001|Overall Study|Lack of Efficacy|34|||
170624414|NCT00475670|616635629|FG000|Overall Study|Refused treatment|0|||
170624415|NCT00475670|616635630|FG001|Overall Study|Refused treatment|2|||
170624416|NCT00475670|616635629|FG000|Overall Study|Failure to Return|0|||
170624417|NCT00475670|616635630|FG001|Overall Study|Failure to Return|1|||
170624418|NCT00475670|616635629|FG000|Overall Study|Other|0|||
170624419|NCT00475670|616635630|FG001|Overall Study|Other|3|||
170624420|NCT02004236|616635633|FG000|Overall Study|Lack of Efficacy|0|||
170624421|NCT02004236|616635634|FG001|Overall Study|Lack of Efficacy|0|||
170624422|NCT02004236|616635635|FG002|Overall Study|Lack of Efficacy|16|||
170624423|NCT01168349|616635637|FG000|Overall Study|Death|157|||
170624424|NCT01168349|616635637|FG000|Overall Study|Lost to Follow-up|34|||
170624425|NCT01168349|616635637|FG000|Overall Study|Withdrawal by Subject|9|||
170624426|NCT01168349|616635637|FG000|Overall Study|Kidney transplantation|3|||
170624427|NCT01168349|616635637|FG000|Overall Study|Other|22|||
170624428|NCT01168349|616635637|FG000|Overall Study|Protocol Violation|76|||
170624429|NCT00551759|616635638|FG000|Overall Study|Adverse Event|7|||
170624430|NCT00551759|616635638|FG000|Overall Study|Death|5|||
170624431|NCT00551759|616635638|FG000|Overall Study|Ineligible|1|||
170624432|NCT01650558|616635639|FG000|Overall Study|Migration out of study area|61|||
170624433|NCT01650558|616635640|FG001|Overall Study|Migration out of study area|71|||
170624434|NCT01650558|616635641|FG002|Overall Study|Migration out of study area|56|||
170624435|NCT01650558|616635639|FG000|Overall Study|Lost to Follow-up|10|||
170624436|NCT01650558|616635640|FG001|Overall Study|Lost to Follow-up|13|||
170624437|NCT01650558|616635641|FG002|Overall Study|Lost to Follow-up|6|||
170624438|NCT01650558|616635639|FG000|Overall Study|Death|10|||
170624439|NCT01650558|616635640|FG001|Overall Study|Death|6|||
170624440|NCT01650558|616635641|FG002|Overall Study|Death|8|||
170624441|NCT01650558|616635639|FG000|Overall Study|Withdrawal by Subject|1|||
170624442|NCT01650558|616635640|FG001|Overall Study|Withdrawal by Subject|1|||
170624443|NCT01650558|616635641|FG002|Overall Study|Withdrawal by Subject|3|||
170624444|NCT01650558|616635639|FG000|Overall Study|Non-compliant participant|1|||
170624445|NCT01650558|616635640|FG001|Overall Study|Non-compliant participant|0|||
170624446|NCT01650558|616635641|FG002|Overall Study|Non-compliant participant|2|||
170624447|NCT01650558|616635639|FG000|Overall Study|Physician Decision|0|||
170624448|NCT01650558|616635640|FG001|Overall Study|Physician Decision|1|||
170624449|NCT01650558|616635641|FG002|Overall Study|Physician Decision|0|||
170624450|NCT00918385|616635642|FG000|Monotherapy|Adverse Event|1|||
170624451|NCT00918385|616635643|FG001|Monotherapy|Adverse Event|6|||
170624452|NCT00918385|616635642|FG000|Monotherapy|Complicating illness|1|||
170624453|NCT00918385|616635643|FG001|Monotherapy|Complicating illness|0|||
170624454|NCT00918385|616635642|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
170624455|NCT00918385|616635643|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
170624456|NCT00918385|616635642|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
170624457|NCT00918385|616635643|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
170624458|NCT00918385|616635642|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
170624459|NCT00918385|616635643|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
170624460|NCT00918385|616635642|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
170624461|NCT00918385|616635643|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
170624462|NCT00660192|616635644|FG000|Overall Study|Lost to Follow-up|2|||
170624463|NCT00660192|616635645|FG001|Overall Study|Lost to Follow-up|3|||
170624464|NCT00322881|616635647|FG000|Overall Study|Death|2|||
170624465|NCT00322881|616635647|FG000|Overall Study|Adverse Event|1|||
170624466|NCT00322881|616635647|FG000|Overall Study|Disease Progression|2|||
170624467|NCT01476722|616635649|FG000|Overall Study|Adverse Event|1|||
170624468|NCT03416868|616635653|FG000|Overall Study|Withdrawal by Subject|2|||
170624469|NCT03416868|616635653|FG000|Overall Study|Lost to Follow-up|1|||
170624470|NCT00960375|616635654|FG000|Overall Study|Lost to Follow-up|20|||
170624471|NCT00960375|616635655|FG001|Overall Study|Lost to Follow-up|22|||
170624472|NCT00083889|616635656|FG000|Overall Study|Adverse Event|76|||
170624473|NCT00083889|616635657|FG001|Overall Study|Adverse Event|86|||
170624474|NCT00083889|616635656|FG000|Overall Study|Protocol Violation|2|||
170624475|NCT00083889|616635657|FG001|Overall Study|Protocol Violation|2|||
170624476|NCT00083889|616635656|FG000|Overall Study|Withdrawal by Subject|22|||
170624477|NCT00083889|616635657|FG001|Overall Study|Withdrawal by Subject|24|||
170624478|NCT00083889|616635656|FG000|Overall Study|Lack of Efficacy|240|||
170624479|NCT00083889|616635657|FG001|Overall Study|Lack of Efficacy|219|||
170624480|NCT00083889|616635656|FG000|Overall Study|Decision of sponsor|32|||
170624481|NCT00083889|616635657|FG001|Overall Study|Decision of sponsor|4|||
170624482|NCT00083889|616635656|FG000|Overall Study|Randomized: did not take study drug|0|||
170624483|NCT00083889|616635657|FG001|Overall Study|Randomized: did not take study drug|15|||
170624484|NCT00083889|616635656|FG000|Overall Study|Completed on marketed sunitinub|3|||
170624485|NCT00083889|616635657|FG001|Overall Study|Completed on marketed sunitinub|0|||
170624486|NCT00083889|616635656|FG000|Overall Study|Crossover to SU011248|0|||
170624487|NCT00083889|616635657|FG001|Overall Study|Crossover to SU011248|25|||
170624488|NCT00168844|616635658|FG000|Overall Study|Adverse Event|31|||
170624489|NCT00168844|616635659|FG001|Overall Study|Adverse Event|32|||
170624490|NCT00168844|616635660|FG002|Overall Study|Adverse Event|48|||
170624491|NCT00168844|616635658|FG000|Overall Study|Lost to Follow-up|4|||
170624492|NCT00168844|616635659|FG001|Overall Study|Lost to Follow-up|5|||
170624493|NCT00168844|616635660|FG002|Overall Study|Lost to Follow-up|11|||
170624494|NCT00168844|616635658|FG000|Overall Study|Withdrawal by Subject|12|||
170624495|NCT00168844|616635659|FG001|Overall Study|Withdrawal by Subject|9|||
170624496|NCT00168844|616635660|FG002|Overall Study|Withdrawal by Subject|19|||
170624497|NCT00168844|616635658|FG000|Overall Study|Protocol Violation|2|||
170669650|NCT00347360|616801159|FG010|Overall Study|Subject refuse to sign updated consent|0|||
170669651|NCT00347360|616801160|FG011|Overall Study|Subject refuse to sign updated consent|0|||
170669652|NCT00347360|616801161|FG012|Overall Study|Subject refuse to sign updated consent|0|||
170669653|NCT00347360|616801162|FG013|Overall Study|Subject refuse to sign updated consent|0|||
170669654|NCT00347360|616801163|FG014|Overall Study|Subject refuse to sign updated consent|1|||
170669655|NCT00347360|616801149|FG000|Overall Study|Visits conflicted with new job|0|||
170669656|NCT00347360|616801150|FG001|Overall Study|Visits conflicted with new job|0|||
170669657|NCT00347360|616801151|FG002|Overall Study|Visits conflicted with new job|0|||
170669658|NCT00347360|616801152|FG003|Overall Study|Visits conflicted with new job|0|||
170669659|NCT00347360|616801153|FG004|Overall Study|Visits conflicted with new job|0|||
170669660|NCT00347360|616801154|FG005|Overall Study|Visits conflicted with new job|0|||
170669661|NCT00347360|616801155|FG006|Overall Study|Visits conflicted with new job|1|||
170669662|NCT00347360|616801156|FG007|Overall Study|Visits conflicted with new job|0|||
170669663|NCT00347360|616801157|FG008|Overall Study|Visits conflicted with new job|0|||
170669664|NCT00347360|616801158|FG009|Overall Study|Visits conflicted with new job|0|||
170669665|NCT00347360|616801159|FG010|Overall Study|Visits conflicted with new job|0|||
170669666|NCT00347360|616801160|FG011|Overall Study|Visits conflicted with new job|0|||
170669667|NCT00347360|616801161|FG012|Overall Study|Visits conflicted with new job|0|||
170669668|NCT00347360|616801162|FG013|Overall Study|Visits conflicted with new job|0|||
170669669|NCT00347360|616801163|FG014|Overall Study|Visits conflicted with new job|0|||
170669670|NCT00913380|616801166|FG000|Clinical Outcomes|Lost to Follow-up|6|||
170669671|NCT00913380|616801167|FG001|Clinical Outcomes|Lost to Follow-up|6|||
170669672|NCT03360747|616801169|FG000|Overall Study|Voluntary Withdrawal|1|||
170669673|NCT01066000|616801170|FG000|Overall Study|Protocol Violation|4|||
170669674|NCT01066000|616801170|FG000|Overall Study|Death|3|||
170669675|NCT01066000|616801170|FG000|Overall Study|Withdrawal by Subject|1|||
170669676|NCT01066000|616801170|FG000|Overall Study|Adverse Event|1|||
170669677|NCT01386008|616801171|FG000|Overall Study|exited w/o incident /study discontinued|17|||
170669678|NCT01386008|616801171|FG000|Overall Study|Adverse Event|3|||
170669679|NCT01067976|616801172|FG000|Overall Study|Study drug never administered|20|||
170669680|NCT01067976|616801172|FG000|Overall Study|Study prematurely discontinued|2|||
170669681|NCT04449861|616801173|FG000|Overall Study|Withdrawal by Subject|4|||
170669682|NCT04449861|616801173|FG000|Overall Study|Lost to Follow-up|5|||
170669683|NCT04449861|616801173|FG000|Overall Study|Death|112|||
170669684|NCT00976677|616801174|FG000|Overall Study|Adverse Event|1|||
170669685|NCT00976677|616801175|FG001|Overall Study|Adverse Event|0|||
170669686|NCT00976677|616801174|FG000|Overall Study|Withdrawal by Subject|0|||
170669687|NCT00976677|616801175|FG001|Overall Study|Withdrawal by Subject|2|||
170669688|NCT00976677|616801174|FG000|Overall Study|Disease progression|1|||
170669689|NCT00976677|616801175|FG001|Overall Study|Disease progression|1|||
170669690|NCT00976677|616801174|FG000|Overall Study|Trial unblinded|2|||
170669691|NCT00976677|616801175|FG001|Overall Study|Trial unblinded|2|||
170669692|NCT00976677|616801174|FG000|Overall Study|Unknown/Missing|1|||
170669693|NCT00976677|616801175|FG001|Overall Study|Unknown/Missing|0|||
170669694|NCT01367002|616803259|FG000|Overall Study|Withdrawal by Subject|1|||
170669695|NCT01367002|616803260|FG001|Overall Study|Withdrawal by Subject|0|||
170669696|NCT01367002|616803259|FG000|Overall Study|Physician Decision|0|||
170669697|NCT01367002|616803260|FG001|Overall Study|Physician Decision|2|||
170669698|NCT01516437|616803261|FG000|Overall Study|Reason not specified|0|||
170669699|NCT01516437|616803262|FG001|Overall Study|Reason not specified|0|||
170669700|NCT01516437|616803263|FG002|Overall Study|Reason not specified|1|||
170669701|NCT01516437|616803264|FG003|Overall Study|Reason not specified|1|||
170669702|NCT00403234|616803265|FG000|Overall Study|Withdrawal by Subject|0|||
170669703|NCT00403234|616803266|FG001|Overall Study|Withdrawal by Subject|1|||
170669704|NCT00403234|616803267|FG002|Overall Study|Withdrawal by Subject|0|||
170669705|NCT00403234|616803268|FG003|Overall Study|Withdrawal by Subject|0|||
170669706|NCT00403234|616803265|FG000|Overall Study|Adverse Event|1|||
170669707|NCT00403234|616803266|FG001|Overall Study|Adverse Event|0|||
170669708|NCT00403234|616803267|FG002|Overall Study|Adverse Event|1|||
170669709|NCT00403234|616803268|FG003|Overall Study|Adverse Event|0|||
170669710|NCT02400333|616803273|FG000|Overall Study|Withdrawal by Subject|0|||
170669711|NCT02400333|616803274|FG001|Overall Study|Withdrawal by Subject|1|||
170669712|NCT02400333|616803275|FG002|Overall Study|Withdrawal by Subject|0|||
170669713|NCT02400333|616803276|FG003|Overall Study|Withdrawal by Subject|1|||
170669714|NCT02400333|616803273|FG000|Overall Study|Protocol Violation|1|||
170669715|NCT02400333|616803274|FG001|Overall Study|Protocol Violation|0|||
170669716|NCT02400333|616803275|FG002|Overall Study|Protocol Violation|2|||
170669717|NCT02400333|616803276|FG003|Overall Study|Protocol Violation|1|||
170669718|NCT01550289|616803277|FG000|Overall Study|Protocol Violation|1|||
170669719|NCT01550289|616803278|FG001|Overall Study|Protocol Violation|0|||
170669720|NCT01550289|616803277|FG000|Overall Study|Lost to Follow-up|1|||
170669721|NCT01550289|616803278|FG001|Overall Study|Lost to Follow-up|1|||
170669722|NCT01550289|616803277|FG000|Overall Study|Withdrawal by Subject|11|||
170669723|NCT01550289|616803278|FG001|Overall Study|Withdrawal by Subject|3|||
170669724|NCT00283400|616803280|FG000|Overall Study|Withdrawal by Subject|1|||
170624498|NCT00168844|616635659|FG001|Overall Study|Protocol Violation|2|||
170624499|NCT00168844|616635660|FG002|Overall Study|Protocol Violation|4|||
170624500|NCT00168844|616635658|FG000|Overall Study|Other|6|||
170624501|NCT00168844|616635659|FG001|Overall Study|Other|7|||
170624502|NCT00168844|616635660|FG002|Overall Study|Other|9|||
170624503|NCT03037385|616637686|FG000|Overall Study|Adverse Event|0|||
170624504|NCT03037385|616637687|FG001|Overall Study|Adverse Event|0|||
170624505|NCT03037385|616637688|FG002|Overall Study|Adverse Event|1|||
170624506|NCT03037385|616637689|FG003|Overall Study|Adverse Event|0|||
170624507|NCT03037385|616637690|FG004|Overall Study|Adverse Event|0|||
170624508|NCT03037385|616637691|FG005|Overall Study|Adverse Event|0|||
170624509|NCT03037385|616637692|FG006|Overall Study|Adverse Event|0|||
170624510|NCT03037385|616637693|FG007|Overall Study|Adverse Event|0|||
170624511|NCT03037385|616637694|FG008|Overall Study|Adverse Event|0|||
170624512|NCT03037385|616637695|FG009|Overall Study|Adverse Event|6|||
170624513|NCT03037385|616637686|FG000|Overall Study|Death|1|||
170624514|NCT03037385|616637687|FG001|Overall Study|Death|4|||
170669725|NCT00283400|616803281|FG001|Overall Study|Withdrawal by Subject|1|||
170669726|NCT00283400|616803282|FG002|Overall Study|Withdrawal by Subject|0|||
170669727|NCT00283400|616803283|FG003|Overall Study|Withdrawal by Subject|0|||
170669728|NCT00283400|616803280|FG000|Overall Study|Death|1|||
170669729|NCT00283400|616803281|FG001|Overall Study|Death|0|||
170669730|NCT00283400|616803282|FG002|Overall Study|Death|1|||
170669731|NCT00283400|616803283|FG003|Overall Study|Death|0|||
170669732|NCT02747875|616803290|FG000|Overall Study|Physician Decision|1|||
170669733|NCT02747875|616803291|FG001|Overall Study|Physician Decision|0|||
170669734|NCT02747875|616803290|FG000|Overall Study|Adverse Event|0|||
170669735|NCT02747875|616803291|FG001|Overall Study|Adverse Event|1|||
170669736|NCT04138810|616803295|FG000|Overall Study|Withdrawal by Subject|0|||
170669737|NCT04138810|616803296|FG001|Overall Study|Withdrawal by Subject|1|||
170669738|NCT04138810|616803295|FG000|Overall Study|Subject cancelled surgery|1|||
170669739|NCT04138810|616803296|FG001|Overall Study|Subject cancelled surgery|0|||
170669740|NCT00696800|616803297|FG000|Overall Study|Adverse Event|16|||
170669741|NCT00696800|616803298|FG001|Overall Study|Adverse Event|3|||
170669742|NCT00696800|616803297|FG000|Overall Study|Insufficient compliance with medication|2|||
170669743|NCT00696800|616803298|FG001|Overall Study|Insufficient compliance with medication|1|||
170669744|NCT00696800|616803297|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
170669745|NCT00696800|616803298|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
170669746|NCT00696800|616803297|FG000|Overall Study|Insufficient ovarian response|4|||
170669747|NCT00696800|616803298|FG001|Overall Study|Insufficient ovarian response|1|||
170669748|NCT00696800|616803297|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
170669749|NCT00696800|616803298|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
170669750|NCT00696800|616803297|FG000|Overall Study|Too high ovarian response|6|||
170669751|NCT00696800|616803298|FG001|Overall Study|Too high ovarian response|1|||
170669752|NCT00696800|616803297|FG000|Overall Study|No/too few/bad quality oocytes|4|||
170669753|NCT00696800|616803298|FG001|Overall Study|No/too few/bad quality oocytes|3|||
170669754|NCT00696800|616803297|FG000|Overall Study|No/abnormal fertilization|11|||
170669755|NCT00696800|616803298|FG001|Overall Study|No/abnormal fertilization|13|||
170669756|NCT00696800|616803297|FG000|Overall Study|No/too few/bad quality embryos|24|||
170624515|NCT03037385|616637688|FG002|Overall Study|Death|2|||
170624516|NCT03037385|616637689|FG003|Overall Study|Death|2|||
170624517|NCT03037385|616637690|FG004|Overall Study|Death|5|||
170624518|NCT03037385|616637691|FG005|Overall Study|Death|2|||
170624519|NCT03037385|616637692|FG006|Overall Study|Death|1|||
170624520|NCT03037385|616637693|FG007|Overall Study|Death|4|||
170624521|NCT03037385|616637694|FG008|Overall Study|Death|3|||
170624522|NCT03037385|616637695|FG009|Overall Study|Death|240|||
170624523|NCT03037385|616637686|FG000|Overall Study|Initiation of Another Therapy|1|||
170624524|NCT03037385|616637687|FG001|Overall Study|Initiation of Another Therapy|0|||
170624525|NCT03037385|616637688|FG002|Overall Study|Initiation of Another Therapy|0|||
170624526|NCT03037385|616637689|FG003|Overall Study|Initiation of Another Therapy|0|||
170624527|NCT03037385|616637690|FG004|Overall Study|Initiation of Another Therapy|0|||
170624528|NCT03037385|616637691|FG005|Overall Study|Initiation of Another Therapy|0|||
170624529|NCT03037385|616637692|FG006|Overall Study|Initiation of Another Therapy|0|||
170624530|NCT03037385|616637693|FG007|Overall Study|Initiation of Another Therapy|1|||
170624531|NCT03037385|616637694|FG008|Overall Study|Initiation of Another Therapy|0|||
170624532|NCT03037385|616637695|FG009|Overall Study|Initiation of Another Therapy|2|||
170624533|NCT03037385|616637686|FG000|Overall Study|Lost to Follow-up|0|||
170624534|NCT03037385|616637687|FG001|Overall Study|Lost to Follow-up|0|||
170624535|NCT03037385|616637688|FG002|Overall Study|Lost to Follow-up|0|||
170624536|NCT03037385|616637689|FG003|Overall Study|Lost to Follow-up|0|||
170624537|NCT03037385|616637690|FG004|Overall Study|Lost to Follow-up|0|||
170624538|NCT03037385|616637691|FG005|Overall Study|Lost to Follow-up|1|||
170624539|NCT03037385|616637692|FG006|Overall Study|Lost to Follow-up|0|||
170624540|NCT03037385|616637693|FG007|Overall Study|Lost to Follow-up|0|||
170624541|NCT03037385|616637694|FG008|Overall Study|Lost to Follow-up|0|||
170624542|NCT03037385|616637695|FG009|Overall Study|Lost to Follow-up|16|||
170624543|NCT03037385|616637686|FG000|Overall Study|Physician Decision|0|||
170624544|NCT03037385|616637687|FG001|Overall Study|Physician Decision|0|||
170624545|NCT03037385|616637688|FG002|Overall Study|Physician Decision|0|||
170624546|NCT03037385|616637689|FG003|Overall Study|Physician Decision|0|||
170624547|NCT03037385|616637690|FG004|Overall Study|Physician Decision|0|||
170624548|NCT03037385|616637691|FG005|Overall Study|Physician Decision|0|||
170624549|NCT03037385|616637692|FG006|Overall Study|Physician Decision|0|||
170624550|NCT03037385|616637693|FG007|Overall Study|Physician Decision|0|||
170624551|NCT03037385|616637694|FG008|Overall Study|Physician Decision|0|||
170624552|NCT03037385|616637695|FG009|Overall Study|Physician Decision|1|||
170624553|NCT03037385|616637686|FG000|Overall Study|Progressive Disease|0|||
170624554|NCT03037385|616637687|FG001|Overall Study|Progressive Disease|1|||
170624555|NCT03037385|616637688|FG002|Overall Study|Progressive Disease|1|||
170624556|NCT03037385|616637689|FG003|Overall Study|Progressive Disease|5|||
170624557|NCT03037385|616637690|FG004|Overall Study|Progressive Disease|2|||
170624558|NCT03037385|616637691|FG005|Overall Study|Progressive Disease|0|||
170624559|NCT03037385|616637692|FG006|Overall Study|Progressive Disease|1|||
170624560|NCT03037385|616637693|FG007|Overall Study|Progressive Disease|0|||
170624561|NCT03037385|616637694|FG008|Overall Study|Progressive Disease|0|||
170624562|NCT03037385|616637695|FG009|Overall Study|Progressive Disease|30|||
170624563|NCT03037385|616637686|FG000|Overall Study|Withdrawal by Subject|0|||
170624564|NCT03037385|616637687|FG001|Overall Study|Withdrawal by Subject|0|||
170624565|NCT03037385|616637688|FG002|Overall Study|Withdrawal by Subject|1|||
170624566|NCT03037385|616637689|FG003|Overall Study|Withdrawal by Subject|2|||
170624567|NCT03037385|616637690|FG004|Overall Study|Withdrawal by Subject|1|||
170624568|NCT03037385|616637691|FG005|Overall Study|Withdrawal by Subject|3|||
170624569|NCT03037385|616637692|FG006|Overall Study|Withdrawal by Subject|0|||
170624570|NCT03037385|616637693|FG007|Overall Study|Withdrawal by Subject|0|||
170624571|NCT03037385|616637694|FG008|Overall Study|Withdrawal by Subject|0|||
170624572|NCT03037385|616637695|FG009|Overall Study|Withdrawal by Subject|52|||
170624573|NCT03037385|616637686|FG000|Overall Study|Reason Not Specified|0|||
170624574|NCT03037385|616637687|FG001|Overall Study|Reason Not Specified|1|||
170624575|NCT03037385|616637688|FG002|Overall Study|Reason Not Specified|0|||
170624576|NCT03037385|616637689|FG003|Overall Study|Reason Not Specified|4|||
170624577|NCT03037385|616637690|FG004|Overall Study|Reason Not Specified|3|||
170624578|NCT03037385|616637691|FG005|Overall Study|Reason Not Specified|6|||
170624579|NCT03037385|616637692|FG006|Overall Study|Reason Not Specified|2|||
170624580|NCT03037385|616637693|FG007|Overall Study|Reason Not Specified|0|||
170624581|NCT03037385|616637694|FG008|Overall Study|Reason Not Specified|1|||
170624582|NCT03037385|616637695|FG009|Overall Study|Reason Not Specified|181|||
170624583|NCT02318706|616637696|FG000|Double-blind Phase|Adverse Event|7|||
170624584|NCT02318706|616637697|FG001|Double-blind Phase|Adverse Event|4|||
170624585|NCT02318706|616637698|FG002|Double-blind Phase|Adverse Event|3|||
170624586|NCT02318706|616637699|FG003|Double-blind Phase|Adverse Event|10|||
170624587|NCT02318706|616637700|FG004|Double-blind Phase|Adverse Event|0|||
170624588|NCT02318706|616637696|FG000|Double-blind Phase|Lost to Follow-up|1|||
170624589|NCT02318706|616637697|FG001|Double-blind Phase|Lost to Follow-up|0|||
170624590|NCT02318706|616637698|FG002|Double-blind Phase|Lost to Follow-up|0|||
170624591|NCT02318706|616637699|FG003|Double-blind Phase|Lost to Follow-up|0|||
170624592|NCT02318706|616637700|FG004|Double-blind Phase|Lost to Follow-up|0|||
170624593|NCT02318706|616637696|FG000|Double-blind Phase|Protocol Violation|4|||
170624594|NCT02318706|616637697|FG001|Double-blind Phase|Protocol Violation|2|||
170624595|NCT02318706|616637698|FG002|Double-blind Phase|Protocol Violation|4|||
170624596|NCT02318706|616637699|FG003|Double-blind Phase|Protocol Violation|3|||
170624597|NCT02318706|616637700|FG004|Double-blind Phase|Protocol Violation|0|||
170624598|NCT02318706|616637696|FG000|Double-blind Phase|Withdrawal by Subject|9|||
170624599|NCT02318706|616637697|FG001|Double-blind Phase|Withdrawal by Subject|5|||
170624600|NCT02318706|616637698|FG002|Double-blind Phase|Withdrawal by Subject|7|||
170624601|NCT02318706|616637699|FG003|Double-blind Phase|Withdrawal by Subject|10|||
170669757|NCT00696800|616803298|FG001|Overall Study|No/too few/bad quality embryos|18|||
170669758|NCT00696800|616803297|FG000|Overall Study|Other Reasons|5|||
170669759|NCT00696800|616803298|FG001|Overall Study|Other Reasons|3|||
170669760|NCT00696800|616803297|FG000|Overall Study|Not treated|1|||
170669761|NCT00696800|616803298|FG001|Overall Study|Not treated|2|||
170669762|NCT00762385|616803299|FG000|First Intervention|Lens Issue|1|||
170669763|NCT00762385|616803300|FG001|First Intervention|Lens Issue|1|||
170669764|NCT00762385|616803299|FG000|First Intervention|Lost to Follow-up|0|||
170669765|NCT00762385|616803300|FG001|First Intervention|Lost to Follow-up|2|||
170669766|NCT00762385|616803299|FG000|First Intervention|Ineligible|1|||
170669767|NCT00762385|616803300|FG001|First Intervention|Ineligible|0|||
170669768|NCT00762385|616803299|FG000|First Intervention|Protocol Violation|0|||
170669769|NCT00762385|616803300|FG001|First Intervention|Protocol Violation|1|||
170669770|NCT00762385|616803299|FG000|Second Intervention|Protocol Violation|3|||
170669771|NCT00762385|616803300|FG001|Second Intervention|Protocol Violation|3|||
170669772|NCT00493025|616803302|FG000|Overall Study|Physician Decision|19|||
170624602|NCT02318706|616637700|FG004|Double-blind Phase|Withdrawal by Subject|0|||
170624603|NCT02318706|616637696|FG000|Double-blind Phase|Other|4|||
170669773|NCT03863197|616803303|FG000|Overall Study|Lost to Follow-up|2|||
170669774|NCT03863197|616803304|FG001|Overall Study|Lost to Follow-up|3|||
170624604|NCT02318706|616637697|FG001|Double-blind Phase|Other|1|||
170624605|NCT02318706|616637698|FG002|Double-blind Phase|Other|2|||
170624606|NCT02318706|616637699|FG003|Double-blind Phase|Other|1|||
170624607|NCT02318706|616637700|FG004|Double-blind Phase|Other|0|||
170624608|NCT02318706|616637696|FG000|Double-blind Phase|Death|0|||
170624609|NCT02318706|616637697|FG001|Double-blind Phase|Death|0|||
170669775|NCT03863197|616803303|FG000|Overall Study|Withdrawal by Subject|4|||
170669776|NCT03863197|616803304|FG001|Overall Study|Withdrawal by Subject|0|||
170669777|NCT03863197|616803303|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
170669778|NCT03863197|616803304|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
170669779|NCT01065597|616803305|FG000|Overall Study|Adverse Event|1|||
170624610|NCT02318706|616637698|FG002|Double-blind Phase|Death|2|||
170624611|NCT02318706|616637699|FG003|Double-blind Phase|Death|0|||
170624612|NCT02318706|616637700|FG004|Double-blind Phase|Death|0|||
170624613|NCT02318706|616637696|FG000|Open-label Extension Phase|Adverse Event|0|||
170669780|NCT01622231|616803306|FG000|Overall Study|Physician Decision|1|||
170669781|NCT01622231|616803306|FG000|Overall Study|Withdrawal by Subject|1|||
170669782|NCT01058655|616803308|FG000|Overall Study|Withdrawal by Subject|1|||
170669783|NCT01058655|616803309|FG001|Overall Study|Withdrawal by Subject|0|||
170669784|NCT01058655|616803310|FG002|Overall Study|Withdrawal by Subject|3|||
170669785|NCT01058655|616803311|FG003|Overall Study|Withdrawal by Subject|4|||
170669786|NCT01058655|616803308|FG000|Overall Study|Prolonged Treatment Delay|0|||
170669787|NCT01058655|616803309|FG001|Overall Study|Prolonged Treatment Delay|0|||
170669788|NCT01058655|616803310|FG002|Overall Study|Prolonged Treatment Delay|0|||
170669789|NCT01058655|616803311|FG003|Overall Study|Prolonged Treatment Delay|2|||
170669790|NCT01058655|616803308|FG000|Overall Study|Symptomatic Deterioration|0|||
170669791|NCT01058655|616803309|FG001|Overall Study|Symptomatic Deterioration|0|||
170669792|NCT01058655|616803310|FG002|Overall Study|Symptomatic Deterioration|0|||
170669793|NCT01058655|616803311|FG003|Overall Study|Symptomatic Deterioration|1|||
170669794|NCT01058655|616803308|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
170669795|NCT01058655|616803309|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
170669796|NCT01058655|616803310|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
170669797|NCT01058655|616803311|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
170669798|NCT01058655|616803308|FG000|Overall Study|Death|0|||
170669799|NCT01058655|616803309|FG001|Overall Study|Death|1|||
170669800|NCT01058655|616803310|FG002|Overall Study|Death|1|||
170669801|NCT01058655|616803311|FG003|Overall Study|Death|0|||
170669802|NCT01058655|616803308|FG000|Overall Study|Disease Progression|1|||
170669803|NCT01058655|616803309|FG001|Overall Study|Disease Progression|2|||
170669804|NCT01058655|616803310|FG002|Overall Study|Disease Progression|4|||
170669805|NCT01058655|616803311|FG003|Overall Study|Disease Progression|24|||
170669806|NCT01058655|616803308|FG000|Overall Study|Other|0|||
170669807|NCT01058655|616803309|FG001|Overall Study|Other|0|||
170669808|NCT01058655|616803310|FG002|Overall Study|Other|0|||
170669809|NCT01058655|616803311|FG003|Overall Study|Other|4|||
170669810|NCT04545060|616803312|FG000|Overall Study|Adverse Event|0|||
170669811|NCT04545060|616803313|FG001|Overall Study|Adverse Event|1|||
170669812|NCT04545060|616803312|FG000|Overall Study|Death|0|||
170624614|NCT02318706|616637697|FG001|Open-label Extension Phase|Adverse Event|0|||
170624615|NCT02318706|616637698|FG002|Open-label Extension Phase|Adverse Event|0|||
170624616|NCT02318706|616637699|FG003|Open-label Extension Phase|Adverse Event|0|||
170624617|NCT02318706|616637700|FG004|Open-label Extension Phase|Adverse Event|21|||
170624618|NCT02318706|616637696|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
170624619|NCT02318706|616637697|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
170624620|NCT02318706|616637698|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
170624621|NCT02318706|616637699|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
170624622|NCT02318706|616637700|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
170624623|NCT02318706|616637696|FG000|Open-label Extension Phase|Death|0|||
170624624|NCT02318706|616637697|FG001|Open-label Extension Phase|Death|0|||
170624625|NCT02318706|616637698|FG002|Open-label Extension Phase|Death|0|||
170624626|NCT02318706|616637699|FG003|Open-label Extension Phase|Death|0|||
170624627|NCT02318706|616637700|FG004|Open-label Extension Phase|Death|1|||
170624628|NCT02318706|616637696|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
170624629|NCT02318706|616637697|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
170624630|NCT02318706|616637698|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
170624631|NCT02318706|616637699|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
170624632|NCT02318706|616637700|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
170624633|NCT04328077|616637701|FG000|Overall Study|Lost to Follow-up|0|||
170624634|NCT04328077|616637702|FG001|Overall Study|Lost to Follow-up|1|||
170624635|NCT04328077|616637703|FG002|Overall Study|Lost to Follow-up|0|||
170624636|NCT04328077|616637704|FG003|Overall Study|Lost to Follow-up|0|||
170624637|NCT04328077|616637701|FG000|Overall Study|Withdrawal by Subject|0|||
170624638|NCT04328077|616637702|FG001|Overall Study|Withdrawal by Subject|1|||
170624639|NCT04328077|616637703|FG002|Overall Study|Withdrawal by Subject|1|||
170624640|NCT04328077|616637704|FG003|Overall Study|Withdrawal by Subject|3|||
170624641|NCT01456039|616637705|FG000|Phase 1 (First Step)|Disease Progression|1|||
170624642|NCT01456039|616637706|FG001|Phase 1 (First Step)|Disease Progression|1|||
170624643|NCT01456039|616637707|FG002|Phase 1 (First Step)|Disease Progression|0|||
170624644|NCT01456039|616637705|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
170624645|NCT01456039|616637706|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
170624646|NCT01456039|616637707|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
170624647|NCT01456039|616637705|FG000|Phase 1 (First Step)|Adverse Event|0|||
170624648|NCT01456039|616637706|FG001|Phase 1 (First Step)|Adverse Event|3|||
170624649|NCT01456039|616637707|FG002|Phase 1 (First Step)|Adverse Event|0|||
170624650|NCT01456039|616637705|FG000|Phase 1 (First Step)|Other|0|||
170624651|NCT01456039|616637706|FG001|Phase 1 (First Step)|Other|1|||
170669813|NCT04545060|616803313|FG001|Overall Study|Death|5|||
170624652|NCT01456039|616637707|FG002|Phase 1 (First Step)|Other|0|||
170669814|NCT04545060|616803312|FG000|Overall Study|Lost to Follow-up|10|||
170669815|NCT04545060|616803313|FG001|Overall Study|Lost to Follow-up|13|||
170669816|NCT04545060|616803312|FG000|Overall Study|Physician Decision|3|||
170669817|NCT04545060|616803313|FG001|Overall Study|Physician Decision|0|||
170624653|NCT01456039|616637705|FG000|Phase 2 (Second Step)|Disease Progression|0|||
170624654|NCT01456039|616637706|FG001|Phase 2 (Second Step)|Disease Progression|0|||
170624655|NCT01456039|616637707|FG002|Phase 2 (Second Step)|Disease Progression|17|||
170624656|NCT01456039|616637705|FG000|Phase 2 (Second Step)|Adverse Event|0|||
170624657|NCT01456039|616637706|FG001|Phase 2 (Second Step)|Adverse Event|0|||
170624658|NCT01456039|616637707|FG002|Phase 2 (Second Step)|Adverse Event|10|||
170624659|NCT01456039|616637705|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
170624660|NCT01456039|616637706|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
170624661|NCT01456039|616637707|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
170624662|NCT01456039|616637705|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
170624663|NCT01456039|616637706|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
170624664|NCT01456039|616637707|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
170624665|NCT01456039|616637705|FG000|Phase 2 (Second Step)|Other|0|||
170624666|NCT01456039|616637706|FG001|Phase 2 (Second Step)|Other|0|||
170624667|NCT01456039|616637707|FG002|Phase 2 (Second Step)|Other|1|||
170624668|NCT00948246|616637710|FG000|Overall Study|Lost to Follow-up|11|||
170624669|NCT00948246|616637710|FG000|Overall Study|Adverse Event|11|||
170624670|NCT00948246|616637710|FG000|Overall Study|Death|1|||
170624671|NCT00948246|616637710|FG000|Overall Study|Withdrawal by Subject|1|||
170624672|NCT00148317|616637711|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
170624673|NCT00148317|616637711|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
170624674|NCT00148317|616637711|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
170624675|NCT04106557|616637720|FG000|Overall Study|Physician Decision|0|||
170624676|NCT04106557|616637721|FG001|Overall Study|Physician Decision|1|||
170624677|NCT04106557|616637722|FG002|Overall Study|Physician Decision|0|||
170624678|NCT04106557|616637720|FG000|Overall Study|Protocol Violation|0|||
170624679|NCT04106557|616637721|FG001|Overall Study|Protocol Violation|1|||
170624680|NCT04106557|616637722|FG002|Overall Study|Protocol Violation|0|||
170624681|NCT04199351|616637724|FG000|Overall Study|Decision by sponsor|0|||
170624682|NCT04199351|616637725|FG001|Overall Study|Decision by sponsor|0|||
170624683|NCT04199351|616637726|FG002|Overall Study|Decision by sponsor|0|||
170624684|NCT04199351|616637727|FG003|Overall Study|Decision by sponsor|2|||
170624685|NCT04199351|616637728|FG004|Overall Study|Decision by sponsor|0|||
170624686|NCT04199351|616637729|FG005|Overall Study|Decision by sponsor|0|||
170624687|NCT04199351|616637730|FG006|Overall Study|Decision by sponsor|0|||
170624688|NCT04199351|616637731|FG007|Overall Study|Decision by sponsor|0|||
170624689|NCT04199351|616637732|FG008|Overall Study|Decision by sponsor|0|||
170624690|NCT04199351|616637733|FG009|Overall Study|Decision by sponsor|6|||
170624691|NCT04199351|616637724|FG000|Overall Study|Lost to Follow-up|0|||
170624692|NCT04199351|616637725|FG001|Overall Study|Lost to Follow-up|0|||
170624693|NCT04199351|616637726|FG002|Overall Study|Lost to Follow-up|1|||
170624694|NCT04199351|616637727|FG003|Overall Study|Lost to Follow-up|0|||
170624695|NCT04199351|616637728|FG004|Overall Study|Lost to Follow-up|0|||
170624696|NCT04199351|616637729|FG005|Overall Study|Lost to Follow-up|1|||
170624697|NCT04199351|616637730|FG006|Overall Study|Lost to Follow-up|0|||
170624698|NCT04199351|616637731|FG007|Overall Study|Lost to Follow-up|0|||
170624699|NCT04199351|616637732|FG008|Overall Study|Lost to Follow-up|0|||
170624700|NCT04199351|616637733|FG009|Overall Study|Lost to Follow-up|0|||
170624701|NCT04199351|616637724|FG000|Overall Study|Withdrawal by Subject|0|||
170624702|NCT04199351|616637725|FG001|Overall Study|Withdrawal by Subject|1|||
170624703|NCT04199351|616637726|FG002|Overall Study|Withdrawal by Subject|0|||
170624704|NCT04199351|616637727|FG003|Overall Study|Withdrawal by Subject|0|||
170624705|NCT04199351|616637728|FG004|Overall Study|Withdrawal by Subject|1|||
170624706|NCT04199351|616637729|FG005|Overall Study|Withdrawal by Subject|4|||
170624707|NCT04199351|616637730|FG006|Overall Study|Withdrawal by Subject|2|||
170624708|NCT04199351|616637731|FG007|Overall Study|Withdrawal by Subject|0|||
170624709|NCT04199351|616637732|FG008|Overall Study|Withdrawal by Subject|3|||
170624710|NCT04199351|616637733|FG009|Overall Study|Withdrawal by Subject|0|||
170624711|NCT00744497|616637734|FG000|Overall Study|Withdrawal by Subject|21|||
170624712|NCT00744497|616637735|FG001|Overall Study|Withdrawal by Subject|18|||
170624713|NCT00744497|616637734|FG000|Overall Study|Death|11|||
170624714|NCT00744497|616637735|FG001|Overall Study|Death|9|||
170624715|NCT00744497|616637734|FG000|Overall Study|Lost to Follow-up|4|||
170624716|NCT00744497|616637735|FG001|Overall Study|Lost to Follow-up|2|||
170624717|NCT00744497|616637734|FG000|Overall Study|Poor compliance/noncompliance|9|||
170624718|NCT00744497|616637735|FG001|Overall Study|Poor compliance/noncompliance|5|||
170624719|NCT00744497|616637734|FG000|Overall Study|No longer meets study criteria|7|||
170624720|NCT00744497|616637735|FG001|Overall Study|No longer meets study criteria|3|||
170624721|NCT00744497|616637734|FG000|Overall Study|Administrative Reason By Sponsor|25|||
170624722|NCT00744497|616637735|FG001|Overall Study|Administrative Reason By Sponsor|8|||
170624723|NCT00744497|616637734|FG000|Overall Study|Disease progression|312|||
170624724|NCT00744497|616637735|FG001|Overall Study|Disease progression|219|||
170624725|NCT00744497|616637734|FG000|Overall Study|Study drug toxicity|68|||
170624726|NCT00744497|616637735|FG001|Overall Study|Study drug toxicity|141|||
170624727|NCT00744497|616637734|FG000|Overall Study|Adverse event unrelated to study drug|78|||
170624728|NCT00744497|616637735|FG001|Overall Study|Adverse event unrelated to study drug|122|||
170624729|NCT00744497|616637734|FG000|Overall Study|Patient requested to stop study drug|65|||
170669818|NCT04545060|616803312|FG000|Overall Study|Withdrawal by Subject|17|||
170669819|NCT04545060|616803313|FG001|Overall Study|Withdrawal by Subject|22|||
170669820|NCT00619177|616803314|FG000|Overall Study|Adverse Event|18|||
170669821|NCT00619177|616803314|FG000|Overall Study|Lost to Follow-up|2|||
170669822|NCT00619177|616803314|FG000|Overall Study|Lack of Efficacy|1|||
170669823|NCT00619177|616803314|FG000|Overall Study|Missing termination information|481|||
170669824|NCT00619177|616803314|FG000|Overall Study|Not specified reasons|6|||
170669825|NCT01609231|616803316|FG000|Overall Study|Adverse Event|1|||
170669826|NCT01609231|616803317|FG001|Overall Study|Adverse Event|3|||
170669827|NCT01609231|616803316|FG000|Overall Study|Physician Decision|1|||
170669828|NCT01609231|616803317|FG001|Overall Study|Physician Decision|0|||
170669829|NCT01609231|616803316|FG000|Overall Study|Withdrawal by Subject|1|||
170669830|NCT01609231|616803317|FG001|Overall Study|Withdrawal by Subject|0|||
170669831|NCT00973674|616803318|FG000|Overall Study|Protocol Violation|2|||
170669832|NCT00973674|616803319|FG001|Overall Study|Protocol Violation|0|||
170669833|NCT01612858|616803331|FG000|Overall Study|Withdrawal by Subject|5|||
170669834|NCT01612858|616803332|FG001|Overall Study|Withdrawal by Subject|1|||
170669835|NCT01484275|616803333|FG000|Overall Study|Study terminated by sponsor|28|||
170669836|NCT01484275|616803334|FG001|Overall Study|Study terminated by sponsor|32|||
170669837|NCT01484275|616803333|FG000|Overall Study|Other|10|||
170669838|NCT01484275|616803334|FG001|Overall Study|Other|0|||
170669839|NCT01484275|616803333|FG000|Overall Study|Death|3|||
170669840|NCT01484275|616803334|FG001|Overall Study|Death|4|||
170669841|NCT01484275|616803333|FG000|Overall Study|Withdrawal by Subject|1|||
170669842|NCT01484275|616803334|FG001|Overall Study|Withdrawal by Subject|5|||
170669843|NCT01484275|616803333|FG000|Overall Study|Lost to Follow-up|1|||
170669844|NCT01484275|616803334|FG001|Overall Study|Lost to Follow-up|1|||
170669845|NCT00657358|616803335|FG000|Overall Study|Lack of Efficacy|6|||
170669846|NCT00005044|616803336|FG000|Overall Study|Protocol Violation|37|||
170669847|NCT00005044|616803337|FG001|Overall Study|Protocol Violation|46|||
170669848|NCT00005044|616803336|FG000|Overall Study|Withdrawal by Subject|1|||
170669849|NCT00005044|616803337|FG001|Overall Study|Withdrawal by Subject|5|||
170669850|NCT00005044|616803336|FG000|Overall Study|No protocol treatment|0|||
170669851|NCT00005044|616803337|FG001|Overall Study|No protocol treatment|1|||
170669852|NCT03113916|616803340|FG000|Overall Study|Withdrawal by Subject|9|||
170669853|NCT03113916|616803341|FG001|Overall Study|Withdrawal by Subject|7|||
170669854|NCT03113916|616803340|FG000|Overall Study|Pregnancy|1|||
170669855|NCT03113916|616803341|FG001|Overall Study|Pregnancy|3|||
170669856|NCT03113916|616803340|FG000|Overall Study|Lost to Follow-up|1|||
170669857|NCT03113916|616803341|FG001|Overall Study|Lost to Follow-up|2|||
170669858|NCT03855228|616803342|FG000|Overall Study|Adverse Event|2|||
170669859|NCT03855228|616803343|FG001|Overall Study|Adverse Event|4|||
170669860|NCT03855228|616803344|FG002|Overall Study|Adverse Event|4|||
170669861|NCT03855228|616803345|FG003|Overall Study|Adverse Event|8|||
170669862|NCT03855228|616803342|FG000|Overall Study|Treatment Failure|1|||
170669863|NCT03855228|616803343|FG001|Overall Study|Treatment Failure|2|||
170669864|NCT03855228|616803344|FG002|Overall Study|Treatment Failure|1|||
170669865|NCT03855228|616803345|FG003|Overall Study|Treatment Failure|8|||
170669866|NCT03855228|616803342|FG000|Overall Study|Lost to Follow-up|0|||
170669867|NCT03855228|616803343|FG001|Overall Study|Lost to Follow-up|0|||
170669868|NCT03855228|616803344|FG002|Overall Study|Lost to Follow-up|0|||
170669869|NCT03855228|616803345|FG003|Overall Study|Lost to Follow-up|1|||
170669870|NCT03855228|616803342|FG000|Overall Study|Protocol Violation|0|||
170669871|NCT03855228|616803343|FG001|Overall Study|Protocol Violation|1|||
170669872|NCT03855228|616803344|FG002|Overall Study|Protocol Violation|2|||
170669873|NCT03855228|616803345|FG003|Overall Study|Protocol Violation|1|||
170669874|NCT03855228|616803342|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
170669875|NCT03855228|616803343|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
170669876|NCT03855228|616803344|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
170669877|NCT03855228|616803345|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
170669878|NCT00843856|616803346|FG000|Overall Study|Lost to Follow-up|1|||
170624730|NCT00744497|616637735|FG001|Overall Study|Patient requested to stop study drug|80|||
170624731|NCT00744497|616637734|FG000|Overall Study|Maximum clinical benefit|141|||
170624732|NCT00744497|616637735|FG001|Overall Study|Maximum clinical benefit|142|||
170624733|NCT00744497|616637734|FG000|Overall Study|Not defined|19|||
170624734|NCT00744497|616637735|FG001|Overall Study|Not defined|13|||
170624735|NCT01903356|616637742|FG000|Overall Study|Lost to Follow-up|7|||
170624736|NCT01903356|616637742|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
170624737|NCT01903356|616637742|FG000|Overall Study|Violated the dosage and administration|3|||
170669879|NCT00843856|616803347|FG001|Overall Study|Lost to Follow-up|2|||
170624738|NCT01546857|616637745|FG000|Overall Study|Withdrawal by Subject|2|||
170669880|NCT01758523|616803349|FG000|Overall Study|Adverse Event|2|||
170669881|NCT01758523|616803350|FG001|Overall Study|Adverse Event|1|||
170669882|NCT01758523|616803349|FG000|Overall Study|Lack of Efficacy|4|||
170669883|NCT01758523|616803350|FG001|Overall Study|Lack of Efficacy|2|||
170669884|NCT01758523|616803349|FG000|Overall Study|Lost to Follow-up|3|||
170669885|NCT01758523|616803350|FG001|Overall Study|Lost to Follow-up|4|||
170669886|NCT01758523|616803349|FG000|Overall Study|Withdrawal by Subject|12|||
170669887|NCT01758523|616803350|FG001|Overall Study|Withdrawal by Subject|7|||
170669888|NCT01893203|616803351|FG000|Overall Study|Withdrawal by Subject|1|||
170669889|NCT00590135|616803352|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
170669890|NCT04729621|616803353|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
170669891|NCT04729621|616803354|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
170669892|NCT04729621|616803355|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
170669893|NCT04729621|616803356|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
170669894|NCT04729621|616803357|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
170669895|NCT04729621|616803353|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
170669896|NCT04729621|616803354|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
170669897|NCT04729621|616803355|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
170669898|NCT04729621|616803356|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
170669899|NCT04729621|616803357|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
170669900|NCT04729621|616803353|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
170669901|NCT04729621|616803354|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
170669902|NCT04729621|616803355|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
170669903|NCT04729621|616803356|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
170669904|NCT04729621|616803357|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
170669905|NCT04729621|616803353|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
170669906|NCT04729621|616803354|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
170669907|NCT04729621|616803355|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
170669908|NCT04729621|616803356|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
170669909|NCT04729621|616803357|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
170669910|NCT04729621|616803353|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
170669911|NCT04729621|616803354|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
170669912|NCT04729621|616803355|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
170669913|NCT04729621|616803356|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
170669914|NCT04729621|616803357|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
170669915|NCT04729621|616803353|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
170669916|NCT04729621|616803354|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
170669917|NCT04729621|616803355|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
170669918|NCT04729621|616803356|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
170669919|NCT04729621|616803357|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
170669920|NCT01449539|616803364|FG000|Overall Study|Withdrawal by Subject|3|||
170669921|NCT01449539|616803364|FG000|Overall Study|Toxicity not study related|1|||
170669922|NCT01387789|616803365|FG000|Overall Study|Adverse Event|5|||
170669923|NCT01387789|616803365|FG000|Overall Study|Lack of Efficacy|2|||
170669924|NCT01387789|616803365|FG000|Overall Study|Lost to Follow-up|1|||
170669925|NCT02187744|616803366|FG000|Study|Participant refused further follow-up|1|||
170669926|NCT02187744|616803367|FG001|Study|Participant refused further follow-up|0|||
170669927|NCT02187744|616803366|FG000|Study|Other|2|||
170669928|NCT02187744|616803367|FG001|Study|Other|1|||
170669929|NCT02187744|616803366|FG000|Study|Lost to Follow-up|0|||
170669930|NCT02187744|616803367|FG001|Study|Lost to Follow-up|2|||
170669931|NCT02187744|616803366|FG000|Study|Related adverse event, not serious|0|||
170669932|NCT02187744|616803367|FG001|Study|Related adverse event, not serious|2|||
170669933|NCT02187744|616803366|FG000|Study|Death|1|||
170669934|NCT02187744|616803367|FG001|Study|Death|0|||
170669935|NCT02187744|616803366|FG000|Study|Related adverse event, serious non-fatal|0|||
170669936|NCT02187744|616803367|FG001|Study|Related adverse event, serious non-fatal|1|||
170669937|NCT02187744|616803366|FG000|Treatment|Death|1|||
170669938|NCT02187744|616803367|FG001|Treatment|Death|0|||
170669939|NCT02187744|616803366|FG000|Treatment|Related adverse event, serious non-fatal|0|||
170669940|NCT02187744|616803367|FG001|Treatment|Related adverse event, serious non-fatal|1|||
170669941|NCT02187744|616803366|FG000|Treatment|Related adverse event, not serious|0|||
170669942|NCT02187744|616803367|FG001|Treatment|Related adverse event, not serious|2|||
170669943|NCT02187744|616803366|FG000|Treatment|Lost to Follow-up|0|||
170669944|NCT02187744|616803367|FG001|Treatment|Lost to Follow-up|1|||
170669945|NCT02187744|616803366|FG000|Treatment|Other|2|||
170669946|NCT02187744|616803367|FG001|Treatment|Other|0|||
170669947|NCT02187744|616803366|FG000|Treatment|Participant refused continued treatment|1|||
170669948|NCT02187744|616803367|FG001|Treatment|Participant refused continued treatment|1|||
170624739|NCT01546857|616637746|FG001|Overall Study|Withdrawal by Subject|3|||
170624740|NCT02542865|616637747|FG000|Overall Study|Identified as screen failure|1|||
170624741|NCT02542865|616637748|FG001|Overall Study|Identified as screen failure|0|||
170624742|NCT02542865|616637747|FG000|Overall Study|Withdrawal by Subject|16|||
170624743|NCT02542865|616637748|FG001|Overall Study|Withdrawal by Subject|0|||
170624744|NCT01339689|616637749|FG000|Overall Study|Adverse Event|1|||
170624745|NCT01339689|616637750|FG001|Overall Study|Adverse Event|2|||
170624746|NCT01339689|616637749|FG000|Overall Study|Lost to Follow-up|9|||
170624747|NCT01339689|616637750|FG001|Overall Study|Lost to Follow-up|3|||
170624748|NCT01339689|616637749|FG000|Overall Study|Withdrawal by Subject|3|||
170624749|NCT01339689|616637750|FG001|Overall Study|Withdrawal by Subject|0|||
170624750|NCT01339689|616637749|FG000|Overall Study|Noncompliance|1|||
170624751|NCT01339689|616637750|FG001|Overall Study|Noncompliance|0|||
170624752|NCT01339689|616637749|FG000|Overall Study|Relocated out of area|0|||
170624753|NCT01339689|616637750|FG001|Overall Study|Relocated out of area|1|||
170624754|NCT01339689|616637749|FG000|Overall Study|Other|2|||
170624755|NCT01339689|616637750|FG001|Overall Study|Other|2|||
170624756|NCT01339689|616637749|FG000|Overall Study|multiple reasons|1|||
170624757|NCT01339689|616637750|FG001|Overall Study|multiple reasons|1|||
170624758|NCT01176032|616637751|FG000|Overall Study|Adverse Event|1|||
170624759|NCT01176032|616637752|FG001|Overall Study|Adverse Event|0|||
170624760|NCT01176032|616637751|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170624761|NCT01176032|616637752|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170624762|NCT01176032|616637751|FG000|Overall Study|Protocol Violation|1|||
170624763|NCT01176032|616637752|FG001|Overall Study|Protocol Violation|0|||
170624764|NCT01176032|616637751|FG000|Overall Study|Informed consent withdrawn|3|||
170624765|NCT01176032|616637752|FG001|Overall Study|Informed consent withdrawn|0|||
170624766|NCT01176032|616637751|FG000|Overall Study|Other|1|||
170624767|NCT01176032|616637752|FG001|Overall Study|Other|0|||
170624768|NCT01469221|616637753|FG000|Double Blind Phase|Protocol Violation|1|||
170624769|NCT01469221|616637754|FG001|Double Blind Phase|Protocol Violation|0|||
170624770|NCT01469221|616637755|FG002|Double Blind Phase|Protocol Violation|0|||
170624771|NCT01469221|616637753|FG000|Double Blind Phase|Physician Decision|1|||
170624772|NCT01469221|616637754|FG001|Double Blind Phase|Physician Decision|1|||
170624773|NCT01469221|616637755|FG002|Double Blind Phase|Physician Decision|0|||
170624774|NCT01469221|616637753|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
170624775|NCT01469221|616637754|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
170624776|NCT01469221|616637755|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
170624777|NCT04913610|616637757|FG000|Randomized Participants|Did Not Receive Treatment|0|||
170624778|NCT04913610|616637758|FG001|Randomized Participants|Did Not Receive Treatment|0|||
170624779|NCT04913610|616637759|FG002|Randomized Participants|Did Not Receive Treatment|1|||
170624780|NCT04913610|616637760|FG003|Randomized Participants|Did Not Receive Treatment|1|||
170624781|NCT04913610|616637761|FG004|Randomized Participants|Did Not Receive Treatment|0|||
170624782|NCT04913610|616637757|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
170624783|NCT04913610|616637758|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
170624784|NCT04913610|616637759|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
170624785|NCT04913610|616637760|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
170624786|NCT04913610|616637761|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
170624787|NCT00659061|616637762|FG000|Overall Study|Migration due to political unrest|21|||
170624788|NCT00659061|616637763|FG001|Overall Study|Migration due to political unrest|15|||
170624789|NCT01149096|616637769|FG000|Overall Study|Lost to Follow-up|0|||
170624790|NCT01149096|616637770|FG001|Overall Study|Lost to Follow-up|1|||
170624791|NCT04739982|616637772|FG000|Overall Study|Lost to Follow-up|176|||
170624792|NCT04739982|616637773|FG001|Overall Study|Lost to Follow-up|65|||
170624793|NCT04739982|616637772|FG000|Overall Study|Withdrawal by Subject|19|||
170624794|NCT04739982|616637773|FG001|Overall Study|Withdrawal by Subject|0|||
170624795|NCT04739982|616637772|FG000|Overall Study|Protocol Violation|0|||
170624796|NCT04739982|616637773|FG001|Overall Study|Protocol Violation|5|||
170624797|NCT04914364|616637776|FG000|Overall Study|No longer eligible for study|1|||
170624798|NCT04914364|616637776|FG000|Overall Study|Lost to Follow-up|2|||
170624799|NCT00953667|616637780|FG000|Overall Study|Lost to Follow-up|11|||
170624800|NCT00953667|616637780|FG000|Overall Study|Physician Decision|35|||
170624801|NCT00953667|616637780|FG000|Overall Study|Withdrawal by Subject|63|||
170624802|NCT00953667|616637780|FG000|Overall Study|Adverse Event|10|||
170624803|NCT00953667|616637780|FG000|Overall Study|poor venous access,unable to draw blood|4|||
170624804|NCT04038359|616637781|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
170624805|NCT04038359|616637782|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
170624806|NCT04038359|616637781|FG000|Overall Study|Death|8|||
170624807|NCT04038359|616637782|FG001|Overall Study|Death|7|||
170624808|NCT04038359|616637781|FG000|Overall Study|Lost to Follow-up|3|||
170624809|NCT04038359|616637782|FG001|Overall Study|Lost to Follow-up|0|||
170624810|NCT04038359|616637781|FG000|Overall Study|Participant Moved|1|||
170624811|NCT04038359|616637782|FG001|Overall Study|Participant Moved|0|||
170624812|NCT04038359|616637781|FG000|Overall Study|Withdrawal by Subject|4|||
170624813|NCT04038359|616637782|FG001|Overall Study|Withdrawal by Subject|3|||
170624814|NCT04038359|616637781|FG000|Overall Study|Physician Decision|3|||
170624815|NCT04038359|616637782|FG001|Overall Study|Physician Decision|2|||
170624816|NCT04038359|616637781|FG000|Overall Study|Adverse Event|0|||
170624817|NCT04038359|616637782|FG001|Overall Study|Adverse Event|2|||
170624818|NCT04038359|616637781|FG000|Overall Study|Progressive Disease|0|||
170624819|NCT04038359|616637782|FG001|Overall Study|Progressive Disease|1|||
170624820|NCT01033240|616637783|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
170624821|NCT01033240|616637784|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
170624822|NCT01033240|616637785|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
170624823|NCT01033240|616637783|FG000|Overall Study|Death|2|||
170669949|NCT01788228|616803368|FG000|Overall Study|Migrated/moved from study area|1|||
170669950|NCT01788228|616803369|FG001|Overall Study|Migrated/moved from study area|0|||
170669951|NCT01972568|616803374|FG000|Overall Study|Other events|3|||
170669952|NCT01972568|616803375|FG001|Overall Study|Other events|0|||
170669953|NCT01972568|616803376|FG002|Overall Study|Other events|0|||
170669954|NCT01972568|616803374|FG000|Overall Study|Lack of Efficacy|0|||
170669955|NCT01972568|616803375|FG001|Overall Study|Lack of Efficacy|1|||
170669956|NCT01972568|616803376|FG002|Overall Study|Lack of Efficacy|2|||
170669957|NCT01972568|616803374|FG000|Overall Study|Protocol Violation|1|||
170669958|NCT01972568|616803375|FG001|Overall Study|Protocol Violation|2|||
170669959|NCT01972568|616803376|FG002|Overall Study|Protocol Violation|2|||
170669960|NCT01972568|616803374|FG000|Overall Study|Withdrawal by Subject|6|||
170669961|NCT01972568|616803375|FG001|Overall Study|Withdrawal by Subject|3|||
170669962|NCT01972568|616803376|FG002|Overall Study|Withdrawal by Subject|7|||
170669963|NCT01972568|616803374|FG000|Overall Study|Lost to Follow-up|1|||
170669964|NCT01972568|616803375|FG001|Overall Study|Lost to Follow-up|0|||
170669965|NCT01972568|616803376|FG002|Overall Study|Lost to Follow-up|0|||
170669966|NCT01972568|616803374|FG000|Overall Study|Adverse Event|5|||
170669967|NCT01972568|616803375|FG001|Overall Study|Adverse Event|6|||
170669968|NCT01972568|616803376|FG002|Overall Study|Adverse Event|5|||
170669969|NCT02059408|616803380|FG000|Overall Study|Did not get tested|0|||
170669970|NCT02059408|616803381|FG001|Overall Study|Did not get tested|330|||
170669971|NCT02059408|616803382|FG002|Overall Study|Did not get tested|358|||
170669972|NCT00508755|616803383|FG000|Overall Study|Withdrawal by Subject|1|||
170669973|NCT00957580|616803384|FG000|Overall Study|Ongoing at data cut-off|0|||
170669974|NCT00957580|616803385|FG001|Overall Study|Ongoing at data cut-off|1|||
170669975|NCT00957580|616803386|FG002|Overall Study|Ongoing at data cut-off|0|||
170669976|NCT00957580|616803384|FG000|Overall Study|Enrolled but not treated|0|||
170669977|NCT00957580|616803385|FG001|Overall Study|Enrolled but not treated|1|||
170669978|NCT00957580|616803386|FG002|Overall Study|Enrolled but not treated|0|||
170669979|NCT00945893|616803387|FG000|Overall Study|Lost to Follow-up|2|||
170669980|NCT00945893|616803388|FG001|Overall Study|Lost to Follow-up|8|||
170669981|NCT00945893|616803387|FG000|Overall Study|Withdrawal of consent|1|||
170669982|NCT00945893|616803388|FG001|Overall Study|Withdrawal of consent|2|||
170669983|NCT03113071|616803389|FG000|Overall Study|Withdrawal by Subject|1|||
170669984|NCT03113071|616803390|FG001|Overall Study|Withdrawal by Subject|0|||
170669985|NCT01611155|616803393|FG000|Overall Study|Adverse Event|1|||
170669986|NCT01611155|616803394|FG001|Overall Study|Adverse Event|1|||
170669987|NCT01611155|616803393|FG000|Overall Study|Refused further treatment|6|||
170669988|NCT01611155|616803394|FG001|Overall Study|Refused further treatment|4|||
170669989|NCT01611155|616803393|FG000|Overall Study|Disease progression|1|||
170669990|NCT01611155|616803394|FG001|Overall Study|Disease progression|0|||
170669991|NCT01611155|616803393|FG000|Overall Study|Withdrawal by Subject|1|||
170669992|NCT01611155|616803394|FG001|Overall Study|Withdrawal by Subject|0|||
170669993|NCT01611155|616803393|FG000|Overall Study|Alternative treatment|0|||
170669994|NCT01611155|616803394|FG001|Overall Study|Alternative treatment|1|||
170669995|NCT01611155|616803393|FG000|Overall Study|Ineligible patient|0|||
170669996|NCT01611155|616803394|FG001|Overall Study|Ineligible patient|1|||
170669997|NCT01602120|616803395|FG000|Overall Study|Adverse Event|3|||
170669998|NCT01602120|616803396|FG001|Overall Study|Adverse Event|6|||
170669999|NCT01602120|616803397|FG002|Overall Study|Adverse Event|0|||
170670000|NCT01602120|616803398|FG003|Overall Study|Adverse Event|2|||
170670001|NCT01602120|616803395|FG000|Overall Study|Death|0|||
170670002|NCT01602120|616803396|FG001|Overall Study|Death|4|||
170670003|NCT01602120|616803397|FG002|Overall Study|Death|0|||
170670004|NCT01602120|616803398|FG003|Overall Study|Death|0|||
170670005|NCT01602120|616803395|FG000|Overall Study|Lost to Follow-up|0|||
170670006|NCT01602120|616803396|FG001|Overall Study|Lost to Follow-up|1|||
170670007|NCT01602120|616803397|FG002|Overall Study|Lost to Follow-up|0|||
170670008|NCT01602120|616803398|FG003|Overall Study|Lost to Follow-up|1|||
170670009|NCT01602120|616803395|FG000|Overall Study|Protocol Violation|1|||
170670010|NCT01602120|616803396|FG001|Overall Study|Protocol Violation|1|||
170670011|NCT01602120|616803397|FG002|Overall Study|Protocol Violation|0|||
170624824|NCT01033240|616637784|FG001|Overall Study|Death|0|||
170624825|NCT01033240|616637785|FG002|Overall Study|Death|0|||
170624826|NCT01033240|616637783|FG000|Overall Study|Withdrew Consent|2|||
170624827|NCT01033240|616637784|FG001|Overall Study|Withdrew Consent|9|||
170624828|NCT01033240|616637785|FG002|Overall Study|Withdrew Consent|2|||
170624829|NCT01033240|616637783|FG000|Overall Study|Disease Progression|35|||
170624830|NCT01033240|616637784|FG001|Overall Study|Disease Progression|32|||
170624831|NCT01033240|616637785|FG002|Overall Study|Disease Progression|41|||
170624832|NCT01033240|616637783|FG000|Overall Study|Investigator Discretion|0|||
170624833|NCT01033240|616637784|FG001|Overall Study|Investigator Discretion|0|||
170624834|NCT01033240|616637785|FG002|Overall Study|Investigator Discretion|2|||
170624835|NCT01033240|616637783|FG000|Overall Study|Other|0|||
170624836|NCT01033240|616637784|FG001|Overall Study|Other|1|||
170624837|NCT01033240|616637785|FG002|Overall Study|Other|2|||
170624838|NCT00758771|616637790|FG000|Overall Study|Withdrawal by Subject|1|||
170624839|NCT00758771|616637791|FG001|Overall Study|Withdrawal by Subject|1|||
170624840|NCT00758771|616637790|FG000|Overall Study|Did not meet eligibility criteria|2|||
170624841|NCT00758771|616637791|FG001|Overall Study|Did not meet eligibility criteria|4|||
170624842|NCT00528957|616637792|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
170624843|NCT00528957|616637793|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
170624844|NCT00528957|616637792|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
170624845|NCT00528957|616637793|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
170624846|NCT00528957|616637792|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
170624847|NCT00528957|616637793|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
170624848|NCT00528957|616637792|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
170624849|NCT00528957|616637793|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
170624850|NCT00528957|616637792|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
170624851|NCT00528957|616637793|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
170624852|NCT00528957|616637792|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
170624853|NCT00528957|616637793|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
170624854|NCT00528957|616637792|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
170624855|NCT00528957|616637793|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
170624856|NCT00528957|616637792|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
170624857|NCT00528957|616637793|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
170624858|NCT00528957|616637792|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
170624859|NCT00528957|616637793|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
170624860|NCT00528957|616637792|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
170624861|NCT00528957|616637793|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
170624862|NCT00528957|616637792|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
170624863|NCT00528957|616637793|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
170624864|NCT00528957|616637792|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
170624865|NCT00528957|616637793|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
170624866|NCT00528957|616637792|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
170624867|NCT00528957|616637793|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
170624868|NCT00528957|616637792|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
170624869|NCT00528957|616637793|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
170624870|NCT00528957|616637792|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
170624871|NCT00528957|616637793|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
170624872|NCT00528957|616637792|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
170624873|NCT00528957|616637793|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
170624874|NCT00918281|616637796|FG000|Overall Study|Physician Decision|29|||
170624875|NCT01323582|616637799|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
170624876|NCT01323582|616637800|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
170624877|NCT01323582|616637799|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
170624878|NCT01323582|616637800|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
170624879|NCT01323582|616637799|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
170624880|NCT01323582|616637800|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
170624881|NCT00112736|616637801|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
170624882|NCT00112736|616637802|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
170624883|NCT02138890|616637803|FG000|Overall Study|Adverse Event|1|||
170624884|NCT02138890|616637804|FG001|Overall Study|Adverse Event|0|||
170624885|NCT05435339|616637805|FG000|Overall Study|Death|1|||
170624886|NCT05435339|616637806|FG001|Overall Study|Death|0|||
170624887|NCT05435339|616637807|FG002|Overall Study|Death|3|||
170624888|NCT05435339|616637808|FG003|Overall Study|Death|1|||
170624889|NCT05435339|616637809|FG004|Overall Study|Death|3|||
170624890|NCT05435339|616637810|FG005|Overall Study|Death|2|||
170624891|NCT05435339|616637811|FG006|Overall Study|Death|4|||
170624892|NCT05435339|616637812|FG007|Overall Study|Death|6|||
170624893|NCT05435339|616637805|FG000|Overall Study|Sponsor Decision|0|||
170624894|NCT05435339|616637806|FG001|Overall Study|Sponsor Decision|1|||
170624895|NCT05435339|616637807|FG002|Overall Study|Sponsor Decision|0|||
170624896|NCT05435339|616637808|FG003|Overall Study|Sponsor Decision|0|||
170624897|NCT05435339|616637809|FG004|Overall Study|Sponsor Decision|2|||
170624898|NCT05435339|616637810|FG005|Overall Study|Sponsor Decision|1|||
170670012|NCT01602120|616803398|FG003|Overall Study|Protocol Violation|0|||
170670013|NCT01602120|616803395|FG000|Overall Study|Non-compliance|0|||
170670014|NCT01602120|616803396|FG001|Overall Study|Non-compliance|3|||
170670015|NCT01602120|616803397|FG002|Overall Study|Non-compliance|0|||
170670016|NCT01602120|616803398|FG003|Overall Study|Non-compliance|1|||
170670017|NCT01602120|616803395|FG000|Overall Study|Withdrawal by Subject|8|||
170670018|NCT01602120|616803396|FG001|Overall Study|Withdrawal by Subject|17|||
170670019|NCT01602120|616803397|FG002|Overall Study|Withdrawal by Subject|0|||
170670020|NCT01602120|616803398|FG003|Overall Study|Withdrawal by Subject|3|||
170670021|NCT01602120|616803395|FG000|Overall Study|Study Terminated by Sponsor|12|||
170670022|NCT01602120|616803396|FG001|Overall Study|Study Terminated by Sponsor|24|||
170670023|NCT01602120|616803397|FG002|Overall Study|Study Terminated by Sponsor|17|||
170670024|NCT01602120|616803398|FG003|Overall Study|Study Terminated by Sponsor|44|||
170670025|NCT01602120|616803395|FG000|Overall Study|Physician Decision|2|||
170670026|NCT01602120|616803396|FG001|Overall Study|Physician Decision|3|||
170670027|NCT01602120|616803397|FG002|Overall Study|Physician Decision|0|||
170670028|NCT01602120|616803398|FG003|Overall Study|Physician Decision|0|||
170670029|NCT01602120|616803395|FG000|Overall Study|Unspecified Reason|3|||
170670030|NCT01602120|616803396|FG001|Overall Study|Unspecified Reason|1|||
170670031|NCT01602120|616803397|FG002|Overall Study|Unspecified Reason|0|||
170670032|NCT01602120|616803398|FG003|Overall Study|Unspecified Reason|2|||
170670033|NCT01681472|616803401|FG000|Overall Study|Adverse Event|0|||
170670034|NCT01681472|616803402|FG001|Overall Study|Adverse Event|1|||
170670035|NCT01681472|616803403|FG002|Overall Study|Adverse Event|0|||
170670036|NCT01681472|616803404|FG003|Overall Study|Adverse Event|0|||
170670037|NCT02369016|616803407|FG000|Overall Study|AE associated with clinical disease progression|2|||
170670038|NCT02369016|616803408|FG001|Overall Study|AE associated with clinical disease progression|1|||
170670039|NCT02369016|616803407|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
170670040|NCT02369016|616803408|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
170670041|NCT02369016|616803407|FG000|Overall Study|Progressive disease - clinical progression|1|||
170670042|NCT02369016|616803408|FG001|Overall Study|Progressive disease - clinical progression|4|||
170670043|NCT02369016|616803407|FG000|Overall Study|withdrawal by patient|4|||
170670044|NCT02369016|616803408|FG001|Overall Study|withdrawal by patient|0|||
170670045|NCT02369016|616803407|FG000|Overall Study|Progressive disease - radiological progression|6|||
170670046|NCT02369016|616803408|FG001|Overall Study|Progressive disease - radiological progression|2|||
170670047|NCT01696071|616803416|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
170670048|NCT01696071|616803417|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
170670049|NCT01187433|616803418|FG000|Overall Study|Protocol Violation|6|||
170670050|NCT01187433|616803419|FG001|Overall Study|Protocol Violation|2|||
170670051|NCT01187433|616803418|FG000|Overall Study|Withdrawal by Subject|5|||
170670052|NCT01187433|616803419|FG001|Overall Study|Withdrawal by Subject|2|||
170670053|NCT00621959|616803420|FG000|Overall Study|Adverse Event|4|||
170670054|NCT00621959|616803421|FG001|Overall Study|Adverse Event|2|||
170670055|NCT00621959|616803420|FG000|Overall Study|Lack of Efficacy|1|||
170670056|NCT00621959|616803421|FG001|Overall Study|Lack of Efficacy|1|||
170670057|NCT00621959|616803420|FG000|Overall Study|Lost to Follow-up|0|||
170670058|NCT00621959|616803421|FG001|Overall Study|Lost to Follow-up|2|||
170670059|NCT00621959|616803420|FG000|Overall Study|Withdrawal by Subject|1|||
170670060|NCT00621959|616803421|FG001|Overall Study|Withdrawal by Subject|1|||
170670061|NCT00621959|616803420|FG000|Overall Study|Other|1|||
170670062|NCT00621959|616803421|FG001|Overall Study|Other|3|||
170670063|NCT02423772|616803426|FG000|Overall Study|Lost to Follow-up|3|||
170670064|NCT02423772|616803427|FG001|Overall Study|Lost to Follow-up|3|||
170670065|NCT02423772|616803426|FG000|Overall Study|Did not begin intervention|2|||
170670066|NCT02423772|616803427|FG001|Overall Study|Did not begin intervention|5|||
170670067|NCT01193842|616803428|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
170670068|NCT01193842|616803429|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
170670069|NCT01193842|616803430|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
170670070|NCT01193842|616803431|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
170670071|NCT01193842|616803432|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
170670072|NCT01193842|616803428|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
170670073|NCT01193842|616803429|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
170670074|NCT01193842|616803430|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
170670075|NCT01193842|616803431|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
170670076|NCT01193842|616803432|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
170670077|NCT01193842|616803428|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
170670078|NCT01193842|616803429|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
170670079|NCT01193842|616803430|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
170670080|NCT01193842|616803431|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
170670081|NCT01193842|616803432|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
170670082|NCT01193842|616803428|FG000|Phase II: Randomized Groups|Death|0|||
170670083|NCT01193842|616803429|FG001|Phase II: Randomized Groups|Death|0|||
170670084|NCT01193842|616803430|FG002|Phase II: Randomized Groups|Death|0|||
170670085|NCT01193842|616803431|FG003|Phase II: Randomized Groups|Death|1|||
170670086|NCT01193842|616803432|FG004|Phase II: Randomized Groups|Death|1|||
170670087|NCT01193842|616803428|FG000|Phase II: Randomized Groups|Adverse Event|0|||
170670088|NCT01193842|616803429|FG001|Phase II: Randomized Groups|Adverse Event|0|||
170670089|NCT01193842|616803430|FG002|Phase II: Randomized Groups|Adverse Event|0|||
170670090|NCT01193842|616803431|FG003|Phase II: Randomized Groups|Adverse Event|5|||
170670091|NCT01193842|616803432|FG004|Phase II: Randomized Groups|Adverse Event|3|||
170670092|NCT01193842|616803428|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
170670093|NCT01193842|616803429|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
170670094|NCT01193842|616803430|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
170670095|NCT01193842|616803431|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
170670096|NCT01193842|616803432|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
170670097|NCT01193842|616803428|FG000|Phase II: Randomized Groups|Ineligible|0|||
170670098|NCT01193842|616803429|FG001|Phase II: Randomized Groups|Ineligible|0|||
170670099|NCT01193842|616803430|FG002|Phase II: Randomized Groups|Ineligible|0|||
170670100|NCT01193842|616803431|FG003|Phase II: Randomized Groups|Ineligible|0|||
170670101|NCT01193842|616803432|FG004|Phase II: Randomized Groups|Ineligible|1|||
170670102|NCT01193842|616803428|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
170670103|NCT01193842|616803429|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
170670104|NCT01193842|616803430|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
170670105|NCT01193842|616803431|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
170670106|NCT01193842|616803432|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
170670107|NCT00678080|616803433|FG000|Overall Study|Physician Decision|2|||
170670108|NCT00678080|616803434|FG001|Overall Study|Physician Decision|0|||
170670109|NCT00678080|616803433|FG000|Overall Study|Lost to Follow-up|1|||
170670110|NCT00678080|616803434|FG001|Overall Study|Lost to Follow-up|0|||
170670111|NCT00678080|616803433|FG000|Overall Study|Withdrawal by Subject|0|||
170670112|NCT00678080|616803434|FG001|Overall Study|Withdrawal by Subject|1|||
170670113|NCT02484690|616803435|FG000|Overall Study|Adverse Event|1|||
170670114|NCT02484690|616803436|FG001|Overall Study|Adverse Event|3|||
170670115|NCT02484690|616803437|FG002|Overall Study|Adverse Event|0|||
170670116|NCT02484690|616803438|FG003|Overall Study|Adverse Event|0|||
170670117|NCT02484690|616803439|FG004|Overall Study|Adverse Event|5|||
170670118|NCT02484690|616803435|FG000|Overall Study|Death|0|||
170670119|NCT02484690|616803436|FG001|Overall Study|Death|0|||
170670120|NCT02484690|616803437|FG002|Overall Study|Death|0|||
170670121|NCT02484690|616803438|FG003|Overall Study|Death|0|||
170670122|NCT02484690|616803439|FG004|Overall Study|Death|1|||
170670123|NCT02484690|616803435|FG000|Overall Study|Withdrawal by Subject|1|||
170670124|NCT02484690|616803436|FG001|Overall Study|Withdrawal by Subject|3|||
170670125|NCT02484690|616803437|FG002|Overall Study|Withdrawal by Subject|1|||
170670126|NCT02484690|616803438|FG003|Overall Study|Withdrawal by Subject|2|||
170670127|NCT02484690|616803439|FG004|Overall Study|Withdrawal by Subject|0|||
170670128|NCT02484690|616803435|FG000|Overall Study|Physician Decision|2|||
170670129|NCT02484690|616803436|FG001|Overall Study|Physician Decision|0|||
170670130|NCT02484690|616803437|FG002|Overall Study|Physician Decision|1|||
170670131|NCT02484690|616803438|FG003|Overall Study|Physician Decision|0|||
170670132|NCT02484690|616803439|FG004|Overall Study|Physician Decision|0|||
170670133|NCT02484690|616803435|FG000|Overall Study|Lost to Follow-up|0|||
170670134|NCT02484690|616803436|FG001|Overall Study|Lost to Follow-up|0|||
170670135|NCT02484690|616803437|FG002|Overall Study|Lost to Follow-up|1|||
170670136|NCT02484690|616803438|FG003|Overall Study|Lost to Follow-up|0|||
170670137|NCT02484690|616803439|FG004|Overall Study|Lost to Follow-up|0|||
170670138|NCT01759511|616803440|FG000|Overall Study|Adverse Event|4|||
170670139|NCT01759511|616803440|FG000|Overall Study|Death|2|||
170670140|NCT01759511|616803440|FG000|Overall Study|Lack of Efficacy|2|||
170670141|NCT01759511|616803440|FG000|Overall Study|Physician Decision|1|||
170670142|NCT01759511|616803440|FG000|Overall Study|Progressive Disease|5|||
170670143|NCT01759511|616803440|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
170670144|NCT01759511|616803440|FG000|Overall Study|Study Terminated by Sponsor|13|||
170670145|NCT01759511|616803440|FG000|Overall Study|Withdrawal by Subject|3|||
170670146|NCT02569671|616803443|FG000|Overall Study|Lost to Follow-up|2|||
170670147|NCT02569671|616803444|FG001|Overall Study|Lost to Follow-up|1|||
170670148|NCT02569671|616803443|FG000|Overall Study|Withdrawal by Subject|1|||
170670149|NCT02569671|616803444|FG001|Overall Study|Withdrawal by Subject|3|||
170670150|NCT06238362|616803445|FG000|Overall Study|Insufficient total sleep time|1|||
170670151|NCT06238362|616803446|FG001|Overall Study|Insufficient total sleep time|0|||
170624899|NCT05435339|616637811|FG006|Overall Study|Sponsor Decision|2|||
170624900|NCT05435339|616637812|FG007|Overall Study|Sponsor Decision|2|||
170624901|NCT05435339|616637805|FG000|Overall Study|Withdrawal by Subject|0|||
170624902|NCT05435339|616637806|FG001|Overall Study|Withdrawal by Subject|0|||
170624903|NCT05435339|616637807|FG002|Overall Study|Withdrawal by Subject|0|||
170624904|NCT05435339|616637808|FG003|Overall Study|Withdrawal by Subject|0|||
170624905|NCT05435339|616637809|FG004|Overall Study|Withdrawal by Subject|1|||
170624906|NCT05435339|616637810|FG005|Overall Study|Withdrawal by Subject|0|||
170624907|NCT05435339|616637811|FG006|Overall Study|Withdrawal by Subject|1|||
170624908|NCT05435339|616637812|FG007|Overall Study|Withdrawal by Subject|1|||
170624909|NCT01446159|616637813|FG000|Overall Study|Withdrawal by Subject|1|||
170624910|NCT01446159|616637814|FG001|Overall Study|Withdrawal by Subject|0|||
170624911|NCT01446159|616637815|FG002|Overall Study|Withdrawal by Subject|14|||
170624912|NCT01446159|616637816|FG003|Overall Study|Withdrawal by Subject|11|||
170624913|NCT01446159|616637813|FG000|Overall Study|Lost to Follow-up|0|||
170624914|NCT01446159|616637814|FG001|Overall Study|Lost to Follow-up|0|||
170624915|NCT01446159|616637815|FG002|Overall Study|Lost to Follow-up|1|||
170624916|NCT01446159|616637816|FG003|Overall Study|Lost to Follow-up|2|||
170624917|NCT01446159|616637813|FG000|Overall Study|Death|2|||
170624918|NCT01446159|616637814|FG001|Overall Study|Death|3|||
170624919|NCT01446159|616637815|FG002|Overall Study|Death|43|||
170624920|NCT01446159|616637816|FG003|Overall Study|Death|36|||
170624921|NCT01446159|616637813|FG000|Overall Study|Other|0|||
170624922|NCT01446159|616637814|FG001|Overall Study|Other|0|||
170624923|NCT01446159|616637815|FG002|Overall Study|Other|13|||
170624924|NCT01446159|616637816|FG003|Overall Study|Other|13|||
170624925|NCT03473236|616637824|FG000|Overall Study|Withdrawal by Subject|0|||
170624926|NCT03473236|616637825|FG001|Overall Study|Withdrawal by Subject|0|||
170624927|NCT03473236|616637826|FG002|Overall Study|Withdrawal by Subject|0|||
170624928|NCT03473236|616637827|FG003|Overall Study|Withdrawal by Subject|0|||
170624929|NCT03473236|616637828|FG004|Overall Study|Withdrawal by Subject|0|||
170624930|NCT03473236|616637829|FG005|Overall Study|Withdrawal by Subject|1|||
170624931|NCT03473236|616637830|FG006|Overall Study|Withdrawal by Subject|0|||
170624932|NCT03473236|616637831|FG007|Overall Study|Withdrawal by Subject|0|||
170624933|NCT03473236|616637832|FG008|Overall Study|Withdrawal by Subject|1|||
170624934|NCT03473236|616637833|FG009|Overall Study|Withdrawal by Subject|0|||
170624935|NCT05135871|616637842|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
170624936|NCT05135871|616637843|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
170624937|NCT05135871|616637844|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
170624938|NCT05135871|616637845|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
170624939|NCT00525512|616637846|FG000|Double-Blind Phase|Adverse Event|48|||
170624940|NCT00525512|616637847|FG001|Double-Blind Phase|Adverse Event|28|||
170624941|NCT00525512|616637848|FG002|Double-Blind Phase|Adverse Event|0|||
170624942|NCT00525512|616637849|FG003|Double-Blind Phase|Adverse Event|0|||
170624943|NCT00525512|616637846|FG000|Double-Blind Phase|Protocol Violation|3|||
170624944|NCT00525512|616637847|FG001|Double-Blind Phase|Protocol Violation|1|||
170624945|NCT00525512|616637848|FG002|Double-Blind Phase|Protocol Violation|0|||
170624946|NCT00525512|616637849|FG003|Double-Blind Phase|Protocol Violation|0|||
170624947|NCT00525512|616637846|FG000|Double-Blind Phase|Lost to Follow-up|3|||
170624948|NCT00525512|616637847|FG001|Double-Blind Phase|Lost to Follow-up|7|||
170624949|NCT00525512|616637848|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170624950|NCT00525512|616637849|FG003|Double-Blind Phase|Lost to Follow-up|0|||
170624951|NCT00525512|616637846|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
170624952|NCT00525512|616637847|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
170624953|NCT00525512|616637848|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
170624954|NCT00525512|616637849|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
170624955|NCT00525512|616637846|FG000|Double-Blind Phase|Lack of Efficacy|13|||
170624956|NCT00525512|616637847|FG001|Double-Blind Phase|Lack of Efficacy|5|||
170624957|NCT00525512|616637848|FG002|Double-Blind Phase|Lack of Efficacy|0|||
170624958|NCT00525512|616637849|FG003|Double-Blind Phase|Lack of Efficacy|0|||
170624959|NCT00525512|616637846|FG000|Double-Blind Phase|Other reason (not specified)|12|||
170624960|NCT00525512|616637847|FG001|Double-Blind Phase|Other reason (not specified)|13|||
170624961|NCT00525512|616637848|FG002|Double-Blind Phase|Other reason (not specified)|0|||
170624962|NCT00525512|616637849|FG003|Double-Blind Phase|Other reason (not specified)|0|||
170624963|NCT00525512|616637846|FG000|Open-Label Phase|Adverse Event|0|||
170624964|NCT00525512|616637847|FG001|Open-Label Phase|Adverse Event|0|||
170624965|NCT00525512|616637848|FG002|Open-Label Phase|Adverse Event|1|||
170624966|NCT00525512|616637849|FG003|Open-Label Phase|Adverse Event|0|||
170624967|NCT00525512|616637846|FG000|Open-Label Phase|Lost to Follow-up|0|||
170624968|NCT00525512|616637847|FG001|Open-Label Phase|Lost to Follow-up|0|||
170624969|NCT00525512|616637848|FG002|Open-Label Phase|Lost to Follow-up|1|||
170624970|NCT00525512|616637849|FG003|Open-Label Phase|Lost to Follow-up|0|||
170670152|NCT06238362|616803445|FG000|Overall Study|Inadequate signal quality|1|||
170670153|NCT06238362|616803446|FG001|Overall Study|Inadequate signal quality|0|||
170670154|NCT00560105|616804845|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
170670155|NCT00560105|616804846|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
170670156|NCT01644565|616804856|FG000|Overall Study|Undisclosed Medical History|1|||
170670157|NCT01644565|616804857|FG001|Overall Study|Undisclosed Medical History|0|||
170670158|NCT01644565|616804858|FG002|Overall Study|Undisclosed Medical History|0|||
170670159|NCT01644565|616804859|FG003|Overall Study|Undisclosed Medical History|0|||
170670160|NCT01644565|616804860|FG004|Overall Study|Undisclosed Medical History|0|||
170670161|NCT01644565|616804861|FG005|Overall Study|Undisclosed Medical History|0|||
170670162|NCT01644565|616804862|FG006|Overall Study|Undisclosed Medical History|0|||
170670163|NCT01644565|616804863|FG007|Overall Study|Undisclosed Medical History|0|||
170670164|NCT01644565|616804864|FG008|Overall Study|Undisclosed Medical History|0|||
170670165|NCT01644565|616804856|FG000|Overall Study|Lost to Follow-up|0|||
170670166|NCT01644565|616804857|FG001|Overall Study|Lost to Follow-up|0|||
170670167|NCT01644565|616804858|FG002|Overall Study|Lost to Follow-up|0|||
170670168|NCT01644565|616804859|FG003|Overall Study|Lost to Follow-up|1|||
170670169|NCT01644565|616804860|FG004|Overall Study|Lost to Follow-up|0|||
170670170|NCT01644565|616804861|FG005|Overall Study|Lost to Follow-up|0|||
170670171|NCT01644565|616804862|FG006|Overall Study|Lost to Follow-up|0|||
170670172|NCT01644565|616804863|FG007|Overall Study|Lost to Follow-up|2|||
170670173|NCT01644565|616804864|FG008|Overall Study|Lost to Follow-up|0|||
170670174|NCT01644565|616804856|FG000|Overall Study|Family emergency|0|||
170670175|NCT01644565|616804857|FG001|Overall Study|Family emergency|0|||
170670176|NCT01644565|616804858|FG002|Overall Study|Family emergency|0|||
170670177|NCT01644565|616804859|FG003|Overall Study|Family emergency|0|||
170670178|NCT01644565|616804860|FG004|Overall Study|Family emergency|1|||
170670179|NCT01644565|616804861|FG005|Overall Study|Family emergency|0|||
170670180|NCT01644565|616804862|FG006|Overall Study|Family emergency|0|||
170670181|NCT01644565|616804863|FG007|Overall Study|Family emergency|0|||
170670182|NCT01644565|616804864|FG008|Overall Study|Family emergency|0|||
170670183|NCT01644565|616804856|FG000|Overall Study|Relocation|0|||
170670184|NCT01644565|616804857|FG001|Overall Study|Relocation|0|||
170670185|NCT01644565|616804858|FG002|Overall Study|Relocation|0|||
170670186|NCT01644565|616804859|FG003|Overall Study|Relocation|0|||
170670187|NCT01644565|616804860|FG004|Overall Study|Relocation|0|||
170670188|NCT01644565|616804861|FG005|Overall Study|Relocation|0|||
170670189|NCT01644565|616804862|FG006|Overall Study|Relocation|0|||
170670190|NCT01644565|616804863|FG007|Overall Study|Relocation|0|||
170670191|NCT01644565|616804864|FG008|Overall Study|Relocation|1|||
170670192|NCT01687998|616804865|FG000|Overall Study|Withdrawal by Subject|49|||
170670193|NCT01687998|616804866|FG001|Overall Study|Withdrawal by Subject|51|||
170670194|NCT01687998|616804865|FG000|Overall Study|Known to be Alive at Study End|54|||
170670195|NCT01687998|616804866|FG001|Overall Study|Known to be Alive at Study End|62|||
170670196|NCT01687998|616804865|FG000|Overall Study|Lost to Follow-up|9|||
170670197|NCT01687998|616804866|FG001|Overall Study|Lost to Follow-up|7|||
170670198|NCT00443261|616804867|FG000|Overall Study|Death|1|||
170670199|NCT01663532|616804868|FG000|Overall Study|Lost to Follow-up|9|||
170670200|NCT01663532|616804869|FG001|Overall Study|Lost to Follow-up|10|||
170670201|NCT01663532|616804868|FG000|Overall Study|Adverse Event|7|||
170670202|NCT01663532|616804869|FG001|Overall Study|Adverse Event|13|||
170670203|NCT01663532|616804868|FG000|Overall Study|Met Withdrawal Criteria|7|||
170670204|NCT01663532|616804869|FG001|Overall Study|Met Withdrawal Criteria|6|||
170670205|NCT01663532|616804868|FG000|Overall Study|Physician Decision|1|||
170670206|NCT01663532|616804869|FG001|Overall Study|Physician Decision|1|||
170670207|NCT01663532|616804868|FG000|Overall Study|Withdrawal by Subject|35|||
170670208|NCT01663532|616804869|FG001|Overall Study|Withdrawal by Subject|17|||
170670209|NCT01663532|616804868|FG000|Overall Study|Lack of Efficacy|15|||
170670210|NCT01663532|616804869|FG001|Overall Study|Lack of Efficacy|60|||
170670211|NCT03539081|616804871|FG000|Overall Study|Withdrawal by Subject|2|||
170670212|NCT03539081|616804872|FG001|Overall Study|Withdrawal by Subject|3|||
170670213|NCT03539081|616804873|FG002|Overall Study|Withdrawal by Subject|0|||
170670214|NCT03539081|616804871|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
170670215|NCT03539081|616804872|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
170670216|NCT03539081|616804873|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
170670217|NCT00787891|616804874|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
170670218|NCT00787891|616804875|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
170670219|NCT00787891|616804874|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
170670220|NCT00787891|616804875|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
170670221|NCT00787891|616804874|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
170670222|NCT00787891|616804875|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
170670223|NCT00787891|616804874|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
170670224|NCT00787891|616804875|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
170670225|NCT00787891|616804874|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
170670226|NCT00787891|616804875|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
170624971|NCT00525512|616637846|FG000|Open-Label Phase|Other reason (not specified)|0|||
170624972|NCT00525512|616637847|FG001|Open-Label Phase|Other reason (not specified)|0|||
170624973|NCT00525512|616637848|FG002|Open-Label Phase|Other reason (not specified)|4|||
170624974|NCT00525512|616637849|FG003|Open-Label Phase|Other reason (not specified)|5|||
170624975|NCT04258423|616637850|FG000|Overall Study|Study Closure|2|||
170624976|NCT04258423|616637851|FG001|Overall Study|Study Closure|2|||
170624977|NCT01601535|616637852|FG000|Phase 1|Adverse Event|1|||
170624978|NCT01601535|616637853|FG001|Phase 1|Adverse Event|0|||
170624979|NCT01601535|616637854|FG002|Phase 1|Adverse Event|2|||
170624980|NCT01601535|616637855|FG003|Phase 1|Adverse Event|1|||
170624981|NCT01601535|616637856|FG004|Phase 1|Adverse Event|0|||
170624982|NCT01601535|616637857|FG005|Phase 1|Adverse Event|0|||
170624983|NCT01601535|616637852|FG000|Phase 1|Withdrawal by Subject|2|||
170624984|NCT01601535|616637853|FG001|Phase 1|Withdrawal by Subject|1|||
170624985|NCT01601535|616637854|FG002|Phase 1|Withdrawal by Subject|1|||
170624986|NCT01601535|616637855|FG003|Phase 1|Withdrawal by Subject|2|||
170624987|NCT01601535|616637856|FG004|Phase 1|Withdrawal by Subject|0|||
170624988|NCT01601535|616637857|FG005|Phase 1|Withdrawal by Subject|0|||
170624989|NCT01601535|616637852|FG000|Phase 1|Progressive Disease|2|||
170624990|NCT01601535|616637853|FG001|Phase 1|Progressive Disease|3|||
170624991|NCT01601535|616637854|FG002|Phase 1|Progressive Disease|2|||
170624992|NCT01601535|616637855|FG003|Phase 1|Progressive Disease|1|||
170624993|NCT01601535|616637856|FG004|Phase 1|Progressive Disease|0|||
170624994|NCT01601535|616637857|FG005|Phase 1|Progressive Disease|0|||
170819747|NCT00296504|617347677|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
170624995|NCT01601535|616637852|FG000|Phase 1|Started Another Treatment|1|||
170624996|NCT01601535|616637853|FG001|Phase 1|Started Another Treatment|2|||
170624997|NCT01601535|616637854|FG002|Phase 1|Started Another Treatment|0|||
170624998|NCT01601535|616637855|FG003|Phase 1|Started Another Treatment|0|||
170624999|NCT01601535|616637856|FG004|Phase 1|Started Another Treatment|0|||
170625000|NCT01601535|616637857|FG005|Phase 1|Started Another Treatment|0|||
170625001|NCT01601535|616637852|FG000|Phase 2|Adverse Event|0|||
170625002|NCT01601535|616637853|FG001|Phase 2|Adverse Event|0|||
170625003|NCT01601535|616637854|FG002|Phase 2|Adverse Event|0|||
170625004|NCT01601535|616637855|FG003|Phase 2|Adverse Event|0|||
170625005|NCT01601535|616637856|FG004|Phase 2|Adverse Event|5|||
170625006|NCT01601535|616637857|FG005|Phase 2|Adverse Event|1|||
170625007|NCT01601535|616637852|FG000|Phase 2|Withdrawal by Subject|0|||
170625008|NCT01601535|616637853|FG001|Phase 2|Withdrawal by Subject|0|||
170625009|NCT01601535|616637854|FG002|Phase 2|Withdrawal by Subject|0|||
170625010|NCT01601535|616637855|FG003|Phase 2|Withdrawal by Subject|0|||
170625011|NCT01601535|616637856|FG004|Phase 2|Withdrawal by Subject|8|||
170625012|NCT01601535|616637857|FG005|Phase 2|Withdrawal by Subject|2|||
170625013|NCT01601535|616637852|FG000|Phase 2|Progressive Disease|0|||
170625014|NCT01601535|616637853|FG001|Phase 2|Progressive Disease|0|||
170625015|NCT01601535|616637854|FG002|Phase 2|Progressive Disease|0|||
170625016|NCT01601535|616637855|FG003|Phase 2|Progressive Disease|0|||
170625017|NCT01601535|616637856|FG004|Phase 2|Progressive Disease|5|||
170625018|NCT01601535|616637857|FG005|Phase 2|Progressive Disease|7|||
170625019|NCT01601535|616637852|FG000|Phase 2|Started Another Treatment|0|||
170625020|NCT01601535|616637853|FG001|Phase 2|Started Another Treatment|0|||
170625021|NCT01601535|616637854|FG002|Phase 2|Started Another Treatment|0|||
170625022|NCT01601535|616637855|FG003|Phase 2|Started Another Treatment|0|||
170625023|NCT01601535|616637856|FG004|Phase 2|Started Another Treatment|1|||
170625024|NCT01601535|616637857|FG005|Phase 2|Started Another Treatment|2|||
170625025|NCT02458313|616639066|FG000|Overall Study|Withdrawal by Subject|6|||
170625026|NCT02458313|616639067|FG001|Overall Study|Withdrawal by Subject|8|||
170625027|NCT02458313|616639066|FG000|Overall Study|Excluded for motion during MRI|1|||
170625028|NCT02458313|616639067|FG001|Overall Study|Excluded for motion during MRI|2|||
170625029|NCT01775501|616639068|FG000|Overall Study|Discontinued prior to treatment|1|||
170625030|NCT02421172|616639069|FG000|Period 1|Adverse Event|1|||
170625031|NCT02421172|616639070|FG001|Period 1|Adverse Event|0|||
170625032|NCT02421172|616639071|FG002|Period 1|Adverse Event|0|||
170625033|NCT02421172|616639072|FG003|Period 1|Adverse Event|0|||
170625034|NCT02421172|616639073|FG004|Period 1|Adverse Event|0|||
170625035|NCT02421172|616639069|FG000|Period 1|Lost to Follow-up|3|||
170625036|NCT02421172|616639070|FG001|Period 1|Lost to Follow-up|1|||
170625037|NCT02421172|616639071|FG002|Period 1|Lost to Follow-up|0|||
170625038|NCT02421172|616639072|FG003|Period 1|Lost to Follow-up|0|||
170625039|NCT02421172|616639073|FG004|Period 1|Lost to Follow-up|0|||
170625040|NCT02421172|616639069|FG000|Period 1|Patient/guardian decision|0|||
170625041|NCT02421172|616639070|FG001|Period 1|Patient/guardian decision|1|||
170625042|NCT02421172|616639071|FG002|Period 1|Patient/guardian decision|0|||
170625043|NCT02421172|616639072|FG003|Period 1|Patient/guardian decision|0|||
170625044|NCT02421172|616639073|FG004|Period 1|Patient/guardian decision|0|||
170625045|NCT02421172|616639069|FG000|Period 2|Adverse Event|0|||
170625046|NCT02421172|616639070|FG001|Period 2|Adverse Event|0|||
170625047|NCT02421172|616639071|FG002|Period 2|Adverse Event|4|||
170625048|NCT02421172|616639072|FG003|Period 2|Adverse Event|0|||
170625049|NCT02421172|616639073|FG004|Period 2|Adverse Event|0|||
170625050|NCT02421172|616639069|FG000|Period 2|Lost to Follow-up|0|||
170625051|NCT02421172|616639070|FG001|Period 2|Lost to Follow-up|0|||
170625052|NCT02421172|616639071|FG002|Period 2|Lost to Follow-up|0|||
170625053|NCT02421172|616639072|FG003|Period 2|Lost to Follow-up|1|||
170625054|NCT02421172|616639073|FG004|Period 2|Lost to Follow-up|0|||
170625055|NCT02421172|616639069|FG000|Period 2|Patient/guardian decision|0|||
170625056|NCT02421172|616639070|FG001|Period 2|Patient/guardian decision|0|||
170625057|NCT02421172|616639071|FG002|Period 2|Patient/guardian decision|3|||
170625058|NCT02421172|616639072|FG003|Period 2|Patient/guardian decision|2|||
170625059|NCT02421172|616639073|FG004|Period 2|Patient/guardian decision|1|||
170625060|NCT05024032|616639074|FG000|Overall Study|Withdrawal by Subject|0|||
170625061|NCT05024032|616639075|FG001|Overall Study|Withdrawal by Subject|3|||
170625062|NCT05024032|616639076|FG002|Overall Study|Withdrawal by Subject|4|||
170625063|NCT05024032|616639074|FG000|Overall Study|Adverse Event|0|||
170625064|NCT05024032|616639075|FG001|Overall Study|Adverse Event|1|||
170625065|NCT05024032|616639076|FG002|Overall Study|Adverse Event|0|||
170625066|NCT05024032|616639074|FG000|Overall Study|Protocol Deviation|1|||
170625067|NCT05024032|616639075|FG001|Overall Study|Protocol Deviation|0|||
170625068|NCT05024032|616639076|FG002|Overall Study|Protocol Deviation|0|||
170625069|NCT00939393|616639077|FG000|Overall Study|Withdrawal by Subject|1|||
170625070|NCT00939393|616639078|FG001|Overall Study|Withdrawal by Subject|0|||
170625071|NCT00939393|616639077|FG000|Overall Study|Lost to Follow-up|3|||
170625072|NCT00939393|616639078|FG001|Overall Study|Lost to Follow-up|0|||
170625073|NCT01709721|616639082|FG000|Open Label Phase|Withdrawal by Subject|0|||
170625074|NCT01709721|616639083|FG001|Open Label Phase|Withdrawal by Subject|0|||
170625075|NCT01709721|616639084|FG002|Open Label Phase|Withdrawal by Subject|5|||
170625076|NCT01709721|616639082|FG000|Open Label Phase|Adverse Event|0|||
170670227|NCT00787891|616804874|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
170670228|NCT00787891|616804875|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
170670229|NCT00787891|616804874|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
170670230|NCT00787891|616804875|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
170670231|NCT00787891|616804874|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
170670232|NCT00787891|616804875|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
170670233|NCT00787891|616804874|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
170670234|NCT00787891|616804875|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
170670235|NCT00787891|616804874|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
170670236|NCT00787891|616804875|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
170670237|NCT01897454|616804876|FG000|Overall Study|Withdrawal by Subject|1|||
170670238|NCT02195583|616804882|FG000|Overall Study|Lost to Follow-up|1|||
170670239|NCT02195583|616804882|FG000|Overall Study|Withdrawal by Subject|4|||
170670240|NCT02195583|616804882|FG000|Overall Study|Adverse Event|2|||
170625077|NCT01709721|616639083|FG001|Open Label Phase|Adverse Event|0|||
170625078|NCT01709721|616639084|FG002|Open Label Phase|Adverse Event|8|||
170625079|NCT01709721|616639082|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
170625080|NCT01709721|616639083|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
170625081|NCT01709721|616639084|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
170625082|NCT01709721|616639082|FG000|Open Label Phase|Investigator Decision|0|||
170625083|NCT01709721|616639083|FG001|Open Label Phase|Investigator Decision|0|||
170625084|NCT01709721|616639084|FG002|Open Label Phase|Investigator Decision|1|||
170819748|NCT00296504|617347678|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
170819749|NCT00296504|617347679|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
170819750|NCT00296504|617347680|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
170819751|NCT00296504|617347681|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
170819752|NCT00296504|617347682|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
170819753|NCT00296504|617347683|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
170819754|NCT00296504|617347675|FG000|Interim Analysis|Participant Moved|1|||
170819755|NCT00296504|617347676|FG001|Interim Analysis|Participant Moved|0|||
170819756|NCT00296504|617347677|FG002|Interim Analysis|Participant Moved|1|||
170819757|NCT00296504|617347678|FG003|Interim Analysis|Participant Moved|0|||
170819758|NCT00296504|617347679|FG004|Interim Analysis|Participant Moved|0|||
170819759|NCT00296504|617347680|FG005|Interim Analysis|Participant Moved|1|||
170819760|NCT00296504|617347681|FG006|Interim Analysis|Participant Moved|1|||
170819761|NCT00296504|617347682|FG007|Interim Analysis|Participant Moved|0|||
170819762|NCT00296504|617347683|FG008|Interim Analysis|Participant Moved|0|||
170819763|NCT00296504|617347675|FG000|Interim Analysis|Participant Was Incarcerated|2|||
170819764|NCT00296504|617347676|FG001|Interim Analysis|Participant Was Incarcerated|0|||
170819765|NCT00296504|617347677|FG002|Interim Analysis|Participant Was Incarcerated|1|||
170819766|NCT00296504|617347678|FG003|Interim Analysis|Participant Was Incarcerated|0|||
170819767|NCT00296504|617347679|FG004|Interim Analysis|Participant Was Incarcerated|0|||
170819768|NCT00296504|617347680|FG005|Interim Analysis|Participant Was Incarcerated|0|||
170819769|NCT00296504|617347681|FG006|Interim Analysis|Participant Was Incarcerated|0|||
170819770|NCT00296504|617347682|FG007|Interim Analysis|Participant Was Incarcerated|0|||
170819771|NCT00296504|617347683|FG008|Interim Analysis|Participant Was Incarcerated|0|||
170819772|NCT00296504|617347675|FG000|Interim Analysis|Resistance to FPV|0|||
170819773|NCT00296504|617347676|FG001|Interim Analysis|Resistance to FPV|0|||
170819774|NCT00296504|617347677|FG002|Interim Analysis|Resistance to FPV|1|||
170819775|NCT00296504|617347678|FG003|Interim Analysis|Resistance to FPV|0|||
170819776|NCT00296504|617347679|FG004|Interim Analysis|Resistance to FPV|0|||
170819777|NCT00296504|617347680|FG005|Interim Analysis|Resistance to FPV|0|||
170819778|NCT00296504|617347681|FG006|Interim Analysis|Resistance to FPV|0|||
170819779|NCT00296504|617347682|FG007|Interim Analysis|Resistance to FPV|0|||
170819780|NCT00296504|617347683|FG008|Interim Analysis|Resistance to FPV|0|||
170819781|NCT00296504|617347675|FG000|Interim Analysis|Physician Decision|0|||
170819782|NCT00296504|617347676|FG001|Interim Analysis|Physician Decision|0|||
170819783|NCT00296504|617347677|FG002|Interim Analysis|Physician Decision|1|||
170819784|NCT00296504|617347678|FG003|Interim Analysis|Physician Decision|0|||
170819785|NCT00296504|617347679|FG004|Interim Analysis|Physician Decision|0|||
170819786|NCT00296504|617347680|FG005|Interim Analysis|Physician Decision|0|||
170819787|NCT00296504|617347681|FG006|Interim Analysis|Physician Decision|0|||
170819788|NCT00296504|617347682|FG007|Interim Analysis|Physician Decision|0|||
170819789|NCT00296504|617347683|FG008|Interim Analysis|Physician Decision|0|||
170819790|NCT00296504|617347675|FG000|Interim Analysis|Principle Investigator Discretion|2|||
170819791|NCT00296504|617347676|FG001|Interim Analysis|Principle Investigator Discretion|0|||
170819792|NCT00296504|617347677|FG002|Interim Analysis|Principle Investigator Discretion|1|||
170819793|NCT00296504|617347678|FG003|Interim Analysis|Principle Investigator Discretion|1|||
170819794|NCT00296504|617347679|FG004|Interim Analysis|Principle Investigator Discretion|0|||
170819795|NCT00296504|617347680|FG005|Interim Analysis|Principle Investigator Discretion|0|||
170819796|NCT00296504|617347681|FG006|Interim Analysis|Principle Investigator Discretion|0|||
170819797|NCT00296504|617347682|FG007|Interim Analysis|Principle Investigator Discretion|0|||
170819798|NCT00296504|617347683|FG008|Interim Analysis|Principle Investigator Discretion|0|||
170819799|NCT00296504|617347675|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
170819800|NCT00296504|617347676|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
170819801|NCT00296504|617347677|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
170819802|NCT00296504|617347678|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
170819803|NCT00296504|617347679|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
170625085|NCT01709721|616639082|FG000|Open Label Phase|Sponsor Decision|0|||
170625086|NCT01709721|616639083|FG001|Open Label Phase|Sponsor Decision|0|||
170625087|NCT01709721|616639084|FG002|Open Label Phase|Sponsor Decision|2|||
170625088|NCT01709721|616639082|FG000|Open Label Phase|Protocol Violation|0|||
170625089|NCT01709721|616639083|FG001|Open Label Phase|Protocol Violation|0|||
170625090|NCT01709721|616639084|FG002|Open Label Phase|Protocol Violation|1|||
170625091|NCT01709721|616639082|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
170625092|NCT01709721|616639083|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
170625093|NCT01709721|616639084|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
170625094|NCT01709721|616639082|FG000|Open Label Phase|Inadequate Pain Control|0|||
170625095|NCT01709721|616639083|FG001|Open Label Phase|Inadequate Pain Control|0|||
170625096|NCT01709721|616639084|FG002|Open Label Phase|Inadequate Pain Control|37|||
170625097|NCT01709721|616639082|FG000|Open Label Phase|Other, Specify in text field in database|0|||
170625098|NCT01709721|616639083|FG001|Open Label Phase|Other, Specify in text field in database|0|||
170625099|NCT01709721|616639084|FG002|Open Label Phase|Other, Specify in text field in database|14|||
170625100|NCT01709721|616639082|FG000|Randomized Phase|Adverse Event|0|||
170625101|NCT01709721|616639083|FG001|Randomized Phase|Adverse Event|1|||
170625102|NCT01709721|616639084|FG002|Randomized Phase|Adverse Event|0|||
170625103|NCT01709721|616639082|FG000|Randomized Phase|Lost to Follow-up|1|||
170625104|NCT01709721|616639083|FG001|Randomized Phase|Lost to Follow-up|0|||
170625105|NCT01709721|616639084|FG002|Randomized Phase|Lost to Follow-up|0|||
170625106|NCT01709721|616639082|FG000|Randomized Phase|Inadequate Pain Control|1|||
170625107|NCT01709721|616639083|FG001|Randomized Phase|Inadequate Pain Control|2|||
170625108|NCT01709721|616639084|FG002|Randomized Phase|Inadequate Pain Control|0|||
170625109|NCT01709721|616639082|FG000|Randomized Phase|Other, Specify text field in database|1|||
170625110|NCT01709721|616639083|FG001|Randomized Phase|Other, Specify text field in database|3|||
170625111|NCT01709721|616639084|FG002|Randomized Phase|Other, Specify text field in database|0|||
170625112|NCT01680341|616639085|FG000|Overall Study|Adverse Event|3|||
170625113|NCT01680341|616639086|FG001|Overall Study|Adverse Event|2|||
170625114|NCT01680341|616639085|FG000|Overall Study|Unclassified|18|||
170625115|NCT01680341|616639086|FG001|Overall Study|Unclassified|15|||
170625116|NCT02587221|616639087|FG000|Overall Study|Adverse Event|3|||
170625117|NCT02587221|616639088|FG001|Overall Study|Adverse Event|3|||
170625118|NCT02587221|616639087|FG000|Overall Study|Death|33|||
170625119|NCT02587221|616639088|FG001|Overall Study|Death|34|||
170625120|NCT02587221|616639087|FG000|Overall Study|Withdrawal by Subject|66|||
170625121|NCT02587221|616639088|FG001|Overall Study|Withdrawal by Subject|61|||
170625122|NCT02587221|616639087|FG000|Overall Study|Lost to Follow-up|21|||
170625123|NCT02587221|616639088|FG001|Overall Study|Lost to Follow-up|19|||
170625124|NCT02587221|616639087|FG000|Overall Study|Protocol Violation|6|||
170625125|NCT02587221|616639088|FG001|Overall Study|Protocol Violation|5|||
170625126|NCT02587221|616639087|FG000|Overall Study|Other Reason or Unspecified|2|||
170625127|NCT02587221|616639088|FG001|Overall Study|Other Reason or Unspecified|1|||
170625128|NCT02558894|616639089|FG000|Overall Study|Death; any cause, entire study duration|28|||
170625129|NCT02558894|616639090|FG001|Overall Study|Death; any cause, entire study duration|31|||
170625130|NCT02558894|616639089|FG000|Overall Study|Withdrawal by Subject|2|||
170625131|NCT02558894|616639090|FG001|Overall Study|Withdrawal by Subject|1|||
170625132|NCT02558894|616639089|FG000|Overall Study|Closure of Part A|2|||
170625133|NCT02558894|616639090|FG001|Overall Study|Closure of Part A|1|||
170625134|NCT02057250|616639091|FG000|AID Assessment Phase|Adverse Event|3|||
170625135|NCT02057250|616639092|FG001|AID Assessment Phase|Adverse Event|2|||
170625136|NCT02057250|616639093|FG002|AID Assessment Phase|Adverse Event|6|||
170625137|NCT02057250|616639094|FG003|AID Assessment Phase|Adverse Event|1|||
170625138|NCT02057250|616639095|FG004|AID Assessment Phase|Adverse Event|0|||
170625139|NCT02057250|616639091|FG000|AID Assessment Phase|Other than specified above|1|||
170625140|NCT02057250|616639092|FG001|AID Assessment Phase|Other than specified above|1|||
170625141|NCT02057250|616639093|FG002|AID Assessment Phase|Other than specified above|1|||
170625142|NCT02057250|616639094|FG003|AID Assessment Phase|Other than specified above|1|||
170625143|NCT02057250|616639095|FG004|AID Assessment Phase|Other than specified above|0|||
170625144|NCT02057250|616639091|FG000|Extension Phase|Adverse Event|0|||
170625145|NCT02057250|616639092|FG001|Extension Phase|Adverse Event|0|||
170625146|NCT02057250|616639093|FG002|Extension Phase|Adverse Event|0|||
170625147|NCT02057250|616639094|FG003|Extension Phase|Adverse Event|0|||
170625148|NCT02057250|616639095|FG004|Extension Phase|Adverse Event|15|||
170625149|NCT02057250|616639091|FG000|Extension Phase|Lack of Efficacy|0|||
170625150|NCT02057250|616639092|FG001|Extension Phase|Lack of Efficacy|0|||
170625151|NCT02057250|616639093|FG002|Extension Phase|Lack of Efficacy|0|||
170625152|NCT02057250|616639094|FG003|Extension Phase|Lack of Efficacy|0|||
170625153|NCT02057250|616639095|FG004|Extension Phase|Lack of Efficacy|10|||
170625154|NCT02057250|616639091|FG000|Extension Phase|Entered in this period but not treated|0|||
170625155|NCT02057250|616639092|FG001|Extension Phase|Entered in this period but not treated|0|||
170625156|NCT02057250|616639093|FG002|Extension Phase|Entered in this period but not treated|0|||
170625157|NCT02057250|616639094|FG003|Extension Phase|Entered in this period but not treated|0|||
170625158|NCT02057250|616639095|FG004|Extension Phase|Entered in this period but not treated|4|||
170625159|NCT02057250|616639091|FG000|Extension Phase|Other than specified above|0|||
170625160|NCT02057250|616639092|FG001|Extension Phase|Other than specified above|0|||
170625161|NCT02057250|616639093|FG002|Extension Phase|Other than specified above|0|||
170625162|NCT02057250|616639094|FG003|Extension Phase|Other than specified above|0|||
170670241|NCT02195583|616804882|FG000|Overall Study|Other Reason|2|||
170670242|NCT01193530|616804886|FG000|Overall Study|Withdrawal by Subject|2|||
170670243|NCT01193530|616804887|FG001|Overall Study|Withdrawal by Subject|2|||
170670244|NCT01193530|616804886|FG000|Overall Study|Began Contraindicated Therapy|1|||
170670245|NCT01193530|616804887|FG001|Overall Study|Began Contraindicated Therapy|0|||
170670246|NCT01193530|616804886|FG000|Overall Study|Lost Light Box|0|||
170670247|NCT01193530|616804887|FG001|Overall Study|Lost Light Box|1|||
170670248|NCT01193530|616804886|FG000|Overall Study|Returned home - out of state|0|||
170670249|NCT01193530|616804887|FG001|Overall Study|Returned home - out of state|1|||
170670250|NCT01193530|616804886|FG000|Overall Study|Non-Compliance|0|||
170670251|NCT01193530|616804887|FG001|Overall Study|Non-Compliance|1|||
170670252|NCT01890473|616804888|FG000|Overall Study|Lost to Follow-up|1|||
170670253|NCT01890473|616804889|FG001|Overall Study|Lost to Follow-up|0|||
170670254|NCT01890473|616804888|FG000|Overall Study|Poor/non-compliance|1|||
170670255|NCT01890473|616804889|FG001|Overall Study|Poor/non-compliance|0|||
170670256|NCT00983437|616804890|FG000|Overall Study|Adverse Event|9|||
170670257|NCT00983437|616804890|FG000|Overall Study|Lack of Efficacy|1|||
170670258|NCT00983437|616804890|FG000|Overall Study|Withdrawal by Subject|8|||
170670259|NCT00983437|616804890|FG000|Overall Study|Noncompliance to Study Procedures|1|||
170670260|NCT00983437|616804890|FG000|Overall Study|Lost to Follow-up|2|||
170670261|NCT00983437|616804890|FG000|Overall Study|Other Reason|26|||
170670262|NCT04019288|616804891|FG000|Overall Study|Death|1|||
170670263|NCT04019288|616804892|FG001|Overall Study|Death|0|||
170670264|NCT04019288|616804893|FG002|Overall Study|Death|0|||
170670265|NCT00934089|616804894|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
170670266|NCT00934089|616804895|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
170670267|NCT00934089|616804894|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
170670268|NCT00934089|616804895|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
170670269|NCT03372096|616804897|FG000|Overall Study|Study Closed|8|||
170819804|NCT00296504|617347680|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
170670270|NCT00040365|616804898|FG000|Overall Study|Death|1|||
170670271|NCT00040365|616804898|FG000|Overall Study|Progressive disease|7|||
170670272|NCT00040365|616804898|FG000|Overall Study|Lost to Follow-up|3|||
170670273|NCT00680017|616804899|FG000|Overall Study|Adverse Event|13|||
170670274|NCT00680017|616804900|FG001|Overall Study|Adverse Event|7|||
170670275|NCT00680017|616804899|FG000|Overall Study|Withdrawal by Subject|2|||
170670276|NCT00680017|616804900|FG001|Overall Study|Withdrawal by Subject|5|||
170670277|NCT00680017|616804899|FG000|Overall Study|Lost to Follow-up|2|||
170670278|NCT00680017|616804900|FG001|Overall Study|Lost to Follow-up|0|||
170670279|NCT01434667|616804904|FG000|Overall Study|Lost to Follow-up|5|||
170670280|NCT01434667|616804905|FG001|Overall Study|Lost to Follow-up|10|||
170670281|NCT02034110|616804908|FG000|Overall Study|Physician Decision|0|||
170670282|NCT02034110|616804909|FG001|Overall Study|Physician Decision|0|||
170670283|NCT02034110|616804910|FG002|Overall Study|Physician Decision|0|||
170670284|NCT02034110|616804911|FG003|Overall Study|Physician Decision|0|||
170670285|NCT02034110|616804912|FG004|Overall Study|Physician Decision|2|||
170670286|NCT02034110|616804913|FG005|Overall Study|Physician Decision|0|||
170670287|NCT02034110|616804914|FG006|Overall Study|Physician Decision|1|||
170670288|NCT02034110|616804915|FG007|Overall Study|Physician Decision|0|||
170670289|NCT02034110|616804908|FG000|Overall Study|Lost to Follow-up|1|||
170670290|NCT02034110|616804909|FG001|Overall Study|Lost to Follow-up|0|||
170670291|NCT02034110|616804910|FG002|Overall Study|Lost to Follow-up|0|||
170670292|NCT02034110|616804911|FG003|Overall Study|Lost to Follow-up|0|||
170670293|NCT02034110|616804912|FG004|Overall Study|Lost to Follow-up|1|||
170670294|NCT02034110|616804913|FG005|Overall Study|Lost to Follow-up|0|||
170670295|NCT02034110|616804914|FG006|Overall Study|Lost to Follow-up|1|||
170670296|NCT02034110|616804915|FG007|Overall Study|Lost to Follow-up|0|||
170670297|NCT02034110|616804908|FG000|Overall Study|Withdrawal by Subject|5|||
170670298|NCT02034110|616804909|FG001|Overall Study|Withdrawal by Subject|7|||
170670299|NCT02034110|616804910|FG002|Overall Study|Withdrawal by Subject|0|||
170670300|NCT02034110|616804911|FG003|Overall Study|Withdrawal by Subject|3|||
170670301|NCT02034110|616804912|FG004|Overall Study|Withdrawal by Subject|7|||
170670302|NCT02034110|616804913|FG005|Overall Study|Withdrawal by Subject|0|||
170670303|NCT02034110|616804914|FG006|Overall Study|Withdrawal by Subject|3|||
170670304|NCT02034110|616804915|FG007|Overall Study|Withdrawal by Subject|1|||
170670305|NCT02034110|616804908|FG000|Overall Study|Study closed by sponsor|6|||
170670306|NCT02034110|616804909|FG001|Overall Study|Study closed by sponsor|2|||
170670307|NCT02034110|616804910|FG002|Overall Study|Study closed by sponsor|0|||
170670308|NCT02034110|616804911|FG003|Overall Study|Study closed by sponsor|6|||
170670309|NCT02034110|616804912|FG004|Overall Study|Study closed by sponsor|7|||
170670310|NCT02034110|616804913|FG005|Overall Study|Study closed by sponsor|0|||
170670311|NCT02034110|616804914|FG006|Overall Study|Study closed by sponsor|42|||
170670312|NCT02034110|616804915|FG007|Overall Study|Study closed by sponsor|0|||
170670313|NCT02555683|616804916|FG000|Overall Study|Physician Decision|1|||
170670314|NCT02555683|616804917|FG001|Overall Study|Physician Decision|0|||
170670315|NCT02555683|616804918|FG002|Overall Study|Physician Decision|2|||
170670316|NCT02555683|616804916|FG000|Overall Study|Lost to Follow-up|2|||
170670317|NCT02555683|616804917|FG001|Overall Study|Lost to Follow-up|1|||
170670318|NCT02555683|616804918|FG002|Overall Study|Lost to Follow-up|2|||
170670319|NCT02555683|616804916|FG000|Overall Study|Technical Problems|1|||
170670320|NCT02555683|616804917|FG001|Overall Study|Technical Problems|1|||
170625163|NCT02057250|616639095|FG004|Extension Phase|Other than specified above|7|||
170625164|NCT03962491|616639096|FG000|Overall Study|Lost to Follow-up|4|||
170625165|NCT03962491|616639097|FG001|Overall Study|Lost to Follow-up|5|||
170625166|NCT00333775|616639102|FG000|Overall Study|Death|144|||
170625167|NCT00333775|616639103|FG001|Overall Study|Death|149|||
170625168|NCT00333775|616639104|FG002|Overall Study|Death|143|||
170625169|NCT00333775|616639102|FG000|Overall Study|In Follow-up When Study Stopped|87|||
170625170|NCT00333775|616639103|FG001|Overall Study|In Follow-up When Study Stopped|92|||
170625171|NCT00333775|616639104|FG002|Overall Study|In Follow-up When Study Stopped|96|||
170625172|NCT00333775|616639102|FG000|Overall Study|Lost to Follow-up|10|||
170625173|NCT00333775|616639103|FG001|Overall Study|Lost to Follow-up|7|||
170625174|NCT00333775|616639104|FG002|Overall Study|Lost to Follow-up|8|||
170625175|NCT03486912|616639105|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
170625176|NCT03486912|616639106|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
170625177|NCT03486912|616639107|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
170625178|NCT03486912|616639108|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
170625179|NCT03486912|616639105|FG000|Treatment Period|Withdrawal by Subject|3|||
170625180|NCT03486912|616639106|FG001|Treatment Period|Withdrawal by Subject|3|||
170670321|NCT02555683|616804918|FG002|Overall Study|Technical Problems|0|||
170670322|NCT02555683|616804916|FG000|Overall Study|Protocol deviation|0|||
170670323|NCT02555683|616804917|FG001|Overall Study|Protocol deviation|1|||
170670324|NCT02555683|616804918|FG002|Overall Study|Protocol deviation|0|||
170670325|NCT02555683|616804916|FG000|Overall Study|Lack of Efficacy|2|||
170625181|NCT03486912|616639107|FG002|Treatment Period|Withdrawal by Subject|3|||
170670326|NCT02555683|616804917|FG001|Overall Study|Lack of Efficacy|0|||
170670327|NCT02555683|616804918|FG002|Overall Study|Lack of Efficacy|0|||
170625182|NCT03486912|616639108|FG003|Treatment Period|Withdrawal by Subject|2|||
170625183|NCT03486912|616639105|FG000|Treatment Period|Other Reasons|0|||
170670328|NCT02555683|616804916|FG000|Overall Study|Death|0|||
170625184|NCT03486912|616639106|FG001|Treatment Period|Other Reasons|2|||
170625185|NCT03486912|616639107|FG002|Treatment Period|Other Reasons|1|||
170625186|NCT03486912|616639108|FG003|Treatment Period|Other Reasons|1|||
170625187|NCT03486912|616639105|FG000|Treatment Period|Adverse Event|0|||
170625188|NCT03486912|616639106|FG001|Treatment Period|Adverse Event|1|||
170625189|NCT03486912|616639107|FG002|Treatment Period|Adverse Event|1|||
170625190|NCT03486912|616639108|FG003|Treatment Period|Adverse Event|0|||
170625191|NCT03486912|616639105|FG000|Treatment Period|Lost to Follow-up|1|||
170625192|NCT03486912|616639106|FG001|Treatment Period|Lost to Follow-up|0|||
170625193|NCT03486912|616639107|FG002|Treatment Period|Lost to Follow-up|0|||
170625194|NCT03486912|616639108|FG003|Treatment Period|Lost to Follow-up|2|||
170625195|NCT01499940|616639109|FG000|Overall Study|Study was withdrawn before completion.|9|||
170625196|NCT04218240|616639111|FG000|Overall Study|Withdrawal by Subject|6|||
170625197|NCT04218240|616639112|FG001|Overall Study|Withdrawal by Subject|0|||
170625198|NCT04218240|616639111|FG000|Overall Study|Lack of Efficacy|24|||
170625199|NCT04218240|616639112|FG001|Overall Study|Lack of Efficacy|19|||
170625200|NCT04218240|616639111|FG000|Overall Study|Physician Decision|0|||
170625201|NCT04218240|616639112|FG001|Overall Study|Physician Decision|1|||
170625202|NCT04218240|616639111|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
170625203|NCT04218240|616639112|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
170625204|NCT02978417|616639115|FG000|Overall Study|Lost to Follow-up|2|||
170625205|NCT02978417|616639116|FG001|Overall Study|Lost to Follow-up|2|||
170625206|NCT01451606|616639117|FG000|Overall Study|Withdrawal by Subject|4|||
170625207|NCT01451606|616639118|FG001|Overall Study|Withdrawal by Subject|3|||
170625208|NCT04484961|616639119|FG000|Overall Study|Lost to Follow-up|9|||
170625209|NCT04484961|616639120|FG001|Overall Study|Lost to Follow-up|9|||
170625210|NCT00388349|616639121|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
170625211|NCT00388349|616639122|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
170625212|NCT01667900|616639123|FG000|Part B|Death|0|||
170625213|NCT01667900|616639124|FG001|Part B|Death|0|||
170625214|NCT01667900|616639125|FG002|Part B|Death|0|||
170625215|NCT01667900|616639126|FG003|Part B|Death|0|||
170625216|NCT01667900|616639127|FG004|Part B|Death|0|||
170625217|NCT01667900|616639128|FG005|Part B|Death|0|||
170625218|NCT01667900|616639129|FG006|Part B|Death|0|||
170625219|NCT01667900|616639130|FG007|Part B|Death|0|||
170625220|NCT01667900|616639131|FG008|Part B|Death|0|||
170625221|NCT01667900|616639132|FG009|Part B|Death|0|||
170625222|NCT01667900|616639133|FG010|Part B|Death|0|||
170625223|NCT01667900|616639134|FG011|Part B|Death|0|||
170625224|NCT01667900|616639135|FG012|Part B|Death|0|||
170625225|NCT01667900|616639136|FG013|Part B|Death|0|||
170625226|NCT01667900|616639137|FG014|Part B|Death|0|||
170625227|NCT01667900|616639138|FG015|Part B|Death|0|||
170625228|NCT01667900|616639139|FG016|Part B|Death|1|||
170625229|NCT01667900|616639140|FG017|Part B|Death|0|||
170625230|NCT01667900|616639141|FG018|Part B|Death|0|||
170625231|NCT01667900|616639142|FG019|Part B|Death|0|||
170625232|NCT03050801|616639147|FG000|Experiment 1|Lost to Follow-up|0|||
170625233|NCT03050801|616639148|FG001|Experiment 1|Lost to Follow-up|1|||
170625234|NCT03050801|616639149|FG002|Experiment 1|Lost to Follow-up|0|||
170625235|NCT03050801|616639150|FG003|Experiment 1|Lost to Follow-up|0|||
170625236|NCT03050801|616639151|FG004|Experiment 1|Lost to Follow-up|0|||
170625237|NCT03050801|616639152|FG005|Experiment 1|Lost to Follow-up|0|||
170625238|NCT03050801|616639147|FG000|Experiment 1|Physician Decision|0|||
170625239|NCT03050801|616639148|FG001|Experiment 1|Physician Decision|3|||
170625240|NCT03050801|616639149|FG002|Experiment 1|Physician Decision|0|||
170625241|NCT03050801|616639150|FG003|Experiment 1|Physician Decision|0|||
170625242|NCT03050801|616639151|FG004|Experiment 1|Physician Decision|0|||
170625243|NCT03050801|616639152|FG005|Experiment 1|Physician Decision|0|||
170625244|NCT03050801|616639147|FG000|Experiment 1|Change of experimental design|0|||
170625245|NCT03050801|616639148|FG001|Experiment 1|Change of experimental design|3|||
170625246|NCT03050801|616639149|FG002|Experiment 1|Change of experimental design|0|||
170625247|NCT03050801|616639150|FG003|Experiment 1|Change of experimental design|0|||
170625248|NCT03050801|616639151|FG004|Experiment 1|Change of experimental design|0|||
170625249|NCT03050801|616639152|FG005|Experiment 1|Change of experimental design|0|||
170625250|NCT03050801|616639147|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
170625251|NCT03050801|616639148|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
170625252|NCT03050801|616639149|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
170625253|NCT03050801|616639150|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
170625254|NCT03050801|616639151|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
170625255|NCT03050801|616639152|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
170625256|NCT03050801|616639147|FG000|Experiment 2|Lost to Follow-up|0|||
170625257|NCT03050801|616639148|FG001|Experiment 2|Lost to Follow-up|0|||
170625258|NCT03050801|616639149|FG002|Experiment 2|Lost to Follow-up|0|||
170625259|NCT03050801|616639150|FG003|Experiment 2|Lost to Follow-up|1|||
170625260|NCT03050801|616639151|FG004|Experiment 2|Lost to Follow-up|1|||
170625261|NCT03050801|616639152|FG005|Experiment 2|Lost to Follow-up|0|||
170625262|NCT03050801|616639147|FG000|Experiment 2|Physician Decision|0|||
170625263|NCT03050801|616639148|FG001|Experiment 2|Physician Decision|0|||
170625264|NCT03050801|616639149|FG002|Experiment 2|Physician Decision|0|||
170625265|NCT03050801|616639150|FG003|Experiment 2|Physician Decision|0|||
170625266|NCT03050801|616639151|FG004|Experiment 2|Physician Decision|1|||
170625267|NCT03050801|616639152|FG005|Experiment 2|Physician Decision|0|||
170625268|NCT03050801|616639147|FG000|Experiment 2|Pregnancy|0|||
170625269|NCT03050801|616639148|FG001|Experiment 2|Pregnancy|0|||
170625270|NCT03050801|616639149|FG002|Experiment 2|Pregnancy|0|||
170625271|NCT03050801|616639150|FG003|Experiment 2|Pregnancy|0|||
170625272|NCT03050801|616639151|FG004|Experiment 2|Pregnancy|1|||
170625273|NCT03050801|616639152|FG005|Experiment 2|Pregnancy|0|||
170625274|NCT03050801|616639147|FG000|Experiment 2|Withdrawal by Subject|0|||
170625275|NCT03050801|616639148|FG001|Experiment 2|Withdrawal by Subject|0|||
170625276|NCT03050801|616639149|FG002|Experiment 2|Withdrawal by Subject|0|||
170625277|NCT03050801|616639150|FG003|Experiment 2|Withdrawal by Subject|1|||
170625278|NCT03050801|616639151|FG004|Experiment 2|Withdrawal by Subject|0|||
170625279|NCT03050801|616639152|FG005|Experiment 2|Withdrawal by Subject|0|||
170625280|NCT03050801|616639147|FG000|Experiment 2|Poor data quality|0|||
170625281|NCT03050801|616639148|FG001|Experiment 2|Poor data quality|0|||
170625282|NCT03050801|616639149|FG002|Experiment 2|Poor data quality|0|||
170625283|NCT03050801|616639150|FG003|Experiment 2|Poor data quality|4|||
170625284|NCT03050801|616639151|FG004|Experiment 2|Poor data quality|1|||
170625285|NCT03050801|616639152|FG005|Experiment 2|Poor data quality|0|||
170625286|NCT03050801|616639147|FG000|Experiment 2|Discomfort during stimulation|0|||
170625287|NCT03050801|616639148|FG001|Experiment 2|Discomfort during stimulation|0|||
170625288|NCT03050801|616639149|FG002|Experiment 2|Discomfort during stimulation|0|||
170625289|NCT03050801|616639150|FG003|Experiment 2|Discomfort during stimulation|0|||
170625290|NCT03050801|616639151|FG004|Experiment 2|Discomfort during stimulation|0|||
170625291|NCT03050801|616639152|FG005|Experiment 2|Discomfort during stimulation|2|||
170625292|NCT03600909|616639153|FG000|Overall Study|Not treated|0|||
170625293|NCT03600909|616639154|FG001|Overall Study|Not treated|3|||
170625294|NCT03600909|616639155|FG002|Overall Study|Not treated|0|||
170625295|NCT04576988|616639156|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
170625296|NCT04576988|616639157|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
170625297|NCT04576988|616639156|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
170625298|NCT04576988|616639157|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
170625299|NCT04576988|616639156|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
170625300|NCT04576988|616639157|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
170625301|NCT04576988|616639156|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
170625302|NCT04576988|616639157|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
170625303|NCT04576988|616639156|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
170625304|NCT04576988|616639157|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
170625305|NCT04576988|616639156|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
170625306|NCT04576988|616639157|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
170625307|NCT04576988|616639156|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
170625308|NCT04576988|616639157|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
170625309|NCT04576988|616639156|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
170625310|NCT04576988|616639157|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
170625311|NCT04576988|616639156|FG000|Long Term Double Blind (LTDB)|Death|2|||
170625312|NCT04576988|616639157|FG001|Long Term Double Blind (LTDB)|Death|1|||
170625313|NCT04576988|616639156|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
170625314|NCT04576988|616639157|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
170625315|NCT02025179|616639160|FG000|Overall Study|Lost to Follow-up|0|||
170625316|NCT02025179|616639161|FG001|Overall Study|Lost to Follow-up|0|||
170625317|NCT02025179|616639162|FG002|Overall Study|Lost to Follow-up|1|||
170625318|NCT00556075|616639163|FG000|Overall Study|Lost to Follow-up|3|||
170625319|NCT00556075|616639164|FG001|Overall Study|Lost to Follow-up|0|||
170625320|NCT00556075|616639165|FG002|Overall Study|Lost to Follow-up|3|||
170625321|NCT00556075|616639163|FG000|Overall Study|Withdrawal by Subject|3|||
170625322|NCT00556075|616639164|FG001|Overall Study|Withdrawal by Subject|3|||
170625323|NCT00556075|616639165|FG002|Overall Study|Withdrawal by Subject|0|||
170625324|NCT00556075|616639163|FG000|Overall Study|Protocol Violation|1|||
170625325|NCT00556075|616639164|FG001|Overall Study|Protocol Violation|1|||
170625326|NCT00556075|616639165|FG002|Overall Study|Protocol Violation|3|||
170625327|NCT00556075|616639163|FG000|Overall Study|Not eligible|1|||
170625328|NCT00556075|616639164|FG001|Overall Study|Not eligible|1|||
170625329|NCT00556075|616639165|FG002|Overall Study|Not eligible|2|||
170625330|NCT00556075|616639163|FG000|Overall Study|Adverse Event|1|||
170625331|NCT00556075|616639164|FG001|Overall Study|Adverse Event|2|||
170625332|NCT00556075|616639165|FG002|Overall Study|Adverse Event|0|||
170625333|NCT00556075|616639163|FG000|Overall Study|Personal issues|4|||
170625334|NCT00556075|616639164|FG001|Overall Study|Personal issues|1|||
170625335|NCT00556075|616639165|FG002|Overall Study|Personal issues|0|||
170625336|NCT00556075|616639163|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
170625337|NCT00556075|616639164|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
170670329|NCT02555683|616804917|FG001|Overall Study|Death|1|||
170670330|NCT02555683|616804918|FG002|Overall Study|Death|2|||
170670331|NCT02555683|616804916|FG000|Overall Study|Adverse Event|1|||
170670332|NCT02555683|616804917|FG001|Overall Study|Adverse Event|0|||
170670333|NCT02555683|616804918|FG002|Overall Study|Adverse Event|1|||
170670334|NCT02555683|616804916|FG000|Overall Study|Subject/guardian decision|12|||
170670335|NCT02555683|616804917|FG001|Overall Study|Subject/guardian decision|12|||
170670336|NCT02555683|616804918|FG002|Overall Study|Subject/guardian decision|22|||
170670337|NCT02555683|616804916|FG000|Overall Study|Death post Treatment/safety period|0|||
170670338|NCT02555683|616804917|FG001|Overall Study|Death post Treatment/safety period|1|||
170670339|NCT02555683|616804918|FG002|Overall Study|Death post Treatment/safety period|0|||
170670340|NCT02279420|616804923|FG000|Overall Study|Lost to Follow-up|23|||
170670341|NCT03535844|616804926|FG000|Overall Study|Withdrawal by Subject|0|||
170670342|NCT03535844|616804927|FG001|Overall Study|Withdrawal by Subject|1|||
170670343|NCT00612040|616804930|FG000|Overall Study|Adverse Event|0|||
170670344|NCT00612040|616804931|FG001|Overall Study|Adverse Event|2|||
170670345|NCT00612040|616804932|FG002|Overall Study|Adverse Event|1|||
170670346|NCT00612040|616804930|FG000|Overall Study|Protocol Violation|1|||
170670347|NCT00612040|616804931|FG001|Overall Study|Protocol Violation|2|||
170670348|NCT00612040|616804932|FG002|Overall Study|Protocol Violation|1|||
170670349|NCT00612040|616804930|FG000|Overall Study|Lack of Efficacy|2|||
170670350|NCT00612040|616804931|FG001|Overall Study|Lack of Efficacy|1|||
170670351|NCT00612040|616804932|FG002|Overall Study|Lack of Efficacy|0|||
170670352|NCT00612040|616804930|FG000|Overall Study|Unclassified|2|||
170670353|NCT00612040|616804931|FG001|Overall Study|Unclassified|2|||
170670354|NCT00612040|616804932|FG002|Overall Study|Unclassified|5|||
170670355|NCT00297830|616804933|FG000|6 Month Visit|Death|1|||
170670356|NCT00297830|616804934|FG001|6 Month Visit|Death|0|||
170670357|NCT00297830|616804935|FG002|6 Month Visit|Death|2|||
170670358|NCT00297830|616804933|FG000|6 Month Visit|Withdrawal by Subject|2|||
170670359|NCT00297830|616804934|FG001|6 Month Visit|Withdrawal by Subject|1|||
170670360|NCT00297830|616804935|FG002|6 Month Visit|Withdrawal by Subject|1|||
170670361|NCT00297830|616804933|FG000|6 Month Visit|Adverse Event|0|||
170670362|NCT00297830|616804934|FG001|6 Month Visit|Adverse Event|1|||
170670363|NCT00297830|616804935|FG002|6 Month Visit|Adverse Event|0|||
170670364|NCT00297830|616804933|FG000|12 Month Visit|Lost to Follow-up|1|||
170670365|NCT00297830|616804934|FG001|12 Month Visit|Lost to Follow-up|0|||
170670366|NCT00297830|616804935|FG002|12 Month Visit|Lost to Follow-up|0|||
170670367|NCT00297830|616804933|FG000|12 Month Visit|Adverse Event|0|||
170670368|NCT00297830|616804934|FG001|12 Month Visit|Adverse Event|3|||
170670369|NCT00297830|616804935|FG002|12 Month Visit|Adverse Event|0|||
170670370|NCT00297830|616804933|FG000|12 Month Visit|Withdrawal by Subject|0|||
170670371|NCT00297830|616804934|FG001|12 Month Visit|Withdrawal by Subject|3|||
170670372|NCT00297830|616804935|FG002|12 Month Visit|Withdrawal by Subject|0|||
170670373|NCT02835820|616804936|FG000|Overall Study|Baseline Screen Failure|0|||
170670374|NCT02835820|616804937|FG001|Overall Study|Baseline Screen Failure|3|||
170670375|NCT03639935|616804941|FG000|Overall Study|Death|3|||
170670376|NCT03639935|616804941|FG000|Overall Study|Adverse Event|1|||
170670377|NCT01397890|616804942|FG000|Overall Study|Withdrawal by Subject|7|||
170670378|NCT01397890|616804943|FG001|Overall Study|Withdrawal by Subject|11|||
170670379|NCT01397890|616804942|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
170670380|NCT01397890|616804943|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
170670381|NCT01397890|616804942|FG000|Overall Study|Death|2|||
170670382|NCT01397890|616804943|FG001|Overall Study|Death|3|||
170670383|NCT01397890|616804942|FG000|Overall Study|Lost to Follow-up|1|||
170670384|NCT01397890|616804943|FG001|Overall Study|Lost to Follow-up|4|||
170670385|NCT01397890|616804942|FG000|Overall Study|Condition under Investigation Worsened|1|||
170670386|NCT01397890|616804943|FG001|Overall Study|Condition under Investigation Worsened|3|||
170670387|NCT01397890|616804942|FG000|Overall Study|Adverse Event|1|||
170670388|NCT01397890|616804943|FG001|Overall Study|Adverse Event|2|||
170670389|NCT01397890|616804942|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
170670390|NCT01397890|616804943|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
170670391|NCT01397890|616804942|FG000|Overall Study|Others|2|||
170670392|NCT01397890|616804943|FG001|Overall Study|Others|1|||
170670393|NCT03750955|616804946|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
170670394|NCT03750955|616804947|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
170670395|NCT03750955|616804946|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
170670396|NCT03750955|616804947|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
170670397|NCT00697788|616804948|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
170670398|NCT00697788|616804949|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
170670399|NCT00697788|616804950|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
170670400|NCT00697788|616804951|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
170670401|NCT00697788|616804952|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
170670402|NCT00697788|616804953|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
170670403|NCT00697788|616804954|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
170670404|NCT00697788|616804955|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
170625338|NCT00556075|616639165|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
170625339|NCT00601835|616639169|FG000|Overall Study|Withdrawal by Subject|9|||
170625340|NCT00601835|616639170|FG001|Overall Study|Withdrawal by Subject|6|||
170625341|NCT00601835|616639169|FG000|Overall Study|Physician Decision|1|||
170625342|NCT00601835|616639170|FG001|Overall Study|Physician Decision|0|||
170625343|NCT00601835|616639169|FG000|Overall Study|Lost to Follow-up|37|||
170625344|NCT00601835|616639170|FG001|Overall Study|Lost to Follow-up|5|||
170625345|NCT00601835|616639169|FG000|Overall Study|Adverse Event|1|||
170625346|NCT00601835|616639170|FG001|Overall Study|Adverse Event|1|||
170625347|NCT00601835|616639169|FG000|Overall Study|Relocate|12|||
170625348|NCT00601835|616639170|FG001|Overall Study|Relocate|2|||
170625349|NCT00517296|616639173|FG000|Overall Study|Withdrawal by Subject|1|||
170625350|NCT00517296|616639174|FG001|Overall Study|Withdrawal by Subject|0|||
170625351|NCT04764162|616639175|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
170625352|NCT04764162|616639176|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
170625353|NCT03980730|616639177|FG000|Overall Study|Study Terminated by Sponsor|0|||
170625354|NCT03980730|616639178|FG001|Overall Study|Study Terminated by Sponsor|3|||
170625355|NCT03980730|616639177|FG000|Overall Study|Adverse Event|2|||
170625356|NCT03980730|616639178|FG001|Overall Study|Adverse Event|0|||
170625357|NCT03980730|616639177|FG000|Overall Study|Sponsor Request|0|||
170625358|NCT03980730|616639178|FG001|Overall Study|Sponsor Request|1|||
170625359|NCT03919773|616639194|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
170625360|NCT03919773|616639195|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
170625361|NCT03919773|616639194|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
170625362|NCT03919773|616639195|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
170625363|NCT02919761|616639197|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
170625364|NCT02919761|616639198|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
170625365|NCT02919761|616639199|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
170625366|NCT02919761|616639197|FG000|Part 1: Open Label|Adverse Event|1|||
170625367|NCT02919761|616639198|FG001|Part 1: Open Label|Adverse Event|0|||
170625368|NCT02919761|616639199|FG002|Part 1: Open Label|Adverse Event|0|||
170625369|NCT02919761|616639197|FG000|Part 1: Open Label|Lost to Follow-up|1|||
170625370|NCT02919761|616639198|FG001|Part 1: Open Label|Lost to Follow-up|0|||
170625371|NCT02919761|616639199|FG002|Part 1: Open Label|Lost to Follow-up|0|||
170625372|NCT02919761|616639197|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
170625373|NCT02919761|616639198|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
170625374|NCT02919761|616639199|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
170625375|NCT02919761|616639197|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
170625376|NCT02919761|616639198|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
170625377|NCT02919761|616639199|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
170625378|NCT02919761|616639197|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
170625379|NCT02919761|616639198|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
170625380|NCT02919761|616639199|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
170625381|NCT02919761|616639197|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
170625382|NCT02919761|616639198|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
170625383|NCT02919761|616639199|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
170625384|NCT02919761|616639197|FG000|Part 1: Open Label|Termination by Sponsor|1|||
170670405|NCT00697788|616804948|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
170670406|NCT00697788|616804949|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
170670407|NCT00697788|616804950|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
170670408|NCT00697788|616804951|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
170670409|NCT00697788|616804952|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
170670410|NCT00697788|616804953|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
170670411|NCT00697788|616804954|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
170670412|NCT00697788|616804955|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
170670413|NCT02763462|616804957|FG000|Overall Study|Protocol Violation|6|||
170670414|NCT03417219|616804958|FG000|Overall Study|Lost to Follow-up|0|||
170670415|NCT03417219|616804959|FG001|Overall Study|Lost to Follow-up|3|||
170670416|NCT00129272|616804960|FG000|Overall Study|Lost to Follow-up|12|||
170670417|NCT00129272|616804961|FG001|Overall Study|Lost to Follow-up|11|||
170670418|NCT00129272|616804960|FG000|Overall Study|Withdrawal by Subject|5|||
170670419|NCT00129272|616804961|FG001|Overall Study|Withdrawal by Subject|11|||
170670420|NCT00675948|616804963|FG000|Overall Study|Adverse Event|23|||
170670421|NCT00675948|616804964|FG001|Overall Study|Adverse Event|1|||
170670422|NCT00675948|616804963|FG000|Overall Study|Lack of Efficacy|3|||
170670423|NCT00675948|616804964|FG001|Overall Study|Lack of Efficacy|0|||
170670424|NCT00675948|616804963|FG000|Overall Study|Withdrawal by Subject|7|||
170670425|NCT00675948|616804964|FG001|Overall Study|Withdrawal by Subject|0|||
170670426|NCT00675948|616804963|FG000|Overall Study|Lost to Follow-up|2|||
170670427|NCT00675948|616804964|FG001|Overall Study|Lost to Follow-up|0|||
170670428|NCT00675948|616804963|FG000|Overall Study|Protocol Violation|1|||
170670429|NCT00675948|616804964|FG001|Overall Study|Protocol Violation|0|||
170670430|NCT00675948|616804963|FG000|Overall Study|Pain under control|1|||
170670431|NCT00675948|616804964|FG001|Overall Study|Pain under control|0|||
170670432|NCT00675948|616804963|FG000|Overall Study|Sponsor decision|0|||
170670433|NCT00675948|616804964|FG001|Overall Study|Sponsor decision|1|||
170670434|NCT00675948|616804963|FG000|Overall Study|Patient died|1|||
170670435|NCT00675948|616804964|FG001|Overall Study|Patient died|0|||
170670436|NCT00675948|616804963|FG000|Overall Study|Patient unable to comply with diaries|1|||
170670437|NCT00675948|616804964|FG001|Overall Study|Patient unable to comply with diaries|0|||
170670438|NCT00675948|616804963|FG000|Overall Study|Patient feels unable to take medication|0|||
170670439|NCT00675948|616804964|FG001|Overall Study|Patient feels unable to take medication|1|||
170670440|NCT02100514|616804965|FG000|Treatment Period|Adverse Event|0|||
170670441|NCT02100514|616804966|FG001|Treatment Period|Adverse Event|5|||
170670442|NCT02100514|616804967|FG002|Treatment Period|Adverse Event|0|||
170670443|NCT02100514|616804968|FG003|Treatment Period|Adverse Event|0|||
170670444|NCT02100514|616804969|FG004|Treatment Period|Adverse Event|0|||
170670445|NCT02100514|616804965|FG000|Treatment Period|Death|2|||
170670446|NCT02100514|616804966|FG001|Treatment Period|Death|2|||
170670447|NCT02100514|616804967|FG002|Treatment Period|Death|0|||
170670448|NCT02100514|616804968|FG003|Treatment Period|Death|0|||
170670449|NCT02100514|616804969|FG004|Treatment Period|Death|0|||
170670450|NCT02100514|616804965|FG000|Treatment Period|Lost to Follow-up|5|||
170670451|NCT02100514|616804966|FG001|Treatment Period|Lost to Follow-up|17|||
170670452|NCT02100514|616804967|FG002|Treatment Period|Lost to Follow-up|0|||
170670453|NCT02100514|616804968|FG003|Treatment Period|Lost to Follow-up|0|||
170670454|NCT02100514|616804969|FG004|Treatment Period|Lost to Follow-up|0|||
170670455|NCT02100514|616804965|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
170670456|NCT02100514|616804966|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
170670457|NCT02100514|616804967|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
170670458|NCT02100514|616804968|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
170670459|NCT02100514|616804969|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
170670460|NCT02100514|616804965|FG000|Treatment Period|Protocol Violation|1|||
170670461|NCT02100514|616804966|FG001|Treatment Period|Protocol Violation|1|||
170670462|NCT02100514|616804967|FG002|Treatment Period|Protocol Violation|0|||
170670463|NCT02100514|616804968|FG003|Treatment Period|Protocol Violation|0|||
170670464|NCT02100514|616804969|FG004|Treatment Period|Protocol Violation|0|||
170670465|NCT02100514|616804965|FG000|Treatment Period|Withdrawal by Subject|12|||
170670466|NCT02100514|616804966|FG001|Treatment Period|Withdrawal by Subject|37|||
170670467|NCT02100514|616804967|FG002|Treatment Period|Withdrawal by Subject|0|||
170670468|NCT02100514|616804968|FG003|Treatment Period|Withdrawal by Subject|0|||
170670469|NCT02100514|616804969|FG004|Treatment Period|Withdrawal by Subject|0|||
170670470|NCT02100514|616804965|FG000|Treatment Period|Other|9|||
170670471|NCT02100514|616804966|FG001|Treatment Period|Other|11|||
170670472|NCT02100514|616804967|FG002|Treatment Period|Other|0|||
170670473|NCT02100514|616804968|FG003|Treatment Period|Other|0|||
170670474|NCT02100514|616804969|FG004|Treatment Period|Other|0|||
170670475|NCT02100514|616804965|FG000|Extension Period|Withdrew consent|0|||
170670476|NCT02100514|616804966|FG001|Extension Period|Withdrew consent|0|||
170670477|NCT02100514|616804967|FG002|Extension Period|Withdrew consent|2|||
170670478|NCT02100514|616804968|FG003|Extension Period|Withdrew consent|0|||
170670479|NCT02100514|616804969|FG004|Extension Period|Withdrew consent|0|||
170670480|NCT01365052|616804970|FG000|Overall Study|Adverse Event|4|||
170670481|NCT01365052|616804971|FG001|Overall Study|Adverse Event|4|||
170625385|NCT02919761|616639198|FG001|Part 1: Open Label|Termination by Sponsor|0|||
170625386|NCT02919761|616639199|FG002|Part 1: Open Label|Termination by Sponsor|0|||
170625387|NCT02919761|616639197|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
170625388|NCT02919761|616639198|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
170625389|NCT02919761|616639199|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
170625390|NCT02919761|616639197|FG000|Part 2: Double-blind|Adverse Event|0|||
170625391|NCT02919761|616639198|FG001|Part 2: Double-blind|Adverse Event|1|||
170625392|NCT02919761|616639199|FG002|Part 2: Double-blind|Adverse Event|0|||
170625393|NCT02919761|616639197|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
170625394|NCT02919761|616639198|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
170625395|NCT02919761|616639199|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
170625396|NCT02919761|616639197|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
170625397|NCT02919761|616639198|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
170625398|NCT02919761|616639199|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
170625399|NCT02919761|616639197|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
170625400|NCT02919761|616639198|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
170625401|NCT02919761|616639199|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
170625402|NCT02919761|616639197|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
170625403|NCT02919761|616639198|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
170625404|NCT02919761|616639199|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
170625405|NCT02919761|616639197|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
170625406|NCT02919761|616639198|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
170625407|NCT02919761|616639199|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
170625408|NCT02919761|616639197|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
170625409|NCT02919761|616639198|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
170625410|NCT02919761|616639199|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
170625411|NCT00410956|616639203|FG000|Overall Study|Adverse Event|1|||
170625412|NCT00410956|616639203|FG000|Overall Study|Death|2|||
170625413|NCT00410956|616639203|FG000|Overall Study|Lack of Efficacy|10|||
170625414|NCT00410956|616639203|FG000|Overall Study|Physician Decision|6|||
170625415|NCT00199381|616640845|FG000|Overall Study|Withdrawal by Subject|38|||
170625416|NCT00199381|616640845|FG000|Overall Study|Adverse Event|73|||
170625417|NCT00199381|616640845|FG000|Overall Study|Protocol Violation|6|||
170625418|NCT00199381|616640845|FG000|Overall Study|Lack of Efficacy|27|||
170625419|NCT00199381|616640845|FG000|Overall Study|Not including due to early termination|37|||
170625420|NCT00199381|616640845|FG000|Overall Study|Study termination by Sponsor|323|||
170625421|NCT00385671|616640846|FG000|Overall Study|Adverse Event|14|||
170625422|NCT00385671|616640847|FG001|Overall Study|Adverse Event|27|||
170625423|NCT00385671|616640848|FG002|Overall Study|Adverse Event|18|||
170625424|NCT00385671|616640846|FG000|Overall Study|Lack of Efficacy|5|||
170625425|NCT00385671|616640847|FG001|Overall Study|Lack of Efficacy|9|||
170625426|NCT00385671|616640848|FG002|Overall Study|Lack of Efficacy|5|||
170625427|NCT00385671|616640846|FG000|Overall Study|Lost to Follow-up|6|||
170625428|NCT00385671|616640847|FG001|Overall Study|Lost to Follow-up|6|||
170625429|NCT00385671|616640848|FG002|Overall Study|Lost to Follow-up|5|||
170625430|NCT00385671|616640846|FG000|Overall Study|Physician Decision|2|||
170625431|NCT00385671|616640847|FG001|Overall Study|Physician Decision|1|||
170625432|NCT00385671|616640848|FG002|Overall Study|Physician Decision|2|||
170625433|NCT00385671|616640846|FG000|Overall Study|Protocol Violation|5|||
170625434|NCT00385671|616640847|FG001|Overall Study|Protocol Violation|2|||
170625435|NCT00385671|616640848|FG002|Overall Study|Protocol Violation|1|||
170625436|NCT00385671|616640846|FG000|Overall Study|Sponsor Decision|2|||
170625437|NCT00385671|616640847|FG001|Overall Study|Sponsor Decision|2|||
170625438|NCT00385671|616640848|FG002|Overall Study|Sponsor Decision|1|||
170625439|NCT00385671|616640846|FG000|Overall Study|Withdrawal by Subject|4|||
170625440|NCT00385671|616640847|FG001|Overall Study|Withdrawal by Subject|4|||
170625441|NCT00385671|616640848|FG002|Overall Study|Withdrawal by Subject|4|||
170625442|NCT01702311|616640851|FG000|Overall Study|Withdrawal by Subject|3|||
170625443|NCT01702311|616640852|FG001|Overall Study|Withdrawal by Subject|2|||
170625444|NCT01702311|616640851|FG000|Overall Study|Discharge less than 24 hours|10|||
170625445|NCT01702311|616640852|FG001|Overall Study|Discharge less than 24 hours|7|||
170625446|NCT01702311|616640851|FG000|Overall Study|Physician Decision|3|||
170625447|NCT01702311|616640852|FG001|Overall Study|Physician Decision|4|||
170625448|NCT02326155|616640853|FG000|Overall Study|Adverse Event|21|||
170625449|NCT02326155|616640854|FG001|Overall Study|Adverse Event|5|||
170625450|NCT02326155|616640853|FG000|Overall Study|Death|3|||
170625451|NCT02326155|616640854|FG001|Overall Study|Death|0|||
170625452|NCT02326155|616640853|FG000|Overall Study|Lack of Efficacy|49|||
170625453|NCT02326155|616640854|FG001|Overall Study|Lack of Efficacy|5|||
170670482|NCT00319553|616804974|FG000|Overall Study|Protocol Violation|1|||
170670483|NCT00319553|616804975|FG001|Overall Study|Protocol Violation|2|||
170670484|NCT00319553|616804974|FG000|Overall Study|Lost to Follow-up|2|||
170670485|NCT00319553|616804975|FG001|Overall Study|Lost to Follow-up|1|||
170670486|NCT00319553|616804974|FG000|Overall Study|Withdrawal by Subject|1|||
170670487|NCT00319553|616804975|FG001|Overall Study|Withdrawal by Subject|1|||
170670488|NCT01145625|616804976|FG000|Overall Study|Lost to Follow-up|8|||
170670489|NCT01145625|616804977|FG001|Overall Study|Lost to Follow-up|9|||
170670490|NCT01145625|616804976|FG000|Overall Study|Adverse Event|6|||
170670491|NCT01145625|616804977|FG001|Overall Study|Adverse Event|4|||
170670492|NCT01145625|616804976|FG000|Overall Study|Protocol Violation|3|||
170670493|NCT01145625|616804977|FG001|Overall Study|Protocol Violation|1|||
170670494|NCT01145625|616804976|FG000|Overall Study|Withdrawal by Subject|7|||
170670495|NCT01145625|616804977|FG001|Overall Study|Withdrawal by Subject|16|||
170670496|NCT01145625|616804976|FG000|Overall Study|Pregnancy|0|||
170670497|NCT01145625|616804977|FG001|Overall Study|Pregnancy|1|||
170670498|NCT01896102|616804978|FG000|Overall Study|Death|1|||
170670499|NCT01896102|616804978|FG000|Overall Study|Participant to receive allogenic transplant|2|||
170670500|NCT01751178|616804979|FG000|Overall Study|Adverse Event|2|||
170670501|NCT01751178|616804980|FG001|Overall Study|Adverse Event|0|||
170670502|NCT01751178|616804981|FG002|Overall Study|Adverse Event|0|||
170670503|NCT01751178|616804979|FG000|Overall Study|Other Reason (unknown)|1|||
170670504|NCT01751178|616804980|FG001|Overall Study|Other Reason (unknown)|0|||
170670505|NCT01751178|616804981|FG002|Overall Study|Other Reason (unknown)|2|||
170670506|NCT04289623|616804982|FG000|Wave 1 Emails|Email was not delivered|268|||
170670507|NCT04289623|616804983|FG001|Wave 1 Emails|Email was not delivered|257|||
170670508|NCT04289623|616804984|FG002|Wave 1 Emails|Email was not delivered|0|||
170670509|NCT04289623|616804985|FG003|Wave 1 Emails|Email was not delivered|0|||
170670510|NCT04289623|616804986|FG004|Wave 1 Emails|Email was not delivered|0|||
170670511|NCT04289623|616804987|FG005|Wave 1 Emails|Email was not delivered|0|||
170670512|NCT00810355|616805003|FG000|Overall Study|Lost to Follow-up|13|||
170670513|NCT00810355|616805004|FG001|Overall Study|Lost to Follow-up|17|||
170670514|NCT00810355|616805005|FG002|Overall Study|Lost to Follow-up|11|||
170670515|NCT00810355|616805003|FG000|Overall Study|Withdrawal by Subject|1|||
170670516|NCT00810355|616805004|FG001|Overall Study|Withdrawal by Subject|0|||
170670517|NCT00810355|616805005|FG002|Overall Study|Withdrawal by Subject|0|||
170670518|NCT03730012|616805009|FG000|Overall Study|Adverse Event|0|||
170670519|NCT03730012|616805010|FG001|Overall Study|Adverse Event|1|||
170670520|NCT03730012|616805009|FG000|Overall Study|Lack of Efficacy|1|||
170670521|NCT03730012|616805010|FG001|Overall Study|Lack of Efficacy|5|||
170670522|NCT03730012|616805009|FG000|Overall Study|Withdrawal by Subject|0|||
170670523|NCT03730012|616805010|FG001|Overall Study|Withdrawal by Subject|1|||
170670524|NCT03730012|616805009|FG000|Overall Study|Miscellaneous|2|||
170670525|NCT03730012|616805010|FG001|Overall Study|Miscellaneous|1|||
170670526|NCT01218113|616806582|FG000|Overall Study|Withdrawal by Subject|1|||
170670527|NCT01218113|616806583|FG001|Overall Study|Withdrawal by Subject|0|||
170670528|NCT01218113|616806584|FG002|Overall Study|Withdrawal by Subject|1|||
170670529|NCT01218113|616806582|FG000|Overall Study|Lost to Follow-up|4|||
170670530|NCT01218113|616806583|FG001|Overall Study|Lost to Follow-up|1|||
170670531|NCT01218113|616806584|FG002|Overall Study|Lost to Follow-up|4|||
170670532|NCT01218113|616806582|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
170670533|NCT01218113|616806583|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
170670534|NCT01218113|616806584|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
170670535|NCT01385566|616806588|FG000|Overall Study|Lost to Follow-up|1|||
170670536|NCT01385566|616806589|FG001|Overall Study|Lost to Follow-up|0|||
170670537|NCT01385566|616806590|FG002|Overall Study|Lost to Follow-up|0|||
170670538|NCT01385566|616806591|FG003|Overall Study|Lost to Follow-up|0|||
170670539|NCT01385566|616806592|FG004|Overall Study|Lost to Follow-up|0|||
170670540|NCT01385566|616806593|FG005|Overall Study|Lost to Follow-up|0|||
170670541|NCT01385566|616806588|FG000|Overall Study|Withdrawal by Subject|0|||
170670542|NCT01385566|616806589|FG001|Overall Study|Withdrawal by Subject|0|||
170670543|NCT01385566|616806590|FG002|Overall Study|Withdrawal by Subject|0|||
170670544|NCT01385566|616806591|FG003|Overall Study|Withdrawal by Subject|1|||
170670545|NCT01385566|616806592|FG004|Overall Study|Withdrawal by Subject|0|||
170670546|NCT01385566|616806593|FG005|Overall Study|Withdrawal by Subject|0|||
170670547|NCT00967668|616806594|FG000|Overall Study|Withdrawal by Subject|13|||
170670548|NCT00967668|616806595|FG001|Overall Study|Withdrawal by Subject|8|||
170670549|NCT00967668|616806596|FG002|Overall Study|Withdrawal by Subject|8|||
170670550|NCT00967668|616806594|FG000|Overall Study|Death|0|||
170819805|NCT00296504|617347681|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
170819806|NCT00296504|617347682|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
170670551|NCT00967668|616806595|FG001|Overall Study|Death|2|||
170670552|NCT00967668|616806596|FG002|Overall Study|Death|4|||
170670553|NCT00967668|616806594|FG000|Overall Study|Removed due to behavior|1|||
170670554|NCT00967668|616806595|FG001|Overall Study|Removed due to behavior|1|||
170670555|NCT00967668|616806596|FG002|Overall Study|Removed due to behavior|2|||
170670556|NCT00967668|616806594|FG000|Overall Study|Refused Year 2|11|||
170670557|NCT00967668|616806595|FG001|Overall Study|Refused Year 2|6|||
170625454|NCT02326155|616640853|FG000|Overall Study|Lost to Follow-up|14|||
170670558|NCT00967668|616806596|FG002|Overall Study|Refused Year 2|4|||
170670559|NCT00967668|616806594|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
170670560|NCT00967668|616806595|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
170670561|NCT00967668|616806596|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
170670562|NCT00967668|616806594|FG000|Overall Study|Lost to Follow-up|15|||
170670563|NCT00967668|616806595|FG001|Overall Study|Lost to Follow-up|9|||
170670564|NCT00967668|616806596|FG002|Overall Study|Lost to Follow-up|16|||
170670565|NCT00967668|616806594|FG000|Overall Study|Refused 12-mo assessment|3|||
170670566|NCT00967668|616806595|FG001|Overall Study|Refused 12-mo assessment|1|||
170670567|NCT00967668|616806596|FG002|Overall Study|Refused 12-mo assessment|9|||
170670568|NCT00967668|616806594|FG000|Overall Study|Pregnancy|1|||
170670569|NCT00967668|616806595|FG001|Overall Study|Pregnancy|0|||
170670570|NCT00967668|616806596|FG002|Overall Study|Pregnancy|0|||
170670571|NCT00825682|616806597|FG000|Overall Study|personal reasons/ inconvenience|13|||
170670572|NCT00825682|616806598|FG001|Overall Study|personal reasons/ inconvenience|5|||
170670573|NCT02025621|616806599|FG000|Overall Study|Withdrawal by Subject|1|||
170670574|NCT02025621|616806600|FG001|Overall Study|Withdrawal by Subject|0|||
170670575|NCT02025621|616806599|FG000|Overall Study|Death|0|||
170670576|NCT02025621|616806600|FG001|Overall Study|Death|1|||
170670577|NCT02025621|616806599|FG000|Overall Study|No longer eligible|10|||
170670578|NCT02025621|616806600|FG001|Overall Study|No longer eligible|15|||
170670579|NCT02025621|616806599|FG000|Overall Study|Surgery initiated before infusion|3|||
170670580|NCT02025621|616806600|FG001|Overall Study|Surgery initiated before infusion|3|||
170670581|NCT01871532|616806601|FG000|Overall Study|Withdrawal by Subject|1|||
170670582|NCT01871532|616806602|FG001|Overall Study|Withdrawal by Subject|2|||
170670583|NCT01543958|616806603|FG000|Overall Study|Loss to follow-up|3|||
170670584|NCT01543958|616806603|FG000|Overall Study|ART initiation|1|||
170670585|NCT01945281|616806604|FG000|Overall Study|Adverse Event|1|||
170670586|NCT01945281|616806605|FG001|Overall Study|Adverse Event|0|||
170670587|NCT01945281|616806604|FG000|Overall Study|Death|3|||
170670588|NCT01945281|616806605|FG001|Overall Study|Death|3|||
170670589|NCT01945281|616806604|FG000|Overall Study|Physician Decision|1|||
170670590|NCT01945281|616806605|FG001|Overall Study|Physician Decision|1|||
170670591|NCT01945281|616806604|FG000|Overall Study|Technical Problems|1|||
170670592|NCT01945281|616806605|FG001|Overall Study|Technical Problems|0|||
170670593|NCT01513343|616806616|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
170670594|NCT01513343|616806617|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
170670595|NCT01513343|616806616|FG000|Post Data Collection|Dropped/withdrew from study|7|||
170625455|NCT02326155|616640854|FG001|Overall Study|Lost to Follow-up|3|||
170625456|NCT02326155|616640853|FG000|Overall Study|Protocol Violation|2|||
170625457|NCT02326155|616640854|FG001|Overall Study|Protocol Violation|0|||
170625458|NCT02326155|616640853|FG000|Overall Study|Withdrawal by Subject|34|||
170625459|NCT02326155|616640854|FG001|Overall Study|Withdrawal by Subject|11|||
170625460|NCT02326155|616640853|FG000|Overall Study|Disease progression|37|||
170625461|NCT02326155|616640854|FG001|Overall Study|Disease progression|4|||
170625462|NCT02326155|616640853|FG000|Overall Study|Study close|188|||
170625463|NCT02326155|616640854|FG001|Overall Study|Study close|21|||
170625464|NCT02326155|616640853|FG000|Overall Study|except for study close|46|||
170625465|NCT02326155|616640854|FG001|Overall Study|except for study close|13|||
170625466|NCT03714672|616640855|FG000|Overall Study|Adverse Event|0|||
170625467|NCT03714672|616640856|FG001|Overall Study|Adverse Event|0|||
170625468|NCT03714672|616640857|FG002|Overall Study|Adverse Event|3|||
170625469|NCT03714672|616640858|FG003|Overall Study|Adverse Event|0|||
170625470|NCT03714672|616640855|FG000|Overall Study|Physician Decision|0|||
170625471|NCT03714672|616640856|FG001|Overall Study|Physician Decision|1|||
170625472|NCT03714672|616640857|FG002|Overall Study|Physician Decision|0|||
170625473|NCT03714672|616640858|FG003|Overall Study|Physician Decision|0|||
170670596|NCT01513343|616806617|FG001|Post Data Collection|Dropped/withdrew from study|1|||
170670597|NCT01513343|616806616|FG000|Post Data Collection|Lost to Follow-up|10|||
170670598|NCT01513343|616806617|FG001|Post Data Collection|Lost to Follow-up|23|||
170670599|NCT01513343|616806616|FG000|6-month Follow-up|Lost to Follow-up|28|||
170670600|NCT01513343|616806617|FG001|6-month Follow-up|Lost to Follow-up|17|||
170670601|NCT01513343|616806616|FG000|12-month Follow-up|Lost to Follow-up|10|||
170670602|NCT01513343|616806617|FG001|12-month Follow-up|Lost to Follow-up|3|||
170670603|NCT00599924|616806618|FG000|Overall Study|Lack of Efficacy|3|||
170625474|NCT03714672|616640855|FG000|Overall Study|Other Reason|1|||
170625475|NCT03714672|616640856|FG001|Overall Study|Other Reason|2|||
170625476|NCT03714672|616640857|FG002|Overall Study|Other Reason|1|||
170625477|NCT03714672|616640858|FG003|Overall Study|Other Reason|1|||
170625478|NCT03714672|616640855|FG000|Overall Study|Lost to Follow-up|1|||
170625479|NCT03714672|616640856|FG001|Overall Study|Lost to Follow-up|1|||
170625480|NCT03714672|616640857|FG002|Overall Study|Lost to Follow-up|0|||
170625481|NCT03714672|616640858|FG003|Overall Study|Lost to Follow-up|0|||
170670604|NCT00599924|616806619|FG001|Overall Study|Lack of Efficacy|5|||
170670605|NCT00599924|616806620|FG002|Overall Study|Lack of Efficacy|1|||
170670606|NCT00599924|616806621|FG003|Overall Study|Lack of Efficacy|2|||
170625482|NCT03453164|616640860|FG000|Overall Study|Lack of Efficacy|16|||
170670607|NCT00599924|616806622|FG004|Overall Study|Lack of Efficacy|3|||
170670608|NCT00599924|616806623|FG005|Overall Study|Lack of Efficacy|2|||
170670609|NCT00599924|616806624|FG006|Overall Study|Lack of Efficacy|0|||
170670610|NCT00599924|616806618|FG000|Overall Study|Adverse Event|0|||
170670611|NCT00599924|616806619|FG001|Overall Study|Adverse Event|0|||
170670612|NCT00599924|616806620|FG002|Overall Study|Adverse Event|0|||
170670613|NCT00599924|616806621|FG003|Overall Study|Adverse Event|2|||
170670614|NCT00599924|616806622|FG004|Overall Study|Adverse Event|0|||
170670615|NCT00599924|616806623|FG005|Overall Study|Adverse Event|0|||
170670616|NCT00599924|616806624|FG006|Overall Study|Adverse Event|2|||
170670617|NCT00599924|616806618|FG000|Overall Study|Death|0|||
170670618|NCT00599924|616806619|FG001|Overall Study|Death|0|||
170670619|NCT00599924|616806620|FG002|Overall Study|Death|0|||
170670620|NCT00599924|616806621|FG003|Overall Study|Death|2|||
170670621|NCT00599924|616806622|FG004|Overall Study|Death|0|||
170670622|NCT00599924|616806623|FG005|Overall Study|Death|2|||
170670623|NCT00599924|616806624|FG006|Overall Study|Death|1|||
170670624|NCT00599924|616806618|FG000|Overall Study|Protocol Violation|0|||
170670625|NCT00599924|616806619|FG001|Overall Study|Protocol Violation|0|||
170670626|NCT00599924|616806620|FG002|Overall Study|Protocol Violation|0|||
170670627|NCT00599924|616806621|FG003|Overall Study|Protocol Violation|1|||
170670628|NCT00599924|616806622|FG004|Overall Study|Protocol Violation|0|||
170670629|NCT00599924|616806623|FG005|Overall Study|Protocol Violation|0|||
170670630|NCT00599924|616806624|FG006|Overall Study|Protocol Violation|0|||
170670631|NCT00599924|616806618|FG000|Overall Study|Withdrawal by Subject|0|||
170670632|NCT00599924|616806619|FG001|Overall Study|Withdrawal by Subject|0|||
170670633|NCT00599924|616806620|FG002|Overall Study|Withdrawal by Subject|1|||
170670634|NCT00599924|616806621|FG003|Overall Study|Withdrawal by Subject|0|||
170670635|NCT00599924|616806622|FG004|Overall Study|Withdrawal by Subject|1|||
170670636|NCT00599924|616806623|FG005|Overall Study|Withdrawal by Subject|0|||
170670637|NCT00599924|616806624|FG006|Overall Study|Withdrawal by Subject|0|||
170670638|NCT00599924|616806618|FG000|Overall Study|Other|0|||
170670639|NCT00599924|616806619|FG001|Overall Study|Other|0|||
170670640|NCT00599924|616806620|FG002|Overall Study|Other|0|||
170670641|NCT00599924|616806621|FG003|Overall Study|Other|1|||
170670642|NCT00599924|616806622|FG004|Overall Study|Other|2|||
170670643|NCT00599924|616806623|FG005|Overall Study|Other|0|||
170670644|NCT00599924|616806624|FG006|Overall Study|Other|2|||
170670645|NCT02165215|616806625|FG000|Induction Phase|Adverse Event|1|||
170670646|NCT02165215|616806626|FG001|Induction Phase|Adverse Event|0|||
170670647|NCT02165215|616806627|FG002|Induction Phase|Adverse Event|0|||
170670648|NCT02165215|616806625|FG000|Induction Phase|Withdrawal by Subject|10|||
170670649|NCT02165215|616806626|FG001|Induction Phase|Withdrawal by Subject|0|||
170670650|NCT02165215|616806627|FG002|Induction Phase|Withdrawal by Subject|0|||
170670651|NCT02165215|616806625|FG000|Induction Phase|Protocol Violation|1|||
170670652|NCT02165215|616806626|FG001|Induction Phase|Protocol Violation|0|||
170670653|NCT02165215|616806627|FG002|Induction Phase|Protocol Violation|0|||
170670654|NCT02165215|616806625|FG000|Induction Phase|Physician Decision|1|||
170670655|NCT02165215|616806626|FG001|Induction Phase|Physician Decision|0|||
170670656|NCT02165215|616806627|FG002|Induction Phase|Physician Decision|0|||
170670657|NCT02165215|616806625|FG000|Induction Phase|Lack of Efficacy|2|||
170670658|NCT02165215|616806626|FG001|Induction Phase|Lack of Efficacy|0|||
170670659|NCT02165215|616806627|FG002|Induction Phase|Lack of Efficacy|0|||
170670660|NCT02165215|616806625|FG000|Induction Phase|Non-Compliance|2|||
170670661|NCT02165215|616806626|FG001|Induction Phase|Non-Compliance|0|||
170670662|NCT02165215|616806627|FG002|Induction Phase|Non-Compliance|0|||
170670663|NCT02165215|616806625|FG000|Induction Phase|Lost to Follow-up|6|||
170670664|NCT02165215|616806626|FG001|Induction Phase|Lost to Follow-up|0|||
170670665|NCT02165215|616806627|FG002|Induction Phase|Lost to Follow-up|0|||
170670666|NCT02165215|616806625|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170670667|NCT02165215|616806626|FG001|Maintenance Phase|Withdrawal by Subject|7|||
170670668|NCT02165215|616806627|FG002|Maintenance Phase|Withdrawal by Subject|3|||
170670669|NCT02165215|616806625|FG000|Maintenance Phase|Multiple reasons|0|||
170670670|NCT02165215|616806626|FG001|Maintenance Phase|Multiple reasons|2|||
170670671|NCT02165215|616806627|FG002|Maintenance Phase|Multiple reasons|1|||
170670672|NCT02165215|616806625|FG000|Maintenance Phase|Lost to Follow-up|0|||
170670673|NCT02165215|616806626|FG001|Maintenance Phase|Lost to Follow-up|2|||
170670674|NCT02165215|616806627|FG002|Maintenance Phase|Lost to Follow-up|0|||
170670675|NCT02165215|616806625|FG000|Maintenance Phase|Adverse Event|0|||
170670676|NCT02165215|616806626|FG001|Maintenance Phase|Adverse Event|1|||
170670677|NCT02165215|616806627|FG002|Maintenance Phase|Adverse Event|1|||
170670678|NCT01877265|616806628|FG000|Treatment Period 1|Sponsor Decision|0|||
170670679|NCT01877265|616806629|FG001|Treatment Period 1|Sponsor Decision|0|||
170670680|NCT01877265|616806630|FG002|Treatment Period 1|Sponsor Decision|1|||
170670681|NCT01877265|616806631|FG003|Treatment Period 1|Sponsor Decision|0|||
170670682|NCT01877265|616806632|FG004|Treatment Period 1|Sponsor Decision|0|||
170670683|NCT01877265|616806633|FG005|Treatment Period 1|Sponsor Decision|0|||
170670684|NCT01877265|616806628|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
170670685|NCT01877265|616806629|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
170670686|NCT01877265|616806630|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
170670687|NCT01877265|616806631|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
170670688|NCT01877265|616806632|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
170670689|NCT01877265|616806633|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
170670690|NCT01877265|616806628|FG000|Treatment Period 3|Lost to Follow-up|1|||
170670691|NCT01877265|616806629|FG001|Treatment Period 3|Lost to Follow-up|0|||
170670692|NCT01877265|616806630|FG002|Treatment Period 3|Lost to Follow-up|0|||
170670693|NCT01877265|616806631|FG003|Treatment Period 3|Lost to Follow-up|0|||
170670694|NCT01877265|616806632|FG004|Treatment Period 3|Lost to Follow-up|0|||
170670695|NCT01877265|616806633|FG005|Treatment Period 3|Lost to Follow-up|0|||
170670696|NCT00592384|616806634|FG000|Overall Study|Withdrawal by Subject|5|||
170670697|NCT00592384|616806635|FG001|Overall Study|Withdrawal by Subject|6|||
170670698|NCT00003473|616806639|FG000|Overall Study|Three patients were not evaluable.|3|||
170670699|NCT00827502|616806640|FG000|Overall Study|randomized but not treated|11|||
170670700|NCT00827502|616806640|FG000|Overall Study|Adverse Event|1|||
170670701|NCT00827502|616806640|FG000|Overall Study|Lost to Follow-up|4|||
170670702|NCT00827502|616806640|FG000|Overall Study|Withdrawal by Subject|5|||
170670703|NCT05096221|616806641|FG000|Part 2|Physician Decision|0|||
170670704|NCT05096221|616806642|FG001|Part 2|Physician Decision|1|||
170670705|NCT04678661|616806646|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
170670706|NCT04678661|616806647|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
170670707|NCT04678661|616806646|FG000|Overall Study|Protocol Violation|2|||
170670708|NCT04678661|616806647|FG001|Overall Study|Protocol Violation|0|||
170670709|NCT04678661|616806646|FG000|Overall Study|Withdrawal by Subject|1|||
170670710|NCT04678661|616806647|FG001|Overall Study|Withdrawal by Subject|0|||
170670711|NCT04678661|616806646|FG000|Overall Study|Lost to Follow-up|2|||
170670712|NCT04678661|616806647|FG001|Overall Study|Lost to Follow-up|0|||
170670713|NCT04678661|616806646|FG000|Overall Study|Death|2|||
170670714|NCT04678661|616806647|FG001|Overall Study|Death|0|||
170670715|NCT01086033|616806648|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
170670716|NCT01086033|616806648|FG000|Overall Study|Lost to Follow-up|86|||
170670717|NCT01086033|616806648|FG000|Overall Study|Adverse Event|42|||
170670718|NCT01086033|616806648|FG000|Overall Study|Withdrawal by Subject|41|||
170670719|NCT01086033|616806648|FG000|Overall Study|Other|14|||
170670720|NCT01086033|616806648|FG000|Overall Study|Other|13|||
170670721|NCT01086033|616806648|FG000|Overall Study|AE and Withdrew Consent|5|||
170670722|NCT01086033|616806648|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
170670723|NCT01086033|616806648|FG000|Overall Study|Withdrew consent and Other Reason|4|||
170670724|NCT01086033|616806648|FG000|Overall Study|AE and Lack of Efficacy|4|||
170670725|NCT01086033|616806648|FG000|Overall Study|Death|1|||
170670726|NCT01086033|616806648|FG000|Overall Study|AE and Lost to Follow-up|1|||
170670727|NCT01086033|616806648|FG000|Overall Study|AE and Other Reason|1|||
170625483|NCT03453164|616640860|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
170625484|NCT03007966|616640863|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
170625485|NCT03007966|616640864|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
170625486|NCT00474487|616640868|FG000|Overall Study|Withdrawal by Subject|6|||
170625487|NCT00474487|616640869|FG001|Overall Study|Withdrawal by Subject|0|||
170625488|NCT00474487|616640870|FG002|Overall Study|Withdrawal by Subject|0|||
170625489|NCT00474487|616640871|FG003|Overall Study|Withdrawal by Subject|0|||
170625490|NCT00474487|616640868|FG000|Overall Study|Lost to Follow-up|20|||
170625491|NCT00474487|616640869|FG001|Overall Study|Lost to Follow-up|1|||
170625492|NCT00474487|616640870|FG002|Overall Study|Lost to Follow-up|7|||
170625493|NCT00474487|616640871|FG003|Overall Study|Lost to Follow-up|0|||
170625494|NCT00474487|616640868|FG000|Overall Study|Inappropriate enrollment|4|||
170670728|NCT01086033|616806648|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
170625495|NCT00474487|616640869|FG001|Overall Study|Inappropriate enrollment|0|||
170670729|NCT02193867|616806650|FG000|Overall Study|Death|2|||
170670730|NCT02193867|616806650|FG000|Overall Study|Sponsor Study Termination|2|||
170670731|NCT04613375|616806651|FG000|Overall Study|Death|198|||
170670732|NCT04613375|616806651|FG000|Overall Study|Withdrawal by Subject|3|||
170670733|NCT01081678|616806652|FG000|Overall Study|Ineligibility Determined|0|||
170670734|NCT01081678|616806653|FG001|Overall Study|Ineligibility Determined|0|||
170625496|NCT00474487|616640870|FG002|Overall Study|Inappropriate enrollment|7|||
170625497|NCT00474487|616640871|FG003|Overall Study|Inappropriate enrollment|0|||
170625498|NCT00474487|616640868|FG000|Overall Study|Death|0|||
170670735|NCT01081678|616806654|FG002|Overall Study|Ineligibility Determined|1|||
170670736|NCT01081678|616806655|FG003|Overall Study|Ineligibility Determined|1|||
170625499|NCT00474487|616640869|FG001|Overall Study|Death|1|||
170625500|NCT00474487|616640870|FG002|Overall Study|Death|0|||
170670737|NCT01081678|616806652|FG000|Overall Study|Noncompliance|3|||
170670738|NCT01081678|616806653|FG001|Overall Study|Noncompliance|4|||
170670739|NCT01081678|616806654|FG002|Overall Study|Noncompliance|5|||
170670740|NCT01081678|616806655|FG003|Overall Study|Noncompliance|2|||
170670741|NCT01081678|616806652|FG000|Overall Study|Adverse Event|2|||
170670742|NCT01081678|616806653|FG001|Overall Study|Adverse Event|1|||
170670743|NCT01081678|616806654|FG002|Overall Study|Adverse Event|2|||
170670744|NCT01081678|616806655|FG003|Overall Study|Adverse Event|2|||
170670745|NCT01081678|616806652|FG000|Overall Study|Withdrawal by Subject|15|||
170670746|NCT01081678|616806653|FG001|Overall Study|Withdrawal by Subject|7|||
170670747|NCT01081678|616806654|FG002|Overall Study|Withdrawal by Subject|17|||
170670748|NCT01081678|616806655|FG003|Overall Study|Withdrawal by Subject|14|||
170670749|NCT01081678|616806652|FG000|Overall Study|Administrative Decision|1|||
170670750|NCT01081678|616806653|FG001|Overall Study|Administrative Decision|0|||
170670751|NCT01081678|616806654|FG002|Overall Study|Administrative Decision|0|||
170670752|NCT01081678|616806655|FG003|Overall Study|Administrative Decision|1|||
170670753|NCT01081678|616806652|FG000|Overall Study|Lost to Follow-up|4|||
170670754|NCT01081678|616806653|FG001|Overall Study|Lost to Follow-up|1|||
170670755|NCT01081678|616806654|FG002|Overall Study|Lost to Follow-up|4|||
170670756|NCT01081678|616806655|FG003|Overall Study|Lost to Follow-up|3|||
170670757|NCT01081678|616806652|FG000|Overall Study|Death|2|||
170670758|NCT01081678|616806653|FG001|Overall Study|Death|2|||
170670759|NCT01081678|616806654|FG002|Overall Study|Death|2|||
170670760|NCT01081678|616806655|FG003|Overall Study|Death|6|||
170670761|NCT01081678|616806652|FG000|Overall Study|Other|0|||
170670762|NCT01081678|616806653|FG001|Overall Study|Other|1|||
170670763|NCT01081678|616806654|FG002|Overall Study|Other|0|||
170670764|NCT01081678|616806655|FG003|Overall Study|Other|0|||
170670765|NCT01619423|616806656|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
170670766|NCT01619423|616806657|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
170670767|NCT01619423|616806658|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
170670768|NCT01619423|616806659|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
170670769|NCT00413244|616806663|FG000|Overall Study|Withdrawal by Subject|10|||
170670770|NCT00413244|616806664|FG001|Overall Study|Withdrawal by Subject|1|||
170670771|NCT02264639|616806665|FG000|Overall Study|Death (after completing single-dose phase)|1|||
170670772|NCT02264639|616806666|FG001|Overall Study|Death (after completing single-dose phase)|0|||
170670773|NCT02264639|616806667|FG002|Overall Study|Death (after completing single-dose phase)|0|||
170670774|NCT02264639|616806668|FG003|Overall Study|Death (after completing single-dose phase)|0|||
170670775|NCT02264639|616806669|FG004|Overall Study|Death (after completing single-dose phase)|0|||
170670776|NCT02264639|616806665|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
170670777|NCT02264639|616806666|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
170670778|NCT02264639|616806667|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
170670779|NCT02264639|616806668|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
170670780|NCT02264639|616806669|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
170670781|NCT02264639|616806665|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
170670782|NCT02264639|616806666|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
170670783|NCT02264639|616806667|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
170670784|NCT02264639|616806668|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
170670785|NCT02264639|616806669|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
170670786|NCT02264639|616806665|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
170670787|NCT02264639|616806666|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
170670788|NCT02264639|616806667|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
170670789|NCT02264639|616806668|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
170670790|NCT02264639|616806669|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
170670791|NCT02319837|616806674|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
170670792|NCT02319837|616806675|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
170670793|NCT02319837|616806676|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
170670794|NCT02319837|616806674|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
170670795|NCT02319837|616806675|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
170670796|NCT02319837|616806676|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
170670797|NCT02319837|616806674|FG000|Study Treatment Phase|Adverse Event|73|||
170670798|NCT02319837|616806675|FG001|Study Treatment Phase|Adverse Event|36|||
170670799|NCT02319837|616806676|FG002|Study Treatment Phase|Adverse Event|63|||
170670800|NCT02319837|616806674|FG000|Study Treatment Phase|Development of castration resistance|0|||
170670801|NCT02319837|616806675|FG001|Study Treatment Phase|Development of castration resistance|2|||
170670802|NCT02319837|616806676|FG002|Study Treatment Phase|Development of castration resistance|0|||
170670803|NCT02319837|616806674|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
170670804|NCT02319837|616806675|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
170670805|NCT02319837|616806676|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
170670806|NCT02319837|616806674|FG000|Study Treatment Phase|Protocol Violation|2|||
170670807|NCT02319837|616806675|FG001|Study Treatment Phase|Protocol Violation|2|||
170670808|NCT02319837|616806676|FG002|Study Treatment Phase|Protocol Violation|1|||
170670809|NCT02319837|616806674|FG000|Study Treatment Phase|Lost to Follow-up|0|||
170670810|NCT02319837|616806675|FG001|Study Treatment Phase|Lost to Follow-up|1|||
170670811|NCT02319837|616806676|FG002|Study Treatment Phase|Lost to Follow-up|0|||
170670812|NCT02319837|616806674|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
170670813|NCT02319837|616806675|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
170670814|NCT02319837|616806676|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
170670815|NCT02319837|616806674|FG000|Study Treatment Phase|Other|0|||
170670816|NCT02319837|616806675|FG001|Study Treatment Phase|Other|1|||
170670817|NCT02319837|616806676|FG002|Study Treatment Phase|Other|0|||
170670818|NCT02319837|616806674|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
170670819|NCT02319837|616806675|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
170670820|NCT02319837|616806676|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
170670821|NCT02319837|616806674|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
170670822|NCT02319837|616806675|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
170670823|NCT02319837|616806676|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
170670824|NCT02319837|616806674|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
170670825|NCT02319837|616806675|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
170670826|NCT02319837|616806676|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
170670827|NCT02319837|616806674|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
170670828|NCT02319837|616806675|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
170670829|NCT02319837|616806676|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
170670830|NCT02319837|616806674|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
170670831|NCT02319837|616806675|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
170670832|NCT02319837|616806676|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
170670833|NCT02319837|616806674|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
170625501|NCT00474487|616640871|FG003|Overall Study|Death|0|||
170625502|NCT03829228|616640872|FG000|Overall Study|Protocol Violation|1|||
170625503|NCT01428258|616640873|FG000|Intervention 1|Withdrawal by Subject|2|||
170625504|NCT01428258|616640874|FG001|Intervention 1|Withdrawal by Subject|0|||
170625505|NCT00419393|616640875|FG000|Overall Study|Adverse Event|5|||
170625506|NCT00419393|616640875|FG000|Overall Study|Protocol Violation|5|||
170625507|NCT00419393|616640875|FG000|Overall Study|Withdrawal by Subject|7|||
170625508|NCT00419393|616640875|FG000|Overall Study|Other: Sponsor request|3|||
170625509|NCT00419393|616640875|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
170625510|NCT00419393|616640875|FG000|Overall Study|Other: Site closure|1|||
170625511|NCT00419393|616640875|FG000|Overall Study|Other: Other health problems|1|||
170625512|NCT00419393|616640875|FG000|Overall Study|Other: Investigator decision|1|||
170625513|NCT03284710|616640879|FG000|Overall Study|Withdrawal by Subject|1|||
170625514|NCT03284710|616640880|FG001|Overall Study|Withdrawal by Subject|0|||
170625515|NCT03284710|616640881|FG002|Overall Study|Withdrawal by Subject|1|||
170625516|NCT03284710|616640882|FG003|Overall Study|Withdrawal by Subject|6|||
170625517|NCT03284710|616640879|FG000|Overall Study|Lost to Follow-up|3|||
170625518|NCT03284710|616640880|FG001|Overall Study|Lost to Follow-up|3|||
170625519|NCT03284710|616640881|FG002|Overall Study|Lost to Follow-up|1|||
170625520|NCT03284710|616640882|FG003|Overall Study|Lost to Follow-up|0|||
170625521|NCT03284710|616640879|FG000|Overall Study|Physician Decision|1|||
170625522|NCT03284710|616640880|FG001|Overall Study|Physician Decision|0|||
170625523|NCT03284710|616640881|FG002|Overall Study|Physician Decision|0|||
170625524|NCT03284710|616640882|FG003|Overall Study|Physician Decision|0|||
170625525|NCT03284710|616640879|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
170625526|NCT03284710|616640880|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
170625527|NCT03284710|616640881|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
170625528|NCT03284710|616640882|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
170625529|NCT03284710|616640879|FG000|Overall Study|HIV Infection|0|||
170625530|NCT03284710|616640880|FG001|Overall Study|HIV Infection|2|||
170625531|NCT03284710|616640881|FG002|Overall Study|HIV Infection|2|||
170625532|NCT03284710|616640882|FG003|Overall Study|HIV Infection|1|||
170625533|NCT01074502|616640883|FG000|Overall Study|Withdrawal by Subject|1|||
170625534|NCT05176314|616640888|FG000|Overall Study|Lost to Follow-up|2|||
170625535|NCT05176314|616640888|FG000|Overall Study|Physician Decision|1|||
170625536|NCT05176314|616640888|FG000|Overall Study|Adverse Event|1|||
170625537|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
170625538|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
170625539|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
170625540|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Death|9|||
170625541|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Death|0|||
170625542|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Death|0|||
170625543|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
170625544|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
170625545|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
170625546|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
170625547|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
170625548|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
170670834|NCT02319837|616806675|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
170670835|NCT02319837|616806676|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
170625549|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Other|135|||
170625550|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Other|0|||
170625551|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Other|0|||
170625552|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
170625553|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
170625554|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
170670836|NCT02319837|616806674|FG000|Long-Term Follow-Up Phase|Death|33|||
170670837|NCT02319837|616806675|FG001|Long-Term Follow-Up Phase|Death|54|||
170670838|NCT02319837|616806676|FG002|Long-Term Follow-Up Phase|Death|42|||
170670839|NCT02435147|616806677|FG000|Overall Study|non-evaluable DXA scan|11|||
170670840|NCT03082261|616806680|FG000|Overall Study|Death|4|||
170670841|NCT03082261|616806680|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
170670842|NCT03082261|616806680|FG000|Overall Study|Insurance denial|1|||
170670843|NCT03082261|616806680|FG000|Overall Study|Peripheral lead added|1|||
170670844|NCT03082261|616806680|FG000|Overall Study|Withdrawal by Subject|40|||
170670845|NCT03082261|616806680|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
170670846|NCT03082261|616806680|FG000|Overall Study|Subject implanted with device other than study device|1|||
170670847|NCT03082261|616806680|FG000|Overall Study|Lost to Follow-up|14|||
170670848|NCT03082261|616806680|FG000|Overall Study|Subject moved to a different state|1|||
170670849|NCT03082261|616806680|FG000|Overall Study|Subject non-compliance|2|||
170670850|NCT03082261|616806680|FG000|Overall Study|Subject participation terminated by investigator|9|||
170670851|NCT03082261|616806680|FG000|Overall Study|Subject participation terminated by sponsor|4|||
170670852|NCT03082261|616806680|FG000|Overall Study|System explant|19|||
170670853|NCT03082261|616806680|FG000|Overall Study|Unable to place lead(s)|2|||
170670854|NCT03082261|616806680|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
170670855|NCT00839852|616806681|FG000|Overall Study|Adverse Event|10|||
170670856|NCT00839852|616806681|FG000|Overall Study|Insufficient Therapeutic Response|3|||
170670857|NCT00839852|616806681|FG000|Overall Study|Protocol Violation|9|||
170670858|NCT00839852|616806681|FG000|Overall Study|Withdrawal of Consent|16|||
170670859|NCT00839852|616806681|FG000|Overall Study|Lost to Follow-up|7|||
170670860|NCT00839852|616806681|FG000|Overall Study|Lack of Compliance While in Jail|1|||
170670861|NCT00839852|616806681|FG000|Overall Study|Pregnancy|1|||
170670862|NCT01313312|616806683|FG000|Overall Study|Adverse Event|5|||
170670863|NCT01313312|616806683|FG000|Overall Study|Withdrawal by Subject|18|||
170670864|NCT01313312|616806683|FG000|Overall Study|Lack of Efficacy|3|||
170670865|NCT01313312|616806683|FG000|Overall Study|Investigator Decision|1|||
170670866|NCT01313312|616806683|FG000|Overall Study|Observational Phase|1|||
170670867|NCT01313312|616806683|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
170670868|NCT01313312|616806683|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
170670869|NCT01206166|616806691|FG000|Overall Study|No evaluable data|2|||
170670870|NCT01206166|616806692|FG001|Overall Study|No evaluable data|3|||
170670871|NCT02716805|616806693|FG000|Overall Study|Progressive disease|2|||
170625555|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
170625556|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
170625557|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
170625558|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
170625559|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
170625560|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
170625561|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Other|3|||
170625562|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Other|0|||
170625563|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Other|0|||
170625564|NCT02118584|616640889|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
170625565|NCT02118584|616640890|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
170625566|NCT02118584|616640891|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
170625567|NCT02118584|616640889|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
170819807|NCT00296504|617347683|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
170819808|NCT00296504|617347675|FG000|Interim Analysis|Non-adherence|2|||
170819809|NCT00296504|617347676|FG001|Interim Analysis|Non-adherence|0|||
170819810|NCT00296504|617347677|FG002|Interim Analysis|Non-adherence|0|||
170819811|NCT00296504|617347678|FG003|Interim Analysis|Non-adherence|0|||
170819812|NCT00296504|617347679|FG004|Interim Analysis|Non-adherence|1|||
170819813|NCT00296504|617347680|FG005|Interim Analysis|Non-adherence|0|||
170819814|NCT00296504|617347681|FG006|Interim Analysis|Non-adherence|0|||
170819815|NCT00296504|617347682|FG007|Interim Analysis|Non-adherence|1|||
170819816|NCT00296504|617347683|FG008|Interim Analysis|Non-adherence|0|||
170819817|NCT00296504|617347675|FG000|Interim Analysis|Site Closing|1|||
170819818|NCT00296504|617347676|FG001|Interim Analysis|Site Closing|0|||
170819819|NCT00296504|617347677|FG002|Interim Analysis|Site Closing|0|||
170819820|NCT00296504|617347678|FG003|Interim Analysis|Site Closing|0|||
170819821|NCT00296504|617347679|FG004|Interim Analysis|Site Closing|0|||
170819822|NCT00296504|617347680|FG005|Interim Analysis|Site Closing|1|||
170819823|NCT00296504|617347681|FG006|Interim Analysis|Site Closing|2|||
170819824|NCT00296504|617347682|FG007|Interim Analysis|Site Closing|0|||
170819825|NCT00296504|617347683|FG008|Interim Analysis|Site Closing|0|||
170819826|NCT00296504|617347675|FG000|Interim Analysis|Lack of Personnel at Site|1|||
170819827|NCT00296504|617347676|FG001|Interim Analysis|Lack of Personnel at Site|0|||
170819828|NCT00296504|617347677|FG002|Interim Analysis|Lack of Personnel at Site|0|||
170819829|NCT00296504|617347678|FG003|Interim Analysis|Lack of Personnel at Site|0|||
170819830|NCT00296504|617347679|FG004|Interim Analysis|Lack of Personnel at Site|0|||
170819831|NCT00296504|617347680|FG005|Interim Analysis|Lack of Personnel at Site|0|||
170819832|NCT00296504|617347681|FG006|Interim Analysis|Lack of Personnel at Site|0|||
170819833|NCT00296504|617347682|FG007|Interim Analysis|Lack of Personnel at Site|0|||
170819834|NCT00296504|617347683|FG008|Interim Analysis|Lack of Personnel at Site|0|||
170819835|NCT00296504|617347675|FG000|Interim Analysis|Missed Schedule Date|1|||
170819836|NCT00296504|617347676|FG001|Interim Analysis|Missed Schedule Date|0|||
170819837|NCT00296504|617347677|FG002|Interim Analysis|Missed Schedule Date|0|||
170819838|NCT00296504|617347678|FG003|Interim Analysis|Missed Schedule Date|0|||
170819839|NCT00296504|617347679|FG004|Interim Analysis|Missed Schedule Date|0|||
170819840|NCT00296504|617347680|FG005|Interim Analysis|Missed Schedule Date|0|||
170819841|NCT00296504|617347681|FG006|Interim Analysis|Missed Schedule Date|0|||
170819842|NCT00296504|617347682|FG007|Interim Analysis|Missed Schedule Date|0|||
170819843|NCT00296504|617347683|FG008|Interim Analysis|Missed Schedule Date|0|||
170819844|NCT00296504|617347675|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
170819845|NCT00296504|617347676|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
170819846|NCT00296504|617347677|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
170819847|NCT00296504|617347678|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
170819848|NCT00296504|617347679|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
170819849|NCT00296504|617347680|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
170819850|NCT00296504|617347681|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
170819851|NCT00296504|617347682|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
170819852|NCT00296504|617347683|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
170819853|NCT00296504|617347675|FG000|Interim Analysis|Participant Stopped|0|||
170819854|NCT00296504|617347676|FG001|Interim Analysis|Participant Stopped|0|||
170819855|NCT00296504|617347677|FG002|Interim Analysis|Participant Stopped|0|||
170819856|NCT00296504|617347678|FG003|Interim Analysis|Participant Stopped|0|||
170819857|NCT00296504|617347679|FG004|Interim Analysis|Participant Stopped|1|||
170819858|NCT00296504|617347680|FG005|Interim Analysis|Participant Stopped|0|||
170819859|NCT00296504|617347681|FG006|Interim Analysis|Participant Stopped|0|||
170819860|NCT00296504|617347682|FG007|Interim Analysis|Participant Stopped|0|||
170819861|NCT00296504|617347683|FG008|Interim Analysis|Participant Stopped|0|||
170819862|NCT00296504|617347675|FG000|Interim Analysis|Physician and Participant Decision|0|||
170819863|NCT00296504|617347676|FG001|Interim Analysis|Physician and Participant Decision|0|||
170819864|NCT00296504|617347677|FG002|Interim Analysis|Physician and Participant Decision|0|||
170819865|NCT00296504|617347678|FG003|Interim Analysis|Physician and Participant Decision|0|||
170819866|NCT00296504|617347679|FG004|Interim Analysis|Physician and Participant Decision|0|||
170670872|NCT02716805|616806694|FG001|Overall Study|Progressive disease|0|||
170670873|NCT02716805|616806695|FG002|Overall Study|Progressive disease|0|||
170670874|NCT02716805|616806696|FG003|Overall Study|Progressive disease|0|||
170670875|NCT00066365|616806697|FG000|Overall Study|Adverse Event|1|||
170670876|NCT00066365|616806698|FG001|Overall Study|Adverse Event|0|||
170670877|NCT00066365|616806697|FG000|Overall Study|Lack of Efficacy|15|||
170670878|NCT00066365|616806698|FG001|Overall Study|Lack of Efficacy|12|||
170670879|NCT00066365|616806697|FG000|Overall Study|Physician Decision|1|||
170670880|NCT00066365|616806698|FG001|Overall Study|Physician Decision|0|||
170670881|NCT00066365|616806697|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
170670882|NCT00066365|616806698|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
170670883|NCT00066365|616806697|FG000|Overall Study|Ineligible|4|||
170670884|NCT00066365|616806698|FG001|Overall Study|Ineligible|2|||
170670885|NCT03576495|616806702|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
170670886|NCT03576495|616806703|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
170670887|NCT01443078|616806704|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
170670888|NCT01443078|616806704|FG000|Overall Study|Withdrawal by Subject|1|||
170670889|NCT01443078|616806704|FG000|Overall Study|Patient had brain mets|1|||
170670890|NCT00415168|616806705|FG000|Overall Study|Death|26|||
170670891|NCT00415168|616806705|FG000|Overall Study|Lost to Follow-up|3|||
170670892|NCT00415168|616806705|FG000|Overall Study|Physician Decision|13|||
170670893|NCT00415168|616806705|FG000|Overall Study|Sponsor Decision|4|||
170670894|NCT00415168|616806705|FG000|Overall Study|Withdrawal by Subject|6|||
170670895|NCT03822182|616806706|FG000|Overall Study|Protocol Violation|0|||
170670896|NCT03822182|616806707|FG001|Overall Study|Protocol Violation|1|||
170670897|NCT03822182|616806708|FG002|Overall Study|Protocol Violation|1|||
170670898|NCT02628938|616806712|FG000|Overall Study|Did not attend the follow up recall|2|||
170670899|NCT02628938|616806713|FG001|Overall Study|Did not attend the follow up recall|2|||
170670900|NCT02628938|616806714|FG002|Overall Study|Did not attend the follow up recall|1|||
170670901|NCT02628938|616806712|FG000|Overall Study|Failure to comply with the instructions|3|||
170670902|NCT02628938|616806713|FG001|Overall Study|Failure to comply with the instructions|0|||
170670903|NCT02628938|616806714|FG002|Overall Study|Failure to comply with the instructions|3|||
170670904|NCT00722800|616806715|FG000|Overall Study|Withdrawal by Subject|1|||
170670905|NCT00722800|616806716|FG001|Overall Study|Withdrawal by Subject|0|||
170670906|NCT00722800|616806715|FG000|Overall Study|Physician Decision|1|||
170670907|NCT00722800|616806716|FG001|Overall Study|Physician Decision|0|||
170670908|NCT02130297|616806717|FG000|Overall Study|Lost to Follow-up|4|||
170670909|NCT02229383|616806722|FG000|Overall Study|Adverse Event|7|||
170670910|NCT02229383|616806723|FG001|Overall Study|Adverse Event|4|||
170670911|NCT02229383|616806722|FG000|Overall Study|Death|0|||
170670912|NCT02229383|616806723|FG001|Overall Study|Death|1|||
170670913|NCT02229383|616806722|FG000|Overall Study|Lost to Follow-up|5|||
170670914|NCT02229383|616806723|FG001|Overall Study|Lost to Follow-up|3|||
170670915|NCT02229383|616806722|FG000|Overall Study|Withdrawal by Subject|4|||
170670916|NCT02229383|616806723|FG001|Overall Study|Withdrawal by Subject|6|||
170670917|NCT02229383|616806722|FG000|Overall Study|Did not receive treatment|1|||
170670918|NCT02229383|616806723|FG001|Overall Study|Did not receive treatment|0|||
170670919|NCT02229383|616806722|FG000|Overall Study|Other|3|||
170670920|NCT02229383|616806723|FG001|Overall Study|Other|8|||
170670921|NCT00939770|616806729|FG000|Overall Study|Adverse Event|1|||
170670922|NCT00939770|616806730|FG001|Overall Study|Adverse Event|1|||
170670923|NCT00939770|616806731|FG002|Overall Study|Adverse Event|0|||
170670924|NCT00939770|616806732|FG003|Overall Study|Adverse Event|0|||
170670925|NCT00939770|616806733|FG004|Overall Study|Adverse Event|6|||
170670926|NCT00939770|616806734|FG005|Overall Study|Adverse Event|2|||
170670927|NCT00939770|616806735|FG006|Overall Study|Adverse Event|1|||
170670928|NCT00939770|616806736|FG007|Overall Study|Adverse Event|1|||
170670929|NCT00939770|616806729|FG000|Overall Study|Lack of Efficacy|4|||
170670930|NCT00939770|616806730|FG001|Overall Study|Lack of Efficacy|6|||
170670931|NCT00939770|616806731|FG002|Overall Study|Lack of Efficacy|13|||
170670932|NCT00939770|616806732|FG003|Overall Study|Lack of Efficacy|9|||
170670933|NCT00939770|616806733|FG004|Overall Study|Lack of Efficacy|16|||
170670934|NCT00939770|616806734|FG005|Overall Study|Lack of Efficacy|8|||
170670935|NCT00939770|616806735|FG006|Overall Study|Lack of Efficacy|11|||
170670936|NCT00939770|616806736|FG007|Overall Study|Lack of Efficacy|1|||
170670937|NCT00939770|616806729|FG000|Overall Study|Lost to Follow-up|0|||
170670938|NCT00939770|616806730|FG001|Overall Study|Lost to Follow-up|0|||
170670939|NCT00939770|616806731|FG002|Overall Study|Lost to Follow-up|0|||
170670940|NCT00939770|616806732|FG003|Overall Study|Lost to Follow-up|0|||
170670941|NCT00939770|616806733|FG004|Overall Study|Lost to Follow-up|1|||
170670942|NCT00939770|616806734|FG005|Overall Study|Lost to Follow-up|0|||
170670943|NCT00939770|616806735|FG006|Overall Study|Lost to Follow-up|0|||
170670944|NCT00939770|616806736|FG007|Overall Study|Lost to Follow-up|0|||
170670945|NCT00939770|616806729|FG000|Overall Study|Physician Decision|0|||
170670946|NCT00939770|616806730|FG001|Overall Study|Physician Decision|0|||
170670947|NCT00939770|616806731|FG002|Overall Study|Physician Decision|2|||
170670948|NCT00939770|616806732|FG003|Overall Study|Physician Decision|0|||
170670949|NCT00939770|616806733|FG004|Overall Study|Physician Decision|7|||
170670950|NCT00939770|616806734|FG005|Overall Study|Physician Decision|1|||
170670951|NCT00939770|616806735|FG006|Overall Study|Physician Decision|0|||
170670952|NCT00939770|616806736|FG007|Overall Study|Physician Decision|6|||
170670953|NCT00939770|616806729|FG000|Overall Study|Protocol Violation|0|||
170670954|NCT00939770|616806730|FG001|Overall Study|Protocol Violation|0|||
170670955|NCT00939770|616806731|FG002|Overall Study|Protocol Violation|0|||
170670956|NCT00939770|616806732|FG003|Overall Study|Protocol Violation|0|||
170670957|NCT00939770|616806733|FG004|Overall Study|Protocol Violation|1|||
170670958|NCT00939770|616806734|FG005|Overall Study|Protocol Violation|0|||
170670959|NCT00939770|616806735|FG006|Overall Study|Protocol Violation|0|||
170670960|NCT00939770|616806736|FG007|Overall Study|Protocol Violation|0|||
170670961|NCT00939770|616806729|FG000|Overall Study|Withdrawal by Subject|0|||
170670962|NCT00939770|616806730|FG001|Overall Study|Withdrawal by Subject|1|||
170670963|NCT00939770|616806731|FG002|Overall Study|Withdrawal by Subject|5|||
170670964|NCT00939770|616806732|FG003|Overall Study|Withdrawal by Subject|2|||
170670965|NCT00939770|616806733|FG004|Overall Study|Withdrawal by Subject|6|||
170670966|NCT00939770|616806734|FG005|Overall Study|Withdrawal by Subject|0|||
170670967|NCT00939770|616806735|FG006|Overall Study|Withdrawal by Subject|2|||
170670968|NCT00939770|616806736|FG007|Overall Study|Withdrawal by Subject|2|||
170670969|NCT00672646|616806737|FG000|Overall Study|Lost to Follow-up|0|||
170670970|NCT00672646|616806738|FG001|Overall Study|Lost to Follow-up|1|||
170670971|NCT00672646|616806739|FG002|Overall Study|Lost to Follow-up|2|||
170670972|NCT00672646|616806737|FG000|Overall Study|Withdrawal by Subject|0|||
170670973|NCT00672646|616806738|FG001|Overall Study|Withdrawal by Subject|0|||
170670974|NCT00672646|616806739|FG002|Overall Study|Withdrawal by Subject|1|||
170670975|NCT05136690|616806740|FG000|Period 1|Withdrawal by Subject|0|||
170670976|NCT05136690|616806741|FG001|Period 1|Withdrawal by Subject|1|||
170670977|NCT05136690|616806740|FG000|Period 2|Lost to Follow-up|0|||
170670978|NCT05136690|616806741|FG001|Period 2|Lost to Follow-up|3|||
170670979|NCT05136690|616806740|FG000|Period 2|Withdrawal by Subject|0|||
170670980|NCT05136690|616806741|FG001|Period 2|Withdrawal by Subject|1|||
170670981|NCT02020577|616806742|FG000|Overall Study|Progressive disease|3|||
170670982|NCT02020577|616806743|FG001|Overall Study|Progressive disease|38|||
170670983|NCT02020577|616806742|FG000|Overall Study|Other AE or clinical progression|0|||
170670984|NCT02020577|616806743|FG001|Overall Study|Other AE or clinical progression|15|||
170670985|NCT02020577|616806742|FG000|Overall Study|Withdrawal by Subject|0|||
170670986|NCT02020577|616806743|FG001|Overall Study|Withdrawal by Subject|1|||
170670987|NCT02020577|616806742|FG000|Overall Study|Other than stated above|0|||
170670988|NCT02020577|616806743|FG001|Overall Study|Other than stated above|1|||
170670989|NCT00739674|616808276|FG000|Overall Study|Screening failures|19|||
170670990|NCT00739674|616808277|FG001|Overall Study|Screening failures|17|||
170670991|NCT00739674|616808276|FG000|Overall Study|Site 212 removal|19|||
170670992|NCT00739674|616808277|FG001|Overall Study|Site 212 removal|13|||
170625568|NCT02118584|616640890|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
170625569|NCT02118584|616640891|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
170625570|NCT02118584|616640889|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
170625571|NCT02118584|616640890|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
170625572|NCT02118584|616640891|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
170625573|NCT02118584|616640889|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
170625574|NCT02118584|616640890|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
170625575|NCT02118584|616640891|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
170625576|NCT02118584|616640889|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
170625577|NCT02118584|616640890|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
170670993|NCT00739674|616808276|FG000|Overall Study|No follow-up data|33|||
170670994|NCT00739674|616808277|FG001|Overall Study|No follow-up data|18|||
170670995|NCT00739674|616808276|FG000|Overall Study|Dietician consultation >30 days|1|||
170670996|NCT00739674|616808277|FG001|Overall Study|Dietician consultation >30 days|9|||
170670997|NCT00739674|616808276|FG000|Overall Study|Adverse Event|22|||
170670998|NCT00739674|616808277|FG001|Overall Study|Adverse Event|13|||
170670999|NCT00739674|616808276|FG000|Overall Study|Death|1|||
170671000|NCT00739674|616808277|FG001|Overall Study|Death|0|||
170671001|NCT00739674|616808276|FG000|Overall Study|Lack of Efficacy|1|||
170671002|NCT00739674|616808277|FG001|Overall Study|Lack of Efficacy|0|||
170671003|NCT00739674|616808276|FG000|Overall Study|Lost to Follow-up|52|||
170671004|NCT00739674|616808277|FG001|Overall Study|Lost to Follow-up|30|||
170671005|NCT00739674|616808276|FG000|Overall Study|Protocol Violation|5|||
170671006|NCT00739674|616808277|FG001|Overall Study|Protocol Violation|5|||
170671007|NCT00739674|616808276|FG000|Overall Study|Withdrawal by Subject|9|||
170671008|NCT00739674|616808277|FG001|Overall Study|Withdrawal by Subject|9|||
170671009|NCT00739674|616808276|FG000|Overall Study|Reason missing|2|||
170671010|NCT00739674|616808277|FG001|Overall Study|Reason missing|0|||
170671011|NCT00739674|616808276|FG000|Overall Study|Clinic closed|6|||
170671012|NCT00739674|616808277|FG001|Overall Study|Clinic closed|4|||
170671013|NCT00739674|616808276|FG000|Overall Study|Patient moved|3|||
170671014|NCT00739674|616808277|FG001|Overall Study|Patient moved|2|||
170671015|NCT00739674|616808276|FG000|Overall Study|Non compliant|4|||
170671016|NCT00739674|616808277|FG001|Overall Study|Non compliant|0|||
170671017|NCT00739674|616808276|FG000|Overall Study|Unable to attend visit|3|||
170671018|NCT00739674|616808277|FG001|Overall Study|Unable to attend visit|1|||
170671019|NCT00739674|616808276|FG000|Overall Study|Home monitoring off meds|1|||
170671020|NCT00739674|616808277|FG001|Overall Study|Home monitoring off meds|0|||
170671021|NCT00739674|616808276|FG000|Overall Study|Erectile dysfunction|0|||
170671022|NCT00739674|616808277|FG001|Overall Study|Erectile dysfunction|1|||
170671023|NCT01594281|616808278|FG000|Interventional Core Phase|Protocol Deviation|1|||
170671024|NCT01594281|616808279|FG001|Interventional Core Phase|Protocol Deviation|0|||
170671025|NCT01594281|616808280|FG002|Interventional Core Phase|Protocol Deviation|0|||
170671026|NCT01594281|616808278|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
170671027|NCT01594281|616808279|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
170671028|NCT01594281|616808280|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
170671029|NCT01594281|616808278|FG000|Interventional Core Phase|Death|1|||
170671030|NCT01594281|616808279|FG001|Interventional Core Phase|Death|1|||
170671031|NCT01594281|616808280|FG002|Interventional Core Phase|Death|2|||
170671032|NCT01594281|616808278|FG000|Interventional Core Phase|Lost to Follow-up|1|||
170671033|NCT01594281|616808279|FG001|Interventional Core Phase|Lost to Follow-up|4|||
170671034|NCT01594281|616808280|FG002|Interventional Core Phase|Lost to Follow-up|1|||
170671035|NCT01594281|616808278|FG000|Interventional Core Phase|Adverse Event|4|||
170671036|NCT01594281|616808279|FG001|Interventional Core Phase|Adverse Event|4|||
170671037|NCT01594281|616808280|FG002|Interventional Core Phase|Adverse Event|4|||
170671038|NCT01594281|616808278|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
170671039|NCT01594281|616808279|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
170671040|NCT01594281|616808280|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
170671041|NCT01594281|616808278|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
170671042|NCT01594281|616808279|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
170671043|NCT01594281|616808280|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
170671044|NCT01594281|616808278|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
170671045|NCT01594281|616808279|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
170671046|NCT01594281|616808280|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
170671047|NCT01020981|616808282|FG000|Overall Study|Did not return mailed survey|74|||
170671048|NCT01020981|616808283|FG001|Overall Study|Did not return mailed survey|58|||
170671049|NCT01020981|616808282|FG000|Overall Study|Survey returned undeliverable|8|||
170671050|NCT01020981|616808283|FG001|Overall Study|Survey returned undeliverable|32|||
170671051|NCT01020981|616808282|FG000|Overall Study|Participant declined to complete survey|2|||
170671052|NCT01020981|616808283|FG001|Overall Study|Participant declined to complete survey|0|||
170671053|NCT00926328|616808288|FG000|Overall Study|Lost to Follow-up|12|||
170671054|NCT00926328|616808289|FG001|Overall Study|Lost to Follow-up|14|||
170671055|NCT00289133|616808290|FG000|Overall Study|Non-study device implanted|12|||
170671056|NCT00289133|616808291|FG001|Overall Study|Non-study device implanted|0|||
170671057|NCT00289133|616808290|FG000|Overall Study|Protocol Violation|32|||
170671058|NCT00289133|616808291|FG001|Overall Study|Protocol Violation|38|||
170671059|NCT00289133|616808290|FG000|Overall Study|Withdrawal by Subject|9|||
170671060|NCT00289133|616808291|FG001|Overall Study|Withdrawal by Subject|10|||
170671061|NCT00289133|616808290|FG000|Overall Study|Death|5|||
170671062|NCT00289133|616808291|FG001|Overall Study|Death|10|||
170671063|NCT00289133|616808290|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
170671064|NCT00289133|616808291|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
170671065|NCT00289133|616808290|FG000|Overall Study|Physician Decision|41|||
170671066|NCT00289133|616808291|FG001|Overall Study|Physician Decision|45|||
170671067|NCT00289133|616808290|FG000|Overall Study|Revision|8|||
170671068|NCT00289133|616808291|FG001|Overall Study|Revision|6|||
170671069|NCT00289133|616808290|FG000|Overall Study|Lost to Follow-up|92|||
170671070|NCT00289133|616808291|FG001|Overall Study|Lost to Follow-up|115|||
170671071|NCT00726986|616808292|FG000|Induction Phase|Adverse Event|4|||
170671072|NCT00726986|616808292|FG000|Induction Phase|Withdrawal by Subject|2|||
170671073|NCT00726986|616808292|FG000|Induction Phase|Death|2|||
170671074|NCT00726986|616808292|FG000|Induction Phase|Lack of Efficacy|5|||
170671075|NCT00726986|616808292|FG000|Induction Phase|Secondary Disease|2|||
170671076|NCT00726986|616808292|FG000|Maintenance Phase|Adverse Event|1|||
170671077|NCT00726986|616808292|FG000|Maintenance Phase|Lack of Efficacy|2|||
170671078|NCT01819831|616808295|FG000|Overall Study|Withdrawal by Subject|1|||
170625578|NCT02118584|616640891|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
170625579|NCT02118584|616640889|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
170625580|NCT02118584|616640890|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
170625581|NCT02118584|616640891|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
170625582|NCT02118584|616640889|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
170625583|NCT02118584|616640890|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
170625584|NCT02118584|616640891|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
170625585|NCT02118584|616640889|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
170625586|NCT02118584|616640890|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
170625587|NCT02118584|616640891|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
170625588|NCT02118584|616640889|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
170625589|NCT02118584|616640890|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
170625590|NCT02118584|616640891|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
170625591|NCT01231984|616640892|FG000|Study Period 1|Withdrawal by Subject|0|||
170625592|NCT01231984|616640893|FG001|Study Period 1|Withdrawal by Subject|0|||
170625593|NCT01231984|616640894|FG002|Study Period 1|Withdrawal by Subject|0|||
170625594|NCT01231984|616640895|FG003|Study Period 1|Withdrawal by Subject|1|||
170625595|NCT01231984|616640892|FG000|Study Period 1|Lost to Follow-up|1|||
170625596|NCT01231984|616640893|FG001|Study Period 1|Lost to Follow-up|1|||
170625597|NCT01231984|616640894|FG002|Study Period 1|Lost to Follow-up|1|||
170625598|NCT01231984|616640895|FG003|Study Period 1|Lost to Follow-up|0|||
170625599|NCT01231984|616640892|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
170625600|NCT01231984|616640893|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
170625601|NCT01231984|616640894|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
170625602|NCT01231984|616640895|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
170625603|NCT01231984|616640892|FG000|Study Period 1|Screen Failure|0|||
170625604|NCT01231984|616640893|FG001|Study Period 1|Screen Failure|0|||
170625605|NCT01231984|616640894|FG002|Study Period 1|Screen Failure|0|||
170625606|NCT01231984|616640895|FG003|Study Period 1|Screen Failure|1|||
170625607|NCT01231984|616640892|FG000|Study Period 1|Non-compliance with study requirements|5|||
170625608|NCT01231984|616640893|FG001|Study Period 1|Non-compliance with study requirements|0|||
170625609|NCT01231984|616640894|FG002|Study Period 1|Non-compliance with study requirements|2|||
170625610|NCT01231984|616640895|FG003|Study Period 1|Non-compliance with study requirements|1|||
170625611|NCT01231984|616640892|FG000|Study Period 1|Protocol Violation|3|||
170625612|NCT01231984|616640893|FG001|Study Period 1|Protocol Violation|4|||
170625613|NCT01231984|616640894|FG002|Study Period 1|Protocol Violation|2|||
170625614|NCT01231984|616640895|FG003|Study Period 1|Protocol Violation|3|||
170625615|NCT01231984|616640892|FG000|Study Period 1|Adverse Event|1|||
170625616|NCT01231984|616640893|FG001|Study Period 1|Adverse Event|0|||
170625617|NCT01231984|616640894|FG002|Study Period 1|Adverse Event|0|||
170625618|NCT01231984|616640895|FG003|Study Period 1|Adverse Event|0|||
170625619|NCT01231984|616640892|FG000|Study Period 1|Other|0|||
170625620|NCT01231984|616640893|FG001|Study Period 1|Other|0|||
170625621|NCT01231984|616640894|FG002|Study Period 1|Other|0|||
170625622|NCT01231984|616640895|FG003|Study Period 1|Other|1|||
170625623|NCT01231984|616640892|FG000|Study Period 2|Withdrawal by Subject|1|||
170625624|NCT01231984|616640893|FG001|Study Period 2|Withdrawal by Subject|1|||
170625625|NCT01231984|616640894|FG002|Study Period 2|Withdrawal by Subject|0|||
170625626|NCT01231984|616640895|FG003|Study Period 2|Withdrawal by Subject|0|||
170625627|NCT01231984|616640892|FG000|Study Period 2|Lost to Follow-up|1|||
170625628|NCT01231984|616640893|FG001|Study Period 2|Lost to Follow-up|0|||
170625629|NCT01231984|616640894|FG002|Study Period 2|Lost to Follow-up|0|||
170625630|NCT01231984|616640895|FG003|Study Period 2|Lost to Follow-up|3|||
170625631|NCT01231984|616640892|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
170625632|NCT01231984|616640893|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
170625633|NCT01231984|616640894|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
170625634|NCT01231984|616640895|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
170625635|NCT03651765|616640905|FG000|Overall Study|Adverse Event|6|||
170625636|NCT03651765|616640905|FG000|Overall Study|Lack of Efficacy|18|||
170625637|NCT03651765|616640905|FG000|Overall Study|Lost to Follow-up|5|||
170625638|NCT03651765|616640905|FG000|Overall Study|Non-Compliance with Study Drug|4|||
170625639|NCT03651765|616640905|FG000|Overall Study|Physician Decision|6|||
170625640|NCT03651765|616640905|FG000|Overall Study|Pregnancy|1|||
170625641|NCT03651765|616640905|FG000|Overall Study|Discontinued by Sponsor|40|||
170625642|NCT03651765|616640905|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
170625643|NCT03651765|616640905|FG000|Overall Study|Withdrawal by Subject|24|||
170625644|NCT03651765|616640905|FG000|Overall Study|Miscellaneous|6|||
170625645|NCT04097678|616640906|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
170625646|NCT04097678|616640907|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
170625647|NCT04711850|616640908|FG000|Overall Study|Graft loss|2|||
170625648|NCT04711850|616640909|FG001|Overall Study|Graft loss|1|||
170625649|NCT04711850|616640908|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
170625650|NCT04711850|616640909|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
170625651|NCT04711850|616640908|FG000|Overall Study|Study terminated by sponsor|5|||
170625652|NCT04711850|616640909|FG001|Overall Study|Study terminated by sponsor|3|||
170625653|NCT04711850|616640908|FG000|Overall Study|Sponsor decision|0|||
170625654|NCT04711850|616640909|FG001|Overall Study|Sponsor decision|2|||
170625655|NCT04819945|616640910|FG000|Overall Study|Lost to Follow-up|1|||
170625656|NCT01126749|616640925|FG000|Phase 1b|Other|0|||
170625657|NCT01126749|616640926|FG001|Phase 1b|Other|1|||
170625658|NCT01126749|616640927|FG002|Phase 1b|Other|0|||
170625659|NCT01126749|616640928|FG003|Phase 1b|Other|0|||
170625660|NCT01126749|616640925|FG000|Phase 1b|Withdrawal by Subject|0|||
170625661|NCT01126749|616640926|FG001|Phase 1b|Withdrawal by Subject|1|||
170625662|NCT01126749|616640927|FG002|Phase 1b|Withdrawal by Subject|0|||
170625663|NCT01126749|616640928|FG003|Phase 1b|Withdrawal by Subject|0|||
170625664|NCT01126749|616640925|FG000|Phase 1b|Death|3|||
170625665|NCT01126749|616640926|FG001|Phase 1b|Death|4|||
170625666|NCT01126749|616640927|FG002|Phase 1b|Death|0|||
170625667|NCT01126749|616640928|FG003|Phase 1b|Death|0|||
170625668|NCT01126749|616640925|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
170625669|NCT01126749|616640926|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
170625670|NCT01126749|616640927|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
170625671|NCT01126749|616640928|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
170671079|NCT00064337|616808296|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
170671080|NCT00064337|616808296|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
170671081|NCT00064337|616808296|FG000|PBSCC or Induction/PBSCC|Progression|3|||
170671082|NCT00064337|616808296|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
170671083|NCT00064337|616808296|FG000|PBSCC or Induction/PBSCC|Death|2|||
170671084|NCT00064337|616808296|FG000|Transplant|Adverse Event|9|||
170671085|NCT00064337|616808296|FG000|Transplant|Not protocol-specified|5|||
170671086|NCT00064337|616808296|FG000|Transplant|Death|3|||
170671087|NCT00064337|616808296|FG000|Transplant|Patient Refusal|2|||
170671088|NCT00064337|616808296|FG000|Transplant|Progression|2|||
170671089|NCT00064337|616808296|FG000|Maintenance|Adverse Event|3|||
170671090|NCT00064337|616808296|FG000|Maintenance|Progression|2|||
170671091|NCT00064337|616808296|FG000|Maintenance|On treatment at time of analysis|2|||
170671092|NCT00064337|616808296|FG000|Maintenance|Not protocol-specified|2|||
170671093|NCT00064337|616808296|FG000|Maintenance|Death|1|||
170671094|NCT01153347|616808297|FG000|Overall Study|Withdrawal by Subject|7|||
170671095|NCT01153347|616808298|FG001|Overall Study|Withdrawal by Subject|7|||
170671096|NCT01153347|616808299|FG002|Overall Study|Withdrawal by Subject|7|||
170671097|NCT01153347|616808300|FG003|Overall Study|Withdrawal by Subject|7|||
170671098|NCT01153347|616808297|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170671099|NCT01153347|616808298|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170671100|NCT01153347|616808299|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
170671101|NCT01153347|616808300|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
170671102|NCT01153347|616808297|FG000|Overall Study|Adverse Event|3|||
170671103|NCT01153347|616808298|FG001|Overall Study|Adverse Event|9|||
170671104|NCT01153347|616808299|FG002|Overall Study|Adverse Event|21|||
170671105|NCT01153347|616808300|FG003|Overall Study|Adverse Event|7|||
170671106|NCT01153347|616808297|FG000|Overall Study|Severe non-compliance to protocol|6|||
170671107|NCT01153347|616808298|FG001|Overall Study|Severe non-compliance to protocol|7|||
170671108|NCT01153347|616808299|FG002|Overall Study|Severe non-compliance to protocol|4|||
170671109|NCT01153347|616808300|FG003|Overall Study|Severe non-compliance to protocol|3|||
170671110|NCT01153347|616808297|FG000|Overall Study|Condition under investigation worsened|1|||
170671111|NCT01153347|616808298|FG001|Overall Study|Condition under investigation worsened|1|||
170671112|NCT01153347|616808299|FG002|Overall Study|Condition under investigation worsened|0|||
170671113|NCT01153347|616808300|FG003|Overall Study|Condition under investigation worsened|0|||
170671114|NCT01153347|616808297|FG000|Overall Study|Lack of Efficacy|2|||
170671115|NCT01153347|616808298|FG001|Overall Study|Lack of Efficacy|2|||
170671116|NCT01153347|616808299|FG002|Overall Study|Lack of Efficacy|0|||
170671117|NCT01153347|616808300|FG003|Overall Study|Lack of Efficacy|4|||
170671118|NCT01153347|616808297|FG000|Overall Study|Study-specific withdrawal criteria|4|||
170671119|NCT01153347|616808298|FG001|Overall Study|Study-specific withdrawal criteria|3|||
170671120|NCT01153347|616808299|FG002|Overall Study|Study-specific withdrawal criteria|1|||
170671121|NCT01153347|616808300|FG003|Overall Study|Study-specific withdrawal criteria|2|||
170671122|NCT01153347|616808297|FG000|Overall Study|Lost to Follow-up|4|||
170671123|NCT01153347|616808298|FG001|Overall Study|Lost to Follow-up|9|||
170671124|NCT01153347|616808299|FG002|Overall Study|Lost to Follow-up|11|||
170671125|NCT01153347|616808300|FG003|Overall Study|Lost to Follow-up|8|||
170671126|NCT01153347|616808297|FG000|Overall Study|Other|5|||
170671127|NCT01153347|616808298|FG001|Overall Study|Other|5|||
170671128|NCT01153347|616808299|FG002|Overall Study|Other|4|||
170671129|NCT01153347|616808300|FG003|Overall Study|Other|0|||
170671130|NCT01153347|616808297|FG000|Overall Study|Death|1|||
170671131|NCT01153347|616808298|FG001|Overall Study|Death|0|||
170671132|NCT01153347|616808299|FG002|Overall Study|Death|0|||
170671133|NCT01153347|616808300|FG003|Overall Study|Death|0|||
170671134|NCT01281865|616808303|FG000|Overall Study|Adverse Event|1|||
170671135|NCT01281865|616808304|FG001|Overall Study|Adverse Event|1|||
170671136|NCT01281865|616808303|FG000|Overall Study|Withdrawal by Subject|1|||
170671137|NCT01281865|616808304|FG001|Overall Study|Withdrawal by Subject|0|||
170671138|NCT01281865|616808303|FG000|Overall Study|Lack of Efficacy|1|||
170671139|NCT01281865|616808304|FG001|Overall Study|Lack of Efficacy|0|||
170671140|NCT03478657|616808306|FG000|Overall Study|Withdrawal by Subject|0|||
170671141|NCT03478657|616808307|FG001|Overall Study|Withdrawal by Subject|1|||
170671142|NCT03733470|616808308|FG000|Overall Study|PI Decision|1|||
170671143|NCT03733470|616808309|FG001|Overall Study|PI Decision|1|||
170671144|NCT04891978|616808311|FG000|Baseline|Protocol Violation|2|||
170671145|NCT04891978|616808312|FG001|Baseline|Protocol Violation|1|||
170671146|NCT04891978|616808313|FG002|Baseline|Protocol Violation|0|||
170671147|NCT04891978|616808311|FG000|Baseline|Missing AIRQ|1|||
170671148|NCT04891978|616808312|FG001|Baseline|Missing AIRQ|0|||
170671149|NCT04891978|616808313|FG002|Baseline|Missing AIRQ|0|||
170671150|NCT04891978|616808311|FG000|Baseline|Did not attend a baseline visit|0|||
170671151|NCT04891978|616808312|FG001|Baseline|Did not attend a baseline visit|0|||
170671152|NCT04891978|616808313|FG002|Baseline|Did not attend a baseline visit|9|||
170671153|NCT03641339|616808314|FG000|Overall Study|Physician Decision|1|||
170671154|NCT03641339|616808315|FG001|Overall Study|Physician Decision|0|||
170671155|NCT03641339|616808316|FG002|Overall Study|Physician Decision|0|||
170671156|NCT03641339|616808317|FG003|Overall Study|Physician Decision|0|||
170671157|NCT03641339|616808318|FG004|Overall Study|Physician Decision|0|||
170671158|NCT03641339|616808319|FG005|Overall Study|Physician Decision|0|||
170671159|NCT03641339|616808314|FG000|Overall Study|Withdrawal by Subject|0|||
170671160|NCT03641339|616808315|FG001|Overall Study|Withdrawal by Subject|2|||
170671161|NCT03641339|616808316|FG002|Overall Study|Withdrawal by Subject|0|||
170671162|NCT03641339|616808317|FG003|Overall Study|Withdrawal by Subject|2|||
170671163|NCT03641339|616808318|FG004|Overall Study|Withdrawal by Subject|0|||
170671164|NCT03641339|616808319|FG005|Overall Study|Withdrawal by Subject|1|||
170671165|NCT05338216|616808322|FG000|Overall Study|Withdrawal by Subject|1|||
170671166|NCT05338216|616808323|FG001|Overall Study|Withdrawal by Subject|1|||
170671167|NCT02329080|616808325|FG000|Overall Study|Adverse Event|1|||
170671168|NCT02329080|616808325|FG000|Overall Study|Death|4|||
170671169|NCT02329080|616808325|FG000|Overall Study|Lack of Efficacy|22|||
170671170|NCT02329080|616808325|FG000|Overall Study|Lost to Follow-up|1|||
170671171|NCT02329080|616808325|FG000|Overall Study|Physician Decision|2|||
170671172|NCT02329080|616808325|FG000|Overall Study|Partial response|4|||
170671173|NCT02329080|616808325|FG000|Overall Study|Complete response|4|||
170671174|NCT00446251|616808328|FG000|Overall Study|On-study Transplants|2|||
170671175|NCT00446251|616808328|FG000|Overall Study|Rituximab Infusion Reaction|2|||
170671176|NCT00446251|616808328|FG000|Overall Study|Lost to Follow-up|1|||
170671177|NCT01986907|616808335|FG000|Overall Study|Adverse Event|11|||
170671178|NCT01986907|616808335|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
170671179|NCT01986907|616808335|FG000|Overall Study|Protocol Violation|4|||
170671180|NCT01986907|616808335|FG000|Overall Study|Withdrawal by Subject|76|||
170671181|NCT01986907|616808335|FG000|Overall Study|Lost to Follow-up|38|||
170671182|NCT01986907|616808335|FG000|Overall Study|Death|9|||
170671183|NCT00932126|616808338|FG000|Overall Study|Adverse Event|0|||
170671184|NCT00932126|616808339|FG001|Overall Study|Adverse Event|0|||
170671185|NCT00932126|616808340|FG002|Overall Study|Adverse Event|0|||
170671186|NCT00932126|616808341|FG003|Overall Study|Adverse Event|0|||
170671187|NCT00932126|616808342|FG004|Overall Study|Adverse Event|0|||
170671188|NCT00932126|616808343|FG005|Overall Study|Adverse Event|0|||
170671189|NCT00932126|616808344|FG006|Overall Study|Adverse Event|1|||
170671190|NCT00932126|616808345|FG007|Overall Study|Adverse Event|2|||
170671191|NCT00932126|616808338|FG000|Overall Study|Protocol Violation|0|||
170671192|NCT00932126|616808339|FG001|Overall Study|Protocol Violation|0|||
170671193|NCT00932126|616808340|FG002|Overall Study|Protocol Violation|0|||
170671194|NCT00932126|616808341|FG003|Overall Study|Protocol Violation|0|||
170671195|NCT00932126|616808342|FG004|Overall Study|Protocol Violation|1|||
170671196|NCT00932126|616808343|FG005|Overall Study|Protocol Violation|0|||
170671197|NCT00932126|616808344|FG006|Overall Study|Protocol Violation|0|||
170671198|NCT00932126|616808345|FG007|Overall Study|Protocol Violation|0|||
170671199|NCT00932126|616808338|FG000|Overall Study|Withdrawal by Subject|0|||
170671200|NCT00932126|616808339|FG001|Overall Study|Withdrawal by Subject|0|||
170671201|NCT00932126|616808340|FG002|Overall Study|Withdrawal by Subject|1|||
170671202|NCT00932126|616808341|FG003|Overall Study|Withdrawal by Subject|0|||
170671203|NCT00932126|616808342|FG004|Overall Study|Withdrawal by Subject|0|||
170671204|NCT00932126|616808343|FG005|Overall Study|Withdrawal by Subject|0|||
170671205|NCT00932126|616808344|FG006|Overall Study|Withdrawal by Subject|0|||
170671206|NCT00932126|616808345|FG007|Overall Study|Withdrawal by Subject|1|||
170671207|NCT00932126|616808338|FG000|Overall Study|Objective progression or relapse|3|||
170671208|NCT00932126|616808339|FG001|Overall Study|Objective progression or relapse|3|||
170671209|NCT00932126|616808340|FG002|Overall Study|Objective progression or relapse|2|||
170671210|NCT00932126|616808341|FG003|Overall Study|Objective progression or relapse|3|||
170671211|NCT00932126|616808342|FG004|Overall Study|Objective progression or relapse|3|||
170671212|NCT00932126|616808343|FG005|Overall Study|Objective progression or relapse|3|||
170671213|NCT00932126|616808344|FG006|Overall Study|Objective progression or relapse|3|||
170671214|NCT00932126|616808345|FG007|Overall Study|Objective progression or relapse|5|||
170671215|NCT00932126|616808338|FG000|Overall Study|Other|0|||
170671216|NCT00932126|616808339|FG001|Overall Study|Other|0|||
170671217|NCT00932126|616808340|FG002|Overall Study|Other|0|||
170671218|NCT00932126|616808341|FG003|Overall Study|Other|0|||
170671219|NCT00932126|616808342|FG004|Overall Study|Other|1|||
170671220|NCT00932126|616808343|FG005|Overall Study|Other|0|||
170671221|NCT00932126|616808344|FG006|Overall Study|Other|1|||
170671222|NCT00932126|616808345|FG007|Overall Study|Other|2|||
170671223|NCT00467857|616808346|FG000|Overall Study|Adverse Event|1|||
170671224|NCT00467857|616808347|FG001|Overall Study|Adverse Event|0|||
170671225|NCT00467857|616808346|FG000|Overall Study|Withdrew consent|2|||
170671226|NCT00467857|616808347|FG001|Overall Study|Withdrew consent|0|||
170671227|NCT00467857|616808346|FG000|Overall Study|Death|0|||
170671228|NCT00467857|616808347|FG001|Overall Study|Death|1|||
170671229|NCT00467857|616808346|FG000|Overall Study|Discharged from court service|0|||
170671230|NCT00467857|616808347|FG001|Overall Study|Discharged from court service|1|||
170671231|NCT00467857|616808346|FG000|Overall Study|Emergency care required|0|||
170671232|NCT00467857|616808347|FG001|Overall Study|Emergency care required|1|||
170671233|NCT00467857|616808346|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
170671234|NCT00467857|616808347|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
170671235|NCT00467857|616808346|FG000|Overall Study|Discontinuation reason missing|0|||
170671236|NCT00467857|616808347|FG001|Overall Study|Discontinuation reason missing|3|||
170671237|NCT04203797|616808354|FG000|Overall Study|Adverse Event|1|||
170671238|NCT04203797|616808355|FG001|Overall Study|Adverse Event|0|||
170671239|NCT04203797|616808354|FG000|Overall Study|Did not complete End of Study follow-up|1|||
170671240|NCT04203797|616808355|FG001|Overall Study|Did not complete End of Study follow-up|0|||
170671241|NCT01146665|616808359|FG000|Overall Study|Withdrawal by Subject|10|||
170671242|NCT01146665|616808360|FG001|Overall Study|Withdrawal by Subject|16|||
170671243|NCT00289783|616808361|FG000|Primary Phase|Adverse Event|10|||
170671244|NCT00289783|616808362|FG001|Primary Phase|Adverse Event|1|||
170671245|NCT00289783|616808361|FG000|Primary Phase|Protocol Violation|27|||
170819867|NCT00296504|617347680|FG005|Interim Analysis|Physician and Participant Decision|1|||
170819868|NCT00296504|617347681|FG006|Interim Analysis|Physician and Participant Decision|0|||
170819869|NCT00296504|617347682|FG007|Interim Analysis|Physician and Participant Decision|0|||
170625672|NCT01126749|616640925|FG000|Phase 2|Study Termination by Sponsor|0|||
170625673|NCT01126749|616640926|FG001|Phase 2|Study Termination by Sponsor|0|||
170625674|NCT01126749|616640927|FG002|Phase 2|Study Termination by Sponsor|12|||
170625675|NCT01126749|616640928|FG003|Phase 2|Study Termination by Sponsor|6|||
170625676|NCT01126749|616640925|FG000|Phase 2|Other|0|||
170625677|NCT01126749|616640926|FG001|Phase 2|Other|0|||
170625678|NCT01126749|616640927|FG002|Phase 2|Other|4|||
170625679|NCT01126749|616640928|FG003|Phase 2|Other|2|||
170625680|NCT01126749|616640925|FG000|Phase 2|Withdrawal by Subject|0|||
170625681|NCT01126749|616640926|FG001|Phase 2|Withdrawal by Subject|0|||
170625682|NCT01126749|616640927|FG002|Phase 2|Withdrawal by Subject|0|||
170625683|NCT01126749|616640928|FG003|Phase 2|Withdrawal by Subject|2|||
170819870|NCT00296504|617347683|FG008|Interim Analysis|Physician and Participant Decision|0|||
170819871|NCT00296504|617347675|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
170819872|NCT00296504|617347676|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
170819873|NCT00296504|617347677|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
170625684|NCT01126749|616640925|FG000|Phase 2|Lost to Follow-up|0|||
170625685|NCT01126749|616640926|FG001|Phase 2|Lost to Follow-up|0|||
170625686|NCT01126749|616640927|FG002|Phase 2|Lost to Follow-up|0|||
170625687|NCT01126749|616640928|FG003|Phase 2|Lost to Follow-up|1|||
170625688|NCT01126749|616640925|FG000|Phase 2|Death|0|||
170625689|NCT01126749|616640926|FG001|Phase 2|Death|0|||
170625690|NCT01126749|616640927|FG002|Phase 2|Death|22|||
170625691|NCT01126749|616640928|FG003|Phase 2|Death|22|||
170625692|NCT01126749|616640925|FG000|Phase 2|Adverse Event|0|||
170625693|NCT01126749|616640926|FG001|Phase 2|Adverse Event|0|||
170625694|NCT01126749|616640927|FG002|Phase 2|Adverse Event|0|||
170625695|NCT01126749|616640928|FG003|Phase 2|Adverse Event|1|||
170625696|NCT00537394|616640929|FG000|First Year of Follow-up|Death|7|||
170625697|NCT00537394|616640930|FG001|First Year of Follow-up|Death|0|||
170625698|NCT00537394|616640931|FG002|First Year of Follow-up|Death|0|||
170625699|NCT00537394|616640929|FG000|First Year of Follow-up|Severe debilitation|1|||
170625700|NCT00537394|616640930|FG001|First Year of Follow-up|Severe debilitation|0|||
170625701|NCT00537394|616640931|FG002|First Year of Follow-up|Severe debilitation|1|||
170625702|NCT00537394|616640929|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
170625703|NCT00537394|616640930|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
170625704|NCT00537394|616640931|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
170625705|NCT00537394|616640929|FG000|First Year of Follow-up|Lost to Follow-up|1|||
170625706|NCT00537394|616640930|FG001|First Year of Follow-up|Lost to Follow-up|5|||
170625707|NCT00537394|616640931|FG002|First Year of Follow-up|Lost to Follow-up|1|||
170625708|NCT00537394|616640929|FG000|2nd Year of Follow-up|Death|4|||
170625709|NCT00537394|616640930|FG001|2nd Year of Follow-up|Death|1|||
170625710|NCT00537394|616640931|FG002|2nd Year of Follow-up|Death|2|||
170625711|NCT00537394|616640929|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
170625712|NCT00537394|616640930|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
170625713|NCT00537394|616640931|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
170671246|NCT00289783|616808362|FG001|Primary Phase|Protocol Violation|6|||
170671247|NCT00289783|616808361|FG000|Primary Phase|Withdrawal by Subject|93|||
170625714|NCT00537394|616640929|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
170625715|NCT00537394|616640930|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
170625716|NCT00537394|616640931|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
170625717|NCT00537394|616640929|FG000|2nd Year of Follow-up|Clinic site closure|1|||
170625718|NCT00537394|616640930|FG001|2nd Year of Follow-up|Clinic site closure|0|||
170625719|NCT00537394|616640931|FG002|2nd Year of Follow-up|Clinic site closure|0|||
170625720|NCT00762164|616640934|FG000|Overall Study|Lost to Follow-up|1|||
170671248|NCT00289783|616808362|FG001|Primary Phase|Withdrawal by Subject|40|||
170671249|NCT00289783|616808361|FG000|Primary Phase|Lost to Follow-up|60|||
170671250|NCT00289783|616808362|FG001|Primary Phase|Lost to Follow-up|14|||
170671251|NCT00289783|616808361|FG000|Primary Phase|Migration from the study area|26|||
170671252|NCT00289783|616808362|FG001|Primary Phase|Migration from the study area|10|||
170671253|NCT00289783|616808361|FG000|Primary Phase|Other|32|||
170671254|NCT00289783|616808362|FG001|Primary Phase|Other|12|||
170671255|NCT00289783|616808361|FG000|Fourth Dose Phase|Adverse Event|1|||
170671256|NCT00289783|616808362|FG001|Fourth Dose Phase|Adverse Event|0|||
170671257|NCT00289783|616808361|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
170671258|NCT00289783|616808362|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
170671259|NCT00289783|616808361|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
170671260|NCT00289783|616808362|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
170671261|NCT00289783|616808361|FG000|Fourth Dose Phase|Migration from the study area|1|||
170671262|NCT00289783|616808362|FG001|Fourth Dose Phase|Migration from the study area|1|||
170671263|NCT00289783|616808361|FG000|Fourth Dose Phase|Other|22|||
170671264|NCT00289783|616808362|FG001|Fourth Dose Phase|Other|10|||
170671265|NCT05248867|616808363|FG000|Double-blind Period|Lost to Follow-up|0|||
170671266|NCT05248867|616808364|FG001|Double-blind Period|Lost to Follow-up|3|||
170671267|NCT05248867|616808365|FG002|Double-blind Period|Lost to Follow-up|0|||
170671268|NCT05248867|616808366|FG003|Double-blind Period|Lost to Follow-up|0|||
170671269|NCT05248867|616808367|FG004|Double-blind Period|Lost to Follow-up|0|||
170671270|NCT05248867|616808368|FG005|Double-blind Period|Lost to Follow-up|0|||
170671271|NCT05248867|616808363|FG000|Double-blind Period|Withdrawal by Subject|5|||
170671272|NCT05248867|616808364|FG001|Double-blind Period|Withdrawal by Subject|14|||
170671273|NCT05248867|616808365|FG002|Double-blind Period|Withdrawal by Subject|0|||
170671274|NCT05248867|616808366|FG003|Double-blind Period|Withdrawal by Subject|0|||
170671275|NCT05248867|616808367|FG004|Double-blind Period|Withdrawal by Subject|0|||
170671276|NCT05248867|616808368|FG005|Double-blind Period|Withdrawal by Subject|0|||
170671277|NCT05248867|616808363|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
170671278|NCT05248867|616808364|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
170671279|NCT05248867|616808365|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
170671280|NCT05248867|616808366|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
170671281|NCT05248867|616808367|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
170671282|NCT05248867|616808368|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
170671283|NCT05248867|616808363|FG000|Double-blind Period|Other, not specified|3|||
170671284|NCT05248867|616808364|FG001|Double-blind Period|Other, not specified|8|||
170671285|NCT05248867|616808365|FG002|Double-blind Period|Other, not specified|0|||
170671286|NCT05248867|616808366|FG003|Double-blind Period|Other, not specified|0|||
170671287|NCT05248867|616808367|FG004|Double-blind Period|Other, not specified|0|||
170671288|NCT05248867|616808368|FG005|Double-blind Period|Other, not specified|0|||
170671289|NCT05248867|616808363|FG000|Open-label Period|Withdrawal by Subject|0|||
170671290|NCT05248867|616808364|FG001|Open-label Period|Withdrawal by Subject|0|||
170625721|NCT00762164|616640935|FG001|Overall Study|Lost to Follow-up|1|||
170625722|NCT00762164|616640934|FG000|Overall Study|Discontinued medication|2|||
170625723|NCT00762164|616640935|FG001|Overall Study|Discontinued medication|0|||
170625724|NCT00762164|616640934|FG000|Overall Study|Withdrawal by Subject|0|||
170625725|NCT00762164|616640935|FG001|Overall Study|Withdrawal by Subject|1|||
170625726|NCT02657889|616640943|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
170625727|NCT02657889|616640944|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
170625728|NCT02657889|616640945|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
170625729|NCT02657889|616640946|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
170625730|NCT02657889|616640943|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
170625731|NCT02657889|616640944|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
170625732|NCT02657889|616640945|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
170625733|NCT02657889|616640946|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
170625734|NCT02657889|616640943|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
170625735|NCT02657889|616640944|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
170625736|NCT02657889|616640945|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
170625737|NCT02657889|616640946|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
170625738|NCT02657889|616640943|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
170625739|NCT02657889|616640944|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
170625740|NCT02657889|616640945|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
170671291|NCT05248867|616808365|FG002|Open-label Period|Withdrawal by Subject|3|||
170671292|NCT05248867|616808366|FG003|Open-label Period|Withdrawal by Subject|1|||
170671293|NCT05248867|616808367|FG004|Open-label Period|Withdrawal by Subject|7|||
170671294|NCT05248867|616808368|FG005|Open-label Period|Withdrawal by Subject|9|||
170671295|NCT05248867|616808363|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
170671296|NCT05248867|616808364|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
170671297|NCT05248867|616808365|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
170625741|NCT02657889|616640946|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
170625742|NCT02657889|616640943|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
170625743|NCT02657889|616640944|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
170625744|NCT02657889|616640945|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
170625745|NCT02657889|616640946|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
170625746|NCT02657889|616640943|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
170625747|NCT02657889|616640944|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
170625748|NCT02657889|616640945|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
170625749|NCT02657889|616640946|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
170625750|NCT02657889|616640943|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
170625751|NCT02657889|616640944|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
170625752|NCT02657889|616640945|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
170625753|NCT02657889|616640946|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
170625754|NCT02657889|616640943|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
170625755|NCT02657889|616640944|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
170625756|NCT02657889|616640945|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
170625757|NCT02657889|616640946|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
170625758|NCT02657889|616640943|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
170625759|NCT02657889|616640944|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
170625760|NCT02657889|616640945|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
170625761|NCT02657889|616640946|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
170625762|NCT02657889|616640943|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
170625763|NCT02657889|616640944|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
170625764|NCT02657889|616640945|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
170625765|NCT02657889|616640946|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
170625766|NCT02657889|616640943|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
170625767|NCT02657889|616640944|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
170625768|NCT02657889|616640945|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
170625769|NCT02657889|616640946|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
170625770|NCT02657889|616640943|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
170625771|NCT02657889|616640944|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
170625772|NCT02657889|616640945|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
170625773|NCT02657889|616640946|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
170625774|NCT01927497|616640949|FG000|Overall Study|Death|0|||
170625775|NCT01927497|616640950|FG001|Overall Study|Death|1|||
170625776|NCT01927497|616640949|FG000|Overall Study|Protocol Violation|2|||
170625777|NCT01927497|616640950|FG001|Overall Study|Protocol Violation|0|||
170625778|NCT03914417|616640951|FG000|Overall Study|Withdrawal by Subject|2|||
170625779|NCT03836625|616640952|FG000|Overall Study|Lost to Follow-up|9|||
170625780|NCT03836625|616640953|FG001|Overall Study|Lost to Follow-up|9|||
170625781|NCT03836625|616640952|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
170625782|NCT03836625|616640953|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
170625783|NCT03836625|616640952|FG000|Overall Study|Death|0|||
170625784|NCT03836625|616640953|FG001|Overall Study|Death|1|||
170625785|NCT03836625|616640952|FG000|Overall Study|Refused follow-up|0|||
170625786|NCT03836625|616640953|FG001|Overall Study|Refused follow-up|1|||
170819874|NCT00296504|617347678|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
170819875|NCT00296504|617347679|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
170819876|NCT00296504|617347680|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
170819877|NCT00296504|617347681|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
170819878|NCT00296504|617347682|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
170819879|NCT00296504|617347683|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
170819880|NCT00296504|617347675|FG000|Interim Analysis|Study Ended|0|||
170819881|NCT00296504|617347676|FG001|Interim Analysis|Study Ended|0|||
170819882|NCT00296504|617347677|FG002|Interim Analysis|Study Ended|0|||
170819883|NCT00296504|617347678|FG003|Interim Analysis|Study Ended|0|||
170819884|NCT00296504|617347679|FG004|Interim Analysis|Study Ended|0|||
170819885|NCT00296504|617347680|FG005|Interim Analysis|Study Ended|0|||
170819886|NCT00296504|617347681|FG006|Interim Analysis|Study Ended|1|||
170819887|NCT00296504|617347682|FG007|Interim Analysis|Study Ended|0|||
170625787|NCT03077542|616640960|FG000|Overall Study|Death|4|||
170625788|NCT03077542|616640961|FG001|Overall Study|Death|0|||
170625789|NCT03077542|616640960|FG000|Overall Study|Physician Decision|6|||
170625790|NCT03077542|616640961|FG001|Overall Study|Physician Decision|1|||
170625791|NCT03077542|616640960|FG000|Overall Study|Withdrawal by Subject|0|||
170625792|NCT03077542|616640961|FG001|Overall Study|Withdrawal by Subject|1|||
170625793|NCT01300728|616640962|FG000|Overall Study|Withdrawal by Subject|1|||
170625794|NCT01300728|616640963|FG001|Overall Study|Withdrawal by Subject|1|||
170625795|NCT01300728|616640962|FG000|Overall Study|Physician Decision|1|||
170625796|NCT01300728|616640963|FG001|Overall Study|Physician Decision|0|||
170625797|NCT01247324|616640964|FG000|Overall Study|Death|6|||
170625798|NCT01247324|616640965|FG001|Overall Study|Death|10|||
170625799|NCT01247324|616640964|FG000|Overall Study|Physician Decision|2|||
170625800|NCT01247324|616640965|FG001|Overall Study|Physician Decision|3|||
170625801|NCT01247324|616640964|FG000|Overall Study|Non-compliance with study drug|3|||
170625802|NCT01247324|616640965|FG001|Overall Study|Non-compliance with study drug|0|||
170625803|NCT01247324|616640964|FG000|Overall Study|Lack of Efficacy|24|||
170625804|NCT01247324|616640965|FG001|Overall Study|Lack of Efficacy|14|||
170625805|NCT01247324|616640964|FG000|Overall Study|Non-compliance|3|||
170625806|NCT01247324|616640965|FG001|Overall Study|Non-compliance|2|||
170625807|NCT01247324|616640964|FG000|Overall Study|Pregnancy|5|||
170625808|NCT01247324|616640965|FG001|Overall Study|Pregnancy|10|||
170625809|NCT01247324|616640964|FG000|Overall Study|Protocol Violation|1|||
170625810|NCT01247324|616640965|FG001|Overall Study|Protocol Violation|1|||
170625811|NCT01247324|616640964|FG000|Overall Study|Reason not specified|42|||
170625812|NCT01247324|616640965|FG001|Overall Study|Reason not specified|32|||
170625813|NCT01247324|616640964|FG000|Overall Study|Consent withdrawn by participant|41|||
170625814|NCT01247324|616640965|FG001|Overall Study|Consent withdrawn by participant|56|||
170625815|NCT01247324|616640964|FG000|Overall Study|Adverse Event|49|||
170671298|NCT05248867|616808366|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
170671299|NCT05248867|616808367|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
170671300|NCT05248867|616808368|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
170671301|NCT05248867|616808363|FG000|Open-label Period|Lost to Follow-up|0|||
170671302|NCT05248867|616808364|FG001|Open-label Period|Lost to Follow-up|0|||
170671303|NCT05248867|616808365|FG002|Open-label Period|Lost to Follow-up|0|||
170671304|NCT05248867|616808366|FG003|Open-label Period|Lost to Follow-up|0|||
170671305|NCT05248867|616808367|FG004|Open-label Period|Lost to Follow-up|5|||
170671306|NCT05248867|616808368|FG005|Open-label Period|Lost to Follow-up|2|||
170671307|NCT05248867|616808363|FG000|Open-label Period|COVID-19 Infection|0|||
170671308|NCT05248867|616808364|FG001|Open-label Period|COVID-19 Infection|0|||
170671309|NCT05248867|616808365|FG002|Open-label Period|COVID-19 Infection|0|||
170671310|NCT05248867|616808366|FG003|Open-label Period|COVID-19 Infection|0|||
170671311|NCT05248867|616808367|FG004|Open-label Period|COVID-19 Infection|1|||
170671312|NCT05248867|616808368|FG005|Open-label Period|COVID-19 Infection|0|||
170671313|NCT05248867|616808363|FG000|Open-label Period|Other, not specified|0|||
170671314|NCT05248867|616808364|FG001|Open-label Period|Other, not specified|0|||
170671315|NCT05248867|616808365|FG002|Open-label Period|Other, not specified|0|||
170671316|NCT05248867|616808366|FG003|Open-label Period|Other, not specified|0|||
170625816|NCT01247324|616640965|FG001|Overall Study|Adverse Event|35|||
170625817|NCT01247324|616640964|FG000|Overall Study|Lost to Follow-up|3|||
170625818|NCT01247324|616640965|FG001|Overall Study|Lost to Follow-up|6|||
170625819|NCT01247324|616640964|FG000|Overall Study|Study Terminated by Sponsor|4|||
170625820|NCT01247324|616640965|FG001|Overall Study|Study Terminated by Sponsor|1|||
170625821|NCT01247324|616640964|FG000|Overall Study|Missing|2|||
170625822|NCT01247324|616640965|FG001|Overall Study|Missing|1|||
170625823|NCT00880620|616640968|FG000|Overall Study|Adverse Event|4|||
170625824|NCT00880620|616640969|FG001|Overall Study|Adverse Event|5|||
170625825|NCT00880620|616640970|FG002|Overall Study|Adverse Event|15|||
170625826|NCT00880620|616640971|FG003|Overall Study|Adverse Event|15|||
170625827|NCT00880620|616640968|FG000|Overall Study|Death|0|||
170625828|NCT00880620|616640969|FG001|Overall Study|Death|0|||
170625829|NCT00880620|616640970|FG002|Overall Study|Death|1|||
170625830|NCT00880620|616640971|FG003|Overall Study|Death|0|||
170625831|NCT00880620|616640968|FG000|Overall Study|Lack of Efficacy|12|||
170625832|NCT00880620|616640969|FG001|Overall Study|Lack of Efficacy|4|||
170625833|NCT00880620|616640970|FG002|Overall Study|Lack of Efficacy|0|||
170625834|NCT00880620|616640971|FG003|Overall Study|Lack of Efficacy|1|||
170625835|NCT00880620|616640968|FG000|Overall Study|Lost to Follow-up|0|||
170625836|NCT00880620|616640969|FG001|Overall Study|Lost to Follow-up|1|||
170625837|NCT00880620|616640970|FG002|Overall Study|Lost to Follow-up|1|||
170671317|NCT05248867|616808367|FG004|Open-label Period|Other, not specified|4|||
170671318|NCT05248867|616808368|FG005|Open-label Period|Other, not specified|0|||
170625838|NCT00880620|616640971|FG003|Overall Study|Lost to Follow-up|0|||
170671319|NCT00873015|616808369|FG000|Overall Study|Withdrawal by Subject|0|||
170671320|NCT00873015|616808370|FG001|Overall Study|Withdrawal by Subject|1|||
170671321|NCT00873015|616808371|FG002|Overall Study|Withdrawal by Subject|0|||
170671322|NCT00873015|616808372|FG003|Overall Study|Withdrawal by Subject|0|||
170671323|NCT03128411|616808373|FG000|Treatment Phase|Adverse Event|21|||
170671324|NCT03128411|616808373|FG000|Treatment Phase|Physician Decision|1|||
170671325|NCT03128411|616808373|FG000|Treatment Phase|Other|2|||
170625839|NCT00880620|616640968|FG000|Overall Study|Protocol Violation|0|||
170625840|NCT00880620|616640969|FG001|Overall Study|Protocol Violation|1|||
170671326|NCT03128411|616808373|FG000|Long Term Follow-up Phase|Death|2|||
170671327|NCT00345839|616808374|FG000|Overall Study|Withdrawal by Subject|91|||
170671328|NCT00345839|616808375|FG001|Overall Study|Withdrawal by Subject|98|||
170671329|NCT00345839|616808374|FG000|Overall Study|Lost to Follow-up|58|||
170671330|NCT00345839|616808375|FG001|Overall Study|Lost to Follow-up|61|||
170671331|NCT03298867|616808376|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
170671332|NCT03298867|616808377|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
170671333|NCT03298867|616808376|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
170671334|NCT03298867|616808377|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
170671335|NCT03298867|616808376|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
170671336|NCT03298867|616808377|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
170671337|NCT03298867|616808376|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
170671338|NCT03298867|616808377|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
170671339|NCT03298867|616808376|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
170671340|NCT03298867|616808377|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
170671341|NCT03298867|616808376|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
170671342|NCT03298867|616808377|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
170671343|NCT03298867|616808376|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
170671344|NCT03298867|616808377|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
170671345|NCT03298867|616808376|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
170671346|NCT03298867|616808377|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
170671347|NCT03298867|616808376|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
170671348|NCT03298867|616808377|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
170671349|NCT00300274|616808378|FG000|Overall Study|Withdrawal by Subject|12|||
170671350|NCT00300274|616808379|FG001|Overall Study|Withdrawal by Subject|3|||
170671351|NCT00300274|616808380|FG002|Overall Study|Withdrawal by Subject|14|||
170671352|NCT00300274|616808378|FG000|Overall Study|Lost to Follow-up|3|||
170671353|NCT00300274|616808379|FG001|Overall Study|Lost to Follow-up|4|||
170671354|NCT00300274|616808380|FG002|Overall Study|Lost to Follow-up|5|||
170671355|NCT00300274|616808378|FG000|Overall Study|Death|31|||
170671356|NCT00300274|616808379|FG001|Overall Study|Death|20|||
170671357|NCT00300274|616808380|FG002|Overall Study|Death|25|||
170671358|NCT00300274|616808378|FG000|Overall Study|Re-transplant|0|||
170671359|NCT00300274|616808379|FG001|Overall Study|Re-transplant|0|||
170671360|NCT00300274|616808380|FG002|Overall Study|Re-transplant|1|||
170671361|NCT00660699|616808381|FG000|Overall Study|Withdrawal by Subject|2|||
170671362|NCT04439201|616808389|FG000|Overall Study|Ineligible|2|||
170671363|NCT04439201|616808389|FG000|Overall Study|Never start protocol therapy|1|||
170671364|NCT04439201|616808389|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
170671365|NCT04439201|616808389|FG000|Overall Study|Mutation status not confirmed|4|||
170671366|NCT04439201|616808389|FG000|Overall Study|Adverse Event|1|||
170671367|NCT04439201|616808389|FG000|Overall Study|Death|7|||
170671368|NCT04439201|616808389|FG000|Overall Study|Withdrawal by Subject|2|||
170671369|NCT04439201|616808389|FG000|Overall Study|Disease progression|20|||
170671370|NCT04439201|616808389|FG000|Overall Study|Alternative therapy|1|||
170819888|NCT00296504|617347683|FG008|Interim Analysis|Study Ended|0|||
170819889|NCT00296504|617347675|FG000|Interim Analysis|Participant Needed Interferon|0|||
170625841|NCT00880620|616640970|FG002|Overall Study|Protocol Violation|0|||
170625842|NCT00880620|616640971|FG003|Overall Study|Protocol Violation|2|||
170625843|NCT00880620|616640968|FG000|Overall Study|Withdrawal by Subject|4|||
170625844|NCT00880620|616640969|FG001|Overall Study|Withdrawal by Subject|3|||
170625845|NCT00880620|616640970|FG002|Overall Study|Withdrawal by Subject|1|||
170625846|NCT00880620|616640971|FG003|Overall Study|Withdrawal by Subject|3|||
170625847|NCT00880620|616640968|FG000|Overall Study|Noncompliance|0|||
170625848|NCT00880620|616640969|FG001|Overall Study|Noncompliance|0|||
170625849|NCT00880620|616640970|FG002|Overall Study|Noncompliance|1|||
170625850|NCT00880620|616640971|FG003|Overall Study|Noncompliance|1|||
170625851|NCT00880620|616640968|FG000|Overall Study|Other|1|||
170625852|NCT00880620|616640969|FG001|Overall Study|Other|1|||
170671371|NCT04439201|616808389|FG000|Overall Study|Physician Decision|1|||
170671372|NCT01757535|616808392|FG000|Overall Study|Disease Relapse|151|||
170671373|NCT01757535|616808393|FG001|Overall Study|Disease Relapse|181|||
170671374|NCT01757535|616808392|FG000|Overall Study|Other Reasons|28|||
170819890|NCT00296504|617347676|FG001|Interim Analysis|Participant Needed Interferon|0|||
170625853|NCT00880620|616640970|FG002|Overall Study|Other|2|||
170671375|NCT01757535|616808393|FG001|Overall Study|Other Reasons|27|||
170671376|NCT01757535|616808392|FG000|Overall Study|Adverse Event|31|||
170671377|NCT01757535|616808393|FG001|Overall Study|Adverse Event|11|||
170671378|NCT01757535|616808392|FG000|Overall Study|Withdrew Consent|19|||
170671379|NCT01757535|616808393|FG001|Overall Study|Withdrew Consent|13|||
170671380|NCT01757535|616808392|FG000|Overall Study|Physician Decision|7|||
170671381|NCT01757535|616808393|FG001|Overall Study|Physician Decision|0|||
170671382|NCT01757535|616808392|FG000|Overall Study|Death|2|||
170671383|NCT01757535|616808393|FG001|Overall Study|Death|2|||
170671384|NCT00589290|616808394|FG000|Overall Study|Withdrawal by Subject|1|||
170671385|NCT03487549|616808401|FG000|Overall Study|Protocol Violation|0|||
170671386|NCT03487549|616808402|FG001|Overall Study|Protocol Violation|1|||
170671387|NCT03487549|616808401|FG000|Overall Study|Lost to Follow-up|2|||
170671388|NCT03487549|616808402|FG001|Overall Study|Lost to Follow-up|1|||
170671389|NCT03487549|616808401|FG000|Overall Study|Withdrawal by Subject|2|||
170671390|NCT03487549|616808402|FG001|Overall Study|Withdrawal by Subject|0|||
170671391|NCT01453361|616808405|FG000|Overall Study|Disease Progression|6|||
170671392|NCT01453361|616808405|FG000|Overall Study|Screen-Failures|10|||
170671393|NCT01752985|616808406|FG000|Treatment Period|Subject request to discontinue treatment|1|||
170671394|NCT01752985|616808407|FG001|Treatment Period|Subject request to discontinue treatment|0|||
170671395|NCT01752985|616808408|FG002|Treatment Period|Subject request to discontinue treatment|1|||
170671396|NCT01752985|616808406|FG000|Treatment Period|Subject no longer meets study criteria|0|||
170671397|NCT01752985|616808407|FG001|Treatment Period|Subject no longer meets study criteria|1|||
170671398|NCT01752985|616808408|FG002|Treatment Period|Subject no longer meets study criteria|1|||
170671399|NCT01752985|616808406|FG000|Treatment Period|Adverse Event|2|||
170671400|NCT01752985|616808407|FG001|Treatment Period|Adverse Event|1|||
170671401|NCT01752985|616808408|FG002|Treatment Period|Adverse Event|2|||
170671402|NCT01752985|616808406|FG000|Treatment Period|Withdrawal by Subject|1|||
170671403|NCT01752985|616808407|FG001|Treatment Period|Withdrawal by Subject|1|||
170671404|NCT01752985|616808408|FG002|Treatment Period|Withdrawal by Subject|0|||
170671405|NCT01752985|616808406|FG000|Treatment Period|Lost to Follow-up|0|||
170671406|NCT01752985|616808407|FG001|Treatment Period|Lost to Follow-up|0|||
170671407|NCT01752985|616808408|FG002|Treatment Period|Lost to Follow-up|1|||
170671408|NCT06934993|616808413|FG000|Overall Study|Withdrawal by Subject|29|||
170671409|NCT06934993|616808413|FG000|Overall Study|elevated postoperative creatinine level|11|||
170671410|NCT06934993|616808413|FG000|Overall Study|Death|3|||
170671411|NCT05147428|616808414|FG000|Overall Study|Removed prior to mailing|289|||
170671412|NCT05147428|616808415|FG001|Overall Study|Removed prior to mailing|306|||
170671413|NCT05147428|616808416|FG002|Overall Study|Removed prior to mailing|270|||
170671414|NCT05147428|616808414|FG000|Overall Study|Died or disenrolled during blackout period|239|||
170671415|NCT05147428|616808415|FG001|Overall Study|Died or disenrolled during blackout period|278|||
170671416|NCT05147428|616808416|FG002|Overall Study|Died or disenrolled during blackout period|273|||
170671417|NCT02468674|616810514|FG000|Overall Study|Adverse Event|0|||
170671418|NCT02468674|616810515|FG001|Overall Study|Adverse Event|0|||
170671419|NCT02468674|616810516|FG002|Overall Study|Adverse Event|0|||
170671420|NCT02468674|616810517|FG003|Overall Study|Adverse Event|1|||
170671421|NCT02468674|616810518|FG004|Overall Study|Adverse Event|0|||
170671422|NCT02468674|616810519|FG005|Overall Study|Adverse Event|1|||
170671423|NCT02468674|616810520|FG006|Overall Study|Adverse Event|0|||
170671424|NCT02468674|616810521|FG007|Overall Study|Adverse Event|0|||
170671425|NCT02468674|616810522|FG008|Overall Study|Adverse Event|0|||
170671426|NCT02468674|616810514|FG000|Overall Study|Lost to Follow-up|1|||
170671427|NCT02468674|616810515|FG001|Overall Study|Lost to Follow-up|0|||
170671428|NCT02468674|616810516|FG002|Overall Study|Lost to Follow-up|0|||
170671429|NCT02468674|616810517|FG003|Overall Study|Lost to Follow-up|0|||
170671430|NCT02468674|616810518|FG004|Overall Study|Lost to Follow-up|0|||
170671431|NCT02468674|616810519|FG005|Overall Study|Lost to Follow-up|0|||
170671432|NCT02468674|616810520|FG006|Overall Study|Lost to Follow-up|0|||
170671433|NCT02468674|616810521|FG007|Overall Study|Lost to Follow-up|1|||
170671434|NCT02468674|616810522|FG008|Overall Study|Lost to Follow-up|1|||
170671435|NCT02468674|616810514|FG000|Overall Study|Physician Decision|0|||
170671436|NCT02468674|616810515|FG001|Overall Study|Physician Decision|0|||
170671437|NCT02468674|616810516|FG002|Overall Study|Physician Decision|0|||
170671438|NCT02468674|616810517|FG003|Overall Study|Physician Decision|0|||
170671439|NCT02468674|616810518|FG004|Overall Study|Physician Decision|0|||
170671440|NCT02468674|616810519|FG005|Overall Study|Physician Decision|0|||
170671441|NCT02468674|616810520|FG006|Overall Study|Physician Decision|1|||
170671442|NCT02468674|616810521|FG007|Overall Study|Physician Decision|0|||
170671443|NCT02468674|616810522|FG008|Overall Study|Physician Decision|0|||
170671444|NCT02468674|616810514|FG000|Overall Study|Patient/Guardian Decision|0|||
170671445|NCT02468674|616810515|FG001|Overall Study|Patient/Guardian Decision|0|||
170671446|NCT02468674|616810516|FG002|Overall Study|Patient/Guardian Decision|0|||
170671447|NCT02468674|616810517|FG003|Overall Study|Patient/Guardian Decision|0|||
170671448|NCT02468674|616810518|FG004|Overall Study|Patient/Guardian Decision|1|||
170671449|NCT02468674|616810519|FG005|Overall Study|Patient/Guardian Decision|0|||
170671450|NCT02468674|616810520|FG006|Overall Study|Patient/Guardian Decision|0|||
170671451|NCT02468674|616810521|FG007|Overall Study|Patient/Guardian Decision|2|||
170671452|NCT02468674|616810522|FG008|Overall Study|Patient/Guardian Decision|1|||
170671453|NCT02468674|616810514|FG000|Overall Study|Protocol Deviation|0|||
170671454|NCT02468674|616810515|FG001|Overall Study|Protocol Deviation|0|||
170671455|NCT02468674|616810516|FG002|Overall Study|Protocol Deviation|0|||
170671456|NCT02468674|616810517|FG003|Overall Study|Protocol Deviation|0|||
170671457|NCT02468674|616810518|FG004|Overall Study|Protocol Deviation|0|||
170671458|NCT02468674|616810519|FG005|Overall Study|Protocol Deviation|0|||
170671459|NCT02468674|616810520|FG006|Overall Study|Protocol Deviation|0|||
170671460|NCT02468674|616810521|FG007|Overall Study|Protocol Deviation|1|||
170671461|NCT02468674|616810522|FG008|Overall Study|Protocol Deviation|1|||
170671462|NCT02200211|616810523|FG000|Overall Study|Lost to Follow-up|7|||
170671463|NCT02200211|616810524|FG001|Overall Study|Lost to Follow-up|7|||
170671464|NCT02200211|616810525|FG002|Overall Study|Lost to Follow-up|1|||
170671465|NCT02200211|616810526|FG003|Overall Study|Lost to Follow-up|2|||
170671466|NCT02200211|616810523|FG000|Overall Study|Withdrawal by Subject|1|||
170671467|NCT02200211|616810524|FG001|Overall Study|Withdrawal by Subject|0|||
170671468|NCT02200211|616810525|FG002|Overall Study|Withdrawal by Subject|0|||
170671469|NCT02200211|616810526|FG003|Overall Study|Withdrawal by Subject|0|||
170671470|NCT00717197|616810534|FG000|Overall Study|Unable to purchase study drug|5|||
170671471|NCT00717197|616810534|FG000|Overall Study|Tumor Progression|1|||
170671472|NCT00717197|616810534|FG000|Overall Study|Physician Decision|1|||
170671473|NCT00982137|616810535|FG000|Overall Study|Lost to Follow-up|0|||
170671474|NCT00982137|616810536|FG001|Overall Study|Lost to Follow-up|0|||
170671475|NCT00982137|616810537|FG002|Overall Study|Lost to Follow-up|0|||
170671476|NCT00982137|616810538|FG003|Overall Study|Lost to Follow-up|1|||
170671477|NCT00982137|616810535|FG000|Overall Study|Withdrawal by Subject|0|||
170671478|NCT00982137|616810536|FG001|Overall Study|Withdrawal by Subject|1|||
170671479|NCT00982137|616810537|FG002|Overall Study|Withdrawal by Subject|0|||
170671480|NCT00982137|616810538|FG003|Overall Study|Withdrawal by Subject|0|||
170671481|NCT01473836|616810541|FG000|Overall Study|Adverse Event|4|||
170671482|NCT01473836|616810541|FG000|Overall Study|Lack of Efficacy|1|||
170671483|NCT01473836|616810541|FG000|Overall Study|Does not meet entrance criteria|1|||
170671484|NCT02550106|616810542|FG000|Overall Study|Adverse Event|1|||
170671485|NCT02550106|616810542|FG000|Overall Study|Lack of Efficacy|3|||
170671486|NCT02550106|616810542|FG000|Overall Study|Protocol Violation|6|||
170671487|NCT02550106|616810542|FG000|Overall Study|Withdrawal by Subject|2|||
170671488|NCT01709513|616810543|FG000|Overall Study|Randomized but not treated|0|||
170671489|NCT01709513|616810544|FG001|Overall Study|Randomized but not treated|1|||
170671490|NCT01709513|616810545|FG002|Overall Study|Randomized but not treated|0|||
170671491|NCT01709513|616810543|FG000|Overall Study|Adverse Event|16|||
170671492|NCT01709513|616810544|FG001|Overall Study|Adverse Event|31|||
170671493|NCT01709513|616810545|FG002|Overall Study|Adverse Event|23|||
170671494|NCT01709513|616810543|FG000|Overall Study|Poor compliance to protocol|2|||
170671495|NCT01709513|616810544|FG001|Overall Study|Poor compliance to protocol|0|||
170671496|NCT01709513|616810545|FG002|Overall Study|Poor compliance to protocol|0|||
170671497|NCT01709513|616810543|FG000|Overall Study|Other|3|||
170671498|NCT01709513|616810544|FG001|Overall Study|Other|11|||
170671499|NCT01709513|616810545|FG002|Overall Study|Other|7|||
170671500|NCT01034631|616810546|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
170671501|NCT01034631|616810547|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
170671502|NCT01034631|616810548|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
170671503|NCT01034631|616810546|FG000|Phase II|Not Evaluable per protocol|0|||
170671504|NCT01034631|616810547|FG001|Phase II|Not Evaluable per protocol|0|||
170671505|NCT01034631|616810548|FG002|Phase II|Not Evaluable per protocol|2|||
170671506|NCT01034631|616810546|FG000|Phase II|Determined Ineligible per protocol|0|||
170671507|NCT01034631|616810547|FG001|Phase II|Determined Ineligible per protocol|1|||
170671508|NCT01034631|616810548|FG002|Phase II|Determined Ineligible per protocol|0|||
170671509|NCT00621985|616810553|FG000|Dexamethasone Admission|Adverse Event|1|||
170671510|NCT05074667|616810554|FG000|Overall Study|Death|1|||
170671511|NCT05074667|616810554|FG000|Overall Study|Withdrawal by Subject|4|||
170671512|NCT05074667|616810554|FG000|Overall Study|Lost to Follow-up|10|||
170671513|NCT03068130|616810559|FG000|Overall Study|Adverse Event|19|||
170671514|NCT03068130|616810559|FG000|Overall Study|Death|14|||
170671515|NCT03068130|616810559|FG000|Overall Study|Lost to Follow-up|4|||
170671516|NCT03068130|616810559|FG000|Overall Study|Withdrawal by Subject|26|||
170671517|NCT03068130|616810559|FG000|Overall Study|Administrative Reasons|3|||
170671518|NCT03068130|616810559|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
170671519|NCT03068130|616810559|FG000|Overall Study|Study terminated by sponsor|194|||
170671520|NCT00590720|616810560|FG000|Overall Study|Lost to Follow-up|1|||
170671521|NCT00590720|616810561|FG001|Overall Study|Lost to Follow-up|0|||
170671522|NCT00590720|616810560|FG000|Overall Study|Withdrawal by Subject|0|||
170671523|NCT00590720|616810561|FG001|Overall Study|Withdrawal by Subject|1|||
170671524|NCT04401423|616810562|FG000|Overall Study|Withdrawal by Subject|3|||
170671525|NCT04401423|616810563|FG001|Overall Study|Withdrawal by Subject|1|||
170671526|NCT04401423|616810562|FG000|Overall Study|Physician Decision|2|||
170671527|NCT04401423|616810563|FG001|Overall Study|Physician Decision|1|||
170671528|NCT02478632|616810569|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
170671529|NCT02478632|616810570|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
170671530|NCT02478632|616810569|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
170671531|NCT02478632|616810570|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
170671532|NCT02478632|616810569|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
170671533|NCT02478632|616810570|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
170671534|NCT03039283|616810573|FG000|Overall Study|Protocol Violation|2|||
170671535|NCT01867424|616810574|FG000|Overall Study|Patient noncompliance|2|||
170671536|NCT01867424|616810575|FG001|Overall Study|Patient noncompliance|1|||
170671537|NCT04343261|616810576|FG000|Overall Study|Adverse Event|1|||
170671538|NCT04343261|616810576|FG000|Overall Study|received inadequate amount of antibodies|7|||
170671539|NCT02924571|616810577|FG000|Overall Study|Lost to Follow-up|1|||
170671540|NCT02924571|616810578|FG001|Overall Study|Lost to Follow-up|1|||
170671541|NCT02924571|616810579|FG002|Overall Study|Lost to Follow-up|0|||
170671542|NCT00434954|616810583|FG000|Overall Study|Adverse Event|17|||
170671543|NCT00434954|616810584|FG001|Overall Study|Adverse Event|2|||
170671544|NCT00434954|616810583|FG000|Overall Study|Entry criteria not met|14|||
170671545|NCT00434954|616810584|FG001|Overall Study|Entry criteria not met|16|||
170671546|NCT00434954|616810583|FG000|Overall Study|Lost to Follow-up|0|||
170671547|NCT00434954|616810584|FG001|Overall Study|Lost to Follow-up|1|||
170671548|NCT00434954|616810583|FG000|Overall Study|Physician Decision|6|||
170671549|NCT00434954|616810584|FG001|Overall Study|Physician Decision|3|||
170671550|NCT00434954|616810583|FG000|Overall Study|Protocol Violation|36|||
170671551|NCT00434954|616810584|FG001|Overall Study|Protocol Violation|27|||
170671552|NCT00434954|616810583|FG000|Overall Study|Sponsor decision|1|||
170671553|NCT00434954|616810584|FG001|Overall Study|Sponsor decision|0|||
170671554|NCT00434954|616810583|FG000|Overall Study|Subject decision|8|||
170671555|NCT00434954|616810584|FG001|Overall Study|Subject decision|22|||
170671556|NCT00864721|616810585|FG000|Overall Study|Patient request|11|||
170671557|NCT00864721|616810585|FG000|Overall Study|Hospitalized|1|||
170671558|NCT00864721|616810585|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
170671559|NCT00864721|616810585|FG000|Overall Study|Adverse Event|21|||
170671560|NCT01773733|616810586|FG000|Overall Study|Adverse Event|3286|||
170671561|NCT01773733|616810587|FG001|Overall Study|Adverse Event|540|||
170671562|NCT01773733|616810586|FG000|Overall Study|Pregnancy|28|||
170671563|NCT01773733|616810587|FG001|Overall Study|Pregnancy|0|||
170671564|NCT01773733|616810586|FG000|Overall Study|Other different categories of not compl|55415|||
170671565|NCT01773733|616810587|FG001|Overall Study|Other different categories of not compl|7781|||
170671566|NCT00261807|616810590|FG000|Overall Study|Lost to Follow-up|2|||
170671567|NCT00261807|616810590|FG000|Overall Study|Adverse Event|2|||
170671568|NCT00261807|616810590|FG000|Overall Study|Death|1|||
170671569|NCT00261807|616810590|FG000|Overall Study|Protocol Violation|2|||
170671570|NCT00762229|616810593|FG000|Overall Study|Lost to Follow-up|1|||
170671571|NCT00762229|616810594|FG001|Overall Study|Lost to Follow-up|1|||
170671572|NCT00762229|616810593|FG000|Overall Study|did not recveive intervention|0|||
170671573|NCT00762229|616810594|FG001|Overall Study|did not recveive intervention|1|||
170671574|NCT01416272|616810600|FG000|Overall Study|Unacceptable distance visual acuity|2|||
170671575|NCT01416272|616810600|FG000|Overall Study|Lost to Follow-up|1|||
170671576|NCT01416272|616810600|FG000|Overall Study|Study related complaints|1|||
170671577|NCT02693119|616810601|FG000|Open-Label Period|Withdrawal by Subject|0|||
170671578|NCT02693119|616810602|FG001|Open-Label Period|Withdrawal by Subject|1|||
170671579|NCT01719783|616810603|FG000|Dose 2|Physician Decision|1|||
170671580|NCT01719783|616810604|FG001|Dose 2|Physician Decision|0|||
170671581|NCT01350492|616810605|FG000|Intervention|Lost to Follow-up|2|||
170671582|NCT01350492|616810606|FG001|Intervention|Lost to Follow-up|5|||
170671583|NCT01350492|616810605|FG000|Intervention|Withdrawal by Subject|3|||
170671584|NCT01350492|616810606|FG001|Intervention|Withdrawal by Subject|1|||
170671585|NCT01350492|616810605|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
170671586|NCT01350492|616810606|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
170671587|NCT01350492|616810605|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
170671588|NCT01350492|616810606|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
170671589|NCT00702689|616810607|FG000|Overall Study|Withdrawal by Subject|4|||
170671590|NCT00702689|616810607|FG000|Overall Study|Recurrent malignancy|1|||
170671591|NCT00702689|616810607|FG000|Overall Study|Adverse Event|1|||
170671592|NCT03800173|616810610|FG000|Overall Study|Lost to Follow-up|0|||
170671593|NCT03800173|616810611|FG001|Overall Study|Lost to Follow-up|0|||
170671594|NCT03800173|616810612|FG002|Overall Study|Lost to Follow-up|0|||
170671595|NCT03800173|616810613|FG003|Overall Study|Lost to Follow-up|0|||
170671596|NCT03800173|616810614|FG004|Overall Study|Lost to Follow-up|1|||
170671597|NCT00239590|616810625|FG000|Randomized|Lost to Follow-up|0|||
170671598|NCT00239590|616810626|FG001|Randomized|Lost to Follow-up|1|||
170671599|NCT00239590|616810625|FG000|Randomized|Withdrawal by Subject|0|||
170671600|NCT00239590|616810626|FG001|Randomized|Withdrawal by Subject|1|||
170671601|NCT00239590|616810625|FG000|Completed Study Protocol|Adverse Event|1|||
170671602|NCT00239590|616810626|FG001|Completed Study Protocol|Adverse Event|1|||
170671603|NCT00239590|616810625|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
170671604|NCT00239590|616810626|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
170671605|NCT05306977|616810632|FG000|Overall Study|Withdrawal by Subject|1|||
170671606|NCT00369824|616810633|FG000|Overall Study|Adverse Event|0|||
170625854|NCT00880620|616640971|FG003|Overall Study|Other|2|||
170671607|NCT00369824|616810634|FG001|Overall Study|Adverse Event|2|||
170671608|NCT00369824|616810635|FG002|Overall Study|Adverse Event|0|||
170671609|NCT00369824|616810636|FG003|Overall Study|Adverse Event|0|||
170671610|NCT00369824|616810637|FG004|Overall Study|Adverse Event|1|||
170671611|NCT00369824|616810638|FG005|Overall Study|Adverse Event|0|||
170671612|NCT00369824|616810633|FG000|Overall Study|Protocol Violation|0|||
170671613|NCT00369824|616810634|FG001|Overall Study|Protocol Violation|1|||
170671614|NCT00369824|616810635|FG002|Overall Study|Protocol Violation|0|||
170671615|NCT00369824|616810636|FG003|Overall Study|Protocol Violation|1|||
170671616|NCT00369824|616810637|FG004|Overall Study|Protocol Violation|1|||
170671617|NCT00369824|616810638|FG005|Overall Study|Protocol Violation|0|||
170671618|NCT00369824|616810633|FG000|Overall Study|Withdrawal by Subject|9|||
170671619|NCT00369824|616810634|FG001|Overall Study|Withdrawal by Subject|5|||
170671620|NCT00369824|616810635|FG002|Overall Study|Withdrawal by Subject|5|||
170671621|NCT00369824|616810636|FG003|Overall Study|Withdrawal by Subject|4|||
170671622|NCT00369824|616810637|FG004|Overall Study|Withdrawal by Subject|6|||
170671623|NCT00369824|616810638|FG005|Overall Study|Withdrawal by Subject|2|||
170671624|NCT00369824|616810633|FG000|Overall Study|Lost to Follow-up|6|||
170671625|NCT00369824|616810634|FG001|Overall Study|Lost to Follow-up|11|||
170671626|NCT00369824|616810635|FG002|Overall Study|Lost to Follow-up|7|||
170671627|NCT00369824|616810636|FG003|Overall Study|Lost to Follow-up|8|||
170671628|NCT00369824|616810637|FG004|Overall Study|Lost to Follow-up|9|||
170671629|NCT00369824|616810638|FG005|Overall Study|Lost to Follow-up|6|||
170671630|NCT00369824|616810633|FG000|Overall Study|Other|0|||
170671631|NCT00369824|616810634|FG001|Overall Study|Other|0|||
170671632|NCT00369824|616810635|FG002|Overall Study|Other|0|||
170671633|NCT00369824|616810636|FG003|Overall Study|Other|2|||
170671634|NCT00369824|616810637|FG004|Overall Study|Other|1|||
170671635|NCT00369824|616810638|FG005|Overall Study|Other|3|||
170671636|NCT01235689|616810639|FG000|Overall Study|Adverse Event|12|||
170671637|NCT01235689|616810640|FG001|Overall Study|Adverse Event|16|||
170671638|NCT01235689|616810639|FG000|Overall Study|Lack of Efficacy|12|||
170671639|NCT01235689|616810640|FG001|Overall Study|Lack of Efficacy|5|||
170671640|NCT01235689|616810639|FG000|Overall Study|Withdrawal by Subject|3|||
170671641|NCT01235689|616810640|FG001|Overall Study|Withdrawal by Subject|4|||
170671642|NCT01235689|616810639|FG000|Overall Study|Lost to Follow-up|1|||
170671643|NCT01235689|616810640|FG001|Overall Study|Lost to Follow-up|2|||
170671644|NCT01235689|616810639|FG000|Overall Study|Miscellaneous|1|||
170671645|NCT01235689|616810640|FG001|Overall Study|Miscellaneous|5|||
170671646|NCT01390649|616810641|FG000|Overall Study|Physician Decision|1|||
170671647|NCT02217878|616810642|FG000|Overall Study|required morphine due to chest pain|1|||
170671648|NCT02217878|616810643|FG001|Overall Study|required morphine due to chest pain|2|||
170671649|NCT02217878|616810642|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
170671650|NCT02217878|616810643|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
170671651|NCT00003487|616810645|FG000|Overall Study|Not evaluable|2|||
170671652|NCT00334958|616810648|FG000|Overall Study|Medication Noncompliance|0|||
170671653|NCT00334958|616810649|FG001|Overall Study|Medication Noncompliance|3|||
170671654|NCT00334958|616810648|FG000|Overall Study|Protocol Violation|2|||
170671655|NCT00334958|616810649|FG001|Overall Study|Protocol Violation|2|||
170671656|NCT00334958|616810648|FG000|Overall Study|Request of the investigator or sponsor|0|||
170671657|NCT00334958|616810649|FG001|Overall Study|Request of the investigator or sponsor|1|||
170671658|NCT00334958|616810648|FG000|Overall Study|Withdrawal by Subject|7|||
170671659|NCT00334958|616810649|FG001|Overall Study|Withdrawal by Subject|4|||
170671660|NCT00334958|616810648|FG000|Overall Study|Adverse Event|27|||
170671661|NCT00334958|616810649|FG001|Overall Study|Adverse Event|12|||
170625855|NCT00301808|616640972|FG000|Overall Study|Adverse Event|5|||
170625856|NCT00301808|616640972|FG000|Overall Study|Death|3|||
170625857|NCT00301808|616640972|FG000|Overall Study|Lack of Efficacy|4|||
170625858|NCT03474588|616640973|FG000|Overall Study|Withdrawal by Subject|4|||
170625859|NCT03474588|616640974|FG001|Overall Study|Withdrawal by Subject|3|||
170625860|NCT03474588|616640973|FG000|Overall Study|Death|0|||
170625861|NCT03474588|616640974|FG001|Overall Study|Death|1|||
170625862|NCT01607957|616640976|FG000|Overall Study|Not treated|1|||
170625863|NCT01607957|616640977|FG001|Overall Study|Not treated|1|||
170625864|NCT01607957|616640976|FG000|Overall Study|Death|367|||
170625865|NCT01607957|616640977|FG001|Overall Study|Death|211|||
170671662|NCT00334958|616810648|FG000|Overall Study|Other|1|||
170671663|NCT00334958|616810649|FG001|Overall Study|Other|2|||
170671664|NCT00241358|616810651|FG000|Overall Study|Determined to be not ineligible|0|||
170671665|NCT00241358|616810652|FG001|Overall Study|Determined to be not ineligible|1|||
170671666|NCT00241358|616810653|FG002|Overall Study|Determined to be not ineligible|1|||
170671667|NCT00806351|616810662|FG000|Overall Study|Death|5|||
170625866|NCT01607957|616640976|FG000|Overall Study|Lost to Follow-up|3|||
170671668|NCT00806351|616810663|FG001|Overall Study|Death|4|||
170671669|NCT00087607|616810664|FG000|Overall Study|Adverse Event|14|||
170671670|NCT00087607|616810665|FG001|Overall Study|Adverse Event|24|||
170671671|NCT00087607|616810664|FG000|Overall Study|Death|0|||
170671672|NCT00087607|616810665|FG001|Overall Study|Death|1|||
170671673|NCT00087607|616810664|FG000|Overall Study|Insufficient Therapeutic Response|53|||
170671674|NCT00087607|616810665|FG001|Overall Study|Insufficient Therapeutic Response|42|||
170671675|NCT00087607|616810664|FG000|Overall Study|Failure to return|21|||
170671676|NCT00087607|616810665|FG001|Overall Study|Failure to return|17|||
170671677|NCT00087607|616810664|FG000|Overall Study|Withdrew Consent|12|||
170671678|NCT00087607|616810665|FG001|Overall Study|Withdrew Consent|16|||
170671679|NCT00087607|616810664|FG000|Overall Study|Administrative|12|||
170671680|NCT00087607|616810665|FG001|Overall Study|Administrative|12|||
170671681|NCT00087607|616810664|FG000|Overall Study|Refused Treatment|5|||
170671682|NCT00087607|616810665|FG001|Overall Study|Refused Treatment|7|||
170671683|NCT00087607|616810664|FG000|Overall Study|Other Protocol Violation|5|||
170671684|NCT00087607|616810665|FG001|Overall Study|Other Protocol Violation|2|||
170671685|NCT00087607|616810664|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
170671686|NCT00087607|616810665|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
170671687|NCT02699593|616810666|FG000|Period 1|Unsatisfactory Visual Response|0|||
170671688|NCT02699593|616810667|FG001|Period 1|Unsatisfactory Visual Response|1|||
170671689|NCT02699593|616810666|FG000|Period 1|Torn Contact Len|4|||
170671690|NCT02699593|616810667|FG001|Period 1|Torn Contact Len|3|||
170671691|NCT02699593|616810666|FG000|Period 1|Protocol Violation|0|||
170671692|NCT02699593|616810667|FG001|Period 1|Protocol Violation|1|||
170671693|NCT02699593|616810666|FG000|Period 1|Withdrawal by Subject|0|||
170671694|NCT02699593|616810667|FG001|Period 1|Withdrawal by Subject|1|||
170671695|NCT02699593|616810666|FG000|Period 1|Adverse Event|1|||
170671696|NCT02699593|616810667|FG001|Period 1|Adverse Event|1|||
170671697|NCT02699593|616810666|FG000|Period 2|Adverse Event|1|||
170671698|NCT02699593|616810667|FG001|Period 2|Adverse Event|1|||
170671699|NCT02699593|616810666|FG000|Period 2|Lost Contact Lens|0|||
170671700|NCT02699593|616810667|FG001|Period 2|Lost Contact Lens|1|||
170671701|NCT02699593|616810666|FG000|Period 2|Torn Contact Lens|1|||
170671702|NCT02699593|616810667|FG001|Period 2|Torn Contact Lens|0|||
170671703|NCT04502433|616810668|FG000|Overall Study|Death|2|||
170671704|NCT04502433|616810669|FG001|Overall Study|Death|4|||
170671705|NCT04502433|616810668|FG000|Overall Study|Lost to Follow-up|1|||
170671706|NCT04502433|616810669|FG001|Overall Study|Lost to Follow-up|0|||
170671707|NCT04502433|616810668|FG000|Overall Study|Physician Decision|0|||
170671708|NCT04502433|616810669|FG001|Overall Study|Physician Decision|1|||
170671709|NCT02015754|616810670|FG000|Overall Study|Disease progression|5|||
170671710|NCT02015754|616810670|FG000|Overall Study|Change in treatment modality|5|||
170671711|NCT02015754|616810670|FG000|Overall Study|Lost to Follow-up|1|||
170671712|NCT02538029|616810672|FG000|Overall Study|unable to complete cognitive assessments|1|||
170671713|NCT02538029|616810673|FG001|Overall Study|unable to complete cognitive assessments|0|||
170671714|NCT02538029|616810674|FG002|Overall Study|unable to complete cognitive assessments|1|||
170671715|NCT01064310|616810677|FG000|Period 1|Adverse Event|7|||
170671716|NCT01064310|616810678|FG001|Period 1|Adverse Event|10|||
170671717|NCT01064310|616810679|FG002|Period 1|Adverse Event|0|||
170671718|NCT01064310|616810677|FG000|Period 1|Physician Decision|1|||
170671719|NCT01064310|616810678|FG001|Period 1|Physician Decision|0|||
170671720|NCT01064310|616810679|FG002|Period 1|Physician Decision|0|||
170671721|NCT01064310|616810677|FG000|Period 1|Withdrawal by Subject|2|||
170671722|NCT01064310|616810678|FG001|Period 1|Withdrawal by Subject|2|||
170671723|NCT01064310|616810679|FG002|Period 1|Withdrawal by Subject|0|||
170671724|NCT01064310|616810677|FG000|Period 1|Lack of Efficacy|3|||
170671725|NCT01064310|616810678|FG001|Period 1|Lack of Efficacy|5|||
170671726|NCT01064310|616810679|FG002|Period 1|Lack of Efficacy|0|||
170671727|NCT01064310|616810677|FG000|Period 1|Entered Open-label Period|1|||
170671728|NCT01064310|616810678|FG001|Period 1|Entered Open-label Period|1|||
170671729|NCT01064310|616810679|FG002|Period 1|Entered Open-label Period|0|||
170671730|NCT01064310|616810677|FG000|Period 2|Adverse Event|2|||
170671731|NCT01064310|616810678|FG001|Period 2|Adverse Event|1|||
170819891|NCT00296504|617347677|FG002|Interim Analysis|Participant Needed Interferon|0|||
170819892|NCT00296504|617347678|FG003|Interim Analysis|Participant Needed Interferon|0|||
170819893|NCT00296504|617347679|FG004|Interim Analysis|Participant Needed Interferon|0|||
170819894|NCT00296504|617347680|FG005|Interim Analysis|Participant Needed Interferon|0|||
170671732|NCT01064310|616810679|FG002|Period 2|Adverse Event|0|||
170671733|NCT01064310|616810677|FG000|Period 2|Physician Decision|0|||
170671734|NCT01064310|616810678|FG001|Period 2|Physician Decision|1|||
170671735|NCT01064310|616810679|FG002|Period 2|Physician Decision|0|||
170671736|NCT01064310|616810677|FG000|Period 2|Entered Open-label Period|1|||
170671737|NCT01064310|616810678|FG001|Period 2|Entered Open-label Period|0|||
170671738|NCT01064310|616810679|FG002|Period 2|Entered Open-label Period|0|||
170671739|NCT01064310|616810677|FG000|Period 2|Lack of Efficacy|1|||
170671740|NCT01064310|616810678|FG001|Period 2|Lack of Efficacy|4|||
170671741|NCT01064310|616810679|FG002|Period 2|Lack of Efficacy|0|||
170671742|NCT01064310|616810677|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
170671743|NCT01064310|616810678|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
170671744|NCT01064310|616810679|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
170819895|NCT00296504|617347681|FG006|Interim Analysis|Participant Needed Interferon|0|||
170671745|NCT01064310|616810677|FG000|Open Label Pazopinib|Adverse Event|0|||
170819896|NCT00296504|617347682|FG007|Interim Analysis|Participant Needed Interferon|1|||
170671746|NCT01064310|616810678|FG001|Open Label Pazopinib|Adverse Event|0|||
170625867|NCT01607957|616640977|FG001|Overall Study|Lost to Follow-up|3|||
170625868|NCT01607957|616640976|FG000|Overall Study|Participant refusal|1|||
170625869|NCT01607957|616640977|FG001|Overall Study|Participant refusal|0|||
170625870|NCT01691794|616640978|FG000|Overall Study|Poor/Non-Compliance|1|||
170625871|NCT01691794|616640979|FG001|Overall Study|Poor/Non-Compliance|4|||
170625872|NCT01691794|616640980|FG002|Overall Study|Poor/Non-Compliance|1|||
170625873|NCT01691794|616640978|FG000|Overall Study|Death|0|||
170625874|NCT01691794|616640979|FG001|Overall Study|Death|0|||
170625875|NCT01691794|616640980|FG002|Overall Study|Death|1|||
170625876|NCT01691794|616640978|FG000|Overall Study|Lack of Efficacy|0|||
170625877|NCT01691794|616640979|FG001|Overall Study|Lack of Efficacy|7|||
170625878|NCT01691794|616640980|FG002|Overall Study|Lack of Efficacy|1|||
170625879|NCT01691794|616640978|FG000|Overall Study|Participant request to discontinue|0|||
170625880|NCT01691794|616640979|FG001|Overall Study|Participant request to discontinue|1|||
170625881|NCT01691794|616640980|FG002|Overall Study|Participant request to discontinue|0|||
170625882|NCT01691794|616640978|FG000|Overall Study|Adverse Event|0|||
170625883|NCT01691794|616640979|FG001|Overall Study|Adverse Event|1|||
170625884|NCT01691794|616640980|FG002|Overall Study|Adverse Event|1|||
170625885|NCT01691794|616640978|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
170625886|NCT01691794|616640979|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
170625887|NCT01691794|616640980|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
170625888|NCT01691794|616640978|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
170625889|NCT01691794|616640979|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
170625890|NCT01691794|616640980|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
170625891|NCT04972786|616640981|FG000|First Intervention (1 Day)|Adverse Event|1|||
170625892|NCT04972786|616640982|FG001|First Intervention (1 Day)|Adverse Event|0|||
170625893|NCT00844844|616640983|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
170625894|NCT00844844|616640983|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
170625895|NCT00844844|616640983|FG000|Extension Treatment Period|Adverse Event|2|||
170625896|NCT00844844|616640983|FG000|Post Treatment Period|Withdrawal by Subject|1|||
170625897|NCT04659044|616640986|FG000|Induction|Physician Decision|1|||
170625898|NCT04659044|616640986|FG000|Induction|Adverse Event|2|||
170625899|NCT03724942|616640989|FG000|Overall Study|Adverse Event|20|||
170625900|NCT03724942|616640990|FG001|Overall Study|Adverse Event|14|||
170625901|NCT03724942|616640989|FG000|Overall Study|Lack of Efficacy|0|||
170625902|NCT03724942|616640990|FG001|Overall Study|Lack of Efficacy|1|||
170625903|NCT03724942|616640989|FG000|Overall Study|Physician Decision|5|||
170625904|NCT03724942|616640990|FG001|Overall Study|Physician Decision|2|||
170625905|NCT03724942|616640989|FG000|Overall Study|Protocol Violation|1|||
170625906|NCT03724942|616640990|FG001|Overall Study|Protocol Violation|0|||
170625907|NCT03724942|616640989|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
170625908|NCT03724942|616640990|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
170625909|NCT03724942|616640989|FG000|Overall Study|Withdrawal by Legal Representative|3|||
170625910|NCT03724942|616640990|FG001|Overall Study|Withdrawal by Legal Representative|0|||
170625911|NCT00880698|616640993|FG000|Overall Study|Death|0|||
170625912|NCT00880698|616640994|FG001|Overall Study|Death|0|||
170625913|NCT00880698|616640995|FG002|Overall Study|Death|1|||
170625914|NCT00880698|616640996|FG003|Overall Study|Death|2|||
170625915|NCT00880698|616640993|FG000|Overall Study|Lost to Follow-up|1|||
170625916|NCT00880698|616640994|FG001|Overall Study|Lost to Follow-up|3|||
170671747|NCT01064310|616810679|FG002|Open Label Pazopinib|Adverse Event|12|||
170671748|NCT01064310|616810677|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
170671749|NCT01064310|616810678|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
170625917|NCT00880698|616640995|FG002|Overall Study|Lost to Follow-up|0|||
170625918|NCT00880698|616640996|FG003|Overall Study|Lost to Follow-up|1|||
170625919|NCT00079417|616643295|FG000|Overall Study|Physician Decision|2|||
170671750|NCT01064310|616810679|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
170671751|NCT01064310|616810677|FG000|Open Label Pazopinib|Physician Decision|0|||
170671752|NCT01064310|616810678|FG001|Open Label Pazopinib|Physician Decision|0|||
170671753|NCT01064310|616810679|FG002|Open Label Pazopinib|Physician Decision|20|||
170625920|NCT00079417|616643295|FG000|Overall Study|Ineligible|7|||
170625921|NCT03459079|616643303|FG000|Overall Study|Adverse Event|4|||
170625922|NCT03459079|616643304|FG001|Overall Study|Adverse Event|2|||
170625923|NCT03459079|616643305|FG002|Overall Study|Adverse Event|0|||
170625924|NCT03459079|616643303|FG000|Overall Study|Withdrawal by Subject|2|||
170625925|NCT03459079|616643304|FG001|Overall Study|Withdrawal by Subject|2|||
170625926|NCT03459079|616643305|FG002|Overall Study|Withdrawal by Subject|0|||
170625927|NCT00914316|616643317|FG000|Phase 1|Physician Decision|4|||
170625928|NCT00914316|616643318|FG001|Phase 1|Physician Decision|0|||
170625929|NCT00914316|616643319|FG002|Phase 1|Physician Decision|1|||
170625930|NCT00914316|616643320|FG003|Phase 1|Physician Decision|2|||
170625931|NCT00914316|616643317|FG000|Phase 1|Withdrawal by Subject|0|||
170625932|NCT00914316|616643318|FG001|Phase 1|Withdrawal by Subject|2|||
170625933|NCT00914316|616643319|FG002|Phase 1|Withdrawal by Subject|4|||
170625934|NCT00914316|616643320|FG003|Phase 1|Withdrawal by Subject|0|||
170625935|NCT00914316|616643317|FG000|Phase 1|Adverse Event|1|||
170625936|NCT00914316|616643318|FG001|Phase 1|Adverse Event|0|||
170625937|NCT00914316|616643319|FG002|Phase 1|Adverse Event|0|||
170625938|NCT00914316|616643320|FG003|Phase 1|Adverse Event|0|||
170625939|NCT00914316|616643317|FG000|Phase 2|Withdrawal by Subject|1|||
170625940|NCT00914316|616643318|FG001|Phase 2|Withdrawal by Subject|0|||
170625941|NCT00914316|616643319|FG002|Phase 2|Withdrawal by Subject|1|||
170625942|NCT00914316|616643320|FG003|Phase 2|Withdrawal by Subject|0|||
170625943|NCT01391546|616643321|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
170625944|NCT01391546|616643322|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
170625945|NCT05660577|616643324|FG000|Overall Study|Discontinued|9|||
170625946|NCT02156076|616643328|FG000|Treatment Period|no longer meets study criteria|0|||
170625947|NCT02156076|616643329|FG001|Treatment Period|no longer meets study criteria|0|||
170625948|NCT02156076|616643330|FG002|Treatment Period|no longer meets study criteria|1|||
170625949|NCT02156076|616643331|FG003|Treatment Period|no longer meets study criteria|0|||
170625950|NCT02156076|616643328|FG000|Treatment Period|Poor/non-compliance|0|||
170625951|NCT02156076|616643329|FG001|Treatment Period|Poor/non-compliance|1|||
170625952|NCT02156076|616643330|FG002|Treatment Period|Poor/non-compliance|0|||
170625953|NCT02156076|616643331|FG003|Treatment Period|Poor/non-compliance|0|||
170625954|NCT02156076|616643328|FG000|Treatment Period|Lost to Follow-up|0|||
170625955|NCT02156076|616643329|FG001|Treatment Period|Lost to Follow-up|0|||
170625956|NCT02156076|616643330|FG002|Treatment Period|Lost to Follow-up|0|||
170625957|NCT02156076|616643331|FG003|Treatment Period|Lost to Follow-up|1|||
170625958|NCT02156076|616643328|FG000|Treatment Period|Withdrawal by Subject|0|||
170625959|NCT02156076|616643329|FG001|Treatment Period|Withdrawal by Subject|0|||
170625960|NCT02156076|616643330|FG002|Treatment Period|Withdrawal by Subject|1|||
170625961|NCT02156076|616643331|FG003|Treatment Period|Withdrawal by Subject|0|||
170625962|NCT02156076|616643328|FG000|Treatment Period|Subject request to discontinue treatment|0|||
170625963|NCT02156076|616643329|FG001|Treatment Period|Subject request to discontinue treatment|1|||
170625964|NCT02156076|616643330|FG002|Treatment Period|Subject request to discontinue treatment|0|||
170625965|NCT02156076|616643331|FG003|Treatment Period|Subject request to discontinue treatment|0|||
170625966|NCT02156076|616643328|FG000|Treatment Period|Adverse Event|0|||
170625967|NCT02156076|616643329|FG001|Treatment Period|Adverse Event|0|||
170625968|NCT02156076|616643330|FG002|Treatment Period|Adverse Event|0|||
170625969|NCT02156076|616643331|FG003|Treatment Period|Adverse Event|1|||
170625970|NCT02156076|616643328|FG000|Follow-up Period|Withdrawal by Subject|1|||
170625971|NCT02156076|616643329|FG001|Follow-up Period|Withdrawal by Subject|0|||
170625972|NCT02156076|616643330|FG002|Follow-up Period|Withdrawal by Subject|0|||
170625973|NCT02156076|616643331|FG003|Follow-up Period|Withdrawal by Subject|0|||
170625974|NCT01980017|616643332|FG000|Overall Study|Lost to Follow-up|30|||
170625975|NCT01980017|616643333|FG001|Overall Study|Lost to Follow-up|21|||
170625976|NCT01980017|616643332|FG000|Overall Study|Death|0|||
170671754|NCT00001880|616810680|FG000|Overall Study|Death|14|||
170625977|NCT01980017|616643333|FG001|Overall Study|Death|1|||
170625978|NCT03044106|616643334|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
170625979|NCT03044106|616643335|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
170625980|NCT01748292|616643336|FG000|Overall Study|Adverse Event|2|||
170625981|NCT01748292|616643337|FG001|Overall Study|Adverse Event|4|||
170625982|NCT01748292|616643336|FG000|Overall Study|Lost to Follow-up|0|||
170625983|NCT01748292|616643337|FG001|Overall Study|Lost to Follow-up|3|||
170671755|NCT00688753|616812136|FG000|Overall Study|Disease progression|55|||
170819897|NCT00296504|617347683|FG008|Interim Analysis|Participant Needed Interferon|0|||
170819898|NCT00296504|617347675|FG000|Interim Analysis|Ongoing|32|||
170625984|NCT01748292|616643336|FG000|Overall Study|Death|0|||
170625985|NCT01748292|616643337|FG001|Overall Study|Death|3|||
170625986|NCT01748292|616643336|FG000|Overall Study|Withdrawal by Subject|0|||
170625987|NCT01748292|616643337|FG001|Overall Study|Withdrawal by Subject|2|||
170625988|NCT00106704|616643344|FG000|Overall Study|Adverse Event|10|||
170625989|NCT00106704|616643345|FG001|Overall Study|Adverse Event|7|||
170625990|NCT00106704|616643344|FG000|Overall Study|Death|2|||
170625991|NCT00106704|616643345|FG001|Overall Study|Death|1|||
170625992|NCT00106704|616643344|FG000|Overall Study|Lack of Efficacy|67|||
170625993|NCT00106704|616643345|FG001|Overall Study|Lack of Efficacy|69|||
170625994|NCT00106704|616643344|FG000|Overall Study|Lost to Follow-up|7|||
170625995|NCT00106704|616643345|FG001|Overall Study|Lost to Follow-up|3|||
170625996|NCT00106704|616643344|FG000|Overall Study|Pregnancy|1|||
170625997|NCT00106704|616643345|FG001|Overall Study|Pregnancy|0|||
170625998|NCT00106704|616643344|FG000|Overall Study|Protocol Violation|4|||
170625999|NCT00106704|616643345|FG001|Overall Study|Protocol Violation|7|||
170626000|NCT00106704|616643344|FG000|Overall Study|Withdrawal by Subject|14|||
170626001|NCT00106704|616643345|FG001|Overall Study|Withdrawal by Subject|21|||
170626002|NCT00106704|616643344|FG000|Overall Study|Patient moved|1|||
170626003|NCT00106704|616643345|FG001|Overall Study|Patient moved|0|||
170626004|NCT00106704|616643344|FG000|Overall Study|Site terminated|0|||
170626005|NCT00106704|616643345|FG001|Overall Study|Site terminated|1|||
170626006|NCT00106704|616643344|FG000|Overall Study|Planned major surgery|1|||
170626007|NCT00106704|616643345|FG001|Overall Study|Planned major surgery|0|||
170626008|NCT00106704|616643344|FG000|Overall Study|Patient Received Glycemic Medication|22|||
170626009|NCT00106704|616643345|FG001|Overall Study|Patient Received Glycemic Medication|41|||
170626010|NCT00106704|616643344|FG000|Overall Study|Unable to re-enter US|1|||
170626011|NCT00106704|616643345|FG001|Overall Study|Unable to re-enter US|0|||
170626012|NCT00106704|616643344|FG000|Overall Study|Laboratory test|1|||
170626013|NCT00106704|616643345|FG001|Overall Study|Laboratory test|1|||
170626014|NCT00482053|616643348|FG000|Inter-treatment Period|Disease progression|1|||
170626015|NCT02476617|616643351|FG000|Overall Study|Adverse Event|1|||
170626016|NCT02476617|616643351|FG000|Overall Study|Lost to Follow-up|1|||
170626017|NCT01263769|616643352|FG000|Overall Study|Non-Compliant with treatment|1|||
170626018|NCT03267277|616643353|FG000|Overall Study|Withdrawal by Subject|1|||
170626019|NCT03521570|616643355|FG000|Overall Study|Not eligible|11|||
170626020|NCT01345240|616643356|FG000|Overall Study|Adverse Event|3|||
170626021|NCT01345240|616643357|FG001|Overall Study|Adverse Event|5|||
170626022|NCT01345240|616643358|FG002|Overall Study|Adverse Event|4|||
170626023|NCT01345240|616643359|FG003|Overall Study|Adverse Event|2|||
170626024|NCT01345240|616643360|FG004|Overall Study|Adverse Event|1|||
170626025|NCT01345240|616643356|FG000|Overall Study|Lost to Follow-up|8|||
170626026|NCT01345240|616643357|FG001|Overall Study|Lost to Follow-up|9|||
170626027|NCT01345240|616643358|FG002|Overall Study|Lost to Follow-up|14|||
170626028|NCT01345240|616643359|FG003|Overall Study|Lost to Follow-up|7|||
170626029|NCT01345240|616643360|FG004|Overall Study|Lost to Follow-up|9|||
170626030|NCT03557970|616643364|FG000|Overall Study|Study closure|1|||
170626031|NCT03557970|616643365|FG001|Overall Study|Study closure|0|||
170626032|NCT03557970|616643364|FG000|Overall Study|Physician Decision|0|||
170626033|NCT03557970|616643365|FG001|Overall Study|Physician Decision|1|||
170626034|NCT03557970|616643364|FG000|Overall Study|Death|0|||
170626035|NCT03557970|616643365|FG001|Overall Study|Death|1|||
170626036|NCT00231816|616643368|FG000|Overall Study|Adverse Event|1|||
170626037|NCT00231816|616643369|FG001|Overall Study|Adverse Event|0|||
170626038|NCT00231816|616643368|FG000|Overall Study|Lost to Follow-up|8|||
170626039|NCT00231816|616643369|FG001|Overall Study|Lost to Follow-up|5|||
170626040|NCT00231816|616643368|FG000|Overall Study|Protocol Violation|2|||
170626041|NCT00231816|616643369|FG001|Overall Study|Protocol Violation|3|||
170626042|NCT00231816|616643368|FG000|Overall Study|Withdrawal by Subject|3|||
170626043|NCT00231816|616643369|FG001|Overall Study|Withdrawal by Subject|3|||
170626044|NCT00231816|616643368|FG000|Overall Study|Other|2|||
170626045|NCT00231816|616643369|FG001|Overall Study|Other|1|||
170626046|NCT00468169|616643370|FG000|Overall Study|Withdrawal by Subject|1|||
170626047|NCT00468169|616643371|FG001|Overall Study|Withdrawal by Subject|0|||
170626048|NCT00774046|616643372|FG000|Screening|Not eligible|56|||
170626049|NCT00774046|616643372|FG000|Enrollment|Desired other therapy/refused|28|||
170626050|NCT00774046|616643372|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
170626051|NCT01283139|616643374|FG000|Overall Study|Lost to Follow-up|5|||
170626052|NCT01283139|616643375|FG001|Overall Study|Lost to Follow-up|2|||
170626053|NCT01283139|616643376|FG002|Overall Study|Lost to Follow-up|3|||
170626054|NCT01283139|616643377|FG003|Overall Study|Lost to Follow-up|1|||
170626055|NCT01283139|616643374|FG000|Overall Study|Withdrawal by Subject|8|||
170626056|NCT01283139|616643375|FG001|Overall Study|Withdrawal by Subject|8|||
170626057|NCT01283139|616643376|FG002|Overall Study|Withdrawal by Subject|6|||
170626058|NCT01283139|616643377|FG003|Overall Study|Withdrawal by Subject|8|||
170626059|NCT01283139|616643374|FG000|Overall Study|Death|2|||
170626060|NCT01283139|616643375|FG001|Overall Study|Death|0|||
170626061|NCT01283139|616643376|FG002|Overall Study|Death|2|||
170626062|NCT01283139|616643377|FG003|Overall Study|Death|2|||
170626063|NCT01283139|616643374|FG000|Overall Study|Lack of Efficacy|1|||
170626064|NCT01283139|616643375|FG001|Overall Study|Lack of Efficacy|2|||
170626065|NCT01283139|616643376|FG002|Overall Study|Lack of Efficacy|2|||
170626066|NCT01283139|616643377|FG003|Overall Study|Lack of Efficacy|1|||
170626067|NCT01283139|616643374|FG000|Overall Study|Early termination due to AE/SAE|1|||
170626068|NCT01283139|616643375|FG001|Overall Study|Early termination due to AE/SAE|1|||
170626069|NCT01283139|616643376|FG002|Overall Study|Early termination due to AE/SAE|0|||
170626070|NCT01283139|616643377|FG003|Overall Study|Early termination due to AE/SAE|0|||
170626071|NCT01283139|616643374|FG000|Overall Study|Participant's refusal to continue|0|||
170626072|NCT01283139|616643375|FG001|Overall Study|Participant's refusal to continue|3|||
170626073|NCT01283139|616643376|FG002|Overall Study|Participant's refusal to continue|1|||
170626074|NCT01283139|616643377|FG003|Overall Study|Participant's refusal to continue|1|||
170626075|NCT01283139|616643374|FG000|Overall Study|Pregnancy|0|||
170626076|NCT01283139|616643375|FG001|Overall Study|Pregnancy|1|||
170626077|NCT01283139|616643376|FG002|Overall Study|Pregnancy|1|||
170626078|NCT01283139|616643377|FG003|Overall Study|Pregnancy|0|||
170626079|NCT01283139|616643374|FG000|Overall Study|Missed follow-up visit|0|||
170626080|NCT01283139|616643375|FG001|Overall Study|Missed follow-up visit|1|||
170626081|NCT01283139|616643376|FG002|Overall Study|Missed follow-up visit|2|||
170626082|NCT01283139|616643377|FG003|Overall Study|Missed follow-up visit|2|||
170626083|NCT01283139|616643374|FG000|Overall Study|Participant randomized in error|0|||
170626084|NCT01283139|616643375|FG001|Overall Study|Participant randomized in error|0|||
170626085|NCT01283139|616643376|FG002|Overall Study|Participant randomized in error|1|||
170626086|NCT01283139|616643377|FG003|Overall Study|Participant randomized in error|0|||
170626087|NCT03668873|616643378|FG000|Overall Study|Lost to Follow-up|6|||
170626088|NCT03668873|616643379|FG001|Overall Study|Lost to Follow-up|3|||
170626089|NCT00976274|616643382|FG000|Overall Study|Lost to Follow-up|5|||
170626090|NCT00976274|616643383|FG001|Overall Study|Lost to Follow-up|5|||
170626091|NCT00976274|616643382|FG000|Overall Study|Withdrawal by Subject|1|||
170626092|NCT00976274|616643383|FG001|Overall Study|Withdrawal by Subject|1|||
170626093|NCT00976274|616643382|FG000|Overall Study|Physician Decision|1|||
170626094|NCT00976274|616643383|FG001|Overall Study|Physician Decision|2|||
170671756|NCT00688753|616812136|FG000|Overall Study|Missing|1|||
170626095|NCT02183675|616643384|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
170626096|NCT02183675|616643385|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
170626097|NCT02183675|616643386|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
170626098|NCT02183675|616643387|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
170626099|NCT02183675|616643388|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
170626100|NCT02183675|616643389|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
170626101|NCT01521117|616643390|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
170626102|NCT01521117|616643391|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
170626103|NCT01521117|616643390|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
170626104|NCT01521117|616643391|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
170626105|NCT01521117|616643390|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
170626106|NCT01521117|616643391|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
170626107|NCT00004563|616643392|FG000|Overall Study|Withdrawal by Subject|20|||
170626108|NCT00004563|616643393|FG001|Overall Study|Withdrawal by Subject|16|||
170626109|NCT00004563|616643392|FG000|Overall Study|Lack of Efficacy|3|||
170626110|NCT00004563|616643393|FG001|Overall Study|Lack of Efficacy|5|||
170626111|NCT00004563|616643392|FG000|Overall Study|Death|2|||
170626112|NCT00004563|616643393|FG001|Overall Study|Death|3|||
170626113|NCT01056822|616643394|FG000|Overall Study|Adverse Event|0|||
170626114|NCT01056822|616643395|FG001|Overall Study|Adverse Event|1|||
170626115|NCT01056822|616643394|FG000|Overall Study|Protocol Violation|6|||
170626116|NCT01056822|616643395|FG001|Overall Study|Protocol Violation|5|||
170626117|NCT01056822|616643394|FG000|Overall Study|Withdrawal by Subject|1|||
170626118|NCT01056822|616643395|FG001|Overall Study|Withdrawal by Subject|1|||
170626119|NCT01056822|616643394|FG000|Overall Study|Lost to Follow-up|1|||
170626120|NCT01056822|616643395|FG001|Overall Study|Lost to Follow-up|0|||
170626121|NCT01614249|616643398|FG000|Overall Study|Lost to Follow-up|11|||
170626122|NCT01614249|616643399|FG001|Overall Study|Lost to Follow-up|23|||
170626123|NCT05498649|616643400|FG000|Overall Study|Lost to Follow-up|1|||
170626124|NCT02946580|616643401|FG000|Overall Study|Withdrawal by Subject|1|||
170626125|NCT02946580|616643402|FG001|Overall Study|Withdrawal by Subject|2|||
170626126|NCT02946580|616643401|FG000|Overall Study|Adverse Event|0|||
170626127|NCT02946580|616643402|FG001|Overall Study|Adverse Event|2|||
170626128|NCT02946580|616643401|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
170626129|NCT02946580|616643402|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
170626130|NCT03094416|616643403|FG000|Run-in|Screening failure|8|||
170626131|NCT03094416|616643403|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
170626132|NCT03094416|616643403|FG000|Run-in|Withdrawal by Subject|3|||
170626133|NCT03094416|616643403|FG000|Treatment Period|Withdrawal by Subject|2|||
170626134|NCT02158442|616643404|FG000|Overall Study|Withdrawal by Subject|1|||
170626135|NCT02158442|616643405|FG001|Overall Study|Withdrawal by Subject|0|||
170626136|NCT02158442|616643404|FG000|Overall Study|Perfusion staff not available|1|||
170626137|NCT02158442|616643405|FG001|Overall Study|Perfusion staff not available|0|||
170626138|NCT00685165|616643409|FG000|Washout Period of 14 Days|Adverse Event|1|||
170626139|NCT00685165|616643410|FG001|Washout Period of 14 Days|Adverse Event|0|||
170626140|NCT02246530|616643420|FG000|Overall Study|Lost to Follow-up|4|||
170626141|NCT02246530|616643421|FG001|Overall Study|Lost to Follow-up|0|||
170626142|NCT00617734|616643422|FG000|Overall Study|Withdrew Consent|2|||
170626143|NCT00617734|616643423|FG001|Overall Study|Withdrew Consent|0|||
170626144|NCT00617734|616643422|FG000|Overall Study|Adverse Event|4|||
170626145|NCT00617734|616643423|FG001|Overall Study|Adverse Event|1|||
170626146|NCT00617734|616643422|FG000|Overall Study|Protocol Violation|1|||
170626147|NCT00617734|616643423|FG001|Overall Study|Protocol Violation|0|||
170626148|NCT00617734|616643422|FG000|Overall Study|Found Ineligible After Randomization|1|||
170626149|NCT00617734|616643423|FG001|Overall Study|Found Ineligible After Randomization|4|||
170626150|NCT00617734|616643422|FG000|Overall Study|Lost to Follow-up|0|||
170626151|NCT00617734|616643423|FG001|Overall Study|Lost to Follow-up|1|||
170626152|NCT01844765|616643424|FG000|Overall Study|Adverse Event|6|||
170626153|NCT01844765|616643425|FG001|Overall Study|Adverse Event|8|||
170626154|NCT01844765|616643424|FG000|Overall Study|Withdrawal by Subject|2|||
170626155|NCT01844765|616643425|FG001|Overall Study|Withdrawal by Subject|3|||
170671757|NCT00688753|616812136|FG000|Overall Study|Death|9|||
170626156|NCT01844765|616643424|FG000|Overall Study|Disease progression|1|||
170626157|NCT01844765|616643425|FG001|Overall Study|Disease progression|0|||
170626158|NCT01844765|616643424|FG000|Overall Study|Administrative problems|3|||
170626159|NCT01844765|616643425|FG001|Overall Study|Administrative problems|4|||
170626160|NCT01844765|616643424|FG000|Overall Study|Protocol deviation|2|||
170626161|NCT01844765|616643425|FG001|Overall Study|Protocol deviation|0|||
170626162|NCT01844765|616643424|FG000|Overall Study|Untreated|1|||
170626163|NCT01844765|616643425|FG001|Overall Study|Untreated|0|||
170626164|NCT00395746|616643426|FG000|Overall Study|Adverse Event|5|||
170626165|NCT00395746|616643427|FG001|Overall Study|Adverse Event|2|||
170626166|NCT00395746|616643428|FG002|Overall Study|Adverse Event|2|||
170626167|NCT00395746|616643426|FG000|Overall Study|Protocol Violation|0|||
170626168|NCT00395746|616643427|FG001|Overall Study|Protocol Violation|1|||
170626169|NCT00395746|616643428|FG002|Overall Study|Protocol Violation|0|||
170626170|NCT00395746|616643426|FG000|Overall Study|Lack of Efficacy|2|||
170626171|NCT00395746|616643427|FG001|Overall Study|Lack of Efficacy|0|||
170626172|NCT00395746|616643428|FG002|Overall Study|Lack of Efficacy|17|||
170626173|NCT00395746|616643426|FG000|Overall Study|Hypoglycaemia|2|||
170626174|NCT00395746|616643427|FG001|Overall Study|Hypoglycaemia|1|||
170626175|NCT00395746|616643428|FG002|Overall Study|Hypoglycaemia|0|||
170626176|NCT00395746|616643426|FG000|Overall Study|Subject decision|0|||
170626177|NCT00395746|616643427|FG001|Overall Study|Subject decision|0|||
170626178|NCT00395746|616643428|FG002|Overall Study|Subject decision|1|||
170626179|NCT00395746|616643426|FG000|Overall Study|Withdrawal of consent|0|||
170626180|NCT00395746|616643427|FG001|Overall Study|Withdrawal of consent|0|||
170626181|NCT00395746|616643428|FG002|Overall Study|Withdrawal of consent|1|||
170626182|NCT00395746|616643426|FG000|Overall Study|Difficultulty in use of device|0|||
170626183|NCT00395746|616643427|FG001|Overall Study|Difficultulty in use of device|0|||
170626184|NCT00395746|616643428|FG002|Overall Study|Difficultulty in use of device|1|||
170626185|NCT00395746|616643426|FG000|Overall Study|Unable to visit site on schedule|1|||
170626186|NCT00395746|616643427|FG001|Overall Study|Unable to visit site on schedule|0|||
170626187|NCT00395746|616643428|FG002|Overall Study|Unable to visit site on schedule|0|||
170626188|NCT04528641|616643429|FG000|Overall Study|Withdrawal by Subject|0|||
170626189|NCT04528641|616643430|FG001|Overall Study|Withdrawal by Subject|0|||
170626190|NCT04528641|616643431|FG002|Overall Study|Withdrawal by Subject|0|||
170626191|NCT04528641|616643432|FG003|Overall Study|Withdrawal by Subject|1|||
170626192|NCT04528641|616643433|FG004|Overall Study|Withdrawal by Subject|0|||
170626193|NCT04528641|616643434|FG005|Overall Study|Withdrawal by Subject|1|||
170626194|NCT03361137|616643437|FG000|Overall Study|Reason not specified|1|||
170626195|NCT03361137|616643438|FG001|Overall Study|Reason not specified|0|||
170671758|NCT00688753|616812136|FG000|Overall Study|Withdrawal by Subject|3|||
170671759|NCT00688753|616812136|FG000|Overall Study|Adverse Event|20|||
170671760|NCT00688753|616812136|FG000|Overall Study|Protocol Violation|1|||
170671761|NCT00688753|616812136|FG000|Overall Study|Lost to Follow-up|3|||
170671762|NCT03749447|616812145|FG000|Overall Study|Adverse Event|11|||
170671763|NCT03749447|616812146|FG001|Overall Study|Adverse Event|3|||
170671764|NCT03749447|616812145|FG000|Overall Study|Death|1|||
170671765|NCT03749447|616812146|FG001|Overall Study|Death|1|||
170671766|NCT03749447|616812145|FG000|Overall Study|Lost to Follow-up|2|||
170671767|NCT03749447|616812146|FG001|Overall Study|Lost to Follow-up|2|||
170671768|NCT03749447|616812145|FG000|Overall Study|Reason Not Specified|0|||
170671769|NCT03749447|616812146|FG001|Overall Study|Reason Not Specified|3|||
170671770|NCT03749447|616812145|FG000|Overall Study|Physician Decision|4|||
170671771|NCT03749447|616812146|FG001|Overall Study|Physician Decision|3|||
170671772|NCT03749447|616812145|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
170671773|NCT03749447|616812146|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
170671774|NCT03749447|616812145|FG000|Overall Study|Study Terminated By Sponsor|112|||
170671775|NCT03749447|616812146|FG001|Overall Study|Study Terminated By Sponsor|105|||
170671776|NCT03749447|616812145|FG000|Overall Study|Withdrawal by Subject|12|||
170671777|NCT03749447|616812146|FG001|Overall Study|Withdrawal by Subject|6|||
170671778|NCT03749447|616812145|FG000|Overall Study|Non-compliance With Study Drug|0|||
170671779|NCT03749447|616812146|FG001|Overall Study|Non-compliance With Study Drug|1|||
170671780|NCT03192462|616812147|FG000|Overall Study|Death|13|||
170671781|NCT03192462|616812148|FG001|Overall Study|Death|11|||
170671782|NCT03192462|616812149|FG002|Overall Study|Death|10|||
170671783|NCT03192462|616812147|FG000|Overall Study|Lost to Follow-up|0|||
170671784|NCT03192462|616812148|FG001|Overall Study|Lost to Follow-up|1|||
170671785|NCT03192462|616812149|FG002|Overall Study|Lost to Follow-up|0|||
170671786|NCT03187197|616812151|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
170671787|NCT03187197|616812152|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
170671788|NCT03187197|616812153|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
170671789|NCT03187197|616812151|FG000|Overall Study|Withdrawal by Subject|8|||
170671790|NCT03187197|616812152|FG001|Overall Study|Withdrawal by Subject|63|||
170671791|NCT03187197|616812153|FG002|Overall Study|Withdrawal by Subject|4|||
170671792|NCT03187197|616812151|FG000|Overall Study|Lost to Follow-up|1|||
170671793|NCT03187197|616812152|FG001|Overall Study|Lost to Follow-up|60|||
170626196|NCT03361137|616643439|FG002|Overall Study|Reason not specified|0|||
170626197|NCT03361137|616643440|FG003|Overall Study|Reason not specified|0|||
170626198|NCT03361137|616643441|FG004|Overall Study|Reason not specified|0|||
170671794|NCT03187197|616812153|FG002|Overall Study|Lost to Follow-up|7|||
170671795|NCT03187197|616812151|FG000|Overall Study|Adverse Event|6|||
170671796|NCT03187197|616812152|FG001|Overall Study|Adverse Event|29|||
170671797|NCT03187197|616812153|FG002|Overall Study|Adverse Event|0|||
170671798|NCT03187197|616812151|FG000|Overall Study|Death|0|||
170671799|NCT03187197|616812152|FG001|Overall Study|Death|11|||
170626199|NCT00791934|616643442|FG000|Overall Study|Withdrawal by Subject|2|||
170626200|NCT00791934|616643442|FG000|Overall Study|Did not consent for extended follow-up|13|||
170671800|NCT03187197|616812153|FG002|Overall Study|Death|0|||
170671801|NCT03187197|616812151|FG000|Overall Study|Administrative problem|1|||
170671802|NCT03187197|616812152|FG001|Overall Study|Administrative problem|1|||
170671803|NCT03187197|616812153|FG002|Overall Study|Administrative problem|0|||
170671804|NCT03187197|616812151|FG000|Overall Study|Reason not listed|2|||
170671805|NCT03187197|616812152|FG001|Overall Study|Reason not listed|54|||
170671806|NCT03187197|616812153|FG002|Overall Study|Reason not listed|1|||
170671807|NCT03187197|616812151|FG000|Overall Study|Missing|1|||
170671808|NCT03187197|616812152|FG001|Overall Study|Missing|32|||
170671809|NCT03187197|616812153|FG002|Overall Study|Missing|3|||
170671810|NCT03187197|616812151|FG000|Overall Study|Status missing|2|||
170671811|NCT03187197|616812152|FG001|Overall Study|Status missing|33|||
170671812|NCT03187197|616812153|FG002|Overall Study|Status missing|3|||
170671813|NCT03187197|616812151|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
170671814|NCT03187197|616812152|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
170671815|NCT03187197|616812153|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
170671816|NCT00259649|616812154|FG000|Overall Study|Lost to Follow-up|7|||
170671817|NCT00259649|616812154|FG000|Overall Study|irregular menses|3|||
170671818|NCT00126191|616812155|FG000|Overall Study|Physician Decision|0|||
170671819|NCT00126191|616812156|FG001|Overall Study|Physician Decision|1|||
170671820|NCT00126191|616812155|FG000|Overall Study|Death|0|||
170671821|NCT00126191|616812156|FG001|Overall Study|Death|1|||
170671822|NCT01898806|616812157|FG000|Overall Study|Withdrawal by Subject|2|||
170671823|NCT01898806|616812157|FG000|Overall Study|Physician Decision|1|||
170671824|NCT02501473|616812160|FG000|Overall Study|Study Terminated|2|||
170671825|NCT02501473|616812161|FG001|Overall Study|Study Terminated|3|||
170671826|NCT02501473|616812162|FG002|Overall Study|Study Terminated|7|||
170671827|NCT02501473|616812163|FG003|Overall Study|Study Terminated|9|||
170671828|NCT02501473|616812164|FG004|Overall Study|Study Terminated|2|||
170671829|NCT02501473|616812165|FG005|Overall Study|Study Terminated|10|||
170671830|NCT02501473|616812166|FG006|Overall Study|Study Terminated|1|||
170671831|NCT02501473|616812167|FG007|Overall Study|Study Terminated|0|||
170671832|NCT02501473|616812160|FG000|Overall Study|Withdrawal by Subject|0|||
170671833|NCT02501473|616812161|FG001|Overall Study|Withdrawal by Subject|0|||
170671834|NCT02501473|616812162|FG002|Overall Study|Withdrawal by Subject|3|||
170671835|NCT02501473|616812163|FG003|Overall Study|Withdrawal by Subject|3|||
170671836|NCT02501473|616812164|FG004|Overall Study|Withdrawal by Subject|2|||
170819899|NCT00296504|617347676|FG001|Interim Analysis|Ongoing|12|||
170819900|NCT00296504|617347677|FG002|Interim Analysis|Ongoing|16|||
170626201|NCT03413891|616643444|FG000|Overall Study|Lost to Follow-up|2|||
170626202|NCT03413891|616643445|FG001|Overall Study|Lost to Follow-up|1|||
170626203|NCT03413891|616643444|FG000|Overall Study|Protocol Violation|0|||
170626204|NCT03413891|616643445|FG001|Overall Study|Protocol Violation|1|||
170626205|NCT00795704|616643448|FG000|Overall Study|Withdrawal by Subject|3|||
170626206|NCT00795704|616643449|FG001|Overall Study|Withdrawal by Subject|2|||
170626207|NCT00795704|616643448|FG000|Overall Study|Adverse Event|1|||
170626208|NCT00795704|616643449|FG001|Overall Study|Adverse Event|1|||
170626209|NCT00506350|616643450|FG000|Overall Study|Serious Adverse Event|1|||
170626210|NCT00506350|616643451|FG001|Overall Study|Serious Adverse Event|0|||
170626211|NCT00506350|616643452|FG002|Overall Study|Serious Adverse Event|0|||
170626212|NCT00506350|616643453|FG003|Overall Study|Serious Adverse Event|0|||
170626213|NCT00506350|616643454|FG004|Overall Study|Serious Adverse Event|0|||
170626214|NCT00506350|616643455|FG005|Overall Study|Serious Adverse Event|0|||
170626215|NCT00506350|616643456|FG006|Overall Study|Serious Adverse Event|0|||
170626216|NCT00506350|616643457|FG007|Overall Study|Serious Adverse Event|0|||
170626217|NCT00506350|616643458|FG008|Overall Study|Serious Adverse Event|0|||
170626218|NCT00506350|616643450|FG000|Overall Study|Adverse Event|0|||
170626219|NCT00506350|616643451|FG001|Overall Study|Adverse Event|0|||
170626220|NCT00506350|616643452|FG002|Overall Study|Adverse Event|0|||
170626221|NCT00506350|616643453|FG003|Overall Study|Adverse Event|0|||
170626222|NCT00506350|616643454|FG004|Overall Study|Adverse Event|0|||
170626223|NCT00506350|616643455|FG005|Overall Study|Adverse Event|0|||
170626224|NCT00506350|616643456|FG006|Overall Study|Adverse Event|0|||
170626225|NCT00506350|616643457|FG007|Overall Study|Adverse Event|1|||
170626226|NCT00506350|616643458|FG008|Overall Study|Adverse Event|1|||
170626227|NCT00506350|616643450|FG000|Overall Study|Protocol Violation|0|||
170819901|NCT00296504|617347678|FG003|Interim Analysis|Ongoing|22|||
170819902|NCT00296504|617347679|FG004|Interim Analysis|Ongoing|0|||
170626228|NCT00506350|616643451|FG001|Overall Study|Protocol Violation|0|||
170626229|NCT00506350|616643452|FG002|Overall Study|Protocol Violation|1|||
170671837|NCT02501473|616812165|FG005|Overall Study|Withdrawal by Subject|2|||
170671838|NCT02501473|616812166|FG006|Overall Study|Withdrawal by Subject|0|||
170671839|NCT02501473|616812167|FG007|Overall Study|Withdrawal by Subject|0|||
170819903|NCT00296504|617347680|FG005|Interim Analysis|Ongoing|0|||
170626230|NCT00506350|616643453|FG003|Overall Study|Protocol Violation|0|||
170671840|NCT02501473|616812160|FG000|Overall Study|Death|0|||
170671841|NCT02501473|616812161|FG001|Overall Study|Death|0|||
170819904|NCT00296504|617347681|FG006|Interim Analysis|Ongoing|30|||
170626231|NCT00506350|616643454|FG004|Overall Study|Protocol Violation|0|||
170626232|NCT00506350|616643455|FG005|Overall Study|Protocol Violation|0|||
170671842|NCT02501473|616812162|FG002|Overall Study|Death|1|||
170671843|NCT02501473|616812163|FG003|Overall Study|Death|1|||
170671844|NCT02501473|616812164|FG004|Overall Study|Death|0|||
170671845|NCT02501473|616812165|FG005|Overall Study|Death|1|||
170819905|NCT00296504|617347682|FG007|Interim Analysis|Ongoing|1|||
170626233|NCT00506350|616643456|FG006|Overall Study|Protocol Violation|1|||
170626234|NCT00506350|616643457|FG007|Overall Study|Protocol Violation|0|||
170626235|NCT00506350|616643458|FG008|Overall Study|Protocol Violation|0|||
170626236|NCT00506350|616643450|FG000|Overall Study|Withdrawal by Subject|0|||
170626237|NCT00506350|616643451|FG001|Overall Study|Withdrawal by Subject|1|||
170626238|NCT00506350|616643452|FG002|Overall Study|Withdrawal by Subject|1|||
170626239|NCT00506350|616643453|FG003|Overall Study|Withdrawal by Subject|1|||
170626240|NCT00506350|616643454|FG004|Overall Study|Withdrawal by Subject|4|||
170626241|NCT00506350|616643455|FG005|Overall Study|Withdrawal by Subject|1|||
170626242|NCT00506350|616643456|FG006|Overall Study|Withdrawal by Subject|1|||
170626243|NCT00506350|616643457|FG007|Overall Study|Withdrawal by Subject|2|||
170626244|NCT00506350|616643458|FG008|Overall Study|Withdrawal by Subject|0|||
170626245|NCT00506350|616643450|FG000|Overall Study|Lost to Follow-up|1|||
170626246|NCT00506350|616643451|FG001|Overall Study|Lost to Follow-up|1|||
170626247|NCT00506350|616643452|FG002|Overall Study|Lost to Follow-up|1|||
170626248|NCT00506350|616643453|FG003|Overall Study|Lost to Follow-up|1|||
170626249|NCT00506350|616643454|FG004|Overall Study|Lost to Follow-up|2|||
170626250|NCT00506350|616643455|FG005|Overall Study|Lost to Follow-up|1|||
170626251|NCT00506350|616643456|FG006|Overall Study|Lost to Follow-up|0|||
170626252|NCT00506350|616643457|FG007|Overall Study|Lost to Follow-up|0|||
170626253|NCT00506350|616643458|FG008|Overall Study|Lost to Follow-up|2|||
170626254|NCT00506350|616643450|FG000|Overall Study|Medical Reason|0|||
170626255|NCT00506350|616643451|FG001|Overall Study|Medical Reason|0|||
170626256|NCT00506350|616643452|FG002|Overall Study|Medical Reason|0|||
170626257|NCT00506350|616643453|FG003|Overall Study|Medical Reason|0|||
170626258|NCT00506350|616643454|FG004|Overall Study|Medical Reason|1|||
170626259|NCT00506350|616643455|FG005|Overall Study|Medical Reason|0|||
170626260|NCT00506350|616643456|FG006|Overall Study|Medical Reason|0|||
170626261|NCT00506350|616643457|FG007|Overall Study|Medical Reason|0|||
170626262|NCT00506350|616643458|FG008|Overall Study|Medical Reason|0|||
170626263|NCT00506350|616643450|FG000|Overall Study|Other|1|||
170626264|NCT00506350|616643451|FG001|Overall Study|Other|1|||
170626265|NCT00506350|616643452|FG002|Overall Study|Other|3|||
170626266|NCT00506350|616643453|FG003|Overall Study|Other|0|||
170626267|NCT00506350|616643454|FG004|Overall Study|Other|3|||
170626268|NCT00506350|616643455|FG005|Overall Study|Other|0|||
170626269|NCT00506350|616643456|FG006|Overall Study|Other|0|||
170626270|NCT00506350|616643457|FG007|Overall Study|Other|2|||
170626271|NCT00506350|616643458|FG008|Overall Study|Other|2|||
170626272|NCT03905096|616643459|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
170626273|NCT03905096|616643460|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
170626274|NCT02016781|616643462|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
170626275|NCT02016781|616643463|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
170626276|NCT02016781|616643462|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
170626277|NCT02016781|616643463|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
170626278|NCT02016781|616643462|FG000|Final Database Lock|Withdrawal by Subject|2|||
170626279|NCT02016781|616643463|FG001|Final Database Lock|Withdrawal by Subject|1|||
170626280|NCT02016781|616643462|FG000|Final Database Lock|Lost to Follow-up|11|||
170626281|NCT02016781|616643463|FG001|Final Database Lock|Lost to Follow-up|4|||
170626282|NCT02016781|616643462|FG000|Final Database Lock|Missing data|0|||
170626283|NCT02016781|616643463|FG001|Final Database Lock|Missing data|3|||
170626284|NCT04886154|616643466|FG000|Overall Study|Adverse Event|0|||
170626285|NCT04886154|616643467|FG001|Overall Study|Adverse Event|0|||
170626286|NCT04886154|616643468|FG002|Overall Study|Adverse Event|0|||
170626287|NCT04886154|616643469|FG003|Overall Study|Adverse Event|0|||
170626288|NCT04886154|616643470|FG004|Overall Study|Adverse Event|1|||
170626289|NCT04886154|616643471|FG005|Overall Study|Adverse Event|0|||
170626290|NCT04886154|616643472|FG006|Overall Study|Adverse Event|0|||
170626291|NCT04886154|616643473|FG007|Overall Study|Adverse Event|1|||
170626292|NCT04886154|616643474|FG008|Overall Study|Adverse Event|1|||
170626293|NCT04886154|616643475|FG009|Overall Study|Adverse Event|0|||
170626294|NCT04886154|616643476|FG010|Overall Study|Adverse Event|0|||
170626295|NCT04886154|616643477|FG011|Overall Study|Adverse Event|1|||
170626296|NCT04886154|616643478|FG012|Overall Study|Adverse Event|0|||
170626297|NCT04886154|616643479|FG013|Overall Study|Adverse Event|0|||
170626298|NCT04886154|616643480|FG014|Overall Study|Adverse Event|3|||
170626299|NCT04886154|616643466|FG000|Overall Study|Lost to Follow-up|1|||
170626300|NCT04886154|616643467|FG001|Overall Study|Lost to Follow-up|0|||
170626301|NCT04886154|616643468|FG002|Overall Study|Lost to Follow-up|2|||
170626302|NCT04886154|616643469|FG003|Overall Study|Lost to Follow-up|0|||
170626303|NCT04886154|616643470|FG004|Overall Study|Lost to Follow-up|17|||
170626304|NCT04886154|616643471|FG005|Overall Study|Lost to Follow-up|7|||
170626305|NCT04886154|616643472|FG006|Overall Study|Lost to Follow-up|8|||
170626306|NCT04886154|616643473|FG007|Overall Study|Lost to Follow-up|7|||
170626307|NCT04886154|616643474|FG008|Overall Study|Lost to Follow-up|8|||
170626308|NCT04886154|616643475|FG009|Overall Study|Lost to Follow-up|0|||
170626309|NCT04886154|616643476|FG010|Overall Study|Lost to Follow-up|2|||
170626310|NCT04886154|616643477|FG011|Overall Study|Lost to Follow-up|0|||
170671846|NCT02501473|616812166|FG006|Overall Study|Death|0|||
170671847|NCT02501473|616812167|FG007|Overall Study|Death|0|||
170671848|NCT02501473|616812160|FG000|Overall Study|Lost to Follow-up|1|||
170671849|NCT02501473|616812161|FG001|Overall Study|Lost to Follow-up|0|||
170671850|NCT02501473|616812162|FG002|Overall Study|Lost to Follow-up|1|||
170671851|NCT02501473|616812163|FG003|Overall Study|Lost to Follow-up|0|||
170671852|NCT02501473|616812164|FG004|Overall Study|Lost to Follow-up|0|||
170671853|NCT02501473|616812165|FG005|Overall Study|Lost to Follow-up|1|||
170671854|NCT02501473|616812166|FG006|Overall Study|Lost to Follow-up|0|||
170671855|NCT02501473|616812167|FG007|Overall Study|Lost to Follow-up|0|||
170671856|NCT02501473|616812160|FG000|Overall Study|Reason not specified|0|||
170671857|NCT02501473|616812161|FG001|Overall Study|Reason not specified|0|||
170671858|NCT02501473|616812162|FG002|Overall Study|Reason not specified|1|||
170671859|NCT02501473|616812163|FG003|Overall Study|Reason not specified|1|||
170671860|NCT02501473|616812164|FG004|Overall Study|Reason not specified|0|||
170671861|NCT02501473|616812165|FG005|Overall Study|Reason not specified|0|||
170671862|NCT02501473|616812166|FG006|Overall Study|Reason not specified|0|||
170671863|NCT02501473|616812167|FG007|Overall Study|Reason not specified|0|||
170671864|NCT01673867|616812172|FG000|Randomization|Adverse event unrelated to study drug|1|||
170671865|NCT01673867|616812173|FG001|Randomization|Adverse event unrelated to study drug|0|||
170671866|NCT01673867|616812172|FG000|Randomization|Participant request to discontinue study treatment|0|||
170671867|NCT01673867|616812173|FG001|Randomization|Participant request to discontinue study treatment|4|||
170671868|NCT01673867|616812172|FG000|Randomization|Withdrawal by participant|0|||
170671869|NCT01673867|616812173|FG001|Randomization|Withdrawal by participant|12|||
170671870|NCT01673867|616812172|FG000|Randomization|Lost to Follow-up|0|||
170671871|NCT01673867|616812173|FG001|Randomization|Lost to Follow-up|1|||
170671872|NCT01673867|616812172|FG000|Randomization|Participant no longer meets study criteria|4|||
170671873|NCT01673867|616812173|FG001|Randomization|Participant no longer meets study criteria|5|||
170671874|NCT01673867|616812172|FG000|Treatment|Disease Progression|208|||
170671875|NCT01673867|616812173|FG001|Treatment|Disease Progression|178|||
170671876|NCT01673867|616812172|FG000|Treatment|Study Drug Toxicity|23|||
170671877|NCT01673867|616812173|FG001|Treatment|Study Drug Toxicity|43|||
170671878|NCT01673867|616812172|FG000|Treatment|Death|2|||
170671879|NCT01673867|616812173|FG001|Treatment|Death|3|||
170671880|NCT01673867|616812172|FG000|Treatment|Adverse event unrelated to study drug|23|||
170671881|NCT01673867|616812173|FG001|Treatment|Adverse event unrelated to study drug|10|||
170671882|NCT01673867|616812172|FG000|Treatment|Participant request to discontinue study treatment|7|||
170671883|NCT01673867|616812173|FG001|Treatment|Participant request to discontinue study treatment|17|||
170671884|NCT01673867|616812172|FG000|Treatment|Withdrawal by participant|5|||
170671885|NCT01673867|616812173|FG001|Treatment|Withdrawal by participant|5|||
170671886|NCT01673867|616812172|FG000|Treatment|Maximum clinical benefit|1|||
170671887|NCT01673867|616812173|FG001|Treatment|Maximum clinical benefit|10|||
170671888|NCT01673867|616812172|FG000|Treatment|Participant no longer meets study criteria|2|||
170671889|NCT01673867|616812173|FG001|Treatment|Participant no longer meets study criteria|0|||
170671890|NCT01673867|616812172|FG000|Treatment|Administrative reason by sponsor|3|||
170671891|NCT01673867|616812173|FG001|Treatment|Administrative reason by sponsor|0|||
170671892|NCT01673867|616812172|FG000|Treatment|Other reason|11|||
170671893|NCT01673867|616812173|FG001|Treatment|Other reason|2|||
170671894|NCT00674700|616812176|FG000|Year 1|Adverse Event|17|||
170671895|NCT00674700|616812177|FG001|Year 1|Adverse Event|20|||
170671896|NCT00674700|616812178|FG002|Year 1|Adverse Event|5|||
170671897|NCT00674700|616812176|FG000|Year 1|Withdrawal by Subject|7|||
170671898|NCT00674700|616812177|FG001|Year 1|Withdrawal by Subject|7|||
170671899|NCT00674700|616812178|FG002|Year 1|Withdrawal by Subject|6|||
170671900|NCT00674700|616812176|FG000|Year 1|Any other reason not above-mentioned|7|||
170671901|NCT00674700|616812177|FG001|Year 1|Any other reason not above-mentioned|7|||
170671902|NCT00674700|616812178|FG002|Year 1|Any other reason not above-mentioned|6|||
170671903|NCT00674700|616812176|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
170671904|NCT00674700|616812177|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
170671905|NCT00674700|616812178|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
170671906|NCT00674700|616812176|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
170671907|NCT00674700|616812177|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
170671908|NCT00674700|616812178|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
170819906|NCT00296504|617347683|FG008|Interim Analysis|Ongoing|0|||
170671909|NCT00674700|616812176|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
170671910|NCT00674700|616812177|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
170671911|NCT00674700|616812178|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
170671912|NCT02954237|616812179|FG000|Overall Study|Withdrawal by Subject|25|||
170671913|NCT02954237|616812179|FG000|Overall Study|Missed visit|16|||
170671914|NCT02954237|616812179|FG000|Overall Study|Death|2|||
170671915|NCT03166735|616812180|FG000|Overall Study|Not Treated|1|||
170671916|NCT03166735|616812181|FG001|Overall Study|Not Treated|0|||
170671917|NCT03166735|616812182|FG002|Overall Study|Not Treated|0|||
170671918|NCT03166735|616812183|FG003|Overall Study|Not Treated|0|||
170819907|NCT00296504|617347675|FG000|Final Analysis|Withdrawal by Subject|0|||
170671919|NCT03166735|616812184|FG004|Overall Study|Not Treated|0|||
170671920|NCT03166735|616812180|FG000|Overall Study|follow-up not completed as planned|0|||
170671921|NCT03166735|616812181|FG001|Overall Study|follow-up not completed as planned|1|||
170671922|NCT03166735|616812182|FG002|Overall Study|follow-up not completed as planned|1|||
170671923|NCT03166735|616812183|FG003|Overall Study|follow-up not completed as planned|0|||
170671924|NCT03166735|616812184|FG004|Overall Study|follow-up not completed as planned|1|||
170671925|NCT03166735|616812180|FG000|Overall Study|Withdrawal by Subject|0|||
170671926|NCT03166735|616812181|FG001|Overall Study|Withdrawal by Subject|0|||
170671927|NCT03166735|616812182|FG002|Overall Study|Withdrawal by Subject|1|||
170671928|NCT03166735|616812183|FG003|Overall Study|Withdrawal by Subject|1|||
170671929|NCT03166735|616812184|FG004|Overall Study|Withdrawal by Subject|2|||
170671930|NCT03166735|616812180|FG000|Overall Study|Lost to Follow-up|0|||
170671931|NCT03166735|616812181|FG001|Overall Study|Lost to Follow-up|2|||
170671932|NCT03166735|616812182|FG002|Overall Study|Lost to Follow-up|1|||
170626311|NCT04886154|616643478|FG012|Overall Study|Lost to Follow-up|0|||
170626312|NCT04886154|616643479|FG013|Overall Study|Lost to Follow-up|0|||
170626313|NCT04886154|616643480|FG014|Overall Study|Lost to Follow-up|0|||
170626314|NCT04886154|616643466|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626315|NCT04886154|616643467|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626316|NCT04886154|616643468|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626317|NCT04886154|616643469|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626318|NCT04886154|616643470|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626319|NCT04886154|616643471|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626320|NCT04886154|616643472|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
170626321|NCT04886154|616643473|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626322|NCT04886154|616643474|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626323|NCT04886154|616643475|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626324|NCT04886154|616643476|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626325|NCT04886154|616643477|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626326|NCT04886154|616643478|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626327|NCT04886154|616643479|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626328|NCT04886154|616643480|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
170626329|NCT04886154|616643466|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626330|NCT04886154|616643467|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626331|NCT04886154|616643468|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626332|NCT04886154|616643469|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626333|NCT04886154|616643470|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170626334|NCT04886154|616643471|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626335|NCT04886154|616643472|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
170671933|NCT03166735|616812183|FG003|Overall Study|Lost to Follow-up|0|||
170671934|NCT03166735|616812184|FG004|Overall Study|Lost to Follow-up|1|||
170819908|NCT00296504|617347676|FG001|Final Analysis|Withdrawal by Subject|0|||
170819909|NCT00296504|617347677|FG002|Final Analysis|Withdrawal by Subject|0|||
170819910|NCT00296504|617347678|FG003|Final Analysis|Withdrawal by Subject|0|||
170819911|NCT00296504|617347679|FG004|Final Analysis|Withdrawal by Subject|0|||
170819912|NCT00296504|617347680|FG005|Final Analysis|Withdrawal by Subject|0|||
170819913|NCT00296504|617347681|FG006|Final Analysis|Withdrawal by Subject|0|||
170819914|NCT00296504|617347682|FG007|Final Analysis|Withdrawal by Subject|0|||
170819915|NCT00296504|617347683|FG008|Final Analysis|Withdrawal by Subject|1|||
170819916|NCT00296504|617347675|FG000|Final Analysis|Lost to Follow-up|0|||
170819917|NCT00296504|617347676|FG001|Final Analysis|Lost to Follow-up|0|||
170819918|NCT00296504|617347677|FG002|Final Analysis|Lost to Follow-up|0|||
170819919|NCT00296504|617347678|FG003|Final Analysis|Lost to Follow-up|0|||
170819920|NCT00296504|617347679|FG004|Final Analysis|Lost to Follow-up|0|||
170819921|NCT00296504|617347680|FG005|Final Analysis|Lost to Follow-up|0|||
170819922|NCT00296504|617347681|FG006|Final Analysis|Lost to Follow-up|0|||
170819923|NCT00296504|617347682|FG007|Final Analysis|Lost to Follow-up|0|||
170819924|NCT00296504|617347683|FG008|Final Analysis|Lost to Follow-up|5|||
170819925|NCT00296504|617347675|FG000|Final Analysis|Insufficient Viral Load Response|0|||
170819926|NCT00296504|617347676|FG001|Final Analysis|Insufficient Viral Load Response|0|||
170819927|NCT00296504|617347677|FG002|Final Analysis|Insufficient Viral Load Response|0|||
170819928|NCT00296504|617347678|FG003|Final Analysis|Insufficient Viral Load Response|0|||
170819929|NCT00296504|617347679|FG004|Final Analysis|Insufficient Viral Load Response|0|||
170819930|NCT00296504|617347680|FG005|Final Analysis|Insufficient Viral Load Response|0|||
170819931|NCT00296504|617347681|FG006|Final Analysis|Insufficient Viral Load Response|0|||
170819932|NCT00296504|617347682|FG007|Final Analysis|Insufficient Viral Load Response|0|||
170819933|NCT00296504|617347683|FG008|Final Analysis|Insufficient Viral Load Response|6|||
170819934|NCT00296504|617347675|FG000|Final Analysis|Adverse Event|0|||
170626336|NCT04886154|616643473|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170626337|NCT04886154|616643474|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626338|NCT04886154|616643475|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170671935|NCT00395304|616812185|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170626339|NCT04886154|616643476|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626340|NCT04886154|616643477|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626341|NCT04886154|616643478|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626342|NCT04886154|616643479|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170626343|NCT04886154|616643480|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170626344|NCT04886154|616643466|FG000|Overall Study|Other, Not Specified|0|||
170626345|NCT04886154|616643467|FG001|Overall Study|Other, Not Specified|0|||
170626346|NCT04886154|616643468|FG002|Overall Study|Other, Not Specified|0|||
170626347|NCT04886154|616643469|FG003|Overall Study|Other, Not Specified|0|||
170626348|NCT04886154|616643470|FG004|Overall Study|Other, Not Specified|11|||
170626349|NCT04886154|616643471|FG005|Overall Study|Other, Not Specified|8|||
170626350|NCT04886154|616643472|FG006|Overall Study|Other, Not Specified|9|||
170626351|NCT04886154|616643473|FG007|Overall Study|Other, Not Specified|10|||
170626352|NCT04886154|616643474|FG008|Overall Study|Other, Not Specified|6|||
170626353|NCT04886154|616643475|FG009|Overall Study|Other, Not Specified|1|||
170626354|NCT04886154|616643476|FG010|Overall Study|Other, Not Specified|1|||
170626355|NCT04886154|616643477|FG011|Overall Study|Other, Not Specified|2|||
170626356|NCT04886154|616643478|FG012|Overall Study|Other, Not Specified|1|||
170626357|NCT04886154|616643479|FG013|Overall Study|Other, Not Specified|2|||
170626358|NCT04886154|616643480|FG014|Overall Study|Other, Not Specified|3|||
170626359|NCT02702492|616643481|FG000|Overall Study|Disease progression|3|||
170626360|NCT02702492|616643482|FG001|Overall Study|Disease progression|3|||
170626361|NCT02702492|616643483|FG002|Overall Study|Disease progression|2|||
170626362|NCT02702492|616643484|FG003|Overall Study|Disease progression|4|||
170626363|NCT02702492|616643485|FG004|Overall Study|Disease progression|4|||
170626364|NCT02702492|616643486|FG005|Overall Study|Disease progression|1|||
170626365|NCT02702492|616643487|FG006|Overall Study|Disease progression|2|||
170626366|NCT02702492|616643488|FG007|Overall Study|Disease progression|8|||
170626367|NCT02702492|616643489|FG008|Overall Study|Disease progression|5|||
170626368|NCT02702492|616643490|FG009|Overall Study|Disease progression|1|||
170626369|NCT02702492|616643491|FG010|Overall Study|Disease progression|0|||
170626370|NCT02702492|616643492|FG011|Overall Study|Disease progression|3|||
170626371|NCT02702492|616643493|FG012|Overall Study|Disease progression|2|||
170626372|NCT02702492|616643481|FG000|Overall Study|Clinical progression|0|||
170626373|NCT02702492|616643482|FG001|Overall Study|Clinical progression|0|||
170626374|NCT02702492|616643483|FG002|Overall Study|Clinical progression|2|||
170626375|NCT02702492|616643484|FG003|Overall Study|Clinical progression|1|||
170626376|NCT02702492|616643485|FG004|Overall Study|Clinical progression|0|||
170626377|NCT02702492|616643486|FG005|Overall Study|Clinical progression|2|||
170626378|NCT02702492|616643487|FG006|Overall Study|Clinical progression|1|||
170626379|NCT02702492|616643488|FG007|Overall Study|Clinical progression|4|||
170626380|NCT02702492|616643489|FG008|Overall Study|Clinical progression|0|||
170626381|NCT02702492|616643490|FG009|Overall Study|Clinical progression|0|||
170626382|NCT02702492|616643491|FG010|Overall Study|Clinical progression|1|||
170626383|NCT02702492|616643492|FG011|Overall Study|Clinical progression|2|||
170626384|NCT02702492|616643493|FG012|Overall Study|Clinical progression|0|||
170626385|NCT02702492|616643481|FG000|Overall Study|Adverse Event|0|||
170626386|NCT02702492|616643482|FG001|Overall Study|Adverse Event|0|||
170626387|NCT02702492|616643483|FG002|Overall Study|Adverse Event|1|||
170626388|NCT02702492|616643484|FG003|Overall Study|Adverse Event|2|||
170626389|NCT02702492|616643485|FG004|Overall Study|Adverse Event|1|||
170626390|NCT02702492|616643486|FG005|Overall Study|Adverse Event|0|||
170626391|NCT02702492|616643487|FG006|Overall Study|Adverse Event|1|||
170626392|NCT02702492|616643488|FG007|Overall Study|Adverse Event|0|||
170626393|NCT02702492|616643489|FG008|Overall Study|Adverse Event|2|||
170626394|NCT02702492|616643490|FG009|Overall Study|Adverse Event|0|||
170626395|NCT02702492|616643491|FG010|Overall Study|Adverse Event|0|||
170671936|NCT00395304|616812186|FG001|Treatment Period 1|Withdrawal by Subject|3|||
170671937|NCT00395304|616812187|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170671938|NCT00395304|616812188|FG003|Treatment Period 1|Withdrawal by Subject|2|||
170671939|NCT00395304|616812189|FG004|Treatment Period 1|Withdrawal by Subject|1|||
170671940|NCT00395304|616812190|FG005|Treatment Period 1|Withdrawal by Subject|1|||
170671941|NCT00395304|616812185|FG000|Treatment Period 1|Lost to Follow-up|1|||
170671942|NCT00395304|616812186|FG001|Treatment Period 1|Lost to Follow-up|0|||
170671943|NCT00395304|616812187|FG002|Treatment Period 1|Lost to Follow-up|0|||
170671944|NCT00395304|616812188|FG003|Treatment Period 1|Lost to Follow-up|1|||
170671945|NCT00395304|616812189|FG004|Treatment Period 1|Lost to Follow-up|0|||
170671946|NCT00395304|616812190|FG005|Treatment Period 1|Lost to Follow-up|1|||
170671947|NCT00395304|616812185|FG000|Treatment Period 1|Physician Decision|0|||
170671948|NCT00395304|616812186|FG001|Treatment Period 1|Physician Decision|1|||
170671949|NCT00395304|616812187|FG002|Treatment Period 1|Physician Decision|0|||
170671950|NCT00395304|616812188|FG003|Treatment Period 1|Physician Decision|0|||
170671951|NCT00395304|616812189|FG004|Treatment Period 1|Physician Decision|0|||
170671952|NCT00395304|616812190|FG005|Treatment Period 1|Physician Decision|0|||
170671953|NCT00395304|616812185|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170671954|NCT00395304|616812186|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170671955|NCT00395304|616812187|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170671956|NCT00395304|616812188|FG003|Treatment Period 2|Withdrawal by Subject|1|||
170671957|NCT00395304|616812189|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170671958|NCT00395304|616812190|FG005|Treatment Period 2|Withdrawal by Subject|2|||
170671959|NCT00395304|616812185|FG000|Treatment Period 2|Lost to Follow-up|0|||
170671960|NCT00395304|616812186|FG001|Treatment Period 2|Lost to Follow-up|3|||
170671961|NCT00395304|616812187|FG002|Treatment Period 2|Lost to Follow-up|0|||
170671962|NCT00395304|616812188|FG003|Treatment Period 2|Lost to Follow-up|0|||
170671963|NCT00395304|616812189|FG004|Treatment Period 2|Lost to Follow-up|0|||
170671964|NCT00395304|616812190|FG005|Treatment Period 2|Lost to Follow-up|0|||
170671965|NCT00395304|616812185|FG000|Treatment Period 2|Physician Decision|0|||
170671966|NCT00395304|616812186|FG001|Treatment Period 2|Physician Decision|0|||
170671967|NCT00395304|616812187|FG002|Treatment Period 2|Physician Decision|1|||
170671968|NCT00395304|616812188|FG003|Treatment Period 2|Physician Decision|0|||
170671969|NCT00395304|616812189|FG004|Treatment Period 2|Physician Decision|0|||
170671970|NCT00395304|616812190|FG005|Treatment Period 2|Physician Decision|0|||
170671971|NCT00395304|616812185|FG000|Treatment Period 2|Other|0|||
170671972|NCT00395304|616812186|FG001|Treatment Period 2|Other|1|||
170671973|NCT00395304|616812187|FG002|Treatment Period 2|Other|0|||
170671974|NCT00395304|616812188|FG003|Treatment Period 2|Other|0|||
170671975|NCT00395304|616812189|FG004|Treatment Period 2|Other|0|||
170671976|NCT00395304|616812190|FG005|Treatment Period 2|Other|0|||
170671977|NCT00395304|616812185|FG000|Treatment Period 3|Withdrawal by Subject|0|||
170671978|NCT00395304|616812186|FG001|Treatment Period 3|Withdrawal by Subject|0|||
170671979|NCT00395304|616812187|FG002|Treatment Period 3|Withdrawal by Subject|0|||
170671980|NCT00395304|616812188|FG003|Treatment Period 3|Withdrawal by Subject|1|||
170671981|NCT00395304|616812189|FG004|Treatment Period 3|Withdrawal by Subject|0|||
170671982|NCT00395304|616812190|FG005|Treatment Period 3|Withdrawal by Subject|1|||
170671983|NCT00395304|616812185|FG000|Treatment Period 3|Lost to Follow-up|1|||
170671984|NCT00395304|616812186|FG001|Treatment Period 3|Lost to Follow-up|1|||
170671985|NCT00395304|616812187|FG002|Treatment Period 3|Lost to Follow-up|0|||
170671986|NCT00395304|616812188|FG003|Treatment Period 3|Lost to Follow-up|0|||
170671987|NCT00395304|616812189|FG004|Treatment Period 3|Lost to Follow-up|0|||
170671988|NCT00395304|616812190|FG005|Treatment Period 3|Lost to Follow-up|0|||
170671989|NCT00395304|616812185|FG000|Treatment Period 3|Physician Decision|0|||
170671990|NCT00395304|616812186|FG001|Treatment Period 3|Physician Decision|1|||
170671991|NCT00395304|616812187|FG002|Treatment Period 3|Physician Decision|0|||
170671992|NCT00395304|616812188|FG003|Treatment Period 3|Physician Decision|0|||
170671993|NCT00395304|616812189|FG004|Treatment Period 3|Physician Decision|0|||
170671994|NCT00395304|616812190|FG005|Treatment Period 3|Physician Decision|0|||
170671995|NCT00395304|616812185|FG000|Treatment Period 3|Other|0|||
170671996|NCT00395304|616812186|FG001|Treatment Period 3|Other|0|||
170671997|NCT00395304|616812187|FG002|Treatment Period 3|Other|0|||
170671998|NCT00395304|616812188|FG003|Treatment Period 3|Other|1|||
170671999|NCT00395304|616812189|FG004|Treatment Period 3|Other|0|||
170672000|NCT00395304|616812190|FG005|Treatment Period 3|Other|0|||
170672001|NCT00799383|616812191|FG000|Overall Study|Protocol Violation|1|||
170672002|NCT00799383|616812192|FG001|Overall Study|Protocol Violation|1|||
170672003|NCT00799383|616812191|FG000|Overall Study|Adverse Event|0|||
170672004|NCT00799383|616812192|FG001|Overall Study|Adverse Event|1|||
170672005|NCT00799383|616812191|FG000|Overall Study|Lost to Follow-up|1|||
170672006|NCT00799383|616812192|FG001|Overall Study|Lost to Follow-up|2|||
170672007|NCT00799383|616812191|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
170672008|NCT00799383|616812192|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
170672009|NCT00799383|616812191|FG000|Overall Study|Withdrawal by Subject|0|||
170672010|NCT00799383|616812192|FG001|Overall Study|Withdrawal by Subject|1|||
170672011|NCT03486223|616812200|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
170672012|NCT03486223|616812201|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
170672013|NCT02587234|616812210|FG000|Overall Study|Withdrawal by Subject|1|||
170672014|NCT02587234|616812211|FG001|Overall Study|Withdrawal by Subject|1|||
170672015|NCT02587234|616812210|FG000|Overall Study|Lost to Follow-up|0|||
170626396|NCT02702492|616643492|FG011|Overall Study|Adverse Event|0|||
170626397|NCT02702492|616643493|FG012|Overall Study|Adverse Event|1|||
170626398|NCT02702492|616643481|FG000|Overall Study|Other|0|||
170626399|NCT02702492|616643482|FG001|Overall Study|Other|0|||
170626400|NCT02702492|616643483|FG002|Overall Study|Other|0|||
170626401|NCT02702492|616643484|FG003|Overall Study|Other|0|||
170626402|NCT02702492|616643485|FG004|Overall Study|Other|0|||
170626403|NCT02702492|616643486|FG005|Overall Study|Other|0|||
170626404|NCT02702492|616643487|FG006|Overall Study|Other|0|||
170626405|NCT02702492|616643488|FG007|Overall Study|Other|0|||
170626406|NCT02702492|616643489|FG008|Overall Study|Other|0|||
170626407|NCT02702492|616643490|FG009|Overall Study|Other|0|||
170626408|NCT02702492|616643491|FG010|Overall Study|Other|0|||
170626409|NCT02702492|616643492|FG011|Overall Study|Other|0|||
170626410|NCT02702492|616643493|FG012|Overall Study|Other|1|||
170626411|NCT01910298|616643494|FG000|Overall Study|Adverse Event|1|||
170626412|NCT01910298|616643495|FG001|Overall Study|Adverse Event|0|||
170626413|NCT01910298|616643494|FG000|Overall Study|Withdrawal by Subject|2|||
170626414|NCT01910298|616643495|FG001|Overall Study|Withdrawal by Subject|7|||
170626415|NCT01910298|616643494|FG000|Overall Study|Protocol Deviation|0|||
170626416|NCT01910298|616643495|FG001|Overall Study|Protocol Deviation|5|||
170626417|NCT01910298|616643494|FG000|Overall Study|Lost to Follow-up|1|||
170626418|NCT01910298|616643495|FG001|Overall Study|Lost to Follow-up|1|||
170626419|NCT01910298|616643494|FG000|Overall Study|Study Terminated by Sponsor|1|||
170626420|NCT01910298|616643495|FG001|Overall Study|Study Terminated by Sponsor|17|||
170626421|NCT01910298|616643494|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170626422|NCT01910298|616643495|FG001|Overall Study|Other Miscellaneous Reasons|2|||
170626423|NCT04972162|616643496|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
170626424|NCT04972162|616643497|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
170626425|NCT00781768|616644907|FG000|Overall Study|Not transplanted.|0|||
170626426|NCT00781768|616644908|FG001|Overall Study|Not transplanted.|2|||
170626427|NCT04944992|616644909|FG000|Overall Study|Lost to Follow-up|1|||
170626428|NCT04944992|616644910|FG001|Overall Study|Lost to Follow-up|1|||
170626429|NCT04944992|616644909|FG000|Overall Study|Physician Decision|1|||
170626430|NCT04944992|616644910|FG001|Overall Study|Physician Decision|0|||
170626431|NCT04944992|616644909|FG000|Overall Study|Withdrawal by Subject|6|||
170626432|NCT04944992|616644910|FG001|Overall Study|Withdrawal by Subject|1|||
170626433|NCT00992108|616644917|FG000|Overall Study|Lost to Follow-up|0|||
170626434|NCT00992108|616644918|FG001|Overall Study|Lost to Follow-up|1|||
170626435|NCT01054885|616644921|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
170626436|NCT01054885|616644922|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170626437|NCT01054885|616644923|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170626438|NCT01054885|616644924|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170626439|NCT01054885|616644925|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170626440|NCT01054885|616644926|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170626441|NCT01054885|616644927|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170626442|NCT01054885|616644921|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
170626443|NCT01054885|616644922|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
170626444|NCT01054885|616644923|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
170626445|NCT01054885|616644924|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
170626446|NCT01054885|616644925|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
170626447|NCT01054885|616644926|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
170626448|NCT01054885|616644927|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
170626449|NCT01054885|616644921|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
170626450|NCT01054885|616644922|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170626451|NCT01054885|616644923|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170626452|NCT01054885|616644924|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170626453|NCT01054885|616644925|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170626454|NCT01054885|616644926|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170626455|NCT01054885|616644927|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170626456|NCT01054885|616644921|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
170626457|NCT01054885|616644922|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170626458|NCT01054885|616644923|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170626459|NCT01054885|616644924|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170626460|NCT01054885|616644925|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170626461|NCT01054885|616644926|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170626462|NCT01054885|616644927|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170626463|NCT01054885|616644921|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
170626464|NCT01054885|616644922|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
170626465|NCT01054885|616644923|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
170626466|NCT01054885|616644924|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
170626467|NCT01054885|616644925|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
170672016|NCT02587234|616812211|FG001|Overall Study|Lost to Follow-up|2|||
170626468|NCT01054885|616644926|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
170626469|NCT01054885|616644927|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
170626470|NCT01054885|616644921|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
170626471|NCT01054885|616644922|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170626472|NCT01054885|616644923|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170626473|NCT01054885|616644924|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170626474|NCT01054885|616644925|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170626475|NCT01054885|616644926|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170626476|NCT01054885|616644927|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
170626477|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
170626478|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
170626479|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
170626480|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
170626481|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
170626482|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
170626483|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
170626484|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170626485|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170626486|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
170626487|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
170626488|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170626489|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
170626490|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170626491|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
170626492|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
170626493|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
170626494|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
170626495|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
170626496|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
170626497|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
170626498|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
170626499|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
170626500|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
170626501|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
170626502|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
170626503|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
170626504|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
170626505|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
170626506|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
170626507|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
170626508|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
170626509|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
170626510|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
170626511|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
170626512|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
170626513|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
170626514|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
170626515|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
170626516|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
170626517|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
170626518|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
170626519|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170626520|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
170672017|NCT00980057|616812212|FG000|Overall Study|Death|13|||
170626521|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
170626522|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170626523|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170626524|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
170626525|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
170626526|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
170626527|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
170626528|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
170626529|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
170626530|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
170626531|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
170626532|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
170626533|NCT01054885|616644921|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
170626534|NCT01054885|616644922|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
170626535|NCT01054885|616644923|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
170626536|NCT01054885|616644924|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
170626537|NCT01054885|616644925|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
170626538|NCT01054885|616644926|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
170626539|NCT01054885|616644927|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
170626540|NCT03182374|616644930|FG000|Overall Study|Lost to Follow-up|3|||
170626541|NCT03182374|616644931|FG001|Overall Study|Lost to Follow-up|2|||
170626542|NCT03182374|616644930|FG000|Overall Study|Lack of Efficacy|8|||
170626543|NCT03182374|616644931|FG001|Overall Study|Lack of Efficacy|14|||
170626544|NCT03182374|616644930|FG000|Overall Study|Withdrawal by Subject|1|||
170626545|NCT03182374|616644931|FG001|Overall Study|Withdrawal by Subject|1|||
170626546|NCT03182374|616644930|FG000|Overall Study|exit for non-compliance|1|||
170626547|NCT03182374|616644931|FG001|Overall Study|exit for non-compliance|1|||
170626548|NCT03182374|616644930|FG000|Overall Study|one subject was randomized but not treated|1|||
170626549|NCT03182374|616644931|FG001|Overall Study|one subject was randomized but not treated|0|||
170626550|NCT03182374|616644930|FG000|Overall Study|Other reasons|0|||
170626551|NCT03182374|616644931|FG001|Overall Study|Other reasons|3|||
170626552|NCT02399163|616644933|FG000|Overall Study|Adverse Event|2|||
170626553|NCT02399163|616644933|FG000|Overall Study|Protocol Deviation|2|||
170626554|NCT02399163|616644933|FG000|Overall Study|Withdrawal by Participant|5|||
170626555|NCT04945733|616644939|FG000|Overall Study|Physician Decision|1|||
170626556|NCT04945733|616644940|FG001|Overall Study|Physician Decision|3|||
170626557|NCT04945733|616644941|FG002|Overall Study|Physician Decision|0|||
170626558|NCT04945733|616644939|FG000|Overall Study|Withdrawal by Subject|3|||
170626559|NCT04945733|616644940|FG001|Overall Study|Withdrawal by Subject|3|||
170626560|NCT04945733|616644941|FG002|Overall Study|Withdrawal by Subject|0|||
170626561|NCT06271993|616644944|FG000|Overall Study|Not reactive to histamine|5|||
170626562|NCT06271993|616644945|FG001|Overall Study|Not reactive to histamine|5|||
170626563|NCT06271993|616644946|FG002|Overall Study|Not reactive to histamine|5|||
170626564|NCT00687596|616644957|FG000|Overall Study|Adverse Event (AE)|10|||
170626565|NCT00687596|616644958|FG001|Overall Study|Adverse Event (AE)|3|||
170626566|NCT00687596|616644957|FG000|Overall Study|Radiological Disease Progression|6|||
170626567|NCT00687596|616644958|FG001|Overall Study|Radiological Disease Progression|2|||
170626568|NCT00687596|616644957|FG000|Overall Study|Clinical Disease Progression|1|||
170626569|NCT00687596|616644958|FG001|Overall Study|Clinical Disease Progression|3|||
170626570|NCT00687596|616644957|FG000|Overall Study|Investigator Discretion|3|||
170626571|NCT00687596|616644958|FG001|Overall Study|Investigator Discretion|1|||
170626572|NCT00687596|616644957|FG000|Overall Study|Sponsor Terminated Study|6|||
170626573|NCT00687596|616644958|FG001|Overall Study|Sponsor Terminated Study|17|||
170626574|NCT00837434|616644961|FG000|Overall Study|Physician Decision|3|||
170626575|NCT00837434|616644962|FG001|Overall Study|Physician Decision|0|||
170626576|NCT00837434|616644961|FG000|Overall Study|Lost to Follow-up|1|||
170626577|NCT00837434|616644962|FG001|Overall Study|Lost to Follow-up|1|||
170626578|NCT00837434|616644961|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
170626579|NCT00837434|616644962|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
170626580|NCT00837434|616644961|FG000|Overall Study|Noncompliant|2|||
170626581|NCT00837434|616644962|FG001|Overall Study|Noncompliant|0|||
170626582|NCT00837434|616644961|FG000|Overall Study|Baseline assessments not done in time|1|||
170626583|NCT00837434|616644962|FG001|Overall Study|Baseline assessments not done in time|0|||
170626584|NCT00837434|616644961|FG000|Overall Study|Unable to obtain study drug|1|||
170626585|NCT00837434|616644962|FG001|Overall Study|Unable to obtain study drug|0|||
170626586|NCT01527149|616644967|FG000|Overall Study|Death|2|||
170626587|NCT02230410|616644970|FG000|Overall Study|Screen Failure|3|||
170672018|NCT00980057|616812213|FG001|Overall Study|Death|3|||
170672019|NCT00980057|616812212|FG000|Overall Study|Adverse Event|0|||
170626588|NCT02992288|616644973|FG000|Overall Study|Adverse Event|8|||
170626589|NCT02992288|616644974|FG001|Overall Study|Adverse Event|2|||
170626590|NCT02992288|616644975|FG002|Overall Study|Adverse Event|2|||
170672020|NCT00980057|616812213|FG001|Overall Study|Adverse Event|1|||
170672021|NCT00980057|616812212|FG000|Overall Study|Physician Decision|4|||
170672022|NCT00980057|616812213|FG001|Overall Study|Physician Decision|0|||
170672023|NCT00980057|616812212|FG000|Overall Study|Lost to Follow-up|1|||
170672024|NCT00980057|616812213|FG001|Overall Study|Lost to Follow-up|0|||
170672025|NCT00980057|616812212|FG000|Overall Study|Withdrawal by Subject|1|||
170672026|NCT00980057|616812213|FG001|Overall Study|Withdrawal by Subject|1|||
170672027|NCT01947582|616812216|FG000|Overall Study|Withdrawal by Subject|1|||
170672028|NCT04645953|616812220|FG000|Overall Study|Lost to Follow-up|2|||
170672029|NCT04645953|616812221|FG001|Overall Study|Lost to Follow-up|1|||
170672030|NCT04645953|616812222|FG002|Overall Study|Lost to Follow-up|1|||
170672031|NCT04645953|616812220|FG000|Overall Study|Withdrawal by Subject|0|||
170672032|NCT04645953|616812221|FG001|Overall Study|Withdrawal by Subject|1|||
170672033|NCT04645953|616812222|FG002|Overall Study|Withdrawal by Subject|0|||
170672034|NCT04645953|616812220|FG000|Overall Study|Physician Decision|0|||
170672035|NCT04645953|616812221|FG001|Overall Study|Physician Decision|1|||
170672036|NCT04645953|616812222|FG002|Overall Study|Physician Decision|0|||
170672037|NCT04645953|616812220|FG000|Overall Study|Discontinued Prior to Dosing|0|||
170626591|NCT02992288|616644976|FG003|Overall Study|Adverse Event|2|||
170626592|NCT02992288|616644977|FG004|Overall Study|Adverse Event|2|||
170626593|NCT02992288|616644978|FG005|Overall Study|Adverse Event|7|||
170626594|NCT02992288|616644973|FG000|Overall Study|Non-compliance with study drug|0|||
170626595|NCT02992288|616644974|FG001|Overall Study|Non-compliance with study drug|1|||
170626596|NCT02992288|616644975|FG002|Overall Study|Non-compliance with study drug|1|||
170626597|NCT02992288|616644976|FG003|Overall Study|Non-compliance with study drug|0|||
170626598|NCT02992288|616644977|FG004|Overall Study|Non-compliance with study drug|1|||
170626599|NCT02992288|616644978|FG005|Overall Study|Non-compliance with study drug|0|||
170626600|NCT02992288|616644973|FG000|Overall Study|Physician Decision|3|||
170626601|NCT02992288|616644974|FG001|Overall Study|Physician Decision|0|||
170626602|NCT02992288|616644975|FG002|Overall Study|Physician Decision|1|||
170626603|NCT02992288|616644976|FG003|Overall Study|Physician Decision|0|||
170626604|NCT02992288|616644977|FG004|Overall Study|Physician Decision|0|||
170626605|NCT02992288|616644978|FG005|Overall Study|Physician Decision|1|||
170626606|NCT02992288|616644973|FG000|Overall Study|Death|2|||
170626607|NCT02992288|616644974|FG001|Overall Study|Death|0|||
170626608|NCT02992288|616644975|FG002|Overall Study|Death|2|||
170626609|NCT02992288|616644976|FG003|Overall Study|Death|1|||
170626610|NCT02992288|616644977|FG004|Overall Study|Death|2|||
170626611|NCT02992288|616644978|FG005|Overall Study|Death|0|||
170626612|NCT02992288|616644973|FG000|Overall Study|Lost to Follow-up|0|||
170626613|NCT02992288|616644974|FG001|Overall Study|Lost to Follow-up|0|||
170626614|NCT02992288|616644975|FG002|Overall Study|Lost to Follow-up|0|||
170626615|NCT02992288|616644976|FG003|Overall Study|Lost to Follow-up|1|||
170626616|NCT02992288|616644977|FG004|Overall Study|Lost to Follow-up|0|||
170626617|NCT02992288|616644978|FG005|Overall Study|Lost to Follow-up|0|||
170626618|NCT02992288|616644973|FG000|Overall Study|Protocol Violation|0|||
170626619|NCT02992288|616644974|FG001|Overall Study|Protocol Violation|0|||
170626620|NCT02992288|616644975|FG002|Overall Study|Protocol Violation|0|||
170626621|NCT02992288|616644976|FG003|Overall Study|Protocol Violation|0|||
170626622|NCT02992288|616644977|FG004|Overall Study|Protocol Violation|0|||
170626623|NCT02992288|616644978|FG005|Overall Study|Protocol Violation|1|||
170626624|NCT02992288|616644973|FG000|Overall Study|Withdrawal by Subject|4|||
170626625|NCT02992288|616644974|FG001|Overall Study|Withdrawal by Subject|2|||
170626626|NCT02992288|616644975|FG002|Overall Study|Withdrawal by Subject|1|||
170626627|NCT02992288|616644976|FG003|Overall Study|Withdrawal by Subject|5|||
170626628|NCT02992288|616644977|FG004|Overall Study|Withdrawal by Subject|3|||
170626629|NCT02992288|616644978|FG005|Overall Study|Withdrawal by Subject|4|||
170626630|NCT00499486|616644979|FG000|Overall Study|Withdrawal by Subject|16|||
170626631|NCT00886379|616644980|FG000|Overall Study|Transferred Schools|0|||
170626632|NCT00886379|616644981|FG001|Overall Study|Transferred Schools|0|||
170626633|NCT00886379|616644982|FG002|Overall Study|Transferred Schools|2|||
170626634|NCT00886379|616644983|FG003|Overall Study|Transferred Schools|1|||
170626635|NCT00886379|616644984|FG004|Overall Study|Transferred Schools|1|||
170626636|NCT00886379|616644980|FG000|Overall Study|Final blood draw not obtained|3|||
170626637|NCT00886379|616644981|FG001|Overall Study|Final blood draw not obtained|3|||
170626638|NCT00886379|616644982|FG002|Overall Study|Final blood draw not obtained|4|||
170626639|NCT00886379|616644983|FG003|Overall Study|Final blood draw not obtained|2|||
170626640|NCT00886379|616644984|FG004|Overall Study|Final blood draw not obtained|2|||
170626641|NCT00656513|616644985|FG000|Overall Study|Protocol Violation|1|||
170626642|NCT00656513|616644986|FG001|Overall Study|Protocol Violation|0|||
170626643|NCT00656513|616644987|FG002|Overall Study|Protocol Violation|2|||
170626644|NCT00656513|616644985|FG000|Overall Study|Withdrawal by Subject|0|||
170626645|NCT00656513|616644986|FG001|Overall Study|Withdrawal by Subject|11|||
170626646|NCT00656513|616644987|FG002|Overall Study|Withdrawal by Subject|4|||
170626647|NCT00656513|616644985|FG000|Overall Study|Death|0|||
170626648|NCT00656513|616644986|FG001|Overall Study|Death|0|||
170626649|NCT00656513|616644987|FG002|Overall Study|Death|1|||
170626650|NCT00656513|616644985|FG000|Overall Study|Missing data|0|||
170626651|NCT00656513|616644986|FG001|Overall Study|Missing data|11|||
170626652|NCT00656513|616644987|FG002|Overall Study|Missing data|9|||
170626653|NCT00656513|616644985|FG000|Overall Study|Incomplete treatment|3|||
170626654|NCT00656513|616644986|FG001|Overall Study|Incomplete treatment|0|||
170626655|NCT00656513|616644987|FG002|Overall Study|Incomplete treatment|0|||
170626656|NCT00656513|616644985|FG000|Overall Study|Treatment completed outside of timeframe|0|||
170626657|NCT00656513|616644986|FG001|Overall Study|Treatment completed outside of timeframe|3|||
170626658|NCT00656513|616644987|FG002|Overall Study|Treatment completed outside of timeframe|1|||
170626659|NCT00656513|616644985|FG000|Overall Study|Missing baseline form|0|||
170626660|NCT00656513|616644986|FG001|Overall Study|Missing baseline form|5|||
170626661|NCT00656513|616644987|FG002|Overall Study|Missing baseline form|5|||
170626662|NCT03219723|616644988|FG000|Overall Study|Case Report Forms Uncollected|6|||
170672038|NCT04645953|616812221|FG001|Overall Study|Discontinued Prior to Dosing|0|||
170672039|NCT04645953|616812222|FG002|Overall Study|Discontinued Prior to Dosing|2|||
170672040|NCT00002651|616812223|FG000|Induction|Adverse Event|44|||
170672041|NCT00002651|616812224|FG001|Induction|Adverse Event|0|||
170672042|NCT00002651|616812225|FG002|Induction|Adverse Event|0|||
170672043|NCT00002651|616812223|FG000|Induction|Refusal unrelated to adverse event|50|||
170672044|NCT00002651|616812224|FG001|Induction|Refusal unrelated to adverse event|0|||
170672045|NCT00002651|616812225|FG002|Induction|Refusal unrelated to adverse event|0|||
170672046|NCT00002651|616812223|FG000|Induction|Progression/relapse|274|||
170672047|NCT00002651|616812224|FG001|Induction|Progression/relapse|0|||
170672048|NCT00002651|616812225|FG002|Induction|Progression/relapse|0|||
170672049|NCT00002651|616812223|FG000|Induction|Death|62|||
170672050|NCT00002651|616812224|FG001|Induction|Death|0|||
170672051|NCT00002651|616812225|FG002|Induction|Death|0|||
170672052|NCT00002651|616812223|FG000|Induction|Other|823|||
170672053|NCT00002651|616812224|FG001|Induction|Other|0|||
170672054|NCT00002651|616812225|FG002|Induction|Other|0|||
170672055|NCT00002651|616812223|FG000|Induction|not eligible|90|||
170672056|NCT00002651|616812224|FG001|Induction|not eligible|0|||
170672057|NCT00002651|616812225|FG002|Induction|not eligible|0|||
170672058|NCT00002651|616812223|FG000|Consolidation and Randomization|Adverse Event|0|||
170672059|NCT00002651|616812224|FG001|Consolidation and Randomization|Adverse Event|36|||
170672060|NCT00002651|616812225|FG002|Consolidation and Randomization|Adverse Event|14|||
170672061|NCT00002651|616812223|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
170672062|NCT00002651|616812224|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
170672063|NCT00002651|616812225|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
170672064|NCT00002651|616812223|FG000|Consolidation and Randomization|Progression/relapse|0|||
170672065|NCT00002651|616812224|FG001|Consolidation and Randomization|Progression/relapse|295|||
170672066|NCT00002651|616812225|FG002|Consolidation and Randomization|Progression/relapse|298|||
170672067|NCT00002651|616812223|FG000|Consolidation and Randomization|Death|0|||
170672068|NCT00002651|616812224|FG001|Consolidation and Randomization|Death|38|||
170672069|NCT00002651|616812225|FG002|Consolidation and Randomization|Death|48|||
170672070|NCT00002651|616812223|FG000|Consolidation and Randomization|Other|0|||
170672071|NCT00002651|616812224|FG001|Consolidation and Randomization|Other|314|||
170672072|NCT00002651|616812225|FG002|Consolidation and Randomization|Other|313|||
170672073|NCT00002651|616812223|FG000|Consolidation and Randomization|not eligible|0|||
170672074|NCT00002651|616812224|FG001|Consolidation and Randomization|not eligible|102|||
170672075|NCT00002651|616812225|FG002|Consolidation and Randomization|not eligible|112|||
170672076|NCT03741062|616812228|FG000|Overall Study|Protocol Violation|1|||
170672077|NCT03741062|616812229|FG001|Overall Study|Protocol Violation|0|||
170672078|NCT02609828|616812231|FG000|Overall Study|Adverse Event|8|||
170672079|NCT02609828|616812232|FG001|Overall Study|Adverse Event|1|||
170672080|NCT02609828|616812233|FG002|Overall Study|Adverse Event|0|||
170672081|NCT02609828|616812234|FG003|Overall Study|Adverse Event|6|||
170672082|NCT02609828|616812231|FG000|Overall Study|Death|15|||
170672083|NCT02609828|616812232|FG001|Overall Study|Death|1|||
170672084|NCT02609828|616812233|FG002|Overall Study|Death|1|||
170672085|NCT02609828|616812234|FG003|Overall Study|Death|19|||
170672086|NCT02609828|616812231|FG000|Overall Study|Insufficient clinical response|2|||
170672087|NCT02609828|616812232|FG001|Overall Study|Insufficient clinical response|1|||
170672088|NCT02609828|616812233|FG002|Overall Study|Insufficient clinical response|0|||
170672089|NCT02609828|616812234|FG003|Overall Study|Insufficient clinical response|0|||
170672090|NCT02609828|616812231|FG000|Overall Study|Lost to Follow-up|0|||
170672091|NCT02609828|616812232|FG001|Overall Study|Lost to Follow-up|0|||
170672092|NCT02609828|616812233|FG002|Overall Study|Lost to Follow-up|0|||
170672093|NCT02609828|616812234|FG003|Overall Study|Lost to Follow-up|1|||
170672094|NCT02609828|616812231|FG000|Overall Study|Protocol Violation|2|||
170672095|NCT02609828|616812232|FG001|Overall Study|Protocol Violation|0|||
170672096|NCT02609828|616812233|FG002|Overall Study|Protocol Violation|0|||
170672097|NCT02609828|616812234|FG003|Overall Study|Protocol Violation|1|||
170672098|NCT02609828|616812231|FG000|Overall Study|Withdrawal by Subject|12|||
170672099|NCT02609828|616812232|FG001|Overall Study|Withdrawal by Subject|1|||
170672100|NCT02609828|616812233|FG002|Overall Study|Withdrawal by Subject|0|||
170672101|NCT02609828|616812234|FG003|Overall Study|Withdrawal by Subject|10|||
170819935|NCT00296504|617347676|FG001|Final Analysis|Adverse Event|0|||
170819936|NCT00296504|617347677|FG002|Final Analysis|Adverse Event|0|||
170819937|NCT00296504|617347678|FG003|Final Analysis|Adverse Event|0|||
170819938|NCT00296504|617347679|FG004|Final Analysis|Adverse Event|0|||
170672102|NCT02609828|616812231|FG000|Overall Study|Other|3|||
170672103|NCT02609828|616812232|FG001|Overall Study|Other|0|||
170819939|NCT00296504|617347680|FG005|Final Analysis|Adverse Event|0|||
170672104|NCT02609828|616812233|FG002|Overall Study|Other|0|||
170672105|NCT02609828|616812234|FG003|Overall Study|Other|6|||
170672106|NCT02609828|616812231|FG000|Overall Study|Randomized but not treated|1|||
170672107|NCT02609828|616812232|FG001|Overall Study|Randomized but not treated|0|||
170672108|NCT02609828|616812233|FG002|Overall Study|Randomized but not treated|0|||
170672109|NCT02609828|616812234|FG003|Overall Study|Randomized but not treated|0|||
170672110|NCT01776840|616812241|FG000|Overall Study|Lost to Follow-up|12|||
170672111|NCT01776840|616812242|FG001|Overall Study|Lost to Follow-up|7|||
170672112|NCT01776840|616812241|FG000|Overall Study|Withdrawal by Subject|32|||
170672113|NCT01776840|616812242|FG001|Overall Study|Withdrawal by Subject|48|||
170672114|NCT01776840|616812241|FG000|Overall Study|Sponsor decision|89|||
170672115|NCT01776840|616812242|FG001|Overall Study|Sponsor decision|87|||
170672116|NCT03068455|616812243|FG000|Pre-treatment Period|Disease progression|0|||
170672117|NCT03068455|616812244|FG001|Pre-treatment Period|Disease progression|1|||
170672118|NCT03068455|616812243|FG000|Pre-treatment Period|Participant withdrew consent|1|||
170672119|NCT03068455|616812244|FG001|Pre-treatment Period|Participant withdrew consent|1|||
170672120|NCT03068455|616812243|FG000|Pre-treatment Period|Poor/non-compliance|0|||
170672121|NCT03068455|616812244|FG001|Pre-treatment Period|Poor/non-compliance|1|||
170672122|NCT03068455|616812243|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
170672123|NCT03068455|616812244|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
170672124|NCT03068455|616812243|FG000|Pre-treatment Period|Not reported|2|||
170672125|NCT03068455|616812244|FG001|Pre-treatment Period|Not reported|1|||
170672126|NCT03068455|616812243|FG000|Treatment Period|Disease progression|166|||
170672127|NCT03068455|616812244|FG001|Treatment Period|Disease progression|208|||
170672128|NCT03068455|616812243|FG000|Treatment Period|Study drug toxicity|317|||
170672129|NCT03068455|616812244|FG001|Treatment Period|Study drug toxicity|104|||
170672130|NCT03068455|616812243|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
170672131|NCT03068455|616812244|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
170672132|NCT03068455|616812243|FG000|Treatment Period|Participant request to stop therapy|33|||
170672133|NCT03068455|616812244|FG001|Treatment Period|Participant request to stop therapy|20|||
170672134|NCT03068455|616812243|FG000|Treatment Period|Participant withdrew consent|5|||
170672135|NCT03068455|616812244|FG001|Treatment Period|Participant withdrew consent|10|||
170672136|NCT03068455|616812243|FG000|Treatment Period|Poor/non-compliance|3|||
170672137|NCT03068455|616812244|FG001|Treatment Period|Poor/non-compliance|0|||
170672138|NCT03068455|616812243|FG000|Treatment Period|Participant no longer meets study criteria|1|||
170672139|NCT03068455|616812244|FG001|Treatment Period|Participant no longer meets study criteria|3|||
170672140|NCT03068455|616812243|FG000|Treatment Period|Other reasons|12|||
170672141|NCT03068455|616812244|FG001|Treatment Period|Other reasons|4|||
170672142|NCT01496807|616812246|FG000|Overall Study|Progressive Disease|21|||
170672143|NCT01496807|616812246|FG000|Overall Study|Participant preference/toxicity|8|||
170672144|NCT01496807|616812246|FG000|Overall Study|Change in diagnosis|1|||
170672145|NCT02589405|616812247|FG000|Overall Study|Adverse Event|3|||
170672146|NCT02589405|616812247|FG000|Overall Study|Withdrawal by Subject|1|||
170672147|NCT04447794|616812248|FG000|Overall Study|Lost to Follow-up|2|||
170672148|NCT04447794|616812249|FG001|Overall Study|Lost to Follow-up|3|||
170672149|NCT04447794|616812250|FG002|Overall Study|Lost to Follow-up|8|||
170672150|NCT04447794|616812248|FG000|Overall Study|Withdrawal by Subject|1|||
170672151|NCT04447794|616812249|FG001|Overall Study|Withdrawal by Subject|1|||
170672152|NCT04447794|616812250|FG002|Overall Study|Withdrawal by Subject|0|||
170672153|NCT00205881|616812252|FG000|Overall Study|Withdrawal by Subject|16|||
170672154|NCT00753766|616812253|FG000|Overall Study|Physician Decision|1|||
170672155|NCT00753766|616812254|FG001|Overall Study|Physician Decision|0|||
170672156|NCT02805972|616812259|FG000|Washout Period|Lost to Follow-up|3|||
170672157|NCT02805972|616812260|FG001|Washout Period|Lost to Follow-up|0|||
170672158|NCT00389597|616812267|FG000|Overall Study|Lost to Follow-up|8|||
170672159|NCT00389597|616812268|FG001|Overall Study|Lost to Follow-up|6|||
170672160|NCT00389597|616812269|FG002|Overall Study|Lost to Follow-up|4|||
170672161|NCT00389597|616812270|FG003|Overall Study|Lost to Follow-up|6|||
170672162|NCT02058693|616812273|FG000|Phase 1|Withdrawal by Subject|3|||
170672163|NCT02058693|616812274|FG001|Phase 1|Withdrawal by Subject|2|||
170672164|NCT02058693|616812273|FG000|Phase 1|Adverse Event|0|||
170672165|NCT02058693|616812274|FG001|Phase 1|Adverse Event|1|||
170672166|NCT02058693|616812273|FG000|Phase 1|Lack of Efficacy|1|||
170672167|NCT02058693|616812274|FG001|Phase 1|Lack of Efficacy|0|||
170672168|NCT02058693|616812273|FG000|Phase 1|Physician Decision|1|||
170672169|NCT02058693|616812274|FG001|Phase 1|Physician Decision|1|||
170672170|NCT02058693|616812273|FG000|Phase 2|Withdrawal by Subject|0|||
170819940|NCT00296504|617347681|FG006|Final Analysis|Adverse Event|0|||
170819941|NCT00296504|617347682|FG007|Final Analysis|Adverse Event|0|||
170819942|NCT00296504|617347683|FG008|Final Analysis|Adverse Event|2|||
170819943|NCT00296504|617347675|FG000|Final Analysis|Pregnancy|0|||
170819944|NCT00296504|617347676|FG001|Final Analysis|Pregnancy|0|||
170819945|NCT00296504|617347677|FG002|Final Analysis|Pregnancy|0|||
170819946|NCT00296504|617347678|FG003|Final Analysis|Pregnancy|0|||
170819947|NCT00296504|617347679|FG004|Final Analysis|Pregnancy|0|||
170672171|NCT02058693|616812274|FG001|Phase 2|Withdrawal by Subject|2|||
170672172|NCT00306189|616812277|FG000|Overall Study|Physician Decision|0|||
170672173|NCT00306189|616812278|FG001|Overall Study|Physician Decision|0|||
170672174|NCT00306189|616812279|FG002|Overall Study|Physician Decision|0|||
170672175|NCT00306189|616812280|FG003|Overall Study|Physician Decision|1|||
170672176|NCT00306189|616812277|FG000|Overall Study|Adverse Event|3|||
170672177|NCT00306189|616812278|FG001|Overall Study|Adverse Event|3|||
170672178|NCT00306189|616812279|FG002|Overall Study|Adverse Event|2|||
170819948|NCT00296504|617347680|FG005|Final Analysis|Pregnancy|0|||
170819949|NCT00296504|617347681|FG006|Final Analysis|Pregnancy|0|||
170672179|NCT00306189|616812280|FG003|Overall Study|Adverse Event|2|||
170672180|NCT00306189|616812277|FG000|Overall Study|Withdrawal by Subject|4|||
170672181|NCT00306189|616812278|FG001|Overall Study|Withdrawal by Subject|2|||
170672182|NCT00306189|616812279|FG002|Overall Study|Withdrawal by Subject|8|||
170672183|NCT00306189|616812280|FG003|Overall Study|Withdrawal by Subject|1|||
170672184|NCT00306189|616812277|FG000|Overall Study|Ineligibility determined|1|||
170672185|NCT00306189|616812278|FG001|Overall Study|Ineligibility determined|1|||
170672186|NCT00306189|616812279|FG002|Overall Study|Ineligibility determined|1|||
170672187|NCT00306189|616812280|FG003|Overall Study|Ineligibility determined|1|||
170672188|NCT00306189|616812277|FG000|Overall Study|Other|1|||
170672189|NCT00306189|616812278|FG001|Overall Study|Other|0|||
170672190|NCT00306189|616812279|FG002|Overall Study|Other|0|||
170672191|NCT00306189|616812280|FG003|Overall Study|Other|0|||
170672192|NCT01548287|616812281|FG000|Screening|No reason provided|0|||
170672193|NCT01548287|616812282|FG001|Screening|No reason provided|0|||
170672194|NCT01548287|616812283|FG002|Screening|No reason provided|0|||
170672195|NCT01548287|616812284|FG003|Screening|No reason provided|0|||
170672196|NCT01548287|616812285|FG004|Screening|No reason provided|9|||
170672197|NCT01548287|616812281|FG000|Screening|Did not meet eligibility criteria|0|||
170672198|NCT01548287|616812282|FG001|Screening|Did not meet eligibility criteria|0|||
170672199|NCT01548287|616812283|FG002|Screening|Did not meet eligibility criteria|0|||
170672200|NCT01548287|616812284|FG003|Screening|Did not meet eligibility criteria|0|||
170672201|NCT01548287|616812285|FG004|Screening|Did not meet eligibility criteria|74|||
170672202|NCT01548287|616812281|FG000|Randomized Period|Did not meet inclusion criteria|0|||
170672203|NCT01548287|616812282|FG001|Randomized Period|Did not meet inclusion criteria|0|||
170672204|NCT01548287|616812283|FG002|Randomized Period|Did not meet inclusion criteria|2|||
170672205|NCT01548287|616812284|FG003|Randomized Period|Did not meet inclusion criteria|0|||
170672206|NCT01548287|616812285|FG004|Randomized Period|Did not meet inclusion criteria|0|||
170672207|NCT01548287|616812281|FG000|Randomized Period|Adverse Event|0|||
170672208|NCT01548287|616812282|FG001|Randomized Period|Adverse Event|2|||
170672209|NCT01548287|616812283|FG002|Randomized Period|Adverse Event|5|||
170672210|NCT01548287|616812284|FG003|Randomized Period|Adverse Event|0|||
170672211|NCT01548287|616812285|FG004|Randomized Period|Adverse Event|0|||
170626663|NCT03219723|616644988|FG000|Overall Study|Protocol Deviation|4|||
170626664|NCT03137381|616644989|FG000|Overall Study|Adverse Event|3|||
170626665|NCT03137381|616644990|FG001|Overall Study|Adverse Event|0|||
170626666|NCT03137381|616644991|FG002|Overall Study|Adverse Event|2|||
170626667|NCT03137381|616644992|FG003|Overall Study|Adverse Event|0|||
170626668|NCT03137381|616644989|FG000|Overall Study|Lost to Follow-up|2|||
170626669|NCT03137381|616644990|FG001|Overall Study|Lost to Follow-up|1|||
170626670|NCT03137381|616644991|FG002|Overall Study|Lost to Follow-up|1|||
170626671|NCT03137381|616644992|FG003|Overall Study|Lost to Follow-up|0|||
170626672|NCT03137381|616644989|FG000|Overall Study|Protocol deviation|1|||
170626673|NCT03137381|616644990|FG001|Overall Study|Protocol deviation|1|||
170626674|NCT03137381|616644991|FG002|Overall Study|Protocol deviation|0|||
170626675|NCT03137381|616644992|FG003|Overall Study|Protocol deviation|1|||
170626676|NCT03137381|616644989|FG000|Overall Study|Withdrawal by Investigator|0|||
170626677|NCT03137381|616644990|FG001|Overall Study|Withdrawal by Investigator|1|||
170626678|NCT03137381|616644991|FG002|Overall Study|Withdrawal by Investigator|1|||
170626679|NCT03137381|616644992|FG003|Overall Study|Withdrawal by Investigator|0|||
170626680|NCT03137381|616644989|FG000|Overall Study|Withdrawal by Subject|3|||
170626681|NCT03137381|616644990|FG001|Overall Study|Withdrawal by Subject|4|||
170626682|NCT03137381|616644991|FG002|Overall Study|Withdrawal by Subject|3|||
170626683|NCT03137381|616644992|FG003|Overall Study|Withdrawal by Subject|0|||
170626684|NCT03137381|616644989|FG000|Overall Study|Pregnancy|0|||
170626685|NCT03137381|616644990|FG001|Overall Study|Pregnancy|0|||
170626686|NCT03137381|616644991|FG002|Overall Study|Pregnancy|1|||
170626687|NCT03137381|616644992|FG003|Overall Study|Pregnancy|0|||
170626688|NCT03199976|616644994|FG000|Overall Study|Lack of Efficacy|3|||
170626689|NCT03199976|616644995|FG001|Overall Study|Lack of Efficacy|6|||
170626690|NCT03199976|616644996|FG002|Overall Study|Lack of Efficacy|13|||
170626691|NCT03199976|616644994|FG000|Overall Study|Withdrawal by Subject|1|||
170626692|NCT03199976|616644995|FG001|Overall Study|Withdrawal by Subject|0|||
170626693|NCT03199976|616644996|FG002|Overall Study|Withdrawal by Subject|0|||
170626694|NCT03199976|616644994|FG000|Overall Study|Lost to Follow-up|0|||
170626695|NCT03199976|616644995|FG001|Overall Study|Lost to Follow-up|1|||
170626696|NCT03199976|616644996|FG002|Overall Study|Lost to Follow-up|1|||
170626697|NCT03367793|616644997|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
170626698|NCT03367793|616644998|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
170626699|NCT03367793|616644999|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
170626700|NCT03367793|616645000|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
170626701|NCT03367793|616645001|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
170626702|NCT03367793|616645002|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
170626703|NCT04004988|616645003|FG000|Period 1|Physician Decision|2|||
170626704|NCT04004988|616645004|FG001|Period 1|Physician Decision|0|||
170626705|NCT04004988|616645003|FG000|Period 1|Withdrawal by Subject|0|||
170626706|NCT04004988|616645004|FG001|Period 1|Withdrawal by Subject|1|||
170626707|NCT04004988|616645003|FG000|Period 1|Adverse Event|1|||
170626708|NCT04004988|616645004|FG001|Period 1|Adverse Event|2|||
170626709|NCT03873116|616645005|FG000|Part 1|Study drug discontinuation due to rash|0|||
170626710|NCT03873116|616645006|FG001|Part 1|Study drug discontinuation due to rash|0|||
170626711|NCT03873116|616645007|FG002|Part 1|Study drug discontinuation due to rash|0|||
170626712|NCT03873116|616645008|FG003|Part 1|Study drug discontinuation due to rash|0|||
170626713|NCT03873116|616645009|FG004|Part 1|Study drug discontinuation due to rash|0|||
170626714|NCT03873116|616645010|FG005|Part 1|Study drug discontinuation due to rash|1|||
170626715|NCT03873116|616645005|FG000|Part 2|Withdrawal by Subject|0|||
170626716|NCT03873116|616645006|FG001|Part 2|Withdrawal by Subject|0|||
170626717|NCT03873116|616645007|FG002|Part 2|Withdrawal by Subject|1|||
170626718|NCT03873116|616645008|FG003|Part 2|Withdrawal by Subject|0|||
170626719|NCT03873116|616645009|FG004|Part 2|Withdrawal by Subject|0|||
170626720|NCT03873116|616645010|FG005|Part 2|Withdrawal by Subject|0|||
170626721|NCT03873116|616645005|FG000|Part 2|Lab abnormality or AE|0|||
170626722|NCT03873116|616645006|FG001|Part 2|Lab abnormality or AE|0|||
170626723|NCT03873116|616645007|FG002|Part 2|Lab abnormality or AE|0|||
170626724|NCT03873116|616645008|FG003|Part 2|Lab abnormality or AE|0|||
170626725|NCT03873116|616645009|FG004|Part 2|Lab abnormality or AE|1|||
170626726|NCT03873116|616645010|FG005|Part 2|Lab abnormality or AE|0|||
170626727|NCT03873116|616645005|FG000|Part 3|Withdrawal by Subject|0|||
170626728|NCT03873116|616645006|FG001|Part 3|Withdrawal by Subject|0|||
170626729|NCT03873116|616645007|FG002|Part 3|Withdrawal by Subject|0|||
170626730|NCT03873116|616645008|FG003|Part 3|Withdrawal by Subject|0|||
170626731|NCT03873116|616645009|FG004|Part 3|Withdrawal by Subject|1|||
170626732|NCT03873116|616645010|FG005|Part 3|Withdrawal by Subject|0|||
170626733|NCT03697252|616645011|FG000|Overall Study|Adverse Event|3|||
170626734|NCT03697252|616645012|FG001|Overall Study|Adverse Event|2|||
170626735|NCT03697252|616645011|FG000|Overall Study|Withdrawal by Subject|14|||
170672212|NCT02993757|616812286|FG000|Overall Study|Non compliance with the protocol|155|||
170672213|NCT02993757|616812287|FG001|Overall Study|Non compliance with the protocol|170|||
170672214|NCT02993757|616812286|FG000|Overall Study|Lost to Follow-up|1|||
170672215|NCT02993757|616812287|FG001|Overall Study|Lost to Follow-up|0|||
170672216|NCT02993757|616812286|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
170672217|NCT02993757|616812287|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
170672218|NCT00190671|616812300|FG000|Overall Study|Satisfactory Response|4|||
170672219|NCT00190671|616812301|FG001|Overall Study|Satisfactory Response|7|||
170672220|NCT00190671|616812300|FG000|Overall Study|Lack of Efficacy|19|||
170672221|NCT00190671|616812301|FG001|Overall Study|Lack of Efficacy|24|||
170672222|NCT00190671|616812300|FG000|Overall Study|Death from Study Disease|1|||
170672223|NCT00190671|616812301|FG001|Overall Study|Death from Study Disease|1|||
170672224|NCT00190671|616812300|FG000|Overall Study|Adverse Event|3|||
170672225|NCT00190671|616812301|FG001|Overall Study|Adverse Event|2|||
170672226|NCT00190671|616812300|FG000|Overall Study|Clinical Relapse|0|||
170672227|NCT00190671|616812301|FG001|Overall Study|Clinical Relapse|1|||
170672228|NCT00190671|616812300|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
170672229|NCT00190671|616812301|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
170672230|NCT00190671|616812300|FG000|Overall Study|Death from Other Causes|0|||
170672231|NCT00190671|616812301|FG001|Overall Study|Death from Other Causes|2|||
170672232|NCT00190671|616812300|FG000|Overall Study|Protocol Violation|0|||
170672233|NCT00190671|616812301|FG001|Overall Study|Protocol Violation|1|||
170672234|NCT00190671|616812300|FG000|Overall Study|Withdrawal by Subject|0|||
170672235|NCT00190671|616812301|FG001|Overall Study|Withdrawal by Subject|2|||
170672236|NCT02151110|616812302|FG000|Overall Study|Withdrawal by Subject|0|||
170672237|NCT02151110|616812303|FG001|Overall Study|Withdrawal by Subject|0|||
170672238|NCT02151110|616812304|FG002|Overall Study|Withdrawal by Subject|0|||
170672239|NCT02151110|616812305|FG003|Overall Study|Withdrawal by Subject|0|||
170672240|NCT02151110|616812306|FG004|Overall Study|Withdrawal by Subject|0|||
170672241|NCT02151110|616812307|FG005|Overall Study|Withdrawal by Subject|0|||
170672242|NCT02151110|616812308|FG006|Overall Study|Withdrawal by Subject|0|||
170672243|NCT02151110|616812309|FG007|Overall Study|Withdrawal by Subject|1|||
170672244|NCT02151110|616812302|FG000|Overall Study|Lost to Follow-up|0|||
170672245|NCT02151110|616812303|FG001|Overall Study|Lost to Follow-up|0|||
170672246|NCT02151110|616812304|FG002|Overall Study|Lost to Follow-up|0|||
170672247|NCT02151110|616812305|FG003|Overall Study|Lost to Follow-up|0|||
170672248|NCT02151110|616812306|FG004|Overall Study|Lost to Follow-up|0|||
170672249|NCT02151110|616812307|FG005|Overall Study|Lost to Follow-up|0|||
170672250|NCT02151110|616812308|FG006|Overall Study|Lost to Follow-up|0|||
170672251|NCT02151110|616812309|FG007|Overall Study|Lost to Follow-up|2|||
170672252|NCT05996718|616814130|FG000|Overall Study|Lost to Follow-up|3|||
170672253|NCT01713686|616814131|FG000|Overall Study|Lost to Follow-up|9|||
170672254|NCT01713686|616814131|FG000|Overall Study|Withdrawal by Subject|6|||
170672255|NCT02385045|616814132|FG000|Overall Study|Endoscopy could not be completed|4|||
170672256|NCT04840615|616814133|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
170672257|NCT04840615|616814134|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
170672258|NCT04840615|616814135|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
170672259|NCT00115739|616814136|FG000|Overall Study|Lost to Follow-up|3|||
170672260|NCT00381485|616814140|FG000|Open-Label Run-In Period|Adverse Event|9|||
170672261|NCT00381485|616814141|FG001|Open-Label Run-In Period|Adverse Event|0|||
170672262|NCT00381485|616814142|FG002|Open-Label Run-In Period|Adverse Event|0|||
170672263|NCT00381485|616814143|FG003|Open-Label Run-In Period|Adverse Event|0|||
170672264|NCT00381485|616814140|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
170672265|NCT00381485|616814141|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
170672266|NCT00381485|616814142|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
170672267|NCT00381485|616814143|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
170672268|NCT00381485|616814140|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
170672269|NCT00381485|616814141|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
170672270|NCT00381485|616814142|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
170672271|NCT00381485|616814143|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
170672272|NCT00381485|616814140|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
170672273|NCT00381485|616814141|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
170672274|NCT00381485|616814142|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
170672275|NCT00381485|616814143|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
170672276|NCT00381485|616814140|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
170672277|NCT00381485|616814141|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
170672278|NCT00381485|616814142|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
170672279|NCT00381485|616814143|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
170672280|NCT00381485|616814140|FG000|Open-Label Run-In Period|Treatment failure|1|||
170672281|NCT00381485|616814141|FG001|Open-Label Run-In Period|Treatment failure|0|||
170672282|NCT00381485|616814142|FG002|Open-Label Run-In Period|Treatment failure|0|||
170672283|NCT00381485|616814143|FG003|Open-Label Run-In Period|Treatment failure|0|||
170672284|NCT00381485|616814140|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170672285|NCT00381485|616814141|FG001|Double-Blind Treatment Period|Adverse Event|2|||
170672286|NCT00381485|616814142|FG002|Double-Blind Treatment Period|Adverse Event|2|||
170672287|NCT00381485|616814143|FG003|Double-Blind Treatment Period|Adverse Event|5|||
170672288|NCT00381485|616814140|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
170672289|NCT00381485|616814141|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
170672290|NCT00381485|616814142|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
170672291|NCT00381485|616814143|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
170672292|NCT00381485|616814140|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170672293|NCT00381485|616814141|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
170672294|NCT00381485|616814142|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
170672295|NCT00381485|616814143|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
170672296|NCT00381485|616814140|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
170672297|NCT00381485|616814141|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
170672298|NCT00381485|616814142|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
170672299|NCT00381485|616814143|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
170672300|NCT00381485|616814140|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
170672301|NCT00381485|616814141|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
170672302|NCT00381485|616814142|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
170672303|NCT00381485|616814143|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
170672304|NCT00381485|616814140|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
170672305|NCT00381485|616814141|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
170672306|NCT00381485|616814142|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
170672307|NCT00381485|616814143|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
170672308|NCT00381485|616814140|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
170672309|NCT00381485|616814141|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
170672310|NCT00381485|616814142|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
170672311|NCT00381485|616814143|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
170672312|NCT00381485|616814140|FG000|Double-Blind Treatment Period|Administrative|0|||
170672313|NCT00381485|616814141|FG001|Double-Blind Treatment Period|Administrative|1|||
170672314|NCT00381485|616814142|FG002|Double-Blind Treatment Period|Administrative|0|||
170672315|NCT00381485|616814143|FG003|Double-Blind Treatment Period|Administrative|1|||
170819950|NCT00296504|617347682|FG007|Final Analysis|Pregnancy|0|||
170819951|NCT00296504|617347683|FG008|Final Analysis|Pregnancy|4|||
170672316|NCT03281577|616814144|FG000|Overall Study|Adverse Event|0|||
170672317|NCT03281577|616814145|FG001|Overall Study|Adverse Event|0|||
170672318|NCT03281577|616814146|FG002|Overall Study|Adverse Event|0|||
170672319|NCT03281577|616814147|FG003|Overall Study|Adverse Event|1|||
170819952|NCT00296504|617347675|FG000|Final Analysis|Tuberculosis|0|||
170819953|NCT00296504|617347676|FG001|Final Analysis|Tuberculosis|0|||
170672320|NCT03281577|616814144|FG000|Overall Study|Withdrawal by Subject|1|||
170672321|NCT03281577|616814145|FG001|Overall Study|Withdrawal by Subject|0|||
170672322|NCT03281577|616814146|FG002|Overall Study|Withdrawal by Subject|0|||
170672323|NCT03281577|616814147|FG003|Overall Study|Withdrawal by Subject|0|||
170672324|NCT01235351|616814148|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
170672325|NCT01235351|616814149|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
170672326|NCT00745823|616814151|FG000|Overall Study|Adverse Event|5|||
170672327|NCT00745823|616814152|FG001|Overall Study|Adverse Event|3|||
170672328|NCT00745823|616814151|FG000|Overall Study|Lack of Efficacy|20|||
170672329|NCT00745823|616814152|FG001|Overall Study|Lack of Efficacy|6|||
170672330|NCT00745823|616814151|FG000|Overall Study|Lost to Follow-up|10|||
170672331|NCT00745823|616814152|FG001|Overall Study|Lost to Follow-up|11|||
170672332|NCT00745823|616814151|FG000|Overall Study|Physician Decision|10|||
170672333|NCT00745823|616814152|FG001|Overall Study|Physician Decision|5|||
170672334|NCT00745823|616814151|FG000|Overall Study|Pregnancy|0|||
170672335|NCT00745823|616814152|FG001|Overall Study|Pregnancy|4|||
170672336|NCT00745823|616814151|FG000|Overall Study|Withdrawal by Subject|14|||
170672337|NCT00745823|616814152|FG001|Overall Study|Withdrawal by Subject|8|||
170672338|NCT00745823|616814151|FG000|Overall Study|Study Terminated by Sponsor|326|||
170672339|NCT00745823|616814152|FG001|Overall Study|Study Terminated by Sponsor|349|||
170672340|NCT02955602|616814167|FG000|Overall Study|Adverse Event|0|||
170672341|NCT02955602|616814168|FG001|Overall Study|Adverse Event|3|||
170672342|NCT02955602|616814169|FG002|Overall Study|Adverse Event|0|||
170672343|NCT02955602|616814167|FG000|Overall Study|Withdrawal of informed consent|1|||
170672344|NCT02955602|616814168|FG001|Overall Study|Withdrawal of informed consent|3|||
170672345|NCT02955602|616814169|FG002|Overall Study|Withdrawal of informed consent|2|||
170672346|NCT02955602|616814167|FG000|Overall Study|Lost to Follow-up|0|||
170672347|NCT02955602|616814168|FG001|Overall Study|Lost to Follow-up|0|||
170672348|NCT02955602|616814169|FG002|Overall Study|Lost to Follow-up|1|||
170672349|NCT02955602|616814167|FG000|Overall Study|Other|0|||
170672350|NCT02955602|616814168|FG001|Overall Study|Other|1|||
170672351|NCT02955602|616814169|FG002|Overall Study|Other|3|||
170672352|NCT02980601|616814170|FG000|Overall Study|Lost to Follow-up|2|||
170672353|NCT02980601|616814171|FG001|Overall Study|Lost to Follow-up|2|||
170672354|NCT02980601|616814170|FG000|Overall Study|Death|0|||
170672355|NCT02980601|616814171|FG001|Overall Study|Death|1|||
170626736|NCT03697252|616645012|FG001|Overall Study|Withdrawal by Subject|14|||
170626737|NCT03697252|616645011|FG000|Overall Study|Lost to Follow-up|0|||
170626738|NCT03697252|616645012|FG001|Overall Study|Lost to Follow-up|1|||
170626739|NCT03697252|616645011|FG000|Overall Study|Physician Decision|1|||
170626740|NCT03697252|616645012|FG001|Overall Study|Physician Decision|1|||
170626741|NCT03697252|616645011|FG000|Overall Study|Other|0|||
170626742|NCT03697252|616645012|FG001|Overall Study|Other|1|||
170626743|NCT03125395|616645013|FG000|Overall Study|Adverse Event|2|||
170626744|NCT03125395|616645013|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
170626745|NCT03125395|616645013|FG000|Overall Study|Physician Decision|2|||
170626746|NCT03125395|616645013|FG000|Overall Study|Commercial drug is available|5|||
170626747|NCT01867671|616645014|FG000|Overall Study|Adverse Event|5|||
170626748|NCT01867671|616645015|FG001|Overall Study|Adverse Event|3|||
170626749|NCT01867671|616645014|FG000|Overall Study|Anaphylaxis|0|||
170626750|NCT01867671|616645015|FG001|Overall Study|Anaphylaxis|1|||
170626751|NCT01867671|616645014|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
170626752|NCT01867671|616645015|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
170626753|NCT01867671|616645014|FG000|Overall Study|Lost to Follow-up|0|||
170626754|NCT01867671|616645015|FG001|Overall Study|Lost to Follow-up|1|||
170626755|NCT01867671|616645014|FG000|Overall Study|Non-compliance with Study Drug|1|||
170626756|NCT01867671|616645015|FG001|Overall Study|Non-compliance with Study Drug|2|||
170626757|NCT01867671|616645014|FG000|Overall Study|Withdrawal by Subject|21|||
170672356|NCT02980601|616814170|FG000|Overall Study|Graft loss|1|||
170672357|NCT02980601|616814171|FG001|Overall Study|Graft loss|0|||
170672358|NCT02980601|616814170|FG000|Overall Study|Failed to sign consent|2|||
170626758|NCT01867671|616645015|FG001|Overall Study|Withdrawal by Subject|21|||
170626759|NCT03796728|616645016|FG000|Overall Study|Lost to Follow-up|8|||
170626760|NCT03796728|616645016|FG000|Overall Study|Reason not Specified|16|||
170626761|NCT05236270|616645017|FG000|Overall Study|Lost to Follow-up|3|||
170672359|NCT02980601|616814171|FG001|Overall Study|Failed to sign consent|0|||
170672360|NCT01575769|616814172|FG000|Overall Study|Adverse Event|1|||
170672361|NCT01575769|616814172|FG000|Overall Study|Study terminated by sponsor|40|||
170672362|NCT01806298|616814181|FG000|Overall Study|Adverse Event|3|||
170672363|NCT01806298|616814181|FG000|Overall Study|Protocol Non-compliance|1|||
170672364|NCT01806298|616814181|FG000|Overall Study|Withdrawal by Subject|1|||
170626762|NCT05236270|616645018|FG001|Overall Study|Lost to Follow-up|2|||
170672365|NCT01806298|616814181|FG000|Overall Study|Other|5|||
170672366|NCT01001377|616814186|FG000|Overall Study|Ineligibility determined|2|||
170672367|NCT01001377|616814187|FG001|Overall Study|Ineligibility determined|0|||
170672368|NCT01001377|616814186|FG000|Overall Study|Withdrawal by Subject|19|||
170672369|NCT01001377|616814187|FG001|Overall Study|Withdrawal by Subject|20|||
170672370|NCT01001377|616814186|FG000|Overall Study|Lost to Follow-up|14|||
170672371|NCT01001377|616814187|FG001|Overall Study|Lost to Follow-up|17|||
170672372|NCT01001377|616814186|FG000|Overall Study|Death|391|||
170672373|NCT01001377|616814187|FG001|Overall Study|Death|384|||
170672374|NCT00964860|616814189|FG000|Overall Study|Withdrawal by Subject|0|||
170672375|NCT00964860|616814190|FG001|Overall Study|Withdrawal by Subject|1|||
170626763|NCT05236270|616645019|FG002|Overall Study|Lost to Follow-up|0|||
170626764|NCT05236270|616645020|FG003|Overall Study|Lost to Follow-up|0|||
170626765|NCT05236270|616645021|FG004|Overall Study|Lost to Follow-up|2|||
170626766|NCT05236270|616645022|FG005|Overall Study|Lost to Follow-up|0|||
170626767|NCT05236270|616645023|FG006|Overall Study|Lost to Follow-up|1|||
170626768|NCT05236270|616645024|FG007|Overall Study|Lost to Follow-up|3|||
170626769|NCT02491684|616645027|FG000|Treatment Phase|Adverse Event|2|||
170626770|NCT02491684|616645028|FG001|Treatment Phase|Adverse Event|2|||
170626771|NCT02491684|616645027|FG000|Treatment Phase|Incorrect randomisation|1|||
170626772|NCT02491684|616645028|FG001|Treatment Phase|Incorrect randomisation|0|||
170626773|NCT02491684|616645027|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
170626774|NCT02491684|616645028|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
170626775|NCT02954536|616645036|FG000|Overall Study|Adverse Event|2|||
170626776|NCT02954536|616645036|FG000|Overall Study|Death|12|||
170626777|NCT00005780|616645037|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
170626778|NCT02651675|616645038|FG000|Overall Study|Death|0|||
170626779|NCT02651675|616645039|FG001|Overall Study|Death|0|||
170626780|NCT02651675|616645040|FG002|Overall Study|Death|1|||
170626781|NCT00374140|616645041|FG000|Overall Study|Lost to Follow-up|1|||
170626782|NCT00374140|616645041|FG000|Overall Study|Protocol Violation|1|||
170626783|NCT01576341|616645042|FG000|Overall Study|Withdrawal by Subject|24|||
170626784|NCT01576341|616645042|FG000|Overall Study|Adverse Event|10|||
170626785|NCT01576341|616645042|FG000|Overall Study|Death|21|||
170626786|NCT01576341|616645042|FG000|Overall Study|Physician Decision|2|||
170626787|NCT01576341|616645042|FG000|Overall Study|Lost to Follow-up|2|||
170626788|NCT01576341|616645042|FG000|Overall Study|Kidney transplantation|10|||
170626789|NCT01576341|616645042|FG000|Overall Study|Protocol Violation|12|||
170626790|NCT01576341|616645042|FG000|Overall Study|Other|12|||
170626791|NCT00945009|616645043|FG000|Overall Study|Lack of Efficacy|10|||
170626792|NCT00945009|616645044|FG001|Overall Study|Lack of Efficacy|0|||
170626793|NCT00945009|616645045|FG002|Overall Study|Lack of Efficacy|0|||
170626794|NCT00945009|616645043|FG000|Overall Study|Physician Decision|21|||
170626795|NCT00945009|616645044|FG001|Overall Study|Physician Decision|4|||
170626796|NCT00945009|616645045|FG002|Overall Study|Physician Decision|3|||
170626797|NCT00945009|616645043|FG000|Overall Study|Protocol Violation|6|||
170626798|NCT00945009|616645044|FG001|Overall Study|Protocol Violation|1|||
170626799|NCT00945009|616645045|FG002|Overall Study|Protocol Violation|0|||
170626800|NCT00945009|616645043|FG000|Overall Study|Withdrawal by Subject|1|||
170626801|NCT00945009|616645044|FG001|Overall Study|Withdrawal by Subject|0|||
170626802|NCT00945009|616645045|FG002|Overall Study|Withdrawal by Subject|0|||
170626803|NCT00945009|616645043|FG000|Overall Study|Ineligible|6|||
170626804|NCT00945009|616645044|FG001|Overall Study|Ineligible|1|||
170626805|NCT00945009|616645045|FG002|Overall Study|Ineligible|0|||
170626806|NCT00945009|616645043|FG000|Overall Study|Inevaluable|0|||
170626807|NCT00945009|616645044|FG001|Overall Study|Inevaluable|1|||
170626808|NCT00945009|616645045|FG002|Overall Study|Inevaluable|0|||
170626809|NCT00945009|616645043|FG000|Overall Study|Refusal of further protocol|1|||
170626810|NCT00945009|616645044|FG001|Overall Study|Refusal of further protocol|0|||
170626811|NCT00945009|616645045|FG002|Overall Study|Refusal of further protocol|0|||
170626812|NCT04825574|616645057|FG000|Overall Study|Commercial treatment became available|1|||
170626813|NCT04825574|616645057|FG000|Overall Study|Disease progression|1|||
170626814|NCT03518086|616645058|FG000|Overall Study|Adverse Event|23|||
170626815|NCT03518086|616645059|FG001|Overall Study|Adverse Event|15|||
170626816|NCT03518086|616645060|FG002|Overall Study|Adverse Event|3|||
170626817|NCT03518086|616645061|FG003|Overall Study|Adverse Event|2|||
170626818|NCT03518086|616645058|FG000|Overall Study|Withdrawal by Subject|8|||
170626819|NCT03518086|616645059|FG001|Overall Study|Withdrawal by Subject|5|||
170672376|NCT03716024|616814191|FG000|Overall Study|Randomized, not Treated|7|||
170626820|NCT03518086|616645060|FG002|Overall Study|Withdrawal by Subject|1|||
170626821|NCT03518086|616645061|FG003|Overall Study|Withdrawal by Subject|0|||
170626822|NCT03518086|616645058|FG000|Overall Study|Lack of Efficacy|5|||
170626823|NCT03518086|616645059|FG001|Overall Study|Lack of Efficacy|5|||
170672377|NCT03716024|616814192|FG001|Overall Study|Randomized, not Treated|8|||
170626824|NCT03518086|616645060|FG002|Overall Study|Lack of Efficacy|0|||
170626825|NCT03518086|616645061|FG003|Overall Study|Lack of Efficacy|2|||
170626826|NCT03518086|616645058|FG000|Overall Study|Protocol Violation|1|||
170626827|NCT03518086|616645059|FG001|Overall Study|Protocol Violation|5|||
170626828|NCT03518086|616645060|FG002|Overall Study|Protocol Violation|1|||
170626829|NCT03518086|616645061|FG003|Overall Study|Protocol Violation|3|||
170626830|NCT03518086|616645058|FG000|Overall Study|Lost to Follow-up|0|||
170819954|NCT00296504|617347677|FG002|Final Analysis|Tuberculosis|0|||
170819955|NCT00296504|617347678|FG003|Final Analysis|Tuberculosis|0|||
170819956|NCT00296504|617347679|FG004|Final Analysis|Tuberculosis|0|||
170819957|NCT00296504|617347680|FG005|Final Analysis|Tuberculosis|0|||
170819958|NCT00296504|617347681|FG006|Final Analysis|Tuberculosis|0|||
170819959|NCT00296504|617347682|FG007|Final Analysis|Tuberculosis|0|||
170819960|NCT00296504|617347683|FG008|Final Analysis|Tuberculosis|1|||
170819961|NCT00296504|617347675|FG000|Final Analysis|Participant Moved to Another Country|0|||
170819962|NCT00296504|617347676|FG001|Final Analysis|Participant Moved to Another Country|0|||
170819963|NCT00296504|617347677|FG002|Final Analysis|Participant Moved to Another Country|0|||
170819964|NCT00296504|617347678|FG003|Final Analysis|Participant Moved to Another Country|0|||
170819965|NCT00296504|617347679|FG004|Final Analysis|Participant Moved to Another Country|0|||
170819966|NCT00296504|617347680|FG005|Final Analysis|Participant Moved to Another Country|0|||
170819967|NCT00296504|617347681|FG006|Final Analysis|Participant Moved to Another Country|0|||
170819968|NCT00296504|617347682|FG007|Final Analysis|Participant Moved to Another Country|0|||
170819969|NCT00296504|617347683|FG008|Final Analysis|Participant Moved to Another Country|1|||
170819970|NCT00296504|617347675|FG000|Final Analysis|Poor Adherence|0|||
170819971|NCT00296504|617347676|FG001|Final Analysis|Poor Adherence|0|||
170819972|NCT00296504|617347677|FG002|Final Analysis|Poor Adherence|0|||
170819973|NCT00296504|617347678|FG003|Final Analysis|Poor Adherence|0|||
170819974|NCT00296504|617347679|FG004|Final Analysis|Poor Adherence|0|||
170819975|NCT00296504|617347680|FG005|Final Analysis|Poor Adherence|0|||
170819976|NCT00296504|617347681|FG006|Final Analysis|Poor Adherence|0|||
170819977|NCT00296504|617347682|FG007|Final Analysis|Poor Adherence|0|||
170819978|NCT00296504|617347683|FG008|Final Analysis|Poor Adherence|1|||
170819979|NCT03045302|617347691|FG000|Overall Study|Pre-treatment adverse event|1|||
170819980|NCT00134056|617347692|FG000|Randomization|Not eligible for assigned treatment|22|||
170819981|NCT00134056|617347693|FG001|Randomization|Not eligible for assigned treatment|20|||
170819982|NCT00134056|617347692|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
170819983|NCT00134056|617347693|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
170819984|NCT00134056|617347692|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
170819985|NCT00134056|617347693|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
170819986|NCT00134056|617347692|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
170819987|NCT00134056|617347693|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
170819988|NCT00134056|617347692|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
170819989|NCT00134056|617347693|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
170819990|NCT02849509|617347695|FG000|Overall Study|Worsening of disease under study|1|||
170819991|NCT02849509|617347696|FG001|Overall Study|Worsening of disease under study|1|||
170819992|NCT02849509|617347697|FG002|Overall Study|Worsening of disease under study|1|||
170819993|NCT02849509|617347695|FG000|Overall Study|Worsening of other pre-existing disease|0|||
170819994|NCT02849509|617347696|FG001|Overall Study|Worsening of other pre-existing disease|1|||
170819995|NCT02849509|617347697|FG002|Overall Study|Worsening of other pre-existing disease|2|||
170819996|NCT02849509|617347695|FG000|Overall Study|Other adverse event|36|||
170819997|NCT02849509|617347696|FG001|Overall Study|Other adverse event|41|||
170819998|NCT02849509|617347697|FG002|Overall Study|Other adverse event|8|||
170819999|NCT02849509|617347695|FG000|Overall Study|Withdrawal by Subject|6|||
170820000|NCT02849509|617347696|FG001|Overall Study|Withdrawal by Subject|17|||
170820001|NCT02849509|617347697|FG002|Overall Study|Withdrawal by Subject|12|||
170820002|NCT02849509|617347695|FG000|Overall Study|Lost to Follow-up|27|||
170820003|NCT02849509|617347696|FG001|Overall Study|Lost to Follow-up|67|||
170820004|NCT02849509|617347697|FG002|Overall Study|Lost to Follow-up|36|||
170820005|NCT02849509|617347695|FG000|Overall Study|Other, reason not specified|14|||
170820006|NCT02849509|617347696|FG001|Overall Study|Other, reason not specified|29|||
170820007|NCT02849509|617347697|FG002|Overall Study|Other, reason not specified|25|||
170820008|NCT02849509|617347695|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
170820009|NCT02849509|617347696|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
170820010|NCT02849509|617347697|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
170820011|NCT00975130|617347698|FG000|Study Part 1|Adverse Event|150|||
170820012|NCT00975130|617347699|FG001|Study Part 1|Adverse Event|0|||
170820013|NCT00975130|617347700|FG002|Study Part 1|Adverse Event|0|||
170820014|NCT00975130|617347698|FG000|Study Part 1|Lost to Follow-up|19|||
170820015|NCT00975130|617347699|FG001|Study Part 1|Lost to Follow-up|0|||
170820016|NCT00975130|617347700|FG002|Study Part 1|Lost to Follow-up|0|||
170820017|NCT00975130|617347698|FG000|Study Part 1|Withdrawal by Subject|61|||
170820018|NCT00975130|617347699|FG001|Study Part 1|Withdrawal by Subject|0|||
170820019|NCT00975130|617347700|FG002|Study Part 1|Withdrawal by Subject|0|||
170820020|NCT00975130|617347698|FG000|Study Part 1|Protocol Violation|13|||
170820021|NCT00975130|617347699|FG001|Study Part 1|Protocol Violation|0|||
170820022|NCT00975130|617347700|FG002|Study Part 1|Protocol Violation|0|||
170626831|NCT03518086|616645059|FG001|Overall Study|Lost to Follow-up|3|||
170820023|NCT00975130|617347698|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
170820024|NCT00975130|617347699|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
170626832|NCT03518086|616645060|FG002|Overall Study|Lost to Follow-up|0|||
170626833|NCT03518086|616645061|FG003|Overall Study|Lost to Follow-up|0|||
170626834|NCT03518086|616645058|FG000|Overall Study|Insufficient Diary Data|0|||
170626835|NCT03518086|616645059|FG001|Overall Study|Insufficient Diary Data|2|||
170626836|NCT03518086|616645060|FG002|Overall Study|Insufficient Diary Data|0|||
170626837|NCT03518086|616645061|FG003|Overall Study|Insufficient Diary Data|0|||
170626838|NCT03518086|616645058|FG000|Overall Study|Non- compliance to Protocol|0|||
170626839|NCT03518086|616645059|FG001|Overall Study|Non- compliance to Protocol|1|||
170626840|NCT03518086|616645060|FG002|Overall Study|Non- compliance to Protocol|0|||
170626841|NCT03518086|616645061|FG003|Overall Study|Non- compliance to Protocol|0|||
170626842|NCT03518086|616645058|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
170626843|NCT03518086|616645059|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
170626844|NCT03518086|616645060|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
170626845|NCT03518086|616645061|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
170626846|NCT03518086|616645058|FG000|Overall Study|Site Terminated by Sponsor|0|||
170626847|NCT03518086|616645059|FG001|Overall Study|Site Terminated by Sponsor|1|||
170626848|NCT03518086|616645060|FG002|Overall Study|Site Terminated by Sponsor|0|||
170626849|NCT03518086|616645061|FG003|Overall Study|Site Terminated by Sponsor|0|||
170626850|NCT03518086|616645058|FG000|Overall Study|Pregnancy|0|||
170626851|NCT03518086|616645059|FG001|Overall Study|Pregnancy|0|||
170626852|NCT03518086|616645060|FG002|Overall Study|Pregnancy|0|||
170626853|NCT03518086|616645061|FG003|Overall Study|Pregnancy|2|||
170626854|NCT05967260|616645062|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
170626855|NCT05967260|616645063|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
170626856|NCT02336282|616645064|FG000|Overall Study|Unrelated illness|1|||
170626857|NCT02336282|616645064|FG000|Overall Study|Uncomfortable with technology|1|||
170626858|NCT02336282|616645064|FG000|Overall Study|Lost to Follow-up|1|||
170626859|NCT02336282|616645064|FG000|Overall Study|Not enough time to complete sessions|2|||
170626860|NCT05565742|616645066|FG000|Overall Study|Withdrawal by Subject|0|||
170626861|NCT05565742|616645067|FG001|Overall Study|Withdrawal by Subject|0|||
170626862|NCT05565742|616645068|FG002|Overall Study|Withdrawal by Subject|2|||
170626863|NCT05565742|616645069|FG003|Overall Study|Withdrawal by Subject|2|||
170626864|NCT05565742|616645070|FG004|Overall Study|Withdrawal by Subject|2|||
170626865|NCT05565742|616645066|FG000|Overall Study|Death|1|||
170626866|NCT05565742|616645067|FG001|Overall Study|Death|0|||
170626867|NCT05565742|616645068|FG002|Overall Study|Death|0|||
170626868|NCT05565742|616645069|FG003|Overall Study|Death|0|||
170626869|NCT05565742|616645070|FG004|Overall Study|Death|0|||
170626870|NCT05565742|616645066|FG000|Overall Study|Participant Travelled Abroad|0|||
170626871|NCT05565742|616645067|FG001|Overall Study|Participant Travelled Abroad|0|||
170626872|NCT05565742|616645068|FG002|Overall Study|Participant Travelled Abroad|0|||
170626873|NCT05565742|616645069|FG003|Overall Study|Participant Travelled Abroad|0|||
170626874|NCT05565742|616645070|FG004|Overall Study|Participant Travelled Abroad|1|||
170626875|NCT04163341|616645071|FG000|Overall Study|Withdrawal by Subject|2|||
170626876|NCT04163341|616645072|FG001|Overall Study|Withdrawal by Subject|0|||
170626877|NCT04163341|616645071|FG000|Overall Study|Lost to Follow-up|3|||
170626878|NCT04163341|616645072|FG001|Overall Study|Lost to Follow-up|4|||
170626879|NCT04875975|616645087|FG000|Overall Study|Adverse Event|1|||
170626880|NCT04875975|616645088|FG001|Overall Study|Adverse Event|2|||
170626881|NCT04875975|616645087|FG000|Overall Study|Lack of Efficacy|2|||
170626882|NCT04875975|616645088|FG001|Overall Study|Lack of Efficacy|2|||
170626883|NCT04875975|616645087|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
170626884|NCT04875975|616645088|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
170626885|NCT04875975|616645087|FG000|Overall Study|Relapse With Insults|0|||
170626886|NCT04875975|616645088|FG001|Overall Study|Relapse With Insults|1|||
170626887|NCT04875975|616645087|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
170626888|NCT04875975|616645088|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
170626889|NCT02429830|616645092|FG000|Overall Study|Lost to Follow-up|1|||
170626890|NCT02429830|616645092|FG000|Overall Study|Device Explant|2|||
170626891|NCT05366738|616647498|FG000|Overall Study|Adverse Event|0|||
170626892|NCT05366738|616647499|FG001|Overall Study|Adverse Event|1|||
170626893|NCT05366738|616647500|FG002|Overall Study|Adverse Event|0|||
170626894|NCT00674817|616647501|FG000|Period 1|Withdrawal by Subject|2|||
170626895|NCT00674817|616647501|FG000|Period 1|Protocol Violation|1|||
170626896|NCT00674817|616647501|FG000|Period 3|Adverse Event|1|||
170626897|NCT00674817|616647501|FG000|Period 3|Protocol Violation|1|||
170626898|NCT00674817|616647501|FG000|Period 4|Adverse Event|1|||
170626899|NCT00981656|616647502|FG000|Overall Study|Protocol Violation|1|||
170672378|NCT03716024|616814191|FG000|Overall Study|Adverse Event|1|||
170672379|NCT03716024|616814192|FG001|Overall Study|Adverse Event|2|||
170672380|NCT03716024|616814191|FG000|Overall Study|Treatment Failure|1|||
170672381|NCT03716024|616814192|FG001|Overall Study|Treatment Failure|0|||
170672382|NCT03716024|616814191|FG000|Overall Study|Lost to Follow-up|2|||
170672383|NCT03716024|616814192|FG001|Overall Study|Lost to Follow-up|6|||
170672384|NCT03716024|616814191|FG000|Overall Study|Withdrawal by Subject|0|||
170820025|NCT00975130|617347700|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
170820026|NCT00975130|617347698|FG000|Study Part 1|Administrative|4|||
170820027|NCT00975130|617347699|FG001|Study Part 1|Administrative|0|||
170820028|NCT00975130|617347700|FG002|Study Part 1|Administrative|0|||
170820029|NCT00975130|617347698|FG000|Study Part 1|Withdrew Consent|24|||
170820030|NCT00975130|617347699|FG001|Study Part 1|Withdrew Consent|0|||
170820031|NCT00975130|617347700|FG002|Study Part 1|Withdrew Consent|0|||
170820032|NCT00975130|617347698|FG000|Study Part 2|Adverse Event|0|||
170820033|NCT00975130|617347699|FG001|Study Part 2|Adverse Event|14|||
170820034|NCT00975130|617347700|FG002|Study Part 2|Adverse Event|7|||
170820035|NCT00975130|617347698|FG000|Study Part 2|Lost to Follow-up|0|||
170820036|NCT00975130|617347699|FG001|Study Part 2|Lost to Follow-up|0|||
170820037|NCT00975130|617347700|FG002|Study Part 2|Lost to Follow-up|1|||
170820038|NCT00975130|617347698|FG000|Study Part 2|Withdrawal by Subject|0|||
170820039|NCT00975130|617347699|FG001|Study Part 2|Withdrawal by Subject|13|||
170820040|NCT00975130|617347700|FG002|Study Part 2|Withdrawal by Subject|5|||
170820041|NCT00975130|617347698|FG000|Study Part 2|Withdrew Consent|0|||
170820042|NCT00975130|617347699|FG001|Study Part 2|Withdrew Consent|6|||
170820043|NCT00975130|617347700|FG002|Study Part 2|Withdrew Consent|2|||
170820044|NCT00975130|617347698|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
170820045|NCT00975130|617347699|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
170820046|NCT00975130|617347700|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
170820047|NCT00975130|617347698|FG000|Study Part 2|Administrative|0|||
170820048|NCT00975130|617347699|FG001|Study Part 2|Administrative|1|||
170820049|NCT00975130|617347700|FG002|Study Part 2|Administrative|0|||
170820050|NCT00975130|617347698|FG000|Study Part 2|Protocol Violation|0|||
170820051|NCT00975130|617347699|FG001|Study Part 2|Protocol Violation|0|||
170820052|NCT00975130|617347700|FG002|Study Part 2|Protocol Violation|1|||
170820053|NCT03747575|617347701|FG000|Overall Study|Withdrawal by Subject|6|||
170820054|NCT03747575|617347702|FG001|Overall Study|Withdrawal by Subject|3|||
170820055|NCT03747575|617347701|FG000|Overall Study|Lost to Follow-up|3|||
170820056|NCT03747575|617347702|FG001|Overall Study|Lost to Follow-up|3|||
170820057|NCT03747575|617347701|FG000|Overall Study|Adverse Event|0|||
170820058|NCT03747575|617347702|FG001|Overall Study|Adverse Event|1|||
170820059|NCT00914732|617347707|FG000|Overall Study|Lost to Follow-up|6|||
170820060|NCT00914732|617347708|FG001|Overall Study|Lost to Follow-up|7|||
170820061|NCT00914732|617347709|FG002|Overall Study|Lost to Follow-up|9|||
170820062|NCT00914732|617347707|FG000|Overall Study|Withdrawal by Subject|3|||
170820063|NCT00914732|617347708|FG001|Overall Study|Withdrawal by Subject|0|||
170820064|NCT00914732|617347709|FG002|Overall Study|Withdrawal by Subject|2|||
170820065|NCT00914732|617347707|FG000|Overall Study|Adverse Event|1|||
170820066|NCT00914732|617347708|FG001|Overall Study|Adverse Event|0|||
170820067|NCT00914732|617347709|FG002|Overall Study|Adverse Event|0|||
170820068|NCT02130401|617347710|FG000|Overall Study|Poor enrollment|6|||
170820069|NCT03005106|617347713|FG000|Overall Study|Lost to Follow-up|16|||
170820070|NCT03005106|617347713|FG000|Overall Study|Adverse Event|1|||
170820071|NCT03005106|617347713|FG000|Overall Study|Physician Decision|1|||
170820072|NCT03005106|617347713|FG000|Overall Study|Death|2|||
170820073|NCT00145496|617347714|FG000|Overall Study|Adverse Event|42|||
170820074|NCT00145496|617347715|FG001|Overall Study|Adverse Event|30|||
170820075|NCT00145496|617347714|FG000|Overall Study|Lack of Efficacy|12|||
170820076|NCT00145496|617347715|FG001|Overall Study|Lack of Efficacy|7|||
170820077|NCT00145496|617347714|FG000|Overall Study|Withdrawal by Subject|32|||
170820078|NCT00145496|617347715|FG001|Overall Study|Withdrawal by Subject|26|||
170820079|NCT00145496|617347714|FG000|Overall Study|Lost to Follow-up|12|||
170672385|NCT03716024|616814192|FG001|Overall Study|Withdrawal by Subject|1|||
170672386|NCT03716024|616814191|FG000|Overall Study|Missing Reason|0|||
170820080|NCT00145496|617347715|FG001|Overall Study|Lost to Follow-up|5|||
170820081|NCT00145496|617347714|FG000|Overall Study|Other|25|||
170820082|NCT00145496|617347715|FG001|Overall Study|Other|13|||
170820083|NCT01429285|617347720|FG000|Overall Study|Protocol Violation|9|||
170820084|NCT01429285|617347721|FG001|Overall Study|Protocol Violation|4|||
170820085|NCT01429285|617347720|FG000|Overall Study|Missing Data|5|||
170820086|NCT01429285|617347721|FG001|Overall Study|Missing Data|3|||
170820087|NCT01429285|617347720|FG000|Overall Study|Erroneously Enrolled Twice|8|||
170820088|NCT01429285|617347721|FG001|Overall Study|Erroneously Enrolled Twice|2|||
170820089|NCT03560206|617347722|FG000|Overall Study|Lost to Follow-up|19|||
170820090|NCT03560206|617347723|FG001|Overall Study|Lost to Follow-up|11|||
170820091|NCT03560206|617347722|FG000|Overall Study|Withdrawal by Subject|2|||
170820092|NCT03560206|617347723|FG001|Overall Study|Withdrawal by Subject|4|||
170820093|NCT03560206|617347722|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
170672387|NCT03716024|616814192|FG001|Overall Study|Missing Reason|1|||
170672388|NCT01056653|616814193|FG000|Overall Study|Lost to Follow-up|0|||
170672389|NCT01056653|616814194|FG001|Overall Study|Lost to Follow-up|0|||
170672390|NCT01056653|616814195|FG002|Overall Study|Lost to Follow-up|2|||
170672391|NCT02585960|616814196|FG000|PK/Safety Assessment Period|Physician Decision|0|||
170672392|NCT02585960|616814197|FG001|PK/Safety Assessment Period|Physician Decision|1|||
170672393|NCT02585960|616814198|FG002|PK/Safety Assessment Period|Physician Decision|0|||
170672394|NCT02585960|616814196|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
170672395|NCT02585960|616814197|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
170672396|NCT02585960|616814198|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
170672397|NCT02585960|616814196|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
170672398|NCT02585960|616814197|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
170626900|NCT00981656|616647502|FG000|Overall Study|Did not start protocol treatment|2|||
170626901|NCT00459316|616647507|FG000|Steps 1 & 2|Other eligibility failure|1|||
170626902|NCT00459316|616647508|FG001|Steps 1 & 2|Other eligibility failure|1|||
170626903|NCT00459316|616647509|FG002|Steps 1 & 2|Other eligibility failure|0|||
170626904|NCT00459316|616647507|FG000|Steps 1 & 2|Death|1|||
170626905|NCT00459316|616647508|FG001|Steps 1 & 2|Death|1|||
170626906|NCT00459316|616647509|FG002|Steps 1 & 2|Death|0|||
170626907|NCT00459316|616647507|FG000|Steps 1 & 2|Not able to get to clinic|7|||
170626908|NCT00459316|616647508|FG001|Steps 1 & 2|Not able to get to clinic|4|||
170626909|NCT00459316|616647509|FG002|Steps 1 & 2|Not able to get to clinic|0|||
170626910|NCT00459316|616647507|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
170626911|NCT00459316|616647508|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
170626912|NCT00459316|616647509|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
170626913|NCT00459316|616647507|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
170626914|NCT00459316|616647508|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
170626915|NCT00459316|616647509|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
170626916|NCT00459316|616647507|FG000|Steps 1 & 2|Lost to Follow-up|5|||
170626917|NCT00459316|616647508|FG001|Steps 1 & 2|Lost to Follow-up|0|||
170626918|NCT00459316|616647509|FG002|Steps 1 & 2|Lost to Follow-up|2|||
170626919|NCT00459316|616647507|FG000|Step 3|Withdrawal by Subject|3|||
170626920|NCT00459316|616647508|FG001|Step 3|Withdrawal by Subject|0|||
170626921|NCT00459316|616647509|FG002|Step 3|Withdrawal by Subject|1|||
170626922|NCT01207414|616647511|FG000|Overall Study|Adverse Event|25|||
170626923|NCT01207414|616647512|FG001|Overall Study|Adverse Event|39|||
170626924|NCT01207414|616647511|FG000|Overall Study|Abnormal test procedure results|0|||
170626925|NCT01207414|616647512|FG001|Overall Study|Abnormal test procedure results|1|||
170626926|NCT01207414|616647511|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
170626927|NCT01207414|616647512|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
170626928|NCT01207414|616647511|FG000|Overall Study|Patient withdrew consent|14|||
170626929|NCT01207414|616647512|FG001|Overall Study|Patient withdrew consent|11|||
170626930|NCT01207414|616647511|FG000|Overall Study|Lost to Follow-up|15|||
170626931|NCT01207414|616647512|FG001|Overall Study|Lost to Follow-up|17|||
170626932|NCT01207414|616647511|FG000|Overall Study|Administrative problems|1|||
170626933|NCT01207414|616647512|FG001|Overall Study|Administrative problems|1|||
170626934|NCT01207414|616647511|FG000|Overall Study|Protocol deviation|12|||
170626935|NCT01207414|616647512|FG001|Overall Study|Protocol deviation|9|||
170626936|NCT01207414|616647511|FG000|Overall Study|Randomized in error|1|||
170626937|NCT01207414|616647512|FG001|Overall Study|Randomized in error|0|||
170626938|NCT01435382|616647516|FG000|Overall Study|Lost to Follow-up|1|||
170626939|NCT01435382|616647517|FG001|Overall Study|Lost to Follow-up|0|||
170626940|NCT01435382|616647518|FG002|Overall Study|Lost to Follow-up|1|||
170626941|NCT01435382|616647519|FG003|Overall Study|Lost to Follow-up|0|||
170626942|NCT01435382|616647516|FG000|Overall Study|Withdrawal by Subject|0|||
170626943|NCT01435382|616647517|FG001|Overall Study|Withdrawal by Subject|2|||
170626944|NCT01435382|616647518|FG002|Overall Study|Withdrawal by Subject|0|||
170626945|NCT01435382|616647519|FG003|Overall Study|Withdrawal by Subject|1|||
170626946|NCT00910650|616647520|FG000|Overall Study|Death|2|||
170626947|NCT00423579|616647521|FG000|Overall Study|Lost to Follow-up|3|||
170626948|NCT00423579|616647522|FG001|Overall Study|Lost to Follow-up|0|||
170626949|NCT00423579|616647521|FG000|Overall Study|Protocol Violation|1|||
170626950|NCT00423579|616647522|FG001|Overall Study|Protocol Violation|3|||
170626951|NCT00423579|616647521|FG000|Overall Study|Diagnosis of diabetes|0|||
170626952|NCT00423579|616647522|FG001|Overall Study|Diagnosis of diabetes|1|||
170626953|NCT00260533|616647523|FG000|Overall Study|Other|3|||
170626954|NCT00260533|616647524|FG001|Overall Study|Other|3|||
170626955|NCT01761877|616647527|FG000|Overall Study|Adverse Event|7|||
170626956|NCT01761877|616647528|FG001|Overall Study|Adverse Event|0|||
170626957|NCT01761877|616647527|FG000|Overall Study|Withdrawal by Subject|6|||
170626958|NCT01761877|616647528|FG001|Overall Study|Withdrawal by Subject|4|||
170626959|NCT01761877|616647527|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
170626960|NCT01761877|616647528|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
170626961|NCT01761877|616647527|FG000|Overall Study|Death|0|||
170626962|NCT01761877|616647528|FG001|Overall Study|Death|1|||
170626963|NCT01761877|616647527|FG000|Overall Study|MRI intolerant|1|||
170626964|NCT01761877|616647528|FG001|Overall Study|MRI intolerant|6|||
170626965|NCT01310777|616647530|FG000|Overall Study|Adverse Event|23|||
170626966|NCT01310777|616647531|FG001|Overall Study|Adverse Event|1|||
170626967|NCT01310777|616647532|FG002|Overall Study|Adverse Event|15|||
170626968|NCT01310777|616647530|FG000|Overall Study|Lost to Follow-up|0|||
170626969|NCT01310777|616647531|FG001|Overall Study|Lost to Follow-up|4|||
170626970|NCT01310777|616647532|FG002|Overall Study|Lost to Follow-up|1|||
170626971|NCT01310777|616647530|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
170626972|NCT01310777|616647531|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
170626973|NCT01310777|616647532|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
170626974|NCT01310777|616647530|FG000|Overall Study|Inadequate Control of IOP|5|||
170626975|NCT01310777|616647531|FG001|Overall Study|Inadequate Control of IOP|7|||
170626976|NCT01310777|616647532|FG002|Overall Study|Inadequate Control of IOP|10|||
170626977|NCT01310777|616647530|FG000|Overall Study|Other|4|||
170672399|NCT02585960|616814198|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
170672400|NCT02585960|616814196|FG000|PK/Safety Assessment Period|Other|4|||
170672401|NCT02585960|616814197|FG001|PK/Safety Assessment Period|Other|4|||
170672402|NCT02585960|616814198|FG002|PK/Safety Assessment Period|Other|0|||
170672403|NCT02585960|616814196|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
170672404|NCT02585960|616814197|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
170672405|NCT02585960|616814198|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
170672406|NCT02585960|616814196|FG000|PK/Safety Assessment Period|Screen Failure|0|||
170672407|NCT02585960|616814197|FG001|PK/Safety Assessment Period|Screen Failure|0|||
170672408|NCT02585960|616814198|FG002|PK/Safety Assessment Period|Screen Failure|1|||
170672409|NCT02585960|616814196|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
170672410|NCT02585960|616814197|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
170672411|NCT02585960|616814198|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
170672412|NCT02585960|616814196|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
170672413|NCT02585960|616814197|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
170672414|NCT02585960|616814198|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
170672415|NCT06333613|616814201|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
170672416|NCT01705730|616814202|FG000|Overall Study|Lack of Efficacy|1|||
170626978|NCT01310777|616647531|FG001|Overall Study|Other|1|||
170626979|NCT01310777|616647532|FG002|Overall Study|Other|2|||
170626980|NCT00003475|616647534|FG000|Overall Study|Not evaluable|13|||
170626981|NCT04682366|616647535|FG000|Overall Study|Lost to Follow-up|1|||
170626982|NCT04682366|616647536|FG001|Overall Study|Lost to Follow-up|1|||
170626983|NCT01383928|616647537|FG000|Overall Study|Initiation of ASCT|2|||
170626984|NCT01383928|616647538|FG001|Overall Study|Initiation of ASCT|1|||
170626985|NCT01383928|616647539|FG002|Overall Study|Initiation of ASCT|18|||
170626986|NCT01383928|616647537|FG000|Overall Study|Adverse Event|1|||
170626987|NCT01383928|616647538|FG001|Overall Study|Adverse Event|2|||
170626988|NCT01383928|616647539|FG002|Overall Study|Adverse Event|8|||
170626989|NCT01383928|616647537|FG000|Overall Study|Other|1|||
170626990|NCT01383928|616647538|FG001|Overall Study|Other|3|||
170626991|NCT01383928|616647539|FG002|Overall Study|Other|4|||
170626992|NCT01383928|616647537|FG000|Overall Study|Progressive Disease|1|||
170626993|NCT01383928|616647538|FG001|Overall Study|Progressive Disease|1|||
170626994|NCT01383928|616647539|FG002|Overall Study|Progressive Disease|5|||
170626995|NCT01383928|616647537|FG000|Overall Study|Withdrawal by Subject|0|||
170626996|NCT01383928|616647538|FG001|Overall Study|Withdrawal by Subject|0|||
170626997|NCT01383928|616647539|FG002|Overall Study|Withdrawal by Subject|4|||
170626998|NCT01383928|616647537|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
170626999|NCT01383928|616647538|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
170627000|NCT01383928|616647539|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
170627001|NCT00412984|616647540|FG000|Overall Study|Death|331|||
170627002|NCT00412984|616647541|FG001|Overall Study|Death|349|||
170627003|NCT00412984|616647540|FG000|Overall Study|Adverse Event|679|||
170627004|NCT00412984|616647541|FG001|Overall Study|Adverse Event|738|||
170627005|NCT00412984|616647540|FG000|Overall Study|Withdrawal by Subject|921|||
170627006|NCT00412984|616647541|FG001|Overall Study|Withdrawal by Subject|989|||
170627007|NCT00412984|616647540|FG000|Overall Study|Lost to Follow-up|51|||
170627008|NCT00412984|616647541|FG001|Overall Study|Lost to Follow-up|39|||
170627009|NCT00412984|616647540|FG000|Overall Study|Poor/Noncompliance|57|||
170627010|NCT00412984|616647541|FG001|Overall Study|Poor/Noncompliance|77|||
170627011|NCT00412984|616647540|FG000|Overall Study|Pregnancy|1|||
170627012|NCT00412984|616647541|FG001|Overall Study|Pregnancy|0|||
170627013|NCT00412984|616647540|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
170627014|NCT00412984|616647541|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
170627015|NCT00412984|616647540|FG000|Overall Study|Administrative Reason by Sponsor|11|||
170627016|NCT00412984|616647541|FG001|Overall Study|Administrative Reason by Sponsor|8|||
170627017|NCT00412984|616647540|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
170627018|NCT00412984|616647541|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
170627019|NCT00412984|616647540|FG000|Overall Study|Other Reason|80|||
170627020|NCT00412984|616647541|FG001|Overall Study|Other Reason|92|||
170627021|NCT00412984|616647540|FG000|Overall Study|Not Reported|11|||
170627022|NCT00412984|616647541|FG001|Overall Study|Not Reported|12|||
170627023|NCT03694678|616647542|FG000|Overall Study|Withdrawal by Subject|2|||
170627024|NCT03694678|616647543|FG001|Overall Study|Withdrawal by Subject|0|||
170627025|NCT03694678|616647542|FG000|Overall Study|Lost to Follow-up|2|||
170627026|NCT03694678|616647543|FG001|Overall Study|Lost to Follow-up|3|||
170627027|NCT02435212|616647544|FG000|Core Phase|Adverse Event|8|||
170627028|NCT02435212|616647545|FG001|Core Phase|Adverse Event|5|||
170627029|NCT02435212|616647544|FG000|Core Phase|Withdrawal by Subject|3|||
170627030|NCT02435212|616647545|FG001|Core Phase|Withdrawal by Subject|0|||
170627031|NCT02435212|616647544|FG000|Core Phase|Withdrawal by parent/guardian|9|||
170627032|NCT02435212|616647545|FG001|Core Phase|Withdrawal by parent/guardian|4|||
170627033|NCT02435212|616647544|FG000|Core Phase|Protocol Violation|1|||
170627034|NCT02435212|616647545|FG001|Core Phase|Protocol Violation|2|||
170672417|NCT01705730|616814202|FG000|Overall Study|Adverse Event|3|||
170672418|NCT01705730|616814202|FG000|Overall Study|Lost to Follow-up|1|||
170672419|NCT01705730|616814202|FG000|Overall Study|Reason not Specified|4|||
170672420|NCT01921387|616814203|FG000|Overall Study|Adverse Event|1|||
170672421|NCT04377620|616814205|FG000|Overall Study|Death|42|||
170672422|NCT04377620|616814206|FG001|Overall Study|Death|48|||
170672423|NCT04377620|616814207|FG002|Overall Study|Death|36|||
170672424|NCT04377620|616814205|FG000|Overall Study|Withdrawal by Subject|0|||
170672425|NCT04377620|616814206|FG001|Overall Study|Withdrawal by Subject|2|||
170672426|NCT04377620|616814207|FG002|Overall Study|Withdrawal by Subject|0|||
170672427|NCT02527161|616814208|FG000|Overall Study|Failed MRI|52|||
170672428|NCT02527161|616814208|FG000|Overall Study|Withdrawal by Subject|19|||
170672429|NCT02527161|616814208|FG000|Overall Study|Delay in or unfit for surgery|16|||
170672430|NCT02527161|616814208|FG000|Overall Study|MRI contraindication|6|||
170672431|NCT02527161|616814208|FG000|Overall Study|Consent violation|4|||
170672432|NCT02527161|616814208|FG000|Overall Study|Only Recruited to Part A|27|||
170672433|NCT02527161|616814208|FG000|Overall Study|Physician Decision|1|||
170672434|NCT02527161|616814208|FG000|Overall Study|Adverse Event|1|||
170672435|NCT02527161|616814208|FG000|Overall Study|Lost to Follow-up|6|||
170672436|NCT02849678|616814209|FG000|Overall Study|Protocol Violation|3|||
170672437|NCT02849678|616814210|FG001|Overall Study|Protocol Violation|6|||
170672438|NCT02590003|616814220|FG000|Overall Study|Death|1|||
170672439|NCT02590003|616814221|FG001|Overall Study|Death|2|||
170672440|NCT02340975|616814224|FG000|Overall Study|Death|6|||
170672441|NCT02340975|616814225|FG001|Overall Study|Death|23|||
170672442|NCT02340975|616814226|FG002|Overall Study|Death|21|||
170672443|NCT02340975|616814227|FG003|Overall Study|Death|7|||
170672444|NCT02340975|616814228|FG004|Overall Study|Death|21|||
170672445|NCT02340975|616814229|FG005|Overall Study|Death|13|||
170672446|NCT02340975|616814224|FG000|Overall Study|Lost to Follow-up|0|||
170672447|NCT02340975|616814225|FG001|Overall Study|Lost to Follow-up|0|||
170672448|NCT02340975|616814226|FG002|Overall Study|Lost to Follow-up|0|||
170672449|NCT02340975|616814227|FG003|Overall Study|Lost to Follow-up|0|||
170672450|NCT02340975|616814228|FG004|Overall Study|Lost to Follow-up|2|||
170672451|NCT02340975|616814229|FG005|Overall Study|Lost to Follow-up|0|||
170672452|NCT02340975|616814224|FG000|Overall Study|Withdrawal by Subject|0|||
170672453|NCT02340975|616814225|FG001|Overall Study|Withdrawal by Subject|0|||
170672454|NCT02340975|616814226|FG002|Overall Study|Withdrawal by Subject|3|||
170672455|NCT02340975|616814227|FG003|Overall Study|Withdrawal by Subject|3|||
170672456|NCT02340975|616814228|FG004|Overall Study|Withdrawal by Subject|2|||
170672457|NCT02340975|616814229|FG005|Overall Study|Withdrawal by Subject|0|||
170672458|NCT02340975|616814224|FG000|Overall Study|Other|0|||
170672459|NCT02340975|616814225|FG001|Overall Study|Other|4|||
170672460|NCT02340975|616814226|FG002|Overall Study|Other|0|||
170672461|NCT02340975|616814227|FG003|Overall Study|Other|2|||
170672462|NCT02340975|616814228|FG004|Overall Study|Other|0|||
170672463|NCT02340975|616814229|FG005|Overall Study|Other|6|||
170672464|NCT01786668|616814230|FG000|Overall Study|Adverse Event|0|||
170672465|NCT01786668|616814231|FG001|Overall Study|Adverse Event|1|||
170672466|NCT01786668|616814232|FG002|Overall Study|Adverse Event|1|||
170672467|NCT01786668|616814233|FG003|Overall Study|Adverse Event|2|||
170627035|NCT02435212|616647544|FG000|Core Phase|Physician Decision|3|||
170627036|NCT02435212|616647545|FG001|Core Phase|Physician Decision|0|||
170627037|NCT02435212|616647544|FG000|Core Phase|Lost to Follow-up|0|||
170627038|NCT02435212|616647545|FG001|Core Phase|Lost to Follow-up|1|||
170627039|NCT02435212|616647544|FG000|Core Phase|Lack of Efficacy|0|||
170627040|NCT02435212|616647545|FG001|Core Phase|Lack of Efficacy|1|||
170627041|NCT02435212|616647544|FG000|Core Phase|Recovery|1|||
170627042|NCT02435212|616647545|FG001|Core Phase|Recovery|0|||
170627043|NCT02435212|616647544|FG000|Optional Extension Phase|Adverse Event|3|||
170627044|NCT02435212|616647545|FG001|Optional Extension Phase|Adverse Event|9|||
170627045|NCT02435212|616647544|FG000|Optional Extension Phase|Physician Decision|6|||
170627046|NCT02435212|616647545|FG001|Optional Extension Phase|Physician Decision|8|||
170627047|NCT02435212|616647544|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
170627048|NCT02435212|616647545|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
170627049|NCT02435212|616647544|FG000|Optional Extension Phase|Lack of Efficacy|2|||
170627050|NCT02435212|616647545|FG001|Optional Extension Phase|Lack of Efficacy|3|||
170627051|NCT02435212|616647544|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
170627052|NCT02435212|616647545|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
170627053|NCT02435212|616647544|FG000|Optional Extension Phase|Protocol Violation|0|||
170672468|NCT01786668|616814230|FG000|Overall Study|Withdrawal by Subject|0|||
170672469|NCT01786668|616814231|FG001|Overall Study|Withdrawal by Subject|0|||
170672470|NCT01786668|616814232|FG002|Overall Study|Withdrawal by Subject|3|||
170672471|NCT01786668|616814233|FG003|Overall Study|Withdrawal by Subject|1|||
170672472|NCT01786668|616814230|FG000|Overall Study|Pregnancy|0|||
170672473|NCT01786668|616814231|FG001|Overall Study|Pregnancy|0|||
170672474|NCT01786668|616814232|FG002|Overall Study|Pregnancy|0|||
170672475|NCT01786668|616814233|FG003|Overall Study|Pregnancy|1|||
170672476|NCT01786668|616814230|FG000|Overall Study|Lost to Follow-up|1|||
170672477|NCT01786668|616814231|FG001|Overall Study|Lost to Follow-up|0|||
170627054|NCT02435212|616647545|FG001|Optional Extension Phase|Protocol Violation|1|||
170627055|NCT02435212|616647544|FG000|Optional Extension Phase|Recovery|1|||
170627056|NCT02435212|616647545|FG001|Optional Extension Phase|Recovery|1|||
170627057|NCT02435212|616647544|FG000|Optional Extension Phase|Death|1|||
170627058|NCT02435212|616647545|FG001|Optional Extension Phase|Death|0|||
170627059|NCT02435212|616647544|FG000|Optional Extension Phase|Technical problems|2|||
170627060|NCT02435212|616647545|FG001|Optional Extension Phase|Technical problems|0|||
170627061|NCT05249582|616647549|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
170627062|NCT05249582|616647550|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
170627063|NCT05249582|616647549|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
170627064|NCT05249582|616647550|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
170627065|NCT05249582|616647549|FG000|Overall Study|Declined to use virtual reality headset|1|||
170627066|NCT05249582|616647550|FG001|Overall Study|Declined to use virtual reality headset|0|||
170627067|NCT01346358|616647551|FG000|Overall Study|Withdrawal by Subject|1|||
170627068|NCT01346358|616647552|FG001|Overall Study|Withdrawal by Subject|0|||
170627069|NCT01346358|616647553|FG002|Overall Study|Withdrawal by Subject|1|||
170627070|NCT01346358|616647554|FG003|Overall Study|Withdrawal by Subject|1|||
170627071|NCT01346358|616647555|FG004|Overall Study|Withdrawal by Subject|0|||
170627072|NCT01346358|616647556|FG005|Overall Study|Withdrawal by Subject|2|||
170627073|NCT01346358|616647557|FG006|Overall Study|Withdrawal by Subject|1|||
170627074|NCT01346358|616647558|FG007|Overall Study|Withdrawal by Subject|1|||
170627075|NCT01346358|616647559|FG008|Overall Study|Withdrawal by Subject|1|||
170627076|NCT01346358|616647551|FG000|Overall Study|Adverse Event|1|||
170627077|NCT01346358|616647552|FG001|Overall Study|Adverse Event|0|||
170627078|NCT01346358|616647553|FG002|Overall Study|Adverse Event|0|||
170627079|NCT01346358|616647554|FG003|Overall Study|Adverse Event|0|||
170627080|NCT01346358|616647555|FG004|Overall Study|Adverse Event|1|||
170627081|NCT01346358|616647556|FG005|Overall Study|Adverse Event|0|||
170627082|NCT01346358|616647557|FG006|Overall Study|Adverse Event|0|||
170627083|NCT01346358|616647558|FG007|Overall Study|Adverse Event|0|||
170627084|NCT01346358|616647559|FG008|Overall Study|Adverse Event|1|||
170627085|NCT01346358|616647551|FG000|Overall Study|Non-Compliance|0|||
170627086|NCT01346358|616647552|FG001|Overall Study|Non-Compliance|0|||
170627087|NCT01346358|616647553|FG002|Overall Study|Non-Compliance|0|||
170627088|NCT01346358|616647554|FG003|Overall Study|Non-Compliance|0|||
170627089|NCT01346358|616647555|FG004|Overall Study|Non-Compliance|0|||
170627090|NCT01346358|616647556|FG005|Overall Study|Non-Compliance|0|||
170627091|NCT01346358|616647557|FG006|Overall Study|Non-Compliance|0|||
170627092|NCT01346358|616647558|FG007|Overall Study|Non-Compliance|2|||
170627093|NCT01346358|616647559|FG008|Overall Study|Non-Compliance|0|||
170627094|NCT01346358|616647551|FG000|Overall Study|Physician Decision|0|||
170627095|NCT01346358|616647552|FG001|Overall Study|Physician Decision|1|||
170627096|NCT01346358|616647553|FG002|Overall Study|Physician Decision|0|||
170627097|NCT01346358|616647554|FG003|Overall Study|Physician Decision|0|||
170627098|NCT01346358|616647555|FG004|Overall Study|Physician Decision|0|||
170627099|NCT01346358|616647556|FG005|Overall Study|Physician Decision|0|||
170627100|NCT01346358|616647557|FG006|Overall Study|Physician Decision|0|||
170627101|NCT01346358|616647558|FG007|Overall Study|Physician Decision|1|||
170627102|NCT01346358|616647559|FG008|Overall Study|Physician Decision|1|||
170627103|NCT00702702|616647562|FG000|Overall Study|Study prematurely terminated|56|||
170627104|NCT02738801|616647574|FG000|Overall Study|Adverse Event|1|||
170627105|NCT02738801|616647575|FG001|Overall Study|Adverse Event|1|||
170627106|NCT02738801|616647574|FG000|Overall Study|Withdrawal by Subject|0|||
170627107|NCT02738801|616647575|FG001|Overall Study|Withdrawal by Subject|1|||
170627108|NCT00771914|616647578|FG000|Overall Study|Physician Decision|0|||
170627109|NCT00771914|616647579|FG001|Overall Study|Physician Decision|0|||
170627110|NCT00771914|616647580|FG002|Overall Study|Physician Decision|0|||
170627111|NCT00771914|616647581|FG003|Overall Study|Physician Decision|1|||
170627112|NCT00771914|616647578|FG000|Overall Study|Lost to Follow-up|0|||
170627113|NCT00771914|616647579|FG001|Overall Study|Lost to Follow-up|0|||
170627114|NCT00771914|616647580|FG002|Overall Study|Lost to Follow-up|0|||
170627115|NCT00771914|616647581|FG003|Overall Study|Lost to Follow-up|1|||
170627116|NCT01743469|616647582|FG000|Active Treatment Phase|Adverse Event|10|||
170627117|NCT01743469|616647583|FG001|Active Treatment Phase|Adverse Event|5|||
170627118|NCT01743469|616647584|FG002|Active Treatment Phase|Adverse Event|8|||
170627119|NCT01743469|616647585|FG003|Active Treatment Phase|Adverse Event|1|||
170672478|NCT01786668|616814232|FG002|Overall Study|Lost to Follow-up|1|||
170672479|NCT01786668|616814233|FG003|Overall Study|Lost to Follow-up|0|||
170672480|NCT00329238|616814238|FG000|Overall Study|Adverse Event|147|||
170627120|NCT01743469|616647582|FG000|Active Treatment Phase|Disease Progression|40|||
170627121|NCT01743469|616647583|FG001|Active Treatment Phase|Disease Progression|47|||
170627122|NCT01743469|616647584|FG002|Active Treatment Phase|Disease Progression|30|||
170627123|NCT01743469|616647585|FG003|Active Treatment Phase|Disease Progression|20|||
170627124|NCT01743469|616647582|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
170627125|NCT01743469|616647583|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
170627126|NCT01743469|616647584|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
170627127|NCT01743469|616647585|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
170627128|NCT01743469|616647582|FG000|Active Treatment Phase|Missing|1|||
170627129|NCT01743469|616647583|FG001|Active Treatment Phase|Missing|0|||
170627130|NCT01743469|616647584|FG002|Active Treatment Phase|Missing|0|||
170627131|NCT01743469|616647585|FG003|Active Treatment Phase|Missing|0|||
170627132|NCT01743469|616647582|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
170627133|NCT01743469|616647583|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
170627134|NCT01743469|616647584|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
170627135|NCT01743469|616647585|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
170627136|NCT01743469|616647582|FG000|Follow-up Period - Post-Treatment|Death|43|||
170627137|NCT01743469|616647583|FG001|Follow-up Period - Post-Treatment|Death|47|||
170627138|NCT01743469|616647584|FG002|Follow-up Period - Post-Treatment|Death|22|||
170627139|NCT01743469|616647585|FG003|Follow-up Period - Post-Treatment|Death|16|||
170627140|NCT01743469|616647582|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
170627141|NCT01743469|616647583|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
170627142|NCT01743469|616647584|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
170627143|NCT01743469|616647585|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
170627144|NCT00317473|616647586|FG000|Overall Study|Withdrawal by Subject|2|||
170627145|NCT00317473|616647587|FG001|Overall Study|Withdrawal by Subject|1|||
170627146|NCT00317473|616647588|FG002|Overall Study|Withdrawal by Subject|2|||
170627147|NCT00317473|616647589|FG003|Overall Study|Withdrawal by Subject|1|||
170627148|NCT00317473|616647590|FG004|Overall Study|Withdrawal by Subject|3|||
170627149|NCT00317473|616647591|FG005|Overall Study|Withdrawal by Subject|1|||
170627150|NCT00317473|616647586|FG000|Overall Study|Relocation|1|||
170627151|NCT00317473|616647587|FG001|Overall Study|Relocation|0|||
170627152|NCT00317473|616647588|FG002|Overall Study|Relocation|1|||
170627153|NCT00317473|616647589|FG003|Overall Study|Relocation|1|||
170627154|NCT00317473|616647590|FG004|Overall Study|Relocation|5|||
170627155|NCT00317473|616647591|FG005|Overall Study|Relocation|2|||
170627156|NCT00317473|616647586|FG000|Overall Study|Death|1|||
170627157|NCT00317473|616647587|FG001|Overall Study|Death|0|||
170627158|NCT00317473|616647588|FG002|Overall Study|Death|0|||
170627159|NCT00317473|616647589|FG003|Overall Study|Death|0|||
170627160|NCT00317473|616647590|FG004|Overall Study|Death|0|||
170627161|NCT00317473|616647591|FG005|Overall Study|Death|0|||
170627162|NCT00317473|616647586|FG000|Overall Study|Other|0|||
170627163|NCT00317473|616647587|FG001|Overall Study|Other|2|||
170627164|NCT00317473|616647588|FG002|Overall Study|Other|0|||
170627165|NCT00317473|616647589|FG003|Overall Study|Other|0|||
170627166|NCT00317473|616647590|FG004|Overall Study|Other|0|||
170627167|NCT00317473|616647591|FG005|Overall Study|Other|0|||
170627168|NCT02285855|616647592|FG000|Overall Study|Withdrawal by Subject|2|||
170627169|NCT02285855|616647593|FG001|Overall Study|Withdrawal by Subject|1|||
170627170|NCT03253796|616647594|FG000|Period 1: Run-In|Adverse Event|4|||
170627171|NCT03253796|616647595|FG001|Period 1: Run-In|Adverse Event|0|||
170627172|NCT03253796|616647596|FG002|Period 1: Run-In|Adverse Event|0|||
170627173|NCT03253796|616647597|FG003|Period 1: Run-In|Adverse Event|0|||
170627174|NCT03253796|616647598|FG004|Period 1: Run-In|Adverse Event|0|||
170627175|NCT03253796|616647594|FG000|Period 1: Run-In|Lack of Efficacy|1|||
170627176|NCT03253796|616647595|FG001|Period 1: Run-In|Lack of Efficacy|0|||
170627177|NCT03253796|616647596|FG002|Period 1: Run-In|Lack of Efficacy|0|||
170627178|NCT03253796|616647597|FG003|Period 1: Run-In|Lack of Efficacy|0|||
170627179|NCT03253796|616647598|FG004|Period 1: Run-In|Lack of Efficacy|0|||
170627180|NCT03253796|616647594|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
170627181|NCT03253796|616647595|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
170627182|NCT03253796|616647596|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
170627183|NCT03253796|616647597|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
170627184|NCT03253796|616647598|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
170627185|NCT03253796|616647594|FG000|Period 1: Run-In|Protocol Violation|5|||
170627186|NCT03253796|616647595|FG001|Period 1: Run-In|Protocol Violation|0|||
170627187|NCT03253796|616647596|FG002|Period 1: Run-In|Protocol Violation|0|||
170627188|NCT03253796|616647597|FG003|Period 1: Run-In|Protocol Violation|0|||
170672481|NCT00329238|616814239|FG001|Overall Study|Adverse Event|129|||
170627189|NCT03253796|616647598|FG004|Period 1: Run-In|Protocol Violation|0|||
170627190|NCT03253796|616647594|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
170627191|NCT03253796|616647595|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
170672482|NCT00329238|616814238|FG000|Overall Study|Protocol Violation|23|||
170627192|NCT03253796|616647596|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
170672483|NCT00329238|616814239|FG001|Overall Study|Protocol Violation|34|||
170672484|NCT00329238|616814238|FG000|Overall Study|Lost to Follow-up|2|||
170672485|NCT00329238|616814239|FG001|Overall Study|Lost to Follow-up|6|||
170672486|NCT00329238|616814238|FG000|Overall Study|Withdrawal by Subject|64|||
170672487|NCT00329238|616814239|FG001|Overall Study|Withdrawal by Subject|58|||
170672488|NCT00329238|616814238|FG000|Overall Study|Other reason (not specified)|40|||
170672489|NCT00329238|616814239|FG001|Overall Study|Other reason (not specified)|54|||
170672490|NCT04457336|616814240|FG000|Period 2: Part A|Withdrawal by Subject|0|||
170672491|NCT04457336|616814241|FG001|Period 2: Part A|Withdrawal by Subject|1|||
170672492|NCT04457336|616814242|FG002|Period 2: Part A|Withdrawal by Subject|1|||
170672493|NCT04457336|616814243|FG003|Period 2: Part A|Withdrawal by Subject|1|||
170672494|NCT04457336|616814244|FG004|Period 2: Part A|Withdrawal by Subject|0|||
170672495|NCT04457336|616814245|FG005|Period 2: Part A|Withdrawal by Subject|0|||
170672496|NCT04457336|616814246|FG006|Period 2: Part A|Withdrawal by Subject|0|||
170672497|NCT04457336|616814247|FG007|Period 2: Part A|Withdrawal by Subject|0|||
170672498|NCT04457336|616814240|FG000|Period 2: Part A|Adverse Event|0|||
170672499|NCT04457336|616814241|FG001|Period 2: Part A|Adverse Event|0|||
170672500|NCT04457336|616814242|FG002|Period 2: Part A|Adverse Event|1|||
170672501|NCT04457336|616814243|FG003|Period 2: Part A|Adverse Event|1|||
170672502|NCT04457336|616814244|FG004|Period 2: Part A|Adverse Event|0|||
170820094|NCT03560206|617347723|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
170627193|NCT03253796|616647597|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
170627194|NCT03253796|616647598|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
170627195|NCT03253796|616647594|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
170627196|NCT03253796|616647595|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
170627197|NCT03253796|616647596|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
170627198|NCT03253796|616647597|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
170627199|NCT03253796|616647598|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
170627200|NCT03253796|616647594|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
170627201|NCT03253796|616647595|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
170627202|NCT03253796|616647596|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
170627203|NCT03253796|616647597|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
170627204|NCT03253796|616647598|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
170627205|NCT03253796|616647594|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
170627206|NCT03253796|616647595|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
170627207|NCT03253796|616647596|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
170627208|NCT03253796|616647597|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
170627209|NCT03253796|616647598|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
170627210|NCT03253796|616647594|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
170627211|NCT03253796|616647595|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
170627212|NCT03253796|616647596|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
170627213|NCT03253796|616647597|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
170627214|NCT03253796|616647598|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
170627215|NCT03253796|616647594|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
170627216|NCT03253796|616647595|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
170627217|NCT03253796|616647596|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
170627218|NCT03253796|616647597|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
170627219|NCT03253796|616647598|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
170627220|NCT03253796|616647594|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
170627221|NCT03253796|616647595|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
170627222|NCT03253796|616647596|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
170627223|NCT03253796|616647597|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
170627224|NCT03253796|616647598|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
170627225|NCT00528112|616647599|FG000|Treatment up to 3 Years|Adverse Event|313|||
170627226|NCT00528112|616647600|FG001|Treatment up to 3 Years|Adverse Event|278|||
170627227|NCT00528112|616647599|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
170627228|NCT00528112|616647600|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
170627229|NCT00528112|616647599|FG000|Treatment up to 3 Years|Protocol Violation|16|||
170627230|NCT00528112|616647600|FG001|Treatment up to 3 Years|Protocol Violation|16|||
170627231|NCT00528112|616647599|FG000|Treatment up to 3 Years|Death|0|||
170627232|NCT00528112|616647600|FG001|Treatment up to 3 Years|Death|1|||
170627233|NCT00528112|616647599|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
170672503|NCT04457336|616814245|FG005|Period 2: Part A|Adverse Event|0|||
170672504|NCT04457336|616814246|FG006|Period 2: Part A|Adverse Event|0|||
170820095|NCT03560206|617347722|FG000|Overall Study|Busy schedule|14|||
170820096|NCT03560206|617347723|FG001|Overall Study|Busy schedule|2|||
170672505|NCT04457336|616814247|FG007|Period 2: Part A|Adverse Event|0|||
170672506|NCT04457336|616814240|FG000|Period 2: Part A|Study Terminated|0|||
170672507|NCT04457336|616814241|FG001|Period 2: Part A|Study Terminated|0|||
170627234|NCT00528112|616647600|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
170627235|NCT00528112|616647599|FG000|Treatment up to 3 Years|Pregnancy|9|||
170627236|NCT00528112|616647600|FG001|Treatment up to 3 Years|Pregnancy|10|||
170627237|NCT00528112|616647599|FG000|Treatment up to 3 Years|Other reasons|186|||
170627238|NCT00528112|616647600|FG001|Treatment up to 3 Years|Other reasons|186|||
170627239|NCT00528112|616647599|FG000|Extension Phase|Withdrawal by Subject|0|||
170627240|NCT00528112|616647600|FG001|Extension Phase|Withdrawal by Subject|3|||
170627241|NCT00528112|616647599|FG000|Extension Phase|Other reasons|0|||
170627242|NCT00528112|616647600|FG001|Extension Phase|Other reasons|100|||
170627243|NCT00528112|616647599|FG000|Extension Phase|Pregnancy|0|||
170627244|NCT00528112|616647600|FG001|Extension Phase|Pregnancy|3|||
170627245|NCT00528112|616647599|FG000|Extension Phase|Lost to Follow-up|0|||
170627246|NCT00528112|616647600|FG001|Extension Phase|Lost to Follow-up|12|||
170627247|NCT00528112|616647599|FG000|Extension Phase|Death|0|||
170627248|NCT00528112|616647600|FG001|Extension Phase|Death|1|||
170627249|NCT00528112|616647599|FG000|Extension Phase|Adverse Event|0|||
170627250|NCT00528112|616647600|FG001|Extension Phase|Adverse Event|36|||
170627251|NCT00528112|616647599|FG000|Extension Phase|Protocol Violation|0|||
170627252|NCT00528112|616647600|FG001|Extension Phase|Protocol Violation|2|||
170627253|NCT02718898|616647603|FG000|Blinded Treatment Period|Adverse Event|5|||
170627254|NCT02718898|616647604|FG001|Blinded Treatment Period|Adverse Event|1|||
170627255|NCT02718898|616647605|FG002|Blinded Treatment Period|Adverse Event|0|||
170627256|NCT02718898|616647606|FG003|Blinded Treatment Period|Adverse Event|0|||
170627257|NCT02718898|616647607|FG004|Blinded Treatment Period|Adverse Event|0|||
170627258|NCT02718898|616647608|FG005|Blinded Treatment Period|Adverse Event|0|||
170627259|NCT02718898|616647609|FG006|Blinded Treatment Period|Adverse Event|0|||
170627260|NCT02718898|616647603|FG000|Blinded Treatment Period|Physician Decision|1|||
170627261|NCT02718898|616647604|FG001|Blinded Treatment Period|Physician Decision|0|||
170627262|NCT02718898|616647605|FG002|Blinded Treatment Period|Physician Decision|0|||
170627263|NCT02718898|616647606|FG003|Blinded Treatment Period|Physician Decision|0|||
170627264|NCT02718898|616647607|FG004|Blinded Treatment Period|Physician Decision|0|||
170627265|NCT02718898|616647608|FG005|Blinded Treatment Period|Physician Decision|0|||
170627266|NCT02718898|616647609|FG006|Blinded Treatment Period|Physician Decision|0|||
170627267|NCT02718898|616647603|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
170627268|NCT02718898|616647604|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
170627269|NCT02718898|616647605|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
170627270|NCT02718898|616647606|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
170627271|NCT02718898|616647607|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
170627272|NCT02718898|616647608|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
170627273|NCT02718898|616647609|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
170627274|NCT02718898|616647603|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
170627275|NCT02718898|616647604|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
170627276|NCT02718898|616647605|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
170627277|NCT02718898|616647606|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
170627278|NCT02718898|616647607|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
170627279|NCT02718898|616647608|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
170627280|NCT02718898|616647609|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
170627281|NCT02718898|616647603|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
170627282|NCT02718898|616647604|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
170627283|NCT02718898|616647605|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
170627284|NCT02718898|616647606|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
170627285|NCT02718898|616647607|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
170627286|NCT02718898|616647608|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
170627287|NCT02718898|616647609|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
170627288|NCT02718898|616647603|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
170627289|NCT02718898|616647604|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
170627290|NCT02718898|616647605|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
170627291|NCT02718898|616647606|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
170627292|NCT02718898|616647607|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
170627293|NCT02718898|616647608|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
170627294|NCT02718898|616647609|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
170627295|NCT02718898|616647603|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170627296|NCT02718898|616647604|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170627297|NCT02718898|616647605|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
170627298|NCT02718898|616647606|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
170627299|NCT02718898|616647607|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170627300|NCT02718898|616647608|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170627301|NCT02718898|616647609|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170627302|NCT02718898|616647603|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
170672508|NCT04457336|616814242|FG002|Period 2: Part A|Study Terminated|1|||
170672509|NCT04457336|616814243|FG003|Period 2: Part A|Study Terminated|0|||
170672510|NCT04457336|616814244|FG004|Period 2: Part A|Study Terminated|0|||
170672511|NCT04457336|616814245|FG005|Period 2: Part A|Study Terminated|0|||
170672512|NCT04457336|616814246|FG006|Period 2: Part A|Study Terminated|0|||
170672513|NCT04457336|616814247|FG007|Period 2: Part A|Study Terminated|0|||
170672514|NCT04457336|616814240|FG000|Period 2: Part A|Protocol Violation|0|||
170672515|NCT04457336|616814241|FG001|Period 2: Part A|Protocol Violation|1|||
170672516|NCT04457336|616814242|FG002|Period 2: Part A|Protocol Violation|0|||
170672517|NCT04457336|616814243|FG003|Period 2: Part A|Protocol Violation|0|||
170672518|NCT04457336|616814244|FG004|Period 2: Part A|Protocol Violation|0|||
170672519|NCT04457336|616814245|FG005|Period 2: Part A|Protocol Violation|0|||
170672520|NCT04457336|616814246|FG006|Period 2: Part A|Protocol Violation|0|||
170672521|NCT04457336|616814247|FG007|Period 2: Part A|Protocol Violation|0|||
170672522|NCT04457336|616814240|FG000|Period 2: Part A|Lost to Follow-up|0|||
170672523|NCT04457336|616814241|FG001|Period 2: Part A|Lost to Follow-up|1|||
170672524|NCT04457336|616814242|FG002|Period 2: Part A|Lost to Follow-up|0|||
170672525|NCT04457336|616814243|FG003|Period 2: Part A|Lost to Follow-up|0|||
170672526|NCT04457336|616814244|FG004|Period 2: Part A|Lost to Follow-up|0|||
170672527|NCT04457336|616814245|FG005|Period 2: Part A|Lost to Follow-up|0|||
170672528|NCT04457336|616814246|FG006|Period 2: Part A|Lost to Follow-up|0|||
170672529|NCT04457336|616814247|FG007|Period 2: Part A|Lost to Follow-up|0|||
170672530|NCT04457336|616814240|FG000|Period 2: Part A|Other|0|||
170672531|NCT04457336|616814241|FG001|Period 2: Part A|Other|1|||
170672532|NCT04457336|616814242|FG002|Period 2: Part A|Other|0|||
170672533|NCT04457336|616814243|FG003|Period 2: Part A|Other|0|||
170672534|NCT04457336|616814244|FG004|Period 2: Part A|Other|0|||
170672535|NCT04457336|616814245|FG005|Period 2: Part A|Other|0|||
170672536|NCT04457336|616814246|FG006|Period 2: Part A|Other|0|||
170672537|NCT04457336|616814247|FG007|Period 2: Part A|Other|0|||
170672538|NCT04457336|616814240|FG000|Period 2: Part A|Physician Decision|0|||
170672539|NCT04457336|616814241|FG001|Period 2: Part A|Physician Decision|0|||
170672540|NCT04457336|616814242|FG002|Period 2: Part A|Physician Decision|0|||
170672541|NCT04457336|616814243|FG003|Period 2: Part A|Physician Decision|1|||
170672542|NCT04457336|616814244|FG004|Period 2: Part A|Physician Decision|0|||
170672543|NCT04457336|616814245|FG005|Period 2: Part A|Physician Decision|0|||
170672544|NCT04457336|616814246|FG006|Period 2: Part A|Physician Decision|0|||
170672545|NCT04457336|616814247|FG007|Period 2: Part A|Physician Decision|0|||
170672546|NCT04457336|616814240|FG000|Period 3: Part B|Study Terminated|0|||
170672547|NCT04457336|616814241|FG001|Period 3: Part B|Study Terminated|0|||
170672548|NCT04457336|616814242|FG002|Period 3: Part B|Study Terminated|0|||
170672549|NCT04457336|616814243|FG003|Period 3: Part B|Study Terminated|0|||
170672550|NCT04457336|616814244|FG004|Period 3: Part B|Study Terminated|1|||
170672551|NCT04457336|616814245|FG005|Period 3: Part B|Study Terminated|10|||
170672552|NCT04457336|616814246|FG006|Period 3: Part B|Study Terminated|13|||
170672553|NCT04457336|616814247|FG007|Period 3: Part B|Study Terminated|0|||
170672554|NCT04457336|616814240|FG000|Period 3: Part B|Withdrawal by Subject|0|||
170672555|NCT04457336|616814241|FG001|Period 3: Part B|Withdrawal by Subject|0|||
170672556|NCT04457336|616814242|FG002|Period 3: Part B|Withdrawal by Subject|0|||
170672557|NCT04457336|616814243|FG003|Period 3: Part B|Withdrawal by Subject|0|||
170627303|NCT02718898|616647604|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
170627304|NCT02718898|616647605|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
170627305|NCT02718898|616647606|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
170627306|NCT02718898|616647607|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
170627307|NCT02718898|616647608|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
170627308|NCT02718898|616647609|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
170627309|NCT02718898|616647603|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
170627310|NCT02718898|616647604|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
170627311|NCT02718898|616647605|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
170627312|NCT02718898|616647606|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
170627313|NCT02718898|616647607|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
170627314|NCT02718898|616647608|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
170627315|NCT02718898|616647609|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
170627316|NCT02718898|616647603|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
170672558|NCT04457336|616814244|FG004|Period 3: Part B|Withdrawal by Subject|0|||
170672559|NCT04457336|616814245|FG005|Period 3: Part B|Withdrawal by Subject|1|||
170672560|NCT04457336|616814246|FG006|Period 3: Part B|Withdrawal by Subject|2|||
170672561|NCT04457336|616814247|FG007|Period 3: Part B|Withdrawal by Subject|0|||
170672562|NCT04457336|616814240|FG000|Period 4: Part C|Study Terminated|0|||
170672563|NCT04457336|616814241|FG001|Period 4: Part C|Study Terminated|0|||
170672564|NCT04457336|616814242|FG002|Period 4: Part C|Study Terminated|0|||
170672565|NCT04457336|616814243|FG003|Period 4: Part C|Study Terminated|0|||
170672566|NCT04457336|616814244|FG004|Period 4: Part C|Study Terminated|0|||
170672567|NCT04457336|616814245|FG005|Period 4: Part C|Study Terminated|0|||
170672568|NCT04457336|616814246|FG006|Period 4: Part C|Study Terminated|0|||
170672569|NCT04457336|616814247|FG007|Period 4: Part C|Study Terminated|30|||
170672570|NCT04457336|616814240|FG000|Period 4: Part C|Adverse Event|0|||
170672571|NCT04457336|616814241|FG001|Period 4: Part C|Adverse Event|0|||
170672572|NCT04457336|616814242|FG002|Period 4: Part C|Adverse Event|0|||
170672573|NCT04457336|616814243|FG003|Period 4: Part C|Adverse Event|0|||
170672574|NCT04457336|616814244|FG004|Period 4: Part C|Adverse Event|0|||
170672575|NCT04457336|616814245|FG005|Period 4: Part C|Adverse Event|0|||
170672576|NCT04457336|616814246|FG006|Period 4: Part C|Adverse Event|0|||
170672577|NCT04457336|616814247|FG007|Period 4: Part C|Adverse Event|2|||
170672578|NCT04457336|616814240|FG000|Period 4: Part C|Site Terminated|0|||
170672579|NCT04457336|616814241|FG001|Period 4: Part C|Site Terminated|0|||
170672580|NCT04457336|616814242|FG002|Period 4: Part C|Site Terminated|0|||
170672581|NCT04457336|616814243|FG003|Period 4: Part C|Site Terminated|0|||
170672582|NCT04457336|616814244|FG004|Period 4: Part C|Site Terminated|0|||
170672583|NCT04457336|616814245|FG005|Period 4: Part C|Site Terminated|0|||
170672584|NCT04457336|616814246|FG006|Period 4: Part C|Site Terminated|0|||
170672585|NCT04457336|616814247|FG007|Period 4: Part C|Site Terminated|1|||
170672586|NCT04457336|616814240|FG000|Period 4: Part C|Other|0|||
170672587|NCT04457336|616814241|FG001|Period 4: Part C|Other|0|||
170672588|NCT04457336|616814242|FG002|Period 4: Part C|Other|0|||
170672589|NCT04457336|616814243|FG003|Period 4: Part C|Other|0|||
170672590|NCT04457336|616814244|FG004|Period 4: Part C|Other|0|||
170672591|NCT04457336|616814245|FG005|Period 4: Part C|Other|0|||
170672592|NCT04457336|616814246|FG006|Period 4: Part C|Other|0|||
170672593|NCT04457336|616814247|FG007|Period 4: Part C|Other|2|||
170672594|NCT04457336|616814240|FG000|Period 4: Part C|Withdrawal by Subject|0|||
170672595|NCT04457336|616814241|FG001|Period 4: Part C|Withdrawal by Subject|0|||
170672596|NCT04457336|616814242|FG002|Period 4: Part C|Withdrawal by Subject|0|||
170672597|NCT04457336|616814243|FG003|Period 4: Part C|Withdrawal by Subject|0|||
170672598|NCT04457336|616814244|FG004|Period 4: Part C|Withdrawal by Subject|0|||
170672599|NCT04457336|616814245|FG005|Period 4: Part C|Withdrawal by Subject|0|||
170672600|NCT04457336|616814246|FG006|Period 4: Part C|Withdrawal by Subject|0|||
170672601|NCT04457336|616814247|FG007|Period 4: Part C|Withdrawal by Subject|3|||
170672602|NCT05379231|616814248|FG000|Home Visit|Withdrawal by Subject|2|||
170672603|NCT05379231|616814248|FG000|In-lab Visit|Withdrawal by Subject|2|||
170672604|NCT04203498|616814258|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
170672605|NCT04203498|616814259|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
170672606|NCT04203498|616814258|FG000|Overall Study|Withdrawal of patient consent|7|||
170672607|NCT04203498|616814259|FG001|Overall Study|Withdrawal of patient consent|2|||
170672608|NCT04203498|616814258|FG000|Overall Study|Adverse Event|4|||
170672609|NCT04203498|616814259|FG001|Overall Study|Adverse Event|1|||
170672610|NCT04203498|616814258|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
170672611|NCT04203498|616814259|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
170672612|NCT04203498|616814258|FG000|Overall Study|Did not receive IMP|2|||
170672613|NCT04203498|616814259|FG001|Overall Study|Did not receive IMP|0|||
170672614|NCT00939640|616814260|FG000|Overall Study|Physician Decision|1|||
170672615|NCT02121522|616814261|FG000|Overall Study|Adverse Event|1|||
170672616|NCT00892047|616814263|FG000|Overall Study|Adverse Event|2|||
170672617|NCT00892047|616814264|FG001|Overall Study|Adverse Event|2|||
170672618|NCT00892047|616814263|FG000|Overall Study|subject burden|2|||
170672619|NCT00892047|616814264|FG001|Overall Study|subject burden|3|||
170672620|NCT00892047|616814263|FG000|Overall Study|Lack of Efficacy|0|||
170672621|NCT00892047|616814264|FG001|Overall Study|Lack of Efficacy|2|||
170672622|NCT02762578|616814270|FG000|Overall Study|Adverse Event|1|||
170672623|NCT02762578|616814271|FG001|Overall Study|Adverse Event|6|||
170672624|NCT02762578|616814270|FG000|Overall Study|Protocol Violation|4|||
170672625|NCT02762578|616814271|FG001|Overall Study|Protocol Violation|2|||
170672626|NCT02762578|616814270|FG000|Overall Study|Withdrawal by Subject|4|||
170672627|NCT02762578|616814271|FG001|Overall Study|Withdrawal by Subject|2|||
170672628|NCT02762578|616814270|FG000|Overall Study|Unclassified|6|||
170672629|NCT02762578|616814271|FG001|Overall Study|Unclassified|0|||
170672630|NCT00259610|616814272|FG000|Overall Study|Withdrawal by Subject|33|||
170672631|NCT00259610|616814273|FG001|Overall Study|Withdrawal by Subject|25|||
170672632|NCT00259610|616814274|FG002|Overall Study|Withdrawal by Subject|29|||
170672633|NCT00259610|616814275|FG003|Overall Study|Withdrawal by Subject|19|||
170672634|NCT00259610|616814272|FG000|Overall Study|Lost to Follow-up|19|||
170672635|NCT00259610|616814273|FG001|Overall Study|Lost to Follow-up|8|||
170672636|NCT00259610|616814274|FG002|Overall Study|Lost to Follow-up|18|||
170672637|NCT00259610|616814275|FG003|Overall Study|Lost to Follow-up|15|||
170672638|NCT00259610|616814272|FG000|Overall Study|Physician Decision|6|||
170672639|NCT00259610|616814273|FG001|Overall Study|Physician Decision|4|||
170672640|NCT00259610|616814274|FG002|Overall Study|Physician Decision|7|||
170672641|NCT00259610|616814275|FG003|Overall Study|Physician Decision|2|||
170672642|NCT00259610|616814272|FG000|Overall Study|Death|1|||
170672643|NCT00259610|616814273|FG001|Overall Study|Death|1|||
170672644|NCT00259610|616814274|FG002|Overall Study|Death|2|||
170672645|NCT00259610|616814275|FG003|Overall Study|Death|0|||
170672646|NCT00259610|616814272|FG000|Overall Study|non medical reason|6|||
170672647|NCT00259610|616814273|FG001|Overall Study|non medical reason|2|||
170672648|NCT00259610|616814274|FG002|Overall Study|non medical reason|10|||
170672649|NCT00259610|616814275|FG003|Overall Study|non medical reason|3|||
170672650|NCT00259610|616814272|FG000|Overall Study|Adverse Event|3|||
170672651|NCT00259610|616814273|FG001|Overall Study|Adverse Event|4|||
170672652|NCT00259610|616814274|FG002|Overall Study|Adverse Event|5|||
170672653|NCT00259610|616814275|FG003|Overall Study|Adverse Event|2|||
170672654|NCT00259610|616814272|FG000|Overall Study|Serious Adverse Event|8|||
170672655|NCT00259610|616814273|FG001|Overall Study|Serious Adverse Event|2|||
170672656|NCT00259610|616814274|FG002|Overall Study|Serious Adverse Event|2|||
170672657|NCT00259610|616814275|FG003|Overall Study|Serious Adverse Event|2|||
170672658|NCT02083965|616814279|FG000|Treatment Period|Other|1|||
170672659|NCT02083965|616814280|FG001|Treatment Period|Other|0|||
170672660|NCT01201785|616814282|FG000|Overall Study|Lost to Follow-up|16|||
170672661|NCT01999179|616814287|FG000|Overall Study|Adverse Event|1|||
170672662|NCT01999179|616814287|FG000|Overall Study|Lost to Follow-up|1|||
170672663|NCT01999179|616814287|FG000|Overall Study|Change in Therapy|3|||
170672664|NCT01999179|616814287|FG000|Overall Study|New catheter|2|||
170672665|NCT00114530|616814289|FG000|Overall Study|Death|3|||
170672666|NCT00114530|616814290|FG001|Overall Study|Death|11|||
170672667|NCT00114530|616814289|FG000|Overall Study|Lost to Follow-up|1|||
170672668|NCT00114530|616814290|FG001|Overall Study|Lost to Follow-up|1|||
170672669|NCT00114530|616814289|FG000|Overall Study|Physician Decision|1|||
170672670|NCT00114530|616814290|FG001|Overall Study|Physician Decision|1|||
170672671|NCT00114530|616814289|FG000|Overall Study|Withdrawal by Subject|2|||
170672672|NCT00114530|616814290|FG001|Overall Study|Withdrawal by Subject|6|||
170672673|NCT00114530|616814289|FG000|Overall Study|Breast Cancer|1|||
170672674|NCT00114530|616814290|FG001|Overall Study|Breast Cancer|0|||
170672675|NCT00114530|616814289|FG000|Overall Study|Subject decision after endpoint failure|0|||
170672676|NCT00114530|616814290|FG001|Overall Study|Subject decision after endpoint failure|1|||
170627317|NCT02718898|616647604|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
170627318|NCT02718898|616647605|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
170627319|NCT02718898|616647606|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
170627320|NCT02718898|616647607|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
170627321|NCT02718898|616647608|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
170627322|NCT02718898|616647609|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
170627323|NCT02718898|616647603|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
170627324|NCT02718898|616647604|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
170627325|NCT02718898|616647605|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
170627326|NCT02718898|616647606|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
170627327|NCT02718898|616647607|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
170627328|NCT02718898|616647608|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
170627329|NCT02718898|616647609|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
170627330|NCT02718898|616647603|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
170627331|NCT02718898|616647604|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
170627332|NCT02718898|616647605|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
170627333|NCT02718898|616647606|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
170627334|NCT02718898|616647607|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
170627335|NCT02718898|616647608|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
170627336|NCT02718898|616647609|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
170627337|NCT02718898|616647603|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170627338|NCT02718898|616647604|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170627339|NCT02718898|616647605|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170627340|NCT02718898|616647606|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170627341|NCT02718898|616647607|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
170627342|NCT02718898|616647608|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
170627343|NCT02718898|616647609|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
170627344|NCT02559622|616647611|FG000|Overall Study|Progressive disease|0|||
170627345|NCT02559622|616647612|FG001|Overall Study|Progressive disease|1|||
170627346|NCT02559622|616647613|FG002|Overall Study|Progressive disease|0|||
170627347|NCT02559622|616647614|FG003|Overall Study|Progressive disease|0|||
170627348|NCT02559622|616647611|FG000|Overall Study|Adverse Event|0|||
170627349|NCT02559622|616647612|FG001|Overall Study|Adverse Event|2|||
170627350|NCT02559622|616647613|FG002|Overall Study|Adverse Event|2|||
170627351|NCT02559622|616647614|FG003|Overall Study|Adverse Event|2|||
170627352|NCT02559622|616647611|FG000|Overall Study|Patient/guardian decision|1|||
170627353|NCT02559622|616647612|FG001|Overall Study|Patient/guardian decision|2|||
170672677|NCT00114530|616814289|FG000|Overall Study|Ineligible|1|||
170672678|NCT00114530|616814290|FG001|Overall Study|Ineligible|0|||
170672679|NCT00404235|616814291|FG000|Overall Study|Withdrawal by Subject|1|||
170672680|NCT00404235|616814292|FG001|Overall Study|Withdrawal by Subject|2|||
170672681|NCT02639065|616814293|FG000|Study Treatment|Disease Progression|13|||
170672682|NCT02639065|616814293|FG000|Study Treatment|Adverse Event|9|||
170627354|NCT02559622|616647613|FG002|Overall Study|Patient/guardian decision|0|||
170627355|NCT02559622|616647614|FG003|Overall Study|Patient/guardian decision|1|||
170627356|NCT02163538|616647615|FG000|Overall Study|Protocol Violation|1|||
170627357|NCT02163538|616647616|FG001|Overall Study|Protocol Violation|0|||
170627358|NCT02163538|616647615|FG000|Overall Study|Physician Decision|0|||
170627359|NCT02163538|616647616|FG001|Overall Study|Physician Decision|1|||
170627360|NCT01710345|616647619|FG000|Overall Study|Adverse Event|0|||
170627361|NCT01710345|616647620|FG001|Overall Study|Adverse Event|2|||
170627362|NCT01710345|616647621|FG002|Overall Study|Adverse Event|0|||
170627363|NCT01710345|616647619|FG000|Overall Study|Lack of Efficacy|2|||
170627364|NCT01710345|616647620|FG001|Overall Study|Lack of Efficacy|3|||
170627365|NCT01710345|616647621|FG002|Overall Study|Lack of Efficacy|1|||
170627366|NCT01710345|616647619|FG000|Overall Study|Drug Dosing Error|1|||
170627367|NCT01710345|616647620|FG001|Overall Study|Drug Dosing Error|0|||
170627368|NCT01710345|616647621|FG002|Overall Study|Drug Dosing Error|0|||
170627369|NCT01339832|616647624|FG000|Overall Study|Lost to Follow-up|3|||
170627370|NCT01339832|616647624|FG000|Overall Study|Death|11|||
170627371|NCT00784563|616647631|FG000|Years 1 & 2|Withdrawal by Subject|3|||
170627372|NCT00784563|616647632|FG001|Years 1 & 2|Withdrawal by Subject|2|||
170627373|NCT00784563|616647633|FG002|Years 1 & 2|Withdrawal by Subject|0|||
170627374|NCT00784563|616647631|FG000|Years 1 & 2|Adverse Event|0|||
170627375|NCT00784563|616647632|FG001|Years 1 & 2|Adverse Event|3|||
170627376|NCT00784563|616647633|FG002|Years 1 & 2|Adverse Event|0|||
170627377|NCT00784563|616647631|FG000|Year 3|Withdrawal by Subject|0|||
170627378|NCT00784563|616647632|FG001|Year 3|Withdrawal by Subject|0|||
170627379|NCT00784563|616647633|FG002|Year 3|Withdrawal by Subject|2|||
170672683|NCT02639065|616814293|FG000|Study Treatment|Withdrawal by Subject|1|||
170672684|NCT02639065|616814293|FG000|Follow up|Subject refused to follow up|1|||
170672685|NCT02639065|616814293|FG000|Follow up|Symptomatic Deterioration|2|||
170672686|NCT02639065|616814293|FG000|Follow up|Death|2|||
170672687|NCT02639065|616814293|FG000|Follow up|Study Terminated|1|||
170672688|NCT02639065|616814293|FG000|Follow up|Disease Progression|3|||
170672689|NCT03003390|616815974|FG000|Overall Study|Physician Decision|2|||
170672690|NCT03003390|616815975|FG001|Overall Study|Physician Decision|0|||
170672691|NCT03003390|616815974|FG000|Overall Study|Parent refused intervention|2|||
170672692|NCT03003390|616815975|FG001|Overall Study|Parent refused intervention|0|||
170672693|NCT01648101|616815976|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
170672694|NCT01648101|616815977|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
170672695|NCT01648101|616815978|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
170672696|NCT01648101|616815976|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
170672697|NCT01648101|616815977|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
170672698|NCT01648101|616815978|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
170672699|NCT01648101|616815976|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
170672700|NCT01648101|616815977|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
170672701|NCT01648101|616815978|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
170672702|NCT01648101|616815976|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
170672703|NCT01648101|616815977|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
170672704|NCT01648101|616815978|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
170672705|NCT01648101|616815976|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
170672706|NCT01648101|616815977|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
170672707|NCT01648101|616815978|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
170672708|NCT01648101|616815976|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
170672709|NCT01648101|616815977|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
170672710|NCT01648101|616815978|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
170672711|NCT01648101|616815976|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
170672712|NCT01648101|616815977|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
170672713|NCT01648101|616815978|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
170672714|NCT01648101|616815976|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
170672715|NCT01648101|616815977|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
170672716|NCT01648101|616815978|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
170672717|NCT01648101|616815976|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
170672718|NCT01648101|616815977|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
170672719|NCT01648101|616815978|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
170672720|NCT01648101|616815976|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
170672721|NCT01648101|616815977|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
170672722|NCT01648101|616815978|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
170672723|NCT01648101|616815976|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
170672724|NCT01648101|616815977|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
170672725|NCT01648101|616815978|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
170672726|NCT02469298|616815980|FG000|Overall Study|Protocol Violation|0|||
170672727|NCT02469298|616815981|FG001|Overall Study|Protocol Violation|1|||
170672728|NCT02469298|616815982|FG002|Overall Study|Protocol Violation|1|||
170672729|NCT02469298|616815983|FG003|Overall Study|Protocol Violation|0|||
170672730|NCT02469298|616815980|FG000|Overall Study|Lost to Follow-up|1|||
170672731|NCT02469298|616815981|FG001|Overall Study|Lost to Follow-up|0|||
170672732|NCT02469298|616815982|FG002|Overall Study|Lost to Follow-up|1|||
170672733|NCT02469298|616815983|FG003|Overall Study|Lost to Follow-up|0|||
170672734|NCT02469298|616815980|FG000|Overall Study|Physician Decision|0|||
170672735|NCT02469298|616815981|FG001|Overall Study|Physician Decision|0|||
170672736|NCT02469298|616815982|FG002|Overall Study|Physician Decision|0|||
170672737|NCT02469298|616815983|FG003|Overall Study|Physician Decision|1|||
170672738|NCT02469298|616815980|FG000|Overall Study|Withdrawal by Subject|0|||
170672739|NCT02469298|616815981|FG001|Overall Study|Withdrawal by Subject|0|||
170672740|NCT02469298|616815982|FG002|Overall Study|Withdrawal by Subject|0|||
170672741|NCT02469298|616815983|FG003|Overall Study|Withdrawal by Subject|1|||
170672742|NCT00307294|616815984|FG000|Overall Study|Withdrawal by Subject|1|||
170672743|NCT03311724|616815985|FG000|Overall Study|Physician Decision|0|||
170672744|NCT03311724|616815986|FG001|Overall Study|Physician Decision|0|||
170672745|NCT03311724|616815987|FG002|Overall Study|Physician Decision|0|||
170672746|NCT03311724|616815988|FG003|Overall Study|Physician Decision|1|||
170672747|NCT03311724|616815985|FG000|Overall Study|Protocol Violation|1|||
170672748|NCT03311724|616815986|FG001|Overall Study|Protocol Violation|0|||
170672749|NCT03311724|616815987|FG002|Overall Study|Protocol Violation|1|||
170672750|NCT03311724|616815988|FG003|Overall Study|Protocol Violation|0|||
170672751|NCT03311724|616815985|FG000|Overall Study|Withdrawal by Subject|1|||
170672752|NCT03311724|616815986|FG001|Overall Study|Withdrawal by Subject|1|||
170672753|NCT03311724|616815987|FG002|Overall Study|Withdrawal by Subject|0|||
170672754|NCT03311724|616815988|FG003|Overall Study|Withdrawal by Subject|0|||
170672755|NCT03311724|616815985|FG000|Overall Study|Lost to Follow-up|1|||
170672756|NCT03311724|616815986|FG001|Overall Study|Lost to Follow-up|0|||
170672757|NCT03311724|616815987|FG002|Overall Study|Lost to Follow-up|0|||
170672758|NCT03311724|616815988|FG003|Overall Study|Lost to Follow-up|0|||
170672759|NCT03311724|616815985|FG000|Overall Study|Sponsor Decision|0|||
170672760|NCT03311724|616815986|FG001|Overall Study|Sponsor Decision|0|||
170672761|NCT03311724|616815987|FG002|Overall Study|Sponsor Decision|1|||
170672762|NCT03311724|616815988|FG003|Overall Study|Sponsor Decision|0|||
170672763|NCT01433991|616816001|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
170672764|NCT01433991|616816002|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
170672765|NCT01433991|616816003|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
170672766|NCT01433991|616816004|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
170672767|NCT01433991|616816001|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
170672768|NCT01433991|616816002|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
170672769|NCT01433991|616816003|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
170672770|NCT01433991|616816004|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
170672771|NCT01433991|616816001|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
170672772|NCT01433991|616816002|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
170672773|NCT01433991|616816003|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
170672774|NCT01433991|616816004|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
170672775|NCT01433991|616816001|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
170672776|NCT01433991|616816002|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
170672777|NCT01433991|616816003|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
170672778|NCT01433991|616816004|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
170672779|NCT01433991|616816001|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
170672780|NCT01433991|616816002|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
170672781|NCT01433991|616816003|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
170672782|NCT01433991|616816004|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
170672783|NCT01433991|616816001|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
170672784|NCT01433991|616816002|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
170672785|NCT01433991|616816003|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
170672786|NCT01433991|616816004|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
170672787|NCT01433991|616816001|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
170672788|NCT01433991|616816002|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
170672789|NCT01433991|616816003|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
170672790|NCT01433991|616816004|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
170672791|NCT00290888|616816007|FG000|Overall Study|Physician Decision|3|||
170672792|NCT00290888|616816008|FG001|Overall Study|Physician Decision|1|||
170672793|NCT01581931|616816009|FG000|Washout|Adverse Event|0|||
170672794|NCT01581931|616816010|FG001|Washout|Adverse Event|1|||
170672795|NCT01847274|616816011|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
170672796|NCT01847274|616816012|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
170672797|NCT01847274|616816013|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
170672798|NCT01847274|616816014|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
170672799|NCT01847274|616816015|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
170672800|NCT01847274|616816016|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
170672801|NCT01847274|616816017|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
170672802|NCT01847274|616816018|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
170672803|NCT01847274|616816019|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
170672804|NCT01847274|616816020|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
170672805|NCT01847274|616816021|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
170672806|NCT01847274|616816011|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
170672807|NCT01847274|616816012|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
170672808|NCT01847274|616816013|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
170672809|NCT01847274|616816014|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
170672810|NCT01847274|616816015|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
170672811|NCT01847274|616816016|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
170672812|NCT01847274|616816017|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
170672813|NCT01847274|616816018|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
170672814|NCT01847274|616816019|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
170672815|NCT01847274|616816020|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
170672816|NCT01847274|616816021|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
170672817|NCT01847274|616816011|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
170672818|NCT01847274|616816012|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
170672819|NCT01847274|616816013|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
170672820|NCT01847274|616816014|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
170672821|NCT01847274|616816015|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
170672822|NCT01847274|616816016|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
170672823|NCT01847274|616816017|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
170672824|NCT01847274|616816018|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
170672825|NCT01847274|616816019|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
170672826|NCT01847274|616816020|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
170672827|NCT01847274|616816021|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
170672828|NCT01847274|616816011|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672829|NCT01847274|616816012|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672830|NCT01847274|616816013|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672831|NCT01847274|616816014|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
170672832|NCT01847274|616816015|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672833|NCT01847274|616816016|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672834|NCT01847274|616816017|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170820097|NCT03560206|617347722|FG000|Overall Study|patients' new health condition such as cancer|10|||
170820098|NCT03560206|617347723|FG001|Overall Study|patients' new health condition such as cancer|1|||
170820099|NCT01549951|617347724|FG000|Overall Study|Adverse Event|15|||
170820100|NCT01549951|617347724|FG000|Overall Study|Withdrawal by Subject|2|||
170820101|NCT01549951|617347724|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
170820102|NCT01549951|617347724|FG000|Overall Study|Progressive disease|29|||
170820103|NCT01549951|617347724|FG000|Overall Study|Symptomatic deterioration|1|||
170820104|NCT01549951|617347724|FG000|Overall Study|Other|2|||
170820105|NCT00738400|617347727|FG000|Overall Study|Adverse Event|3|||
170820106|NCT00738400|617347728|FG001|Overall Study|Adverse Event|1|||
170820107|NCT00738400|617347727|FG000|Overall Study|Withdrawal by Subject|0|||
170820108|NCT00738400|617347728|FG001|Overall Study|Withdrawal by Subject|1|||
170820109|NCT00738400|617347727|FG000|Overall Study|Lack of Efficacy|0|||
170820110|NCT00738400|617347728|FG001|Overall Study|Lack of Efficacy|1|||
170820111|NCT00738400|617347727|FG000|Overall Study|Lost to Follow-up|0|||
170820112|NCT00738400|617347728|FG001|Overall Study|Lost to Follow-up|3|||
170820113|NCT00738400|617347727|FG000|Overall Study|Protocol Violation|1|||
170820114|NCT00738400|617347728|FG001|Overall Study|Protocol Violation|0|||
170820115|NCT00738400|617347727|FG000|Overall Study|Non-compliant with study medication|0|||
170820116|NCT00738400|617347728|FG001|Overall Study|Non-compliant with study medication|1|||
170820117|NCT03138499|617347729|FG000|Overall Study|Lost to Follow-up|1|||
170820118|NCT03138499|617347730|FG001|Overall Study|Lost to Follow-up|0|||
170820119|NCT03138499|617347729|FG000|Overall Study|Participants withdrew consent|1|||
170820120|NCT03138499|617347730|FG001|Overall Study|Participants withdrew consent|0|||
170820121|NCT03138499|617347729|FG000|Overall Study|Participant discontinued study before treatment|0|||
170820122|NCT03138499|617347730|FG001|Overall Study|Participant discontinued study before treatment|1|||
170820123|NCT03138499|617347729|FG000|Overall Study|Disease Progression|2|||
170820124|NCT03138499|617347730|FG001|Overall Study|Disease Progression|6|||
170820125|NCT03138499|617347729|FG000|Overall Study|Study drug toxicity|2|||
170820126|NCT03138499|617347730|FG001|Overall Study|Study drug toxicity|2|||
170820127|NCT03138499|617347729|FG000|Overall Study|Participant request to discontinue study treatment|1|||
170820128|NCT03138499|617347730|FG001|Overall Study|Participant request to discontinue study treatment|1|||
170820129|NCT03138499|617347729|FG000|Overall Study|Other reasons|2|||
170820130|NCT03138499|617347730|FG001|Overall Study|Other reasons|0|||
170820131|NCT02255474|617347731|FG000|Overall Study|Lost to Follow-up|1|||
170820132|NCT02255474|617347732|FG001|Overall Study|Lost to Follow-up|1|||
170820133|NCT02255474|617347733|FG002|Overall Study|Lost to Follow-up|3|||
170820134|NCT02255474|617347731|FG000|Overall Study|Withdrawal by Subject|1|||
170820135|NCT02255474|617347732|FG001|Overall Study|Withdrawal by Subject|1|||
170820136|NCT02255474|617347733|FG002|Overall Study|Withdrawal by Subject|0|||
170820137|NCT01123200|617347736|FG000|Overall Study|Withdrawal by Subject|1|||
170820138|NCT03394508|617347742|FG000|Overall Study|Protocol Violation|0|||
170820139|NCT03394508|617347743|FG001|Overall Study|Protocol Violation|3|||
170820140|NCT03394508|617347742|FG000|Overall Study|Lost to Follow-up|1|||
170820141|NCT03394508|617347743|FG001|Overall Study|Lost to Follow-up|0|||
170820142|NCT02577315|617347746|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
170820143|NCT02577315|617347747|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
170820144|NCT00308113|617347748|FG000|Overall Study|Protocol closure|0|||
170820145|NCT00308113|617347749|FG001|Overall Study|Protocol closure|0|||
170820146|NCT00308113|617347750|FG002|Overall Study|Protocol closure|0|||
170820147|NCT00308113|617347751|FG003|Overall Study|Protocol closure|1|||
170820148|NCT02819141|617347754|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
170820149|NCT02819141|617347755|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
170820150|NCT03556891|617347756|FG000|Initial Pivotal Study|Adverse Event|4|||
170672835|NCT01847274|616816018|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672836|NCT01847274|616816019|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672837|NCT01847274|616816020|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672838|NCT01847274|616816021|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
170672839|NCT01847274|616816011|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
170672840|NCT01847274|616816012|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
170672841|NCT01847274|616816013|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
170672842|NCT01847274|616816014|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
170672843|NCT01847274|616816015|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
170672844|NCT01847274|616816016|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
170672845|NCT01847274|616816017|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
170672846|NCT01847274|616816018|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
170672847|NCT01847274|616816019|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
170672848|NCT01847274|616816020|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
170672849|NCT01847274|616816021|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
170672850|NCT01847274|616816011|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
170672851|NCT01847274|616816012|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
170672852|NCT01847274|616816013|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
170672853|NCT01847274|616816014|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
170672854|NCT01847274|616816015|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
170672855|NCT01847274|616816016|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
170672856|NCT01847274|616816017|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
170672857|NCT01847274|616816018|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
170672858|NCT01847274|616816019|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
170672859|NCT01847274|616816020|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
170672860|NCT01847274|616816021|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
170672861|NCT01847274|616816011|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
170672862|NCT01847274|616816012|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
170672863|NCT01847274|616816013|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
170672864|NCT01847274|616816014|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
170672865|NCT01847274|616816015|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
170672866|NCT01847274|616816016|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
170672867|NCT01847274|616816017|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
170672868|NCT01847274|616816018|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
170672869|NCT01847274|616816019|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
170672870|NCT01847274|616816020|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
170672871|NCT01847274|616816021|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
170672872|NCT01847274|616816011|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672873|NCT01847274|616816012|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672874|NCT01847274|616816013|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672875|NCT01847274|616816014|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672876|NCT01847274|616816015|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672877|NCT01847274|616816016|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
170672878|NCT01847274|616816017|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672879|NCT01847274|616816018|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672880|NCT01847274|616816019|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672881|NCT01847274|616816020|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672882|NCT01847274|616816021|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
170672883|NCT01847274|616816011|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672884|NCT01847274|616816012|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672885|NCT01847274|616816013|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672886|NCT01847274|616816014|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672887|NCT01847274|616816015|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
170672888|NCT01847274|616816016|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672889|NCT01847274|616816017|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672890|NCT01847274|616816018|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672891|NCT01847274|616816019|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672892|NCT01847274|616816020|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672893|NCT01847274|616816021|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
170672894|NCT01847274|616816011|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672895|NCT01847274|616816012|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672896|NCT01847274|616816013|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672897|NCT01847274|616816014|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170820151|NCT03556891|617347756|FG000|Initial Pivotal Study|MRI Need|3|||
170672898|NCT01847274|616816015|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672899|NCT01847274|616816016|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672900|NCT01847274|616816017|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
170672901|NCT01847274|616816018|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672902|NCT01847274|616816019|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672903|NCT01847274|616816020|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672904|NCT01847274|616816021|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
170672905|NCT01847274|616816011|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672906|NCT01847274|616816012|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672907|NCT01847274|616816013|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672908|NCT01847274|616816014|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672909|NCT01847274|616816015|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672910|NCT01847274|616816016|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672911|NCT01847274|616816017|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
170672912|NCT01847274|616816018|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672913|NCT01847274|616816019|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672914|NCT01847274|616816020|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672915|NCT01847274|616816021|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
170672916|NCT01847274|616816011|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672917|NCT01847274|616816012|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672918|NCT01847274|616816013|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672919|NCT01847274|616816014|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672920|NCT01847274|616816015|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672921|NCT01847274|616816016|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672922|NCT01847274|616816017|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
170672923|NCT01847274|616816018|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672924|NCT01847274|616816019|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672925|NCT01847274|616816020|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672926|NCT01847274|616816021|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
170672927|NCT01847274|616816011|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
170672928|NCT01847274|616816012|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
170672929|NCT01847274|616816013|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
170672930|NCT01847274|616816014|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
170672931|NCT01847274|616816015|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
170672932|NCT01847274|616816016|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
170672933|NCT01847274|616816017|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
170672934|NCT01847274|616816018|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
170672935|NCT01847274|616816019|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
170672936|NCT01847274|616816020|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
170672937|NCT01847274|616816021|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
170672938|NCT01847274|616816011|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672939|NCT01847274|616816012|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672940|NCT01847274|616816013|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672941|NCT01847274|616816014|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672942|NCT01847274|616816015|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672943|NCT01847274|616816016|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672944|NCT01847274|616816017|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672945|NCT01847274|616816018|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
170672946|NCT01847274|616816019|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672947|NCT01847274|616816020|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
170672948|NCT01847274|616816021|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
170672949|NCT01847274|616816011|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
170672950|NCT01847274|616816012|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
170672951|NCT01847274|616816013|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
170672952|NCT01847274|616816014|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
170672953|NCT01847274|616816015|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
170672954|NCT01847274|616816016|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
170672955|NCT01847274|616816017|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
170672956|NCT01847274|616816018|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
170672957|NCT01847274|616816019|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
170672958|NCT01847274|616816020|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
170672959|NCT01847274|616816021|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
170672960|NCT01847274|616816011|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170627380|NCT00784563|616647631|FG000|Year 3|Adverse Event|0|||
170627381|NCT00784563|616647632|FG001|Year 3|Adverse Event|0|||
170627382|NCT00784563|616647633|FG002|Year 3|Adverse Event|1|||
170627383|NCT00321789|616647634|FG000|Overall Study|Lost to Follow-up|4|||
170627384|NCT00321789|616647635|FG001|Overall Study|Lost to Follow-up|7|||
170627385|NCT00321789|616647634|FG000|Overall Study|Withdrawal by Subject|6|||
170627386|NCT00321789|616647635|FG001|Overall Study|Withdrawal by Subject|6|||
170627387|NCT00321789|616647634|FG000|Overall Study|Protocol Violation|5|||
170627388|NCT00321789|616647635|FG001|Overall Study|Protocol Violation|3|||
170627389|NCT05712460|616647637|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170672961|NCT01847274|616816012|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672962|NCT01847274|616816013|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672963|NCT01847274|616816014|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672964|NCT01847274|616816015|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672965|NCT01847274|616816016|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672966|NCT01847274|616816017|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672967|NCT01847274|616816018|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672968|NCT01847274|616816019|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672969|NCT01847274|616816020|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
170672970|NCT01847274|616816021|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
170672971|NCT03727230|616816022|FG000|Overall Study|Lost to Follow-up|12|||
170672972|NCT01706146|616816024|FG000|Overall Study|Withdrawal by Subject|1|||
170672973|NCT01706146|616816024|FG000|Overall Study|Adverse Event|3|||
170672974|NCT01706146|616816024|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
170672975|NCT02582983|616816025|FG000|Overall Study|Death|3|||
170672976|NCT02582983|616816025|FG000|Overall Study|Withdrawal by Subject|2|||
170672977|NCT02582983|616816025|FG000|Overall Study|Adverse Event|1|||
170672978|NCT02059395|616816026|FG000|Overall Study|Lost to Follow-up|2|||
170672979|NCT02059395|616816027|FG001|Overall Study|Lost to Follow-up|4|||
170672980|NCT05209360|616816028|FG000|Overall Study|Withdrawal by Subject|0|||
170672981|NCT05209360|616816029|FG001|Overall Study|Withdrawal by Subject|0|||
170672982|NCT05209360|616816030|FG002|Overall Study|Withdrawal by Subject|1|||
170672983|NCT05209360|616816031|FG003|Overall Study|Withdrawal by Subject|0|||
170672984|NCT05209360|616816032|FG004|Overall Study|Withdrawal by Subject|0|||
170672985|NCT05209360|616816033|FG005|Overall Study|Withdrawal by Subject|0|||
170672986|NCT00134082|616816034|FG000|Overall Study|Adverse Event|2|||
170672987|NCT00134082|616816034|FG000|Overall Study|Death|1|||
170672988|NCT00724932|616816037|FG000|Overall Study|Lost to Follow-up|1|||
170672989|NCT00724932|616816038|FG001|Overall Study|Lost to Follow-up|0|||
170672990|NCT00724932|616816037|FG000|Overall Study|Not treated|4|||
170672991|NCT00724932|616816038|FG001|Overall Study|Not treated|3|||
170672992|NCT02021331|616816039|FG000|Overall Study|Adverse Event|0|||
170672993|NCT02021331|616816040|FG001|Overall Study|Adverse Event|2|||
170672994|NCT01488370|616816041|FG000|Overall Study|Protocol Violation|0|||
170672995|NCT01488370|616816042|FG001|Overall Study|Protocol Violation|1|||
170672996|NCT01488370|616816043|FG002|Overall Study|Protocol Violation|1|||
170672997|NCT00044083|616816045|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
170672998|NCT00044083|616816046|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
170672999|NCT00044083|616816045|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
170673000|NCT00044083|616816046|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
170673001|NCT00044083|616816045|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
170673002|NCT00044083|616816046|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
170673003|NCT00044083|616816045|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
170820152|NCT03556891|617347756|FG000|Initial Pivotal Study|Device Failure|1|||
170820153|NCT03556891|617347756|FG000|Initial Pivotal Study|Death|1|||
170820154|NCT03556891|617347756|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
170820155|NCT03556891|617347756|FG000|Initial Pivotal Study|Missing at random|1|||
170820156|NCT03556891|617347756|FG000|Initial Pivotal Study|Missing due to COVID|1|||
170627390|NCT05712460|616647638|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627391|NCT05712460|616647639|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627392|NCT05712460|616647640|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627393|NCT05712460|616647641|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627394|NCT05712460|616647642|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627395|NCT05712460|616647643|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627396|NCT05712460|616647644|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
170627397|NCT05712460|616647645|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627398|NCT05712460|616647646|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627399|NCT05712460|616647647|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627400|NCT05712460|616647648|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
170627401|NCT02485691|616647652|FG000|Overall Study|Adverse Event|25|||
170627402|NCT02485691|616647653|FG001|Overall Study|Adverse Event|11|||
170627403|NCT02485691|616647652|FG000|Overall Study|Poor compliance to protocol|0|||
170627404|NCT02485691|616647653|FG001|Overall Study|Poor compliance to protocol|1|||
170627405|NCT02485691|616647652|FG000|Overall Study|Disease progression|57|||
170627406|NCT02485691|616647653|FG001|Overall Study|Disease progression|92|||
170627407|NCT02485691|616647652|FG000|Overall Study|Investigator's decision|23|||
170627408|NCT02485691|616647653|FG001|Overall Study|Investigator's decision|5|||
170627409|NCT02485691|616647652|FG000|Overall Study|Participant's request|13|||
170627410|NCT02485691|616647653|FG001|Overall Study|Participant's request|6|||
170627411|NCT02485691|616647652|FG000|Overall Study|Other reason|8|||
170627412|NCT02485691|616647653|FG001|Overall Study|Other reason|9|||
170627413|NCT02485691|616647652|FG000|Overall Study|Randomized and not treated|3|||
170627414|NCT02485691|616647653|FG001|Overall Study|Randomized and not treated|2|||
170627415|NCT04292535|616647654|FG000|Overall Study|Withdrawal by Subject|0|||
170627416|NCT04292535|616647655|FG001|Overall Study|Withdrawal by Subject|0|||
170627417|NCT04292535|616647656|FG002|Overall Study|Withdrawal by Subject|0|||
170627418|NCT04292535|616647657|FG003|Overall Study|Withdrawal by Subject|0|||
170627419|NCT04292535|616647658|FG004|Overall Study|Withdrawal by Subject|0|||
170627420|NCT04292535|616647659|FG005|Overall Study|Withdrawal by Subject|0|||
170627421|NCT04292535|616647660|FG006|Overall Study|Withdrawal by Subject|0|||
170627422|NCT04292535|616647661|FG007|Overall Study|Withdrawal by Subject|1|||
170627423|NCT04292535|616647662|FG008|Overall Study|Withdrawal by Subject|0|||
170627424|NCT04292535|616647663|FG009|Overall Study|Withdrawal by Subject|0|||
170627425|NCT04292535|616647664|FG010|Overall Study|Withdrawal by Subject|0|||
170627426|NCT04292535|616647665|FG011|Overall Study|Withdrawal by Subject|0|||
170627427|NCT04292535|616647666|FG012|Overall Study|Withdrawal by Subject|0|||
170627428|NCT04292535|616647667|FG013|Overall Study|Withdrawal by Subject|0|||
170627429|NCT04292535|616647654|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627430|NCT04292535|616647655|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627431|NCT04292535|616647656|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627432|NCT04292535|616647657|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627433|NCT04292535|616647658|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627434|NCT04292535|616647659|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627435|NCT04292535|616647660|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627436|NCT04292535|616647661|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
170627437|NCT04292535|616647662|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627438|NCT04292535|616647663|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627439|NCT04292535|616647664|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627440|NCT04292535|616647665|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
170627441|NCT04292535|616647666|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
170627442|NCT04292535|616647667|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
170627443|NCT04292535|616647654|FG000|Overall Study|Report of Dizziness|0|||
170627444|NCT04292535|616647655|FG001|Overall Study|Report of Dizziness|0|||
170627445|NCT04292535|616647656|FG002|Overall Study|Report of Dizziness|0|||
170627446|NCT04292535|616647657|FG003|Overall Study|Report of Dizziness|0|||
170627447|NCT04292535|616647658|FG004|Overall Study|Report of Dizziness|0|||
170627448|NCT04292535|616647659|FG005|Overall Study|Report of Dizziness|0|||
170627449|NCT04292535|616647660|FG006|Overall Study|Report of Dizziness|0|||
170627450|NCT04292535|616647661|FG007|Overall Study|Report of Dizziness|0|||
170627451|NCT04292535|616647662|FG008|Overall Study|Report of Dizziness|0|||
170627452|NCT04292535|616647663|FG009|Overall Study|Report of Dizziness|0|||
170627453|NCT04292535|616647664|FG010|Overall Study|Report of Dizziness|0|||
170627454|NCT04292535|616647665|FG011|Overall Study|Report of Dizziness|0|||
170627455|NCT04292535|616647666|FG012|Overall Study|Report of Dizziness|0|||
170820157|NCT03556891|617347756|FG000|Initial Pivotal Study|Protocol Violation|1|||
170627456|NCT04292535|616647667|FG013|Overall Study|Report of Dizziness|1|||
170627457|NCT04292535|616647654|FG000|Overall Study|Equipment Failure|0|||
170627458|NCT04292535|616647655|FG001|Overall Study|Equipment Failure|0|||
170627459|NCT04292535|616647656|FG002|Overall Study|Equipment Failure|0|||
170627460|NCT04292535|616647657|FG003|Overall Study|Equipment Failure|0|||
170627461|NCT04292535|616647658|FG004|Overall Study|Equipment Failure|0|||
170627462|NCT04292535|616647659|FG005|Overall Study|Equipment Failure|0|||
170627463|NCT04292535|616647660|FG006|Overall Study|Equipment Failure|0|||
170627464|NCT04292535|616647661|FG007|Overall Study|Equipment Failure|0|||
170627465|NCT04292535|616647662|FG008|Overall Study|Equipment Failure|0|||
170627466|NCT04292535|616647663|FG009|Overall Study|Equipment Failure|0|||
170627467|NCT04292535|616647664|FG010|Overall Study|Equipment Failure|0|||
170627468|NCT04292535|616647665|FG011|Overall Study|Equipment Failure|1|||
170627469|NCT04292535|616647666|FG012|Overall Study|Equipment Failure|0|||
170627470|NCT04292535|616647667|FG013|Overall Study|Equipment Failure|0|||
170627471|NCT01420861|616647668|FG000|Overall Study|Adverse Event|2|||
170627472|NCT01420861|616647668|FG000|Overall Study|Study terminated by Sponsor|7|||
170627473|NCT01420861|616647668|FG000|Overall Study|Screen failure|7|||
170627474|NCT01420861|616647668|FG000|Overall Study|Randomized not Treated|2|||
170627475|NCT01099267|616647670|FG000|MDS-003 Study|Adverse Event|37|||
170627476|NCT01099267|616647670|FG000|MDS-003 Study|Lack of Efficacy|52|||
170627477|NCT01099267|616647670|FG000|MDS-003 Study|Withdrawal by Subject|8|||
170627478|NCT01099267|616647670|FG000|MDS-003 Study|Lost to Follow-up|1|||
170627479|NCT01099267|616647670|FG000|MDS-003 Study|Death|11|||
170627480|NCT01099267|616647670|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
170627481|NCT01099267|616647670|FG000|MDS-003 Study|Disease Progression|7|||
170627482|NCT01099267|616647670|FG000|MDS-003 Study|Investigator Decision|2|||
170627483|NCT01099267|616647670|FG000|MDS-003 Study|Non-Compliance|2|||
170627484|NCT01099267|616647670|FG000|MDS-003 Study|Loss of Response|1|||
170627485|NCT01099267|616647670|FG000|MDS-003 Study|Secondary Malign Disease|1|||
170627486|NCT04986904|616647671|FG000|Overall Study|Lost to Follow-up|11|||
170627487|NCT04986904|616647671|FG000|Overall Study|Withdrawal by Subject|1|||
170627488|NCT01486966|616647676|FG000|Overall Study|Adverse Event|0|||
170627489|NCT01486966|616647677|FG001|Overall Study|Adverse Event|1|||
170627490|NCT01486966|616647676|FG000|Overall Study|Withdrawal by Subject|0|||
170627491|NCT01486966|616647677|FG001|Overall Study|Withdrawal by Subject|1|||
170627492|NCT03157830|616647678|FG000|Overall Study|Lost to Follow-up|1|||
170627493|NCT03157830|616647678|FG000|Overall Study|Withdrawal by Subject|1|||
170627494|NCT01074970|616647685|FG000|Overall Study|Never Treated|0|||
170627495|NCT01074970|616647686|FG001|Overall Study|Never Treated|0|||
170627496|NCT01074970|616647687|FG002|Overall Study|Never Treated|8|||
170627497|NCT01074970|616647688|FG003|Overall Study|Never Treated|1|||
170627498|NCT01074970|616647685|FG000|Overall Study|Adverse Event|1|||
170627499|NCT01074970|616647686|FG001|Overall Study|Adverse Event|0|||
170627500|NCT01074970|616647687|FG002|Overall Study|Adverse Event|4|||
170627501|NCT01074970|616647688|FG003|Overall Study|Adverse Event|3|||
170627502|NCT01074970|616647685|FG000|Overall Study|Disease progression during treatment|3|||
170627503|NCT01074970|616647686|FG001|Overall Study|Disease progression during treatment|1|||
170627504|NCT01074970|616647687|FG002|Overall Study|Disease progression during treatment|2|||
170627505|NCT01074970|616647688|FG003|Overall Study|Disease progression during treatment|9|||
170627506|NCT01074970|616647685|FG000|Overall Study|Lost to Follow-up|0|||
170627507|NCT01074970|616647686|FG001|Overall Study|Lost to Follow-up|0|||
170627508|NCT01074970|616647687|FG002|Overall Study|Lost to Follow-up|1|||
170627509|NCT01074970|616647688|FG003|Overall Study|Lost to Follow-up|0|||
170627510|NCT01074970|616647685|FG000|Overall Study|Withdrawal by Subject|0|||
170627511|NCT01074970|616647686|FG001|Overall Study|Withdrawal by Subject|0|||
170627512|NCT01074970|616647687|FG002|Overall Study|Withdrawal by Subject|6|||
170627513|NCT01074970|616647688|FG003|Overall Study|Withdrawal by Subject|4|||
170627514|NCT00734149|616647689|FG000|Overall Study|Withdrawal by Subject|1|||
170627515|NCT04314284|616647690|FG000|Overall Study|Withdrawal by Subject|4|||
170627516|NCT04314284|616647691|FG001|Overall Study|Withdrawal by Subject|7|||
170627517|NCT04314284|616647690|FG000|Overall Study|Consented but did not complete survey|0|||
170627518|NCT04314284|616647691|FG001|Overall Study|Consented but did not complete survey|6|||
170627519|NCT01652235|616647694|FG000|Overall Study|Death|9|||
170627520|NCT01652235|616647694|FG000|Overall Study|Lost to Follow-up|5|||
170627521|NCT01652235|616647694|FG000|Overall Study|Withdrawal by Subject|2|||
170627522|NCT02331134|616647695|FG000|Overall Study|Withdrawal by Subject|1|||
170627523|NCT04966013|616647696|FG000|Overall Study|Withdrawal by Subject|0|||
170627524|NCT04966013|616647697|FG001|Overall Study|Withdrawal by Subject|2|||
170627525|NCT04966013|616647698|FG002|Overall Study|Withdrawal by Subject|1|||
170627526|NCT04966013|616647696|FG000|Overall Study|Adverse Event|2|||
170627527|NCT04966013|616647697|FG001|Overall Study|Adverse Event|1|||
170627528|NCT04966013|616647698|FG002|Overall Study|Adverse Event|1|||
170627529|NCT00668148|616647699|FG000|Overall Study|Adverse Event|5|||
170627530|NCT00668148|616647699|FG000|Overall Study|Subject Non-compliance|1|||
170627531|NCT00668148|616647699|FG000|Overall Study|Progressive Disease Before Treatment|2|||
170627532|NCT00668148|616647699|FG000|Overall Study|Withdrawal of Consent|2|||
170627533|NCT05472090|616647706|FG000|Overall Study|Adverse Event|2|||
170673004|NCT00044083|616816046|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
170673005|NCT00044083|616816045|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
170673006|NCT00044083|616816046|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
170673007|NCT00044083|616816045|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
170673008|NCT00044083|616816046|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
170673009|NCT00044083|616816045|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
170673010|NCT00044083|616816046|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
170673011|NCT00044083|616816045|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
170673012|NCT00044083|616816046|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
170673013|NCT00044083|616816045|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
170673014|NCT00044083|616816046|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
170673015|NCT00044083|616816045|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
170673016|NCT00044083|616816046|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
170673017|NCT00289991|616816049|FG000|Overall Study|Death|35|||
170673018|NCT00289991|616816050|FG001|Overall Study|Death|38|||
170673019|NCT00289991|616816049|FG000|Overall Study|Adverse Event|15|||
170673020|NCT00289991|616816050|FG001|Overall Study|Adverse Event|13|||
170673021|NCT00289991|616816049|FG000|Overall Study|Failure of prophylaxis|1|||
170673022|NCT00289991|616816050|FG001|Overall Study|Failure of prophylaxis|1|||
170673023|NCT00289991|616816049|FG000|Overall Study|Fungal breakthrough infection|0|||
170673024|NCT00289991|616816050|FG001|Overall Study|Fungal breakthrough infection|1|||
170673025|NCT00289991|616816049|FG000|Overall Study|Lost to Follow-up|0|||
170673026|NCT00289991|616816050|FG001|Overall Study|Lost to Follow-up|1|||
170673027|NCT00289991|616816049|FG000|Overall Study|Withdrawal by Subject|2|||
170673028|NCT00289991|616816050|FG001|Overall Study|Withdrawal by Subject|12|||
170673029|NCT00289991|616816049|FG000|Overall Study|Other|5|||
170673030|NCT00289991|616816050|FG001|Overall Study|Other|14|||
170673031|NCT01007812|616816059|FG000|Period 1, One Week|Lost to Follow-up|0|||
170673032|NCT01007812|616816060|FG001|Period 1, One Week|Lost to Follow-up|1|||
170673033|NCT01007812|616816059|FG000|Period 1, One Week|Discomfort|1|||
170673034|NCT01007812|616816060|FG001|Period 1, One Week|Discomfort|0|||
170673035|NCT00963937|616816065|FG000|Overall Study|Protocol Violation|1|||
170673036|NCT00963937|616816066|FG001|Overall Study|Protocol Violation|1|||
170673037|NCT00963937|616816067|FG002|Overall Study|Protocol Violation|0|||
170673038|NCT00963937|616816065|FG000|Overall Study|Physician Decision|18|||
170673039|NCT00963937|616816066|FG001|Overall Study|Physician Decision|10|||
170673040|NCT00963937|616816067|FG002|Overall Study|Physician Decision|4|||
170673041|NCT00181155|616816068|FG000|Overall Study|Physician Decision|1|||
170673042|NCT00181155|616816069|FG001|Overall Study|Physician Decision|0|||
170673043|NCT00181155|616816068|FG000|Overall Study|Withdrawal by Subject|1|||
170673044|NCT00181155|616816069|FG001|Overall Study|Withdrawal by Subject|0|||
170673045|NCT01090492|616816070|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
170673046|NCT01090492|616816071|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
170673047|NCT01090492|616816072|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
170673048|NCT01090492|616816073|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
170673049|NCT01090492|616816074|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
170673050|NCT01090492|616816075|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
170673051|NCT01090492|616816076|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
170673052|NCT01090492|616816077|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
170673053|NCT01090492|616816070|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
170673054|NCT01090492|616816071|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
170673055|NCT01090492|616816072|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
170673056|NCT01090492|616816073|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
170673057|NCT01090492|616816074|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
170673058|NCT01090492|616816075|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
170673059|NCT01090492|616816076|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
170673060|NCT01090492|616816077|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
170673061|NCT01090492|616816070|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673062|NCT01090492|616816071|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673063|NCT01090492|616816072|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
170673064|NCT01090492|616816073|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673065|NCT01090492|616816074|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673066|NCT01090492|616816075|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673067|NCT01090492|616816076|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673068|NCT01090492|616816077|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673069|NCT01090492|616816070|FG000|First Intervention Period (4 Weeks)|Other|0|||
170673070|NCT01090492|616816071|FG001|First Intervention Period (4 Weeks)|Other|0|||
170673071|NCT01090492|616816072|FG002|First Intervention Period (4 Weeks)|Other|1|||
170673072|NCT01090492|616816073|FG003|First Intervention Period (4 Weeks)|Other|1|||
170673073|NCT01090492|616816074|FG004|First Intervention Period (4 Weeks)|Other|2|||
170673074|NCT01090492|616816075|FG005|First Intervention Period (4 Weeks)|Other|0|||
170673075|NCT01090492|616816076|FG006|First Intervention Period (4 Weeks)|Other|0|||
170673076|NCT01090492|616816077|FG007|First Intervention Period (4 Weeks)|Other|0|||
170673077|NCT01090492|616816070|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
170673078|NCT01090492|616816071|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
170673079|NCT01090492|616816072|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
170673080|NCT01090492|616816073|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
170673081|NCT01090492|616816074|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
170673082|NCT01090492|616816075|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
170673083|NCT01090492|616816076|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
170673084|NCT01090492|616816077|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
170673085|NCT01090492|616816070|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
170673086|NCT01090492|616816071|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
170820158|NCT01002547|617349567|FG000|Overall Study|Withdrawal by Subject|4|||
170820159|NCT01002547|617349568|FG001|Overall Study|Withdrawal by Subject|0|||
170673087|NCT01090492|616816072|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
170673088|NCT01090492|616816073|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
170673089|NCT01090492|616816074|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
170673090|NCT01090492|616816075|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
170673091|NCT01090492|616816076|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
170673092|NCT01090492|616816077|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
170673093|NCT01090492|616816070|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
170673094|NCT01090492|616816071|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
170673095|NCT01090492|616816072|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
170673096|NCT01090492|616816073|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
170673097|NCT01090492|616816074|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
170627534|NCT05472090|616647707|FG001|Overall Study|Adverse Event|3|||
170627535|NCT05472090|616647706|FG000|Overall Study|Lack of Efficacy|1|||
170673098|NCT01090492|616816075|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
170673099|NCT01090492|616816076|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
170673100|NCT01090492|616816077|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
170673101|NCT01090492|616816070|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
170673102|NCT01090492|616816071|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
170673103|NCT01090492|616816072|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
170673104|NCT01090492|616816073|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
170673105|NCT01090492|616816074|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
170673106|NCT01090492|616816075|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
170673107|NCT01090492|616816076|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
170673108|NCT01090492|616816077|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
170673109|NCT01090492|616816070|FG000|Second Intervention Period (4 Weeks)|Other|0|||
170673110|NCT01090492|616816071|FG001|Second Intervention Period (4 Weeks)|Other|1|||
170627536|NCT05472090|616647707|FG001|Overall Study|Lack of Efficacy|0|||
170627537|NCT05472090|616647706|FG000|Overall Study|Physician Decision|1|||
170627538|NCT05472090|616647707|FG001|Overall Study|Physician Decision|0|||
170627539|NCT05472090|616647706|FG000|Overall Study|Withdrawal by Subject|2|||
170627540|NCT05472090|616647707|FG001|Overall Study|Withdrawal by Subject|0|||
170627541|NCT05472090|616647706|FG000|Overall Study|Lost to Follow-up|0|||
170627542|NCT05472090|616647707|FG001|Overall Study|Lost to Follow-up|3|||
170627543|NCT01615939|616649458|FG000|Overall Study|Lost to Follow-up|5|||
170627544|NCT01615939|616649459|FG001|Overall Study|Lost to Follow-up|0|||
170627545|NCT01586364|616649460|FG000|Overall Study|Withdrawal by Subject|40|||
170627546|NCT01586364|616649460|FG000|Overall Study|Adverse Event|37|||
170627547|NCT01586364|616649460|FG000|Overall Study|Lost to Follow-up|17|||
170627548|NCT01586364|616649460|FG000|Overall Study|Protocol Violation|16|||
170627549|NCT01586364|616649460|FG000|Overall Study|Lack of Efficacy|1|||
170627550|NCT01586364|616649460|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
170627551|NCT01586364|616649460|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
170627552|NCT01586364|616649460|FG000|Overall Study|Other-Site closure due to PI illness|1|||
170627553|NCT01586364|616649460|FG000|Overall Study|Other-PI discretion, site closing|2|||
170627554|NCT01586364|616649460|FG000|Overall Study|Other-Not specified|1|||
170627555|NCT02121535|616649461|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
170627556|NCT02121535|616649462|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
170627557|NCT02121535|616649461|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
170627558|NCT02121535|616649462|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
170627559|NCT00092417|616649463|FG000|Overall Study|Lost to Follow-up|2|||
170627560|NCT00092417|616649464|FG001|Overall Study|Lost to Follow-up|0|||
170627561|NCT00092417|616649463|FG000|Overall Study|Withdrawal by Subject|2|||
170627562|NCT00092417|616649464|FG001|Overall Study|Withdrawal by Subject|1|||
170627563|NCT00092417|616649463|FG000|Overall Study|Other|1|||
170627564|NCT00092417|616649464|FG001|Overall Study|Other|0|||
170627565|NCT01520506|616649465|FG000|Overall Study|Missed Visit|4|||
170627566|NCT01520506|616649465|FG000|Overall Study|Lost to Follow-up|1|||
170627567|NCT01520506|616649465|FG000|Overall Study|Withdrawal by Subject|1|||
170627568|NCT00425269|616649466|FG000|Overall Study|Pregnancy|5|||
170627569|NCT00425269|616649467|FG001|Overall Study|Pregnancy|7|||
170627570|NCT00425269|616649466|FG000|Overall Study|Lost to Follow-up|9|||
170627571|NCT00425269|616649467|FG001|Overall Study|Lost to Follow-up|9|||
170627572|NCT00425269|616649466|FG000|Overall Study|moved or medical reason|5|||
170627573|NCT00425269|616649467|FG001|Overall Study|moved or medical reason|4|||
170627574|NCT01084655|616649470|FG000|Overall Study|Radiographic disease progression|3|||
170627575|NCT01084655|616649471|FG001|Overall Study|Radiographic disease progression|2|||
170627576|NCT01084655|616649472|FG002|Overall Study|Radiographic disease progression|8|||
170627577|NCT01084655|616649470|FG000|Overall Study|Withdrawal by Subject|1|||
170627578|NCT01084655|616649471|FG001|Overall Study|Withdrawal by Subject|0|||
170627579|NCT01084655|616649472|FG002|Overall Study|Withdrawal by Subject|4|||
170627580|NCT01084655|616649470|FG000|Overall Study|Adverse Event|2|||
170627581|NCT01084655|616649471|FG001|Overall Study|Adverse Event|1|||
170627582|NCT01084655|616649472|FG002|Overall Study|Adverse Event|2|||
170627583|NCT01084655|616649470|FG000|Overall Study|Other|0|||
170627584|NCT01084655|616649471|FG001|Overall Study|Other|3|||
170627585|NCT01084655|616649472|FG002|Overall Study|Other|2|||
170673111|NCT01090492|616816072|FG002|Second Intervention Period (4 Weeks)|Other|1|||
170673112|NCT01090492|616816073|FG003|Second Intervention Period (4 Weeks)|Other|0|||
170627586|NCT01084655|616649470|FG000|Overall Study|Symptomatic deterioration|0|||
170627587|NCT01084655|616649471|FG001|Overall Study|Symptomatic deterioration|0|||
170627588|NCT01084655|616649472|FG002|Overall Study|Symptomatic deterioration|2|||
170627589|NCT01084655|616649470|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
170627590|NCT01084655|616649471|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
170627591|NCT01084655|616649472|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
170627592|NCT00696072|616649473|FG000|Overall Study|continuing active treatment|10|||
170627593|NCT00696072|616649474|FG001|Overall Study|continuing active treatment|13|||
170627594|NCT00696072|616649473|FG000|Overall Study|Adverse Event|10|||
170627595|NCT00696072|616649474|FG001|Overall Study|Adverse Event|6|||
170627596|NCT00696072|616649473|FG000|Overall Study|Patient Request|3|||
170627597|NCT00696072|616649474|FG001|Overall Study|Patient Request|7|||
170627598|NCT00696072|616649473|FG000|Overall Study|Investigator Request|1|||
170627599|NCT00696072|616649474|FG001|Overall Study|Investigator Request|4|||
170627600|NCT00696072|616649473|FG000|Overall Study|Sponsor Request|0|||
170627601|NCT00696072|616649474|FG001|Overall Study|Sponsor Request|1|||
170627602|NCT00696072|616649473|FG000|Overall Study|Disease Progression|32|||
170627603|NCT00696072|616649474|FG001|Overall Study|Disease Progression|30|||
170627604|NCT00696072|616649473|FG000|Overall Study|Non-specified|1|||
170627605|NCT00696072|616649474|FG001|Overall Study|Non-specified|2|||
170627606|NCT00335777|616649475|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
170627607|NCT00335777|616649475|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
170627608|NCT00335777|616649475|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
170627609|NCT00335777|616649475|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
170627610|NCT00335777|616649475|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
170627611|NCT02419001|616649480|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
170627612|NCT02419001|616649481|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
170627613|NCT02345070|616649482|FG000|Overall Study|Adverse Event|12|||
170627614|NCT02345070|616649483|FG001|Overall Study|Adverse Event|8|||
170627615|NCT02345070|616649484|FG002|Overall Study|Adverse Event|16|||
170627616|NCT02345070|616649482|FG000|Overall Study|Poor compliance to protocol|2|||
170627617|NCT02345070|616649483|FG001|Overall Study|Poor compliance to protocol|0|||
170627618|NCT02345070|616649484|FG002|Overall Study|Poor compliance to protocol|0|||
170627619|NCT02345070|616649482|FG000|Overall Study|Other than specified above|6|||
170627620|NCT02345070|616649483|FG001|Overall Study|Other than specified above|3|||
170627621|NCT02345070|616649484|FG002|Overall Study|Other than specified above|7|||
170627622|NCT02151058|616649485|FG000|Overall Study|Withdrawal by Subject|1|||
170627623|NCT02151058|616649486|FG001|Overall Study|Withdrawal by Subject|1|||
170627624|NCT02151058|616649487|FG002|Overall Study|Withdrawal by Subject|3|||
170627625|NCT02151058|616649485|FG000|Overall Study|Lost to Follow-up|1|||
170627626|NCT02151058|616649486|FG001|Overall Study|Lost to Follow-up|0|||
170627627|NCT02151058|616649487|FG002|Overall Study|Lost to Follow-up|2|||
170627628|NCT00804908|616649488|FG000|Overall Study|Other|115|||
170627629|NCT00804908|616649489|FG001|Overall Study|Other|116|||
170627630|NCT00804908|616649490|FG002|Overall Study|Other|114|||
170627631|NCT01280903|616649491|FG000|Overall Study|Lost to Follow-up|23|||
170627632|NCT01280903|616649492|FG001|Overall Study|Lost to Follow-up|16|||
170627633|NCT01942837|616649493|FG000|Overall Study|Death|1|||
170627634|NCT01942837|616649493|FG000|Overall Study|Symptomatic or radiographic progression|49|||
170627635|NCT01942837|616649493|FG000|Overall Study|Adverse Event|6|||
170627636|NCT01942837|616649493|FG000|Overall Study|Physician Decision|3|||
170627637|NCT01942837|616649493|FG000|Overall Study|Withdrawal by Subject|2|||
170627638|NCT01942837|616649493|FG000|Overall Study|Intercurrent Illness|1|||
170627639|NCT01942837|616649493|FG000|Overall Study|On treatment|3|||
170627640|NCT01942837|616649493|FG000|Overall Study|Never initiate the treatment|2|||
170627641|NCT02266888|616649496|FG000|Overall Study|Death|2|||
170627642|NCT02266888|616649497|FG001|Overall Study|Death|2|||
170627643|NCT02266888|616649498|FG002|Overall Study|Death|4|||
170627644|NCT02266888|616649499|FG003|Overall Study|Death|2|||
170627645|NCT02266888|616649496|FG000|Overall Study|Physician Decision|0|||
170627646|NCT02266888|616649497|FG001|Overall Study|Physician Decision|1|||
170627647|NCT02266888|616649498|FG002|Overall Study|Physician Decision|2|||
170627648|NCT02266888|616649499|FG003|Overall Study|Physician Decision|2|||
170627649|NCT02266888|616649496|FG000|Overall Study|Study Terminated|5|||
170627650|NCT02266888|616649497|FG001|Overall Study|Study Terminated|1|||
170627651|NCT02266888|616649498|FG002|Overall Study|Study Terminated|0|||
170627652|NCT02266888|616649499|FG003|Overall Study|Study Terminated|0|||
170627653|NCT02266888|616649496|FG000|Overall Study|No Longer Eligible|0|||
170627654|NCT02266888|616649497|FG001|Overall Study|No Longer Eligible|0|||
170627655|NCT02266888|616649498|FG002|Overall Study|No Longer Eligible|0|||
170627656|NCT02266888|616649499|FG003|Overall Study|No Longer Eligible|2|||
170627657|NCT02266888|616649496|FG000|Overall Study|Randomization Closed|0|||
170627658|NCT02266888|616649497|FG001|Overall Study|Randomization Closed|0|||
170627659|NCT02266888|616649498|FG002|Overall Study|Randomization Closed|4|||
170627660|NCT02266888|616649499|FG003|Overall Study|Randomization Closed|0|||
170627661|NCT02266888|616649496|FG000|Overall Study|Personnel unavailable at transplant|0|||
170627662|NCT02266888|616649497|FG001|Overall Study|Personnel unavailable at transplant|0|||
170627663|NCT02266888|616649498|FG002|Overall Study|Personnel unavailable at transplant|0|||
170627664|NCT02266888|616649499|FG003|Overall Study|Personnel unavailable at transplant|1|||
170627665|NCT02266888|616649496|FG000|Overall Study|Transfer of care|0|||
170627666|NCT02266888|616649497|FG001|Overall Study|Transfer of care|0|||
170627667|NCT02266888|616649498|FG002|Overall Study|Transfer of care|1|||
170627668|NCT02266888|616649499|FG003|Overall Study|Transfer of care|0|||
170627669|NCT02177695|616649500|FG000|ITT Analysis|Ineligible|5|||
170627670|NCT02177695|616649501|FG001|ITT Analysis|Ineligible|5|||
170627671|NCT02177695|616649500|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
170627672|NCT02177695|616649501|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
170627673|NCT02177695|616649500|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
170627674|NCT02177695|616649501|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
170627675|NCT02177695|616649500|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
170627676|NCT02177695|616649501|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
170627677|NCT03181932|616649502|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
170627678|NCT03181932|616649503|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
170627679|NCT03181932|616649502|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
170627680|NCT03181932|616649503|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
170627681|NCT03181932|616649502|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
170627682|NCT03181932|616649503|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
170627683|NCT03181932|616649502|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
170627684|NCT03181932|616649503|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
170627685|NCT03181932|616649502|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
170627686|NCT03181932|616649503|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
170627687|NCT03181932|616649502|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
170627688|NCT03181932|616649503|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
170627689|NCT03181932|616649502|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
170627690|NCT03181932|616649503|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
170627691|NCT03181932|616649502|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
170627692|NCT03181932|616649503|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
170627693|NCT03181932|616649502|FG000|Period 2 (Open-label Period)|Reason missing|2|||
170627694|NCT03181932|616649503|FG001|Period 2 (Open-label Period)|Reason missing|0|||
170627695|NCT03304626|616649504|FG000|Overall Study|Adverse Event|1|||
170627696|NCT03304626|616649505|FG001|Overall Study|Adverse Event|0|||
170627697|NCT03304626|616649504|FG000|Overall Study|Lack of Efficacy|1|||
170627698|NCT03304626|616649505|FG001|Overall Study|Lack of Efficacy|1|||
170627699|NCT02038933|616649511|FG000|Overall Study|Disease progression|104|||
170627700|NCT02038933|616649511|FG000|Overall Study|Study drug toxicity|6|||
170627701|NCT02038933|616649511|FG000|Overall Study|Adverse event unrelated to study drug|6|||
170627702|NCT02038933|616649511|FG000|Overall Study|Participant request to discontinue treatment|2|||
170627703|NCT02038933|616649511|FG000|Overall Study|Lost to Follow-up|1|||
170820160|NCT01002547|617349569|FG002|Overall Study|Withdrawal by Subject|5|||
170627704|NCT02038933|616649511|FG000|Overall Study|Other reasons|2|||
170627705|NCT02443688|616649512|FG000|Overall Study|Adverse Event|2|||
170627706|NCT02443688|616649513|FG001|Overall Study|Adverse Event|3|||
170820161|NCT01002547|617349567|FG000|Overall Study|Lost to Follow-up|2|||
170820162|NCT01002547|617349568|FG001|Overall Study|Lost to Follow-up|1|||
170820163|NCT01002547|617349569|FG002|Overall Study|Lost to Follow-up|1|||
170820164|NCT01002547|617349567|FG000|Overall Study|Physician Decision|1|||
170820165|NCT01002547|617349568|FG001|Overall Study|Physician Decision|0|||
170820166|NCT01002547|617349569|FG002|Overall Study|Physician Decision|0|||
170820167|NCT01002547|617349567|FG000|Overall Study|Death|0|||
170820168|NCT01002547|617349568|FG001|Overall Study|Death|2|||
170820169|NCT01002547|617349569|FG002|Overall Study|Death|2|||
170820170|NCT01002547|617349567|FG000|Overall Study|Adverse Event|1|||
170820171|NCT01002547|617349568|FG001|Overall Study|Adverse Event|0|||
170820172|NCT01002547|617349569|FG002|Overall Study|Adverse Event|0|||
170820173|NCT00925288|617349570|FG000|Overall Study|Lost to Follow-up|9|||
170820174|NCT00925288|617349571|FG001|Overall Study|Lost to Follow-up|7|||
170820175|NCT00635570|617349573|FG000|Overall Study|Lost to Follow-up|8|||
170820176|NCT00635570|617349574|FG001|Overall Study|Lost to Follow-up|8|||
170820177|NCT00635570|617349573|FG000|Overall Study|Withdrawal by Subject|1|||
170820178|NCT00635570|617349574|FG001|Overall Study|Withdrawal by Subject|1|||
170820179|NCT00635570|617349573|FG000|Overall Study|Adverse Event|2|||
170820180|NCT00635570|617349574|FG001|Overall Study|Adverse Event|0|||
170820181|NCT00635570|617349573|FG000|Overall Study|Physician Decision|1|||
170820182|NCT00635570|617349574|FG001|Overall Study|Physician Decision|0|||
170820183|NCT00635570|617349573|FG000|Overall Study|Did not complete survey|2|||
170820184|NCT00635570|617349574|FG001|Overall Study|Did not complete survey|1|||
170820185|NCT00635570|617349573|FG000|Overall Study|Early termination(No sexual activity)|1|||
170820186|NCT00635570|617349574|FG001|Overall Study|Early termination(No sexual activity)|1|||
170820187|NCT02176356|617349575|FG000|Overall Study|Screen Failure|14|||
170820188|NCT02176356|617349575|FG000|Overall Study|Lost to Follow-up|4|||
170820189|NCT02176356|617349575|FG000|Overall Study|Personal Reasons|3|||
170820190|NCT02176356|617349575|FG000|Overall Study|Other Miscellaneous Reasons|2|||
170820191|NCT00381888|617349579|FG000|Overall Study|Death|1|||
170820192|NCT00381888|617349579|FG000|Overall Study|Withdrawal by Subject|1|||
170820193|NCT00381888|617349579|FG000|Overall Study|Physician Decision|1|||
170820194|NCT00381888|617349579|FG000|Overall Study|Protocol Violation|9|||
170820195|NCT00381888|617349579|FG000|Overall Study|Had laparoscopic surgery|2|||
170820196|NCT00381888|617349579|FG000|Overall Study|Surgery was cancelled|2|||
170820197|NCT00381888|617349579|FG000|Overall Study|Adverse Event|1|||
170820198|NCT01537120|617349583|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
170673113|NCT01090492|616816074|FG004|Second Intervention Period (4 Weeks)|Other|0|||
170673114|NCT01090492|616816075|FG005|Second Intervention Period (4 Weeks)|Other|0|||
170673115|NCT01090492|616816076|FG006|Second Intervention Period (4 Weeks)|Other|0|||
170627707|NCT02443688|616649514|FG002|Overall Study|Adverse Event|2|||
170627708|NCT02443688|616649512|FG000|Overall Study|Lost to Follow-up|1|||
170627709|NCT02443688|616649513|FG001|Overall Study|Lost to Follow-up|0|||
170627710|NCT02443688|616649514|FG002|Overall Study|Lost to Follow-up|0|||
170627711|NCT02443688|616649512|FG000|Overall Study|Physician Decision|3|||
170627712|NCT02443688|616649513|FG001|Overall Study|Physician Decision|0|||
170627713|NCT02443688|616649514|FG002|Overall Study|Physician Decision|1|||
170627714|NCT02443688|616649512|FG000|Overall Study|Pregnancy|0|||
170627715|NCT02443688|616649513|FG001|Overall Study|Pregnancy|0|||
170627716|NCT02443688|616649514|FG002|Overall Study|Pregnancy|1|||
170627717|NCT02443688|616649512|FG000|Overall Study|Withdrawal by Subject|3|||
170627718|NCT02443688|616649513|FG001|Overall Study|Withdrawal by Subject|3|||
170627719|NCT02443688|616649514|FG002|Overall Study|Withdrawal by Subject|4|||
170627720|NCT02443688|616649512|FG000|Overall Study|Non-compliance with study drug|1|||
170673116|NCT01090492|616816077|FG007|Second Intervention Period (4 Weeks)|Other|0|||
170673117|NCT01090492|616816070|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
170673118|NCT01090492|616816071|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
170673119|NCT01090492|616816072|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
170673120|NCT01090492|616816073|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
170673121|NCT01090492|616816074|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
170673122|NCT01090492|616816075|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
170673123|NCT01090492|616816076|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
170673124|NCT01090492|616816077|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
170673125|NCT01090492|616816070|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673126|NCT01090492|616816071|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673127|NCT01090492|616816072|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673128|NCT01090492|616816073|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673129|NCT01090492|616816074|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673130|NCT01090492|616816075|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673131|NCT01090492|616816076|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
170673132|NCT01090492|616816077|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
170673133|NCT02243696|616816078|FG000|Overall Study|Death|282|||
170673134|NCT02243696|616816078|FG000|Overall Study|Withdrawal by Subject|79|||
170673135|NCT02243696|616816078|FG000|Overall Study|Lost to Follow-up|57|||
170673136|NCT02243696|616816078|FG000|Overall Study|Subject No Longer has Study System|42|||
170673137|NCT02243696|616816078|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
170673138|NCT02243696|616816078|FG000|Overall Study|Study Terminated for EP PASSION|961|||
170673139|NCT00622284|616816080|FG000|Overall Study|Lack of Efficacy|45|||
170673140|NCT00622284|616816081|FG001|Overall Study|Lack of Efficacy|15|||
170673141|NCT00622284|616816080|FG000|Overall Study|Adverse Event|61|||
170673142|NCT00622284|616816081|FG001|Overall Study|Adverse Event|90|||
170673143|NCT00622284|616816080|FG000|Overall Study|Protocol Violation|12|||
170673144|NCT00622284|616816081|FG001|Overall Study|Protocol Violation|5|||
170673145|NCT00622284|616816080|FG000|Overall Study|Lost to Follow-up|11|||
170673146|NCT00622284|616816081|FG001|Overall Study|Lost to Follow-up|13|||
170673147|NCT00622284|616816080|FG000|Overall Study|Withdrawal by Subject|27|||
170673148|NCT00622284|616816081|FG001|Overall Study|Withdrawal by Subject|24|||
170673149|NCT00622284|616816080|FG000|Overall Study|Other reason (not specified)|33|||
170673150|NCT00622284|616816081|FG001|Overall Study|Other reason (not specified)|24|||
170673151|NCT00282984|616816082|FG000|Overall Study|Death|2|||
170673152|NCT00282984|616816083|FG001|Overall Study|Death|5|||
170673153|NCT00282984|616816082|FG000|Overall Study|Adverse Event|8|||
170673154|NCT00282984|616816083|FG001|Overall Study|Adverse Event|5|||
170673155|NCT00282984|616816082|FG000|Overall Study|Lack of Efficacy|0|||
170673156|NCT00282984|616816083|FG001|Overall Study|Lack of Efficacy|2|||
170673157|NCT00282984|616816082|FG000|Overall Study|Lost to Follow-up|14|||
170673158|NCT00282984|616816083|FG001|Overall Study|Lost to Follow-up|10|||
170673159|NCT00282984|616816082|FG000|Overall Study|Withdrawal by Participant|22|||
170673160|NCT00282984|616816083|FG001|Overall Study|Withdrawal by Participant|34|||
170673161|NCT00282984|616816082|FG000|Overall Study|Participant stopped study medication|2|||
170673162|NCT00282984|616816083|FG001|Overall Study|Participant stopped study medication|2|||
170673163|NCT00282984|616816082|FG000|Overall Study|Participant only allowed phone follow-up|0|||
170673164|NCT00282984|616816083|FG001|Overall Study|Participant only allowed phone follow-up|1|||
170673165|NCT00282984|616816082|FG000|Overall Study|Participant used antipsychosis meds|0|||
170627721|NCT02443688|616649513|FG001|Overall Study|Non-compliance with study drug|2|||
170627722|NCT02443688|616649514|FG002|Overall Study|Non-compliance with study drug|4|||
170627723|NCT02443688|616649512|FG000|Overall Study|Sponsor Request|2|||
170627724|NCT02443688|616649513|FG001|Overall Study|Sponsor Request|1|||
170673166|NCT00282984|616816083|FG001|Overall Study|Participant used antipsychosis meds|1|||
170627725|NCT02443688|616649514|FG002|Overall Study|Sponsor Request|0|||
170627726|NCT03250273|616649547|FG000|Overall Study|Disease Progression|2|||
170673167|NCT00282984|616816082|FG000|Overall Study|lack of motivation|1|||
170627727|NCT03250273|616649548|FG001|Overall Study|Disease Progression|11|||
170673168|NCT00282984|616816083|FG001|Overall Study|lack of motivation|0|||
170673169|NCT00282984|616816082|FG000|Overall Study|in prison|0|||
170673170|NCT00282984|616816083|FG001|Overall Study|in prison|1|||
170673171|NCT00282984|616816082|FG000|Overall Study|Protocol Violation|2|||
170820199|NCT01537120|617349583|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
170627728|NCT03250273|616649547|FG000|Overall Study|Death|0|||
170627729|NCT03250273|616649548|FG001|Overall Study|Death|1|||
170627730|NCT04154904|616649549|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
170627731|NCT04154904|616649550|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
170627732|NCT04154904|616649551|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
170627733|NCT00936715|616649552|FG000|Overall Study|Investigators Discretion|1|||
170627734|NCT00936715|616649552|FG000|Overall Study|Protocol Violation|1|||
170627735|NCT00936715|616649552|FG000|Overall Study|Safety or Tolerability Reasons|4|||
170627736|NCT01462370|616649554|FG000|Overall Study|Lack of Qualifying Event|1|||
170627737|NCT01462370|616649555|FG001|Overall Study|Lack of Qualifying Event|1|||
170627738|NCT01462370|616649554|FG000|Overall Study|Physician Decision|0|||
170627739|NCT01462370|616649555|FG001|Overall Study|Physician Decision|1|||
170627740|NCT01462370|616649554|FG000|Overall Study|Withdrawal by Subject|0|||
170627741|NCT01462370|616649555|FG001|Overall Study|Withdrawal by Subject|3|||
170627742|NCT01747876|616649556|FG000|Overall Study|Adverse Event|1|||
170627743|NCT01747876|616649557|FG001|Overall Study|Adverse Event|0|||
170627744|NCT01747876|616649558|FG002|Overall Study|Adverse Event|2|||
170627745|NCT01747876|616649556|FG000|Overall Study|Withdrawal by Subject|0|||
170627746|NCT01747876|616649557|FG001|Overall Study|Withdrawal by Subject|1|||
170627747|NCT01747876|616649558|FG002|Overall Study|Withdrawal by Subject|1|||
170627748|NCT01747876|616649556|FG000|Overall Study|Disease progression|4|||
170627749|NCT01747876|616649557|FG001|Overall Study|Disease progression|13|||
170627750|NCT01747876|616649558|FG002|Overall Study|Disease progression|8|||
170627751|NCT01747876|616649556|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
170627752|NCT01747876|616649557|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
170627753|NCT01747876|616649558|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
170627754|NCT03198715|616649561|FG000|Overall Study|Death|0|||
170627755|NCT03198715|616649562|FG001|Overall Study|Death|0|||
170627756|NCT03198715|616649563|FG002|Overall Study|Death|1|||
170627757|NCT03198715|616649564|FG003|Overall Study|Death|0|||
170627758|NCT03198715|616649565|FG004|Overall Study|Death|2|||
170627759|NCT03198715|616649561|FG000|Overall Study|Other|0|||
170627760|NCT03198715|616649562|FG001|Overall Study|Other|1|||
170627761|NCT03198715|616649563|FG002|Overall Study|Other|1|||
170627762|NCT03198715|616649564|FG003|Overall Study|Other|0|||
170627763|NCT03198715|616649565|FG004|Overall Study|Other|0|||
170627764|NCT00473564|616649566|FG000|Overall Study|robot surgery aborted in OR|23|||
170627765|NCT01112917|616649568|FG000|Overall Study|Death|2|||
170627766|NCT01112917|616649569|FG001|Overall Study|Death|11|||
170627767|NCT01112917|616649568|FG000|Overall Study|Lost to Follow-up|1|||
170627768|NCT01112917|616649569|FG001|Overall Study|Lost to Follow-up|1|||
170627769|NCT01112917|616649568|FG000|Overall Study|Withdrawal by Subject|1|||
170627770|NCT01112917|616649569|FG001|Overall Study|Withdrawal by Subject|3|||
170673172|NCT00282984|616816083|FG001|Overall Study|Protocol Violation|0|||
170673173|NCT00868608|616816084|FG000|Overall Study|Withdrawal by Subject|3|||
170820200|NCT00506922|617349584|FG000|Overall Study|Physician Decision|0|||
170820201|NCT00506922|617349585|FG001|Overall Study|Physician Decision|0|||
170820202|NCT00506922|617349586|FG002|Overall Study|Physician Decision|0|||
170820203|NCT00506922|617349587|FG003|Overall Study|Physician Decision|2|||
170820204|NCT00506922|617349588|FG004|Overall Study|Physician Decision|0|||
170820205|NCT00506922|617349584|FG000|Overall Study|Withdrawal by Subject|0|||
170820206|NCT00506922|617349585|FG001|Overall Study|Withdrawal by Subject|0|||
170820207|NCT00506922|617349586|FG002|Overall Study|Withdrawal by Subject|0|||
170820208|NCT00506922|617349587|FG003|Overall Study|Withdrawal by Subject|0|||
170820209|NCT00506922|617349588|FG004|Overall Study|Withdrawal by Subject|1|||
170820210|NCT03722485|617349589|FG000|Overall Study|Withdrawal by Subject|1|||
170820211|NCT03722485|617349590|FG001|Overall Study|Withdrawal by Subject|0|||
170820212|NCT03722485|617349589|FG000|Overall Study|Adverse Event|0|||
170820213|NCT03722485|617349590|FG001|Overall Study|Adverse Event|2|||
170820214|NCT03722485|617349589|FG000|Overall Study|subject discharged prior to study completion|1|||
170820215|NCT03722485|617349590|FG001|Overall Study|subject discharged prior to study completion|5|||
170820216|NCT03722485|617349589|FG000|Overall Study|eligibility criteria not met|2|||
170820217|NCT03722485|617349590|FG001|Overall Study|eligibility criteria not met|0|||
170820218|NCT04307134|617349591|FG000|Overall Study|Lost to Follow-up|2|||
170820219|NCT04307134|617349591|FG000|Overall Study|Withdrawal by Subject|3|||
170627771|NCT01112917|616649568|FG000|Overall Study|Unable to Convert Filter|3|||
170627772|NCT01112917|616649569|FG001|Overall Study|Unable to Convert Filter|0|||
170627773|NCT05101122|616649570|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
170627774|NCT05101122|616649570|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
170673174|NCT00868608|616816085|FG001|Overall Study|Withdrawal by Subject|1|||
170673175|NCT00868608|616816086|FG002|Overall Study|Withdrawal by Subject|0|||
170673176|NCT00868608|616816084|FG000|Overall Study|Lost to Follow-up|3|||
170673177|NCT00868608|616816085|FG001|Overall Study|Lost to Follow-up|0|||
170627775|NCT05101122|616649570|FG000|AD313 80/5|Withdrawal by Subject|1|||
170673178|NCT00868608|616816086|FG002|Overall Study|Lost to Follow-up|1|||
170673179|NCT00868608|616816084|FG000|Overall Study|Death|16|||
170673180|NCT00868608|616816085|FG001|Overall Study|Death|2|||
170673181|NCT00868608|616816086|FG002|Overall Study|Death|4|||
170673182|NCT00868608|616816084|FG000|Overall Study|Other - Unspecified|1|||
170673183|NCT00868608|616816085|FG001|Overall Study|Other - Unspecified|0|||
170673184|NCT00868608|616816086|FG002|Overall Study|Other - Unspecified|0|||
170673185|NCT00911547|616816087|FG000|Overall Study|Adverse Event|8|||
170673186|NCT00911547|616816088|FG001|Overall Study|Adverse Event|27|||
170673187|NCT00911547|616816089|FG002|Overall Study|Adverse Event|11|||
170673188|NCT00911547|616816090|FG003|Overall Study|Adverse Event|6|||
170673189|NCT00911547|616816087|FG000|Overall Study|Lost to Follow-up|0|||
170673190|NCT00911547|616816088|FG001|Overall Study|Lost to Follow-up|0|||
170673191|NCT00911547|616816089|FG002|Overall Study|Lost to Follow-up|2|||
170673192|NCT00911547|616816090|FG003|Overall Study|Lost to Follow-up|1|||
170673193|NCT00911547|616816087|FG000|Overall Study|Protocol Violation|0|||
170627776|NCT05101122|616649570|FG000|AD313 80/10|Physician Decision|1|||
170627777|NCT03131219|616649571|FG000|Initial Evaluation Period|Adverse Event|2|||
170627778|NCT03131219|616649572|FG001|Initial Evaluation Period|Adverse Event|0|||
170627779|NCT03131219|616649571|FG000|Initial Evaluation Period|Protocol Violation|1|||
170627780|NCT03131219|616649572|FG001|Initial Evaluation Period|Protocol Violation|0|||
170627781|NCT03131219|616649571|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
170627782|NCT03131219|616649572|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
170627783|NCT03131219|616649571|FG000|Initial Evaluation Period|Physician Decision|1|||
170627784|NCT03131219|616649572|FG001|Initial Evaluation Period|Physician Decision|0|||
170627785|NCT03131219|616649571|FG000|Extension Period|Physician Decision|1|||
170627786|NCT03131219|616649572|FG001|Extension Period|Physician Decision|0|||
170627787|NCT00616759|616649574|FG000|Overall Study|Physician Decision|2|||
170627788|NCT00616759|616649575|FG001|Overall Study|Physician Decision|0|||
170627789|NCT00616759|616649574|FG000|Overall Study|Withdrawal by Subject|1|||
170627790|NCT00616759|616649575|FG001|Overall Study|Withdrawal by Subject|2|||
170627791|NCT00726063|616649580|FG000|Overall Study|Adverse Event|9|||
170627792|NCT00726063|616649581|FG001|Overall Study|Adverse Event|7|||
170627793|NCT02007096|616649582|FG000|Overall Study|medication not available|2|||
170627794|NCT02007096|616649583|FG001|Overall Study|medication not available|0|||
170627795|NCT02007096|616649582|FG000|Overall Study|did not inject saline|0|||
170627796|NCT02007096|616649583|FG001|Overall Study|did not inject saline|3|||
170627797|NCT02007096|616649582|FG000|Overall Study|did not follow postoperative protocol|8|||
170627798|NCT02007096|616649583|FG001|Overall Study|did not follow postoperative protocol|11|||
170627799|NCT02007096|616649582|FG000|Overall Study|converted to open surgery|1|||
170627800|NCT02007096|616649583|FG001|Overall Study|converted to open surgery|1|||
170627801|NCT02007096|616649582|FG000|Overall Study|no mesh placed|0|||
170627802|NCT02007096|616649583|FG001|Overall Study|no mesh placed|1|||
170627803|NCT03363841|616649584|FG000|Overall Study|Adverse Event|1|||
170627804|NCT03363841|616649584|FG000|Overall Study|Withdrawal by Subject|1|||
170627805|NCT03363841|616649584|FG000|Overall Study|Death|7|||
170627806|NCT03363841|616649584|FG000|Overall Study|Physician Decision|1|||
170627807|NCT05058365|616649591|FG000|Overall Study|Migration|1|||
170627808|NCT05058365|616649592|FG001|Overall Study|Migration|1|||
170627809|NCT03279081|616649596|FG000|Overall Study|Withdrawal by Subject|12|||
170627810|NCT03279081|616649597|FG001|Overall Study|Withdrawal by Subject|20|||
170627811|NCT03279081|616649596|FG000|Overall Study|Physician Decision|4|||
170627812|NCT03279081|616649597|FG001|Overall Study|Physician Decision|1|||
170627813|NCT03279081|616649596|FG000|Overall Study|Lost to Follow-up|8|||
170627814|NCT03279081|616649597|FG001|Overall Study|Lost to Follow-up|8|||
170627815|NCT03279081|616649596|FG000|Overall Study|Death|0|||
170627816|NCT03279081|616649597|FG001|Overall Study|Death|1|||
170627817|NCT03279081|616649596|FG000|Overall Study|Adverse Event|1|||
170673194|NCT00911547|616816088|FG001|Overall Study|Protocol Violation|5|||
170673195|NCT00911547|616816089|FG002|Overall Study|Protocol Violation|5|||
170673196|NCT00911547|616816090|FG003|Overall Study|Protocol Violation|1|||
170673197|NCT00911547|616816087|FG000|Overall Study|Withdrawal by Subject|3|||
170673198|NCT00911547|616816088|FG001|Overall Study|Withdrawal by Subject|10|||
170673199|NCT00911547|616816089|FG002|Overall Study|Withdrawal by Subject|4|||
170673200|NCT00911547|616816090|FG003|Overall Study|Withdrawal by Subject|8|||
170673201|NCT00457301|616816091|FG000|Overall Study|Withdrawal by Subject|3|||
170673202|NCT00457301|616816092|FG001|Overall Study|Withdrawal by Subject|3|||
170673203|NCT00457301|616816091|FG000|Overall Study|Censored out of the study|15|||
170673204|NCT00457301|616816092|FG001|Overall Study|Censored out of the study|14|||
170673205|NCT00457301|616816091|FG000|Overall Study|Death|5|||
170673206|NCT00457301|616816092|FG001|Overall Study|Death|7|||
170673207|NCT00191269|616816093|FG000|Overall Study|Protocol Violation|0|||
170673208|NCT00191269|616816094|FG001|Overall Study|Protocol Violation|2|||
170673209|NCT00191269|616816093|FG000|Overall Study|Adverse Event|1|||
170673210|NCT00191269|616816094|FG001|Overall Study|Adverse Event|4|||
170673211|NCT00191269|616816093|FG000|Overall Study|Progression of Disease|4|||
170673212|NCT00191269|616816094|FG001|Overall Study|Progression of Disease|42|||
170673213|NCT00191269|616816093|FG000|Overall Study|Lack of Efficacy|1|||
170673214|NCT00191269|616816094|FG001|Overall Study|Lack of Efficacy|5|||
170673215|NCT00191269|616816093|FG000|Overall Study|Withdrawal by Subject|0|||
170673216|NCT00191269|616816094|FG001|Overall Study|Withdrawal by Subject|1|||
170673217|NCT00191269|616816093|FG000|Overall Study|Pathologic Aggrevation|0|||
170673218|NCT00191269|616816094|FG001|Overall Study|Pathologic Aggrevation|1|||
170673219|NCT00191269|616816093|FG000|Overall Study|Physician Decision|0|||
170673220|NCT00191269|616816094|FG001|Overall Study|Physician Decision|3|||
170673221|NCT03386448|616816097|FG000|Overall Study|Adverse Event|0|||
170673222|NCT03386448|616816098|FG001|Overall Study|Adverse Event|2|||
170673223|NCT01558271|616816101|FG000|Overall Study|Adverse Event|6|||
170673224|NCT01558271|616816102|FG001|Overall Study|Adverse Event|3|||
170673225|NCT01558271|616816103|FG002|Overall Study|Adverse Event|4|||
170673226|NCT01558271|616816101|FG000|Overall Study|Lost to Follow-up|1|||
170673227|NCT01558271|616816102|FG001|Overall Study|Lost to Follow-up|0|||
170673228|NCT01558271|616816103|FG002|Overall Study|Lost to Follow-up|0|||
170673229|NCT01558271|616816101|FG000|Overall Study|Protocol Violation|1|||
170673230|NCT01558271|616816102|FG001|Overall Study|Protocol Violation|0|||
170673231|NCT01558271|616816103|FG002|Overall Study|Protocol Violation|0|||
170673232|NCT01558271|616816101|FG000|Overall Study|Withdrawal by Subject|10|||
170673233|NCT01558271|616816102|FG001|Overall Study|Withdrawal by Subject|6|||
170673234|NCT01558271|616816103|FG002|Overall Study|Withdrawal by Subject|12|||
170673235|NCT01558271|616816101|FG000|Overall Study|Physician Decision|0|||
170673236|NCT01558271|616816102|FG001|Overall Study|Physician Decision|2|||
170673237|NCT01558271|616816103|FG002|Overall Study|Physician Decision|1|||
170673238|NCT02610725|616816105|FG000|Overall Study|Lost to Follow-up|197|||
170673239|NCT02610725|616816105|FG000|Overall Study|self-reported contraindication|9|||
170673240|NCT00743483|616816108|FG000|Baseline Period|Physician Decision|1|||
170673241|NCT00743483|616816108|FG000|Treatment Period|Adverse Event|1|||
170673242|NCT01084083|616816109|FG000|Overall Study|Adverse Event|5|||
170673243|NCT01084083|616816109|FG000|Overall Study|Death|1|||
170673244|NCT01084083|616816109|FG000|Overall Study|Withdrawal by Subject|2|||
170673245|NCT01084083|616816109|FG000|Overall Study|Complicating disease|1|||
170673246|NCT01084083|616816109|FG000|Overall Study|Other|2|||
170673247|NCT01084083|616816109|FG000|Overall Study|Never started assigned therapy|1|||
170673248|NCT01466153|616816112|FG000|Overall Study|Disease Progression|2|||
170673249|NCT01466153|616816113|FG001|Overall Study|Disease Progression|2|||
170673250|NCT01466153|616816114|FG002|Overall Study|Disease Progression|0|||
170673251|NCT01466153|616816112|FG000|Overall Study|Adverse Event|14|||
170673252|NCT01466153|616816113|FG001|Overall Study|Adverse Event|13|||
170673253|NCT01466153|616816114|FG002|Overall Study|Adverse Event|17|||
170673254|NCT01466153|616816112|FG000|Overall Study|Withdrawal of Consent|2|||
170673255|NCT01466153|616816113|FG001|Overall Study|Withdrawal of Consent|0|||
170673256|NCT01466153|616816114|FG002|Overall Study|Withdrawal of Consent|0|||
170673257|NCT01466153|616816112|FG000|Overall Study|Investigator Discretion|3|||
170673258|NCT01466153|616816113|FG001|Overall Study|Investigator Discretion|2|||
170820220|NCT04307134|617349591|FG000|Overall Study|Other|3|||
170820221|NCT04307134|617349591|FG000|Overall Study|Death|21|||
170820222|NCT04307134|617349591|FG000|Overall Study|Enrolled but not Treated|1|||
170673259|NCT01466153|616816114|FG002|Overall Study|Investigator Discretion|2|||
170673260|NCT01466153|616816112|FG000|Overall Study|Randomized-Not Treated|2|||
170673261|NCT01466153|616816113|FG001|Overall Study|Randomized-Not Treated|3|||
170673262|NCT01466153|616816114|FG002|Overall Study|Randomized-Not Treated|4|||
170673263|NCT01466153|616816112|FG000|Overall Study|Other-Unspecified|6|||
170673264|NCT01466153|616816113|FG001|Overall Study|Other-Unspecified|4|||
170673265|NCT01466153|616816114|FG002|Overall Study|Other-Unspecified|2|||
170820223|NCT03672188|617349599|FG000|Overall Study|Withdrawal by Subject|0|||
170820224|NCT03672188|617349600|FG001|Overall Study|Withdrawal by Subject|0|||
170673266|NCT01088997|616816117|FG000|Overall Study|Physician Decision|1|||
170673267|NCT01088997|616816118|FG001|Overall Study|Physician Decision|1|||
170673268|NCT01088997|616816117|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
170673269|NCT01088997|616816118|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
170673270|NCT01088997|616816117|FG000|Overall Study|Excluded prior to receiving drug|1|||
170673271|NCT01088997|616816118|FG001|Overall Study|Excluded prior to receiving drug|1|||
170673272|NCT02302807|616816123|FG000|Overall Study|Withdrawal by Subject|28|||
170673273|NCT02302807|616816124|FG001|Overall Study|Withdrawal by Subject|11|||
170673274|NCT02302807|616816123|FG000|Overall Study|Lost to Follow-up|4|||
170673275|NCT02302807|616816124|FG001|Overall Study|Lost to Follow-up|6|||
170673276|NCT02302807|616816123|FG000|Overall Study|Death|397|||
170673277|NCT02302807|616816124|FG001|Overall Study|Death|385|||
170673278|NCT02302807|616816123|FG000|Overall Study|Study Terminated By Sponsor|35|||
170673279|NCT02302807|616816124|FG001|Overall Study|Study Terminated By Sponsor|64|||
170673280|NCT02302807|616816123|FG000|Overall Study|Physician Decision|0|||
170673281|NCT02302807|616816124|FG001|Overall Study|Physician Decision|1|||
170673282|NCT03128047|616816126|FG000|Overall Study|Withdrawal by Subject|1|||
170673283|NCT04218695|616817768|FG000|Overall Study|Adverse Event|1|||
170673284|NCT04218695|616817769|FG001|Overall Study|Adverse Event|0|||
170673285|NCT03130257|616817775|FG000|Overall Study|Withdrawal by Subject|1|||
170673286|NCT03130257|616817776|FG001|Overall Study|Withdrawal by Subject|0|||
170673287|NCT03130257|616817777|FG002|Overall Study|Withdrawal by Subject|2|||
170673288|NCT01508650|616817778|FG000|Overall Study|Lost to Follow-up|0|||
170673289|NCT01508650|616817779|FG001|Overall Study|Lost to Follow-up|3|||
170673290|NCT02064894|616817780|FG000|Overall Study|Withdrawal by Subject|43|||
170673291|NCT02064894|616817781|FG001|Overall Study|Withdrawal by Subject|102|||
170673292|NCT02064894|616817782|FG002|Overall Study|Withdrawal by Subject|115|||
170673293|NCT03052725|616817783|FG000|Overall Study|Adverse Event|2|||
170673294|NCT03052725|616817784|FG001|Overall Study|Adverse Event|0|||
170673295|NCT03052725|616817783|FG000|Overall Study|Withdrawal by Subject|3|||
170673296|NCT03052725|616817784|FG001|Overall Study|Withdrawal by Subject|4|||
170673297|NCT03052725|616817783|FG000|Overall Study|Pregnancy|0|||
170673298|NCT03052725|616817784|FG001|Overall Study|Pregnancy|1|||
170673299|NCT03052725|616817783|FG000|Overall Study|Site closure|0|||
170673300|NCT03052725|616817784|FG001|Overall Study|Site closure|1|||
170673301|NCT03052725|616817783|FG000|Overall Study|Study terminated by sponsor|143|||
170673302|NCT03052725|616817784|FG001|Overall Study|Study terminated by sponsor|144|||
170673303|NCT00777608|616817785|FG000|Overall Study|Lost to Follow-up|1|||
170673304|NCT00777608|616817786|FG001|Overall Study|Lost to Follow-up|1|||
170673305|NCT00777608|616817785|FG000|Overall Study|Withdrawal by Subject|1|||
170673306|NCT00777608|616817786|FG001|Overall Study|Withdrawal by Subject|3|||
170673307|NCT00777608|616817785|FG000|Overall Study|Protocol Violation|1|||
170673308|NCT00777608|616817786|FG001|Overall Study|Protocol Violation|0|||
170673309|NCT00777608|616817785|FG000|Overall Study|Investigator Decision|1|||
170673310|NCT00777608|616817786|FG001|Overall Study|Investigator Decision|2|||
170673311|NCT02732119|616817787|FG000|Phase I|Adverse Event|1|||
170673312|NCT02732119|616817788|FG001|Phase I|Adverse Event|3|||
170673313|NCT02732119|616817789|FG002|Phase I|Adverse Event|1|||
170673314|NCT02732119|616817790|FG003|Phase I|Adverse Event|0|||
170673315|NCT02732119|616817791|FG004|Phase I|Adverse Event|0|||
170673316|NCT02732119|616817787|FG000|Phase I|Progressive disease|7|||
170820225|NCT03672188|617349601|FG002|Overall Study|Withdrawal by Subject|0|||
170820226|NCT03672188|617349602|FG003|Overall Study|Withdrawal by Subject|3|||
170820227|NCT03672188|617349603|FG004|Overall Study|Withdrawal by Subject|0|||
170820228|NCT03672188|617349604|FG005|Overall Study|Withdrawal by Subject|0|||
170820229|NCT03672188|617349605|FG006|Overall Study|Withdrawal by Subject|0|||
170820230|NCT03672188|617349606|FG007|Overall Study|Withdrawal by Subject|0|||
170820231|NCT03672188|617349607|FG008|Overall Study|Withdrawal by Subject|0|||
170820232|NCT03672188|617349608|FG009|Overall Study|Withdrawal by Subject|0|||
170820233|NCT03672188|617349609|FG010|Overall Study|Withdrawal by Subject|0|||
170820234|NCT03672188|617349610|FG011|Overall Study|Withdrawal by Subject|0|||
170820235|NCT03672188|617349611|FG012|Overall Study|Withdrawal by Subject|0|||
170820236|NCT03672188|617349612|FG013|Overall Study|Withdrawal by Subject|0|||
170820237|NCT03672188|617349613|FG014|Overall Study|Withdrawal by Subject|0|||
170820238|NCT03672188|617349599|FG000|Overall Study|Death|0|||
170820239|NCT03672188|617349600|FG001|Overall Study|Death|0|||
170820240|NCT03672188|617349601|FG002|Overall Study|Death|0|||
170820241|NCT03672188|617349602|FG003|Overall Study|Death|0|||
170820242|NCT03672188|617349603|FG004|Overall Study|Death|0|||
170673317|NCT02732119|616817788|FG001|Phase I|Progressive disease|3|||
170673318|NCT02732119|616817789|FG002|Phase I|Progressive disease|2|||
170673319|NCT02732119|616817790|FG003|Phase I|Progressive disease|0|||
170673320|NCT02732119|616817791|FG004|Phase I|Progressive disease|0|||
170673321|NCT02732119|616817787|FG000|Phase I|Protocol deviation|0|||
170673322|NCT02732119|616817788|FG001|Phase I|Protocol deviation|1|||
170673323|NCT02732119|616817789|FG002|Phase I|Protocol deviation|0|||
170673324|NCT02732119|616817790|FG003|Phase I|Protocol deviation|0|||
170673325|NCT02732119|616817791|FG004|Phase I|Protocol deviation|0|||
170673326|NCT02732119|616817787|FG000|Phase I|Physician Decision|0|||
170673327|NCT02732119|616817788|FG001|Phase I|Physician Decision|3|||
170673328|NCT02732119|616817789|FG002|Phase I|Physician Decision|4|||
170673329|NCT02732119|616817790|FG003|Phase I|Physician Decision|0|||
170673330|NCT02732119|616817791|FG004|Phase I|Physician Decision|0|||
170673331|NCT02732119|616817787|FG000|Phase II|Adverse Event|0|||
170820243|NCT03672188|617349604|FG005|Overall Study|Death|0|||
170673332|NCT02732119|616817788|FG001|Phase II|Adverse Event|0|||
170820244|NCT03672188|617349605|FG006|Overall Study|Death|0|||
170820245|NCT03672188|617349606|FG007|Overall Study|Death|0|||
170627818|NCT03279081|616649597|FG001|Overall Study|Adverse Event|0|||
170627819|NCT03279081|616649596|FG000|Overall Study|Reason not Specified|14|||
170627820|NCT03279081|616649597|FG001|Overall Study|Reason not Specified|4|||
170627821|NCT04531176|616649600|FG000|Overall Study|Study was stopped early|24|||
170627822|NCT04531176|616649601|FG001|Overall Study|Study was stopped early|26|||
170627823|NCT04531176|616649602|FG002|Overall Study|Study was stopped early|24|||
170627824|NCT00561652|616649603|FG000|Overall Study|Withdrawal by Subject|0|||
170627825|NCT00561652|616649604|FG001|Overall Study|Withdrawal by Subject|1|||
170627826|NCT04842747|616649607|FG000|Overall Study|Withdrawal by Subject|6|||
170627827|NCT04842747|616649608|FG001|Overall Study|Withdrawal by Subject|2|||
170627828|NCT04842747|616649607|FG000|Overall Study|Lost to Follow-up|1|||
170627829|NCT04842747|616649608|FG001|Overall Study|Lost to Follow-up|2|||
170627830|NCT04842747|616649607|FG000|Overall Study|Physician Decision|1|||
170627831|NCT04842747|616649608|FG001|Overall Study|Physician Decision|0|||
170627832|NCT04842747|616649607|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
170627833|NCT04842747|616649608|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
170627834|NCT01033019|616649611|FG000|Overall Study|Withdrawal by Subject|1|||
170627835|NCT01033019|616649612|FG001|Overall Study|Withdrawal by Subject|0|||
170627836|NCT01075243|616649613|FG000|Overall Study|Lost to Follow-up|5|||
170627837|NCT01075243|616649614|FG001|Overall Study|Lost to Follow-up|2|||
170627838|NCT01075243|616649615|FG002|Overall Study|Lost to Follow-up|0|||
170627839|NCT01075243|616649613|FG000|Overall Study|Withdrawal by Subject|1|||
170627840|NCT01075243|616649614|FG001|Overall Study|Withdrawal by Subject|1|||
170627841|NCT01075243|616649615|FG002|Overall Study|Withdrawal by Subject|0|||
170627842|NCT00888173|616649629|FG000|Overall Study|Wrong Primary|1|||
170627843|NCT00888173|616649629|FG000|Overall Study|Ineligible: required test not done|1|||
170627844|NCT05135767|616649630|FG000|Baseline|Lost to Follow-up|1|||
170627845|NCT05135767|616649631|FG001|Baseline|Lost to Follow-up|1|||
170627846|NCT05135767|616649630|FG000|Baseline|Withdrawal by Subject|0|||
170627847|NCT05135767|616649631|FG001|Baseline|Withdrawal by Subject|2|||
170627848|NCT05135767|616649630|FG000|Active Study Phase|Lost to Follow-up|2|||
170627849|NCT05135767|616649631|FG001|Active Study Phase|Lost to Follow-up|0|||
170627850|NCT02694185|616649632|FG000|Overall Study|Withdrawal by Subject|45|||
170627851|NCT02694185|616649633|FG001|Overall Study|Withdrawal by Subject|0|||
170627852|NCT05082857|616649634|FG000|Overall Study|participants relocated and could not continue|2|||
170627853|NCT05082857|616649635|FG001|Overall Study|participants relocated and could not continue|1|||
170627854|NCT05082857|616649634|FG000|Overall Study|Lost to Follow-up|1|||
170627855|NCT05082857|616649635|FG001|Overall Study|Lost to Follow-up|3|||
170627856|NCT03597347|616649638|FG000|Overall Study|Withdrawal by Subject|1|||
170627857|NCT03597347|616649639|FG001|Overall Study|Withdrawal by Subject|1|||
170627858|NCT03597347|616649640|FG002|Overall Study|Withdrawal by Subject|0|||
170627859|NCT03597347|616649638|FG000|Overall Study|Withdrawal due to Covid-19|3|||
170627860|NCT03597347|616649639|FG001|Overall Study|Withdrawal due to Covid-19|0|||
170627861|NCT03597347|616649640|FG002|Overall Study|Withdrawal due to Covid-19|0|||
170627862|NCT03597347|616649638|FG000|Overall Study|Sponsor decision to terminate study|3|||
170627863|NCT03597347|616649639|FG001|Overall Study|Sponsor decision to terminate study|2|||
170627864|NCT03597347|616649640|FG002|Overall Study|Sponsor decision to terminate study|4|||
170627865|NCT04606134|616649641|FG000|Overall Study|Adverse Event|0|||
170627866|NCT04606134|616649642|FG001|Overall Study|Adverse Event|1|||
170627867|NCT03341299|616649643|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
170627868|NCT03341299|616649644|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
170627869|NCT03341299|616649645|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
170627870|NCT03341299|616649646|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
170627871|NCT03312634|616651877|FG000|Overall Study|Adverse Event|11|||
170627872|NCT03312634|616651878|FG001|Overall Study|Adverse Event|0|||
170627873|NCT03312634|616651877|FG000|Overall Study|Sponsor request|2|||
170627874|NCT03312634|616651878|FG001|Overall Study|Sponsor request|0|||
170627875|NCT03312634|616651877|FG000|Overall Study|Withdrawal by Subject|31|||
170627876|NCT03312634|616651878|FG001|Overall Study|Withdrawal by Subject|9|||
170627877|NCT03312634|616651877|FG000|Overall Study|Enrolled in an interventional study|0|||
170627878|NCT03312634|616651878|FG001|Overall Study|Enrolled in an interventional study|52|||
170627879|NCT03312634|616651877|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
170627880|NCT03312634|616651878|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
170627881|NCT03312634|616651877|FG000|Overall Study|Death|0|||
170627882|NCT03312634|616651878|FG001|Overall Study|Death|1|||
170627883|NCT03312634|616651877|FG000|Overall Study|Non-compliance|0|||
170627884|NCT03312634|616651878|FG001|Overall Study|Non-compliance|2|||
170627885|NCT03312634|616651877|FG000|Overall Study|Lost to Follow-up|0|||
170627886|NCT03312634|616651878|FG001|Overall Study|Lost to Follow-up|1|||
170627887|NCT03312634|616651877|FG000|Overall Study|Enrolled into non-interventional study|0|||
170627888|NCT03312634|616651878|FG001|Overall Study|Enrolled into non-interventional study|5|||
170673333|NCT02732119|616817789|FG002|Phase II|Adverse Event|0|||
170673334|NCT02732119|616817790|FG003|Phase II|Adverse Event|3|||
170673335|NCT02732119|616817791|FG004|Phase II|Adverse Event|3|||
170673336|NCT02732119|616817787|FG000|Phase II|Death|0|||
170673337|NCT02732119|616817788|FG001|Phase II|Death|0|||
170673338|NCT02732119|616817789|FG002|Phase II|Death|0|||
170673339|NCT02732119|616817790|FG003|Phase II|Death|1|||
170673340|NCT02732119|616817791|FG004|Phase II|Death|0|||
170673341|NCT02732119|616817787|FG000|Phase II|Progressive dissease|0|||
170673342|NCT02732119|616817788|FG001|Phase II|Progressive dissease|0|||
170673343|NCT02732119|616817789|FG002|Phase II|Progressive dissease|0|||
170673344|NCT02732119|616817790|FG003|Phase II|Progressive dissease|30|||
170673345|NCT02732119|616817791|FG004|Phase II|Progressive dissease|23|||
170673346|NCT02732119|616817787|FG000|Phase II|Study terminated by sponsor|0|||
170673347|NCT02732119|616817788|FG001|Phase II|Study terminated by sponsor|0|||
170673348|NCT02732119|616817789|FG002|Phase II|Study terminated by sponsor|0|||
170673349|NCT02732119|616817790|FG003|Phase II|Study terminated by sponsor|2|||
170673350|NCT02732119|616817791|FG004|Phase II|Study terminated by sponsor|2|||
170673351|NCT02732119|616817787|FG000|Phase II|Other|0|||
170673352|NCT02732119|616817788|FG001|Phase II|Other|0|||
170673353|NCT02732119|616817789|FG002|Phase II|Other|0|||
170673354|NCT02732119|616817790|FG003|Phase II|Other|2|||
170673355|NCT02732119|616817791|FG004|Phase II|Other|0|||
170673356|NCT02732119|616817787|FG000|Phase II|Physician Decision|0|||
170673357|NCT02732119|616817788|FG001|Phase II|Physician Decision|0|||
170673358|NCT02732119|616817789|FG002|Phase II|Physician Decision|0|||
170673359|NCT02732119|616817790|FG003|Phase II|Physician Decision|8|||
170673360|NCT02732119|616817791|FG004|Phase II|Physician Decision|5|||
170673361|NCT00867568|616817792|FG000|Overall Study|Lack of Efficacy|10|||
170673362|NCT00867568|616817792|FG000|Overall Study|Adverse Event|4|||
170673363|NCT00867568|616817792|FG000|Overall Study|Withdrawal by Subject|1|||
170673364|NCT05275400|616817793|FG000|Treatment Period|Adverse Event|7|||
170673365|NCT05275400|616817794|FG001|Treatment Period|Adverse Event|1|||
170673366|NCT05275400|616817793|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
170673367|NCT05275400|616817794|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
170673368|NCT05275400|616817793|FG000|Treatment Period|Death|5|||
170673369|NCT05275400|616817794|FG001|Treatment Period|Death|2|||
170673370|NCT05275400|616817793|FG000|Treatment Period|Protocol Violation|1|||
170673371|NCT05275400|616817794|FG001|Treatment Period|Protocol Violation|0|||
170673372|NCT05275400|616817793|FG000|Treatment Period|Physician Decision|5|||
170673373|NCT05275400|616817794|FG001|Treatment Period|Physician Decision|4|||
170673374|NCT05275400|616817793|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
170673375|NCT05275400|616817794|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
170673376|NCT05275400|616817793|FG000|Treatment Period|Withdrawal by Subject|30|||
170673377|NCT05275400|616817794|FG001|Treatment Period|Withdrawal by Subject|12|||
170673378|NCT05275400|616817793|FG000|Treatment Period|Lost to Follow-up|1|||
170673379|NCT05275400|616817794|FG001|Treatment Period|Lost to Follow-up|5|||
170673380|NCT05275400|616817793|FG000|Treatment Period|Lack of Efficacy|1|||
170673381|NCT05275400|616817794|FG001|Treatment Period|Lack of Efficacy|0|||
170820246|NCT03672188|617349607|FG008|Overall Study|Death|0|||
170820247|NCT03672188|617349608|FG009|Overall Study|Death|0|||
170820248|NCT03672188|617349609|FG010|Overall Study|Death|0|||
170820249|NCT03672188|617349610|FG011|Overall Study|Death|0|||
170820250|NCT03672188|617349611|FG012|Overall Study|Death|1|||
170820251|NCT03672188|617349612|FG013|Overall Study|Death|0|||
170820252|NCT03672188|617349613|FG014|Overall Study|Death|0|||
170820253|NCT03672188|617349599|FG000|Overall Study|Lost to Follow-up|0|||
170820254|NCT03672188|617349600|FG001|Overall Study|Lost to Follow-up|0|||
170820255|NCT03672188|617349601|FG002|Overall Study|Lost to Follow-up|1|||
170820256|NCT03672188|617349602|FG003|Overall Study|Lost to Follow-up|0|||
170820257|NCT03672188|617349603|FG004|Overall Study|Lost to Follow-up|0|||
170820258|NCT03672188|617349604|FG005|Overall Study|Lost to Follow-up|0|||
170820259|NCT03672188|617349605|FG006|Overall Study|Lost to Follow-up|0|||
170820260|NCT03672188|617349606|FG007|Overall Study|Lost to Follow-up|0|||
170820261|NCT03672188|617349607|FG008|Overall Study|Lost to Follow-up|0|||
170820262|NCT03672188|617349608|FG009|Overall Study|Lost to Follow-up|0|||
170820263|NCT03672188|617349609|FG010|Overall Study|Lost to Follow-up|0|||
170820264|NCT03672188|617349610|FG011|Overall Study|Lost to Follow-up|0|||
170820265|NCT03672188|617349611|FG012|Overall Study|Lost to Follow-up|0|||
170820266|NCT03672188|617349612|FG013|Overall Study|Lost to Follow-up|0|||
170820267|NCT03672188|617349613|FG014|Overall Study|Lost to Follow-up|0|||
170820268|NCT01107353|617349618|FG000|Overall Study|Positive Drug Screen|1|||
170673382|NCT05275400|616817793|FG000|Treatment Period|Sponsor Decision|1|||
170673383|NCT05275400|616817794|FG001|Treatment Period|Sponsor Decision|0|||
170820269|NCT01107353|617349619|FG001|Overall Study|Positive Drug Screen|0|||
170673384|NCT05275400|616817793|FG000|Follow-Up Period|Death|2|||
170673385|NCT05275400|616817794|FG001|Follow-Up Period|Death|0|||
170673386|NCT05275400|616817793|FG000|Follow-Up Period|Protocol Violation|1|||
170673387|NCT05275400|616817794|FG001|Follow-Up Period|Protocol Violation|0|||
170673388|NCT05275400|616817793|FG000|Follow-Up Period|Withdrawal by Subject|3|||
170673389|NCT05275400|616817794|FG001|Follow-Up Period|Withdrawal by Subject|0|||
170627889|NCT03312634|616651877|FG000|Overall Study|Worsening clinical condition|0|||
170627890|NCT03312634|616651878|FG001|Overall Study|Worsening clinical condition|1|||
170627891|NCT03312634|616651877|FG000|Overall Study|Participant did not want to travel|0|||
170627892|NCT03312634|616651878|FG001|Overall Study|Participant did not want to travel|1|||
170627893|NCT03312634|616651877|FG000|Overall Study|Physician Decision|1|||
170627894|NCT03312634|616651878|FG001|Overall Study|Physician Decision|0|||
170627895|NCT03312634|616651877|FG000|Overall Study|Other|13|||
170627896|NCT03312634|616651878|FG001|Overall Study|Other|0|||
170627897|NCT01148979|616651879|FG000|Overall Study|Lost to Follow-up|0|||
170627898|NCT01148979|616651880|FG001|Overall Study|Lost to Follow-up|1|||
170627899|NCT00906204|616651881|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
170627900|NCT00906204|616651882|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
170627901|NCT00906204|616651881|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
170627902|NCT00906204|616651882|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
170627903|NCT00906204|616651881|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
170627904|NCT00906204|616651882|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
170627905|NCT00906204|616651881|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
170627906|NCT00906204|616651882|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
170627907|NCT00906204|616651881|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
170627908|NCT00906204|616651882|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
170627909|NCT01597596|616651883|FG000|Overall Study|Study terminated by sponsor|1|||
170627910|NCT01597596|616651884|FG001|Overall Study|Study terminated by sponsor|0|||
170627911|NCT01597596|616651883|FG000|Overall Study|Physician Decision|0|||
170627912|NCT01597596|616651884|FG001|Overall Study|Physician Decision|1|||
170627913|NCT04639245|616651885|FG000|Overall Study|Death|1|||
170627914|NCT00535496|616651888|FG000|Overall Study|Lost to Follow-up|0|||
170627915|NCT00535496|616651889|FG001|Overall Study|Lost to Follow-up|1|||
170627916|NCT00535496|616651890|FG002|Overall Study|Lost to Follow-up|0|||
170627917|NCT00535496|616651891|FG003|Overall Study|Lost to Follow-up|0|||
170627918|NCT00535496|616651888|FG000|Overall Study|Not treated with sugammadex|0|||
170627919|NCT00535496|616651889|FG001|Overall Study|Not treated with sugammadex|1|||
170627920|NCT00535496|616651890|FG002|Overall Study|Not treated with sugammadex|0|||
170627921|NCT00535496|616651891|FG003|Overall Study|Not treated with sugammadex|0|||
170627922|NCT01209689|616651895|FG000|Overall Study|Insufficient Therapeutic Response|7|||
170627923|NCT01209689|616651896|FG001|Overall Study|Insufficient Therapeutic Response|2|||
170627924|NCT01209689|616651895|FG000|Overall Study|Refused Treatment|8|||
170627925|NCT01209689|616651896|FG001|Overall Study|Refused Treatment|3|||
170627926|NCT01209689|616651895|FG000|Overall Study|Adverse Event|4|||
170673390|NCT01651039|616817795|FG000|Overall Study|Non-evaluables|5|||
170673391|NCT01651039|616817795|FG000|Overall Study|Physician Decision|2|||
170673392|NCT01651039|616817795|FG000|Overall Study|Withdrawal by Subject|1|||
170673393|NCT01651039|616817795|FG000|Overall Study|Progressive Disease|22|||
170673394|NCT04930965|616817796|FG000|Overall Study|Lost to Follow-up|7|||
170673395|NCT04930965|616817797|FG001|Overall Study|Lost to Follow-up|5|||
170673396|NCT01091974|616817798|FG000|Overall Study|Did not start intervention|3|||
170673397|NCT01091974|616817799|FG001|Overall Study|Did not start intervention|1|||
170673398|NCT01091974|616817800|FG002|Overall Study|Did not start intervention|3|||
170673399|NCT01091974|616817801|FG003|Overall Study|Did not start intervention|1|||
170673400|NCT01091974|616817798|FG000|Overall Study|resumed sleep medication|0|||
170673401|NCT01091974|616817799|FG001|Overall Study|resumed sleep medication|0|||
170673402|NCT01091974|616817800|FG002|Overall Study|resumed sleep medication|1|||
170673403|NCT01091974|616817801|FG003|Overall Study|resumed sleep medication|2|||
170673404|NCT01091974|616817798|FG000|Overall Study|Withdrawal by Subject|1|||
170673405|NCT01091974|616817799|FG001|Overall Study|Withdrawal by Subject|3|||
170673406|NCT01091974|616817800|FG002|Overall Study|Withdrawal by Subject|2|||
170673407|NCT01091974|616817801|FG003|Overall Study|Withdrawal by Subject|2|||
170673408|NCT01091974|616817798|FG000|Overall Study|side-effects|1|||
170673409|NCT01091974|616817799|FG001|Overall Study|side-effects|1|||
170673410|NCT01091974|616817800|FG002|Overall Study|side-effects|0|||
170673411|NCT01091974|616817801|FG003|Overall Study|side-effects|2|||
170673412|NCT03066804|616817802|FG000|Overall Study|Physician Decision|0|||
170627927|NCT01209689|616651896|FG001|Overall Study|Adverse Event|0|||
170627928|NCT01209689|616651895|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
170627929|NCT01209689|616651896|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
170627930|NCT01209689|616651895|FG000|Overall Study|Failure to Return|3|||
170627931|NCT01209689|616651896|FG001|Overall Study|Failure to Return|0|||
170627932|NCT01209689|616651895|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
170673413|NCT03066804|616817803|FG001|Overall Study|Physician Decision|4|||
170673414|NCT03066804|616817802|FG000|Overall Study|Death|23|||
170627933|NCT01209689|616651896|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
170627934|NCT03780244|616651899|FG000|Overall Study|Lost to Follow-up|1|||
170627935|NCT03780244|616651900|FG001|Overall Study|Lost to Follow-up|0|||
170627936|NCT01298648|616651902|FG000|Overall Study|Withdrawal by Subject|2|||
170673415|NCT03066804|616817803|FG001|Overall Study|Death|17|||
170673416|NCT03066804|616817802|FG000|Overall Study|Withdrawal by Subject|19|||
170673417|NCT03066804|616817803|FG001|Overall Study|Withdrawal by Subject|25|||
170673418|NCT03066804|616817802|FG000|Overall Study|Lost to Follow-up|2|||
170673419|NCT03066804|616817803|FG001|Overall Study|Lost to Follow-up|0|||
170673420|NCT03066804|616817802|FG000|Overall Study|Adverse Event|2|||
170673421|NCT03066804|616817803|FG001|Overall Study|Adverse Event|3|||
170673422|NCT03066804|616817802|FG000|Overall Study|Technical problems|5|||
170673423|NCT03066804|616817803|FG001|Overall Study|Technical problems|1|||
170673424|NCT03948581|616817807|FG000|Overall Study|Lost to Follow-up|0|||
170673425|NCT03948581|616817808|FG001|Overall Study|Lost to Follow-up|1|||
170673426|NCT05393895|616817811|FG000|Overall Study|Adverse Event|2|||
170673427|NCT05393895|616817812|FG001|Overall Study|Adverse Event|3|||
170673428|NCT05393895|616817811|FG000|Overall Study|Lost to Follow-up|4|||
170673429|NCT05393895|616817812|FG001|Overall Study|Lost to Follow-up|3|||
170673430|NCT05393895|616817811|FG000|Overall Study|Protocol Violation|1|||
170820270|NCT02660034|617349622|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
170627937|NCT01298648|616651902|FG000|Overall Study|Lost to Follow-up|21|||
170627938|NCT00124943|616651903|FG000|Phase II|Adverse Event|0|||
170627939|NCT00124943|616651904|FG001|Phase II|Adverse Event|2|||
170627940|NCT00124943|616651905|FG002|Phase II|Adverse Event|0|||
170627941|NCT00124943|616651906|FG003|Phase II|Adverse Event|1|||
170627942|NCT00124943|616651903|FG000|Phase II|Protocol Violation|0|||
170627943|NCT00124943|616651904|FG001|Phase II|Protocol Violation|0|||
170627944|NCT00124943|616651905|FG002|Phase II|Protocol Violation|0|||
170627945|NCT00124943|616651906|FG003|Phase II|Protocol Violation|1|||
170627946|NCT00124943|616651903|FG000|Phase II|Lost to Follow-up|0|||
170627947|NCT00124943|616651904|FG001|Phase II|Lost to Follow-up|0|||
170627948|NCT00124943|616651905|FG002|Phase II|Lost to Follow-up|0|||
170627949|NCT00124943|616651906|FG003|Phase II|Lost to Follow-up|1|||
170627950|NCT00124943|616651903|FG000|Phase II|Withdrawal by Subject|0|||
170627951|NCT00124943|616651904|FG001|Phase II|Withdrawal by Subject|0|||
170627952|NCT00124943|616651905|FG002|Phase II|Withdrawal by Subject|0|||
170627953|NCT00124943|616651906|FG003|Phase II|Withdrawal by Subject|2|||
170627954|NCT00321620|616651908|FG000|Overall Study|Death|269|||
170627955|NCT00321620|616651909|FG001|Overall Study|Death|294|||
170627956|NCT00321620|616651908|FG000|Overall Study|Withdrawal by Subject|164|||
170627957|NCT00321620|616651909|FG001|Overall Study|Withdrawal by Subject|147|||
170627958|NCT00321620|616651908|FG000|Overall Study|Disease progression|113|||
170627959|NCT00321620|616651909|FG001|Overall Study|Disease progression|117|||
170627960|NCT00321620|616651908|FG000|Overall Study|Adverse Event|43|||
170627961|NCT00321620|616651909|FG001|Overall Study|Adverse Event|56|||
170627962|NCT00321620|616651908|FG000|Overall Study|Lost to Follow-up|13|||
170627963|NCT00321620|616651909|FG001|Overall Study|Lost to Follow-up|9|||
170627964|NCT00321620|616651908|FG000|Overall Study|Physician Decision|4|||
170627965|NCT00321620|616651909|FG001|Overall Study|Physician Decision|1|||
170627966|NCT00321620|616651908|FG000|Overall Study|Noncompliance|14|||
170627967|NCT00321620|616651909|FG001|Overall Study|Noncompliance|7|||
170627968|NCT00321620|616651908|FG000|Overall Study|Protocol deviation|4|||
170627969|NCT00321620|616651909|FG001|Overall Study|Protocol deviation|3|||
170627970|NCT00321620|616651908|FG000|Overall Study|Ineligibility determined|2|||
170627971|NCT00321620|616651909|FG001|Overall Study|Ineligibility determined|3|||
170627972|NCT00321620|616651908|FG000|Overall Study|Participant request|75|||
170627973|NCT00321620|616651909|FG001|Overall Study|Participant request|52|||
170627974|NCT00321620|616651908|FG000|Overall Study|Other|42|||
170627975|NCT00321620|616651909|FG001|Overall Study|Other|33|||
170627976|NCT02177123|616651910|FG000|Overall Study|Lost to Follow-up|6|||
170627977|NCT02177123|616651910|FG000|Overall Study|Withdrawal by Subject|4|||
170627978|NCT02177123|616651910|FG000|Overall Study|Adverse Event|4|||
170627979|NCT02177123|616651910|FG000|Overall Study|Physician Decision|3|||
170627980|NCT02177123|616651910|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
170627981|NCT02177123|616651910|FG000|Overall Study|Excluded for medical reasons|2|||
170627982|NCT02177123|616651910|FG000|Overall Study|Death|1|||
170627983|NCT02177123|616651910|FG000|Overall Study|Other|1|||
170627984|NCT02177123|616651910|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
170627985|NCT03466658|616651911|FG000|Overall Study|Withdrawal by Subject|3|||
170627986|NCT01921205|616651912|FG000|Overall Study|Adverse Event|12|||
170627987|NCT01921205|616651913|FG001|Overall Study|Adverse Event|7|||
170627988|NCT01921205|616651912|FG000|Overall Study|Lack of Efficacy|1|||
170627989|NCT01921205|616651913|FG001|Overall Study|Lack of Efficacy|0|||
170627990|NCT01921205|616651912|FG000|Overall Study|Protocol Violation|1|||
170627991|NCT01921205|616651913|FG001|Overall Study|Protocol Violation|3|||
170627992|NCT01921205|616651912|FG000|Overall Study|Lost to Follow-up|1|||
170627993|NCT01921205|616651913|FG001|Overall Study|Lost to Follow-up|1|||
170627994|NCT01921205|616651912|FG000|Overall Study|Withdrawal by Subject|6|||
170627995|NCT01921205|616651913|FG001|Overall Study|Withdrawal by Subject|5|||
170627996|NCT01921205|616651912|FG000|Overall Study|Use Of Prohibited Medication|0|||
170673431|NCT05393895|616817812|FG001|Overall Study|Protocol Violation|0|||
170627997|NCT01921205|616651913|FG001|Overall Study|Use Of Prohibited Medication|1|||
170627998|NCT01921205|616651912|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
170627999|NCT01921205|616651913|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
170673432|NCT05393895|616817811|FG000|Overall Study|Withdrawal by Subject|1|||
170673433|NCT05393895|616817812|FG001|Overall Study|Withdrawal by Subject|4|||
170673434|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
170673435|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
170673436|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
170673437|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
170673438|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
170673439|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
170673440|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
170673441|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
170673442|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
170673443|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
170673444|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
170673445|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
170673446|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
170673447|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
170673448|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
170673449|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
170673450|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
170673451|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
170673452|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
170673453|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
170673454|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
170673455|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
170673456|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
170673457|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
170673458|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
170673459|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
170673460|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
170673461|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
170673462|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
170673463|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
170673464|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
170673465|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
170673466|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
170673467|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
170673468|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
170673469|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
170673470|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
170673471|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
170673472|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
170673473|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
170673474|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
170673475|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
170673476|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
170673477|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
170673478|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
170673479|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
170673480|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
170673481|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
170673482|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
170673483|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
170673484|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
170673485|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
170673486|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
170673487|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
170673488|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
170673489|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
170673490|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
170673491|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
170673492|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
170673493|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
170673494|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
170673495|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
170673496|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
170673497|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
170673498|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
170673499|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
170673500|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
170673501|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
170673502|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
170673503|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
170673504|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Change of location|0|||
170673505|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Change of location|0|||
170673506|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Change of location|0|||
170673507|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Change of location|1|||
170673508|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Change of location|0|||
170673509|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
170673510|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
170673511|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
170673512|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
170673513|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
170673514|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
170673515|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
170673516|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
170673517|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
170673518|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
170673519|NCT00730405|616817815|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
170673520|NCT00730405|616817816|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
170673521|NCT00730405|616817817|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
170673522|NCT00730405|616817818|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
170673523|NCT00730405|616817819|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
170673524|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
170673525|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
170673526|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
170673527|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
170673528|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
170673529|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
170673530|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
170673531|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
170673532|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
170673533|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
170673534|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
170673535|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
170673536|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
170673537|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
170673538|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
170673539|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Death|0|||
170673540|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Death|1|||
170673541|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Death|0|||
170673542|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Death|1|||
170673543|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Death|0|||
170673544|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Change of location|1|||
170673545|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Change of location|1|||
170673546|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Change of location|0|||
170673547|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Change of location|1|||
170673548|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Change of location|0|||
170673549|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
170673550|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
170673551|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
170673552|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
170673553|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
170673554|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
170673555|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
170673556|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
170673557|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
170820271|NCT02660034|617349623|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
170820272|NCT02660034|617349624|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
170820273|NCT02660034|617349625|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
170820274|NCT02660034|617349626|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
170820275|NCT02660034|617349627|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
170628000|NCT01921205|616651912|FG000|Overall Study|Non Compliance Of The Parent|0|||
170628001|NCT01921205|616651913|FG001|Overall Study|Non Compliance Of The Parent|1|||
170628002|NCT01921205|616651912|FG000|Overall Study|Non Compliance Of Child|0|||
170628003|NCT01921205|616651913|FG001|Overall Study|Non Compliance Of Child|1|||
170628004|NCT03331315|616651916|FG000|Overall Study|Physician Decision|18|||
170628005|NCT03331315|616651917|FG001|Overall Study|Physician Decision|14|||
170628006|NCT00360230|616651918|FG000|Overall Study|Withdrawal by Subject|1|||
170628007|NCT00360230|616651919|FG001|Overall Study|Withdrawal by Subject|1|||
170628008|NCT00360230|616651920|FG002|Overall Study|Withdrawal by Subject|0|||
170628009|NCT00360230|616651921|FG003|Overall Study|Withdrawal by Subject|1|||
170628010|NCT00360230|616651922|FG004|Overall Study|Withdrawal by Subject|1|||
170628011|NCT00360230|616651923|FG005|Overall Study|Withdrawal by Subject|1|||
170628012|NCT00360230|616651924|FG006|Overall Study|Withdrawal by Subject|0|||
170628013|NCT00360230|616651918|FG000|Overall Study|Migrated|4|||
170628014|NCT00360230|616651919|FG001|Overall Study|Migrated|1|||
170628015|NCT00360230|616651920|FG002|Overall Study|Migrated|3|||
170628016|NCT00360230|616651921|FG003|Overall Study|Migrated|1|||
170628017|NCT00360230|616651922|FG004|Overall Study|Migrated|4|||
170628018|NCT00360230|616651923|FG005|Overall Study|Migrated|1|||
170628019|NCT00360230|616651924|FG006|Overall Study|Migrated|1|||
170628020|NCT00360230|616651918|FG000|Overall Study|Other|1|||
170628021|NCT00360230|616651919|FG001|Overall Study|Other|0|||
170628022|NCT00360230|616651920|FG002|Overall Study|Other|0|||
170628023|NCT00360230|616651921|FG003|Overall Study|Other|0|||
170628024|NCT00360230|616651922|FG004|Overall Study|Other|0|||
170628025|NCT00360230|616651923|FG005|Overall Study|Other|0|||
170628026|NCT00360230|616651924|FG006|Overall Study|Other|0|||
170628027|NCT00360230|616651918|FG000|Overall Study|Protocol Violation|0|||
170628028|NCT00360230|616651919|FG001|Overall Study|Protocol Violation|0|||
170628029|NCT00360230|616651920|FG002|Overall Study|Protocol Violation|0|||
170628030|NCT00360230|616651921|FG003|Overall Study|Protocol Violation|0|||
170628031|NCT00360230|616651922|FG004|Overall Study|Protocol Violation|0|||
170628032|NCT00360230|616651923|FG005|Overall Study|Protocol Violation|1|||
170628033|NCT00360230|616651924|FG006|Overall Study|Protocol Violation|0|||
170628034|NCT00360230|616651918|FG000|Overall Study|Death|0|||
170628035|NCT00360230|616651919|FG001|Overall Study|Death|1|||
170628036|NCT00360230|616651920|FG002|Overall Study|Death|0|||
170628037|NCT00360230|616651921|FG003|Overall Study|Death|0|||
170628038|NCT00360230|616651922|FG004|Overall Study|Death|0|||
170628039|NCT00360230|616651923|FG005|Overall Study|Death|1|||
170628040|NCT00360230|616651924|FG006|Overall Study|Death|1|||
170628041|NCT02703597|616651925|FG000|Assignment to Baseline|Lost to Follow-up|17|||
170628042|NCT02703597|616651926|FG001|Assignment to Baseline|Lost to Follow-up|16|||
170628043|NCT02703597|616651925|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
170628044|NCT02703597|616651926|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
170628045|NCT02703597|616651925|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
170628046|NCT02703597|616651926|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
170628047|NCT02703597|616651925|FG000|First Post-test to First Follow-up|Site drop out|0|||
170628048|NCT02703597|616651926|FG001|First Post-test to First Follow-up|Site drop out|58|||
170628049|NCT02703597|616651925|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
170628050|NCT02703597|616651926|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
170628051|NCT02703597|616651925|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
170628052|NCT02703597|616651926|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
170628053|NCT02703597|616651925|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
170628054|NCT02703597|616651926|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
170628055|NCT00481832|616651927|FG000|Enrollment|Physician Decision|8|||
170628056|NCT00481832|616651927|FG000|Enrollment|Unable to collect enough stem cells|2|||
170628057|NCT00481832|616651927|FG000|Inter-transplant Period|Adverse Event|4|||
170628058|NCT00481832|616651927|FG000|Inter-transplant Period|Death|3|||
170628059|NCT00481832|616651927|FG000|Inter-transplant Period|Physician Decision|4|||
170628060|NCT00481832|616651927|FG000|Inter-transplant Period|Disease relapse|11|||
170628061|NCT00481832|616651927|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
170628062|NCT02006472|616651931|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
170628063|NCT02006472|616651932|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
170628064|NCT02006472|616651933|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
170628065|NCT02006472|616651934|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
170628066|NCT02006472|616651935|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
170628067|NCT02006472|616651931|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
170628068|NCT02006472|616651932|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
170628069|NCT02006472|616651933|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
170628070|NCT02006472|616651934|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
170628071|NCT02006472|616651935|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
170628072|NCT02006472|616651931|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
170628073|NCT02006472|616651932|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
170673558|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
170673559|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
170673560|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
170673561|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
170673562|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
170673563|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
170673564|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
170673565|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
170673566|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
170673567|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
170673568|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
170673569|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
170673570|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
170673571|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
170673572|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
170673573|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
170673574|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
170673575|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
170673576|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
170673577|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
170673578|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
170673579|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
170673580|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
170673581|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
170673582|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
170673583|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
170673584|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
170673585|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
170673586|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
170673587|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
170673588|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
170673589|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
170673590|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
170673591|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
170673592|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
170673593|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
170673594|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
170673595|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
170673596|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
170673597|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
170673598|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
170673599|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Missing|0|||
170673600|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Missing|0|||
170673601|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Missing|2|||
170673602|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Missing|0|||
170673603|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Missing|0|||
170673604|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
170673605|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
170673606|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
170673607|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
170673608|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
170673609|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
170820276|NCT02660034|617349628|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
170628074|NCT02006472|616651933|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
170628075|NCT02006472|616651934|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
170628076|NCT02006472|616651935|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
170628077|NCT02006472|616651931|FG000|Period 1 (Through Week 26)|Other|1|||
170628078|NCT02006472|616651932|FG001|Period 1 (Through Week 26)|Other|5|||
170628079|NCT02006472|616651933|FG002|Period 1 (Through Week 26)|Other|0|||
170628080|NCT02006472|616651934|FG003|Period 1 (Through Week 26)|Other|2|||
170628081|NCT02006472|616651935|FG004|Period 1 (Through Week 26)|Other|3|||
170628082|NCT02006472|616651931|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
170628083|NCT02006472|616651932|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
170628084|NCT02006472|616651933|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
170628085|NCT02006472|616651934|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
170628086|NCT02006472|616651935|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
170673610|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
170673611|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
170673612|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
170673613|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
170673614|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
170673615|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
170673616|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
170673617|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
170673618|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
170673619|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
170673620|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
170673621|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
170673622|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
170673623|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
170673624|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
170673625|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
170673626|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
170673627|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
170673628|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
170673629|NCT00730405|616817815|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
170673630|NCT00730405|616817816|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
170673631|NCT00730405|616817817|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
170673632|NCT00730405|616817818|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
170673633|NCT00730405|616817819|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
170673634|NCT03330288|616817828|FG000|Overall Study|Other reason|1|||
170673635|NCT03330288|616817829|FG001|Overall Study|Other reason|1|||
170673636|NCT03330288|616817828|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
170673637|NCT03330288|616817829|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
170673638|NCT03330288|616817828|FG000|Overall Study|Adverse Event|1|||
170673639|NCT03330288|616817829|FG001|Overall Study|Adverse Event|0|||
170628087|NCT02006472|616651931|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
170628088|NCT02006472|616651932|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
170628089|NCT02006472|616651933|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
170628090|NCT02006472|616651934|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
170628091|NCT02006472|616651935|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
170628092|NCT02006472|616651931|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
170628093|NCT02006472|616651932|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
170628094|NCT02006472|616651933|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
170628095|NCT02006472|616651934|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
170673640|NCT03330288|616817828|FG000|Overall Study|Withdrawal by Subject|1|||
170673641|NCT03330288|616817829|FG001|Overall Study|Withdrawal by Subject|0|||
170673642|NCT03330288|616817828|FG000|Overall Study|Lost to Follow-up|26|||
170673643|NCT03330288|616817829|FG001|Overall Study|Lost to Follow-up|7|||
170673644|NCT03617185|616817830|FG000|Baseline|Lost to Follow-up|0|||
170673645|NCT03617185|616817831|FG001|Baseline|Lost to Follow-up|2|||
170673646|NCT03617185|616817832|FG002|Baseline|Lost to Follow-up|1|||
170673647|NCT03617185|616817833|FG003|Baseline|Lost to Follow-up|1|||
170673648|NCT03617185|616817830|FG000|Baseline|Withdrawal by Subject|0|||
170673649|NCT03617185|616817831|FG001|Baseline|Withdrawal by Subject|1|||
170673650|NCT03617185|616817832|FG002|Baseline|Withdrawal by Subject|0|||
170673651|NCT03617185|616817833|FG003|Baseline|Withdrawal by Subject|1|||
170673652|NCT03617185|616817830|FG000|Baseline|Driving Distance/Travel|0|||
170673653|NCT03617185|616817831|FG001|Baseline|Driving Distance/Travel|0|||
170673654|NCT03617185|616817832|FG002|Baseline|Driving Distance/Travel|2|||
170673655|NCT03617185|616817833|FG003|Baseline|Driving Distance/Travel|0|||
170673656|NCT03617185|616817830|FG000|Baseline|Family Obligations|0|||
170673657|NCT03617185|616817831|FG001|Baseline|Family Obligations|0|||
170673658|NCT03617185|616817832|FG002|Baseline|Family Obligations|0|||
170673659|NCT03617185|616817833|FG003|Baseline|Family Obligations|1|||
170673660|NCT03617185|616817830|FG000|3 Months|Lost to Follow-up|4|||
170673661|NCT03617185|616817831|FG001|3 Months|Lost to Follow-up|1|||
170673662|NCT03617185|616817832|FG002|3 Months|Lost to Follow-up|0|||
170673663|NCT03617185|616817833|FG003|3 Months|Lost to Follow-up|2|||
170673664|NCT03617185|616817830|FG000|3 Months|Withdrawal by Subject|1|||
170628096|NCT02006472|616651935|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
170628097|NCT02006472|616651931|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
170628098|NCT02006472|616651932|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
170628099|NCT02006472|616651933|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
170628100|NCT02006472|616651934|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
170673665|NCT03617185|616817831|FG001|3 Months|Withdrawal by Subject|3|||
170673666|NCT03617185|616817832|FG002|3 Months|Withdrawal by Subject|0|||
170673667|NCT03617185|616817833|FG003|3 Months|Withdrawal by Subject|0|||
170673668|NCT03617185|616817830|FG000|3 Months|Driving Distance/Travel|1|||
170673669|NCT03617185|616817831|FG001|3 Months|Driving Distance/Travel|0|||
170673670|NCT03617185|616817832|FG002|3 Months|Driving Distance/Travel|0|||
170673671|NCT03617185|616817833|FG003|3 Months|Driving Distance/Travel|0|||
170673672|NCT03617185|616817830|FG000|3 Months|Family Obligations|0|||
170673673|NCT03617185|616817831|FG001|3 Months|Family Obligations|0|||
170673674|NCT03617185|616817832|FG002|3 Months|Family Obligations|0|||
170673675|NCT03617185|616817833|FG003|3 Months|Family Obligations|1|||
170673676|NCT03617185|616817830|FG000|12 Months|Lost to Follow-up|3|||
170673677|NCT03617185|616817831|FG001|12 Months|Lost to Follow-up|1|||
170673678|NCT03617185|616817832|FG002|12 Months|Lost to Follow-up|3|||
170673679|NCT03617185|616817833|FG003|12 Months|Lost to Follow-up|0|||
170673680|NCT03617185|616817830|FG000|12 Months|Withdrawal by Subject|0|||
170673681|NCT03617185|616817831|FG001|12 Months|Withdrawal by Subject|0|||
170673682|NCT03617185|616817832|FG002|12 Months|Withdrawal by Subject|0|||
170673683|NCT03617185|616817833|FG003|12 Months|Withdrawal by Subject|1|||
170673684|NCT03617185|616817830|FG000|12 Months|Driving Distance/Travel|0|||
170673685|NCT03617185|616817831|FG001|12 Months|Driving Distance/Travel|0|||
170673686|NCT03617185|616817832|FG002|12 Months|Driving Distance/Travel|1|||
170673687|NCT03617185|616817833|FG003|12 Months|Driving Distance/Travel|0|||
170673688|NCT01964430|616817834|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
170673689|NCT01964430|616817835|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
170673690|NCT01964430|616817834|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
170673691|NCT01964430|616817835|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
170673692|NCT01964430|616817834|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
170673693|NCT01964430|616817835|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
170673694|NCT01964430|616817834|FG000|Treatment Period|Adverse Event|71|||
170673695|NCT01964430|616817835|FG001|Treatment Period|Adverse Event|37|||
170673696|NCT01964430|616817834|FG000|Treatment Period|Withdrawal by Subject|36|||
170673697|NCT01964430|616817835|FG001|Treatment Period|Withdrawal by Subject|27|||
170673698|NCT01964430|616817834|FG000|Treatment Period|Death|1|||
170673699|NCT01964430|616817835|FG001|Treatment Period|Death|3|||
170673700|NCT01964430|616817834|FG000|Treatment Period|Protocol Deviation|0|||
170673701|NCT01964430|616817835|FG001|Treatment Period|Protocol Deviation|1|||
170673702|NCT01964430|616817834|FG000|Treatment Period|Physician Decision|5|||
170673703|NCT01964430|616817835|FG001|Treatment Period|Physician Decision|4|||
170673704|NCT01964430|616817834|FG000|Treatment Period|Disease Relapse|28|||
170673705|NCT01964430|616817835|FG001|Treatment Period|Disease Relapse|38|||
170673706|NCT01964430|616817834|FG000|Treatment Period|Other reasons|1|||
170673707|NCT01964430|616817835|FG001|Treatment Period|Other reasons|3|||
170673708|NCT02591290|616817836|FG000|Overall Study|Withdrawal by Subject|2|||
170673709|NCT02571075|616817839|FG000|Overall Study|Lost to Follow-up|20|||
170673710|NCT02571075|616817840|FG001|Overall Study|Lost to Follow-up|24|||
170673711|NCT03546062|616817843|FG000|Overall Study|Adverse Event|6|||
170673712|NCT03546062|616817844|FG001|Overall Study|Adverse Event|5|||
170673713|NCT03546062|616817845|FG002|Overall Study|Adverse Event|8|||
170673714|NCT02572401|616817848|FG000|Overall Study|Lost to Follow-up|5|||
170673715|NCT02572401|616817849|FG001|Overall Study|Lost to Follow-up|8|||
170673716|NCT02572401|616817850|FG002|Overall Study|Lost to Follow-up|9|||
170673717|NCT02572401|616817851|FG003|Overall Study|Lost to Follow-up|9|||
170673718|NCT02572401|616817848|FG000|Overall Study|Death|0|||
170673719|NCT02572401|616817849|FG001|Overall Study|Death|0|||
170673720|NCT02572401|616817850|FG002|Overall Study|Death|0|||
170673721|NCT02572401|616817851|FG003|Overall Study|Death|1|||
170673722|NCT01768286|616817852|FG000|Overall Study|Randomized But Not Treated|0|||
170673723|NCT01768286|616817853|FG001|Overall Study|Randomized But Not Treated|0|||
170673724|NCT01768286|616817854|FG002|Overall Study|Randomized But Not Treated|1|||
170673725|NCT01768286|616817855|FG003|Overall Study|Randomized But Not Treated|0|||
170673726|NCT01768286|616817852|FG000|Overall Study|Lack of Efficacy|7|||
170673727|NCT01768286|616817853|FG001|Overall Study|Lack of Efficacy|4|||
170673728|NCT01768286|616817854|FG002|Overall Study|Lack of Efficacy|0|||
170673729|NCT01768286|616817855|FG003|Overall Study|Lack of Efficacy|1|||
170673730|NCT01768286|616817852|FG000|Overall Study|Withdrew Consent|0|||
170673731|NCT01768286|616817853|FG001|Overall Study|Withdrew Consent|0|||
170673732|NCT01768286|616817854|FG002|Overall Study|Withdrew Consent|1|||
170673733|NCT01768286|616817855|FG003|Overall Study|Withdrew Consent|0|||
170673734|NCT02935842|616817856|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
170673735|NCT02935842|616817857|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
170673736|NCT02935842|616817858|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
170673737|NCT02935842|616817859|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
170673738|NCT02935842|616817856|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
170673739|NCT02935842|616817857|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
170673740|NCT02935842|616817858|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
170673741|NCT02935842|616817859|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
170673742|NCT02935842|616817856|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
170673743|NCT02935842|616817857|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
170673744|NCT02935842|616817858|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
170673745|NCT02935842|616817859|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
170673746|NCT02935842|616817856|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
170673747|NCT02935842|616817857|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
170673748|NCT02935842|616817858|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
170673749|NCT02935842|616817859|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
170673750|NCT02935842|616817856|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
170673751|NCT02935842|616817857|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
170673752|NCT02935842|616817858|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
170673753|NCT02935842|616817859|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
170673754|NCT00915278|616817860|FG000|Overall Study|Death|1|||
170673755|NCT00915278|616817861|FG001|Overall Study|Death|0|||
170673756|NCT00915278|616817862|FG002|Overall Study|Death|0|||
170673757|NCT00915278|616817863|FG003|Overall Study|Death|0|||
170673758|NCT00915278|616817864|FG004|Overall Study|Death|0|||
170673759|NCT00915278|616817865|FG005|Overall Study|Death|0|||
170673760|NCT00915278|616817860|FG000|Overall Study|Lost to Follow-up|0|||
170673761|NCT00915278|616817861|FG001|Overall Study|Lost to Follow-up|1|||
170673762|NCT00915278|616817862|FG002|Overall Study|Lost to Follow-up|0|||
170673763|NCT00915278|616817863|FG003|Overall Study|Lost to Follow-up|0|||
170673764|NCT00915278|616817864|FG004|Overall Study|Lost to Follow-up|0|||
170673765|NCT00915278|616817865|FG005|Overall Study|Lost to Follow-up|0|||
170673766|NCT00915278|616817860|FG000|Overall Study|Withdrawal by Subject|0|||
170673767|NCT00915278|616817861|FG001|Overall Study|Withdrawal by Subject|1|||
170673768|NCT00915278|616817862|FG002|Overall Study|Withdrawal by Subject|0|||
170673769|NCT00915278|616817863|FG003|Overall Study|Withdrawal by Subject|0|||
170673770|NCT00915278|616817864|FG004|Overall Study|Withdrawal by Subject|1|||
170673771|NCT00915278|616817865|FG005|Overall Study|Withdrawal by Subject|4|||
170673772|NCT00915278|616817860|FG000|Overall Study|Adverse Event|4|||
170673773|NCT00915278|616817861|FG001|Overall Study|Adverse Event|1|||
170673774|NCT00915278|616817862|FG002|Overall Study|Adverse Event|0|||
170673775|NCT00915278|616817863|FG003|Overall Study|Adverse Event|0|||
170673776|NCT00915278|616817864|FG004|Overall Study|Adverse Event|0|||
170673777|NCT00915278|616817865|FG005|Overall Study|Adverse Event|0|||
170673778|NCT00915278|616817860|FG000|Overall Study|Progressive disease/clinical progression|0|||
170673779|NCT00915278|616817861|FG001|Overall Study|Progressive disease/clinical progression|0|||
170673780|NCT00915278|616817862|FG002|Overall Study|Progressive disease/clinical progression|0|||
170673781|NCT00915278|616817863|FG003|Overall Study|Progressive disease/clinical progression|3|||
170673782|NCT00915278|616817864|FG004|Overall Study|Progressive disease/clinical progression|1|||
170673783|NCT00915278|616817865|FG005|Overall Study|Progressive disease/clinical progression|2|||
170673784|NCT00915278|616817860|FG000|Overall Study|Infusion related AEs|0|||
170673785|NCT00915278|616817861|FG001|Overall Study|Infusion related AEs|0|||
170673786|NCT00915278|616817862|FG002|Overall Study|Infusion related AEs|0|||
170673787|NCT00915278|616817863|FG003|Overall Study|Infusion related AEs|0|||
170673788|NCT00915278|616817864|FG004|Overall Study|Infusion related AEs|0|||
170673789|NCT00915278|616817865|FG005|Overall Study|Infusion related AEs|2|||
170673790|NCT00915278|616817860|FG000|Overall Study|Admission to hospice|0|||
170673791|NCT00915278|616817861|FG001|Overall Study|Admission to hospice|0|||
170673792|NCT00915278|616817862|FG002|Overall Study|Admission to hospice|1|||
170673793|NCT00915278|616817863|FG003|Overall Study|Admission to hospice|0|||
170673794|NCT00915278|616817864|FG004|Overall Study|Admission to hospice|0|||
170673795|NCT00915278|616817865|FG005|Overall Study|Admission to hospice|0|||
170673796|NCT00674362|616817866|FG000|Double Blind|Adverse Event|6|||
170673797|NCT00674362|616817867|FG001|Double Blind|Adverse Event|6|||
170673798|NCT00674362|616817866|FG000|Double Blind|Lack of Efficacy|2|||
170673799|NCT00674362|616817867|FG001|Double Blind|Lack of Efficacy|6|||
170673800|NCT00674362|616817866|FG000|Double Blind|Loss of efficacy|0|||
170673801|NCT00674362|616817867|FG001|Double Blind|Loss of efficacy|1|||
170673802|NCT00674362|616817866|FG000|Double Blind|Withdrawal by Subject|4|||
170673803|NCT00674362|616817867|FG001|Double Blind|Withdrawal by Subject|3|||
170673804|NCT00674362|616817866|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
170673805|NCT00674362|616817867|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
170673806|NCT00674362|616817866|FG000|Double Blind|Other: Surgery|0|||
170673807|NCT00674362|616817867|FG001|Double Blind|Other: Surgery|1|||
170673808|NCT00674362|616817866|FG000|Open Label|Adverse Event|1|||
170673809|NCT00674362|616817867|FG001|Open Label|Adverse Event|0|||
170673810|NCT00674362|616817866|FG000|Open Label|Other: Subject moved to extension study|1|||
170673811|NCT00674362|616817867|FG001|Open Label|Other: Subject moved to extension study|0|||
170673812|NCT02465515|616817868|FG000|Overall Study|Investigator site closed|4|||
170673813|NCT02465515|616817869|FG001|Overall Study|Investigator site closed|5|||
170673814|NCT02465515|616817868|FG000|Overall Study|Withdrawal by Subject|74|||
170673815|NCT02465515|616817869|FG001|Overall Study|Withdrawal by Subject|43|||
170673816|NCT02465515|616817868|FG000|Overall Study|Physician Decision|8|||
170673817|NCT02465515|616817869|FG001|Overall Study|Physician Decision|12|||
170673818|NCT02465515|616817868|FG000|Overall Study|Lost to Follow-up|68|||
170673819|NCT02465515|616817869|FG001|Overall Study|Lost to Follow-up|51|||
170673820|NCT00629707|616817874|FG000|Overall Study|Withdrawal by Subject|0|||
170673821|NCT00629707|616817875|FG001|Overall Study|Withdrawal by Subject|1|||
170673822|NCT00629707|616817874|FG000|Overall Study|Physician Decision|0|||
170673823|NCT00629707|616817875|FG001|Overall Study|Physician Decision|1|||
170673824|NCT00293033|616817876|FG000|Open-label Titration Period|Adverse Event|10|||
170673825|NCT00293033|616817876|FG000|Open-label Titration Period|Death|3|||
170673826|NCT00293033|616817876|FG000|Open-label Titration Period|Lack of Efficacy|5|||
170673827|NCT00293033|616817876|FG000|Open-label Titration Period|Protocol Violation|2|||
170673828|NCT00293033|616817876|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
170673829|NCT00293033|616817876|FG000|Open-label Titration Period|Noncompliance and other|27|||
170673830|NCT00293033|616817876|FG000|Double-blind Treatment Period|Adverse Event|3|||
170673831|NCT00293033|616817876|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
170673832|NCT00293033|616817876|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
170673833|NCT00293033|616817876|FG000|Double-blind Treatment Period|Noncompliance|4|||
170673834|NCT03583697|616817877|FG000|Overall Study|Withdrawal by Subject|0|||
170673835|NCT03583697|616817878|FG001|Overall Study|Withdrawal by Subject|0|||
170673836|NCT03583697|616817879|FG002|Overall Study|Withdrawal by Subject|1|||
170673837|NCT03583697|616817877|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
170673838|NCT03583697|616817878|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
170673839|NCT03583697|616817879|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
170673840|NCT00365508|616817880|FG000|Overall Study|Lost to Follow-up|139|||
170673841|NCT00365508|616817881|FG001|Overall Study|Lost to Follow-up|154|||
170673842|NCT01817530|616817882|FG000|Overall Study|Exclusionary Medication Received|0|||
170673843|NCT01817530|616817883|FG001|Overall Study|Exclusionary Medication Received|0|||
170673844|NCT01817530|616817884|FG002|Overall Study|Exclusionary Medication Received|0|||
170673845|NCT01817530|616817885|FG003|Overall Study|Exclusionary Medication Received|0|||
170673846|NCT01817530|616817886|FG004|Overall Study|Exclusionary Medication Received|1|||
170673847|NCT01817530|616817887|FG005|Overall Study|Exclusionary Medication Received|0|||
170673848|NCT01817530|616817888|FG006|Overall Study|Exclusionary Medication Received|0|||
170673849|NCT01817530|616817889|FG007|Overall Study|Exclusionary Medication Received|0|||
170673850|NCT01817530|616817882|FG000|Overall Study|Adverse Event|6|||
170673851|NCT01817530|616817883|FG001|Overall Study|Adverse Event|3|||
170673852|NCT01817530|616817884|FG002|Overall Study|Adverse Event|2|||
170673853|NCT01817530|616817885|FG003|Overall Study|Adverse Event|5|||
170673854|NCT01817530|616817886|FG004|Overall Study|Adverse Event|0|||
170673855|NCT01817530|616817887|FG005|Overall Study|Adverse Event|10|||
170673856|NCT01817530|616817888|FG006|Overall Study|Adverse Event|5|||
170673857|NCT01817530|616817889|FG007|Overall Study|Adverse Event|8|||
170673858|NCT01817530|616817882|FG000|Overall Study|Subject Noncompliant|3|||
170673859|NCT01817530|616817883|FG001|Overall Study|Subject Noncompliant|1|||
170673860|NCT01817530|616817884|FG002|Overall Study|Subject Noncompliant|0|||
170673861|NCT01817530|616817885|FG003|Overall Study|Subject Noncompliant|4|||
170673862|NCT01817530|616817886|FG004|Overall Study|Subject Noncompliant|0|||
170673863|NCT01817530|616817887|FG005|Overall Study|Subject Noncompliant|1|||
170673864|NCT01817530|616817888|FG006|Overall Study|Subject Noncompliant|1|||
170673865|NCT01817530|616817889|FG007|Overall Study|Subject Noncompliant|1|||
170673866|NCT01817530|616817882|FG000|Overall Study|Lack of Efficacy|1|||
170820277|NCT02660034|617349629|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
170820278|NCT02660034|617349630|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
170673867|NCT01817530|616817883|FG001|Overall Study|Lack of Efficacy|0|||
170673868|NCT01817530|616817884|FG002|Overall Study|Lack of Efficacy|0|||
170673869|NCT01817530|616817885|FG003|Overall Study|Lack of Efficacy|0|||
170673870|NCT01817530|616817886|FG004|Overall Study|Lack of Efficacy|0|||
170673871|NCT01817530|616817887|FG005|Overall Study|Lack of Efficacy|1|||
170628101|NCT02006472|616651935|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
170628102|NCT02006472|616651931|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
170628103|NCT02006472|616651932|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
170628104|NCT02006472|616651933|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
170628105|NCT02006472|616651934|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
170628106|NCT02006472|616651935|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
170673872|NCT01817530|616817888|FG006|Overall Study|Lack of Efficacy|0|||
170673873|NCT01817530|616817889|FG007|Overall Study|Lack of Efficacy|1|||
170673874|NCT01817530|616817882|FG000|Overall Study|Pregnancy|0|||
170673875|NCT01817530|616817883|FG001|Overall Study|Pregnancy|0|||
170673876|NCT01817530|616817884|FG002|Overall Study|Pregnancy|0|||
170673877|NCT01817530|616817885|FG003|Overall Study|Pregnancy|0|||
170673878|NCT01817530|616817886|FG004|Overall Study|Pregnancy|0|||
170673879|NCT01817530|616817887|FG005|Overall Study|Pregnancy|1|||
170673880|NCT01817530|616817888|FG006|Overall Study|Pregnancy|0|||
170673881|NCT01817530|616817889|FG007|Overall Study|Pregnancy|0|||
170673882|NCT01817530|616817882|FG000|Overall Study|Other|0|||
170673883|NCT01817530|616817883|FG001|Overall Study|Other|1|||
170673884|NCT01817530|616817884|FG002|Overall Study|Other|0|||
170673885|NCT01817530|616817885|FG003|Overall Study|Other|0|||
170673886|NCT01817530|616817886|FG004|Overall Study|Other|1|||
170673887|NCT01817530|616817887|FG005|Overall Study|Other|0|||
170673888|NCT01817530|616817888|FG006|Overall Study|Other|5|||
170673889|NCT01817530|616817889|FG007|Overall Study|Other|0|||
170673890|NCT01817530|616817882|FG000|Overall Study|Surgery or Invasive Intervention|1|||
170820279|NCT02660034|617349631|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
170820280|NCT02660034|617349632|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
170820281|NCT02660034|617349633|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
170820282|NCT02660034|617349634|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
170628107|NCT02006472|616651931|FG000|Period 2 (Through Week 52)|Other|0|||
170628108|NCT02006472|616651932|FG001|Period 2 (Through Week 52)|Other|1|||
170628109|NCT02006472|616651933|FG002|Period 2 (Through Week 52)|Other|0|||
170628110|NCT02006472|616651934|FG003|Period 2 (Through Week 52)|Other|1|||
170628111|NCT02006472|616651935|FG004|Period 2 (Through Week 52)|Other|0|||
170628112|NCT02006472|616651931|FG000|Period 2 (Through Week 52)|Not treated|0|||
170628113|NCT02006472|616651932|FG001|Period 2 (Through Week 52)|Not treated|0|||
170628114|NCT02006472|616651933|FG002|Period 2 (Through Week 52)|Not treated|2|||
170628115|NCT02006472|616651934|FG003|Period 2 (Through Week 52)|Not treated|0|||
170628116|NCT02006472|616651935|FG004|Period 2 (Through Week 52)|Not treated|0|||
170628117|NCT02006472|616651931|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
170628118|NCT02006472|616651932|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
170628119|NCT02006472|616651933|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
170628120|NCT02006472|616651934|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
170628121|NCT02006472|616651935|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
170628122|NCT02006472|616651931|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
170628123|NCT02006472|616651932|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
170628124|NCT02006472|616651933|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
170673891|NCT01817530|616817883|FG001|Overall Study|Surgery or Invasive Intervention|0|||
170673892|NCT01817530|616817884|FG002|Overall Study|Surgery or Invasive Intervention|0|||
170673893|NCT01817530|616817885|FG003|Overall Study|Surgery or Invasive Intervention|0|||
170673894|NCT01817530|616817886|FG004|Overall Study|Surgery or Invasive Intervention|1|||
170673895|NCT01817530|616817887|FG005|Overall Study|Surgery or Invasive Intervention|1|||
170673896|NCT01817530|616817888|FG006|Overall Study|Surgery or Invasive Intervention|1|||
170673897|NCT01817530|616817889|FG007|Overall Study|Surgery or Invasive Intervention|0|||
170673898|NCT01817530|616817882|FG000|Overall Study|Consent Withdrawn by Subject|3|||
170673899|NCT01817530|616817883|FG001|Overall Study|Consent Withdrawn by Subject|4|||
170820283|NCT02660034|617349635|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
170820284|NCT02660034|617349622|FG000|Overall Study|Progressive Disease (Clinical)|7|||
170820285|NCT02660034|617349623|FG001|Overall Study|Progressive Disease (Clinical)|8|||
170820286|NCT02660034|617349624|FG002|Overall Study|Progressive Disease (Clinical)|3|||
170820287|NCT02660034|617349625|FG003|Overall Study|Progressive Disease (Clinical)|9|||
170820288|NCT02660034|617349626|FG004|Overall Study|Progressive Disease (Clinical)|3|||
170820289|NCT02660034|617349627|FG005|Overall Study|Progressive Disease (Clinical)|0|||
170820290|NCT02660034|617349628|FG006|Overall Study|Progressive Disease (Clinical)|0|||
170820291|NCT02660034|617349629|FG007|Overall Study|Progressive Disease (Clinical)|0|||
170820292|NCT02660034|617349630|FG008|Overall Study|Progressive Disease (Clinical)|0|||
170673900|NCT01817530|616817884|FG002|Overall Study|Consent Withdrawn by Subject|7|||
170673901|NCT01817530|616817885|FG003|Overall Study|Consent Withdrawn by Subject|3|||
170673902|NCT01817530|616817886|FG004|Overall Study|Consent Withdrawn by Subject|5|||
170820293|NCT02660034|617349631|FG009|Overall Study|Progressive Disease (Clinical)|0|||
170820294|NCT02660034|617349632|FG010|Overall Study|Progressive Disease (Clinical)|0|||
170628125|NCT02006472|616651934|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
170628126|NCT02006472|616651935|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
170628127|NCT03379818|616651936|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
170628128|NCT03379818|616651937|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
170628129|NCT03379818|616651936|FG000|Overall Study|Withdrawal by Subject|2|||
170628130|NCT03379818|616651937|FG001|Overall Study|Withdrawal by Subject|3|||
170628131|NCT03379818|616651936|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
170628132|NCT03379818|616651937|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
170628133|NCT02531802|616651938|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
170628134|NCT02531802|616651939|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
170628135|NCT02531802|616651940|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
170628136|NCT02531802|616651941|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
170628137|NCT02531802|616651942|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
170628138|NCT02531802|616651943|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
170628139|NCT02531802|616651944|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
170628140|NCT02531802|616651945|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
170628141|NCT02531802|616651946|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
170628142|NCT02531802|616651947|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
170628143|NCT02531802|616651948|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
170628144|NCT02531802|616651949|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
170628145|NCT02531802|616651950|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
170628146|NCT02531802|616651951|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
170628147|NCT02531802|616651952|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
170628148|NCT02531802|616651953|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
170628149|NCT02531802|616651954|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
170628150|NCT02531802|616651955|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
170628151|NCT02531802|616651956|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
170628152|NCT02531802|616651957|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
170628153|NCT02531802|616651958|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
170628154|NCT02531802|616651938|FG000|Received Vaccination 2|Physician Decision|0|||
170628155|NCT02531802|616651939|FG001|Received Vaccination 2|Physician Decision|0|||
170628156|NCT02531802|616651940|FG002|Received Vaccination 2|Physician Decision|0|||
170628157|NCT02531802|616651941|FG003|Received Vaccination 2|Physician Decision|0|||
170628158|NCT02531802|616651942|FG004|Received Vaccination 2|Physician Decision|0|||
170628159|NCT02531802|616651943|FG005|Received Vaccination 2|Physician Decision|1|||
170673903|NCT01817530|616817887|FG005|Overall Study|Consent Withdrawn by Subject|3|||
170673904|NCT01817530|616817888|FG006|Overall Study|Consent Withdrawn by Subject|3|||
170673905|NCT01817530|616817889|FG007|Overall Study|Consent Withdrawn by Subject|10|||
170673906|NCT01817530|616817882|FG000|Overall Study|Lost to Follow-up|1|||
170673907|NCT01817530|616817883|FG001|Overall Study|Lost to Follow-up|4|||
170673908|NCT01817530|616817884|FG002|Overall Study|Lost to Follow-up|2|||
170673909|NCT01817530|616817885|FG003|Overall Study|Lost to Follow-up|1|||
170673910|NCT01817530|616817886|FG004|Overall Study|Lost to Follow-up|3|||
170673911|NCT01817530|616817887|FG005|Overall Study|Lost to Follow-up|2|||
170673912|NCT01817530|616817888|FG006|Overall Study|Lost to Follow-up|8|||
170673913|NCT01817530|616817889|FG007|Overall Study|Lost to Follow-up|4|||
170673914|NCT00873912|616817891|FG000|Overall Study|Withdrawal by Subject|1|||
170673915|NCT00873912|616817892|FG001|Overall Study|Withdrawal by Subject|0|||
170673916|NCT00873912|616817891|FG000|Overall Study|Lost to Follow-up|2|||
170673917|NCT00873912|616817892|FG001|Overall Study|Lost to Follow-up|0|||
170673918|NCT05570500|616817895|FG000|Overall Study|Lost to Follow-up|7|||
170673919|NCT05570500|616817896|FG001|Overall Study|Lost to Follow-up|5|||
170673920|NCT01095731|616817897|FG000|Overall Study|Protocol Violation|1|||
170673921|NCT01095731|616817898|FG001|Overall Study|Protocol Violation|1|||
170673922|NCT01095731|616817897|FG000|Overall Study|Withdrawal by Subject|0|||
170673923|NCT01095731|616817898|FG001|Overall Study|Withdrawal by Subject|1|||
170820295|NCT02660034|617349633|FG011|Overall Study|Progressive Disease (Clinical)|0|||
170820296|NCT02660034|617349634|FG012|Overall Study|Progressive Disease (Clinical)|0|||
170628160|NCT02531802|616651944|FG006|Received Vaccination 2|Physician Decision|0|||
170628161|NCT02531802|616651945|FG007|Received Vaccination 2|Physician Decision|0|||
170628162|NCT02531802|616651946|FG008|Received Vaccination 2|Physician Decision|0|||
170628163|NCT02531802|616651947|FG009|Received Vaccination 2|Physician Decision|2|||
170628164|NCT02531802|616651948|FG010|Received Vaccination 2|Physician Decision|0|||
170628165|NCT02531802|616651949|FG011|Received Vaccination 2|Physician Decision|0|||
170628166|NCT02531802|616651950|FG012|Received Vaccination 2|Physician Decision|0|||
170628167|NCT02531802|616651951|FG013|Received Vaccination 2|Physician Decision|1|||
170628168|NCT02531802|616651952|FG014|Received Vaccination 2|Physician Decision|0|||
170628169|NCT02531802|616651953|FG015|Received Vaccination 2|Physician Decision|0|||
170628170|NCT02531802|616651954|FG016|Received Vaccination 2|Physician Decision|0|||
170673924|NCT01389817|616819604|FG000|Overall Study|Physician Decision|1|||
170673925|NCT01389817|616819605|FG001|Overall Study|Physician Decision|0|||
170820297|NCT02660034|617349635|FG013|Overall Study|Progressive Disease (Clinical)|0|||
170820298|NCT02660034|617349622|FG000|Overall Study|Lost to Follow-up|0|||
170628171|NCT02531802|616651955|FG017|Received Vaccination 2|Physician Decision|1|||
170673926|NCT01389817|616819604|FG000|Overall Study|Lost to Follow-up|1|||
170673927|NCT01389817|616819605|FG001|Overall Study|Lost to Follow-up|0|||
170673928|NCT01389817|616819604|FG000|Overall Study|Withdrawal by Subject|2|||
170673929|NCT01389817|616819605|FG001|Overall Study|Withdrawal by Subject|0|||
170673930|NCT01749137|616819606|FG000|Overall Study|Adverse Event|4|||
170673931|NCT01749137|616819607|FG001|Overall Study|Adverse Event|4|||
170673932|NCT01749137|616819606|FG000|Overall Study|Lost to Follow-up|2|||
170673933|NCT01749137|616819607|FG001|Overall Study|Lost to Follow-up|3|||
170673934|NCT01749137|616819606|FG000|Overall Study|Physician Decision|1|||
170673935|NCT01749137|616819607|FG001|Overall Study|Physician Decision|0|||
170673936|NCT01749137|616819606|FG000|Overall Study|Withdrawal by Subject|8|||
170673937|NCT01749137|616819607|FG001|Overall Study|Withdrawal by Subject|4|||
170673938|NCT01976338|616819616|FG000|Overall Study|Physician Decision|0|||
170673939|NCT01976338|616819617|FG001|Overall Study|Physician Decision|1|||
170673940|NCT01976338|616819616|FG000|Overall Study|Lost to Follow-up|3|||
170673941|NCT01976338|616819617|FG001|Overall Study|Lost to Follow-up|0|||
170673942|NCT01976338|616819616|FG000|Overall Study|Withdrawal by Subject|5|||
170673943|NCT01976338|616819617|FG001|Overall Study|Withdrawal by Subject|2|||
170673944|NCT01976338|616819616|FG000|Overall Study|Adverse Event|5|||
170673945|NCT01976338|616819617|FG001|Overall Study|Adverse Event|1|||
170673946|NCT01471171|616819618|FG000|Treatment Period 1|Adverse Event|4|||
170673947|NCT01471171|616819619|FG001|Treatment Period 1|Adverse Event|1|||
170673948|NCT01471171|616819618|FG000|Treatment Period 2|Adverse Event|1|||
170673949|NCT01471171|616819619|FG001|Treatment Period 2|Adverse Event|0|||
170673950|NCT04189081|616819620|FG000|Overall Study|Lost to Follow-up|1|||
170673951|NCT04189081|616819621|FG001|Overall Study|Lost to Follow-up|0|||
170673952|NCT04189081|616819622|FG002|Overall Study|Lost to Follow-up|0|||
170673953|NCT04189081|616819620|FG000|Overall Study|Withdrawal by Subject|0|||
170673954|NCT04189081|616819621|FG001|Overall Study|Withdrawal by Subject|0|||
170673955|NCT04189081|616819622|FG002|Overall Study|Withdrawal by Subject|1|||
170673956|NCT00705484|616819628|FG000|Overall Study|Adverse Event|28|||
170673957|NCT00705484|616819629|FG001|Overall Study|Adverse Event|27|||
170673958|NCT00705484|616819628|FG000|Overall Study|Lost to Follow-up|169|||
170673959|NCT00705484|616819629|FG001|Overall Study|Lost to Follow-up|250|||
170673960|NCT00705484|616819628|FG000|Overall Study|Withdrawal by Subject|96|||
170673961|NCT00705484|616819629|FG001|Overall Study|Withdrawal by Subject|72|||
170673962|NCT00705484|616819628|FG000|Overall Study|Administrative|89|||
170673963|NCT00705484|616819629|FG001|Overall Study|Administrative|59|||
170673964|NCT00444912|616819630|FG000|Overall Study|Death|1|||
170673965|NCT00444912|616819631|FG001|Overall Study|Death|2|||
170673966|NCT00444912|616819630|FG000|Overall Study|Lost to Follow-up|1|||
170673967|NCT00444912|616819631|FG001|Overall Study|Lost to Follow-up|0|||
170673968|NCT00444912|616819630|FG000|Overall Study|Participant Failed Mobilization|1|||
170673969|NCT00444912|616819631|FG001|Overall Study|Participant Failed Mobilization|0|||
170673970|NCT03758066|616819632|FG000|Overall Study|Lost to Follow-up|14|||
170673971|NCT02499783|616819634|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
170673972|NCT02499783|616819635|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
170673973|NCT02499783|616819636|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
170673974|NCT02499783|616819634|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
170673975|NCT02499783|616819635|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
170673976|NCT02499783|616819636|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
170673977|NCT02499783|616819634|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
170673978|NCT02499783|616819635|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
170673979|NCT02499783|616819636|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
170673980|NCT02499783|616819634|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
170673981|NCT02499783|616819635|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
170673982|NCT02499783|616819636|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
170673983|NCT02499783|616819634|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
170673984|NCT02499783|616819635|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
170673985|NCT02499783|616819636|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
170673986|NCT02499783|616819634|FG000|DB Period: Weeks 0-8|Other|1|||
170673987|NCT02499783|616819635|FG001|DB Period: Weeks 0-8|Other|1|||
170673988|NCT02499783|616819636|FG002|DB Period: Weeks 0-8|Other|0|||
170673989|NCT02499783|616819634|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
170673990|NCT02499783|616819635|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
170673991|NCT02499783|616819636|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
170673992|NCT02499783|616819634|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
170673993|NCT02499783|616819635|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
170673994|NCT02499783|616819636|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
170673995|NCT02499783|616819634|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
170673996|NCT02499783|616819635|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
170673997|NCT02499783|616819636|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
170673998|NCT02499783|616819634|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
170673999|NCT02499783|616819635|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
170674000|NCT02499783|616819636|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
170674001|NCT01243892|616819637|FG000|Overall Study|Did not meet eligibility criteria|2|||
170674002|NCT01243892|616819638|FG001|Overall Study|Did not meet eligibility criteria|0|||
170674003|NCT00119106|616819639|FG000|Overall Study|HIV infected at baseline|179|||
170674004|NCT00119106|616819640|FG001|Overall Study|HIV infected at baseline|178|||
170674005|NCT01866293|616819641|FG000|Overall Study|Adverse Event|2|||
170674006|NCT00730132|616819643|FG000|Overall Study|Protocol Violation|154|||
170674007|NCT00730132|616819643|FG000|Overall Study|Death|1|||
170674008|NCT03982368|616819644|FG000|Overall Study|Adverse Event|6|||
170674009|NCT03982368|616819645|FG001|Overall Study|Adverse Event|4|||
170674010|NCT03982368|616819646|FG002|Overall Study|Adverse Event|3|||
170674011|NCT03982368|616819644|FG000|Overall Study|Lost to Follow-up|2|||
170674012|NCT03982368|616819645|FG001|Overall Study|Lost to Follow-up|1|||
170674013|NCT03982368|616819646|FG002|Overall Study|Lost to Follow-up|0|||
170674014|NCT03982368|616819644|FG000|Overall Study|Withdrawal by Subject|1|||
170674015|NCT03982368|616819645|FG001|Overall Study|Withdrawal by Subject|2|||
170674016|NCT03982368|616819646|FG002|Overall Study|Withdrawal by Subject|0|||
170674017|NCT03982368|616819644|FG000|Overall Study|unknow|4|||
170674018|NCT03982368|616819645|FG001|Overall Study|unknow|0|||
170674019|NCT03982368|616819646|FG002|Overall Study|unknow|2|||
170674020|NCT03570697|616819647|FG000|Overall Study|Lost to Follow-up|0|||
170674021|NCT03570697|616819648|FG001|Overall Study|Lost to Follow-up|1|||
170674022|NCT03570697|616819647|FG000|Overall Study|Death|2|||
170674023|NCT03570697|616819648|FG001|Overall Study|Death|0|||
170674024|NCT03570697|616819647|FG000|Overall Study|Withdrawal by Subject|4|||
170674025|NCT03570697|616819648|FG001|Overall Study|Withdrawal by Subject|2|||
170674026|NCT00518284|616819649|FG000|Overall Study|Adverse Event|0|||
170674027|NCT00518284|616819650|FG001|Overall Study|Adverse Event|1|||
170674028|NCT00518284|616819651|FG002|Overall Study|Adverse Event|0|||
170674029|NCT00518284|616819652|FG003|Overall Study|Adverse Event|0|||
170674030|NCT00518284|616819649|FG000|Overall Study|Study Termination|0|||
170674031|NCT00518284|616819650|FG001|Overall Study|Study Termination|2|||
170674032|NCT00518284|616819651|FG002|Overall Study|Study Termination|1|||
170674033|NCT00518284|616819652|FG003|Overall Study|Study Termination|2|||
170674034|NCT01849783|616819653|FG000|Overall Study|Adverse Event|5|||
170674035|NCT01849783|616819653|FG000|Overall Study|Death|2|||
170674036|NCT01849783|616819653|FG000|Overall Study|Physician Decision|1|||
170674037|NCT01849783|616819653|FG000|Overall Study|Withdrawal by Subject|1|||
170674038|NCT01849783|616819653|FG000|Overall Study|Unable to comply|2|||
170674039|NCT01849783|616819653|FG000|Overall Study|Disease progression|11|||
170674040|NCT02571777|616819657|FG000|Overall Study|Subject/guardian decision|34|||
170674041|NCT02571777|616819658|FG001|Overall Study|Subject/guardian decision|26|||
170674042|NCT02571777|616819659|FG002|Overall Study|Subject/guardian decision|26|||
170674043|NCT02571777|616819660|FG003|Overall Study|Subject/guardian decision|25|||
170674044|NCT02571777|616819661|FG004|Overall Study|Subject/guardian decision|27|||
170674045|NCT02571777|616819657|FG000|Overall Study|Protocol Deviation|2|||
170674046|NCT02571777|616819658|FG001|Overall Study|Protocol Deviation|3|||
170674047|NCT02571777|616819659|FG002|Overall Study|Protocol Deviation|4|||
170674048|NCT02571777|616819660|FG003|Overall Study|Protocol Deviation|8|||
170674049|NCT02571777|616819661|FG004|Overall Study|Protocol Deviation|4|||
170674050|NCT02571777|616819657|FG000|Overall Study|Death|1|||
170674051|NCT02571777|616819658|FG001|Overall Study|Death|1|||
170674052|NCT02571777|616819659|FG002|Overall Study|Death|4|||
170674053|NCT02571777|616819660|FG003|Overall Study|Death|0|||
170674054|NCT02571777|616819661|FG004|Overall Study|Death|0|||
170674055|NCT02571777|616819657|FG000|Overall Study|Lost to Follow-up|1|||
170674056|NCT02571777|616819658|FG001|Overall Study|Lost to Follow-up|1|||
170674057|NCT02571777|616819659|FG002|Overall Study|Lost to Follow-up|2|||
170674058|NCT02571777|616819660|FG003|Overall Study|Lost to Follow-up|0|||
170674059|NCT02571777|616819661|FG004|Overall Study|Lost to Follow-up|1|||
170674060|NCT02571777|616819657|FG000|Overall Study|Physician Decision|1|||
170674061|NCT02571777|616819658|FG001|Overall Study|Physician Decision|7|||
170674062|NCT02571777|616819659|FG002|Overall Study|Physician Decision|5|||
170674063|NCT02571777|616819660|FG003|Overall Study|Physician Decision|2|||
170674064|NCT02571777|616819661|FG004|Overall Study|Physician Decision|4|||
170674065|NCT02571777|616819657|FG000|Overall Study|Pregnancy|0|||
170674066|NCT02571777|616819658|FG001|Overall Study|Pregnancy|0|||
170674067|NCT02571777|616819659|FG002|Overall Study|Pregnancy|0|||
170674068|NCT02571777|616819660|FG003|Overall Study|Pregnancy|2|||
170674069|NCT02571777|616819661|FG004|Overall Study|Pregnancy|0|||
170674070|NCT03173313|616819662|FG000|Overall Study|Lost to Follow-up|2|||
170674071|NCT03173313|616819663|FG001|Overall Study|Lost to Follow-up|3|||
170674072|NCT03173313|616819662|FG000|Overall Study|Withdrawal by Subject|0|||
170674073|NCT03173313|616819663|FG001|Overall Study|Withdrawal by Subject|1|||
170674074|NCT03173313|616819662|FG000|Overall Study|Death|5|||
170674075|NCT03173313|616819663|FG001|Overall Study|Death|0|||
170674076|NCT03173313|616819662|FG000|Overall Study|Physician Decision|1|||
170674077|NCT03173313|616819663|FG001|Overall Study|Physician Decision|0|||
170674078|NCT03173313|616819662|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
170674079|NCT03173313|616819663|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
170674080|NCT03173313|616819662|FG000|Overall Study|Bone Fracture|1|||
170674081|NCT03173313|616819663|FG001|Overall Study|Bone Fracture|0|||
170674082|NCT01876420|616819664|FG000|Overall Study|Missed 30 day visit|1|||
170674083|NCT03706079|616819665|FG000|Predecessor Study|Death|0|||
170674084|NCT03706079|616819666|FG001|Predecessor Study|Death|2|||
170674085|NCT03706079|616819667|FG002|Predecessor Study|Death|0|||
170674086|NCT03706079|616819668|FG003|Predecessor Study|Death|1|||
170674087|NCT03706079|616819669|FG004|Predecessor Study|Death|0|||
170674088|NCT03706079|616819670|FG005|Predecessor Study|Death|0|||
170674089|NCT03706079|616819665|FG000|Predecessor Study|Lost to Follow-up|5|||
170674090|NCT03706079|616819666|FG001|Predecessor Study|Lost to Follow-up|2|||
170674091|NCT03706079|616819667|FG002|Predecessor Study|Lost to Follow-up|0|||
170674092|NCT03706079|616819668|FG003|Predecessor Study|Lost to Follow-up|0|||
170674093|NCT03706079|616819669|FG004|Predecessor Study|Lost to Follow-up|1|||
170674094|NCT03706079|616819670|FG005|Predecessor Study|Lost to Follow-up|0|||
170674095|NCT03706079|616819665|FG000|Predecessor Study|Withdrawal by Subject|8|||
170674096|NCT03706079|616819666|FG001|Predecessor Study|Withdrawal by Subject|15|||
170674097|NCT03706079|616819667|FG002|Predecessor Study|Withdrawal by Subject|0|||
170674098|NCT03706079|616819668|FG003|Predecessor Study|Withdrawal by Subject|5|||
170674099|NCT03706079|616819669|FG004|Predecessor Study|Withdrawal by Subject|2|||
170674100|NCT03706079|616819670|FG005|Predecessor Study|Withdrawal by Subject|0|||
170674101|NCT03706079|616819665|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
170674102|NCT03706079|616819666|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
170674103|NCT03706079|616819667|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
170674104|NCT03706079|616819668|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
170674105|NCT03706079|616819669|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
170674106|NCT03706079|616819670|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
170674107|NCT03706079|616819665|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
170674108|NCT03706079|616819666|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
170674109|NCT03706079|616819667|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
170674110|NCT03706079|616819668|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
170674111|NCT03706079|616819669|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
170674112|NCT03706079|616819670|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
170674113|NCT03706079|616819665|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
170674114|NCT03706079|616819666|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
170674115|NCT03706079|616819667|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
170674116|NCT03706079|616819668|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
170674117|NCT03706079|616819669|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
170674118|NCT03706079|616819670|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
170674119|NCT03706079|616819665|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
170674120|NCT03706079|616819666|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
170674121|NCT03706079|616819667|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
170674122|NCT03706079|616819668|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
170674123|NCT03706079|616819669|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
170674124|NCT03706079|616819670|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
170674125|NCT03706079|616819665|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
170674126|NCT03706079|616819666|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
170674127|NCT03706079|616819667|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
170674128|NCT03706079|616819668|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
170674129|NCT03706079|616819669|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
170674130|NCT03706079|616819670|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
170674131|NCT03706079|616819665|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
170674132|NCT03706079|616819666|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
170674133|NCT03706079|616819667|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
170674134|NCT03706079|616819668|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
170674135|NCT03706079|616819669|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
170674136|NCT03706079|616819670|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
170674137|NCT03706079|616819665|FG000|Long Term Extension (DESTINATION)|Death|8|||
170674138|NCT03706079|616819666|FG001|Long Term Extension (DESTINATION)|Death|2|||
170674139|NCT03706079|616819667|FG002|Long Term Extension (DESTINATION)|Death|2|||
170674140|NCT03706079|616819668|FG003|Long Term Extension (DESTINATION)|Death|1|||
170674141|NCT03706079|616819669|FG004|Long Term Extension (DESTINATION)|Death|0|||
170674142|NCT03706079|616819670|FG005|Long Term Extension (DESTINATION)|Death|0|||
170674143|NCT03851705|616819677|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
170674144|NCT03851705|616819678|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
170674145|NCT03851705|616819679|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
170674146|NCT03851705|616819680|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
170674147|NCT03851705|616819677|FG000|Part 1: Double-Blind Period|Other reason|1|||
170628172|NCT02531802|616651956|FG018|Received Vaccination 2|Physician Decision|0|||
170628173|NCT02531802|616651957|FG019|Received Vaccination 2|Physician Decision|0|||
170628174|NCT02531802|616651958|FG020|Received Vaccination 2|Physician Decision|0|||
170628175|NCT02531802|616651938|FG000|Received Vaccination 2|Adverse Event|0|||
170628176|NCT02531802|616651939|FG001|Received Vaccination 2|Adverse Event|0|||
170628177|NCT02531802|616651940|FG002|Received Vaccination 2|Adverse Event|0|||
170628178|NCT02531802|616651941|FG003|Received Vaccination 2|Adverse Event|0|||
170628179|NCT02531802|616651942|FG004|Received Vaccination 2|Adverse Event|0|||
170628180|NCT02531802|616651943|FG005|Received Vaccination 2|Adverse Event|2|||
170628181|NCT02531802|616651944|FG006|Received Vaccination 2|Adverse Event|0|||
170628182|NCT02531802|616651945|FG007|Received Vaccination 2|Adverse Event|0|||
170628183|NCT02531802|616651946|FG008|Received Vaccination 2|Adverse Event|0|||
170628184|NCT02531802|616651947|FG009|Received Vaccination 2|Adverse Event|0|||
170628185|NCT02531802|616651948|FG010|Received Vaccination 2|Adverse Event|0|||
170628186|NCT02531802|616651949|FG011|Received Vaccination 2|Adverse Event|0|||
170628187|NCT02531802|616651950|FG012|Received Vaccination 2|Adverse Event|0|||
170628188|NCT02531802|616651951|FG013|Received Vaccination 2|Adverse Event|0|||
170628189|NCT02531802|616651952|FG014|Received Vaccination 2|Adverse Event|0|||
170628190|NCT02531802|616651953|FG015|Received Vaccination 2|Adverse Event|0|||
170628191|NCT02531802|616651954|FG016|Received Vaccination 2|Adverse Event|0|||
170628192|NCT02531802|616651955|FG017|Received Vaccination 2|Adverse Event|2|||
170628193|NCT02531802|616651956|FG018|Received Vaccination 2|Adverse Event|1|||
170628194|NCT02531802|616651957|FG019|Received Vaccination 2|Adverse Event|0|||
170628195|NCT02531802|616651958|FG020|Received Vaccination 2|Adverse Event|1|||
170628196|NCT02531802|616651938|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
170628197|NCT02531802|616651939|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
170628198|NCT02531802|616651940|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
170628199|NCT02531802|616651941|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
170628200|NCT02531802|616651942|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
170628201|NCT02531802|616651943|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
170628202|NCT02531802|616651944|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
170628203|NCT02531802|616651945|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
170628204|NCT02531802|616651946|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
170628205|NCT02531802|616651947|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
170628206|NCT02531802|616651948|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
170628207|NCT02531802|616651949|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
170628208|NCT02531802|616651950|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
170628209|NCT02531802|616651951|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
170628210|NCT02531802|616651952|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
170628211|NCT02531802|616651953|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
170628212|NCT02531802|616651954|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
170628213|NCT02531802|616651955|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
170628214|NCT02531802|616651956|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
170628215|NCT02531802|616651957|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
170628216|NCT02531802|616651958|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
170628217|NCT01780506|616651959|FG000|Double-Blind Phase|Randomized but not Treated|3|||
170628218|NCT01780506|616651960|FG001|Double-Blind Phase|Randomized but not Treated|2|||
170628219|NCT01780506|616651959|FG000|Double-Blind Phase|Adverse Event|4|||
170628220|NCT01780506|616651960|FG001|Double-Blind Phase|Adverse Event|14|||
170628221|NCT01780506|616651959|FG000|Double-Blind Phase|Death|1|||
170628222|NCT01780506|616651960|FG001|Double-Blind Phase|Death|2|||
170628223|NCT01780506|616651959|FG000|Double-Blind Phase|Pregnancy|2|||
170628224|NCT01780506|616651960|FG001|Double-Blind Phase|Pregnancy|1|||
170628225|NCT01780506|616651959|FG000|Double-Blind Phase|Lack of Efficacy|1|||
170628226|NCT01780506|616651960|FG001|Double-Blind Phase|Lack of Efficacy|1|||
170628227|NCT01780506|616651959|FG000|Double-Blind Phase|Investigator's Discretion|5|||
170674148|NCT03851705|616819678|FG001|Part 1: Double-Blind Period|Other reason|0|||
170674149|NCT03851705|616819679|FG002|Part 1: Double-Blind Period|Other reason|0|||
170674150|NCT03851705|616819680|FG003|Part 1: Double-Blind Period|Other reason|0|||
170674151|NCT03851705|616819677|FG000|Part 2: Open-Label Period|Other reason|0|||
170674152|NCT03851705|616819678|FG001|Part 2: Open-Label Period|Other reason|0|||
170674153|NCT03851705|616819679|FG002|Part 2: Open-Label Period|Other reason|0|||
170628228|NCT01780506|616651960|FG001|Double-Blind Phase|Investigator's Discretion|2|||
170628229|NCT01780506|616651959|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
170674154|NCT03851705|616819680|FG003|Part 2: Open-Label Period|Other reason|1|||
170674155|NCT03851705|616819677|FG000|Part 2: Open-Label Period|Death|0|||
170674156|NCT03851705|616819678|FG001|Part 2: Open-Label Period|Death|0|||
170674157|NCT03851705|616819679|FG002|Part 2: Open-Label Period|Death|3|||
170628230|NCT01780506|616651960|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
170628231|NCT01780506|616651959|FG000|Double-Blind Phase|Protocol Violation|4|||
170628232|NCT01780506|616651960|FG001|Double-Blind Phase|Protocol Violation|3|||
170628233|NCT01780506|616651959|FG000|Double-Blind Phase|Withdrew Consent|23|||
170628234|NCT01780506|616651960|FG001|Double-Blind Phase|Withdrew Consent|24|||
170628235|NCT01780506|616651959|FG000|Double-Blind Phase|Lost to Follow-up|23|||
170674158|NCT03851705|616819680|FG003|Part 2: Open-Label Period|Death|0|||
170674159|NCT03851705|616819677|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
170674160|NCT03851705|616819678|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
170674161|NCT03851705|616819679|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
170674162|NCT03851705|616819680|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
170674163|NCT00621582|616819681|FG000|Overall Study|Adverse Event|7|||
170674164|NCT00621582|616819681|FG000|Overall Study|Protocol Violation|57|||
170674165|NCT00621582|616819681|FG000|Overall Study|Lost to Follow-up|24|||
170674166|NCT00621582|616819681|FG000|Overall Study|issues not identified by investigators|18|||
170674167|NCT01042678|616819682|FG000|Overall Study|Physician Decision|1|||
170674168|NCT01042678|616819683|FG001|Overall Study|Physician Decision|0|||
170674169|NCT01042678|616819684|FG002|Overall Study|Physician Decision|0|||
170674170|NCT01042678|616819685|FG003|Overall Study|Physician Decision|0|||
170674171|NCT01042678|616819686|FG004|Overall Study|Physician Decision|0|||
170674172|NCT01042678|616819687|FG005|Overall Study|Physician Decision|0|||
170674173|NCT00913497|616819694|FG000|Overall Study|Adverse Event|1|||
170674174|NCT00913497|616819694|FG000|Overall Study|Withdrawal by Subject|2|||
170674175|NCT01306942|616819695|FG000|Phase I|Adverse Event|2|||
170674176|NCT01306942|616819696|FG001|Phase I|Adverse Event|2|||
170674177|NCT01306942|616819697|FG002|Phase I|Adverse Event|0|||
170674178|NCT01306942|616819698|FG003|Phase I|Adverse Event|0|||
170674179|NCT01306942|616819695|FG000|Phase I|Physician Decision|3|||
170674180|NCT01306942|616819696|FG001|Phase I|Physician Decision|1|||
170674181|NCT01306942|616819697|FG002|Phase I|Physician Decision|0|||
170628236|NCT01780506|616651960|FG001|Double-Blind Phase|Lost to Follow-up|26|||
170628237|NCT01780506|616651959|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
170628238|NCT01780506|616651960|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
170628239|NCT02224560|616651964|FG000|Overall Study|Protocol Deviation|1|||
170628240|NCT02224560|616651965|FG001|Overall Study|Protocol Deviation|0|||
170628241|NCT02224560|616651966|FG002|Overall Study|Protocol Deviation|0|||
170628242|NCT02224560|616651964|FG000|Overall Study|Withdrawal by Subject|2|||
170628243|NCT02224560|616651965|FG001|Overall Study|Withdrawal by Subject|0|||
170628244|NCT02224560|616651966|FG002|Overall Study|Withdrawal by Subject|1|||
170628245|NCT02224560|616651964|FG000|Overall Study|Met Withdrawal Criteria|1|||
170628246|NCT02224560|616651965|FG001|Overall Study|Met Withdrawal Criteria|0|||
170628247|NCT02224560|616651966|FG002|Overall Study|Met Withdrawal Criteria|0|||
170628248|NCT02224560|616651964|FG000|Overall Study|Adverse Event|4|||
170628249|NCT02224560|616651965|FG001|Overall Study|Adverse Event|1|||
170628250|NCT02224560|616651966|FG002|Overall Study|Adverse Event|1|||
170628251|NCT02224560|616651964|FG000|Overall Study|Withdrawn by Investigator|1|||
170628252|NCT02224560|616651965|FG001|Overall Study|Withdrawn by Investigator|1|||
170628253|NCT02224560|616651966|FG002|Overall Study|Withdrawn by Investigator|0|||
170628254|NCT00728689|616651967|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
170820299|NCT02660034|617349623|FG001|Overall Study|Lost to Follow-up|0|||
170628255|NCT00728689|616651968|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
170628256|NCT01523366|616651969|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170628257|NCT01523366|616651970|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170628258|NCT01523366|616651969|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
170674182|NCT01306942|616819698|FG003|Phase I|Physician Decision|0|||
170674183|NCT01306942|616819695|FG000|Phase II|Adverse Event|0|||
170628259|NCT01523366|616651970|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
170628260|NCT02461758|616651971|FG000|Overall Study|Lost to Follow-up|0|||
170628261|NCT02461758|616651972|FG001|Overall Study|Lost to Follow-up|1|||
170628262|NCT02461758|616651973|FG002|Overall Study|Lost to Follow-up|1|||
170628263|NCT02461758|616651974|FG003|Overall Study|Lost to Follow-up|0|||
170628264|NCT04030143|616651978|FG000|Overall Study|Adverse Event|5|||
170628265|NCT04030143|616651979|FG001|Overall Study|Adverse Event|10|||
170628266|NCT04030143|616651978|FG000|Overall Study|Lost to Follow-up|3|||
170628267|NCT04030143|616651979|FG001|Overall Study|Lost to Follow-up|7|||
170628268|NCT04030143|616651978|FG000|Overall Study|Protocol Deviation|2|||
170628269|NCT04030143|616651979|FG001|Overall Study|Protocol Deviation|2|||
170628270|NCT04030143|616651978|FG000|Overall Study|Withdrawal by Subject|16|||
170628271|NCT04030143|616651979|FG001|Overall Study|Withdrawal by Subject|18|||
170628272|NCT04030143|616651978|FG000|Overall Study|Physician Decision|1|||
170628273|NCT04030143|616651979|FG001|Overall Study|Physician Decision|1|||
170628274|NCT04030143|616651978|FG000|Overall Study|Due to Covid-19|2|||
170628275|NCT04030143|616651979|FG001|Overall Study|Due to Covid-19|3|||
170628276|NCT04030143|616651978|FG000|Overall Study|Not Due to Covid-19|1|||
170628277|NCT04030143|616651979|FG001|Overall Study|Not Due to Covid-19|1|||
170628278|NCT04852302|616651986|FG000|Overall Study|Withdrawal by Subject|2|||
170628279|NCT04852302|616651986|FG000|Overall Study|Did not complete CALM therapy.|2|||
170628280|NCT04011540|616651992|FG000|Overall Study|Lost to Follow-up|9|||
170628281|NCT04011540|616651993|FG001|Overall Study|Lost to Follow-up|6|||
170628282|NCT00551642|616651998|FG000|Treatment Period|Protocol Deviation|6|||
170628283|NCT00551642|616651999|FG001|Treatment Period|Protocol Deviation|11|||
170628284|NCT00551642|616651998|FG000|Treatment Period|Delivery device failure|1|||
170628285|NCT00551642|616651999|FG001|Treatment Period|Delivery device failure|3|||
170628286|NCT00551642|616651998|FG000|Treatment Period|Physician Decision|0|||
170628287|NCT00551642|616651999|FG001|Treatment Period|Physician Decision|1|||
170628288|NCT00551642|616651998|FG000|Treatment Period|Death|33|||
170628289|NCT00551642|616651999|FG001|Treatment Period|Death|31|||
170628290|NCT00551642|616651998|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
170628291|NCT00551642|616651999|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
170628292|NCT00551642|616651998|FG000|Treatment Period|Adverse Event|15|||
170628293|NCT00551642|616651999|FG001|Treatment Period|Adverse Event|12|||
170628294|NCT00551642|616651998|FG000|Treatment Period|Withdrawal by Subject|2|||
170628295|NCT00551642|616651999|FG001|Treatment Period|Withdrawal by Subject|1|||
170628296|NCT00283296|616652000|FG000|Overall Study|in-home trial not completed|5|||
170628297|NCT03043313|616652003|FG000|Overall Study|Withdrawal by Subject|5|||
170628298|NCT03043313|616652004|FG001|Overall Study|Withdrawal by Subject|1|||
170628299|NCT03043313|616652005|FG002|Overall Study|Withdrawal by Subject|1|||
170628300|NCT03043313|616652003|FG000|Overall Study|Lost to Follow-up|1|||
170628301|NCT03043313|616652004|FG001|Overall Study|Lost to Follow-up|1|||
170628302|NCT03043313|616652005|FG002|Overall Study|Lost to Follow-up|0|||
170628303|NCT03043313|616652003|FG000|Overall Study|Death|28|||
170628304|NCT03043313|616652004|FG001|Overall Study|Death|26|||
170628305|NCT03043313|616652005|FG002|Overall Study|Death|17|||
170628306|NCT03043313|616652003|FG000|Overall Study|Participation terminated by sponsor|11|||
170628307|NCT03043313|616652004|FG001|Overall Study|Participation terminated by sponsor|13|||
170628308|NCT03043313|616652005|FG002|Overall Study|Participation terminated by sponsor|13|||
170628309|NCT03155724|616652006|FG000|Overall Study|Death|3|||
170628310|NCT03155724|616652006|FG000|Overall Study|Physician Decision|1|||
170628311|NCT03155724|616652006|FG000|Overall Study|Study closure|7|||
170628312|NCT02059278|616652008|FG000|Overall Study|Adverse Event|1|||
170628313|NCT02059278|616652009|FG001|Overall Study|Adverse Event|1|||
170628314|NCT02059278|616652008|FG000|Overall Study|Lost to Follow-up|1|||
170628315|NCT02059278|616652009|FG001|Overall Study|Lost to Follow-up|0|||
170628316|NCT02059278|616652008|FG000|Overall Study|Withdrawal by Subject|0|||
170628317|NCT02059278|616652009|FG001|Overall Study|Withdrawal by Subject|3|||
170628318|NCT02059278|616652008|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
170628319|NCT02059278|616652009|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
170628320|NCT01488890|616652010|FG000|Overall Study|Serious adverse event|2|||
170628321|NCT01488890|616652011|FG001|Overall Study|Serious adverse event|0|||
170628322|NCT01488890|616652012|FG002|Overall Study|Serious adverse event|0|||
170628323|NCT01488890|616652013|FG003|Overall Study|Serious adverse event|0|||
170628324|NCT01488890|616652010|FG000|Overall Study|Protocol Violation|3|||
170628325|NCT01488890|616652011|FG001|Overall Study|Protocol Violation|0|||
170628326|NCT01488890|616652012|FG002|Overall Study|Protocol Violation|4|||
170628327|NCT01488890|616652013|FG003|Overall Study|Protocol Violation|0|||
170628328|NCT01488890|616652010|FG000|Overall Study|Lost to Follow-up|13|||
170628329|NCT01488890|616652011|FG001|Overall Study|Lost to Follow-up|10|||
170628330|NCT01488890|616652012|FG002|Overall Study|Lost to Follow-up|20|||
170628331|NCT01488890|616652013|FG003|Overall Study|Lost to Follow-up|3|||
170628332|NCT01488890|616652010|FG000|Overall Study|Withdrawal by Subject|14|||
170628333|NCT01488890|616652011|FG001|Overall Study|Withdrawal by Subject|10|||
170628334|NCT01488890|616652012|FG002|Overall Study|Withdrawal by Subject|11|||
170628335|NCT01488890|616652013|FG003|Overall Study|Withdrawal by Subject|2|||
170628336|NCT02628873|616652014|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
170674184|NCT01306942|616819696|FG001|Phase II|Adverse Event|0|||
170674185|NCT01306942|616819697|FG002|Phase II|Adverse Event|0|||
170674186|NCT01306942|616819698|FG003|Phase II|Adverse Event|6|||
170674187|NCT01306942|616819695|FG000|Phase II|Physician Decision|2|||
170674188|NCT01306942|616819696|FG001|Phase II|Physician Decision|0|||
170674189|NCT01306942|616819697|FG002|Phase II|Physician Decision|0|||
170674190|NCT01306942|616819698|FG003|Phase II|Physician Decision|5|||
170674191|NCT01306942|616819695|FG000|Phase II|Withdrawal by Subject|0|||
170820300|NCT02660034|617349624|FG002|Overall Study|Lost to Follow-up|1|||
170820301|NCT02660034|617349625|FG003|Overall Study|Lost to Follow-up|1|||
170820302|NCT02660034|617349626|FG004|Overall Study|Lost to Follow-up|0|||
170820303|NCT02660034|617349627|FG005|Overall Study|Lost to Follow-up|0|||
170820304|NCT02660034|617349628|FG006|Overall Study|Lost to Follow-up|0|||
170820305|NCT02660034|617349629|FG007|Overall Study|Lost to Follow-up|0|||
170820306|NCT02660034|617349630|FG008|Overall Study|Lost to Follow-up|0|||
170820307|NCT02660034|617349631|FG009|Overall Study|Lost to Follow-up|1|||
170820308|NCT02660034|617349632|FG010|Overall Study|Lost to Follow-up|1|||
170820309|NCT02660034|617349633|FG011|Overall Study|Lost to Follow-up|1|||
170820310|NCT02660034|617349634|FG012|Overall Study|Lost to Follow-up|0|||
170820311|NCT02660034|617349635|FG013|Overall Study|Lost to Follow-up|0|||
170820312|NCT02660034|617349622|FG000|Overall Study|Participant moved into special access scheme|1|||
170820313|NCT02660034|617349623|FG001|Overall Study|Participant moved into special access scheme|2|||
170820314|NCT02660034|617349624|FG002|Overall Study|Participant moved into special access scheme|0|||
170820315|NCT02660034|617349625|FG003|Overall Study|Participant moved into special access scheme|0|||
170820316|NCT02660034|617349626|FG004|Overall Study|Participant moved into special access scheme|0|||
170820317|NCT02660034|617349627|FG005|Overall Study|Participant moved into special access scheme|0|||
170820318|NCT02660034|617349628|FG006|Overall Study|Participant moved into special access scheme|0|||
170820319|NCT02660034|617349629|FG007|Overall Study|Participant moved into special access scheme|0|||
170820320|NCT02660034|617349630|FG008|Overall Study|Participant moved into special access scheme|0|||
170820321|NCT02660034|617349631|FG009|Overall Study|Participant moved into special access scheme|0|||
170820322|NCT02660034|617349632|FG010|Overall Study|Participant moved into special access scheme|0|||
170820323|NCT02660034|617349633|FG011|Overall Study|Participant moved into special access scheme|0|||
170820324|NCT02660034|617349634|FG012|Overall Study|Participant moved into special access scheme|0|||
170820325|NCT02660034|617349635|FG013|Overall Study|Participant moved into special access scheme|0|||
170820326|NCT02660034|617349622|FG000|Overall Study|Adverse Event|1|||
170820327|NCT02660034|617349623|FG001|Overall Study|Adverse Event|0|||
170820328|NCT02660034|617349624|FG002|Overall Study|Adverse Event|0|||
170820329|NCT02660034|617349625|FG003|Overall Study|Adverse Event|0|||
170820330|NCT02660034|617349626|FG004|Overall Study|Adverse Event|0|||
170820331|NCT02660034|617349627|FG005|Overall Study|Adverse Event|0|||
170820332|NCT02660034|617349628|FG006|Overall Study|Adverse Event|0|||
170820333|NCT02660034|617349629|FG007|Overall Study|Adverse Event|0|||
170820334|NCT02660034|617349630|FG008|Overall Study|Adverse Event|0|||
170674192|NCT01306942|616819696|FG001|Phase II|Withdrawal by Subject|0|||
170674193|NCT01306942|616819697|FG002|Phase II|Withdrawal by Subject|0|||
170628337|NCT02628873|616652015|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
170628338|NCT02628873|616652014|FG000|Second Test (1 Hour)|Physician Decision|1|||
170628339|NCT02628873|616652015|FG001|Second Test (1 Hour)|Physician Decision|0|||
170628340|NCT04366349|616652016|FG000|Overall Study|Withdrawal by Subject|1|||
170628341|NCT04366349|616652017|FG001|Overall Study|Withdrawal by Subject|0|||
170628342|NCT04366349|616652018|FG002|Overall Study|Withdrawal by Subject|0|||
170628343|NCT04366349|616652019|FG003|Overall Study|Withdrawal by Subject|0|||
170628344|NCT04366349|616652020|FG004|Overall Study|Withdrawal by Subject|0|||
170628345|NCT04366349|616652021|FG005|Overall Study|Withdrawal by Subject|0|||
170628346|NCT00107653|616652023|FG000|Overall Study|Adverse Event|24|||
170628347|NCT00107653|616652024|FG001|Overall Study|Adverse Event|43|||
170628348|NCT00107653|616652023|FG000|Overall Study|Insufficient Therapeutic Response|25|||
170628349|NCT00107653|616652024|FG001|Overall Study|Insufficient Therapeutic Response|11|||
170628350|NCT00107653|616652023|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
170628351|NCT00107653|616652024|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
170628352|NCT00107653|616652023|FG000|Overall Study|Protocol Violation|1|||
170628353|NCT00107653|616652024|FG001|Overall Study|Protocol Violation|0|||
170628354|NCT00107653|616652023|FG000|Overall Study|Withdrawal by Subject|12|||
170628355|NCT00107653|616652024|FG001|Overall Study|Withdrawal by Subject|13|||
170628356|NCT00107653|616652023|FG000|Overall Study|Lost to Follow-up|13|||
170628357|NCT00107653|616652024|FG001|Overall Study|Lost to Follow-up|5|||
170628358|NCT00107653|616652023|FG000|Overall Study|Administrative Reasons|3|||
170628359|NCT00107653|616652024|FG001|Overall Study|Administrative Reasons|3|||
170628360|NCT04905134|616652028|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
170628361|NCT04905134|616652028|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
170628362|NCT03009058|616652029|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
170628363|NCT05556265|616652030|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
170628364|NCT05556265|616652031|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
170628365|NCT05556265|616652032|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
170628366|NCT05556265|616652033|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
170628367|NCT05556265|616652034|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
170628368|NCT05556265|616652030|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
170628369|NCT05556265|616652031|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
170628370|NCT05556265|616652032|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
170628371|NCT05556265|616652033|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
170628372|NCT05556265|616652034|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
170628373|NCT05556265|616652030|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
170628374|NCT05556265|616652031|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
170628375|NCT05556265|616652032|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
170628376|NCT05556265|616652033|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
170628377|NCT05556265|616652034|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
170628378|NCT05556265|616652030|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
170628379|NCT05556265|616652031|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
170628380|NCT05556265|616652032|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
170628381|NCT05556265|616652033|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
170628382|NCT05556265|616652034|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
170628383|NCT05556265|616652030|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
170628384|NCT05556265|616652031|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
170628385|NCT05556265|616652032|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
170628386|NCT05556265|616652033|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
170628387|NCT05556265|616652034|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
170628388|NCT05556265|616652030|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
170628389|NCT05556265|616652031|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
170628390|NCT05556265|616652032|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
170628391|NCT05556265|616652033|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
170628392|NCT05556265|616652034|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
170628393|NCT05556265|616652030|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
170820335|NCT02660034|617349631|FG009|Overall Study|Adverse Event|0|||
170674194|NCT01306942|616819698|FG003|Phase II|Withdrawal by Subject|2|||
170674195|NCT01306942|616819695|FG000|Phase II|Death|0|||
170674196|NCT01306942|616819696|FG001|Phase II|Death|0|||
170674197|NCT01306942|616819697|FG002|Phase II|Death|0|||
170674198|NCT01306942|616819698|FG003|Phase II|Death|1|||
170674199|NCT01306942|616819695|FG000|Phase II|Not finished treatment|0|||
170674200|NCT01306942|616819696|FG001|Phase II|Not finished treatment|0|||
170674201|NCT01306942|616819697|FG002|Phase II|Not finished treatment|0|||
170674202|NCT01306942|616819698|FG003|Phase II|Not finished treatment|1|||
170674203|NCT01306942|616819695|FG000|Phase II|Protocol Violation|0|||
170674204|NCT01306942|616819696|FG001|Phase II|Protocol Violation|0|||
170674205|NCT01306942|616819697|FG002|Phase II|Protocol Violation|0|||
170674206|NCT01306942|616819698|FG003|Phase II|Protocol Violation|1|||
170674207|NCT03190915|616819699|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
170674208|NCT03190915|616819699|FG000|Overall Study|Progressive Disease|3|||
170674209|NCT02106975|616819701|FG000|Overall Study|Death|25|||
170674210|NCT02106975|616819702|FG001|Overall Study|Death|39|||
170674211|NCT03988088|616819703|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
170674212|NCT03988088|616819704|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
170674213|NCT03988088|616819705|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
170674214|NCT03988088|616819706|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
170674215|NCT03988088|616819703|FG000|Open-Label Addendum|Lost to Follow-up|0|||
170674216|NCT03988088|616819704|FG001|Open-Label Addendum|Lost to Follow-up|0|||
170674217|NCT03988088|616819705|FG002|Open-Label Addendum|Lost to Follow-up|1|||
170674218|NCT03988088|616819706|FG003|Open-Label Addendum|Lost to Follow-up|0|||
170674219|NCT04431453|616819707|FG000|Overall Study|Withdrew Consent|0|||
170674220|NCT04431453|616819708|FG001|Overall Study|Withdrew Consent|1|||
170674221|NCT04431453|616819709|FG002|Overall Study|Withdrew Consent|0|||
170674222|NCT04431453|616819710|FG003|Overall Study|Withdrew Consent|2|||
170674223|NCT04431453|616819711|FG004|Overall Study|Withdrew Consent|0|||
170674224|NCT04431453|616819712|FG005|Overall Study|Withdrew Consent|0|||
170674225|NCT04431453|616819713|FG006|Overall Study|Withdrew Consent|0|||
170674226|NCT04431453|616819714|FG007|Overall Study|Withdrew Consent|0|||
170674227|NCT04431453|616819707|FG000|Overall Study|Death|1|||
170674228|NCT04431453|616819708|FG001|Overall Study|Death|0|||
170674229|NCT04431453|616819709|FG002|Overall Study|Death|0|||
170674230|NCT04431453|616819710|FG003|Overall Study|Death|0|||
170674231|NCT04431453|616819711|FG004|Overall Study|Death|0|||
170674232|NCT04431453|616819712|FG005|Overall Study|Death|0|||
170674233|NCT04431453|616819713|FG006|Overall Study|Death|0|||
170674234|NCT04431453|616819714|FG007|Overall Study|Death|1|||
170674235|NCT04431453|616819707|FG000|Overall Study|Lost to Follow-up|0|||
170674236|NCT04431453|616819708|FG001|Overall Study|Lost to Follow-up|0|||
170674237|NCT04431453|616819709|FG002|Overall Study|Lost to Follow-up|1|||
170674238|NCT04431453|616819710|FG003|Overall Study|Lost to Follow-up|1|||
170674239|NCT04431453|616819711|FG004|Overall Study|Lost to Follow-up|0|||
170674240|NCT04431453|616819712|FG005|Overall Study|Lost to Follow-up|0|||
170674241|NCT04431453|616819713|FG006|Overall Study|Lost to Follow-up|0|||
170674242|NCT04431453|616819714|FG007|Overall Study|Lost to Follow-up|0|||
170674243|NCT04431453|616819707|FG000|Overall Study|Enrolled but Never Treated|0|||
170674244|NCT04431453|616819708|FG001|Overall Study|Enrolled but Never Treated|0|||
170674245|NCT04431453|616819709|FG002|Overall Study|Enrolled but Never Treated|0|||
170674246|NCT04431453|616819710|FG003|Overall Study|Enrolled but Never Treated|0|||
170674247|NCT04431453|616819711|FG004|Overall Study|Enrolled but Never Treated|1|||
170674248|NCT04431453|616819712|FG005|Overall Study|Enrolled but Never Treated|0|||
170674249|NCT04431453|616819713|FG006|Overall Study|Enrolled but Never Treated|0|||
170674250|NCT04431453|616819714|FG007|Overall Study|Enrolled but Never Treated|0|||
170674251|NCT00622401|616819715|FG000|Overall Study|Disease progression prior to treatment|3|||
170674252|NCT00622401|616819716|FG001|Overall Study|Disease progression prior to treatment|2|||
170674253|NCT00622401|616819717|FG002|Overall Study|Disease progression prior to treatment|0|||
170674254|NCT01546883|616819727|FG000|Overall Study|Withdrawal by Subject|3|||
170674255|NCT01546883|616819727|FG000|Overall Study|Adverse Event|4|||
170674256|NCT01546883|616819727|FG000|Overall Study|Lost to Follow-up|2|||
170674257|NCT01546883|616819727|FG000|Overall Study|early closure of study|2|||
170674258|NCT01546883|616819727|FG000|Overall Study|other unrelated illness|1|||
170674259|NCT02256631|616819730|FG000|Overall Study|Lost to Follow-up|1|||
170674260|NCT02256631|616819731|FG001|Overall Study|Lost to Follow-up|1|||
170674261|NCT02256631|616819732|FG002|Overall Study|Lost to Follow-up|0|||
170674262|NCT02256631|616819733|FG003|Overall Study|Lost to Follow-up|2|||
170674263|NCT02256631|616819734|FG004|Overall Study|Lost to Follow-up|0|||
170674264|NCT02256631|616819735|FG005|Overall Study|Lost to Follow-up|4|||
170674265|NCT02256631|616819736|FG006|Overall Study|Lost to Follow-up|1|||
170674266|NCT02256631|616819730|FG000|Overall Study|Withdrawal by Subject|0|||
170674267|NCT02256631|616819731|FG001|Overall Study|Withdrawal by Subject|0|||
170674268|NCT02256631|616819732|FG002|Overall Study|Withdrawal by Subject|0|||
170674269|NCT02256631|616819733|FG003|Overall Study|Withdrawal by Subject|1|||
170674270|NCT02256631|616819734|FG004|Overall Study|Withdrawal by Subject|1|||
170674271|NCT02256631|616819735|FG005|Overall Study|Withdrawal by Subject|0|||
170674272|NCT02256631|616819736|FG006|Overall Study|Withdrawal by Subject|1|||
170674273|NCT02256631|616819730|FG000|Overall Study|Unable to get to clinic|0|||
170674274|NCT02256631|616819731|FG001|Overall Study|Unable to get to clinic|2|||
170628394|NCT05556265|616652031|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
170628395|NCT05556265|616652032|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
170628396|NCT05556265|616652033|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
170628397|NCT05556265|616652034|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
170628398|NCT05556265|616652030|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
170628399|NCT05556265|616652031|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
170628400|NCT05556265|616652032|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
170628401|NCT05556265|616652033|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
170628402|NCT05556265|616652034|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
170628403|NCT05556265|616652030|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
170628404|NCT05556265|616652031|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
170674275|NCT02256631|616819732|FG002|Overall Study|Unable to get to clinic|0|||
170674276|NCT02256631|616819733|FG003|Overall Study|Unable to get to clinic|1|||
170674277|NCT02256631|616819734|FG004|Overall Study|Unable to get to clinic|0|||
170674278|NCT02256631|616819735|FG005|Overall Study|Unable to get to clinic|1|||
170674279|NCT02256631|616819736|FG006|Overall Study|Unable to get to clinic|2|||
170674280|NCT02021773|616819737|FG000|Overall Study|Adverse Event|1|||
170674281|NCT02021773|616819738|FG001|Overall Study|Adverse Event|4|||
170674282|NCT02021773|616819739|FG002|Overall Study|Adverse Event|3|||
170674283|NCT02021773|616819737|FG000|Overall Study|Lack of Efficacy|2|||
170674284|NCT02021773|616819738|FG001|Overall Study|Lack of Efficacy|2|||
170674285|NCT02021773|616819739|FG002|Overall Study|Lack of Efficacy|2|||
170674286|NCT02021773|616819737|FG000|Overall Study|Protocol Violation|2|||
170674287|NCT02021773|616819738|FG001|Overall Study|Protocol Violation|3|||
170674288|NCT02021773|616819739|FG002|Overall Study|Protocol Violation|1|||
170674289|NCT02021773|616819737|FG000|Overall Study|Withdrawal by Subject|3|||
170674290|NCT02021773|616819738|FG001|Overall Study|Withdrawal by Subject|4|||
170674291|NCT02021773|616819739|FG002|Overall Study|Withdrawal by Subject|5|||
170674292|NCT02021773|616819737|FG000|Overall Study|Lost to Follow-up|1|||
170674293|NCT02021773|616819738|FG001|Overall Study|Lost to Follow-up|3|||
170674294|NCT02021773|616819739|FG002|Overall Study|Lost to Follow-up|0|||
170674295|NCT02021773|616819737|FG000|Overall Study|Reason not specified|3|||
170674296|NCT02021773|616819738|FG001|Overall Study|Reason not specified|0|||
170674297|NCT02021773|616819739|FG002|Overall Study|Reason not specified|0|||
170674298|NCT04502693|616819742|FG000|Overall Study|Adverse Event|7|||
170674299|NCT04502693|616819743|FG001|Overall Study|Adverse Event|6|||
170674300|NCT04502693|616819744|FG002|Overall Study|Adverse Event|11|||
170674301|NCT04502693|616819745|FG003|Overall Study|Adverse Event|1|||
170674302|NCT04502693|616819742|FG000|Overall Study|Lost to Follow-up|32|||
170674303|NCT04502693|616819743|FG001|Overall Study|Lost to Follow-up|36|||
170674304|NCT04502693|616819744|FG002|Overall Study|Lost to Follow-up|69|||
170674305|NCT04502693|616819745|FG003|Overall Study|Lost to Follow-up|4|||
170674306|NCT04502693|616819742|FG000|Overall Study|Protocol Violation|8|||
170674307|NCT04502693|616819743|FG001|Overall Study|Protocol Violation|8|||
170674308|NCT04502693|616819744|FG002|Overall Study|Protocol Violation|16|||
170674309|NCT04502693|616819745|FG003|Overall Study|Protocol Violation|1|||
170628405|NCT05556265|616652032|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
170628406|NCT05556265|616652033|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
170674310|NCT04502693|616819742|FG000|Overall Study|Withdrawal by Subject|46|||
170674311|NCT04502693|616819743|FG001|Overall Study|Withdrawal by Subject|38|||
170628407|NCT05556265|616652034|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
170674312|NCT04502693|616819744|FG002|Overall Study|Withdrawal by Subject|54|||
170674313|NCT04502693|616819745|FG003|Overall Study|Withdrawal by Subject|7|||
170674314|NCT04502693|616819742|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
170674315|NCT04502693|616819743|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
170674316|NCT04502693|616819744|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
170674317|NCT04502693|616819745|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170674318|NCT04502693|616819742|FG000|Overall Study|Other|1|||
170674319|NCT04502693|616819743|FG001|Overall Study|Other|0|||
170674320|NCT04502693|616819744|FG002|Overall Study|Other|1|||
170674321|NCT04502693|616819745|FG003|Overall Study|Other|1|||
170674322|NCT01201850|616819747|FG000|Overall Study|Tumor progression|4|||
170674323|NCT03137537|616819748|FG000|Overall Study|Adverse Event|0|||
170674324|NCT03137537|616819749|FG001|Overall Study|Adverse Event|1|||
170674325|NCT04066023|616819750|FG000|Overall Study|Adverse Event|0|||
170674326|NCT04066023|616819751|FG001|Overall Study|Adverse Event|0|||
170674327|NCT04066023|616819752|FG002|Overall Study|Adverse Event|1|||
170674328|NCT04066023|616819750|FG000|Overall Study|Sponsor decision|3|||
170674329|NCT04066023|616819751|FG001|Overall Study|Sponsor decision|6|||
170674330|NCT04066023|616819752|FG002|Overall Study|Sponsor decision|2|||
170674331|NCT04066023|616819750|FG000|Overall Study|Physician Decision|0|||
170674332|NCT04066023|616819751|FG001|Overall Study|Physician Decision|0|||
170674333|NCT04066023|616819752|FG002|Overall Study|Physician Decision|1|||
170674334|NCT04066023|616819750|FG000|Overall Study|Lost to Follow-up|0|||
170674335|NCT04066023|616819751|FG001|Overall Study|Lost to Follow-up|1|||
170674336|NCT04066023|616819752|FG002|Overall Study|Lost to Follow-up|1|||
170674337|NCT04066023|616819750|FG000|Overall Study|Noncompliance|0|||
170674338|NCT04066023|616819751|FG001|Overall Study|Noncompliance|1|||
170674339|NCT04066023|616819752|FG002|Overall Study|Noncompliance|1|||
170674340|NCT01552694|616819753|FG000|Overall Study|Lost to Follow-up|0|||
170674341|NCT01552694|616819754|FG001|Overall Study|Lost to Follow-up|1|||
170674342|NCT01552694|616819753|FG000|Overall Study|Protocol Violation|0|||
170674343|NCT01552694|616819754|FG001|Overall Study|Protocol Violation|1|||
170674344|NCT00191139|616819755|FG000|Overall Study|Adverse Event|2|||
170674345|NCT00191139|616819756|FG001|Overall Study|Adverse Event|6|||
170674346|NCT00191139|616819755|FG000|Overall Study|Death|2|||
170674347|NCT00191139|616819756|FG001|Overall Study|Death|0|||
170674348|NCT00191139|616819755|FG000|Overall Study|Withdrawal by Subject|0|||
170674349|NCT00191139|616819756|FG001|Overall Study|Withdrawal by Subject|3|||
170674350|NCT00191139|616819755|FG000|Overall Study|Disease Progression|0|||
170674351|NCT00191139|616819756|FG001|Overall Study|Disease Progression|1|||
170674352|NCT00191139|616819755|FG000|Overall Study|Other|1|||
170674353|NCT00191139|616819756|FG001|Overall Study|Other|2|||
170674354|NCT03338010|616819757|FG000|Overall Study|Withdrawal by Subject|14|||
170674355|NCT03338010|616819758|FG001|Overall Study|Withdrawal by Subject|8|||
170674356|NCT03338010|616819757|FG000|Overall Study|Lost to Follow-up|4|||
170674357|NCT03338010|616819758|FG001|Overall Study|Lost to Follow-up|2|||
170674358|NCT03338010|616819757|FG000|Overall Study|Adverse Event|3|||
170674359|NCT03338010|616819758|FG001|Overall Study|Adverse Event|2|||
170674360|NCT03338010|616819757|FG000|Overall Study|Physician Decision|2|||
170674361|NCT03338010|616819758|FG001|Overall Study|Physician Decision|2|||
170674362|NCT03338010|616819757|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170674363|NCT03338010|616819758|FG001|Overall Study|Non-Compliance with Study Drug|3|||
170674364|NCT03338010|616819757|FG000|Overall Study|Protocol Violation|0|||
170674365|NCT03338010|616819758|FG001|Overall Study|Protocol Violation|1|||
170674366|NCT02564796|616819761|FG000|Overall Study|Physician Decision|2|||
170674367|NCT02564796|616819762|FG001|Overall Study|Physician Decision|2|||
170674368|NCT00453063|616819763|FG000|Overall Study|Adverse Event|1|||
170674369|NCT00453063|616819764|FG001|Overall Study|Adverse Event|2|||
170674370|NCT00453063|616819763|FG000|Overall Study|Withdrawal by Subject|1|||
170674371|NCT00453063|616819764|FG001|Overall Study|Withdrawal by Subject|1|||
170674372|NCT00453063|616819763|FG000|Overall Study|Protocol Violation|1|||
170674373|NCT00453063|616819764|FG001|Overall Study|Protocol Violation|0|||
170674374|NCT03724032|616819767|FG000|Overall Study|Physician Decision|1|||
170674375|NCT03724032|616819768|FG001|Overall Study|Physician Decision|0|||
170674376|NCT03724032|616819769|FG002|Overall Study|Physician Decision|0|||
170674377|NCT03724032|616819767|FG000|Overall Study|Protocol Violation|2|||
170674378|NCT03724032|616819768|FG001|Overall Study|Protocol Violation|2|||
170674379|NCT03724032|616819769|FG002|Overall Study|Protocol Violation|1|||
170674380|NCT00751933|616819770|FG000|Overall Study|Withdrawal by Subject|0|||
170674381|NCT00751933|616819771|FG001|Overall Study|Withdrawal by Subject|1|||
170674382|NCT00751933|616819772|FG002|Overall Study|Withdrawal by Subject|0|||
170674383|NCT00751933|616819773|FG003|Overall Study|Withdrawal by Subject|0|||
170674384|NCT00751933|616819770|FG000|Overall Study|Physician Decision|0|||
170674385|NCT00751933|616819771|FG001|Overall Study|Physician Decision|0|||
170674386|NCT00751933|616819772|FG002|Overall Study|Physician Decision|1|||
170674387|NCT00751933|616819773|FG003|Overall Study|Physician Decision|1|||
170674388|NCT01918774|616821450|FG000|Overall Study|Lost prior to first CBTw session|4|||
170674389|NCT01918774|616821450|FG000|Overall Study|Lost to Follow-up|1|||
170674390|NCT03000439|616821453|FG000|Open Label Part 1|Adverse Event|6|||
170674391|NCT03000439|616821454|FG001|Open Label Part 1|Adverse Event|0|||
170674392|NCT03000439|616821455|FG002|Open Label Part 1|Adverse Event|0|||
170674393|NCT03000439|616821456|FG003|Open Label Part 1|Adverse Event|0|||
170674394|NCT03000439|616821453|FG000|Open Label Part 1|Other|2|||
170674395|NCT03000439|616821454|FG001|Open Label Part 1|Other|0|||
170674396|NCT03000439|616821455|FG002|Open Label Part 1|Other|0|||
170674397|NCT03000439|616821456|FG003|Open Label Part 1|Other|0|||
170674398|NCT03000439|616821453|FG000|Open Label Part 1|Insufficient clinical response|16|||
170674399|NCT03000439|616821454|FG001|Open Label Part 1|Insufficient clinical response|0|||
170674400|NCT03000439|616821455|FG002|Open Label Part 1|Insufficient clinical response|0|||
170674401|NCT03000439|616821456|FG003|Open Label Part 1|Insufficient clinical response|0|||
170674402|NCT03000439|616821453|FG000|Open Label Part 2|Other|0|||
170674403|NCT03000439|616821454|FG001|Open Label Part 2|Other|5|||
170674404|NCT03000439|616821455|FG002|Open Label Part 2|Other|0|||
170674405|NCT03000439|616821456|FG003|Open Label Part 2|Other|0|||
170674406|NCT03000439|616821453|FG000|Open Label Part 2|Insufficient clinical response|0|||
170674407|NCT03000439|616821454|FG001|Open Label Part 2|Insufficient clinical response|12|||
170674408|NCT03000439|616821455|FG002|Open Label Part 2|Insufficient clinical response|0|||
170674409|NCT03000439|616821456|FG003|Open Label Part 2|Insufficient clinical response|0|||
170674410|NCT03000439|616821453|FG000|Double Blind Phase|Adverse Event|0|||
170674411|NCT03000439|616821454|FG001|Double Blind Phase|Adverse Event|0|||
170674412|NCT03000439|616821455|FG002|Double Blind Phase|Adverse Event|2|||
170674413|NCT03000439|616821456|FG003|Double Blind Phase|Adverse Event|1|||
170674414|NCT03000439|616821453|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
170674415|NCT03000439|616821454|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
170674416|NCT03000439|616821455|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
170674417|NCT03000439|616821456|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
170674418|NCT03000439|616821453|FG000|Double Blind Phase|Other|0|||
170674419|NCT03000439|616821454|FG001|Double Blind Phase|Other|0|||
170674420|NCT03000439|616821455|FG002|Double Blind Phase|Other|10|||
170674421|NCT03000439|616821456|FG003|Double Blind Phase|Other|11|||
170674422|NCT03000439|616821453|FG000|Double Blind Phase|Insufficient clinical response|0|||
170674423|NCT03000439|616821454|FG001|Double Blind Phase|Insufficient clinical response|0|||
170674424|NCT03000439|616821455|FG002|Double Blind Phase|Insufficient clinical response|0|||
170674425|NCT03000439|616821456|FG003|Double Blind Phase|Insufficient clinical response|2|||
170674426|NCT00691015|616821457|FG000|Overall Study|Refused further treatment|1|||
170674427|NCT02151591|616821458|FG000|Overall Study|Lost to Follow-up|6|||
170674428|NCT02151591|616821459|FG001|Overall Study|Lost to Follow-up|3|||
170674429|NCT00587054|616821462|FG000|Overall Study|Patient not treated|9|||
170674430|NCT00726232|616821463|FG000|Initial Phase (Dose-finding)|Death|0|||
170674431|NCT00726232|616821464|FG001|Initial Phase (Dose-finding)|Death|0|||
170674432|NCT00726232|616821465|FG002|Initial Phase (Dose-finding)|Death|0|||
170674433|NCT00726232|616821466|FG003|Initial Phase (Dose-finding)|Death|0|||
170674434|NCT00726232|616821467|FG004|Initial Phase (Dose-finding)|Death|1|||
170674435|NCT00726232|616821468|FG005|Initial Phase (Dose-finding)|Death|0|||
170674436|NCT00726232|616821469|FG006|Initial Phase (Dose-finding)|Death|0|||
170674437|NCT00726232|616821470|FG007|Initial Phase (Dose-finding)|Death|0|||
170674438|NCT00726232|616821463|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
170674439|NCT00726232|616821464|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
170674440|NCT00726232|616821465|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
170674441|NCT00726232|616821466|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
170674442|NCT00726232|616821467|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
170674443|NCT00726232|616821468|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
170674444|NCT00726232|616821469|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
170674445|NCT00726232|616821470|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
170674446|NCT00726232|616821463|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
170820336|NCT02660034|617349632|FG010|Overall Study|Adverse Event|0|||
170820337|NCT02660034|617349633|FG011|Overall Study|Adverse Event|0|||
170820338|NCT02660034|617349634|FG012|Overall Study|Adverse Event|0|||
170820339|NCT02660034|617349635|FG013|Overall Study|Adverse Event|0|||
170820340|NCT02660034|617349622|FG000|Overall Study|Sponsor Decision|0|||
170820341|NCT02660034|617349623|FG001|Overall Study|Sponsor Decision|1|||
170820342|NCT02660034|617349624|FG002|Overall Study|Sponsor Decision|2|||
170820343|NCT02660034|617349625|FG003|Overall Study|Sponsor Decision|2|||
170820344|NCT02660034|617349626|FG004|Overall Study|Sponsor Decision|3|||
170820345|NCT02660034|617349627|FG005|Overall Study|Sponsor Decision|0|||
170820346|NCT02660034|617349628|FG006|Overall Study|Sponsor Decision|0|||
170820347|NCT02660034|617349629|FG007|Overall Study|Sponsor Decision|0|||
170820348|NCT02660034|617349630|FG008|Overall Study|Sponsor Decision|0|||
170674447|NCT00726232|616821464|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
170674448|NCT00726232|616821465|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
170674449|NCT00726232|616821466|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
170674450|NCT00726232|616821467|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
170674451|NCT00726232|616821468|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
170674452|NCT00726232|616821469|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
170674453|NCT00726232|616821470|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
170674454|NCT00726232|616821463|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
170674455|NCT00726232|616821464|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
170674456|NCT00726232|616821465|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
170674457|NCT00726232|616821466|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
170674458|NCT00726232|616821467|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
170674459|NCT00726232|616821468|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
170674460|NCT00726232|616821469|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
170674461|NCT00726232|616821470|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
170674462|NCT00726232|616821463|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
170674463|NCT00726232|616821464|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
170674464|NCT00726232|616821465|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
170674465|NCT00726232|616821466|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
170674466|NCT00726232|616821467|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
170674467|NCT00726232|616821468|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
170674468|NCT00726232|616821469|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
170674469|NCT00726232|616821470|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
170674470|NCT00726232|616821463|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
170674471|NCT00726232|616821464|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
170674472|NCT00726232|616821465|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
170674473|NCT00726232|616821466|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
170674474|NCT00726232|616821467|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
170674475|NCT00726232|616821468|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
170674476|NCT00726232|616821469|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
170674477|NCT00726232|616821470|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
170674478|NCT00726232|616821463|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
170674479|NCT00726232|616821464|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
170674480|NCT00726232|616821465|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
170674481|NCT00726232|616821466|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
170674482|NCT00726232|616821467|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
170674483|NCT00726232|616821468|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
170674484|NCT00726232|616821469|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
170674485|NCT00726232|616821470|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
170674486|NCT00726232|616821463|FG000|Expansion Phase|Death|0|||
170674487|NCT00726232|616821464|FG001|Expansion Phase|Death|0|||
170674488|NCT00726232|616821465|FG002|Expansion Phase|Death|0|||
170674489|NCT00726232|616821466|FG003|Expansion Phase|Death|0|||
170674490|NCT00726232|616821467|FG004|Expansion Phase|Death|0|||
170674491|NCT00726232|616821468|FG005|Expansion Phase|Death|0|||
170674492|NCT00726232|616821469|FG006|Expansion Phase|Death|0|||
170674493|NCT00726232|616821470|FG007|Expansion Phase|Death|1|||
170674494|NCT00726232|616821463|FG000|Expansion Phase|Adverse Event|0|||
170674495|NCT00726232|616821464|FG001|Expansion Phase|Adverse Event|0|||
170674496|NCT00726232|616821465|FG002|Expansion Phase|Adverse Event|0|||
170674497|NCT00726232|616821466|FG003|Expansion Phase|Adverse Event|0|||
170674498|NCT00726232|616821467|FG004|Expansion Phase|Adverse Event|0|||
170674499|NCT00726232|616821468|FG005|Expansion Phase|Adverse Event|0|||
170674500|NCT00726232|616821469|FG006|Expansion Phase|Adverse Event|6|||
170674501|NCT00726232|616821470|FG007|Expansion Phase|Adverse Event|11|||
170674502|NCT00726232|616821463|FG000|Expansion Phase|Withdrawal by Subject|0|||
170674503|NCT00726232|616821464|FG001|Expansion Phase|Withdrawal by Subject|0|||
170674504|NCT00726232|616821465|FG002|Expansion Phase|Withdrawal by Subject|0|||
170674505|NCT00726232|616821466|FG003|Expansion Phase|Withdrawal by Subject|0|||
170674506|NCT00726232|616821467|FG004|Expansion Phase|Withdrawal by Subject|0|||
170674507|NCT00726232|616821468|FG005|Expansion Phase|Withdrawal by Subject|0|||
170674508|NCT00726232|616821469|FG006|Expansion Phase|Withdrawal by Subject|2|||
170674509|NCT00726232|616821470|FG007|Expansion Phase|Withdrawal by Subject|3|||
170674510|NCT00726232|616821463|FG000|Expansion Phase|Disease progression|0|||
170674511|NCT00726232|616821464|FG001|Expansion Phase|Disease progression|0|||
170674512|NCT00726232|616821465|FG002|Expansion Phase|Disease progression|0|||
170674513|NCT00726232|616821466|FG003|Expansion Phase|Disease progression|0|||
170674514|NCT00726232|616821467|FG004|Expansion Phase|Disease progression|0|||
170674515|NCT00726232|616821468|FG005|Expansion Phase|Disease progression|0|||
170674516|NCT00726232|616821469|FG006|Expansion Phase|Disease progression|4|||
170674517|NCT00726232|616821470|FG007|Expansion Phase|Disease progression|0|||
170674518|NCT00726232|616821463|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
170674519|NCT00726232|616821464|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
170674520|NCT00726232|616821465|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
170674521|NCT00726232|616821466|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
170674522|NCT00726232|616821467|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
170674523|NCT00726232|616821468|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
170674524|NCT00726232|616821469|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
170674525|NCT00726232|616821470|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
170674526|NCT00726232|616821463|FG000|Expansion Phase|Per Investigator: lack of response|0|||
170674527|NCT00726232|616821464|FG001|Expansion Phase|Per Investigator: lack of response|0|||
170674528|NCT00726232|616821465|FG002|Expansion Phase|Per Investigator: lack of response|0|||
170674529|NCT00726232|616821466|FG003|Expansion Phase|Per Investigator: lack of response|0|||
170674530|NCT00726232|616821467|FG004|Expansion Phase|Per Investigator: lack of response|0|||
170674531|NCT00726232|616821468|FG005|Expansion Phase|Per Investigator: lack of response|0|||
170674532|NCT00726232|616821469|FG006|Expansion Phase|Per Investigator: lack of response|1|||
170674533|NCT00726232|616821470|FG007|Expansion Phase|Per Investigator: lack of response|7|||
170674534|NCT00726232|616821463|FG000|Expansion Phase|Unspecified reason|0|||
170674535|NCT00726232|616821464|FG001|Expansion Phase|Unspecified reason|0|||
170674536|NCT00726232|616821465|FG002|Expansion Phase|Unspecified reason|0|||
170674537|NCT00726232|616821466|FG003|Expansion Phase|Unspecified reason|0|||
170674538|NCT00726232|616821467|FG004|Expansion Phase|Unspecified reason|0|||
170674539|NCT00726232|616821468|FG005|Expansion Phase|Unspecified reason|0|||
170674540|NCT00726232|616821469|FG006|Expansion Phase|Unspecified reason|1|||
170674541|NCT00726232|616821470|FG007|Expansion Phase|Unspecified reason|0|||
170674542|NCT02864498|616821477|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
170674543|NCT02864498|616821478|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
170674544|NCT02864498|616821479|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
170674545|NCT02864498|616821477|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
170674546|NCT02864498|616821478|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
170674547|NCT02864498|616821479|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
170674548|NCT02864498|616821477|FG000|Overall Study|Investigator Discretion|0|||
170674549|NCT02864498|616821478|FG001|Overall Study|Investigator Discretion|2|||
170674550|NCT02864498|616821479|FG002|Overall Study|Investigator Discretion|1|||
170674551|NCT02864498|616821477|FG000|Overall Study|Lost to Follow-up|8|||
170674552|NCT02864498|616821478|FG001|Overall Study|Lost to Follow-up|6|||
170674553|NCT02864498|616821479|FG002|Overall Study|Lost to Follow-up|3|||
170674554|NCT02864498|616821477|FG000|Overall Study|Lack of Efficacy|5|||
170674555|NCT02864498|616821478|FG001|Overall Study|Lack of Efficacy|3|||
170674556|NCT02864498|616821479|FG002|Overall Study|Lack of Efficacy|3|||
170674557|NCT02864498|616821477|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
170674558|NCT02864498|616821478|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
170674559|NCT02864498|616821479|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
170674560|NCT02864498|616821477|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
170674561|NCT02864498|616821478|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
170674562|NCT02864498|616821479|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
170674563|NCT02864498|616821477|FG000|Overall Study|Subject moved out of the country.|0|||
170674564|NCT02864498|616821478|FG001|Overall Study|Subject moved out of the country.|0|||
170674565|NCT02864498|616821479|FG002|Overall Study|Subject moved out of the country.|1|||
170674566|NCT03478930|616821480|FG000|Overall Study|Adverse Event|0|||
170674567|NCT03478930|616821481|FG001|Overall Study|Adverse Event|1|||
170674568|NCT03478930|616821480|FG000|Overall Study|Lack of Efficacy|3|||
170674569|NCT03478930|616821481|FG001|Overall Study|Lack of Efficacy|3|||
170674570|NCT03478930|616821480|FG000|Overall Study|Withdrawal by Subject|6|||
170674571|NCT03478930|616821481|FG001|Overall Study|Withdrawal by Subject|5|||
170674572|NCT00288054|616821482|FG000|Overall Study|Protocol Violation|2|||
170674573|NCT00288054|616821482|FG000|Overall Study|Lack of Efficacy|16|||
170674574|NCT00288054|616821482|FG000|Overall Study|Adverse Event|3|||
170674575|NCT00288054|616821482|FG000|Overall Study|Withdrawal by Subject|1|||
170674576|NCT00288054|616821482|FG000|Overall Study|Not protocol specified|2|||
170674577|NCT02197247|616821483|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
170674578|NCT02197247|616821483|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
170674579|NCT02197247|616821483|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
170674580|NCT02197247|616821483|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
170674581|NCT02197247|616821483|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
170674582|NCT02197247|616821483|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
170674583|NCT02197247|616821483|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
170674584|NCT02197247|616821483|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
170674585|NCT01336764|616821484|FG000|Overall Study|Withdrawal by Subject|5|||
170674586|NCT01336764|616821485|FG001|Overall Study|Withdrawal by Subject|5|||
170674587|NCT01010061|616821486|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
170674588|NCT01010061|616821487|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
170674589|NCT01010061|616821486|FG000|Overall Study|Disease Progression|2|||
170674590|NCT01010061|616821487|FG001|Overall Study|Disease Progression|8|||
170674591|NCT01010061|616821486|FG000|Overall Study|Withdrew Consent|5|||
170674592|NCT01010061|616821487|FG001|Overall Study|Withdrew Consent|1|||
170674593|NCT01010061|616821486|FG000|Overall Study|Death|3|||
170674594|NCT01010061|616821487|FG001|Overall Study|Death|6|||
170674595|NCT01010061|616821486|FG000|Overall Study|Administrative/Other|0|||
170674596|NCT01010061|616821487|FG001|Overall Study|Administrative/Other|1|||
170674597|NCT01010061|616821486|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
170674598|NCT01010061|616821487|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
170674599|NCT01010061|616821486|FG000|Overall Study|Insufficient Therapeutic Response|1|||
170674600|NCT01010061|616821487|FG001|Overall Study|Insufficient Therapeutic Response|5|||
170674601|NCT01010061|616821486|FG000|Overall Study|Violation of Selection Criteria|0|||
170674602|NCT01010061|616821487|FG001|Overall Study|Violation of Selection Criteria|1|||
170674603|NCT01010061|616821486|FG000|Overall Study|Did Not Receive Treatment|2|||
170674604|NCT01010061|616821487|FG001|Overall Study|Did Not Receive Treatment|2|||
170674605|NCT01203098|616821490|FG000|Overall Study|Adverse Event|3|||
170674606|NCT01203098|616821491|FG001|Overall Study|Adverse Event|1|||
170674607|NCT01203098|616821492|FG002|Overall Study|Adverse Event|7|||
170674608|NCT01203098|616821490|FG000|Overall Study|Lost to Follow-up|0|||
170674609|NCT01203098|616821491|FG001|Overall Study|Lost to Follow-up|0|||
170674610|NCT01203098|616821492|FG002|Overall Study|Lost to Follow-up|1|||
170674611|NCT01203098|616821490|FG000|Overall Study|Physician Decision|2|||
170674612|NCT01203098|616821491|FG001|Overall Study|Physician Decision|2|||
170674613|NCT01203098|616821492|FG002|Overall Study|Physician Decision|0|||
170674614|NCT01203098|616821490|FG000|Overall Study|Withdrawal by Subject|1|||
170674615|NCT01203098|616821491|FG001|Overall Study|Withdrawal by Subject|1|||
170674616|NCT01203098|616821492|FG002|Overall Study|Withdrawal by Subject|3|||
170674617|NCT03095612|616821497|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
170674618|NCT03095612|616821498|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
170674619|NCT03095612|616821499|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
170674620|NCT03095612|616821500|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
170674621|NCT03095612|616821501|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
170674622|NCT03095612|616821502|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
170674623|NCT03095612|616821503|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
170674624|NCT01387932|616821504|FG000|Randomized and Treated|Physician Decision|3|||
170674625|NCT01387932|616821505|FG001|Randomized and Treated|Physician Decision|2|||
170674626|NCT01387932|616821504|FG000|Randomized and Treated|Withdrawal by Subject|4|||
170674627|NCT01387932|616821505|FG001|Randomized and Treated|Withdrawal by Subject|2|||
170674628|NCT01387932|616821504|FG000|Survival Follow-up|Liver Transplant|24|||
170674629|NCT01387932|616821505|FG001|Survival Follow-up|Liver Transplant|28|||
170674630|NCT01387932|616821504|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
170674631|NCT01387932|616821505|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
170674632|NCT01387932|616821504|FG000|Survival Follow-up|Withdrawal by Subject|2|||
170674633|NCT01387932|616821505|FG001|Survival Follow-up|Withdrawal by Subject|4|||
170674634|NCT01387932|616821504|FG000|Survival Follow-up|Lost to Follow-up|6|||
170674635|NCT01387932|616821505|FG001|Survival Follow-up|Lost to Follow-up|5|||
170674636|NCT02197520|616821506|FG000|Period 1|Withdrawal by Subject|1|||
170674637|NCT02197520|616821507|FG001|Period 1|Withdrawal by Subject|0|||
170674638|NCT02197520|616821506|FG000|Period 2|Adverse Event|0|||
170674639|NCT02197520|616821507|FG001|Period 2|Adverse Event|2|||
170674640|NCT02197520|616821506|FG000|Period 2|Withdrawal by Subject|1|||
170674641|NCT02197520|616821507|FG001|Period 2|Withdrawal by Subject|0|||
170674642|NCT03208244|616821508|FG000|Overall Study|Death|1|||
170674643|NCT03385564|616821517|FG000|Overall Study|Adverse Event|0|||
170674644|NCT03385564|616821518|FG001|Overall Study|Adverse Event|0|||
170674645|NCT03385564|616821519|FG002|Overall Study|Adverse Event|3|||
170674646|NCT03385564|616821520|FG003|Overall Study|Adverse Event|3|||
170674647|NCT03385564|616821517|FG000|Overall Study|Other than listed|0|||
170674648|NCT03385564|616821518|FG001|Overall Study|Other than listed|0|||
170674649|NCT03385564|616821519|FG002|Overall Study|Other than listed|0|||
170674650|NCT03385564|616821520|FG003|Overall Study|Other than listed|5|||
170674651|NCT03385564|616821517|FG000|Overall Study|Withdrawal by Subject|0|||
170674652|NCT03385564|616821518|FG001|Overall Study|Withdrawal by Subject|1|||
170674653|NCT03385564|616821519|FG002|Overall Study|Withdrawal by Subject|1|||
170674654|NCT03385564|616821520|FG003|Overall Study|Withdrawal by Subject|0|||
170674655|NCT03385564|616821517|FG000|Overall Study|Lack of Efficacy|0|||
170674656|NCT03385564|616821518|FG001|Overall Study|Lack of Efficacy|0|||
170674657|NCT03385564|616821519|FG002|Overall Study|Lack of Efficacy|0|||
170674658|NCT03385564|616821520|FG003|Overall Study|Lack of Efficacy|1|||
170674659|NCT03385564|616821517|FG000|Overall Study|Death|0|||
170674660|NCT03385564|616821518|FG001|Overall Study|Death|0|||
170674661|NCT03385564|616821519|FG002|Overall Study|Death|1|||
170674662|NCT03385564|616821520|FG003|Overall Study|Death|0|||
170674663|NCT01427972|616821525|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674664|NCT01427972|616821526|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674665|NCT01427972|616821527|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674666|NCT01427972|616821528|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674667|NCT01427972|616821529|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674668|NCT01427972|616821530|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674669|NCT01427972|616821531|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674670|NCT01427972|616821532|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
170674671|NCT01427972|616821533|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674672|NCT01427972|616821534|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674673|NCT01427972|616821535|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674674|NCT01427972|616821536|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
170674675|NCT01427972|616821525|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674676|NCT01427972|616821526|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674677|NCT01427972|616821527|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674678|NCT01427972|616821528|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674679|NCT01427972|616821529|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674680|NCT01427972|616821530|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
170674681|NCT01427972|616821531|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674682|NCT01427972|616821532|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674683|NCT01427972|616821533|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674684|NCT01427972|616821534|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674685|NCT01427972|616821535|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674686|NCT01427972|616821536|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
170674687|NCT01427972|616821525|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674688|NCT01427972|616821526|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
170674689|NCT01427972|616821527|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674690|NCT01427972|616821528|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674691|NCT01427972|616821529|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674692|NCT01427972|616821530|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674693|NCT01427972|616821531|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674694|NCT01427972|616821532|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674695|NCT01427972|616821533|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674696|NCT01427972|616821534|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674697|NCT01427972|616821535|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674698|NCT01427972|616821536|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
170674699|NCT03344796|616821537|FG000|Overall Study|Lost to Follow-up|0|||
170674700|NCT03344796|616821538|FG001|Overall Study|Lost to Follow-up|0|||
170674701|NCT03344796|616821539|FG002|Overall Study|Lost to Follow-up|0|||
170674702|NCT03344796|616821540|FG003|Overall Study|Lost to Follow-up|0|||
170674703|NCT03344796|616821541|FG004|Overall Study|Lost to Follow-up|0|||
170674704|NCT03344796|616821542|FG005|Overall Study|Lost to Follow-up|2|||
170674705|NCT02412618|616821546|FG000|Overall Study|Withdrawal by Subject|1|||
170674706|NCT02412618|616821547|FG001|Overall Study|Withdrawal by Subject|1|||
170674707|NCT02412618|616821546|FG000|Overall Study|Expulsion|1|||
170674708|NCT02412618|616821547|FG001|Overall Study|Expulsion|1|||
170674709|NCT01253408|616821548|FG000|Overall Study|Adverse Event|0|||
170674710|NCT01253408|616821549|FG001|Overall Study|Adverse Event|1|||
170674711|NCT01253408|616821550|FG002|Overall Study|Adverse Event|0|||
170674712|NCT00816595|616821551|FG000|Overall Study|Withdrawal by Subject|2|||
170674713|NCT00816595|616821552|FG001|Overall Study|Withdrawal by Subject|0|||
170674714|NCT00679432|616821555|FG000|Overall Study|Adverse Event|5|||
170674715|NCT00679432|616821556|FG001|Overall Study|Adverse Event|6|||
170674716|NCT00679432|616821557|FG002|Overall Study|Adverse Event|10|||
170674717|NCT00679432|616821558|FG003|Overall Study|Adverse Event|7|||
170674718|NCT00679432|616821555|FG000|Overall Study|Protocol Violation|1|||
170674719|NCT00679432|616821556|FG001|Overall Study|Protocol Violation|1|||
170674720|NCT00679432|616821557|FG002|Overall Study|Protocol Violation|2|||
170674721|NCT00679432|616821558|FG003|Overall Study|Protocol Violation|1|||
170674722|NCT00679432|616821555|FG000|Overall Study|Withdrawal by Subject|8|||
170674723|NCT00679432|616821556|FG001|Overall Study|Withdrawal by Subject|11|||
170674724|NCT00679432|616821557|FG002|Overall Study|Withdrawal by Subject|10|||
170674725|NCT00679432|616821558|FG003|Overall Study|Withdrawal by Subject|9|||
170674726|NCT00679432|616821555|FG000|Overall Study|Lost to Follow-up|1|||
170674727|NCT00679432|616821556|FG001|Overall Study|Lost to Follow-up|5|||
170674728|NCT00679432|616821557|FG002|Overall Study|Lost to Follow-up|4|||
170674729|NCT00679432|616821558|FG003|Overall Study|Lost to Follow-up|2|||
170674730|NCT00679432|616821555|FG000|Overall Study|Physician Decision|3|||
170674731|NCT00679432|616821556|FG001|Overall Study|Physician Decision|2|||
170674732|NCT00679432|616821557|FG002|Overall Study|Physician Decision|2|||
170674733|NCT00679432|616821558|FG003|Overall Study|Physician Decision|2|||
170674734|NCT00679432|616821555|FG000|Overall Study|Sponsor decision|1|||
170674735|NCT00679432|616821556|FG001|Overall Study|Sponsor decision|0|||
170674736|NCT00679432|616821557|FG002|Overall Study|Sponsor decision|0|||
170674737|NCT00679432|616821558|FG003|Overall Study|Sponsor decision|0|||
170674738|NCT00679432|616821555|FG000|Overall Study|Lack of Efficacy|13|||
170674739|NCT00679432|616821556|FG001|Overall Study|Lack of Efficacy|9|||
170674740|NCT00679432|616821557|FG002|Overall Study|Lack of Efficacy|14|||
170674741|NCT00679432|616821558|FG003|Overall Study|Lack of Efficacy|8|||
170628408|NCT03221556|616652037|FG000|Allocation|post-randomization exclusion|0|||
170628409|NCT03221556|616652038|FG001|Allocation|post-randomization exclusion|1|||
170628410|NCT03221556|616652037|FG000|Follow-Up|Withdrawal by Subject|0|||
170628411|NCT03221556|616652038|FG001|Follow-Up|Withdrawal by Subject|1|||
170628412|NCT02532517|616652039|FG000|Overall Study|Did not complete 24-Month visit|4|||
170628413|NCT02532517|616652039|FG000|Overall Study|Failed Angiographic eligibility|1|||
170628414|NCT02532517|616652039|FG000|Overall Study|Lost to Follow-up|4|||
170674742|NCT00679432|616821555|FG000|Overall Study|Infectious colitis, normal histology|5|||
170674743|NCT00679432|616821556|FG001|Overall Study|Infectious colitis, normal histology|4|||
170674744|NCT00679432|616821557|FG002|Overall Study|Infectious colitis, normal histology|8|||
170674745|NCT00679432|616821558|FG003|Overall Study|Infectious colitis, normal histology|3|||
170674746|NCT00679432|616821555|FG000|Overall Study|Randomization error, return to prior Rx|0|||
170674747|NCT00679432|616821556|FG001|Overall Study|Randomization error, return to prior Rx|0|||
170674748|NCT00679432|616821557|FG002|Overall Study|Randomization error, return to prior Rx|3|||
170674749|NCT00679432|616821558|FG003|Overall Study|Randomization error, return to prior Rx|0|||
170674750|NCT00824720|616821559|FG000|Overall Study|failed plug insertion|3|||
170674751|NCT00824720|616821560|FG001|Overall Study|failed plug insertion|1|||
170674752|NCT00824720|616821561|FG002|Overall Study|failed plug insertion|0|||
170674753|NCT00824720|616821559|FG000|Overall Study|Protocol Violation|0|||
170674754|NCT00824720|616821560|FG001|Overall Study|Protocol Violation|0|||
170674755|NCT00824720|616821561|FG002|Overall Study|Protocol Violation|1|||
170674756|NCT04875195|616821562|FG000|Overall Study|Death|9|||
170674757|NCT04875195|616821563|FG001|Overall Study|Death|3|||
170674758|NCT04875195|616821562|FG000|Overall Study|Withdrawal by Subject|2|||
170674759|NCT04875195|616821563|FG001|Overall Study|Withdrawal by Subject|1|||
170674760|NCT04875195|616821562|FG000|Overall Study|Ongoing in study|49|||
170674761|NCT04875195|616821563|FG001|Overall Study|Ongoing in study|2|||
170674762|NCT04094883|616821564|FG000|Overall Study|Withdrawal by Subject|1|||
170674763|NCT00826943|616821565|FG000|Overall Study|Withdrawal by Subject|0|||
170674764|NCT00826943|616821566|FG001|Overall Study|Withdrawal by Subject|0|||
170674765|NCT00826943|616821567|FG002|Overall Study|Withdrawal by Subject|0|||
170628415|NCT02532517|616652039|FG000|Overall Study|Withdrawal by Subject|4|||
170674766|NCT00826943|616821568|FG003|Overall Study|Withdrawal by Subject|0|||
170674767|NCT00826943|616821569|FG004|Overall Study|Withdrawal by Subject|1|||
170674768|NCT00826943|616821570|FG005|Overall Study|Withdrawal by Subject|0|||
170674769|NCT00074152|616821571|FG000|Overall Study|Death|21|||
170674770|NCT00074152|616821572|FG001|Overall Study|Death|9|||
170674771|NCT00074152|616821571|FG000|Overall Study|Lack of Efficacy|34|||
170628416|NCT02532517|616652039|FG000|Overall Study|Death|4|||
170628417|NCT02234843|616652040|FG000|Overall Study|Death|1|||
170628418|NCT02234843|616652041|FG001|Overall Study|Death|0|||
170628419|NCT02234843|616652042|FG002|Overall Study|Death|0|||
170628420|NCT02234843|616652043|FG003|Overall Study|Death|0|||
170628421|NCT02234843|616652044|FG004|Overall Study|Death|0|||
170628422|NCT02234843|616652045|FG005|Overall Study|Death|0|||
170628423|NCT02234843|616652046|FG006|Overall Study|Death|0|||
170628424|NCT02234843|616652047|FG007|Overall Study|Death|0|||
170628425|NCT02234843|616652048|FG008|Overall Study|Death|0|||
170628426|NCT02234843|616652049|FG009|Overall Study|Death|0|||
170628427|NCT02234843|616652040|FG000|Overall Study|Protocol Violation|1|||
170628428|NCT02234843|616652041|FG001|Overall Study|Protocol Violation|0|||
170628429|NCT02234843|616652042|FG002|Overall Study|Protocol Violation|1|||
170628430|NCT02234843|616652043|FG003|Overall Study|Protocol Violation|0|||
170674772|NCT00074152|616821572|FG001|Overall Study|Lack of Efficacy|24|||
170674773|NCT00228384|616821573|FG000|Overall Study|Death|9|||
170674774|NCT00228384|616821574|FG001|Overall Study|Death|3|||
170628431|NCT02234843|616652044|FG004|Overall Study|Protocol Violation|0|||
170628432|NCT02234843|616652045|FG005|Overall Study|Protocol Violation|0|||
170628433|NCT02234843|616652046|FG006|Overall Study|Protocol Violation|0|||
170628434|NCT02234843|616652047|FG007|Overall Study|Protocol Violation|0|||
170628435|NCT02234843|616652048|FG008|Overall Study|Protocol Violation|0|||
170628436|NCT02234843|616652049|FG009|Overall Study|Protocol Violation|0|||
170628437|NCT02234843|616652040|FG000|Overall Study|Efficacy outcome reached|2|||
170628438|NCT02234843|616652041|FG001|Overall Study|Efficacy outcome reached|0|||
170628439|NCT02234843|616652042|FG002|Overall Study|Efficacy outcome reached|0|||
170628440|NCT02234843|616652043|FG003|Overall Study|Efficacy outcome reached|0|||
170628441|NCT02234843|616652044|FG004|Overall Study|Efficacy outcome reached|0|||
170628442|NCT02234843|616652045|FG005|Overall Study|Efficacy outcome reached|2|||
170628443|NCT02234843|616652046|FG006|Overall Study|Efficacy outcome reached|0|||
170628444|NCT02234843|616652047|FG007|Overall Study|Efficacy outcome reached|0|||
170628445|NCT02234843|616652048|FG008|Overall Study|Efficacy outcome reached|0|||
170628446|NCT02234843|616652049|FG009|Overall Study|Efficacy outcome reached|0|||
170628447|NCT02234843|616652040|FG000|Overall Study|Patient convenience|2|||
170628448|NCT02234843|616652041|FG001|Overall Study|Patient convenience|0|||
170628449|NCT02234843|616652042|FG002|Overall Study|Patient convenience|0|||
170628450|NCT02234843|616652043|FG003|Overall Study|Patient convenience|0|||
170628451|NCT02234843|616652044|FG004|Overall Study|Patient convenience|0|||
170628452|NCT02234843|616652045|FG005|Overall Study|Patient convenience|1|||
170628453|NCT02234843|616652046|FG006|Overall Study|Patient convenience|0|||
170628454|NCT02234843|616652047|FG007|Overall Study|Patient convenience|0|||
170628455|NCT02234843|616652048|FG008|Overall Study|Patient convenience|0|||
170628456|NCT02234843|616652049|FG009|Overall Study|Patient convenience|0|||
170628457|NCT02234843|616652040|FG000|Overall Study|Withdrawal by Subject|5|||
170628458|NCT02234843|616652041|FG001|Overall Study|Withdrawal by Subject|1|||
170628459|NCT02234843|616652042|FG002|Overall Study|Withdrawal by Subject|1|||
170628460|NCT02234843|616652043|FG003|Overall Study|Withdrawal by Subject|0|||
170628461|NCT02234843|616652044|FG004|Overall Study|Withdrawal by Subject|0|||
170628462|NCT02234843|616652045|FG005|Overall Study|Withdrawal by Subject|7|||
170628463|NCT02234843|616652046|FG006|Overall Study|Withdrawal by Subject|0|||
170628464|NCT02234843|616652047|FG007|Overall Study|Withdrawal by Subject|0|||
170628465|NCT02234843|616652048|FG008|Overall Study|Withdrawal by Subject|0|||
170674775|NCT00228384|616821573|FG000|Overall Study|Lost to Follow-up|6|||
170674776|NCT00228384|616821574|FG001|Overall Study|Lost to Follow-up|10|||
170674777|NCT00228384|616821573|FG000|Overall Study|Surgical Intervention (bypass)|5|||
170674778|NCT00228384|616821574|FG001|Overall Study|Surgical Intervention (bypass)|5|||
170674779|NCT00228384|616821573|FG000|Overall Study|Withdrawal by Subject|9|||
170674780|NCT00228384|616821574|FG001|Overall Study|Withdrawal by Subject|10|||
170674781|NCT00228384|616821573|FG000|Overall Study|Physician Decision|0|||
170674782|NCT00228384|616821574|FG001|Overall Study|Physician Decision|1|||
170674783|NCT03715530|616821575|FG000|Overall Study|Lost to Follow-up|3|||
170674784|NCT03715530|616821576|FG001|Overall Study|Lost to Follow-up|1|||
170674785|NCT03715530|616821577|FG002|Overall Study|Lost to Follow-up|2|||
170674786|NCT01594762|616821578|FG000|Overall Study|Withdrawal by Subject|1|||
170674787|NCT01594762|616821579|FG001|Overall Study|Withdrawal by Subject|0|||
170674788|NCT01594762|616821578|FG000|Overall Study|Lost to Follow-up|10|||
170674789|NCT01594762|616821579|FG001|Overall Study|Lost to Follow-up|10|||
170674790|NCT01785069|616821583|FG000|Overall Study|Implanted with nonstudy device|1|||
170674791|NCT01785069|616821584|FG001|Overall Study|Implanted with nonstudy device|2|||
170674792|NCT01785069|616821585|FG002|Overall Study|Implanted with nonstudy device|1|||
170674793|NCT01785069|616821586|FG003|Overall Study|Implanted with nonstudy device|0|||
170674794|NCT01785069|616821583|FG000|Overall Study|Death|0|||
170674795|NCT01785069|616821584|FG001|Overall Study|Death|0|||
170674796|NCT01785069|616821585|FG002|Overall Study|Death|2|||
170674797|NCT01785069|616821586|FG003|Overall Study|Death|0|||
170674798|NCT01785069|616821583|FG000|Overall Study|Subject choice|2|||
170674799|NCT01785069|616821584|FG001|Overall Study|Subject choice|2|||
170674800|NCT01785069|616821585|FG002|Overall Study|Subject choice|0|||
170674801|NCT01785069|616821586|FG003|Overall Study|Subject choice|1|||
170674802|NCT01785069|616821583|FG000|Overall Study|Lost to Follow-up|1|||
170674803|NCT01785069|616821584|FG001|Overall Study|Lost to Follow-up|2|||
170674804|NCT01785069|616821585|FG002|Overall Study|Lost to Follow-up|4|||
170674805|NCT01785069|616821586|FG003|Overall Study|Lost to Follow-up|1|||
170674806|NCT01785069|616821583|FG000|Overall Study|Reason not Specified|1|||
170674807|NCT01785069|616821584|FG001|Overall Study|Reason not Specified|2|||
170674808|NCT01785069|616821585|FG002|Overall Study|Reason not Specified|1|||
170674809|NCT01785069|616821586|FG003|Overall Study|Reason not Specified|4|||
170674810|NCT01785069|616821583|FG000|Overall Study|Not evaluable|7|||
170674811|NCT01785069|616821584|FG001|Overall Study|Not evaluable|4|||
170674812|NCT01785069|616821585|FG002|Overall Study|Not evaluable|5|||
170674813|NCT01785069|616821586|FG003|Overall Study|Not evaluable|8|||
170674814|NCT03338998|616821587|FG000|Treatment Period|Withdrawal by Subject|1|||
170674815|NCT03338998|616821588|FG001|Treatment Period|Withdrawal by Subject|1|||
170674816|NCT03338998|616821587|FG000|Treatment Period|Adverse Event|0|||
170674817|NCT03338998|616821588|FG001|Treatment Period|Adverse Event|2|||
170674818|NCT03338998|616821587|FG000|Treatment Period|Protocol deviation|1|||
170674819|NCT03338998|616821588|FG001|Treatment Period|Protocol deviation|0|||
170674820|NCT03338998|616821587|FG000|Treatment Period|Physician Decision|2|||
170674821|NCT03338998|616821588|FG001|Treatment Period|Physician Decision|0|||
170674822|NCT03338998|616821587|FG000|Treatment Period|Subject failed swallow test|4|||
170674823|NCT03338998|616821588|FG001|Treatment Period|Subject failed swallow test|0|||
170674824|NCT03338998|616821587|FG000|Safety Follow-Up Period|Adverse Event|0|||
170820349|NCT02660034|617349631|FG009|Overall Study|Sponsor Decision|0|||
170820350|NCT02660034|617349632|FG010|Overall Study|Sponsor Decision|0|||
170820351|NCT02660034|617349633|FG011|Overall Study|Sponsor Decision|0|||
170820352|NCT02660034|617349634|FG012|Overall Study|Sponsor Decision|0|||
170820353|NCT02660034|617349635|FG013|Overall Study|Sponsor Decision|1|||
170820354|NCT02660034|617349622|FG000|Overall Study|Withdrawal by Subject|0|||
170820355|NCT02660034|617349623|FG001|Overall Study|Withdrawal by Subject|0|||
170820356|NCT02660034|617349624|FG002|Overall Study|Withdrawal by Subject|0|||
170820357|NCT02660034|617349625|FG003|Overall Study|Withdrawal by Subject|0|||
170820358|NCT02660034|617349626|FG004|Overall Study|Withdrawal by Subject|0|||
170820359|NCT02660034|617349627|FG005|Overall Study|Withdrawal by Subject|0|||
170820360|NCT02660034|617349628|FG006|Overall Study|Withdrawal by Subject|1|||
170820361|NCT02660034|617349629|FG007|Overall Study|Withdrawal by Subject|1|||
170628466|NCT02234843|616652049|FG009|Overall Study|Withdrawal by Subject|0|||
170628467|NCT02234843|616652040|FG000|Overall Study|Recovery|1|||
170628468|NCT02234843|616652041|FG001|Overall Study|Recovery|0|||
170628469|NCT02234843|616652042|FG002|Overall Study|Recovery|0|||
170628470|NCT02234843|616652043|FG003|Overall Study|Recovery|0|||
170628471|NCT02234843|616652044|FG004|Overall Study|Recovery|0|||
170628472|NCT02234843|616652045|FG005|Overall Study|Recovery|0|||
170628473|NCT02234843|616652046|FG006|Overall Study|Recovery|0|||
170628474|NCT02234843|616652047|FG007|Overall Study|Recovery|0|||
170628475|NCT02234843|616652048|FG008|Overall Study|Recovery|0|||
170628476|NCT02234843|616652049|FG009|Overall Study|Recovery|0|||
170628477|NCT02234843|616652040|FG000|Overall Study|Other|0|||
170628478|NCT02234843|616652041|FG001|Overall Study|Other|2|||
170628479|NCT02234843|616652042|FG002|Overall Study|Other|0|||
170628480|NCT02234843|616652043|FG003|Overall Study|Other|1|||
170628481|NCT02234843|616652044|FG004|Overall Study|Other|0|||
170628482|NCT02234843|616652045|FG005|Overall Study|Other|1|||
170628483|NCT02234843|616652046|FG006|Overall Study|Other|0|||
170628484|NCT02234843|616652047|FG007|Overall Study|Other|1|||
170628485|NCT02234843|616652048|FG008|Overall Study|Other|0|||
170628486|NCT02234843|616652049|FG009|Overall Study|Other|0|||
170628487|NCT02234843|616652040|FG000|Overall Study|Physician Decision|4|||
170628488|NCT02234843|616652041|FG001|Overall Study|Physician Decision|1|||
170628489|NCT02234843|616652042|FG002|Overall Study|Physician Decision|0|||
170628490|NCT02234843|616652043|FG003|Overall Study|Physician Decision|1|||
170628491|NCT02234843|616652044|FG004|Overall Study|Physician Decision|0|||
170628492|NCT02234843|616652045|FG005|Overall Study|Physician Decision|0|||
170628493|NCT02234843|616652046|FG006|Overall Study|Physician Decision|0|||
170628494|NCT02234843|616652047|FG007|Overall Study|Physician Decision|1|||
170628495|NCT02234843|616652048|FG008|Overall Study|Physician Decision|0|||
170628496|NCT02234843|616652049|FG009|Overall Study|Physician Decision|0|||
170628497|NCT02234843|616652040|FG000|Overall Study|Adverse Event|5|||
170628498|NCT02234843|616652041|FG001|Overall Study|Adverse Event|1|||
170628499|NCT02234843|616652042|FG002|Overall Study|Adverse Event|1|||
170628500|NCT02234843|616652043|FG003|Overall Study|Adverse Event|3|||
170628501|NCT02234843|616652044|FG004|Overall Study|Adverse Event|2|||
170628502|NCT02234843|616652045|FG005|Overall Study|Adverse Event|1|||
170628503|NCT02234843|616652046|FG006|Overall Study|Adverse Event|0|||
170628504|NCT02234843|616652047|FG007|Overall Study|Adverse Event|0|||
170628505|NCT02234843|616652048|FG008|Overall Study|Adverse Event|1|||
170628506|NCT02234843|616652049|FG009|Overall Study|Adverse Event|0|||
170628507|NCT02234843|616652040|FG000|Overall Study|Non-compliance with study drug|1|||
170820362|NCT02660034|617349630|FG008|Overall Study|Withdrawal by Subject|1|||
170628508|NCT02234843|616652041|FG001|Overall Study|Non-compliance with study drug|0|||
170628509|NCT02234843|616652042|FG002|Overall Study|Non-compliance with study drug|0|||
170628510|NCT02234843|616652043|FG003|Overall Study|Non-compliance with study drug|0|||
170628511|NCT02234843|616652044|FG004|Overall Study|Non-compliance with study drug|0|||
170628512|NCT02234843|616652045|FG005|Overall Study|Non-compliance with study drug|1|||
170628513|NCT02234843|616652046|FG006|Overall Study|Non-compliance with study drug|1|||
170628514|NCT02234843|616652047|FG007|Overall Study|Non-compliance with study drug|0|||
170628515|NCT02234843|616652048|FG008|Overall Study|Non-compliance with study drug|0|||
170628516|NCT02234843|616652049|FG009|Overall Study|Non-compliance with study drug|0|||
170628517|NCT02234843|616652040|FG000|Overall Study|Lost to Follow-up|0|||
170628518|NCT02234843|616652041|FG001|Overall Study|Lost to Follow-up|1|||
170628519|NCT02234843|616652042|FG002|Overall Study|Lost to Follow-up|0|||
170628520|NCT02234843|616652043|FG003|Overall Study|Lost to Follow-up|0|||
170628521|NCT02234843|616652044|FG004|Overall Study|Lost to Follow-up|0|||
170628522|NCT02234843|616652045|FG005|Overall Study|Lost to Follow-up|0|||
170628523|NCT02234843|616652046|FG006|Overall Study|Lost to Follow-up|1|||
170628524|NCT02234843|616652047|FG007|Overall Study|Lost to Follow-up|0|||
170628525|NCT02234843|616652048|FG008|Overall Study|Lost to Follow-up|0|||
170628526|NCT02234843|616652049|FG009|Overall Study|Lost to Follow-up|0|||
170628527|NCT03694353|616652050|FG000|Overall Study|Withdrawal by Subject|1|||
170628528|NCT03694353|616652050|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
170628529|NCT05138653|616652051|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
170628530|NCT05138653|616652052|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628531|NCT05138653|616652053|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628532|NCT05138653|616652054|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628533|NCT05138653|616652055|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628534|NCT05138653|616652056|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628535|NCT05138653|616652057|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628536|NCT05138653|616652058|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628537|NCT05138653|616652059|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628538|NCT05138653|616652060|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628539|NCT05138653|616652061|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628540|NCT05138653|616652062|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628541|NCT05138653|616652063|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628542|NCT05138653|616652064|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628543|NCT05138653|616652065|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628544|NCT05138653|616652066|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
170628545|NCT05138653|616652051|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628546|NCT05138653|616652052|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
170628547|NCT05138653|616652053|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628548|NCT05138653|616652054|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628549|NCT05138653|616652055|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628550|NCT05138653|616652056|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628551|NCT05138653|616652057|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628552|NCT05138653|616652058|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628553|NCT05138653|616652059|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
170628554|NCT05138653|616652060|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628555|NCT05138653|616652061|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628556|NCT05138653|616652062|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628557|NCT05138653|616652063|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628558|NCT05138653|616652064|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628559|NCT05138653|616652065|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628560|NCT05138653|616652066|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
170628561|NCT05138653|616652051|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628562|NCT05138653|616652052|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
170628563|NCT05138653|616652053|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628564|NCT05138653|616652054|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628565|NCT05138653|616652055|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
170628566|NCT05138653|616652056|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628567|NCT05138653|616652057|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628568|NCT05138653|616652058|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628569|NCT05138653|616652059|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628570|NCT05138653|616652060|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628571|NCT05138653|616652061|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628572|NCT05138653|616652062|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628573|NCT05138653|616652063|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628574|NCT05138653|616652064|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628575|NCT05138653|616652065|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170628576|NCT05138653|616652066|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
170674825|NCT03338998|616821588|FG001|Safety Follow-Up Period|Adverse Event|1|||
170674826|NCT03338998|616821587|FG000|Safety Follow-Up Period|Protocol deviation|1|||
170674827|NCT03338998|616821588|FG001|Safety Follow-Up Period|Protocol deviation|0|||
170674828|NCT03338998|616821587|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
170674829|NCT03338998|616821588|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
170674830|NCT03288129|616821591|FG000|Overall Study|Adverse Event|10|||
170674831|NCT03288129|616821591|FG000|Overall Study|Lost to Follow-up|3|||
170674832|NCT03288129|616821591|FG000|Overall Study|Withdrawal by Subject|3|||
170674833|NCT03288129|616821591|FG000|Overall Study|Withdrawal of consent/assent|1|||
170674834|NCT03288129|616821591|FG000|Overall Study|Other|5|||
170674835|NCT04404361|616821592|FG000|Overall Study|Death|12|||
170674836|NCT04404361|616821593|FG001|Overall Study|Death|12|||
170674837|NCT04404361|616821592|FG000|Overall Study|Withdrawal by Subject|13|||
170674838|NCT04404361|616821593|FG001|Overall Study|Withdrawal by Subject|5|||
170674839|NCT04404361|616821592|FG000|Overall Study|Lost to Follow-up|6|||
170674840|NCT04404361|616821593|FG001|Overall Study|Lost to Follow-up|3|||
170674841|NCT04404361|616821592|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
170674842|NCT04404361|616821593|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
170674843|NCT04706091|616821599|FG000|Treatment 2|Withdrawal by Subject|1|||
170674844|NCT04706091|616821600|FG001|Treatment 2|Withdrawal by Subject|0|||
170674845|NCT01446289|616821601|FG000|Overall Study|Withdrawal by Subject|1|||
170674846|NCT01446289|616821602|FG001|Overall Study|Withdrawal by Subject|0|||
170674847|NCT01446289|616821603|FG002|Overall Study|Withdrawal by Subject|1|||
170674848|NCT01446289|616821604|FG003|Overall Study|Withdrawal by Subject|0|||
170674849|NCT03329573|616821605|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
170674850|NCT03329573|616821606|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
170674851|NCT03329573|616821607|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
170674852|NCT03329573|616821608|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
170674853|NCT03329573|616821605|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
170674854|NCT03329573|616821606|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
170674855|NCT03329573|616821607|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170674856|NCT03329573|616821608|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170674857|NCT03329573|616821605|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
170674858|NCT03329573|616821606|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
170674859|NCT03329573|616821607|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
170674860|NCT03329573|616821608|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
170674861|NCT03329573|616821605|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
170674862|NCT03329573|616821606|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
170674863|NCT03329573|616821607|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
170674864|NCT03329573|616821608|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
170674865|NCT02777333|616821611|FG000|Overall Study|Withdrawal by Subject|0|||
170674866|NCT02777333|616821612|FG001|Overall Study|Withdrawal by Subject|1|||
170674867|NCT02777333|616821611|FG000|Overall Study|Lost to Follow-up|0|||
170674868|NCT02777333|616821612|FG001|Overall Study|Lost to Follow-up|1|||
170674869|NCT01980940|616821614|FG000|Overall Study|Protocol Violation|0|||
170674870|NCT01980940|616821615|FG001|Overall Study|Protocol Violation|0|||
170674871|NCT01980940|616821616|FG002|Overall Study|Protocol Violation|0|||
170628577|NCT05138653|616652051|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628578|NCT05138653|616652052|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628579|NCT05138653|616652053|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628580|NCT05138653|616652054|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628581|NCT05138653|616652055|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628582|NCT05138653|616652056|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628583|NCT05138653|616652057|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
170628584|NCT05138653|616652058|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628585|NCT05138653|616652059|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628586|NCT05138653|616652060|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628587|NCT05138653|616652061|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628588|NCT05138653|616652062|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170674872|NCT01980940|616821617|FG003|Overall Study|Protocol Violation|0|||
170674873|NCT01980940|616821618|FG004|Overall Study|Protocol Violation|0|||
170628589|NCT05138653|616652063|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628590|NCT05138653|616652064|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628591|NCT05138653|616652065|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628592|NCT05138653|616652066|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
170628593|NCT05138653|616652051|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170674874|NCT01980940|616821619|FG005|Overall Study|Protocol Violation|2|||
170674875|NCT01980940|616821620|FG006|Overall Study|Protocol Violation|0|||
170674876|NCT01980940|616821621|FG007|Overall Study|Protocol Violation|0|||
170674877|NCT00837811|616821622|FG000|Overall Study|Adverse Event|4|||
170674878|NCT00837811|616821623|FG001|Overall Study|Adverse Event|6|||
170674879|NCT00837811|616821624|FG002|Overall Study|Adverse Event|0|||
170628594|NCT05138653|616652052|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628595|NCT05138653|616652053|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628596|NCT05138653|616652054|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628597|NCT05138653|616652055|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628598|NCT05138653|616652056|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628599|NCT05138653|616652057|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628600|NCT05138653|616652058|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628601|NCT05138653|616652059|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628602|NCT05138653|616652060|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628603|NCT05138653|616652061|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
170628604|NCT05138653|616652062|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628605|NCT05138653|616652063|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
170628606|NCT05138653|616652064|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628607|NCT05138653|616652065|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
170628608|NCT05138653|616652066|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
170628609|NCT05138653|616652051|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628610|NCT05138653|616652052|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628611|NCT05138653|616652053|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628612|NCT05138653|616652054|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628613|NCT05138653|616652055|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628614|NCT05138653|616652056|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628615|NCT05138653|616652057|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628616|NCT05138653|616652058|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628617|NCT05138653|616652059|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628618|NCT05138653|616652060|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628619|NCT05138653|616652061|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628620|NCT05138653|616652062|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628621|NCT05138653|616652063|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628622|NCT05138653|616652064|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628623|NCT05138653|616652065|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
170628624|NCT05138653|616652066|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
170628625|NCT05138653|616652051|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628626|NCT05138653|616652052|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628627|NCT05138653|616652053|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628628|NCT05138653|616652054|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628629|NCT05138653|616652055|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628630|NCT05138653|616652056|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628631|NCT05138653|616652057|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628632|NCT05138653|616652058|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628633|NCT05138653|616652059|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628634|NCT05138653|616652060|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628635|NCT05138653|616652061|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628636|NCT05138653|616652062|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628637|NCT05138653|616652063|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628638|NCT05138653|616652064|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
170628639|NCT05138653|616652065|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628640|NCT05138653|616652066|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
170628641|NCT00091949|616654188|FG000|Overall Study|Withdrawal by Subject|117|||
170628642|NCT00091949|616654189|FG001|Overall Study|Withdrawal by Subject|110|||
170628643|NCT00091949|616654188|FG000|Overall Study|Lost to Follow-up|58|||
170628644|NCT00091949|616654189|FG001|Overall Study|Lost to Follow-up|41|||
170628645|NCT00303069|616654190|FG000|Overall Study|Lost to Follow-up|1|||
170628646|NCT00303069|616654191|FG001|Overall Study|Lost to Follow-up|0|||
170628647|NCT00303069|616654192|FG002|Overall Study|Lost to Follow-up|0|||
170628648|NCT00303069|616654193|FG003|Overall Study|Lost to Follow-up|2|||
170628649|NCT00303069|616654190|FG000|Overall Study|subject moved|1|||
170628650|NCT00303069|616654191|FG001|Overall Study|subject moved|0|||
170628651|NCT00303069|616654192|FG002|Overall Study|subject moved|0|||
170628652|NCT00303069|616654193|FG003|Overall Study|subject moved|0|||
170628653|NCT00303069|616654190|FG000|Overall Study|Recruitment into Army Reserves|0|||
170628654|NCT00303069|616654191|FG001|Overall Study|Recruitment into Army Reserves|0|||
170628655|NCT00303069|616654192|FG002|Overall Study|Recruitment into Army Reserves|1|||
170628656|NCT00303069|616654193|FG003|Overall Study|Recruitment into Army Reserves|0|||
170628657|NCT01256788|616654196|FG000|Overall Study|Lost to Follow-up|5|||
170628658|NCT01256788|616654197|FG001|Overall Study|Lost to Follow-up|8|||
170674880|NCT00837811|616821622|FG000|Overall Study|Death|1|||
170674881|NCT00837811|616821623|FG001|Overall Study|Death|1|||
170674882|NCT00837811|616821624|FG002|Overall Study|Death|0|||
170674883|NCT00837811|616821622|FG000|Overall Study|Lack of Efficacy|0|||
170674884|NCT00837811|616821623|FG001|Overall Study|Lack of Efficacy|11|||
170674885|NCT00837811|616821624|FG002|Overall Study|Lack of Efficacy|0|||
170674886|NCT00837811|616821622|FG000|Overall Study|Lost to Follow-up|1|||
170674887|NCT00837811|616821623|FG001|Overall Study|Lost to Follow-up|3|||
170674888|NCT00837811|616821624|FG002|Overall Study|Lost to Follow-up|0|||
170674889|NCT00837811|616821622|FG000|Overall Study|Physician Decision|0|||
170674890|NCT00837811|616821623|FG001|Overall Study|Physician Decision|2|||
170674891|NCT00837811|616821624|FG002|Overall Study|Physician Decision|1|||
170674892|NCT00837811|616821622|FG000|Overall Study|Withdrawal by Subject|1|||
170674893|NCT00837811|616821623|FG001|Overall Study|Withdrawal by Subject|9|||
170674894|NCT00837811|616821624|FG002|Overall Study|Withdrawal by Subject|0|||
170674895|NCT00837811|616821622|FG000|Overall Study|Sponsor Decision|0|||
170674896|NCT00837811|616821623|FG001|Overall Study|Sponsor Decision|2|||
170674897|NCT00837811|616821624|FG002|Overall Study|Sponsor Decision|0|||
170674898|NCT05695209|616821631|FG000|3-months|Withdrawal by Subject|2|||
170674899|NCT05695209|616821632|FG001|3-months|Withdrawal by Subject|0|||
170674900|NCT05695209|616821631|FG000|3-months|Unable to contact for 3-month data collection|0|||
170674901|NCT05695209|616821632|FG001|3-months|Unable to contact for 3-month data collection|1|||
170674902|NCT05695209|616821631|FG000|6-months|Lost to Follow-up|1|||
170674903|NCT05695209|616821632|FG001|6-months|Lost to Follow-up|1|||
170674904|NCT01397708|616821641|FG000|Overall Study|Withdrawal by Subject|0|||
170674905|NCT01397708|616821642|FG001|Overall Study|Withdrawal by Subject|0|||
170674906|NCT01397708|616821643|FG002|Overall Study|Withdrawal by Subject|1|||
170674907|NCT01397708|616821644|FG003|Overall Study|Withdrawal by Subject|0|||
170674908|NCT01397708|616821645|FG004|Overall Study|Withdrawal by Subject|0|||
170674909|NCT01397708|616821646|FG005|Overall Study|Withdrawal by Subject|0|||
170674910|NCT01397708|616821647|FG006|Overall Study|Withdrawal by Subject|0|||
170674911|NCT01397708|616821648|FG007|Overall Study|Withdrawal by Subject|1|||
170674912|NCT01397708|616821641|FG000|Overall Study|Death|0|||
170674913|NCT01397708|616821642|FG001|Overall Study|Death|0|||
170674914|NCT01397708|616821643|FG002|Overall Study|Death|1|||
170674915|NCT01397708|616821644|FG003|Overall Study|Death|1|||
170674916|NCT01397708|616821645|FG004|Overall Study|Death|0|||
170674917|NCT01397708|616821646|FG005|Overall Study|Death|0|||
170674918|NCT01397708|616821647|FG006|Overall Study|Death|0|||
170674919|NCT01397708|616821648|FG007|Overall Study|Death|0|||
170674920|NCT01397708|616821641|FG000|Overall Study|Lost to Follow-up|0|||
170674921|NCT01397708|616821642|FG001|Overall Study|Lost to Follow-up|0|||
170674922|NCT01397708|616821643|FG002|Overall Study|Lost to Follow-up|0|||
170674923|NCT01397708|616821644|FG003|Overall Study|Lost to Follow-up|0|||
170674924|NCT01397708|616821645|FG004|Overall Study|Lost to Follow-up|1|||
170674925|NCT01397708|616821646|FG005|Overall Study|Lost to Follow-up|0|||
170674926|NCT01397708|616821647|FG006|Overall Study|Lost to Follow-up|0|||
170674927|NCT01397708|616821648|FG007|Overall Study|Lost to Follow-up|0|||
170674928|NCT01397708|616821641|FG000|Overall Study|Other|0|||
170674929|NCT01397708|616821642|FG001|Overall Study|Other|0|||
170674930|NCT01397708|616821643|FG002|Overall Study|Other|0|||
170674931|NCT01397708|616821644|FG003|Overall Study|Other|0|||
170674932|NCT01397708|616821645|FG004|Overall Study|Other|0|||
170674933|NCT01397708|616821646|FG005|Overall Study|Other|0|||
170674934|NCT01397708|616821647|FG006|Overall Study|Other|1|||
170674935|NCT01397708|616821648|FG007|Overall Study|Other|0|||
170674936|NCT04731363|616821654|FG000|Overall Study|Could not obtain samples|0|||
170674937|NCT04731363|616821655|FG001|Overall Study|Could not obtain samples|1|||
170674938|NCT04731363|616821656|FG002|Overall Study|Could not obtain samples|0|||
170674939|NCT04731363|616821657|FG003|Overall Study|Could not obtain samples|0|||
170674940|NCT04731363|616821654|FG000|Overall Study|Physician Decision|0|||
170674941|NCT04731363|616821655|FG001|Overall Study|Physician Decision|1|||
170674942|NCT04731363|616821656|FG002|Overall Study|Physician Decision|0|||
170674943|NCT04731363|616821657|FG003|Overall Study|Physician Decision|0|||
170674944|NCT04997304|616821658|FG000|Overall Study|Lost to Follow-up|11|||
170674945|NCT04997304|616821658|FG000|Overall Study|Death|1|||
170674946|NCT04997304|616821658|FG000|Overall Study|Withdrawal by Subject|14|||
170674947|NCT01664533|616823297|FG000|Overall Study|Death|42|||
170674948|NCT01664533|616823297|FG000|Overall Study|Lost to Follow-up|3|||
170674949|NCT01664533|616823297|FG000|Overall Study|Study termination|9|||
170674950|NCT01664533|616823297|FG000|Overall Study|Protocol Violation|3|||
170674951|NCT00844831|616823298|FG000|Overall Study|Withdrawal by Subject|4|||
170674952|NCT00844831|616823298|FG000|Overall Study|Adverse Event|1|||
170674953|NCT00844831|616823298|FG000|Overall Study|Physician Decision|1|||
170674954|NCT05255068|616823299|FG000|Overall Study|Lost to Follow-up|0|||
170674955|NCT05255068|616823300|FG001|Overall Study|Lost to Follow-up|1|||
170674956|NCT02370160|616823304|FG000|Overall Study|Death|3|||
170674957|NCT02370160|616823305|FG001|Overall Study|Death|4|||
170674958|NCT02370160|616823306|FG002|Overall Study|Death|1|||
170674959|NCT04487730|616823307|FG000|Overall Study|Withdrawal by Subject|3|||
170674960|NCT04487730|616823308|FG001|Overall Study|Withdrawal by Subject|1|||
170674961|NCT04487730|616823307|FG000|Overall Study|Lost to Follow-up|0|||
170674962|NCT04487730|616823308|FG001|Overall Study|Lost to Follow-up|1|||
170674963|NCT04487730|616823307|FG000|Overall Study|Physician Decision|0|||
170674964|NCT04487730|616823308|FG001|Overall Study|Physician Decision|1|||
170674965|NCT00907777|616823309|FG000|Overall Study|Withdrawal by Subject|0|||
170674966|NCT00907777|616823310|FG001|Overall Study|Withdrawal by Subject|1|||
170674967|NCT03156543|616823311|FG000|Overall Study|Withdrawal by Subject|1|||
170674968|NCT03156543|616823312|FG001|Overall Study|Withdrawal by Subject|0|||
170674969|NCT03364023|616823313|FG000|Overall Study|Lost to Follow-up|3|||
170674970|NCT03364023|616823313|FG000|Overall Study|Death|14|||
170674971|NCT02891850|616823314|FG000|Overall Study|Adverse Event|3|||
170674972|NCT02891850|616823315|FG001|Overall Study|Adverse Event|0|||
170674973|NCT02891850|616823314|FG000|Overall Study|Death|0|||
170674974|NCT02891850|616823315|FG001|Overall Study|Death|4|||
170674975|NCT02891850|616823314|FG000|Overall Study|Physician Decision|1|||
170674976|NCT02891850|616823315|FG001|Overall Study|Physician Decision|0|||
170674977|NCT02891850|616823314|FG000|Overall Study|Pregnancy|1|||
170674978|NCT02891850|616823315|FG001|Overall Study|Pregnancy|0|||
170674979|NCT02891850|616823314|FG000|Overall Study|Withdrawal by Subject|2|||
170674980|NCT02891850|616823315|FG001|Overall Study|Withdrawal by Subject|3|||
170674981|NCT01408485|616823316|FG000|Overall Study|Withdrawal by Subject|21|||
170674982|NCT04160195|616823317|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
170674983|NCT04160195|616823318|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
170674984|NCT01751867|616823319|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
170674985|NCT01751867|616823320|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
170674986|NCT01751867|616823319|FG000|Overall Study|Diease Progression|4|||
170674987|NCT01751867|616823320|FG001|Overall Study|Diease Progression|18|||
170674988|NCT01751867|616823319|FG000|Overall Study|Adverse Event|8|||
170674989|NCT01751867|616823320|FG001|Overall Study|Adverse Event|15|||
170674990|NCT01751867|616823319|FG000|Overall Study|Poor Compliance|0|||
170674991|NCT01751867|616823320|FG001|Overall Study|Poor Compliance|5|||
170674992|NCT01751867|616823319|FG000|Overall Study|Withdrawal by Subject|3|||
170674993|NCT01751867|616823320|FG001|Overall Study|Withdrawal by Subject|1|||
170674994|NCT01751867|616823319|FG000|Overall Study|Physician Decision|4|||
170674995|NCT01751867|616823320|FG001|Overall Study|Physician Decision|7|||
170674996|NCT01751867|616823319|FG000|Overall Study|Protocol Violation|0|||
170674997|NCT01751867|616823320|FG001|Overall Study|Protocol Violation|2|||
170674998|NCT01751867|616823319|FG000|Overall Study|Death|0|||
170674999|NCT01751867|616823320|FG001|Overall Study|Death|5|||
170675000|NCT01751867|616823319|FG000|Overall Study|Other|11|||
170675001|NCT01751867|616823320|FG001|Overall Study|Other|37|||
170675002|NCT01751867|616823319|FG000|Overall Study|Randomized but not treated.|2|||
170675003|NCT01751867|616823320|FG001|Overall Study|Randomized but not treated.|1|||
170675004|NCT01396148|616823321|FG000|Overall Study|Patient Decision|1|||
170675005|NCT00224042|616823330|FG000|Overall Study|Adverse Event|2|||
170675006|NCT00224042|616823331|FG001|Overall Study|Adverse Event|1|||
170675007|NCT00224042|616823330|FG000|Overall Study|Protocol Violation|0|||
170675008|NCT00224042|616823331|FG001|Overall Study|Protocol Violation|1|||
170675009|NCT00224042|616823330|FG000|Overall Study|Physician Decision|0|||
170675010|NCT00224042|616823331|FG001|Overall Study|Physician Decision|1|||
170675011|NCT00224042|616823330|FG000|Overall Study|Did not meet lab incusion criteria|2|||
170675012|NCT00224042|616823331|FG001|Overall Study|Did not meet lab incusion criteria|3|||
170675013|NCT00224042|616823330|FG000|Overall Study|Other|2|||
170675014|NCT00224042|616823331|FG001|Overall Study|Other|0|||
170675015|NCT00840450|616823332|FG000|Overall Study|Adverse Event|1|||
170675016|NCT00840450|616823332|FG000|Overall Study|Lack of Efficacy|2|||
170675017|NCT03095066|616823335|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
170675018|NCT03095066|616823336|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
170820363|NCT02660034|617349631|FG009|Overall Study|Withdrawal by Subject|0|||
170820364|NCT02660034|617349632|FG010|Overall Study|Withdrawal by Subject|0|||
170820365|NCT02660034|617349633|FG011|Overall Study|Withdrawal by Subject|1|||
170820366|NCT02660034|617349634|FG012|Overall Study|Withdrawal by Subject|2|||
170820367|NCT02660034|617349635|FG013|Overall Study|Withdrawal by Subject|0|||
170820368|NCT02660034|617349622|FG000|Overall Study|Death|0|||
170820369|NCT02660034|617349623|FG001|Overall Study|Death|0|||
170820370|NCT02660034|617349624|FG002|Overall Study|Death|0|||
170820371|NCT02660034|617349625|FG003|Overall Study|Death|0|||
170675019|NCT03095066|616823337|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
170675020|NCT03095066|616823338|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
170675021|NCT03095066|616823339|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
170675022|NCT03095066|616823340|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
170675023|NCT03095066|616823341|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
170675024|NCT03095066|616823342|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
170820372|NCT02660034|617349626|FG004|Overall Study|Death|0|||
170820373|NCT02660034|617349627|FG005|Overall Study|Death|13|||
170628659|NCT01256788|616654198|FG002|Overall Study|Lost to Follow-up|3|||
170628660|NCT00777153|616654207|FG000|Overall Study|Lost to Follow-up|1|||
170628661|NCT00777153|616654208|FG001|Overall Study|Lost to Follow-up|1|||
170628662|NCT00777153|616654209|FG002|Overall Study|Lost to Follow-up|0|||
170628663|NCT00777153|616654207|FG000|Overall Study|Death|85|||
170628664|NCT00777153|616654208|FG001|Overall Study|Death|73|||
170628665|NCT00777153|616654209|FG002|Overall Study|Death|33|||
170628666|NCT00777153|616654207|FG000|Overall Study|Withdrawal by Subject|3|||
170628667|NCT00777153|616654208|FG001|Overall Study|Withdrawal by Subject|4|||
170628668|NCT00777153|616654209|FG002|Overall Study|Withdrawal by Subject|3|||
170628669|NCT00777153|616654207|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
170628670|NCT00777153|616654208|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
170628671|NCT00777153|616654209|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
170675025|NCT03095066|616823335|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
170675026|NCT03095066|616823336|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
170675027|NCT03095066|616823337|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
170675028|NCT03095066|616823338|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
170675029|NCT03095066|616823339|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
170628672|NCT01083771|616654210|FG000|Overall Study|non-compliant|2|||
170628673|NCT01083771|616654210|FG000|Overall Study|Withdrawal by Subject|3|||
170675030|NCT03095066|616823340|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
170675031|NCT03095066|616823341|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
170675032|NCT03095066|616823342|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
170675033|NCT03095066|616823335|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
170675034|NCT03095066|616823336|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
170675035|NCT03095066|616823337|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
170675036|NCT03095066|616823338|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
170675037|NCT03095066|616823339|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
170675038|NCT03095066|616823340|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
170675039|NCT03095066|616823341|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
170675040|NCT03095066|616823342|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
170675041|NCT03095066|616823335|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
170675042|NCT03095066|616823336|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
170675043|NCT03095066|616823337|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
170675044|NCT03095066|616823338|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
170675045|NCT03095066|616823339|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
170675046|NCT03095066|616823340|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
170675047|NCT03095066|616823341|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
170675048|NCT03095066|616823342|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
170675049|NCT03095066|616823335|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
170675050|NCT03095066|616823336|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
170675051|NCT03095066|616823337|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
170675052|NCT03095066|616823338|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
170675053|NCT03095066|616823339|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
170675054|NCT03095066|616823340|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
170675055|NCT03095066|616823341|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
170675056|NCT03095066|616823342|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
170675057|NCT03095066|616823335|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
170675058|NCT03095066|616823336|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
170675059|NCT03095066|616823337|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
170675060|NCT03095066|616823338|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
170675061|NCT03095066|616823339|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
170675062|NCT03095066|616823340|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
170675063|NCT03095066|616823341|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
170675064|NCT03095066|616823342|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
170675065|NCT03095066|616823335|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
170675066|NCT03095066|616823336|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
170675067|NCT03095066|616823337|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
170675068|NCT03095066|616823338|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
170820374|NCT02660034|617349628|FG006|Overall Study|Death|14|||
170628674|NCT03175367|616654211|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
170628675|NCT03175367|616654212|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
170628676|NCT03175367|616654213|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
170628677|NCT03175367|616654214|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
170628678|NCT03175367|616654215|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
170628679|NCT03175367|616654216|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
170628680|NCT03175367|616654217|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
170628681|NCT03175367|616654211|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
170628682|NCT03175367|616654212|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
170628683|NCT03175367|616654213|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
170628684|NCT03175367|616654214|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
170628685|NCT03175367|616654215|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
170628686|NCT03175367|616654216|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
170628687|NCT03175367|616654217|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
170628688|NCT03175367|616654211|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
170628689|NCT03175367|616654212|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
170628690|NCT03175367|616654213|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
170628691|NCT03175367|616654214|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
170628692|NCT03175367|616654215|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
170628693|NCT03175367|616654216|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
170628694|NCT03175367|616654217|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
170628695|NCT03175367|616654211|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
170628696|NCT03175367|616654212|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
170628697|NCT03175367|616654213|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
170628698|NCT03175367|616654214|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
170628699|NCT03175367|616654215|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
170628700|NCT03175367|616654216|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
170628701|NCT03175367|616654217|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
170628702|NCT03175367|616654211|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170628703|NCT03175367|616654212|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170628704|NCT03175367|616654213|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
170628705|NCT03175367|616654214|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170628706|NCT03175367|616654215|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
170628707|NCT03175367|616654216|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170628708|NCT03175367|616654217|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
170628709|NCT03175367|616654211|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
170628710|NCT03175367|616654212|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
170628711|NCT03175367|616654213|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
170628712|NCT03175367|616654214|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
170628713|NCT03175367|616654215|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
170628714|NCT03175367|616654216|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
170628715|NCT03175367|616654217|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
170628716|NCT03175367|616654211|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170628717|NCT03175367|616654212|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170628718|NCT03175367|616654213|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170628719|NCT03175367|616654214|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170628720|NCT03175367|616654215|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
170628721|NCT03175367|616654216|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
170628722|NCT03175367|616654217|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
170628723|NCT02851615|616654218|FG000|Overall Study|Cognitive Issue|1|||
170628724|NCT02851615|616654219|FG001|Overall Study|Cognitive Issue|0|||
170628725|NCT02851615|616654218|FG000|Overall Study|Lost to Follow-up|0|||
170628726|NCT02851615|616654219|FG001|Overall Study|Lost to Follow-up|4|||
170628727|NCT00371150|616654221|FG000|Overall Study|Lost to Follow-up|3|||
170628728|NCT00371150|616654222|FG001|Overall Study|Lost to Follow-up|2|||
170628729|NCT01389596|616654224|FG000|Overall Study|Protocol Violation|3|||
170628730|NCT01389596|616654225|FG001|Overall Study|Protocol Violation|4|||
170628731|NCT01389596|616654226|FG002|Overall Study|Protocol Violation|3|||
170628732|NCT01389596|616654224|FG000|Overall Study|Withdrawal by Subject|1|||
170628733|NCT01389596|616654225|FG001|Overall Study|Withdrawal by Subject|2|||
170628734|NCT01389596|616654226|FG002|Overall Study|Withdrawal by Subject|2|||
170675069|NCT03095066|616823339|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
170675070|NCT03095066|616823340|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
170675071|NCT03095066|616823341|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
170675072|NCT03095066|616823342|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
170675073|NCT03095066|616823335|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
170675074|NCT03095066|616823336|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
170675075|NCT03095066|616823337|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
170675076|NCT03095066|616823338|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
170675077|NCT03095066|616823339|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
170675078|NCT03095066|616823340|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
170675079|NCT03095066|616823341|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
170628735|NCT01389596|616654224|FG000|Overall Study|Insufficient Clinical Response|3|||
170628736|NCT01389596|616654225|FG001|Overall Study|Insufficient Clinical Response|4|||
170628737|NCT01389596|616654226|FG002|Overall Study|Insufficient Clinical Response|5|||
170628738|NCT01389596|616654224|FG000|Overall Study|Adverse Event|1|||
170628739|NCT01389596|616654225|FG001|Overall Study|Adverse Event|4|||
170628740|NCT01389596|616654226|FG002|Overall Study|Adverse Event|0|||
170628741|NCT01389596|616654224|FG000|Overall Study|Death|0|||
170628742|NCT01389596|616654225|FG001|Overall Study|Death|1|||
170628743|NCT01389596|616654226|FG002|Overall Study|Death|0|||
170675080|NCT03095066|616823342|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
170675081|NCT03095066|616823335|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
170675082|NCT03095066|616823336|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
170675083|NCT03095066|616823337|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
170675084|NCT03095066|616823338|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
170675085|NCT03095066|616823339|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
170675086|NCT03095066|616823340|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
170675087|NCT03095066|616823341|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
170675088|NCT03095066|616823342|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
170675089|NCT03095066|616823335|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
170675090|NCT03095066|616823336|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
170675091|NCT03095066|616823337|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
170675092|NCT03095066|616823338|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
170675093|NCT03095066|616823339|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
170675094|NCT03095066|616823340|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
170675095|NCT03095066|616823341|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
170675096|NCT03095066|616823342|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
170675097|NCT03095066|616823335|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
170675098|NCT03095066|616823336|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
170675099|NCT03095066|616823337|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
170675100|NCT03095066|616823338|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
170675101|NCT03095066|616823339|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
170675102|NCT03095066|616823340|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
170675103|NCT03095066|616823341|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
170675104|NCT03095066|616823342|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
170675105|NCT03095066|616823335|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
170675106|NCT03095066|616823336|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
170675107|NCT03095066|616823337|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
170675108|NCT03095066|616823338|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
170675109|NCT03095066|616823339|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
170675110|NCT03095066|616823340|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
170675111|NCT03095066|616823341|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
170675112|NCT03095066|616823342|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
170675113|NCT03095066|616823335|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
170675114|NCT03095066|616823336|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
170675115|NCT03095066|616823337|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
170675116|NCT03095066|616823338|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
170675117|NCT03095066|616823339|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
170675118|NCT03095066|616823340|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
170675119|NCT03095066|616823341|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
170675120|NCT03095066|616823342|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
170675121|NCT03095066|616823335|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
170675122|NCT03095066|616823336|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
170675123|NCT03095066|616823337|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
170675124|NCT03095066|616823338|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
170675125|NCT03095066|616823339|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
170675126|NCT03095066|616823340|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
170675127|NCT03095066|616823341|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
170675128|NCT03095066|616823342|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
170675129|NCT03095066|616823335|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
170675130|NCT03095066|616823336|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
170675131|NCT03095066|616823337|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
170675132|NCT03095066|616823338|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
170675133|NCT03095066|616823339|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
170675134|NCT03095066|616823340|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
170675135|NCT03095066|616823341|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
170675136|NCT03095066|616823342|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
170628744|NCT01389596|616654224|FG000|Overall Study|Other Unspecified|2|||
170628745|NCT01389596|616654225|FG001|Overall Study|Other Unspecified|1|||
170675137|NCT03095066|616823335|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
170675138|NCT03095066|616823336|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
170675139|NCT03095066|616823337|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
170675140|NCT03095066|616823338|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
170675141|NCT03095066|616823339|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
170675142|NCT03095066|616823340|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
170675143|NCT03095066|616823341|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
170628746|NCT01389596|616654226|FG002|Overall Study|Other Unspecified|0|||
170628747|NCT01709084|616654227|FG000|Overall Study|Lost to Follow-up|4|||
170628748|NCT01709084|616654228|FG001|Overall Study|Lost to Follow-up|7|||
170628749|NCT01709084|616654227|FG000|Overall Study|Withdrawal by Subject|2|||
170628750|NCT01709084|616654228|FG001|Overall Study|Withdrawal by Subject|2|||
170628751|NCT01709084|616654227|FG000|Overall Study|Adverse Event|5|||
170628752|NCT01709084|616654228|FG001|Overall Study|Adverse Event|0|||
170628753|NCT01709084|616654227|FG000|Overall Study|Other|5|||
170628754|NCT01709084|616654228|FG001|Overall Study|Other|3|||
170628755|NCT01709084|616654227|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
170628756|NCT01709084|616654228|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
170628757|NCT01709084|616654227|FG000|Overall Study|Not Treated|0|||
170628758|NCT01709084|616654228|FG001|Overall Study|Not Treated|2|||
170628759|NCT04610281|616654232|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
170628760|NCT04610281|616654233|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
170628761|NCT03337477|616654242|FG000|Overall Study|not categorized into the listed ones|11|||
170628762|NCT03337477|616654243|FG001|Overall Study|not categorized into the listed ones|9|||
170628763|NCT03337477|616654242|FG000|Overall Study|Withdrawal by Subject|0|||
170628764|NCT03337477|616654243|FG001|Overall Study|Withdrawal by Subject|1|||
170628765|NCT03337477|616654242|FG000|Overall Study|Death|0|||
170628766|NCT03337477|616654243|FG001|Overall Study|Death|1|||
170628767|NCT03337477|616654242|FG000|Overall Study|Lost to Follow-up|0|||
170628768|NCT03337477|616654243|FG001|Overall Study|Lost to Follow-up|2|||
170628769|NCT01458392|616654248|FG000|Overall Study|Death|2|||
170675144|NCT03095066|616823342|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
170675145|NCT03095066|616823335|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
170675146|NCT03095066|616823336|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
170675147|NCT03095066|616823337|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
170675148|NCT03095066|616823338|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
170675149|NCT03095066|616823339|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
170675150|NCT03095066|616823340|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
170675151|NCT03095066|616823341|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
170675152|NCT03095066|616823342|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
170675153|NCT03095066|616823335|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
170675154|NCT03095066|616823336|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
170675155|NCT03095066|616823337|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
170675156|NCT03095066|616823338|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
170675157|NCT03095066|616823339|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
170675158|NCT03095066|616823340|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
170675159|NCT03095066|616823341|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
170675160|NCT03095066|616823342|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
170675161|NCT03095066|616823335|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
170628770|NCT01458392|616654249|FG001|Overall Study|Death|11|||
170628771|NCT01458392|616654250|FG002|Overall Study|Death|22|||
170628772|NCT01458392|616654248|FG000|Overall Study|At the discretion of the sponsor|0|||
170628773|NCT01458392|616654249|FG001|Overall Study|At the discretion of the sponsor|2|||
170628774|NCT01458392|616654250|FG002|Overall Study|At the discretion of the sponsor|7|||
170628775|NCT01458392|616654248|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
170628776|NCT01458392|616654249|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
170628777|NCT01458392|616654250|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
170628778|NCT00408317|616654252|FG000|First Intervention Period|Adverse Event|0|||
170628779|NCT00408317|616654253|FG001|First Intervention Period|Adverse Event|1|||
170628780|NCT00408317|616654252|FG000|Second Intervention Period|Adverse Event|2|||
170628781|NCT00408317|616654253|FG001|Second Intervention Period|Adverse Event|0|||
170628782|NCT00408317|616654252|FG000|Second Intervention Period|Protocol Violation|0|||
170628783|NCT00408317|616654253|FG001|Second Intervention Period|Protocol Violation|1|||
170628784|NCT00408317|616654252|FG000|Second Intervention Period|Withdrawal of consent|0|||
170628785|NCT00408317|616654253|FG001|Second Intervention Period|Withdrawal of consent|1|||
170628786|NCT01337960|616654254|FG000|Overall Study|Lost to Follow-up|1|||
170628787|NCT01337960|616654255|FG001|Overall Study|Lost to Follow-up|0|||
170628788|NCT01337960|616654256|FG002|Overall Study|Lost to Follow-up|0|||
170675162|NCT03095066|616823336|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
170628789|NCT01337960|616654254|FG000|Overall Study|Withdrawal by Subject|1|||
170628790|NCT01337960|616654255|FG001|Overall Study|Withdrawal by Subject|0|||
170628791|NCT01337960|616654256|FG002|Overall Study|Withdrawal by Subject|0|||
170628792|NCT03763877|616654258|FG000|Overall Study|Withdrawal by Subject|3|||
170675163|NCT03095066|616823337|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
170675164|NCT03095066|616823338|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
170675165|NCT03095066|616823339|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
170675166|NCT03095066|616823340|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
170675167|NCT03095066|616823341|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
170675168|NCT03095066|616823342|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
170675169|NCT03095066|616823335|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
170675170|NCT03095066|616823336|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
170675171|NCT03095066|616823337|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
170675172|NCT03095066|616823338|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
170675173|NCT03095066|616823339|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
170675174|NCT03095066|616823340|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
170675175|NCT03095066|616823341|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
170675176|NCT03095066|616823342|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
170675177|NCT00160693|616823343|FG000|Overall Study|Adverse Event|97|||
170675178|NCT00160693|616823343|FG000|Overall Study|Lack of Efficacy|30|||
170675179|NCT00160693|616823343|FG000|Overall Study|Protocol Violation|24|||
170675180|NCT00160693|616823343|FG000|Overall Study|Lost to Follow-up|15|||
170675181|NCT00160693|616823343|FG000|Overall Study|Withdrawal by Subject|54|||
170628793|NCT03763877|616654259|FG001|Overall Study|Withdrawal by Subject|1|||
170675182|NCT00160693|616823343|FG000|Overall Study|Study terminated by sponsor|15|||
170675183|NCT04213079|616823345|FG000|Overall Study|Lost to Follow-up|0|||
170675184|NCT04213079|616823346|FG001|Overall Study|Lost to Follow-up|2|||
170675185|NCT03766581|616823348|FG000|Randomization|Other reasons|2|||
170675186|NCT03766581|616823349|FG001|Randomization|Other reasons|1|||
170675187|NCT03766581|616823350|FG002|Randomization|Other reasons|0|||
170675188|NCT03766581|616823351|FG003|Randomization|Other reasons|1|||
170675189|NCT03766581|616823352|FG004|Randomization|Other reasons|0|||
170675190|NCT03766581|616823353|FG005|Randomization|Other reasons|0|||
170675191|NCT03766581|616823354|FG006|Randomization|Other reasons|0|||
170675192|NCT03766581|616823355|FG007|Randomization|Other reasons|0|||
170675193|NCT03766581|616823348|FG000|Randomization|Participant no longer meets study criteria|5|||
170675194|NCT03766581|616823349|FG001|Randomization|Participant no longer meets study criteria|3|||
170675195|NCT03766581|616823350|FG002|Randomization|Participant no longer meets study criteria|4|||
170675196|NCT03766581|616823351|FG003|Randomization|Participant no longer meets study criteria|0|||
170675197|NCT03766581|616823352|FG004|Randomization|Participant no longer meets study criteria|2|||
170675198|NCT03766581|616823353|FG005|Randomization|Participant no longer meets study criteria|3|||
170675199|NCT03766581|616823354|FG006|Randomization|Participant no longer meets study criteria|0|||
170675200|NCT03766581|616823355|FG007|Randomization|Participant no longer meets study criteria|1|||
170675201|NCT03766581|616823348|FG000|Randomization|Participant request to discontinue study treatment|1|||
170675202|NCT03766581|616823349|FG001|Randomization|Participant request to discontinue study treatment|0|||
170675203|NCT03766581|616823350|FG002|Randomization|Participant request to discontinue study treatment|0|||
170675204|NCT03766581|616823351|FG003|Randomization|Participant request to discontinue study treatment|0|||
170675205|NCT03766581|616823352|FG004|Randomization|Participant request to discontinue study treatment|1|||
170628794|NCT03763877|616654260|FG002|Overall Study|Withdrawal by Subject|3|||
170628795|NCT03763877|616654261|FG003|Overall Study|Withdrawal by Subject|4|||
170628796|NCT03763877|616654258|FG000|Overall Study|Adverse Event|1|||
170628797|NCT03763877|616654259|FG001|Overall Study|Adverse Event|1|||
170628798|NCT03763877|616654260|FG002|Overall Study|Adverse Event|3|||
170628799|NCT03763877|616654261|FG003|Overall Study|Adverse Event|1|||
170628800|NCT03763877|616654258|FG000|Overall Study|Protocol Violation|1|||
170628801|NCT03763877|616654259|FG001|Overall Study|Protocol Violation|1|||
170628802|NCT03763877|616654260|FG002|Overall Study|Protocol Violation|0|||
170628803|NCT03763877|616654261|FG003|Overall Study|Protocol Violation|0|||
170628804|NCT03763877|616654258|FG000|Overall Study|Lost to Follow-up|0|||
170628805|NCT03763877|616654259|FG001|Overall Study|Lost to Follow-up|1|||
170628806|NCT03763877|616654260|FG002|Overall Study|Lost to Follow-up|1|||
170675206|NCT03766581|616823353|FG005|Randomization|Participant request to discontinue study treatment|2|||
170628807|NCT03763877|616654261|FG003|Overall Study|Lost to Follow-up|0|||
170628808|NCT03040336|616654262|FG000|Overall Study|Death|1|||
170628809|NCT03040336|616654263|FG001|Overall Study|Death|0|||
170628810|NCT03040336|616654262|FG000|Overall Study|Withdrawal by Subject|2|||
170628811|NCT03040336|616654263|FG001|Overall Study|Withdrawal by Subject|3|||
170628812|NCT00853307|616654264|FG000|Overall Study|Adverse Event|1|||
170628813|NCT00853307|616654265|FG001|Overall Study|Adverse Event|2|||
170628814|NCT00853307|616654264|FG000|Overall Study|Withdrawal by Subject|1|||
170628815|NCT00853307|616654265|FG001|Overall Study|Withdrawal by Subject|2|||
170628816|NCT00853307|616654264|FG000|Overall Study|Reason Not Specified|0|||
170628817|NCT00853307|616654265|FG001|Overall Study|Reason Not Specified|1|||
170628818|NCT02379728|616654271|FG000|Overall Study|Lost to Follow-up|1|||
170628819|NCT02379728|616654272|FG001|Overall Study|Lost to Follow-up|0|||
170628820|NCT02379728|616654273|FG002|Overall Study|Lost to Follow-up|3|||
170628821|NCT02379728|616654274|FG003|Overall Study|Lost to Follow-up|0|||
170628822|NCT02379728|616654271|FG000|Overall Study|Withdrawal by Subject|5|||
170628823|NCT02379728|616654272|FG001|Overall Study|Withdrawal by Subject|0|||
170628824|NCT02379728|616654273|FG002|Overall Study|Withdrawal by Subject|5|||
170628825|NCT02379728|616654274|FG003|Overall Study|Withdrawal by Subject|3|||
170628826|NCT02379728|616654271|FG000|Overall Study|Protocol Violation|0|||
170628827|NCT02379728|616654272|FG001|Overall Study|Protocol Violation|0|||
170628828|NCT02379728|616654273|FG002|Overall Study|Protocol Violation|2|||
170628829|NCT02379728|616654274|FG003|Overall Study|Protocol Violation|0|||
170628830|NCT03938259|616654275|FG000|Overall Study|unable to establish baseline for ventilation|1|||
170628831|NCT03938259|616654276|FG001|Overall Study|unable to establish baseline for ventilation|1|||
170628832|NCT04613362|616654277|FG000|3 Month Follow-up|Lost to Follow-up|1|||
170628833|NCT04613362|616654278|FG001|3 Month Follow-up|Lost to Follow-up|2|||
170628834|NCT04613362|616654277|FG000|6 Month Follow-up|Lost to Follow-up|0|||
170628835|NCT04613362|616654278|FG001|6 Month Follow-up|Lost to Follow-up|1|||
170628836|NCT04225897|616654279|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628837|NCT04225897|616654280|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
170628838|NCT04225897|616654281|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628839|NCT04225897|616654282|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628840|NCT04225897|616654283|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628841|NCT04225897|616654284|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628842|NCT04225897|616654285|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628843|NCT04225897|616654286|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628844|NCT04225897|616654287|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628845|NCT04225897|616654288|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628846|NCT04225897|616654289|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628847|NCT04225897|616654290|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
170628848|NCT04225897|616654279|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628849|NCT04225897|616654280|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628850|NCT04225897|616654281|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
170628851|NCT04225897|616654282|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628852|NCT04225897|616654283|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628853|NCT04225897|616654284|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628854|NCT04225897|616654285|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628855|NCT04225897|616654286|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628856|NCT04225897|616654287|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628857|NCT04225897|616654288|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628858|NCT04225897|616654289|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628859|NCT04225897|616654290|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
170628860|NCT04225897|616654279|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628861|NCT04225897|616654280|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628862|NCT04225897|616654281|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
170628863|NCT04225897|616654282|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628864|NCT04225897|616654283|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628865|NCT04225897|616654284|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628866|NCT04225897|616654285|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628867|NCT04225897|616654286|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628868|NCT04225897|616654287|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628869|NCT04225897|616654288|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628870|NCT04225897|616654289|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628871|NCT04225897|616654290|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
170628872|NCT04225897|616654279|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628873|NCT04225897|616654280|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628874|NCT04225897|616654281|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628875|NCT04225897|616654282|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628876|NCT04225897|616654283|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628877|NCT04225897|616654284|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628878|NCT04225897|616654285|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628879|NCT04225897|616654286|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
170628880|NCT04225897|616654287|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628881|NCT04225897|616654288|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628882|NCT04225897|616654289|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628883|NCT04225897|616654290|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
170628884|NCT00074711|616654291|FG000|Overall Study|Withdrawal by Subject|1|||
170628885|NCT00074711|616654292|FG001|Overall Study|Withdrawal by Subject|1|||
170628886|NCT00074711|616654291|FG000|Overall Study|Lost to Follow-up|10|||
170628887|NCT00074711|616654292|FG001|Overall Study|Lost to Follow-up|8|||
170628888|NCT00074711|616654291|FG000|Overall Study|Participant stopped study drug|4|||
170628889|NCT00074711|616654292|FG001|Overall Study|Participant stopped study drug|6|||
170628890|NCT00456846|616654295|FG000|Overall Study|Adverse Event|2|||
170628891|NCT00456846|616654296|FG001|Overall Study|Adverse Event|15|||
170628892|NCT00456846|616654295|FG000|Overall Study|Physician Decision|11|||
170628893|NCT00456846|616654296|FG001|Overall Study|Physician Decision|6|||
170628894|NCT00456846|616654295|FG000|Overall Study|Protocol Deviation|2|||
170628895|NCT00456846|616654296|FG001|Overall Study|Protocol Deviation|0|||
170628896|NCT00456846|616654295|FG000|Overall Study|Participant Discretion|1|||
170628897|NCT00456846|616654296|FG001|Overall Study|Participant Discretion|5|||
170628898|NCT00456846|616654295|FG000|Overall Study|Other|0|||
170628899|NCT00456846|616654296|FG001|Overall Study|Other|2|||
170628900|NCT00581308|616654297|FG000|Pre Discharge|Lost to Follow-up|1|||
170628901|NCT00581308|616654297|FG000|Pre Discharge|Device Removed|1|||
170628902|NCT00581308|616654297|FG000|Month 1|Lost to Follow-up|3|||
170628903|NCT00581308|616654297|FG000|Month 1|Withdrawal by Subject|2|||
170628904|NCT00581308|616654297|FG000|Month 1|Device Removed|2|||
170675207|NCT03766581|616823354|FG006|Randomization|Participant request to discontinue study treatment|0|||
170675208|NCT03766581|616823355|FG007|Randomization|Participant request to discontinue study treatment|0|||
170675209|NCT03766581|616823348|FG000|Randomization|Participant withdrew consent|1|||
170675210|NCT03766581|616823349|FG001|Randomization|Participant withdrew consent|0|||
170675211|NCT03766581|616823350|FG002|Randomization|Participant withdrew consent|1|||
170675212|NCT03766581|616823351|FG003|Randomization|Participant withdrew consent|2|||
170675213|NCT03766581|616823352|FG004|Randomization|Participant withdrew consent|1|||
170675214|NCT03766581|616823353|FG005|Randomization|Participant withdrew consent|1|||
170675215|NCT03766581|616823354|FG006|Randomization|Participant withdrew consent|0|||
170675216|NCT03766581|616823355|FG007|Randomization|Participant withdrew consent|0|||
170675217|NCT03766581|616823348|FG000|Treatment|Adverse Event|82|||
170628905|NCT00581308|616654297|FG000|Month 1|Uknown|1|||
170628906|NCT00581308|616654297|FG000|Month 6|Lost to Follow-up|1|||
170628907|NCT00581308|616654297|FG000|Month 6|Withdrawal by Subject|2|||
170628908|NCT00581308|616654297|FG000|Month 12|Death|1|||
170628909|NCT00581308|616654297|FG000|Month 12|Lost to Follow-up|14|||
170628910|NCT00581308|616654297|FG000|Month 12|Withdrawal by Subject|3|||
170628911|NCT00581308|616654297|FG000|Month 12|Device Removed|1|||
170628912|NCT00581308|616654297|FG000|Month 12|Other|1|||
170628913|NCT04558125|616654298|FG000|Overall Study|Death|1|||
170628914|NCT01614886|616654299|FG000|Overall Study|Adverse Event|15|||
170628915|NCT01614886|616654300|FG001|Overall Study|Adverse Event|20|||
170628916|NCT01614886|616654299|FG000|Overall Study|Withdrawal by Subject|4|||
170628917|NCT01614886|616654300|FG001|Overall Study|Withdrawal by Subject|4|||
170628918|NCT01614886|616654299|FG000|Overall Study|Death|1|||
170628919|NCT01614886|616654300|FG001|Overall Study|Death|0|||
170628920|NCT01614886|616654299|FG000|Overall Study|Protocol deviation|0|||
170628921|NCT01614886|616654300|FG001|Overall Study|Protocol deviation|2|||
170628922|NCT02435992|616654301|FG000|Overall Study|non compliance with protocol|2|||
170628923|NCT02435992|616654302|FG001|Overall Study|non compliance with protocol|0|||
170628924|NCT02435992|616654303|FG002|Overall Study|non compliance with protocol|1|||
170628925|NCT02435992|616654304|FG003|Overall Study|non compliance with protocol|0|||
170628926|NCT02435992|616654305|FG004|Overall Study|non compliance with protocol|0|||
170628927|NCT02435992|616654301|FG000|Overall Study|Adverse Event|11|||
170628928|NCT02435992|616654302|FG001|Overall Study|Adverse Event|6|||
170628929|NCT02435992|616654303|FG002|Overall Study|Adverse Event|12|||
170628930|NCT02435992|616654304|FG003|Overall Study|Adverse Event|0|||
170675218|NCT03766581|616823349|FG001|Treatment|Adverse Event|44|||
170628931|NCT02435992|616654305|FG004|Overall Study|Adverse Event|0|||
170628932|NCT02435992|616654301|FG000|Overall Study|Lack of Efficacy|4|||
170628933|NCT02435992|616654302|FG001|Overall Study|Lack of Efficacy|10|||
170628934|NCT02435992|616654303|FG002|Overall Study|Lack of Efficacy|9|||
170628935|NCT02435992|616654304|FG003|Overall Study|Lack of Efficacy|0|||
170628936|NCT02435992|616654305|FG004|Overall Study|Lack of Efficacy|0|||
170628937|NCT02435992|616654301|FG000|Overall Study|Withdrawal by Subject|10|||
170628938|NCT02435992|616654302|FG001|Overall Study|Withdrawal by Subject|8|||
170628939|NCT02435992|616654303|FG002|Overall Study|Withdrawal by Subject|20|||
170628940|NCT02435992|616654304|FG003|Overall Study|Withdrawal by Subject|0|||
170628941|NCT02435992|616654305|FG004|Overall Study|Withdrawal by Subject|0|||
170628942|NCT02435992|616654301|FG000|Overall Study|Other Reason|1|||
170628943|NCT02435992|616654302|FG001|Overall Study|Other Reason|0|||
170628944|NCT02435992|616654303|FG002|Overall Study|Other Reason|0|||
170628945|NCT02435992|616654304|FG003|Overall Study|Other Reason|0|||
170628946|NCT02435992|616654305|FG004|Overall Study|Other Reason|0|||
170628947|NCT02435992|616654301|FG000|Overall Study|Physician Decision|0|||
170628948|NCT02435992|616654302|FG001|Overall Study|Physician Decision|0|||
170628949|NCT02435992|616654303|FG002|Overall Study|Physician Decision|1|||
170628950|NCT02435992|616654304|FG003|Overall Study|Physician Decision|0|||
170628951|NCT02435992|616654305|FG004|Overall Study|Physician Decision|0|||
170628952|NCT03879772|616654306|FG000|Overall Study|Adverse Event|2|||
170628953|NCT03879772|616654307|FG001|Overall Study|Adverse Event|2|||
170628954|NCT03879772|616654308|FG002|Overall Study|Adverse Event|3|||
170628955|NCT03879772|616654309|FG003|Overall Study|Adverse Event|4|||
170628956|NCT03879772|616654310|FG004|Overall Study|Adverse Event|3|||
170628957|NCT03879772|616654306|FG000|Overall Study|Treatment Failure|1|||
170628958|NCT03879772|616654307|FG001|Overall Study|Treatment Failure|0|||
170628959|NCT03879772|616654308|FG002|Overall Study|Treatment Failure|0|||
170628960|NCT03879772|616654309|FG003|Overall Study|Treatment Failure|2|||
170628961|NCT03879772|616654310|FG004|Overall Study|Treatment Failure|1|||
170628962|NCT03879772|616654306|FG000|Overall Study|Lost to Follow-up|0|||
170628963|NCT03879772|616654307|FG001|Overall Study|Lost to Follow-up|0|||
170628964|NCT03879772|616654308|FG002|Overall Study|Lost to Follow-up|0|||
170628965|NCT03879772|616654309|FG003|Overall Study|Lost to Follow-up|0|||
170628966|NCT03879772|616654310|FG004|Overall Study|Lost to Follow-up|1|||
170628967|NCT03879772|616654306|FG000|Overall Study|Withdrawal by Subject|0|||
170628968|NCT03879772|616654307|FG001|Overall Study|Withdrawal by Subject|1|||
170628969|NCT03879772|616654308|FG002|Overall Study|Withdrawal by Subject|3|||
170628970|NCT03879772|616654309|FG003|Overall Study|Withdrawal by Subject|1|||
170628971|NCT03879772|616654310|FG004|Overall Study|Withdrawal by Subject|1|||
170628972|NCT03879772|616654306|FG000|Overall Study|Protocol Violation|0|||
170628973|NCT03879772|616654307|FG001|Overall Study|Protocol Violation|0|||
170628974|NCT03879772|616654308|FG002|Overall Study|Protocol Violation|3|||
170628975|NCT03879772|616654309|FG003|Overall Study|Protocol Violation|1|||
170628976|NCT03879772|616654310|FG004|Overall Study|Protocol Violation|2|||
170628977|NCT03879772|616654306|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
170628978|NCT03879772|616654307|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
170628979|NCT03879772|616654308|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
170628980|NCT03879772|616654309|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
170675219|NCT03766581|616823350|FG002|Treatment|Adverse Event|47|||
170675220|NCT03766581|616823351|FG003|Treatment|Adverse Event|46|||
170675221|NCT03766581|616823352|FG004|Treatment|Adverse Event|50|||
170675222|NCT03766581|616823353|FG005|Treatment|Adverse Event|77|||
170675223|NCT03766581|616823354|FG006|Treatment|Adverse Event|5|||
170675224|NCT03766581|616823355|FG007|Treatment|Adverse Event|2|||
170675225|NCT03766581|616823348|FG000|Treatment|Participant request to discontinue treatment|34|||
170675226|NCT03766581|616823349|FG001|Treatment|Participant request to discontinue treatment|6|||
170675227|NCT03766581|616823350|FG002|Treatment|Participant request to discontinue treatment|10|||
170675228|NCT03766581|616823351|FG003|Treatment|Participant request to discontinue treatment|10|||
170675229|NCT03766581|616823352|FG004|Treatment|Participant request to discontinue treatment|14|||
170675230|NCT03766581|616823353|FG005|Treatment|Participant request to discontinue treatment|15|||
170675231|NCT03766581|616823354|FG006|Treatment|Participant request to discontinue treatment|0|||
170675232|NCT03766581|616823355|FG007|Treatment|Participant request to discontinue treatment|1|||
170675233|NCT03766581|616823348|FG000|Treatment|Participant withdrew consent|11|||
170675234|NCT03766581|616823349|FG001|Treatment|Participant withdrew consent|4|||
170675235|NCT03766581|616823350|FG002|Treatment|Participant withdrew consent|5|||
170675236|NCT03766581|616823351|FG003|Treatment|Participant withdrew consent|5|||
170675237|NCT03766581|616823352|FG004|Treatment|Participant withdrew consent|4|||
170675238|NCT03766581|616823353|FG005|Treatment|Participant withdrew consent|4|||
170675239|NCT03766581|616823354|FG006|Treatment|Participant withdrew consent|0|||
170675240|NCT03766581|616823355|FG007|Treatment|Participant withdrew consent|0|||
170675241|NCT03766581|616823348|FG000|Treatment|Death|1|||
170675242|NCT03766581|616823349|FG001|Treatment|Death|0|||
170675243|NCT03766581|616823350|FG002|Treatment|Death|0|||
170675244|NCT03766581|616823351|FG003|Treatment|Death|0|||
170675245|NCT03766581|616823352|FG004|Treatment|Death|0|||
170675246|NCT03766581|616823353|FG005|Treatment|Death|0|||
170675247|NCT03766581|616823354|FG006|Treatment|Death|0|||
170675248|NCT03766581|616823355|FG007|Treatment|Death|0|||
170675249|NCT03766581|616823348|FG000|Treatment|Lost to Follow-up|1|||
170675250|NCT03766581|616823349|FG001|Treatment|Lost to Follow-up|0|||
170675251|NCT03766581|616823350|FG002|Treatment|Lost to Follow-up|0|||
170675252|NCT03766581|616823351|FG003|Treatment|Lost to Follow-up|1|||
170675253|NCT03766581|616823352|FG004|Treatment|Lost to Follow-up|0|||
170675254|NCT03766581|616823353|FG005|Treatment|Lost to Follow-up|0|||
170675255|NCT03766581|616823354|FG006|Treatment|Lost to Follow-up|0|||
170675256|NCT03766581|616823355|FG007|Treatment|Lost to Follow-up|0|||
170675257|NCT03766581|616823348|FG000|Treatment|Poor/Non compliance|2|||
170675258|NCT03766581|616823349|FG001|Treatment|Poor/Non compliance|2|||
170675259|NCT03766581|616823350|FG002|Treatment|Poor/Non compliance|1|||
170675260|NCT03766581|616823351|FG003|Treatment|Poor/Non compliance|1|||
170675261|NCT03766581|616823352|FG004|Treatment|Poor/Non compliance|1|||
170675262|NCT03766581|616823353|FG005|Treatment|Poor/Non compliance|1|||
170675263|NCT03766581|616823354|FG006|Treatment|Poor/Non compliance|0|||
170675264|NCT03766581|616823355|FG007|Treatment|Poor/Non compliance|0|||
170675265|NCT03766581|616823348|FG000|Treatment|Participant no longer meets study criteria|9|||
170675266|NCT03766581|616823349|FG001|Treatment|Participant no longer meets study criteria|1|||
170675267|NCT03766581|616823350|FG002|Treatment|Participant no longer meets study criteria|5|||
170675268|NCT03766581|616823351|FG003|Treatment|Participant no longer meets study criteria|4|||
170675269|NCT03766581|616823352|FG004|Treatment|Participant no longer meets study criteria|4|||
170675270|NCT03766581|616823353|FG005|Treatment|Participant no longer meets study criteria|4|||
170675271|NCT03766581|616823354|FG006|Treatment|Participant no longer meets study criteria|2|||
170675272|NCT03766581|616823355|FG007|Treatment|Participant no longer meets study criteria|0|||
170675273|NCT03766581|616823348|FG000|Treatment|Other reasons|13|||
170675274|NCT03766581|616823349|FG001|Treatment|Other reasons|8|||
170675275|NCT03766581|616823350|FG002|Treatment|Other reasons|3|||
170675276|NCT03766581|616823351|FG003|Treatment|Other reasons|7|||
170675277|NCT03766581|616823352|FG004|Treatment|Other reasons|3|||
170675278|NCT03766581|616823353|FG005|Treatment|Other reasons|3|||
170675279|NCT03766581|616823354|FG006|Treatment|Other reasons|0|||
170675280|NCT03766581|616823355|FG007|Treatment|Other reasons|0|||
170675281|NCT05988619|616823359|FG000|Overall Study|Lost to Follow-up|1|||
170675282|NCT05988619|616823360|FG001|Overall Study|Lost to Follow-up|4|||
170675283|NCT05988619|616823359|FG000|Overall Study|Withdrawal by Subject|2|||
170675284|NCT05988619|616823360|FG001|Overall Study|Withdrawal by Subject|9|||
170675285|NCT03858309|616823361|FG000|Overall Study|Withdrawal by Subject|2|||
170675286|NCT03858309|616823362|FG001|Overall Study|Withdrawal by Subject|3|||
170675287|NCT03600818|616823363|FG000|Overall Study|Adverse Event|4|||
170675288|NCT03600818|616823364|FG001|Overall Study|Adverse Event|7|||
170675289|NCT03600818|616823363|FG000|Overall Study|Lack of Efficacy|9|||
170675290|NCT03600818|616823364|FG001|Overall Study|Lack of Efficacy|4|||
170675291|NCT03600818|616823363|FG000|Overall Study|Withdrawal by Subject|4|||
170675292|NCT03600818|616823364|FG001|Overall Study|Withdrawal by Subject|3|||
170675293|NCT03600818|616823363|FG000|Overall Study|Other-unspecified|5|||
170675294|NCT03600818|616823364|FG001|Overall Study|Other-unspecified|3|||
170675295|NCT03600818|616823363|FG000|Overall Study|Randomized and not treated|0|||
170675296|NCT03600818|616823364|FG001|Overall Study|Randomized and not treated|1|||
170675297|NCT01812174|616823365|FG000|Overall Study|Death|1|||
170675298|NCT01812174|616823366|FG001|Overall Study|Death|0|||
170675299|NCT01812174|616823365|FG000|Overall Study|Protocol Violation|2|||
170675300|NCT01812174|616823366|FG001|Overall Study|Protocol Violation|0|||
170675301|NCT01606007|616823367|FG000|Overall Study|Reason 'Other' in the protocol|0|||
170675302|NCT01606007|616823368|FG001|Overall Study|Reason 'Other' in the protocol|1|||
170675303|NCT01606007|616823369|FG002|Overall Study|Reason 'Other' in the protocol|1|||
170675304|NCT01606007|616823367|FG000|Overall Study|Pregnancy|0|||
170675305|NCT01606007|616823368|FG001|Overall Study|Pregnancy|1|||
170675306|NCT01606007|616823369|FG002|Overall Study|Pregnancy|1|||
170675307|NCT01606007|616823367|FG000|Overall Study|Withdrawal by Subject|8|||
170675308|NCT01606007|616823368|FG001|Overall Study|Withdrawal by Subject|6|||
170675309|NCT01606007|616823369|FG002|Overall Study|Withdrawal by Subject|1|||
170675310|NCT01606007|616823367|FG000|Overall Study|Adverse Event|0|||
170675311|NCT01606007|616823368|FG001|Overall Study|Adverse Event|1|||
170675312|NCT01606007|616823369|FG002|Overall Study|Adverse Event|1|||
170628981|NCT03879772|616654310|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
170628982|NCT04543279|616654317|FG000|Overall Study|Withdrawal by Subject|1|||
170628983|NCT04543279|616654318|FG001|Overall Study|Withdrawal by Subject|0|||
170628984|NCT04543279|616654317|FG000|Overall Study|Adverse Event|1|||
170628985|NCT04543279|616654318|FG001|Overall Study|Adverse Event|0|||
170628986|NCT04543279|616654317|FG000|Overall Study|Physician Decision|1|||
170628987|NCT04543279|616654318|FG001|Overall Study|Physician Decision|0|||
170628988|NCT00929695|616654321|FG000|Overall Study|Death|2|||
170628989|NCT00929695|616654322|FG001|Overall Study|Death|1|||
170628990|NCT00929695|616654321|FG000|Overall Study|Withdrawal by Subject|0|||
170628991|NCT00929695|616654322|FG001|Overall Study|Withdrawal by Subject|2|||
170628992|NCT00929695|616654321|FG000|Overall Study|discharge home|4|||
170675313|NCT01606007|616823367|FG000|Overall Study|discontinue study treatment|0|||
170675314|NCT01606007|616823368|FG001|Overall Study|discontinue study treatment|2|||
170675315|NCT01606007|616823369|FG002|Overall Study|discontinue study treatment|1|||
170675316|NCT01606007|616823367|FG000|Overall Study|Lost to Follow-up|6|||
170675317|NCT01606007|616823368|FG001|Overall Study|Lost to Follow-up|8|||
170675318|NCT01606007|616823369|FG002|Overall Study|Lost to Follow-up|5|||
170675319|NCT01606007|616823367|FG000|Overall Study|Poor/Non-compliance|1|||
170675320|NCT01606007|616823368|FG001|Overall Study|Poor/Non-compliance|0|||
170675321|NCT01606007|616823369|FG002|Overall Study|Poor/Non-compliance|0|||
170675322|NCT02228460|616823372|FG000|Overall Study|Adverse Event|1|||
170675323|NCT02228460|616823372|FG000|Overall Study|Lost to Follow-up|1|||
170675324|NCT01051323|616823377|FG000|Overall Study|Discontinuation of treatment|103|||
170675325|NCT01051323|616823377|FG000|Overall Study|Transplantation|28|||
170675326|NCT01051323|616823377|FG000|Overall Study|Dialysis dependency|22|||
170675327|NCT01051323|616823377|FG000|Overall Study|Withdrawal by Subject|13|||
170675328|NCT01051323|616823377|FG000|Overall Study|Lost to Follow-up|31|||
170675329|NCT01051323|616823377|FG000|Overall Study|Death|129|||
170675330|NCT01051323|616823377|FG000|Overall Study|Hospitalization|28|||
170675331|NCT01051323|616823377|FG000|Overall Study|Other|148|||
170675332|NCT01051323|616823377|FG000|Overall Study|Missing|37|||
170628993|NCT00929695|616654322|FG001|Overall Study|discharge home|3|||
170628994|NCT00929695|616654321|FG000|Overall Study|incorrect stratification|2|||
170675333|NCT01626391|616823378|FG000|Overall Study|Physician Decision|1|||
170675334|NCT01626391|616823379|FG001|Overall Study|Physician Decision|0|||
170675335|NCT01626391|616823378|FG000|Overall Study|Withdrawal by Subject|1|||
170675336|NCT01626391|616823379|FG001|Overall Study|Withdrawal by Subject|0|||
170675337|NCT00370032|616823380|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
170675338|NCT00370032|616823381|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
170675339|NCT00370032|616823380|FG000|Washout Period|Withdrawal by Subject|0|||
170675340|NCT00370032|616823381|FG001|Washout Period|Withdrawal by Subject|1|||
170675341|NCT00370032|616823380|FG000|Washout Period|Lost to Follow-up|0|||
170628995|NCT00929695|616654322|FG001|Overall Study|incorrect stratification|0|||
170675342|NCT00370032|616823381|FG001|Washout Period|Lost to Follow-up|1|||
170675343|NCT00370032|616823380|FG000|Washout Period|Adverse Event|1|||
170675344|NCT00370032|616823381|FG001|Washout Period|Adverse Event|0|||
170675345|NCT00370032|616823380|FG000|Follow-up Period|Withdrawal by Subject|1|||
170675346|NCT00370032|616823381|FG001|Follow-up Period|Withdrawal by Subject|0|||
170675347|NCT00801632|616823382|FG000|Overall Study|Re-transplant|1|||
170675348|NCT05469178|616823383|FG000|Overall Study|Death|1|||
170675349|NCT05469178|616823384|FG001|Overall Study|Death|1|||
170675350|NCT05469178|616823385|FG002|Overall Study|Death|3|||
170675351|NCT05469178|616823386|FG003|Overall Study|Death|6|||
170675352|NCT05469178|616823383|FG000|Overall Study|Lack of Efficacy|2|||
170675353|NCT05469178|616823384|FG001|Overall Study|Lack of Efficacy|2|||
170675354|NCT05469178|616823385|FG002|Overall Study|Lack of Efficacy|1|||
170675355|NCT05469178|616823386|FG003|Overall Study|Lack of Efficacy|10|||
170675356|NCT00968513|616823387|FG000|Overall Study|Death|4|||
170675357|NCT00968513|616823388|FG001|Overall Study|Death|10|||
170675358|NCT00968513|616823389|FG002|Overall Study|Death|15|||
170675359|NCT02099708|616823390|FG000|Overall Study|Data Not Available|30|||
170675360|NCT02099708|616823390|FG000|Overall Study|Lost to Follow-up|141|||
170675361|NCT02099708|616823390|FG000|Overall Study|Other|29|||
170675362|NCT05466682|616823395|FG000|Overall Study|Withdrawal by Subject|0|||
170675363|NCT05466682|616823396|FG001|Overall Study|Withdrawal by Subject|2|||
170675364|NCT05466682|616823395|FG000|Overall Study|Lost to Follow-up|2|||
170675365|NCT05466682|616823396|FG001|Overall Study|Lost to Follow-up|1|||
170675366|NCT02801396|616823397|FG000|Period 1|Withdrawal by Subject|0|||
170675367|NCT02801396|616823398|FG001|Period 1|Withdrawal by Subject|0|||
170675368|NCT02801396|616823399|FG002|Period 1|Withdrawal by Subject|0|||
170675369|NCT02801396|616823400|FG003|Period 1|Withdrawal by Subject|0|||
170675370|NCT02801396|616823401|FG004|Period 1|Withdrawal by Subject|1|||
170675371|NCT02801396|616823402|FG005|Period 1|Withdrawal by Subject|0|||
170675372|NCT00702923|616823403|FG000|Overall Study|Adverse Event|1|||
170675373|NCT01233258|616823408|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
170675374|NCT01233258|616823409|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
170675375|NCT01233258|616823410|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
170675376|NCT01233258|616823411|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
170675377|NCT01233258|616823412|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
170675378|NCT01233258|616823413|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
170675379|NCT01233258|616823408|FG000|First Intervention (6 Months)|Protocol Violation|0|||
170675380|NCT01233258|616823409|FG001|First Intervention (6 Months)|Protocol Violation|0|||
170675381|NCT01233258|616823410|FG002|First Intervention (6 Months)|Protocol Violation|1|||
170675382|NCT01233258|616823411|FG003|First Intervention (6 Months)|Protocol Violation|0|||
170675383|NCT01233258|616823412|FG004|First Intervention (6 Months)|Protocol Violation|0|||
170675384|NCT01233258|616823413|FG005|First Intervention (6 Months)|Protocol Violation|0|||
170675385|NCT01233258|616823408|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
170675386|NCT01233258|616823409|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
170675387|NCT01233258|616823410|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
170675388|NCT01233258|616823411|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
170628996|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
170628997|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
170628998|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
170628999|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
170629000|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
170629001|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
170629002|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
170629003|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
170675389|NCT01233258|616823412|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
170675390|NCT01233258|616823413|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
170675391|NCT01534962|616823414|FG000|Overall Study|Randomized but did not start treatment|2|||
170675392|NCT01534962|616823415|FG001|Overall Study|Randomized but did not start treatment|0|||
170675393|NCT01534962|616823416|FG002|Overall Study|Randomized but did not start treatment|0|||
170675394|NCT01534962|616823417|FG003|Overall Study|Randomized but did not start treatment|1|||
170675395|NCT01534962|616823414|FG000|Overall Study|Discontinued at AF recurrence|35|||
170675396|NCT01534962|616823415|FG001|Overall Study|Discontinued at AF recurrence|26|||
170675397|NCT01534962|616823416|FG002|Overall Study|Discontinued at AF recurrence|24|||
170675398|NCT01534962|616823417|FG003|Overall Study|Discontinued at AF recurrence|31|||
170675399|NCT00880009|616823418|FG000|Overall Study|Study terminated by sponsor|14|||
170675400|NCT00880009|616823418|FG000|Overall Study|Withdrawal by Subject|1|||
170675401|NCT00880009|616823418|FG000|Overall Study|Protocol Violation|1|||
170675402|NCT04528732|616823419|FG000|Overall Study|Death|1|||
170675403|NCT04528732|616823420|FG001|Overall Study|Death|0|||
170675404|NCT04528732|616823421|FG002|Overall Study|Death|1|||
170675405|NCT04528732|616823419|FG000|Overall Study|Lost to Follow-up|0|||
170675406|NCT04528732|616823420|FG001|Overall Study|Lost to Follow-up|1|||
170675407|NCT04528732|616823421|FG002|Overall Study|Lost to Follow-up|2|||
170675408|NCT03408483|616823422|FG000|Overall Study|Physician Decision|3|||
170675409|NCT03408483|616823423|FG001|Overall Study|Physician Decision|3|||
170675410|NCT03408483|616823422|FG000|Overall Study|Lost to Follow-up|3|||
170675411|NCT03408483|616823423|FG001|Overall Study|Lost to Follow-up|0|||
170675412|NCT00478231|616823424|FG000|Overall Study|Death|7|||
170675413|NCT00478231|616823424|FG000|Overall Study|Lack of Efficacy|47|||
170675414|NCT00478231|616823424|FG000|Overall Study|Lost to Follow-up|7|||
170675415|NCT00478231|616823424|FG000|Overall Study|Withdrawal by Subject|6|||
170675416|NCT00478231|616823424|FG000|Overall Study|Other|9|||
170675417|NCT00478231|616823424|FG000|Overall Study|Adverse Event|5|||
170675418|NCT00478231|616823424|FG000|Overall Study|Randomized, not treated|3|||
170675419|NCT01702961|616823425|FG000|Overall Study|Additional treatment|3|||
170675420|NCT01702961|616823425|FG000|Overall Study|Progressive disease|5|||
170675421|NCT01702961|616823425|FG000|Overall Study|Relapse|20|||
170675422|NCT01702961|616823425|FG000|Overall Study|Death|6|||
170675423|NCT01702961|616823425|FG000|Overall Study|Lost to Follow-up|2|||
170675424|NCT01702961|616823425|FG000|Overall Study|Ongoing|11|||
170675425|NCT04967443|616823434|FG000|Open Label Treatment|Death|1|||
170675426|NCT04967443|616823435|FG001|Open Label Treatment|Death|0|||
170675427|NCT04967443|616823436|FG002|Open Label Treatment|Death|0|||
170675428|NCT04967443|616823437|FG003|Open Label Treatment|Death|0|||
170675429|NCT04967443|616823438|FG004|Open Label Treatment|Death|0|||
170675430|NCT04967443|616823439|FG005|Open Label Treatment|Death|0|||
170675431|NCT04967443|616823440|FG006|Open Label Treatment|Death|0|||
170675432|NCT04967443|616823441|FG007|Open Label Treatment|Death|0|||
170675433|NCT04967443|616823434|FG000|Open Label Treatment|Lost to Follow-up|0|||
170675434|NCT04967443|616823435|FG001|Open Label Treatment|Lost to Follow-up|0|||
170675435|NCT04967443|616823436|FG002|Open Label Treatment|Lost to Follow-up|1|||
170675436|NCT04967443|616823437|FG003|Open Label Treatment|Lost to Follow-up|0|||
170675437|NCT04967443|616823438|FG004|Open Label Treatment|Lost to Follow-up|0|||
170675438|NCT04967443|616823439|FG005|Open Label Treatment|Lost to Follow-up|0|||
170675439|NCT04967443|616823440|FG006|Open Label Treatment|Lost to Follow-up|0|||
170675440|NCT04967443|616823441|FG007|Open Label Treatment|Lost to Follow-up|0|||
170675441|NCT04967443|616823434|FG000|Open Label Treatment|Withdrawal by Subject|0|||
170675442|NCT04967443|616823435|FG001|Open Label Treatment|Withdrawal by Subject|1|||
170675443|NCT04967443|616823436|FG002|Open Label Treatment|Withdrawal by Subject|0|||
170675444|NCT04967443|616823437|FG003|Open Label Treatment|Withdrawal by Subject|1|||
170675445|NCT04967443|616823438|FG004|Open Label Treatment|Withdrawal by Subject|0|||
170675446|NCT04967443|616823439|FG005|Open Label Treatment|Withdrawal by Subject|1|||
170675447|NCT04967443|616823440|FG006|Open Label Treatment|Withdrawal by Subject|2|||
170675448|NCT04967443|616823441|FG007|Open Label Treatment|Withdrawal by Subject|3|||
170675449|NCT04967443|616823434|FG000|Follow-Up|Death|1|||
170675450|NCT04967443|616823435|FG001|Follow-Up|Death|0|||
170675451|NCT04967443|616823436|FG002|Follow-Up|Death|0|||
170675452|NCT04967443|616823437|FG003|Follow-Up|Death|0|||
170675453|NCT04967443|616823438|FG004|Follow-Up|Death|0|||
170675454|NCT04967443|616823439|FG005|Follow-Up|Death|0|||
170675455|NCT04967443|616823440|FG006|Follow-Up|Death|0|||
170675456|NCT04967443|616823441|FG007|Follow-Up|Death|0|||
170675457|NCT04967443|616823434|FG000|Follow-Up|Lost to Follow-up|0|||
170675458|NCT04967443|616823435|FG001|Follow-Up|Lost to Follow-up|0|||
170675459|NCT04967443|616823436|FG002|Follow-Up|Lost to Follow-up|1|||
170675460|NCT04967443|616823437|FG003|Follow-Up|Lost to Follow-up|1|||
170675461|NCT04967443|616823438|FG004|Follow-Up|Lost to Follow-up|0|||
170675462|NCT04967443|616823439|FG005|Follow-Up|Lost to Follow-up|0|||
170675463|NCT04967443|616823440|FG006|Follow-Up|Lost to Follow-up|0|||
170675464|NCT04967443|616823441|FG007|Follow-Up|Lost to Follow-up|0|||
170675465|NCT04967443|616823434|FG000|Follow-Up|Withdrawal by Subject|0|||
170675466|NCT04967443|616823435|FG001|Follow-Up|Withdrawal by Subject|1|||
170675467|NCT04967443|616823436|FG002|Follow-Up|Withdrawal by Subject|0|||
170675468|NCT04967443|616823437|FG003|Follow-Up|Withdrawal by Subject|1|||
170675469|NCT04967443|616823438|FG004|Follow-Up|Withdrawal by Subject|0|||
170675470|NCT04967443|616823439|FG005|Follow-Up|Withdrawal by Subject|1|||
170675471|NCT04967443|616823440|FG006|Follow-Up|Withdrawal by Subject|2|||
170675472|NCT04967443|616823441|FG007|Follow-Up|Withdrawal by Subject|3|||
170675473|NCT02405780|616823443|FG000|Period I|Adverse Event|8|||
170675474|NCT02405780|616823444|FG001|Period I|Adverse Event|0|||
170675475|NCT02405780|616823445|FG002|Period I|Adverse Event|3|||
170675476|NCT02405780|616823446|FG003|Period I|Adverse Event|7|||
170675477|NCT02405780|616823443|FG000|Period I|Medical reasons|1|||
170675478|NCT02405780|616823444|FG001|Period I|Medical reasons|1|||
170675479|NCT02405780|616823445|FG002|Period I|Medical reasons|0|||
170675480|NCT02405780|616823446|FG003|Period I|Medical reasons|1|||
170675481|NCT02405780|616823443|FG000|Period I|Screening Failure|1|||
170675482|NCT02405780|616823444|FG001|Period I|Screening Failure|0|||
170675483|NCT02405780|616823445|FG002|Period I|Screening Failure|1|||
170675484|NCT02405780|616823446|FG003|Period I|Screening Failure|0|||
170675485|NCT02405780|616823443|FG000|Period I|Withdrawal by Subject|9|||
170675486|NCT02405780|616823444|FG001|Period I|Withdrawal by Subject|1|||
170675487|NCT02405780|616823445|FG002|Period I|Withdrawal by Subject|3|||
170675488|NCT02405780|616823446|FG003|Period I|Withdrawal by Subject|4|||
170675489|NCT02405780|616823443|FG000|Period I|Non-compliance with study procedures|8|||
170675490|NCT02405780|616823444|FG001|Period I|Non-compliance with study procedures|6|||
170675491|NCT02405780|616823445|FG002|Period I|Non-compliance with study procedures|8|||
170675492|NCT02405780|616823446|FG003|Period I|Non-compliance with study procedures|11|||
170675493|NCT02405780|616823443|FG000|Period II|Adverse Event|3|||
170675494|NCT02405780|616823444|FG001|Period II|Adverse Event|5|||
170675495|NCT02405780|616823445|FG002|Period II|Adverse Event|4|||
170675496|NCT02405780|616823446|FG003|Period II|Adverse Event|11|||
170675497|NCT02405780|616823443|FG000|Period II|Medical reason|0|||
170675498|NCT02405780|616823444|FG001|Period II|Medical reason|1|||
170675499|NCT02405780|616823445|FG002|Period II|Medical reason|0|||
170675500|NCT02405780|616823446|FG003|Period II|Medical reason|0|||
170675501|NCT02405780|616823443|FG000|Period II|Pregnancy|0|||
170675502|NCT02405780|616823444|FG001|Period II|Pregnancy|0|||
170675503|NCT02405780|616823445|FG002|Period II|Pregnancy|1|||
170675504|NCT02405780|616823446|FG003|Period II|Pregnancy|0|||
170675505|NCT02405780|616823443|FG000|Period II|Withdrawal by Subject|7|||
170675506|NCT02405780|616823444|FG001|Period II|Withdrawal by Subject|4|||
170675507|NCT02405780|616823445|FG002|Period II|Withdrawal by Subject|0|||
170675508|NCT02405780|616823446|FG003|Period II|Withdrawal by Subject|3|||
170675509|NCT02405780|616823443|FG000|Period II|Non-compliance with study procedures|5|||
170675510|NCT02405780|616823444|FG001|Period II|Non-compliance with study procedures|2|||
170675511|NCT02405780|616823445|FG002|Period II|Non-compliance with study procedures|7|||
170675512|NCT02405780|616823446|FG003|Period II|Non-compliance with study procedures|4|||
170675513|NCT01654536|616823447|FG000|Overall Study|Lost to Follow-up|5|||
170675514|NCT01654536|616823448|FG001|Overall Study|Lost to Follow-up|5|||
170675515|NCT01654536|616823447|FG000|Overall Study|Physician Decision|12|||
170675516|NCT01654536|616823448|FG001|Overall Study|Physician Decision|8|||
170675517|NCT01654536|616823447|FG000|Overall Study|Withdrawal by Subject|27|||
170675518|NCT01654536|616823448|FG001|Overall Study|Withdrawal by Subject|25|||
170675519|NCT00668707|616823449|FG000|Overall Study|Cancer Recurrence|58|||
170675520|NCT00668707|616823450|FG001|Overall Study|Cancer Recurrence|58|||
170675521|NCT00668707|616823449|FG000|Overall Study|Withdrawal by Subject|117|||
170675522|NCT00668707|616823450|FG001|Overall Study|Withdrawal by Subject|100|||
170675523|NCT00668707|616823449|FG000|Overall Study|Lost to Follow-up|3|||
170675524|NCT00668707|616823450|FG001|Overall Study|Lost to Follow-up|6|||
170675525|NCT00668707|616823449|FG000|Overall Study|Protocol Violation|10|||
170675526|NCT00668707|616823450|FG001|Overall Study|Protocol Violation|12|||
170675527|NCT00668707|616823449|FG000|Overall Study|Death|11|||
170675528|NCT00668707|616823450|FG001|Overall Study|Death|4|||
170675529|NCT00390468|616823451|FG000|Overall Study|Protocol Violation|2|||
170675530|NCT00390468|616823451|FG000|Overall Study|Lack of Efficacy|1|||
170675531|NCT00923156|616823452|FG000|Overall Study|Adverse Event|0|||
170675532|NCT00923156|616823453|FG001|Overall Study|Adverse Event|2|||
170675533|NCT00923156|616823454|FG002|Overall Study|Adverse Event|1|||
170675534|NCT00923156|616823452|FG000|Overall Study|Abnormal laboratory values|0|||
170675535|NCT00923156|616823453|FG001|Overall Study|Abnormal laboratory values|0|||
170675536|NCT00923156|616823454|FG002|Overall Study|Abnormal laboratory values|1|||
170675537|NCT00923156|616823452|FG000|Overall Study|Withdrawal by Subject|0|||
170675538|NCT00923156|616823453|FG001|Overall Study|Withdrawal by Subject|1|||
170675539|NCT00923156|616823454|FG002|Overall Study|Withdrawal by Subject|0|||
170675540|NCT00923156|616823452|FG000|Overall Study|Death|0|||
170675541|NCT00923156|616823453|FG001|Overall Study|Death|1|||
170675542|NCT00923156|616823454|FG002|Overall Study|Death|0|||
170675543|NCT00923156|616823452|FG000|Overall Study|Lack of Efficacy|0|||
170675544|NCT00923156|616823453|FG001|Overall Study|Lack of Efficacy|0|||
170675545|NCT00923156|616823454|FG002|Overall Study|Lack of Efficacy|1|||
170675546|NCT02657369|616823462|FG000|Overall Study|Death|27|||
170675547|NCT02657369|616823462|FG000|Overall Study|Study terminated by sponsor|7|||
170675548|NCT00361569|616823463|FG000|Overall Study|Protocol Violation|3|||
170675549|NCT00361569|616823464|FG001|Overall Study|Protocol Violation|2|||
170675550|NCT00361569|616823465|FG002|Overall Study|Protocol Violation|4|||
170675551|NCT00361569|616823466|FG003|Overall Study|Protocol Violation|2|||
170675552|NCT00361569|616823463|FG000|Overall Study|Withdrawal by Subject|2|||
170675553|NCT00361569|616823464|FG001|Overall Study|Withdrawal by Subject|1|||
170675554|NCT00361569|616823465|FG002|Overall Study|Withdrawal by Subject|9|||
170675555|NCT00361569|616823466|FG003|Overall Study|Withdrawal by Subject|14|||
170675556|NCT00361569|616823463|FG000|Overall Study|Adverse Event|3|||
170675557|NCT00361569|616823464|FG001|Overall Study|Adverse Event|5|||
170675558|NCT00361569|616823465|FG002|Overall Study|Adverse Event|2|||
170675559|NCT00361569|616823466|FG003|Overall Study|Adverse Event|2|||
170675560|NCT00361569|616823463|FG000|Overall Study|Lost to Follow-up|2|||
170675561|NCT00361569|616823464|FG001|Overall Study|Lost to Follow-up|3|||
170675562|NCT00361569|616823465|FG002|Overall Study|Lost to Follow-up|3|||
170675563|NCT00361569|616823466|FG003|Overall Study|Lost to Follow-up|2|||
170675564|NCT00361569|616823463|FG000|Overall Study|Not specified by investigator|2|||
170675565|NCT00361569|616823464|FG001|Overall Study|Not specified by investigator|0|||
170675566|NCT00361569|616823465|FG002|Overall Study|Not specified by investigator|0|||
170675567|NCT00361569|616823466|FG003|Overall Study|Not specified by investigator|1|||
170675568|NCT02605824|616823467|FG000|Overall Study|Physician Decision|1|||
170675569|NCT02605824|616823468|FG001|Overall Study|Physician Decision|0|||
170675570|NCT00481078|616823469|FG000|Overall Study|Progression of disease|11|||
170675571|NCT00481078|616823470|FG001|Overall Study|Progression of disease|11|||
170675572|NCT00481078|616823469|FG000|Overall Study|Adverse Event|15|||
170675573|NCT00481078|616823470|FG001|Overall Study|Adverse Event|3|||
170675574|NCT00481078|616823469|FG000|Overall Study|Death|5|||
170675575|NCT00481078|616823470|FG001|Overall Study|Death|3|||
170675576|NCT00481078|616823469|FG000|Overall Study|Intercurrent illness|1|||
170675577|NCT00481078|616823470|FG001|Overall Study|Intercurrent illness|0|||
170675578|NCT00481078|616823469|FG000|Overall Study|Withdrawal by Subject|7|||
170675579|NCT00481078|616823470|FG001|Overall Study|Withdrawal by Subject|1|||
170675580|NCT00481078|616823469|FG000|Overall Study|Information not available|1|||
170675581|NCT00481078|616823470|FG001|Overall Study|Information not available|0|||
170675582|NCT00481078|616823469|FG000|Overall Study|Received other treatment|2|||
170675583|NCT00481078|616823470|FG001|Overall Study|Received other treatment|1|||
170675584|NCT00481078|616823469|FG000|Overall Study|Brain metastasis|0|||
170675585|NCT00481078|616823470|FG001|Overall Study|Brain metastasis|1|||
170675586|NCT02339584|616823471|FG000|Overall Study|Adverse Event|11|||
170675587|NCT02339584|616823472|FG001|Overall Study|Adverse Event|7|||
170675588|NCT02339584|616823471|FG000|Overall Study|Lack of Efficacy|0|||
170675589|NCT02339584|616823472|FG001|Overall Study|Lack of Efficacy|1|||
170675590|NCT02339584|616823471|FG000|Overall Study|Physician Decision|1|||
170675591|NCT02339584|616823472|FG001|Overall Study|Physician Decision|2|||
170675592|NCT02339584|616823471|FG000|Overall Study|Protocol Violation|1|||
170675593|NCT02339584|616823472|FG001|Overall Study|Protocol Violation|1|||
170675594|NCT02339584|616823471|FG000|Overall Study|Withdrawal by Subject|2|||
170675595|NCT02339584|616823472|FG001|Overall Study|Withdrawal by Subject|4|||
170675596|NCT03307967|616823473|FG000|Overall Study|Lost to Follow-up|4|||
170675597|NCT04362072|616823474|FG000|Treatment|Adverse Event|1|||
170675598|NCT04362072|616823474|FG000|Treatment|Death|9|||
170675599|NCT04362072|616823474|FG000|Treatment|Physician Decision|2|||
170675600|NCT04362072|616823474|FG000|Treatment|Progressive disease|27|||
170675601|NCT04362072|616823474|FG000|Treatment|Withdrawal by Subject|4|||
170675602|NCT04362072|616823474|FG000|Treatment|Global deterioration of health status|1|||
170675603|NCT04362072|616823474|FG000|Treatment|Switched to commercial Lorlatinib|13|||
170675604|NCT04362072|616823474|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
170675605|NCT04362072|616823474|FG000|Treatment|Other|3|||
170675606|NCT04362072|616823474|FG000|Follow up|Death|2|||
170675607|NCT04362072|616823474|FG000|Follow up|Other|2|||
170675608|NCT04524689|616823475|FG000|Overall Study|Withdrawal by Subject|1|||
170675609|NCT04524689|616823476|FG001|Overall Study|Withdrawal by Subject|1|||
170675610|NCT04524689|616823477|FG002|Overall Study|Withdrawal by Subject|0|||
170675611|NCT04524689|616823478|FG003|Overall Study|Withdrawal by Subject|0|||
170675612|NCT04524689|616823479|FG004|Overall Study|Withdrawal by Subject|2|||
170675613|NCT04524689|616823480|FG005|Overall Study|Withdrawal by Subject|0|||
170675614|NCT04524689|616823475|FG000|Overall Study|Study terminated by Sponsor|6|||
170675615|NCT04524689|616823476|FG001|Overall Study|Study terminated by Sponsor|0|||
170675616|NCT04524689|616823477|FG002|Overall Study|Study terminated by Sponsor|1|||
170675617|NCT04524689|616823478|FG003|Overall Study|Study terminated by Sponsor|0|||
170675618|NCT04524689|616823479|FG004|Overall Study|Study terminated by Sponsor|4|||
170675619|NCT04524689|616823480|FG005|Overall Study|Study terminated by Sponsor|0|||
170675620|NCT04524689|616823475|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
170675621|NCT04524689|616823476|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
170675622|NCT04524689|616823477|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
170675623|NCT04524689|616823478|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
170675624|NCT04524689|616823479|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
170675625|NCT04524689|616823480|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
170675626|NCT01606800|616825326|FG000|Overall Study|Adverse Event|3|||
170675627|NCT01606800|616825327|FG001|Overall Study|Adverse Event|1|||
170675628|NCT01606800|616825326|FG000|Overall Study|Participant withdrew consent|0|||
170675629|NCT01606800|616825327|FG001|Overall Study|Participant withdrew consent|1|||
170675630|NCT01606800|616825326|FG000|Overall Study|Missing completion status|2|||
170675631|NCT01606800|616825327|FG001|Overall Study|Missing completion status|0|||
170675632|NCT00638378|616825333|FG000|Overall Study|Death|2|||
170675633|NCT00638378|616825333|FG000|Overall Study|Adverse Event|1|||
170675634|NCT00638378|616825333|FG000|Overall Study|Disease progression|15|||
170675635|NCT00638378|616825333|FG000|Overall Study|Physician Decision|4|||
170675636|NCT03291808|616825334|FG000|Overall Study|Lost to Follow-up|6|||
170675637|NCT03291808|616825334|FG000|Overall Study|Research burden|4|||
170675638|NCT03797014|616825337|FG000|Overall Study|Withdrawal by Subject|1|||
170675639|NCT03797014|616825337|FG000|Overall Study|Lost to Follow-up|1|||
170675640|NCT03797014|616825337|FG000|Overall Study|Protocol Violation|1|||
170675641|NCT01970397|616825338|FG000|Overall Study|Adverse Event|0|||
170675642|NCT01970397|616825339|FG001|Overall Study|Adverse Event|1|||
170675643|NCT01970397|616825338|FG000|Overall Study|Lost to Follow-up|0|||
170675644|NCT01970397|616825339|FG001|Overall Study|Lost to Follow-up|1|||
170675645|NCT01970397|616825338|FG000|Overall Study|Personal Reasons|1|||
170675646|NCT01970397|616825339|FG001|Overall Study|Personal Reasons|2|||
170675647|NCT01970397|616825338|FG000|Overall Study|Protocol Violation|1|||
170675648|NCT01970397|616825339|FG001|Overall Study|Protocol Violation|1|||
170675649|NCT03305575|616825340|FG000|Overall Study|Physician Decision|1|||
170675650|NCT03305575|616825341|FG001|Overall Study|Physician Decision|0|||
170675651|NCT02397278|616825342|FG000|Overall Study|Withdrawal by Subject|0|||
170675652|NCT02397278|616825343|FG001|Overall Study|Withdrawal by Subject|2|||
170675653|NCT02397278|616825342|FG000|Overall Study|Deemed ineligible following surgery|1|||
170675654|NCT02397278|616825343|FG001|Overall Study|Deemed ineligible following surgery|1|||
170675655|NCT04115839|616825347|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
170675656|NCT04115839|616825348|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
170675657|NCT04115839|616825349|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
170675658|NCT04115839|616825350|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
170675659|NCT04115839|616825351|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
170675660|NCT04115839|616825352|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
170675661|NCT04115839|616825353|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
170675662|NCT04115839|616825347|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
170675663|NCT04115839|616825348|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
170675664|NCT04115839|616825349|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
170675665|NCT04115839|616825350|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
170675666|NCT04115839|616825351|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
170675667|NCT04115839|616825352|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
170675668|NCT04115839|616825353|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
170675669|NCT04115839|616825347|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
170675670|NCT04115839|616825348|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
170675671|NCT04115839|616825349|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
170675672|NCT04115839|616825350|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
170675673|NCT04115839|616825351|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
170675674|NCT04115839|616825352|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
170675675|NCT04115839|616825353|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
170675676|NCT04115839|616825347|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
170675677|NCT04115839|616825348|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
170675678|NCT04115839|616825349|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
170675679|NCT04115839|616825350|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
170675680|NCT04115839|616825351|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
170675681|NCT04115839|616825352|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
170675682|NCT04115839|616825353|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
170675683|NCT04115839|616825347|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
170675684|NCT04115839|616825348|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
170675685|NCT04115839|616825349|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
170675686|NCT04115839|616825350|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
170675687|NCT04115839|616825351|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
170820375|NCT02660034|617349629|FG007|Overall Study|Death|10|||
170820376|NCT02660034|617349630|FG008|Overall Study|Death|9|||
170820377|NCT02660034|617349631|FG009|Overall Study|Death|21|||
170820378|NCT02660034|617349632|FG010|Overall Study|Death|17|||
170820379|NCT02660034|617349633|FG011|Overall Study|Death|15|||
170820380|NCT02660034|617349634|FG012|Overall Study|Death|18|||
170820381|NCT02660034|617349635|FG013|Overall Study|Death|7|||
170820382|NCT02660034|617349622|FG000|Overall Study|Physician Decision|0|||
170820383|NCT02660034|617349623|FG001|Overall Study|Physician Decision|0|||
170820384|NCT02660034|617349624|FG002|Overall Study|Physician Decision|0|||
170820385|NCT02660034|617349625|FG003|Overall Study|Physician Decision|0|||
170820386|NCT02660034|617349626|FG004|Overall Study|Physician Decision|0|||
170820387|NCT02660034|617349627|FG005|Overall Study|Physician Decision|0|||
170820388|NCT02660034|617349628|FG006|Overall Study|Physician Decision|0|||
170675688|NCT04115839|616825352|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
170675689|NCT04115839|616825353|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
170675690|NCT04115839|616825347|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
170675691|NCT04115839|616825348|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
170675692|NCT04115839|616825349|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
170675693|NCT04115839|616825350|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
170675694|NCT04115839|616825351|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
170675695|NCT04115839|616825352|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
170675696|NCT04115839|616825353|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
170675697|NCT02966028|616825354|FG000|Overall Study|Adverse Event|7|||
170675698|NCT02966028|616825355|FG001|Overall Study|Adverse Event|13|||
170675699|NCT02966028|616825356|FG002|Overall Study|Adverse Event|10|||
170675700|NCT02966028|616825354|FG000|Overall Study|Physician Decision|1|||
170675701|NCT02966028|616825355|FG001|Overall Study|Physician Decision|0|||
170675702|NCT02966028|616825356|FG002|Overall Study|Physician Decision|2|||
170675703|NCT02966028|616825354|FG000|Overall Study|Withdrawal by Subject|7|||
170675704|NCT02966028|616825355|FG001|Overall Study|Withdrawal by Subject|5|||
170675705|NCT02966028|616825356|FG002|Overall Study|Withdrawal by Subject|5|||
170675706|NCT02966028|616825354|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
170675707|NCT02966028|616825355|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
170675708|NCT02966028|616825356|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
170675709|NCT04980040|616825358|FG000|Overall Study|Violated the Inclusion Criteria|260|||
170675710|NCT04980040|616825358|FG000|Overall Study|Violated the Administration & Dosage|225|||
170675711|NCT04980040|616825358|FG000|Overall Study|Lost to Safety-Follow-up|4|||
170675712|NCT04980040|616825358|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
170675713|NCT02820753|616825359|FG000|2 Month|Withdrawal by Subject|3|||
170675714|NCT02820753|616825360|FG001|2 Month|Withdrawal by Subject|3|||
170675715|NCT02820753|616825359|FG000|2 Month|Lost to Follow-up|24|||
170675716|NCT02820753|616825360|FG001|2 Month|Lost to Follow-up|26|||
170675717|NCT02820753|616825359|FG000|2 Month|Stopped per NIH Hold|51|||
170675718|NCT02820753|616825360|FG001|2 Month|Stopped per NIH Hold|13|||
170675719|NCT02820753|616825359|FG000|6 Month|Withdrawal by Subject|2|||
170675720|NCT02820753|616825360|FG001|6 Month|Withdrawal by Subject|2|||
170675721|NCT02820753|616825359|FG000|6 Month|Lost to Follow-up|20|||
170675722|NCT02820753|616825360|FG001|6 Month|Lost to Follow-up|27|||
170675723|NCT02820753|616825359|FG000|6 Month|Stopped per NIH Hold|81|||
170675724|NCT02820753|616825360|FG001|6 Month|Stopped per NIH Hold|81|||
170675725|NCT02820753|616825359|FG000|6 Month|Death|0|||
170675726|NCT02820753|616825360|FG001|6 Month|Death|1|||
170675727|NCT01397084|616825365|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
170675728|NCT01397084|616825365|FG000|Overall Study|Protocol Violation|2|||
170675729|NCT01397084|616825365|FG000|Overall Study|Adverse Event|2|||
170675730|NCT01397084|616825365|FG000|Overall Study|Withdrawal by Subject|1|||
170675731|NCT01397084|616825365|FG000|Overall Study|Lost to Follow-up|1|||
170675732|NCT01397084|616825365|FG000|Overall Study|Used other proton pump inhibitor|1|||
170675733|NCT00573469|616825366|FG000|Overall Study|Adverse Event|1|||
170675734|NCT00573469|616825367|FG001|Overall Study|Adverse Event|1|||
170675735|NCT00573469|616825368|FG002|Overall Study|Adverse Event|1|||
170675736|NCT00573469|616825366|FG000|Overall Study|Withdrawal by Subject|0|||
170675737|NCT00573469|616825367|FG001|Overall Study|Withdrawal by Subject|2|||
170675738|NCT00573469|616825368|FG002|Overall Study|Withdrawal by Subject|0|||
170675739|NCT00573469|616825366|FG000|Overall Study|Other|5|||
170675740|NCT00573469|616825367|FG001|Overall Study|Other|1|||
170675741|NCT00573469|616825368|FG002|Overall Study|Other|3|||
170675742|NCT01652703|616825374|FG000|Overall Study|Withdrawal by Subject|0|||
170675743|NCT01652703|616825375|FG001|Overall Study|Withdrawal by Subject|1|||
170675744|NCT01652703|616825376|FG002|Overall Study|Withdrawal by Subject|3|||
170675745|NCT01652703|616825377|FG003|Overall Study|Withdrawal by Subject|1|||
170675746|NCT01652703|616825378|FG004|Overall Study|Withdrawal by Subject|0|||
170675747|NCT01652703|616825379|FG005|Overall Study|Withdrawal by Subject|1|||
170675748|NCT01652703|616825374|FG000|Overall Study|Other|0|||
170675749|NCT01652703|616825375|FG001|Overall Study|Other|0|||
170675750|NCT01652703|616825376|FG002|Overall Study|Other|0|||
170675751|NCT01652703|616825377|FG003|Overall Study|Other|1|||
170675752|NCT01652703|616825378|FG004|Overall Study|Other|1|||
170675753|NCT01652703|616825379|FG005|Overall Study|Other|1|||
170675754|NCT02155608|616825383|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
170675755|NCT02155608|616825384|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
170675756|NCT02155608|616825383|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
170675757|NCT02155608|616825384|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
170675758|NCT03555591|616825385|FG000|Overall Study|Protocol Violation|77|||
170675759|NCT02380677|616825393|FG000|Overall Study|Adverse Event|0|||
170675760|NCT02380677|616825394|FG001|Overall Study|Adverse Event|0|||
170675761|NCT02380677|616825395|FG002|Overall Study|Adverse Event|0|||
170675762|NCT02380677|616825396|FG003|Overall Study|Adverse Event|1|||
170675763|NCT02380677|616825397|FG004|Overall Study|Adverse Event|1|||
170675764|NCT02380677|616825398|FG005|Overall Study|Adverse Event|4|||
170675765|NCT02380677|616825399|FG006|Overall Study|Adverse Event|2|||
170675766|NCT02380677|616825400|FG007|Overall Study|Adverse Event|2|||
170675767|NCT02380677|616825401|FG008|Overall Study|Adverse Event|2|||
170675768|NCT02380677|616825402|FG009|Overall Study|Adverse Event|1|||
170675769|NCT02380677|616825403|FG010|Overall Study|Adverse Event|2|||
170675770|NCT02380677|616825404|FG011|Overall Study|Adverse Event|1|||
170675771|NCT02380677|616825393|FG000|Overall Study|Physician Decision|1|||
170675772|NCT02380677|616825394|FG001|Overall Study|Physician Decision|0|||
170675773|NCT02380677|616825395|FG002|Overall Study|Physician Decision|1|||
170820389|NCT02660034|617349629|FG007|Overall Study|Physician Decision|0|||
170820390|NCT02660034|617349630|FG008|Overall Study|Physician Decision|0|||
170820391|NCT02660034|617349631|FG009|Overall Study|Physician Decision|0|||
170820392|NCT02660034|617349632|FG010|Overall Study|Physician Decision|0|||
170820393|NCT02660034|617349633|FG011|Overall Study|Physician Decision|0|||
170820394|NCT02660034|617349634|FG012|Overall Study|Physician Decision|0|||
170820395|NCT02660034|617349635|FG013|Overall Study|Physician Decision|1|||
170820396|NCT02660034|617349622|FG000|Overall Study|Participants transferred to LTE|0|||
170820397|NCT02660034|617349623|FG001|Overall Study|Participants transferred to LTE|0|||
170820398|NCT02660034|617349624|FG002|Overall Study|Participants transferred to LTE|0|||
170820399|NCT02660034|617349625|FG003|Overall Study|Participants transferred to LTE|0|||
170820400|NCT02660034|617349626|FG004|Overall Study|Participants transferred to LTE|0|||
170820401|NCT02660034|617349627|FG005|Overall Study|Participants transferred to LTE|10|||
170820402|NCT02660034|617349628|FG006|Overall Study|Participants transferred to LTE|8|||
170820403|NCT02660034|617349629|FG007|Overall Study|Participants transferred to LTE|8|||
170820404|NCT02660034|617349630|FG008|Overall Study|Participants transferred to LTE|10|||
170820405|NCT02660034|617349631|FG009|Overall Study|Participants transferred to LTE|1|||
170820406|NCT02660034|617349632|FG010|Overall Study|Participants transferred to LTE|2|||
170820407|NCT02660034|617349633|FG011|Overall Study|Participants transferred to LTE|4|||
170820408|NCT02660034|617349634|FG012|Overall Study|Participants transferred to LTE|1|||
170820409|NCT02660034|617349635|FG013|Overall Study|Participants transferred to LTE|1|||
170820410|NCT02592434|617349645|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
170820411|NCT02592434|617349646|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
170820412|NCT02592434|617349647|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
170820413|NCT02592434|617349645|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
170820414|NCT02592434|617349646|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
170820415|NCT02592434|617349647|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
170820416|NCT02592434|617349645|FG000|Open-Label Phase (18 Weeks)|Other|3|||
170820417|NCT02592434|617349646|FG001|Open-Label Phase (18 Weeks)|Other|0|||
170820418|NCT02592434|617349647|FG002|Open-Label Phase (18 Weeks)|Other|0|||
170820419|NCT02592434|617349645|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
170820420|NCT02592434|617349646|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
170820421|NCT02592434|617349647|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
170820422|NCT02592434|617349645|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
170820423|NCT02592434|617349646|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
170820424|NCT02592434|617349647|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
170820425|NCT02592434|617349645|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
170820426|NCT02592434|617349646|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
170820427|NCT02592434|617349647|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
170820428|NCT02592434|617349645|FG000|Double Blind Phase (26 Weeks)|Other|0|||
170820429|NCT02592434|617349646|FG001|Double Blind Phase (26 Weeks)|Other|1|||
170820430|NCT02592434|617349647|FG002|Double Blind Phase (26 Weeks)|Other|0|||
170820431|NCT02592434|617349645|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
170820432|NCT02592434|617349646|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
170820433|NCT02592434|617349647|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
170820434|NCT02592434|617349645|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
170820435|NCT02592434|617349646|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
170820436|NCT02592434|617349647|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
170820437|NCT02592434|617349645|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
170820438|NCT02592434|617349646|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
170820439|NCT02592434|617349647|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
170820440|NCT00730925|617349648|FG000|Overall Study|Progressive Disease|21|||
170820441|NCT00730925|617349648|FG000|Overall Study|Dose reducing Event|2|||
170675774|NCT02380677|616825396|FG003|Overall Study|Physician Decision|1|||
170675775|NCT02380677|616825397|FG004|Overall Study|Physician Decision|0|||
170820442|NCT00730925|617349648|FG000|Overall Study|Other Averse Event|7|||
170820443|NCT00730925|617349648|FG000|Overall Study|Protocol Violation|1|||
170820444|NCT00730925|617349648|FG000|Overall Study|Withdrawal by Subject|1|||
170820445|NCT00730925|617349648|FG000|Overall Study|Switch to combination therapy|8|||
170820446|NCT00730925|617349648|FG000|Overall Study|Other|1|||
170820447|NCT02475733|617349649|FG000|Overall Study|Withdrawal by Subject|1|||
170820448|NCT02475733|617349650|FG001|Overall Study|Withdrawal by Subject|0|||
170820449|NCT02475733|617349649|FG000|Overall Study|Physician Decision|1|||
170675776|NCT02380677|616825398|FG005|Overall Study|Physician Decision|0|||
170675777|NCT02380677|616825399|FG006|Overall Study|Physician Decision|0|||
170675778|NCT02380677|616825400|FG007|Overall Study|Physician Decision|0|||
170675779|NCT02380677|616825401|FG008|Overall Study|Physician Decision|0|||
170675780|NCT02380677|616825402|FG009|Overall Study|Physician Decision|0|||
170675781|NCT02380677|616825403|FG010|Overall Study|Physician Decision|0|||
170675782|NCT02380677|616825404|FG011|Overall Study|Physician Decision|0|||
170675783|NCT02380677|616825393|FG000|Overall Study|Lack of Efficacy|0|||
170675784|NCT02380677|616825394|FG001|Overall Study|Lack of Efficacy|1|||
170675785|NCT02380677|616825395|FG002|Overall Study|Lack of Efficacy|2|||
170675786|NCT02380677|616825396|FG003|Overall Study|Lack of Efficacy|0|||
170675787|NCT02380677|616825397|FG004|Overall Study|Lack of Efficacy|4|||
170675788|NCT02380677|616825398|FG005|Overall Study|Lack of Efficacy|1|||
170675789|NCT02380677|616825399|FG006|Overall Study|Lack of Efficacy|1|||
170675790|NCT02380677|616825400|FG007|Overall Study|Lack of Efficacy|2|||
170675791|NCT02380677|616825401|FG008|Overall Study|Lack of Efficacy|2|||
170675792|NCT02380677|616825402|FG009|Overall Study|Lack of Efficacy|0|||
170675793|NCT02380677|616825403|FG010|Overall Study|Lack of Efficacy|2|||
170675794|NCT02380677|616825404|FG011|Overall Study|Lack of Efficacy|1|||
170675795|NCT02380677|616825393|FG000|Overall Study|Withdrawal by Subject|0|||
170675796|NCT02380677|616825394|FG001|Overall Study|Withdrawal by Subject|0|||
170675797|NCT02380677|616825395|FG002|Overall Study|Withdrawal by Subject|0|||
170675798|NCT02380677|616825396|FG003|Overall Study|Withdrawal by Subject|0|||
170675799|NCT02380677|616825397|FG004|Overall Study|Withdrawal by Subject|0|||
170675800|NCT02380677|616825398|FG005|Overall Study|Withdrawal by Subject|0|||
170675801|NCT02380677|616825399|FG006|Overall Study|Withdrawal by Subject|0|||
170675802|NCT02380677|616825400|FG007|Overall Study|Withdrawal by Subject|0|||
170675803|NCT02380677|616825401|FG008|Overall Study|Withdrawal by Subject|0|||
170675804|NCT02380677|616825402|FG009|Overall Study|Withdrawal by Subject|1|||
170675805|NCT02380677|616825403|FG010|Overall Study|Withdrawal by Subject|0|||
170675806|NCT02380677|616825404|FG011|Overall Study|Withdrawal by Subject|3|||
170675807|NCT02380677|616825393|FG000|Overall Study|Other|0|||
170675808|NCT02380677|616825394|FG001|Overall Study|Other|0|||
170675809|NCT02380677|616825395|FG002|Overall Study|Other|0|||
170675810|NCT02380677|616825396|FG003|Overall Study|Other|1|||
170675811|NCT02380677|616825397|FG004|Overall Study|Other|1|||
170675812|NCT02380677|616825398|FG005|Overall Study|Other|1|||
170675813|NCT02380677|616825399|FG006|Overall Study|Other|0|||
170675814|NCT02380677|616825400|FG007|Overall Study|Other|0|||
170675815|NCT02380677|616825401|FG008|Overall Study|Other|0|||
170675816|NCT02380677|616825402|FG009|Overall Study|Other|0|||
170675817|NCT02380677|616825403|FG010|Overall Study|Other|0|||
170675818|NCT02380677|616825404|FG011|Overall Study|Other|0|||
170675819|NCT03217175|616825405|FG000|Overall Study|Physician Decision|4|||
170675820|NCT03217175|616825406|FG001|Overall Study|Physician Decision|1|||
170675821|NCT05035550|616825412|FG000|Overall Study|Withdrawal by Subject|3|||
170675822|NCT05035550|616825413|FG001|Overall Study|Withdrawal by Subject|0|||
170675823|NCT00429273|616825414|FG000|Overall Study|Lost to Follow-up|1|||
170675824|NCT00429273|616825415|FG001|Overall Study|Lost to Follow-up|2|||
170675825|NCT00429273|616825416|FG002|Overall Study|Lost to Follow-up|2|||
170675826|NCT00429273|616825414|FG000|Overall Study|Physician Decision|6|||
170675827|NCT00429273|616825415|FG001|Overall Study|Physician Decision|5|||
170675828|NCT00429273|616825416|FG002|Overall Study|Physician Decision|5|||
170675829|NCT00429273|616825414|FG000|Overall Study|Adverse Event|1|||
170675830|NCT00429273|616825415|FG001|Overall Study|Adverse Event|1|||
170675831|NCT00429273|616825416|FG002|Overall Study|Adverse Event|2|||
170675832|NCT00617123|616825417|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
170675833|NCT00617123|616825418|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
170675834|NCT00617123|616825417|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
170675835|NCT00617123|616825418|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
170675836|NCT00617123|616825417|FG000|Referral Screening Period|Adverse Event|0|||
170675837|NCT00617123|616825418|FG001|Referral Screening Period|Adverse Event|1|||
170675838|NCT00617123|616825417|FG000|Study Treatment Period|Withdrawal by Subject|8|||
170675839|NCT00617123|616825418|FG001|Study Treatment Period|Withdrawal by Subject|12|||
170820450|NCT02475733|617349650|FG001|Overall Study|Physician Decision|0|||
170675840|NCT00617123|616825417|FG000|Study Treatment Period|Adverse Event|7|||
170675841|NCT00617123|616825418|FG001|Study Treatment Period|Adverse Event|3|||
170675842|NCT00617123|616825417|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
170675843|NCT00617123|616825418|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
170675844|NCT00617123|616825417|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
170675845|NCT00617123|616825418|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
170675846|NCT02269241|616825420|FG000|Overall Study|Lost to Follow-up|269|||
170675847|NCT02269241|616825420|FG000|Overall Study|Withdrawal by Subject|155|||
170675848|NCT02269241|616825420|FG000|Overall Study|Protocol Violation|1|||
170675849|NCT02269241|616825420|FG000|Overall Study|Physician Decision|7|||
170675850|NCT02269241|616825420|FG000|Overall Study|Pregnancy|15|||
170675851|NCT02269241|616825420|FG000|Overall Study|Wish for pregnancy|5|||
170675852|NCT02269241|616825420|FG000|Overall Study|Development of an exclusion criteria|16|||
170675853|NCT02269241|616825420|FG000|Overall Study|Adverse Event|113|||
170675854|NCT02269241|616825420|FG000|Overall Study|At the specific request of the sponsor|20|||
170675855|NCT02269241|616825420|FG000|Overall Study|Several reasons not classified|53|||
170675856|NCT02269241|616825420|FG000|Overall Study|Screening failures|546|||
170675857|NCT00520936|616825421|FG000|Overall Study|Physician Decision|0|||
170675858|NCT00520936|616825422|FG001|Overall Study|Physician Decision|2|||
170675859|NCT00520936|616825423|FG002|Overall Study|Physician Decision|1|||
170675860|NCT00520936|616825424|FG003|Overall Study|Physician Decision|0|||
170675861|NCT00520936|616825425|FG004|Overall Study|Physician Decision|0|||
170675862|NCT00520936|616825426|FG005|Overall Study|Physician Decision|0|||
170675863|NCT00520936|616825427|FG006|Overall Study|Physician Decision|0|||
170675864|NCT00520936|616825428|FG007|Overall Study|Physician Decision|0|||
170675865|NCT00520936|616825421|FG000|Overall Study|Withdrawal by Subject|0|||
170675866|NCT00520936|616825422|FG001|Overall Study|Withdrawal by Subject|0|||
170675867|NCT00520936|616825423|FG002|Overall Study|Withdrawal by Subject|0|||
170675868|NCT00520936|616825424|FG003|Overall Study|Withdrawal by Subject|0|||
170675869|NCT00520936|616825425|FG004|Overall Study|Withdrawal by Subject|0|||
170675870|NCT00520936|616825426|FG005|Overall Study|Withdrawal by Subject|0|||
170675871|NCT00520936|616825427|FG006|Overall Study|Withdrawal by Subject|0|||
170675872|NCT00520936|616825428|FG007|Overall Study|Withdrawal by Subject|1|||
170675873|NCT00520936|616825421|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
170675874|NCT00520936|616825422|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
170675875|NCT00520936|616825423|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
170675876|NCT00520936|616825424|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
170675877|NCT00520936|616825425|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
170675878|NCT00520936|616825426|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
170675879|NCT00520936|616825427|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
170675880|NCT00520936|616825428|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
170675881|NCT00520936|616825421|FG000|Overall Study|Death|0|||
170675882|NCT00520936|616825422|FG001|Overall Study|Death|0|||
170675883|NCT00520936|616825423|FG002|Overall Study|Death|0|||
170675884|NCT00520936|616825424|FG003|Overall Study|Death|0|||
170675885|NCT00520936|616825425|FG004|Overall Study|Death|0|||
170675886|NCT00520936|616825426|FG005|Overall Study|Death|0|||
170675887|NCT00520936|616825427|FG006|Overall Study|Death|1|||
170675888|NCT00520936|616825428|FG007|Overall Study|Death|0|||
170675889|NCT00520936|616825421|FG000|Overall Study|Protocol Violation|0|||
170675890|NCT00520936|616825422|FG001|Overall Study|Protocol Violation|1|||
170675891|NCT00520936|616825423|FG002|Overall Study|Protocol Violation|1|||
170675892|NCT00520936|616825424|FG003|Overall Study|Protocol Violation|0|||
170675893|NCT00520936|616825425|FG004|Overall Study|Protocol Violation|1|||
170675894|NCT00520936|616825426|FG005|Overall Study|Protocol Violation|0|||
170675895|NCT00520936|616825427|FG006|Overall Study|Protocol Violation|1|||
170675896|NCT00520936|616825428|FG007|Overall Study|Protocol Violation|0|||
170675897|NCT01061177|616825429|FG000|Overall Study|Adverse Event|117|||
170675898|NCT01061177|616825429|FG000|Overall Study|Withdrawal by Subject|27|||
170675899|NCT01061177|616825429|FG000|Overall Study|Disease progression|17|||
170675900|NCT01061177|616825429|FG000|Overall Study|Protocol Violation|11|||
170675901|NCT01061177|616825429|FG000|Overall Study|Lost to Follow-up|9|||
170675902|NCT01061177|616825429|FG000|Overall Study|New cancer therapy|9|||
170675903|NCT01061177|616825429|FG000|Overall Study|Abnormal laboratory values|6|||
170675904|NCT01061177|616825429|FG000|Overall Study|Abnormal test procedure results|4|||
170675905|NCT01061177|616825429|FG000|Overall Study|Administratie problems|4|||
170675906|NCT01061177|616825429|FG000|Overall Study|Death|4|||
170675907|NCT03616600|616825430|FG000|Overall Study|Withdrawal by Subject|1|||
170675908|NCT03616600|616825431|FG001|Overall Study|Withdrawal by Subject|0|||
170675909|NCT03984994|616825432|FG000|Overall Study|Withdrawal by Subject|2|||
170675910|NCT03984994|616825433|FG001|Overall Study|Withdrawal by Subject|1|||
170675911|NCT03010176|616825435|FG000|Overall Study|Death|21|||
170675912|NCT03010176|616825436|FG001|Overall Study|Death|35|||
170675913|NCT03010176|616825437|FG002|Overall Study|Death|19|||
170675914|NCT03010176|616825438|FG003|Overall Study|Death|19|||
170675915|NCT03010176|616825439|FG004|Overall Study|Death|14|||
170675916|NCT03010176|616825440|FG005|Overall Study|Death|0|||
170675917|NCT03010176|616825435|FG000|Overall Study|Lost to Follow-up|0|||
170675918|NCT03010176|616825436|FG001|Overall Study|Lost to Follow-up|0|||
170675919|NCT03010176|616825437|FG002|Overall Study|Lost to Follow-up|0|||
170675920|NCT03010176|616825438|FG003|Overall Study|Lost to Follow-up|0|||
170675921|NCT03010176|616825439|FG004|Overall Study|Lost to Follow-up|1|||
170675922|NCT03010176|616825440|FG005|Overall Study|Lost to Follow-up|0|||
170675923|NCT03010176|616825435|FG000|Overall Study|Physician Decision|0|||
170675924|NCT03010176|616825436|FG001|Overall Study|Physician Decision|4|||
170675925|NCT03010176|616825437|FG002|Overall Study|Physician Decision|0|||
170675926|NCT03010176|616825438|FG003|Overall Study|Physician Decision|1|||
170675927|NCT03010176|616825439|FG004|Overall Study|Physician Decision|0|||
170675928|NCT03010176|616825440|FG005|Overall Study|Physician Decision|0|||
170675929|NCT03010176|616825435|FG000|Overall Study|Sponsor Decision|0|||
170675930|NCT03010176|616825436|FG001|Overall Study|Sponsor Decision|4|||
170675931|NCT03010176|616825437|FG002|Overall Study|Sponsor Decision|4|||
170675932|NCT03010176|616825438|FG003|Overall Study|Sponsor Decision|1|||
170675933|NCT03010176|616825439|FG004|Overall Study|Sponsor Decision|6|||
170675934|NCT03010176|616825440|FG005|Overall Study|Sponsor Decision|0|||
170675935|NCT03010176|616825435|FG000|Overall Study|Withdrawal by Subject|11|||
170675936|NCT03010176|616825436|FG001|Overall Study|Withdrawal by Subject|9|||
170675937|NCT03010176|616825437|FG002|Overall Study|Withdrawal by Subject|3|||
170675938|NCT03010176|616825438|FG003|Overall Study|Withdrawal by Subject|0|||
170675939|NCT03010176|616825439|FG004|Overall Study|Withdrawal by Subject|4|||
170675940|NCT03010176|616825440|FG005|Overall Study|Withdrawal by Subject|0|||
170675941|NCT04220866|616825441|FG000|Overall Study|Death|4|||
170675942|NCT04220866|616825442|FG001|Overall Study|Death|5|||
170675943|NCT04220866|616825441|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
170675944|NCT04220866|616825442|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
170675945|NCT04220866|616825441|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
170675946|NCT04220866|616825442|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
170675947|NCT04220866|616825441|FG000|Overall Study|Withdrawal by Subject|0|||
170675948|NCT04220866|616825442|FG001|Overall Study|Withdrawal by Subject|1|||
170675949|NCT00709761|616825452|FG000|Overall Study|Withdrawal by Subject|8|||
170675950|NCT00709761|616825452|FG000|Overall Study|study closed/terminated|17|||
170675951|NCT00709761|616825452|FG000|Overall Study|Lost to Follow-up|2|||
170675952|NCT00847379|616825453|FG000|Overall Study|Study terminated by Sponsor|59|||
170675953|NCT00847379|616825454|FG001|Overall Study|Study terminated by Sponsor|57|||
170675954|NCT00847379|616825455|FG002|Overall Study|Study terminated by Sponsor|57|||
170675955|NCT01192516|616825456|FG000|Overall Study|Lost to Follow-up|7|||
170675956|NCT01192516|616825457|FG001|Overall Study|Lost to Follow-up|10|||
170675957|NCT01192516|616825458|FG002|Overall Study|Lost to Follow-up|7|||
170675958|NCT01192516|616825456|FG000|Overall Study|Withdrawal by Subject|4|||
170675959|NCT01192516|616825457|FG001|Overall Study|Withdrawal by Subject|4|||
170675960|NCT01192516|616825458|FG002|Overall Study|Withdrawal by Subject|1|||
170675961|NCT01192516|616825456|FG000|Overall Study|started new treatment|5|||
170675962|NCT01192516|616825457|FG001|Overall Study|started new treatment|1|||
170675963|NCT01192516|616825458|FG002|Overall Study|started new treatment|0|||
170675964|NCT01192516|616825456|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
170675965|NCT01192516|616825457|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
170675966|NCT01192516|616825458|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
170675967|NCT00407797|616825459|FG000|Overall Study|Lost to Follow-up|2|||
170675968|NCT00407797|616825459|FG000|Overall Study|Adverse Event|6|||
170675969|NCT00407797|616825459|FG000|Overall Study|Other|7|||
170675970|NCT00407797|616825459|FG000|Overall Study|Withdrawal by Subject|3|||
170675971|NCT00553644|616825462|FG000|Overall Study|Adverse Event|17|||
170675972|NCT00553644|616825462|FG000|Overall Study|Withdrawal by Subject|4|||
170675973|NCT00553644|616825462|FG000|Overall Study|Physician Decision|1|||
170675974|NCT00553644|616825462|FG000|Overall Study|Alternative therapy|6|||
170675975|NCT00851747|616825463|FG000|Overall Study|Physician Decision|6|||
170675976|NCT00851747|616825464|FG001|Overall Study|Physician Decision|6|||
170675977|NCT00851747|616825465|FG002|Overall Study|Physician Decision|6|||
170675978|NCT00555971|616825471|FG000|Overall Study|Adverse Event|1|||
170675979|NCT00555971|616825472|FG001|Overall Study|Adverse Event|1|||
170675980|NCT02573311|616825473|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
170675981|NCT02573311|616825474|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
170675982|NCT02573311|616825473|FG000|Disposition for Part 2|Physician Decision|25|||
170675983|NCT02573311|616825474|FG001|Disposition for Part 2|Physician Decision|7|||
170675984|NCT02573311|616825473|FG000|Disposition for Part 2|Adverse Event|36|||
170675985|NCT02573311|616825474|FG001|Disposition for Part 2|Adverse Event|5|||
170675986|NCT02573311|616825473|FG000|Disposition for Part 2|Lost to Follow-up|76|||
170675987|NCT02573311|616825474|FG001|Disposition for Part 2|Lost to Follow-up|7|||
170675988|NCT02573311|616825473|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
170675989|NCT02573311|616825474|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
170675990|NCT02573311|616825473|FG000|Disposition for Part 2|Investigator decision|0|||
170675991|NCT02573311|616825474|FG001|Disposition for Part 2|Investigator decision|1|||
170675992|NCT02573311|616825473|FG000|Disposition for Part 2|Other than specified above|13|||
170675993|NCT02573311|616825474|FG001|Disposition for Part 2|Other than specified above|3|||
170675994|NCT05683249|616825476|FG000|Overall Study|Adverse Event|3|||
170675995|NCT05683249|616825477|FG001|Overall Study|Adverse Event|1|||
170675996|NCT05683249|616825476|FG000|Overall Study|Lack of Efficacy|0|||
170675997|NCT05683249|616825477|FG001|Overall Study|Lack of Efficacy|2|||
170675998|NCT05683249|616825476|FG000|Overall Study|Lost to Follow-up|6|||
170675999|NCT05683249|616825477|FG001|Overall Study|Lost to Follow-up|5|||
170676000|NCT05683249|616825476|FG000|Overall Study|Non-compliance with Study Drug|2|||
170676001|NCT05683249|616825477|FG001|Overall Study|Non-compliance with Study Drug|0|||
170676002|NCT05683249|616825476|FG000|Overall Study|Protocol Violation|6|||
170676003|NCT05683249|616825477|FG001|Overall Study|Protocol Violation|3|||
170676004|NCT05683249|616825476|FG000|Overall Study|Withdrawal by Subject|9|||
170676005|NCT05683249|616825477|FG001|Overall Study|Withdrawal by Subject|8|||
170676006|NCT05683249|616825476|FG000|Overall Study|Other|0|||
170676007|NCT05683249|616825477|FG001|Overall Study|Other|2|||
170676008|NCT04862585|616825478|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
170676009|NCT04862585|616825479|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
170676010|NCT04862585|616825478|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
170676011|NCT04862585|616825479|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
170676012|NCT04862585|616825478|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
170676013|NCT04862585|616825479|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
170676014|NCT04862585|616825478|FG000|Overall Study|one withdrew without providing a reason|0|||
170676015|NCT04862585|616825479|FG001|Overall Study|one withdrew without providing a reason|1|||
170676016|NCT01328431|616825480|FG000|Baseline|Protocol Violation|0|||
170676017|NCT01328431|616825481|FG001|Baseline|Protocol Violation|2|||
170676018|NCT01328431|616825480|FG000|1 Month (1M)|Lost to Follow-up|55|||
170676019|NCT01328431|616825481|FG001|1 Month (1M)|Lost to Follow-up|58|||
170676020|NCT01328431|616825480|FG000|3 Month (3M)|Death|2|||
170676021|NCT01328431|616825481|FG001|3 Month (3M)|Death|2|||
170676022|NCT01328431|616825480|FG000|3 Month (3M)|Lost to Follow-up|75|||
170676023|NCT01328431|616825481|FG001|3 Month (3M)|Lost to Follow-up|70|||
170676024|NCT01328431|616825480|FG000|12 Month (12M)|Death|2|||
170676025|NCT01328431|616825481|FG001|12 Month (12M)|Death|6|||
170676026|NCT01328431|616825480|FG000|12 Month (12M)|Lost to Follow-up|82|||
170676027|NCT01328431|616825481|FG001|12 Month (12M)|Lost to Follow-up|91|||
170676028|NCT03087643|616825483|FG000|Overall Study|Withdrawal by Subject|2|||
170676029|NCT03087643|616825484|FG001|Overall Study|Withdrawal by Subject|4|||
170676030|NCT03087643|616825483|FG000|Overall Study|Death|2|||
170676031|NCT03087643|616825484|FG001|Overall Study|Death|2|||
170676032|NCT00566995|616825487|FG000|Overall Study|Toxicity|4|||
170676033|NCT00566995|616825487|FG000|Overall Study|Withdrew consent|3|||
170676034|NCT02784431|616825489|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
170676035|NCT02784431|616825489|FG000|Overall Study|Early Study Termination|19|||
170676036|NCT02795832|616825490|FG000|Overall Study|Adverse Event|0|||
170676037|NCT02795832|616825491|FG001|Overall Study|Adverse Event|0|||
170676038|NCT02795832|616825492|FG002|Overall Study|Adverse Event|0|||
170676039|NCT02795832|616825493|FG003|Overall Study|Adverse Event|0|||
170676040|NCT02795832|616825494|FG004|Overall Study|Adverse Event|0|||
170676041|NCT02795832|616825495|FG005|Overall Study|Adverse Event|3|||
170676042|NCT01846416|616825496|FG000|Treatment Phase|Death|2|||
170676043|NCT01846416|616825497|FG001|Treatment Phase|Death|9|||
170676044|NCT01846416|616825498|FG002|Treatment Phase|Death|1|||
170676045|NCT01846416|616825496|FG000|Treatment Phase|Withdrawal by Subject|2|||
170676046|NCT01846416|616825497|FG001|Treatment Phase|Withdrawal by Subject|4|||
170676047|NCT01846416|616825498|FG002|Treatment Phase|Withdrawal by Subject|2|||
170676048|NCT01846416|616825496|FG000|Treatment Phase|Other|1|||
170676049|NCT01846416|616825497|FG001|Treatment Phase|Other|5|||
170676050|NCT01846416|616825498|FG002|Treatment Phase|Other|1|||
170676051|NCT01846416|616825496|FG000|Treatment Phase|Physician Decision|1|||
170676052|NCT01846416|616825497|FG001|Treatment Phase|Physician Decision|2|||
170676053|NCT01846416|616825498|FG002|Treatment Phase|Physician Decision|0|||
170676054|NCT01846416|616825496|FG000|Treatment Phase|Adverse Event|3|||
170676055|NCT01846416|616825497|FG001|Treatment Phase|Adverse Event|4|||
170676056|NCT01846416|616825498|FG002|Treatment Phase|Adverse Event|0|||
170676057|NCT01846416|616825496|FG000|Treatment Phase|Non-compliance|0|||
170676058|NCT01846416|616825497|FG001|Treatment Phase|Non-compliance|2|||
170676059|NCT01846416|616825498|FG002|Treatment Phase|Non-compliance|0|||
170676060|NCT01846416|616825496|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
170676061|NCT01846416|616825497|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
170676062|NCT01846416|616825498|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
170676063|NCT01846416|616825496|FG000|Treatment Phase|Progressive Disease|21|||
170676064|NCT01846416|616825497|FG001|Treatment Phase|Progressive Disease|63|||
170676065|NCT01846416|616825498|FG002|Treatment Phase|Progressive Disease|9|||
170676066|NCT01846416|616825496|FG000|Survival Follow-up|Death|21|||
170676067|NCT01846416|616825497|FG001|Survival Follow-up|Death|62|||
170676068|NCT01846416|616825498|FG002|Survival Follow-up|Death|9|||
170676069|NCT01846416|616825496|FG000|Survival Follow-up|Lost to Follow-up|0|||
170676070|NCT01846416|616825497|FG001|Survival Follow-up|Lost to Follow-up|2|||
170676071|NCT01846416|616825498|FG002|Survival Follow-up|Lost to Follow-up|2|||
170676072|NCT01846416|616825496|FG000|Survival Follow-up|Withdrawal by Subject|2|||
170676073|NCT01846416|616825497|FG001|Survival Follow-up|Withdrawal by Subject|7|||
170676074|NCT01846416|616825498|FG002|Survival Follow-up|Withdrawal by Subject|0|||
170676075|NCT01846416|616825496|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
170676076|NCT01846416|616825497|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
170676077|NCT01846416|616825498|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
170676078|NCT01846416|616825496|FG000|Survival Follow-up|Other|3|||
170676079|NCT01846416|616825497|FG001|Survival Follow-up|Other|1|||
170676080|NCT01846416|616825498|FG002|Survival Follow-up|Other|1|||
170676081|NCT01744197|616825500|FG000|Overall Study|Received 1 patch|2|||
170676082|NCT01744197|616825501|FG001|Overall Study|Received 1 patch|1|||
170676083|NCT01744197|616825500|FG000|Overall Study|No patch received|2|||
170676084|NCT01744197|616825501|FG001|Overall Study|No patch received|2|||
170676085|NCT02801331|616825515|FG000|Overall Study|Transferred to another hospital|8|||
170676086|NCT02801331|616825516|FG001|Overall Study|Transferred to another hospital|7|||
170676087|NCT02801331|616825515|FG000|Overall Study|Withdrawal by Subject|0|||
170676088|NCT02801331|616825516|FG001|Overall Study|Withdrawal by Subject|4|||
170676089|NCT02801331|616825515|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
170676090|NCT02801331|616825516|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
170676091|NCT04698187|616825518|FG000|Overall Study|Withdrawal by Subject|7|||
170676092|NCT04698187|616825518|FG000|Overall Study|Death|21|||
170676093|NCT04698187|616825518|FG000|Overall Study|Sponsor Decision|15|||
170676094|NCT04698187|616825518|FG000|Overall Study|In-transit Disease|1|||
170676095|NCT03069378|616825519|FG000|Overall Study|Withdrawal by Subject|1|||
170676096|NCT01133522|616825522|FG000|Overall Study|Withdrawal by Subject|0|||
170676097|NCT01133522|616825523|FG001|Overall Study|Withdrawal by Subject|1|||
170676098|NCT01133522|616825524|FG002|Overall Study|Withdrawal by Subject|0|||
170676099|NCT01133522|616825525|FG003|Overall Study|Withdrawal by Subject|1|||
170676100|NCT01133522|616825526|FG004|Overall Study|Withdrawal by Subject|0|||
170676101|NCT01133522|616825527|FG005|Overall Study|Withdrawal by Subject|0|||
170676102|NCT01133522|616825528|FG006|Overall Study|Withdrawal by Subject|0|||
170676103|NCT01133522|616825529|FG007|Overall Study|Withdrawal by Subject|0|||
170676104|NCT01133522|616825530|FG008|Overall Study|Withdrawal by Subject|0|||
170676105|NCT01133522|616825531|FG009|Overall Study|Withdrawal by Subject|0|||
170676106|NCT01133522|616825522|FG000|Overall Study|Physician Decision|0|||
170676107|NCT01133522|616825523|FG001|Overall Study|Physician Decision|0|||
170676108|NCT01133522|616825524|FG002|Overall Study|Physician Decision|0|||
170676109|NCT01133522|616825525|FG003|Overall Study|Physician Decision|0|||
170676110|NCT01133522|616825526|FG004|Overall Study|Physician Decision|1|||
170676111|NCT01133522|616825527|FG005|Overall Study|Physician Decision|0|||
170676112|NCT01133522|616825528|FG006|Overall Study|Physician Decision|0|||
170676113|NCT01133522|616825529|FG007|Overall Study|Physician Decision|0|||
170676114|NCT01133522|616825530|FG008|Overall Study|Physician Decision|0|||
170676115|NCT01133522|616825531|FG009|Overall Study|Physician Decision|0|||
170676116|NCT00612690|616827723|FG000|Overall Study|Lost to Follow-up|72|||
170676117|NCT00612690|616827724|FG001|Overall Study|Lost to Follow-up|98|||
170676118|NCT00612690|616827723|FG000|Overall Study|Withdrawal by Subject|32|||
170676119|NCT00612690|616827724|FG001|Overall Study|Withdrawal by Subject|20|||
170676120|NCT00612690|616827723|FG000|Overall Study|Withdrawal by Site|11|||
170676121|NCT00612690|616827724|FG001|Overall Study|Withdrawal by Site|0|||
170676122|NCT02601469|616827726|FG000|Overall Study|Enrolled in Error|1|||
170676123|NCT02601469|616827727|FG001|Overall Study|Enrolled in Error|0|||
170676124|NCT00056316|616827728|FG000|Overall Study|Withdrawal by Subject|2|||
170676125|NCT00056316|616827729|FG001|Overall Study|Withdrawal by Subject|2|||
170676126|NCT00056316|616827728|FG000|Overall Study|Death/NH placement of pt|1|||
170676127|NCT00056316|616827729|FG001|Overall Study|Death/NH placement of pt|1|||
170676128|NCT02161731|616827730|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
170676129|NCT02161731|616827731|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
170676130|NCT02161731|616827730|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
170676131|NCT02161731|616827731|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
170676132|NCT01315678|616827732|FG000|Overall Study|Withdrawal by Subject|7|||
170676133|NCT01315678|616827733|FG001|Overall Study|Withdrawal by Subject|3|||
170676134|NCT01315678|616827732|FG000|Overall Study|Adverse Event|3|||
170676135|NCT01315678|616827733|FG001|Overall Study|Adverse Event|1|||
170676136|NCT01315678|616827732|FG000|Overall Study|Lost to Follow-up|1|||
170676137|NCT01315678|616827733|FG001|Overall Study|Lost to Follow-up|0|||
170676138|NCT01315678|616827732|FG000|Overall Study|similar reason to those listed above|3|||
170676139|NCT01315678|616827733|FG001|Overall Study|similar reason to those listed above|2|||
170676140|NCT00790023|616827737|FG000|Overall Study|Adverse Event|2|||
170676141|NCT00790023|616827738|FG001|Overall Study|Adverse Event|1|||
170676142|NCT00790023|616827739|FG002|Overall Study|Adverse Event|4|||
170676143|NCT00790023|616827737|FG000|Overall Study|Protocol Violation|2|||
170676144|NCT00790023|616827738|FG001|Overall Study|Protocol Violation|4|||
170676145|NCT00790023|616827739|FG002|Overall Study|Protocol Violation|2|||
170676146|NCT00790023|616827737|FG000|Overall Study|Withdrawal by Subject|2|||
170676147|NCT00790023|616827738|FG001|Overall Study|Withdrawal by Subject|0|||
170676148|NCT00790023|616827739|FG002|Overall Study|Withdrawal by Subject|6|||
170676149|NCT00790023|616827737|FG000|Overall Study|Lost to Follow-up|0|||
170676150|NCT00790023|616827738|FG001|Overall Study|Lost to Follow-up|0|||
170676151|NCT00790023|616827739|FG002|Overall Study|Lost to Follow-up|1|||
170676152|NCT00790023|616827737|FG000|Overall Study|Other|5|||
170676153|NCT00790023|616827738|FG001|Overall Study|Other|5|||
170676154|NCT00790023|616827739|FG002|Overall Study|Other|8|||
170676155|NCT01338792|616827740|FG000|Overall Study|Adverse Event|2|||
170676156|NCT01338792|616827740|FG000|Overall Study|Death|1|||
170676157|NCT01338792|616827740|FG000|Overall Study|Withdrawal by Subject|1|||
170676158|NCT02468414|616827741|FG000|Overall Study|Early Study Termination by Sponsor|1|||
170676159|NCT02468414|616827742|FG001|Overall Study|Early Study Termination by Sponsor|0|||
170676160|NCT02468414|616827741|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
170676161|NCT02468414|616827742|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
170676162|NCT02468414|616827741|FG000|Overall Study|Screen Failure|1|||
170676163|NCT02468414|616827742|FG001|Overall Study|Screen Failure|0|||
170676164|NCT00004978|616827743|FG000|Overall Study|Death|107|||
170676165|NCT00004978|616827744|FG001|Overall Study|Death|116|||
170676166|NCT00004978|616827743|FG000|Overall Study|Lost to Follow-up|101|||
170676167|NCT00004978|616827744|FG001|Overall Study|Lost to Follow-up|108|||
170676168|NCT00004978|616827743|FG000|Overall Study|Withdrawal by Subject|17|||
170676169|NCT00004978|616827744|FG001|Overall Study|Withdrawal by Subject|26|||
170676170|NCT00004978|616827743|FG000|Overall Study|site closure - not in analysis cohort|19|||
170676171|NCT00004978|616827744|FG001|Overall Study|site closure - not in analysis cohort|20|||
170676172|NCT00062374|616827745|FG000|Overall Study|Not treated|12|||
170676173|NCT01532414|616827746|FG000|Overall Study|Lost to Follow-up|3|||
170676174|NCT01532414|616827747|FG001|Overall Study|Lost to Follow-up|0|||
170676175|NCT01532414|616827748|FG002|Overall Study|Lost to Follow-up|1|||
170676176|NCT01532414|616827746|FG000|Overall Study|Withdrawal by Subject|3|||
170676177|NCT01532414|616827747|FG001|Overall Study|Withdrawal by Subject|0|||
170676178|NCT01532414|616827748|FG002|Overall Study|Withdrawal by Subject|0|||
170676179|NCT01532414|616827746|FG000|Overall Study|No V6 semen sample|0|||
170676180|NCT01532414|616827747|FG001|Overall Study|No V6 semen sample|1|||
170676181|NCT01532414|616827748|FG002|Overall Study|No V6 semen sample|0|||
170676182|NCT01532414|616827746|FG000|Overall Study|Adverse Event|0|||
170676183|NCT01532414|616827747|FG001|Overall Study|Adverse Event|1|||
170676184|NCT01532414|616827748|FG002|Overall Study|Adverse Event|1|||
170676185|NCT01532414|616827746|FG000|Overall Study|Unable to complete 24 hour PK|0|||
170676186|NCT01532414|616827747|FG001|Overall Study|Unable to complete 24 hour PK|0|||
170676187|NCT01532414|616827748|FG002|Overall Study|Unable to complete 24 hour PK|1|||
170676188|NCT01532414|616827746|FG000|Overall Study|Withdrawn by sponsor|1|||
170676189|NCT01532414|616827747|FG001|Overall Study|Withdrawn by sponsor|0|||
170676190|NCT01532414|616827748|FG002|Overall Study|Withdrawn by sponsor|0|||
170676191|NCT02599129|616827753|FG000|Overall Study|Lack of Efficacy|2|||
170676192|NCT02599129|616827754|FG001|Overall Study|Lack of Efficacy|2|||
170676193|NCT02599129|616827753|FG000|Overall Study|Lost to Follow-up|1|||
170676194|NCT02599129|616827754|FG001|Overall Study|Lost to Follow-up|0|||
170676195|NCT02599129|616827753|FG000|Overall Study|Withdrawal by Subject|2|||
170676196|NCT02599129|616827754|FG001|Overall Study|Withdrawal by Subject|1|||
170676197|NCT00617773|616827755|FG000|Overall Study|Physician Decision|1|||
170676198|NCT00617773|616827755|FG000|Overall Study|Lack of compliance with the protocol|1|||
170676199|NCT00617773|616827755|FG000|Overall Study|Withdrawal by Subject|1|||
170676200|NCT00617773|616827755|FG000|Overall Study|Death|1|||
170676201|NCT00617773|616827755|FG000|Overall Study|Progressive disease|19|||
170676202|NCT00617773|616827755|FG000|Overall Study|Protocol Violation|1|||
170676203|NCT01342796|616827756|FG000|Overall Study|Withdrawal by Subject|2|||
170676204|NCT01342796|616827757|FG001|Overall Study|Withdrawal by Subject|0|||
170676205|NCT01342796|616827756|FG000|Overall Study|Lost to Follow-up|0|||
170676206|NCT01342796|616827757|FG001|Overall Study|Lost to Follow-up|3|||
170676207|NCT01342796|616827756|FG000|Overall Study|Inappropriate enrollment|1|||
170676208|NCT01342796|616827757|FG001|Overall Study|Inappropriate enrollment|0|||
170676209|NCT01218204|616827763|FG000|Part B Washout|Adverse Event|0|||
170676210|NCT01218204|616827764|FG001|Part B Washout|Adverse Event|1|||
170676211|NCT01218204|616827765|FG002|Part B Washout|Adverse Event|0|||
170676212|NCT01218204|616827766|FG003|Part B Washout|Adverse Event|0|||
170676213|NCT01218204|616827763|FG000|Part B Washout|Lost to Follow-up|0|||
170676214|NCT01218204|616827764|FG001|Part B Washout|Lost to Follow-up|2|||
170676215|NCT01218204|616827765|FG002|Part B Washout|Lost to Follow-up|0|||
170676216|NCT01218204|616827766|FG003|Part B Washout|Lost to Follow-up|0|||
170676217|NCT01218204|616827763|FG000|Part B Washout|Physician Decision|0|||
170676218|NCT01218204|616827764|FG001|Part B Washout|Physician Decision|14|||
170676219|NCT01218204|616827765|FG002|Part B Washout|Physician Decision|0|||
170676220|NCT01218204|616827766|FG003|Part B Washout|Physician Decision|0|||
170676221|NCT01218204|616827763|FG000|Part B Washout|Withdrawal by Subject|0|||
170676222|NCT01218204|616827764|FG001|Part B Washout|Withdrawal by Subject|14|||
170676223|NCT01218204|616827765|FG002|Part B Washout|Withdrawal by Subject|0|||
170676224|NCT01218204|616827766|FG003|Part B Washout|Withdrawal by Subject|0|||
170676225|NCT01218204|616827763|FG000|Part B Washout|Reached defined stopping criteria|0|||
170676226|NCT01218204|616827764|FG001|Part B Washout|Reached defined stopping criteria|2|||
170676227|NCT01218204|616827765|FG002|Part B Washout|Reached defined stopping criteria|0|||
170676228|NCT01218204|616827766|FG003|Part B Washout|Reached defined stopping criteria|0|||
170676229|NCT01218204|616827763|FG000|Part B Washout|Did not meet continuation criteria|0|||
170676230|NCT01218204|616827764|FG001|Part B Washout|Did not meet continuation criteria|112|||
170676231|NCT01218204|616827765|FG002|Part B Washout|Did not meet continuation criteria|0|||
170676232|NCT01218204|616827766|FG003|Part B Washout|Did not meet continuation criteria|0|||
170676233|NCT01218204|616827763|FG000|Part B Run-in|Adverse Event|0|||
170676234|NCT01218204|616827764|FG001|Part B Run-in|Adverse Event|0|||
170676235|NCT01218204|616827765|FG002|Part B Run-in|Adverse Event|1|||
170676236|NCT01218204|616827766|FG003|Part B Run-in|Adverse Event|0|||
170676237|NCT01218204|616827763|FG000|Part B Run-in|Protocol Violation|0|||
170676238|NCT01218204|616827764|FG001|Part B Run-in|Protocol Violation|0|||
170676239|NCT01218204|616827765|FG002|Part B Run-in|Protocol Violation|2|||
170676240|NCT01218204|616827766|FG003|Part B Run-in|Protocol Violation|0|||
170676241|NCT01218204|616827763|FG000|Part B Run-in|Withdrawal by Subject|0|||
170676242|NCT01218204|616827764|FG001|Part B Run-in|Withdrawal by Subject|0|||
170676243|NCT01218204|616827765|FG002|Part B Run-in|Withdrawal by Subject|3|||
170676244|NCT01218204|616827766|FG003|Part B Run-in|Withdrawal by Subject|0|||
170676245|NCT01218204|616827763|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
170676246|NCT01218204|616827764|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
170676247|NCT01218204|616827765|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
170676248|NCT01218204|616827766|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
170676249|NCT01218204|616827763|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
170676250|NCT01218204|616827764|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
170676251|NCT01218204|616827765|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
170676252|NCT01218204|616827766|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
170676253|NCT01539538|616827772|FG000|Overall Study|Adverse Event|13|||
170676254|NCT01539538|616827773|FG001|Overall Study|Adverse Event|18|||
170676255|NCT01539538|616827772|FG000|Overall Study|Lack of Efficacy|13|||
170676256|NCT01539538|616827773|FG001|Overall Study|Lack of Efficacy|16|||
170676257|NCT01539538|616827772|FG000|Overall Study|Withdrawal by Subject|2|||
170676258|NCT01539538|616827773|FG001|Overall Study|Withdrawal by Subject|3|||
170676259|NCT01539538|616827772|FG000|Overall Study|PCA no longer required or PCA problem|3|||
170676260|NCT01539538|616827773|FG001|Overall Study|PCA no longer required or PCA problem|7|||
170676261|NCT03897465|616827774|FG000|Overall Study|Lost to Follow-up|2|||
170676262|NCT03897465|616827775|FG001|Overall Study|Lost to Follow-up|1|||
170676263|NCT03897465|616827774|FG000|Overall Study|Adverse Event|2|||
170676264|NCT03897465|616827775|FG001|Overall Study|Adverse Event|0|||
170676265|NCT03897465|616827774|FG000|Overall Study|complete healing by V2|1|||
170676266|NCT03897465|616827775|FG001|Overall Study|complete healing by V2|0|||
170676267|NCT03897465|616827774|FG000|Overall Study|occurence of exclusion criterion|1|||
170676268|NCT03897465|616827775|FG001|Overall Study|occurence of exclusion criterion|1|||
170676269|NCT03897465|616827774|FG000|Overall Study|Other|1|||
170676270|NCT03897465|616827775|FG001|Overall Study|Other|0|||
170676271|NCT00521014|616827776|FG000|Overall Study|Inevaluable, not treated|1|||
170676272|NCT04390191|616827777|FG000|Overall Study|Withdrawal by Subject|1|||
170676273|NCT04390191|616827778|FG001|Overall Study|Withdrawal by Subject|0|||
170676274|NCT03978832|616827781|FG000|Overall Study|Adverse Event|1|||
170676275|NCT03978832|616827781|FG000|Overall Study|Lost to Follow-up|1|||
170676276|NCT03978832|616827781|FG000|Overall Study|Withdrawal by Subject|6|||
170676277|NCT03978832|616827781|FG000|Overall Study|Physician Decision|2|||
170676278|NCT03978832|616827781|FG000|Overall Study|did not pass screening criteria|44|||
170676279|NCT00003499|616827782|FG000|Overall Study|Not evaluable|8|||
170676280|NCT02042183|616827787|FG000|Overall Study|Physician Decision|7|||
170676281|NCT02042183|616827788|FG001|Overall Study|Physician Decision|2|||
170676282|NCT02042183|616827787|FG000|Overall Study|Lack of Efficacy|4|||
170676283|NCT02042183|616827788|FG001|Overall Study|Lack of Efficacy|3|||
170676284|NCT02042183|616827787|FG000|Overall Study|Non-compliance with Study Drug|2|||
170676285|NCT02042183|616827788|FG001|Overall Study|Non-compliance with Study Drug|3|||
170676286|NCT02042183|616827787|FG000|Overall Study|Adverse Event|17|||
170676287|NCT02042183|616827788|FG001|Overall Study|Adverse Event|6|||
170676288|NCT02042183|616827787|FG000|Overall Study|Other|3|||
170676289|NCT02042183|616827788|FG001|Overall Study|Other|3|||
170676290|NCT02042183|616827787|FG000|Overall Study|Withdrawal by Subject|21|||
170676291|NCT02042183|616827788|FG001|Overall Study|Withdrawal by Subject|16|||
170676292|NCT02042183|616827787|FG000|Overall Study|Site Terminated by Sponsor|2|||
170676293|NCT02042183|616827788|FG001|Overall Study|Site Terminated by Sponsor|1|||
170676294|NCT02042183|616827787|FG000|Overall Study|Lost to Follow-up|9|||
170676295|NCT02042183|616827788|FG001|Overall Study|Lost to Follow-up|2|||
170676296|NCT01727297|616827789|FG000|Overall Study|Death|13|||
170676297|NCT01727297|616827790|FG001|Overall Study|Death|0|||
170676298|NCT01727297|616827789|FG000|Overall Study|Protocol Violation|1|||
170676299|NCT01727297|616827790|FG001|Overall Study|Protocol Violation|10|||
170676300|NCT01727297|616827789|FG000|Overall Study|Adverse Event|3|||
170676301|NCT01727297|616827790|FG001|Overall Study|Adverse Event|1|||
170676302|NCT01727297|616827789|FG000|Overall Study|Lost to Follow-up|11|||
170676303|NCT01727297|616827790|FG001|Overall Study|Lost to Follow-up|0|||
170676304|NCT01727297|616827789|FG000|Overall Study|Withdrawal by Subject|26|||
170676305|NCT01727297|616827790|FG001|Overall Study|Withdrawal by Subject|27|||
170676306|NCT01727297|616827789|FG000|Overall Study|Physician Decision|19|||
170676307|NCT01727297|616827790|FG001|Overall Study|Physician Decision|5|||
170676308|NCT01727297|616827789|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
170676309|NCT01727297|616827790|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
170676310|NCT01256008|616827791|FG000|Overall Study|Lost to Follow-up|6|||
170676311|NCT01256008|616827792|FG001|Overall Study|Lost to Follow-up|4|||
170676312|NCT01256008|616827793|FG002|Overall Study|Lost to Follow-up|11|||
170676313|NCT01256008|616827791|FG000|Overall Study|Withdrawal by Subject|2|||
170676314|NCT01256008|616827792|FG001|Overall Study|Withdrawal by Subject|3|||
170676315|NCT01256008|616827793|FG002|Overall Study|Withdrawal by Subject|10|||
170676316|NCT02244606|616827794|FG000|Overall Study|Adverse Event|0|||
170676317|NCT02244606|616827795|FG001|Overall Study|Adverse Event|1|||
170676318|NCT02244606|616827796|FG002|Overall Study|Adverse Event|1|||
170676319|NCT02244606|616827797|FG003|Overall Study|Adverse Event|0|||
170676320|NCT02244606|616827794|FG000|Overall Study|Lost to Follow-up|2|||
170676321|NCT02244606|616827795|FG001|Overall Study|Lost to Follow-up|2|||
170676322|NCT02244606|616827796|FG002|Overall Study|Lost to Follow-up|1|||
170676323|NCT02244606|616827797|FG003|Overall Study|Lost to Follow-up|0|||
170676324|NCT02244606|616827794|FG000|Overall Study|Protocol Violation|0|||
170676325|NCT02244606|616827795|FG001|Overall Study|Protocol Violation|0|||
170676326|NCT02244606|616827796|FG002|Overall Study|Protocol Violation|0|||
170676327|NCT02244606|616827797|FG003|Overall Study|Protocol Violation|1|||
170676328|NCT02244606|616827794|FG000|Overall Study|Withdrawal by Subject|1|||
170676329|NCT02244606|616827795|FG001|Overall Study|Withdrawal by Subject|1|||
170676330|NCT02244606|616827796|FG002|Overall Study|Withdrawal by Subject|0|||
170676331|NCT02244606|616827797|FG003|Overall Study|Withdrawal by Subject|0|||
170676332|NCT02244606|616827794|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
170676333|NCT02244606|616827795|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
170676334|NCT02244606|616827796|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
170676335|NCT02244606|616827797|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
170676336|NCT00378378|616827800|FG000|Overall Study|Withdrawal by Subject|0|||
170676337|NCT00378378|616827801|FG001|Overall Study|Withdrawal by Subject|1|||
170676338|NCT00378378|616827802|FG002|Overall Study|Withdrawal by Subject|0|||
170676339|NCT00378378|616827800|FG000|Overall Study|Treatment Failure|0|||
170676340|NCT00378378|616827801|FG001|Overall Study|Treatment Failure|0|||
170676341|NCT00378378|616827802|FG002|Overall Study|Treatment Failure|1|||
170676342|NCT00378378|616827800|FG000|Overall Study|Non-compliance with protocol|0|||
170676343|NCT00378378|616827801|FG001|Overall Study|Non-compliance with protocol|0|||
170676344|NCT00378378|616827802|FG002|Overall Study|Non-compliance with protocol|1|||
170676345|NCT01402492|616827810|FG000|Overall Study|Withdrawal by Subject|17|||
170676346|NCT01402492|616827811|FG001|Overall Study|Withdrawal by Subject|11|||
170676347|NCT01402492|616827812|FG002|Overall Study|Withdrawal by Subject|11|||
170676348|NCT01402492|616827810|FG000|Overall Study|Adverse Event|2|||
170676349|NCT01402492|616827811|FG001|Overall Study|Adverse Event|3|||
170676350|NCT01402492|616827812|FG002|Overall Study|Adverse Event|4|||
170676351|NCT01402492|616827810|FG000|Overall Study|Physician Decision|0|||
170676352|NCT01402492|616827811|FG001|Overall Study|Physician Decision|3|||
170676353|NCT01402492|616827812|FG002|Overall Study|Physician Decision|0|||
170676354|NCT01402492|616827810|FG000|Overall Study|Incarcerated (N=3)|2|||
170676355|NCT01402492|616827811|FG001|Overall Study|Incarcerated (N=3)|0|||
170676356|NCT01402492|616827812|FG002|Overall Study|Incarcerated (N=3)|1|||
170676357|NCT02321800|616827820|FG000|Overall Study|Withdrawal by Subject|3|||
170676358|NCT02321800|616827821|FG001|Overall Study|Withdrawal by Subject|3|||
170676359|NCT02321800|616827820|FG000|Overall Study|Death|1|||
170676360|NCT02321800|616827821|FG001|Overall Study|Death|0|||
170676361|NCT02321800|616827820|FG000|Overall Study|Protocol Violation|1|||
170676362|NCT02321800|616827821|FG001|Overall Study|Protocol Violation|0|||
170676363|NCT02321800|616827820|FG000|Overall Study|Lost to Follow-up|10|||
170676364|NCT02321800|616827821|FG001|Overall Study|Lost to Follow-up|4|||
170676365|NCT02321800|616827820|FG000|Overall Study|Adverse Event|2|||
170676366|NCT02321800|616827821|FG001|Overall Study|Adverse Event|3|||
170676367|NCT02321800|616827820|FG000|Overall Study|Other, Miscellaneous|3|||
170676368|NCT02321800|616827821|FG001|Overall Study|Other, Miscellaneous|1|||
170676369|NCT02083783|616827831|FG000|Overall Study|Withdrawal by Subject|1|||
170676370|NCT02083783|616827832|FG001|Overall Study|Withdrawal by Subject|0|||
170676371|NCT02094677|616827836|FG000|Overall Study|Screening|3|||
170676372|NCT02094677|616827837|FG001|Overall Study|Screening|1|||
170676373|NCT00602797|616827846|FG000|Overall Study|Adverse Event|1|||
170676374|NCT03846804|616827847|FG000|Overall Study|Refused blood draw|1|||
170676375|NCT03846804|616827847|FG000|Overall Study|Protocol Violation|1|||
170676376|NCT02695329|616827852|FG000|Overall Study|Adverse Event|1|||
170676377|NCT02695329|616827853|FG001|Overall Study|Adverse Event|0|||
170676378|NCT02695329|616827852|FG000|Overall Study|Poor X-ray quality for measurement|4|||
170676379|NCT02695329|616827853|FG001|Overall Study|Poor X-ray quality for measurement|5|||
170676380|NCT01348165|616827854|FG000|Overall Study|Adverse Event|0|||
170676381|NCT01348165|616827855|FG001|Overall Study|Adverse Event|0|||
170676382|NCT01348165|616827856|FG002|Overall Study|Adverse Event|0|||
170676383|NCT01348165|616827857|FG003|Overall Study|Adverse Event|0|||
170676384|NCT01348165|616827858|FG004|Overall Study|Adverse Event|0|||
170676385|NCT01348165|616827859|FG005|Overall Study|Adverse Event|0|||
170676386|NCT01348165|616827860|FG006|Overall Study|Adverse Event|1|||
170676387|NCT01382212|616827861|FG000|Overall Study|Kidney transplant|1|||
170676388|NCT01382212|616827861|FG000|Overall Study|Withdrew consent|1|||
170676389|NCT01273597|616827862|FG000|Overall Study|Adverse Event|5|||
170676390|NCT01273597|616827862|FG000|Overall Study|Underwent Kidney Transplantation|2|||
170676391|NCT01273597|616827862|FG000|Overall Study|Reason Not Reported|1|||
170676392|NCT00393029|616827863|FG000|Overall Study|Not treated|0|||
170676393|NCT00393029|616827864|FG001|Overall Study|Not treated|1|||
170676394|NCT03547583|616827866|FG000|Overall Study|Adverse Event|16|||
170676395|NCT03547583|616827867|FG001|Overall Study|Adverse Event|11|||
170676396|NCT03547583|616827868|FG002|Overall Study|Adverse Event|10|||
170676397|NCT03547583|616827866|FG000|Overall Study|Death|11|||
170676398|NCT03547583|616827867|FG001|Overall Study|Death|7|||
170676399|NCT03547583|616827868|FG002|Overall Study|Death|4|||
170676400|NCT03547583|616827866|FG000|Overall Study|Lost to Follow-up|1|||
170676401|NCT03547583|616827867|FG001|Overall Study|Lost to Follow-up|0|||
170676402|NCT03547583|616827868|FG002|Overall Study|Lost to Follow-up|0|||
170676403|NCT03547583|616827866|FG000|Overall Study|Non-compliance with study drug|0|||
170676404|NCT03547583|616827867|FG001|Overall Study|Non-compliance with study drug|0|||
170676405|NCT03547583|616827868|FG002|Overall Study|Non-compliance with study drug|1|||
170676406|NCT03547583|616827866|FG000|Overall Study|Physician Decision|1|||
170676407|NCT03547583|616827867|FG001|Overall Study|Physician Decision|0|||
170676408|NCT03547583|616827868|FG002|Overall Study|Physician Decision|3|||
170676409|NCT03547583|616827866|FG000|Overall Study|Protocol Violation|2|||
170676410|NCT03547583|616827867|FG001|Overall Study|Protocol Violation|1|||
170676411|NCT03547583|616827868|FG002|Overall Study|Protocol Violation|1|||
170676412|NCT03547583|616827866|FG000|Overall Study|Withdrawal by Subject|12|||
170676413|NCT03547583|616827867|FG001|Overall Study|Withdrawal by Subject|19|||
170676414|NCT03547583|616827868|FG002|Overall Study|Withdrawal by Subject|10|||
170676415|NCT03547583|616827866|FG000|Overall Study|Other|2|||
170676416|NCT03547583|616827867|FG001|Overall Study|Other|2|||
170676417|NCT03547583|616827868|FG002|Overall Study|Other|3|||
170676418|NCT00382252|616827869|FG000|Overall Study|Death|4|||
170676419|NCT00382252|616827869|FG000|Overall Study|Protocol Violation|8|||
170676420|NCT00382252|616827869|FG000|Overall Study|Not treated by RFA|1|||
170676421|NCT00833794|616827870|FG000|Open-label Phase|Adverse Event|225|||
170676422|NCT00833794|616827871|FG001|Open-label Phase|Adverse Event|0|||
170676423|NCT00833794|616827870|FG000|Open-label Phase|Lack of Efficacy|28|||
170676424|NCT00833794|616827871|FG001|Open-label Phase|Lack of Efficacy|0|||
170676425|NCT00833794|616827870|FG000|Open-label Phase|Withdrawal by Subject|48|||
170676426|NCT00833794|616827871|FG001|Open-label Phase|Withdrawal by Subject|0|||
170676427|NCT00833794|616827870|FG000|Open-label Phase|Physician Decision|20|||
170676428|NCT00833794|616827871|FG001|Open-label Phase|Physician Decision|0|||
170676429|NCT00833794|616827870|FG000|Open-label Phase|Administrative reason|1|||
170676430|NCT00833794|616827871|FG001|Open-label Phase|Administrative reason|0|||
170676431|NCT00833794|616827870|FG000|Open-label Phase|Protocol Violation|47|||
170676432|NCT00833794|616827871|FG001|Open-label Phase|Protocol Violation|0|||
170676433|NCT00833794|616827870|FG000|Open-label Phase|Did not complete wash-out period|12|||
170676434|NCT00833794|616827871|FG001|Open-label Phase|Did not complete wash-out period|0|||
170676435|NCT00833794|616827870|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
170676436|NCT00833794|616827871|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
170676437|NCT00833794|616827870|FG000|Double-blind Phase|Adverse Event|44|||
170676438|NCT00833794|616827871|FG001|Double-blind Phase|Adverse Event|11|||
170676439|NCT00833794|616827870|FG000|Double-blind Phase|Lack of Efficacy|34|||
170676440|NCT00833794|616827871|FG001|Double-blind Phase|Lack of Efficacy|22|||
170676441|NCT00833794|616827870|FG000|Double-blind Phase|Withdrawal by Subject|23|||
170676442|NCT00833794|616827871|FG001|Double-blind Phase|Withdrawal by Subject|6|||
170676443|NCT00833794|616827870|FG000|Double-blind Phase|Physician Decision|4|||
170676444|NCT00833794|616827871|FG001|Double-blind Phase|Physician Decision|7|||
170676445|NCT00833794|616827870|FG000|Double-blind Phase|Administrative reason|1|||
170676446|NCT00833794|616827871|FG001|Double-blind Phase|Administrative reason|3|||
170676447|NCT00039130|616827874|FG000|Overall Study|Adverse Event|11|||
170676448|NCT00039130|616827874|FG000|Overall Study|Death|9|||
170676449|NCT00039130|616827874|FG000|Overall Study|Withdrawal by Subject|3|||
170676450|NCT00039130|616827874|FG000|Overall Study|Progression|2|||
170676451|NCT00039130|616827874|FG000|Overall Study|Subsequent treatment|2|||
170676452|NCT00039130|616827874|FG000|Overall Study|Physician Decision|3|||
170676453|NCT02612727|616827878|FG000|Overall Study|Parent request|4|||
170676454|NCT02612727|616827879|FG001|Overall Study|Parent request|1|||
170676455|NCT02612727|616827878|FG000|Overall Study|Needed treatment incompatible with PT|1|||
170676456|NCT02612727|616827879|FG001|Overall Study|Needed treatment incompatible with PT|1|||
170676457|NCT02612727|616827878|FG000|Overall Study|Direct hyperbilirubinemia|0|||
170676458|NCT02612727|616827879|FG001|Overall Study|Direct hyperbilirubinemia|2|||
170676459|NCT01949506|616827880|FG000|Overall Study|Physician Decision|1|||
170676460|NCT02915016|616827881|FG000|Overall Study|Lost to Follow-up|4|||
170676461|NCT02915016|616827882|FG001|Overall Study|Lost to Follow-up|2|||
170676462|NCT02915016|616827883|FG002|Overall Study|Lost to Follow-up|5|||
170676463|NCT02915016|616827884|FG003|Overall Study|Lost to Follow-up|3|||
170676464|NCT02915016|616827885|FG004|Overall Study|Lost to Follow-up|5|||
170676465|NCT02915016|616827886|FG005|Overall Study|Lost to Follow-up|2|||
170676466|NCT02915016|616827887|FG006|Overall Study|Lost to Follow-up|8|||
170676467|NCT02915016|616827888|FG007|Overall Study|Lost to Follow-up|2|||
170676468|NCT02915016|616827881|FG000|Overall Study|Physician Decision|0|||
170676469|NCT02915016|616827882|FG001|Overall Study|Physician Decision|0|||
170676470|NCT02915016|616827883|FG002|Overall Study|Physician Decision|1|||
170676471|NCT02915016|616827884|FG003|Overall Study|Physician Decision|0|||
170676472|NCT02915016|616827885|FG004|Overall Study|Physician Decision|0|||
170676473|NCT02915016|616827886|FG005|Overall Study|Physician Decision|1|||
170676474|NCT02915016|616827887|FG006|Overall Study|Physician Decision|2|||
170676475|NCT02915016|616827888|FG007|Overall Study|Physician Decision|0|||
170676476|NCT02915016|616827881|FG000|Overall Study|Withdrawal by Subject|2|||
170676477|NCT02915016|616827882|FG001|Overall Study|Withdrawal by Subject|0|||
170676478|NCT02915016|616827883|FG002|Overall Study|Withdrawal by Subject|1|||
170676479|NCT02915016|616827884|FG003|Overall Study|Withdrawal by Subject|0|||
170676480|NCT02915016|616827885|FG004|Overall Study|Withdrawal by Subject|1|||
170676481|NCT02915016|616827886|FG005|Overall Study|Withdrawal by Subject|3|||
170676482|NCT02915016|616827887|FG006|Overall Study|Withdrawal by Subject|1|||
170676483|NCT02915016|616827888|FG007|Overall Study|Withdrawal by Subject|1|||
170676484|NCT02915016|616827881|FG000|Overall Study|Elected not to continue|0|||
170676485|NCT02915016|616827882|FG001|Overall Study|Elected not to continue|0|||
170676486|NCT02915016|616827883|FG002|Overall Study|Elected not to continue|0|||
170676487|NCT02915016|616827884|FG003|Overall Study|Elected not to continue|1|||
170676488|NCT02915016|616827885|FG004|Overall Study|Elected not to continue|0|||
170676489|NCT02915016|616827886|FG005|Overall Study|Elected not to continue|0|||
170676490|NCT02915016|616827887|FG006|Overall Study|Elected not to continue|1|||
170676491|NCT02915016|616827888|FG007|Overall Study|Elected not to continue|0|||
170676492|NCT02915016|616827881|FG000|Overall Study|HIV infection|1|||
170676493|NCT02915016|616827882|FG001|Overall Study|HIV infection|1|||
170676494|NCT02915016|616827883|FG002|Overall Study|HIV infection|1|||
170676495|NCT02915016|616827884|FG003|Overall Study|HIV infection|0|||
170676496|NCT02915016|616827885|FG004|Overall Study|HIV infection|1|||
170676497|NCT02915016|616827886|FG005|Overall Study|HIV infection|0|||
170676498|NCT02915016|616827887|FG006|Overall Study|HIV infection|0|||
170676499|NCT02915016|616827888|FG007|Overall Study|HIV infection|0|||
170676500|NCT02915016|616827881|FG000|Overall Study|Participant unable to adhere|0|||
170676501|NCT02915016|616827882|FG001|Overall Study|Participant unable to adhere|0|||
170676502|NCT02915016|616827883|FG002|Overall Study|Participant unable to adhere|0|||
170676503|NCT02915016|616827884|FG003|Overall Study|Participant unable to adhere|0|||
170676504|NCT02915016|616827885|FG004|Overall Study|Participant unable to adhere|0|||
170676505|NCT02915016|616827886|FG005|Overall Study|Participant unable to adhere|0|||
170676506|NCT02915016|616827887|FG006|Overall Study|Participant unable to adhere|0|||
170676507|NCT02915016|616827888|FG007|Overall Study|Participant unable to adhere|1|||
170676508|NCT02578316|616827889|FG000|Extension Phase|Progression of disease|6|||
170676509|NCT02166905|616827890|FG000|Overall Study|Withdrawal by Subject|1|||
170676510|NCT02166905|616827891|FG001|Overall Study|Withdrawal by Subject|0|||
170676511|NCT02166905|616827892|FG002|Overall Study|Withdrawal by Subject|0|||
170676512|NCT02166905|616827893|FG003|Overall Study|Withdrawal by Subject|0|||
170676513|NCT02617628|616827894|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
170676514|NCT02617628|616827895|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
170676515|NCT03278873|616827897|FG000|Overall Study|Withdrawal by Subject|0|||
170676516|NCT03278873|616827898|FG001|Overall Study|Withdrawal by Subject|1|||
170676517|NCT03278873|616827899|FG002|Overall Study|Withdrawal by Subject|0|||
170676518|NCT03278873|616827900|FG003|Overall Study|Withdrawal by Subject|0|||
170676519|NCT03278873|616827897|FG000|Overall Study|Sponsor's decision|0|||
170676520|NCT03278873|616827898|FG001|Overall Study|Sponsor's decision|1|||
170676521|NCT03278873|616827899|FG002|Overall Study|Sponsor's decision|0|||
170676522|NCT03278873|616827900|FG003|Overall Study|Sponsor's decision|0|||
170676523|NCT03278873|616827897|FG000|Overall Study|Early Termination|2|||
170676524|NCT03278873|616827898|FG001|Overall Study|Early Termination|6|||
170676525|NCT03278873|616827899|FG002|Overall Study|Early Termination|0|||
170676526|NCT03278873|616827900|FG003|Overall Study|Early Termination|4|||
170676527|NCT03278873|616827897|FG000|Overall Study|Lost to Follow-up|0|||
170676528|NCT03278873|616827898|FG001|Overall Study|Lost to Follow-up|0|||
170676529|NCT03278873|616827899|FG002|Overall Study|Lost to Follow-up|2|||
170676530|NCT03278873|616827900|FG003|Overall Study|Lost to Follow-up|0|||
170676531|NCT03278873|616827897|FG000|Overall Study|The patient decided to withdraw via email|1|||
170676532|NCT03278873|616827898|FG001|Overall Study|The patient decided to withdraw via email|0|||
170676533|NCT03278873|616827899|FG002|Overall Study|The patient decided to withdraw via email|0|||
170676534|NCT03278873|616827900|FG003|Overall Study|The patient decided to withdraw via email|0|||
170676535|NCT03278873|616827897|FG000|Overall Study|The patient was unresponsive to contact|0|||
170676536|NCT03278873|616827898|FG001|Overall Study|The patient was unresponsive to contact|0|||
170676537|NCT03278873|616827899|FG002|Overall Study|The patient was unresponsive to contact|0|||
170676538|NCT03278873|616827900|FG003|Overall Study|The patient was unresponsive to contact|4|||
170676539|NCT03278873|616827897|FG000|Overall Study|The patient wished to participate no longer|0|||
170676540|NCT03278873|616827898|FG001|Overall Study|The patient wished to participate no longer|1|||
170676541|NCT03278873|616827899|FG002|Overall Study|The patient wished to participate no longer|0|||
170676542|NCT03278873|616827900|FG003|Overall Study|The patient wished to participate no longer|0|||
170676543|NCT03278873|616827897|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
170676544|NCT03278873|616827898|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
170676545|NCT03278873|616827899|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
170676546|NCT03278873|616827900|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
170676547|NCT05243641|616827901|FG000|Overall Study|Adverse Event|3|||
170676548|NCT05243641|616827902|FG001|Overall Study|Adverse Event|0|||
170676549|NCT05243641|616827903|FG002|Overall Study|Adverse Event|0|||
170676550|NCT05243641|616827904|FG003|Overall Study|Adverse Event|1|||
170676551|NCT05243641|616827905|FG004|Overall Study|Adverse Event|0|||
170676552|NCT05243641|616827906|FG005|Overall Study|Adverse Event|0|||
170676553|NCT05243641|616827901|FG000|Overall Study|Disease progression|4|||
170676554|NCT05243641|616827902|FG001|Overall Study|Disease progression|0|||
170676555|NCT05243641|616827903|FG002|Overall Study|Disease progression|0|||
170676556|NCT05243641|616827904|FG003|Overall Study|Disease progression|2|||
170676557|NCT05243641|616827905|FG004|Overall Study|Disease progression|0|||
170676558|NCT05243641|616827906|FG005|Overall Study|Disease progression|0|||
170676559|NCT04518306|616827910|FG000|Double-Blind Period|Run in failure|0|||
170676560|NCT04518306|616827911|FG001|Double-Blind Period|Run in failure|0|||
170676561|NCT04518306|616827912|FG002|Double-Blind Period|Run in failure|1|||
170676562|NCT04518306|616827910|FG000|Double-Blind Period|Adverse Event|0|||
170676563|NCT04518306|616827911|FG001|Double-Blind Period|Adverse Event|2|||
170676564|NCT04518306|616827912|FG002|Double-Blind Period|Adverse Event|2|||
170676565|NCT04518306|616827910|FG000|Double-Blind Period|Lost to Follow-up|1|||
170676566|NCT04518306|616827911|FG001|Double-Blind Period|Lost to Follow-up|2|||
170676567|NCT04518306|616827912|FG002|Double-Blind Period|Lost to Follow-up|2|||
170676568|NCT04518306|616827910|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
170676569|NCT04518306|616827911|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
170676570|NCT04518306|616827912|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
170676571|NCT04518306|616827910|FG000|Double-Blind Period|Other|0|||
170676572|NCT04518306|616827911|FG001|Double-Blind Period|Other|2|||
170676573|NCT04518306|616827912|FG002|Double-Blind Period|Other|0|||
170676574|NCT04518306|616827910|FG000|Double-Blind Period|Missing|0|||
170676575|NCT04518306|616827911|FG001|Double-Blind Period|Missing|1|||
170676576|NCT04518306|616827912|FG002|Double-Blind Period|Missing|0|||
170676577|NCT00540514|616829374|FG000|Overall Study|Still on treatment|3|||
170676578|NCT00540514|616829375|FG001|Overall Study|Still on treatment|0|||
170676579|NCT00540514|616829374|FG000|Overall Study|Unacceptable Toxicity|61|||
170676580|NCT00540514|616829375|FG001|Overall Study|Unacceptable Toxicity|62|||
170676581|NCT00540514|616829374|FG000|Overall Study|Adverse Event|20|||
170676582|NCT00540514|616829375|FG001|Overall Study|Adverse Event|24|||
170676583|NCT00540514|616829374|FG000|Overall Study|Physician Decision|86|||
170676584|NCT00540514|616829375|FG001|Overall Study|Physician Decision|99|||
170676585|NCT00540514|616829374|FG000|Overall Study|Protocol Deviation|3|||
170676586|NCT00540514|616829375|FG001|Overall Study|Protocol Deviation|4|||
170676587|NCT00540514|616829374|FG000|Overall Study|Lost to Follow-up|1|||
170676588|NCT00540514|616829375|FG001|Overall Study|Lost to Follow-up|1|||
170676589|NCT00540514|616829374|FG000|Overall Study|Withdrawal by Subject|65|||
170676590|NCT00540514|616829375|FG001|Overall Study|Withdrawal by Subject|67|||
170676591|NCT00540514|616829374|FG000|Overall Study|Excluded prior to treatment|7|||
170676592|NCT00540514|616829375|FG001|Overall Study|Excluded prior to treatment|7|||
170676593|NCT00540514|616829374|FG000|Overall Study|Paclitaxel not available|0|||
170676594|NCT00540514|616829375|FG001|Overall Study|Paclitaxel not available|2|||
170676595|NCT03602482|616829382|FG000|Overall Study|Withdrawal by Subject|6|||
170676596|NCT03602482|616829383|FG001|Overall Study|Withdrawal by Subject|7|||
170676597|NCT03602482|616829384|FG002|Overall Study|Withdrawal by Subject|0|||
170676598|NCT03602482|616829385|FG003|Overall Study|Withdrawal by Subject|0|||
170676599|NCT00105469|616829391|FG000|Overall Study|Adverse Event|9|||
170676600|NCT00105469|616829392|FG001|Overall Study|Adverse Event|8|||
170676601|NCT00105469|616829391|FG000|Overall Study|Protocol Violation|4|||
170676602|NCT00105469|616829392|FG001|Overall Study|Protocol Violation|0|||
170676603|NCT00105469|616829391|FG000|Overall Study|Withdrawal by Subject|2|||
170676604|NCT00105469|616829392|FG001|Overall Study|Withdrawal by Subject|3|||
170676605|NCT00105469|616829391|FG000|Overall Study|Lost to Follow-up|1|||
170676606|NCT00105469|616829392|FG001|Overall Study|Lost to Follow-up|0|||
170676607|NCT00105469|616829391|FG000|Overall Study|Lack of Efficacy|2|||
170676608|NCT00105469|616829392|FG001|Overall Study|Lack of Efficacy|0|||
170676609|NCT00105469|616829391|FG000|Overall Study|Other Reason|4|||
170676610|NCT00105469|616829392|FG001|Overall Study|Other Reason|0|||
170676611|NCT02871297|616829394|FG000|Overall Study|Adverse Event|34|||
170676612|NCT02871297|616829394|FG000|Overall Study|Lack of Efficacy|10|||
170676613|NCT02871297|616829394|FG000|Overall Study|Non-compliance with study drug|15|||
170676614|NCT02871297|616829394|FG000|Overall Study|Protocol Violation|3|||
170676615|NCT02871297|616829394|FG000|Overall Study|Withdrawal by Subject|20|||
170676616|NCT02871297|616829394|FG000|Overall Study|Lost to Follow-up|13|||
170676617|NCT02871297|616829394|FG000|Overall Study|Rolled over to 13546A|2|||
170676618|NCT02871297|616829394|FG000|Overall Study|Other than specified|39|||
170676619|NCT01411774|616829399|FG000|Overall Study|Withdrawal by Subject|0|||
170676620|NCT01411774|616829400|FG001|Overall Study|Withdrawal by Subject|3|||
170676621|NCT03808545|616829401|FG000|Overall Study|Withdrawal by Subject|1|||
170676622|NCT03808545|616829402|FG001|Overall Study|Withdrawal by Subject|1|||
170676623|NCT00618072|616829406|FG000|Overall Study|Lost to Follow-up|2|||
170676624|NCT00618072|616829407|FG001|Overall Study|Lost to Follow-up|0|||
170676625|NCT00618072|616829408|FG002|Overall Study|Lost to Follow-up|3|||
170676626|NCT00618072|616829406|FG000|Overall Study|Physician Decision|0|||
170676627|NCT00618072|616829407|FG001|Overall Study|Physician Decision|1|||
170676628|NCT00618072|616829408|FG002|Overall Study|Physician Decision|1|||
170676629|NCT03633695|616829409|FG000|Overall Study|Lost to Follow-up|4|||
170676630|NCT03633695|616829410|FG001|Overall Study|Lost to Follow-up|5|||
170676631|NCT03633695|616829409|FG000|Overall Study|Discontinued|8|||
170676632|NCT03633695|616829410|FG001|Overall Study|Discontinued|4|||
170676633|NCT00684593|616829411|FG000|Overall Study|Adverse Event|0|||
170676634|NCT00684593|616829412|FG001|Overall Study|Adverse Event|2|||
170676635|NCT01029795|616829416|FG000|Overall Study|Entry Criteria Not Met|2|||
170676636|NCT01029795|616829417|FG001|Overall Study|Entry Criteria Not Met|1|||
170676637|NCT01029795|616829416|FG000|Overall Study|Physician Decision|2|||
170676638|NCT01029795|616829417|FG001|Overall Study|Physician Decision|1|||
170676639|NCT01029795|616829416|FG000|Overall Study|Sponsor Decision|11|||
170676640|NCT01029795|616829417|FG001|Overall Study|Sponsor Decision|17|||
170676641|NCT01029795|616829416|FG000|Overall Study|Withdrawal by Subject|1|||
170676642|NCT01029795|616829417|FG001|Overall Study|Withdrawal by Subject|3|||
170676643|NCT00133952|616829422|FG000|Overall Study|Adverse Event|1|||
170676644|NCT00133952|616829423|FG001|Overall Study|Adverse Event|2|||
170676645|NCT00133952|616829422|FG000|Overall Study|Death|3|||
170676646|NCT00133952|616829423|FG001|Overall Study|Death|2|||
170676647|NCT00133952|616829422|FG000|Overall Study|Lost to Follow-up|9|||
170676648|NCT00133952|616829423|FG001|Overall Study|Lost to Follow-up|14|||
170676649|NCT00133952|616829422|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
170676650|NCT00133952|616829423|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
170676651|NCT00133952|616829422|FG000|Overall Study|Protocol Violation|1|||
170676652|NCT00133952|616829423|FG001|Overall Study|Protocol Violation|1|||
170676653|NCT00133952|616829422|FG000|Overall Study|Withdrawal by Subject|20|||
170676654|NCT00133952|616829423|FG001|Overall Study|Withdrawal by Subject|4|||
170676655|NCT00133952|616829422|FG000|Overall Study|Physician Decision|4|||
170676656|NCT00133952|616829423|FG001|Overall Study|Physician Decision|3|||
170676657|NCT00133952|616829422|FG000|Overall Study|Sponsor Decision|0|||
170676658|NCT00133952|616829423|FG001|Overall Study|Sponsor Decision|1|||
170676659|NCT02170298|616829428|FG000|Overall Study|Withdrawal by Subject|0|||
170676660|NCT02170298|616829429|FG001|Overall Study|Withdrawal by Subject|1|||
170676661|NCT02170298|616829428|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
170676662|NCT02170298|616829429|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
170676663|NCT05048784|616829437|FG000|Period 1|Adverse Event|3|||
170676664|NCT05048784|616829438|FG001|Period 1|Adverse Event|1|||
170676665|NCT05048784|616829439|FG002|Period 1|Adverse Event|0|||
170676666|NCT05048784|616829440|FG003|Period 1|Adverse Event|0|||
170676667|NCT05048784|616829437|FG000|Period 2|Lost to Follow-up|0|||
170676668|NCT05048784|616829438|FG001|Period 2|Lost to Follow-up|1|||
170676669|NCT05048784|616829439|FG002|Period 2|Lost to Follow-up|0|||
170676670|NCT05048784|616829440|FG003|Period 2|Lost to Follow-up|0|||
170676671|NCT02853604|616829445|FG000|Overall Study|Withdrawal by Subject|12|||
170676672|NCT02853604|616829446|FG001|Overall Study|Withdrawal by Subject|35|||
170676673|NCT02853604|616829445|FG000|Overall Study|Lost to Follow-up|4|||
170676674|NCT02853604|616829446|FG001|Overall Study|Lost to Follow-up|8|||
170676675|NCT02853604|616829445|FG000|Overall Study|Death|1|||
170676676|NCT02853604|616829446|FG001|Overall Study|Death|5|||
170676677|NCT02853604|616829445|FG000|Overall Study|Miscellaneous|11|||
170676678|NCT02853604|616829446|FG001|Overall Study|Miscellaneous|2|||
170676679|NCT02853604|616829445|FG000|Overall Study|Progressive Disease|0|||
170676680|NCT02853604|616829446|FG001|Overall Study|Progressive Disease|2|||
170676681|NCT00727025|616829447|FG000|Overall Study|Physician Decision|23|||
170676682|NCT02101060|616829448|FG000|Overall Study|Adverse Event|1|||
170676683|NCT02101060|616829449|FG001|Overall Study|Adverse Event|0|||
170676684|NCT02101060|616829448|FG000|Overall Study|Withdrawal by Subject|1|||
170676685|NCT02101060|616829449|FG001|Overall Study|Withdrawal by Subject|1|||
170676686|NCT02101060|616829448|FG000|Overall Study|Lost to Follow-up|3|||
170676687|NCT02101060|616829449|FG001|Overall Study|Lost to Follow-up|3|||
170676688|NCT03020160|616829450|FG000|Overall Study|Withdrawal by Subject|1|||
170676689|NCT03020160|616829451|FG001|Overall Study|Withdrawal by Subject|0|||
170676690|NCT02270957|616829452|FG000|Overall Study|Lack of Efficacy|2|||
170676691|NCT02270957|616829453|FG001|Overall Study|Lack of Efficacy|4|||
170676692|NCT02270957|616829452|FG000|Overall Study|Adverse Event|2|||
170676693|NCT02270957|616829453|FG001|Overall Study|Adverse Event|0|||
170676694|NCT00601458|616829458|FG000|Overall Study|Dosing Error|1|||
170676695|NCT00601458|616829459|FG001|Overall Study|Dosing Error|0|||
170676696|NCT00601458|616829460|FG002|Overall Study|Dosing Error|0|||
170676697|NCT00601458|616829458|FG000|Overall Study|Incomplete Data|0|||
170676698|NCT00601458|616829459|FG001|Overall Study|Incomplete Data|2|||
170676699|NCT00601458|616829460|FG002|Overall Study|Incomplete Data|0|||
170676700|NCT00601458|616829458|FG000|Overall Study|Protocol Violation|3|||
170676701|NCT00601458|616829459|FG001|Overall Study|Protocol Violation|2|||
170676702|NCT00601458|616829460|FG002|Overall Study|Protocol Violation|1|||
170676703|NCT00601458|616829458|FG000|Overall Study|Early Termination|0|||
170676704|NCT00601458|616829459|FG001|Overall Study|Early Termination|1|||
170676705|NCT00601458|616829460|FG002|Overall Study|Early Termination|1|||
170676706|NCT00642460|616829461|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
170676707|NCT00642460|616829462|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
170676708|NCT00642460|616829463|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
170676709|NCT00642460|616829464|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
170676710|NCT00642460|616829465|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
170676711|NCT00642460|616829466|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
170676712|NCT00642460|616829461|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
170676713|NCT00642460|616829462|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
170676714|NCT00642460|616829463|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
170676715|NCT00642460|616829464|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
170676716|NCT00642460|616829465|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
170676717|NCT00642460|616829466|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
170676718|NCT00642460|616829461|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
170676719|NCT00642460|616829462|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
170676720|NCT00642460|616829463|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
170676721|NCT00642460|616829464|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
170676722|NCT00642460|616829465|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
170676723|NCT00642460|616829466|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
170676724|NCT00642460|616829461|FG000|Part II: Open-Label Up to Week 92|Death|0|||
170676725|NCT00642460|616829462|FG001|Part II: Open-Label Up to Week 92|Death|1|||
170676726|NCT00642460|616829463|FG002|Part II: Open-Label Up to Week 92|Death|0|||
170676727|NCT00642460|616829464|FG003|Part II: Open-Label Up to Week 92|Death|2|||
170676728|NCT00642460|616829465|FG004|Part II: Open-Label Up to Week 92|Death|0|||
170676729|NCT00642460|616829466|FG005|Part II: Open-Label Up to Week 92|Death|0|||
170676730|NCT00642460|616829461|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
170676731|NCT00642460|616829462|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
170676732|NCT00642460|616829463|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
170676733|NCT00642460|616829464|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
170676734|NCT00642460|616829465|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
170676735|NCT00642460|616829466|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
170676736|NCT00642460|616829461|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
170676737|NCT00642460|616829462|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
170676738|NCT00642460|616829463|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
170676739|NCT00642460|616829464|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
170676740|NCT00642460|616829465|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
170676741|NCT00642460|616829466|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
170676742|NCT00642460|616829461|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
170676743|NCT00642460|616829462|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
170676744|NCT00642460|616829463|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
170676745|NCT00642460|616829464|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
170676746|NCT00642460|616829465|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
170676747|NCT00642460|616829466|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
170676748|NCT00642460|616829461|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
170676749|NCT00642460|616829462|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
170676750|NCT00642460|616829463|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
170676751|NCT00642460|616829464|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
170676752|NCT00642460|616829465|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
170676753|NCT00642460|616829466|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
170676754|NCT00642460|616829461|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
170676755|NCT00642460|616829462|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
170676756|NCT00642460|616829463|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
170676757|NCT00642460|616829464|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
170676758|NCT00642460|616829465|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
170676759|NCT00642460|616829466|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
170676760|NCT00642460|616829461|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
170676761|NCT00642460|616829462|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
170676762|NCT00642460|616829463|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
170676763|NCT00642460|616829464|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
170676764|NCT00642460|616829465|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
170820451|NCT02131155|617349651|FG000|Overall Study|Adverse Event|1|||
170820452|NCT02131155|617349652|FG001|Overall Study|Adverse Event|0|||
170820453|NCT02131155|617349651|FG000|Overall Study|Treatment completed|1|||
170820454|NCT02131155|617349652|FG001|Overall Study|Treatment completed|0|||
170820455|NCT02131155|617349651|FG000|Overall Study|Primary tumour recurrence|2|||
170820456|NCT02131155|617349652|FG001|Overall Study|Primary tumour recurrence|1|||
170820457|NCT02131155|617349651|FG000|Overall Study|Refused to continue study medication|1|||
170820458|NCT02131155|617349652|FG001|Overall Study|Refused to continue study medication|0|||
170820459|NCT02131155|617349651|FG000|Overall Study|Study early termination|20|||
170820460|NCT02131155|617349652|FG001|Overall Study|Study early termination|10|||
170820461|NCT01887418|617349653|FG000|Overall Study|Travelling difficulties|0|||
170820462|NCT01887418|617349654|FG001|Overall Study|Travelling difficulties|0|||
170820463|NCT01887418|617349655|FG002|Overall Study|Travelling difficulties|1|||
170820464|NCT01014013|617349656|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
170820465|NCT01014013|617349657|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
170820466|NCT01014013|617349656|FG000|Overall Study|Clinical adverse experience|4|||
170820467|NCT01014013|617349657|FG001|Overall Study|Clinical adverse experience|2|||
170820468|NCT01014013|617349656|FG000|Overall Study|Laboratory adverse experience|1|||
170820469|NCT01014013|617349657|FG001|Overall Study|Laboratory adverse experience|1|||
170820470|NCT01014013|617349656|FG000|Overall Study|Protocol Violation|1|||
170820471|NCT01014013|617349657|FG001|Overall Study|Protocol Violation|3|||
170820472|NCT01014013|617349656|FG000|Overall Study|Withdrawal by Subject|7|||
170820473|NCT01014013|617349657|FG001|Overall Study|Withdrawal by Subject|4|||
170820474|NCT01014013|617349656|FG000|Overall Study|Clinical/microbiologic failure|1|||
170820475|NCT01014013|617349657|FG001|Overall Study|Clinical/microbiologic failure|2|||
170820476|NCT01014013|617349656|FG000|Overall Study|Pathogen culture = no growth|26|||
170820477|NCT01014013|617349657|FG001|Overall Study|Pathogen culture = no growth|34|||
170820478|NCT01014013|617349656|FG000|Overall Study|Negative urine culture|2|||
170820479|NCT01014013|617349657|FG001|Overall Study|Negative urine culture|0|||
170820480|NCT01014013|617349656|FG000|Overall Study|Pathogen resistant|7|||
170820481|NCT01014013|617349657|FG001|Overall Study|Pathogen resistant|4|||
170820482|NCT01014013|617349656|FG000|Overall Study|Physician Decision|0|||
170820483|NCT01014013|617349657|FG001|Overall Study|Physician Decision|1|||
170820484|NCT01014013|617349656|FG000|Overall Study|Another antibiotic therapy required|0|||
170820485|NCT01014013|617349657|FG001|Overall Study|Another antibiotic therapy required|1|||
170820486|NCT01014013|617349656|FG000|Overall Study|Appendectomy|1|||
170820487|NCT01014013|617349657|FG001|Overall Study|Appendectomy|0|||
170820488|NCT01014013|617349656|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
170820489|NCT01014013|617349657|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
170820490|NCT00316121|617349661|FG000|Overall Study|Death|1|||
170820491|NCT00316121|617349662|FG001|Overall Study|Death|0|||
170820492|NCT00316121|617349661|FG000|Overall Study|Lost to Follow-up|14|||
170820493|NCT00316121|617349662|FG001|Overall Study|Lost to Follow-up|8|||
170820494|NCT00316121|617349661|FG000|Overall Study|Withdrawal by Subject|2|||
170820495|NCT00316121|617349662|FG001|Overall Study|Withdrawal by Subject|0|||
170820496|NCT00316121|617349661|FG000|Overall Study|Reason is missing|1|||
170820497|NCT00316121|617349662|FG001|Overall Study|Reason is missing|0|||
170820498|NCT00316121|617349661|FG000|Overall Study|Subject relocated|1|||
170820499|NCT00316121|617349662|FG001|Overall Study|Subject relocated|1|||
170820500|NCT00316121|617349661|FG000|Overall Study|Subject refused to return|1|||
170820501|NCT00316121|617349662|FG001|Overall Study|Subject refused to return|0|||
170820502|NCT00316121|617349661|FG000|Overall Study|Subject no show for visit x 3|1|||
170820503|NCT00316121|617349662|FG001|Overall Study|Subject no show for visit x 3|0|||
170820504|NCT00316121|617349661|FG000|Overall Study|Subject did not have 24 month visit|1|||
170820505|NCT00316121|617349662|FG001|Overall Study|Subject did not have 24 month visit|0|||
170820506|NCT00460577|617349669|FG000|Overall Study|Protocol Violation|2|||
170820507|NCT00460577|617349670|FG001|Overall Study|Protocol Violation|6|||
170820508|NCT02162771|617349674|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
170820509|NCT02162771|617349675|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
170820510|NCT02162771|617349674|FG000|Core Study Period (Part 2)|Adverse Event|4|||
170820511|NCT02162771|617349675|FG001|Core Study Period (Part 2)|Adverse Event|1|||
170820512|NCT02162771|617349674|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
170676765|NCT00642460|616829466|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
170676766|NCT00642460|616829461|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
170676767|NCT00642460|616829462|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
170676768|NCT00642460|616829463|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
170676769|NCT00642460|616829464|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
170676770|NCT00642460|616829465|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
170676771|NCT00642460|616829466|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
170676772|NCT00642460|616829461|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
170676773|NCT00642460|616829462|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
170676774|NCT00642460|616829463|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
170676775|NCT00642460|616829464|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
170676776|NCT00642460|616829465|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
170676777|NCT00642460|616829466|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
170676778|NCT00642460|616829461|FG000|Part III: Open-Label Up to Week 260|Other|0|||
170676779|NCT00642460|616829462|FG001|Part III: Open-Label Up to Week 260|Other|0|||
170676780|NCT00642460|616829463|FG002|Part III: Open-Label Up to Week 260|Other|0|||
170676781|NCT00642460|616829464|FG003|Part III: Open-Label Up to Week 260|Other|0|||
170676782|NCT00642460|616829465|FG004|Part III: Open-Label Up to Week 260|Other|2|||
170676783|NCT00642460|616829466|FG005|Part III: Open-Label Up to Week 260|Other|2|||
170676784|NCT00642460|616829461|FG000|Part III: Open-Label Up to Week 260|Death|0|||
170820513|NCT02162771|617349675|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
170820514|NCT02162771|617349674|FG000|Core Study Period (Part 2)|Physician Decision|0|||
170820515|NCT02162771|617349675|FG001|Core Study Period (Part 2)|Physician Decision|2|||
170820516|NCT02162771|617349674|FG000|Core Study Period (Part 2)|Death|1|||
170820517|NCT02162771|617349675|FG001|Core Study Period (Part 2)|Death|0|||
170820518|NCT02162771|617349674|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
170820519|NCT02162771|617349675|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
170820520|NCT02162771|617349674|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
170820521|NCT02162771|617349675|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
170676785|NCT00642460|616829462|FG001|Part III: Open-Label Up to Week 260|Death|0|||
170676786|NCT00642460|616829463|FG002|Part III: Open-Label Up to Week 260|Death|0|||
170676787|NCT00642460|616829464|FG003|Part III: Open-Label Up to Week 260|Death|0|||
170676788|NCT00642460|616829465|FG004|Part III: Open-Label Up to Week 260|Death|0|||
170676789|NCT00642460|616829466|FG005|Part III: Open-Label Up to Week 260|Death|3|||
170676790|NCT00642460|616829461|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
170676791|NCT00642460|616829462|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
170676792|NCT00642460|616829463|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
170676793|NCT00642460|616829464|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
170676794|NCT00642460|616829465|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
170676795|NCT00642460|616829466|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
170676796|NCT00642460|616829461|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
170676797|NCT00642460|616829462|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
170676798|NCT00642460|616829463|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
170676799|NCT00642460|616829464|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
170676800|NCT00642460|616829465|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
170676801|NCT00642460|616829466|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
170676802|NCT01447433|616829470|FG000|Overall Study|Lost to Follow-up|0|||
170676803|NCT01447433|616829471|FG001|Overall Study|Lost to Follow-up|2|||
170676804|NCT01447433|616829470|FG000|Overall Study|Withdrawal by Subject|3|||
170676805|NCT01447433|616829471|FG001|Overall Study|Withdrawal by Subject|3|||
170676806|NCT01447433|616829470|FG000|Overall Study|Protocol Violation|1|||
170676807|NCT01447433|616829471|FG001|Overall Study|Protocol Violation|1|||
170676808|NCT02002091|616829472|FG000|Screening|Lost to Follow-up|10|||
170676809|NCT02002091|616829473|FG001|Screening|Lost to Follow-up|12|||
170676810|NCT02002091|616829472|FG000|Screening|Death|3|||
170676811|NCT02002091|616829473|FG001|Screening|Death|2|||
170676812|NCT03322631|616829474|FG000|Overall Study|Withdrawal by Subject|0|||
170676813|NCT03322631|616829475|FG001|Overall Study|Withdrawal by Subject|1|||
170676814|NCT03322631|616829476|FG002|Overall Study|Withdrawal by Subject|0|||
170676815|NCT03322631|616829477|FG003|Overall Study|Withdrawal by Subject|0|||
170676816|NCT03322631|616829474|FG000|Overall Study|Adverse Event|0|||
170676817|NCT03322631|616829475|FG001|Overall Study|Adverse Event|0|||
170676818|NCT03322631|616829476|FG002|Overall Study|Adverse Event|1|||
170676819|NCT03322631|616829477|FG003|Overall Study|Adverse Event|0|||
170676820|NCT02378961|616829478|FG000|Overall Study|Lack of Efficacy|4|||
170676821|NCT02378961|616829479|FG001|Overall Study|Lack of Efficacy|2|||
170676822|NCT02378961|616829480|FG002|Overall Study|Lack of Efficacy|0|||
170676823|NCT02378961|616829481|FG003|Overall Study|Lack of Efficacy|1|||
170676824|NCT02378961|616829478|FG000|Overall Study|Death|0|||
170676825|NCT02378961|616829479|FG001|Overall Study|Death|0|||
170676826|NCT02378961|616829480|FG002|Overall Study|Death|1|||
170676827|NCT02378961|616829481|FG003|Overall Study|Death|0|||
170676828|NCT01049308|616829482|FG000|Pill Counts|Withdrawal by Subject|83|||
170676829|NCT03943147|616829485|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
170676830|NCT03943147|616829486|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
170676831|NCT03943147|616829485|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
170676832|NCT03943147|616829486|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
170676833|NCT03943147|616829485|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
170676834|NCT03943147|616829486|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
170676835|NCT03943147|616829485|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
170676836|NCT03943147|616829486|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
170676837|NCT03943147|616829485|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
170676838|NCT03943147|616829486|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
170676839|NCT03943147|616829485|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
170676840|NCT03943147|616829486|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
170676841|NCT03736447|616829490|FG000|Overall Study|Adverse Event|5|||
170676842|NCT03736447|616829491|FG001|Overall Study|Adverse Event|1|||
170676843|NCT03736447|616829490|FG000|Overall Study|Withdrawal by Subject|5|||
170676844|NCT03736447|616829491|FG001|Overall Study|Withdrawal by Subject|1|||
170676845|NCT03736447|616829490|FG000|Overall Study|Lost to Follow-up|1|||
170676846|NCT03736447|616829491|FG001|Overall Study|Lost to Follow-up|0|||
170676847|NCT03736447|616829490|FG000|Overall Study|Physician Decision|1|||
170676848|NCT03736447|616829491|FG001|Overall Study|Physician Decision|0|||
170676849|NCT03736447|616829490|FG000|Overall Study|Continued commitment to study treatment|3|||
170676850|NCT03736447|616829491|FG001|Overall Study|Continued commitment to study treatment|0|||
170676851|NCT03736447|616829490|FG000|Overall Study|Taste aversion to study product|0|||
170676852|NCT03736447|616829491|FG001|Overall Study|Taste aversion to study product|1|||
170676853|NCT02619175|616829493|FG000|Overall Study|Withdrawal by Subject|1|||
170676854|NCT02619175|616829494|FG001|Overall Study|Withdrawal by Subject|0|||
170676855|NCT02619175|616829493|FG000|Overall Study|foot pain|1|||
170676856|NCT02619175|616829494|FG001|Overall Study|foot pain|0|||
170676857|NCT04523220|616829495|FG000|Main Treatment Period|Physician Decision|1|||
170676858|NCT04523220|616829496|FG001|Main Treatment Period|Physician Decision|1|||
170676859|NCT04523220|616829497|FG002|Main Treatment Period|Physician Decision|0|||
170676860|NCT04523220|616829495|FG000|Main Treatment Period|Other|5|||
170676861|NCT04523220|616829496|FG001|Main Treatment Period|Other|2|||
170676862|NCT04523220|616829497|FG002|Main Treatment Period|Other|4|||
170676863|NCT04523220|616829495|FG000|Main Treatment Period|Subject Decision|5|||
170676864|NCT04523220|616829496|FG001|Main Treatment Period|Subject Decision|7|||
170676865|NCT04523220|616829497|FG002|Main Treatment Period|Subject Decision|3|||
170676866|NCT04523220|616829495|FG000|Main Treatment Period|Death|5|||
170676867|NCT04523220|616829496|FG001|Main Treatment Period|Death|11|||
170676868|NCT04523220|616829497|FG002|Main Treatment Period|Death|4|||
170676869|NCT04523220|616829495|FG000|Main Treatment Period|Adverse Event|11|||
170676870|NCT04523220|616829496|FG001|Main Treatment Period|Adverse Event|9|||
170676871|NCT04523220|616829497|FG002|Main Treatment Period|Adverse Event|9|||
170676872|NCT04523220|616829495|FG000|Main Treatment Period|Withdrawal by Subject|3|||
170676873|NCT04523220|616829496|FG001|Main Treatment Period|Withdrawal by Subject|3|||
170676874|NCT04523220|616829497|FG002|Main Treatment Period|Withdrawal by Subject|4|||
170676875|NCT04523220|616829495|FG000|Main Treatment Period|Study drug never adminstered|10|||
170676876|NCT04523220|616829496|FG001|Main Treatment Period|Study drug never adminstered|3|||
170676877|NCT04523220|616829497|FG002|Main Treatment Period|Study drug never adminstered|5|||
170676878|NCT04523220|616829495|FG000|Extension Treatment Period|Physician Decision|1|||
170676879|NCT04523220|616829496|FG001|Extension Treatment Period|Physician Decision|0|||
170676880|NCT04523220|616829497|FG002|Extension Treatment Period|Physician Decision|3|||
170676881|NCT04523220|616829495|FG000|Extension Treatment Period|Other|2|||
170676882|NCT04523220|616829496|FG001|Extension Treatment Period|Other|6|||
170676883|NCT04523220|616829497|FG002|Extension Treatment Period|Other|6|||
170676884|NCT04523220|616829495|FG000|Extension Treatment Period|Subject Decision|5|||
170676885|NCT04523220|616829496|FG001|Extension Treatment Period|Subject Decision|2|||
170676886|NCT04523220|616829497|FG002|Extension Treatment Period|Subject Decision|4|||
170676887|NCT04523220|616829495|FG000|Extension Treatment Period|Death|6|||
170676888|NCT04523220|616829496|FG001|Extension Treatment Period|Death|4|||
170676889|NCT04523220|616829497|FG002|Extension Treatment Period|Death|7|||
170676890|NCT04523220|616829495|FG000|Extension Treatment Period|Adverse Event|6|||
170676891|NCT04523220|616829496|FG001|Extension Treatment Period|Adverse Event|7|||
170676892|NCT04523220|616829497|FG002|Extension Treatment Period|Adverse Event|9|||
170676893|NCT04523220|616829495|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
170676894|NCT04523220|616829496|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
170676895|NCT04523220|616829497|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
170676896|NCT04523220|616829495|FG000|Extension Treatment Period|Study drug never administered|0|||
170676897|NCT04523220|616829496|FG001|Extension Treatment Period|Study drug never administered|1|||
170676898|NCT04523220|616829497|FG002|Extension Treatment Period|Study drug never administered|0|||
170676899|NCT01929343|616829498|FG000|Overall Study|Physician Decision|0|||
170676900|NCT01929343|616829499|FG001|Overall Study|Physician Decision|2|||
170676901|NCT01929343|616829500|FG002|Overall Study|Physician Decision|0|||
170676902|NCT01929343|616829498|FG000|Overall Study|Withdrawal by Subject|1|||
170676903|NCT01929343|616829499|FG001|Overall Study|Withdrawal by Subject|0|||
170676904|NCT01929343|616829500|FG002|Overall Study|Withdrawal by Subject|0|||
170676905|NCT03268954|616829503|FG000|Overall Study|Withdrawal by Subject|27|||
170676906|NCT03268954|616829504|FG001|Overall Study|Withdrawal by Subject|17|||
170676907|NCT03268954|616829503|FG000|Overall Study|Lost to Follow-up|2|||
170676908|NCT03268954|616829504|FG001|Overall Study|Lost to Follow-up|3|||
170676909|NCT03268954|616829503|FG000|Overall Study|Reason Not Specified|3|||
170676910|NCT03268954|616829504|FG001|Overall Study|Reason Not Specified|8|||
170676911|NCT05372419|616829505|FG000|Overall Study|Protocol Deviation|1|||
170676912|NCT05372419|616829505|FG000|Overall Study|Withdrawal by Subject|5|||
170676913|NCT05372419|616829505|FG000|Overall Study|Lost to Follow-up|7|||
170676914|NCT01638546|616829516|FG000|Overall Study|Adverse Event|1|||
170820522|NCT02162771|617349674|FG000|Maintenance Study Period (Part 2)|Death|2|||
170676915|NCT01638546|616829517|FG001|Overall Study|Adverse Event|3|||
170820523|NCT02162771|617349675|FG001|Maintenance Study Period (Part 2)|Death|1|||
170676916|NCT00996216|616831561|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
170676917|NCT00996216|616831561|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
170676918|NCT00996216|616831561|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
170676919|NCT01892293|616831568|FG000|Overall Study|Apheresed but not treated|4|||
170676920|NCT03292588|616831583|FG000|Overall Study|Death|1|||
170676921|NCT03292588|616831584|FG001|Overall Study|Death|0|||
170676922|NCT03292588|616831583|FG000|Overall Study|Lost to Follow-up|12|||
170676923|NCT03292588|616831584|FG001|Overall Study|Lost to Follow-up|16|||
170676924|NCT03292588|616831583|FG000|Overall Study|Physician Decision|0|||
170676925|NCT03292588|616831584|FG001|Overall Study|Physician Decision|1|||
170676926|NCT03292588|616831583|FG000|Overall Study|Withdrawal by Subject|4|||
170676927|NCT03292588|616831584|FG001|Overall Study|Withdrawal by Subject|4|||
170676928|NCT03292588|616831583|FG000|Overall Study|Move out of town|1|||
170676929|NCT03292588|616831584|FG001|Overall Study|Move out of town|0|||
170676930|NCT03292588|616831583|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
170676931|NCT03292588|616831584|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
170676932|NCT00684307|616831585|FG000|Overall Study|Adverse Event|11|||
170676933|NCT00684307|616831586|FG001|Overall Study|Adverse Event|6|||
170676934|NCT00684307|616831587|FG002|Overall Study|Adverse Event|15|||
170676935|NCT00684307|616831588|FG003|Overall Study|Adverse Event|16|||
170676936|NCT00684307|616831589|FG004|Overall Study|Adverse Event|8|||
170676937|NCT00684307|616831585|FG000|Overall Study|Development of increasing Liver Function|0|||
170676938|NCT00684307|616831586|FG001|Overall Study|Development of increasing Liver Function|2|||
170676939|NCT00684307|616831587|FG002|Overall Study|Development of increasing Liver Function|0|||
170676940|NCT00684307|616831588|FG003|Overall Study|Development of increasing Liver Function|1|||
170676941|NCT00684307|616831589|FG004|Overall Study|Development of increasing Liver Function|0|||
170676942|NCT00684307|616831585|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
170676943|NCT00684307|616831586|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
170676944|NCT00684307|616831587|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
170676945|NCT00684307|616831588|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
170676946|NCT00684307|616831589|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
170820524|NCT02162771|617349674|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
170676947|NCT00684307|616831585|FG000|Overall Study|Incorrect enrolment or randomization|4|||
170676948|NCT00684307|616831586|FG001|Overall Study|Incorrect enrolment or randomization|0|||
170676949|NCT00684307|616831587|FG002|Overall Study|Incorrect enrolment or randomization|0|||
170676950|NCT00684307|616831588|FG003|Overall Study|Incorrect enrolment or randomization|0|||
170676951|NCT00684307|616831589|FG004|Overall Study|Incorrect enrolment or randomization|0|||
170676952|NCT00684307|616831585|FG000|Overall Study|Interupted IP for more than 7 days|0|||
170676953|NCT00684307|616831586|FG001|Overall Study|Interupted IP for more than 7 days|4|||
170676954|NCT00684307|616831587|FG002|Overall Study|Interupted IP for more than 7 days|1|||
170676955|NCT00684307|616831588|FG003|Overall Study|Interupted IP for more than 7 days|3|||
170676956|NCT00684307|616831589|FG004|Overall Study|Interupted IP for more than 7 days|3|||
170676957|NCT00684307|616831585|FG000|Overall Study|Severe non compliance to protocol|1|||
170676958|NCT00684307|616831586|FG001|Overall Study|Severe non compliance to protocol|0|||
170676959|NCT00684307|616831587|FG002|Overall Study|Severe non compliance to protocol|0|||
170676960|NCT00684307|616831588|FG003|Overall Study|Severe non compliance to protocol|1|||
170676961|NCT00684307|616831589|FG004|Overall Study|Severe non compliance to protocol|2|||
170676962|NCT00684307|616831585|FG000|Overall Study|Participant not willing to continue|7|||
170676963|NCT00684307|616831586|FG001|Overall Study|Participant not willing to continue|10|||
170676964|NCT00684307|616831587|FG002|Overall Study|Participant not willing to continue|11|||
170676965|NCT00684307|616831588|FG003|Overall Study|Participant not willing to continue|5|||
170676966|NCT00684307|616831589|FG004|Overall Study|Participant not willing to continue|8|||
170676967|NCT00684307|616831585|FG000|Overall Study|Criteria from the CSR|0|||
170676968|NCT00684307|616831586|FG001|Overall Study|Criteria from the CSR|0|||
170676969|NCT00684307|616831587|FG002|Overall Study|Criteria from the CSR|1|||
170676970|NCT00684307|616831588|FG003|Overall Study|Criteria from the CSR|3|||
170676971|NCT00684307|616831589|FG004|Overall Study|Criteria from the CSR|3|||
170676972|NCT00884312|616831590|FG000|Overall Study|Non-fatal Progressive Disease|0|||
170676973|NCT00884312|616831591|FG001|Overall Study|Non-fatal Progressive Disease|8|||
170676974|NCT00884312|616831590|FG000|Overall Study|Fatal Progressive Disease|0|||
170676975|NCT00884312|616831591|FG001|Overall Study|Fatal Progressive Disease|1|||
170676976|NCT00884312|616831590|FG000|Overall Study|Non-fatal Adverse Event|1|||
170676977|NCT00884312|616831591|FG001|Overall Study|Non-fatal Adverse Event|0|||
170676978|NCT00884312|616831590|FG000|Overall Study|Fatal Adverse Event|1|||
170676979|NCT00884312|616831591|FG001|Overall Study|Fatal Adverse Event|4|||
170676980|NCT00884312|616831590|FG000|Overall Study|Withdrawal by Subject|0|||
170676981|NCT00884312|616831591|FG001|Overall Study|Withdrawal by Subject|6|||
170676982|NCT00884312|616831590|FG000|Overall Study|Physician Decision|0|||
170676983|NCT00884312|616831591|FG001|Overall Study|Physician Decision|1|||
170676984|NCT00884312|616831590|FG000|Overall Study|Other|0|||
170676985|NCT00884312|616831591|FG001|Overall Study|Other|4|||
170676986|NCT00884312|616831590|FG000|Overall Study|Did Not Receive Study Drug|0|||
170676987|NCT00884312|616831591|FG001|Overall Study|Did Not Receive Study Drug|1|||
170676988|NCT03462082|616831596|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
170676989|NCT03462082|616831597|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
170676990|NCT03462082|616831598|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
170676991|NCT03462082|616831599|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
170676992|NCT03462082|616831600|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
170676993|NCT03462082|616831601|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
170676994|NCT03462082|616831602|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
170676995|NCT03462082|616831603|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
170676996|NCT00284050|616831608|FG000|Overall Study|Adverse Event|1|||
170676997|NCT00284050|616831609|FG001|Overall Study|Adverse Event|1|||
170676998|NCT00284050|616831610|FG002|Overall Study|Adverse Event|1|||
170676999|NCT00284050|616831608|FG000|Overall Study|Lack of Efficacy|0|||
170677000|NCT00284050|616831609|FG001|Overall Study|Lack of Efficacy|1|||
170677001|NCT00284050|616831610|FG002|Overall Study|Lack of Efficacy|3|||
170677002|NCT00284050|616831608|FG000|Overall Study|Protocol Violation|0|||
170677003|NCT00284050|616831609|FG001|Overall Study|Protocol Violation|1|||
170677004|NCT00284050|616831610|FG002|Overall Study|Protocol Violation|2|||
170677005|NCT00284050|616831608|FG000|Overall Study|Withdrawal by Subject|2|||
170677006|NCT00284050|616831609|FG001|Overall Study|Withdrawal by Subject|2|||
170677007|NCT00284050|616831610|FG002|Overall Study|Withdrawal by Subject|2|||
170677008|NCT00284050|616831608|FG000|Overall Study|Lost to Follow-up|1|||
170677009|NCT00284050|616831609|FG001|Overall Study|Lost to Follow-up|0|||
170677010|NCT00284050|616831610|FG002|Overall Study|Lost to Follow-up|1|||
170677011|NCT00284050|616831608|FG000|Overall Study|Death|1|||
170677012|NCT00284050|616831609|FG001|Overall Study|Death|0|||
170677013|NCT00284050|616831610|FG002|Overall Study|Death|0|||
170677014|NCT00545168|616831617|FG000|Overall Study|Lost to Follow-up|5|||
170677015|NCT00545168|616831618|FG001|Overall Study|Lost to Follow-up|5|||
170677016|NCT00545168|616831619|FG002|Overall Study|Lost to Follow-up|5|||
170677017|NCT00545168|616831617|FG000|Overall Study|Withdrawal by Subject|9|||
170677018|NCT00545168|616831618|FG001|Overall Study|Withdrawal by Subject|0|||
170677019|NCT00545168|616831619|FG002|Overall Study|Withdrawal by Subject|13|||
170677020|NCT00545168|616831617|FG000|Overall Study|Protocol Violation|1|||
170677021|NCT00545168|616831618|FG001|Overall Study|Protocol Violation|0|||
170677022|NCT00545168|616831619|FG002|Overall Study|Protocol Violation|1|||
170677023|NCT00545168|616831617|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
170677024|NCT00545168|616831618|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
170677025|NCT00545168|616831619|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
170677026|NCT00743340|616831622|FG000|Overall Study|Study medication non-compliance|1|||
170677027|NCT00743340|616831622|FG000|Overall Study|Lost to Follow-up|1|||
170677028|NCT00743340|616831622|FG000|Overall Study|Withdrawal from the Study|5|||
170677029|NCT00743340|616831622|FG000|Overall Study|Protocol Violation|1|||
170677030|NCT00743340|616831622|FG000|Overall Study|Virologic failure|8|||
170677031|NCT00743340|616831622|FG000|Overall Study|Pregnancy|1|||
170677032|NCT00743340|616831622|FG000|Overall Study|Rolled over to other Gilead Study|23|||
170677033|NCT00743340|616831622|FG000|Overall Study|Participant Relocated|1|||
170677034|NCT01987505|616831625|FG000|Overall Study|Other|9|||
170677035|NCT01987505|616831625|FG000|Overall Study|Withdrawal by Subject|2|||
170677036|NCT01987505|616831625|FG000|Overall Study|Other Reason|2|||
170677037|NCT01987505|616831625|FG000|Overall Study|Lost to Follow-up|15|||
170677038|NCT01987505|616831625|FG000|Overall Study|Investigator Decision|2|||
170677039|NCT01987505|616831625|FG000|Overall Study|Death|4|||
170677040|NCT01425281|616831626|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
170677041|NCT01425281|616831627|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
170677042|NCT01425281|616831626|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
170677043|NCT01425281|616831627|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
170677044|NCT01425281|616831626|FG000|At 180-day Clinical Follow-up|Death|0|||
170677045|NCT01425281|616831627|FG001|At 180-day Clinical Follow-up|Death|1|||
170677046|NCT01425281|616831626|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
170677047|NCT01425281|616831627|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
170677048|NCT01425281|616831626|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
170677049|NCT01425281|616831627|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
170677050|NCT01425281|616831626|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
170677051|NCT01425281|616831627|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
170677052|NCT01425281|616831626|FG000|At 2-year Clinical Follow-up|Death|2|||
170677053|NCT01425281|616831627|FG001|At 2-year Clinical Follow-up|Death|0|||
170677054|NCT01425281|616831626|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
170677055|NCT01425281|616831627|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
170677056|NCT01425281|616831626|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
170677057|NCT01425281|616831627|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
170677058|NCT01425281|616831626|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
170677059|NCT01425281|616831627|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
170677060|NCT01425281|616831626|FG000|At 3-year Clinical Follow-up|Death|2|||
170677061|NCT01425281|616831627|FG001|At 3-year Clinical Follow-up|Death|3|||
170677062|NCT01425281|616831626|FG000|At 4-year Clinical Follow-up|Death|7|||
170677063|NCT01425281|616831627|FG001|At 4-year Clinical Follow-up|Death|3|||
170677064|NCT01425281|616831626|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
170677065|NCT01425281|616831627|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
170677066|NCT01425281|616831626|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
170677067|NCT01425281|616831627|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
170677068|NCT01425281|616831626|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
170677069|NCT01425281|616831627|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
170677070|NCT01425281|616831626|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
170677071|NCT01425281|616831627|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
170677072|NCT01425281|616831626|FG000|At 5-year Clinical Follow-up|Death|2|||
170677073|NCT01425281|616831627|FG001|At 5-year Clinical Follow-up|Death|0|||
170677074|NCT01425281|616831626|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
170677075|NCT01425281|616831627|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
170677076|NCT01425281|616831626|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
170677077|NCT01425281|616831627|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
170677078|NCT01425281|616831626|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
170677079|NCT01425281|616831627|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
170677080|NCT01833520|616831628|FG000|Overall Study|Lack of Efficacy|3|||
170677081|NCT01833520|616831629|FG001|Overall Study|Lack of Efficacy|3|||
170677082|NCT01833520|616831630|FG002|Overall Study|Lack of Efficacy|8|||
170677083|NCT01833520|616831631|FG003|Overall Study|Lack of Efficacy|3|||
170677084|NCT00003479|616831643|FG000|Overall Study|Not evaluable|3|||
170677085|NCT02551731|616831644|FG000|Overall Study|Withdrawal by Subject|2|||
170677086|NCT00982878|616831655|FG000|Overall Study|Physician Decision|1|||
170677087|NCT01854710|616831656|FG000|Overall Study|Withdrawal by Subject|2|||
170677088|NCT01854710|616831657|FG001|Overall Study|Withdrawal by Subject|1|||
170677089|NCT01854710|616831658|FG002|Overall Study|Withdrawal by Subject|0|||
170677090|NCT01854710|616831659|FG003|Overall Study|Withdrawal by Subject|0|||
170677091|NCT01854710|616831660|FG004|Overall Study|Withdrawal by Subject|0|||
170677092|NCT01854710|616831661|FG005|Overall Study|Withdrawal by Subject|0|||
170677093|NCT01854710|616831656|FG000|Overall Study|CRI procedural error|2|||
170677094|NCT01854710|616831657|FG001|Overall Study|CRI procedural error|2|||
170677095|NCT01854710|616831658|FG002|Overall Study|CRI procedural error|2|||
170677096|NCT01854710|616831659|FG003|Overall Study|CRI procedural error|2|||
170677097|NCT01854710|616831660|FG004|Overall Study|CRI procedural error|2|||
170677098|NCT01854710|616831661|FG005|Overall Study|CRI procedural error|2|||
170677099|NCT03132220|616831662|FG000|Overall Study|Lost to Follow-up|17|||
170677100|NCT03132220|616831663|FG001|Overall Study|Lost to Follow-up|8|||
170677101|NCT03132220|616831662|FG000|Overall Study|Withdrawal by Subject|1|||
170677102|NCT03132220|616831663|FG001|Overall Study|Withdrawal by Subject|4|||
170677103|NCT05228132|616831664|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
170677104|NCT05228132|616831664|FG000|Overall Study|Adverse Event|3|||
170677105|NCT05228132|616831664|FG000|Overall Study|Lost to Follow-up|1|||
170677106|NCT05228132|616831664|FG000|Overall Study|Arteriovenous-fistula mature|1|||
170677107|NCT03018704|616831665|FG000|Overall Study|Lost to Follow-up|1|||
170677108|NCT03018704|616831666|FG001|Overall Study|Lost to Follow-up|1|||
170677109|NCT00320411|616831667|FG000|Overall Study|No investigational product admin.|4|||
170677110|NCT00518986|616831670|FG000|Overall Study|Adverse Event|12|||
170677111|NCT00518986|616831671|FG001|Overall Study|Adverse Event|7|||
170677112|NCT00518986|616831670|FG000|Overall Study|Lack of Efficacy|0|||
170677113|NCT00518986|616831671|FG001|Overall Study|Lack of Efficacy|2|||
170677114|NCT00518986|616831670|FG000|Overall Study|Lost to Follow-up|3|||
170677115|NCT00518986|616831671|FG001|Overall Study|Lost to Follow-up|2|||
170677116|NCT00518986|616831670|FG000|Overall Study|Physician Decision|0|||
170677117|NCT00518986|616831671|FG001|Overall Study|Physician Decision|3|||
170677118|NCT00518986|616831670|FG000|Overall Study|Protocol Violation|5|||
170677119|NCT00518986|616831671|FG001|Overall Study|Protocol Violation|7|||
170677120|NCT00518986|616831670|FG000|Overall Study|Withdrawal by Subject|4|||
170677121|NCT00518986|616831671|FG001|Overall Study|Withdrawal by Subject|4|||
170677122|NCT00518986|616831670|FG000|Overall Study|Non-Specific|2|||
170677123|NCT00518986|616831671|FG001|Overall Study|Non-Specific|1|||
170677124|NCT04605484|616831672|FG000|Overall Study|Lost to Follow-up|0|||
170677125|NCT04605484|616831673|FG001|Overall Study|Lost to Follow-up|1|||
170677126|NCT04605484|616831674|FG002|Overall Study|Lost to Follow-up|1|||
170677127|NCT04605484|616831672|FG000|Overall Study|Other|0|||
170677128|NCT04605484|616831673|FG001|Overall Study|Other|1|||
170677129|NCT04605484|616831674|FG002|Overall Study|Other|0|||
170677130|NCT04171531|616831679|FG000|Overall Study|Lost to Follow-up|4|||
170677131|NCT04171531|616831680|FG001|Overall Study|Lost to Follow-up|5|||
170820525|NCT02162771|617349675|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
170820526|NCT02162771|617349674|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
170677132|NCT04171531|616831679|FG000|Overall Study|Consent only through 6 months|1|||
170677133|NCT04171531|616831680|FG001|Overall Study|Consent only through 6 months|1|||
170677134|NCT04171531|616831679|FG000|Overall Study|Insurance did not cover procedure|0|||
170677135|NCT04171531|616831680|FG001|Overall Study|Insurance did not cover procedure|1|||
170677136|NCT04171531|616831679|FG000|Overall Study|Physician Decision|0|||
170677137|NCT04171531|616831680|FG001|Overall Study|Physician Decision|3|||
170677138|NCT04171531|616831679|FG000|Overall Study|Withdrawal by Subject|1|||
170677139|NCT04171531|616831680|FG001|Overall Study|Withdrawal by Subject|5|||
170677140|NCT05537883|616831685|FG000|Overall Study|revisional surgery|4|||
170677141|NCT05537883|616831686|FG001|Overall Study|revisional surgery|2|||
170677142|NCT05537883|616831685|FG000|Overall Study|surgeries were cancelled|0|||
170677143|NCT05537883|616831686|FG001|Overall Study|surgeries were cancelled|2|||
170677144|NCT05537883|616831685|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
170677145|NCT05537883|616831686|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
170677146|NCT03366337|616831687|FG000|Overall Study|Lost to Follow-up|1|||
170677147|NCT03366337|616831688|FG001|Overall Study|Lost to Follow-up|0|||
170677148|NCT03366337|616831689|FG002|Overall Study|Lost to Follow-up|1|||
170677149|NCT03366337|616831690|FG003|Overall Study|Lost to Follow-up|0|||
170677150|NCT03366337|616831687|FG000|Overall Study|Withdrawal by Subject|2|||
170677151|NCT03366337|616831688|FG001|Overall Study|Withdrawal by Subject|0|||
170677152|NCT03366337|616831689|FG002|Overall Study|Withdrawal by Subject|1|||
170677153|NCT03366337|616831690|FG003|Overall Study|Withdrawal by Subject|1|||
170677154|NCT05288062|616831691|FG000|Overall Study|Ineligible|0|||
170677155|NCT05288062|616831692|FG001|Overall Study|Ineligible|0|||
170677156|NCT05288062|616831693|FG002|Overall Study|Ineligible|1|||
170677157|NCT05288062|616831694|FG003|Overall Study|Ineligible|0|||
170677158|NCT05288062|616831691|FG000|Overall Study|Withdrawal by Subject|0|||
170677159|NCT05288062|616831692|FG001|Overall Study|Withdrawal by Subject|0|||
170677160|NCT05288062|616831693|FG002|Overall Study|Withdrawal by Subject|1|||
170677161|NCT05288062|616831694|FG003|Overall Study|Withdrawal by Subject|0|||
170677162|NCT02296320|616831696|FG000|Overall Study|Withdrawal by Subject|4|||
170677163|NCT02296320|616831697|FG001|Overall Study|Withdrawal by Subject|0|||
170677164|NCT02296320|616831698|FG002|Overall Study|Withdrawal by Subject|2|||
170677165|NCT02296320|616831696|FG000|Overall Study|Death|24|||
170677166|NCT02296320|616831697|FG001|Overall Study|Death|3|||
170677167|NCT02296320|616831698|FG002|Overall Study|Death|27|||
170677168|NCT02296320|616831696|FG000|Overall Study|Lost to Follow-up|5|||
170677169|NCT02296320|616831697|FG001|Overall Study|Lost to Follow-up|2|||
170677170|NCT02296320|616831698|FG002|Overall Study|Lost to Follow-up|7|||
170677171|NCT02296320|616831696|FG000|Overall Study|Not treated|2|||
170677172|NCT02296320|616831697|FG001|Overall Study|Not treated|0|||
170677173|NCT02296320|616831698|FG002|Overall Study|Not treated|0|||
170677174|NCT02296320|616831696|FG000|Overall Study|Not - specified|0|||
170677175|NCT02296320|616831697|FG001|Overall Study|Not - specified|0|||
170677176|NCT02296320|616831698|FG002|Overall Study|Not - specified|1|||
170677177|NCT05229406|616831702|FG000|Overall Study|Withdrawal by Subject|1|||
170677178|NCT05229406|616831703|FG001|Overall Study|Withdrawal by Subject|2|||
170677179|NCT01930123|616831706|FG000|Overall Study|Adverse Event|1|||
170677180|NCT01930123|616831707|FG001|Overall Study|Adverse Event|0|||
170677181|NCT01930123|616831706|FG000|Overall Study|Physician Decision|21|||
170677182|NCT01930123|616831707|FG001|Overall Study|Physician Decision|8|||
170677183|NCT01930123|616831706|FG000|Overall Study|Withdrawal by Subject|1|||
170677184|NCT01930123|616831707|FG001|Overall Study|Withdrawal by Subject|0|||
170677185|NCT01578187|616831708|FG000|Usability Phase|Withdrawal by Subject|1|||
170677186|NCT01709162|616831710|FG000|Overall Study|Disease progression|3|||
170677187|NCT01709162|616831711|FG001|Overall Study|Disease progression|3|||
170677188|NCT01709162|616831710|FG000|Overall Study|Study drug toxicity|2|||
170677189|NCT01709162|616831711|FG001|Overall Study|Study drug toxicity|0|||
170677190|NCT01709162|616831710|FG000|Overall Study|Administrative reason by sponsor|0|||
170677191|NCT01709162|616831711|FG001|Overall Study|Administrative reason by sponsor|1|||
170677192|NCT01709162|616831710|FG000|Overall Study|Other|1|||
170677193|NCT01709162|616831711|FG001|Overall Study|Other|0|||
170677194|NCT01709162|616831710|FG000|Overall Study|Withdrawal by Subject|0|||
170677195|NCT01709162|616831711|FG001|Overall Study|Withdrawal by Subject|1|||
170677196|NCT00729651|616831713|FG000|Overall Study|Withdrawal by Subject|5|||
170677197|NCT00729651|616831714|FG001|Overall Study|Withdrawal by Subject|6|||
170677198|NCT00729651|616831713|FG000|Overall Study|Lost to Follow-up|5|||
170677199|NCT00729651|616831714|FG001|Overall Study|Lost to Follow-up|4|||
170677200|NCT00729651|616831713|FG000|Overall Study|Protocol Violation|0|||
170677201|NCT00729651|616831714|FG001|Overall Study|Protocol Violation|1|||
170677202|NCT00729651|616831713|FG000|Overall Study|Adverse Event|7|||
170677203|NCT00729651|616831714|FG001|Overall Study|Adverse Event|3|||
170677204|NCT00729651|616831713|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
170677205|NCT00729651|616831714|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
170677206|NCT00729651|616831713|FG000|Overall Study|Subject's private reason|2|||
170677207|NCT00729651|616831714|FG001|Overall Study|Subject's private reason|0|||
170677208|NCT03310021|616831715|FG000|Overall Study|Withdrawal by Subject|0|||
170677209|NCT03310021|616831716|FG001|Overall Study|Withdrawal by Subject|0|||
170677210|NCT03310021|616831717|FG002|Overall Study|Withdrawal by Subject|0|||
170677211|NCT03310021|616831718|FG003|Overall Study|Withdrawal by Subject|0|||
170677212|NCT03310021|616831719|FG004|Overall Study|Withdrawal by Subject|0|||
170677213|NCT03310021|616831720|FG005|Overall Study|Withdrawal by Subject|0|||
170677214|NCT03310021|616831721|FG006|Overall Study|Withdrawal by Subject|1|||
170677215|NCT03310021|616831722|FG007|Overall Study|Withdrawal by Subject|0|||
170677216|NCT03310021|616831723|FG008|Overall Study|Withdrawal by Subject|0|||
170677217|NCT03310021|616831724|FG009|Overall Study|Withdrawal by Subject|0|||
170677218|NCT03310021|616831725|FG010|Overall Study|Withdrawal by Subject|0|||
170677219|NCT03310021|616831726|FG011|Overall Study|Withdrawal by Subject|0|||
170677220|NCT03310021|616831727|FG012|Overall Study|Withdrawal by Subject|0|||
170677221|NCT03310021|616831728|FG013|Overall Study|Withdrawal by Subject|0|||
170677222|NCT03310021|616831729|FG014|Overall Study|Withdrawal by Subject|0|||
170677223|NCT03310021|616831730|FG015|Overall Study|Withdrawal by Subject|0|||
170677224|NCT03310021|616831731|FG016|Overall Study|Withdrawal by Subject|0|||
170677225|NCT03310021|616831732|FG017|Overall Study|Withdrawal by Subject|0|||
170677226|NCT03310021|616831733|FG018|Overall Study|Withdrawal by Subject|0|||
170677227|NCT03310021|616831734|FG019|Overall Study|Withdrawal by Subject|0|||
170677228|NCT03310021|616831715|FG000|Overall Study|Lost to Follow-up|0|||
170677229|NCT03310021|616831716|FG001|Overall Study|Lost to Follow-up|0|||
170677230|NCT03310021|616831717|FG002|Overall Study|Lost to Follow-up|0|||
170677231|NCT03310021|616831718|FG003|Overall Study|Lost to Follow-up|0|||
170677232|NCT03310021|616831719|FG004|Overall Study|Lost to Follow-up|0|||
170677233|NCT03310021|616831720|FG005|Overall Study|Lost to Follow-up|0|||
170677234|NCT03310021|616831721|FG006|Overall Study|Lost to Follow-up|0|||
170677235|NCT03310021|616831722|FG007|Overall Study|Lost to Follow-up|0|||
170677236|NCT03310021|616831723|FG008|Overall Study|Lost to Follow-up|0|||
170677237|NCT03310021|616831724|FG009|Overall Study|Lost to Follow-up|0|||
170677238|NCT03310021|616831725|FG010|Overall Study|Lost to Follow-up|1|||
170677239|NCT03310021|616831726|FG011|Overall Study|Lost to Follow-up|0|||
170677240|NCT03310021|616831727|FG012|Overall Study|Lost to Follow-up|0|||
170677241|NCT03310021|616831728|FG013|Overall Study|Lost to Follow-up|0|||
170677242|NCT03310021|616831729|FG014|Overall Study|Lost to Follow-up|0|||
170677243|NCT03310021|616831730|FG015|Overall Study|Lost to Follow-up|0|||
170677244|NCT03310021|616831731|FG016|Overall Study|Lost to Follow-up|0|||
170677245|NCT03310021|616831732|FG017|Overall Study|Lost to Follow-up|0|||
170677246|NCT03310021|616831733|FG018|Overall Study|Lost to Follow-up|0|||
170677247|NCT03310021|616831734|FG019|Overall Study|Lost to Follow-up|0|||
170677248|NCT01874054|616831735|FG000|Overall Study|Withdrawal by Subject|3|||
170677249|NCT01874054|616831735|FG000|Overall Study|Study Termination by Sponsor|42|||
170677250|NCT01874054|616831735|FG000|Overall Study|Lost to Follow-up|5|||
170677251|NCT01874054|616831735|FG000|Overall Study|Death|5|||
170677252|NCT03953820|616831736|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
170677253|NCT03953820|616831737|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
170677254|NCT03953820|616831738|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
170677255|NCT03953820|616831736|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
170677256|NCT03953820|616831737|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
170677257|NCT03953820|616831738|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
170677258|NCT00530946|616831741|FG000|Overall Study|Adverse Event|1|||
170677259|NCT00530946|616831742|FG001|Overall Study|Adverse Event|2|||
170677260|NCT00530946|616831743|FG002|Overall Study|Adverse Event|1|||
170677261|NCT00530946|616831744|FG003|Overall Study|Adverse Event|1|||
170677262|NCT00530946|616831741|FG000|Overall Study|Protocol Violation|0|||
170677263|NCT00530946|616831742|FG001|Overall Study|Protocol Violation|0|||
170677264|NCT00530946|616831743|FG002|Overall Study|Protocol Violation|0|||
170677265|NCT00530946|616831744|FG003|Overall Study|Protocol Violation|1|||
170677266|NCT00530946|616831741|FG000|Overall Study|Noncompliance|1|||
170677267|NCT00530946|616831742|FG001|Overall Study|Noncompliance|0|||
170677268|NCT00530946|616831743|FG002|Overall Study|Noncompliance|0|||
170677269|NCT00530946|616831744|FG003|Overall Study|Noncompliance|0|||
170677270|NCT05399641|616831751|FG000|Overall Study|Adverse Event|0|||
170677271|NCT05399641|616831752|FG001|Overall Study|Adverse Event|1|||
170677272|NCT05399641|616831753|FG002|Overall Study|Adverse Event|1|||
170677273|NCT05399641|616831751|FG000|Overall Study|Lost to Follow-up|1|||
170677274|NCT05399641|616831752|FG001|Overall Study|Lost to Follow-up|2|||
170677275|NCT05399641|616831753|FG002|Overall Study|Lost to Follow-up|2|||
170677276|NCT05399641|616831751|FG000|Overall Study|Physician Decision|1|||
170677277|NCT05399641|616831752|FG001|Overall Study|Physician Decision|3|||
170677278|NCT05399641|616831753|FG002|Overall Study|Physician Decision|3|||
170677279|NCT05399641|616831751|FG000|Overall Study|Withdrawal by Subject|4|||
170677280|NCT05399641|616831752|FG001|Overall Study|Withdrawal by Subject|11|||
170677281|NCT05399641|616831753|FG002|Overall Study|Withdrawal by Subject|7|||
170677282|NCT05399641|616831751|FG000|Overall Study|Reason not defined|3|||
170820527|NCT02162771|617349675|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
170677283|NCT05399641|616831752|FG001|Overall Study|Reason not defined|5|||
170677284|NCT05399641|616831753|FG002|Overall Study|Reason not defined|6|||
170677285|NCT01269463|616831754|FG000|First Intervention|Withdrawal by Subject|1|||
170677286|NCT01269463|616831755|FG001|First Intervention|Withdrawal by Subject|0|||
170677287|NCT01269463|616831754|FG000|First Intervention|Adverse Event|1|||
170677288|NCT01269463|616831755|FG001|First Intervention|Adverse Event|0|||
170677289|NCT01269463|616831754|FG000|First Intervention|Lack of Efficacy|0|||
170677290|NCT01269463|616831755|FG001|First Intervention|Lack of Efficacy|1|||
170677291|NCT01269463|616831754|FG000|First Intervention|Physician Decision|0|||
170677292|NCT01269463|616831755|FG001|First Intervention|Physician Decision|1|||
170677293|NCT00279305|616831756|FG000|Overall Study|Pregnancy|1|||
170677294|NCT00279305|616831757|FG001|Overall Study|Pregnancy|0|||
170677295|NCT00279305|616831756|FG000|Overall Study|Withdrawal by Subject|2|||
170677296|NCT00279305|616831757|FG001|Overall Study|Withdrawal by Subject|0|||
170677297|NCT00279305|616831756|FG000|Overall Study|Dificulting establishing IV|1|||
170677298|NCT00279305|616831757|FG001|Overall Study|Dificulting establishing IV|0|||
170677299|NCT00279305|616831756|FG000|Overall Study|FDA Safety Alert|4|||
170677300|NCT00279305|616831757|FG001|Overall Study|FDA Safety Alert|1|||
170677301|NCT05358444|616831758|FG000|Overall Study|Withdrawal by Subject|0|||
170677302|NCT05358444|616831759|FG001|Overall Study|Withdrawal by Subject|1|||
170677303|NCT05358444|616831758|FG000|Overall Study|Lost to Follow-up|0|||
170677304|NCT05358444|616831759|FG001|Overall Study|Lost to Follow-up|3|||
170677305|NCT02993146|616831761|FG000|Overall Study|Withdrawal by Subject|0|||
170677306|NCT02993146|616831762|FG001|Overall Study|Withdrawal by Subject|0|||
170677307|NCT02993146|616831763|FG002|Overall Study|Withdrawal by Subject|1|||
170677308|NCT02993146|616831764|FG003|Overall Study|Withdrawal by Subject|1|||
170677309|NCT02674529|616833318|FG000|Overall Study|Lost to Follow-up|1|||
170677310|NCT02674529|616833319|FG001|Overall Study|Lost to Follow-up|2|||
170677311|NCT02674529|616833318|FG000|Overall Study|Withdrawal by Subject|2|||
170677312|NCT02674529|616833319|FG001|Overall Study|Withdrawal by Subject|1|||
170677313|NCT02674529|616833318|FG000|Overall Study|Physician Decision|0|||
170677314|NCT02674529|616833319|FG001|Overall Study|Physician Decision|1|||
170677315|NCT02674529|616833318|FG000|Overall Study|Protocol Violation|0|||
170677316|NCT02674529|616833319|FG001|Overall Study|Protocol Violation|1|||
170677317|NCT03761277|616833323|FG000|Enrollment to Implant|Screen Failure|17|||
170677318|NCT03761277|616833323|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
170677319|NCT03761277|616833323|FG000|Enrollment to Implant|Physician Decision|2|||
170677320|NCT03761277|616833323|FG000|Enrollment to Implant|Site Closure|3|||
170677321|NCT03761277|616833323|FG000|Enrollment to Implant|Sponsor Request|2|||
170677322|NCT03761277|616833323|FG000|Post-Implant to 6 Months|Adverse Event|2|||
170677323|NCT03761277|616833323|FG000|Post-Implant to 6 Months|Death|1|||
170677324|NCT03761277|616833323|FG000|Post-Implant to 6 Months|Site Closure|2|||
170677325|NCT03761277|616833323|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
170677326|NCT03761277|616833323|FG000|6 Months to 12 Months|Physician Decision|2|||
170677327|NCT03761277|616833323|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
170677328|NCT04532164|616833328|FG000|Overall Study|Adverse Event|1|||
170677329|NCT04532164|616833328|FG000|Overall Study|Protocol Violation|5|||
170677330|NCT04532164|616833328|FG000|Overall Study|Lost to Follow-up|1|||
170677331|NCT04532164|616833328|FG000|Overall Study|Found to be Ineligible|3|||
170677332|NCT04532164|616833328|FG000|Overall Study|Withdrawal by Subject|14|||
170677333|NCT02483520|616833329|FG000|Overall Study|Lost to Follow-up|3|||
170677334|NCT02483520|616833330|FG001|Overall Study|Lost to Follow-up|4|||
170677335|NCT02483520|616833329|FG000|Overall Study|Withdrawal by Subject|4|||
170677336|NCT02483520|616833330|FG001|Overall Study|Withdrawal by Subject|14|||
170677337|NCT02483520|616833329|FG000|Overall Study|Hospitalized|2|||
170677338|NCT02483520|616833330|FG001|Overall Study|Hospitalized|3|||
170677339|NCT02483520|616833329|FG000|Overall Study|Moved to LTC|2|||
170677340|NCT02483520|616833330|FG001|Overall Study|Moved to LTC|3|||
170677341|NCT00411645|616833333|FG000|Overall Study|Consent Withdrawn|13|||
170677342|NCT00411645|616833334|FG001|Overall Study|Consent Withdrawn|22|||
170677343|NCT00411645|616833333|FG000|Overall Study|Death|56|||
170677344|NCT00411645|616833334|FG001|Overall Study|Death|135|||
170677345|NCT00411645|616833333|FG000|Overall Study|Investigator/Sponsor Decision|10|||
170677346|NCT00411645|616833334|FG001|Overall Study|Investigator/Sponsor Decision|7|||
170677347|NCT00411645|616833333|FG000|Overall Study|Lost to Follow-up|2|||
170677348|NCT00411645|616833334|FG001|Overall Study|Lost to Follow-up|0|||
170677349|NCT01697566|616833346|FG000|Overall Study|Withdrawal by Subject|0|||
170677350|NCT01697566|616833347|FG001|Overall Study|Withdrawal by Subject|0|||
170677351|NCT01697566|616833348|FG002|Overall Study|Withdrawal by Subject|1|||
170677352|NCT01697566|616833349|FG003|Overall Study|Withdrawal by Subject|1|||
170677353|NCT01697566|616833346|FG000|Overall Study|Final biopsy not obtained|0|||
170677354|NCT01697566|616833347|FG001|Overall Study|Final biopsy not obtained|0|||
170677355|NCT01697566|616833348|FG002|Overall Study|Final biopsy not obtained|1|||
170677356|NCT01697566|616833349|FG003|Overall Study|Final biopsy not obtained|0|||
170677357|NCT02516163|616833354|FG000|Overall Study|Withdrawal by Subject|1|||
170677358|NCT02516163|616833354|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
170677359|NCT02516163|616833354|FG000|Overall Study|Unfit/delay in surgery|3|||
170677360|NCT02516163|616833354|FG000|Overall Study|Use of incorrect measurement technique|5|||
170677361|NCT02516163|616833354|FG000|Overall Study|Data not recorded|2|||
170677362|NCT02516163|616833354|FG000|Overall Study|MRI contraindication exclusion|6|||
170677363|NCT01217814|616833355|FG000|Overall Study|Adverse Event|1|||
170677364|NCT01217814|616833356|FG001|Overall Study|Adverse Event|1|||
170677365|NCT01217814|616833357|FG002|Overall Study|Adverse Event|0|||
170677366|NCT01217814|616833355|FG000|Overall Study|Lack of Efficacy|0|||
170677367|NCT01217814|616833356|FG001|Overall Study|Lack of Efficacy|0|||
170677368|NCT01217814|616833357|FG002|Overall Study|Lack of Efficacy|1|||
170677369|NCT01370356|616833358|FG000|Overall Study|Death|1|||
170677370|NCT01370356|616833359|FG001|Overall Study|Death|0|||
170677371|NCT01370356|616833358|FG000|Overall Study|Lack of Efficacy|6|||
170677372|NCT01370356|616833359|FG001|Overall Study|Lack of Efficacy|28|||
170677373|NCT01370356|616833358|FG000|Overall Study|Lost to Follow-up|76|||
170677374|NCT01370356|616833359|FG001|Overall Study|Lost to Follow-up|81|||
170677375|NCT01370356|616833358|FG000|Overall Study|Withdrawal by Subject|54|||
170677376|NCT01370356|616833359|FG001|Overall Study|Withdrawal by Subject|59|||
170677377|NCT01370356|616833358|FG000|Overall Study|Reason not specified|39|||
170677378|NCT01370356|616833359|FG001|Overall Study|Reason not specified|43|||
170677379|NCT01370356|616833358|FG000|Overall Study|Protocol Violation|3|||
170677380|NCT01370356|616833359|FG001|Overall Study|Protocol Violation|3|||
170677381|NCT01370356|616833358|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
170677382|NCT01370356|616833359|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
170677383|NCT01370356|616833358|FG000|Overall Study|AE Not Related to Study Drug|1|||
170677384|NCT01370356|616833359|FG001|Overall Study|AE Not Related to Study Drug|4|||
170677385|NCT01658072|616833362|FG000|Overall Study|Protocol Violation|4|||
170677386|NCT01658072|616833363|FG001|Overall Study|Protocol Violation|2|||
170677387|NCT01128842|616833368|FG000|Overall Study|Adverse Event|1|||
170677388|NCT01128842|616833368|FG000|Overall Study|Disease Progression|6|||
170677389|NCT01844518|616833370|FG000|Overall Study|Adverse Event|7|||
170677390|NCT01844518|616833371|FG001|Overall Study|Adverse Event|1|||
170677391|NCT01844518|616833370|FG000|Overall Study|Lack of Efficacy|17|||
170677392|NCT01844518|616833371|FG001|Overall Study|Lack of Efficacy|5|||
170677393|NCT01844518|616833370|FG000|Overall Study|Participant's request to discontinue|4|||
170677394|NCT01844518|616833371|FG001|Overall Study|Participant's request to discontinue|1|||
170677395|NCT01844518|616833370|FG000|Overall Study|Poor/Non-compliance|1|||
170677396|NCT01844518|616833371|FG001|Overall Study|Poor/Non-compliance|0|||
170677397|NCT01844518|616833370|FG000|Overall Study|No Longer Met Study Criteria|2|||
170677398|NCT01844518|616833371|FG001|Overall Study|No Longer Met Study Criteria|0|||
170677399|NCT01844518|616833370|FG000|Overall Study|Withdrawal by Subject|9|||
170677400|NCT01844518|616833371|FG001|Overall Study|Withdrawal by Subject|0|||
170677401|NCT01844518|616833370|FG000|Overall Study|Pregnancy|1|||
170677402|NCT01844518|616833371|FG001|Overall Study|Pregnancy|0|||
170677403|NCT01300650|616833372|FG000|Overall Study|Adverse Event|1|||
170677404|NCT01496612|616833373|FG000|1st Intervention|Adverse Event|1|||
170677405|NCT01496612|616833374|FG001|1st Intervention|Adverse Event|0|||
170677406|NCT01496612|616833373|FG000|1st Intervention|Withdrawal by Subject|1|||
170677407|NCT01496612|616833374|FG001|1st Intervention|Withdrawal by Subject|0|||
170677408|NCT03845985|616833381|FG000|Overall Study|Lost to Follow-up|2|||
170677409|NCT03845985|616833382|FG001|Overall Study|Lost to Follow-up|1|||
170677410|NCT03845985|616833381|FG000|Overall Study|Physician Decision|1|||
170677411|NCT03845985|616833382|FG001|Overall Study|Physician Decision|0|||
170677412|NCT03845985|616833381|FG000|Overall Study|Withdrawal by Subject|4|||
170677413|NCT03845985|616833382|FG001|Overall Study|Withdrawal by Subject|1|||
170677414|NCT02756013|616833383|FG000|Overall Study|Adverse Event|1|||
170677415|NCT02756013|616833383|FG000|Overall Study|Hypersensitivity|1|||
170677416|NCT01318993|616833384|FG000|Overall Study|Adverse Event|53|||
170677417|NCT01318993|616833384|FG000|Overall Study|Lack of Efficacy|121|||
170677418|NCT01318993|616833384|FG000|Overall Study|Protocol Violation|3|||
170677419|NCT01318993|616833384|FG000|Overall Study|Protocol based stopping criteria|6|||
170677420|NCT01318993|616833384|FG000|Overall Study|Study closed or terminated|174|||
170677421|NCT01318993|616833384|FG000|Overall Study|Lost to Follow-up|4|||
170677422|NCT01318993|616833384|FG000|Overall Study|Physician Decision|13|||
170677423|NCT01318993|616833384|FG000|Overall Study|Withdrawal by Subject|24|||
170677424|NCT03926169|616833385|FG000|Period A|Adverse Event|2|||
170677425|NCT03926169|616833386|FG001|Period A|Adverse Event|2|||
170677426|NCT03926169|616833387|FG002|Period A|Adverse Event|1|||
170677427|NCT03926169|616833385|FG000|Period A|Withdrawal by Subject|2|||
170677428|NCT03926169|616833386|FG001|Period A|Withdrawal by Subject|2|||
170677429|NCT03926169|616833387|FG002|Period A|Withdrawal by Subject|2|||
170677430|NCT03926169|616833385|FG000|Period A|Lost to Follow-up|3|||
170677431|NCT03926169|616833386|FG001|Period A|Lost to Follow-up|1|||
170677432|NCT03926169|616833387|FG002|Period A|Lost to Follow-up|0|||
170677433|NCT03926169|616833385|FG000|Period A|Lack of Efficacy|0|||
170677434|NCT03926169|616833386|FG001|Period A|Lack of Efficacy|2|||
170677435|NCT03926169|616833387|FG002|Period A|Lack of Efficacy|2|||
170677436|NCT03926169|616833385|FG000|Period A|COVID-19 Infection|0|||
170677437|NCT03926169|616833386|FG001|Period A|COVID-19 Infection|1|||
170677438|NCT03926169|616833387|FG002|Period A|COVID-19 Infection|0|||
170677439|NCT03926169|616833385|FG000|Period A|COVID-19 Logistical Restrictions|0|||
170677440|NCT03926169|616833386|FG001|Period A|COVID-19 Logistical Restrictions|2|||
170677441|NCT03926169|616833387|FG002|Period A|COVID-19 Logistical Restrictions|1|||
170677442|NCT03926169|616833385|FG000|Period A|Other, Not Specified|1|||
170677443|NCT03926169|616833386|FG001|Period A|Other, Not Specified|0|||
170677444|NCT03926169|616833387|FG002|Period A|Other, Not Specified|0|||
170677445|NCT03926169|616833385|FG000|Period B|Adverse Event|3|||
170677446|NCT03926169|616833386|FG001|Period B|Adverse Event|1|||
170677447|NCT03926169|616833387|FG002|Period B|Adverse Event|1|||
170677448|NCT03926169|616833385|FG000|Period B|Withdrawal by Subject|1|||
170677449|NCT03926169|616833386|FG001|Period B|Withdrawal by Subject|3|||
170677450|NCT03926169|616833387|FG002|Period B|Withdrawal by Subject|0|||
170677451|NCT03926169|616833385|FG000|Period B|Lack of Efficacy|3|||
170677452|NCT03926169|616833386|FG001|Period B|Lack of Efficacy|1|||
170677453|NCT03926169|616833387|FG002|Period B|Lack of Efficacy|1|||
170677454|NCT03926169|616833385|FG000|Period B|Lost to Follow-up|1|||
170677455|NCT03926169|616833386|FG001|Period B|Lost to Follow-up|1|||
170677456|NCT03926169|616833387|FG002|Period B|Lost to Follow-up|4|||
170677457|NCT03926169|616833385|FG000|Period B|Other, Not Specified|62|||
170677458|NCT03926169|616833386|FG001|Period B|Other, Not Specified|57|||
170677459|NCT03926169|616833387|FG002|Period B|Other, Not Specified|65|||
170677460|NCT03334539|616833388|FG000|Overall Study|Adverse Event|3|||
170677461|NCT03334539|616833389|FG001|Overall Study|Adverse Event|5|||
170677462|NCT03334539|616833390|FG002|Overall Study|Adverse Event|0|||
170677463|NCT03334539|616833388|FG000|Overall Study|Withdrawal by Subject|0|||
170677464|NCT03334539|616833389|FG001|Overall Study|Withdrawal by Subject|1|||
170677465|NCT03334539|616833390|FG002|Overall Study|Withdrawal by Subject|1|||
170677466|NCT03334539|616833388|FG000|Overall Study|Administrative Reasons|1|||
170677467|NCT03334539|616833389|FG001|Overall Study|Administrative Reasons|0|||
170677468|NCT03334539|616833390|FG002|Overall Study|Administrative Reasons|0|||
170677469|NCT03334539|616833388|FG000|Overall Study|Hypertension Not Controlled|0|||
170677470|NCT03334539|616833389|FG001|Overall Study|Hypertension Not Controlled|1|||
170677471|NCT03334539|616833390|FG002|Overall Study|Hypertension Not Controlled|0|||
170677472|NCT00968201|616833391|FG000|Base Study - (Period II)|Adverse Event|8|||
170677473|NCT00968201|616833392|FG001|Base Study - (Period II)|Adverse Event|0|||
170677474|NCT00968201|616833393|FG002|Base Study - (Period II)|Adverse Event|16|||
170677475|NCT00968201|616833391|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
170677476|NCT00968201|616833392|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
170677477|NCT00968201|616833393|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
170677478|NCT00968201|616833391|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
170677479|NCT00968201|616833392|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
170677480|NCT00968201|616833393|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
170677481|NCT00968201|616833391|FG000|Base Study - (Period II)|Protocol Violation|12|||
170677482|NCT00968201|616833392|FG001|Base Study - (Period II)|Protocol Violation|0|||
170677483|NCT00968201|616833393|FG002|Base Study - (Period II)|Protocol Violation|12|||
170677484|NCT00968201|616833391|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
170677485|NCT00968201|616833392|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
170677486|NCT00968201|616833393|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
170677487|NCT00968201|616833391|FG000|Base Study - (Period II)|Site Error|0|||
170677488|NCT00968201|616833392|FG001|Base Study - (Period II)|Site Error|0|||
170677489|NCT00968201|616833393|FG002|Base Study - (Period II)|Site Error|1|||
170677490|NCT00968201|616833391|FG000|Extension Study - (Period III)|Adverse Event|0|||
170677491|NCT00968201|616833392|FG001|Extension Study - (Period III)|Adverse Event|5|||
170677492|NCT00968201|616833393|FG002|Extension Study - (Period III)|Adverse Event|22|||
170677493|NCT00968201|616833391|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
170677494|NCT00968201|616833392|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
170677495|NCT00968201|616833393|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
170677496|NCT00968201|616833391|FG000|Extension Study - (Period III)|Protocol Violation|0|||
170677497|NCT00968201|616833392|FG001|Extension Study - (Period III)|Protocol Violation|17|||
170677498|NCT00968201|616833393|FG002|Extension Study - (Period III)|Protocol Violation|14|||
170677499|NCT00968201|616833391|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
170677500|NCT00968201|616833392|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
170677501|NCT00968201|616833393|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
170677502|NCT00968201|616833391|FG000|Extension Study - (Period III)|Patient Relocated|0|||
170677503|NCT00968201|616833392|FG001|Extension Study - (Period III)|Patient Relocated|1|||
170677504|NCT00968201|616833393|FG002|Extension Study - (Period III)|Patient Relocated|1|||
170677505|NCT00968201|616833391|FG000|Extension Study - (Period III)|Noncompliance|0|||
170677506|NCT00968201|616833392|FG001|Extension Study - (Period III)|Noncompliance|0|||
170677507|NCT00968201|616833393|FG002|Extension Study - (Period III)|Noncompliance|3|||
170677508|NCT00968201|616833391|FG000|Extension Study - (Period III)|Other|0|||
170677509|NCT00968201|616833392|FG001|Extension Study - (Period III)|Other|0|||
170677510|NCT00968201|616833393|FG002|Extension Study - (Period III)|Other|2|||
170677511|NCT00968201|616833391|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
170677512|NCT00968201|616833392|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
170677513|NCT00968201|616833393|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
170677514|NCT04974697|616833397|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
170677515|NCT04974697|616833397|FG000|Overall Study|Lens discomfort|1|||
170677516|NCT03706456|616833398|FG000|Overall Study|Adverse Event|1|||
170677517|NCT03706456|616833398|FG000|Overall Study|Lack of Efficacy|2|||
170677518|NCT03302234|616833399|FG000|Overall Study|Death|191|||
170677519|NCT03302234|616833400|FG001|Overall Study|Death|192|||
170677520|NCT03302234|616833399|FG000|Overall Study|Withdrawal by Subject|2|||
170677521|NCT03302234|616833400|FG001|Overall Study|Withdrawal by Subject|2|||
170677522|NCT03302234|616833399|FG000|Overall Study|Sponsor Decision|90|||
170677523|NCT03302234|616833400|FG001|Overall Study|Sponsor Decision|89|||
170677524|NCT03302234|616833399|FG000|Overall Study|Laryngeal carcinoma|0|||
170677525|NCT03302234|616833400|FG001|Overall Study|Laryngeal carcinoma|1|||
170677526|NCT03302234|616833399|FG000|Overall Study|Not Reported|1|||
170677527|NCT03302234|616833400|FG001|Overall Study|Not Reported|0|||
170677528|NCT04112784|616833402|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
170677529|NCT04112784|616833402|FG000|Overall Study|Screen Failures|4|||
170677530|NCT00221403|616833404|FG000|Overall Study|Protocol Violation|1|||
170677531|NCT00221403|616833405|FG001|Overall Study|Protocol Violation|0|||
170677532|NCT00221403|616833406|FG002|Overall Study|Protocol Violation|0|||
170677533|NCT00221403|616833404|FG000|Overall Study|Physician Decision|1|||
170677534|NCT00221403|616833405|FG001|Overall Study|Physician Decision|0|||
170677535|NCT00221403|616833406|FG002|Overall Study|Physician Decision|0|||
170677536|NCT00221403|616833404|FG000|Overall Study|Withdrawal by Subject|0|||
170677537|NCT00221403|616833405|FG001|Overall Study|Withdrawal by Subject|3|||
170677538|NCT00221403|616833406|FG002|Overall Study|Withdrawal by Subject|0|||
170677539|NCT00221403|616833404|FG000|Overall Study|Lack of Efficacy|0|||
170677540|NCT00221403|616833405|FG001|Overall Study|Lack of Efficacy|1|||
170677541|NCT00221403|616833406|FG002|Overall Study|Lack of Efficacy|0|||
170677542|NCT00221403|616833404|FG000|Overall Study|Adverse Event|0|||
170677543|NCT00221403|616833405|FG001|Overall Study|Adverse Event|1|||
170677544|NCT00221403|616833406|FG002|Overall Study|Adverse Event|0|||
170677545|NCT02010775|616833408|FG000|Overall Study|Adverse Event|0|||
170677546|NCT02010775|616833409|FG001|Overall Study|Adverse Event|0|||
170677547|NCT02010775|616833410|FG002|Overall Study|Adverse Event|0|||
170677548|NCT02010775|616833411|FG003|Overall Study|Adverse Event|0|||
170677549|NCT02010775|616833412|FG004|Overall Study|Adverse Event|1|||
170677550|NCT02010775|616833408|FG000|Overall Study|Pregnancy|0|||
170677551|NCT02010775|616833409|FG001|Overall Study|Pregnancy|0|||
170677552|NCT02010775|616833410|FG002|Overall Study|Pregnancy|2|||
170677553|NCT02010775|616833411|FG003|Overall Study|Pregnancy|0|||
170677554|NCT02010775|616833412|FG004|Overall Study|Pregnancy|0|||
170677555|NCT02010775|616833408|FG000|Overall Study|Lost to Follow-up|2|||
170677556|NCT02010775|616833409|FG001|Overall Study|Lost to Follow-up|0|||
170677557|NCT02010775|616833410|FG002|Overall Study|Lost to Follow-up|0|||
170677558|NCT02010775|616833411|FG003|Overall Study|Lost to Follow-up|1|||
170677559|NCT02010775|616833412|FG004|Overall Study|Lost to Follow-up|1|||
170677560|NCT02010775|616833408|FG000|Overall Study|Personal Reasons|3|||
170820528|NCT02162771|617349674|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
170820529|NCT02162771|617349675|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
170820530|NCT01047306|617349679|FG000|Overall Study|Withdrawal by Subject|2|||
170820531|NCT01047306|617349680|FG001|Overall Study|Withdrawal by Subject|0|||
170820532|NCT01047306|617349679|FG000|Overall Study|Lost to Follow-up|1|||
170820533|NCT01047306|617349680|FG001|Overall Study|Lost to Follow-up|0|||
170820534|NCT01878253|617349681|FG000|Overall Study|Death|1|||
170820535|NCT01878253|617349681|FG000|Overall Study|SIdus System Removal|3|||
170820536|NCT01878253|617349681|FG000|Overall Study|Withdrawal by Subject|1|||
170820537|NCT01878253|617349681|FG000|Overall Study|Lost to Follow-up|2|||
170820538|NCT01878253|617349681|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
170820539|NCT01721109|617349682|FG000|Overall Study|Lack of Efficacy|1|||
170820540|NCT01721109|617349682|FG000|Overall Study|Non- Compliance with Study Drug|3|||
170820541|NCT01721109|617349682|FG000|Overall Study|Withdrew Consent|1|||
170677561|NCT02010775|616833409|FG001|Overall Study|Personal Reasons|3|||
170677562|NCT02010775|616833410|FG002|Overall Study|Personal Reasons|1|||
170677563|NCT02010775|616833411|FG003|Overall Study|Personal Reasons|2|||
170820542|NCT01721109|617349682|FG000|Overall Study|Lost to Follow-up|2|||
170820543|NCT05287178|617349683|FG000|Overall Study|Lost to Follow-up|2|||
170820544|NCT01426217|617349684|FG000|Overall Study|lost sample|8|||
170677564|NCT02010775|616833412|FG004|Overall Study|Personal Reasons|4|||
170677565|NCT00256750|616833413|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
170677566|NCT00256750|616833414|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
170677567|NCT00256750|616833415|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
170677568|NCT00256750|616833413|FG000|Transplanted Pre-Treatment|Other|2|||
170677569|NCT00256750|616833414|FG001|Transplanted Pre-Treatment|Other|0|||
170677570|NCT00256750|616833415|FG002|Transplanted Pre-Treatment|Other|0|||
170677571|NCT00256750|616833413|FG000|Transplanted Pre-Treatment|Death|1|||
170677572|NCT00256750|616833414|FG001|Transplanted Pre-Treatment|Death|0|||
170677573|NCT00256750|616833415|FG002|Transplanted Pre-Treatment|Death|0|||
170677574|NCT00256750|616833413|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
170677575|NCT00256750|616833414|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
170677576|NCT00256750|616833415|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
170677577|NCT00256750|616833413|FG000|Post-Transplant Treated (12 Months)|Death|3|||
170677578|NCT00256750|616833414|FG001|Post-Transplant Treated (12 Months)|Death|2|||
170677579|NCT00256750|616833415|FG002|Post-Transplant Treated (12 Months)|Death|4|||
170677580|NCT00256750|616833413|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
170677581|NCT00256750|616833414|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
170677582|NCT00256750|616833415|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
170677583|NCT00256750|616833413|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
170677584|NCT00256750|616833414|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
170677585|NCT00256750|616833415|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
170677586|NCT00256750|616833413|FG000|Post-Transplant Treated (12 Months)|Other|5|||
170677587|NCT00256750|616833414|FG001|Post-Transplant Treated (12 Months)|Other|4|||
170677588|NCT00256750|616833415|FG002|Post-Transplant Treated (12 Months)|Other|2|||
170677589|NCT00256750|616833413|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
170677590|NCT00256750|616833414|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
170677591|NCT00256750|616833415|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
170677592|NCT00256750|616833413|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
170677593|NCT00256750|616833414|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
170677594|NCT00256750|616833415|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
170677595|NCT00256750|616833413|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
170677596|NCT00256750|616833414|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
170677597|NCT00256750|616833415|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
170677598|NCT00256750|616833413|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
170677599|NCT00256750|616833414|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
170677600|NCT00256750|616833415|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
170677601|NCT00256750|616833413|FG000|Post-Transplant Treated (24 Months)|Death|3|||
170677602|NCT00256750|616833414|FG001|Post-Transplant Treated (24 Months)|Death|0|||
170677603|NCT00256750|616833415|FG002|Post-Transplant Treated (24 Months)|Death|0|||
170677604|NCT00256750|616833413|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
170677605|NCT00256750|616833414|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
170677606|NCT00256750|616833415|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
170677607|NCT00256750|616833413|FG000|Post-Transplant Treated (24 Months)|Other|2|||
170677608|NCT00256750|616833414|FG001|Post-Transplant Treated (24 Months)|Other|0|||
170677609|NCT00256750|616833415|FG002|Post-Transplant Treated (24 Months)|Other|1|||
170677610|NCT00256750|616833413|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
170677611|NCT00256750|616833414|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
170677612|NCT00256750|616833415|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
170677613|NCT00256750|616833413|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
170677614|NCT00256750|616833414|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
170677615|NCT00256750|616833415|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
170677616|NCT00256750|616833413|FG000|Post-Transplant Treated (36 Months)|Death|0|||
170677617|NCT00256750|616833414|FG001|Post-Transplant Treated (36 Months)|Death|2|||
170677618|NCT00256750|616833415|FG002|Post-Transplant Treated (36 Months)|Death|1|||
170677619|NCT00256750|616833413|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
170677620|NCT00256750|616833414|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
170677621|NCT00256750|616833415|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
170677622|NCT00256750|616833413|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
170677623|NCT00256750|616833414|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
170677624|NCT00256750|616833415|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
170677625|NCT00256750|616833413|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
170677626|NCT00256750|616833414|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
170677627|NCT00256750|616833415|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
170677628|NCT00256750|616833413|FG000|Post-Transplant Treated (36 Months)|Other|0|||
170677629|NCT00256750|616833414|FG001|Post-Transplant Treated (36 Months)|Other|1|||
170677630|NCT00256750|616833415|FG002|Post-Transplant Treated (36 Months)|Other|1|||
170677631|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
170677632|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
170677633|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
170677634|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
170677635|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
170677636|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
170677637|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
170677638|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
170677639|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
170677640|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
170677641|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
170677642|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
170677643|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
170677644|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
170677645|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
170677646|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
170677647|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
170677648|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
170677649|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
170677650|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
170677651|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
170677652|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
170677653|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
170677654|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
170677655|NCT00256750|616833413|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
170677656|NCT00256750|616833414|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
170677657|NCT00256750|616833415|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
170677658|NCT02030041|616833416|FG000|Overall Study|Withdrawal by Subject|2|||
170677659|NCT02030041|616833417|FG001|Overall Study|Withdrawal by Subject|2|||
170677660|NCT02030041|616833418|FG002|Overall Study|Withdrawal by Subject|1|||
170677661|NCT04659161|616833420|FG000|Overall Study|Adverse Event|10|||
170677662|NCT04659161|616833421|FG001|Overall Study|Adverse Event|6|||
170677663|NCT04659161|616833420|FG000|Overall Study|Withdrawal by Subject|13|||
170677664|NCT04659161|616833421|FG001|Overall Study|Withdrawal by Subject|12|||
170677665|NCT04659161|616833420|FG000|Overall Study|Other|9|||
170677666|NCT04659161|616833421|FG001|Overall Study|Other|8|||
170677667|NCT00471328|616833431|FG000|Core Phase|Adverse Event|18|||
170677668|NCT00471328|616833432|FG001|Core Phase|Adverse Event|6|||
170677669|NCT00471328|616833431|FG000|Core Phase|Death|8|||
170677670|NCT00471328|616833432|FG001|Core Phase|Death|4|||
170677671|NCT00471328|616833431|FG000|Core Phase|Withdrawal by Subject|2|||
170677672|NCT00471328|616833432|FG001|Core Phase|Withdrawal by Subject|2|||
170677673|NCT00471328|616833431|FG000|Core Phase|Abnormal laboratory value|1|||
170677674|NCT00471328|616833432|FG001|Core Phase|Abnormal laboratory value|0|||
170677675|NCT00471328|616833431|FG000|Core Phase|Disease Progression|78|||
170677676|NCT00471328|616833432|FG001|Core Phase|Disease Progression|53|||
170677677|NCT00471328|616833431|FG000|Core Phase|Administrative Problem|0|||
170677678|NCT00471328|616833432|FG001|Core Phase|Administrative Problem|1|||
170677679|NCT00471328|616833431|FG000|Core Phase|Protocol Deviation|0|||
170677680|NCT00471328|616833432|FG001|Core Phase|Protocol Deviation|1|||
170677681|NCT00471328|616833431|FG000|Extension Phase|Adverse Event|3|||
170677682|NCT00471328|616833432|FG001|Extension Phase|Adverse Event|12|||
170677683|NCT00471328|616833431|FG000|Extension Phase|Withdrawal by Subject|0|||
170677684|NCT00471328|616833432|FG001|Extension Phase|Withdrawal by Subject|2|||
170677685|NCT00471328|616833431|FG000|Extension Phase|Death|1|||
170677686|NCT00471328|616833432|FG001|Extension Phase|Death|7|||
170677687|NCT00471328|616833431|FG000|Extension Phase|Protocol Deviation|3|||
170677688|NCT00471328|616833432|FG001|Extension Phase|Protocol Deviation|1|||
170677689|NCT00471328|616833431|FG000|Extension Phase|Treatment duration as per protocol|0|||
170677690|NCT00471328|616833432|FG001|Extension Phase|Treatment duration as per protocol|1|||
170677691|NCT00471328|616833431|FG000|Extension Phase|Disease Progression|32|||
170677692|NCT00471328|616833432|FG001|Extension Phase|Disease Progression|44|||
170677693|NCT00471328|616833431|FG000|Extension Phase|New cancer Therapy|1|||
170677694|NCT00471328|616833432|FG001|Extension Phase|New cancer Therapy|0|||
170677695|NCT00471328|616833431|FG000|Extension Phase|Administrative Problem|1|||
170677696|NCT00471328|616833432|FG001|Extension Phase|Administrative Problem|0|||
170677697|NCT00519831|616833433|FG000|Overall Study|Adverse Event|3|||
170677698|NCT02854631|616833434|FG000|Overall Study|Adverse Event|1|||
170677699|NCT02854631|616833435|FG001|Overall Study|Adverse Event|2|||
170677700|NCT02854631|616833434|FG000|Overall Study|Withdrew Consent|3|||
170677701|NCT02854631|616833435|FG001|Overall Study|Withdrew Consent|2|||
170677702|NCT02854631|616833434|FG000|Overall Study|Investigator's Discretion|2|||
170677703|NCT02854631|616833435|FG001|Overall Study|Investigator's Discretion|0|||
170677704|NCT02854631|616833434|FG000|Overall Study|Death|12|||
170677705|NCT02854631|616833435|FG001|Overall Study|Death|8|||
170677706|NCT02854631|616833434|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
170677707|NCT02854631|616833435|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
170677708|NCT02854631|616833434|FG000|Overall Study|Protocol Violation|0|||
170677709|NCT02854631|616833435|FG001|Overall Study|Protocol Violation|1|||
170677710|NCT02854631|616833434|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
170677711|NCT02854631|616833435|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
170677712|NCT02854631|616833434|FG000|Overall Study|Lost to Follow-up|4|||
170677713|NCT02854631|616833435|FG001|Overall Study|Lost to Follow-up|2|||
170677714|NCT03930797|616833436|FG000|Overall Study|Lost to Follow-up|3|||
170820545|NCT01426217|617349685|FG001|Overall Study|lost sample|14|||
170820546|NCT01920178|617349686|FG000|Overall Study|Lost to Follow-up|2|||
170820547|NCT01920178|617349687|FG001|Overall Study|Lost to Follow-up|1|||
170820548|NCT02991456|617349691|FG000|Overall Study|Adverse Event|2|||
170820549|NCT02991456|617349692|FG001|Overall Study|Adverse Event|0|||
170820550|NCT02991456|617349691|FG000|Overall Study|Lost to Follow-up|0|||
170820551|NCT02991456|617349692|FG001|Overall Study|Lost to Follow-up|2|||
170820552|NCT02991456|617349691|FG000|Overall Study|Withdrawal by Subject|1|||
170820553|NCT02991456|617349692|FG001|Overall Study|Withdrawal by Subject|0|||
170820554|NCT03953079|617349695|FG000|Core Study|Withdrawal by Subject|1|||
170820555|NCT03953079|617349696|FG001|Core Study|Withdrawal by Subject|2|||
170820556|NCT03953079|617349697|FG002|Core Study|Withdrawal by Subject|1|||
170820557|NCT03953079|617349695|FG000|Core Study|COVID-19|0|||
170820558|NCT03953079|617349696|FG001|Core Study|COVID-19|1|||
170820559|NCT03953079|617349697|FG002|Core Study|COVID-19|0|||
170820560|NCT03953079|617349695|FG000|Core Study|Difficulties leaving the house|0|||
170820561|NCT03953079|617349696|FG001|Core Study|Difficulties leaving the house|1|||
170820562|NCT03953079|617349697|FG002|Core Study|Difficulties leaving the house|0|||
170820563|NCT03953079|617349695|FG000|Extension Study|Withdrawal by Subject|1|||
170820564|NCT03953079|617349696|FG001|Extension Study|Withdrawal by Subject|0|||
170820565|NCT03953079|617349697|FG002|Extension Study|Withdrawal by Subject|0|||
170820566|NCT03953079|617349695|FG000|Extension Study|Received Rescue Treatment|5|||
170820567|NCT03953079|617349696|FG001|Extension Study|Received Rescue Treatment|6|||
170820568|NCT03953079|617349697|FG002|Extension Study|Received Rescue Treatment|5|||
170820569|NCT00512902|617349698|FG000|Overall Study|Adverse Event|7|||
170820570|NCT00512902|617349698|FG000|Overall Study|Lost to Follow-up|1|||
170820571|NCT03019289|617349699|FG000|Overall Study|Adverse Event|1|||
170820572|NCT03019289|617349700|FG001|Overall Study|Adverse Event|0|||
170820573|NCT03019289|617349701|FG002|Overall Study|Adverse Event|0|||
170820574|NCT03019289|617349702|FG003|Overall Study|Adverse Event|0|||
170820575|NCT03019289|617349703|FG004|Overall Study|Adverse Event|0|||
170820576|NCT03019289|617349704|FG005|Overall Study|Adverse Event|0|||
170820577|NCT03019289|617349705|FG006|Overall Study|Adverse Event|0|||
170820578|NCT03019289|617349706|FG007|Overall Study|Adverse Event|0|||
170820579|NCT03019289|617349707|FG008|Overall Study|Adverse Event|1|||
170820580|NCT03019289|617349699|FG000|Overall Study|Other|1|||
170820581|NCT03019289|617349700|FG001|Overall Study|Other|0|||
170820582|NCT03019289|617349701|FG002|Overall Study|Other|0|||
170820583|NCT03019289|617349702|FG003|Overall Study|Other|0|||
170820584|NCT03019289|617349703|FG004|Overall Study|Other|0|||
170820585|NCT03019289|617349704|FG005|Overall Study|Other|0|||
170820586|NCT03019289|617349705|FG006|Overall Study|Other|0|||
170820587|NCT03019289|617349706|FG007|Overall Study|Other|0|||
170820588|NCT03019289|617349707|FG008|Overall Study|Other|0|||
170820589|NCT02389894|617349709|FG000|Overall Study|Death|4|||
170820590|NCT02389894|617349710|FG001|Overall Study|Death|5|||
170820591|NCT02389894|617349711|FG002|Overall Study|Death|3|||
170820592|NCT02389894|617349709|FG000|Overall Study|Withdrawal by Subject|2|||
170820593|NCT02389894|617349710|FG001|Overall Study|Withdrawal by Subject|4|||
170820594|NCT02389894|617349711|FG002|Overall Study|Withdrawal by Subject|5|||
170820595|NCT02389894|617349709|FG000|Overall Study|Lost to Follow-up|2|||
170820596|NCT02389894|617349710|FG001|Overall Study|Lost to Follow-up|1|||
170820597|NCT02389894|617349711|FG002|Overall Study|Lost to Follow-up|1|||
170677715|NCT03930797|616833437|FG001|Overall Study|Lost to Follow-up|10|||
170677716|NCT00662012|616833438|FG000|Overall Study|Lost to Follow-up|85|||
170820598|NCT01721759|617349712|FG000|Treatment Period|Disease Progression|85|||
170820599|NCT01721759|617349712|FG000|Treatment Period|Study drug toxicity|14|||
170820600|NCT01721759|617349712|FG000|Treatment Period|Death|1|||
170820601|NCT01721759|617349712|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
170820602|NCT01721759|617349712|FG000|Treatment Period|Participant request to withdraw|3|||
170820603|NCT01721759|617349712|FG000|Treatment Period|Other Reasons|3|||
170820604|NCT01721759|617349712|FG000|End of Study Period|Participant Withdrew Consent|5|||
170820605|NCT01721759|617349712|FG000|End of Study Period|Death|101|||
170820606|NCT01721759|617349712|FG000|End of Study Period|Lost to Follow-up|1|||
170820607|NCT01721759|617349712|FG000|End of Study Period|Other Reasons|10|||
170820608|NCT02312245|617349713|FG000|Overall Study|Death|0|||
170820609|NCT02312245|617349714|FG001|Overall Study|Death|0|||
170820610|NCT02312245|617349715|FG002|Overall Study|Death|0|||
170820611|NCT02312245|617349716|FG003|Overall Study|Death|1|||
170820612|NCT02312245|617349713|FG000|Overall Study|Withdrawal by Subject|1|||
170820613|NCT02312245|617349714|FG001|Overall Study|Withdrawal by Subject|1|||
170677717|NCT00662012|616833438|FG000|Overall Study|Death|1|||
170677718|NCT00662012|616833438|FG000|Overall Study|Withdrawal by Subject|1|||
170677719|NCT00317356|616833439|FG000|Overall Study|Adverse Event|0|||
170677720|NCT00317356|616833440|FG001|Overall Study|Adverse Event|0|||
170677721|NCT00317356|616833441|FG002|Overall Study|Adverse Event|1|||
170677722|NCT00317356|616833442|FG003|Overall Study|Adverse Event|0|||
170677723|NCT00317356|616833439|FG000|Overall Study|Lack of Efficacy|1|||
170677724|NCT00317356|616833440|FG001|Overall Study|Lack of Efficacy|1|||
170677725|NCT00317356|616833441|FG002|Overall Study|Lack of Efficacy|0|||
170677726|NCT00317356|616833442|FG003|Overall Study|Lack of Efficacy|3|||
170677727|NCT00317356|616833439|FG000|Overall Study|Physician Decision|0|||
170677728|NCT00317356|616833440|FG001|Overall Study|Physician Decision|1|||
170677729|NCT00317356|616833441|FG002|Overall Study|Physician Decision|0|||
170677730|NCT00317356|616833442|FG003|Overall Study|Physician Decision|0|||
170677731|NCT01063868|616833443|FG000|Overall Study|Adverse Event|9|||
170677732|NCT01063868|616833444|FG001|Overall Study|Adverse Event|7|||
170677733|NCT01063868|616833443|FG000|Overall Study|Withdrawal by Subject|3|||
170677734|NCT01063868|616833444|FG001|Overall Study|Withdrawal by Subject|1|||
170677735|NCT01063868|616833443|FG000|Overall Study|Study Terminated By Sponsor|23|||
170677736|NCT01063868|616833444|FG001|Overall Study|Study Terminated By Sponsor|4|||
170677737|NCT02443987|616833449|FG000|Overall Study|Bladder injury|1|||
170677738|NCT02443987|616833450|FG001|Overall Study|Bladder injury|1|||
170677739|NCT02443987|616833449|FG000|Overall Study|Other|0|||
170677740|NCT02443987|616833450|FG001|Overall Study|Other|1|||
170677741|NCT03727347|616833451|FG000|Overall Study|Withdrawal by Subject|2|||
170677742|NCT03727347|616833451|FG000|Overall Study|Lost to Follow-up|1|||
170677743|NCT05766423|616833452|FG000|Overall Study|Withdrawal by Subject|1|||
170677744|NCT05766423|616833453|FG001|Overall Study|Withdrawal by Subject|0|||
170677745|NCT05766423|616833452|FG000|Overall Study|Consented, not scheduled|3|||
170677746|NCT05766423|616833453|FG001|Overall Study|Consented, not scheduled|5|||
170677747|NCT00759031|616835763|FG000|First Intervention (1 Day)|Physician Decision|1|||
170677748|NCT00759031|616835764|FG001|First Intervention (1 Day)|Physician Decision|0|||
170677749|NCT00759031|616835763|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
170677750|NCT00759031|616835764|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
170677751|NCT00759031|616835763|FG000|First Intervention (1 Day)|Screening failure|1|||
170677752|NCT00759031|616835764|FG001|First Intervention (1 Day)|Screening failure|0|||
170677753|NCT01104493|616835769|FG000|Overall Study|Lost to Follow-up|0|||
170677754|NCT01104493|616835770|FG001|Overall Study|Lost to Follow-up|2|||
170677755|NCT02899988|616835782|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
170677756|NCT02899988|616835783|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
170677757|NCT02899988|616835784|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677758|NCT02899988|616835785|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677759|NCT02899988|616835786|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677760|NCT02899988|616835787|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677761|NCT02899988|616835788|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677762|NCT02899988|616835789|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677763|NCT02899988|616835790|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677764|NCT02899988|616835791|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677765|NCT02899988|616835792|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170677766|NCT02899988|616835782|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
170677767|NCT02899988|616835783|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
170677768|NCT02899988|616835784|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
170677769|NCT02899988|616835785|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
170677770|NCT02899988|616835786|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
170677771|NCT02899988|616835787|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
170677772|NCT02899988|616835788|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
170677773|NCT02899988|616835789|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
170677774|NCT02899988|616835790|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
170677775|NCT02899988|616835791|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
170677776|NCT02899988|616835792|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
170677777|NCT02899988|616835782|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
170677778|NCT02899988|616835783|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
170677779|NCT02899988|616835784|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
170677780|NCT02899988|616835785|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
170677781|NCT02899988|616835786|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
170677782|NCT02899988|616835787|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
170677783|NCT02899988|616835788|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
170677784|NCT02899988|616835789|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
170677785|NCT02899988|616835790|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
170677786|NCT02899988|616835791|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
170677787|NCT02899988|616835792|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
170677788|NCT02899988|616835782|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
170677789|NCT02899988|616835783|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
170677790|NCT02899988|616835784|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
170677791|NCT02899988|616835785|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
170677792|NCT02899988|616835786|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
170677793|NCT02899988|616835787|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
170677794|NCT02899988|616835788|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
170677795|NCT02899988|616835789|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
170677796|NCT02899988|616835790|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
170677797|NCT02899988|616835791|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
170677798|NCT02899988|616835792|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
170677799|NCT02899988|616835782|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677800|NCT02899988|616835783|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677801|NCT02899988|616835784|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677802|NCT02899988|616835785|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677803|NCT02899988|616835786|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677804|NCT02899988|616835787|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
170677805|NCT02899988|616835788|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677806|NCT02899988|616835789|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
170677807|NCT02899988|616835790|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677808|NCT02899988|616835791|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677809|NCT02899988|616835792|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
170677810|NCT02899988|616835782|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
170677811|NCT02899988|616835783|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
170677812|NCT02899988|616835784|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
170677813|NCT02899988|616835785|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
170677814|NCT02899988|616835786|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
170677815|NCT02899988|616835787|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
170677816|NCT02899988|616835788|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
170677817|NCT02899988|616835789|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
170677818|NCT02899988|616835790|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
170677819|NCT02899988|616835791|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
170677820|NCT02899988|616835792|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
170677821|NCT05526716|616835794|FG000|Overall Study|Death|1|||
170677822|NCT05526716|616835795|FG001|Overall Study|Death|2|||
170677823|NCT05526716|616835794|FG000|Overall Study|Lost to Follow-up|17|||
170677824|NCT05526716|616835795|FG001|Overall Study|Lost to Follow-up|15|||
170677825|NCT05526716|616835794|FG000|Overall Study|Physician Decision|0|||
170677826|NCT05526716|616835795|FG001|Overall Study|Physician Decision|1|||
170677827|NCT05526716|616835794|FG000|Overall Study|Randomized by mistake without study treatment|0|||
170677828|NCT05526716|616835795|FG001|Overall Study|Randomized by mistake without study treatment|1|||
170677829|NCT05526716|616835794|FG000|Overall Study|Withdrawal by Subject|12|||
170677830|NCT05526716|616835795|FG001|Overall Study|Withdrawal by Subject|12|||
170677831|NCT05526716|616835794|FG000|Overall Study|Not reported|0|||
170677832|NCT05526716|616835795|FG001|Overall Study|Not reported|2|||
170677833|NCT02511184|616835799|FG000|Overall Study|Death|1|||
170677834|NCT02511184|616835800|FG001|Overall Study|Death|0|||
170677835|NCT02511184|616835799|FG000|Overall Study|Lost to Follow-up|0|||
170677836|NCT02511184|616835800|FG001|Overall Study|Lost to Follow-up|1|||
170677837|NCT02511184|616835799|FG000|Overall Study|Study terminated by sponsor|1|||
170677838|NCT02511184|616835800|FG001|Overall Study|Study terminated by sponsor|5|||
170677839|NCT02511184|616835799|FG000|Overall Study|Withdrawal by Subject|0|||
170677840|NCT02511184|616835800|FG001|Overall Study|Withdrawal by Subject|1|||
170677841|NCT01806545|616835801|FG000|Overall Study|Adverse Event|2|||
170677842|NCT01806545|616835802|FG001|Overall Study|Adverse Event|3|||
170677843|NCT01806545|616835801|FG000|Overall Study|Lost to Follow-up|1|||
170677844|NCT01806545|616835802|FG001|Overall Study|Lost to Follow-up|0|||
170677845|NCT01806545|616835801|FG000|Overall Study|Withdrawal by Subject|3|||
170677846|NCT01806545|616835802|FG001|Overall Study|Withdrawal by Subject|2|||
170677847|NCT04932096|616835805|FG000|Overall Study|Withdrawal by Subject|1|||
170677848|NCT04932096|616835806|FG001|Overall Study|Withdrawal by Subject|1|||
170677849|NCT04932096|616835805|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
170677850|NCT04932096|616835806|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
170677851|NCT02041286|616835807|FG000|Overall Study|Adverse Event|1|||
170677852|NCT01438957|616835813|FG000|Overall Study|Physician Decision|1|||
170677853|NCT01438957|616835814|FG001|Overall Study|Physician Decision|1|||
170677854|NCT01438957|616835815|FG002|Overall Study|Physician Decision|0|||
170677855|NCT01438957|616835816|FG003|Overall Study|Physician Decision|1|||
170677856|NCT01438957|616835817|FG004|Overall Study|Physician Decision|0|||
170677857|NCT01349790|616835818|FG000|Overall Study|Investigator Judgement|3|||
170677858|NCT01349790|616835818|FG000|Overall Study|Death|2|||
170677859|NCT01349790|616835818|FG000|Overall Study|Withdrawal by Patient|2|||
170677860|NCT01349790|616835818|FG000|Overall Study|Adverse Event|1|||
170677861|NCT01349790|616835818|FG000|Overall Study|Lost to Follow-up|1|||
170677862|NCT03902574|616835819|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
170677863|NCT03902574|616835820|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
170677864|NCT03902574|616835821|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
170677865|NCT03521934|616835824|FG000|Overall Study|Death|65|||
170677866|NCT03521934|616835825|FG001|Overall Study|Death|73|||
170677867|NCT03521934|616835824|FG000|Overall Study|Withdrawal by Subject|18|||
170677868|NCT03521934|616835825|FG001|Overall Study|Withdrawal by Subject|23|||
170677869|NCT03521934|616835824|FG000|Overall Study|Site Terminated by Sponsor|39|||
170677870|NCT03521934|616835825|FG001|Overall Study|Site Terminated by Sponsor|35|||
170677871|NCT03521934|616835824|FG000|Overall Study|Study Terminated by Sponsor|483|||
170677872|NCT03521934|616835825|FG001|Overall Study|Study Terminated by Sponsor|477|||
170677873|NCT03521934|616835824|FG000|Overall Study|Reason not Specified|3|||
170677874|NCT03521934|616835825|FG001|Overall Study|Reason not Specified|6|||
170677875|NCT01513473|616835826|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
170677876|NCT01513473|616835827|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
170677877|NCT01513473|616835826|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
170677878|NCT01513473|616835827|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
170677879|NCT01513473|616835826|FG000|Main Trial (26 Weeks)|Unclassified|0|||
170677880|NCT01513473|616835827|FG001|Main Trial (26 Weeks)|Unclassified|2|||
170677881|NCT01513473|616835826|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
170677882|NCT01513473|616835827|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
170677883|NCT01513473|616835826|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
170677884|NCT01513473|616835827|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
170677885|NCT04016285|616835828|FG000|Overall Study|Did not progress to surgery|2|||
170677886|NCT04016285|616835829|FG001|Overall Study|Did not progress to surgery|5|||
170677887|NCT04016285|616835828|FG000|Overall Study|Failed to collect outcome data|5|||
170677888|NCT04016285|616835829|FG001|Overall Study|Failed to collect outcome data|3|||
170677889|NCT00166114|616835830|FG000|Overall Study|Protocol Violation|2|||
170677890|NCT00166114|616835831|FG001|Overall Study|Protocol Violation|1|||
170677891|NCT00166114|616835830|FG000|Overall Study|Withdrawal by Subject|10|||
170677892|NCT00166114|616835831|FG001|Overall Study|Withdrawal by Subject|4|||
170677893|NCT00166114|616835830|FG000|Overall Study|Adverse Event|2|||
170677894|NCT00166114|616835831|FG001|Overall Study|Adverse Event|1|||
170820614|NCT02312245|617349715|FG002|Overall Study|Withdrawal by Subject|0|||
170820615|NCT02312245|617349716|FG003|Overall Study|Withdrawal by Subject|2|||
170820616|NCT02312245|617349713|FG000|Overall Study|Alternative Therapy|1|||
170820617|NCT02312245|617349714|FG001|Overall Study|Alternative Therapy|0|||
170820618|NCT02312245|617349715|FG002|Overall Study|Alternative Therapy|0|||
170820619|NCT02312245|617349716|FG003|Overall Study|Alternative Therapy|0|||
170820620|NCT02312245|617349713|FG000|Overall Study|Progression|0|||
170820621|NCT02312245|617349714|FG001|Overall Study|Progression|0|||
170677895|NCT00127660|616835833|FG000|Overall Study|Protocol Violation|3|||
170677896|NCT00127660|616835834|FG001|Overall Study|Protocol Violation|3|||
170677897|NCT00127660|616835835|FG002|Overall Study|Protocol Violation|5|||
170677898|NCT00127660|616835836|FG003|Overall Study|Protocol Violation|0|||
170677899|NCT01749514|616835837|FG000|Overall Study|Lost to Follow-up|0|||
170677900|NCT01749514|616835838|FG001|Overall Study|Lost to Follow-up|0|||
170820622|NCT02312245|617349715|FG002|Overall Study|Progression|0|||
170820623|NCT02312245|617349716|FG003|Overall Study|Progression|5|||
170677901|NCT01749514|616835839|FG002|Overall Study|Lost to Follow-up|0|||
170677902|NCT01749514|616835840|FG003|Overall Study|Lost to Follow-up|0|||
170677903|NCT01749514|616835841|FG004|Overall Study|Lost to Follow-up|0|||
170677904|NCT01749514|616835842|FG005|Overall Study|Lost to Follow-up|0|||
170677905|NCT01749514|616835843|FG006|Overall Study|Lost to Follow-up|0|||
170677906|NCT01749514|616835844|FG007|Overall Study|Lost to Follow-up|1|||
170677907|NCT01749514|616835837|FG000|Overall Study|Withdrawal by Subject|0|||
170677908|NCT01749514|616835838|FG001|Overall Study|Withdrawal by Subject|0|||
170677909|NCT01749514|616835839|FG002|Overall Study|Withdrawal by Subject|0|||
170677910|NCT01749514|616835840|FG003|Overall Study|Withdrawal by Subject|0|||
170677911|NCT01749514|616835841|FG004|Overall Study|Withdrawal by Subject|0|||
170677912|NCT01749514|616835842|FG005|Overall Study|Withdrawal by Subject|1|||
170677913|NCT01749514|616835843|FG006|Overall Study|Withdrawal by Subject|0|||
170677914|NCT01749514|616835844|FG007|Overall Study|Withdrawal by Subject|1|||
170677915|NCT01749514|616835837|FG000|Overall Study|Not Reported|0|||
170677916|NCT01749514|616835838|FG001|Overall Study|Not Reported|0|||
170677917|NCT01749514|616835839|FG002|Overall Study|Not Reported|0|||
170677918|NCT01749514|616835840|FG003|Overall Study|Not Reported|0|||
170677919|NCT01749514|616835841|FG004|Overall Study|Not Reported|0|||
170677920|NCT01749514|616835842|FG005|Overall Study|Not Reported|0|||
170677921|NCT01749514|616835843|FG006|Overall Study|Not Reported|0|||
170677922|NCT01749514|616835844|FG007|Overall Study|Not Reported|5|||
170677923|NCT02509156|616835845|FG000|Randomized Phase|Death|1|||
170677924|NCT02509156|616835846|FG001|Randomized Phase|Death|0|||
170677925|NCT02509156|616835845|FG000|Randomized Phase|Withdrawal by Subject|1|||
170677926|NCT02509156|616835846|FG001|Randomized Phase|Withdrawal by Subject|1|||
170677927|NCT03042533|616835847|FG000|Overall Study|MD left program|1|||
170677928|NCT03042533|616835848|FG001|Overall Study|MD left program|4|||
170677929|NCT03042533|616835849|FG002|Overall Study|MD left program|1|||
170677930|NCT00489541|616835850|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
170677931|NCT00489541|616835851|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
170677932|NCT00489541|616835850|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
170820624|NCT02312245|617349713|FG000|Overall Study|Patient went to hospice|0|||
170820625|NCT02312245|617349714|FG001|Overall Study|Patient went to hospice|0|||
170820626|NCT02312245|617349715|FG002|Overall Study|Patient went to hospice|0|||
170820627|NCT02312245|617349716|FG003|Overall Study|Patient went to hospice|1|||
170820628|NCT02312245|617349713|FG000|Overall Study|Ineligible|1|||
170820629|NCT02312245|617349714|FG001|Overall Study|Ineligible|0|||
170820630|NCT02312245|617349715|FG002|Overall Study|Ineligible|0|||
170820631|NCT02312245|617349716|FG003|Overall Study|Ineligible|0|||
170820632|NCT02676778|617349719|FG000|Overall Study|Disease Progression|7|||
170820633|NCT02676778|617349720|FG001|Overall Study|Disease Progression|3|||
170820634|NCT02676778|617349721|FG002|Overall Study|Disease Progression|1|||
170820635|NCT02676778|617349719|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
170820636|NCT02676778|617349720|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
170820637|NCT02676778|617349721|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
170820638|NCT02676778|617349719|FG000|Overall Study|Withdrawal by Subject|3|||
170820639|NCT02676778|617349720|FG001|Overall Study|Withdrawal by Subject|2|||
170820640|NCT02676778|617349721|FG002|Overall Study|Withdrawal by Subject|0|||
170820641|NCT02676778|617349719|FG000|Overall Study|Other|4|||
170820642|NCT02676778|617349720|FG001|Overall Study|Other|3|||
170820643|NCT02676778|617349721|FG002|Overall Study|Other|0|||
170820644|NCT02676778|617349719|FG000|Overall Study|Adverse Event|2|||
170820645|NCT02676778|617349720|FG001|Overall Study|Adverse Event|3|||
170820646|NCT02676778|617349721|FG002|Overall Study|Adverse Event|0|||
170820647|NCT00509821|617351434|FG000|Study Period 1 (Induction)|Death|0|||
170820648|NCT00509821|617351435|FG001|Study Period 1 (Induction)|Death|1|||
170820649|NCT00509821|617351434|FG000|Study Period 1 (Induction)|Adverse Event|0|||
170820650|NCT00509821|617351435|FG001|Study Period 1 (Induction)|Adverse Event|2|||
170820651|NCT00509821|617351434|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
170820652|NCT00509821|617351435|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
170820653|NCT04816708|617351440|FG000|Overall Study|Lost to Follow-up|10|||
170820654|NCT04816708|617351441|FG001|Overall Study|Lost to Follow-up|4|||
170820655|NCT01268488|617351470|FG000|Overall Study|Adverse Event|3|||
170820656|NCT01268488|617351470|FG000|Overall Study|Physician Decision|2|||
170820657|NCT00442559|617351471|FG000|Overall Study|Lost to Follow-up|32|||
170820658|NCT00442559|617351472|FG001|Overall Study|Lost to Follow-up|34|||
170820659|NCT00442559|617351471|FG000|Overall Study|Protocol Violation|1|||
170820660|NCT00442559|617351472|FG001|Overall Study|Protocol Violation|1|||
170820661|NCT00442559|617351471|FG000|Overall Study|Withdrawal by Subject|1|||
170820662|NCT00442559|617351472|FG001|Overall Study|Withdrawal by Subject|0|||
170820663|NCT02305797|617351473|FG000|Overall Study|Adverse Event|11|||
170820664|NCT02305797|617351474|FG001|Overall Study|Adverse Event|2|||
170820665|NCT02305797|617351473|FG000|Overall Study|Withdrawal by Subject|9|||
170820666|NCT02305797|617351474|FG001|Overall Study|Withdrawal by Subject|10|||
170820667|NCT02305797|617351473|FG000|Overall Study|Lack of Efficacy|6|||
170820668|NCT02305797|617351474|FG001|Overall Study|Lack of Efficacy|0|||
170820669|NCT02305797|617351473|FG000|Overall Study|Lost to Follow-up|5|||
170677933|NCT00489541|616835851|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
170677934|NCT00489541|616835850|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
170677935|NCT00489541|616835851|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
170677936|NCT00489541|616835850|FG000|12-Month Clinical Follow-up|Death|3|||
170677937|NCT00489541|616835851|FG001|12-Month Clinical Follow-up|Death|2|||
170677938|NCT00489541|616835850|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
170677939|NCT00489541|616835851|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
170677940|NCT00489541|616835850|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
170677941|NCT00489541|616835851|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
170677942|NCT05131646|616835852|FG000|Overall Study|Withdrawal by Subject|1|||
170677943|NCT05131646|616835853|FG001|Overall Study|Withdrawal by Subject|0|||
170677944|NCT05131646|616835854|FG002|Overall Study|Withdrawal by Subject|0|||
170677945|NCT04182763|616835855|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
170677946|NCT04182763|616835856|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
170677947|NCT04182763|616835857|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
170677948|NCT04182763|616835858|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
170677949|NCT04182763|616835859|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
170677950|NCT04182763|616835855|FG000|Double-Blind Period, initial 6 months|Death|0|||
170677951|NCT04182763|616835856|FG001|Double-Blind Period, initial 6 months|Death|1|||
170677952|NCT04182763|616835857|FG002|Double-Blind Period, initial 6 months|Death|0|||
170677953|NCT04182763|616835858|FG003|Double-Blind Period, initial 6 months|Death|0|||
170677954|NCT04182763|616835859|FG004|Double-Blind Period, initial 6 months|Death|0|||
170677955|NCT04182763|616835855|FG000|Open-Label Period, subsequent 18 months|Death|3|||
170677956|NCT04182763|616835856|FG001|Open-Label Period, subsequent 18 months|Death|2|||
170677957|NCT04182763|616835857|FG002|Open-Label Period, subsequent 18 months|Death|2|||
170677958|NCT04182763|616835858|FG003|Open-Label Period, subsequent 18 months|Death|0|||
170677959|NCT04182763|616835859|FG004|Open-Label Period, subsequent 18 months|Death|1|||
170677960|NCT04182763|616835855|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
170677961|NCT04182763|616835856|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
170677962|NCT04182763|616835857|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
170677963|NCT04182763|616835858|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
170677964|NCT04182763|616835859|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
170677965|NCT04182763|616835855|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
170677966|NCT04182763|616835856|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
170677967|NCT04182763|616835857|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
170677968|NCT04182763|616835858|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
170677969|NCT04182763|616835859|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
170677970|NCT03266107|616835860|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
170677971|NCT03266107|616835860|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
170677972|NCT03266107|616835860|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
170677973|NCT03266107|616835860|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
170677974|NCT02548650|616835863|FG000|Triple Therapy|Adverse Event|1|||
170677975|NCT02548650|616835864|FG001|Triple Therapy|Adverse Event|0|||
170677976|NCT02548650|616835863|FG000|Triple Therapy|Withdrawal by Subject|0|||
170677977|NCT02548650|616835864|FG001|Triple Therapy|Withdrawal by Subject|4|||
170677978|NCT02548650|616835863|FG000|Double Therapy|Adverse Event|1|||
170677979|NCT02548650|616835864|FG001|Double Therapy|Adverse Event|1|||
170677980|NCT02548650|616835863|FG000|Double Therapy|Withdrawal by Subject|0|||
170677981|NCT02548650|616835864|FG001|Double Therapy|Withdrawal by Subject|1|||
170677982|NCT01191801|616835866|FG000|Overall Study|Death|36|||
170677983|NCT01191801|616835867|FG001|Overall Study|Death|12|||
170677984|NCT01191801|616835866|FG000|Overall Study|Lack of Efficacy|176|||
170677985|NCT01191801|616835867|FG001|Overall Study|Lack of Efficacy|258|||
170677986|NCT01191801|616835866|FG000|Overall Study|Adverse Event|9|||
170677987|NCT01191801|616835867|FG001|Overall Study|Adverse Event|8|||
170677988|NCT01191801|616835866|FG000|Overall Study|Protocol Violation|2|||
170677989|NCT01191801|616835867|FG001|Overall Study|Protocol Violation|4|||
170677990|NCT01191801|616835866|FG000|Overall Study|Physician Decision|47|||
170677991|NCT01191801|616835867|FG001|Overall Study|Physician Decision|24|||
170677992|NCT01191801|616835866|FG000|Overall Study|Withdrawal by Subject|1|||
170677993|NCT01191801|616835867|FG001|Overall Study|Withdrawal by Subject|4|||
170677994|NCT01191801|616835866|FG000|Overall Study|Not Provided|45|||
170677995|NCT01191801|616835867|FG001|Overall Study|Not Provided|27|||
170677996|NCT02128113|616835869|FG000|Overall Study|Withdrawal by Subject|3|||
170677997|NCT02128113|616835870|FG001|Overall Study|Withdrawal by Subject|1|||
170677998|NCT02128113|616835871|FG002|Overall Study|Withdrawal by Subject|0|||
170677999|NCT02128113|616835869|FG000|Overall Study|Protocol Violation|0|||
170678000|NCT02128113|616835870|FG001|Overall Study|Protocol Violation|1|||
170678001|NCT02128113|616835871|FG002|Overall Study|Protocol Violation|0|||
170678002|NCT02128113|616835869|FG000|Overall Study|Surgery cancelled|0|||
170678003|NCT02128113|616835870|FG001|Overall Study|Surgery cancelled|1|||
170678004|NCT02128113|616835871|FG002|Overall Study|Surgery cancelled|0|||
170678005|NCT02128113|616835869|FG000|Overall Study|Adverse Event|0|||
170678006|NCT02128113|616835870|FG001|Overall Study|Adverse Event|0|||
170678007|NCT02128113|616835871|FG002|Overall Study|Adverse Event|1|||
170678008|NCT01750242|616835882|FG000|Overall Study|Unreadable Images|3|||
170678009|NCT03765918|616835883|FG000|Overall Study|Death|109|||
170678010|NCT03765918|616835884|FG001|Overall Study|Death|127|||
170678011|NCT03765918|616835883|FG000|Overall Study|Lost to Follow-up|2|||
170678012|NCT03765918|616835884|FG001|Overall Study|Lost to Follow-up|3|||
170678013|NCT03765918|616835883|FG000|Overall Study|Withdrawal by Subject|12|||
170678014|NCT03765918|616835884|FG001|Overall Study|Withdrawal by Subject|16|||
170678015|NCT03765918|616835883|FG000|Overall Study|Participants Ongoing|240|||
170678016|NCT03765918|616835884|FG001|Overall Study|Participants Ongoing|205|||
170678017|NCT02969369|616835885|FG000|Study|Adverse Event|1|||
170678018|NCT02969369|616835886|FG001|Study|Adverse Event|6|||
170678019|NCT02969369|616835885|FG000|Study|Lack of Efficacy|0|||
170678020|NCT02969369|616835886|FG001|Study|Lack of Efficacy|1|||
170678021|NCT02969369|616835885|FG000|Study|Lost to Follow-up|0|||
170678022|NCT02969369|616835886|FG001|Study|Lost to Follow-up|1|||
170678023|NCT02969369|616835885|FG000|Study|Withdrawal by Subject|3|||
170678024|NCT02969369|616835886|FG001|Study|Withdrawal by Subject|5|||
170678025|NCT02969369|616835885|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
170678026|NCT02969369|616835886|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
170678027|NCT02969369|616835885|FG000|Double-blind Period|Adverse Event|1|||
170678028|NCT02969369|616835886|FG001|Double-blind Period|Adverse Event|5|||
170678029|NCT02969369|616835885|FG000|Double-blind Period|Lost to Follow-up|0|||
170678030|NCT02969369|616835886|FG001|Double-blind Period|Lost to Follow-up|1|||
170678031|NCT02969369|616835885|FG000|Double-blind Period|Withdrawal by Subject|2|||
170678032|NCT02969369|616835886|FG001|Double-blind Period|Withdrawal by Subject|3|||
170678033|NCT02969369|616835885|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
170678034|NCT02969369|616835886|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
170678035|NCT02969369|616835885|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
170678036|NCT02969369|616835886|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
170678037|NCT02969369|616835885|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
170678038|NCT02969369|616835886|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
170678039|NCT02969369|616835885|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
170678040|NCT02969369|616835886|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
170678041|NCT01484197|616835887|FG000|Treatment Period 1|Adverse Event|1|||
170678042|NCT01484197|616835888|FG001|Treatment Period 1|Adverse Event|0|||
170678043|NCT01484197|616835889|FG002|Treatment Period 1|Adverse Event|0|||
170678044|NCT01484197|616835890|FG003|Treatment Period 1|Adverse Event|0|||
170678045|NCT01484197|616835887|FG000|Treatment Period 2|Subject withdrew consent|0|||
170678046|NCT01484197|616835888|FG001|Treatment Period 2|Subject withdrew consent|0|||
170678047|NCT01484197|616835889|FG002|Treatment Period 2|Subject withdrew consent|0|||
170678048|NCT01484197|616835890|FG003|Treatment Period 2|Subject withdrew consent|1|||
170678049|NCT00814164|616835891|FG000|Overall Study|Progression|7|||
170678050|NCT00814164|616835891|FG000|Overall Study|not stated|7|||
170678051|NCT00814164|616835891|FG000|Overall Study|Death|5|||
170678052|NCT00299975|616835892|FG000|Overall Study|Adverse Event|1|||
170678053|NCT00299975|616835893|FG001|Overall Study|Adverse Event|0|||
170678054|NCT00299975|616835894|FG002|Overall Study|Adverse Event|2|||
170678055|NCT00299975|616835892|FG000|Overall Study|Pregnancy|0|||
170678056|NCT00299975|616835893|FG001|Overall Study|Pregnancy|0|||
170678057|NCT00299975|616835894|FG002|Overall Study|Pregnancy|1|||
170678058|NCT00299975|616835892|FG000|Overall Study|Lack of Efficacy|1|||
170678059|NCT00299975|616835893|FG001|Overall Study|Lack of Efficacy|0|||
170678060|NCT00299975|616835894|FG002|Overall Study|Lack of Efficacy|1|||
170678061|NCT00299975|616835892|FG000|Overall Study|Lost to Follow-up|1|||
170678062|NCT00299975|616835893|FG001|Overall Study|Lost to Follow-up|0|||
170678063|NCT00299975|616835894|FG002|Overall Study|Lost to Follow-up|0|||
170678064|NCT00299975|616835892|FG000|Overall Study|Withdrawal by Subject|0|||
170678065|NCT00299975|616835893|FG001|Overall Study|Withdrawal by Subject|1|||
170678066|NCT00299975|616835894|FG002|Overall Study|Withdrawal by Subject|3|||
170678067|NCT00299975|616835892|FG000|Overall Study|Physician Decision|0|||
170678068|NCT00299975|616835893|FG001|Overall Study|Physician Decision|0|||
170678069|NCT00299975|616835894|FG002|Overall Study|Physician Decision|1|||
170678070|NCT01169493|616835901|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
170678071|NCT01169493|616835902|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
170678072|NCT01169493|616835903|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
170678073|NCT01169493|616835904|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
170678074|NCT01169493|616835905|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
170678075|NCT01169493|616835906|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
170678076|NCT01169493|616835901|FG000|Period 3 (6 Months)|Adverse Event|0|||
170678077|NCT01169493|616835902|FG001|Period 3 (6 Months)|Adverse Event|1|||
170678078|NCT01169493|616835903|FG002|Period 3 (6 Months)|Adverse Event|0|||
170678079|NCT01169493|616835904|FG003|Period 3 (6 Months)|Adverse Event|0|||
170678080|NCT01169493|616835905|FG004|Period 3 (6 Months)|Adverse Event|0|||
170678081|NCT01169493|616835906|FG005|Period 3 (6 Months)|Adverse Event|0|||
170678082|NCT01169493|616835901|FG000|Period 3 (6 Months)|Physician Decision|0|||
170678083|NCT01169493|616835902|FG001|Period 3 (6 Months)|Physician Decision|1|||
170678084|NCT01169493|616835903|FG002|Period 3 (6 Months)|Physician Decision|1|||
170678085|NCT01169493|616835904|FG003|Period 3 (6 Months)|Physician Decision|0|||
170678086|NCT01169493|616835905|FG004|Period 3 (6 Months)|Physician Decision|0|||
170678087|NCT01169493|616835906|FG005|Period 3 (6 Months)|Physician Decision|0|||
170678088|NCT02627144|616835907|FG000|Overall Study|Serious adverse event|32|||
170678089|NCT02627144|616835907|FG000|Overall Study|Cancer progression|171|||
170678090|NCT02627144|616835907|FG000|Overall Study|Death from cancer|20|||
170678091|NCT02627144|616835907|FG000|Overall Study|Death from other cause|8|||
170678092|NCT02627144|616835907|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
170678093|NCT02627144|616835907|FG000|Overall Study|Administrative reasons|65|||
170678094|NCT02627144|616835907|FG000|Overall Study|Lost to Follow-up|8|||
170678095|NCT02627144|616835907|FG000|Overall Study|Enrolled, not treated|6|||
170678096|NCT02627144|616835907|FG000|Overall Study|Other|17|||
170678097|NCT02651922|616835909|FG000|Overall Study|due to exclusion criteria|2|||
170678098|NCT02088047|616835910|FG000|Overall Study|Withdrawal by Subject|1|||
170678099|NCT02088047|616835911|FG001|Overall Study|Withdrawal by Subject|0|||
170678100|NCT01537393|616835912|FG000|Overall Study|Exclude prior to study|32|||
170678101|NCT01537393|616835913|FG001|Overall Study|Exclude prior to study|44|||
170678102|NCT01537393|616835912|FG000|Overall Study|Death|20|||
170678103|NCT01537393|616835913|FG001|Overall Study|Death|32|||
170678104|NCT01537393|616835912|FG000|Overall Study|Withdrawal by Subject|18|||
170678105|NCT01537393|616835913|FG001|Overall Study|Withdrawal by Subject|17|||
170678106|NCT01537393|616835912|FG000|Overall Study|Lost to Follow-up|53|||
170678107|NCT01537393|616835913|FG001|Overall Study|Lost to Follow-up|48|||
170678108|NCT01537393|616835912|FG000|Overall Study|Failure - Regrafted|28|||
170678109|NCT01537393|616835913|FG001|Overall Study|Failure - Regrafted|43|||
170678110|NCT01537393|616835912|FG000|Overall Study|Failure - Not regrafted|2|||
170678111|NCT01537393|616835913|FG001|Overall Study|Failure - Not regrafted|6|||
170678112|NCT01537393|616835912|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
170678113|NCT01537393|616835913|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
170678114|NCT00036270|616835917|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
170678115|NCT00036270|616835918|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
170678116|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
170678117|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
170678118|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
170678119|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
170678120|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
170678121|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
170678122|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Other|277|||
170678123|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Other|288|||
170678124|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
170678125|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
170678126|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
170678127|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
170678128|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
170678129|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
170678130|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
170678131|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
170678132|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
170678133|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
170678134|NCT00036270|616835917|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
170678135|NCT00036270|616835918|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
170678136|NCT00496470|616835919|FG000|Overall Study|Adverse Event|8|||
170678137|NCT00496470|616835920|FG001|Overall Study|Adverse Event|10|||
170678138|NCT00496470|616835919|FG000|Overall Study|Withdrawal by Subject|5|||
170678139|NCT00496470|616835920|FG001|Overall Study|Withdrawal by Subject|12|||
170678140|NCT00496470|616835919|FG000|Overall Study|Incorrectly enrolled|13|||
170678141|NCT00496470|616835920|FG001|Overall Study|Incorrectly enrolled|5|||
170678142|NCT00496470|616835919|FG000|Overall Study|Other reason|0|||
170678143|NCT00496470|616835920|FG001|Overall Study|Other reason|2|||
170678144|NCT00040664|616835923|FG000|Overall Study|Adverse Event|12|||
170678145|NCT00040664|616835924|FG001|Overall Study|Adverse Event|3|||
170678146|NCT00040664|616835925|FG002|Overall Study|Adverse Event|2|||
170678147|NCT00040664|616835926|FG003|Overall Study|Adverse Event|7|||
170678148|NCT00040664|616835923|FG000|Overall Study|Lack of Efficacy|9|||
170678149|NCT00040664|616835924|FG001|Overall Study|Lack of Efficacy|2|||
170678150|NCT00040664|616835925|FG002|Overall Study|Lack of Efficacy|3|||
170678151|NCT00040664|616835926|FG003|Overall Study|Lack of Efficacy|4|||
170678152|NCT00040664|616835923|FG000|Overall Study|Insufficient CD4 response|1|||
170678153|NCT00040664|616835924|FG001|Overall Study|Insufficient CD4 response|0|||
170678154|NCT00040664|616835925|FG002|Overall Study|Insufficient CD4 response|1|||
170678155|NCT00040664|616835926|FG003|Overall Study|Insufficient CD4 response|0|||
170678156|NCT00040664|616835923|FG000|Overall Study|Lost to Follow-up|4|||
170678157|NCT00040664|616835924|FG001|Overall Study|Lost to Follow-up|2|||
170678158|NCT00040664|616835925|FG002|Overall Study|Lost to Follow-up|0|||
170678159|NCT00040664|616835926|FG003|Overall Study|Lost to Follow-up|2|||
170678160|NCT00040664|616835923|FG000|Overall Study|Protocol Violation|2|||
170678161|NCT00040664|616835924|FG001|Overall Study|Protocol Violation|1|||
170678162|NCT00040664|616835925|FG002|Overall Study|Protocol Violation|0|||
170678163|NCT00040664|616835926|FG003|Overall Study|Protocol Violation|1|||
170678164|NCT00040664|616835923|FG000|Overall Study|Withdrawal by Subject|7|||
170678165|NCT00040664|616835924|FG001|Overall Study|Withdrawal by Subject|0|||
170678166|NCT00040664|616835925|FG002|Overall Study|Withdrawal by Subject|3|||
170678167|NCT00040664|616835926|FG003|Overall Study|Withdrawal by Subject|4|||
170678168|NCT00040664|616835923|FG000|Overall Study|Pregnancy|3|||
170678169|NCT00040664|616835924|FG001|Overall Study|Pregnancy|0|||
170678170|NCT00040664|616835925|FG002|Overall Study|Pregnancy|0|||
170678171|NCT00040664|616835926|FG003|Overall Study|Pregnancy|3|||
170678172|NCT00040664|616835923|FG000|Overall Study|Medication adherence/compliance problems|8|||
170678173|NCT00040664|616835924|FG001|Overall Study|Medication adherence/compliance problems|2|||
170678174|NCT00040664|616835925|FG002|Overall Study|Medication adherence/compliance problems|1|||
170678175|NCT00040664|616835926|FG003|Overall Study|Medication adherence/compliance problems|5|||
170678176|NCT00040664|616835923|FG000|Overall Study|Poor taste|2|||
170678177|NCT00040664|616835924|FG001|Overall Study|Poor taste|0|||
170678178|NCT00040664|616835925|FG002|Overall Study|Poor taste|2|||
170678179|NCT00040664|616835926|FG003|Overall Study|Poor taste|0|||
170678180|NCT00040664|616835923|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
170678181|NCT00040664|616835924|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
170678182|NCT00040664|616835925|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
170678183|NCT00040664|616835926|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
170678184|NCT00040664|616835923|FG000|Overall Study|Change of formulation|2|||
170678185|NCT00040664|616835924|FG001|Overall Study|Change of formulation|2|||
170678186|NCT00040664|616835925|FG002|Overall Study|Change of formulation|0|||
170678187|NCT00040664|616835926|FG003|Overall Study|Change of formulation|0|||
170678188|NCT00040664|616835923|FG000|Overall Study|Non-viability of oral suspension|1|||
170678189|NCT00040664|616835924|FG001|Overall Study|Non-viability of oral suspension|0|||
170678190|NCT00040664|616835925|FG002|Overall Study|Non-viability of oral suspension|1|||
170678191|NCT00040664|616835926|FG003|Overall Study|Non-viability of oral suspension|0|||
170678192|NCT01637272|616835939|FG000|Overall Study|Adverse Event|6|||
170678193|NCT01637272|616835939|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170678194|NCT01637272|616835939|FG000|Overall Study|Withdrawal by Subject|3|||
170678195|NCT01637272|616835939|FG000|Overall Study|Lost to Follow-up|2|||
170678196|NCT01637272|616835939|FG000|Overall Study|completed core, did not enter ext. phase|4|||
170678197|NCT01637272|616835939|FG000|Overall Study|Administrative problems|1|||
170678198|NCT01637272|616835939|FG000|Overall Study|Protocol Violation|2|||
170678199|NCT01217801|616835940|FG000|Period 1|Protocol Violation|1|||
170678200|NCT01217801|616835941|FG001|Period 1|Protocol Violation|1|||
170678201|NCT01217801|616835940|FG000|Period 1|Withdrawal by Subject|0|||
170678202|NCT01217801|616835941|FG001|Period 1|Withdrawal by Subject|1|||
170678203|NCT02439138|616835942|FG000|Overall Study|Adverse Event|1|||
170678204|NCT02439138|616835942|FG000|Overall Study|PI decision to terminate the study|2|||
170678205|NCT02197130|616835947|FG000|Overall Study|Adverse Event|13|||
170678206|NCT02197130|616835948|FG001|Overall Study|Adverse Event|4|||
170678207|NCT02197130|616835949|FG002|Overall Study|Adverse Event|23|||
170678208|NCT02197130|616835947|FG000|Overall Study|Death|0|||
170678209|NCT02197130|616835948|FG001|Overall Study|Death|1|||
170678210|NCT02197130|616835949|FG002|Overall Study|Death|0|||
170678211|NCT02197130|616835947|FG000|Overall Study|Lost to Follow-up|2|||
170678212|NCT02197130|616835948|FG001|Overall Study|Lost to Follow-up|0|||
170678213|NCT02197130|616835949|FG002|Overall Study|Lost to Follow-up|1|||
170678214|NCT02197130|616835947|FG000|Overall Study|Does not meet entrance criteria|0|||
170678215|NCT02197130|616835948|FG001|Overall Study|Does not meet entrance criteria|0|||
170678216|NCT02197130|616835949|FG002|Overall Study|Does not meet entrance criteria|1|||
170678217|NCT02197130|616835947|FG000|Overall Study|Withdrawal by Subject|0|||
170678218|NCT02197130|616835948|FG001|Overall Study|Withdrawal by Subject|3|||
170678219|NCT02197130|616835949|FG002|Overall Study|Withdrawal by Subject|4|||
170678220|NCT02197130|616835947|FG000|Overall Study|Other|1|||
170678221|NCT02197130|616835948|FG001|Overall Study|Other|0|||
170678222|NCT02197130|616835949|FG002|Overall Study|Other|3|||
170678223|NCT01950741|616835950|FG000|Overall Study|Lost to Follow-up|1|||
170678224|NCT01950741|616835950|FG000|Overall Study|Death|1|||
170678225|NCT01950741|616835950|FG000|Overall Study|Withdrawal by Subject|1|||
170678226|NCT03648983|616835951|FG000|Overall Study|Study was terminated due to PI departure|95|||
170678227|NCT01866930|616835952|FG000|Treatment Period|Other|1|||
170678228|NCT01866930|616835953|FG001|Treatment Period|Other|0|||
170678229|NCT01866930|616835952|FG000|Treatment Period|Death|0|||
170678230|NCT01866930|616835953|FG001|Treatment Period|Death|2|||
170678231|NCT01866930|616835952|FG000|Treatment Period|Poor/non compliance|0|||
170678232|NCT01866930|616835953|FG001|Treatment Period|Poor/non compliance|2|||
170678233|NCT01866930|616835952|FG000|Treatment Period|No longer meets study criteria|0|||
170678234|NCT01866930|616835953|FG001|Treatment Period|No longer meets study criteria|1|||
170678235|NCT01866930|616835952|FG000|Treatment Period|Withdrawal by Subject|2|||
170678236|NCT01866930|616835953|FG001|Treatment Period|Withdrawal by Subject|8|||
170678237|NCT01866930|616835952|FG000|Treatment Period|Lack of Efficacy|1|||
170678238|NCT01866930|616835953|FG001|Treatment Period|Lack of Efficacy|9|||
170678239|NCT01866930|616835952|FG000|Treatment Period|Adverse Event|4|||
170678240|NCT01866930|616835953|FG001|Treatment Period|Adverse Event|12|||
170678241|NCT01866930|616835952|FG000|Treatment Period|Lost to Follow-up|1|||
170678242|NCT01866930|616835953|FG001|Treatment Period|Lost to Follow-up|1|||
170678243|NCT01866930|616835952|FG000|Follow-up Period|Lost to Follow-up|1|||
170678244|NCT01866930|616835953|FG001|Follow-up Period|Lost to Follow-up|1|||
170678245|NCT01866930|616835952|FG000|Follow-up Period|Other|1|||
170678246|NCT01866930|616835953|FG001|Follow-up Period|Other|5|||
170678247|NCT01866930|616835952|FG000|Follow-up Period|No longer required per protocol|1|||
170678248|NCT01866930|616835953|FG001|Follow-up Period|No longer required per protocol|0|||
170678249|NCT01866930|616835952|FG000|Follow-up Period|Withdrawal by Subject|3|||
170678250|NCT01866930|616835953|FG001|Follow-up Period|Withdrawal by Subject|3|||
170678251|NCT02521870|616835958|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678252|NCT02521870|616835959|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
170678253|NCT02521870|616835960|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678254|NCT02521870|616835961|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678255|NCT02521870|616835962|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678256|NCT02521870|616835963|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678257|NCT02521870|616835964|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678258|NCT02521870|616835965|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678259|NCT02521870|616835966|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678260|NCT02521870|616835967|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678261|NCT02521870|616835968|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678262|NCT02521870|616835969|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170678263|NCT02521870|616835958|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
170678264|NCT02521870|616835959|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
170678265|NCT02521870|616835960|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
170678266|NCT02521870|616835961|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
170678267|NCT02521870|616835962|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
170678268|NCT02521870|616835963|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
170678269|NCT02521870|616835964|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
170678270|NCT02521870|616835965|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
170678271|NCT02521870|616835966|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
170678272|NCT02521870|616835967|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
170678273|NCT02521870|616835968|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
170678274|NCT02521870|616835969|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
170678275|NCT02521870|616835958|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
170678276|NCT02521870|616835959|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
170678277|NCT02521870|616835960|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
170678278|NCT02521870|616835961|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
170678279|NCT02521870|616835962|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
170678280|NCT02521870|616835963|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
170678281|NCT02521870|616835964|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
170678282|NCT02521870|616835965|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
170678283|NCT02521870|616835966|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
170678284|NCT02521870|616835967|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
170678285|NCT02521870|616835968|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
170678286|NCT02521870|616835969|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
170678287|NCT02521870|616835958|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170678288|NCT02521870|616835959|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170678289|NCT02521870|616835960|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170678290|NCT02521870|616835961|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170678291|NCT02521870|616835962|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
170678292|NCT02521870|616835963|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
170678293|NCT02521870|616835964|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
170678294|NCT02521870|616835965|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170678295|NCT02521870|616835966|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
170678296|NCT02521870|616835967|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
170678297|NCT02521870|616835968|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
170678298|NCT02521870|616835969|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170678299|NCT02521870|616835958|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
170678300|NCT02521870|616835959|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
170678301|NCT02521870|616835960|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
170678302|NCT02521870|616835961|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
170678303|NCT02521870|616835962|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
170678304|NCT02521870|616835963|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
170678305|NCT02521870|616835964|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
170678306|NCT02521870|616835965|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
170678307|NCT02521870|616835966|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
170678308|NCT02521870|616835967|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
170678309|NCT02521870|616835968|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
170678310|NCT02521870|616835969|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
170678311|NCT02521870|616835958|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
170678312|NCT02521870|616835959|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
170678313|NCT02521870|616835960|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
170678314|NCT02521870|616835961|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
170678315|NCT02521870|616835962|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
170678316|NCT02521870|616835963|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
170678317|NCT02521870|616835964|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
170678318|NCT02521870|616835965|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
170678319|NCT02521870|616835966|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
170678320|NCT02521870|616835967|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
170678321|NCT02521870|616835968|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
170678322|NCT02521870|616835969|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
170678323|NCT02521870|616835958|FG000|Phase 2: Dose Expansion|Death|0|||
170678324|NCT02521870|616835959|FG001|Phase 2: Dose Expansion|Death|0|||
170678325|NCT02521870|616835960|FG002|Phase 2: Dose Expansion|Death|0|||
170678326|NCT02521870|616835961|FG003|Phase 2: Dose Expansion|Death|0|||
170678327|NCT02521870|616835962|FG004|Phase 2: Dose Expansion|Death|1|||
170678328|NCT02521870|616835963|FG005|Phase 2: Dose Expansion|Death|1|||
170678329|NCT02521870|616835964|FG006|Phase 2: Dose Expansion|Death|3|||
170678330|NCT02521870|616835965|FG007|Phase 2: Dose Expansion|Death|1|||
170678331|NCT02521870|616835966|FG008|Phase 2: Dose Expansion|Death|1|||
170678332|NCT02521870|616835967|FG009|Phase 2: Dose Expansion|Death|5|||
170678333|NCT02521870|616835968|FG010|Phase 2: Dose Expansion|Death|2|||
170678334|NCT02521870|616835969|FG011|Phase 2: Dose Expansion|Death|2|||
170678335|NCT02521870|616835958|FG000|Phase 2: Dose Expansion|Other|0|||
170678336|NCT02521870|616835959|FG001|Phase 2: Dose Expansion|Other|0|||
170678337|NCT02521870|616835960|FG002|Phase 2: Dose Expansion|Other|0|||
170678338|NCT02521870|616835961|FG003|Phase 2: Dose Expansion|Other|0|||
170678339|NCT02521870|616835962|FG004|Phase 2: Dose Expansion|Other|10|||
170678340|NCT02521870|616835963|FG005|Phase 2: Dose Expansion|Other|3|||
170678341|NCT02521870|616835964|FG006|Phase 2: Dose Expansion|Other|2|||
170678342|NCT02521870|616835965|FG007|Phase 2: Dose Expansion|Other|0|||
170678343|NCT02521870|616835966|FG008|Phase 2: Dose Expansion|Other|10|||
170678344|NCT02521870|616835967|FG009|Phase 2: Dose Expansion|Other|5|||
170678345|NCT02521870|616835968|FG010|Phase 2: Dose Expansion|Other|1|||
170678346|NCT02521870|616835969|FG011|Phase 2: Dose Expansion|Other|7|||
170678347|NCT02521870|616835958|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678348|NCT02521870|616835959|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678349|NCT02521870|616835960|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678350|NCT02521870|616835961|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678351|NCT02521870|616835962|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
170678352|NCT02521870|616835963|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678353|NCT02521870|616835964|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678354|NCT02521870|616835965|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678355|NCT02521870|616835966|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678356|NCT02521870|616835967|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678357|NCT02521870|616835968|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678358|NCT02521870|616835969|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170678359|NCT02521870|616835958|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678360|NCT02521870|616835959|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678361|NCT02521870|616835960|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678362|NCT02521870|616835961|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678363|NCT02521870|616835962|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
170678364|NCT02521870|616835963|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678365|NCT02521870|616835964|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678366|NCT02521870|616835965|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678367|NCT02521870|616835966|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678368|NCT02521870|616835967|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678369|NCT02521870|616835968|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678370|NCT02521870|616835969|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
170678371|NCT00558558|616835974|FG000|Overall Study|Unable to swallow|1|||
170678372|NCT00558558|616835974|FG000|Overall Study|Withdrawal by Subject|1|||
170678373|NCT00558558|616835974|FG000|Overall Study|Lack of Efficacy|4|||
170678374|NCT02549937|616835976|FG000|Overall Study|Death|0|||
170678375|NCT02549937|616835977|FG001|Overall Study|Death|1|||
170678376|NCT02549937|616835978|FG002|Overall Study|Death|0|||
170678377|NCT02549937|616835979|FG003|Overall Study|Death|1|||
170678378|NCT02549937|616835980|FG004|Overall Study|Death|0|||
170678379|NCT02549937|616835981|FG005|Overall Study|Death|8|||
170678380|NCT02549937|616835982|FG006|Overall Study|Death|0|||
170678381|NCT02549937|616835983|FG007|Overall Study|Death|0|||
170678382|NCT02549937|616835984|FG008|Overall Study|Death|19|||
170678383|NCT02549937|616835976|FG000|Overall Study|No follow up required|3|||
170678384|NCT02549937|616835977|FG001|Overall Study|No follow up required|6|||
170678385|NCT02549937|616835978|FG002|Overall Study|No follow up required|3|||
170678386|NCT02549937|616835979|FG003|Overall Study|No follow up required|8|||
170678387|NCT02549937|616835980|FG004|Overall Study|No follow up required|12|||
170678388|NCT02549937|616835981|FG005|Overall Study|No follow up required|21|||
170678389|NCT02549937|616835982|FG006|Overall Study|No follow up required|9|||
170678390|NCT02549937|616835983|FG007|Overall Study|No follow up required|11|||
170678391|NCT02549937|616835984|FG008|Overall Study|No follow up required|0|||
170678392|NCT02549937|616835976|FG000|Overall Study|Other|0|||
170678393|NCT02549937|616835977|FG001|Overall Study|Other|0|||
170678394|NCT02549937|616835978|FG002|Overall Study|Other|0|||
170678395|NCT02549937|616835979|FG003|Overall Study|Other|0|||
170678396|NCT02549937|616835980|FG004|Overall Study|Other|1|||
170678397|NCT02549937|616835981|FG005|Overall Study|Other|0|||
170678398|NCT02549937|616835982|FG006|Overall Study|Other|3|||
170678399|NCT02549937|616835983|FG007|Overall Study|Other|2|||
170678400|NCT02549937|616835984|FG008|Overall Study|Other|3|||
170678401|NCT02549937|616835976|FG000|Overall Study|Lost to Follow-up|0|||
170678402|NCT02549937|616835977|FG001|Overall Study|Lost to Follow-up|0|||
170678403|NCT02549937|616835978|FG002|Overall Study|Lost to Follow-up|0|||
170678404|NCT02549937|616835979|FG003|Overall Study|Lost to Follow-up|0|||
170678405|NCT02549937|616835980|FG004|Overall Study|Lost to Follow-up|0|||
170678406|NCT02549937|616835981|FG005|Overall Study|Lost to Follow-up|0|||
170678407|NCT02549937|616835982|FG006|Overall Study|Lost to Follow-up|0|||
170678408|NCT02549937|616835983|FG007|Overall Study|Lost to Follow-up|0|||
170678409|NCT02549937|616835984|FG008|Overall Study|Lost to Follow-up|3|||
170678410|NCT02549937|616835976|FG000|Overall Study|Withdrawal by Subject|0|||
170678411|NCT02549937|616835977|FG001|Overall Study|Withdrawal by Subject|0|||
170678412|NCT02549937|616835978|FG002|Overall Study|Withdrawal by Subject|0|||
170678413|NCT02549937|616835979|FG003|Overall Study|Withdrawal by Subject|0|||
170678414|NCT02549937|616835980|FG004|Overall Study|Withdrawal by Subject|0|||
170678415|NCT02549937|616835981|FG005|Overall Study|Withdrawal by Subject|1|||
170678416|NCT02549937|616835982|FG006|Overall Study|Withdrawal by Subject|4|||
170678417|NCT02549937|616835983|FG007|Overall Study|Withdrawal by Subject|3|||
170678418|NCT02549937|616835984|FG008|Overall Study|Withdrawal by Subject|2|||
170678419|NCT02549937|616835976|FG000|Overall Study|Sponsor Decision|0|||
170678420|NCT02549937|616835977|FG001|Overall Study|Sponsor Decision|0|||
170678421|NCT02549937|616835978|FG002|Overall Study|Sponsor Decision|0|||
170678422|NCT02549937|616835979|FG003|Overall Study|Sponsor Decision|0|||
170678423|NCT02549937|616835980|FG004|Overall Study|Sponsor Decision|0|||
170678424|NCT02549937|616835981|FG005|Overall Study|Sponsor Decision|0|||
170678425|NCT02549937|616835982|FG006|Overall Study|Sponsor Decision|0|||
170678426|NCT02549937|616835983|FG007|Overall Study|Sponsor Decision|0|||
170678427|NCT02549937|616835984|FG008|Overall Study|Sponsor Decision|6|||
170678428|NCT04292743|616835989|FG000|Overall Study|Physician Decision|1|||
170678429|NCT04292743|616835990|FG001|Overall Study|Physician Decision|3|||
170678430|NCT04292743|616835991|FG002|Overall Study|Physician Decision|0|||
170678431|NCT04292743|616835992|FG003|Overall Study|Physician Decision|0|||
170678432|NCT04292743|616835989|FG000|Overall Study|Withdrawal by Subject|0|||
170678433|NCT04292743|616835990|FG001|Overall Study|Withdrawal by Subject|5|||
170678434|NCT04292743|616835991|FG002|Overall Study|Withdrawal by Subject|0|||
170678435|NCT04292743|616835992|FG003|Overall Study|Withdrawal by Subject|0|||
170678436|NCT04292743|616835989|FG000|Overall Study|Death|0|||
170678437|NCT04292743|616835990|FG001|Overall Study|Death|1|||
170678438|NCT04292743|616835991|FG002|Overall Study|Death|0|||
170678439|NCT04292743|616835992|FG003|Overall Study|Death|0|||
170678440|NCT04292743|616835989|FG000|Overall Study|Progression of Disease|2|||
170678441|NCT04292743|616835990|FG001|Overall Study|Progression of Disease|5|||
170678442|NCT04292743|616835991|FG002|Overall Study|Progression of Disease|0|||
170678443|NCT04292743|616835992|FG003|Overall Study|Progression of Disease|0|||
170678444|NCT04292743|616835989|FG000|Overall Study|No Treatment per protocol|0|||
170678445|NCT04292743|616835990|FG001|Overall Study|No Treatment per protocol|2|||
170678446|NCT04292743|616835991|FG002|Overall Study|No Treatment per protocol|0|||
170678447|NCT04292743|616835992|FG003|Overall Study|No Treatment per protocol|0|||
170678448|NCT01943292|616837874|FG000|Overall Study|Withdrawal by Subject|1|||
170678449|NCT01943292|616837875|FG001|Overall Study|Withdrawal by Subject|0|||
170678450|NCT01943292|616837876|FG002|Overall Study|Withdrawal by Subject|0|||
170678451|NCT00911820|616837877|FG000|Overall Study|RECIST progression|12|||
170678452|NCT00911820|616837878|FG001|Overall Study|RECIST progression|8|||
170678453|NCT00911820|616837877|FG000|Overall Study|Adverse Event|8|||
170678454|NCT00911820|616837878|FG001|Overall Study|Adverse Event|8|||
170678455|NCT00911820|616837877|FG000|Overall Study|Clinical Progression|7|||
170678456|NCT00911820|616837878|FG001|Overall Study|Clinical Progression|5|||
170678457|NCT00911820|616837877|FG000|Overall Study|Physician Decision|5|||
170678458|NCT00911820|616837878|FG001|Overall Study|Physician Decision|9|||
170678459|NCT00911820|616837877|FG000|Overall Study|Decline in Performance Status|4|||
170678460|NCT00911820|616837878|FG001|Overall Study|Decline in Performance Status|2|||
170678461|NCT00911820|616837877|FG000|Overall Study|Withdrawal by Subject|3|||
170678462|NCT00911820|616837878|FG001|Overall Study|Withdrawal by Subject|4|||
170678463|NCT00911820|616837877|FG000|Overall Study|Death|1|||
170678464|NCT00911820|616837878|FG001|Overall Study|Death|2|||
170678465|NCT00911820|616837877|FG000|Overall Study|Pursue surgery|1|||
170678466|NCT00911820|616837878|FG001|Overall Study|Pursue surgery|1|||
170678467|NCT00911820|616837877|FG000|Overall Study|Pursue Radiation|1|||
170678468|NCT00911820|616837878|FG001|Overall Study|Pursue Radiation|0|||
170678469|NCT00911820|616837877|FG000|Overall Study|Still on Therapy|2|||
170678470|NCT00911820|616837878|FG001|Overall Study|Still on Therapy|2|||
170678471|NCT00911820|616837877|FG000|Overall Study|Pathology Not Confirmed|1|||
170678472|NCT00911820|616837878|FG001|Overall Study|Pathology Not Confirmed|0|||
170678473|NCT00911820|616837877|FG000|Overall Study|Withdraw before Receive Treatment|0|||
170678474|NCT00911820|616837878|FG001|Overall Study|Withdraw before Receive Treatment|2|||
170678475|NCT00963547|616837884|FG000|Overall Study|Adverse Event|0|||
170678476|NCT00963547|616837885|FG001|Overall Study|Adverse Event|1|||
170678477|NCT00963547|616837886|FG002|Overall Study|Adverse Event|0|||
170678478|NCT00963547|616837887|FG003|Overall Study|Adverse Event|1|||
170678479|NCT00963547|616837888|FG004|Overall Study|Adverse Event|0|||
170678480|NCT00963547|616837889|FG005|Overall Study|Adverse Event|0|||
170678481|NCT00963547|616837890|FG006|Overall Study|Adverse Event|0|||
170678482|NCT00963547|616837884|FG000|Overall Study|Physician Decision|1|||
170678483|NCT00963547|616837885|FG001|Overall Study|Physician Decision|1|||
170678484|NCT00963547|616837886|FG002|Overall Study|Physician Decision|0|||
170678485|NCT00963547|616837887|FG003|Overall Study|Physician Decision|0|||
170678486|NCT00963547|616837888|FG004|Overall Study|Physician Decision|0|||
170678487|NCT00963547|616837889|FG005|Overall Study|Physician Decision|0|||
170678488|NCT00963547|616837890|FG006|Overall Study|Physician Decision|0|||
170678489|NCT00963547|616837884|FG000|Overall Study|Progressive Disease|3|||
170678490|NCT00963547|616837885|FG001|Overall Study|Progressive Disease|8|||
170678491|NCT00963547|616837886|FG002|Overall Study|Progressive Disease|9|||
170678492|NCT00963547|616837887|FG003|Overall Study|Progressive Disease|5|||
170678493|NCT00963547|616837888|FG004|Overall Study|Progressive Disease|0|||
170678494|NCT00963547|616837889|FG005|Overall Study|Progressive Disease|0|||
170678495|NCT00963547|616837890|FG006|Overall Study|Progressive Disease|0|||
170678496|NCT00963547|616837884|FG000|Overall Study|Withdrawal by Subject|0|||
170678497|NCT00963547|616837885|FG001|Overall Study|Withdrawal by Subject|0|||
170678498|NCT00963547|616837886|FG002|Overall Study|Withdrawal by Subject|3|||
170678499|NCT00963547|616837887|FG003|Overall Study|Withdrawal by Subject|0|||
170678500|NCT00963547|616837888|FG004|Overall Study|Withdrawal by Subject|0|||
170678501|NCT00963547|616837889|FG005|Overall Study|Withdrawal by Subject|0|||
170678502|NCT00963547|616837890|FG006|Overall Study|Withdrawal by Subject|0|||
170678503|NCT00963547|616837884|FG000|Overall Study|Reason Unknown|0|||
170678504|NCT00963547|616837885|FG001|Overall Study|Reason Unknown|1|||
170678505|NCT00963547|616837886|FG002|Overall Study|Reason Unknown|0|||
170678506|NCT00963547|616837887|FG003|Overall Study|Reason Unknown|0|||
170678507|NCT00963547|616837888|FG004|Overall Study|Reason Unknown|0|||
170678508|NCT00963547|616837889|FG005|Overall Study|Reason Unknown|0|||
170678509|NCT00963547|616837890|FG006|Overall Study|Reason Unknown|0|||
170678510|NCT00903695|616837893|FG000|Overall Study|medical exclusion after 1st testing|1|||
170678511|NCT00903695|616837894|FG001|Overall Study|medical exclusion after 1st testing|0|||
170678512|NCT00903695|616837893|FG000|Overall Study|lung cancer|1|||
170678513|NCT00903695|616837894|FG001|Overall Study|lung cancer|0|||
170678514|NCT01549860|616837895|FG000|Overall Study|Withdrawal by Subject|1|||
170678515|NCT01549860|616837896|FG001|Overall Study|Withdrawal by Subject|0|||
170678516|NCT01549860|616837895|FG000|Overall Study|Physician Decision|1|||
170678517|NCT01549860|616837896|FG001|Overall Study|Physician Decision|1|||
170678518|NCT00187486|616837897|FG000|Overall Study|Protocol Violation|1|||
170678519|NCT03489720|616837898|FG000|Overall Study|Withdrawal by Subject|2|||
170678520|NCT03489720|616837899|FG001|Overall Study|Withdrawal by Subject|0|||
170678521|NCT04166435|616837902|FG000|Overall Study|2 patients ineligible for response|2|||
170678522|NCT02708121|616837905|FG000|Overall Study|Withdrawn by Study Team|1|||
170678523|NCT02708121|616837906|FG001|Overall Study|Withdrawn by Study Team|1|||
170678524|NCT02708121|616837905|FG000|Overall Study|Withdrawal by Subject|0|||
170678525|NCT02708121|616837906|FG001|Overall Study|Withdrawal by Subject|4|||
170678526|NCT02743520|616837907|FG000|Overall Study|Withdrawal by Subject|1|||
170678527|NCT03247530|616837908|FG000|Overall Study|Withdrawal by caregiver|19|||
170678528|NCT03247530|616837909|FG001|Overall Study|Withdrawal by caregiver|8|||
170678529|NCT03247530|616837910|FG002|Overall Study|Withdrawal by caregiver|10|||
170678530|NCT03247530|616837908|FG000|Overall Study|Lost to Follow-up|3|||
170678531|NCT03247530|616837909|FG001|Overall Study|Lost to Follow-up|9|||
170678532|NCT03247530|616837910|FG002|Overall Study|Lost to Follow-up|6|||
170678533|NCT03247530|616837908|FG000|Overall Study|Adverse Event|2|||
170678534|NCT03247530|616837909|FG001|Overall Study|Adverse Event|5|||
170678535|NCT03247530|616837910|FG002|Overall Study|Adverse Event|2|||
170820670|NCT02305797|617351474|FG001|Overall Study|Lost to Follow-up|11|||
170678536|NCT03247530|616837908|FG000|Overall Study|Failure to follow procedure|1|||
170678537|NCT03247530|616837909|FG001|Overall Study|Failure to follow procedure|1|||
170678538|NCT03247530|616837910|FG002|Overall Study|Failure to follow procedure|1|||
170678539|NCT03247530|616837908|FG000|Overall Study|Withdrawal by Subject|1|||
170678540|NCT03247530|616837909|FG001|Overall Study|Withdrawal by Subject|1|||
170678541|NCT03247530|616837910|FG002|Overall Study|Withdrawal by Subject|0|||
170678542|NCT03247530|616837908|FG000|Overall Study|Study medication misuse|0|||
170678543|NCT03247530|616837909|FG001|Overall Study|Study medication misuse|1|||
170678544|NCT03247530|616837910|FG002|Overall Study|Study medication misuse|0|||
170678545|NCT03247530|616837908|FG000|Overall Study|Other, multiple categories|1|||
170678546|NCT03247530|616837909|FG001|Overall Study|Other, multiple categories|3|||
170678547|NCT03247530|616837910|FG002|Overall Study|Other, multiple categories|1|||
170678548|NCT00299104|616837911|FG000|Treatment Period|Adverse Event|14|||
170678549|NCT00299104|616837912|FG001|Treatment Period|Adverse Event|9|||
170678550|NCT00299104|616837913|FG002|Treatment Period|Adverse Event|7|||
170678551|NCT00299104|616837911|FG000|Treatment Period|Death|1|||
170678552|NCT00299104|616837912|FG001|Treatment Period|Death|1|||
170678553|NCT00299104|616837913|FG002|Treatment Period|Death|1|||
170678554|NCT00299104|616837911|FG000|Treatment Period|Insufficient therapeutic response|34|||
170678555|NCT00299104|616837912|FG001|Treatment Period|Insufficient therapeutic response|13|||
170678556|NCT00299104|616837913|FG002|Treatment Period|Insufficient therapeutic response|8|||
170678557|NCT00299104|616837911|FG000|Treatment Period|Failure to return|9|||
170678558|NCT00299104|616837912|FG001|Treatment Period|Failure to return|8|||
170678559|NCT00299104|616837913|FG002|Treatment Period|Failure to return|8|||
170678560|NCT00299104|616837911|FG000|Treatment Period|Violation of selection criteria|1|||
170678561|NCT00299104|616837912|FG001|Treatment Period|Violation of selection criteria|2|||
170678562|NCT00299104|616837913|FG002|Treatment Period|Violation of selection criteria|0|||
170678563|NCT00299104|616837911|FG000|Treatment Period|Protocol Violation|1|||
170678564|NCT00299104|616837912|FG001|Treatment Period|Protocol Violation|1|||
170678565|NCT00299104|616837913|FG002|Treatment Period|Protocol Violation|0|||
170678566|NCT00299104|616837911|FG000|Treatment Period|Refused treatment|9|||
170678567|NCT00299104|616837912|FG001|Treatment Period|Refused treatment|2|||
170678568|NCT00299104|616837913|FG002|Treatment Period|Refused treatment|2|||
170678569|NCT00299104|616837911|FG000|Treatment Period|Withdrew consent|14|||
170678570|NCT00299104|616837912|FG001|Treatment Period|Withdrew consent|19|||
170678571|NCT00299104|616837913|FG002|Treatment Period|Withdrew consent|9|||
170678572|NCT00299104|616837911|FG000|Treatment Period|Administrative reasons|106|||
170678573|NCT00299104|616837912|FG001|Treatment Period|Administrative reasons|120|||
170678574|NCT00299104|616837913|FG002|Treatment Period|Administrative reasons|137|||
170678575|NCT00299104|616837911|FG000|Safety Follow-Up (SFU) Period|Death|3|||
170678576|NCT00299104|616837912|FG001|Safety Follow-Up (SFU) Period|Death|2|||
170678577|NCT00299104|616837913|FG002|Safety Follow-Up (SFU) Period|Death|1|||
170678578|NCT00299104|616837911|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
170678579|NCT00299104|616837912|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
170678580|NCT00299104|616837913|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
170678581|NCT00299104|616837911|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
170678582|NCT00299104|616837912|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
170678583|NCT00299104|616837913|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
170678584|NCT00299104|616837911|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
170678585|NCT00299104|616837912|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
170678586|NCT00299104|616837913|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
170678587|NCT00299104|616837911|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
170678588|NCT00299104|616837912|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
170678589|NCT00299104|616837913|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
170678590|NCT00299104|616837911|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
170678591|NCT00299104|616837912|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
170678592|NCT00299104|616837913|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
170678593|NCT00299104|616837911|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
170678594|NCT00299104|616837912|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
170678595|NCT00299104|616837913|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
170678596|NCT00299104|616837911|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
170678597|NCT00299104|616837912|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
170678598|NCT00299104|616837913|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
170678599|NCT04202965|616837914|FG000|Overall Study|Adverse Event|3|||
170678600|NCT04202965|616837914|FG000|Overall Study|Did not meet inclusion criteria|1|||
170678601|NCT01980992|616837917|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
170678602|NCT01980992|616837918|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
170678603|NCT01980992|616837917|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
170678604|NCT01980992|616837918|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
170678605|NCT01980992|616837917|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
170678606|NCT01980992|616837918|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
170678607|NCT01980992|616837917|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
170678608|NCT01980992|616837918|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
170678609|NCT01980992|616837917|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
170678610|NCT01980992|616837918|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
170678611|NCT01980992|616837917|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
170678612|NCT01980992|616837918|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
170678613|NCT03167411|616837920|FG000|Overall Study|Adverse Event|0|||
170678614|NCT03167411|616837921|FG001|Overall Study|Adverse Event|1|||
170678615|NCT00855920|616837929|FG000|Overall Study|Protocol Violation|0|||
170678616|NCT00855920|616837930|FG001|Overall Study|Protocol Violation|0|||
170678617|NCT00855920|616837931|FG002|Overall Study|Protocol Violation|2|||
170678618|NCT00855920|616837929|FG000|Overall Study|Adverse Event|2|||
170678619|NCT00855920|616837930|FG001|Overall Study|Adverse Event|1|||
170678620|NCT00855920|616837931|FG002|Overall Study|Adverse Event|1|||
170678621|NCT00855920|616837929|FG000|Overall Study|Lack of Efficacy|2|||
170678622|NCT00855920|616837930|FG001|Overall Study|Lack of Efficacy|2|||
170678623|NCT00855920|616837931|FG002|Overall Study|Lack of Efficacy|2|||
170678624|NCT00855920|616837929|FG000|Overall Study|Withdrawal by Subject|2|||
170678625|NCT00855920|616837930|FG001|Overall Study|Withdrawal by Subject|3|||
170678626|NCT00855920|616837931|FG002|Overall Study|Withdrawal by Subject|2|||
170678627|NCT00855920|616837929|FG000|Overall Study|Lost to Follow-up|1|||
170678628|NCT00855920|616837930|FG001|Overall Study|Lost to Follow-up|0|||
170678629|NCT00855920|616837931|FG002|Overall Study|Lost to Follow-up|2|||
170678630|NCT00855920|616837929|FG000|Overall Study|Death|0|||
170678631|NCT00855920|616837930|FG001|Overall Study|Death|1|||
170678632|NCT00855920|616837931|FG002|Overall Study|Death|0|||
170678633|NCT00855920|616837929|FG000|Overall Study|Decision by the sponsor|0|||
170678634|NCT00855920|616837930|FG001|Overall Study|Decision by the sponsor|1|||
170678635|NCT00855920|616837931|FG002|Overall Study|Decision by the sponsor|1|||
170678636|NCT00855920|616837929|FG000|Overall Study|Other than specified above|1|||
170678637|NCT00855920|616837930|FG001|Overall Study|Other than specified above|1|||
170678638|NCT00855920|616837931|FG002|Overall Study|Other than specified above|1|||
170678639|NCT00291577|616837933|FG000|Overall Study|Adverse Event|1|||
170678640|NCT00291577|616837933|FG000|Overall Study|Other|4|||
170678641|NCT00291577|616837933|FG000|Overall Study|Withdrawal by Subject|2|||
170678642|NCT00291577|616837933|FG000|Overall Study|Lack of Efficacy|14|||
170678643|NCT03129100|616837936|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
170678644|NCT03129100|616837937|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
170678645|NCT03129100|616837938|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
170678646|NCT03129100|616837939|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
170678647|NCT03129100|616837940|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
170678648|NCT03129100|616837941|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
170678649|NCT03129100|616837942|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
170678650|NCT03129100|616837943|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
170678651|NCT03129100|616837944|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
170678652|NCT03129100|616837945|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
170678653|NCT03129100|616837946|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
170678654|NCT03129100|616837947|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
170678655|NCT03129100|616837948|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
170678656|NCT03129100|616837949|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
170678657|NCT03129100|616837950|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
170678658|NCT03129100|616837951|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
170678659|NCT03129100|616837952|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
170678660|NCT03129100|616837953|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
170678661|NCT03129100|616837954|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
170678662|NCT03129100|616837955|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
170678663|NCT03129100|616837956|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
170678664|NCT03129100|616837957|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
170678665|NCT03129100|616837958|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
170678666|NCT03129100|616837959|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
170678667|NCT03129100|616837960|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
170678668|NCT03129100|616837961|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
170678669|NCT03129100|616837936|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
170678670|NCT03129100|616837937|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678671|NCT03129100|616837938|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678672|NCT03129100|616837939|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678673|NCT03129100|616837940|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678674|NCT03129100|616837941|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678675|NCT03129100|616837942|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678676|NCT03129100|616837943|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678677|NCT03129100|616837944|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678678|NCT03129100|616837945|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678679|NCT03129100|616837946|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678680|NCT03129100|616837947|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678681|NCT03129100|616837948|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678682|NCT03129100|616837949|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678683|NCT03129100|616837950|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678684|NCT03129100|616837951|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678685|NCT03129100|616837952|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678686|NCT03129100|616837953|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678687|NCT03129100|616837954|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678688|NCT03129100|616837955|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678689|NCT03129100|616837956|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170820671|NCT02305797|617351473|FG000|Overall Study|Pregnancy|0|||
170820672|NCT02305797|617351474|FG001|Overall Study|Pregnancy|2|||
170820673|NCT02305797|617351473|FG000|Overall Study|Noncompliance|14|||
170820674|NCT02305797|617351474|FG001|Overall Study|Noncompliance|12|||
170678690|NCT03129100|616837957|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678691|NCT03129100|616837958|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170820675|NCT02305797|617351473|FG000|Overall Study|Reason not collected|0|||
170820676|NCT02305797|617351474|FG001|Overall Study|Reason not collected|1|||
170820677|NCT02522299|617351475|FG000|Overall Study|Adverse Event|2|||
170820678|NCT02522299|617351476|FG001|Overall Study|Adverse Event|0|||
170820679|NCT02522299|617351475|FG000|Overall Study|Physician Decision|0|||
170820680|NCT02522299|617351476|FG001|Overall Study|Physician Decision|1|||
170678692|NCT03129100|616837959|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678693|NCT03129100|616837960|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678694|NCT03129100|616837961|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
170678695|NCT03129100|616837936|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
170678696|NCT03129100|616837937|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
170678697|NCT03129100|616837938|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678698|NCT03129100|616837939|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678699|NCT03129100|616837940|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678700|NCT03129100|616837941|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678701|NCT03129100|616837942|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678702|NCT03129100|616837943|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678703|NCT03129100|616837944|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678704|NCT03129100|616837945|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678705|NCT03129100|616837946|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678706|NCT03129100|616837947|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678707|NCT03129100|616837948|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678708|NCT03129100|616837949|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678709|NCT03129100|616837950|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678710|NCT03129100|616837951|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678711|NCT03129100|616837952|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678712|NCT03129100|616837953|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678713|NCT03129100|616837954|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678714|NCT03129100|616837955|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678715|NCT03129100|616837956|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678716|NCT03129100|616837957|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678717|NCT03129100|616837958|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678718|NCT03129100|616837959|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678719|NCT03129100|616837960|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678720|NCT03129100|616837961|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
170678721|NCT03129100|616837936|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
170678722|NCT03129100|616837937|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
170678723|NCT03129100|616837938|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678724|NCT03129100|616837939|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678725|NCT03129100|616837940|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678726|NCT03129100|616837941|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678727|NCT03129100|616837942|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678728|NCT03129100|616837943|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678729|NCT03129100|616837944|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678730|NCT03129100|616837945|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678731|NCT03129100|616837946|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678732|NCT03129100|616837947|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678733|NCT03129100|616837948|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678734|NCT03129100|616837949|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678735|NCT03129100|616837950|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678736|NCT03129100|616837951|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678737|NCT03129100|616837952|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678738|NCT03129100|616837953|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678739|NCT03129100|616837954|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678740|NCT03129100|616837955|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678741|NCT03129100|616837956|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678742|NCT03129100|616837957|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678743|NCT03129100|616837958|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678744|NCT03129100|616837959|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678745|NCT03129100|616837960|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678746|NCT03129100|616837961|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
170678747|NCT03129100|616837936|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678748|NCT03129100|616837937|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
170678749|NCT03129100|616837938|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678750|NCT03129100|616837939|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678751|NCT03129100|616837940|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678752|NCT03129100|616837941|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678753|NCT03129100|616837942|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678754|NCT03129100|616837943|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678755|NCT03129100|616837944|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678756|NCT03129100|616837945|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678757|NCT03129100|616837946|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678758|NCT03129100|616837947|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678759|NCT03129100|616837948|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678760|NCT03129100|616837949|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678761|NCT03129100|616837950|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678762|NCT03129100|616837951|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678763|NCT03129100|616837952|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678764|NCT03129100|616837953|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678765|NCT03129100|616837954|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678766|NCT03129100|616837955|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678767|NCT03129100|616837956|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678768|NCT03129100|616837957|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678769|NCT03129100|616837958|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678770|NCT03129100|616837959|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678771|NCT03129100|616837960|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678772|NCT03129100|616837961|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
170678773|NCT03129100|616837936|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678774|NCT03129100|616837937|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678775|NCT03129100|616837938|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
170678776|NCT03129100|616837939|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
170678777|NCT03129100|616837940|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678778|NCT03129100|616837941|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
170678779|NCT03129100|616837942|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678780|NCT03129100|616837943|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678781|NCT03129100|616837944|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678782|NCT03129100|616837945|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678783|NCT03129100|616837946|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678784|NCT03129100|616837947|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678785|NCT03129100|616837948|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678786|NCT03129100|616837949|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678787|NCT03129100|616837950|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678788|NCT03129100|616837951|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678789|NCT03129100|616837952|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678790|NCT03129100|616837953|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678791|NCT03129100|616837954|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678792|NCT03129100|616837955|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678793|NCT03129100|616837956|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678794|NCT03129100|616837957|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678795|NCT03129100|616837958|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678796|NCT03129100|616837959|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678797|NCT03129100|616837960|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678798|NCT03129100|616837961|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
170678799|NCT03129100|616837936|FG000|Period2 Extension Period (Group A and B)|Death|0|||
170678800|NCT03129100|616837937|FG001|Period2 Extension Period (Group A and B)|Death|0|||
170678801|NCT03129100|616837938|FG002|Period2 Extension Period (Group A and B)|Death|1|||
170678802|NCT03129100|616837939|FG003|Period2 Extension Period (Group A and B)|Death|0|||
170678803|NCT03129100|616837940|FG004|Period2 Extension Period (Group A and B)|Death|0|||
170678804|NCT03129100|616837941|FG005|Period2 Extension Period (Group A and B)|Death|0|||
170678805|NCT03129100|616837942|FG006|Period2 Extension Period (Group A and B)|Death|0|||
170678806|NCT03129100|616837943|FG007|Period2 Extension Period (Group A and B)|Death|0|||
170678807|NCT03129100|616837944|FG008|Period2 Extension Period (Group A and B)|Death|0|||
170678808|NCT03129100|616837945|FG009|Period2 Extension Period (Group A and B)|Death|0|||
170678809|NCT03129100|616837946|FG010|Period2 Extension Period (Group A and B)|Death|0|||
170678810|NCT03129100|616837947|FG011|Period2 Extension Period (Group A and B)|Death|0|||
170678811|NCT03129100|616837948|FG012|Period2 Extension Period (Group A and B)|Death|0|||
170678812|NCT03129100|616837949|FG013|Period2 Extension Period (Group A and B)|Death|0|||
170678813|NCT03129100|616837950|FG014|Period2 Extension Period (Group A and B)|Death|0|||
170678814|NCT03129100|616837951|FG015|Period2 Extension Period (Group A and B)|Death|0|||
170678815|NCT03129100|616837952|FG016|Period2 Extension Period (Group A and B)|Death|0|||
170678816|NCT03129100|616837953|FG017|Period2 Extension Period (Group A and B)|Death|0|||
170678817|NCT03129100|616837954|FG018|Period2 Extension Period (Group A and B)|Death|0|||
170678818|NCT03129100|616837955|FG019|Period2 Extension Period (Group A and B)|Death|0|||
170678819|NCT03129100|616837956|FG020|Period2 Extension Period (Group A and B)|Death|0|||
170678820|NCT03129100|616837957|FG021|Period2 Extension Period (Group A and B)|Death|0|||
170678821|NCT03129100|616837958|FG022|Period2 Extension Period (Group A and B)|Death|0|||
170678822|NCT03129100|616837959|FG023|Period2 Extension Period (Group A and B)|Death|0|||
170678823|NCT03129100|616837960|FG024|Period2 Extension Period (Group A and B)|Death|0|||
170678824|NCT03129100|616837961|FG025|Period2 Extension Period (Group A and B)|Death|0|||
170678825|NCT03129100|616837936|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678826|NCT03129100|616837937|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678827|NCT03129100|616837938|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
170678828|NCT03129100|616837939|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
170678829|NCT03129100|616837940|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
170678830|NCT03129100|616837941|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
170678831|NCT03129100|616837942|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
170678832|NCT03129100|616837943|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678833|NCT03129100|616837944|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678834|NCT03129100|616837945|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678835|NCT03129100|616837946|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678836|NCT03129100|616837947|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678837|NCT03129100|616837948|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678838|NCT03129100|616837949|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678839|NCT03129100|616837950|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678840|NCT03129100|616837951|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678841|NCT03129100|616837952|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678842|NCT03129100|616837953|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678843|NCT03129100|616837954|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678844|NCT03129100|616837955|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678845|NCT03129100|616837956|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678846|NCT03129100|616837957|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678847|NCT03129100|616837958|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678848|NCT03129100|616837959|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678849|NCT03129100|616837960|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678850|NCT03129100|616837961|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
170678851|NCT03129100|616837936|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678852|NCT03129100|616837937|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678853|NCT03129100|616837938|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
170678854|NCT03129100|616837939|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678855|NCT03129100|616837940|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678856|NCT03129100|616837941|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678857|NCT03129100|616837942|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678858|NCT03129100|616837943|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678859|NCT03129100|616837944|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678860|NCT03129100|616837945|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678861|NCT03129100|616837946|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678862|NCT03129100|616837947|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678863|NCT03129100|616837948|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678864|NCT03129100|616837949|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678865|NCT03129100|616837950|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678866|NCT03129100|616837951|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678867|NCT03129100|616837952|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678868|NCT03129100|616837953|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678869|NCT03129100|616837954|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678870|NCT03129100|616837955|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678871|NCT03129100|616837956|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678872|NCT03129100|616837957|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678873|NCT03129100|616837958|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678874|NCT03129100|616837959|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678875|NCT03129100|616837960|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678876|NCT03129100|616837961|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
170678877|NCT03129100|616837936|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678878|NCT03129100|616837937|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678879|NCT03129100|616837938|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
170678880|NCT03129100|616837939|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678881|NCT03129100|616837940|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678882|NCT03129100|616837941|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678883|NCT03129100|616837942|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678884|NCT03129100|616837943|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678885|NCT03129100|616837944|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678886|NCT03129100|616837945|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678887|NCT03129100|616837946|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678888|NCT03129100|616837947|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678889|NCT03129100|616837948|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678890|NCT03129100|616837949|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678891|NCT03129100|616837950|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678892|NCT03129100|616837951|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678893|NCT03129100|616837952|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678894|NCT03129100|616837953|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678895|NCT03129100|616837954|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678896|NCT03129100|616837955|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678897|NCT03129100|616837956|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678898|NCT03129100|616837957|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678899|NCT03129100|616837958|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678900|NCT03129100|616837959|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678901|NCT03129100|616837960|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678902|NCT03129100|616837961|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
170678903|NCT03129100|616837936|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678904|NCT03129100|616837937|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678905|NCT03129100|616837938|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
170678906|NCT03129100|616837939|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678907|NCT03129100|616837940|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678908|NCT03129100|616837941|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678909|NCT03129100|616837942|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678910|NCT03129100|616837943|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678911|NCT03129100|616837944|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678912|NCT03129100|616837945|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678913|NCT03129100|616837946|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678914|NCT03129100|616837947|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678915|NCT03129100|616837948|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678916|NCT03129100|616837949|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678917|NCT03129100|616837950|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678918|NCT03129100|616837951|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678919|NCT03129100|616837952|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678920|NCT03129100|616837953|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678921|NCT03129100|616837954|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678922|NCT03129100|616837955|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678923|NCT03129100|616837956|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678924|NCT03129100|616837957|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678925|NCT03129100|616837958|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678926|NCT03129100|616837959|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678927|NCT03129100|616837960|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678928|NCT03129100|616837961|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
170678929|NCT03129100|616837936|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678930|NCT03129100|616837937|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678931|NCT03129100|616837938|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678932|NCT03129100|616837939|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678933|NCT03129100|616837940|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
170678934|NCT03129100|616837941|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
170678935|NCT03129100|616837942|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
170678936|NCT03129100|616837943|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678937|NCT03129100|616837944|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678938|NCT03129100|616837945|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678939|NCT03129100|616837946|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678940|NCT03129100|616837947|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678941|NCT03129100|616837948|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678942|NCT03129100|616837949|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678943|NCT03129100|616837950|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678944|NCT03129100|616837951|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678945|NCT03129100|616837952|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678946|NCT03129100|616837953|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678947|NCT03129100|616837954|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678948|NCT03129100|616837955|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678949|NCT03129100|616837956|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678950|NCT03129100|616837957|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678951|NCT03129100|616837958|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678952|NCT03129100|616837959|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678953|NCT03129100|616837960|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678954|NCT03129100|616837961|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
170678955|NCT03129100|616837936|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678956|NCT03129100|616837937|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678957|NCT03129100|616837938|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678958|NCT03129100|616837939|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678959|NCT03129100|616837940|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678960|NCT03129100|616837941|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678961|NCT03129100|616837942|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678962|NCT03129100|616837943|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678963|NCT03129100|616837944|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678964|NCT03129100|616837945|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
170678965|NCT03129100|616837946|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678966|NCT03129100|616837947|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678967|NCT03129100|616837948|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678968|NCT03129100|616837949|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678969|NCT03129100|616837950|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678970|NCT03129100|616837951|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678971|NCT03129100|616837952|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678972|NCT03129100|616837953|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678973|NCT03129100|616837954|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678974|NCT03129100|616837955|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678975|NCT03129100|616837956|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678976|NCT03129100|616837957|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678977|NCT03129100|616837958|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678978|NCT03129100|616837959|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678979|NCT03129100|616837960|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678980|NCT03129100|616837961|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
170678981|NCT03129100|616837936|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678982|NCT03129100|616837937|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678983|NCT03129100|616837938|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678984|NCT03129100|616837939|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678985|NCT03129100|616837940|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678986|NCT03129100|616837941|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678987|NCT03129100|616837942|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678988|NCT03129100|616837943|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678989|NCT03129100|616837944|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678990|NCT03129100|616837945|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678991|NCT03129100|616837946|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678992|NCT03129100|616837947|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
170678993|NCT03129100|616837948|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678994|NCT03129100|616837949|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678995|NCT03129100|616837950|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678996|NCT03129100|616837951|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678997|NCT03129100|616837952|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678998|NCT03129100|616837953|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170678999|NCT03129100|616837954|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170679000|NCT03129100|616837955|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170679001|NCT03129100|616837956|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170679002|NCT03129100|616837957|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170679003|NCT03129100|616837958|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170679004|NCT03129100|616837959|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170679005|NCT03129100|616837960|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170679006|NCT03129100|616837961|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
170679007|NCT03129100|616837936|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679008|NCT03129100|616837937|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679009|NCT03129100|616837938|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679010|NCT03129100|616837939|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679011|NCT03129100|616837940|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679012|NCT03129100|616837941|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679013|NCT03129100|616837942|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679014|NCT03129100|616837943|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679015|NCT03129100|616837944|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679016|NCT03129100|616837945|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679017|NCT03129100|616837946|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679018|NCT03129100|616837947|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
170679019|NCT03129100|616837948|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
170679020|NCT03129100|616837949|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
170679021|NCT03129100|616837950|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
170679022|NCT03129100|616837951|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679023|NCT03129100|616837952|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679024|NCT03129100|616837953|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679025|NCT03129100|616837954|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679026|NCT03129100|616837955|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679027|NCT03129100|616837956|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679028|NCT03129100|616837957|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679029|NCT03129100|616837958|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679030|NCT03129100|616837959|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679031|NCT03129100|616837960|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679032|NCT03129100|616837961|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
170679033|NCT03129100|616837936|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679034|NCT03129100|616837937|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679035|NCT03129100|616837938|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679036|NCT03129100|616837939|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679037|NCT03129100|616837940|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679038|NCT03129100|616837941|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679039|NCT03129100|616837942|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679040|NCT03129100|616837943|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679041|NCT03129100|616837944|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679042|NCT03129100|616837945|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679043|NCT03129100|616837946|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679044|NCT03129100|616837947|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
170679045|NCT03129100|616837948|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679046|NCT03129100|616837949|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
170679047|NCT03129100|616837950|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
170679048|NCT03129100|616837951|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679049|NCT03129100|616837952|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170820681|NCT02522299|617351475|FG000|Overall Study|Withdrawal by Subject|2|||
170820682|NCT02522299|617351476|FG001|Overall Study|Withdrawal by Subject|0|||
170679050|NCT03129100|616837953|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679051|NCT03129100|616837954|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679052|NCT03129100|616837955|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679053|NCT03129100|616837956|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679054|NCT03129100|616837957|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679055|NCT03129100|616837958|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679056|NCT03129100|616837959|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679057|NCT03129100|616837960|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679058|NCT03129100|616837961|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
170679059|NCT03129100|616837936|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679060|NCT03129100|616837937|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679061|NCT03129100|616837938|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679062|NCT03129100|616837939|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679063|NCT03129100|616837940|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679064|NCT03129100|616837941|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679065|NCT03129100|616837942|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679066|NCT03129100|616837943|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679067|NCT03129100|616837944|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679068|NCT03129100|616837945|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679069|NCT03129100|616837946|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679070|NCT03129100|616837947|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679071|NCT03129100|616837948|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679072|NCT03129100|616837949|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679073|NCT03129100|616837950|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679074|NCT03129100|616837951|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
170679075|NCT03129100|616837952|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679076|NCT03129100|616837953|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679077|NCT03129100|616837954|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679078|NCT03129100|616837955|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679079|NCT03129100|616837956|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679080|NCT03129100|616837957|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679081|NCT03129100|616837958|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679082|NCT03129100|616837959|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679083|NCT03129100|616837960|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679084|NCT03129100|616837961|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
170679085|NCT03129100|616837936|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679086|NCT03129100|616837937|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679087|NCT03129100|616837938|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679088|NCT03129100|616837939|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679089|NCT03129100|616837940|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679090|NCT03129100|616837941|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679091|NCT03129100|616837942|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679092|NCT03129100|616837943|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679093|NCT03129100|616837944|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679094|NCT03129100|616837945|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679095|NCT03129100|616837946|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679096|NCT03129100|616837947|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679097|NCT03129100|616837948|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
170679098|NCT03129100|616837949|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679099|NCT03129100|616837950|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
170679100|NCT03129100|616837951|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
170679101|NCT03129100|616837952|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679102|NCT03129100|616837953|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679103|NCT03129100|616837954|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679104|NCT03129100|616837955|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679105|NCT03129100|616837956|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679106|NCT03129100|616837957|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679107|NCT03129100|616837958|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679108|NCT03129100|616837959|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679109|NCT03129100|616837960|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679110|NCT03129100|616837961|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
170679111|NCT03129100|616837936|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679112|NCT03129100|616837937|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679113|NCT03129100|616837938|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679114|NCT03129100|616837939|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679115|NCT03129100|616837940|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679116|NCT03129100|616837941|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679117|NCT03129100|616837942|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679118|NCT03129100|616837943|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679119|NCT03129100|616837944|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679120|NCT03129100|616837945|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679121|NCT03129100|616837946|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679122|NCT03129100|616837947|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679123|NCT03129100|616837948|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679124|NCT03129100|616837949|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679125|NCT03129100|616837950|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679126|NCT03129100|616837951|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679127|NCT03129100|616837952|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679128|NCT03129100|616837953|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
170679129|NCT03129100|616837954|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679130|NCT03129100|616837955|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
170679131|NCT03129100|616837956|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679132|NCT03129100|616837957|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679133|NCT03129100|616837958|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679134|NCT03129100|616837959|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679135|NCT03129100|616837960|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679136|NCT03129100|616837961|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
170679137|NCT03129100|616837936|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679138|NCT03129100|616837937|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679139|NCT03129100|616837938|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679140|NCT03129100|616837939|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679141|NCT03129100|616837940|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679142|NCT03129100|616837941|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679143|NCT03129100|616837942|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679144|NCT03129100|616837943|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679145|NCT03129100|616837944|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679146|NCT03129100|616837945|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679147|NCT03129100|616837946|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679148|NCT03129100|616837947|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679149|NCT03129100|616837948|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679150|NCT03129100|616837949|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679151|NCT03129100|616837950|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679152|NCT03129100|616837951|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679153|NCT03129100|616837952|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679154|NCT03129100|616837953|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679155|NCT03129100|616837954|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679156|NCT03129100|616837955|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679157|NCT03129100|616837956|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
170679158|NCT03129100|616837957|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679159|NCT03129100|616837958|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679160|NCT03129100|616837959|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679161|NCT03129100|616837960|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679162|NCT03129100|616837961|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
170679163|NCT03129100|616837936|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
170679164|NCT03129100|616837937|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
170679165|NCT03129100|616837938|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
170679166|NCT03129100|616837939|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
170679167|NCT03129100|616837940|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
170679168|NCT03129100|616837941|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
170679169|NCT03129100|616837942|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
170679170|NCT03129100|616837943|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
170679171|NCT03129100|616837944|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
170679172|NCT03129100|616837945|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
170679173|NCT03129100|616837946|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
170820683|NCT03906240|617351479|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
170820684|NCT03906240|617351480|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
170820685|NCT03906240|617351479|FG000|Overall Study|Lost to Follow-up|1|||
170820686|NCT03906240|617351480|FG001|Overall Study|Lost to Follow-up|0|||
170820687|NCT03906240|617351479|FG000|Overall Study|Withdrawal by Subject|0|||
170820688|NCT03906240|617351480|FG001|Overall Study|Withdrawal by Subject|1|||
170820689|NCT03575572|617351481|FG000|Overall Study|Withdrawal by Subject|2|||
170679174|NCT03129100|616837947|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
170679175|NCT03129100|616837948|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
170679176|NCT03129100|616837949|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
170679177|NCT03129100|616837950|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
170679178|NCT03129100|616837951|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
170679179|NCT03129100|616837952|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
170679180|NCT03129100|616837953|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
170679181|NCT03129100|616837954|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
170679182|NCT03129100|616837955|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
170679183|NCT03129100|616837956|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
170679184|NCT03129100|616837957|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
170679185|NCT03129100|616837958|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
170679186|NCT03129100|616837959|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
170679187|NCT03129100|616837960|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
170679188|NCT03129100|616837961|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
170679189|NCT03129100|616837936|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679190|NCT03129100|616837937|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679191|NCT03129100|616837938|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679192|NCT03129100|616837939|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679193|NCT03129100|616837940|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679194|NCT03129100|616837941|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679195|NCT03129100|616837942|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679196|NCT03129100|616837943|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679197|NCT03129100|616837944|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679198|NCT03129100|616837945|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679199|NCT03129100|616837946|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679200|NCT03129100|616837947|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679201|NCT03129100|616837948|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679202|NCT03129100|616837949|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679203|NCT03129100|616837950|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679204|NCT03129100|616837951|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679205|NCT03129100|616837952|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679206|NCT03129100|616837953|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679207|NCT03129100|616837954|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679208|NCT03129100|616837955|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679209|NCT03129100|616837956|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
170679210|NCT03129100|616837957|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679211|NCT03129100|616837958|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679212|NCT03129100|616837959|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679213|NCT03129100|616837960|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679214|NCT03129100|616837961|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
170679215|NCT03129100|616837936|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
170679216|NCT03129100|616837937|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
170679217|NCT03129100|616837938|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
170679218|NCT03129100|616837939|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
170679219|NCT03129100|616837940|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
170679220|NCT03129100|616837941|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
170679221|NCT03129100|616837942|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
170679222|NCT03129100|616837943|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
170679223|NCT03129100|616837944|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
170679224|NCT03129100|616837945|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
170679225|NCT03129100|616837946|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
170679226|NCT03129100|616837947|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
170679227|NCT03129100|616837948|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
170679228|NCT03129100|616837949|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
170679229|NCT03129100|616837950|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
170679230|NCT03129100|616837951|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
170679231|NCT03129100|616837952|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
170679232|NCT03129100|616837953|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
170679233|NCT03129100|616837954|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
170679234|NCT03129100|616837955|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
170679235|NCT03129100|616837956|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
170679236|NCT03129100|616837957|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
170679237|NCT03129100|616837958|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
170679238|NCT03129100|616837959|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
170679239|NCT03129100|616837960|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
170679240|NCT03129100|616837961|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
170679241|NCT03129100|616837936|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679242|NCT03129100|616837937|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679243|NCT03129100|616837938|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679244|NCT03129100|616837939|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170820690|NCT03575572|617351481|FG000|Overall Study|Physician Decision|2|||
170679245|NCT03129100|616837940|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679246|NCT03129100|616837941|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679247|NCT03129100|616837942|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679248|NCT03129100|616837943|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679249|NCT03129100|616837944|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679250|NCT03129100|616837945|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679251|NCT03129100|616837946|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679252|NCT03129100|616837947|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679253|NCT03129100|616837948|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679254|NCT03129100|616837949|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679255|NCT03129100|616837950|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679256|NCT03129100|616837951|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679257|NCT03129100|616837952|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679258|NCT03129100|616837953|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679259|NCT03129100|616837954|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679260|NCT03129100|616837955|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679261|NCT03129100|616837956|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679262|NCT03129100|616837957|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679263|NCT03129100|616837958|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679264|NCT03129100|616837959|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
170679265|NCT03129100|616837960|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
170679266|NCT03129100|616837961|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
170679267|NCT03129100|616837936|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679268|NCT03129100|616837937|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679269|NCT03129100|616837938|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679270|NCT03129100|616837939|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679271|NCT03129100|616837940|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679272|NCT03129100|616837941|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679273|NCT03129100|616837942|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679274|NCT03129100|616837943|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679275|NCT03129100|616837944|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679276|NCT03129100|616837945|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679277|NCT03129100|616837946|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679278|NCT03129100|616837947|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679279|NCT03129100|616837948|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679280|NCT03129100|616837949|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679281|NCT03129100|616837950|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679282|NCT03129100|616837951|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679283|NCT03129100|616837952|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679284|NCT03129100|616837953|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679285|NCT03129100|616837954|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679286|NCT03129100|616837955|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679287|NCT03129100|616837956|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679288|NCT03129100|616837957|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679289|NCT03129100|616837958|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
170679290|NCT03129100|616837959|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
170679291|NCT03129100|616837960|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
170679292|NCT03129100|616837961|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
170679293|NCT03129100|616837936|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679294|NCT03129100|616837937|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679295|NCT03129100|616837938|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679296|NCT03129100|616837939|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679297|NCT03129100|616837940|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679298|NCT03129100|616837941|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679299|NCT03129100|616837942|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679300|NCT03129100|616837943|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679301|NCT03129100|616837944|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679302|NCT03129100|616837945|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679303|NCT03129100|616837946|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679304|NCT03129100|616837947|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679305|NCT03129100|616837948|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679306|NCT03129100|616837949|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679307|NCT03129100|616837950|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679308|NCT03129100|616837951|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679309|NCT03129100|616837952|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679310|NCT03129100|616837953|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679311|NCT03129100|616837954|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679312|NCT03129100|616837955|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679313|NCT03129100|616837956|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679314|NCT03129100|616837957|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679315|NCT03129100|616837958|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679316|NCT03129100|616837959|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679317|NCT03129100|616837960|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
170679318|NCT03129100|616837961|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
170679319|NCT03129100|616837936|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679320|NCT03129100|616837937|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679321|NCT03129100|616837938|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679322|NCT03129100|616837939|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679323|NCT03129100|616837940|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679324|NCT03129100|616837941|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679325|NCT03129100|616837942|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679326|NCT03129100|616837943|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679327|NCT03129100|616837944|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679328|NCT03129100|616837945|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679329|NCT03129100|616837946|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679330|NCT03129100|616837947|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679331|NCT03129100|616837948|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679332|NCT03129100|616837949|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679333|NCT03129100|616837950|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679334|NCT03129100|616837951|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679335|NCT03129100|616837952|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679336|NCT03129100|616837953|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679337|NCT03129100|616837954|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679338|NCT03129100|616837955|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679339|NCT03129100|616837956|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679340|NCT03129100|616837957|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679341|NCT03129100|616837958|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679342|NCT03129100|616837959|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679343|NCT03129100|616837960|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
170679344|NCT03129100|616837961|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
170679345|NCT03129100|616837936|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
170679346|NCT03129100|616837937|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
170679347|NCT03129100|616837938|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
170679348|NCT03129100|616837939|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
170679349|NCT03129100|616837940|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
170679350|NCT03129100|616837941|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
170679351|NCT03129100|616837942|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
170679352|NCT03129100|616837943|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
170679353|NCT03129100|616837944|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
170679354|NCT03129100|616837945|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
170679355|NCT03129100|616837946|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
170679356|NCT03129100|616837947|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
170679357|NCT03129100|616837948|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
170679358|NCT03129100|616837949|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
170679359|NCT03129100|616837950|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
170679360|NCT03129100|616837951|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
170679361|NCT03129100|616837952|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
170679362|NCT03129100|616837953|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
170679363|NCT03129100|616837954|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
170679364|NCT03129100|616837955|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
170679365|NCT03129100|616837956|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
170679366|NCT03129100|616837957|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
170679367|NCT03129100|616837958|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
170679368|NCT03129100|616837959|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
170679369|NCT03129100|616837960|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
170679370|NCT03129100|616837961|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
170679371|NCT01587001|616837962|FG000|Overall Study|Lost to Follow-up|2|||
170679372|NCT01587001|616837963|FG001|Overall Study|Lost to Follow-up|0|||
170679373|NCT01587001|616837962|FG000|Overall Study|Insufficient samples to complete testing|4|||
170679374|NCT01587001|616837963|FG001|Overall Study|Insufficient samples to complete testing|1|||
170679375|NCT03708328|616837968|FG000|Overall Study|Death|3|||
170679376|NCT03708328|616837969|FG001|Overall Study|Death|3|||
170679377|NCT03708328|616837970|FG002|Overall Study|Death|4|||
170679378|NCT03708328|616837971|FG003|Overall Study|Death|2|||
170679379|NCT03708328|616837972|FG004|Overall Study|Death|2|||
170679380|NCT03708328|616837973|FG005|Overall Study|Death|13|||
170679381|NCT03708328|616837974|FG006|Overall Study|Death|26|||
170679382|NCT03708328|616837975|FG007|Overall Study|Death|18|||
170679383|NCT03708328|616837976|FG008|Overall Study|Death|13|||
170679384|NCT03708328|616837977|FG009|Overall Study|Death|8|||
170679385|NCT03708328|616837968|FG000|Overall Study|Lost to Follow-up|0|||
170679386|NCT03708328|616837969|FG001|Overall Study|Lost to Follow-up|1|||
170679387|NCT03708328|616837970|FG002|Overall Study|Lost to Follow-up|0|||
170679388|NCT03708328|616837971|FG003|Overall Study|Lost to Follow-up|1|||
170679389|NCT03708328|616837972|FG004|Overall Study|Lost to Follow-up|0|||
170679390|NCT03708328|616837973|FG005|Overall Study|Lost to Follow-up|3|||
170679391|NCT03708328|616837974|FG006|Overall Study|Lost to Follow-up|3|||
170679392|NCT03708328|616837975|FG007|Overall Study|Lost to Follow-up|0|||
170679393|NCT03708328|616837976|FG008|Overall Study|Lost to Follow-up|0|||
170679394|NCT03708328|616837977|FG009|Overall Study|Lost to Follow-up|1|||
170679395|NCT03708328|616837968|FG000|Overall Study|Physician Decision|0|||
170679396|NCT03708328|616837969|FG001|Overall Study|Physician Decision|0|||
170679397|NCT03708328|616837970|FG002|Overall Study|Physician Decision|0|||
170679398|NCT03708328|616837971|FG003|Overall Study|Physician Decision|0|||
170679399|NCT03708328|616837972|FG004|Overall Study|Physician Decision|0|||
170679400|NCT03708328|616837973|FG005|Overall Study|Physician Decision|1|||
170679401|NCT03708328|616837974|FG006|Overall Study|Physician Decision|0|||
170679402|NCT03708328|616837975|FG007|Overall Study|Physician Decision|0|||
170679403|NCT03708328|616837976|FG008|Overall Study|Physician Decision|0|||
170679404|NCT03708328|616837977|FG009|Overall Study|Physician Decision|0|||
170679405|NCT03708328|616837968|FG000|Overall Study|Withdrawal by Subject|0|||
170679406|NCT03708328|616837969|FG001|Overall Study|Withdrawal by Subject|0|||
170679407|NCT03708328|616837970|FG002|Overall Study|Withdrawal by Subject|0|||
170679408|NCT03708328|616837971|FG003|Overall Study|Withdrawal by Subject|0|||
170679409|NCT03708328|616837972|FG004|Overall Study|Withdrawal by Subject|1|||
170679410|NCT03708328|616837973|FG005|Overall Study|Withdrawal by Subject|0|||
170679411|NCT03708328|616837974|FG006|Overall Study|Withdrawal by Subject|2|||
170679412|NCT03708328|616837975|FG007|Overall Study|Withdrawal by Subject|4|||
170679413|NCT03708328|616837976|FG008|Overall Study|Withdrawal by Subject|1|||
170679414|NCT03708328|616837977|FG009|Overall Study|Withdrawal by Subject|5|||
170679415|NCT03708328|616837968|FG000|Overall Study|Study Closed Locally|0|||
170679416|NCT03708328|616837969|FG001|Overall Study|Study Closed Locally|0|||
170679417|NCT03708328|616837970|FG002|Overall Study|Study Closed Locally|0|||
170679418|NCT03708328|616837971|FG003|Overall Study|Study Closed Locally|0|||
170679419|NCT03708328|616837972|FG004|Overall Study|Study Closed Locally|0|||
170679420|NCT03708328|616837973|FG005|Overall Study|Study Closed Locally|0|||
170679421|NCT03708328|616837974|FG006|Overall Study|Study Closed Locally|0|||
170679422|NCT03708328|616837975|FG007|Overall Study|Study Closed Locally|1|||
170679423|NCT03708328|616837976|FG008|Overall Study|Study Closed Locally|0|||
170679424|NCT03708328|616837977|FG009|Overall Study|Study Closed Locally|0|||
170679425|NCT03708328|616837968|FG000|Overall Study|Study Ended By Sponsor|0|||
170679426|NCT03708328|616837969|FG001|Overall Study|Study Ended By Sponsor|0|||
170679427|NCT03708328|616837970|FG002|Overall Study|Study Ended By Sponsor|0|||
170679428|NCT03708328|616837971|FG003|Overall Study|Study Ended By Sponsor|0|||
170679429|NCT03708328|616837972|FG004|Overall Study|Study Ended By Sponsor|0|||
170679430|NCT03708328|616837973|FG005|Overall Study|Study Ended By Sponsor|1|||
170679431|NCT03708328|616837974|FG006|Overall Study|Study Ended By Sponsor|0|||
170679432|NCT03708328|616837975|FG007|Overall Study|Study Ended By Sponsor|1|||
170679433|NCT03708328|616837976|FG008|Overall Study|Study Ended By Sponsor|0|||
170679434|NCT03708328|616837977|FG009|Overall Study|Study Ended By Sponsor|0|||
170679435|NCT03708328|616837968|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679436|NCT03708328|616837969|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679437|NCT03708328|616837970|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679438|NCT03708328|616837971|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679439|NCT03708328|616837972|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679440|NCT03708328|616837973|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679441|NCT03708328|616837974|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679442|NCT03708328|616837975|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679443|NCT03708328|616837976|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
170679444|NCT03708328|616837977|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
170679445|NCT00571948|616837978|FG000|Overall Study|Lost to Follow-up|2|||
170679446|NCT00571948|616837979|FG001|Overall Study|Lost to Follow-up|0|||
170679447|NCT00571948|616837978|FG000|Overall Study|Withdrawal by Subject|1|||
170679448|NCT00571948|616837979|FG001|Overall Study|Withdrawal by Subject|2|||
170679449|NCT00571948|616837978|FG000|Overall Study|Protocol Violation|3|||
170679450|NCT00571948|616837979|FG001|Overall Study|Protocol Violation|3|||
170679451|NCT00571948|616837978|FG000|Overall Study|infant refused study meal|3|||
170679452|NCT00571948|616837979|FG001|Overall Study|infant refused study meal|4|||
170679453|NCT00571948|616837978|FG000|Overall Study|Parent were afraid of blood colection|2|||
170679454|NCT00571948|616837979|FG001|Overall Study|Parent were afraid of blood colection|5|||
170679455|NCT01845831|616837980|FG000|Inpatient Phase|Withdrawal by Subject|1|||
170679456|NCT01845831|616837981|FG001|Inpatient Phase|Withdrawal by Subject|1|||
170679457|NCT01845831|616837982|FG002|Inpatient Phase|Withdrawal by Subject|0|||
170679458|NCT01845831|616837983|FG003|Inpatient Phase|Withdrawal by Subject|0|||
170679459|NCT01845831|616837984|FG004|Inpatient Phase|Withdrawal by Subject|0|||
170679460|NCT04786990|616837985|FG000|Overall Study|Withdrawal by Subject|1|||
170679461|NCT04786990|616837985|FG000|Overall Study|Adverse Event|1|||
170679462|NCT04786990|616837985|FG000|Overall Study|Lost to Follow-up|1|||
170679463|NCT04786990|616837985|FG000|Overall Study|Noncompliance|1|||
170679464|NCT04786990|616837985|FG000|Overall Study|Unable to complete site visits|1|||
170679465|NCT04786990|616837985|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
170679466|NCT01032837|616837986|FG000|Overall Study|Adverse event/internal illness|0|||
170679467|NCT01032837|616837987|FG001|Overall Study|Adverse event/internal illness|1|||
170679468|NCT01032837|616837988|FG002|Overall Study|Adverse event/internal illness|0|||
170679469|NCT01032837|616837989|FG003|Overall Study|Adverse event/internal illness|1|||
170679470|NCT01032837|616837986|FG000|Overall Study|Withdrew consent|0|||
170679471|NCT01032837|616837987|FG001|Overall Study|Withdrew consent|2|||
170679472|NCT01032837|616837988|FG002|Overall Study|Withdrew consent|0|||
170679473|NCT01032837|616837989|FG003|Overall Study|Withdrew consent|1|||
170679474|NCT01032837|616837986|FG000|Overall Study|Failed to return|0|||
170679475|NCT01032837|616837987|FG001|Overall Study|Failed to return|0|||
170679476|NCT01032837|616837988|FG002|Overall Study|Failed to return|1|||
170679477|NCT01032837|616837989|FG003|Overall Study|Failed to return|0|||
170679478|NCT01032837|616837986|FG000|Overall Study|Refused treatment|0|||
170679479|NCT01032837|616837987|FG001|Overall Study|Refused treatment|0|||
170679480|NCT01032837|616837988|FG002|Overall Study|Refused treatment|0|||
170679481|NCT01032837|616837989|FG003|Overall Study|Refused treatment|1|||
170679482|NCT00843024|616837990|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
170679483|NCT00843024|616837991|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
170679484|NCT00843024|616837992|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
170679485|NCT00843024|616837993|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
170679486|NCT00843024|616837994|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
170679487|NCT00843024|616837995|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
170679488|NCT00843024|616837990|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
170679489|NCT00843024|616837991|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
170679490|NCT00843024|616837992|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
170679491|NCT00843024|616837993|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
170679492|NCT00843024|616837994|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
170679493|NCT00843024|616837995|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
170679494|NCT00843024|616837990|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
170679495|NCT00843024|616837991|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
170679496|NCT00843024|616837992|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
170679497|NCT00843024|616837993|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
170679498|NCT00843024|616837994|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
170679499|NCT00843024|616837995|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
170679500|NCT00843024|616837990|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
170679501|NCT00843024|616837991|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
170679502|NCT00843024|616837992|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
170679503|NCT00843024|616837993|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
170679504|NCT00843024|616837994|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
170679505|NCT00843024|616837995|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
170679506|NCT00843024|616837990|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
170679507|NCT00843024|616837991|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
170679508|NCT00843024|616837992|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
170679509|NCT00843024|616837993|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
170679510|NCT00843024|616837994|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
170679511|NCT00843024|616837995|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
170679512|NCT00843024|616837990|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
170679513|NCT00843024|616837991|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
170679514|NCT00843024|616837992|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
170679515|NCT00843024|616837993|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
170679516|NCT00843024|616837994|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
170679517|NCT00843024|616837995|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
170679518|NCT00843024|616837990|FG000|Single-blind Placebo Run-In Phase|Other|0|||
170820691|NCT04908800|617351482|FG000|Overall Study|Adverse Event|0|||
170820692|NCT04908800|617351483|FG001|Overall Study|Adverse Event|0|||
170820693|NCT04908800|617351484|FG002|Overall Study|Adverse Event|0|||
170820694|NCT04908800|617351485|FG003|Overall Study|Adverse Event|0|||
170820695|NCT04908800|617351486|FG004|Overall Study|Adverse Event|0|||
170679519|NCT00843024|616837991|FG001|Single-blind Placebo Run-In Phase|Other|1|||
170679520|NCT00843024|616837992|FG002|Single-blind Placebo Run-In Phase|Other|0|||
170679521|NCT00843024|616837993|FG003|Single-blind Placebo Run-In Phase|Other|0|||
170679522|NCT00843024|616837994|FG004|Single-blind Placebo Run-In Phase|Other|0|||
170679523|NCT00843024|616837995|FG005|Single-blind Placebo Run-In Phase|Other|0|||
170679524|NCT00843024|616837990|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
170679525|NCT00843024|616837991|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
170679526|NCT00843024|616837992|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
170679527|NCT00843024|616837993|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
170679528|NCT00843024|616837994|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
170679529|NCT00843024|616837995|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
170679530|NCT00843024|616837990|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
170679531|NCT00843024|616837991|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
170679532|NCT00843024|616837992|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
170679533|NCT00843024|616837993|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
170679534|NCT00843024|616837994|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
170679535|NCT00843024|616837995|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
170679536|NCT00843024|616837990|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170679537|NCT00843024|616837991|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170679538|NCT00843024|616837992|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170679539|NCT00843024|616837993|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
170820696|NCT04908800|617351487|FG005|Overall Study|Adverse Event|0|||
170820697|NCT04908800|617351488|FG006|Overall Study|Adverse Event|0|||
170820698|NCT04908800|617351489|FG007|Overall Study|Adverse Event|0|||
170820699|NCT04908800|617351490|FG008|Overall Study|Adverse Event|0|||
170820700|NCT04908800|617351491|FG009|Overall Study|Adverse Event|0|||
170820701|NCT04908800|617351492|FG010|Overall Study|Adverse Event|1|||
170820702|NCT04908800|617351493|FG011|Overall Study|Adverse Event|0|||
170820703|NCT04908800|617351494|FG012|Overall Study|Adverse Event|0|||
170820704|NCT03751280|617351495|FG000|Overall Study|Adverse Event|0|||
170820705|NCT03751280|617351496|FG001|Overall Study|Adverse Event|1|||
170820706|NCT03751280|617351495|FG000|Overall Study|Lost to Follow-up|3|||
170820707|NCT03751280|617351496|FG001|Overall Study|Lost to Follow-up|5|||
170820708|NCT03751280|617351495|FG000|Overall Study|Physician Decision|0|||
170820709|NCT03751280|617351496|FG001|Overall Study|Physician Decision|2|||
170820710|NCT03751280|617351495|FG000|Overall Study|Protocol Violation|0|||
170820711|NCT03751280|617351496|FG001|Overall Study|Protocol Violation|2|||
170820712|NCT03751280|617351495|FG000|Overall Study|Withdrawal by Subject|5|||
170820713|NCT03751280|617351496|FG001|Overall Study|Withdrawal by Subject|2|||
170820714|NCT01190228|617351504|FG000|Overall Study|Protocol Violation|4|||
170820715|NCT01190228|617351505|FG001|Overall Study|Protocol Violation|0|||
170820716|NCT01190228|617351506|FG002|Overall Study|Protocol Violation|0|||
170820717|NCT01190228|617351504|FG000|Overall Study|Withdrawal by Subject|1|||
170820718|NCT01190228|617351505|FG001|Overall Study|Withdrawal by Subject|0|||
170820719|NCT01190228|617351506|FG002|Overall Study|Withdrawal by Subject|0|||
170820720|NCT01395914|617351510|FG000|Overall Study|Unrelated to study drug AE|6|||
170679540|NCT00843024|616837994|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170679541|NCT00843024|616837995|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
170679542|NCT00843024|616837990|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
170679543|NCT00843024|616837991|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
170679544|NCT00843024|616837992|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
170679545|NCT00843024|616837993|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
170679546|NCT00843024|616837994|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
170679547|NCT00843024|616837995|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
170679548|NCT00843024|616837990|FG000|Double-blind Treatment Phase|Physician Decision|0|||
170679549|NCT00843024|616837991|FG001|Double-blind Treatment Phase|Physician Decision|0|||
170679550|NCT00843024|616837992|FG002|Double-blind Treatment Phase|Physician Decision|0|||
170679551|NCT00843024|616837993|FG003|Double-blind Treatment Phase|Physician Decision|3|||
170679552|NCT00843024|616837994|FG004|Double-blind Treatment Phase|Physician Decision|1|||
170679553|NCT00843024|616837995|FG005|Double-blind Treatment Phase|Physician Decision|1|||
170679554|NCT00843024|616837990|FG000|Double-blind Treatment Phase|Adverse Event|0|||
170679555|NCT00843024|616837991|FG001|Double-blind Treatment Phase|Adverse Event|0|||
170679556|NCT00843024|616837992|FG002|Double-blind Treatment Phase|Adverse Event|0|||
170679557|NCT00843024|616837993|FG003|Double-blind Treatment Phase|Adverse Event|0|||
170679558|NCT00843024|616837994|FG004|Double-blind Treatment Phase|Adverse Event|1|||
170679559|NCT00843024|616837995|FG005|Double-blind Treatment Phase|Adverse Event|1|||
170679560|NCT00843024|616837990|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
170679561|NCT00843024|616837991|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
170679562|NCT00843024|616837992|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
170679563|NCT00843024|616837993|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
170679564|NCT00843024|616837994|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
170679565|NCT00843024|616837995|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
170679566|NCT01197560|616837996|FG000|Overall Study|Adverse Event|6|||
170679567|NCT01197560|616837997|FG001|Overall Study|Adverse Event|8|||
170679568|NCT01197560|616837996|FG000|Overall Study|Death|3|||
170679569|NCT01197560|616837997|FG001|Overall Study|Death|5|||
170679570|NCT01197560|616837996|FG000|Overall Study|Withdrawal by Subject|1|||
170679571|NCT01197560|616837997|FG001|Overall Study|Withdrawal by Subject|1|||
170679572|NCT01197560|616837996|FG000|Overall Study|Disease progression|40|||
170679573|NCT01197560|616837997|FG001|Overall Study|Disease progression|35|||
170679574|NCT01197560|616837996|FG000|Overall Study|Miscellaneous|4|||
170679575|NCT01197560|616837997|FG001|Overall Study|Miscellaneous|3|||
170679576|NCT01197560|616837996|FG000|Overall Study|Missing|0|||
170679577|NCT01197560|616837997|FG001|Overall Study|Missing|1|||
170679578|NCT05201703|616837998|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
170679579|NCT05201703|616837999|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
170679580|NCT05201703|616837998|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
170679581|NCT05201703|616837999|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
170679582|NCT02006719|616838000|FG000|Overall Study|Withdrawal by Subject|10|||
170679583|NCT02006719|616838001|FG001|Overall Study|Withdrawal by Subject|2|||
170679584|NCT02006719|616838000|FG000|Overall Study|Lost to Follow-up|5|||
170679585|NCT02006719|616838001|FG001|Overall Study|Lost to Follow-up|1|||
170679586|NCT02006719|616838000|FG000|Overall Study|Protocol Violation|2|||
170820721|NCT01395914|617351511|FG001|Overall Study|Unrelated to study drug AE|1|||
170820722|NCT01395914|617351510|FG000|Overall Study|Death|23|||
170820723|NCT01395914|617351511|FG001|Overall Study|Death|17|||
170820724|NCT01395914|617351510|FG000|Overall Study|Other|9|||
170820725|NCT01395914|617351511|FG001|Overall Study|Other|3|||
170820726|NCT01395914|617351510|FG000|Overall Study|Withdrawal by patient|27|||
170820727|NCT01395914|617351511|FG001|Overall Study|Withdrawal by patient|14|||
170820728|NCT01395914|617351510|FG000|Overall Study|Study drug-related AE|1|||
170820729|NCT01395914|617351511|FG001|Overall Study|Study drug-related AE|0|||
170820730|NCT01395914|617351510|FG000|Overall Study|Lost to Follow-up|6|||
170820731|NCT01395914|617351511|FG001|Overall Study|Lost to Follow-up|2|||
170820732|NCT01648699|617351512|FG000|Overall Study|Death|1|||
170820733|NCT01648699|617351512|FG000|Overall Study|Lost to Follow-up|2|||
170820734|NCT01648699|617351512|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
170820735|NCT05234632|617351513|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
170820736|NCT05234632|617351514|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
170820737|NCT05234632|617351513|FG000|Overall Study|Withdrawal by Subject|2|||
170820738|NCT05234632|617351514|FG001|Overall Study|Withdrawal by Subject|0|||
170820739|NCT05234632|617351513|FG000|Overall Study|Adverse Event|0|||
170820740|NCT05234632|617351514|FG001|Overall Study|Adverse Event|4|||
170820741|NCT05234632|617351513|FG000|Overall Study|Physician Decision|1|||
170820742|NCT05234632|617351514|FG001|Overall Study|Physician Decision|1|||
170820743|NCT05234632|617351513|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
170820744|NCT05234632|617351514|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
170820745|NCT05234632|617351513|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
170679587|NCT02006719|616838001|FG001|Overall Study|Protocol Violation|0|||
170679588|NCT02006719|616838000|FG000|Overall Study|Adverse Event|1|||
170679589|NCT02006719|616838001|FG001|Overall Study|Adverse Event|1|||
170679590|NCT02006719|616838000|FG000|Overall Study|Other/Unknown|0|||
170679591|NCT02006719|616838001|FG001|Overall Study|Other/Unknown|1|||
170679592|NCT02615145|616838003|FG000|Overall Study|Did Not Start Treatment|0|||
170679593|NCT02615145|616838004|FG001|Overall Study|Did Not Start Treatment|0|||
170679594|NCT02615145|616838005|FG002|Overall Study|Did Not Start Treatment|1|||
170679595|NCT02615145|616838006|FG003|Overall Study|Did Not Start Treatment|1|||
170679596|NCT02615145|616838003|FG000|Overall Study|Failure to Return|20|||
170679597|NCT02615145|616838004|FG001|Overall Study|Failure to Return|10|||
170679598|NCT02615145|616838005|FG002|Overall Study|Failure to Return|7|||
170679599|NCT02615145|616838006|FG003|Overall Study|Failure to Return|0|||
170679600|NCT02615145|616838003|FG000|Overall Study|Death|2|||
170679601|NCT02615145|616838004|FG001|Overall Study|Death|3|||
170679602|NCT02615145|616838005|FG002|Overall Study|Death|0|||
170679603|NCT02615145|616838006|FG003|Overall Study|Death|0|||
170679604|NCT02615145|616838003|FG000|Overall Study|Other, Not Specified|5|||
170679605|NCT02615145|616838004|FG001|Overall Study|Other, Not Specified|2|||
170679606|NCT02615145|616838005|FG002|Overall Study|Other, Not Specified|0|||
170679607|NCT02615145|616838006|FG003|Overall Study|Other, Not Specified|0|||
170679608|NCT00006237|616838011|FG000|Overall Study|Adverse Event|39|||
170679609|NCT00006237|616838012|FG001|Overall Study|Adverse Event|29|||
170679610|NCT00006237|616838011|FG000|Overall Study|Death|1|||
170679611|NCT00006237|616838012|FG001|Overall Study|Death|0|||
170679612|NCT00006237|616838011|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
170679613|NCT00006237|616838012|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
170679614|NCT00006237|616838011|FG000|Overall Study|Progression/relapse|54|||
170679615|NCT00006237|616838012|FG001|Overall Study|Progression/relapse|2|||
170679616|NCT00006237|616838011|FG000|Overall Study|Not eligible|9|||
170679617|NCT00006237|616838012|FG001|Overall Study|Not eligible|20|||
170679618|NCT00006237|616838011|FG000|Overall Study|Withdrawal by Subject|0|||
170679619|NCT00006237|616838012|FG001|Overall Study|Withdrawal by Subject|1|||
170679620|NCT00006237|616838011|FG000|Overall Study|Not protocol specified|14|||
170679621|NCT00006237|616838012|FG001|Overall Study|Not protocol specified|5|||
170679622|NCT00211510|616838017|FG000|Overall Study|Physician Decision|3|||
170679623|NCT00211510|616838018|FG001|Overall Study|Physician Decision|1|||
170679624|NCT00211510|616838017|FG000|Overall Study|Withdrawal by Subject|3|||
170679625|NCT00211510|616838018|FG001|Overall Study|Withdrawal by Subject|1|||
170679626|NCT01487200|616838019|FG000|Overall Study|Withdrawal by Subject|0|||
170679627|NCT01487200|616838020|FG001|Overall Study|Withdrawal by Subject|1|||
170679628|NCT01487200|616838021|FG002|Overall Study|Withdrawal by Subject|0|||
170679629|NCT01487200|616838022|FG003|Overall Study|Withdrawal by Subject|0|||
170679630|NCT00496054|616838029|FG000|Overall Study|Adverse Event|1|||
170679631|NCT00496054|616838029|FG000|Overall Study|Lost to Follow-up|7|||
170679632|NCT01737697|616838030|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679633|NCT01737697|616838031|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
170679634|NCT01737697|616838032|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679635|NCT01737697|616838033|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
170679636|NCT01737697|616838034|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
170679637|NCT01737697|616838035|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679638|NCT01737697|616838036|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679639|NCT01737697|616838037|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679640|NCT01737697|616838038|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679641|NCT01737697|616838039|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679642|NCT01737697|616838040|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679643|NCT01737697|616838041|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679644|NCT01737697|616838042|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679645|NCT01737697|616838043|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679646|NCT01737697|616838044|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
170679647|NCT01737697|616838030|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
170679648|NCT01737697|616838031|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
170679649|NCT01737697|616838032|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
170679650|NCT01737697|616838033|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679651|NCT01737697|616838034|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679652|NCT01737697|616838035|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679653|NCT01737697|616838036|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679654|NCT01737697|616838037|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679655|NCT01737697|616838038|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679656|NCT01737697|616838039|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679657|NCT01737697|616838040|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679658|NCT01737697|616838041|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679659|NCT01737697|616838042|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679660|NCT01737697|616838043|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679661|NCT01737697|616838044|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
170679662|NCT01737697|616838030|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679663|NCT01737697|616838031|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679664|NCT01737697|616838032|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679665|NCT01737697|616838033|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
170679666|NCT01737697|616838034|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679667|NCT01737697|616838035|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679668|NCT01737697|616838036|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679669|NCT01737697|616838037|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679670|NCT01737697|616838038|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679671|NCT01737697|616838039|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679672|NCT01737697|616838040|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679673|NCT01737697|616838041|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679674|NCT01737697|616838042|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679675|NCT01737697|616838043|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679676|NCT01737697|616838044|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
170679677|NCT01737697|616838030|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679678|NCT01737697|616838031|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
170679679|NCT01737697|616838032|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679680|NCT01737697|616838033|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679681|NCT01737697|616838034|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679682|NCT01737697|616838035|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679683|NCT01737697|616838036|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679684|NCT01737697|616838037|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679685|NCT01737697|616838038|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679686|NCT01737697|616838039|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679687|NCT01737697|616838040|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679688|NCT01737697|616838041|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679689|NCT01737697|616838042|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679690|NCT01737697|616838043|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679691|NCT01737697|616838044|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
170679692|NCT01737697|616838030|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679693|NCT01737697|616838031|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679694|NCT01737697|616838032|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679695|NCT01737697|616838033|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679696|NCT01737697|616838034|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
170679697|NCT01737697|616838035|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679698|NCT01737697|616838036|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679699|NCT01737697|616838037|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679700|NCT01737697|616838038|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679701|NCT01737697|616838039|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679702|NCT01737697|616838040|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679703|NCT01737697|616838041|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679704|NCT01737697|616838042|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679705|NCT01737697|616838043|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679706|NCT01737697|616838044|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
170679707|NCT01737697|616838030|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679708|NCT01737697|616838031|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
170679709|NCT01737697|616838032|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
170820746|NCT05234632|617351514|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
170820747|NCT04799587|617351515|FG000|Overall Study|Withdrawal by Subject|0|||
170820748|NCT04799587|617351516|FG001|Overall Study|Withdrawal by Subject|1|||
170820749|NCT00728884|617351517|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
170820750|NCT00728884|617351517|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
170820751|NCT05216835|617351521|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
170820752|NCT05216835|617351522|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
170820753|NCT05216835|617351523|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
170820754|NCT05216835|617351524|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
170820755|NCT05216835|617351525|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
170820756|NCT05216835|617351526|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
170820757|NCT05216835|617351527|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
170820758|NCT05216835|617351528|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
170679710|NCT01737697|616838033|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
170679711|NCT01737697|616838034|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
170679712|NCT01737697|616838035|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679713|NCT01737697|616838036|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679714|NCT01737697|616838037|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679715|NCT01737697|616838038|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679716|NCT01737697|616838039|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679717|NCT01737697|616838040|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679718|NCT01737697|616838041|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679719|NCT01737697|616838042|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679720|NCT01737697|616838043|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679721|NCT01737697|616838044|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
170679722|NCT01737697|616838030|FG000|Subacute Phase|Adverse Event|0|||
170820759|NCT05216835|617351521|FG000|Overall Study|Death|0|||
170820760|NCT05216835|617351522|FG001|Overall Study|Death|0|||
170820761|NCT05216835|617351523|FG002|Overall Study|Death|0|||
170820762|NCT05216835|617351524|FG003|Overall Study|Death|1|||
170820763|NCT05216835|617351525|FG004|Overall Study|Death|1|||
170820764|NCT05216835|617351526|FG005|Overall Study|Death|1|||
170820765|NCT05216835|617351527|FG006|Overall Study|Death|1|||
170820766|NCT05216835|617351528|FG007|Overall Study|Death|1|||
170820767|NCT05216835|617351521|FG000|Overall Study|Physician Decision|0|||
170820768|NCT05216835|617351522|FG001|Overall Study|Physician Decision|0|||
170820769|NCT05216835|617351523|FG002|Overall Study|Physician Decision|0|||
170820770|NCT05216835|617351524|FG003|Overall Study|Physician Decision|0|||
170820771|NCT05216835|617351525|FG004|Overall Study|Physician Decision|0|||
170820772|NCT05216835|617351526|FG005|Overall Study|Physician Decision|1|||
170820773|NCT05216835|617351527|FG006|Overall Study|Physician Decision|1|||
170820774|NCT05216835|617351528|FG007|Overall Study|Physician Decision|0|||
170820775|NCT05216835|617351521|FG000|Overall Study|Study terminated by Sponsor|0|||
170820776|NCT05216835|617351522|FG001|Overall Study|Study terminated by Sponsor|0|||
170820777|NCT05216835|617351523|FG002|Overall Study|Study terminated by Sponsor|0|||
170820778|NCT05216835|617351524|FG003|Overall Study|Study terminated by Sponsor|0|||
170820779|NCT05216835|617351525|FG004|Overall Study|Study terminated by Sponsor|0|||
170679723|NCT01737697|616838031|FG001|Subacute Phase|Adverse Event|0|||
170679724|NCT01737697|616838032|FG002|Subacute Phase|Adverse Event|0|||
170679725|NCT01737697|616838033|FG003|Subacute Phase|Adverse Event|0|||
170679726|NCT01737697|616838034|FG004|Subacute Phase|Adverse Event|0|||
170679727|NCT01737697|616838035|FG005|Subacute Phase|Adverse Event|1|||
170679728|NCT01737697|616838036|FG006|Subacute Phase|Adverse Event|1|||
170679729|NCT01737697|616838037|FG007|Subacute Phase|Adverse Event|1|||
170679730|NCT01737697|616838038|FG008|Subacute Phase|Adverse Event|1|||
170679731|NCT01737697|616838039|FG009|Subacute Phase|Adverse Event|1|||
170679732|NCT01737697|616838040|FG010|Subacute Phase|Adverse Event|4|||
170679733|NCT01737697|616838041|FG011|Subacute Phase|Adverse Event|1|||
170679734|NCT01737697|616838042|FG012|Subacute Phase|Adverse Event|1|||
170679735|NCT01737697|616838043|FG013|Subacute Phase|Adverse Event|0|||
170679736|NCT01737697|616838044|FG014|Subacute Phase|Adverse Event|0|||
170679737|NCT01737697|616838030|FG000|Subacute Phase|Withdrawal by Subject|0|||
170679738|NCT01737697|616838031|FG001|Subacute Phase|Withdrawal by Subject|0|||
170679739|NCT01737697|616838032|FG002|Subacute Phase|Withdrawal by Subject|0|||
170679740|NCT01737697|616838033|FG003|Subacute Phase|Withdrawal by Subject|0|||
170679741|NCT01737697|616838034|FG004|Subacute Phase|Withdrawal by Subject|0|||
170679742|NCT01737697|616838035|FG005|Subacute Phase|Withdrawal by Subject|1|||
170679743|NCT01737697|616838036|FG006|Subacute Phase|Withdrawal by Subject|0|||
170679744|NCT01737697|616838037|FG007|Subacute Phase|Withdrawal by Subject|2|||
170679745|NCT01737697|616838038|FG008|Subacute Phase|Withdrawal by Subject|0|||
170679746|NCT01737697|616838039|FG009|Subacute Phase|Withdrawal by Subject|1|||
170679747|NCT01737697|616838040|FG010|Subacute Phase|Withdrawal by Subject|0|||
170679748|NCT01737697|616838041|FG011|Subacute Phase|Withdrawal by Subject|1|||
170679749|NCT01737697|616838042|FG012|Subacute Phase|Withdrawal by Subject|1|||
170679750|NCT01737697|616838043|FG013|Subacute Phase|Withdrawal by Subject|1|||
170679751|NCT01737697|616838044|FG014|Subacute Phase|Withdrawal by Subject|0|||
170679752|NCT01737697|616838030|FG000|Subacute Phase|Lost to Follow-up|0|||
170679753|NCT01737697|616838031|FG001|Subacute Phase|Lost to Follow-up|0|||
170679754|NCT01737697|616838032|FG002|Subacute Phase|Lost to Follow-up|0|||
170679755|NCT01737697|616838033|FG003|Subacute Phase|Lost to Follow-up|0|||
170679756|NCT01737697|616838034|FG004|Subacute Phase|Lost to Follow-up|0|||
170679757|NCT01737697|616838035|FG005|Subacute Phase|Lost to Follow-up|0|||
170679758|NCT01737697|616838036|FG006|Subacute Phase|Lost to Follow-up|0|||
170679759|NCT01737697|616838037|FG007|Subacute Phase|Lost to Follow-up|0|||
170679760|NCT01737697|616838038|FG008|Subacute Phase|Lost to Follow-up|0|||
170679761|NCT01737697|616838039|FG009|Subacute Phase|Lost to Follow-up|0|||
170679762|NCT01737697|616838040|FG010|Subacute Phase|Lost to Follow-up|0|||
170679763|NCT01737697|616838041|FG011|Subacute Phase|Lost to Follow-up|0|||
170679764|NCT01737697|616838042|FG012|Subacute Phase|Lost to Follow-up|0|||
170679765|NCT01737697|616838043|FG013|Subacute Phase|Lost to Follow-up|0|||
170679766|NCT01737697|616838044|FG014|Subacute Phase|Lost to Follow-up|1|||
170679767|NCT01737697|616838030|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
170679768|NCT01737697|616838031|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
170679769|NCT01737697|616838032|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
170679770|NCT01737697|616838033|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
170679771|NCT01737697|616838034|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
170679772|NCT01737697|616838035|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
170679773|NCT01737697|616838036|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
170679774|NCT01737697|616838037|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
170679775|NCT01737697|616838038|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
170679776|NCT01737697|616838039|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
170679777|NCT01737697|616838040|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
170679778|NCT01737697|616838041|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
170679779|NCT01737697|616838042|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
170679780|NCT01737697|616838043|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
170679781|NCT01737697|616838044|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
170679782|NCT01737697|616838030|FG000|Subacute Phase|Protocol Violation|0|||
170679783|NCT01737697|616838031|FG001|Subacute Phase|Protocol Violation|0|||
170679784|NCT01737697|616838032|FG002|Subacute Phase|Protocol Violation|0|||
170679785|NCT01737697|616838033|FG003|Subacute Phase|Protocol Violation|0|||
170679786|NCT01737697|616838034|FG004|Subacute Phase|Protocol Violation|0|||
170679787|NCT01737697|616838035|FG005|Subacute Phase|Protocol Violation|1|||
170679788|NCT01737697|616838036|FG006|Subacute Phase|Protocol Violation|0|||
170679789|NCT01737697|616838037|FG007|Subacute Phase|Protocol Violation|0|||
170679790|NCT01737697|616838038|FG008|Subacute Phase|Protocol Violation|0|||
170679791|NCT01737697|616838039|FG009|Subacute Phase|Protocol Violation|0|||
170679792|NCT01737697|616838040|FG010|Subacute Phase|Protocol Violation|1|||
170679793|NCT01737697|616838041|FG011|Subacute Phase|Protocol Violation|0|||
170679794|NCT01737697|616838042|FG012|Subacute Phase|Protocol Violation|0|||
170679795|NCT01737697|616838043|FG013|Subacute Phase|Protocol Violation|0|||
170679796|NCT01737697|616838044|FG014|Subacute Phase|Protocol Violation|0|||
170679797|NCT01737697|616838030|FG000|Subacute Phase|Physician Decision|0|||
170679798|NCT01737697|616838031|FG001|Subacute Phase|Physician Decision|0|||
170679799|NCT01737697|616838032|FG002|Subacute Phase|Physician Decision|0|||
170679800|NCT01737697|616838033|FG003|Subacute Phase|Physician Decision|0|||
170679801|NCT01737697|616838034|FG004|Subacute Phase|Physician Decision|0|||
170679802|NCT01737697|616838035|FG005|Subacute Phase|Physician Decision|0|||
170679803|NCT01737697|616838036|FG006|Subacute Phase|Physician Decision|0|||
170679804|NCT01737697|616838037|FG007|Subacute Phase|Physician Decision|0|||
170679805|NCT01737697|616838038|FG008|Subacute Phase|Physician Decision|1|||
170679806|NCT01737697|616838039|FG009|Subacute Phase|Physician Decision|0|||
170679807|NCT01737697|616838040|FG010|Subacute Phase|Physician Decision|0|||
170679808|NCT01737697|616838041|FG011|Subacute Phase|Physician Decision|0|||
170679809|NCT01737697|616838042|FG012|Subacute Phase|Physician Decision|0|||
170679810|NCT01737697|616838043|FG013|Subacute Phase|Physician Decision|0|||
170679811|NCT01737697|616838044|FG014|Subacute Phase|Physician Decision|0|||
170679812|NCT01737697|616838030|FG000|Subacute Phase|Death|0|||
170679813|NCT01737697|616838031|FG001|Subacute Phase|Death|0|||
170679814|NCT01737697|616838032|FG002|Subacute Phase|Death|0|||
170679815|NCT01737697|616838033|FG003|Subacute Phase|Death|0|||
170679816|NCT01737697|616838034|FG004|Subacute Phase|Death|0|||
170679817|NCT01737697|616838035|FG005|Subacute Phase|Death|0|||
170679818|NCT01737697|616838036|FG006|Subacute Phase|Death|0|||
170679819|NCT01737697|616838037|FG007|Subacute Phase|Death|0|||
170679820|NCT01737697|616838038|FG008|Subacute Phase|Death|0|||
170679821|NCT01737697|616838039|FG009|Subacute Phase|Death|0|||
170679822|NCT01737697|616838040|FG010|Subacute Phase|Death|1|||
170679823|NCT01737697|616838041|FG011|Subacute Phase|Death|0|||
170679824|NCT01737697|616838042|FG012|Subacute Phase|Death|0|||
170679825|NCT01737697|616838043|FG013|Subacute Phase|Death|0|||
170679826|NCT01737697|616838044|FG014|Subacute Phase|Death|0|||
170679827|NCT02862171|616838047|FG000|Overall Study|Death|1|||
170679828|NCT02862171|616838047|FG000|Overall Study|Lost to Follow-up|13|||
170679829|NCT02862171|616838047|FG000|Overall Study|Withdrawal by Subject|57|||
170679830|NCT02862171|616838047|FG000|Overall Study|Non-compliance|4|||
170679831|NCT02862171|616838047|FG000|Overall Study|HIV-1 seroconversion|18|||
170679832|NCT01962896|616838048|FG000|Overall Study|Lack of Efficacy|4|||
170679833|NCT00458211|616838049|FG000|Overall Study|Lack of Efficacy|12|||
170679834|NCT00458211|616838049|FG000|Overall Study|Withdrawal by Subject|2|||
170679835|NCT00458211|616838049|FG000|Overall Study|Protocol Violation|2|||
170679836|NCT02144012|616838050|FG000|Overall Study|Adverse Event|1|||
170679837|NCT02144012|616838051|FG001|Overall Study|Adverse Event|0|||
170679838|NCT02144012|616838050|FG000|Overall Study|Death|1|||
170679839|NCT02144012|616838051|FG001|Overall Study|Death|0|||
170679840|NCT02144012|616838050|FG000|Overall Study|Withdrawal by Subject|11|||
170679841|NCT02144012|616838051|FG001|Overall Study|Withdrawal by Subject|3|||
170679842|NCT02144012|616838050|FG000|Overall Study|Study Terminated by Sponsor|18|||
170679843|NCT02144012|616838051|FG001|Overall Study|Study Terminated by Sponsor|12|||
170679844|NCT02144012|616838050|FG000|Overall Study|Other|3|||
170679845|NCT02144012|616838051|FG001|Overall Study|Other|0|||
170679846|NCT04342897|616838052|FG000|Overall Study|Death|7|||
170679847|NCT04342897|616838053|FG001|Overall Study|Death|4|||
170679848|NCT04342897|616838052|FG000|Overall Study|Lost to Follow-up|6|||
170679849|NCT04342897|616838053|FG001|Overall Study|Lost to Follow-up|6|||
170679850|NCT04342897|616838052|FG000|Overall Study|Withdrawal by Subject|1|||
170679851|NCT04342897|616838053|FG001|Overall Study|Withdrawal by Subject|2|||
170679852|NCT00621153|616838058|FG000|Overall Study|Safety Reason|8|||
170679853|NCT00621153|616838059|FG001|Overall Study|Safety Reason|7|||
170679854|NCT00621153|616838058|FG000|Overall Study|Adverse Event|3|||
170679855|NCT00621153|616838059|FG001|Overall Study|Adverse Event|2|||
170679856|NCT00621153|616838058|FG000|Overall Study|Lost to Follow-up|5|||
170679857|NCT00621153|616838059|FG001|Overall Study|Lost to Follow-up|1|||
170679858|NCT00621153|616838058|FG000|Overall Study|Withdrawal by Subject|4|||
170679859|NCT00621153|616838059|FG001|Overall Study|Withdrawal by Subject|5|||
170679860|NCT01753856|616838064|FG000|Overall Study|Adverse Event|1|||
170679861|NCT01753856|616838065|FG001|Overall Study|Adverse Event|0|||
170679862|NCT01753856|616838064|FG000|Overall Study|Withdrawal by Subject|0|||
170679863|NCT01753856|616838065|FG001|Overall Study|Withdrawal by Subject|2|||
170679864|NCT01753856|616838064|FG000|Overall Study|Sponsor Decision|2|||
170679865|NCT01753856|616838065|FG001|Overall Study|Sponsor Decision|0|||
170679866|NCT04600921|616838066|FG000|Overall Study|Withdrawal by Subject|3|||
170679867|NCT04600921|616838067|FG001|Overall Study|Withdrawal by Subject|5|||
170679868|NCT04600921|616838066|FG000|Overall Study|Death|0|||
170679869|NCT04600921|616838067|FG001|Overall Study|Death|1|||
170679870|NCT05330702|616838068|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
170679871|NCT05330702|616838069|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
170679872|NCT05330702|616838070|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
170679873|NCT02881554|616838071|FG000|Overall Study|Withdrawal by Subject|2|||
170679874|NCT02881554|616838072|FG001|Overall Study|Withdrawal by Subject|0|||
170679875|NCT03909295|616840255|FG000|Overall Study|Adverse Event|2|||
170679876|NCT03909295|616840255|FG000|Overall Study|Study terminated by sponsor|50|||
170679877|NCT02141282|616840256|FG000|Overall Study|Adverse event, not related to progression|8|||
170679878|NCT02141282|616840257|FG001|Overall Study|Adverse event, not related to progression|1|||
170679879|NCT02141282|616840258|FG002|Overall Study|Adverse event, not related to progression|3|||
170679880|NCT02141282|616840259|FG003|Overall Study|Adverse event, not related to progression|1|||
170679881|NCT02141282|616840256|FG000|Overall Study|Adverse event, related to progression|1|||
170679882|NCT02141282|616840257|FG001|Overall Study|Adverse event, related to progression|0|||
170679883|NCT02141282|616840258|FG002|Overall Study|Adverse event, related to progression|2|||
170679884|NCT02141282|616840259|FG003|Overall Study|Adverse event, related to progression|0|||
170679885|NCT02141282|616840256|FG000|Overall Study|COVID-19 infection|1|||
170679886|NCT02141282|616840257|FG001|Overall Study|COVID-19 infection|0|||
170679887|NCT02141282|616840258|FG002|Overall Study|COVID-19 infection|0|||
170679888|NCT02141282|616840259|FG003|Overall Study|COVID-19 infection|0|||
170679889|NCT02141282|616840256|FG000|Overall Study|Lost to Follow-up|0|||
170679890|NCT02141282|616840257|FG001|Overall Study|Lost to Follow-up|0|||
170679891|NCT02141282|616840258|FG002|Overall Study|Lost to Follow-up|4|||
170679892|NCT02141282|616840259|FG003|Overall Study|Lost to Follow-up|2|||
170679893|NCT02141282|616840256|FG000|Overall Study|Other, not specified|14|||
170679894|NCT02141282|616840257|FG001|Overall Study|Other, not specified|11|||
170679895|NCT02141282|616840258|FG002|Overall Study|Other, not specified|23|||
170679896|NCT02141282|616840259|FG003|Overall Study|Other, not specified|9|||
170679897|NCT02141282|616840256|FG000|Overall Study|Progressive disease, Richter's|4|||
170679898|NCT02141282|616840257|FG001|Overall Study|Progressive disease, Richter's|1|||
170679899|NCT02141282|616840258|FG002|Overall Study|Progressive disease, Richter's|1|||
170679900|NCT02141282|616840259|FG003|Overall Study|Progressive disease, Richter's|1|||
170679901|NCT02141282|616840256|FG000|Overall Study|Progressive disease per protocol|12|||
170679902|NCT02141282|616840257|FG001|Overall Study|Progressive disease per protocol|7|||
170679903|NCT02141282|616840258|FG002|Overall Study|Progressive disease per protocol|9|||
170679904|NCT02141282|616840259|FG003|Overall Study|Progressive disease per protocol|2|||
170679905|NCT02141282|616840256|FG000|Overall Study|Stem cell transplant|1|||
170679906|NCT02141282|616840257|FG001|Overall Study|Stem cell transplant|0|||
170679907|NCT02141282|616840258|FG002|Overall Study|Stem cell transplant|1|||
170679908|NCT02141282|616840259|FG003|Overall Study|Stem cell transplant|0|||
170679909|NCT02141282|616840256|FG000|Overall Study|Study terminated by Sponsor|0|||
170679910|NCT02141282|616840257|FG001|Overall Study|Study terminated by Sponsor|1|||
170679911|NCT02141282|616840258|FG002|Overall Study|Study terminated by Sponsor|0|||
170679912|NCT02141282|616840259|FG003|Overall Study|Study terminated by Sponsor|0|||
170679913|NCT02141282|616840256|FG000|Overall Study|Subject non-compliance|0|||
170679914|NCT02141282|616840257|FG001|Overall Study|Subject non-compliance|0|||
170679915|NCT02141282|616840258|FG002|Overall Study|Subject non-compliance|1|||
170679916|NCT02141282|616840259|FG003|Overall Study|Subject non-compliance|0|||
170679917|NCT02141282|616840256|FG000|Overall Study|Withdrew consent|2|||
170679918|NCT02141282|616840257|FG001|Overall Study|Withdrew consent|0|||
170679919|NCT02141282|616840258|FG002|Overall Study|Withdrew consent|4|||
170679920|NCT02141282|616840259|FG003|Overall Study|Withdrew consent|0|||
170820780|NCT05216835|617351526|FG005|Overall Study|Study terminated by Sponsor|0|||
170820781|NCT05216835|617351527|FG006|Overall Study|Study terminated by Sponsor|0|||
170820782|NCT05216835|617351528|FG007|Overall Study|Study terminated by Sponsor|1|||
170820783|NCT05216835|617351521|FG000|Overall Study|Withdrawal by Subject|1|||
170820784|NCT05216835|617351522|FG001|Overall Study|Withdrawal by Subject|0|||
170820785|NCT05216835|617351523|FG002|Overall Study|Withdrawal by Subject|1|||
170820786|NCT05216835|617351524|FG003|Overall Study|Withdrawal by Subject|0|||
170820787|NCT05216835|617351525|FG004|Overall Study|Withdrawal by Subject|1|||
170820788|NCT05216835|617351526|FG005|Overall Study|Withdrawal by Subject|0|||
170820789|NCT05216835|617351527|FG006|Overall Study|Withdrawal by Subject|0|||
170820790|NCT05216835|617351528|FG007|Overall Study|Withdrawal by Subject|1|||
170820791|NCT05216835|617351521|FG000|Overall Study|Other|0|||
170820792|NCT05216835|617351522|FG001|Overall Study|Other|1|||
170820793|NCT05216835|617351523|FG002|Overall Study|Other|0|||
170820794|NCT05216835|617351524|FG003|Overall Study|Other|0|||
170820795|NCT05216835|617351525|FG004|Overall Study|Other|0|||
170820796|NCT05216835|617351526|FG005|Overall Study|Other|0|||
170820797|NCT05216835|617351527|FG006|Overall Study|Other|0|||
170820798|NCT05216835|617351528|FG007|Overall Study|Other|0|||
170820799|NCT04930445|617351531|FG000|Overall Study|Adverse Event|7|||
170820800|NCT04930445|617351531|FG000|Overall Study|Lost to Follow-up|1|||
170820801|NCT04930445|617351531|FG000|Overall Study|Physician Decision|1|||
170820802|NCT04930445|617351531|FG000|Overall Study|Lack of Efficacy|1|||
170820803|NCT04930445|617351531|FG000|Overall Study|Study Terminated by Sponsor|245|||
170820804|NCT04930445|617351531|FG000|Overall Study|Screen Failure|8|||
170820805|NCT04930445|617351531|FG000|Overall Study|Other|2|||
170820806|NCT00617708|617351532|FG000|Overall Study|Adverse Event|0|||
170820807|NCT00617708|617351533|FG001|Overall Study|Adverse Event|6|||
170820808|NCT00617708|617351534|FG002|Overall Study|Adverse Event|9|||
170679921|NCT00331682|616840260|FG000|Overall Study|Adverse Event|1|||
170820809|NCT00617708|617351532|FG000|Overall Study|Withdrawal by Subject|1|||
170820810|NCT00617708|617351533|FG001|Overall Study|Withdrawal by Subject|1|||
170820811|NCT00617708|617351534|FG002|Overall Study|Withdrawal by Subject|7|||
170820812|NCT00617708|617351532|FG000|Overall Study|Death|0|||
170820813|NCT00617708|617351533|FG001|Overall Study|Death|6|||
170820814|NCT00617708|617351534|FG002|Overall Study|Death|5|||
170820815|NCT00617708|617351532|FG000|Overall Study|Progression/Relapse|7|||
170820816|NCT00617708|617351533|FG001|Overall Study|Progression/Relapse|40|||
170679922|NCT02670083|616840261|FG000|Overall Study|Adverse Event|16|||
170679923|NCT02670083|616840262|FG001|Overall Study|Adverse Event|13|||
170679924|NCT02670083|616840261|FG000|Overall Study|Death|4|||
170679925|NCT02670083|616840262|FG001|Overall Study|Death|6|||
170679926|NCT02670083|616840261|FG000|Overall Study|Lost to Follow-up|2|||
170679927|NCT02670083|616840262|FG001|Overall Study|Lost to Follow-up|2|||
170679928|NCT02670083|616840261|FG000|Overall Study|Multiple Reasons|9|||
170679929|NCT02670083|616840262|FG001|Overall Study|Multiple Reasons|9|||
170679930|NCT02670083|616840261|FG000|Overall Study|Physician Decision|0|||
170679931|NCT02670083|616840262|FG001|Overall Study|Physician Decision|2|||
170679932|NCT02670083|616840261|FG000|Overall Study|Study Terminated By Sponsor|257|||
170679933|NCT02670083|616840262|FG001|Overall Study|Study Terminated By Sponsor|254|||
170679934|NCT02670083|616840261|FG000|Overall Study|Symptomatic Deterioration|0|||
170679935|NCT02670083|616840262|FG001|Overall Study|Symptomatic Deterioration|2|||
170679936|NCT02670083|616840261|FG000|Overall Study|Withdrawal by Subject|32|||
170679937|NCT02670083|616840262|FG001|Overall Study|Withdrawal by Subject|31|||
170679938|NCT02670083|616840261|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170679939|NCT02670083|616840262|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170679940|NCT01366521|616840266|FG000|Overall Study|Adverse Event|1|||
170679941|NCT01366521|616840267|FG001|Overall Study|Adverse Event|0|||
170679942|NCT01366521|616840268|FG002|Overall Study|Adverse Event|0|||
170679943|NCT01366521|616840269|FG003|Overall Study|Adverse Event|0|||
170679944|NCT01366521|616840266|FG000|Overall Study|Protocol Violation|0|||
170679945|NCT01366521|616840267|FG001|Overall Study|Protocol Violation|0|||
170679946|NCT01366521|616840268|FG002|Overall Study|Protocol Violation|1|||
170679947|NCT01366521|616840269|FG003|Overall Study|Protocol Violation|0|||
170679948|NCT01366521|616840266|FG000|Overall Study|Physician Decision|0|||
170679949|NCT01366521|616840267|FG001|Overall Study|Physician Decision|0|||
170679950|NCT01366521|616840268|FG002|Overall Study|Physician Decision|1|||
170679951|NCT01366521|616840269|FG003|Overall Study|Physician Decision|0|||
170679952|NCT01366521|616840266|FG000|Overall Study|Withdrawal by Subject|0|||
170679953|NCT01366521|616840267|FG001|Overall Study|Withdrawal by Subject|1|||
170679954|NCT01366521|616840268|FG002|Overall Study|Withdrawal by Subject|0|||
170679955|NCT01366521|616840269|FG003|Overall Study|Withdrawal by Subject|0|||
170679956|NCT00543140|616840270|FG000|Overall Study|Lost to Follow-up|33|||
170679957|NCT00543140|616840270|FG000|Overall Study|Withdrawal by Subject|13|||
170679958|NCT00543140|616840270|FG000|Overall Study|Protocol Violation|10|||
170679959|NCT00543140|616840270|FG000|Overall Study|Insufficient weight loss|10|||
170679960|NCT00543140|616840270|FG000|Overall Study|SAE leading to explant of SAGB|3|||
170679961|NCT00543140|616840270|FG000|Overall Study|Death|1|||
170679962|NCT00543140|616840270|FG000|Overall Study|Subject moved|1|||
170679963|NCT00543140|616840270|FG000|Overall Study|Conversion to different procedure|1|||
170679964|NCT02430311|616840271|FG000|Part A|Adverse Event|0|||
170679965|NCT02430311|616840272|FG001|Part A|Adverse Event|1|||
170679966|NCT02430311|616840271|FG000|Part A|Withdrawal by Subject|1|||
170679967|NCT02430311|616840272|FG001|Part A|Withdrawal by Subject|0|||
170679968|NCT02430311|616840271|FG000|Part B|Meet study-specific withdrawal criteria|6|||
170679969|NCT02430311|616840272|FG001|Part B|Meet study-specific withdrawal criteria|6|||
170679970|NCT02430311|616840271|FG000|Part B|Withdrawal by Subject|2|||
170679971|NCT02430311|616840272|FG001|Part B|Withdrawal by Subject|2|||
170679972|NCT02430311|616840271|FG000|Part B|Adverse Event|1|||
170679973|NCT02430311|616840272|FG001|Part B|Adverse Event|0|||
170679974|NCT02430311|616840271|FG000|Part B|Death|1|||
170679975|NCT02430311|616840272|FG001|Part B|Death|0|||
170679976|NCT00578812|616840273|FG000|Overall Study|Not treated|6|||
170679977|NCT00578812|616840274|FG001|Overall Study|Not treated|7|||
170679978|NCT00309387|616840275|FG000|Overall Study|Death|72|||
170679979|NCT00309387|616840276|FG001|Overall Study|Death|73|||
170679980|NCT00309387|616840275|FG000|Overall Study|Lost to Follow-up|70|||
170679981|NCT00309387|616840276|FG001|Overall Study|Lost to Follow-up|86|||
170679982|NCT00609492|616840277|FG000|Overall Study|Withdrawal by Subject|0|||
170679983|NCT00609492|616840278|FG001|Overall Study|Withdrawal by Subject|2|||
170679984|NCT00609492|616840279|FG002|Overall Study|Withdrawal by Subject|3|||
170679985|NCT00609492|616840277|FG000|Overall Study|Lost to Follow-up|1|||
170679986|NCT00609492|616840278|FG001|Overall Study|Lost to Follow-up|1|||
170679987|NCT00609492|616840279|FG002|Overall Study|Lost to Follow-up|4|||
170679988|NCT01599234|616840280|FG000|Overall Study|Adverse Event|9|||
170679989|NCT01599234|616840281|FG001|Overall Study|Adverse Event|5|||
170679990|NCT01599234|616840280|FG000|Overall Study|Withdrawal by Subject|2|||
170679991|NCT01599234|616840281|FG001|Overall Study|Withdrawal by Subject|1|||
170679992|NCT01599234|616840280|FG000|Overall Study|Lost to Follow-up|1|||
170679993|NCT01599234|616840281|FG001|Overall Study|Lost to Follow-up|2|||
170679994|NCT01599234|616840280|FG000|Overall Study|Lack of Efficacy|2|||
170679995|NCT01599234|616840281|FG001|Overall Study|Lack of Efficacy|4|||
170679996|NCT01599234|616840280|FG000|Overall Study|Unable to operate spray|1|||
170679997|NCT01599234|616840281|FG001|Overall Study|Unable to operate spray|0|||
170679998|NCT01599234|616840280|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
170679999|NCT01599234|616840281|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
170680000|NCT01599234|616840280|FG000|Overall Study|Death|1|||
170680001|NCT01599234|616840281|FG001|Overall Study|Death|0|||
170680002|NCT01599234|616840280|FG000|Overall Study|Patient would not stop driving|1|||
170680003|NCT01599234|616840281|FG001|Overall Study|Patient would not stop driving|0|||
170680004|NCT01599234|616840280|FG000|Overall Study|Contra-indication discovered|0|||
170680005|NCT01599234|616840281|FG001|Overall Study|Contra-indication discovered|1|||
170680006|NCT01599234|616840280|FG000|Overall Study|Pregnancy|0|||
170680007|NCT01599234|616840281|FG001|Overall Study|Pregnancy|1|||
170680008|NCT02433483|616840282|FG000|Overall Study|Unacceptable toxicity|1|||
170680009|NCT02433483|616840282|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
170680010|NCT03824912|616840286|FG000|Overall Study|Lost to Follow-up|18|||
170680011|NCT03824912|616840287|FG001|Overall Study|Lost to Follow-up|15|||
170680012|NCT03824912|616840288|FG002|Overall Study|Lost to Follow-up|8|||
170680013|NCT03824912|616840286|FG000|Overall Study|Negative Baseline Culture Result|118|||
170680014|NCT03824912|616840287|FG001|Overall Study|Negative Baseline Culture Result|112|||
170680015|NCT03824912|616840288|FG002|Overall Study|Negative Baseline Culture Result|57|||
170680016|NCT03824912|616840286|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170680017|NCT03824912|616840287|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170680018|NCT03824912|616840288|FG002|Overall Study|Non-Compliance with Study Drug|1|||
170680019|NCT03824912|616840286|FG000|Overall Study|Protocol Violation|1|||
170680020|NCT03824912|616840287|FG001|Overall Study|Protocol Violation|4|||
170680021|NCT03824912|616840288|FG002|Overall Study|Protocol Violation|1|||
170680022|NCT03824912|616840286|FG000|Overall Study|Withdrawal by Subject|3|||
170680023|NCT03824912|616840287|FG001|Overall Study|Withdrawal by Subject|2|||
170680024|NCT03824912|616840288|FG002|Overall Study|Withdrawal by Subject|1|||
170680025|NCT03824912|616840286|FG000|Overall Study|Participation in another study|0|||
170680026|NCT03824912|616840287|FG001|Overall Study|Participation in another study|1|||
170680027|NCT03824912|616840288|FG002|Overall Study|Participation in another study|0|||
170680028|NCT02485301|616840289|FG000|Overall Study|Serious Adverse Events|2|||
170680029|NCT02485301|616840290|FG001|Overall Study|Serious Adverse Events|1|||
170680030|NCT02485301|616840289|FG000|Overall Study|Protocol Violation|0|||
170680031|NCT02485301|616840290|FG001|Overall Study|Protocol Violation|1|||
170680032|NCT02485301|616840289|FG000|Overall Study|Withdrawal by Subject|6|||
170680033|NCT02485301|616840290|FG001|Overall Study|Withdrawal by Subject|7|||
170680034|NCT02485301|616840289|FG000|Overall Study|Migrated/moved from study area|10|||
170680035|NCT02485301|616840290|FG001|Overall Study|Migrated/moved from study area|19|||
170680036|NCT02485301|616840289|FG000|Overall Study|Lost to Follow-up|17|||
170680037|NCT02485301|616840290|FG001|Overall Study|Lost to Follow-up|17|||
170680038|NCT02485301|616840289|FG000|Overall Study|Other|3|||
170680039|NCT02485301|616840290|FG001|Overall Study|Other|4|||
170680040|NCT00549302|616840291|FG000|Double-Blind|Death|2|||
170680041|NCT00549302|616840292|FG001|Double-Blind|Death|9|||
170680042|NCT00549302|616840293|FG002|Double-Blind|Death|0|||
170680043|NCT00549302|616840291|FG000|Double-Blind|Adverse Event|3|||
170680044|NCT00549302|616840292|FG001|Double-Blind|Adverse Event|16|||
170680045|NCT00549302|616840293|FG002|Double-Blind|Adverse Event|0|||
170680046|NCT00549302|616840291|FG000|Double-Blind|Withdrawal by Subject|3|||
170680047|NCT00549302|616840292|FG001|Double-Blind|Withdrawal by Subject|8|||
170680048|NCT00549302|616840293|FG002|Double-Blind|Withdrawal by Subject|0|||
170680049|NCT00549302|616840291|FG000|Double-Blind|Investigator Decision|1|||
170680050|NCT00549302|616840292|FG001|Double-Blind|Investigator Decision|5|||
170680051|NCT00549302|616840293|FG002|Double-Blind|Investigator Decision|0|||
170680052|NCT00549302|616840291|FG000|Double-Blind|Sponsor Decision|0|||
170680053|NCT00549302|616840292|FG001|Double-Blind|Sponsor Decision|1|||
170680054|NCT00549302|616840293|FG002|Double-Blind|Sponsor Decision|0|||
170680055|NCT00549302|616840291|FG000|Double-Blind|Lost to Follow-up|1|||
170680056|NCT00549302|616840292|FG001|Double-Blind|Lost to Follow-up|2|||
170680057|NCT00549302|616840293|FG002|Double-Blind|Lost to Follow-up|0|||
170680058|NCT00549302|616840291|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
170680059|NCT00549302|616840292|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
170680060|NCT00549302|616840293|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
170680061|NCT00549302|616840291|FG000|Double-Blind|New condition or starts new therapy|0|||
170680062|NCT00549302|616840292|FG001|Double-Blind|New condition or starts new therapy|2|||
170680063|NCT00549302|616840293|FG002|Double-Blind|New condition or starts new therapy|0|||
170680064|NCT00549302|616840291|FG000|Open-Label|Adverse Event|0|||
170680065|NCT00549302|616840292|FG001|Open-Label|Adverse Event|0|||
170680066|NCT00549302|616840293|FG002|Open-Label|Adverse Event|11|||
170680067|NCT00549302|616840291|FG000|Open-Label|Death|0|||
170680068|NCT00549302|616840292|FG001|Open-Label|Death|0|||
170680069|NCT00549302|616840293|FG002|Open-Label|Death|40|||
170680070|NCT00549302|616840291|FG000|Open-Label|Investigator Decision|0|||
170680071|NCT00549302|616840292|FG001|Open-Label|Investigator Decision|0|||
170680072|NCT00549302|616840293|FG002|Open-Label|Investigator Decision|5|||
170680073|NCT00549302|616840291|FG000|Open-Label|Lost to Follow-up|0|||
170680074|NCT00549302|616840292|FG001|Open-Label|Lost to Follow-up|0|||
170680075|NCT00549302|616840293|FG002|Open-Label|Lost to Follow-up|2|||
170680076|NCT00549302|616840291|FG000|Open-Label|Other|0|||
170680077|NCT00549302|616840292|FG001|Open-Label|Other|0|||
170680078|NCT00549302|616840293|FG002|Open-Label|Other|3|||
170680079|NCT00549302|616840291|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
170680080|NCT00549302|616840292|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
170680081|NCT00549302|616840293|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
170680082|NCT00549302|616840291|FG000|Open-Label|Withdrawal by Subject|0|||
170680083|NCT00549302|616840292|FG001|Open-Label|Withdrawal by Subject|0|||
170680084|NCT00549302|616840293|FG002|Open-Label|Withdrawal by Subject|6|||
170680085|NCT00105482|616840294|FG000|Overall Study|Adverse Event|1|||
170680086|NCT00105482|616840295|FG001|Overall Study|Adverse Event|1|||
170680087|NCT00105482|616840294|FG000|Overall Study|Lost to Follow-up|26|||
170680088|NCT00105482|616840295|FG001|Overall Study|Lost to Follow-up|17|||
170680089|NCT00105482|616840294|FG000|Overall Study|Withdrawal by Subject|0|||
170680090|NCT00105482|616840295|FG001|Overall Study|Withdrawal by Subject|1|||
170680091|NCT00105482|616840294|FG000|Overall Study|Lost Interest|29|||
170680092|NCT00105482|616840295|FG001|Overall Study|Lost Interest|32|||
170680093|NCT00105482|616840294|FG000|Overall Study|Scheduling Conflict|2|||
170680094|NCT00105482|616840295|FG001|Overall Study|Scheduling Conflict|3|||
170680095|NCT00105482|616840294|FG000|Overall Study|Withdrawn by PI|1|||
170680096|NCT00105482|616840295|FG001|Overall Study|Withdrawn by PI|1|||
170680097|NCT00085631|616840299|FG000|Overall Study|Missing Data|4|||
170680098|NCT00085631|616840300|FG001|Overall Study|Missing Data|11|||
170820817|NCT00617708|617351534|FG002|Overall Study|Progression/Relapse|36|||
170820818|NCT00617708|617351532|FG000|Overall Study|Not protocol specified|1|||
170820819|NCT00617708|617351533|FG001|Overall Study|Not protocol specified|4|||
170820820|NCT00617708|617351534|FG002|Overall Study|Not protocol specified|2|||
170820821|NCT00617708|617351532|FG000|Overall Study|Not eligible|1|||
170820822|NCT00617708|617351533|FG001|Overall Study|Not eligible|3|||
170820823|NCT00617708|617351534|FG002|Overall Study|Not eligible|5|||
170820824|NCT01075815|617351535|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
170820825|NCT01075815|617351536|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
170820826|NCT01075815|617351535|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
170820827|NCT01075815|617351536|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
170820828|NCT01075815|617351535|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
170820829|NCT01075815|617351536|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
170820830|NCT01261793|617351543|FG000|Overall Study|Lack of Efficacy|44|||
170820831|NCT01261793|617351544|FG001|Overall Study|Lack of Efficacy|37|||
170820832|NCT01261793|617351545|FG002|Overall Study|Lack of Efficacy|32|||
170820833|NCT01261793|617351543|FG000|Overall Study|Protocol Violation|3|||
170820834|NCT01261793|617351544|FG001|Overall Study|Protocol Violation|5|||
170820835|NCT01261793|617351545|FG002|Overall Study|Protocol Violation|6|||
170820836|NCT01261793|617351543|FG000|Overall Study|Lost to Follow-up|10|||
170820837|NCT01261793|617351544|FG001|Overall Study|Lost to Follow-up|3|||
170820838|NCT01261793|617351545|FG002|Overall Study|Lost to Follow-up|7|||
170820839|NCT01261793|617351543|FG000|Overall Study|Withdrawal by Subject|12|||
170820840|NCT01261793|617351544|FG001|Overall Study|Withdrawal by Subject|14|||
170820841|NCT01261793|617351545|FG002|Overall Study|Withdrawal by Subject|14|||
170820842|NCT01261793|617351543|FG000|Overall Study|Death|3|||
170820843|NCT01261793|617351544|FG001|Overall Study|Death|1|||
170820844|NCT01261793|617351545|FG002|Overall Study|Death|0|||
170820845|NCT01261793|617351543|FG000|Overall Study|Adverse Event|9|||
170820846|NCT01261793|617351544|FG001|Overall Study|Adverse Event|24|||
170820847|NCT01261793|617351545|FG002|Overall Study|Adverse Event|19|||
170820848|NCT01261793|617351543|FG000|Overall Study|Patient non-availability|1|||
170820849|NCT01261793|617351544|FG001|Overall Study|Patient non-availability|1|||
170820850|NCT01261793|617351545|FG002|Overall Study|Patient non-availability|1|||
170820851|NCT01261793|617351543|FG000|Overall Study|Suspected pregnancy|1|||
170820852|NCT01261793|617351544|FG001|Overall Study|Suspected pregnancy|1|||
170820853|NCT01261793|617351545|FG002|Overall Study|Suspected pregnancy|0|||
170820854|NCT01261793|617351543|FG000|Overall Study|Patient non-compliance|1|||
170820855|NCT01261793|617351544|FG001|Overall Study|Patient non-compliance|0|||
170820856|NCT01261793|617351545|FG002|Overall Study|Patient non-compliance|1|||
170820857|NCT01261793|617351543|FG000|Overall Study|Patient pregnant|1|||
170820858|NCT01261793|617351544|FG001|Overall Study|Patient pregnant|0|||
170680099|NCT00085631|616840301|FG002|Overall Study|Missing Data|7|||
170680100|NCT02289690|616840302|FG000|Overall Study|Adverse Event Related to Progression|0|||
170680101|NCT02289690|616840303|FG001|Overall Study|Adverse Event Related to Progression|1|||
170680102|NCT02289690|616840304|FG002|Overall Study|Adverse Event Related to Progression|1|||
170680103|NCT02289690|616840305|FG003|Overall Study|Adverse Event Related to Progression|0|||
170680104|NCT02289690|616840306|FG004|Overall Study|Adverse Event Related to Progression|1|||
170680105|NCT02289690|616840307|FG005|Overall Study|Adverse Event Related to Progression|0|||
170680106|NCT02289690|616840308|FG006|Overall Study|Adverse Event Related to Progression|1|||
170680107|NCT02289690|616840309|FG007|Overall Study|Adverse Event Related to Progression|0|||
170680108|NCT02289690|616840310|FG008|Overall Study|Adverse Event Related to Progression|0|||
170680109|NCT02289690|616840311|FG009|Overall Study|Adverse Event Related to Progression|0|||
170680110|NCT02289690|616840302|FG000|Overall Study|Withdrawal by Subject|1|||
170680111|NCT02289690|616840303|FG001|Overall Study|Withdrawal by Subject|0|||
170680112|NCT02289690|616840304|FG002|Overall Study|Withdrawal by Subject|0|||
170680113|NCT02289690|616840305|FG003|Overall Study|Withdrawal by Subject|0|||
170680114|NCT02289690|616840306|FG004|Overall Study|Withdrawal by Subject|1|||
170680115|NCT02289690|616840307|FG005|Overall Study|Withdrawal by Subject|1|||
170680116|NCT02289690|616840308|FG006|Overall Study|Withdrawal by Subject|0|||
170680117|NCT02289690|616840309|FG007|Overall Study|Withdrawal by Subject|0|||
170680118|NCT02289690|616840310|FG008|Overall Study|Withdrawal by Subject|4|||
170680119|NCT02289690|616840311|FG009|Overall Study|Withdrawal by Subject|2|||
170680120|NCT02289690|616840302|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
170680121|NCT02289690|616840303|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
170680122|NCT02289690|616840304|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
170680123|NCT02289690|616840305|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
170680124|NCT02289690|616840306|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
170680125|NCT02289690|616840307|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
170680126|NCT02289690|616840308|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
170680127|NCT02289690|616840309|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
170680128|NCT02289690|616840310|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
170680129|NCT02289690|616840311|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
170680130|NCT02289690|616840302|FG000|Overall Study|Lost to Follow-up|0|||
170680131|NCT02289690|616840303|FG001|Overall Study|Lost to Follow-up|0|||
170680132|NCT02289690|616840304|FG002|Overall Study|Lost to Follow-up|0|||
170680133|NCT02289690|616840305|FG003|Overall Study|Lost to Follow-up|0|||
170680134|NCT02289690|616840306|FG004|Overall Study|Lost to Follow-up|0|||
170680135|NCT02289690|616840307|FG005|Overall Study|Lost to Follow-up|0|||
170680136|NCT02289690|616840308|FG006|Overall Study|Lost to Follow-up|0|||
170680137|NCT02289690|616840309|FG007|Overall Study|Lost to Follow-up|1|||
170680138|NCT02289690|616840310|FG008|Overall Study|Lost to Follow-up|0|||
170680139|NCT02289690|616840311|FG009|Overall Study|Lost to Follow-up|2|||
170680140|NCT02289690|616840302|FG000|Overall Study|Death|0|||
170680141|NCT02289690|616840303|FG001|Overall Study|Death|0|||
170680142|NCT02289690|616840304|FG002|Overall Study|Death|0|||
170680143|NCT02289690|616840305|FG003|Overall Study|Death|0|||
170680144|NCT02289690|616840306|FG004|Overall Study|Death|0|||
170680145|NCT02289690|616840307|FG005|Overall Study|Death|0|||
170680146|NCT02289690|616840308|FG006|Overall Study|Death|0|||
170680147|NCT02289690|616840309|FG007|Overall Study|Death|49|||
170680148|NCT02289690|616840310|FG008|Overall Study|Death|45|||
170680149|NCT02289690|616840311|FG009|Overall Study|Death|41|||
170680150|NCT02289690|616840302|FG000|Overall Study|Sponsor Discontinued Study|0|||
170680151|NCT02289690|616840303|FG001|Overall Study|Sponsor Discontinued Study|0|||
170680152|NCT02289690|616840304|FG002|Overall Study|Sponsor Discontinued Study|0|||
170680153|NCT02289690|616840305|FG003|Overall Study|Sponsor Discontinued Study|0|||
170680154|NCT02289690|616840306|FG004|Overall Study|Sponsor Discontinued Study|0|||
170680155|NCT02289690|616840307|FG005|Overall Study|Sponsor Discontinued Study|0|||
170680156|NCT02289690|616840308|FG006|Overall Study|Sponsor Discontinued Study|0|||
170680157|NCT02289690|616840309|FG007|Overall Study|Sponsor Discontinued Study|9|||
170680158|NCT02289690|616840310|FG008|Overall Study|Sponsor Discontinued Study|7|||
170680159|NCT02289690|616840311|FG009|Overall Study|Sponsor Discontinued Study|15|||
170680160|NCT02289690|616840302|FG000|Overall Study|Other|0|||
170680161|NCT02289690|616840303|FG001|Overall Study|Other|0|||
170680162|NCT02289690|616840304|FG002|Overall Study|Other|0|||
170820859|NCT01261793|617351545|FG002|Overall Study|Patient pregnant|0|||
170820860|NCT01261793|617351543|FG000|Overall Study|Outside the study area|0|||
170820861|NCT01261793|617351544|FG001|Overall Study|Outside the study area|2|||
170820862|NCT01261793|617351545|FG002|Overall Study|Outside the study area|1|||
170820863|NCT01261793|617351543|FG000|Overall Study|Lack of efficacy & patient not available|0|||
170820864|NCT01261793|617351544|FG001|Overall Study|Lack of efficacy & patient not available|1|||
170680163|NCT02289690|616840305|FG003|Overall Study|Other|1|||
170680164|NCT02289690|616840306|FG004|Overall Study|Other|1|||
170680165|NCT02289690|616840307|FG005|Overall Study|Other|0|||
170680166|NCT02289690|616840308|FG006|Overall Study|Other|1|||
170680167|NCT02289690|616840309|FG007|Overall Study|Other|2|||
170680168|NCT02289690|616840310|FG008|Overall Study|Other|3|||
170680169|NCT02289690|616840311|FG009|Overall Study|Other|1|||
170680170|NCT02495168|616840312|FG000|Overall Study|Other than Specified|18|||
170680171|NCT02495168|616840313|FG001|Overall Study|Other than Specified|22|||
170680172|NCT02495168|616840314|FG002|Overall Study|Other than Specified|5|||
170820865|NCT01261793|617351545|FG002|Overall Study|Lack of efficacy & patient not available|0|||
170680173|NCT02495168|616840312|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
170680174|NCT02495168|616840313|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
170680175|NCT02495168|616840314|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
170680176|NCT02495168|616840312|FG000|Overall Study|Physician Decision|1|||
170680177|NCT02495168|616840313|FG001|Overall Study|Physician Decision|1|||
170680178|NCT02495168|616840314|FG002|Overall Study|Physician Decision|0|||
170680179|NCT02495168|616840312|FG000|Overall Study|Lost to Follow-up|10|||
170680180|NCT02495168|616840313|FG001|Overall Study|Lost to Follow-up|6|||
170680181|NCT02495168|616840314|FG002|Overall Study|Lost to Follow-up|1|||
170680182|NCT02495168|616840312|FG000|Overall Study|Withdrawal by Subject|1|||
170680183|NCT02495168|616840313|FG001|Overall Study|Withdrawal by Subject|4|||
170680184|NCT02495168|616840314|FG002|Overall Study|Withdrawal by Subject|2|||
170680185|NCT02495168|616840312|FG000|Overall Study|Protocol Violation|0|||
170680186|NCT02495168|616840313|FG001|Overall Study|Protocol Violation|10|||
170680187|NCT02495168|616840314|FG002|Overall Study|Protocol Violation|1|||
170680188|NCT02495168|616840312|FG000|Overall Study|Adverse Event|4|||
170680189|NCT02495168|616840313|FG001|Overall Study|Adverse Event|8|||
170680190|NCT02495168|616840314|FG002|Overall Study|Adverse Event|3|||
170680191|NCT02495168|616840312|FG000|Overall Study|Lack of Efficacy|0|||
170680192|NCT02495168|616840313|FG001|Overall Study|Lack of Efficacy|0|||
170680193|NCT02495168|616840314|FG002|Overall Study|Lack of Efficacy|3|||
170680194|NCT00865124|616840317|FG000|Overall Study|Physician Decision|2|||
170680195|NCT00865124|616840318|FG001|Overall Study|Physician Decision|1|||
170680196|NCT00865124|616840319|FG002|Overall Study|Physician Decision|0|||
170680197|NCT00865124|616840317|FG000|Overall Study|Withdrawn consent|2|||
170680198|NCT00865124|616840318|FG001|Overall Study|Withdrawn consent|0|||
170680199|NCT00865124|616840319|FG002|Overall Study|Withdrawn consent|0|||
170680200|NCT01366209|616840320|FG000|Overall Study|Adverse Event|6|||
170680201|NCT01366209|616840321|FG001|Overall Study|Adverse Event|7|||
170680202|NCT01366209|616840320|FG000|Overall Study|Withdrawal by Subject|4|||
170680203|NCT01366209|616840321|FG001|Overall Study|Withdrawal by Subject|4|||
170680204|NCT01366209|616840320|FG000|Overall Study|Death|12|||
170680205|NCT01366209|616840321|FG001|Overall Study|Death|19|||
170680206|NCT01366209|616840320|FG000|Overall Study|Lung transplantation|6|||
170680207|NCT01366209|616840321|FG001|Overall Study|Lung transplantation|1|||
170680208|NCT01366209|616840320|FG000|Overall Study|Lost to Follow-up|2|||
170680209|NCT01366209|616840321|FG001|Overall Study|Lost to Follow-up|1|||
170680210|NCT01366209|616840320|FG000|Overall Study|Physician Decision|1|||
170680211|NCT01366209|616840321|FG001|Overall Study|Physician Decision|0|||
170680212|NCT01366209|616840320|FG000|Overall Study|Sponsors decision|0|||
170680213|NCT01366209|616840321|FG001|Overall Study|Sponsors decision|1|||
170680214|NCT01366209|616840320|FG000|Overall Study|Withdrew consent|4|||
170680215|NCT01366209|616840321|FG001|Overall Study|Withdrew consent|3|||
170680216|NCT01053221|616840322|FG000|Overall Study|The study was closed prematurely|5|||
170680217|NCT01053221|616840323|FG001|Overall Study|The study was closed prematurely|9|||
170680218|NCT00553514|616840325|FG000|Overall Study|Protocol deviation|0|||
170680219|NCT00553514|616840326|FG001|Overall Study|Protocol deviation|0|||
170680220|NCT00553514|616840327|FG002|Overall Study|Protocol deviation|0|||
170680221|NCT00553514|616840328|FG003|Overall Study|Protocol deviation|1|||
170680222|NCT00553514|616840329|FG004|Overall Study|Protocol deviation|0|||
170680223|NCT00553514|616840325|FG000|Overall Study|Lack of ovarian response|4|||
170680224|NCT00553514|616840326|FG001|Overall Study|Lack of ovarian response|5|||
170680225|NCT00553514|616840327|FG002|Overall Study|Lack of ovarian response|5|||
170680226|NCT00553514|616840328|FG003|Overall Study|Lack of ovarian response|5|||
170680227|NCT00553514|616840329|FG004|Overall Study|Lack of ovarian response|6|||
170680228|NCT00553514|616840325|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
170680229|NCT00553514|616840326|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
170680230|NCT00553514|616840327|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
170680231|NCT00553514|616840328|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
170680232|NCT00553514|616840329|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
170680233|NCT00553514|616840325|FG000|Overall Study|Risk of multiple pregnancy|0|||
170680234|NCT00553514|616840326|FG001|Overall Study|Risk of multiple pregnancy|2|||
170680235|NCT00553514|616840327|FG002|Overall Study|Risk of multiple pregnancy|0|||
170680236|NCT00553514|616840328|FG003|Overall Study|Risk of multiple pregnancy|1|||
170680237|NCT00553514|616840329|FG004|Overall Study|Risk of multiple pregnancy|0|||
170680238|NCT00553514|616840325|FG000|Overall Study|Other|1|||
170680239|NCT00553514|616840326|FG001|Overall Study|Other|1|||
170680240|NCT00553514|616840327|FG002|Overall Study|Other|0|||
170680241|NCT00553514|616840328|FG003|Overall Study|Other|0|||
170680242|NCT00553514|616840329|FG004|Overall Study|Other|1|||
170680243|NCT00420927|616840330|FG000|Period 1|Adverse Event|19|||
170680244|NCT00420927|616840331|FG001|Period 1|Adverse Event|15|||
170680245|NCT00420927|616840332|FG002|Period 1|Adverse Event|0|||
170680246|NCT00420927|616840333|FG003|Period 1|Adverse Event|0|||
170680247|NCT00420927|616840334|FG004|Period 1|Adverse Event|0|||
170680248|NCT00420927|616840335|FG005|Period 1|Adverse Event|0|||
170680249|NCT00420927|616840336|FG006|Period 1|Adverse Event|0|||
170680250|NCT00420927|616840330|FG000|Period 1|Withdrawal by Subject|7|||
170680251|NCT00420927|616840331|FG001|Period 1|Withdrawal by Subject|12|||
170680252|NCT00420927|616840332|FG002|Period 1|Withdrawal by Subject|0|||
170680253|NCT00420927|616840333|FG003|Period 1|Withdrawal by Subject|0|||
170680254|NCT00420927|616840334|FG004|Period 1|Withdrawal by Subject|0|||
170680255|NCT00420927|616840335|FG005|Period 1|Withdrawal by Subject|0|||
170680256|NCT00420927|616840336|FG006|Period 1|Withdrawal by Subject|0|||
170680257|NCT00420927|616840330|FG000|Period 1|Lost to Follow-up|8|||
170680258|NCT00420927|616840331|FG001|Period 1|Lost to Follow-up|6|||
170680259|NCT00420927|616840332|FG002|Period 1|Lost to Follow-up|0|||
170680260|NCT00420927|616840333|FG003|Period 1|Lost to Follow-up|0|||
170680261|NCT00420927|616840334|FG004|Period 1|Lost to Follow-up|0|||
170680262|NCT00420927|616840335|FG005|Period 1|Lost to Follow-up|0|||
170680263|NCT00420927|616840336|FG006|Period 1|Lost to Follow-up|0|||
170680264|NCT00420927|616840330|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
170680265|NCT00420927|616840331|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
170680266|NCT00420927|616840332|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
170680267|NCT00420927|616840333|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
170680268|NCT00420927|616840334|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
170680269|NCT00420927|616840335|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
170680270|NCT00420927|616840336|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
170680271|NCT00420927|616840330|FG000|Period 1|Death|2|||
170680272|NCT00420927|616840331|FG001|Period 1|Death|0|||
170680273|NCT00420927|616840332|FG002|Period 1|Death|0|||
170680274|NCT00420927|616840333|FG003|Period 1|Death|0|||
170680275|NCT00420927|616840334|FG004|Period 1|Death|0|||
170680276|NCT00420927|616840335|FG005|Period 1|Death|0|||
170680277|NCT00420927|616840336|FG006|Period 1|Death|0|||
170680278|NCT00420927|616840330|FG000|Period 1|Subject moved/relocated|0|||
170680279|NCT00420927|616840331|FG001|Period 1|Subject moved/relocated|2|||
170680280|NCT00420927|616840332|FG002|Period 1|Subject moved/relocated|0|||
170680281|NCT00420927|616840333|FG003|Period 1|Subject moved/relocated|0|||
170680282|NCT00420927|616840334|FG004|Period 1|Subject moved/relocated|0|||
170680283|NCT00420927|616840335|FG005|Period 1|Subject moved/relocated|0|||
170680284|NCT00420927|616840336|FG006|Period 1|Subject moved/relocated|0|||
170680285|NCT00420927|616840330|FG000|Period 1|Noncompliant with study drug|1|||
170680286|NCT00420927|616840331|FG001|Period 1|Noncompliant with study drug|1|||
170680287|NCT00420927|616840332|FG002|Period 1|Noncompliant with study drug|0|||
170680288|NCT00420927|616840333|FG003|Period 1|Noncompliant with study drug|0|||
170680289|NCT00420927|616840334|FG004|Period 1|Noncompliant with study drug|0|||
170680290|NCT00420927|616840335|FG005|Period 1|Noncompliant with study drug|0|||
170680291|NCT00420927|616840336|FG006|Period 1|Noncompliant with study drug|0|||
170680292|NCT00420927|616840330|FG000|Period 1|Randomization error|1|||
170680293|NCT00420927|616840331|FG001|Period 1|Randomization error|0|||
170680294|NCT00420927|616840332|FG002|Period 1|Randomization error|0|||
170680295|NCT00420927|616840333|FG003|Period 1|Randomization error|0|||
170680296|NCT00420927|616840334|FG004|Period 1|Randomization error|0|||
170680297|NCT00420927|616840335|FG005|Period 1|Randomization error|0|||
170680298|NCT00420927|616840336|FG006|Period 1|Randomization error|0|||
170680299|NCT00420927|616840330|FG000|Period 1|Suspected tuberculosis/positive test|1|||
170680300|NCT00420927|616840331|FG001|Period 1|Suspected tuberculosis/positive test|1|||
170680301|NCT00420927|616840332|FG002|Period 1|Suspected tuberculosis/positive test|0|||
170680302|NCT00420927|616840333|FG003|Period 1|Suspected tuberculosis/positive test|0|||
170680303|NCT00420927|616840334|FG004|Period 1|Suspected tuberculosis/positive test|0|||
170680304|NCT00420927|616840335|FG005|Period 1|Suspected tuberculosis/positive test|0|||
170680305|NCT00420927|616840336|FG006|Period 1|Suspected tuberculosis/positive test|0|||
170680306|NCT00420927|616840330|FG000|Period 1|Study site closure|0|||
170680307|NCT00420927|616840331|FG001|Period 1|Study site closure|1|||
170680308|NCT00420927|616840332|FG002|Period 1|Study site closure|0|||
170680309|NCT00420927|616840333|FG003|Period 1|Study site closure|0|||
170680310|NCT00420927|616840334|FG004|Period 1|Study site closure|0|||
170680311|NCT00420927|616840335|FG005|Period 1|Study site closure|0|||
170680312|NCT00420927|616840336|FG006|Period 1|Study site closure|0|||
170680313|NCT00420927|616840330|FG000|Period 1|Subject received new diagnosis|0|||
170680314|NCT00420927|616840331|FG001|Period 1|Subject received new diagnosis|2|||
170680315|NCT00420927|616840332|FG002|Period 1|Subject received new diagnosis|0|||
170680316|NCT00420927|616840333|FG003|Period 1|Subject received new diagnosis|0|||
170680317|NCT00420927|616840334|FG004|Period 1|Subject received new diagnosis|0|||
170680318|NCT00420927|616840335|FG005|Period 1|Subject received new diagnosis|0|||
170680319|NCT00420927|616840336|FG006|Period 1|Subject received new diagnosis|0|||
170680320|NCT00420927|616840330|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
170680321|NCT00420927|616840331|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
170680322|NCT00420927|616840332|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
170680323|NCT00420927|616840333|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
170680324|NCT00420927|616840334|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
170680325|NCT00420927|616840335|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
170680326|NCT00420927|616840336|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
170680327|NCT00420927|616840330|FG000|Period 1|Failed to meet entry criteria|8|||
170680328|NCT00420927|616840331|FG001|Period 1|Failed to meet entry criteria|7|||
170680329|NCT00420927|616840332|FG002|Period 1|Failed to meet entry criteria|0|||
170680330|NCT00420927|616840333|FG003|Period 1|Failed to meet entry criteria|0|||
170680331|NCT00420927|616840334|FG004|Period 1|Failed to meet entry criteria|0|||
170680332|NCT00420927|616840335|FG005|Period 1|Failed to meet entry criteria|0|||
170680333|NCT00420927|616840336|FG006|Period 1|Failed to meet entry criteria|0|||
170680334|NCT00420927|616840330|FG000|Period 1|Took prohibited medication|1|||
170680335|NCT00420927|616840331|FG001|Period 1|Took prohibited medication|3|||
170680336|NCT00420927|616840332|FG002|Period 1|Took prohibited medication|0|||
170680337|NCT00420927|616840333|FG003|Period 1|Took prohibited medication|0|||
170680338|NCT00420927|616840334|FG004|Period 1|Took prohibited medication|0|||
170680339|NCT00420927|616840335|FG005|Period 1|Took prohibited medication|0|||
170680340|NCT00420927|616840336|FG006|Period 1|Took prohibited medication|0|||
170680341|NCT00420927|616840330|FG000|Period 2|Adverse Event|0|||
170680342|NCT00420927|616840331|FG001|Period 2|Adverse Event|0|||
170680343|NCT00420927|616840332|FG002|Period 2|Adverse Event|7|||
170680344|NCT00420927|616840333|FG003|Period 2|Adverse Event|3|||
170680345|NCT00420927|616840334|FG004|Period 2|Adverse Event|17|||
170680346|NCT00420927|616840335|FG005|Period 2|Adverse Event|6|||
170680347|NCT00420927|616840336|FG006|Period 2|Adverse Event|20|||
170680348|NCT00420927|616840330|FG000|Period 2|Withdrawal by Subject|0|||
170680349|NCT00420927|616840331|FG001|Period 2|Withdrawal by Subject|0|||
170680350|NCT00420927|616840332|FG002|Period 2|Withdrawal by Subject|1|||
170680351|NCT00420927|616840333|FG003|Period 2|Withdrawal by Subject|3|||
170680352|NCT00420927|616840334|FG004|Period 2|Withdrawal by Subject|11|||
170680353|NCT00420927|616840335|FG005|Period 2|Withdrawal by Subject|2|||
170680354|NCT00420927|616840336|FG006|Period 2|Withdrawal by Subject|12|||
170680355|NCT00420927|616840330|FG000|Period 2|Lost to Follow-up|0|||
170680356|NCT00420927|616840331|FG001|Period 2|Lost to Follow-up|0|||
170680357|NCT00420927|616840332|FG002|Period 2|Lost to Follow-up|2|||
170680358|NCT00420927|616840333|FG003|Period 2|Lost to Follow-up|2|||
170680359|NCT00420927|616840334|FG004|Period 2|Lost to Follow-up|6|||
170680360|NCT00420927|616840335|FG005|Period 2|Lost to Follow-up|3|||
170680361|NCT00420927|616840336|FG006|Period 2|Lost to Follow-up|9|||
170680362|NCT00420927|616840330|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
170680363|NCT00420927|616840331|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
170680364|NCT00420927|616840332|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
170680365|NCT00420927|616840333|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
170680366|NCT00420927|616840334|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
170680367|NCT00420927|616840335|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
170680368|NCT00420927|616840336|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
170680369|NCT00420927|616840330|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
170680370|NCT00420927|616840331|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
170680371|NCT00420927|616840332|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
170680372|NCT00420927|616840333|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
170680373|NCT00420927|616840334|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
170680374|NCT00420927|616840335|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
170680375|NCT00420927|616840336|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
170680376|NCT00420927|616840330|FG000|Period 2|Subject unable to find transportation|0|||
170680377|NCT00420927|616840331|FG001|Period 2|Subject unable to find transportation|0|||
170680378|NCT00420927|616840332|FG002|Period 2|Subject unable to find transportation|0|||
170680379|NCT00420927|616840333|FG003|Period 2|Subject unable to find transportation|0|||
170680380|NCT00420927|616840334|FG004|Period 2|Subject unable to find transportation|0|||
170680381|NCT00420927|616840335|FG005|Period 2|Subject unable to find transportation|0|||
170680382|NCT00420927|616840336|FG006|Period 2|Subject unable to find transportation|1|||
170680383|NCT00420927|616840330|FG000|Period 2|Physician Decision|0|||
170680384|NCT00420927|616840331|FG001|Period 2|Physician Decision|0|||
170680385|NCT00420927|616840332|FG002|Period 2|Physician Decision|0|||
170680386|NCT00420927|616840333|FG003|Period 2|Physician Decision|0|||
170680387|NCT00420927|616840334|FG004|Period 2|Physician Decision|1|||
170680388|NCT00420927|616840335|FG005|Period 2|Physician Decision|1|||
170680389|NCT00420927|616840336|FG006|Period 2|Physician Decision|0|||
170680390|NCT00420927|616840330|FG000|Period 2|Sponsor decision|0|||
170680391|NCT00420927|616840331|FG001|Period 2|Sponsor decision|0|||
170680392|NCT00420927|616840332|FG002|Period 2|Sponsor decision|1|||
170680393|NCT00420927|616840333|FG003|Period 2|Sponsor decision|0|||
170680394|NCT00420927|616840334|FG004|Period 2|Sponsor decision|0|||
170680395|NCT00420927|616840335|FG005|Period 2|Sponsor decision|0|||
170680396|NCT00420927|616840336|FG006|Period 2|Sponsor decision|1|||
170680397|NCT00420927|616840330|FG000|Period 2|Randomization error|0|||
170680398|NCT00420927|616840331|FG001|Period 2|Randomization error|0|||
170680399|NCT00420927|616840332|FG002|Period 2|Randomization error|0|||
170680400|NCT00420927|616840333|FG003|Period 2|Randomization error|0|||
170680401|NCT00420927|616840334|FG004|Period 2|Randomization error|1|||
170680402|NCT00420927|616840335|FG005|Period 2|Randomization error|1|||
170680403|NCT00420927|616840336|FG006|Period 2|Randomization error|0|||
170680404|NCT00420927|616840330|FG000|Period 2|Noncompliant with study drug|0|||
170680405|NCT00420927|616840331|FG001|Period 2|Noncompliant with study drug|0|||
170680406|NCT00420927|616840332|FG002|Period 2|Noncompliant with study drug|0|||
170680407|NCT00420927|616840333|FG003|Period 2|Noncompliant with study drug|1|||
170680408|NCT00420927|616840334|FG004|Period 2|Noncompliant with study drug|0|||
170680409|NCT00420927|616840335|FG005|Period 2|Noncompliant with study drug|0|||
170680410|NCT00420927|616840336|FG006|Period 2|Noncompliant with study drug|2|||
170680411|NCT00420927|616840330|FG000|Period 2|Methotrexate intolerance|0|||
170680412|NCT00420927|616840331|FG001|Period 2|Methotrexate intolerance|0|||
170680413|NCT00420927|616840332|FG002|Period 2|Methotrexate intolerance|0|||
170680414|NCT00420927|616840333|FG003|Period 2|Methotrexate intolerance|0|||
170680415|NCT00420927|616840334|FG004|Period 2|Methotrexate intolerance|0|||
170680416|NCT00420927|616840335|FG005|Period 2|Methotrexate intolerance|0|||
170680417|NCT00420927|616840336|FG006|Period 2|Methotrexate intolerance|1|||
170680418|NCT00420927|616840330|FG000|Period 2|Took prohibited medication|0|||
170680419|NCT00420927|616840331|FG001|Period 2|Took prohibited medication|0|||
170680420|NCT00420927|616840332|FG002|Period 2|Took prohibited medication|0|||
170680421|NCT00420927|616840333|FG003|Period 2|Took prohibited medication|0|||
170680422|NCT00420927|616840334|FG004|Period 2|Took prohibited medication|1|||
170680423|NCT00420927|616840335|FG005|Period 2|Took prohibited medication|0|||
170680424|NCT00420927|616840336|FG006|Period 2|Took prohibited medication|0|||
170680425|NCT04448171|616840337|FG000|Overall Study|Procedure Cancelled|1|||
170680426|NCT04448171|616840338|FG001|Overall Study|Procedure Cancelled|0|||
170680427|NCT04448171|616840337|FG000|Overall Study|Protocol Violation|1|||
170680428|NCT04448171|616840338|FG001|Overall Study|Protocol Violation|0|||
170680429|NCT01025752|616840342|FG000|Overall Study|Lost to Follow-up|7|||
170680430|NCT01025752|616840343|FG001|Overall Study|Lost to Follow-up|10|||
170680431|NCT01025752|616840342|FG000|Overall Study|Physician Decision|1|||
170680432|NCT01025752|616840343|FG001|Overall Study|Physician Decision|3|||
170680433|NCT00211809|616840344|FG000|Overall Study|Lack of Efficacy|1|||
170680434|NCT00211809|616840344|FG000|Overall Study|Lost to Follow-up|2|||
170680435|NCT00211809|616840344|FG000|Overall Study|Pregnancy|1|||
170680436|NCT00211809|616840344|FG000|Overall Study|side effects|2|||
170680437|NCT01417234|616840345|FG000|Overall Study|Subject non-compliant|3|||
170680438|NCT00023764|616840346|FG000|Overall Study|Other|1|||
170680439|NCT00023764|616840346|FG000|Overall Study|Adverse Event|4|||
170680440|NCT00023764|616840346|FG000|Overall Study|Withdrawal by Subject|1|||
170680441|NCT00023764|616840346|FG000|Overall Study|Progression of disease|6|||
170680442|NCT00023764|616840346|FG000|Overall Study|patient received other treatment|1|||
170680443|NCT00023764|616840346|FG000|Overall Study|delay in obtaining staging images|1|||
170680444|NCT00459953|616840347|FG000|Overall Study|not analyzed-household member in study|1|||
170680445|NCT00459953|616840348|FG001|Overall Study|not analyzed-household member in study|1|||
170680446|NCT01218243|616840350|FG000|Overall Study|Lack of Efficacy|1|||
170680447|NCT01218243|616840351|FG001|Overall Study|Lack of Efficacy|1|||
170680448|NCT01218243|616840350|FG000|Overall Study|Lost to Follow-up|3|||
170680449|NCT01218243|616840351|FG001|Overall Study|Lost to Follow-up|3|||
170680450|NCT01218243|616840350|FG000|Overall Study|Protocol Violation|5|||
170680451|NCT01218243|616840351|FG001|Overall Study|Protocol Violation|10|||
170680452|NCT00799422|616840352|FG000|First Week of Wear|Lost to Follow-up|0|||
170680453|NCT00799422|616840353|FG001|First Week of Wear|Lost to Follow-up|0|||
170680454|NCT00799422|616840354|FG002|First Week of Wear|Lost to Follow-up|1|||
170680455|NCT00799422|616840355|FG003|First Week of Wear|Lost to Follow-up|0|||
170680456|NCT00799422|616840356|FG004|First Week of Wear|Lost to Follow-up|0|||
170680457|NCT00799422|616840357|FG005|First Week of Wear|Lost to Follow-up|0|||
170680458|NCT00799422|616840352|FG000|First Week of Wear|Adverse Event|0|||
170680459|NCT00799422|616840353|FG001|First Week of Wear|Adverse Event|0|||
170680460|NCT00799422|616840354|FG002|First Week of Wear|Adverse Event|0|||
170680461|NCT00799422|616840355|FG003|First Week of Wear|Adverse Event|1|||
170680462|NCT00799422|616840356|FG004|First Week of Wear|Adverse Event|0|||
170680463|NCT00799422|616840357|FG005|First Week of Wear|Adverse Event|0|||
170680464|NCT04545385|616840358|FG000|Overall Study|Withdrawal by Subject|2|||
170680465|NCT04545385|616840359|FG001|Overall Study|Withdrawal by Subject|0|||
170680466|NCT04545385|616840358|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
170680467|NCT04545385|616840359|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
170680468|NCT04545385|616840358|FG000|Overall Study|Study termination|10|||
170680469|NCT04545385|616840359|FG001|Overall Study|Study termination|10|||
170680470|NCT04545385|616840358|FG000|Overall Study|Sponsor decision|2|||
170680471|NCT04545385|616840359|FG001|Overall Study|Sponsor decision|2|||
170680472|NCT04545385|616840358|FG000|Overall Study|Other than specified|1|||
170680473|NCT04545385|616840359|FG001|Overall Study|Other than specified|0|||
170680474|NCT04584645|616840360|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
170680475|NCT04584645|616840361|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
170680476|NCT02207244|616840365|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
170680477|NCT02207244|616840366|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
170680478|NCT02207244|616840367|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
170680479|NCT02207244|616840368|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
170680480|NCT02207244|616840369|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
170680481|NCT02207244|616840370|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
170680482|NCT02207244|616840371|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
170680483|NCT02207244|616840372|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
170680484|NCT02207244|616840373|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
170680485|NCT02207244|616840374|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
170680486|NCT02207244|616840375|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
170680487|NCT02207244|616840365|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
170680488|NCT02207244|616840366|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680489|NCT02207244|616840367|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
170680490|NCT02207244|616840368|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680491|NCT02207244|616840369|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680492|NCT02207244|616840370|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680493|NCT02207244|616840371|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680494|NCT02207244|616840372|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680495|NCT02207244|616840373|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680496|NCT02207244|616840374|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680497|NCT02207244|616840375|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
170680498|NCT02207244|616840365|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
170680499|NCT02207244|616840366|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
170680500|NCT02207244|616840367|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
170680501|NCT02207244|616840368|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
170680502|NCT02207244|616840369|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
170680503|NCT02207244|616840370|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
170680504|NCT02207244|616840371|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
170680505|NCT02207244|616840372|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
170680506|NCT02207244|616840373|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
170680507|NCT02207244|616840374|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
170680508|NCT02207244|616840375|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
170680509|NCT02207244|616840365|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
170680510|NCT02207244|616840366|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
170680511|NCT02207244|616840367|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680512|NCT02207244|616840368|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680513|NCT02207244|616840369|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680514|NCT02207244|616840370|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680515|NCT02207244|616840371|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680516|NCT02207244|616840372|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680517|NCT02207244|616840373|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680518|NCT02207244|616840374|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680519|NCT02207244|616840375|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
170680520|NCT02207244|616840365|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
170680521|NCT02207244|616840366|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
170680522|NCT02207244|616840367|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
170680523|NCT02207244|616840368|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
170680524|NCT02207244|616840369|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
170680525|NCT02207244|616840370|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
170680526|NCT02207244|616840371|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
170680527|NCT02207244|616840372|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
170680528|NCT02207244|616840373|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
170680529|NCT02207244|616840374|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
170680530|NCT02207244|616840375|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
170680531|NCT02207244|616840365|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680532|NCT02207244|616840366|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
170680533|NCT02207244|616840367|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
170680534|NCT02207244|616840368|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680535|NCT02207244|616840369|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680536|NCT02207244|616840370|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680537|NCT02207244|616840371|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680538|NCT02207244|616840372|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680539|NCT02207244|616840373|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680540|NCT02207244|616840374|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680541|NCT02207244|616840375|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
170680542|NCT02207244|616840365|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680543|NCT02207244|616840366|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
170680544|NCT02207244|616840367|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680545|NCT02207244|616840368|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680546|NCT02207244|616840369|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680547|NCT02207244|616840370|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680548|NCT02207244|616840371|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680549|NCT02207244|616840372|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680550|NCT02207244|616840373|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680551|NCT02207244|616840374|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680552|NCT02207244|616840375|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
170680553|NCT02207244|616840365|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680554|NCT02207244|616840366|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680555|NCT02207244|616840367|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680556|NCT02207244|616840368|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680557|NCT02207244|616840369|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
170680558|NCT02207244|616840370|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
170680559|NCT02207244|616840371|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680560|NCT02207244|616840372|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680561|NCT02207244|616840373|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680562|NCT02207244|616840374|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680563|NCT02207244|616840375|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
170680564|NCT02207244|616840365|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680565|NCT02207244|616840366|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680566|NCT02207244|616840367|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680567|NCT02207244|616840368|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680568|NCT02207244|616840369|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680569|NCT02207244|616840370|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
170680570|NCT02207244|616840371|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680571|NCT02207244|616840372|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680572|NCT02207244|616840373|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680573|NCT02207244|616840374|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680574|NCT02207244|616840375|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
170680575|NCT02207244|616840365|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
170680576|NCT02207244|616840366|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
170680577|NCT02207244|616840367|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
170680578|NCT02207244|616840368|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
170680579|NCT02207244|616840369|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
170680580|NCT02207244|616840370|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
170680581|NCT02207244|616840371|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
170680582|NCT02207244|616840372|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
170680583|NCT02207244|616840373|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
170680584|NCT02207244|616840374|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
170680585|NCT02207244|616840375|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
170680586|NCT02207244|616840365|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
170680587|NCT02207244|616840366|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
170680588|NCT02207244|616840367|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
170680589|NCT02207244|616840368|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
170680590|NCT02207244|616840369|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
170680591|NCT02207244|616840370|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
170680592|NCT02207244|616840371|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
170680593|NCT02207244|616840372|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
170680594|NCT02207244|616840373|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
170680595|NCT02207244|616840374|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
170680596|NCT02207244|616840375|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
170680597|NCT02207244|616840365|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680598|NCT02207244|616840366|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680599|NCT02207244|616840367|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680600|NCT02207244|616840368|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
170680601|NCT02207244|616840369|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680602|NCT02207244|616840370|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
170680603|NCT02207244|616840371|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680604|NCT02207244|616840372|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680605|NCT02207244|616840373|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680606|NCT02207244|616840374|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680607|NCT02207244|616840375|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
170680608|NCT02207244|616840365|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680609|NCT02207244|616840366|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680610|NCT02207244|616840367|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680611|NCT02207244|616840368|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
170680612|NCT02207244|616840369|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680613|NCT02207244|616840370|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680614|NCT02207244|616840371|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680615|NCT02207244|616840372|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680616|NCT02207244|616840373|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680617|NCT02207244|616840374|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680618|NCT02207244|616840375|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
170680619|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
170680620|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
170680621|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
170680622|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
170680623|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
170680624|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
170680625|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
170680626|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
170680627|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
170680628|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
170680629|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
170680630|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680631|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680632|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680633|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680634|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680635|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680636|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680637|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
170680638|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680639|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680640|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
170680641|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
170680642|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
170680643|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
170680644|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
170680645|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
170680646|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
170680647|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
170680648|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
170680649|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
170680650|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
170680651|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
170680652|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
170680653|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
170680654|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
170680655|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
170680656|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
170680657|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
170680658|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
170680659|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
170680660|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
170680661|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
170680662|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
170680663|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
170680664|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
170680665|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
170680666|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
170680667|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
170680668|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
170680669|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
170680670|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
170680671|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
170680672|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
170680673|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
170680674|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170680675|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170680676|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170680677|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170680678|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170680679|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170820866|NCT01261793|617351543|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
170820867|NCT01261793|617351544|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
170820868|NCT01261793|617351545|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
170820869|NCT01261793|617351543|FG000|Overall Study|Randomization error|0|||
170820870|NCT01261793|617351544|FG001|Overall Study|Randomization error|1|||
170820871|NCT01261793|617351545|FG002|Overall Study|Randomization error|0|||
170820872|NCT01261793|617351543|FG000|Overall Study|Patient unable to start IV line|0|||
170820873|NCT01261793|617351544|FG001|Overall Study|Patient unable to start IV line|0|||
170820874|NCT01261793|617351545|FG002|Overall Study|Patient unable to start IV line|1|||
170820875|NCT03219216|617351550|FG000|Overall Study|Lost to Follow-up|0|||
170820876|NCT03219216|617351551|FG001|Overall Study|Lost to Follow-up|1|||
170820877|NCT05431543|617351554|FG000|Overall Study|Medical History|1|||
170820878|NCT05431543|617351555|FG001|Overall Study|Medical History|0|||
170820879|NCT05431543|617351556|FG002|Overall Study|Medical History|0|||
170820880|NCT02784535|617351557|FG000|Overall Study|Adverse Event|1|||
170820881|NCT02784535|617351558|FG001|Overall Study|Adverse Event|0|||
170820882|NCT02784535|617351557|FG000|Overall Study|Withdrawal by Subject|0|||
170820883|NCT02784535|617351558|FG001|Overall Study|Withdrawal by Subject|1|||
170820884|NCT02784535|617351557|FG000|Overall Study|Physician Decision|0|||
170820885|NCT02784535|617351558|FG001|Overall Study|Physician Decision|1|||
170820886|NCT03926117|617351559|FG000|Overall Study|Unclassified|1|||
170820887|NCT03926117|617351560|FG001|Overall Study|Unclassified|4|||
170820888|NCT03926117|617351561|FG002|Overall Study|Unclassified|1|||
170820889|NCT03926117|617351562|FG003|Overall Study|Unclassified|4|||
170820890|NCT03926117|617351559|FG000|Overall Study|Withdrawal by Subject|3|||
170820891|NCT03926117|617351560|FG001|Overall Study|Withdrawal by Subject|0|||
170820892|NCT03926117|617351561|FG002|Overall Study|Withdrawal by Subject|1|||
170820893|NCT03926117|617351562|FG003|Overall Study|Withdrawal by Subject|1|||
170820894|NCT03926117|617351559|FG000|Overall Study|Lost to Follow-up|0|||
170820895|NCT03926117|617351560|FG001|Overall Study|Lost to Follow-up|2|||
170680680|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170680681|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
170680682|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
170680683|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170680684|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
170680685|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680686|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680687|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680688|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680689|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680690|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680691|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680692|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680693|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
170680694|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680695|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
170680696|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680697|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680698|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680699|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680700|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680701|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680702|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680703|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
170680704|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680705|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680706|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
170680707|NCT02207244|616840365|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680708|NCT02207244|616840366|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680709|NCT02207244|616840367|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680710|NCT02207244|616840368|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680711|NCT02207244|616840369|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680712|NCT02207244|616840370|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680713|NCT02207244|616840371|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
170680714|NCT02207244|616840372|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680715|NCT02207244|616840373|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680716|NCT02207244|616840374|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680717|NCT02207244|616840375|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
170680718|NCT02207244|616840365|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680719|NCT02207244|616840366|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680720|NCT02207244|616840367|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680721|NCT02207244|616840368|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680722|NCT02207244|616840369|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680723|NCT02207244|616840370|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680724|NCT02207244|616840371|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680725|NCT02207244|616840372|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680726|NCT02207244|616840373|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
170680727|NCT02207244|616840374|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
170680728|NCT02207244|616840375|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
170680729|NCT02207244|616840365|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170680730|NCT02207244|616840366|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170680731|NCT02207244|616840367|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170680732|NCT02207244|616840368|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170680733|NCT02207244|616840369|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170680734|NCT02207244|616840370|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170680735|NCT02207244|616840371|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170680736|NCT02207244|616840372|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170680737|NCT02207244|616840373|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
170680738|NCT02207244|616840374|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
170820896|NCT03926117|617351561|FG002|Overall Study|Lost to Follow-up|1|||
170820897|NCT03926117|617351562|FG003|Overall Study|Lost to Follow-up|0|||
170820898|NCT03926117|617351559|FG000|Overall Study|Adverse Event|1|||
170820899|NCT03926117|617351560|FG001|Overall Study|Adverse Event|2|||
170820900|NCT03926117|617351561|FG002|Overall Study|Adverse Event|3|||
170680739|NCT02207244|616840375|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
170680740|NCT02207244|616840365|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680741|NCT02207244|616840366|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680742|NCT02207244|616840367|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680743|NCT02207244|616840368|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680744|NCT02207244|616840369|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680745|NCT02207244|616840370|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680746|NCT02207244|616840371|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680747|NCT02207244|616840372|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680748|NCT02207244|616840373|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
170680749|NCT02207244|616840374|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
170680750|NCT02207244|616840375|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
170680751|NCT02207244|616840365|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680752|NCT02207244|616840366|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680753|NCT02207244|616840367|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680754|NCT02207244|616840368|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680755|NCT02207244|616840369|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680756|NCT02207244|616840370|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680757|NCT02207244|616840371|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680758|NCT02207244|616840372|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680759|NCT02207244|616840373|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
170680760|NCT02207244|616840374|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
170680761|NCT02207244|616840375|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
170680762|NCT02207244|616840365|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
170680763|NCT02207244|616840366|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
170680764|NCT02207244|616840367|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
170680765|NCT02207244|616840368|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
170680766|NCT02207244|616840369|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
170680767|NCT02207244|616840370|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
170680768|NCT02207244|616840371|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
170680769|NCT02207244|616840372|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
170680770|NCT02207244|616840373|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
170680771|NCT02207244|616840374|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
170680772|NCT02207244|616840375|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
170680773|NCT02207244|616840365|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
170680774|NCT02207244|616840366|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
170680775|NCT02207244|616840367|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
170680776|NCT02207244|616840368|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
170680777|NCT02207244|616840369|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
170680778|NCT02207244|616840370|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
170680779|NCT02207244|616840371|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
170680780|NCT02207244|616840372|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
170680781|NCT02207244|616840373|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
170680782|NCT02207244|616840374|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
170680783|NCT02207244|616840375|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
170680784|NCT02207244|616840365|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680785|NCT02207244|616840366|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680786|NCT02207244|616840367|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680787|NCT02207244|616840368|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680788|NCT02207244|616840369|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680789|NCT02207244|616840370|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680790|NCT02207244|616840371|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680791|NCT02207244|616840372|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680792|NCT02207244|616840373|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680793|NCT02207244|616840374|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
170680794|NCT02207244|616840375|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
170680795|NCT02216591|616840376|FG000|Overall Study|Lost to Follow-up|0|||
170680796|NCT02216591|616840377|FG001|Overall Study|Lost to Follow-up|1|||
170680797|NCT04051008|616840378|FG000|Overall Study|Withdrawal by Subject|2|||
170680798|NCT04051008|616840379|FG001|Overall Study|Withdrawal by Subject|0|||
170680799|NCT04051008|616840380|FG002|Overall Study|Withdrawal by Subject|1|||
170680800|NCT00753415|616840381|FG000|Part A|Disease progression|1|||
170680801|NCT00753415|616840382|FG001|Part A|Disease progression|0|||
170680802|NCT00753415|616840383|FG002|Part A|Disease progression|1|||
170680803|NCT00753415|616840384|FG003|Part A|Disease progression|2|||
170680804|NCT00753415|616840385|FG004|Part A|Disease progression|0|||
170680805|NCT00753415|616840386|FG005|Part A|Disease progression|0|||
170680806|NCT00753415|616840387|FG006|Part A|Disease progression|0|||
170680807|NCT00753415|616840388|FG007|Part A|Disease progression|0|||
170680808|NCT00753415|616840389|FG008|Part A|Disease progression|0|||
170680809|NCT00753415|616840390|FG009|Part A|Disease progression|0|||
170680810|NCT00753415|616840381|FG000|Part A|Withdrawal by Subject|0|||
170680811|NCT00753415|616840382|FG001|Part A|Withdrawal by Subject|0|||
170680812|NCT00753415|616840383|FG002|Part A|Withdrawal by Subject|1|||
170680813|NCT00753415|616840384|FG003|Part A|Withdrawal by Subject|0|||
170680814|NCT00753415|616840385|FG004|Part A|Withdrawal by Subject|0|||
170680815|NCT00753415|616840386|FG005|Part A|Withdrawal by Subject|0|||
170680816|NCT00753415|616840387|FG006|Part A|Withdrawal by Subject|0|||
170680817|NCT00753415|616840388|FG007|Part A|Withdrawal by Subject|0|||
170680818|NCT00753415|616840389|FG008|Part A|Withdrawal by Subject|0|||
170680819|NCT00753415|616840390|FG009|Part A|Withdrawal by Subject|0|||
170680820|NCT00753415|616840381|FG000|Part B|Lost to Follow-up|0|||
170680821|NCT00753415|616840382|FG001|Part B|Lost to Follow-up|0|||
170680822|NCT00753415|616840383|FG002|Part B|Lost to Follow-up|0|||
170680823|NCT00753415|616840384|FG003|Part B|Lost to Follow-up|0|||
170680824|NCT00753415|616840385|FG004|Part B|Lost to Follow-up|0|||
170680825|NCT00753415|616840386|FG005|Part B|Lost to Follow-up|0|||
170680826|NCT00753415|616840387|FG006|Part B|Lost to Follow-up|0|||
170680827|NCT00753415|616840388|FG007|Part B|Lost to Follow-up|1|||
170680828|NCT00753415|616840389|FG008|Part B|Lost to Follow-up|1|||
170680829|NCT00753415|616840390|FG009|Part B|Lost to Follow-up|0|||
170680830|NCT00753415|616840381|FG000|Part B|Disease progression|0|||
170680831|NCT00753415|616840382|FG001|Part B|Disease progression|0|||
170680832|NCT00753415|616840383|FG002|Part B|Disease progression|0|||
170680833|NCT00753415|616840384|FG003|Part B|Disease progression|0|||
170680834|NCT00753415|616840385|FG004|Part B|Disease progression|0|||
170680835|NCT00753415|616840386|FG005|Part B|Disease progression|0|||
170680836|NCT00753415|616840387|FG006|Part B|Disease progression|0|||
170680837|NCT00753415|616840388|FG007|Part B|Disease progression|0|||
170680838|NCT00753415|616840389|FG008|Part B|Disease progression|2|||
170680839|NCT00753415|616840390|FG009|Part B|Disease progression|1|||
170680840|NCT02132130|616840391|FG000|Overall Study|Lost to Follow-up|0|||
170680841|NCT02132130|616840392|FG001|Overall Study|Lost to Follow-up|2|||
170680842|NCT02132130|616840393|FG002|Overall Study|Lost to Follow-up|0|||
170680843|NCT02132130|616840394|FG003|Overall Study|Lost to Follow-up|0|||
170680844|NCT02132130|616840391|FG000|Overall Study|Withdrawal by Subject|0|||
170680845|NCT02132130|616840392|FG001|Overall Study|Withdrawal by Subject|0|||
170680846|NCT02132130|616840393|FG002|Overall Study|Withdrawal by Subject|0|||
170680847|NCT02132130|616840394|FG003|Overall Study|Withdrawal by Subject|1|||
170680848|NCT00838578|616840395|FG000|Overall Study|Protocol Violation|2|||
170680849|NCT00598832|616840396|FG000|Overall Study|Lack of Efficacy|3|||
170680850|NCT00598832|616840397|FG001|Overall Study|Lack of Efficacy|7|||
170680851|NCT00598832|616840396|FG000|Overall Study|Adverse Event|6|||
170680852|NCT00598832|616840397|FG001|Overall Study|Adverse Event|2|||
170680853|NCT00598832|616840396|FG000|Overall Study|Withdrawal by Subject|25|||
170680854|NCT00598832|616840397|FG001|Overall Study|Withdrawal by Subject|36|||
170680855|NCT00598832|616840396|FG000|Overall Study|Protocol Violation|0|||
170680856|NCT00598832|616840397|FG001|Overall Study|Protocol Violation|2|||
170680857|NCT00598832|616840396|FG000|Overall Study|Lost to Follow-up|24|||
170680858|NCT00598832|616840397|FG001|Overall Study|Lost to Follow-up|29|||
170680859|NCT00598832|616840396|FG000|Overall Study|Pregnancy|2|||
170680860|NCT00598832|616840397|FG001|Overall Study|Pregnancy|2|||
170680861|NCT00598832|616840396|FG000|Overall Study|Physician Decision|1|||
170680862|NCT00598832|616840397|FG001|Overall Study|Physician Decision|4|||
170680863|NCT00598832|616840396|FG000|Overall Study|Non compliance|1|||
170680864|NCT00598832|616840397|FG001|Overall Study|Non compliance|0|||
170680865|NCT00357968|616840401|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
170680866|NCT00357968|616840402|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
170680867|NCT00357968|616840401|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
170680868|NCT00357968|616840402|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
170680869|NCT03919799|616840403|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
170680870|NCT03919799|616840404|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
170680871|NCT03919799|616840405|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
170680872|NCT03919799|616840406|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
170680873|NCT03919799|616840407|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
170680874|NCT03919799|616840403|FG000|DB Period (28 Weeks)|Adverse Event|1|||
170680875|NCT03919799|616840404|FG001|DB Period (28 Weeks)|Adverse Event|1|||
170680876|NCT03919799|616840405|FG002|DB Period (28 Weeks)|Adverse Event|1|||
170680877|NCT03919799|616840406|FG003|DB Period (28 Weeks)|Adverse Event|0|||
170680878|NCT03919799|616840407|FG004|DB Period (28 Weeks)|Adverse Event|0|||
170680879|NCT03919799|616840403|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
170680880|NCT03919799|616840404|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
170680881|NCT03919799|616840405|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
170680882|NCT03919799|616840406|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
170680883|NCT03919799|616840407|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
170680884|NCT03919799|616840403|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
170680885|NCT03919799|616840404|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
170680886|NCT03919799|616840405|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
170680887|NCT03919799|616840406|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
170680888|NCT03919799|616840407|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
170680889|NCT03919799|616840403|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
170680890|NCT03919799|616840404|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
170680891|NCT03919799|616840405|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
170680892|NCT03919799|616840406|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
170680893|NCT03919799|616840407|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
170680894|NCT02142959|616840409|FG000|Overall Study|Adverse Event|1|||
170680895|NCT02142959|616840410|FG001|Overall Study|Adverse Event|0|||
170680896|NCT02142959|616840411|FG002|Overall Study|Adverse Event|0|||
170680897|NCT02142959|616840409|FG000|Overall Study|Death|0|||
170680898|NCT02142959|616840410|FG001|Overall Study|Death|1|||
170680899|NCT02142959|616840411|FG002|Overall Study|Death|0|||
170680900|NCT02142959|616840409|FG000|Overall Study|Withdrawal by Subject|3|||
170680901|NCT02142959|616840410|FG001|Overall Study|Withdrawal by Subject|1|||
170680902|NCT02142959|616840411|FG002|Overall Study|Withdrawal by Subject|3|||
170680903|NCT02142959|616840409|FG000|Overall Study|Administrative Reasons|1|||
170680904|NCT02142959|616840410|FG001|Overall Study|Administrative Reasons|0|||
170680905|NCT02142959|616840411|FG002|Overall Study|Administrative Reasons|1|||
170680906|NCT02142959|616840409|FG000|Overall Study|Missing|0|||
170680907|NCT02142959|616840410|FG001|Overall Study|Missing|1|||
170680908|NCT02142959|616840411|FG002|Overall Study|Missing|0|||
170680909|NCT02142959|616840409|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
170680910|NCT02142959|616840410|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
170680911|NCT02142959|616840411|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
170680912|NCT02142959|616840409|FG000|Overall Study|Patient didn't complete end of study visit|0|||
170680913|NCT02142959|616840410|FG001|Overall Study|Patient didn't complete end of study visit|0|||
170680914|NCT02142959|616840411|FG002|Overall Study|Patient didn't complete end of study visit|1|||
170680915|NCT00679302|616840413|FG000|Overall Study|Lost to Follow-up|8|||
170680916|NCT00679302|616840414|FG001|Overall Study|Lost to Follow-up|4|||
170680917|NCT03547687|616840415|FG000|Overall Study|Withdrawal by Subject|1|||
170680918|NCT03547687|616840415|FG000|Overall Study|Death|1|||
170680919|NCT00646776|616840416|FG000|Overall Study|Adverse Event|1|||
170680920|NCT00646776|616840417|FG001|Overall Study|Adverse Event|9|||
170680921|NCT00646776|616840416|FG000|Overall Study|Investigator discretion|0|||
170680922|NCT00646776|616840417|FG001|Overall Study|Investigator discretion|4|||
170680923|NCT02700815|616842285|FG000|Overall Study|Adverse Event|0|||
170680924|NCT02700815|616842286|FG001|Overall Study|Adverse Event|6|||
170680925|NCT02700815|616842287|FG002|Overall Study|Adverse Event|2|||
170680926|NCT02700815|616842288|FG003|Overall Study|Adverse Event|3|||
170680927|NCT02700815|616842285|FG000|Overall Study|Lack of Efficacy|0|||
170680928|NCT02700815|616842286|FG001|Overall Study|Lack of Efficacy|0|||
170680929|NCT02700815|616842287|FG002|Overall Study|Lack of Efficacy|1|||
170680930|NCT02700815|616842288|FG003|Overall Study|Lack of Efficacy|2|||
170680931|NCT02700815|616842285|FG000|Overall Study|Lost to Follow-up|1|||
170680932|NCT02700815|616842286|FG001|Overall Study|Lost to Follow-up|0|||
170680933|NCT02700815|616842287|FG002|Overall Study|Lost to Follow-up|0|||
170680934|NCT02700815|616842288|FG003|Overall Study|Lost to Follow-up|1|||
170680935|NCT02700815|616842285|FG000|Overall Study|Refusal to continue medication|0|||
170680936|NCT02700815|616842286|FG001|Overall Study|Refusal to continue medication|1|||
170680937|NCT02700815|616842287|FG002|Overall Study|Refusal to continue medication|0|||
170680938|NCT02700815|616842288|FG003|Overall Study|Refusal to continue medication|1|||
170680939|NCT02700815|616842285|FG000|Overall Study|Withdrawal by Subject|0|||
170680940|NCT02700815|616842286|FG001|Overall Study|Withdrawal by Subject|0|||
170680941|NCT02700815|616842287|FG002|Overall Study|Withdrawal by Subject|1|||
170680942|NCT02700815|616842288|FG003|Overall Study|Withdrawal by Subject|0|||
170680943|NCT00524368|616842289|FG000|Overall Study|Adverse Event|10|||
170680944|NCT00524368|616842290|FG001|Overall Study|Adverse Event|12|||
170680945|NCT00524368|616842289|FG000|Overall Study|Lost to Follow-up|9|||
170680946|NCT00524368|616842290|FG001|Overall Study|Lost to Follow-up|13|||
170680947|NCT00524368|616842289|FG000|Overall Study|Withdrawal by Subject|4|||
170680948|NCT00524368|616842290|FG001|Overall Study|Withdrawal by Subject|5|||
170680949|NCT00524368|616842289|FG000|Overall Study|Non-compliant|8|||
170680950|NCT00524368|616842290|FG001|Overall Study|Non-compliant|9|||
170680951|NCT00524368|616842289|FG000|Overall Study|Reached a Virologic Endpoint|3|||
170680952|NCT00524368|616842290|FG001|Overall Study|Reached a Virologic Endpoint|2|||
170680953|NCT00524368|616842289|FG000|Overall Study|Sponsor's Decision|2|||
170680954|NCT00524368|616842290|FG001|Overall Study|Sponsor's Decision|0|||
170680955|NCT00524368|616842289|FG000|Overall Study|Ineligible to Continue the study|2|||
170680956|NCT00524368|616842290|FG001|Overall Study|Ineligible to Continue the study|5|||
170680957|NCT00524368|616842289|FG000|Overall Study|Other|3|||
170680958|NCT00524368|616842290|FG001|Overall Study|Other|2|||
170680959|NCT04023526|616842291|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
170680960|NCT04023526|616842292|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
170680961|NCT04023526|616842291|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
170680962|NCT04023526|616842292|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
170680963|NCT01955733|616842296|FG000|Period 1|Lost to Follow-up|1|||
170680964|NCT01955733|616842297|FG001|Period 1|Lost to Follow-up|0|||
170680965|NCT01955733|616842298|FG002|Period 1|Lost to Follow-up|0|||
170680966|NCT01955733|616842296|FG000|Period 2|Adverse Event|1|||
170680967|NCT01955733|616842297|FG001|Period 2|Adverse Event|0|||
170680968|NCT01955733|616842298|FG002|Period 2|Adverse Event|0|||
170680969|NCT01955733|616842296|FG000|Period 2|Physician Decision|0|||
170680970|NCT01955733|616842297|FG001|Period 2|Physician Decision|0|||
170680971|NCT01955733|616842298|FG002|Period 2|Physician Decision|1|||
170680972|NCT01955733|616842296|FG000|Period 2|Withdrawal by Subject|1|||
170680973|NCT01955733|616842297|FG001|Period 2|Withdrawal by Subject|3|||
170680974|NCT01955733|616842298|FG002|Period 2|Withdrawal by Subject|2|||
170680975|NCT01955733|616842296|FG000|Period 2|Study terminated by sponsor|8|||
170680976|NCT01955733|616842297|FG001|Period 2|Study terminated by sponsor|14|||
170680977|NCT01955733|616842298|FG002|Period 2|Study terminated by sponsor|16|||
170680978|NCT01955733|616842296|FG000|Period 2|Lost to Follow-up|2|||
170680979|NCT01955733|616842297|FG001|Period 2|Lost to Follow-up|0|||
170680980|NCT01955733|616842298|FG002|Period 2|Lost to Follow-up|0|||
170680981|NCT01955733|616842296|FG000|Period 2|Other not defined above|0|||
170680982|NCT01955733|616842297|FG001|Period 2|Other not defined above|2|||
170680983|NCT01955733|616842298|FG002|Period 2|Other not defined above|2|||
170680984|NCT04221009|616842299|FG000|Overall Study|Withdrawal by Subject|4|||
170680985|NCT00793598|616842300|FG000|Overall Study|Patient Request|0|||
170680986|NCT00793598|616842301|FG001|Overall Study|Patient Request|1|||
170680987|NCT00793598|616842302|FG002|Overall Study|Patient Request|0|||
170680988|NCT00793598|616842303|FG003|Overall Study|Patient Request|0|||
170680989|NCT00793598|616842304|FG004|Overall Study|Patient Request|0|||
170680990|NCT00793598|616842305|FG005|Overall Study|Patient Request|0|||
170680991|NCT00793598|616842306|FG006|Overall Study|Patient Request|0|||
170680992|NCT00793598|616842307|FG007|Overall Study|Patient Request|0|||
170680993|NCT00793598|616842300|FG000|Overall Study|Protocol Violation|0|||
170680994|NCT00793598|616842301|FG001|Overall Study|Protocol Violation|0|||
170680995|NCT00793598|616842302|FG002|Overall Study|Protocol Violation|0|||
170680996|NCT00793598|616842303|FG003|Overall Study|Protocol Violation|0|||
170680997|NCT00793598|616842304|FG004|Overall Study|Protocol Violation|0|||
170680998|NCT00793598|616842305|FG005|Overall Study|Protocol Violation|0|||
170680999|NCT00793598|616842306|FG006|Overall Study|Protocol Violation|0|||
170681000|NCT00793598|616842307|FG007|Overall Study|Protocol Violation|1|||
170681001|NCT00793598|616842300|FG000|Overall Study|Subject not dosed|0|||
170681002|NCT00793598|616842301|FG001|Overall Study|Subject not dosed|0|||
170681003|NCT00793598|616842302|FG002|Overall Study|Subject not dosed|0|||
170681004|NCT00793598|616842303|FG003|Overall Study|Subject not dosed|0|||
170681005|NCT00793598|616842304|FG004|Overall Study|Subject not dosed|0|||
170681006|NCT00793598|616842305|FG005|Overall Study|Subject not dosed|1|||
170681007|NCT00793598|616842306|FG006|Overall Study|Subject not dosed|0|||
170681008|NCT00793598|616842307|FG007|Overall Study|Subject not dosed|0|||
170681009|NCT01852110|616842312|FG000|Overall Study|Adverse Event|12|||
170681010|NCT01852110|616842313|FG001|Overall Study|Adverse Event|5|||
170681011|NCT01852110|616842314|FG002|Overall Study|Adverse Event|0|||
170681012|NCT01852110|616842315|FG003|Overall Study|Adverse Event|0|||
170681013|NCT01852110|616842316|FG004|Overall Study|Adverse Event|0|||
170681014|NCT01852110|616842317|FG005|Overall Study|Adverse Event|0|||
170681015|NCT01852110|616842312|FG000|Overall Study|Lost to Follow-up|1|||
170681016|NCT01852110|616842313|FG001|Overall Study|Lost to Follow-up|3|||
170681017|NCT01852110|616842314|FG002|Overall Study|Lost to Follow-up|0|||
170681018|NCT01852110|616842315|FG003|Overall Study|Lost to Follow-up|0|||
170681019|NCT01852110|616842316|FG004|Overall Study|Lost to Follow-up|0|||
170681020|NCT01852110|616842317|FG005|Overall Study|Lost to Follow-up|0|||
170681021|NCT01852110|616842312|FG000|Overall Study|Non-compliance with Study Drug|2|||
170681022|NCT01852110|616842313|FG001|Overall Study|Non-compliance with Study Drug|1|||
170681023|NCT01852110|616842314|FG002|Overall Study|Non-compliance with Study Drug|0|||
170681024|NCT01852110|616842315|FG003|Overall Study|Non-compliance with Study Drug|0|||
170681025|NCT01852110|616842316|FG004|Overall Study|Non-compliance with Study Drug|0|||
170681026|NCT01852110|616842317|FG005|Overall Study|Non-compliance with Study Drug|0|||
170681027|NCT01852110|616842312|FG000|Overall Study|Physician Decision|1|||
170681028|NCT01852110|616842313|FG001|Overall Study|Physician Decision|0|||
170681029|NCT01852110|616842314|FG002|Overall Study|Physician Decision|0|||
170681030|NCT01852110|616842315|FG003|Overall Study|Physician Decision|0|||
170681031|NCT01852110|616842316|FG004|Overall Study|Physician Decision|0|||
170681032|NCT01852110|616842317|FG005|Overall Study|Physician Decision|0|||
170681033|NCT01852110|616842312|FG000|Overall Study|Protocol Violation|0|||
170681034|NCT01852110|616842313|FG001|Overall Study|Protocol Violation|1|||
170681035|NCT01852110|616842314|FG002|Overall Study|Protocol Violation|0|||
170681036|NCT01852110|616842315|FG003|Overall Study|Protocol Violation|0|||
170681037|NCT01852110|616842316|FG004|Overall Study|Protocol Violation|0|||
170681038|NCT01852110|616842317|FG005|Overall Study|Protocol Violation|0|||
170681039|NCT01852110|616842312|FG000|Overall Study|Study Terminated by Sponsor|30|||
170681040|NCT01852110|616842313|FG001|Overall Study|Study Terminated by Sponsor|32|||
170681041|NCT01852110|616842314|FG002|Overall Study|Study Terminated by Sponsor|0|||
170681042|NCT01852110|616842315|FG003|Overall Study|Study Terminated by Sponsor|0|||
170681043|NCT01852110|616842316|FG004|Overall Study|Study Terminated by Sponsor|0|||
170681044|NCT01852110|616842317|FG005|Overall Study|Study Terminated by Sponsor|0|||
170681045|NCT01852110|616842312|FG000|Overall Study|Withdrawal by Subject|4|||
170681046|NCT01852110|616842313|FG001|Overall Study|Withdrawal by Subject|4|||
170681047|NCT01852110|616842314|FG002|Overall Study|Withdrawal by Subject|0|||
170681048|NCT01852110|616842315|FG003|Overall Study|Withdrawal by Subject|0|||
170681049|NCT01852110|616842316|FG004|Overall Study|Withdrawal by Subject|0|||
170681050|NCT01852110|616842317|FG005|Overall Study|Withdrawal by Subject|0|||
170681051|NCT00793403|616842318|FG000|Overall Study|Other|73|||
170681052|NCT00842712|616842327|FG000|Safety Run-in Part|Adverse Event|0|||
170681053|NCT00842712|616842328|FG001|Safety Run-in Part|Adverse Event|1|||
170681054|NCT00842712|616842329|FG002|Safety Run-in Part|Adverse Event|0|||
170681055|NCT00842712|616842330|FG003|Safety Run-in Part|Adverse Event|0|||
170681056|NCT00842712|616842331|FG004|Safety Run-in Part|Adverse Event|0|||
170681057|NCT00842712|616842332|FG005|Safety Run-in Part|Adverse Event|0|||
170681058|NCT00842712|616842333|FG006|Safety Run-in Part|Adverse Event|0|||
170681059|NCT00842712|616842327|FG000|Safety Run-in Part|Progressive disease|3|||
170681060|NCT00842712|616842328|FG001|Safety Run-in Part|Progressive disease|1|||
170681061|NCT00842712|616842329|FG002|Safety Run-in Part|Progressive disease|0|||
170681062|NCT00842712|616842330|FG003|Safety Run-in Part|Progressive disease|1|||
170681063|NCT00842712|616842331|FG004|Safety Run-in Part|Progressive disease|0|||
170681064|NCT00842712|616842332|FG005|Safety Run-in Part|Progressive disease|0|||
170681065|NCT00842712|616842333|FG006|Safety Run-in Part|Progressive disease|0|||
170681066|NCT00842712|616842327|FG000|Randomized Part|Randomized but not treated|0|||
170681067|NCT00842712|616842328|FG001|Randomized Part|Randomized but not treated|0|||
170681068|NCT00842712|616842329|FG002|Randomized Part|Randomized but not treated|0|||
170681069|NCT00842712|616842330|FG003|Randomized Part|Randomized but not treated|0|||
170681070|NCT00842712|616842331|FG004|Randomized Part|Randomized but not treated|0|||
170681071|NCT00842712|616842332|FG005|Randomized Part|Randomized but not treated|1|||
170681072|NCT00842712|616842333|FG006|Randomized Part|Randomized but not treated|4|||
170681073|NCT00842712|616842327|FG000|Randomized Part|Ongoing at cut-off date|0|||
170681074|NCT00842712|616842328|FG001|Randomized Part|Ongoing at cut-off date|0|||
170681075|NCT00842712|616842329|FG002|Randomized Part|Ongoing at cut-off date|0|||
170681076|NCT00842712|616842330|FG003|Randomized Part|Ongoing at cut-off date|0|||
170681077|NCT00842712|616842331|FG004|Randomized Part|Ongoing at cut-off date|0|||
170681078|NCT00842712|616842332|FG005|Randomized Part|Ongoing at cut-off date|0|||
170681079|NCT00842712|616842333|FG006|Randomized Part|Ongoing at cut-off date|2|||
170681080|NCT00410046|616842334|FG000|Overall Study|Adverse Event|3|||
170681081|NCT00410046|616842334|FG000|Overall Study|Withdrawal by Subject|1|||
170681082|NCT00410046|616842334|FG000|Overall Study|Lost to Follow-up|1|||
170681083|NCT03312933|616842339|FG000|Overall Study|Protocol Violation|15|||
170681084|NCT03312933|616842339|FG000|Overall Study|Lost to Follow-up|36|||
170681085|NCT03312933|616842339|FG000|Overall Study|Withdrawal by Subject|3|||
170681086|NCT00664742|616842340|FG000|Overall Study|Withdrawn due to adverse events|3|||
170681087|NCT00664742|616842340|FG000|Overall Study|Withdrawal by Subject|31|||
170681088|NCT00664742|616842340|FG000|Overall Study|Lost to Follow-up|92|||
170681089|NCT00848081|616842341|FG000|Overall Study|Adverse Event|6|||
170681090|NCT00848081|616842342|FG001|Overall Study|Adverse Event|7|||
170681091|NCT00848081|616842341|FG000|Overall Study|Protocol Violation|8|||
170681092|NCT00848081|616842342|FG001|Overall Study|Protocol Violation|5|||
170681093|NCT00848081|616842341|FG000|Overall Study|Lost to Follow-up|1|||
170681094|NCT00848081|616842342|FG001|Overall Study|Lost to Follow-up|0|||
170681095|NCT00848081|616842341|FG000|Overall Study|Physician Decision|0|||
170681096|NCT00848081|616842342|FG001|Overall Study|Physician Decision|3|||
170681097|NCT00848081|616842341|FG000|Overall Study|Withdrawal by Subject|5|||
170681098|NCT00848081|616842342|FG001|Overall Study|Withdrawal by Subject|3|||
170681099|NCT01752907|616842344|FG000|Overall Study|Withdrawal by Subject|4|||
170681100|NCT01752907|616842345|FG001|Overall Study|Withdrawal by Subject|10|||
170681101|NCT01752907|616842344|FG000|Overall Study|Lost to Follow-up|2|||
170681102|NCT01752907|616842345|FG001|Overall Study|Lost to Follow-up|1|||
170681103|NCT01752907|616842344|FG000|Overall Study|Decision by Sponsor|6|||
170681104|NCT01752907|616842345|FG001|Overall Study|Decision by Sponsor|9|||
170681105|NCT03098550|616842346|FG000|Overall Study|Disease Progression|30|||
170681106|NCT03098550|616842347|FG001|Overall Study|Disease Progression|19|||
170681107|NCT03098550|616842348|FG002|Overall Study|Disease Progression|41|||
170681108|NCT03098550|616842346|FG000|Overall Study|Study Drug Toxicity|2|||
170681109|NCT03098550|616842347|FG001|Overall Study|Study Drug Toxicity|1|||
170681110|NCT03098550|616842348|FG002|Overall Study|Study Drug Toxicity|0|||
170681111|NCT03098550|616842346|FG000|Overall Study|Death|1|||
170681112|NCT03098550|616842347|FG001|Overall Study|Death|0|||
170681113|NCT03098550|616842348|FG002|Overall Study|Death|0|||
170681114|NCT03098550|616842346|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
170681115|NCT03098550|616842347|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
170681116|NCT03098550|616842348|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
170681117|NCT03098550|616842346|FG000|Overall Study|Administrative reason by sponsor|0|||
170681118|NCT03098550|616842347|FG001|Overall Study|Administrative reason by sponsor|0|||
170681119|NCT03098550|616842348|FG002|Overall Study|Administrative reason by sponsor|1|||
170681120|NCT03098550|616842346|FG000|Overall Study|Other reasons|2|||
170681121|NCT03098550|616842347|FG001|Overall Study|Other reasons|0|||
170681122|NCT03098550|616842348|FG002|Overall Study|Other reasons|0|||
170681123|NCT02310568|616842352|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
170681124|NCT02310568|616842353|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
170681125|NCT02310568|616842354|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
170681126|NCT02310568|616842355|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
170681127|NCT02310568|616842356|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
170681128|NCT02310568|616842352|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
170681129|NCT02310568|616842353|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
170681130|NCT02310568|616842354|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
170681131|NCT02310568|616842355|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
170681132|NCT02310568|616842356|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
170681133|NCT02310568|616842352|FG000|Stage 1 ( 4 Weeks)|Other|1|||
170681134|NCT02310568|616842353|FG001|Stage 1 ( 4 Weeks)|Other|1|||
170681135|NCT02310568|616842354|FG002|Stage 1 ( 4 Weeks)|Other|0|||
170681136|NCT02310568|616842355|FG003|Stage 1 ( 4 Weeks)|Other|0|||
170681137|NCT02310568|616842356|FG004|Stage 1 ( 4 Weeks)|Other|0|||
170681138|NCT02310568|616842352|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
170681139|NCT02310568|616842353|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
170681140|NCT02310568|616842354|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
170681141|NCT02310568|616842355|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
170681142|NCT02310568|616842356|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
170681143|NCT02310568|616842352|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
170681144|NCT02310568|616842353|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
170681145|NCT02310568|616842354|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
170681146|NCT02310568|616842355|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
170681147|NCT02310568|616842356|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
170681148|NCT02310568|616842352|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
170681149|NCT02310568|616842353|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
170681150|NCT02310568|616842354|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
170681151|NCT02310568|616842355|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
170681152|NCT02310568|616842356|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
170681153|NCT02310568|616842352|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
170681154|NCT02310568|616842353|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
170681155|NCT02310568|616842354|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
170681156|NCT02310568|616842355|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
170681157|NCT02310568|616842356|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
170681158|NCT02310568|616842352|FG000|Stage 2 (4 Weeks)|Other|0|||
170681159|NCT02310568|616842353|FG001|Stage 2 (4 Weeks)|Other|1|||
170681160|NCT02310568|616842354|FG002|Stage 2 (4 Weeks)|Other|1|||
170681161|NCT02310568|616842355|FG003|Stage 2 (4 Weeks)|Other|0|||
170681162|NCT02310568|616842356|FG004|Stage 2 (4 Weeks)|Other|0|||
170681163|NCT02310568|616842352|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
170681164|NCT02310568|616842353|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
170681165|NCT02310568|616842354|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
170681166|NCT02310568|616842355|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
170681167|NCT02310568|616842356|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
170681168|NCT02310568|616842352|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
170681169|NCT02310568|616842353|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
170681170|NCT02310568|616842354|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
170681171|NCT02310568|616842355|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
170681172|NCT02310568|616842356|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
170681173|NCT02310568|616842352|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
170681174|NCT02310568|616842353|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
170681175|NCT02310568|616842354|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
170681176|NCT02310568|616842355|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
170681177|NCT02310568|616842356|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
170681178|NCT01384760|616842360|FG000|Overall Study|Lost to Follow-up|0|||
170681179|NCT01384760|616842361|FG001|Overall Study|Lost to Follow-up|6|||
170681180|NCT01384760|616842360|FG000|Overall Study|Protocol Violation|16|||
170681181|NCT01384760|616842361|FG001|Overall Study|Protocol Violation|0|||
170681182|NCT00630396|616842365|FG000|Overall Study|Death|4|||
170681183|NCT00630396|616842365|FG000|Overall Study|Lost to Follow-up|3|||
170681184|NCT02990910|616842369|FG000|Overall Study|Lack of Efficacy|6|||
170681185|NCT02990910|616842370|FG001|Overall Study|Lack of Efficacy|10|||
170681186|NCT02989194|616842380|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
170681187|NCT02989194|616842381|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
170681188|NCT02989194|616842382|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
170681189|NCT02989194|616842380|FG000|Overall Study|Lost to Follow-up|0|||
170681190|NCT02989194|616842381|FG001|Overall Study|Lost to Follow-up|1|||
170681191|NCT02989194|616842382|FG002|Overall Study|Lost to Follow-up|0|||
170681192|NCT02989194|616842380|FG000|Overall Study|Withdrawal by Subject|0|||
170681193|NCT02989194|616842381|FG001|Overall Study|Withdrawal by Subject|1|||
170681194|NCT02989194|616842382|FG002|Overall Study|Withdrawal by Subject|0|||
170681195|NCT02064868|616842384|FG000|Overall Study|Lost to Follow-up|14|||
170681196|NCT02064868|616842385|FG001|Overall Study|Lost to Follow-up|8|||
170681197|NCT02064868|616842384|FG000|Overall Study|Physician Decision|1|||
170681198|NCT02064868|616842385|FG001|Overall Study|Physician Decision|0|||
170681199|NCT02064868|616842384|FG000|Overall Study|Withdrawal by Subject|14|||
170681200|NCT02064868|616842385|FG001|Overall Study|Withdrawal by Subject|3|||
170681201|NCT02064868|616842384|FG000|Overall Study|Technical Problems or Missing|5|||
170681202|NCT02064868|616842385|FG001|Overall Study|Technical Problems or Missing|2|||
170681203|NCT02825992|616842388|FG000|Overall Study|Withdrawal by Subject|4|||
170681204|NCT02825992|616842388|FG000|Overall Study|Lost to Follow-up|2|||
170681205|NCT02825992|616842388|FG000|Overall Study|Procedure terminated|2|||
170681206|NCT00482612|616842389|FG000|In-treatment Period|No study medication administered|0|||
170681207|NCT00482612|616842390|FG001|In-treatment Period|No study medication administered|0|||
170681208|NCT00482612|616842391|FG002|In-treatment Period|No study medication administered|1|||
170681209|NCT00482612|616842392|FG003|In-treatment Period|No study medication administered|0|||
170681210|NCT00482612|616842389|FG000|Follow-up Period|Other|4|||
170681211|NCT00482612|616842390|FG001|Follow-up Period|Other|2|||
170681212|NCT00482612|616842391|FG002|Follow-up Period|Other|1|||
170681213|NCT00482612|616842392|FG003|Follow-up Period|Other|2|||
170681214|NCT00482612|616842389|FG000|Follow-up Period|Lack of compliance|0|||
170681215|NCT00482612|616842390|FG001|Follow-up Period|Lack of compliance|0|||
170681216|NCT00482612|616842391|FG002|Follow-up Period|Lack of compliance|1|||
170681217|NCT00482612|616842392|FG003|Follow-up Period|Lack of compliance|0|||
170681218|NCT00482612|616842389|FG000|Follow-up Period|Lost to Follow-up|0|||
170681219|NCT00482612|616842390|FG001|Follow-up Period|Lost to Follow-up|4|||
170681220|NCT00482612|616842391|FG002|Follow-up Period|Lost to Follow-up|2|||
170681221|NCT00482612|616842392|FG003|Follow-up Period|Lost to Follow-up|1|||
170681222|NCT00482612|616842389|FG000|Follow-up Period|Adverse Event|4|||
170681223|NCT00482612|616842390|FG001|Follow-up Period|Adverse Event|7|||
170681224|NCT00482612|616842391|FG002|Follow-up Period|Adverse Event|9|||
170681225|NCT00482612|616842392|FG003|Follow-up Period|Adverse Event|0|||
170681226|NCT00482612|616842389|FG000|Follow-up Period|Lack of Efficacy|2|||
170681227|NCT00482612|616842390|FG001|Follow-up Period|Lack of Efficacy|0|||
170681228|NCT00482612|616842391|FG002|Follow-up Period|Lack of Efficacy|1|||
170681229|NCT00482612|616842392|FG003|Follow-up Period|Lack of Efficacy|0|||
170681230|NCT00482612|616842389|FG000|Follow-up Period|Withdrawal by Subject|3|||
170681231|NCT00482612|616842390|FG001|Follow-up Period|Withdrawal by Subject|5|||
170681232|NCT00482612|616842391|FG002|Follow-up Period|Withdrawal by Subject|7|||
170681233|NCT00482612|616842392|FG003|Follow-up Period|Withdrawal by Subject|2|||
170681234|NCT00482612|616842389|FG000|Follow-up Period|Reasons not related to trial|1|||
170681235|NCT00482612|616842390|FG001|Follow-up Period|Reasons not related to trial|0|||
170681236|NCT00482612|616842391|FG002|Follow-up Period|Reasons not related to trial|1|||
170681237|NCT00482612|616842392|FG003|Follow-up Period|Reasons not related to trial|3|||
170681238|NCT00660023|616842393|FG000|Overall Study|Adverse Event|2|||
170681239|NCT00660023|616842393|FG000|Overall Study|Death|8|||
170681240|NCT00660023|616842393|FG000|Overall Study|Blood Transfusion|5|||
170681241|NCT00660023|616842393|FG000|Overall Study|Renal Transplantation|3|||
170681242|NCT00660023|616842393|FG000|Overall Study|Withdrawal by Subject|1|||
170681243|NCT00660023|616842393|FG000|Overall Study|Missed Pregnancy Test|1|||
170681244|NCT00660023|616842393|FG000|Overall Study|Other Screening Failure|9|||
170681245|NCT04180488|616842395|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
170681246|NCT04180488|616842396|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
170681247|NCT04180488|616842397|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
170681248|NCT04180488|616842398|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
170681249|NCT04180488|616842399|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
170681250|NCT04180488|616842400|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
170681251|NCT04180488|616842395|FG000|Overall Study|Withdrawal by Subject|8|||
170681252|NCT04180488|616842396|FG001|Overall Study|Withdrawal by Subject|4|||
170681253|NCT04180488|616842397|FG002|Overall Study|Withdrawal by Subject|5|||
170681254|NCT04180488|616842398|FG003|Overall Study|Withdrawal by Subject|2|||
170681255|NCT04180488|616842399|FG004|Overall Study|Withdrawal by Subject|8|||
170681256|NCT04180488|616842400|FG005|Overall Study|Withdrawal by Subject|6|||
170681257|NCT04180488|616842395|FG000|Overall Study|Adverse Event|3|||
170820901|NCT03926117|617351562|FG003|Overall Study|Adverse Event|1|||
170820902|NCT03926117|617351559|FG000|Overall Study|Randomized but not treated|1|||
170681258|NCT04180488|616842396|FG001|Overall Study|Adverse Event|2|||
170681259|NCT04180488|616842397|FG002|Overall Study|Adverse Event|0|||
170681260|NCT04180488|616842398|FG003|Overall Study|Adverse Event|0|||
170681261|NCT04180488|616842399|FG004|Overall Study|Adverse Event|0|||
170681262|NCT04180488|616842400|FG005|Overall Study|Adverse Event|0|||
170681263|NCT04180488|616842395|FG000|Overall Study|Poor compliance to protocol|0|||
170681264|NCT04180488|616842396|FG001|Overall Study|Poor compliance to protocol|0|||
170681265|NCT04180488|616842397|FG002|Overall Study|Poor compliance to protocol|1|||
170681266|NCT04180488|616842398|FG003|Overall Study|Poor compliance to protocol|0|||
170681267|NCT04180488|616842399|FG004|Overall Study|Poor compliance to protocol|0|||
170681268|NCT04180488|616842400|FG005|Overall Study|Poor compliance to protocol|0|||
170681269|NCT03506815|616842401|FG000|Overall Study|Adverse Event|8|||
170681270|NCT03506815|616842402|FG001|Overall Study|Adverse Event|0|||
170681271|NCT03506815|616842401|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
170681272|NCT03506815|616842402|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
170681273|NCT03506815|616842401|FG000|Overall Study|Protocol Violation|1|||
170681274|NCT03506815|616842402|FG001|Overall Study|Protocol Violation|0|||
170681275|NCT03506815|616842401|FG000|Overall Study|Elective Surgery|1|||
170681276|NCT03506815|616842402|FG001|Overall Study|Elective Surgery|0|||
170681277|NCT04160091|616842403|FG000|Overall Study|Terminated by Sponsor|7|||
170681278|NCT04160091|616842404|FG001|Overall Study|Terminated by Sponsor|3|||
170681279|NCT04160091|616842405|FG002|Overall Study|Terminated by Sponsor|5|||
170681280|NCT04160091|616842406|FG003|Overall Study|Terminated by Sponsor|2|||
170681281|NCT04160091|616842403|FG000|Overall Study|Noncompliance|0|||
170681282|NCT04160091|616842404|FG001|Overall Study|Noncompliance|0|||
170681283|NCT04160091|616842405|FG002|Overall Study|Noncompliance|0|||
170681284|NCT04160091|616842406|FG003|Overall Study|Noncompliance|1|||
170681285|NCT04160091|616842403|FG000|Overall Study|Withdrawal by Subject|0|||
170681286|NCT04160091|616842404|FG001|Overall Study|Withdrawal by Subject|0|||
170681287|NCT04160091|616842405|FG002|Overall Study|Withdrawal by Subject|0|||
170681288|NCT04160091|616842406|FG003|Overall Study|Withdrawal by Subject|1|||
170681289|NCT01059825|616842412|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
170681290|NCT01059825|616842413|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
170681291|NCT01059825|616842414|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
170681292|NCT01059825|616842415|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
170681293|NCT01059825|616842416|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
170681294|NCT01059825|616842417|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
170681295|NCT01059825|616842418|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
170681296|NCT01059825|616842412|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
170681297|NCT01059825|616842413|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
170681298|NCT01059825|616842414|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
170681299|NCT01059825|616842415|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
170681300|NCT01059825|616842416|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
170681301|NCT01059825|616842417|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
170681302|NCT01059825|616842418|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
170681303|NCT01059825|616842412|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
170681304|NCT01059825|616842413|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
170681305|NCT01059825|616842414|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
170681306|NCT01059825|616842415|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
170681307|NCT01059825|616842416|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
170681308|NCT01059825|616842417|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
170681309|NCT01059825|616842418|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
170681310|NCT01059825|616842412|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
170681311|NCT01059825|616842413|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
170681312|NCT01059825|616842414|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
170681313|NCT01059825|616842415|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
170681314|NCT01059825|616842416|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
170681315|NCT01059825|616842417|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
170681316|NCT01059825|616842418|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
170681317|NCT01059825|616842412|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
170681318|NCT01059825|616842413|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
170681319|NCT01059825|616842414|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
170681320|NCT01059825|616842415|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
170681321|NCT01059825|616842416|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
170681322|NCT01059825|616842417|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
170681323|NCT01059825|616842418|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
170820903|NCT03926117|617351560|FG001|Overall Study|Randomized but not treated|1|||
170820904|NCT03926117|617351561|FG002|Overall Study|Randomized but not treated|0|||
170820905|NCT03926117|617351562|FG003|Overall Study|Randomized but not treated|1|||
170820906|NCT00990314|617351563|FG000|Overall Study|Death|2|||
170820907|NCT00990314|617351563|FG000|Overall Study|Adverse Event|2|||
170681324|NCT01059825|616842412|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
170681325|NCT01059825|616842413|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
170681326|NCT01059825|616842414|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
170681327|NCT01059825|616842415|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
170681328|NCT01059825|616842416|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
170681329|NCT01059825|616842417|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
170681330|NCT01059825|616842418|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
170681331|NCT01059825|616842412|FG000|Treatment Period|Lost to Follow-up|2|||
170681332|NCT01059825|616842413|FG001|Treatment Period|Lost to Follow-up|1|||
170681333|NCT01059825|616842414|FG002|Treatment Period|Lost to Follow-up|0|||
170681334|NCT01059825|616842415|FG003|Treatment Period|Lost to Follow-up|1|||
170681335|NCT01059825|616842416|FG004|Treatment Period|Lost to Follow-up|2|||
170681336|NCT01059825|616842417|FG005|Treatment Period|Lost to Follow-up|0|||
170681337|NCT01059825|616842418|FG006|Treatment Period|Lost to Follow-up|0|||
170681338|NCT01059825|616842412|FG000|Treatment Period|Withdrawal by Subject|3|||
170681339|NCT01059825|616842413|FG001|Treatment Period|Withdrawal by Subject|0|||
170681340|NCT01059825|616842414|FG002|Treatment Period|Withdrawal by Subject|1|||
170681341|NCT01059825|616842415|FG003|Treatment Period|Withdrawal by Subject|5|||
170681342|NCT01059825|616842416|FG004|Treatment Period|Withdrawal by Subject|4|||
170681343|NCT01059825|616842417|FG005|Treatment Period|Withdrawal by Subject|1|||
170681344|NCT01059825|616842418|FG006|Treatment Period|Withdrawal by Subject|0|||
170681345|NCT01059825|616842412|FG000|Treatment Period|Other reason not specified|1|||
170681346|NCT01059825|616842413|FG001|Treatment Period|Other reason not specified|2|||
170681347|NCT01059825|616842414|FG002|Treatment Period|Other reason not specified|1|||
170681348|NCT01059825|616842415|FG003|Treatment Period|Other reason not specified|2|||
170681349|NCT01059825|616842416|FG004|Treatment Period|Other reason not specified|0|||
170681350|NCT01059825|616842417|FG005|Treatment Period|Other reason not specified|0|||
170681351|NCT01059825|616842418|FG006|Treatment Period|Other reason not specified|0|||
170681352|NCT01059825|616842412|FG000|Treatment Period|Protocol Violation|0|||
170681353|NCT01059825|616842413|FG001|Treatment Period|Protocol Violation|0|||
170681354|NCT01059825|616842414|FG002|Treatment Period|Protocol Violation|1|||
170681355|NCT01059825|616842415|FG003|Treatment Period|Protocol Violation|1|||
170681356|NCT01059825|616842416|FG004|Treatment Period|Protocol Violation|1|||
170681357|NCT01059825|616842417|FG005|Treatment Period|Protocol Violation|1|||
170681358|NCT01059825|616842418|FG006|Treatment Period|Protocol Violation|0|||
170681359|NCT01059825|616842412|FG000|Treatment Period|Adverse event related to study drug|1|||
170681360|NCT01059825|616842413|FG001|Treatment Period|Adverse event related to study drug|0|||
170681361|NCT01059825|616842414|FG002|Treatment Period|Adverse event related to study drug|1|||
170681362|NCT01059825|616842415|FG003|Treatment Period|Adverse event related to study drug|1|||
170681363|NCT01059825|616842416|FG004|Treatment Period|Adverse event related to study drug|0|||
170681364|NCT01059825|616842417|FG005|Treatment Period|Adverse event related to study drug|0|||
170681365|NCT01059825|616842418|FG006|Treatment Period|Adverse event related to study drug|0|||
170681366|NCT01059825|616842412|FG000|Treatment Period|Insufficient clinical response|3|||
170681367|NCT01059825|616842413|FG001|Treatment Period|Insufficient clinical response|0|||
170681368|NCT01059825|616842414|FG002|Treatment Period|Insufficient clinical response|0|||
170681369|NCT01059825|616842415|FG003|Treatment Period|Insufficient clinical response|0|||
170681370|NCT01059825|616842416|FG004|Treatment Period|Insufficient clinical response|0|||
170681371|NCT01059825|616842417|FG005|Treatment Period|Insufficient clinical response|0|||
170681372|NCT01059825|616842418|FG006|Treatment Period|Insufficient clinical response|0|||
170681373|NCT01059825|616842412|FG000|Treatment Period|Adverse event not related to study drug|0|||
170681374|NCT01059825|616842413|FG001|Treatment Period|Adverse event not related to study drug|1|||
170681375|NCT01059825|616842414|FG002|Treatment Period|Adverse event not related to study drug|2|||
170681376|NCT01059825|616842415|FG003|Treatment Period|Adverse event not related to study drug|1|||
170681377|NCT01059825|616842416|FG004|Treatment Period|Adverse event not related to study drug|1|||
170681378|NCT01059825|616842417|FG005|Treatment Period|Adverse event not related to study drug|1|||
170681379|NCT01059825|616842418|FG006|Treatment Period|Adverse event not related to study drug|0|||
170681380|NCT03342690|616842425|FG000|Overall Study|Missing Information|9|||
170681381|NCT03342690|616842425|FG000|Overall Study|Protocol Violation|16|||
170681382|NCT03138889|616842426|FG000|Overall Study|Withdrawal by Subject|5|||
170681383|NCT03138889|616842427|FG001|Overall Study|Withdrawal by Subject|5|||
170681384|NCT03138889|616842428|FG002|Overall Study|Withdrawal by Subject|0|||
170681385|NCT03138889|616842429|FG003|Overall Study|Withdrawal by Subject|2|||
170681386|NCT03138889|616842430|FG004|Overall Study|Withdrawal by Subject|1|||
170681387|NCT03138889|616842431|FG005|Overall Study|Withdrawal by Subject|3|||
170681388|NCT03138889|616842432|FG006|Overall Study|Withdrawal by Subject|0|||
170681389|NCT03138889|616842433|FG007|Overall Study|Withdrawal by Subject|1|||
170681390|NCT01414114|616842440|FG000|Overall Study|Adverse Event|2|||
170681391|NCT01414114|616842440|FG000|Overall Study|Withdrawal by Subject|1|||
170681392|NCT01414114|616842440|FG000|Overall Study|Other|2|||
170681393|NCT00779467|616842445|FG000|Overall Study|Lack of Efficacy|11|||
170681394|NCT00779467|616842446|FG001|Overall Study|Lack of Efficacy|2|||
170681395|NCT00779467|616842447|FG002|Overall Study|Lack of Efficacy|6|||
170681396|NCT00779467|616842448|FG003|Overall Study|Lack of Efficacy|11|||
170681397|NCT00779467|616842445|FG000|Overall Study|failed inclusion criteria|3|||
170681398|NCT00779467|616842446|FG001|Overall Study|failed inclusion criteria|3|||
170681399|NCT00779467|616842447|FG002|Overall Study|failed inclusion criteria|1|||
170681400|NCT00779467|616842448|FG003|Overall Study|failed inclusion criteria|2|||
170681401|NCT00779467|616842445|FG000|Overall Study|missing data|1|||
170681402|NCT00779467|616842446|FG001|Overall Study|missing data|0|||
170681403|NCT00779467|616842447|FG002|Overall Study|missing data|1|||
170681404|NCT00779467|616842448|FG003|Overall Study|missing data|4|||
170681405|NCT00779467|616842445|FG000|Overall Study|technical issue|0|||
170681406|NCT00779467|616842446|FG001|Overall Study|technical issue|0|||
170681407|NCT00779467|616842447|FG002|Overall Study|technical issue|2|||
170681408|NCT00779467|616842448|FG003|Overall Study|technical issue|1|||
170681409|NCT00779467|616842445|FG000|Overall Study|unavailable research staff|0|||
170681410|NCT00779467|616842446|FG001|Overall Study|unavailable research staff|0|||
170681411|NCT00779467|616842447|FG002|Overall Study|unavailable research staff|0|||
170681412|NCT00779467|616842448|FG003|Overall Study|unavailable research staff|1|||
170681413|NCT00460408|616842449|FG000|Overall Study|Adverse Event|1|||
170681414|NCT00460408|616842450|FG001|Overall Study|Adverse Event|0|||
170681415|NCT00460408|616842451|FG002|Overall Study|Adverse Event|0|||
170681416|NCT00460408|616842452|FG003|Overall Study|Adverse Event|0|||
170681417|NCT00460408|616842449|FG000|Overall Study|Death|7|||
170681418|NCT00460408|616842450|FG001|Overall Study|Death|0|||
170681419|NCT00460408|616842451|FG002|Overall Study|Death|0|||
170681420|NCT00460408|616842452|FG003|Overall Study|Death|0|||
170681421|NCT00460408|616842449|FG000|Overall Study|Lost to Follow-up|11|||
170681422|NCT00460408|616842450|FG001|Overall Study|Lost to Follow-up|0|||
170681423|NCT00460408|616842451|FG002|Overall Study|Lost to Follow-up|1|||
170681424|NCT00460408|616842452|FG003|Overall Study|Lost to Follow-up|0|||
170681425|NCT00460408|616842449|FG000|Overall Study|Withdrawal by Subject|31|||
170681426|NCT00460408|616842450|FG001|Overall Study|Withdrawal by Subject|0|||
170681427|NCT00460408|616842451|FG002|Overall Study|Withdrawal by Subject|0|||
170681428|NCT00460408|616842452|FG003|Overall Study|Withdrawal by Subject|0|||
170681429|NCT00460408|616842449|FG000|Overall Study|Insufficient clinical response|5|||
170681430|NCT00460408|616842450|FG001|Overall Study|Insufficient clinical response|1|||
170681431|NCT00460408|616842451|FG002|Overall Study|Insufficient clinical response|5|||
170681432|NCT00460408|616842452|FG003|Overall Study|Insufficient clinical response|0|||
170681433|NCT00460408|616842449|FG000|Overall Study|Other|12|||
170681434|NCT00460408|616842450|FG001|Overall Study|Other|2|||
170681435|NCT00460408|616842451|FG002|Overall Study|Other|0|||
170681436|NCT00460408|616842452|FG003|Overall Study|Other|0|||
170681437|NCT01909674|616842460|FG000|Overall Study|Withdrawal by Subject|5|||
170681438|NCT01909674|616842461|FG001|Overall Study|Withdrawal by Subject|2|||
170681439|NCT04212650|616842465|FG000|Overall Study|Withdrawal by Subject|1|||
170681440|NCT04212650|616842466|FG001|Overall Study|Withdrawal by Subject|0|||
170681441|NCT04656691|616842467|FG000|Overall Study|Adverse Event|1|||
170681442|NCT00887978|616842468|FG000|Overall Study|Adverse Event|18|||
170681443|NCT00887978|616842469|FG001|Overall Study|Adverse Event|5|||
170681444|NCT00887978|616842468|FG000|Overall Study|Clinical Worsening|4|||
170681445|NCT00887978|616842469|FG001|Overall Study|Clinical Worsening|4|||
170681446|NCT00887978|616842468|FG000|Overall Study|Death|2|||
170681447|NCT00887978|616842469|FG001|Overall Study|Death|3|||
170681448|NCT00887978|616842468|FG000|Overall Study|Withdrawal by Subject|1|||
170681449|NCT00887978|616842469|FG001|Overall Study|Withdrawal by Subject|2|||
170681450|NCT00887978|616842468|FG000|Overall Study|Lost to Follow-up|0|||
170681451|NCT00887978|616842469|FG001|Overall Study|Lost to Follow-up|1|||
170681452|NCT05980182|616842475|FG000|Overall Study|Lost to Follow-up|10|||
170681453|NCT05353985|616842483|FG000|Overall Study|Adverse Event|5|||
170681454|NCT05353985|616842484|FG001|Overall Study|Adverse Event|7|||
170681455|NCT05353985|616842483|FG000|Overall Study|Lost to Follow-up|1|||
170681456|NCT05353985|616842484|FG001|Overall Study|Lost to Follow-up|1|||
170681457|NCT05353985|616842483|FG000|Overall Study|Protocol Violation|1|||
170681458|NCT05353985|616842484|FG001|Overall Study|Protocol Violation|0|||
170681459|NCT05353985|616842483|FG000|Overall Study|Withdrawal by Subject|13|||
170681460|NCT05353985|616842484|FG001|Overall Study|Withdrawal by Subject|17|||
170681461|NCT05353985|616842483|FG000|Overall Study|Reason Not Specified|1|||
170681462|NCT05353985|616842484|FG001|Overall Study|Reason Not Specified|0|||
170681463|NCT05353985|616842483|FG000|Overall Study|Randomized in Error & Not Treated|0|||
170681464|NCT05353985|616842484|FG001|Overall Study|Randomized in Error & Not Treated|1|||
170681465|NCT05425745|616842486|FG000|Overall Study|Withdrawal of Consent|3|||
170681466|NCT05425745|616842487|FG001|Overall Study|Withdrawal of Consent|3|||
170681467|NCT05425745|616842486|FG000|Overall Study|Death|2|||
170681468|NCT05425745|616842487|FG001|Overall Study|Death|3|||
170681469|NCT05425745|616842486|FG000|Overall Study|Lost to Follow-up|1|||
170681470|NCT05425745|616842487|FG001|Overall Study|Lost to Follow-up|2|||
170681471|NCT05425745|616842486|FG000|Overall Study|Adverse Event|0|||
170681472|NCT05425745|616842487|FG001|Overall Study|Adverse Event|1|||
170681473|NCT05425745|616842486|FG000|Overall Study|Did not return for end of study visit|0|||
170681474|NCT05425745|616842487|FG001|Overall Study|Did not return for end of study visit|1|||
170681475|NCT05425745|616842486|FG000|Overall Study|End of study visit completed by phone|1|||
170681476|NCT05425745|616842487|FG001|Overall Study|End of study visit completed by phone|0|||
170681477|NCT05425745|616842486|FG000|Overall Study|Subject decision|1|||
170681478|NCT05425745|616842487|FG001|Overall Study|Subject decision|0|||
170681479|NCT02927080|616844027|FG000|Overall Study|Withdrawal by Subject|0|||
170681480|NCT02927080|616844028|FG001|Overall Study|Withdrawal by Subject|0|||
170681481|NCT02927080|616844029|FG002|Overall Study|Withdrawal by Subject|0|||
170681482|NCT02927080|616844030|FG003|Overall Study|Withdrawal by Subject|0|||
170681483|NCT02927080|616844031|FG004|Overall Study|Withdrawal by Subject|1|||
170681484|NCT02927080|616844032|FG005|Overall Study|Withdrawal by Subject|0|||
170681485|NCT02927080|616844033|FG006|Overall Study|Withdrawal by Subject|1|||
170681486|NCT02927080|616844034|FG007|Overall Study|Withdrawal by Subject|1|||
170681487|NCT02927080|616844035|FG008|Overall Study|Withdrawal by Subject|0|||
170681488|NCT02927080|616844036|FG009|Overall Study|Withdrawal by Subject|2|||
170681489|NCT02927080|616844027|FG000|Overall Study|Willingness to comply with protocol|0|||
170681490|NCT02927080|616844028|FG001|Overall Study|Willingness to comply with protocol|0|||
170681491|NCT02927080|616844029|FG002|Overall Study|Willingness to comply with protocol|0|||
170681492|NCT02927080|616844030|FG003|Overall Study|Willingness to comply with protocol|0|||
170681493|NCT02927080|616844031|FG004|Overall Study|Willingness to comply with protocol|0|||
170681494|NCT02927080|616844032|FG005|Overall Study|Willingness to comply with protocol|0|||
170681495|NCT02927080|616844033|FG006|Overall Study|Willingness to comply with protocol|0|||
170681496|NCT02927080|616844034|FG007|Overall Study|Willingness to comply with protocol|0|||
170681497|NCT02927080|616844035|FG008|Overall Study|Willingness to comply with protocol|0|||
170681498|NCT02927080|616844036|FG009|Overall Study|Willingness to comply with protocol|1|||
170681499|NCT02927080|616844027|FG000|Overall Study|Study terminated by Sponsor|0|||
170681500|NCT02927080|616844028|FG001|Overall Study|Study terminated by Sponsor|0|||
170681501|NCT02927080|616844029|FG002|Overall Study|Study terminated by Sponsor|0|||
170681502|NCT02927080|616844030|FG003|Overall Study|Study terminated by Sponsor|0|||
170681503|NCT02927080|616844031|FG004|Overall Study|Study terminated by Sponsor|0|||
170681504|NCT02927080|616844032|FG005|Overall Study|Study terminated by Sponsor|0|||
170681505|NCT02927080|616844033|FG006|Overall Study|Study terminated by Sponsor|6|||
170681506|NCT02927080|616844034|FG007|Overall Study|Study terminated by Sponsor|7|||
170681507|NCT02927080|616844035|FG008|Overall Study|Study terminated by Sponsor|2|||
170681508|NCT02927080|616844036|FG009|Overall Study|Study terminated by Sponsor|3|||
170681509|NCT02927080|616844027|FG000|Overall Study|Adverse Event|0|||
170681510|NCT02927080|616844028|FG001|Overall Study|Adverse Event|1|||
170681511|NCT02927080|616844029|FG002|Overall Study|Adverse Event|0|||
170681512|NCT02927080|616844030|FG003|Overall Study|Adverse Event|0|||
170681513|NCT02927080|616844031|FG004|Overall Study|Adverse Event|0|||
170681514|NCT02927080|616844032|FG005|Overall Study|Adverse Event|0|||
170681515|NCT02927080|616844033|FG006|Overall Study|Adverse Event|0|||
170681516|NCT02927080|616844034|FG007|Overall Study|Adverse Event|1|||
170681517|NCT02927080|616844035|FG008|Overall Study|Adverse Event|0|||
170681518|NCT02927080|616844036|FG009|Overall Study|Adverse Event|1|||
170681519|NCT02927080|616844027|FG000|Overall Study|Other|0|||
170681520|NCT02927080|616844028|FG001|Overall Study|Other|0|||
170681521|NCT02927080|616844029|FG002|Overall Study|Other|0|||
170681522|NCT02927080|616844030|FG003|Overall Study|Other|0|||
170681523|NCT02927080|616844031|FG004|Overall Study|Other|0|||
170681524|NCT02927080|616844032|FG005|Overall Study|Other|0|||
170681525|NCT02927080|616844033|FG006|Overall Study|Other|1|||
170681526|NCT02927080|616844034|FG007|Overall Study|Other|0|||
170681527|NCT02927080|616844035|FG008|Overall Study|Other|1|||
170681528|NCT02927080|616844036|FG009|Overall Study|Other|0|||
170681529|NCT01411228|616844047|FG000|Overall Study|Lost to Follow-up|0|||
170681530|NCT01411228|616844048|FG001|Overall Study|Lost to Follow-up|0|||
170681531|NCT01411228|616844049|FG002|Overall Study|Lost to Follow-up|1|||
170681532|NCT01411228|616844047|FG000|Overall Study|Withdrawal by Subject|1|||
170681533|NCT01411228|616844048|FG001|Overall Study|Withdrawal by Subject|0|||
170681534|NCT01411228|616844049|FG002|Overall Study|Withdrawal by Subject|0|||
170681535|NCT00381095|616844053|FG000|Overall Study|Death|3|||
170681536|NCT00381095|616844054|FG001|Overall Study|Death|4|||
170681537|NCT00381095|616844053|FG000|Overall Study|Lack of Efficacy|2|||
170681538|NCT00381095|616844054|FG001|Overall Study|Lack of Efficacy|4|||
170681539|NCT00381095|616844053|FG000|Overall Study|Other|2|||
170681540|NCT00381095|616844054|FG001|Overall Study|Other|2|||
170681541|NCT00381095|616844053|FG000|Overall Study|Protocol Violation|1|||
170681542|NCT00381095|616844054|FG001|Overall Study|Protocol Violation|1|||
170681543|NCT00381095|616844053|FG000|Overall Study|Withdrawal by Subject|3|||
170681544|NCT00381095|616844054|FG001|Overall Study|Withdrawal by Subject|3|||
170681545|NCT00381095|616844053|FG000|Overall Study|Adverse Event|2|||
170681546|NCT00381095|616844054|FG001|Overall Study|Adverse Event|7|||
170681547|NCT02057406|616844055|FG000|Overall Study|Physician Decision|0|||
170681548|NCT02057406|616844056|FG001|Overall Study|Physician Decision|0|||
170681549|NCT02057406|616844057|FG002|Overall Study|Physician Decision|2|||
170681550|NCT02057406|616844055|FG000|Overall Study|Withdrawal by Subject|0|||
170681551|NCT02057406|616844056|FG001|Overall Study|Withdrawal by Subject|2|||
170681552|NCT02057406|616844057|FG002|Overall Study|Withdrawal by Subject|0|||
170681553|NCT02057406|616844055|FG000|Overall Study|Lost to Follow-up|0|||
170681554|NCT02057406|616844056|FG001|Overall Study|Lost to Follow-up|0|||
170681555|NCT02057406|616844057|FG002|Overall Study|Lost to Follow-up|1|||
170681556|NCT02057406|616844055|FG000|Overall Study|Death|1|||
170681557|NCT02057406|616844056|FG001|Overall Study|Death|0|||
170681558|NCT02057406|616844057|FG002|Overall Study|Death|0|||
170681559|NCT02057406|616844055|FG000|Overall Study|Protocol Violation|0|||
170681560|NCT02057406|616844056|FG001|Overall Study|Protocol Violation|1|||
170681561|NCT02057406|616844057|FG002|Overall Study|Protocol Violation|0|||
170681562|NCT02057406|616844055|FG000|Overall Study|Patient transportation issues|0|||
170681563|NCT02057406|616844056|FG001|Overall Study|Patient transportation issues|0|||
170681564|NCT02057406|616844057|FG002|Overall Study|Patient transportation issues|1|||
170681565|NCT03562481|616844059|FG000|First Intervention|Lost to Follow-up|1|||
170681566|NCT03562481|616844060|FG001|First Intervention|Lost to Follow-up|0|||
170681567|NCT01401283|616844062|FG000|Overall Study|surgery cancelled|5|||
170681568|NCT01401283|616844063|FG001|Overall Study|surgery cancelled|8|||
170681569|NCT01401283|616844062|FG000|Overall Study|preoperative arrhythmia|5|||
170681570|NCT01401283|616844063|FG001|Overall Study|preoperative arrhythmia|0|||
170681571|NCT01401283|616844062|FG000|Overall Study|no central venous access|0|||
170681572|NCT01401283|616844063|FG001|Overall Study|no central venous access|1|||
170681573|NCT01401283|616844062|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
170681574|NCT01401283|616844063|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
170681575|NCT00856284|616844068|FG000|Overall Study|Hyperglycemic rescue|231|||
170681576|NCT00856284|616844069|FG001|Overall Study|Hyperglycemic rescue|201|||
170681577|NCT00856284|616844070|FG002|Overall Study|Hyperglycemic rescue|235|||
170681578|NCT00856284|616844068|FG000|Overall Study|Adverse Event|60|||
170681579|NCT00856284|616844069|FG001|Overall Study|Adverse Event|74|||
170681580|NCT00856284|616844070|FG002|Overall Study|Adverse Event|82|||
170681581|NCT00856284|616844068|FG000|Overall Study|Major protocol deviation|24|||
170681582|NCT00856284|616844069|FG001|Overall Study|Major protocol deviation|16|||
170681583|NCT00856284|616844070|FG002|Overall Study|Major protocol deviation|15|||
170681584|NCT00856284|616844068|FG000|Overall Study|Lost to Follow-up|20|||
170681585|NCT00856284|616844069|FG001|Overall Study|Lost to Follow-up|22|||
170681586|NCT00856284|616844070|FG002|Overall Study|Lost to Follow-up|28|||
170681587|NCT00856284|616844068|FG000|Overall Study|Voluntary withdrawal|48|||
170681588|NCT00856284|616844069|FG001|Overall Study|Voluntary withdrawal|52|||
170681589|NCT00856284|616844070|FG002|Overall Study|Voluntary withdrawal|62|||
170681590|NCT00856284|616844068|FG000|Overall Study|Pregnancy|1|||
170681591|NCT00856284|616844069|FG001|Overall Study|Pregnancy|2|||
170681592|NCT00856284|616844070|FG002|Overall Study|Pregnancy|0|||
170681593|NCT00856284|616844068|FG000|Overall Study|Investigator discretion|9|||
170681594|NCT00856284|616844069|FG001|Overall Study|Investigator discretion|8|||
170681595|NCT00856284|616844070|FG002|Overall Study|Investigator discretion|10|||
170681596|NCT00856284|616844068|FG000|Overall Study|Other|15|||
170681597|NCT00856284|616844069|FG001|Overall Study|Other|17|||
170681598|NCT00856284|616844070|FG002|Overall Study|Other|14|||
170681599|NCT00856284|616844068|FG000|Overall Study|Randomized in error|0|||
170681600|NCT00856284|616844069|FG001|Overall Study|Randomized in error|0|||
170681601|NCT00856284|616844070|FG002|Overall Study|Randomized in error|1|||
170681602|NCT01327885|616844075|FG000|Overall Study|Disease progression-according to RECIST|173|||
170681603|NCT01327885|616844076|FG001|Overall Study|Disease progression-according to RECIST|165|||
170681604|NCT01327885|616844075|FG000|Overall Study|Clinical progression|24|||
170681605|NCT01327885|616844076|FG001|Overall Study|Clinical progression|27|||
170681606|NCT01327885|616844075|FG000|Overall Study|Adverse Event|14|||
170681607|NCT01327885|616844076|FG001|Overall Study|Adverse Event|10|||
170681608|NCT01327885|616844075|FG000|Overall Study|Subject choice|5|||
170681609|NCT01327885|616844076|FG001|Overall Study|Subject choice|10|||
170681610|NCT01327885|616844075|FG000|Overall Study|Other|8|||
170681611|NCT01327885|616844076|FG001|Overall Study|Other|6|||
170681612|NCT01327885|616844075|FG000|Overall Study|Withdrawal of consent from study|3|||
170681613|NCT01327885|616844076|FG001|Overall Study|Withdrawal of consent from study|4|||
170681614|NCT01327885|616844075|FG000|Overall Study|Not treated|1|||
170681615|NCT01327885|616844076|FG001|Overall Study|Not treated|1|||
170681616|NCT01327885|616844075|FG000|Overall Study|Administrative decision|0|||
170681617|NCT01327885|616844076|FG001|Overall Study|Administrative decision|1|||
170681618|NCT04271605|616844077|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
170681619|NCT00644995|616844080|FG000|Overall Study|Lost to Follow-up|1|||
170681620|NCT00644995|616844081|FG001|Overall Study|Lost to Follow-up|4|||
170681621|NCT00644995|616844080|FG000|Overall Study|Refused|1|||
170681622|NCT00644995|616844081|FG001|Overall Study|Refused|0|||
170681623|NCT02117648|616844088|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
170681624|NCT02117648|616844088|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
170681625|NCT02117648|616844088|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
170681626|NCT02117648|616844088|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
170681627|NCT02117648|616844088|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
170681628|NCT02117648|616844088|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
170681629|NCT02117648|616844088|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
170681630|NCT02117648|616844088|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
170681631|NCT02117648|616844088|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
170681632|NCT02117648|616844088|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
170681633|NCT02117648|616844088|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
170681634|NCT05025241|616844089|FG000|Screening|Failed Screening|5|||
170681635|NCT05025241|616844089|FG000|Treatment and Follow Up|Adverse Event|3|||
170681636|NCT02670837|616844090|FG000|Overall Study|Death|2|||
170681637|NCT02670837|616844091|FG001|Overall Study|Death|0|||
170681638|NCT02670837|616844092|FG002|Overall Study|Death|0|||
170681639|NCT01276353|616844093|FG000|Double-blind|Adverse Event|2|||
170681640|NCT01276353|616844094|FG001|Double-blind|Adverse Event|0|||
170681641|NCT01276353|616844093|FG000|Double-blind|Withdrawal by Subject|1|||
170681642|NCT01276353|616844094|FG001|Double-blind|Withdrawal by Subject|0|||
170681643|NCT01276353|616844093|FG000|Extension|Adverse Event|2|||
170681644|NCT01276353|616844094|FG001|Extension|Adverse Event|5|||
170681645|NCT01276353|616844093|FG000|Extension|Withdrawal by Subject|1|||
170681646|NCT01276353|616844094|FG001|Extension|Withdrawal by Subject|2|||
170681647|NCT01276353|616844093|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
170681648|NCT01276353|616844094|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
170681649|NCT01276353|616844093|FG000|Extension|Physician Decision|1|||
170681650|NCT01276353|616844094|FG001|Extension|Physician Decision|0|||
170681651|NCT01276353|616844093|FG000|Extension|Prohibited concomitant medications|0|||
170681652|NCT01276353|616844094|FG001|Extension|Prohibited concomitant medications|1|||
170681653|NCT02266225|616844095|FG000|Overall Study|Lost to Follow-up|2|||
170681654|NCT02266225|616844095|FG000|Overall Study|Death|1|||
170681655|NCT02266225|616844095|FG000|Overall Study|Withdrawal by Subject|13|||
170681656|NCT01465997|616844096|FG000|Overall Study|Adverse Event|12|||
170681657|NCT01465997|616844097|FG001|Overall Study|Adverse Event|22|||
170681658|NCT01465997|616844096|FG000|Overall Study|Lack of Efficacy|13|||
170681659|NCT01465997|616844097|FG001|Overall Study|Lack of Efficacy|1|||
170681660|NCT01465997|616844096|FG000|Overall Study|Protocol Violation|1|||
170681661|NCT01465997|616844097|FG001|Overall Study|Protocol Violation|4|||
170681662|NCT01465997|616844096|FG000|Overall Study|Lost to Follow-up|6|||
170681663|NCT01465997|616844097|FG001|Overall Study|Lost to Follow-up|9|||
170681664|NCT01465997|616844096|FG000|Overall Study|Withdrawal by Subject|32|||
170681665|NCT01465997|616844097|FG001|Overall Study|Withdrawal by Subject|35|||
170681666|NCT01465997|616844096|FG000|Overall Study|investigator's decision|1|||
170681667|NCT01465997|616844097|FG001|Overall Study|investigator's decision|1|||
170681668|NCT01465997|616844096|FG000|Overall Study|Death|0|||
170681669|NCT01465997|616844097|FG001|Overall Study|Death|1|||
170681670|NCT01465997|616844096|FG000|Overall Study|sponsor's decision|1|||
170681671|NCT01465997|616844097|FG001|Overall Study|sponsor's decision|1|||
170681672|NCT01465997|616844096|FG000|Overall Study|subject withdrew consent|1|||
170681673|NCT01465997|616844097|FG001|Overall Study|subject withdrew consent|0|||
170681674|NCT01465997|616844096|FG000|Overall Study|local lab unblinded site|1|||
170681675|NCT01465997|616844097|FG001|Overall Study|local lab unblinded site|0|||
170681676|NCT01465997|616844096|FG000|Overall Study|withdrew before follow-up|0|||
170681677|NCT01465997|616844097|FG001|Overall Study|withdrew before follow-up|13|||
170681678|NCT01465997|616844096|FG000|Overall Study|decision by site staff|0|||
170681679|NCT01465997|616844097|FG001|Overall Study|decision by site staff|1|||
170681680|NCT01465997|616844096|FG000|Overall Study|subject left participation SP0993|0|||
170681681|NCT01465997|616844097|FG001|Overall Study|subject left participation SP0993|1|||
170681682|NCT02532972|616844098|FG000|Overall Study|Withdrawal by Subject|1|||
170681683|NCT02268084|616844103|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
170681684|NCT02268084|616844104|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
170681685|NCT02268084|616844103|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
170681686|NCT02268084|616844104|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
170681687|NCT05227027|616844105|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
170681688|NCT05227027|616844106|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
170681689|NCT02603419|616844107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
170681690|NCT02603419|616844108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
170681691|NCT02603419|616844109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
170681692|NCT02603419|616844110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
170681693|NCT02603419|616844111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
170681694|NCT02603419|616844112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
170681695|NCT02603419|616844107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
170681696|NCT02603419|616844108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
170681697|NCT02603419|616844109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
170681698|NCT02603419|616844110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
170681699|NCT02603419|616844111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
170681700|NCT02603419|616844112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
170681701|NCT02603419|616844107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
170681702|NCT02603419|616844108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
170681703|NCT02603419|616844109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
170681704|NCT02603419|616844110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
170681705|NCT02603419|616844111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
170681706|NCT02603419|616844112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
170681707|NCT02603419|616844107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
170820908|NCT00990314|617351563|FG000|Overall Study|Withdrawal by Subject|3|||
170820909|NCT00990314|617351563|FG000|Overall Study|Non-Compliance|1|||
170820910|NCT00990314|617351563|FG000|Overall Study|Physician Decision|3|||
170820911|NCT00990314|617351563|FG000|Overall Study|Lack of Efficacy|1|||
170820912|NCT03686176|617351568|FG000|Overall Study|Procedure cancelled|1|||
170820913|NCT03686176|617351569|FG001|Overall Study|Procedure cancelled|0|||
170820914|NCT03686176|617351570|FG002|Overall Study|Procedure cancelled|0|||
170820915|NCT03686176|617351568|FG000|Overall Study|VR Malfunction|1|||
170820916|NCT03686176|617351569|FG001|Overall Study|VR Malfunction|0|||
170820917|NCT03686176|617351570|FG002|Overall Study|VR Malfunction|0|||
170820918|NCT02938520|617351573|FG000|Overall Study|On-going at the time of analysis|258|||
170820919|NCT02938520|617351574|FG001|Overall Study|On-going at the time of analysis|261|||
170681708|NCT02603419|616844108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
170820920|NCT02938520|617351573|FG000|Overall Study|Physician Decision|2|||
170820921|NCT02938520|617351574|FG001|Overall Study|Physician Decision|5|||
170681709|NCT02603419|616844109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
170681710|NCT02603419|616844110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
170681711|NCT02603419|616844111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
170681712|NCT02603419|616844112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
170681713|NCT02603419|616844107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
170681714|NCT02603419|616844108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
170681715|NCT02603419|616844109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
170681716|NCT02603419|616844110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
170681717|NCT02603419|616844111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
170681718|NCT02603419|616844112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
170681719|NCT02603419|616844107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
170681720|NCT02603419|616844108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
170681721|NCT02603419|616844109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
170681722|NCT02603419|616844110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
170681723|NCT02603419|616844111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
170681724|NCT02603419|616844112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
170681725|NCT02603419|616844107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
170681726|NCT02603419|616844108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
170681727|NCT02603419|616844109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
170681728|NCT02603419|616844110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
170681729|NCT02603419|616844111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
170681730|NCT02603419|616844112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
170681731|NCT02603419|616844107|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
170681732|NCT02603419|616844108|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
170681733|NCT02603419|616844109|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
170681734|NCT02603419|616844110|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
170681735|NCT02603419|616844111|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
170681736|NCT02603419|616844112|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
170681737|NCT02603419|616844107|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
170681738|NCT02603419|616844108|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
170681739|NCT02603419|616844109|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
170681740|NCT02603419|616844110|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
170681741|NCT02603419|616844111|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
170681742|NCT02603419|616844112|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
170681743|NCT02603419|616844107|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
170681744|NCT02603419|616844108|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
170681745|NCT02603419|616844109|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
170681746|NCT02603419|616844110|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
170681747|NCT02603419|616844111|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
170681748|NCT02603419|616844112|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
170681749|NCT03552198|616844113|FG000|Overall Study|Lost to Follow-up|42|||
170681750|NCT03552198|616844114|FG001|Overall Study|Lost to Follow-up|48|||
170681751|NCT03552198|616844115|FG002|Overall Study|Lost to Follow-up|15|||
170681752|NCT03552198|616844116|FG003|Overall Study|Lost to Follow-up|19|||
170681753|NCT03552198|616844113|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
170681754|NCT03552198|616844114|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
170681755|NCT03552198|616844115|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
170681756|NCT03552198|616844116|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
170681757|NCT03552198|616844113|FG000|Overall Study|Did not receive air alerts|1|||
170681758|NCT03552198|616844114|FG001|Overall Study|Did not receive air alerts|0|||
170681759|NCT03552198|616844115|FG002|Overall Study|Did not receive air alerts|0|||
170681760|NCT03552198|616844116|FG003|Overall Study|Did not receive air alerts|1|||
170681761|NCT06149247|616844117|FG000|Overall Study|Adverse Event|0|||
170681762|NCT06149247|616844118|FG001|Overall Study|Adverse Event|1|||
170681763|NCT00371137|616844123|FG000|Overall Study|Adverse Event|20|||
170681764|NCT00371137|616844124|FG001|Overall Study|Adverse Event|35|||
170681765|NCT00371137|616844125|FG002|Overall Study|Adverse Event|42|||
170681766|NCT00371137|616844123|FG000|Overall Study|Withdrawal by Subject|11|||
170681767|NCT00371137|616844124|FG001|Overall Study|Withdrawal by Subject|10|||
170681768|NCT00371137|616844125|FG002|Overall Study|Withdrawal by Subject|15|||
170681769|NCT00371137|616844123|FG000|Overall Study|Lost to Follow-up|6|||
170681770|NCT00371137|616844124|FG001|Overall Study|Lost to Follow-up|3|||
170681771|NCT00371137|616844125|FG002|Overall Study|Lost to Follow-up|5|||
170681772|NCT00371137|616844123|FG000|Overall Study|Lack of Efficacy|30|||
170681773|NCT00371137|616844124|FG001|Overall Study|Lack of Efficacy|12|||
170681774|NCT00371137|616844125|FG002|Overall Study|Lack of Efficacy|13|||
170681775|NCT00371137|616844123|FG000|Overall Study|Sponsor Decision|2|||
170681776|NCT00371137|616844124|FG001|Overall Study|Sponsor Decision|1|||
170681777|NCT00371137|616844125|FG002|Overall Study|Sponsor Decision|2|||
170681778|NCT00371137|616844123|FG000|Overall Study|Physician Decision|1|||
170681779|NCT00371137|616844124|FG001|Overall Study|Physician Decision|1|||
170681780|NCT00371137|616844125|FG002|Overall Study|Physician Decision|1|||
170681781|NCT00371137|616844123|FG000|Overall Study|Protocol Violation|2|||
170681782|NCT00371137|616844124|FG001|Overall Study|Protocol Violation|1|||
170681783|NCT00371137|616844125|FG002|Overall Study|Protocol Violation|1|||
170681784|NCT02013791|616844128|FG000|Period 1|Lost to Follow-up|0|||
170681785|NCT02013791|616844129|FG001|Period 1|Lost to Follow-up|0|||
170681786|NCT02013791|616844130|FG002|Period 1|Lost to Follow-up|0|||
170681787|NCT02013791|616844131|FG003|Period 1|Lost to Follow-up|1|||
170681788|NCT02013791|616844132|FG004|Period 1|Lost to Follow-up|0|||
170681789|NCT02013791|616844133|FG005|Period 1|Lost to Follow-up|0|||
170681790|NCT02013791|616844134|FG006|Period 1|Lost to Follow-up|1|||
170681791|NCT02013791|616844135|FG007|Period 1|Lost to Follow-up|1|||
170681792|NCT02013791|616844136|FG008|Period 1|Lost to Follow-up|0|||
170681793|NCT02013791|616844128|FG000|Period 1|Other Miscellaneous Reasons|0|||
170681794|NCT02013791|616844129|FG001|Period 1|Other Miscellaneous Reasons|2|||
170681795|NCT02013791|616844130|FG002|Period 1|Other Miscellaneous Reasons|0|||
170681796|NCT02013791|616844131|FG003|Period 1|Other Miscellaneous Reasons|0|||
170681797|NCT02013791|616844132|FG004|Period 1|Other Miscellaneous Reasons|0|||
170681798|NCT02013791|616844133|FG005|Period 1|Other Miscellaneous Reasons|0|||
170681799|NCT02013791|616844134|FG006|Period 1|Other Miscellaneous Reasons|0|||
170681800|NCT02013791|616844135|FG007|Period 1|Other Miscellaneous Reasons|0|||
170681801|NCT02013791|616844136|FG008|Period 1|Other Miscellaneous Reasons|0|||
170681802|NCT03798483|616844137|FG000|Overall Study|Lost to Follow-up|2|||
170681803|NCT02643082|616844138|FG000|Period 1|Adverse Event|1|||
170681804|NCT02643082|616844139|FG001|Period 1|Adverse Event|0|||
170681805|NCT01666782|616844140|FG000|Overall Study|Received 2 doses of vaccine|0|||
170681806|NCT01666782|616844141|FG001|Overall Study|Received 2 doses of vaccine|1|||
170681807|NCT01666782|616844140|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
170681808|NCT01666782|616844141|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
170681809|NCT01756898|616844142|FG000|Overall Study|Adverse Event|7|||
170681810|NCT01756898|616844143|FG001|Overall Study|Adverse Event|1|||
170681811|NCT01756898|616844144|FG002|Overall Study|Adverse Event|0|||
170681812|NCT01756898|616844145|FG003|Overall Study|Adverse Event|0|||
170681813|NCT01756898|616844142|FG000|Overall Study|Lack of Efficacy|4|||
170681814|NCT01756898|616844143|FG001|Overall Study|Lack of Efficacy|7|||
170681815|NCT01756898|616844144|FG002|Overall Study|Lack of Efficacy|6|||
170681816|NCT01756898|616844145|FG003|Overall Study|Lack of Efficacy|6|||
170681817|NCT01756898|616844142|FG000|Overall Study|Lost to Follow-up|2|||
170681818|NCT01756898|616844143|FG001|Overall Study|Lost to Follow-up|4|||
170681819|NCT01756898|616844144|FG002|Overall Study|Lost to Follow-up|2|||
170681820|NCT01756898|616844145|FG003|Overall Study|Lost to Follow-up|3|||
170681821|NCT01756898|616844142|FG000|Overall Study|Protocol Violation|1|||
170681822|NCT01756898|616844143|FG001|Overall Study|Protocol Violation|2|||
170681823|NCT01756898|616844144|FG002|Overall Study|Protocol Violation|2|||
170681824|NCT01756898|616844145|FG003|Overall Study|Protocol Violation|1|||
170681825|NCT01756898|616844142|FG000|Overall Study|Withdrew Consent|5|||
170681826|NCT01756898|616844143|FG001|Overall Study|Withdrew Consent|3|||
170681827|NCT01756898|616844144|FG002|Overall Study|Withdrew Consent|5|||
170681828|NCT01756898|616844145|FG003|Overall Study|Withdrew Consent|6|||
170681829|NCT01756898|616844142|FG000|Overall Study|Other|0|||
170681830|NCT01756898|616844143|FG001|Overall Study|Other|2|||
170681831|NCT01756898|616844144|FG002|Overall Study|Other|2|||
170681832|NCT01756898|616844145|FG003|Overall Study|Other|0|||
170681833|NCT01500694|616844146|FG000|Overall Study|Adverse Event|4|||
170681834|NCT01500694|616844147|FG001|Overall Study|Adverse Event|3|||
170681835|NCT01500694|616844146|FG000|Overall Study|Protocol Violation|0|||
170681836|NCT01500694|616844147|FG001|Overall Study|Protocol Violation|1|||
170681837|NCT01500694|616844146|FG000|Overall Study|Withdrawal by Subject|23|||
170681838|NCT01500694|616844147|FG001|Overall Study|Withdrawal by Subject|14|||
170681839|NCT01500694|616844146|FG000|Overall Study|Lost to Follow-up|2|||
170681840|NCT01500694|616844147|FG001|Overall Study|Lost to Follow-up|3|||
170681841|NCT01500694|616844146|FG000|Overall Study|Lack of Efficacy|14|||
170681842|NCT01500694|616844147|FG001|Overall Study|Lack of Efficacy|5|||
170681843|NCT01500694|616844146|FG000|Overall Study|Other|9|||
170681844|NCT01500694|616844147|FG001|Overall Study|Other|3|||
170681845|NCT02007109|616844148|FG000|Overall Study|Diary not returned or excluded|102|||
170681846|NCT02007109|616844148|FG000|Overall Study|Excluded - Age<7yo|9|||
170681847|NCT01858389|616844149|FG000|Overall Study|Death|1|||
170681848|NCT01858389|616844150|FG001|Overall Study|Death|3|||
170681849|NCT01858389|616844149|FG000|Overall Study|Study terminated by sponsor|0|||
170681850|NCT01858389|616844150|FG001|Overall Study|Study terminated by sponsor|2|||
170681851|NCT01858389|616844149|FG000|Overall Study|Withdrawal by Subject|0|||
170681852|NCT01858389|616844150|FG001|Overall Study|Withdrawal by Subject|1|||
170681853|NCT01858389|616844149|FG000|Overall Study|Progressive disease|10|||
170681854|NCT01858389|616844150|FG001|Overall Study|Progressive disease|11|||
170681855|NCT01858389|616844149|FG000|Overall Study|Other|2|||
170681856|NCT01858389|616844150|FG001|Overall Study|Other|4|||
170681857|NCT01858389|616844149|FG000|Overall Study|Adverse Event|3|||
170681858|NCT01858389|616844150|FG001|Overall Study|Adverse Event|1|||
170681859|NCT01858389|616844149|FG000|Overall Study|Did not receive treatment|0|||
170681860|NCT01858389|616844150|FG001|Overall Study|Did not receive treatment|3|||
170681861|NCT03572062|616844151|FG000|Overall Study|Adverse Event|0|||
170681862|NCT03572062|616844152|FG001|Overall Study|Adverse Event|0|||
170681863|NCT03572062|616844153|FG002|Overall Study|Adverse Event|0|||
170681864|NCT03572062|616844154|FG003|Overall Study|Adverse Event|0|||
170681865|NCT03572062|616844155|FG004|Overall Study|Adverse Event|0|||
170681866|NCT03572062|616844156|FG005|Overall Study|Adverse Event|0|||
170681867|NCT03572062|616844157|FG006|Overall Study|Adverse Event|0|||
170681868|NCT03572062|616844158|FG007|Overall Study|Adverse Event|0|||
170681869|NCT03572062|616844159|FG008|Overall Study|Adverse Event|1|||
170681870|NCT03572062|616844160|FG009|Overall Study|Adverse Event|3|||
170681871|NCT03572062|616844151|FG000|Overall Study|Death|0|||
170681872|NCT03572062|616844152|FG001|Overall Study|Death|0|||
170681873|NCT03572062|616844153|FG002|Overall Study|Death|0|||
170681874|NCT03572062|616844154|FG003|Overall Study|Death|0|||
170681875|NCT03572062|616844155|FG004|Overall Study|Death|0|||
170681876|NCT03572062|616844156|FG005|Overall Study|Death|1|||
170681877|NCT03572062|616844157|FG006|Overall Study|Death|0|||
170681878|NCT03572062|616844158|FG007|Overall Study|Death|0|||
170681879|NCT03572062|616844159|FG008|Overall Study|Death|0|||
170681880|NCT03572062|616844160|FG009|Overall Study|Death|0|||
170681881|NCT03572062|616844151|FG000|Overall Study|Lost to Follow-up|0|||
170681882|NCT03572062|616844152|FG001|Overall Study|Lost to Follow-up|0|||
170681883|NCT03572062|616844153|FG002|Overall Study|Lost to Follow-up|0|||
170681884|NCT03572062|616844154|FG003|Overall Study|Lost to Follow-up|0|||
170681885|NCT03572062|616844155|FG004|Overall Study|Lost to Follow-up|0|||
170681886|NCT03572062|616844156|FG005|Overall Study|Lost to Follow-up|1|||
170681887|NCT03572062|616844157|FG006|Overall Study|Lost to Follow-up|1|||
170681888|NCT03572062|616844158|FG007|Overall Study|Lost to Follow-up|0|||
170681889|NCT03572062|616844159|FG008|Overall Study|Lost to Follow-up|0|||
170681890|NCT03572062|616844160|FG009|Overall Study|Lost to Follow-up|0|||
170681891|NCT03572062|616844151|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681892|NCT03572062|616844152|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681893|NCT03572062|616844153|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681894|NCT03572062|616844154|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681895|NCT03572062|616844155|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681896|NCT03572062|616844156|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681897|NCT03572062|616844157|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681898|NCT03572062|616844158|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681899|NCT03572062|616844159|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
170681900|NCT03572062|616844160|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
170681901|NCT03572062|616844151|FG000|Overall Study|Study Terminated By Sponsor|0|||
170681902|NCT03572062|616844152|FG001|Overall Study|Study Terminated By Sponsor|0|||
170681903|NCT03572062|616844153|FG002|Overall Study|Study Terminated By Sponsor|0|||
170681904|NCT03572062|616844154|FG003|Overall Study|Study Terminated By Sponsor|0|||
170681905|NCT03572062|616844155|FG004|Overall Study|Study Terminated By Sponsor|0|||
170681906|NCT03572062|616844156|FG005|Overall Study|Study Terminated By Sponsor|0|||
170681907|NCT03572062|616844157|FG006|Overall Study|Study Terminated By Sponsor|0|||
170681908|NCT03572062|616844158|FG007|Overall Study|Study Terminated By Sponsor|0|||
170681909|NCT03572062|616844159|FG008|Overall Study|Study Terminated By Sponsor|29|||
170681910|NCT03572062|616844160|FG009|Overall Study|Study Terminated By Sponsor|27|||
170681911|NCT03572062|616844151|FG000|Overall Study|Physician Decision|0|||
170681912|NCT03572062|616844152|FG001|Overall Study|Physician Decision|0|||
170681913|NCT03572062|616844153|FG002|Overall Study|Physician Decision|0|||
170681914|NCT03572062|616844154|FG003|Overall Study|Physician Decision|0|||
170681915|NCT03572062|616844155|FG004|Overall Study|Physician Decision|0|||
170681916|NCT03572062|616844156|FG005|Overall Study|Physician Decision|0|||
170681917|NCT03572062|616844157|FG006|Overall Study|Physician Decision|0|||
170681918|NCT03572062|616844158|FG007|Overall Study|Physician Decision|0|||
170681919|NCT03572062|616844159|FG008|Overall Study|Physician Decision|1|||
170681920|NCT03572062|616844160|FG009|Overall Study|Physician Decision|0|||
170681921|NCT03572062|616844151|FG000|Overall Study|Withdrawal by Subject|0|||
170681922|NCT03572062|616844152|FG001|Overall Study|Withdrawal by Subject|0|||
170681923|NCT03572062|616844153|FG002|Overall Study|Withdrawal by Subject|0|||
170681924|NCT03572062|616844154|FG003|Overall Study|Withdrawal by Subject|0|||
170681925|NCT03572062|616844155|FG004|Overall Study|Withdrawal by Subject|0|||
170681926|NCT03572062|616844156|FG005|Overall Study|Withdrawal by Subject|0|||
170681927|NCT03572062|616844157|FG006|Overall Study|Withdrawal by Subject|0|||
170681928|NCT03572062|616844158|FG007|Overall Study|Withdrawal by Subject|0|||
170681929|NCT03572062|616844159|FG008|Overall Study|Withdrawal by Subject|0|||
170681930|NCT03572062|616844160|FG009|Overall Study|Withdrawal by Subject|1|||
170681931|NCT03572062|616844151|FG000|Overall Study|Randomized But Not Treated|0|||
170681932|NCT03572062|616844152|FG001|Overall Study|Randomized But Not Treated|0|||
170681933|NCT03572062|616844153|FG002|Overall Study|Randomized But Not Treated|0|||
170681934|NCT03572062|616844154|FG003|Overall Study|Randomized But Not Treated|0|||
170681935|NCT03572062|616844155|FG004|Overall Study|Randomized But Not Treated|1|||
170681936|NCT03572062|616844156|FG005|Overall Study|Randomized But Not Treated|2|||
170681937|NCT03572062|616844157|FG006|Overall Study|Randomized But Not Treated|0|||
170681938|NCT03572062|616844158|FG007|Overall Study|Randomized But Not Treated|1|||
170681939|NCT03572062|616844159|FG008|Overall Study|Randomized But Not Treated|0|||
170681940|NCT03572062|616844160|FG009|Overall Study|Randomized But Not Treated|0|||
170681941|NCT03978520|616844161|FG000|Overall Study|Adverse Event|2|||
170681942|NCT03978520|616844162|FG001|Overall Study|Adverse Event|5|||
170681943|NCT03978520|616844163|FG002|Overall Study|Adverse Event|3|||
170681944|NCT03978520|616844164|FG003|Overall Study|Adverse Event|5|||
170681945|NCT03978520|616844165|FG004|Overall Study|Adverse Event|6|||
170681946|NCT03978520|616844161|FG000|Overall Study|Withdrawal by Subject|10|||
170681947|NCT03978520|616844162|FG001|Overall Study|Withdrawal by Subject|4|||
170681948|NCT03978520|616844163|FG002|Overall Study|Withdrawal by Subject|5|||
170681949|NCT03978520|616844164|FG003|Overall Study|Withdrawal by Subject|6|||
170681950|NCT03978520|616844165|FG004|Overall Study|Withdrawal by Subject|5|||
170681951|NCT03978520|616844161|FG000|Overall Study|Lost to Follow-up|2|||
170681952|NCT03978520|616844162|FG001|Overall Study|Lost to Follow-up|2|||
170681953|NCT03978520|616844163|FG002|Overall Study|Lost to Follow-up|2|||
170681954|NCT03978520|616844164|FG003|Overall Study|Lost to Follow-up|0|||
170681955|NCT03978520|616844165|FG004|Overall Study|Lost to Follow-up|1|||
170681956|NCT03978520|616844161|FG000|Overall Study|COVID-19 infection|0|||
170681957|NCT03978520|616844162|FG001|Overall Study|COVID-19 infection|1|||
170681958|NCT03978520|616844163|FG002|Overall Study|COVID-19 infection|0|||
170681959|NCT03978520|616844164|FG003|Overall Study|COVID-19 infection|0|||
170681960|NCT03978520|616844165|FG004|Overall Study|COVID-19 infection|0|||
170681961|NCT03978520|616844161|FG000|Overall Study|Other, not specified|9|||
170681962|NCT03978520|616844162|FG001|Overall Study|Other, not specified|4|||
170681963|NCT03978520|616844163|FG002|Overall Study|Other, not specified|1|||
170681964|NCT03978520|616844164|FG003|Overall Study|Other, not specified|1|||
170681965|NCT03978520|616844165|FG004|Overall Study|Other, not specified|2|||
170681966|NCT03978520|616844161|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
170681967|NCT03978520|616844162|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
170681968|NCT03978520|616844163|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
170681969|NCT03978520|616844164|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
170681970|NCT03978520|616844165|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
170681971|NCT02837783|616844166|FG000|Overall Study|Adverse Event|1|||
170681972|NCT02837783|616844167|FG001|Overall Study|Adverse Event|0|||
170681973|NCT02837783|616844166|FG000|Overall Study|Other, Not Specified|1|||
170681974|NCT02837783|616844167|FG001|Overall Study|Other, Not Specified|2|||
170681975|NCT00844896|616844168|FG000|Overall Study|Lost to Follow-up|12|||
170681976|NCT00844896|616844169|FG001|Overall Study|Lost to Follow-up|16|||
170681977|NCT00844896|616844168|FG000|Overall Study|Parents did not have time to complete|0|||
170681978|NCT00844896|616844169|FG001|Overall Study|Parents did not have time to complete|1|||
170681979|NCT02233647|616844170|FG000|Overall Study|Adverse Event|1|||
170681980|NCT00439244|616844174|FG000|Overall Study|Adverse Event|5|||
170681981|NCT00439244|616844175|FG001|Overall Study|Adverse Event|2|||
170681982|NCT00439244|616844176|FG002|Overall Study|Adverse Event|3|||
170681983|NCT00439244|616844174|FG000|Overall Study|Withdrawal by Subject|3|||
170681984|NCT00439244|616844175|FG001|Overall Study|Withdrawal by Subject|1|||
170681985|NCT00439244|616844176|FG002|Overall Study|Withdrawal by Subject|2|||
170681986|NCT00439244|616844174|FG000|Overall Study|Lost to Follow-up|2|||
170681987|NCT00439244|616844175|FG001|Overall Study|Lost to Follow-up|1|||
170681988|NCT00439244|616844176|FG002|Overall Study|Lost to Follow-up|2|||
170681989|NCT00439244|616844174|FG000|Overall Study|Death|0|||
170681990|NCT00439244|616844175|FG001|Overall Study|Death|1|||
170681991|NCT00439244|616844176|FG002|Overall Study|Death|0|||
170681992|NCT00439244|616844174|FG000|Overall Study|Protocol Violation|0|||
170681993|NCT00439244|616844175|FG001|Overall Study|Protocol Violation|1|||
170681994|NCT00439244|616844176|FG002|Overall Study|Protocol Violation|0|||
170681995|NCT00439244|616844174|FG000|Overall Study|Administrative problems|1|||
170681996|NCT00439244|616844175|FG001|Overall Study|Administrative problems|0|||
170681997|NCT00439244|616844176|FG002|Overall Study|Administrative problems|0|||
170681998|NCT03278613|616844177|FG000|Overall Study|Lost to Follow-up|3|||
170681999|NCT03278613|616844178|FG001|Overall Study|Lost to Follow-up|1|||
170682000|NCT05355805|616844179|FG000|Overall Study|Lost to Follow-up|6|||
170682001|NCT05355805|616844180|FG001|Overall Study|Lost to Follow-up|11|||
170682002|NCT05355805|616844181|FG002|Overall Study|Lost to Follow-up|10|||
170682003|NCT05355805|616844182|FG003|Overall Study|Lost to Follow-up|6|||
170682004|NCT05355805|616844179|FG000|Overall Study|Decision by Sponsor|0|||
170682005|NCT05355805|616844180|FG001|Overall Study|Decision by Sponsor|0|||
170682006|NCT05355805|616844181|FG002|Overall Study|Decision by Sponsor|1|||
170682007|NCT05355805|616844182|FG003|Overall Study|Decision by Sponsor|0|||
170682008|NCT05355805|616844179|FG000|Overall Study|Withdrawal by Subject|7|||
170682009|NCT05355805|616844180|FG001|Overall Study|Withdrawal by Subject|14|||
170682010|NCT05355805|616844181|FG002|Overall Study|Withdrawal by Subject|15|||
170682011|NCT05355805|616844182|FG003|Overall Study|Withdrawal by Subject|13|||
170682012|NCT04419714|616844183|FG000|Overall Study|Technical Fault|5|||
170682013|NCT04419714|616844183|FG000|Overall Study|Protocol Deviation|2|||
170682014|NCT04419714|616844183|FG000|Overall Study|Withdrawal by Subject|1|||
170682015|NCT02762266|616845560|FG000|Overall Study|Physician Decision|2|||
170682016|NCT02762266|616845561|FG001|Overall Study|Physician Decision|0|||
170682017|NCT01438424|616845562|FG000|Overall Study|Continuing treatment|29|||
170682018|NCT01438424|616845562|FG000|Overall Study|Minimal virologic response|95|||
170682019|NCT01438424|616845562|FG000|Overall Study|Not identified|55|||
170682020|NCT01438424|616845562|FG000|Overall Study|Withdrawal by Subject|104|||
170682021|NCT01438424|616845562|FG000|Overall Study|Progression of chronic hepatitis B|22|||
170682022|NCT01438424|616845562|FG000|Overall Study|Death|22|||
170682023|NCT01438424|616845562|FG000|Overall Study|Adverse Event|17|||
170682024|NCT01438424|616845562|FG000|Overall Study|Lost to Follow-up|17|||
170682025|NCT01438424|616845562|FG000|Overall Study|Abnormal laboratory test result|14|||
170682026|NCT01438424|616845562|FG000|Overall Study|Need for drug prohibited by protocol|14|||
170682027|NCT01438424|616845562|FG000|Overall Study|Pregnancy|7|||
170682028|NCT01438424|616845562|FG000|Overall Study|No longer met inclusion criteria|1|||
170682029|NCT01438424|616845562|FG000|Overall Study|Participant noncompliance|20|||
170682030|NCT02239978|616845563|FG000|Overall Study|Withdrawal by Subject|2|||
170682031|NCT02239978|616845564|FG001|Overall Study|Withdrawal by Subject|0|||
170682032|NCT02324569|616845573|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
170682033|NCT02324569|616845574|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
170682034|NCT02324569|616845573|FG000|Overall Study|Voluntary Withdrawal|3|||
170682035|NCT02324569|616845574|FG001|Overall Study|Voluntary Withdrawal|6|||
170682036|NCT02324569|616845573|FG000|Overall Study|Lack of Efficacy|2|||
170682037|NCT02324569|616845574|FG001|Overall Study|Lack of Efficacy|3|||
170682038|NCT02324569|616845573|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
170682039|NCT02324569|616845574|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
170682040|NCT02324569|616845573|FG000|Overall Study|Inconvenient Schedule|2|||
170682041|NCT02324569|616845574|FG001|Overall Study|Inconvenient Schedule|0|||
170682042|NCT02154490|616845581|FG000|Overall Study|No tissue submitted|23|||
170682043|NCT02154490|616845581|FG000|Overall Study|No biomarker results|167|||
170682044|NCT02154490|616845581|FG000|Overall Study|Not assigned to a sub-study|270|||
170682045|NCT02154490|616845581|FG000|Overall Study|Did not register to a sub-study|749|||
170682046|NCT02961751|616845586|FG000|Overall Study|Lost to Follow-up|11|||
170682047|NCT02961751|616845586|FG000|Overall Study|Physician Decision|2|||
170682048|NCT02961751|616845586|FG000|Overall Study|Not Eligible at Enrollment|1|||
170682049|NCT02961751|616845586|FG000|Overall Study|Protocol Violation|1|||
170682050|NCT02373202|616845587|FG000|Overall Study|Adverse Event|2|||
170682051|NCT02373202|616845588|FG001|Overall Study|Adverse Event|5|||
170682052|NCT02373202|616845589|FG002|Overall Study|Adverse Event|2|||
170682053|NCT02373202|616845590|FG003|Overall Study|Adverse Event|1|||
170682054|NCT02373202|616845587|FG000|Overall Study|Lack of Efficacy|0|||
170682055|NCT02373202|616845588|FG001|Overall Study|Lack of Efficacy|0|||
170682056|NCT02373202|616845589|FG002|Overall Study|Lack of Efficacy|1|||
170682057|NCT02373202|616845590|FG003|Overall Study|Lack of Efficacy|0|||
170682058|NCT02373202|616845587|FG000|Overall Study|Other|0|||
170682059|NCT02373202|616845588|FG001|Overall Study|Other|1|||
170682060|NCT02373202|616845589|FG002|Overall Study|Other|0|||
170682061|NCT02373202|616845590|FG003|Overall Study|Other|0|||
170682062|NCT03010254|616845591|FG000|Overall Study|Adverse Event|0|||
170682063|NCT03010254|616845592|FG001|Overall Study|Adverse Event|1|||
170682064|NCT03010254|616845591|FG000|Overall Study|Lost to Follow-up|4|||
170682065|NCT03010254|616845592|FG001|Overall Study|Lost to Follow-up|0|||
170682066|NCT03010254|616845591|FG000|Overall Study|Withdrawal by Subject|1|||
170682067|NCT03010254|616845592|FG001|Overall Study|Withdrawal by Subject|1|||
170682068|NCT03010254|616845591|FG000|Overall Study|Other|2|||
170682069|NCT03010254|616845592|FG001|Overall Study|Other|3|||
170682070|NCT01404325|616845593|FG000|Overall Study|Lost to Follow-up|1|||
170682071|NCT01404325|616845594|FG001|Overall Study|Lost to Follow-up|0|||
170682072|NCT01404325|616845593|FG000|Overall Study|Death|2|||
170682073|NCT01404325|616845594|FG001|Overall Study|Death|0|||
170682074|NCT01404325|616845593|FG000|Overall Study|Graft loss/Retransplantation|1|||
170682075|NCT01404325|616845594|FG001|Overall Study|Graft loss/Retransplantation|0|||
170682076|NCT01404325|616845593|FG000|Overall Study|non-specified reason|0|||
170682077|NCT01404325|616845594|FG001|Overall Study|non-specified reason|2|||
170682078|NCT00754624|616845598|FG000|Overall Study|Adverse Event|16|||
170682079|NCT00754624|616845598|FG000|Overall Study|Death|1|||
170682080|NCT00754624|616845598|FG000|Overall Study|Physician Decision|8|||
170682081|NCT00754624|616845598|FG000|Overall Study|Protocol Violation|1|||
170682082|NCT00754624|616845598|FG000|Overall Study|Withdrawal by Subject|28|||
170682083|NCT00754624|616845598|FG000|Overall Study|Various|12|||
170682084|NCT00754624|616845598|FG000|Overall Study|Lost to Follow-up|3|||
170682085|NCT01224431|616845599|FG000|Overall Study|not randomized|0|||
170682086|NCT01224431|616845600|FG001|Overall Study|not randomized|4|||
170682087|NCT01224431|616845599|FG000|Overall Study|no video record|0|||
170682088|NCT01224431|616845600|FG001|Overall Study|no video record|1|||
170682089|NCT02692716|616845601|FG000|Overall Study|Lost to Follow-up|2|||
170682090|NCT02692716|616845602|FG001|Overall Study|Lost to Follow-up|5|||
170682091|NCT02692716|616845601|FG000|Overall Study|Withdrawal by Subject|3|||
170682092|NCT02692716|616845602|FG001|Overall Study|Withdrawal by Subject|1|||
170682093|NCT04492618|616845607|FG000|Overall Study|Withdrawal by Subject|1|||
170682094|NCT01963403|616845621|FG000|Overall Study|Lost to Follow-up|2|||
170682095|NCT01963403|616845622|FG001|Overall Study|Lost to Follow-up|3|||
170682096|NCT01963403|616845621|FG000|Overall Study|Implant removal|0|||
170682097|NCT01963403|616845622|FG001|Overall Study|Implant removal|1|||
170682098|NCT05620563|616845625|FG000|Overall Study|Adverse Event|3|||
170682099|NCT05620563|616845626|FG001|Overall Study|Adverse Event|1|||
170682100|NCT05620563|616845625|FG000|Overall Study|Lost to Follow-up|0|||
170682101|NCT05620563|616845626|FG001|Overall Study|Lost to Follow-up|2|||
170682102|NCT05620563|616845625|FG000|Overall Study|Protocol Deviation|1|||
170682103|NCT05620563|616845626|FG001|Overall Study|Protocol Deviation|2|||
170682104|NCT05620563|616845625|FG000|Overall Study|Withdrawal by Subject|3|||
170682105|NCT05620563|616845626|FG001|Overall Study|Withdrawal by Subject|3|||
170682106|NCT05620563|616845625|FG000|Overall Study|Physician Decision|0|||
170682107|NCT05620563|616845626|FG001|Overall Study|Physician Decision|1|||
170682108|NCT01356966|616845627|FG000|Overall Study|Withdrawal by Subject|1|||
170682109|NCT01356966|616845628|FG001|Overall Study|Withdrawal by Subject|2|||
170682110|NCT01356966|616845627|FG000|Overall Study|Physician Decision|1|||
170682111|NCT01356966|616845628|FG001|Overall Study|Physician Decision|0|||
170682112|NCT02743806|616845629|FG000|Overall Study|Adverse Event|9|||
170682113|NCT02743806|616845629|FG000|Overall Study|Lost to Follow-up|8|||
170682114|NCT02743806|616845629|FG000|Overall Study|Voluntary Withdrawal|54|||
170682115|NCT02743806|616845629|FG000|Overall Study|Study Termination|65|||
170682116|NCT02743806|616845629|FG000|Overall Study|Pregnancy|6|||
170682117|NCT02743806|616845629|FG000|Overall Study|No Longer Clinically Benefiting|27|||
170682118|NCT02743806|616845629|FG000|Overall Study|Reason Not Specified|12|||
170682119|NCT00849381|616845631|FG000|Overall Study|Adverse Event|1|||
170682120|NCT00849381|616845631|FG000|Overall Study|Lost to Follow-up|129|||
170682121|NCT00849381|616845631|FG000|Overall Study|Protocol Violation|5|||
170682122|NCT00849381|616845631|FG000|Overall Study|Withdrawal by Subject|6|||
170682123|NCT00849381|616845631|FG000|Overall Study|Other|4|||
170682124|NCT04429061|616845635|FG000|Overall Study|Lost to Follow-up|62|||
170682125|NCT04429061|616845636|FG001|Overall Study|Lost to Follow-up|87|||
170682126|NCT04429061|616845635|FG000|Overall Study|Withdrawal by Subject|3|||
170682127|NCT04429061|616845636|FG001|Overall Study|Withdrawal by Subject|4|||
170682128|NCT02573350|616845637|FG000|Overall Study|Lost to Follow-up|2|||
170682129|NCT02573350|616845638|FG001|Overall Study|Lost to Follow-up|1|||
170682130|NCT02573350|616845637|FG000|Overall Study|Adverse Event|3|||
170682131|NCT02573350|616845638|FG001|Overall Study|Adverse Event|4|||
170682132|NCT02573350|616845637|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
170682133|NCT02573350|616845638|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
170682134|NCT02573350|616845637|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
170682135|NCT02573350|616845638|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
170682136|NCT02573350|616845637|FG000|Overall Study|Subject withdrew consent to participate|6|||
170682137|NCT02573350|616845638|FG001|Overall Study|Subject withdrew consent to participate|1|||
170682138|NCT02573350|616845637|FG000|Overall Study|Protocol Deviation|1|||
170682139|NCT02573350|616845638|FG001|Overall Study|Protocol Deviation|1|||
170682140|NCT01442493|616845640|FG000|Overall Study|withdrawn from study|3|||
170682141|NCT01442493|616845641|FG001|Overall Study|withdrawn from study|2|||
170682142|NCT00938639|616845642|FG000|Overall Study|Moved away from study area|0|||
170682143|NCT00938639|616845643|FG001|Overall Study|Moved away from study area|1|||
170682144|NCT00938639|616845642|FG000|Overall Study|Lost to Follow-up|1|||
170682145|NCT00938639|616845643|FG001|Overall Study|Lost to Follow-up|2|||
170682146|NCT00938639|616845642|FG000|Overall Study|Family issues|1|||
170682147|NCT00938639|616845643|FG001|Overall Study|Family issues|1|||
170682148|NCT00938639|616845642|FG000|Overall Study|Participant noncompliance|1|||
170682149|NCT00938639|616845643|FG001|Overall Study|Participant noncompliance|0|||
170682150|NCT04326231|616845644|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
170682151|NCT03303079|616845645|FG000|Overall Study|Adverse Event|0|||
170682152|NCT03303079|616845646|FG001|Overall Study|Adverse Event|1|||
170682153|NCT03303079|616845647|FG002|Overall Study|Adverse Event|3|||
170682154|NCT03303079|616845645|FG000|Overall Study|Protocol Violation|5|||
170682155|NCT03303079|616845646|FG001|Overall Study|Protocol Violation|4|||
170682156|NCT03303079|616845647|FG002|Overall Study|Protocol Violation|7|||
170682157|NCT03303079|616845645|FG000|Overall Study|Withdrawal by Subject|2|||
170682158|NCT03303079|616845646|FG001|Overall Study|Withdrawal by Subject|4|||
170682159|NCT03303079|616845647|FG002|Overall Study|Withdrawal by Subject|2|||
170682160|NCT03303079|616845645|FG000|Overall Study|Other than specified|0|||
170682161|NCT03303079|616845646|FG001|Overall Study|Other than specified|2|||
170682162|NCT03303079|616845647|FG002|Overall Study|Other than specified|0|||
170682163|NCT03454997|616845648|FG000|Overall Study|Staff Coach - Left Oranization|1|||
170682164|NCT03454997|616845649|FG001|Overall Study|Staff Coach - Left Oranization|1|||
170682165|NCT03454997|616845648|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
170682166|NCT03454997|616845649|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
170682167|NCT03454997|616845648|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
170682168|NCT03454997|616845649|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
170682169|NCT03454997|616845648|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
170682170|NCT03454997|616845649|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
170682171|NCT03454997|616845648|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
170682172|NCT03454997|616845649|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
170682173|NCT03454997|616845648|FG000|Overall Study|Client with SMI - Left organization|0|||
170682174|NCT03454997|616845649|FG001|Overall Study|Client with SMI - Left organization|1|||
170682175|NCT03454997|616845648|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
170682176|NCT03454997|616845649|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
170682177|NCT02794883|616845654|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
170682178|NCT02794883|616845655|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
170682179|NCT02794883|616845656|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
170682180|NCT02794883|616845654|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
170682181|NCT02794883|616845655|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
170682182|NCT02794883|616845656|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
170682183|NCT02794883|616845654|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
170682184|NCT02794883|616845655|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
170682185|NCT02794883|616845656|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
170682186|NCT02794883|616845654|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
170682187|NCT02794883|616845655|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
170682188|NCT02794883|616845656|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
170682189|NCT02794883|616845654|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
170682190|NCT02794883|616845655|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
170682191|NCT02794883|616845656|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
170682192|NCT02794883|616845654|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
170682193|NCT02794883|616845655|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
170682194|NCT02794883|616845656|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
170682195|NCT02794883|616845654|FG000|Follow-up Period (up to 2 Years)|Death|12|||
170682196|NCT02794883|616845655|FG001|Follow-up Period (up to 2 Years)|Death|10|||
170682197|NCT02794883|616845656|FG002|Follow-up Period (up to 2 Years)|Death|10|||
170682198|NCT04649060|616845660|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
170682199|NCT04649060|616845661|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
170682200|NCT04649060|616845660|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
170682201|NCT04649060|616845661|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
170682202|NCT04649060|616845660|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
170682203|NCT04649060|616845661|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
170682204|NCT04649060|616845660|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
170682205|NCT04649060|616845661|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
170682206|NCT04649060|616845660|FG000|Arm A/Arm B Treatment|Patient Request|1|||
170682207|NCT04649060|616845661|FG001|Arm A/Arm B Treatment|Patient Request|0|||
170682208|NCT04649060|616845660|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
170682209|NCT04649060|616845661|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
170682210|NCT04649060|616845660|FG000|Arm A/Arm B Treatment|Other|1|||
170682211|NCT04649060|616845661|FG001|Arm A/Arm B Treatment|Other|0|||
170682212|NCT04649060|616845660|FG000|Crossover (Arm B)|Adverse Event|0|||
170682213|NCT04649060|616845661|FG001|Crossover (Arm B)|Adverse Event|1|||
170682214|NCT04649060|616845660|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
170682215|NCT04649060|616845661|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
170682216|NCT02706691|616845662|FG000|Overall Study|Adverse Event|1|||
170682217|NCT01906008|616845666|FG000|Overall Study|Lost to Follow-up|2|||
170682218|NCT01906008|616845667|FG001|Overall Study|Lost to Follow-up|0|||
170682219|NCT01906008|616845666|FG000|Overall Study|Oxaliplatin toxicity|2|||
170682220|NCT01906008|616845667|FG001|Overall Study|Oxaliplatin toxicity|0|||
170682221|NCT01906008|616845666|FG000|Overall Study|Protocol Violation|0|||
170682222|NCT01906008|616845667|FG001|Overall Study|Protocol Violation|1|||
170682223|NCT01906008|616845666|FG000|Overall Study|Withdrawal by Subject|1|||
170682224|NCT01906008|616845667|FG001|Overall Study|Withdrawal by Subject|5|||
170682225|NCT01906008|616845666|FG000|Overall Study|Did not start study med|3|||
170682226|NCT01906008|616845667|FG001|Overall Study|Did not start study med|4|||
170682227|NCT01906008|616845666|FG000|Overall Study|Oxaliplatin stops|10|||
170682228|NCT01906008|616845667|FG001|Overall Study|Oxaliplatin stops|8|||
170682229|NCT01906008|616845666|FG000|Overall Study|Hospice|1|||
170820922|NCT02938520|617351573|FG000|Overall Study|Lost to Follow-up|2|||
170820923|NCT02938520|617351574|FG001|Overall Study|Lost to Follow-up|2|||
170820924|NCT02938520|617351573|FG000|Overall Study|Withdrawal by Subject|7|||
170820925|NCT02938520|617351574|FG001|Overall Study|Withdrawal by Subject|7|||
170820926|NCT02938520|617351573|FG000|Overall Study|Protocol Violation|0|||
170820927|NCT02938520|617351574|FG001|Overall Study|Protocol Violation|1|||
170820928|NCT02938520|617351573|FG000|Overall Study|Lack of Efficacy|5|||
170820929|NCT02938520|617351574|FG001|Overall Study|Lack of Efficacy|3|||
170682230|NCT01906008|616845667|FG001|Overall Study|Hospice|0|||
170682231|NCT01906008|616845666|FG000|Overall Study|Physician Decision|3|||
170682232|NCT01906008|616845667|FG001|Overall Study|Physician Decision|3|||
170682233|NCT01906008|616845666|FG000|Overall Study|Lack of compliance of study med|5|||
170682234|NCT01906008|616845667|FG001|Overall Study|Lack of compliance of study med|3|||
170682235|NCT01906008|616845666|FG000|Overall Study|Adverse Event|0|||
170682236|NCT01906008|616845667|FG001|Overall Study|Adverse Event|3|||
170682237|NCT01830972|616845668|FG000|Part II|Withdrawal by Subject|2|||
170682238|NCT01830972|616845669|FG001|Part II|Withdrawal by Subject|2|||
170682239|NCT01830972|616845668|FG000|Part III|Withdrawal by Subject|1|||
170682240|NCT01830972|616845669|FG001|Part III|Withdrawal by Subject|0|||
170682241|NCT01830972|616845668|FG000|Part III|Noncompliance|1|||
170682242|NCT01830972|616845669|FG001|Part III|Noncompliance|0|||
170682243|NCT01830972|616845668|FG000|Part IV|Withdrawal by Subject|2|||
170682244|NCT01830972|616845669|FG001|Part IV|Withdrawal by Subject|1|||
170682245|NCT01830972|616845668|FG000|Part IV|Non-Compliance|1|||
170682246|NCT01830972|616845669|FG001|Part IV|Non-Compliance|0|||
170682247|NCT02505867|616845670|FG000|Overall Study|Lack of Efficacy|6|||
170682248|NCT02505867|616845671|FG001|Overall Study|Lack of Efficacy|6|||
170682249|NCT01691781|616845674|FG000|Overall Study|Withdrawal by Subject|4|||
170682250|NCT01691781|616845675|FG001|Overall Study|Withdrawal by Subject|3|||
170682251|NCT01691781|616845674|FG000|Overall Study|Physician Decision|1|||
170682252|NCT01691781|616845675|FG001|Overall Study|Physician Decision|1|||
170682253|NCT01691781|616845674|FG000|Overall Study|Protocol Violation|2|||
170682254|NCT01691781|616845675|FG001|Overall Study|Protocol Violation|2|||
170682255|NCT01691781|616845674|FG000|Overall Study|Adverse Event|0|||
170682256|NCT01691781|616845675|FG001|Overall Study|Adverse Event|1|||
170682257|NCT02760069|616845676|FG000|Overall Study|Withdrawal by Subject|0|||
170682258|NCT02760069|616845677|FG001|Overall Study|Withdrawal by Subject|1|||
170682259|NCT02760069|616845678|FG002|Overall Study|Withdrawal by Subject|1|||
170682260|NCT00600483|616845687|FG000|Overall Study|Lost to Follow-up|26|||
170682261|NCT00600483|616845688|FG001|Overall Study|Lost to Follow-up|47|||
170682262|NCT00600483|616845687|FG000|Overall Study|Randomized but not treated|10|||
170682263|NCT00600483|616845688|FG001|Overall Study|Randomized but not treated|0|||
170682264|NCT05109442|616845689|FG000|Overall Study|Withdrawal by Subject|0|||
170682265|NCT05109442|616845690|FG001|Overall Study|Withdrawal by Subject|0|||
170682266|NCT05109442|616845691|FG002|Overall Study|Withdrawal by Subject|1|||
170682267|NCT05109442|616845692|FG003|Overall Study|Withdrawal by Subject|0|||
170682268|NCT05109442|616845693|FG004|Overall Study|Withdrawal by Subject|0|||
170682269|NCT05109442|616845694|FG005|Overall Study|Withdrawal by Subject|0|||
170682270|NCT05109442|616845689|FG000|Overall Study|Adverse Event|0|||
170682271|NCT05109442|616845690|FG001|Overall Study|Adverse Event|1|||
170682272|NCT05109442|616845691|FG002|Overall Study|Adverse Event|5|||
170682273|NCT05109442|616845692|FG003|Overall Study|Adverse Event|0|||
170682274|NCT05109442|616845693|FG004|Overall Study|Adverse Event|0|||
170682275|NCT05109442|616845694|FG005|Overall Study|Adverse Event|2|||
170682276|NCT05109442|616845689|FG000|Overall Study|Death|0|||
170682277|NCT05109442|616845690|FG001|Overall Study|Death|0|||
170682278|NCT05109442|616845691|FG002|Overall Study|Death|4|||
170682279|NCT05109442|616845692|FG003|Overall Study|Death|0|||
170682280|NCT05109442|616845693|FG004|Overall Study|Death|0|||
170682281|NCT05109442|616845694|FG005|Overall Study|Death|1|||
170682282|NCT05109442|616845689|FG000|Overall Study|Physician Decision|1|||
170682283|NCT05109442|616845690|FG001|Overall Study|Physician Decision|0|||
170682284|NCT05109442|616845691|FG002|Overall Study|Physician Decision|1|||
170682285|NCT05109442|616845692|FG003|Overall Study|Physician Decision|0|||
170682286|NCT05109442|616845693|FG004|Overall Study|Physician Decision|0|||
170682287|NCT05109442|616845694|FG005|Overall Study|Physician Decision|2|||
170682288|NCT05109442|616845689|FG000|Overall Study|Other than listed|0|||
170682289|NCT05109442|616845690|FG001|Overall Study|Other than listed|0|||
170682290|NCT05109442|616845691|FG002|Overall Study|Other than listed|9|||
170682291|NCT05109442|616845692|FG003|Overall Study|Other than listed|2|||
170682292|NCT05109442|616845693|FG004|Overall Study|Other than listed|0|||
170682293|NCT05109442|616845694|FG005|Overall Study|Other than listed|8|||
170682294|NCT05109442|616845689|FG000|Overall Study|Lack of Efficacy|3|||
170682295|NCT05109442|616845690|FG001|Overall Study|Lack of Efficacy|5|||
170682296|NCT05109442|616845691|FG002|Overall Study|Lack of Efficacy|29|||
170682297|NCT05109442|616845692|FG003|Overall Study|Lack of Efficacy|10|||
170682298|NCT05109442|616845693|FG004|Overall Study|Lack of Efficacy|11|||
170682299|NCT05109442|616845694|FG005|Overall Study|Lack of Efficacy|17|||
170682300|NCT03519932|616847366|FG000|First Intervention|Adverse Event|1|||
170682301|NCT03519932|616847367|FG001|First Intervention|Adverse Event|3|||
170682302|NCT01350414|616847368|FG000|Overall Study|Lost to Follow-up|13|||
170682303|NCT01350414|616847368|FG000|Overall Study|Withdrawal by Subject|4|||
170682304|NCT01350414|616847368|FG000|Overall Study|Physician Decision|2|||
170682305|NCT00267046|616847374|FG000|Overall Study|Disease progression|4|||
170682306|NCT00267046|616847375|FG001|Overall Study|Disease progression|2|||
170682307|NCT00267046|616847374|FG000|Overall Study|Chemotoxicity|2|||
170682308|NCT00267046|616847375|FG001|Overall Study|Chemotoxicity|0|||
170682309|NCT00267046|616847374|FG000|Overall Study|Open-label palifermin|2|||
170820930|NCT02938520|617351573|FG000|Overall Study|Adverse Event|9|||
170682310|NCT00267046|616847375|FG001|Overall Study|Open-label palifermin|7|||
170682311|NCT00267046|616847374|FG000|Overall Study|Surgery|3|||
170682312|NCT00267046|616847375|FG001|Overall Study|Surgery|1|||
170682313|NCT00267046|616847374|FG000|Overall Study|Withdrawal by Subject|1|||
170682314|NCT00267046|616847375|FG001|Overall Study|Withdrawal by Subject|0|||
170682315|NCT00267046|616847374|FG000|Overall Study|Radiation|0|||
170682316|NCT00267046|616847375|FG001|Overall Study|Radiation|1|||
170682317|NCT00103142|616847376|FG000|Overall Study|Adverse Event|1|||
170682318|NCT00103142|616847377|FG001|Overall Study|Adverse Event|0|||
170682319|NCT00103142|616847376|FG000|Overall Study|Progression of disease|2|||
170682320|NCT00103142|616847377|FG001|Overall Study|Progression of disease|1|||
170682321|NCT02772081|616847378|FG000|Overall Study|Physician Decision|1|||
170682322|NCT02772081|616847379|FG001|Overall Study|Physician Decision|1|||
170682323|NCT02772081|616847378|FG000|Overall Study|Death|1|||
170682324|NCT02772081|616847379|FG001|Overall Study|Death|1|||
170682325|NCT01741701|616847393|FG000|Overall Study|Adverse Event|5|||
170682326|NCT01741701|616847394|FG001|Overall Study|Adverse Event|1|||
170682327|NCT01741701|616847393|FG000|Overall Study|Withdrawal by Subject|0|||
170682328|NCT01741701|616847394|FG001|Overall Study|Withdrawal by Subject|1|||
170682329|NCT00006903|616847397|FG000|Overall Study|Still receiving treatment|0|||
170682330|NCT00006903|616847398|FG001|Overall Study|Still receiving treatment|0|||
170682331|NCT00006903|616847399|FG002|Overall Study|Still receiving treatment|1|||
170682332|NCT00006903|616847397|FG000|Overall Study|Refused further treatment|0|||
170682333|NCT00006903|616847398|FG001|Overall Study|Refused further treatment|2|||
170682334|NCT00006903|616847399|FG002|Overall Study|Refused further treatment|1|||
170682335|NCT00006903|616847397|FG000|Overall Study|Adverse Event|0|||
170682336|NCT00006903|616847398|FG001|Overall Study|Adverse Event|0|||
170682337|NCT00006903|616847399|FG002|Overall Study|Adverse Event|1|||
170682338|NCT00006903|616847397|FG000|Overall Study|Death|0|||
170682339|NCT00006903|616847398|FG001|Overall Study|Death|1|||
170682340|NCT00006903|616847399|FG002|Overall Study|Death|0|||
170682341|NCT00006903|616847397|FG000|Overall Study|Patient never treated|0|||
170682342|NCT00006903|616847398|FG001|Overall Study|Patient never treated|0|||
170682343|NCT00006903|616847399|FG002|Overall Study|Patient never treated|1|||
170682344|NCT00006903|616847397|FG000|Overall Study|Ineligible|10|||
170682345|NCT00006903|616847398|FG001|Overall Study|Ineligible|1|||
170682346|NCT00006903|616847399|FG002|Overall Study|Ineligible|2|||
170682347|NCT00372112|616847401|FG000|Overall Study|Adverse Event|0|||
170682348|NCT00372112|616847402|FG001|Overall Study|Adverse Event|1|||
170682349|NCT00372112|616847403|FG002|Overall Study|Adverse Event|1|||
170682350|NCT00372112|616847404|FG003|Overall Study|Adverse Event|1|||
170682351|NCT00372112|616847401|FG000|Overall Study|Withdrawal by Subject|0|||
170682352|NCT00372112|616847402|FG001|Overall Study|Withdrawal by Subject|0|||
170682353|NCT00372112|616847403|FG002|Overall Study|Withdrawal by Subject|2|||
170682354|NCT00372112|616847404|FG003|Overall Study|Withdrawal by Subject|1|||
170682355|NCT00372112|616847401|FG000|Overall Study|Exacerbation|0|||
170682356|NCT00372112|616847402|FG001|Overall Study|Exacerbation|0|||
170682357|NCT00372112|616847403|FG002|Overall Study|Exacerbation|0|||
170682358|NCT00372112|616847404|FG003|Overall Study|Exacerbation|1|||
170682359|NCT00372112|616847401|FG000|Overall Study|PR >240 at Visit 3|0|||
170682360|NCT00372112|616847402|FG001|Overall Study|PR >240 at Visit 3|0|||
170682361|NCT00372112|616847403|FG002|Overall Study|PR >240 at Visit 3|0|||
170682362|NCT00372112|616847404|FG003|Overall Study|PR >240 at Visit 3|1|||
170682363|NCT00372112|616847401|FG000|Overall Study|Hepatitis B|1|||
170682364|NCT00372112|616847402|FG001|Overall Study|Hepatitis B|0|||
170682365|NCT00372112|616847403|FG002|Overall Study|Hepatitis B|0|||
170682366|NCT00372112|616847404|FG003|Overall Study|Hepatitis B|0|||
170682367|NCT00372112|616847401|FG000|Overall Study|Other-protocol violation|0|||
170682368|NCT00372112|616847402|FG001|Overall Study|Other-protocol violation|0|||
170682369|NCT00372112|616847403|FG002|Overall Study|Other-protocol violation|1|||
170682370|NCT00372112|616847404|FG003|Overall Study|Other-protocol violation|0|||
170682371|NCT01678911|616847405|FG000|Second Intervention|Lost to Follow-up|2|||
170682372|NCT01678911|616847406|FG001|Second Intervention|Lost to Follow-up|0|||
170682373|NCT00171730|616847409|FG000|Overall Study|Adverse Event|3|||
170820931|NCT02938520|617351574|FG001|Overall Study|Adverse Event|4|||
170820932|NCT04448561|617351575|FG000|Overall Study|Noncompliance|1|||
170820933|NCT04448561|617351576|FG001|Overall Study|Noncompliance|0|||
170820934|NCT01816685|617353195|FG000|Overall Study|Lost to Follow-up|7|||
170682374|NCT00171730|616847409|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
170682375|NCT00171730|616847409|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
170682376|NCT00171730|616847409|FG000|Overall Study|Withdrawal by Subject|3|||
170682377|NCT01829191|616847410|FG000|Overall Study|Relocation|0|||
170682378|NCT01829191|616847411|FG001|Overall Study|Relocation|1|||
170682379|NCT01829191|616847410|FG000|Overall Study|Lens discomfort|0|||
170682380|NCT01829191|616847411|FG001|Overall Study|Lens discomfort|3|||
170682381|NCT01829191|616847410|FG000|Overall Study|Lens handling difficulty|1|||
170682382|NCT01829191|616847411|FG001|Overall Study|Lens handling difficulty|4|||
170820935|NCT01816685|617353196|FG001|Overall Study|Lost to Follow-up|9|||
170820936|NCT01816685|617353195|FG000|Overall Study|Surgery Cancelled|3|||
170820937|NCT01816685|617353196|FG001|Overall Study|Surgery Cancelled|2|||
170682383|NCT01829191|616847410|FG000|Overall Study|Protocol Violation|4|||
170682384|NCT01829191|616847411|FG001|Overall Study|Protocol Violation|1|||
170682385|NCT01829191|616847410|FG000|Overall Study|Withdrawal by Subject|2|||
170682386|NCT01829191|616847411|FG001|Overall Study|Withdrawal by Subject|3|||
170682387|NCT01829191|616847410|FG000|Overall Study|Lost to Follow-up|0|||
170682388|NCT01829191|616847411|FG001|Overall Study|Lost to Follow-up|1|||
170682389|NCT01829191|616847410|FG000|Overall Study|Subject was fit for ortho - k|0|||
170682390|NCT01829191|616847411|FG001|Overall Study|Subject was fit for ortho - k|1|||
170682391|NCT02220205|616847412|FG000|Overall Study|Withdrawal by Subject|1|||
170682392|NCT02220205|616847413|FG001|Overall Study|Withdrawal by Subject|0|||
170682393|NCT02205814|616847418|FG000|Overall Study|Lost to Follow-up|0|||
170682394|NCT02205814|616847419|FG001|Overall Study|Lost to Follow-up|0|||
170682395|NCT02205814|616847420|FG002|Overall Study|Lost to Follow-up|0|||
170682396|NCT02205814|616847421|FG003|Overall Study|Lost to Follow-up|1|||
170682397|NCT02205814|616847418|FG000|Overall Study|Lack of Efficacy|1|||
170682398|NCT02205814|616847419|FG001|Overall Study|Lack of Efficacy|0|||
170682399|NCT02205814|616847420|FG002|Overall Study|Lack of Efficacy|1|||
170682400|NCT02205814|616847421|FG003|Overall Study|Lack of Efficacy|1|||
170682401|NCT02205814|616847418|FG000|Overall Study|Physician Decision|0|||
170682402|NCT02205814|616847419|FG001|Overall Study|Physician Decision|0|||
170682403|NCT02205814|616847420|FG002|Overall Study|Physician Decision|1|||
170682404|NCT02205814|616847421|FG003|Overall Study|Physician Decision|0|||
170682405|NCT02205814|616847418|FG000|Overall Study|Protocol Violation|1|||
170682406|NCT02205814|616847419|FG001|Overall Study|Protocol Violation|0|||
170682407|NCT02205814|616847420|FG002|Overall Study|Protocol Violation|0|||
170682408|NCT02205814|616847421|FG003|Overall Study|Protocol Violation|1|||
170682409|NCT02205814|616847418|FG000|Overall Study|Withdrawal by Subject|0|||
170682410|NCT02205814|616847419|FG001|Overall Study|Withdrawal by Subject|1|||
170682411|NCT02205814|616847420|FG002|Overall Study|Withdrawal by Subject|2|||
170682412|NCT02205814|616847421|FG003|Overall Study|Withdrawal by Subject|1|||
170682413|NCT02205814|616847418|FG000|Overall Study|not compliant with study procedures|0|||
170682414|NCT02205814|616847419|FG001|Overall Study|not compliant with study procedures|0|||
170682415|NCT02205814|616847420|FG002|Overall Study|not compliant with study procedures|1|||
170682416|NCT02205814|616847421|FG003|Overall Study|not compliant with study procedures|0|||
170682417|NCT01426373|616847422|FG000|Overall Study|Adverse Event|6|||
170682418|NCT01426373|616847422|FG000|Overall Study|Lost to Follow-up|14|||
170682419|NCT01426373|616847422|FG000|Overall Study|Participant Convenience|10|||
170682420|NCT01426373|616847422|FG000|Overall Study|Miscellaneous Reasons|4|||
170682421|NCT00726661|616847423|FG000|Overall Study|Lost to Follow-up|36|||
170682422|NCT00726661|616847424|FG001|Overall Study|Lost to Follow-up|11|||
170682423|NCT00726661|616847423|FG000|Overall Study|Withdrawal by Subject|17|||
170682424|NCT00726661|616847424|FG001|Overall Study|Withdrawal by Subject|13|||
170682425|NCT00726661|616847423|FG000|Overall Study|Trial terminated by sponsor|214|||
170682426|NCT00726661|616847424|FG001|Overall Study|Trial terminated by sponsor|187|||
170682427|NCT00726661|616847423|FG000|Overall Study|Death|475|||
170682428|NCT00726661|616847424|FG001|Overall Study|Death|159|||
170682429|NCT00726661|616847423|FG000|Overall Study|Physician Decision|25|||
170682430|NCT00726661|616847424|FG001|Overall Study|Physician Decision|13|||
170682431|NCT00726661|616847423|FG000|Overall Study|Other|47|||
170682432|NCT00726661|616847424|FG001|Overall Study|Other|35|||
170682433|NCT01574326|616847425|FG000|Overall Study|Randomized but not treated|0|||
170682434|NCT01574326|616847426|FG001|Overall Study|Randomized but not treated|1|||
170682435|NCT01574326|616847425|FG000|Overall Study|Withdrawal by Participant|2|||
170682436|NCT01574326|616847426|FG001|Overall Study|Withdrawal by Participant|4|||
170682437|NCT01574326|616847425|FG000|Overall Study|Physician Decision|5|||
170682438|NCT01574326|616847426|FG001|Overall Study|Physician Decision|3|||
170682439|NCT01574326|616847425|FG000|Overall Study|Adverse Event|1|||
170682440|NCT01574326|616847426|FG001|Overall Study|Adverse Event|3|||
170682441|NCT01574326|616847425|FG000|Overall Study|Other: Mainly kidney transplant|8|||
170682442|NCT01574326|616847426|FG001|Overall Study|Other: Mainly kidney transplant|8|||
170682443|NCT00137046|616847436|FG000|Overall Study|Death|2|||
170820938|NCT00043186|617353198|FG000|Overall Study|Physician Decision|0|||
170820939|NCT00043186|617353199|FG001|Overall Study|Physician Decision|0|||
170820940|NCT00043186|617353200|FG002|Overall Study|Physician Decision|3|||
170682444|NCT00137046|616847437|FG001|Overall Study|Death|1|||
170682445|NCT00137046|616847436|FG000|Overall Study|Adverse Event|16|||
170682446|NCT00137046|616847437|FG001|Overall Study|Adverse Event|5|||
170682447|NCT00137046|616847436|FG000|Overall Study|Laboratory Abnormality|2|||
170682448|NCT00137046|616847437|FG001|Overall Study|Laboratory Abnormality|0|||
170682449|NCT00137046|616847436|FG000|Overall Study|Lack of Efficacy|13|||
170682450|NCT00137046|616847437|FG001|Overall Study|Lack of Efficacy|1|||
170682451|NCT00137046|616847436|FG000|Overall Study|Lost to Follow-up|8|||
170682452|NCT00137046|616847437|FG001|Overall Study|Lost to Follow-up|24|||
170682453|NCT00137046|616847436|FG000|Overall Study|Other|23|||
170682454|NCT00137046|616847437|FG001|Overall Study|Other|19|||
170682455|NCT00137046|616847436|FG000|Overall Study|Withdrawal by Subject|33|||
170682456|NCT00137046|616847437|FG001|Overall Study|Withdrawal by Subject|42|||
170820941|NCT00043186|617353201|FG003|Overall Study|Physician Decision|0|||
170820942|NCT00043186|617353202|FG004|Overall Study|Physician Decision|1|||
170682457|NCT00137046|616847436|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
170682458|NCT00137046|616847437|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
170682459|NCT00137046|616847436|FG000|Overall Study|Withdrew prior to study treatment|1|||
170682460|NCT00137046|616847437|FG001|Overall Study|Withdrew prior to study treatment|1|||
170682461|NCT00160251|616847438|FG000|Prior to Amendment 2|Adverse Event|2|||
170682462|NCT00160251|616847439|FG001|Prior to Amendment 2|Adverse Event|1|||
170682463|NCT00160251|616847440|FG002|Prior to Amendment 2|Adverse Event|3|||
170682464|NCT00160251|616847441|FG003|Prior to Amendment 2|Adverse Event|1|||
170682465|NCT00160251|616847442|FG004|Prior to Amendment 2|Adverse Event|1|||
170682466|NCT00160251|616847443|FG005|Prior to Amendment 2|Adverse Event|1|||
170682467|NCT00160251|616847444|FG006|Prior to Amendment 2|Adverse Event|1|||
170682468|NCT00160251|616847445|FG007|Prior to Amendment 2|Adverse Event|0|||
170682469|NCT00160251|616847438|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
170682470|NCT00160251|616847439|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
170682471|NCT00160251|616847440|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
170682472|NCT00160251|616847441|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
170682473|NCT00160251|616847442|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
170682474|NCT00160251|616847443|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
170682475|NCT00160251|616847444|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
170682476|NCT00160251|616847445|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
170682477|NCT00160251|616847438|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
170682478|NCT00160251|616847439|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
170682479|NCT00160251|616847440|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
170682480|NCT00160251|616847441|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
170682481|NCT00160251|616847442|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
170682482|NCT00160251|616847443|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
170682483|NCT00160251|616847444|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
170682484|NCT00160251|616847445|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
170682485|NCT00160251|616847438|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
170682486|NCT00160251|616847439|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
170682487|NCT00160251|616847440|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
170682488|NCT00160251|616847441|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
170682489|NCT00160251|616847442|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
170682490|NCT00160251|616847443|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
170682491|NCT00160251|616847444|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
170682492|NCT00160251|616847445|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
170682493|NCT00160251|616847438|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
170682494|NCT00160251|616847439|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
170682495|NCT00160251|616847440|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
170682496|NCT00160251|616847441|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
170682497|NCT00160251|616847442|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
170682498|NCT00160251|616847443|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
170682499|NCT00160251|616847444|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
170682500|NCT00160251|616847445|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
170682501|NCT00160251|616847438|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
170682502|NCT00160251|616847439|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
170682503|NCT00160251|616847440|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
170682504|NCT00160251|616847441|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
170682505|NCT00160251|616847442|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
170682506|NCT00160251|616847443|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
170682507|NCT00160251|616847444|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
170682508|NCT00160251|616847445|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
170682509|NCT00160251|616847438|FG000|Post-amendment 2|Adverse Event|0|||
170682510|NCT00160251|616847439|FG001|Post-amendment 2|Adverse Event|0|||
170682511|NCT00160251|616847440|FG002|Post-amendment 2|Adverse Event|0|||
170682512|NCT00160251|616847441|FG003|Post-amendment 2|Adverse Event|0|||
170682513|NCT00160251|616847442|FG004|Post-amendment 2|Adverse Event|0|||
170682514|NCT00160251|616847443|FG005|Post-amendment 2|Adverse Event|0|||
170682515|NCT00160251|616847444|FG006|Post-amendment 2|Adverse Event|0|||
170682516|NCT00160251|616847445|FG007|Post-amendment 2|Adverse Event|20|||
170682517|NCT00160251|616847438|FG000|Post-amendment 2|Lack of Efficacy|0|||
170682518|NCT00160251|616847439|FG001|Post-amendment 2|Lack of Efficacy|0|||
170682519|NCT00160251|616847440|FG002|Post-amendment 2|Lack of Efficacy|0|||
170682520|NCT00160251|616847441|FG003|Post-amendment 2|Lack of Efficacy|0|||
170682521|NCT00160251|616847442|FG004|Post-amendment 2|Lack of Efficacy|0|||
170682522|NCT00160251|616847443|FG005|Post-amendment 2|Lack of Efficacy|0|||
170682523|NCT00160251|616847444|FG006|Post-amendment 2|Lack of Efficacy|0|||
170682524|NCT00160251|616847445|FG007|Post-amendment 2|Lack of Efficacy|24|||
170682525|NCT00160251|616847438|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
170682526|NCT00160251|616847439|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
170682527|NCT00160251|616847440|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
170682528|NCT00160251|616847441|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
170682529|NCT00160251|616847442|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
170682530|NCT00160251|616847443|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
170682531|NCT00160251|616847444|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
170682532|NCT00160251|616847445|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
170682533|NCT01574612|616847448|FG000|Overall Study|Adverse Event|3|||
170682534|NCT01574612|616847448|FG000|Overall Study|non compliant with drug|2|||
170682535|NCT01574612|616847448|FG000|Overall Study|Withdrawal by Subject|1|||
170682536|NCT01574612|616847448|FG000|Overall Study|Lost to Follow-up|2|||
170682537|NCT00582166|616847453|FG000|Overall Study|Death|1|||
170682538|NCT00582166|616847453|FG000|Overall Study|Ineligible pathology|1|||
170682539|NCT01606436|616847454|FG000|Overall Study|Withdrawal by Subject|0|||
170682540|NCT01606436|616847455|FG001|Overall Study|Withdrawal by Subject|0|||
170682541|NCT01606436|616847456|FG002|Overall Study|Withdrawal by Subject|1|||
170682542|NCT01606436|616847457|FG003|Overall Study|Withdrawal by Subject|1|||
170682543|NCT01606436|616847458|FG004|Overall Study|Withdrawal by Subject|1|||
170682544|NCT01606436|616847459|FG005|Overall Study|Withdrawal by Subject|0|||
170682545|NCT01606436|616847454|FG000|Overall Study|Adverse Event|0|||
170682546|NCT01606436|616847455|FG001|Overall Study|Adverse Event|0|||
170682547|NCT01606436|616847456|FG002|Overall Study|Adverse Event|1|||
170682548|NCT01606436|616847457|FG003|Overall Study|Adverse Event|0|||
170682549|NCT01606436|616847458|FG004|Overall Study|Adverse Event|0|||
170682550|NCT01606436|616847459|FG005|Overall Study|Adverse Event|0|||
170682551|NCT01606436|616847454|FG000|Overall Study|Sponsor Decision|0|||
170682552|NCT01606436|616847455|FG001|Overall Study|Sponsor Decision|0|||
170682553|NCT01606436|616847456|FG002|Overall Study|Sponsor Decision|0|||
170682554|NCT01606436|616847457|FG003|Overall Study|Sponsor Decision|1|||
170682555|NCT01606436|616847458|FG004|Overall Study|Sponsor Decision|0|||
170682556|NCT01606436|616847459|FG005|Overall Study|Sponsor Decision|0|||
170682557|NCT02859454|616847460|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
170682558|NCT00110149|616847461|FG000|Overall Study|Physician Decision|3|||
170682559|NCT02452398|616847466|FG000|Overall Study|Adverse Event|1|||
170682560|NCT02452398|616847466|FG000|Overall Study|Lost to Follow-up|28|||
170682561|NCT02452398|616847466|FG000|Overall Study|Physician Decision|2|||
170682562|NCT02452398|616847466|FG000|Overall Study|Withdrawal by Subject|6|||
170682563|NCT02452398|616847466|FG000|Overall Study|Moved away|4|||
170682564|NCT03944954|616847467|FG000|Overall Study|Withdrawal by Subject|22|||
170682565|NCT03944954|616847468|FG001|Overall Study|Withdrawal by Subject|4|||
170682566|NCT03944954|616847467|FG000|Overall Study|Lost to Follow-up|18|||
170682567|NCT03944954|616847468|FG001|Overall Study|Lost to Follow-up|0|||
170682568|NCT03944954|616847467|FG000|Overall Study|Failed Medical Screening|7|||
170682569|NCT03944954|616847468|FG001|Overall Study|Failed Medical Screening|0|||
170682570|NCT00748033|616847469|FG000|Overall Study|Adverse Event|0|||
170682571|NCT00748033|616847470|FG001|Overall Study|Adverse Event|1|||
170682572|NCT01018186|616847471|FG000|2-week Run-in Period|Protocol Violation|1|||
170682573|NCT01018186|616847472|FG001|2-week Run-in Period|Protocol Violation|0|||
170682574|NCT01018186|616847473|FG002|2-week Run-in Period|Protocol Violation|0|||
170682575|NCT01018186|616847474|FG003|2-week Run-in Period|Protocol Violation|0|||
170682576|NCT01018186|616847471|FG000|2-week Run-in Period|Lost to Follow-up|2|||
170682577|NCT01018186|616847472|FG001|2-week Run-in Period|Lost to Follow-up|0|||
170682578|NCT01018186|616847473|FG002|2-week Run-in Period|Lost to Follow-up|0|||
170682579|NCT01018186|616847474|FG003|2-week Run-in Period|Lost to Follow-up|0|||
170682580|NCT01018186|616847471|FG000|2-week Run-in Period|Physician Decision|3|||
170682581|NCT01018186|616847472|FG001|2-week Run-in Period|Physician Decision|0|||
170682582|NCT01018186|616847473|FG002|2-week Run-in Period|Physician Decision|0|||
170682583|NCT01018186|616847474|FG003|2-week Run-in Period|Physician Decision|0|||
170682584|NCT01018186|616847471|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
170682585|NCT01018186|616847472|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
170682586|NCT01018186|616847473|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
170682587|NCT01018186|616847474|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
170682588|NCT01018186|616847471|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
170682589|NCT01018186|616847472|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
170682590|NCT01018186|616847473|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
170682591|NCT01018186|616847474|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
170682592|NCT01018186|616847471|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
170682593|NCT01018186|616847472|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
170682594|NCT01018186|616847473|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
170682595|NCT01018186|616847474|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
170682596|NCT01018186|616847471|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
170682597|NCT01018186|616847472|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
170682598|NCT01018186|616847473|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
170682599|NCT01018186|616847474|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
170682600|NCT01018186|616847471|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
170682601|NCT01018186|616847472|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
170682602|NCT01018186|616847473|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
170682603|NCT01018186|616847474|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
170682604|NCT01018186|616847471|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
170682605|NCT01018186|616847472|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
170682606|NCT01018186|616847473|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
170682607|NCT01018186|616847474|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
170682608|NCT01018186|616847471|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
170682609|NCT01018186|616847472|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
170682610|NCT01018186|616847473|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
170682611|NCT01018186|616847474|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
170682612|NCT01018186|616847471|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
170682613|NCT01018186|616847472|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
170682614|NCT01018186|616847473|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
170682615|NCT01018186|616847474|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
170682616|NCT01018186|616847471|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
170682617|NCT01018186|616847472|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
170682618|NCT01018186|616847473|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
170682619|NCT01018186|616847474|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
170682620|NCT01365910|616847480|FG000|Overall Study|Withdrawal by Subject|7|||
170682621|NCT01365910|616847480|FG000|Overall Study|disease progression|18|||
170682622|NCT01365910|616847480|FG000|Overall Study|Adverse Event|3|||
170682623|NCT01365910|616847480|FG000|Overall Study|other complicating disease|1|||
170682624|NCT01365910|616847480|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
170682625|NCT03200860|616847482|FG000|Overall Study|Withdrawal by Subject|1|||
170682626|NCT03200860|616847483|FG001|Overall Study|Withdrawal by Subject|0|||
170682627|NCT03672747|616847484|FG000|Overall Study|Lost to Follow-up|1|||
170682628|NCT03672747|616847485|FG001|Overall Study|Lost to Follow-up|1|||
170682629|NCT03672747|616847486|FG002|Overall Study|Lost to Follow-up|2|||
170682630|NCT03672747|616847487|FG003|Overall Study|Lost to Follow-up|2|||
170682631|NCT03672747|616847488|FG004|Overall Study|Lost to Follow-up|2|||
170682632|NCT03672747|616847489|FG005|Overall Study|Lost to Follow-up|1|||
170682633|NCT03667924|616847494|FG000|Baseline Completed|Lost to Follow-up|0|||
170682634|NCT03667924|616847495|FG001|Baseline Completed|Lost to Follow-up|2|||
170682635|NCT03667924|616847496|FG002|Baseline Completed|Lost to Follow-up|0|||
170682636|NCT03667924|616847494|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
170682637|NCT03667924|616847495|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
170682638|NCT03667924|616847496|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
170682639|NCT03667924|616847494|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
170682640|NCT03667924|616847495|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
170682641|NCT03667924|616847496|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
170682642|NCT03667924|616847494|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
170682643|NCT03667924|616847495|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
170682644|NCT03667924|616847496|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
170682645|NCT03667924|616847494|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
170682646|NCT03667924|616847495|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
170682647|NCT03667924|616847496|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
170682648|NCT03667924|616847494|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
170682649|NCT03667924|616847495|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
170682650|NCT03667924|616847496|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
170682651|NCT03667924|616847494|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
170682652|NCT03667924|616847495|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
170682653|NCT03667924|616847496|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
170682654|NCT00126568|616847497|FG000|Overall Study|Death|2|||
170682655|NCT02846779|616847503|FG000|Overall Study|Lost Enrollment|83|||
170682656|NCT02846779|616847504|FG001|Overall Study|Lost Enrollment|82|||
170682657|NCT02846779|616847505|FG002|Overall Study|Lost Enrollment|86|||
170682658|NCT02846779|616847503|FG000|Overall Study|Less than 31 days of follow-up|56|||
170682659|NCT02846779|616847504|FG001|Overall Study|Less than 31 days of follow-up|45|||
170682660|NCT02846779|616847505|FG002|Overall Study|Less than 31 days of follow-up|52|||
170682661|NCT03694821|616847508|FG000|Overall Study|Study terminated|4|||
170682662|NCT03694821|616847509|FG001|Overall Study|Study terminated|8|||
170682663|NCT03694821|616847510|FG002|Overall Study|Study terminated|4|||
170682664|NCT01428453|616847511|FG000|Overall Study|Adverse Event|2|||
170682665|NCT01428453|616847512|FG001|Overall Study|Adverse Event|7|||
170682666|NCT01428453|616847511|FG000|Overall Study|Protocol Violation|1|||
170682667|NCT01428453|616847512|FG001|Overall Study|Protocol Violation|0|||
170682668|NCT01428453|616847511|FG000|Overall Study|Lost to Follow-up|0|||
170682669|NCT01428453|616847512|FG001|Overall Study|Lost to Follow-up|1|||
170682670|NCT01428453|616847511|FG000|Overall Study|Withdrawal by Subject|3|||
170682671|NCT01428453|616847512|FG001|Overall Study|Withdrawal by Subject|1|||
170682672|NCT01996709|616847513|FG000|Overall Study|Withdrawal by Subject|1|||
170682673|NCT01996709|616847514|FG001|Overall Study|Withdrawal by Subject|0|||
170682674|NCT01996709|616847513|FG000|Overall Study|Lost to Follow-up|3|||
170682675|NCT01996709|616847514|FG001|Overall Study|Lost to Follow-up|0|||
170682676|NCT01996709|616847513|FG000|Overall Study|Subject Non-Compliant|1|||
170682677|NCT01996709|616847514|FG001|Overall Study|Subject Non-Compliant|0|||
170682678|NCT01996709|616847513|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
170682679|NCT01996709|616847514|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
170682680|NCT01405456|616847519|FG000|Overall Study|Lost to Follow-up|2|||
170682681|NCT01405456|616847520|FG001|Overall Study|Lost to Follow-up|1|||
170682682|NCT01405456|616847519|FG000|Overall Study|Physician Decision|1|||
170682683|NCT01405456|616847520|FG001|Overall Study|Physician Decision|0|||
170682684|NCT05475236|616847522|FG000|Overall Study|Withdrawal by Subject|0|||
170682685|NCT05475236|616847523|FG001|Overall Study|Withdrawal by Subject|1|||
170682686|NCT01134783|616849451|FG000|Overall Study|Pregnancy|16|||
170682687|NCT01134783|616849452|FG001|Overall Study|Pregnancy|8|||
170682688|NCT01134783|616849451|FG000|Overall Study|Withdrawal by Subject|15|||
170682689|NCT01134783|616849452|FG001|Overall Study|Withdrawal by Subject|9|||
170682690|NCT01134783|616849451|FG000|Overall Study|Lost to Follow-up|5|||
170682691|NCT01134783|616849452|FG001|Overall Study|Lost to Follow-up|20|||
170682692|NCT00531232|616849453|FG000|Overall Study|Investigator decision|0|||
170682693|NCT00531232|616849454|FG001|Overall Study|Investigator decision|0|||
170682694|NCT00531232|616849455|FG002|Overall Study|Investigator decision|4|||
170682695|NCT00531232|616849453|FG000|Overall Study|Participants refused further treatment|0|||
170682696|NCT00531232|616849454|FG001|Overall Study|Participants refused further treatment|1|||
170682697|NCT00531232|616849455|FG002|Overall Study|Participants refused further treatment|2|||
170682698|NCT00531232|616849453|FG000|Overall Study|Adverse events (AEs)|1|||
170682699|NCT00531232|616849454|FG001|Overall Study|Adverse events (AEs)|2|||
170682700|NCT00531232|616849455|FG002|Overall Study|Adverse events (AEs)|2|||
170682701|NCT00531232|616849453|FG000|Overall Study|Treatment failure|1|||
170682702|NCT00531232|616849454|FG001|Overall Study|Treatment failure|3|||
170682703|NCT00531232|616849455|FG002|Overall Study|Treatment failure|7|||
170682704|NCT00531232|616849453|FG000|Overall Study|Disease recurrence|0|||
170682705|NCT00531232|616849454|FG001|Overall Study|Disease recurrence|0|||
170682706|NCT00531232|616849455|FG002|Overall Study|Disease recurrence|1|||
170682707|NCT00531232|616849453|FG000|Overall Study|Deceased|2|||
170682708|NCT00531232|616849454|FG001|Overall Study|Deceased|2|||
170682709|NCT00531232|616849455|FG002|Overall Study|Deceased|2|||
170682710|NCT00531232|616849453|FG000|Overall Study|Withdrawal by Subject|0|||
170682711|NCT00531232|616849454|FG001|Overall Study|Withdrawal by Subject|1|||
170682712|NCT00531232|616849455|FG002|Overall Study|Withdrawal by Subject|2|||
170682713|NCT00531232|616849453|FG000|Overall Study|Other|0|||
170682714|NCT00531232|616849454|FG001|Overall Study|Other|0|||
170682715|NCT00531232|616849455|FG002|Overall Study|Other|5|||
170682716|NCT00397982|616849456|FG000|Overall Study|Withdrawal by Subject|1|||
170682717|NCT00397982|616849456|FG000|Overall Study|Adverse Event|1|||
170682718|NCT00397982|616849456|FG000|Overall Study|noncompliance|1|||
170682719|NCT00397982|616849456|FG000|Overall Study|Unrelated health issues|1|||
170682720|NCT02345850|616849461|FG000|Overall Study|Not transplanted|10|||
170682721|NCT02345850|616849462|FG001|Overall Study|Not transplanted|5|||
170682722|NCT02345850|616849463|FG002|Overall Study|Not transplanted|4|||
170682723|NCT02345850|616849461|FG000|Overall Study|Lost to Follow-up|2|||
170682724|NCT02345850|616849462|FG001|Overall Study|Lost to Follow-up|3|||
170682725|NCT02345850|616849463|FG002|Overall Study|Lost to Follow-up|2|||
170682726|NCT02345850|616849461|FG000|Overall Study|Withdrawal by Subject|1|||
170682727|NCT02345850|616849462|FG001|Overall Study|Withdrawal by Subject|0|||
170682728|NCT02345850|616849463|FG002|Overall Study|Withdrawal by Subject|0|||
170682729|NCT00463346|616849466|FG000|Overall Study|Withdrawal by Subject|3|||
170682730|NCT00463346|616849467|FG001|Overall Study|Withdrawal by Subject|3|||
170682731|NCT03641651|616849468|FG000|Overall Study|organizational issues at one study site|1|||
170682732|NCT01991067|616849470|FG000|Overall Study|Lost to Follow-up|6|||
170682733|NCT01991067|616849471|FG001|Overall Study|Lost to Follow-up|5|||
170682734|NCT00127712|616849472|FG000|Overall Study|Adverse Event|3|||
170682735|NCT00127712|616849473|FG001|Overall Study|Adverse Event|0|||
170682736|NCT00127712|616849472|FG000|Overall Study|Lack of GI access to continue|2|||
170682737|NCT00127712|616849473|FG001|Overall Study|Lack of GI access to continue|0|||
170682738|NCT00407563|616849474|FG000|Overall Study|Patient continues on treatment|1|||
170682739|NCT03055260|616849475|FG000|Overall Study|Withdrawal by Subject|1|||
170682740|NCT03055260|616849476|FG001|Overall Study|Withdrawal by Subject|0|||
170682741|NCT02014597|616849477|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
170682742|NCT02014597|616849478|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
170682743|NCT02279173|616849480|FG000|Overall Study|Protocol-specified Criteria|67|||
170682744|NCT02279173|616849480|FG000|Overall Study|Withdrawal by Subject|20|||
170682745|NCT02279173|616849480|FG000|Overall Study|Decision by Sponsor|4|||
170682746|NCT02279173|616849480|FG000|Overall Study|Lost to Follow-up|3|||
170682747|NCT00720434|616849483|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
170682748|NCT00720434|616849484|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
170682749|NCT00720434|616849485|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
170682750|NCT00720434|616849486|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
170682751|NCT00720434|616849483|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
170682752|NCT00720434|616849484|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
170682753|NCT00720434|616849485|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
170682754|NCT00720434|616849486|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
170682755|NCT00720434|616849483|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
170682756|NCT00720434|616849484|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
170682757|NCT00720434|616849485|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
170682758|NCT00720434|616849486|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
170682759|NCT00720434|616849483|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
170682760|NCT00720434|616849484|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
170682761|NCT00720434|616849485|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
170682762|NCT00720434|616849486|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
170682763|NCT00720434|616849483|FG000|Open-Label Period (Week 5-72)|Other|4|||
170682764|NCT00720434|616849484|FG001|Open-Label Period (Week 5-72)|Other|3|||
170682765|NCT00720434|616849485|FG002|Open-Label Period (Week 5-72)|Other|3|||
170682766|NCT00720434|616849486|FG003|Open-Label Period (Week 5-72)|Other|2|||
170682767|NCT00418314|616849487|FG000|Overall Study|Withdrawal by Subject|1|||
170682768|NCT00418314|616849488|FG001|Overall Study|Withdrawal by Subject|2|||
170682769|NCT00967798|616849489|FG000|Overall Study|Withdrawal by Subject|5|||
170682770|NCT00967798|616849490|FG001|Overall Study|Withdrawal by Subject|2|||
170682771|NCT00967798|616849489|FG000|Overall Study|Lost to Follow-up|4|||
170682772|NCT00967798|616849490|FG001|Overall Study|Lost to Follow-up|1|||
170682773|NCT03585504|616849495|FG000|Overall Study|Lost to Follow-up|26|||
170682774|NCT03585504|616849496|FG001|Overall Study|Lost to Follow-up|29|||
170682775|NCT02564042|616849497|FG000|Overall Study|Adverse Event|4|||
170682776|NCT02564042|616849498|FG001|Overall Study|Adverse Event|4|||
170682777|NCT02564042|616849499|FG002|Overall Study|Adverse Event|3|||
170682778|NCT02564042|616849500|FG003|Overall Study|Adverse Event|0|||
170682779|NCT02564042|616849501|FG004|Overall Study|Adverse Event|0|||
170682780|NCT02564042|616849502|FG005|Overall Study|Adverse Event|1|||
170682781|NCT02564042|616849497|FG000|Overall Study|Lost to Follow-up|1|||
170682782|NCT02564042|616849498|FG001|Overall Study|Lost to Follow-up|1|||
170682783|NCT02564042|616849499|FG002|Overall Study|Lost to Follow-up|1|||
170682784|NCT02564042|616849500|FG003|Overall Study|Lost to Follow-up|0|||
170682785|NCT02564042|616849501|FG004|Overall Study|Lost to Follow-up|1|||
170682786|NCT02564042|616849502|FG005|Overall Study|Lost to Follow-up|1|||
170682787|NCT02564042|616849497|FG000|Overall Study|Physician Decision|1|||
170682788|NCT02564042|616849498|FG001|Overall Study|Physician Decision|0|||
170682789|NCT02564042|616849499|FG002|Overall Study|Physician Decision|0|||
170682790|NCT02564042|616849500|FG003|Overall Study|Physician Decision|1|||
170682791|NCT02564042|616849501|FG004|Overall Study|Physician Decision|0|||
170682792|NCT02564042|616849502|FG005|Overall Study|Physician Decision|0|||
170682793|NCT02564042|616849497|FG000|Overall Study|Withdrawal by Subject|5|||
170682794|NCT02564042|616849498|FG001|Overall Study|Withdrawal by Subject|3|||
170682795|NCT02564042|616849499|FG002|Overall Study|Withdrawal by Subject|2|||
170682796|NCT02564042|616849500|FG003|Overall Study|Withdrawal by Subject|2|||
170682797|NCT02564042|616849501|FG004|Overall Study|Withdrawal by Subject|10|||
170682798|NCT02564042|616849502|FG005|Overall Study|Withdrawal by Subject|12|||
170682799|NCT02085785|616849505|FG000|Overall Study|Withdrawal by Subject|2|||
170682800|NCT02085785|616849506|FG001|Overall Study|Withdrawal by Subject|1|||
170682801|NCT02085785|616849505|FG000|Overall Study|Lost to Follow-up|0|||
170682802|NCT02085785|616849506|FG001|Overall Study|Lost to Follow-up|1|||
170682803|NCT03590041|616849511|FG000|Overall Study|Protocol Violation|4|||
170682804|NCT03590041|616849512|FG001|Overall Study|Protocol Violation|3|||
170682805|NCT03590041|616849511|FG000|Overall Study|No session data recorded|14|||
170682806|NCT03590041|616849512|FG001|Overall Study|No session data recorded|2|||
170682807|NCT04626297|616849513|FG000|Overall Study|Adverse Event|5|||
170682808|NCT04626297|616849514|FG001|Overall Study|Adverse Event|3|||
170682809|NCT04626297|616849513|FG000|Overall Study|Lost to Follow-up|7|||
170682810|NCT04626297|616849514|FG001|Overall Study|Lost to Follow-up|3|||
170682811|NCT04626297|616849513|FG000|Overall Study|Protocol Violation|5|||
170682812|NCT04626297|616849514|FG001|Overall Study|Protocol Violation|1|||
170682813|NCT04626297|616849513|FG000|Overall Study|Withdrawal by Subject|20|||
170682814|NCT04626297|616849514|FG001|Overall Study|Withdrawal by Subject|6|||
170682815|NCT04626297|616849513|FG000|Overall Study|Sponsor decision|2|||
170682816|NCT04626297|616849514|FG001|Overall Study|Sponsor decision|1|||
170682817|NCT04118166|616849515|FG000|Overall Study|Adverse Event|1|||
170682818|NCT02254486|616849516|FG000|Overall Study|Adverse Event|1|||
170682819|NCT02254486|616849517|FG001|Overall Study|Adverse Event|1|||
170682820|NCT02254486|616849516|FG000|Overall Study|Lack of Efficacy|1|||
170682821|NCT02254486|616849517|FG001|Overall Study|Lack of Efficacy|0|||
170682822|NCT02254486|616849516|FG000|Overall Study|Lost to Follow-up|2|||
170682823|NCT02254486|616849517|FG001|Overall Study|Lost to Follow-up|4|||
170682824|NCT02254486|616849516|FG000|Overall Study|Protocol Violation|1|||
170682825|NCT02254486|616849517|FG001|Overall Study|Protocol Violation|2|||
170682826|NCT02254486|616849516|FG000|Overall Study|Withdrawal by Subject|17|||
170682827|NCT02254486|616849517|FG001|Overall Study|Withdrawal by Subject|15|||
170682828|NCT02254486|616849516|FG000|Overall Study|GFR<60mL/min|16|||
170682829|NCT02254486|616849517|FG001|Overall Study|GFR<60mL/min|21|||
170682830|NCT02254486|616849516|FG000|Overall Study|Various|12|||
170682831|NCT02254486|616849517|FG001|Overall Study|Various|12|||
170682832|NCT01979016|616849522|FG000|Overall Study|Withdrawal by Subject|2|||
170682833|NCT01979016|616849523|FG001|Overall Study|Withdrawal by Subject|0|||
170682834|NCT01979016|616849522|FG000|Overall Study|Adverse Event|0|||
170682835|NCT01979016|616849523|FG001|Overall Study|Adverse Event|1|||
170682836|NCT01986985|616849524|FG000|Overall Study|Withdrawal by Subject|4|||
170682837|NCT01986985|616849524|FG000|Overall Study|Scan not completed due to malfunction|3|||
170682838|NCT02547649|616849525|FG000|Overall Study|Lost to Follow-up|3|||
170682839|NCT02547649|616849526|FG001|Overall Study|Lost to Follow-up|1|||
170682840|NCT02547649|616849527|FG002|Overall Study|Lost to Follow-up|1|||
170682841|NCT02547649|616849525|FG000|Overall Study|Not vaccinated|0|||
170682842|NCT02547649|616849526|FG001|Overall Study|Not vaccinated|0|||
170682843|NCT02547649|616849527|FG002|Overall Study|Not vaccinated|1|||
170682844|NCT02547649|616849525|FG000|Overall Study|Withdrawal by Subject|0|||
170682845|NCT02547649|616849526|FG001|Overall Study|Withdrawal by Subject|4|||
170682846|NCT02547649|616849527|FG002|Overall Study|Withdrawal by Subject|2|||
170682847|NCT02005445|616849528|FG000|Overall Study|Dual study enrollment|0|||
170682848|NCT02005445|616849529|FG001|Overall Study|Dual study enrollment|1|||
170682849|NCT01111149|616849530|FG000|Overall Study|Protocol Violation|1|||
170682850|NCT01111149|616849531|FG001|Overall Study|Protocol Violation|1|||
170682851|NCT01111149|616849532|FG002|Overall Study|Protocol Violation|2|||
170682852|NCT01111149|616849530|FG000|Overall Study|Withdrawal by Subject|1|||
170682853|NCT01111149|616849531|FG001|Overall Study|Withdrawal by Subject|0|||
170682854|NCT01111149|616849532|FG002|Overall Study|Withdrawal by Subject|2|||
170682855|NCT00010374|616849536|FG000|Overall Study|False positive phrenic nerve test|1|||
170682856|NCT03033394|616849543|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
170682857|NCT03033394|616849543|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
170682858|NCT03033394|616849543|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
170682859|NCT03033394|616849543|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
170682860|NCT03033394|616849543|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
170682861|NCT01985867|616849545|FG000|Overall Study|Lost to Follow-up|3|||
170682862|NCT01985867|616849546|FG001|Overall Study|Lost to Follow-up|4|||
170682863|NCT01985867|616849545|FG000|Overall Study|Adverse Event|3|||
170682864|NCT01985867|616849546|FG001|Overall Study|Adverse Event|2|||
170682865|NCT01985867|616849545|FG000|Overall Study|Lack of Efficacy|1|||
170682866|NCT01985867|616849546|FG001|Overall Study|Lack of Efficacy|0|||
170682867|NCT02557646|616849551|FG000|Overall Study|Adverse Event|40|||
170682868|NCT02557646|616849551|FG000|Overall Study|Death|1|||
170682869|NCT02557646|616849551|FG000|Overall Study|Lack of Efficacy|186|||
170682870|NCT02557646|616849551|FG000|Overall Study|Withdrawal by Subject|18|||
170682871|NCT02557646|616849551|FG000|Overall Study|Lost to Follow-up|17|||
170682872|NCT02557646|616849551|FG000|Overall Study|Other|14|||
170682873|NCT02925494|616849552|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
170682874|NCT02925494|616849553|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
170682875|NCT02925494|616849554|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
170682876|NCT02925494|616849555|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
170682877|NCT02925494|616849552|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
170682878|NCT02925494|616849553|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
170682879|NCT02925494|616849554|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
170682880|NCT02925494|616849555|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
170682881|NCT02925494|616849552|FG000|Post-Treatment Follow-Up Period|Other|1|||
170682882|NCT02925494|616849553|FG001|Post-Treatment Follow-Up Period|Other|4|||
170682883|NCT02925494|616849554|FG002|Post-Treatment Follow-Up Period|Other|3|||
170682884|NCT02925494|616849555|FG003|Post-Treatment Follow-Up Period|Other|6|||
170682885|NCT02925494|616849552|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
170682886|NCT02925494|616849553|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
170682887|NCT02925494|616849554|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
170682888|NCT02925494|616849555|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
170682889|NCT02925494|616849552|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
170682890|NCT02925494|616849553|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
170682891|NCT02925494|616849554|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
170682892|NCT02925494|616849555|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
170682893|NCT02925494|616849552|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
170682894|NCT02925494|616849553|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
170682895|NCT02925494|616849554|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
170682896|NCT02925494|616849555|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
170682897|NCT02925494|616849552|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
170682898|NCT02925494|616849553|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
170682899|NCT02925494|616849554|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
170682900|NCT02925494|616849555|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
170682901|NCT03334448|616849556|FG000|Washout|Personal Reason|0|||
170682902|NCT03334448|616849557|FG001|Washout|Personal Reason|1|||
170682903|NCT03334448|616849558|FG002|Washout|Personal Reason|0|||
170682904|NCT03334448|616849559|FG003|Washout|Personal Reason|0|||
170682905|NCT03334448|616849556|FG000|Washout|Protocol Violation|0|||
170682906|NCT03334448|616849557|FG001|Washout|Protocol Violation|0|||
170682907|NCT03334448|616849558|FG002|Washout|Protocol Violation|0|||
170682908|NCT03334448|616849559|FG003|Washout|Protocol Violation|1|||
170682909|NCT02326025|616849560|FG000|Overall Study|Adverse Event|3|||
170682910|NCT02326025|616849561|FG001|Overall Study|Adverse Event|0|||
170682911|NCT02326025|616849560|FG000|Overall Study|Physician Decision|1|||
170682912|NCT02326025|616849561|FG001|Overall Study|Physician Decision|2|||
170682913|NCT02326025|616849560|FG000|Overall Study|Physician and Participant Decision|1|||
170682914|NCT02326025|616849561|FG001|Overall Study|Physician and Participant Decision|0|||
170682915|NCT02326025|616849560|FG000|Overall Study|Withdrawal by Subject|0|||
170682916|NCT02326025|616849561|FG001|Overall Study|Withdrawal by Subject|2|||
170682917|NCT02326025|616849560|FG000|Overall Study|Protocol Violation|0|||
170682918|NCT02326025|616849561|FG001|Overall Study|Protocol Violation|1|||
170682919|NCT00536198|616849562|FG000|Overall Study|Lost to Follow-up|15|||
170682920|NCT00536198|616849563|FG001|Overall Study|Lost to Follow-up|14|||
170682921|NCT00536198|616849562|FG000|Overall Study|Withdrawal by Subject|16|||
170682922|NCT00536198|616849563|FG001|Overall Study|Withdrawal by Subject|12|||
170682923|NCT00536198|616849562|FG000|Overall Study|Adverse Event|2|||
170682924|NCT00536198|616849563|FG001|Overall Study|Adverse Event|2|||
170682925|NCT00536198|616849562|FG000|Overall Study|Rescue|3|||
170682926|NCT00536198|616849563|FG001|Overall Study|Rescue|9|||
170820943|NCT00043186|617353203|FG005|Overall Study|Physician Decision|0|||
170820944|NCT00043186|617353204|FG006|Overall Study|Physician Decision|0|||
170820945|NCT00043186|617353205|FG007|Overall Study|Physician Decision|1|||
170820946|NCT00043186|617353206|FG008|Overall Study|Physician Decision|1|||
170820947|NCT00043186|617353198|FG000|Overall Study|Adverse Event|2|||
170820948|NCT00043186|617353199|FG001|Overall Study|Adverse Event|2|||
170682927|NCT00536198|616849562|FG000|Overall Study|Pregnancy|1|||
170682928|NCT00536198|616849563|FG001|Overall Study|Pregnancy|1|||
170682929|NCT00536198|616849562|FG000|Overall Study|Protocol Violation|0|||
170682930|NCT00536198|616849563|FG001|Overall Study|Protocol Violation|1|||
170682931|NCT00881712|616849564|FG000|Overall Study|Death|1|||
170682932|NCT00881712|616849565|FG001|Overall Study|Death|0|||
170682933|NCT00881712|616849566|FG002|Overall Study|Death|0|||
170682934|NCT00881712|616849564|FG000|Overall Study|Withdrawal by Subject|1|||
170820949|NCT00043186|617353200|FG002|Overall Study|Adverse Event|2|||
170682935|NCT00881712|616849565|FG001|Overall Study|Withdrawal by Subject|0|||
170682936|NCT00881712|616849566|FG002|Overall Study|Withdrawal by Subject|0|||
170682937|NCT02289417|616849567|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
170682938|NCT02289417|616849568|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
170682939|NCT02289417|616849569|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
170682940|NCT02289417|616849570|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
170682941|NCT02289417|616849571|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
170682942|NCT02289417|616849572|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
170682943|NCT02289417|616849573|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
170682944|NCT02289417|616849574|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
170682945|NCT02289417|616849575|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
170682946|NCT02289417|616849567|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
170682947|NCT02289417|616849568|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
170682948|NCT02289417|616849569|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
170682949|NCT02289417|616849570|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
170682950|NCT02289417|616849571|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
170682951|NCT02289417|616849572|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
170682952|NCT02289417|616849573|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
170682953|NCT02289417|616849574|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
170682954|NCT02289417|616849575|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
170682955|NCT02289417|616849567|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
170682956|NCT02289417|616849568|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
170682957|NCT02289417|616849569|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
170682958|NCT02289417|616849570|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
170682959|NCT02289417|616849571|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
170682960|NCT02289417|616849572|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
170682961|NCT02289417|616849573|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
170682962|NCT02289417|616849574|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
170682963|NCT02289417|616849575|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
170682964|NCT02289417|616849567|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
170682965|NCT02289417|616849568|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
170682966|NCT02289417|616849569|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
170682967|NCT02289417|616849570|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
170682968|NCT02289417|616849571|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
170682969|NCT02289417|616849572|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
170682970|NCT02289417|616849573|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
170682971|NCT02289417|616849574|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
170682972|NCT02289417|616849575|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
170682973|NCT02289417|616849567|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
170682974|NCT02289417|616849568|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
170682975|NCT02289417|616849569|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
170682976|NCT02289417|616849570|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
170682977|NCT02289417|616849571|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
170682978|NCT02289417|616849572|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
170682979|NCT02289417|616849573|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
170682980|NCT02289417|616849574|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
170682981|NCT02289417|616849575|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
170682982|NCT02289417|616849567|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
170682983|NCT02289417|616849568|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
170682984|NCT02289417|616849569|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
170682985|NCT02289417|616849570|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
170682986|NCT02289417|616849571|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
170682987|NCT02289417|616849572|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
170682988|NCT02289417|616849573|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
170682989|NCT02289417|616849574|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
170682990|NCT02289417|616849575|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
170682991|NCT02289417|616849567|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
170682992|NCT02289417|616849568|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
170682993|NCT02289417|616849569|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
170682994|NCT02289417|616849570|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
170682995|NCT02289417|616849571|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
170682996|NCT02289417|616849572|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
170682997|NCT02289417|616849573|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
170682998|NCT02289417|616849574|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
170682999|NCT02289417|616849575|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
170683000|NCT02289417|616849567|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
170683001|NCT02289417|616849568|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
170820950|NCT00043186|617353201|FG003|Overall Study|Adverse Event|3|||
170683002|NCT02289417|616849569|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
170683003|NCT02289417|616849570|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
170683004|NCT02289417|616849571|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
170683005|NCT02289417|616849572|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
170683006|NCT02289417|616849573|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
170683007|NCT02289417|616849574|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
170683008|NCT02289417|616849575|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
170683009|NCT02289417|616849567|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
170683010|NCT02289417|616849568|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
170683011|NCT02289417|616849569|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
170683012|NCT02289417|616849570|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
170683013|NCT02289417|616849571|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
170683014|NCT02289417|616849572|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
170683015|NCT02289417|616849573|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
170683016|NCT02289417|616849574|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
170683017|NCT02289417|616849575|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
170683018|NCT02289417|616849567|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
170683019|NCT02289417|616849568|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
170683020|NCT02289417|616849569|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
170683021|NCT02289417|616849570|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
170683022|NCT02289417|616849571|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
170683023|NCT02289417|616849572|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
170683024|NCT02289417|616849573|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
170683025|NCT02289417|616849574|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
170683026|NCT02289417|616849575|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
170683027|NCT02289417|616849567|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
170683028|NCT02289417|616849568|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
170683029|NCT02289417|616849569|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
170683030|NCT02289417|616849570|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
170683031|NCT02289417|616849571|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
170683032|NCT02289417|616849572|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
170683033|NCT02289417|616849573|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
170683034|NCT02289417|616849574|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
170683035|NCT02289417|616849575|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
170683036|NCT02289417|616849567|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
170683037|NCT02289417|616849568|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
170683038|NCT02289417|616849569|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
170683039|NCT02289417|616849570|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
170683040|NCT02289417|616849571|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
170683041|NCT02289417|616849572|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
170683042|NCT02289417|616849573|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
170683043|NCT02289417|616849574|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
170683044|NCT02289417|616849575|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
170683045|NCT02289417|616849567|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
170683046|NCT02289417|616849568|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
170683047|NCT02289417|616849569|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
170683048|NCT02289417|616849570|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
170683049|NCT02289417|616849571|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
170683050|NCT02289417|616849572|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
170683051|NCT02289417|616849573|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
170683052|NCT02289417|616849574|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
170683053|NCT02289417|616849575|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
170683054|NCT02289417|616849567|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
170683055|NCT02289417|616849568|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
170683056|NCT02289417|616849569|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
170683057|NCT02289417|616849570|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
170683058|NCT02289417|616849571|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
170683059|NCT02289417|616849572|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
170683060|NCT02289417|616849573|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
170683061|NCT02289417|616849574|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
170683062|NCT02289417|616849575|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
170683063|NCT00276744|616849576|FG000|PART A|Reason unknown|98|||
170683064|NCT02725710|616849578|FG000|Overall Study|Lost to Follow-up|1|||
170683065|NCT02725710|616849579|FG001|Overall Study|Lost to Follow-up|0|||
170683066|NCT01605877|616849596|FG000|Overall Study|Withdrawal by Subject|1|||
170683067|NCT01918085|616849599|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
170683068|NCT01918085|616849600|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
170683069|NCT01835587|616849601|FG000|Overall Study|Disease Recurrence or Relapse|0|||
170683070|NCT01835587|616849602|FG001|Overall Study|Disease Recurrence or Relapse|3|||
170683071|NCT01835587|616849603|FG002|Overall Study|Disease Recurrence or Relapse|0|||
170683072|NCT01835587|616849604|FG003|Overall Study|Disease Recurrence or Relapse|3|||
170683073|NCT01835587|616849601|FG000|Overall Study|Withdrawal by Subject|2|||
170683074|NCT01835587|616849602|FG001|Overall Study|Withdrawal by Subject|0|||
170683075|NCT01835587|616849603|FG002|Overall Study|Withdrawal by Subject|0|||
170683076|NCT01835587|616849604|FG003|Overall Study|Withdrawal by Subject|3|||
170683077|NCT01835587|616849601|FG000|Overall Study|Adverse Event|0|||
170683078|NCT01835587|616849602|FG001|Overall Study|Adverse Event|0|||
170683079|NCT01835587|616849603|FG002|Overall Study|Adverse Event|2|||
170683080|NCT01835587|616849604|FG003|Overall Study|Adverse Event|2|||
170683081|NCT01835587|616849601|FG000|Overall Study|Death|0|||
170683082|NCT01835587|616849602|FG001|Overall Study|Death|0|||
170683083|NCT01835587|616849603|FG002|Overall Study|Death|0|||
170683084|NCT01835587|616849604|FG003|Overall Study|Death|1|||
170683085|NCT01835587|616849601|FG000|Overall Study|Miscellaneous|0|||
170683086|NCT01835587|616849602|FG001|Overall Study|Miscellaneous|1|||
170683087|NCT01835587|616849603|FG002|Overall Study|Miscellaneous|0|||
170683088|NCT01835587|616849604|FG003|Overall Study|Miscellaneous|0|||
170683089|NCT03228537|616849607|FG000|Neoadjuvant|Adverse Event|2|||
170683090|NCT03228537|616849607|FG000|Neoadjuvant|Progression/Relapse|4|||
170683091|NCT03228537|616849607|FG000|Neoadjuvant|Death|1|||
170683092|NCT03228537|616849607|FG000|Surgery|Death|1|||
170683093|NCT03228537|616849607|FG000|Surgery|Other - Not Protocol Specified|2|||
170683094|NCT03228537|616849607|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
170683095|NCT03228537|616849607|FG000|Maintenance|Progression/Relapse|10|||
170683096|NCT02634320|616849610|FG000|Overall Study|Adverse Event|2|||
170683097|NCT02634320|616849610|FG000|Overall Study|Lost to Follow-up|3|||
170683098|NCT02634320|616849610|FG000|Overall Study|Moved out of area|2|||
170683099|NCT02634320|616849610|FG000|Overall Study|Out of window for study visits|1|||
170683100|NCT02634320|616849610|FG000|Overall Study|Protocol Violation|1|||
170683101|NCT02634320|616849610|FG000|Overall Study|Withdrawal by Subject|5|||
170683102|NCT02634320|616849610|FG000|Overall Study|Lack of Efficacy|2|||
170683103|NCT00687323|616849612|FG000|Overall Study|Death|25|||
170683104|NCT00687323|616849612|FG000|Overall Study|Withdrawal by Subject|1|||
170683105|NCT00687323|616849612|FG000|Overall Study|Excluded from efficacy evaluations|6|||
170683106|NCT00687323|616849612|FG000|Overall Study|Screen failure|148|||
170683107|NCT00965718|616849617|FG000|Overall Study|Withdrawal by Subject|4|||
170683108|NCT02547454|616849618|FG000|Overall Study|Due to hemodialysis|53|||
170683109|NCT02547454|616849618|FG000|Overall Study|Due to transplantation|1|||
170683110|NCT02547454|616849618|FG000|Overall Study|Due to no further need to treat|4|||
170683111|NCT02547454|616849618|FG000|Overall Study|Death|38|||
170683112|NCT02547454|616849618|FG000|Overall Study|Lost to Follow-up|26|||
170683113|NCT02547454|616849618|FG000|Overall Study|Other|39|||
170683114|NCT02547454|616849618|FG000|Overall Study|No data|11|||
170683115|NCT03031678|616849621|FG000|Overall Study|Study closed prior to completion|1|||
170683116|NCT04557371|616849622|FG000|Overall Study|Covid-19-related|0|||
170683117|NCT04557371|616849623|FG001|Overall Study|Covid-19-related|1|||
170683118|NCT04557371|616849624|FG002|Overall Study|Covid-19-related|0|||
170683119|NCT04557371|616849622|FG000|Overall Study|Withdrawal by Subject|0|||
170683120|NCT04557371|616849623|FG001|Overall Study|Withdrawal by Subject|1|||
170683121|NCT04557371|616849624|FG002|Overall Study|Withdrawal by Subject|0|||
170683122|NCT04557371|616849622|FG000|Overall Study|Adverse Event|1|||
170683123|NCT04557371|616849623|FG001|Overall Study|Adverse Event|0|||
170683124|NCT04557371|616849624|FG002|Overall Study|Adverse Event|0|||
170683125|NCT00224055|616851517|FG000|Overall Study|Adverse Event|9|||
170683126|NCT00224055|616851518|FG001|Overall Study|Adverse Event|3|||
170683127|NCT00224055|616851517|FG000|Overall Study|Lost to Follow-up|1|||
170683128|NCT00224055|616851518|FG001|Overall Study|Lost to Follow-up|2|||
170683129|NCT00224055|616851517|FG000|Overall Study|Protocol Violation|1|||
170683130|NCT00224055|616851518|FG001|Overall Study|Protocol Violation|1|||
170683131|NCT00224055|616851517|FG000|Overall Study|Inclusion Violation|3|||
170683132|NCT00224055|616851518|FG001|Overall Study|Inclusion Violation|6|||
170683133|NCT00224055|616851517|FG000|Overall Study|Withdrawal by Subject|0|||
170683134|NCT00224055|616851518|FG001|Overall Study|Withdrawal by Subject|2|||
170683135|NCT00224055|616851517|FG000|Overall Study|Other|1|||
170683136|NCT00224055|616851518|FG001|Overall Study|Other|0|||
170683137|NCT01986855|616851519|FG000|Overall Study|Adverse Event|1|||
170683138|NCT01986855|616851520|FG001|Overall Study|Adverse Event|0|||
170683139|NCT01986855|616851521|FG002|Overall Study|Adverse Event|0|||
170683140|NCT01986855|616851519|FG000|Overall Study|Death|3|||
170683141|NCT01986855|616851520|FG001|Overall Study|Death|4|||
170683142|NCT01986855|616851521|FG002|Overall Study|Death|4|||
170683143|NCT01986855|616851519|FG000|Overall Study|Lost to Follow-up|2|||
170683144|NCT01986855|616851520|FG001|Overall Study|Lost to Follow-up|1|||
170683145|NCT01986855|616851521|FG002|Overall Study|Lost to Follow-up|0|||
170683146|NCT01986855|616851519|FG000|Overall Study|Screen Failure|0|||
170683147|NCT01986855|616851520|FG001|Overall Study|Screen Failure|1|||
170683148|NCT01986855|616851521|FG002|Overall Study|Screen Failure|0|||
170683149|NCT01986855|616851519|FG000|Overall Study|Participant Moved|0|||
170683150|NCT01986855|616851520|FG001|Overall Study|Participant Moved|0|||
170683151|NCT01986855|616851521|FG002|Overall Study|Participant Moved|2|||
170683152|NCT01986855|616851519|FG000|Overall Study|Withdrawal by Subject|7|||
170683153|NCT01986855|616851520|FG001|Overall Study|Withdrawal by Subject|8|||
170683154|NCT01986855|616851521|FG002|Overall Study|Withdrawal by Subject|5|||
170683155|NCT04317066|616851522|FG000|Overall Study|Sponsor decision|5|||
170683156|NCT04317066|616851522|FG000|Overall Study|Death|2|||
170683157|NCT00464087|616851528|FG000|Overall Study|No PCI per inclusion criteria|0|||
170683158|NCT00464087|616851529|FG001|Overall Study|No PCI per inclusion criteria|0|||
170683159|NCT00464087|616851530|FG002|Overall Study|No PCI per inclusion criteria|29|||
170683160|NCT01164956|616851531|FG000|Overall Study|Side Effects|1|||
170683161|NCT01164956|616851532|FG001|Overall Study|Side Effects|0|||
170683162|NCT01164956|616851533|FG002|Overall Study|Side Effects|1|||
170683163|NCT01313767|616851534|FG000|Overall Study|Adverse Event|1|||
170683164|NCT01313767|616851535|FG001|Overall Study|Adverse Event|0|||
170683165|NCT01313767|616851534|FG000|Overall Study|Lost to Follow-up|1|||
170683166|NCT01313767|616851535|FG001|Overall Study|Lost to Follow-up|0|||
170683167|NCT01313767|616851534|FG000|Overall Study|Withdrawal by Subject|2|||
170683168|NCT01313767|616851535|FG001|Overall Study|Withdrawal by Subject|1|||
170683169|NCT01313767|616851534|FG000|Overall Study|Protocol Violation|3|||
170683170|NCT01313767|616851535|FG001|Overall Study|Protocol Violation|1|||
170683171|NCT02904512|616851536|FG000|Overall Study|Withdrawal by Subject|1|||
170683172|NCT02904512|616851537|FG001|Overall Study|Withdrawal by Subject|0|||
170683173|NCT02904512|616851536|FG000|Overall Study|Transferred to ICU|1|||
170683174|NCT02904512|616851537|FG001|Overall Study|Transferred to ICU|0|||
170683175|NCT02904512|616851536|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
170683176|NCT02904512|616851537|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
170683177|NCT00588848|616851538|FG000|Overall Study|Physician Decision|0|||
170683178|NCT00588848|616851539|FG001|Overall Study|Physician Decision|3|||
170683179|NCT00589914|616851544|FG000|Overall Study|Adverse Event|19|||
170683180|NCT00589914|616851545|FG001|Overall Study|Adverse Event|10|||
170683181|NCT00589914|616851544|FG000|Overall Study|Death|2|||
170683182|NCT00589914|616851545|FG001|Overall Study|Death|0|||
170683183|NCT00589914|616851544|FG000|Overall Study|Lack of Efficacy|40|||
170683184|NCT00589914|616851545|FG001|Overall Study|Lack of Efficacy|43|||
170683185|NCT00589914|616851544|FG000|Overall Study|Lost to Follow-up|11|||
170683186|NCT00589914|616851545|FG001|Overall Study|Lost to Follow-up|18|||
170683187|NCT00589914|616851544|FG000|Overall Study|Pregnancy|1|||
170683188|NCT00589914|616851545|FG001|Overall Study|Pregnancy|0|||
170683189|NCT00589914|616851544|FG000|Overall Study|Withdrawal by Subject|55|||
170683190|NCT00589914|616851545|FG001|Overall Study|Withdrawal by Subject|49|||
170683191|NCT00589914|616851544|FG000|Overall Study|Other|22|||
170683192|NCT00589914|616851545|FG001|Overall Study|Other|17|||
170683193|NCT00799487|616851546|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
170683194|NCT00799487|616851547|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
170683195|NCT00799487|616851548|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
170683196|NCT00799487|616851546|FG000|Dose Adjustment Period|Adverse Event|2|||
170683197|NCT00799487|616851547|FG001|Dose Adjustment Period|Adverse Event|0|||
170683198|NCT00799487|616851548|FG002|Dose Adjustment Period|Adverse Event|0|||
170683199|NCT00799487|616851546|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
170683200|NCT00799487|616851547|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
170683201|NCT00799487|616851548|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
170683202|NCT00799487|616851546|FG000|Dose Adjustment Period|Investigator Discretion|2|||
170683203|NCT00799487|616851547|FG001|Dose Adjustment Period|Investigator Discretion|0|||
170683204|NCT00799487|616851548|FG002|Dose Adjustment Period|Investigator Discretion|0|||
170683205|NCT00799487|616851546|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
170683206|NCT00799487|616851547|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
170683207|NCT00799487|616851548|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
170683208|NCT00799487|616851546|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
170683209|NCT00799487|616851547|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
170683210|NCT00799487|616851548|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
170683211|NCT00799487|616851546|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
170683212|NCT00799487|616851547|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
170683213|NCT00799487|616851548|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
170683214|NCT00799487|616851546|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
170683215|NCT00799487|616851547|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
170683216|NCT00799487|616851548|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
170683217|NCT00799487|616851546|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
170820951|NCT00043186|617353202|FG004|Overall Study|Adverse Event|2|||
170683218|NCT00799487|616851547|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
170683219|NCT00799487|616851548|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
170683220|NCT00799487|616851546|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
170683221|NCT00799487|616851547|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
170683222|NCT00799487|616851548|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
170683223|NCT00799487|616851546|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
170683224|NCT00799487|616851547|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
170683225|NCT00799487|616851548|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
170683226|NCT00799487|616851546|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
170683227|NCT00799487|616851547|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
170683228|NCT00799487|616851548|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
170683229|NCT02692703|616851549|FG000|Overall Study|Lost to Follow-up|1|||
170683230|NCT02692703|616851549|FG000|Overall Study|Other|1|||
170683231|NCT02289898|616851550|FG000|Overall Study|Death|5|||
170683232|NCT02289898|616851551|FG001|Overall Study|Death|4|||
170683233|NCT02289898|616851552|FG002|Overall Study|Death|3|||
170683234|NCT02289898|616851550|FG000|Overall Study|Physician Decision|2|||
170683235|NCT02289898|616851551|FG001|Overall Study|Physician Decision|5|||
170683236|NCT02289898|616851552|FG002|Overall Study|Physician Decision|2|||
170683237|NCT02289898|616851550|FG000|Overall Study|Withdrawal by Subject|0|||
170683238|NCT02289898|616851551|FG001|Overall Study|Withdrawal by Subject|4|||
170683239|NCT02289898|616851552|FG002|Overall Study|Withdrawal by Subject|1|||
170683240|NCT02289898|616851550|FG000|Overall Study|Adverse Event|3|||
170683241|NCT02289898|616851551|FG001|Overall Study|Adverse Event|5|||
170683242|NCT02289898|616851552|FG002|Overall Study|Adverse Event|5|||
170683243|NCT02289898|616851550|FG000|Overall Study|Disease progression|34|||
170683244|NCT02289898|616851551|FG001|Overall Study|Disease progression|28|||
170683245|NCT02289898|616851552|FG002|Overall Study|Disease progression|34|||
170683246|NCT02289898|616851550|FG000|Overall Study|Use of another anticancer therapy|0|||
170683247|NCT02289898|616851551|FG001|Overall Study|Use of another anticancer therapy|0|||
170683248|NCT02289898|616851552|FG002|Overall Study|Use of another anticancer therapy|1|||
170683249|NCT02289898|616851550|FG000|Overall Study|Other|8|||
170683250|NCT02289898|616851551|FG001|Overall Study|Other|7|||
170683251|NCT02289898|616851552|FG002|Overall Study|Other|10|||
170683252|NCT00759954|616851556|FG000|Overall Study|Personal reason|1|||
170683253|NCT00759954|616851557|FG001|Overall Study|Personal reason|0|||
170683254|NCT00759954|616851556|FG000|Overall Study|Adverse Event|1|||
170683255|NCT00759954|616851557|FG001|Overall Study|Adverse Event|2|||
170683256|NCT00276159|616851563|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
170683257|NCT00333866|616851564|FG000|Overall Study|Adverse Event|23|||
170683258|NCT00333866|616851565|FG001|Overall Study|Adverse Event|37|||
170683259|NCT00333866|616851566|FG002|Overall Study|Adverse Event|38|||
170683260|NCT00333866|616851567|FG003|Overall Study|Adverse Event|47|||
170683261|NCT00333866|616851564|FG000|Overall Study|Other|3|||
170683262|NCT00333866|616851565|FG001|Overall Study|Other|2|||
170683263|NCT00333866|616851566|FG002|Overall Study|Other|2|||
170683264|NCT00333866|616851567|FG003|Overall Study|Other|2|||
170683265|NCT00333866|616851564|FG000|Overall Study|Lack of Efficacy|8|||
170683266|NCT00333866|616851565|FG001|Overall Study|Lack of Efficacy|6|||
170683267|NCT00333866|616851566|FG002|Overall Study|Lack of Efficacy|3|||
170683268|NCT00333866|616851567|FG003|Overall Study|Lack of Efficacy|5|||
170683269|NCT00333866|616851564|FG000|Overall Study|Lost to Follow-up|1|||
170683270|NCT00333866|616851565|FG001|Overall Study|Lost to Follow-up|2|||
170683271|NCT00333866|616851566|FG002|Overall Study|Lost to Follow-up|2|||
170683272|NCT00333866|616851567|FG003|Overall Study|Lost to Follow-up|2|||
170683273|NCT00333866|616851564|FG000|Overall Study|Withdrawal by Subject|8|||
170683274|NCT00333866|616851565|FG001|Overall Study|Withdrawal by Subject|14|||
170683275|NCT00333866|616851566|FG002|Overall Study|Withdrawal by Subject|4|||
170683276|NCT00333866|616851567|FG003|Overall Study|Withdrawal by Subject|9|||
170683277|NCT00333866|616851564|FG000|Overall Study|Randomized but not Treated|5|||
170683278|NCT00333866|616851565|FG001|Overall Study|Randomized but not Treated|3|||
170683279|NCT00333866|616851566|FG002|Overall Study|Randomized but not Treated|2|||
170683280|NCT00333866|616851567|FG003|Overall Study|Randomized but not Treated|1|||
170683281|NCT00356369|616851568|FG000|Active Phase|Withdrawal by Subject|2|||
170683282|NCT00356369|616851569|FG001|Active Phase|Withdrawal by Subject|1|||
170683283|NCT02927431|616851570|FG000|Overall Study|Withdrawal by Subject|0|||
170683284|NCT02927431|616851571|FG001|Overall Study|Withdrawal by Subject|0|||
170683285|NCT02927431|616851572|FG002|Overall Study|Withdrawal by Subject|1|||
170683286|NCT01907815|616851575|FG000|Overall Study|Withdrawal by Subject|1|||
170683287|NCT01907815|616851576|FG001|Overall Study|Withdrawal by Subject|0|||
170683288|NCT02246660|616851577|FG000|Overall Study|Withdrawal by Subject|0|||
170683289|NCT02246660|616851578|FG001|Overall Study|Withdrawal by Subject|1|||
170683290|NCT02246660|616851579|FG002|Overall Study|Withdrawal by Subject|0|||
170683291|NCT02246660|616851577|FG000|Overall Study|Death|0|||
170683292|NCT02246660|616851578|FG001|Overall Study|Death|0|||
170683293|NCT02246660|616851579|FG002|Overall Study|Death|1|||
170683294|NCT04952402|616851580|FG000|Overall Study|Lost to Follow-up|1|||
170683295|NCT04952402|616851581|FG001|Overall Study|Lost to Follow-up|3|||
170683296|NCT04952402|616851580|FG000|Overall Study|Lack Of Venous Access|0|||
170683297|NCT04952402|616851581|FG001|Overall Study|Lack Of Venous Access|1|||
170683298|NCT01285310|616851582|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
170683299|NCT01285310|616851583|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
170683300|NCT01285310|616851584|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
170683301|NCT01285310|616851585|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
170683302|NCT01285310|616851586|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
170683303|NCT01285310|616851582|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
170683304|NCT01285310|616851583|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
170683305|NCT01285310|616851584|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
170683306|NCT01285310|616851585|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
170683307|NCT01285310|616851586|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
170683308|NCT01285310|616851582|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
170683309|NCT01285310|616851583|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
170683310|NCT01285310|616851584|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
170683311|NCT01285310|616851585|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
170683312|NCT01285310|616851586|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
170683313|NCT01285310|616851582|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
170683314|NCT01285310|616851583|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
170683315|NCT01285310|616851584|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
170683316|NCT01285310|616851585|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
170683317|NCT01285310|616851586|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
170683318|NCT01285310|616851582|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
170683319|NCT01285310|616851583|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
170683320|NCT01285310|616851584|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
170683321|NCT01285310|616851585|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
170683322|NCT01285310|616851586|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
170683323|NCT01285310|616851582|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
170683324|NCT01285310|616851583|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
170683325|NCT01285310|616851584|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
170683326|NCT01285310|616851585|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
170683327|NCT01285310|616851586|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
170683328|NCT01285310|616851582|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
170683329|NCT01285310|616851583|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
170683330|NCT01285310|616851584|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
170683331|NCT01285310|616851585|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
170683332|NCT01285310|616851586|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
170683333|NCT01285310|616851582|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
170683334|NCT01285310|616851583|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
170683335|NCT01285310|616851584|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
170683336|NCT01285310|616851585|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
170683337|NCT01285310|616851586|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
170683338|NCT01285310|616851582|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
170683339|NCT01285310|616851583|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
170683340|NCT01285310|616851584|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
170683341|NCT01285310|616851585|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
170683342|NCT01285310|616851586|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
170683343|NCT01285310|616851582|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
170683344|NCT01285310|616851583|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
170683345|NCT01285310|616851584|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
170683346|NCT01285310|616851585|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
170683347|NCT01285310|616851586|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
170683348|NCT01285310|616851582|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
170683349|NCT01285310|616851583|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
170683350|NCT01285310|616851584|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
170683351|NCT01285310|616851585|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
170683352|NCT01285310|616851586|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
170820952|NCT00043186|617353203|FG005|Overall Study|Adverse Event|1|||
170820953|NCT00043186|617353204|FG006|Overall Study|Adverse Event|2|||
170683353|NCT01285310|616851582|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
170683354|NCT01285310|616851583|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
170683355|NCT01285310|616851584|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
170683356|NCT01285310|616851585|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
170683357|NCT01285310|616851586|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
170683358|NCT00143403|616851587|FG000|Overall Study|Adverse Event|3|||
170683359|NCT00143403|616851588|FG001|Overall Study|Adverse Event|8|||
170683360|NCT00143403|616851587|FG000|Overall Study|Death|1|||
170683361|NCT00143403|616851588|FG001|Overall Study|Death|0|||
170683362|NCT00143403|616851587|FG000|Overall Study|Withdrawal by Subject|3|||
170683363|NCT00143403|616851588|FG001|Overall Study|Withdrawal by Subject|12|||
170683364|NCT00143403|616851587|FG000|Overall Study|Relapse|15|||
170683365|NCT00143403|616851588|FG001|Overall Study|Relapse|7|||
170683366|NCT00143403|616851587|FG000|Overall Study|Protocol Violation|2|||
170683367|NCT00143403|616851588|FG001|Overall Study|Protocol Violation|2|||
170683368|NCT00143403|616851587|FG000|Overall Study|specified by site|4|||
170683369|NCT00143403|616851588|FG001|Overall Study|specified by site|9|||
170683370|NCT00143403|616851587|FG000|Overall Study|Randomized Not Treated|7|||
170683371|NCT00143403|616851588|FG001|Overall Study|Randomized Not Treated|8|||
170683372|NCT00514540|616851589|FG000|First-Line Chemo|Withdrawal by Subject|1|||
170683373|NCT00514540|616851589|FG000|First-Line Chemo|Protocol Violation|7|||
170683374|NCT00514540|616851589|FG000|Second-Line|Physician/Patient Decision|31|||
170683375|NCT00587639|616851590|FG000|Overall Study|Withdrawal by Subject|1|||
170683376|NCT01996982|616851591|FG000|Overall Study|PI/team left institution|7|||
170683377|NCT00660309|616851612|FG000|Overall Study|Adverse Event|2|||
170683378|NCT00660309|616851613|FG001|Overall Study|Adverse Event|0|||
170683379|NCT00660309|616851612|FG000|Overall Study|Withdrawal by Subject|0|||
170683380|NCT00660309|616851613|FG001|Overall Study|Withdrawal by Subject|3|||
170683381|NCT01442675|616851614|FG000|Overall Study|Protocol Violation|6|||
170683382|NCT01442675|616851614|FG000|Overall Study|Lost to Follow-up|2|||
170683383|NCT01442675|616851614|FG000|Overall Study|Withdrawal by Subject|4|||
170683384|NCT00005937|616851617|FG000|Overall Study|Lack of Efficacy|5|||
170683385|NCT01288469|616851618|FG000|Overall Study|Adverse Event|4|||
170683386|NCT01288469|616851619|FG001|Overall Study|Adverse Event|1|||
170683387|NCT01288469|616851620|FG002|Overall Study|Adverse Event|1|||
170683388|NCT01288469|616851618|FG000|Overall Study|Poor compliance to protocol|0|||
170683389|NCT01288469|616851619|FG001|Overall Study|Poor compliance to protocol|1|||
170683390|NCT01288469|616851620|FG002|Overall Study|Poor compliance to protocol|0|||
170683391|NCT01288469|616851618|FG000|Overall Study|Participant Moved|1|||
170683392|NCT01288469|616851619|FG001|Overall Study|Participant Moved|0|||
170683393|NCT01288469|616851620|FG002|Overall Study|Participant Moved|0|||
170683394|NCT01288469|616851618|FG000|Overall Study|Consent withdrawn by subject|1|||
170683395|NCT01288469|616851619|FG001|Overall Study|Consent withdrawn by subject|1|||
170683396|NCT01288469|616851620|FG002|Overall Study|Consent withdrawn by subject|1|||
170683397|NCT01288469|616851618|FG000|Overall Study|Exclusion criteria finally met|1|||
170683398|NCT01288469|616851619|FG001|Overall Study|Exclusion criteria finally met|0|||
170683399|NCT01288469|616851620|FG002|Overall Study|Exclusion criteria finally met|0|||
170683400|NCT02407704|616851627|FG000|Overall Study|Lost to Follow-up|0|||
170683401|NCT02407704|616851628|FG001|Overall Study|Lost to Follow-up|0|||
170683402|NCT02407704|616851629|FG002|Overall Study|Lost to Follow-up|0|||
170683403|NCT02407704|616851630|FG003|Overall Study|Lost to Follow-up|2|||
170683404|NCT02407704|616851627|FG000|Overall Study|Protocol Violation|0|||
170683405|NCT02407704|616851628|FG001|Overall Study|Protocol Violation|0|||
170683406|NCT02407704|616851629|FG002|Overall Study|Protocol Violation|0|||
170683407|NCT02407704|616851630|FG003|Overall Study|Protocol Violation|1|||
170683408|NCT02407704|616851627|FG000|Overall Study|Withdrawal by Subject|0|||
170683409|NCT02407704|616851628|FG001|Overall Study|Withdrawal by Subject|0|||
170683410|NCT02407704|616851629|FG002|Overall Study|Withdrawal by Subject|1|||
170683411|NCT02407704|616851630|FG003|Overall Study|Withdrawal by Subject|0|||
170683412|NCT01957644|616851631|FG000|Overall Study|Adverse Event|4|||
170683413|NCT01957644|616851632|FG001|Overall Study|Adverse Event|2|||
170683414|NCT01957644|616851633|FG002|Overall Study|Adverse Event|0|||
170683415|NCT01957644|616851634|FG003|Overall Study|Adverse Event|0|||
170683416|NCT01957644|616851635|FG004|Overall Study|Adverse Event|1|||
170683417|NCT01957644|616851631|FG000|Overall Study|Progressive disease / relapse|0|||
170683418|NCT01957644|616851632|FG001|Overall Study|Progressive disease / relapse|1|||
170683419|NCT01957644|616851633|FG002|Overall Study|Progressive disease / relapse|0|||
170683420|NCT01957644|616851634|FG003|Overall Study|Progressive disease / relapse|1|||
170683421|NCT01957644|616851635|FG004|Overall Study|Progressive disease / relapse|0|||
170683422|NCT01957644|616851631|FG000|Overall Study|Other reason|1|||
170683423|NCT01957644|616851632|FG001|Overall Study|Other reason|2|||
170683424|NCT01957644|616851633|FG002|Overall Study|Other reason|1|||
170683425|NCT01957644|616851634|FG003|Overall Study|Other reason|1|||
170683426|NCT01957644|616851635|FG004|Overall Study|Other reason|0|||
170683427|NCT01957644|616851631|FG000|Overall Study|Withdrawal by Subject|1|||
170683428|NCT01957644|616851632|FG001|Overall Study|Withdrawal by Subject|0|||
170683429|NCT01957644|616851633|FG002|Overall Study|Withdrawal by Subject|0|||
170683430|NCT01957644|616851634|FG003|Overall Study|Withdrawal by Subject|0|||
170683431|NCT01957644|616851635|FG004|Overall Study|Withdrawal by Subject|0|||
170683432|NCT01957644|616851631|FG000|Overall Study|Protocol Violation|0|||
170683433|NCT01957644|616851632|FG001|Overall Study|Protocol Violation|1|||
170683434|NCT01957644|616851633|FG002|Overall Study|Protocol Violation|0|||
170683435|NCT01957644|616851634|FG003|Overall Study|Protocol Violation|0|||
170683436|NCT01957644|616851635|FG004|Overall Study|Protocol Violation|0|||
170683437|NCT01957553|616851636|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
170683438|NCT01957553|616851637|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
170683439|NCT01957553|616851636|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
170683440|NCT01957553|616851637|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
170683441|NCT01957553|616851636|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
170683442|NCT01957553|616851637|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
170683443|NCT01957553|616851636|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
170683444|NCT01957553|616851637|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
170683445|NCT01957553|616851636|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
170683446|NCT01957553|616851637|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
170683447|NCT01957553|616851636|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
170683448|NCT01957553|616851637|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
170683449|NCT01957553|616851636|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
170683450|NCT01957553|616851637|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
170683451|NCT01957553|616851636|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
170683452|NCT01957553|616851637|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
170683453|NCT01957553|616851636|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
170683454|NCT01957553|616851637|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
170683455|NCT04044716|616851638|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
170683456|NCT04044716|616851639|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
170683457|NCT04044716|616851640|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
170683458|NCT04044716|616851638|FG000|Overall Study|Lost to Follow-up|2|||
170683459|NCT04044716|616851639|FG001|Overall Study|Lost to Follow-up|3|||
170683460|NCT04044716|616851640|FG002|Overall Study|Lost to Follow-up|0|||
170683461|NCT03235154|616851647|FG000|Overall Study|Withdrawal by Subject|1|||
170683462|NCT03235154|616851647|FG000|Overall Study|Adverse Event|1|||
170683463|NCT03235154|616851647|FG000|Overall Study|Lost to Follow-up|2|||
170683464|NCT02496611|616851648|FG000|Overall Study|Lost to Follow-up|2|||
170683465|NCT02496611|616851649|FG001|Overall Study|Lost to Follow-up|1|||
170683466|NCT02496611|616851648|FG000|Overall Study|Withdrawal by Subject|5|||
170683467|NCT02496611|616851649|FG001|Overall Study|Withdrawal by Subject|2|||
170683468|NCT01782222|616851652|FG000|Overall Study|Adverse Event|4|||
170683469|NCT01782222|616851653|FG001|Overall Study|Adverse Event|5|||
170683470|NCT01782222|616851654|FG002|Overall Study|Adverse Event|3|||
170683471|NCT01782222|616851652|FG000|Overall Study|Lack of Efficacy|2|||
170683472|NCT01782222|616851653|FG001|Overall Study|Lack of Efficacy|1|||
170683473|NCT01782222|616851654|FG002|Overall Study|Lack of Efficacy|0|||
170683474|NCT01782222|616851652|FG000|Overall Study|Protocol Violation|1|||
170683475|NCT01782222|616851653|FG001|Overall Study|Protocol Violation|0|||
170683476|NCT01782222|616851654|FG002|Overall Study|Protocol Violation|0|||
170683477|NCT01782222|616851652|FG000|Overall Study|Withdrawal by Subject|1|||
170683478|NCT01782222|616851653|FG001|Overall Study|Withdrawal by Subject|4|||
170683479|NCT01782222|616851654|FG002|Overall Study|Withdrawal by Subject|1|||
170683480|NCT01782222|616851652|FG000|Overall Study|Moved to other state|0|||
170683481|NCT01782222|616851653|FG001|Overall Study|Moved to other state|1|||
170683482|NCT01782222|616851654|FG002|Overall Study|Moved to other state|0|||
170683483|NCT01648205|616851656|FG000|Placebo|Pregnancy|1|||
170683484|NCT01648205|616851656|FG000|Placebo|Withdrawal by Subject|1|||
170683485|NCT01648205|616851656|FG000|Placebo|Protocol Violation|2|||
170683486|NCT01648205|616851656|FG000|Ranolazine|Death|1|||
170683487|NCT01648205|616851656|FG000|Ranolazine|Withdrawal by Subject|1|||
170683488|NCT01648205|616851656|FG000|Ranolazine|Protocol Violation|3|||
170683489|NCT00241280|616851658|FG000|Overall Study|Adverse Event|2|||
170683490|NCT00241280|616851659|FG001|Overall Study|Adverse Event|6|||
170683491|NCT00241280|616851658|FG000|Overall Study|Discomfort|11|||
170683492|NCT00241280|616851659|FG001|Overall Study|Discomfort|16|||
170683493|NCT00241280|616851658|FG000|Overall Study|Pregnancy|1|||
170683494|NCT00241280|616851659|FG001|Overall Study|Pregnancy|5|||
170683495|NCT00241280|616851658|FG000|Overall Study|Lost to Follow-up|5|||
170683496|NCT00241280|616851659|FG001|Overall Study|Lost to Follow-up|8|||
170683497|NCT00241280|616851658|FG000|Overall Study|Withdrawal by Subject|7|||
170683498|NCT00241280|616851659|FG001|Overall Study|Withdrawal by Subject|4|||
170683499|NCT00241280|616851658|FG000|Overall Study|Protocol Violation|4|||
170683500|NCT00241280|616851659|FG001|Overall Study|Protocol Violation|10|||
170683501|NCT00241280|616851658|FG000|Overall Study|Relocation|4|||
170683502|NCT00241280|616851659|FG001|Overall Study|Relocation|4|||
170683503|NCT00241280|616851658|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
170683504|NCT00241280|616851659|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
170683505|NCT00241280|616851658|FG000|Overall Study|Unsatisfactory Visual Response|1|||
170683506|NCT00241280|616851659|FG001|Overall Study|Unsatisfactory Visual Response|1|||
170683507|NCT00241280|616851658|FG000|Overall Study|Diabetic|1|||
170683508|NCT00241280|616851659|FG001|Overall Study|Diabetic|0|||
170683509|NCT00241280|616851658|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
170683510|NCT00241280|616851659|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
170683511|NCT00241280|616851658|FG000|Overall Study|Dispensed incorrect test article|1|||
170683512|NCT00241280|616851659|FG001|Overall Study|Dispensed incorrect test article|2|||
170683513|NCT00241280|616851658|FG000|Overall Study|Unacceptable Fit|0|||
170683514|NCT00241280|616851659|FG001|Overall Study|Unacceptable Fit|1|||
170683515|NCT00241280|616851658|FG000|Overall Study|Scheduling Conflict|0|||
170683516|NCT00241280|616851659|FG001|Overall Study|Scheduling Conflict|2|||
170683517|NCT00241280|616851658|FG000|Overall Study|History of Ocular Surgery|0|||
170683518|NCT00241280|616851659|FG001|Overall Study|History of Ocular Surgery|1|||
170683519|NCT00241280|616851658|FG000|Overall Study|Coating on Lens|1|||
170683520|NCT00241280|616851659|FG001|Overall Study|Coating on Lens|0|||
170683521|NCT00241280|616851658|FG000|Overall Study|Excessive Dryness|0|||
170683522|NCT00241280|616851659|FG001|Overall Study|Excessive Dryness|1|||
170683523|NCT01774968|616851662|FG000|Overall Study|Adverse Event|4|||
170683524|NCT01774968|616851663|FG001|Overall Study|Adverse Event|4|||
170683525|NCT01774968|616851662|FG000|Overall Study|Death|0|||
170683526|NCT01774968|616851663|FG001|Overall Study|Death|1|||
170683527|NCT01774968|616851662|FG000|Overall Study|Lost to Follow-up|1|||
170683528|NCT01774968|616851663|FG001|Overall Study|Lost to Follow-up|3|||
170683529|NCT01774968|616851662|FG000|Overall Study|Physician Decision|5|||
170683530|NCT01774968|616851663|FG001|Overall Study|Physician Decision|1|||
170683531|NCT01774968|616851662|FG000|Overall Study|Protocol Violation|14|||
170683532|NCT01774968|616851663|FG001|Overall Study|Protocol Violation|13|||
170683533|NCT01774968|616851662|FG000|Overall Study|Sponsor Decision|0|||
170683534|NCT01774968|616851663|FG001|Overall Study|Sponsor Decision|2|||
170683535|NCT01774968|616851662|FG000|Overall Study|Withdrawal by Subject|6|||
170683536|NCT01774968|616851663|FG001|Overall Study|Withdrawal by Subject|11|||
170683537|NCT01853826|616853814|FG000|Overall Study|Patients who switched to commercial drug|11|||
170683538|NCT01853826|616853814|FG000|Overall Study|Patient refused to continue medication|21|||
170683539|NCT01853826|616853814|FG000|Overall Study|Lost to Follow-up|2|||
170683540|NCT01853826|616853814|FG000|Overall Study|Non-compliant with protocol|4|||
170683541|NCT01853826|616853814|FG000|Overall Study|Other adverse events (AE)|62|||
170683542|NCT01853826|616853814|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
170683543|NCT01853826|616853814|FG000|Overall Study|Progressive disease|342|||
170683544|NCT01853826|616853814|FG000|Overall Study|Other than listed|13|||
170683545|NCT01853826|616853814|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
170683546|NCT00733408|616853816|FG000|Overall Study|Adverse Event|4|||
170683547|NCT04232124|616853818|FG000|Overall Study|Lost to Follow-up|3|||
170683548|NCT02392247|616853825|FG000|Overall Study|Withdrawal by Subject|1|||
170683549|NCT02392247|616853825|FG000|Overall Study|Surgery cancelled; no data|1|||
170683550|NCT04779489|616853827|FG000|Overall Study|Physician Decision|1|||
170683551|NCT00951665|616853828|FG000|Phase 1b|Adverse Event|2|||
170683552|NCT00951665|616853829|FG001|Phase 1b|Adverse Event|1|||
170683553|NCT00951665|616853830|FG002|Phase 1b|Adverse Event|0|||
170683554|NCT00951665|616853831|FG003|Phase 1b|Adverse Event|1|||
170683555|NCT00951665|616853832|FG004|Phase 1b|Adverse Event|0|||
170683556|NCT00951665|616853833|FG005|Phase 1b|Adverse Event|0|||
170683557|NCT00951665|616853828|FG000|Phase 1b|Death|1|||
170683558|NCT00951665|616853829|FG001|Phase 1b|Death|0|||
170683559|NCT00951665|616853830|FG002|Phase 1b|Death|2|||
170683560|NCT00951665|616853831|FG003|Phase 1b|Death|0|||
170683561|NCT00951665|616853832|FG004|Phase 1b|Death|0|||
170683562|NCT00951665|616853833|FG005|Phase 1b|Death|0|||
170683563|NCT00951665|616853828|FG000|Phase 1b|Physician Decision|4|||
170683564|NCT00951665|616853829|FG001|Phase 1b|Physician Decision|0|||
170683565|NCT00951665|616853830|FG002|Phase 1b|Physician Decision|1|||
170683566|NCT00951665|616853831|FG003|Phase 1b|Physician Decision|0|||
170683567|NCT00951665|616853832|FG004|Phase 1b|Physician Decision|0|||
170683568|NCT00951665|616853833|FG005|Phase 1b|Physician Decision|0|||
170683569|NCT00951665|616853828|FG000|Phase 1b|Withdrawal by Subject|0|||
170683570|NCT00951665|616853829|FG001|Phase 1b|Withdrawal by Subject|1|||
170683571|NCT00951665|616853830|FG002|Phase 1b|Withdrawal by Subject|0|||
170683572|NCT00951665|616853831|FG003|Phase 1b|Withdrawal by Subject|0|||
170683573|NCT00951665|616853832|FG004|Phase 1b|Withdrawal by Subject|0|||
170683574|NCT00951665|616853833|FG005|Phase 1b|Withdrawal by Subject|0|||
170683575|NCT00951665|616853828|FG000|Phase 1b|Disease Progression|13|||
170683576|NCT00951665|616853829|FG001|Phase 1b|Disease Progression|2|||
170683577|NCT00951665|616853830|FG002|Phase 1b|Disease Progression|14|||
170683578|NCT00951665|616853831|FG003|Phase 1b|Disease Progression|0|||
170683579|NCT00951665|616853832|FG004|Phase 1b|Disease Progression|0|||
170683580|NCT00951665|616853833|FG005|Phase 1b|Disease Progression|0|||
170683581|NCT00951665|616853828|FG000|Phase 1b|Protocol Violation|2|||
170683582|NCT00951665|616853829|FG001|Phase 1b|Protocol Violation|0|||
170683583|NCT00951665|616853830|FG002|Phase 1b|Protocol Violation|0|||
170683584|NCT00951665|616853831|FG003|Phase 1b|Protocol Violation|0|||
170683585|NCT00951665|616853832|FG004|Phase 1b|Protocol Violation|0|||
170683586|NCT00951665|616853833|FG005|Phase 1b|Protocol Violation|0|||
170683587|NCT00951665|616853828|FG000|Phase 2a|Adverse Event|0|||
170683588|NCT00951665|616853829|FG001|Phase 2a|Adverse Event|0|||
170683589|NCT00951665|616853830|FG002|Phase 2a|Adverse Event|0|||
170683590|NCT00951665|616853831|FG003|Phase 2a|Adverse Event|0|||
170683591|NCT00951665|616853832|FG004|Phase 2a|Adverse Event|2|||
170683592|NCT00951665|616853833|FG005|Phase 2a|Adverse Event|0|||
170683593|NCT00951665|616853828|FG000|Phase 2a|Death|0|||
170683594|NCT00951665|616853829|FG001|Phase 2a|Death|0|||
170683595|NCT00951665|616853830|FG002|Phase 2a|Death|0|||
170683596|NCT00951665|616853831|FG003|Phase 2a|Death|0|||
170683597|NCT00951665|616853832|FG004|Phase 2a|Death|1|||
170683598|NCT00951665|616853833|FG005|Phase 2a|Death|1|||
170683599|NCT00951665|616853828|FG000|Phase 2a|Lost to Follow-up|0|||
170683600|NCT00951665|616853829|FG001|Phase 2a|Lost to Follow-up|0|||
170683601|NCT00951665|616853830|FG002|Phase 2a|Lost to Follow-up|0|||
170683602|NCT00951665|616853831|FG003|Phase 2a|Lost to Follow-up|0|||
170683603|NCT00951665|616853832|FG004|Phase 2a|Lost to Follow-up|1|||
170683604|NCT00951665|616853833|FG005|Phase 2a|Lost to Follow-up|0|||
170683605|NCT00951665|616853828|FG000|Phase 2a|Physician Decision|0|||
170683606|NCT00951665|616853829|FG001|Phase 2a|Physician Decision|0|||
170683607|NCT00951665|616853830|FG002|Phase 2a|Physician Decision|0|||
170683608|NCT00951665|616853831|FG003|Phase 2a|Physician Decision|0|||
170683609|NCT00951665|616853832|FG004|Phase 2a|Physician Decision|0|||
170683610|NCT00951665|616853833|FG005|Phase 2a|Physician Decision|1|||
170683611|NCT00951665|616853828|FG000|Phase 2a|Withdrawal by Subject|0|||
170683612|NCT00951665|616853829|FG001|Phase 2a|Withdrawal by Subject|0|||
170683613|NCT00951665|616853830|FG002|Phase 2a|Withdrawal by Subject|0|||
170683614|NCT00951665|616853831|FG003|Phase 2a|Withdrawal by Subject|0|||
170683615|NCT00951665|616853832|FG004|Phase 2a|Withdrawal by Subject|2|||
170683616|NCT00951665|616853833|FG005|Phase 2a|Withdrawal by Subject|0|||
170683617|NCT00951665|616853828|FG000|Phase 2a|Disease Progression|0|||
170683618|NCT00951665|616853829|FG001|Phase 2a|Disease Progression|0|||
170683619|NCT00951665|616853830|FG002|Phase 2a|Disease Progression|0|||
170683620|NCT00951665|616853831|FG003|Phase 2a|Disease Progression|0|||
170683621|NCT00951665|616853832|FG004|Phase 2a|Disease Progression|6|||
170683622|NCT00951665|616853833|FG005|Phase 2a|Disease Progression|5|||
170683623|NCT02068443|616853834|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
170683624|NCT02068443|616853835|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
170683625|NCT02068443|616853836|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
170683626|NCT02068443|616853834|FG000|Overall Study|Voluntary Withdrawal|4|||
170683627|NCT02068443|616853835|FG001|Overall Study|Voluntary Withdrawal|0|||
170683628|NCT02068443|616853836|FG002|Overall Study|Voluntary Withdrawal|1|||
170683629|NCT02068443|616853834|FG000|Overall Study|Lack of Efficacy|2|||
170683630|NCT02068443|616853835|FG001|Overall Study|Lack of Efficacy|1|||
170683631|NCT02068443|616853836|FG002|Overall Study|Lack of Efficacy|0|||
170683632|NCT02068443|616853834|FG000|Overall Study|Other Reason Not Specified|1|||
170683633|NCT02068443|616853835|FG001|Overall Study|Other Reason Not Specified|0|||
170683634|NCT02068443|616853836|FG002|Overall Study|Other Reason Not Specified|0|||
170683635|NCT02723084|616853838|FG000|Overall Study|Withdrawal by Subject|1|||
170683636|NCT02723084|616853839|FG001|Overall Study|Withdrawal by Subject|1|||
170683637|NCT02723084|616853838|FG000|Overall Study|Lost to Follow-up|3|||
170683638|NCT02723084|616853839|FG001|Overall Study|Lost to Follow-up|0|||
170683639|NCT05126901|616853844|FG000|Overall Study|Withdrawal by Subject|1|||
170683640|NCT05126901|616853845|FG001|Overall Study|Withdrawal by Subject|1|||
170683641|NCT05126901|616853846|FG002|Overall Study|Withdrawal by Subject|4|||
170683642|NCT05126901|616853844|FG000|Overall Study|Adverse Event|0|||
170683643|NCT05126901|616853845|FG001|Overall Study|Adverse Event|0|||
170683644|NCT05126901|616853846|FG002|Overall Study|Adverse Event|1|||
170683645|NCT05126901|616853844|FG000|Overall Study|Lost to Follow-up|0|||
170683646|NCT05126901|616853845|FG001|Overall Study|Lost to Follow-up|2|||
170683647|NCT05126901|616853846|FG002|Overall Study|Lost to Follow-up|0|||
170683648|NCT02282020|616853847|FG000|Overall Study|Objective Disease Progression|128|||
170683649|NCT02282020|616853848|FG001|Overall Study|Objective Disease Progression|30|||
170683650|NCT02282020|616853847|FG000|Overall Study|Adverse Event|18|||
170683651|NCT02282020|616853848|FG001|Overall Study|Adverse Event|15|||
170683652|NCT02282020|616853847|FG000|Overall Study|Withdrawal by Subject|7|||
170683653|NCT02282020|616853848|FG001|Overall Study|Withdrawal by Subject|10|||
170683654|NCT02282020|616853847|FG000|Overall Study|Miscellaneous|5|||
170683655|NCT02282020|616853848|FG001|Overall Study|Miscellaneous|19|||
170683656|NCT02282020|616853847|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
170683657|NCT02282020|616853848|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
170683658|NCT02282020|616853847|FG000|Overall Study|Developed Discontinuation Criteria|0|||
170683659|NCT02282020|616853848|FG001|Overall Study|Developed Discontinuation Criteria|2|||
170683660|NCT02282020|616853847|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
170683661|NCT02282020|616853848|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
170683662|NCT02618434|616853849|FG000|Overall Study|Withdrawal by Subject|0|||
170683663|NCT02618434|616853850|FG001|Overall Study|Withdrawal by Subject|2|||
170683664|NCT02618434|616853851|FG002|Overall Study|Withdrawal by Subject|3|||
170683665|NCT02618434|616853849|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
170683666|NCT02618434|616853850|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
170683667|NCT02618434|616853851|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
170683668|NCT02618434|616853849|FG000|Overall Study|Lost to Follow-up|3|||
170683669|NCT02618434|616853850|FG001|Overall Study|Lost to Follow-up|1|||
170683670|NCT02618434|616853851|FG002|Overall Study|Lost to Follow-up|3|||
170683671|NCT02618434|616853849|FG000|Overall Study|Adverse Event|1|||
170683672|NCT02618434|616853850|FG001|Overall Study|Adverse Event|0|||
170683673|NCT02618434|616853851|FG002|Overall Study|Adverse Event|12|||
170683674|NCT02618434|616853849|FG000|Overall Study|Physician Decision|0|||
170683675|NCT02618434|616853850|FG001|Overall Study|Physician Decision|1|||
170683676|NCT02618434|616853851|FG002|Overall Study|Physician Decision|0|||
170683677|NCT02618434|616853849|FG000|Overall Study|Protocol Violation|0|||
170683678|NCT02618434|616853850|FG001|Overall Study|Protocol Violation|0|||
170683679|NCT02618434|616853851|FG002|Overall Study|Protocol Violation|1|||
170683680|NCT02618434|616853849|FG000|Overall Study|Other, Multiple categories|1|||
170683681|NCT02618434|616853850|FG001|Overall Study|Other, Multiple categories|1|||
170683682|NCT02618434|616853851|FG002|Overall Study|Other, Multiple categories|1|||
170683683|NCT05492942|616853854|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
170683684|NCT05492942|616853855|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
170683685|NCT05492942|616853856|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
170683686|NCT05492942|616853857|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
170683687|NCT02506153|616853861|FG000|Overall Study|Adverse Event|359|||
170683688|NCT02506153|616853862|FG001|Overall Study|Adverse Event|114|||
170683689|NCT02506153|616853861|FG000|Overall Study|Refused unrelated to adverse event|127|||
170683690|NCT02506153|616853862|FG001|Overall Study|Refused unrelated to adverse event|18|||
170683691|NCT02506153|616853861|FG000|Overall Study|Progression/relapse|91|||
170683692|NCT02506153|616853862|FG001|Overall Study|Progression/relapse|136|||
170683693|NCT02506153|616853861|FG000|Overall Study|Death|2|||
170683694|NCT02506153|616853862|FG001|Overall Study|Death|1|||
170683695|NCT02506153|616853861|FG000|Overall Study|Other - not protocol specified|23|||
170683696|NCT02506153|616853862|FG001|Overall Study|Other - not protocol specified|12|||
170683697|NCT00885105|616853863|FG000|Overall Study|Withdrawal by Subject|0|||
170683698|NCT00885105|616853864|FG001|Overall Study|Withdrawal by Subject|8|||
170683699|NCT00885105|616853863|FG000|Overall Study|Adverse Event|1|||
170683700|NCT00885105|616853864|FG001|Overall Study|Adverse Event|0|||
170683701|NCT00885105|616853863|FG000|Overall Study|Protocol Violation|0|||
170683702|NCT00885105|616853864|FG001|Overall Study|Protocol Violation|2|||
170683703|NCT02066233|616853867|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
170683704|NCT02066233|616853868|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
170683705|NCT02598076|616853869|FG000|Overall Study|Lost to Follow-up|2|||
170683706|NCT02598076|616853870|FG001|Overall Study|Lost to Follow-up|3|||
170683707|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Death|3|||
170683708|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Death|3|||
170683709|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Death|0|||
170683710|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Death|0|||
170683711|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
170683712|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
170683713|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
170683714|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
170683715|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
170683716|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
170683717|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
170683718|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
170683719|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
170683720|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
170683721|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
170683722|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
170683723|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
170683724|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
170683725|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
170683726|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
170683727|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
170683728|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
170683729|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
170683730|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
170683731|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
170683732|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
170683733|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
170683734|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
170683735|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Other|6|||
170683736|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Other|3|||
170683737|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Other|0|||
170683738|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Other|0|||
170683739|NCT02051608|616853871|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
170683740|NCT02051608|616853872|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
170683741|NCT02051608|616853873|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
170683742|NCT02051608|616853874|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
170683743|NCT02051608|616853871|FG000|Part 2: Open-label Extension|Adverse Event|0|||
170683744|NCT02051608|616853872|FG001|Part 2: Open-label Extension|Adverse Event|0|||
170683745|NCT02051608|616853873|FG002|Part 2: Open-label Extension|Adverse Event|6|||
170683746|NCT02051608|616853874|FG003|Part 2: Open-label Extension|Adverse Event|8|||
170683747|NCT02051608|616853871|FG000|Part 2: Open-label Extension|Death|0|||
170683748|NCT02051608|616853872|FG001|Part 2: Open-label Extension|Death|0|||
170683749|NCT02051608|616853873|FG002|Part 2: Open-label Extension|Death|7|||
170683750|NCT02051608|616853874|FG003|Part 2: Open-label Extension|Death|4|||
170683751|NCT02051608|616853871|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
170683752|NCT02051608|616853872|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
170683753|NCT02051608|616853873|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
170683754|NCT02051608|616853874|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
170683755|NCT02051608|616853871|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
170683756|NCT02051608|616853872|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
170683757|NCT02051608|616853873|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
170683758|NCT02051608|616853874|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
170683759|NCT02051608|616853871|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
170683760|NCT02051608|616853872|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
170683761|NCT02051608|616853873|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
170683762|NCT02051608|616853874|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
170683763|NCT02051608|616853871|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
170683764|NCT02051608|616853872|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
170683765|NCT02051608|616853873|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
170683766|NCT02051608|616853874|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
170683767|NCT02051608|616853871|FG000|Part 2: Open-label Extension|Physician Decision|0|||
170683768|NCT02051608|616853872|FG001|Part 2: Open-label Extension|Physician Decision|0|||
170683769|NCT02051608|616853873|FG002|Part 2: Open-label Extension|Physician Decision|8|||
170683770|NCT02051608|616853874|FG003|Part 2: Open-label Extension|Physician Decision|5|||
170683771|NCT02051608|616853871|FG000|Part 2: Open-label Extension|Other|0|||
170683772|NCT02051608|616853872|FG001|Part 2: Open-label Extension|Other|0|||
170683773|NCT02051608|616853873|FG002|Part 2: Open-label Extension|Other|9|||
170683774|NCT02051608|616853874|FG003|Part 2: Open-label Extension|Other|9|||
170683775|NCT00142584|616853875|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
170683776|NCT00142584|616853876|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
170683777|NCT00142584|616853875|FG000|Overall Study|Withdrawal by Subject|30|||
170683778|NCT00142584|616853876|FG001|Overall Study|Withdrawal by Subject|16|||
170683779|NCT00142584|616853875|FG000|Overall Study|Lost to Follow-up|22|||
170683780|NCT00142584|616853876|FG001|Overall Study|Lost to Follow-up|12|||
170683781|NCT00142584|616853875|FG000|Overall Study|Adverse Event|14|||
170683782|NCT00142584|616853876|FG001|Overall Study|Adverse Event|5|||
170683783|NCT00142584|616853875|FG000|Overall Study|Protocol Violation|4|||
170683784|NCT00142584|616853876|FG001|Overall Study|Protocol Violation|7|||
170683785|NCT00142584|616853875|FG000|Overall Study|Treatment Failure|2|||
170683786|NCT00142584|616853876|FG001|Overall Study|Treatment Failure|0|||
170683787|NCT03070782|616853877|FG000|Overall Study|Adverse Event|3|||
170683788|NCT03070782|616853878|FG001|Overall Study|Adverse Event|0|||
170683789|NCT03070782|616853879|FG002|Overall Study|Adverse Event|3|||
170683790|NCT03070782|616853880|FG003|Overall Study|Adverse Event|1|||
170683791|NCT03070782|616853881|FG004|Overall Study|Adverse Event|6|||
170683792|NCT03070782|616853882|FG005|Overall Study|Adverse Event|2|||
170683793|NCT03070782|616853877|FG000|Overall Study|Withdrawal by Subject|2|||
170683794|NCT03070782|616853878|FG001|Overall Study|Withdrawal by Subject|1|||
170683795|NCT03070782|616853879|FG002|Overall Study|Withdrawal by Subject|1|||
170683796|NCT03070782|616853880|FG003|Overall Study|Withdrawal by Subject|0|||
170683797|NCT03070782|616853881|FG004|Overall Study|Withdrawal by Subject|4|||
170683798|NCT03070782|616853882|FG005|Overall Study|Withdrawal by Subject|3|||
170683799|NCT03070782|616853877|FG000|Overall Study|Reason Not Specified|2|||
170683800|NCT03070782|616853878|FG001|Overall Study|Reason Not Specified|0|||
170683801|NCT03070782|616853879|FG002|Overall Study|Reason Not Specified|0|||
170683802|NCT03070782|616853880|FG003|Overall Study|Reason Not Specified|1|||
170683803|NCT03070782|616853881|FG004|Overall Study|Reason Not Specified|2|||
170683804|NCT03070782|616853882|FG005|Overall Study|Reason Not Specified|1|||
170683805|NCT03070782|616853877|FG000|Overall Study|Ineligibility|0|||
170683806|NCT03070782|616853878|FG001|Overall Study|Ineligibility|0|||
170683807|NCT03070782|616853879|FG002|Overall Study|Ineligibility|0|||
170683808|NCT03070782|616853880|FG003|Overall Study|Ineligibility|1|||
170683809|NCT03070782|616853881|FG004|Overall Study|Ineligibility|0|||
170683810|NCT03070782|616853882|FG005|Overall Study|Ineligibility|1|||
170683811|NCT03070782|616853877|FG000|Overall Study|Pregnancy|0|||
170683812|NCT03070782|616853878|FG001|Overall Study|Pregnancy|0|||
170683813|NCT03070782|616853879|FG002|Overall Study|Pregnancy|0|||
170683814|NCT03070782|616853880|FG003|Overall Study|Pregnancy|1|||
170683815|NCT03070782|616853881|FG004|Overall Study|Pregnancy|0|||
170683816|NCT03070782|616853882|FG005|Overall Study|Pregnancy|0|||
170683817|NCT03070782|616853877|FG000|Overall Study|Investigator Judgement|0|||
170683818|NCT03070782|616853878|FG001|Overall Study|Investigator Judgement|0|||
170683819|NCT03070782|616853879|FG002|Overall Study|Investigator Judgement|0|||
170683820|NCT03070782|616853880|FG003|Overall Study|Investigator Judgement|1|||
170683821|NCT03070782|616853881|FG004|Overall Study|Investigator Judgement|0|||
170683822|NCT03070782|616853882|FG005|Overall Study|Investigator Judgement|0|||
170683823|NCT01083576|616853885|FG000|Overall Study|Treatment Failure|6|||
170683824|NCT01083576|616853886|FG001|Overall Study|Treatment Failure|1|||
170683825|NCT03527966|616853887|FG000|Overall Study|Lost to Follow-up|3|||
170683826|NCT03527966|616853888|FG001|Overall Study|Lost to Follow-up|0|||
170683827|NCT01782859|616853890|FG000|Overall Study|Protocol Violation|6|||
170683828|NCT01782859|616853891|FG001|Overall Study|Protocol Violation|6|||
170683829|NCT01782859|616853890|FG000|Overall Study|Withdrawal by Subject|0|||
170683830|NCT01782859|616853891|FG001|Overall Study|Withdrawal by Subject|1|||
170683831|NCT00449540|616853892|FG000|Pretreatment Phase|No migraine experienced|66|||
170683832|NCT00449540|616853893|FG001|Pretreatment Phase|No migraine experienced|0|||
170683833|NCT00449540|616853894|FG002|Pretreatment Phase|No migraine experienced|0|||
170683834|NCT00449540|616853892|FG000|Treatment Phase|did not experience or treat migraine|0|||
170683835|NCT00449540|616853893|FG001|Treatment Phase|did not experience or treat migraine|20|||
170683836|NCT00449540|616853894|FG002|Treatment Phase|did not experience or treat migraine|17|||
170683837|NCT02709785|616853897|FG000|Overall Study|Withdrawal by Subject|1|||
170683838|NCT02709785|616853898|FG001|Overall Study|Withdrawal by Subject|2|||
170683839|NCT02709785|616853899|FG002|Overall Study|Withdrawal by Subject|1|||
170683840|NCT04577118|616853900|FG000|Overall Study|Withdrawal by Subject|4|||
170683841|NCT01961323|616853901|FG000|Overall Study|Withdrawal by Subject|7|||
170683842|NCT01961323|616853901|FG000|Overall Study|Lost to Follow-up|8|||
170683843|NCT01961323|616853901|FG000|Overall Study|screen failure|34|||
170683844|NCT00810407|616853902|FG000|Overall Study|Protocol Violation|3|||
170683845|NCT00810407|616853902|FG000|Overall Study|No Visit After First Day of Treatment|3|||
170683846|NCT02320149|616853906|FG000|Overall Study|Adverse Event|3|||
170683847|NCT02320149|616853907|FG001|Overall Study|Adverse Event|7|||
170683848|NCT02320149|616853906|FG000|Overall Study|Withdrawal of Consent|28|||
170683849|NCT02320149|616853907|FG001|Overall Study|Withdrawal of Consent|32|||
170683850|NCT02320149|616853906|FG000|Overall Study|Lost to Follow-up|21|||
170683851|NCT02320149|616853907|FG001|Overall Study|Lost to Follow-up|34|||
170683852|NCT02320149|616853906|FG000|Overall Study|Protocol Violation|2|||
170683853|NCT02320149|616853907|FG001|Overall Study|Protocol Violation|1|||
170683854|NCT02320149|616853906|FG000|Overall Study|Noncompliance with Study Treatment|7|||
170683855|NCT02320149|616853907|FG001|Overall Study|Noncompliance with Study Treatment|2|||
170683856|NCT02320149|616853906|FG000|Overall Study|Lack of Efficacy|0|||
170683857|NCT02320149|616853907|FG001|Overall Study|Lack of Efficacy|1|||
170683858|NCT02320149|616853906|FG000|Overall Study|Other Miscellaneous Reasons|2|||
170683859|NCT02320149|616853907|FG001|Overall Study|Other Miscellaneous Reasons|3|||
170683860|NCT00022633|616853908|FG000|Overall Study|Adverse Event|11|||
170683861|NCT00022633|616853909|FG001|Overall Study|Adverse Event|1|||
170683862|NCT00022633|616853908|FG000|Overall Study|Refusal unrelated to adverse event|1|||
170683863|NCT00022633|616853909|FG001|Overall Study|Refusal unrelated to adverse event|0|||
170683864|NCT00022633|616853908|FG000|Overall Study|Progression/relapse|9|||
170683865|NCT00022633|616853909|FG001|Overall Study|Progression/relapse|2|||
170683866|NCT00022633|616853908|FG000|Overall Study|Death|4|||
170683867|NCT00022633|616853909|FG001|Overall Study|Death|0|||
170683868|NCT00022633|616853908|FG000|Overall Study|Other - not protocol specified|3|||
170683869|NCT00022633|616853909|FG001|Overall Study|Other - not protocol specified|2|||
170683870|NCT00022633|616853908|FG000|Overall Study|Ineligible|4|||
170683871|NCT00022633|616853909|FG001|Overall Study|Ineligible|0|||
170683872|NCT01195415|616853926|FG000|Overall Study|No repeat biopsy due to progression|2|||
170683873|NCT00533845|616853927|FG000|Overall Study|Physician Decision|1|||
170683874|NCT00533845|616853928|FG001|Overall Study|Physician Decision|0|||
170683875|NCT04997161|616853929|FG000|Overall Study|Study terminated by sponsor|3|||
170683876|NCT01919723|616853930|FG000|Overall Study|Blood Samples Hemolyzed|2|||
170683877|NCT01919723|616853931|FG001|Overall Study|Blood Samples Hemolyzed|2|||
170683878|NCT04502589|616853932|FG000|Overall Study|Physician Decision|1|||
170683879|NCT04502589|616853933|FG001|Overall Study|Physician Decision|0|||
170683880|NCT00555321|616853935|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
170683881|NCT00555321|616853936|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
170683882|NCT00555321|616853937|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
170683883|NCT00555321|616853938|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
170683884|NCT00555321|616853939|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
170683885|NCT00555321|616853935|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
170683886|NCT00555321|616853936|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
170683887|NCT00555321|616853937|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
170683888|NCT00555321|616853938|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
170683889|NCT00555321|616853939|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
170683890|NCT00555321|616853935|FG000|Treatment Phase up to 12-months|Death|2|||
170683891|NCT00555321|616853936|FG001|Treatment Phase up to 12-months|Death|1|||
170683892|NCT00555321|616853937|FG002|Treatment Phase up to 12-months|Death|4|||
170683893|NCT00555321|616853938|FG003|Treatment Phase up to 12-months|Death|0|||
170683894|NCT00555321|616853939|FG004|Treatment Phase up to 12-months|Death|0|||
170683895|NCT00555321|616853935|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
170683896|NCT00555321|616853936|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
170683897|NCT00555321|616853937|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
170683898|NCT00555321|616853938|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
170683899|NCT00555321|616853939|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
170683900|NCT00555321|616853935|FG000|Treatment Phase up to 12-months|Other Reason|1|||
170683901|NCT00555321|616853936|FG001|Treatment Phase up to 12-months|Other Reason|3|||
170683902|NCT00555321|616853937|FG002|Treatment Phase up to 12-months|Other Reason|2|||
170683903|NCT00555321|616853938|FG003|Treatment Phase up to 12-months|Other Reason|0|||
170683904|NCT00555321|616853939|FG004|Treatment Phase up to 12-months|Other Reason|0|||
170683905|NCT00555321|616853935|FG000|Treatment Phase up to 12-months|Never treated|2|||
170683906|NCT00555321|616853936|FG001|Treatment Phase up to 12-months|Never treated|3|||
170683907|NCT00555321|616853937|FG002|Treatment Phase up to 12-months|Never treated|1|||
170683908|NCT00555321|616853938|FG003|Treatment Phase up to 12-months|Never treated|0|||
170683909|NCT00555321|616853939|FG004|Treatment Phase up to 12-months|Never treated|4|||
170683910|NCT00555321|616853935|FG000|Long-term Extension Phase|Adverse Event|2|||
170683911|NCT00555321|616853936|FG001|Long-term Extension Phase|Adverse Event|5|||
170683912|NCT00555321|616853937|FG002|Long-term Extension Phase|Adverse Event|2|||
170683913|NCT00555321|616853938|FG003|Long-term Extension Phase|Adverse Event|1|||
170683914|NCT00555321|616853939|FG004|Long-term Extension Phase|Adverse Event|0|||
170683915|NCT00555321|616853935|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
170683916|NCT00555321|616853936|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
170683917|NCT00555321|616853937|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
170683918|NCT00555321|616853938|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
170683919|NCT00555321|616853939|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
170683920|NCT00555321|616853935|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
170683921|NCT00555321|616853936|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
170683922|NCT00555321|616853937|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
170683923|NCT00555321|616853938|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
170683924|NCT00555321|616853939|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
170683925|NCT00555321|616853935|FG000|Long-term Extension Phase|Death|2|||
170683926|NCT00555321|616853936|FG001|Long-term Extension Phase|Death|0|||
170683927|NCT00555321|616853937|FG002|Long-term Extension Phase|Death|0|||
170683928|NCT00555321|616853938|FG003|Long-term Extension Phase|Death|3|||
170683929|NCT00555321|616853939|FG004|Long-term Extension Phase|Death|0|||
170683930|NCT00555321|616853935|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
170683931|NCT00555321|616853936|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
170683932|NCT00555321|616853937|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
170683933|NCT00555321|616853938|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
170683934|NCT00555321|616853939|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
170683935|NCT00555321|616853935|FG000|Long-term Extension Phase|Other Reason|1|||
170683936|NCT00555321|616853936|FG001|Long-term Extension Phase|Other Reason|0|||
170683937|NCT00555321|616853937|FG002|Long-term Extension Phase|Other Reason|2|||
170683938|NCT00555321|616853938|FG003|Long-term Extension Phase|Other Reason|0|||
170683939|NCT00555321|616853939|FG004|Long-term Extension Phase|Other Reason|0|||
170683940|NCT00667368|616853940|FG000|Overall Study|Lost to Follow-up|176|||
170683941|NCT00667368|616853941|FG001|Overall Study|Lost to Follow-up|155|||
170683942|NCT00667368|616853940|FG000|Overall Study|Discontinued early|24|||
170683943|NCT00667368|616853941|FG001|Overall Study|Discontinued early|17|||
170683944|NCT03310775|616853949|FG000|Overall Study|Lost to Follow-up|2|||
170683945|NCT03310775|616853950|FG001|Overall Study|Lost to Follow-up|3|||
170683946|NCT03310775|616853949|FG000|Overall Study|aggravation of depression|0|||
170683947|NCT03310775|616853950|FG001|Overall Study|aggravation of depression|1|||
170683948|NCT02622321|616853951|FG000|Overall Study|Withdrawal by Subject|2|||
170683949|NCT02622321|616853952|FG001|Overall Study|Withdrawal by Subject|0|||
170683950|NCT02622321|616853953|FG002|Overall Study|Withdrawal by Subject|0|||
170683951|NCT02622321|616853954|FG003|Overall Study|Withdrawal by Subject|0|||
170683952|NCT02622321|616853951|FG000|Overall Study|Death|0|||
170683953|NCT02622321|616853952|FG001|Overall Study|Death|0|||
170683954|NCT02622321|616853953|FG002|Overall Study|Death|1|||
170683955|NCT02622321|616853954|FG003|Overall Study|Death|0|||
170683956|NCT02622321|616853951|FG000|Overall Study|Physician Decision|1|||
170683957|NCT02622321|616853952|FG001|Overall Study|Physician Decision|0|||
170683958|NCT02622321|616853953|FG002|Overall Study|Physician Decision|0|||
170683959|NCT02622321|616853954|FG003|Overall Study|Physician Decision|0|||
170683960|NCT02260921|616853962|FG000|Overall Study|Adverse Event|1|||
170683961|NCT02260921|616853963|FG001|Overall Study|Adverse Event|0|||
170683962|NCT02260921|616853962|FG000|Overall Study|Lost to Follow-up|4|||
170683963|NCT02260921|616853963|FG001|Overall Study|Lost to Follow-up|3|||
170683964|NCT02260921|616853962|FG000|Overall Study|Withdraw Consent|4|||
170683965|NCT02260921|616853963|FG001|Overall Study|Withdraw Consent|1|||
170683966|NCT02260921|616853962|FG000|Overall Study|Death|1|||
170683967|NCT02260921|616853963|FG001|Overall Study|Death|0|||
170683968|NCT02260921|616853962|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
170683969|NCT02260921|616853963|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
170683970|NCT03358290|616853969|FG000|Overall Study|Study discontinued by Sponsor|0|||
170683971|NCT03358290|616853970|FG001|Overall Study|Study discontinued by Sponsor|1|||
170683972|NCT03358290|616853971|FG002|Overall Study|Study discontinued by Sponsor|1|||
170683973|NCT03358290|616853972|FG003|Overall Study|Study discontinued by Sponsor|0|||
170683974|NCT03358290|616853973|FG004|Overall Study|Study discontinued by Sponsor|0|||
170683975|NCT03358290|616853969|FG000|Overall Study|Adverse Event|0|||
170683976|NCT03358290|616853970|FG001|Overall Study|Adverse Event|0|||
170683977|NCT03358290|616853971|FG002|Overall Study|Adverse Event|1|||
170683978|NCT03358290|616853972|FG003|Overall Study|Adverse Event|2|||
170683979|NCT03358290|616853973|FG004|Overall Study|Adverse Event|0|||
170683980|NCT03358290|616853969|FG000|Overall Study|Withdrawal by Subject|0|||
170683981|NCT03358290|616853970|FG001|Overall Study|Withdrawal by Subject|0|||
170683982|NCT03358290|616853971|FG002|Overall Study|Withdrawal by Subject|0|||
170683983|NCT03358290|616853972|FG003|Overall Study|Withdrawal by Subject|0|||
170683984|NCT03358290|616853973|FG004|Overall Study|Withdrawal by Subject|1|||
170683985|NCT02999854|616853974|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
170683986|NCT02999854|616853975|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
170683987|NCT02999854|616853974|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
170683988|NCT02999854|616853975|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
170683989|NCT02999854|616853974|FG000|Active Study Phase (up to 18 Months)|Death|7|||
170683990|NCT02999854|616853975|FG001|Active Study Phase (up to 18 Months)|Death|5|||
170683991|NCT02999854|616853974|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
170683992|NCT02999854|616853975|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
170683993|NCT02999854|616853974|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
170683994|NCT02999854|616853975|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
170683995|NCT02999854|616853974|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
170683996|NCT02999854|616853975|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
170683997|NCT02999854|616853974|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
170683998|NCT02999854|616853975|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
170683999|NCT02999854|616853974|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
170684000|NCT02999854|616853975|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
170684001|NCT03064451|616853976|FG000|Overall Study|Lost to Follow-up|1|||
170684002|NCT03064451|616853976|FG000|Overall Study|Mapping Failure|4|||
170684003|NCT03064451|616853976|FG000|Overall Study|Exited prior to procedure|8|||
170684004|NCT03064451|616853976|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
170684005|NCT01482884|616853977|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
170684006|NCT01482884|616853978|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
170684007|NCT01482884|616853977|FG000|Overall Study|Protocol Violation|1|||
170684008|NCT01482884|616853978|FG001|Overall Study|Protocol Violation|0|||
170684009|NCT01482884|616853977|FG000|Overall Study|Lost to Follow-up|2|||
170684010|NCT01482884|616853978|FG001|Overall Study|Lost to Follow-up|2|||
170684011|NCT01482884|616853977|FG000|Overall Study|Lack of Efficacy|0|||
170684012|NCT01482884|616853978|FG001|Overall Study|Lack of Efficacy|1|||
170684013|NCT01482884|616853977|FG000|Overall Study|Adverse Event|2|||
170684014|NCT01482884|616853978|FG001|Overall Study|Adverse Event|1|||
170684015|NCT01482884|616853977|FG000|Overall Study|Withdrawal by Subject|8|||
170684016|NCT01482884|616853978|FG001|Overall Study|Withdrawal by Subject|13|||
170684017|NCT04102020|616853979|FG000|Overall Study|Adverse Event|1|||
170684018|NCT04102020|616853980|FG001|Overall Study|Adverse Event|0|||
170684019|NCT04102020|616853981|FG002|Overall Study|Adverse Event|0|||
170684020|NCT04102020|616853982|FG003|Overall Study|Adverse Event|1|||
170684021|NCT04102020|616853983|FG004|Overall Study|Adverse Event|0|||
170684022|NCT04102020|616853979|FG000|Overall Study|Withdrawal by Subject|0|||
170684023|NCT04102020|616853980|FG001|Overall Study|Withdrawal by Subject|1|||
170684024|NCT04102020|616853981|FG002|Overall Study|Withdrawal by Subject|1|||
170684025|NCT04102020|616853982|FG003|Overall Study|Withdrawal by Subject|1|||
170684026|NCT04102020|616853983|FG004|Overall Study|Withdrawal by Subject|1|||
170684027|NCT04102020|616853979|FG000|Overall Study|Death|1|||
170684028|NCT04102020|616853980|FG001|Overall Study|Death|4|||
170684029|NCT04102020|616853981|FG002|Overall Study|Death|1|||
170684030|NCT04102020|616853982|FG003|Overall Study|Death|1|||
170684031|NCT04102020|616853983|FG004|Overall Study|Death|0|||
170684032|NCT04102020|616853979|FG000|Overall Study|Physician Decision|1|||
170684033|NCT04102020|616853980|FG001|Overall Study|Physician Decision|2|||
170684034|NCT04102020|616853981|FG002|Overall Study|Physician Decision|2|||
170684035|NCT04102020|616853982|FG003|Overall Study|Physician Decision|0|||
170684036|NCT04102020|616853983|FG004|Overall Study|Physician Decision|1|||
170684037|NCT04102020|616853979|FG000|Overall Study|COVID-19 Infection|1|||
170684038|NCT04102020|616853980|FG001|Overall Study|COVID-19 Infection|0|||
170684039|NCT04102020|616853981|FG002|Overall Study|COVID-19 Infection|0|||
170684040|NCT04102020|616853982|FG003|Overall Study|COVID-19 Infection|0|||
170684041|NCT04102020|616853983|FG004|Overall Study|COVID-19 Infection|0|||
170684042|NCT04102020|616853979|FG000|Overall Study|Not disclosed|5|||
170684043|NCT04102020|616853980|FG001|Overall Study|Not disclosed|3|||
170684044|NCT04102020|616853981|FG002|Overall Study|Not disclosed|8|||
170684045|NCT04102020|616853982|FG003|Overall Study|Not disclosed|0|||
170684046|NCT04102020|616853983|FG004|Overall Study|Not disclosed|1|||
170684047|NCT04102020|616853979|FG000|Overall Study|MIssing|1|||
170684048|NCT04102020|616853980|FG001|Overall Study|MIssing|0|||
170684049|NCT04102020|616853981|FG002|Overall Study|MIssing|1|||
170684050|NCT04102020|616853982|FG003|Overall Study|MIssing|1|||
170684051|NCT04102020|616853983|FG004|Overall Study|MIssing|1|||
170684052|NCT04102020|616853979|FG000|Overall Study|Continuing in ongoing study|13|||
170684053|NCT04102020|616853980|FG001|Overall Study|Continuing in ongoing study|13|||
170684054|NCT04102020|616853981|FG002|Overall Study|Continuing in ongoing study|7|||
170684055|NCT04102020|616853982|FG003|Overall Study|Continuing in ongoing study|26|||
170684056|NCT04102020|616853983|FG004|Overall Study|Continuing in ongoing study|12|||
170684057|NCT04853225|616853984|FG000|Overall Study|Withdrawal by Subject|81|||
170684058|NCT04853225|616853985|FG001|Overall Study|Withdrawal by Subject|4|||
170684059|NCT04853225|616853986|FG002|Overall Study|Withdrawal by Subject|1|||
170684060|NCT04853225|616853984|FG000|Overall Study|Physician Decision|12|||
170684061|NCT04853225|616853985|FG001|Overall Study|Physician Decision|4|||
170684062|NCT04853225|616853986|FG002|Overall Study|Physician Decision|1|||
170684063|NCT04853225|616853984|FG000|Overall Study|Lost to Follow-up|50|||
170684064|NCT04853225|616853985|FG001|Overall Study|Lost to Follow-up|0|||
170684065|NCT04853225|616853986|FG002|Overall Study|Lost to Follow-up|0|||
170684066|NCT04853225|616853984|FG000|Overall Study|Other|102|||
170684067|NCT04853225|616853985|FG001|Overall Study|Other|11|||
170684068|NCT04853225|616853986|FG002|Overall Study|Other|5|||
170684069|NCT04853225|616853984|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
170684070|NCT04853225|616853985|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
170684071|NCT04853225|616853986|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
170684072|NCT04853225|616853984|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
170684073|NCT04853225|616853985|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
170684074|NCT04853225|616853986|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
170684075|NCT03918447|616853987|FG000|Overall Study|Death|1|||
170684076|NCT03918447|616853988|FG001|Overall Study|Death|0|||
170684077|NCT03918447|616853987|FG000|Overall Study|Lost to Follow-up|13|||
170684078|NCT03918447|616853988|FG001|Overall Study|Lost to Follow-up|6|||
170684079|NCT03918447|616853987|FG000|Overall Study|Withdrawal by Subject|19|||
170684080|NCT03918447|616853988|FG001|Overall Study|Withdrawal by Subject|17|||
170684081|NCT03918447|616853987|FG000|Overall Study|Study Terminated by Sponsor|195|||
170684082|NCT03918447|616853988|FG001|Overall Study|Study Terminated by Sponsor|197|||
170684083|NCT03918447|616853987|FG000|Overall Study|Reason not Specified|0|||
170684084|NCT03918447|616853988|FG001|Overall Study|Reason not Specified|1|||
170684085|NCT00850564|616853989|FG000|Overall Study|Withdrawal by Subject|2|||
170684086|NCT00477971|616853990|FG000|Overall Study|Disease progression|6|||
170684087|NCT00477971|616853991|FG001|Overall Study|Disease progression|0|||
170684088|NCT00477971|616853990|FG000|Overall Study|Withdrawal by Subject|3|||
170684089|NCT00477971|616853991|FG001|Overall Study|Withdrawal by Subject|1|||
170684090|NCT00477971|616853990|FG000|Overall Study|Adverse Event|3|||
170684091|NCT00477971|616853991|FG001|Overall Study|Adverse Event|0|||
170684092|NCT00477971|616853990|FG000|Overall Study|Death|2|||
170684093|NCT00477971|616853991|FG001|Overall Study|Death|4|||
170684094|NCT00477971|616853990|FG000|Overall Study|Alternative treatment|3|||
170684095|NCT00477971|616853991|FG001|Overall Study|Alternative treatment|1|||
170684096|NCT02450903|616855396|FG000|Overall Study|Adverse Event|3|||
170684097|NCT02450903|616855396|FG000|Overall Study|Progressive disease|15|||
170684098|NCT02450903|616855396|FG000|Overall Study|Switched to commercial drug|1|||
170684099|NCT02450903|616855396|FG000|Overall Study|Subject/guardian decision|1|||
170684100|NCT04067544|616855397|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
170684101|NCT02425046|616855398|FG000|Overall Study|Lost to Follow-up|52|||
170684102|NCT02425046|616855399|FG001|Overall Study|Lost to Follow-up|50|||
170684103|NCT02425046|616855400|FG002|Overall Study|Lost to Follow-up|56|||
170684104|NCT02425046|616855398|FG000|Overall Study|Withdrawal by Subject|16|||
170684105|NCT02425046|616855399|FG001|Overall Study|Withdrawal by Subject|12|||
170684106|NCT02425046|616855400|FG002|Overall Study|Withdrawal by Subject|0|||
170684107|NCT01320085|616855401|FG000|Overall Study|Disease Progression|26|||
170684108|NCT01320085|616855402|FG001|Overall Study|Disease Progression|93|||
170684109|NCT01320085|616855403|FG002|Overall Study|Disease Progression|17|||
170684110|NCT01320085|616855401|FG000|Overall Study|Adverse Event|12|||
170684111|NCT01320085|616855402|FG001|Overall Study|Adverse Event|20|||
170684112|NCT01320085|616855403|FG002|Overall Study|Adverse Event|5|||
170684113|NCT01320085|616855401|FG000|Overall Study|Withdrawal by Subject|2|||
170684114|NCT01320085|616855402|FG001|Overall Study|Withdrawal by Subject|4|||
170684115|NCT01320085|616855403|FG002|Overall Study|Withdrawal by Subject|1|||
170684116|NCT01320085|616855401|FG000|Overall Study|Protocol Deviation|1|||
170684117|NCT01320085|616855402|FG001|Overall Study|Protocol Deviation|0|||
170684118|NCT01320085|616855403|FG002|Overall Study|Protocol Deviation|1|||
170684119|NCT01320085|616855401|FG000|Overall Study|Administrative problems|0|||
170684120|NCT01320085|616855402|FG001|Overall Study|Administrative problems|0|||
170684121|NCT01320085|616855403|FG002|Overall Study|Administrative problems|1|||
170684122|NCT01409564|616855406|FG000|Overall Study|low medication compliance|4|||
170684123|NCT01409564|616855407|FG001|Overall Study|low medication compliance|3|||
170684124|NCT01409564|616855406|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
170684125|NCT01409564|616855407|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
170684126|NCT00254540|616855408|FG000|Overall Study|Adverse Event|6|||
170684127|NCT00254540|616855409|FG001|Overall Study|Adverse Event|7|||
170684128|NCT00254540|616855408|FG000|Overall Study|Lack of Efficacy|13|||
170684129|NCT00254540|616855409|FG001|Overall Study|Lack of Efficacy|13|||
170684130|NCT00254540|616855408|FG000|Overall Study|Death|0|||
170684131|NCT00254540|616855409|FG001|Overall Study|Death|1|||
170684132|NCT00254540|616855408|FG000|Overall Study|Laboratory Test Abnormality|0|||
170684133|NCT00254540|616855409|FG001|Overall Study|Laboratory Test Abnormality|1|||
170684134|NCT00225251|616855410|FG000|Overall Study|Withdrawal by Subject|1|||
170684135|NCT00225251|616855411|FG001|Overall Study|Withdrawal by Subject|1|||
170684136|NCT02782780|616855412|FG000|Overall Study|dropped out after randomization.|7|||
170684137|NCT02782780|616855413|FG001|Overall Study|dropped out after randomization.|5|||
170684138|NCT02782780|616855412|FG000|Overall Study|Protocol Violation|0|||
170684139|NCT02782780|616855413|FG001|Overall Study|Protocol Violation|2|||
170684140|NCT01413191|616855414|FG000|Overall Study|Lost to Follow-up|5|||
170684141|NCT01413191|616855414|FG000|Overall Study|Disease Progression|5|||
170684142|NCT01413191|616855414|FG000|Overall Study|Death|1|||
170684143|NCT03654651|616855415|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
170684144|NCT03654651|616855416|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
170684145|NCT05040386|616855417|FG000|Overall Study|Withdrawal by Subject|1|||
170684146|NCT05040386|616855418|FG001|Overall Study|Withdrawal by Subject|0|||
170684147|NCT05040386|616855419|FG002|Overall Study|Withdrawal by Subject|1|||
170684148|NCT05040386|616855420|FG003|Overall Study|Withdrawal by Subject|0|||
170684149|NCT05040386|616855417|FG000|Overall Study|Lost to Follow-up|0|||
170684150|NCT05040386|616855418|FG001|Overall Study|Lost to Follow-up|0|||
170684151|NCT05040386|616855419|FG002|Overall Study|Lost to Follow-up|1|||
170684152|NCT05040386|616855420|FG003|Overall Study|Lost to Follow-up|0|||
170684153|NCT01702454|616855421|FG000|Overall Study|Consent withdrawal|0|||
170684154|NCT01702454|616855422|FG001|Overall Study|Consent withdrawal|1|||
170684155|NCT01702454|616855421|FG000|Overall Study|Migrated/moved from study area|0|||
170684156|NCT01702454|616855422|FG001|Overall Study|Migrated/moved from study area|1|||
170684157|NCT01702454|616855421|FG000|Overall Study|Lost to Follow-up|3|||
170684158|NCT01702454|616855422|FG001|Overall Study|Lost to Follow-up|6|||
170684159|NCT00710710|616855423|FG000|Overall Study|Consent withdrawn|2|||
170684160|NCT00710710|616855424|FG001|Overall Study|Consent withdrawn|2|||
170684161|NCT00710710|616855423|FG000|Overall Study|Protocol Violation|0|||
170684162|NCT00710710|616855424|FG001|Overall Study|Protocol Violation|1|||
170684163|NCT00710710|616855423|FG000|Overall Study|Adverse Event|3|||
170684164|NCT00710710|616855424|FG001|Overall Study|Adverse Event|3|||
170684165|NCT00710710|616855423|FG000|Overall Study|Progressive disease|40|||
170684166|NCT00710710|616855424|FG001|Overall Study|Progressive disease|38|||
170684167|NCT03045328|616855425|FG000|Overall Study|Withdrawal by Subject|2|||
170684168|NCT00715078|616855428|FG000|Overall Study|Death|29|||
170684169|NCT00715078|616855429|FG001|Overall Study|Death|36|||
170684170|NCT00715078|616855430|FG002|Overall Study|Death|36|||
170684171|NCT00715078|616855428|FG000|Overall Study|Withdrawal by Subject|1|||
170684172|NCT00715078|616855429|FG001|Overall Study|Withdrawal by Subject|0|||
170684173|NCT00715078|616855430|FG002|Overall Study|Withdrawal by Subject|1|||
170684174|NCT00715078|616855428|FG000|Overall Study|Unable to start due to disease prog.|0|||
170684175|NCT00715078|616855429|FG001|Overall Study|Unable to start due to disease prog.|0|||
170684176|NCT00715078|616855430|FG002|Overall Study|Unable to start due to disease prog.|1|||
170684177|NCT00592839|616855431|FG000|Overall Study|Withdrawal by Subject|1|||
170684178|NCT00592839|616855432|FG001|Overall Study|Withdrawal by Subject|1|||
170684179|NCT00592839|616855433|FG002|Overall Study|Withdrawal by Subject|3|||
170684180|NCT00592839|616855431|FG000|Overall Study|Protocol Violation|1|||
170684181|NCT00592839|616855432|FG001|Overall Study|Protocol Violation|1|||
170684182|NCT00592839|616855433|FG002|Overall Study|Protocol Violation|2|||
170684183|NCT00592839|616855431|FG000|Overall Study|Adverse Event|0|||
170684184|NCT00592839|616855432|FG001|Overall Study|Adverse Event|1|||
170684185|NCT00592839|616855433|FG002|Overall Study|Adverse Event|0|||
170684186|NCT00592839|616855431|FG000|Overall Study|Lost to Follow-up|0|||
170684187|NCT00592839|616855432|FG001|Overall Study|Lost to Follow-up|1|||
170684188|NCT00592839|616855433|FG002|Overall Study|Lost to Follow-up|1|||
170684189|NCT01529346|616855434|FG000|Overall Study|Lost to Follow-up|2|||
170684190|NCT01529346|616855435|FG001|Overall Study|Lost to Follow-up|0|||
170684191|NCT01529346|616855436|FG002|Overall Study|Lost to Follow-up|1|||
170684192|NCT01529346|616855437|FG003|Overall Study|Lost to Follow-up|0|||
170684193|NCT01529346|616855438|FG004|Overall Study|Lost to Follow-up|0|||
170684194|NCT01529346|616855434|FG000|Overall Study|Other|0|||
170684195|NCT01529346|616855435|FG001|Overall Study|Other|1|||
170684196|NCT01529346|616855436|FG002|Overall Study|Other|1|||
170684197|NCT01529346|616855437|FG003|Overall Study|Other|0|||
170684198|NCT01529346|616855438|FG004|Overall Study|Other|0|||
170684199|NCT00249444|616855441|FG000|Overall Study|Lost to Follow-up|2|||
170684200|NCT00249444|616855442|FG001|Overall Study|Lost to Follow-up|2|||
170684201|NCT00249444|616855441|FG000|Overall Study|non-compliant|9|||
170684202|NCT00249444|616855442|FG001|Overall Study|non-compliant|11|||
170684203|NCT00249444|616855441|FG000|Overall Study|Adverse Event|1|||
170684204|NCT00249444|616855442|FG001|Overall Study|Adverse Event|1|||
170684205|NCT00249444|616855441|FG000|Overall Study|life event|0|||
170684206|NCT00249444|616855442|FG001|Overall Study|life event|1|||
170684207|NCT02673489|616855443|FG000|Treatment Period|Lost to Follow-up|3|||
170684208|NCT02673489|616855444|FG001|Treatment Period|Lost to Follow-up|0|||
170684209|NCT02673489|616855443|FG000|Treatment Period|Participant request to discontinue|1|||
170684210|NCT02673489|616855444|FG001|Treatment Period|Participant request to discontinue|1|||
170684211|NCT02673489|616855443|FG000|Treatment Period|Participant moved to another province|1|||
170684212|NCT02673489|616855444|FG001|Treatment Period|Participant moved to another province|0|||
170684213|NCT02673489|616855443|FG000|Treatment Period|Participant was incarcerated|0|||
170684214|NCT02673489|616855444|FG001|Treatment Period|Participant was incarcerated|1|||
170684215|NCT02673489|616855443|FG000|Treatment Period|Adverse Event|0|||
170684216|NCT02673489|616855444|FG001|Treatment Period|Adverse Event|1|||
170684217|NCT02673489|616855443|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
170684218|NCT02673489|616855444|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
170684219|NCT02673489|616855443|FG000|Follow Up Period|Unable to return for follow-up|0|||
170684220|NCT02673489|616855444|FG001|Follow Up Period|Unable to return for follow-up|1|||
170684221|NCT02233309|616855450|FG000|Overall Study|Physician Decision|5|||
170684222|NCT00232817|616855453|FG000|Overall Study|Protocol Violation|2|||
170684223|NCT00232817|616855454|FG001|Overall Study|Protocol Violation|1|||
170684224|NCT00475176|616855455|FG000|Overall Study|Adverse Event|2|||
170684225|NCT00475176|616855455|FG000|Overall Study|Withdrawal by Subject|1|||
170684226|NCT00475176|616855455|FG000|Overall Study|Protocol Violation|1|||
170684227|NCT01484873|616855459|FG000|Overall Study|Withdrawal by Subject|2|||
170684228|NCT01549392|616855460|FG000|Overall Study|Withdrawal by Subject|1|||
170684229|NCT01549392|616855461|FG001|Overall Study|Withdrawal by Subject|0|||
170684230|NCT01475331|616855462|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
170684231|NCT01475331|616855463|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
170684232|NCT01475331|616855462|FG000|Overall Study|excessive main duct communication|1|||
170684233|NCT01475331|616855463|FG001|Overall Study|excessive main duct communication|1|||
170684234|NCT01475331|616855462|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
170684235|NCT01475331|616855463|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
170684236|NCT01475331|616855462|FG000|Overall Study|Sign of malignancy during the procedure|2|||
170684237|NCT01475331|616855463|FG001|Overall Study|Sign of malignancy during the procedure|0|||
170684238|NCT01475331|616855462|FG000|Overall Study|cyst found to be prohibitively small|0|||
170684239|NCT01475331|616855463|FG001|Overall Study|cyst found to be prohibitively small|1|||
170684240|NCT00462761|616855464|FG000|Overall Study|Adverse Event|6|||
170684241|NCT00462761|616855464|FG000|Overall Study|Withdrawal by Subject|9|||
170684242|NCT00462761|616855464|FG000|Overall Study|Physician Decision|5|||
170684243|NCT00462761|616855464|FG000|Overall Study|Disease progression|43|||
170684244|NCT00462761|616855464|FG000|Overall Study|Death|12|||
170684245|NCT00462761|616855464|FG000|Overall Study|Other|1|||
170684246|NCT02877082|616855465|FG000|Overall Study|Trial was closed early|5|||
170684247|NCT00311623|616855466|FG000|Overall Study|Physician Decision|0|||
170684248|NCT00311623|616855467|FG001|Overall Study|Physician Decision|0|||
170684249|NCT00311623|616855468|FG002|Overall Study|Physician Decision|2|||
170684250|NCT05682326|616855469|FG000|Overall Study|Withdrawal by Subject|1|||
170684251|NCT05682326|616855470|FG001|Overall Study|Withdrawal by Subject|0|||
170684252|NCT03998189|616855471|FG000|Overall Study|Lack of Efficacy|0|||
170684253|NCT03998189|616855472|FG001|Overall Study|Lack of Efficacy|1|||
170684254|NCT01124422|616855473|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
170684255|NCT01124422|616855474|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
170684256|NCT01124422|616855475|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
170684257|NCT01124422|616855473|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
170684258|NCT01124422|616855474|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
170684259|NCT01124422|616855475|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
170684260|NCT01124422|616855473|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
170684261|NCT01124422|616855474|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
170684262|NCT01124422|616855475|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
170684263|NCT01124422|616855473|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
170684264|NCT01124422|616855474|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
170684265|NCT01124422|616855475|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
170684266|NCT01124422|616855473|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
170684267|NCT01124422|616855474|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
170684268|NCT01124422|616855475|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
170684269|NCT01124422|616855473|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
170684270|NCT01124422|616855474|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
170684271|NCT01124422|616855475|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
170684272|NCT01124422|616855473|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
170684273|NCT01124422|616855474|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
170684274|NCT01124422|616855475|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
170684275|NCT01124422|616855473|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
170684276|NCT01124422|616855474|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
170684277|NCT01124422|616855475|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
170684278|NCT01124422|616855473|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
170684279|NCT01124422|616855474|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
170684280|NCT01124422|616855475|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
170684281|NCT01124422|616855473|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
170684282|NCT01124422|616855474|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
170684283|NCT01124422|616855475|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
170684284|NCT04294472|616855480|FG000|Overall Study|Adverse Event|0|||
170684285|NCT04294472|616855481|FG001|Overall Study|Adverse Event|1|||
170684286|NCT04294472|616855482|FG002|Overall Study|Adverse Event|1|||
170684287|NCT04294472|616855480|FG000|Overall Study|Randomized but not treated|0|||
170684288|NCT04294472|616855481|FG001|Overall Study|Randomized but not treated|1|||
170684289|NCT04294472|616855482|FG002|Overall Study|Randomized but not treated|1|||
170684290|NCT01324999|616855485|FG000|Overall Study|Adverse Event|3|||
170684291|NCT01324999|616855485|FG000|Overall Study|Withdrawal by Subject|2|||
170684292|NCT00640601|616855488|FG000|Overall Study|Adverse Event|43|||
170684293|NCT00640601|616855488|FG000|Overall Study|Withdrawal by Subject|20|||
170684294|NCT00640601|616855488|FG000|Overall Study|Protocol Violation|6|||
170684295|NCT00640601|616855488|FG000|Overall Study|Lack of Efficacy|16|||
170684296|NCT00640601|616855488|FG000|Overall Study|Lost to Follow-up|9|||
170684297|NCT00640601|616855488|FG000|Overall Study|Physician Decision|8|||
170684298|NCT00640601|616855488|FG000|Overall Study|treatment naive, combination therapy|10|||
170684299|NCT00230607|616855489|FG000|Overall Study|Other|3|||
170684300|NCT03198234|616855490|FG000|Overall Study|Relapse of primary disease|0|||
170684301|NCT03198234|616855491|FG001|Overall Study|Relapse of primary disease|1|||
170684302|NCT03198234|616855492|FG002|Overall Study|Relapse of primary disease|0|||
170684303|NCT00165776|616855493|FG000|Overall Study|Lack of Efficacy|0|||
170684304|NCT00165776|616855494|FG001|Overall Study|Lack of Efficacy|0|||
170684305|NCT00165776|616855495|FG002|Overall Study|Lack of Efficacy|0|||
170684306|NCT00165776|616855496|FG003|Overall Study|Lack of Efficacy|1|||
170684307|NCT00165776|616855493|FG000|Overall Study|Withdrawal by Subject|4|||
170684308|NCT00165776|616855494|FG001|Overall Study|Withdrawal by Subject|1|||
170684309|NCT00165776|616855495|FG002|Overall Study|Withdrawal by Subject|2|||
170684310|NCT00165776|616855496|FG003|Overall Study|Withdrawal by Subject|0|||
170684311|NCT00165776|616855493|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
170684312|NCT00165776|616855494|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
170684313|NCT00165776|616855495|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
170684314|NCT00165776|616855496|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
170684315|NCT01958008|616855497|FG000|Overall Study|Worsening of disease under study|0|||
170684316|NCT01958008|616855498|FG001|Overall Study|Worsening of disease under study|0|||
170684317|NCT01958008|616855499|FG002|Overall Study|Worsening of disease under study|1|||
170684318|NCT01958008|616855500|FG003|Overall Study|Worsening of disease under study|0|||
170684319|NCT01958008|616855497|FG000|Overall Study|Other adverse event|1|||
170684320|NCT01958008|616855498|FG001|Overall Study|Other adverse event|0|||
170684321|NCT01958008|616855499|FG002|Overall Study|Other adverse event|0|||
170684322|NCT01958008|616855500|FG003|Overall Study|Other adverse event|0|||
170684323|NCT01414855|616855501|FG000|Overall Study|Death|17|||
170684324|NCT01414855|616855501|FG000|Overall Study|Lost to Follow-up|5|||
170684325|NCT01414855|616855501|FG000|Overall Study|Withdrawal by Subject|7|||
170684326|NCT01244425|616855502|FG000|Overall Study|Withdrawal by Subject|2|||
170684327|NCT01244425|616855503|FG001|Overall Study|Withdrawal by Subject|2|||
170684328|NCT01244425|616855502|FG000|Overall Study|Adverse Event|1|||
170684329|NCT01244425|616855503|FG001|Overall Study|Adverse Event|1|||
170684330|NCT03032705|616855505|FG000|Overall Study|Lost to Follow-up|16|||
170684331|NCT03032705|616855506|FG001|Overall Study|Lost to Follow-up|17|||
170684332|NCT03032705|616855505|FG000|Overall Study|did not quality|6|||
170684333|NCT03032705|616855506|FG001|Overall Study|did not quality|6|||
170684334|NCT04818840|616855509|FG000|Overall Study|Lost to Follow-up|0|||
170684335|NCT04818840|616855510|FG001|Overall Study|Lost to Follow-up|5|||
170684336|NCT04818840|616855509|FG000|Overall Study|Physician Decision|1|||
170684337|NCT04818840|616855510|FG001|Overall Study|Physician Decision|0|||
170684338|NCT04818840|616855509|FG000|Overall Study|Site Terminated by Sponsor|0|||
170684339|NCT04818840|616855510|FG001|Overall Study|Site Terminated by Sponsor|3|||
170684340|NCT04818840|616855509|FG000|Overall Study|Study Terminated by Sponsor|43|||
170684341|NCT04818840|616855510|FG001|Overall Study|Study Terminated by Sponsor|7|||
170684342|NCT04818840|616855509|FG000|Overall Study|Withdrawal by Subject|0|||
170684343|NCT04818840|616855510|FG001|Overall Study|Withdrawal by Subject|1|||
170684344|NCT04847557|616855515|FG000|Overall Study|Adverse Event|1|||
170684345|NCT04847557|616855516|FG001|Overall Study|Adverse Event|0|||
170684346|NCT04847557|616855515|FG000|Overall Study|Death|19|||
170684347|NCT04847557|616855516|FG001|Overall Study|Death|15|||
170684348|NCT04847557|616855515|FG000|Overall Study|Lost to Follow-up|3|||
170684349|NCT04847557|616855516|FG001|Overall Study|Lost to Follow-up|6|||
170684350|NCT04847557|616855515|FG000|Overall Study|Physician Decision|1|||
170684351|NCT04847557|616855516|FG001|Overall Study|Physician Decision|0|||
170684352|NCT04847557|616855515|FG000|Overall Study|Protocol Violation|0|||
170684353|NCT04847557|616855516|FG001|Overall Study|Protocol Violation|1|||
170684354|NCT04847557|616855515|FG000|Overall Study|Withdrawal by Subject|8|||
170684355|NCT04847557|616855516|FG001|Overall Study|Withdrawal by Subject|14|||
170684356|NCT00670800|616857097|FG000|Overall Study|2 controls were insulin resistant|0|||
170684357|NCT00670800|616857098|FG001|Overall Study|2 controls were insulin resistant|2|||
170684358|NCT03653637|616857099|FG000|Overall Study|Death|1|||
170684359|NCT03653637|616857100|FG001|Overall Study|Death|3|||
170684360|NCT03653637|616857099|FG000|Overall Study|Lost to Follow-up|29|||
170684361|NCT03653637|616857100|FG001|Overall Study|Lost to Follow-up|30|||
170684362|NCT03653637|616857099|FG000|Overall Study|Physician Decision|1|||
170684363|NCT03653637|616857100|FG001|Overall Study|Physician Decision|1|||
170684364|NCT03653637|616857099|FG000|Overall Study|Withdrawal by Subject|7|||
170684365|NCT03653637|616857100|FG001|Overall Study|Withdrawal by Subject|4|||
170684366|NCT04244786|616857103|FG000|Overall Study|Adverse Event|0|||
170684367|NCT04244786|616857104|FG001|Overall Study|Adverse Event|0|||
170684368|NCT04244786|616857105|FG002|Overall Study|Adverse Event|2|||
170684369|NCT04244786|616857103|FG000|Overall Study|Withdrawal by Subject|0|||
170684370|NCT04244786|616857104|FG001|Overall Study|Withdrawal by Subject|0|||
170684371|NCT04244786|616857105|FG002|Overall Study|Withdrawal by Subject|5|||
170684372|NCT02329730|616857106|FG000|Overall Study|Protocol Violation|0|||
170684373|NCT02329730|616857107|FG001|Overall Study|Protocol Violation|0|||
170684374|NCT02329730|616857108|FG002|Overall Study|Protocol Violation|0|||
170684375|NCT02329730|616857109|FG003|Overall Study|Protocol Violation|0|||
170684376|NCT02329730|616857110|FG004|Overall Study|Protocol Violation|2|||
170684377|NCT02329730|616857111|FG005|Overall Study|Protocol Violation|2|||
170684378|NCT02329730|616857112|FG006|Overall Study|Protocol Violation|0|||
170684379|NCT02329730|616857113|FG007|Overall Study|Protocol Violation|0|||
170684380|NCT02329730|616857114|FG008|Overall Study|Protocol Violation|0|||
170684381|NCT02329730|616857115|FG009|Overall Study|Protocol Violation|0|||
170684382|NCT02329730|616857116|FG010|Overall Study|Protocol Violation|0|||
170684383|NCT02329730|616857117|FG011|Overall Study|Protocol Violation|0|||
170684384|NCT02329730|616857106|FG000|Overall Study|Withdrawal by Subject|0|||
170684385|NCT02329730|616857107|FG001|Overall Study|Withdrawal by Subject|0|||
170684386|NCT02329730|616857108|FG002|Overall Study|Withdrawal by Subject|0|||
170684387|NCT02329730|616857109|FG003|Overall Study|Withdrawal by Subject|0|||
170684388|NCT02329730|616857110|FG004|Overall Study|Withdrawal by Subject|1|||
170684389|NCT02329730|616857111|FG005|Overall Study|Withdrawal by Subject|0|||
170684390|NCT02329730|616857112|FG006|Overall Study|Withdrawal by Subject|1|||
170684391|NCT02329730|616857113|FG007|Overall Study|Withdrawal by Subject|1|||
170684392|NCT02329730|616857114|FG008|Overall Study|Withdrawal by Subject|1|||
170684393|NCT02329730|616857115|FG009|Overall Study|Withdrawal by Subject|1|||
170684394|NCT02329730|616857116|FG010|Overall Study|Withdrawal by Subject|0|||
170684395|NCT02329730|616857117|FG011|Overall Study|Withdrawal by Subject|0|||
170684396|NCT00157950|616857121|FG000|Overall Study|Death|1|||
170684397|NCT00157950|616857122|FG001|Overall Study|Death|0|||
170684398|NCT01463878|616857123|FG000|Overall Study|no longer met criteria for tube feed|2|||
170684399|NCT01463878|616857124|FG001|Overall Study|no longer met criteria for tube feed|2|||
170684400|NCT04532099|616857125|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
170684401|NCT04532099|616857126|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
170684402|NCT04532099|616857127|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
170684403|NCT01946425|616857130|FG000|Overall Study|Protocol Violation|1|||
170684404|NCT01946425|616857131|FG001|Overall Study|Protocol Violation|0|||
170684405|NCT01946425|616857130|FG000|Overall Study|Withdrawal by Subject|1|||
170684406|NCT01946425|616857131|FG001|Overall Study|Withdrawal by Subject|0|||
170684407|NCT04876274|616857135|FG000|Overall Study|Lost to Follow-up|9|||
170684408|NCT04876274|616857136|FG001|Overall Study|Lost to Follow-up|12|||
170684409|NCT03454893|616857137|FG000|Overall Study|Study Terminated by the Sponsor|5|||
170684410|NCT03454893|616857137|FG000|Overall Study|Did not pass screening|4|||
170684411|NCT05247866|616857140|FG000|Overall Study|Adverse Event|2|||
170684412|NCT05247866|616857140|FG000|Overall Study|Lack of Efficacy|1|||
170684413|NCT05247866|616857140|FG000|Overall Study|Protocol Violation|1|||
170684414|NCT05247866|616857140|FG000|Overall Study|Withdrawal by Subject|3|||
170684415|NCT04463719|616857145|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
170684416|NCT04463719|616857146|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
170684417|NCT04463719|616857147|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
170684418|NCT02436356|616857150|FG000|Overall Study|Excluded by MRI Screening|0|||
170684419|NCT02436356|616857151|FG001|Overall Study|Excluded by MRI Screening|0|||
170684420|NCT02436356|616857152|FG002|Overall Study|Excluded by MRI Screening|2|||
170684421|NCT02436356|616857150|FG000|Overall Study|Lost to Follow-up|0|||
170684422|NCT02436356|616857151|FG001|Overall Study|Lost to Follow-up|1|||
170684423|NCT02436356|616857152|FG002|Overall Study|Lost to Follow-up|0|||
170684424|NCT02436356|616857150|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
170684425|NCT02436356|616857151|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
170684426|NCT02436356|616857152|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
170684427|NCT02436356|616857150|FG000|Overall Study|Excluded due to other medical conditions|3|||
170684428|NCT02436356|616857151|FG001|Overall Study|Excluded due to other medical conditions|0|||
170684429|NCT02436356|616857152|FG002|Overall Study|Excluded due to other medical conditions|0|||
170684430|NCT02436356|616857150|FG000|Overall Study|Withdrawal by Subject|1|||
170684431|NCT02436356|616857151|FG001|Overall Study|Withdrawal by Subject|0|||
170684432|NCT02436356|616857152|FG002|Overall Study|Withdrawal by Subject|0|||
170684433|NCT03315208|616857153|FG000|Overall Study|Lost to Follow-up|11|||
170684434|NCT03315208|616857154|FG001|Overall Study|Lost to Follow-up|6|||
170684435|NCT03315208|616857153|FG000|Overall Study|Withdrawal by Subject|2|||
170684436|NCT03315208|616857154|FG001|Overall Study|Withdrawal by Subject|0|||
170684437|NCT02875860|616857155|FG000|Overall Study|Withdrawal by Subject|0|||
170684438|NCT02875860|616857156|FG001|Overall Study|Withdrawal by Subject|1|||
170684439|NCT06133348|616857159|FG000|Overall Study|Death|3|||
170684440|NCT06133348|616857159|FG000|Overall Study|Lost to Follow-up|1|||
170684441|NCT06133348|616857159|FG000|Overall Study|Physician Decision|1|||
170684442|NCT06133348|616857159|FG000|Overall Study|Withdrawal by Subject|5|||
170684443|NCT00487747|616857160|FG000|Overall Study|Adverse Event|1|||
170684444|NCT00487747|616857160|FG000|Overall Study|Lost to Follow-up|9|||
170684445|NCT00487747|616857160|FG000|Overall Study|Lack of Efficacy|1|||
170684446|NCT04483011|616857161|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
170684447|NCT04483011|616857162|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
170684448|NCT01359449|616857163|FG000|Overall Study|Lost to Follow-up|1|||
170684449|NCT01359449|616857164|FG001|Overall Study|Lost to Follow-up|0|||
170684450|NCT01359449|616857163|FG000|Overall Study|Protocol Violation|0|||
170684451|NCT01359449|616857164|FG001|Overall Study|Protocol Violation|2|||
170684452|NCT01359449|616857163|FG000|Overall Study|Withdrawal by Subject|3|||
170684453|NCT01359449|616857164|FG001|Overall Study|Withdrawal by Subject|2|||
170684454|NCT02036294|616857165|FG000|Overall Study|Death|7|||
170684455|NCT02036294|616857166|FG001|Overall Study|Death|8|||
170684456|NCT02036294|616857165|FG000|Overall Study|Withdrawal by Subject|2|||
170684457|NCT02036294|616857166|FG001|Overall Study|Withdrawal by Subject|3|||
170684458|NCT02393547|616857167|FG000|Overall Study|Adverse Event|2|||
170684459|NCT02393547|616857167|FG000|Overall Study|Withdrawal by Subject|3|||
170684460|NCT02393547|616857167|FG000|Overall Study|Lost to Follow-up|1|||
170684461|NCT00563381|616857181|FG000|Overall Study|Adverse Event|264|||
170684462|NCT00563381|616857182|FG001|Overall Study|Adverse Event|292|||
170684463|NCT00563381|616857181|FG000|Overall Study|Protocol Violation|66|||
170684464|NCT00563381|616857182|FG001|Overall Study|Protocol Violation|74|||
170684465|NCT00563381|616857181|FG000|Overall Study|Lost to Follow-up|7|||
170684466|NCT00563381|616857182|FG001|Overall Study|Lost to Follow-up|15|||
170684467|NCT00563381|616857181|FG000|Overall Study|Withdrawal by Subject|192|||
170684468|NCT00563381|616857182|FG001|Overall Study|Withdrawal by Subject|209|||
170684469|NCT00563381|616857181|FG000|Overall Study|Lack of Efficacy|32|||
170684470|NCT00563381|616857182|FG001|Overall Study|Lack of Efficacy|24|||
170684471|NCT00563381|616857181|FG000|Overall Study|Individual different reasons|24|||
170684472|NCT00563381|616857182|FG001|Overall Study|Individual different reasons|34|||
170684473|NCT00191789|616857185|FG000|Overall Study|Adverse Event|5|||
170684474|NCT00191789|616857185|FG000|Overall Study|Patient: Satisfactory Response|5|||
170684475|NCT00191789|616857185|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
170684476|NCT00191789|616857185|FG000|Overall Study|Withdrawal by Subject|4|||
170684477|NCT00191789|616857185|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
170684478|NCT00191789|616857185|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
170684479|NCT00191789|616857185|FG000|Overall Study|Death - Not Study-Drug Related|1|||
170684480|NCT03049280|616857186|FG000|Overall Study|Physician Decision|1|||
170684481|NCT01922089|616857193|FG000|Overall Study|Adverse Event|18|||
170684482|NCT01922089|616857194|FG001|Overall Study|Adverse Event|13|||
170684483|NCT01922089|616857193|FG000|Overall Study|Protocol Deviation|10|||
170684484|NCT01922089|616857194|FG001|Overall Study|Protocol Deviation|7|||
170684485|NCT01922089|616857193|FG000|Overall Study|Withdrawal by Subject|3|||
170684486|NCT01922089|616857194|FG001|Overall Study|Withdrawal by Subject|4|||
170684487|NCT01922089|616857193|FG000|Overall Study|administrative problems|4|||
170684488|NCT01922089|616857194|FG001|Overall Study|administrative problems|1|||
170684489|NCT01922089|616857193|FG000|Overall Study|Physician Decision|2|||
170684490|NCT01922089|616857194|FG001|Overall Study|Physician Decision|3|||
170684491|NCT01922089|616857193|FG000|Overall Study|Death|2|||
170684492|NCT01922089|616857194|FG001|Overall Study|Death|1|||
170684493|NCT01922089|616857193|FG000|Overall Study|Lost to Follow-up|0|||
170684494|NCT01922089|616857194|FG001|Overall Study|Lost to Follow-up|1|||
170684495|NCT01683383|616857196|FG000|Overall Study|Infant was not transported|1|||
170684496|NCT01683383|616857197|FG001|Overall Study|Infant was not transported|0|||
170684497|NCT02850965|616857198|FG000|Overall Study|Other than listed|3|||
170684498|NCT02850965|616857199|FG001|Overall Study|Other than listed|4|||
170684499|NCT02850965|616857198|FG000|Overall Study|Protocol Violation|0|||
170684500|NCT02850965|616857199|FG001|Overall Study|Protocol Violation|2|||
170684501|NCT02850965|616857198|FG000|Overall Study|Lost to Follow-up|5|||
170684502|NCT02850965|616857199|FG001|Overall Study|Lost to Follow-up|3|||
170684503|NCT02850965|616857198|FG000|Overall Study|Lack of Efficacy|4|||
170684504|NCT02850965|616857199|FG001|Overall Study|Lack of Efficacy|8|||
170684505|NCT02850965|616857198|FG000|Overall Study|Adverse Event|3|||
170684506|NCT02850965|616857199|FG001|Overall Study|Adverse Event|2|||
170684507|NCT02850965|616857198|FG000|Overall Study|Withdrawal by Subject|3|||
170684508|NCT02850965|616857199|FG001|Overall Study|Withdrawal by Subject|4|||
170684509|NCT02850965|616857198|FG000|Overall Study|Physician Decision|0|||
170684510|NCT02850965|616857199|FG001|Overall Study|Physician Decision|1|||
170684511|NCT02850965|616857198|FG000|Overall Study|Randomized but not treated|0|||
170684512|NCT02850965|616857199|FG001|Overall Study|Randomized but not treated|1|||
170684513|NCT02788357|616857200|FG000|Overall Study|Lost to Follow-up|3|||
170684514|NCT02788357|616857201|FG001|Overall Study|Lost to Follow-up|0|||
170684515|NCT02170051|616857202|FG000|Overall Study|Withdrawal by Subject|10|||
170684516|NCT02170051|616857203|FG001|Overall Study|Withdrawal by Subject|10|||
170684517|NCT02170051|616857202|FG000|Overall Study|Lost to Follow-up|1|||
170684518|NCT02170051|616857203|FG001|Overall Study|Lost to Follow-up|3|||
170684519|NCT04551092|616857204|FG000|Overall Study|Lost to Follow-up|7|||
170684520|NCT04551092|616857204|FG000|Overall Study|Withdrawal by Subject|4|||
170684521|NCT01782495|616857209|FG000|Overall Study|Adverse Event|0|||
170684522|NCT01782495|616857210|FG001|Overall Study|Adverse Event|0|||
170684523|NCT01782495|616857211|FG002|Overall Study|Adverse Event|0|||
170684524|NCT01782495|616857212|FG003|Overall Study|Adverse Event|0|||
170684525|NCT01782495|616857213|FG004|Overall Study|Adverse Event|0|||
170684526|NCT01782495|616857214|FG005|Overall Study|Adverse Event|0|||
170684527|NCT01782495|616857215|FG006|Overall Study|Adverse Event|0|||
170684528|NCT01782495|616857216|FG007|Overall Study|Adverse Event|2|||
170684529|NCT01782495|616857217|FG008|Overall Study|Adverse Event|0|||
170684530|NCT01782495|616857218|FG009|Overall Study|Adverse Event|0|||
170684531|NCT01782495|616857219|FG010|Overall Study|Adverse Event|0|||
170684532|NCT01782495|616857209|FG000|Overall Study|Withdrew Consent|0|||
170684533|NCT01782495|616857210|FG001|Overall Study|Withdrew Consent|1|||
170684534|NCT01782495|616857211|FG002|Overall Study|Withdrew Consent|0|||
170684535|NCT01782495|616857212|FG003|Overall Study|Withdrew Consent|0|||
170684536|NCT01782495|616857213|FG004|Overall Study|Withdrew Consent|0|||
170684537|NCT01782495|616857214|FG005|Overall Study|Withdrew Consent|0|||
170684538|NCT01782495|616857215|FG006|Overall Study|Withdrew Consent|0|||
170684539|NCT01782495|616857216|FG007|Overall Study|Withdrew Consent|1|||
170684540|NCT01782495|616857217|FG008|Overall Study|Withdrew Consent|0|||
170684541|NCT01782495|616857218|FG009|Overall Study|Withdrew Consent|0|||
170684542|NCT01782495|616857219|FG010|Overall Study|Withdrew Consent|0|||
170684543|NCT00580606|616857230|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
170684544|NCT00580606|616857231|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
170684545|NCT00580606|616857230|FG000|Open Label (OL)|Withdrawal by Subject|4|||
170684546|NCT00580606|616857231|FG001|Open Label (OL)|Withdrawal by Subject|6|||
170684547|NCT00580606|616857230|FG000|Open Label (OL)|Dosing Symptoms|0|||
170684548|NCT00580606|616857231|FG001|Open Label (OL)|Dosing Symptoms|1|||
170684549|NCT00580606|616857230|FG000|Open Label (OL)|Lost to Follow-up|0|||
170684550|NCT00580606|616857231|FG001|Open Label (OL)|Lost to Follow-up|1|||
170684551|NCT00580606|616857230|FG000|Open Label (OL)|Pregnancy|0|||
170684552|NCT00580606|616857231|FG001|Open Label (OL)|Pregnancy|1|||
170684553|NCT00580606|616857230|FG000|Open Label (OL)|Non-compliance|2|||
170684554|NCT00580606|616857231|FG001|Open Label (OL)|Non-compliance|0|||
170684555|NCT00580606|616857230|FG000|Open Label (OL)|Physician Decision|1|||
170684556|NCT00580606|616857231|FG001|Open Label (OL)|Physician Decision|1|||
170684557|NCT00580606|616857230|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
170684558|NCT00580606|616857231|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
170684559|NCT03655691|616857232|FG000|Overall Study|Adverse Event|0|||
170684560|NCT03655691|616857233|FG001|Overall Study|Adverse Event|0|||
170684561|NCT03655691|616857234|FG002|Overall Study|Adverse Event|1|||
170684562|NCT03655691|616857232|FG000|Overall Study|Lost to Follow-up|1|||
170684563|NCT03655691|616857233|FG001|Overall Study|Lost to Follow-up|1|||
170684564|NCT03655691|616857234|FG002|Overall Study|Lost to Follow-up|2|||
170684565|NCT03655691|616857232|FG000|Overall Study|Protocol Violation|0|||
170684566|NCT03655691|616857233|FG001|Overall Study|Protocol Violation|1|||
170684567|NCT03655691|616857234|FG002|Overall Study|Protocol Violation|0|||
170684568|NCT03655691|616857232|FG000|Overall Study|Withdrawal by Subject|1|||
170684569|NCT03655691|616857233|FG001|Overall Study|Withdrawal by Subject|1|||
170684570|NCT03655691|616857234|FG002|Overall Study|Withdrawal by Subject|0|||
170684571|NCT02743871|616857235|FG000|Overall Study|Lost to Follow-up|0|||
170684572|NCT02743871|616857236|FG001|Overall Study|Lost to Follow-up|0|||
170684573|NCT02743871|616857237|FG002|Overall Study|Lost to Follow-up|0|||
170684574|NCT02743871|616857238|FG003|Overall Study|Lost to Follow-up|1|||
170684575|NCT02743871|616857239|FG004|Overall Study|Lost to Follow-up|0|||
170684576|NCT02743871|616857240|FG005|Overall Study|Lost to Follow-up|0|||
170684577|NCT02743871|616857241|FG006|Overall Study|Lost to Follow-up|1|||
170684578|NCT02743871|616857242|FG007|Overall Study|Lost to Follow-up|0|||
170684579|NCT02743871|616857243|FG008|Overall Study|Lost to Follow-up|0|||
170684580|NCT02743871|616857244|FG009|Overall Study|Lost to Follow-up|0|||
170684581|NCT02743871|616857245|FG010|Overall Study|Lost to Follow-up|0|||
170684582|NCT02743871|616857246|FG011|Overall Study|Lost to Follow-up|2|||
170684583|NCT02743871|616857247|FG012|Overall Study|Lost to Follow-up|0|||
170684584|NCT02743871|616857248|FG013|Overall Study|Lost to Follow-up|0|||
170684585|NCT02743871|616857235|FG000|Overall Study|Withdrawal by Subject|0|||
170684586|NCT02743871|616857236|FG001|Overall Study|Withdrawal by Subject|0|||
170684587|NCT02743871|616857237|FG002|Overall Study|Withdrawal by Subject|0|||
170684588|NCT02743871|616857238|FG003|Overall Study|Withdrawal by Subject|0|||
170684589|NCT02743871|616857239|FG004|Overall Study|Withdrawal by Subject|0|||
170684590|NCT02743871|616857240|FG005|Overall Study|Withdrawal by Subject|0|||
170684591|NCT02743871|616857241|FG006|Overall Study|Withdrawal by Subject|0|||
170684592|NCT02743871|616857242|FG007|Overall Study|Withdrawal by Subject|0|||
170684593|NCT02743871|616857243|FG008|Overall Study|Withdrawal by Subject|0|||
170684594|NCT02743871|616857244|FG009|Overall Study|Withdrawal by Subject|0|||
170684595|NCT02743871|616857245|FG010|Overall Study|Withdrawal by Subject|1|||
170684596|NCT02743871|616857246|FG011|Overall Study|Withdrawal by Subject|0|||
170684597|NCT02743871|616857247|FG012|Overall Study|Withdrawal by Subject|12|||
170684598|NCT02743871|616857248|FG013|Overall Study|Withdrawal by Subject|6|||
170684599|NCT02743871|616857235|FG000|Overall Study|Adverse Event|1|||
170684600|NCT02743871|616857236|FG001|Overall Study|Adverse Event|0|||
170684601|NCT02743871|616857237|FG002|Overall Study|Adverse Event|0|||
170684602|NCT02743871|616857238|FG003|Overall Study|Adverse Event|0|||
170684603|NCT02743871|616857239|FG004|Overall Study|Adverse Event|0|||
170684604|NCT02743871|616857240|FG005|Overall Study|Adverse Event|0|||
170684605|NCT02743871|616857241|FG006|Overall Study|Adverse Event|0|||
170684606|NCT02743871|616857242|FG007|Overall Study|Adverse Event|0|||
170684607|NCT02743871|616857243|FG008|Overall Study|Adverse Event|0|||
170684608|NCT02743871|616857244|FG009|Overall Study|Adverse Event|0|||
170684609|NCT02743871|616857245|FG010|Overall Study|Adverse Event|0|||
170684610|NCT02743871|616857246|FG011|Overall Study|Adverse Event|0|||
170684611|NCT02743871|616857247|FG012|Overall Study|Adverse Event|0|||
170684612|NCT02743871|616857248|FG013|Overall Study|Adverse Event|0|||
170684613|NCT02743871|616857235|FG000|Overall Study|Other|0|||
170684614|NCT02743871|616857236|FG001|Overall Study|Other|0|||
170684615|NCT02743871|616857237|FG002|Overall Study|Other|0|||
170684616|NCT02743871|616857238|FG003|Overall Study|Other|0|||
170684617|NCT02743871|616857239|FG004|Overall Study|Other|0|||
170684618|NCT02743871|616857240|FG005|Overall Study|Other|0|||
170684619|NCT02743871|616857241|FG006|Overall Study|Other|0|||
170684620|NCT02743871|616857242|FG007|Overall Study|Other|0|||
170684621|NCT02743871|616857243|FG008|Overall Study|Other|0|||
170684622|NCT02743871|616857244|FG009|Overall Study|Other|0|||
170684623|NCT02743871|616857245|FG010|Overall Study|Other|0|||
170684624|NCT02743871|616857246|FG011|Overall Study|Other|1|||
170684625|NCT02743871|616857247|FG012|Overall Study|Other|1|||
170684626|NCT02743871|616857248|FG013|Overall Study|Other|1|||
170684627|NCT02743871|616857235|FG000|Overall Study|Protocol Violation|0|||
170684628|NCT02743871|616857236|FG001|Overall Study|Protocol Violation|0|||
170684629|NCT02743871|616857237|FG002|Overall Study|Protocol Violation|0|||
170684630|NCT02743871|616857238|FG003|Overall Study|Protocol Violation|0|||
170684631|NCT02743871|616857239|FG004|Overall Study|Protocol Violation|0|||
170684632|NCT02743871|616857240|FG005|Overall Study|Protocol Violation|0|||
170684633|NCT02743871|616857241|FG006|Overall Study|Protocol Violation|0|||
170684634|NCT02743871|616857242|FG007|Overall Study|Protocol Violation|0|||
170684635|NCT02743871|616857243|FG008|Overall Study|Protocol Violation|0|||
170684636|NCT02743871|616857244|FG009|Overall Study|Protocol Violation|0|||
170684637|NCT02743871|616857245|FG010|Overall Study|Protocol Violation|0|||
170684638|NCT02743871|616857246|FG011|Overall Study|Protocol Violation|0|||
170684639|NCT02743871|616857247|FG012|Overall Study|Protocol Violation|2|||
170684640|NCT02743871|616857248|FG013|Overall Study|Protocol Violation|0|||
170684641|NCT00203996|616857249|FG000|Overall Study|Lost to Follow-up|0|||
170684642|NCT00203996|616857250|FG001|Overall Study|Lost to Follow-up|0|||
170684643|NCT00203996|616857251|FG002|Overall Study|Lost to Follow-up|0|||
170684644|NCT00203996|616857252|FG003|Overall Study|Lost to Follow-up|1|||
170684645|NCT00203996|616857253|FG004|Overall Study|Lost to Follow-up|0|||
170684646|NCT00203996|616857254|FG005|Overall Study|Lost to Follow-up|0|||
170684647|NCT00203996|616857255|FG006|Overall Study|Lost to Follow-up|0|||
170684648|NCT00203996|616857256|FG007|Overall Study|Lost to Follow-up|0|||
170684649|NCT00203996|616857257|FG008|Overall Study|Lost to Follow-up|0|||
170684650|NCT00203996|616857258|FG009|Overall Study|Lost to Follow-up|0|||
170684651|NCT00203996|616857249|FG000|Overall Study|Protocol Violation|0|||
170684652|NCT00203996|616857250|FG001|Overall Study|Protocol Violation|0|||
170684653|NCT00203996|616857251|FG002|Overall Study|Protocol Violation|0|||
170684654|NCT00203996|616857252|FG003|Overall Study|Protocol Violation|6|||
170684655|NCT00203996|616857253|FG004|Overall Study|Protocol Violation|1|||
170684656|NCT00203996|616857254|FG005|Overall Study|Protocol Violation|0|||
170684657|NCT00203996|616857255|FG006|Overall Study|Protocol Violation|0|||
170684658|NCT00203996|616857256|FG007|Overall Study|Protocol Violation|0|||
170684659|NCT00203996|616857257|FG008|Overall Study|Protocol Violation|0|||
170684660|NCT00203996|616857258|FG009|Overall Study|Protocol Violation|0|||
170684661|NCT00203996|616857249|FG000|Overall Study|Physician Decision|0|||
170684662|NCT00203996|616857250|FG001|Overall Study|Physician Decision|0|||
170684663|NCT00203996|616857251|FG002|Overall Study|Physician Decision|0|||
170684664|NCT00203996|616857252|FG003|Overall Study|Physician Decision|2|||
170684665|NCT00203996|616857253|FG004|Overall Study|Physician Decision|0|||
170684666|NCT00203996|616857254|FG005|Overall Study|Physician Decision|0|||
170684667|NCT00203996|616857255|FG006|Overall Study|Physician Decision|0|||
170684668|NCT00203996|616857256|FG007|Overall Study|Physician Decision|0|||
170684669|NCT00203996|616857257|FG008|Overall Study|Physician Decision|0|||
170684670|NCT00203996|616857258|FG009|Overall Study|Physician Decision|1|||
170684671|NCT00203996|616857249|FG000|Overall Study|CPAP machine malfunction|0|||
170684672|NCT00203996|616857250|FG001|Overall Study|CPAP machine malfunction|0|||
170684673|NCT00203996|616857251|FG002|Overall Study|CPAP machine malfunction|0|||
170684674|NCT00203996|616857252|FG003|Overall Study|CPAP machine malfunction|1|||
170684675|NCT00203996|616857253|FG004|Overall Study|CPAP machine malfunction|0|||
170684676|NCT00203996|616857254|FG005|Overall Study|CPAP machine malfunction|0|||
170684677|NCT00203996|616857255|FG006|Overall Study|CPAP machine malfunction|0|||
170684678|NCT00203996|616857256|FG007|Overall Study|CPAP machine malfunction|0|||
170684679|NCT00203996|616857257|FG008|Overall Study|CPAP machine malfunction|0|||
170684680|NCT00203996|616857258|FG009|Overall Study|CPAP machine malfunction|0|||
170684681|NCT00203996|616857249|FG000|Overall Study|Scheduling issue|0|||
170684682|NCT00203996|616857250|FG001|Overall Study|Scheduling issue|0|||
170684683|NCT00203996|616857251|FG002|Overall Study|Scheduling issue|0|||
170684684|NCT00203996|616857252|FG003|Overall Study|Scheduling issue|0|||
170684685|NCT00203996|616857253|FG004|Overall Study|Scheduling issue|0|||
170684686|NCT00203996|616857254|FG005|Overall Study|Scheduling issue|0|||
170684687|NCT00203996|616857255|FG006|Overall Study|Scheduling issue|0|||
170684688|NCT00203996|616857256|FG007|Overall Study|Scheduling issue|2|||
170684689|NCT00203996|616857257|FG008|Overall Study|Scheduling issue|0|||
170684690|NCT00203996|616857258|FG009|Overall Study|Scheduling issue|0|||
170684691|NCT00434330|616857261|FG000|Overall Study|Adverse Event|0|||
170684692|NCT00434330|616857262|FG001|Overall Study|Adverse Event|0|||
170684693|NCT00434330|616857263|FG002|Overall Study|Adverse Event|1|||
170684694|NCT00434330|616857264|FG003|Overall Study|Adverse Event|0|||
170820954|NCT00043186|617353205|FG007|Overall Study|Adverse Event|1|||
170684695|NCT00434330|616857265|FG004|Overall Study|Adverse Event|0|||
170684696|NCT00434330|616857266|FG005|Overall Study|Adverse Event|0|||
170684697|NCT00434330|616857261|FG000|Overall Study|Death|1|||
170684698|NCT00434330|616857262|FG001|Overall Study|Death|0|||
170684699|NCT00434330|616857263|FG002|Overall Study|Death|0|||
170684700|NCT00434330|616857264|FG003|Overall Study|Death|0|||
170684701|NCT00434330|616857265|FG004|Overall Study|Death|1|||
170684702|NCT00434330|616857266|FG005|Overall Study|Death|1|||
170684703|NCT00434330|616857261|FG000|Overall Study|Withdrawal by Subject|0|||
170684704|NCT00434330|616857262|FG001|Overall Study|Withdrawal by Subject|0|||
170684705|NCT00434330|616857263|FG002|Overall Study|Withdrawal by Subject|1|||
170684706|NCT00434330|616857264|FG003|Overall Study|Withdrawal by Subject|1|||
170684707|NCT00434330|616857265|FG004|Overall Study|Withdrawal by Subject|0|||
170684708|NCT00434330|616857266|FG005|Overall Study|Withdrawal by Subject|0|||
170684709|NCT00434330|616857261|FG000|Overall Study|Renal transplant|0|||
170684710|NCT00434330|616857262|FG001|Overall Study|Renal transplant|0|||
170684711|NCT00434330|616857263|FG002|Overall Study|Renal transplant|0|||
170684712|NCT00434330|616857264|FG003|Overall Study|Renal transplant|1|||
170684713|NCT00434330|616857265|FG004|Overall Study|Renal transplant|0|||
170684714|NCT00434330|616857266|FG005|Overall Study|Renal transplant|0|||
170684715|NCT00434330|616857261|FG000|Overall Study|Subject Not Compliant With Study|0|||
170684716|NCT00434330|616857262|FG001|Overall Study|Subject Not Compliant With Study|0|||
170684717|NCT00434330|616857263|FG002|Overall Study|Subject Not Compliant With Study|1|||
170684718|NCT00434330|616857264|FG003|Overall Study|Subject Not Compliant With Study|0|||
170684719|NCT00434330|616857265|FG004|Overall Study|Subject Not Compliant With Study|0|||
170684720|NCT00434330|616857266|FG005|Overall Study|Subject Not Compliant With Study|0|||
170684721|NCT03789318|616857267|FG000|Overall Study|Adverse Event|0|||
170684722|NCT03789318|616857268|FG001|Overall Study|Adverse Event|0|||
170684723|NCT03789318|616857269|FG002|Overall Study|Adverse Event|1|||
170684724|NCT03789318|616857270|FG003|Overall Study|Adverse Event|1|||
170684725|NCT03789318|616857271|FG004|Overall Study|Adverse Event|0|||
170684726|NCT03789318|616857267|FG000|Overall Study|Lost to Follow-up|0|||
170684727|NCT03789318|616857268|FG001|Overall Study|Lost to Follow-up|0|||
170684728|NCT03789318|616857269|FG002|Overall Study|Lost to Follow-up|1|||
170684729|NCT03789318|616857270|FG003|Overall Study|Lost to Follow-up|0|||
170684730|NCT03789318|616857271|FG004|Overall Study|Lost to Follow-up|0|||
170684731|NCT03789318|616857267|FG000|Overall Study|Withdrawal by Subject|0|||
170684732|NCT03789318|616857268|FG001|Overall Study|Withdrawal by Subject|0|||
170684733|NCT03789318|616857269|FG002|Overall Study|Withdrawal by Subject|1|||
170684734|NCT03789318|616857270|FG003|Overall Study|Withdrawal by Subject|0|||
170684735|NCT03789318|616857271|FG004|Overall Study|Withdrawal by Subject|0|||
170684736|NCT01317160|616857272|FG000|Overall Study|Incorrect inclusion|1|||
170684737|NCT01317160|616857273|FG001|Overall Study|Incorrect inclusion|1|||
170684738|NCT01317160|616857272|FG000|Overall Study|Lost to Follow-up|3|||
170684739|NCT01317160|616857273|FG001|Overall Study|Lost to Follow-up|3|||
170684740|NCT01317160|616857272|FG000|Overall Study|Withdrawal by Subject|0|||
170684741|NCT01317160|616857273|FG001|Overall Study|Withdrawal by Subject|2|||
170684742|NCT01325584|616857274|FG000|Overall Study|Death|1|||
170684743|NCT02636868|616859038|FG000|Overall Study|Death|0|||
170684744|NCT02636868|616859039|FG001|Overall Study|Death|1|||
170684745|NCT02636868|616859040|FG002|Overall Study|Death|2|||
170684746|NCT01594125|616859044|FG000|Overall Study|Withdrawal by Subject|1|||
170684747|NCT01594125|616859045|FG001|Overall Study|Withdrawal by Subject|0|||
170684748|NCT01594125|616859046|FG002|Overall Study|Withdrawal by Subject|0|||
170684749|NCT01594125|616859047|FG003|Overall Study|Withdrawal by Subject|1|||
170684750|NCT01594125|616859048|FG004|Overall Study|Withdrawal by Subject|0|||
170684751|NCT01594125|616859044|FG000|Overall Study|Progressive Disease|3|||
170684752|NCT01594125|616859045|FG001|Overall Study|Progressive Disease|12|||
170684753|NCT01594125|616859046|FG002|Overall Study|Progressive Disease|3|||
170684754|NCT01594125|616859047|FG003|Overall Study|Progressive Disease|3|||
170684755|NCT01594125|616859048|FG004|Overall Study|Progressive Disease|7|||
170684756|NCT02169739|616859049|FG000|Overall Study|Lost to Follow-up|0|||
170684757|NCT02169739|616859050|FG001|Overall Study|Lost to Follow-up|4|||
170684758|NCT00227903|616859051|FG000|Overall Study|Withdrawal by Subject|2|||
170684759|NCT00227903|616859052|FG001|Overall Study|Withdrawal by Subject|5|||
170684760|NCT00227903|616859051|FG000|Overall Study|Subject moved out of area|1|||
170684761|NCT00227903|616859052|FG001|Overall Study|Subject moved out of area|2|||
170684762|NCT00227903|616859051|FG000|Overall Study|Lost to Follow-up|1|||
170684763|NCT00227903|616859052|FG001|Overall Study|Lost to Follow-up|3|||
170684764|NCT00227903|616859051|FG000|Overall Study|Miscarriage|1|||
170684765|NCT00227903|616859052|FG001|Overall Study|Miscarriage|0|||
170684766|NCT01113801|616859053|FG000|Overall Study|Adverse Event|4|||
170684767|NCT01113801|616859054|FG001|Overall Study|Adverse Event|0|||
170684768|NCT01113801|616859055|FG002|Overall Study|Adverse Event|2|||
170684769|NCT01113801|616859056|FG003|Overall Study|Adverse Event|6|||
170684770|NCT01113801|616859053|FG000|Overall Study|Death|4|||
170684771|NCT01113801|616859054|FG001|Overall Study|Death|5|||
170684772|NCT01113801|616859055|FG002|Overall Study|Death|3|||
170684773|NCT01113801|616859056|FG003|Overall Study|Death|4|||
170684774|NCT01113801|616859053|FG000|Overall Study|Protocol Violation|0|||
170684775|NCT01113801|616859054|FG001|Overall Study|Protocol Violation|1|||
170684776|NCT01113801|616859055|FG002|Overall Study|Protocol Violation|0|||
170684777|NCT01113801|616859056|FG003|Overall Study|Protocol Violation|0|||
170684778|NCT01113801|616859053|FG000|Overall Study|Withdrawal by Subject|9|||
170684779|NCT01113801|616859054|FG001|Overall Study|Withdrawal by Subject|7|||
170684780|NCT01113801|616859055|FG002|Overall Study|Withdrawal by Subject|7|||
170684781|NCT01113801|616859056|FG003|Overall Study|Withdrawal by Subject|8|||
170684782|NCT01113801|616859053|FG000|Overall Study|Physician Decision|2|||
170684783|NCT01113801|616859054|FG001|Overall Study|Physician Decision|2|||
170684784|NCT01113801|616859055|FG002|Overall Study|Physician Decision|3|||
170684785|NCT01113801|616859056|FG003|Overall Study|Physician Decision|3|||
170684786|NCT01113801|616859053|FG000|Overall Study|Sponsor Decision|15|||
170684787|NCT01113801|616859054|FG001|Overall Study|Sponsor Decision|21|||
170684788|NCT01113801|616859055|FG002|Overall Study|Sponsor Decision|20|||
170684789|NCT01113801|616859056|FG003|Overall Study|Sponsor Decision|15|||
170684790|NCT01113801|616859053|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
170684791|NCT01113801|616859054|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
170684792|NCT01113801|616859055|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
170684793|NCT01113801|616859056|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
170684794|NCT01948050|616859062|FG000|Overall Study|Withdrawal by Subject|0|||
170684795|NCT01948050|616859063|FG001|Overall Study|Withdrawal by Subject|1|||
170684796|NCT01506479|616859065|FG000|Overall Study|Lost to Follow-up|1|||
170684797|NCT01506479|616859066|FG001|Overall Study|Lost to Follow-up|2|||
170684798|NCT01506479|616859067|FG002|Overall Study|Lost to Follow-up|2|||
170684799|NCT01506479|616859065|FG000|Overall Study|Withdrawal by Subject|1|||
170684800|NCT01506479|616859066|FG001|Overall Study|Withdrawal by Subject|2|||
170684801|NCT01506479|616859067|FG002|Overall Study|Withdrawal by Subject|1|||
170684802|NCT01506479|616859065|FG000|Overall Study|Missing assessment|1|||
170684803|NCT01506479|616859066|FG001|Overall Study|Missing assessment|0|||
170684804|NCT01506479|616859067|FG002|Overall Study|Missing assessment|0|||
170684805|NCT01506479|616859065|FG000|Overall Study|Adverse Event|0|||
170684806|NCT01506479|616859066|FG001|Overall Study|Adverse Event|1|||
170684807|NCT01506479|616859067|FG002|Overall Study|Adverse Event|0|||
170684808|NCT03287804|616859068|FG000|Overall Study|Death|1|||
170684809|NCT03287804|616859068|FG000|Overall Study|Physician Decision|2|||
170684810|NCT03287804|616859068|FG000|Overall Study|Progressive disease|8|||
170684811|NCT02746874|616859069|FG000|Overall Study|Withdrawal by Subject|0|||
170684812|NCT02746874|616859070|FG001|Overall Study|Withdrawal by Subject|1|||
170684813|NCT02746874|616859069|FG000|Overall Study|Surgery Date Changed|0|||
170684814|NCT02746874|616859070|FG001|Overall Study|Surgery Date Changed|2|||
170684815|NCT01881776|616859071|FG000|Overall Study|Lost to Follow-up|1|||
170684816|NCT01881776|616859072|FG001|Overall Study|Lost to Follow-up|2|||
170684817|NCT01881776|616859073|FG002|Overall Study|Lost to Follow-up|1|||
170684818|NCT01881776|616859071|FG000|Overall Study|Protocol Violation|0|||
170684819|NCT01881776|616859072|FG001|Overall Study|Protocol Violation|2|||
170684820|NCT01881776|616859073|FG002|Overall Study|Protocol Violation|1|||
170684821|NCT01156311|616859077|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
170684822|NCT01156311|616859078|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
170684823|NCT01156311|616859079|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
170684824|NCT01156311|616859080|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
170684825|NCT01156311|616859077|FG000|2-Month Monotherapy Period|Physician Decision|0|||
170684826|NCT01156311|616859078|FG001|2-Month Monotherapy Period|Physician Decision|1|||
170684827|NCT01156311|616859079|FG002|2-Month Monotherapy Period|Physician Decision|0|||
170684828|NCT01156311|616859080|FG003|2-Month Monotherapy Period|Physician Decision|0|||
170684829|NCT01156311|616859077|FG000|2-Month Monotherapy Period|Other|1|||
170684830|NCT01156311|616859078|FG001|2-Month Monotherapy Period|Other|0|||
170684831|NCT01156311|616859079|FG002|2-Month Monotherapy Period|Other|0|||
170684832|NCT01156311|616859080|FG003|2-Month Monotherapy Period|Other|0|||
170684833|NCT01156311|616859077|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
170684834|NCT01156311|616859078|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
170684835|NCT01156311|616859079|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
170684836|NCT01156311|616859080|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
170684837|NCT01156311|616859077|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
170684838|NCT01156311|616859078|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
170684839|NCT01156311|616859079|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
170684840|NCT01156311|616859080|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
170684841|NCT01156311|616859077|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
170684842|NCT01156311|616859078|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
170684843|NCT01156311|616859079|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
170684844|NCT01156311|616859080|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
170684845|NCT01156311|616859077|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
170684846|NCT01156311|616859078|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
170684847|NCT01156311|616859079|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
170684848|NCT01156311|616859080|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
170684849|NCT01156311|616859077|FG000|6-month Add-on Therapy Period|Other|0|||
170684850|NCT01156311|616859078|FG001|6-month Add-on Therapy Period|Other|0|||
170684851|NCT01156311|616859079|FG002|6-month Add-on Therapy Period|Other|1|||
170684852|NCT01156311|616859080|FG003|6-month Add-on Therapy Period|Other|2|||
170684853|NCT06073119|616859083|FG000|Overall Study|Adverse Event|1|||
170684854|NCT06073119|616859084|FG001|Overall Study|Adverse Event|3|||
170684855|NCT06073119|616859085|FG002|Overall Study|Adverse Event|0|||
170684856|NCT06073119|616859086|FG003|Overall Study|Adverse Event|0|||
170684857|NCT06073119|616859087|FG004|Overall Study|Adverse Event|1|||
170684858|NCT06073119|616859088|FG005|Overall Study|Adverse Event|0|||
170820955|NCT00043186|617353206|FG008|Overall Study|Adverse Event|3|||
170820956|NCT00043186|617353198|FG000|Overall Study|Withdrawal by Subject|11|||
170820957|NCT00043186|617353199|FG001|Overall Study|Withdrawal by Subject|8|||
170820958|NCT00043186|617353200|FG002|Overall Study|Withdrawal by Subject|11|||
170820959|NCT00043186|617353201|FG003|Overall Study|Withdrawal by Subject|13|||
170820960|NCT00043186|617353202|FG004|Overall Study|Withdrawal by Subject|14|||
170820961|NCT00043186|617353203|FG005|Overall Study|Withdrawal by Subject|6|||
170820962|NCT00043186|617353204|FG006|Overall Study|Withdrawal by Subject|12|||
170820963|NCT00043186|617353205|FG007|Overall Study|Withdrawal by Subject|9|||
170820964|NCT00043186|617353206|FG008|Overall Study|Withdrawal by Subject|10|||
170820965|NCT00043186|617353198|FG000|Overall Study|Death|0|||
170820966|NCT00043186|617353199|FG001|Overall Study|Death|0|||
170820967|NCT00043186|617353200|FG002|Overall Study|Death|1|||
170820968|NCT00043186|617353201|FG003|Overall Study|Death|0|||
170820969|NCT00043186|617353202|FG004|Overall Study|Death|0|||
170820970|NCT00043186|617353203|FG005|Overall Study|Death|0|||
170820971|NCT00043186|617353204|FG006|Overall Study|Death|2|||
170684859|NCT06073119|616859083|FG000|Overall Study|Non-compliance with study schedule|1|||
170684860|NCT06073119|616859084|FG001|Overall Study|Non-compliance with study schedule|0|||
170684861|NCT06073119|616859085|FG002|Overall Study|Non-compliance with study schedule|0|||
170684862|NCT06073119|616859086|FG003|Overall Study|Non-compliance with study schedule|0|||
170684863|NCT06073119|616859087|FG004|Overall Study|Non-compliance with study schedule|1|||
170684864|NCT06073119|616859088|FG005|Overall Study|Non-compliance with study schedule|0|||
170684865|NCT06073119|616859083|FG000|Overall Study|Withdrawal by Subject|4|||
170684866|NCT06073119|616859084|FG001|Overall Study|Withdrawal by Subject|4|||
170820972|NCT00043186|617353205|FG007|Overall Study|Death|0|||
170820973|NCT00043186|617353206|FG008|Overall Study|Death|0|||
170684867|NCT06073119|616859085|FG002|Overall Study|Withdrawal by Subject|3|||
170684868|NCT06073119|616859086|FG003|Overall Study|Withdrawal by Subject|5|||
170684869|NCT06073119|616859087|FG004|Overall Study|Withdrawal by Subject|3|||
170684870|NCT06073119|616859088|FG005|Overall Study|Withdrawal by Subject|1|||
170684871|NCT06073119|616859083|FG000|Overall Study|Other|2|||
170684872|NCT06073119|616859084|FG001|Overall Study|Other|4|||
170684873|NCT06073119|616859085|FG002|Overall Study|Other|1|||
170684874|NCT06073119|616859086|FG003|Overall Study|Other|0|||
170684875|NCT06073119|616859087|FG004|Overall Study|Other|1|||
170684876|NCT06073119|616859088|FG005|Overall Study|Other|0|||
170684877|NCT00673465|616859099|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684878|NCT00673465|616859100|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684879|NCT00673465|616859101|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684880|NCT00673465|616859102|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684881|NCT00673465|616859103|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
170684882|NCT00673465|616859104|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
170684883|NCT00673465|616859105|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684884|NCT00673465|616859106|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684885|NCT00673465|616859107|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684886|NCT00673465|616859108|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684887|NCT00673465|616859109|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684888|NCT00673465|616859110|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
170684889|NCT00673465|616859099|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684890|NCT00673465|616859100|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684891|NCT00673465|616859101|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684892|NCT00673465|616859102|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684893|NCT00673465|616859103|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
170684894|NCT00673465|616859104|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684895|NCT00673465|616859105|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684896|NCT00673465|616859106|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684897|NCT00673465|616859107|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684898|NCT00673465|616859108|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684899|NCT00673465|616859109|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684900|NCT00673465|616859110|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
170684901|NCT00680745|616859116|FG000|Overall Study|Withdrawal by Subject|8|||
170684902|NCT00680745|616859117|FG001|Overall Study|Withdrawal by Subject|3|||
170684903|NCT00680745|616859118|FG002|Overall Study|Withdrawal by Subject|2|||
170684904|NCT00680745|616859119|FG003|Overall Study|Withdrawal by Subject|8|||
170684905|NCT00680745|616859116|FG000|Overall Study|Lost to Follow-up|0|||
170684906|NCT00680745|616859117|FG001|Overall Study|Lost to Follow-up|1|||
170684907|NCT00680745|616859118|FG002|Overall Study|Lost to Follow-up|1|||
170684908|NCT00680745|616859119|FG003|Overall Study|Lost to Follow-up|0|||
170684909|NCT00680745|616859116|FG000|Overall Study|Death|1|||
170684910|NCT00680745|616859117|FG001|Overall Study|Death|0|||
170684911|NCT00680745|616859118|FG002|Overall Study|Death|1|||
170684912|NCT00680745|616859119|FG003|Overall Study|Death|0|||
170684913|NCT00680745|616859116|FG000|Overall Study|Adverse Event|5|||
170684914|NCT00680745|616859117|FG001|Overall Study|Adverse Event|3|||
170684915|NCT00680745|616859118|FG002|Overall Study|Adverse Event|3|||
170684916|NCT00680745|616859119|FG003|Overall Study|Adverse Event|3|||
170684917|NCT00680745|616859116|FG000|Overall Study|Poor/Non-compliance|0|||
170684918|NCT00680745|616859117|FG001|Overall Study|Poor/Non-compliance|3|||
170684919|NCT00680745|616859118|FG002|Overall Study|Poor/Non-compliance|0|||
170684920|NCT00680745|616859119|FG003|Overall Study|Poor/Non-compliance|0|||
170684921|NCT00680745|616859116|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
170684922|NCT00680745|616859117|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
170684923|NCT00680745|616859118|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
170684924|NCT00680745|616859119|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
170684925|NCT00680745|616859116|FG000|Overall Study|False Treatment|0|||
170684926|NCT00680745|616859117|FG001|Overall Study|False Treatment|1|||
170684927|NCT00680745|616859118|FG002|Overall Study|False Treatment|3|||
170684928|NCT00680745|616859119|FG003|Overall Study|False Treatment|0|||
170684929|NCT01408914|616859122|FG000|Overall Study|Could not complete tx in protocol period|5|||
170684930|NCT01408914|616859123|FG001|Overall Study|Could not complete tx in protocol period|5|||
170684931|NCT01408914|616859124|FG002|Overall Study|Could not complete tx in protocol period|6|||
170684932|NCT01408914|616859122|FG000|Overall Study|Lost to Follow-up|4|||
170684933|NCT01408914|616859123|FG001|Overall Study|Lost to Follow-up|1|||
170684934|NCT01408914|616859124|FG002|Overall Study|Lost to Follow-up|2|||
170684935|NCT01408914|616859122|FG000|Overall Study|Physician Decision|1|||
170684936|NCT01408914|616859123|FG001|Overall Study|Physician Decision|1|||
170684937|NCT01408914|616859124|FG002|Overall Study|Physician Decision|0|||
170684938|NCT01408914|616859122|FG000|Overall Study|Withdrawal by Subject|1|||
170684939|NCT01408914|616859123|FG001|Overall Study|Withdrawal by Subject|0|||
170820974|NCT00043186|617353198|FG000|Overall Study|Disease progression|1|||
170684940|NCT01408914|616859124|FG002|Overall Study|Withdrawal by Subject|1|||
170684941|NCT01408914|616859122|FG000|Overall Study|Moved out of study jurisdiction|1|||
170684942|NCT01408914|616859123|FG001|Overall Study|Moved out of study jurisdiction|1|||
170684943|NCT01408914|616859124|FG002|Overall Study|Moved out of study jurisdiction|0|||
170684944|NCT01408914|616859122|FG000|Overall Study|Late exclusion|0|||
170684945|NCT01408914|616859123|FG001|Overall Study|Late exclusion|3|||
170684946|NCT01408914|616859124|FG002|Overall Study|Late exclusion|3|||
170684947|NCT01408914|616859122|FG000|Overall Study|Change in local TB/HIV norms|0|||
170684948|NCT01408914|616859123|FG001|Overall Study|Change in local TB/HIV norms|1|||
170684949|NCT01408914|616859124|FG002|Overall Study|Change in local TB/HIV norms|1|||
170684950|NCT01585194|616859127|FG000|Overall Study|Withdrawal by Subject|1|||
170684951|NCT01585194|616859127|FG000|Overall Study|Physician Decision|2|||
170684952|NCT01585194|616859127|FG000|Overall Study|Lack of insurance|1|||
170684953|NCT02730455|616859128|FG000|Overall Study|Death|5|||
170684954|NCT02730455|616859129|FG001|Overall Study|Death|6|||
170684955|NCT02730455|616859130|FG002|Overall Study|Death|4|||
170684956|NCT02730455|616859128|FG000|Overall Study|Consent withdrawn|2|||
170684957|NCT02730455|616859129|FG001|Overall Study|Consent withdrawn|4|||
170684958|NCT02730455|616859130|FG002|Overall Study|Consent withdrawn|1|||
170684959|NCT02730455|616859128|FG000|Overall Study|Lost to Follow-up|3|||
170684960|NCT02730455|616859129|FG001|Overall Study|Lost to Follow-up|1|||
170684961|NCT02730455|616859130|FG002|Overall Study|Lost to Follow-up|4|||
170684962|NCT02730455|616859128|FG000|Overall Study|Other|1|||
170684963|NCT02730455|616859129|FG001|Overall Study|Other|1|||
170684964|NCT02730455|616859130|FG002|Overall Study|Other|2|||
170684965|NCT02730455|616859128|FG000|Overall Study|Other|2|||
170684966|NCT02730455|616859129|FG001|Overall Study|Other|2|||
170684967|NCT02730455|616859130|FG002|Overall Study|Other|0|||
170684968|NCT00993291|616859131|FG000|Overall Study|Withdrawal by Subject|1|||
170684969|NCT00003492|616859132|FG000|Overall Study|Not evaluable|6|||
170684970|NCT02733367|616859133|FG000|Overall Study|Withdrawal by Subject|6|||
170684971|NCT01348347|616859134|FG000|Overall Study|Withdrawal by Subject|1|||
170684972|NCT01348347|616859135|FG001|Overall Study|Withdrawal by Subject|1|||
170684973|NCT01348347|616859136|FG002|Overall Study|Withdrawal by Subject|1|||
170684974|NCT01348347|616859134|FG000|Overall Study|Progressive disease|2|||
170684975|NCT01348347|616859135|FG001|Overall Study|Progressive disease|5|||
170684976|NCT01348347|616859136|FG002|Overall Study|Progressive disease|5|||
170684977|NCT04903626|616859137|FG000|Overall Study|Lost to Follow-up|6|||
170684978|NCT04903626|616859137|FG000|Overall Study|Withdrawal by Subject|1|||
170684979|NCT04903626|616859137|FG000|Overall Study|Other, Not Specified|1|||
170684980|NCT05582889|616859138|FG000|Overall Study|Health event|3|||
170684981|NCT05582889|616859139|FG001|Overall Study|Health event|2|||
170684982|NCT05582889|616859138|FG000|Overall Study|Lost to Follow-up|2|||
170684983|NCT05582889|616859139|FG001|Overall Study|Lost to Follow-up|4|||
170684984|NCT00996307|616859140|FG000|Overall Study|Adverse Event|0|||
170684985|NCT00996307|616859141|FG001|Overall Study|Adverse Event|1|||
170684986|NCT00996307|616859142|FG002|Overall Study|Adverse Event|0|||
170684987|NCT00996307|616859143|FG003|Overall Study|Adverse Event|0|||
170684988|NCT00996307|616859140|FG000|Overall Study|Withdrawal by Subject|3|||
170684989|NCT00996307|616859141|FG001|Overall Study|Withdrawal by Subject|2|||
170684990|NCT00996307|616859142|FG002|Overall Study|Withdrawal by Subject|5|||
170684991|NCT00996307|616859143|FG003|Overall Study|Withdrawal by Subject|5|||
170684992|NCT00996307|616859140|FG000|Overall Study|Lost to Follow-up|13|||
170684993|NCT00996307|616859141|FG001|Overall Study|Lost to Follow-up|13|||
170684994|NCT00996307|616859142|FG002|Overall Study|Lost to Follow-up|7|||
170684995|NCT00996307|616859143|FG003|Overall Study|Lost to Follow-up|15|||
170684996|NCT00996307|616859140|FG000|Overall Study|Administrative reason|0|||
170684997|NCT00996307|616859141|FG001|Overall Study|Administrative reason|1|||
170684998|NCT00996307|616859142|FG002|Overall Study|Administrative reason|0|||
170684999|NCT00996307|616859143|FG003|Overall Study|Administrative reason|0|||
170685000|NCT00996307|616859140|FG000|Overall Study|Unable to classify|4|||
170685001|NCT00996307|616859141|FG001|Overall Study|Unable to classify|0|||
170685002|NCT00996307|616859142|FG002|Overall Study|Unable to classify|2|||
170685003|NCT00996307|616859143|FG003|Overall Study|Unable to classify|1|||
170685004|NCT01867021|616859144|FG000|Overall Study|Adverse Event|0|||
170685005|NCT01867021|616859145|FG001|Overall Study|Adverse Event|1|||
170685006|NCT01867021|616859144|FG000|Overall Study|Not Eligible|0|||
170685007|NCT01867021|616859145|FG001|Overall Study|Not Eligible|1|||
170685008|NCT01867021|616859144|FG000|Overall Study|Death|1|||
170685009|NCT01867021|616859145|FG001|Overall Study|Death|0|||
170685010|NCT01867021|616859144|FG000|Overall Study|Lost to Follow-up|0|||
170820975|NCT00043186|617353199|FG001|Overall Study|Disease progression|0|||
170685011|NCT01867021|616859145|FG001|Overall Study|Lost to Follow-up|2|||
170685012|NCT01867021|616859144|FG000|Overall Study|Withdrawal by Subject|1|||
170685013|NCT01867021|616859145|FG001|Overall Study|Withdrawal by Subject|6|||
170685014|NCT01712490|616859146|FG000|Overall Study|Ongoing|601|||
170685015|NCT01712490|616859147|FG001|Overall Study|Ongoing|586|||
170685016|NCT01712490|616859146|FG000|Overall Study|Other|11|||
170685017|NCT01712490|616859147|FG001|Overall Study|Other|11|||
170685018|NCT01712490|616859146|FG000|Overall Study|Withdrawal by Subject|36|||
170685019|NCT01712490|616859147|FG001|Overall Study|Withdrawal by Subject|44|||
170685020|NCT01712490|616859146|FG000|Overall Study|Lost to Follow-up|16|||
170685021|NCT01712490|616859147|FG001|Overall Study|Lost to Follow-up|29|||
170685022|NCT03060629|616859152|FG000|Overall Study|Death|4|||
170685023|NCT03060629|616859153|FG001|Overall Study|Death|5|||
170685024|NCT03060629|616859152|FG000|Overall Study|Withdrawal by Subject|50|||
170685025|NCT03060629|616859153|FG001|Overall Study|Withdrawal by Subject|35|||
170685026|NCT03060629|616859152|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
170685027|NCT03060629|616859153|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
170685028|NCT03060629|616859152|FG000|Overall Study|Participant Relocate|15|||
170685029|NCT03060629|616859153|FG001|Overall Study|Participant Relocate|15|||
170685030|NCT03060629|616859152|FG000|Overall Study|Unable to Contact Participant|34|||
170685031|NCT03060629|616859153|FG001|Overall Study|Unable to Contact Participant|23|||
170685032|NCT03060629|616859152|FG000|Overall Study|Investigator Decision|7|||
170685033|NCT03060629|616859153|FG001|Overall Study|Investigator Decision|7|||
170685034|NCT03060629|616859152|FG000|Overall Study|Study Terminated by Sponsor|1100|||
170685035|NCT03060629|616859153|FG001|Overall Study|Study Terminated by Sponsor|1123|||
170685036|NCT03060629|616859152|FG000|Overall Study|Other|4|||
170685037|NCT03060629|616859153|FG001|Overall Study|Other|4|||
170685038|NCT01927367|616859157|FG000|Overall Study|Withdrawal by Subject|7|||
170685039|NCT01927367|616859158|FG001|Overall Study|Withdrawal by Subject|4|||
170685040|NCT01927367|616859157|FG000|Overall Study|No baseline data|0|||
170685041|NCT01927367|616859158|FG001|Overall Study|No baseline data|1|||
170685042|NCT01634360|616859159|FG000|Overall Study|Adverse Event|10|||
170685043|NCT01634360|616859160|FG001|Overall Study|Adverse Event|34|||
170685044|NCT01634360|616859159|FG000|Overall Study|subject withdrew consent|13|||
170685045|NCT01634360|616859160|FG001|Overall Study|subject withdrew consent|23|||
170685046|NCT01634360|616859159|FG000|Overall Study|Protocol Violation|1|||
170685047|NCT01634360|616859160|FG001|Overall Study|Protocol Violation|1|||
170685048|NCT01634360|616859159|FG000|Overall Study|Lack of Efficacy|4|||
170685049|NCT01634360|616859160|FG001|Overall Study|Lack of Efficacy|14|||
170685050|NCT01634360|616859159|FG000|Overall Study|Other|3|||
170685051|NCT01634360|616859160|FG001|Overall Study|Other|20|||
170685052|NCT01634360|616859159|FG000|Overall Study|Study termination by sponsor|18|||
170685053|NCT01634360|616859160|FG001|Overall Study|Study termination by sponsor|44|||
170685054|NCT03171415|616859162|FG000|Overall Study|Lost to Follow-up|0|||
170685055|NCT03171415|616859163|FG001|Overall Study|Lost to Follow-up|0|||
170685056|NCT03171415|616859164|FG002|Overall Study|Lost to Follow-up|0|||
170685057|NCT03171415|616859165|FG003|Overall Study|Lost to Follow-up|0|||
170685058|NCT03171415|616859166|FG004|Overall Study|Lost to Follow-up|2|||
170685059|NCT02848651|616859171|FG000|Overall Study|Death|85|||
170685060|NCT02848651|616859171|FG000|Overall Study|Lost to Follow-up|1|||
170685061|NCT02848651|616859171|FG000|Overall Study|Non-Compliance|1|||
170685062|NCT02848651|616859171|FG000|Overall Study|Symptomatic Deterioration|1|||
170685063|NCT02848651|616859171|FG000|Overall Study|Physician Decision|4|||
170685064|NCT02848651|616859171|FG000|Overall Study|Withdrawal by Subject|14|||
170685065|NCT00883116|616859172|FG000|Overall Study|Adverse event unrelated to study drug|5|||
170685066|NCT00883116|616859173|FG001|Overall Study|Adverse event unrelated to study drug|10|||
170685067|NCT00883116|616859172|FG000|Overall Study|Death|6|||
170685068|NCT00883116|616859173|FG001|Overall Study|Death|2|||
170685069|NCT00883116|616859172|FG000|Overall Study|Disease progression|130|||
170685070|NCT00883116|616859173|FG001|Overall Study|Disease progression|128|||
170685071|NCT00883116|616859172|FG000|Overall Study|Lost to Follow-up|0|||
170685072|NCT00883116|616859173|FG001|Overall Study|Lost to Follow-up|1|||
170685073|NCT00883116|616859172|FG000|Overall Study|Maximum clinical benefit|13|||
170685074|NCT00883116|616859173|FG001|Overall Study|Maximum clinical benefit|46|||
170685075|NCT00883116|616859172|FG000|Overall Study|Not identified|3|||
170685076|NCT00883116|616859173|FG001|Overall Study|Not identified|6|||
170685077|NCT00883116|616859172|FG000|Overall Study|Study drug toxicity|36|||
170685078|NCT00883116|616859173|FG001|Overall Study|Study drug toxicity|16|||
170685079|NCT00883116|616859172|FG000|Overall Study|Withdrawal by Subject|14|||
170685080|NCT00883116|616859173|FG001|Overall Study|Withdrawal by Subject|8|||
170685081|NCT00883116|616859172|FG000|Overall Study|No longer meets study criteria|2|||
170685082|NCT00883116|616859173|FG001|Overall Study|No longer meets study criteria|2|||
170685083|NCT00897104|616859174|FG000|Overall Study|Lost to Follow-up|12|||
170685084|NCT00897104|616859175|FG001|Overall Study|Lost to Follow-up|17|||
170685085|NCT00897104|616859176|FG002|Overall Study|Lost to Follow-up|2|||
170685086|NCT00897104|616859174|FG000|Overall Study|Pregnancy|0|||
170685087|NCT00897104|616859175|FG001|Overall Study|Pregnancy|1|||
170685088|NCT00897104|616859176|FG002|Overall Study|Pregnancy|0|||
170685089|NCT00897104|616859174|FG000|Overall Study|Protocol Violation|0|||
170820976|NCT00043186|617353200|FG002|Overall Study|Disease progression|0|||
170820977|NCT00043186|617353201|FG003|Overall Study|Disease progression|3|||
170820978|NCT00043186|617353202|FG004|Overall Study|Disease progression|0|||
170820979|NCT00043186|617353203|FG005|Overall Study|Disease progression|0|||
170820980|NCT00043186|617353204|FG006|Overall Study|Disease progression|0|||
170820981|NCT00043186|617353205|FG007|Overall Study|Disease progression|4|||
170685090|NCT00897104|616859175|FG001|Overall Study|Protocol Violation|1|||
170685091|NCT00897104|616859176|FG002|Overall Study|Protocol Violation|0|||
170685092|NCT00897104|616859174|FG000|Overall Study|Withdrawal by Subject|23|||
170685093|NCT00897104|616859175|FG001|Overall Study|Withdrawal by Subject|27|||
170685094|NCT00897104|616859176|FG002|Overall Study|Withdrawal by Subject|3|||
170685095|NCT00897104|616859174|FG000|Overall Study|Abnormal Prestudy Labs|2|||
170685096|NCT00897104|616859175|FG001|Overall Study|Abnormal Prestudy Labs|0|||
170685097|NCT00897104|616859176|FG002|Overall Study|Abnormal Prestudy Labs|0|||
170685098|NCT00897104|616859174|FG000|Overall Study|Abnormal Baseline ECG|2|||
170685099|NCT00897104|616859175|FG001|Overall Study|Abnormal Baseline ECG|2|||
170685100|NCT00897104|616859176|FG002|Overall Study|Abnormal Baseline ECG|0|||
170685101|NCT00897104|616859174|FG000|Overall Study|Need for Concom. Med.|0|||
170685102|NCT00897104|616859175|FG001|Overall Study|Need for Concom. Med.|1|||
170685103|NCT00897104|616859176|FG002|Overall Study|Need for Concom. Med.|1|||
170685104|NCT00897104|616859174|FG000|Overall Study|Lack of Migraine Attack|20|||
170685105|NCT00897104|616859175|FG001|Overall Study|Lack of Migraine Attack|22|||
170685106|NCT00897104|616859176|FG002|Overall Study|Lack of Migraine Attack|1|||
170685107|NCT00897104|616859174|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
170685108|NCT00897104|616859175|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
170685109|NCT00897104|616859176|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
170685110|NCT00897104|616859174|FG000|Overall Study|Other|3|||
170685111|NCT00897104|616859175|FG001|Overall Study|Other|0|||
170685112|NCT00897104|616859176|FG002|Overall Study|Other|0|||
170685113|NCT00897104|616859174|FG000|Overall Study|Protocol Violation|1|||
170685114|NCT00897104|616859175|FG001|Overall Study|Protocol Violation|0|||
170685115|NCT00897104|616859176|FG002|Overall Study|Protocol Violation|0|||
170685116|NCT00897104|616859174|FG000|Overall Study|Withdrawal by Subject|0|||
170685117|NCT00897104|616859175|FG001|Overall Study|Withdrawal by Subject|0|||
170685118|NCT00897104|616859176|FG002|Overall Study|Withdrawal by Subject|1|||
170685119|NCT04140292|616859177|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
170685120|NCT04140292|616859178|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
170685121|NCT00396591|616859179|FG000|Overall Study|Disease Progression|13|||
170685122|NCT00396591|616859179|FG000|Overall Study|Adverse Event|2|||
170685123|NCT00396591|616859179|FG000|Overall Study|Participant request|1|||
170685124|NCT00750204|616859180|FG000|Overall Study|study halted prematurely|1|||
170685125|NCT00750204|616859181|FG001|Overall Study|study halted prematurely|1|||
170685126|NCT01962207|616859183|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
170685127|NCT01962207|616859184|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
170685128|NCT01962207|616859185|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
170685129|NCT01962207|616859186|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
170685130|NCT01962207|616859183|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
170685131|NCT01962207|616859184|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
170685132|NCT01962207|616859185|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
170685133|NCT01962207|616859186|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
170685134|NCT01962207|616859183|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
170685135|NCT01962207|616859184|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
170685136|NCT01962207|616859185|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
170685137|NCT01962207|616859186|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
170685138|NCT01962207|616859183|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
170685139|NCT01962207|616859184|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
170685140|NCT01962207|616859185|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
170685141|NCT01962207|616859186|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
170685142|NCT01962207|616859183|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
170685143|NCT01962207|616859184|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
170685144|NCT01962207|616859185|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
170685145|NCT01962207|616859186|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
170685146|NCT01962207|616859183|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
170685147|NCT01962207|616859184|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
170685148|NCT01962207|616859185|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
170685149|NCT01962207|616859186|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
170685150|NCT00680043|616859187|FG000|Overall Study|Withdrawal by Subject|1|||
170685151|NCT00680043|616859188|FG001|Overall Study|Withdrawal by Subject|0|||
170685152|NCT00680043|616859189|FG002|Overall Study|Withdrawal by Subject|0|||
170685153|NCT00680043|616859187|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
170685154|NCT00680043|616859188|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
170685155|NCT00680043|616859189|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
170685156|NCT00680043|616859187|FG000|Overall Study|Renal Transplant|1|||
170685157|NCT00680043|616859188|FG001|Overall Study|Renal Transplant|0|||
170685158|NCT00680043|616859189|FG002|Overall Study|Renal Transplant|4|||
170685159|NCT02484729|616859190|FG000|Overall Study|Failure of IntelliCap Error|0|||
170685160|NCT02484729|616859191|FG001|Overall Study|Failure of IntelliCap Error|0|||
170685161|NCT02484729|616859192|FG002|Overall Study|Failure of IntelliCap Error|0|||
170685162|NCT02484729|616859193|FG003|Overall Study|Failure of IntelliCap Error|0|||
170685163|NCT02484729|616859194|FG004|Overall Study|Failure of IntelliCap Error|0|||
170685164|NCT02484729|616859195|FG005|Overall Study|Failure of IntelliCap Error|0|||
170685165|NCT02484729|616859196|FG006|Overall Study|Failure of IntelliCap Error|0|||
170685166|NCT02484729|616859197|FG007|Overall Study|Failure of IntelliCap Error|0|||
170685167|NCT02484729|616859198|FG008|Overall Study|Failure of IntelliCap Error|0|||
170685168|NCT02484729|616859199|FG009|Overall Study|Failure of IntelliCap Error|1|||
170685169|NCT01031069|616859202|FG000|Overall Study|Serious Adverse Event|0|||
170685170|NCT01031069|616859203|FG001|Overall Study|Serious Adverse Event|1|||
170685171|NCT01031069|616859204|FG002|Overall Study|Serious Adverse Event|0|||
170685172|NCT01031069|616859205|FG003|Overall Study|Serious Adverse Event|0|||
170685173|NCT01031069|616859202|FG000|Overall Study|Withdrawal by Subject|2|||
170685174|NCT01031069|616859203|FG001|Overall Study|Withdrawal by Subject|3|||
170685175|NCT01031069|616859204|FG002|Overall Study|Withdrawal by Subject|18|||
170685176|NCT01031069|616859205|FG003|Overall Study|Withdrawal by Subject|18|||
170685177|NCT01031069|616859202|FG000|Overall Study|Migrated/moved from study area|1|||
170685178|NCT01031069|616859203|FG001|Overall Study|Migrated/moved from study area|2|||
170685179|NCT01031069|616859204|FG002|Overall Study|Migrated/moved from study area|1|||
170685180|NCT01031069|616859205|FG003|Overall Study|Migrated/moved from study area|1|||
170685181|NCT01031069|616859202|FG000|Overall Study|Lost to Follow-up|9|||
170685182|NCT01031069|616859203|FG001|Overall Study|Lost to Follow-up|5|||
170685183|NCT01031069|616859204|FG002|Overall Study|Lost to Follow-up|21|||
170685184|NCT01031069|616859205|FG003|Overall Study|Lost to Follow-up|15|||
170685185|NCT01031069|616859202|FG000|Overall Study|Other|0|||
170685186|NCT01031069|616859203|FG001|Overall Study|Other|0|||
170685187|NCT01031069|616859204|FG002|Overall Study|Other|1|||
170685188|NCT01031069|616859205|FG003|Overall Study|Other|0|||
170685189|NCT00415909|616861443|FG000|Overall Study|Withdrawal by Subject|2|||
170685190|NCT00415909|616861443|FG000|Overall Study|Death|1|||
170685191|NCT05024058|616861444|FG000|Treatment|Study terminated by sponsor|5|||
170685192|NCT05024058|616861445|FG001|Treatment|Study terminated by sponsor|6|||
170685193|NCT05024058|616861446|FG002|Treatment|Study terminated by sponsor|4|||
170685194|NCT05024058|616861447|FG003|Treatment|Study terminated by sponsor|2|||
170685195|NCT05024058|616861448|FG004|Treatment|Study terminated by sponsor|3|||
170685196|NCT05024058|616861449|FG005|Treatment|Study terminated by sponsor|3|||
170685197|NCT05024058|616861450|FG006|Treatment|Study terminated by sponsor|1|||
170685198|NCT05024058|616861451|FG007|Treatment|Study terminated by sponsor|3|||
170685199|NCT05024058|616861452|FG008|Treatment|Study terminated by sponsor|6|||
170685200|NCT05024058|616861453|FG009|Treatment|Study terminated by sponsor|6|||
170685201|NCT05024058|616861444|FG000|Follow-up|Withdrawal by Subject|1|||
170685202|NCT05024058|616861445|FG001|Follow-up|Withdrawal by Subject|0|||
170685203|NCT05024058|616861446|FG002|Follow-up|Withdrawal by Subject|1|||
170685204|NCT05024058|616861447|FG003|Follow-up|Withdrawal by Subject|0|||
170685205|NCT05024058|616861448|FG004|Follow-up|Withdrawal by Subject|0|||
170685206|NCT05024058|616861449|FG005|Follow-up|Withdrawal by Subject|0|||
170685207|NCT05024058|616861450|FG006|Follow-up|Withdrawal by Subject|0|||
170685208|NCT05024058|616861451|FG007|Follow-up|Withdrawal by Subject|1|||
170685209|NCT05024058|616861452|FG008|Follow-up|Withdrawal by Subject|0|||
170685210|NCT05024058|616861453|FG009|Follow-up|Withdrawal by Subject|1|||
170685211|NCT02507505|616861458|FG000|Overall Study|Withdrawal by Subject|13|||
170685212|NCT02507505|616861459|FG001|Overall Study|Withdrawal by Subject|11|||
170685213|NCT02507505|616861458|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
170685214|NCT02507505|616861459|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
170685215|NCT02507505|616861458|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
170685216|NCT02507505|616861459|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
170685217|NCT02507505|616861458|FG000|Overall Study|Death before receipt of anesthesia|0|||
170685218|NCT02507505|616861459|FG001|Overall Study|Death before receipt of anesthesia|1|||
170685219|NCT00931762|616861460|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
170685220|NCT00931762|616861460|FG000|Overall Study|Administrative Problems|5|||
170685221|NCT00931762|616861460|FG000|Overall Study|Death|1|||
170685222|NCT00931762|616861460|FG000|Overall Study|Disease Progression|3|||
170685223|NCT00931762|616861460|FG000|Overall Study|Adverse Event (s)|11|||
170685224|NCT00931762|616861460|FG000|Overall Study|Subject withdrew consent|13|||
170685225|NCT03182829|616861461|FG000|Overall Study|Protocol Violation|12|||
170685226|NCT03182829|616861462|FG001|Overall Study|Protocol Violation|12|||
170685227|NCT03182829|616861461|FG000|Overall Study|Other|4|||
170685228|NCT03182829|616861462|FG001|Overall Study|Other|3|||
170685229|NCT02664441|616861463|FG000|Randomization|Withdrawal by Subject|0|||
170685230|NCT02664441|616861464|FG001|Randomization|Withdrawal by Subject|1|||
170685231|NCT02664441|616861463|FG000|36-week Randomized Trial|Adverse Event|2|||
170685232|NCT02664441|616861464|FG001|36-week Randomized Trial|Adverse Event|0|||
170685233|NCT02664441|616861463|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
170685234|NCT02664441|616861464|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
170685235|NCT02664441|616861463|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
170685236|NCT02664441|616861464|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
170685237|NCT02664441|616861463|FG000|18-week Open Label Extension|Adverse Event|1|||
170685238|NCT02664441|616861464|FG001|18-week Open Label Extension|Adverse Event|0|||
170685239|NCT02664441|616861463|FG000|18-week Open Label Extension|Physician Decision|1|||
170685240|NCT02664441|616861464|FG001|18-week Open Label Extension|Physician Decision|0|||
170685241|NCT02664441|616861463|FG000|18-week Open Label Extension|Death|1|||
170685242|NCT02664441|616861464|FG001|18-week Open Label Extension|Death|0|||
170685243|NCT02664441|616861463|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
170685244|NCT02664441|616861464|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
170685245|NCT03510884|616861465|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
170685246|NCT03510884|616861466|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
170685247|NCT03510884|616861467|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
170685248|NCT03510884|616861468|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
170685249|NCT03510884|616861465|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
170685250|NCT03510884|616861466|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
170685251|NCT03510884|616861467|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
170685252|NCT03510884|616861468|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
170685253|NCT03510884|616861465|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
170685254|NCT03510884|616861466|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
170685255|NCT03510884|616861467|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
170685256|NCT03510884|616861468|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
170685257|NCT03510884|616861465|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
170685258|NCT03510884|616861466|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
170685259|NCT03510884|616861467|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
170685260|NCT03510884|616861468|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
170685261|NCT03510884|616861465|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
170685262|NCT03510884|616861466|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
170685263|NCT03510884|616861467|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
170685264|NCT03510884|616861468|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
170685265|NCT03510884|616861465|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
170685266|NCT03510884|616861466|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
170685267|NCT03510884|616861467|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
170685268|NCT03510884|616861468|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
170685269|NCT03510884|616861465|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
170685270|NCT03510884|616861466|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
170685271|NCT03510884|616861467|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
170685272|NCT03510884|616861468|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
170685273|NCT03510884|616861465|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
170685274|NCT03510884|616861466|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
170685275|NCT03510884|616861467|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
170685276|NCT03510884|616861468|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
170685277|NCT03510884|616861465|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
170685278|NCT03510884|616861466|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
170685279|NCT03510884|616861467|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
170685280|NCT03510884|616861468|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
170685281|NCT03510884|616861465|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
170685282|NCT03510884|616861466|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
170685283|NCT03510884|616861467|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
170685284|NCT03510884|616861468|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
170685285|NCT01287897|616861469|FG000|Overall Study|Adverse Event|5|||
170685286|NCT01287897|616861470|FG001|Overall Study|Adverse Event|3|||
170685287|NCT01287897|616861471|FG002|Overall Study|Adverse Event|6|||
170685288|NCT01287897|616861472|FG003|Overall Study|Adverse Event|4|||
170685289|NCT01287897|616861469|FG000|Overall Study|Lack of Efficacy|2|||
170685290|NCT01287897|616861470|FG001|Overall Study|Lack of Efficacy|0|||
170685291|NCT01287897|616861471|FG002|Overall Study|Lack of Efficacy|0|||
170685292|NCT01287897|616861472|FG003|Overall Study|Lack of Efficacy|0|||
170685293|NCT01287897|616861469|FG000|Overall Study|Protocol Violation|1|||
170685294|NCT01287897|616861470|FG001|Overall Study|Protocol Violation|1|||
170685295|NCT01287897|616861471|FG002|Overall Study|Protocol Violation|0|||
170685296|NCT01287897|616861472|FG003|Overall Study|Protocol Violation|1|||
170685297|NCT01287897|616861469|FG000|Overall Study|Lost to Follow-up|0|||
170685298|NCT01287897|616861470|FG001|Overall Study|Lost to Follow-up|0|||
170685299|NCT01287897|616861471|FG002|Overall Study|Lost to Follow-up|2|||
170820982|NCT00043186|617353206|FG008|Overall Study|Disease progression|0|||
170820983|NCT00043186|617353198|FG000|Overall Study|Ineligibility determined|0|||
170820984|NCT00043186|617353199|FG001|Overall Study|Ineligibility determined|0|||
170820985|NCT00043186|617353200|FG002|Overall Study|Ineligibility determined|0|||
170820986|NCT00043186|617353201|FG003|Overall Study|Ineligibility determined|0|||
170820987|NCT00043186|617353202|FG004|Overall Study|Ineligibility determined|0|||
170820988|NCT00043186|617353203|FG005|Overall Study|Ineligibility determined|0|||
170820989|NCT00043186|617353204|FG006|Overall Study|Ineligibility determined|0|||
170820990|NCT00043186|617353205|FG007|Overall Study|Ineligibility determined|0|||
170820991|NCT00043186|617353206|FG008|Overall Study|Ineligibility determined|1|||
170820992|NCT00043186|617353198|FG000|Overall Study|Lost to Follow-up|3|||
170820993|NCT00043186|617353199|FG001|Overall Study|Lost to Follow-up|5|||
170820994|NCT00043186|617353200|FG002|Overall Study|Lost to Follow-up|1|||
170820995|NCT00043186|617353201|FG003|Overall Study|Lost to Follow-up|1|||
170820996|NCT00043186|617353202|FG004|Overall Study|Lost to Follow-up|1|||
170820997|NCT00043186|617353203|FG005|Overall Study|Lost to Follow-up|1|||
170820998|NCT00043186|617353204|FG006|Overall Study|Lost to Follow-up|1|||
170820999|NCT00043186|617353205|FG007|Overall Study|Lost to Follow-up|1|||
170821000|NCT00043186|617353206|FG008|Overall Study|Lost to Follow-up|2|||
170821001|NCT00043186|617353198|FG000|Overall Study|Noncompliance|0|||
170821002|NCT00043186|617353199|FG001|Overall Study|Noncompliance|0|||
170821003|NCT00043186|617353200|FG002|Overall Study|Noncompliance|1|||
170821004|NCT00043186|617353201|FG003|Overall Study|Noncompliance|1|||
170821005|NCT00043186|617353202|FG004|Overall Study|Noncompliance|0|||
170821006|NCT00043186|617353203|FG005|Overall Study|Noncompliance|0|||
170821007|NCT00043186|617353204|FG006|Overall Study|Noncompliance|0|||
170821008|NCT00043186|617353205|FG007|Overall Study|Noncompliance|0|||
170821009|NCT00043186|617353206|FG008|Overall Study|Noncompliance|0|||
170821010|NCT00043186|617353198|FG000|Overall Study|Other|0|||
170821011|NCT00043186|617353199|FG001|Overall Study|Other|0|||
170821012|NCT00043186|617353200|FG002|Overall Study|Other|1|||
170821013|NCT00043186|617353201|FG003|Overall Study|Other|1|||
170821014|NCT00043186|617353202|FG004|Overall Study|Other|0|||
170821015|NCT00043186|617353203|FG005|Overall Study|Other|0|||
170821016|NCT00043186|617353204|FG006|Overall Study|Other|0|||
170821017|NCT00043186|617353205|FG007|Overall Study|Other|0|||
170821018|NCT00043186|617353206|FG008|Overall Study|Other|0|||
170821019|NCT02151643|617353207|FG000|Overall Study|Adverse Event|2|||
170821020|NCT02151643|617353208|FG001|Overall Study|Adverse Event|0|||
170821021|NCT02151643|617353209|FG002|Overall Study|Adverse Event|1|||
170821022|NCT02151643|617353210|FG003|Overall Study|Adverse Event|4|||
170821023|NCT02151643|617353211|FG004|Overall Study|Adverse Event|0|||
170821024|NCT02151643|617353207|FG000|Overall Study|Withdrawal by Subject|0|||
170821025|NCT02151643|617353208|FG001|Overall Study|Withdrawal by Subject|1|||
170821026|NCT02151643|617353209|FG002|Overall Study|Withdrawal by Subject|1|||
170821027|NCT02151643|617353210|FG003|Overall Study|Withdrawal by Subject|1|||
170821028|NCT02151643|617353211|FG004|Overall Study|Withdrawal by Subject|1|||
170821029|NCT02151643|617353207|FG000|Overall Study|Hyperphosphataemia|1|||
170821030|NCT02151643|617353208|FG001|Overall Study|Hyperphosphataemia|0|||
170821031|NCT02151643|617353209|FG002|Overall Study|Hyperphosphataemia|0|||
170821032|NCT02151643|617353210|FG003|Overall Study|Hyperphosphataemia|0|||
170821033|NCT02151643|617353211|FG004|Overall Study|Hyperphosphataemia|1|||
170821034|NCT02151643|617353207|FG000|Overall Study|High Ferritin levels|3|||
170821035|NCT02151643|617353208|FG001|Overall Study|High Ferritin levels|3|||
170821036|NCT02151643|617353209|FG002|Overall Study|High Ferritin levels|2|||
170821037|NCT02151643|617353210|FG003|Overall Study|High Ferritin levels|2|||
170821038|NCT02151643|617353211|FG004|Overall Study|High Ferritin levels|1|||
170821039|NCT00508274|617353212|FG000|Overall Study|Adverse Event|5|||
170821040|NCT00508274|617353212|FG000|Overall Study|Death|7|||
170821041|NCT00508274|617353212|FG000|Overall Study|Disease progression|32|||
170821042|NCT00508274|617353212|FG000|Overall Study|Withdrawal by Subject|1|||
170821043|NCT00508274|617353212|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
170821044|NCT00508274|617353212|FG000|Overall Study|Missing|3|||
170821045|NCT00197106|617353213|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
170821046|NCT00197106|617353214|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
170821047|NCT00197106|617353215|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
170821048|NCT00197106|617353213|FG000|Overall Treatment Period|Lack of Efficacy|0|||
170821049|NCT00197106|617353214|FG001|Overall Treatment Period|Lack of Efficacy|1|||
170821050|NCT00197106|617353215|FG002|Overall Treatment Period|Lack of Efficacy|0|||
170821051|NCT00197106|617353213|FG000|Overall Treatment Period|Lost to Follow-up|0|||
170821052|NCT00197106|617353214|FG001|Overall Treatment Period|Lost to Follow-up|0|||
170821053|NCT00197106|617353215|FG002|Overall Treatment Period|Lost to Follow-up|2|||
170821054|NCT00197106|617353213|FG000|Overall Treatment Period|Protocol Violation|0|||
170821055|NCT00197106|617353214|FG001|Overall Treatment Period|Protocol Violation|0|||
170821056|NCT00197106|617353215|FG002|Overall Treatment Period|Protocol Violation|2|||
170821057|NCT00197106|617353213|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
170821058|NCT00197106|617353214|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
170821059|NCT00197106|617353215|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
170821060|NCT02531126|617353216|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
170821061|NCT02531126|617353217|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
170821062|NCT02531126|617353218|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
170821063|NCT02531126|617353219|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
170821064|NCT02531126|617353216|FG000|Overall Study|Adverse Event|16|||
170821065|NCT02531126|617353217|FG001|Overall Study|Adverse Event|13|||
170821066|NCT02531126|617353218|FG002|Overall Study|Adverse Event|27|||
170821067|NCT02531126|617353219|FG003|Overall Study|Adverse Event|4|||
170821068|NCT02531126|617353216|FG000|Overall Study|Lack of Efficacy|50|||
170821069|NCT02531126|617353217|FG001|Overall Study|Lack of Efficacy|32|||
170821070|NCT02531126|617353218|FG002|Overall Study|Lack of Efficacy|121|||
170821071|NCT02531126|617353219|FG003|Overall Study|Lack of Efficacy|0|||
170821072|NCT02531126|617353216|FG000|Overall Study|Withdrawal by Subject|38|||
170821073|NCT02531126|617353217|FG001|Overall Study|Withdrawal by Subject|31|||
170821074|NCT02531126|617353218|FG002|Overall Study|Withdrawal by Subject|96|||
170821075|NCT02531126|617353219|FG003|Overall Study|Withdrawal by Subject|6|||
170821076|NCT02531126|617353216|FG000|Overall Study|Pregnancy|2|||
170821077|NCT02531126|617353217|FG001|Overall Study|Pregnancy|3|||
170821078|NCT02531126|617353218|FG002|Overall Study|Pregnancy|2|||
170821079|NCT02531126|617353219|FG003|Overall Study|Pregnancy|0|||
170821080|NCT02531126|617353216|FG000|Overall Study|Switched to commercial drug|2|||
170821081|NCT02531126|617353217|FG001|Overall Study|Switched to commercial drug|4|||
170821082|NCT02531126|617353218|FG002|Overall Study|Switched to commercial drug|4|||
170821083|NCT02531126|617353219|FG003|Overall Study|Switched to commercial drug|0|||
170821084|NCT02531126|617353216|FG000|Overall Study|Other reasons|23|||
170821085|NCT02531126|617353217|FG001|Overall Study|Other reasons|29|||
170821086|NCT02531126|617353218|FG002|Overall Study|Other reasons|27|||
170821087|NCT02531126|617353219|FG003|Overall Study|Other reasons|15|||
170821088|NCT02531126|617353216|FG000|Overall Study|Physician Decision|6|||
170821089|NCT02531126|617353217|FG001|Overall Study|Physician Decision|6|||
170821090|NCT02531126|617353218|FG002|Overall Study|Physician Decision|28|||
170821091|NCT02531126|617353219|FG003|Overall Study|Physician Decision|0|||
170821092|NCT02531126|617353216|FG000|Overall Study|Non-compliance with investigational drug|1|||
170821093|NCT02531126|617353217|FG001|Overall Study|Non-compliance with investigational drug|0|||
170821094|NCT02531126|617353218|FG002|Overall Study|Non-compliance with investigational drug|0|||
170821095|NCT02531126|617353219|FG003|Overall Study|Non-compliance with investigational drug|0|||
170821096|NCT00377312|617353220|FG000|Overall Study|Adverse Event|1|||
170821097|NCT00377312|617353221|FG001|Overall Study|Adverse Event|1|||
170821098|NCT00917462|617353224|FG000|Overall Study|Clinical Deterioration|1|||
170821099|NCT01441583|617353225|FG000|Overall Study|Withdrawal by Subject|1|||
170821100|NCT01441583|617353226|FG001|Overall Study|Withdrawal by Subject|1|||
170821101|NCT01441583|617353227|FG002|Overall Study|Withdrawal by Subject|1|||
170821102|NCT01441583|617353225|FG000|Overall Study|Death|1|||
170821103|NCT01441583|617353226|FG001|Overall Study|Death|0|||
170821104|NCT01441583|617353227|FG002|Overall Study|Death|4|||
170821105|NCT01441583|617353225|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
170821106|NCT01441583|617353226|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
170821107|NCT01441583|617353227|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
170821108|NCT03451292|617353228|FG000|Overall Study|Death|44|||
170821109|NCT03451292|617353229|FG001|Overall Study|Death|59|||
170821110|NCT03451292|617353228|FG000|Overall Study|Withdrawal by Subject|18|||
170821111|NCT03451292|617353229|FG001|Overall Study|Withdrawal by Subject|13|||
170821112|NCT03451292|617353228|FG000|Overall Study|Transplantation|18|||
170821113|NCT03451292|617353229|FG001|Overall Study|Transplantation|12|||
170821114|NCT03451292|617353228|FG000|Overall Study|Lost to Follow-up|4|||
170821115|NCT03451292|617353229|FG001|Overall Study|Lost to Follow-up|12|||
170821116|NCT03451292|617353228|FG000|Overall Study|Physician Decision|4|||
170821117|NCT03451292|617353229|FG001|Overall Study|Physician Decision|3|||
170821118|NCT03451292|617353228|FG000|Overall Study|Adverse Event|3|||
170821119|NCT03451292|617353229|FG001|Overall Study|Adverse Event|3|||
170821120|NCT03451292|617353228|FG000|Overall Study|Non-compliance with Study Drug|2|||
170821121|NCT03451292|617353229|FG001|Overall Study|Non-compliance with Study Drug|0|||
170685300|NCT01287897|616861472|FG003|Overall Study|Lost to Follow-up|0|||
170685301|NCT01287897|616861469|FG000|Overall Study|Withdrawal by Subject|1|||
170685302|NCT01287897|616861470|FG001|Overall Study|Withdrawal by Subject|5|||
170685303|NCT01287897|616861471|FG002|Overall Study|Withdrawal by Subject|3|||
170685304|NCT01287897|616861472|FG003|Overall Study|Withdrawal by Subject|2|||
170685305|NCT01287897|616861469|FG000|Overall Study|Not consented properly|0|||
170685306|NCT01287897|616861470|FG001|Overall Study|Not consented properly|1|||
170685307|NCT01287897|616861471|FG002|Overall Study|Not consented properly|0|||
170685308|NCT01287897|616861472|FG003|Overall Study|Not consented properly|0|||
170685309|NCT01287897|616861469|FG000|Overall Study|Not meeting entrance criteria|1|||
170685310|NCT01287897|616861470|FG001|Overall Study|Not meeting entrance criteria|1|||
170685311|NCT01287897|616861471|FG002|Overall Study|Not meeting entrance criteria|0|||
170685312|NCT01287897|616861472|FG003|Overall Study|Not meeting entrance criteria|0|||
170685313|NCT01287897|616861469|FG000|Overall Study|Other|1|||
170685314|NCT01287897|616861470|FG001|Overall Study|Other|0|||
170685315|NCT01287897|616861471|FG002|Overall Study|Other|1|||
170685316|NCT01287897|616861472|FG003|Overall Study|Other|0|||
170685317|NCT02892760|616861473|FG000|Overall Study|Withdrawal by Subject|3|||
170685318|NCT01500629|616861482|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
170685319|NCT01500629|616861483|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
170685320|NCT01499667|616861484|FG000|Overall Study|administrative problems|4|||
170685321|NCT01499667|616861485|FG001|Overall Study|administrative problems|5|||
170685322|NCT01499667|616861486|FG002|Overall Study|administrative problems|5|||
170685323|NCT01499667|616861484|FG000|Overall Study|Protocol Violation|1|||
170685324|NCT01499667|616861485|FG001|Overall Study|Protocol Violation|3|||
170685325|NCT01499667|616861486|FG002|Overall Study|Protocol Violation|2|||
170685326|NCT01499667|616861484|FG000|Overall Study|Adverse Event|0|||
170685327|NCT01499667|616861485|FG001|Overall Study|Adverse Event|2|||
170685328|NCT01499667|616861486|FG002|Overall Study|Adverse Event|2|||
170685329|NCT01499667|616861484|FG000|Overall Study|Withdrawal by Subject|2|||
170685330|NCT01499667|616861485|FG001|Overall Study|Withdrawal by Subject|1|||
170685331|NCT01499667|616861486|FG002|Overall Study|Withdrawal by Subject|1|||
170685332|NCT01499667|616861484|FG000|Overall Study|Lack of Efficacy|2|||
170685333|NCT01499667|616861485|FG001|Overall Study|Lack of Efficacy|0|||
170685334|NCT01499667|616861486|FG002|Overall Study|Lack of Efficacy|0|||
170685335|NCT00082355|616861487|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
170685336|NCT00082355|616861487|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
170685337|NCT00082355|616861487|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
170685338|NCT02335489|616861488|FG000|Overall Study|Sponsor terminated study|4|||
170685339|NCT02335489|616861488|FG000|Overall Study|Lost to Follow-up|1|||
170685340|NCT02335489|616861488|FG000|Overall Study|Withdrawal by Subject|2|||
170685341|NCT02335489|616861488|FG000|Overall Study|Physician Decision|2|||
170685342|NCT02335489|616861488|FG000|Overall Study|Lack of Efficacy|1|||
170685343|NCT00412854|616861489|FG000|Overall Study|Withdrawn due to adverse events|1|||
170685344|NCT00412854|616861490|FG001|Overall Study|Withdrawn due to adverse events|5|||
170685345|NCT00412854|616861489|FG000|Overall Study|Withdrawn for other reasons|13|||
170685346|NCT00412854|616861490|FG001|Overall Study|Withdrawn for other reasons|11|||
170685347|NCT03263442|616861491|FG000|Inpatient Phase|Death|1|||
170685348|NCT03263442|616861492|FG001|Inpatient Phase|Death|0|||
170685349|NCT03263442|616861491|FG000|Inpatient Phase|Withdrawal by Subject|1|||
170685350|NCT03263442|616861492|FG001|Inpatient Phase|Withdrawal by Subject|0|||
170685351|NCT03263442|616861491|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
170685352|NCT03263442|616861492|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
170685353|NCT03263442|616861491|FG000|1-month Follow-Up|Lost to Follow-up|1|||
170685354|NCT03263442|616861492|FG001|1-month Follow-Up|Lost to Follow-up|0|||
170685355|NCT03263442|616861491|FG000|3-month Follow-Up|Lost to Follow-up|1|||
170685356|NCT03263442|616861492|FG001|3-month Follow-Up|Lost to Follow-up|3|||
170821122|NCT03341312|617353230|FG000|Period 1|Withdrawal by Subject|0|||
170821123|NCT03341312|617353231|FG001|Period 1|Withdrawal by Subject|1|||
170821124|NCT03341312|617353232|FG002|Period 1|Withdrawal by Subject|0|||
170821125|NCT03341312|617353233|FG003|Period 1|Withdrawal by Subject|0|||
170685357|NCT03263442|616861491|FG000|6-month Follow-Up|Lost to Follow-up|2|||
170821126|NCT03840993|617353236|FG000|Overall Study|Adverse Event|1|||
170821127|NCT03840993|617353237|FG001|Overall Study|Adverse Event|0|||
170685358|NCT03263442|616861492|FG001|6-month Follow-Up|Lost to Follow-up|2|||
170685359|NCT03045081|616861493|FG000|Overall Study|Withdrawal by Subject|6|||
170685360|NCT03045081|616861494|FG001|Overall Study|Withdrawal by Subject|11|||
170685361|NCT01084174|616861495|FG000|Overall Study|gastrointestinal symptoms|1|||
170685362|NCT01084174|616861496|FG001|Overall Study|gastrointestinal symptoms|1|||
170685363|NCT01084174|616861495|FG000|Overall Study|Eosinophilic esophagitis|0|||
170685364|NCT01084174|616861496|FG001|Overall Study|Eosinophilic esophagitis|1|||
170685365|NCT01084174|616861495|FG000|Overall Study|Anaphylaxis|0|||
170685366|NCT01084174|616861496|FG001|Overall Study|Anaphylaxis|1|||
170821128|NCT03840993|617353236|FG000|Overall Study|Lost to Follow-up|4|||
170821129|NCT03840993|617353237|FG001|Overall Study|Lost to Follow-up|0|||
170821130|NCT03840993|617353236|FG000|Overall Study|Physician Decision|0|||
170821131|NCT03840993|617353237|FG001|Overall Study|Physician Decision|1|||
170685367|NCT01084174|616861495|FG000|Overall Study|Participant noncompliance|0|||
170685368|NCT01084174|616861496|FG001|Overall Study|Participant noncompliance|1|||
170685369|NCT01034462|616861497|FG000|Overall Study|Adverse Event|7|||
170685370|NCT01034462|616861498|FG001|Overall Study|Adverse Event|17|||
170685371|NCT01034462|616861497|FG000|Overall Study|Lack of Efficacy|4|||
170685372|NCT01034462|616861498|FG001|Overall Study|Lack of Efficacy|4|||
170685373|NCT01034462|616861497|FG000|Overall Study|Protocol Violation|10|||
170685374|NCT01034462|616861498|FG001|Overall Study|Protocol Violation|7|||
170685375|NCT01034462|616861497|FG000|Overall Study|Withdrawal by Subject|9|||
170685376|NCT01034462|616861498|FG001|Overall Study|Withdrawal by Subject|8|||
170685377|NCT01034462|616861497|FG000|Overall Study|Lost to Follow-up|14|||
170685378|NCT01034462|616861498|FG001|Overall Study|Lost to Follow-up|16|||
170685379|NCT01034462|616861497|FG000|Overall Study|Other reasons|1|||
170685380|NCT01034462|616861498|FG001|Overall Study|Other reasons|2|||
170685381|NCT00708643|616861500|FG000|Overall Study|Adverse Event|0|||
170685382|NCT00708643|616861501|FG001|Overall Study|Adverse Event|1|||
170685383|NCT03635957|616861502|FG000|Run-In Period|Lost to Follow-up|1|||
170685384|NCT03635957|616861502|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
170685385|NCT01710033|616861503|FG000|Stage 2|Adverse Event|0|||
170685386|NCT01710033|616861504|FG001|Stage 2|Adverse Event|0|||
170685387|NCT01710033|616861505|FG002|Stage 2|Adverse Event|0|||
170685388|NCT01710033|616861506|FG003|Stage 2|Adverse Event|0|||
170685389|NCT01710033|616861507|FG004|Stage 2|Adverse Event|1|||
170685390|NCT03480750|616861509|FG000|Overall Study|Withdrawal by Subject|0|||
170685391|NCT03480750|616861510|FG001|Overall Study|Withdrawal by Subject|1|||
170685392|NCT03480750|616861511|FG002|Overall Study|Withdrawal by Subject|0|||
170685393|NCT03480750|616861512|FG003|Overall Study|Withdrawal by Subject|0|||
170685394|NCT03480750|616861513|FG004|Overall Study|Withdrawal by Subject|0|||
170685395|NCT03480750|616861514|FG005|Overall Study|Withdrawal by Subject|0|||
170685396|NCT03480750|616861509|FG000|Overall Study|The interruption in Trientine shippment|0|||
170685397|NCT03480750|616861510|FG001|Overall Study|The interruption in Trientine shippment|0|||
170685398|NCT03480750|616861511|FG002|Overall Study|The interruption in Trientine shippment|0|||
170685399|NCT03480750|616861512|FG003|Overall Study|The interruption in Trientine shippment|0|||
170685400|NCT03480750|616861513|FG004|Overall Study|The interruption in Trientine shippment|0|||
170685401|NCT03480750|616861514|FG005|Overall Study|The interruption in Trientine shippment|1|||
170685402|NCT04273217|616861515|FG000|Overall Study|Lost to Follow-up|0|||
170685403|NCT04273217|616861516|FG001|Overall Study|Lost to Follow-up|0|||
170685404|NCT04273217|616861517|FG002|Overall Study|Lost to Follow-up|0|||
170685405|NCT04273217|616861518|FG003|Overall Study|Lost to Follow-up|0|||
170685406|NCT04273217|616861519|FG004|Overall Study|Lost to Follow-up|0|||
170685407|NCT04273217|616861520|FG005|Overall Study|Lost to Follow-up|1|||
170685408|NCT04273217|616861515|FG000|Overall Study|Participant non-compliance|0|||
170685409|NCT04273217|616861516|FG001|Overall Study|Participant non-compliance|0|||
170685410|NCT04273217|616861517|FG002|Overall Study|Participant non-compliance|0|||
170685411|NCT04273217|616861518|FG003|Overall Study|Participant non-compliance|0|||
170685412|NCT04273217|616861519|FG004|Overall Study|Participant non-compliance|1|||
170685413|NCT04273217|616861520|FG005|Overall Study|Participant non-compliance|0|||
170685414|NCT04273217|616861515|FG000|Overall Study|Positive urine drug screen|1|||
170685415|NCT04273217|616861516|FG001|Overall Study|Positive urine drug screen|0|||
170685416|NCT04273217|616861517|FG002|Overall Study|Positive urine drug screen|1|||
170685417|NCT04273217|616861518|FG003|Overall Study|Positive urine drug screen|0|||
170685418|NCT04273217|616861519|FG004|Overall Study|Positive urine drug screen|0|||
170685419|NCT04273217|616861520|FG005|Overall Study|Positive urine drug screen|1|||
170685420|NCT03060447|616861527|FG000|Overall Study|Withdrawal by Subject|2|||
170685421|NCT03060447|616861528|FG001|Overall Study|Withdrawal by Subject|0|||
170685422|NCT01988103|616861533|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
170685423|NCT01988103|616861534|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
170685424|NCT01988103|616861535|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
170685425|NCT01988103|616861536|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
170685426|NCT01988103|616861537|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
170685427|NCT01988103|616861533|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
170685428|NCT01988103|616861534|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
170685429|NCT01988103|616861535|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
170685430|NCT01988103|616861536|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
170685431|NCT01988103|616861537|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
170685432|NCT01988103|616861533|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
170685433|NCT01988103|616861534|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
170685434|NCT01988103|616861535|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
170685435|NCT01988103|616861536|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
170685436|NCT01988103|616861537|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
170685437|NCT01988103|616861533|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
170685438|NCT01988103|616861534|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
170685439|NCT01988103|616861535|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
170685440|NCT01988103|616861536|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
170685441|NCT01988103|616861537|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
170685442|NCT01988103|616861533|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
170685443|NCT01988103|616861534|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
170685444|NCT01988103|616861535|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
170685445|NCT01988103|616861536|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
170685446|NCT01988103|616861537|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
170685447|NCT01988103|616861533|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
170685448|NCT01988103|616861534|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
170685449|NCT01988103|616861535|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
170685450|NCT01988103|616861536|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
170685451|NCT01988103|616861537|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
170685452|NCT01988103|616861533|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
170685453|NCT01988103|616861534|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
170685454|NCT01988103|616861535|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
170685455|NCT01988103|616861536|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
170685456|NCT01988103|616861537|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
170685457|NCT03045887|616861539|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
170685458|NCT03045887|616861540|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685459|NCT03045887|616861541|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685460|NCT03045887|616861542|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685461|NCT03045887|616861543|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685462|NCT03045887|616861544|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685463|NCT03045887|616861545|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685464|NCT03045887|616861546|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685465|NCT03045887|616861547|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685466|NCT03045887|616861548|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
170685467|NCT03045887|616861539|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685468|NCT03045887|616861540|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685469|NCT03045887|616861541|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685470|NCT03045887|616861542|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
170685471|NCT03045887|616861543|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685472|NCT03045887|616861544|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685473|NCT03045887|616861545|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685474|NCT03045887|616861546|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685475|NCT03045887|616861547|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685476|NCT03045887|616861548|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
170685477|NCT03045887|616861539|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
170685478|NCT03045887|616861540|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685479|NCT03045887|616861541|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685480|NCT03045887|616861542|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685481|NCT03045887|616861543|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685482|NCT03045887|616861544|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685483|NCT03045887|616861545|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685484|NCT03045887|616861546|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685485|NCT03045887|616861547|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685486|NCT03045887|616861548|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
170685487|NCT03045887|616861539|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
170685488|NCT03045887|616861540|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
170685489|NCT03045887|616861541|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
170685490|NCT03045887|616861542|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
170685491|NCT03045887|616861543|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
170685492|NCT03045887|616861544|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
170685493|NCT03045887|616861545|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
170685494|NCT03045887|616861546|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
170685495|NCT03045887|616861547|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
170685496|NCT03045887|616861548|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
170685497|NCT03045887|616861539|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170685498|NCT03045887|616861540|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170685499|NCT03045887|616861541|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170685500|NCT03045887|616861542|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
170685501|NCT03045887|616861543|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170685502|NCT03045887|616861544|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170821132|NCT03840993|617353236|FG000|Overall Study|Pregnancy|0|||
170821133|NCT03840993|617353237|FG001|Overall Study|Pregnancy|1|||
170685503|NCT03045887|616861545|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170685504|NCT03045887|616861546|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170685505|NCT03045887|616861547|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170685506|NCT03045887|616861548|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170685507|NCT03103919|616861549|FG000|Overall Study|Adverse Event|2|||
170685508|NCT03103919|616861550|FG001|Overall Study|Adverse Event|2|||
170685509|NCT00546637|616861551|FG000|Overall Study|Adverse Event|46|||
170685510|NCT00546637|616861552|FG001|Overall Study|Adverse Event|20|||
170685511|NCT00546637|616861551|FG000|Overall Study|Lack of Efficacy|5|||
170685512|NCT00546637|616861552|FG001|Overall Study|Lack of Efficacy|5|||
170685513|NCT00546637|616861551|FG000|Overall Study|Lost to Follow-up|2|||
170685514|NCT00546637|616861552|FG001|Overall Study|Lost to Follow-up|2|||
170685515|NCT00546637|616861551|FG000|Overall Study|Other|10|||
170685516|NCT00546637|616861552|FG001|Overall Study|Other|12|||
170685517|NCT00546637|616861551|FG000|Overall Study|Withdrawal by Subject|7|||
170685518|NCT00546637|616861552|FG001|Overall Study|Withdrawal by Subject|9|||
170685519|NCT00546637|616861551|FG000|Overall Study|Randomized, but not treated|3|||
170685520|NCT00546637|616861552|FG001|Overall Study|Randomized, but not treated|1|||
170685521|NCT04983264|616861553|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
170685522|NCT04983264|616861554|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
170685523|NCT04983264|616861555|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
170685524|NCT04983264|616861553|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
170685525|NCT04983264|616861554|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
170685526|NCT04983264|616861555|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
170685527|NCT01402544|616861556|FG000|Overall Study|Withdrawal by Subject|6|||
170685528|NCT01828281|616861557|FG000|Overall Study|Withdrawal by Subject|1|||
170685529|NCT01828281|616861558|FG001|Overall Study|Withdrawal by Subject|0|||
170685530|NCT00390858|616861561|FG000|Overall Study|Adverse Event|6|||
170685531|NCT00390858|616861562|FG001|Overall Study|Adverse Event|2|||
170685532|NCT00390858|616861561|FG000|Overall Study|Lack of Efficacy|0|||
170685533|NCT00390858|616861562|FG001|Overall Study|Lack of Efficacy|1|||
170685534|NCT00390858|616861561|FG000|Overall Study|Withdrawal by Subject|3|||
170685535|NCT00390858|616861562|FG001|Overall Study|Withdrawal by Subject|4|||
170685536|NCT03414424|616861563|FG000|Overall Study|Screened out after consent|0|||
170685537|NCT03414424|616861564|FG001|Overall Study|Screened out after consent|2|||
170685538|NCT03414424|616861563|FG000|Overall Study|Lost to Follow-up|0|||
170685539|NCT03414424|616861564|FG001|Overall Study|Lost to Follow-up|1|||
170685540|NCT01949051|616861568|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
170685541|NCT01949051|616861569|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
170685542|NCT01949051|616861570|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
170685543|NCT01949051|616861571|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
170685544|NCT01949051|616861572|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
170685545|NCT01949051|616861573|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
170821134|NCT03840993|617353236|FG000|Overall Study|Withdrawal by Subject|1|||
170821135|NCT03840993|617353237|FG001|Overall Study|Withdrawal by Subject|3|||
170821136|NCT03840993|617353236|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
170821137|NCT03840993|617353237|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
170821138|NCT01572493|617353238|FG000|Overall Study|Physician Decision|1|||
170821139|NCT01572493|617353239|FG001|Overall Study|Physician Decision|0|||
170821140|NCT01572493|617353240|FG002|Overall Study|Physician Decision|0|||
170685546|NCT01949051|616861568|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
170685547|NCT01949051|616861569|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170685548|NCT01949051|616861570|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170685549|NCT01949051|616861571|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170685550|NCT01949051|616861572|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170685551|NCT01949051|616861573|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
170685552|NCT01949051|616861568|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
170685553|NCT01949051|616861569|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
170821141|NCT01572493|617353241|FG003|Overall Study|Physician Decision|0|||
170821142|NCT01572493|617353242|FG004|Overall Study|Physician Decision|0|||
170821143|NCT01572493|617353243|FG005|Overall Study|Physician Decision|0|||
170821144|NCT01572493|617353244|FG006|Overall Study|Physician Decision|0|||
170821145|NCT01572493|617353245|FG007|Overall Study|Physician Decision|0|||
170685554|NCT01949051|616861570|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
170685555|NCT01949051|616861571|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
170685556|NCT01949051|616861572|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
170685557|NCT01949051|616861573|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
170685558|NCT01949051|616861568|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
170685559|NCT01949051|616861569|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
170685560|NCT01949051|616861570|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
170685561|NCT01949051|616861571|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
170685562|NCT01949051|616861572|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
170685563|NCT01949051|616861573|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
170685564|NCT01949051|616861568|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
170685565|NCT01949051|616861569|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
170685566|NCT01949051|616861570|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
170685567|NCT01949051|616861571|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
170685568|NCT01949051|616861572|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
170685569|NCT01949051|616861573|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
170685570|NCT02288559|616861574|FG000|Overall Study|Adverse Event|1|||
170685571|NCT02288559|616861575|FG001|Overall Study|Adverse Event|1|||
170685572|NCT02288559|616861576|FG002|Overall Study|Adverse Event|5|||
170685573|NCT02288559|616861577|FG003|Overall Study|Adverse Event|0|||
170685574|NCT02288559|616861574|FG000|Overall Study|Death|0|||
170685575|NCT02288559|616861575|FG001|Overall Study|Death|0|||
170685576|NCT02288559|616861576|FG002|Overall Study|Death|1|||
170685577|NCT02288559|616861577|FG003|Overall Study|Death|0|||
170685578|NCT02288559|616861574|FG000|Overall Study|Lost to Follow-up|0|||
170821146|NCT01572493|617353246|FG008|Overall Study|Physician Decision|0|||
170821147|NCT01572493|617353238|FG000|Overall Study|Switched to alternative treatment|0|||
170821148|NCT01572493|617353239|FG001|Overall Study|Switched to alternative treatment|1|||
170821149|NCT01572493|617353240|FG002|Overall Study|Switched to alternative treatment|2|||
170821150|NCT01572493|617353241|FG003|Overall Study|Switched to alternative treatment|1|||
170821151|NCT01572493|617353242|FG004|Overall Study|Switched to alternative treatment|2|||
170821152|NCT01572493|617353243|FG005|Overall Study|Switched to alternative treatment|0|||
170821153|NCT01572493|617353244|FG006|Overall Study|Switched to alternative treatment|2|||
170821154|NCT01572493|617353245|FG007|Overall Study|Switched to alternative treatment|0|||
170821155|NCT01572493|617353246|FG008|Overall Study|Switched to alternative treatment|2|||
170821156|NCT01572493|617353238|FG000|Overall Study|Death|0|||
170821157|NCT01572493|617353239|FG001|Overall Study|Death|0|||
170821158|NCT01572493|617353240|FG002|Overall Study|Death|0|||
170821159|NCT01572493|617353241|FG003|Overall Study|Death|1|||
170821160|NCT01572493|617353242|FG004|Overall Study|Death|0|||
170821161|NCT01572493|617353243|FG005|Overall Study|Death|1|||
170821162|NCT01572493|617353244|FG006|Overall Study|Death|0|||
170821163|NCT01572493|617353245|FG007|Overall Study|Death|0|||
170821164|NCT01572493|617353246|FG008|Overall Study|Death|0|||
170821165|NCT01572493|617353238|FG000|Overall Study|Adverse Event|0|||
170821166|NCT01572493|617353239|FG001|Overall Study|Adverse Event|0|||
170821167|NCT01572493|617353240|FG002|Overall Study|Adverse Event|0|||
170685579|NCT02288559|616861575|FG001|Overall Study|Lost to Follow-up|0|||
170685580|NCT02288559|616861576|FG002|Overall Study|Lost to Follow-up|0|||
170685581|NCT02288559|616861577|FG003|Overall Study|Lost to Follow-up|1|||
170685582|NCT02288559|616861574|FG000|Overall Study|Withdrawal by Subject|0|||
170685583|NCT02288559|616861575|FG001|Overall Study|Withdrawal by Subject|0|||
170685584|NCT02288559|616861576|FG002|Overall Study|Withdrawal by Subject|2|||
170685585|NCT02288559|616861577|FG003|Overall Study|Withdrawal by Subject|1|||
170685586|NCT02288559|616861574|FG000|Overall Study|Reason Not Specified|0|||
170685587|NCT02288559|616861575|FG001|Overall Study|Reason Not Specified|0|||
170685588|NCT02288559|616861576|FG002|Overall Study|Reason Not Specified|3|||
170685589|NCT02288559|616861577|FG003|Overall Study|Reason Not Specified|0|||
170685590|NCT00558025|616861578|FG000|Overall Study|Adverse Event|1|||
170685591|NCT00558025|616861579|FG001|Overall Study|Adverse Event|1|||
170821168|NCT01572493|617353241|FG003|Overall Study|Adverse Event|0|||
170821169|NCT01572493|617353242|FG004|Overall Study|Adverse Event|0|||
170821170|NCT01572493|617353243|FG005|Overall Study|Adverse Event|0|||
170821171|NCT01572493|617353244|FG006|Overall Study|Adverse Event|1|||
170821172|NCT01572493|617353245|FG007|Overall Study|Adverse Event|0|||
170821173|NCT01572493|617353246|FG008|Overall Study|Adverse Event|0|||
170821174|NCT00609245|617353247|FG000|Overall Study|Adverse Event|1|||
170821175|NCT02798861|617353250|FG000|Overall Study|Lost to Follow-up|22|||
170821176|NCT02798861|617353250|FG000|Overall Study|Withdrawal by Subject|1|||
170685592|NCT00558025|616861578|FG000|Overall Study|Withdrawal by Subject|2|||
170685593|NCT00558025|616861579|FG001|Overall Study|Withdrawal by Subject|2|||
170685594|NCT00558025|616861578|FG000|Overall Study|Protocol Violation|1|||
170685595|NCT00558025|616861579|FG001|Overall Study|Protocol Violation|0|||
170685596|NCT01314443|616861580|FG000|Overall Study|Withdrawal by Subject|2|||
170685597|NCT01314443|616861581|FG001|Overall Study|Withdrawal by Subject|1|||
170685598|NCT01314443|616861582|FG002|Overall Study|Withdrawal by Subject|1|||
170685599|NCT01314443|616861583|FG003|Overall Study|Withdrawal by Subject|1|||
170685600|NCT01314443|616861580|FG000|Overall Study|Protocol Violation|2|||
170685601|NCT01314443|616861581|FG001|Overall Study|Protocol Violation|2|||
170685602|NCT01314443|616861582|FG002|Overall Study|Protocol Violation|1|||
170685603|NCT01314443|616861583|FG003|Overall Study|Protocol Violation|1|||
170685604|NCT03178773|616861585|FG000|Overall Study|Death|0|||
170685605|NCT03178773|616861586|FG001|Overall Study|Death|1|||
170685606|NCT03178773|616861585|FG000|Overall Study|Lost to Follow-up|29|||
170685607|NCT03178773|616861586|FG001|Overall Study|Lost to Follow-up|25|||
170685608|NCT03178773|616861585|FG000|Overall Study|Withdrawal by Subject|10|||
170685609|NCT03178773|616861586|FG001|Overall Study|Withdrawal by Subject|14|||
170685610|NCT05185089|616861587|FG000|First Intervention (4 weeks)|Adverse Event|0|||
170685611|NCT05185089|616861588|FG001|First Intervention (4 weeks)|Adverse Event|0|||
170685612|NCT05185089|616861589|FG002|First Intervention (4 weeks)|Adverse Event|0|||
170685613|NCT05185089|616861590|FG003|First Intervention (4 weeks)|Adverse Event|1|||
170685614|NCT05185089|616861587|FG000|Second Intervention (4 weeks)|Death|0|||
170685615|NCT05185089|616861588|FG001|Second Intervention (4 weeks)|Death|1|||
170685616|NCT05185089|616861589|FG002|Second Intervention (4 weeks)|Death|0|||
170685617|NCT05185089|616861590|FG003|Second Intervention (4 weeks)|Death|0|||
170685618|NCT05185089|616861587|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
170685619|NCT05185089|616861588|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
170685620|NCT05185089|616861589|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
170685621|NCT05185089|616861590|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
170685622|NCT00001723|616861593|FG000|Overall Study|Lack of Efficacy|6|||
170685623|NCT00001723|616861594|FG001|Overall Study|Lack of Efficacy|7|||
170685624|NCT00001723|616861593|FG000|Overall Study|Lack of family interest|4|||
170685625|NCT00001723|616861594|FG001|Overall Study|Lack of family interest|5|||
170685626|NCT00001723|616861593|FG000|Overall Study|Lost to Follow-up|2|||
170685627|NCT00001723|616861594|FG001|Overall Study|Lost to Follow-up|2|||
170685628|NCT00001723|616861593|FG000|Overall Study|medication intolerance|1|||
170685629|NCT00001723|616861594|FG001|Overall Study|medication intolerance|2|||
170685630|NCT06112756|616861595|FG000|Overall Study|Withdrawal by Subject|0|||
170685631|NCT06112756|616861596|FG001|Overall Study|Withdrawal by Subject|2|||
170685632|NCT06112756|616861595|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
170685633|NCT06112756|616861596|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
170685634|NCT06112756|616861595|FG000|Overall Study|Adverse Event|2|||
170685635|NCT06112756|616861596|FG001|Overall Study|Adverse Event|2|||
170685636|NCT01862874|616861602|FG000|Overall Study|Randomized not treated|1|||
170685637|NCT01862874|616861603|FG001|Overall Study|Randomized not treated|0|||
170685638|NCT01862874|616861602|FG000|Overall Study|Adverse Event|0|||
170685639|NCT01862874|616861603|FG001|Overall Study|Adverse Event|3|||
170685640|NCT01862874|616861602|FG000|Overall Study|Lost to Follow-up|26|||
170685641|NCT01862874|616861603|FG001|Overall Study|Lost to Follow-up|29|||
170685642|NCT01862874|616861602|FG000|Overall Study|Physician Decision|5|||
170685643|NCT01862874|616861603|FG001|Overall Study|Physician Decision|3|||
170685644|NCT01862874|616861602|FG000|Overall Study|Withdrawn by parent/guardian|1|||
170685645|NCT01862874|616861603|FG001|Overall Study|Withdrawn by parent/guardian|1|||
170685646|NCT01862874|616861602|FG000|Overall Study|Withdrawal by Subject|46|||
170685647|NCT01862874|616861603|FG001|Overall Study|Withdrawal by Subject|40|||
170685648|NCT01862874|616861602|FG000|Overall Study|Death|0|||
170685649|NCT01862874|616861603|FG001|Overall Study|Death|1|||
170685650|NCT03681405|616861604|FG000|Overall Study|Found to be ineligible after randomized|1|||
170685651|NCT03681405|616861605|FG001|Overall Study|Found to be ineligible after randomized|0|||
170685652|NCT01714635|616861607|FG000|Overall Study|Discontinued|1|||
170685653|NCT01714635|616861608|FG001|Overall Study|Discontinued|0|||
170685654|NCT01714635|616861609|FG002|Overall Study|Discontinued|2|||
170685655|NCT01714635|616861607|FG000|Overall Study|Missed 6-month exam|1|||
170685656|NCT01714635|616861608|FG001|Overall Study|Missed 6-month exam|0|||
170685657|NCT01714635|616861609|FG002|Overall Study|Missed 6-month exam|0|||
170685658|NCT02860169|616861610|FG000|Part A|Withdrawal by Subject|1|||
170685659|NCT02860169|616861610|FG000|Part A|Other (Screening failure)|6|||
170821177|NCT00907517|617353251|FG000|Overall Study|Progressive Disease|3|||
170821178|NCT00907517|617353252|FG001|Overall Study|Progressive Disease|3|||
170821179|NCT00907517|617353253|FG002|Overall Study|Progressive Disease|4|||
170821180|NCT00907517|617353254|FG003|Overall Study|Progressive Disease|4|||
170821181|NCT00907517|617353255|FG004|Overall Study|Progressive Disease|4|||
170821182|NCT00907517|617353251|FG000|Overall Study|Symptomatic Deterioration|0|||
170821183|NCT00907517|617353252|FG001|Overall Study|Symptomatic Deterioration|0|||
170821184|NCT00907517|617353253|FG002|Overall Study|Symptomatic Deterioration|0|||
170821185|NCT00907517|617353254|FG003|Overall Study|Symptomatic Deterioration|0|||
170821186|NCT00907517|617353255|FG004|Overall Study|Symptomatic Deterioration|1|||
170821187|NCT02253147|617353257|FG000|Overall Study|Protocol Violation|30|||
170821188|NCT02253147|617353257|FG000|Overall Study|Did not consent to study extension|9|||
170821189|NCT02253147|617353257|FG000|Overall Study|Conditional re-treatment at W52|5|||
170821190|NCT02253147|617353257|FG000|Overall Study|Lost to Follow-up|2|||
170821191|NCT02253147|617353257|FG000|Overall Study|Withdrawal by Subject|1|||
170821192|NCT02986659|617353258|FG000|First Intervention Period|Adverse Event|3|||
170821193|NCT02986659|617353259|FG001|First Intervention Period|Adverse Event|1|||
170821194|NCT02986659|617353258|FG000|First Intervention Period|Lost to Follow-up|1|||
170821195|NCT02986659|617353259|FG001|First Intervention Period|Lost to Follow-up|0|||
170821196|NCT02986659|617353258|FG000|First Intervention Period|Withdrawal by Subject|0|||
170821197|NCT02986659|617353259|FG001|First Intervention Period|Withdrawal by Subject|1|||
170821198|NCT02986659|617353258|FG000|Second Intervention Period|Adverse Event|0|||
170821199|NCT02986659|617353259|FG001|Second Intervention Period|Adverse Event|6|||
170821200|NCT02097056|617353260|FG000|Overall Study|Protocol Violation|2|||
170821201|NCT02097056|617353260|FG000|Overall Study|Withdrawal by Subject|15|||
170821202|NCT02097056|617353260|FG000|Overall Study|Lost to Follow-up|2|||
170821203|NCT02097056|617353260|FG000|Overall Study|Adverse Event|37|||
170821204|NCT02097056|617353260|FG000|Overall Study|Other|2|||
170821205|NCT01446042|617353261|FG000|Overall Study|Withdrawal by Subject|12|||
170821206|NCT01446042|617353262|FG001|Overall Study|Withdrawal by Subject|2|||
170821207|NCT01446042|617353263|FG002|Overall Study|Withdrawal by Subject|4|||
170685660|NCT02860169|616861610|FG000|Part A|Other (Survey not completed)|3|||
170685661|NCT02860169|616861610|FG000|Part A|Other (did not completed consent)|1|||
170685662|NCT02860169|616861610|FG000|Part B|Other (Screening failure)|10|||
170685663|NCT02860169|616861610|FG000|Part B|Withdrawal by Subject|1|||
170685664|NCT02860169|616861610|FG000|Part C|Other (Screening failure)|1|||
170685665|NCT04285879|616861611|FG000|Overall Study|Lost to Follow-up|1|||
170685666|NCT04285879|616861612|FG001|Overall Study|Lost to Follow-up|8|||
170685667|NCT04285879|616861611|FG000|Overall Study|medical/surgical exclusion|16|||
170685668|NCT04285879|616861612|FG001|Overall Study|medical/surgical exclusion|0|||
170685669|NCT02056340|616861613|FG000|Overall Study|Lost to Follow-up|5|||
170685670|NCT02056340|616861614|FG001|Overall Study|Lost to Follow-up|5|||
170685671|NCT02056340|616861613|FG000|Overall Study|Withdrawal by Subject|2|||
170685672|NCT02056340|616861614|FG001|Overall Study|Withdrawal by Subject|6|||
170685673|NCT02744391|616861618|FG000|Overall Study|Lost to Follow-up|9|||
170685674|NCT02744391|616861618|FG000|Overall Study|Physician Decision|2|||
170685675|NCT02744391|616861618|FG000|Overall Study|Withdrawal by Subject|3|||
170685676|NCT02480114|616861619|FG000|Overall Study|Not completing surveys|3|||
170685677|NCT02480114|616861620|FG001|Overall Study|Not completing surveys|2|||
170685678|NCT02480114|616861619|FG000|Overall Study|Withdrawal by Subject|2|||
170685679|NCT02480114|616861620|FG001|Overall Study|Withdrawal by Subject|4|||
170685680|NCT02480114|616861619|FG000|Overall Study|Disease progression|3|||
170685681|NCT02480114|616861620|FG001|Overall Study|Disease progression|0|||
170685682|NCT02480114|616861619|FG000|Overall Study|Improper completion of survey|1|||
170685683|NCT02480114|616861620|FG001|Overall Study|Improper completion of survey|1|||
170685684|NCT02480114|616861619|FG000|Overall Study|Not eligible|0|||
170685685|NCT02480114|616861620|FG001|Overall Study|Not eligible|1|||
170685686|NCT01535053|616861621|FG000|Overall Study|Ineligible|1|||
170685687|NCT01535053|616861622|FG001|Overall Study|Ineligible|2|||
170685688|NCT00512707|616861623|FG000|Overall Study|Lost to Follow-up|5|||
170821208|NCT01446042|617353261|FG000|Overall Study|Adverse Event|1|||
170821209|NCT01446042|617353262|FG001|Overall Study|Adverse Event|0|||
170821210|NCT01446042|617353263|FG002|Overall Study|Adverse Event|4|||
170821211|NCT01446042|617353261|FG000|Overall Study|Lost to Follow-up|5|||
170821212|NCT01446042|617353262|FG001|Overall Study|Lost to Follow-up|0|||
170821213|NCT01446042|617353263|FG002|Overall Study|Lost to Follow-up|0|||
170821214|NCT01446042|617353261|FG000|Overall Study|Other reasons|2|||
170821215|NCT01446042|617353262|FG001|Overall Study|Other reasons|1|||
170821216|NCT01446042|617353263|FG002|Overall Study|Other reasons|1|||
170821217|NCT05714345|617353267|FG000|Overall Study|Death|1|||
170821218|NCT05714345|617353268|FG001|Overall Study|Death|1|||
170821219|NCT04474691|617353269|FG000|Overall Study|Withdrawal by Subject|9|||
170821220|NCT01323309|617353270|FG000|Overall Study|Death|9|||
170821221|NCT01323309|617353271|FG001|Overall Study|Death|15|||
170821222|NCT01323309|617353272|FG002|Overall Study|Death|5|||
170685689|NCT00512707|616861624|FG001|Overall Study|Lost to Follow-up|11|||
170821223|NCT01323309|617353270|FG000|Overall Study|Lost to Follow-up|11|||
170685690|NCT00512707|616861623|FG000|Overall Study|Developed skin irritation|2|||
170685691|NCT00512707|616861624|FG001|Overall Study|Developed skin irritation|1|||
170685692|NCT00512707|616861623|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
170685693|NCT00512707|616861624|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
170685694|NCT00512707|616861623|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
170685695|NCT00512707|616861624|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
170685696|NCT01937559|616861626|FG000|Overall Study|Physician Decision|3|||
170685697|NCT01937559|616861627|FG001|Overall Study|Physician Decision|3|||
170685698|NCT01937559|616861628|FG002|Overall Study|Physician Decision|0|||
170685699|NCT01937559|616861626|FG000|Overall Study|Withdrawal by Subject|6|||
170685700|NCT01937559|616861627|FG001|Overall Study|Withdrawal by Subject|4|||
170685701|NCT01937559|616861628|FG002|Overall Study|Withdrawal by Subject|0|||
170685702|NCT01937559|616861626|FG000|Overall Study|screen fail|2|||
170685703|NCT01937559|616861627|FG001|Overall Study|screen fail|4|||
170685704|NCT01937559|616861628|FG002|Overall Study|screen fail|0|||
170685705|NCT02167893|616861629|FG000|Overall Study|Investigator transferred|85|||
170685706|NCT02167893|616861629|FG000|Overall Study|Investigator health reasons|10|||
170685707|NCT02167893|616861629|FG000|Overall Study|Case report forms not collected|68|||
170685708|NCT03578367|616861630|FG000|Overall Study|Adverse Event|0|||
170685709|NCT03578367|616861631|FG001|Overall Study|Adverse Event|3|||
170685710|NCT03578367|616861632|FG002|Overall Study|Adverse Event|0|||
170685711|NCT03578367|616861633|FG003|Overall Study|Adverse Event|5|||
170685712|NCT03578367|616861630|FG000|Overall Study|Withdrawal by Subject|2|||
170685713|NCT03578367|616861631|FG001|Overall Study|Withdrawal by Subject|2|||
170685714|NCT03578367|616861632|FG002|Overall Study|Withdrawal by Subject|1|||
170685715|NCT03578367|616861633|FG003|Overall Study|Withdrawal by Subject|3|||
170685716|NCT03578367|616861630|FG000|Overall Study|Physician Decision|0|||
170685717|NCT03578367|616861631|FG001|Overall Study|Physician Decision|0|||
170685718|NCT03578367|616861632|FG002|Overall Study|Physician Decision|14|||
170685719|NCT03578367|616861633|FG003|Overall Study|Physician Decision|0|||
170685720|NCT03578367|616861630|FG000|Overall Study|Death|1|||
170685721|NCT03578367|616861631|FG001|Overall Study|Death|0|||
170685722|NCT03578367|616861632|FG002|Overall Study|Death|0|||
170685723|NCT03578367|616861633|FG003|Overall Study|Death|0|||
170685724|NCT03578367|616861630|FG000|Overall Study|Not treated|0|||
170685725|NCT03578367|616861631|FG001|Overall Study|Not treated|0|||
170685726|NCT03578367|616861632|FG002|Overall Study|Not treated|1|||
170685727|NCT03578367|616861633|FG003|Overall Study|Not treated|0|||
170685728|NCT00001596|616863578|FG000|Overall Study|Death|1|||
170685729|NCT00001596|616863579|FG001|Overall Study|Death|0|||
170685730|NCT00001596|616863578|FG000|Overall Study|Withdrawal by Subject|3|||
170685731|NCT00001596|616863579|FG001|Overall Study|Withdrawal by Subject|1|||
170685732|NCT00001596|616863578|FG000|Overall Study|Study Termination|12|||
170685733|NCT00001596|616863579|FG001|Overall Study|Study Termination|9|||
170685734|NCT00001596|616863578|FG000|Overall Study|Adverse Event|1|||
170685735|NCT00001596|616863579|FG001|Overall Study|Adverse Event|0|||
170685736|NCT01572909|616863580|FG000|Overall Study|Adverse Event|7|||
170685737|NCT01572909|616863581|FG001|Overall Study|Adverse Event|2|||
170685738|NCT01572909|616863580|FG000|Overall Study|Death|3|||
170685739|NCT01572909|616863581|FG001|Overall Study|Death|1|||
170685740|NCT01572909|616863580|FG000|Overall Study|Lost to Follow-up|8|||
170685741|NCT01572909|616863581|FG001|Overall Study|Lost to Follow-up|7|||
170685742|NCT01572909|616863580|FG000|Overall Study|Physician Decision|1|||
170685743|NCT01572909|616863581|FG001|Overall Study|Physician Decision|1|||
170685744|NCT01572909|616863580|FG000|Overall Study|Technical Issues|1|||
170685745|NCT01572909|616863581|FG001|Overall Study|Technical Issues|0|||
170685746|NCT01572909|616863580|FG000|Overall Study|Withdrawal by Subject|12|||
170685747|NCT01572909|616863581|FG001|Overall Study|Withdrawal by Subject|11|||
170685748|NCT01572909|616863580|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
170685749|NCT01572909|616863581|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
170685750|NCT01199289|616863582|FG000|Overall Study|Ineligibility determined|2|||
170685751|NCT01199289|616863583|FG001|Overall Study|Ineligibility determined|1|||
170685752|NCT01199289|616863584|FG002|Overall Study|Ineligibility determined|0|||
170685753|NCT01199289|616863585|FG003|Overall Study|Ineligibility determined|0|||
170685754|NCT01199289|616863582|FG000|Overall Study|Protocol Violation|1|||
170685755|NCT01199289|616863583|FG001|Overall Study|Protocol Violation|0|||
170685756|NCT01199289|616863584|FG002|Overall Study|Protocol Violation|0|||
170685757|NCT01199289|616863585|FG003|Overall Study|Protocol Violation|1|||
170685758|NCT01199289|616863582|FG000|Overall Study|Noncompliance|1|||
170685759|NCT01199289|616863583|FG001|Overall Study|Noncompliance|0|||
170685760|NCT01199289|616863584|FG002|Overall Study|Noncompliance|2|||
170685761|NCT01199289|616863585|FG003|Overall Study|Noncompliance|0|||
170685762|NCT01199289|616863582|FG000|Overall Study|Adverse Event|0|||
170685763|NCT01199289|616863583|FG001|Overall Study|Adverse Event|3|||
170685764|NCT01199289|616863584|FG002|Overall Study|Adverse Event|1|||
170685765|NCT01199289|616863585|FG003|Overall Study|Adverse Event|4|||
170685766|NCT01199289|616863582|FG000|Overall Study|Full consent withdrawn|2|||
170685767|NCT01199289|616863583|FG001|Overall Study|Full consent withdrawn|2|||
170685768|NCT01199289|616863584|FG002|Overall Study|Full consent withdrawn|2|||
170685769|NCT01199289|616863585|FG003|Overall Study|Full consent withdrawn|3|||
170685770|NCT01199289|616863582|FG000|Overall Study|Administrative decision|0|||
170685771|NCT01199289|616863583|FG001|Overall Study|Administrative decision|0|||
170685772|NCT01199289|616863584|FG002|Overall Study|Administrative decision|0|||
170685773|NCT01199289|616863585|FG003|Overall Study|Administrative decision|1|||
170685774|NCT01199289|616863582|FG000|Overall Study|Lost to Follow-up|0|||
170685775|NCT01199289|616863583|FG001|Overall Study|Lost to Follow-up|0|||
170685776|NCT01199289|616863584|FG002|Overall Study|Lost to Follow-up|0|||
170685777|NCT01199289|616863585|FG003|Overall Study|Lost to Follow-up|1|||
170685778|NCT01199289|616863582|FG000|Overall Study|Protocol-specified criteria|3|||
170685779|NCT01199289|616863583|FG001|Overall Study|Protocol-specified criteria|0|||
170685780|NCT01199289|616863584|FG002|Overall Study|Protocol-specified criteria|0|||
170685781|NCT01199289|616863585|FG003|Overall Study|Protocol-specified criteria|1|||
170685782|NCT01199289|616863582|FG000|Overall Study|Pregnancy|0|||
170685783|NCT01199289|616863583|FG001|Overall Study|Pregnancy|1|||
170685784|NCT01199289|616863584|FG002|Overall Study|Pregnancy|0|||
170685785|NCT01199289|616863585|FG003|Overall Study|Pregnancy|1|||
170685786|NCT02902965|616863589|FG000|Overall Study|Withdrawal by Subject|10|||
170685787|NCT00293254|616863590|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
170685788|NCT00293254|616863591|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
170685789|NCT00293254|616863590|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
170685790|NCT00293254|616863591|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
170685791|NCT00293254|616863590|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
170685792|NCT00293254|616863591|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
170685793|NCT00293254|616863590|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
170685794|NCT00293254|616863591|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
170685795|NCT00293254|616863590|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
170685796|NCT00293254|616863591|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
170685797|NCT00293254|616863590|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
170685798|NCT00293254|616863591|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
170685799|NCT00293254|616863590|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
170685800|NCT00293254|616863591|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
170685801|NCT00293254|616863590|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
170685802|NCT00293254|616863591|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
170685803|NCT00293254|616863590|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
170685804|NCT00293254|616863591|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
170685805|NCT00293254|616863590|FG000|Extension - Double-Blind Week 49-156|Death|4|||
170685806|NCT00293254|616863591|FG001|Extension - Double-Blind Week 49-156|Death|1|||
170685807|NCT00293254|616863590|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
170685808|NCT00293254|616863591|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
170685809|NCT00293254|616863590|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
170685810|NCT00293254|616863591|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
170685811|NCT00293254|616863590|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
170685812|NCT00293254|616863591|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
170685813|NCT00293254|616863590|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
170685814|NCT00293254|616863591|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
170685815|NCT00293254|616863590|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
170685816|NCT00293254|616863591|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
170685817|NCT00293254|616863590|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
170685818|NCT00293254|616863591|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
170685819|NCT00293254|616863590|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
170685820|NCT00293254|616863591|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
170685821|NCT00293254|616863590|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
170685822|NCT00293254|616863591|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
170821224|NCT01323309|617353271|FG001|Overall Study|Lost to Follow-up|14|||
170821225|NCT01323309|617353272|FG002|Overall Study|Lost to Follow-up|24|||
170821226|NCT01323309|617353270|FG000|Overall Study|Withdrawal by Subject|14|||
170821227|NCT01323309|617353271|FG001|Overall Study|Withdrawal by Subject|14|||
170821228|NCT01323309|617353272|FG002|Overall Study|Withdrawal by Subject|18|||
170821229|NCT01323309|617353270|FG000|Overall Study|Disease progression|5|||
170821230|NCT01323309|617353271|FG001|Overall Study|Disease progression|11|||
170821231|NCT01323309|617353272|FG002|Overall Study|Disease progression|4|||
170821232|NCT03048058|617353279|FG000|Overall Study|Lost to Follow-up|4|||
170821233|NCT03048058|617353280|FG001|Overall Study|Lost to Follow-up|0|||
170821234|NCT03048058|617353279|FG000|Overall Study|Withdrawal by Subject|0|||
170821235|NCT03048058|617353280|FG001|Overall Study|Withdrawal by Subject|4|||
170685823|NCT00293254|616863590|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
170685824|NCT00293254|616863591|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
170821236|NCT01078571|617353281|FG000|Overall Study|Adverse Event|36|||
170821237|NCT01078571|617353281|FG000|Overall Study|Lack of effectiveness|36|||
170821238|NCT01078571|617353281|FG000|Overall Study|Reason not reported|21|||
170685825|NCT00293254|616863590|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
170685826|NCT00293254|616863591|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
170685827|NCT00293254|616863590|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
170685828|NCT00293254|616863591|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
170685829|NCT00293254|616863590|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
170685830|NCT00293254|616863591|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
170685831|NCT00293254|616863590|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
170685832|NCT00293254|616863591|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
170685833|NCT00293254|616863590|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
170685834|NCT00293254|616863591|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
170685835|NCT00293254|616863590|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
170685836|NCT00293254|616863591|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
170685837|NCT00293254|616863590|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
170685838|NCT00293254|616863591|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
170685839|NCT00293254|616863590|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
170685840|NCT00293254|616863591|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
170685841|NCT02259582|616863592|FG000|Overall Study|Physician Decision|0|||
170685842|NCT02259582|616863593|FG001|Overall Study|Physician Decision|1|||
170685843|NCT02259582|616863594|FG002|Overall Study|Physician Decision|0|||
170685844|NCT02259582|616863592|FG000|Overall Study|Death|0|||
170685845|NCT02259582|616863593|FG001|Overall Study|Death|0|||
170685846|NCT02259582|616863594|FG002|Overall Study|Death|1|||
170685847|NCT02259582|616863592|FG000|Overall Study|Adverse Event|1|||
170685848|NCT02259582|616863593|FG001|Overall Study|Adverse Event|0|||
170685849|NCT02259582|616863594|FG002|Overall Study|Adverse Event|1|||
170685850|NCT02259582|616863592|FG000|Overall Study|Withdrawal by Subject|0|||
170685851|NCT02259582|616863593|FG001|Overall Study|Withdrawal by Subject|0|||
170685852|NCT02259582|616863594|FG002|Overall Study|Withdrawal by Subject|1|||
170685853|NCT02259582|616863592|FG000|Overall Study|Disease progression|14|||
170685854|NCT02259582|616863593|FG001|Overall Study|Disease progression|15|||
170685855|NCT02259582|616863594|FG002|Overall Study|Disease progression|17|||
170685856|NCT02259582|616863592|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
170685857|NCT02259582|616863593|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
170685858|NCT02259582|616863594|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
170685859|NCT00759863|616863595|FG000|Overall Study|Death, moved, or lost contact|20|||
170685860|NCT00759863|616863596|FG001|Overall Study|Death, moved, or lost contact|18|||
170685861|NCT00503308|616863597|FG000|Overall Study|Protocol Violation|2|||
170685862|NCT00503308|616863598|FG001|Overall Study|Protocol Violation|1|||
170685863|NCT00531050|616863599|FG000|Part 1: Period 1|Adverse Event|0|||
170685864|NCT00531050|616863600|FG001|Part 1: Period 1|Adverse Event|1|||
170685865|NCT00531050|616863601|FG002|Part 1: Period 1|Adverse Event|0|||
170685866|NCT00531050|616863602|FG003|Part 1: Period 1|Adverse Event|0|||
170685867|NCT00531050|616863603|FG004|Part 1: Period 1|Adverse Event|0|||
170685868|NCT00531050|616863604|FG005|Part 1: Period 1|Adverse Event|0|||
170685869|NCT00531050|616863599|FG000|Part 1: Period 1|Protocol Deviation|0|||
170685870|NCT00531050|616863600|FG001|Part 1: Period 1|Protocol Deviation|0|||
170685871|NCT00531050|616863601|FG002|Part 1: Period 1|Protocol Deviation|0|||
170685872|NCT00531050|616863602|FG003|Part 1: Period 1|Protocol Deviation|1|||
170685873|NCT00531050|616863603|FG004|Part 1: Period 1|Protocol Deviation|0|||
170685874|NCT00531050|616863604|FG005|Part 1: Period 1|Protocol Deviation|0|||
170685875|NCT00531050|616863599|FG000|Part 1: Period 3|Adverse Event|1|||
170685876|NCT00531050|616863600|FG001|Part 1: Period 3|Adverse Event|0|||
170685877|NCT00531050|616863601|FG002|Part 1: Period 3|Adverse Event|0|||
170685878|NCT00531050|616863602|FG003|Part 1: Period 3|Adverse Event|0|||
170685879|NCT00531050|616863603|FG004|Part 1: Period 3|Adverse Event|0|||
170685880|NCT00531050|616863604|FG005|Part 1: Period 3|Adverse Event|0|||
170685881|NCT00531050|616863599|FG000|Part 2: Period 1|Adverse Event|0|||
170685882|NCT00531050|616863600|FG001|Part 2: Period 1|Adverse Event|0|||
170685883|NCT00531050|616863601|FG002|Part 2: Period 1|Adverse Event|0|||
170685884|NCT00531050|616863602|FG003|Part 2: Period 1|Adverse Event|0|||
170685885|NCT00531050|616863603|FG004|Part 2: Period 1|Adverse Event|0|||
170685886|NCT00531050|616863604|FG005|Part 2: Period 1|Adverse Event|1|||
170685887|NCT00531050|616863599|FG000|Part 2: Period 3|Abnormal test procedure|1|||
170685888|NCT00531050|616863600|FG001|Part 2: Period 3|Abnormal test procedure|0|||
170685889|NCT00531050|616863601|FG002|Part 2: Period 3|Abnormal test procedure|0|||
170685890|NCT00531050|616863602|FG003|Part 2: Period 3|Abnormal test procedure|0|||
170685891|NCT00531050|616863603|FG004|Part 2: Period 3|Abnormal test procedure|0|||
170685892|NCT00531050|616863604|FG005|Part 2: Period 3|Abnormal test procedure|1|||
170685893|NCT01525550|616863609|FG000|Overall Study|Lost to Follow-up|8|||
170685894|NCT01525550|616863610|FG001|Overall Study|Lost to Follow-up|2|||
170685895|NCT01525550|616863609|FG000|Overall Study|Death|19|||
170685896|NCT01525550|616863610|FG001|Overall Study|Death|28|||
170685897|NCT01525550|616863609|FG000|Overall Study|Other|0|||
170685898|NCT01525550|616863610|FG001|Overall Study|Other|4|||
170685899|NCT01525550|616863609|FG000|Overall Study|Sponsor's Decision|30|||
170821239|NCT01078571|617353281|FG000|Overall Study|Withdrawal by Subject|12|||
170821240|NCT01078571|617353281|FG000|Overall Study|Lost to Follow-up|8|||
170821241|NCT01078571|617353281|FG000|Overall Study|Protocol Violation|2|||
170821242|NCT03647709|617353295|FG000|Overall Study|Lost to Follow-up|5|||
170821243|NCT03647709|617353295|FG000|Overall Study|Physician Decision|6|||
170821244|NCT03647709|617353295|FG000|Overall Study|Withdrawal by Subject|3|||
170821245|NCT00449033|617353300|FG000|Treatment Period|Adverse Event|117|||
170821246|NCT00449033|617353301|FG001|Treatment Period|Adverse Event|83|||
170821247|NCT00449033|617353300|FG000|Treatment Period|Death|21|||
170821248|NCT00449033|617353301|FG001|Treatment Period|Death|12|||
170821249|NCT00449033|617353300|FG000|Treatment Period|Lost to Follow-up|0|||
170821250|NCT00449033|617353301|FG001|Treatment Period|Lost to Follow-up|2|||
170821251|NCT00449033|617353300|FG000|Treatment Period|Physician Decision|4|||
170821252|NCT00449033|617353301|FG001|Treatment Period|Physician Decision|5|||
170821253|NCT00449033|617353300|FG000|Treatment Period|Protocol Violation|8|||
170821254|NCT00449033|617353301|FG001|Treatment Period|Protocol Violation|7|||
170821255|NCT00449033|617353300|FG000|Treatment Period|Disease Progression|231|||
170821256|NCT00449033|617353301|FG001|Treatment Period|Disease Progression|288|||
170821257|NCT00449033|617353300|FG000|Treatment Period|Consent Withdrawn|36|||
170821258|NCT00449033|617353301|FG001|Treatment Period|Consent Withdrawn|20|||
170821259|NCT00449033|617353300|FG000|Treatment Period|Amended Protocol Criteria|22|||
170821260|NCT00449033|617353301|FG001|Treatment Period|Amended Protocol Criteria|18|||
170821261|NCT00449033|617353300|FG000|Treatment Period|Non-compliance|7|||
170821262|NCT00449033|617353301|FG001|Treatment Period|Non-compliance|8|||
170821263|NCT00449033|617353300|FG000|Treatment Period|Second Malignancy|0|||
170821264|NCT00449033|617353301|FG001|Treatment Period|Second Malignancy|1|||
170821265|NCT00449033|617353300|FG000|Treatment Period|Reason Missing|0|||
170821266|NCT00449033|617353301|FG001|Treatment Period|Reason Missing|4|||
170821267|NCT00449033|617353300|FG000|Treatment Period|Treatment Ongoing|6|||
170821268|NCT00449033|617353301|FG001|Treatment Period|Treatment Ongoing|4|||
170821269|NCT00449033|617353300|FG000|Follow-up Period|Death|299|||
170821270|NCT00449033|617353301|FG001|Follow-up Period|Death|311|||
170821271|NCT00449033|617353300|FG000|Follow-up Period|Lost to Follow-up|6|||
170821272|NCT00449033|617353301|FG001|Follow-up Period|Lost to Follow-up|10|||
170821273|NCT00449033|617353300|FG000|Follow-up Period|Reason Missing|120|||
170821274|NCT00449033|617353301|FG001|Follow-up Period|Reason Missing|113|||
170821275|NCT01257698|617353302|FG000|Overall Study|Protocol Violation|4|||
170821276|NCT01257698|617353303|FG001|Overall Study|Protocol Violation|0|||
170821277|NCT04393779|617353304|FG000|Overall Study|Death|1|||
170821278|NCT04393779|617353304|FG000|Overall Study|Device reintervention or explant|4|||
170821279|NCT03802513|617353305|FG000|Overall Study|Lost to Follow-up|1|||
170821280|NCT03928821|617353306|FG000|Overall Study|Death|0|||
170821281|NCT03928821|617353307|FG001|Overall Study|Death|1|||
170821282|NCT03928821|617353308|FG002|Overall Study|Death|0|||
170821283|NCT03928821|617353309|FG003|Overall Study|Death|0|||
170821284|NCT03928821|617353306|FG000|Overall Study|Lost to Follow-up|0|||
170821285|NCT03928821|617353307|FG001|Overall Study|Lost to Follow-up|2|||
170821286|NCT03928821|617353308|FG002|Overall Study|Lost to Follow-up|3|||
170821287|NCT03928821|617353309|FG003|Overall Study|Lost to Follow-up|0|||
170821288|NCT03928821|617353306|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
170821289|NCT03928821|617353307|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
170821290|NCT03928821|617353308|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
170821291|NCT03928821|617353309|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
170821292|NCT01288729|617353319|FG000|Overall Study|Withdrawal by Subject|1|||
170821293|NCT01288729|617353320|FG001|Overall Study|Withdrawal by Subject|0|||
170821294|NCT00990821|617353326|FG000|Overall Study|Withdrawal by Subject|0|||
170821295|NCT00990821|617353327|FG001|Overall Study|Withdrawal by Subject|2|||
170821296|NCT00990821|617353328|FG002|Overall Study|Withdrawal by Subject|0|||
170821297|NCT00990821|617353329|FG003|Overall Study|Withdrawal by Subject|0|||
170821298|NCT00990821|617353330|FG004|Overall Study|Withdrawal by Subject|3|||
170821299|NCT00990821|617353331|FG005|Overall Study|Withdrawal by Subject|3|||
170821300|NCT00990821|617353332|FG006|Overall Study|Withdrawal by Subject|1|||
170821301|NCT00990821|617353333|FG007|Overall Study|Withdrawal by Subject|0|||
170821302|NCT00990821|617353334|FG008|Overall Study|Withdrawal by Subject|0|||
170821303|NCT00990821|617353335|FG009|Overall Study|Withdrawal by Subject|1|||
170821304|NCT00990821|617353336|FG010|Overall Study|Withdrawal by Subject|3|||
170821305|NCT00990821|617353337|FG011|Overall Study|Withdrawal by Subject|5|||
170821306|NCT00990821|617353338|FG012|Overall Study|Withdrawal by Subject|2|||
170821307|NCT00990821|617353339|FG013|Overall Study|Withdrawal by Subject|1|||
170821308|NCT03530345|617353340|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
170821309|NCT03530345|617353341|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
170821310|NCT03530345|617353340|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
170821311|NCT03530345|617353341|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
170821312|NCT03530345|617353340|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
170821313|NCT03530345|617353341|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
170821314|NCT03530345|617353340|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
170821315|NCT03530345|617353341|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
170821316|NCT04150250|617353342|FG000|Overall Study|Lost to Follow-up|0|||
170821317|NCT04150250|617353343|FG001|Overall Study|Lost to Follow-up|2|||
170821318|NCT00170950|617353349|FG000|Overall Study|Death|236|||
170821319|NCT00170950|617353350|FG001|Overall Study|Death|274|||
170821320|NCT00170950|617353349|FG000|Overall Study|Withdrawal by Subject|496|||
170821321|NCT00170950|617353350|FG001|Overall Study|Withdrawal by Subject|498|||
170821322|NCT00170950|617353349|FG000|Overall Study|Lost to Follow-up|134|||
170821323|NCT00170950|617353350|FG001|Overall Study|Lost to Follow-up|115|||
170821324|NCT00170950|617353349|FG000|Overall Study|Missing|2|||
170821325|NCT00170950|617353350|FG001|Overall Study|Missing|1|||
170821326|NCT00170950|617353349|FG000|Overall Study|Termination Data Not Recorded|17|||
170821327|NCT00170950|617353350|FG001|Overall Study|Termination Data Not Recorded|22|||
170821328|NCT00748098|617353351|FG000|First Treatment Intervention Period|Adverse Event|1|||
170821329|NCT00748098|617353352|FG001|First Treatment Intervention Period|Adverse Event|1|||
170821330|NCT00748098|617353351|FG000|First Treatment Intervention Period|Protocol Violation|1|||
170821331|NCT00748098|617353352|FG001|First Treatment Intervention Period|Protocol Violation|0|||
170821332|NCT00748098|617353351|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
170821333|NCT00748098|617353352|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
170821334|NCT00748098|617353351|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
170821335|NCT00748098|617353352|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
170821336|NCT00748098|617353351|FG000|First Taper Period|Protocol Violation|1|||
170821337|NCT00748098|617353352|FG001|First Taper Period|Protocol Violation|0|||
170821338|NCT00748098|617353351|FG000|First Taper Period|Withdrawal by Subject|2|||
170821339|NCT00748098|617353352|FG001|First Taper Period|Withdrawal by Subject|0|||
170821340|NCT00748098|617353351|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
170685900|NCT01525550|616863610|FG001|Overall Study|Sponsor's Decision|11|||
170685901|NCT01525550|616863609|FG000|Overall Study|Withdrawal by Subject|4|||
170685902|NCT01525550|616863610|FG001|Overall Study|Withdrawal by Subject|0|||
170685903|NCT00723892|616863612|FG000|Overall Study|Participant not tracked|33|||
170685904|NCT00723892|616863613|FG001|Overall Study|Participant not tracked|35|||
170685905|NCT00723892|616863612|FG000|Overall Study|Virological criterion|24|||
170685906|NCT00723892|616863613|FG001|Overall Study|Virological criterion|9|||
170685907|NCT00723892|616863612|FG000|Overall Study|Withdrawal by Subject|6|||
170685908|NCT00723892|616863613|FG001|Overall Study|Withdrawal by Subject|9|||
170685909|NCT00723892|616863612|FG000|Overall Study|End planned|11|||
170685910|NCT00723892|616863613|FG001|Overall Study|End planned|7|||
170685911|NCT00723892|616863612|FG000|Overall Study|Bad tolerance|5|||
170685912|NCT00723892|616863613|FG001|Overall Study|Bad tolerance|5|||
170685913|NCT00723892|616863612|FG000|Overall Study|Multiple reasons|17|||
170685914|NCT00723892|616863613|FG001|Overall Study|Multiple reasons|12|||
170685915|NCT00723892|616863612|FG000|Overall Study|Other|6|||
170685916|NCT00723892|616863613|FG001|Overall Study|Other|3|||
170685917|NCT00723892|616863612|FG000|Overall Study|Study end|1|||
170685918|NCT00723892|616863613|FG001|Overall Study|Study end|3|||
170685919|NCT00723892|616863612|FG000|Overall Study|Weight loss|1|||
170685920|NCT00723892|616863613|FG001|Overall Study|Weight loss|3|||
170685921|NCT00723892|616863612|FG000|Overall Study|Alcohol abuse|0|||
170685922|NCT00723892|616863613|FG001|Overall Study|Alcohol abuse|1|||
170685923|NCT00723892|616863612|FG000|Overall Study|Intercurrent infection|2|||
170685924|NCT00723892|616863613|FG001|Overall Study|Intercurrent infection|0|||
170685925|NCT00723892|616863612|FG000|Overall Study|Drug addiction|1|||
170685926|NCT00723892|616863613|FG001|Overall Study|Drug addiction|0|||
170685927|NCT03683758|616863614|FG000|Overall Study|Non-study commitment conflict|1|||
170685928|NCT03683758|616863615|FG001|Overall Study|Non-study commitment conflict|3|||
170685929|NCT03683758|616863614|FG000|Overall Study|Illness preventing participation|1|||
170685930|NCT03683758|616863615|FG001|Overall Study|Illness preventing participation|0|||
170685931|NCT03683758|616863614|FG000|Overall Study|Adverse Event|1|||
170685932|NCT03683758|616863615|FG001|Overall Study|Adverse Event|0|||
170685933|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
170685934|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
170821341|NCT00748098|617353352|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
170821342|NCT00748098|617353351|FG000|1-Week Washout Period|Adverse Event|0|||
170821343|NCT00748098|617353352|FG001|1-Week Washout Period|Adverse Event|1|||
170821344|NCT00748098|617353351|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
170821345|NCT00748098|617353352|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
170821346|NCT00748098|617353351|FG000|Second Treatment Intervention Period|Adverse Event|4|||
170821347|NCT00748098|617353352|FG001|Second Treatment Intervention Period|Adverse Event|1|||
170821348|NCT00748098|617353351|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
170821349|NCT00748098|617353352|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
170685935|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
170685936|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
170685937|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
170685938|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
170685939|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
170685940|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
170685941|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
170685942|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
170685943|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
170685944|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
170685945|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
170685946|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
170685947|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
170685948|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
170685949|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
170685950|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
170685951|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
170685952|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
170685953|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
170685954|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
170685955|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
170685956|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
170685957|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
170685958|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
170685959|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
170685960|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
170685961|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
170685962|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
170685963|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
170685964|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
170685965|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
170685966|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
170685967|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
170685968|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
170685969|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
170685970|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
170685971|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
170685972|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
170685973|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
170685974|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
170685975|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
170685976|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
170685977|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
170685978|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
170685979|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
170685980|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
170685981|NCT03720470|616863618|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
170685982|NCT03720470|616863619|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
170685983|NCT03720470|616863620|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
170685984|NCT03720470|616863621|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
170685985|NCT03720470|616863622|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
170685986|NCT03720470|616863623|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
170685987|NCT03720470|616863618|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
170685988|NCT03720470|616863619|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
170685989|NCT03720470|616863620|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
170685990|NCT03720470|616863621|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
170685991|NCT03720470|616863622|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
170685992|NCT03720470|616863623|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
170685993|NCT03720470|616863618|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
170685994|NCT03720470|616863619|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
170685995|NCT03720470|616863620|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
170685996|NCT03720470|616863621|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
170685997|NCT03720470|616863622|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
170685998|NCT03720470|616863623|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
170685999|NCT03720470|616863618|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
170686000|NCT03720470|616863619|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
170686001|NCT03720470|616863620|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
170686002|NCT03720470|616863621|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
170686003|NCT03720470|616863622|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
170686004|NCT03720470|616863623|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
170686005|NCT03720470|616863618|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
170686006|NCT03720470|616863619|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
170686007|NCT03720470|616863620|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
170686008|NCT03720470|616863621|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
170686009|NCT03720470|616863622|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
170686010|NCT03720470|616863623|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
170686011|NCT03720470|616863618|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
170686012|NCT03720470|616863619|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
170686013|NCT03720470|616863620|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
170686014|NCT03720470|616863621|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
170686015|NCT03720470|616863622|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
170686016|NCT03720470|616863623|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
170686017|NCT03720470|616863618|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
170686018|NCT03720470|616863619|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
170686019|NCT03720470|616863620|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
170686020|NCT03720470|616863621|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
170686021|NCT03720470|616863622|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
170686022|NCT03720470|616863623|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
170686023|NCT03720470|616863618|FG000|Treatment Period: Final 4 Weeks|Other|0|||
170686024|NCT03720470|616863619|FG001|Treatment Period: Final 4 Weeks|Other|1|||
170686025|NCT03720470|616863620|FG002|Treatment Period: Final 4 Weeks|Other|0|||
170686026|NCT03720470|616863621|FG003|Treatment Period: Final 4 Weeks|Other|2|||
170686027|NCT03720470|616863622|FG004|Treatment Period: Final 4 Weeks|Other|1|||
170686028|NCT03720470|616863623|FG005|Treatment Period: Final 4 Weeks|Other|0|||
170686029|NCT02411292|616863624|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
170686030|NCT02411292|616863624|FG000|Overall Study|Death|2|||
170686031|NCT02411292|616863624|FG000|Overall Study|Lost to Follow-up|3|||
170686032|NCT00453921|616863625|FG000|Overall Study|Withdrawal by Subject|1|||
170686033|NCT00453921|616863626|FG001|Overall Study|Withdrawal by Subject|1|||
170686034|NCT00453921|616863627|FG002|Overall Study|Withdrawal by Subject|1|||
170686035|NCT00453921|616863628|FG003|Overall Study|Withdrawal by Subject|1|||
170686036|NCT00453921|616863625|FG000|Overall Study|Lost to Follow-up|0|||
170686037|NCT00453921|616863626|FG001|Overall Study|Lost to Follow-up|0|||
170686038|NCT00453921|616863627|FG002|Overall Study|Lost to Follow-up|1|||
170686039|NCT00453921|616863628|FG003|Overall Study|Lost to Follow-up|0|||
170686040|NCT00303498|616863629|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
170686041|NCT00303498|616863630|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
170686042|NCT00303498|616863629|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
170686043|NCT00303498|616863630|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
170686044|NCT00303498|616863629|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
170686045|NCT00303498|616863630|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
170686046|NCT00303498|616863629|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
170686047|NCT00303498|616863630|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
170686048|NCT00303498|616863629|FG000|Run-In-Phase (10 Weeks)|Other|4|||
170686049|NCT00303498|616863630|FG001|Run-In-Phase (10 Weeks)|Other|1|||
170686050|NCT00303498|616863629|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
170686051|NCT00303498|616863630|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
170686052|NCT00303498|616863629|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
170686053|NCT00303498|616863630|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
170686054|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
170686055|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
170686056|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Death|1|||
170686057|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Death|0|||
170686058|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
170686059|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
170686060|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
170686061|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
170686062|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
170686063|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
170686064|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
170686065|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
170686066|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Other|1|||
170686067|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Other|0|||
170686068|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
170686069|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
170686070|NCT00303498|616863629|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
170686071|NCT00303498|616863630|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
170686072|NCT00174915|616863631|FG000|Overall Study|Lost to Follow-up|19|||
170686073|NCT00174915|616863632|FG001|Overall Study|Lost to Follow-up|17|||
170686074|NCT00174915|616863633|FG002|Overall Study|Lost to Follow-up|9|||
170686075|NCT00174915|616863634|FG003|Overall Study|Lost to Follow-up|17|||
170686076|NCT00174915|616863635|FG004|Overall Study|Lost to Follow-up|10|||
170686077|NCT00174915|616863631|FG000|Overall Study|Adverse Event|18|||
170686078|NCT00174915|616863632|FG001|Overall Study|Adverse Event|16|||
170686079|NCT00174915|616863633|FG002|Overall Study|Adverse Event|11|||
170686080|NCT00174915|616863634|FG003|Overall Study|Adverse Event|18|||
170686081|NCT00174915|616863635|FG004|Overall Study|Adverse Event|5|||
170686082|NCT00174915|616863631|FG000|Overall Study|Personal Reason(s)|16|||
170686083|NCT00174915|616863632|FG001|Overall Study|Personal Reason(s)|16|||
170686084|NCT00174915|616863633|FG002|Overall Study|Personal Reason(s)|9|||
170686085|NCT00174915|616863634|FG003|Overall Study|Personal Reason(s)|9|||
170686086|NCT00174915|616863635|FG004|Overall Study|Personal Reason(s)|9|||
170686087|NCT00174915|616863631|FG000|Overall Study|Other|15|||
170686088|NCT00174915|616863632|FG001|Overall Study|Other|8|||
170686089|NCT00174915|616863633|FG002|Overall Study|Other|6|||
170686090|NCT00174915|616863634|FG003|Overall Study|Other|5|||
170686091|NCT00174915|616863635|FG004|Overall Study|Other|3|||
170686092|NCT00174915|616863631|FG000|Overall Study|Gout Flare|13|||
170686093|NCT00174915|616863632|FG001|Overall Study|Gout Flare|6|||
170686094|NCT00174915|616863633|FG002|Overall Study|Gout Flare|8|||
170686095|NCT00174915|616863634|FG003|Overall Study|Gout Flare|1|||
170686096|NCT00174915|616863635|FG004|Overall Study|Gout Flare|0|||
170686097|NCT00174915|616863631|FG000|Overall Study|Protocol Violation|6|||
170686098|NCT00174915|616863632|FG001|Overall Study|Protocol Violation|3|||
170686099|NCT00174915|616863633|FG002|Overall Study|Protocol Violation|3|||
170686100|NCT00174915|616863634|FG003|Overall Study|Protocol Violation|6|||
170686101|NCT00174915|616863635|FG004|Overall Study|Protocol Violation|3|||
170686102|NCT00174915|616863631|FG000|Overall Study|Therapeutic Failure|6|||
170686103|NCT00174915|616863632|FG001|Overall Study|Therapeutic Failure|3|||
170686104|NCT00174915|616863633|FG002|Overall Study|Therapeutic Failure|2|||
170686105|NCT00174915|616863634|FG003|Overall Study|Therapeutic Failure|1|||
170686106|NCT00174915|616863635|FG004|Overall Study|Therapeutic Failure|3|||
170686107|NCT02232425|616863636|FG000|Overall Study|Lost to Follow-up|6|||
170686108|NCT02232425|616863637|FG001|Overall Study|Lost to Follow-up|2|||
170686109|NCT02232425|616863636|FG000|Overall Study|Adverse Event|2|||
170686110|NCT02232425|616863637|FG001|Overall Study|Adverse Event|0|||
170686111|NCT02232425|616863636|FG000|Overall Study|Withdrawal by Subject|5|||
170686112|NCT02232425|616863637|FG001|Overall Study|Withdrawal by Subject|6|||
170686113|NCT02232425|616863636|FG000|Overall Study|Lack of Efficacy|1|||
170686114|NCT02232425|616863637|FG001|Overall Study|Lack of Efficacy|0|||
170686115|NCT00460031|616863638|FG000|Overall Study|Adverse Event|5|||
170686116|NCT00460031|616863638|FG000|Overall Study|Withdrawal by Subject|5|||
170686117|NCT00460031|616863638|FG000|Overall Study|Death|1|||
170686118|NCT01601626|616863641|FG000|Overall Study|Death|1|||
170686119|NCT01601626|616863642|FG001|Overall Study|Death|1|||
170686120|NCT01601626|616863643|FG002|Overall Study|Death|1|||
170686121|NCT01601626|616863641|FG000|Overall Study|Lost to Follow-up|1|||
170686122|NCT01601626|616863642|FG001|Overall Study|Lost to Follow-up|2|||
170686123|NCT01601626|616863643|FG002|Overall Study|Lost to Follow-up|0|||
170686124|NCT01601626|616863641|FG000|Overall Study|Unable to Get to Clinic|0|||
170821350|NCT00748098|617353351|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
170686125|NCT01601626|616863642|FG001|Overall Study|Unable to Get to Clinic|1|||
170821351|NCT00748098|617353352|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
170821352|NCT02442622|617353355|FG000|Overall Study|Withdrawal by Subject|3|||
170686126|NCT01601626|616863643|FG002|Overall Study|Unable to Get to Clinic|0|||
170686127|NCT01601626|616863641|FG000|Overall Study|Withdrawal by Subject|0|||
170686128|NCT01601626|616863642|FG001|Overall Study|Withdrawal by Subject|1|||
170686129|NCT01601626|616863643|FG002|Overall Study|Withdrawal by Subject|1|||
170686130|NCT01601626|616863641|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
170686131|NCT01601626|616863642|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
170686132|NCT01601626|616863643|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
170686133|NCT00498602|616863644|FG000|Overall Study|Death|0|||
170686134|NCT00498602|616863645|FG001|Overall Study|Death|0|||
170686135|NCT00498602|616863646|FG002|Overall Study|Death|0|||
170686136|NCT00498602|616863647|FG003|Overall Study|Death|0|||
170686137|NCT00498602|616863648|FG004|Overall Study|Death|0|||
170686138|NCT00498602|616863649|FG005|Overall Study|Death|1|||
170686139|NCT00498602|616863650|FG006|Overall Study|Death|0|||
170686140|NCT00498602|616863644|FG000|Overall Study|Lack of Efficacy|1|||
170686141|NCT00498602|616863645|FG001|Overall Study|Lack of Efficacy|0|||
170686142|NCT00498602|616863646|FG002|Overall Study|Lack of Efficacy|0|||
170686143|NCT00498602|616863647|FG003|Overall Study|Lack of Efficacy|0|||
170686144|NCT00498602|616863648|FG004|Overall Study|Lack of Efficacy|0|||
170686145|NCT00498602|616863649|FG005|Overall Study|Lack of Efficacy|0|||
170686146|NCT00498602|616863650|FG006|Overall Study|Lack of Efficacy|0|||
170686147|NCT00498602|616863644|FG000|Overall Study|Lost to Follow-up|0|||
170686148|NCT00498602|616863645|FG001|Overall Study|Lost to Follow-up|2|||
170686149|NCT00498602|616863646|FG002|Overall Study|Lost to Follow-up|0|||
170686150|NCT00498602|616863647|FG003|Overall Study|Lost to Follow-up|2|||
170686151|NCT00498602|616863648|FG004|Overall Study|Lost to Follow-up|0|||
170686152|NCT00498602|616863649|FG005|Overall Study|Lost to Follow-up|0|||
170686153|NCT00498602|616863650|FG006|Overall Study|Lost to Follow-up|0|||
170686154|NCT00498602|616863644|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
170686155|NCT00498602|616863645|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
170686156|NCT00498602|616863646|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
170686157|NCT00498602|616863647|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
170686158|NCT00498602|616863648|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
170686159|NCT00498602|616863649|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
170686160|NCT00498602|616863650|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
170686161|NCT00498602|616863644|FG000|Overall Study|AE not related to Study Drug|1|||
170686162|NCT00498602|616863645|FG001|Overall Study|AE not related to Study Drug|3|||
170686163|NCT00498602|616863646|FG002|Overall Study|AE not related to Study Drug|0|||
170686164|NCT00498602|616863647|FG003|Overall Study|AE not related to Study Drug|0|||
170686165|NCT00498602|616863648|FG004|Overall Study|AE not related to Study Drug|2|||
170686166|NCT00498602|616863649|FG005|Overall Study|AE not related to Study Drug|2|||
170686167|NCT00498602|616863650|FG006|Overall Study|AE not related to Study Drug|1|||
170686168|NCT00498602|616863644|FG000|Overall Study|Caregiver Request|2|||
170686169|NCT00498602|616863645|FG001|Overall Study|Caregiver Request|2|||
170686170|NCT00498602|616863646|FG002|Overall Study|Caregiver Request|2|||
170686171|NCT00498602|616863647|FG003|Overall Study|Caregiver Request|0|||
170686172|NCT00498602|616863648|FG004|Overall Study|Caregiver Request|1|||
170686173|NCT00498602|616863649|FG005|Overall Study|Caregiver Request|2|||
170686174|NCT00498602|616863650|FG006|Overall Study|Caregiver Request|0|||
170686175|NCT00498602|616863644|FG000|Overall Study|Investigator Request|0|||
170686176|NCT00498602|616863645|FG001|Overall Study|Investigator Request|0|||
170686177|NCT00498602|616863646|FG002|Overall Study|Investigator Request|1|||
170686178|NCT00498602|616863647|FG003|Overall Study|Investigator Request|0|||
170686179|NCT00498602|616863648|FG004|Overall Study|Investigator Request|0|||
170686180|NCT00498602|616863649|FG005|Overall Study|Investigator Request|0|||
170686181|NCT00498602|616863650|FG006|Overall Study|Investigator Request|0|||
170686182|NCT00498602|616863644|FG000|Overall Study|Subject Request|3|||
170686183|NCT00498602|616863645|FG001|Overall Study|Subject Request|0|||
170686184|NCT00498602|616863646|FG002|Overall Study|Subject Request|1|||
170686185|NCT00498602|616863647|FG003|Overall Study|Subject Request|1|||
170686186|NCT00498602|616863648|FG004|Overall Study|Subject Request|1|||
170686187|NCT00498602|616863649|FG005|Overall Study|Subject Request|4|||
170686188|NCT00498602|616863650|FG006|Overall Study|Subject Request|1|||
170686189|NCT00498602|616863644|FG000|Overall Study|Other|2|||
170686190|NCT00498602|616863645|FG001|Overall Study|Other|3|||
170686191|NCT00498602|616863646|FG002|Overall Study|Other|1|||
170686192|NCT00498602|616863647|FG003|Overall Study|Other|0|||
170686193|NCT00498602|616863648|FG004|Overall Study|Other|0|||
170686194|NCT00498602|616863649|FG005|Overall Study|Other|3|||
170686195|NCT00498602|616863650|FG006|Overall Study|Other|0|||
170686196|NCT01110707|616863651|FG000|Overall Study|Protocol Violation|0|||
170686197|NCT01110707|616863652|FG001|Overall Study|Protocol Violation|3|||
170821353|NCT02442622|617353356|FG001|Overall Study|Withdrawal by Subject|1|||
170821354|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
170686198|NCT00674661|616863662|FG000|Overall Study|Other|5|||
170686199|NCT00674661|616863663|FG001|Overall Study|Other|7|||
170686200|NCT00674661|616863662|FG000|Overall Study|Lost to Follow-up|6|||
170686201|NCT00674661|616863663|FG001|Overall Study|Lost to Follow-up|3|||
170686202|NCT00674661|616863662|FG000|Overall Study|Withdrawal by Subject|0|||
170686203|NCT00674661|616863663|FG001|Overall Study|Withdrawal by Subject|5|||
170686204|NCT03108027|616863664|FG000|Period 1|Subject/Guardian Decision|0|||
170686205|NCT03108027|616863665|FG001|Period 1|Subject/Guardian Decision|0|||
170686206|NCT03108027|616863666|FG002|Period 1|Subject/Guardian Decision|0|||
170686207|NCT03108027|616863667|FG003|Period 1|Subject/Guardian Decision|2|||
170686208|NCT03108027|616863668|FG004|Period 1|Subject/Guardian Decision|0|||
170686209|NCT03108027|616863669|FG005|Period 1|Subject/Guardian Decision|0|||
170686210|NCT03108027|616863664|FG000|Period 3|Adverse Event|0|||
170686211|NCT03108027|616863665|FG001|Period 3|Adverse Event|1|||
170686212|NCT03108027|616863666|FG002|Period 3|Adverse Event|0|||
170686213|NCT03108027|616863667|FG003|Period 3|Adverse Event|0|||
170686214|NCT03108027|616863668|FG004|Period 3|Adverse Event|0|||
170686215|NCT03108027|616863669|FG005|Period 3|Adverse Event|0|||
170686216|NCT02979522|616863673|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
170686217|NCT02979522|616863674|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
170686218|NCT02979522|616863673|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
170686219|NCT02979522|616863674|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
170686220|NCT00003901|616863675|FG000|Overall Study|Adverse Event|1|||
170686221|NCT00003901|616863675|FG000|Overall Study|Withdrawal by Subject|1|||
170686222|NCT00003901|616863675|FG000|Overall Study|Ineligible|6|||
170686223|NCT00003901|616863675|FG000|Overall Study|CT Scan not within protocol requirement|2|||
170686224|NCT00003901|616863675|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
170686225|NCT00003901|616863675|FG000|Overall Study|Medical problems|6|||
170686226|NCT00429104|616863676|FG000|Overall Study|Protocol Violation|1|||
170686227|NCT01896531|616863681|FG000|Overall Study|Death|57|||
170686228|NCT01896531|616863682|FG001|Overall Study|Death|59|||
170686229|NCT01896531|616863681|FG000|Overall Study|Lost to Follow-up|3|||
170686230|NCT01896531|616863682|FG001|Overall Study|Lost to Follow-up|0|||
170686231|NCT01896531|616863681|FG000|Overall Study|Non-compliance|0|||
170686232|NCT01896531|616863682|FG001|Overall Study|Non-compliance|1|||
170686233|NCT01896531|616863681|FG000|Overall Study|Study Ended by Sponsor|7|||
170686234|NCT01896531|616863682|FG001|Overall Study|Study Ended by Sponsor|20|||
170686235|NCT01896531|616863681|FG000|Overall Study|Withdrawal by Subject|3|||
170686236|NCT01896531|616863682|FG001|Overall Study|Withdrawal by Subject|2|||
170686237|NCT01896531|616863681|FG000|Overall Study|Death Prior to Treatment|1|||
170686238|NCT01896531|616863682|FG001|Overall Study|Death Prior to Treatment|0|||
170686239|NCT00268996|616863683|FG000|Overall Study|Adverse Event|11|||
170686240|NCT00268996|616863684|FG001|Overall Study|Adverse Event|7|||
170686241|NCT00268996|616863683|FG000|Overall Study|Lost to Follow-up|3|||
170686242|NCT00268996|616863684|FG001|Overall Study|Lost to Follow-up|1|||
170686243|NCT00268996|616863683|FG000|Overall Study|Withdrawal by Subject|5|||
170686244|NCT00268996|616863684|FG001|Overall Study|Withdrawal by Subject|11|||
170686245|NCT00268996|616863683|FG000|Overall Study|Non-compliance|1|||
170686246|NCT00268996|616863684|FG001|Overall Study|Non-compliance|0|||
170686247|NCT00268996|616863683|FG000|Overall Study|Other|1|||
170686248|NCT00268996|616863684|FG001|Overall Study|Other|1|||
170686249|NCT02956486|616863685|FG000|Core Phase|Adverse Event|51|||
170686250|NCT02956486|616863686|FG001|Core Phase|Adverse Event|88|||
170686251|NCT02956486|616863687|FG002|Core Phase|Adverse Event|0|||
170686252|NCT02956486|616863685|FG000|Core Phase|Lost to Follow-up|8|||
170686253|NCT02956486|616863686|FG001|Core Phase|Lost to Follow-up|6|||
170686254|NCT02956486|616863687|FG002|Core Phase|Lost to Follow-up|0|||
170686255|NCT02956486|616863685|FG000|Core Phase|Inadequate therapeutic effect|4|||
170686256|NCT02956486|616863686|FG001|Core Phase|Inadequate therapeutic effect|5|||
170686257|NCT02956486|616863687|FG002|Core Phase|Inadequate therapeutic effect|0|||
170686258|NCT02956486|616863685|FG000|Core Phase|Withdrawal by Subject|101|||
170686259|NCT02956486|616863686|FG001|Core Phase|Withdrawal by Subject|104|||
170686260|NCT02956486|616863687|FG002|Core Phase|Withdrawal by Subject|0|||
170686261|NCT02956486|616863685|FG000|Core Phase|Study terminated by sponsor|888|||
170686262|NCT02956486|616863686|FG001|Core Phase|Study terminated by sponsor|848|||
170686263|NCT02956486|616863687|FG002|Core Phase|Study terminated by sponsor|0|||
170686264|NCT02956486|616863685|FG000|Core Phase|Other|27|||
170686265|NCT02956486|616863686|FG001|Core Phase|Other|18|||
170686266|NCT02956486|616863687|FG002|Core Phase|Other|0|||
170686267|NCT02956486|616863685|FG000|Core Phase|Not treated|0|||
170686268|NCT02956486|616863686|FG001|Core Phase|Not treated|3|||
170686269|NCT02956486|616863687|FG002|Core Phase|Not treated|0|||
170686270|NCT02956486|616863685|FG000|Extension Phase|Adverse Event|0|||
170686271|NCT02956486|616863686|FG001|Extension Phase|Adverse Event|0|||
170686272|NCT02956486|616863687|FG002|Extension Phase|Adverse Event|2|||
170686273|NCT02956486|616863685|FG000|Extension Phase|Study terminated by sponsor|0|||
170686274|NCT02956486|616863686|FG001|Extension Phase|Study terminated by sponsor|0|||
170686275|NCT02956486|616863687|FG002|Extension Phase|Study terminated by sponsor|16|||
170686276|NCT02956486|616863685|FG000|Extension Phase|Not Treated|0|||
170686277|NCT02956486|616863686|FG001|Extension Phase|Not Treated|0|||
170686278|NCT02956486|616863687|FG002|Extension Phase|Not Treated|1|||
170686279|NCT03325075|616863690|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
170686280|NCT03325075|616863691|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
170686281|NCT03325075|616863692|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
170686282|NCT03325075|616863693|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
170686283|NCT03325075|616863690|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
170686284|NCT03325075|616863691|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
170686285|NCT03325075|616863692|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
170686286|NCT03325075|616863693|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
170686287|NCT03325075|616863690|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
170686288|NCT03325075|616863691|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
170686289|NCT03325075|616863692|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
170686290|NCT03325075|616863693|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
170686291|NCT00422591|616863694|FG000|Overall Study|Physician Decision|4|||
170686292|NCT00422591|616863694|FG000|Overall Study|Withdrawal by Subject|2|||
170686293|NCT04446377|616863708|FG000|Overall Study|Withdrawal by Subject|6|||
170686294|NCT04446377|616863709|FG001|Overall Study|Withdrawal by Subject|1|||
170686295|NCT04446377|616863708|FG000|Overall Study|Physician Decision|1|||
170686296|NCT04446377|616863709|FG001|Overall Study|Physician Decision|1|||
170686297|NCT04446377|616863708|FG000|Overall Study|Lost to Follow-up|0|||
170686298|NCT04446377|616863709|FG001|Overall Study|Lost to Follow-up|2|||
170686299|NCT04446377|616863708|FG000|Overall Study|Not eligible|0|||
170686300|NCT04446377|616863709|FG001|Overall Study|Not eligible|1|||
170686301|NCT00573534|616863719|FG000|Overall Study|oppositional behavior|3|||
170686302|NCT01129960|616863720|FG000|Overall Study|Withdrawal by Subject|3|||
170686303|NCT01129960|616863721|FG001|Overall Study|Withdrawal by Subject|0|||
170686304|NCT01129960|616863722|FG002|Overall Study|Withdrawal by Subject|3|||
170686305|NCT01129960|616863723|FG003|Overall Study|Withdrawal by Subject|2|||
170686306|NCT01129960|616863720|FG000|Overall Study|Lack of Efficacy|1|||
170686307|NCT01129960|616863721|FG001|Overall Study|Lack of Efficacy|1|||
170686308|NCT01129960|616863722|FG002|Overall Study|Lack of Efficacy|1|||
170686309|NCT01129960|616863723|FG003|Overall Study|Lack of Efficacy|1|||
170686310|NCT01129960|616863720|FG000|Overall Study|Adverse Event|23|||
170686311|NCT01129960|616863721|FG001|Overall Study|Adverse Event|16|||
170686312|NCT01129960|616863722|FG002|Overall Study|Adverse Event|16|||
170686313|NCT01129960|616863723|FG003|Overall Study|Adverse Event|7|||
170686314|NCT01129960|616863720|FG000|Overall Study|Protocol Violation|1|||
170686315|NCT01129960|616863721|FG001|Overall Study|Protocol Violation|2|||
170686316|NCT01129960|616863722|FG002|Overall Study|Protocol Violation|3|||
170686317|NCT01129960|616863723|FG003|Overall Study|Protocol Violation|0|||
170686318|NCT01129960|616863720|FG000|Overall Study|Lost to Follow-up|0|||
170686319|NCT01129960|616863721|FG001|Overall Study|Lost to Follow-up|2|||
170686320|NCT01129960|616863722|FG002|Overall Study|Lost to Follow-up|3|||
170686321|NCT01129960|616863723|FG003|Overall Study|Lost to Follow-up|3|||
170686322|NCT01129960|616863720|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
170686323|NCT01129960|616863721|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
170686324|NCT01129960|616863722|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
170686325|NCT01129960|616863723|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
170686326|NCT01129960|616863720|FG000|Overall Study|Physician Decision|1|||
170686327|NCT01129960|616863721|FG001|Overall Study|Physician Decision|0|||
170686328|NCT01129960|616863722|FG002|Overall Study|Physician Decision|0|||
170686329|NCT01129960|616863723|FG003|Overall Study|Physician Decision|0|||
170686330|NCT01129960|616863720|FG000|Overall Study|Pregnancy|1|||
170686331|NCT01129960|616863721|FG001|Overall Study|Pregnancy|0|||
170686332|NCT01129960|616863722|FG002|Overall Study|Pregnancy|0|||
170686333|NCT01129960|616863723|FG003|Overall Study|Pregnancy|0|||
170686334|NCT00071513|616863724|FG000|Intervention Component|Withdrawal by Subject|2|||
170686335|NCT00071513|616863725|FG001|Intervention Component|Withdrawal by Subject|3|||
170686336|NCT00071513|616863724|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
170686337|NCT00071513|616863725|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
170686338|NCT03473808|616863727|FG000|Overall Study|Withdrawal by Subject|1|||
170686339|NCT02157298|616863730|FG000|Overall Study|Adverse Event|1|||
170686340|NCT02157298|616863731|FG001|Overall Study|Adverse Event|0|||
170686341|NCT02157298|616863730|FG000|Overall Study|Subject no longer meets study criteria|1|||
170686342|NCT02157298|616863731|FG001|Overall Study|Subject no longer meets study criteria|2|||
170686343|NCT02157298|616863730|FG000|Overall Study|Poor/Non-compliance|1|||
170686344|NCT02157298|616863731|FG001|Overall Study|Poor/Non-compliance|0|||
170686345|NCT02157298|616863730|FG000|Overall Study|Withdrawal by Subject|1|||
170686346|NCT02157298|616863731|FG001|Overall Study|Withdrawal by Subject|0|||
170686347|NCT04059094|616863732|FG000|Overall Study|Adverse Event|0|||
170686348|NCT04059094|616863733|FG001|Overall Study|Adverse Event|0|||
170686349|NCT04059094|616863734|FG002|Overall Study|Adverse Event|0|||
170686350|NCT04059094|616863735|FG003|Overall Study|Adverse Event|0|||
170686351|NCT04059094|616863736|FG004|Overall Study|Adverse Event|1|||
170686352|NCT04059094|616863732|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
170686353|NCT04059094|616863733|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
170686354|NCT04059094|616863734|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
170686355|NCT04059094|616863735|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
170686356|NCT04059094|616863736|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
170686357|NCT01339429|616863739|FG000|Overall Study|Withdrawal by Subject|1|||
170686358|NCT01339429|616863739|FG000|Overall Study|Physician Decision|3|||
170686359|NCT01085591|616863740|FG000|Overall Study|Adverse Event|0|||
170686360|NCT01085591|616863741|FG001|Overall Study|Adverse Event|1|||
170686361|NCT01085591|616863742|FG002|Overall Study|Adverse Event|3|||
170686362|NCT01085591|616863740|FG000|Overall Study|Physician Decision|1|||
170686363|NCT01085591|616863741|FG001|Overall Study|Physician Decision|0|||
170686364|NCT01085591|616863742|FG002|Overall Study|Physician Decision|1|||
170686365|NCT01085591|616863740|FG000|Overall Study|Withdrawal by Subject|0|||
170686366|NCT01085591|616863741|FG001|Overall Study|Withdrawal by Subject|2|||
170686367|NCT01085591|616863742|FG002|Overall Study|Withdrawal by Subject|1|||
170686368|NCT01085591|616863740|FG000|Overall Study|Lost to Follow-up|0|||
170686369|NCT01085591|616863741|FG001|Overall Study|Lost to Follow-up|1|||
170686370|NCT01085591|616863742|FG002|Overall Study|Lost to Follow-up|1|||
170686371|NCT01085591|616863740|FG000|Overall Study|Protocol Violation|1|||
170686372|NCT01085591|616863741|FG001|Overall Study|Protocol Violation|1|||
170686373|NCT01085591|616863742|FG002|Overall Study|Protocol Violation|1|||
170686374|NCT01085591|616863740|FG000|Overall Study|Other|0|||
170686375|NCT01085591|616863741|FG001|Overall Study|Other|1|||
170686376|NCT01085591|616863742|FG002|Overall Study|Other|0|||
170686377|NCT01085591|616863740|FG000|Overall Study|Not Properly Consented|1|||
170686378|NCT01085591|616863741|FG001|Overall Study|Not Properly Consented|0|||
170686379|NCT01085591|616863742|FG002|Overall Study|Not Properly Consented|0|||
170686380|NCT00459667|616863743|FG000|Overall Study|Adverse Event|9|||
170686381|NCT00459667|616863744|FG001|Overall Study|Adverse Event|12|||
170686382|NCT00459667|616863745|FG002|Overall Study|Adverse Event|8|||
170686383|NCT00459667|616863743|FG000|Overall Study|Lost to Follow-up|5|||
170686384|NCT00459667|616863744|FG001|Overall Study|Lost to Follow-up|9|||
170686385|NCT00459667|616863745|FG002|Overall Study|Lost to Follow-up|3|||
170686386|NCT00459667|616863743|FG000|Overall Study|Pregnancy|1|||
170686387|NCT00459667|616863744|FG001|Overall Study|Pregnancy|1|||
170686388|NCT00459667|616863745|FG002|Overall Study|Pregnancy|1|||
170686389|NCT00459667|616863743|FG000|Overall Study|Protocol Violation|1|||
170686390|NCT00459667|616863744|FG001|Overall Study|Protocol Violation|0|||
170686391|NCT00459667|616863745|FG002|Overall Study|Protocol Violation|0|||
170686392|NCT00459667|616863743|FG000|Overall Study|Withdrawal by Subject|3|||
170686393|NCT00459667|616863744|FG001|Overall Study|Withdrawal by Subject|5|||
170686394|NCT00459667|616863745|FG002|Overall Study|Withdrawal by Subject|5|||
170686395|NCT00459667|616863743|FG000|Overall Study|Other disease modifying treatment|1|||
170686396|NCT00459667|616863744|FG001|Overall Study|Other disease modifying treatment|2|||
170686397|NCT00459667|616863745|FG002|Overall Study|Other disease modifying treatment|1|||
170686398|NCT00459667|616863743|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
170686399|NCT00459667|616863744|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
170686400|NCT00459667|616863745|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
170686401|NCT00459667|616863743|FG000|Overall Study|No treatment administered|6|||
170686402|NCT00459667|616863744|FG001|Overall Study|No treatment administered|3|||
170686403|NCT00459667|616863745|FG002|Overall Study|No treatment administered|1|||
170686404|NCT03715764|616863746|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
170686405|NCT03715764|616863747|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
170686406|NCT03715764|616863746|FG000|3 Month Follow-up|Lost to Follow-up|2|||
170686407|NCT03715764|616863747|FG001|3 Month Follow-up|Lost to Follow-up|2|||
170686408|NCT03715764|616863746|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
170686409|NCT03715764|616863747|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
170686410|NCT03715764|616863746|FG000|6 Month Follow-up|Lost to Follow-up|3|||
170686411|NCT03715764|616863747|FG001|6 Month Follow-up|Lost to Follow-up|0|||
170686412|NCT03715764|616863746|FG000|12 Month Follow-up|Lost to Follow-up|2|||
170686413|NCT03715764|616863747|FG001|12 Month Follow-up|Lost to Follow-up|3|||
170686414|NCT03715764|616863746|FG000|12 Month Follow-up|Pregnancy|0|||
170686415|NCT03715764|616863747|FG001|12 Month Follow-up|Pregnancy|1|||
170686416|NCT03715764|616863746|FG000|12 Month Follow-up|Surgery|2|||
170686417|NCT03715764|616863747|FG001|12 Month Follow-up|Surgery|0|||
170686418|NCT03715764|616863746|FG000|12 Month Follow-up|Wrong address|1|||
170686419|NCT03715764|616863747|FG001|12 Month Follow-up|Wrong address|0|||
170686420|NCT03715764|616863746|FG000|12 Month Follow-up|No symptoms|1|||
170686421|NCT03715764|616863747|FG001|12 Month Follow-up|No symptoms|0|||
170686422|NCT03715764|616863746|FG000|12 Month Follow-up|Changed primary care centre|0|||
170686423|NCT03715764|616863747|FG001|12 Month Follow-up|Changed primary care centre|1|||
170686424|NCT01013701|616863752|FG000|Overall Study|study prematurely terminated|7|||
170686425|NCT03241342|616863754|FG000|Overall Study|Adverse Event|5|||
170686426|NCT03241342|616863755|FG001|Overall Study|Adverse Event|8|||
170686427|NCT03241342|616863756|FG002|Overall Study|Adverse Event|4|||
170686428|NCT03241342|616863754|FG000|Overall Study|Lack of Efficacy|0|||
170821355|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
170686429|NCT03241342|616863755|FG001|Overall Study|Lack of Efficacy|0|||
170686430|NCT03241342|616863756|FG002|Overall Study|Lack of Efficacy|1|||
170686431|NCT03241342|616863754|FG000|Overall Study|noncompliance with study drug|2|||
170686432|NCT03241342|616863755|FG001|Overall Study|noncompliance with study drug|1|||
170686433|NCT03241342|616863756|FG002|Overall Study|noncompliance with study drug|1|||
170686434|NCT03241342|616863754|FG000|Overall Study|sponsor decision|0|||
170686435|NCT03241342|616863755|FG001|Overall Study|sponsor decision|1|||
170686436|NCT03241342|616863756|FG002|Overall Study|sponsor decision|2|||
170686437|NCT03241342|616863754|FG000|Overall Study|not reported|15|||
170686438|NCT03241342|616863755|FG001|Overall Study|not reported|21|||
170686439|NCT03241342|616863756|FG002|Overall Study|not reported|19|||
170686440|NCT00556712|616863757|FG000|Overall Study|Adverse Event|7|||
170686441|NCT00556712|616863758|FG001|Overall Study|Adverse Event|19|||
170686442|NCT00556712|616863757|FG000|Overall Study|Death|5|||
170686443|NCT00556712|616863758|FG001|Overall Study|Death|10|||
170686444|NCT00556712|616863757|FG000|Overall Study|Progressive Disease|383|||
170686445|NCT00556712|616863758|FG001|Overall Study|Progressive Disease|320|||
170686446|NCT00556712|616863757|FG000|Overall Study|Protocol Violation|3|||
170686447|NCT00556712|616863758|FG001|Overall Study|Protocol Violation|2|||
170686448|NCT00556712|616863757|FG000|Overall Study|Refused Treatment|17|||
170686449|NCT00556712|616863758|FG001|Overall Study|Refused Treatment|16|||
170686450|NCT00556712|616863757|FG000|Overall Study|Failure to Return|2|||
170686451|NCT00556712|616863758|FG001|Overall Study|Failure to Return|3|||
170686452|NCT00556712|616863757|FG000|Overall Study|Other|2|||
170686453|NCT00556712|616863758|FG001|Overall Study|Other|2|||
170686454|NCT00556712|616863757|FG000|Overall Study|Ongoing at Data Cutoff|32|||
170686455|NCT00556712|616863758|FG001|Overall Study|Ongoing at Data Cutoff|66|||
170686456|NCT00587561|616865408|FG000|Overall Study|Lost to Follow-up|6|||
170686457|NCT00587561|616865409|FG001|Overall Study|Lost to Follow-up|4|||
170686458|NCT05661942|616865410|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
170686459|NCT05661942|616865411|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
170686460|NCT02081690|616865421|FG000|Overall Study|Death|3|||
170686461|NCT02081690|616865421|FG000|Overall Study|Physician Decision|3|||
170686462|NCT02081690|616865421|FG000|Overall Study|Withdrawal by Subject|1|||
170686463|NCT00982488|616865423|FG000|Overall Study|Administrative reason by sponsor|81|||
170686464|NCT00982488|616865424|FG001|Overall Study|Administrative reason by sponsor|3|||
170686465|NCT00982488|616865425|FG002|Overall Study|Administrative reason by sponsor|11|||
170686466|NCT00982488|616865426|FG003|Overall Study|Administrative reason by sponsor|0|||
170686467|NCT00982488|616865427|FG004|Overall Study|Administrative reason by sponsor|0|||
170686468|NCT00982488|616865423|FG000|Overall Study|Adverse event unrelated to study drug|5|||
170686469|NCT00982488|616865424|FG001|Overall Study|Adverse event unrelated to study drug|1|||
170686470|NCT00982488|616865425|FG002|Overall Study|Adverse event unrelated to study drug|0|||
170686471|NCT00982488|616865426|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170686472|NCT00982488|616865427|FG004|Overall Study|Adverse event unrelated to study drug|0|||
170686473|NCT00982488|616865423|FG000|Overall Study|Death|11|||
170686474|NCT00982488|616865424|FG001|Overall Study|Death|0|||
170686475|NCT00982488|616865425|FG002|Overall Study|Death|2|||
170686476|NCT00982488|616865426|FG003|Overall Study|Death|0|||
170686477|NCT00982488|616865427|FG004|Overall Study|Death|0|||
170686478|NCT00982488|616865423|FG000|Overall Study|Disease progression|30|||
170686479|NCT00982488|616865424|FG001|Overall Study|Disease progression|5|||
170686480|NCT00982488|616865425|FG002|Overall Study|Disease progression|10|||
170686481|NCT00982488|616865426|FG003|Overall Study|Disease progression|1|||
170686482|NCT00982488|616865427|FG004|Overall Study|Disease progression|1|||
170686483|NCT00982488|616865423|FG000|Overall Study|Lost to Follow-up|1|||
170686484|NCT00982488|616865424|FG001|Overall Study|Lost to Follow-up|0|||
170821356|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
170821357|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
170821358|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
170821359|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
170821360|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
170821361|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
170686485|NCT00982488|616865425|FG002|Overall Study|Lost to Follow-up|0|||
170686486|NCT00982488|616865426|FG003|Overall Study|Lost to Follow-up|0|||
170686487|NCT00982488|616865427|FG004|Overall Study|Lost to Follow-up|0|||
170686488|NCT00982488|616865423|FG000|Overall Study|Maximum clinical benefit|1|||
170686489|NCT00982488|616865424|FG001|Overall Study|Maximum clinical benefit|1|||
170686490|NCT00982488|616865425|FG002|Overall Study|Maximum clinical benefit|1|||
170686491|NCT00982488|616865426|FG003|Overall Study|Maximum clinical benefit|0|||
170686492|NCT00982488|616865427|FG004|Overall Study|Maximum clinical benefit|0|||
170686493|NCT00982488|616865423|FG000|Overall Study|Other|15|||
170686494|NCT00982488|616865424|FG001|Overall Study|Other|1|||
170686495|NCT00982488|616865425|FG002|Overall Study|Other|3|||
170686496|NCT00982488|616865426|FG003|Overall Study|Other|1|||
170686497|NCT00982488|616865427|FG004|Overall Study|Other|0|||
170686498|NCT00982488|616865423|FG000|Overall Study|Poor compliance/noncompliance|0|||
170686499|NCT00982488|616865424|FG001|Overall Study|Poor compliance/noncompliance|1|||
170686500|NCT00982488|616865425|FG002|Overall Study|Poor compliance/noncompliance|0|||
170686501|NCT00982488|616865426|FG003|Overall Study|Poor compliance/noncompliance|0|||
170686502|NCT00982488|616865427|FG004|Overall Study|Poor compliance/noncompliance|0|||
170686503|NCT00982488|616865423|FG000|Overall Study|Stem cell transplant|2|||
170686504|NCT00982488|616865424|FG001|Overall Study|Stem cell transplant|0|||
170686505|NCT00982488|616865425|FG002|Overall Study|Stem cell transplant|0|||
170686506|NCT00982488|616865426|FG003|Overall Study|Stem cell transplant|1|||
170686507|NCT00982488|616865427|FG004|Overall Study|Stem cell transplant|0|||
170686508|NCT00982488|616865423|FG000|Overall Study|Study drug toxicity|34|||
170686509|NCT00982488|616865424|FG001|Overall Study|Study drug toxicity|1|||
170686510|NCT00982488|616865425|FG002|Overall Study|Study drug toxicity|6|||
170686511|NCT00982488|616865426|FG003|Overall Study|Study drug toxicity|0|||
170686512|NCT00982488|616865427|FG004|Overall Study|Study drug toxicity|0|||
170686513|NCT00982488|616865423|FG000|Overall Study|Withdrawal by Subject|5|||
170686514|NCT00982488|616865424|FG001|Overall Study|Withdrawal by Subject|1|||
170686515|NCT00982488|616865425|FG002|Overall Study|Withdrawal by Subject|1|||
170686516|NCT00982488|616865426|FG003|Overall Study|Withdrawal by Subject|0|||
170686517|NCT00982488|616865427|FG004|Overall Study|Withdrawal by Subject|0|||
170686518|NCT03204981|616865428|FG000|Overall Study|Physician Decision|2|||
170686519|NCT03204981|616865428|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
170686520|NCT04203238|616865429|FG000|Overall Study|Withdrawal by Subject|1|||
170686521|NCT04203238|616865430|FG001|Overall Study|Withdrawal by Subject|1|||
170686522|NCT04203238|616865429|FG000|Overall Study|Covid-19|3|||
170686523|NCT04203238|616865430|FG001|Overall Study|Covid-19|0|||
170686524|NCT03025542|616865431|FG000|Overall Study|Adverse Event|0|||
170686525|NCT03025542|616865432|FG001|Overall Study|Adverse Event|2|||
170686526|NCT03025542|616865431|FG000|Overall Study|Lost to Follow-up|1|||
170686527|NCT03025542|616865432|FG001|Overall Study|Lost to Follow-up|0|||
170686528|NCT03025542|616865431|FG000|Overall Study|Withdrawal by Subject|1|||
170686529|NCT03025542|616865432|FG001|Overall Study|Withdrawal by Subject|0|||
170686530|NCT00386776|616865433|FG000|Overall Study|Withdrawal by Subject|8|||
170686531|NCT03518073|616865437|FG000|Overall Study|Adverse Event|2|||
170686532|NCT03518073|616865438|FG001|Overall Study|Adverse Event|4|||
170686533|NCT03518073|616865439|FG002|Overall Study|Adverse Event|2|||
170686534|NCT03518073|616865437|FG000|Overall Study|Death|2|||
170686535|NCT03518073|616865438|FG001|Overall Study|Death|1|||
170686536|NCT03518073|616865439|FG002|Overall Study|Death|3|||
170686537|NCT03518073|616865437|FG000|Overall Study|Lost to Follow-up|1|||
170686538|NCT03518073|616865438|FG001|Overall Study|Lost to Follow-up|0|||
170686539|NCT03518073|616865439|FG002|Overall Study|Lost to Follow-up|1|||
170686540|NCT03518073|616865437|FG000|Overall Study|Physician Decision|5|||
170686541|NCT03518073|616865438|FG001|Overall Study|Physician Decision|0|||
170686542|NCT03518073|616865439|FG002|Overall Study|Physician Decision|2|||
170686543|NCT03518073|616865437|FG000|Overall Study|Progressive disease|1|||
170686544|NCT03518073|616865438|FG001|Overall Study|Progressive disease|1|||
170686545|NCT03518073|616865439|FG002|Overall Study|Progressive disease|1|||
170686546|NCT03518073|616865437|FG000|Overall Study|Protocol Violation|1|||
170686547|NCT03518073|616865438|FG001|Overall Study|Protocol Violation|0|||
170686548|NCT03518073|616865439|FG002|Overall Study|Protocol Violation|0|||
170686549|NCT03518073|616865437|FG000|Overall Study|Withdrawal by Subject|30|||
170686550|NCT03518073|616865438|FG001|Overall Study|Withdrawal by Subject|34|||
170686551|NCT03518073|616865439|FG002|Overall Study|Withdrawal by Subject|29|||
170686552|NCT03518073|616865437|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
170686553|NCT03518073|616865438|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
170686554|NCT03518073|616865439|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
170686555|NCT03518073|616865437|FG000|Overall Study|Covid-19|1|||
170686556|NCT03518073|616865438|FG001|Overall Study|Covid-19|2|||
170686557|NCT03518073|616865439|FG002|Overall Study|Covid-19|1|||
170686558|NCT03804879|616865440|FG000|Overall Study|Adverse Event|3|||
170686559|NCT03804879|616865441|FG001|Overall Study|Adverse Event|0|||
170686560|NCT03804879|616865440|FG000|Overall Study|Study Terminated By Sponsor|10|||
170686561|NCT03804879|616865441|FG001|Overall Study|Study Terminated By Sponsor|12|||
170686562|NCT03804879|616865440|FG000|Overall Study|Withdrawal by Subject|3|||
170686563|NCT03804879|616865441|FG001|Overall Study|Withdrawal by Subject|1|||
170821362|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
170821363|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
170821364|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
170821365|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
170821366|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
170821367|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
170821368|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
170821369|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
170686564|NCT02436889|616865442|FG000|Overall Study|No improvement in symptoms|1|||
170686565|NCT02436889|616865443|FG001|Overall Study|No improvement in symptoms|0|||
170686566|NCT02436889|616865442|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
170686567|NCT02436889|616865443|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
170686568|NCT01585428|616865444|FG000|Overall Study|Death during treatment|1|||
170686569|NCT01585428|616865445|FG001|Overall Study|Death during treatment|0|||
170686570|NCT02057198|616865446|FG000|Overall Study|Death|0|||
170686571|NCT02057198|616865447|FG001|Overall Study|Death|0|||
170686572|NCT02057198|616865448|FG002|Overall Study|Death|1|||
170686573|NCT02057198|616865446|FG000|Overall Study|Discharged early; lost to followup|0|||
170686574|NCT02057198|616865447|FG001|Overall Study|Discharged early; lost to followup|1|||
170686575|NCT02057198|616865448|FG002|Overall Study|Discharged early; lost to followup|0|||
170686576|NCT02355691|616865452|FG000|Overall Study|Loss of Research Personnel|7|||
170686577|NCT02355691|616865453|FG001|Overall Study|Loss of Research Personnel|9|||
170686578|NCT00350636|616865454|FG000|Overall Study|Adverse Event|19|||
170686579|NCT00350636|616865455|FG001|Overall Study|Adverse Event|13|||
170686580|NCT00350636|616865454|FG000|Overall Study|Protocol Violation|1|||
170686581|NCT00350636|616865455|FG001|Overall Study|Protocol Violation|3|||
170686582|NCT00350636|616865454|FG000|Overall Study|Withdrawal by Subject|13|||
170686583|NCT00350636|616865455|FG001|Overall Study|Withdrawal by Subject|17|||
170686584|NCT00350636|616865454|FG000|Overall Study|Lost to Follow-up|9|||
170686585|NCT00350636|616865455|FG001|Overall Study|Lost to Follow-up|8|||
170686586|NCT00350636|616865454|FG000|Overall Study|Physician Decision|0|||
170686587|NCT00350636|616865455|FG001|Overall Study|Physician Decision|2|||
170686588|NCT00350636|616865454|FG000|Overall Study|Other|1|||
170686589|NCT00350636|616865455|FG001|Overall Study|Other|2|||
170686590|NCT00100815|616865456|FG000|Overall Study|Progression|24|||
170686591|NCT00100815|616865456|FG000|Overall Study|Adverse Event|18|||
170686592|NCT00100815|616865456|FG000|Overall Study|Death|4|||
170686593|NCT00100815|616865456|FG000|Overall Study|Other|3|||
170686594|NCT01042236|616865460|FG000|Treatment Period 1|Adverse Event|0|||
170686595|NCT01042236|616865461|FG001|Treatment Period 1|Adverse Event|1|||
170686596|NCT01042236|616865462|FG002|Treatment Period 1|Adverse Event|0|||
170686597|NCT01042236|616865463|FG003|Treatment Period 1|Adverse Event|0|||
170686598|NCT01042236|616865464|FG004|Treatment Period 1|Adverse Event|1|||
170686599|NCT01042236|616865465|FG005|Treatment Period 1|Adverse Event|0|||
170686600|NCT01042236|616865460|FG000|Treatment Period 3|Adverse Event|0|||
170686601|NCT01042236|616865461|FG001|Treatment Period 3|Adverse Event|0|||
170686602|NCT01042236|616865462|FG002|Treatment Period 3|Adverse Event|0|||
170686603|NCT01042236|616865463|FG003|Treatment Period 3|Adverse Event|1|||
170686604|NCT01042236|616865464|FG004|Treatment Period 3|Adverse Event|0|||
170686605|NCT01042236|616865465|FG005|Treatment Period 3|Adverse Event|0|||
170686606|NCT01042236|616865460|FG000|Treatment Period 3|Protocol Violation|0|||
170686607|NCT01042236|616865461|FG001|Treatment Period 3|Protocol Violation|0|||
170686608|NCT01042236|616865462|FG002|Treatment Period 3|Protocol Violation|0|||
170686609|NCT01042236|616865463|FG003|Treatment Period 3|Protocol Violation|1|||
170686610|NCT01042236|616865464|FG004|Treatment Period 3|Protocol Violation|0|||
170686611|NCT01042236|616865465|FG005|Treatment Period 3|Protocol Violation|0|||
170686612|NCT01244906|616865468|FG000|Overall Study|Death|2|||
170686613|NCT01244906|616865468|FG000|Overall Study|Progression of disease post treatment|6|||
170686614|NCT01172847|616865473|FG000|Overall Study|Withdrawal by Subject|3|||
170686615|NCT00665353|616865478|FG000|Study Step 1|Adverse Event|1|||
170686616|NCT00665353|616865478|FG000|Study Step 1|Withdrawal by Subject|2|||
170686617|NCT00665353|616865478|FG000|Study Step 2|Lost to Follow-up|2|||
170686618|NCT00665353|616865478|FG000|Study Step 2|Lack of Efficacy|12|||
170686619|NCT01870583|616865479|FG000|Overall Study|Protocol Violation|0|||
170686620|NCT01870583|616865480|FG001|Overall Study|Protocol Violation|5|||
170686621|NCT01870583|616865481|FG002|Overall Study|Protocol Violation|3|||
170686622|NCT01870583|616865479|FG000|Overall Study|Lost to Follow-up|11|||
170686623|NCT01870583|616865480|FG001|Overall Study|Lost to Follow-up|13|||
170686624|NCT01870583|616865481|FG002|Overall Study|Lost to Follow-up|5|||
170686625|NCT00937157|616865482|FG000|Overall Study|Pregnancy|1|||
170686626|NCT00937157|616865482|FG000|Overall Study|Lost to Follow-up|3|||
170686627|NCT01846507|616865483|FG000|Overall Study|Lost to Follow-up|4|||
170686628|NCT01846507|616865483|FG000|Overall Study|Protocol Violation|1|||
170686629|NCT01846507|616865483|FG000|Overall Study|Missing data|2|||
170686630|NCT04984993|616865484|FG000|Overall Study|Withdrawal by Subject|8|||
170686631|NCT04984993|616865485|FG001|Overall Study|Withdrawal by Subject|2|||
170686632|NCT04984993|616865484|FG000|Overall Study|Lost to Follow-up|2|||
170686633|NCT04984993|616865485|FG001|Overall Study|Lost to Follow-up|2|||
170686634|NCT04984993|616865484|FG000|Overall Study|Both patients moved to another country|4|||
170686635|NCT04984993|616865485|FG001|Overall Study|Both patients moved to another country|0|||
170686636|NCT02865187|616865486|FG000|Overall Study|Lost to Follow-up|12|||
170686637|NCT02865187|616865487|FG001|Overall Study|Lost to Follow-up|7|||
170686638|NCT02865187|616865486|FG000|Overall Study|Adverse Event|1|||
170686639|NCT02865187|616865487|FG001|Overall Study|Adverse Event|0|||
170686640|NCT04267133|616865488|FG000|Overall Study|Withdrawal by Subject|1|||
170686641|NCT04267133|616865488|FG000|Overall Study|Adverse Event|4|||
170686642|NCT03318315|616865489|FG000|Overall Study|Lost to Follow-up|3|||
170686643|NCT03318315|616865490|FG001|Overall Study|Lost to Follow-up|2|||
170686644|NCT03318315|616865491|FG002|Overall Study|Lost to Follow-up|1|||
170686645|NCT03318315|616865489|FG000|Overall Study|Protocol Violation|1|||
170686646|NCT03318315|616865490|FG001|Overall Study|Protocol Violation|1|||
170686647|NCT03318315|616865491|FG002|Overall Study|Protocol Violation|1|||
170686648|NCT03318315|616865489|FG000|Overall Study|Withdrawal by Subject|0|||
170686649|NCT03318315|616865490|FG001|Overall Study|Withdrawal by Subject|0|||
170686650|NCT03318315|616865491|FG002|Overall Study|Withdrawal by Subject|2|||
170686651|NCT01382446|616865495|FG000|Overall Study|Withdrawal by Subject|0|||
170686652|NCT01382446|616865496|FG001|Overall Study|Withdrawal by Subject|1|||
170686653|NCT01382446|616865495|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
170686654|NCT01382446|616865496|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
170686655|NCT00770289|616865498|FG000|Overall Study|Other|6|||
170686656|NCT02733991|616865499|FG000|Overall Study|Adverse Event|1|||
170686657|NCT02733991|616865500|FG001|Overall Study|Adverse Event|0|||
170686658|NCT02733991|616865499|FG000|Overall Study|Withdrawal by Subject|0|||
170686659|NCT02733991|616865500|FG001|Overall Study|Withdrawal by Subject|5|||
170686660|NCT00495170|616865501|FG000|Overall Study|Lost to Follow-up|9|||
170686661|NCT00495170|616865501|FG000|Overall Study|Withdrawal by Subject|3|||
170686662|NCT00495170|616865501|FG000|Overall Study|Inappropriate staging|8|||
170686663|NCT00752232|616865502|FG000|Overall Study|Protocol Violation|0|||
170686664|NCT00752232|616865503|FG001|Overall Study|Protocol Violation|0|||
170686665|NCT00752232|616865504|FG002|Overall Study|Protocol Violation|0|||
170686666|NCT00752232|616865505|FG003|Overall Study|Protocol Violation|0|||
170686667|NCT00752232|616865506|FG004|Overall Study|Protocol Violation|0|||
170686668|NCT00752232|616865507|FG005|Overall Study|Protocol Violation|1|||
170686669|NCT00752232|616865508|FG006|Overall Study|Protocol Violation|0|||
170686670|NCT00752232|616865502|FG000|Overall Study|Caregiver request|2|||
170686671|NCT00752232|616865503|FG001|Overall Study|Caregiver request|0|||
170686672|NCT00752232|616865504|FG002|Overall Study|Caregiver request|0|||
170686673|NCT00752232|616865505|FG003|Overall Study|Caregiver request|0|||
170686674|NCT00752232|616865506|FG004|Overall Study|Caregiver request|1|||
170686675|NCT00752232|616865507|FG005|Overall Study|Caregiver request|0|||
170686676|NCT00752232|616865508|FG006|Overall Study|Caregiver request|0|||
170686677|NCT00752232|616865502|FG000|Overall Study|Investigator request|0|||
170686678|NCT00752232|616865503|FG001|Overall Study|Investigator request|0|||
170686679|NCT00752232|616865504|FG002|Overall Study|Investigator request|0|||
170686680|NCT00752232|616865505|FG003|Overall Study|Investigator request|0|||
170686681|NCT00752232|616865506|FG004|Overall Study|Investigator request|1|||
170686682|NCT00752232|616865507|FG005|Overall Study|Investigator request|0|||
170686683|NCT00752232|616865508|FG006|Overall Study|Investigator request|0|||
170821370|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
170821371|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
170821372|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
170821373|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
170686684|NCT00752232|616865502|FG000|Overall Study|Subject request|0|||
170686685|NCT00752232|616865503|FG001|Overall Study|Subject request|0|||
170686686|NCT00752232|616865504|FG002|Overall Study|Subject request|1|||
170686687|NCT00752232|616865505|FG003|Overall Study|Subject request|0|||
170686688|NCT00752232|616865506|FG004|Overall Study|Subject request|0|||
170686689|NCT00752232|616865507|FG005|Overall Study|Subject request|0|||
170686690|NCT00752232|616865508|FG006|Overall Study|Subject request|0|||
170686691|NCT00752232|616865502|FG000|Overall Study|Group home admission|0|||
170686692|NCT00752232|616865503|FG001|Overall Study|Group home admission|0|||
170686693|NCT00752232|616865504|FG002|Overall Study|Group home admission|0|||
170686694|NCT00752232|616865505|FG003|Overall Study|Group home admission|1|||
170686695|NCT00752232|616865506|FG004|Overall Study|Group home admission|0|||
170686696|NCT00752232|616865507|FG005|Overall Study|Group home admission|0|||
170686697|NCT00752232|616865508|FG006|Overall Study|Group home admission|0|||
170686698|NCT00752232|616865502|FG000|Overall Study|Caregiver could not attend the subject|0|||
170686699|NCT00752232|616865503|FG001|Overall Study|Caregiver could not attend the subject|0|||
170686700|NCT00752232|616865504|FG002|Overall Study|Caregiver could not attend the subject|0|||
170686701|NCT00752232|616865505|FG003|Overall Study|Caregiver could not attend the subject|0|||
170686702|NCT00752232|616865506|FG004|Overall Study|Caregiver could not attend the subject|1|||
170686703|NCT00752232|616865507|FG005|Overall Study|Caregiver could not attend the subject|0|||
170686704|NCT00752232|616865508|FG006|Overall Study|Caregiver could not attend the subject|0|||
170686705|NCT02485574|616865511|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
170686706|NCT00330616|616865513|FG000|Overall Study|Adverse Event|13|||
170686707|NCT00330616|616865513|FG000|Overall Study|Lack of Efficacy|1|||
170686708|NCT00330616|616865513|FG000|Overall Study|Lost to Follow-up|2|||
170686709|NCT00330616|616865513|FG000|Overall Study|Withdrawal by Subject|4|||
170686710|NCT00330616|616865513|FG000|Overall Study|Other|1|||
170686711|NCT02617511|616865516|FG000|Overall Study|Withdrawal by Subject|1|||
170686712|NCT02617511|616865517|FG001|Overall Study|Withdrawal by Subject|0|||
170686713|NCT00255047|616865518|FG000|Overall Study|Serious Adverse Events|2|||
170686714|NCT00255047|616865519|FG001|Overall Study|Serious Adverse Events|1|||
170686715|NCT00255047|616865520|FG002|Overall Study|Serious Adverse Events|2|||
170686716|NCT00255047|616865521|FG003|Overall Study|Serious Adverse Events|1|||
170686717|NCT00255047|616865518|FG000|Overall Study|Adverse Event|0|||
170686718|NCT00255047|616865519|FG001|Overall Study|Adverse Event|3|||
170686719|NCT00255047|616865520|FG002|Overall Study|Adverse Event|2|||
170686720|NCT00255047|616865521|FG003|Overall Study|Adverse Event|1|||
170686721|NCT00255047|616865518|FG000|Overall Study|Protocol Violation|13|||
170686722|NCT00255047|616865519|FG001|Overall Study|Protocol Violation|13|||
170686723|NCT00255047|616865520|FG002|Overall Study|Protocol Violation|16|||
170686724|NCT00255047|616865521|FG003|Overall Study|Protocol Violation|20|||
170686725|NCT00255047|616865518|FG000|Overall Study|Lost to Follow-up|9|||
170686726|NCT00255047|616865519|FG001|Overall Study|Lost to Follow-up|8|||
170686727|NCT00255047|616865520|FG002|Overall Study|Lost to Follow-up|5|||
170686728|NCT00255047|616865521|FG003|Overall Study|Lost to Follow-up|6|||
170686729|NCT00255047|616865518|FG000|Overall Study|Withdrawal by Subject|24|||
170686730|NCT00255047|616865519|FG001|Overall Study|Withdrawal by Subject|23|||
170686731|NCT00255047|616865520|FG002|Overall Study|Withdrawal by Subject|25|||
170686732|NCT00255047|616865521|FG003|Overall Study|Withdrawal by Subject|18|||
170686733|NCT02141997|616865522|FG000|Overall Study|Adverse Event|0|||
170686734|NCT02141997|616865523|FG001|Overall Study|Adverse Event|2|||
170686735|NCT02141997|616865524|FG002|Overall Study|Adverse Event|0|||
170686736|NCT02141997|616865525|FG003|Overall Study|Adverse Event|1|||
170686737|NCT02141997|616865522|FG000|Overall Study|Participant noncompliance|1|||
170686738|NCT02141997|616865523|FG001|Overall Study|Participant noncompliance|0|||
170686739|NCT02141997|616865524|FG002|Overall Study|Participant noncompliance|0|||
170686740|NCT02141997|616865525|FG003|Overall Study|Participant noncompliance|0|||
170686741|NCT02141997|616865522|FG000|Overall Study|Withdrew consent|1|||
170686742|NCT02141997|616865523|FG001|Overall Study|Withdrew consent|0|||
170686743|NCT02141997|616865524|FG002|Overall Study|Withdrew consent|3|||
170686744|NCT02141997|616865525|FG003|Overall Study|Withdrew consent|0|||
170686745|NCT02141997|616865522|FG000|Overall Study|Other|1|||
170686746|NCT02141997|616865523|FG001|Overall Study|Other|4|||
170686747|NCT02141997|616865524|FG002|Overall Study|Other|0|||
170686748|NCT02141997|616865525|FG003|Overall Study|Other|0|||
170686749|NCT00811473|616865526|FG000|Overall Study|Adverse Event|3|||
170686750|NCT00811473|616865527|FG001|Overall Study|Adverse Event|12|||
170686751|NCT00811473|616865526|FG000|Overall Study|Lost to Follow-up|5|||
170686752|NCT00811473|616865527|FG001|Overall Study|Lost to Follow-up|1|||
170686753|NCT00811473|616865526|FG000|Overall Study|Withdrawal by Subject|2|||
170686754|NCT00811473|616865527|FG001|Overall Study|Withdrawal by Subject|4|||
170686755|NCT00811473|616865526|FG000|Overall Study|Severe non-compliance to protocol|2|||
170686756|NCT00811473|616865527|FG001|Overall Study|Severe non-compliance to protocol|4|||
170686757|NCT00811473|616865526|FG000|Overall Study|Lack of therapeutic response|4|||
170686758|NCT00811473|616865527|FG001|Overall Study|Lack of therapeutic response|1|||
170821374|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
170821375|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
170821376|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
170821377|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
170821378|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
170821379|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
170821380|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
170821381|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
170686759|NCT00811473|616865526|FG000|Overall Study|Condition under investigation worsened|1|||
170686760|NCT00811473|616865527|FG001|Overall Study|Condition under investigation worsened|3|||
170686761|NCT00811473|616865526|FG000|Overall Study|Other 2|4|||
170686762|NCT00811473|616865527|FG001|Overall Study|Other 2|1|||
170821382|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
170686763|NCT00811473|616865526|FG000|Overall Study|Incorrect Enrollment|1|||
170686764|NCT00811473|616865527|FG001|Overall Study|Incorrect Enrollment|0|||
170686765|NCT00811473|616865526|FG000|Overall Study|Safety Reasons|1|||
170686766|NCT00811473|616865527|FG001|Overall Study|Safety Reasons|0|||
170686767|NCT01119131|616865528|FG000|Overall Study|Adverse Event|1|||
170686768|NCT01119131|616865529|FG001|Overall Study|Adverse Event|1|||
170686769|NCT01119131|616865530|FG002|Overall Study|Adverse Event|1|||
170686770|NCT01119131|616865528|FG000|Overall Study|Non-Compliance|1|||
170686771|NCT01119131|616865529|FG001|Overall Study|Non-Compliance|0|||
170686772|NCT01119131|616865530|FG002|Overall Study|Non-Compliance|4|||
170686773|NCT01119131|616865528|FG000|Overall Study|Physician Decision|0|||
170686774|NCT01119131|616865529|FG001|Overall Study|Physician Decision|0|||
170686775|NCT01119131|616865530|FG002|Overall Study|Physician Decision|1|||
170686776|NCT01909479|616865533|FG000|From Baseline to Week 26|Adverse Event|3|||
170686777|NCT01909479|616865534|FG001|From Baseline to Week 26|Adverse Event|2|||
170686778|NCT01909479|616865533|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
170686779|NCT01909479|616865534|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
170686780|NCT01909479|616865533|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
170686781|NCT01909479|616865534|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
170686782|NCT01909479|616865533|FG000|26 - 52 Weeks|Adverse Event|0|||
170686783|NCT01909479|616865534|FG001|26 - 52 Weeks|Adverse Event|1|||
170686784|NCT01909479|616865533|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
170686785|NCT01909479|616865534|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
170686786|NCT01909479|616865533|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
170686787|NCT01909479|616865534|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
170686788|NCT01909479|616865533|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
170686789|NCT01909479|616865534|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
170686790|NCT01909479|616865533|FG000|52 Weeks to End of Study|Adverse Event|2|||
170686791|NCT01909479|616865534|FG001|52 Weeks to End of Study|Adverse Event|1|||
170686792|NCT01909479|616865533|FG000|52 Weeks to End of Study|Death|0|||
170686793|NCT01909479|616865534|FG001|52 Weeks to End of Study|Death|1|||
170686794|NCT01909479|616865533|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
170686795|NCT01909479|616865534|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
170686796|NCT01909479|616865533|FG000|52 Weeks to End of Study|Protocol Violation|1|||
170686797|NCT01909479|616865534|FG001|52 Weeks to End of Study|Protocol Violation|0|||
170686798|NCT01909479|616865533|FG000|52 Weeks to End of Study|Progressive disease|1|||
170686799|NCT01909479|616865534|FG001|52 Weeks to End of Study|Progressive disease|1|||
170686800|NCT01909479|616865533|FG000|52 Weeks to End of Study|Personal reasons|2|||
170686801|NCT01909479|616865534|FG001|52 Weeks to End of Study|Personal reasons|1|||
170686802|NCT01909479|616865533|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
170686803|NCT01909479|616865534|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
170686804|NCT01909479|616865533|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
170686805|NCT01909479|616865534|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
170686806|NCT01909479|616865533|FG000|52 Weeks to End of Study|Lack of contact|1|||
170686807|NCT01909479|616865534|FG001|52 Weeks to End of Study|Lack of contact|0|||
170686808|NCT01909479|616865533|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
170686809|NCT01909479|616865534|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
170686810|NCT01909479|616865533|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
170686811|NCT01909479|616865534|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
170686812|NCT02049957|616865540|FG000|Overall Study|Progressive Disease|5|||
170686813|NCT02049957|616865541|FG001|Overall Study|Progressive Disease|4|||
170686814|NCT02049957|616865542|FG002|Overall Study|Progressive Disease|2|||
170686815|NCT02049957|616865543|FG003|Overall Study|Progressive Disease|2|||
170686816|NCT02049957|616865544|FG004|Overall Study|Progressive Disease|6|||
170686817|NCT02049957|616865545|FG005|Overall Study|Progressive Disease|35|||
170686818|NCT02049957|616865546|FG006|Overall Study|Progressive Disease|7|||
170686819|NCT02049957|616865547|FG007|Overall Study|Progressive Disease|26|||
170686820|NCT02049957|616865548|FG008|Overall Study|Progressive Disease|6|||
170686821|NCT02049957|616865540|FG000|Overall Study|Adverse Event|1|||
170686822|NCT02049957|616865541|FG001|Overall Study|Adverse Event|1|||
170686823|NCT02049957|616865542|FG002|Overall Study|Adverse Event|1|||
170686824|NCT02049957|616865543|FG003|Overall Study|Adverse Event|0|||
170686825|NCT02049957|616865544|FG004|Overall Study|Adverse Event|0|||
170686826|NCT02049957|616865545|FG005|Overall Study|Adverse Event|5|||
170686827|NCT02049957|616865546|FG006|Overall Study|Adverse Event|0|||
170686828|NCT02049957|616865547|FG007|Overall Study|Adverse Event|6|||
170686829|NCT02049957|616865548|FG008|Overall Study|Adverse Event|1|||
170686830|NCT02049957|616865540|FG000|Overall Study|Study Terminated by Sponsor|0|||
170686831|NCT02049957|616865541|FG001|Overall Study|Study Terminated by Sponsor|1|||
170686832|NCT02049957|616865542|FG002|Overall Study|Study Terminated by Sponsor|0|||
170686833|NCT02049957|616865543|FG003|Overall Study|Study Terminated by Sponsor|0|||
170821383|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
170821384|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
170686834|NCT02049957|616865544|FG004|Overall Study|Study Terminated by Sponsor|0|||
170686835|NCT02049957|616865545|FG005|Overall Study|Study Terminated by Sponsor|0|||
170686836|NCT02049957|616865546|FG006|Overall Study|Study Terminated by Sponsor|1|||
170686837|NCT02049957|616865547|FG007|Overall Study|Study Terminated by Sponsor|0|||
170686838|NCT02049957|616865548|FG008|Overall Study|Study Terminated by Sponsor|0|||
170686839|NCT02049957|616865540|FG000|Overall Study|Withdrawal by Subject|0|||
170686840|NCT02049957|616865541|FG001|Overall Study|Withdrawal by Subject|0|||
170821385|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
170686841|NCT02049957|616865542|FG002|Overall Study|Withdrawal by Subject|0|||
170686842|NCT02049957|616865543|FG003|Overall Study|Withdrawal by Subject|1|||
170686843|NCT02049957|616865544|FG004|Overall Study|Withdrawal by Subject|0|||
170686844|NCT02049957|616865545|FG005|Overall Study|Withdrawal by Subject|2|||
170686845|NCT02049957|616865546|FG006|Overall Study|Withdrawal by Subject|0|||
170686846|NCT02049957|616865547|FG007|Overall Study|Withdrawal by Subject|3|||
170686847|NCT02049957|616865548|FG008|Overall Study|Withdrawal by Subject|1|||
170686848|NCT02049957|616865540|FG000|Overall Study|Physician Decision|0|||
170686849|NCT02049957|616865541|FG001|Overall Study|Physician Decision|0|||
170686850|NCT02049957|616865542|FG002|Overall Study|Physician Decision|0|||
170686851|NCT02049957|616865543|FG003|Overall Study|Physician Decision|0|||
170686852|NCT02049957|616865544|FG004|Overall Study|Physician Decision|0|||
170686853|NCT02049957|616865545|FG005|Overall Study|Physician Decision|1|||
170686854|NCT02049957|616865546|FG006|Overall Study|Physician Decision|0|||
170686855|NCT02049957|616865547|FG007|Overall Study|Physician Decision|0|||
170686856|NCT02049957|616865548|FG008|Overall Study|Physician Decision|0|||
170686857|NCT03742037|616865549|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
170686858|NCT03742037|616865550|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
170686859|NCT03742037|616865551|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
170686860|NCT03742037|616865552|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
170686861|NCT03742037|616865553|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
170686862|NCT03742037|616865554|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
170686863|NCT03742037|616865555|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
170686864|NCT03742037|616865549|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
170686865|NCT03742037|616865550|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
170686866|NCT03742037|616865551|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
170686867|NCT03742037|616865552|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
170686868|NCT03742037|616865553|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
170686869|NCT03742037|616865554|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
170686870|NCT03742037|616865555|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
170686871|NCT03742037|616865549|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
170686872|NCT03742037|616865550|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
170686873|NCT03742037|616865551|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
170686874|NCT03742037|616865552|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
170686875|NCT03742037|616865553|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
170686876|NCT03742037|616865554|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
170686877|NCT03742037|616865555|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
170686878|NCT03742037|616865549|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
170686879|NCT03742037|616865550|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
170686880|NCT03742037|616865551|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
170686881|NCT03742037|616865552|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
170686882|NCT03742037|616865553|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
170686883|NCT03742037|616865554|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
170686884|NCT03742037|616865555|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
170686885|NCT03742037|616865549|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
170686886|NCT03742037|616865550|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
170686887|NCT03742037|616865551|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
170686888|NCT03742037|616865552|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
170686889|NCT03742037|616865553|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
170686890|NCT03742037|616865554|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
170686891|NCT03742037|616865555|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
170686892|NCT03742037|616865549|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
170686893|NCT03742037|616865550|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
170686894|NCT03742037|616865551|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
170686895|NCT03742037|616865552|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
170821386|NCT03602859|617353362|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
170821387|NCT03602859|617353363|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
170821388|NCT03602859|617353364|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
170686896|NCT03742037|616865553|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
170686897|NCT03742037|616865554|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
170686898|NCT03742037|616865555|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
170686899|NCT03742037|616865549|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
170686900|NCT03742037|616865550|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
170686901|NCT03742037|616865551|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
170686902|NCT03742037|616865552|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
170821389|NCT03602859|617353365|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
170686903|NCT03742037|616865553|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
170686904|NCT03742037|616865554|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
170686905|NCT03742037|616865555|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
170686906|NCT03742037|616865549|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
170686907|NCT03742037|616865550|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
170686908|NCT03742037|616865551|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
170686909|NCT03742037|616865552|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
170686910|NCT03742037|616865553|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
170686911|NCT03742037|616865554|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
170686912|NCT03742037|616865555|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
170686913|NCT03742037|616865549|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
170686914|NCT03742037|616865550|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
170686915|NCT03742037|616865551|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
170686916|NCT03742037|616865552|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
170686917|NCT03742037|616865553|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
170686918|NCT03742037|616865554|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
170686919|NCT03742037|616865555|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
170686920|NCT03742037|616865549|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
170686921|NCT03742037|616865550|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
170686922|NCT03742037|616865551|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
170686923|NCT03742037|616865552|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
170686924|NCT03742037|616865553|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
170686925|NCT03742037|616865554|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
170686926|NCT03742037|616865555|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
170686927|NCT03742037|616865549|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
170686928|NCT03742037|616865550|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
170686929|NCT03742037|616865551|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
170686930|NCT03742037|616865552|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
170686931|NCT03742037|616865553|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
170686932|NCT03742037|616865554|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
170686933|NCT03742037|616865555|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
170686934|NCT03742037|616865549|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
170686935|NCT03742037|616865550|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
170686936|NCT03742037|616865551|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
170686937|NCT03742037|616865552|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
170686938|NCT03742037|616865553|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
170686939|NCT03742037|616865554|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
170686940|NCT03742037|616865555|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
170686941|NCT03742037|616865549|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
170686942|NCT03742037|616865550|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
170686943|NCT03742037|616865551|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
170686944|NCT03742037|616865552|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
170686945|NCT03742037|616865553|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
170686946|NCT03742037|616865554|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
170686947|NCT03742037|616865555|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
170686948|NCT03742037|616865549|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
170686949|NCT03742037|616865550|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
170686950|NCT03742037|616865551|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
170686951|NCT03742037|616865552|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
170686952|NCT03742037|616865553|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
170686953|NCT03742037|616865554|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
170686954|NCT03742037|616865555|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
170686955|NCT03742037|616865549|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
170686956|NCT03742037|616865550|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
170686957|NCT03742037|616865551|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
170686958|NCT03742037|616865552|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
170686959|NCT03742037|616865553|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
170686960|NCT03742037|616865554|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
170686961|NCT03742037|616865555|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
170686962|NCT01414075|616865556|FG000|Overall Study|Adverse Event|1|||
170686963|NCT01414075|616865557|FG001|Overall Study|Adverse Event|0|||
170686964|NCT01414075|616865558|FG002|Overall Study|Adverse Event|1|||
170686965|NCT01414075|616865559|FG003|Overall Study|Adverse Event|0|||
170686966|NCT01414075|616865556|FG000|Overall Study|Death|1|||
170686967|NCT01414075|616865557|FG001|Overall Study|Death|0|||
170686968|NCT01414075|616865558|FG002|Overall Study|Death|0|||
170686969|NCT01414075|616865559|FG003|Overall Study|Death|1|||
170686970|NCT01414075|616865556|FG000|Overall Study|Withdrawal by Subject|0|||
170686971|NCT01414075|616865557|FG001|Overall Study|Withdrawal by Subject|0|||
170686972|NCT01414075|616865558|FG002|Overall Study|Withdrawal by Subject|0|||
170686973|NCT01414075|616865559|FG003|Overall Study|Withdrawal by Subject|1|||
170686974|NCT01414075|616865556|FG000|Overall Study|Other than specified|1|||
170686975|NCT01414075|616865557|FG001|Overall Study|Other than specified|0|||
170686976|NCT01414075|616865558|FG002|Overall Study|Other than specified|1|||
170686977|NCT01414075|616865559|FG003|Overall Study|Other than specified|0|||
170686978|NCT01187043|616865560|FG000|Overall Study|Adverse Event|0|||
170686979|NCT01187043|616865561|FG001|Overall Study|Adverse Event|0|||
170686980|NCT01187043|616865562|FG002|Overall Study|Adverse Event|0|||
170686981|NCT01187043|616865563|FG003|Overall Study|Adverse Event|0|||
170686982|NCT01187043|616865564|FG004|Overall Study|Adverse Event|1|||
170686983|NCT01187043|616865560|FG000|Overall Study|Unable to make scheduled visits|1|||
170686984|NCT01187043|616865561|FG001|Overall Study|Unable to make scheduled visits|0|||
170686985|NCT01187043|616865562|FG002|Overall Study|Unable to make scheduled visits|4|||
170686986|NCT01187043|616865563|FG003|Overall Study|Unable to make scheduled visits|0|||
170686987|NCT01187043|616865564|FG004|Overall Study|Unable to make scheduled visits|1|||
170686988|NCT03035409|616865565|FG000|Overall Study|Adverse Event|5|||
170686989|NCT03035409|616865565|FG000|Overall Study|Death|2|||
170686990|NCT03035409|616865565|FG000|Overall Study|Withdrawal by Subject|2|||
170686991|NCT03035409|616865565|FG000|Overall Study|Non compliance|4|||
170686992|NCT03035409|616865565|FG000|Overall Study|Patient was jittery|1|||
170686993|NCT03035409|616865565|FG000|Overall Study|Did not like Questionnaire|1|||
170686994|NCT03035409|616865565|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
170686995|NCT03035409|616865565|FG000|Overall Study|Did not like taking drugs|1|||
170686996|NCT00927784|616865570|FG000|Overall Study|Death|1|||
170686997|NCT00927784|616865571|FG001|Overall Study|Death|0|||
170686998|NCT00927784|616865570|FG000|Overall Study|Withdrawal by Subject|1|||
170686999|NCT00927784|616865571|FG001|Overall Study|Withdrawal by Subject|0|||
170687000|NCT02457910|616865572|FG000|Overall Study|Withdrawal by Subject|0|||
170687001|NCT02457910|616865573|FG001|Overall Study|Withdrawal by Subject|0|||
170687002|NCT02457910|616865574|FG002|Overall Study|Withdrawal by Subject|0|||
170687003|NCT02457910|616865575|FG003|Overall Study|Withdrawal by Subject|0|||
170687004|NCT02457910|616865576|FG004|Overall Study|Withdrawal by Subject|0|||
170687005|NCT02457910|616865577|FG005|Overall Study|Withdrawal by Subject|1|||
170687006|NCT02457910|616865572|FG000|Overall Study|Adverse Event|0|||
170687007|NCT02457910|616865573|FG001|Overall Study|Adverse Event|2|||
170687008|NCT02457910|616865574|FG002|Overall Study|Adverse Event|1|||
170687009|NCT02457910|616865575|FG003|Overall Study|Adverse Event|1|||
170687010|NCT02457910|616865576|FG004|Overall Study|Adverse Event|1|||
170687011|NCT02457910|616865577|FG005|Overall Study|Adverse Event|3|||
170821390|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
170821391|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
170821392|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
170821393|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
170821394|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
170821395|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
170821396|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
170821397|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
170821398|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
170821399|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
170821400|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
170821401|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
170821402|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
170821403|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
170821404|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
170687012|NCT02457910|616865572|FG000|Overall Study|Disease progression|3|||
170687013|NCT02457910|616865573|FG001|Overall Study|Disease progression|3|||
170687014|NCT02457910|616865574|FG002|Overall Study|Disease progression|1|||
170687015|NCT02457910|616865575|FG003|Overall Study|Disease progression|1|||
170687016|NCT02457910|616865576|FG004|Overall Study|Disease progression|4|||
170687017|NCT02457910|616865577|FG005|Overall Study|Disease progression|6|||
170687018|NCT02457910|616865572|FG000|Overall Study|Other complicating illness|0|||
170687019|NCT02457910|616865573|FG001|Overall Study|Other complicating illness|0|||
170687020|NCT02457910|616865574|FG002|Overall Study|Other complicating illness|0|||
170687021|NCT02457910|616865575|FG003|Overall Study|Other complicating illness|0|||
170687022|NCT02457910|616865576|FG004|Overall Study|Other complicating illness|0|||
170821405|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
170821406|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
170821407|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
170821408|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
170821409|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
170821410|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
170687023|NCT02457910|616865577|FG005|Overall Study|Other complicating illness|1|||
170687024|NCT02457910|616865572|FG000|Overall Study|Death|0|||
170687025|NCT02457910|616865573|FG001|Overall Study|Death|0|||
170687026|NCT02457910|616865574|FG002|Overall Study|Death|1|||
170687027|NCT02457910|616865575|FG003|Overall Study|Death|0|||
170687028|NCT02457910|616865576|FG004|Overall Study|Death|0|||
170687029|NCT02457910|616865577|FG005|Overall Study|Death|0|||
170687030|NCT00467259|616865578|FG000|Overall Study|Adverse Event|24|||
170687031|NCT00467259|616865579|FG001|Overall Study|Adverse Event|90|||
170687032|NCT00467259|616865578|FG000|Overall Study|Protocol Violation|1|||
170687033|NCT00467259|616865579|FG001|Overall Study|Protocol Violation|7|||
170687034|NCT00467259|616865578|FG000|Overall Study|Withdrawal by Subject|34|||
170687035|NCT00467259|616865579|FG001|Overall Study|Withdrawal by Subject|108|||
170687036|NCT00467259|616865578|FG000|Overall Study|Physician Decision|0|||
170687037|NCT00467259|616865579|FG001|Overall Study|Physician Decision|2|||
170687038|NCT00467259|616865578|FG000|Overall Study|Lost to Follow-up|14|||
170687039|NCT00467259|616865579|FG001|Overall Study|Lost to Follow-up|34|||
170687040|NCT00467259|616865578|FG000|Overall Study|Site Closed|2|||
170687041|NCT00467259|616865579|FG001|Overall Study|Site Closed|1|||
170687042|NCT06079320|616865580|FG000|Follow up Phase|Lost to Follow-up|1|||
170687043|NCT06079320|616865581|FG001|Follow up Phase|Lost to Follow-up|0|||
170687044|NCT02196558|616865582|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
170687045|NCT02196558|616865583|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
170687046|NCT02196558|616865584|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
170687047|NCT02196558|616865582|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
170687048|NCT02196558|616865583|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
170687049|NCT02196558|616865584|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
170687050|NCT02196558|616865582|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
170687051|NCT02196558|616865583|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
170687052|NCT02196558|616865584|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
170687053|NCT02196558|616865582|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
170687054|NCT02196558|616865583|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
170687055|NCT02196558|616865584|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
170687056|NCT02196558|616865582|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
170687057|NCT02196558|616865583|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
170687058|NCT02196558|616865584|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
170687059|NCT04851314|616865586|FG000|Overall Study|Unable to complete research set-up procedures|0|||
170687060|NCT04851314|616865587|FG001|Overall Study|Unable to complete research set-up procedures|2|||
170687061|NCT04851314|616865586|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
170687062|NCT04851314|616865587|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
170687063|NCT01846611|616865590|FG000|Overall Study|Lost to Follow-up|4|||
170687064|NCT01846611|616865591|FG001|Overall Study|Lost to Follow-up|6|||
170687065|NCT01846611|616865590|FG000|Overall Study|Withdrawal by Subject|15|||
170687066|NCT01846611|616865591|FG001|Overall Study|Withdrawal by Subject|19|||
170687067|NCT01846611|616865590|FG000|Overall Study|Other|19|||
170687068|NCT01846611|616865591|FG001|Overall Study|Other|18|||
170687069|NCT00541034|616865592|FG000|Overall Study|Non-Compliance|3|||
170687070|NCT00847704|616865593|FG000|Overall Study|Withdrawal by Subject|1|||
170687071|NCT01786629|616867347|FG000|Overall Study|Lack of Efficacy|0|||
170687072|NCT01786629|616867348|FG001|Overall Study|Lack of Efficacy|4|||
170821411|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
170687073|NCT01786629|616867347|FG000|Overall Study|Adverse Event|0|||
170687074|NCT01786629|616867348|FG001|Overall Study|Adverse Event|1|||
170687075|NCT00410761|616867349|FG000|Randomized Treatment Period|Adverse Event|34|||
170687076|NCT00410761|616867350|FG001|Randomized Treatment Period|Adverse Event|3|||
170687077|NCT00410761|616867349|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
170687078|NCT00410761|616867350|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
170687079|NCT00410761|616867349|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
170687080|NCT00410761|616867350|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
170687081|NCT00410761|616867349|FG000|Randomized Treatment Period|Other|69|||
170687082|NCT00410761|616867350|FG001|Randomized Treatment Period|Other|21|||
170687083|NCT00410761|616867349|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
170687084|NCT00410761|616867350|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
170687085|NCT00410761|616867349|FG000|Open-Label Treatment Period|Adverse Event|13|||
170687086|NCT00410761|616867350|FG001|Open-Label Treatment Period|Adverse Event|15|||
170687087|NCT00410761|616867349|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
170687088|NCT00410761|616867350|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
170687089|NCT00410761|616867349|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
170687090|NCT00410761|616867350|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
170687091|NCT00410761|616867349|FG000|Open-Label Treatment Period|Other|18|||
170687092|NCT00410761|616867350|FG001|Open-Label Treatment Period|Other|9|||
170687093|NCT00180414|616867354|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
170687094|NCT00180414|616867355|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
170687095|NCT00613938|616867356|FG000|Overall Study|Withdrawal by Subject|2|||
170687096|NCT00613938|616867357|FG001|Overall Study|Withdrawal by Subject|4|||
170687097|NCT00613938|616867358|FG002|Overall Study|Withdrawal by Subject|9|||
170687098|NCT00613938|616867359|FG003|Overall Study|Withdrawal by Subject|9|||
170687099|NCT00613938|616867356|FG000|Overall Study|Adverse Event|1|||
170687100|NCT00613938|616867357|FG001|Overall Study|Adverse Event|4|||
170687101|NCT00613938|616867358|FG002|Overall Study|Adverse Event|8|||
170687102|NCT00613938|616867359|FG003|Overall Study|Adverse Event|5|||
170687103|NCT00613938|616867356|FG000|Overall Study|Lack of Efficacy|16|||
170687104|NCT00613938|616867357|FG001|Overall Study|Lack of Efficacy|18|||
170687105|NCT00613938|616867358|FG002|Overall Study|Lack of Efficacy|5|||
170687106|NCT00613938|616867359|FG003|Overall Study|Lack of Efficacy|9|||
170687107|NCT00613938|616867356|FG000|Overall Study|Other|1|||
170687108|NCT00613938|616867357|FG001|Overall Study|Other|2|||
170687109|NCT00613938|616867358|FG002|Overall Study|Other|1|||
170687110|NCT00613938|616867359|FG003|Overall Study|Other|3|||
170687111|NCT00623727|616867360|FG000|Double Blind (DB)|Adverse Event|1|||
170687112|NCT00623727|616867361|FG001|Double Blind (DB)|Adverse Event|3|||
170687113|NCT00623727|616867360|FG000|Double Blind (DB)|Physician Decision|0|||
170687114|NCT00623727|616867361|FG001|Double Blind (DB)|Physician Decision|1|||
170687115|NCT00623727|616867360|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
170687116|NCT00623727|616867361|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
170687117|NCT00623727|616867360|FG000|Double Blind (DB)|Lack of Efficacy|2|||
170687118|NCT00623727|616867361|FG001|Double Blind (DB)|Lack of Efficacy|2|||
170687119|NCT00623727|616867360|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
170687120|NCT00623727|616867361|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
170687121|NCT00623727|616867360|FG000|Double Blind (DB)|Lost to Follow-up|1|||
170687122|NCT00623727|616867361|FG001|Double Blind (DB)|Lost to Follow-up|1|||
170687123|NCT00623727|616867360|FG000|Double Blind (DB)|Protocol Violation|2|||
170687124|NCT00623727|616867361|FG001|Double Blind (DB)|Protocol Violation|2|||
170687125|NCT00623727|616867360|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
170687126|NCT00623727|616867361|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
170687127|NCT00623727|616867360|FG000|Open Label Follow-up|Study termination|0|||
170687128|NCT00623727|616867361|FG001|Open Label Follow-up|Study termination|6|||
170687129|NCT00623727|616867360|FG000|Open Label Follow-up|Participant convenience|0|||
170687130|NCT00623727|616867361|FG001|Open Label Follow-up|Participant convenience|1|||
170687131|NCT01852942|616867362|FG000|Overall Study|Physician Decision|1|||
170687132|NCT01852942|616867363|FG001|Overall Study|Physician Decision|0|||
170687133|NCT01852942|616867362|FG000|Overall Study|Death|1|||
170687134|NCT01852942|616867363|FG001|Overall Study|Death|1|||
170687135|NCT01852942|616867362|FG000|Overall Study|Withdrawal by Subject|2|||
170687136|NCT01852942|616867363|FG001|Overall Study|Withdrawal by Subject|3|||
170687137|NCT01852942|616867362|FG000|Overall Study|Lost to Follow-up|1|||
170687138|NCT01852942|616867363|FG001|Overall Study|Lost to Follow-up|2|||
170687139|NCT03220217|616867365|FG000|Overall Study|Withdrawal by Subject|0|||
170687140|NCT03220217|616867366|FG001|Overall Study|Withdrawal by Subject|1|||
170687141|NCT03220217|616867367|FG002|Overall Study|Withdrawal by Subject|0|||
170687142|NCT03220217|616867365|FG000|Overall Study|Subject Missed Procedure|0|||
170687143|NCT03220217|616867366|FG001|Overall Study|Subject Missed Procedure|0|||
170687144|NCT03220217|616867367|FG002|Overall Study|Subject Missed Procedure|1|||
170687145|NCT00312494|616867369|FG000|Overall Study|Randomized; not treated with study drug|9|||
170687146|NCT00312494|616867370|FG001|Overall Study|Randomized; not treated with study drug|10|||
170687147|NCT00312494|616867371|FG002|Overall Study|Randomized; not treated with study drug|5|||
170687148|NCT00312494|616867369|FG000|Overall Study|Adverse Event|33|||
170687149|NCT00312494|616867370|FG001|Overall Study|Adverse Event|15|||
170687150|NCT00312494|616867371|FG002|Overall Study|Adverse Event|11|||
170687151|NCT00312494|616867369|FG000|Overall Study|Lack of Efficacy|4|||
170687152|NCT00312494|616867370|FG001|Overall Study|Lack of Efficacy|6|||
170687153|NCT00312494|616867371|FG002|Overall Study|Lack of Efficacy|8|||
170687154|NCT00312494|616867369|FG000|Overall Study|Laboratory abnormality|1|||
170687155|NCT00312494|616867370|FG001|Overall Study|Laboratory abnormality|0|||
170687156|NCT00312494|616867371|FG002|Overall Study|Laboratory abnormality|0|||
170687157|NCT00312494|616867369|FG000|Overall Study|Lost to Follow-up|8|||
170687158|NCT00312494|616867370|FG001|Overall Study|Lost to Follow-up|8|||
170687159|NCT00312494|616867371|FG002|Overall Study|Lost to Follow-up|8|||
170687160|NCT00312494|616867369|FG000|Overall Study|Withdrawal by Subject|6|||
170687161|NCT00312494|616867370|FG001|Overall Study|Withdrawal by Subject|9|||
170687162|NCT00312494|616867371|FG002|Overall Study|Withdrawal by Subject|10|||
170687163|NCT00312494|616867369|FG000|Overall Study|Other|10|||
170687164|NCT00312494|616867370|FG001|Overall Study|Other|10|||
170687165|NCT00312494|616867371|FG002|Overall Study|Other|1|||
170687166|NCT00501293|616867372|FG000|Optimization Period|Enrolled in error|1|||
170687167|NCT00501293|616867373|FG001|Optimization Period|Enrolled in error|0|||
170687168|NCT00501293|616867372|FG000|Maintenance Period|Withdrawal by Subject|14|||
170687169|NCT00501293|616867373|FG001|Maintenance Period|Withdrawal by Subject|13|||
170687170|NCT00501293|616867372|FG000|Maintenance Period|Lost to Follow-up|12|||
170687171|NCT00501293|616867373|FG001|Maintenance Period|Lost to Follow-up|7|||
170687172|NCT00501293|616867372|FG000|Maintenance Period|Adverse Event|6|||
170687173|NCT00501293|616867373|FG001|Maintenance Period|Adverse Event|6|||
170687174|NCT00501293|616867372|FG000|Maintenance Period|Protocol Violation|2|||
170687175|NCT00501293|616867373|FG001|Maintenance Period|Protocol Violation|1|||
170687176|NCT00501293|616867372|FG000|Maintenance Period|Lack of Efficacy|4|||
170687177|NCT00501293|616867373|FG001|Maintenance Period|Lack of Efficacy|1|||
170687178|NCT00501293|616867372|FG000|Maintenance Period|Noncompliant with study medication|5|||
170687179|NCT00501293|616867373|FG001|Maintenance Period|Noncompliant with study medication|0|||
170687180|NCT00501293|616867372|FG000|Maintenance Period|Went into rehabilitation|1|||
170687181|NCT00501293|616867373|FG001|Maintenance Period|Went into rehabilitation|0|||
170687182|NCT00501293|616867372|FG000|Maintenance Period|Would not wear patch|1|||
170687183|NCT00501293|616867373|FG001|Maintenance Period|Would not wear patch|0|||
170687184|NCT00501293|616867372|FG000|Maintenance Period|Application site reaction|1|||
170687185|NCT00501293|616867373|FG001|Maintenance Period|Application site reaction|0|||
170687186|NCT02734810|616867375|FG000|Overall Study|Adverse Event|1|||
170687187|NCT02734810|616867376|FG001|Overall Study|Adverse Event|0|||
170687188|NCT02734810|616867375|FG000|Overall Study|Lack of Efficacy|1|||
170687189|NCT02734810|616867376|FG001|Overall Study|Lack of Efficacy|0|||
170687190|NCT00488345|616867377|FG000|Overall Study|Adverse Event|0|||
170687191|NCT00488345|616867378|FG001|Overall Study|Adverse Event|1|||
170687192|NCT00488345|616867379|FG002|Overall Study|Adverse Event|1|||
170687193|NCT00488345|616867377|FG000|Overall Study|Unable to administer antibiotics at home|0|||
170687194|NCT00488345|616867378|FG001|Overall Study|Unable to administer antibiotics at home|1|||
170687195|NCT00488345|616867379|FG002|Overall Study|Unable to administer antibiotics at home|0|||
170687196|NCT00488345|616867377|FG000|Overall Study|Institutional Review Board review|0|||
170687197|NCT00488345|616867378|FG001|Overall Study|Institutional Review Board review|0|||
170687198|NCT00488345|616867379|FG002|Overall Study|Institutional Review Board review|1|||
170687199|NCT00488345|616867377|FG000|Overall Study|Surgical team recommendation|0|||
170687200|NCT00488345|616867378|FG001|Overall Study|Surgical team recommendation|1|||
170687201|NCT00488345|616867379|FG002|Overall Study|Surgical team recommendation|0|||
170687202|NCT00488345|616867377|FG000|Overall Study|Parent/legal guardian request|0|||
170687203|NCT00488345|616867378|FG001|Overall Study|Parent/legal guardian request|1|||
170687204|NCT00488345|616867379|FG002|Overall Study|Parent/legal guardian request|1|||
170687205|NCT00903617|616867383|FG000|Overall Study|Adverse Event|0|||
170687206|NCT00903617|616867384|FG001|Overall Study|Adverse Event|1|||
170687207|NCT00903617|616867385|FG002|Overall Study|Adverse Event|1|||
170687208|NCT00903617|616867386|FG003|Overall Study|Adverse Event|0|||
170687209|NCT00903617|616867383|FG000|Overall Study|Protocol-defined stopping criteria|0|||
170687210|NCT00903617|616867384|FG001|Overall Study|Protocol-defined stopping criteria|2|||
170687211|NCT00903617|616867385|FG002|Overall Study|Protocol-defined stopping criteria|0|||
170687212|NCT00903617|616867386|FG003|Overall Study|Protocol-defined stopping criteria|0|||
170687213|NCT00903617|616867383|FG000|Overall Study|Lost to Follow-up|2|||
170687214|NCT00903617|616867384|FG001|Overall Study|Lost to Follow-up|0|||
170687215|NCT00903617|616867385|FG002|Overall Study|Lost to Follow-up|1|||
170687216|NCT00903617|616867386|FG003|Overall Study|Lost to Follow-up|1|||
170687217|NCT00903617|616867383|FG000|Overall Study|Withdrawal by Subject|1|||
170687218|NCT00903617|616867384|FG001|Overall Study|Withdrawal by Subject|2|||
170687219|NCT00903617|616867385|FG002|Overall Study|Withdrawal by Subject|3|||
170687220|NCT00903617|616867386|FG003|Overall Study|Withdrawal by Subject|0|||
170687221|NCT01104636|616867387|FG000|Overall Study|Lack of Efficacy|43|||
170687222|NCT01104636|616867387|FG000|Overall Study|Lost to Follow-up|24|||
170687223|NCT01104636|616867387|FG000|Overall Study|Withdrawal by Subject|4|||
170687224|NCT01104636|616867387|FG000|Overall Study|Other|43|||
170687225|NCT01104636|616867387|FG000|Overall Study|Study terminated by sponsor|1|||
170687226|NCT01104636|616867387|FG000|Overall Study|Pregnancy|2|||
170687227|NCT01104636|616867387|FG000|Overall Study|Adverse Event|40|||
170821412|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
170821413|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
170821414|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
170821415|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
170821416|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
170821417|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
170821418|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
170821419|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
170821420|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
170821421|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
170821422|NCT03602859|617353362|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
170821423|NCT03602859|617353363|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
170821424|NCT03602859|617353364|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
170821425|NCT03602859|617353365|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
170821426|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
170821427|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
170821428|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
170821429|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
170821430|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
170821431|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
170821432|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
170821433|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
170821434|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
170821435|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
170821436|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
170821437|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
170821438|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
170821439|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
170821440|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
170821441|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
170821442|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
170821443|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
170821444|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
170821445|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
170821446|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
170687228|NCT01104636|616867387|FG000|Overall Study|Ongoing|21|||
170687229|NCT01706003|616867388|FG000|Overall Study|Withdrawal by Subject|2|||
170687230|NCT01706003|616867389|FG001|Overall Study|Withdrawal by Subject|0|||
170687231|NCT01706003|616867388|FG000|Overall Study|Not scheduled|3|||
170687232|NCT01706003|616867389|FG001|Overall Study|Not scheduled|0|||
170687233|NCT01706003|616867388|FG000|Overall Study|Lost to Follow-up|6|||
170687234|NCT01706003|616867389|FG001|Overall Study|Lost to Follow-up|4|||
170687235|NCT02642614|616867390|FG000|Overall Study|Adverse Event|1|||
170687236|NCT02642614|616867391|FG001|Overall Study|Adverse Event|1|||
170687237|NCT02642614|616867392|FG002|Overall Study|Adverse Event|2|||
170687238|NCT02642614|616867393|FG003|Overall Study|Adverse Event|2|||
170687239|NCT02642614|616867390|FG000|Overall Study|Lost to Follow-up|1|||
170687240|NCT02642614|616867391|FG001|Overall Study|Lost to Follow-up|0|||
170687241|NCT02642614|616867392|FG002|Overall Study|Lost to Follow-up|0|||
170687242|NCT02642614|616867393|FG003|Overall Study|Lost to Follow-up|0|||
170687243|NCT02642614|616867390|FG000|Overall Study|Withdrawal by Subject|1|||
170687244|NCT02642614|616867391|FG001|Overall Study|Withdrawal by Subject|1|||
170687245|NCT02642614|616867392|FG002|Overall Study|Withdrawal by Subject|0|||
170821447|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
170821448|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
170821449|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
170821450|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
170687246|NCT02642614|616867393|FG003|Overall Study|Withdrawal by Subject|0|||
170687247|NCT03316131|616867394|FG000|Treatment Period 2|Protocol deviation|1|||
170687248|NCT03316131|616867395|FG001|Treatment Period 2|Protocol deviation|0|||
170687249|NCT05608005|616867397|FG000|Overall Study|Adverse Event|2|||
170687250|NCT05608005|616867398|FG001|Overall Study|Adverse Event|1|||
170687251|NCT05608005|616867399|FG002|Overall Study|Adverse Event|3|||
170821451|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
170687252|NCT05608005|616867397|FG000|Overall Study|Protocol Violation|2|||
170687253|NCT05608005|616867398|FG001|Overall Study|Protocol Violation|3|||
170687254|NCT05608005|616867399|FG002|Overall Study|Protocol Violation|0|||
170687255|NCT05608005|616867397|FG000|Overall Study|Withdrawal by Subject|10|||
170687256|NCT05608005|616867398|FG001|Overall Study|Withdrawal by Subject|12|||
170687257|NCT05608005|616867399|FG002|Overall Study|Withdrawal by Subject|4|||
170687258|NCT05608005|616867397|FG000|Overall Study|Lost to Follow-up|25|||
170687259|NCT05608005|616867398|FG001|Overall Study|Lost to Follow-up|27|||
170687260|NCT05608005|616867399|FG002|Overall Study|Lost to Follow-up|15|||
170687261|NCT05608005|616867397|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
170687262|NCT05608005|616867398|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
170687263|NCT05608005|616867399|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
170687264|NCT02632552|616867403|FG000|Overall Study|Lost to Follow-up|14|||
170687265|NCT02632552|616867404|FG001|Overall Study|Lost to Follow-up|8|||
170687266|NCT02632552|616867403|FG000|Overall Study|Withdrawal by Subject|2|||
170687267|NCT02632552|616867404|FG001|Overall Study|Withdrawal by Subject|0|||
170687268|NCT02632552|616867403|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
170687269|NCT02632552|616867404|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
170687270|NCT02132767|616867409|FG000|Overall Study|Death|3|||
170687271|NCT02132767|616867410|FG001|Overall Study|Death|2|||
170687272|NCT02132767|616867409|FG000|Overall Study|Withdrawal by Subject|10|||
170687273|NCT02132767|616867410|FG001|Overall Study|Withdrawal by Subject|9|||
170687274|NCT02132767|616867409|FG000|Overall Study|Lost to Follow-up|4|||
170687275|NCT02132767|616867410|FG001|Overall Study|Lost to Follow-up|4|||
170687276|NCT00450450|616867416|FG000|Overall Study|Death|1|||
170687277|NCT00450450|616867417|FG001|Overall Study|Death|3|||
170687278|NCT00450450|616867416|FG000|Overall Study|Relapse|2|||
170687279|NCT00450450|616867417|FG001|Overall Study|Relapse|0|||
170687280|NCT00450450|616867416|FG000|Overall Study|Missing Data|2|||
170687281|NCT00450450|616867417|FG001|Overall Study|Missing Data|0|||
170687282|NCT02968563|616867420|FG000|Overall Study|Adverse Event|0|||
170687283|NCT02968563|616867421|FG001|Overall Study|Adverse Event|6|||
170687284|NCT02968563|616867420|FG000|Overall Study|Death|1|||
170687285|NCT02968563|616867421|FG001|Overall Study|Death|1|||
170687286|NCT02968563|616867420|FG000|Overall Study|Lost to Follow-up|0|||
170687287|NCT02968563|616867421|FG001|Overall Study|Lost to Follow-up|1|||
170687288|NCT02426892|616867423|FG000|Overall Study|Adverse Event|2|||
170687289|NCT02426892|616867423|FG000|Overall Study|Lack of Efficacy|17|||
170687290|NCT02426892|616867423|FG000|Overall Study|Withdrawal by Subject|1|||
170687291|NCT00867009|616867426|FG000|Induction Period|Nonserious Adverse Event|5|||
170687292|NCT00867009|616867426|FG000|Induction Period|Serious Adverse Event|10|||
170687293|NCT00867009|616867426|FG000|Induction Period|Death due to serious adverse event|6|||
170687294|NCT00867009|616867426|FG000|Induction Period|Death due to Study Disease|4|||
170687295|NCT00867009|616867426|FG000|Induction Period|Protocol Violation|1|||
170687296|NCT00867009|616867426|FG000|Induction Period|Withdrawal by Subject|8|||
170687297|NCT00867009|616867426|FG000|Induction Period|Physician Decision|3|||
170687298|NCT00867009|616867426|FG000|Induction Period|Progressive Disease (PD)|25|||
170687299|NCT00867009|616867426|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
170687300|NCT03266094|616867429|FG000|Overall Study|Lost to Follow-up|1|||
170687301|NCT03266094|616867429|FG000|Overall Study|Withdrawal by Subject|1|||
170687302|NCT01850524|616867431|FG000|Overall Study|Lost to Follow-up|5|||
170687303|NCT01850524|616867432|FG001|Overall Study|Lost to Follow-up|10|||
170687304|NCT01850524|616867431|FG000|Overall Study|Withdrawal by Subject|24|||
170687305|NCT01850524|616867432|FG001|Overall Study|Withdrawal by Subject|22|||
170687306|NCT01850524|616867431|FG000|Overall Study|Reason not Specified|142|||
170687307|NCT01850524|616867432|FG001|Overall Study|Reason not Specified|141|||
170687308|NCT00818662|616867443|FG000|Overall Study|Adverse Event|5|||
170687309|NCT00818662|616867444|FG001|Overall Study|Adverse Event|14|||
170687310|NCT00818662|616867445|FG002|Overall Study|Adverse Event|4|||
170687311|NCT00818662|616867446|FG003|Overall Study|Adverse Event|3|||
170687312|NCT00818662|616867443|FG000|Overall Study|Withdrawal by Subject|5|||
170687313|NCT00818662|616867444|FG001|Overall Study|Withdrawal by Subject|4|||
170687314|NCT00818662|616867445|FG002|Overall Study|Withdrawal by Subject|2|||
170687315|NCT00818662|616867446|FG003|Overall Study|Withdrawal by Subject|2|||
170687316|NCT00818662|616867443|FG000|Overall Study|Death|1|||
170687317|NCT00818662|616867444|FG001|Overall Study|Death|3|||
170687318|NCT00818662|616867445|FG002|Overall Study|Death|0|||
170687319|NCT00818662|616867446|FG003|Overall Study|Death|0|||
170687320|NCT00818662|616867443|FG000|Overall Study|Physician Decision|1|||
170687321|NCT00818662|616867444|FG001|Overall Study|Physician Decision|0|||
170687322|NCT00818662|616867445|FG002|Overall Study|Physician Decision|0|||
170687323|NCT00818662|616867446|FG003|Overall Study|Physician Decision|0|||
170687324|NCT00818662|616867443|FG000|Overall Study|Lost to Follow-up|0|||
170687325|NCT00818662|616867444|FG001|Overall Study|Lost to Follow-up|0|||
170687326|NCT00818662|616867445|FG002|Overall Study|Lost to Follow-up|0|||
170687327|NCT00818662|616867446|FG003|Overall Study|Lost to Follow-up|1|||
170687328|NCT00818662|616867443|FG000|Overall Study|Unwilling or Unable to Participate|4|||
170687329|NCT00818662|616867444|FG001|Overall Study|Unwilling or Unable to Participate|6|||
170687330|NCT00818662|616867445|FG002|Overall Study|Unwilling or Unable to Participate|2|||
170687331|NCT00818662|616867446|FG003|Overall Study|Unwilling or Unable to Participate|4|||
170687332|NCT00818662|616867443|FG000|Overall Study|Protocol Violation|1|||
170687333|NCT00818662|616867444|FG001|Overall Study|Protocol Violation|1|||
170687334|NCT00818662|616867445|FG002|Overall Study|Protocol Violation|0|||
170687335|NCT00818662|616867446|FG003|Overall Study|Protocol Violation|0|||
170687336|NCT00818662|616867443|FG000|Overall Study|Requires a Prohibited Medication|1|||
170687337|NCT00818662|616867444|FG001|Overall Study|Requires a Prohibited Medication|0|||
170687338|NCT00818662|616867445|FG002|Overall Study|Requires a Prohibited Medication|0|||
170687339|NCT00818662|616867446|FG003|Overall Study|Requires a Prohibited Medication|0|||
170687340|NCT00818662|616867443|FG000|Overall Study|Safety Risk|1|||
170687341|NCT00818662|616867444|FG001|Overall Study|Safety Risk|1|||
170687342|NCT00818662|616867445|FG002|Overall Study|Safety Risk|0|||
170687343|NCT00818662|616867446|FG003|Overall Study|Safety Risk|1|||
170687344|NCT00818662|616867443|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
170687345|NCT00818662|616867444|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
170687346|NCT00818662|616867445|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
170687347|NCT00818662|616867446|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
170687348|NCT00818662|616867443|FG000|Overall Study|Participant's health declined|0|||
170687349|NCT00818662|616867444|FG001|Overall Study|Participant's health declined|0|||
170687350|NCT00818662|616867445|FG002|Overall Study|Participant's health declined|0|||
170687351|NCT00818662|616867446|FG003|Overall Study|Participant's health declined|1|||
170687352|NCT00818662|616867443|FG000|Overall Study|Caregiver to pursue other treatment|0|||
170687353|NCT00818662|616867444|FG001|Overall Study|Caregiver to pursue other treatment|1|||
170687354|NCT00818662|616867445|FG002|Overall Study|Caregiver to pursue other treatment|0|||
170687355|NCT00818662|616867446|FG003|Overall Study|Caregiver to pursue other treatment|0|||
170687356|NCT00818662|616867443|FG000|Overall Study|Moving out of state|0|||
170687357|NCT00818662|616867444|FG001|Overall Study|Moving out of state|0|||
170687358|NCT00818662|616867445|FG002|Overall Study|Moving out of state|0|||
170687359|NCT00818662|616867446|FG003|Overall Study|Moving out of state|1|||
170687360|NCT00818662|616867443|FG000|Overall Study|Declined move to another study site|1|||
170687361|NCT00818662|616867444|FG001|Overall Study|Declined move to another study site|0|||
170687362|NCT00818662|616867445|FG002|Overall Study|Declined move to another study site|0|||
170687363|NCT00818662|616867446|FG003|Overall Study|Declined move to another study site|0|||
170687364|NCT00818662|616867443|FG000|Overall Study|Change in living situation|0|||
170687365|NCT00818662|616867444|FG001|Overall Study|Change in living situation|0|||
170687366|NCT00818662|616867445|FG002|Overall Study|Change in living situation|0|||
170687367|NCT00818662|616867446|FG003|Overall Study|Change in living situation|1|||
170687368|NCT00818662|616867443|FG000|Overall Study|Study partner decision|0|||
170687369|NCT00818662|616867444|FG001|Overall Study|Study partner decision|0|||
170687370|NCT00818662|616867445|FG002|Overall Study|Study partner decision|0|||
170687371|NCT00818662|616867446|FG003|Overall Study|Study partner decision|1|||
170687372|NCT00818662|616867443|FG000|Overall Study|Admitted to long term nursing care|0|||
170687373|NCT00818662|616867444|FG001|Overall Study|Admitted to long term nursing care|1|||
170687374|NCT00818662|616867445|FG002|Overall Study|Admitted to long term nursing care|0|||
170687375|NCT00818662|616867446|FG003|Overall Study|Admitted to long term nursing care|0|||
170687376|NCT01106898|616867447|FG000|Overall Study|Adverse Event|6|||
170687377|NCT01722071|616867448|FG000|Overall Study|Protocol Violation|1|||
170687378|NCT01722071|616867449|FG001|Overall Study|Protocol Violation|0|||
170687379|NCT03021265|616867450|FG000|Overall Study|Adverse Event|29|||
170687380|NCT03021265|616867450|FG000|Overall Study|Lack of Efficacy|3|||
170687381|NCT03021265|616867450|FG000|Overall Study|Improved|17|||
170687382|NCT03021265|616867450|FG000|Overall Study|Lost to Follow-up|67|||
170687383|NCT03021265|616867450|FG000|Overall Study|No reason given|2|||
170687384|NCT03021265|616867450|FG000|Overall Study|No visit since the first visit|4|||
170687385|NCT01338493|616867451|FG000|Enrolled|Withdrawal by Subject|1|||
170687386|NCT01338493|616867451|FG000|Enrolled|Patient not implanted|4|||
170687387|NCT01338493|616867451|FG000|Discharge|Death|1|||
170687388|NCT01338493|616867451|FG000|Discharge|Missed visit|1|||
170687389|NCT01338493|616867451|FG000|6 Months Follow up|Lost to Follow-up|11|||
170687390|NCT01338493|616867451|FG000|6 Months Follow up|Missed visit|8|||
170687391|NCT01338493|616867451|FG000|12 Months Follow up|Lost to Follow-up|9|||
170687392|NCT02671422|616867452|FG000|Overall Study|Lost to Follow-up|1|||
170687393|NCT02671422|616867452|FG000|Overall Study|Adverse Event|68|||
170687394|NCT02671422|616867452|FG000|Overall Study|Lack of Efficacy|1|||
170687395|NCT02671422|616867452|FG000|Overall Study|Lost to Follow-up|4|||
170687396|NCT02671422|616867452|FG000|Overall Study|Withdrawal by Subject|7|||
170687397|NCT02671422|616867452|FG000|Overall Study|Progressive Disease|156|||
170687398|NCT02671422|616867452|FG000|Overall Study|Worsening of Disease|4|||
170687399|NCT02671422|616867452|FG000|Overall Study|Sponsor decision|5|||
170687400|NCT02671422|616867452|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
170687401|NCT02671422|616867452|FG000|Overall Study|Not treated with Vargatef®|3|||
170687402|NCT02671422|616867452|FG000|Overall Study|Other not defined above|3|||
170687403|NCT02289079|616867453|FG000|Overall Study|Physician Decision|2|||
170687404|NCT02289079|616867454|FG001|Overall Study|Physician Decision|0|||
170687405|NCT02289079|616867453|FG000|Overall Study|Lost to Follow-up|0|||
170687406|NCT02289079|616867454|FG001|Overall Study|Lost to Follow-up|1|||
170687407|NCT02111850|616867455|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687408|NCT02111850|616867456|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687409|NCT02111850|616867457|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687410|NCT02111850|616867458|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687411|NCT02111850|616867459|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
170687412|NCT02111850|616867460|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687413|NCT02111850|616867461|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687414|NCT02111850|616867462|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687415|NCT02111850|616867463|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687416|NCT02111850|616867464|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687417|NCT02111850|616867465|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
170687418|NCT02625259|616867466|FG000|First Intervention (Day 1)|Other|0|||
170687419|NCT02625259|616867467|FG001|First Intervention (Day 1)|Other|0|||
170687420|NCT02625259|616867468|FG002|First Intervention (Day 1)|Other|1|||
170687421|NCT02625259|616867469|FG003|First Intervention (Day 1)|Other|0|||
170687422|NCT02625259|616867470|FG004|First Intervention (Day 1)|Other|0|||
170687423|NCT02625259|616867466|FG000|First Intervention (Day 1)|Adverse Event|2|||
170687424|NCT02625259|616867467|FG001|First Intervention (Day 1)|Adverse Event|1|||
170687425|NCT02625259|616867468|FG002|First Intervention (Day 1)|Adverse Event|0|||
170687426|NCT02625259|616867469|FG003|First Intervention (Day 1)|Adverse Event|0|||
170687427|NCT02625259|616867470|FG004|First Intervention (Day 1)|Adverse Event|0|||
170687428|NCT02625259|616867466|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
170687429|NCT02625259|616867467|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
170687430|NCT02625259|616867468|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
170687431|NCT02625259|616867469|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
170687432|NCT02625259|616867470|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
170687433|NCT01686633|616867471|FG000|Overall Study|Lack of Efficacy|33|||
170687434|NCT01686633|616867472|FG001|Overall Study|Lack of Efficacy|13|||
170687435|NCT01686633|616867473|FG002|Overall Study|Lack of Efficacy|11|||
170687436|NCT01686633|616867471|FG000|Overall Study|Withdrawal by Subject|8|||
170687437|NCT01686633|616867472|FG001|Overall Study|Withdrawal by Subject|8|||
170687438|NCT01686633|616867473|FG002|Overall Study|Withdrawal by Subject|5|||
170687439|NCT01686633|616867471|FG000|Overall Study|Physician Decision|3|||
170687440|NCT01686633|616867472|FG001|Overall Study|Physician Decision|4|||
170687441|NCT01686633|616867473|FG002|Overall Study|Physician Decision|4|||
170687442|NCT01686633|616867471|FG000|Overall Study|Adverse Event|4|||
170687443|NCT01686633|616867472|FG001|Overall Study|Adverse Event|3|||
170687444|NCT01686633|616867473|FG002|Overall Study|Adverse Event|3|||
170687445|NCT01686633|616867471|FG000|Overall Study|Protocol Violation|2|||
170687446|NCT01686633|616867472|FG001|Overall Study|Protocol Violation|3|||
170687447|NCT01686633|616867473|FG002|Overall Study|Protocol Violation|0|||
170687448|NCT01686633|616867471|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
170687449|NCT01686633|616867472|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
170687450|NCT01686633|616867473|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
170687451|NCT01686633|616867471|FG000|Overall Study|Lost to Follow-up|0|||
170687452|NCT01686633|616867472|FG001|Overall Study|Lost to Follow-up|1|||
170687453|NCT01686633|616867473|FG002|Overall Study|Lost to Follow-up|1|||
170687454|NCT04772755|616867475|FG000|Overall Study|Withdrawal by Subject|1|||
170687455|NCT04772755|616867476|FG001|Overall Study|Withdrawal by Subject|0|||
170687456|NCT04772755|616867475|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
170687457|NCT04772755|616867476|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
170687458|NCT00511667|616867477|FG000|Overall Study|Adverse Event|1|||
170687459|NCT00511667|616867478|FG001|Overall Study|Adverse Event|0|||
170687460|NCT00511667|616867477|FG000|Overall Study|Protocol Violation|1|||
170687461|NCT00511667|616867478|FG001|Overall Study|Protocol Violation|1|||
170687462|NCT00511667|616867477|FG000|Overall Study|Withdrawal by Subject|2|||
170687463|NCT00511667|616867478|FG001|Overall Study|Withdrawal by Subject|0|||
170687464|NCT00511667|616867477|FG000|Overall Study|Site terminated|6|||
170687465|NCT00511667|616867478|FG001|Overall Study|Site terminated|1|||
170687466|NCT00511667|616867477|FG000|Overall Study|Other|2|||
170687467|NCT00511667|616867478|FG001|Overall Study|Other|1|||
170687468|NCT00662363|616867479|FG000|Overall Study|Withdrawal by Subject|6|||
170687469|NCT00662363|616867480|FG001|Overall Study|Withdrawal by Subject|5|||
170687470|NCT00662363|616867479|FG000|Overall Study|Adverse Event|0|||
170687471|NCT00662363|616867480|FG001|Overall Study|Adverse Event|3|||
170687472|NCT00662363|616867479|FG000|Overall Study|Discharged early from rehab|4|||
170687473|NCT00662363|616867480|FG001|Overall Study|Discharged early from rehab|1|||
170687474|NCT00662363|616867479|FG000|Overall Study|Protocol Violation|1|||
170687475|NCT00662363|616867480|FG001|Overall Study|Protocol Violation|1|||
170687476|NCT01905657|616867481|FG000|Overall Study|Adverse Event|23|||
170687477|NCT01905657|616867482|FG001|Overall Study|Adverse Event|17|||
170687478|NCT01905657|616867483|FG002|Overall Study|Adverse Event|18|||
170687479|NCT01905657|616867481|FG000|Overall Study|Clinical Progression|103|||
170687480|NCT01905657|616867482|FG001|Overall Study|Clinical Progression|78|||
170687481|NCT01905657|616867483|FG002|Overall Study|Clinical Progression|59|||
170687482|NCT01905657|616867481|FG000|Overall Study|Death|40|||
170687483|NCT01905657|616867482|FG001|Overall Study|Death|43|||
170687484|NCT01905657|616867483|FG002|Overall Study|Death|47|||
170687485|NCT01905657|616867481|FG000|Overall Study|Excluded Medication|13|||
170687486|NCT01905657|616867482|FG001|Overall Study|Excluded Medication|16|||
170687487|NCT01905657|616867483|FG002|Overall Study|Excluded Medication|9|||
170687488|NCT01905657|616867481|FG000|Overall Study|Lost to Follow-up|1|||
170687489|NCT01905657|616867482|FG001|Overall Study|Lost to Follow-up|2|||
170687490|NCT01905657|616867483|FG002|Overall Study|Lost to Follow-up|1|||
170687491|NCT01905657|616867481|FG000|Overall Study|Physician Decision|5|||
170687492|NCT01905657|616867482|FG001|Overall Study|Physician Decision|8|||
170687493|NCT01905657|616867483|FG002|Overall Study|Physician Decision|12|||
170687494|NCT01905657|616867481|FG000|Overall Study|Protocol Violation|2|||
170687495|NCT01905657|616867482|FG001|Overall Study|Protocol Violation|1|||
170687496|NCT01905657|616867483|FG002|Overall Study|Protocol Violation|1|||
170687497|NCT01905657|616867481|FG000|Overall Study|Screen Failure|0|||
170687498|NCT01905657|616867482|FG001|Overall Study|Screen Failure|1|||
170687499|NCT01905657|616867483|FG002|Overall Study|Screen Failure|0|||
170687500|NCT01905657|616867481|FG000|Overall Study|Withdrawal by Subject|15|||
170687501|NCT01905657|616867482|FG001|Overall Study|Withdrawal by Subject|21|||
170687502|NCT01905657|616867483|FG002|Overall Study|Withdrawal by Subject|53|||
170687503|NCT01905657|616867481|FG000|Overall Study|Sponsor Decision|1|||
170687504|NCT01905657|616867482|FG001|Overall Study|Sponsor Decision|0|||
170687505|NCT01905657|616867483|FG002|Overall Study|Sponsor Decision|0|||
170687506|NCT05838742|616867484|FG000|Overall Study|Adverse Event|2|||
170687507|NCT05838742|616867485|FG001|Overall Study|Adverse Event|0|||
170687508|NCT05838742|616867486|FG002|Overall Study|Adverse Event|1|||
170687509|NCT05838742|616867487|FG003|Overall Study|Adverse Event|0|||
170687510|NCT05838742|616867488|FG004|Overall Study|Adverse Event|1|||
170687511|NCT05838742|616867484|FG000|Overall Study|Lost to Follow-up|1|||
170687512|NCT05838742|616867485|FG001|Overall Study|Lost to Follow-up|1|||
170687513|NCT05838742|616867486|FG002|Overall Study|Lost to Follow-up|1|||
170687514|NCT05838742|616867487|FG003|Overall Study|Lost to Follow-up|0|||
170687515|NCT05838742|616867488|FG004|Overall Study|Lost to Follow-up|0|||
170687516|NCT05838742|616867484|FG000|Overall Study|Physician Decision|0|||
170687517|NCT05838742|616867485|FG001|Overall Study|Physician Decision|0|||
170687518|NCT05838742|616867486|FG002|Overall Study|Physician Decision|0|||
170687519|NCT05838742|616867487|FG003|Overall Study|Physician Decision|0|||
170687520|NCT05838742|616867488|FG004|Overall Study|Physician Decision|1|||
170687521|NCT05838742|616867484|FG000|Overall Study|Withdrawal by Subject|8|||
170687522|NCT05838742|616867485|FG001|Overall Study|Withdrawal by Subject|3|||
170687523|NCT05838742|616867486|FG002|Overall Study|Withdrawal by Subject|3|||
170687524|NCT05838742|616867487|FG003|Overall Study|Withdrawal by Subject|1|||
170687525|NCT05838742|616867488|FG004|Overall Study|Withdrawal by Subject|4|||
170687526|NCT05838742|616867484|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
170687527|NCT05838742|616867485|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
170687528|NCT05838742|616867486|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
170687529|NCT05838742|616867487|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
170687530|NCT05838742|616867488|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
170687531|NCT05838742|616867484|FG000|Overall Study|Lack of Efficacy|0|||
170687532|NCT05838742|616867485|FG001|Overall Study|Lack of Efficacy|0|||
170687533|NCT05838742|616867486|FG002|Overall Study|Lack of Efficacy|0|||
170687534|NCT05838742|616867487|FG003|Overall Study|Lack of Efficacy|1|||
170687535|NCT05838742|616867488|FG004|Overall Study|Lack of Efficacy|0|||
170687536|NCT05838742|616867484|FG000|Overall Study|Randomized, not treated|2|||
170687537|NCT05838742|616867485|FG001|Overall Study|Randomized, not treated|1|||
170687538|NCT05838742|616867486|FG002|Overall Study|Randomized, not treated|0|||
170687539|NCT05838742|616867487|FG003|Overall Study|Randomized, not treated|1|||
170687540|NCT05838742|616867488|FG004|Overall Study|Randomized, not treated|0|||
170687541|NCT01367158|616867491|FG000|Overall Study|Withdrew consent|0|||
170687542|NCT01367158|616867492|FG001|Overall Study|Withdrew consent|2|||
170687543|NCT01367158|616867493|FG002|Overall Study|Withdrew consent|1|||
170687544|NCT01367158|616867494|FG003|Overall Study|Withdrew consent|0|||
170687545|NCT01367158|616867495|FG004|Overall Study|Withdrew consent|2|||
170687546|NCT01367158|616867496|FG005|Overall Study|Withdrew consent|0|||
170687547|NCT01367158|616867497|FG006|Overall Study|Withdrew consent|0|||
170687548|NCT01367158|616867498|FG007|Overall Study|Withdrew consent|1|||
170687549|NCT01367158|616867499|FG008|Overall Study|Withdrew consent|0|||
170821452|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
170821453|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
170821454|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
170821455|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
170821456|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
170821457|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
170821458|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
170821459|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
170821460|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
170821461|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
170821462|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
170821463|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
170821464|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
170821465|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
170821466|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
170821467|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
170821468|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
170821469|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
170821470|NCT03602859|617353362|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
170821471|NCT03602859|617353363|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
170821472|NCT03602859|617353364|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
170821473|NCT03602859|617353365|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
170821474|NCT03596905|617354727|FG000|Overall Study|Protocol Violation|0|||
170821475|NCT03596905|617354728|FG001|Overall Study|Protocol Violation|0|||
170821476|NCT03596905|617354729|FG002|Overall Study|Protocol Violation|0|||
170821477|NCT03596905|617354730|FG003|Overall Study|Protocol Violation|0|||
170821478|NCT03596905|617354731|FG004|Overall Study|Protocol Violation|1|||
170821479|NCT03596905|617354732|FG005|Overall Study|Protocol Violation|0|||
170821480|NCT03596905|617354733|FG006|Overall Study|Protocol Violation|0|||
170821481|NCT03596905|617354727|FG000|Overall Study|Withdrawal by Subject|0|||
170821482|NCT03596905|617354728|FG001|Overall Study|Withdrawal by Subject|2|||
170821483|NCT03596905|617354729|FG002|Overall Study|Withdrawal by Subject|1|||
170821484|NCT03596905|617354730|FG003|Overall Study|Withdrawal by Subject|0|||
170821485|NCT03596905|617354731|FG004|Overall Study|Withdrawal by Subject|2|||
170821486|NCT03596905|617354732|FG005|Overall Study|Withdrawal by Subject|0|||
170821487|NCT03596905|617354733|FG006|Overall Study|Withdrawal by Subject|0|||
170821488|NCT03596905|617354727|FG000|Overall Study|Participant moved and was unable to complete study|0|||
170821489|NCT03596905|617354728|FG001|Overall Study|Participant moved and was unable to complete study|1|||
170687550|NCT01367158|616867500|FG009|Overall Study|Withdrew consent|0|||
170687551|NCT01367158|616867501|FG010|Overall Study|Withdrew consent|0|||
170687552|NCT01367158|616867491|FG000|Overall Study|Lost to Follow-up|0|||
170687553|NCT01367158|616867492|FG001|Overall Study|Lost to Follow-up|0|||
170687554|NCT01367158|616867493|FG002|Overall Study|Lost to Follow-up|0|||
170687555|NCT01367158|616867494|FG003|Overall Study|Lost to Follow-up|1|||
170687556|NCT01367158|616867495|FG004|Overall Study|Lost to Follow-up|0|||
170687557|NCT01367158|616867496|FG005|Overall Study|Lost to Follow-up|2|||
170687558|NCT01367158|616867497|FG006|Overall Study|Lost to Follow-up|0|||
170687559|NCT01367158|616867498|FG007|Overall Study|Lost to Follow-up|1|||
170687560|NCT01367158|616867499|FG008|Overall Study|Lost to Follow-up|0|||
170687561|NCT01367158|616867500|FG009|Overall Study|Lost to Follow-up|0|||
170687562|NCT01367158|616867501|FG010|Overall Study|Lost to Follow-up|1|||
170687563|NCT01367158|616867491|FG000|Overall Study|Protocol Violation|0|||
170687564|NCT01367158|616867492|FG001|Overall Study|Protocol Violation|1|||
170687565|NCT01367158|616867493|FG002|Overall Study|Protocol Violation|0|||
170687566|NCT01367158|616867494|FG003|Overall Study|Protocol Violation|0|||
170687567|NCT01367158|616867495|FG004|Overall Study|Protocol Violation|0|||
170687568|NCT01367158|616867496|FG005|Overall Study|Protocol Violation|0|||
170687569|NCT01367158|616867497|FG006|Overall Study|Protocol Violation|0|||
170687570|NCT01367158|616867498|FG007|Overall Study|Protocol Violation|0|||
170687571|NCT01367158|616867499|FG008|Overall Study|Protocol Violation|0|||
170821490|NCT03596905|617354729|FG002|Overall Study|Participant moved and was unable to complete study|0|||
170821491|NCT03596905|617354730|FG003|Overall Study|Participant moved and was unable to complete study|0|||
170821492|NCT03596905|617354731|FG004|Overall Study|Participant moved and was unable to complete study|0|||
170821493|NCT03596905|617354732|FG005|Overall Study|Participant moved and was unable to complete study|0|||
170821494|NCT03596905|617354733|FG006|Overall Study|Participant moved and was unable to complete study|0|||
170687572|NCT01367158|616867500|FG009|Overall Study|Protocol Violation|0|||
170821495|NCT03596905|617354727|FG000|Overall Study|Adverse Event|0|||
170687573|NCT01367158|616867501|FG010|Overall Study|Protocol Violation|0|||
170687574|NCT02623439|616867506|FG000|Overall Study|Withdrawal by Subject|1|||
170687575|NCT02623439|616867506|FG000|Overall Study|Screen Failure|1|||
170687576|NCT02200445|616867510|FG000|Overall Study|Lack of Efficacy|1|||
170687577|NCT02200445|616867511|FG001|Overall Study|Lack of Efficacy|2|||
170687578|NCT02200445|616867512|FG002|Overall Study|Lack of Efficacy|2|||
170821496|NCT03596905|617354728|FG001|Overall Study|Adverse Event|0|||
170821497|NCT03596905|617354729|FG002|Overall Study|Adverse Event|0|||
170821498|NCT03596905|617354730|FG003|Overall Study|Adverse Event|0|||
170821499|NCT03596905|617354731|FG004|Overall Study|Adverse Event|0|||
170821500|NCT03596905|617354732|FG005|Overall Study|Adverse Event|0|||
170821501|NCT03596905|617354733|FG006|Overall Study|Adverse Event|1|||
170821502|NCT03596905|617354727|FG000|Overall Study|Non-Compliance with eDiary|1|||
170821503|NCT03596905|617354728|FG001|Overall Study|Non-Compliance with eDiary|0|||
170821504|NCT03596905|617354729|FG002|Overall Study|Non-Compliance with eDiary|0|||
170821505|NCT03596905|617354730|FG003|Overall Study|Non-Compliance with eDiary|0|||
170821506|NCT03596905|617354731|FG004|Overall Study|Non-Compliance with eDiary|1|||
170821507|NCT03596905|617354732|FG005|Overall Study|Non-Compliance with eDiary|0|||
170821508|NCT03596905|617354733|FG006|Overall Study|Non-Compliance with eDiary|2|||
170821509|NCT03596905|617354727|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170821510|NCT03596905|617354728|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170821511|NCT03596905|617354729|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170821512|NCT03596905|617354730|FG003|Overall Study|Non-Compliance with Study Drug|0|||
170821513|NCT03596905|617354731|FG004|Overall Study|Non-Compliance with Study Drug|1|||
170821514|NCT03596905|617354732|FG005|Overall Study|Non-Compliance with Study Drug|0|||
170821515|NCT03596905|617354733|FG006|Overall Study|Non-Compliance with Study Drug|0|||
170821516|NCT03596905|617354727|FG000|Overall Study|Lost to Follow-up|0|||
170821517|NCT03596905|617354728|FG001|Overall Study|Lost to Follow-up|0|||
170821518|NCT03596905|617354729|FG002|Overall Study|Lost to Follow-up|0|||
170821519|NCT03596905|617354730|FG003|Overall Study|Lost to Follow-up|0|||
170821520|NCT03596905|617354731|FG004|Overall Study|Lost to Follow-up|0|||
170821521|NCT03596905|617354732|FG005|Overall Study|Lost to Follow-up|1|||
170821522|NCT03596905|617354733|FG006|Overall Study|Lost to Follow-up|0|||
170821523|NCT03085433|617354734|FG000|Overall Study|Withdrawal by Subject|2|||
170821524|NCT03085433|617354735|FG001|Overall Study|Withdrawal by Subject|4|||
170821525|NCT03085433|617354734|FG000|Overall Study|Physician Decision|33|||
170821526|NCT03085433|617354735|FG001|Overall Study|Physician Decision|50|||
170821527|NCT01797562|617354736|FG000|Overall Study|Protocol Violation|5|||
170821528|NCT03809039|617354737|FG000|Part 1|Withdrawal by Subject|1|||
170821529|NCT03809039|617354738|FG001|Part 1|Withdrawal by Subject|0|||
170821530|NCT03809039|617354739|FG002|Part 1|Withdrawal by Subject|0|||
170821531|NCT03809039|617354740|FG003|Part 1|Withdrawal by Subject|1|||
170821532|NCT03809039|617354741|FG004|Part 1|Withdrawal by Subject|0|||
170821533|NCT03809039|617354742|FG005|Part 1|Withdrawal by Subject|0|||
170821534|NCT03809039|617354743|FG006|Part 1|Withdrawal by Subject|0|||
170821535|NCT03809039|617354744|FG007|Part 1|Withdrawal by Subject|0|||
170821536|NCT03809039|617354745|FG008|Part 1|Withdrawal by Subject|0|||
170821537|NCT03809039|617354737|FG000|Part 3|Withdrawn by study termination|0|||
170821538|NCT03809039|617354738|FG001|Part 3|Withdrawn by study termination|0|||
170687579|NCT02200445|616867510|FG000|Overall Study|Adverse Event|0|||
170687580|NCT02200445|616867511|FG001|Overall Study|Adverse Event|2|||
170687581|NCT02200445|616867512|FG002|Overall Study|Adverse Event|0|||
170687582|NCT04484142|616867513|FG000|Overall Study|Adverse Event|13|||
170687583|NCT04484142|616867513|FG000|Overall Study|Progressive Disease|87|||
170687584|NCT04484142|616867513|FG000|Overall Study|Clinical Progression|10|||
170687585|NCT04484142|616867513|FG000|Overall Study|Withdrawal by Subject|6|||
170687586|NCT04484142|616867513|FG000|Overall Study|Physician Decision|1|||
170687587|NCT03700671|616867514|FG000|Overall Study|Lack of Efficacy|1|||
170687588|NCT03700671|616867515|FG001|Overall Study|Lack of Efficacy|2|||
170687589|NCT00066703|616868909|FG000|Overall Study|Adverse Event|83|||
170687590|NCT00066703|616868910|FG001|Overall Study|Adverse Event|116|||
170687591|NCT00066703|616868909|FG000|Overall Study|Death|3|||
170687592|NCT00066703|616868910|FG001|Overall Study|Death|0|||
170687593|NCT00066703|616868909|FG000|Overall Study|Lack of Efficacy|126|||
170687594|NCT00066703|616868910|FG001|Overall Study|Lack of Efficacy|78|||
170687595|NCT00066703|616868909|FG000|Overall Study|Lost to Follow-up|45|||
170821539|NCT03809039|617354739|FG002|Part 3|Withdrawn by study termination|0|||
170821540|NCT03809039|617354740|FG003|Part 3|Withdrawn by study termination|0|||
170821541|NCT03809039|617354741|FG004|Part 3|Withdrawn by study termination|0|||
170821542|NCT03809039|617354742|FG005|Part 3|Withdrawn by study termination|0|||
170821543|NCT03809039|617354743|FG006|Part 3|Withdrawn by study termination|0|||
170821544|NCT03809039|617354744|FG007|Part 3|Withdrawn by study termination|2|||
170821545|NCT03809039|617354745|FG008|Part 3|Withdrawn by study termination|6|||
170687596|NCT00066703|616868910|FG001|Overall Study|Lost to Follow-up|43|||
170687597|NCT00066703|616868909|FG000|Overall Study|Withdrawal by Subject|43|||
170687598|NCT00066703|616868910|FG001|Overall Study|Withdrawal by Subject|75|||
170821546|NCT05271552|617354746|FG000|Overall Study|Adverse Event|4|||
170821547|NCT05271552|617354747|FG001|Overall Study|Adverse Event|6|||
170687599|NCT03653507|616868911|FG000|Overall Study|Miscellaneous|28|||
170687600|NCT03653507|616868912|FG001|Overall Study|Miscellaneous|19|||
170821548|NCT05271552|617354748|FG002|Overall Study|Adverse Event|3|||
170821549|NCT05271552|617354746|FG000|Overall Study|Death|1|||
170821550|NCT05271552|617354747|FG001|Overall Study|Death|1|||
170821551|NCT05271552|617354748|FG002|Overall Study|Death|1|||
170821552|NCT05271552|617354746|FG000|Overall Study|Lost to Follow-up|1|||
170687601|NCT03653507|616868911|FG000|Overall Study|Withdrawal by Subject|37|||
170687602|NCT03653507|616868912|FG001|Overall Study|Withdrawal by Subject|22|||
170687603|NCT03653507|616868911|FG000|Overall Study|Protocol Deviation|2|||
170687604|NCT03653507|616868912|FG001|Overall Study|Protocol Deviation|1|||
170687605|NCT03653507|616868911|FG000|Overall Study|Progressive disease|117|||
170687606|NCT03653507|616868912|FG001|Overall Study|Progressive disease|168|||
170687607|NCT03653507|616868911|FG000|Overall Study|Lost to Follow-up|1|||
170687608|NCT03653507|616868912|FG001|Overall Study|Lost to Follow-up|1|||
170687609|NCT03653507|616868911|FG000|Overall Study|Death|25|||
170687610|NCT03653507|616868912|FG001|Overall Study|Death|22|||
170687611|NCT03653507|616868911|FG000|Overall Study|Adverse Event|35|||
170687612|NCT03653507|616868912|FG001|Overall Study|Adverse Event|14|||
170687613|NCT02029443|616868913|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
170687614|NCT02029443|616868914|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
170687615|NCT02029443|616868915|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
170687616|NCT02029443|616868916|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
170687617|NCT02029443|616868917|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
170687618|NCT02029443|616868913|FG000|Overall Study|Death|13|||
170687619|NCT02029443|616868914|FG001|Overall Study|Death|2|||
170687620|NCT02029443|616868915|FG002|Overall Study|Death|2|||
170687621|NCT02029443|616868916|FG003|Overall Study|Death|11|||
170687622|NCT02029443|616868917|FG004|Overall Study|Death|2|||
170687623|NCT02029443|616868913|FG000|Overall Study|Lost to Follow-up|1|||
170687624|NCT02029443|616868914|FG001|Overall Study|Lost to Follow-up|0|||
170687625|NCT02029443|616868915|FG002|Overall Study|Lost to Follow-up|1|||
170687626|NCT02029443|616868916|FG003|Overall Study|Lost to Follow-up|1|||
170687627|NCT02029443|616868917|FG004|Overall Study|Lost to Follow-up|0|||
170687628|NCT02029443|616868913|FG000|Overall Study|Started other anti-cancer therapy|17|||
170687629|NCT02029443|616868914|FG001|Overall Study|Started other anti-cancer therapy|4|||
170687630|NCT02029443|616868915|FG002|Overall Study|Started other anti-cancer therapy|7|||
170687631|NCT02029443|616868916|FG003|Overall Study|Started other anti-cancer therapy|9|||
170687632|NCT02029443|616868917|FG004|Overall Study|Started other anti-cancer therapy|3|||
170687633|NCT02029443|616868913|FG000|Overall Study|Withdrawal by Subject|3|||
170687634|NCT02029443|616868914|FG001|Overall Study|Withdrawal by Subject|1|||
170687635|NCT02029443|616868915|FG002|Overall Study|Withdrawal by Subject|1|||
170687636|NCT02029443|616868916|FG003|Overall Study|Withdrawal by Subject|1|||
170687637|NCT02029443|616868917|FG004|Overall Study|Withdrawal by Subject|0|||
170687638|NCT02029443|616868913|FG000|Overall Study|Other|6|||
170687639|NCT02029443|616868914|FG001|Overall Study|Other|6|||
170687640|NCT02029443|616868915|FG002|Overall Study|Other|4|||
170687641|NCT02029443|616868916|FG003|Overall Study|Other|2|||
170687642|NCT02029443|616868917|FG004|Overall Study|Other|0|||
170687643|NCT00066690|616868918|FG000|Overall Study|Adverse Event|146|||
170687644|NCT00066690|616868919|FG001|Overall Study|Adverse Event|70|||
170687645|NCT00066690|616868920|FG002|Overall Study|Adverse Event|135|||
170687646|NCT00066690|616868918|FG000|Overall Study|Death|3|||
170687647|NCT00066690|616868919|FG001|Overall Study|Death|0|||
170687648|NCT00066690|616868920|FG002|Overall Study|Death|2|||
170687649|NCT00066690|616868918|FG000|Overall Study|Lack of Efficacy|114|||
170687650|NCT00066690|616868919|FG001|Overall Study|Lack of Efficacy|113|||
170687651|NCT00066690|616868920|FG002|Overall Study|Lack of Efficacy|77|||
170687652|NCT00066690|616868918|FG000|Overall Study|Lost to Follow-up|50|||
170687653|NCT00066690|616868919|FG001|Overall Study|Lost to Follow-up|33|||
170687654|NCT00066690|616868920|FG002|Overall Study|Lost to Follow-up|39|||
170687655|NCT00066690|616868918|FG000|Overall Study|Withdrawal by Subject|54|||
170687656|NCT00066690|616868919|FG001|Overall Study|Withdrawal by Subject|57|||
170687657|NCT00066690|616868920|FG002|Overall Study|Withdrawal by Subject|49|||
170687658|NCT05974267|616868921|FG000|Overall Study|Lack of Efficacy|19|||
170687659|NCT05974267|616868922|FG001|Overall Study|Lack of Efficacy|19|||
170687660|NCT05974267|616868923|FG002|Overall Study|Lack of Efficacy|15|||
170687661|NCT05974267|616868924|FG003|Overall Study|Lack of Efficacy|15|||
170687662|NCT05974267|616868921|FG000|Overall Study|OTHER: THE PARENT OF THE PARTICIPANT WHO IS A MINOR, WITHDREW THE PARTICIPANT FROM THE TRIAL|1|||
170687663|NCT05974267|616868922|FG001|Overall Study|OTHER: THE PARENT OF THE PARTICIPANT WHO IS A MINOR, WITHDREW THE PARTICIPANT FROM THE TRIAL|0|||
170687664|NCT05974267|616868923|FG002|Overall Study|OTHER: THE PARENT OF THE PARTICIPANT WHO IS A MINOR, WITHDREW THE PARTICIPANT FROM THE TRIAL|0|||
170687665|NCT05974267|616868924|FG003|Overall Study|OTHER: THE PARENT OF THE PARTICIPANT WHO IS A MINOR, WITHDREW THE PARTICIPANT FROM THE TRIAL|0|||
170687666|NCT05974267|616868921|FG000|Overall Study|Protocol Deviation|0|||
170687667|NCT05974267|616868922|FG001|Overall Study|Protocol Deviation|1|||
170687668|NCT05974267|616868923|FG002|Overall Study|Protocol Deviation|0|||
170687669|NCT05974267|616868924|FG003|Overall Study|Protocol Deviation|0|||
170687670|NCT05974267|616868921|FG000|Overall Study|Withdrawal by Subject|0|||
170687671|NCT05974267|616868922|FG001|Overall Study|Withdrawal by Subject|0|||
170687672|NCT05974267|616868923|FG002|Overall Study|Withdrawal by Subject|1|||
170687673|NCT05974267|616868924|FG003|Overall Study|Withdrawal by Subject|1|||
170687674|NCT02681042|616868925|FG000|Overall Study|Implant Failure|3|||
170687675|NCT02611778|616868933|FG000|Overall Study|Withdrawal by Subject|2|||
170687676|NCT02611778|616868934|FG001|Overall Study|Withdrawal by Subject|8|||
170687677|NCT02611778|616868933|FG000|Overall Study|Adverse Event|1|||
170687678|NCT02611778|616868934|FG001|Overall Study|Adverse Event|2|||
170687679|NCT02611778|616868933|FG000|Overall Study|Death|2|||
170687680|NCT02611778|616868934|FG001|Overall Study|Death|1|||
170687681|NCT02611778|616868933|FG000|Overall Study|Protocol Violation|1|||
170687682|NCT02611778|616868934|FG001|Overall Study|Protocol Violation|0|||
170687683|NCT02611778|616868933|FG000|Overall Study|Lost to Follow-up|3|||
170687684|NCT02611778|616868934|FG001|Overall Study|Lost to Follow-up|1|||
170687685|NCT02611778|616868933|FG000|Overall Study|Need for alternative treatment|1|||
170687686|NCT02611778|616868934|FG001|Overall Study|Need for alternative treatment|0|||
170687687|NCT02611778|616868933|FG000|Overall Study|Other Reason|2|||
170687688|NCT02611778|616868934|FG001|Overall Study|Other Reason|1|||
170687689|NCT02369341|616868935|FG000|Overall Study|Migrated/moved from study area|1|||
170687690|NCT02369341|616868936|FG001|Overall Study|Migrated/moved from study area|0|||
170687691|NCT03405792|616868940|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
170687692|NCT03405792|616868941|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
170687693|NCT03405792|616868940|FG000|Overall Study|o Did not receive pembrolizumab|1|||
170687694|NCT03405792|616868941|FG001|Overall Study|o Did not receive pembrolizumab|0|||
170687695|NCT00451321|616868950|FG000|Overall Study|Lost to Follow-up|3|||
170687696|NCT00451321|616868951|FG001|Overall Study|Lost to Follow-up|3|||
170687697|NCT00451321|616868952|FG002|Overall Study|Lost to Follow-up|1|||
170687698|NCT00451321|616868953|FG003|Overall Study|Lost to Follow-up|3|||
170687699|NCT00451321|616868954|FG004|Overall Study|Lost to Follow-up|0|||
170687700|NCT00451321|616868955|FG005|Overall Study|Lost to Follow-up|1|||
170687701|NCT00451321|616868956|FG006|Overall Study|Lost to Follow-up|0|||
170687702|NCT00451321|616868957|FG007|Overall Study|Lost to Follow-up|0|||
170687703|NCT00451321|616868950|FG000|Overall Study|Withdrawal by Subject|3|||
170687704|NCT00451321|616868951|FG001|Overall Study|Withdrawal by Subject|1|||
170687705|NCT00451321|616868952|FG002|Overall Study|Withdrawal by Subject|0|||
170687706|NCT00451321|616868953|FG003|Overall Study|Withdrawal by Subject|4|||
170687707|NCT00451321|616868954|FG004|Overall Study|Withdrawal by Subject|0|||
170687708|NCT00451321|616868955|FG005|Overall Study|Withdrawal by Subject|0|||
170687709|NCT00451321|616868956|FG006|Overall Study|Withdrawal by Subject|0|||
170687710|NCT00451321|616868957|FG007|Overall Study|Withdrawal by Subject|0|||
170687711|NCT00451321|616868950|FG000|Overall Study|Study closed/terminated|1|||
170687712|NCT00451321|616868951|FG001|Overall Study|Study closed/terminated|1|||
170687713|NCT00451321|616868952|FG002|Overall Study|Study closed/terminated|17|||
170687714|NCT00451321|616868953|FG003|Overall Study|Study closed/terminated|5|||
170687715|NCT00451321|616868954|FG004|Overall Study|Study closed/terminated|7|||
170687716|NCT00451321|616868955|FG005|Overall Study|Study closed/terminated|7|||
170687717|NCT00451321|616868956|FG006|Overall Study|Study closed/terminated|5|||
170687718|NCT00451321|616868957|FG007|Overall Study|Study closed/terminated|3|||
170687719|NCT00451321|616868950|FG000|Overall Study|Sponsor decision to amend protocol|0|||
170687720|NCT00451321|616868951|FG001|Overall Study|Sponsor decision to amend protocol|0|||
170687721|NCT00451321|616868952|FG002|Overall Study|Sponsor decision to amend protocol|0|||
170687722|NCT00451321|616868953|FG003|Overall Study|Sponsor decision to amend protocol|0|||
170687723|NCT00451321|616868954|FG004|Overall Study|Sponsor decision to amend protocol|0|||
170687724|NCT00451321|616868955|FG005|Overall Study|Sponsor decision to amend protocol|1|||
170687725|NCT00451321|616868956|FG006|Overall Study|Sponsor decision to amend protocol|1|||
170687726|NCT00451321|616868957|FG007|Overall Study|Sponsor decision to amend protocol|3|||
170687727|NCT03133546|616868963|FG000|Overall Study|Death|46|||
170687728|NCT03133546|616868964|FG001|Overall Study|Death|43|||
170821553|NCT05271552|617354747|FG001|Overall Study|Lost to Follow-up|5|||
170821554|NCT05271552|617354748|FG002|Overall Study|Lost to Follow-up|4|||
170821555|NCT05271552|617354746|FG000|Overall Study|Withdrawal by Subject|0|||
170821556|NCT05271552|617354747|FG001|Overall Study|Withdrawal by Subject|4|||
170821557|NCT05271552|617354748|FG002|Overall Study|Withdrawal by Subject|7|||
170821558|NCT05271552|617354746|FG000|Overall Study|Other medical reason.|1|||
170821559|NCT05271552|617354747|FG001|Overall Study|Other medical reason.|2|||
170687729|NCT03133546|616868963|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
170687730|NCT03133546|616868964|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
170687731|NCT00732615|616868965|FG000|Overall Study|Withdrawal by Subject|3|||
170687732|NCT00732615|616868966|FG001|Overall Study|Withdrawal by Subject|1|||
170687733|NCT00732615|616868965|FG000|Overall Study|Lost to Follow-up|0|||
170687734|NCT00732615|616868966|FG001|Overall Study|Lost to Follow-up|1|||
170687735|NCT00732615|616868965|FG000|Overall Study|Adverse Event|0|||
170687736|NCT00732615|616868966|FG001|Overall Study|Adverse Event|2|||
170687737|NCT00732615|616868965|FG000|Overall Study|Physician Decision|3|||
170687738|NCT00732615|616868966|FG001|Overall Study|Physician Decision|0|||
170687739|NCT00732615|616868965|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
170687740|NCT00732615|616868966|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
170687741|NCT04821453|616868970|FG000|Mechanical Ventilation Sequence 1|Unable to complete due to change in patient status.|1|||
170687742|NCT04821453|616868971|FG001|Mechanical Ventilation Sequence 1|Unable to complete due to change in patient status.|0|||
170687743|NCT04821453|616868970|FG000|Mechanical Ventilation Sequence 1|Patient transferred|1|||
170687744|NCT04821453|616868971|FG001|Mechanical Ventilation Sequence 1|Patient transferred|0|||
170687745|NCT04821453|616868970|FG000|Mechanical Ventilation Sequence 2|Adverse Event|0|||
170687746|NCT04821453|616868971|FG001|Mechanical Ventilation Sequence 2|Adverse Event|1|||
170687747|NCT04900220|616868974|FG000|Overall Study|Lost to Follow-up|1|||
170687748|NCT04900220|616868975|FG001|Overall Study|Lost to Follow-up|1|||
170687749|NCT02669433|616868976|FG000|Overall Study|Protocol Violation|0|||
170687750|NCT02669433|616868977|FG001|Overall Study|Protocol Violation|4|||
170687751|NCT02669433|616868978|FG002|Overall Study|Protocol Violation|1|||
170687752|NCT02669433|616868976|FG000|Overall Study|Disease Progression|1|||
170687753|NCT02669433|616868977|FG001|Overall Study|Disease Progression|0|||
170687754|NCT02669433|616868978|FG002|Overall Study|Disease Progression|0|||
170687755|NCT02669433|616868976|FG000|Overall Study|Physician Decision|1|||
170687756|NCT02669433|616868977|FG001|Overall Study|Physician Decision|1|||
170687757|NCT02669433|616868978|FG002|Overall Study|Physician Decision|0|||
170687758|NCT02669433|616868976|FG000|Overall Study|Adverse Event|6|||
170687759|NCT02669433|616868977|FG001|Overall Study|Adverse Event|7|||
170687760|NCT02669433|616868978|FG002|Overall Study|Adverse Event|10|||
170687761|NCT02669433|616868976|FG000|Overall Study|Sponsor Termination|1|||
170687762|NCT02669433|616868977|FG001|Overall Study|Sponsor Termination|0|||
170687763|NCT02669433|616868978|FG002|Overall Study|Sponsor Termination|1|||
170687764|NCT02669433|616868976|FG000|Overall Study|Withdrawal by Subject|5|||
170687765|NCT02669433|616868977|FG001|Overall Study|Withdrawal by Subject|1|||
170687766|NCT02669433|616868978|FG002|Overall Study|Withdrawal by Subject|0|||
170687767|NCT02669433|616868976|FG000|Overall Study|Withdrawal by Caregiver|1|||
170687768|NCT02669433|616868977|FG001|Overall Study|Withdrawal by Caregiver|0|||
170687769|NCT02669433|616868978|FG002|Overall Study|Withdrawal by Caregiver|2|||
170687770|NCT02669433|616868976|FG000|Overall Study|Death|0|||
170687771|NCT02669433|616868977|FG001|Overall Study|Death|1|||
170687772|NCT02669433|616868978|FG002|Overall Study|Death|1|||
170687773|NCT00368355|616868979|FG000|Overall Study|Adverse Event|1|||
170687774|NCT00368355|616868980|FG001|Overall Study|Adverse Event|0|||
170687775|NCT00368355|616868979|FG000|Overall Study|Death|2|||
170687776|NCT00368355|616868980|FG001|Overall Study|Death|4|||
170687777|NCT00368355|616868979|FG000|Overall Study|Relapse|6|||
170687778|NCT00368355|616868980|FG001|Overall Study|Relapse|10|||
170687779|NCT00368355|616868979|FG000|Overall Study|Subsequent transplant|0|||
170687780|NCT00368355|616868980|FG001|Overall Study|Subsequent transplant|3|||
170687781|NCT00368355|616868979|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
170687782|NCT00368355|616868980|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
170687783|NCT01059799|616868984|FG000|Overall Study|Adverse Event|2|||
170687784|NCT01059799|616868985|FG001|Overall Study|Adverse Event|3|||
170687785|NCT01059799|616868984|FG000|Overall Study|Lack of Efficacy|1|||
170687786|NCT01059799|616868985|FG001|Overall Study|Lack of Efficacy|0|||
170687787|NCT01059799|616868984|FG000|Overall Study|Protocol Violation|3|||
170687788|NCT01059799|616868985|FG001|Overall Study|Protocol Violation|2|||
170687789|NCT01059799|616868984|FG000|Overall Study|Withdrawal criteria|13|||
170687790|NCT01059799|616868985|FG001|Overall Study|Withdrawal criteria|2|||
170687791|NCT01059799|616868984|FG000|Overall Study|Other|12|||
170687792|NCT01059799|616868985|FG001|Overall Study|Other|3|||
170687793|NCT01361464|616868988|FG000|Overall Study|Death|1|||
170687794|NCT01361464|616868988|FG000|Overall Study|Withdrawal by Subject|2|||
170687795|NCT01614067|616868989|FG000|Overall Study|Pregnancy|1|||
170687796|NCT01614067|616868990|FG001|Overall Study|Pregnancy|0|||
170687797|NCT01614067|616868989|FG000|Overall Study|Physician Decision|6|||
170687798|NCT01614067|616868990|FG001|Overall Study|Physician Decision|5|||
170687799|NCT01614067|616868989|FG000|Overall Study|Withdrawal by Subject|0|||
170687800|NCT01614067|616868990|FG001|Overall Study|Withdrawal by Subject|1|||
170687801|NCT01614067|616868989|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
170687802|NCT01614067|616868990|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
170687803|NCT03036072|616868991|FG000|Overall Study|Death|0|||
170687804|NCT03036072|616868992|FG001|Overall Study|Death|1|||
170687805|NCT03036072|616868991|FG000|Overall Study|Withdrawal by Subject|0|||
170687806|NCT03036072|616868992|FG001|Overall Study|Withdrawal by Subject|1|||
170687807|NCT03036072|616868991|FG000|Overall Study|Physician Decision|0|||
170687808|NCT03036072|616868992|FG001|Overall Study|Physician Decision|1|||
170821560|NCT05271552|617354748|FG002|Overall Study|Other medical reason.|0|||
170687809|NCT03061331|616868993|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
170687810|NCT03061331|616868994|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
170687811|NCT01980875|616868998|FG000|Overall Study|Withdrew Consent|1|||
170687812|NCT01980875|616868999|FG001|Overall Study|Withdrew Consent|1|||
170821561|NCT05271552|617354746|FG000|Overall Study|Other|3|||
170687813|NCT01980875|616869000|FG002|Overall Study|Withdrew Consent|1|||
170687814|NCT01980875|616868998|FG000|Overall Study|Study Terminated by Sponsor|7|||
170687815|NCT01980875|616868999|FG001|Overall Study|Study Terminated by Sponsor|24|||
170687816|NCT01980875|616869000|FG002|Overall Study|Study Terminated by Sponsor|22|||
170687817|NCT01980875|616868998|FG000|Overall Study|Lost to Follow-up|0|||
170687818|NCT01980875|616868999|FG001|Overall Study|Lost to Follow-up|0|||
170687819|NCT01980875|616869000|FG002|Overall Study|Lost to Follow-up|1|||
170687820|NCT00665847|616869001|FG000|Overall Study|Adverse Event|8|||
170687821|NCT00665847|616869001|FG000|Overall Study|Withdrawal by Subject|2|||
170687822|NCT00665847|616869001|FG000|Overall Study|Subject non-compliant|8|||
170687823|NCT00665847|616869001|FG000|Overall Study|Subject reached a virologic endpoint|4|||
170687824|NCT00665847|616869001|FG000|Overall Study|Resistance to TMC125|1|||
170687825|NCT00665847|616869001|FG000|Overall Study|Subject ineligible to continue the trial|1|||
170687826|NCT00665847|616869001|FG000|Overall Study|Switch to Commercial Medication|1|||
170687827|NCT00513474|616869002|FG000|Overall Study|Death|6|||
170687828|NCT00513474|616869003|FG001|Overall Study|Death|9|||
170687829|NCT00513474|616869002|FG000|Overall Study|Participant Withdrew Consent|1|||
170687830|NCT00513474|616869003|FG001|Overall Study|Participant Withdrew Consent|0|||
170687831|NCT00195676|616869008|FG000|Period O - Open-label Treatment|Adverse Event|82|||
170687832|NCT00195676|616869008|FG000|Period O - Open-label Treatment|Death|6|||
170687833|NCT00195676|616869008|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
170687834|NCT00195676|616869008|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
170687835|NCT00195676|616869008|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
170687836|NCT00195676|616869008|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
170687837|NCT00195676|616869008|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
170687838|NCT00195676|616869008|FG000|Period O - Open-label Treatment|Other reasons|68|||
170687839|NCT00195676|616869008|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
170687840|NCT00195676|616869008|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
170687841|NCT00195676|616869008|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
170687842|NCT00195676|616869008|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
170687843|NCT00195676|616869008|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
170687844|NCT00195676|616869008|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
170687845|NCT00195676|616869008|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
170687846|NCT00195676|616869008|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
170687847|NCT00195676|616869008|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
170687848|NCT00195676|616869008|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
170687849|NCT00195676|616869008|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
170687850|NCT00195676|616869008|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
170687851|NCT00195676|616869008|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
170687852|NCT02045797|616869009|FG000|Overall Study|Adverse Event|3|||
170687853|NCT02045797|616869010|FG001|Overall Study|Adverse Event|1|||
170687854|NCT02045797|616869011|FG002|Overall Study|Adverse Event|0|||
170687855|NCT02045797|616869009|FG000|Overall Study|Lack of Efficacy|1|||
170687856|NCT02045797|616869010|FG001|Overall Study|Lack of Efficacy|0|||
170687857|NCT02045797|616869011|FG002|Overall Study|Lack of Efficacy|0|||
170687858|NCT02045797|616869009|FG000|Overall Study|Lost to Follow-up|2|||
170687859|NCT02045797|616869010|FG001|Overall Study|Lost to Follow-up|3|||
170687860|NCT02045797|616869011|FG002|Overall Study|Lost to Follow-up|1|||
170687861|NCT02045797|616869009|FG000|Overall Study|Physician Decision|0|||
170687862|NCT02045797|616869010|FG001|Overall Study|Physician Decision|1|||
170687863|NCT02045797|616869011|FG002|Overall Study|Physician Decision|0|||
170687864|NCT02045797|616869009|FG000|Overall Study|Withdrawal by Subject|1|||
170687865|NCT02045797|616869010|FG001|Overall Study|Withdrawal by Subject|2|||
170687866|NCT02045797|616869011|FG002|Overall Study|Withdrawal by Subject|0|||
170687867|NCT02446236|616869012|FG000|Overall Study|Screen Failure|1|||
170687868|NCT02446236|616869013|FG001|Overall Study|Screen Failure|0|||
170687869|NCT02446236|616869014|FG002|Overall Study|Screen Failure|1|||
170687870|NCT02446236|616869012|FG000|Overall Study|Actively Receiving Therapy|0|||
170687871|NCT02446236|616869013|FG001|Overall Study|Actively Receiving Therapy|0|||
170687872|NCT02446236|616869014|FG002|Overall Study|Actively Receiving Therapy|1|||
170687873|NCT01237054|616869015|FG000|Overall Study|imaging 10C0096|1|||
170687874|NCT05371509|616869016|FG000|Overall Study|Physician Decision|1|||
170687875|NCT05371509|616869017|FG001|Overall Study|Physician Decision|0|||
170687876|NCT03334903|616869018|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
170687877|NCT03334903|616869019|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
170687878|NCT03334903|616869018|FG000|Overall Study|Protocol Violation|1|||
170821562|NCT05271552|617354747|FG001|Overall Study|Other|3|||
170821563|NCT05271552|617354748|FG002|Overall Study|Other|6|||
170687879|NCT03334903|616869019|FG001|Overall Study|Protocol Violation|3|||
170687880|NCT03334903|616869018|FG000|Overall Study|Surgery postponed|1|||
170687881|NCT03334903|616869019|FG001|Overall Study|Surgery postponed|0|||
170821564|NCT01090076|617354754|FG000|Overall Study|Death|1|||
170821565|NCT01090076|617354755|FG001|Overall Study|Death|1|||
170821566|NCT01090076|617354754|FG000|Overall Study|Withdrawal by Subject|0|||
170687882|NCT03334903|616869018|FG000|Overall Study|Adverse Event|1|||
170687883|NCT03334903|616869019|FG001|Overall Study|Adverse Event|1|||
170687884|NCT03334903|616869018|FG000|Overall Study|Withdrawal by Subject|0|||
170821567|NCT01090076|617354755|FG001|Overall Study|Withdrawal by Subject|1|||
170821568|NCT02176018|617354756|FG000|Overall Study|Adverse Event|0|||
170821569|NCT02176018|617354757|FG001|Overall Study|Adverse Event|2|||
170821570|NCT02176018|617354756|FG000|Overall Study|Lost to Follow-up|3|||
170687885|NCT03334903|616869019|FG001|Overall Study|Withdrawal by Subject|1|||
170687886|NCT05180669|616869020|FG000|Overall Study|Lost to Follow-up|21|||
170687887|NCT05180669|616869021|FG001|Overall Study|Lost to Follow-up|20|||
170687888|NCT02879305|616869026|FG000|Overall Study|Investigator Site Closed|55|||
170687889|NCT02879305|616869027|FG001|Overall Study|Investigator Site Closed|57|||
170687890|NCT02879305|616869026|FG000|Overall Study|Withdrawal by Subject|44|||
170687891|NCT02879305|616869027|FG001|Overall Study|Withdrawal by Subject|42|||
170687892|NCT02879305|616869026|FG000|Overall Study|Lost to Follow-up|17|||
170687893|NCT02879305|616869027|FG001|Overall Study|Lost to Follow-up|12|||
170687894|NCT02879305|616869026|FG000|Overall Study|Other|1|||
170687895|NCT02879305|616869027|FG001|Overall Study|Other|0|||
170687896|NCT04736199|616870163|FG000|Overall Study|Adverse Event|28|||
170687897|NCT04736199|616870164|FG001|Overall Study|Adverse Event|22|||
170687898|NCT04736199|616870163|FG000|Overall Study|Death|9|||
170687899|NCT04736199|616870164|FG001|Overall Study|Death|3|||
170687900|NCT04736199|616870163|FG000|Overall Study|Lost to Follow-up|4|||
170687901|NCT04736199|616870164|FG001|Overall Study|Lost to Follow-up|1|||
170687902|NCT04736199|616870163|FG000|Overall Study|Physician Decision|5|||
170687903|NCT04736199|616870164|FG001|Overall Study|Physician Decision|9|||
170687904|NCT04736199|616870163|FG000|Overall Study|Withdrawal by Subject|21|||
170687905|NCT04736199|616870164|FG001|Overall Study|Withdrawal by Subject|9|||
170687906|NCT04736199|616870163|FG000|Overall Study|Progressive disease|120|||
170687907|NCT04736199|616870164|FG001|Overall Study|Progressive disease|101|||
170687908|NCT04736199|616870163|FG000|Overall Study|Subject decision|13|||
170687909|NCT04736199|616870164|FG001|Overall Study|Subject decision|13|||
170687910|NCT04736199|616870163|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
170687911|NCT04736199|616870164|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
170687912|NCT04736199|616870163|FG000|Overall Study|Additional primary malignancy|1|||
170687913|NCT04736199|616870164|FG001|Overall Study|Additional primary malignancy|0|||
170687914|NCT04736199|616870163|FG000|Overall Study|Non-compliance with study drug|0|||
170687915|NCT04736199|616870164|FG001|Overall Study|Non-compliance with study drug|1|||
170687916|NCT04736199|616870163|FG000|Overall Study|Other reason|0|||
170687917|NCT04736199|616870164|FG001|Overall Study|Other reason|1|||
170687918|NCT04736199|616870163|FG000|Overall Study|Ongoing with study drug|240|||
170687919|NCT04736199|616870164|FG001|Overall Study|Ongoing with study drug|63|||
170687920|NCT04736199|616870163|FG000|Overall Study|Study drug never administered|3|||
170687921|NCT04736199|616870164|FG001|Overall Study|Study drug never administered|0|||
170687922|NCT02152631|616870167|FG000|Overall Study|Adverse Event|32|||
170687923|NCT02152631|616870168|FG001|Overall Study|Adverse Event|4|||
170687924|NCT02152631|616870167|FG000|Overall Study|Withdrawal by Subject|13|||
170687925|NCT02152631|616870168|FG001|Overall Study|Withdrawal by Subject|16|||
170687926|NCT02152631|616870167|FG000|Overall Study|Noncompliance with study drug|1|||
170687927|NCT02152631|616870168|FG001|Overall Study|Noncompliance with study drug|0|||
170687928|NCT02152631|616870167|FG000|Overall Study|Physician Decision|1|||
170687929|NCT02152631|616870168|FG001|Overall Study|Physician Decision|2|||
170687930|NCT02152631|616870167|FG000|Overall Study|Lost to Follow-up|0|||
170687931|NCT02152631|616870168|FG001|Overall Study|Lost to Follow-up|1|||
170687932|NCT02152631|616870167|FG000|Overall Study|On Treatment|19|||
170687933|NCT02152631|616870168|FG001|Overall Study|On Treatment|3|||
170687934|NCT03203473|616870169|FG000|Induction phase|Never started primary treatment|2|||
170687935|NCT03203473|616870170|FG001|Induction phase|Never started primary treatment|0|||
170687936|NCT03203473|616870171|FG002|Induction phase|Never started primary treatment|0|||
170687937|NCT03203473|616870169|FG000|Induction phase|Withdrew from study due to progressive disease|7|||
170687938|NCT03203473|616870170|FG001|Induction phase|Withdrew from study due to progressive disease|0|||
170687939|NCT03203473|616870171|FG002|Induction phase|Withdrew from study due to progressive disease|0|||
170687940|NCT03203473|616870169|FG000|Induction phase|Withdrew from study due to toxicity|7|||
170687941|NCT03203473|616870170|FG001|Induction phase|Withdrew from study due to toxicity|0|||
170687942|NCT03203473|616870171|FG002|Induction phase|Withdrew from study due to toxicity|0|||
170687943|NCT03203473|616870169|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
170687944|NCT03203473|616870170|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
170687945|NCT03203473|616870171|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
170687946|NCT03203473|616870169|FG000|Arm Allocation Phase|started salvage therapy|0|||
170687947|NCT03203473|616870170|FG001|Arm Allocation Phase|started salvage therapy|5|||
170687948|NCT03203473|616870171|FG002|Arm Allocation Phase|started salvage therapy|0|||
170687949|NCT03203473|616870169|FG000|Arm Allocation Phase|Disease progression|0|||
170687950|NCT03203473|616870170|FG001|Arm Allocation Phase|Disease progression|0|||
170687951|NCT03203473|616870171|FG002|Arm Allocation Phase|Disease progression|37|||
170821571|NCT02176018|617354757|FG001|Overall Study|Lost to Follow-up|1|||
170821572|NCT02176018|617354756|FG000|Overall Study|Protocol Violation|1|||
170821573|NCT02176018|617354757|FG001|Overall Study|Protocol Violation|1|||
170821574|NCT02176018|617354756|FG000|Overall Study|Withdrawal by Subject|1|||
170821575|NCT02176018|617354757|FG001|Overall Study|Withdrawal by Subject|2|||
170821576|NCT03022045|617354761|FG000|Overall Study|Adverse Event|0|||
170821577|NCT03022045|617354762|FG001|Overall Study|Adverse Event|1|||
170821578|NCT03022045|617354761|FG000|Overall Study|Withdrawal by Subject|1|||
170821579|NCT03022045|617354762|FG001|Overall Study|Withdrawal by Subject|1|||
170821580|NCT02469077|617354764|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
170821581|NCT02469077|617354765|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
170821582|NCT02469077|617354764|FG000|Post Randomization/Intervention Period|Relocated|1|||
170821583|NCT02469077|617354765|FG001|Post Randomization/Intervention Period|Relocated|1|||
170821584|NCT02469077|617354764|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
170821585|NCT02469077|617354765|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
170821586|NCT02469077|617354764|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
170821587|NCT02469077|617354765|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
170821588|NCT02973477|617354766|FG000|First Intervention|Lost to Follow-up|0|||
170821589|NCT02973477|617354767|FG001|First Intervention|Lost to Follow-up|2|||
170821590|NCT02973477|617354766|FG000|Washout|Withdrawal by Subject|1|||
170821591|NCT02973477|617354767|FG001|Washout|Withdrawal by Subject|0|||
170821592|NCT02973477|617354766|FG000|Second Intervention|Lost to Follow-up|1|||
170821593|NCT02973477|617354767|FG001|Second Intervention|Lost to Follow-up|0|||
170821594|NCT02402465|617354769|FG000|Overall Study|Withdrawal by Subject|0|||
170821595|NCT02402465|617354770|FG001|Overall Study|Withdrawal by Subject|0|||
170821596|NCT02402465|617354771|FG002|Overall Study|Withdrawal by Subject|0|||
170821597|NCT02402465|617354772|FG003|Overall Study|Withdrawal by Subject|0|||
170821598|NCT02402465|617354773|FG004|Overall Study|Withdrawal by Subject|0|||
170821599|NCT02402465|617354774|FG005|Overall Study|Withdrawal by Subject|1|||
170821600|NCT02402465|617354769|FG000|Overall Study|Lost to Follow-up|0|||
170821601|NCT02402465|617354770|FG001|Overall Study|Lost to Follow-up|1|||
170821602|NCT02402465|617354771|FG002|Overall Study|Lost to Follow-up|0|||
170821603|NCT02402465|617354772|FG003|Overall Study|Lost to Follow-up|0|||
170821604|NCT02402465|617354773|FG004|Overall Study|Lost to Follow-up|1|||
170821605|NCT02402465|617354774|FG005|Overall Study|Lost to Follow-up|0|||
170821606|NCT01284634|617354775|FG000|Overall Study|Adverse Event|1|||
170821607|NCT01284634|617354776|FG001|Overall Study|Adverse Event|0|||
170821608|NCT01284634|617354777|FG002|Overall Study|Adverse Event|2|||
170821609|NCT01284634|617354778|FG003|Overall Study|Adverse Event|1|||
170821610|NCT03807700|617354779|FG000|Overall Study|Withdrawal by Subject|2|||
170821611|NCT03807700|617354780|FG001|Overall Study|Withdrawal by Subject|1|||
170821612|NCT01059526|617354781|FG000|Overall Study|Patient enrolled but not treated|20|||
170821613|NCT01059526|617354782|FG001|Overall Study|Patient enrolled but not treated|17|||
170821614|NCT01059526|617354781|FG000|Overall Study|Adverse Event|2|||
170821615|NCT01059526|617354782|FG001|Overall Study|Adverse Event|2|||
170821616|NCT01059526|617354781|FG000|Overall Study|Protocol Violation|0|||
170821617|NCT01059526|617354782|FG001|Overall Study|Protocol Violation|1|||
170821618|NCT01059526|617354781|FG000|Overall Study|Withdrawal by Subject|3|||
170821619|NCT01059526|617354782|FG001|Overall Study|Withdrawal by Subject|1|||
170821620|NCT01059526|617354781|FG000|Overall Study|Lost to Follow-up|4|||
170821621|NCT01059526|617354782|FG001|Overall Study|Lost to Follow-up|1|||
170821622|NCT01059526|617354781|FG000|Overall Study|Patient found to be dermatographic|1|||
170821623|NCT01059526|617354782|FG001|Overall Study|Patient found to be dermatographic|0|||
170821624|NCT02720081|617354783|FG000|Overall Study|Adverse Event|0|||
170821625|NCT02720081|617354784|FG001|Overall Study|Adverse Event|3|||
170821626|NCT02720081|617354783|FG000|Overall Study|Protocol Violation|4|||
170821627|NCT02720081|617354784|FG001|Overall Study|Protocol Violation|1|||
170821628|NCT01732588|617354785|FG000|First Intervention (7 Days)|Adverse Event|0|||
170821629|NCT01732588|617354786|FG001|First Intervention (7 Days)|Adverse Event|1|||
170821630|NCT01732588|617354787|FG002|First Intervention (7 Days)|Adverse Event|0|||
170821631|NCT02236598|617354788|FG000|Overall Study|Adverse Event|0|||
170821632|NCT02236598|617354789|FG001|Overall Study|Adverse Event|1|||
170821633|NCT02236598|617354788|FG000|Overall Study|Withdrawal by Subject|0|||
170821634|NCT02236598|617354789|FG001|Overall Study|Withdrawal by Subject|1|||
170821635|NCT04879823|617354790|FG000|Overall Study|Physician Decision|3|||
170821636|NCT04879823|617354791|FG001|Overall Study|Physician Decision|1|||
170821637|NCT04879823|617354790|FG000|Overall Study|Protocol Violation|2|||
170821638|NCT04879823|617354791|FG001|Overall Study|Protocol Violation|3|||
170821639|NCT04879823|617354790|FG000|Overall Study|Lost to Follow-up|43|||
170821640|NCT04879823|617354791|FG001|Overall Study|Lost to Follow-up|35|||
170821641|NCT00191984|617354802|FG000|Overall Study|Disease Progression|21|||
170821642|NCT00191984|617354802|FG000|Overall Study|Adverse Event|4|||
170821643|NCT00191984|617354802|FG000|Overall Study|Death|2|||
170821644|NCT00191984|617354802|FG000|Overall Study|Entry Criteria Exclusion|1|||
170821645|NCT00191984|617354802|FG000|Overall Study|Withdrawal by Subject|7|||
170821646|NCT00191984|617354802|FG000|Overall Study|Physician Decision|4|||
170821647|NCT03303521|617354803|FG000|Overall Study|Withdrawal by Subject|2|||
170821648|NCT03303521|617354804|FG001|Overall Study|Withdrawal by Subject|0|||
170821649|NCT03303521|617354803|FG000|Overall Study|Death|1|||
170821650|NCT03303521|617354804|FG001|Overall Study|Death|0|||
170821651|NCT03303521|617354803|FG000|Overall Study|Kidney transplantation|0|||
170821652|NCT03303521|617354804|FG001|Overall Study|Kidney transplantation|1|||
170821653|NCT03303521|617354803|FG000|Overall Study|Investigational product discontinuation|0|||
170821654|NCT03303521|617354804|FG001|Overall Study|Investigational product discontinuation|1|||
170687952|NCT03203473|616870169|FG000|Arm Allocation Phase|Adverse Event|0|||
170687953|NCT03203473|616870170|FG001|Arm Allocation Phase|Adverse Event|0|||
170687954|NCT03203473|616870171|FG002|Arm Allocation Phase|Adverse Event|11|||
170687955|NCT03203473|616870169|FG000|Arm Allocation Phase|Physician Decision|0|||
170687956|NCT03203473|616870170|FG001|Arm Allocation Phase|Physician Decision|0|||
170687957|NCT03203473|616870171|FG002|Arm Allocation Phase|Physician Decision|3|||
170687958|NCT03203473|616870169|FG000|Arm Allocation Phase|Death|0|||
170687959|NCT03203473|616870170|FG001|Arm Allocation Phase|Death|0|||
170687960|NCT03203473|616870171|FG002|Arm Allocation Phase|Death|1|||
170687961|NCT03203473|616870169|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
170687962|NCT03203473|616870170|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
170687963|NCT03203473|616870171|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
170687964|NCT03203473|616870169|FG000|Arm Allocation Phase|Intercurrent illness|0|||
170687965|NCT03203473|616870170|FG001|Arm Allocation Phase|Intercurrent illness|0|||
170687966|NCT03203473|616870171|FG002|Arm Allocation Phase|Intercurrent illness|1|||
170687967|NCT03203473|616870169|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
170687968|NCT03203473|616870170|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
170687969|NCT03203473|616870171|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
170687970|NCT02143414|616870176|FG000|Induction|Adverse Event|1|||
170687971|NCT02143414|616870177|FG001|Induction|Adverse Event|2|||
170687972|NCT02143414|616870176|FG000|Induction|Death|1|||
170687973|NCT02143414|616870177|FG001|Induction|Death|2|||
170687974|NCT02143414|616870176|FG000|Induction|Patient refusal|1|||
170687975|NCT02143414|616870177|FG001|Induction|Patient refusal|1|||
170687976|NCT02143414|616870176|FG000|Induction|Refractory|1|||
170687977|NCT02143414|616870177|FG001|Induction|Refractory|0|||
170687978|NCT02143414|616870176|FG000|Induction|Began alternative treatment|1|||
170687979|NCT02143414|616870177|FG001|Induction|Began alternative treatment|0|||
170687980|NCT02143414|616870176|FG000|Induction|Ineligible for postremission|5|||
170687981|NCT02143414|616870177|FG001|Induction|Ineligible for postremission|1|||
170687982|NCT02143414|616870176|FG000|Post-remission|Adverse Event|0|||
170687983|NCT02143414|616870177|FG001|Post-remission|Adverse Event|2|||
170687984|NCT02143414|616870176|FG000|Post-remission|Disease progression/relapse|5|||
170687985|NCT02143414|616870177|FG001|Post-remission|Disease progression/relapse|0|||
170687986|NCT02143414|616870176|FG000|Maintenance|Adverse Event|4|||
170687987|NCT02143414|616870177|FG001|Maintenance|Adverse Event|6|||
170687988|NCT02143414|616870176|FG000|Maintenance|Disease progression/relapse|3|||
170687989|NCT02143414|616870177|FG001|Maintenance|Disease progression/relapse|2|||
170687990|NCT02143414|616870176|FG000|Maintenance|Patient refusal|2|||
170687991|NCT02143414|616870177|FG001|Maintenance|Patient refusal|1|||
170687992|NCT02143414|616870176|FG000|Maintenance|Physician Decision|1|||
170687993|NCT02143414|616870177|FG001|Maintenance|Physician Decision|0|||
170687994|NCT02143414|616870176|FG000|Maintenance|Death|0|||
170687995|NCT02143414|616870177|FG001|Maintenance|Death|1|||
170687996|NCT02143414|616870176|FG000|Maintenance|On protocol treatment|0|||
170687997|NCT02143414|616870177|FG001|Maintenance|On protocol treatment|6|||
170687998|NCT05280756|616870178|FG000|Overall Study|Lost to Follow-up|1|||
170687999|NCT05280756|616870179|FG001|Overall Study|Lost to Follow-up|1|||
170688000|NCT04849416|616870180|FG000|Overall Study|Ongoing Treatment|12|||
170688001|NCT04849416|616870181|FG001|Overall Study|Ongoing Treatment|5|||
170688002|NCT04849416|616870182|FG002|Overall Study|Ongoing Treatment|3|||
170688003|NCT04849416|616870180|FG000|Overall Study|On Post-Treatment Follow-up|8|||
170688004|NCT04849416|616870181|FG001|Overall Study|On Post-Treatment Follow-up|9|||
170688005|NCT04849416|616870182|FG002|Overall Study|On Post-Treatment Follow-up|10|||
170688006|NCT04849416|616870180|FG000|Overall Study|Withdrawal by Subject|0|||
170688007|NCT04849416|616870181|FG001|Overall Study|Withdrawal by Subject|0|||
170688008|NCT04849416|616870182|FG002|Overall Study|Withdrawal by Subject|1|||
170688009|NCT04849416|616870180|FG000|Overall Study|Lost to Follow-up|1|||
170688010|NCT04849416|616870181|FG001|Overall Study|Lost to Follow-up|0|||
170688011|NCT04849416|616870182|FG002|Overall Study|Lost to Follow-up|0|||
170688012|NCT04618471|616870183|FG000|Overall Study|Screen Failure|62|||
170821655|NCT03303521|617354803|FG000|Overall Study|Transferred to non-study dialysis center|1|||
170821656|NCT03303521|617354804|FG001|Overall Study|Transferred to non-study dialysis center|0|||
170821657|NCT03303521|617354803|FG000|Overall Study|Non-comliance to study protocol|0|||
170688013|NCT04618471|616870183|FG000|Overall Study|Withdrawal by Subject|6|||
170688014|NCT04618471|616870183|FG000|Overall Study|Physician Decision|2|||
170688015|NCT04618471|616870183|FG000|Overall Study|Lost to Follow-up|1|||
170688016|NCT04618471|616870183|FG000|Overall Study|Various other reasons|2|||
170688017|NCT04618471|616870183|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
170688018|NCT05571397|616870188|FG000|Overall Study|Lost to Follow-up|1|||
170688019|NCT05571397|616870189|FG001|Overall Study|Lost to Follow-up|0|||
170688020|NCT03631199|616870190|FG000|Overall Study|Progressive disease|9|||
170688021|NCT03631199|616870191|FG001|Overall Study|Progressive disease|5|||
170688022|NCT03631199|616870192|FG002|Overall Study|Progressive disease|5|||
170688023|NCT03631199|616870193|FG003|Overall Study|Progressive disease|149|||
170688024|NCT03631199|616870194|FG004|Overall Study|Progressive disease|148|||
170688025|NCT03631199|616870190|FG000|Overall Study|Physician Decision|0|||
170688026|NCT03631199|616870191|FG001|Overall Study|Physician Decision|2|||
170688027|NCT03631199|616870192|FG002|Overall Study|Physician Decision|3|||
170688028|NCT03631199|616870193|FG003|Overall Study|Physician Decision|19|||
170688029|NCT03631199|616870194|FG004|Overall Study|Physician Decision|13|||
170688030|NCT03631199|616870190|FG000|Overall Study|Adverse Event|1|||
170688031|NCT03631199|616870191|FG001|Overall Study|Adverse Event|1|||
170688032|NCT03631199|616870192|FG002|Overall Study|Adverse Event|0|||
170688033|NCT03631199|616870193|FG003|Overall Study|Adverse Event|28|||
170688034|NCT03631199|616870194|FG004|Overall Study|Adverse Event|29|||
170688035|NCT03631199|616870190|FG000|Overall Study|Death|0|||
170688036|NCT03631199|616870191|FG001|Overall Study|Death|1|||
170688037|NCT03631199|616870192|FG002|Overall Study|Death|0|||
170688038|NCT03631199|616870193|FG003|Overall Study|Death|35|||
170688039|NCT03631199|616870194|FG004|Overall Study|Death|48|||
170688040|NCT03631199|616870190|FG000|Overall Study|Subject decision|0|||
170688041|NCT03631199|616870191|FG001|Overall Study|Subject decision|1|||
170688042|NCT03631199|616870192|FG002|Overall Study|Subject decision|0|||
170688043|NCT03631199|616870193|FG003|Overall Study|Subject decision|12|||
170688044|NCT03631199|616870194|FG004|Overall Study|Subject decision|12|||
170688045|NCT03631199|616870190|FG000|Overall Study|No treated|0|||
170688046|NCT03631199|616870191|FG001|Overall Study|No treated|0|||
170688047|NCT03631199|616870192|FG002|Overall Study|No treated|0|||
170688048|NCT03631199|616870193|FG003|Overall Study|No treated|0|||
170688049|NCT03631199|616870194|FG004|Overall Study|No treated|1|||
170688050|NCT03631199|616870190|FG000|Overall Study|Treatment ongoing|0|||
170688051|NCT03631199|616870191|FG001|Overall Study|Treatment ongoing|1|||
170688052|NCT03631199|616870192|FG002|Overall Study|Treatment ongoing|1|||
170688053|NCT03631199|616870193|FG003|Overall Study|Treatment ongoing|76|||
170688054|NCT03631199|616870194|FG004|Overall Study|Treatment ongoing|71|||
170688055|NCT03631199|616870190|FG000|Overall Study|Guardian decision|0|||
170688056|NCT03631199|616870191|FG001|Overall Study|Guardian decision|0|||
170688057|NCT03631199|616870192|FG002|Overall Study|Guardian decision|0|||
170688058|NCT03631199|616870193|FG003|Overall Study|Guardian decision|1|||
170688059|NCT03631199|616870194|FG004|Overall Study|Guardian decision|1|||
170688060|NCT04221477|616870198|FG000|Overall Study|Adverse Event|1|||
170688061|NCT04221477|616870199|FG001|Overall Study|Adverse Event|1|||
170688062|NCT04221477|616870198|FG000|Overall Study|Death|5|||
170688063|NCT04221477|616870199|FG001|Overall Study|Death|4|||
170688064|NCT04221477|616870198|FG000|Overall Study|Lack of Efficacy|1|||
170688065|NCT04221477|616870199|FG001|Overall Study|Lack of Efficacy|2|||
170688066|NCT04221477|616870198|FG000|Overall Study|Lost to Follow-up|1|||
170688067|NCT04221477|616870199|FG001|Overall Study|Lost to Follow-up|2|||
170688068|NCT04221477|616870198|FG000|Overall Study|Non-compliance with Study Drug|1|||
170688069|NCT04221477|616870199|FG001|Overall Study|Non-compliance with Study Drug|0|||
170688070|NCT04221477|616870198|FG000|Overall Study|Reason not Specified|0|||
170688071|NCT04221477|616870199|FG001|Overall Study|Reason not Specified|5|||
170688072|NCT04221477|616870198|FG000|Overall Study|Physician Decision|0|||
170688073|NCT04221477|616870199|FG001|Overall Study|Physician Decision|6|||
170688074|NCT04221477|616870198|FG000|Overall Study|Withdrawal by Subject|10|||
170688075|NCT04221477|616870199|FG001|Overall Study|Withdrawal by Subject|14|||
170688076|NCT04221477|616870198|FG000|Overall Study|Ongoing in the Study|116|||
170688077|NCT04221477|616870199|FG001|Overall Study|Ongoing in the Study|102|||
170688078|NCT02438722|616870200|FG000|Overall Study|Adverse Event|12|||
170688079|NCT02438722|616870201|FG001|Overall Study|Adverse Event|9|||
170688080|NCT02438722|616870200|FG000|Overall Study|Refusal unrelated to AE|2|||
170688081|NCT02438722|616870201|FG001|Overall Study|Refusal unrelated to AE|5|||
170688082|NCT02438722|616870200|FG000|Overall Study|Disease progression/relapse|46|||
170688083|NCT02438722|616870201|FG001|Overall Study|Disease progression/relapse|51|||
170688084|NCT02438722|616870200|FG000|Overall Study|Death|0|||
170688085|NCT02438722|616870201|FG001|Overall Study|Death|3|||
170821658|NCT03303521|617354804|FG001|Overall Study|Non-comliance to study protocol|1|||
170821659|NCT03303521|617354803|FG000|Overall Study|Adverse Event|1|||
170821660|NCT03303521|617354804|FG001|Overall Study|Adverse Event|0|||
170821661|NCT01654289|617354805|FG000|Overall Study|Withdrawal by Subject|10|||
170688086|NCT02438722|616870200|FG000|Overall Study|Physician Decision|2|||
170688087|NCT02438722|616870201|FG001|Overall Study|Physician Decision|2|||
170688088|NCT02438722|616870200|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
170688089|NCT02438722|616870201|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
170688090|NCT02438722|616870200|FG000|Overall Study|Withdrawal by Subject|0|||
170688091|NCT02438722|616870201|FG001|Overall Study|Withdrawal by Subject|1|||
170688092|NCT02438722|616870200|FG000|Overall Study|On protocol treatment|15|||
170688093|NCT02438722|616870201|FG001|Overall Study|On protocol treatment|14|||
170688094|NCT02438722|616870200|FG000|Overall Study|Did not receive protocol treatment|5|||
170821662|NCT01654289|617354806|FG001|Overall Study|Withdrawal by Subject|8|||
170688095|NCT02438722|616870201|FG001|Overall Study|Did not receive protocol treatment|0|||
170688096|NCT03025035|616870202|FG000|Overall Study|Death|2|||
170688097|NCT03025035|616870202|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
170688098|NCT03693807|616870203|FG000|Overall Study|Adverse Event|1|||
170688099|NCT03693807|616870204|FG001|Overall Study|Adverse Event|3|||
170821663|NCT01654289|617354807|FG002|Overall Study|Withdrawal by Subject|5|||
170821664|NCT01654289|617354805|FG000|Overall Study|Withdrew from intervention only|17|||
170821665|NCT01654289|617354806|FG001|Overall Study|Withdrew from intervention only|20|||
170821666|NCT01654289|617354807|FG002|Overall Study|Withdrew from intervention only|0|||
170821667|NCT04748445|617354810|FG000|Overall Study|No longer met eligibility criteria|12|||
170821668|NCT04748445|617354810|FG000|Overall Study|Other|36|||
170821669|NCT04748445|617354810|FG000|Overall Study|Withdrawal by Subject|553|||
170821670|NCT04748445|617354810|FG000|Overall Study|Lost to Follow-up|30|||
170821671|NCT00938041|617354811|FG000|Overall Study|Lost to Follow-up|6|||
170821672|NCT00938041|617354811|FG000|Overall Study|Received Alternative Therapy|1|||
170821673|NCT00938041|617354811|FG000|Overall Study|Progressive Disease|5|||
170821674|NCT00938041|617354811|FG000|Overall Study|Death|12|||
170821675|NCT00938041|617354811|FG000|Overall Study|Adrenal Insufficiency|3|||
170821676|NCT03042559|617354812|FG000|Overall Study|drop out|1|||
170821677|NCT03042559|617354813|FG001|Overall Study|drop out|1|||
170821678|NCT00428441|617354814|FG000|Overall Study|Lost to Follow-up|1|||
170821679|NCT01475370|617354815|FG000|Overall Study|Exacerbation of primary disease|2|||
170821680|NCT01475370|617354816|FG001|Overall Study|Exacerbation of primary disease|2|||
170821681|NCT01475370|617354817|FG002|Overall Study|Exacerbation of primary disease|2|||
170821682|NCT01475370|617354815|FG000|Overall Study|Study drug administration difficult|0|||
170821683|NCT01475370|617354816|FG001|Overall Study|Study drug administration difficult|1|||
170821684|NCT01475370|617354817|FG002|Overall Study|Study drug administration difficult|1|||
170821685|NCT01475370|617354815|FG000|Overall Study|Other than specified|1|||
170821686|NCT01475370|617354816|FG001|Overall Study|Other than specified|0|||
170821687|NCT01475370|617354817|FG002|Overall Study|Other than specified|0|||
170821688|NCT03132753|617354820|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
170688100|NCT03693807|616870205|FG002|Overall Study|Adverse Event|1|||
170688101|NCT03693807|616870203|FG000|Overall Study|Physician Decision|1|||
170688102|NCT03693807|616870204|FG001|Overall Study|Physician Decision|0|||
170688103|NCT03693807|616870205|FG002|Overall Study|Physician Decision|1|||
170688104|NCT03693807|616870203|FG000|Overall Study|Withdrawal by Subject|2|||
170688105|NCT03693807|616870204|FG001|Overall Study|Withdrawal by Subject|0|||
170688106|NCT03693807|616870205|FG002|Overall Study|Withdrawal by Subject|0|||
170688107|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
170688108|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
170688109|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
170688110|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
170688111|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
170821689|NCT03132753|617354821|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
170821690|NCT03132753|617354820|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
170821691|NCT03132753|617354821|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
170821692|NCT00084747|617354822|FG000|Overall Study|Relapsed|8|||
170821693|NCT00084747|617354822|FG000|Overall Study|Death|3|||
170821694|NCT00084747|617354822|FG000|Overall Study|Withdrawal by Subject|2|||
170821695|NCT04203160|617354823|FG000|Overall Study|Alternative Therapy|3|||
170821696|NCT04203160|617354824|FG001|Overall Study|Alternative Therapy|0|||
170821697|NCT04203160|617354825|FG002|Overall Study|Alternative Therapy|1|||
170821698|NCT04203160|617354826|FG003|Overall Study|Alternative Therapy|0|||
170821699|NCT04203160|617354827|FG004|Overall Study|Alternative Therapy|0|||
170821700|NCT04203160|617354828|FG005|Overall Study|Alternative Therapy|2|||
170821701|NCT04203160|617354823|FG000|Overall Study|Withdrawal by Subject|4|||
170821702|NCT04203160|617354824|FG001|Overall Study|Withdrawal by Subject|5|||
170821703|NCT04203160|617354825|FG002|Overall Study|Withdrawal by Subject|0|||
170821704|NCT04203160|617354826|FG003|Overall Study|Withdrawal by Subject|0|||
170821705|NCT04203160|617354827|FG004|Overall Study|Withdrawal by Subject|0|||
170821706|NCT04203160|617354828|FG005|Overall Study|Withdrawal by Subject|4|||
170821707|NCT04203160|617354823|FG000|Overall Study|Adverse Event|7|||
170821708|NCT04203160|617354824|FG001|Overall Study|Adverse Event|5|||
170688112|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
170688113|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
170688114|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
170688115|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
170688116|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
170688117|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
170821709|NCT04203160|617354825|FG002|Overall Study|Adverse Event|0|||
170821710|NCT04203160|617354826|FG003|Overall Study|Adverse Event|0|||
170821711|NCT04203160|617354827|FG004|Overall Study|Adverse Event|0|||
170688118|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
170821712|NCT04203160|617354828|FG005|Overall Study|Adverse Event|0|||
170821713|NCT04203160|617354823|FG000|Overall Study|Sponsor Termination|1|||
170688119|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
170688120|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
170688121|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
170688122|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
170688123|NCT03182244|616870206|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
170688124|NCT03182244|616870207|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
170688125|NCT03182244|616870206|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
170688126|NCT03182244|616870207|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
170688127|NCT03182244|616870206|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
170688128|NCT03182244|616870207|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
170688129|NCT03182244|616870206|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
170688130|NCT03182244|616870207|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
170688131|NCT03182244|616870206|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
170688132|NCT03182244|616870207|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
170688133|NCT04044768|616870209|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
170688134|NCT04044768|616870210|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
170688135|NCT03851302|616870213|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
170688136|NCT03851302|616870214|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
170688137|NCT03851302|616870215|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
170688138|NCT03851302|616870216|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
170688139|NCT03851302|616870217|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
170688140|NCT03851302|616870218|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
170688141|NCT03851302|616870213|FG000|Screening (1 Day)|Screened out|0|||
170688142|NCT03851302|616870214|FG001|Screening (1 Day)|Screened out|0|||
170688143|NCT03851302|616870215|FG002|Screening (1 Day)|Screened out|1|||
170688144|NCT03851302|616870216|FG003|Screening (1 Day)|Screened out|1|||
170688145|NCT03851302|616870217|FG004|Screening (1 Day)|Screened out|0|||
170688146|NCT03851302|616870218|FG005|Screening (1 Day)|Screened out|0|||
170688147|NCT03851302|616870213|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
170688148|NCT03851302|616870214|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
170688149|NCT03851302|616870215|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
170688150|NCT03851302|616870216|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
170688151|NCT03851302|616870217|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
170688152|NCT03851302|616870218|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
170688153|NCT04405037|616870223|FG000|Overall Study|Withdrawal by Subject|1|||
170688154|NCT04405037|616870224|FG001|Overall Study|Withdrawal by Subject|0|||
170688155|NCT04405037|616870223|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
170688156|NCT04405037|616870224|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
170688157|NCT03789110|616870225|FG000|Overall Study|Adverse Event|2|||
170688158|NCT03789110|616870225|FG000|Overall Study|Physician Decision|1|||
170688159|NCT03789110|616870225|FG000|Overall Study|Withdrawal by Subject|2|||
170688160|NCT03789110|616870225|FG000|Overall Study|Lack of Efficacy|22|||
170688161|NCT03789110|616870225|FG000|Overall Study|still on treatment|3|||
170688162|NCT04434092|616870226|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
170688163|NCT04434092|616870227|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
170688164|NCT04434092|616870228|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
170688165|NCT04434092|616870226|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
170688166|NCT04434092|616870227|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
170688167|NCT04434092|616870228|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
170688168|NCT04434092|616870226|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
170688169|NCT04434092|616870227|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
170688170|NCT04434092|616870228|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
170688171|NCT04434092|616870226|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
170688172|NCT04434092|616870227|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
170688173|NCT04434092|616870228|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
170688174|NCT04434092|616870226|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
170688175|NCT04434092|616870227|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
170688176|NCT04434092|616870228|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
170688177|NCT04434092|616870226|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
170688178|NCT04434092|616870227|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
170688179|NCT04434092|616870228|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
170688180|NCT04434092|616870226|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
170688181|NCT04434092|616870227|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
170688182|NCT04434092|616870228|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
170688183|NCT04559581|616870235|FG000|Overall Study|Adverse Event|130|||
170688184|NCT04559581|616870235|FG000|Overall Study|Adverse event / Patient's wish|15|||
170688185|NCT04559581|616870235|FG000|Overall Study|Adverse event / Other personal reasons|2|||
170688186|NCT04559581|616870235|FG000|Overall Study|Improved|2|||
170688187|NCT04559581|616870235|FG000|Overall Study|No visit after last visit|17|||
170688188|NCT04559581|616870235|FG000|Overall Study|No visit after last visit / Other personal reasons|3|||
170688189|NCT04559581|616870235|FG000|Overall Study|Other personal reasons|36|||
170688190|NCT04559581|616870235|FG000|Overall Study|Patient's wish|38|||
170688191|NCT02554812|616870236|FG000|Overall Study|Adverse Event|2|||
170688192|NCT02554812|616870237|FG001|Overall Study|Adverse Event|5|||
170688193|NCT02554812|616870238|FG002|Overall Study|Adverse Event|3|||
170688194|NCT02554812|616870239|FG003|Overall Study|Adverse Event|0|||
170688195|NCT02554812|616870240|FG004|Overall Study|Adverse Event|5|||
170688196|NCT02554812|616870241|FG005|Overall Study|Adverse Event|0|||
170688197|NCT02554812|616870242|FG006|Overall Study|Adverse Event|1|||
170688198|NCT02554812|616870243|FG007|Overall Study|Adverse Event|6|||
170688199|NCT02554812|616870244|FG008|Overall Study|Adverse Event|2|||
170688200|NCT02554812|616870245|FG009|Overall Study|Adverse Event|2|||
170688201|NCT02554812|616870246|FG010|Overall Study|Adverse Event|1|||
170688202|NCT02554812|616870247|FG011|Overall Study|Adverse Event|2|||
170688203|NCT02554812|616870248|FG012|Overall Study|Adverse Event|0|||
170688204|NCT02554812|616870249|FG013|Overall Study|Adverse Event|3|||
170688205|NCT02554812|616870250|FG014|Overall Study|Adverse Event|2|||
170688206|NCT02554812|616870251|FG015|Overall Study|Adverse Event|1|||
170688207|NCT02554812|616870252|FG016|Overall Study|Adverse Event|0|||
170688208|NCT02554812|616870253|FG017|Overall Study|Adverse Event|1|||
170688209|NCT02554812|616870254|FG018|Overall Study|Adverse Event|0|||
170688210|NCT02554812|616870255|FG019|Overall Study|Adverse Event|0|||
170688211|NCT02554812|616870256|FG020|Overall Study|Adverse Event|0|||
170688212|NCT02554812|616870257|FG021|Overall Study|Adverse Event|2|||
170688213|NCT02554812|616870258|FG022|Overall Study|Adverse Event|1|||
170688214|NCT02554812|616870259|FG023|Overall Study|Adverse Event|1|||
170688215|NCT02554812|616870260|FG024|Overall Study|Adverse Event|1|||
170688216|NCT02554812|616870261|FG025|Overall Study|Adverse Event|2|||
170688217|NCT02554812|616870262|FG026|Overall Study|Adverse Event|1|||
170688218|NCT02554812|616870236|FG000|Overall Study|Death|1|||
170688219|NCT02554812|616870237|FG001|Overall Study|Death|2|||
170688220|NCT02554812|616870238|FG002|Overall Study|Death|2|||
170688221|NCT02554812|616870239|FG003|Overall Study|Death|2|||
170688222|NCT02554812|616870240|FG004|Overall Study|Death|0|||
170688223|NCT02554812|616870241|FG005|Overall Study|Death|1|||
170688224|NCT02554812|616870242|FG006|Overall Study|Death|1|||
170688225|NCT02554812|616870243|FG007|Overall Study|Death|1|||
170688226|NCT02554812|616870244|FG008|Overall Study|Death|0|||
170688227|NCT02554812|616870245|FG009|Overall Study|Death|0|||
170688228|NCT02554812|616870246|FG010|Overall Study|Death|0|||
170688229|NCT02554812|616870247|FG011|Overall Study|Death|0|||
170688230|NCT02554812|616870248|FG012|Overall Study|Death|0|||
170688231|NCT02554812|616870249|FG013|Overall Study|Death|0|||
170688232|NCT02554812|616870250|FG014|Overall Study|Death|1|||
170688233|NCT02554812|616870251|FG015|Overall Study|Death|1|||
170688234|NCT02554812|616870252|FG016|Overall Study|Death|1|||
170688235|NCT02554812|616870253|FG017|Overall Study|Death|0|||
170688236|NCT02554812|616870254|FG018|Overall Study|Death|1|||
170688237|NCT02554812|616870255|FG019|Overall Study|Death|2|||
170688238|NCT02554812|616870256|FG020|Overall Study|Death|0|||
170688239|NCT02554812|616870257|FG021|Overall Study|Death|1|||
170688240|NCT02554812|616870258|FG022|Overall Study|Death|1|||
170688241|NCT02554812|616870259|FG023|Overall Study|Death|0|||
170688242|NCT02554812|616870260|FG024|Overall Study|Death|0|||
170688243|NCT02554812|616870261|FG025|Overall Study|Death|0|||
170688244|NCT02554812|616870262|FG026|Overall Study|Death|0|||
170688245|NCT02554812|616870236|FG000|Overall Study|Lost to Follow-up|0|||
170688246|NCT02554812|616870237|FG001|Overall Study|Lost to Follow-up|1|||
170688247|NCT02554812|616870238|FG002|Overall Study|Lost to Follow-up|0|||
170688248|NCT02554812|616870239|FG003|Overall Study|Lost to Follow-up|0|||
170688249|NCT02554812|616870240|FG004|Overall Study|Lost to Follow-up|0|||
170688250|NCT02554812|616870241|FG005|Overall Study|Lost to Follow-up|0|||
170688251|NCT02554812|616870242|FG006|Overall Study|Lost to Follow-up|0|||
170688252|NCT02554812|616870243|FG007|Overall Study|Lost to Follow-up|0|||
170688253|NCT02554812|616870244|FG008|Overall Study|Lost to Follow-up|0|||
170688254|NCT02554812|616870245|FG009|Overall Study|Lost to Follow-up|0|||
170688255|NCT02554812|616870246|FG010|Overall Study|Lost to Follow-up|0|||
170821714|NCT04203160|617354824|FG001|Overall Study|Sponsor Termination|0|||
170688256|NCT02554812|616870247|FG011|Overall Study|Lost to Follow-up|0|||
170688257|NCT02554812|616870248|FG012|Overall Study|Lost to Follow-up|0|||
170688258|NCT02554812|616870249|FG013|Overall Study|Lost to Follow-up|0|||
170688259|NCT02554812|616870250|FG014|Overall Study|Lost to Follow-up|0|||
170821715|NCT04203160|617354825|FG002|Overall Study|Sponsor Termination|0|||
170688260|NCT02554812|616870251|FG015|Overall Study|Lost to Follow-up|0|||
170688261|NCT02554812|616870252|FG016|Overall Study|Lost to Follow-up|0|||
170688262|NCT02554812|616870253|FG017|Overall Study|Lost to Follow-up|0|||
170688263|NCT02554812|616870254|FG018|Overall Study|Lost to Follow-up|0|||
170688264|NCT02554812|616870255|FG019|Overall Study|Lost to Follow-up|0|||
170688265|NCT02554812|616870256|FG020|Overall Study|Lost to Follow-up|0|||
170688266|NCT02554812|616870257|FG021|Overall Study|Lost to Follow-up|0|||
170688267|NCT02554812|616870258|FG022|Overall Study|Lost to Follow-up|0|||
170821716|NCT04203160|617354826|FG003|Overall Study|Sponsor Termination|0|||
170821717|NCT04203160|617354827|FG004|Overall Study|Sponsor Termination|0|||
170821718|NCT04203160|617354828|FG005|Overall Study|Sponsor Termination|0|||
170821719|NCT04203160|617354823|FG000|Overall Study|Physician Decision|3|||
170821720|NCT04203160|617354824|FG001|Overall Study|Physician Decision|2|||
170821721|NCT04203160|617354825|FG002|Overall Study|Physician Decision|0|||
170821722|NCT04203160|617354826|FG003|Overall Study|Physician Decision|0|||
170821723|NCT04203160|617354827|FG004|Overall Study|Physician Decision|0|||
170821724|NCT04203160|617354828|FG005|Overall Study|Physician Decision|0|||
170821725|NCT00679549|617354830|FG000|Overall Study|dropout|2|||
170821726|NCT00679549|617354831|FG001|Overall Study|dropout|4|||
170821727|NCT00679549|617354830|FG000|Overall Study|missing outcome echocardiograms|4|||
170821728|NCT00679549|617354831|FG001|Overall Study|missing outcome echocardiograms|5|||
170821729|NCT02744898|617354834|FG000|Overall Study|Progressive Disease|2|||
170821730|NCT02744898|617354834|FG000|Overall Study|Physician Decision|1|||
170821731|NCT02744898|617354834|FG000|Overall Study|Toxicity|1|||
170821732|NCT03023878|617354840|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
170821733|NCT03023878|617354840|FG000|Pre-Study Run-In Period|Death|1|||
170821734|NCT03023878|617354840|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
170821735|NCT03023878|617354840|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
170821736|NCT03023878|617354840|FG000|Treatment Period|Disease Progression|1|||
170821737|NCT03023878|617354840|FG000|Treatment Period|Withdrawal by Subject|1|||
170821738|NCT03023878|617354840|FG000|Treatment Period|Adverse Event|1|||
170821739|NCT03023878|617354840|FG000|Long Term Follow-Up Period|Death|2|||
170821740|NCT01812837|617354841|FG000|Overall Study|Lost to Follow-up|1|||
170821741|NCT01812837|617354842|FG001|Overall Study|Lost to Follow-up|1|||
170821742|NCT01812837|617354843|FG002|Overall Study|Lost to Follow-up|0|||
170821743|NCT01812837|617354841|FG000|Overall Study|Protocol Violation|1|||
170821744|NCT01812837|617354842|FG001|Overall Study|Protocol Violation|0|||
170821745|NCT01812837|617354843|FG002|Overall Study|Protocol Violation|0|||
170821746|NCT00288353|617354848|FG000|Overall Study|Lack of Efficacy|2|||
170821747|NCT00288353|617354849|FG001|Overall Study|Lack of Efficacy|2|||
170821748|NCT00288353|617354848|FG000|Overall Study|Withdrawal by Subject|5|||
170821749|NCT00288353|617354849|FG001|Overall Study|Withdrawal by Subject|5|||
170821750|NCT04115319|617354850|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
170821751|NCT04115319|617354851|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
170821752|NCT04115319|617354850|FG000|Overall Study|Withdrawal by participant|17|||
170688268|NCT02554812|616870259|FG023|Overall Study|Lost to Follow-up|0|||
170688269|NCT02554812|616870260|FG024|Overall Study|Lost to Follow-up|0|||
170688270|NCT02554812|616870261|FG025|Overall Study|Lost to Follow-up|0|||
170688271|NCT02554812|616870262|FG026|Overall Study|Lost to Follow-up|0|||
170688272|NCT02554812|616870236|FG000|Overall Study|Global deterioration of health status|4|||
170688273|NCT02554812|616870237|FG001|Overall Study|Global deterioration of health status|3|||
170821753|NCT04115319|617354851|FG001|Overall Study|Withdrawal by participant|9|||
170821754|NCT04115319|617354850|FG000|Overall Study|Geopolitical Conflict Related|2|||
170821755|NCT04115319|617354851|FG001|Overall Study|Geopolitical Conflict Related|1|||
170821756|NCT04115319|617354850|FG000|Overall Study|COVID-19 Related|1|||
170688274|NCT02554812|616870238|FG002|Overall Study|Global deterioration of health status|3|||
170688275|NCT02554812|616870239|FG003|Overall Study|Global deterioration of health status|2|||
170688276|NCT02554812|616870240|FG004|Overall Study|Global deterioration of health status|5|||
170688277|NCT02554812|616870241|FG005|Overall Study|Global deterioration of health status|0|||
170688278|NCT02554812|616870242|FG006|Overall Study|Global deterioration of health status|2|||
170821757|NCT04115319|617354851|FG001|Overall Study|COVID-19 Related|0|||
170821758|NCT04115319|617354850|FG000|Overall Study|Adverse Event|48|||
170821759|NCT04115319|617354851|FG001|Overall Study|Adverse Event|21|||
170688279|NCT02554812|616870243|FG007|Overall Study|Global deterioration of health status|1|||
170688280|NCT02554812|616870244|FG008|Overall Study|Global deterioration of health status|1|||
170688281|NCT02554812|616870245|FG009|Overall Study|Global deterioration of health status|1|||
170688282|NCT02554812|616870246|FG010|Overall Study|Global deterioration of health status|2|||
170688283|NCT02554812|616870247|FG011|Overall Study|Global deterioration of health status|1|||
170688284|NCT02554812|616870248|FG012|Overall Study|Global deterioration of health status|0|||
170688285|NCT02554812|616870249|FG013|Overall Study|Global deterioration of health status|0|||
170688286|NCT02554812|616870250|FG014|Overall Study|Global deterioration of health status|0|||
170688287|NCT02554812|616870251|FG015|Overall Study|Global deterioration of health status|1|||
170688288|NCT02554812|616870252|FG016|Overall Study|Global deterioration of health status|0|||
170688289|NCT02554812|616870253|FG017|Overall Study|Global deterioration of health status|0|||
170688290|NCT02554812|616870254|FG018|Overall Study|Global deterioration of health status|0|||
170688291|NCT02554812|616870255|FG019|Overall Study|Global deterioration of health status|0|||
170688292|NCT02554812|616870256|FG020|Overall Study|Global deterioration of health status|0|||
170688293|NCT02554812|616870257|FG021|Overall Study|Global deterioration of health status|0|||
170688294|NCT02554812|616870258|FG022|Overall Study|Global deterioration of health status|0|||
170688295|NCT02554812|616870259|FG023|Overall Study|Global deterioration of health status|0|||
170688296|NCT02554812|616870260|FG024|Overall Study|Global deterioration of health status|0|||
170688297|NCT02554812|616870261|FG025|Overall Study|Global deterioration of health status|0|||
170688298|NCT02554812|616870262|FG026|Overall Study|Global deterioration of health status|0|||
170688299|NCT02554812|616870236|FG000|Overall Study|Progressive disease|20|||
170688300|NCT02554812|616870237|FG001|Overall Study|Progressive disease|16|||
170688301|NCT02554812|616870238|FG002|Overall Study|Progressive disease|19|||
170688302|NCT02554812|616870239|FG003|Overall Study|Progressive disease|18|||
170688303|NCT02554812|616870240|FG004|Overall Study|Progressive disease|21|||
170688304|NCT02554812|616870241|FG005|Overall Study|Progressive disease|15|||
170688305|NCT02554812|616870242|FG006|Overall Study|Progressive disease|6|||
170688306|NCT02554812|616870243|FG007|Overall Study|Progressive disease|13|||
170688307|NCT02554812|616870244|FG008|Overall Study|Progressive disease|6|||
170688308|NCT02554812|616870245|FG009|Overall Study|Progressive disease|6|||
170688309|NCT02554812|616870246|FG010|Overall Study|Progressive disease|8|||
170821760|NCT04115319|617354850|FG000|Overall Study|Noncompliance with Study Drug|5|||
170821761|NCT04115319|617354851|FG001|Overall Study|Noncompliance with Study Drug|1|||
170821762|NCT04115319|617354850|FG000|Overall Study|Lack of Efficacy|6|||
170821763|NCT04115319|617354851|FG001|Overall Study|Lack of Efficacy|2|||
170821764|NCT04115319|617354850|FG000|Overall Study|Lost to Follow-up|6|||
170821765|NCT04115319|617354851|FG001|Overall Study|Lost to Follow-up|7|||
170821766|NCT04115319|617354850|FG000|Overall Study|Protocol Deviation|5|||
170821767|NCT04115319|617354851|FG001|Overall Study|Protocol Deviation|1|||
170821768|NCT04115319|617354850|FG000|Overall Study|Participant relocated|5|||
170821769|NCT04115319|617354851|FG001|Overall Study|Participant relocated|2|||
170688310|NCT02554812|616870247|FG011|Overall Study|Progressive disease|8|||
170688311|NCT02554812|616870248|FG012|Overall Study|Progressive disease|6|||
170821770|NCT04115319|617354850|FG000|Overall Study|Personal Reasons|0|||
170688312|NCT02554812|616870249|FG013|Overall Study|Progressive disease|10|||
170688313|NCT02554812|616870250|FG014|Overall Study|Progressive disease|20|||
170688314|NCT02554812|616870251|FG015|Overall Study|Progressive disease|6|||
170821771|NCT04115319|617354851|FG001|Overall Study|Personal Reasons|1|||
170821772|NCT04115319|617354850|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
170821773|NCT04115319|617354851|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
170821774|NCT04372186|617354852|FG000|Overall Study|Death|24|||
170821775|NCT04372186|617354853|FG001|Overall Study|Death|11|||
170821776|NCT04372186|617354852|FG000|Overall Study|Transferred to a different facility for care|0|||
170821777|NCT04372186|617354853|FG001|Overall Study|Transferred to a different facility for care|2|||
170821778|NCT04736472|617354854|FG000|Overall Study|Lost to Follow-up|1|||
170821779|NCT04736472|617354855|FG001|Overall Study|Lost to Follow-up|0|||
170821780|NCT04736472|617354856|FG002|Overall Study|Lost to Follow-up|0|||
170821781|NCT04736472|617354854|FG000|Overall Study|Withdrawal by Subject|2|||
170821782|NCT04736472|617354855|FG001|Overall Study|Withdrawal by Subject|0|||
170821783|NCT04736472|617354856|FG002|Overall Study|Withdrawal by Subject|0|||
170821784|NCT04736472|617354854|FG000|Overall Study|Protocol Violation|48|||
170821785|NCT04736472|617354855|FG001|Overall Study|Protocol Violation|0|||
170821786|NCT04736472|617354856|FG002|Overall Study|Protocol Violation|6|||
170821787|NCT02256488|617354857|FG000|Overall Study|Lost to Follow-up|6|||
170821788|NCT02256488|617354858|FG001|Overall Study|Lost to Follow-up|6|||
170821789|NCT02256488|617354859|FG002|Overall Study|Lost to Follow-up|9|||
170821790|NCT02256488|617354860|FG003|Overall Study|Lost to Follow-up|3|||
170821791|NCT02256488|617354857|FG000|Overall Study|OTHER|1|||
170821792|NCT02256488|617354858|FG001|Overall Study|OTHER|0|||
170821793|NCT02256488|617354859|FG002|Overall Study|OTHER|1|||
170821794|NCT02256488|617354860|FG003|Overall Study|OTHER|1|||
170821795|NCT02256488|617354857|FG000|Overall Study|Withdrawal by Subject|1|||
170821796|NCT02256488|617354858|FG001|Overall Study|Withdrawal by Subject|0|||
170821797|NCT02256488|617354859|FG002|Overall Study|Withdrawal by Subject|0|||
170821798|NCT02256488|617354860|FG003|Overall Study|Withdrawal by Subject|2|||
170821799|NCT02268526|617354861|FG000|Overall Study|Adverse Event|0|||
170821800|NCT02268526|617354862|FG001|Overall Study|Adverse Event|2|||
170821801|NCT02268526|617354863|FG002|Overall Study|Adverse Event|1|||
170821802|NCT02268526|617354861|FG000|Overall Study|Death|1|||
170821803|NCT02268526|617354862|FG001|Overall Study|Death|11|||
170821804|NCT02268526|617354863|FG002|Overall Study|Death|0|||
170821805|NCT02268526|617354861|FG000|Overall Study|protocol deviation|0|||
170821806|NCT02268526|617354862|FG001|Overall Study|protocol deviation|1|||
170821807|NCT02268526|617354863|FG002|Overall Study|protocol deviation|0|||
170821808|NCT02268526|617354861|FG000|Overall Study|Physician Decision|0|||
170821809|NCT02268526|617354862|FG001|Overall Study|Physician Decision|0|||
170821810|NCT02268526|617354863|FG002|Overall Study|Physician Decision|1|||
170821811|NCT02268526|617354861|FG000|Overall Study|Subject/guardian decision|0|||
170821812|NCT02268526|617354862|FG001|Overall Study|Subject/guardian decision|7|||
170821813|NCT02268526|617354863|FG002|Overall Study|Subject/guardian decision|3|||
170821814|NCT03214198|617354864|FG000|Overall Study|Case Report Forms Uncollected|18|||
170821815|NCT03214198|617354864|FG000|Overall Study|Protocol Deviation|18|||
170821816|NCT01636778|617354867|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
170821817|NCT01636778|617354868|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
170821818|NCT01636778|617354869|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
170821819|NCT01636778|617354867|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
170821820|NCT01636778|617354868|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
170821821|NCT01636778|617354869|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
170821822|NCT01636778|617354867|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
170821823|NCT01636778|617354868|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
170821824|NCT01636778|617354869|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
170821825|NCT01636778|617354867|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
170821826|NCT01636778|617354868|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
170821827|NCT01636778|617354869|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
170821828|NCT01636778|617354867|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
170821829|NCT01636778|617354868|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
170821830|NCT01636778|617354869|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
170821831|NCT01636778|617354867|FG000|Follow-up Period After Part 2|Other|0|||
170821832|NCT01636778|617354868|FG001|Follow-up Period After Part 2|Other|0|||
170821833|NCT01636778|617354869|FG002|Follow-up Period After Part 2|Other|1|||
170821834|NCT01636778|617354867|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
170821835|NCT01636778|617354868|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
170821836|NCT01636778|617354869|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
170821837|NCT01636778|617354867|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
170821838|NCT01636778|617354868|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
170821839|NCT01636778|617354869|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
170821840|NCT01157351|617355914|FG000|Overall Study|Adverse Event|5|||
170821841|NCT01157351|617355915|FG001|Overall Study|Adverse Event|4|||
170821842|NCT01157351|617355914|FG000|Overall Study|Death|1|||
170821843|NCT01157351|617355915|FG001|Overall Study|Death|0|||
170821844|NCT01157351|617355914|FG000|Overall Study|Lost to Follow-up|53|||
170688315|NCT02554812|616870252|FG016|Overall Study|Progressive disease|3|||
170688316|NCT02554812|616870253|FG017|Overall Study|Progressive disease|3|||
170688317|NCT02554812|616870254|FG018|Overall Study|Progressive disease|11|||
170688318|NCT02554812|616870255|FG019|Overall Study|Progressive disease|7|||
170688319|NCT02554812|616870256|FG020|Overall Study|Progressive disease|11|||
170688320|NCT02554812|616870257|FG021|Overall Study|Progressive disease|6|||
170688321|NCT02554812|616870258|FG022|Overall Study|Progressive disease|9|||
170688322|NCT02554812|616870259|FG023|Overall Study|Progressive disease|9|||
170688323|NCT02554812|616870260|FG024|Overall Study|Progressive disease|4|||
170688324|NCT02554812|616870261|FG025|Overall Study|Progressive disease|5|||
170688325|NCT02554812|616870262|FG026|Overall Study|Progressive disease|5|||
170688326|NCT02554812|616870236|FG000|Overall Study|Other|0|||
170688327|NCT02554812|616870237|FG001|Overall Study|Other|0|||
170821845|NCT01157351|617355915|FG001|Overall Study|Lost to Follow-up|55|||
170821846|NCT01157351|617355914|FG000|Overall Study|Withdrawal by Subject|37|||
170821847|NCT01157351|617355915|FG001|Overall Study|Withdrawal by Subject|27|||
170821848|NCT01157351|617355914|FG000|Overall Study|Physician Decision|5|||
170688328|NCT02554812|616870238|FG002|Overall Study|Other|2|||
170821849|NCT01157351|617355915|FG001|Overall Study|Physician Decision|4|||
170821850|NCT01157351|617355914|FG000|Overall Study|Protocol Violation|0|||
170821851|NCT01157351|617355915|FG001|Overall Study|Protocol Violation|1|||
170821852|NCT01157351|617355914|FG000|Overall Study|Other|32|||
170688329|NCT02554812|616870239|FG003|Overall Study|Other|3|||
170688330|NCT02554812|616870240|FG004|Overall Study|Other|2|||
170688331|NCT02554812|616870241|FG005|Overall Study|Other|1|||
170688332|NCT02554812|616870242|FG006|Overall Study|Other|0|||
170688333|NCT02554812|616870243|FG007|Overall Study|Other|0|||
170688334|NCT02554812|616870244|FG008|Overall Study|Other|1|||
170688335|NCT02554812|616870245|FG009|Overall Study|Other|1|||
170821853|NCT01157351|617355915|FG001|Overall Study|Other|36|||
170821854|NCT01157351|617355914|FG000|Overall Study|Noncompliance with Study Drug|0|||
170821855|NCT01157351|617355915|FG001|Overall Study|Noncompliance with Study Drug|3|||
170821856|NCT01157351|617355914|FG000|Overall Study|Randomized but not Treated|4|||
170688336|NCT02554812|616870246|FG010|Overall Study|Other|0|||
170688337|NCT02554812|616870247|FG011|Overall Study|Other|0|||
170688338|NCT02554812|616870248|FG012|Overall Study|Other|1|||
170688339|NCT02554812|616870249|FG013|Overall Study|Other|0|||
170688340|NCT02554812|616870250|FG014|Overall Study|Other|1|||
170688341|NCT02554812|616870251|FG015|Overall Study|Other|0|||
170821857|NCT01157351|617355915|FG001|Overall Study|Randomized but not Treated|2|||
170821858|NCT01589523|617355917|FG000|Overall Study|Withdrawal by Subject|1|||
170821859|NCT00792259|617355918|FG000|Overall Study|Poor Quality Scans|1|||
170821860|NCT00792259|617355919|FG001|Overall Study|Poor Quality Scans|0|||
170821861|NCT00792259|617355920|FG002|Overall Study|Poor Quality Scans|0|||
170821862|NCT00371462|617355921|FG000|Overall Study|Withdrawal by Subject|1|||
170821863|NCT00371462|617355922|FG001|Overall Study|Withdrawal by Subject|0|||
170821864|NCT00371462|617355921|FG000|Overall Study|Other|7|||
170821865|NCT00371462|617355922|FG001|Overall Study|Other|8|||
170688342|NCT02554812|616870252|FG016|Overall Study|Other|0|||
170688343|NCT02554812|616870253|FG017|Overall Study|Other|0|||
170688344|NCT02554812|616870254|FG018|Overall Study|Other|0|||
170688345|NCT02554812|616870255|FG019|Overall Study|Other|0|||
170688346|NCT02554812|616870256|FG020|Overall Study|Other|0|||
170688347|NCT02554812|616870257|FG021|Overall Study|Other|2|||
170688348|NCT02554812|616870258|FG022|Overall Study|Other|0|||
170688349|NCT02554812|616870259|FG023|Overall Study|Other|0|||
170688350|NCT02554812|616870260|FG024|Overall Study|Other|0|||
170688351|NCT02554812|616870261|FG025|Overall Study|Other|0|||
170688352|NCT02554812|616870262|FG026|Overall Study|Other|0|||
170688353|NCT02554812|616870236|FG000|Overall Study|Withdrawal by Subject|1|||
170688354|NCT02554812|616870237|FG001|Overall Study|Withdrawal by Subject|0|||
170688355|NCT02554812|616870238|FG002|Overall Study|Withdrawal by Subject|0|||
170688356|NCT02554812|616870239|FG003|Overall Study|Withdrawal by Subject|2|||
170688357|NCT02554812|616870240|FG004|Overall Study|Withdrawal by Subject|2|||
170688358|NCT02554812|616870241|FG005|Overall Study|Withdrawal by Subject|3|||
170688359|NCT02554812|616870242|FG006|Overall Study|Withdrawal by Subject|0|||
170688360|NCT02554812|616870243|FG007|Overall Study|Withdrawal by Subject|0|||
170688361|NCT02554812|616870244|FG008|Overall Study|Withdrawal by Subject|1|||
170821866|NCT03721978|617355923|FG000|Overall Study|Withdrawal by Subject|6|||
170821867|NCT03721978|617355924|FG001|Overall Study|Withdrawal by Subject|1|||
170821868|NCT03721978|617355923|FG000|Overall Study|Adverse Event|1|||
170688362|NCT02554812|616870245|FG009|Overall Study|Withdrawal by Subject|1|||
170688363|NCT02554812|616870246|FG010|Overall Study|Withdrawal by Subject|0|||
170688364|NCT02554812|616870247|FG011|Overall Study|Withdrawal by Subject|1|||
170688365|NCT02554812|616870248|FG012|Overall Study|Withdrawal by Subject|1|||
170688366|NCT02554812|616870249|FG013|Overall Study|Withdrawal by Subject|1|||
170688367|NCT02554812|616870250|FG014|Overall Study|Withdrawal by Subject|1|||
170688368|NCT02554812|616870251|FG015|Overall Study|Withdrawal by Subject|1|||
170688369|NCT02554812|616870252|FG016|Overall Study|Withdrawal by Subject|3|||
170688370|NCT02554812|616870253|FG017|Overall Study|Withdrawal by Subject|1|||
170688371|NCT02554812|616870254|FG018|Overall Study|Withdrawal by Subject|0|||
170821869|NCT03721978|617355924|FG001|Overall Study|Adverse Event|1|||
170821870|NCT03721978|617355923|FG000|Overall Study|Progressive Disease|1|||
170821871|NCT03721978|617355924|FG001|Overall Study|Progressive Disease|0|||
170821872|NCT03721978|617355923|FG000|Overall Study|Lost to Follow-up|5|||
170821873|NCT03721978|617355924|FG001|Overall Study|Lost to Follow-up|1|||
170821874|NCT03721978|617355923|FG000|Overall Study|Reason not Specified|0|||
170821875|NCT03721978|617355924|FG001|Overall Study|Reason not Specified|2|||
170821876|NCT05244226|617355925|FG000|Overall Study|Adverse Event|1|||
170821877|NCT05244226|617355926|FG001|Overall Study|Adverse Event|0|||
170821878|NCT05244226|617355927|FG002|Overall Study|Adverse Event|0|||
170821879|NCT05244226|617355925|FG000|Overall Study|Lost to Follow-up|0|||
170821880|NCT05244226|617355926|FG001|Overall Study|Lost to Follow-up|0|||
170821881|NCT05244226|617355927|FG002|Overall Study|Lost to Follow-up|1|||
170821882|NCT05244226|617355925|FG000|Overall Study|Protocol Violation|0|||
170821883|NCT05244226|617355926|FG001|Overall Study|Protocol Violation|2|||
170821884|NCT05244226|617355927|FG002|Overall Study|Protocol Violation|2|||
170821885|NCT02675998|617355928|FG000|8-Week Treatment Period|Adverse Event|6|||
170821886|NCT02675998|617355929|FG001|8-Week Treatment Period|Adverse Event|5|||
170821887|NCT02675998|617355930|FG002|8-Week Treatment Period|Adverse Event|6|||
170821888|NCT02675998|617355931|FG003|8-Week Treatment Period|Adverse Event|0|||
170688372|NCT02554812|616870255|FG019|Overall Study|Withdrawal by Subject|2|||
170688373|NCT02554812|616870256|FG020|Overall Study|Withdrawal by Subject|0|||
170688374|NCT02554812|616870257|FG021|Overall Study|Withdrawal by Subject|1|||
170688375|NCT02554812|616870258|FG022|Overall Study|Withdrawal by Subject|0|||
170821889|NCT02675998|617355928|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
170821890|NCT02675998|617355929|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
170821891|NCT02675998|617355930|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
170821892|NCT02675998|617355931|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
170821893|NCT02675998|617355928|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
170821894|NCT02675998|617355929|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
170821895|NCT02675998|617355930|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
170821896|NCT02675998|617355931|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
170821897|NCT02675998|617355928|FG000|8-Week Treatment Period|Physician Decision|1|||
170821898|NCT02675998|617355929|FG001|8-Week Treatment Period|Physician Decision|0|||
170821899|NCT02675998|617355930|FG002|8-Week Treatment Period|Physician Decision|2|||
170821900|NCT02675998|617355931|FG003|8-Week Treatment Period|Physician Decision|0|||
170821901|NCT02675998|617355928|FG000|8-Week Treatment Period|GI side Effects|1|||
170821902|NCT02675998|617355929|FG001|8-Week Treatment Period|GI side Effects|4|||
170821903|NCT02675998|617355930|FG002|8-Week Treatment Period|GI side Effects|2|||
170821904|NCT02675998|617355931|FG003|8-Week Treatment Period|GI side Effects|0|||
170821905|NCT02675998|617355928|FG000|8-Week Treatment Period|Protocol Violation|1|||
170821906|NCT02675998|617355929|FG001|8-Week Treatment Period|Protocol Violation|1|||
170821907|NCT02675998|617355930|FG002|8-Week Treatment Period|Protocol Violation|1|||
170821908|NCT02675998|617355931|FG003|8-Week Treatment Period|Protocol Violation|0|||
170821909|NCT02675998|617355928|FG000|8-Week Treatment Period|Other|3|||
170821910|NCT02675998|617355929|FG001|8-Week Treatment Period|Other|1|||
170821911|NCT02675998|617355930|FG002|8-Week Treatment Period|Other|2|||
170821912|NCT02675998|617355931|FG003|8-Week Treatment Period|Other|0|||
170821913|NCT02675998|617355928|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
170821914|NCT02675998|617355929|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
170821915|NCT02675998|617355930|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
170821916|NCT02675998|617355931|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
170821917|NCT02675998|617355928|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
170821918|NCT02675998|617355929|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
170821919|NCT02675998|617355930|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
170821920|NCT02675998|617355931|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
170821921|NCT02675998|617355928|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
170821922|NCT02675998|617355929|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
170821923|NCT02675998|617355930|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
170821924|NCT02675998|617355931|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
170821925|NCT02675998|617355928|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
170821926|NCT02675998|617355929|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
170821927|NCT02675998|617355930|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
170821928|NCT02675998|617355931|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
170821929|NCT02675998|617355928|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
170821930|NCT02675998|617355929|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
170821931|NCT02675998|617355930|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
170821932|NCT02675998|617355931|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
170821933|NCT00443898|617355934|FG000|Overall Study|Adverse Event|0|||
170821934|NCT00443898|617355935|FG001|Overall Study|Adverse Event|0|||
170821935|NCT00443898|617355936|FG002|Overall Study|Adverse Event|1|||
170821936|NCT00443898|617355937|FG003|Overall Study|Adverse Event|1|||
170688376|NCT02554812|616870259|FG023|Overall Study|Withdrawal by Subject|1|||
170688377|NCT02554812|616870260|FG024|Overall Study|Withdrawal by Subject|0|||
170688378|NCT02554812|616870261|FG025|Overall Study|Withdrawal by Subject|0|||
170688379|NCT02554812|616870262|FG026|Overall Study|Withdrawal by Subject|1|||
170688380|NCT02554812|616870236|FG000|Overall Study|Physician Decision|1|||
170688381|NCT02554812|616870237|FG001|Overall Study|Physician Decision|0|||
170688382|NCT02554812|616870238|FG002|Overall Study|Physician Decision|0|||
170688383|NCT02554812|616870239|FG003|Overall Study|Physician Decision|1|||
170688384|NCT02554812|616870240|FG004|Overall Study|Physician Decision|0|||
170688385|NCT02554812|616870241|FG005|Overall Study|Physician Decision|1|||
170688386|NCT02554812|616870242|FG006|Overall Study|Physician Decision|0|||
170688387|NCT02554812|616870243|FG007|Overall Study|Physician Decision|0|||
170688388|NCT02554812|616870244|FG008|Overall Study|Physician Decision|0|||
170688389|NCT02554812|616870245|FG009|Overall Study|Physician Decision|0|||
170688390|NCT02554812|616870246|FG010|Overall Study|Physician Decision|1|||
170688391|NCT02554812|616870247|FG011|Overall Study|Physician Decision|0|||
170688392|NCT02554812|616870248|FG012|Overall Study|Physician Decision|0|||
170688393|NCT02554812|616870249|FG013|Overall Study|Physician Decision|0|||
170688394|NCT02554812|616870250|FG014|Overall Study|Physician Decision|0|||
170688395|NCT02554812|616870251|FG015|Overall Study|Physician Decision|0|||
170688396|NCT02554812|616870252|FG016|Overall Study|Physician Decision|1|||
170688397|NCT02554812|616870253|FG017|Overall Study|Physician Decision|1|||
170688398|NCT02554812|616870254|FG018|Overall Study|Physician Decision|0|||
170688399|NCT02554812|616870255|FG019|Overall Study|Physician Decision|1|||
170688400|NCT02554812|616870256|FG020|Overall Study|Physician Decision|1|||
170688401|NCT02554812|616870257|FG021|Overall Study|Physician Decision|0|||
170688402|NCT02554812|616870258|FG022|Overall Study|Physician Decision|1|||
170688403|NCT02554812|616870259|FG023|Overall Study|Physician Decision|0|||
170688404|NCT02554812|616870260|FG024|Overall Study|Physician Decision|0|||
170688405|NCT02554812|616870261|FG025|Overall Study|Physician Decision|0|||
170688406|NCT02554812|616870262|FG026|Overall Study|Physician Decision|0|||
170688407|NCT02554812|616870236|FG000|Overall Study|Study terminated by sponsor|0|||
170688408|NCT02554812|616870237|FG001|Overall Study|Study terminated by sponsor|0|||
170688409|NCT02554812|616870238|FG002|Overall Study|Study terminated by sponsor|0|||
170688410|NCT02554812|616870239|FG003|Overall Study|Study terminated by sponsor|0|||
170688411|NCT02554812|616870240|FG004|Overall Study|Study terminated by sponsor|0|||
170688412|NCT02554812|616870241|FG005|Overall Study|Study terminated by sponsor|0|||
170688413|NCT02554812|616870242|FG006|Overall Study|Study terminated by sponsor|0|||
170688414|NCT02554812|616870243|FG007|Overall Study|Study terminated by sponsor|0|||
170688415|NCT02554812|616870244|FG008|Overall Study|Study terminated by sponsor|0|||
170688416|NCT02554812|616870245|FG009|Overall Study|Study terminated by sponsor|0|||
170688417|NCT02554812|616870246|FG010|Overall Study|Study terminated by sponsor|0|||
170688418|NCT02554812|616870247|FG011|Overall Study|Study terminated by sponsor|0|||
170688419|NCT02554812|616870248|FG012|Overall Study|Study terminated by sponsor|0|||
170688420|NCT02554812|616870249|FG013|Overall Study|Study terminated by sponsor|0|||
170688421|NCT02554812|616870250|FG014|Overall Study|Study terminated by sponsor|0|||
170688422|NCT02554812|616870251|FG015|Overall Study|Study terminated by sponsor|0|||
170688423|NCT02554812|616870252|FG016|Overall Study|Study terminated by sponsor|0|||
170688424|NCT02554812|616870253|FG017|Overall Study|Study terminated by sponsor|0|||
170688425|NCT02554812|616870254|FG018|Overall Study|Study terminated by sponsor|0|||
170688426|NCT02554812|616870255|FG019|Overall Study|Study terminated by sponsor|0|||
170688427|NCT02554812|616870256|FG020|Overall Study|Study terminated by sponsor|0|||
170688428|NCT02554812|616870257|FG021|Overall Study|Study terminated by sponsor|0|||
170688429|NCT02554812|616870258|FG022|Overall Study|Study terminated by sponsor|0|||
170688430|NCT02554812|616870259|FG023|Overall Study|Study terminated by sponsor|0|||
170688431|NCT02554812|616870260|FG024|Overall Study|Study terminated by sponsor|1|||
170688432|NCT02554812|616870261|FG025|Overall Study|Study terminated by sponsor|0|||
170688433|NCT02554812|616870262|FG026|Overall Study|Study terminated by sponsor|0|||
170688434|NCT02554812|616870236|FG000|Overall Study|No longer meets eligibility criteria|0|||
170688435|NCT02554812|616870237|FG001|Overall Study|No longer meets eligibility criteria|1|||
170688436|NCT02554812|616870238|FG002|Overall Study|No longer meets eligibility criteria|0|||
170688437|NCT02554812|616870239|FG003|Overall Study|No longer meets eligibility criteria|0|||
170688438|NCT02554812|616870240|FG004|Overall Study|No longer meets eligibility criteria|0|||
170688439|NCT02554812|616870241|FG005|Overall Study|No longer meets eligibility criteria|0|||
170688440|NCT02554812|616870242|FG006|Overall Study|No longer meets eligibility criteria|0|||
170688441|NCT02554812|616870243|FG007|Overall Study|No longer meets eligibility criteria|0|||
170688442|NCT02554812|616870244|FG008|Overall Study|No longer meets eligibility criteria|0|||
170688443|NCT02554812|616870245|FG009|Overall Study|No longer meets eligibility criteria|0|||
170688444|NCT02554812|616870246|FG010|Overall Study|No longer meets eligibility criteria|0|||
170688445|NCT02554812|616870247|FG011|Overall Study|No longer meets eligibility criteria|0|||
170688446|NCT02554812|616870248|FG012|Overall Study|No longer meets eligibility criteria|0|||
170821937|NCT00443898|617355934|FG000|Overall Study|Lack of Efficacy|2|||
170821938|NCT00443898|617355935|FG001|Overall Study|Lack of Efficacy|3|||
170821939|NCT00443898|617355936|FG002|Overall Study|Lack of Efficacy|3|||
170821940|NCT00443898|617355937|FG003|Overall Study|Lack of Efficacy|1|||
170821941|NCT00443898|617355934|FG000|Overall Study|Protocol Violation|1|||
170821942|NCT00443898|617355935|FG001|Overall Study|Protocol Violation|1|||
170821943|NCT00443898|617355936|FG002|Overall Study|Protocol Violation|1|||
170821944|NCT00443898|617355937|FG003|Overall Study|Protocol Violation|0|||
170821945|NCT00443898|617355934|FG000|Overall Study|Withdrawal by Subject|11|||
170821946|NCT00443898|617355935|FG001|Overall Study|Withdrawal by Subject|10|||
170821947|NCT00443898|617355936|FG002|Overall Study|Withdrawal by Subject|10|||
170821948|NCT00443898|617355937|FG003|Overall Study|Withdrawal by Subject|6|||
170821949|NCT00443898|617355934|FG000|Overall Study|Lost to Follow-up|10|||
170821950|NCT00443898|617355935|FG001|Overall Study|Lost to Follow-up|10|||
170821951|NCT00443898|617355936|FG002|Overall Study|Lost to Follow-up|14|||
170821952|NCT00443898|617355937|FG003|Overall Study|Lost to Follow-up|10|||
170821953|NCT00443898|617355934|FG000|Overall Study|Death|0|||
170821954|NCT00443898|617355935|FG001|Overall Study|Death|1|||
170821955|NCT00443898|617355936|FG002|Overall Study|Death|0|||
170821956|NCT00443898|617355937|FG003|Overall Study|Death|0|||
170821957|NCT04050722|617355939|FG000|Overall Study|Withdrawal by Subject|1|||
170821958|NCT04050722|617355940|FG001|Overall Study|Withdrawal by Subject|0|||
170821959|NCT00111839|617355941|FG000|Overall Study|Disease Progression|30|||
170821960|NCT00111839|617355942|FG001|Overall Study|Disease Progression|33|||
170821961|NCT00111839|617355943|FG002|Overall Study|Disease Progression|33|||
170821962|NCT00111839|617355941|FG000|Overall Study|Adverse Event|5|||
170821963|NCT00111839|617355942|FG001|Overall Study|Adverse Event|3|||
170821964|NCT00111839|617355943|FG002|Overall Study|Adverse Event|1|||
170821965|NCT00111839|617355941|FG000|Overall Study|Protocol Violation|2|||
170821966|NCT00111839|617355942|FG001|Overall Study|Protocol Violation|4|||
170821967|NCT00111839|617355943|FG002|Overall Study|Protocol Violation|2|||
170821968|NCT00111839|617355941|FG000|Overall Study|Death|1|||
170821969|NCT00111839|617355942|FG001|Overall Study|Death|1|||
170821970|NCT00111839|617355943|FG002|Overall Study|Death|6|||
170821971|NCT00111839|617355941|FG000|Overall Study|Withdrawal by Subject|2|||
170821972|NCT00111839|617355942|FG001|Overall Study|Withdrawal by Subject|2|||
170821973|NCT00111839|617355943|FG002|Overall Study|Withdrawal by Subject|2|||
170821974|NCT00111839|617355941|FG000|Overall Study|Lost to Follow-up|1|||
170821975|NCT00111839|617355942|FG001|Overall Study|Lost to Follow-up|0|||
170821976|NCT00111839|617355943|FG002|Overall Study|Lost to Follow-up|0|||
170821977|NCT00111839|617355941|FG000|Overall Study|Logistical Constraint|1|||
170821978|NCT00111839|617355942|FG001|Overall Study|Logistical Constraint|0|||
170821979|NCT00111839|617355943|FG002|Overall Study|Logistical Constraint|0|||
170821980|NCT00111839|617355941|FG000|Overall Study|Other|6|||
170821981|NCT00111839|617355942|FG001|Overall Study|Other|3|||
170821982|NCT00111839|617355943|FG002|Overall Study|Other|3|||
170821983|NCT00111839|617355941|FG000|Overall Study|Randomized but Not Treated|0|||
170821984|NCT00111839|617355942|FG001|Overall Study|Randomized but Not Treated|0|||
170821985|NCT00111839|617355943|FG002|Overall Study|Randomized but Not Treated|2|||
170821986|NCT00382408|617355944|FG000|Overall Study|Did not meet protocol requirement|3|||
170821987|NCT00382408|617355945|FG001|Overall Study|Did not meet protocol requirement|3|||
170821988|NCT00382408|617355944|FG000|Overall Study|Protocol Violation|2|||
170821989|NCT00382408|617355945|FG001|Overall Study|Protocol Violation|2|||
170821990|NCT00382408|617355944|FG000|Overall Study|Physician Decision|1|||
170821991|NCT00382408|617355945|FG001|Overall Study|Physician Decision|0|||
170821992|NCT00382408|617355944|FG000|Overall Study|Withdrawal by Subject|17|||
170821993|NCT00382408|617355945|FG001|Overall Study|Withdrawal by Subject|6|||
170821994|NCT00382408|617355944|FG000|Overall Study|Pregnancy|2|||
170821995|NCT00382408|617355945|FG001|Overall Study|Pregnancy|0|||
170688447|NCT02554812|616870249|FG013|Overall Study|No longer meets eligibility criteria|0|||
170688448|NCT02554812|616870250|FG014|Overall Study|No longer meets eligibility criteria|0|||
170688449|NCT02554812|616870251|FG015|Overall Study|No longer meets eligibility criteria|0|||
170688450|NCT02554812|616870252|FG016|Overall Study|No longer meets eligibility criteria|0|||
170688451|NCT02554812|616870253|FG017|Overall Study|No longer meets eligibility criteria|0|||
170688452|NCT02554812|616870254|FG018|Overall Study|No longer meets eligibility criteria|0|||
170688453|NCT02554812|616870255|FG019|Overall Study|No longer meets eligibility criteria|0|||
170688454|NCT02554812|616870256|FG020|Overall Study|No longer meets eligibility criteria|0|||
170688455|NCT02554812|616870257|FG021|Overall Study|No longer meets eligibility criteria|0|||
170688456|NCT02554812|616870258|FG022|Overall Study|No longer meets eligibility criteria|0|||
170688457|NCT02554812|616870259|FG023|Overall Study|No longer meets eligibility criteria|0|||
170688458|NCT02554812|616870260|FG024|Overall Study|No longer meets eligibility criteria|0|||
170688459|NCT02554812|616870261|FG025|Overall Study|No longer meets eligibility criteria|0|||
170688460|NCT02554812|616870262|FG026|Overall Study|No longer meets eligibility criteria|0|||
170821996|NCT00382408|617355944|FG000|Overall Study|Lost to Follow-up|19|||
170821997|NCT00382408|617355945|FG001|Overall Study|Lost to Follow-up|8|||
170821998|NCT00382408|617355944|FG000|Overall Study|Other|100|||
170821999|NCT00382408|617355945|FG001|Overall Study|Other|35|||
170822000|NCT00762723|617355946|FG000|Overall Study|Study Terminated slow enrollement|5|||
170822001|NCT00762723|617355947|FG001|Overall Study|Study Terminated slow enrollement|5|||
170822002|NCT00762723|617355948|FG002|Overall Study|Study Terminated slow enrollement|3|||
170822003|NCT01145417|617355949|FG000|Overall Study|Death|1|||
170822004|NCT01145417|617355950|FG001|Overall Study|Death|0|||
170822005|NCT01145417|617355949|FG000|Overall Study|Lost to Follow-up|2|||
170822006|NCT01145417|617355950|FG001|Overall Study|Lost to Follow-up|1|||
170822007|NCT01145417|617355949|FG000|Overall Study|Withdrawal by Subject|1|||
170822008|NCT01145417|617355950|FG001|Overall Study|Withdrawal by Subject|2|||
170822009|NCT01145417|617355949|FG000|Overall Study|Pregnancy|1|||
170822010|NCT01145417|617355950|FG001|Overall Study|Pregnancy|0|||
170822011|NCT01145417|617355949|FG000|Overall Study|Adverse Event|0|||
170822012|NCT01145417|617355950|FG001|Overall Study|Adverse Event|1|||
170822013|NCT01145417|617355949|FG000|Overall Study|Study terminated by sponsor|35|||
170822014|NCT01145417|617355950|FG001|Overall Study|Study terminated by sponsor|43|||
170822015|NCT01145417|617355949|FG000|Overall Study|Other|1|||
170822016|NCT01145417|617355950|FG001|Overall Study|Other|0|||
170822017|NCT03924947|617355951|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
170822018|NCT03924947|617355952|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
170822019|NCT03924947|617355953|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
170822020|NCT03924947|617355954|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
170822021|NCT03924947|617355955|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
170822022|NCT03924947|617355956|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
170822023|NCT00839306|617355957|FG000|Overall Study|Adverse Event|3|||
170822024|NCT00839306|617355958|FG001|Overall Study|Adverse Event|5|||
170822025|NCT00839306|617355957|FG000|Overall Study|Lost to Follow-up|6|||
170822026|NCT00839306|617355958|FG001|Overall Study|Lost to Follow-up|9|||
170822027|NCT00839306|617355957|FG000|Overall Study|Withdrawal by Subject|5|||
170822028|NCT00839306|617355958|FG001|Overall Study|Withdrawal by Subject|7|||
170822029|NCT00839306|617355957|FG000|Overall Study|Lack of Efficacy|5|||
170822030|NCT00839306|617355958|FG001|Overall Study|Lack of Efficacy|4|||
170822031|NCT00839306|617355957|FG000|Overall Study|Other|6|||
170822032|NCT00839306|617355958|FG001|Overall Study|Other|18|||
170822033|NCT01812707|617355959|FG000|Overall Study|Adverse Event|0|||
170822034|NCT01812707|617355960|FG001|Overall Study|Adverse Event|0|||
170822035|NCT01812707|617355961|FG002|Overall Study|Adverse Event|0|||
170822036|NCT01812707|617355962|FG003|Overall Study|Adverse Event|2|||
170822037|NCT01812707|617355959|FG000|Overall Study|Poor compliance to protocol|1|||
170822038|NCT01812707|617355960|FG001|Overall Study|Poor compliance to protocol|0|||
170822039|NCT01812707|617355961|FG002|Overall Study|Poor compliance to protocol|0|||
170822040|NCT01812707|617355962|FG003|Overall Study|Poor compliance to protocol|0|||
170822041|NCT01812707|617355959|FG000|Overall Study|Consent withdrawn by participant|1|||
170822042|NCT01812707|617355960|FG001|Overall Study|Consent withdrawn by participant|0|||
170822043|NCT01812707|617355961|FG002|Overall Study|Consent withdrawn by participant|0|||
170822044|NCT01812707|617355962|FG003|Overall Study|Consent withdrawn by participant|0|||
170822045|NCT01066897|617355964|FG000|Overall Study|Withdrawal by Subject|1|||
170822046|NCT01066897|617355965|FG001|Overall Study|Withdrawal by Subject|0|||
170822047|NCT01066897|617355964|FG000|Overall Study|stopped study after developing the flu.|1|||
170822048|NCT01066897|617355965|FG001|Overall Study|stopped study after developing the flu.|0|||
170822049|NCT01631825|617355966|FG000|Overall Study|Adverse Event|42|||
170822050|NCT01631825|617355966|FG000|Overall Study|Lack of Efficacy|7|||
170822051|NCT01631825|617355966|FG000|Overall Study|Withdrawal by Subject|9|||
170822052|NCT01631825|617355966|FG000|Overall Study|Protocol Violation|4|||
170822053|NCT01631825|617355966|FG000|Overall Study|Discontinuation criteria|1|||
170822054|NCT01631825|617355966|FG000|Overall Study|Physician Decision|2|||
170822055|NCT02110225|617355967|FG000|Overall Study|Lost to Follow-up|0|||
170688461|NCT00936910|616871187|FG000|Overall Study|Lack of Efficacy|3|||
170688462|NCT03020407|616871188|FG000|Overall Study|Withdrawal by Subject|2|||
170688463|NCT03020407|616871189|FG001|Overall Study|Withdrawal by Subject|1|||
170688464|NCT03020407|616871188|FG000|Overall Study|Lost to Follow-up|2|||
170688465|NCT03020407|616871189|FG001|Overall Study|Lost to Follow-up|3|||
170688466|NCT03020407|616871188|FG000|Overall Study|Protocol Violation|0|||
170688467|NCT03020407|616871189|FG001|Overall Study|Protocol Violation|1|||
170688468|NCT02699554|616871190|FG000|Overall Study|Lost to Follow-up|9|||
170688469|NCT00788151|616871191|FG000|Overall Study|Other adverse event|0|||
170688470|NCT00788151|616871192|FG001|Overall Study|Other adverse event|2|||
170688471|NCT00788151|616871191|FG000|Overall Study|Protocol Violation|0|||
170688472|NCT00788151|616871192|FG001|Overall Study|Protocol Violation|1|||
170688473|NCT00788151|616871191|FG000|Overall Study|Withdrawal by Subject|13|||
170688474|NCT00788151|616871192|FG001|Overall Study|Withdrawal by Subject|6|||
170688475|NCT00788151|616871191|FG000|Overall Study|Enrolled but not treated|1|||
170688476|NCT00788151|616871192|FG001|Overall Study|Enrolled but not treated|1|||
170688477|NCT00503009|616871193|FG000|Overall Study|Protocol Violation|1|||
170688478|NCT00503009|616871194|FG001|Overall Study|Protocol Violation|0|||
170688479|NCT00503009|616871195|FG002|Overall Study|Protocol Violation|1|||
170688480|NCT00503009|616871193|FG000|Overall Study|Withdrawal by Subject|0|||
170688481|NCT00503009|616871194|FG001|Overall Study|Withdrawal by Subject|1|||
170688482|NCT00503009|616871195|FG002|Overall Study|Withdrawal by Subject|1|||
170688483|NCT00503009|616871193|FG000|Overall Study|Physician Decision|0|||
170688484|NCT00503009|616871194|FG001|Overall Study|Physician Decision|1|||
170688485|NCT00503009|616871195|FG002|Overall Study|Physician Decision|1|||
170688486|NCT00065507|616871197|FG000|Overall Study|Death|16|||
170688487|NCT00065507|616871198|FG001|Overall Study|Death|17|||
170688488|NCT00065507|616871197|FG000|Overall Study|Adverse Event|4|||
170688489|NCT00065507|616871198|FG001|Overall Study|Adverse Event|3|||
170688490|NCT00065507|616871197|FG000|Overall Study|Lack of Efficacy|0|||
170688491|NCT00065507|616871198|FG001|Overall Study|Lack of Efficacy|6|||
170688492|NCT00065507|616871197|FG000|Overall Study|Poor/Non-compliance|3|||
170688493|NCT00065507|616871198|FG001|Overall Study|Poor/Non-compliance|2|||
170688494|NCT00065507|616871197|FG000|Overall Study|Lost to Follow-up|3|||
170688495|NCT00065507|616871198|FG001|Overall Study|Lost to Follow-up|0|||
170688496|NCT00065507|616871197|FG000|Overall Study|Subject Withdrew Consent|2|||
170688497|NCT00065507|616871198|FG001|Overall Study|Subject Withdrew Consent|1|||
170688498|NCT00065507|616871197|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
170688499|NCT00065507|616871198|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
170688500|NCT01349803|616871199|FG000|Overall Study|Adverse Event|0|||
170688501|NCT01349803|616871200|FG001|Overall Study|Adverse Event|0|||
170688502|NCT01349803|616871201|FG002|Overall Study|Adverse Event|0|||
170688503|NCT01349803|616871202|FG003|Overall Study|Adverse Event|2|||
170688504|NCT01349803|616871199|FG000|Overall Study|Withdrawal by Subject|1|||
170688505|NCT01349803|616871200|FG001|Overall Study|Withdrawal by Subject|0|||
170688506|NCT01349803|616871201|FG002|Overall Study|Withdrawal by Subject|0|||
170688507|NCT01349803|616871202|FG003|Overall Study|Withdrawal by Subject|0|||
170688508|NCT01349803|616871199|FG000|Overall Study|Protocol-specified criteria|0|||
170688509|NCT01349803|616871200|FG001|Overall Study|Protocol-specified criteria|1|||
170688510|NCT01349803|616871201|FG002|Overall Study|Protocol-specified criteria|3|||
170688511|NCT01349803|616871202|FG003|Overall Study|Protocol-specified criteria|0|||
170688512|NCT01851720|616871203|FG000|Overall Study|Lost to Follow-up|0|||
170688513|NCT01851720|616871204|FG001|Overall Study|Lost to Follow-up|1|||
170688514|NCT02389998|616871211|FG000|Overall Study|car accident|1|||
170688515|NCT02389998|616871212|FG001|Overall Study|car accident|0|||
170688516|NCT03525574|616871215|FG000|Overall Study|Adverse Event|15|||
170688517|NCT03525574|616871216|FG001|Overall Study|Adverse Event|0|||
170688518|NCT03525574|616871215|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
170688519|NCT03525574|616871216|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
170688520|NCT03525574|616871215|FG000|Overall Study|Lost to Follow-up|4|||
170688521|NCT03525574|616871216|FG001|Overall Study|Lost to Follow-up|0|||
170688522|NCT03525574|616871215|FG000|Overall Study|Commercial drug is Available for participant|48|||
170688523|NCT03525574|616871216|FG001|Overall Study|Commercial drug is Available for participant|0|||
170688524|NCT03525574|616871215|FG000|Overall Study|Death|1|||
170688525|NCT03525574|616871216|FG001|Overall Study|Death|0|||
170688526|NCT03525574|616871215|FG000|Overall Study|Other non-compliance|2|||
170688527|NCT03525574|616871216|FG001|Overall Study|Other non-compliance|0|||
170688528|NCT03525574|616871215|FG000|Overall Study|Physician Decision|6|||
170688529|NCT03525574|616871216|FG001|Overall Study|Physician Decision|0|||
170688530|NCT03525574|616871215|FG000|Overall Study|Other|58|||
170688531|NCT03525574|616871216|FG001|Overall Study|Other|0|||
170688532|NCT03525574|616871215|FG000|Overall Study|Enrolled but never dosed|1|||
170688533|NCT03525574|616871216|FG001|Overall Study|Enrolled but never dosed|0|||
170688534|NCT03525574|616871215|FG000|Overall Study|Not enrolled in 105 study|0|||
170688535|NCT03525574|616871216|FG001|Overall Study|Not enrolled in 105 study|3|||
170688536|NCT04741074|616871219|FG000|Overall Study|Withdrawal by Subject|1|||
170688537|NCT04741074|616871220|FG001|Overall Study|Withdrawal by Subject|1|||
170688538|NCT04741074|616871219|FG000|Overall Study|Study terminated prematurely|1|||
170688539|NCT04741074|616871220|FG001|Overall Study|Study terminated prematurely|0|||
170688540|NCT01770379|616871221|FG000|Overall Study|Technical issues|1|||
170688541|NCT01770379|616871222|FG001|Overall Study|Technical issues|0|||
170688542|NCT01770379|616871223|FG002|Overall Study|Technical issues|0|||
170688543|NCT01770379|616871221|FG000|Overall Study|Withdrawal by Subject|7|||
170688544|NCT01770379|616871222|FG001|Overall Study|Withdrawal by Subject|10|||
170688545|NCT01770379|616871223|FG002|Overall Study|Withdrawal by Subject|7|||
170688546|NCT01770379|616871221|FG000|Overall Study|study terminated by sponsor|22|||
170688547|NCT01770379|616871222|FG001|Overall Study|study terminated by sponsor|23|||
170688548|NCT01770379|616871223|FG002|Overall Study|study terminated by sponsor|22|||
170688549|NCT01770379|616871221|FG000|Overall Study|Protocol Violation|0|||
170688550|NCT01770379|616871222|FG001|Overall Study|Protocol Violation|1|||
170688551|NCT01770379|616871223|FG002|Overall Study|Protocol Violation|1|||
170688552|NCT01770379|616871221|FG000|Overall Study|Physician Decision|0|||
170688553|NCT01770379|616871222|FG001|Overall Study|Physician Decision|1|||
170688554|NCT01770379|616871223|FG002|Overall Study|Physician Decision|2|||
170688555|NCT01770379|616871221|FG000|Overall Study|Lost to Follow-up|0|||
170688556|NCT01770379|616871222|FG001|Overall Study|Lost to Follow-up|0|||
170688557|NCT01770379|616871223|FG002|Overall Study|Lost to Follow-up|2|||
170688558|NCT01770379|616871221|FG000|Overall Study|Lack of Efficacy|8|||
170688559|NCT01770379|616871222|FG001|Overall Study|Lack of Efficacy|6|||
170688560|NCT01770379|616871223|FG002|Overall Study|Lack of Efficacy|6|||
170688561|NCT01770379|616871221|FG000|Overall Study|Adverse Event|1|||
170688562|NCT01770379|616871222|FG001|Overall Study|Adverse Event|3|||
170688563|NCT01770379|616871223|FG002|Overall Study|Adverse Event|2|||
170688564|NCT00778700|616871224|FG000|Overall Study|Adverse Event|6|||
170688565|NCT00778700|616871225|FG001|Overall Study|Adverse Event|1|||
170688566|NCT00778700|616871226|FG002|Overall Study|Adverse Event|3|||
170688567|NCT00778700|616871227|FG003|Overall Study|Adverse Event|5|||
170688568|NCT00778700|616871224|FG000|Overall Study|Protocol Violation|1|||
170688569|NCT00778700|616871225|FG001|Overall Study|Protocol Violation|1|||
170688570|NCT00778700|616871226|FG002|Overall Study|Protocol Violation|0|||
170688571|NCT00778700|616871227|FG003|Overall Study|Protocol Violation|0|||
170688572|NCT00778700|616871224|FG000|Overall Study|Subject Withdrew Consent|6|||
170688573|NCT00778700|616871225|FG001|Overall Study|Subject Withdrew Consent|4|||
170688574|NCT00778700|616871226|FG002|Overall Study|Subject Withdrew Consent|1|||
170688575|NCT00778700|616871227|FG003|Overall Study|Subject Withdrew Consent|4|||
170688576|NCT00778700|616871224|FG000|Overall Study|Lost to Follow-up|3|||
170688577|NCT00778700|616871225|FG001|Overall Study|Lost to Follow-up|1|||
170688578|NCT00778700|616871226|FG002|Overall Study|Lost to Follow-up|0|||
170688579|NCT00778700|616871227|FG003|Overall Study|Lost to Follow-up|1|||
170688580|NCT00778700|616871224|FG000|Overall Study|Reason not Specified|2|||
170688581|NCT00778700|616871225|FG001|Overall Study|Reason not Specified|0|||
170688582|NCT00778700|616871226|FG002|Overall Study|Reason not Specified|1|||
170688583|NCT00778700|616871227|FG003|Overall Study|Reason not Specified|3|||
170688584|NCT00778700|616871224|FG000|Overall Study|Other|0|||
170688585|NCT00778700|616871225|FG001|Overall Study|Other|0|||
170688586|NCT00778700|616871226|FG002|Overall Study|Other|1|||
170688587|NCT00778700|616871227|FG003|Overall Study|Other|0|||
170688588|NCT04745884|616871232|FG000|Overall Study|Excessive Signal Feedback-Uninterpretable Data|3|||
170688589|NCT00453544|616871233|FG000|Overall Study|Withdrawal by Subject|1|||
170688590|NCT00453544|616871234|FG001|Overall Study|Withdrawal by Subject|0|||
170688591|NCT00453544|616871235|FG002|Overall Study|Withdrawal by Subject|0|||
170688592|NCT00453544|616871236|FG003|Overall Study|Withdrawal by Subject|0|||
170688593|NCT00453544|616871233|FG000|Overall Study|Primary outcome measure not completed|1|||
170688594|NCT00453544|616871234|FG001|Overall Study|Primary outcome measure not completed|1|||
170688595|NCT00453544|616871235|FG002|Overall Study|Primary outcome measure not completed|0|||
170688596|NCT00453544|616871236|FG003|Overall Study|Primary outcome measure not completed|1|||
170688597|NCT01405742|616871239|FG000|Overall Study|Lost to Follow-up|1|||
170688598|NCT01405742|616871240|FG001|Overall Study|Lost to Follow-up|0|||
170688599|NCT03428360|616871241|FG000|Overall Study|Informed consent withdrawn|5|||
170688600|NCT03428360|616871241|FG000|Overall Study|Withdrawal by Subject|4|||
170688601|NCT03428360|616871241|FG000|Overall Study|Lost to Follow-up|5|||
170688602|NCT03428360|616871241|FG000|Overall Study|Physician Decision|2|||
170688603|NCT03428360|616871241|FG000|Overall Study|Informed consent withdrawn|5|||
170688604|NCT03428360|616871241|FG000|Overall Study|Study terminated by sponsor|10|||
170688605|NCT03428360|616871241|FG000|Overall Study|Non-compliant with study|1|||
170688606|NCT03428360|616871241|FG000|Overall Study|Non-compliant with study drug|3|||
170688607|NCT03428360|616871241|FG000|Overall Study|Death|3|||
170688608|NCT03428360|616871241|FG000|Overall Study|Adverse Event|1|||
170688609|NCT03428360|616871241|FG000|Overall Study|Not on antiepileptic drug|1|||
170688610|NCT02028065|616871242|FG000|Randomization Through Start Treatment|Not treated|1|||
170688611|NCT02028065|616871243|FG001|Randomization Through Start Treatment|Not treated|3|||
170822056|NCT02110225|617355968|FG001|Overall Study|Lost to Follow-up|1|||
170688612|NCT02028065|616871244|FG002|Randomization Through Start Treatment|Not treated|3|||
170688613|NCT02028065|616871242|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
170688614|NCT02028065|616871243|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
170688615|NCT02028065|616871244|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
170688616|NCT02028065|616871242|FG000|Treatment Through Study Completion|Physician Decision|1|||
170688617|NCT02028065|616871243|FG001|Treatment Through Study Completion|Physician Decision|0|||
170688618|NCT02028065|616871244|FG002|Treatment Through Study Completion|Physician Decision|0|||
170688619|NCT02028065|616871242|FG000|Treatment Through Study Completion|Protocol Violation|1|||
170688620|NCT02028065|616871243|FG001|Treatment Through Study Completion|Protocol Violation|4|||
170688621|NCT02028065|616871244|FG002|Treatment Through Study Completion|Protocol Violation|0|||
170688622|NCT02028065|616871242|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
170688623|NCT02028065|616871243|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
170688624|NCT02028065|616871244|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
170688625|NCT02028065|616871242|FG000|Treatment Through Study Completion|Adverse Event|3|||
170688626|NCT02028065|616871243|FG001|Treatment Through Study Completion|Adverse Event|3|||
170688627|NCT02028065|616871244|FG002|Treatment Through Study Completion|Adverse Event|5|||
170688628|NCT02107482|616871250|FG000|Overall Study|inconveinence|2|||
170688629|NCT02107482|616871250|FG000|Overall Study|Lost to Follow-up|1|||
170688630|NCT02107482|616871250|FG000|Overall Study|Lack of Efficacy|1|||
170688631|NCT04868890|616871251|FG000|Overall Study|Death|2|||
170688632|NCT04868890|616871252|FG001|Overall Study|Death|1|||
170688633|NCT04868890|616871251|FG000|Overall Study|Withdrawal by Subject|1|||
170688634|NCT04868890|616871252|FG001|Overall Study|Withdrawal by Subject|5|||
170688635|NCT00576927|616871257|FG000|Clinical Assessment|Lack of Efficacy|24|||
170688636|NCT00576927|616871257|FG000|Clinical Assessment|Death|1|||
170688637|NCT00576927|616871257|FG000|Clinical Assessment|Withdrawal by Subject|10|||
170688638|NCT00576927|616871257|FG000|Clinical Assessment|Physician Decision|1|||
170688639|NCT00576927|616871257|FG000|Baseline|Physician Decision|9|||
170688640|NCT00576927|616871257|FG000|Baseline|Medication Change by PCP of subject|1|||
170688641|NCT00576927|616871257|FG000|Baseline|Withdrawal by Subject|3|||
170688642|NCT00576927|616871257|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
170688643|NCT00576927|616871257|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
170688644|NCT00576927|616871257|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
170688645|NCT00576927|616871257|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
170688646|NCT00576927|616871257|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
170688647|NCT03128892|616871258|FG000|Overall Study|Withdrawal by Subject|2|||
170688648|NCT03128892|616871258|FG000|Overall Study|Physician Decision|1|||
170688649|NCT01189812|616871259|FG000|Overall Study|Withdrawal by Subject|2|||
170688650|NCT01189812|616871260|FG001|Overall Study|Withdrawal by Subject|3|||
170688651|NCT01189812|616871259|FG000|Overall Study|Adverse Event|1|||
170688652|NCT01189812|616871260|FG001|Overall Study|Adverse Event|0|||
170688653|NCT01189812|616871259|FG000|Overall Study|Out of Window|4|||
170688654|NCT01189812|616871260|FG001|Overall Study|Out of Window|3|||
170688655|NCT01189812|616871259|FG000|Overall Study|Moved out of State|1|||
170688656|NCT01189812|616871260|FG001|Overall Study|Moved out of State|2|||
170688657|NCT02970318|616871261|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
170688658|NCT02970318|616871262|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
170688659|NCT02970318|616871263|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
170688660|NCT02970318|616871264|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
170688661|NCT02970318|616871261|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
170688662|NCT02970318|616871262|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
170688663|NCT02970318|616871263|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
170688664|NCT02970318|616871264|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
170688665|NCT02970318|616871261|FG000|Overall for Arm A & Main for Arm B|Death|41|||
170688666|NCT02970318|616871262|FG001|Overall for Arm A & Main for Arm B|Death|33|||
170688667|NCT02970318|616871263|FG002|Overall for Arm A & Main for Arm B|Death|0|||
170688668|NCT02970318|616871264|FG003|Overall for Arm A & Main for Arm B|Death|0|||
170688669|NCT02970318|616871261|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
170688670|NCT02970318|616871262|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
170688671|NCT02970318|616871263|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
170688672|NCT02970318|616871264|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
170688673|NCT02970318|616871261|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
170688674|NCT02970318|616871262|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
170688675|NCT02970318|616871263|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
170688676|NCT02970318|616871264|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
170688677|NCT02970318|616871261|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
170688678|NCT02970318|616871262|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
170822057|NCT02110225|617355969|FG002|Overall Study|Lost to Follow-up|0|||
170688679|NCT02970318|616871263|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
170688680|NCT02970318|616871264|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
170688681|NCT02970318|616871261|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
170688682|NCT02970318|616871262|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
170688683|NCT02970318|616871263|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
170688684|NCT02970318|616871264|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
170688685|NCT02747004|616871265|FG000|Overall Study|Withdrawal by Subject|8|||
170688686|NCT02747004|616871266|FG001|Overall Study|Withdrawal by Subject|5|||
170688687|NCT02747004|616871267|FG002|Overall Study|Withdrawal by Subject|4|||
170688688|NCT02747004|616871265|FG000|Overall Study|Lost to Follow-up|1|||
170688689|NCT02747004|616871266|FG001|Overall Study|Lost to Follow-up|2|||
170688690|NCT02747004|616871267|FG002|Overall Study|Lost to Follow-up|2|||
170688691|NCT02747004|616871265|FG000|Overall Study|on study treatment/follow-up|48|||
170688692|NCT02747004|616871266|FG001|Overall Study|on study treatment/follow-up|42|||
170688693|NCT02747004|616871267|FG002|Overall Study|on study treatment/follow-up|41|||
170688694|NCT04860830|616871268|FG000|Overall Study|Adverse Event|8|||
170688695|NCT04860830|616871269|FG001|Overall Study|Adverse Event|18|||
170688696|NCT04860830|616871268|FG000|Overall Study|Perceived lack of efficacy|1|||
170688697|NCT04860830|616871269|FG001|Overall Study|Perceived lack of efficacy|6|||
170688698|NCT04860830|616871268|FG000|Overall Study|Change of residence|4|||
170688699|NCT04860830|616871269|FG001|Overall Study|Change of residence|2|||
170688700|NCT04860830|616871268|FG000|Overall Study|Burden of study procedures|2|||
170688701|NCT04860830|616871269|FG001|Overall Study|Burden of study procedures|4|||
170688702|NCT04860830|616871268|FG000|Overall Study|No reason available|3|||
170688703|NCT04860830|616871269|FG001|Overall Study|No reason available|2|||
170688704|NCT04860830|616871268|FG000|Overall Study|Subject decision|9|||
170688705|NCT04860830|616871269|FG001|Overall Study|Subject decision|12|||
170688706|NCT04860830|616871268|FG000|Overall Study|Physician Decision|1|||
170688707|NCT04860830|616871269|FG001|Overall Study|Physician Decision|0|||
170688708|NCT04860830|616871268|FG000|Overall Study|Other than listed|2|||
170688709|NCT04860830|616871269|FG001|Overall Study|Other than listed|3|||
170688710|NCT04860830|616871268|FG000|Overall Study|Not treated|1|||
170688711|NCT04860830|616871269|FG001|Overall Study|Not treated|0|||
170688712|NCT04860830|616871268|FG000|Overall Study|Randomized in error and not treated|1|||
170688713|NCT04860830|616871269|FG001|Overall Study|Randomized in error and not treated|1|||
170688714|NCT04076059|616871270|FG000|Double Blind Phase|Progressive disease|22|||
170688715|NCT04076059|616871271|FG001|Double Blind Phase|Progressive disease|26|||
170688716|NCT04076059|616871272|FG002|Double Blind Phase|Progressive disease|0|||
170688717|NCT04076059|616871270|FG000|Double Blind Phase|Withdrawal by Subject|4|||
170688718|NCT04076059|616871271|FG001|Double Blind Phase|Withdrawal by Subject|11|||
170688719|NCT04076059|616871272|FG002|Double Blind Phase|Withdrawal by Subject|0|||
170688720|NCT04076059|616871270|FG000|Double Blind Phase|Death|1|||
170688721|NCT04076059|616871271|FG001|Double Blind Phase|Death|1|||
170688722|NCT04076059|616871272|FG002|Double Blind Phase|Death|0|||
170688723|NCT04076059|616871270|FG000|Double Blind Phase|Lost to Follow-up|1|||
170688724|NCT04076059|616871271|FG001|Double Blind Phase|Lost to Follow-up|0|||
170688725|NCT04076059|616871272|FG002|Double Blind Phase|Lost to Follow-up|0|||
170688726|NCT04076059|616871270|FG000|Double Blind Phase|Adverse Event|5|||
170688727|NCT04076059|616871271|FG001|Double Blind Phase|Adverse Event|1|||
170688728|NCT04076059|616871272|FG002|Double Blind Phase|Adverse Event|0|||
170688729|NCT04076059|616871270|FG000|Double Blind Phase|Ongoing Participants|82|||
170688730|NCT04076059|616871271|FG001|Double Blind Phase|Ongoing Participants|18|||
170688731|NCT04076059|616871272|FG002|Double Blind Phase|Ongoing Participants|0|||
170688732|NCT04076059|616871270|FG000|Double Blind Phase|Miscellaneous|3|||
170688733|NCT04076059|616871271|FG001|Double Blind Phase|Miscellaneous|1|||
170688734|NCT04076059|616871272|FG002|Double Blind Phase|Miscellaneous|0|||
170688735|NCT04076059|616871270|FG000|Double Blind Phase|Protocol Deviation|1|||
170688736|NCT04076059|616871271|FG001|Double Blind Phase|Protocol Deviation|1|||
170688737|NCT04076059|616871272|FG002|Double Blind Phase|Protocol Deviation|0|||
170688738|NCT04076059|616871270|FG000|Double Blind Phase|Did not take study drug|1|||
170688739|NCT04076059|616871271|FG001|Double Blind Phase|Did not take study drug|1|||
170688740|NCT04076059|616871272|FG002|Double Blind Phase|Did not take study drug|0|||
170688741|NCT04076059|616871270|FG000|Open Label Phase|Progressive disease|0|||
170688742|NCT04076059|616871271|FG001|Open Label Phase|Progressive disease|0|||
170688743|NCT04076059|616871272|FG002|Open Label Phase|Progressive disease|7|||
170688744|NCT04076059|616871270|FG000|Open Label Phase|Withdrawal by Subject|0|||
170688745|NCT04076059|616871271|FG001|Open Label Phase|Withdrawal by Subject|0|||
170688746|NCT04076059|616871272|FG002|Open Label Phase|Withdrawal by Subject|3|||
170688747|NCT04076059|616871270|FG000|Open Label Phase|Death|0|||
170688748|NCT04076059|616871271|FG001|Open Label Phase|Death|0|||
170688749|NCT04076059|616871272|FG002|Open Label Phase|Death|2|||
170688750|NCT04076059|616871270|FG000|Open Label Phase|Ongoing Participants|0|||
170688751|NCT04076059|616871271|FG001|Open Label Phase|Ongoing Participants|0|||
170688752|NCT04076059|616871272|FG002|Open Label Phase|Ongoing Participants|11|||
170688753|NCT04409457|616871274|FG000|Screening Prior to Randomization|Screening fail prior to randomization|16|||
170688754|NCT04409457|616871275|FG001|Screening Prior to Randomization|Screening fail prior to randomization|13|||
170688755|NCT04409457|616871276|FG002|Screening Prior to Randomization|Screening fail prior to randomization|0|||
170688756|NCT04409457|616871277|FG003|Screening Prior to Randomization|Screening fail prior to randomization|0|||
170688757|NCT04409457|616871278|FG004|Screening Prior to Randomization|Screening fail prior to randomization|0|||
170688758|NCT04409457|616871279|FG005|Screening Prior to Randomization|Screening fail prior to randomization|0|||
170688759|NCT04409457|616871274|FG000|Screening Prior to Randomization|Withdrawal by Subject|2|||
170688760|NCT04409457|616871275|FG001|Screening Prior to Randomization|Withdrawal by Subject|1|||
170688761|NCT04409457|616871276|FG002|Screening Prior to Randomization|Withdrawal by Subject|0|||
170688762|NCT04409457|616871277|FG003|Screening Prior to Randomization|Withdrawal by Subject|0|||
170688763|NCT04409457|616871278|FG004|Screening Prior to Randomization|Withdrawal by Subject|0|||
170688764|NCT04409457|616871279|FG005|Screening Prior to Randomization|Withdrawal by Subject|0|||
170688765|NCT04409457|616871274|FG000|Randomization|Withdrawal by Subject|0|||
170688766|NCT04409457|616871275|FG001|Randomization|Withdrawal by Subject|0|||
170688767|NCT04409457|616871276|FG002|Randomization|Withdrawal by Subject|0|||
170688768|NCT04409457|616871277|FG003|Randomization|Withdrawal by Subject|0|||
170688769|NCT04409457|616871278|FG004|Randomization|Withdrawal by Subject|1|||
170688770|NCT04409457|616871279|FG005|Randomization|Withdrawal by Subject|0|||
170688771|NCT04409457|616871274|FG000|Randomization|Incidental MRI finding at scan 1|0|||
170688772|NCT04409457|616871275|FG001|Randomization|Incidental MRI finding at scan 1|0|||
170688773|NCT04409457|616871276|FG002|Randomization|Incidental MRI finding at scan 1|0|||
170688774|NCT04409457|616871277|FG003|Randomization|Incidental MRI finding at scan 1|1|||
170688775|NCT04409457|616871278|FG004|Randomization|Incidental MRI finding at scan 1|0|||
170688776|NCT04409457|616871279|FG005|Randomization|Incidental MRI finding at scan 1|1|||
170688777|NCT04409457|616871274|FG000|Randomization|Technical/equipment error at scan 1|0|||
170688778|NCT04409457|616871275|FG001|Randomization|Technical/equipment error at scan 1|0|||
170688779|NCT04409457|616871276|FG002|Randomization|Technical/equipment error at scan 1|0|||
170688780|NCT04409457|616871277|FG003|Randomization|Technical/equipment error at scan 1|0|||
170688781|NCT04409457|616871278|FG004|Randomization|Technical/equipment error at scan 1|0|||
170688782|NCT04409457|616871279|FG005|Randomization|Technical/equipment error at scan 1|1|||
170688783|NCT03827798|616871280|FG000|Treatment Epoch|Adverse Event|1|||
170688784|NCT03827798|616871281|FG001|Treatment Epoch|Adverse Event|1|||
170688785|NCT03827798|616871282|FG002|Treatment Epoch|Adverse Event|1|||
170688786|NCT03827798|616871283|FG003|Treatment Epoch|Adverse Event|1|||
170688787|NCT03827798|616871284|FG004|Treatment Epoch|Adverse Event|1|||
170688788|NCT03827798|616871285|FG005|Treatment Epoch|Adverse Event|0|||
170688789|NCT03827798|616871286|FG006|Treatment Epoch|Adverse Event|0|||
170688790|NCT03827798|616871287|FG007|Treatment Epoch|Adverse Event|3|||
170688791|NCT03827798|616871288|FG008|Treatment Epoch|Adverse Event|0|||
170688792|NCT03827798|616871289|FG009|Treatment Epoch|Adverse Event|0|||
170688793|NCT03827798|616871290|FG010|Treatment Epoch|Adverse Event|0|||
170688794|NCT03827798|616871280|FG000|Treatment Epoch|Physician Decision|1|||
170688795|NCT03827798|616871281|FG001|Treatment Epoch|Physician Decision|0|||
170688796|NCT03827798|616871282|FG002|Treatment Epoch|Physician Decision|1|||
170688797|NCT03827798|616871283|FG003|Treatment Epoch|Physician Decision|2|||
170688798|NCT03827798|616871284|FG004|Treatment Epoch|Physician Decision|1|||
170688799|NCT03827798|616871285|FG005|Treatment Epoch|Physician Decision|0|||
170688800|NCT03827798|616871286|FG006|Treatment Epoch|Physician Decision|0|||
170688801|NCT03827798|616871287|FG007|Treatment Epoch|Physician Decision|0|||
170688802|NCT03827798|616871288|FG008|Treatment Epoch|Physician Decision|0|||
170688803|NCT03827798|616871289|FG009|Treatment Epoch|Physician Decision|0|||
170688804|NCT03827798|616871290|FG010|Treatment Epoch|Physician Decision|0|||
170688805|NCT03827798|616871280|FG000|Treatment Epoch|Protocol Deviation|0|||
170688806|NCT03827798|616871281|FG001|Treatment Epoch|Protocol Deviation|0|||
170688807|NCT03827798|616871282|FG002|Treatment Epoch|Protocol Deviation|1|||
170688808|NCT03827798|616871283|FG003|Treatment Epoch|Protocol Deviation|0|||
170688809|NCT03827798|616871284|FG004|Treatment Epoch|Protocol Deviation|0|||
170688810|NCT03827798|616871285|FG005|Treatment Epoch|Protocol Deviation|0|||
170688811|NCT03827798|616871286|FG006|Treatment Epoch|Protocol Deviation|0|||
170688812|NCT03827798|616871287|FG007|Treatment Epoch|Protocol Deviation|0|||
170688813|NCT03827798|616871288|FG008|Treatment Epoch|Protocol Deviation|0|||
170688814|NCT03827798|616871289|FG009|Treatment Epoch|Protocol Deviation|0|||
170688815|NCT03827798|616871290|FG010|Treatment Epoch|Protocol Deviation|0|||
170688816|NCT03827798|616871280|FG000|Treatment Epoch|Withdrawal by Subject|2|||
170688817|NCT03827798|616871281|FG001|Treatment Epoch|Withdrawal by Subject|3|||
170688818|NCT03827798|616871282|FG002|Treatment Epoch|Withdrawal by Subject|4|||
170688819|NCT03827798|616871283|FG003|Treatment Epoch|Withdrawal by Subject|1|||
170688820|NCT03827798|616871284|FG004|Treatment Epoch|Withdrawal by Subject|2|||
170688821|NCT03827798|616871285|FG005|Treatment Epoch|Withdrawal by Subject|1|||
170688822|NCT03827798|616871286|FG006|Treatment Epoch|Withdrawal by Subject|4|||
170688823|NCT03827798|616871287|FG007|Treatment Epoch|Withdrawal by Subject|3|||
170688824|NCT03827798|616871288|FG008|Treatment Epoch|Withdrawal by Subject|2|||
170688825|NCT03827798|616871289|FG009|Treatment Epoch|Withdrawal by Subject|8|||
170688826|NCT03827798|616871290|FG010|Treatment Epoch|Withdrawal by Subject|1|||
170688827|NCT03827798|616871280|FG000|Treatment Epoch|Lost to Follow-up|0|||
170688828|NCT03827798|616871281|FG001|Treatment Epoch|Lost to Follow-up|0|||
170688829|NCT03827798|616871282|FG002|Treatment Epoch|Lost to Follow-up|0|||
170688830|NCT03827798|616871283|FG003|Treatment Epoch|Lost to Follow-up|0|||
170688831|NCT03827798|616871284|FG004|Treatment Epoch|Lost to Follow-up|0|||
170688832|NCT03827798|616871285|FG005|Treatment Epoch|Lost to Follow-up|0|||
170688833|NCT03827798|616871286|FG006|Treatment Epoch|Lost to Follow-up|0|||
170688834|NCT03827798|616871287|FG007|Treatment Epoch|Lost to Follow-up|1|||
170688835|NCT03827798|616871288|FG008|Treatment Epoch|Lost to Follow-up|1|||
170688836|NCT03827798|616871289|FG009|Treatment Epoch|Lost to Follow-up|1|||
170688837|NCT03827798|616871290|FG010|Treatment Epoch|Lost to Follow-up|0|||
170688838|NCT03827798|616871280|FG000|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688839|NCT03827798|616871281|FG001|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688840|NCT03827798|616871282|FG002|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688841|NCT03827798|616871283|FG003|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688842|NCT03827798|616871284|FG004|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688843|NCT03827798|616871285|FG005|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688844|NCT03827798|616871286|FG006|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688845|NCT03827798|616871287|FG007|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688846|NCT03827798|616871288|FG008|Entered Post-treatment Follow-up|Follow up ongoing|0|||
170688847|NCT03827798|616871289|FG009|Entered Post-treatment Follow-up|Follow up ongoing|21|||
170688848|NCT03827798|616871290|FG010|Entered Post-treatment Follow-up|Follow up ongoing|9|||
170688849|NCT03827798|616871280|FG000|Entered Post-treatment Follow-up|Lost to Follow-up|1|||
170688850|NCT03827798|616871281|FG001|Entered Post-treatment Follow-up|Lost to Follow-up|0|||
170688851|NCT03827798|616871282|FG002|Entered Post-treatment Follow-up|Lost to Follow-up|1|||
170688852|NCT03827798|616871283|FG003|Entered Post-treatment Follow-up|Lost to Follow-up|1|||
170688853|NCT03827798|616871284|FG004|Entered Post-treatment Follow-up|Lost to Follow-up|2|||
170688854|NCT03827798|616871285|FG005|Entered Post-treatment Follow-up|Lost to Follow-up|0|||
170688855|NCT03827798|616871286|FG006|Entered Post-treatment Follow-up|Lost to Follow-up|0|||
170688856|NCT03827798|616871287|FG007|Entered Post-treatment Follow-up|Lost to Follow-up|2|||
170688857|NCT03827798|616871288|FG008|Entered Post-treatment Follow-up|Lost to Follow-up|0|||
170688858|NCT03827798|616871289|FG009|Entered Post-treatment Follow-up|Lost to Follow-up|0|||
170688859|NCT03827798|616871290|FG010|Entered Post-treatment Follow-up|Lost to Follow-up|0|||
170688860|NCT03827798|616871280|FG000|Entered Post-treatment Follow-up|Withdrawal by Subject|1|||
170688861|NCT03827798|616871281|FG001|Entered Post-treatment Follow-up|Withdrawal by Subject|1|||
170688862|NCT03827798|616871282|FG002|Entered Post-treatment Follow-up|Withdrawal by Subject|1|||
170688863|NCT03827798|616871283|FG003|Entered Post-treatment Follow-up|Withdrawal by Subject|0|||
170688864|NCT03827798|616871284|FG004|Entered Post-treatment Follow-up|Withdrawal by Subject|0|||
170688865|NCT03827798|616871285|FG005|Entered Post-treatment Follow-up|Withdrawal by Subject|2|||
170688866|NCT03827798|616871286|FG006|Entered Post-treatment Follow-up|Withdrawal by Subject|0|||
170688867|NCT03827798|616871287|FG007|Entered Post-treatment Follow-up|Withdrawal by Subject|0|||
170688868|NCT03827798|616871288|FG008|Entered Post-treatment Follow-up|Withdrawal by Subject|0|||
170688869|NCT03827798|616871289|FG009|Entered Post-treatment Follow-up|Withdrawal by Subject|2|||
170688870|NCT03827798|616871290|FG010|Entered Post-treatment Follow-up|Withdrawal by Subject|0|||
170688871|NCT05662306|616871291|FG000|Overall Study|Sponsor terminated and PI withdrew participant|1|||
170688872|NCT04995029|616871292|FG000|Induction Phase|Did not meet eligibility criteria|5|||
170688873|NCT04995029|616871293|FG001|Induction Phase|Did not meet eligibility criteria|2|||
170688874|NCT04995029|616871294|FG002|Induction Phase|Did not meet eligibility criteria|0|||
170688875|NCT04995029|616871295|FG003|Induction Phase|Did not meet eligibility criteria|0|||
170688876|NCT04995029|616871292|FG000|Induction Phase|Withdrawal by Subject|85|||
170688877|NCT04995029|616871293|FG001|Induction Phase|Withdrawal by Subject|42|||
170688878|NCT04995029|616871294|FG002|Induction Phase|Withdrawal by Subject|0|||
170688879|NCT04995029|616871295|FG003|Induction Phase|Withdrawal by Subject|0|||
170688880|NCT04995029|616871292|FG000|Induction Phase|Lost to Follow-up|103|||
170688881|NCT04995029|616871293|FG001|Induction Phase|Lost to Follow-up|67|||
170688882|NCT04995029|616871294|FG002|Induction Phase|Lost to Follow-up|0|||
170688883|NCT04995029|616871295|FG003|Induction Phase|Lost to Follow-up|0|||
170688884|NCT04995029|616871292|FG000|Induction Phase|Adverse Event|5|||
170688885|NCT04995029|616871293|FG001|Induction Phase|Adverse Event|3|||
170688886|NCT04995029|616871294|FG002|Induction Phase|Adverse Event|0|||
170688887|NCT04995029|616871295|FG003|Induction Phase|Adverse Event|0|||
170688888|NCT04995029|616871292|FG000|Induction Phase|Physician Decision|11|||
170688889|NCT04995029|616871293|FG001|Induction Phase|Physician Decision|8|||
170688890|NCT04995029|616871294|FG002|Induction Phase|Physician Decision|0|||
170822058|NCT03441789|617355975|FG000|Overall Study|Withdrawal by Subject|1|||
170822059|NCT03441789|617355976|FG001|Overall Study|Withdrawal by Subject|1|||
170688891|NCT04995029|616871295|FG003|Induction Phase|Physician Decision|0|||
170688892|NCT04995029|616871292|FG000|Induction Phase|Incarceration|6|||
170822060|NCT03441789|617355975|FG000|Overall Study|Adverse Event|0|||
170822061|NCT03441789|617355976|FG001|Overall Study|Adverse Event|1|||
170688893|NCT04995029|616871293|FG001|Induction Phase|Incarceration|3|||
170688894|NCT04995029|616871294|FG002|Induction Phase|Incarceration|0|||
170688895|NCT04995029|616871295|FG003|Induction Phase|Incarceration|0|||
170688896|NCT04995029|616871292|FG000|Induction Phase|Not otherwise described|5|||
170688897|NCT04995029|616871293|FG001|Induction Phase|Not otherwise described|5|||
170688898|NCT04995029|616871294|FG002|Induction Phase|Not otherwise described|0|||
170688899|NCT04995029|616871295|FG003|Induction Phase|Not otherwise described|0|||
170688900|NCT04995029|616871292|FG000|Maintenance Phase|Lost to Follow-up|0|||
170688901|NCT04995029|616871293|FG001|Maintenance Phase|Lost to Follow-up|0|||
170688902|NCT04995029|616871294|FG002|Maintenance Phase|Lost to Follow-up|51|||
170688903|NCT04995029|616871295|FG003|Maintenance Phase|Lost to Follow-up|44|||
170688904|NCT04995029|616871292|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
170688905|NCT04995029|616871293|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
170688906|NCT04995029|616871294|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
170688907|NCT04995029|616871295|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
170688908|NCT04995029|616871292|FG000|Maintenance Phase|Adverse Event|0|||
170688909|NCT04995029|616871293|FG001|Maintenance Phase|Adverse Event|0|||
170688910|NCT04995029|616871294|FG002|Maintenance Phase|Adverse Event|0|||
170688911|NCT04995029|616871295|FG003|Maintenance Phase|Adverse Event|1|||
170688912|NCT04995029|616871292|FG000|Maintenance Phase|Physician Decision|0|||
170688913|NCT04995029|616871293|FG001|Maintenance Phase|Physician Decision|0|||
170688914|NCT04995029|616871294|FG002|Maintenance Phase|Physician Decision|8|||
170688915|NCT04995029|616871295|FG003|Maintenance Phase|Physician Decision|4|||
170688916|NCT04995029|616871292|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170688917|NCT04995029|616871293|FG001|Maintenance Phase|Withdrawal by Subject|0|||
170688918|NCT04995029|616871294|FG002|Maintenance Phase|Withdrawal by Subject|17|||
170688919|NCT04995029|616871295|FG003|Maintenance Phase|Withdrawal by Subject|31|||
170688920|NCT04995029|616871292|FG000|Maintenance Phase|Incarceration|0|||
170688921|NCT04995029|616871293|FG001|Maintenance Phase|Incarceration|0|||
170688922|NCT04995029|616871294|FG002|Maintenance Phase|Incarceration|4|||
170688923|NCT04995029|616871295|FG003|Maintenance Phase|Incarceration|3|||
170688924|NCT04995029|616871292|FG000|Maintenance Phase|Not otherwise described|0|||
170688925|NCT04995029|616871293|FG001|Maintenance Phase|Not otherwise described|0|||
170688926|NCT04995029|616871294|FG002|Maintenance Phase|Not otherwise described|2|||
170688927|NCT04995029|616871295|FG003|Maintenance Phase|Not otherwise described|3|||
170688928|NCT04995029|616871292|FG000|Maintenance Phase|Pregnancy|0|||
170688929|NCT04995029|616871293|FG001|Maintenance Phase|Pregnancy|0|||
170688930|NCT04995029|616871294|FG002|Maintenance Phase|Pregnancy|2|||
170688931|NCT04995029|616871295|FG003|Maintenance Phase|Pregnancy|2|||
170688932|NCT04708886|616872479|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
170688933|NCT04708886|616872479|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
170688934|NCT00773292|616872480|FG000|Treatment 48 Weeks|Adverse Event|1|||
170688935|NCT00773292|616872480|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
170688936|NCT01853046|616872481|FG000|Overall Study|Withdrawal by Subject|1|||
170688937|NCT01853046|616872482|FG001|Overall Study|Withdrawal by Subject|1|||
170688938|NCT01853046|616872481|FG000|Overall Study|Adverse Event|4|||
170688939|NCT01853046|616872482|FG001|Overall Study|Adverse Event|2|||
170688940|NCT01853046|616872481|FG000|Overall Study|Disease progression|13|||
170688941|NCT01853046|616872482|FG001|Overall Study|Disease progression|3|||
170688942|NCT00708162|616872484|FG000|Randomized Phase|Randomized but Not Treated|7|||
170688943|NCT00708162|616872485|FG001|Randomized Phase|Randomized but Not Treated|5|||
170688944|NCT00708162|616872484|FG000|Randomized Phase|Participant Noncompliance|40|||
170688945|NCT00708162|616872485|FG001|Randomized Phase|Participant Noncompliance|32|||
170688946|NCT00708162|616872484|FG000|Randomized Phase|Lost to Follow-up|34|||
170688947|NCT00708162|616872485|FG001|Randomized Phase|Lost to Follow-up|34|||
170688948|NCT00708162|616872484|FG000|Randomized Phase|Withdrew Consent|31|||
170688949|NCT00708162|616872485|FG001|Randomized Phase|Withdrew Consent|22|||
170688950|NCT00708162|616872484|FG000|Randomized Phase|Lack of Efficacy|14|||
170688951|NCT00708162|616872485|FG001|Randomized Phase|Lack of Efficacy|19|||
170688952|NCT00708162|616872484|FG000|Randomized Phase|Protocol Violation|10|||
170688953|NCT00708162|616872485|FG001|Randomized Phase|Protocol Violation|11|||
170688954|NCT00708162|616872484|FG000|Randomized Phase|Adverse Event|8|||
170822062|NCT03441789|617355975|FG000|Overall Study|Protocol Violation|0|||
170822063|NCT03441789|617355976|FG001|Overall Study|Protocol Violation|1|||
170688955|NCT00708162|616872485|FG001|Randomized Phase|Adverse Event|12|||
170688956|NCT00708162|616872484|FG000|Randomized Phase|Investigator's Discretion|7|||
170688957|NCT00708162|616872485|FG001|Randomized Phase|Investigator's Discretion|10|||
170688958|NCT00708162|616872484|FG000|Randomized Phase|Death|2|||
170688959|NCT00708162|616872485|FG001|Randomized Phase|Death|9|||
170688960|NCT00708162|616872484|FG000|Randomized Phase|Pregnancy|3|||
170688961|NCT00708162|616872485|FG001|Randomized Phase|Pregnancy|0|||
170688962|NCT00708162|616872484|FG000|Open-Label Phase|Lost to Follow-up|10|||
170688963|NCT00708162|616872485|FG001|Open-Label Phase|Lost to Follow-up|8|||
170688964|NCT00708162|616872484|FG000|Open-Label Phase|Withdrew Consent|12|||
170688965|NCT00708162|616872485|FG001|Open-Label Phase|Withdrew Consent|6|||
170688966|NCT00708162|616872484|FG000|Open-Label Phase|Participant Noncompliance|7|||
170688967|NCT00708162|616872485|FG001|Open-Label Phase|Participant Noncompliance|7|||
170688968|NCT00708162|616872484|FG000|Open-Label Phase|Lack of Efficacy|7|||
170688969|NCT00708162|616872485|FG001|Open-Label Phase|Lack of Efficacy|4|||
170688970|NCT00708162|616872484|FG000|Open-Label Phase|Investigator's Discretion|3|||
170688971|NCT00708162|616872485|FG001|Open-Label Phase|Investigator's Discretion|2|||
170688972|NCT00708162|616872484|FG000|Open-Label Phase|Death|3|||
170688973|NCT00708162|616872485|FG001|Open-Label Phase|Death|1|||
170688974|NCT00708162|616872484|FG000|Open-Label Phase|Adverse Event|1|||
170688975|NCT00708162|616872485|FG001|Open-Label Phase|Adverse Event|2|||
170688976|NCT00708162|616872484|FG000|Open-Label Phase|Other|1|||
170688977|NCT00708162|616872485|FG001|Open-Label Phase|Other|0|||
170688978|NCT01266460|616872486|FG000|Overall Study|Adverse Event|3|||
170688979|NCT01266460|616872486|FG000|Overall Study|Withdrawal by Subject|5|||
170688980|NCT01266460|616872486|FG000|Overall Study|Disease Progression|18|||
170688981|NCT01266460|616872486|FG000|Overall Study|Not otherwise specified|8|||
170688982|NCT01132547|616872491|FG000|Overall Study|Withdrawal by Subject|3|||
170688983|NCT01132547|616872492|FG001|Overall Study|Withdrawal by Subject|1|||
170688984|NCT01132547|616872491|FG000|Overall Study|Death|1|||
170688985|NCT01132547|616872492|FG001|Overall Study|Death|0|||
170688986|NCT04210310|616872493|FG000|Overall Study|Lost to Follow-up|32|||
170688987|NCT04210310|616872494|FG001|Overall Study|Lost to Follow-up|1|||
170688988|NCT05407675|616872495|FG000|Overall Study|Withdrawal by Subject|0|||
170688989|NCT05407675|616872496|FG001|Overall Study|Withdrawal by Subject|2|||
170688990|NCT05407675|616872497|FG002|Overall Study|Withdrawal by Subject|3|||
170688991|NCT05407675|616872498|FG003|Overall Study|Withdrawal by Subject|5|||
170688992|NCT05407675|616872499|FG004|Overall Study|Withdrawal by Subject|0|||
170688993|NCT05407675|616872500|FG005|Overall Study|Withdrawal by Subject|2|||
170688994|NCT05407675|616872501|FG006|Overall Study|Withdrawal by Subject|0|||
170688995|NCT05407675|616872502|FG007|Overall Study|Withdrawal by Subject|0|||
170688996|NCT05407675|616872503|FG008|Overall Study|Withdrawal by Subject|2|||
170688997|NCT05407675|616872504|FG009|Overall Study|Withdrawal by Subject|0|||
170688998|NCT05407675|616872505|FG010|Overall Study|Withdrawal by Subject|1|||
170688999|NCT05407675|616872506|FG011|Overall Study|Withdrawal by Subject|0|||
170689000|NCT05407675|616872507|FG012|Overall Study|Withdrawal by Subject|0|||
170689001|NCT05407675|616872495|FG000|Overall Study|Site terminated by sponsor|0|||
170689002|NCT05407675|616872496|FG001|Overall Study|Site terminated by sponsor|0|||
170689003|NCT05407675|616872497|FG002|Overall Study|Site terminated by sponsor|1|||
170689004|NCT05407675|616872498|FG003|Overall Study|Site terminated by sponsor|0|||
170689005|NCT05407675|616872499|FG004|Overall Study|Site terminated by sponsor|2|||
170689006|NCT05407675|616872500|FG005|Overall Study|Site terminated by sponsor|0|||
170689007|NCT05407675|616872501|FG006|Overall Study|Site terminated by sponsor|1|||
170689008|NCT05407675|616872502|FG007|Overall Study|Site terminated by sponsor|0|||
170689009|NCT05407675|616872503|FG008|Overall Study|Site terminated by sponsor|0|||
170689010|NCT05407675|616872504|FG009|Overall Study|Site terminated by sponsor|2|||
170689011|NCT05407675|616872505|FG010|Overall Study|Site terminated by sponsor|2|||
170689012|NCT05407675|616872506|FG011|Overall Study|Site terminated by sponsor|2|||
170689013|NCT05407675|616872507|FG012|Overall Study|Site terminated by sponsor|1|||
170689014|NCT05407675|616872495|FG000|Overall Study|Disease Progression|0|||
170689015|NCT05407675|616872496|FG001|Overall Study|Disease Progression|0|||
170689016|NCT05407675|616872497|FG002|Overall Study|Disease Progression|0|||
170689017|NCT05407675|616872498|FG003|Overall Study|Disease Progression|0|||
170689018|NCT05407675|616872499|FG004|Overall Study|Disease Progression|0|||
170689019|NCT05407675|616872500|FG005|Overall Study|Disease Progression|0|||
170689020|NCT05407675|616872501|FG006|Overall Study|Disease Progression|0|||
170689021|NCT05407675|616872502|FG007|Overall Study|Disease Progression|0|||
170689022|NCT05407675|616872503|FG008|Overall Study|Disease Progression|0|||
170689023|NCT05407675|616872504|FG009|Overall Study|Disease Progression|0|||
170689024|NCT05407675|616872505|FG010|Overall Study|Disease Progression|1|||
170689025|NCT05407675|616872506|FG011|Overall Study|Disease Progression|0|||
170689026|NCT05407675|616872507|FG012|Overall Study|Disease Progression|0|||
170689027|NCT05407675|616872495|FG000|Overall Study|Physician Decision|0|||
170689028|NCT05407675|616872496|FG001|Overall Study|Physician Decision|0|||
170689029|NCT05407675|616872497|FG002|Overall Study|Physician Decision|0|||
170689030|NCT05407675|616872498|FG003|Overall Study|Physician Decision|0|||
170689031|NCT05407675|616872499|FG004|Overall Study|Physician Decision|0|||
170689032|NCT05407675|616872500|FG005|Overall Study|Physician Decision|0|||
170689033|NCT05407675|616872501|FG006|Overall Study|Physician Decision|0|||
170689034|NCT05407675|616872502|FG007|Overall Study|Physician Decision|0|||
170689035|NCT05407675|616872503|FG008|Overall Study|Physician Decision|0|||
170689036|NCT05407675|616872504|FG009|Overall Study|Physician Decision|0|||
170689037|NCT05407675|616872505|FG010|Overall Study|Physician Decision|1|||
170689038|NCT05407675|616872506|FG011|Overall Study|Physician Decision|0|||
170689039|NCT05407675|616872507|FG012|Overall Study|Physician Decision|0|||
170689040|NCT05407675|616872495|FG000|Overall Study|Other reasons|0|||
170689041|NCT05407675|616872496|FG001|Overall Study|Other reasons|0|||
170689042|NCT05407675|616872497|FG002|Overall Study|Other reasons|0|||
170689043|NCT05407675|616872498|FG003|Overall Study|Other reasons|0|||
170689044|NCT05407675|616872499|FG004|Overall Study|Other reasons|0|||
170689045|NCT05407675|616872500|FG005|Overall Study|Other reasons|0|||
170822064|NCT03441789|617355975|FG000|Overall Study|Lost to Follow-up|0|||
170822065|NCT03441789|617355976|FG001|Overall Study|Lost to Follow-up|1|||
170822066|NCT05372913|617355977|FG000|Overall Study|Withdrawal by Subject|0|||
170822067|NCT05372913|617355978|FG001|Overall Study|Withdrawal by Subject|2|||
170822068|NCT05372913|617355977|FG000|Overall Study|Protocol Violation|2|||
170822069|NCT05372913|617355978|FG001|Overall Study|Protocol Violation|2|||
170822070|NCT05372913|617355977|FG000|Overall Study|Adverse Event|0|||
170822071|NCT05372913|617355978|FG001|Overall Study|Adverse Event|1|||
170822072|NCT03275402|617355979|FG000|Overall Study|Death|17|||
170822073|NCT03275402|617355979|FG000|Overall Study|Study terminated by sponsor|21|||
170822074|NCT03275402|617355979|FG000|Overall Study|Withdrawal by Subject|1|||
170822075|NCT01536535|617355982|FG000|Overall Study|Withdrawal by Subject|10|||
170822076|NCT01536535|617355983|FG001|Overall Study|Withdrawal by Subject|5|||
170822077|NCT01536535|617355982|FG000|Overall Study|Lost to Follow-up|4|||
170822078|NCT01536535|617355983|FG001|Overall Study|Lost to Follow-up|6|||
170822079|NCT01536535|617355982|FG000|Overall Study|Physician Decision|1|||
170822080|NCT01536535|617355983|FG001|Overall Study|Physician Decision|1|||
170822081|NCT01536535|617355982|FG000|Overall Study|Participant moved|0|||
170822082|NCT01536535|617355983|FG001|Overall Study|Participant moved|1|||
170822083|NCT02538471|617355984|FG000|Overall Study|Progression of disease|2|||
170822084|NCT01348763|617355989|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
170822085|NCT01348763|617355989|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
170822086|NCT03305458|617355994|FG000|Overall Study|Withdrawal by Subject|50|||
170822087|NCT03305458|617355995|FG001|Overall Study|Withdrawal by Subject|46|||
170822088|NCT03305458|617355996|FG002|Overall Study|Withdrawal by Subject|93|||
170822089|NCT03305458|617355994|FG000|Overall Study|Lost to Follow-up|85|||
170822090|NCT03305458|617355995|FG001|Overall Study|Lost to Follow-up|85|||
170822091|NCT03305458|617355996|FG002|Overall Study|Lost to Follow-up|35|||
170822092|NCT00498797|617355997|FG000|Overall Study|Withdrawal by Subject|4|||
170822093|NCT00498797|617355998|FG001|Overall Study|Withdrawal by Subject|2|||
170822094|NCT00498797|617355997|FG000|Overall Study|Adverse Event|12|||
170822095|NCT00498797|617355998|FG001|Overall Study|Adverse Event|5|||
170822096|NCT00498797|617355997|FG000|Overall Study|Condition under investigation worsened|19|||
170822097|NCT00498797|617355998|FG001|Overall Study|Condition under investigation worsened|21|||
170822098|NCT00498797|617355997|FG000|Overall Study|Other|3|||
170822099|NCT00498797|617355998|FG001|Overall Study|Other|1|||
170822100|NCT03562117|617355999|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
170822101|NCT03562117|617356000|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
170822102|NCT03562117|617356001|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
170822103|NCT03520036|617356002|FG000|Overall Study|Adverse Event|1|||
170822104|NCT03520036|617356003|FG001|Overall Study|Adverse Event|2|||
170822105|NCT03520036|617356004|FG002|Overall Study|Adverse Event|0|||
170822106|NCT03520036|617356002|FG000|Overall Study|Protocol Violation|1|||
170822107|NCT03520036|617356003|FG001|Overall Study|Protocol Violation|0|||
170822108|NCT03520036|617356004|FG002|Overall Study|Protocol Violation|0|||
170822109|NCT03520036|617356002|FG000|Overall Study|Withdrawal by Subject|0|||
170822110|NCT03520036|617356003|FG001|Overall Study|Withdrawal by Subject|1|||
170822111|NCT03520036|617356004|FG002|Overall Study|Withdrawal by Subject|4|||
170822112|NCT03520036|617356002|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
170822113|NCT03520036|617356003|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
170822114|NCT03520036|617356004|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
170822115|NCT01855399|617356005|FG000|6 Month|Lost to Follow-up|12|||
170822116|NCT01855399|617356006|FG001|6 Month|Lost to Follow-up|9|||
170822117|NCT01855399|617356005|FG000|6 Month|Withdrawal by Subject|8|||
170822118|NCT01855399|617356006|FG001|6 Month|Withdrawal by Subject|6|||
170822119|NCT01855399|617356005|FG000|12 Month|Lost to Follow-up|7|||
170822120|NCT01855399|617356006|FG001|12 Month|Lost to Follow-up|11|||
170822121|NCT04743999|617356007|FG000|3-month Questionnaire|Death|1|||
170689046|NCT05407675|616872501|FG006|Overall Study|Other reasons|0|||
170689047|NCT05407675|616872502|FG007|Overall Study|Other reasons|0|||
170689048|NCT05407675|616872503|FG008|Overall Study|Other reasons|1|||
170689049|NCT05407675|616872504|FG009|Overall Study|Other reasons|1|||
170689050|NCT05407675|616872505|FG010|Overall Study|Other reasons|1|||
170822122|NCT04743999|617356007|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
170822123|NCT04743999|617356007|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
170822124|NCT04743999|617356007|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
170822125|NCT01945086|617356015|FG000|Overall Study|Withdrawal by Subject|1|||
170822126|NCT01945086|617356016|FG001|Overall Study|Withdrawal by Subject|0|||
170822127|NCT01945086|617356017|FG002|Overall Study|Withdrawal by Subject|1|||
170822128|NCT01945086|617356015|FG000|Overall Study|Adverse Event|0|||
170822129|NCT01945086|617356016|FG001|Overall Study|Adverse Event|0|||
170822130|NCT01945086|617356017|FG002|Overall Study|Adverse Event|1|||
170689051|NCT05407675|616872506|FG011|Overall Study|Other reasons|1|||
170689052|NCT05407675|616872507|FG012|Overall Study|Other reasons|0|||
170822131|NCT01524887|617356018|FG000|Overall Study|Withdrawal by Subject|6|||
170822132|NCT01524887|617356019|FG001|Overall Study|Withdrawal by Subject|2|||
170822133|NCT01524887|617356020|FG002|Overall Study|Withdrawal by Subject|3|||
170822134|NCT01524887|617356018|FG000|Overall Study|Adverse Event|5|||
170822135|NCT01524887|617356019|FG001|Overall Study|Adverse Event|1|||
170822136|NCT01524887|617356020|FG002|Overall Study|Adverse Event|1|||
170822137|NCT01524887|617356018|FG000|Overall Study|Protocol Violation|0|||
170822138|NCT01524887|617356019|FG001|Overall Study|Protocol Violation|0|||
170822139|NCT01524887|617356020|FG002|Overall Study|Protocol Violation|1|||
170822140|NCT01524887|617356018|FG000|Overall Study|Study termination|73|||
170822141|NCT01524887|617356019|FG001|Overall Study|Study termination|87|||
170822142|NCT01524887|617356020|FG002|Overall Study|Study termination|79|||
170822143|NCT01524887|617356018|FG000|Overall Study|Withdrawal by Caregiver|0|||
170822144|NCT01524887|617356019|FG001|Overall Study|Withdrawal by Caregiver|0|||
170822145|NCT01524887|617356020|FG002|Overall Study|Withdrawal by Caregiver|2|||
170822146|NCT01524887|617356018|FG000|Overall Study|Use of prohibited medication|1|||
170822147|NCT01524887|617356019|FG001|Overall Study|Use of prohibited medication|0|||
170822148|NCT01524887|617356020|FG002|Overall Study|Use of prohibited medication|0|||
170822149|NCT05379023|617356021|FG000|Overall Study|Lost to Follow-up|1|||
170822150|NCT05379023|617356022|FG001|Overall Study|Lost to Follow-up|0|||
170822151|NCT05379023|617356023|FG002|Overall Study|Lost to Follow-up|0|||
170822152|NCT05379023|617356021|FG000|Overall Study|Withdrawal by Subject|2|||
170822153|NCT05379023|617356022|FG001|Overall Study|Withdrawal by Subject|0|||
170822154|NCT05379023|617356023|FG002|Overall Study|Withdrawal by Subject|0|||
170822155|NCT02093897|617357341|FG000|Overall Study|Physician Decision|1|||
170822156|NCT02093897|617357341|FG000|Overall Study|Planned age group closure - no's reached|17|||
170822157|NCT02093897|617357341|FG000|Overall Study|Adverse event, non-fatal|1|||
170822158|NCT02972242|617357342|FG000|Overall Study|Withdrawal by Subject|1|||
170822159|NCT02972242|617357343|FG001|Overall Study|Withdrawal by Subject|0|||
170822160|NCT04572997|617357347|FG000|Overall Study|Adverse Event|1|||
170822161|NCT03098797|617357348|FG000|Part 2 Open Label Extension|Adverse Event|2|||
170822162|NCT03098797|617357349|FG001|Part 2 Open Label Extension|Adverse Event|0|||
170822163|NCT02956278|617357350|FG000|Overall Study|Withdrawal by Subject|6|||
170822164|NCT02956278|617357351|FG001|Overall Study|Withdrawal by Subject|2|||
170822165|NCT02956278|617357352|FG002|Overall Study|Withdrawal by Subject|0|||
170822166|NCT01967719|617357353|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
170822167|NCT01967719|617357354|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
170822168|NCT01967719|617357355|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
170822169|NCT01967719|617357356|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
170822170|NCT01967719|617357353|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
170822171|NCT01967719|617357354|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
170822172|NCT01967719|617357355|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
170822173|NCT01967719|617357356|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
170822174|NCT02329223|617357357|FG000|Overall Study|Withdrawal by Subject|1|||
170822175|NCT02329223|617357358|FG001|Overall Study|Withdrawal by Subject|2|||
170822176|NCT02329223|617357359|FG002|Overall Study|Withdrawal by Subject|5|||
170822177|NCT02329223|617357357|FG000|Overall Study|Physician Decision|0|||
170822178|NCT02329223|617357358|FG001|Overall Study|Physician Decision|0|||
170822179|NCT02329223|617357359|FG002|Overall Study|Physician Decision|1|||
170822180|NCT02329223|617357357|FG000|Overall Study|Adverse Event|0|||
170822181|NCT02329223|617357358|FG001|Overall Study|Adverse Event|1|||
170822182|NCT02329223|617357359|FG002|Overall Study|Adverse Event|0|||
170822183|NCT00651937|617357360|FG000|Overall Study|Withdrawal by Subject|4|||
170822184|NCT00651937|617357361|FG001|Overall Study|Withdrawal by Subject|1|||
170822185|NCT01904019|617357363|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
170822186|NCT01904019|617357363|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
170822187|NCT01904019|617357363|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
170822188|NCT01904019|617357363|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
170822189|NCT01904019|617357363|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
170822190|NCT01904019|617357363|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
170822191|NCT00552513|617357373|FG000|Overall Study|Lost to Follow-up|5|||
170822192|NCT00552513|617357374|FG001|Overall Study|Lost to Follow-up|1|||
170822193|NCT02720185|617357377|FG000|Overall Study|Lost to Follow-up|1|||
170822194|NCT00332488|617357378|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
170822195|NCT00332488|617357379|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
170822196|NCT00332488|617357380|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
170822197|NCT00332488|617357378|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
170822198|NCT00332488|617357379|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
170822199|NCT00332488|617357380|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
170689053|NCT05407675|616872495|FG000|Overall Study|Death|3|||
170689054|NCT05407675|616872496|FG001|Overall Study|Death|4|||
170689055|NCT05407675|616872497|FG002|Overall Study|Death|3|||
170689056|NCT05407675|616872498|FG003|Overall Study|Death|6|||
170689057|NCT05407675|616872499|FG004|Overall Study|Death|0|||
170689058|NCT05407675|616872500|FG005|Overall Study|Death|2|||
170689059|NCT05407675|616872501|FG006|Overall Study|Death|4|||
170689060|NCT05407675|616872502|FG007|Overall Study|Death|2|||
170689061|NCT05407675|616872503|FG008|Overall Study|Death|2|||
170689062|NCT05407675|616872504|FG009|Overall Study|Death|4|||
170689063|NCT05407675|616872505|FG010|Overall Study|Death|2|||
170689064|NCT05407675|616872506|FG011|Overall Study|Death|1|||
170689065|NCT05407675|616872507|FG012|Overall Study|Death|0|||
170689066|NCT05407675|616872495|FG000|Overall Study|Adverse Event|0|||
170689067|NCT05407675|616872496|FG001|Overall Study|Adverse Event|0|||
170689068|NCT05407675|616872497|FG002|Overall Study|Adverse Event|0|||
170689069|NCT05407675|616872498|FG003|Overall Study|Adverse Event|0|||
170689070|NCT05407675|616872499|FG004|Overall Study|Adverse Event|1|||
170689071|NCT05407675|616872500|FG005|Overall Study|Adverse Event|0|||
170689072|NCT05407675|616872501|FG006|Overall Study|Adverse Event|0|||
170689073|NCT05407675|616872502|FG007|Overall Study|Adverse Event|0|||
170689074|NCT05407675|616872503|FG008|Overall Study|Adverse Event|0|||
170689075|NCT05407675|616872504|FG009|Overall Study|Adverse Event|0|||
170689076|NCT05407675|616872505|FG010|Overall Study|Adverse Event|0|||
170689077|NCT05407675|616872506|FG011|Overall Study|Adverse Event|1|||
170689078|NCT05407675|616872507|FG012|Overall Study|Adverse Event|0|||
170689079|NCT05407675|616872495|FG000|Overall Study|Ongoing Treatment|0|||
170689080|NCT05407675|616872496|FG001|Overall Study|Ongoing Treatment|0|||
170689081|NCT05407675|616872497|FG002|Overall Study|Ongoing Treatment|0|||
170689082|NCT05407675|616872498|FG003|Overall Study|Ongoing Treatment|0|||
170689083|NCT05407675|616872499|FG004|Overall Study|Ongoing Treatment|0|||
170689084|NCT05407675|616872500|FG005|Overall Study|Ongoing Treatment|0|||
170689085|NCT05407675|616872501|FG006|Overall Study|Ongoing Treatment|0|||
170689086|NCT05407675|616872502|FG007|Overall Study|Ongoing Treatment|0|||
170689087|NCT05407675|616872503|FG008|Overall Study|Ongoing Treatment|1|||
170689088|NCT05407675|616872504|FG009|Overall Study|Ongoing Treatment|0|||
170689089|NCT05407675|616872505|FG010|Overall Study|Ongoing Treatment|0|||
170689090|NCT05407675|616872506|FG011|Overall Study|Ongoing Treatment|0|||
170689091|NCT05407675|616872507|FG012|Overall Study|Ongoing Treatment|0|||
170689092|NCT00857220|616872508|FG000|Overall Study|Adverse Event|35|||
170689093|NCT00857220|616872508|FG000|Overall Study|Death|1|||
170689094|NCT00857220|616872508|FG000|Overall Study|Lack of Efficacy|11|||
170689095|NCT00857220|616872508|FG000|Overall Study|Lost to Follow-up|30|||
170689096|NCT00857220|616872508|FG000|Overall Study|Physician Decision|4|||
170689097|NCT00857220|616872508|FG000|Overall Study|Protocol Violation|16|||
170689098|NCT00857220|616872508|FG000|Overall Study|Withdrawal by Subject|67|||
170689099|NCT00857220|616872508|FG000|Overall Study|Clinical Hold|6|||
170689100|NCT00857220|616872508|FG000|Overall Study|Site Closed|5|||
170689101|NCT00857220|616872508|FG000|Overall Study|Miscellaneous|8|||
170689102|NCT00742001|616872509|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
170689103|NCT00742001|616872510|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
170689104|NCT00742001|616872511|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
170689105|NCT01050257|616872514|FG000|Overall Study|Adverse Event|4|||
170689106|NCT01050257|616872515|FG001|Overall Study|Adverse Event|4|||
170689107|NCT01050257|616872516|FG002|Overall Study|Adverse Event|2|||
170689108|NCT01050257|616872514|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
170689109|NCT01050257|616872515|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
170689110|NCT01050257|616872516|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
170689111|NCT01050257|616872514|FG000|Overall Study|Withdrawal by Subject|0|||
170689112|NCT01050257|616872515|FG001|Overall Study|Withdrawal by Subject|3|||
170689113|NCT01050257|616872516|FG002|Overall Study|Withdrawal by Subject|0|||
170689114|NCT01050257|616872514|FG000|Overall Study|No reason specified|0|||
170689115|NCT01050257|616872515|FG001|Overall Study|No reason specified|0|||
170689116|NCT01050257|616872516|FG002|Overall Study|No reason specified|2|||
170689117|NCT01050257|616872514|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
170689118|NCT01050257|616872515|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
170689119|NCT01050257|616872516|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
170689120|NCT01050257|616872514|FG000|Overall Study|Violation criteria|0|||
170689121|NCT01050257|616872515|FG001|Overall Study|Violation criteria|1|||
170689122|NCT01050257|616872516|FG002|Overall Study|Violation criteria|0|||
170689123|NCT01050257|616872514|FG000|Overall Study|Failure to return|0|||
170689124|NCT01050257|616872515|FG001|Overall Study|Failure to return|2|||
170689125|NCT01050257|616872516|FG002|Overall Study|Failure to return|0|||
170689126|NCT01050257|616872514|FG000|Overall Study|Death|0|||
170689127|NCT01050257|616872515|FG001|Overall Study|Death|0|||
170689128|NCT01050257|616872516|FG002|Overall Study|Death|1|||
170689129|NCT00171223|616872517|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
170689130|NCT00171223|616872518|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
170689131|NCT00171223|616872519|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
170689132|NCT00171223|616872517|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
170689133|NCT00171223|616872518|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
170689134|NCT00171223|616872519|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
170689135|NCT00171223|616872517|FG000|Overall Study|Abnormal Procedure|1|||
170689136|NCT00171223|616872518|FG001|Overall Study|Abnormal Procedure|0|||
170689137|NCT00171223|616872519|FG002|Overall Study|Abnormal Procedure|0|||
170689138|NCT00171223|616872517|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
170689139|NCT00171223|616872518|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
170689140|NCT00171223|616872519|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
170689141|NCT00171223|616872517|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
170689142|NCT00171223|616872518|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
170689143|NCT00171223|616872519|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
170689144|NCT00171223|616872517|FG000|Overall Study|Protocol Violation|2|||
170822200|NCT00332488|617357378|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
170822201|NCT00332488|617357379|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
170822202|NCT00332488|617357380|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
170822203|NCT00332488|617357378|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
170822204|NCT00332488|617357379|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
170822205|NCT00332488|617357380|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
170822206|NCT00332488|617357378|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
170822207|NCT00332488|617357379|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
170822208|NCT00332488|617357380|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
170822209|NCT00332488|617357378|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
170822210|NCT00332488|617357379|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
170822211|NCT00332488|617357380|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
170822212|NCT00332488|617357378|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
170822213|NCT00332488|617357379|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
170822214|NCT00332488|617357380|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
170822215|NCT00332488|617357378|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
170822216|NCT00332488|617357379|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
170822217|NCT00332488|617357380|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
170822218|NCT00332488|617357378|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
170822219|NCT00332488|617357379|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
170822220|NCT00332488|617357380|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
170822221|NCT00332488|617357378|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
170822222|NCT00332488|617357379|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
170822223|NCT00332488|617357380|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
170822224|NCT00332488|617357378|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
170822225|NCT00332488|617357379|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
170822226|NCT00332488|617357380|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
170822227|NCT00332488|617357378|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
170822228|NCT00332488|617357379|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
170822229|NCT00332488|617357380|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
170822230|NCT02507687|617357383|FG000|Overall Study|Adverse Event|3|||
170822231|NCT02507687|617357384|FG001|Overall Study|Adverse Event|2|||
170822232|NCT02507687|617357385|FG002|Overall Study|Adverse Event|2|||
170822233|NCT02507687|617357386|FG003|Overall Study|Adverse Event|2|||
170822234|NCT02507687|617357383|FG000|Overall Study|Withdrawal by Subject|1|||
170822235|NCT02507687|617357384|FG001|Overall Study|Withdrawal by Subject|4|||
170822236|NCT02507687|617357385|FG002|Overall Study|Withdrawal by Subject|6|||
170822237|NCT02507687|617357386|FG003|Overall Study|Withdrawal by Subject|6|||
170822238|NCT02507687|617357383|FG000|Overall Study|Protocol Violation|1|||
170822239|NCT02507687|617357384|FG001|Overall Study|Protocol Violation|0|||
170822240|NCT02507687|617357385|FG002|Overall Study|Protocol Violation|2|||
170822241|NCT02507687|617357386|FG003|Overall Study|Protocol Violation|0|||
170822242|NCT02507687|617357383|FG000|Overall Study|Lost to Follow-up|0|||
170822243|NCT02507687|617357384|FG001|Overall Study|Lost to Follow-up|0|||
170822244|NCT02507687|617357385|FG002|Overall Study|Lost to Follow-up|2|||
170689145|NCT00171223|616872518|FG001|Overall Study|Protocol Violation|2|||
170822245|NCT02507687|617357386|FG003|Overall Study|Lost to Follow-up|1|||
170822246|NCT02507687|617357383|FG000|Overall Study|Screen Failure|0|||
170822247|NCT02507687|617357384|FG001|Overall Study|Screen Failure|0|||
170822248|NCT02507687|617357385|FG002|Overall Study|Screen Failure|1|||
170822249|NCT02507687|617357386|FG003|Overall Study|Screen Failure|0|||
170689146|NCT00171223|616872519|FG002|Overall Study|Protocol Violation|3|||
170689147|NCT00171223|616872517|FG000|Overall Study|Participant Withdrew Consent|12|||
170822250|NCT02507687|617357383|FG000|Overall Study|Other, Not Specified|0|||
170822251|NCT02507687|617357384|FG001|Overall Study|Other, Not Specified|0|||
170822252|NCT02507687|617357385|FG002|Overall Study|Other, Not Specified|2|||
170822253|NCT02507687|617357386|FG003|Overall Study|Other, Not Specified|4|||
170822254|NCT00733226|617357387|FG000|Overall Study|Withdrawal by Subject|1|||
170822255|NCT00733226|617357388|FG001|Overall Study|Withdrawal by Subject|0|||
170822256|NCT00733226|617357387|FG000|Overall Study|Lost to Follow-up|2|||
170822257|NCT00733226|617357388|FG001|Overall Study|Lost to Follow-up|0|||
170822258|NCT00733226|617357387|FG000|Overall Study|moved to another place|2|||
170822259|NCT00733226|617357388|FG001|Overall Study|moved to another place|0|||
170822260|NCT02561078|617357389|FG000|Overall Study|Adverse Event|5|||
170822261|NCT02561078|617357390|FG001|Overall Study|Adverse Event|2|||
170822262|NCT02561078|617357389|FG000|Overall Study|Death|2|||
170822263|NCT02561078|617357390|FG001|Overall Study|Death|1|||
170822264|NCT02561078|617357389|FG000|Overall Study|Lost to Follow-up|2|||
170822265|NCT02561078|617357390|FG001|Overall Study|Lost to Follow-up|6|||
170822266|NCT02561078|617357389|FG000|Overall Study|Non-Compliance with Study Drug|6|||
170822267|NCT02561078|617357390|FG001|Overall Study|Non-Compliance with Study Drug|3|||
170822268|NCT02561078|617357389|FG000|Overall Study|Physician Decision|2|||
170822269|NCT02561078|617357390|FG001|Overall Study|Physician Decision|3|||
170822270|NCT02561078|617357389|FG000|Overall Study|Withdrawal by Subject|13|||
170822271|NCT02561078|617357390|FG001|Overall Study|Withdrawal by Subject|10|||
170822272|NCT00598871|617357391|FG000|Overall Study|Adverse Event|0|||
170822273|NCT00598871|617357392|FG001|Overall Study|Adverse Event|1|||
170822274|NCT01194271|617357393|FG000|Overall Study|Withdrawal by Subject|1|||
170822275|NCT01194271|617357393|FG000|Overall Study|Ineligible, Screen Failure|1|||
170822276|NCT01194271|617357393|FG000|Overall Study|Death|1|||
170822277|NCT01503515|617357396|FG000|Overall Study|Adverse Event|4|||
170822278|NCT01503515|617357397|FG001|Overall Study|Adverse Event|5|||
170822279|NCT01503515|617357396|FG000|Overall Study|Death|0|||
170822280|NCT01503515|617357397|FG001|Overall Study|Death|1|||
170822281|NCT01503515|617357396|FG000|Overall Study|Physician Decision|14|||
170822282|NCT01503515|617357397|FG001|Overall Study|Physician Decision|23|||
170822283|NCT01503515|617357396|FG000|Overall Study|Withdrawal by Subject|0|||
170822284|NCT01503515|617357397|FG001|Overall Study|Withdrawal by Subject|1|||
170822285|NCT01503515|617357396|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
170822286|NCT01503515|617357397|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
170822287|NCT01503515|617357396|FG000|Overall Study|Ineligible|1|||
170822288|NCT01503515|617357397|FG001|Overall Study|Ineligible|1|||
170822289|NCT00520403|617357401|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
170822290|NCT00520403|617357401|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
170822291|NCT00520403|617357401|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
170822292|NCT00520403|617357401|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
170822293|NCT00520403|617357401|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
170822294|NCT00520403|617357401|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
170822295|NCT00520403|617357401|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
170822296|NCT00520403|617357401|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
170822297|NCT00805285|617357404|FG000|Overall Study|Lack of Efficacy|1|||
170822298|NCT05060237|617357408|FG000|Overall Study|Withdrawal by Subject|4|||
170822299|NCT05060237|617357408|FG000|Overall Study|Screening failure|8|||
170822300|NCT01697592|617357411|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
170822301|NCT01697592|617357412|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170822302|NCT01697592|617357413|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170822303|NCT01697592|617357414|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170689148|NCT00171223|616872518|FG001|Overall Study|Participant Withdrew Consent|21|||
170689149|NCT00171223|616872519|FG002|Overall Study|Participant Withdrew Consent|15|||
170689150|NCT00171223|616872517|FG000|Overall Study|Lost to Follow-up|5|||
170689151|NCT00171223|616872518|FG001|Overall Study|Lost to Follow-up|2|||
170689152|NCT00171223|616872519|FG002|Overall Study|Lost to Follow-up|3|||
170689153|NCT00171223|616872517|FG000|Overall Study|Administrative Problems|4|||
170689154|NCT00171223|616872518|FG001|Overall Study|Administrative Problems|7|||
170689155|NCT00171223|616872519|FG002|Overall Study|Administrative Problems|6|||
170689156|NCT00171223|616872517|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
170689157|NCT00171223|616872518|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
170689158|NCT00171223|616872519|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
170689159|NCT00171223|616872517|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
170689160|NCT00171223|616872518|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
170689161|NCT00171223|616872519|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
170689162|NCT00278109|616872520|FG000|Overall Study|Adverse Event|3|||
170689163|NCT00278109|616872520|FG000|Overall Study|social circumstances|1|||
170689164|NCT02064166|616872521|FG000|Overall Study|Adverse Event|1|||
170689165|NCT02064166|616872522|FG001|Overall Study|Adverse Event|0|||
170689166|NCT00909389|616872528|FG000|Overall Study|Adverse Event|6|||
170689167|NCT00909389|616872528|FG000|Overall Study|Death|4|||
170689168|NCT00909389|616872528|FG000|Overall Study|Poor Compliance|16|||
170689169|NCT00909389|616872528|FG000|Overall Study|Lost to Follow-up|4|||
170689170|NCT00909389|616872528|FG000|Overall Study|No Information|103|||
170689171|NCT00597766|616872529|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
170689172|NCT00597766|616872530|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
170689173|NCT00597766|616872531|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
170689174|NCT00597766|616872529|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
170689175|NCT00597766|616872530|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
170689176|NCT00597766|616872531|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
170689177|NCT01333059|616872532|FG000|Overall Study|Physician Decision|3|||
170689178|NCT01333059|616872533|FG001|Overall Study|Physician Decision|3|||
170689179|NCT01333059|616872532|FG000|Overall Study|Protocol Violation|3|||
170689180|NCT01333059|616872533|FG001|Overall Study|Protocol Violation|0|||
170689181|NCT03566823|616872535|FG000|Overall Study|Lack of Efficacy|0|||
170689182|NCT03566823|616872536|FG001|Overall Study|Lack of Efficacy|1|||
170689183|NCT03566823|616872537|FG002|Overall Study|Lack of Efficacy|0|||
170689184|NCT03566823|616872535|FG000|Overall Study|Withdrawal by Subject|1|||
170689185|NCT03566823|616872536|FG001|Overall Study|Withdrawal by Subject|2|||
170689186|NCT03566823|616872537|FG002|Overall Study|Withdrawal by Subject|0|||
170689187|NCT03566823|616872535|FG000|Overall Study|Adverse Event|1|||
170689188|NCT03566823|616872536|FG001|Overall Study|Adverse Event|0|||
170689189|NCT03566823|616872537|FG002|Overall Study|Adverse Event|2|||
170689190|NCT01166763|616872538|FG000|Overall Study|Withdrawal by Subject|3|||
170689191|NCT01528254|616872539|FG000|Overall Study|Administrative problems|96|||
170689192|NCT01528254|616872540|FG001|Overall Study|Administrative problems|94|||
170689193|NCT01528254|616872539|FG000|Overall Study|Adverse Event|28|||
170689194|NCT01528254|616872540|FG001|Overall Study|Adverse Event|44|||
170689195|NCT01528254|616872539|FG000|Overall Study|Lost to Follow-up|17|||
170689196|NCT01528254|616872540|FG001|Overall Study|Lost to Follow-up|24|||
170689197|NCT01528254|616872539|FG000|Overall Study|Death|13|||
170689198|NCT01528254|616872540|FG001|Overall Study|Death|9|||
170689199|NCT01528254|616872539|FG000|Overall Study|Protocol deviation|9|||
170689200|NCT01528254|616872540|FG001|Overall Study|Protocol deviation|19|||
170689201|NCT01528254|616872539|FG000|Overall Study|New therapy for study indication|8|||
170689202|NCT01528254|616872540|FG001|Overall Study|New therapy for study indication|6|||
170689203|NCT01528254|616872539|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
170689204|NCT01528254|616872540|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
170689205|NCT01528254|616872539|FG000|Overall Study|Withdrawal by Subject|5|||
170689206|NCT01528254|616872540|FG001|Overall Study|Withdrawal by Subject|4|||
170689207|NCT01528254|616872539|FG000|Overall Study|Abnormal laboratory value(s)|3|||
170689208|NCT01528254|616872540|FG001|Overall Study|Abnormal laboratory value(s)|7|||
170689209|NCT01528254|616872539|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170689210|NCT01528254|616872540|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170822304|NCT01697592|617357415|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170822305|NCT01697592|617357416|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170689211|NCT01528254|616872539|FG000|Overall Study|No longer requires study drug|1|||
170689212|NCT01528254|616872540|FG001|Overall Study|No longer requires study drug|1|||
170689213|NCT00737282|616872541|FG000|Overall Study|Study prematurely terminated|175|||
170689214|NCT02763189|616872542|FG000|Overall Study|Device failure|0|||
170689215|NCT02763189|616872543|FG001|Overall Study|Device failure|2|||
170689216|NCT03557151|616872544|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
170689217|NCT03557151|616872545|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
170689218|NCT03557151|616872544|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
170689219|NCT03557151|616872545|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
170822306|NCT01697592|617357417|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170689220|NCT03557151|616872544|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
170689221|NCT03557151|616872545|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
170689222|NCT02810392|616872546|FG000|Overall Study|Subject too ill to continue|1|||
170689223|NCT02810392|616872547|FG001|Overall Study|Subject too ill to continue|0|||
170689224|NCT02810392|616872546|FG000|Overall Study|COVID 19 research restrictions|0|||
170689225|NCT02810392|616872547|FG001|Overall Study|COVID 19 research restrictions|1|||
170689226|NCT03721276|616872550|FG000|Overall Study|Lost to Follow-up|5|||
170689227|NCT03721276|616872551|FG001|Overall Study|Lost to Follow-up|3|||
170689228|NCT03721276|616872550|FG000|Overall Study|Adverse Event|0|||
170689229|NCT03721276|616872551|FG001|Overall Study|Adverse Event|1|||
170689230|NCT00656474|616872554|FG000|Overall Study|Other Reason|1|||
170689231|NCT02062879|616872560|FG000|Overall Study|Withdrawal by Subject|4|||
170689232|NCT02062879|616872561|FG001|Overall Study|Withdrawal by Subject|1|||
170689233|NCT00056407|616872563|FG000|Overall Study|Adverse Event|282|||
170689234|NCT00056407|616872564|FG001|Overall Study|Adverse Event|364|||
170689235|NCT00056407|616872563|FG000|Overall Study|Withdrawal by Subject|377|||
170689236|NCT00056407|616872564|FG001|Overall Study|Withdrawal by Subject|361|||
170689237|NCT00056407|616872563|FG000|Overall Study|Lost to Follow-up|123|||
170689238|NCT00056407|616872564|FG001|Overall Study|Lost to Follow-up|113|||
170689239|NCT00056407|616872563|FG000|Overall Study|Protocol Violation|104|||
170689240|NCT00056407|616872564|FG001|Overall Study|Protocol Violation|95|||
170689241|NCT00056407|616872563|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
170689242|NCT00056407|616872564|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
170689243|NCT00056407|616872563|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
170689244|NCT00056407|616872564|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
170689245|NCT00056407|616872563|FG000|Overall Study|Missing|25|||
170689246|NCT00056407|616872564|FG001|Overall Study|Missing|34|||
170689247|NCT03761147|616872566|FG000|Overall Study|Withdrawal by Subject|6|||
170689248|NCT03761147|616872567|FG001|Overall Study|Withdrawal by Subject|1|||
170689249|NCT03761147|616872566|FG000|Overall Study|Adverse Event|1|||
170689250|NCT03761147|616872567|FG001|Overall Study|Adverse Event|3|||
170689251|NCT04080297|616872568|FG000|Overall Study|Adverse Event|1|||
170689252|NCT04080297|616872569|FG001|Overall Study|Adverse Event|3|||
170689253|NCT04080297|616872568|FG000|Overall Study|concurrent illness|1|||
170689254|NCT04080297|616872569|FG001|Overall Study|concurrent illness|0|||
170689255|NCT01026792|616872571|FG000|Overall Study|Protocol Violation|1|||
170689256|NCT02335099|616872574|FG000|Treatment|Withdrawal by Subject|1|||
170689257|NCT02335099|616872575|FG001|Treatment|Withdrawal by Subject|3|||
170689258|NCT02335099|616872574|FG000|Treatment|Lost to Follow-up|2|||
170689259|NCT02335099|616872575|FG001|Treatment|Lost to Follow-up|0|||
170689260|NCT02335099|616872574|FG000|Treatment|Death|1|||
170689261|NCT02335099|616872575|FG001|Treatment|Death|0|||
170689262|NCT02335099|616872574|FG000|Treatment|Adverse Event|1|||
170689263|NCT02335099|616872575|FG001|Treatment|Adverse Event|2|||
170689264|NCT02335099|616872574|FG000|Follow-up|Death|0|||
170689265|NCT02335099|616872575|FG001|Follow-up|Death|1|||
170689266|NCT03564145|616872576|FG000|Overall Study|Adverse Event|4|||
170689267|NCT03564145|616872576|FG000|Overall Study|Lost to Follow-up|21|||
170689268|NCT03564145|616872576|FG000|Overall Study|Protocol Violation|2|||
170689269|NCT03564145|616872576|FG000|Overall Study|Withdrawal by Subject|48|||
170689270|NCT03564145|616872576|FG000|Overall Study|Study Terminated by Sponsor|146|||
170689271|NCT03564145|616872576|FG000|Overall Study|Physician Decision|1|||
170689272|NCT03564145|616872576|FG000|Overall Study|Other Than Specified|1|||
170689273|NCT03564145|616872576|FG000|Overall Study|Pregnancy|1|||
170689274|NCT00238121|616872577|FG000|Overall Study|Withdrawal by Subject|1|||
170689275|NCT00238121|616872578|FG001|Overall Study|Withdrawal by Subject|1|||
170689276|NCT00238121|616872577|FG000|Overall Study|Adverse Event|2|||
170689277|NCT00238121|616872578|FG001|Overall Study|Adverse Event|1|||
170689278|NCT01386554|616872579|FG000|Overall Study|Lost to Follow-up|0|||
170689279|NCT01386554|616872580|FG001|Overall Study|Lost to Follow-up|0|||
170689280|NCT01386554|616872581|FG002|Overall Study|Lost to Follow-up|1|||
170689281|NCT01386554|616872579|FG000|Overall Study|Adverse Event|2|||
170689282|NCT01386554|616872580|FG001|Overall Study|Adverse Event|5|||
170689283|NCT01386554|616872581|FG002|Overall Study|Adverse Event|2|||
170689284|NCT01386554|616872579|FG000|Overall Study|Progressive disease|1|||
170689285|NCT01386554|616872580|FG001|Overall Study|Progressive disease|2|||
170689286|NCT01386554|616872581|FG002|Overall Study|Progressive disease|2|||
170689287|NCT01386554|616872579|FG000|Overall Study|Administration of live vaccines|0|||
170689288|NCT01386554|616872580|FG001|Overall Study|Administration of live vaccines|1|||
170689289|NCT01386554|616872581|FG002|Overall Study|Administration of live vaccines|0|||
170689290|NCT01386554|616872579|FG000|Overall Study|Investigator discretion|0|||
170689291|NCT01386554|616872580|FG001|Overall Study|Investigator discretion|0|||
170689292|NCT01386554|616872581|FG002|Overall Study|Investigator discretion|1|||
170689293|NCT01386554|616872579|FG000|Overall Study|Reason not collected|0|||
170689294|NCT01386554|616872580|FG001|Overall Study|Reason not collected|1|||
170689295|NCT01386554|616872581|FG002|Overall Study|Reason not collected|0|||
170689296|NCT02759471|616872582|FG000|Overall Study|discomfort|2|||
170689297|NCT04219891|616872585|FG000|Overall Study|Lost to Follow-up|3|||
170689298|NCT04219891|616872585|FG000|Overall Study|Withdrawal by Subject|2|||
170689299|NCT02356783|616874223|FG000|Overall Study|Lost to Follow-up|1|||
170689300|NCT02356783|616874224|FG001|Overall Study|Lost to Follow-up|3|||
170689301|NCT01729754|616874228|FG000|Part 1|Adverse Event|2|||
170689302|NCT01729754|616874229|FG001|Part 1|Adverse Event|0|||
170689303|NCT01729754|616874230|FG002|Part 1|Adverse Event|0|||
170689304|NCT01729754|616874231|FG003|Part 1|Adverse Event|1|||
170689305|NCT01729754|616874232|FG004|Part 1|Adverse Event|0|||
170689306|NCT01729754|616874233|FG005|Part 1|Adverse Event|0|||
170689307|NCT01729754|616874234|FG006|Part 1|Adverse Event|2|||
170689308|NCT01729754|616874235|FG007|Part 1|Adverse Event|0|||
170689309|NCT01729754|616874236|FG008|Part 1|Adverse Event|0|||
170689310|NCT01729754|616874237|FG009|Part 1|Adverse Event|5|||
170689311|NCT01729754|616874228|FG000|Part 1|Lack of Efficacy|1|||
170689312|NCT01729754|616874229|FG001|Part 1|Lack of Efficacy|0|||
170689313|NCT01729754|616874230|FG002|Part 1|Lack of Efficacy|0|||
170689314|NCT01729754|616874231|FG003|Part 1|Lack of Efficacy|0|||
170689315|NCT01729754|616874232|FG004|Part 1|Lack of Efficacy|0|||
170689316|NCT01729754|616874233|FG005|Part 1|Lack of Efficacy|0|||
170689317|NCT01729754|616874234|FG006|Part 1|Lack of Efficacy|2|||
170689318|NCT01729754|616874235|FG007|Part 1|Lack of Efficacy|0|||
170689319|NCT01729754|616874236|FG008|Part 1|Lack of Efficacy|0|||
170689320|NCT01729754|616874237|FG009|Part 1|Lack of Efficacy|0|||
170689321|NCT01729754|616874228|FG000|Part 1|Lost to Follow-up|1|||
170689322|NCT01729754|616874229|FG001|Part 1|Lost to Follow-up|0|||
170689323|NCT01729754|616874230|FG002|Part 1|Lost to Follow-up|0|||
170689324|NCT01729754|616874231|FG003|Part 1|Lost to Follow-up|2|||
170689325|NCT01729754|616874232|FG004|Part 1|Lost to Follow-up|0|||
170689326|NCT01729754|616874233|FG005|Part 1|Lost to Follow-up|0|||
170689327|NCT01729754|616874234|FG006|Part 1|Lost to Follow-up|3|||
170689328|NCT01729754|616874235|FG007|Part 1|Lost to Follow-up|0|||
170689329|NCT01729754|616874236|FG008|Part 1|Lost to Follow-up|0|||
170689330|NCT01729754|616874237|FG009|Part 1|Lost to Follow-up|3|||
170689331|NCT01729754|616874228|FG000|Part 1|Non-compliance with Study Drug|1|||
170689332|NCT01729754|616874229|FG001|Part 1|Non-compliance with Study Drug|0|||
170689333|NCT01729754|616874230|FG002|Part 1|Non-compliance with Study Drug|0|||
170689334|NCT01729754|616874231|FG003|Part 1|Non-compliance with Study Drug|0|||
170689335|NCT01729754|616874232|FG004|Part 1|Non-compliance with Study Drug|0|||
170689336|NCT01729754|616874233|FG005|Part 1|Non-compliance with Study Drug|0|||
170689337|NCT01729754|616874234|FG006|Part 1|Non-compliance with Study Drug|0|||
170689338|NCT01729754|616874235|FG007|Part 1|Non-compliance with Study Drug|0|||
170689339|NCT01729754|616874236|FG008|Part 1|Non-compliance with Study Drug|0|||
170689340|NCT01729754|616874237|FG009|Part 1|Non-compliance with Study Drug|0|||
170689341|NCT01729754|616874228|FG000|Part 1|Physician Decision|0|||
170689342|NCT01729754|616874229|FG001|Part 1|Physician Decision|0|||
170689343|NCT01729754|616874230|FG002|Part 1|Physician Decision|0|||
170689344|NCT01729754|616874231|FG003|Part 1|Physician Decision|0|||
170689345|NCT01729754|616874232|FG004|Part 1|Physician Decision|0|||
170689346|NCT01729754|616874233|FG005|Part 1|Physician Decision|0|||
170689347|NCT01729754|616874234|FG006|Part 1|Physician Decision|0|||
170689348|NCT01729754|616874235|FG007|Part 1|Physician Decision|0|||
170689349|NCT01729754|616874236|FG008|Part 1|Physician Decision|0|||
170689350|NCT01729754|616874237|FG009|Part 1|Physician Decision|4|||
170689351|NCT01729754|616874228|FG000|Part 1|Pregnancy|0|||
170689352|NCT01729754|616874229|FG001|Part 1|Pregnancy|0|||
170689353|NCT01729754|616874230|FG002|Part 1|Pregnancy|0|||
170689354|NCT01729754|616874231|FG003|Part 1|Pregnancy|1|||
170689355|NCT01729754|616874232|FG004|Part 1|Pregnancy|0|||
170689356|NCT01729754|616874233|FG005|Part 1|Pregnancy|0|||
170689357|NCT01729754|616874234|FG006|Part 1|Pregnancy|0|||
170689358|NCT01729754|616874235|FG007|Part 1|Pregnancy|0|||
170822307|NCT01697592|617357418|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170689359|NCT01729754|616874236|FG008|Part 1|Pregnancy|0|||
170689360|NCT01729754|616874237|FG009|Part 1|Pregnancy|1|||
170689361|NCT01729754|616874228|FG000|Part 1|Progressive Disease|0|||
170689362|NCT01729754|616874229|FG001|Part 1|Progressive Disease|0|||
170689363|NCT01729754|616874230|FG002|Part 1|Progressive Disease|0|||
170689364|NCT01729754|616874231|FG003|Part 1|Progressive Disease|0|||
170689365|NCT01729754|616874232|FG004|Part 1|Progressive Disease|0|||
170689366|NCT01729754|616874233|FG005|Part 1|Progressive Disease|0|||
170689367|NCT01729754|616874234|FG006|Part 1|Progressive Disease|0|||
170689368|NCT01729754|616874235|FG007|Part 1|Progressive Disease|0|||
170689369|NCT01729754|616874236|FG008|Part 1|Progressive Disease|0|||
170689370|NCT01729754|616874237|FG009|Part 1|Progressive Disease|1|||
170689371|NCT01729754|616874228|FG000|Part 1|Protocol Violation|2|||
170689372|NCT01729754|616874229|FG001|Part 1|Protocol Violation|0|||
170689373|NCT01729754|616874230|FG002|Part 1|Protocol Violation|0|||
170689374|NCT01729754|616874231|FG003|Part 1|Protocol Violation|1|||
170689375|NCT01729754|616874232|FG004|Part 1|Protocol Violation|0|||
170689376|NCT01729754|616874233|FG005|Part 1|Protocol Violation|0|||
170689377|NCT01729754|616874234|FG006|Part 1|Protocol Violation|1|||
170689378|NCT01729754|616874235|FG007|Part 1|Protocol Violation|0|||
170689379|NCT01729754|616874236|FG008|Part 1|Protocol Violation|0|||
170689380|NCT01729754|616874237|FG009|Part 1|Protocol Violation|0|||
170689381|NCT01729754|616874228|FG000|Part 1|Withdrawal by Subject|5|||
170822308|NCT01697592|617357419|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170822309|NCT01697592|617357420|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
170822310|NCT01697592|617357411|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822311|NCT01697592|617357412|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822312|NCT01697592|617357413|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822313|NCT01697592|617357414|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822314|NCT01697592|617357415|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822315|NCT01697592|617357416|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
170822316|NCT01697592|617357417|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822317|NCT01697592|617357418|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822318|NCT01697592|617357419|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822319|NCT01697592|617357420|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
170822320|NCT01697592|617357411|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
170822321|NCT01697592|617357412|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822322|NCT01697592|617357413|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822323|NCT01697592|617357414|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822324|NCT01697592|617357415|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822325|NCT01697592|617357416|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822326|NCT01697592|617357417|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822327|NCT01697592|617357418|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822328|NCT01697592|617357419|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822329|NCT01697592|617357420|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
170822330|NCT01697592|617357411|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
170822331|NCT01697592|617357412|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
170822332|NCT01697592|617357413|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
170822333|NCT01697592|617357414|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
170822334|NCT01697592|617357415|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
170822335|NCT01697592|617357416|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
170822336|NCT01697592|617357417|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
170822337|NCT01697592|617357418|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
170822338|NCT01697592|617357419|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
170822339|NCT01697592|617357420|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
170822340|NCT01697592|617357411|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
170822341|NCT01697592|617357412|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
170822342|NCT01697592|617357413|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
170822343|NCT01697592|617357414|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
170822344|NCT01697592|617357415|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
170822345|NCT01697592|617357416|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
170822346|NCT01697592|617357417|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
170822347|NCT01697592|617357418|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
170822348|NCT01697592|617357419|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
170822349|NCT01697592|617357420|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
170822350|NCT01697592|617357411|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
170822351|NCT01697592|617357412|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
170822352|NCT01697592|617357413|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
170822353|NCT01697592|617357414|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
170822354|NCT01697592|617357415|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
170822355|NCT01697592|617357416|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
170822356|NCT01697592|617357417|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
170822357|NCT01697592|617357418|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
170822358|NCT01697592|617357419|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
170822359|NCT01697592|617357420|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
170822360|NCT01697592|617357411|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
170822361|NCT01697592|617357412|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
170822362|NCT01697592|617357413|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
170822363|NCT01697592|617357414|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
170822364|NCT01697592|617357415|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
170822365|NCT01697592|617357416|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
170822366|NCT01697592|617357417|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
170822367|NCT01697592|617357418|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
170822368|NCT01697592|617357419|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
170822369|NCT01697592|617357420|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
170822370|NCT01697592|617357411|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
170689382|NCT01729754|616874229|FG001|Part 1|Withdrawal by Subject|0|||
170689383|NCT01729754|616874230|FG002|Part 1|Withdrawal by Subject|0|||
170689384|NCT01729754|616874231|FG003|Part 1|Withdrawal by Subject|7|||
170689385|NCT01729754|616874232|FG004|Part 1|Withdrawal by Subject|0|||
170689386|NCT01729754|616874233|FG005|Part 1|Withdrawal by Subject|0|||
170689387|NCT01729754|616874234|FG006|Part 1|Withdrawal by Subject|5|||
170689388|NCT01729754|616874235|FG007|Part 1|Withdrawal by Subject|0|||
170689389|NCT01729754|616874236|FG008|Part 1|Withdrawal by Subject|0|||
170689390|NCT01729754|616874237|FG009|Part 1|Withdrawal by Subject|6|||
170689391|NCT01729754|616874228|FG000|Part 1|Other Protocol Specified Criteria|2|||
170689392|NCT01729754|616874229|FG001|Part 1|Other Protocol Specified Criteria|0|||
170689393|NCT01729754|616874230|FG002|Part 1|Other Protocol Specified Criteria|0|||
170689394|NCT01729754|616874231|FG003|Part 1|Other Protocol Specified Criteria|0|||
170689395|NCT01729754|616874232|FG004|Part 1|Other Protocol Specified Criteria|0|||
170689396|NCT01729754|616874233|FG005|Part 1|Other Protocol Specified Criteria|0|||
170689397|NCT01729754|616874234|FG006|Part 1|Other Protocol Specified Criteria|1|||
170689398|NCT01729754|616874235|FG007|Part 1|Other Protocol Specified Criteria|0|||
170689399|NCT01729754|616874236|FG008|Part 1|Other Protocol Specified Criteria|0|||
170689400|NCT01729754|616874237|FG009|Part 1|Other Protocol Specified Criteria|4|||
170689401|NCT01729754|616874228|FG000|Part 2|Adverse Event|2|||
170689402|NCT01729754|616874229|FG001|Part 2|Adverse Event|0|||
170689403|NCT01729754|616874230|FG002|Part 2|Adverse Event|0|||
170689404|NCT01729754|616874231|FG003|Part 2|Adverse Event|0|||
170689405|NCT01729754|616874232|FG004|Part 2|Adverse Event|0|||
170689406|NCT01729754|616874233|FG005|Part 2|Adverse Event|0|||
170689407|NCT01729754|616874234|FG006|Part 2|Adverse Event|0|||
170689408|NCT01729754|616874235|FG007|Part 2|Adverse Event|0|||
170689409|NCT01729754|616874236|FG008|Part 2|Adverse Event|1|||
170689410|NCT01729754|616874237|FG009|Part 2|Adverse Event|2|||
170689411|NCT01729754|616874228|FG000|Part 2|Lack of Efficacy|0|||
170689412|NCT01729754|616874229|FG001|Part 2|Lack of Efficacy|0|||
170689413|NCT01729754|616874230|FG002|Part 2|Lack of Efficacy|0|||
170689414|NCT01729754|616874231|FG003|Part 2|Lack of Efficacy|0|||
170689415|NCT01729754|616874232|FG004|Part 2|Lack of Efficacy|0|||
170689416|NCT01729754|616874233|FG005|Part 2|Lack of Efficacy|0|||
170689417|NCT01729754|616874234|FG006|Part 2|Lack of Efficacy|0|||
170689418|NCT01729754|616874235|FG007|Part 2|Lack of Efficacy|0|||
170689419|NCT01729754|616874236|FG008|Part 2|Lack of Efficacy|2|||
170689420|NCT01729754|616874237|FG009|Part 2|Lack of Efficacy|2|||
170689421|NCT01729754|616874228|FG000|Part 2|Lost to Follow-up|0|||
170689422|NCT01729754|616874229|FG001|Part 2|Lost to Follow-up|0|||
170689423|NCT01729754|616874230|FG002|Part 2|Lost to Follow-up|0|||
170689424|NCT01729754|616874231|FG003|Part 2|Lost to Follow-up|2|||
170689425|NCT01729754|616874232|FG004|Part 2|Lost to Follow-up|0|||
170689426|NCT01729754|616874233|FG005|Part 2|Lost to Follow-up|0|||
170689427|NCT01729754|616874234|FG006|Part 2|Lost to Follow-up|0|||
170689428|NCT01729754|616874235|FG007|Part 2|Lost to Follow-up|1|||
170689429|NCT01729754|616874236|FG008|Part 2|Lost to Follow-up|0|||
170689430|NCT01729754|616874237|FG009|Part 2|Lost to Follow-up|2|||
170689431|NCT01729754|616874228|FG000|Part 2|Non-Compliance with Study Drug|0|||
170689432|NCT01729754|616874229|FG001|Part 2|Non-Compliance with Study Drug|0|||
170689433|NCT01729754|616874230|FG002|Part 2|Non-Compliance with Study Drug|0|||
170689434|NCT01729754|616874231|FG003|Part 2|Non-Compliance with Study Drug|0|||
170689435|NCT01729754|616874232|FG004|Part 2|Non-Compliance with Study Drug|0|||
170689436|NCT01729754|616874233|FG005|Part 2|Non-Compliance with Study Drug|0|||
170689437|NCT01729754|616874234|FG006|Part 2|Non-Compliance with Study Drug|0|||
170689438|NCT01729754|616874235|FG007|Part 2|Non-Compliance with Study Drug|0|||
170689439|NCT01729754|616874236|FG008|Part 2|Non-Compliance with Study Drug|0|||
170689440|NCT01729754|616874237|FG009|Part 2|Non-Compliance with Study Drug|1|||
170822371|NCT01697592|617357412|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
170822372|NCT01697592|617357413|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
170822373|NCT01697592|617357414|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
170689441|NCT01729754|616874228|FG000|Part 2|Pregnancy|0|||
170689442|NCT01729754|616874229|FG001|Part 2|Pregnancy|0|||
170689443|NCT01729754|616874230|FG002|Part 2|Pregnancy|0|||
170689444|NCT01729754|616874231|FG003|Part 2|Pregnancy|1|||
170689445|NCT01729754|616874232|FG004|Part 2|Pregnancy|0|||
170689446|NCT01729754|616874233|FG005|Part 2|Pregnancy|0|||
170689447|NCT01729754|616874234|FG006|Part 2|Pregnancy|0|||
170689448|NCT01729754|616874235|FG007|Part 2|Pregnancy|0|||
170689449|NCT01729754|616874236|FG008|Part 2|Pregnancy|0|||
170689450|NCT01729754|616874237|FG009|Part 2|Pregnancy|1|||
170689451|NCT01729754|616874228|FG000|Part 2|Withdrawal by Subject|3|||
170689452|NCT01729754|616874229|FG001|Part 2|Withdrawal by Subject|0|||
170689453|NCT01729754|616874230|FG002|Part 2|Withdrawal by Subject|0|||
170822374|NCT01697592|617357415|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
170689454|NCT01729754|616874231|FG003|Part 2|Withdrawal by Subject|2|||
170689455|NCT01729754|616874232|FG004|Part 2|Withdrawal by Subject|0|||
170689456|NCT01729754|616874233|FG005|Part 2|Withdrawal by Subject|0|||
170689457|NCT01729754|616874234|FG006|Part 2|Withdrawal by Subject|0|||
170689458|NCT01729754|616874235|FG007|Part 2|Withdrawal by Subject|1|||
170689459|NCT01729754|616874236|FG008|Part 2|Withdrawal by Subject|1|||
170689460|NCT01729754|616874237|FG009|Part 2|Withdrawal by Subject|4|||
170822375|NCT01697592|617357416|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
170689461|NCT01729754|616874228|FG000|Part 2|Other Protocol Specified Criteria|1|||
170689462|NCT01729754|616874229|FG001|Part 2|Other Protocol Specified Criteria|0|||
170689463|NCT01729754|616874230|FG002|Part 2|Other Protocol Specified Criteria|0|||
170689464|NCT01729754|616874231|FG003|Part 2|Other Protocol Specified Criteria|0|||
170689465|NCT01729754|616874232|FG004|Part 2|Other Protocol Specified Criteria|0|||
170689466|NCT01729754|616874233|FG005|Part 2|Other Protocol Specified Criteria|0|||
170689467|NCT01729754|616874234|FG006|Part 2|Other Protocol Specified Criteria|0|||
170689468|NCT01729754|616874235|FG007|Part 2|Other Protocol Specified Criteria|1|||
170689469|NCT01729754|616874236|FG008|Part 2|Other Protocol Specified Criteria|0|||
170689470|NCT01729754|616874237|FG009|Part 2|Other Protocol Specified Criteria|0|||
170689471|NCT01729754|616874228|FG000|Part 3|Adverse Event|0|||
170689472|NCT01729754|616874229|FG001|Part 3|Adverse Event|0|||
170689473|NCT01729754|616874230|FG002|Part 3|Adverse Event|1|||
170689474|NCT01729754|616874231|FG003|Part 3|Adverse Event|0|||
170689475|NCT01729754|616874232|FG004|Part 3|Adverse Event|0|||
170689476|NCT01729754|616874233|FG005|Part 3|Adverse Event|5|||
170689477|NCT01729754|616874234|FG006|Part 3|Adverse Event|0|||
170689478|NCT01729754|616874235|FG007|Part 3|Adverse Event|0|||
170689479|NCT01729754|616874236|FG008|Part 3|Adverse Event|0|||
170689480|NCT01729754|616874237|FG009|Part 3|Adverse Event|3|||
170689481|NCT01729754|616874228|FG000|Part 3|Death|0|||
170689482|NCT01729754|616874229|FG001|Part 3|Death|0|||
170689483|NCT01729754|616874230|FG002|Part 3|Death|0|||
170689484|NCT01729754|616874231|FG003|Part 3|Death|0|||
170689485|NCT01729754|616874232|FG004|Part 3|Death|0|||
170689486|NCT01729754|616874233|FG005|Part 3|Death|2|||
170689487|NCT01729754|616874234|FG006|Part 3|Death|0|||
170689488|NCT01729754|616874235|FG007|Part 3|Death|0|||
170689489|NCT01729754|616874236|FG008|Part 3|Death|0|||
170689490|NCT01729754|616874237|FG009|Part 3|Death|0|||
170689491|NCT01729754|616874228|FG000|Part 3|Lack of Efficacy|0|||
170689492|NCT01729754|616874229|FG001|Part 3|Lack of Efficacy|0|||
170689493|NCT01729754|616874230|FG002|Part 3|Lack of Efficacy|0|||
170689494|NCT01729754|616874231|FG003|Part 3|Lack of Efficacy|0|||
170689495|NCT01729754|616874232|FG004|Part 3|Lack of Efficacy|2|||
170689496|NCT01729754|616874233|FG005|Part 3|Lack of Efficacy|0|||
170689497|NCT01729754|616874234|FG006|Part 3|Lack of Efficacy|0|||
170689498|NCT01729754|616874235|FG007|Part 3|Lack of Efficacy|0|||
170689499|NCT01729754|616874236|FG008|Part 3|Lack of Efficacy|0|||
170689500|NCT01729754|616874237|FG009|Part 3|Lack of Efficacy|4|||
170689501|NCT01729754|616874228|FG000|Part 3|Lost to Follow-up|0|||
170689502|NCT01729754|616874229|FG001|Part 3|Lost to Follow-up|1|||
170689503|NCT01729754|616874230|FG002|Part 3|Lost to Follow-up|2|||
170689504|NCT01729754|616874231|FG003|Part 3|Lost to Follow-up|0|||
170689505|NCT01729754|616874232|FG004|Part 3|Lost to Follow-up|0|||
170689506|NCT01729754|616874233|FG005|Part 3|Lost to Follow-up|3|||
170689507|NCT01729754|616874234|FG006|Part 3|Lost to Follow-up|0|||
170689508|NCT01729754|616874235|FG007|Part 3|Lost to Follow-up|0|||
170689509|NCT01729754|616874236|FG008|Part 3|Lost to Follow-up|1|||
170689510|NCT01729754|616874237|FG009|Part 3|Lost to Follow-up|0|||
170689511|NCT01729754|616874228|FG000|Part 3|Physician Decision|0|||
170689512|NCT01729754|616874229|FG001|Part 3|Physician Decision|0|||
170689513|NCT01729754|616874230|FG002|Part 3|Physician Decision|1|||
170689514|NCT01729754|616874231|FG003|Part 3|Physician Decision|0|||
170689515|NCT01729754|616874232|FG004|Part 3|Physician Decision|0|||
170689516|NCT01729754|616874233|FG005|Part 3|Physician Decision|0|||
170689517|NCT01729754|616874234|FG006|Part 3|Physician Decision|0|||
170689518|NCT01729754|616874235|FG007|Part 3|Physician Decision|0|||
170689519|NCT01729754|616874236|FG008|Part 3|Physician Decision|0|||
170689520|NCT01729754|616874237|FG009|Part 3|Physician Decision|0|||
170689521|NCT01729754|616874228|FG000|Part 3|Withdrawal by Subject|0|||
170689522|NCT01729754|616874229|FG001|Part 3|Withdrawal by Subject|4|||
170689523|NCT01729754|616874230|FG002|Part 3|Withdrawal by Subject|1|||
170689524|NCT01729754|616874231|FG003|Part 3|Withdrawal by Subject|0|||
170822376|NCT01697592|617357417|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
170689525|NCT01729754|616874232|FG004|Part 3|Withdrawal by Subject|2|||
170689526|NCT01729754|616874233|FG005|Part 3|Withdrawal by Subject|1|||
170689527|NCT01729754|616874234|FG006|Part 3|Withdrawal by Subject|0|||
170689528|NCT01729754|616874235|FG007|Part 3|Withdrawal by Subject|2|||
170689529|NCT01729754|616874236|FG008|Part 3|Withdrawal by Subject|0|||
170689530|NCT01729754|616874237|FG009|Part 3|Withdrawal by Subject|0|||
170689531|NCT01729754|616874228|FG000|Part 3|Other Protocol Specified Criteria|0|||
170689532|NCT01729754|616874229|FG001|Part 3|Other Protocol Specified Criteria|0|||
170689533|NCT01729754|616874230|FG002|Part 3|Other Protocol Specified Criteria|0|||
170689534|NCT01729754|616874231|FG003|Part 3|Other Protocol Specified Criteria|0|||
170689535|NCT01729754|616874232|FG004|Part 3|Other Protocol Specified Criteria|0|||
170822377|NCT01697592|617357418|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
170822378|NCT01697592|617357419|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
170689536|NCT01729754|616874233|FG005|Part 3|Other Protocol Specified Criteria|2|||
170689537|NCT01729754|616874234|FG006|Part 3|Other Protocol Specified Criteria|0|||
170689538|NCT01729754|616874235|FG007|Part 3|Other Protocol Specified Criteria|1|||
170689539|NCT01729754|616874236|FG008|Part 3|Other Protocol Specified Criteria|0|||
170689540|NCT01729754|616874237|FG009|Part 3|Other Protocol Specified Criteria|0|||
170689541|NCT01485640|616874238|FG000|Overall Study|Adverse Event|10|||
170689542|NCT01485640|616874238|FG000|Overall Study|Lack of Efficacy|2|||
170689543|NCT01485640|616874238|FG000|Overall Study|Protocol Violation|1|||
170689544|NCT01485640|616874238|FG000|Overall Study|Withdrawal by Subject|14|||
170689545|NCT01485640|616874238|FG000|Overall Study|Terminated by Sponsor|95|||
170689546|NCT00202644|616874241|FG000|Overall Study|Adverse Event|12|||
170689547|NCT00202644|616874242|FG001|Overall Study|Adverse Event|13|||
170689548|NCT00202644|616874241|FG000|Overall Study|Withdrawal by Subject|8|||
170689549|NCT00202644|616874242|FG001|Overall Study|Withdrawal by Subject|6|||
170689550|NCT00202644|616874241|FG000|Overall Study|Lack of Efficacy|6|||
170689551|NCT00202644|616874242|FG001|Overall Study|Lack of Efficacy|6|||
170689552|NCT00202644|616874241|FG000|Overall Study|Lost to Follow-up|0|||
170689553|NCT00202644|616874242|FG001|Overall Study|Lost to Follow-up|1|||
170689554|NCT00202644|616874241|FG000|Overall Study|Other|9|||
170689555|NCT00202644|616874242|FG001|Overall Study|Other|1|||
170689556|NCT00573755|616874248|FG000|Overall Study|Still receiving treatment|1|||
170689557|NCT00573755|616874249|FG001|Overall Study|Still receiving treatment|0|||
170689558|NCT03724812|616874250|FG000|Overall Study|Missed Visit|1|||
170689559|NCT03724812|616874250|FG000|Overall Study|Death|2|||
170689560|NCT03724812|616874250|FG000|Overall Study|Withdrawal by Subject|1|||
170689561|NCT01394523|616874254|FG000|Overall Study|Unable to place block|1|||
170689562|NCT01394523|616874255|FG001|Overall Study|Unable to place block|0|||
170689563|NCT01394523|616874256|FG002|Overall Study|Unable to place block|0|||
170689564|NCT03274440|616874261|FG000|Overall Study|Time commitment too great|1|||
170689565|NCT03274440|616874262|FG001|Overall Study|Time commitment too great|0|||
170689566|NCT03274440|616874263|FG002|Overall Study|Time commitment too great|0|||
170689567|NCT03274440|616874264|FG003|Overall Study|Time commitment too great|1|||
170689568|NCT03274440|616874265|FG004|Overall Study|Time commitment too great|0|||
170689569|NCT03274440|616874266|FG005|Overall Study|Time commitment too great|0|||
170689570|NCT01291173|616874267|FG000|Overall Study|Adverse Event|0|||
170689571|NCT01291173|616874268|FG001|Overall Study|Adverse Event|3|||
170689572|NCT01291173|616874269|FG002|Overall Study|Adverse Event|1|||
170689573|NCT01291173|616874270|FG003|Overall Study|Adverse Event|3|||
170689574|NCT01291173|616874267|FG000|Overall Study|Protocol Violation|7|||
170689575|NCT01291173|616874268|FG001|Overall Study|Protocol Violation|2|||
170689576|NCT01291173|616874269|FG002|Overall Study|Protocol Violation|2|||
170689577|NCT01291173|616874270|FG003|Overall Study|Protocol Violation|5|||
170689578|NCT01291173|616874267|FG000|Overall Study|Withdrawal by Subject|6|||
170689579|NCT01291173|616874268|FG001|Overall Study|Withdrawal by Subject|4|||
170689580|NCT01291173|616874269|FG002|Overall Study|Withdrawal by Subject|4|||
170689581|NCT01291173|616874270|FG003|Overall Study|Withdrawal by Subject|2|||
170689582|NCT01291173|616874267|FG000|Overall Study|Lost to Follow-up|4|||
170689583|NCT01291173|616874268|FG001|Overall Study|Lost to Follow-up|6|||
170689584|NCT01291173|616874269|FG002|Overall Study|Lost to Follow-up|3|||
170689585|NCT01291173|616874270|FG003|Overall Study|Lost to Follow-up|2|||
170689586|NCT01291173|616874267|FG000|Overall Study|Unable to meet visit schedule|0|||
170689587|NCT01291173|616874268|FG001|Overall Study|Unable to meet visit schedule|0|||
170689588|NCT01291173|616874269|FG002|Overall Study|Unable to meet visit schedule|1|||
170689589|NCT01291173|616874270|FG003|Overall Study|Unable to meet visit schedule|0|||
170689590|NCT01291173|616874267|FG000|Overall Study|Lack of compliance|0|||
170689591|NCT01291173|616874268|FG001|Overall Study|Lack of compliance|0|||
170689592|NCT01291173|616874269|FG002|Overall Study|Lack of compliance|0|||
170689593|NCT01291173|616874270|FG003|Overall Study|Lack of compliance|1|||
170689594|NCT01291173|616874267|FG000|Overall Study|Subject was unblinded|0|||
170689595|NCT01291173|616874268|FG001|Overall Study|Subject was unblinded|0|||
170689596|NCT01291173|616874269|FG002|Overall Study|Subject was unblinded|1|||
170689597|NCT01291173|616874270|FG003|Overall Study|Subject was unblinded|0|||
170689598|NCT01291173|616874267|FG000|Overall Study|Excluded therapy|0|||
170689599|NCT01291173|616874268|FG001|Overall Study|Excluded therapy|0|||
170689600|NCT01291173|616874269|FG002|Overall Study|Excluded therapy|1|||
170689601|NCT01291173|616874270|FG003|Overall Study|Excluded therapy|0|||
170689602|NCT01074450|616874272|FG000|First Intervention|Emesis in Dosing Interval|0|||
170689603|NCT01074450|616874273|FG001|First Intervention|Emesis in Dosing Interval|2|||
170689604|NCT01074450|616874272|FG000|Second Intervention|Protocol Violation|1|||
170689605|NCT01074450|616874273|FG001|Second Intervention|Protocol Violation|0|||
170689606|NCT01074450|616874272|FG000|Second Intervention|Physician Decision|0|||
170689607|NCT01074450|616874273|FG001|Second Intervention|Physician Decision|1|||
170689608|NCT02024867|616874274|FG000|Overall Study|Protocol Violation|3|||
170689609|NCT02024867|616874275|FG001|Overall Study|Protocol Violation|3|||
170689610|NCT02024867|616874274|FG000|Overall Study|Lost to Follow-up|6|||
170689611|NCT02024867|616874275|FG001|Overall Study|Lost to Follow-up|4|||
170689612|NCT02150954|616874276|FG000|Overall Study|Protocol Violation|1|||
170689613|NCT02150954|616874277|FG001|Overall Study|Protocol Violation|0|||
170689614|NCT01086540|616874279|FG000|Overall Study|Death|3|||
170689615|NCT01086540|616874280|FG001|Overall Study|Death|1|||
170689616|NCT01086540|616874279|FG000|Overall Study|Physician Decision|2|||
170689617|NCT01086540|616874280|FG001|Overall Study|Physician Decision|1|||
170689618|NCT01086540|616874279|FG000|Overall Study|Addition of new therapy for PAH|1|||
170689619|NCT01086540|616874280|FG001|Overall Study|Addition of new therapy for PAH|0|||
170689620|NCT04008030|616874281|FG000|Pre-Treatment|Withdrawal by Subject|0|||
170689621|NCT04008030|616874282|FG001|Pre-Treatment|Withdrawal by Subject|0|||
170689622|NCT04008030|616874283|FG002|Pre-Treatment|Withdrawal by Subject|9|||
170689623|NCT04008030|616874281|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
170689624|NCT04008030|616874282|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
170689625|NCT04008030|616874283|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
170689626|NCT04008030|616874281|FG000|Pre-Treatment|Other reasons|0|||
170689627|NCT04008030|616874282|FG001|Pre-Treatment|Other reasons|1|||
170689628|NCT04008030|616874283|FG002|Pre-Treatment|Other reasons|6|||
170689629|NCT04008030|616874281|FG000|Treatment|Withdrawal by Subject|1|||
170689630|NCT04008030|616874282|FG001|Treatment|Withdrawal by Subject|1|||
170689631|NCT04008030|616874283|FG002|Treatment|Withdrawal by Subject|1|||
170689632|NCT04008030|616874281|FG000|Treatment|Death|2|||
170689633|NCT04008030|616874282|FG001|Treatment|Death|4|||
170689634|NCT04008030|616874283|FG002|Treatment|Death|0|||
170689635|NCT04008030|616874281|FG000|Treatment|Pregnancy|0|||
170689636|NCT04008030|616874282|FG001|Treatment|Pregnancy|1|||
170689637|NCT04008030|616874283|FG002|Treatment|Pregnancy|0|||
170689638|NCT04008030|616874281|FG000|Treatment|Participant no longer meets study criteria|0|||
170689639|NCT04008030|616874282|FG001|Treatment|Participant no longer meets study criteria|1|||
170689640|NCT04008030|616874283|FG002|Treatment|Participant no longer meets study criteria|0|||
170689641|NCT04008030|616874281|FG000|Treatment|Other reasons|5|||
170689642|NCT04008030|616874282|FG001|Treatment|Other reasons|13|||
170689643|NCT04008030|616874283|FG002|Treatment|Other reasons|6|||
170689644|NCT04008030|616874281|FG000|Treatment|Disease Progression|137|||
170689645|NCT04008030|616874282|FG001|Treatment|Disease Progression|82|||
170689646|NCT04008030|616874283|FG002|Treatment|Disease Progression|85|||
170689647|NCT04008030|616874281|FG000|Treatment|Study drug toxicity|28|||
170689648|NCT04008030|616874282|FG001|Treatment|Study drug toxicity|48|||
170689649|NCT04008030|616874283|FG002|Treatment|Study drug toxicity|8|||
170689650|NCT04008030|616874281|FG000|Treatment|Adverse Event unrelated to study drug|28|||
170689651|NCT04008030|616874282|FG001|Treatment|Adverse Event unrelated to study drug|22|||
170689652|NCT04008030|616874283|FG002|Treatment|Adverse Event unrelated to study drug|6|||
170689653|NCT04008030|616874281|FG000|Treatment|Maximum Clinical Benefit|0|||
170689654|NCT04008030|616874282|FG001|Treatment|Maximum Clinical Benefit|1|||
170689655|NCT04008030|616874283|FG002|Treatment|Maximum Clinical Benefit|9|||
170689656|NCT04008030|616874281|FG000|Treatment|On-going treatment|13|||
170689657|NCT04008030|616874282|FG001|Treatment|On-going treatment|20|||
170689658|NCT04008030|616874283|FG002|Treatment|On-going treatment|0|||
170689659|NCT05811234|616874286|FG000|Overall Study|Loss of Effectiveness|2|||
170689660|NCT05811234|616874286|FG000|Overall Study|Adverse Event|4|||
170689661|NCT05811234|616874286|FG000|Overall Study|Pregnancy|1|||
170689662|NCT05811234|616874286|FG000|Overall Study|Disease progression|1|||
170689663|NCT05811234|616874286|FG000|Overall Study|Withdrawal by Subject|4|||
170689664|NCT05811234|616874286|FG000|Overall Study|Lost to Follow-up|13|||
170689665|NCT05811234|616874286|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
170689666|NCT02710045|616874287|FG000|Overall Study|Death|1|||
170689667|NCT02710045|616874288|FG001|Overall Study|Death|2|||
170689668|NCT02710045|616874289|FG002|Overall Study|Death|0|||
170689669|NCT02710045|616874287|FG000|Overall Study|Withdrawal by Subject|6|||
170689670|NCT02710045|616874288|FG001|Overall Study|Withdrawal by Subject|6|||
170689671|NCT02710045|616874289|FG002|Overall Study|Withdrawal by Subject|2|||
170689672|NCT02710045|616874287|FG000|Overall Study|Protocol Violation|1|||
170689673|NCT02710045|616874288|FG001|Overall Study|Protocol Violation|2|||
170689674|NCT02710045|616874289|FG002|Overall Study|Protocol Violation|3|||
170689675|NCT02710045|616874287|FG000|Overall Study|Lost to Follow-up|3|||
170689676|NCT02710045|616874288|FG001|Overall Study|Lost to Follow-up|6|||
170689677|NCT02710045|616874289|FG002|Overall Study|Lost to Follow-up|7|||
170689678|NCT02710045|616874287|FG000|Overall Study|Physician Decision|0|||
170689679|NCT02710045|616874288|FG001|Overall Study|Physician Decision|0|||
170689680|NCT02710045|616874289|FG002|Overall Study|Physician Decision|1|||
170689681|NCT02710045|616874287|FG000|Overall Study|Poor Attendance|0|||
170689682|NCT02710045|616874288|FG001|Overall Study|Poor Attendance|1|||
170689683|NCT02710045|616874289|FG002|Overall Study|Poor Attendance|0|||
170689684|NCT02268864|616874290|FG000|Overall Study|Withdrawal by Subject|2|||
170689685|NCT02268864|616874291|FG001|Overall Study|Withdrawal by Subject|0|||
170689686|NCT02268864|616874292|FG002|Overall Study|Withdrawal by Subject|0|||
170689687|NCT02268864|616874290|FG000|Overall Study|Death|0|||
170689688|NCT02268864|616874291|FG001|Overall Study|Death|1|||
170689689|NCT02268864|616874292|FG002|Overall Study|Death|0|||
170689690|NCT02377466|616874293|FG000|Overall Study|Other: Randomized and not treated|0|||
170689691|NCT02377466|616874294|FG001|Overall Study|Other: Randomized and not treated|2|||
170689692|NCT01496313|616874295|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
170689693|NCT01496313|616874296|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
170689694|NCT01496313|616874297|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
170689695|NCT01496313|616874298|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
170689696|NCT01496313|616874299|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
170689697|NCT01496313|616874300|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
170689698|NCT01496313|616874295|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
170689699|NCT01496313|616874296|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
170689700|NCT01496313|616874297|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
170689701|NCT01496313|616874298|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
170689702|NCT01496313|616874299|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
170689703|NCT01496313|616874300|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
170689704|NCT01496313|616874295|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
170689705|NCT01496313|616874296|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
170689706|NCT01496313|616874297|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
170689707|NCT01496313|616874298|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
170689708|NCT01496313|616874299|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
170689709|NCT01496313|616874300|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
170689710|NCT01496313|616874295|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
170689711|NCT01496313|616874296|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
170689712|NCT01496313|616874297|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
170689713|NCT01496313|616874298|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
170689714|NCT01496313|616874299|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
170689715|NCT01496313|616874300|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
170689716|NCT01496313|616874295|FG000|Randomized Period (up to 14 Months)|Other|1|||
170689717|NCT01496313|616874296|FG001|Randomized Period (up to 14 Months)|Other|2|||
170689718|NCT01496313|616874297|FG002|Randomized Period (up to 14 Months)|Other|0|||
170689719|NCT01496313|616874298|FG003|Randomized Period (up to 14 Months)|Other|0|||
170689720|NCT01496313|616874299|FG004|Randomized Period (up to 14 Months)|Other|0|||
170689721|NCT01496313|616874300|FG005|Randomized Period (up to 14 Months)|Other|0|||
170689722|NCT01496313|616874295|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
170689723|NCT01496313|616874296|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
170689724|NCT01496313|616874297|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
170689725|NCT01496313|616874298|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
170689726|NCT01496313|616874299|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
170689727|NCT01496313|616874300|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
170689728|NCT01496313|616874295|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
170689729|NCT01496313|616874296|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
170689730|NCT01496313|616874297|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
170689731|NCT01496313|616874298|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
170689732|NCT01496313|616874299|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
170689733|NCT01496313|616874300|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
170689734|NCT01496313|616874295|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
170689735|NCT01496313|616874296|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
170689736|NCT01496313|616874297|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
170689737|NCT01496313|616874298|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
170689738|NCT01496313|616874299|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
170689739|NCT01496313|616874300|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
170689740|NCT02580357|616874308|FG000|Overall Study|Lost to Follow-up|2|||
170689741|NCT02580357|616874309|FG001|Overall Study|Lost to Follow-up|0|||
170689742|NCT02580357|616874310|FG002|Overall Study|Lost to Follow-up|0|||
170689743|NCT02580357|616874308|FG000|Overall Study|Protocol Violation|1|||
170689744|NCT02580357|616874309|FG001|Overall Study|Protocol Violation|0|||
170689745|NCT02580357|616874310|FG002|Overall Study|Protocol Violation|0|||
170689746|NCT04339296|616874313|FG000|Overall Study|Refuse to participate after allocation|1|||
170689747|NCT04339296|616874314|FG001|Overall Study|Refuse to participate after allocation|1|||
170689748|NCT04339296|616874313|FG000|Overall Study|Withdrew after completion of baseline|2|||
170689749|NCT04339296|616874314|FG001|Overall Study|Withdrew after completion of baseline|1|||
170689750|NCT04339296|616874313|FG000|Overall Study|Lost to Follow-up|0|||
170689751|NCT04339296|616874314|FG001|Overall Study|Lost to Follow-up|4|||
170689752|NCT04339296|616874313|FG000|Overall Study|Discontinued intervention|5|||
170689753|NCT04339296|616874314|FG001|Overall Study|Discontinued intervention|3|||
170689754|NCT04447755|616874315|FG000|Overall Study|Death|9|||
170689755|NCT04447755|616874316|FG001|Overall Study|Death|16|||
170689756|NCT04447755|616874317|FG002|Overall Study|Death|8|||
170689757|NCT04447755|616874318|FG003|Overall Study|Death|9|||
170689758|NCT04447755|616874319|FG004|Overall Study|Death|8|||
170689759|NCT04447755|616874320|FG005|Overall Study|Death|9|||
170689760|NCT04447755|616874321|FG006|Overall Study|Death|55|||
170689761|NCT04447755|616874315|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170689762|NCT04447755|616874316|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170689763|NCT04447755|616874317|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170689764|NCT04447755|616874318|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170822379|NCT01697592|617357420|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
170822380|NCT01116440|617357421|FG000|Treatment|Withdrawal by Subject|2|||
170822381|NCT01116440|617357422|FG001|Treatment|Withdrawal by Subject|2|||
170689765|NCT04447755|616874319|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
170689766|NCT04447755|616874320|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
170822382|NCT01116440|617357421|FG000|Treatment|Lost to Follow-up|1|||
170822383|NCT01116440|617357422|FG001|Treatment|Lost to Follow-up|1|||
170822384|NCT01116440|617357421|FG000|Treatment|Protocol Violation|0|||
170822385|NCT01116440|617357422|FG001|Treatment|Protocol Violation|2|||
170822386|NCT01116440|617357421|FG000|Treatment|Lack of Efficacy|0|||
170822387|NCT01116440|617357422|FG001|Treatment|Lack of Efficacy|1|||
170822388|NCT01116440|617357421|FG000|Treatment|Adverse Event|0|||
170822389|NCT01116440|617357422|FG001|Treatment|Adverse Event|1|||
170822390|NCT01116440|617357421|FG000|Withdrawal|Withdrawal by Subject|0|||
170822391|NCT01116440|617357422|FG001|Withdrawal|Withdrawal by Subject|1|||
170822392|NCT01116440|617357421|FG000|Withdrawal|Lost to Follow-up|0|||
170822393|NCT01116440|617357422|FG001|Withdrawal|Lost to Follow-up|1|||
170822394|NCT01116440|617357421|FG000|Follow-up|Lost to Follow-up|0|||
170822395|NCT01116440|617357422|FG001|Follow-up|Lost to Follow-up|1|||
170822396|NCT01116440|617357421|FG000|Follow-up|Withdrawal by Subject|0|||
170822397|NCT01116440|617357422|FG001|Follow-up|Withdrawal by Subject|1|||
170822398|NCT00774306|617357423|FG000|Overall Study|Adverse Event|3|||
170822399|NCT00774306|617357424|FG001|Overall Study|Adverse Event|0|||
170822400|NCT00774306|617357425|FG002|Overall Study|Adverse Event|0|||
170822401|NCT00774306|617357426|FG003|Overall Study|Adverse Event|0|||
170822402|NCT00774306|617357423|FG000|Overall Study|Protocol Violation|2|||
170822403|NCT00774306|617357424|FG001|Overall Study|Protocol Violation|0|||
170822404|NCT00774306|617357425|FG002|Overall Study|Protocol Violation|3|||
170822405|NCT00774306|617357426|FG003|Overall Study|Protocol Violation|0|||
170822406|NCT00774306|617357423|FG000|Overall Study|Withdrawal by Subject|6|||
170689767|NCT04447755|616874321|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
170689768|NCT04447755|616874315|FG000|Overall Study|Sponsor Decision|0|||
170689769|NCT04447755|616874316|FG001|Overall Study|Sponsor Decision|0|||
170689770|NCT04447755|616874317|FG002|Overall Study|Sponsor Decision|0|||
170689771|NCT04447755|616874318|FG003|Overall Study|Sponsor Decision|0|||
170689772|NCT04447755|616874319|FG004|Overall Study|Sponsor Decision|1|||
170689773|NCT04447755|616874320|FG005|Overall Study|Sponsor Decision|0|||
170689774|NCT04447755|616874321|FG006|Overall Study|Sponsor Decision|10|||
170689775|NCT04447755|616874315|FG000|Overall Study|Lost to Follow-up|0|||
170689776|NCT04447755|616874316|FG001|Overall Study|Lost to Follow-up|0|||
170689777|NCT04447755|616874317|FG002|Overall Study|Lost to Follow-up|0|||
170689778|NCT04447755|616874318|FG003|Overall Study|Lost to Follow-up|0|||
170689779|NCT04447755|616874319|FG004|Overall Study|Lost to Follow-up|0|||
170689780|NCT04447755|616874320|FG005|Overall Study|Lost to Follow-up|0|||
170689781|NCT04447755|616874321|FG006|Overall Study|Lost to Follow-up|1|||
170689782|NCT00840294|616874322|FG000|Overall Study|Withdrawal by Subject|2|||
170689783|NCT00840294|616874323|FG001|Overall Study|Withdrawal by Subject|1|||
170689784|NCT00840294|616874322|FG000|Overall Study|Protocol Violation|1|||
170689785|NCT00840294|616874323|FG001|Overall Study|Protocol Violation|3|||
170689786|NCT00840294|616874322|FG000|Overall Study|Illness|0|||
170689787|NCT00840294|616874323|FG001|Overall Study|Illness|1|||
170689788|NCT01994629|616874324|FG000|Overall Study|Withdrawal by Subject|1|||
170689789|NCT01994629|616874325|FG001|Overall Study|Withdrawal by Subject|0|||
170822407|NCT00774306|617357424|FG001|Overall Study|Withdrawal by Subject|1|||
170822408|NCT00774306|617357425|FG002|Overall Study|Withdrawal by Subject|1|||
170822409|NCT00774306|617357426|FG003|Overall Study|Withdrawal by Subject|0|||
170822410|NCT00774306|617357423|FG000|Overall Study|Lost to Follow-up|6|||
170822411|NCT00774306|617357424|FG001|Overall Study|Lost to Follow-up|0|||
170822412|NCT00774306|617357425|FG002|Overall Study|Lost to Follow-up|4|||
170822413|NCT00774306|617357426|FG003|Overall Study|Lost to Follow-up|5|||
170822414|NCT00774306|617357423|FG000|Overall Study|Death|1|||
170689790|NCT01994629|616874324|FG000|Overall Study|Lost to Follow-up|0|||
170822415|NCT00774306|617357424|FG001|Overall Study|Death|1|||
170822416|NCT00774306|617357425|FG002|Overall Study|Death|0|||
170689791|NCT01994629|616874325|FG001|Overall Study|Lost to Follow-up|3|||
170822417|NCT00774306|617357426|FG003|Overall Study|Death|0|||
170822418|NCT01126879|617357430|FG000|Overall Study|Progressive Disease|3|||
170822419|NCT01126879|617357431|FG001|Overall Study|Progressive Disease|1|||
170822420|NCT01126879|617357430|FG000|Overall Study|Withdrawal by Subject|1|||
170822421|NCT01126879|617357431|FG001|Overall Study|Withdrawal by Subject|0|||
170822422|NCT01126879|617357430|FG000|Overall Study|Adverse Event|0|||
170822423|NCT01126879|617357431|FG001|Overall Study|Adverse Event|1|||
170822424|NCT01126879|617357430|FG000|Overall Study|Physician Decision|1|||
170822425|NCT01126879|617357431|FG001|Overall Study|Physician Decision|0|||
170822426|NCT00666835|617357432|FG000|Overall Study|Withdrawal by Subject|5|||
170822427|NCT00666835|617357433|FG001|Overall Study|Withdrawal by Subject|2|||
170822428|NCT00666835|617357432|FG000|Overall Study|Lack of Efficacy|0|||
170822429|NCT00666835|617357433|FG001|Overall Study|Lack of Efficacy|1|||
170822430|NCT00666835|617357432|FG000|Overall Study|Incl./excl. not fulfilled|7|||
170822431|NCT00666835|617357433|FG001|Overall Study|Incl./excl. not fulfilled|2|||
170822432|NCT00666835|617357432|FG000|Overall Study|Adverse Event|7|||
170822433|NCT00666835|617357433|FG001|Overall Study|Adverse Event|6|||
170822434|NCT00666835|617357432|FG000|Overall Study|Protocol Violation|2|||
170822435|NCT00666835|617357433|FG001|Overall Study|Protocol Violation|0|||
170822436|NCT00666835|617357432|FG000|Overall Study|Death|15|||
170822437|NCT00666835|617357433|FG001|Overall Study|Death|4|||
170822438|NCT00666835|617357432|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
170822439|NCT00666835|617357433|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
170822440|NCT00666835|617357432|FG000|Overall Study|Hemoglobulin concentration|4|||
170822441|NCT00666835|617357433|FG001|Overall Study|Hemoglobulin concentration|3|||
170822442|NCT00666835|617357432|FG000|Overall Study|Planned operation|2|||
170822443|NCT00666835|617357433|FG001|Overall Study|Planned operation|0|||
170822444|NCT00666835|617357432|FG000|Overall Study|Physician Decision|1|||
170822445|NCT00666835|617357433|FG001|Overall Study|Physician Decision|2|||
170822446|NCT00511147|617357436|FG000|Overall Study|Withdrawal by Subject|1|||
170822447|NCT00511147|617357436|FG000|Overall Study|Disease progression|5|||
170822448|NCT00511147|617357436|FG000|Overall Study|Required platelet transfusion|1|||
170822449|NCT00809783|617357439|FG000|Overall Study|Death|1|||
170822450|NCT00809783|617357440|FG001|Overall Study|Death|0|||
170822451|NCT00809783|617357441|FG002|Overall Study|Death|0|||
170822452|NCT00809783|617357439|FG000|Overall Study|Adverse Event|34|||
170822453|NCT00809783|617357440|FG001|Overall Study|Adverse Event|52|||
170822454|NCT00809783|617357441|FG002|Overall Study|Adverse Event|71|||
170822455|NCT00809783|617357439|FG000|Overall Study|Lack of Efficacy|39|||
170822456|NCT00809783|617357440|FG001|Overall Study|Lack of Efficacy|52|||
170822457|NCT00809783|617357441|FG002|Overall Study|Lack of Efficacy|63|||
170822458|NCT00809783|617357439|FG000|Overall Study|Lost to Follow-up|0|||
170822459|NCT00809783|617357440|FG001|Overall Study|Lost to Follow-up|3|||
170822460|NCT00809783|617357441|FG002|Overall Study|Lost to Follow-up|4|||
170822461|NCT00809783|617357439|FG000|Overall Study|Withdrawal by Subject|47|||
170822462|NCT00809783|617357440|FG001|Overall Study|Withdrawal by Subject|72|||
170822463|NCT00809783|617357441|FG002|Overall Study|Withdrawal by Subject|64|||
170822464|NCT00809783|617357439|FG000|Overall Study|Protocol Violation|2|||
170822465|NCT00809783|617357440|FG001|Overall Study|Protocol Violation|6|||
170822466|NCT00809783|617357441|FG002|Overall Study|Protocol Violation|5|||
170822467|NCT00809783|617357439|FG000|Overall Study|Randomized, but not treated|3|||
170822468|NCT00809783|617357440|FG001|Overall Study|Randomized, but not treated|0|||
170822469|NCT00809783|617357441|FG002|Overall Study|Randomized, but not treated|2|||
170822470|NCT00809783|617357439|FG000|Overall Study|Study Terminated by Sponsor|378|||
170822471|NCT00809783|617357440|FG001|Overall Study|Study Terminated by Sponsor|626|||
170822472|NCT00809783|617357441|FG002|Overall Study|Study Terminated by Sponsor|565|||
170822473|NCT00809783|617357439|FG000|Overall Study|Other|21|||
170822474|NCT00809783|617357440|FG001|Overall Study|Other|21|||
170822475|NCT00809783|617357441|FG002|Overall Study|Other|16|||
170822476|NCT00126555|617357442|FG000|Overall Study|Withdrawal by Subject|1|||
170822477|NCT00126555|617357442|FG000|Overall Study|Adverse Event|2|||
170822478|NCT00126555|617357442|FG000|Overall Study|Progressive Disease|3|||
170822479|NCT01780545|617357444|FG000|Overall Study|Withdrawal by Subject|3|||
170689792|NCT03338062|616874328|FG000|Overall Study|Alternative Therapy|1|||
170689793|NCT03338062|616874329|FG001|Overall Study|Alternative Therapy|0|||
170689794|NCT00383149|616874332|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
170689795|NCT00383149|616874332|FG000|Overall Study|Death|2|||
170689796|NCT00383149|616874332|FG000|Overall Study|Disease Progression|38|||
170689797|NCT00383149|616874332|FG000|Overall Study|Lost to Follow-up|1|||
170689798|NCT00383149|616874332|FG000|Overall Study|Other|1|||
170689799|NCT00383149|616874332|FG000|Overall Study|Study Drug Toxicity|4|||
170689800|NCT00383149|616874332|FG000|Overall Study|Request to Discontinue Treatment|4|||
170689801|NCT00383149|616874332|FG000|Overall Study|Participant Withdrew Consent|1|||
170689802|NCT01340898|616874335|FG000|Primary Phase|Serious Adverse Events|0|||
170689803|NCT01340898|616874336|FG001|Primary Phase|Serious Adverse Events|0|||
170689804|NCT01340898|616874337|FG002|Primary Phase|Serious Adverse Events|1|||
170689805|NCT01340898|616874335|FG000|Primary Phase|Withdrawal by Subject|8|||
170689806|NCT01340898|616874336|FG001|Primary Phase|Withdrawal by Subject|7|||
170689807|NCT01340898|616874337|FG002|Primary Phase|Withdrawal by Subject|5|||
170689808|NCT01340898|616874335|FG000|Primary Phase|Migrated/moved from study area|4|||
170689809|NCT01340898|616874336|FG001|Primary Phase|Migrated/moved from study area|1|||
170689810|NCT01340898|616874337|FG002|Primary Phase|Migrated/moved from study area|0|||
170689811|NCT01340898|616874335|FG000|Primary Phase|Lost to Follow-up|4|||
170689812|NCT01340898|616874336|FG001|Primary Phase|Lost to Follow-up|1|||
170689813|NCT01340898|616874337|FG002|Primary Phase|Lost to Follow-up|0|||
170689814|NCT01340898|616874335|FG000|Booster Phase|Withdrawal by Subject|3|||
170689815|NCT01340898|616874336|FG001|Booster Phase|Withdrawal by Subject|0|||
170689816|NCT01340898|616874337|FG002|Booster Phase|Withdrawal by Subject|4|||
170689817|NCT01340898|616874335|FG000|Booster Phase|Migrated/moved from study area|3|||
170689818|NCT01340898|616874336|FG001|Booster Phase|Migrated/moved from study area|0|||
170689819|NCT01340898|616874337|FG002|Booster Phase|Migrated/moved from study area|0|||
170689820|NCT01340898|616874335|FG000|Booster Phase|Lost to Follow-up|4|||
170689821|NCT01340898|616874336|FG001|Booster Phase|Lost to Follow-up|2|||
170689822|NCT01340898|616874337|FG002|Booster Phase|Lost to Follow-up|3|||
170689823|NCT00416078|616874343|FG000|Overall Study|Death|3|||
170689824|NCT00416078|616874344|FG001|Overall Study|Death|4|||
170689825|NCT00416078|616874343|FG000|Overall Study|Withdrawal by Subject|3|||
170689826|NCT00416078|616874344|FG001|Overall Study|Withdrawal by Subject|2|||
170689827|NCT00416078|616874343|FG000|Overall Study|Physician Decision|1|||
170689828|NCT00416078|616874344|FG001|Overall Study|Physician Decision|0|||
170689829|NCT00416078|616874343|FG000|Overall Study|Lost to Follow-up|4|||
170689830|NCT00416078|616874344|FG001|Overall Study|Lost to Follow-up|2|||
170689831|NCT00969150|616874353|FG000|Overall Study|Adverse Event|4|||
170689832|NCT00969150|616874354|FG001|Overall Study|Adverse Event|14|||
170689833|NCT00969150|616874353|FG000|Overall Study|Lack of Efficacy|1|||
170689834|NCT00969150|616874354|FG001|Overall Study|Lack of Efficacy|1|||
170689835|NCT00969150|616874353|FG000|Overall Study|Protocol Violation|9|||
170689836|NCT00969150|616874354|FG001|Overall Study|Protocol Violation|12|||
170689837|NCT00969150|616874353|FG000|Overall Study|Withdrawal by Subject|13|||
170689838|NCT00969150|616874354|FG001|Overall Study|Withdrawal by Subject|9|||
170689839|NCT00969150|616874353|FG000|Overall Study|Lost to Follow-up|5|||
170689840|NCT00969150|616874354|FG001|Overall Study|Lost to Follow-up|4|||
170689841|NCT00969150|616874353|FG000|Overall Study|Other reasons|1|||
170689842|NCT00969150|616874354|FG001|Overall Study|Other reasons|0|||
170689843|NCT00461682|616874355|FG000|Overall Study|Protocol Violation|1|||
170689844|NCT04501666|616874360|FG000|Overall Study|Physician Decision|0|||
170689845|NCT04501666|616874361|FG001|Overall Study|Physician Decision|1|||
170689846|NCT04501666|616874360|FG000|Overall Study|Adverse Event|12|||
170689847|NCT04501666|616874361|FG001|Overall Study|Adverse Event|4|||
170689848|NCT04501666|616874360|FG000|Overall Study|Subject's request|10|||
170689849|NCT04501666|616874361|FG001|Overall Study|Subject's request|6|||
170689850|NCT04501666|616874360|FG000|Overall Study|Protocol Deviation|2|||
170689851|NCT04501666|616874361|FG001|Overall Study|Protocol Deviation|1|||
170689852|NCT04501666|616874360|FG000|Overall Study|Other-- site permanently closing|0|||
170689853|NCT04501666|616874361|FG001|Overall Study|Other-- site permanently closing|1|||
170689854|NCT04128267|616874364|FG000|Overall Study|Withdrawal by Subject|6|||
170689855|NCT04128267|616874364|FG000|Overall Study|Death|2|||
170689856|NCT04128267|616874364|FG000|Overall Study|Disease progression|1|||
170689857|NCT04128267|616874364|FG000|Overall Study|Participant had other medical issues|4|||
170689858|NCT04128267|616874364|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
170689859|NCT00642941|616874365|FG000|Overall Study|Physician Decision|3|||
170689860|NCT00642941|616874366|FG001|Overall Study|Physician Decision|1|||
170689861|NCT00642941|616874367|FG002|Overall Study|Physician Decision|0|||
170689862|NCT00642941|616874368|FG003|Overall Study|Physician Decision|0|||
170689863|NCT00642941|616874369|FG004|Overall Study|Physician Decision|0|||
170689864|NCT00642941|616874370|FG005|Overall Study|Physician Decision|0|||
170689865|NCT00642941|616874371|FG006|Overall Study|Physician Decision|1|||
170689866|NCT00642941|616874372|FG007|Overall Study|Physician Decision|0|||
170689867|NCT00642941|616874373|FG008|Overall Study|Physician Decision|0|||
170689868|NCT00642941|616874374|FG009|Overall Study|Physician Decision|1|||
170689869|NCT00642941|616874375|FG010|Overall Study|Physician Decision|0|||
170822480|NCT01780545|617357445|FG001|Overall Study|Withdrawal by Subject|1|||
170822481|NCT01780545|617357444|FG000|Overall Study|Lost to Follow-up|1|||
170822482|NCT01780545|617357445|FG001|Overall Study|Lost to Follow-up|1|||
170822483|NCT00744796|617357450|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
170822484|NCT02581189|617357454|FG000|Overall Study|Failure to return|36|||
170822485|NCT02581189|617357454|FG000|Overall Study|Withdrew consent|5|||
170822486|NCT02581189|617357454|FG000|Overall Study|Death|3|||
170822487|NCT02581189|617357454|FG000|Overall Study|Insufficient virological response|2|||
170822488|NCT02581189|617357454|FG000|Overall Study|Other, not specified|7|||
170822489|NCT01514864|617357459|FG000|Overall Study|Disease progression|7|||
170822490|NCT01514864|617357460|FG001|Overall Study|Disease progression|5|||
170822491|NCT01514864|617357459|FG000|Overall Study|Study drug toxicity|2|||
170822492|NCT01514864|617357460|FG001|Overall Study|Study drug toxicity|0|||
170822493|NCT05135156|617357461|FG000|Overall Study|Lost to Follow-up|0|||
170822494|NCT05135156|617357462|FG001|Overall Study|Lost to Follow-up|0|||
170822495|NCT05135156|617357463|FG002|Overall Study|Lost to Follow-up|2|||
170689870|NCT00642941|616874376|FG011|Overall Study|Physician Decision|1|||
170689871|NCT00642941|616874365|FG000|Overall Study|Death|4|||
170689872|NCT00642941|616874366|FG001|Overall Study|Death|0|||
170689873|NCT00642941|616874367|FG002|Overall Study|Death|1|||
170689874|NCT00642941|616874368|FG003|Overall Study|Death|1|||
170689875|NCT00642941|616874369|FG004|Overall Study|Death|2|||
170689876|NCT00642941|616874370|FG005|Overall Study|Death|1|||
170689877|NCT00642941|616874371|FG006|Overall Study|Death|0|||
170689878|NCT00642941|616874372|FG007|Overall Study|Death|0|||
170689879|NCT00642941|616874373|FG008|Overall Study|Death|0|||
170689880|NCT00642941|616874374|FG009|Overall Study|Death|0|||
170689881|NCT00642941|616874375|FG010|Overall Study|Death|0|||
170689882|NCT00642941|616874376|FG011|Overall Study|Death|1|||
170689883|NCT00642941|616874365|FG000|Overall Study|Study closed by Sponsor|0|||
170689884|NCT00642941|616874366|FG001|Overall Study|Study closed by Sponsor|1|||
170689885|NCT00642941|616874367|FG002|Overall Study|Study closed by Sponsor|0|||
170689886|NCT00642941|616874368|FG003|Overall Study|Study closed by Sponsor|0|||
170689887|NCT00642941|616874369|FG004|Overall Study|Study closed by Sponsor|0|||
170689888|NCT00642941|616874370|FG005|Overall Study|Study closed by Sponsor|0|||
170689889|NCT00642941|616874371|FG006|Overall Study|Study closed by Sponsor|0|||
170689890|NCT00642941|616874372|FG007|Overall Study|Study closed by Sponsor|0|||
170689891|NCT00642941|616874373|FG008|Overall Study|Study closed by Sponsor|0|||
170689892|NCT00642941|616874374|FG009|Overall Study|Study closed by Sponsor|0|||
170689893|NCT00642941|616874375|FG010|Overall Study|Study closed by Sponsor|0|||
170689894|NCT00642941|616874376|FG011|Overall Study|Study closed by Sponsor|0|||
170689895|NCT00642941|616874365|FG000|Overall Study|Withdrawal by Subject|1|||
170689896|NCT00642941|616874366|FG001|Overall Study|Withdrawal by Subject|0|||
170689897|NCT00642941|616874367|FG002|Overall Study|Withdrawal by Subject|0|||
170689898|NCT00642941|616874368|FG003|Overall Study|Withdrawal by Subject|2|||
170689899|NCT00642941|616874369|FG004|Overall Study|Withdrawal by Subject|0|||
170689900|NCT00642941|616874370|FG005|Overall Study|Withdrawal by Subject|0|||
170689901|NCT00642941|616874371|FG006|Overall Study|Withdrawal by Subject|2|||
170689902|NCT00642941|616874372|FG007|Overall Study|Withdrawal by Subject|0|||
170689903|NCT00642941|616874373|FG008|Overall Study|Withdrawal by Subject|1|||
170689904|NCT00642941|616874374|FG009|Overall Study|Withdrawal by Subject|0|||
170689905|NCT00642941|616874375|FG010|Overall Study|Withdrawal by Subject|0|||
170689906|NCT00642941|616874376|FG011|Overall Study|Withdrawal by Subject|1|||
170689907|NCT00642941|616874365|FG000|Overall Study|Protocol Violation|0|||
170689908|NCT00642941|616874366|FG001|Overall Study|Protocol Violation|0|||
170689909|NCT00642941|616874367|FG002|Overall Study|Protocol Violation|0|||
170689910|NCT00642941|616874368|FG003|Overall Study|Protocol Violation|0|||
170689911|NCT00642941|616874369|FG004|Overall Study|Protocol Violation|0|||
170689912|NCT00642941|616874370|FG005|Overall Study|Protocol Violation|0|||
170689913|NCT00642941|616874371|FG006|Overall Study|Protocol Violation|1|||
170822496|NCT01379521|617357473|FG000|Overall Study -Treatment Period|Adverse Event|3|||
170689914|NCT00642941|616874372|FG007|Overall Study|Protocol Violation|0|||
170822497|NCT01379521|617357474|FG001|Overall Study -Treatment Period|Adverse Event|0|||
170689915|NCT00642941|616874373|FG008|Overall Study|Protocol Violation|0|||
170689916|NCT00642941|616874374|FG009|Overall Study|Protocol Violation|0|||
170689917|NCT00642941|616874375|FG010|Overall Study|Protocol Violation|0|||
170689918|NCT00642941|616874376|FG011|Overall Study|Protocol Violation|0|||
170689919|NCT00642941|616874365|FG000|Overall Study|Adverse Event|1|||
170822498|NCT01379521|617357473|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
170689920|NCT00642941|616874366|FG001|Overall Study|Adverse Event|1|||
170689921|NCT00642941|616874367|FG002|Overall Study|Adverse Event|0|||
170822499|NCT01379521|617357474|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
170689922|NCT00642941|616874368|FG003|Overall Study|Adverse Event|0|||
170689923|NCT00642941|616874369|FG004|Overall Study|Adverse Event|0|||
170689924|NCT00642941|616874370|FG005|Overall Study|Adverse Event|0|||
170689925|NCT00642941|616874371|FG006|Overall Study|Adverse Event|1|||
170689926|NCT00642941|616874372|FG007|Overall Study|Adverse Event|1|||
170689927|NCT00642941|616874373|FG008|Overall Study|Adverse Event|0|||
170689928|NCT00642941|616874374|FG009|Overall Study|Adverse Event|1|||
170689929|NCT00642941|616874375|FG010|Overall Study|Adverse Event|0|||
170689930|NCT00642941|616874376|FG011|Overall Study|Adverse Event|0|||
170689931|NCT00642941|616874365|FG000|Overall Study|Other|1|||
170689932|NCT00642941|616874366|FG001|Overall Study|Other|1|||
170689933|NCT00642941|616874367|FG002|Overall Study|Other|1|||
170689934|NCT00642941|616874368|FG003|Overall Study|Other|1|||
170689935|NCT00642941|616874369|FG004|Overall Study|Other|0|||
170689936|NCT00642941|616874370|FG005|Overall Study|Other|1|||
170689937|NCT00642941|616874371|FG006|Overall Study|Other|0|||
170689938|NCT00642941|616874372|FG007|Overall Study|Other|1|||
170689939|NCT00642941|616874373|FG008|Overall Study|Other|0|||
170689940|NCT00642941|616874374|FG009|Overall Study|Other|0|||
170689941|NCT00642941|616874375|FG010|Overall Study|Other|0|||
170689942|NCT00642941|616874376|FG011|Overall Study|Other|1|||
170689943|NCT00642941|616874365|FG000|Overall Study|Disease progression|60|||
170689944|NCT00642941|616874366|FG001|Overall Study|Disease progression|50|||
170689945|NCT00642941|616874367|FG002|Overall Study|Disease progression|5|||
170689946|NCT00642941|616874368|FG003|Overall Study|Disease progression|36|||
170689947|NCT00642941|616874369|FG004|Overall Study|Disease progression|23|||
170689948|NCT00642941|616874370|FG005|Overall Study|Disease progression|39|||
170689949|NCT00642941|616874371|FG006|Overall Study|Disease progression|18|||
170689950|NCT00642941|616874372|FG007|Overall Study|Disease progression|12|||
170689951|NCT00642941|616874373|FG008|Overall Study|Disease progression|10|||
170689952|NCT00642941|616874374|FG009|Overall Study|Disease progression|7|||
170689953|NCT00642941|616874375|FG010|Overall Study|Disease progression|12|||
170689954|NCT00642941|616874376|FG011|Overall Study|Disease progression|7|||
170689955|NCT01698801|616874377|FG000|Treatment Phase|Adverse Event|4|||
170689956|NCT01698801|616874377|FG000|Treatment Phase|Protocol Violation|1|||
170689957|NCT01698801|616874377|FG000|Treatment Phase|Other|4|||
170689958|NCT01698801|616874377|FG000|Treatment Phase|Withdrawal by Subject|1|||
170689959|NCT01698801|616874377|FG000|Treatment Phase|Disease progression|1|||
170689960|NCT01698801|616874377|FG000|Follow Up Phase|Withdrawal by Subject|1|||
170689961|NCT01698801|616874377|FG000|Follow Up Phase|Death|4|||
170689962|NCT02998840|616874379|FG000|Overall Study|Lost to Follow-up|1|||
170689963|NCT02998840|616874380|FG001|Overall Study|Lost to Follow-up|1|||
170689964|NCT02998840|616874381|FG002|Overall Study|Lost to Follow-up|2|||
170689965|NCT02998840|616874382|FG003|Overall Study|Lost to Follow-up|3|||
170689966|NCT02998840|616874379|FG000|Overall Study|Withdrawal by Subject|1|||
170689967|NCT02998840|616874380|FG001|Overall Study|Withdrawal by Subject|1|||
170689968|NCT02998840|616874381|FG002|Overall Study|Withdrawal by Subject|0|||
170689969|NCT02998840|616874382|FG003|Overall Study|Withdrawal by Subject|1|||
170689970|NCT02998840|616874379|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
170689971|NCT02998840|616874380|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
170689972|NCT02998840|616874381|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
170689973|NCT02998840|616874382|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
170689974|NCT00616655|616874383|FG000|Overall Study|Adverse Event|10|||
170689975|NCT00616655|616874384|FG001|Overall Study|Adverse Event|7|||
170689976|NCT00616655|616874385|FG002|Overall Study|Adverse Event|12|||
170689977|NCT00616655|616874383|FG000|Overall Study|Lack of Efficacy|5|||
170689978|NCT00616655|616874384|FG001|Overall Study|Lack of Efficacy|5|||
170689979|NCT00616655|616874385|FG002|Overall Study|Lack of Efficacy|5|||
170689980|NCT00616655|616874383|FG000|Overall Study|Lost to Follow-up|3|||
170689981|NCT00616655|616874384|FG001|Overall Study|Lost to Follow-up|12|||
170689982|NCT00616655|616874385|FG002|Overall Study|Lost to Follow-up|10|||
170689983|NCT00616655|616874383|FG000|Overall Study|Protocol Violation|2|||
170689984|NCT00616655|616874384|FG001|Overall Study|Protocol Violation|4|||
170689985|NCT00616655|616874385|FG002|Overall Study|Protocol Violation|3|||
170689986|NCT00616655|616874383|FG000|Overall Study|Withdrawal by Subject|9|||
170689987|NCT00616655|616874384|FG001|Overall Study|Withdrawal by Subject|7|||
170689988|NCT00616655|616874385|FG002|Overall Study|Withdrawal by Subject|11|||
170689989|NCT00616655|616874383|FG000|Overall Study|Does not meet in/ex criteria|0|||
170689990|NCT00616655|616874384|FG001|Overall Study|Does not meet in/ex criteria|0|||
170689991|NCT00616655|616874385|FG002|Overall Study|Does not meet in/ex criteria|2|||
170689992|NCT00616655|616874383|FG000|Overall Study|Other|6|||
170689993|NCT00616655|616874384|FG001|Overall Study|Other|6|||
170689994|NCT00616655|616874385|FG002|Overall Study|Other|5|||
170689995|NCT00309842|616874386|FG000|Overall Study|Lost to Follow-up|1|||
170689996|NCT03712904|616875824|FG000|Overall Study|Death|0|||
170822500|NCT01379521|617357473|FG000|Overall Study -Treatment Period|Disease Progression|23|||
170822501|NCT01379521|617357474|FG001|Overall Study -Treatment Period|Disease Progression|22|||
170822502|NCT01379521|617357473|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
170822503|NCT01379521|617357474|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
170822504|NCT01379521|617357473|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
170689997|NCT03712904|616875825|FG001|Overall Study|Death|1|||
170689998|NCT03712904|616875824|FG000|Overall Study|Withdrawal by Subject|0|||
170689999|NCT03712904|616875825|FG001|Overall Study|Withdrawal by Subject|1|||
170690000|NCT03712904|616875824|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
170690001|NCT03712904|616875825|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
170690002|NCT04568590|616875828|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
170690003|NCT03745937|616875829|FG000|Overall Study|Withdrawal by Subject|0|||
170690004|NCT03745937|616875830|FG001|Overall Study|Withdrawal by Subject|0|||
170690005|NCT03745937|616875831|FG002|Overall Study|Withdrawal by Subject|0|||
170690006|NCT03745937|616875832|FG003|Overall Study|Withdrawal by Subject|1|||
170690007|NCT03745937|616875829|FG000|Overall Study|Not-specifed|0|||
170690008|NCT03745937|616875830|FG001|Overall Study|Not-specifed|1|||
170690009|NCT03745937|616875831|FG002|Overall Study|Not-specifed|0|||
170690010|NCT03745937|616875832|FG003|Overall Study|Not-specifed|1|||
170690011|NCT01190254|616875833|FG000|Overall Study|Adverse Event|3|||
170690012|NCT01190254|616875834|FG001|Overall Study|Adverse Event|6|||
170690013|NCT01190254|616875835|FG002|Overall Study|Adverse Event|8|||
170690014|NCT01190254|616875833|FG000|Overall Study|Lack of Efficacy|7|||
170690015|NCT01190254|616875834|FG001|Overall Study|Lack of Efficacy|4|||
170690016|NCT01190254|616875835|FG002|Overall Study|Lack of Efficacy|5|||
170690017|NCT01190254|616875833|FG000|Overall Study|Lost to Follow-up|4|||
170690018|NCT01190254|616875834|FG001|Overall Study|Lost to Follow-up|2|||
170690019|NCT01190254|616875835|FG002|Overall Study|Lost to Follow-up|0|||
170690020|NCT01190254|616875833|FG000|Overall Study|Withdrawal by Subject|4|||
170690021|NCT01190254|616875834|FG001|Overall Study|Withdrawal by Subject|5|||
170690022|NCT01190254|616875835|FG002|Overall Study|Withdrawal by Subject|7|||
170690023|NCT01190254|616875833|FG000|Overall Study|Protocol Violation|2|||
170690024|NCT01190254|616875834|FG001|Overall Study|Protocol Violation|0|||
170690025|NCT01190254|616875835|FG002|Overall Study|Protocol Violation|2|||
170690026|NCT01190254|616875833|FG000|Overall Study|Did not meet protocol eligibility|1|||
170690027|NCT01190254|616875834|FG001|Overall Study|Did not meet protocol eligibility|0|||
170690028|NCT01190254|616875835|FG002|Overall Study|Did not meet protocol eligibility|0|||
170690029|NCT00696696|616875836|FG000|Overall Study|Adverse Event|5|||
170690030|NCT00696696|616875836|FG000|Overall Study|Withdrawal by Subject|8|||
170690031|NCT00696696|616875836|FG000|Overall Study|Physician Decision|2|||
170690032|NCT00696696|616875836|FG000|Overall Study|Death|3|||
170690033|NCT02345811|616875841|FG000|First Intervention|Withdrawal by Subject|1|||
170690034|NCT02345811|616875842|FG001|First Intervention|Withdrawal by Subject|1|||
170690035|NCT02522286|616875843|FG000|Overall Study|Withdrawal by Subject|3|||
170690036|NCT02522286|616875844|FG001|Overall Study|Withdrawal by Subject|0|||
170690037|NCT02522286|616875845|FG002|Overall Study|Withdrawal by Subject|0|||
170690038|NCT02522286|616875846|FG003|Overall Study|Withdrawal by Subject|3|||
170690039|NCT02489344|616875848|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
170690040|NCT02489344|616875848|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
170690041|NCT02489344|616875848|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
170690042|NCT02489344|616875848|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
170690043|NCT00605813|616875849|FG000|Overall Study|Protocol Violation|25|||
170690044|NCT01163279|616875851|FG000|Overall Study|Withdrawal by Subject|2|||
170690045|NCT01163279|616875852|FG001|Overall Study|Withdrawal by Subject|0|||
170690046|NCT05333900|616875855|FG000|Overall Study|Protocol Violation|0|||
170690047|NCT05333900|616875856|FG001|Overall Study|Protocol Violation|1|||
170690048|NCT05333900|616875855|FG000|Overall Study|Withdrawal by Subject|0|||
170690049|NCT05333900|616875856|FG001|Overall Study|Withdrawal by Subject|1|||
170690050|NCT05333900|616875855|FG000|Overall Study|COVID-19 Pandemic|1|||
170690051|NCT05333900|616875856|FG001|Overall Study|COVID-19 Pandemic|1|||
170690052|NCT04762680|616875857|FG000|Phase 2|Adverse Event|0|||
170690053|NCT04762680|616875858|FG001|Phase 2|Adverse Event|1|||
170690054|NCT04762680|616875859|FG002|Phase 2|Adverse Event|0|||
170690055|NCT04762680|616875860|FG003|Phase 2|Adverse Event|0|||
170690056|NCT04762680|616875861|FG004|Phase 2|Adverse Event|0|||
170690057|NCT04762680|616875862|FG005|Phase 2|Adverse Event|0|||
170690058|NCT04762680|616875863|FG006|Phase 2|Adverse Event|0|||
170690059|NCT04762680|616875864|FG007|Phase 2|Adverse Event|0|||
170690060|NCT04762680|616875865|FG008|Phase 2|Adverse Event|0|||
170690061|NCT04762680|616875866|FG009|Phase 2|Adverse Event|0|||
170690062|NCT04762680|616875867|FG010|Phase 2|Adverse Event|0|||
170690063|NCT04762680|616875868|FG011|Phase 2|Adverse Event|0|||
170690064|NCT04762680|616875869|FG012|Phase 2|Adverse Event|0|||
170690065|NCT04762680|616875870|FG013|Phase 2|Adverse Event|0|||
170690066|NCT04762680|616875871|FG014|Phase 2|Adverse Event|0|||
170690067|NCT04762680|616875872|FG015|Phase 2|Adverse Event|0|||
170690068|NCT04762680|616875873|FG016|Phase 2|Adverse Event|0|||
170690069|NCT04762680|616875874|FG017|Phase 2|Adverse Event|0|||
170690070|NCT04762680|616875875|FG018|Phase 2|Adverse Event|0|||
170690071|NCT04762680|616875876|FG019|Phase 2|Adverse Event|0|||
170690072|NCT04762680|616875877|FG020|Phase 2|Adverse Event|0|||
170690073|NCT04762680|616875878|FG021|Phase 2|Adverse Event|0|||
170690074|NCT04762680|616875857|FG000|Phase 2|Protocol Violation|5|||
170690075|NCT04762680|616875858|FG001|Phase 2|Protocol Violation|5|||
170690076|NCT04762680|616875859|FG002|Phase 2|Protocol Violation|1|||
170690077|NCT04762680|616875860|FG003|Phase 2|Protocol Violation|0|||
170690078|NCT04762680|616875861|FG004|Phase 2|Protocol Violation|0|||
170690079|NCT04762680|616875862|FG005|Phase 2|Protocol Violation|0|||
170690080|NCT04762680|616875863|FG006|Phase 2|Protocol Violation|0|||
170690081|NCT04762680|616875864|FG007|Phase 2|Protocol Violation|0|||
170690082|NCT04762680|616875865|FG008|Phase 2|Protocol Violation|0|||
170690083|NCT04762680|616875866|FG009|Phase 2|Protocol Violation|0|||
170690084|NCT04762680|616875867|FG010|Phase 2|Protocol Violation|0|||
170690085|NCT04762680|616875868|FG011|Phase 2|Protocol Violation|0|||
170690086|NCT04762680|616875869|FG012|Phase 2|Protocol Violation|0|||
170690087|NCT04762680|616875870|FG013|Phase 2|Protocol Violation|0|||
170690088|NCT04762680|616875871|FG014|Phase 2|Protocol Violation|0|||
170690089|NCT04762680|616875872|FG015|Phase 2|Protocol Violation|0|||
170690090|NCT04762680|616875873|FG016|Phase 2|Protocol Violation|0|||
170690091|NCT04762680|616875874|FG017|Phase 2|Protocol Violation|0|||
170690092|NCT04762680|616875875|FG018|Phase 2|Protocol Violation|0|||
170690093|NCT04762680|616875876|FG019|Phase 2|Protocol Violation|0|||
170690094|NCT04762680|616875877|FG020|Phase 2|Protocol Violation|0|||
170690095|NCT04762680|616875878|FG021|Phase 2|Protocol Violation|0|||
170690096|NCT04762680|616875857|FG000|Phase 2|Withdrawal by Subject|23|||
170690097|NCT04762680|616875858|FG001|Phase 2|Withdrawal by Subject|21|||
170690098|NCT04762680|616875859|FG002|Phase 2|Withdrawal by Subject|28|||
170690099|NCT04762680|616875860|FG003|Phase 2|Withdrawal by Subject|0|||
170690100|NCT04762680|616875861|FG004|Phase 2|Withdrawal by Subject|0|||
170690101|NCT04762680|616875862|FG005|Phase 2|Withdrawal by Subject|0|||
170690102|NCT04762680|616875863|FG006|Phase 2|Withdrawal by Subject|0|||
170690103|NCT04762680|616875864|FG007|Phase 2|Withdrawal by Subject|0|||
170690104|NCT04762680|616875865|FG008|Phase 2|Withdrawal by Subject|0|||
170690105|NCT04762680|616875866|FG009|Phase 2|Withdrawal by Subject|0|||
170690106|NCT04762680|616875867|FG010|Phase 2|Withdrawal by Subject|0|||
170690107|NCT04762680|616875868|FG011|Phase 2|Withdrawal by Subject|0|||
170690108|NCT04762680|616875869|FG012|Phase 2|Withdrawal by Subject|0|||
170690109|NCT04762680|616875870|FG013|Phase 2|Withdrawal by Subject|0|||
170690110|NCT04762680|616875871|FG014|Phase 2|Withdrawal by Subject|0|||
170690111|NCT04762680|616875872|FG015|Phase 2|Withdrawal by Subject|0|||
170690112|NCT04762680|616875873|FG016|Phase 2|Withdrawal by Subject|0|||
170690113|NCT04762680|616875874|FG017|Phase 2|Withdrawal by Subject|0|||
170690114|NCT04762680|616875875|FG018|Phase 2|Withdrawal by Subject|0|||
170690115|NCT04762680|616875876|FG019|Phase 2|Withdrawal by Subject|0|||
170690116|NCT04762680|616875877|FG020|Phase 2|Withdrawal by Subject|0|||
170690117|NCT04762680|616875878|FG021|Phase 2|Withdrawal by Subject|0|||
170690118|NCT04762680|616875857|FG000|Phase 2|Lost to Follow-up|14|||
170690119|NCT04762680|616875858|FG001|Phase 2|Lost to Follow-up|8|||
170690120|NCT04762680|616875859|FG002|Phase 2|Lost to Follow-up|9|||
170690121|NCT04762680|616875860|FG003|Phase 2|Lost to Follow-up|0|||
170690122|NCT04762680|616875861|FG004|Phase 2|Lost to Follow-up|0|||
170690123|NCT04762680|616875862|FG005|Phase 2|Lost to Follow-up|0|||
170690124|NCT04762680|616875863|FG006|Phase 2|Lost to Follow-up|0|||
170690125|NCT04762680|616875864|FG007|Phase 2|Lost to Follow-up|0|||
170690126|NCT04762680|616875865|FG008|Phase 2|Lost to Follow-up|0|||
170690127|NCT04762680|616875866|FG009|Phase 2|Lost to Follow-up|0|||
170690128|NCT04762680|616875867|FG010|Phase 2|Lost to Follow-up|0|||
170690129|NCT04762680|616875868|FG011|Phase 2|Lost to Follow-up|0|||
170690130|NCT04762680|616875869|FG012|Phase 2|Lost to Follow-up|0|||
170690131|NCT04762680|616875870|FG013|Phase 2|Lost to Follow-up|0|||
170690132|NCT04762680|616875871|FG014|Phase 2|Lost to Follow-up|0|||
170690133|NCT04762680|616875872|FG015|Phase 2|Lost to Follow-up|0|||
170690134|NCT04762680|616875873|FG016|Phase 2|Lost to Follow-up|0|||
170690135|NCT04762680|616875874|FG017|Phase 2|Lost to Follow-up|0|||
170690136|NCT04762680|616875875|FG018|Phase 2|Lost to Follow-up|0|||
170690137|NCT04762680|616875876|FG019|Phase 2|Lost to Follow-up|0|||
170690138|NCT04762680|616875877|FG020|Phase 2|Lost to Follow-up|0|||
170690139|NCT04762680|616875878|FG021|Phase 2|Lost to Follow-up|0|||
170690140|NCT04762680|616875857|FG000|Phase 3|Adverse Event|0|||
170690141|NCT04762680|616875858|FG001|Phase 3|Adverse Event|0|||
170690142|NCT04762680|616875859|FG002|Phase 3|Adverse Event|0|||
170690143|NCT04762680|616875860|FG003|Phase 3|Adverse Event|1|||
170690144|NCT04762680|616875861|FG004|Phase 3|Adverse Event|0|||
170690145|NCT04762680|616875862|FG005|Phase 3|Adverse Event|0|||
170690146|NCT04762680|616875863|FG006|Phase 3|Adverse Event|0|||
170690147|NCT04762680|616875864|FG007|Phase 3|Adverse Event|0|||
170690148|NCT04762680|616875865|FG008|Phase 3|Adverse Event|0|||
170690149|NCT04762680|616875866|FG009|Phase 3|Adverse Event|0|||
170690150|NCT04762680|616875867|FG010|Phase 3|Adverse Event|0|||
170690151|NCT04762680|616875868|FG011|Phase 3|Adverse Event|0|||
170690152|NCT04762680|616875869|FG012|Phase 3|Adverse Event|0|||
170690153|NCT04762680|616875870|FG013|Phase 3|Adverse Event|0|||
170690154|NCT04762680|616875871|FG014|Phase 3|Adverse Event|0|||
170690155|NCT04762680|616875872|FG015|Phase 3|Adverse Event|0|||
170690156|NCT04762680|616875873|FG016|Phase 3|Adverse Event|0|||
170690157|NCT04762680|616875874|FG017|Phase 3|Adverse Event|3|||
170690158|NCT04762680|616875875|FG018|Phase 3|Adverse Event|0|||
170690159|NCT04762680|616875876|FG019|Phase 3|Adverse Event|0|||
170690160|NCT04762680|616875877|FG020|Phase 3|Adverse Event|0|||
170690161|NCT04762680|616875878|FG021|Phase 3|Adverse Event|0|||
170690162|NCT04762680|616875857|FG000|Phase 3|Protocol Violation|0|||
170690163|NCT04762680|616875858|FG001|Phase 3|Protocol Violation|0|||
170690164|NCT04762680|616875859|FG002|Phase 3|Protocol Violation|0|||
170690165|NCT04762680|616875860|FG003|Phase 3|Protocol Violation|4|||
170690166|NCT04762680|616875861|FG004|Phase 3|Protocol Violation|1|||
170690167|NCT04762680|616875862|FG005|Phase 3|Protocol Violation|5|||
170690168|NCT04762680|616875863|FG006|Phase 3|Protocol Violation|1|||
170690169|NCT04762680|616875864|FG007|Phase 3|Protocol Violation|0|||
170690170|NCT04762680|616875865|FG008|Phase 3|Protocol Violation|0|||
170690171|NCT04762680|616875866|FG009|Phase 3|Protocol Violation|0|||
170690172|NCT04762680|616875867|FG010|Phase 3|Protocol Violation|0|||
170690173|NCT04762680|616875868|FG011|Phase 3|Protocol Violation|2|||
170690174|NCT04762680|616875869|FG012|Phase 3|Protocol Violation|3|||
170690175|NCT04762680|616875870|FG013|Phase 3|Protocol Violation|0|||
170690176|NCT04762680|616875871|FG014|Phase 3|Protocol Violation|0|||
170690177|NCT04762680|616875872|FG015|Phase 3|Protocol Violation|1|||
170690178|NCT04762680|616875873|FG016|Phase 3|Protocol Violation|0|||
170690179|NCT04762680|616875874|FG017|Phase 3|Protocol Violation|10|||
170690180|NCT04762680|616875875|FG018|Phase 3|Protocol Violation|0|||
170690181|NCT04762680|616875876|FG019|Phase 3|Protocol Violation|0|||
170690182|NCT04762680|616875877|FG020|Phase 3|Protocol Violation|0|||
170690183|NCT04762680|616875878|FG021|Phase 3|Protocol Violation|0|||
170690184|NCT04762680|616875857|FG000|Phase 3|Withdrawal by Subject|0|||
170690185|NCT04762680|616875858|FG001|Phase 3|Withdrawal by Subject|0|||
170690186|NCT04762680|616875859|FG002|Phase 3|Withdrawal by Subject|0|||
170690187|NCT04762680|616875860|FG003|Phase 3|Withdrawal by Subject|13|||
170690188|NCT04762680|616875861|FG004|Phase 3|Withdrawal by Subject|17|||
170690189|NCT04762680|616875862|FG005|Phase 3|Withdrawal by Subject|12|||
170690190|NCT04762680|616875863|FG006|Phase 3|Withdrawal by Subject|8|||
170690191|NCT04762680|616875864|FG007|Phase 3|Withdrawal by Subject|3|||
170690192|NCT04762680|616875865|FG008|Phase 3|Withdrawal by Subject|2|||
170690193|NCT04762680|616875866|FG009|Phase 3|Withdrawal by Subject|4|||
170690194|NCT04762680|616875867|FG010|Phase 3|Withdrawal by Subject|3|||
170690195|NCT04762680|616875868|FG011|Phase 3|Withdrawal by Subject|1|||
170690196|NCT04762680|616875869|FG012|Phase 3|Withdrawal by Subject|3|||
170690197|NCT04762680|616875870|FG013|Phase 3|Withdrawal by Subject|2|||
170690198|NCT04762680|616875871|FG014|Phase 3|Withdrawal by Subject|1|||
170690199|NCT04762680|616875872|FG015|Phase 3|Withdrawal by Subject|4|||
170690200|NCT04762680|616875873|FG016|Phase 3|Withdrawal by Subject|6|||
170690201|NCT04762680|616875874|FG017|Phase 3|Withdrawal by Subject|32|||
170690202|NCT04762680|616875875|FG018|Phase 3|Withdrawal by Subject|0|||
170690203|NCT04762680|616875876|FG019|Phase 3|Withdrawal by Subject|0|||
170690204|NCT04762680|616875877|FG020|Phase 3|Withdrawal by Subject|0|||
170690205|NCT04762680|616875878|FG021|Phase 3|Withdrawal by Subject|0|||
170690206|NCT04762680|616875857|FG000|Phase 3|Lost to Follow-up|0|||
170690207|NCT04762680|616875858|FG001|Phase 3|Lost to Follow-up|0|||
170690208|NCT04762680|616875859|FG002|Phase 3|Lost to Follow-up|0|||
170690209|NCT04762680|616875860|FG003|Phase 3|Lost to Follow-up|9|||
170690210|NCT04762680|616875861|FG004|Phase 3|Lost to Follow-up|22|||
170690211|NCT04762680|616875862|FG005|Phase 3|Lost to Follow-up|24|||
170690212|NCT04762680|616875863|FG006|Phase 3|Lost to Follow-up|2|||
170690213|NCT04762680|616875864|FG007|Phase 3|Lost to Follow-up|4|||
170690214|NCT04762680|616875865|FG008|Phase 3|Lost to Follow-up|6|||
170690215|NCT04762680|616875866|FG009|Phase 3|Lost to Follow-up|4|||
170690216|NCT04762680|616875867|FG010|Phase 3|Lost to Follow-up|3|||
170690217|NCT04762680|616875868|FG011|Phase 3|Lost to Follow-up|0|||
170690218|NCT04762680|616875869|FG012|Phase 3|Lost to Follow-up|5|||
170690219|NCT04762680|616875870|FG013|Phase 3|Lost to Follow-up|4|||
170690220|NCT04762680|616875871|FG014|Phase 3|Lost to Follow-up|6|||
170690221|NCT04762680|616875872|FG015|Phase 3|Lost to Follow-up|1|||
170690222|NCT04762680|616875873|FG016|Phase 3|Lost to Follow-up|1|||
170690223|NCT04762680|616875874|FG017|Phase 3|Lost to Follow-up|66|||
170690224|NCT04762680|616875875|FG018|Phase 3|Lost to Follow-up|0|||
170690225|NCT04762680|616875876|FG019|Phase 3|Lost to Follow-up|0|||
170690226|NCT04762680|616875877|FG020|Phase 3|Lost to Follow-up|0|||
170690227|NCT04762680|616875878|FG021|Phase 3|Lost to Follow-up|0|||
170690228|NCT04762680|616875857|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690229|NCT04762680|616875858|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690230|NCT04762680|616875859|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690231|NCT04762680|616875860|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690232|NCT04762680|616875861|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690233|NCT04762680|616875862|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690234|NCT04762680|616875863|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690235|NCT04762680|616875864|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690236|NCT04762680|616875865|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690237|NCT04762680|616875866|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690238|NCT04762680|616875867|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690239|NCT04762680|616875868|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690240|NCT04762680|616875869|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690241|NCT04762680|616875870|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690242|NCT04762680|616875871|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690243|NCT04762680|616875872|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690244|NCT04762680|616875873|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690245|NCT04762680|616875874|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690246|NCT04762680|616875875|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690247|NCT04762680|616875876|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690248|NCT04762680|616875877|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
170690249|NCT04762680|616875878|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
170690250|NCT04762680|616875857|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690251|NCT04762680|616875858|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690252|NCT04762680|616875859|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690253|NCT04762680|616875860|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690254|NCT04762680|616875861|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690255|NCT04762680|616875862|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690256|NCT04762680|616875863|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690257|NCT04762680|616875864|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690258|NCT04762680|616875865|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690259|NCT04762680|616875866|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690260|NCT04762680|616875867|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690261|NCT04762680|616875868|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690262|NCT04762680|616875869|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690263|NCT04762680|616875870|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690264|NCT04762680|616875871|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690265|NCT04762680|616875872|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690266|NCT04762680|616875873|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690267|NCT04762680|616875874|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690268|NCT04762680|616875875|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690269|NCT04762680|616875876|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
170690270|NCT04762680|616875877|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690271|NCT04762680|616875878|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
170690272|NCT01290666|616875879|FG000|Overall Study|Lost to Follow-up|11|||
170690273|NCT01290666|616875879|FG000|Overall Study|Withdrawal by Subject|23|||
170690274|NCT01290666|616875879|FG000|Overall Study|Early Termination of Study|4|||
170690275|NCT03227029|616875880|FG000|Overall Study|Child Wheezed (no treatment)|0|||
170690276|NCT03227029|616875881|FG001|Overall Study|Child Wheezed (no treatment)|1|||
170690277|NCT03227029|616875882|FG002|Overall Study|Child Wheezed (no treatment)|0|||
170690278|NCT03227029|616875880|FG000|Overall Study|No post RSV season visit due to COVID|3|||
170690279|NCT03227029|616875881|FG001|Overall Study|No post RSV season visit due to COVID|3|||
170690280|NCT03227029|616875882|FG002|Overall Study|No post RSV season visit due to COVID|2|||
170690281|NCT03227029|616875880|FG000|Overall Study|Not able to get to clinic|0|||
170690282|NCT03227029|616875881|FG001|Overall Study|Not able to get to clinic|0|||
170690283|NCT03227029|616875882|FG002|Overall Study|Not able to get to clinic|1|||
170690284|NCT03227029|616875880|FG000|Overall Study|Withdrawal by Subject|1|||
170690285|NCT03227029|616875881|FG001|Overall Study|Withdrawal by Subject|0|||
170690286|NCT03227029|616875882|FG002|Overall Study|Withdrawal by Subject|0|||
170690287|NCT03227029|616875880|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
170690288|NCT03227029|616875881|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
170690289|NCT03227029|616875882|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
170690290|NCT02728895|616875887|FG000|Overall Study|Other|1|||
170690291|NCT02728895|616875888|FG001|Overall Study|Other|2|||
170690292|NCT02728895|616875887|FG000|Overall Study|Withdrawal by Subject|0|||
170690293|NCT02728895|616875888|FG001|Overall Study|Withdrawal by Subject|3|||
170690294|NCT02769247|616875889|FG000|Overall Study|Withdrawal by Subject|1|||
170690295|NCT02769247|616875890|FG001|Overall Study|Withdrawal by Subject|0|||
170690296|NCT02769247|616875891|FG002|Overall Study|Withdrawal by Subject|0|||
170690297|NCT02769247|616875892|FG003|Overall Study|Withdrawal by Subject|1|||
170690298|NCT02769247|616875889|FG000|Overall Study|Protocol Violation|0|||
170690299|NCT02769247|616875890|FG001|Overall Study|Protocol Violation|0|||
170690300|NCT02769247|616875891|FG002|Overall Study|Protocol Violation|1|||
170690301|NCT02769247|616875892|FG003|Overall Study|Protocol Violation|0|||
170690302|NCT02769247|616875889|FG000|Overall Study|Physician Decision|1|||
170690303|NCT02769247|616875890|FG001|Overall Study|Physician Decision|0|||
170690304|NCT02769247|616875891|FG002|Overall Study|Physician Decision|0|||
170690305|NCT02769247|616875892|FG003|Overall Study|Physician Decision|0|||
170690306|NCT04788953|616875893|FG000|Overall Study|Adverse Event|1|||
170690307|NCT04788953|616875894|FG001|Overall Study|Adverse Event|1|||
170690308|NCT04788953|616875893|FG000|Overall Study|Withdrawal by Subject|1|||
170690309|NCT04788953|616875894|FG001|Overall Study|Withdrawal by Subject|0|||
170690310|NCT04788953|616875893|FG000|Overall Study|Protocol Violation|0|||
170690311|NCT04788953|616875894|FG001|Overall Study|Protocol Violation|1|||
170690312|NCT00469092|616875895|FG000|Overall Study|Adverse Event|5|||
170690313|NCT00469092|616875896|FG001|Overall Study|Adverse Event|4|||
170690314|NCT00469092|616875895|FG000|Overall Study|Lack of Efficacy|1|||
170690315|NCT00469092|616875896|FG001|Overall Study|Lack of Efficacy|0|||
170690316|NCT00469092|616875895|FG000|Overall Study|Lost to Follow-up|1|||
170690317|NCT00469092|616875896|FG001|Overall Study|Lost to Follow-up|2|||
170690318|NCT00469092|616875895|FG000|Overall Study|Protocol Violation|3|||
170690319|NCT00469092|616875896|FG001|Overall Study|Protocol Violation|3|||
170690320|NCT00469092|616875895|FG000|Overall Study|Withdrawal by Subject|4|||
170690321|NCT00469092|616875896|FG001|Overall Study|Withdrawal by Subject|4|||
170690322|NCT00469092|616875895|FG000|Overall Study|Withdrawal Criteria|3|||
170690323|NCT00469092|616875896|FG001|Overall Study|Withdrawal Criteria|4|||
170690324|NCT00469092|616875895|FG000|Overall Study|Incorrectly Randomised|4|||
170690325|NCT00469092|616875896|FG001|Overall Study|Incorrectly Randomised|3|||
170690326|NCT00469092|616875895|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
170690327|NCT00469092|616875896|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
170690328|NCT00469092|616875895|FG000|Overall Study|Use of lipid lowering drug|1|||
170690329|NCT00469092|616875896|FG001|Overall Study|Use of lipid lowering drug|0|||
170690330|NCT00469092|616875895|FG000|Overall Study|Hypoglycaemic Episodes|1|||
170690331|NCT00469092|616875896|FG001|Overall Study|Hypoglycaemic Episodes|1|||
170690332|NCT00469092|616875895|FG000|Overall Study|Abnormal lab value|1|||
170690333|NCT00469092|616875896|FG001|Overall Study|Abnormal lab value|0|||
170690334|NCT00469092|616875895|FG000|Overall Study|Use of Corticosteroid|1|||
170690335|NCT00469092|616875896|FG001|Overall Study|Use of Corticosteroid|0|||
170690336|NCT01998633|616875897|FG000|Overall Study|Death|1|||
170690337|NCT05089682|616875899|FG000|Overall Study|Withdrawal by Subject|2|||
170690338|NCT02278263|616875902|FG000|Overall Study|Protocol Violation|7|||
170690339|NCT02278263|616875903|FG001|Overall Study|Protocol Violation|0|||
170690340|NCT02278263|616875904|FG002|Overall Study|Protocol Violation|9|||
170690341|NCT01998737|616875905|FG000|Overall Study|Corrupted database|23|||
170690342|NCT01998737|616875906|FG001|Overall Study|Corrupted database|0|||
170690343|NCT02092662|616875909|FG000|Overall Study|Lost to Follow-up|13|||
170690344|NCT02092662|616875910|FG001|Overall Study|Lost to Follow-up|0|||
170690345|NCT00772707|616875912|FG000|Overall Study|Withdrawn|3|||
170690346|NCT02574247|616875915|FG000|Overall Study|Withdrawal by Subject|1|||
170690347|NCT02574247|616875916|FG001|Overall Study|Withdrawal by Subject|0|||
170690348|NCT02574247|616875917|FG002|Overall Study|Withdrawal by Subject|0|||
170690349|NCT02574247|616875915|FG000|Overall Study|Did not meet inclusion criteria|4|||
170690350|NCT02574247|616875916|FG001|Overall Study|Did not meet inclusion criteria|3|||
170690351|NCT02574247|616875917|FG002|Overall Study|Did not meet inclusion criteria|5|||
170690352|NCT01705652|616875920|FG000|Overall Study|Adverse Event|1|||
170690353|NCT01705652|616875921|FG001|Overall Study|Adverse Event|0|||
170690354|NCT01705652|616875920|FG000|Overall Study|Withdrawal by Subject|1|||
170690355|NCT01705652|616875921|FG001|Overall Study|Withdrawal by Subject|2|||
170690356|NCT01705652|616875920|FG000|Overall Study|non-compliance|1|||
170690357|NCT01705652|616875921|FG001|Overall Study|non-compliance|1|||
170690358|NCT01288287|616875923|FG000|Overall Study|Lost to Follow-up|8|||
170690359|NCT01288287|616875923|FG000|Overall Study|Withdrawal by Subject|4|||
170690360|NCT01288287|616875923|FG000|Overall Study|Lack of Efficacy|13|||
170690361|NCT01288287|616875923|FG000|Overall Study|Other Reason|13|||
170690362|NCT01288287|616875923|FG000|Overall Study|Unknown Reason|1|||
170690363|NCT01288287|616875923|FG000|Overall Study|Unknown Status|7|||
170690364|NCT01472081|616875924|FG000|Overall Study|Continuing treatment at time of analysis|1|||
170690365|NCT01472081|616875925|FG001|Overall Study|Continuing treatment at time of analysis|4|||
170690366|NCT01472081|616875926|FG002|Overall Study|Continuing treatment at time of analysis|1|||
170690367|NCT01472081|616875927|FG003|Overall Study|Continuing treatment at time of analysis|8|||
170690368|NCT01472081|616875928|FG004|Overall Study|Continuing treatment at time of analysis|9|||
170690369|NCT01472081|616875929|FG005|Overall Study|Continuing treatment at time of analysis|0|||
170690370|NCT01472081|616875924|FG000|Overall Study|Disease Progression|4|||
170690371|NCT01472081|616875925|FG001|Overall Study|Disease Progression|10|||
170690372|NCT01472081|616875926|FG002|Overall Study|Disease Progression|12|||
170690373|NCT01472081|616875927|FG003|Overall Study|Disease Progression|31|||
170690374|NCT01472081|616875928|FG004|Overall Study|Disease Progression|22|||
170690375|NCT01472081|616875929|FG005|Overall Study|Disease Progression|3|||
170690376|NCT01472081|616875924|FG000|Overall Study|Study drug toxicity|2|||
170690377|NCT01472081|616875925|FG001|Overall Study|Study drug toxicity|9|||
170690378|NCT01472081|616875926|FG002|Overall Study|Study drug toxicity|4|||
170690379|NCT01472081|616875927|FG003|Overall Study|Study drug toxicity|6|||
170690380|NCT01472081|616875928|FG004|Overall Study|Study drug toxicity|13|||
170690381|NCT01472081|616875929|FG005|Overall Study|Study drug toxicity|2|||
170690382|NCT01472081|616875924|FG000|Overall Study|Death|0|||
170690383|NCT01472081|616875925|FG001|Overall Study|Death|0|||
170690384|NCT01472081|616875926|FG002|Overall Study|Death|0|||
170690385|NCT01472081|616875927|FG003|Overall Study|Death|0|||
170690386|NCT01472081|616875928|FG004|Overall Study|Death|1|||
170690387|NCT01472081|616875929|FG005|Overall Study|Death|0|||
170690388|NCT01472081|616875924|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
170690389|NCT01472081|616875925|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
170690390|NCT01472081|616875926|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
170690391|NCT01472081|616875927|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
170690392|NCT01472081|616875928|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
170690393|NCT01472081|616875929|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
170690394|NCT01472081|616875924|FG000|Overall Study|Withdrawal by Subject|0|||
170690395|NCT01472081|616875925|FG001|Overall Study|Withdrawal by Subject|0|||
170690396|NCT01472081|616875926|FG002|Overall Study|Withdrawal by Subject|0|||
170690397|NCT01472081|616875927|FG003|Overall Study|Withdrawal by Subject|0|||
170690398|NCT01472081|616875928|FG004|Overall Study|Withdrawal by Subject|0|||
170690399|NCT01472081|616875929|FG005|Overall Study|Withdrawal by Subject|1|||
170690400|NCT01472081|616875924|FG000|Overall Study|Poor/non-compliance|0|||
170690401|NCT01472081|616875925|FG001|Overall Study|Poor/non-compliance|0|||
170690402|NCT01472081|616875926|FG002|Overall Study|Poor/non-compliance|1|||
170690403|NCT01472081|616875927|FG003|Overall Study|Poor/non-compliance|0|||
170690404|NCT01472081|616875928|FG004|Overall Study|Poor/non-compliance|1|||
170690405|NCT01472081|616875929|FG005|Overall Study|Poor/non-compliance|0|||
170690406|NCT01472081|616875924|FG000|Overall Study|No longer meets study criteria|0|||
170690407|NCT01472081|616875925|FG001|Overall Study|No longer meets study criteria|0|||
170690408|NCT01472081|616875926|FG002|Overall Study|No longer meets study criteria|1|||
170690409|NCT01472081|616875927|FG003|Overall Study|No longer meets study criteria|0|||
170690410|NCT01472081|616875928|FG004|Overall Study|No longer meets study criteria|0|||
170690411|NCT01472081|616875929|FG005|Overall Study|No longer meets study criteria|0|||
170690412|NCT01472081|616875924|FG000|Overall Study|Subject request to discontinue treatment|0|||
170690413|NCT01472081|616875925|FG001|Overall Study|Subject request to discontinue treatment|3|||
170690414|NCT01472081|616875926|FG002|Overall Study|Subject request to discontinue treatment|1|||
170690415|NCT01472081|616875927|FG003|Overall Study|Subject request to discontinue treatment|1|||
170690416|NCT01472081|616875928|FG004|Overall Study|Subject request to discontinue treatment|0|||
170690417|NCT01472081|616875929|FG005|Overall Study|Subject request to discontinue treatment|0|||
170690418|NCT00101907|616875931|FG000|Overall Study|Adverse Event|1|||
170690419|NCT00101907|616875932|FG001|Overall Study|Adverse Event|0|||
170690420|NCT00101907|616875933|FG002|Overall Study|Adverse Event|0|||
170690421|NCT00101907|616875934|FG003|Overall Study|Adverse Event|0|||
170690422|NCT00101907|616875935|FG004|Overall Study|Adverse Event|0|||
170690423|NCT00101907|616875936|FG005|Overall Study|Adverse Event|0|||
170690424|NCT00101907|616875931|FG000|Overall Study|Death|0|||
170690425|NCT00101907|616875932|FG001|Overall Study|Death|1|||
170690426|NCT00101907|616875933|FG002|Overall Study|Death|0|||
170690427|NCT00101907|616875934|FG003|Overall Study|Death|0|||
170690428|NCT00101907|616875935|FG004|Overall Study|Death|3|||
170690429|NCT00101907|616875936|FG005|Overall Study|Death|0|||
170690430|NCT00101907|616875931|FG000|Overall Study|Physician Decision|0|||
170690431|NCT00101907|616875932|FG001|Overall Study|Physician Decision|0|||
170690432|NCT00101907|616875933|FG002|Overall Study|Physician Decision|0|||
170690433|NCT00101907|616875934|FG003|Overall Study|Physician Decision|1|||
170690434|NCT00101907|616875935|FG004|Overall Study|Physician Decision|1|||
170690435|NCT00101907|616875936|FG005|Overall Study|Physician Decision|0|||
170690436|NCT00101907|616875931|FG000|Overall Study|Withdrawal by Subject|1|||
170690437|NCT00101907|616875932|FG001|Overall Study|Withdrawal by Subject|0|||
170690438|NCT00101907|616875933|FG002|Overall Study|Withdrawal by Subject|1|||
170690439|NCT00101907|616875934|FG003|Overall Study|Withdrawal by Subject|0|||
170690440|NCT00101907|616875935|FG004|Overall Study|Withdrawal by Subject|1|||
170690441|NCT00101907|616875936|FG005|Overall Study|Withdrawal by Subject|0|||
170690442|NCT04702997|616875938|FG000|Overall Study|Withdrawal by Subject|1|||
170690443|NCT04702997|616875939|FG001|Overall Study|Withdrawal by Subject|1|||
170690444|NCT03915496|616875940|FG000|Overall Study|Adverse Event|2|||
170690445|NCT03915496|616875941|FG001|Overall Study|Adverse Event|1|||
170690446|NCT03915496|616875942|FG002|Overall Study|Adverse Event|2|||
170690447|NCT01103284|616875943|FG000|Overall Study|Death|2|||
170690448|NCT01103284|616875944|FG001|Overall Study|Death|0|||
170690449|NCT01103284|616875943|FG000|Overall Study|Lost to Follow-up|9|||
170690450|NCT01103284|616875944|FG001|Overall Study|Lost to Follow-up|10|||
170690451|NCT01103284|616875943|FG000|Overall Study|Pregnancy|3|||
170690452|NCT01103284|616875944|FG001|Overall Study|Pregnancy|1|||
170690453|NCT01103284|616875943|FG000|Overall Study|Protocol Violation|12|||
170690454|NCT01103284|616875944|FG001|Overall Study|Protocol Violation|5|||
170690455|NCT01103284|616875943|FG000|Overall Study|Adverse Event|0|||
170690456|NCT01103284|616875944|FG001|Overall Study|Adverse Event|5|||
170690457|NCT01103284|616875943|FG000|Overall Study|Withdrawal by Subject|14|||
170690458|NCT01103284|616875944|FG001|Overall Study|Withdrawal by Subject|18|||
170690459|NCT01103284|616875943|FG000|Overall Study|Dermal Hypersensitivity|0|||
170690460|NCT01103284|616875944|FG001|Overall Study|Dermal Hypersensitivity|1|||
170690461|NCT01103284|616875943|FG000|Overall Study|Termination by the Sponsor|0|||
170690462|NCT01103284|616875944|FG001|Overall Study|Termination by the Sponsor|1|||
170690463|NCT01103284|616875943|FG000|Overall Study|Not described|2|||
170690464|NCT01103284|616875944|FG001|Overall Study|Not described|1|||
170690465|NCT01103284|616875943|FG000|Overall Study|Missing CRF entries for study completion|0|||
170690466|NCT01103284|616875944|FG001|Overall Study|Missing CRF entries for study completion|2|||
170690467|NCT04318080|616877679|FG000|Overall Study|Study closed by sponsor|10|||
170690468|NCT04318080|616877680|FG001|Overall Study|Study closed by sponsor|22|||
170690469|NCT04318080|616877679|FG000|Overall Study|Death|3|||
170690470|NCT04318080|616877680|FG001|Overall Study|Death|9|||
170690471|NCT04318080|616877679|FG000|Overall Study|Withdrawal by Subject|1|||
170690472|NCT04318080|616877680|FG001|Overall Study|Withdrawal by Subject|0|||
170690473|NCT04318080|616877679|FG000|Overall Study|Protocol Deviation|1|||
170690474|NCT04318080|616877680|FG001|Overall Study|Protocol Deviation|0|||
170690475|NCT06308822|616877681|FG000|Overall Study|Mutation Status Not Confirmed|17|||
170690476|NCT06308822|616877681|FG000|Overall Study|Adverse Event|1|||
170690477|NCT06308822|616877681|FG000|Overall Study|Death|5|||
170690478|NCT06308822|616877681|FG000|Overall Study|Disease progression|8|||
170690479|NCT06308822|616877681|FG000|Overall Study|Withdrawal by Subject|1|||
170690480|NCT06308822|616877681|FG000|Overall Study|Physician Decision|3|||
170690481|NCT01536379|616877683|FG000|Overall Study|Adverse Event|1|||
170690482|NCT01536379|616877684|FG001|Overall Study|Adverse Event|2|||
170690483|NCT01536379|616877683|FG000|Overall Study|Withdrawal by Subject|1|||
170690484|NCT01536379|616877684|FG001|Overall Study|Withdrawal by Subject|1|||
170690485|NCT02659631|616877691|FG000|Overall Study|Lost to Follow-up|0|||
170690486|NCT02659631|616877692|FG001|Overall Study|Lost to Follow-up|0|||
170690487|NCT02659631|616877693|FG002|Overall Study|Lost to Follow-up|2|||
170690488|NCT02659631|616877694|FG003|Overall Study|Lost to Follow-up|0|||
170690489|NCT02659631|616877695|FG004|Overall Study|Lost to Follow-up|0|||
170690490|NCT02659631|616877696|FG005|Overall Study|Lost to Follow-up|1|||
170690491|NCT02659631|616877697|FG006|Overall Study|Lost to Follow-up|0|||
170690492|NCT02659631|616877698|FG007|Overall Study|Lost to Follow-up|0|||
170690493|NCT02659631|616877699|FG008|Overall Study|Lost to Follow-up|0|||
170690494|NCT02659631|616877700|FG009|Overall Study|Lost to Follow-up|0|||
170690495|NCT02659631|616877691|FG000|Overall Study|Withdrawal prior to treatment|0|||
170690496|NCT02659631|616877692|FG001|Overall Study|Withdrawal prior to treatment|0|||
170690497|NCT02659631|616877693|FG002|Overall Study|Withdrawal prior to treatment|0|||
170690498|NCT02659631|616877694|FG003|Overall Study|Withdrawal prior to treatment|0|||
170690499|NCT02659631|616877695|FG004|Overall Study|Withdrawal prior to treatment|1|||
170690500|NCT02659631|616877696|FG005|Overall Study|Withdrawal prior to treatment|0|||
170690501|NCT02659631|616877697|FG006|Overall Study|Withdrawal prior to treatment|0|||
170690502|NCT02659631|616877698|FG007|Overall Study|Withdrawal prior to treatment|0|||
170690503|NCT02659631|616877699|FG008|Overall Study|Withdrawal prior to treatment|0|||
170690504|NCT02659631|616877700|FG009|Overall Study|Withdrawal prior to treatment|0|||
170690505|NCT02659631|616877691|FG000|Overall Study|Participant refused further follow-up|0|||
170690506|NCT02659631|616877692|FG001|Overall Study|Participant refused further follow-up|0|||
170690507|NCT02659631|616877693|FG002|Overall Study|Participant refused further follow-up|0|||
170690508|NCT02659631|616877694|FG003|Overall Study|Participant refused further follow-up|1|||
170690509|NCT02659631|616877695|FG004|Overall Study|Participant refused further follow-up|0|||
170690510|NCT02659631|616877696|FG005|Overall Study|Participant refused further follow-up|0|||
170690511|NCT02659631|616877697|FG006|Overall Study|Participant refused further follow-up|0|||
170690512|NCT02659631|616877698|FG007|Overall Study|Participant refused further follow-up|0|||
170690513|NCT02659631|616877699|FG008|Overall Study|Participant refused further follow-up|1|||
170690514|NCT02659631|616877700|FG009|Overall Study|Participant refused further follow-up|0|||
170690515|NCT02659631|616877691|FG000|Overall Study|Death (follow-up phase)|1|||
170690516|NCT02659631|616877692|FG001|Overall Study|Death (follow-up phase)|2|||
170690517|NCT02659631|616877693|FG002|Overall Study|Death (follow-up phase)|1|||
170690518|NCT02659631|616877694|FG003|Overall Study|Death (follow-up phase)|1|||
170690519|NCT02659631|616877695|FG004|Overall Study|Death (follow-up phase)|3|||
170690520|NCT02659631|616877696|FG005|Overall Study|Death (follow-up phase)|2|||
170690521|NCT02659631|616877697|FG006|Overall Study|Death (follow-up phase)|0|||
170690522|NCT02659631|616877698|FG007|Overall Study|Death (follow-up phase)|3|||
170690523|NCT02659631|616877699|FG008|Overall Study|Death (follow-up phase)|1|||
170690524|NCT02659631|616877700|FG009|Overall Study|Death (follow-up phase)|0|||
170690525|NCT02659631|616877691|FG000|Overall Study|Death (treatment phase)|0|||
170690526|NCT02659631|616877692|FG001|Overall Study|Death (treatment phase)|0|||
170690527|NCT02659631|616877693|FG002|Overall Study|Death (treatment phase)|0|||
170690528|NCT02659631|616877694|FG003|Overall Study|Death (treatment phase)|0|||
170690529|NCT02659631|616877695|FG004|Overall Study|Death (treatment phase)|1|||
170690530|NCT02659631|616877696|FG005|Overall Study|Death (treatment phase)|0|||
170690531|NCT02659631|616877697|FG006|Overall Study|Death (treatment phase)|1|||
170690532|NCT02659631|616877698|FG007|Overall Study|Death (treatment phase)|0|||
170690533|NCT02659631|616877699|FG008|Overall Study|Death (treatment phase)|0|||
170690534|NCT02659631|616877700|FG009|Overall Study|Death (treatment phase)|0|||
170690535|NCT02612428|616877703|FG000|VTL-308|Death|14|||
170690536|NCT02612428|616877704|FG001|VTL-308|Death|16|||
170690537|NCT02612428|616877703|FG000|VTL-308|Withdrawal by Subject|0|||
170690538|NCT02612428|616877704|FG001|VTL-308|Withdrawal by Subject|1|||
170690539|NCT02612428|616877703|FG000|VTL-308E|Death|9|||
170690540|NCT02612428|616877704|FG001|VTL-308E|Death|7|||
170690541|NCT02612428|616877703|FG000|VTL-308E|Lost to Follow-up|2|||
170690542|NCT02612428|616877704|FG001|VTL-308E|Lost to Follow-up|0|||
170690543|NCT00137423|616877707|FG000|Overall Study|Adverse Event|7|||
170690544|NCT00137423|616877708|FG001|Overall Study|Adverse Event|9|||
170690545|NCT00137423|616877707|FG000|Overall Study|consent withdrawn|1|||
170690546|NCT00137423|616877708|FG001|Overall Study|consent withdrawn|1|||
170690547|NCT00137423|616877707|FG000|Overall Study|Lack of Efficacy|31|||
170690548|NCT00137423|616877708|FG001|Overall Study|Lack of Efficacy|33|||
170690549|NCT00137423|616877707|FG000|Overall Study|Death|0|||
170690550|NCT00137423|616877708|FG001|Overall Study|Death|1|||
170690551|NCT01928329|616877709|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
170690552|NCT01928329|616877710|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
170690553|NCT01928329|616877709|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
170690554|NCT01928329|616877710|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
170690555|NCT01928329|616877709|FG000|Overall Study|Adverse Event|5|||
170690556|NCT01928329|616877710|FG001|Overall Study|Adverse Event|3|||
170690557|NCT01928329|616877709|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
170690558|NCT01928329|616877710|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
170690559|NCT01928329|616877709|FG000|Overall Study|Withdrawal by Subject|1|||
170690560|NCT01928329|616877710|FG001|Overall Study|Withdrawal by Subject|5|||
170690561|NCT01928329|616877709|FG000|Overall Study|Physician Decision|1|||
170822505|NCT01379521|617357474|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
170822506|NCT01379521|617357473|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
170822507|NCT01379521|617357474|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
170822508|NCT01379521|617357473|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
170822509|NCT01379521|617357474|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
170822510|NCT01379521|617357473|FG000|Overall Study -Treatment Period|Death|2|||
170690562|NCT01928329|616877710|FG001|Overall Study|Physician Decision|1|||
170690563|NCT03187262|616877711|FG000|Induction|Lack of Efficacy|2|||
170690564|NCT03187262|616877711|FG000|Induction|Progressive Disease|4|||
170690565|NCT03187262|616877711|FG000|Consolidation|Progressive Disease|5|||
170690566|NCT00613015|616877715|FG000|Overall Study|Lost to Follow-up|0|||
170690567|NCT00613015|616877716|FG001|Overall Study|Lost to Follow-up|1|||
170690568|NCT00613015|616877717|FG002|Overall Study|Lost to Follow-up|3|||
170690569|NCT00613015|616877718|FG003|Overall Study|Lost to Follow-up|3|||
170690570|NCT00613015|616877719|FG004|Overall Study|Lost to Follow-up|2|||
170690571|NCT00613015|616877720|FG005|Overall Study|Lost to Follow-up|3|||
170690572|NCT00071760|616877723|FG000|Overall Study|Adverse Event|2|||
170690573|NCT00071760|616877724|FG001|Overall Study|Adverse Event|1|||
170690574|NCT00071760|616877723|FG000|Overall Study|Lost to Follow-up|0|||
170690575|NCT00071760|616877724|FG001|Overall Study|Lost to Follow-up|3|||
170690576|NCT00071760|616877723|FG000|Overall Study|Protocol Violation|1|||
170690577|NCT00071760|616877724|FG001|Overall Study|Protocol Violation|0|||
170822511|NCT01379521|617357474|FG001|Overall Study -Treatment Period|Death|1|||
170690578|NCT00071760|616877723|FG000|Overall Study|Withdrawal by Subject|0|||
170690579|NCT00071760|616877724|FG001|Overall Study|Withdrawal by Subject|1|||
170690580|NCT00071760|616877723|FG000|Overall Study|Insufficient Viral Load Response|1|||
170690581|NCT00071760|616877724|FG001|Overall Study|Insufficient Viral Load Response|1|||
170690582|NCT00071760|616877723|FG000|Overall Study|Lack of availability of RTV|1|||
170690583|NCT00071760|616877724|FG001|Overall Study|Lack of availability of RTV|0|||
170690584|NCT00071760|616877723|FG000|Overall Study|Physician Decision|2|||
170690585|NCT00071760|616877724|FG001|Overall Study|Physician Decision|1|||
170690586|NCT00071760|616877723|FG000|Overall Study|Relocation|0|||
170690587|NCT00071760|616877724|FG001|Overall Study|Relocation|1|||
170690588|NCT02073279|616877725|FG000|Double-blind Period|Adverse Event|1|||
170690589|NCT02073279|616877726|FG001|Double-blind Period|Adverse Event|1|||
170690590|NCT02073279|616877725|FG000|Double-blind Period|Switched to another treatment|1|||
170690591|NCT02073279|616877726|FG001|Double-blind Period|Switched to another treatment|2|||
170690592|NCT02073279|616877725|FG000|Double-blind Period|Protocol Violation|0|||
170690593|NCT02073279|616877726|FG001|Double-blind Period|Protocol Violation|1|||
170690594|NCT02073279|616877725|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
170690595|NCT02073279|616877726|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
170690596|NCT02073279|616877725|FG000|Double-blind Period|Withdrawal by Subject|2|||
170690597|NCT02073279|616877726|FG001|Double-blind Period|Withdrawal by Subject|2|||
170690598|NCT02073279|616877725|FG000|Open-label Extension Period|Adverse Event|1|||
170690599|NCT02073279|616877726|FG001|Open-label Extension Period|Adverse Event|0|||
170690600|NCT02073279|616877725|FG000|Open-label Extension Period|Lack of Efficacy|1|||
170690601|NCT02073279|616877726|FG001|Open-label Extension Period|Lack of Efficacy|0|||
170690602|NCT02073279|616877725|FG000|Open-label Extension Period|Lost to Follow-up|0|||
170690603|NCT02073279|616877726|FG001|Open-label Extension Period|Lost to Follow-up|4|||
170690604|NCT02073279|616877725|FG000|Open-label Extension Period|Switched to another treatment|1|||
170690605|NCT02073279|616877726|FG001|Open-label Extension Period|Switched to another treatment|4|||
170690606|NCT02073279|616877725|FG000|Open-label Extension Period|Protocol Violation|0|||
170690607|NCT02073279|616877726|FG001|Open-label Extension Period|Protocol Violation|1|||
170690608|NCT02073279|616877725|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
170690609|NCT02073279|616877726|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
170690610|NCT02073279|616877725|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
170690611|NCT02073279|616877726|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
170690612|NCT03424265|616877740|FG000|Overall Study|screening failure|1|||
170690613|NCT03424265|616877741|FG001|Overall Study|screening failure|0|||
170690614|NCT03424265|616877740|FG000|Overall Study|Withdrawal by Subject|0|||
170690615|NCT03424265|616877741|FG001|Overall Study|Withdrawal by Subject|2|||
170690616|NCT00619801|616877742|FG000|Overall Study|Lack of Efficacy|0|||
170690617|NCT00619801|616877743|FG001|Overall Study|Lack of Efficacy|1|||
170690618|NCT00619801|616877742|FG000|Overall Study|Withdrawal by Subject|1|||
170690619|NCT00619801|616877743|FG001|Overall Study|Withdrawal by Subject|1|||
170690620|NCT00619801|616877742|FG000|Overall Study|Loss of efficacy|0|||
170690621|NCT00619801|616877743|FG001|Overall Study|Loss of efficacy|1|||
170690622|NCT00450333|616877748|FG000|Overall Study|Study terminated|47|||
170690623|NCT00450333|616877749|FG001|Overall Study|Study terminated|54|||
170690624|NCT00450333|616877750|FG002|Overall Study|Study terminated|16|||
170690625|NCT00450333|616877751|FG003|Overall Study|Study terminated|21|||
170690626|NCT00450333|616877748|FG000|Overall Study|Adverse Event|1|||
170690627|NCT00450333|616877749|FG001|Overall Study|Adverse Event|7|||
170690628|NCT00450333|616877750|FG002|Overall Study|Adverse Event|2|||
170690629|NCT00450333|616877751|FG003|Overall Study|Adverse Event|2|||
170690630|NCT00450333|616877748|FG000|Overall Study|Protocol Violation|1|||
170690631|NCT00450333|616877749|FG001|Overall Study|Protocol Violation|0|||
170690632|NCT00450333|616877750|FG002|Overall Study|Protocol Violation|1|||
170690633|NCT00450333|616877751|FG003|Overall Study|Protocol Violation|0|||
170690634|NCT00450333|616877748|FG000|Overall Study|Withdrawal by Subject|1|||
170690635|NCT00450333|616877749|FG001|Overall Study|Withdrawal by Subject|0|||
170690636|NCT00450333|616877750|FG002|Overall Study|Withdrawal by Subject|3|||
170690637|NCT00450333|616877751|FG003|Overall Study|Withdrawal by Subject|0|||
170690638|NCT00450333|616877748|FG000|Overall Study|Kidney transplant|1|||
170690639|NCT00450333|616877749|FG001|Overall Study|Kidney transplant|0|||
170690640|NCT00450333|616877750|FG002|Overall Study|Kidney transplant|1|||
170690641|NCT00450333|616877751|FG003|Overall Study|Kidney transplant|3|||
170690642|NCT00450333|616877748|FG000|Overall Study|Death|3|||
170690643|NCT00450333|616877749|FG001|Overall Study|Death|2|||
170690644|NCT00450333|616877750|FG002|Overall Study|Death|2|||
170690645|NCT00450333|616877751|FG003|Overall Study|Death|2|||
170690646|NCT04340362|616877757|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
170690647|NCT02375113|616877761|FG000|Overall Study|Undisclosed Reason(s).|1|||
170690648|NCT02375113|616877762|FG001|Overall Study|Undisclosed Reason(s).|1|||
170690649|NCT02375113|616877761|FG000|Overall Study|Poor adherence (<70%).|1|||
170690650|NCT02375113|616877762|FG001|Overall Study|Poor adherence (<70%).|0|||
170690651|NCT02375113|616877761|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
170690652|NCT02375113|616877762|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
170690653|NCT01214629|616877763|FG000|Overall Study|Progressive Disease|1|||
170690654|NCT01214629|616877764|FG001|Overall Study|Progressive Disease|1|||
170690655|NCT01214629|616877765|FG002|Overall Study|Progressive Disease|0|||
170690656|NCT01214629|616877766|FG003|Overall Study|Progressive Disease|1|||
170690657|NCT01214629|616877767|FG004|Overall Study|Progressive Disease|2|||
170690658|NCT01214629|616877768|FG005|Overall Study|Progressive Disease|3|||
170690659|NCT01214629|616877769|FG006|Overall Study|Progressive Disease|1|||
170690660|NCT01214629|616877770|FG007|Overall Study|Progressive Disease|1|||
170690661|NCT01214629|616877771|FG008|Overall Study|Progressive Disease|1|||
170690662|NCT01214629|616877772|FG009|Overall Study|Progressive Disease|5|||
170690663|NCT01214629|616877773|FG010|Overall Study|Progressive Disease|1|||
170690664|NCT01214629|616877763|FG000|Overall Study|Adverse Event|0|||
170690665|NCT01214629|616877764|FG001|Overall Study|Adverse Event|0|||
170690666|NCT01214629|616877765|FG002|Overall Study|Adverse Event|0|||
170690667|NCT01214629|616877766|FG003|Overall Study|Adverse Event|1|||
170690668|NCT01214629|616877767|FG004|Overall Study|Adverse Event|0|||
170690669|NCT01214629|616877768|FG005|Overall Study|Adverse Event|1|||
170690670|NCT01214629|616877769|FG006|Overall Study|Adverse Event|0|||
170690671|NCT01214629|616877770|FG007|Overall Study|Adverse Event|0|||
170690672|NCT01214629|616877771|FG008|Overall Study|Adverse Event|0|||
170690673|NCT01214629|616877772|FG009|Overall Study|Adverse Event|1|||
170690674|NCT01214629|616877773|FG010|Overall Study|Adverse Event|0|||
170690675|NCT01214629|616877763|FG000|Overall Study|Physician Decision|0|||
170690676|NCT01214629|616877764|FG001|Overall Study|Physician Decision|0|||
170690677|NCT01214629|616877765|FG002|Overall Study|Physician Decision|0|||
170690678|NCT01214629|616877766|FG003|Overall Study|Physician Decision|0|||
170690679|NCT01214629|616877767|FG004|Overall Study|Physician Decision|0|||
170690680|NCT01214629|616877768|FG005|Overall Study|Physician Decision|0|||
170690681|NCT01214629|616877769|FG006|Overall Study|Physician Decision|0|||
170690682|NCT01214629|616877770|FG007|Overall Study|Physician Decision|0|||
170690683|NCT01214629|616877771|FG008|Overall Study|Physician Decision|0|||
170690684|NCT01214629|616877772|FG009|Overall Study|Physician Decision|0|||
170690685|NCT01214629|616877773|FG010|Overall Study|Physician Decision|1|||
170690686|NCT01214629|616877763|FG000|Overall Study|Withdrawal by Subject|0|||
170690687|NCT01214629|616877764|FG001|Overall Study|Withdrawal by Subject|0|||
170690688|NCT01214629|616877765|FG002|Overall Study|Withdrawal by Subject|0|||
170690689|NCT01214629|616877766|FG003|Overall Study|Withdrawal by Subject|0|||
170690690|NCT01214629|616877767|FG004|Overall Study|Withdrawal by Subject|0|||
170690691|NCT01214629|616877768|FG005|Overall Study|Withdrawal by Subject|0|||
170690692|NCT01214629|616877769|FG006|Overall Study|Withdrawal by Subject|0|||
170690693|NCT01214629|616877770|FG007|Overall Study|Withdrawal by Subject|0|||
170690694|NCT01214629|616877771|FG008|Overall Study|Withdrawal by Subject|0|||
170690695|NCT01214629|616877772|FG009|Overall Study|Withdrawal by Subject|1|||
170690696|NCT01214629|616877773|FG010|Overall Study|Withdrawal by Subject|0|||
170690697|NCT00877383|616877776|FG000|Overall Study|Adverse Event|13|||
170690698|NCT00877383|616877777|FG001|Overall Study|Adverse Event|14|||
170690699|NCT00877383|616877776|FG000|Overall Study|Lost to Follow-up|5|||
170690700|NCT00877383|616877777|FG001|Overall Study|Lost to Follow-up|3|||
170690701|NCT00877383|616877776|FG000|Overall Study|Subject withdrew consent|3|||
170690702|NCT00877383|616877777|FG001|Overall Study|Subject withdrew consent|12|||
170690703|NCT00877383|616877776|FG000|Overall Study|Subject no longer requires study drug|2|||
170690704|NCT00877383|616877777|FG001|Overall Study|Subject no longer requires study drug|0|||
170690705|NCT00877383|616877776|FG000|Overall Study|Administrative problems|2|||
170690706|NCT00877383|616877777|FG001|Overall Study|Administrative problems|0|||
170690707|NCT00877383|616877776|FG000|Overall Study|Protocol deviation|2|||
170690708|NCT00877383|616877777|FG001|Overall Study|Protocol deviation|6|||
170690709|NCT00877383|616877776|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170690710|NCT00877383|616877777|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170690711|NCT00877383|616877776|FG000|Overall Study|Death|1|||
170690712|NCT00877383|616877777|FG001|Overall Study|Death|2|||
170690713|NCT01829230|616877778|FG000|Overall Study|Protocol Violation|0|||
170690714|NCT01829230|616877779|FG001|Overall Study|Protocol Violation|2|||
170690715|NCT01829230|616877778|FG000|Overall Study|Withdrawal by Subject|0|||
170690716|NCT01829230|616877779|FG001|Overall Study|Withdrawal by Subject|1|||
170690717|NCT01829230|616877778|FG000|Overall Study|Lost to Follow-up|1|||
170690718|NCT01829230|616877779|FG001|Overall Study|Lost to Follow-up|1|||
170690719|NCT04387435|616877781|FG000|Overall Study|Physician Decision|1|||
170690720|NCT00391274|616877784|FG000|Overall Study|Death Due to Study Disease|55|||
170690721|NCT00391274|616877785|FG001|Overall Study|Death Due to Study Disease|45|||
170690722|NCT00391274|616877784|FG000|Overall Study|Lost to Follow-up|0|||
170690723|NCT00391274|616877785|FG001|Overall Study|Lost to Follow-up|3|||
170690724|NCT00391274|616877784|FG000|Overall Study|Physician Decision|4|||
170690725|NCT00391274|616877785|FG001|Overall Study|Physician Decision|2|||
170690726|NCT00391274|616877784|FG000|Overall Study|Withdrawal by Subject|0|||
170690727|NCT00391274|616877785|FG001|Overall Study|Withdrawal by Subject|3|||
170690728|NCT00391274|616877784|FG000|Overall Study|Death Due to Adverse Event|1|||
170690729|NCT00391274|616877785|FG001|Overall Study|Death Due to Adverse Event|3|||
170690730|NCT00391274|616877784|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
170690731|NCT00391274|616877785|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
170690732|NCT00391274|616877784|FG000|Overall Study|Death Not Study Related|0|||
170690733|NCT00391274|616877785|FG001|Overall Study|Death Not Study Related|1|||
170690734|NCT00399360|616877786|FG000|Overall Study|Lost to Follow-up|2|||
170690735|NCT00399360|616877787|FG001|Overall Study|Lost to Follow-up|1|||
170690736|NCT00399360|616877788|FG002|Overall Study|Lost to Follow-up|2|||
170690737|NCT00399360|616877789|FG003|Overall Study|Lost to Follow-up|4|||
170690738|NCT00399360|616877786|FG000|Overall Study|Adverse Event|0|||
170690739|NCT00399360|616877787|FG001|Overall Study|Adverse Event|0|||
170690740|NCT00399360|616877788|FG002|Overall Study|Adverse Event|1|||
170690741|NCT00399360|616877789|FG003|Overall Study|Adverse Event|0|||
170690742|NCT00399360|616877786|FG000|Overall Study|Withdrawal by Subject|0|||
170690743|NCT00399360|616877787|FG001|Overall Study|Withdrawal by Subject|2|||
170690744|NCT00399360|616877788|FG002|Overall Study|Withdrawal by Subject|0|||
170690745|NCT00399360|616877789|FG003|Overall Study|Withdrawal by Subject|2|||
170690746|NCT02663674|616877792|FG000|Overall Study|Lost to Follow-up|5|||
170690747|NCT02663674|616877793|FG001|Overall Study|Lost to Follow-up|4|||
170690748|NCT02663674|616877792|FG000|Overall Study|Withdrawal by Subject|1|||
170690749|NCT02663674|616877793|FG001|Overall Study|Withdrawal by Subject|4|||
170690750|NCT02663674|616877792|FG000|Overall Study|Physician Decision|1|||
170690751|NCT02663674|616877793|FG001|Overall Study|Physician Decision|1|||
170690752|NCT02663674|616877792|FG000|Overall Study|Other Event (Health Related)|0|||
170690753|NCT02663674|616877793|FG001|Overall Study|Other Event (Health Related)|1|||
170690754|NCT03158051|616877794|FG000|Overall Study|Lost to Follow-up|41|||
170690755|NCT03158051|616877795|FG001|Overall Study|Lost to Follow-up|47|||
170690756|NCT03158051|616877794|FG000|Overall Study|Physician Decision|6|||
170690757|NCT03158051|616877795|FG001|Overall Study|Physician Decision|7|||
170690758|NCT03158051|616877794|FG000|Overall Study|Withdrawal by Subject|24|||
170690759|NCT03158051|616877795|FG001|Overall Study|Withdrawal by Subject|15|||
170690760|NCT03158051|616877794|FG000|Overall Study|Death|0|||
170690761|NCT03158051|616877795|FG001|Overall Study|Death|1|||
170690762|NCT02005250|616877796|FG000|Overall Study|Lost to Follow-up|15|||
170690763|NCT02005250|616877797|FG001|Overall Study|Lost to Follow-up|5|||
170690764|NCT02588833|616877798|FG000|Part 1|Withdrawal by Subject|1|||
170690765|NCT02588833|616877799|FG001|Part 1|Withdrawal by Subject|0|||
170690766|NCT02588833|616877798|FG000|Part 2A|Physician Decision|0|||
170690767|NCT02588833|616877799|FG001|Part 2A|Physician Decision|1|||
170690768|NCT02588833|616877798|FG000|Part 2A|Withdrawal by Subject|0|||
170690769|NCT02588833|616877799|FG001|Part 2A|Withdrawal by Subject|1|||
170690770|NCT02588833|616877798|FG000|Part 2B|Adverse Event|0|||
170690771|NCT02588833|616877799|FG001|Part 2B|Adverse Event|1|||
170690772|NCT02588833|616877798|FG000|Part 2C|Adverse Event|0|||
170690773|NCT02588833|616877799|FG001|Part 2C|Adverse Event|1|||
170690774|NCT02588833|616877798|FG000|Part 2C|Withdrawal by Subject|0|||
170690775|NCT02588833|616877799|FG001|Part 2C|Withdrawal by Subject|1|||
170690776|NCT02588833|616877798|FG000|Part 3 (Safety Follow-up)|Other|0|||
170690777|NCT02588833|616877799|FG001|Part 3 (Safety Follow-up)|Other|2|||
170690778|NCT02738151|616877800|FG000|Overall Study|Randomized but not treated|4|||
170690779|NCT02738151|616877801|FG001|Overall Study|Randomized but not treated|1|||
170690780|NCT02738151|616877800|FG000|Overall Study|Adverse Event|4|||
170690781|NCT02738151|616877801|FG001|Overall Study|Adverse Event|5|||
170690782|NCT02738151|616877800|FG000|Overall Study|Hypoglycemia|0|||
170690783|NCT02738151|616877801|FG001|Overall Study|Hypoglycemia|1|||
170690784|NCT02738151|616877800|FG000|Overall Study|Poor Compliance to Protocol|4|||
170690785|NCT02738151|616877801|FG001|Overall Study|Poor Compliance to Protocol|3|||
170690786|NCT02738151|616877800|FG000|Overall Study|Other than specified above|11|||
170690787|NCT02738151|616877801|FG001|Overall Study|Other than specified above|21|||
170690788|NCT03333044|616877803|FG000|Overall Study|Pregnancy|1|||
170690789|NCT03333044|616877804|FG001|Overall Study|Pregnancy|0|||
170690790|NCT03333044|616877805|FG002|Overall Study|Pregnancy|0|||
170690791|NCT03333044|616877803|FG000|Overall Study|Lost to Follow-up|0|||
170690792|NCT03333044|616877804|FG001|Overall Study|Lost to Follow-up|14|||
170690793|NCT03333044|616877805|FG002|Overall Study|Lost to Follow-up|6|||
170690794|NCT03649711|616877806|FG000|Overall Study|Adverse Event|0|||
170690795|NCT03649711|616877807|FG001|Overall Study|Adverse Event|1|||
170690796|NCT03649711|616877808|FG002|Overall Study|Adverse Event|0|||
170690797|NCT03649711|616877806|FG000|Overall Study|Kidney Transplant|1|||
170690798|NCT03649711|616877807|FG001|Overall Study|Kidney Transplant|0|||
170690799|NCT03649711|616877808|FG002|Overall Study|Kidney Transplant|0|||
170690800|NCT04350788|616877819|FG000|Overall Study|Lost to Follow-up|6|||
170690801|NCT04350788|616877820|FG001|Overall Study|Lost to Follow-up|2|||
170690802|NCT04350788|616877819|FG000|Overall Study|Withdrawal by Subject|2|||
170690803|NCT04350788|616877820|FG001|Overall Study|Withdrawal by Subject|4|||
170690804|NCT04350788|616877819|FG000|Overall Study|Protocol Violation|4|||
170690805|NCT04350788|616877820|FG001|Overall Study|Protocol Violation|0|||
170690806|NCT01581307|616877821|FG000|Overall Study|Withdrawal by Subject|1|||
170690807|NCT02070744|616877822|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
170690808|NCT02070744|616877823|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
170690809|NCT02070744|616877824|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
170690810|NCT02070744|616877825|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
170690811|NCT02070744|616877826|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
170690812|NCT02070744|616877822|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
170690813|NCT02070744|616877823|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
170690814|NCT02070744|616877824|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
170690815|NCT02070744|616877825|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
170690816|NCT02070744|616877826|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
170690817|NCT02070744|616877822|FG000|OLE Phase (48 Weeks)|Other|0|||
170690818|NCT02070744|616877823|FG001|OLE Phase (48 Weeks)|Other|0|||
170690819|NCT02070744|616877824|FG002|OLE Phase (48 Weeks)|Other|0|||
170690820|NCT02070744|616877825|FG003|OLE Phase (48 Weeks)|Other|0|||
170690821|NCT02070744|616877826|FG004|OLE Phase (48 Weeks)|Other|1|||
170690822|NCT02472795|616877827|FG000|Overall Study|Adverse Event|0|||
170690823|NCT02472795|616877828|FG001|Overall Study|Adverse Event|1|||
170690824|NCT02472795|616877829|FG002|Overall Study|Adverse Event|0|||
170690825|NCT02472795|616877830|FG003|Overall Study|Adverse Event|0|||
170690826|NCT02472795|616877831|FG004|Overall Study|Adverse Event|2|||
170690827|NCT02472795|616877827|FG000|Overall Study|Withdrawal by Subject|0|||
170690828|NCT02472795|616877828|FG001|Overall Study|Withdrawal by Subject|0|||
170690829|NCT02472795|616877829|FG002|Overall Study|Withdrawal by Subject|0|||
170690830|NCT02472795|616877830|FG003|Overall Study|Withdrawal by Subject|0|||
170690831|NCT02472795|616877831|FG004|Overall Study|Withdrawal by Subject|1|||
170690832|NCT00353262|616877832|FG000|Overall Study|Adverse Event|8|||
170690833|NCT00353262|616877832|FG000|Overall Study|Withdrawal by Subject|2|||
170690834|NCT00353262|616877832|FG000|Overall Study|Insufficient Therapeutic Response|13|||
170690835|NCT00353262|616877832|FG000|Overall Study|Progression|1|||
170690836|NCT00353262|616877832|FG000|Overall Study|Surgery|4|||
170690837|NCT00353262|616877832|FG000|Overall Study|Break from Chemotherapy|1|||
170690838|NCT04166513|616877833|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
170690839|NCT04166513|616877834|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
170690840|NCT04166513|616877835|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
170690841|NCT04166513|616877836|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
170690842|NCT04166513|616877833|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
170690843|NCT04166513|616877834|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
170690844|NCT04166513|616877835|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
170690845|NCT04166513|616877836|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
170690846|NCT04166513|616877833|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
170690847|NCT04166513|616877834|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
170690848|NCT04166513|616877835|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
170690849|NCT04166513|616877836|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
170690850|NCT04166513|616877833|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
170690851|NCT04166513|616877834|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
170690852|NCT04166513|616877835|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
170690853|NCT04166513|616877836|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
170690854|NCT04166513|616877833|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
170690855|NCT04166513|616877834|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
170690856|NCT04166513|616877835|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
170690857|NCT04166513|616877836|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
170690858|NCT05286307|616877837|FG000|Overall Study|Incomplete outcome assessments|2|||
170690859|NCT05286307|616877838|FG001|Overall Study|Incomplete outcome assessments|1|||
170690860|NCT05286307|616877837|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
170690861|NCT05286307|616877838|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
170690862|NCT05286307|616877837|FG000|Overall Study|Lost to follow up at 6 months|25|||
170690863|NCT05286307|616877838|FG001|Overall Study|Lost to follow up at 6 months|35|||
170690864|NCT05286307|616877837|FG000|Overall Study|Study medication not available|1|||
170690865|NCT05286307|616877838|FG001|Overall Study|Study medication not available|1|||
170690866|NCT04734652|616879549|FG000|Overall Study|Withdrawal by Subject|2|||
170690867|NCT04734652|616879550|FG001|Overall Study|Withdrawal by Subject|0|||
170690868|NCT04734652|616879549|FG000|Overall Study|Death|0|||
170690869|NCT04734652|616879550|FG001|Overall Study|Death|1|||
170690870|NCT02603809|616879554|FG000|Overall Study|Withdrawal by Subject|4|||
170690871|NCT02603809|616879555|FG001|Overall Study|Withdrawal by Subject|1|||
170690872|NCT02603809|616879556|FG002|Overall Study|Withdrawal by Subject|2|||
170690873|NCT02603809|616879557|FG003|Overall Study|Withdrawal by Subject|3|||
170690874|NCT02603809|616879558|FG004|Overall Study|Withdrawal by Subject|3|||
170690875|NCT02603809|616879559|FG005|Overall Study|Withdrawal by Subject|4|||
170690876|NCT02603809|616879554|FG000|Overall Study|Lost to Follow-up|2|||
170690877|NCT02603809|616879555|FG001|Overall Study|Lost to Follow-up|3|||
170690878|NCT02603809|616879556|FG002|Overall Study|Lost to Follow-up|1|||
170690879|NCT02603809|616879557|FG003|Overall Study|Lost to Follow-up|4|||
170690880|NCT02603809|616879558|FG004|Overall Study|Lost to Follow-up|2|||
170690881|NCT02603809|616879559|FG005|Overall Study|Lost to Follow-up|2|||
170690882|NCT02603809|616879554|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
170690883|NCT02603809|616879555|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
170690884|NCT02603809|616879556|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
170690885|NCT02603809|616879557|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
170690886|NCT02603809|616879558|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
170690887|NCT02603809|616879559|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
170690888|NCT02603809|616879554|FG000|Overall Study|Physician Decision|0|||
170690889|NCT02603809|616879555|FG001|Overall Study|Physician Decision|0|||
170690890|NCT02603809|616879556|FG002|Overall Study|Physician Decision|0|||
170690891|NCT02603809|616879557|FG003|Overall Study|Physician Decision|1|||
170690892|NCT02603809|616879558|FG004|Overall Study|Physician Decision|2|||
170690893|NCT02603809|616879559|FG005|Overall Study|Physician Decision|1|||
170690894|NCT02603809|616879554|FG000|Overall Study|Adverse Event|3|||
170690895|NCT02603809|616879555|FG001|Overall Study|Adverse Event|0|||
170690896|NCT02603809|616879556|FG002|Overall Study|Adverse Event|2|||
170690897|NCT02603809|616879557|FG003|Overall Study|Adverse Event|2|||
170690898|NCT02603809|616879558|FG004|Overall Study|Adverse Event|1|||
170690899|NCT02603809|616879559|FG005|Overall Study|Adverse Event|1|||
170690900|NCT02603809|616879554|FG000|Overall Study|Lack of Efficacy|0|||
170690901|NCT02603809|616879555|FG001|Overall Study|Lack of Efficacy|1|||
170690902|NCT02603809|616879556|FG002|Overall Study|Lack of Efficacy|0|||
170690903|NCT02603809|616879557|FG003|Overall Study|Lack of Efficacy|0|||
170690904|NCT02603809|616879558|FG004|Overall Study|Lack of Efficacy|0|||
170690905|NCT02603809|616879559|FG005|Overall Study|Lack of Efficacy|1|||
170690906|NCT00380978|616879561|FG000|Overall Study|Refused allocated intervention|0|||
170690907|NCT00380978|616879562|FG001|Overall Study|Refused allocated intervention|6|||
170690908|NCT00380978|616879561|FG000|Overall Study|Wrong study envelope|0|||
170690909|NCT00380978|616879562|FG001|Overall Study|Wrong study envelope|2|||
170690910|NCT00380978|616879561|FG000|Overall Study|Allocation prior to analgesia request|1|||
170690911|NCT00380978|616879562|FG001|Overall Study|Allocation prior to analgesia request|2|||
170690912|NCT00380978|616879561|FG000|Overall Study|Parous patient|1|||
170690913|NCT00380978|616879562|FG001|Overall Study|Parous patient|0|||
170690914|NCT04146545|616879563|FG000|Overall Study|deemed ineligible after randomization|1|||
170690915|NCT04146545|616879564|FG001|Overall Study|deemed ineligible after randomization|0|||
170690916|NCT01647282|616879566|FG000|Overall Study|Physician Decision|7|||
170690917|NCT01647282|616879567|FG001|Overall Study|Physician Decision|5|||
170690918|NCT03232281|616879568|FG000|Overall Study|Adverse Event|1|||
170690919|NCT03232281|616879569|FG001|Overall Study|Adverse Event|1|||
170690920|NCT03232281|616879568|FG000|Overall Study|Withdrawal by Subject|5|||
170690921|NCT03232281|616879569|FG001|Overall Study|Withdrawal by Subject|4|||
170690922|NCT03232281|616879568|FG000|Overall Study|Protocol Deviation|1|||
170690923|NCT03232281|616879569|FG001|Overall Study|Protocol Deviation|1|||
170690924|NCT01372501|616879570|FG000|Overall Study|Adverse Event|4|||
170690925|NCT01372501|616879570|FG000|Overall Study|Device migration|1|||
170690926|NCT01132482|616879571|FG000|Overall Study|Adverse Event|1|||
170690927|NCT01132482|616879572|FG001|Overall Study|Adverse Event|0|||
170690928|NCT01139450|616879573|FG000|Overall Study|Withdrawal by Subject|7|||
170690929|NCT01139450|616879574|FG001|Overall Study|Withdrawal by Subject|10|||
170690930|NCT01139450|616879575|FG002|Overall Study|Withdrawal by Subject|13|||
170690931|NCT01139450|616879573|FG000|Overall Study|Lack of Efficacy|3|||
170690932|NCT01139450|616879574|FG001|Overall Study|Lack of Efficacy|1|||
170690933|NCT01139450|616879575|FG002|Overall Study|Lack of Efficacy|8|||
170690934|NCT01139450|616879573|FG000|Overall Study|Protocol Violation|6|||
170690935|NCT01139450|616879574|FG001|Overall Study|Protocol Violation|5|||
170690936|NCT01139450|616879575|FG002|Overall Study|Protocol Violation|2|||
170690937|NCT01139450|616879573|FG000|Overall Study|Lost to Follow-up|9|||
170690938|NCT01139450|616879574|FG001|Overall Study|Lost to Follow-up|7|||
170690939|NCT01139450|616879575|FG002|Overall Study|Lost to Follow-up|11|||
170690940|NCT01139450|616879573|FG000|Overall Study|Administrative|0|||
170690941|NCT01139450|616879574|FG001|Overall Study|Administrative|0|||
170690942|NCT01139450|616879575|FG002|Overall Study|Administrative|1|||
170690943|NCT01139450|616879573|FG000|Overall Study|Adverse Event|2|||
170690944|NCT01139450|616879574|FG001|Overall Study|Adverse Event|2|||
170690945|NCT01139450|616879575|FG002|Overall Study|Adverse Event|3|||
170690946|NCT01277523|616879576|FG000|Overall Study|Adverse Event|1|||
170690947|NCT01277523|616879577|FG001|Overall Study|Adverse Event|0|||
170690948|NCT01277523|616879578|FG002|Overall Study|Adverse Event|0|||
170690949|NCT01277523|616879576|FG000|Overall Study|Protocol Violation|2|||
170690950|NCT01277523|616879577|FG001|Overall Study|Protocol Violation|0|||
170690951|NCT01277523|616879578|FG002|Overall Study|Protocol Violation|0|||
170690952|NCT01277523|616879576|FG000|Overall Study|Other Reason not Defined|0|||
170690953|NCT01277523|616879577|FG001|Overall Study|Other Reason not Defined|1|||
170690954|NCT01277523|616879578|FG002|Overall Study|Other Reason not Defined|0|||
170690955|NCT02385266|616879579|FG000|Overall Study|Withdrawal by Subject|1|||
170690956|NCT02385266|616879580|FG001|Overall Study|Withdrawal by Subject|3|||
170690957|NCT00914810|616879581|FG000|Overall Study|Withdrawal by Subject|1|||
170690958|NCT00914810|616879582|FG001|Overall Study|Withdrawal by Subject|0|||
170690959|NCT00914810|616879581|FG000|Overall Study|Relocated out of state|1|||
170690960|NCT00914810|616879582|FG001|Overall Study|Relocated out of state|0|||
170690961|NCT00914810|616879581|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
170690962|NCT00914810|616879582|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
170690963|NCT02432846|616879583|FG000|Overall Study (4 Arms/Strata)|Death|3|||
170690964|NCT02432846|616879584|FG001|Overall Study (4 Arms/Strata)|Death|2|||
170690965|NCT02432846|616879585|FG002|Overall Study (4 Arms/Strata)|Death|4|||
170690966|NCT02432846|616879586|FG003|Overall Study (4 Arms/Strata)|Death|3|||
170690967|NCT02432846|616879587|FG004|Overall Study (4 Arms/Strata)|Death|0|||
170690968|NCT02432846|616879588|FG005|Overall Study (4 Arms/Strata)|Death|0|||
170690969|NCT02432846|616879583|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
170690970|NCT02432846|616879584|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
170690971|NCT02432846|616879585|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
170690972|NCT02432846|616879586|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
170690973|NCT02432846|616879587|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
170690974|NCT02432846|616879588|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
170690975|NCT02432846|616879583|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
170690976|NCT02432846|616879584|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
170690977|NCT02432846|616879585|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
170690978|NCT02432846|616879586|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
170690979|NCT02432846|616879587|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
170690980|NCT02432846|616879588|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
170690981|NCT02432846|616879583|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
170690982|NCT02432846|616879584|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
170690983|NCT02432846|616879585|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
170690984|NCT02432846|616879586|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
170690985|NCT02432846|616879587|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
170690986|NCT02432846|616879588|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
170690987|NCT02432846|616879583|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
170690988|NCT02432846|616879584|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
170690989|NCT02432846|616879585|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
170690990|NCT02432846|616879586|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
170690991|NCT02432846|616879587|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
170690992|NCT02432846|616879588|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
170690993|NCT02432846|616879583|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
170690994|NCT02432846|616879584|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
170690995|NCT02432846|616879585|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
170690996|NCT02432846|616879586|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
170690997|NCT02432846|616879587|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
170690998|NCT02432846|616879588|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
170690999|NCT02432846|616879583|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
170691000|NCT02432846|616879584|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
170691001|NCT02432846|616879585|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
170691002|NCT02432846|616879586|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
170691003|NCT02432846|616879587|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
170691004|NCT02432846|616879588|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
170691005|NCT02432846|616879583|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
170691006|NCT02432846|616879584|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
170691007|NCT02432846|616879585|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
170691008|NCT02432846|616879586|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
170691009|NCT02432846|616879587|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
170691010|NCT02432846|616879588|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
170691011|NCT02432846|616879583|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
170691012|NCT02432846|616879584|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
170691013|NCT02432846|616879585|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
170691014|NCT02432846|616879586|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
170691015|NCT02432846|616879587|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
170691016|NCT02432846|616879588|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
170691017|NCT02432846|616879583|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
170691018|NCT02432846|616879584|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
170691019|NCT02432846|616879585|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
170691020|NCT02432846|616879586|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
170691021|NCT02432846|616879587|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
170691022|NCT02432846|616879588|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
170691023|NCT02432846|616879583|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
170691024|NCT02432846|616879584|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
170691025|NCT02432846|616879585|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
170691026|NCT02432846|616879586|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
170691027|NCT02432846|616879587|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
170691028|NCT02432846|616879588|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
170691029|NCT02432846|616879583|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
170691030|NCT02432846|616879584|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
170691031|NCT02432846|616879585|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
170691032|NCT02432846|616879586|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
170691033|NCT02432846|616879587|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
170691034|NCT02432846|616879588|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
170691035|NCT02432846|616879583|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
170691036|NCT02432846|616879584|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
170691037|NCT02432846|616879585|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
170691038|NCT02432846|616879586|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
170691039|NCT02432846|616879587|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
170691040|NCT02432846|616879588|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
170691041|NCT02432846|616879583|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
170691042|NCT02432846|616879584|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
170691043|NCT02432846|616879585|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
170691044|NCT02432846|616879586|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
170691045|NCT02432846|616879587|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
170691046|NCT02432846|616879588|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
170691047|NCT02631850|616879589|FG000|Treatment Period|Lost to Follow-up|0|||
170822512|NCT01379521|617357473|FG000|Post-Treatment Evaluations|Disease Progression|22|||
170822513|NCT01379521|617357474|FG001|Post-Treatment Evaluations|Disease Progression|20|||
170822514|NCT01379521|617357473|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
170822515|NCT01379521|617357474|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
170822516|NCT01379521|617357473|FG000|Post-Treatment Evaluations|Death|1|||
170822517|NCT01379521|617357474|FG001|Post-Treatment Evaluations|Death|0|||
170822518|NCT01713998|617357476|FG000|Overall Study|Lost to Follow-up|2|||
170822519|NCT01713998|617357477|FG001|Overall Study|Lost to Follow-up|0|||
170822520|NCT01713998|617357478|FG002|Overall Study|Lost to Follow-up|2|||
170691048|NCT02631850|616879590|FG001|Treatment Period|Lost to Follow-up|1|||
170822521|NCT01713998|617357476|FG000|Overall Study|Withdrawal by Subject|1|||
170691049|NCT02631850|616879591|FG002|Treatment Period|Lost to Follow-up|0|||
170691050|NCT02631850|616879592|FG003|Treatment Period|Lost to Follow-up|0|||
170691051|NCT02631850|616879589|FG000|Treatment Period|Protocol Violation|1|||
170691052|NCT02631850|616879590|FG001|Treatment Period|Protocol Violation|0|||
170691053|NCT02631850|616879591|FG002|Treatment Period|Protocol Violation|0|||
170691054|NCT02631850|616879592|FG003|Treatment Period|Protocol Violation|0|||
170691055|NCT02631850|616879589|FG000|Treatment Period|Withdrawal by Subject|0|||
170691056|NCT02631850|616879590|FG001|Treatment Period|Withdrawal by Subject|5|||
170691057|NCT02631850|616879591|FG002|Treatment Period|Withdrawal by Subject|2|||
170691058|NCT02631850|616879592|FG003|Treatment Period|Withdrawal by Subject|2|||
170691059|NCT02631850|616879589|FG000|Treatment Period|Adverse Event|1|||
170691060|NCT02631850|616879590|FG001|Treatment Period|Adverse Event|0|||
170691061|NCT02631850|616879591|FG002|Treatment Period|Adverse Event|2|||
170691062|NCT02631850|616879592|FG003|Treatment Period|Adverse Event|3|||
170691063|NCT02631850|616879589|FG000|Treatment Period|Family medical issue|1|||
170691064|NCT02631850|616879590|FG001|Treatment Period|Family medical issue|0|||
170691065|NCT02631850|616879591|FG002|Treatment Period|Family medical issue|0|||
170691066|NCT02631850|616879592|FG003|Treatment Period|Family medical issue|0|||
170691067|NCT02631850|616879589|FG000|6 Month Follow up|Lost to Follow-up|5|||
170691068|NCT02631850|616879590|FG001|6 Month Follow up|Lost to Follow-up|8|||
170691069|NCT02631850|616879591|FG002|6 Month Follow up|Lost to Follow-up|3|||
170691070|NCT02631850|616879592|FG003|6 Month Follow up|Lost to Follow-up|5|||
170691071|NCT02631850|616879589|FG000|6 Month Follow up|Withdrawal by Subject|1|||
170691072|NCT02631850|616879590|FG001|6 Month Follow up|Withdrawal by Subject|0|||
170691073|NCT02631850|616879591|FG002|6 Month Follow up|Withdrawal by Subject|0|||
170691074|NCT02631850|616879592|FG003|6 Month Follow up|Withdrawal by Subject|2|||
170691075|NCT02631850|616879589|FG000|6 Month Follow up|Adverse Event|1|||
170691076|NCT02631850|616879590|FG001|6 Month Follow up|Adverse Event|4|||
170691077|NCT02631850|616879591|FG002|6 Month Follow up|Adverse Event|1|||
170691078|NCT02631850|616879592|FG003|6 Month Follow up|Adverse Event|3|||
170691079|NCT02631850|616879589|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
170691080|NCT02631850|616879590|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
170691081|NCT02631850|616879591|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
170691082|NCT02631850|616879592|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
170691083|NCT01462084|616879593|FG000|Overall Study|Withdrawal by Subject|1|||
170691084|NCT01462084|616879594|FG001|Overall Study|Withdrawal by Subject|0|||
170691085|NCT01462084|616879593|FG000|Overall Study|Protocol Violation|1|||
170691086|NCT01462084|616879594|FG001|Overall Study|Protocol Violation|1|||
170691087|NCT00695396|616879595|FG000|Overall Study|Study Closed Prematurely|5|||
170691088|NCT00695396|616879596|FG001|Overall Study|Study Closed Prematurely|6|||
170691089|NCT00695396|616879597|FG002|Overall Study|Study Closed Prematurely|8|||
170691090|NCT00695396|616879595|FG000|Overall Study|Withdrawal by Subject|2|||
170691091|NCT00695396|616879596|FG001|Overall Study|Withdrawal by Subject|2|||
170691092|NCT00695396|616879597|FG002|Overall Study|Withdrawal by Subject|0|||
170691093|NCT01514760|616879599|FG000|Overall Study|Lost to Follow-up|2|||
170691094|NCT04499781|616879601|FG000|Overall Study|Lost to Follow-up|2|||
170691095|NCT04499781|616879602|FG001|Overall Study|Lost to Follow-up|3|||
170691096|NCT04499781|616879601|FG000|Overall Study|Withdrawal by Subject|2|||
170691097|NCT04499781|616879602|FG001|Overall Study|Withdrawal by Subject|0|||
170691098|NCT00227305|616879603|FG000|Overall Study|Adverse Event|40|||
170691099|NCT00227305|616879603|FG000|Overall Study|Withdrawal by Subject|42|||
170691100|NCT00227305|616879603|FG000|Overall Study|Lost to Follow-up|33|||
170822522|NCT01713998|617357477|FG001|Overall Study|Withdrawal by Subject|0|||
170822523|NCT01713998|617357478|FG002|Overall Study|Withdrawal by Subject|0|||
170822524|NCT02350127|617357479|FG000|4-Month Assessment|Withdrawal by Subject|10|||
170822525|NCT02350127|617357480|FG001|4-Month Assessment|Withdrawal by Subject|9|||
170691101|NCT00227305|616879603|FG000|Overall Study|Study specific discontinuation|13|||
170691102|NCT00227305|616879603|FG000|Overall Study|MOVED OUT OF AREA|3|||
170691103|NCT00227305|616879603|FG000|Overall Study|Lack of Efficacy|7|||
170691104|NCT00227305|616879603|FG000|Overall Study|Physician Decision|3|||
170691105|NCT00227305|616879603|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
170691106|NCT00227305|616879603|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
170691107|NCT00227305|616879603|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
170691108|NCT02118012|616879604|FG000|Overall Study|Adverse Event|0|||
170691109|NCT02118012|616879605|FG001|Overall Study|Adverse Event|1|||
170691110|NCT02118012|616879604|FG000|Overall Study|Physician Decision|0|||
170691111|NCT02118012|616879605|FG001|Overall Study|Physician Decision|1|||
170691112|NCT00536107|616879606|FG000|Overall Study|Death|5|||
170691113|NCT00536107|616879607|FG001|Overall Study|Death|1|||
170691114|NCT00536107|616879606|FG000|Overall Study|Incorrect enrolment|1|||
170691115|NCT00536107|616879607|FG001|Overall Study|Incorrect enrolment|0|||
170691116|NCT00536107|616879606|FG000|Overall Study|Withdrawal by Subject|0|||
170691117|NCT00536107|616879607|FG001|Overall Study|Withdrawal by Subject|1|||
170691118|NCT00536107|616879606|FG000|Overall Study|Study Termination|2|||
170691119|NCT00536107|616879607|FG001|Overall Study|Study Termination|4|||
170691120|NCT02707991|616879608|FG000|Overall Study|Protocol Violation|1|||
170691121|NCT02707991|616879609|FG001|Overall Study|Protocol Violation|0|||
170691122|NCT02707991|616879608|FG000|Overall Study|Became ineligible|0|||
170691123|NCT02707991|616879609|FG001|Overall Study|Became ineligible|1|||
170691124|NCT03329690|616879610|FG000|Overall Study|Progressive disease per RECIST|85|||
170691125|NCT03329690|616879611|FG001|Overall Study|Progressive disease per RECIST|44|||
170691126|NCT03329690|616879612|FG002|Overall Study|Progressive disease per RECIST|6|||
170691127|NCT03329690|616879613|FG003|Overall Study|Progressive disease per RECIST|16|||
170691128|NCT03329690|616879614|FG004|Overall Study|Progressive disease per RECIST|20|||
170691129|NCT03329690|616879610|FG000|Overall Study|Clinical progression|7|||
170691130|NCT03329690|616879611|FG001|Overall Study|Clinical progression|4|||
170691131|NCT03329690|616879612|FG002|Overall Study|Clinical progression|1|||
170691132|NCT03329690|616879613|FG003|Overall Study|Clinical progression|1|||
170691133|NCT03329690|616879614|FG004|Overall Study|Clinical progression|1|||
170691134|NCT03329690|616879610|FG000|Overall Study|Adverse Event|22|||
170691135|NCT03329690|616879611|FG001|Overall Study|Adverse Event|4|||
170691136|NCT03329690|616879612|FG002|Overall Study|Adverse Event|0|||
170691137|NCT03329690|616879613|FG003|Overall Study|Adverse Event|1|||
170691138|NCT03329690|616879614|FG004|Overall Study|Adverse Event|2|||
170691139|NCT03329690|616879610|FG000|Overall Study|Death|2|||
170691140|NCT03329690|616879611|FG001|Overall Study|Death|0|||
170691141|NCT03329690|616879612|FG002|Overall Study|Death|0|||
170691142|NCT03329690|616879613|FG003|Overall Study|Death|1|||
170691143|NCT03329690|616879614|FG004|Overall Study|Death|0|||
170691144|NCT03329690|616879610|FG000|Overall Study|Withdrawal by Subject|2|||
170691145|NCT03329690|616879611|FG001|Overall Study|Withdrawal by Subject|3|||
170691146|NCT03329690|616879612|FG002|Overall Study|Withdrawal by Subject|0|||
170691147|NCT03329690|616879613|FG003|Overall Study|Withdrawal by Subject|1|||
170691148|NCT03329690|616879614|FG004|Overall Study|Withdrawal by Subject|0|||
170691149|NCT03329690|616879610|FG000|Overall Study|Physician Decision|1|||
170691150|NCT03329690|616879611|FG001|Overall Study|Physician Decision|0|||
170691151|NCT03329690|616879612|FG002|Overall Study|Physician Decision|0|||
170691152|NCT03329690|616879613|FG003|Overall Study|Physician Decision|0|||
170691153|NCT03329690|616879614|FG004|Overall Study|Physician Decision|1|||
170691154|NCT03329690|616879610|FG000|Overall Study|Miscellaneous|6|||
170691155|NCT03329690|616879611|FG001|Overall Study|Miscellaneous|0|||
170691156|NCT03329690|616879612|FG002|Overall Study|Miscellaneous|0|||
170691157|NCT03329690|616879613|FG003|Overall Study|Miscellaneous|0|||
170691158|NCT03329690|616879614|FG004|Overall Study|Miscellaneous|0|||
170691159|NCT03329690|616879610|FG000|Overall Study|Did not receive treatment|1|||
170691160|NCT03329690|616879611|FG001|Overall Study|Did not receive treatment|0|||
170691161|NCT03329690|616879612|FG002|Overall Study|Did not receive treatment|0|||
170691162|NCT03329690|616879613|FG003|Overall Study|Did not receive treatment|1|||
170691163|NCT03329690|616879614|FG004|Overall Study|Did not receive treatment|0|||
170691164|NCT04105998|616879617|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
170691165|NCT04105998|616879618|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
170691166|NCT00459108|616879623|FG000|Overall Study|Withdrawal by Subject|5|||
170691167|NCT00459108|616879623|FG000|Overall Study|Adverse Event|3|||
170691168|NCT00459108|616879623|FG000|Overall Study|Death|2|||
170691169|NCT00459108|616879623|FG000|Overall Study|Progression|1|||
170691170|NCT01505868|616879634|FG000|Overall Study|Withdrawal by Subject|1|||
170691171|NCT01505868|616879635|FG001|Overall Study|Withdrawal by Subject|0|||
170691172|NCT01505868|616879636|FG002|Overall Study|Withdrawal by Subject|0|||
170691173|NCT01505868|616879637|FG003|Overall Study|Withdrawal by Subject|0|||
170691174|NCT01505868|616879638|FG004|Overall Study|Withdrawal by Subject|0|||
170691175|NCT00975481|616879646|FG000|Second Intervention Period|Adverse Event|2|||
170691176|NCT00975481|616879647|FG001|Second Intervention Period|Adverse Event|1|||
170691177|NCT00975481|616879648|FG002|Second Intervention Period|Adverse Event|0|||
170691178|NCT00975481|616879649|FG003|Second Intervention Period|Adverse Event|0|||
170691179|NCT00975481|616879650|FG004|Second Intervention Period|Adverse Event|0|||
170691180|NCT00975481|616879651|FG005|Second Intervention Period|Adverse Event|0|||
170691181|NCT00975481|616879646|FG000|Second Intervention Period|Withdrawal by Subject|0|||
170691182|NCT00975481|616879647|FG001|Second Intervention Period|Withdrawal by Subject|0|||
170691183|NCT00975481|616879648|FG002|Second Intervention Period|Withdrawal by Subject|1|||
170691184|NCT00975481|616879649|FG003|Second Intervention Period|Withdrawal by Subject|0|||
170691185|NCT00975481|616879650|FG004|Second Intervention Period|Withdrawal by Subject|0|||
170691186|NCT00975481|616879651|FG005|Second Intervention Period|Withdrawal by Subject|0|||
170822526|NCT02350127|617357479|FG000|4-Month Assessment|Death|1|||
170691187|NCT00975481|616879646|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
170691188|NCT00975481|616879647|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
170822527|NCT02350127|617357480|FG001|4-Month Assessment|Death|0|||
170822528|NCT02350127|617357479|FG000|8-Month Assessment|Death|1|||
170822529|NCT02350127|617357480|FG001|8-Month Assessment|Death|1|||
170822530|NCT02350127|617357479|FG000|8-Month Assessment|Withdrawal by Subject|5|||
170822531|NCT02350127|617357480|FG001|8-Month Assessment|Withdrawal by Subject|8|||
170822532|NCT04601857|617357481|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
170822533|NCT04601857|617357482|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
170822534|NCT04601857|617357481|FG000|Overall Study|Disease Progression|2|||
170822535|NCT04601857|617357482|FG001|Overall Study|Disease Progression|4|||
170822536|NCT04601857|617357481|FG000|Overall Study|Clinical Disease Progression|2|||
170822537|NCT04601857|617357482|FG001|Overall Study|Clinical Disease Progression|1|||
170822538|NCT04601857|617357481|FG000|Overall Study|Radiological Progression|4|||
170822539|NCT04601857|617357482|FG001|Overall Study|Radiological Progression|11|||
170822540|NCT04601857|617357481|FG000|Overall Study|Death|1|||
170822541|NCT04601857|617357482|FG001|Overall Study|Death|0|||
170822542|NCT04601857|617357481|FG000|Overall Study|Reason Not Specified|0|||
170822543|NCT04601857|617357482|FG001|Overall Study|Reason Not Specified|1|||
170822544|NCT04601857|617357481|FG000|Overall Study|At the Participant's Request|0|||
170822545|NCT04601857|617357482|FG001|Overall Study|At the Participant's Request|1|||
170822546|NCT00794573|617357483|FG000|Overall Study|Death|3|||
170822547|NCT00794573|617357484|FG001|Overall Study|Death|0|||
170822548|NCT00794573|617357483|FG000|Overall Study|Withdrawal by Subject|9|||
170822549|NCT00794573|617357484|FG001|Overall Study|Withdrawal by Subject|12|||
170822550|NCT00794573|617357483|FG000|Overall Study|Lost to Follow-up|26|||
170822551|NCT00794573|617357484|FG001|Overall Study|Lost to Follow-up|33|||
170822552|NCT01207453|617357492|FG000|First Intervention|Adverse Event|2|||
170822553|NCT01207453|617357493|FG001|First Intervention|Adverse Event|1|||
170822554|NCT01207453|617357492|FG000|Washout|Adverse Event|1|||
170822555|NCT01207453|617357493|FG001|Washout|Adverse Event|0|||
170691189|NCT00975481|616879648|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
170691190|NCT00975481|616879649|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
170691191|NCT00975481|616879650|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
170691192|NCT00975481|616879651|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
170691193|NCT00975481|616879646|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
170691194|NCT00975481|616879647|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
170691195|NCT00975481|616879648|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
170691196|NCT00975481|616879649|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
170691197|NCT00975481|616879650|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
170691198|NCT00975481|616879651|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
170691199|NCT01519960|616879653|FG000|Overall Study|Withdrawal from the study|26|||
170691200|NCT01519960|616879654|FG001|Overall Study|Withdrawal from the study|22|||
170691201|NCT01519960|616879655|FG002|Overall Study|Withdrawal from the study|5|||
170691202|NCT01387347|616879656|FG000|Overall Study|Lost to Follow-up|2|||
170691203|NCT01387347|616879657|FG001|Overall Study|Lost to Follow-up|1|||
170691204|NCT03605303|616879664|FG000|Period 1|Study Terminated|2|||
170691205|NCT03605303|616879665|FG001|Period 1|Study Terminated|1|||
170691206|NCT02626520|616879668|FG000|Overall Study|Physician Decision|1|||
170691207|NCT02626520|616879669|FG001|Overall Study|Physician Decision|1|||
170691208|NCT02626520|616879668|FG000|Overall Study|Adverse Event|0|||
170822556|NCT01207453|617357492|FG000|Washout|Lost to Follow-up|1|||
170822557|NCT01207453|617357493|FG001|Washout|Lost to Follow-up|0|||
170822558|NCT01207453|617357492|FG000|2nd Intervention|Adverse Event|1|||
170822559|NCT01207453|617357493|FG001|2nd Intervention|Adverse Event|2|||
170822560|NCT01207453|617357492|FG000|2nd Intervention|Lost to Follow-up|1|||
170822561|NCT01207453|617357493|FG001|2nd Intervention|Lost to Follow-up|0|||
170822562|NCT01334606|617357497|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
170822563|NCT00417989|617357501|FG000|Overall Study|Withdrawal by Subject|13|||
170691209|NCT02626520|616879669|FG001|Overall Study|Adverse Event|4|||
170691210|NCT02626520|616879668|FG000|Overall Study|Lack of Efficacy|0|||
170691211|NCT02626520|616879669|FG001|Overall Study|Lack of Efficacy|2|||
170691212|NCT02626520|616879668|FG000|Overall Study|Did not start protocol therapy|0|||
170691213|NCT02626520|616879669|FG001|Overall Study|Did not start protocol therapy|2|||
170822564|NCT00417989|617357502|FG001|Overall Study|Withdrawal by Subject|13|||
170822565|NCT00417989|617357501|FG000|Overall Study|Lost to Follow-up|1|||
170691214|NCT02626520|616879668|FG000|Overall Study|Study terminated|0|||
170691215|NCT02626520|616879669|FG001|Overall Study|Study terminated|1|||
170691216|NCT02953314|616879670|FG000|Overall Study|Adverse Event|0|||
170691217|NCT02953314|616879671|FG001|Overall Study|Adverse Event|1|||
170691218|NCT02953314|616879670|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
170691219|NCT02953314|616879671|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
170691220|NCT01474876|616879680|FG000|Overall Study|Adverse Event|11|||
170691221|NCT01474876|616879681|FG001|Overall Study|Adverse Event|5|||
170691222|NCT01474876|616879682|FG002|Overall Study|Adverse Event|0|||
170691223|NCT01474876|616879680|FG000|Overall Study|Serious Adverse Event|2|||
170691224|NCT01474876|616879681|FG001|Overall Study|Serious Adverse Event|3|||
170691225|NCT01474876|616879682|FG002|Overall Study|Serious Adverse Event|0|||
170691226|NCT01474876|616879680|FG000|Overall Study|Lost to Follow-up|5|||
170691227|NCT01474876|616879681|FG001|Overall Study|Lost to Follow-up|4|||
170691228|NCT01474876|616879682|FG002|Overall Study|Lost to Follow-up|0|||
170691229|NCT01474876|616879680|FG000|Overall Study|Investigator's decision|28|||
170691230|NCT01474876|616879681|FG001|Overall Study|Investigator's decision|6|||
170691231|NCT01474876|616879682|FG002|Overall Study|Investigator's decision|0|||
170691232|NCT01474876|616879680|FG000|Overall Study|Patient's request|19|||
170691233|NCT01474876|616879681|FG001|Overall Study|Patient's request|5|||
170691234|NCT01474876|616879682|FG002|Overall Study|Patient's request|0|||
170691235|NCT01474876|616879680|FG000|Overall Study|Investigator's decision and pt request|1|||
170691236|NCT01474876|616879681|FG001|Overall Study|Investigator's decision and pt request|0|||
170691237|NCT01474876|616879682|FG002|Overall Study|Investigator's decision and pt request|0|||
170691238|NCT02291055|616879683|FG000|Overall Study|Death|2|||
170691239|NCT02291055|616879684|FG001|Overall Study|Death|2|||
170691240|NCT02291055|616879685|FG002|Overall Study|Death|5|||
170691241|NCT02291055|616879686|FG003|Overall Study|Death|8|||
170691242|NCT02291055|616879687|FG004|Overall Study|Death|12|||
170691243|NCT02291055|616879683|FG000|Overall Study|Lost to Follow-up|0|||
170691244|NCT02291055|616879684|FG001|Overall Study|Lost to Follow-up|0|||
170691245|NCT02291055|616879685|FG002|Overall Study|Lost to Follow-up|0|||
170691246|NCT02291055|616879686|FG003|Overall Study|Lost to Follow-up|1|||
170691247|NCT02291055|616879687|FG004|Overall Study|Lost to Follow-up|2|||
170691248|NCT02291055|616879683|FG000|Overall Study|Withdrawal by Subject|3|||
170691249|NCT02291055|616879684|FG001|Overall Study|Withdrawal by Subject|1|||
170691250|NCT02291055|616879685|FG002|Overall Study|Withdrawal by Subject|1|||
170691251|NCT02291055|616879686|FG003|Overall Study|Withdrawal by Subject|5|||
170691252|NCT02291055|616879687|FG004|Overall Study|Withdrawal by Subject|10|||
170691253|NCT02291055|616879683|FG000|Overall Study|Progressive Disease|0|||
170691254|NCT02291055|616879684|FG001|Overall Study|Progressive Disease|0|||
170691255|NCT02291055|616879685|FG002|Overall Study|Progressive Disease|1|||
170691256|NCT02291055|616879686|FG003|Overall Study|Progressive Disease|4|||
170691257|NCT02291055|616879687|FG004|Overall Study|Progressive Disease|2|||
170691258|NCT02291055|616879683|FG000|Overall Study|Study Terminated by Sponsor|0|||
170691259|NCT02291055|616879684|FG001|Overall Study|Study Terminated by Sponsor|0|||
170691260|NCT02291055|616879685|FG002|Overall Study|Study Terminated by Sponsor|0|||
170691261|NCT02291055|616879686|FG003|Overall Study|Study Terminated by Sponsor|5|||
170691262|NCT02291055|616879687|FG004|Overall Study|Study Terminated by Sponsor|1|||
170691263|NCT02291055|616879683|FG000|Overall Study|Other|0|||
170691264|NCT02291055|616879684|FG001|Overall Study|Other|2|||
170691265|NCT02291055|616879685|FG002|Overall Study|Other|1|||
170691266|NCT02291055|616879686|FG003|Overall Study|Other|4|||
170691267|NCT02291055|616879687|FG004|Overall Study|Other|0|||
170691268|NCT01523886|616879688|FG000|Overall Study|surgery cancelled|0|||
170691269|NCT01523886|616879689|FG001|Overall Study|surgery cancelled|1|||
170691270|NCT03839212|616879693|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
170691271|NCT00679263|616879694|FG000|Visit 2/Dose 1|Adverse Event|1|||
170691272|NCT00679263|616879695|FG001|Visit 2/Dose 1|Adverse Event|0|||
170691273|NCT00679263|616879696|FG002|Visit 2/Dose 1|Adverse Event|0|||
170691274|NCT00679263|616879694|FG000|Visit 2/Dose 1|subject not compliance|1|||
170691275|NCT00679263|616879695|FG001|Visit 2/Dose 1|subject not compliance|1|||
170691276|NCT00679263|616879696|FG002|Visit 2/Dose 1|subject not compliance|0|||
170691277|NCT01765153|616879699|FG000|Training Phase 1|Format of intervention differed|1|||
170691278|NCT01765153|616879700|FG001|Training Phase 1|Format of intervention differed|0|||
170691279|NCT01765153|616879699|FG000|Training Phase 1|Poor participation in intervention|0|||
170691280|NCT01765153|616879700|FG001|Training Phase 1|Poor participation in intervention|1|||
170691281|NCT01765153|616879699|FG000|Rest Phase 1|Withdrawal by Subject|0|||
170691282|NCT01765153|616879700|FG001|Rest Phase 1|Withdrawal by Subject|1|||
170691283|NCT01765153|616879699|FG000|Training Phase 2|Withdrawal by Subject|0|||
170691284|NCT01765153|616879700|FG001|Training Phase 2|Withdrawal by Subject|1|||
170691285|NCT01765153|616879699|FG000|Rest Phase 2|Lost to Follow-up|2|||
170691286|NCT01765153|616879700|FG001|Rest Phase 2|Lost to Follow-up|1|||
170691287|NCT00597012|616879705|FG000|Overall Study|Death|1|||
170691288|NCT00597012|616879706|FG001|Overall Study|Death|1|||
170691289|NCT00597012|616879705|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
170822566|NCT00417989|617357502|FG001|Overall Study|Lost to Follow-up|6|||
170822567|NCT00417989|617357501|FG000|Overall Study|Protocol Violation|1|||
170691290|NCT00597012|616879706|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
170691291|NCT00597012|616879705|FG000|Overall Study|Withdrawal by Subject|7|||
170691292|NCT00597012|616879706|FG001|Overall Study|Withdrawal by Subject|4|||
170691293|NCT00597012|616879705|FG000|Overall Study|Ineligible|2|||
170691294|NCT00597012|616879706|FG001|Overall Study|Ineligible|0|||
170691295|NCT00597012|616879705|FG000|Overall Study|Lost to Follow-up|0|||
170691296|NCT00597012|616879706|FG001|Overall Study|Lost to Follow-up|2|||
170691297|NCT01254227|616882415|FG000|Overall Study|Withdrawal by Subject|6|||
170691298|NCT01254227|616882415|FG000|Overall Study|Lost to Follow-up|6|||
170691299|NCT01254227|616882415|FG000|Overall Study|Adverse Event|5|||
170691300|NCT01254227|616882415|FG000|Overall Study|Abnormal test procedure result|5|||
170691301|NCT01254227|616882415|FG000|Overall Study|Administrative problems|2|||
170691302|NCT01254227|616882415|FG000|Overall Study|Death|1|||
170691303|NCT01254227|616882415|FG000|Overall Study|Protocol deviation|1|||
170691304|NCT04729127|616882416|FG000|Overall Study|Suspended/Terminated EI Services|4|||
170691305|NCT04729127|616882417|FG001|Overall Study|Suspended/Terminated EI Services|0|||
170691306|NCT04729127|616882418|FG002|Overall Study|Suspended/Terminated EI Services|4|||
170691307|NCT04729127|616882419|FG003|Overall Study|Suspended/Terminated EI Services|6|||
170691308|NCT04729127|616882420|FG004|Overall Study|Suspended/Terminated EI Services|0|||
170691309|NCT04729127|616882421|FG005|Overall Study|Suspended/Terminated EI Services|6|||
170691310|NCT04729127|616882422|FG006|Overall Study|Suspended/Terminated EI Services|2|||
170691311|NCT04729127|616882423|FG007|Overall Study|Suspended/Terminated EI Services|0|||
170691312|NCT04729127|616882424|FG008|Overall Study|Suspended/Terminated EI Services|2|||
170691313|NCT04729127|616882416|FG000|Overall Study|Withdrawal by Subject|1|||
170691314|NCT04729127|616882417|FG001|Overall Study|Withdrawal by Subject|0|||
170691315|NCT04729127|616882418|FG002|Overall Study|Withdrawal by Subject|1|||
170691316|NCT04729127|616882419|FG003|Overall Study|Withdrawal by Subject|0|||
170691317|NCT04729127|616882420|FG004|Overall Study|Withdrawal by Subject|0|||
170691318|NCT04729127|616882421|FG005|Overall Study|Withdrawal by Subject|0|||
170691319|NCT04729127|616882422|FG006|Overall Study|Withdrawal by Subject|0|||
170691320|NCT04729127|616882423|FG007|Overall Study|Withdrawal by Subject|0|||
170691321|NCT04729127|616882424|FG008|Overall Study|Withdrawal by Subject|0|||
170691322|NCT04729127|616882416|FG000|Overall Study|Switched Agency/Setting|1|||
170691323|NCT04729127|616882417|FG001|Overall Study|Switched Agency/Setting|0|||
170691324|NCT04729127|616882418|FG002|Overall Study|Switched Agency/Setting|1|||
170691325|NCT04729127|616882419|FG003|Overall Study|Switched Agency/Setting|1|||
170691326|NCT04729127|616882420|FG004|Overall Study|Switched Agency/Setting|0|||
170691327|NCT04729127|616882421|FG005|Overall Study|Switched Agency/Setting|1|||
170691328|NCT04729127|616882422|FG006|Overall Study|Switched Agency/Setting|1|||
170691329|NCT04729127|616882423|FG007|Overall Study|Switched Agency/Setting|0|||
170691330|NCT04729127|616882424|FG008|Overall Study|Switched Agency/Setting|1|||
170691331|NCT02750592|616882425|FG000|Overall Study|Adverse Event|3|||
170691332|NCT02750592|616882425|FG000|Overall Study|Lack of Efficacy|2|||
170691333|NCT02981342|616882426|FG000|Overall Study|Adverse Event|0|||
170691334|NCT02981342|616882427|FG001|Overall Study|Adverse Event|0|||
170691335|NCT02981342|616882428|FG002|Overall Study|Adverse Event|0|||
170691336|NCT02981342|616882429|FG003|Overall Study|Adverse Event|1|||
170691337|NCT02981342|616882426|FG000|Overall Study|Death|0|||
170691338|NCT02981342|616882427|FG001|Overall Study|Death|9|||
170691339|NCT02981342|616882428|FG002|Overall Study|Death|9|||
170691340|NCT02981342|616882429|FG003|Overall Study|Death|4|||
170691341|NCT02981342|616882426|FG000|Overall Study|Withdrawal by Subject|0|||
170691342|NCT02981342|616882427|FG001|Overall Study|Withdrawal by Subject|0|||
170691343|NCT02981342|616882428|FG002|Overall Study|Withdrawal by Subject|3|||
170691344|NCT02981342|616882429|FG003|Overall Study|Withdrawal by Subject|1|||
170691345|NCT02981342|616882426|FG000|Overall Study|Study closed by sponsor|0|||
170691346|NCT02981342|616882427|FG001|Overall Study|Study closed by sponsor|0|||
170691347|NCT02981342|616882428|FG002|Overall Study|Study closed by sponsor|1|||
170691348|NCT02981342|616882429|FG003|Overall Study|Study closed by sponsor|1|||
170691349|NCT02981342|616882426|FG000|Overall Study|Randomized, Never Treated|0|||
170691350|NCT02981342|616882427|FG001|Overall Study|Randomized, Never Treated|1|||
170822568|NCT00417989|617357502|FG001|Overall Study|Protocol Violation|0|||
170822569|NCT00417989|617357501|FG000|Overall Study|Death|0|||
170822570|NCT00417989|617357502|FG001|Overall Study|Death|1|||
170691351|NCT02981342|616882428|FG002|Overall Study|Randomized, Never Treated|0|||
170691352|NCT02981342|616882429|FG003|Overall Study|Randomized, Never Treated|7|||
170691353|NCT02981342|616882426|FG000|Overall Study|Lost to Follow-up|0|||
170691354|NCT02981342|616882427|FG001|Overall Study|Lost to Follow-up|1|||
170691355|NCT02981342|616882428|FG002|Overall Study|Lost to Follow-up|0|||
170691356|NCT02981342|616882429|FG003|Overall Study|Lost to Follow-up|0|||
170822571|NCT00417989|617357501|FG000|Overall Study|Physician Decision|5|||
170822572|NCT00417989|617357502|FG001|Overall Study|Physician Decision|2|||
170691357|NCT03970733|616882430|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
170691358|NCT03970733|616882431|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
170691359|NCT03970733|616882432|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
170691360|NCT03970733|616882433|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
170691361|NCT03970733|616882434|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
170691362|NCT03970733|616882430|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
170691363|NCT03970733|616882431|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
170691364|NCT03970733|616882432|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
170691365|NCT03970733|616882433|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
170691366|NCT03970733|616882434|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
170691367|NCT03970733|616882430|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
170691368|NCT03970733|616882431|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
170691369|NCT03970733|616882432|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
170691370|NCT03970733|616882433|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
170691371|NCT03970733|616882434|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
170691372|NCT03970733|616882430|FG000|Main Study Phase (18 Months)|Other|1|||
170691373|NCT03970733|616882431|FG001|Main Study Phase (18 Months)|Other|1|||
170691374|NCT03970733|616882432|FG002|Main Study Phase (18 Months)|Other|0|||
170691375|NCT03970733|616882433|FG003|Main Study Phase (18 Months)|Other|0|||
170691376|NCT03970733|616882434|FG004|Main Study Phase (18 Months)|Other|0|||
170691377|NCT03970733|616882430|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
170691378|NCT03970733|616882431|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
170691379|NCT03970733|616882432|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
170691380|NCT03970733|616882433|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
170691381|NCT03970733|616882434|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
170691382|NCT02794103|616882438|FG000|Overall Study|Loss to follow up due to high sedation|3|||
170691383|NCT00112502|616882439|FG000|Overall Study|Withdrawal by Subject|0|||
170691384|NCT00112502|616882440|FG001|Overall Study|Withdrawal by Subject|1|||
170691385|NCT00112502|616882441|FG002|Overall Study|Withdrawal by Subject|1|||
170691386|NCT00112502|616882442|FG003|Overall Study|Withdrawal by Subject|4|||
170691387|NCT00112502|616882443|FG004|Overall Study|Withdrawal by Subject|2|||
170691388|NCT00112502|616882444|FG005|Overall Study|Withdrawal by Subject|5|||
170691389|NCT00112502|616882445|FG006|Overall Study|Withdrawal by Subject|3|||
170691390|NCT00112502|616882446|FG007|Overall Study|Withdrawal by Subject|7|||
170691391|NCT02608268|616882449|FG000|Overall Study|Adverse Event|0|||
170691392|NCT02608268|616882450|FG001|Overall Study|Adverse Event|0|||
170691393|NCT02608268|616882451|FG002|Overall Study|Adverse Event|1|||
170691394|NCT02608268|616882452|FG003|Overall Study|Adverse Event|0|||
170691395|NCT02608268|616882453|FG004|Overall Study|Adverse Event|0|||
170691396|NCT02608268|616882454|FG005|Overall Study|Adverse Event|0|||
170691397|NCT02608268|616882455|FG006|Overall Study|Adverse Event|0|||
170691398|NCT02608268|616882456|FG007|Overall Study|Adverse Event|0|||
170691399|NCT02608268|616882457|FG008|Overall Study|Adverse Event|0|||
170691400|NCT02608268|616882458|FG009|Overall Study|Adverse Event|0|||
170691401|NCT02608268|616882459|FG010|Overall Study|Adverse Event|0|||
170691402|NCT02608268|616882460|FG011|Overall Study|Adverse Event|0|||
170691403|NCT02608268|616882461|FG012|Overall Study|Adverse Event|2|||
170691404|NCT02608268|616882462|FG013|Overall Study|Adverse Event|0|||
170691405|NCT02608268|616882463|FG014|Overall Study|Adverse Event|0|||
170691406|NCT02608268|616882464|FG015|Overall Study|Adverse Event|0|||
170691407|NCT02608268|616882465|FG016|Overall Study|Adverse Event|0|||
170691408|NCT02608268|616882466|FG017|Overall Study|Adverse Event|0|||
170691409|NCT02608268|616882467|FG018|Overall Study|Adverse Event|0|||
170691410|NCT02608268|616882468|FG019|Overall Study|Adverse Event|0|||
170691411|NCT02608268|616882469|FG020|Overall Study|Adverse Event|1|||
170691412|NCT02608268|616882470|FG021|Overall Study|Adverse Event|1|||
170691413|NCT02608268|616882471|FG022|Overall Study|Adverse Event|0|||
170691414|NCT02608268|616882472|FG023|Overall Study|Adverse Event|0|||
170691415|NCT02608268|616882473|FG024|Overall Study|Adverse Event|1|||
170691416|NCT02608268|616882474|FG025|Overall Study|Adverse Event|0|||
170691417|NCT02608268|616882475|FG026|Overall Study|Adverse Event|0|||
170691418|NCT02608268|616882476|FG027|Overall Study|Adverse Event|0|||
170691419|NCT02608268|616882477|FG028|Overall Study|Adverse Event|1|||
170691420|NCT02608268|616882478|FG029|Overall Study|Adverse Event|0|||
170691421|NCT02608268|616882449|FG000|Overall Study|Death|1|||
170691422|NCT02608268|616882450|FG001|Overall Study|Death|0|||
170691423|NCT02608268|616882451|FG002|Overall Study|Death|0|||
170691424|NCT02608268|616882452|FG003|Overall Study|Death|0|||
170691425|NCT02608268|616882453|FG004|Overall Study|Death|0|||
170691426|NCT02608268|616882454|FG005|Overall Study|Death|0|||
170691427|NCT02608268|616882455|FG006|Overall Study|Death|0|||
170691428|NCT02608268|616882456|FG007|Overall Study|Death|0|||
170691429|NCT02608268|616882457|FG008|Overall Study|Death|1|||
170691430|NCT02608268|616882458|FG009|Overall Study|Death|1|||
170691431|NCT02608268|616882459|FG010|Overall Study|Death|0|||
170822573|NCT00961896|617358837|FG000|Overall Study|Abnormal laboratory value|0|||
170822574|NCT00961896|617358838|FG001|Overall Study|Abnormal laboratory value|0|||
170822575|NCT00961896|617358839|FG002|Overall Study|Abnormal laboratory value|1|||
170822576|NCT00275301|617358841|FG000|Overall Study|Adverse Event|5|||
170822577|NCT04357964|617358842|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
170691432|NCT02608268|616882460|FG011|Overall Study|Death|0|||
170691433|NCT02608268|616882461|FG012|Overall Study|Death|0|||
170691434|NCT02608268|616882462|FG013|Overall Study|Death|0|||
170822578|NCT04357964|617358843|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
170822579|NCT04357964|617358842|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
170822580|NCT04357964|617358843|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
170822581|NCT04357964|617358842|FG000|Overall Study|Adipose sample was insufficient quality|0|||
170822582|NCT04357964|617358843|FG001|Overall Study|Adipose sample was insufficient quality|1|||
170822583|NCT00848393|617358846|FG000|Overall Study|Protocol Violation|0|||
170822584|NCT00848393|617358847|FG001|Overall Study|Protocol Violation|0|||
170822585|NCT00848393|617358848|FG002|Overall Study|Protocol Violation|1|||
170822586|NCT00848393|617358846|FG000|Overall Study|surgical complications unrelated to stud|0|||
170822587|NCT00848393|617358847|FG001|Overall Study|surgical complications unrelated to stud|0|||
170822588|NCT00848393|617358848|FG002|Overall Study|surgical complications unrelated to stud|2|||
170822589|NCT03511378|617358852|FG000|Overall Study|Withdrawal by Subject|2|||
170822590|NCT03511378|617358853|FG001|Overall Study|Withdrawal by Subject|2|||
170822591|NCT03511378|617358852|FG000|Overall Study|Patient not coming or schedule visit|1|||
170822592|NCT03511378|617358853|FG001|Overall Study|Patient not coming or schedule visit|0|||
170822593|NCT00755716|617358856|FG000|Overall Study|Adverse Event|1|||
170822594|NCT00755716|617358857|FG001|Overall Study|Adverse Event|4|||
170822595|NCT00755716|617358858|FG002|Overall Study|Adverse Event|1|||
170822596|NCT00755716|617358856|FG000|Overall Study|Lack of Efficacy|2|||
170822597|NCT00755716|617358857|FG001|Overall Study|Lack of Efficacy|0|||
170822598|NCT00755716|617358858|FG002|Overall Study|Lack of Efficacy|0|||
170822599|NCT00755716|617358856|FG000|Overall Study|Lost to Follow-up|5|||
170822600|NCT00755716|617358857|FG001|Overall Study|Lost to Follow-up|3|||
170822601|NCT00755716|617358858|FG002|Overall Study|Lost to Follow-up|1|||
170822602|NCT00755716|617358856|FG000|Overall Study|work schedule issues|0|||
170822603|NCT00755716|617358857|FG001|Overall Study|work schedule issues|1|||
170822604|NCT00755716|617358858|FG002|Overall Study|work schedule issues|1|||
170822605|NCT01350102|617358859|FG000|Overall Study|Adverse Event|0|||
170822606|NCT01350102|617358860|FG001|Overall Study|Adverse Event|0|||
170822607|NCT01350102|617358861|FG002|Overall Study|Adverse Event|1|||
170822608|NCT01350102|617358862|FG003|Overall Study|Adverse Event|0|||
170822609|NCT00550771|617358863|FG000|Overall Study|Adverse Event|11|||
170822610|NCT00550771|617358864|FG001|Overall Study|Adverse Event|3|||
170691435|NCT02608268|616882463|FG014|Overall Study|Death|0|||
170691436|NCT02608268|616882464|FG015|Overall Study|Death|1|||
170691437|NCT02608268|616882465|FG016|Overall Study|Death|0|||
170691438|NCT02608268|616882466|FG017|Overall Study|Death|1|||
170691439|NCT02608268|616882467|FG018|Overall Study|Death|0|||
170691440|NCT02608268|616882468|FG019|Overall Study|Death|1|||
170691441|NCT02608268|616882469|FG020|Overall Study|Death|1|||
170822611|NCT00550771|617358863|FG000|Overall Study|Discontinued for study-related reasons|0|||
170822612|NCT00550771|617358864|FG001|Overall Study|Discontinued for study-related reasons|1|||
170822613|NCT00550771|617358863|FG000|Overall Study|Physician Decision|2|||
170822614|NCT00550771|617358864|FG001|Overall Study|Physician Decision|0|||
170822615|NCT00550771|617358863|FG000|Overall Study|Withdrawal by Subject|0|||
170822616|NCT00550771|617358864|FG001|Overall Study|Withdrawal by Subject|1|||
170822617|NCT00550771|617358863|FG000|Overall Study|Protocol Violation|4|||
170822618|NCT00550771|617358864|FG001|Overall Study|Protocol Violation|5|||
170822619|NCT01243411|617358865|FG000|Overall Study|Withdrawal by Subject|18|||
170822620|NCT01243411|617358865|FG000|Overall Study|Lost to Follow-up|10|||
170822621|NCT01243411|617358865|FG000|Overall Study|Adverse Event|5|||
170822622|NCT01243411|617358865|FG000|Overall Study|Other|8|||
170822623|NCT03022578|617358868|FG000|Overall Study|Adverse Event|1|||
170822624|NCT03022578|617358868|FG000|Overall Study|Lack of Efficacy|2|||
170822625|NCT03022578|617358868|FG000|Overall Study|Withdrawal by Subject|1|||
170822626|NCT00488319|617358869|FG000|Overall Study|Adverse Event|1|||
170822627|NCT00488319|617358870|FG001|Overall Study|Adverse Event|2|||
170691442|NCT02608268|616882470|FG021|Overall Study|Death|0|||
170691443|NCT02608268|616882471|FG022|Overall Study|Death|0|||
170691444|NCT02608268|616882472|FG023|Overall Study|Death|0|||
170822628|NCT00488319|617358871|FG002|Overall Study|Adverse Event|23|||
170691445|NCT02608268|616882473|FG024|Overall Study|Death|1|||
170691446|NCT02608268|616882474|FG025|Overall Study|Death|2|||
170691447|NCT02608268|616882475|FG026|Overall Study|Death|0|||
170691448|NCT02608268|616882476|FG027|Overall Study|Death|1|||
170691449|NCT02608268|616882477|FG028|Overall Study|Death|4|||
170691450|NCT02608268|616882478|FG029|Overall Study|Death|0|||
170691451|NCT02608268|616882449|FG000|Overall Study|Physician Decision|0|||
170691452|NCT02608268|616882450|FG001|Overall Study|Physician Decision|0|||
170691453|NCT02608268|616882451|FG002|Overall Study|Physician Decision|0|||
170691454|NCT02608268|616882452|FG003|Overall Study|Physician Decision|0|||
170691455|NCT02608268|616882453|FG004|Overall Study|Physician Decision|0|||
170691456|NCT02608268|616882454|FG005|Overall Study|Physician Decision|0|||
170691457|NCT02608268|616882455|FG006|Overall Study|Physician Decision|0|||
170691458|NCT02608268|616882456|FG007|Overall Study|Physician Decision|0|||
170691459|NCT02608268|616882457|FG008|Overall Study|Physician Decision|0|||
170691460|NCT02608268|616882458|FG009|Overall Study|Physician Decision|0|||
170691461|NCT02608268|616882459|FG010|Overall Study|Physician Decision|1|||
170691462|NCT02608268|616882460|FG011|Overall Study|Physician Decision|0|||
170691463|NCT02608268|616882461|FG012|Overall Study|Physician Decision|0|||
170691464|NCT02608268|616882462|FG013|Overall Study|Physician Decision|1|||
170691465|NCT02608268|616882463|FG014|Overall Study|Physician Decision|0|||
170691466|NCT02608268|616882464|FG015|Overall Study|Physician Decision|0|||
170691467|NCT02608268|616882465|FG016|Overall Study|Physician Decision|0|||
170691468|NCT02608268|616882466|FG017|Overall Study|Physician Decision|0|||
170691469|NCT02608268|616882467|FG018|Overall Study|Physician Decision|0|||
170691470|NCT02608268|616882468|FG019|Overall Study|Physician Decision|0|||
170691471|NCT02608268|616882469|FG020|Overall Study|Physician Decision|0|||
170691472|NCT02608268|616882470|FG021|Overall Study|Physician Decision|0|||
170691473|NCT02608268|616882471|FG022|Overall Study|Physician Decision|1|||
170691474|NCT02608268|616882472|FG023|Overall Study|Physician Decision|1|||
170691475|NCT02608268|616882473|FG024|Overall Study|Physician Decision|1|||
170691476|NCT02608268|616882474|FG025|Overall Study|Physician Decision|0|||
170691477|NCT02608268|616882475|FG026|Overall Study|Physician Decision|0|||
170691478|NCT02608268|616882476|FG027|Overall Study|Physician Decision|2|||
170691479|NCT02608268|616882477|FG028|Overall Study|Physician Decision|1|||
170691480|NCT02608268|616882478|FG029|Overall Study|Physician Decision|1|||
170691481|NCT02608268|616882449|FG000|Overall Study|Progressive disease|12|||
170691482|NCT02608268|616882450|FG001|Overall Study|Progressive disease|8|||
170691483|NCT02608268|616882451|FG002|Overall Study|Progressive disease|13|||
170691484|NCT02608268|616882452|FG003|Overall Study|Progressive disease|5|||
170691485|NCT02608268|616882453|FG004|Overall Study|Progressive disease|2|||
170691486|NCT02608268|616882454|FG005|Overall Study|Progressive disease|4|||
170691487|NCT02608268|616882455|FG006|Overall Study|Progressive disease|6|||
170691488|NCT02608268|616882456|FG007|Overall Study|Progressive disease|2|||
170691489|NCT02608268|616882457|FG008|Overall Study|Progressive disease|5|||
170691490|NCT02608268|616882458|FG009|Overall Study|Progressive disease|6|||
170691491|NCT02608268|616882459|FG010|Overall Study|Progressive disease|5|||
170691492|NCT02608268|616882460|FG011|Overall Study|Progressive disease|5|||
170691493|NCT02608268|616882461|FG012|Overall Study|Progressive disease|4|||
170691494|NCT02608268|616882462|FG013|Overall Study|Progressive disease|11|||
170691495|NCT02608268|616882463|FG014|Overall Study|Progressive disease|6|||
170691496|NCT02608268|616882464|FG015|Overall Study|Progressive disease|3|||
170691497|NCT02608268|616882465|FG016|Overall Study|Progressive disease|5|||
170691498|NCT02608268|616882466|FG017|Overall Study|Progressive disease|5|||
170691499|NCT02608268|616882467|FG018|Overall Study|Progressive disease|5|||
170691500|NCT02608268|616882468|FG019|Overall Study|Progressive disease|2|||
170691501|NCT02608268|616882469|FG020|Overall Study|Progressive disease|10|||
170691502|NCT02608268|616882470|FG021|Overall Study|Progressive disease|4|||
170691503|NCT02608268|616882471|FG022|Overall Study|Progressive disease|5|||
170691504|NCT02608268|616882472|FG023|Overall Study|Progressive disease|5|||
170691505|NCT02608268|616882473|FG024|Overall Study|Progressive disease|3|||
170691506|NCT02608268|616882474|FG025|Overall Study|Progressive disease|11|||
170691507|NCT02608268|616882475|FG026|Overall Study|Progressive disease|16|||
170691508|NCT02608268|616882476|FG027|Overall Study|Progressive disease|11|||
170691509|NCT02608268|616882477|FG028|Overall Study|Progressive disease|10|||
170691510|NCT02608268|616882478|FG029|Overall Study|Progressive disease|15|||
170691511|NCT02608268|616882449|FG000|Overall Study|Subject/guardian decision|1|||
170691512|NCT02608268|616882450|FG001|Overall Study|Subject/guardian decision|1|||
170691513|NCT02608268|616882451|FG002|Overall Study|Subject/guardian decision|2|||
170822629|NCT00488319|617358869|FG000|Overall Study|Lack of Efficacy|6|||
170691514|NCT02608268|616882452|FG003|Overall Study|Subject/guardian decision|0|||
170691515|NCT02608268|616882453|FG004|Overall Study|Subject/guardian decision|0|||
170691516|NCT02608268|616882454|FG005|Overall Study|Subject/guardian decision|0|||
170691517|NCT02608268|616882455|FG006|Overall Study|Subject/guardian decision|0|||
170691518|NCT02608268|616882456|FG007|Overall Study|Subject/guardian decision|0|||
170691519|NCT02608268|616882457|FG008|Overall Study|Subject/guardian decision|2|||
170691520|NCT02608268|616882458|FG009|Overall Study|Subject/guardian decision|2|||
170691521|NCT02608268|616882459|FG010|Overall Study|Subject/guardian decision|0|||
170691522|NCT02608268|616882460|FG011|Overall Study|Subject/guardian decision|1|||
170691523|NCT02608268|616882461|FG012|Overall Study|Subject/guardian decision|0|||
170691524|NCT02608268|616882462|FG013|Overall Study|Subject/guardian decision|1|||
170691525|NCT02608268|616882463|FG014|Overall Study|Subject/guardian decision|0|||
170691526|NCT02608268|616882464|FG015|Overall Study|Subject/guardian decision|1|||
170691527|NCT02608268|616882465|FG016|Overall Study|Subject/guardian decision|0|||
170691528|NCT02608268|616882466|FG017|Overall Study|Subject/guardian decision|0|||
170691529|NCT02608268|616882467|FG018|Overall Study|Subject/guardian decision|1|||
170691530|NCT02608268|616882468|FG019|Overall Study|Subject/guardian decision|0|||
170691531|NCT02608268|616882469|FG020|Overall Study|Subject/guardian decision|0|||
170691532|NCT02608268|616882470|FG021|Overall Study|Subject/guardian decision|0|||
170691533|NCT02608268|616882471|FG022|Overall Study|Subject/guardian decision|1|||
170691534|NCT02608268|616882472|FG023|Overall Study|Subject/guardian decision|0|||
170691535|NCT02608268|616882473|FG024|Overall Study|Subject/guardian decision|0|||
170691536|NCT02608268|616882474|FG025|Overall Study|Subject/guardian decision|1|||
170691537|NCT02608268|616882475|FG026|Overall Study|Subject/guardian decision|1|||
170691538|NCT02608268|616882476|FG027|Overall Study|Subject/guardian decision|1|||
170691539|NCT02608268|616882477|FG028|Overall Study|Subject/guardian decision|1|||
170691540|NCT02608268|616882478|FG029|Overall Study|Subject/guardian decision|0|||
170691541|NCT03662542|616882481|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
170691542|NCT03662542|616882482|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
170691543|NCT03662542|616882483|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
170691544|NCT03662542|616882484|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
170691545|NCT03662542|616882485|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
170691546|NCT03662542|616882486|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
170691547|NCT03662542|616882487|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
170691548|NCT03662542|616882488|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
170691549|NCT03662542|616882489|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
170691550|NCT03662542|616882481|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
170691551|NCT03662542|616882482|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
170691552|NCT03662542|616882483|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
170691553|NCT03662542|616882484|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
170691554|NCT03662542|616882485|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
170691555|NCT03662542|616882486|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
170691556|NCT03662542|616882487|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
170691557|NCT03662542|616882488|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
170691558|NCT03662542|616882489|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
170691559|NCT03662542|616882481|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
170691560|NCT03662542|616882482|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
170691561|NCT03662542|616882483|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
170691562|NCT03662542|616882484|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
170691563|NCT03662542|616882485|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
170691564|NCT03662542|616882486|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
170691565|NCT03662542|616882487|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
170691566|NCT03662542|616882488|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
170691567|NCT03662542|616882489|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
170691568|NCT03662542|616882481|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
170691569|NCT03662542|616882482|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
170691570|NCT03662542|616882483|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
170691571|NCT03662542|616882484|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
170691572|NCT03662542|616882485|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
170691573|NCT03662542|616882486|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
170691574|NCT03662542|616882487|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
170691575|NCT03662542|616882488|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
170691576|NCT03662542|616882489|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
170691577|NCT03662542|616882481|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
170691578|NCT03662542|616882482|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
170691579|NCT03662542|616882483|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
170691580|NCT03662542|616882484|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
170691581|NCT03662542|616882485|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
170691582|NCT03662542|616882486|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
170691583|NCT03662542|616882487|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
170691584|NCT03662542|616882488|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
170691585|NCT03662542|616882489|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
170691586|NCT03662542|616882481|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
170691587|NCT03662542|616882482|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
170691588|NCT03662542|616882483|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
170691589|NCT03662542|616882484|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
170691590|NCT03662542|616882485|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
170691591|NCT03662542|616882486|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
170691592|NCT03662542|616882487|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
170691593|NCT03662542|616882488|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
170691594|NCT03662542|616882489|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
170691595|NCT03662542|616882481|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
170691596|NCT03662542|616882482|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
170691597|NCT03662542|616882483|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
170691598|NCT03662542|616882484|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
170691599|NCT03662542|616882485|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
170691600|NCT03662542|616882486|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
170691601|NCT03662542|616882487|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
170691602|NCT03662542|616882488|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
170691603|NCT03662542|616882489|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
170691604|NCT03662542|616882481|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
170691605|NCT03662542|616882482|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
170691606|NCT03662542|616882483|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
170691607|NCT03662542|616882484|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
170691608|NCT03662542|616882485|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
170691609|NCT03662542|616882486|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
170691610|NCT03662542|616882487|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
170691611|NCT03662542|616882488|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
170691612|NCT03662542|616882489|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
170691613|NCT03662542|616882481|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
170691614|NCT03662542|616882482|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
170691615|NCT03662542|616882483|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
170691616|NCT03662542|616882484|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
170691617|NCT03662542|616882485|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
170691618|NCT03662542|616882486|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
170691619|NCT03662542|616882487|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
170691620|NCT03662542|616882488|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
170691621|NCT03662542|616882489|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
170691622|NCT03662542|616882481|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
170691623|NCT03662542|616882482|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
170691624|NCT03662542|616882483|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
170691625|NCT03662542|616882484|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
170691626|NCT03662542|616882485|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
170691627|NCT03662542|616882486|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
170691628|NCT03662542|616882487|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
170691629|NCT03662542|616882488|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
170691630|NCT03662542|616882489|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
170691631|NCT03662542|616882481|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
170691632|NCT03662542|616882482|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
170691633|NCT03662542|616882483|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
170691634|NCT03662542|616882484|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
170691635|NCT03662542|616882485|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
170691636|NCT03662542|616882486|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
170691637|NCT03662542|616882487|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
170691638|NCT03662542|616882488|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
170691639|NCT03662542|616882489|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
170691640|NCT03662542|616882481|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
170691641|NCT03662542|616882482|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
170691642|NCT03662542|616882483|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
170691643|NCT03662542|616882484|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
170691644|NCT03662542|616882485|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
170691645|NCT03662542|616882486|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
170691646|NCT03662542|616882487|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
170691647|NCT03662542|616882488|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
170691648|NCT03662542|616882489|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
170691649|NCT03662542|616882481|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
170691650|NCT03662542|616882482|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
170691651|NCT03662542|616882483|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
170691652|NCT03662542|616882484|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
170691653|NCT03662542|616882485|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
170691654|NCT03662542|616882486|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
170691655|NCT03662542|616882487|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
170691656|NCT03662542|616882488|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
170691657|NCT03662542|616882489|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
170691658|NCT01217060|616882490|FG000|Overall Study|Withdrawal by Subject|1|||
170691659|NCT03388138|616882499|FG000|Overall Study|Protocol Violation|1|||
170691660|NCT03388138|616882500|FG001|Overall Study|Protocol Violation|0|||
170691661|NCT01859494|616882514|FG000|Overall Study|Adverse Event|1|||
170691662|NCT02436759|616882516|FG000|Overall Study|Adverse Event|3|||
170691663|NCT02436759|616882517|FG001|Overall Study|Adverse Event|0|||
170691664|NCT02436759|616882516|FG000|Overall Study|Protocol Violation|1|||
170691665|NCT02436759|616882517|FG001|Overall Study|Protocol Violation|0|||
170691666|NCT02436759|616882516|FG000|Overall Study|Withdrawal by Subject|0|||
170691667|NCT02436759|616882517|FG001|Overall Study|Withdrawal by Subject|1|||
170691668|NCT01727141|616882520|FG000|Overall Study|Physician Decision|0|||
170691669|NCT01727141|616882521|FG001|Overall Study|Physician Decision|1|||
170691670|NCT01727141|616882522|FG002|Overall Study|Physician Decision|0|||
170691671|NCT01727141|616882523|FG003|Overall Study|Physician Decision|2|||
170691672|NCT01727141|616882520|FG000|Overall Study|Lost to Follow-up|0|||
170691673|NCT01727141|616882521|FG001|Overall Study|Lost to Follow-up|2|||
170691674|NCT01727141|616882522|FG002|Overall Study|Lost to Follow-up|0|||
170691675|NCT01727141|616882523|FG003|Overall Study|Lost to Follow-up|0|||
170691676|NCT01727141|616882520|FG000|Overall Study|Death|0|||
170691677|NCT01727141|616882521|FG001|Overall Study|Death|1|||
170691678|NCT01727141|616882522|FG002|Overall Study|Death|1|||
170691679|NCT01727141|616882523|FG003|Overall Study|Death|1|||
170691680|NCT01727141|616882520|FG000|Overall Study|Protocol deviation|1|||
170691681|NCT01727141|616882521|FG001|Overall Study|Protocol deviation|1|||
170691682|NCT01727141|616882522|FG002|Overall Study|Protocol deviation|0|||
170691683|NCT01727141|616882523|FG003|Overall Study|Protocol deviation|1|||
170691684|NCT01727141|616882520|FG000|Overall Study|Withdrawal by Subject|4|||
170691685|NCT01727141|616882521|FG001|Overall Study|Withdrawal by Subject|4|||
170691686|NCT01727141|616882522|FG002|Overall Study|Withdrawal by Subject|2|||
170691687|NCT01727141|616882523|FG003|Overall Study|Withdrawal by Subject|11|||
170691688|NCT04014075|616882524|FG000|Overall Study|Progressive Disease|53|||
170691689|NCT04014075|616882524|FG000|Overall Study|Adverse Event|15|||
170691690|NCT04014075|616882524|FG000|Overall Study|Clinical Progression|4|||
170691691|NCT04014075|616882524|FG000|Overall Study|Death|2|||
170691692|NCT04014075|616882524|FG000|Overall Study|Withdrawal by Subject|2|||
170691693|NCT04014075|616882524|FG000|Overall Study|Miscellaneous|2|||
170691694|NCT04014075|616882524|FG000|Overall Study|Physician Decision|1|||
170691695|NCT02584504|616882527|FG000|Double-blind Treatment|Participant withdrew consent|0|||
170691696|NCT02584504|616882528|FG001|Double-blind Treatment|Participant withdrew consent|0|||
170691697|NCT02584504|616882529|FG002|Double-blind Treatment|Participant withdrew consent|1|||
170691698|NCT02584504|616882527|FG000|Double-blind Treatment|Adverse Event|0|||
170691699|NCT02584504|616882528|FG001|Double-blind Treatment|Adverse Event|1|||
170691700|NCT02584504|616882529|FG002|Double-blind Treatment|Adverse Event|0|||
170691701|NCT02584504|616882527|FG000|Double-blind Treatment|Family Matter|0|||
170691702|NCT02584504|616882528|FG001|Double-blind Treatment|Family Matter|1|||
170691703|NCT02584504|616882529|FG002|Double-blind Treatment|Family Matter|0|||
170691704|NCT02584504|616882527|FG000|Open-label Treatment|Participant withdrew consent|0|||
170691705|NCT02584504|616882528|FG001|Open-label Treatment|Participant withdrew consent|0|||
170691706|NCT02584504|616882529|FG002|Open-label Treatment|Participant withdrew consent|4|||
170691707|NCT02584504|616882527|FG000|Open-label Treatment|Adverse Event|2|||
170691708|NCT02584504|616882528|FG001|Open-label Treatment|Adverse Event|2|||
170691709|NCT02584504|616882529|FG002|Open-label Treatment|Adverse Event|3|||
170691710|NCT02584504|616882527|FG000|Open-label Treatment|Physician Decision|0|||
170691711|NCT02584504|616882528|FG001|Open-label Treatment|Physician Decision|1|||
170691712|NCT02584504|616882529|FG002|Open-label Treatment|Physician Decision|0|||
170691713|NCT02584504|616882527|FG000|Open-label Treatment|Entered but not treated|0|||
170691714|NCT02584504|616882528|FG001|Open-label Treatment|Entered but not treated|1|||
170691715|NCT02584504|616882529|FG002|Open-label Treatment|Entered but not treated|1|||
170691716|NCT03102918|616882530|FG000|Overall Study|Protocol Violation|1|||
170691717|NCT03102918|616882531|FG001|Overall Study|Protocol Violation|0|||
170691718|NCT02731729|616882534|FG000|Overall Study|Death|2|||
170822630|NCT00488319|617358870|FG001|Overall Study|Lack of Efficacy|12|||
170822631|NCT00488319|617358871|FG002|Overall Study|Lack of Efficacy|27|||
170822632|NCT00488319|617358869|FG000|Overall Study|Lost to Follow-up|3|||
170822633|NCT00488319|617358870|FG001|Overall Study|Lost to Follow-up|5|||
170822634|NCT00488319|617358871|FG002|Overall Study|Lost to Follow-up|16|||
170822635|NCT00488319|617358869|FG000|Overall Study|Withdrawal by Subject|5|||
170822636|NCT00488319|617358870|FG001|Overall Study|Withdrawal by Subject|20|||
170822637|NCT00488319|617358871|FG002|Overall Study|Withdrawal by Subject|44|||
170691719|NCT02731729|616882535|FG001|Overall Study|Death|2|||
170691720|NCT02731729|616882534|FG000|Overall Study|Study terminated by Sponsor|6|||
170691721|NCT02731729|616882535|FG001|Overall Study|Study terminated by Sponsor|6|||
170691722|NCT02731729|616882534|FG000|Overall Study|Withdrawal by Subject|1|||
170691723|NCT02731729|616882535|FG001|Overall Study|Withdrawal by Subject|0|||
170691724|NCT01344447|616882536|FG000|Overall Study|Adverse Event|1|||
170691725|NCT01344447|616882536|FG000|Overall Study|Protocol Violation|1|||
170691726|NCT01344447|616882536|FG000|Overall Study|Withdrawal by Subject|1|||
170691727|NCT01344447|616882536|FG000|Overall Study|The contrast was not seen|1|||
170691728|NCT01344447|616882536|FG000|Overall Study|Physician Decision|1|||
170691729|NCT01344447|616882536|FG000|Overall Study|MRA unsuccessful|1|||
170691730|NCT01344447|616882536|FG000|Overall Study|Bolus tracking failed|1|||
170691731|NCT01344447|616882536|FG000|Overall Study|Error of power injector|1|||
170691732|NCT01912287|616882538|FG000|Overall Study|Ineligible|1|||
170691733|NCT01912287|616882539|FG001|Overall Study|Ineligible|0|||
170691734|NCT01912287|616882540|FG002|Overall Study|Ineligible|1|||
170691735|NCT01912287|616882538|FG000|Overall Study|No-show|0|||
170691736|NCT01912287|616882539|FG001|Overall Study|No-show|0|||
170691737|NCT01912287|616882540|FG002|Overall Study|No-show|1|||
170691738|NCT01912287|616882538|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
170691739|NCT01912287|616882539|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
170691740|NCT01912287|616882540|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
170691741|NCT01912287|616882538|FG000|Overall Study|Felt treatment no longer needed|0|||
170691742|NCT01912287|616882539|FG001|Overall Study|Felt treatment no longer needed|1|||
170691743|NCT01912287|616882540|FG002|Overall Study|Felt treatment no longer needed|0|||
170691744|NCT01912287|616882538|FG000|Overall Study|Life circumstances|4|||
170691745|NCT01912287|616882539|FG001|Overall Study|Life circumstances|2|||
170691746|NCT01912287|616882540|FG002|Overall Study|Life circumstances|0|||
170691747|NCT01912287|616882538|FG000|Overall Study|Lost Interest|1|||
170691748|NCT01912287|616882539|FG001|Overall Study|Lost Interest|0|||
170691749|NCT01912287|616882540|FG002|Overall Study|Lost Interest|0|||
170691750|NCT01912287|616882538|FG000|Overall Study|Uknown reason - subject drop out|5|||
170691751|NCT01912287|616882539|FG001|Overall Study|Uknown reason - subject drop out|7|||
170691752|NCT01912287|616882540|FG002|Overall Study|Uknown reason - subject drop out|3|||
170691753|NCT01912287|616882538|FG000|Overall Study|Missed Assesment|1|||
170691754|NCT01912287|616882539|FG001|Overall Study|Missed Assesment|1|||
170691755|NCT01912287|616882540|FG002|Overall Study|Missed Assesment|1|||
170691756|NCT01912287|616882538|FG000|Overall Study|Scheduling/change in availability|17|||
170691757|NCT01912287|616882539|FG001|Overall Study|Scheduling/change in availability|10|||
170691758|NCT01912287|616882540|FG002|Overall Study|Scheduling/change in availability|8|||
170691759|NCT01558752|616882543|FG000|Overall Study|Physician Decision|2|||
170691760|NCT01558752|616882544|FG001|Overall Study|Physician Decision|0|||
170691761|NCT03855280|616882550|FG000|Treatment Phase|Adverse Event|1|||
170691762|NCT03855280|616882550|FG000|Treatment Phase|Withdrawal by Subject|1|||
170691763|NCT03855280|616882550|FG000|Continuation Phase|Protocol Violation|1|||
170691764|NCT03855280|616882550|FG000|Continuation Phase|Adverse Event|1|||
170691765|NCT03855280|616882550|FG000|Continuation Phase|Sponsor Concluded Study|1|||
170691766|NCT03051607|616882554|FG000|Overall Study|Adverse Event|66|||
170691767|NCT00894322|616882555|FG000|Overall Study|Withdrawal by Subject|1|||
170691768|NCT00894322|616882556|FG001|Overall Study|Withdrawal by Subject|0|||
170691769|NCT00894322|616882557|FG002|Overall Study|Withdrawal by Subject|0|||
170691770|NCT00553150|616882560|FG000|Overall Study|Withdrawal by Subject|0|||
170691771|NCT00553150|616882561|FG001|Overall Study|Withdrawal by Subject|0|||
170691772|NCT00553150|616882562|FG002|Overall Study|Withdrawal by Subject|0|||
170691773|NCT00553150|616882563|FG003|Overall Study|Withdrawal by Subject|2|||
170691774|NCT00553150|616882560|FG000|Overall Study|Protocol Violation|0|||
170691775|NCT00553150|616882561|FG001|Overall Study|Protocol Violation|0|||
170691776|NCT00553150|616882562|FG002|Overall Study|Protocol Violation|0|||
170691777|NCT00553150|616882563|FG003|Overall Study|Protocol Violation|1|||
170691778|NCT00553150|616882560|FG000|Overall Study|Ineligible|0|||
170822638|NCT00488319|617358869|FG000|Overall Study|Other reasons for withdrawal|0|||
170822639|NCT00488319|617358870|FG001|Overall Study|Other reasons for withdrawal|4|||
170822640|NCT00488319|617358871|FG002|Overall Study|Other reasons for withdrawal|12|||
170822641|NCT02316847|617358873|FG000|Overall Study|Adverse Event|0|||
170822642|NCT02316847|617358874|FG001|Overall Study|Adverse Event|3|||
170822643|NCT02316847|617358873|FG000|Overall Study|Lost to Follow-up|0|||
170822644|NCT02316847|617358874|FG001|Overall Study|Lost to Follow-up|2|||
170822645|NCT02316847|617358873|FG000|Overall Study|Physician Decision|0|||
170822646|NCT02316847|617358874|FG001|Overall Study|Physician Decision|1|||
170691779|NCT00553150|616882561|FG001|Overall Study|Ineligible|0|||
170691780|NCT00553150|616882562|FG002|Overall Study|Ineligible|0|||
170691781|NCT00553150|616882563|FG003|Overall Study|Ineligible|1|||
170691782|NCT03338855|616882564|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
170822647|NCT02316847|617358873|FG000|Overall Study|Pregnancy|0|||
170822648|NCT02316847|617358874|FG001|Overall Study|Pregnancy|1|||
170822649|NCT02316847|617358873|FG000|Overall Study|Withdrawal by Subject|2|||
170822650|NCT02316847|617358874|FG001|Overall Study|Withdrawal by Subject|9|||
170822651|NCT02316847|617358873|FG000|Overall Study|Noncompliance with study drug|0|||
170822652|NCT02316847|617358874|FG001|Overall Study|Noncompliance with study drug|3|||
170822653|NCT02316847|617358873|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
170691783|NCT03338855|616882565|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
170691784|NCT00535223|616882569|FG000|Overall Study|Withdrawal by Subject|4|||
170691785|NCT00535223|616882570|FG001|Overall Study|Withdrawal by Subject|1|||
170691786|NCT00492115|616882571|FG000|Overall Study|Withdrawal by Subject|3|||
170691787|NCT00492115|616882572|FG001|Overall Study|Withdrawal by Subject|4|||
170691788|NCT01092182|616882573|FG000|Overall Study|Death|0|||
170691789|NCT01092182|616882574|FG001|Overall Study|Death|5|||
170691790|NCT01092182|616882575|FG002|Overall Study|Death|3|||
170691791|NCT01092182|616882573|FG000|Overall Study|participant safety|1|||
170691792|NCT01092182|616882574|FG001|Overall Study|participant safety|2|||
170691793|NCT01092182|616882575|FG002|Overall Study|participant safety|0|||
170691794|NCT01092182|616882573|FG000|Overall Study|Physician Decision|0|||
170691795|NCT01092182|616882574|FG001|Overall Study|Physician Decision|6|||
170691796|NCT01092182|616882575|FG002|Overall Study|Physician Decision|0|||
170691797|NCT01092182|616882573|FG000|Overall Study|Did not meet criteria|0|||
170691798|NCT01092182|616882574|FG001|Overall Study|Did not meet criteria|0|||
170691799|NCT01092182|616882575|FG002|Overall Study|Did not meet criteria|25|||
170691800|NCT01092182|616882573|FG000|Overall Study|Non-compliance|0|||
170691801|NCT01092182|616882574|FG001|Overall Study|Non-compliance|3|||
170691802|NCT01092182|616882575|FG002|Overall Study|Non-compliance|0|||
170691803|NCT01092182|616882573|FG000|Overall Study|Participant refused follow-up|0|||
170691804|NCT01092182|616882574|FG001|Overall Study|Participant refused follow-up|2|||
170691805|NCT01092182|616882575|FG002|Overall Study|Participant refused follow-up|0|||
170691806|NCT02515045|616882582|FG000|Overall Study|Adverse Event|0|||
170691807|NCT02515045|616882583|FG001|Overall Study|Adverse Event|3|||
170691808|NCT02515045|616882584|FG002|Overall Study|Adverse Event|3|||
170691809|NCT02515045|616882582|FG000|Overall Study|Lost to Follow-up|0|||
170691810|NCT02515045|616882583|FG001|Overall Study|Lost to Follow-up|1|||
170691811|NCT02515045|616882584|FG002|Overall Study|Lost to Follow-up|1|||
170691812|NCT03255382|616882585|FG000|Overall Study|Adverse Event|3|||
170691813|NCT03255382|616882586|FG001|Overall Study|Adverse Event|0|||
170691814|NCT03255382|616882585|FG000|Overall Study|Lost to Follow-up|2|||
170691815|NCT03255382|616882586|FG001|Overall Study|Lost to Follow-up|0|||
170691816|NCT03255382|616882585|FG000|Overall Study|Withdrawal by Subject|2|||
170691817|NCT03255382|616882586|FG001|Overall Study|Withdrawal by Subject|0|||
170691818|NCT03255382|616882585|FG000|Overall Study|Other|6|||
170691819|NCT03255382|616882586|FG001|Overall Study|Other|0|||
170691820|NCT02221284|616882587|FG000|Overall Study|Case Report Forms Uncollected|56|||
170691821|NCT02221284|616882587|FG000|Overall Study|Protocol Deviation|5|||
170691822|NCT04948450|616882590|FG000|Overall Study|Return home|1|||
170691823|NCT04948450|616882591|FG001|Overall Study|Return home|3|||
170691824|NCT00624052|616882594|FG000|Overall Study|Adverse Event|7|||
170691825|NCT00624052|616882595|FG001|Overall Study|Adverse Event|6|||
170691826|NCT00624052|616882596|FG002|Overall Study|Adverse Event|0|||
170691827|NCT00624052|616882597|FG003|Overall Study|Adverse Event|3|||
170691828|NCT00624052|616882594|FG000|Overall Study|Lack of Efficacy|1|||
170691829|NCT00624052|616882595|FG001|Overall Study|Lack of Efficacy|1|||
170691830|NCT00624052|616882596|FG002|Overall Study|Lack of Efficacy|0|||
170691831|NCT00624052|616882597|FG003|Overall Study|Lack of Efficacy|0|||
170691832|NCT00624052|616882594|FG000|Overall Study|Lost to Follow-up|2|||
170691833|NCT00624052|616882595|FG001|Overall Study|Lost to Follow-up|3|||
170691834|NCT00624052|616882596|FG002|Overall Study|Lost to Follow-up|1|||
170691835|NCT00624052|616882597|FG003|Overall Study|Lost to Follow-up|0|||
170691836|NCT00624052|616882594|FG000|Overall Study|Non compliant with the protocol|2|||
170691837|NCT00624052|616882595|FG001|Overall Study|Non compliant with the protocol|1|||
170691838|NCT00624052|616882596|FG002|Overall Study|Non compliant with the protocol|1|||
170822654|NCT02316847|617358874|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
170822655|NCT01370018|617358875|FG000|Overall Study|Did not meet criteria for analysis|1|||
170822656|NCT04736602|617358877|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
170822657|NCT04736602|617358877|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
170822658|NCT00404547|617358879|FG000|Overall Study|Adverse Event|39|||
170822659|NCT00404547|617358880|FG001|Overall Study|Adverse Event|6|||
170822660|NCT00404547|617358879|FG000|Overall Study|Withdrawal by Subject|19|||
170691839|NCT00624052|616882597|FG003|Overall Study|Non compliant with the protocol|1|||
170691840|NCT00624052|616882594|FG000|Overall Study|Consent withdrawn|3|||
170691841|NCT00624052|616882595|FG001|Overall Study|Consent withdrawn|1|||
170691842|NCT00624052|616882596|FG002|Overall Study|Consent withdrawn|1|||
170691843|NCT00624052|616882597|FG003|Overall Study|Consent withdrawn|0|||
170691844|NCT00624052|616882594|FG000|Overall Study|Changed job/ran out if meds|0|||
170691845|NCT00624052|616882595|FG001|Overall Study|Changed job/ran out if meds|2|||
170691846|NCT00624052|616882596|FG002|Overall Study|Changed job/ran out if meds|0|||
170691847|NCT00624052|616882597|FG003|Overall Study|Changed job/ran out if meds|0|||
170691848|NCT01464346|616882605|FG000|Overall Study|Withdrawal by Subject|0|||
170691849|NCT01464346|616882606|FG001|Overall Study|Withdrawal by Subject|0|||
170691850|NCT01464346|616882607|FG002|Overall Study|Withdrawal by Subject|1|||
170691851|NCT00733746|616882608|FG000|Overall Study|Ineligible|5|||
170691852|NCT02295995|616882609|FG000|Overall Study|Lost to Follow-up|5|||
170691853|NCT02295995|616882610|FG001|Overall Study|Lost to Follow-up|1|||
170691854|NCT01848756|616882611|FG000|Overall Study|Adverse Event|1|||
170691855|NCT01848756|616882611|FG000|Overall Study|Withdrawal by Subject|1|||
170691856|NCT01848756|616882611|FG000|Overall Study|Enrolled in Error|1|||
170691857|NCT01173718|616882614|FG000|Overall Study|Death|17|||
170691858|NCT01173718|616882614|FG000|Overall Study|Abandonment of study graft|27|||
170691859|NCT01286012|616882615|FG000|Overall Study|Adverse Event|3|||
170691860|NCT01286012|616882616|FG001|Overall Study|Adverse Event|3|||
170691861|NCT01286012|616882615|FG000|Overall Study|Death|2|||
170691862|NCT01286012|616882616|FG001|Overall Study|Death|3|||
170691863|NCT01286012|616882615|FG000|Overall Study|Protocol Violation|1|||
170691864|NCT01286012|616882616|FG001|Overall Study|Protocol Violation|1|||
170691865|NCT01286012|616882615|FG000|Overall Study|Withdrawal by Subject|4|||
170691866|NCT01286012|616882616|FG001|Overall Study|Withdrawal by Subject|4|||
170691867|NCT01286012|616882615|FG000|Overall Study|Physician Decision|2|||
170691868|NCT01286012|616882616|FG001|Overall Study|Physician Decision|0|||
170691869|NCT01286012|616882615|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
170691870|NCT01286012|616882616|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
170691871|NCT02113956|616882619|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
170691872|NCT02113956|616882620|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
170691873|NCT02113956|616882619|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
170691874|NCT02113956|616882620|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
170691875|NCT02113956|616882619|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
170691876|NCT02113956|616882620|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
170691877|NCT04056195|616882621|FG000|Overall Study|Adverse Event|1|||
170691878|NCT04056195|616882622|FG001|Overall Study|Adverse Event|0|||
170691879|NCT04056195|616882623|FG002|Overall Study|Adverse Event|0|||
170691880|NCT04056195|616882621|FG000|Overall Study|Withdrawal by Subject|0|||
170691881|NCT04056195|616882622|FG001|Overall Study|Withdrawal by Subject|1|||
170691882|NCT04056195|616882623|FG002|Overall Study|Withdrawal by Subject|1|||
170691883|NCT04056195|616882621|FG000|Overall Study|Physician Decision|1|||
170691884|NCT04056195|616882622|FG001|Overall Study|Physician Decision|1|||
170691885|NCT04056195|616882623|FG002|Overall Study|Physician Decision|1|||
170691886|NCT03658538|616882627|FG000|Overall Study|Death|2|||
170691887|NCT03658538|616882628|FG001|Overall Study|Death|1|||
170691888|NCT03658538|616882627|FG000|Overall Study|Cancer diagnosis|1|||
170691889|NCT03658538|616882628|FG001|Overall Study|Cancer diagnosis|0|||
170691890|NCT03658538|616882627|FG000|Overall Study|Change residence|1|||
170691891|NCT03658538|616882628|FG001|Overall Study|Change residence|2|||
170691892|NCT03658538|616882627|FG000|Overall Study|Lost to Follow-up|3|||
170691893|NCT03658538|616882628|FG001|Overall Study|Lost to Follow-up|3|||
170691894|NCT03658538|616882627|FG000|Overall Study|Unblinded|2|||
170691895|NCT03658538|616882628|FG001|Overall Study|Unblinded|3|||
170691896|NCT03658538|616882627|FG000|Overall Study|Physician Decision|0|||
170691897|NCT03658538|616882628|FG001|Overall Study|Physician Decision|1|||
170691898|NCT03658538|616882627|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
170691899|NCT03658538|616882628|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
170691900|NCT03658538|616882627|FG000|Overall Study|Evicted from home|1|||
170691901|NCT03658538|616882628|FG001|Overall Study|Evicted from home|0|||
170691902|NCT01239368|616884733|FG000|Overall Study|Principal investigator discretion|1|||
170691903|NCT01239368|616884734|FG001|Overall Study|Principal investigator discretion|0|||
170691904|NCT01239368|616884735|FG002|Overall Study|Principal investigator discretion|0|||
170691905|NCT01239368|616884736|FG003|Overall Study|Principal investigator discretion|0|||
170691906|NCT01239368|616884737|FG004|Overall Study|Principal investigator discretion|1|||
170691907|NCT01239368|616884738|FG005|Overall Study|Principal investigator discretion|2|||
170691908|NCT01239368|616884739|FG006|Overall Study|Principal investigator discretion|0|||
170691909|NCT01239368|616884740|FG007|Overall Study|Principal investigator discretion|0|||
170691910|NCT01239368|616884741|FG008|Overall Study|Principal investigator discretion|0|||
170691911|NCT01239368|616884742|FG009|Overall Study|Principal investigator discretion|1|||
170691912|NCT01239368|616884733|FG000|Overall Study|Disease progression on study|1|||
170691913|NCT01239368|616884734|FG001|Overall Study|Disease progression on study|1|||
170691914|NCT01239368|616884735|FG002|Overall Study|Disease progression on study|1|||
170691915|NCT01239368|616884736|FG003|Overall Study|Disease progression on study|1|||
170691916|NCT01239368|616884737|FG004|Overall Study|Disease progression on study|4|||
170691917|NCT01239368|616884738|FG005|Overall Study|Disease progression on study|2|||
170691918|NCT01239368|616884739|FG006|Overall Study|Disease progression on study|5|||
170691919|NCT01239368|616884740|FG007|Overall Study|Disease progression on study|0|||
170691920|NCT01239368|616884741|FG008|Overall Study|Disease progression on study|0|||
170691921|NCT01239368|616884742|FG009|Overall Study|Disease progression on study|2|||
170691922|NCT01239368|616884733|FG000|Overall Study|Refused further treatment|0|||
170691923|NCT01239368|616884734|FG001|Overall Study|Refused further treatment|0|||
170691924|NCT01239368|616884735|FG002|Overall Study|Refused further treatment|0|||
170691925|NCT01239368|616884736|FG003|Overall Study|Refused further treatment|0|||
170691926|NCT01239368|616884737|FG004|Overall Study|Refused further treatment|0|||
170691927|NCT01239368|616884738|FG005|Overall Study|Refused further treatment|0|||
170691928|NCT01239368|616884739|FG006|Overall Study|Refused further treatment|0|||
170691929|NCT01239368|616884740|FG007|Overall Study|Refused further treatment|0|||
170691930|NCT01239368|616884741|FG008|Overall Study|Refused further treatment|0|||
170691931|NCT01239368|616884742|FG009|Overall Study|Refused further treatment|1|||
170691932|NCT01239368|616884733|FG000|Overall Study|Death|0|||
170691933|NCT01239368|616884734|FG001|Overall Study|Death|0|||
170691934|NCT01239368|616884735|FG002|Overall Study|Death|0|||
170691935|NCT01239368|616884736|FG003|Overall Study|Death|0|||
170691936|NCT01239368|616884737|FG004|Overall Study|Death|0|||
170691937|NCT01239368|616884738|FG005|Overall Study|Death|0|||
170691938|NCT01239368|616884739|FG006|Overall Study|Death|1|||
170691939|NCT01239368|616884740|FG007|Overall Study|Death|0|||
170691940|NCT01239368|616884741|FG008|Overall Study|Death|0|||
170691941|NCT01239368|616884742|FG009|Overall Study|Death|0|||
170691942|NCT03181399|616884743|FG000|6 Months on Treatment|Protocol non-compliance|7|||
170691943|NCT03181399|616884743|FG000|6 Months on Treatment|Adverse Event|4|||
170691944|NCT03181399|616884743|FG000|6 Months on Treatment|Tried alternative treatment|2|||
170691945|NCT03181399|616884743|FG000|6 Months on Treatment|Lost to Follow-up|2|||
170691946|NCT03181399|616884743|FG000|6 Months on Treatment|Personal reasons|1|||
170691947|NCT03181399|616884743|FG000|3 Months Off-treatment|Parent unable to travel|1|||
170691948|NCT02967692|616884744|FG000|Overall Study|Progressive disease|3|||
170691949|NCT02967692|616884745|FG001|Overall Study|Progressive disease|15|||
170691950|NCT02967692|616884746|FG002|Overall Study|Progressive disease|114|||
170691951|NCT02967692|616884747|FG003|Overall Study|Progressive disease|151|||
170691952|NCT02967692|616884744|FG000|Overall Study|Subject/guardian decision|1|||
170691953|NCT02967692|616884745|FG001|Overall Study|Subject/guardian decision|1|||
170691954|NCT02967692|616884746|FG002|Overall Study|Subject/guardian decision|14|||
170691955|NCT02967692|616884747|FG003|Overall Study|Subject/guardian decision|22|||
170691956|NCT02967692|616884744|FG000|Overall Study|Death|0|||
170691957|NCT02967692|616884745|FG001|Overall Study|Death|1|||
170691958|NCT02967692|616884746|FG002|Overall Study|Death|13|||
170691959|NCT02967692|616884747|FG003|Overall Study|Death|13|||
170691960|NCT02967692|616884744|FG000|Overall Study|Protocol deviation|1|||
170691961|NCT02967692|616884745|FG001|Overall Study|Protocol deviation|0|||
170691962|NCT02967692|616884746|FG002|Overall Study|Protocol deviation|1|||
170691963|NCT02967692|616884747|FG003|Overall Study|Protocol deviation|1|||
170691964|NCT02967692|616884744|FG000|Overall Study|Lost to Follow-up|0|||
170691965|NCT02967692|616884745|FG001|Overall Study|Lost to Follow-up|0|||
170691966|NCT02967692|616884746|FG002|Overall Study|Lost to Follow-up|1|||
170691967|NCT02967692|616884747|FG003|Overall Study|Lost to Follow-up|0|||
170691968|NCT02967692|616884744|FG000|Overall Study|Physician Decision|0|||
170691969|NCT02967692|616884745|FG001|Overall Study|Physician Decision|0|||
170691970|NCT02967692|616884746|FG002|Overall Study|Physician Decision|22|||
170691971|NCT02967692|616884747|FG003|Overall Study|Physician Decision|13|||
170691972|NCT02967692|616884744|FG000|Overall Study|Adverse Event|2|||
170691973|NCT02967692|616884745|FG001|Overall Study|Adverse Event|9|||
170691974|NCT02967692|616884746|FG002|Overall Study|Adverse Event|60|||
170691975|NCT02967692|616884747|FG003|Overall Study|Adverse Event|28|||
170691976|NCT02967692|616884744|FG000|Overall Study|Study terminated by sponsor|2|||
170691977|NCT02967692|616884745|FG001|Overall Study|Study terminated by sponsor|1|||
170691978|NCT02967692|616884746|FG002|Overall Study|Study terminated by sponsor|42|||
170691979|NCT02967692|616884747|FG003|Overall Study|Study terminated by sponsor|37|||
170691980|NCT02926924|616884748|FG000|Overall Study|withdrawal - reason unknown|0|||
170822661|NCT00404547|617358880|FG001|Overall Study|Withdrawal by Subject|2|||
170822662|NCT00404547|617358879|FG000|Overall Study|Protocol Violation|0|||
170822663|NCT00404547|617358880|FG001|Overall Study|Protocol Violation|1|||
170822664|NCT00404547|617358879|FG000|Overall Study|Lost to Follow-up|20|||
170822665|NCT00404547|617358880|FG001|Overall Study|Lost to Follow-up|9|||
170822666|NCT00404547|617358879|FG000|Overall Study|Lack of compliance|5|||
170822667|NCT00404547|617358880|FG001|Overall Study|Lack of compliance|1|||
170822668|NCT00404547|617358879|FG000|Overall Study|Other|4|||
170822669|NCT00404547|617358880|FG001|Overall Study|Other|0|||
170822670|NCT00404547|617358879|FG000|Overall Study|Reason not stated|3|||
170691981|NCT02926924|616884749|FG001|Overall Study|withdrawal - reason unknown|1|||
170691982|NCT00192504|616884757|FG000|Overall Study|Lost to Follow-up|1|||
170691983|NCT00192504|616884758|FG001|Overall Study|Lost to Follow-up|0|||
170691984|NCT00192504|616884759|FG002|Overall Study|Lost to Follow-up|0|||
170822671|NCT00404547|617358880|FG001|Overall Study|Reason not stated|6|||
170822672|NCT00274846|617358885|FG000|Overall Study|Did not receive adequate NK cells|1|||
170822673|NCT01313299|617358894|FG000|Overall Study|Adverse Event|3|||
170691985|NCT00192504|616884760|FG003|Overall Study|Lost to Follow-up|0|||
170691986|NCT00192504|616884757|FG000|Overall Study|Dosing window missed|0|||
170691987|NCT00192504|616884758|FG001|Overall Study|Dosing window missed|0|||
170691988|NCT00192504|616884759|FG002|Overall Study|Dosing window missed|1|||
170691989|NCT00192504|616884760|FG003|Overall Study|Dosing window missed|0|||
170691990|NCT02189473|616884761|FG000|Overall Study|Death|22|||
170691991|NCT02189473|616884762|FG001|Overall Study|Death|23|||
170691992|NCT02189473|616884761|FG000|Overall Study|Lost to Follow-up|1|||
170691993|NCT02189473|616884762|FG001|Overall Study|Lost to Follow-up|2|||
170691994|NCT02784821|616884763|FG000|Overall Study|Death|0|||
170691995|NCT02784821|616884764|FG001|Overall Study|Death|5|||
170691996|NCT02784821|616884765|FG002|Overall Study|Death|4|||
170691997|NCT02784821|616884766|FG003|Overall Study|Death|5|||
170691998|NCT03020823|616884783|FG000|Overall Study|Physician Decision|4|||
170691999|NCT03020823|616884783|FG000|Overall Study|Lack of Efficacy|4|||
170692000|NCT03020823|616884783|FG000|Overall Study|Adverse Event|2|||
170692001|NCT03739112|616884785|FG000|Overall Study|Adverse Event|2|||
170692002|NCT03739112|616884786|FG001|Overall Study|Adverse Event|2|||
170692003|NCT03739112|616884785|FG000|Overall Study|Withdrawal by Subject|38|||
170692004|NCT03739112|616884786|FG001|Overall Study|Withdrawal by Subject|19|||
170692005|NCT03739112|616884785|FG000|Overall Study|Lost to Follow-up|31|||
170692006|NCT03739112|616884786|FG001|Overall Study|Lost to Follow-up|33|||
170692007|NCT03739112|616884785|FG000|Overall Study|Protocol Deviation|12|||
170692008|NCT03739112|616884786|FG001|Overall Study|Protocol Deviation|9|||
170692009|NCT03739112|616884785|FG000|Overall Study|Physician Decision|1|||
170692010|NCT03739112|616884786|FG001|Overall Study|Physician Decision|0|||
170692011|NCT03739112|616884785|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
170692012|NCT03739112|616884786|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
170692013|NCT03739112|616884785|FG000|Overall Study|Site went on hold|65|||
170692014|NCT03739112|616884786|FG001|Overall Study|Site went on hold|67|||
170692015|NCT03739112|616884785|FG000|Overall Study|Other than specified|8|||
170692016|NCT03739112|616884786|FG001|Overall Study|Other than specified|5|||
170692017|NCT03739112|616884785|FG000|Overall Study|Randomized but not vaccinated|31|||
170692018|NCT03739112|616884786|FG001|Overall Study|Randomized but not vaccinated|25|||
170692019|NCT00588822|616884787|FG000|Overall Study|progression of disease|8|||
170692020|NCT02082210|616884789|FG000|Overall Study|Death|0|||
170692021|NCT02082210|616884790|FG001|Overall Study|Death|0|||
170692022|NCT02082210|616884791|FG002|Overall Study|Death|1|||
170692023|NCT02082210|616884792|FG003|Overall Study|Death|1|||
170692024|NCT02082210|616884793|FG004|Overall Study|Death|1|||
170692025|NCT02082210|616884794|FG005|Overall Study|Death|0|||
170692026|NCT02082210|616884789|FG000|Overall Study|Withdrawal by Subject|0|||
170692027|NCT02082210|616884790|FG001|Overall Study|Withdrawal by Subject|0|||
170692028|NCT02082210|616884791|FG002|Overall Study|Withdrawal by Subject|0|||
170692029|NCT02082210|616884792|FG003|Overall Study|Withdrawal by Subject|1|||
170692030|NCT02082210|616884793|FG004|Overall Study|Withdrawal by Subject|2|||
170692031|NCT02082210|616884794|FG005|Overall Study|Withdrawal by Subject|2|||
170692032|NCT02082210|616884789|FG000|Overall Study|Clinical Progression|0|||
170692033|NCT02082210|616884790|FG001|Overall Study|Clinical Progression|0|||
170692034|NCT02082210|616884791|FG002|Overall Study|Clinical Progression|0|||
170692035|NCT02082210|616884792|FG003|Overall Study|Clinical Progression|1|||
170692036|NCT02082210|616884793|FG004|Overall Study|Clinical Progression|0|||
170692037|NCT02082210|616884794|FG005|Overall Study|Clinical Progression|0|||
170692038|NCT02082210|616884789|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
170692039|NCT02082210|616884790|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
170692040|NCT02082210|616884791|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
170692041|NCT02082210|616884792|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
170692042|NCT02082210|616884793|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
170692043|NCT02082210|616884794|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
170692044|NCT02082210|616884789|FG000|Overall Study|Physician Decision|0|||
170692045|NCT02082210|616884790|FG001|Overall Study|Physician Decision|0|||
170692046|NCT02082210|616884791|FG002|Overall Study|Physician Decision|1|||
170692047|NCT02082210|616884792|FG003|Overall Study|Physician Decision|1|||
170692048|NCT02082210|616884793|FG004|Overall Study|Physician Decision|0|||
170692049|NCT02082210|616884794|FG005|Overall Study|Physician Decision|0|||
170692050|NCT01528072|616884795|FG000|Overall Study|Withdrawal by Subject|5|||
170822674|NCT01313299|617358895|FG001|Overall Study|Adverse Event|1|||
170692051|NCT01528072|616884795|FG000|Overall Study|Physician Decision|1|||
170692052|NCT01528072|616884795|FG000|Overall Study|Determined not eligible by AEAC|1|||
170692053|NCT01528072|616884795|FG000|Overall Study|Missed Visit|2|||
170692054|NCT01528072|616884795|FG000|Overall Study|Lost to Follow-up|5|||
170692055|NCT01528072|616884795|FG000|Overall Study|Explanted|2|||
170692056|NCT01528072|616884795|FG000|Overall Study|Site Closure|4|||
170692057|NCT01528072|616884795|FG000|Overall Study|Death|2|||
170692058|NCT01528072|616884795|FG000|Overall Study|Early Termination of Study|52|||
170692059|NCT00297037|616884796|FG000|Overall Study|Withdrawal by Subject|2|||
170692060|NCT00297037|616884797|FG001|Overall Study|Withdrawal by Subject|0|||
170692061|NCT00581776|616884798|FG000|Overall Study|Disease progression or no response|3|||
170692062|NCT00326950|616884800|FG000|Overall Study|Progressive Disease|1|||
170692063|NCT01275833|616884802|FG000|Overall Study|Study terminated|1|||
170692064|NCT01275833|616884803|FG001|Overall Study|Study terminated|1|||
170822675|NCT01313299|617358896|FG002|Overall Study|Adverse Event|1|||
170822676|NCT01313299|617358894|FG000|Overall Study|Lost to Follow-up|1|||
170822677|NCT01313299|617358895|FG001|Overall Study|Lost to Follow-up|0|||
170822678|NCT01313299|617358896|FG002|Overall Study|Lost to Follow-up|0|||
170822679|NCT01313299|617358894|FG000|Overall Study|Protocol Violation|2|||
170822680|NCT01313299|617358895|FG001|Overall Study|Protocol Violation|0|||
170822681|NCT01313299|617358896|FG002|Overall Study|Protocol Violation|0|||
170822682|NCT01313299|617358894|FG000|Overall Study|Withdrawal by Subject|1|||
170822683|NCT01313299|617358895|FG001|Overall Study|Withdrawal by Subject|0|||
170822684|NCT01313299|617358896|FG002|Overall Study|Withdrawal by Subject|2|||
170822685|NCT01313299|617358894|FG000|Overall Study|Family reason and moved out of state|0|||
170822686|NCT01313299|617358895|FG001|Overall Study|Family reason and moved out of state|2|||
170822687|NCT01313299|617358896|FG002|Overall Study|Family reason and moved out of state|0|||
170822688|NCT01313299|617358894|FG000|Overall Study|Lack of subject compliance|0|||
170822689|NCT01313299|617358895|FG001|Overall Study|Lack of subject compliance|0|||
170822690|NCT01313299|617358896|FG002|Overall Study|Lack of subject compliance|1|||
170822691|NCT01919398|617358897|FG000|Overall Study|Progressive Disease|0|||
170822692|NCT01919398|617358898|FG001|Overall Study|Progressive Disease|0|||
170822693|NCT01919398|617358899|FG002|Overall Study|Progressive Disease|4|||
170822694|NCT02391545|617358903|FG000|Overall Study|Death|0|||
170822695|NCT02391545|617358904|FG001|Overall Study|Death|2|||
170822696|NCT02391545|617358903|FG000|Overall Study|Lost to Follow-up|0|||
170822697|NCT02391545|617358904|FG001|Overall Study|Lost to Follow-up|1|||
170822698|NCT02391545|617358903|FG000|Overall Study|Termination of study by sponsor|20|||
170822699|NCT02391545|617358904|FG001|Overall Study|Termination of study by sponsor|20|||
170822700|NCT02391545|617358903|FG000|Overall Study|Withdrawal by Subject|0|||
170822701|NCT02391545|617358904|FG001|Overall Study|Withdrawal by Subject|1|||
170822702|NCT02391545|617358903|FG000|Overall Study|Other Reasons|6|||
170822703|NCT02391545|617358904|FG001|Overall Study|Other Reasons|4|||
170822704|NCT00050167|617358907|FG000|Overall Study|not eligible not invasive|1|||
170822705|NCT00050167|617358908|FG001|Overall Study|not eligible not invasive|1|||
170822706|NCT04754594|617358912|FG000|Blinded Period|Withdrawal by Subject|4|||
170822707|NCT04754594|617358913|FG001|Blinded Period|Withdrawal by Subject|9|||
170822708|NCT04754594|617358914|FG002|Blinded Period|Withdrawal by Subject|0|||
170822709|NCT04754594|617358915|FG003|Blinded Period|Withdrawal by Subject|0|||
170822710|NCT04754594|617358912|FG000|Blinded Period|Protocol Violation|2|||
170822711|NCT04754594|617358913|FG001|Blinded Period|Protocol Violation|2|||
170822712|NCT04754594|617358914|FG002|Blinded Period|Protocol Violation|0|||
170822713|NCT04754594|617358915|FG003|Blinded Period|Protocol Violation|0|||
170822714|NCT04754594|617358912|FG000|Blinded Period|Lost to Follow-up|1|||
170822715|NCT04754594|617358913|FG001|Blinded Period|Lost to Follow-up|1|||
170822716|NCT04754594|617358914|FG002|Blinded Period|Lost to Follow-up|0|||
170822717|NCT04754594|617358915|FG003|Blinded Period|Lost to Follow-up|0|||
170822718|NCT04754594|617358912|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
170822719|NCT04754594|617358913|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
170822720|NCT04754594|617358914|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
170822721|NCT04754594|617358915|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
170822722|NCT04754594|617358912|FG000|Unblinded Period|Withdrawal by Subject|6|||
170822723|NCT04754594|617358913|FG001|Unblinded Period|Withdrawal by Subject|8|||
170822724|NCT04754594|617358914|FG002|Unblinded Period|Withdrawal by Subject|0|||
170822725|NCT04754594|617358915|FG003|Unblinded Period|Withdrawal by Subject|0|||
170822726|NCT04754594|617358912|FG000|Unblinded Period|Lost to Follow-up|5|||
170822727|NCT04754594|617358913|FG001|Unblinded Period|Lost to Follow-up|3|||
170822728|NCT04754594|617358914|FG002|Unblinded Period|Lost to Follow-up|0|||
170822729|NCT04754594|617358915|FG003|Unblinded Period|Lost to Follow-up|0|||
170822730|NCT04754594|617358912|FG000|Unblinded Period|Protocol Violation|2|||
170822731|NCT04754594|617358913|FG001|Unblinded Period|Protocol Violation|4|||
170822732|NCT04754594|617358914|FG002|Unblinded Period|Protocol Violation|0|||
170822733|NCT04754594|617358915|FG003|Unblinded Period|Protocol Violation|0|||
170822734|NCT04754594|617358912|FG000|Unblinded Period|Other|3|||
170822735|NCT04754594|617358913|FG001|Unblinded Period|Other|0|||
170822736|NCT04754594|617358914|FG002|Unblinded Period|Other|0|||
170822737|NCT04754594|617358915|FG003|Unblinded Period|Other|0|||
170822738|NCT04754594|617358912|FG000|Infant Participants|Withdrawal by Subject|0|||
170822739|NCT04754594|617358913|FG001|Infant Participants|Withdrawal by Subject|0|||
170822740|NCT04754594|617358914|FG002|Infant Participants|Withdrawal by Subject|9|||
170822741|NCT04754594|617358915|FG003|Infant Participants|Withdrawal by Subject|17|||
170822742|NCT04754594|617358912|FG000|Infant Participants|Lost to Follow-up|0|||
170822743|NCT04754594|617358913|FG001|Infant Participants|Lost to Follow-up|0|||
170822744|NCT04754594|617358914|FG002|Infant Participants|Lost to Follow-up|4|||
170822745|NCT04754594|617358915|FG003|Infant Participants|Lost to Follow-up|10|||
170822746|NCT04754594|617358912|FG000|Infant Participants|Death|0|||
170822747|NCT04754594|617358913|FG001|Infant Participants|Death|0|||
170822748|NCT04754594|617358914|FG002|Infant Participants|Death|1|||
170822749|NCT04754594|617358915|FG003|Infant Participants|Death|1|||
170822750|NCT04754594|617358912|FG000|Infant Participants|Other|0|||
170822751|NCT04754594|617358913|FG001|Infant Participants|Other|0|||
170822752|NCT04754594|617358914|FG002|Infant Participants|Other|1|||
170822753|NCT04754594|617358915|FG003|Infant Participants|Other|1|||
170822754|NCT00980954|617358916|FG000|Overall Study|Protocol Violation|9|||
170822755|NCT00980954|617358917|FG001|Overall Study|Protocol Violation|15|||
170822756|NCT01247922|617358920|FG000|Overall Study|Disease progression|4|||
170822757|NCT01876823|617358921|FG000|Overall Study|Withdrawal by Subject|5|||
170822758|NCT01876823|617358921|FG000|Overall Study|Physician Decision|2|||
170822759|NCT01876823|617358921|FG000|Overall Study|Patients moved|2|||
170822760|NCT03356145|617358922|FG000|Overall Study|Withdrawal by Subject|2|||
170822761|NCT03356145|617358923|FG001|Overall Study|Withdrawal by Subject|1|||
170822762|NCT03356145|617358922|FG000|Overall Study|Did not meet inclusion criteria|1|||
170822763|NCT03356145|617358923|FG001|Overall Study|Did not meet inclusion criteria|0|||
170822764|NCT05615870|617358926|FG000|Overall Study|Lost to Follow-up|10|||
170822765|NCT05615870|617358927|FG001|Overall Study|Lost to Follow-up|13|||
170822766|NCT05615870|617358926|FG000|Overall Study|Physician Decision|2|||
170822767|NCT05615870|617358927|FG001|Overall Study|Physician Decision|0|||
170822768|NCT05615870|617358926|FG000|Overall Study|Withdrawal by Subject|0|||
170822769|NCT05615870|617358927|FG001|Overall Study|Withdrawal by Subject|2|||
170822770|NCT05615870|617358926|FG000|Overall Study|Protocol Violation|0|||
170822771|NCT05615870|617358927|FG001|Overall Study|Protocol Violation|3|||
170822772|NCT05615870|617358926|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
170822773|NCT05615870|617358927|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
170822774|NCT05615870|617358926|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
170822775|NCT05615870|617358927|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
170822776|NCT05615870|617358926|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
170822777|NCT05615870|617358927|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
170822778|NCT01911819|617358928|FG000|Overall Study|Adverse Event|0|||
170822779|NCT01911819|617358929|FG001|Overall Study|Adverse Event|1|||
170822780|NCT01911819|617358930|FG002|Overall Study|Adverse Event|0|||
170822781|NCT01911819|617358928|FG000|Overall Study|Withdrawal by Subject|1|||
170822782|NCT01911819|617358929|FG001|Overall Study|Withdrawal by Subject|1|||
170822783|NCT01911819|617358930|FG002|Overall Study|Withdrawal by Subject|0|||
170822784|NCT01052714|617358934|FG000|Overall Study|Adverse Event|6|||
170822785|NCT01052714|617358935|FG001|Overall Study|Adverse Event|3|||
170822786|NCT01052714|617358936|FG002|Overall Study|Adverse Event|0|||
170822787|NCT01052714|617358934|FG000|Overall Study|Death|1|||
170822788|NCT01052714|617358935|FG001|Overall Study|Death|2|||
170822789|NCT01052714|617358936|FG002|Overall Study|Death|0|||
170822790|NCT01052714|617358934|FG000|Overall Study|Lost to Follow-up|2|||
170822791|NCT01052714|617358935|FG001|Overall Study|Lost to Follow-up|3|||
170822792|NCT01052714|617358936|FG002|Overall Study|Lost to Follow-up|0|||
170822793|NCT01052714|617358934|FG000|Overall Study|Physician Decision|9|||
170822794|NCT01052714|617358935|FG001|Overall Study|Physician Decision|9|||
170822795|NCT01052714|617358936|FG002|Overall Study|Physician Decision|1|||
170822796|NCT01052714|617358934|FG000|Overall Study|Withdrawal by Subject|7|||
170822797|NCT01052714|617358935|FG001|Overall Study|Withdrawal by Subject|12|||
170822798|NCT01052714|617358936|FG002|Overall Study|Withdrawal by Subject|1|||
170822799|NCT04382053|617358937|FG000|Overall Study|Death|6|||
170822800|NCT04382053|617358938|FG001|Overall Study|Death|8|||
170822801|NCT04382053|617358937|FG000|Overall Study|Lost to Follow-up|0|||
170822802|NCT04382053|617358938|FG001|Overall Study|Lost to Follow-up|2|||
170822803|NCT04382053|617358937|FG000|Overall Study|Protocol Deviation|1|||
170822804|NCT04382053|617358938|FG001|Overall Study|Protocol Deviation|2|||
170822805|NCT04382053|617358937|FG000|Overall Study|Withdrawal by Subject|2|||
170822806|NCT04382053|617358938|FG001|Overall Study|Withdrawal by Subject|1|||
170822807|NCT01399905|617358944|FG000|Overall Study|Withdrawal by Subject|1|||
170822808|NCT01399905|617358945|FG001|Overall Study|Withdrawal by Subject|1|||
170822809|NCT00714688|617358946|FG000|Overall Study|Lack of Efficacy|14|||
170822810|NCT00714688|617358947|FG001|Overall Study|Lack of Efficacy|1|||
170822811|NCT00714688|617358948|FG002|Overall Study|Lack of Efficacy|4|||
170822812|NCT00714688|617358946|FG000|Overall Study|Withdrawal by Subject|4|||
170822813|NCT00714688|617358947|FG001|Overall Study|Withdrawal by Subject|3|||
170822814|NCT00714688|617358948|FG002|Overall Study|Withdrawal by Subject|3|||
170822815|NCT00714688|617358946|FG000|Overall Study|Lost to Follow-up|5|||
170822816|NCT00714688|617358947|FG001|Overall Study|Lost to Follow-up|2|||
170822817|NCT00714688|617358948|FG002|Overall Study|Lost to Follow-up|0|||
170822818|NCT00714688|617358946|FG000|Overall Study|Adverse Event|2|||
170822819|NCT00714688|617358947|FG001|Overall Study|Adverse Event|15|||
170822820|NCT00714688|617358948|FG002|Overall Study|Adverse Event|19|||
170822821|NCT00714688|617358946|FG000|Overall Study|Subject Non-compliant|3|||
170822822|NCT00714688|617358947|FG001|Overall Study|Subject Non-compliant|5|||
170822823|NCT00714688|617358948|FG002|Overall Study|Subject Non-compliant|5|||
170822824|NCT00714688|617358946|FG000|Overall Study|Ineligible to Continue the Study|0|||
170822825|NCT00714688|617358947|FG001|Overall Study|Ineligible to Continue the Study|1|||
170822826|NCT00714688|617358948|FG002|Overall Study|Ineligible to Continue the Study|1|||
170692065|NCT00371254|616884806|FG000|Overall Study|Disease progression|13|||
170692066|NCT00371254|616884807|FG001|Overall Study|Disease progression|13|||
170692067|NCT00371254|616884806|FG000|Overall Study|Study drug toxicity|3|||
170692068|NCT00371254|616884807|FG001|Overall Study|Study drug toxicity|5|||
170692069|NCT00371254|616884806|FG000|Overall Study|Subject request|5|||
170692070|NCT00371254|616884807|FG001|Overall Study|Subject request|0|||
170692071|NCT00371254|616884806|FG000|Overall Study|Investigator Decision|2|||
170692072|NCT00371254|616884807|FG001|Overall Study|Investigator Decision|0|||
170692073|NCT00371254|616884806|FG000|Overall Study|Adverse event unrelated to study drug|0|||
170692074|NCT00371254|616884807|FG001|Overall Study|Adverse event unrelated to study drug|1|||
170692075|NCT00371254|616884806|FG000|Overall Study|Lost to Follow-up|0|||
170692076|NCT00371254|616884807|FG001|Overall Study|Lost to Follow-up|1|||
170692077|NCT00371254|616884806|FG000|Overall Study|Withdrawal by Subject|0|||
170692078|NCT00371254|616884807|FG001|Overall Study|Withdrawal by Subject|1|||
170692079|NCT02246673|616884808|FG000|Overall Study|Sponsor Decision|1|||
170692080|NCT02246673|616884809|FG001|Overall Study|Sponsor Decision|0|||
170692081|NCT02246673|616884810|FG002|Overall Study|Sponsor Decision|0|||
170692082|NCT02246673|616884811|FG003|Overall Study|Sponsor Decision|0|||
170692083|NCT02246673|616884812|FG004|Overall Study|Sponsor Decision|0|||
170692084|NCT02246673|616884808|FG000|Overall Study|Withdrawal by Subject|0|||
170692085|NCT02246673|616884809|FG001|Overall Study|Withdrawal by Subject|0|||
170692086|NCT02246673|616884810|FG002|Overall Study|Withdrawal by Subject|0|||
170692087|NCT02246673|616884811|FG003|Overall Study|Withdrawal by Subject|0|||
170692088|NCT02246673|616884812|FG004|Overall Study|Withdrawal by Subject|1|||
170692089|NCT02246673|616884808|FG000|Overall Study|Lost to Follow-up|0|||
170692090|NCT02246673|616884809|FG001|Overall Study|Lost to Follow-up|0|||
170692091|NCT02246673|616884810|FG002|Overall Study|Lost to Follow-up|0|||
170692092|NCT02246673|616884811|FG003|Overall Study|Lost to Follow-up|1|||
170692093|NCT02246673|616884812|FG004|Overall Study|Lost to Follow-up|0|||
170692094|NCT02246673|616884808|FG000|Overall Study|Protocol Violation|0|||
170692095|NCT02246673|616884809|FG001|Overall Study|Protocol Violation|0|||
170692096|NCT02246673|616884810|FG002|Overall Study|Protocol Violation|0|||
170692097|NCT02246673|616884811|FG003|Overall Study|Protocol Violation|1|||
170692098|NCT02246673|616884812|FG004|Overall Study|Protocol Violation|0|||
170692099|NCT02809677|616884813|FG000|Overall Study|Withdrawal by Subject|8|||
170692100|NCT05172544|616884814|FG000|Overall Study|Withdrawal by Subject|1|||
170692101|NCT05172544|616884815|FG001|Overall Study|Withdrawal by Subject|0|||
170692102|NCT05172544|616884816|FG002|Overall Study|Withdrawal by Subject|0|||
170692103|NCT05172544|616884814|FG000|Overall Study|Physician Decision|0|||
170692104|NCT05172544|616884815|FG001|Overall Study|Physician Decision|0|||
170692105|NCT05172544|616884816|FG002|Overall Study|Physician Decision|1|||
170692106|NCT03559257|616884820|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
170692107|NCT03559257|616884821|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
170692108|NCT03559257|616884820|FG000|Double Blind Treatment Period|Protocol Violation|1|||
170692109|NCT03559257|616884821|FG001|Double Blind Treatment Period|Protocol Violation|4|||
170692110|NCT03559257|616884820|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
170692111|NCT03559257|616884821|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
170692112|NCT03559257|616884820|FG000|Double Blind Treatment Period|Adverse Event|0|||
170692113|NCT03559257|616884821|FG001|Double Blind Treatment Period|Adverse Event|1|||
170692114|NCT03559257|616884820|FG000|Double Blind Treatment Period|Screen Failure|0|||
170692115|NCT03559257|616884821|FG001|Double Blind Treatment Period|Screen Failure|1|||
170692116|NCT03559257|616884820|FG000|Open-label Treatment Period|Adverse Event|1|||
170692117|NCT03559257|616884821|FG001|Open-label Treatment Period|Adverse Event|4|||
170692118|NCT03559257|616884820|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
170822827|NCT00714688|617358946|FG000|Overall Study|Sponsor's Decision|0|||
170822828|NCT00714688|617358947|FG001|Overall Study|Sponsor's Decision|2|||
170822829|NCT00714688|617358948|FG002|Overall Study|Sponsor's Decision|0|||
170822830|NCT00714688|617358946|FG000|Overall Study|Other|1|||
170822831|NCT00714688|617358947|FG001|Overall Study|Other|6|||
170822832|NCT00714688|617358948|FG002|Overall Study|Other|5|||
170822833|NCT00500539|617358949|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
170822834|NCT00500539|617358949|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
170822835|NCT00500539|617358949|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
170822836|NCT00500539|617358949|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
170822837|NCT00500539|617358949|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
170692119|NCT03559257|616884821|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
170692120|NCT03559257|616884820|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
170692121|NCT03559257|616884821|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
170692122|NCT03559257|616884820|FG000|Open-label Treatment Period|Protocol Violation|2|||
170692123|NCT03559257|616884821|FG001|Open-label Treatment Period|Protocol Violation|0|||
170692124|NCT03559257|616884820|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
170692125|NCT03559257|616884821|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
170692126|NCT03559257|616884820|FG000|Open-label Treatment Period|Physician Decision|0|||
170692127|NCT03559257|616884821|FG001|Open-label Treatment Period|Physician Decision|1|||
170822838|NCT00500539|617358949|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
170692128|NCT02738450|616884822|FG000|Overall Study|Withdrawal by Subject|0|||
170692129|NCT02738450|616884823|FG001|Overall Study|Withdrawal by Subject|2|||
170692130|NCT02738450|616884824|FG002|Overall Study|Withdrawal by Subject|0|||
170692131|NCT03630120|616884825|FG000|Overall Study|Disease progression|0|||
170692132|NCT03630120|616884826|FG001|Overall Study|Disease progression|1|||
170692133|NCT03630120|616884827|FG002|Overall Study|Disease progression|1|||
170692134|NCT03630120|616884828|FG003|Overall Study|Disease progression|1|||
170692135|NCT03251079|616884829|FG000|Overall Study|Withdrawal by Subject|1|||
170692136|NCT00561080|616884832|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
170692137|NCT00561080|616884833|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
170692138|NCT00561080|616884834|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
170692139|NCT00561080|616884832|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
170692140|NCT00561080|616884833|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
170692141|NCT00561080|616884834|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
170692142|NCT00561080|616884832|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
170692143|NCT00561080|616884833|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
170692144|NCT00561080|616884834|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
170692145|NCT00561080|616884832|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
170692146|NCT00561080|616884833|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
170692147|NCT00561080|616884834|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
170692148|NCT00561080|616884832|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
170692149|NCT00561080|616884833|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
170692150|NCT00561080|616884834|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
170692151|NCT00561080|616884832|FG000|Vaccination Period (up to Month 4)|Other|0|||
170692152|NCT00561080|616884833|FG001|Vaccination Period (up to Month 4)|Other|2|||
170692153|NCT00561080|616884834|FG002|Vaccination Period (up to Month 4)|Other|1|||
170692154|NCT00561080|616884832|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
170692155|NCT00561080|616884833|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
170692156|NCT00561080|616884834|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
170692157|NCT00561080|616884832|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
170692158|NCT00561080|616884833|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
170692159|NCT00561080|616884834|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
170692160|NCT00561080|616884832|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
170692161|NCT00561080|616884833|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
170692162|NCT00561080|616884834|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
170692163|NCT00561080|616884832|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
170692164|NCT00561080|616884833|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
170692165|NCT00561080|616884834|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
170692166|NCT03204305|616884835|FG000|Overall Study|Lost to Follow-up|6|||
170692167|NCT03204305|616884836|FG001|Overall Study|Lost to Follow-up|4|||
170692168|NCT03204305|616884837|FG002|Overall Study|Lost to Follow-up|0|||
170692169|NCT03204305|616884838|FG003|Overall Study|Lost to Follow-up|0|||
170692170|NCT03204305|616884835|FG000|Overall Study|Physician Decision|1|||
170692171|NCT03204305|616884836|FG001|Overall Study|Physician Decision|0|||
170692172|NCT03204305|616884837|FG002|Overall Study|Physician Decision|0|||
170692173|NCT03204305|616884838|FG003|Overall Study|Physician Decision|0|||
170692174|NCT03204305|616884835|FG000|Overall Study|failure to place arterial line|2|||
170692175|NCT03204305|616884836|FG001|Overall Study|failure to place arterial line|1|||
170692176|NCT03204305|616884837|FG002|Overall Study|failure to place arterial line|0|||
170692177|NCT03204305|616884838|FG003|Overall Study|failure to place arterial line|0|||
170692178|NCT03204305|616884835|FG000|Overall Study|Withdrawal by Subject|2|||
170692179|NCT03204305|616884836|FG001|Overall Study|Withdrawal by Subject|0|||
170692180|NCT03204305|616884837|FG002|Overall Study|Withdrawal by Subject|0|||
170692181|NCT03204305|616884838|FG003|Overall Study|Withdrawal by Subject|0|||
170692182|NCT01165554|616884839|FG000|Overall Study|Withdrawal by Subject|23|||
170692183|NCT02951156|616884846|FG000|Overall Study|Death|3|||
170692184|NCT02951156|616884847|FG001|Overall Study|Death|8|||
170692185|NCT02951156|616884848|FG002|Overall Study|Death|5|||
170692186|NCT02951156|616884846|FG000|Overall Study|Progressive disease|1|||
170692187|NCT02951156|616884847|FG001|Overall Study|Progressive disease|0|||
170692188|NCT02951156|616884848|FG002|Overall Study|Progressive disease|1|||
170692189|NCT02951156|616884846|FG000|Overall Study|Withdrawal by Subject|0|||
170692190|NCT02951156|616884847|FG001|Overall Study|Withdrawal by Subject|0|||
170692191|NCT02951156|616884848|FG002|Overall Study|Withdrawal by Subject|1|||
170692192|NCT02951156|616884846|FG000|Overall Study|Study terminated by sponsor|0|||
170692193|NCT02951156|616884847|FG001|Overall Study|Study terminated by sponsor|0|||
170692194|NCT02951156|616884848|FG002|Overall Study|Study terminated by sponsor|1|||
170692195|NCT02951156|616884846|FG000|Overall Study|Other|5|||
170692196|NCT02951156|616884847|FG001|Overall Study|Other|1|||
170692197|NCT02951156|616884848|FG002|Overall Study|Other|2|||
170692198|NCT01603459|616884851|FG000|Overall Study|Adverse Event|5|||
170692199|NCT01603459|616884851|FG000|Overall Study|Withdrawal by Subject|5|||
170692200|NCT01603459|616884851|FG000|Overall Study|Lost to Follow-up|3|||
170692201|NCT01603459|616884851|FG000|Overall Study|Predefined discontinuation criteria|3|||
170692202|NCT01603459|616884851|FG000|Overall Study|Non-compliance|1|||
170692203|NCT01603459|616884851|FG000|Overall Study|Administrative reason|1|||
170692204|NCT03519347|616884856|FG000|Interventional Crossover Period 1|Death|0|||
170692205|NCT03519347|616884857|FG001|Interventional Crossover Period 1|Death|0|||
170692206|NCT03519347|616884858|FG002|Interventional Crossover Period 1|Death|0|||
170692207|NCT03519347|616884859|FG003|Interventional Crossover Period 1|Death|1|||
170692208|NCT01675128|616884860|FG000|Overall Study|Disease progression on study|1|||
170692209|NCT01675128|616884861|FG001|Overall Study|Disease progression on study|1|||
170692210|NCT01675128|616884862|FG002|Overall Study|Disease progression on study|1|||
170692211|NCT01675128|616884860|FG000|Overall Study|Refused further treatment|1|||
170692212|NCT01675128|616884861|FG001|Overall Study|Refused further treatment|0|||
170692213|NCT01675128|616884862|FG002|Overall Study|Refused further treatment|0|||
170692214|NCT01675128|616884860|FG000|Overall Study|Pulmonary complication; off study|0|||
170692215|NCT01675128|616884861|FG001|Overall Study|Pulmonary complication; off study|1|||
170692216|NCT01675128|616884862|FG002|Overall Study|Pulmonary complication; off study|0|||
170692217|NCT01166178|616884863|FG000|Overall Study|Withdrawal by Subject|1|||
170692218|NCT01166178|616884864|FG001|Overall Study|Withdrawal by Subject|0|||
170692219|NCT01166178|616884863|FG000|Overall Study|Study was terminated|20|||
170692220|NCT01166178|616884864|FG001|Overall Study|Study was terminated|8|||
170692221|NCT03526458|616884865|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
170692222|NCT03526458|616884866|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
170692223|NCT03526458|616884865|FG000|Overall Study|Stone passed, surgery cancelled|2|||
170692224|NCT03526458|616884866|FG001|Overall Study|Stone passed, surgery cancelled|1|||
170692225|NCT03526458|616884865|FG000|Overall Study|Withdrawal by Subject|1|||
170692226|NCT03526458|616884866|FG001|Overall Study|Withdrawal by Subject|0|||
170692227|NCT03526458|616884865|FG000|Overall Study|Physician Decision|2|||
170692228|NCT03526458|616884866|FG001|Overall Study|Physician Decision|1|||
170692229|NCT03526458|616884865|FG000|Overall Study|Lack of equipment|1|||
170692230|NCT03526458|616884866|FG001|Overall Study|Lack of equipment|1|||
170692231|NCT00484939|616884867|FG000|Overall Study|Death|9|||
170692232|NCT00484939|616884868|FG001|Overall Study|Death|13|||
170692233|NCT00484939|616884867|FG000|Overall Study|Adverse Event|22|||
170692234|NCT00484939|616884868|FG001|Overall Study|Adverse Event|12|||
170692235|NCT00484939|616884867|FG000|Overall Study|Patient Withdrew Consent|19|||
170692236|NCT00484939|616884868|FG001|Overall Study|Patient Withdrew Consent|10|||
170692237|NCT00484939|616884867|FG000|Overall Study|Protocol Violation|3|||
170692238|NCT00484939|616884868|FG001|Overall Study|Protocol Violation|3|||
170692239|NCT00484939|616884867|FG000|Overall Study|Lost to Follow-up|0|||
170692240|NCT00484939|616884868|FG001|Overall Study|Lost to Follow-up|3|||
170692241|NCT00484939|616884867|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
170692242|NCT00484939|616884868|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
170692243|NCT00484939|616884867|FG000|Overall Study|Disease progression|67|||
170692244|NCT00484939|616884868|FG001|Overall Study|Disease progression|88|||
170692245|NCT00484939|616884867|FG000|Overall Study|Screen Failure|2|||
170692246|NCT00484939|616884868|FG001|Overall Study|Screen Failure|2|||
170692247|NCT00484939|616884867|FG000|Overall Study|Reason Not Specified|11|||
170692248|NCT00484939|616884868|FG001|Overall Study|Reason Not Specified|6|||
170692249|NCT04404855|616884869|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
170692250|NCT04404855|616884870|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
170692251|NCT00529542|616884871|FG000|Overall Study|Withdrawal by Subject|1|||
170692252|NCT00529542|616884872|FG001|Overall Study|Withdrawal by Subject|0|||
170692253|NCT00529542|616884871|FG000|Overall Study|Lost to Follow-up|0|||
170692254|NCT00529542|616884872|FG001|Overall Study|Lost to Follow-up|1|||
170692255|NCT05104567|616884879|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
170692256|NCT05104567|616884880|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
170692257|NCT05104567|616884881|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
170692258|NCT05104567|616884882|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
170822839|NCT00500539|617358949|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
170692259|NCT05104567|616884883|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
170692260|NCT05104567|616884884|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
170822840|NCT00500539|617358949|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
170692261|NCT05104567|616884885|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
170692262|NCT05104567|616884879|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
170692263|NCT05104567|616884880|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
170692264|NCT05104567|616884881|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
170692265|NCT05104567|616884882|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
170692266|NCT05104567|616884883|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
170692267|NCT05104567|616884884|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
170692268|NCT05104567|616884885|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
170692269|NCT05104567|616884879|FG000|Overall Study|Progressive disease|3|||
170692270|NCT05104567|616884880|FG001|Overall Study|Progressive disease|13|||
170692271|NCT05104567|616884881|FG002|Overall Study|Progressive disease|13|||
170692272|NCT05104567|616884882|FG003|Overall Study|Progressive disease|17|||
170692273|NCT05104567|616884883|FG004|Overall Study|Progressive disease|17|||
170692274|NCT05104567|616884884|FG005|Overall Study|Progressive disease|28|||
170692275|NCT05104567|616884885|FG006|Overall Study|Progressive disease|24|||
170692276|NCT05104567|616884879|FG000|Overall Study|Withdrawal by Subject|1|||
170692277|NCT05104567|616884880|FG001|Overall Study|Withdrawal by Subject|1|||
170692278|NCT05104567|616884881|FG002|Overall Study|Withdrawal by Subject|2|||
170692279|NCT05104567|616884882|FG003|Overall Study|Withdrawal by Subject|0|||
170692280|NCT05104567|616884883|FG004|Overall Study|Withdrawal by Subject|0|||
170692281|NCT05104567|616884884|FG005|Overall Study|Withdrawal by Subject|0|||
170692282|NCT05104567|616884885|FG006|Overall Study|Withdrawal by Subject|0|||
170692283|NCT05104567|616884879|FG000|Overall Study|Other|1|||
170692284|NCT05104567|616884880|FG001|Overall Study|Other|1|||
170692285|NCT05104567|616884881|FG002|Overall Study|Other|1|||
170692286|NCT05104567|616884882|FG003|Overall Study|Other|0|||
170692287|NCT05104567|616884883|FG004|Overall Study|Other|0|||
170692288|NCT05104567|616884884|FG005|Overall Study|Other|0|||
170692289|NCT05104567|616884885|FG006|Overall Study|Other|0|||
170692290|NCT04007094|616884894|FG000|Overall Study|Lost to Follow-up|1|||
170692291|NCT04007094|616884895|FG001|Overall Study|Lost to Follow-up|1|||
170692292|NCT02921776|616884896|FG000|Overall Study|patient deterioration, fatigue|2|||
170692293|NCT02921776|616884897|FG001|Overall Study|patient deterioration, fatigue|6|||
170692294|NCT02921776|616884898|FG002|Overall Study|patient deterioration, fatigue|0|||
170692295|NCT02921776|616884899|FG003|Overall Study|patient deterioration, fatigue|0|||
170692296|NCT02921776|616884900|FG004|Overall Study|patient deterioration, fatigue|0|||
170692297|NCT02921776|616884901|FG005|Overall Study|patient deterioration, fatigue|0|||
170692298|NCT02921776|616884902|FG006|Overall Study|patient deterioration, fatigue|0|||
170692299|NCT02921776|616884903|FG007|Overall Study|patient deterioration, fatigue|0|||
170692300|NCT02921776|616884896|FG000|Overall Study|Withdrawal by Subject|0|||
170692301|NCT02921776|616884897|FG001|Overall Study|Withdrawal by Subject|2|||
170692302|NCT02921776|616884898|FG002|Overall Study|Withdrawal by Subject|0|||
170692303|NCT02921776|616884899|FG003|Overall Study|Withdrawal by Subject|1|||
170692304|NCT02921776|616884900|FG004|Overall Study|Withdrawal by Subject|1|||
170692305|NCT02921776|616884901|FG005|Overall Study|Withdrawal by Subject|0|||
170692306|NCT02921776|616884902|FG006|Overall Study|Withdrawal by Subject|8|||
170692307|NCT02921776|616884903|FG007|Overall Study|Withdrawal by Subject|1|||
170692308|NCT02921776|616884896|FG000|Overall Study|Death|0|||
170692309|NCT02921776|616884897|FG001|Overall Study|Death|0|||
170692310|NCT02921776|616884898|FG002|Overall Study|Death|0|||
170692311|NCT02921776|616884899|FG003|Overall Study|Death|2|||
170692312|NCT02921776|616884900|FG004|Overall Study|Death|0|||
170692313|NCT02921776|616884901|FG005|Overall Study|Death|0|||
170692314|NCT02921776|616884902|FG006|Overall Study|Death|0|||
170692315|NCT02921776|616884903|FG007|Overall Study|Death|0|||
170692316|NCT02921776|616884896|FG000|Overall Study|extubation or early discharge|0|||
170692317|NCT02921776|616884897|FG001|Overall Study|extubation or early discharge|0|||
170692318|NCT02921776|616884898|FG002|Overall Study|extubation or early discharge|0|||
170692319|NCT02921776|616884899|FG003|Overall Study|extubation or early discharge|5|||
170692320|NCT02921776|616884900|FG004|Overall Study|extubation or early discharge|5|||
170692321|NCT02921776|616884901|FG005|Overall Study|extubation or early discharge|0|||
170692322|NCT02921776|616884902|FG006|Overall Study|extubation or early discharge|0|||
170692323|NCT02921776|616884903|FG007|Overall Study|extubation or early discharge|0|||
170692324|NCT02921776|616884896|FG000|Overall Study|Lost to Follow-up|0|||
170692325|NCT02921776|616884897|FG001|Overall Study|Lost to Follow-up|0|||
170692326|NCT02921776|616884898|FG002|Overall Study|Lost to Follow-up|0|||
170692327|NCT02921776|616884899|FG003|Overall Study|Lost to Follow-up|0|||
170692328|NCT02921776|616884900|FG004|Overall Study|Lost to Follow-up|0|||
170692329|NCT02921776|616884901|FG005|Overall Study|Lost to Follow-up|2|||
170692330|NCT02921776|616884902|FG006|Overall Study|Lost to Follow-up|3|||
170692331|NCT02921776|616884903|FG007|Overall Study|Lost to Follow-up|6|||
170692332|NCT04537234|616884913|FG000|Overall Study|Withdrawal by Subject|2|||
170692333|NCT04537234|616884914|FG001|Overall Study|Withdrawal by Subject|0|||
170692334|NCT00378209|616884919|FG000|Overall Study|Progressive disease|11|||
170692335|NCT00378209|616884919|FG000|Overall Study|Adverse Event|3|||
170692336|NCT00378209|616884919|FG000|Overall Study|Initiation of non-protocol therapy|3|||
170692337|NCT00378209|616884919|FG000|Overall Study|Physician Decision|3|||
170692338|NCT00378209|616884919|FG000|Overall Study|Death|1|||
170692339|NCT00378209|616884919|FG000|Overall Study|Treatment delay|1|||
170692340|NCT07114198|616884923|FG000|Overall Study|Protocol Violation|1|||
170822841|NCT00500539|617358949|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
170822842|NCT00500539|617358949|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
170822843|NCT00500539|617358949|FG000|Follow-up Period (16 Weeks)|Death|1|||
170822844|NCT00500539|617358949|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
170822845|NCT00500539|617358949|FG000|Follow-up Period (16 Weeks)|Missing|3|||
170822846|NCT01786551|617358950|FG000|Overall Study|Participant withdrew consent|2|||
170822847|NCT01808144|617358951|FG000|Overall Study|Death|1|||
170822848|NCT01808144|617358952|FG001|Overall Study|Death|0|||
170822849|NCT01808144|617358951|FG000|Overall Study|Withdrawal by Subject|16|||
170822850|NCT01808144|617358952|FG001|Overall Study|Withdrawal by Subject|23|||
170822851|NCT01808144|617358951|FG000|Overall Study|Lost to Follow-up|6|||
170822852|NCT01808144|617358952|FG001|Overall Study|Lost to Follow-up|3|||
170822853|NCT01808144|617358951|FG000|Overall Study|Protocol Violation|6|||
170822854|NCT01808144|617358952|FG001|Overall Study|Protocol Violation|6|||
170822855|NCT01808144|617358951|FG000|Overall Study|Gout flare|0|||
170822856|NCT01808144|617358952|FG001|Overall Study|Gout flare|1|||
170822857|NCT01808144|617358951|FG000|Overall Study|Adverse Event|11|||
170822858|NCT01808144|617358952|FG001|Overall Study|Adverse Event|15|||
170822859|NCT04212299|617358953|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
170822860|NCT03993054|617358954|FG000|Overall Study|PI Decision|1|||
170822861|NCT00383500|617358955|FG000|Overall Study|Withdrawal by Subject|8|||
170822862|NCT00383500|617358956|FG001|Overall Study|Withdrawal by Subject|3|||
170822863|NCT00383500|617358957|FG002|Overall Study|Withdrawal by Subject|0|||
170822864|NCT00383500|617358955|FG000|Overall Study|Lost to Follow-up|0|||
170822865|NCT00383500|617358956|FG001|Overall Study|Lost to Follow-up|0|||
170822866|NCT00383500|617358957|FG002|Overall Study|Lost to Follow-up|2|||
170822867|NCT02951052|617358959|FG000|Overall Study|Adverse Event|13|||
170822868|NCT02951052|617358960|FG001|Overall Study|Adverse Event|5|||
170822869|NCT02951052|617358959|FG000|Overall Study|Withdrawal by Subject|1|||
170822870|NCT02951052|617358960|FG001|Overall Study|Withdrawal by Subject|5|||
170822871|NCT02951052|617358959|FG000|Overall Study|Physician Decision|2|||
170822872|NCT02951052|617358960|FG001|Overall Study|Physician Decision|0|||
170822873|NCT02951052|617358959|FG000|Overall Study|Lost to Follow-up|1|||
170822874|NCT02951052|617358960|FG001|Overall Study|Lost to Follow-up|1|||
170692341|NCT07114198|616884924|FG001|Overall Study|Protocol Violation|1|||
170692342|NCT04447417|616886639|FG000|Overall Study|Withdrawal by Subject|1|||
170692343|NCT04447417|616886640|FG001|Overall Study|Withdrawal by Subject|0|||
170692344|NCT04447417|616886639|FG000|Overall Study|Failure to meet inclusion criteria|1|||
170692345|NCT04447417|616886640|FG001|Overall Study|Failure to meet inclusion criteria|0|||
170692346|NCT04447417|616886639|FG000|Overall Study|Lost to Follow-up|1|||
170692347|NCT04447417|616886640|FG001|Overall Study|Lost to Follow-up|0|||
170692348|NCT01921179|616886641|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
170692349|NCT01921179|616886642|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
170692350|NCT01921179|616886641|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
170692351|NCT01921179|616886642|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
170692352|NCT00858442|616886643|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
170692353|NCT00858442|616886644|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
170692354|NCT02016625|616886645|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
170692355|NCT02016625|616886646|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
170692356|NCT02016625|616886645|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
170692357|NCT02016625|616886646|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
170692358|NCT02016625|616886645|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
170692359|NCT02016625|616886646|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
170692360|NCT00542919|616886649|FG000|Overall Study|Adverse Event|1|||
170692361|NCT00542919|616886650|FG001|Overall Study|Adverse Event|5|||
170692362|NCT00542919|616886651|FG002|Overall Study|Adverse Event|1|||
170692363|NCT00542919|616886649|FG000|Overall Study|Withdrawal by Subject|1|||
170822875|NCT02951052|617358959|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
170692364|NCT00542919|616886650|FG001|Overall Study|Withdrawal by Subject|0|||
170692365|NCT00542919|616886651|FG002|Overall Study|Withdrawal by Subject|3|||
170692366|NCT00542919|616886649|FG000|Overall Study|Physician Decision|2|||
170692367|NCT00542919|616886650|FG001|Overall Study|Physician Decision|2|||
170692368|NCT00542919|616886651|FG002|Overall Study|Physician Decision|1|||
170822876|NCT02951052|617358960|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
170822877|NCT02951052|617358959|FG000|Overall Study|Protocol Violation|5|||
170822878|NCT02951052|617358960|FG001|Overall Study|Protocol Violation|3|||
170822879|NCT02951052|617358959|FG000|Overall Study|Lack of Efficacy|3|||
170822880|NCT02951052|617358960|FG001|Overall Study|Lack of Efficacy|4|||
170692369|NCT00542919|616886649|FG000|Overall Study|Sponsor Decision|1|||
170692370|NCT00542919|616886650|FG001|Overall Study|Sponsor Decision|0|||
170692371|NCT00542919|616886651|FG002|Overall Study|Sponsor Decision|0|||
170692372|NCT00542919|616886649|FG000|Overall Study|Lost to Follow-up|2|||
170822881|NCT02951052|617358959|FG000|Overall Study|Ongoing|1|||
170822882|NCT02951052|617358960|FG001|Overall Study|Ongoing|0|||
170822883|NCT01772147|617360377|FG000|Overall Study|Adverse Event|13|||
170822884|NCT01772147|617360378|FG001|Overall Study|Adverse Event|10|||
170692373|NCT00542919|616886650|FG001|Overall Study|Lost to Follow-up|0|||
170692374|NCT00542919|616886651|FG002|Overall Study|Lost to Follow-up|1|||
170692375|NCT05123222|616886652|FG000|Overall Study|Lost to Follow-up|2|||
170692376|NCT05123222|616886653|FG001|Overall Study|Lost to Follow-up|0|||
170692377|NCT05123222|616886654|FG002|Overall Study|Lost to Follow-up|0|||
170692378|NCT05123222|616886655|FG003|Overall Study|Lost to Follow-up|0|||
170692379|NCT05123222|616886652|FG000|Overall Study|Protocol Violation|0|||
170692380|NCT05123222|616886653|FG001|Overall Study|Protocol Violation|0|||
170692381|NCT05123222|616886654|FG002|Overall Study|Protocol Violation|1|||
170692382|NCT05123222|616886655|FG003|Overall Study|Protocol Violation|0|||
170692383|NCT00265343|616886656|FG000|Overall Study|Adverse Event|10|||
170692384|NCT00265343|616886657|FG001|Overall Study|Adverse Event|7|||
170692385|NCT00265343|616886656|FG000|Overall Study|Withdrawal by Subject|3|||
170692386|NCT00265343|616886657|FG001|Overall Study|Withdrawal by Subject|9|||
170692387|NCT00265343|616886656|FG000|Overall Study|Other|8|||
170692388|NCT00265343|616886657|FG001|Overall Study|Other|3|||
170692389|NCT02535741|616886660|FG000|Overall Study|Adverse Event|3|||
170692390|NCT02535741|616886660|FG000|Overall Study|Withdrawal by Subject|9|||
170692391|NCT02535741|616886660|FG000|Overall Study|Lost to Follow-up|10|||
170692392|NCT02535741|616886660|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
170692393|NCT02535741|616886660|FG000|Overall Study|Missing data|6|||
170692394|NCT01063764|616886664|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
170692395|NCT01063764|616886664|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
170692396|NCT01063764|616886664|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
170692397|NCT01063764|616886664|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
170692398|NCT01063764|616886664|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
170692399|NCT01063764|616886664|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
170692400|NCT01063764|616886664|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
170692401|NCT02603432|616886667|FG000|Overall Study|Adverse Event|1|||
170692402|NCT02603432|616886668|FG001|Overall Study|Adverse Event|0|||
170692403|NCT02603432|616886667|FG000|Overall Study|Death|221|||
170692404|NCT02603432|616886668|FG001|Overall Study|Death|242|||
170692405|NCT02603432|616886667|FG000|Overall Study|Lost to Follow-up|3|||
170692406|NCT02603432|616886668|FG001|Overall Study|Lost to Follow-up|9|||
170692407|NCT02603432|616886667|FG000|Overall Study|Progressive Disease|7|||
170692408|NCT02603432|616886668|FG001|Overall Study|Progressive Disease|5|||
170692409|NCT02603432|616886667|FG000|Overall Study|Withdrawal by Subject|12|||
170692410|NCT02603432|616886668|FG001|Overall Study|Withdrawal by Subject|18|||
170692411|NCT02603432|616886667|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
170692412|NCT02603432|616886668|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170692413|NCT02603432|616886667|FG000|Overall Study|Study terminated by sponsor|74|||
170692414|NCT02603432|616886668|FG001|Overall Study|Study terminated by sponsor|75|||
170692415|NCT02603432|616886667|FG000|Overall Study|Other|13|||
170692416|NCT02603432|616886668|FG001|Overall Study|Other|0|||
170692417|NCT01957462|616886669|FG000|Test Period 1|Withdrawal by Subject|1|||
170692418|NCT01957462|616886670|FG001|Test Period 1|Withdrawal by Subject|0|||
170692419|NCT01957462|616886669|FG000|Test Period 1|Adverse Event|1|||
170692420|NCT01957462|616886670|FG001|Test Period 1|Adverse Event|0|||
170692421|NCT02529137|616886671|FG000|Overall Study|Discontinuation for different reasons|8|||
170692422|NCT04765358|616886674|FG000|Overall Study|Withdrawal by Subject|1|||
170692423|NCT01660711|616886675|FG000|Overall Study|Adverse Event|7|||
170692424|NCT01660711|616886675|FG000|Overall Study|Withdrawal by Subject|1|||
170692425|NCT02066467|616886681|FG000|Overall Study|Did not undergo implant procedure|24|||
170692426|NCT02066467|616886681|FG000|Overall Study|Attempted to implant withoput success|43|||
170692427|NCT02066467|616886681|FG000|Overall Study|Consent ineligible|1|||
170692428|NCT02066467|616886681|FG000|Overall Study|Death|54|||
170692429|NCT02066467|616886681|FG000|Overall Study|Lost to Follow-up|51|||
170692430|NCT02066467|616886681|FG000|Overall Study|Adverse Event|20|||
170692431|NCT02066467|616886681|FG000|Overall Study|Withdrawal by Subject|16|||
170692432|NCT02066467|616886681|FG000|Overall Study|Physician Decision|2|||
170692433|NCT02066467|616886681|FG000|Overall Study|Not defined|4|||
170692434|NCT02357901|616886682|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
170692435|NCT02357901|616886683|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
170692436|NCT02357901|616886684|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
170692437|NCT02357901|616886685|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
170692438|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
170692439|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
170692440|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
170692441|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
170692442|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
170692443|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
170692444|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
170692445|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
170692446|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
170822885|NCT01772147|617360379|FG002|Overall Study|Adverse Event|6|||
170692447|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
170692448|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
170692449|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
170692450|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
170692451|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
170692452|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
170692453|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
170692454|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
170692455|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
170692456|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
170692457|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
170692458|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
170692459|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
170692460|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
170692461|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
170692462|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
170692463|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
170692464|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
170692465|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
170692466|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
170692467|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
170692468|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
170692469|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
170692470|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
170692471|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
170692472|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
170692473|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
170692474|NCT02357901|616886682|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
170692475|NCT02357901|616886683|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
170692476|NCT02357901|616886684|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
170692477|NCT02357901|616886685|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
170692478|NCT02759120|616886694|FG000|Overall Study|Death|34|||
170692479|NCT02759120|616886695|FG001|Overall Study|Death|36|||
170692480|NCT02759120|616886694|FG000|Overall Study|Lost to Follow-up|4|||
170692481|NCT02759120|616886695|FG001|Overall Study|Lost to Follow-up|7|||
170692482|NCT02759120|616886694|FG000|Overall Study|Physician Decision|3|||
170692483|NCT02759120|616886695|FG001|Overall Study|Physician Decision|0|||
170692484|NCT02759120|616886694|FG000|Overall Study|Withdrawal by Subject|28|||
170692485|NCT02759120|616886695|FG001|Overall Study|Withdrawal by Subject|15|||
170692486|NCT02759120|616886694|FG000|Overall Study|Moved out of area|3|||
170692487|NCT02759120|616886695|FG001|Overall Study|Moved out of area|4|||
170692488|NCT02759120|616886694|FG000|Overall Study|Lung transplant|3|||
170692489|NCT02759120|616886695|FG001|Overall Study|Lung transplant|5|||
170692490|NCT02759120|616886694|FG000|Overall Study|Other reason not completed|10|||
170692491|NCT02759120|616886695|FG001|Overall Study|Other reason not completed|12|||
170692492|NCT00413192|616886696|FG000|Overall Study|Disease progression|26|||
170692493|NCT00413192|616886697|FG001|Overall Study|Disease progression|31|||
170692494|NCT00413192|616886698|FG002|Overall Study|Disease progression|16|||
170692495|NCT00413192|616886699|FG003|Overall Study|Disease progression|25|||
170692496|NCT00413192|616886696|FG000|Overall Study|Toxicity|3|||
170692497|NCT00413192|616886697|FG001|Overall Study|Toxicity|2|||
170692498|NCT00413192|616886698|FG002|Overall Study|Toxicity|2|||
170692499|NCT00413192|616886699|FG003|Overall Study|Toxicity|2|||
170692500|NCT00413192|616886696|FG000|Overall Study|Withdrawal by Subject|3|||
170692501|NCT00413192|616886697|FG001|Overall Study|Withdrawal by Subject|5|||
170692502|NCT00413192|616886698|FG002|Overall Study|Withdrawal by Subject|0|||
170692503|NCT00413192|616886699|FG003|Overall Study|Withdrawal by Subject|1|||
170692504|NCT00413192|616886696|FG000|Overall Study|Intercurrent illness|0|||
170692505|NCT00413192|616886697|FG001|Overall Study|Intercurrent illness|0|||
170692506|NCT00413192|616886698|FG002|Overall Study|Intercurrent illness|0|||
170692507|NCT00413192|616886699|FG003|Overall Study|Intercurrent illness|1|||
170692508|NCT00413192|616886696|FG000|Overall Study|Intercurrent death|0|||
170692509|NCT00413192|616886697|FG001|Overall Study|Intercurrent death|1|||
170692510|NCT00413192|616886698|FG002|Overall Study|Intercurrent death|0|||
170692511|NCT00413192|616886699|FG003|Overall Study|Intercurrent death|0|||
170692512|NCT00413192|616886696|FG000|Overall Study|Other|5|||
170692513|NCT00413192|616886697|FG001|Overall Study|Other|1|||
170692514|NCT00413192|616886698|FG002|Overall Study|Other|1|||
170692515|NCT00413192|616886699|FG003|Overall Study|Other|2|||
170692516|NCT00413192|616886696|FG000|Overall Study|Not treated|0|||
170692517|NCT00413192|616886697|FG001|Overall Study|Not treated|0|||
170692518|NCT00413192|616886698|FG002|Overall Study|Not treated|0|||
170692519|NCT00413192|616886699|FG003|Overall Study|Not treated|1|||
170692520|NCT03992781|616886700|FG000|Overall Study|Lost to Follow-up|5|||
170692521|NCT03992781|616886700|FG000|Overall Study|Adverse Event|1|||
170692522|NCT03992781|616886700|FG000|Overall Study|Lack of Efficacy|5|||
170692523|NCT01996826|616886701|FG000|Overall Study|Lost to Follow-up|6|||
170692524|NCT01996826|616886702|FG001|Overall Study|Lost to Follow-up|2|||
170692525|NCT01996826|616886701|FG000|Overall Study|Physician Decision|1|||
170692526|NCT01996826|616886702|FG001|Overall Study|Physician Decision|1|||
170692527|NCT00518323|616886704|FG000|Overall Study|Lack of Efficacy|14|||
170692528|NCT00518323|616886705|FG001|Overall Study|Lack of Efficacy|2|||
170692529|NCT00518323|616886706|FG002|Overall Study|Lack of Efficacy|4|||
170692530|NCT00518323|616886707|FG003|Overall Study|Lack of Efficacy|20|||
170692531|NCT00518323|616886704|FG000|Overall Study|Withdrawal by Subject|1|||
170692532|NCT00518323|616886705|FG001|Overall Study|Withdrawal by Subject|2|||
170692533|NCT00518323|616886706|FG002|Overall Study|Withdrawal by Subject|4|||
170692534|NCT00518323|616886707|FG003|Overall Study|Withdrawal by Subject|2|||
170692535|NCT00518323|616886704|FG000|Overall Study|Lost to Follow-up|0|||
170692536|NCT00518323|616886705|FG001|Overall Study|Lost to Follow-up|2|||
170692537|NCT00518323|616886706|FG002|Overall Study|Lost to Follow-up|1|||
170692538|NCT00518323|616886707|FG003|Overall Study|Lost to Follow-up|3|||
170692539|NCT00518323|616886704|FG000|Overall Study|Adverse Event|1|||
170692540|NCT00518323|616886705|FG001|Overall Study|Adverse Event|1|||
170692541|NCT00518323|616886706|FG002|Overall Study|Adverse Event|1|||
170692542|NCT00518323|616886707|FG003|Overall Study|Adverse Event|0|||
170692543|NCT00518323|616886704|FG000|Overall Study|Prohibited medication and others|3|||
170692544|NCT00518323|616886705|FG001|Overall Study|Prohibited medication and others|1|||
170692545|NCT00518323|616886706|FG002|Overall Study|Prohibited medication and others|1|||
170692546|NCT00518323|616886707|FG003|Overall Study|Prohibited medication and others|0|||
170692547|NCT03164928|616886708|FG000|Overall Study|Lost to Follow-up|1|||
170692548|NCT03164928|616886709|FG001|Overall Study|Lost to Follow-up|0|||
170692549|NCT01817725|616886713|FG000|Overall Study|Withdrawal by Subject|1|||
170692550|NCT02418468|616886714|FG000|Overall Study|Adverse Event|1|||
170692551|NCT02418468|616886715|FG001|Overall Study|Adverse Event|0|||
170692552|NCT02418468|616886714|FG000|Overall Study|Withdrawal of informed consent|1|||
170692553|NCT02418468|616886715|FG001|Overall Study|Withdrawal of informed consent|1|||
170692554|NCT00909779|616886716|FG000|Overall Study|Adverse Event|53|||
170692555|NCT00909779|616886717|FG001|Overall Study|Adverse Event|55|||
170692556|NCT00909779|616886716|FG000|Overall Study|Lack of Efficacy|7|||
170692557|NCT00909779|616886717|FG001|Overall Study|Lack of Efficacy|4|||
170692558|NCT00909779|616886716|FG000|Overall Study|Lost to Follow-up|19|||
170692559|NCT00909779|616886717|FG001|Overall Study|Lost to Follow-up|15|||
170692560|NCT00909779|616886716|FG000|Overall Study|Physician Decision|8|||
170692561|NCT00909779|616886717|FG001|Overall Study|Physician Decision|2|||
170692562|NCT00909779|616886716|FG000|Overall Study|Protocol Violation|2|||
170692563|NCT00909779|616886717|FG001|Overall Study|Protocol Violation|5|||
170692564|NCT00909779|616886716|FG000|Overall Study|Withdrawal by Subject|116|||
170692565|NCT00909779|616886717|FG001|Overall Study|Withdrawal by Subject|80|||
170692566|NCT00909779|616886716|FG000|Overall Study|Site Ceasing Operation|2|||
170692567|NCT00909779|616886717|FG001|Overall Study|Site Ceasing Operation|2|||
170692568|NCT00909779|616886716|FG000|Overall Study|Medical Monitor Decision|1|||
170692569|NCT00909779|616886717|FG001|Overall Study|Medical Monitor Decision|0|||
170692570|NCT00909779|616886716|FG000|Overall Study|Noncompliance|1|||
170692571|NCT00909779|616886717|FG001|Overall Study|Noncompliance|1|||
170692572|NCT00909779|616886716|FG000|Overall Study|Randomized in error|1|||
170692573|NCT00909779|616886717|FG001|Overall Study|Randomized in error|1|||
170692574|NCT01592344|616886718|FG000|Overall Study|Adverse Event|1|||
170692575|NCT01592344|616886719|FG001|Overall Study|Adverse Event|1|||
170692576|NCT01592344|616886718|FG000|Overall Study|Lack of Efficacy|1|||
170692577|NCT01592344|616886719|FG001|Overall Study|Lack of Efficacy|0|||
170692578|NCT01592344|616886718|FG000|Overall Study|not available at primary outcome visit|2|||
170692579|NCT01592344|616886719|FG001|Overall Study|not available at primary outcome visit|4|||
170692580|NCT02738333|616886720|FG000|Overall Study|Death|1|||
170692581|NCT02738333|616886721|FG001|Overall Study|Death|0|||
170692582|NCT02738333|616886722|FG002|Overall Study|Death|0|||
170692583|NCT02738333|616886720|FG000|Overall Study|Lost to Follow-up|1|||
170692584|NCT02738333|616886721|FG001|Overall Study|Lost to Follow-up|0|||
170692585|NCT02738333|616886722|FG002|Overall Study|Lost to Follow-up|0|||
170692586|NCT00949325|616886723|FG000|Overall Study|Adverse Event|0|||
170692587|NCT00949325|616886724|FG001|Overall Study|Adverse Event|2|||
170692588|NCT00949325|616886725|FG002|Overall Study|Adverse Event|0|||
170692589|NCT04829318|616886728|FG000|Overall Study|Adverse Event|6|||
170692590|NCT04829318|616886728|FG000|Overall Study|Death|1|||
170692591|NCT04829318|616886728|FG000|Overall Study|Lost to Follow-up|1|||
170692592|NCT04829318|616886728|FG000|Overall Study|Physician Decision|1|||
170692593|NCT04829318|616886728|FG000|Overall Study|Withdrawal by Subject|19|||
170692594|NCT04829318|616886728|FG000|Overall Study|Site terminated by sponsor|1|||
170692595|NCT04829318|616886728|FG000|Overall Study|Sponsor decision|5|||
170692596|NCT04829318|616886728|FG000|Overall Study|Other|1|||
170692597|NCT03447990|616886730|FG000|Overall Study|Withdrawal by Subject|0|||
170692598|NCT03447990|616886731|FG001|Overall Study|Withdrawal by Subject|0|||
170692599|NCT03447990|616886732|FG002|Overall Study|Withdrawal by Subject|0|||
170692600|NCT03447990|616886733|FG003|Overall Study|Withdrawal by Subject|0|||
170692601|NCT03447990|616886734|FG004|Overall Study|Withdrawal by Subject|0|||
170692602|NCT03447990|616886735|FG005|Overall Study|Withdrawal by Subject|0|||
170692603|NCT03447990|616886736|FG006|Overall Study|Withdrawal by Subject|1|||
170692604|NCT03755414|616886738|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
170692605|NCT03755414|616886739|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
170692606|NCT03755414|616886740|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
170692607|NCT03755414|616886738|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
170692608|NCT03755414|616886739|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
170692609|NCT03755414|616886740|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
170692610|NCT03755414|616886738|FG000|Overall Study|Non-compliance|0|||
170692611|NCT03755414|616886739|FG001|Overall Study|Non-compliance|1|||
170692612|NCT03755414|616886740|FG002|Overall Study|Non-compliance|0|||
170692613|NCT01641692|616886741|FG000|Treatment Period 1|Adverse Event|1|||
170692614|NCT01641692|616886742|FG001|Treatment Period 1|Adverse Event|0|||
170692615|NCT01641692|616886743|FG002|Treatment Period 1|Adverse Event|0|||
170692616|NCT01641692|616886744|FG003|Treatment Period 1|Adverse Event|0|||
170692617|NCT01641692|616886745|FG004|Treatment Period 1|Adverse Event|0|||
170692618|NCT01641692|616886746|FG005|Treatment Period 1|Adverse Event|0|||
170692619|NCT01641692|616886747|FG006|Treatment Period 1|Adverse Event|0|||
170692620|NCT01641692|616886748|FG007|Treatment Period 1|Adverse Event|0|||
170692621|NCT01641692|616886741|FG000|Treatment Period 1|Lack of Efficacy|0|||
170692622|NCT01641692|616886742|FG001|Treatment Period 1|Lack of Efficacy|0|||
170692623|NCT01641692|616886743|FG002|Treatment Period 1|Lack of Efficacy|0|||
170822886|NCT01772147|617360377|FG000|Overall Study|Withdrew Consent|7|||
170822887|NCT01772147|617360378|FG001|Overall Study|Withdrew Consent|8|||
170822888|NCT01772147|617360379|FG002|Overall Study|Withdrew Consent|4|||
170822889|NCT01772147|617360377|FG000|Overall Study|Lost to Follow-up|1|||
170822890|NCT01772147|617360378|FG001|Overall Study|Lost to Follow-up|0|||
170822891|NCT01772147|617360379|FG002|Overall Study|Lost to Follow-up|1|||
170822892|NCT01772147|617360377|FG000|Overall Study|Protocol Deviation|2|||
170822893|NCT01772147|617360378|FG001|Overall Study|Protocol Deviation|1|||
170822894|NCT01772147|617360379|FG002|Overall Study|Protocol Deviation|1|||
170822895|NCT01772147|617360377|FG000|Overall Study|Lack of Efficacy|8|||
170822896|NCT01772147|617360378|FG001|Overall Study|Lack of Efficacy|6|||
170822897|NCT01772147|617360379|FG002|Overall Study|Lack of Efficacy|6|||
170822898|NCT00796614|617360384|FG000|Overall Study|Adverse Event|1|||
170822899|NCT00796614|617360385|FG001|Overall Study|Adverse Event|2|||
170822900|NCT00796614|617360386|FG002|Overall Study|Adverse Event|0|||
170822901|NCT00796614|617360387|FG003|Overall Study|Adverse Event|0|||
170822902|NCT00796614|617360384|FG000|Overall Study|Protocol Violation|0|||
170822903|NCT00796614|617360385|FG001|Overall Study|Protocol Violation|0|||
170822904|NCT00796614|617360386|FG002|Overall Study|Protocol Violation|2|||
170692624|NCT01641692|616886744|FG003|Treatment Period 1|Lack of Efficacy|0|||
170692625|NCT01641692|616886745|FG004|Treatment Period 1|Lack of Efficacy|0|||
170692626|NCT01641692|616886746|FG005|Treatment Period 1|Lack of Efficacy|0|||
170692627|NCT01641692|616886747|FG006|Treatment Period 1|Lack of Efficacy|0|||
170692628|NCT01641692|616886748|FG007|Treatment Period 1|Lack of Efficacy|1|||
170692629|NCT01641692|616886741|FG000|Treatment Period 1|Protocol Violation|1|||
170692630|NCT01641692|616886742|FG001|Treatment Period 1|Protocol Violation|0|||
170692631|NCT01641692|616886743|FG002|Treatment Period 1|Protocol Violation|0|||
170822905|NCT00796614|617360387|FG003|Overall Study|Protocol Violation|0|||
170822906|NCT00796614|617360384|FG000|Overall Study|Lost to Follow-up|2|||
170822907|NCT00796614|617360385|FG001|Overall Study|Lost to Follow-up|2|||
170822908|NCT00796614|617360386|FG002|Overall Study|Lost to Follow-up|1|||
170822909|NCT00796614|617360387|FG003|Overall Study|Lost to Follow-up|0|||
170822910|NCT00796614|617360384|FG000|Overall Study|Withdrawal by Subject|1|||
170822911|NCT00796614|617360385|FG001|Overall Study|Withdrawal by Subject|0|||
170822912|NCT00796614|617360386|FG002|Overall Study|Withdrawal by Subject|0|||
170822913|NCT00796614|617360387|FG003|Overall Study|Withdrawal by Subject|1|||
170822914|NCT00796614|617360384|FG000|Overall Study|Other than stated|1|||
170822915|NCT00796614|617360385|FG001|Overall Study|Other than stated|0|||
170822916|NCT00796614|617360386|FG002|Overall Study|Other than stated|0|||
170822917|NCT00796614|617360387|FG003|Overall Study|Other than stated|0|||
170822918|NCT00740597|617360388|FG000|Overall Study|insurance would not cover treatment|1|||
170822919|NCT00957996|617360389|FG000|Overall Study|Death|4|||
170822920|NCT00957996|617360390|FG001|Overall Study|Death|10|||
170822921|NCT00957996|617360389|FG000|Overall Study|Lost to Follow-up|4|||
170822922|NCT00957996|617360390|FG001|Overall Study|Lost to Follow-up|7|||
170822923|NCT00957996|617360389|FG000|Overall Study|Withdrawal by Subject|9|||
170822924|NCT00957996|617360390|FG001|Overall Study|Withdrawal by Subject|2|||
170822925|NCT00957996|617360389|FG000|Overall Study|Adverse Event|2|||
170822926|NCT00957996|617360390|FG001|Overall Study|Adverse Event|1|||
170822927|NCT00957996|617360389|FG000|Overall Study|Physician Decision|1|||
170822928|NCT00957996|617360390|FG001|Overall Study|Physician Decision|1|||
170822929|NCT00957996|617360389|FG000|Overall Study|Influenza-related complication|0|||
170822930|NCT00957996|617360390|FG001|Overall Study|Influenza-related complication|1|||
170822931|NCT00957996|617360389|FG000|Overall Study|Missing|1|||
170822932|NCT00957996|617360390|FG001|Overall Study|Missing|0|||
170822933|NCT00957996|617360389|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
170822934|NCT00957996|617360390|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
170822935|NCT01983462|617360395|FG000|Overall Study|Adverse Event|1|||
170822936|NCT01983462|617360396|FG001|Overall Study|Adverse Event|0|||
170822937|NCT01983462|617360397|FG002|Overall Study|Adverse Event|0|||
170822938|NCT00349622|617360400|FG000|Overall Study|Death|168|||
170822939|NCT00349622|617360401|FG001|Overall Study|Death|86|||
170822940|NCT00349622|617360400|FG000|Overall Study|Lost to Follow-up|5|||
170822941|NCT00349622|617360401|FG001|Overall Study|Lost to Follow-up|1|||
170822942|NCT00349622|617360400|FG000|Overall Study|Withdrawal by Subject|5|||
170822943|NCT00349622|617360401|FG001|Overall Study|Withdrawal by Subject|9|||
170822944|NCT03296566|617360404|FG000|Overall Study|Lost to Follow-up|19|||
170822945|NCT03296566|617360405|FG001|Overall Study|Lost to Follow-up|46|||
170822946|NCT03296566|617360404|FG000|Overall Study|Withdrawal by Subject|0|||
170822947|NCT03296566|617360405|FG001|Overall Study|Withdrawal by Subject|3|||
170822948|NCT01902381|617360406|FG000|Overall Study|Withdrawal by Subject|1|||
170822949|NCT03681353|617360407|FG000|Overall Study|Lost to Follow-up|2|||
170822950|NCT03681353|617360407|FG000|Overall Study|Withdrawal by Subject|3|||
170822951|NCT03681353|617360407|FG000|Overall Study|withdrawn by PI|2|||
170822952|NCT02679079|617360410|FG000|Overall Study|Adverse Event|2|||
170822953|NCT02679079|617360411|FG001|Overall Study|Adverse Event|0|||
170692632|NCT01641692|616886744|FG003|Treatment Period 1|Protocol Violation|0|||
170692633|NCT01641692|616886745|FG004|Treatment Period 1|Protocol Violation|2|||
170692634|NCT01641692|616886746|FG005|Treatment Period 1|Protocol Violation|0|||
170692635|NCT01641692|616886747|FG006|Treatment Period 1|Protocol Violation|0|||
170692636|NCT01641692|616886748|FG007|Treatment Period 1|Protocol Violation|0|||
170692637|NCT01641692|616886741|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
170692638|NCT01641692|616886742|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
170692639|NCT01641692|616886743|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
170692640|NCT01641692|616886744|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
170692641|NCT01641692|616886745|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
170692642|NCT01641692|616886746|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
170692643|NCT01641692|616886747|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
170692644|NCT01641692|616886748|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
170692645|NCT01641692|616886741|FG000|Treatment Period 1|Lost to Follow-up|0|||
170692646|NCT01641692|616886742|FG001|Treatment Period 1|Lost to Follow-up|0|||
170692647|NCT01641692|616886743|FG002|Treatment Period 1|Lost to Follow-up|1|||
170692648|NCT01641692|616886744|FG003|Treatment Period 1|Lost to Follow-up|0|||
170822954|NCT02679079|617360412|FG002|Overall Study|Adverse Event|2|||
170822955|NCT02679079|617360410|FG000|Overall Study|Protocol Violation|0|||
170822956|NCT02679079|617360411|FG001|Overall Study|Protocol Violation|1|||
170822957|NCT02679079|617360412|FG002|Overall Study|Protocol Violation|0|||
170822958|NCT02679079|617360410|FG000|Overall Study|Withdrawal by Subject|2|||
170822959|NCT02679079|617360411|FG001|Overall Study|Withdrawal by Subject|1|||
170822960|NCT02679079|617360412|FG002|Overall Study|Withdrawal by Subject|0|||
170822961|NCT00726388|617360413|FG000|Overall Study|Withdrawal by Subject|5|||
170822962|NCT00726388|617360413|FG000|Overall Study|Adverse Event|3|||
170822963|NCT00726388|617360413|FG000|Overall Study|Lost to Follow-up|10|||
170692649|NCT01641692|616886745|FG004|Treatment Period 1|Lost to Follow-up|0|||
170822964|NCT00726388|617360413|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
170822965|NCT00726388|617360413|FG000|Overall Study|Other|5|||
170692650|NCT01641692|616886746|FG005|Treatment Period 1|Lost to Follow-up|0|||
170692651|NCT01641692|616886747|FG006|Treatment Period 1|Lost to Follow-up|0|||
170692652|NCT01641692|616886748|FG007|Treatment Period 1|Lost to Follow-up|0|||
170692653|NCT01641692|616886741|FG000|Treatment Period 1|Physician Decision|0|||
170692654|NCT01641692|616886742|FG001|Treatment Period 1|Physician Decision|0|||
170692655|NCT01641692|616886743|FG002|Treatment Period 1|Physician Decision|0|||
170692656|NCT01641692|616886744|FG003|Treatment Period 1|Physician Decision|0|||
170692657|NCT01641692|616886745|FG004|Treatment Period 1|Physician Decision|1|||
170692658|NCT01641692|616886746|FG005|Treatment Period 1|Physician Decision|0|||
170692659|NCT01641692|616886747|FG006|Treatment Period 1|Physician Decision|0|||
170692660|NCT01641692|616886748|FG007|Treatment Period 1|Physician Decision|0|||
170692661|NCT01641692|616886741|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170692662|NCT01641692|616886742|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170692663|NCT01641692|616886743|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170692664|NCT01641692|616886744|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170692665|NCT01641692|616886745|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170692666|NCT01641692|616886746|FG005|Treatment Period 1|Withdrawal by Subject|2|||
170692667|NCT01641692|616886747|FG006|Treatment Period 1|Withdrawal by Subject|0|||
170692668|NCT01641692|616886748|FG007|Treatment Period 1|Withdrawal by Subject|1|||
170692669|NCT01641692|616886741|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
170692670|NCT01641692|616886742|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
170692671|NCT01641692|616886743|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
170692672|NCT01641692|616886744|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
170692673|NCT01641692|616886745|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
170692674|NCT01641692|616886746|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
170692675|NCT01641692|616886747|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
170692676|NCT01641692|616886748|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
170692677|NCT01641692|616886741|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170692678|NCT01641692|616886742|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170692679|NCT01641692|616886743|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170692680|NCT01641692|616886744|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170692681|NCT01641692|616886745|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170692682|NCT01641692|616886746|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170692683|NCT01641692|616886747|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
170692684|NCT01641692|616886748|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170692685|NCT01641692|616886741|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
170692686|NCT01641692|616886742|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692687|NCT01641692|616886743|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
170692688|NCT01641692|616886744|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
170692689|NCT01641692|616886745|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
170692690|NCT01641692|616886746|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692691|NCT01641692|616886747|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692692|NCT01641692|616886748|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
170692693|NCT01641692|616886741|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
170692694|NCT01641692|616886742|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
170692695|NCT01641692|616886743|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
170692696|NCT01641692|616886744|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
170692697|NCT01641692|616886745|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
170692698|NCT01641692|616886746|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
170692699|NCT01641692|616886747|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
170692700|NCT01641692|616886748|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
170692701|NCT01641692|616886741|FG000|Treatment Period 2|Lack of Efficacy|1|||
170692702|NCT01641692|616886742|FG001|Treatment Period 2|Lack of Efficacy|0|||
170692703|NCT01641692|616886743|FG002|Treatment Period 2|Lack of Efficacy|0|||
170692704|NCT01641692|616886744|FG003|Treatment Period 2|Lack of Efficacy|0|||
170692705|NCT01641692|616886745|FG004|Treatment Period 2|Lack of Efficacy|0|||
170692706|NCT01641692|616886746|FG005|Treatment Period 2|Lack of Efficacy|0|||
170692707|NCT01641692|616886747|FG006|Treatment Period 2|Lack of Efficacy|0|||
170692708|NCT01641692|616886748|FG007|Treatment Period 2|Lack of Efficacy|0|||
170692709|NCT01641692|616886741|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
170692710|NCT01641692|616886742|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170692711|NCT01641692|616886743|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170692712|NCT01641692|616886744|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170692713|NCT01641692|616886745|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170692714|NCT01641692|616886746|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170692715|NCT01641692|616886747|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170692716|NCT01641692|616886748|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
170692717|NCT01641692|616886741|FG000|Treatment Period 2|Lost to Follow-up|0|||
170692718|NCT01641692|616886742|FG001|Treatment Period 2|Lost to Follow-up|0|||
170692719|NCT01641692|616886743|FG002|Treatment Period 2|Lost to Follow-up|0|||
170692720|NCT01641692|616886744|FG003|Treatment Period 2|Lost to Follow-up|0|||
170692721|NCT01641692|616886745|FG004|Treatment Period 2|Lost to Follow-up|0|||
170692722|NCT01641692|616886746|FG005|Treatment Period 2|Lost to Follow-up|1|||
170692723|NCT01641692|616886747|FG006|Treatment Period 2|Lost to Follow-up|0|||
170692724|NCT01641692|616886748|FG007|Treatment Period 2|Lost to Follow-up|0|||
170692725|NCT01641692|616886741|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170692726|NCT01641692|616886742|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170692727|NCT01641692|616886743|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170692728|NCT01641692|616886744|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170692729|NCT01641692|616886745|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170692730|NCT01641692|616886746|FG005|Treatment Period 2|Withdrawal by Subject|1|||
170692731|NCT01641692|616886747|FG006|Treatment Period 2|Withdrawal by Subject|0|||
170692732|NCT01641692|616886748|FG007|Treatment Period 2|Withdrawal by Subject|1|||
170692733|NCT01641692|616886741|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692734|NCT01641692|616886742|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692735|NCT01641692|616886743|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692736|NCT01641692|616886744|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692737|NCT01641692|616886745|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
170692738|NCT01641692|616886746|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692739|NCT01641692|616886747|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
170692740|NCT01641692|616886748|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
170692741|NCT01641692|616886741|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170692742|NCT01641692|616886742|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170692743|NCT01641692|616886743|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
170692744|NCT01641692|616886744|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170692745|NCT01641692|616886745|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170692746|NCT01641692|616886746|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
170692747|NCT01641692|616886747|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170692748|NCT01641692|616886748|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
170692749|NCT01641692|616886741|FG000|Treatment Period 3|Adverse Event|0|||
170692750|NCT01641692|616886742|FG001|Treatment Period 3|Adverse Event|0|||
170692751|NCT01641692|616886743|FG002|Treatment Period 3|Adverse Event|0|||
170692752|NCT01641692|616886744|FG003|Treatment Period 3|Adverse Event|0|||
170692753|NCT01641692|616886745|FG004|Treatment Period 3|Adverse Event|0|||
170692754|NCT01641692|616886746|FG005|Treatment Period 3|Adverse Event|0|||
170692755|NCT01641692|616886747|FG006|Treatment Period 3|Adverse Event|1|||
170692756|NCT01641692|616886748|FG007|Treatment Period 3|Adverse Event|0|||
170692757|NCT01641692|616886741|FG000|Treatment Period 3|Protocol Violation|0|||
170692758|NCT01641692|616886742|FG001|Treatment Period 3|Protocol Violation|0|||
170692759|NCT01641692|616886743|FG002|Treatment Period 3|Protocol Violation|1|||
170692760|NCT01641692|616886744|FG003|Treatment Period 3|Protocol Violation|0|||
170692761|NCT01641692|616886745|FG004|Treatment Period 3|Protocol Violation|0|||
170692762|NCT01641692|616886746|FG005|Treatment Period 3|Protocol Violation|0|||
170692763|NCT01641692|616886747|FG006|Treatment Period 3|Protocol Violation|0|||
170692764|NCT01641692|616886748|FG007|Treatment Period 3|Protocol Violation|0|||
170692765|NCT01641692|616886741|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170692766|NCT01641692|616886742|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170692767|NCT01641692|616886743|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170692768|NCT01641692|616886744|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170692769|NCT01641692|616886745|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170692770|NCT01641692|616886746|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170692771|NCT01641692|616886747|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
170692772|NCT01641692|616886748|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
170692773|NCT01641692|616886741|FG000|Treatment Period 3|Lost to Follow-up|0|||
170692774|NCT01641692|616886742|FG001|Treatment Period 3|Lost to Follow-up|1|||
170692775|NCT01641692|616886743|FG002|Treatment Period 3|Lost to Follow-up|0|||
170692776|NCT01641692|616886744|FG003|Treatment Period 3|Lost to Follow-up|0|||
170692777|NCT01641692|616886745|FG004|Treatment Period 3|Lost to Follow-up|0|||
170692778|NCT01641692|616886746|FG005|Treatment Period 3|Lost to Follow-up|0|||
170692779|NCT01641692|616886747|FG006|Treatment Period 3|Lost to Follow-up|0|||
170692780|NCT01641692|616886748|FG007|Treatment Period 3|Lost to Follow-up|0|||
170692781|NCT01641692|616886741|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
170692782|NCT01641692|616886742|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
170692783|NCT01641692|616886743|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
170692784|NCT01641692|616886744|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
170692785|NCT01641692|616886745|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
170692786|NCT01641692|616886746|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
170692787|NCT01641692|616886747|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
170692788|NCT01641692|616886748|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
170692789|NCT01641692|616886741|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
170692790|NCT01641692|616886742|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
170692791|NCT01641692|616886743|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
170692792|NCT01641692|616886744|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
170692793|NCT01641692|616886745|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
170692794|NCT01641692|616886746|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
170692795|NCT01641692|616886747|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
170692796|NCT01641692|616886748|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
170692797|NCT03999892|616886752|FG000|Overall Study|Lost to Follow-up|1|||
170692798|NCT02226003|616886756|FG000|Overall Study|Lost to Follow-up|2|||
170692799|NCT02226003|616886757|FG001|Overall Study|Lost to Follow-up|1|||
170692800|NCT02226003|616886758|FG002|Overall Study|Lost to Follow-up|3|||
170692801|NCT02226003|616886756|FG000|Overall Study|Withdrawal by Subject|0|||
170692802|NCT02226003|616886757|FG001|Overall Study|Withdrawal by Subject|0|||
170692803|NCT02226003|616886758|FG002|Overall Study|Withdrawal by Subject|3|||
170692804|NCT01499563|616886761|FG000|Overall Study|Withdrawal by Subject|10|||
170692805|NCT01499563|616886762|FG001|Overall Study|Withdrawal by Subject|11|||
170692806|NCT01499563|616886763|FG002|Overall Study|Withdrawal by Subject|7|||
170692807|NCT01499563|616886764|FG003|Overall Study|Withdrawal by Subject|8|||
170692808|NCT01499563|616886761|FG000|Overall Study|Physician Decision|2|||
170692809|NCT01499563|616886762|FG001|Overall Study|Physician Decision|1|||
170692810|NCT01499563|616886763|FG002|Overall Study|Physician Decision|3|||
170692811|NCT01499563|616886764|FG003|Overall Study|Physician Decision|0|||
170692812|NCT01499563|616886761|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
170692813|NCT01499563|616886762|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
170692814|NCT01499563|616886763|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
170692815|NCT01499563|616886764|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
170692816|NCT01499563|616886761|FG000|Overall Study|Adverse Event|2|||
170692817|NCT01499563|616886762|FG001|Overall Study|Adverse Event|0|||
170692818|NCT01499563|616886763|FG002|Overall Study|Adverse Event|1|||
170692819|NCT01499563|616886764|FG003|Overall Study|Adverse Event|3|||
170692820|NCT01499563|616886761|FG000|Overall Study|Lack of Efficacy|0|||
170692821|NCT01499563|616886762|FG001|Overall Study|Lack of Efficacy|1|||
170692822|NCT01499563|616886763|FG002|Overall Study|Lack of Efficacy|6|||
170692823|NCT01499563|616886764|FG003|Overall Study|Lack of Efficacy|3|||
170692824|NCT01499563|616886761|FG000|Overall Study|Other|8|||
170692825|NCT01499563|616886762|FG001|Overall Study|Other|6|||
170692826|NCT01499563|616886763|FG002|Overall Study|Other|6|||
170692827|NCT01499563|616886764|FG003|Overall Study|Other|4|||
170692828|NCT05760300|616886765|FG000|Overall Study|Adverse Event|0|||
170692829|NCT05760300|616886766|FG001|Overall Study|Adverse Event|0|||
170692830|NCT05760300|616886767|FG002|Overall Study|Adverse Event|1|||
170692831|NCT05760300|616886768|FG003|Overall Study|Adverse Event|0|||
170692832|NCT05760300|616886765|FG000|Overall Study|Participant Decision|1|||
170692833|NCT05760300|616886766|FG001|Overall Study|Participant Decision|0|||
170692834|NCT05760300|616886767|FG002|Overall Study|Participant Decision|0|||
170692835|NCT05760300|616886768|FG003|Overall Study|Participant Decision|0|||
170692836|NCT01064401|616886771|FG000|Overall Study|Adverse Event|47|||
170692837|NCT01064401|616886772|FG001|Overall Study|Adverse Event|56|||
170692838|NCT01064401|616886771|FG000|Overall Study|Lack of Efficacy|46|||
170692839|NCT01064401|616886772|FG001|Overall Study|Lack of Efficacy|23|||
170692840|NCT01064401|616886771|FG000|Overall Study|Lost to Follow-up|12|||
170822966|NCT00726388|617360413|FG000|Overall Study|Enrolled, Not Treated|79|||
170822967|NCT02396758|617360419|FG000|Overall Study|Withdrawal by Subject|2|||
170692841|NCT01064401|616886772|FG001|Overall Study|Lost to Follow-up|9|||
170692842|NCT01064401|616886771|FG000|Overall Study|Consent Withdrawn|98|||
170692843|NCT01064401|616886772|FG001|Overall Study|Consent Withdrawn|80|||
170692844|NCT01064401|616886771|FG000|Overall Study|Investigator Decision|4|||
170692845|NCT01064401|616886772|FG001|Overall Study|Investigator Decision|6|||
170692846|NCT01064401|616886771|FG000|Overall Study|Death|4|||
170692847|NCT01064401|616886772|FG001|Overall Study|Death|0|||
170692848|NCT01064401|616886771|FG000|Overall Study|Pregnancy|4|||
170692849|NCT01064401|616886772|FG001|Overall Study|Pregnancy|7|||
170692850|NCT01064401|616886771|FG000|Overall Study|Noncompliance|7|||
170692851|NCT01064401|616886772|FG001|Overall Study|Noncompliance|8|||
170692852|NCT01064401|616886771|FG000|Overall Study|Site Closure|4|||
170692853|NCT01064401|616886772|FG001|Overall Study|Site Closure|5|||
170692854|NCT01064401|616886771|FG000|Overall Study|Other|2|||
170692855|NCT01064401|616886772|FG001|Overall Study|Other|1|||
170692856|NCT04199117|616886773|FG000|Overall Study|Withdrawal by Subject|3|||
170692857|NCT04199117|616886774|FG001|Overall Study|Withdrawal by Subject|0|||
170692858|NCT04199117|616886775|FG002|Overall Study|Withdrawal by Subject|0|||
170692859|NCT04199117|616886776|FG003|Overall Study|Withdrawal by Subject|1|||
170692860|NCT04199117|616886777|FG004|Overall Study|Withdrawal by Subject|1|||
170692861|NCT04199117|616886778|FG005|Overall Study|Withdrawal by Subject|0|||
170692862|NCT04199117|616886779|FG006|Overall Study|Withdrawal by Subject|0|||
170692863|NCT04199117|616886780|FG007|Overall Study|Withdrawal by Subject|2|||
170692864|NCT04199117|616886781|FG008|Overall Study|Withdrawal by Subject|0|||
170692865|NCT04199117|616886782|FG009|Overall Study|Withdrawal by Subject|0|||
170692866|NCT04199117|616886783|FG010|Overall Study|Withdrawal by Subject|1|||
170692867|NCT04199117|616886784|FG011|Overall Study|Withdrawal by Subject|1|||
170822968|NCT02396758|617360420|FG001|Overall Study|Withdrawal by Subject|0|||
170692868|NCT04199117|616886785|FG012|Overall Study|Withdrawal by Subject|2|||
170692869|NCT04199117|616886786|FG013|Overall Study|Withdrawal by Subject|1|||
170692870|NCT04199117|616886787|FG014|Overall Study|Withdrawal by Subject|1|||
170692871|NCT04199117|616886788|FG015|Overall Study|Withdrawal by Subject|1|||
170692872|NCT04199117|616886773|FG000|Overall Study|Death|1|||
170822969|NCT02396758|617360421|FG002|Overall Study|Withdrawal by Subject|0|||
170692873|NCT04199117|616886774|FG001|Overall Study|Death|1|||
170692874|NCT04199117|616886775|FG002|Overall Study|Death|0|||
170822970|NCT02396758|617360422|FG003|Overall Study|Withdrawal by Subject|1|||
170692875|NCT04199117|616886776|FG003|Overall Study|Death|0|||
170692876|NCT04199117|616886777|FG004|Overall Study|Death|0|||
170692877|NCT04199117|616886778|FG005|Overall Study|Death|0|||
170692878|NCT04199117|616886779|FG006|Overall Study|Death|0|||
170692879|NCT04199117|616886780|FG007|Overall Study|Death|0|||
170692880|NCT04199117|616886781|FG008|Overall Study|Death|0|||
170692881|NCT04199117|616886782|FG009|Overall Study|Death|0|||
170692882|NCT04199117|616886783|FG010|Overall Study|Death|0|||
170692883|NCT04199117|616886784|FG011|Overall Study|Death|1|||
170692884|NCT04199117|616886785|FG012|Overall Study|Death|0|||
170692885|NCT04199117|616886786|FG013|Overall Study|Death|1|||
170692886|NCT04199117|616886787|FG014|Overall Study|Death|0|||
170692887|NCT04199117|616886788|FG015|Overall Study|Death|0|||
170692888|NCT04199117|616886773|FG000|Overall Study|Withdrawal by PI|0|||
170692889|NCT04199117|616886774|FG001|Overall Study|Withdrawal by PI|0|||
170692890|NCT04199117|616886775|FG002|Overall Study|Withdrawal by PI|0|||
170692891|NCT04199117|616886776|FG003|Overall Study|Withdrawal by PI|0|||
170692892|NCT04199117|616886777|FG004|Overall Study|Withdrawal by PI|0|||
170692893|NCT04199117|616886778|FG005|Overall Study|Withdrawal by PI|0|||
170692894|NCT04199117|616886779|FG006|Overall Study|Withdrawal by PI|0|||
170692895|NCT04199117|616886780|FG007|Overall Study|Withdrawal by PI|0|||
170692896|NCT04199117|616886781|FG008|Overall Study|Withdrawal by PI|0|||
170692897|NCT04199117|616886782|FG009|Overall Study|Withdrawal by PI|0|||
170692898|NCT04199117|616886783|FG010|Overall Study|Withdrawal by PI|0|||
170692899|NCT04199117|616886784|FG011|Overall Study|Withdrawal by PI|0|||
170692900|NCT04199117|616886785|FG012|Overall Study|Withdrawal by PI|1|||
170692901|NCT04199117|616886786|FG013|Overall Study|Withdrawal by PI|0|||
170692902|NCT04199117|616886787|FG014|Overall Study|Withdrawal by PI|0|||
170692903|NCT04199117|616886788|FG015|Overall Study|Withdrawal by PI|0|||
170692904|NCT04709575|616888960|FG000|Overall Study|Withdrawal by Subject|6|||
170692905|NCT04709575|616888961|FG001|Overall Study|Withdrawal by Subject|2|||
170692906|NCT04709575|616888960|FG000|Overall Study|Lost to Follow-up|2|||
170692907|NCT04709575|616888961|FG001|Overall Study|Lost to Follow-up|2|||
170692908|NCT04709575|616888960|FG000|Overall Study|Adverse Event|1|||
170692909|NCT04709575|616888961|FG001|Overall Study|Adverse Event|0|||
170692910|NCT04709575|616888960|FG000|Overall Study|Protocol Violation|1|||
170692911|NCT04709575|616888961|FG001|Overall Study|Protocol Violation|1|||
170692912|NCT00699972|616888962|FG000|Overall Study|Adverse Event|7|||
170692913|NCT00699972|616888963|FG001|Overall Study|Adverse Event|9|||
170692914|NCT00699972|616888964|FG002|Overall Study|Adverse Event|24|||
170692915|NCT00699972|616888962|FG000|Overall Study|Lost to Follow-up|0|||
170692916|NCT00699972|616888963|FG001|Overall Study|Lost to Follow-up|2|||
170692917|NCT00699972|616888964|FG002|Overall Study|Lost to Follow-up|0|||
170692918|NCT00699972|616888962|FG000|Overall Study|Withdrawal by Subject|3|||
170692919|NCT00699972|616888963|FG001|Overall Study|Withdrawal by Subject|7|||
170692920|NCT00699972|616888964|FG002|Overall Study|Withdrawal by Subject|4|||
170692921|NCT00699972|616888962|FG000|Overall Study|Lack of Efficacy|2|||
170692922|NCT00699972|616888963|FG001|Overall Study|Lack of Efficacy|0|||
170692923|NCT00699972|616888964|FG002|Overall Study|Lack of Efficacy|2|||
170692924|NCT00699972|616888962|FG000|Overall Study|Administrative/Other|3|||
170692925|NCT00699972|616888963|FG001|Overall Study|Administrative/Other|1|||
170692926|NCT00699972|616888964|FG002|Overall Study|Administrative/Other|4|||
170692927|NCT00699972|616888962|FG000|Overall Study|Randomized, Not Treated|1|||
170692928|NCT00699972|616888963|FG001|Overall Study|Randomized, Not Treated|0|||
170692929|NCT00699972|616888964|FG002|Overall Study|Randomized, Not Treated|1|||
170692930|NCT01545817|616888965|FG000|Pazopanib|Disease progression|51|||
170692931|NCT01545817|616888966|FG001|Pazopanib|Disease progression|0|||
170692932|NCT01545817|616888965|FG000|Pazopanib|Adverse Event|19|||
170692933|NCT01545817|616888966|FG001|Pazopanib|Adverse Event|0|||
170692934|NCT01545817|616888965|FG000|Pazopanib|Other reason|4|||
170692935|NCT01545817|616888966|FG001|Pazopanib|Other reason|0|||
170692936|NCT01545817|616888965|FG000|Everolimus|Other reason|0|||
170692937|NCT01545817|616888966|FG001|Everolimus|Other reason|7|||
170822971|NCT02396758|617360419|FG000|Overall Study|Lost to Follow-up|8|||
170692938|NCT01545817|616888965|FG000|Everolimus|Disease progression|0|||
170692939|NCT01545817|616888966|FG001|Everolimus|Disease progression|25|||
170692940|NCT01545817|616888965|FG000|Everolimus|Adverse Event|0|||
170692941|NCT01545817|616888966|FG001|Everolimus|Adverse Event|6|||
170692942|NCT04439253|616888969|FG000|Overall Study|Adverse Event|1|||
170692943|NCT04439253|616888969|FG000|Overall Study|Disease progression|2|||
170692944|NCT04439253|616888969|FG000|Overall Study|Complicating disease|1|||
170692945|NCT03971695|616888971|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
170692946|NCT03971695|616888972|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
170692947|NCT03971695|616888973|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
170692948|NCT03971695|616888974|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
170692949|NCT03971695|616888975|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
170822972|NCT02396758|617360420|FG001|Overall Study|Lost to Follow-up|5|||
170822973|NCT02396758|617360421|FG002|Overall Study|Lost to Follow-up|3|||
170692950|NCT03971695|616888976|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
170692951|NCT03971695|616888977|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
170692952|NCT03971695|616888978|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
170822974|NCT02396758|617360422|FG003|Overall Study|Lost to Follow-up|3|||
170692953|NCT03971695|616888979|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
170692954|NCT03971695|616888980|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
170692955|NCT03971695|616888981|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
170692956|NCT03971695|616888982|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
170692957|NCT03971695|616888983|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
170692958|NCT00939809|616888984|FG000|Overall Study|Adverse Event|2|||
170692959|NCT00939809|616888984|FG000|Overall Study|Death|1|||
170692960|NCT00702403|616888985|FG000|From Consent to Engraftment|Progressive leukemia|6|||
170692961|NCT00702403|616888985|FG000|From Consent to Engraftment|Critically ill|2|||
170692962|NCT00702403|616888985|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
170692963|NCT00702403|616888985|FG000|From Consent to Engraftment|Myocardial infarction|1|||
170692964|NCT00702403|616888985|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
170692965|NCT00702403|616888985|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
170692966|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
170692967|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
170692968|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Non-compliance|2|||
170692969|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
170692970|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
170692971|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Suicide|1|||
170692972|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
170692973|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
170692974|NCT00702403|616888985|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
170692975|NCT00066066|616888989|FG000|Overall Study|Lost to Follow-up|6|||
170692976|NCT00066066|616888990|FG001|Overall Study|Lost to Follow-up|4|||
170692977|NCT00066066|616888991|FG002|Overall Study|Lost to Follow-up|7|||
170692978|NCT00066066|616888992|FG003|Overall Study|Lost to Follow-up|4|||
170692979|NCT00066066|616888993|FG004|Overall Study|Lost to Follow-up|3|||
170692980|NCT00066066|616888994|FG005|Overall Study|Lost to Follow-up|5|||
170692981|NCT02155738|616888999|FG000|Overall Study|Missing critical information|1|||
170692982|NCT02155738|616889000|FG001|Overall Study|Missing critical information|0|||
170692983|NCT02155738|616889001|FG002|Overall Study|Missing critical information|0|||
170692984|NCT02155738|616889002|FG003|Overall Study|Missing critical information|1|||
170692985|NCT00156533|616889005|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
170692986|NCT00156533|616889006|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
170692987|NCT00156533|616889007|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
170692988|NCT00156533|616889008|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
170692989|NCT00156533|616889005|FG000|Overall Study|Withdrawal by Subject|1|||
170692990|NCT00156533|616889006|FG001|Overall Study|Withdrawal by Subject|0|||
170692991|NCT00156533|616889007|FG002|Overall Study|Withdrawal by Subject|0|||
170692992|NCT00156533|616889008|FG003|Overall Study|Withdrawal by Subject|1|||
170692993|NCT00156533|616889005|FG000|Overall Study|Failed Screening|1|||
170692994|NCT00156533|616889006|FG001|Overall Study|Failed Screening|0|||
170692995|NCT00156533|616889007|FG002|Overall Study|Failed Screening|1|||
170692996|NCT00156533|616889008|FG003|Overall Study|Failed Screening|1|||
170692997|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
170692998|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
170692999|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
170693000|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
170693001|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
170693002|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
170693003|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
170693004|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
170693005|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
170693006|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
170693007|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
170693008|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
170693009|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
170693010|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
170693011|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
170693012|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
170693013|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
170693014|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
170693015|NCT00887354|616889009|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
170693016|NCT00887354|616889010|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
170693017|NCT00887354|616889009|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
170693018|NCT00887354|616889010|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
170693019|NCT00887354|616889009|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
170693020|NCT00887354|616889010|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
170693021|NCT00887354|616889009|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
170693022|NCT00887354|616889010|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
170693023|NCT00887354|616889009|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
170693024|NCT00887354|616889010|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
170693025|NCT00887354|616889009|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
170693026|NCT00887354|616889010|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
170693027|NCT01466348|616889013|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
170693028|NCT01466348|616889014|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
170693029|NCT01955161|616889015|FG000|Overall Study|Withdrawal before treatment|2|||
170693030|NCT01955161|616889016|FG001|Overall Study|Withdrawal before treatment|0|||
170693031|NCT01955161|616889017|FG002|Overall Study|Withdrawal before treatment|1|||
170693032|NCT01955161|616889015|FG000|Overall Study|Adverse Event|10|||
170693033|NCT01955161|616889016|FG001|Overall Study|Adverse Event|14|||
170693034|NCT01955161|616889017|FG002|Overall Study|Adverse Event|15|||
170693035|NCT01955161|616889015|FG000|Overall Study|Death|1|||
170693036|NCT01955161|616889016|FG001|Overall Study|Death|1|||
170693037|NCT01955161|616889017|FG002|Overall Study|Death|3|||
170693038|NCT01955161|616889015|FG000|Overall Study|Withdrawal by Subject|9|||
170693039|NCT01955161|616889016|FG001|Overall Study|Withdrawal by Subject|8|||
170693040|NCT01955161|616889017|FG002|Overall Study|Withdrawal by Subject|12|||
170693041|NCT01955161|616889015|FG000|Overall Study|Protocol Violation|2|||
170693042|NCT01955161|616889016|FG001|Overall Study|Protocol Violation|0|||
170693043|NCT01955161|616889017|FG002|Overall Study|Protocol Violation|0|||
170693044|NCT01955161|616889015|FG000|Overall Study|Other reason: physician decision|0|||
170693045|NCT01955161|616889016|FG001|Overall Study|Other reason: physician decision|1|||
170693046|NCT01955161|616889017|FG002|Overall Study|Other reason: physician decision|1|||
170693047|NCT01955161|616889015|FG000|Overall Study|Other reason: disallowed medication|1|||
170693048|NCT01955161|616889016|FG001|Overall Study|Other reason: disallowed medication|0|||
170822975|NCT02396758|617360419|FG000|Overall Study|Death|1|||
170822976|NCT02396758|617360420|FG001|Overall Study|Death|1|||
170822977|NCT02396758|617360421|FG002|Overall Study|Death|0|||
170822978|NCT02396758|617360422|FG003|Overall Study|Death|1|||
170822979|NCT02396758|617360419|FG000|Overall Study|Randomized but not treated|1|||
170822980|NCT02396758|617360420|FG001|Overall Study|Randomized but not treated|0|||
170822981|NCT02396758|617360421|FG002|Overall Study|Randomized but not treated|1|||
170822982|NCT02396758|617360422|FG003|Overall Study|Randomized but not treated|0|||
170822983|NCT00265096|617360423|FG000|Overall Study|Adverse Event|14|||
170822984|NCT00265096|617360424|FG001|Overall Study|Adverse Event|18|||
170822985|NCT00265096|617360425|FG002|Overall Study|Adverse Event|18|||
170822986|NCT00265096|617360423|FG000|Overall Study|Lost to Follow-up|2|||
170822987|NCT00265096|617360424|FG001|Overall Study|Lost to Follow-up|5|||
170822988|NCT00265096|617360425|FG002|Overall Study|Lost to Follow-up|3|||
170822989|NCT00265096|617360423|FG000|Overall Study|Death|0|||
170822990|NCT00265096|617360424|FG001|Overall Study|Death|1|||
170822991|NCT00265096|617360425|FG002|Overall Study|Death|2|||
170693049|NCT01955161|616889017|FG002|Overall Study|Other reason: disallowed medication|1|||
170693050|NCT01955161|616889015|FG000|Overall Study|Other reason: caregiver unavailable|1|||
170693051|NCT01955161|616889016|FG001|Overall Study|Other reason: caregiver unavailable|0|||
170822992|NCT00265096|617360423|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
170822993|NCT00265096|617360424|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
170822994|NCT00265096|617360425|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
170822995|NCT00265096|617360423|FG000|Overall Study|Other|11|||
170822996|NCT00265096|617360424|FG001|Overall Study|Other|19|||
170693052|NCT01955161|616889017|FG002|Overall Study|Other reason: caregiver unavailable|0|||
170693053|NCT01955161|616889015|FG000|Overall Study|Other reason: moved to nursing home|0|||
170693054|NCT01955161|616889016|FG001|Overall Study|Other reason: moved to nursing home|1|||
170693055|NCT01955161|616889017|FG002|Overall Study|Other reason: moved to nursing home|0|||
170693056|NCT01955161|616889015|FG000|Overall Study|Other reason: insufficient compliance|0|||
170693057|NCT01955161|616889016|FG001|Overall Study|Other reason: insufficient compliance|0|||
170693058|NCT01955161|616889017|FG002|Overall Study|Other reason: insufficient compliance|1|||
170693059|NCT01955161|616889015|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
170693060|NCT01955161|616889016|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
170693061|NCT01955161|616889017|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
170693062|NCT01955161|616889015|FG000|Overall Study|Other reason: patient's will|0|||
170693063|NCT01955161|616889016|FG001|Overall Study|Other reason: patient's will|0|||
170693064|NCT01955161|616889017|FG002|Overall Study|Other reason: patient's will|1|||
170693065|NCT05129488|616889018|FG000|Overall Study|Protocol Violation|3|||
170693066|NCT00706641|616889019|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
170693067|NCT00706641|616889019|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
170693068|NCT00706641|616889019|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
170693069|NCT04782856|616889020|FG000|Overall Study|Withdrawal by Subject|0|||
170693070|NCT04782856|616889021|FG001|Overall Study|Withdrawal by Subject|1|||
170693071|NCT01030523|616889022|FG000|Initial Study (5 Years)|Death|1|||
170693072|NCT01030523|616889023|FG001|Initial Study (5 Years)|Death|0|||
170693073|NCT01030523|616889022|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
170693074|NCT01030523|616889023|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
170693075|NCT01030523|616889022|FG000|Initial Study (5 Years)|Implant failure|1|||
170693076|NCT01030523|616889023|FG001|Initial Study (5 Years)|Implant failure|0|||
170693077|NCT01030523|616889022|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
170693078|NCT01030523|616889023|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
170693079|NCT01030523|616889022|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
170693080|NCT01030523|616889023|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
170693081|NCT01030523|616889022|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
170693082|NCT01030523|616889023|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
170693083|NCT01327300|616889024|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
170693084|NCT01327300|616889025|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
170693085|NCT04307446|616889026|FG000|Overall Study|Lost to Follow-up|2|||
170693086|NCT04307446|616889027|FG001|Overall Study|Lost to Follow-up|0|||
170693087|NCT00697515|616889028|FG000|Dose Optimization Period|Adverse Event|4|||
170693088|NCT00697515|616889029|FG001|Dose Optimization Period|Adverse Event|0|||
170693089|NCT00697515|616889028|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
170693090|NCT00697515|616889029|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
170693091|NCT00697515|616889028|FG000|Dose Optimization Period|Lost to Follow-up|2|||
170693092|NCT00697515|616889029|FG001|Dose Optimization Period|Lost to Follow-up|0|||
170693093|NCT00697515|616889028|FG000|Dose Optimization Period|sponsor request|2|||
170693094|NCT00697515|616889029|FG001|Dose Optimization Period|sponsor request|0|||
170693095|NCT00697515|616889028|FG000|Dose Optimization Period|called to active duty|1|||
170693096|NCT00697515|616889029|FG001|Dose Optimization Period|called to active duty|0|||
170693097|NCT00697515|616889028|FG000|Dose Optimization Period|elevated QTc|1|||
170693098|NCT00697515|616889029|FG001|Dose Optimization Period|elevated QTc|0|||
170693099|NCT00697515|616889028|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
170693100|NCT00697515|616889029|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
170693101|NCT00697515|616889028|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
170693102|NCT00697515|616889029|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
170693103|NCT00697515|616889028|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
170693104|NCT00697515|616889029|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
170693105|NCT00697515|616889028|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
170822997|NCT00265096|617360425|FG002|Overall Study|Other|10|||
170822998|NCT03568708|617360426|FG000|Overall Study|Withdrawal by Subject|1|||
170693106|NCT00697515|616889029|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
170693107|NCT01316276|616889034|FG000|Overall Study|Death|1|||
170693108|NCT01316276|616889034|FG000|Overall Study|Adverse Event|19|||
170822999|NCT03568708|617360427|FG001|Overall Study|Withdrawal by Subject|1|||
170823000|NCT03568708|617360426|FG000|Overall Study|Lost to Follow-up|0|||
170823001|NCT03568708|617360427|FG001|Overall Study|Lost to Follow-up|1|||
170693109|NCT01316276|616889034|FG000|Overall Study|Withdrawal of consent|24|||
170693110|NCT01316276|616889034|FG000|Overall Study|Lost to Follow-up|1|||
170693111|NCT01316276|616889034|FG000|Overall Study|Other|22|||
170693112|NCT00605475|616889035|FG000|Overall Study|Abnormal Laboratory Values|0|||
170693113|NCT00605475|616889036|FG001|Overall Study|Abnormal Laboratory Values|0|||
170693114|NCT00605475|616889037|FG002|Overall Study|Abnormal Laboratory Values|0|||
170823002|NCT00899379|617360428|FG000|Overall Study|Adverse Event|2|||
170823003|NCT00899379|617360429|FG001|Overall Study|Adverse Event|2|||
170823004|NCT00899379|617360430|FG002|Overall Study|Adverse Event|1|||
170823005|NCT00899379|617360431|FG003|Overall Study|Adverse Event|1|||
170693115|NCT00605475|616889038|FG003|Overall Study|Abnormal Laboratory Values|0|||
170693116|NCT00605475|616889039|FG004|Overall Study|Abnormal Laboratory Values|0|||
170693117|NCT00605475|616889040|FG005|Overall Study|Abnormal Laboratory Values|0|||
170693118|NCT00605475|616889041|FG006|Overall Study|Abnormal Laboratory Values|0|||
170693119|NCT00605475|616889042|FG007|Overall Study|Abnormal Laboratory Values|0|||
170693120|NCT00605475|616889043|FG008|Overall Study|Abnormal Laboratory Values|1|||
170693121|NCT00605475|616889044|FG009|Overall Study|Abnormal Laboratory Values|0|||
170693122|NCT00605475|616889035|FG000|Overall Study|Administrative problems|0|||
170693123|NCT00605475|616889036|FG001|Overall Study|Administrative problems|0|||
170693124|NCT00605475|616889037|FG002|Overall Study|Administrative problems|0|||
170693125|NCT00605475|616889038|FG003|Overall Study|Administrative problems|0|||
170693126|NCT00605475|616889039|FG004|Overall Study|Administrative problems|0|||
170693127|NCT00605475|616889040|FG005|Overall Study|Administrative problems|0|||
170693128|NCT00605475|616889041|FG006|Overall Study|Administrative problems|1|||
170693129|NCT00605475|616889042|FG007|Overall Study|Administrative problems|0|||
170693130|NCT00605475|616889043|FG008|Overall Study|Administrative problems|0|||
170693131|NCT00605475|616889044|FG009|Overall Study|Administrative problems|0|||
170693132|NCT00605475|616889035|FG000|Overall Study|Lost to Follow-up|0|||
170693133|NCT00605475|616889036|FG001|Overall Study|Lost to Follow-up|0|||
170693134|NCT00605475|616889037|FG002|Overall Study|Lost to Follow-up|0|||
170693135|NCT00605475|616889038|FG003|Overall Study|Lost to Follow-up|0|||
170693136|NCT00605475|616889039|FG004|Overall Study|Lost to Follow-up|0|||
170693137|NCT00605475|616889040|FG005|Overall Study|Lost to Follow-up|0|||
170693138|NCT00605475|616889041|FG006|Overall Study|Lost to Follow-up|0|||
170693139|NCT00605475|616889042|FG007|Overall Study|Lost to Follow-up|0|||
170693140|NCT00605475|616889043|FG008|Overall Study|Lost to Follow-up|1|||
170693141|NCT00605475|616889044|FG009|Overall Study|Lost to Follow-up|1|||
170693142|NCT00605475|616889035|FG000|Overall Study|Protocol Violation|0|||
170693143|NCT00605475|616889036|FG001|Overall Study|Protocol Violation|0|||
170693144|NCT00605475|616889037|FG002|Overall Study|Protocol Violation|0|||
170693145|NCT00605475|616889038|FG003|Overall Study|Protocol Violation|0|||
170693146|NCT00605475|616889039|FG004|Overall Study|Protocol Violation|1|||
170693147|NCT00605475|616889040|FG005|Overall Study|Protocol Violation|0|||
170693148|NCT00605475|616889041|FG006|Overall Study|Protocol Violation|0|||
170693149|NCT00605475|616889042|FG007|Overall Study|Protocol Violation|0|||
170693150|NCT00605475|616889043|FG008|Overall Study|Protocol Violation|0|||
170693151|NCT00605475|616889044|FG009|Overall Study|Protocol Violation|0|||
170693152|NCT00605475|616889035|FG000|Overall Study|Withdrawal by Subject|0|||
170693153|NCT00605475|616889036|FG001|Overall Study|Withdrawal by Subject|0|||
170693154|NCT00605475|616889037|FG002|Overall Study|Withdrawal by Subject|0|||
170693155|NCT00605475|616889038|FG003|Overall Study|Withdrawal by Subject|0|||
170693156|NCT00605475|616889039|FG004|Overall Study|Withdrawal by Subject|0|||
170693157|NCT00605475|616889040|FG005|Overall Study|Withdrawal by Subject|2|||
170693158|NCT00605475|616889041|FG006|Overall Study|Withdrawal by Subject|0|||
170693159|NCT00605475|616889042|FG007|Overall Study|Withdrawal by Subject|0|||
170693160|NCT00605475|616889043|FG008|Overall Study|Withdrawal by Subject|0|||
170693161|NCT00605475|616889044|FG009|Overall Study|Withdrawal by Subject|1|||
170693162|NCT04461015|616889047|FG000|Overall Study|IV access lost during the study|0|||
170693163|NCT04461015|616889048|FG001|Overall Study|IV access lost during the study|1|||
170693164|NCT04461015|616889047|FG000|Overall Study|Withdrawal by Subject|0|||
170693165|NCT04461015|616889048|FG001|Overall Study|Withdrawal by Subject|1|||
170693166|NCT01413360|616889049|FG000|Overall Study|Lost to Follow-up|2|||
170693167|NCT01413360|616889049|FG000|Overall Study|Adverse Event|1|||
170693168|NCT02914769|616889053|FG000|Overall Study|Protocol Violation|3|||
170693169|NCT02914769|616889054|FG001|Overall Study|Protocol Violation|2|||
170693170|NCT02914769|616889053|FG000|Overall Study|Withdrawal by Subject|0|||
170693171|NCT02914769|616889054|FG001|Overall Study|Withdrawal by Subject|1|||
170693172|NCT00099437|616889056|FG000|Overall Study|Lost to Follow-up|30|||
170693173|NCT00099437|616889057|FG001|Overall Study|Lost to Follow-up|33|||
170693174|NCT00099437|616889056|FG000|Overall Study|Death|293|||
170693175|NCT00099437|616889057|FG001|Overall Study|Death|261|||
170693176|NCT00099437|616889056|FG000|Overall Study|Withdrawal by Subject|6|||
170693177|NCT00099437|616889057|FG001|Overall Study|Withdrawal by Subject|10|||
170693178|NCT00099437|616889056|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
170693179|NCT00099437|616889057|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
170823006|NCT00899379|617360432|FG004|Overall Study|Adverse Event|2|||
170693180|NCT05413369|616889058|FG000|Overall Study|Adverse Event|1|||
170693181|NCT05413369|616889059|FG001|Overall Study|Adverse Event|1|||
170693182|NCT05413369|616889058|FG000|Overall Study|Withdrawal by Subject|13|||
170693183|NCT05413369|616889059|FG001|Overall Study|Withdrawal by Subject|4|||
170693184|NCT05413369|616889058|FG000|Overall Study|Non-compliance with study schedule|2|||
170693185|NCT05413369|616889059|FG001|Overall Study|Non-compliance with study schedule|1|||
170693186|NCT05413369|616889058|FG000|Overall Study|Other|1|||
170693187|NCT05413369|616889059|FG001|Overall Study|Other|1|||
170693188|NCT00730912|616889066|FG000|Overall Study|Discontinued|0|||
170823007|NCT00899379|617360428|FG000|Overall Study|Lack of Efficacy|0|||
170693189|NCT00730912|616889067|FG001|Overall Study|Discontinued|0|||
170693190|NCT00730912|616889068|FG002|Overall Study|Discontinued|1|||
170693191|NCT03311659|616889071|FG000|Overall Study|Protocol Violation|1|||
170693192|NCT02205333|616889072|FG000|Overall Study|Death|5|||
170693193|NCT02205333|616889073|FG001|Overall Study|Death|6|||
170693194|NCT02205333|616889074|FG002|Overall Study|Death|2|||
170693195|NCT02205333|616889075|FG003|Overall Study|Death|6|||
170693196|NCT02205333|616889076|FG004|Overall Study|Death|5|||
170693197|NCT02205333|616889077|FG005|Overall Study|Death|3|||
170693198|NCT02205333|616889078|FG006|Overall Study|Death|3|||
170693199|NCT02205333|616889079|FG007|Overall Study|Death|2|||
170693200|NCT02205333|616889080|FG008|Overall Study|Death|0|||
170693201|NCT02205333|616889072|FG000|Overall Study|Withdrawal by Subject|1|||
170693202|NCT02205333|616889073|FG001|Overall Study|Withdrawal by Subject|0|||
170693203|NCT02205333|616889074|FG002|Overall Study|Withdrawal by Subject|0|||
170693204|NCT02205333|616889075|FG003|Overall Study|Withdrawal by Subject|1|||
170693205|NCT02205333|616889076|FG004|Overall Study|Withdrawal by Subject|0|||
170693206|NCT02205333|616889077|FG005|Overall Study|Withdrawal by Subject|0|||
170693207|NCT02205333|616889078|FG006|Overall Study|Withdrawal by Subject|2|||
170693208|NCT02205333|616889079|FG007|Overall Study|Withdrawal by Subject|0|||
170693209|NCT02205333|616889080|FG008|Overall Study|Withdrawal by Subject|0|||
170693210|NCT01176266|616889081|FG000|Overall Study|Death|6|||
170693211|NCT01176266|616889081|FG000|Overall Study|Withdrawal by Subject|3|||
170693212|NCT01179477|616889082|FG000|Overall Study|Death|542|||
170693213|NCT01179477|616889082|FG000|Overall Study|Unsuccessful implant|80|||
170693214|NCT01179477|616889082|FG000|Overall Study|Non-death withdrawal|438|||
170693215|NCT01179477|616889082|FG000|Overall Study|Did not complete final visit|27|||
170693216|NCT04327388|616889084|FG000|Overall Study|Adverse Event|17|||
170693217|NCT04327388|616889085|FG001|Overall Study|Adverse Event|18|||
170693218|NCT04327388|616889086|FG002|Overall Study|Adverse Event|9|||
170693219|NCT04327388|616889084|FG000|Overall Study|Other|1|||
170693220|NCT04327388|616889085|FG001|Overall Study|Other|2|||
170693221|NCT04327388|616889086|FG002|Overall Study|Other|0|||
170693222|NCT04327388|616889084|FG000|Overall Study|Randomized and not treated|2|||
170693223|NCT04327388|616889085|FG001|Overall Study|Randomized and not treated|0|||
170693224|NCT04327388|616889086|FG002|Overall Study|Randomized and not treated|2|||
170693225|NCT00728130|616889087|FG000|Overall Study|Withdrawal by Subject|1|||
170693226|NCT00728130|616889087|FG000|Overall Study|Paperwork not completed in time|1|||
170693227|NCT00728130|616889087|FG000|Overall Study|Physician Decision|1|||
170693228|NCT04053023|616889090|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
170693229|NCT04053023|616889091|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
170693230|NCT02153112|616889092|FG000|Overall Study|Adverse Event|0|||
170823008|NCT00899379|617360429|FG001|Overall Study|Lack of Efficacy|4|||
170823009|NCT00899379|617360430|FG002|Overall Study|Lack of Efficacy|3|||
170823010|NCT00899379|617360431|FG003|Overall Study|Lack of Efficacy|0|||
170823011|NCT00899379|617360432|FG004|Overall Study|Lack of Efficacy|1|||
170823012|NCT00899379|617360428|FG000|Overall Study|Lost to Follow-up|9|||
170823013|NCT00899379|617360429|FG001|Overall Study|Lost to Follow-up|3|||
170823014|NCT00899379|617360430|FG002|Overall Study|Lost to Follow-up|0|||
170823015|NCT00899379|617360431|FG003|Overall Study|Lost to Follow-up|6|||
170823016|NCT00899379|617360432|FG004|Overall Study|Lost to Follow-up|2|||
170823017|NCT00899379|617360428|FG000|Overall Study|Protocol Violation|0|||
170823018|NCT00899379|617360429|FG001|Overall Study|Protocol Violation|0|||
170823019|NCT00899379|617360430|FG002|Overall Study|Protocol Violation|1|||
170823020|NCT00899379|617360431|FG003|Overall Study|Protocol Violation|1|||
170823021|NCT00899379|617360432|FG004|Overall Study|Protocol Violation|0|||
170823022|NCT00899379|617360428|FG000|Overall Study|Withdrawal by Subject|2|||
170823023|NCT00899379|617360429|FG001|Overall Study|Withdrawal by Subject|4|||
170823024|NCT00899379|617360430|FG002|Overall Study|Withdrawal by Subject|2|||
170823025|NCT00899379|617360431|FG003|Overall Study|Withdrawal by Subject|3|||
170823026|NCT00899379|617360432|FG004|Overall Study|Withdrawal by Subject|6|||
170693231|NCT02153112|616889093|FG001|Overall Study|Adverse Event|0|||
170693232|NCT02153112|616889094|FG002|Overall Study|Adverse Event|1|||
170693233|NCT02153112|616889095|FG003|Overall Study|Adverse Event|0|||
170823027|NCT00899379|617360428|FG000|Overall Study|Pregnancy|0|||
170823028|NCT00899379|617360429|FG001|Overall Study|Pregnancy|0|||
170823029|NCT00899379|617360430|FG002|Overall Study|Pregnancy|1|||
170693234|NCT02153112|616889096|FG004|Overall Study|Adverse Event|0|||
170693235|NCT02153112|616889097|FG005|Overall Study|Adverse Event|0|||
170693236|NCT02153112|616889098|FG006|Overall Study|Adverse Event|0|||
170693237|NCT02153112|616889099|FG007|Overall Study|Adverse Event|0|||
170693238|NCT02153112|616889100|FG008|Overall Study|Adverse Event|0|||
170693239|NCT02153112|616889101|FG009|Overall Study|Adverse Event|0|||
170693240|NCT02153112|616889092|FG000|Overall Study|Lost to Follow-up|1|||
170693241|NCT02153112|616889093|FG001|Overall Study|Lost to Follow-up|1|||
170693242|NCT02153112|616889094|FG002|Overall Study|Lost to Follow-up|0|||
170693243|NCT02153112|616889095|FG003|Overall Study|Lost to Follow-up|0|||
170823030|NCT00899379|617360431|FG003|Overall Study|Pregnancy|0|||
170693244|NCT02153112|616889096|FG004|Overall Study|Lost to Follow-up|2|||
170693245|NCT02153112|616889097|FG005|Overall Study|Lost to Follow-up|1|||
170693246|NCT02153112|616889098|FG006|Overall Study|Lost to Follow-up|1|||
170693247|NCT02153112|616889099|FG007|Overall Study|Lost to Follow-up|0|||
170693248|NCT02153112|616889100|FG008|Overall Study|Lost to Follow-up|1|||
170693249|NCT02153112|616889101|FG009|Overall Study|Lost to Follow-up|1|||
170693250|NCT02153112|616889092|FG000|Overall Study|Withdrawal by Subject|3|||
170693251|NCT02153112|616889093|FG001|Overall Study|Withdrawal by Subject|1|||
170693252|NCT02153112|616889094|FG002|Overall Study|Withdrawal by Subject|2|||
170693253|NCT02153112|616889095|FG003|Overall Study|Withdrawal by Subject|2|||
170693254|NCT02153112|616889096|FG004|Overall Study|Withdrawal by Subject|1|||
170693255|NCT02153112|616889097|FG005|Overall Study|Withdrawal by Subject|1|||
170693256|NCT02153112|616889098|FG006|Overall Study|Withdrawal by Subject|7|||
170693257|NCT02153112|616889099|FG007|Overall Study|Withdrawal by Subject|2|||
170693258|NCT02153112|616889100|FG008|Overall Study|Withdrawal by Subject|13|||
170693259|NCT02153112|616889101|FG009|Overall Study|Withdrawal by Subject|12|||
170693260|NCT02153112|616889092|FG000|Overall Study|Reason not Specified|0|||
170693261|NCT02153112|616889093|FG001|Overall Study|Reason not Specified|0|||
170693262|NCT02153112|616889094|FG002|Overall Study|Reason not Specified|0|||
170693263|NCT02153112|616889095|FG003|Overall Study|Reason not Specified|0|||
170693264|NCT02153112|616889096|FG004|Overall Study|Reason not Specified|0|||
170693265|NCT02153112|616889097|FG005|Overall Study|Reason not Specified|0|||
170693266|NCT02153112|616889098|FG006|Overall Study|Reason not Specified|0|||
170693267|NCT02153112|616889099|FG007|Overall Study|Reason not Specified|0|||
170693268|NCT02153112|616889100|FG008|Overall Study|Reason not Specified|1|||
170693269|NCT02153112|616889101|FG009|Overall Study|Reason not Specified|1|||
170693270|NCT04351087|616889102|FG000|Overall Study|Lost to Follow-up|7|||
170693271|NCT04351087|616889103|FG001|Overall Study|Lost to Follow-up|3|||
170693272|NCT04351087|616889102|FG000|Overall Study|Withdrawal by Subject|3|||
170693273|NCT04351087|616889103|FG001|Overall Study|Withdrawal by Subject|4|||
170693274|NCT04351087|616889102|FG000|Overall Study|Lack of Efficacy|3|||
170693275|NCT04351087|616889103|FG001|Overall Study|Lack of Efficacy|2|||
170693276|NCT03886220|616889104|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
170693277|NCT03886220|616889105|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
170693278|NCT03886220|616889104|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
170693279|NCT03886220|616889105|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170693280|NCT03886220|616889104|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
170693281|NCT03886220|616889105|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
170693282|NCT01522365|616889112|FG000|Overall Study|Withdrawal by Subject|1|||
170693283|NCT01522365|616889113|FG001|Overall Study|Withdrawal by Subject|1|||
170693284|NCT01522365|616889112|FG000|Overall Study|Lost to Follow-up|1|||
170693285|NCT01522365|616889113|FG001|Overall Study|Lost to Follow-up|1|||
170693286|NCT00651755|616889114|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
170693287|NCT00651755|616889115|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
170693288|NCT00651755|616889114|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
170693289|NCT00651755|616889115|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
170693290|NCT02466555|616889118|FG000|Overall Study|Lost to Follow-up|2|||
170693291|NCT01120756|616889119|FG000|Overall Study|Withdrawal by Subject|1|||
170693292|NCT01120756|616889120|FG001|Overall Study|Withdrawal by Subject|1|||
170693293|NCT00698581|616889125|FG000|Overall Study|Lack of Efficacy|23|||
170693294|NCT00698581|616889126|FG001|Overall Study|Lack of Efficacy|11|||
170693295|NCT00698581|616889125|FG000|Overall Study|Withdrawal by Subject|6|||
170693296|NCT00698581|616889126|FG001|Overall Study|Withdrawal by Subject|0|||
170693297|NCT00698581|616889125|FG000|Overall Study|Other reason|9|||
170693298|NCT00698581|616889126|FG001|Overall Study|Other reason|1|||
170693299|NCT00698581|616889125|FG000|Overall Study|SAE, non-fatal|1|||
170693300|NCT00698581|616889126|FG001|Overall Study|SAE, non-fatal|0|||
170693301|NCT00698581|616889125|FG000|Overall Study|AE, non-serious non-fatal|4|||
170693302|NCT00698581|616889126|FG001|Overall Study|AE, non-serious non-fatal|0|||
170693303|NCT00698581|616889125|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
170693304|NCT00698581|616889126|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
170693305|NCT00698581|616889125|FG000|Overall Study|AE of unknown type|1|||
170693306|NCT00698581|616889126|FG001|Overall Study|AE of unknown type|0|||
170693307|NCT03760146|616889127|FG000|Overall Study|Adverse Event|11|||
170823031|NCT00899379|617360432|FG004|Overall Study|Pregnancy|1|||
170693308|NCT03760146|616889128|FG001|Overall Study|Adverse Event|8|||
170693309|NCT03760146|616889129|FG002|Overall Study|Adverse Event|0|||
170693310|NCT03760146|616889130|FG003|Overall Study|Adverse Event|0|||
170693311|NCT03760146|616889131|FG004|Overall Study|Adverse Event|0|||
170693312|NCT03760146|616889132|FG005|Overall Study|Adverse Event|0|||
170823032|NCT00899379|617360428|FG000|Overall Study|Patient Uncooperative|0|||
170823033|NCT00899379|617360429|FG001|Overall Study|Patient Uncooperative|1|||
170823034|NCT00899379|617360430|FG002|Overall Study|Patient Uncooperative|0|||
170693313|NCT03760146|616889127|FG000|Overall Study|Death|1|||
170693314|NCT03760146|616889128|FG001|Overall Study|Death|0|||
170693315|NCT03760146|616889129|FG002|Overall Study|Death|0|||
170693316|NCT03760146|616889130|FG003|Overall Study|Death|0|||
170693317|NCT03760146|616889131|FG004|Overall Study|Death|0|||
170693318|NCT03760146|616889132|FG005|Overall Study|Death|0|||
170693319|NCT03760146|616889127|FG000|Overall Study|Lost to Follow-up|41|||
170693320|NCT03760146|616889128|FG001|Overall Study|Lost to Follow-up|28|||
170693321|NCT03760146|616889129|FG002|Overall Study|Lost to Follow-up|9|||
170693322|NCT03760146|616889130|FG003|Overall Study|Lost to Follow-up|2|||
170693323|NCT03760146|616889131|FG004|Overall Study|Lost to Follow-up|14|||
170693324|NCT03760146|616889132|FG005|Overall Study|Lost to Follow-up|8|||
170693325|NCT03760146|616889127|FG000|Overall Study|No longer met eligibility criteria|3|||
170693326|NCT03760146|616889128|FG001|Overall Study|No longer met eligibility criteria|9|||
170693327|NCT03760146|616889129|FG002|Overall Study|No longer met eligibility criteria|0|||
170693328|NCT03760146|616889130|FG003|Overall Study|No longer met eligibility criteria|0|||
170693329|NCT03760146|616889131|FG004|Overall Study|No longer met eligibility criteria|1|||
170693330|NCT03760146|616889132|FG005|Overall Study|No longer met eligibility criteria|0|||
170693331|NCT03760146|616889127|FG000|Overall Study|Protocol Violation|21|||
170693332|NCT03760146|616889128|FG001|Overall Study|Protocol Violation|13|||
170693333|NCT03760146|616889129|FG002|Overall Study|Protocol Violation|1|||
170693334|NCT03760146|616889130|FG003|Overall Study|Protocol Violation|0|||
170693335|NCT03760146|616889131|FG004|Overall Study|Protocol Violation|1|||
170693336|NCT03760146|616889132|FG005|Overall Study|Protocol Violation|0|||
170693337|NCT03760146|616889127|FG000|Overall Study|Withdrawal by Subject|19|||
170693338|NCT03760146|616889128|FG001|Overall Study|Withdrawal by Subject|20|||
170693339|NCT03760146|616889129|FG002|Overall Study|Withdrawal by Subject|1|||
170693340|NCT03760146|616889130|FG003|Overall Study|Withdrawal by Subject|0|||
170693341|NCT03760146|616889131|FG004|Overall Study|Withdrawal by Subject|1|||
170693342|NCT03760146|616889132|FG005|Overall Study|Withdrawal by Subject|0|||
170693343|NCT00445965|616889135|FG000|Overall Study|Adverse Event|2|||
170693344|NCT00445965|616889135|FG000|Overall Study|Physician Decision|1|||
170693345|NCT00445965|616889135|FG000|Overall Study|Enrolled but not treated|1|||
170693346|NCT00445965|616889135|FG000|Overall Study|Removed due to progressive disease|29|||
170693347|NCT01498458|616889136|FG000|Overall Study|Adverse Event|4|||
170693348|NCT01498458|616889136|FG000|Overall Study|Physician Decision|3|||
170693349|NCT02865915|616889137|FG000|Overall Study|Pregnancy|1|||
170693350|NCT02865915|616889138|FG001|Overall Study|Pregnancy|0|||
170693351|NCT02865915|616889137|FG000|Overall Study|Withdrawal by Subject|1|||
170693352|NCT02865915|616889138|FG001|Overall Study|Withdrawal by Subject|1|||
170693353|NCT02865915|616889137|FG000|Overall Study|Adverse Event|0|||
170693354|NCT02865915|616889138|FG001|Overall Study|Adverse Event|4|||
170693355|NCT02865915|616889137|FG000|Overall Study|Lost to Follow-up|0|||
170693356|NCT02865915|616889138|FG001|Overall Study|Lost to Follow-up|1|||
170693357|NCT02865915|616889137|FG000|Overall Study|Protocol Violation|0|||
170693358|NCT02865915|616889138|FG001|Overall Study|Protocol Violation|1|||
170693359|NCT02865915|616889137|FG000|Overall Study|Study terminated by sponsor|23|||
170693360|NCT02865915|616889138|FG001|Overall Study|Study terminated by sponsor|18|||
170693361|NCT02865915|616889137|FG000|Overall Study|Dosing group discontinued|0|||
170693362|NCT02865915|616889138|FG001|Overall Study|Dosing group discontinued|5|||
170693363|NCT02446990|616889144|FG000|Overall Study|Death|485|||
170693364|NCT02446990|616889145|FG001|Overall Study|Death|458|||
170693365|NCT02446990|616889144|FG000|Overall Study|Lost to Follow-up|3|||
170693366|NCT02446990|616889145|FG001|Overall Study|Lost to Follow-up|1|||
170693367|NCT02446990|616889144|FG000|Overall Study|Physician Decision|1|||
170693368|NCT02446990|616889145|FG001|Overall Study|Physician Decision|0|||
170693369|NCT02446990|616889144|FG000|Overall Study|Withdrawal by Subject|231|||
170693370|NCT02446990|616889145|FG001|Overall Study|Withdrawal by Subject|199|||
170693371|NCT01252940|616889148|FG000|Main Study Phase|Randomized but not treated|4|||
170693372|NCT01252940|616889149|FG001|Main Study Phase|Randomized but not treated|2|||
170693373|NCT01252940|616889148|FG000|Main Study Phase|Adverse Event|3|||
170693374|NCT01252940|616889149|FG001|Main Study Phase|Adverse Event|1|||
170693375|NCT01252940|616889148|FG000|Main Study Phase|Lack of Efficacy|1|||
170693376|NCT01252940|616889149|FG001|Main Study Phase|Lack of Efficacy|0|||
170693377|NCT01252940|616889148|FG000|Main Study Phase|Lost to Follow-up|6|||
170693378|NCT01252940|616889149|FG001|Main Study Phase|Lost to Follow-up|1|||
170693379|NCT01252940|616889148|FG000|Main Study Phase|Physician Decision|1|||
170693380|NCT01252940|616889149|FG001|Main Study Phase|Physician Decision|0|||
170693381|NCT01252940|616889148|FG000|Main Study Phase|Protocol Violation|4|||
170693382|NCT01252940|616889149|FG001|Main Study Phase|Protocol Violation|2|||
170693383|NCT01252940|616889148|FG000|Main Study Phase|Withdrawal by Subject|6|||
170693384|NCT01252940|616889149|FG001|Main Study Phase|Withdrawal by Subject|5|||
170693385|NCT01252940|616889148|FG000|Main Study Phase|Subject Non-compliance|1|||
170693386|NCT01252940|616889149|FG001|Main Study Phase|Subject Non-compliance|1|||
170693387|NCT01252940|616889148|FG000|Extension Phase|Adverse Event|2|||
170693388|NCT01252940|616889149|FG001|Extension Phase|Adverse Event|1|||
170693389|NCT01252940|616889148|FG000|Extension Phase|Lack of Efficacy|1|||
170693390|NCT01252940|616889149|FG001|Extension Phase|Lack of Efficacy|0|||
170693391|NCT01252940|616889148|FG000|Extension Phase|Lost to Follow-up|5|||
170693392|NCT01252940|616889149|FG001|Extension Phase|Lost to Follow-up|0|||
170693393|NCT01252940|616889148|FG000|Extension Phase|Physician Decision|0|||
170693394|NCT01252940|616889149|FG001|Extension Phase|Physician Decision|1|||
170693395|NCT01252940|616889148|FG000|Extension Phase|Subject Non-compliance|1|||
170693396|NCT01252940|616889149|FG001|Extension Phase|Subject Non-compliance|0|||
170693397|NCT01252940|616889148|FG000|Extension Phase|Withdrawal by Subject|1|||
170693398|NCT01252940|616889149|FG001|Extension Phase|Withdrawal by Subject|1|||
170693399|NCT03482791|616889154|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
170693400|NCT03482791|616889155|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
170693401|NCT00798369|616890687|FG000|Overall Study|Subject withdrew consent|0|||
170693402|NCT00798369|616890688|FG001|Overall Study|Subject withdrew consent|0|||
170693403|NCT00798369|616890689|FG002|Overall Study|Subject withdrew consent|1|||
170693404|NCT00798369|616890690|FG003|Overall Study|Subject withdrew consent|1|||
170693405|NCT00798369|616890691|FG004|Overall Study|Subject withdrew consent|0|||
170693406|NCT00798369|616890692|FG005|Overall Study|Subject withdrew consent|2|||
170693407|NCT00798369|616890687|FG000|Overall Study|Lost to Follow-up|1|||
170693408|NCT00798369|616890688|FG001|Overall Study|Lost to Follow-up|1|||
170693409|NCT00798369|616890689|FG002|Overall Study|Lost to Follow-up|1|||
170693410|NCT00798369|616890690|FG003|Overall Study|Lost to Follow-up|0|||
170693411|NCT00798369|616890691|FG004|Overall Study|Lost to Follow-up|1|||
170693412|NCT00798369|616890692|FG005|Overall Study|Lost to Follow-up|0|||
170693413|NCT00798369|616890687|FG000|Overall Study|Adminstrative problems|0|||
170693414|NCT00798369|616890688|FG001|Overall Study|Adminstrative problems|0|||
170693415|NCT00798369|616890689|FG002|Overall Study|Adminstrative problems|0|||
170693416|NCT00798369|616890690|FG003|Overall Study|Adminstrative problems|0|||
170693417|NCT00798369|616890691|FG004|Overall Study|Adminstrative problems|0|||
170693418|NCT00798369|616890692|FG005|Overall Study|Adminstrative problems|1|||
170693419|NCT04475588|616890693|FG000|Overall Study|Adverse Event|2|||
170693420|NCT04475588|616890694|FG001|Overall Study|Adverse Event|0|||
170693421|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
170693422|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
170693423|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
170693424|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
170693425|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
170693426|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
170693427|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
170693428|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
170693429|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
170693430|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
170693431|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
170693432|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
170693433|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
170693434|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
170693435|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
170693436|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
170693437|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
170693438|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
170693439|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
170693440|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
170693441|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
170693442|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
170693443|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
170693444|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
170693445|NCT00277212|616890695|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
170693446|NCT00277212|616890696|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
170693447|NCT00277212|616890697|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
170693448|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
170693449|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
170693450|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
170693451|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
170693452|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
170693453|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
170693454|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
170693455|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
170693456|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
170693457|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
170693458|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
170693459|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
170693460|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
170693461|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
170693462|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
170693463|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
170693464|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
170693465|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
170693466|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
170693467|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
170693468|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
170693469|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
170693470|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
170693471|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
170693472|NCT00277212|616890695|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
170693473|NCT00277212|616890696|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
170693474|NCT00277212|616890697|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
170693475|NCT05620576|616890698|FG000|Overall Study|Adverse Event|1|||
170693476|NCT05620576|616890699|FG001|Overall Study|Adverse Event|1|||
170693477|NCT05620576|616890698|FG000|Overall Study|Lost to Follow-up|3|||
170823035|NCT00899379|617360431|FG003|Overall Study|Patient Uncooperative|1|||
170823036|NCT00899379|617360432|FG004|Overall Study|Patient Uncooperative|2|||
170823037|NCT00899379|617360428|FG000|Overall Study|Abnormal Baseline ECG|0|||
170823038|NCT00899379|617360429|FG001|Overall Study|Abnormal Baseline ECG|0|||
170823039|NCT00899379|617360430|FG002|Overall Study|Abnormal Baseline ECG|0|||
170823040|NCT00899379|617360431|FG003|Overall Study|Abnormal Baseline ECG|1|||
170823041|NCT00899379|617360432|FG004|Overall Study|Abnormal Baseline ECG|0|||
170823042|NCT00899379|617360428|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
170823043|NCT00899379|617360429|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
170823044|NCT00899379|617360430|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
170823045|NCT00899379|617360431|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
170823046|NCT00899379|617360432|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
170823047|NCT00899379|617360428|FG000|Overall Study|Not Completed/Entered Extn|5|||
170823048|NCT00899379|617360429|FG001|Overall Study|Not Completed/Entered Extn|1|||
170823049|NCT00899379|617360430|FG002|Overall Study|Not Completed/Entered Extn|6|||
170823050|NCT00899379|617360431|FG003|Overall Study|Not Completed/Entered Extn|4|||
170823051|NCT00899379|617360432|FG004|Overall Study|Not Completed/Entered Extn|3|||
170823052|NCT00899379|617360428|FG000|Overall Study|Study Terminated|3|||
170823053|NCT00899379|617360429|FG001|Overall Study|Study Terminated|0|||
170823054|NCT00899379|617360430|FG002|Overall Study|Study Terminated|3|||
170823055|NCT00899379|617360431|FG003|Overall Study|Study Terminated|3|||
170823056|NCT00899379|617360432|FG004|Overall Study|Study Terminated|1|||
170823057|NCT00899379|617360428|FG000|Overall Study|Lost to Follow-up|3|||
170823058|NCT00899379|617360429|FG001|Overall Study|Lost to Follow-up|1|||
170823059|NCT00899379|617360430|FG002|Overall Study|Lost to Follow-up|0|||
170823060|NCT00899379|617360431|FG003|Overall Study|Lost to Follow-up|2|||
170823061|NCT00899379|617360432|FG004|Overall Study|Lost to Follow-up|5|||
170823062|NCT00899379|617360428|FG000|Overall Study|Withdrawal by Subject|4|||
170823063|NCT00899379|617360429|FG001|Overall Study|Withdrawal by Subject|7|||
170823064|NCT00899379|617360430|FG002|Overall Study|Withdrawal by Subject|4|||
170823065|NCT00899379|617360431|FG003|Overall Study|Withdrawal by Subject|7|||
170823066|NCT00899379|617360432|FG004|Overall Study|Withdrawal by Subject|2|||
170823067|NCT00899379|617360428|FG000|Overall Study|Pregnancy|1|||
170823068|NCT00899379|617360429|FG001|Overall Study|Pregnancy|0|||
170823069|NCT00899379|617360430|FG002|Overall Study|Pregnancy|0|||
170823070|NCT00899379|617360431|FG003|Overall Study|Pregnancy|0|||
170823071|NCT00899379|617360432|FG004|Overall Study|Pregnancy|0|||
170823072|NCT00899379|617360428|FG000|Overall Study|Patient Uncooperative|0|||
170823073|NCT00899379|617360429|FG001|Overall Study|Patient Uncooperative|0|||
170823074|NCT00899379|617360430|FG002|Overall Study|Patient Uncooperative|0|||
170823075|NCT00899379|617360431|FG003|Overall Study|Patient Uncooperative|1|||
170823076|NCT00899379|617360432|FG004|Overall Study|Patient Uncooperative|0|||
170823077|NCT00899379|617360428|FG000|Overall Study|Abnormal Prestudy Labs|0|||
170823078|NCT00899379|617360429|FG001|Overall Study|Abnormal Prestudy Labs|0|||
170823079|NCT00899379|617360430|FG002|Overall Study|Abnormal Prestudy Labs|0|||
170823080|NCT00899379|617360431|FG003|Overall Study|Abnormal Prestudy Labs|0|||
170823081|NCT00899379|617360432|FG004|Overall Study|Abnormal Prestudy Labs|2|||
170823082|NCT00899379|617360428|FG000|Overall Study|Abnormal Baseline ECG|0|||
170823083|NCT00899379|617360429|FG001|Overall Study|Abnormal Baseline ECG|0|||
170823084|NCT00899379|617360430|FG002|Overall Study|Abnormal Baseline ECG|1|||
170823085|NCT00899379|617360431|FG003|Overall Study|Abnormal Baseline ECG|1|||
170823086|NCT00899379|617360432|FG004|Overall Study|Abnormal Baseline ECG|0|||
170823087|NCT00899379|617360428|FG000|Overall Study|No Attack Pretreatment|3|||
170823088|NCT00899379|617360429|FG001|Overall Study|No Attack Pretreatment|5|||
170823089|NCT00899379|617360430|FG002|Overall Study|No Attack Pretreatment|5|||
170823090|NCT00899379|617360431|FG003|Overall Study|No Attack Pretreatment|6|||
170823091|NCT00899379|617360432|FG004|Overall Study|No Attack Pretreatment|4|||
170823092|NCT00899379|617360428|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
170823093|NCT00899379|617360429|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
170823094|NCT00899379|617360430|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
170823095|NCT00899379|617360431|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
170823096|NCT00899379|617360432|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
170823097|NCT00899379|617360428|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
170823098|NCT00899379|617360429|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
170823099|NCT00899379|617360430|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
170823100|NCT00899379|617360431|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
170823101|NCT00899379|617360432|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
170823102|NCT02254681|617360441|FG000|Overall Study|Lack of Efficacy|6|||
170823103|NCT00396097|617360443|FG000|Overall Study|Withdrawal by Subject|17|||
170823104|NCT00396097|617360444|FG001|Overall Study|Withdrawal by Subject|17|||
170823105|NCT00396097|617360443|FG000|Overall Study|Lost to Follow-up|4|||
170693478|NCT05620576|616890699|FG001|Overall Study|Lost to Follow-up|1|||
170693479|NCT05620576|616890698|FG000|Overall Study|Physician Decision|0|||
170693480|NCT05620576|616890699|FG001|Overall Study|Physician Decision|1|||
170693481|NCT05620576|616890698|FG000|Overall Study|Protocol Deviation|1|||
170823106|NCT00396097|617360444|FG001|Overall Study|Lost to Follow-up|9|||
170823107|NCT00396097|617360443|FG000|Overall Study|Other|3|||
170823108|NCT00396097|617360444|FG001|Overall Study|Other|5|||
170693482|NCT05620576|616890699|FG001|Overall Study|Protocol Deviation|1|||
170693483|NCT05620576|616890698|FG000|Overall Study|Withdrawal by Subject|2|||
170693484|NCT05620576|616890699|FG001|Overall Study|Withdrawal by Subject|3|||
170693485|NCT02622828|616890700|FG000|Overall Study|participant withdrew|3|||
170693486|NCT00666757|616890704|FG000|Overall Study|Lost to Follow-up|39|||
170693487|NCT00666757|616890705|FG001|Overall Study|Lost to Follow-up|35|||
170693488|NCT00666757|616890704|FG000|Overall Study|Protocol Violation|23|||
170693489|NCT00666757|616890705|FG001|Overall Study|Protocol Violation|24|||
170693490|NCT00666757|616890704|FG000|Overall Study|Adverse Event|22|||
170693491|NCT00666757|616890705|FG001|Overall Study|Adverse Event|12|||
170693492|NCT00666757|616890704|FG000|Overall Study|Withdrawal by Subject|13|||
170693493|NCT00666757|616890705|FG001|Overall Study|Withdrawal by Subject|17|||
170693494|NCT00666757|616890704|FG000|Overall Study|Lack of Efficacy|3|||
170693495|NCT00666757|616890705|FG001|Overall Study|Lack of Efficacy|6|||
170693496|NCT00666757|616890704|FG000|Overall Study|Physician Decision|0|||
170693497|NCT00666757|616890705|FG001|Overall Study|Physician Decision|2|||
170693498|NCT00666757|616890704|FG000|Overall Study|Sponsor decision|0|||
170693499|NCT00666757|616890705|FG001|Overall Study|Sponsor decision|1|||
170693500|NCT01231581|616890706|FG000|Overall Study|Lost to Follow-up|2|||
170693501|NCT01231581|616890707|FG001|Overall Study|Lost to Follow-up|2|||
170693502|NCT01231581|616890706|FG000|Overall Study|Withdrawal by Subject|6|||
170693503|NCT01231581|616890707|FG001|Overall Study|Withdrawal by Subject|9|||
170693504|NCT01231581|616890706|FG000|Overall Study|Study Closed/Terminated|6|||
170693505|NCT01231581|616890707|FG001|Overall Study|Study Closed/Terminated|5|||
170693506|NCT01231581|616890706|FG000|Overall Study|Death|65|||
170823109|NCT00396097|617360443|FG000|Overall Study|Protocol Violation|0|||
170823110|NCT00396097|617360444|FG001|Overall Study|Protocol Violation|6|||
170823111|NCT00396097|617360443|FG000|Overall Study|Adverse Event|1|||
170823112|NCT00396097|617360444|FG001|Overall Study|Adverse Event|5|||
170693507|NCT01231581|616890707|FG001|Overall Study|Death|64|||
170693508|NCT01231581|616890706|FG000|Overall Study|Ongoing|1|||
170693509|NCT01231581|616890707|FG001|Overall Study|Ongoing|0|||
170693510|NCT05954052|616890708|FG000|Overall Study|Adverse Event|1|||
170693511|NCT01723163|616890711|FG000|Treatment Phase|Withdrawal by Subject|14|||
170693512|NCT01723163|616890712|FG001|Treatment Phase|Withdrawal by Subject|6|||
170823113|NCT00396097|617360443|FG000|Overall Study|Insufficient Clinical Response|1|||
170823114|NCT00396097|617360444|FG001|Overall Study|Insufficient Clinical Response|4|||
170693513|NCT01723163|616890711|FG000|Treatment Phase|Withdrawal by PI|5|||
170823115|NCT00523549|617360445|FG000|Overall Study|Adverse Event|6|||
170823116|NCT00523549|617360446|FG001|Overall Study|Adverse Event|3|||
170823117|NCT00523549|617360445|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170823118|NCT00523549|617360446|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170823119|NCT00523549|617360445|FG000|Overall Study|Protocol Deviation|3|||
170693514|NCT01723163|616890712|FG001|Treatment Phase|Withdrawal by PI|1|||
170693515|NCT01723163|616890711|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
170693516|NCT01723163|616890712|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
170693517|NCT01723163|616890711|FG000|3-Month Follow-up|Unable to Contact|12|||
170693518|NCT01723163|616890712|FG001|3-Month Follow-up|Unable to Contact|19|||
170693519|NCT01723163|616890711|FG000|6-Month Follow-up|Death|1|||
170693520|NCT01723163|616890712|FG001|6-Month Follow-up|Death|0|||
170693521|NCT01723163|616890711|FG000|6-Month Follow-up|Unable to Contact|17|||
170693522|NCT01723163|616890712|FG001|6-Month Follow-up|Unable to Contact|15|||
170693523|NCT01723163|616890711|FG000|12-Month Follow-up|Death|1|||
170693524|NCT01723163|616890712|FG001|12-Month Follow-up|Death|0|||
170693525|NCT01723163|616890711|FG000|12-Month Follow-up|Unable to Contact|23|||
170693526|NCT01723163|616890712|FG001|12-Month Follow-up|Unable to Contact|28|||
170693527|NCT02510794|616890713|FG000|Overall Study|Adverse Event|0|||
170693528|NCT02510794|616890714|FG001|Overall Study|Adverse Event|1|||
170693529|NCT02510794|616890715|FG002|Overall Study|Adverse Event|0|||
170693530|NCT02510794|616890716|FG003|Overall Study|Adverse Event|0|||
170693531|NCT02510794|616890713|FG000|Overall Study|Death|1|||
170693532|NCT02510794|616890714|FG001|Overall Study|Death|2|||
170693533|NCT02510794|616890715|FG002|Overall Study|Death|1|||
170693534|NCT02510794|616890716|FG003|Overall Study|Death|1|||
170693535|NCT02510794|616890713|FG000|Overall Study|Lack of Efficacy|3|||
170693536|NCT02510794|616890714|FG001|Overall Study|Lack of Efficacy|1|||
170693537|NCT02510794|616890715|FG002|Overall Study|Lack of Efficacy|1|||
170693538|NCT02510794|616890716|FG003|Overall Study|Lack of Efficacy|0|||
170693539|NCT02510794|616890713|FG000|Overall Study|Participant moved out of the area|0|||
170693540|NCT02510794|616890714|FG001|Overall Study|Participant moved out of the area|0|||
170693541|NCT02510794|616890715|FG002|Overall Study|Participant moved out of the area|0|||
170693542|NCT02510794|616890716|FG003|Overall Study|Participant moved out of the area|1|||
170693543|NCT02510794|616890713|FG000|Overall Study|Physician Decision|3|||
170693544|NCT02510794|616890714|FG001|Overall Study|Physician Decision|0|||
170693545|NCT02510794|616890715|FG002|Overall Study|Physician Decision|0|||
170693546|NCT02510794|616890716|FG003|Overall Study|Physician Decision|0|||
170693547|NCT02510794|616890713|FG000|Overall Study|Protocol Violation|0|||
170693548|NCT02510794|616890714|FG001|Overall Study|Protocol Violation|0|||
170693549|NCT02510794|616890715|FG002|Overall Study|Protocol Violation|1|||
170693550|NCT02510794|616890716|FG003|Overall Study|Protocol Violation|0|||
170693551|NCT02510794|616890713|FG000|Overall Study|Withdrawal by Subject|1|||
170693552|NCT02510794|616890714|FG001|Overall Study|Withdrawal by Subject|2|||
170693553|NCT02510794|616890715|FG002|Overall Study|Withdrawal by Subject|4|||
170693554|NCT02510794|616890716|FG003|Overall Study|Withdrawal by Subject|3|||
170693555|NCT01649375|616890717|FG000|Up to Week 16|Adverse Event|2|||
170693556|NCT01649375|616890718|FG001|Up to Week 16|Adverse Event|5|||
170693557|NCT01649375|616890719|FG002|Up to Week 16|Adverse Event|4|||
170693558|NCT01649375|616890720|FG003|Up to Week 16|Adverse Event|0|||
170693559|NCT01649375|616890721|FG004|Up to Week 16|Adverse Event|0|||
170693560|NCT01649375|616890717|FG000|Up to Week 16|Lack of Efficacy|0|||
170693561|NCT01649375|616890718|FG001|Up to Week 16|Lack of Efficacy|0|||
170693562|NCT01649375|616890719|FG002|Up to Week 16|Lack of Efficacy|1|||
170693563|NCT01649375|616890720|FG003|Up to Week 16|Lack of Efficacy|0|||
170693564|NCT01649375|616890721|FG004|Up to Week 16|Lack of Efficacy|0|||
170693565|NCT01649375|616890717|FG000|Up to Week 16|Physician Decision|0|||
170693566|NCT01649375|616890718|FG001|Up to Week 16|Physician Decision|0|||
170693567|NCT01649375|616890719|FG002|Up to Week 16|Physician Decision|1|||
170693568|NCT01649375|616890720|FG003|Up to Week 16|Physician Decision|0|||
170693569|NCT01649375|616890721|FG004|Up to Week 16|Physician Decision|0|||
170693570|NCT01649375|616890717|FG000|Up to Week 16|Withdrawal by Subject|2|||
170693571|NCT01649375|616890718|FG001|Up to Week 16|Withdrawal by Subject|1|||
170693572|NCT01649375|616890719|FG002|Up to Week 16|Withdrawal by Subject|2|||
170693573|NCT01649375|616890720|FG003|Up to Week 16|Withdrawal by Subject|0|||
170693574|NCT01649375|616890721|FG004|Up to Week 16|Withdrawal by Subject|0|||
170693575|NCT01649375|616890717|FG000|Up to Week 16|Death|1|||
170693576|NCT01649375|616890718|FG001|Up to Week 16|Death|0|||
170823120|NCT00523549|617360446|FG001|Overall Study|Protocol Deviation|1|||
170693577|NCT01649375|616890719|FG002|Up to Week 16|Death|0|||
170693578|NCT01649375|616890720|FG003|Up to Week 16|Death|0|||
170693579|NCT01649375|616890721|FG004|Up to Week 16|Death|0|||
170693580|NCT01649375|616890717|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
170693581|NCT01649375|616890718|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
170693582|NCT01649375|616890719|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
170693583|NCT01649375|616890720|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
170693584|NCT01649375|616890721|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
170693585|NCT01649375|616890717|FG000|Week 16 up to Week 260|Non-compliance|0|||
170693586|NCT01649375|616890718|FG001|Week 16 up to Week 260|Non-compliance|1|||
170823121|NCT00523549|617360445|FG000|Overall Study|Patient withdrew consent|7|||
170693587|NCT01649375|616890719|FG002|Week 16 up to Week 260|Non-compliance|0|||
170693588|NCT01649375|616890720|FG003|Week 16 up to Week 260|Non-compliance|1|||
170693589|NCT01649375|616890721|FG004|Week 16 up to Week 260|Non-compliance|0|||
170823122|NCT00523549|617360446|FG001|Overall Study|Patient withdrew consent|6|||
170823123|NCT00523549|617360445|FG000|Overall Study|Lost to Follow-up|3|||
170823124|NCT00523549|617360446|FG001|Overall Study|Lost to Follow-up|5|||
170823125|NCT00439647|617360447|FG000|Overall Study|Withdrawal by Subject|25|||
170823126|NCT00439647|617360448|FG001|Overall Study|Withdrawal by Subject|22|||
170823127|NCT00439647|617360447|FG000|Overall Study|Death|15|||
170823128|NCT00439647|617360448|FG001|Overall Study|Death|18|||
170823129|NCT00439647|617360447|FG000|Overall Study|Adverse Event|11|||
170823130|NCT00439647|617360448|FG001|Overall Study|Adverse Event|11|||
170823131|NCT00439647|617360447|FG000|Overall Study|Lost to Follow-up|4|||
170823132|NCT00439647|617360448|FG001|Overall Study|Lost to Follow-up|12|||
170823133|NCT00439647|617360447|FG000|Overall Study|Protocol Violation|3|||
170823134|NCT00439647|617360448|FG001|Overall Study|Protocol Violation|4|||
170823135|NCT00439647|617360447|FG000|Overall Study|Lack of Efficacy|0|||
170823136|NCT00439647|617360448|FG001|Overall Study|Lack of Efficacy|4|||
170823137|NCT02005029|617360449|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
170823138|NCT02005029|617360450|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
170823139|NCT01525641|617360451|FG000|Overall Study|Case report form not collected|25|||
170823140|NCT01525641|617360451|FG000|Overall Study|No visit since the first visit|16|||
170823141|NCT01525641|617360451|FG000|Overall Study|Adverse Event|73|||
170823142|NCT01525641|617360451|FG000|Overall Study|Lack of Efficacy|24|||
170823143|NCT01525641|617360451|FG000|Overall Study|Improvement|5|||
170823144|NCT01525641|617360451|FG000|Overall Study|Lost to follow-up (relocation)|1|||
170823145|NCT01525641|617360451|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
170823146|NCT01525641|617360451|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
170823147|NCT01525641|617360451|FG000|Overall Study|Other than stated above|7|||
170823148|NCT02204319|617360452|FG000|Overall Study|Pregnancy|1|||
170823149|NCT02204319|617360452|FG000|Overall Study|Withdrawal by Subject|2|||
170823150|NCT02381652|617360465|FG000|Overall Study|Withdrawal by Subject|0|||
170693590|NCT01649375|616890717|FG000|Week 16 up to Week 260|Physician Decision|0|||
170693591|NCT01649375|616890718|FG001|Week 16 up to Week 260|Physician Decision|2|||
170693592|NCT01649375|616890719|FG002|Week 16 up to Week 260|Physician Decision|0|||
170693593|NCT01649375|616890720|FG003|Week 16 up to Week 260|Physician Decision|0|||
170693594|NCT01649375|616890721|FG004|Week 16 up to Week 260|Physician Decision|0|||
170693595|NCT01649375|616890717|FG000|Week 16 up to Week 260|Technical issues|0|||
170693596|NCT01649375|616890718|FG001|Week 16 up to Week 260|Technical issues|1|||
170693597|NCT01649375|616890719|FG002|Week 16 up to Week 260|Technical issues|0|||
170693598|NCT01649375|616890720|FG003|Week 16 up to Week 260|Technical issues|1|||
170693599|NCT01649375|616890721|FG004|Week 16 up to Week 260|Technical issues|0|||
170693600|NCT01649375|616890717|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
170693601|NCT01649375|616890718|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
170693602|NCT01649375|616890719|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
170693603|NCT01649375|616890720|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
170693604|NCT01649375|616890721|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
170693605|NCT01649375|616890717|FG000|Week 16 up to Week 260|Death|1|||
170693606|NCT01649375|616890718|FG001|Week 16 up to Week 260|Death|1|||
170693607|NCT01649375|616890719|FG002|Week 16 up to Week 260|Death|0|||
170693608|NCT01649375|616890720|FG003|Week 16 up to Week 260|Death|0|||
170693609|NCT01649375|616890721|FG004|Week 16 up to Week 260|Death|0|||
170693610|NCT01649375|616890717|FG000|Week 16 up to Week 260|Adverse Event|5|||
170693611|NCT01649375|616890718|FG001|Week 16 up to Week 260|Adverse Event|2|||
170693612|NCT01649375|616890719|FG002|Week 16 up to Week 260|Adverse Event|0|||
170693613|NCT01649375|616890720|FG003|Week 16 up to Week 260|Adverse Event|3|||
170693614|NCT01649375|616890721|FG004|Week 16 up to Week 260|Adverse Event|2|||
170693615|NCT01124604|616890724|FG000|Overall Study|Adverse Event|10|||
170693616|NCT01124604|616890725|FG001|Overall Study|Adverse Event|1|||
170693617|NCT01124604|616890724|FG000|Overall Study|Lack of Efficacy|1|||
170693618|NCT01124604|616890725|FG001|Overall Study|Lack of Efficacy|0|||
170693619|NCT01124604|616890724|FG000|Overall Study|Withdrawal by Subject|4|||
170693620|NCT01124604|616890725|FG001|Overall Study|Withdrawal by Subject|0|||
170693621|NCT01124604|616890724|FG000|Overall Study|Disease Progression|0|||
170693622|NCT01124604|616890725|FG001|Overall Study|Disease Progression|1|||
170693623|NCT01856790|616890726|FG000|Closed Loop Control|Withdrawal by Subject|2|||
170693624|NCT01856790|616890726|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
170693625|NCT01859507|616890727|FG000|Overall Study|left the country|4|||
170693626|NCT04091646|616890728|FG000|Overall Study|Adverse Event|2|||
170693627|NCT04091646|616890729|FG001|Overall Study|Adverse Event|1|||
170693628|NCT04091646|616890728|FG000|Overall Study|Lost to Follow-up|6|||
170693629|NCT04091646|616890729|FG001|Overall Study|Lost to Follow-up|2|||
170693630|NCT04091646|616890728|FG000|Overall Study|Protocol Violation|0|||
170693631|NCT04091646|616890729|FG001|Overall Study|Protocol Violation|1|||
170693632|NCT04091646|616890728|FG000|Overall Study|Withdrawal by Subject|4|||
170693633|NCT04091646|616890729|FG001|Overall Study|Withdrawal by Subject|1|||
170693634|NCT04091646|616890728|FG000|Overall Study|Participant Incarcerated|1|||
170823151|NCT02381652|617360466|FG001|Overall Study|Withdrawal by Subject|0|||
170823152|NCT02381652|617360467|FG002|Overall Study|Withdrawal by Subject|1|||
170693635|NCT04091646|616890729|FG001|Overall Study|Participant Incarcerated|0|||
170693636|NCT01921829|616890730|FG000|Overall Study|Withdrawal by Subject|0|||
170693637|NCT01921829|616890731|FG001|Overall Study|Withdrawal by Subject|1|||
170693638|NCT02474199|616890735|FG000|Overall Study|Lost to Follow-up|1|||
170693639|NCT02474199|616890736|FG001|Overall Study|Lost to Follow-up|0|||
170693640|NCT02474199|616890737|FG002|Overall Study|Lost to Follow-up|0|||
170693641|NCT02474199|616890738|FG003|Overall Study|Lost to Follow-up|0|||
170693642|NCT02474199|616890735|FG000|Overall Study|Withdrawal by Subject|1|||
170693643|NCT02474199|616890736|FG001|Overall Study|Withdrawal by Subject|2|||
170693644|NCT02474199|616890737|FG002|Overall Study|Withdrawal by Subject|0|||
170693645|NCT02474199|616890738|FG003|Overall Study|Withdrawal by Subject|1|||
170693646|NCT02474199|616890735|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
170693647|NCT02474199|616890736|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
170693648|NCT02474199|616890737|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
170693649|NCT02474199|616890738|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
170693650|NCT02474199|616890735|FG000|Overall Study|Did not meet eligibility criteria|0|||
170693651|NCT02474199|616890736|FG001|Overall Study|Did not meet eligibility criteria|0|||
170693652|NCT02474199|616890737|FG002|Overall Study|Did not meet eligibility criteria|2|||
170693653|NCT02474199|616890738|FG003|Overall Study|Did not meet eligibility criteria|2|||
170693654|NCT03090100|616890739|FG000|Overall Study|Adverse Event|9|||
170693655|NCT03090100|616890740|FG001|Overall Study|Adverse Event|11|||
170693656|NCT03090100|616890739|FG000|Overall Study|Pregnancy|1|||
170693657|NCT03090100|616890740|FG001|Overall Study|Pregnancy|1|||
170693658|NCT03090100|616890739|FG000|Overall Study|Lack of Efficacy|2|||
170693659|NCT03090100|616890740|FG001|Overall Study|Lack of Efficacy|7|||
170693660|NCT03090100|616890739|FG000|Overall Study|Lost to Follow-up|2|||
170693661|NCT03090100|616890740|FG001|Overall Study|Lost to Follow-up|2|||
170693662|NCT03090100|616890739|FG000|Overall Study|Withdrawal by Subject|7|||
170693663|NCT03090100|616890740|FG001|Overall Study|Withdrawal by Subject|19|||
170693664|NCT03090100|616890739|FG000|Overall Study|Protocol Violation|2|||
170693665|NCT03090100|616890740|FG001|Overall Study|Protocol Violation|6|||
170693666|NCT03090100|616890739|FG000|Overall Study|Non-compliance|2|||
170693667|NCT03090100|616890740|FG001|Overall Study|Non-compliance|0|||
170693668|NCT03090100|616890739|FG000|Overall Study|Other|2|||
170693669|NCT03090100|616890740|FG001|Overall Study|Other|2|||
170693670|NCT00952341|616890741|FG000|Cycle 1|Adverse Event|4|||
170693671|NCT00952341|616890742|FG001|Cycle 1|Adverse Event|1|||
170693672|NCT00952341|616890741|FG000|Cycle 1|Withdrawal by Subject|3|||
170693673|NCT00952341|616890742|FG001|Cycle 1|Withdrawal by Subject|8|||
170693674|NCT00952341|616890741|FG000|Cycle 1|Protocol Violation|2|||
170693675|NCT00952341|616890742|FG001|Cycle 1|Protocol Violation|1|||
170693676|NCT00952341|616890741|FG000|Cycle 1|Lost to Follow-up|11|||
170693677|NCT00952341|616890742|FG001|Cycle 1|Lost to Follow-up|2|||
170693678|NCT00952341|616890741|FG000|Cycle 1|Physician Decision|0|||
170693679|NCT00952341|616890742|FG001|Cycle 1|Physician Decision|1|||
170693680|NCT00952341|616890741|FG000|Cycle 2|Withdrawal by Subject|1|||
170693681|NCT00952341|616890742|FG001|Cycle 2|Withdrawal by Subject|1|||
170693682|NCT00952341|616890741|FG000|Cycle 2|Protocol Violation|1|||
170693683|NCT00952341|616890742|FG001|Cycle 2|Protocol Violation|0|||
170693684|NCT00952341|616890741|FG000|Cycle 2|Lost to Follow-up|6|||
170693685|NCT00952341|616890742|FG001|Cycle 2|Lost to Follow-up|9|||
170693686|NCT00952341|616890741|FG000|Cycle 2|Physician Decision|1|||
170693687|NCT00952341|616890742|FG001|Cycle 2|Physician Decision|1|||
170693688|NCT00952341|616890741|FG000|Cycle 2|Progressive Disease|0|||
170693689|NCT00952341|616890742|FG001|Cycle 2|Progressive Disease|1|||
170693690|NCT01652664|616890743|FG000|Overall Study|Treatment Failure|5|||
170693691|NCT01652664|616890744|FG001|Overall Study|Treatment Failure|1|||
170693692|NCT01652664|616890743|FG000|Overall Study|Inadequate IOP control|1|||
170693693|NCT01652664|616890744|FG001|Overall Study|Inadequate IOP control|0|||
170693694|NCT00491387|616890748|FG000|Overall Study|study terminated|20|||
170693695|NCT02063854|616890756|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
170693696|NCT02063854|616890757|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
170693697|NCT02063854|616890758|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
170693698|NCT02063854|616890759|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
170693699|NCT02063854|616890760|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
170693700|NCT02063854|616890761|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
170693701|NCT02063854|616890762|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
170693702|NCT02063854|616890756|FG000|Overall Study|Major Protocol Deviation|0|||
170693703|NCT02063854|616890757|FG001|Overall Study|Major Protocol Deviation|0|||
170823153|NCT03187353|617360469|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
170693704|NCT02063854|616890758|FG002|Overall Study|Major Protocol Deviation|3|||
170693705|NCT02063854|616890759|FG003|Overall Study|Major Protocol Deviation|0|||
170693706|NCT02063854|616890760|FG004|Overall Study|Major Protocol Deviation|0|||
170693707|NCT02063854|616890761|FG005|Overall Study|Major Protocol Deviation|0|||
170693708|NCT02063854|616890762|FG006|Overall Study|Major Protocol Deviation|0|||
170693709|NCT02063854|616890756|FG000|Overall Study|Voluntary Withdrawal|2|||
170693710|NCT02063854|616890757|FG001|Overall Study|Voluntary Withdrawal|0|||
170693711|NCT02063854|616890758|FG002|Overall Study|Voluntary Withdrawal|8|||
170693712|NCT02063854|616890759|FG003|Overall Study|Voluntary Withdrawal|1|||
170693713|NCT02063854|616890760|FG004|Overall Study|Voluntary Withdrawal|3|||
170693714|NCT02063854|616890761|FG005|Overall Study|Voluntary Withdrawal|6|||
170693715|NCT02063854|616890762|FG006|Overall Study|Voluntary Withdrawal|1|||
170693716|NCT02063854|616890756|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
170693717|NCT02063854|616890757|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
170693718|NCT02063854|616890758|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
170693719|NCT02063854|616890759|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
170693720|NCT02063854|616890760|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
170693721|NCT02063854|616890761|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
170693722|NCT02063854|616890762|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
170693723|NCT02063854|616890756|FG000|Overall Study|Reason Not Specified|1|||
170693724|NCT02063854|616890757|FG001|Overall Study|Reason Not Specified|0|||
170693725|NCT02063854|616890758|FG002|Overall Study|Reason Not Specified|0|||
170693726|NCT02063854|616890759|FG003|Overall Study|Reason Not Specified|0|||
170693727|NCT02063854|616890760|FG004|Overall Study|Reason Not Specified|0|||
170693728|NCT02063854|616890761|FG005|Overall Study|Reason Not Specified|0|||
170693729|NCT02063854|616890762|FG006|Overall Study|Reason Not Specified|0|||
170693730|NCT02063854|616890756|FG000|Overall Study|Did Not Receive Study Drug|0|||
170693731|NCT02063854|616890757|FG001|Overall Study|Did Not Receive Study Drug|0|||
170693732|NCT02063854|616890758|FG002|Overall Study|Did Not Receive Study Drug|0|||
170693733|NCT02063854|616890759|FG003|Overall Study|Did Not Receive Study Drug|0|||
170693734|NCT02063854|616890760|FG004|Overall Study|Did Not Receive Study Drug|0|||
170693735|NCT02063854|616890761|FG005|Overall Study|Did Not Receive Study Drug|1|||
170693736|NCT02063854|616890762|FG006|Overall Study|Did Not Receive Study Drug|0|||
170693737|NCT03538158|616890763|FG000|Overall Study|Lost to Follow-up|13|||
170693738|NCT03538158|616890764|FG001|Overall Study|Lost to Follow-up|7|||
170693739|NCT03538158|616890763|FG000|Overall Study|Withdrawal by Subject|2|||
170693740|NCT03538158|616890764|FG001|Overall Study|Withdrawal by Subject|1|||
170693741|NCT00483379|616890774|FG000|Treatment Period|Adverse Event|1|||
170693742|NCT00483379|616890775|FG001|Treatment Period|Adverse Event|0|||
170693743|NCT00483379|616890774|FG000|Treatment Period|Withdrawal by Subject|1|||
170693744|NCT00483379|616890775|FG001|Treatment Period|Withdrawal by Subject|0|||
170693745|NCT02337907|616890776|FG000|Overall Study|Other than listed|1|||
170693746|NCT02337907|616890777|FG001|Overall Study|Other than listed|0|||
170693747|NCT02337907|616890778|FG002|Overall Study|Other than listed|0|||
170693748|NCT02337907|616890779|FG003|Overall Study|Other than listed|1|||
170693749|NCT02337907|616890780|FG004|Overall Study|Other than listed|1|||
170693750|NCT02337907|616890781|FG005|Overall Study|Other than listed|0|||
170693751|NCT02337907|616890776|FG000|Overall Study|Withdrawal by Subject|2|||
170693752|NCT02337907|616890777|FG001|Overall Study|Withdrawal by Subject|3|||
170693753|NCT02337907|616890778|FG002|Overall Study|Withdrawal by Subject|0|||
170693754|NCT02337907|616890779|FG003|Overall Study|Withdrawal by Subject|2|||
170693755|NCT02337907|616890780|FG004|Overall Study|Withdrawal by Subject|5|||
170693756|NCT02337907|616890781|FG005|Overall Study|Withdrawal by Subject|0|||
170693757|NCT02337907|616890776|FG000|Overall Study|Lost to Follow-up|0|||
170693758|NCT02337907|616890777|FG001|Overall Study|Lost to Follow-up|0|||
170693759|NCT02337907|616890778|FG002|Overall Study|Lost to Follow-up|0|||
170693760|NCT02337907|616890779|FG003|Overall Study|Lost to Follow-up|0|||
170693761|NCT02337907|616890780|FG004|Overall Study|Lost to Follow-up|0|||
170693762|NCT02337907|616890781|FG005|Overall Study|Lost to Follow-up|1|||
170693763|NCT02337907|616890776|FG000|Overall Study|Adverse Event|1|||
170693764|NCT02337907|616890777|FG001|Overall Study|Adverse Event|1|||
170693765|NCT02337907|616890778|FG002|Overall Study|Adverse Event|1|||
170693766|NCT02337907|616890779|FG003|Overall Study|Adverse Event|1|||
170693767|NCT02337907|616890780|FG004|Overall Study|Adverse Event|4|||
170693768|NCT02337907|616890781|FG005|Overall Study|Adverse Event|0|||
170693769|NCT02410954|616890786|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
170693770|NCT02410954|616890787|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
170693771|NCT02410954|616890786|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
170693772|NCT02410954|616890787|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
170693773|NCT02488681|616890789|FG000|Overall Study|Implant unsuccessful|7|||
170693774|NCT00423150|616890793|FG000|Overall Study|Adverse Event|11|||
170693775|NCT00423150|616890793|FG000|Overall Study|Progression of disease being studied|69|||
170693776|NCT00423150|616890793|FG000|Overall Study|Withdrawal by Subject|1|||
170693777|NCT00423150|616890793|FG000|Overall Study|Non-compliance with protocol|1|||
170693778|NCT00423150|616890793|FG000|Overall Study|Administrative|4|||
170693779|NCT00003641|616890794|FG000|Overall Study|Withdrawal by Subject|0|||
170693780|NCT00003641|616890795|FG001|Overall Study|Withdrawal by Subject|100|||
170693781|NCT00003641|616890794|FG000|Overall Study|Adverse Event|0|||
170693782|NCT00003641|616890795|FG001|Overall Study|Adverse Event|38|||
170693783|NCT00003641|616890794|FG000|Overall Study|Disease progression|0|||
170693784|NCT00003641|616890795|FG001|Overall Study|Disease progression|2|||
170693785|NCT00003641|616890794|FG000|Overall Study|Unknown/missing|0|||
170693786|NCT00003641|616890795|FG001|Overall Study|Unknown/missing|22|||
170693787|NCT00003641|616890794|FG000|Overall Study|Should not receive interferon therapy|2|||
170693788|NCT00003641|616890795|FG001|Overall Study|Should not receive interferon therapy|0|||
170693789|NCT00003641|616890794|FG000|Overall Study|Never started interferon|567|||
170693790|NCT00003641|616890795|FG001|Overall Study|Never started interferon|12|||
170693791|NCT01412021|616890796|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
170693792|NCT01412021|616890796|FG000|Overall Study|Treatment Prior to Approval|3|||
170693793|NCT01412021|616890796|FG000|Overall Study|Transferred to Other Hospital|9|||
170693794|NCT04248933|616890797|FG000|Overall Study|Lost to Follow-up|9|||
170693795|NCT04248933|616890797|FG000|Overall Study|Withdrawal by Subject|2|||
170693796|NCT05778786|616890800|FG000|Period 1|COVID-19 Related|3|||
170693797|NCT05778786|616890801|FG001|Period 1|COVID-19 Related|3|||
170693798|NCT05778786|616890800|FG000|Period 1|Withdrew Consent during Study|1|||
170693799|NCT05778786|616890801|FG001|Period 1|Withdrew Consent during Study|0|||
170693800|NCT05778786|616890800|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
170693801|NCT05778786|616890801|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
170693802|NCT05778786|616890800|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
170693803|NCT05778786|616890801|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
170693804|NCT02075658|616890802|FG000|Overall Study|Physician Decision|2|||
170693805|NCT02075658|616890803|FG001|Overall Study|Physician Decision|2|||
170693806|NCT02406651|616890805|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
170693807|NCT00718328|616890807|FG000|Overall Study|Lost to Follow-up|1|||
170693808|NCT00718328|616890808|FG001|Overall Study|Lost to Follow-up|0|||
170693809|NCT00663052|616890809|FG000|Overall Study|Adverse Event|6|||
170693810|NCT00663052|616890810|FG001|Overall Study|Adverse Event|3|||
170693811|NCT00663052|616890809|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
170693812|NCT00663052|616890810|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
170693813|NCT00663052|616890809|FG000|Overall Study|Protocol Violation|1|||
170693814|NCT00663052|616890810|FG001|Overall Study|Protocol Violation|0|||
170693815|NCT00663052|616890809|FG000|Overall Study|Withdrawal by Subject|2|||
170693816|NCT00663052|616890810|FG001|Overall Study|Withdrawal by Subject|5|||
170693817|NCT00663052|616890809|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
170693818|NCT00663052|616890810|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
170693819|NCT00663052|616890809|FG000|Overall Study|Other|0|||
170693820|NCT00663052|616890810|FG001|Overall Study|Other|1|||
170693821|NCT04383743|616890811|FG000|Overall Study|Withdrawal by Subject|1|||
170693822|NCT04383743|616890811|FG000|Overall Study|Adverse Event|1|||
170693823|NCT01721330|616890812|FG000|Overall Study|Withdrawal by Subject|0|||
170693824|NCT01721330|616890813|FG001|Overall Study|Withdrawal by Subject|1|||
170693825|NCT00296374|616890814|FG000|Overall Study|Adverse Event|14|||
170693826|NCT00296374|616890815|FG001|Overall Study|Adverse Event|10|||
170693827|NCT00296374|616890816|FG002|Overall Study|Adverse Event|7|||
170693828|NCT00296374|616890814|FG000|Overall Study|Withdrawal by Subject|3|||
170693829|NCT00296374|616890815|FG001|Overall Study|Withdrawal by Subject|5|||
170693830|NCT00296374|616890816|FG002|Overall Study|Withdrawal by Subject|11|||
170693831|NCT00296374|616890814|FG000|Overall Study|Incorrect enrollment|3|||
170693832|NCT00296374|616890815|FG001|Overall Study|Incorrect enrollment|3|||
170693833|NCT00296374|616890816|FG002|Overall Study|Incorrect enrollment|4|||
170693834|NCT00296374|616890814|FG000|Overall Study|Protocol Violation|1|||
170693835|NCT00296374|616890815|FG001|Overall Study|Protocol Violation|2|||
170693836|NCT00296374|616890816|FG002|Overall Study|Protocol Violation|3|||
170693837|NCT00296374|616890814|FG000|Overall Study|Lost to Follow-up|3|||
170693838|NCT00296374|616890815|FG001|Overall Study|Lost to Follow-up|1|||
170693839|NCT00296374|616890816|FG002|Overall Study|Lost to Follow-up|1|||
170693840|NCT00296374|616890814|FG000|Overall Study|Relocated to another state|1|||
170693841|NCT00296374|616890815|FG001|Overall Study|Relocated to another state|0|||
170693842|NCT00296374|616890816|FG002|Overall Study|Relocated to another state|0|||
170693843|NCT00296374|616890814|FG000|Overall Study|Stopped drug before end of study visit|0|||
170693844|NCT00296374|616890815|FG001|Overall Study|Stopped drug before end of study visit|1|||
170693845|NCT00296374|616890816|FG002|Overall Study|Stopped drug before end of study visit|0|||
170693846|NCT00296374|616890814|FG000|Overall Study|Nephrologist introduced ACE|0|||
170693847|NCT00296374|616890815|FG001|Overall Study|Nephrologist introduced ACE|1|||
170693848|NCT00296374|616890816|FG002|Overall Study|Nephrologist introduced ACE|0|||
170693849|NCT00296374|616890814|FG000|Overall Study|Pregnancy|0|||
170693850|NCT00296374|616890815|FG001|Overall Study|Pregnancy|0|||
170693851|NCT00296374|616890816|FG002|Overall Study|Pregnancy|2|||
170693852|NCT00296374|616890814|FG000|Overall Study|Other|0|||
170693853|NCT00296374|616890815|FG001|Overall Study|Other|0|||
170693854|NCT00296374|616890816|FG002|Overall Study|Other|1|||
170693855|NCT01816893|616890817|FG000|Washout Period|Withdrawal by Subject|2|||
170693856|NCT01816893|616890818|FG001|Washout Period|Withdrawal by Subject|0|||
170823154|NCT03187353|617360470|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
170823155|NCT03187353|617360469|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
170823156|NCT03187353|617360470|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
170823157|NCT03187353|617360469|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
170693857|NCT01365507|616892878|FG000|Overall Study|Withdrawal Criteria|8|||
170693858|NCT01365507|616892879|FG001|Overall Study|Withdrawal Criteria|5|||
170693859|NCT01365507|616892878|FG000|Overall Study|Unclassified|1|||
170693860|NCT01365507|616892879|FG001|Overall Study|Unclassified|4|||
170693861|NCT03989440|616892880|FG000|Overall Study|COVID-19 travel restrictions|0|||
170693862|NCT03989440|616892881|FG001|Overall Study|COVID-19 travel restrictions|0|||
170693863|NCT03989440|616892882|FG002|Overall Study|COVID-19 travel restrictions|1|||
170693864|NCT03989440|616892883|FG003|Overall Study|COVID-19 travel restrictions|0|||
170693865|NCT03989440|616892884|FG004|Overall Study|COVID-19 travel restrictions|0|||
170693866|NCT03989440|616892885|FG005|Overall Study|COVID-19 travel restrictions|0|||
170693867|NCT03989440|616892880|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
170693868|NCT03989440|616892881|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
170693869|NCT03989440|616892882|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
170693870|NCT03989440|616892883|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
170693871|NCT03989440|616892884|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
170693872|NCT03989440|616892885|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
170693873|NCT01614990|616892886|FG000|Overall Study|Protocol Violation|1|||
170693874|NCT01614990|616892887|FG001|Overall Study|Protocol Violation|1|||
170693875|NCT04608500|616892888|FG000|Overall Study|Adverse Event|2|||
170693876|NCT04608500|616892889|FG001|Overall Study|Adverse Event|0|||
170693877|NCT04608500|616892888|FG000|Overall Study|Lost to Follow-up|15|||
170693878|NCT04608500|616892889|FG001|Overall Study|Lost to Follow-up|9|||
170693879|NCT04608500|616892888|FG000|Overall Study|Participant request|11|||
170693880|NCT04608500|616892889|FG001|Overall Study|Participant request|7|||
170693881|NCT04608500|616892888|FG000|Overall Study|Protocol Violation|1|||
170693882|NCT04608500|616892889|FG001|Overall Study|Protocol Violation|0|||
170693883|NCT04608500|616892888|FG000|Overall Study|Other|6|||
170693884|NCT04608500|616892889|FG001|Overall Study|Other|2|||
170693885|NCT02515942|616892897|FG000|Overall Study|Adverse Event|5|||
170693886|NCT02515942|616892898|FG001|Overall Study|Adverse Event|0|||
170693887|NCT02515942|616892899|FG002|Overall Study|Adverse Event|0|||
170693888|NCT02515942|616892897|FG000|Overall Study|Death|0|||
170693889|NCT02515942|616892898|FG001|Overall Study|Death|0|||
170693890|NCT02515942|616892899|FG002|Overall Study|Death|1|||
170693891|NCT02515942|616892897|FG000|Overall Study|Lack of Efficacy|0|||
170693892|NCT02515942|616892898|FG001|Overall Study|Lack of Efficacy|0|||
170693893|NCT02515942|616892899|FG002|Overall Study|Lack of Efficacy|1|||
170693894|NCT02515942|616892897|FG000|Overall Study|Lost to Follow-up|2|||
170693895|NCT02515942|616892898|FG001|Overall Study|Lost to Follow-up|0|||
170693896|NCT02515942|616892899|FG002|Overall Study|Lost to Follow-up|0|||
170693897|NCT02515942|616892897|FG000|Overall Study|Withdrawal by Subject|0|||
170693898|NCT02515942|616892898|FG001|Overall Study|Withdrawal by Subject|3|||
170693899|NCT02515942|616892899|FG002|Overall Study|Withdrawal by Subject|2|||
170693900|NCT01762943|616892900|FG000|Overall Study|Physician Decision|1|||
170693901|NCT01762943|616892901|FG001|Overall Study|Physician Decision|1|||
170693902|NCT01762943|616892900|FG000|Overall Study|Protocol Violation|1|||
170693903|NCT01762943|616892901|FG001|Overall Study|Protocol Violation|0|||
170693904|NCT01762943|616892900|FG000|Overall Study|Withdrawal by Subject|2|||
170693905|NCT01762943|616892901|FG001|Overall Study|Withdrawal by Subject|1|||
170693906|NCT00539838|616892902|FG000|Overall Study|Fail to return|2|||
170693907|NCT00539838|616892903|FG001|Overall Study|Fail to return|0|||
170693908|NCT00539838|616892904|FG002|Overall Study|Fail to return|0|||
170693909|NCT00539838|616892902|FG000|Overall Study|Withdrawal by Subject|0|||
170693910|NCT00539838|616892903|FG001|Overall Study|Withdrawal by Subject|4|||
170693911|NCT00539838|616892904|FG002|Overall Study|Withdrawal by Subject|0|||
170693912|NCT00539838|616892902|FG000|Overall Study|Death|0|||
170693913|NCT00539838|616892903|FG001|Overall Study|Death|2|||
170693914|NCT00539838|616892904|FG002|Overall Study|Death|0|||
170693915|NCT00539838|616892902|FG000|Overall Study|Did not cooperate|1|||
170823158|NCT03187353|617360470|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
170693916|NCT00539838|616892903|FG001|Overall Study|Did not cooperate|0|||
170693917|NCT00539838|616892904|FG002|Overall Study|Did not cooperate|1|||
170693918|NCT00539838|616892902|FG000|Overall Study|Administrative|4|||
170693919|NCT00539838|616892903|FG001|Overall Study|Administrative|0|||
170693920|NCT00539838|616892904|FG002|Overall Study|Administrative|8|||
170693921|NCT02658890|616892905|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693922|NCT02658890|616892906|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693923|NCT02658890|616892907|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693924|NCT02658890|616892908|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170823159|NCT03187353|617360469|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
170823160|NCT03187353|617360470|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
170693925|NCT02658890|616892909|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693926|NCT02658890|616892910|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693927|NCT02658890|616892911|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170823161|NCT03187353|617360469|FG000|Washout (2 Weeks)|Adverse Event|2|||
170823162|NCT03187353|617360470|FG001|Washout (2 Weeks)|Adverse Event|0|||
170823163|NCT03187353|617360469|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
170693928|NCT02658890|616892912|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693929|NCT02658890|616892913|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
170693930|NCT02658890|616892914|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693931|NCT02658890|616892915|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693932|NCT02658890|616892916|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693933|NCT02658890|616892917|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693934|NCT02658890|616892918|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693935|NCT02658890|616892919|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693936|NCT02658890|616892920|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693937|NCT02658890|616892921|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693938|NCT02658890|616892922|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693939|NCT02658890|616892923|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693940|NCT02658890|616892924|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693941|NCT02658890|616892925|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693942|NCT02658890|616892926|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693943|NCT02658890|616892927|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693944|NCT02658890|616892928|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693945|NCT02658890|616892929|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693946|NCT02658890|616892930|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693947|NCT02658890|616892931|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170693948|NCT02658890|616892905|FG000|Treatment Phase|Adverse Event|0|||
170693949|NCT02658890|616892906|FG001|Treatment Phase|Adverse Event|1|||
170693950|NCT02658890|616892907|FG002|Treatment Phase|Adverse Event|2|||
170693951|NCT02658890|616892908|FG003|Treatment Phase|Adverse Event|2|||
170693952|NCT02658890|616892909|FG004|Treatment Phase|Adverse Event|1|||
170693953|NCT02658890|616892910|FG005|Treatment Phase|Adverse Event|0|||
170693954|NCT02658890|616892911|FG006|Treatment Phase|Adverse Event|0|||
170693955|NCT02658890|616892912|FG007|Treatment Phase|Adverse Event|2|||
170693956|NCT02658890|616892913|FG008|Treatment Phase|Adverse Event|1|||
170693957|NCT02658890|616892914|FG009|Treatment Phase|Adverse Event|2|||
170693958|NCT02658890|616892915|FG010|Treatment Phase|Adverse Event|3|||
170693959|NCT02658890|616892916|FG011|Treatment Phase|Adverse Event|0|||
170693960|NCT02658890|616892917|FG012|Treatment Phase|Adverse Event|1|||
170693961|NCT02658890|616892918|FG013|Treatment Phase|Adverse Event|4|||
170693962|NCT02658890|616892919|FG014|Treatment Phase|Adverse Event|0|||
170693963|NCT02658890|616892920|FG015|Treatment Phase|Adverse Event|0|||
170693964|NCT02658890|616892921|FG016|Treatment Phase|Adverse Event|0|||
170693965|NCT02658890|616892922|FG017|Treatment Phase|Adverse Event|0|||
170693966|NCT02658890|616892923|FG018|Treatment Phase|Adverse Event|5|||
170693967|NCT02658890|616892924|FG019|Treatment Phase|Adverse Event|1|||
170693968|NCT02658890|616892925|FG020|Treatment Phase|Adverse Event|3|||
170693969|NCT02658890|616892926|FG021|Treatment Phase|Adverse Event|0|||
170693970|NCT02658890|616892927|FG022|Treatment Phase|Adverse Event|5|||
170693971|NCT02658890|616892928|FG023|Treatment Phase|Adverse Event|0|||
170693972|NCT02658890|616892929|FG024|Treatment Phase|Adverse Event|0|||
170693973|NCT02658890|616892930|FG025|Treatment Phase|Adverse Event|2|||
170693974|NCT02658890|616892931|FG026|Treatment Phase|Adverse Event|1|||
170693975|NCT02658890|616892905|FG000|Treatment Phase|Death|0|||
170693976|NCT02658890|616892906|FG001|Treatment Phase|Death|0|||
170693977|NCT02658890|616892907|FG002|Treatment Phase|Death|0|||
170693978|NCT02658890|616892908|FG003|Treatment Phase|Death|0|||
170693979|NCT02658890|616892909|FG004|Treatment Phase|Death|0|||
170693980|NCT02658890|616892910|FG005|Treatment Phase|Death|0|||
170693981|NCT02658890|616892911|FG006|Treatment Phase|Death|0|||
170693982|NCT02658890|616892912|FG007|Treatment Phase|Death|0|||
170693983|NCT02658890|616892913|FG008|Treatment Phase|Death|0|||
170693984|NCT02658890|616892914|FG009|Treatment Phase|Death|0|||
170693985|NCT02658890|616892915|FG010|Treatment Phase|Death|0|||
170693986|NCT02658890|616892916|FG011|Treatment Phase|Death|0|||
170693987|NCT02658890|616892917|FG012|Treatment Phase|Death|0|||
170693988|NCT02658890|616892918|FG013|Treatment Phase|Death|0|||
170693989|NCT02658890|616892919|FG014|Treatment Phase|Death|0|||
170693990|NCT02658890|616892920|FG015|Treatment Phase|Death|0|||
170693991|NCT02658890|616892921|FG016|Treatment Phase|Death|0|||
170693992|NCT02658890|616892922|FG017|Treatment Phase|Death|0|||
170693993|NCT02658890|616892923|FG018|Treatment Phase|Death|1|||
170693994|NCT02658890|616892924|FG019|Treatment Phase|Death|0|||
170693995|NCT02658890|616892925|FG020|Treatment Phase|Death|0|||
170693996|NCT02658890|616892926|FG021|Treatment Phase|Death|0|||
170693997|NCT02658890|616892927|FG022|Treatment Phase|Death|0|||
170693998|NCT02658890|616892928|FG023|Treatment Phase|Death|0|||
170693999|NCT02658890|616892929|FG024|Treatment Phase|Death|0|||
170694000|NCT02658890|616892930|FG025|Treatment Phase|Death|0|||
170694001|NCT02658890|616892931|FG026|Treatment Phase|Death|0|||
170694002|NCT02658890|616892905|FG000|Treatment Phase|Lost to Follow-up|0|||
170694003|NCT02658890|616892906|FG001|Treatment Phase|Lost to Follow-up|0|||
170694004|NCT02658890|616892907|FG002|Treatment Phase|Lost to Follow-up|0|||
170823164|NCT03187353|617360470|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
170823165|NCT03746483|617360471|FG000|Overall Study|Adverse Event|0|||
170823166|NCT03746483|617360472|FG001|Overall Study|Adverse Event|1|||
170823167|NCT03746483|617360471|FG000|Overall Study|Lack of Efficacy|3|||
170823168|NCT03746483|617360472|FG001|Overall Study|Lack of Efficacy|2|||
170823169|NCT03746483|617360471|FG000|Overall Study|Lost to Follow-up|1|||
170823170|NCT03746483|617360472|FG001|Overall Study|Lost to Follow-up|0|||
170823171|NCT03746483|617360471|FG000|Overall Study|Protocol Violation|2|||
170823172|NCT03746483|617360472|FG001|Overall Study|Protocol Violation|0|||
170823173|NCT00187135|617360473|FG000|Visit One|Withdrawal by Subject|1|||
170823174|NCT00187135|617360474|FG001|Visit One|Withdrawal by Subject|0|||
170823175|NCT00187135|617360475|FG002|Visit One|Withdrawal by Subject|0|||
170823176|NCT00187135|617360476|FG003|Visit One|Withdrawal by Subject|0|||
170823177|NCT00187135|617360477|FG004|Visit One|Withdrawal by Subject|0|||
170823178|NCT00187135|617360478|FG005|Visit One|Withdrawal by Subject|1|||
170823179|NCT00187135|617360473|FG000|Visit One|Physician Decision|3|||
170823180|NCT00187135|617360474|FG001|Visit One|Physician Decision|1|||
170823181|NCT00187135|617360475|FG002|Visit One|Physician Decision|0|||
170823182|NCT00187135|617360476|FG003|Visit One|Physician Decision|0|||
170823183|NCT00187135|617360477|FG004|Visit One|Physician Decision|0|||
170823184|NCT00187135|617360478|FG005|Visit One|Physician Decision|1|||
170823185|NCT00187135|617360473|FG000|Visit Two|Death|0|||
170823186|NCT00187135|617360474|FG001|Visit Two|Death|0|||
170823187|NCT00187135|617360475|FG002|Visit Two|Death|0|||
170823188|NCT00187135|617360476|FG003|Visit Two|Death|1|||
170823189|NCT00187135|617360477|FG004|Visit Two|Death|0|||
170823190|NCT00187135|617360478|FG005|Visit Two|Death|1|||
170823191|NCT00187135|617360473|FG000|Visit Two|Physician Decision|1|||
170823192|NCT00187135|617360474|FG001|Visit Two|Physician Decision|0|||
170823193|NCT00187135|617360475|FG002|Visit Two|Physician Decision|0|||
170823194|NCT00187135|617360476|FG003|Visit Two|Physician Decision|0|||
170823195|NCT00187135|617360477|FG004|Visit Two|Physician Decision|0|||
170823196|NCT00187135|617360478|FG005|Visit Two|Physician Decision|0|||
170823197|NCT00187135|617360473|FG000|Visit Two|Withdrawal by Subject|1|||
170823198|NCT00187135|617360474|FG001|Visit Two|Withdrawal by Subject|1|||
170823199|NCT00187135|617360475|FG002|Visit Two|Withdrawal by Subject|1|||
170823200|NCT00187135|617360476|FG003|Visit Two|Withdrawal by Subject|0|||
170823201|NCT00187135|617360477|FG004|Visit Two|Withdrawal by Subject|1|||
170823202|NCT00187135|617360478|FG005|Visit Two|Withdrawal by Subject|1|||
170823203|NCT00187135|617360473|FG000|Visit Two|Study Discontinued|3|||
170823204|NCT00187135|617360474|FG001|Visit Two|Study Discontinued|2|||
170823205|NCT00187135|617360475|FG002|Visit Two|Study Discontinued|1|||
170823206|NCT00187135|617360476|FG003|Visit Two|Study Discontinued|7|||
170823207|NCT00187135|617360477|FG004|Visit Two|Study Discontinued|5|||
170823208|NCT00187135|617360478|FG005|Visit Two|Study Discontinued|6|||
170823209|NCT00187135|617360473|FG000|Visit Three|Death|0|||
170823210|NCT00187135|617360474|FG001|Visit Three|Death|0|||
170823211|NCT00187135|617360475|FG002|Visit Three|Death|1|||
170823212|NCT00187135|617360476|FG003|Visit Three|Death|0|||
170823213|NCT00187135|617360477|FG004|Visit Three|Death|1|||
170823214|NCT00187135|617360478|FG005|Visit Three|Death|0|||
170823215|NCT00187135|617360473|FG000|Visit Three|Withdrawal by Subject|0|||
170823216|NCT00187135|617360474|FG001|Visit Three|Withdrawal by Subject|1|||
170823217|NCT00187135|617360475|FG002|Visit Three|Withdrawal by Subject|1|||
170823218|NCT00187135|617360476|FG003|Visit Three|Withdrawal by Subject|2|||
170823219|NCT00187135|617360477|FG004|Visit Three|Withdrawal by Subject|0|||
170823220|NCT00187135|617360478|FG005|Visit Three|Withdrawal by Subject|0|||
170823221|NCT00187135|617360473|FG000|Visit Three|Study Discontinued|7|||
170823222|NCT00187135|617360474|FG001|Visit Three|Study Discontinued|6|||
170823223|NCT00187135|617360475|FG002|Visit Three|Study Discontinued|7|||
170823224|NCT00187135|617360476|FG003|Visit Three|Study Discontinued|7|||
170823225|NCT00187135|617360477|FG004|Visit Three|Study Discontinued|7|||
170823226|NCT00187135|617360478|FG005|Visit Three|Study Discontinued|6|||
170694005|NCT02658890|616892908|FG003|Treatment Phase|Lost to Follow-up|0|||
170694006|NCT02658890|616892909|FG004|Treatment Phase|Lost to Follow-up|0|||
170694007|NCT02658890|616892910|FG005|Treatment Phase|Lost to Follow-up|0|||
170694008|NCT02658890|616892911|FG006|Treatment Phase|Lost to Follow-up|1|||
170694009|NCT02658890|616892912|FG007|Treatment Phase|Lost to Follow-up|0|||
170694010|NCT02658890|616892913|FG008|Treatment Phase|Lost to Follow-up|0|||
170694011|NCT02658890|616892914|FG009|Treatment Phase|Lost to Follow-up|0|||
170694012|NCT02658890|616892915|FG010|Treatment Phase|Lost to Follow-up|0|||
170694013|NCT02658890|616892916|FG011|Treatment Phase|Lost to Follow-up|0|||
170694014|NCT02658890|616892917|FG012|Treatment Phase|Lost to Follow-up|0|||
170694015|NCT02658890|616892918|FG013|Treatment Phase|Lost to Follow-up|0|||
170694016|NCT02658890|616892919|FG014|Treatment Phase|Lost to Follow-up|0|||
170694017|NCT02658890|616892920|FG015|Treatment Phase|Lost to Follow-up|0|||
170694018|NCT02658890|616892921|FG016|Treatment Phase|Lost to Follow-up|0|||
170694019|NCT02658890|616892922|FG017|Treatment Phase|Lost to Follow-up|0|||
170694020|NCT02658890|616892923|FG018|Treatment Phase|Lost to Follow-up|0|||
170694021|NCT02658890|616892924|FG019|Treatment Phase|Lost to Follow-up|0|||
170694022|NCT02658890|616892925|FG020|Treatment Phase|Lost to Follow-up|0|||
170694023|NCT02658890|616892926|FG021|Treatment Phase|Lost to Follow-up|0|||
170694024|NCT02658890|616892927|FG022|Treatment Phase|Lost to Follow-up|0|||
170694025|NCT02658890|616892928|FG023|Treatment Phase|Lost to Follow-up|0|||
170694026|NCT02658890|616892929|FG024|Treatment Phase|Lost to Follow-up|0|||
170694027|NCT02658890|616892930|FG025|Treatment Phase|Lost to Follow-up|0|||
170694028|NCT02658890|616892931|FG026|Treatment Phase|Lost to Follow-up|0|||
170694029|NCT02658890|616892905|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
170694030|NCT02658890|616892906|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
170694031|NCT02658890|616892907|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
170694032|NCT02658890|616892908|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
170694033|NCT02658890|616892909|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
170694034|NCT02658890|616892910|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
170694035|NCT02658890|616892911|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
170694036|NCT02658890|616892912|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
170694037|NCT02658890|616892913|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
170694038|NCT02658890|616892914|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
170694039|NCT02658890|616892915|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
170694040|NCT02658890|616892916|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
170694041|NCT02658890|616892917|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
170694042|NCT02658890|616892918|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
170694043|NCT02658890|616892919|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
170694044|NCT02658890|616892920|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
170694045|NCT02658890|616892921|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
170694046|NCT02658890|616892922|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
170694047|NCT02658890|616892923|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
170694048|NCT02658890|616892924|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
170694049|NCT02658890|616892925|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
170694050|NCT02658890|616892926|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
170694051|NCT02658890|616892927|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
170694052|NCT02658890|616892928|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
170694053|NCT02658890|616892929|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
170694054|NCT02658890|616892930|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
170694055|NCT02658890|616892931|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
170694056|NCT02658890|616892905|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
170694057|NCT02658890|616892906|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
170694058|NCT02658890|616892907|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
170694059|NCT02658890|616892908|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
170694060|NCT02658890|616892909|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
170694061|NCT02658890|616892910|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
170694062|NCT02658890|616892911|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
170694063|NCT02658890|616892912|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
170694064|NCT02658890|616892913|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
170694065|NCT02658890|616892914|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
170694066|NCT02658890|616892915|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
170694067|NCT02658890|616892916|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
170694068|NCT02658890|616892917|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
170694069|NCT02658890|616892918|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
170694070|NCT02658890|616892919|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
170694071|NCT02658890|616892920|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
170694072|NCT02658890|616892921|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
170694073|NCT02658890|616892922|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
170694074|NCT02658890|616892923|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
170694075|NCT02658890|616892924|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
170694076|NCT02658890|616892925|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
170694077|NCT02658890|616892926|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
170694078|NCT02658890|616892927|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
170694079|NCT02658890|616892928|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
170694080|NCT02658890|616892929|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
170694081|NCT02658890|616892930|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
170694082|NCT02658890|616892931|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
170694083|NCT02658890|616892905|FG000|Treatment Phase|Other Reasons|0|||
170694084|NCT02658890|616892906|FG001|Treatment Phase|Other Reasons|0|||
170694085|NCT02658890|616892907|FG002|Treatment Phase|Other Reasons|0|||
170694086|NCT02658890|616892908|FG003|Treatment Phase|Other Reasons|0|||
170694087|NCT02658890|616892909|FG004|Treatment Phase|Other Reasons|0|||
170694088|NCT02658890|616892910|FG005|Treatment Phase|Other Reasons|0|||
170694089|NCT02658890|616892911|FG006|Treatment Phase|Other Reasons|1|||
170694090|NCT02658890|616892912|FG007|Treatment Phase|Other Reasons|0|||
170694091|NCT02658890|616892913|FG008|Treatment Phase|Other Reasons|1|||
170694092|NCT02658890|616892914|FG009|Treatment Phase|Other Reasons|0|||
170694093|NCT02658890|616892915|FG010|Treatment Phase|Other Reasons|0|||
170694094|NCT02658890|616892916|FG011|Treatment Phase|Other Reasons|0|||
170694095|NCT02658890|616892917|FG012|Treatment Phase|Other Reasons|0|||
170694096|NCT02658890|616892918|FG013|Treatment Phase|Other Reasons|2|||
170694097|NCT02658890|616892919|FG014|Treatment Phase|Other Reasons|0|||
170694098|NCT02658890|616892920|FG015|Treatment Phase|Other Reasons|0|||
170694099|NCT02658890|616892921|FG016|Treatment Phase|Other Reasons|0|||
170694100|NCT02658890|616892922|FG017|Treatment Phase|Other Reasons|0|||
170694101|NCT02658890|616892923|FG018|Treatment Phase|Other Reasons|1|||
170694102|NCT02658890|616892924|FG019|Treatment Phase|Other Reasons|0|||
170694103|NCT02658890|616892925|FG020|Treatment Phase|Other Reasons|0|||
170694104|NCT02658890|616892926|FG021|Treatment Phase|Other Reasons|0|||
170694105|NCT02658890|616892927|FG022|Treatment Phase|Other Reasons|0|||
170694106|NCT02658890|616892928|FG023|Treatment Phase|Other Reasons|0|||
170694107|NCT02658890|616892929|FG024|Treatment Phase|Other Reasons|1|||
170694108|NCT02658890|616892930|FG025|Treatment Phase|Other Reasons|0|||
170694109|NCT02658890|616892931|FG026|Treatment Phase|Other Reasons|1|||
170694110|NCT02658890|616892905|FG000|Treatment Phase|Progressive Disease|6|||
170694111|NCT02658890|616892906|FG001|Treatment Phase|Progressive Disease|7|||
170694112|NCT02658890|616892907|FG002|Treatment Phase|Progressive Disease|6|||
170694113|NCT02658890|616892908|FG003|Treatment Phase|Progressive Disease|12|||
170694114|NCT02658890|616892909|FG004|Treatment Phase|Progressive Disease|6|||
170694115|NCT02658890|616892910|FG005|Treatment Phase|Progressive Disease|18|||
170694116|NCT02658890|616892911|FG006|Treatment Phase|Progressive Disease|12|||
170694117|NCT02658890|616892912|FG007|Treatment Phase|Progressive Disease|19|||
170694118|NCT02658890|616892913|FG008|Treatment Phase|Progressive Disease|26|||
170694119|NCT02658890|616892914|FG009|Treatment Phase|Progressive Disease|8|||
170694120|NCT02658890|616892915|FG010|Treatment Phase|Progressive Disease|7|||
170694121|NCT02658890|616892916|FG011|Treatment Phase|Progressive Disease|9|||
170694122|NCT02658890|616892917|FG012|Treatment Phase|Progressive Disease|8|||
170694123|NCT02658890|616892918|FG013|Treatment Phase|Progressive Disease|29|||
170694124|NCT02658890|616892919|FG014|Treatment Phase|Progressive Disease|6|||
170694125|NCT02658890|616892920|FG015|Treatment Phase|Progressive Disease|2|||
170694126|NCT02658890|616892921|FG016|Treatment Phase|Progressive Disease|32|||
170694127|NCT02658890|616892922|FG017|Treatment Phase|Progressive Disease|14|||
170694128|NCT02658890|616892923|FG018|Treatment Phase|Progressive Disease|40|||
170694129|NCT02658890|616892924|FG019|Treatment Phase|Progressive Disease|32|||
170694130|NCT02658890|616892925|FG020|Treatment Phase|Progressive Disease|19|||
170694131|NCT02658890|616892926|FG021|Treatment Phase|Progressive Disease|30|||
170694132|NCT02658890|616892927|FG022|Treatment Phase|Progressive Disease|15|||
170694133|NCT02658890|616892928|FG023|Treatment Phase|Progressive Disease|0|||
170694134|NCT02658890|616892929|FG024|Treatment Phase|Progressive Disease|0|||
170694135|NCT02658890|616892930|FG025|Treatment Phase|Progressive Disease|14|||
170694136|NCT02658890|616892931|FG026|Treatment Phase|Progressive Disease|11|||
170694137|NCT02658890|616892905|FG000|Treatment Phase|Study Drug Toxicity|0|||
170694138|NCT02658890|616892906|FG001|Treatment Phase|Study Drug Toxicity|0|||
170694139|NCT02658890|616892907|FG002|Treatment Phase|Study Drug Toxicity|2|||
170694140|NCT02658890|616892908|FG003|Treatment Phase|Study Drug Toxicity|0|||
170694141|NCT02658890|616892909|FG004|Treatment Phase|Study Drug Toxicity|0|||
170694142|NCT02658890|616892910|FG005|Treatment Phase|Study Drug Toxicity|0|||
170694143|NCT02658890|616892911|FG006|Treatment Phase|Study Drug Toxicity|0|||
170694144|NCT02658890|616892912|FG007|Treatment Phase|Study Drug Toxicity|0|||
170694145|NCT02658890|616892913|FG008|Treatment Phase|Study Drug Toxicity|3|||
170694146|NCT02658890|616892914|FG009|Treatment Phase|Study Drug Toxicity|0|||
170694147|NCT02658890|616892915|FG010|Treatment Phase|Study Drug Toxicity|1|||
170694148|NCT02658890|616892916|FG011|Treatment Phase|Study Drug Toxicity|1|||
170694149|NCT02658890|616892917|FG012|Treatment Phase|Study Drug Toxicity|2|||
170694150|NCT02658890|616892918|FG013|Treatment Phase|Study Drug Toxicity|9|||
170694151|NCT02658890|616892919|FG014|Treatment Phase|Study Drug Toxicity|0|||
170694152|NCT02658890|616892920|FG015|Treatment Phase|Study Drug Toxicity|1|||
170694153|NCT02658890|616892921|FG016|Treatment Phase|Study Drug Toxicity|1|||
170694154|NCT02658890|616892922|FG017|Treatment Phase|Study Drug Toxicity|0|||
170694155|NCT02658890|616892923|FG018|Treatment Phase|Study Drug Toxicity|8|||
170694156|NCT02658890|616892924|FG019|Treatment Phase|Study Drug Toxicity|3|||
170694157|NCT02658890|616892925|FG020|Treatment Phase|Study Drug Toxicity|2|||
170694158|NCT02658890|616892926|FG021|Treatment Phase|Study Drug Toxicity|0|||
170694159|NCT02658890|616892927|FG022|Treatment Phase|Study Drug Toxicity|8|||
170694160|NCT02658890|616892928|FG023|Treatment Phase|Study Drug Toxicity|0|||
170694161|NCT02658890|616892929|FG024|Treatment Phase|Study Drug Toxicity|0|||
170694162|NCT02658890|616892930|FG025|Treatment Phase|Study Drug Toxicity|2|||
170694163|NCT02658890|616892931|FG026|Treatment Phase|Study Drug Toxicity|0|||
170694164|NCT02658890|616892905|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694165|NCT02658890|616892906|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694166|NCT02658890|616892907|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694167|NCT02658890|616892908|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
170694168|NCT02658890|616892909|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694169|NCT02658890|616892910|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694170|NCT02658890|616892911|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694171|NCT02658890|616892912|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694172|NCT02658890|616892913|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694173|NCT02658890|616892914|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
170694174|NCT02658890|616892915|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694175|NCT02658890|616892916|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694176|NCT02658890|616892917|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694177|NCT02658890|616892918|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694178|NCT02658890|616892919|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694179|NCT02658890|616892920|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694180|NCT02658890|616892921|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694181|NCT02658890|616892922|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694182|NCT02658890|616892923|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
170694183|NCT02658890|616892924|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694184|NCT02658890|616892925|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694185|NCT02658890|616892926|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694186|NCT02658890|616892927|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
170694187|NCT02658890|616892928|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694188|NCT02658890|616892929|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694189|NCT02658890|616892930|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694190|NCT02658890|616892931|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
170694191|NCT02658890|616892905|FG000|Treatment Phase|Withdrawal by Subject|0|||
170694192|NCT02658890|616892906|FG001|Treatment Phase|Withdrawal by Subject|1|||
170694193|NCT02658890|616892907|FG002|Treatment Phase|Withdrawal by Subject|0|||
170694194|NCT02658890|616892908|FG003|Treatment Phase|Withdrawal by Subject|0|||
170694195|NCT02658890|616892909|FG004|Treatment Phase|Withdrawal by Subject|0|||
170694196|NCT02658890|616892910|FG005|Treatment Phase|Withdrawal by Subject|0|||
170694197|NCT02658890|616892911|FG006|Treatment Phase|Withdrawal by Subject|1|||
170694198|NCT02658890|616892912|FG007|Treatment Phase|Withdrawal by Subject|0|||
170694199|NCT02658890|616892913|FG008|Treatment Phase|Withdrawal by Subject|0|||
170694200|NCT02658890|616892914|FG009|Treatment Phase|Withdrawal by Subject|1|||
170694201|NCT02658890|616892915|FG010|Treatment Phase|Withdrawal by Subject|0|||
170694202|NCT02658890|616892916|FG011|Treatment Phase|Withdrawal by Subject|0|||
170694203|NCT02658890|616892917|FG012|Treatment Phase|Withdrawal by Subject|1|||
170694204|NCT02658890|616892918|FG013|Treatment Phase|Withdrawal by Subject|3|||
170694205|NCT02658890|616892919|FG014|Treatment Phase|Withdrawal by Subject|0|||
170694206|NCT02658890|616892920|FG015|Treatment Phase|Withdrawal by Subject|0|||
170694207|NCT02658890|616892921|FG016|Treatment Phase|Withdrawal by Subject|1|||
170694208|NCT02658890|616892922|FG017|Treatment Phase|Withdrawal by Subject|0|||
170694209|NCT02658890|616892923|FG018|Treatment Phase|Withdrawal by Subject|4|||
170694210|NCT02658890|616892924|FG019|Treatment Phase|Withdrawal by Subject|3|||
170694211|NCT02658890|616892925|FG020|Treatment Phase|Withdrawal by Subject|0|||
170694212|NCT02658890|616892926|FG021|Treatment Phase|Withdrawal by Subject|4|||
170694213|NCT02658890|616892927|FG022|Treatment Phase|Withdrawal by Subject|1|||
170694214|NCT02658890|616892928|FG023|Treatment Phase|Withdrawal by Subject|1|||
170694215|NCT02658890|616892929|FG024|Treatment Phase|Withdrawal by Subject|0|||
170694216|NCT02658890|616892930|FG025|Treatment Phase|Withdrawal by Subject|0|||
170694217|NCT02658890|616892931|FG026|Treatment Phase|Withdrawal by Subject|0|||
170694218|NCT00456521|616892932|FG000|Overall Study|Adverse Event|150|||
170694219|NCT00456521|616892933|FG001|Overall Study|Adverse Event|25|||
170694220|NCT00456521|616892932|FG000|Overall Study|Withdrawal by Subject|43|||
170694221|NCT00456521|616892933|FG001|Overall Study|Withdrawal by Subject|24|||
170694222|NCT00456521|616892932|FG000|Overall Study|Lost to Follow-up|22|||
170694223|NCT00456521|616892933|FG001|Overall Study|Lost to Follow-up|17|||
170694224|NCT00456521|616892932|FG000|Overall Study|Lack of Efficacy|3|||
170694225|NCT00456521|616892933|FG001|Overall Study|Lack of Efficacy|6|||
170694226|NCT00456521|616892932|FG000|Overall Study|Protocol Violation|4|||
170694227|NCT00456521|616892933|FG001|Overall Study|Protocol Violation|0|||
170694228|NCT00456521|616892932|FG000|Overall Study|Pregnancy|1|||
170694229|NCT00456521|616892933|FG001|Overall Study|Pregnancy|1|||
170694230|NCT00456521|616892932|FG000|Overall Study|Drug non-compliance, moved, other|26|||
170694231|NCT00456521|616892933|FG001|Overall Study|Drug non-compliance, moved, other|11|||
170694232|NCT00405587|616892940|FG000|Overall Study|Death|0|||
170694233|NCT00405587|616892941|FG001|Overall Study|Death|0|||
170694234|NCT00405587|616892942|FG002|Overall Study|Death|0|||
170694235|NCT00405587|616892943|FG003|Overall Study|Death|1|||
170694236|NCT00405587|616892940|FG000|Overall Study|Disease Progression|22|||
170694237|NCT00405587|616892941|FG001|Overall Study|Disease Progression|23|||
170694238|NCT00405587|616892942|FG002|Overall Study|Disease Progression|21|||
170694239|NCT00405587|616892943|FG003|Overall Study|Disease Progression|17|||
170694240|NCT00405587|616892940|FG000|Overall Study|Physician Decision|3|||
170694241|NCT00405587|616892941|FG001|Overall Study|Physician Decision|2|||
170694242|NCT00405587|616892942|FG002|Overall Study|Physician Decision|0|||
170694243|NCT00405587|616892943|FG003|Overall Study|Physician Decision|0|||
170694244|NCT00405587|616892940|FG000|Overall Study|Adverse Event|1|||
170694245|NCT00405587|616892941|FG001|Overall Study|Adverse Event|0|||
170694246|NCT00405587|616892942|FG002|Overall Study|Adverse Event|0|||
170694247|NCT00405587|616892943|FG003|Overall Study|Adverse Event|0|||
170694248|NCT00405587|616892940|FG000|Overall Study|Lost to Follow-up|0|||
170694249|NCT00405587|616892941|FG001|Overall Study|Lost to Follow-up|1|||
170694250|NCT00405587|616892942|FG002|Overall Study|Lost to Follow-up|1|||
170694251|NCT00405587|616892943|FG003|Overall Study|Lost to Follow-up|0|||
170694252|NCT00405587|616892940|FG000|Overall Study|Radiation induced necrosis|0|||
170694253|NCT00405587|616892941|FG001|Overall Study|Radiation induced necrosis|1|||
170694254|NCT00405587|616892942|FG002|Overall Study|Radiation induced necrosis|0|||
170694255|NCT00405587|616892943|FG003|Overall Study|Radiation induced necrosis|0|||
170694256|NCT00405587|616892940|FG000|Overall Study|Withdrawal by Subject|0|||
170694257|NCT00405587|616892941|FG001|Overall Study|Withdrawal by Subject|0|||
170694258|NCT00405587|616892942|FG002|Overall Study|Withdrawal by Subject|0|||
170694259|NCT00405587|616892943|FG003|Overall Study|Withdrawal by Subject|2|||
170694260|NCT00405587|616892940|FG000|Overall Study|Participant not dosed|0|||
170694261|NCT00405587|616892941|FG001|Overall Study|Participant not dosed|1|||
170694262|NCT00405587|616892942|FG002|Overall Study|Participant not dosed|0|||
170694263|NCT00405587|616892943|FG003|Overall Study|Participant not dosed|0|||
170694264|NCT02419742|616892946|FG000|Overall Study|Adverse Event|2|||
170823227|NCT00005908|617360479|FG000|Overall Study|Withdrawal by Subject|1|||
170694265|NCT02419742|616892947|FG001|Overall Study|Adverse Event|0|||
170694266|NCT02419742|616892946|FG000|Overall Study|Disease Progression|0|||
170694267|NCT02419742|616892947|FG001|Overall Study|Disease Progression|1|||
170694268|NCT02419742|616892946|FG000|Overall Study|Withdrew Consent|2|||
170694269|NCT02419742|616892947|FG001|Overall Study|Withdrew Consent|1|||
170694270|NCT02419742|616892946|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
170694271|NCT02419742|616892947|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
170694272|NCT00930579|616892948|FG000|Overall Study|Withdrawal by Subject|1|||
170694273|NCT00930579|616892948|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
170823228|NCT00005908|617360480|FG001|Overall Study|Withdrawal by Subject|0|||
170823229|NCT01954771|617360481|FG000|Overall Study|Missing HbA1c of end-point|1|||
170694274|NCT03168464|616892954|FG000|Overall Study|Death|9|||
170694275|NCT03168464|616892954|FG000|Overall Study|Progression of disease|6|||
170694276|NCT00634088|616892955|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
170694277|NCT00634088|616892956|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
170694278|NCT00634088|616892957|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
170694279|NCT00634088|616892958|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
170694280|NCT00634088|616892955|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
170823230|NCT01954771|617360482|FG001|Overall Study|Missing HbA1c of end-point|1|||
170694281|NCT00634088|616892956|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
170694282|NCT00634088|616892957|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
170694283|NCT00634088|616892958|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
170694284|NCT00634088|616892955|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
170694285|NCT00634088|616892956|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
170694286|NCT00634088|616892957|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
170694287|NCT00634088|616892958|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
170694288|NCT00634088|616892955|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
170694289|NCT00634088|616892956|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
170694290|NCT00634088|616892957|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
170694291|NCT00634088|616892958|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
170694292|NCT00634088|616892955|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
170694293|NCT00634088|616892956|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
170694294|NCT00634088|616892957|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
170694295|NCT00634088|616892958|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
170694296|NCT00634088|616892955|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
170694297|NCT00634088|616892956|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
170694298|NCT00634088|616892957|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
170694299|NCT00634088|616892958|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
170694300|NCT04356963|616892959|FG000|First Session|Withdrawal by Subject|1|||
170694301|NCT04356963|616892959|FG000|Second Session|Withdrawal by Subject|3|||
170694302|NCT04356963|616892959|FG000|Second Session|Lost to Follow-up|1|||
170694303|NCT04356963|616892959|FG000|Third Session|Lost to Follow-up|6|||
170694304|NCT04356963|616892959|FG000|Third Session|Withdrawal by Subject|1|||
170694305|NCT01577758|616892960|FG000|Dose Escalation Phase|Adverse Event|0|||
170694306|NCT01577758|616892961|FG001|Dose Escalation Phase|Adverse Event|0|||
170694307|NCT01577758|616892962|FG002|Dose Escalation Phase|Adverse Event|0|||
170694308|NCT01577758|616892963|FG003|Dose Escalation Phase|Adverse Event|0|||
170694309|NCT01577758|616892964|FG004|Dose Escalation Phase|Adverse Event|0|||
170694310|NCT01577758|616892965|FG005|Dose Escalation Phase|Adverse Event|2|||
170694311|NCT01577758|616892966|FG006|Dose Escalation Phase|Adverse Event|1|||
170694312|NCT01577758|616892967|FG007|Dose Escalation Phase|Adverse Event|0|||
170694313|NCT01577758|616892960|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
170694314|NCT01577758|616892961|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
170694315|NCT01577758|616892962|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
170694316|NCT01577758|616892963|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
170694317|NCT01577758|616892964|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
170694318|NCT01577758|616892965|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
170694319|NCT01577758|616892966|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
170694320|NCT01577758|616892967|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
170694321|NCT01577758|616892960|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
170694322|NCT01577758|616892961|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
170694323|NCT01577758|616892962|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
170694324|NCT01577758|616892963|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
170694325|NCT01577758|616892964|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
170694326|NCT01577758|616892965|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
170694327|NCT01577758|616892966|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
170694328|NCT01577758|616892967|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
170694329|NCT01577758|616892960|FG000|Dose Escalation Phase|Progression Disease|2|||
170694330|NCT01577758|616892961|FG001|Dose Escalation Phase|Progression Disease|2|||
170694331|NCT01577758|616892962|FG002|Dose Escalation Phase|Progression Disease|1|||
170694332|NCT01577758|616892963|FG003|Dose Escalation Phase|Progression Disease|2|||
170694333|NCT01577758|616892964|FG004|Dose Escalation Phase|Progression Disease|5|||
170694334|NCT01577758|616892965|FG005|Dose Escalation Phase|Progression Disease|0|||
170823231|NCT01954771|617360483|FG002|Overall Study|Missing HbA1c of end-point|0|||
170823232|NCT01954771|617360481|FG000|Overall Study|Missing CGMS of end-point|1|||
170823233|NCT01954771|617360482|FG001|Overall Study|Missing CGMS of end-point|1|||
170823234|NCT01954771|617360483|FG002|Overall Study|Missing CGMS of end-point|0|||
170823235|NCT01954771|617360481|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
170823236|NCT01954771|617360482|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
170823237|NCT01954771|617360483|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
170823238|NCT00475735|617360490|FG000|Treatment Period 1|Adverse Event|2|||
170823239|NCT00475735|617360491|FG001|Treatment Period 1|Adverse Event|0|||
170823240|NCT00475735|617360492|FG002|Treatment Period 1|Adverse Event|0|||
170823241|NCT00475735|617360493|FG003|Treatment Period 1|Adverse Event|0|||
170823242|NCT00475735|617360494|FG004|Treatment Period 1|Adverse Event|0|||
170823243|NCT00475735|617360495|FG005|Treatment Period 1|Adverse Event|0|||
170823244|NCT00475735|617360490|FG000|Treatment Period 1|Lack of Efficacy|1|||
170694335|NCT01577758|616892966|FG006|Dose Escalation Phase|Progression Disease|0|||
170694336|NCT01577758|616892967|FG007|Dose Escalation Phase|Progression Disease|0|||
170694337|NCT01577758|616892960|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
170694338|NCT01577758|616892961|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
170694339|NCT01577758|616892962|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
170694340|NCT01577758|616892963|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
170694341|NCT01577758|616892964|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
170694342|NCT01577758|616892965|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
170694343|NCT01577758|616892966|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
170694344|NCT01577758|616892967|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
170694345|NCT01577758|616892960|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
170694346|NCT01577758|616892961|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
170694347|NCT01577758|616892962|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
170694348|NCT01577758|616892963|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
170694349|NCT01577758|616892964|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
170694350|NCT01577758|616892965|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
170694351|NCT01577758|616892966|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
170694352|NCT01577758|616892967|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
170694353|NCT01577758|616892960|FG000|mCRC Expansion Phase|Progression Disease|0|||
170694354|NCT01577758|616892961|FG001|mCRC Expansion Phase|Progression Disease|0|||
170694355|NCT01577758|616892962|FG002|mCRC Expansion Phase|Progression Disease|0|||
170694356|NCT01577758|616892963|FG003|mCRC Expansion Phase|Progression Disease|0|||
170694357|NCT01577758|616892964|FG004|mCRC Expansion Phase|Progression Disease|0|||
170694358|NCT01577758|616892965|FG005|mCRC Expansion Phase|Progression Disease|0|||
170694359|NCT01577758|616892966|FG006|mCRC Expansion Phase|Progression Disease|0|||
170694360|NCT01577758|616892967|FG007|mCRC Expansion Phase|Progression Disease|19|||
170694361|NCT03054870|616892979|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
170694362|NCT03054870|616892979|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
170694363|NCT02009046|616892980|FG000|Overall Study|Lost to Follow-up|256|||
170694364|NCT02009046|616892981|FG001|Overall Study|Lost to Follow-up|206|||
170694365|NCT00973479|616892988|FG000|Overall Study|Lost to Follow-up|0|||
170694366|NCT00973479|616892989|FG001|Overall Study|Lost to Follow-up|3|||
170694367|NCT00973479|616892988|FG000|Overall Study|Death|2|||
170694368|NCT00973479|616892989|FG001|Overall Study|Death|2|||
170694369|NCT00973479|616892988|FG000|Overall Study|Withdrawal by Subject|15|||
170694370|NCT00973479|616892989|FG001|Overall Study|Withdrawal by Subject|16|||
170694371|NCT00973479|616892988|FG000|Overall Study|Lack of Efficacy|5|||
170694372|NCT00973479|616892989|FG001|Overall Study|Lack of Efficacy|7|||
170694373|NCT00973479|616892988|FG000|Overall Study|Adverse Event|12|||
170694374|NCT00973479|616892989|FG001|Overall Study|Adverse Event|32|||
170694375|NCT00973479|616892988|FG000|Overall Study|Protocol Violation|2|||
170694376|NCT00973479|616892989|FG001|Overall Study|Protocol Violation|2|||
170694377|NCT00973479|616892988|FG000|Overall Study|Other|1|||
170694378|NCT00973479|616892989|FG001|Overall Study|Other|7|||
170694379|NCT05075850|616892990|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
170694380|NCT04256785|616892991|FG000|Overall Study|Adverse Event|8|||
170694381|NCT04256785|616892992|FG001|Overall Study|Adverse Event|6|||
170823245|NCT00475735|617360491|FG001|Treatment Period 1|Lack of Efficacy|0|||
170823246|NCT00475735|617360492|FG002|Treatment Period 1|Lack of Efficacy|0|||
170823247|NCT00475735|617360493|FG003|Treatment Period 1|Lack of Efficacy|0|||
170823248|NCT00475735|617360494|FG004|Treatment Period 1|Lack of Efficacy|0|||
170823249|NCT00475735|617360495|FG005|Treatment Period 1|Lack of Efficacy|0|||
170823250|NCT00475735|617360490|FG000|Treatment Period 1|Lost to Follow-up|0|||
170823251|NCT00475735|617360491|FG001|Treatment Period 1|Lost to Follow-up|0|||
170823252|NCT00475735|617360492|FG002|Treatment Period 1|Lost to Follow-up|0|||
170823253|NCT00475735|617360493|FG003|Treatment Period 1|Lost to Follow-up|0|||
170823254|NCT00475735|617360494|FG004|Treatment Period 1|Lost to Follow-up|0|||
170823255|NCT00475735|617360495|FG005|Treatment Period 1|Lost to Follow-up|1|||
170823256|NCT00475735|617360490|FG000|Treatment Period 1|Protocol Violation|0|||
170823257|NCT00475735|617360491|FG001|Treatment Period 1|Protocol Violation|0|||
170823258|NCT00475735|617360492|FG002|Treatment Period 1|Protocol Violation|0|||
170823259|NCT00475735|617360493|FG003|Treatment Period 1|Protocol Violation|1|||
170823260|NCT00475735|617360494|FG004|Treatment Period 1|Protocol Violation|0|||
170823261|NCT00475735|617360495|FG005|Treatment Period 1|Protocol Violation|0|||
170823262|NCT00475735|617360490|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170823263|NCT00475735|617360491|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170823264|NCT00475735|617360492|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170694382|NCT04256785|616892991|FG000|Overall Study|Lack of Efficacy|3|||
170694383|NCT04256785|616892992|FG001|Overall Study|Lack of Efficacy|4|||
170694384|NCT04256785|616892991|FG000|Overall Study|Lost to Follow-up|7|||
170694385|NCT04256785|616892992|FG001|Overall Study|Lost to Follow-up|7|||
170694386|NCT04256785|616892991|FG000|Overall Study|Protocol Violation|1|||
170823265|NCT00475735|617360493|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170823266|NCT00475735|617360494|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170823267|NCT00475735|617360495|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170823268|NCT00475735|617360490|FG000|Treatment Period 1|DC due to AE but continuing|0|||
170823269|NCT00475735|617360491|FG001|Treatment Period 1|DC due to AE but continuing|0|||
170823270|NCT00475735|617360492|FG002|Treatment Period 1|DC due to AE but continuing|0|||
170823271|NCT00475735|617360493|FG003|Treatment Period 1|DC due to AE but continuing|1|||
170694387|NCT04256785|616892992|FG001|Overall Study|Protocol Violation|0|||
170694388|NCT04256785|616892991|FG000|Overall Study|Withdrawal by Subject|4|||
170694389|NCT04256785|616892992|FG001|Overall Study|Withdrawal by Subject|1|||
170694390|NCT04256785|616892991|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
170694391|NCT04256785|616892992|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
170694392|NCT01265849|616892993|FG000|Overall Study|Randomized//Treatment not initiated|1|||
170694393|NCT01265849|616892994|FG001|Overall Study|Randomized//Treatment not initiated|4|||
170694394|NCT01265849|616892995|FG002|Overall Study|Randomized//Treatment not initiated|0|||
170694395|NCT01265849|616892993|FG000|Overall Study|Physician Decision|1|||
170694396|NCT01265849|616892994|FG001|Overall Study|Physician Decision|2|||
170694397|NCT01265849|616892995|FG002|Overall Study|Physician Decision|0|||
170694398|NCT01265849|616892993|FG000|Overall Study|Lost to Follow-up|18|||
170694399|NCT01265849|616892994|FG001|Overall Study|Lost to Follow-up|15|||
170694400|NCT01265849|616892995|FG002|Overall Study|Lost to Follow-up|5|||
170694401|NCT01265849|616892993|FG000|Overall Study|Not otherwise specified|1|||
170694402|NCT01265849|616892994|FG001|Overall Study|Not otherwise specified|6|||
170694403|NCT01265849|616892995|FG002|Overall Study|Not otherwise specified|1|||
170694404|NCT01265849|616892993|FG000|Overall Study|Withdrawal by Subject|25|||
170694405|NCT01265849|616892994|FG001|Overall Study|Withdrawal by Subject|34|||
170694406|NCT01265849|616892995|FG002|Overall Study|Withdrawal by Subject|13|||
170694407|NCT00362115|616892996|FG000|Overall Study|Adverse Event|0|||
170694408|NCT00362115|616892997|FG001|Overall Study|Adverse Event|1|||
170694409|NCT00362115|616892998|FG002|Overall Study|Adverse Event|1|||
170694410|NCT00362115|616892999|FG003|Overall Study|Adverse Event|1|||
170694411|NCT00362115|616893000|FG004|Overall Study|Adverse Event|2|||
170694412|NCT00362115|616893001|FG005|Overall Study|Adverse Event|2|||
170694413|NCT00362115|616893002|FG006|Overall Study|Adverse Event|1|||
170694414|NCT00362115|616892996|FG000|Overall Study|Protocol Violation|0|||
170694415|NCT00362115|616892997|FG001|Overall Study|Protocol Violation|0|||
170694416|NCT00362115|616892998|FG002|Overall Study|Protocol Violation|0|||
170694417|NCT00362115|616892999|FG003|Overall Study|Protocol Violation|0|||
170694418|NCT00362115|616893000|FG004|Overall Study|Protocol Violation|0|||
170694419|NCT00362115|616893001|FG005|Overall Study|Protocol Violation|1|||
170694420|NCT00362115|616893002|FG006|Overall Study|Protocol Violation|0|||
170694421|NCT00362115|616892996|FG000|Overall Study|Lost to Follow-up|0|||
170694422|NCT00362115|616892997|FG001|Overall Study|Lost to Follow-up|1|||
170694423|NCT00362115|616892998|FG002|Overall Study|Lost to Follow-up|0|||
170694424|NCT00362115|616892999|FG003|Overall Study|Lost to Follow-up|0|||
170694425|NCT00362115|616893000|FG004|Overall Study|Lost to Follow-up|2|||
170694426|NCT00362115|616893001|FG005|Overall Study|Lost to Follow-up|0|||
170694427|NCT00362115|616893002|FG006|Overall Study|Lost to Follow-up|1|||
170694428|NCT00362115|616892996|FG000|Overall Study|Withdrawal by Subject|1|||
170694429|NCT00362115|616892997|FG001|Overall Study|Withdrawal by Subject|3|||
170694430|NCT00362115|616892998|FG002|Overall Study|Withdrawal by Subject|1|||
170694431|NCT00362115|616892999|FG003|Overall Study|Withdrawal by Subject|0|||
170694432|NCT00362115|616893000|FG004|Overall Study|Withdrawal by Subject|1|||
170694433|NCT00362115|616893001|FG005|Overall Study|Withdrawal by Subject|3|||
170694434|NCT00362115|616893002|FG006|Overall Study|Withdrawal by Subject|4|||
170694435|NCT00362115|616892996|FG000|Overall Study|Lack of Efficacy|1|||
170694436|NCT00362115|616892997|FG001|Overall Study|Lack of Efficacy|0|||
170694437|NCT00362115|616892998|FG002|Overall Study|Lack of Efficacy|5|||
170694438|NCT00362115|616892999|FG003|Overall Study|Lack of Efficacy|2|||
170694439|NCT00362115|616893000|FG004|Overall Study|Lack of Efficacy|2|||
170694440|NCT00362115|616893001|FG005|Overall Study|Lack of Efficacy|0|||
170694441|NCT00362115|616893002|FG006|Overall Study|Lack of Efficacy|3|||
170694442|NCT00362115|616892996|FG000|Overall Study|Physician Decision|0|||
170694443|NCT00362115|616892997|FG001|Overall Study|Physician Decision|0|||
170694444|NCT00362115|616892998|FG002|Overall Study|Physician Decision|0|||
170694445|NCT00362115|616892999|FG003|Overall Study|Physician Decision|0|||
170694446|NCT00362115|616893000|FG004|Overall Study|Physician Decision|0|||
170694447|NCT00362115|616893001|FG005|Overall Study|Physician Decision|0|||
170694448|NCT00362115|616893002|FG006|Overall Study|Physician Decision|3|||
170694449|NCT00362115|616892996|FG000|Overall Study|Other|0|||
170694450|NCT00362115|616892997|FG001|Overall Study|Other|1|||
170694451|NCT00362115|616892998|FG002|Overall Study|Other|0|||
170694452|NCT00362115|616892999|FG003|Overall Study|Other|1|||
170694453|NCT00362115|616893000|FG004|Overall Study|Other|0|||
170694454|NCT00362115|616893001|FG005|Overall Study|Other|1|||
170694455|NCT00362115|616893002|FG006|Overall Study|Other|0|||
170694456|NCT03341533|616893003|FG000|Overall Study|Withdrawal by Subject|1|||
170694457|NCT03341533|616893004|FG001|Overall Study|Withdrawal by Subject|1|||
170694458|NCT03341533|616893003|FG000|Overall Study|Not eligible after randomization|2|||
170694459|NCT03341533|616893004|FG001|Overall Study|Not eligible after randomization|1|||
170694460|NCT00643682|616893005|FG000|Overall Study|did not keep appointment|522|||
170694461|NCT00643682|616893006|FG001|Overall Study|did not keep appointment|509|||
170694462|NCT00455429|616893013|FG000|Overall Study|Study Terminated by Sponsor|0|||
170694463|NCT00455429|616893014|FG001|Overall Study|Study Terminated by Sponsor|0|||
170694464|NCT00455429|616893015|FG002|Overall Study|Study Terminated by Sponsor|0|||
170694465|NCT00455429|616893016|FG003|Overall Study|Study Terminated by Sponsor|3|||
170694466|NCT00455429|616893013|FG000|Overall Study|Lost to Follow-up|1|||
170694467|NCT00455429|616893014|FG001|Overall Study|Lost to Follow-up|0|||
170694468|NCT00455429|616893015|FG002|Overall Study|Lost to Follow-up|0|||
170694469|NCT00455429|616893016|FG003|Overall Study|Lost to Follow-up|3|||
170694470|NCT00455429|616893013|FG000|Overall Study|Withdrawal by Subject|0|||
170694471|NCT00455429|616893014|FG001|Overall Study|Withdrawal by Subject|1|||
170694472|NCT00455429|616893015|FG002|Overall Study|Withdrawal by Subject|1|||
170694473|NCT00455429|616893016|FG003|Overall Study|Withdrawal by Subject|0|||
170694474|NCT00455429|616893013|FG000|Overall Study|Lack of Efficacy|0|||
170694475|NCT00455429|616893014|FG001|Overall Study|Lack of Efficacy|1|||
170694476|NCT00455429|616893015|FG002|Overall Study|Lack of Efficacy|0|||
170694477|NCT00455429|616893016|FG003|Overall Study|Lack of Efficacy|1|||
170694478|NCT00455429|616893013|FG000|Overall Study|Adverse Event|0|||
170694479|NCT00455429|616893014|FG001|Overall Study|Adverse Event|1|||
170694480|NCT00455429|616893015|FG002|Overall Study|Adverse Event|0|||
170694481|NCT00455429|616893016|FG003|Overall Study|Adverse Event|3|||
170694482|NCT00455429|616893013|FG000|Overall Study|Randomly assigned but not treated|0|||
170694483|NCT00455429|616893014|FG001|Overall Study|Randomly assigned but not treated|0|||
170694484|NCT00455429|616893015|FG002|Overall Study|Randomly assigned but not treated|0|||
170694485|NCT00455429|616893016|FG003|Overall Study|Randomly assigned but not treated|2|||
170694486|NCT00455429|616893013|FG000|Overall Study|Personal Reason|1|||
170694487|NCT00455429|616893014|FG001|Overall Study|Personal Reason|0|||
170694488|NCT00455429|616893015|FG002|Overall Study|Personal Reason|0|||
170694489|NCT00455429|616893016|FG003|Overall Study|Personal Reason|0|||
170694490|NCT00455429|616893013|FG000|Overall Study|Non-compliance|0|||
170694491|NCT00455429|616893014|FG001|Overall Study|Non-compliance|0|||
170694492|NCT00455429|616893015|FG002|Overall Study|Non-compliance|0|||
170694493|NCT00455429|616893016|FG003|Overall Study|Non-compliance|1|||
170694494|NCT00455429|616893013|FG000|Overall Study|Other|0|||
170694495|NCT00455429|616893014|FG001|Overall Study|Other|2|||
170694496|NCT00455429|616893015|FG002|Overall Study|Other|0|||
170694497|NCT00455429|616893016|FG003|Overall Study|Other|1|||
170694498|NCT05517382|616893017|FG000|Overall Study|Lost to Follow-up|0|||
170694499|NCT05517382|616893018|FG001|Overall Study|Lost to Follow-up|1|||
170694500|NCT00271947|616893025|FG000|Overall Study|Lost to Follow-up|1|||
170694501|NCT04170348|616893026|FG000|Overall Study|Lost to Follow-up|2|||
170694502|NCT04170348|616893027|FG001|Overall Study|Lost to Follow-up|2|||
170694503|NCT04170348|616893026|FG000|Overall Study|Withdrawal by Subject|1|||
170694504|NCT04170348|616893027|FG001|Overall Study|Withdrawal by Subject|5|||
170694505|NCT04170348|616893026|FG000|Overall Study|Non-adherence|1|||
170694506|NCT04170348|616893027|FG001|Overall Study|Non-adherence|1|||
170694507|NCT04170348|616893026|FG000|Overall Study|Adverse Event|1|||
170694508|NCT04170348|616893027|FG001|Overall Study|Adverse Event|0|||
170694509|NCT00449644|616893029|FG000|Overall Study|Adverse Event|0|||
170694510|NCT00449644|616893030|FG001|Overall Study|Adverse Event|0|||
170694511|NCT00449644|616893031|FG002|Overall Study|Adverse Event|3|||
170694512|NCT00449644|616893032|FG003|Overall Study|Adverse Event|5|||
170694513|NCT00449644|616893029|FG000|Overall Study|Death|1|||
170694514|NCT00449644|616893030|FG001|Overall Study|Death|0|||
170694515|NCT00449644|616893031|FG002|Overall Study|Death|6|||
170694516|NCT00449644|616893032|FG003|Overall Study|Death|1|||
170694517|NCT00449644|616893029|FG000|Overall Study|Lost to Follow-up|1|||
170694518|NCT00449644|616893030|FG001|Overall Study|Lost to Follow-up|1|||
170694519|NCT00449644|616893031|FG002|Overall Study|Lost to Follow-up|5|||
170694520|NCT00449644|616893032|FG003|Overall Study|Lost to Follow-up|3|||
170694521|NCT00449644|616893029|FG000|Overall Study|Pregnancy|0|||
170694522|NCT00449644|616893030|FG001|Overall Study|Pregnancy|0|||
170694523|NCT00449644|616893031|FG002|Overall Study|Pregnancy|3|||
170694524|NCT00449644|616893032|FG003|Overall Study|Pregnancy|2|||
170694525|NCT00449644|616893029|FG000|Overall Study|Protocol Violation|4|||
170694526|NCT00449644|616893030|FG001|Overall Study|Protocol Violation|4|||
170694527|NCT00449644|616893031|FG002|Overall Study|Protocol Violation|3|||
170694528|NCT00449644|616893032|FG003|Overall Study|Protocol Violation|7|||
170694529|NCT00449644|616893029|FG000|Overall Study|Withdrawal by Subject|3|||
170694530|NCT00449644|616893030|FG001|Overall Study|Withdrawal by Subject|4|||
170694531|NCT00449644|616893031|FG002|Overall Study|Withdrawal by Subject|6|||
170694532|NCT00449644|616893032|FG003|Overall Study|Withdrawal by Subject|7|||
170694533|NCT00449644|616893029|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
170694534|NCT00449644|616893030|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
170694535|NCT00449644|616893031|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
170694536|NCT00449644|616893032|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
170694537|NCT00449644|616893029|FG000|Overall Study|Other|1|||
170694538|NCT00449644|616893030|FG001|Overall Study|Other|4|||
170823272|NCT00475735|617360494|FG004|Treatment Period 1|DC due to AE but continuing|2|||
170694539|NCT00449644|616893031|FG002|Overall Study|Other|1|||
170694540|NCT00449644|616893032|FG003|Overall Study|Other|0|||
170823273|NCT00475735|617360495|FG005|Treatment Period 1|DC due to AE but continuing|2|||
170694541|NCT00449644|616893029|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
170694542|NCT00449644|616893030|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
170694543|NCT00449644|616893031|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
170694544|NCT00449644|616893032|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
170694545|NCT03642717|616893033|FG000|Overall Study|Lost to Follow-up|2|||
170694546|NCT03642717|616893033|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
170694547|NCT03642717|616893033|FG000|Overall Study|Taken study drug prior to contract date|3|||
170694548|NCT02587065|616893036|FG000|Overall Study|Adverse Event|14|||
170694549|NCT02587065|616893036|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
170694550|NCT02587065|616893036|FG000|Overall Study|Non-adherence to the Protocol|3|||
170694551|NCT02587065|616893036|FG000|Overall Study|Discontinuation of Study Medication|2|||
170694552|NCT02587065|616893036|FG000|Overall Study|Reason not Specified|3|||
170694553|NCT00302458|616893039|FG000|Overall Study|Lost to Follow-up|1|||
170694554|NCT00302458|616893039|FG000|Overall Study|Ineligible after screening|1|||
170694555|NCT00302458|616893039|FG000|Overall Study|Withdrawal by Subject|1|||
170694556|NCT00853723|616893040|FG000|Overall Study|Adverse Event|3|||
170694557|NCT00853723|616893041|FG001|Overall Study|Adverse Event|4|||
170694558|NCT00853723|616893042|FG002|Overall Study|Adverse Event|1|||
170694559|NCT00853723|616893040|FG000|Overall Study|Withdrawal by Subject|2|||
170694560|NCT00853723|616893041|FG001|Overall Study|Withdrawal by Subject|1|||
170694561|NCT00853723|616893042|FG002|Overall Study|Withdrawal by Subject|0|||
170694562|NCT00853723|616893040|FG000|Overall Study|Protocol Violation|1|||
170694563|NCT00853723|616893041|FG001|Overall Study|Protocol Violation|2|||
170694564|NCT00853723|616893042|FG002|Overall Study|Protocol Violation|1|||
170694565|NCT05198843|616893043|FG000|Overall Study|Lack of Efficacy|1|||
170694566|NCT03795298|616893047|FG000|Overall Study|Death|34|||
170694567|NCT03795298|616893048|FG001|Overall Study|Death|29|||
170694568|NCT03795298|616893047|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
170694569|NCT03795298|616893048|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
170694570|NCT03795298|616893047|FG000|Overall Study|Lost to Follow-up|28|||
170694571|NCT03795298|616893048|FG001|Overall Study|Lost to Follow-up|17|||
170694572|NCT03795298|616893047|FG000|Overall Study|Physician Decision|5|||
170694573|NCT03795298|616893048|FG001|Overall Study|Physician Decision|4|||
170694574|NCT03795298|616893047|FG000|Overall Study|Withdrawal by Subject|43|||
170694575|NCT03795298|616893048|FG001|Overall Study|Withdrawal by Subject|28|||
170694576|NCT03795298|616893047|FG000|Overall Study|Reason not reported|7|||
170694577|NCT03795298|616893048|FG001|Overall Study|Reason not reported|9|||
170694578|NCT01541969|616894160|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
170694579|NCT01541969|616894161|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
170694580|NCT01541969|616894160|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
170694581|NCT01541969|616894161|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
170694582|NCT01541969|616894160|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
170694583|NCT01541969|616894161|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
170694584|NCT01541969|616894160|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
170694585|NCT01541969|616894161|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
170694586|NCT01541969|616894160|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
170694587|NCT01541969|616894161|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
170694588|NCT01541969|616894160|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
170694589|NCT01541969|616894161|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
170694590|NCT01541969|616894160|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
170694591|NCT01541969|616894161|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
170694592|NCT01541969|616894160|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
170694593|NCT01541969|616894161|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
170694594|NCT01541969|616894160|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
170694595|NCT01541969|616894161|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
170694596|NCT01541969|616894160|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
170694597|NCT01541969|616894161|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
170694598|NCT01881230|616894162|FG000|Overall Study|Death|2|||
170694599|NCT01881230|616894163|FG001|Overall Study|Death|0|||
170694600|NCT01881230|616894164|FG002|Overall Study|Death|1|||
170694601|NCT01881230|616894162|FG000|Overall Study|Adverse Event|9|||
170694602|NCT01881230|616894163|FG001|Overall Study|Adverse Event|13|||
170694603|NCT01881230|616894164|FG002|Overall Study|Adverse Event|12|||
170694604|NCT01881230|616894162|FG000|Overall Study|Progressive Disease|31|||
170694605|NCT01881230|616894163|FG001|Overall Study|Progressive Disease|35|||
170694606|NCT01881230|616894164|FG002|Overall Study|Progressive Disease|36|||
170694607|NCT01881230|616894162|FG000|Overall Study|Symptomatic Deterioration|3|||
170694608|NCT01881230|616894163|FG001|Overall Study|Symptomatic Deterioration|3|||
170694609|NCT01881230|616894164|FG002|Overall Study|Symptomatic Deterioration|1|||
170694610|NCT01881230|616894162|FG000|Overall Study|Withdrawal by Subject|6|||
170823274|NCT00475735|617360490|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
170823275|NCT00475735|617360491|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
170823276|NCT00475735|617360492|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
170823277|NCT00475735|617360493|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
170694611|NCT01881230|616894163|FG001|Overall Study|Withdrawal by Subject|4|||
170694612|NCT01881230|616894164|FG002|Overall Study|Withdrawal by Subject|6|||
170694613|NCT01881230|616894162|FG000|Overall Study|Physician Decision|4|||
170694614|NCT01881230|616894163|FG001|Overall Study|Physician Decision|3|||
170694615|NCT01881230|616894164|FG002|Overall Study|Physician Decision|6|||
170694616|NCT01881230|616894162|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170694617|NCT01881230|616894163|FG001|Overall Study|Non-Compliance with Study Drug|2|||
170694618|NCT01881230|616894164|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170694619|NCT01881230|616894162|FG000|Overall Study|Given Commercially Available Drug|0|||
170694620|NCT01881230|616894163|FG001|Overall Study|Given Commercially Available Drug|0|||
170694621|NCT01881230|616894164|FG002|Overall Study|Given Commercially Available Drug|2|||
170694622|NCT01881230|616894162|FG000|Overall Study|Protocol Violation|1|||
170694623|NCT01881230|616894163|FG001|Overall Study|Protocol Violation|1|||
170694624|NCT01881230|616894164|FG002|Overall Study|Protocol Violation|0|||
170694625|NCT01881230|616894162|FG000|Overall Study|Miscellaneous|3|||
170694626|NCT01881230|616894163|FG001|Overall Study|Miscellaneous|3|||
170694627|NCT01881230|616894164|FG002|Overall Study|Miscellaneous|0|||
170694628|NCT01881230|616894162|FG000|Overall Study|Untreated: Other|0|||
170694629|NCT01881230|616894163|FG001|Overall Study|Untreated: Other|0|||
170694630|NCT01881230|616894164|FG002|Overall Study|Untreated: Other|1|||
170694631|NCT01881230|616894162|FG000|Overall Study|Untreated: Death|0|||
170694632|NCT01881230|616894163|FG001|Overall Study|Untreated: Death|0|||
170694633|NCT01881230|616894164|FG002|Overall Study|Untreated: Death|1|||
170694634|NCT01881230|616894162|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
170694635|NCT01881230|616894163|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
170694636|NCT01881230|616894164|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
170694637|NCT02747420|616894165|FG000|Overall Study|Lost to Follow-up|4|||
170694638|NCT02747420|616894166|FG001|Overall Study|Lost to Follow-up|2|||
170694639|NCT02747420|616894165|FG000|Overall Study|Withdrawal by Subject|3|||
170694640|NCT02747420|616894166|FG001|Overall Study|Withdrawal by Subject|2|||
170694641|NCT03616912|616894171|FG000|Overall Study|Adverse Event|17|||
170694642|NCT03616912|616894172|FG001|Overall Study|Adverse Event|21|||
170694643|NCT03616912|616894173|FG002|Overall Study|Adverse Event|9|||
170694644|NCT03616912|616894174|FG003|Overall Study|Adverse Event|0|||
170694645|NCT03616912|616894175|FG004|Overall Study|Adverse Event|0|||
170694646|NCT03616912|616894176|FG005|Overall Study|Adverse Event|0|||
170694647|NCT03616912|616894171|FG000|Overall Study|Death|1|||
170694648|NCT03616912|616894172|FG001|Overall Study|Death|1|||
170694649|NCT03616912|616894173|FG002|Overall Study|Death|0|||
170694650|NCT03616912|616894174|FG003|Overall Study|Death|0|||
170694651|NCT03616912|616894175|FG004|Overall Study|Death|0|||
170694652|NCT03616912|616894176|FG005|Overall Study|Death|0|||
170694653|NCT03616912|616894171|FG000|Overall Study|Lack of Efficacy|13|||
170694654|NCT03616912|616894172|FG001|Overall Study|Lack of Efficacy|6|||
170694655|NCT03616912|616894173|FG002|Overall Study|Lack of Efficacy|8|||
170694656|NCT03616912|616894174|FG003|Overall Study|Lack of Efficacy|4|||
170694657|NCT03616912|616894175|FG004|Overall Study|Lack of Efficacy|5|||
170694658|NCT03616912|616894176|FG005|Overall Study|Lack of Efficacy|1|||
170694659|NCT03616912|616894171|FG000|Overall Study|Lost to Follow-up|1|||
170694660|NCT03616912|616894172|FG001|Overall Study|Lost to Follow-up|2|||
170694661|NCT03616912|616894173|FG002|Overall Study|Lost to Follow-up|3|||
170694662|NCT03616912|616894174|FG003|Overall Study|Lost to Follow-up|0|||
170694663|NCT03616912|616894175|FG004|Overall Study|Lost to Follow-up|0|||
170694664|NCT03616912|616894176|FG005|Overall Study|Lost to Follow-up|0|||
170694665|NCT03616912|616894171|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
170694666|NCT03616912|616894172|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
170694667|NCT03616912|616894173|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
170694668|NCT03616912|616894174|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
170694669|NCT03616912|616894175|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
170694670|NCT03616912|616894176|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
170694671|NCT03616912|616894171|FG000|Overall Study|Withdrawal by Subject|12|||
170694672|NCT03616912|616894172|FG001|Overall Study|Withdrawal by Subject|12|||
170694673|NCT03616912|616894173|FG002|Overall Study|Withdrawal by Subject|15|||
170694674|NCT03616912|616894174|FG003|Overall Study|Withdrawal by Subject|2|||
170694675|NCT03616912|616894175|FG004|Overall Study|Withdrawal by Subject|0|||
170694676|NCT03616912|616894176|FG005|Overall Study|Withdrawal by Subject|2|||
170694677|NCT03616912|616894171|FG000|Overall Study|Study Terminated by Sponsor|0|||
170694678|NCT03616912|616894172|FG001|Overall Study|Study Terminated by Sponsor|0|||
170694679|NCT03616912|616894173|FG002|Overall Study|Study Terminated by Sponsor|0|||
170694680|NCT03616912|616894174|FG003|Overall Study|Study Terminated by Sponsor|10|||
170694681|NCT03616912|616894175|FG004|Overall Study|Study Terminated by Sponsor|9|||
170694682|NCT03616912|616894176|FG005|Overall Study|Study Terminated by Sponsor|11|||
170694683|NCT03616912|616894171|FG000|Overall Study|Protocol Deviation|1|||
170694684|NCT03616912|616894172|FG001|Overall Study|Protocol Deviation|1|||
170694685|NCT03616912|616894173|FG002|Overall Study|Protocol Deviation|0|||
170694686|NCT03616912|616894174|FG003|Overall Study|Protocol Deviation|0|||
170694687|NCT03616912|616894175|FG004|Overall Study|Protocol Deviation|0|||
170694688|NCT03616912|616894176|FG005|Overall Study|Protocol Deviation|0|||
170694689|NCT03616912|616894171|FG000|Overall Study|Pregnancy|1|||
170694690|NCT03616912|616894172|FG001|Overall Study|Pregnancy|0|||
170694691|NCT03616912|616894173|FG002|Overall Study|Pregnancy|4|||
170694692|NCT03616912|616894174|FG003|Overall Study|Pregnancy|0|||
170694693|NCT03616912|616894175|FG004|Overall Study|Pregnancy|0|||
170694694|NCT03616912|616894176|FG005|Overall Study|Pregnancy|0|||
170694695|NCT03616912|616894171|FG000|Overall Study|Protocol Violation|1|||
170694696|NCT03616912|616894172|FG001|Overall Study|Protocol Violation|0|||
170694697|NCT03616912|616894173|FG002|Overall Study|Protocol Violation|2|||
170694698|NCT03616912|616894174|FG003|Overall Study|Protocol Violation|0|||
170694699|NCT03616912|616894175|FG004|Overall Study|Protocol Violation|0|||
170694700|NCT03616912|616894176|FG005|Overall Study|Protocol Violation|0|||
170694701|NCT03616912|616894171|FG000|Overall Study|Physician Decision|2|||
170694702|NCT03616912|616894172|FG001|Overall Study|Physician Decision|0|||
170694703|NCT03616912|616894173|FG002|Overall Study|Physician Decision|0|||
170694704|NCT03616912|616894174|FG003|Overall Study|Physician Decision|0|||
170694705|NCT03616912|616894175|FG004|Overall Study|Physician Decision|1|||
170694706|NCT03616912|616894176|FG005|Overall Study|Physician Decision|0|||
170694707|NCT03616912|616894171|FG000|Overall Study|Randomized But Never Treated|0|||
170694708|NCT03616912|616894172|FG001|Overall Study|Randomized But Never Treated|2|||
170694709|NCT03616912|616894173|FG002|Overall Study|Randomized But Never Treated|0|||
170694710|NCT03616912|616894174|FG003|Overall Study|Randomized But Never Treated|0|||
170694711|NCT03616912|616894175|FG004|Overall Study|Randomized But Never Treated|0|||
170694712|NCT03616912|616894176|FG005|Overall Study|Randomized But Never Treated|0|||
170694713|NCT02404311|616894177|FG000|Part A: Month 0-18|Death|2|||
170694714|NCT02404311|616894178|FG001|Part A: Month 0-18|Death|0|||
170694715|NCT02404311|616894179|FG002|Part A: Month 0-18|Death|0|||
170694716|NCT02404311|616894180|FG003|Part A: Month 0-18|Death|0|||
170694717|NCT02404311|616894181|FG004|Part A: Month 0-18|Death|0|||
170694718|NCT02404311|616894177|FG000|Part A: Month 0-18|Physician Decision|1|||
170694719|NCT02404311|616894178|FG001|Part A: Month 0-18|Physician Decision|0|||
170694720|NCT02404311|616894179|FG002|Part A: Month 0-18|Physician Decision|0|||
170694721|NCT02404311|616894180|FG003|Part A: Month 0-18|Physician Decision|0|||
170694722|NCT02404311|616894181|FG004|Part A: Month 0-18|Physician Decision|0|||
170694723|NCT02404311|616894177|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
170694724|NCT02404311|616894178|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
170694725|NCT02404311|616894179|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
170694726|NCT02404311|616894180|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
170694727|NCT02404311|616894181|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
170694728|NCT02404311|616894177|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
170694729|NCT02404311|616894178|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
170694730|NCT02404311|616894179|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
170694731|NCT02404311|616894180|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
170694732|NCT02404311|616894181|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
170694733|NCT02404311|616894177|FG000|Part A: Month 0-18|HIV Infection|6|||
170694734|NCT02404311|616894178|FG001|Part A: Month 0-18|HIV Infection|2|||
170694735|NCT02404311|616894179|FG002|Part A: Month 0-18|HIV Infection|0|||
170694736|NCT02404311|616894180|FG003|Part A: Month 0-18|HIV Infection|0|||
170694737|NCT02404311|616894181|FG004|Part A: Month 0-18|HIV Infection|0|||
170694738|NCT02404311|616894177|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
170694739|NCT02404311|616894178|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
170694740|NCT02404311|616894179|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
170694741|NCT02404311|616894180|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
170694742|NCT02404311|616894181|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
170694743|NCT00278954|616894186|FG000|Overall Study|Adverse Event|3|||
170694744|NCT00278954|616894186|FG000|Overall Study|Lost to Follow-up|1|||
170823278|NCT00475735|617360494|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
170694745|NCT00278954|616894186|FG000|Overall Study|Withdrawal by Subject|1|||
170694746|NCT03406858|616894187|FG000|Overall Study|Failure to receive treatment drug.|1|||
170694747|NCT03406858|616894187|FG000|Overall Study|ineligible|1|||
170694748|NCT06027866|616894188|FG000|Overall Study|Withdrawal by Subject|2|||
170694749|NCT00507442|616894189|FG000|Overall Study|Adverse Event|8|||
170694750|NCT00507442|616894190|FG001|Overall Study|Adverse Event|11|||
170823279|NCT00475735|617360495|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
170823280|NCT00475735|617360490|FG000|Treatment Washout|Lost to Follow-up|0|||
170823281|NCT00475735|617360491|FG001|Treatment Washout|Lost to Follow-up|1|||
170694751|NCT00507442|616894191|FG002|Overall Study|Adverse Event|4|||
170694752|NCT00507442|616894192|FG003|Overall Study|Adverse Event|1|||
170694753|NCT00507442|616894189|FG000|Overall Study|Protocol Violation|0|||
170694754|NCT00507442|616894190|FG001|Overall Study|Protocol Violation|1|||
170694755|NCT00507442|616894191|FG002|Overall Study|Protocol Violation|0|||
170823282|NCT00475735|617360492|FG002|Treatment Washout|Lost to Follow-up|0|||
170694756|NCT00507442|616894192|FG003|Overall Study|Protocol Violation|0|||
170694757|NCT00507442|616894189|FG000|Overall Study|Lost to Follow-up|0|||
170694758|NCT00507442|616894190|FG001|Overall Study|Lost to Follow-up|0|||
170694759|NCT00507442|616894191|FG002|Overall Study|Lost to Follow-up|1|||
170694760|NCT00507442|616894192|FG003|Overall Study|Lost to Follow-up|0|||
170694761|NCT00507442|616894189|FG000|Overall Study|Physician Decision|0|||
170694762|NCT00507442|616894190|FG001|Overall Study|Physician Decision|2|||
170694763|NCT00507442|616894191|FG002|Overall Study|Physician Decision|4|||
170694764|NCT00507442|616894192|FG003|Overall Study|Physician Decision|1|||
170823283|NCT00475735|617360493|FG003|Treatment Washout|Lost to Follow-up|0|||
170823284|NCT00475735|617360494|FG004|Treatment Washout|Lost to Follow-up|0|||
170823285|NCT00475735|617360495|FG005|Treatment Washout|Lost to Follow-up|0|||
170823286|NCT00475735|617360490|FG000|Treatment Washout|Protocol Violation|0|||
170823287|NCT00475735|617360491|FG001|Treatment Washout|Protocol Violation|1|||
170823288|NCT00475735|617360492|FG002|Treatment Washout|Protocol Violation|0|||
170823289|NCT00475735|617360493|FG003|Treatment Washout|Protocol Violation|0|||
170823290|NCT00475735|617360494|FG004|Treatment Washout|Protocol Violation|0|||
170823291|NCT00475735|617360495|FG005|Treatment Washout|Protocol Violation|0|||
170823292|NCT00475735|617360490|FG000|Treatment Period 2|Adverse Event|0|||
170823293|NCT00475735|617360491|FG001|Treatment Period 2|Adverse Event|1|||
170823294|NCT00475735|617360492|FG002|Treatment Period 2|Adverse Event|0|||
170823295|NCT00475735|617360493|FG003|Treatment Period 2|Adverse Event|2|||
170694765|NCT00507442|616894189|FG000|Overall Study|Progressive Disease|2|||
170694766|NCT00507442|616894190|FG001|Overall Study|Progressive Disease|4|||
170694767|NCT00507442|616894191|FG002|Overall Study|Progressive Disease|2|||
170694768|NCT00507442|616894192|FG003|Overall Study|Progressive Disease|0|||
170694769|NCT00507442|616894189|FG000|Overall Study|Withdrawal by Subject|4|||
170694770|NCT00507442|616894190|FG001|Overall Study|Withdrawal by Subject|4|||
170694771|NCT00507442|616894191|FG002|Overall Study|Withdrawal by Subject|2|||
170694772|NCT00507442|616894192|FG003|Overall Study|Withdrawal by Subject|1|||
170694773|NCT00507442|616894189|FG000|Overall Study|Other|2|||
170694774|NCT00507442|616894190|FG001|Overall Study|Other|5|||
170694775|NCT00507442|616894191|FG002|Overall Study|Other|2|||
170694776|NCT00507442|616894192|FG003|Overall Study|Other|2|||
170694777|NCT01454570|616894201|FG000|Overall Study|Withdrawal by Subject|2|||
170694778|NCT01454570|616894201|FG000|Overall Study|Screen Failure|7|||
170694779|NCT03506373|616894202|FG000|Overall Study|Adverse Event|6|||
170694780|NCT03506373|616894202|FG000|Overall Study|Withdrawal by Subject|2|||
170694781|NCT03506373|616894202|FG000|Overall Study|Disease progression|5|||
170694782|NCT03506373|616894202|FG000|Overall Study|Other|3|||
170694783|NCT00107198|616894206|FG000|Overall Study|Lack of Efficacy|28|||
170694784|NCT00107198|616894206|FG000|Overall Study|Lost to Follow-up|12|||
170694785|NCT00107198|616894206|FG000|Overall Study|Protocol Violation|1|||
170694786|NCT00107198|616894206|FG000|Overall Study|Withdrawal by Subject|6|||
170694787|NCT00107198|616894206|FG000|Overall Study|Ineligible|5|||
170694788|NCT02420691|616894209|FG000|Overall Study|Adverse Event|3|||
170694789|NCT02420691|616894209|FG000|Overall Study|Withdrawal by Subject|3|||
170694790|NCT00325754|616894210|FG000|Overall Study|Adverse Event|4|||
170694791|NCT00325754|616894211|FG001|Overall Study|Adverse Event|1|||
170694792|NCT01852812|616894215|FG000|Overall Study|Adverse Event|0|||
170694793|NCT01852812|616894216|FG001|Overall Study|Adverse Event|0|||
170694794|NCT01852812|616894217|FG002|Overall Study|Adverse Event|1|||
170694795|NCT01852812|616894215|FG000|Overall Study|Non-compliance With Study Drug|0|||
170694796|NCT01852812|616894216|FG001|Overall Study|Non-compliance With Study Drug|1|||
170694797|NCT01852812|616894217|FG002|Overall Study|Non-compliance With Study Drug|0|||
170694798|NCT00791518|616894218|FG000|Overall Study|Protocol Violation|93|||
170694799|NCT00720057|616894221|FG000|Overall Study|Lost to Follow-up|0|||
170694800|NCT00720057|616894222|FG001|Overall Study|Lost to Follow-up|2|||
170694801|NCT00720057|616894221|FG000|Overall Study|Protocol Violation|1|||
170694802|NCT00720057|616894222|FG001|Overall Study|Protocol Violation|0|||
170694803|NCT00720057|616894221|FG000|Overall Study|Withdrawal by Subject|0|||
170694804|NCT00720057|616894222|FG001|Overall Study|Withdrawal by Subject|1|||
170694805|NCT04969224|616894225|FG000|Overall Study|Adverse Event|1|||
170823296|NCT00475735|617360494|FG004|Treatment Period 2|Adverse Event|0|||
170823297|NCT00475735|617360495|FG005|Treatment Period 2|Adverse Event|0|||
170694806|NCT04969224|616894225|FG000|Overall Study|Enrolled but never dosed|1|||
170823298|NCT00475735|617360490|FG000|Treatment Period 2|Lack of Efficacy|0|||
170823299|NCT00475735|617360491|FG001|Treatment Period 2|Lack of Efficacy|0|||
170823300|NCT00475735|617360492|FG002|Treatment Period 2|Lack of Efficacy|0|||
170823301|NCT00475735|617360493|FG003|Treatment Period 2|Lack of Efficacy|0|||
170823302|NCT00475735|617360494|FG004|Treatment Period 2|Lack of Efficacy|0|||
170694807|NCT02726074|616894233|FG000|Overall Study|Withdrawal by Subject|4|||
170694808|NCT02726074|616894233|FG000|Overall Study|Adverse Event|14|||
170694809|NCT02726074|616894233|FG000|Overall Study|Protocol Violation|3|||
170823303|NCT00475735|617360495|FG005|Treatment Period 2|Lack of Efficacy|1|||
170823304|NCT00475735|617360490|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170823305|NCT00475735|617360491|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170823306|NCT00475735|617360492|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170823307|NCT00475735|617360493|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170823308|NCT00475735|617360494|FG004|Treatment Period 2|Withdrawal by Subject|1|||
170823309|NCT00475735|617360495|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170694810|NCT02726074|616894233|FG000|Overall Study|Lost to Follow-up|2|||
170694811|NCT02726074|616894233|FG000|Overall Study|Others|3|||
170694812|NCT00579826|616894234|FG000|Overall Study|Withdrawal by Subject|5|||
170694813|NCT00579826|616894235|FG001|Overall Study|Withdrawal by Subject|3|||
170694814|NCT04191382|616894236|FG000|Overall Study|Withdrawal by Subject|1|||
170694815|NCT04191382|616894237|FG001|Overall Study|Withdrawal by Subject|0|||
170823310|NCT00745121|617360496|FG000|Overall Study|Death|3|||
170823311|NCT00745121|617360497|FG001|Overall Study|Death|0|||
170823312|NCT00745121|617360496|FG000|Overall Study|Adverse Event|1|||
170823313|NCT00745121|617360497|FG001|Overall Study|Adverse Event|0|||
170823314|NCT00745121|617360496|FG000|Overall Study|Lost to Follow-up|1|||
170823315|NCT00745121|617360497|FG001|Overall Study|Lost to Follow-up|0|||
170823316|NCT00745121|617360496|FG000|Overall Study|Withdrawal by Subject|4|||
170823317|NCT00745121|617360497|FG001|Overall Study|Withdrawal by Subject|2|||
170823318|NCT01187407|617360498|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
170823319|NCT01187407|617360499|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170823320|NCT01187407|617360500|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170823321|NCT01187407|617360501|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170823322|NCT01187407|617360502|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
170823323|NCT01187407|617360498|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
170823324|NCT01187407|617360499|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170823325|NCT01187407|617360500|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170823326|NCT01187407|617360501|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170823327|NCT01187407|617360502|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
170823328|NCT01187407|617360498|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
170823329|NCT01187407|617360499|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170823330|NCT01187407|617360500|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170823331|NCT01187407|617360501|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170823332|NCT01187407|617360502|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
170823333|NCT01187407|617360498|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
170823334|NCT01187407|617360499|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170823335|NCT01187407|617360500|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170823336|NCT01187407|617360501|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170823337|NCT01187407|617360502|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
170823338|NCT01187407|617360498|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
170823339|NCT01187407|617360499|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170823340|NCT01187407|617360500|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170823341|NCT01187407|617360501|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170823342|NCT01187407|617360502|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
170823343|NCT01187407|617360498|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
170823344|NCT01187407|617360499|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170823345|NCT01187407|617360500|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170823346|NCT01187407|617360501|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170823347|NCT01187407|617360502|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
170823348|NCT01187407|617360498|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
170823349|NCT01187407|617360499|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170823350|NCT01187407|617360500|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170823351|NCT01187407|617360501|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170694816|NCT04191382|616894238|FG002|Overall Study|Withdrawal by Subject|0|||
170694817|NCT06049043|616894241|FG000|Overall Study|Lost to Follow-up|11|||
170694818|NCT06049043|616894242|FG001|Overall Study|Lost to Follow-up|9|||
170694819|NCT00271609|616894243|FG000|Overall Study|Adverse Event|11|||
170694820|NCT00271609|616894244|FG001|Overall Study|Adverse Event|3|||
170694821|NCT00271609|616894243|FG000|Overall Study|Withdrawal by Subject|2|||
170694822|NCT00271609|616894244|FG001|Overall Study|Withdrawal by Subject|0|||
170694823|NCT00768300|616894247|FG000|Overall Study|Randomized but not treated|1|||
170694824|NCT00768300|616894248|FG001|Overall Study|Randomized but not treated|1|||
170694825|NCT00768300|616894247|FG000|Overall Study|Adverse Event|10|||
170694826|NCT00768300|616894248|FG001|Overall Study|Adverse Event|2|||
170694827|NCT00768300|616894247|FG000|Overall Study|Protocol Violation|6|||
170694828|NCT00768300|616894248|FG001|Overall Study|Protocol Violation|1|||
170694829|NCT00768300|616894247|FG000|Overall Study|Withdrawal by Subject|13|||
170694830|NCT00768300|616894248|FG001|Overall Study|Withdrawal by Subject|7|||
170694831|NCT00768300|616894247|FG000|Overall Study|Physician Decision|2|||
170823352|NCT01187407|617360502|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
170823353|NCT01187407|617360498|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
170823354|NCT01187407|617360499|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
170823355|NCT01187407|617360500|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
170823356|NCT01187407|617360501|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
170823357|NCT01187407|617360502|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
170823358|NCT01187407|617360498|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
170694832|NCT00768300|616894248|FG001|Overall Study|Physician Decision|3|||
170694833|NCT00768300|616894247|FG000|Overall Study|Study discontinued by Sponsor|271|||
170823359|NCT01187407|617360499|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
170694834|NCT00768300|616894248|FG001|Overall Study|Study discontinued by Sponsor|140|||
170694835|NCT00768300|616894247|FG000|Overall Study|Death|21|||
170694836|NCT00768300|616894248|FG001|Overall Study|Death|5|||
170694837|NCT00768300|616894247|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
170694838|NCT00768300|616894248|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
170694839|NCT00768300|616894247|FG000|Overall Study|Screen failure following randomization|1|||
170694840|NCT00768300|616894248|FG001|Overall Study|Screen failure following randomization|0|||
170694841|NCT00768300|616894247|FG000|Overall Study|Received lung transplant|1|||
170694842|NCT00768300|616894248|FG001|Overall Study|Received lung transplant|1|||
170694843|NCT00768300|616894247|FG000|Overall Study|Lost to Follow-up|0|||
170694844|NCT00768300|616894248|FG001|Overall Study|Lost to Follow-up|1|||
170694845|NCT00768300|616894247|FG000|Overall Study|Began prohibited concomitant medication|0|||
170694846|NCT00768300|616894248|FG001|Overall Study|Began prohibited concomitant medication|1|||
170694847|NCT00768300|616894247|FG000|Overall Study|Treated but never dosed with Study drug|1|||
170694848|NCT00768300|616894248|FG001|Overall Study|Treated but never dosed with Study drug|0|||
170694849|NCT00768300|616894247|FG000|Overall Study|Missing data|1|||
170694850|NCT00768300|616894248|FG001|Overall Study|Missing data|0|||
170694851|NCT02068222|616894249|FG000|Overall Study|Lost to Follow-up|1|||
170694852|NCT00735878|616894253|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
170694853|NCT00735878|616894254|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
170694854|NCT00735878|616894255|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
170694855|NCT01082965|616894256|FG000|Overall Study|Protocol Violation|0|||
170694856|NCT01082965|616894257|FG001|Overall Study|Protocol Violation|1|||
170694857|NCT01082965|616894256|FG000|Overall Study|Other|1|||
170694858|NCT01082965|616894257|FG001|Overall Study|Other|1|||
170694859|NCT01559012|616894260|FG000|Overall Study|Withdrawal by Subject|0|||
170694860|NCT01559012|616894261|FG001|Overall Study|Withdrawal by Subject|1|||
170694861|NCT00946712|616894262|FG000|Overall Study|Adverse Event|118|||
170694862|NCT00946712|616894263|FG001|Overall Study|Adverse Event|124|||
170694863|NCT00946712|616894262|FG000|Overall Study|Disease progression|308|||
170694864|NCT00946712|616894263|FG001|Overall Study|Disease progression|404|||
170694865|NCT00946712|616894262|FG000|Overall Study|Death|21|||
170694866|NCT00946712|616894263|FG001|Overall Study|Death|22|||
170694867|NCT00946712|616894262|FG000|Overall Study|No treatment given|25|||
170694868|NCT00946712|616894263|FG001|Overall Study|No treatment given|29|||
170694869|NCT00946712|616894262|FG000|Overall Study|Other reasons|61|||
170694870|NCT00946712|616894263|FG001|Overall Study|Other reasons|73|||
170694871|NCT00946712|616894262|FG000|Overall Study|On Treatment|0|||
170694872|NCT00946712|616894263|FG001|Overall Study|On Treatment|4|||
170694873|NCT00946712|616894262|FG000|Overall Study|Ineligible|14|||
170694874|NCT00946712|616894263|FG001|Overall Study|Ineligible|6|||
170694875|NCT02642432|616894265|FG000|Overall Study|Adverse Event|2|||
170694876|NCT02642432|616894265|FG000|Overall Study|Withdrew Consent|1|||
170694877|NCT02642432|616894265|FG000|Overall Study|Lost to Follow-up|2|||
170694878|NCT02642432|616894265|FG000|Overall Study|Other|3|||
170694879|NCT02447081|616894266|FG000|Overall Study|Death|161|||
170694880|NCT02447081|616894266|FG000|Overall Study|Lost to Follow-up|36|||
170694881|NCT02447081|616894266|FG000|Overall Study|Visit not completed|17|||
170694882|NCT02447081|616894266|FG000|Overall Study|unsuccessful implant procedure|10|||
170694883|NCT02867709|616894269|FG000|Treatment Period|Adverse Event|1|||
170694884|NCT02867709|616894270|FG001|Treatment Period|Adverse Event|1|||
170694885|NCT02867709|616894271|FG002|Treatment Period|Adverse Event|2|||
170694886|NCT02867709|616894269|FG000|Treatment Period|Withdrawal of Consent|7|||
170694887|NCT02867709|616894270|FG001|Treatment Period|Withdrawal of Consent|9|||
170694888|NCT02867709|616894271|FG002|Treatment Period|Withdrawal of Consent|8|||
170694889|NCT02867709|616894269|FG000|Treatment Period|Lost to Follow-up|17|||
170823360|NCT01187407|617360500|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
170823361|NCT01187407|617360501|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
170823362|NCT01187407|617360502|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
170823363|NCT01187407|617360498|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
170823364|NCT01187407|617360499|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
170694890|NCT02867709|616894270|FG001|Treatment Period|Lost to Follow-up|20|||
170694891|NCT02867709|616894271|FG002|Treatment Period|Lost to Follow-up|20|||
170694892|NCT02867709|616894269|FG000|Treatment Period|Lack of Qualifying Event|42|||
170823365|NCT01187407|617360500|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
170694893|NCT02867709|616894270|FG001|Treatment Period|Lack of Qualifying Event|55|||
170694894|NCT02867709|616894271|FG002|Treatment Period|Lack of Qualifying Event|42|||
170694895|NCT02867709|616894269|FG000|Treatment Period|Protocol Violation|3|||
170694896|NCT02867709|616894270|FG001|Treatment Period|Protocol Violation|2|||
170694897|NCT02867709|616894271|FG002|Treatment Period|Protocol Violation|3|||
170694898|NCT02867709|616894269|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
170694899|NCT02867709|616894270|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
170694900|NCT02867709|616894271|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
170694901|NCT02867709|616894269|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
170694902|NCT02867709|616894270|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
170694903|NCT02867709|616894271|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
170694904|NCT02867709|616894269|FG000|Safety Follow-up Period|Pregnancy|0|||
170694905|NCT02867709|616894270|FG001|Safety Follow-up Period|Pregnancy|1|||
170694906|NCT02867709|616894271|FG002|Safety Follow-up Period|Pregnancy|0|||
170694907|NCT02867709|616894269|FG000|Safety Follow-up Period|Protocol Violation|0|||
170694908|NCT02867709|616894270|FG001|Safety Follow-up Period|Protocol Violation|1|||
170694909|NCT02867709|616894271|FG002|Safety Follow-up Period|Protocol Violation|1|||
170694910|NCT03188094|616894272|FG000|Overall Study|Screen failure|1|||
170694911|NCT03188094|616894273|FG001|Overall Study|Screen failure|0|||
170694912|NCT03188094|616894274|FG002|Overall Study|Screen failure|0|||
170694913|NCT03188094|616894272|FG000|Overall Study|Pregnancy|3|||
170694914|NCT03188094|616894273|FG001|Overall Study|Pregnancy|0|||
170694915|NCT03188094|616894274|FG002|Overall Study|Pregnancy|0|||
170694916|NCT03188094|616894272|FG000|Overall Study|Ineligible|1|||
170694917|NCT03188094|616894273|FG001|Overall Study|Ineligible|0|||
170694918|NCT03188094|616894274|FG002|Overall Study|Ineligible|0|||
170694919|NCT03188094|616894272|FG000|Overall Study|Lost to Follow-up|0|||
170694920|NCT03188094|616894273|FG001|Overall Study|Lost to Follow-up|0|||
170694921|NCT03188094|616894274|FG002|Overall Study|Lost to Follow-up|17|||
170694922|NCT02946047|616894275|FG000|Overall Study|Adverse Event|1|||
170694923|NCT02946047|616894276|FG001|Overall Study|Adverse Event|0|||
170694924|NCT02946047|616894277|FG002|Overall Study|Adverse Event|0|||
170694925|NCT02946047|616894278|FG003|Overall Study|Adverse Event|0|||
170694926|NCT03615105|616894279|FG000|Overall Study|Protocol Violation|1|||
170694927|NCT03615105|616894280|FG001|Overall Study|Protocol Violation|0|||
170694928|NCT03615105|616894281|FG002|Overall Study|Protocol Violation|0|||
170694929|NCT03615105|616894279|FG000|Overall Study|Death|0|||
170694930|NCT03615105|616894280|FG001|Overall Study|Death|2|||
170694931|NCT03615105|616894281|FG002|Overall Study|Death|0|||
170694932|NCT05041322|616894282|FG000|Baseline|Withdrawal by Subject|1|||
170694933|NCT05041322|616894283|FG001|Baseline|Withdrawal by Subject|0|||
170694934|NCT05041322|616894282|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
170694935|NCT05041322|616894283|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
170694936|NCT05041322|616894282|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
170694937|NCT05041322|616894283|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
170694938|NCT01894581|616894284|FG000|Overall Study|Withdrawal by Subject|2|||
170694939|NCT01894581|616894285|FG001|Overall Study|Withdrawal by Subject|3|||
170694940|NCT01894581|616894284|FG000|Overall Study|Screen Failure|3|||
170694941|NCT01894581|616894285|FG001|Overall Study|Screen Failure|4|||
170694942|NCT03313804|616894286|FG000|Treatment|Death|5|||
170694943|NCT03313804|616894286|FG000|Treatment|still on treatment|2|||
170694944|NCT03313804|616894286|FG000|Follow Up|still on follow up|3|||
170694945|NCT01502423|616894287|FG000|Overall Study|Withdrawal by Subject|0|||
170694946|NCT01502423|616894288|FG001|Overall Study|Withdrawal by Subject|1|||
170694947|NCT04814433|616894291|FG000|Overall Study|Survey not returned|4|||
170694948|NCT04814433|616894292|FG001|Overall Study|Survey not returned|8|||
170694949|NCT04814433|616894293|FG002|Overall Study|Survey not returned|4|||
170694950|NCT04814433|616894294|FG003|Overall Study|Survey not returned|5|||
170694951|NCT02255500|616896166|FG000|Overall Study|Withdrawal by Subject|1|||
170694952|NCT02255500|616896167|FG001|Overall Study|Withdrawal by Subject|0|||
170694953|NCT03257631|616896172|FG000|Overall Study|Death|1|||
170694954|NCT03257631|616896173|FG001|Overall Study|Death|0|||
170694955|NCT03257631|616896174|FG002|Overall Study|Death|1|||
170694956|NCT03257631|616896175|FG003|Overall Study|Death|1|||
170694957|NCT03257631|616896172|FG000|Overall Study|Progressive Disease|10|||
170694958|NCT03257631|616896173|FG001|Overall Study|Progressive Disease|9|||
170694959|NCT03257631|616896174|FG002|Overall Study|Progressive Disease|17|||
170694960|NCT03257631|616896175|FG003|Overall Study|Progressive Disease|8|||
170694961|NCT03257631|616896172|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170694962|NCT03257631|616896173|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170694963|NCT03257631|616896174|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
170694964|NCT03257631|616896175|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
170694965|NCT03257631|616896172|FG000|Overall Study|Adverse Event|0|||
170694966|NCT03257631|616896173|FG001|Overall Study|Adverse Event|0|||
170694967|NCT03257631|616896174|FG002|Overall Study|Adverse Event|2|||
170694968|NCT03257631|616896175|FG003|Overall Study|Adverse Event|0|||
170694969|NCT03509675|616896179|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
170694970|NCT03509675|616896180|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
170694971|NCT03509675|616896179|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
170694972|NCT03509675|616896180|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
170694973|NCT03509675|616896179|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
170694974|NCT03509675|616896180|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
170694975|NCT03509675|616896179|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
170694976|NCT03509675|616896180|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
170694977|NCT00902564|616896181|FG000|Overall Study|Withdrawal by Subject|2|||
170694978|NCT03336216|616896184|FG000|Randomization|Not reported|2|||
170694979|NCT03336216|616896185|FG001|Randomization|Not reported|0|||
170694980|NCT03336216|616896186|FG002|Randomization|Not reported|1|||
170823366|NCT01187407|617360501|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
170823367|NCT01187407|617360502|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
170823368|NCT01187407|617360498|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
170823369|NCT01187407|617360499|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
170823370|NCT01187407|617360500|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
170823371|NCT01187407|617360501|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
170823372|NCT01187407|617360502|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
170823373|NCT01187407|617360498|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
170823374|NCT01187407|617360499|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
170823375|NCT01187407|617360500|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
170823376|NCT01187407|617360501|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
170823377|NCT01187407|617360502|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
170823378|NCT01187407|617360498|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
170823379|NCT01187407|617360499|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
170823380|NCT01187407|617360500|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
170823381|NCT01187407|617360501|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
170823382|NCT01187407|617360502|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
170823383|NCT01187407|617360498|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
170823384|NCT01187407|617360499|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
170823385|NCT01187407|617360500|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
170823386|NCT01187407|617360501|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
170823387|NCT01187407|617360502|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
170823388|NCT02382406|617360503|FG000|Study Treatment|Disease Progression|8|||
170823389|NCT02382406|617360504|FG001|Study Treatment|Disease Progression|0|||
170823390|NCT02382406|617360505|FG002|Study Treatment|Disease Progression|20|||
170823391|NCT02382406|617360503|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
170823392|NCT02382406|617360504|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
170823393|NCT02382406|617360505|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
170823394|NCT02382406|617360503|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
170823395|NCT02382406|617360504|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
170823396|NCT02382406|617360505|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
170823397|NCT02382406|617360503|FG000|Study Treatment|symptomatic deterioration|1|||
170823398|NCT02382406|617360504|FG001|Study Treatment|symptomatic deterioration|0|||
170823399|NCT02382406|617360505|FG002|Study Treatment|symptomatic deterioration|1|||
170823400|NCT02382406|617360503|FG000|Study Treatment|Death|0|||
170823401|NCT02382406|617360504|FG001|Study Treatment|Death|0|||
170823402|NCT02382406|617360505|FG002|Study Treatment|Death|2|||
170823403|NCT02382406|617360503|FG000|Follow up|Death|11|||
170823404|NCT02382406|617360504|FG001|Follow up|Death|0|||
170823405|NCT02382406|617360505|FG002|Follow up|Death|19|||
170823406|NCT02382406|617360503|FG000|Follow up|Symptomatic deterioration|1|||
170823407|NCT02382406|617360504|FG001|Follow up|Symptomatic deterioration|0|||
170823408|NCT02382406|617360505|FG002|Follow up|Symptomatic deterioration|1|||
170823409|NCT02382406|617360503|FG000|Follow up|Patient Refused Follow-up|1|||
170823410|NCT02382406|617360504|FG001|Follow up|Patient Refused Follow-up|0|||
170823411|NCT02382406|617360505|FG002|Follow up|Patient Refused Follow-up|0|||
170823412|NCT02382406|617360503|FG000|Follow up|Study Terminated|1|||
170823413|NCT02382406|617360504|FG001|Follow up|Study Terminated|0|||
170823414|NCT02382406|617360505|FG002|Follow up|Study Terminated|8|||
170823415|NCT02382406|617360503|FG000|Follow up|Withdrawal by Subject|0|||
170823416|NCT02382406|617360504|FG001|Follow up|Withdrawal by Subject|0|||
170823417|NCT02382406|617360505|FG002|Follow up|Withdrawal by Subject|2|||
170823418|NCT00853021|617360508|FG000|Overall Study|Adverse Event|2|||
170823419|NCT00853021|617360508|FG000|Overall Study|Withdrawal by Subject|2|||
170823420|NCT00853021|617360508|FG000|Overall Study|Death|1|||
170823421|NCT01770509|617360509|FG000|Overall Study|Injury|0|||
170823422|NCT01770509|617360510|FG001|Overall Study|Injury|1|||
170823423|NCT01770509|617360509|FG000|Overall Study|Lost to Follow-up|1|||
170823424|NCT01770509|617360510|FG001|Overall Study|Lost to Follow-up|2|||
170823425|NCT02332824|617360516|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
170823426|NCT02332824|617360517|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
170823427|NCT02332824|617360518|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
170823428|NCT02332824|617360519|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
170823429|NCT02332824|617360520|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
170823430|NCT02332824|617360521|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
170823431|NCT02332824|617360516|FG000|Overall Study|Voluntary Withdrawal|1|||
170823432|NCT02332824|617360517|FG001|Overall Study|Voluntary Withdrawal|0|||
170823433|NCT02332824|617360518|FG002|Overall Study|Voluntary Withdrawal|0|||
170823434|NCT02332824|617360519|FG003|Overall Study|Voluntary Withdrawal|0|||
170823435|NCT02332824|617360520|FG004|Overall Study|Voluntary Withdrawal|0|||
170694981|NCT03336216|616896187|FG003|Randomization|Not reported|0|||
170694982|NCT03336216|616896184|FG000|Randomization|Other reasons|1|||
170694983|NCT03336216|616896185|FG001|Randomization|Other reasons|1|||
170694984|NCT03336216|616896186|FG002|Randomization|Other reasons|1|||
170694985|NCT03336216|616896187|FG003|Randomization|Other reasons|0|||
170694986|NCT03336216|616896184|FG000|Randomization|Participant no longer meets study criteria|0|||
170694987|NCT03336216|616896185|FG001|Randomization|Participant no longer meets study criteria|2|||
170694988|NCT03336216|616896186|FG002|Randomization|Participant no longer meets study criteria|4|||
170694989|NCT03336216|616896187|FG003|Randomization|Participant no longer meets study criteria|1|||
170694990|NCT03336216|616896184|FG000|Randomization|Lost to Follow-up|1|||
170694991|NCT03336216|616896185|FG001|Randomization|Lost to Follow-up|0|||
170694992|NCT03336216|616896186|FG002|Randomization|Lost to Follow-up|0|||
170694993|NCT03336216|616896187|FG003|Randomization|Lost to Follow-up|0|||
170694994|NCT03336216|616896184|FG000|Randomization|Participant withdrew consent|9|||
170694995|NCT03336216|616896185|FG001|Randomization|Participant withdrew consent|1|||
170694996|NCT03336216|616896186|FG002|Randomization|Participant withdrew consent|0|||
170694997|NCT03336216|616896187|FG003|Randomization|Participant withdrew consent|0|||
170694998|NCT03336216|616896184|FG000|Randomization|Adverse Event|1|||
170694999|NCT03336216|616896185|FG001|Randomization|Adverse Event|1|||
170695000|NCT03336216|616896186|FG002|Randomization|Adverse Event|0|||
170695001|NCT03336216|616896187|FG003|Randomization|Adverse Event|0|||
170695002|NCT03336216|616896184|FG000|Treatment|Adverse Event|2|||
170695003|NCT03336216|616896185|FG001|Treatment|Adverse Event|3|||
170695004|NCT03336216|616896186|FG002|Treatment|Adverse Event|4|||
170695005|NCT03336216|616896187|FG003|Treatment|Adverse Event|4|||
170695006|NCT03336216|616896184|FG000|Treatment|Participant request to discontinue treatment|2|||
170695007|NCT03336216|616896185|FG001|Treatment|Participant request to discontinue treatment|1|||
170695008|NCT03336216|616896186|FG002|Treatment|Participant request to discontinue treatment|2|||
170695009|NCT03336216|616896187|FG003|Treatment|Participant request to discontinue treatment|2|||
170695010|NCT03336216|616896184|FG000|Treatment|Participant withdrew consent|7|||
170695011|NCT03336216|616896185|FG001|Treatment|Participant withdrew consent|2|||
170695012|NCT03336216|616896186|FG002|Treatment|Participant withdrew consent|3|||
170695013|NCT03336216|616896187|FG003|Treatment|Participant withdrew consent|2|||
170695014|NCT03336216|616896184|FG000|Treatment|Death|2|||
170695015|NCT03336216|616896185|FG001|Treatment|Death|3|||
170695016|NCT03336216|616896186|FG002|Treatment|Death|3|||
170695017|NCT03336216|616896187|FG003|Treatment|Death|4|||
170695018|NCT03336216|616896184|FG000|Treatment|Participant no longer meets study criteria|0|||
170695019|NCT03336216|616896185|FG001|Treatment|Participant no longer meets study criteria|1|||
170695020|NCT03336216|616896186|FG002|Treatment|Participant no longer meets study criteria|0|||
170695021|NCT03336216|616896187|FG003|Treatment|Participant no longer meets study criteria|0|||
170695022|NCT03336216|616896184|FG000|Treatment|Other reasons|2|||
170695023|NCT03336216|616896185|FG001|Treatment|Other reasons|0|||
170695024|NCT03336216|616896186|FG002|Treatment|Other reasons|0|||
170695025|NCT03336216|616896187|FG003|Treatment|Other reasons|3|||
170695026|NCT03336216|616896184|FG000|Treatment|Disease progression|23|||
170695027|NCT03336216|616896185|FG001|Treatment|Disease progression|34|||
170695028|NCT03336216|616896186|FG002|Treatment|Disease progression|33|||
170695029|NCT03336216|616896187|FG003|Treatment|Disease progression|26|||
170695030|NCT03336216|616896184|FG000|Treatment|Study drug toxicity|0|||
170695031|NCT03336216|616896185|FG001|Treatment|Study drug toxicity|3|||
170695032|NCT03336216|616896186|FG002|Treatment|Study drug toxicity|2|||
170695033|NCT03336216|616896187|FG003|Treatment|Study drug toxicity|0|||
170695034|NCT03336216|616896184|FG000|Treatment|Adverse Event unrelated to study drug|1|||
170695035|NCT03336216|616896185|FG001|Treatment|Adverse Event unrelated to study drug|1|||
170695036|NCT03336216|616896186|FG002|Treatment|Adverse Event unrelated to study drug|1|||
170695037|NCT03336216|616896187|FG003|Treatment|Adverse Event unrelated to study drug|0|||
170695038|NCT03336216|616896184|FG000|Treatment|Disease Recurrence|1|||
170695039|NCT03336216|616896185|FG001|Treatment|Disease Recurrence|0|||
170695040|NCT03336216|616896186|FG002|Treatment|Disease Recurrence|0|||
170695041|NCT03336216|616896187|FG003|Treatment|Disease Recurrence|0|||
170695042|NCT03239470|616896190|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
170695043|NCT03239470|616896191|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
170695044|NCT01023581|616896192|FG000|Overall Study|Adverse Event|4|||
170695045|NCT01023581|616896193|FG001|Overall Study|Adverse Event|4|||
170695046|NCT01023581|616896194|FG002|Overall Study|Adverse Event|7|||
170695047|NCT01023581|616896195|FG003|Overall Study|Adverse Event|3|||
170695048|NCT01023581|616896196|FG004|Overall Study|Adverse Event|2|||
170695049|NCT01023581|616896197|FG005|Overall Study|Adverse Event|5|||
170695050|NCT01023581|616896198|FG006|Overall Study|Adverse Event|11|||
170695051|NCT01023581|616896192|FG000|Overall Study|Major protocol deviation|2|||
170695052|NCT01023581|616896193|FG001|Overall Study|Major protocol deviation|0|||
170695053|NCT01023581|616896194|FG002|Overall Study|Major protocol deviation|3|||
170695054|NCT01023581|616896195|FG003|Overall Study|Major protocol deviation|0|||
170695055|NCT01023581|616896196|FG004|Overall Study|Major protocol deviation|0|||
170695056|NCT01023581|616896197|FG005|Overall Study|Major protocol deviation|0|||
170695057|NCT01023581|616896198|FG006|Overall Study|Major protocol deviation|0|||
170695058|NCT01023581|616896192|FG000|Overall Study|Lost to Follow-up|4|||
170695059|NCT01023581|616896193|FG001|Overall Study|Lost to Follow-up|8|||
170695060|NCT01023581|616896194|FG002|Overall Study|Lost to Follow-up|7|||
170695061|NCT01023581|616896195|FG003|Overall Study|Lost to Follow-up|2|||
170695062|NCT01023581|616896196|FG004|Overall Study|Lost to Follow-up|5|||
170695063|NCT01023581|616896197|FG005|Overall Study|Lost to Follow-up|2|||
170695064|NCT01023581|616896198|FG006|Overall Study|Lost to Follow-up|2|||
170695065|NCT01023581|616896192|FG000|Overall Study|Withdrawal by Subject|13|||
170695066|NCT01023581|616896193|FG001|Overall Study|Withdrawal by Subject|8|||
170695067|NCT01023581|616896194|FG002|Overall Study|Withdrawal by Subject|16|||
170695068|NCT01023581|616896195|FG003|Overall Study|Withdrawal by Subject|10|||
170695069|NCT01023581|616896196|FG004|Overall Study|Withdrawal by Subject|6|||
170695070|NCT01023581|616896197|FG005|Overall Study|Withdrawal by Subject|8|||
170695071|NCT01023581|616896198|FG006|Overall Study|Withdrawal by Subject|5|||
170695072|NCT01023581|616896192|FG000|Overall Study|Pregnancy|0|||
170695073|NCT01023581|616896193|FG001|Overall Study|Pregnancy|0|||
170695074|NCT01023581|616896194|FG002|Overall Study|Pregnancy|0|||
170695075|NCT01023581|616896195|FG003|Overall Study|Pregnancy|2|||
170695076|NCT01023581|616896196|FG004|Overall Study|Pregnancy|0|||
170695077|NCT01023581|616896197|FG005|Overall Study|Pregnancy|1|||
170695078|NCT01023581|616896198|FG006|Overall Study|Pregnancy|0|||
170695079|NCT01023581|616896192|FG000|Overall Study|Lack of Efficacy|9|||
170695080|NCT01023581|616896193|FG001|Overall Study|Lack of Efficacy|3|||
170695081|NCT01023581|616896194|FG002|Overall Study|Lack of Efficacy|6|||
170695082|NCT01023581|616896195|FG003|Overall Study|Lack of Efficacy|2|||
170695083|NCT01023581|616896196|FG004|Overall Study|Lack of Efficacy|1|||
170695084|NCT01023581|616896197|FG005|Overall Study|Lack of Efficacy|2|||
170695085|NCT01023581|616896198|FG006|Overall Study|Lack of Efficacy|1|||
170695086|NCT01023581|616896192|FG000|Overall Study|Physician Decision|2|||
170695087|NCT01023581|616896193|FG001|Overall Study|Physician Decision|0|||
170695088|NCT01023581|616896194|FG002|Overall Study|Physician Decision|2|||
170695089|NCT01023581|616896195|FG003|Overall Study|Physician Decision|1|||
170695090|NCT01023581|616896196|FG004|Overall Study|Physician Decision|1|||
170695091|NCT01023581|616896197|FG005|Overall Study|Physician Decision|1|||
170695092|NCT01023581|616896198|FG006|Overall Study|Physician Decision|1|||
170695093|NCT01023581|616896192|FG000|Overall Study|Other|1|||
170695094|NCT01023581|616896193|FG001|Overall Study|Other|0|||
170695095|NCT01023581|616896194|FG002|Overall Study|Other|1|||
170695096|NCT01023581|616896195|FG003|Overall Study|Other|0|||
170695097|NCT01023581|616896196|FG004|Overall Study|Other|1|||
170695098|NCT01023581|616896197|FG005|Overall Study|Other|0|||
170695099|NCT01023581|616896198|FG006|Overall Study|Other|0|||
170695100|NCT01046682|616896203|FG000|Overall Study|Adverse Event|2|||
170695101|NCT01046682|616896204|FG001|Overall Study|Adverse Event|0|||
170695102|NCT05071183|616896207|FG000|Overall Study|Death|1|||
170695103|NCT05071183|616896208|FG001|Overall Study|Death|2|||
170695104|NCT05071183|616896209|FG002|Overall Study|Death|0|||
170823436|NCT02332824|617360521|FG005|Overall Study|Voluntary Withdrawal|0|||
170823437|NCT02332824|617360516|FG000|Overall Study|Inconvenient schedule|1|||
170823438|NCT02332824|617360517|FG001|Overall Study|Inconvenient schedule|1|||
170823439|NCT02332824|617360518|FG002|Overall Study|Inconvenient schedule|0|||
170823440|NCT02332824|617360519|FG003|Overall Study|Inconvenient schedule|0|||
170823441|NCT02332824|617360520|FG004|Overall Study|Inconvenient schedule|0|||
170823442|NCT02332824|617360521|FG005|Overall Study|Inconvenient schedule|0|||
170823443|NCT02332824|617360516|FG000|Overall Study|Transfer|0|||
170823444|NCT02332824|617360517|FG001|Overall Study|Transfer|0|||
170823445|NCT02332824|617360518|FG002|Overall Study|Transfer|1|||
170695105|NCT05071183|616896207|FG000|Overall Study|Other Reasons|1|||
170695106|NCT05071183|616896208|FG001|Overall Study|Other Reasons|3|||
170695107|NCT05071183|616896209|FG002|Overall Study|Other Reasons|2|||
170695108|NCT02046148|616896211|FG000|Overall Study|Lost to Follow-up|1|||
170823446|NCT02332824|617360519|FG003|Overall Study|Transfer|1|||
170823447|NCT02332824|617360520|FG004|Overall Study|Transfer|0|||
170695109|NCT02046148|616896212|FG001|Overall Study|Lost to Follow-up|1|||
170823448|NCT02332824|617360521|FG005|Overall Study|Transfer|0|||
170823449|NCT00440037|617360522|FG000|Overall Study|Withdrawal by Subject|6|||
170695110|NCT02046148|616896211|FG000|Overall Study|Withdrawal by Subject|0|||
170695111|NCT02046148|616896212|FG001|Overall Study|Withdrawal by Subject|2|||
170823450|NCT00440037|617360522|FG000|Overall Study|Administrative decision|3|||
170695112|NCT02864251|616896216|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
170695113|NCT02864251|616896217|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
170695114|NCT02864251|616896218|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
170695115|NCT02864251|616896216|FG000|Pre-Treatment|Withdrawal by Participant|0|||
170695116|NCT02864251|616896217|FG001|Pre-Treatment|Withdrawal by Participant|0|||
170695117|NCT02864251|616896218|FG002|Pre-Treatment|Withdrawal by Participant|4|||
170695118|NCT02864251|616896216|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
170695119|NCT02864251|616896217|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
170695120|NCT02864251|616896218|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
170695121|NCT02864251|616896216|FG000|Pre-Treatment|Other Reasons|0|||
170695122|NCT02864251|616896217|FG001|Pre-Treatment|Other Reasons|1|||
170695123|NCT02864251|616896218|FG002|Pre-Treatment|Other Reasons|1|||
170695124|NCT02864251|616896216|FG000|Treatment|Disease Progression|109|||
170695125|NCT02864251|616896217|FG001|Treatment|Disease Progression|52|||
170695126|NCT02864251|616896218|FG002|Treatment|Disease Progression|101|||
170695127|NCT02864251|616896216|FG000|Treatment|Study Drug Toxicity|9|||
170695128|NCT02864251|616896217|FG001|Treatment|Study Drug Toxicity|4|||
170695129|NCT02864251|616896218|FG002|Treatment|Study Drug Toxicity|10|||
170695130|NCT02864251|616896216|FG000|Treatment|Death|0|||
170695131|NCT02864251|616896217|FG001|Treatment|Death|2|||
170695132|NCT02864251|616896218|FG002|Treatment|Death|3|||
170695133|NCT02864251|616896216|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
170695134|NCT02864251|616896217|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
170695135|NCT02864251|616896218|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
170695136|NCT02864251|616896216|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
170695137|NCT02864251|616896217|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
170695138|NCT02864251|616896218|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
170695139|NCT02864251|616896216|FG000|Treatment|Withdrawal by Participant|8|||
170695140|NCT02864251|616896217|FG001|Treatment|Withdrawal by Participant|5|||
170695141|NCT02864251|616896218|FG002|Treatment|Withdrawal by Participant|13|||
170695142|NCT02864251|616896216|FG000|Treatment|Maximum Clinical Benefit|1|||
170695143|NCT02864251|616896217|FG001|Treatment|Maximum Clinical Benefit|0|||
170695144|NCT02864251|616896218|FG002|Treatment|Maximum Clinical Benefit|1|||
170695145|NCT02864251|616896216|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
170695146|NCT02864251|616896217|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
170695147|NCT02864251|616896218|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
170695148|NCT02864251|616896216|FG000|Treatment|Other Reasons|1|||
170695149|NCT02864251|616896217|FG001|Treatment|Other Reasons|1|||
170695150|NCT02864251|616896218|FG002|Treatment|Other Reasons|4|||
170695151|NCT02864251|616896216|FG000|Treatment|Administrative Reason by Sponsor|1|||
170695152|NCT02864251|616896217|FG001|Treatment|Administrative Reason by Sponsor|0|||
170695153|NCT02864251|616896218|FG002|Treatment|Administrative Reason by Sponsor|0|||
170695154|NCT00885755|616896221|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
170695155|NCT00885755|616896222|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
170695156|NCT00885755|616896223|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
170695157|NCT00885755|616896221|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
170695158|NCT00885755|616896222|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
170695159|NCT00885755|616896223|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
170695160|NCT00885755|616896221|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
170695161|NCT00885755|616896222|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
170695162|NCT00885755|616896223|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
170695163|NCT00885755|616896221|FG000|Part I: Trastuzumab+Taxane|Death|0|||
170695164|NCT00885755|616896222|FG001|Part I: Trastuzumab+Taxane|Death|0|||
170695165|NCT00885755|616896223|FG002|Part I: Trastuzumab+Taxane|Death|1|||
170695166|NCT00885755|616896221|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
170695167|NCT00885755|616896222|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
170695168|NCT00885755|616896223|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
170695169|NCT02532647|616896224|FG000|Overall Study|Did not receive trial medication|1|||
170695170|NCT02532647|616896225|FG001|Overall Study|Did not receive trial medication|0|||
170695171|NCT02532647|616896226|FG002|Overall Study|Did not receive trial medication|1|||
170695172|NCT02939560|616896231|FG000|Overall Study|Withdrawal by Subject|2|||
170695173|NCT02939560|616896231|FG000|Overall Study|Protocol Violation|1|||
170695174|NCT03340025|616896232|FG000|Overall Study|Lost to Follow-up|2|||
170695175|NCT03340025|616896233|FG001|Overall Study|Lost to Follow-up|2|||
170695176|NCT02424383|616896238|FG000|Overall Study|Withdrawal by Subject|32|||
170695177|NCT02424383|616896238|FG000|Overall Study|Death|170|||
170695178|NCT02424383|616896238|FG000|Overall Study|Sponsor's decision|3|||
170695179|NCT02424383|616896238|FG000|Overall Study|Investigator's decision|44|||
170695180|NCT02424383|616896238|FG000|Overall Study|Lost to Follow-up|81|||
170695181|NCT02424383|616896238|FG000|Overall Study|Other|7|||
170695182|NCT02424383|616896238|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
170695183|NCT03412084|616896242|FG000|Overall Study|Withdrawal by Subject|2|||
170695184|NCT03412084|616896243|FG001|Overall Study|Withdrawal by Subject|0|||
170695185|NCT03412084|616896242|FG000|Overall Study|Participant moved|1|||
170695186|NCT03412084|616896243|FG001|Overall Study|Participant moved|0|||
170695187|NCT03412084|616896242|FG000|Overall Study|Lost to Follow-up|1|||
170695188|NCT03412084|616896243|FG001|Overall Study|Lost to Follow-up|1|||
170695189|NCT04649164|616896251|FG000|Overall Study|Withdrawal by Subject|1|||
170695190|NCT04649164|616896252|FG001|Overall Study|Withdrawal by Subject|1|||
170695191|NCT04649164|616896253|FG002|Overall Study|Withdrawal by Subject|2|||
170695192|NCT04649164|616896251|FG000|Overall Study|Participant's care recipient expired|0|||
170695193|NCT04649164|616896252|FG001|Overall Study|Participant's care recipient expired|0|||
170695194|NCT04649164|616896253|FG002|Overall Study|Participant's care recipient expired|2|||
170695195|NCT01549964|616896254|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
170695196|NCT01549964|616896255|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
170695197|NCT01549964|616896256|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
170695198|NCT01549964|616896257|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
170695199|NCT01549964|616896254|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
170695200|NCT01549964|616896255|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
170695201|NCT01549964|616896256|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
170695202|NCT01549964|616896257|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
170695203|NCT01549964|616896254|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
170695204|NCT01549964|616896255|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
170695205|NCT01549964|616896256|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
170695206|NCT01549964|616896257|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
170695207|NCT01549964|616896254|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
170695208|NCT01549964|616896255|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
170695209|NCT01549964|616896256|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
170695210|NCT01549964|616896257|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
170695211|NCT01549964|616896254|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
170695212|NCT01549964|616896255|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
170695213|NCT01549964|616896256|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
170695214|NCT01549964|616896257|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
170695215|NCT01549964|616896254|FG000|24-Week Treatment Period|Other|1|||
170695216|NCT01549964|616896255|FG001|24-Week Treatment Period|Other|0|||
170695217|NCT01549964|616896256|FG002|24-Week Treatment Period|Other|1|||
170695218|NCT01549964|616896257|FG003|24-Week Treatment Period|Other|0|||
170695219|NCT01549964|616896254|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
170695220|NCT01549964|616896255|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
170695221|NCT01549964|616896256|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
170695222|NCT01549964|616896257|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
170695223|NCT01549964|616896254|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
170695224|NCT01549964|616896255|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
170695225|NCT01549964|616896256|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
170695226|NCT01549964|616896257|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
170695227|NCT01549964|616896254|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
170695228|NCT01549964|616896255|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
170695229|NCT01549964|616896256|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
170695230|NCT01549964|616896257|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
170695231|NCT01549964|616896254|FG000|80-Week Extension Period|Pregnancy|0|||
170695232|NCT01549964|616896255|FG001|80-Week Extension Period|Pregnancy|0|||
170695233|NCT01549964|616896256|FG002|80-Week Extension Period|Pregnancy|1|||
170695234|NCT01549964|616896257|FG003|80-Week Extension Period|Pregnancy|0|||
170695235|NCT01549964|616896254|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
170695236|NCT01549964|616896255|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
170695237|NCT01549964|616896256|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
170695238|NCT01549964|616896257|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
170695239|NCT01549964|616896254|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
170695240|NCT01549964|616896255|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
170695241|NCT01549964|616896256|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
170695242|NCT01549964|616896257|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
170695243|NCT01549964|616896254|FG000|80-Week Extension Period|Lost to Follow-up|1|||
170695244|NCT01549964|616896255|FG001|80-Week Extension Period|Lost to Follow-up|0|||
170695245|NCT01549964|616896256|FG002|80-Week Extension Period|Lost to Follow-up|2|||
170695246|NCT01549964|616896257|FG003|80-Week Extension Period|Lost to Follow-up|1|||
170695247|NCT01549964|616896254|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
170695248|NCT01549964|616896255|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
170695249|NCT01549964|616896256|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
170695250|NCT01549964|616896257|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
170695251|NCT02439320|616896264|FG000|Overall Study|Adverse Event|0|||
170695252|NCT02439320|616896265|FG001|Overall Study|Adverse Event|2|||
170695253|NCT02439320|616896266|FG002|Overall Study|Adverse Event|0|||
170695254|NCT02439320|616896264|FG000|Overall Study|Lost to Follow-up|37|||
170695255|NCT02439320|616896265|FG001|Overall Study|Lost to Follow-up|34|||
170695256|NCT02439320|616896266|FG002|Overall Study|Lost to Follow-up|42|||
170695257|NCT02439320|616896264|FG000|Overall Study|Death|0|||
170695258|NCT02439320|616896265|FG001|Overall Study|Death|1|||
170695259|NCT02439320|616896266|FG002|Overall Study|Death|0|||
170695260|NCT02439320|616896264|FG000|Overall Study|Noncompliance with Protocol|10|||
170695261|NCT02439320|616896265|FG001|Overall Study|Noncompliance with Protocol|11|||
170695262|NCT02439320|616896266|FG002|Overall Study|Noncompliance with Protocol|7|||
170695263|NCT02439320|616896264|FG000|Overall Study|Pregnancy|0|||
170695264|NCT02439320|616896265|FG001|Overall Study|Pregnancy|1|||
170695265|NCT02439320|616896266|FG002|Overall Study|Pregnancy|1|||
170695266|NCT02439320|616896264|FG000|Overall Study|Withdrawal by Subject|12|||
170695267|NCT02439320|616896265|FG001|Overall Study|Withdrawal by Subject|16|||
170695268|NCT02439320|616896266|FG002|Overall Study|Withdrawal by Subject|14|||
170695269|NCT02439320|616896264|FG000|Overall Study|Physician Decision|2|||
170695270|NCT02439320|616896265|FG001|Overall Study|Physician Decision|1|||
170695271|NCT02439320|616896266|FG002|Overall Study|Physician Decision|0|||
170695272|NCT02439320|616896264|FG000|Overall Study|Sponsor Request|0|||
170695273|NCT02439320|616896265|FG001|Overall Study|Sponsor Request|2|||
170695274|NCT02439320|616896266|FG002|Overall Study|Sponsor Request|1|||
170695275|NCT02439320|616896264|FG000|Overall Study|Randomization Failure|35|||
170695276|NCT02439320|616896265|FG001|Overall Study|Randomization Failure|46|||
170695277|NCT02439320|616896266|FG002|Overall Study|Randomization Failure|34|||
170695278|NCT03343483|616896268|FG000|Overall Study|Death|0|||
170695279|NCT03343483|616896269|FG001|Overall Study|Death|3|||
170695280|NCT03343483|616896268|FG000|Overall Study|Lost to Follow-up|9|||
170695281|NCT03343483|616896269|FG001|Overall Study|Lost to Follow-up|13|||
170695282|NCT03343483|616896268|FG000|Overall Study|Withdrawal by Subject|8|||
170695283|NCT03343483|616896269|FG001|Overall Study|Withdrawal by Subject|17|||
170695284|NCT01505608|616896272|FG000|Phase I|Lack of Efficacy|0|||
170695285|NCT01505608|616896273|FG001|Phase I|Lack of Efficacy|4|||
170695286|NCT01505608|616896272|FG000|Phase I|Adverse Event|0|||
170695287|NCT01505608|616896273|FG001|Phase I|Adverse Event|1|||
170695288|NCT01505608|616896272|FG000|Phase I|Withdrawal by Subject|0|||
170695289|NCT01505608|616896273|FG001|Phase I|Withdrawal by Subject|1|||
170695290|NCT01505608|616896272|FG000|Phase II|Lack of Efficacy|2|||
170695291|NCT01505608|616896273|FG001|Phase II|Lack of Efficacy|1|||
170695292|NCT01505608|616896272|FG000|Phase II|Protocol Violation|0|||
170695293|NCT01505608|616896273|FG001|Phase II|Protocol Violation|1|||
170695294|NCT01488097|616896274|FG000|Overall Study|Lost to Follow-up|1|||
170695295|NCT03144180|616896278|FG000|Overall Study|STAT Delivery|1|||
170695296|NCT03144180|616896279|FG001|Overall Study|STAT Delivery|1|||
170695297|NCT03144180|616896278|FG000|Overall Study|Provider forgot to fill out forms|1|||
170695298|NCT03144180|616896279|FG001|Overall Study|Provider forgot to fill out forms|3|||
170695299|NCT03144180|616896278|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
170695300|NCT03144180|616896279|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
170695301|NCT03144180|616896278|FG000|Overall Study|Scrub tech removed tube cap|0|||
170695302|NCT03144180|616896279|FG001|Overall Study|Scrub tech removed tube cap|1|||
170695303|NCT01293240|616896286|FG000|Overall Study|Noncompliance|2|||
170695304|NCT01498952|616896288|FG000|Overall Study|Death|2|||
170695305|NCT01498952|616896289|FG001|Overall Study|Death|2|||
170695306|NCT01498952|616896290|FG002|Overall Study|Death|0|||
170695307|NCT01498952|616896291|FG003|Overall Study|Death|0|||
170695308|NCT01498952|616896292|FG004|Overall Study|Death|0|||
170695309|NCT04519645|616896293|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
170695310|NCT04519645|616896294|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
170695311|NCT04519645|616896295|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
170695312|NCT04519645|616896293|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
170695313|NCT04519645|616896294|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
170695314|NCT04519645|616896295|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
170695315|NCT04519645|616896293|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
170695316|NCT04519645|616896294|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
170695317|NCT04519645|616896295|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
170695318|NCT04519645|616896293|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
170695319|NCT04519645|616896294|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
170695320|NCT04519645|616896295|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
170695321|NCT01679002|616896296|FG000|Overall Study|Adverse Event|1|||
170695322|NCT01679002|616896297|FG001|Overall Study|Adverse Event|1|||
170695323|NCT01679002|616896298|FG002|Overall Study|Adverse Event|0|||
170695324|NCT00454987|616896299|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
170695325|NCT00454987|616896300|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
170695326|NCT00454987|616896301|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
170695327|NCT00454987|616896299|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
170695328|NCT00454987|616896300|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
170695329|NCT00454987|616896301|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
170695330|NCT00454987|616896299|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
170695331|NCT00454987|616896300|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
170695332|NCT00454987|616896301|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
170695333|NCT01085097|616896305|FG000|Overall Study|Adverse Event|0|||
170695334|NCT01085097|616896306|FG001|Overall Study|Adverse Event|0|||
170695335|NCT01085097|616896307|FG002|Overall Study|Adverse Event|2|||
170695336|NCT01085097|616896305|FG000|Overall Study|Treatment failure|2|||
170695337|NCT01085097|616896306|FG001|Overall Study|Treatment failure|0|||
170695338|NCT01085097|616896307|FG002|Overall Study|Treatment failure|0|||
170695339|NCT00304356|616896308|FG000|Nitazoxanide|Physician Decision|5|||
170695340|NCT00304356|616896308|FG000|Nitazoxanide|Physician Decision|1|||
170695341|NCT00304356|616896308|FG000|Nitazoxanide|number is 0|1|||
170695342|NCT00304356|616896308|FG000|Nitazoxanide|Physician Decision|1|||
170695343|NCT00304356|616896308|FG000|Nitazoxanide|Physician Decision|1|||
170695344|NCT00304356|616896308|FG000|Nitazoxanide|Physician Decision|1|||
170695345|NCT04120974|616896309|FG000|Overall Study|Death|1|||
170695346|NCT04120974|616896309|FG000|Overall Study|Physician Decision|1|||
170695347|NCT04120974|616896309|FG000|Overall Study|Lost to Follow-up|6|||
170695348|NCT01154218|616896310|FG000|Third Intervention Period|Adverse Event|0|||
170695349|NCT01154218|616896311|FG001|Third Intervention Period|Adverse Event|1|||
170695350|NCT01154218|616896312|FG002|Third Intervention Period|Adverse Event|0|||
170695351|NCT01154218|616896313|FG003|Third Intervention Period|Adverse Event|0|||
170695352|NCT01154218|616896310|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
170695353|NCT01154218|616896311|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
170695354|NCT01154218|616896312|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
170695355|NCT01154218|616896313|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
170695356|NCT01154218|616896310|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
170695357|NCT01154218|616896311|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
170695358|NCT01154218|616896312|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
170695359|NCT01154218|616896313|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
170695360|NCT01170091|616896314|FG000|Overall Study|Missing efficacy evaluation|3|||
170695361|NCT01170091|616896314|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
170695362|NCT03194321|616896315|FG000|Overall Study|Withdrawal by Subject|1|||
170695363|NCT03194321|616896315|FG000|Overall Study|Lost to Follow-up|1|||
170695364|NCT03194321|616896315|FG000|Overall Study|Travel for Follow-up|1|||
170695365|NCT02188589|616896324|FG000|Overall Study|Withdrawal by Subject|5|||
170695366|NCT00322842|616896331|FG000|Overall Study|Withdrawal by Subject|0|||
170695367|NCT00322842|616896332|FG001|Overall Study|Withdrawal by Subject|1|||
170695368|NCT00322842|616896331|FG000|Overall Study|Lost to Follow-up|0|||
170695369|NCT00322842|616896332|FG001|Overall Study|Lost to Follow-up|1|||
170695370|NCT00322842|616896331|FG000|Overall Study|Refused transplant|1|||
170695371|NCT00322842|616896332|FG001|Overall Study|Refused transplant|0|||
170695372|NCT00322842|616896331|FG000|Overall Study|Death|1|||
170695373|NCT00322842|616896332|FG001|Overall Study|Death|0|||
170695374|NCT00323492|616896333|FG000|Study Phase 1|Adverse Event|2|||
170695375|NCT00323492|616896334|FG001|Study Phase 1|Adverse Event|0|||
170695376|NCT00323492|616896335|FG002|Study Phase 1|Adverse Event|0|||
170695377|NCT00323492|616896333|FG000|Study Phase 2|Adverse Event|1|||
170695378|NCT00323492|616896334|FG001|Study Phase 2|Adverse Event|0|||
170695379|NCT00323492|616896335|FG002|Study Phase 2|Adverse Event|0|||
170695380|NCT00323492|616896333|FG000|Study Phase 2|Physician Decision|1|||
170695381|NCT00323492|616896334|FG001|Study Phase 2|Physician Decision|0|||
170695382|NCT00323492|616896335|FG002|Study Phase 2|Physician Decision|0|||
170695383|NCT00323492|616896333|FG000|Study Phase 2|Lost to Follow-up|1|||
170695384|NCT00323492|616896334|FG001|Study Phase 2|Lost to Follow-up|0|||
170695385|NCT00323492|616896335|FG002|Study Phase 2|Lost to Follow-up|0|||
170695386|NCT00323492|616896333|FG000|Study Phase 2|Withdrawal by Subject|0|||
170695387|NCT00323492|616896334|FG001|Study Phase 2|Withdrawal by Subject|1|||
170695388|NCT00323492|616896335|FG002|Study Phase 2|Withdrawal by Subject|0|||
170695389|NCT00323492|616896333|FG000|Study Phase 2|Noncompliance with study schedule|0|||
170695390|NCT00323492|616896334|FG001|Study Phase 2|Noncompliance with study schedule|0|||
170695391|NCT00323492|616896335|FG002|Study Phase 2|Noncompliance with study schedule|1|||
170695392|NCT00323492|616896333|FG000|Study Phase 2|Protocol Violation|1|||
170695393|NCT00323492|616896334|FG001|Study Phase 2|Protocol Violation|0|||
170695394|NCT00323492|616896335|FG002|Study Phase 2|Protocol Violation|0|||
170695395|NCT03082599|616896336|FG000|Overall Study|Lost to Follow-up|1|||
170695396|NCT03082599|616896337|FG001|Overall Study|Lost to Follow-up|0|||
170695397|NCT01466387|616896338|FG000|Overall Study|Adverse Event|0|||
170695398|NCT01466387|616896339|FG001|Overall Study|Adverse Event|0|||
170695399|NCT01466387|616896340|FG002|Overall Study|Adverse Event|1|||
170695400|NCT01466387|616896341|FG003|Overall Study|Adverse Event|1|||
170695401|NCT01466387|616896342|FG004|Overall Study|Adverse Event|0|||
170695402|NCT01466387|616896343|FG005|Overall Study|Adverse Event|0|||
170695403|NCT01466387|616896338|FG000|Overall Study|Lost to Follow-up|0|||
170695404|NCT01466387|616896339|FG001|Overall Study|Lost to Follow-up|0|||
170695405|NCT01466387|616896340|FG002|Overall Study|Lost to Follow-up|0|||
170695406|NCT01466387|616896341|FG003|Overall Study|Lost to Follow-up|0|||
170695407|NCT01466387|616896342|FG004|Overall Study|Lost to Follow-up|0|||
170695408|NCT01466387|616896343|FG005|Overall Study|Lost to Follow-up|1|||
170695409|NCT01466387|616896338|FG000|Overall Study|Protocol Violation|1|||
170695410|NCT01466387|616896339|FG001|Overall Study|Protocol Violation|0|||
170695411|NCT01466387|616896340|FG002|Overall Study|Protocol Violation|0|||
170695412|NCT01466387|616896341|FG003|Overall Study|Protocol Violation|1|||
170695413|NCT01466387|616896342|FG004|Overall Study|Protocol Violation|0|||
170695414|NCT01466387|616896343|FG005|Overall Study|Protocol Violation|0|||
170695415|NCT00832585|616896352|FG000|Overall Study|Withdrawal by Subject|1|||
170695416|NCT00832585|616896352|FG000|Overall Study|Lost to Follow-up|1|||
170695417|NCT01374087|616896353|FG000|Overall Study|Adverse Event|1|||
170695418|NCT01374087|616896354|FG001|Overall Study|Adverse Event|0|||
170695419|NCT01374087|616896353|FG000|Overall Study|Disease progression|2|||
170695420|NCT01374087|616896354|FG001|Overall Study|Disease progression|2|||
170695421|NCT01374087|616896353|FG000|Overall Study|Study discontinued|13|||
170695422|NCT01374087|616896354|FG001|Overall Study|Study discontinued|13|||
170695423|NCT03011307|616896355|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
170695424|NCT03011307|616896356|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
170695425|NCT03011307|616896355|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
170695426|NCT03011307|616896356|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
170695427|NCT03011307|616896355|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
170695428|NCT03011307|616896356|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
170695429|NCT01782664|616896357|FG000|Overall Study|Adverse Event|2|||
170695430|NCT01782664|616896358|FG001|Overall Study|Adverse Event|2|||
170695431|NCT01782664|616896359|FG002|Overall Study|Adverse Event|2|||
170695432|NCT01782664|616896360|FG003|Overall Study|Adverse Event|2|||
170695433|NCT01782664|616896361|FG004|Overall Study|Adverse Event|0|||
170695434|NCT01782664|616896362|FG005|Overall Study|Adverse Event|0|||
170695435|NCT01782664|616896357|FG000|Overall Study|Lack of Efficacy|2|||
170695436|NCT01782664|616896358|FG001|Overall Study|Lack of Efficacy|0|||
170695437|NCT01782664|616896359|FG002|Overall Study|Lack of Efficacy|2|||
170695438|NCT01782664|616896360|FG003|Overall Study|Lack of Efficacy|2|||
170695439|NCT01782664|616896361|FG004|Overall Study|Lack of Efficacy|0|||
170695440|NCT01782664|616896362|FG005|Overall Study|Lack of Efficacy|0|||
170695441|NCT01782664|616896357|FG000|Overall Study|Protocol Violation|0|||
170695442|NCT01782664|616896358|FG001|Overall Study|Protocol Violation|1|||
170695443|NCT01782664|616896359|FG002|Overall Study|Protocol Violation|0|||
170695444|NCT01782664|616896360|FG003|Overall Study|Protocol Violation|1|||
170695445|NCT01782664|616896361|FG004|Overall Study|Protocol Violation|0|||
170695446|NCT01782664|616896362|FG005|Overall Study|Protocol Violation|0|||
170695447|NCT01782664|616896357|FG000|Overall Study|Withdrawal by Subject|2|||
170695448|NCT01782664|616896358|FG001|Overall Study|Withdrawal by Subject|2|||
170695449|NCT01782664|616896359|FG002|Overall Study|Withdrawal by Subject|0|||
170695450|NCT01782664|616896360|FG003|Overall Study|Withdrawal by Subject|0|||
170695451|NCT01782664|616896361|FG004|Overall Study|Withdrawal by Subject|0|||
170695452|NCT01782664|616896362|FG005|Overall Study|Withdrawal by Subject|0|||
170695453|NCT00567892|616896363|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
170695454|NCT00567892|616896364|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
170695455|NCT00567892|616896365|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
170695456|NCT00567892|616896366|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
170695457|NCT00567892|616896363|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
170695458|NCT00567892|616896364|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
170695459|NCT00567892|616896365|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
170695460|NCT00567892|616896366|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
170695461|NCT04254978|616898217|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
170695462|NCT04254978|616898217|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
170695463|NCT04254978|616898217|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
170695464|NCT04254978|616898217|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
170695465|NCT04254978|616898217|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
170695466|NCT04254978|616898217|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
170695467|NCT02449239|616898218|FG000|Induction Phase|Lack of Efficacy|64|||
170695468|NCT02449239|616898218|FG000|Induction Phase|Adverse Event|1|||
170695469|NCT02449239|616898218|FG000|Induction Phase|Lost to Follow-up|1|||
170695470|NCT02449239|616898218|FG000|Induction Phase|Protocol Violation|1|||
170695471|NCT02449239|616898218|FG000|Induction Phase|Physician Decision|1|||
170695472|NCT02449239|616898218|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
170695473|NCT02449239|616898218|FG000|Induction Phase|Withdrawal by Subject|1|||
170695474|NCT02449239|616898218|FG000|Maintenance Month 3|Lack of Efficacy|14|||
170695475|NCT02449239|616898218|FG000|Maintenance Month 6|Lack of Efficacy|10|||
170695476|NCT02449239|616898218|FG000|Maintenance Month 6|Adverse Event|2|||
170695477|NCT02449239|616898218|FG000|Maintenance Month 6|Physician Decision|1|||
170695478|NCT02449239|616898218|FG000|Maintenance Month 9|Lack of Efficacy|2|||
170695479|NCT02449239|616898218|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
170695480|NCT02449239|616898218|FG000|Maintenance Month 12|Lack of Efficacy|5|||
170695481|NCT02449239|616898218|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
170695482|NCT02449239|616898218|FG000|Maintenance Month 12|Subject moved from area|1|||
170695483|NCT02449239|616898218|FG000|Maintenance Month 15|Lack of Efficacy|1|||
170695484|NCT02449239|616898218|FG000|Maintenance Month 21|Lack of Efficacy|1|||
170695485|NCT02449239|616898218|FG000|Maintenance Month 21|Sponsor decision|1|||
170695486|NCT00922766|616898219|FG000|Overall Study|Death|3|||
170695487|NCT00922766|616898219|FG000|Overall Study|Withdrawal by Subject|2|||
170695488|NCT00922766|616898219|FG000|Overall Study|Other|1|||
170695489|NCT00922766|616898219|FG000|Overall Study|Adverse Event|1|||
170695490|NCT00380393|616898220|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
170695491|NCT00380393|616898221|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
170695492|NCT00380393|616898220|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
170695493|NCT00380393|616898221|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
170695494|NCT00380393|616898220|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
170695495|NCT00380393|616898221|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
170695496|NCT00380393|616898220|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
170695497|NCT00380393|616898221|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
170695498|NCT00380393|616898220|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
170695499|NCT00380393|616898221|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
170695500|NCT00380393|616898220|FG000|Month 14|Withdrawal by Subject|9|||
170695501|NCT00380393|616898221|FG001|Month 14|Withdrawal by Subject|7|||
170695502|NCT00380393|616898220|FG000|Month 14|Death|1|||
170695503|NCT00380393|616898221|FG001|Month 14|Death|0|||
170695504|NCT00380393|616898220|FG000|Month 14|Lost to Follow-up|0|||
170695505|NCT00380393|616898221|FG001|Month 14|Lost to Follow-up|1|||
170695506|NCT00380393|616898220|FG000|Month 14|Migrated/moved from study area|39|||
170695507|NCT00380393|616898221|FG001|Month 14|Migrated/moved from study area|42|||
170695508|NCT00380393|616898220|FG000|Month 14|Protocol Violation|2|||
170695509|NCT00380393|616898221|FG001|Month 14|Protocol Violation|0|||
170695510|NCT00380393|616898220|FG000|Month 14|Others|6|||
170695511|NCT00380393|616898221|FG001|Month 14|Others|6|||
170695512|NCT00159588|616898227|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
170695513|NCT00159588|616898228|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
170695514|NCT00159588|616898229|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
170695515|NCT03446040|616898235|FG000|Overall Study|Disease progression|3|||
170695516|NCT03446040|616898236|FG001|Overall Study|Disease progression|3|||
170695517|NCT03446040|616898237|FG002|Overall Study|Disease progression|3|||
170695518|NCT03446040|616898238|FG003|Overall Study|Disease progression|4|||
170695519|NCT03446040|616898239|FG004|Overall Study|Disease progression|4|||
170695520|NCT03446040|616898240|FG005|Overall Study|Disease progression|6|||
170695521|NCT03446040|616898241|FG006|Overall Study|Disease progression|3|||
170695522|NCT03446040|616898242|FG007|Overall Study|Disease progression|4|||
170695523|NCT03446040|616898243|FG008|Overall Study|Disease progression|2|||
170695524|NCT03446040|616898244|FG009|Overall Study|Disease progression|4|||
170695525|NCT03446040|616898245|FG010|Overall Study|Disease progression|9|||
170695526|NCT03446040|616898246|FG011|Overall Study|Disease progression|3|||
170695527|NCT03446040|616898247|FG012|Overall Study|Disease progression|7|||
170695528|NCT03446040|616898248|FG013|Overall Study|Disease progression|7|||
170695529|NCT03446040|616898235|FG000|Overall Study|Study drug toxicity|0|||
170695530|NCT03446040|616898236|FG001|Overall Study|Study drug toxicity|0|||
170695531|NCT03446040|616898237|FG002|Overall Study|Study drug toxicity|0|||
170695532|NCT03446040|616898238|FG003|Overall Study|Study drug toxicity|0|||
170695533|NCT03446040|616898239|FG004|Overall Study|Study drug toxicity|0|||
170695534|NCT03446040|616898240|FG005|Overall Study|Study drug toxicity|0|||
170695535|NCT03446040|616898241|FG006|Overall Study|Study drug toxicity|0|||
170695536|NCT03446040|616898242|FG007|Overall Study|Study drug toxicity|0|||
170695537|NCT03446040|616898243|FG008|Overall Study|Study drug toxicity|1|||
170695538|NCT03446040|616898244|FG009|Overall Study|Study drug toxicity|0|||
170695539|NCT03446040|616898245|FG010|Overall Study|Study drug toxicity|0|||
170695540|NCT03446040|616898246|FG011|Overall Study|Study drug toxicity|0|||
170695541|NCT03446040|616898247|FG012|Overall Study|Study drug toxicity|0|||
170695542|NCT03446040|616898248|FG013|Overall Study|Study drug toxicity|0|||
170695543|NCT03446040|616898235|FG000|Overall Study|Adverse Event|0|||
170695544|NCT03446040|616898236|FG001|Overall Study|Adverse Event|0|||
170695545|NCT03446040|616898237|FG002|Overall Study|Adverse Event|0|||
170695546|NCT03446040|616898238|FG003|Overall Study|Adverse Event|0|||
170695547|NCT03446040|616898239|FG004|Overall Study|Adverse Event|0|||
170695548|NCT03446040|616898240|FG005|Overall Study|Adverse Event|2|||
170695549|NCT03446040|616898241|FG006|Overall Study|Adverse Event|0|||
170695550|NCT03446040|616898242|FG007|Overall Study|Adverse Event|0|||
170695551|NCT03446040|616898243|FG008|Overall Study|Adverse Event|1|||
170695552|NCT03446040|616898244|FG009|Overall Study|Adverse Event|0|||
170695553|NCT03446040|616898245|FG010|Overall Study|Adverse Event|0|||
170695554|NCT03446040|616898246|FG011|Overall Study|Adverse Event|0|||
170695555|NCT03446040|616898247|FG012|Overall Study|Adverse Event|0|||
170695556|NCT03446040|616898248|FG013|Overall Study|Adverse Event|0|||
170695557|NCT03446040|616898235|FG000|Overall Study|Death|0|||
170695558|NCT03446040|616898236|FG001|Overall Study|Death|0|||
170695559|NCT03446040|616898237|FG002|Overall Study|Death|0|||
170695560|NCT03446040|616898238|FG003|Overall Study|Death|0|||
170695561|NCT03446040|616898239|FG004|Overall Study|Death|0|||
170695562|NCT03446040|616898240|FG005|Overall Study|Death|0|||
170695563|NCT03446040|616898241|FG006|Overall Study|Death|0|||
170695564|NCT03446040|616898242|FG007|Overall Study|Death|0|||
170695565|NCT03446040|616898243|FG008|Overall Study|Death|0|||
170695566|NCT03446040|616898244|FG009|Overall Study|Death|0|||
170695567|NCT03446040|616898245|FG010|Overall Study|Death|1|||
170695568|NCT03446040|616898246|FG011|Overall Study|Death|0|||
170695569|NCT03446040|616898247|FG012|Overall Study|Death|0|||
170695570|NCT03446040|616898248|FG013|Overall Study|Death|2|||
170695571|NCT03446040|616898235|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
170695572|NCT03446040|616898236|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
170695573|NCT03446040|616898237|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
170695574|NCT03446040|616898238|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
170695575|NCT03446040|616898239|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
170695576|NCT03446040|616898240|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
170695577|NCT03446040|616898241|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
170695578|NCT03446040|616898242|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
170695579|NCT03446040|616898243|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
170695580|NCT03446040|616898244|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
170695581|NCT03446040|616898245|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
170695582|NCT03446040|616898246|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
170695583|NCT03446040|616898247|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
170695584|NCT03446040|616898248|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
170695585|NCT03446040|616898235|FG000|Overall Study|Participant withdrew consent|0|||
170695586|NCT03446040|616898236|FG001|Overall Study|Participant withdrew consent|0|||
170695587|NCT03446040|616898237|FG002|Overall Study|Participant withdrew consent|0|||
170695588|NCT03446040|616898238|FG003|Overall Study|Participant withdrew consent|0|||
170695589|NCT03446040|616898239|FG004|Overall Study|Participant withdrew consent|0|||
170695590|NCT03446040|616898240|FG005|Overall Study|Participant withdrew consent|1|||
170695591|NCT03446040|616898241|FG006|Overall Study|Participant withdrew consent|0|||
170695592|NCT03446040|616898242|FG007|Overall Study|Participant withdrew consent|1|||
170695593|NCT03446040|616898243|FG008|Overall Study|Participant withdrew consent|0|||
170695594|NCT03446040|616898244|FG009|Overall Study|Participant withdrew consent|0|||
170695595|NCT03446040|616898245|FG010|Overall Study|Participant withdrew consent|0|||
170695596|NCT03446040|616898246|FG011|Overall Study|Participant withdrew consent|0|||
170695597|NCT03446040|616898247|FG012|Overall Study|Participant withdrew consent|0|||
170695598|NCT03446040|616898248|FG013|Overall Study|Participant withdrew consent|0|||
170695599|NCT03446040|616898235|FG000|Overall Study|Not reported|0|||
170695600|NCT03446040|616898236|FG001|Overall Study|Not reported|0|||
170695601|NCT03446040|616898237|FG002|Overall Study|Not reported|1|||
170695602|NCT03446040|616898238|FG003|Overall Study|Not reported|0|||
170695603|NCT03446040|616898239|FG004|Overall Study|Not reported|0|||
170695604|NCT03446040|616898240|FG005|Overall Study|Not reported|0|||
170695605|NCT03446040|616898241|FG006|Overall Study|Not reported|0|||
170695606|NCT03446040|616898242|FG007|Overall Study|Not reported|0|||
170695607|NCT03446040|616898243|FG008|Overall Study|Not reported|0|||
170695608|NCT03446040|616898244|FG009|Overall Study|Not reported|0|||
170695609|NCT03446040|616898245|FG010|Overall Study|Not reported|0|||
170695610|NCT03446040|616898246|FG011|Overall Study|Not reported|0|||
170695611|NCT03446040|616898247|FG012|Overall Study|Not reported|0|||
170695612|NCT03446040|616898248|FG013|Overall Study|Not reported|0|||
170695613|NCT02596854|616898254|FG000|Overall Study|Withdrawn|8|||
170695614|NCT00076011|616898259|FG000|Overall Study|Death|1|||
170695615|NCT00076011|616898259|FG000|Overall Study|Adverse Event|10|||
170695616|NCT00076011|616898259|FG000|Overall Study|Lack of Efficacy|25|||
170695617|NCT00076011|616898259|FG000|Overall Study|Withdrawal by Subject|1|||
170695618|NCT00076011|616898259|FG000|Overall Study|Study terminated by sponsor|3|||
170695619|NCT00076011|616898259|FG000|Overall Study|Other|11|||
170695620|NCT00076011|616898259|FG000|Overall Study|Ongoing|1|||
170695621|NCT03314584|616898264|FG000|Overall Study|Withdrawal by Subject|3|||
170695622|NCT03314584|616898265|FG001|Overall Study|Withdrawal by Subject|3|||
170695623|NCT03314584|616898264|FG000|Overall Study|Lost to Follow-up|4|||
170695624|NCT03314584|616898265|FG001|Overall Study|Lost to Follow-up|0|||
170695625|NCT06134817|616898266|FG000|Overall Study|Physician Departure - termination of study|1|||
170695626|NCT00464568|616898273|FG000|Overall Study|Adverse Event|2|||
170695627|NCT02255981|616898275|FG000|Overall Study|Lost to Follow-up|3|||
170695628|NCT02255981|616898275|FG000|Overall Study|Withdrawal by Subject|1|||
170695629|NCT02672423|616898276|FG000|Period 1|Adverse Event|0|||
170695630|NCT02672423|616898277|FG001|Period 1|Adverse Event|0|||
170695631|NCT02672423|616898278|FG002|Period 1|Adverse Event|0|||
170695632|NCT02672423|616898279|FG003|Period 1|Adverse Event|0|||
170695633|NCT02672423|616898280|FG004|Period 1|Adverse Event|1|||
170695634|NCT02672423|616898281|FG005|Period 1|Adverse Event|0|||
170695635|NCT02672423|616898282|FG006|Period 1|Adverse Event|0|||
170695636|NCT02672423|616898283|FG007|Period 1|Adverse Event|0|||
170695637|NCT02672423|616898284|FG008|Period 1|Adverse Event|0|||
170695638|NCT02672423|616898285|FG009|Period 1|Adverse Event|0|||
170695639|NCT02672423|616898276|FG000|Period 2|Withdrawal by Subject|0|||
170695640|NCT02672423|616898277|FG001|Period 2|Withdrawal by Subject|0|||
170695641|NCT02672423|616898278|FG002|Period 2|Withdrawal by Subject|1|||
170695642|NCT02672423|616898279|FG003|Period 2|Withdrawal by Subject|0|||
170695643|NCT02672423|616898280|FG004|Period 2|Withdrawal by Subject|0|||
170695644|NCT02672423|616898281|FG005|Period 2|Withdrawal by Subject|0|||
170695645|NCT02672423|616898282|FG006|Period 2|Withdrawal by Subject|0|||
170695646|NCT02672423|616898283|FG007|Period 2|Withdrawal by Subject|0|||
170695647|NCT02672423|616898284|FG008|Period 2|Withdrawal by Subject|0|||
170695648|NCT02672423|616898285|FG009|Period 2|Withdrawal by Subject|0|||
170695649|NCT02672423|616898276|FG000|Period 3|Withdrawal by Subject|0|||
170695650|NCT02672423|616898277|FG001|Period 3|Withdrawal by Subject|0|||
170695651|NCT02672423|616898278|FG002|Period 3|Withdrawal by Subject|0|||
170695652|NCT02672423|616898279|FG003|Period 3|Withdrawal by Subject|0|||
170695653|NCT02672423|616898280|FG004|Period 3|Withdrawal by Subject|0|||
170695654|NCT02672423|616898281|FG005|Period 3|Withdrawal by Subject|0|||
170695655|NCT02672423|616898282|FG006|Period 3|Withdrawal by Subject|0|||
170695656|NCT02672423|616898283|FG007|Period 3|Withdrawal by Subject|1|||
170695657|NCT02672423|616898284|FG008|Period 3|Withdrawal by Subject|0|||
170695658|NCT02672423|616898285|FG009|Period 3|Withdrawal by Subject|0|||
170695659|NCT02672423|616898276|FG000|Period 3|Physician Decision|0|||
170695660|NCT02672423|616898277|FG001|Period 3|Physician Decision|0|||
170695661|NCT02672423|616898278|FG002|Period 3|Physician Decision|0|||
170695662|NCT02672423|616898279|FG003|Period 3|Physician Decision|0|||
170695663|NCT02672423|616898280|FG004|Period 3|Physician Decision|0|||
170695664|NCT02672423|616898281|FG005|Period 3|Physician Decision|1|||
170695665|NCT02672423|616898282|FG006|Period 3|Physician Decision|0|||
170695666|NCT02672423|616898283|FG007|Period 3|Physician Decision|0|||
170695667|NCT02672423|616898284|FG008|Period 3|Physician Decision|0|||
170695668|NCT02672423|616898285|FG009|Period 3|Physician Decision|0|||
170695669|NCT03897179|616898286|FG000|Overall Study|Withdrawal by Subject|1|||
170695670|NCT01480076|616898287|FG000|Overall Study|Run-in Failure|52|||
170695671|NCT01480076|616898287|FG000|Overall Study|Adverse Event|39|||
170695672|NCT01480076|616898287|FG000|Overall Study|Death|2|||
170695673|NCT01480076|616898287|FG000|Overall Study|Disease Progression|5|||
170695674|NCT01480076|616898287|FG000|Overall Study|Non-compliance With Study Protocol|15|||
170695675|NCT01480076|616898287|FG000|Overall Study|Withdrawal by Subject|105|||
170695676|NCT01480076|616898287|FG000|Overall Study|Lost to Follow-up|7|||
170695677|NCT01480076|616898287|FG000|Overall Study|Investigator Decision|13|||
170695678|NCT01480076|616898287|FG000|Overall Study|Other|52|||
170695679|NCT00704535|616898288|FG000|Overall Study|Adverse Event|2|||
170695680|NCT00704535|616898288|FG000|Overall Study|Death|2|||
170695681|NCT00704535|616898288|FG000|Overall Study|Lost to Follow-up|8|||
170695682|NCT00704535|616898288|FG000|Overall Study|Protocol Violation|10|||
170695683|NCT00704535|616898288|FG000|Overall Study|Completed status not on Case Report Form|124|||
170695684|NCT02503332|616898290|FG000|Overall Study|Adverse Event|17|||
170695685|NCT02503332|616898291|FG001|Overall Study|Adverse Event|5|||
170695686|NCT02503332|616898292|FG002|Overall Study|Adverse Event|3|||
170695687|NCT02503332|616898293|FG003|Overall Study|Adverse Event|1|||
170695688|NCT02503332|616898290|FG000|Overall Study|Investigator's Decision|5|||
170695689|NCT02503332|616898291|FG001|Overall Study|Investigator's Decision|1|||
170695690|NCT02503332|616898292|FG002|Overall Study|Investigator's Decision|0|||
170695691|NCT02503332|616898293|FG003|Overall Study|Investigator's Decision|0|||
170695692|NCT02503332|616898290|FG000|Overall Study|Sponsor's Decision|1|||
170695693|NCT02503332|616898291|FG001|Overall Study|Sponsor's Decision|0|||
170695694|NCT02503332|616898292|FG002|Overall Study|Sponsor's Decision|0|||
170695695|NCT02503332|616898293|FG003|Overall Study|Sponsor's Decision|1|||
170695696|NCT02503332|616898290|FG000|Overall Study|Subject Request|6|||
170695697|NCT02503332|616898291|FG001|Overall Study|Subject Request|5|||
170695698|NCT02503332|616898292|FG002|Overall Study|Subject Request|2|||
170695699|NCT02503332|616898293|FG003|Overall Study|Subject Request|1|||
170695700|NCT02503332|616898290|FG000|Overall Study|Death|0|||
170695701|NCT02503332|616898291|FG001|Overall Study|Death|2|||
170695702|NCT02503332|616898292|FG002|Overall Study|Death|2|||
170695703|NCT02503332|616898293|FG003|Overall Study|Death|0|||
170695704|NCT02503332|616898290|FG000|Overall Study|Other|5|||
170695705|NCT02503332|616898291|FG001|Overall Study|Other|6|||
170695706|NCT02503332|616898292|FG002|Overall Study|Other|1|||
170695707|NCT02503332|616898293|FG003|Overall Study|Other|1|||
170695708|NCT05694546|616898294|FG000|Overall Study|Lost to Follow-up|11|||
170695709|NCT02120950|616898295|FG000|Overall Study|Adverse Event|5|||
170695710|NCT02120950|616898296|FG001|Overall Study|Adverse Event|4|||
170695711|NCT02120950|616898297|FG002|Overall Study|Adverse Event|3|||
170695712|NCT02120950|616898295|FG000|Overall Study|Death|3|||
170695713|NCT02120950|616898296|FG001|Overall Study|Death|0|||
170695714|NCT02120950|616898297|FG002|Overall Study|Death|1|||
170695715|NCT02120950|616898295|FG000|Overall Study|Withdrawal by Subject|6|||
170695716|NCT02120950|616898296|FG001|Overall Study|Withdrawal by Subject|3|||
170695717|NCT02120950|616898297|FG002|Overall Study|Withdrawal by Subject|2|||
170695718|NCT02120950|616898295|FG000|Overall Study|Protocol Violation|1|||
170695719|NCT02120950|616898296|FG001|Overall Study|Protocol Violation|1|||
170695720|NCT02120950|616898297|FG002|Overall Study|Protocol Violation|7|||
170695721|NCT02120950|616898295|FG000|Overall Study|Other reasons|5|||
170695722|NCT02120950|616898296|FG001|Overall Study|Other reasons|4|||
170695723|NCT02120950|616898297|FG002|Overall Study|Other reasons|1|||
170695724|NCT02120950|616898295|FG000|Overall Study|Lost to Follow-up|0|||
170695725|NCT02120950|616898296|FG001|Overall Study|Lost to Follow-up|2|||
170695726|NCT02120950|616898297|FG002|Overall Study|Lost to Follow-up|1|||
170695727|NCT01589445|616898298|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
170695728|NCT01589445|616898298|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
170695729|NCT01589445|616898298|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
170695730|NCT01589445|616898298|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
170695731|NCT01589445|616898298|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
170695732|NCT01589445|616898298|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
170695733|NCT01589445|616898298|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
170695734|NCT01589445|616898298|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
170695735|NCT01589445|616898298|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
170695736|NCT01589445|616898298|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
170695737|NCT01752855|616898302|FG000|Overall Study|Adverse Event|1|||
170695738|NCT01752855|616898303|FG001|Overall Study|Adverse Event|0|||
170823451|NCT03740919|617360523|FG000|Lead-in Period|Lost to Follow-up|1|||
170695739|NCT01752855|616898302|FG000|Overall Study|Withdrew Consent|0|||
170695740|NCT01752855|616898303|FG001|Overall Study|Withdrew Consent|2|||
170695741|NCT01752855|616898302|FG000|Overall Study|Lack of Efficacy|0|||
170695742|NCT01752855|616898303|FG001|Overall Study|Lack of Efficacy|2|||
170695743|NCT01478321|616898304|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
170695744|NCT01478321|616898304|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
170695745|NCT01478321|616898304|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
170695746|NCT01478321|616898304|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
170695747|NCT01478321|616898304|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
170695748|NCT01478321|616898304|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
170695749|NCT01478321|616898304|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
170695750|NCT01478321|616898304|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
170695751|NCT02625090|616898306|FG000|Overall Study|Participant wants to be pregnant|2|||
170695752|NCT02625090|616898306|FG000|Overall Study|For the Promoter|1|||
170695753|NCT02625090|616898306|FG000|Overall Study|Sponsor's Decision|9|||
170695754|NCT02625090|616898306|FG000|Overall Study|Somnolence|1|||
170695755|NCT02625090|616898306|FG000|Overall Study|Study terminated by Sponsor|7|||
170695756|NCT02625090|616898306|FG000|Overall Study|Negative Benefit/Risk|1|||
170695757|NCT02625090|616898306|FG000|Overall Study|Protocol Deviation|2|||
170695758|NCT02625090|616898306|FG000|Overall Study|Lack of Efficacy|16|||
170823452|NCT03740919|617360524|FG001|Lead-in Period|Lost to Follow-up|0|||
170823453|NCT03740919|617360525|FG002|Lead-in Period|Lost to Follow-up|0|||
170695759|NCT02625090|616898306|FG000|Overall Study|Adverse Event|3|||
170695760|NCT00314574|616898307|FG000|Overall Study|Death|3|||
170695761|NCT00314574|616898308|FG001|Overall Study|Death|0|||
170695762|NCT00314574|616898307|FG000|Overall Study|Adverse Event|11|||
170695763|NCT00314574|616898308|FG001|Overall Study|Adverse Event|16|||
170695764|NCT00314574|616898307|FG000|Overall Study|Lost to Follow-up|19|||
170695765|NCT00314574|616898308|FG001|Overall Study|Lost to Follow-up|25|||
170695766|NCT00314574|616898307|FG000|Overall Study|Withdrawal by Subject|33|||
170695767|NCT00314574|616898308|FG001|Overall Study|Withdrawal by Subject|22|||
170695768|NCT00314574|616898307|FG000|Overall Study|Physician Decision|22|||
170695769|NCT00314574|616898308|FG001|Overall Study|Physician Decision|15|||
170695770|NCT00314574|616898307|FG000|Overall Study|Pregnancy|6|||
170695771|NCT00314574|616898308|FG001|Overall Study|Pregnancy|4|||
170695772|NCT00314574|616898307|FG000|Overall Study|Data unknown at database lock|0|||
170695773|NCT00314574|616898308|FG001|Overall Study|Data unknown at database lock|1|||
170695774|NCT02250443|616898309|FG000|Overall Study|Administrative problems|7|||
170695775|NCT02250443|616898309|FG000|Overall Study|Adverse Event|3|||
170695776|NCT02053753|616898310|FG000|Overall Study|Withdrawal by Subject|2|||
170695777|NCT02053753|616898311|FG001|Overall Study|Withdrawal by Subject|4|||
170695778|NCT02053753|616898310|FG000|Overall Study|Decision by Sponsor|1|||
170695779|NCT02053753|616898311|FG001|Overall Study|Decision by Sponsor|1|||
170695780|NCT02053753|616898310|FG000|Overall Study|Lost to Follow-up|4|||
170695781|NCT02053753|616898311|FG001|Overall Study|Lost to Follow-up|3|||
170695782|NCT02290821|616898316|FG000|Overall Study|Withdrawal by Subject|1|||
170695783|NCT02290821|616898317|FG001|Overall Study|Withdrawal by Subject|1|||
170695784|NCT02290821|616898316|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
170695785|NCT02290821|616898317|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
170695786|NCT02290821|616898316|FG000|Overall Study|Lost to Follow-up|3|||
170695787|NCT02290821|616898317|FG001|Overall Study|Lost to Follow-up|2|||
170695788|NCT01289847|616898318|FG000|Overall Study|Patient could not comply with visits|1|||
170695789|NCT01520363|616898329|FG000|Overall Study|Withdrawal by Subject|2|||
170695790|NCT01520363|616898330|FG001|Overall Study|Withdrawal by Subject|0|||
170695791|NCT01251380|616898337|FG000|Overall Study|Other (Not otherwise specified)|12|||
170695792|NCT01251380|616898337|FG000|Overall Study|Withdrawal by Subject|6|||
170695793|NCT01251380|616898337|FG000|Overall Study|Lack of Efficacy|1|||
170695794|NCT01251380|616898337|FG000|Overall Study|Adverse Event|1|||
170695795|NCT01251380|616898337|FG000|Overall Study|Lost to Follow-up|2|||
170695796|NCT00751348|616898338|FG000|Overall Study|Withdrawal by Subject|5|||
170695797|NCT00751348|616898339|FG001|Overall Study|Withdrawal by Subject|2|||
170695798|NCT00751348|616898338|FG000|Overall Study|Migration from study area|1|||
170695799|NCT00751348|616898339|FG001|Overall Study|Migration from study area|0|||
170695800|NCT03165110|616898340|FG000|Overall Study|Anroid phone software incompatibility|1|||
170695801|NCT05533632|616898341|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
170695802|NCT05533632|616898341|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
170695803|NCT05533632|616898341|FG000|Overall Study|Lost to Follow-up|1|||
170695804|NCT05533632|616898341|FG000|Overall Study|Withdrawal by Subject|4|||
170695805|NCT05533632|616898341|FG000|Overall Study|Adverse Event|4|||
170695806|NCT05389657|616898348|FG000|Overall Study|Lost to Follow-up|7|||
170695807|NCT05389657|616898349|FG001|Overall Study|Lost to Follow-up|8|||
170695808|NCT00743652|616898350|FG000|Overall Study|Parent/Legal Guardian Request|3|||
170695809|NCT00743652|616898351|FG001|Overall Study|Parent/Legal Guardian Request|2|||
170695810|NCT00743652|616898352|FG002|Overall Study|Parent/Legal Guardian Request|2|||
170695811|NCT00743652|616898353|FG003|Overall Study|Parent/Legal Guardian Request|2|||
170695812|NCT00743652|616898354|FG004|Overall Study|Parent/Legal Guardian Request|0|||
170695813|NCT00743652|616898350|FG000|Overall Study|Adverse Event|3|||
170823454|NCT03740919|617360526|FG003|Lead-in Period|Lost to Follow-up|0|||
170823455|NCT03740919|617360523|FG000|Lead-in Period|Physician Decision|2|||
170823456|NCT03740919|617360524|FG001|Lead-in Period|Physician Decision|0|||
170695814|NCT00743652|616898351|FG001|Overall Study|Adverse Event|0|||
170695815|NCT00743652|616898352|FG002|Overall Study|Adverse Event|0|||
170695816|NCT00743652|616898353|FG003|Overall Study|Adverse Event|0|||
170695817|NCT00743652|616898354|FG004|Overall Study|Adverse Event|0|||
170823457|NCT03740919|617360525|FG002|Lead-in Period|Physician Decision|0|||
170823458|NCT03740919|617360526|FG003|Lead-in Period|Physician Decision|0|||
170823459|NCT03740919|617360523|FG000|Lead-in Period|Protocol Violation|1|||
170695818|NCT00743652|616898350|FG000|Overall Study|Death|2|||
170695819|NCT00743652|616898351|FG001|Overall Study|Death|0|||
170695820|NCT00743652|616898352|FG002|Overall Study|Death|0|||
170695821|NCT00743652|616898353|FG003|Overall Study|Death|0|||
170695822|NCT00743652|616898354|FG004|Overall Study|Death|0|||
170695823|NCT00743652|616898350|FG000|Overall Study|Investigator Request|0|||
170695824|NCT00743652|616898351|FG001|Overall Study|Investigator Request|0|||
170695825|NCT00743652|616898352|FG002|Overall Study|Investigator Request|0|||
170695826|NCT00743652|616898353|FG003|Overall Study|Investigator Request|2|||
170695827|NCT00743652|616898354|FG004|Overall Study|Investigator Request|0|||
170695828|NCT00743652|616898350|FG000|Overall Study|Other|1|||
170823460|NCT03740919|617360524|FG001|Lead-in Period|Protocol Violation|0|||
170823461|NCT03740919|617360525|FG002|Lead-in Period|Protocol Violation|0|||
170695829|NCT00743652|616898351|FG001|Overall Study|Other|1|||
170695830|NCT00743652|616898352|FG002|Overall Study|Other|0|||
170695831|NCT00743652|616898353|FG003|Overall Study|Other|0|||
170695832|NCT00743652|616898354|FG004|Overall Study|Other|0|||
170695833|NCT00743652|616898350|FG000|Overall Study|Lost to Follow-up|1|||
170695834|NCT00743652|616898351|FG001|Overall Study|Lost to Follow-up|0|||
170695835|NCT00743652|616898352|FG002|Overall Study|Lost to Follow-up|0|||
170695836|NCT00743652|616898353|FG003|Overall Study|Lost to Follow-up|0|||
170695837|NCT00743652|616898354|FG004|Overall Study|Lost to Follow-up|0|||
170695838|NCT05237206|616898355|FG000|Overall Study|screen failure-did not receive treatment|8|||
170695839|NCT05237206|616898355|FG000|Overall Study|did not receive treatment|3|||
170695840|NCT03774433|616898358|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
170695841|NCT00108160|616898359|FG000|Overall Study|Lost to Follow-up|25|||
170695842|NCT00108160|616898360|FG001|Overall Study|Lost to Follow-up|12|||
170695843|NCT00108160|616898359|FG000|Overall Study|Death|1|||
170695844|NCT00108160|616898360|FG001|Overall Study|Death|2|||
170695845|NCT00108160|616898359|FG000|Overall Study|Withdrawal by Subject|4|||
170695846|NCT00108160|616898360|FG001|Overall Study|Withdrawal by Subject|2|||
170695847|NCT00108160|616898359|FG000|Overall Study|Protocol Violation|9|||
170695848|NCT00108160|616898360|FG001|Overall Study|Protocol Violation|5|||
170695849|NCT02154581|616898362|FG000|Overall Study|Lost to Follow-up|7|||
170695850|NCT02154581|616898363|FG001|Overall Study|Lost to Follow-up|8|||
170695851|NCT00741039|616898364|FG000|Overall Study|Patient non-compliance|2|||
170695852|NCT00741039|616898365|FG001|Overall Study|Patient non-compliance|0|||
170695853|NCT02081079|616898366|FG000|Overall Study|Lack of Efficacy|3|||
170695854|NCT02081079|616898367|FG001|Overall Study|Lack of Efficacy|2|||
170695855|NCT02081079|616898366|FG000|Overall Study|Lost to Follow-up|1|||
170695856|NCT02081079|616898367|FG001|Overall Study|Lost to Follow-up|0|||
170695857|NCT00878709|616898368|FG000|Overall Study|Withdrawal by Subject|197|||
170695858|NCT00878709|616898369|FG001|Overall Study|Withdrawal by Subject|120|||
170695859|NCT00878709|616898368|FG000|Overall Study|Lost to Follow-up|35|||
170695860|NCT00878709|616898369|FG001|Overall Study|Lost to Follow-up|33|||
170695861|NCT00878709|616898368|FG000|Overall Study|Other Reasons|93|||
170695862|NCT00878709|616898369|FG001|Overall Study|Other Reasons|84|||
170695863|NCT00768144|616898370|FG000|Overall Study|Adverse Event|13|||
170695864|NCT00768144|616898370|FG000|Overall Study|Progressive Disease|21|||
170695865|NCT00768144|616898370|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
170695866|NCT00768144|616898370|FG000|Overall Study|Pt Withdrew Consent|1|||
170695867|NCT01712854|616898371|FG000|Overall Study|Physician Decision|1|||
170695868|NCT02171260|616898372|FG000|Overall Study|Death|0|||
170695869|NCT02171260|616898373|FG001|Overall Study|Death|0|||
170695870|NCT02171260|616898374|FG002|Overall Study|Death|0|||
170695871|NCT02171260|616898375|FG003|Overall Study|Death|1|||
170695872|NCT02171260|616898372|FG000|Overall Study|Physician Decision|1|||
170695873|NCT02171260|616898373|FG001|Overall Study|Physician Decision|0|||
170695874|NCT02171260|616898374|FG002|Overall Study|Physician Decision|1|||
170695875|NCT02171260|616898375|FG003|Overall Study|Physician Decision|0|||
170695876|NCT02171260|616898372|FG000|Overall Study|Withdrawal by Subject|1|||
170695877|NCT02171260|616898373|FG001|Overall Study|Withdrawal by Subject|0|||
170695878|NCT02171260|616898374|FG002|Overall Study|Withdrawal by Subject|0|||
170695879|NCT02171260|616898375|FG003|Overall Study|Withdrawal by Subject|0|||
170695880|NCT02171260|616898372|FG000|Overall Study|Evidence of progressive disease|4|||
170695881|NCT02171260|616898373|FG001|Overall Study|Evidence of progressive disease|6|||
170695882|NCT02171260|616898374|FG002|Overall Study|Evidence of progressive disease|4|||
170695883|NCT02171260|616898375|FG003|Overall Study|Evidence of progressive disease|4|||
170695884|NCT00403273|616899933|FG000|Overall Study|Lost to Follow-up|3|||
170695885|NCT00403273|616899934|FG001|Overall Study|Lost to Follow-up|2|||
170695886|NCT00403273|616899933|FG000|Overall Study|Physician Decision|0|||
170695887|NCT00403273|616899934|FG001|Overall Study|Physician Decision|1|||
170695888|NCT00403273|616899933|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
170695889|NCT00403273|616899934|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
170695890|NCT00502697|616899940|FG000|Overall Study|Withdrawal by Subject|3|||
170695891|NCT00502697|616899941|FG001|Overall Study|Withdrawal by Subject|1|||
170695892|NCT00502697|616899940|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
170695893|NCT00502697|616899941|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
170695894|NCT00502697|616899940|FG000|Overall Study|found not to meet eligibility criteria|3|||
170695895|NCT00502697|616899941|FG001|Overall Study|found not to meet eligibility criteria|4|||
170695896|NCT00502697|616899940|FG000|Overall Study|did not meet assignment criteria|4|||
170695897|NCT00502697|616899941|FG001|Overall Study|did not meet assignment criteria|2|||
170695898|NCT00589108|616899945|FG000|Overall Study|Lost to Follow-up|1|||
170695899|NCT00589108|616899946|FG001|Overall Study|Lost to Follow-up|1|||
170695900|NCT00589108|616899947|FG002|Overall Study|Lost to Follow-up|1|||
170695901|NCT00589108|616899945|FG000|Overall Study|Death|3|||
170695902|NCT00589108|616899946|FG001|Overall Study|Death|3|||
170695903|NCT00589108|616899947|FG002|Overall Study|Death|4|||
170695904|NCT03256552|616899948|FG000|Overall Study|Protocol Violation|1|||
170695905|NCT03256552|616899948|FG000|Overall Study|Physician Decision|1|||
170695906|NCT03256552|616899948|FG000|Overall Study|Adverse Event|1|||
170695907|NCT03256552|616899948|FG000|Overall Study|Withdrawal by Subject|2|||
170695908|NCT03026257|616899951|FG000|Overall Study|Adverse Event|3|||
170695909|NCT03026257|616899952|FG001|Overall Study|Adverse Event|0|||
170695910|NCT03026257|616899953|FG002|Overall Study|Adverse Event|0|||
170695911|NCT03026257|616899954|FG003|Overall Study|Adverse Event|0|||
170695912|NCT03026257|616899955|FG004|Overall Study|Adverse Event|0|||
170695913|NCT03026257|616899956|FG005|Overall Study|Adverse Event|0|||
170695914|NCT03026257|616899951|FG000|Overall Study|Lost to Follow-up|1|||
170695915|NCT03026257|616899952|FG001|Overall Study|Lost to Follow-up|0|||
170695916|NCT03026257|616899953|FG002|Overall Study|Lost to Follow-up|0|||
170695917|NCT03026257|616899954|FG003|Overall Study|Lost to Follow-up|0|||
170695918|NCT03026257|616899955|FG004|Overall Study|Lost to Follow-up|0|||
170695919|NCT03026257|616899956|FG005|Overall Study|Lost to Follow-up|0|||
170695920|NCT03026257|616899951|FG000|Overall Study|Protocol Violation|1|||
170695921|NCT03026257|616899952|FG001|Overall Study|Protocol Violation|0|||
170695922|NCT03026257|616899953|FG002|Overall Study|Protocol Violation|0|||
170695923|NCT03026257|616899954|FG003|Overall Study|Protocol Violation|1|||
170695924|NCT03026257|616899955|FG004|Overall Study|Protocol Violation|1|||
170695925|NCT03026257|616899956|FG005|Overall Study|Protocol Violation|0|||
170695926|NCT03026257|616899951|FG000|Overall Study|Withdrawal by Subject|1|||
170695927|NCT03026257|616899952|FG001|Overall Study|Withdrawal by Subject|1|||
170695928|NCT03026257|616899953|FG002|Overall Study|Withdrawal by Subject|0|||
170695929|NCT03026257|616899954|FG003|Overall Study|Withdrawal by Subject|0|||
170695930|NCT03026257|616899955|FG004|Overall Study|Withdrawal by Subject|0|||
170695931|NCT03026257|616899956|FG005|Overall Study|Withdrawal by Subject|0|||
170695932|NCT02181556|616899958|FG000|Overall Study|Withdrawal by Subject|1|||
170695933|NCT00838201|616899959|FG000|Overall Study|Investigator decision, or other reasons|2|||
170695934|NCT00838201|616899960|FG001|Overall Study|Investigator decision, or other reasons|3|||
170695935|NCT00838201|616899959|FG000|Overall Study|Noncompliance|0|||
170695936|NCT00838201|616899960|FG001|Overall Study|Noncompliance|1|||
170695937|NCT00838201|616899959|FG000|Overall Study|Administrative decision|1|||
170695938|NCT00838201|616899960|FG001|Overall Study|Administrative decision|2|||
170695939|NCT00838201|616899959|FG000|Overall Study|Disease progression|3|||
170695940|NCT00838201|616899960|FG001|Overall Study|Disease progression|3|||
170695941|NCT00838201|616899959|FG000|Overall Study|Consent withdrawn|16|||
170695942|NCT00838201|616899960|FG001|Overall Study|Consent withdrawn|19|||
170695943|NCT00838201|616899959|FG000|Overall Study|Lost to Follow-up|4|||
170695944|NCT00838201|616899960|FG001|Overall Study|Lost to Follow-up|3|||
170695945|NCT00838201|616899959|FG000|Overall Study|Adverse Event|5|||
170695946|NCT00838201|616899960|FG001|Overall Study|Adverse Event|9|||
170695947|NCT00838201|616899959|FG000|Overall Study|Death|11|||
170695948|NCT00838201|616899960|FG001|Overall Study|Death|13|||
170695949|NCT00489853|616899961|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
170695950|NCT00489853|616899962|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
170695951|NCT00489853|616899963|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
170695952|NCT00489853|616899961|FG000|Wash-out Period 1|Adverse Event|0|||
170695953|NCT00489853|616899962|FG001|Wash-out Period 1|Adverse Event|1|||
170695954|NCT00489853|616899963|FG002|Wash-out Period 1|Adverse Event|1|||
170695955|NCT00489853|616899961|FG000|Wash-out Period 1|Protocol Violation|0|||
170695956|NCT00489853|616899962|FG001|Wash-out Period 1|Protocol Violation|1|||
170695957|NCT00489853|616899963|FG002|Wash-out Period 1|Protocol Violation|1|||
170695958|NCT00489853|616899961|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
170695959|NCT00489853|616899962|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
170695960|NCT00489853|616899963|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
170695961|NCT00489853|616899961|FG000|Wash-out Period 2|Adverse Event|1|||
170695962|NCT00489853|616899962|FG001|Wash-out Period 2|Adverse Event|1|||
170695963|NCT00489853|616899963|FG002|Wash-out Period 2|Adverse Event|0|||
170695964|NCT00489853|616899961|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
170695965|NCT00489853|616899962|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
170695966|NCT00489853|616899963|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
170695967|NCT00489853|616899961|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
170695968|NCT00489853|616899962|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
170695969|NCT00489853|616899963|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
170695970|NCT04171414|616899969|FG000|Overall Study|Death|1|||
170695971|NCT04171414|616899969|FG000|Overall Study|Withdrawal by Subject|1|||
170695972|NCT04343521|616899977|FG000|Overall Study|Adverse Event|0|||
170695973|NCT04343521|616899978|FG001|Overall Study|Adverse Event|2|||
170695974|NCT04343521|616899977|FG000|Overall Study|Death|1|||
170695975|NCT04343521|616899978|FG001|Overall Study|Death|2|||
170695976|NCT04343521|616899977|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
170695977|NCT04343521|616899978|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
170695978|NCT04343521|616899977|FG000|Overall Study|Withdrawal by Subject|70|||
170695979|NCT04343521|616899978|FG001|Overall Study|Withdrawal by Subject|95|||
170695980|NCT04343521|616899977|FG000|Overall Study|Withdrawal by study team|6|||
170695981|NCT04343521|616899978|FG001|Overall Study|Withdrawal by study team|12|||
170695982|NCT02211131|616899979|FG000|Overall Study|Death|26|||
170695983|NCT02211131|616899980|FG001|Overall Study|Death|16|||
170695984|NCT02211131|616899979|FG000|Overall Study|Lost to Follow-up|4|||
170695985|NCT02211131|616899980|FG001|Overall Study|Lost to Follow-up|3|||
170695986|NCT02211131|616899979|FG000|Overall Study|Decision by Sponsor|1|||
170695987|NCT02211131|616899980|FG001|Overall Study|Decision by Sponsor|1|||
170695988|NCT02211131|616899979|FG000|Overall Study|Withdrawal by Subject|3|||
170695989|NCT02211131|616899980|FG001|Overall Study|Withdrawal by Subject|8|||
170695990|NCT05664490|616899983|FG000|Overall Study|Withdrawal by Subject|0|||
170695991|NCT05664490|616899984|FG001|Overall Study|Withdrawal by Subject|1|||
170695992|NCT05664490|616899983|FG000|Overall Study|Lost to Follow-up|14|||
170695993|NCT05664490|616899984|FG001|Overall Study|Lost to Follow-up|22|||
170695994|NCT01928862|616899985|FG000|Overall Study|Lost to Follow-up|1|||
170695995|NCT01928862|616899986|FG001|Overall Study|Lost to Follow-up|0|||
170695996|NCT01928862|616899987|FG002|Overall Study|Lost to Follow-up|0|||
170695997|NCT01928862|616899988|FG003|Overall Study|Lost to Follow-up|0|||
170695998|NCT01928862|616899989|FG004|Overall Study|Lost to Follow-up|1|||
170695999|NCT00481195|616899997|FG000|Overall Study|Adverse Event|16|||
170696000|NCT00481195|616899998|FG001|Overall Study|Adverse Event|11|||
170696001|NCT00481195|616899997|FG000|Overall Study|Lack of Efficacy|1|||
170696002|NCT00481195|616899998|FG001|Overall Study|Lack of Efficacy|3|||
170696003|NCT00481195|616899997|FG000|Overall Study|Lost to Follow-up|4|||
170696004|NCT00481195|616899998|FG001|Overall Study|Lost to Follow-up|6|||
170696005|NCT00481195|616899997|FG000|Overall Study|Physician Decision|3|||
170696006|NCT00481195|616899998|FG001|Overall Study|Physician Decision|1|||
170696007|NCT00481195|616899997|FG000|Overall Study|Protocol Violation|10|||
170696008|NCT00481195|616899998|FG001|Overall Study|Protocol Violation|7|||
170696009|NCT00481195|616899997|FG000|Overall Study|Withdrawal by Subject|3|||
170696010|NCT00481195|616899998|FG001|Overall Study|Withdrawal by Subject|9|||
170696011|NCT00481195|616899997|FG000|Overall Study|Miscellaneous|2|||
170696012|NCT00481195|616899998|FG001|Overall Study|Miscellaneous|2|||
170696013|NCT00006478|616900003|FG000|Overall Study|Vaccine could not be produced|1|||
170696014|NCT00006478|616900003|FG000|Overall Study|Physician Decision|6|||
170696015|NCT02404350|616900005|FG000|Overall Study|Adverse Event|2|||
170696016|NCT02404350|616900006|FG001|Overall Study|Adverse Event|2|||
170696017|NCT02404350|616900007|FG002|Overall Study|Adverse Event|3|||
170696018|NCT02404350|616900008|FG003|Overall Study|Adverse Event|9|||
170696019|NCT02404350|616900005|FG000|Overall Study|Lack of Efficacy|3|||
170696020|NCT02404350|616900006|FG001|Overall Study|Lack of Efficacy|1|||
170696021|NCT02404350|616900007|FG002|Overall Study|Lack of Efficacy|0|||
170696022|NCT02404350|616900008|FG003|Overall Study|Lack of Efficacy|3|||
170696023|NCT02404350|616900005|FG000|Overall Study|Lost to Follow-up|2|||
170696024|NCT02404350|616900006|FG001|Overall Study|Lost to Follow-up|0|||
170696025|NCT02404350|616900007|FG002|Overall Study|Lost to Follow-up|0|||
170696026|NCT02404350|616900008|FG003|Overall Study|Lost to Follow-up|1|||
170696027|NCT02404350|616900005|FG000|Overall Study|Physician Decision|1|||
170696028|NCT02404350|616900006|FG001|Overall Study|Physician Decision|0|||
170696029|NCT02404350|616900007|FG002|Overall Study|Physician Decision|0|||
170696030|NCT02404350|616900008|FG003|Overall Study|Physician Decision|2|||
170696031|NCT02404350|616900005|FG000|Overall Study|Pregnancy|0|||
170696032|NCT02404350|616900006|FG001|Overall Study|Pregnancy|0|||
170696033|NCT02404350|616900007|FG002|Overall Study|Pregnancy|0|||
170696034|NCT02404350|616900008|FG003|Overall Study|Pregnancy|1|||
170823462|NCT03740919|617360526|FG003|Lead-in Period|Protocol Violation|0|||
170823463|NCT03740919|617360523|FG000|Lead-in Period|Withdrawal by Subject|10|||
170696035|NCT02404350|616900005|FG000|Overall Study|Withdrawal by Subject|7|||
170696036|NCT02404350|616900006|FG001|Overall Study|Withdrawal by Subject|3|||
170696037|NCT02404350|616900007|FG002|Overall Study|Withdrawal by Subject|3|||
170696038|NCT02404350|616900008|FG003|Overall Study|Withdrawal by Subject|19|||
170696039|NCT02404350|616900005|FG000|Overall Study|Due to Non-compliance with treatment|0|||
170696040|NCT02404350|616900006|FG001|Overall Study|Due to Non-compliance with treatment|0|||
170696041|NCT02404350|616900007|FG002|Overall Study|Due to Non-compliance with treatment|0|||
170696042|NCT02404350|616900008|FG003|Overall Study|Due to Non-compliance with treatment|1|||
170696043|NCT02404350|616900005|FG000|Overall Study|Due to Technical problems|0|||
170696044|NCT02404350|616900006|FG001|Overall Study|Due to Technical problems|0|||
170696045|NCT02404350|616900007|FG002|Overall Study|Due to Technical problems|0|||
170696046|NCT02404350|616900008|FG003|Overall Study|Due to Technical problems|1|||
170696047|NCT00600756|616900009|FG000|Analysis After 6 Months|Adverse Event|43|||
170696048|NCT00600756|616900010|FG001|Analysis After 6 Months|Adverse Event|33|||
170696049|NCT00600756|616900009|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
170696050|NCT00600756|616900010|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
170696051|NCT00600756|616900009|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
170696052|NCT00600756|616900010|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
170696053|NCT00600756|616900009|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
170696054|NCT00600756|616900010|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
170696055|NCT00600756|616900009|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
170696056|NCT00600756|616900010|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
170696057|NCT00600756|616900009|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
170696058|NCT00600756|616900010|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
170696059|NCT00600756|616900009|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
170696060|NCT00600756|616900010|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
170696061|NCT00600756|616900009|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
170696062|NCT00600756|616900010|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
170696063|NCT00600756|616900009|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
170696064|NCT00600756|616900010|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
170696065|NCT00600756|616900009|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
170696066|NCT00600756|616900010|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
170696067|NCT00600756|616900009|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
170696068|NCT00600756|616900010|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
170696069|NCT00600756|616900009|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
170696070|NCT00600756|616900010|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
170696071|NCT00600756|616900009|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
170696072|NCT00600756|616900010|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
170696073|NCT00600756|616900009|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
170696074|NCT00600756|616900010|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
170696075|NCT03261947|616900012|FG000|Overall Study|Death|10|||
170696076|NCT03261947|616900013|FG001|Overall Study|Death|13|||
170696077|NCT03261947|616900014|FG002|Overall Study|Death|17|||
170696078|NCT03261947|616900015|FG003|Overall Study|Death|12|||
170696079|NCT03261947|616900016|FG004|Overall Study|Death|8|||
170696080|NCT03261947|616900012|FG000|Overall Study|Lost to Follow-up|0|||
170696081|NCT03261947|616900013|FG001|Overall Study|Lost to Follow-up|0|||
170696082|NCT03261947|616900014|FG002|Overall Study|Lost to Follow-up|2|||
170696083|NCT03261947|616900015|FG003|Overall Study|Lost to Follow-up|1|||
170696084|NCT03261947|616900016|FG004|Overall Study|Lost to Follow-up|0|||
170696085|NCT03261947|616900012|FG000|Overall Study|Withdrawal by Subject|0|||
170696086|NCT03261947|616900013|FG001|Overall Study|Withdrawal by Subject|0|||
170696087|NCT03261947|616900014|FG002|Overall Study|Withdrawal by Subject|3|||
170696088|NCT03261947|616900015|FG003|Overall Study|Withdrawal by Subject|0|||
170696089|NCT03261947|616900016|FG004|Overall Study|Withdrawal by Subject|1|||
170696090|NCT03261947|616900012|FG000|Overall Study|Site Terminated by Sponsor|0|||
170696091|NCT03261947|616900013|FG001|Overall Study|Site Terminated by Sponsor|0|||
170696092|NCT03261947|616900014|FG002|Overall Study|Site Terminated by Sponsor|4|||
170696093|NCT03261947|616900015|FG003|Overall Study|Site Terminated by Sponsor|7|||
170696094|NCT03261947|616900016|FG004|Overall Study|Site Terminated by Sponsor|5|||
170696095|NCT03261947|616900012|FG000|Overall Study|Reason not Specified|2|||
170696096|NCT03261947|616900013|FG001|Overall Study|Reason not Specified|0|||
170696097|NCT03261947|616900014|FG002|Overall Study|Reason not Specified|4|||
170696098|NCT03261947|616900015|FG003|Overall Study|Reason not Specified|1|||
170696099|NCT03261947|616900016|FG004|Overall Study|Reason not Specified|3|||
170696100|NCT03969992|616900017|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
170696101|NCT03969992|616900018|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
170696102|NCT03969992|616900019|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
170696103|NCT03969992|616900017|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
170696104|NCT03969992|616900018|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
170696105|NCT03969992|616900019|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
170696106|NCT03969992|616900017|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
170696107|NCT03969992|616900018|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
170696108|NCT03969992|616900019|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
170696109|NCT03969992|616900017|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
170696110|NCT03969992|616900018|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
170823464|NCT03740919|617360524|FG001|Lead-in Period|Withdrawal by Subject|0|||
170823465|NCT03740919|617360525|FG002|Lead-in Period|Withdrawal by Subject|0|||
170823466|NCT03740919|617360526|FG003|Lead-in Period|Withdrawal by Subject|0|||
170823467|NCT03740919|617360523|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
170823468|NCT03740919|617360524|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
170696111|NCT03969992|616900019|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
170823469|NCT03740919|617360525|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
170823470|NCT03740919|617360526|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
170696112|NCT03969992|616900017|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
170696113|NCT03969992|616900018|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
170696114|NCT03969992|616900019|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
170696115|NCT00228917|616900020|FG000|Overall Study|Migrated/moved from study area|0|||
170696116|NCT00228917|616900021|FG001|Overall Study|Migrated/moved from study area|0|||
170696117|NCT00228917|616900022|FG002|Overall Study|Migrated/moved from study area|0|||
170696118|NCT00228917|616900023|FG003|Overall Study|Migrated/moved from study area|0|||
170696119|NCT00228917|616900024|FG004|Overall Study|Migrated/moved from study area|0|||
170696120|NCT00228917|616900025|FG005|Overall Study|Migrated/moved from study area|2|||
170696121|NCT00228917|616900026|FG006|Overall Study|Migrated/moved from study area|0|||
170696122|NCT00228917|616900027|FG007|Overall Study|Migrated/moved from study area|0|||
170696123|NCT01476696|616900028|FG000|Overall Study|Sponsor decision|2|||
170696124|NCT01476696|616900029|FG001|Overall Study|Sponsor decision|1|||
170696125|NCT01476696|616900030|FG002|Overall Study|Sponsor decision|0|||
170696126|NCT01476696|616900028|FG000|Overall Study|Withdrawal by Subject|1|||
170696127|NCT01476696|616900029|FG001|Overall Study|Withdrawal by Subject|0|||
170696128|NCT01476696|616900030|FG002|Overall Study|Withdrawal by Subject|0|||
170696129|NCT02063737|616900033|FG000|Overall Study|Lost to Follow-up|11|||
170696130|NCT02063737|616900034|FG001|Overall Study|Lost to Follow-up|4|||
170696131|NCT00439556|616900035|FG000|Overall Study|Patient was taken off study for non-comp|0|||
170696132|NCT00439556|616900036|FG001|Overall Study|Patient was taken off study for non-comp|1|||
170696133|NCT00439556|616900037|FG002|Overall Study|Patient was taken off study for non-comp|0|||
170696134|NCT04372602|616900040|FG000|Overall Study|Withdrawal by Subject|1|||
170696135|NCT04372602|616900041|FG001|Overall Study|Withdrawal by Subject|1|||
170696136|NCT04372602|616900040|FG000|Overall Study|Adverse Event|0|||
170696137|NCT04372602|616900041|FG001|Overall Study|Adverse Event|1|||
170696138|NCT04372602|616900040|FG000|Overall Study|Transitioned to comfort care|0|||
170696139|NCT04372602|616900041|FG001|Overall Study|Transitioned to comfort care|1|||
170696140|NCT01324388|616900042|FG000|Part 1 of Study|Adverse Event|2|||
170696141|NCT01324388|616900043|FG001|Part 1 of Study|Adverse Event|0|||
170696142|NCT01324388|616900044|FG002|Part 1 of Study|Adverse Event|0|||
170696143|NCT01324388|616900045|FG003|Part 1 of Study|Adverse Event|0|||
170696144|NCT01324388|616900042|FG000|Part 1 of Study|Protocol Violation|1|||
170696145|NCT01324388|616900043|FG001|Part 1 of Study|Protocol Violation|2|||
170696146|NCT01324388|616900044|FG002|Part 1 of Study|Protocol Violation|0|||
170696147|NCT01324388|616900045|FG003|Part 1 of Study|Protocol Violation|0|||
170696148|NCT01324388|616900042|FG000|Part 1 of Study|Physician Decision|1|||
170696149|NCT01324388|616900043|FG001|Part 1 of Study|Physician Decision|0|||
170696150|NCT01324388|616900044|FG002|Part 1 of Study|Physician Decision|0|||
170696151|NCT01324388|616900045|FG003|Part 1 of Study|Physician Decision|0|||
170696152|NCT01324388|616900042|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
170696153|NCT01324388|616900043|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
170696154|NCT01324388|616900044|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
170696155|NCT01324388|616900045|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
170696156|NCT01324388|616900042|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
170696157|NCT01324388|616900043|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
170696158|NCT01324388|616900044|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
170696159|NCT01324388|616900045|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
170696160|NCT00129129|616900046|FG000|Primary Phase|Adverse Event|2|||
170696161|NCT00129129|616900047|FG001|Primary Phase|Adverse Event|1|||
170696162|NCT00129129|616900048|FG002|Primary Phase|Adverse Event|0|||
170696163|NCT00129129|616900049|FG003|Primary Phase|Adverse Event|0|||
170696164|NCT00129129|616900050|FG004|Primary Phase|Adverse Event|0|||
170696165|NCT00129129|616900046|FG000|Primary Phase|Withdrawal by Subject|12|||
170696166|NCT00129129|616900047|FG001|Primary Phase|Withdrawal by Subject|10|||
170696167|NCT00129129|616900048|FG002|Primary Phase|Withdrawal by Subject|0|||
170696168|NCT00129129|616900049|FG003|Primary Phase|Withdrawal by Subject|0|||
170696169|NCT00129129|616900050|FG004|Primary Phase|Withdrawal by Subject|0|||
170696170|NCT00129129|616900046|FG000|Primary Phase|Migration from study area|1|||
170696171|NCT00129129|616900047|FG001|Primary Phase|Migration from study area|3|||
170696172|NCT00129129|616900048|FG002|Primary Phase|Migration from study area|0|||
170696173|NCT00129129|616900049|FG003|Primary Phase|Migration from study area|0|||
170696174|NCT00129129|616900050|FG004|Primary Phase|Migration from study area|0|||
170823471|NCT03740919|617360523|FG000|Lead-in Period|Study Task Too Burdensome|1|||
170823472|NCT03740919|617360524|FG001|Lead-in Period|Study Task Too Burdensome|0|||
170696175|NCT00129129|616900046|FG000|Primary Phase|Lost to Follow-up|8|||
170696176|NCT00129129|616900047|FG001|Primary Phase|Lost to Follow-up|6|||
170696177|NCT00129129|616900048|FG002|Primary Phase|Lost to Follow-up|0|||
170696178|NCT00129129|616900049|FG003|Primary Phase|Lost to Follow-up|0|||
170696179|NCT00129129|616900050|FG004|Primary Phase|Lost to Follow-up|0|||
170696180|NCT00129129|616900046|FG000|Primary Phase|Other|2|||
170696181|NCT00129129|616900047|FG001|Primary Phase|Other|5|||
170696182|NCT00129129|616900048|FG002|Primary Phase|Other|0|||
170696183|NCT00129129|616900049|FG003|Primary Phase|Other|0|||
170696184|NCT00129129|616900050|FG004|Primary Phase|Other|0|||
170696185|NCT00129129|616900046|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
170823473|NCT03740919|617360525|FG002|Lead-in Period|Study Task Too Burdensome|0|||
170696186|NCT00129129|616900047|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
170696187|NCT00129129|616900048|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
170696188|NCT00129129|616900049|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
170696189|NCT00129129|616900050|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
170696190|NCT00129129|616900046|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
170696191|NCT00129129|616900047|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
170696192|NCT00129129|616900048|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
170696193|NCT00129129|616900049|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
170696194|NCT00129129|616900050|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
170696195|NCT00129129|616900046|FG000|Fourth Dose Phase|Migration from study area|0|||
170696196|NCT00129129|616900047|FG001|Fourth Dose Phase|Migration from study area|0|||
170696197|NCT00129129|616900048|FG002|Fourth Dose Phase|Migration from study area|0|||
170696198|NCT00129129|616900049|FG003|Fourth Dose Phase|Migration from study area|0|||
170696199|NCT00129129|616900050|FG004|Fourth Dose Phase|Migration from study area|2|||
170696200|NCT00129129|616900046|FG000|Fourth Dose Phase|Other|0|||
170696201|NCT00129129|616900047|FG001|Fourth Dose Phase|Other|0|||
170696202|NCT00129129|616900048|FG002|Fourth Dose Phase|Other|0|||
170696203|NCT00129129|616900049|FG003|Fourth Dose Phase|Other|1|||
170696204|NCT00129129|616900050|FG004|Fourth Dose Phase|Other|1|||
170696205|NCT00129129|616900046|FG000|Fourth Dose Phase|Protocol Violation|0|||
170696206|NCT00129129|616900047|FG001|Fourth Dose Phase|Protocol Violation|0|||
170696207|NCT00129129|616900048|FG002|Fourth Dose Phase|Protocol Violation|0|||
170696208|NCT00129129|616900049|FG003|Fourth Dose Phase|Protocol Violation|1|||
170696209|NCT00129129|616900050|FG004|Fourth Dose Phase|Protocol Violation|0|||
170696210|NCT00335972|616900053|FG000|Overall Study|not given treatments|0|||
170696211|NCT00335972|616900054|FG001|Overall Study|not given treatments|3|||
170696212|NCT01358357|616900061|FG000|Open Label Phase|Adverse Event|0|||
170696213|NCT01358357|616900062|FG001|Open Label Phase|Adverse Event|0|||
170696214|NCT01358357|616900063|FG002|Open Label Phase|Adverse Event|59|||
170696215|NCT01358357|616900061|FG000|Open Label Phase|Lack of Efficacy|0|||
170696216|NCT01358357|616900062|FG001|Open Label Phase|Lack of Efficacy|0|||
170696217|NCT01358357|616900063|FG002|Open Label Phase|Lack of Efficacy|107|||
170696218|NCT01358357|616900061|FG000|Open Label Phase|Lost to Follow-up|0|||
170696219|NCT01358357|616900062|FG001|Open Label Phase|Lost to Follow-up|0|||
170696220|NCT01358357|616900063|FG002|Open Label Phase|Lost to Follow-up|76|||
170696221|NCT01358357|616900061|FG000|Open Label Phase|Protocol Violation|0|||
170696222|NCT01358357|616900062|FG001|Open Label Phase|Protocol Violation|0|||
170696223|NCT01358357|616900063|FG002|Open Label Phase|Protocol Violation|45|||
170696224|NCT01358357|616900061|FG000|Open Label Phase|Withdrawal by Subject|0|||
170696225|NCT01358357|616900062|FG001|Open Label Phase|Withdrawal by Subject|0|||
170696226|NCT01358357|616900063|FG002|Open Label Phase|Withdrawal by Subject|112|||
170696227|NCT01358357|616900061|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
170696228|NCT01358357|616900062|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
170696229|NCT01358357|616900063|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
170696230|NCT01358357|616900061|FG000|Open Label Phase|Terminated at study completion|0|||
170696231|NCT01358357|616900062|FG001|Open Label Phase|Terminated at study completion|0|||
170696232|NCT01358357|616900063|FG002|Open Label Phase|Terminated at study completion|5|||
170696233|NCT01358357|616900061|FG000|Open Label Phase|Mood episode|0|||
170696234|NCT01358357|616900062|FG001|Open Label Phase|Mood episode|0|||
170696235|NCT01358357|616900063|FG002|Open Label Phase|Mood episode|42|||
170696236|NCT01358357|616900061|FG000|Double-Blind Phase|Adverse Event|8|||
170696237|NCT01358357|616900062|FG001|Double-Blind Phase|Adverse Event|5|||
170696238|NCT01358357|616900063|FG002|Double-Blind Phase|Adverse Event|0|||
170696239|NCT01358357|616900061|FG000|Double-Blind Phase|Lost to Follow-up|5|||
170696240|NCT01358357|616900062|FG001|Double-Blind Phase|Lost to Follow-up|7|||
170696241|NCT01358357|616900063|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170696242|NCT01358357|616900061|FG000|Double-Blind Phase|Protocol Violation|1|||
170696243|NCT01358357|616900062|FG001|Double-Blind Phase|Protocol Violation|11|||
170696244|NCT01358357|616900063|FG002|Double-Blind Phase|Protocol Violation|0|||
170696245|NCT01358357|616900061|FG000|Double-Blind Phase|Protocol Violation|16|||
170696246|NCT01358357|616900062|FG001|Double-Blind Phase|Protocol Violation|12|||
170696247|NCT01358357|616900063|FG002|Double-Blind Phase|Protocol Violation|0|||
170696248|NCT01358357|616900061|FG000|Double-Blind Phase|Terminated at study completion|2|||
170696249|NCT01358357|616900062|FG001|Double-Blind Phase|Terminated at study completion|0|||
170696250|NCT01358357|616900063|FG002|Double-Blind Phase|Terminated at study completion|0|||
170696251|NCT01358357|616900061|FG000|Double-Blind Phase|Recurrence of mood event|48|||
170696252|NCT01358357|616900062|FG001|Double-Blind Phase|Recurrence of mood event|64|||
170696253|NCT01358357|616900063|FG002|Double-Blind Phase|Recurrence of mood event|0|||
170696254|NCT01358357|616900061|FG000|Double-Blind Phase|Administrative|0|||
170696255|NCT01358357|616900062|FG001|Double-Blind Phase|Administrative|1|||
170696256|NCT01358357|616900063|FG002|Double-Blind Phase|Administrative|0|||
170696257|NCT03200899|616900064|FG000|Overall Study|Lost to Follow-up|10|||
170696258|NCT03200899|616900065|FG001|Overall Study|Lost to Follow-up|23|||
170696259|NCT01344161|616900074|FG000|Overall Study|Lost to Follow-up|4|||
170696260|NCT01344161|616900075|FG001|Overall Study|Lost to Follow-up|1|||
170696261|NCT01344161|616900074|FG000|Overall Study|Pregnancy|0|||
170696262|NCT01344161|616900075|FG001|Overall Study|Pregnancy|1|||
170696263|NCT01344161|616900074|FG000|Overall Study|Protocol Violation|1|||
170696264|NCT01344161|616900075|FG001|Overall Study|Protocol Violation|1|||
170696265|NCT04364620|616900076|FG000|Overall Study|Disease Progression|20|||
170696266|NCT04364620|616900076|FG000|Overall Study|Adverse Event|5|||
170696267|NCT04364620|616900076|FG000|Overall Study|Physician Decision|4|||
170696268|NCT04364620|616900076|FG000|Overall Study|Death|3|||
170696269|NCT04364620|616900076|FG000|Overall Study|Other|2|||
170696270|NCT04364620|616900076|FG000|Overall Study|Withdrawal by Subject|1|||
170696271|NCT02268409|616901611|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
170696272|NCT02268409|616901611|FG000|Overall Study|Death|1|||
170696273|NCT02268409|616901611|FG000|Overall Study|Lost to Follow-up|1|||
170696274|NCT02268409|616901611|FG000|Overall Study|Protocol Violation|3|||
170696275|NCT02268409|616901611|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
170696276|NCT02268409|616901611|FG000|Overall Study|Withdrawal by Subject|5|||
170696277|NCT03265249|616901612|FG000|Overall Study|Withdrawal by Subject|0|||
170696278|NCT03265249|616901613|FG001|Overall Study|Withdrawal by Subject|1|||
170696279|NCT03873987|616901614|FG000|Overall Study|Adverse Event|1|||
170696280|NCT03873987|616901615|FG001|Overall Study|Adverse Event|0|||
170696281|NCT03873987|616901614|FG000|Overall Study|staff was unable to start a new IV line|1|||
170696282|NCT03873987|616901615|FG001|Overall Study|staff was unable to start a new IV line|0|||
170696283|NCT03873987|616901614|FG000|Overall Study|Lost to Follow-up|0|||
170696284|NCT03873987|616901615|FG001|Overall Study|Lost to Follow-up|1|||
170696285|NCT01465022|616901616|FG000|Overall Study|Lost to Follow-up|15|||
170696286|NCT01465022|616901617|FG001|Overall Study|Lost to Follow-up|14|||
170696287|NCT01465022|616901618|FG002|Overall Study|Lost to Follow-up|0|||
170696288|NCT01465022|616901616|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
170696289|NCT01465022|616901617|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
170696290|NCT01465022|616901618|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
170696291|NCT01465022|616901616|FG000|Overall Study|Not Randomized|0|||
170696292|NCT01465022|616901617|FG001|Overall Study|Not Randomized|0|||
170696293|NCT01465022|616901618|FG002|Overall Study|Not Randomized|70|||
170696294|NCT00644969|616901619|FG000|Treatment Phase|Randomized, not treated|1|||
170696295|NCT00644969|616901620|FG001|Treatment Phase|Randomized, not treated|0|||
170696296|NCT00644969|616901619|FG000|Treatment Phase|Adverse Event|3|||
170696297|NCT00644969|616901620|FG001|Treatment Phase|Adverse Event|0|||
170696298|NCT00644969|616901619|FG000|Treatment Phase|Withdrawal by Subject|4|||
170696299|NCT00644969|616901620|FG001|Treatment Phase|Withdrawal by Subject|0|||
170696300|NCT00644969|616901619|FG000|Treatment Phase|Lost to Follow-up|2|||
170696301|NCT00644969|616901620|FG001|Treatment Phase|Lost to Follow-up|2|||
170696302|NCT00644969|616901619|FG000|Treatment Phase|Other|4|||
170696303|NCT00644969|616901620|FG001|Treatment Phase|Other|1|||
170696304|NCT00644969|616901619|FG000|Post Treatment Phase|Death|1|||
170696305|NCT00644969|616901620|FG001|Post Treatment Phase|Death|0|||
170696306|NCT00644969|616901619|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
170696307|NCT00644969|616901620|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
170696308|NCT00644969|616901619|FG000|Post Treatment Phase|Lost to Follow-up|4|||
170696309|NCT00644969|616901620|FG001|Post Treatment Phase|Lost to Follow-up|1|||
170696310|NCT00644969|616901619|FG000|Post Treatment Phase|Other|1|||
170696311|NCT00644969|616901620|FG001|Post Treatment Phase|Other|0|||
170696312|NCT03161483|616901621|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
170696313|NCT03161483|616901622|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
170696314|NCT03161483|616901623|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
170696315|NCT03161483|616901624|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
170696316|NCT03161483|616901621|FG000|Treatment Period|Death|1|||
170696317|NCT03161483|616901622|FG001|Treatment Period|Death|0|||
170696318|NCT03161483|616901623|FG002|Treatment Period|Death|0|||
170696319|NCT03161483|616901624|FG003|Treatment Period|Death|0|||
170696320|NCT03161483|616901621|FG000|Treatment Period|Adverse Event|5|||
170696321|NCT03161483|616901622|FG001|Treatment Period|Adverse Event|2|||
170696322|NCT03161483|616901623|FG002|Treatment Period|Adverse Event|1|||
170696323|NCT03161483|616901624|FG003|Treatment Period|Adverse Event|11|||
170696324|NCT03161483|616901621|FG000|Treatment Period|Pregnancy|1|||
170696325|NCT03161483|616901622|FG001|Treatment Period|Pregnancy|0|||
170696326|NCT03161483|616901623|FG002|Treatment Period|Pregnancy|0|||
170696327|NCT03161483|616901624|FG003|Treatment Period|Pregnancy|0|||
170696328|NCT03161483|616901621|FG000|Treatment Period|Lack of Efficacy|0|||
170696329|NCT03161483|616901622|FG001|Treatment Period|Lack of Efficacy|0|||
170696330|NCT03161483|616901623|FG002|Treatment Period|Lack of Efficacy|0|||
170696331|NCT03161483|616901624|FG003|Treatment Period|Lack of Efficacy|1|||
170696332|NCT03161483|616901621|FG000|Treatment Period|Withdrawal by Subject|2|||
170696333|NCT03161483|616901622|FG001|Treatment Period|Withdrawal by Subject|5|||
170696334|NCT03161483|616901623|FG002|Treatment Period|Withdrawal by Subject|2|||
170696335|NCT03161483|616901624|FG003|Treatment Period|Withdrawal by Subject|6|||
170696336|NCT03161483|616901621|FG000|Treatment Period|Lost to Follow-up|0|||
170696337|NCT03161483|616901622|FG001|Treatment Period|Lost to Follow-up|0|||
170696338|NCT03161483|616901623|FG002|Treatment Period|Lost to Follow-up|0|||
170696339|NCT03161483|616901624|FG003|Treatment Period|Lost to Follow-up|1|||
170696340|NCT03161483|616901621|FG000|Treatment Period|Protocol Violation|0|||
170696341|NCT03161483|616901622|FG001|Treatment Period|Protocol Violation|0|||
170696342|NCT03161483|616901623|FG002|Treatment Period|Protocol Violation|0|||
170696343|NCT03161483|616901624|FG003|Treatment Period|Protocol Violation|1|||
170696344|NCT03161483|616901621|FG000|Treatment Period|Other reasons|1|||
170696345|NCT03161483|616901622|FG001|Treatment Period|Other reasons|1|||
170696346|NCT03161483|616901623|FG002|Treatment Period|Other reasons|0|||
170696347|NCT03161483|616901624|FG003|Treatment Period|Other reasons|0|||
170696348|NCT00409617|616901628|FG000|Overall Study|Adverse Event|57|||
170696349|NCT00409617|616901628|FG000|Overall Study|Lack of Efficacy|54|||
170696350|NCT00409617|616901628|FG000|Overall Study|Lost to Follow-up|2|||
170696351|NCT00409617|616901628|FG000|Overall Study|Protocol Violation|24|||
170696352|NCT00409617|616901628|FG000|Overall Study|Withdrawal by Subject|8|||
170696353|NCT00409617|616901628|FG000|Overall Study|Administrative reasons|1|||
170696354|NCT00409617|616901628|FG000|Overall Study|Not described|14|||
170696355|NCT04753164|616901637|FG000|Overall Study|Adverse Event|0|||
170696356|NCT04753164|616901638|FG001|Overall Study|Adverse Event|2|||
170696357|NCT04753164|616901637|FG000|Overall Study|Withdrawal by Subject|9|||
170696358|NCT04753164|616901638|FG001|Overall Study|Withdrawal by Subject|7|||
170696359|NCT04753164|616901637|FG000|Overall Study|Lost to Follow-up|6|||
170696360|NCT04753164|616901638|FG001|Overall Study|Lost to Follow-up|6|||
170696361|NCT04753164|616901637|FG000|Overall Study|Other|12|||
170696362|NCT04753164|616901638|FG001|Overall Study|Other|5|||
170696363|NCT00694369|616901639|FG000|Overall Study|Adverse Event|0|||
170696364|NCT00694369|616901640|FG001|Overall Study|Adverse Event|1|||
170696365|NCT00694369|616901641|FG002|Overall Study|Adverse Event|0|||
170696366|NCT00694369|616901642|FG003|Overall Study|Adverse Event|1|||
170696367|NCT00694369|616901643|FG004|Overall Study|Adverse Event|3|||
170696368|NCT00694369|616901639|FG000|Overall Study|Lost to Follow-up|0|||
170696369|NCT00694369|616901640|FG001|Overall Study|Lost to Follow-up|0|||
170696370|NCT00694369|616901641|FG002|Overall Study|Lost to Follow-up|1|||
170696371|NCT00694369|616901642|FG003|Overall Study|Lost to Follow-up|1|||
170696372|NCT00694369|616901643|FG004|Overall Study|Lost to Follow-up|0|||
170696373|NCT00694369|616901639|FG000|Overall Study|Physician Decision|0|||
170696374|NCT00694369|616901640|FG001|Overall Study|Physician Decision|0|||
170696375|NCT00694369|616901641|FG002|Overall Study|Physician Decision|0|||
170696376|NCT00694369|616901642|FG003|Overall Study|Physician Decision|0|||
170696377|NCT00694369|616901643|FG004|Overall Study|Physician Decision|1|||
170696378|NCT00694369|616901639|FG000|Overall Study|Protocol Violation|0|||
170696379|NCT00694369|616901640|FG001|Overall Study|Protocol Violation|1|||
170696380|NCT00694369|616901641|FG002|Overall Study|Protocol Violation|0|||
170696381|NCT00694369|616901642|FG003|Overall Study|Protocol Violation|0|||
170696382|NCT00694369|616901643|FG004|Overall Study|Protocol Violation|0|||
170696383|NCT00694369|616901639|FG000|Overall Study|Withdrawal by Subject|1|||
170696384|NCT00694369|616901640|FG001|Overall Study|Withdrawal by Subject|1|||
170696385|NCT00694369|616901641|FG002|Overall Study|Withdrawal by Subject|1|||
170696386|NCT00694369|616901642|FG003|Overall Study|Withdrawal by Subject|1|||
170696387|NCT00694369|616901643|FG004|Overall Study|Withdrawal by Subject|2|||
170696388|NCT00907374|616901644|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
170696389|NCT00907374|616901645|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
170696390|NCT02871739|616901646|FG000|Overall Study|Lost to Follow-up|3|||
170696391|NCT02871739|616901647|FG001|Overall Study|Lost to Follow-up|2|||
170696392|NCT02871739|616901648|FG002|Overall Study|Lost to Follow-up|0|||
170696393|NCT02871739|616901649|FG003|Overall Study|Lost to Follow-up|2|||
170696394|NCT00594464|616901650|FG000|Overall Study|Withdrawal by Subject|1|||
170696395|NCT00594464|616901650|FG000|Overall Study|Delay in operation|2|||
170696396|NCT02907359|616901654|FG000|Overall Study|Death|234|||
170696397|NCT02907359|616901655|FG001|Overall Study|Death|117|||
170696398|NCT02907359|616901654|FG000|Overall Study|Withdrawal by Subject|6|||
170696399|NCT02907359|616901655|FG001|Overall Study|Withdrawal by Subject|11|||
170696400|NCT02907359|616901654|FG000|Overall Study|Lost to Follow-up|1|||
170696401|NCT02907359|616901655|FG001|Overall Study|Lost to Follow-up|0|||
170696402|NCT03089606|616901661|FG000|Overall Study|Progression after Cycle 1|1|||
170696403|NCT03965962|616901662|FG000|Overall Study|Adverse Event|1|||
170696404|NCT03965962|616901663|FG001|Overall Study|Adverse Event|0|||
170696405|NCT03965962|616901664|FG002|Overall Study|Adverse Event|0|||
170696406|NCT03965962|616901665|FG003|Overall Study|Adverse Event|0|||
170696407|NCT03965962|616901662|FG000|Overall Study|Protocol Violation|21|||
170696408|NCT03965962|616901663|FG001|Overall Study|Protocol Violation|4|||
170696409|NCT03965962|616901664|FG002|Overall Study|Protocol Violation|10|||
170696410|NCT03965962|616901665|FG003|Overall Study|Protocol Violation|5|||
170696411|NCT03965962|616901662|FG000|Overall Study|Lost to Follow-up|0|||
170696412|NCT03965962|616901663|FG001|Overall Study|Lost to Follow-up|1|||
170696413|NCT03965962|616901664|FG002|Overall Study|Lost to Follow-up|0|||
170696414|NCT03965962|616901665|FG003|Overall Study|Lost to Follow-up|0|||
170696415|NCT03965962|616901662|FG000|Overall Study|Withdrawal by Subject|3|||
170696416|NCT03965962|616901663|FG001|Overall Study|Withdrawal by Subject|0|||
170696417|NCT03965962|616901664|FG002|Overall Study|Withdrawal by Subject|0|||
170696418|NCT03965962|616901665|FG003|Overall Study|Withdrawal by Subject|1|||
170696419|NCT01524692|616901666|FG000|Overall Study|Withdrawal by Subject|3|||
170696420|NCT02590939|616901668|FG000|Overall Study|Withdrawal by Subject|3|||
170696421|NCT02590939|616901669|FG001|Overall Study|Withdrawal by Subject|1|||
170696422|NCT02590939|616901668|FG000|Overall Study|Failed the nociceptive test|2|||
170696423|NCT02590939|616901669|FG001|Overall Study|Failed the nociceptive test|1|||
170696424|NCT03065244|616901670|FG000|Overall Study|Lost to Follow-up|1|||
170696425|NCT03065244|616901671|FG001|Overall Study|Lost to Follow-up|1|||
170696426|NCT03065244|616901670|FG000|Overall Study|Diagnosed with a different disease|1|||
170696427|NCT03065244|616901671|FG001|Overall Study|Diagnosed with a different disease|1|||
170696428|NCT03065244|616901670|FG000|Overall Study|Protocol Violation|0|||
170696429|NCT03065244|616901671|FG001|Overall Study|Protocol Violation|1|||
170696430|NCT03065244|616901670|FG000|Overall Study|Withdrawal by Subject|1|||
170696431|NCT03065244|616901671|FG001|Overall Study|Withdrawal by Subject|1|||
170696432|NCT02741700|616901674|FG000|Overall Study|Lost to Follow-up|17|||
170696433|NCT02741700|616901675|FG001|Overall Study|Lost to Follow-up|8|||
170696434|NCT02741700|616901674|FG000|Overall Study|Withdrawal by Subject|2|||
170696435|NCT02741700|616901675|FG001|Overall Study|Withdrawal by Subject|5|||
170696436|NCT02741700|616901674|FG000|Overall Study|Physician Decision|3|||
170696437|NCT02741700|616901675|FG001|Overall Study|Physician Decision|0|||
170696438|NCT02741700|616901674|FG000|Overall Study|Moved out of State|0|||
170696439|NCT02741700|616901675|FG001|Overall Study|Moved out of State|1|||
170696440|NCT02741700|616901674|FG000|Overall Study|Death|4|||
170696441|NCT02741700|616901675|FG001|Overall Study|Death|5|||
170696442|NCT01774786|616901676|FG000|Overall Study|Death|300|||
170696443|NCT01774786|616901677|FG001|Overall Study|Death|319|||
170696444|NCT01774786|616901676|FG000|Overall Study|Lost to Follow-up|6|||
170696445|NCT01774786|616901677|FG001|Overall Study|Lost to Follow-up|7|||
170696446|NCT01774786|616901676|FG000|Overall Study|Withdrawal by Subject|18|||
170696447|NCT01774786|616901677|FG001|Overall Study|Withdrawal by Subject|14|||
170696448|NCT01774786|616901676|FG000|Overall Study|Physician Decision|2|||
170696449|NCT01774786|616901677|FG001|Overall Study|Physician Decision|0|||
170696450|NCT01774786|616901676|FG000|Overall Study|Non-compliance|0|||
170696451|NCT01774786|616901677|FG001|Overall Study|Non-compliance|1|||
170696452|NCT01774786|616901676|FG000|Overall Study|Reason Not Specified|2|||
170696453|NCT01774786|616901677|FG001|Overall Study|Reason Not Specified|5|||
170696454|NCT00744627|616901682|FG000|Overall Study|Adverse Event|6|||
170696455|NCT00744627|616901683|FG001|Overall Study|Adverse Event|9|||
170696456|NCT00744627|616901682|FG000|Overall Study|Lack of Efficacy|7|||
170696457|NCT00744627|616901683|FG001|Overall Study|Lack of Efficacy|3|||
170696458|NCT00744627|616901682|FG000|Overall Study|Noncompliance|0|||
170696459|NCT00744627|616901683|FG001|Overall Study|Noncompliance|1|||
170696460|NCT00744627|616901682|FG000|Overall Study|Protocol Deviations|0|||
170696461|NCT00744627|616901683|FG001|Overall Study|Protocol Deviations|2|||
170696462|NCT00744627|616901682|FG000|Overall Study|Voluntary Withdrawal|9|||
170823474|NCT03740919|617360526|FG003|Lead-in Period|Study Task Too Burdensome|0|||
170823475|NCT03740919|617360523|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
170696463|NCT00744627|616901683|FG001|Overall Study|Voluntary Withdrawal|6|||
170696464|NCT00744627|616901682|FG000|Overall Study|Lost to Follow-up|2|||
170696465|NCT00744627|616901683|FG001|Overall Study|Lost to Follow-up|1|||
170696466|NCT00744627|616901682|FG000|Overall Study|Other|1|||
170696467|NCT00744627|616901683|FG001|Overall Study|Other|0|||
170696468|NCT02268786|616901684|FG000|Overall Study|No Euploid Embryos available|42|||
170696469|NCT02268786|616901685|FG001|Overall Study|No Euploid Embryos available|0|||
170696470|NCT02268786|616901684|FG000|Overall Study|Withdrawal by Subject|7|||
170696471|NCT02268786|616901685|FG001|Overall Study|Withdrawal by Subject|14|||
170696472|NCT02268786|616901684|FG000|Overall Study|Thaw Failure|6|||
170696473|NCT02268786|616901685|FG001|Overall Study|Thaw Failure|4|||
170696474|NCT02268786|616901684|FG000|Overall Study|Protocol Violation|1|||
170696475|NCT02268786|616901685|FG001|Overall Study|Protocol Violation|0|||
170696476|NCT01150123|616901686|FG000|Overall Study|Withdrawal by Subject|1|||
170696477|NCT01150123|616901687|FG001|Overall Study|Withdrawal by Subject|1|||
170696478|NCT01150123|616901688|FG002|Overall Study|Withdrawal by Subject|2|||
170696479|NCT01150123|616901689|FG003|Overall Study|Withdrawal by Subject|1|||
170696480|NCT01150123|616901690|FG004|Overall Study|Withdrawal by Subject|1|||
170696481|NCT01150123|616901691|FG005|Overall Study|Withdrawal by Subject|1|||
170696482|NCT01150123|616901692|FG006|Overall Study|Withdrawal by Subject|0|||
170696483|NCT01150123|616901693|FG007|Overall Study|Withdrawal by Subject|3|||
170696484|NCT01150123|616901694|FG008|Overall Study|Withdrawal by Subject|2|||
170696485|NCT01150123|616901695|FG009|Overall Study|Withdrawal by Subject|0|||
170696486|NCT01150123|616901696|FG010|Overall Study|Withdrawal by Subject|1|||
170696487|NCT01150123|616901697|FG011|Overall Study|Withdrawal by Subject|0|||
170696488|NCT01150123|616901698|FG012|Overall Study|Withdrawal by Subject|1|||
170696489|NCT01150123|616901699|FG013|Overall Study|Withdrawal by Subject|0|||
170696490|NCT01150123|616901700|FG014|Overall Study|Withdrawal by Subject|0|||
170696491|NCT01150123|616901701|FG015|Overall Study|Withdrawal by Subject|1|||
170696492|NCT01150123|616901702|FG016|Overall Study|Withdrawal by Subject|0|||
170696493|NCT01150123|616901703|FG017|Overall Study|Withdrawal by Subject|1|||
170696494|NCT01150123|616901686|FG000|Overall Study|Lost to Follow-up|2|||
170696495|NCT01150123|616901687|FG001|Overall Study|Lost to Follow-up|1|||
170696496|NCT01150123|616901688|FG002|Overall Study|Lost to Follow-up|2|||
170696497|NCT01150123|616901689|FG003|Overall Study|Lost to Follow-up|2|||
170696498|NCT01150123|616901690|FG004|Overall Study|Lost to Follow-up|2|||
170696499|NCT01150123|616901691|FG005|Overall Study|Lost to Follow-up|5|||
170696500|NCT01150123|616901692|FG006|Overall Study|Lost to Follow-up|0|||
170696501|NCT01150123|616901693|FG007|Overall Study|Lost to Follow-up|0|||
170696502|NCT01150123|616901694|FG008|Overall Study|Lost to Follow-up|3|||
170696503|NCT01150123|616901695|FG009|Overall Study|Lost to Follow-up|1|||
170696504|NCT01150123|616901696|FG010|Overall Study|Lost to Follow-up|1|||
170696505|NCT01150123|616901697|FG011|Overall Study|Lost to Follow-up|1|||
170696506|NCT01150123|616901698|FG012|Overall Study|Lost to Follow-up|2|||
170696507|NCT01150123|616901699|FG013|Overall Study|Lost to Follow-up|0|||
170696508|NCT01150123|616901700|FG014|Overall Study|Lost to Follow-up|0|||
170696509|NCT01150123|616901701|FG015|Overall Study|Lost to Follow-up|0|||
170696510|NCT01150123|616901702|FG016|Overall Study|Lost to Follow-up|0|||
170696511|NCT01150123|616901703|FG017|Overall Study|Lost to Follow-up|0|||
170696512|NCT01062555|616901708|FG000|Phase 1|Death|10|||
170696513|NCT01062555|616901709|FG001|Phase 1|Death|17|||
170696514|NCT01062555|616901710|FG002|Phase 1|Death|0|||
170696515|NCT01062555|616901711|FG003|Phase 1|Death|0|||
170696516|NCT01062555|616901708|FG000|Phase 1|Graft Failure|12|||
170696517|NCT01062555|616901709|FG001|Phase 1|Graft Failure|8|||
170696518|NCT01062555|616901710|FG002|Phase 1|Graft Failure|0|||
170696519|NCT01062555|616901711|FG003|Phase 1|Graft Failure|0|||
170696520|NCT01062555|616901708|FG000|Phase 1|Withdrawal by Subject|1|||
170696521|NCT01062555|616901709|FG001|Phase 1|Withdrawal by Subject|1|||
170696522|NCT01062555|616901710|FG002|Phase 1|Withdrawal by Subject|0|||
170696523|NCT01062555|616901711|FG003|Phase 1|Withdrawal by Subject|0|||
170696524|NCT01062555|616901708|FG000|Phase 2|Death|0|||
170696525|NCT01062555|616901709|FG001|Phase 2|Death|0|||
170696526|NCT01062555|616901710|FG002|Phase 2|Death|8|||
170696527|NCT01062555|616901711|FG003|Phase 2|Death|3|||
170696528|NCT01062555|616901708|FG000|Phase 2|Graft failure|0|||
170696529|NCT01062555|616901709|FG001|Phase 2|Graft failure|0|||
170696530|NCT01062555|616901710|FG002|Phase 2|Graft failure|7|||
170696531|NCT01062555|616901711|FG003|Phase 2|Graft failure|4|||
170696532|NCT01062555|616901708|FG000|Phase 2|Withdrawal by Subject|0|||
170696533|NCT01062555|616901709|FG001|Phase 2|Withdrawal by Subject|0|||
170696534|NCT01062555|616901710|FG002|Phase 2|Withdrawal by Subject|0|||
170696535|NCT01062555|616901711|FG003|Phase 2|Withdrawal by Subject|7|||
170696536|NCT01062555|616901708|FG000|Phase 2|Protocol Violation|0|||
170696537|NCT01062555|616901709|FG001|Phase 2|Protocol Violation|0|||
170696538|NCT01062555|616901710|FG002|Phase 2|Protocol Violation|0|||
170696539|NCT01062555|616901711|FG003|Phase 2|Protocol Violation|3|||
170696540|NCT01062555|616901708|FG000|Phase 2|Physician Decision|0|||
170696541|NCT01062555|616901709|FG001|Phase 2|Physician Decision|0|||
170696542|NCT01062555|616901710|FG002|Phase 2|Physician Decision|0|||
170696543|NCT01062555|616901711|FG003|Phase 2|Physician Decision|17|||
170696544|NCT01319877|616901716|FG000|Overall Study|Lost to Follow-up|100|||
170696545|NCT01319877|616901717|FG001|Overall Study|Lost to Follow-up|37|||
170696546|NCT01319877|616901716|FG000|Overall Study|Physician Decision|2|||
170696547|NCT01319877|616901717|FG001|Overall Study|Physician Decision|0|||
170696548|NCT01319877|616901716|FG000|Overall Study|Disease Progression|2|||
170696549|NCT01319877|616901717|FG001|Overall Study|Disease Progression|2|||
170696550|NCT01319877|616901716|FG000|Overall Study|Withdrawal by Subject|0|||
170696551|NCT01319877|616901717|FG001|Overall Study|Withdrawal by Subject|1|||
170696552|NCT01319877|616901716|FG000|Overall Study|Reason Not Specified|4|||
170696553|NCT01319877|616901717|FG001|Overall Study|Reason Not Specified|5|||
170696554|NCT00673179|616901722|FG000|Overall Study|Toxicity/Complications|3|||
170696555|NCT00673179|616901723|FG001|Overall Study|Toxicity/Complications|0|||
170696556|NCT00281684|616901724|FG000|Overall Study|Lost to Follow-up|0|||
170696557|NCT00281684|616901725|FG001|Overall Study|Lost to Follow-up|0|||
170696558|NCT00281684|616901726|FG002|Overall Study|Lost to Follow-up|1|||
170696559|NCT00281684|616901727|FG003|Overall Study|Lost to Follow-up|0|||
170696560|NCT00281684|616901724|FG000|Overall Study|Withdrawal by Subject|1|||
170696561|NCT00281684|616901725|FG001|Overall Study|Withdrawal by Subject|0|||
170696562|NCT00281684|616901726|FG002|Overall Study|Withdrawal by Subject|0|||
170696563|NCT00281684|616901727|FG003|Overall Study|Withdrawal by Subject|0|||
170696564|NCT01359254|616901728|FG000|Overall Study|Death|1|||
170696565|NCT01359254|616901729|FG001|Overall Study|Death|0|||
170696566|NCT04668950|616901731|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
170696567|NCT04668950|616901732|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
170696568|NCT04668950|616901731|FG000|Overall Study|Could not confirm started study medication|15|||
170696569|NCT04668950|616901732|FG001|Overall Study|Could not confirm started study medication|15|||
170696570|NCT04668950|616901731|FG000|Overall Study|Could not confirm baseline status|6|||
170696571|NCT04668950|616901732|FG001|Overall Study|Could not confirm baseline status|2|||
170696572|NCT04668950|616901731|FG000|Overall Study|Drop out and did not start medication|15|||
170696573|NCT04668950|616901732|FG001|Overall Study|Drop out and did not start medication|17|||
170696574|NCT04668950|616901731|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
170696575|NCT04668950|616901732|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
170696576|NCT04668950|616901731|FG000|Overall Study|Other|2|||
170696577|NCT04668950|616901732|FG001|Overall Study|Other|4|||
170696578|NCT01531387|616901735|FG000|Overall Study|Early termination of study|11|||
170696579|NCT01531387|616901736|FG001|Overall Study|Early termination of study|11|||
170696580|NCT00578942|616901737|FG000|Overall Study|Lost to Follow-up|1|||
170696581|NCT00600938|616901740|FG000|Core Study|Abnormal test procedure result(s)|3|||
170696582|NCT00600938|616901741|FG001|Core Study|Abnormal test procedure result(s)|2|||
170696583|NCT00600938|616901742|FG002|Core Study|Abnormal test procedure result(s)|0|||
170696584|NCT00600938|616901743|FG003|Core Study|Abnormal test procedure result(s)|0|||
170696585|NCT00600938|616901740|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
170696586|NCT00600938|616901741|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
170696587|NCT00600938|616901742|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
170696588|NCT00600938|616901743|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
170696589|NCT00600938|616901740|FG000|Core Study|Patient withdrew consent|7|||
170696590|NCT00600938|616901741|FG001|Core Study|Patient withdrew consent|12|||
170696591|NCT00600938|616901742|FG002|Core Study|Patient withdrew consent|0|||
170696592|NCT00600938|616901743|FG003|Core Study|Patient withdrew consent|0|||
170696593|NCT00600938|616901740|FG000|Core Study|Lost to Follow-up|3|||
170696594|NCT00600938|616901741|FG001|Core Study|Lost to Follow-up|2|||
170696595|NCT00600938|616901742|FG002|Core Study|Lost to Follow-up|0|||
170696596|NCT00600938|616901743|FG003|Core Study|Lost to Follow-up|0|||
170696597|NCT00600938|616901740|FG000|Core Study|Death|1|||
170696598|NCT00600938|616901741|FG001|Core Study|Death|1|||
170696599|NCT00600938|616901742|FG002|Core Study|Death|0|||
170696600|NCT00600938|616901743|FG003|Core Study|Death|0|||
170696601|NCT00600938|616901740|FG000|Core Study|Protocol Violation|1|||
170696602|NCT00600938|616901741|FG001|Core Study|Protocol Violation|2|||
170696603|NCT00600938|616901742|FG002|Core Study|Protocol Violation|0|||
170696604|NCT00600938|616901743|FG003|Core Study|Protocol Violation|0|||
170696605|NCT00600938|616901740|FG000|Extension Study|Adverse Event|1|||
170696606|NCT00600938|616901741|FG001|Extension Study|Adverse Event|0|||
170696607|NCT00600938|616901742|FG002|Extension Study|Adverse Event|2|||
170696608|NCT00600938|616901743|FG003|Extension Study|Adverse Event|0|||
170696609|NCT00600938|616901740|FG000|Extension Study|Abnormal test procedure results|0|||
170696610|NCT00600938|616901741|FG001|Extension Study|Abnormal test procedure results|1|||
170696611|NCT00600938|616901742|FG002|Extension Study|Abnormal test procedure results|1|||
170696612|NCT00600938|616901743|FG003|Extension Study|Abnormal test procedure results|1|||
170696613|NCT00600938|616901740|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
170823476|NCT03740919|617360524|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
170823477|NCT03740919|617360525|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
170823478|NCT03740919|617360526|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
170823479|NCT03740919|617360523|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
170823480|NCT03740919|617360524|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
170823481|NCT03740919|617360525|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
170823482|NCT03740919|617360526|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
170823483|NCT03740919|617360523|FG000|Treatment Period|Adverse Event|0|||
170696614|NCT00600938|616901741|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
170696615|NCT00600938|616901742|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
170696616|NCT00600938|616901743|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
170696617|NCT00600938|616901740|FG000|Extension Study|Withdrawal by Subject|2|||
170696618|NCT00600938|616901741|FG001|Extension Study|Withdrawal by Subject|2|||
170696619|NCT00600938|616901742|FG002|Extension Study|Withdrawal by Subject|3|||
170696620|NCT00600938|616901743|FG003|Extension Study|Withdrawal by Subject|0|||
170696621|NCT00600938|616901740|FG000|Extension Study|Lost to Follow-up|1|||
170696622|NCT00600938|616901741|FG001|Extension Study|Lost to Follow-up|1|||
170696623|NCT00600938|616901742|FG002|Extension Study|Lost to Follow-up|2|||
170696624|NCT00600938|616901743|FG003|Extension Study|Lost to Follow-up|0|||
170696625|NCT00600938|616901740|FG000|Extension Study|Death|1|||
170696626|NCT00600938|616901741|FG001|Extension Study|Death|0|||
170696627|NCT00600938|616901742|FG002|Extension Study|Death|0|||
170696628|NCT00600938|616901743|FG003|Extension Study|Death|0|||
170696629|NCT01124643|616901744|FG000|Overall Study|Death|1|||
170696630|NCT04220411|616901745|FG000|Overall Study|Adverse Event|0|||
170696631|NCT04220411|616901746|FG001|Overall Study|Adverse Event|0|||
170696632|NCT04220411|616901747|FG002|Overall Study|Adverse Event|0|||
170696633|NCT04220411|616901748|FG003|Overall Study|Adverse Event|1|||
170696634|NCT02678676|616901749|FG000|Overall Study|Death|619|||
170696635|NCT02678676|616901750|FG001|Overall Study|Death|649|||
170696636|NCT02678676|616901749|FG000|Overall Study|Withdrawal by Subject|13|||
170696637|NCT02678676|616901750|FG001|Overall Study|Withdrawal by Subject|5|||
170696638|NCT02678676|616901749|FG000|Overall Study|Lost to Follow-up|171|||
170696639|NCT02678676|616901750|FG001|Overall Study|Lost to Follow-up|151|||
170696640|NCT02678676|616901749|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
170696641|NCT02678676|616901750|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
170696642|NCT01400516|616901758|FG000|Primary Trial|Withdrawal by Subject|0|||
170696643|NCT01400516|616901759|FG001|Primary Trial|Withdrawal by Subject|2|||
170696644|NCT00549562|616901762|FG000|Overall Study|Adverse Event|1|||
170696645|NCT00549562|616901762|FG000|Overall Study|Lack of Efficacy|1|||
170696646|NCT04837131|616901766|FG000|Overall Study|Death|1|||
170696647|NCT04837131|616901766|FG000|Overall Study|Withdrawal by Subject|1|||
170696648|NCT04837131|616901766|FG000|Overall Study|Adverse Event|1|||
170696649|NCT04837131|616901766|FG000|Overall Study|Protocol Violation|1|||
170696650|NCT04690751|616901767|FG000|Overall Study|Protocol Violation|0|||
170696651|NCT04690751|616901768|FG001|Overall Study|Protocol Violation|1|||
170696652|NCT04690751|616901769|FG002|Overall Study|Protocol Violation|0|||
170696653|NCT04690751|616901770|FG003|Overall Study|Protocol Violation|1|||
170696654|NCT04690751|616901771|FG004|Overall Study|Protocol Violation|2|||
170696655|NCT04690751|616901772|FG005|Overall Study|Protocol Violation|0|||
170696656|NCT04690751|616901767|FG000|Overall Study|Adverse Event|0|||
170696657|NCT04690751|616901768|FG001|Overall Study|Adverse Event|0|||
170696658|NCT04690751|616901769|FG002|Overall Study|Adverse Event|1|||
170696659|NCT04690751|616901770|FG003|Overall Study|Adverse Event|0|||
170696660|NCT04690751|616901771|FG004|Overall Study|Adverse Event|0|||
170696661|NCT04690751|616901772|FG005|Overall Study|Adverse Event|0|||
170696662|NCT04690751|616901767|FG000|Overall Study|Positive urine drug screen test|0|||
170696663|NCT04690751|616901768|FG001|Overall Study|Positive urine drug screen test|0|||
170696664|NCT04690751|616901769|FG002|Overall Study|Positive urine drug screen test|0|||
170696665|NCT04690751|616901770|FG003|Overall Study|Positive urine drug screen test|0|||
170696666|NCT04690751|616901771|FG004|Overall Study|Positive urine drug screen test|1|||
170696667|NCT04690751|616901772|FG005|Overall Study|Positive urine drug screen test|0|||
170696668|NCT00427635|616903338|FG000|Treatment Phase|Withdrawal by Subject|1|||
170696669|NCT00427635|616903339|FG001|Treatment Phase|Withdrawal by Subject|0|||
170696670|NCT00427635|616903338|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
170696671|NCT00427635|616903339|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
170696672|NCT01012622|616903349|FG000|Overall Study|Withdrawal by Subject|6|||
170696673|NCT01012622|616903349|FG000|Overall Study|Lost to Follow-up|5|||
170696674|NCT01012622|616903349|FG000|Overall Study|Adverse Event|7|||
170696675|NCT01012622|616903349|FG000|Overall Study|non-compliance with the drug|9|||
170696676|NCT01012622|616903349|FG000|Overall Study|Other|1|||
170696677|NCT01012622|616903349|FG000|Overall Study|screening failure|1|||
170696678|NCT01012622|616903349|FG000|Overall Study|withdrawal of consent by a parent|2|||
170696679|NCT00004888|616903350|FG000|Overall Study|Adverse Event|5|||
170696680|NCT00004888|616903351|FG001|Overall Study|Adverse Event|10|||
170696681|NCT00004888|616903350|FG000|Overall Study|Withdrawal by Subject|0|||
170696682|NCT00004888|616903351|FG001|Overall Study|Withdrawal by Subject|3|||
170696683|NCT00004888|616903350|FG000|Overall Study|Physician Decision|1|||
170696684|NCT00004888|616903351|FG001|Overall Study|Physician Decision|1|||
170696685|NCT00004888|616903350|FG000|Overall Study|Progressive Disease|4|||
170696686|NCT00004888|616903351|FG001|Overall Study|Progressive Disease|9|||
170696687|NCT00004888|616903350|FG000|Overall Study|Death without progressive disease|0|||
170696688|NCT00004888|616903351|FG001|Overall Study|Death without progressive disease|1|||
170696689|NCT00004888|616903350|FG000|Overall Study|Toxic death|1|||
170696690|NCT00004888|616903351|FG001|Overall Study|Toxic death|0|||
170696691|NCT00136084|616903352|FG000|Overall Study|Death|12|||
170696692|NCT00136084|616903353|FG001|Overall Study|Death|5|||
170696693|NCT00136084|616903352|FG000|Overall Study|Unacceptable toxicity|8|||
170696694|NCT00136084|616903353|FG001|Overall Study|Unacceptable toxicity|11|||
170696695|NCT00136084|616903352|FG000|Overall Study|Relapse|20|||
170696696|NCT00136084|616903353|FG001|Overall Study|Relapse|23|||
170696697|NCT00136084|616903352|FG000|Overall Study|Lost to Follow-up|2|||
170696698|NCT00136084|616903353|FG001|Overall Study|Lost to Follow-up|0|||
170696699|NCT00136084|616903352|FG000|Overall Study|No Response|1|||
170696700|NCT00136084|616903353|FG001|Overall Study|No Response|2|||
170696701|NCT00136084|616903352|FG000|Overall Study|Withdrawal by Subject|5|||
170696702|NCT00136084|616903353|FG001|Overall Study|Withdrawal by Subject|1|||
170696703|NCT02579265|616903354|FG000|Overall Study|Weaned off earlier than 28 days|44|||
170696704|NCT02579265|616903355|FG001|Overall Study|Weaned off earlier than 28 days|43|||
170696705|NCT02579265|616903354|FG000|Overall Study|Adverse Event|2|||
170696706|NCT02579265|616903355|FG001|Overall Study|Adverse Event|0|||
170696707|NCT02579265|616903354|FG000|Overall Study|Any other reason not specified|0|||
170696708|NCT02579265|616903355|FG001|Overall Study|Any other reason not specified|2|||
170696709|NCT02579265|616903354|FG000|Overall Study|Withdrawal by Subject|2|||
170696710|NCT02579265|616903355|FG001|Overall Study|Withdrawal by Subject|0|||
170696711|NCT02579265|616903354|FG000|Overall Study|Physician Decision|1|||
170696712|NCT02579265|616903355|FG001|Overall Study|Physician Decision|0|||
170696713|NCT02579265|616903354|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
170696714|NCT02579265|616903355|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
170696715|NCT02174848|616903356|FG000|Overall Study|Adverse Event|2|||
170696716|NCT02174848|616903357|FG001|Overall Study|Adverse Event|1|||
170696717|NCT02174848|616903356|FG000|Overall Study|Withdrawal by Subject|3|||
170696718|NCT02174848|616903357|FG001|Overall Study|Withdrawal by Subject|3|||
170696719|NCT02174848|616903356|FG000|Overall Study|Lost to Follow-up|0|||
170696720|NCT02174848|616903357|FG001|Overall Study|Lost to Follow-up|1|||
170696721|NCT02174848|616903356|FG000|Overall Study|Worsening of disease|1|||
170696722|NCT02174848|616903357|FG001|Overall Study|Worsening of disease|1|||
170696723|NCT02174848|616903356|FG000|Overall Study|Unable to comply with study requirements|1|||
170696724|NCT02174848|616903357|FG001|Overall Study|Unable to comply with study requirements|0|||
170696725|NCT02520011|616903359|FG000|Overall Study|Adverse Event|0|||
170696726|NCT02520011|616903360|FG001|Overall Study|Adverse Event|1|||
170696727|NCT02520011|616903361|FG002|Overall Study|Adverse Event|2|||
170696728|NCT02520011|616903359|FG000|Overall Study|Death|0|||
170696729|NCT02520011|616903360|FG001|Overall Study|Death|8|||
170696730|NCT02520011|616903361|FG002|Overall Study|Death|1|||
170696731|NCT02520011|616903359|FG000|Overall Study|Lack of Efficacy|4|||
170696732|NCT02520011|616903360|FG001|Overall Study|Lack of Efficacy|26|||
170696733|NCT02520011|616903361|FG002|Overall Study|Lack of Efficacy|4|||
170696734|NCT02520011|616903359|FG000|Overall Study|Physician Decision|0|||
170696735|NCT02520011|616903360|FG001|Overall Study|Physician Decision|2|||
170696736|NCT02520011|616903361|FG002|Overall Study|Physician Decision|0|||
170696737|NCT02520011|616903359|FG000|Overall Study|Withdrawal by Subject|1|||
170696738|NCT02520011|616903360|FG001|Overall Study|Withdrawal by Subject|3|||
170696739|NCT02520011|616903361|FG002|Overall Study|Withdrawal by Subject|0|||
170696740|NCT02520011|616903359|FG000|Overall Study|Protocol Deviation|0|||
170696741|NCT02520011|616903360|FG001|Overall Study|Protocol Deviation|1|||
170696742|NCT02520011|616903361|FG002|Overall Study|Protocol Deviation|0|||
170696743|NCT02520011|616903359|FG000|Overall Study|Patient went to hospice|0|||
170696744|NCT02520011|616903360|FG001|Overall Study|Patient went to hospice|1|||
170696745|NCT02520011|616903361|FG002|Overall Study|Patient went to hospice|0|||
170696746|NCT02520011|616903359|FG000|Overall Study|Progressive disease following response|0|||
170696747|NCT02520011|616903360|FG001|Overall Study|Progressive disease following response|4|||
170696748|NCT02520011|616903361|FG002|Overall Study|Progressive disease following response|2|||
170696749|NCT01176292|616903367|FG000|Overall Study|Lost to Follow-up|2|||
170696750|NCT01176292|616903368|FG001|Overall Study|Lost to Follow-up|4|||
170696751|NCT01176292|616903367|FG000|Overall Study|Adverse Event|1|||
170696752|NCT01176292|616903368|FG001|Overall Study|Adverse Event|1|||
170696753|NCT01176292|616903367|FG000|Overall Study|Physician Decision|0|||
170696754|NCT01176292|616903368|FG001|Overall Study|Physician Decision|2|||
170696755|NCT01176292|616903367|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
170696756|NCT01176292|616903368|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
170696757|NCT01714310|616903373|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
170696758|NCT01714310|616903374|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
170696759|NCT01714310|616903375|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
170696760|NCT01714310|616903373|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
170696761|NCT01714310|616903374|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
170696762|NCT01714310|616903375|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
170696763|NCT01714310|616903373|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
170696764|NCT01714310|616903374|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
170696765|NCT01714310|616903375|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
170696766|NCT01714310|616903373|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
170696767|NCT01714310|616903374|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
170696768|NCT01714310|616903375|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
170696769|NCT02487394|616903376|FG000|Phase 1|Withdrawal by Subject|0|||
170696770|NCT02487394|616903377|FG001|Phase 1|Withdrawal by Subject|1|||
170696771|NCT01641367|616903378|FG000|Cohorts|Death|18|||
170696772|NCT01641367|616903379|FG001|Cohorts|Death|1|||
170696773|NCT01641367|616903380|FG002|Cohorts|Death|2|||
170696774|NCT01641367|616903381|FG003|Cohorts|Death|0|||
170696775|NCT01641367|616903382|FG004|Cohorts|Death|1|||
170696776|NCT01641367|616903383|FG005|Cohorts|Death|1|||
170696777|NCT01641367|616903384|FG006|Cohorts|Death|0|||
170696778|NCT01641367|616903385|FG007|Cohorts|Death|0|||
170696779|NCT01641367|616903378|FG000|Cohorts|Lost to Follow-up|16|||
170696780|NCT01641367|616903379|FG001|Cohorts|Lost to Follow-up|0|||
170696781|NCT01641367|616903380|FG002|Cohorts|Lost to Follow-up|2|||
170696782|NCT01641367|616903381|FG003|Cohorts|Lost to Follow-up|0|||
170696783|NCT01641367|616903382|FG004|Cohorts|Lost to Follow-up|2|||
170696784|NCT01641367|616903383|FG005|Cohorts|Lost to Follow-up|0|||
170696785|NCT01641367|616903384|FG006|Cohorts|Lost to Follow-up|0|||
170696786|NCT01641367|616903385|FG007|Cohorts|Lost to Follow-up|0|||
170696787|NCT01641367|616903378|FG000|Randomized Adherence Intervention|Death|0|||
170696788|NCT01641367|616903379|FG001|Randomized Adherence Intervention|Death|0|||
170696789|NCT01641367|616903380|FG002|Randomized Adherence Intervention|Death|0|||
170696790|NCT01641367|616903381|FG003|Randomized Adherence Intervention|Death|0|||
170696791|NCT01641367|616903382|FG004|Randomized Adherence Intervention|Death|0|||
170696792|NCT01641367|616903383|FG005|Randomized Adherence Intervention|Death|0|||
170696793|NCT01641367|616903384|FG006|Randomized Adherence Intervention|Death|11|||
170696794|NCT01641367|616903385|FG007|Randomized Adherence Intervention|Death|12|||
170696795|NCT01641367|616903378|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
170696796|NCT01641367|616903379|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
170696797|NCT01641367|616903380|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
170696798|NCT01641367|616903381|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
170696799|NCT01641367|616903382|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
170696800|NCT01641367|616903383|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
170696801|NCT01641367|616903384|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
170696802|NCT01641367|616903385|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
170696803|NCT02586493|616903386|FG000|Overall Study|Adverse Event|4|||
170696804|NCT02586493|616903386|FG000|Overall Study|Protocol Violation|6|||
170696805|NCT02586493|616903386|FG000|Overall Study|Lost to Follow-up|1|||
170696806|NCT02586493|616903386|FG000|Overall Study|Withdrawal by Subject|1|||
170696807|NCT00436748|616903393|FG000|Overall Study|Ineligibility Determined|1|||
170696808|NCT00436748|616903394|FG001|Overall Study|Ineligibility Determined|1|||
170696809|NCT00436748|616903393|FG000|Overall Study|Adverse Event|0|||
170696810|NCT00436748|616903394|FG001|Overall Study|Adverse Event|2|||
170696811|NCT00436748|616903393|FG000|Overall Study|Consent Withdrawn|1|||
170696812|NCT00436748|616903394|FG001|Overall Study|Consent Withdrawn|4|||
170696813|NCT00436748|616903393|FG000|Overall Study|Administrative Decision|1|||
170696814|NCT00436748|616903394|FG001|Overall Study|Administrative Decision|0|||
170696815|NCT00436748|616903393|FG000|Overall Study|Lost to Follow-up|0|||
170696816|NCT00436748|616903394|FG001|Overall Study|Lost to Follow-up|1|||
170696817|NCT00436748|616903393|FG000|Overall Study|Protocol-specified Criteria|5|||
170696818|NCT00436748|616903394|FG001|Overall Study|Protocol-specified Criteria|4|||
170696819|NCT00436748|616903393|FG000|Overall Study|Other|3|||
170696820|NCT00436748|616903394|FG001|Overall Study|Other|0|||
170696821|NCT02711800|616903395|FG000|Overall Study|Lost to Follow-up|1|||
170696822|NCT02711800|616903395|FG000|Overall Study|Withdrawal by Subject|1|||
170696823|NCT01990495|616903411|FG000|Overall Study|Physician Decision|5|||
170696824|NCT01990495|616903412|FG001|Overall Study|Physician Decision|4|||
170696825|NCT00354172|616903417|FG000|Overall Study|Did not receive transplant|1|||
170696826|NCT01828034|616903418|FG000|Overall Study|Withdrawal by Subject|0|||
170696827|NCT01828034|616903419|FG001|Overall Study|Withdrawal by Subject|0|||
170696828|NCT01828034|616903420|FG002|Overall Study|Withdrawal by Subject|0|||
170696829|NCT01828034|616903421|FG003|Overall Study|Withdrawal by Subject|1|||
170696830|NCT04064294|616903422|FG000|Overall Study|Adverse Event|1|||
170696831|NCT04064294|616903423|FG001|Overall Study|Adverse Event|0|||
170696832|NCT04064294|616903424|FG002|Overall Study|Adverse Event|0|||
170696833|NCT02932904|616903425|FG000|Overall Study|Reason not Specified|1|||
170696834|NCT02932904|616903426|FG001|Overall Study|Reason not Specified|0|||
170696835|NCT02932904|616903427|FG002|Overall Study|Reason not Specified|2|||
170696836|NCT02932904|616903428|FG003|Overall Study|Reason not Specified|2|||
170696837|NCT02932904|616903425|FG000|Overall Study|Noncompliance with Study Drug|2|||
170696838|NCT02932904|616903426|FG001|Overall Study|Noncompliance with Study Drug|3|||
170696839|NCT02932904|616903427|FG002|Overall Study|Noncompliance with Study Drug|3|||
170696840|NCT02932904|616903428|FG003|Overall Study|Noncompliance with Study Drug|4|||
170696841|NCT02932904|616903425|FG000|Overall Study|Pregnancy|0|||
170696842|NCT02932904|616903426|FG001|Overall Study|Pregnancy|1|||
170696843|NCT02932904|616903427|FG002|Overall Study|Pregnancy|1|||
170696844|NCT02932904|616903428|FG003|Overall Study|Pregnancy|0|||
170696845|NCT02932904|616903425|FG000|Overall Study|Study Termination|0|||
170696846|NCT02932904|616903426|FG001|Overall Study|Study Termination|1|||
170696847|NCT02932904|616903427|FG002|Overall Study|Study Termination|0|||
170696848|NCT02932904|616903428|FG003|Overall Study|Study Termination|0|||
170696849|NCT02932904|616903425|FG000|Overall Study|Voluntary Withdrawal|2|||
170696850|NCT02932904|616903426|FG001|Overall Study|Voluntary Withdrawal|1|||
170696851|NCT02932904|616903427|FG002|Overall Study|Voluntary Withdrawal|4|||
170696852|NCT02932904|616903428|FG003|Overall Study|Voluntary Withdrawal|2|||
170696853|NCT02932904|616903425|FG000|Overall Study|Lost to Follow-up|5|||
170696854|NCT02932904|616903426|FG001|Overall Study|Lost to Follow-up|3|||
170696855|NCT02932904|616903427|FG002|Overall Study|Lost to Follow-up|6|||
170696856|NCT02932904|616903428|FG003|Overall Study|Lost to Follow-up|0|||
170696857|NCT02932904|616903425|FG000|Overall Study|Significant Protocol Deviation|2|||
170696858|NCT02932904|616903426|FG001|Overall Study|Significant Protocol Deviation|3|||
170696859|NCT02932904|616903427|FG002|Overall Study|Significant Protocol Deviation|6|||
170696860|NCT02932904|616903428|FG003|Overall Study|Significant Protocol Deviation|1|||
170696861|NCT02932904|616903425|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
170696862|NCT02932904|616903426|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
170696863|NCT02932904|616903427|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
170696864|NCT02932904|616903428|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
170696865|NCT02932904|616903425|FG000|Overall Study|Randomized But Not Treated|1|||
170696866|NCT02932904|616903426|FG001|Overall Study|Randomized But Not Treated|1|||
170696867|NCT02932904|616903427|FG002|Overall Study|Randomized But Not Treated|0|||
170696868|NCT02932904|616903428|FG003|Overall Study|Randomized But Not Treated|2|||
170696869|NCT00149747|616903433|FG000|Overall Study|Death|1|||
170696870|NCT00149747|616903434|FG001|Overall Study|Death|0|||
170696871|NCT00149747|616903433|FG000|Overall Study|Withdrawal by Subject|3|||
170696872|NCT00149747|616903434|FG001|Overall Study|Withdrawal by Subject|3|||
170696873|NCT03373383|616903435|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
170696874|NCT03373383|616903436|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
170696875|NCT03373383|616903437|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
170696876|NCT03373383|616903438|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
170696877|NCT03373383|616903439|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
170696878|NCT03373383|616903435|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
170696879|NCT03373383|616903436|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
170696880|NCT03373383|616903437|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
170696881|NCT03373383|616903438|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
170696882|NCT03373383|616903439|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
170696883|NCT03373383|616903435|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
170696884|NCT03373383|616903436|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
170696885|NCT03373383|616903437|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
170696886|NCT03373383|616903438|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
170696887|NCT03373383|616903439|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
170696888|NCT03373383|616903435|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
170696889|NCT03373383|616903436|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
170696890|NCT03373383|616903437|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
170696891|NCT03373383|616903438|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
170696892|NCT03373383|616903439|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
170696893|NCT03373383|616903435|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
170696894|NCT03373383|616903436|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
170696895|NCT03373383|616903437|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
170696896|NCT03373383|616903438|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
170696897|NCT03373383|616903439|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
170696898|NCT03373383|616903435|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
170696899|NCT03373383|616903436|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
170696900|NCT03373383|616903437|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
170696901|NCT03373383|616903438|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
170696902|NCT03373383|616903439|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
170696903|NCT03373383|616903435|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
170696904|NCT03373383|616903436|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
170696905|NCT03373383|616903437|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
170696906|NCT03373383|616903438|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
170696907|NCT03373383|616903439|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
170696908|NCT03373383|616903435|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
170696909|NCT03373383|616903436|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
170696910|NCT03373383|616903437|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
170696911|NCT03373383|616903438|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
170696912|NCT03373383|616903439|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
170696913|NCT03373383|616903435|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
170823484|NCT03740919|617360524|FG001|Treatment Period|Adverse Event|0|||
170823485|NCT03740919|617360525|FG002|Treatment Period|Adverse Event|2|||
170823486|NCT03740919|617360526|FG003|Treatment Period|Adverse Event|0|||
170696914|NCT03373383|616903436|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
170696915|NCT03373383|616903437|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
170696916|NCT03373383|616903438|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
170823487|NCT03740919|617360523|FG000|Treatment Period|Protocol Violation|0|||
170823488|NCT03740919|617360524|FG001|Treatment Period|Protocol Violation|1|||
170696917|NCT03373383|616903439|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
170696918|NCT02140567|616903441|FG000|Overall Study|Problems with recording equipment|6|||
170696919|NCT02802592|616903442|FG000|Overall Study|Study terminated due to loss of funding|4|||
170696920|NCT04007523|616903443|FG000|Overall Study|Withdrawal by Subject|0|||
170696921|NCT04007523|616903444|FG001|Overall Study|Withdrawal by Subject|1|||
170696922|NCT04007523|616903445|FG002|Overall Study|Withdrawal by Subject|1|||
170696923|NCT04007523|616903446|FG003|Overall Study|Withdrawal by Subject|0|||
170696924|NCT04007523|616903443|FG000|Overall Study|ICU Transfer|0|||
170696925|NCT04007523|616903444|FG001|Overall Study|ICU Transfer|1|||
170696926|NCT04007523|616903445|FG002|Overall Study|ICU Transfer|0|||
170696927|NCT04007523|616903446|FG003|Overall Study|ICU Transfer|0|||
170696928|NCT04007523|616903443|FG000|Overall Study|COVID hospital closure|0|||
170696929|NCT04007523|616903444|FG001|Overall Study|COVID hospital closure|0|||
170696930|NCT04007523|616903445|FG002|Overall Study|COVID hospital closure|1|||
170696931|NCT04007523|616903446|FG003|Overall Study|COVID hospital closure|2|||
170696932|NCT04007523|616903443|FG000|Overall Study|Surgery cancelled|0|||
170696933|NCT04007523|616903444|FG001|Overall Study|Surgery cancelled|0|||
170696934|NCT04007523|616903445|FG002|Overall Study|Surgery cancelled|1|||
170696935|NCT04007523|616903446|FG003|Overall Study|Surgery cancelled|1|||
170696936|NCT02882854|616903449|FG000|Overall Study|Lost to Follow-up|1|||
170696937|NCT02882854|616903450|FG001|Overall Study|Lost to Follow-up|2|||
170696938|NCT02882854|616903449|FG000|Overall Study|Physician Decision|0|||
170696939|NCT02882854|616903450|FG001|Overall Study|Physician Decision|1|||
170696940|NCT02039674|616903453|FG000|Overall Study|Adverse Event|0|||
170696941|NCT02039674|616903454|FG001|Overall Study|Adverse Event|0|||
170696942|NCT02039674|616903455|FG002|Overall Study|Adverse Event|0|||
170696943|NCT02039674|616903456|FG003|Overall Study|Adverse Event|1|||
170696944|NCT02039674|616903457|FG004|Overall Study|Adverse Event|0|||
170696945|NCT02039674|616903458|FG005|Overall Study|Adverse Event|0|||
170696946|NCT02039674|616903459|FG006|Overall Study|Adverse Event|0|||
170696947|NCT02039674|616903460|FG007|Overall Study|Adverse Event|0|||
170696948|NCT02039674|616903461|FG008|Overall Study|Adverse Event|2|||
170696949|NCT02039674|616903462|FG009|Overall Study|Adverse Event|1|||
170696950|NCT02039674|616903463|FG010|Overall Study|Adverse Event|0|||
170696951|NCT02039674|616903464|FG011|Overall Study|Adverse Event|2|||
170696952|NCT02039674|616903465|FG012|Overall Study|Adverse Event|3|||
170696953|NCT02039674|616903466|FG013|Overall Study|Adverse Event|1|||
170696954|NCT02039674|616903453|FG000|Overall Study|Death|2|||
170696955|NCT02039674|616903454|FG001|Overall Study|Death|0|||
170696956|NCT02039674|616903455|FG002|Overall Study|Death|2|||
170696957|NCT02039674|616903456|FG003|Overall Study|Death|3|||
170696958|NCT02039674|616903457|FG004|Overall Study|Death|0|||
170696959|NCT02039674|616903458|FG005|Overall Study|Death|0|||
170696960|NCT02039674|616903459|FG006|Overall Study|Death|1|||
170696961|NCT02039674|616903460|FG007|Overall Study|Death|0|||
170696962|NCT02039674|616903461|FG008|Overall Study|Death|2|||
170696963|NCT02039674|616903462|FG009|Overall Study|Death|0|||
170696964|NCT02039674|616903463|FG010|Overall Study|Death|1|||
170696965|NCT02039674|616903464|FG011|Overall Study|Death|3|||
170696966|NCT02039674|616903465|FG012|Overall Study|Death|2|||
170696967|NCT02039674|616903466|FG013|Overall Study|Death|8|||
170696968|NCT02039674|616903453|FG000|Overall Study|Excluded Medication|1|||
170696969|NCT02039674|616903454|FG001|Overall Study|Excluded Medication|1|||
170696970|NCT02039674|616903455|FG002|Overall Study|Excluded Medication|0|||
170696971|NCT02039674|616903456|FG003|Overall Study|Excluded Medication|1|||
170696972|NCT02039674|616903457|FG004|Overall Study|Excluded Medication|0|||
170823489|NCT03740919|617360525|FG002|Treatment Period|Protocol Violation|0|||
170823490|NCT03740919|617360526|FG003|Treatment Period|Protocol Violation|0|||
170823491|NCT03740919|617360523|FG000|Treatment Period|Withdrawal by Subject|0|||
170823492|NCT03740919|617360524|FG001|Treatment Period|Withdrawal by Subject|7|||
170823493|NCT03740919|617360525|FG002|Treatment Period|Withdrawal by Subject|6|||
170823494|NCT03740919|617360526|FG003|Treatment Period|Withdrawal by Subject|2|||
170823495|NCT03740919|617360523|FG000|Treatment Period|Terminated by Sponsor|0|||
170823496|NCT03740919|617360524|FG001|Treatment Period|Terminated by Sponsor|1|||
170823497|NCT03740919|617360525|FG002|Treatment Period|Terminated by Sponsor|0|||
170823498|NCT03740919|617360526|FG003|Treatment Period|Terminated by Sponsor|0|||
170696973|NCT02039674|616903458|FG005|Overall Study|Excluded Medication|1|||
170696974|NCT02039674|616903459|FG006|Overall Study|Excluded Medication|0|||
170696975|NCT02039674|616903460|FG007|Overall Study|Excluded Medication|0|||
170696976|NCT02039674|616903461|FG008|Overall Study|Excluded Medication|2|||
170696977|NCT02039674|616903462|FG009|Overall Study|Excluded Medication|3|||
170696978|NCT02039674|616903463|FG010|Overall Study|Excluded Medication|5|||
170696979|NCT02039674|616903464|FG011|Overall Study|Excluded Medication|6|||
170696980|NCT02039674|616903465|FG012|Overall Study|Excluded Medication|8|||
170696981|NCT02039674|616903466|FG013|Overall Study|Excluded Medication|3|||
170696982|NCT02039674|616903453|FG000|Overall Study|Lost to Follow-up|0|||
170823499|NCT03740919|617360523|FG000|Treatment Period|Issue with Insulin Pump|0|||
170696983|NCT02039674|616903454|FG001|Overall Study|Lost to Follow-up|0|||
170696984|NCT02039674|616903455|FG002|Overall Study|Lost to Follow-up|0|||
170696985|NCT02039674|616903456|FG003|Overall Study|Lost to Follow-up|0|||
170696986|NCT02039674|616903457|FG004|Overall Study|Lost to Follow-up|1|||
170696987|NCT02039674|616903458|FG005|Overall Study|Lost to Follow-up|1|||
170696988|NCT02039674|616903459|FG006|Overall Study|Lost to Follow-up|0|||
170696989|NCT02039674|616903460|FG007|Overall Study|Lost to Follow-up|0|||
170696990|NCT02039674|616903461|FG008|Overall Study|Lost to Follow-up|0|||
170696991|NCT02039674|616903462|FG009|Overall Study|Lost to Follow-up|0|||
170696992|NCT02039674|616903463|FG010|Overall Study|Lost to Follow-up|0|||
170696993|NCT02039674|616903464|FG011|Overall Study|Lost to Follow-up|2|||
170696994|NCT02039674|616903465|FG012|Overall Study|Lost to Follow-up|2|||
170696995|NCT02039674|616903466|FG013|Overall Study|Lost to Follow-up|1|||
170696996|NCT02039674|616903453|FG000|Overall Study|Physician Decision|0|||
170696997|NCT02039674|616903454|FG001|Overall Study|Physician Decision|0|||
170696998|NCT02039674|616903455|FG002|Overall Study|Physician Decision|0|||
170696999|NCT02039674|616903456|FG003|Overall Study|Physician Decision|0|||
170697000|NCT02039674|616903457|FG004|Overall Study|Physician Decision|0|||
170697001|NCT02039674|616903458|FG005|Overall Study|Physician Decision|0|||
170697002|NCT02039674|616903459|FG006|Overall Study|Physician Decision|0|||
170697003|NCT02039674|616903460|FG007|Overall Study|Physician Decision|0|||
170697004|NCT02039674|616903461|FG008|Overall Study|Physician Decision|0|||
170697005|NCT02039674|616903462|FG009|Overall Study|Physician Decision|0|||
170697006|NCT02039674|616903463|FG010|Overall Study|Physician Decision|0|||
170697007|NCT02039674|616903464|FG011|Overall Study|Physician Decision|1|||
170697008|NCT02039674|616903465|FG012|Overall Study|Physician Decision|1|||
170697009|NCT02039674|616903466|FG013|Overall Study|Physician Decision|0|||
170697010|NCT02039674|616903453|FG000|Overall Study|Progressive Disease|8|||
170697011|NCT02039674|616903454|FG001|Overall Study|Progressive Disease|8|||
170697012|NCT02039674|616903455|FG002|Overall Study|Progressive Disease|6|||
170697013|NCT02039674|616903456|FG003|Overall Study|Progressive Disease|7|||
170697014|NCT02039674|616903457|FG004|Overall Study|Progressive Disease|9|||
170697015|NCT02039674|616903458|FG005|Overall Study|Progressive Disease|10|||
170697016|NCT02039674|616903459|FG006|Overall Study|Progressive Disease|1|||
170697017|NCT02039674|616903460|FG007|Overall Study|Progressive Disease|3|||
170697018|NCT02039674|616903461|FG008|Overall Study|Progressive Disease|6|||
170697019|NCT02039674|616903462|FG009|Overall Study|Progressive Disease|4|||
170697020|NCT02039674|616903463|FG010|Overall Study|Progressive Disease|0|||
170697021|NCT02039674|616903464|FG011|Overall Study|Progressive Disease|34|||
170697022|NCT02039674|616903465|FG012|Overall Study|Progressive Disease|34|||
170697023|NCT02039674|616903466|FG013|Overall Study|Progressive Disease|18|||
170697024|NCT02039674|616903453|FG000|Overall Study|Withdrawal by Subject|1|||
170697025|NCT02039674|616903454|FG001|Overall Study|Withdrawal by Subject|2|||
170697026|NCT02039674|616903455|FG002|Overall Study|Withdrawal by Subject|3|||
170697027|NCT02039674|616903456|FG003|Overall Study|Withdrawal by Subject|0|||
170697028|NCT02039674|616903457|FG004|Overall Study|Withdrawal by Subject|1|||
170697029|NCT02039674|616903458|FG005|Overall Study|Withdrawal by Subject|0|||
170697030|NCT02039674|616903459|FG006|Overall Study|Withdrawal by Subject|0|||
170697031|NCT02039674|616903460|FG007|Overall Study|Withdrawal by Subject|0|||
170697032|NCT02039674|616903461|FG008|Overall Study|Withdrawal by Subject|0|||
170697033|NCT02039674|616903462|FG009|Overall Study|Withdrawal by Subject|1|||
170697034|NCT02039674|616903463|FG010|Overall Study|Withdrawal by Subject|1|||
170697035|NCT02039674|616903464|FG011|Overall Study|Withdrawal by Subject|4|||
170697036|NCT02039674|616903465|FG012|Overall Study|Withdrawal by Subject|6|||
170697037|NCT02039674|616903466|FG013|Overall Study|Withdrawal by Subject|2|||
170697038|NCT02039674|616903453|FG000|Overall Study|Clinical Progression|0|||
170697039|NCT02039674|616903454|FG001|Overall Study|Clinical Progression|0|||
170697040|NCT02039674|616903455|FG002|Overall Study|Clinical Progression|0|||
170697041|NCT02039674|616903456|FG003|Overall Study|Clinical Progression|0|||
170697042|NCT02039674|616903457|FG004|Overall Study|Clinical Progression|0|||
170697043|NCT02039674|616903458|FG005|Overall Study|Clinical Progression|0|||
170697044|NCT02039674|616903459|FG006|Overall Study|Clinical Progression|1|||
170697045|NCT02039674|616903460|FG007|Overall Study|Clinical Progression|0|||
170697046|NCT02039674|616903461|FG008|Overall Study|Clinical Progression|0|||
170697047|NCT02039674|616903462|FG009|Overall Study|Clinical Progression|0|||
170697048|NCT02039674|616903463|FG010|Overall Study|Clinical Progression|0|||
170697049|NCT02039674|616903464|FG011|Overall Study|Clinical Progression|0|||
170697050|NCT02039674|616903465|FG012|Overall Study|Clinical Progression|1|||
170697051|NCT02039674|616903466|FG013|Overall Study|Clinical Progression|0|||
170697052|NCT02039674|616903453|FG000|Overall Study|Sponsor Decision|1|||
170697053|NCT02039674|616903454|FG001|Overall Study|Sponsor Decision|1|||
170697054|NCT02039674|616903455|FG002|Overall Study|Sponsor Decision|1|||
170697055|NCT02039674|616903456|FG003|Overall Study|Sponsor Decision|1|||
170697056|NCT02039674|616903457|FG004|Overall Study|Sponsor Decision|1|||
170697057|NCT02039674|616903458|FG005|Overall Study|Sponsor Decision|0|||
170697058|NCT02039674|616903459|FG006|Overall Study|Sponsor Decision|0|||
170697059|NCT02039674|616903460|FG007|Overall Study|Sponsor Decision|0|||
170697060|NCT02039674|616903461|FG008|Overall Study|Sponsor Decision|0|||
170697061|NCT02039674|616903462|FG009|Overall Study|Sponsor Decision|3|||
170697062|NCT02039674|616903463|FG010|Overall Study|Sponsor Decision|0|||
170697063|NCT02039674|616903464|FG011|Overall Study|Sponsor Decision|8|||
170697064|NCT02039674|616903465|FG012|Overall Study|Sponsor Decision|5|||
170697065|NCT02039674|616903466|FG013|Overall Study|Sponsor Decision|0|||
170697066|NCT02039674|616903453|FG000|Overall Study|Other|0|||
170697067|NCT02039674|616903454|FG001|Overall Study|Other|0|||
170697068|NCT02039674|616903455|FG002|Overall Study|Other|0|||
170697069|NCT02039674|616903456|FG003|Overall Study|Other|0|||
170697070|NCT02039674|616903457|FG004|Overall Study|Other|0|||
170697071|NCT02039674|616903458|FG005|Overall Study|Other|0|||
170697072|NCT02039674|616903459|FG006|Overall Study|Other|0|||
170697073|NCT02039674|616903460|FG007|Overall Study|Other|0|||
170697074|NCT02039674|616903461|FG008|Overall Study|Other|0|||
170697075|NCT02039674|616903462|FG009|Overall Study|Other|0|||
170697076|NCT02039674|616903463|FG010|Overall Study|Other|0|||
170697077|NCT02039674|616903464|FG011|Overall Study|Other|0|||
170697078|NCT02039674|616903465|FG012|Overall Study|Other|1|||
170697079|NCT02039674|616903466|FG013|Overall Study|Other|0|||
170697080|NCT01826487|616903467|FG000|Overall Study|Adverse Event|1|||
170697081|NCT01826487|616903468|FG001|Overall Study|Adverse Event|1|||
170697082|NCT01826487|616903467|FG000|Overall Study|Lost to Follow-up|1|||
170697083|NCT01826487|616903468|FG001|Overall Study|Lost to Follow-up|0|||
170697084|NCT01826487|616903467|FG000|Overall Study|Withdrawal by Subject|1|||
170697085|NCT01826487|616903468|FG001|Overall Study|Withdrawal by Subject|3|||
170697086|NCT01826487|616903467|FG000|Overall Study|Protocol Violation|1|||
170697087|NCT01826487|616903468|FG001|Overall Study|Protocol Violation|1|||
170697088|NCT01408030|616903469|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
170697089|NCT01408030|616903470|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
170697090|NCT01408030|616903471|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
170697091|NCT01408030|616903472|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
170697092|NCT01408030|616903469|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
170697093|NCT01408030|616903470|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
170697094|NCT01408030|616903471|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
170697095|NCT01408030|616903472|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
170697096|NCT01408030|616903469|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
170697097|NCT01408030|616903470|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
170697098|NCT01408030|616903471|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
170697099|NCT01408030|616903472|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
170697100|NCT01408030|616903469|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
170697101|NCT01408030|616903470|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
170697102|NCT01408030|616903471|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
170697103|NCT01408030|616903472|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
170697104|NCT01408030|616903469|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
170697105|NCT01408030|616903470|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
170697106|NCT01408030|616903471|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
170697107|NCT01408030|616903472|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
170697108|NCT01408030|616903469|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
170697109|NCT01408030|616903470|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
170697110|NCT01408030|616903471|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
170697111|NCT01408030|616903472|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
170697112|NCT01408030|616903469|FG000|Observation Phase (Off Drug)|Other|1|||
170697113|NCT01408030|616903470|FG001|Observation Phase (Off Drug)|Other|1|||
170697114|NCT01408030|616903471|FG002|Observation Phase (Off Drug)|Other|1|||
170697115|NCT01408030|616903472|FG003|Observation Phase (Off Drug)|Other|1|||
170697116|NCT01894152|616903477|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
170697117|NCT00075582|616903479|FG000|Overall Study|Adverse Event|3|||
170697118|NCT00075582|616903480|FG001|Overall Study|Adverse Event|1|||
170697119|NCT00075582|616903479|FG000|Overall Study|Lack of Efficacy|4|||
170697120|NCT00075582|616903480|FG001|Overall Study|Lack of Efficacy|8|||
170697121|NCT00075582|616903479|FG000|Overall Study|Physician Decision|5|||
170697122|NCT00075582|616903480|FG001|Overall Study|Physician Decision|8|||
170697123|NCT00075582|616903479|FG000|Overall Study|Withdrawal by Subject|2|||
170697124|NCT00075582|616903480|FG001|Overall Study|Withdrawal by Subject|2|||
170697125|NCT00075582|616903479|FG000|Overall Study|Ineligible for study|36|||
170697126|NCT00075582|616903480|FG001|Overall Study|Ineligible for study|16|||
170697127|NCT02965703|616903481|FG000|Overall Study|Withdrawal by Subject|6|||
170697128|NCT02965703|616903482|FG001|Overall Study|Withdrawal by Subject|3|||
170697129|NCT02965703|616903483|FG002|Overall Study|Withdrawal by Subject|1|||
170697130|NCT02965703|616903481|FG000|Overall Study|Protocol Violation|1|||
170697131|NCT02965703|616903482|FG001|Overall Study|Protocol Violation|0|||
170697132|NCT02965703|616903483|FG002|Overall Study|Protocol Violation|0|||
170697133|NCT02965703|616903481|FG000|Overall Study|Adverse Event|1|||
170697134|NCT02965703|616903482|FG001|Overall Study|Adverse Event|1|||
170697135|NCT02965703|616903483|FG002|Overall Study|Adverse Event|0|||
170697136|NCT02965703|616903481|FG000|Overall Study|Lost to Follow-up|2|||
170697137|NCT02965703|616903482|FG001|Overall Study|Lost to Follow-up|1|||
170697138|NCT02965703|616903483|FG002|Overall Study|Lost to Follow-up|1|||
170697139|NCT02225743|616903484|FG000|Overall Study|Withdrawal by Subject|18|||
170697140|NCT02486042|616903494|FG000|Overall Study|Physician Decision|1|||
170697141|NCT02486042|616903495|FG001|Overall Study|Physician Decision|7|||
170697142|NCT02486042|616903494|FG000|Overall Study|Hospital transfer|2|||
170697143|NCT02486042|616903495|FG001|Overall Study|Hospital transfer|2|||
170697144|NCT02486042|616903494|FG000|Overall Study|Withdrawal by Subject|0|||
170697145|NCT02486042|616903495|FG001|Overall Study|Withdrawal by Subject|2|||
170697146|NCT02347189|616903496|FG000|Overall Study|No implant attempted of study device|9|||
170697147|NCT02347189|616903496|FG000|Overall Study|No primary outcome data available|2|||
170697148|NCT03320564|616903497|FG000|Overall Study|Protocol Violation|1|||
170697149|NCT00352846|616903498|FG000|Overall Study|Disease progression|0|||
170697150|NCT00352846|616903499|FG001|Overall Study|Disease progression|2|||
170697151|NCT00352846|616903498|FG000|Overall Study|Withdrawal by Subject|3|||
170697152|NCT00352846|616903499|FG001|Overall Study|Withdrawal by Subject|8|||
170697153|NCT00352846|616903498|FG000|Overall Study|Ineligible|3|||
170697154|NCT00352846|616903499|FG001|Overall Study|Ineligible|2|||
170697155|NCT00352846|616903498|FG000|Overall Study|Non-compliance|2|||
170697156|NCT00352846|616903499|FG001|Overall Study|Non-compliance|0|||
170697157|NCT00352846|616903498|FG000|Overall Study|Death|0|||
170697158|NCT00352846|616903499|FG001|Overall Study|Death|1|||
170697159|NCT01527682|616903500|FG000|Overall Study|Protocol Violation|8|||
170697160|NCT00323115|616903502|FG000|Vaccine Administration|Adverse Event|1|||
170697161|NCT00323115|616903502|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
170697162|NCT04365556|616903503|FG000|Overall Study|No longer eligible due to treatment plan|1|||
170697163|NCT04365556|616903504|FG001|Overall Study|No longer eligible due to treatment plan|0|||
170697164|NCT04365556|616903503|FG000|Overall Study|Lost to Follow-up|3|||
170697165|NCT04365556|616903504|FG001|Overall Study|Lost to Follow-up|2|||
170697166|NCT02496533|616903505|FG000|Overall Study|Lack of data on outcome|3|||
170697167|NCT02496533|616903506|FG001|Overall Study|Lack of data on outcome|0|||
170697168|NCT02496533|616903505|FG000|Overall Study|Patient did not complete all measures|0|||
170697169|NCT02496533|616903506|FG001|Overall Study|Patient did not complete all measures|4|||
170697170|NCT02496533|616903505|FG000|Overall Study|Late for radiologic testing|0|||
170697171|NCT02496533|616903506|FG001|Overall Study|Late for radiologic testing|2|||
170697172|NCT05756790|616903507|FG000|Overall Study|Withdrawal by Subject|1|||
170697173|NCT05756790|616903508|FG001|Overall Study|Withdrawal by Subject|1|||
170697174|NCT05756790|616903509|FG002|Overall Study|Withdrawal by Subject|1|||
170697175|NCT05756790|616903510|FG003|Overall Study|Withdrawal by Subject|1|||
170697176|NCT05756790|616903511|FG004|Overall Study|Withdrawal by Subject|0|||
170697177|NCT05756790|616903512|FG005|Overall Study|Withdrawal by Subject|0|||
170697178|NCT05756790|616903507|FG000|Overall Study|Protocol Violation|0|||
170697179|NCT05756790|616903508|FG001|Overall Study|Protocol Violation|0|||
170697180|NCT05756790|616903509|FG002|Overall Study|Protocol Violation|1|||
170697181|NCT05756790|616903510|FG003|Overall Study|Protocol Violation|1|||
170697182|NCT05756790|616903511|FG004|Overall Study|Protocol Violation|0|||
170697183|NCT05756790|616903512|FG005|Overall Study|Protocol Violation|0|||
170697184|NCT05756790|616903507|FG000|Overall Study|Ineligible|0|||
170697185|NCT05756790|616903508|FG001|Overall Study|Ineligible|0|||
170697186|NCT05756790|616903509|FG002|Overall Study|Ineligible|0|||
170697187|NCT05756790|616903510|FG003|Overall Study|Ineligible|0|||
170697188|NCT05756790|616903511|FG004|Overall Study|Ineligible|2|||
170697189|NCT05756790|616903512|FG005|Overall Study|Ineligible|2|||
170697190|NCT04439318|616903513|FG000|Overall Study|Ineligible|1|||
170697191|NCT04439318|616903513|FG000|Overall Study|Never Started Treatment|3|||
170697192|NCT04439318|616903513|FG000|Overall Study|Adverse Event|10|||
170697193|NCT04439318|616903513|FG000|Overall Study|Death|2|||
170697194|NCT04439318|616903513|FG000|Overall Study|Disease Progression|25|||
170697195|NCT04439318|616903513|FG000|Overall Study|Other Complicating Disease|2|||
170697196|NCT04439318|616903513|FG000|Overall Study|Withdrawal by Subject|4|||
170697197|NCT04439318|616903513|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
170697198|NCT04439318|616903513|FG000|Overall Study|Non-Compliance|1|||
170697199|NCT04439318|616903513|FG000|Overall Study|Still on Treatment|1|||
170697200|NCT04380857|616904686|FG000|Overall Study|Lost to Follow-up|3|||
170697201|NCT04380857|616904687|FG001|Overall Study|Lost to Follow-up|3|||
170697202|NCT02042924|616904689|FG000|Overall Study|Early Death|1|||
170697203|NCT04033003|616904690|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
170697204|NCT04033003|616904691|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
170697205|NCT04033003|616904690|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
170697206|NCT04033003|616904691|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
170697207|NCT04033003|616904690|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
170697208|NCT04033003|616904691|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
170697209|NCT04033003|616904690|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
170697210|NCT04033003|616904691|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
170697211|NCT04033003|616904690|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
170697212|NCT04033003|616904691|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
170697213|NCT04033003|616904690|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
170697214|NCT04033003|616904691|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
170697215|NCT04033003|616904690|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
170697216|NCT04033003|616904691|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
170697217|NCT04033003|616904690|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
170697218|NCT04033003|616904691|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
170697219|NCT04033003|616904690|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
170697220|NCT04033003|616904691|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
170697221|NCT04033003|616904690|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
170697222|NCT04033003|616904691|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
170697223|NCT04033003|616904690|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
170697224|NCT04033003|616904691|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
170697225|NCT04033003|616904690|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
170697226|NCT04033003|616904691|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
170697227|NCT04033003|616904690|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
170697228|NCT04033003|616904691|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
170697229|NCT02919670|616904692|FG000|Overall Study|Only 17 participants met compliance|43|||
170697230|NCT02919670|616904693|FG001|Overall Study|Only 17 participants met compliance|39|||
170697231|NCT04920123|616904698|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
170697232|NCT04920123|616904699|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
170697233|NCT04920123|616904700|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
170697234|NCT00826267|616904701|FG000|Overall Study|Other Adverse Event|1|||
170697235|NCT00826267|616904702|FG001|Overall Study|Other Adverse Event|0|||
170697236|NCT00826267|616904703|FG002|Overall Study|Other Adverse Event|0|||
170697237|NCT03818516|616904716|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
170697238|NCT00850395|616904723|FG000|Overall Study|Death|1|||
170697239|NCT00850395|616904723|FG000|Overall Study|Adverse Event|1|||
170697240|NCT00850395|616904723|FG000|Overall Study|Insufficient clinical response|3|||
170697241|NCT00850395|616904723|FG000|Overall Study|Other|5|||
170697242|NCT01737047|616904724|FG000|Overall Study|Death|10|||
170697243|NCT01737047|616904725|FG001|Overall Study|Death|0|||
170697244|NCT01737047|616904726|FG002|Overall Study|Death|1|||
170697245|NCT01737047|616904724|FG000|Overall Study|Withdrawal by Subject|17|||
170697246|NCT01737047|616904725|FG001|Overall Study|Withdrawal by Subject|11|||
170697247|NCT01737047|616904726|FG002|Overall Study|Withdrawal by Subject|4|||
170697248|NCT03190889|616904729|FG000|Overall Study|Lost to Follow-up|7|||
170697249|NCT03190889|616904730|FG001|Overall Study|Lost to Follow-up|7|||
170697250|NCT03190889|616904731|FG002|Overall Study|Lost to Follow-up|3|||
170697251|NCT03190889|616904729|FG000|Overall Study|Withdrawal by Subject|1|||
170697252|NCT03190889|616904730|FG001|Overall Study|Withdrawal by Subject|1|||
170697253|NCT03190889|616904731|FG002|Overall Study|Withdrawal by Subject|2|||
170697254|NCT03190889|616904729|FG000|Overall Study|Did not complete protocol|4|||
170697255|NCT03190889|616904730|FG001|Overall Study|Did not complete protocol|9|||
170697256|NCT03190889|616904731|FG002|Overall Study|Did not complete protocol|0|||
170697257|NCT03190889|616904729|FG000|Overall Study|COVID-19|1|||
170697258|NCT03190889|616904730|FG001|Overall Study|COVID-19|0|||
170697259|NCT03190889|616904731|FG002|Overall Study|COVID-19|2|||
170697260|NCT01709695|616904733|FG000|Overall Study|Withdrawal by Subject|1|||
170697261|NCT01709695|616904734|FG001|Overall Study|Withdrawal by Subject|1|||
170697262|NCT00500292|616904736|FG000|Overall Study|Adverse Event|3|||
170697263|NCT00500292|616904737|FG001|Overall Study|Adverse Event|6|||
170697264|NCT00500292|616904738|FG002|Overall Study|Adverse Event|4|||
170697265|NCT00500292|616904736|FG000|Overall Study|Condition under investigation worsened|21|||
170697266|NCT00500292|616904737|FG001|Overall Study|Condition under investigation worsened|23|||
170697267|NCT00500292|616904738|FG002|Overall Study|Condition under investigation worsened|19|||
170697268|NCT00500292|616904736|FG000|Overall Study|Withdrawal by Subject|0|||
170697269|NCT00500292|616904737|FG001|Overall Study|Withdrawal by Subject|1|||
170697270|NCT00500292|616904738|FG002|Overall Study|Withdrawal by Subject|0|||
170697271|NCT00500292|616904736|FG000|Overall Study|Other|1|||
170697272|NCT00500292|616904737|FG001|Overall Study|Other|1|||
170697273|NCT00500292|616904738|FG002|Overall Study|Other|4|||
170697274|NCT04544293|616904739|FG000|Double-blind|Adverse Event|2|||
170697275|NCT04544293|616904740|FG001|Double-blind|Adverse Event|1|||
170697276|NCT04544293|616904739|FG000|Double-blind|Pregnancy|0|||
170697277|NCT04544293|616904740|FG001|Double-blind|Pregnancy|1|||
170697278|NCT04544293|616904739|FG000|Double-blind|Lost to Follow-up|0|||
170697279|NCT04544293|616904740|FG001|Double-blind|Lost to Follow-up|1|||
170697280|NCT04544293|616904739|FG000|Open-Label Extension|Study ongoing|79|||
170697281|NCT04544293|616904740|FG001|Open-Label Extension|Study ongoing|81|||
170697282|NCT03560531|616904742|FG000|Overall Study|Death|4|||
170697283|NCT03560531|616904743|FG001|Overall Study|Death|1|||
170697284|NCT03560531|616904744|FG002|Overall Study|Death|1|||
170697285|NCT03560531|616904745|FG003|Overall Study|Death|2|||
170697286|NCT03560531|616904746|FG004|Overall Study|Death|6|||
170697287|NCT03560531|616904747|FG005|Overall Study|Death|1|||
170697288|NCT03560531|616904748|FG006|Overall Study|Death|4|||
170697289|NCT03560531|616904749|FG007|Overall Study|Death|8|||
170697290|NCT03560531|616904750|FG008|Overall Study|Death|1|||
170697291|NCT03560531|616904751|FG009|Overall Study|Death|3|||
170697292|NCT03560531|616904752|FG010|Overall Study|Death|2|||
170697293|NCT03560531|616904753|FG011|Overall Study|Death|0|||
170697294|NCT03560531|616904754|FG012|Overall Study|Death|4|||
170697295|NCT03560531|616904755|FG013|Overall Study|Death|1|||
170697296|NCT03560531|616904742|FG000|Overall Study|Lost to Follow-up|1|||
170697297|NCT03560531|616904743|FG001|Overall Study|Lost to Follow-up|1|||
170697298|NCT03560531|616904744|FG002|Overall Study|Lost to Follow-up|0|||
170697299|NCT03560531|616904745|FG003|Overall Study|Lost to Follow-up|0|||
170697300|NCT03560531|616904746|FG004|Overall Study|Lost to Follow-up|0|||
170697301|NCT03560531|616904747|FG005|Overall Study|Lost to Follow-up|0|||
170697302|NCT03560531|616904748|FG006|Overall Study|Lost to Follow-up|1|||
170697303|NCT03560531|616904749|FG007|Overall Study|Lost to Follow-up|0|||
170697304|NCT03560531|616904750|FG008|Overall Study|Lost to Follow-up|0|||
170697305|NCT03560531|616904751|FG009|Overall Study|Lost to Follow-up|0|||
170697306|NCT03560531|616904752|FG010|Overall Study|Lost to Follow-up|0|||
170697307|NCT03560531|616904753|FG011|Overall Study|Lost to Follow-up|0|||
170697308|NCT03560531|616904754|FG012|Overall Study|Lost to Follow-up|0|||
170697309|NCT03560531|616904755|FG013|Overall Study|Lost to Follow-up|0|||
170697310|NCT03560531|616904742|FG000|Overall Study|Withdrawal by Subject|1|||
170697311|NCT03560531|616904743|FG001|Overall Study|Withdrawal by Subject|0|||
170697312|NCT03560531|616904744|FG002|Overall Study|Withdrawal by Subject|0|||
170697313|NCT03560531|616904745|FG003|Overall Study|Withdrawal by Subject|0|||
170697314|NCT03560531|616904746|FG004|Overall Study|Withdrawal by Subject|0|||
170697315|NCT03560531|616904747|FG005|Overall Study|Withdrawal by Subject|0|||
170697316|NCT03560531|616904748|FG006|Overall Study|Withdrawal by Subject|0|||
170697317|NCT03560531|616904749|FG007|Overall Study|Withdrawal by Subject|3|||
170697318|NCT03560531|616904750|FG008|Overall Study|Withdrawal by Subject|2|||
170697319|NCT03560531|616904751|FG009|Overall Study|Withdrawal by Subject|0|||
170697320|NCT03560531|616904752|FG010|Overall Study|Withdrawal by Subject|0|||
170697321|NCT03560531|616904753|FG011|Overall Study|Withdrawal by Subject|0|||
170697322|NCT03560531|616904754|FG012|Overall Study|Withdrawal by Subject|2|||
170697323|NCT03560531|616904755|FG013|Overall Study|Withdrawal by Subject|0|||
170697324|NCT03560531|616904742|FG000|Overall Study|Study end per-protocol|1|||
170697325|NCT03560531|616904743|FG001|Overall Study|Study end per-protocol|1|||
170697326|NCT03560531|616904744|FG002|Overall Study|Study end per-protocol|2|||
170697327|NCT03560531|616904745|FG003|Overall Study|Study end per-protocol|0|||
170697328|NCT03560531|616904746|FG004|Overall Study|Study end per-protocol|1|||
170697329|NCT03560531|616904747|FG005|Overall Study|Study end per-protocol|0|||
170697330|NCT03560531|616904748|FG006|Overall Study|Study end per-protocol|0|||
170697331|NCT03560531|616904749|FG007|Overall Study|Study end per-protocol|0|||
170823500|NCT03740919|617360524|FG001|Treatment Period|Issue with Insulin Pump|1|||
170823501|NCT03740919|617360525|FG002|Treatment Period|Issue with Insulin Pump|0|||
170823502|NCT03740919|617360526|FG003|Treatment Period|Issue with Insulin Pump|0|||
170823503|NCT03740919|617360523|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
170823504|NCT03740919|617360524|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
170823505|NCT03740919|617360525|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
170823506|NCT03740919|617360526|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
170823507|NCT03740919|617360523|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
170823508|NCT03740919|617360524|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
170823509|NCT03740919|617360525|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
170823510|NCT03740919|617360526|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
170697332|NCT03560531|616904750|FG008|Overall Study|Study end per-protocol|0|||
170697333|NCT03560531|616904751|FG009|Overall Study|Study end per-protocol|0|||
170697334|NCT03560531|616904752|FG010|Overall Study|Study end per-protocol|0|||
170697335|NCT03560531|616904753|FG011|Overall Study|Study end per-protocol|0|||
170697336|NCT03560531|616904754|FG012|Overall Study|Study end per-protocol|0|||
170697337|NCT03560531|616904755|FG013|Overall Study|Study end per-protocol|0|||
170697338|NCT03560531|616904742|FG000|Overall Study|Early study termination by sponsor|9|||
170697339|NCT03560531|616904743|FG001|Overall Study|Early study termination by sponsor|0|||
170697340|NCT03560531|616904744|FG002|Overall Study|Early study termination by sponsor|0|||
170697341|NCT03560531|616904745|FG003|Overall Study|Early study termination by sponsor|4|||
170697342|NCT03560531|616904746|FG004|Overall Study|Early study termination by sponsor|8|||
170697343|NCT03560531|616904747|FG005|Overall Study|Early study termination by sponsor|2|||
170697344|NCT03560531|616904748|FG006|Overall Study|Early study termination by sponsor|5|||
170697345|NCT03560531|616904749|FG007|Overall Study|Early study termination by sponsor|64|||
170697346|NCT03560531|616904750|FG008|Overall Study|Early study termination by sponsor|7|||
170697347|NCT03560531|616904751|FG009|Overall Study|Early study termination by sponsor|2|||
170697348|NCT03560531|616904752|FG010|Overall Study|Early study termination by sponsor|16|||
170697349|NCT03560531|616904753|FG011|Overall Study|Early study termination by sponsor|2|||
170697350|NCT03560531|616904754|FG012|Overall Study|Early study termination by sponsor|6|||
170697351|NCT03560531|616904755|FG013|Overall Study|Early study termination by sponsor|2|||
170697352|NCT02968979|616904756|FG000|Overall Study|Protocol Violation|7|||
170697353|NCT02968979|616904756|FG000|Overall Study|Withdrawal by Subject|1|||
170697354|NCT01471379|616904757|FG000|Overall Study|Adverse Event|1|||
170697355|NCT01471379|616904758|FG001|Overall Study|Adverse Event|0|||
170697356|NCT01471379|616904759|FG002|Overall Study|Adverse Event|0|||
170697357|NCT01471379|616904757|FG000|Overall Study|Study terminated|0|||
170697358|NCT01471379|616904758|FG001|Overall Study|Study terminated|1|||
170697359|NCT01471379|616904759|FG002|Overall Study|Study terminated|0|||
170697360|NCT02677987|616904760|FG000|Overall Study|Withdrawal by Subject|3|||
170697361|NCT02677987|616904761|FG001|Overall Study|Withdrawal by Subject|0|||
170697362|NCT02677987|616904760|FG000|Overall Study|Lost to Follow-up|1|||
170697363|NCT02677987|616904761|FG001|Overall Study|Lost to Follow-up|0|||
170697364|NCT00788827|616904762|FG000|Overall Study|Lack of Efficacy|2|||
170697365|NCT00729183|616904763|FG000|Overall Study|Adverse Event|11|||
170697366|NCT00729183|616904764|FG001|Overall Study|Adverse Event|5|||
170697367|NCT00729183|616904763|FG000|Overall Study|Lack of Efficacy|0|||
170697368|NCT00729183|616904764|FG001|Overall Study|Lack of Efficacy|1|||
170697369|NCT00729183|616904763|FG000|Overall Study|Lost to Follow-up|3|||
170697370|NCT00729183|616904764|FG001|Overall Study|Lost to Follow-up|1|||
170697371|NCT00729183|616904763|FG000|Overall Study|Physician Decision|1|||
170697372|NCT00729183|616904764|FG001|Overall Study|Physician Decision|1|||
170697373|NCT00729183|616904763|FG000|Overall Study|Protocol Violation|1|||
170697374|NCT00729183|616904764|FG001|Overall Study|Protocol Violation|0|||
170697375|NCT00729183|616904763|FG000|Overall Study|Withdrawal by Subject|9|||
170697376|NCT00729183|616904764|FG001|Overall Study|Withdrawal by Subject|7|||
170697377|NCT03608774|616904765|FG000|Overall Study|Lost to Follow-up|5|||
170697378|NCT03608774|616904766|FG001|Overall Study|Lost to Follow-up|5|||
170697379|NCT03608774|616904765|FG000|Overall Study|Withdrawal by Subject|1|||
170697380|NCT03608774|616904766|FG001|Overall Study|Withdrawal by Subject|0|||
170697381|NCT03608774|616904765|FG000|Overall Study|Protocol Violation|1|||
170697382|NCT03608774|616904766|FG001|Overall Study|Protocol Violation|0|||
170697383|NCT03608774|616904765|FG000|Overall Study|Not eligible at enrollment|0|||
170697384|NCT03608774|616904766|FG001|Overall Study|Not eligible at enrollment|1|||
170697385|NCT03608774|616904765|FG000|Overall Study|Health related event|0|||
170697386|NCT03608774|616904766|FG001|Overall Study|Health related event|1|||
170697387|NCT01586819|616904767|FG000|Overall Study|Withdrawal by Subject|1|||
170697388|NCT01586819|616904768|FG001|Overall Study|Withdrawal by Subject|0|||
170697389|NCT03979638|616904775|FG000|Period 1|Physician Decision|1|||
170697390|NCT03979638|616904776|FG001|Period 1|Physician Decision|1|||
170697391|NCT03979638|616904775|FG000|Period 1|Withdrawal by Subject|4|||
170697392|NCT03979638|616904776|FG001|Period 1|Withdrawal by Subject|3|||
170697393|NCT03979638|616904775|FG000|Period 1|Study terminated by Sponsor|1|||
170697394|NCT03979638|616904776|FG001|Period 1|Study terminated by Sponsor|3|||
170697395|NCT03979638|616904775|FG000|Period 1|Protocol Violation|1|||
170697396|NCT03979638|616904776|FG001|Period 1|Protocol Violation|0|||
170697397|NCT03979638|616904775|FG000|Period 2|Study terminated by Sponsor|1|||
170697398|NCT03979638|616904776|FG001|Period 2|Study terminated by Sponsor|1|||
170697399|NCT02818777|616904781|FG000|Overall Study|Adverse Event|3|||
170697400|NCT02028988|616904783|FG000|Overall Study|Withdrawal by Subject|2|||
170697401|NCT02680639|616904786|FG000|Screening Period|Screen Failure|7|||
170697402|NCT02680639|616904787|FG001|Screening Period|Screen Failure|0|||
170697403|NCT02680639|616904788|FG002|Screening Period|Screen Failure|0|||
170697404|NCT00747435|616904789|FG000|Overall Study|Lost to Follow-up|2|||
170697405|NCT00747435|616904789|FG000|Overall Study|Withdrawal by Subject|3|||
170697406|NCT00747435|616904789|FG000|Overall Study|Still undergoing follow up|1|||
170697407|NCT00748215|616904790|FG000|Overall Study|Withdrawal by Subject|7|||
170823511|NCT03740919|617360523|FG000|Treatment Period|Not Completing Diary|0|||
170823512|NCT03740919|617360524|FG001|Treatment Period|Not Completing Diary|0|||
170823513|NCT03740919|617360525|FG002|Treatment Period|Not Completing Diary|1|||
170823514|NCT03740919|617360526|FG003|Treatment Period|Not Completing Diary|0|||
170823515|NCT03740919|617360523|FG000|Treatment Period|Insulin Painful to Participant|0|||
170823516|NCT03740919|617360524|FG001|Treatment Period|Insulin Painful to Participant|0|||
170823517|NCT03740919|617360525|FG002|Treatment Period|Insulin Painful to Participant|1|||
170823518|NCT03740919|617360526|FG003|Treatment Period|Insulin Painful to Participant|0|||
170697408|NCT00748215|616904791|FG001|Overall Study|Withdrawal by Subject|7|||
170697409|NCT00748215|616904790|FG000|Overall Study|Treatment change|2|||
170697410|NCT00748215|616904791|FG001|Overall Study|Treatment change|1|||
170697411|NCT00748215|616904790|FG000|Overall Study|Change in patient condition|0|||
170697412|NCT00748215|616904791|FG001|Overall Study|Change in patient condition|3|||
170697413|NCT00748215|616904790|FG000|Overall Study|Non-compliant|0|||
170697414|NCT00748215|616904791|FG001|Overall Study|Non-compliant|2|||
170697415|NCT00748215|616904790|FG000|Overall Study|Adverse Event|0|||
170697416|NCT00748215|616904791|FG001|Overall Study|Adverse Event|5|||
170697417|NCT00851799|616904794|FG000|Overall Study|Death|1|||
170697418|NCT00851799|616904795|FG001|Overall Study|Death|0|||
170697419|NCT00851799|616904796|FG002|Overall Study|Death|1|||
170697420|NCT00851799|616904794|FG000|Overall Study|Lost to Follow-up|5|||
170697421|NCT00851799|616904795|FG001|Overall Study|Lost to Follow-up|3|||
170697422|NCT00851799|616904796|FG002|Overall Study|Lost to Follow-up|10|||
170697423|NCT00851799|616904794|FG000|Overall Study|Not able to get to clinic|8|||
170697424|NCT00851799|616904795|FG001|Overall Study|Not able to get to clinic|5|||
170697425|NCT00851799|616904796|FG002|Overall Study|Not able to get to clinic|9|||
170697426|NCT00851799|616904794|FG000|Overall Study|Not willing to adhere to requirements|1|||
170697427|NCT00851799|616904795|FG001|Overall Study|Not willing to adhere to requirements|2|||
170697428|NCT00851799|616904796|FG002|Overall Study|Not willing to adhere to requirements|2|||
170697429|NCT00851799|616904794|FG000|Overall Study|Withdrew consent prior study completion|1|||
170697430|NCT00851799|616904795|FG001|Overall Study|Withdrew consent prior study completion|2|||
170697431|NCT00851799|616904796|FG002|Overall Study|Withdrew consent prior study completion|1|||
170697432|NCT00851799|616904794|FG000|Overall Study|Severe Debilitation|0|||
170697433|NCT00851799|616904795|FG001|Overall Study|Severe Debilitation|1|||
170697434|NCT00851799|616904796|FG002|Overall Study|Severe Debilitation|0|||
170697435|NCT00851799|616904794|FG000|Overall Study|Completed protocol due to pregnancy|0|||
170697436|NCT00851799|616904795|FG001|Overall Study|Completed protocol due to pregnancy|0|||
170697437|NCT00851799|616904796|FG002|Overall Study|Completed protocol due to pregnancy|1|||
170697438|NCT01113879|616904801|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
170697439|NCT01113879|616904802|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
170697440|NCT04151290|616904803|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
170697441|NCT01342510|616904804|FG000|Overall Study|Protocol Violation|12|||
170697442|NCT01342510|616904805|FG001|Overall Study|Protocol Violation|6|||
170697443|NCT01342510|616904806|FG002|Overall Study|Protocol Violation|13|||
170697444|NCT01342510|616904807|FG003|Overall Study|Protocol Violation|11|||
170697445|NCT04615949|616906571|FG000|Overall Study|Withdrawal by Subject|2|||
170697446|NCT04615949|616906572|FG001|Overall Study|Withdrawal by Subject|4|||
170697447|NCT04615949|616906571|FG000|Overall Study|Lost to Follow-up|2|||
170697448|NCT04615949|616906572|FG001|Overall Study|Lost to Follow-up|2|||
170697449|NCT04615949|616906571|FG000|Overall Study|Death|0|||
170697450|NCT04615949|616906572|FG001|Overall Study|Death|2|||
170697451|NCT03036566|616906573|FG000|Overall Study|Lost to Follow-up|3|||
170697452|NCT01852292|616906577|FG000|Overall Study|Untreated - did not receive study drug|3|||
170697453|NCT01852292|616906578|FG001|Overall Study|Untreated - did not receive study drug|1|||
170697454|NCT01852292|616906577|FG000|Overall Study|Death|9|||
170697455|NCT01852292|616906578|FG001|Overall Study|Death|8|||
170697456|NCT01852292|616906577|FG000|Overall Study|Patient/guardian decision|8|||
170697457|NCT01852292|616906578|FG001|Overall Study|Patient/guardian decision|4|||
170697458|NCT01852292|616906577|FG000|Overall Study|Adverse Event|8|||
170697459|NCT01852292|616906578|FG001|Overall Study|Adverse Event|11|||
170697460|NCT01852292|616906577|FG000|Overall Study|Physician Decision|6|||
170697461|NCT01852292|616906578|FG001|Overall Study|Physician Decision|2|||
170697462|NCT01852292|616906577|FG000|Overall Study|Protocol Violation|2|||
170697463|NCT01852292|616906578|FG001|Overall Study|Protocol Violation|0|||
170697464|NCT01852292|616906577|FG000|Overall Study|Non-compliance with study treatment|1|||
170697465|NCT01852292|616906578|FG001|Overall Study|Non-compliance with study treatment|0|||
170697466|NCT01852292|616906577|FG000|Overall Study|Study terminated by Sponsor|0|||
170697467|NCT01852292|616906578|FG001|Overall Study|Study terminated by Sponsor|1|||
170697468|NCT01852292|616906577|FG000|Overall Study|Progressive disease|42|||
170697469|NCT01852292|616906578|FG001|Overall Study|Progressive disease|52|||
170697470|NCT03299842|616906581|FG000|Overall Study|Caregiver withdrew consent|2|||
170697471|NCT03299842|616906581|FG000|Overall Study|Child would not keep the watch on|3|||
170697472|NCT02558790|616906584|FG000|Overall Study|Lost to Follow-up|2|||
170697473|NCT02558790|616906584|FG000|Overall Study|Physician Decision|1|||
170697474|NCT02558790|616906584|FG000|Overall Study|Withdrawal by Subject|1|||
170697475|NCT02558790|616906584|FG000|Overall Study|Screen Fail|3|||
170697476|NCT03568942|616906587|FG000|Overall Study|Family emergency|1|||
170697477|NCT03568942|616906587|FG000|Overall Study|Lost to Follow-up|1|||
170697478|NCT01275066|616906588|FG000|Overall Study|Withdrawal by Subject|0|||
170697479|NCT01275066|616906589|FG001|Overall Study|Withdrawal by Subject|0|||
170697480|NCT01275066|616906590|FG002|Overall Study|Withdrawal by Subject|1|||
170697481|NCT01275066|616906588|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
170697482|NCT01275066|616906589|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
170697483|NCT01275066|616906590|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
170697484|NCT00749463|616906591|FG000|Overall Study|Adverse Event|0|||
170697485|NCT00749463|616906592|FG001|Overall Study|Adverse Event|4|||
170697486|NCT00749463|616906593|FG002|Overall Study|Adverse Event|1|||
170697487|NCT00749463|616906591|FG000|Overall Study|Withdrawal by Subject|1|||
170697488|NCT00749463|616906592|FG001|Overall Study|Withdrawal by Subject|0|||
170697489|NCT00749463|616906593|FG002|Overall Study|Withdrawal by Subject|0|||
170697490|NCT00997503|616906596|FG000|Overall Study|Death|53|||
170697491|NCT00997503|616906596|FG000|Overall Study|Withdrawal by Subject|76|||
170697492|NCT00997503|616906596|FG000|Overall Study|Lost to Follow-up|33|||
170697493|NCT00997503|616906596|FG000|Overall Study|Adverse Event|3|||
170697494|NCT00997503|616906596|FG000|Overall Study|Physician Decision|10|||
170697495|NCT00997503|616906596|FG000|Overall Study|Missed 12-month follow-up|85|||
170697496|NCT00997503|616906596|FG000|Overall Study|Other reason|13|||
170697497|NCT01933048|616906597|FG000|Overall Study|Lost to Follow-up|15|||
170697498|NCT01933048|616906598|FG001|Overall Study|Lost to Follow-up|18|||
170697499|NCT01933048|616906597|FG000|Overall Study|personal reasons|1|||
170697500|NCT01933048|616906598|FG001|Overall Study|personal reasons|1|||
170697501|NCT01933048|616906597|FG000|Overall Study|Protocol Violation|7|||
170697502|NCT01933048|616906598|FG001|Overall Study|Protocol Violation|8|||
170697503|NCT01933048|616906597|FG000|Overall Study|Physician Decision|1|||
170697504|NCT01933048|616906598|FG001|Overall Study|Physician Decision|0|||
170697505|NCT01933048|616906597|FG000|Overall Study|unknown reasons|1|||
170697506|NCT01933048|616906598|FG001|Overall Study|unknown reasons|1|||
170697507|NCT02780804|616906602|FG000|Overall Study|Death|1|||
170697508|NCT02780804|616906603|FG001|Overall Study|Death|0|||
170697509|NCT02780804|616906604|FG002|Overall Study|Death|0|||
170697510|NCT02780804|616906602|FG000|Overall Study|Lack of Efficacy|5|||
170697511|NCT02780804|616906603|FG001|Overall Study|Lack of Efficacy|8|||
170697512|NCT02780804|616906604|FG002|Overall Study|Lack of Efficacy|4|||
170697513|NCT02780804|616906602|FG000|Overall Study|Physician Decision|0|||
170697514|NCT02780804|616906603|FG001|Overall Study|Physician Decision|0|||
170697515|NCT02780804|616906604|FG002|Overall Study|Physician Decision|2|||
170697516|NCT02780804|616906602|FG000|Overall Study|Withdrawal by Subject|0|||
170697517|NCT02780804|616906603|FG001|Overall Study|Withdrawal by Subject|1|||
170697518|NCT02780804|616906604|FG002|Overall Study|Withdrawal by Subject|0|||
170697519|NCT02476968|616906605|FG000|Overall Study|Other|0|||
170697520|NCT02476968|616906606|FG001|Overall Study|Other|2|||
170697521|NCT02476968|616906607|FG002|Overall Study|Other|0|||
170697522|NCT02476968|616906605|FG000|Overall Study|Lost to Follow-up|10|||
170697523|NCT02476968|616906606|FG001|Overall Study|Lost to Follow-up|0|||
170697524|NCT02476968|616906607|FG002|Overall Study|Lost to Follow-up|1|||
170697525|NCT02476968|616906605|FG000|Overall Study|Death|48|||
170697526|NCT02476968|616906606|FG001|Overall Study|Death|8|||
170697527|NCT02476968|616906607|FG002|Overall Study|Death|1|||
170697528|NCT02476968|616906605|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170697529|NCT02476968|616906606|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170697530|NCT02476968|616906607|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
170697531|NCT02476968|616906605|FG000|Overall Study|Patient decision|37|||
170697532|NCT02476968|616906606|FG001|Overall Study|Patient decision|8|||
170823519|NCT02418819|617360531|FG000|Overall Study|Adverse Event|0|||
170823520|NCT02418819|617360532|FG001|Overall Study|Adverse Event|0|||
170823521|NCT02418819|617360533|FG002|Overall Study|Adverse Event|1|||
170823522|NCT02418819|617360534|FG003|Overall Study|Adverse Event|0|||
170823523|NCT02418819|617360531|FG000|Overall Study|Lost to Follow-up|1|||
170697533|NCT02476968|616906607|FG002|Overall Study|Patient decision|0|||
170697534|NCT04476030|616906610|FG000|Overall Study|Withdrawal by Subject|20|||
170697535|NCT04476030|616906611|FG001|Overall Study|Withdrawal by Subject|16|||
170823524|NCT02418819|617360532|FG001|Overall Study|Lost to Follow-up|0|||
170697536|NCT04476030|616906610|FG000|Overall Study|Adverse Event|10|||
170697537|NCT04476030|616906611|FG001|Overall Study|Adverse Event|11|||
170697538|NCT04476030|616906610|FG000|Overall Study|Lost to Follow-up|7|||
170697539|NCT04476030|616906611|FG001|Overall Study|Lost to Follow-up|4|||
170697540|NCT04476030|616906610|FG000|Overall Study|Physician Decision|1|||
170697541|NCT04476030|616906611|FG001|Overall Study|Physician Decision|1|||
170697542|NCT04476030|616906610|FG000|Overall Study|Protocol Deviation|2|||
170823525|NCT02418819|617360533|FG002|Overall Study|Lost to Follow-up|0|||
170697543|NCT04476030|616906611|FG001|Overall Study|Protocol Deviation|0|||
170697544|NCT04476030|616906610|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
170697545|NCT04476030|616906611|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
170823526|NCT02418819|617360534|FG003|Overall Study|Lost to Follow-up|0|||
170697546|NCT04476030|616906610|FG000|Overall Study|Randomized but not Dosed|2|||
170697547|NCT04476030|616906611|FG001|Overall Study|Randomized but not Dosed|8|||
170697548|NCT00302003|616906612|FG000|Overall Study|Lack of Efficacy|62|||
170697549|NCT00302003|616906612|FG000|Overall Study|Lost to Follow-up|1|||
170697550|NCT00302003|616906612|FG000|Overall Study|Physician Decision|2|||
170697551|NCT00302003|616906612|FG000|Overall Study|Withdrawal by Subject|5|||
170697552|NCT00302003|616906612|FG000|Overall Study|Ineligible|9|||
170697553|NCT00302003|616906612|FG000|Overall Study|Protocol Violation|1|||
170697554|NCT02256891|616906615|FG000|Overall Study|Death|0|||
170697555|NCT02256891|616906616|FG001|Overall Study|Death|2|||
170697556|NCT02256891|616906615|FG000|Overall Study|Lost to Follow-up|0|||
170697557|NCT02256891|616906616|FG001|Overall Study|Lost to Follow-up|3|||
170697558|NCT02256891|616906615|FG000|Overall Study|Physician Decision|7|||
170697559|NCT02256891|616906616|FG001|Overall Study|Physician Decision|3|||
170697560|NCT02256891|616906615|FG000|Overall Study|Screen Fail|5|||
170697561|NCT02256891|616906616|FG001|Overall Study|Screen Fail|4|||
170697562|NCT02256891|616906615|FG000|Overall Study|Equipment Malfunction|0|||
170697563|NCT02256891|616906616|FG001|Overall Study|Equipment Malfunction|1|||
170697564|NCT00218296|616906627|FG000|Overall Study|Lost to Follow-up|9|||
170697565|NCT00218296|616906628|FG001|Overall Study|Lost to Follow-up|7|||
170697566|NCT00218296|616906627|FG000|Overall Study|Withdrawal by Subject|36|||
170697567|NCT00218296|616906628|FG001|Overall Study|Withdrawal by Subject|47|||
170697568|NCT00218296|616906627|FG000|Overall Study|Randomized but did not enter treatment|66|||
170697569|NCT00218296|616906628|FG001|Overall Study|Randomized but did not enter treatment|67|||
170697570|NCT01675882|616906633|FG000|Overall Study|Adverse Event|0|||
170697571|NCT01675882|616906634|FG001|Overall Study|Adverse Event|2|||
170697572|NCT01675882|616906635|FG002|Overall Study|Adverse Event|1|||
170697573|NCT01675882|616906636|FG003|Overall Study|Adverse Event|0|||
170697574|NCT01675882|616906633|FG000|Overall Study|Participant unwilling to continue|2|||
170697575|NCT01675882|616906634|FG001|Overall Study|Participant unwilling to continue|4|||
170697576|NCT01675882|616906635|FG002|Overall Study|Participant unwilling to continue|2|||
170697577|NCT01675882|616906636|FG003|Overall Study|Participant unwilling to continue|1|||
170697578|NCT01675882|616906633|FG000|Overall Study|Lost to Follow-up|0|||
170697579|NCT01675882|616906634|FG001|Overall Study|Lost to Follow-up|1|||
170697580|NCT01675882|616906635|FG002|Overall Study|Lost to Follow-up|0|||
170697581|NCT01675882|616906636|FG003|Overall Study|Lost to Follow-up|0|||
170697582|NCT01675882|616906633|FG000|Overall Study|Non-compliance|0|||
170697583|NCT01675882|616906634|FG001|Overall Study|Non-compliance|0|||
170697584|NCT01675882|616906635|FG002|Overall Study|Non-compliance|0|||
170697585|NCT01675882|616906636|FG003|Overall Study|Non-compliance|1|||
170697586|NCT01604343|616906639|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
170697587|NCT01604343|616906640|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
170697588|NCT01604343|616906641|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
170697589|NCT01604343|616906642|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
170697590|NCT01604343|616906643|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
170697591|NCT01604343|616906639|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
170697592|NCT01604343|616906640|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
170697593|NCT01604343|616906641|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
170823527|NCT02418819|617360531|FG000|Overall Study|No longer meets eligibility criteria|0|||
170697594|NCT01604343|616906642|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
170697595|NCT01604343|616906643|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
170697596|NCT01604343|616906639|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
170697597|NCT01604343|616906640|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
170697598|NCT01604343|616906641|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
170823528|NCT02418819|617360532|FG001|Overall Study|No longer meets eligibility criteria|0|||
170823529|NCT02418819|617360533|FG002|Overall Study|No longer meets eligibility criteria|1|||
170823530|NCT02418819|617360534|FG003|Overall Study|No longer meets eligibility criteria|0|||
170697599|NCT01604343|616906642|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
170697600|NCT01604343|616906643|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
170697601|NCT01604343|616906639|FG000|Prior to W52 Administration(Through W52)|Death|5|||
170697602|NCT01604343|616906640|FG001|Prior to W52 Administration(Through W52)|Death|0|||
170697603|NCT01604343|616906641|FG002|Prior to W52 Administration(Through W52)|Death|2|||
170823531|NCT02418819|617360531|FG000|Overall Study|No longer willing to participate|0|||
170823532|NCT02418819|617360532|FG001|Overall Study|No longer willing to participate|0|||
170823533|NCT02418819|617360533|FG002|Overall Study|No longer willing to participate|2|||
170823534|NCT02418819|617360534|FG003|Overall Study|No longer willing to participate|1|||
170823535|NCT00448344|617360535|FG000|Overall Study|Lost to Follow-up|20|||
170823536|NCT00448344|617360536|FG001|Overall Study|Lost to Follow-up|22|||
170823537|NCT00448344|617360535|FG000|Overall Study|Withdrawal by Subject|6|||
170697604|NCT01604343|616906642|FG003|Prior to W52 Administration(Through W52)|Death|0|||
170823538|NCT00448344|617360536|FG001|Overall Study|Withdrawal by Subject|8|||
170823539|NCT00448344|617360535|FG000|Overall Study|Death|3|||
170823540|NCT00448344|617360536|FG001|Overall Study|Death|4|||
170823541|NCT00448344|617360535|FG000|Overall Study|Physician Decision|1|||
170823542|NCT00448344|617360536|FG001|Overall Study|Physician Decision|2|||
170823543|NCT01821729|617362811|FG000|Overall Study|Withdrawal by Subject|1|||
170823544|NCT02762500|617362816|FG000|Overall Study|Lack of Efficacy|1|||
170823545|NCT02762500|617362817|FG001|Overall Study|Lack of Efficacy|0|||
170823546|NCT02762500|617362816|FG000|Overall Study|Withdrawal by Subject|1|||
170823547|NCT02762500|617362817|FG001|Overall Study|Withdrawal by Subject|1|||
170823548|NCT02762500|617362816|FG000|Overall Study|Adverse Event|0|||
170823549|NCT02762500|617362817|FG001|Overall Study|Adverse Event|2|||
170823550|NCT02229396|617362818|FG000|Overall Study|Adverse Event|6|||
170823551|NCT02229396|617362819|FG001|Overall Study|Adverse Event|12|||
170823552|NCT02229396|617362820|FG002|Overall Study|Adverse Event|12|||
170823553|NCT02229396|617362818|FG000|Overall Study|Death|2|||
170823554|NCT02229396|617362819|FG001|Overall Study|Death|3|||
170823555|NCT02229396|617362820|FG002|Overall Study|Death|1|||
170823556|NCT02229396|617362818|FG000|Overall Study|Lost to Follow-up|14|||
170823557|NCT02229396|617362819|FG001|Overall Study|Lost to Follow-up|14|||
170823558|NCT02229396|617362820|FG002|Overall Study|Lost to Follow-up|21|||
170823559|NCT02229396|617362818|FG000|Overall Study|Protocol Violation|2|||
170823560|NCT02229396|617362819|FG001|Overall Study|Protocol Violation|1|||
170697605|NCT01604343|616906643|FG004|Prior to W52 Administration(Through W52)|Death|4|||
170697606|NCT01604343|616906639|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
170697607|NCT01604343|616906640|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
170697608|NCT01604343|616906641|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
170697609|NCT01604343|616906642|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
170697610|NCT01604343|616906643|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
170697611|NCT01604343|616906639|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
170697612|NCT01604343|616906640|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
170697613|NCT01604343|616906641|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
170697614|NCT01604343|616906642|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
170697615|NCT01604343|616906643|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
170697616|NCT01604343|616906639|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
170697617|NCT01604343|616906640|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
170697618|NCT01604343|616906641|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
170697619|NCT01604343|616906642|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
170697620|NCT01604343|616906643|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
170697621|NCT01604343|616906639|FG000|Prior to W52 Administration(Through W52)|Other|15|||
170697622|NCT01604343|616906640|FG001|Prior to W52 Administration(Through W52)|Other|0|||
170697623|NCT01604343|616906641|FG002|Prior to W52 Administration(Through W52)|Other|10|||
170697624|NCT01604343|616906642|FG003|Prior to W52 Administration(Through W52)|Other|0|||
170697625|NCT01604343|616906643|FG004|Prior to W52 Administration(Through W52)|Other|6|||
170697626|NCT01604343|616906639|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
170697627|NCT01604343|616906640|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
170697628|NCT01604343|616906641|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
170697629|NCT01604343|616906642|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
170697630|NCT01604343|616906643|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
170697631|NCT01604343|616906639|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
170697632|NCT01604343|616906640|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
170697633|NCT01604343|616906641|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
170697634|NCT01604343|616906642|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
170697635|NCT01604343|616906643|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
170697636|NCT01604343|616906639|FG000|Week 52 to Week 104|Adverse Event|0|||
170697637|NCT01604343|616906640|FG001|Week 52 to Week 104|Adverse Event|12|||
170697638|NCT01604343|616906641|FG002|Week 52 to Week 104|Adverse Event|26|||
170697639|NCT01604343|616906642|FG003|Week 52 to Week 104|Adverse Event|21|||
170697640|NCT01604343|616906643|FG004|Week 52 to Week 104|Adverse Event|27|||
170697641|NCT01604343|616906639|FG000|Week 52 to Week 104|Death|0|||
170697642|NCT01604343|616906640|FG001|Week 52 to Week 104|Death|4|||
170697643|NCT01604343|616906641|FG002|Week 52 to Week 104|Death|2|||
170697644|NCT01604343|616906642|FG003|Week 52 to Week 104|Death|5|||
170697645|NCT01604343|616906643|FG004|Week 52 to Week 104|Death|0|||
170697646|NCT01604343|616906639|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
170697647|NCT01604343|616906640|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
170697648|NCT01604343|616906641|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
170823561|NCT02229396|617362820|FG002|Overall Study|Protocol Violation|0|||
170823562|NCT02229396|617362818|FG000|Overall Study|Patient Incorrectly Randomized|0|||
170823563|NCT02229396|617362819|FG001|Overall Study|Patient Incorrectly Randomized|0|||
170823564|NCT02229396|617362820|FG002|Overall Study|Patient Incorrectly Randomized|1|||
170823565|NCT02229396|617362818|FG000|Overall Study|Other|10|||
170823566|NCT02229396|617362819|FG001|Overall Study|Other|18|||
170823567|NCT02229396|617362820|FG002|Overall Study|Other|15|||
170697649|NCT01604343|616906642|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
170697650|NCT01604343|616906643|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
170697651|NCT01604343|616906639|FG000|Week 52 to Week 104|Physician Decision|0|||
170697652|NCT01604343|616906640|FG001|Week 52 to Week 104|Physician Decision|1|||
170697653|NCT01604343|616906641|FG002|Week 52 to Week 104|Physician Decision|0|||
170697654|NCT01604343|616906642|FG003|Week 52 to Week 104|Physician Decision|0|||
170697655|NCT01604343|616906643|FG004|Week 52 to Week 104|Physician Decision|2|||
170697656|NCT01604343|616906639|FG000|Week 52 to Week 104|Pregnancy|0|||
170697657|NCT01604343|616906640|FG001|Week 52 to Week 104|Pregnancy|0|||
170697658|NCT01604343|616906641|FG002|Week 52 to Week 104|Pregnancy|1|||
170697659|NCT01604343|616906642|FG003|Week 52 to Week 104|Pregnancy|2|||
170697660|NCT01604343|616906643|FG004|Week 52 to Week 104|Pregnancy|1|||
170697661|NCT01604343|616906639|FG000|Week 52 to Week 104|Other|0|||
170697662|NCT01604343|616906640|FG001|Week 52 to Week 104|Other|11|||
170697663|NCT01604343|616906641|FG002|Week 52 to Week 104|Other|11|||
170697664|NCT01604343|616906642|FG003|Week 52 to Week 104|Other|6|||
170697665|NCT01604343|616906643|FG004|Week 52 to Week 104|Other|3|||
170697666|NCT01604343|616906639|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
170697667|NCT01604343|616906640|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
170697668|NCT01604343|616906641|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
170697669|NCT01604343|616906642|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
170697670|NCT01604343|616906643|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
170697671|NCT01604343|616906639|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
170697672|NCT01604343|616906640|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
170697673|NCT01604343|616906641|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
170697674|NCT01604343|616906642|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
170697675|NCT01604343|616906643|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
170697676|NCT01604343|616906639|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
170697677|NCT01604343|616906640|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
170697678|NCT01604343|616906641|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
170697679|NCT01604343|616906642|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
170697680|NCT01604343|616906643|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
170697681|NCT00850200|616906647|FG000|Overall Study|Physician Decision|2|||
170697682|NCT00850200|616906647|FG000|Overall Study|Did not recieve treatment|2|||
170697683|NCT00850200|616906647|FG000|Overall Study|Withdrawal by Subject|1|||
170697684|NCT05442554|616906650|FG000|Overall Study|Adverse Event|1|||
170697685|NCT00097721|616906651|FG000|Overall Study|Adverse Event|8|||
170697686|NCT00097721|616906652|FG001|Overall Study|Adverse Event|1|||
170697687|NCT00097721|616906651|FG000|Overall Study|Withdrawal by Subject|6|||
170697688|NCT00097721|616906652|FG001|Overall Study|Withdrawal by Subject|1|||
170697689|NCT00097721|616906651|FG000|Overall Study|Progressive Disease|55|||
170697690|NCT00097721|616906652|FG001|Overall Study|Progressive Disease|27|||
170697691|NCT00097721|616906651|FG000|Overall Study|Physician Decision|1|||
170697692|NCT00097721|616906652|FG001|Overall Study|Physician Decision|3|||
170697693|NCT00097721|616906651|FG000|Overall Study|Reason not given|1|||
170697694|NCT00097721|616906652|FG001|Overall Study|Reason not given|1|||
170697695|NCT00449956|616906653|FG000|Overall Study|Adverse Event|7|||
170697696|NCT00449956|616906654|FG001|Overall Study|Adverse Event|1|||
170697697|NCT00449956|616906655|FG002|Overall Study|Adverse Event|6|||
170697698|NCT00449956|616906653|FG000|Overall Study|Lack of Efficacy|0|||
170697699|NCT00449956|616906654|FG001|Overall Study|Lack of Efficacy|0|||
170697700|NCT00449956|616906655|FG002|Overall Study|Lack of Efficacy|1|||
170697701|NCT00449956|616906653|FG000|Overall Study|Protocol Violation|1|||
170697702|NCT00449956|616906654|FG001|Overall Study|Protocol Violation|1|||
170697703|NCT00449956|616906655|FG002|Overall Study|Protocol Violation|1|||
170697704|NCT00449956|616906653|FG000|Overall Study|Withdrawal by Subject|0|||
170697705|NCT00449956|616906654|FG001|Overall Study|Withdrawal by Subject|1|||
170697706|NCT00449956|616906655|FG002|Overall Study|Withdrawal by Subject|0|||
170697707|NCT00449956|616906653|FG000|Overall Study|Physician Decision|2|||
170697708|NCT00449956|616906654|FG001|Overall Study|Physician Decision|1|||
170697709|NCT00449956|616906655|FG002|Overall Study|Physician Decision|1|||
170697710|NCT02972632|616906667|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
170697711|NCT02972632|616906667|FG000|Overall Study|Lost to Follow-up|4|||
170697712|NCT02972632|616906667|FG000|Overall Study|Voluntary Withdrawal|10|||
170697713|NCT02126969|616906668|FG000|Overall Study|Withdrawal by Subject|1|||
170697714|NCT02126969|616906669|FG001|Overall Study|Withdrawal by Subject|2|||
170697715|NCT01446965|616906670|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
170697716|NCT01446965|616906671|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
170697717|NCT01446965|616906670|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
170697718|NCT01446965|616906671|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
170697719|NCT03450707|616906672|FG000|Overall Study|Outside enrollment window|4|||
170697720|NCT03450707|616906673|FG001|Overall Study|Outside enrollment window|1|||
170697721|NCT03450707|616906672|FG000|Overall Study|Death|1|||
170823568|NCT02229396|617362818|FG000|Overall Study|Withdrawal by Subject|42|||
170823569|NCT02229396|617362819|FG001|Overall Study|Withdrawal by Subject|28|||
170823570|NCT02229396|617362820|FG002|Overall Study|Withdrawal by Subject|41|||
170823571|NCT02229396|617362818|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
170823572|NCT02229396|617362819|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
170823573|NCT02229396|617362820|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
170823574|NCT02229396|617362818|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
170823575|NCT02229396|617362819|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
170823576|NCT02229396|617362820|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
170823577|NCT00730847|617362821|FG000|Overall Study|Adverse Event|1|||
170823578|NCT00730847|617362821|FG000|Overall Study|Protocol Violation|2|||
170823579|NCT00730847|617362821|FG000|Overall Study|Withdrawal by Subject|16|||
170823580|NCT00730847|617362821|FG000|Overall Study|Lost to Follow-up|67|||
170823581|NCT00730847|617362821|FG000|Overall Study|Unknown completion status|21|||
170823582|NCT00730847|617362821|FG000|Overall Study|Other|24|||
170823583|NCT00280683|617362825|FG000|Overall Study|Withdrawal by Subject|1|||
170823584|NCT00280683|617362826|FG001|Overall Study|Withdrawal by Subject|2|||
170823585|NCT00280683|617362825|FG000|Overall Study|Adverse Event|1|||
170823586|NCT00280683|617362826|FG001|Overall Study|Adverse Event|1|||
170823587|NCT00632931|617362832|FG000|Part 1, Period 1|Protocol Violation|1|||
170823588|NCT00632931|617362833|FG001|Part 1, Period 1|Protocol Violation|0|||
170823589|NCT00632931|617362834|FG002|Part 1, Period 1|Protocol Violation|0|||
170823590|NCT00632931|617362832|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
170823591|NCT00632931|617362833|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
170823592|NCT00632931|617362834|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
170823593|NCT00632931|617362832|FG000|Part 2|Adverse Event|0|||
170823594|NCT00632931|617362833|FG001|Part 2|Adverse Event|0|||
170823595|NCT00632931|617362834|FG002|Part 2|Adverse Event|3|||
170823596|NCT00632931|617362832|FG000|Part 2|Death|0|||
170823597|NCT00632931|617362833|FG001|Part 2|Death|0|||
170823598|NCT00632931|617362834|FG002|Part 2|Death|1|||
170823599|NCT00632931|617362832|FG000|Part 2|Lack of Efficacy|0|||
170823600|NCT00632931|617362833|FG001|Part 2|Lack of Efficacy|0|||
170823601|NCT00632931|617362834|FG002|Part 2|Lack of Efficacy|17|||
170823602|NCT00632931|617362832|FG000|Part 2|Withdrawal by Subject|0|||
170823603|NCT00632931|617362833|FG001|Part 2|Withdrawal by Subject|0|||
170823604|NCT00632931|617362834|FG002|Part 2|Withdrawal by Subject|3|||
170823605|NCT00307164|617362835|FG000|Overall Study|Death|1|||
170823606|NCT00307164|617362836|FG001|Overall Study|Death|0|||
170823607|NCT00307164|617362835|FG000|Overall Study|Severe debilitation, unable to continue|1|||
170823608|NCT00307164|617362836|FG001|Overall Study|Severe debilitation, unable to continue|0|||
170823609|NCT00307164|617362835|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
170823610|NCT00307164|617362836|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
170823611|NCT00307164|617362835|FG000|Overall Study|Withdrawal by Subject|1|||
170823612|NCT00307164|617362836|FG001|Overall Study|Withdrawal by Subject|8|||
170823613|NCT00307164|617362835|FG000|Overall Study|Not compliant with requirements|4|||
170823614|NCT00307164|617362836|FG001|Overall Study|Not compliant with requirements|4|||
170823615|NCT00307164|617362835|FG000|Overall Study|Lost to Follow-up|6|||
170823616|NCT00307164|617362836|FG001|Overall Study|Lost to Follow-up|1|||
170823617|NCT03712449|617362837|FG000|Overall Study|Withdraw Consent|0|||
170823618|NCT03712449|617362838|FG001|Overall Study|Withdraw Consent|1|||
170823619|NCT00922441|617362841|FG000|Overall Study|Protocol Violation|0|||
170823620|NCT00922441|617362842|FG001|Overall Study|Protocol Violation|0|||
170823621|NCT00922441|617362843|FG002|Overall Study|Protocol Violation|2|||
170823622|NCT00922441|617362841|FG000|Overall Study|Withdrawal by Subject|0|||
170823623|NCT00922441|617362842|FG001|Overall Study|Withdrawal by Subject|0|||
170823624|NCT00922441|617362843|FG002|Overall Study|Withdrawal by Subject|1|||
170823625|NCT00468858|617362848|FG000|Overall Study|Adverse Event|0|||
170823626|NCT00468858|617362849|FG001|Overall Study|Adverse Event|1|||
170823627|NCT00468858|617362850|FG002|Overall Study|Adverse Event|0|||
170823628|NCT00468858|617362848|FG000|Overall Study|Withdrawal by Subject|7|||
170823629|NCT00468858|617362849|FG001|Overall Study|Withdrawal by Subject|4|||
170823630|NCT00468858|617362850|FG002|Overall Study|Withdrawal by Subject|5|||
170697722|NCT03450707|616906673|FG001|Overall Study|Death|0|||
170697723|NCT03450707|616906672|FG000|Overall Study|Indication for thiamine|1|||
170697724|NCT03450707|616906673|FG001|Overall Study|Indication for thiamine|1|||
170697725|NCT03450707|616906672|FG000|Overall Study|Evidence of traumatic brain injury|1|||
170697726|NCT03450707|616906673|FG001|Overall Study|Evidence of traumatic brain injury|0|||
170697727|NCT03450707|616906672|FG000|Overall Study|Following commands|0|||
170697728|NCT03450707|616906673|FG001|Overall Study|Following commands|3|||
170697729|NCT03450707|616906672|FG000|Overall Study|Lactate < 3.5|0|||
170697730|NCT03450707|616906673|FG001|Overall Study|Lactate < 3.5|2|||
170697731|NCT03450707|616906672|FG000|Overall Study|Rearrest with ECMO|0|||
170697732|NCT03450707|616906673|FG001|Overall Study|Rearrest with ECMO|1|||
170697733|NCT03450707|616906672|FG000|Overall Study|Indication for thiamine + head CT results|0|||
170697734|NCT03450707|616906673|FG001|Overall Study|Indication for thiamine + head CT results|1|||
170697735|NCT03450707|616906672|FG000|Overall Study|Family/patient goals of care|0|||
170697736|NCT03450707|616906673|FG001|Overall Study|Family/patient goals of care|1|||
170697737|NCT03387813|616906674|FG000|Overall Study|Death|40|||
170697738|NCT03387813|616906675|FG001|Overall Study|Death|37|||
170697739|NCT03387813|616906676|FG002|Overall Study|Death|190|||
170697740|NCT03387813|616906674|FG000|Overall Study|Withdrawal by Subject|9|||
170697741|NCT03387813|616906675|FG001|Overall Study|Withdrawal by Subject|19|||
170697742|NCT03387813|616906676|FG002|Overall Study|Withdrawal by Subject|32|||
170697743|NCT03387813|616906674|FG000|Overall Study|Lost to Follow-up|3|||
170697744|NCT03387813|616906675|FG001|Overall Study|Lost to Follow-up|9|||
170697745|NCT03387813|616906676|FG002|Overall Study|Lost to Follow-up|15|||
170697746|NCT03387813|616906674|FG000|Overall Study|Non-Compliance|6|||
170697747|NCT03387813|616906675|FG001|Overall Study|Non-Compliance|6|||
170697748|NCT03387813|616906676|FG002|Overall Study|Non-Compliance|31|||
170697749|NCT03387813|616906674|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
170697750|NCT03387813|616906675|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
170697751|NCT03387813|616906676|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
170697752|NCT00606892|616906680|FG000|First Intervention|Protocol Violation|1|||
170697753|NCT00606892|616906681|FG001|First Intervention|Protocol Violation|4|||
170697754|NCT00829296|616906687|FG000|Overall Study|Adverse Event|5|||
170697755|NCT00829296|616906688|FG001|Overall Study|Adverse Event|4|||
170697756|NCT04960228|616906694|FG000|Overall Study|Withdrawal by Subject|216|||
170697757|NCT04960228|616906695|FG001|Overall Study|Withdrawal by Subject|35|||
170697758|NCT04960228|616906694|FG000|Overall Study|Failed attention check|69|||
170697759|NCT04960228|616906695|FG001|Overall Study|Failed attention check|148|||
170697760|NCT04960228|616906694|FG000|Overall Study|Flagged for response quality by Dynata|3|||
170697761|NCT04960228|616906695|FG001|Overall Study|Flagged for response quality by Dynata|3|||
170697762|NCT01585766|616906696|FG000|Overall Study|Withdrawal by Subject|0|||
170697763|NCT01585766|616906697|FG001|Overall Study|Withdrawal by Subject|1|||
170697764|NCT01585766|616906698|FG002|Overall Study|Withdrawal by Subject|1|||
170697765|NCT01585766|616906699|FG003|Overall Study|Withdrawal by Subject|0|||
170697766|NCT01585766|616906700|FG004|Overall Study|Withdrawal by Subject|0|||
170697767|NCT01585766|616906701|FG005|Overall Study|Withdrawal by Subject|0|||
170697768|NCT01585766|616906696|FG000|Overall Study|Death|0|||
170697769|NCT01585766|616906697|FG001|Overall Study|Death|1|||
170697770|NCT01585766|616906698|FG002|Overall Study|Death|0|||
170697771|NCT01585766|616906699|FG003|Overall Study|Death|0|||
170697772|NCT01585766|616906700|FG004|Overall Study|Death|0|||
170697773|NCT01585766|616906701|FG005|Overall Study|Death|0|||
170697774|NCT01585766|616906696|FG000|Overall Study|Physician Decision|0|||
170697775|NCT01585766|616906697|FG001|Overall Study|Physician Decision|0|||
170697776|NCT01585766|616906698|FG002|Overall Study|Physician Decision|1|||
170697777|NCT01585766|616906699|FG003|Overall Study|Physician Decision|0|||
170697778|NCT01585766|616906700|FG004|Overall Study|Physician Decision|0|||
170697779|NCT01585766|616906701|FG005|Overall Study|Physician Decision|0|||
170697780|NCT01364428|616906702|FG000|Overall Study|Adverse Event|1|||
170697781|NCT01364428|616906703|FG001|Overall Study|Adverse Event|2|||
170697782|NCT01364428|616906702|FG000|Overall Study|Protocol Violation|2|||
170697783|NCT01364428|616906703|FG001|Overall Study|Protocol Violation|0|||
170697784|NCT01364428|616906702|FG000|Overall Study|Withdrawal Criteria|14|||
170697785|NCT01364428|616906703|FG001|Overall Study|Withdrawal Criteria|10|||
170697786|NCT01364428|616906702|FG000|Overall Study|Other|3|||
170697787|NCT01364428|616906703|FG001|Overall Study|Other|3|||
170697788|NCT01987427|616906704|FG000|Overall Study|Adverse Event|4|||
170697789|NCT01987427|616906705|FG001|Overall Study|Adverse Event|2|||
170697790|NCT01987427|616906706|FG002|Overall Study|Adverse Event|8|||
170697791|NCT01987427|616906704|FG000|Overall Study|Lost to Follow-up|6|||
170697792|NCT01987427|616906705|FG001|Overall Study|Lost to Follow-up|6|||
170697793|NCT01987427|616906706|FG002|Overall Study|Lost to Follow-up|9|||
170697794|NCT01987427|616906704|FG000|Overall Study|Withdrawal by Subject|2|||
170697795|NCT01987427|616906705|FG001|Overall Study|Withdrawal by Subject|1|||
170697796|NCT01987427|616906706|FG002|Overall Study|Withdrawal by Subject|3|||
170697797|NCT01987427|616906704|FG000|Overall Study|Lack of Efficacy|1|||
170697798|NCT01987427|616906705|FG001|Overall Study|Lack of Efficacy|0|||
170697799|NCT01987427|616906706|FG002|Overall Study|Lack of Efficacy|0|||
170697800|NCT01987427|616906704|FG000|Overall Study|Other|1|||
170697801|NCT01987427|616906705|FG001|Overall Study|Other|1|||
170697802|NCT01987427|616906706|FG002|Overall Study|Other|0|||
170697803|NCT00785486|616906710|FG000|Midazolam Alone|Withdrawal by Subject|1|||
170697804|NCT01405963|616906711|FG000|Overall Study|Moved Away|2|||
170697805|NCT01405963|616906712|FG001|Overall Study|Moved Away|0|||
170697806|NCT01405963|616906711|FG000|Overall Study|Adverse Event|0|||
170697807|NCT01405963|616906712|FG001|Overall Study|Adverse Event|1|||
170697808|NCT01405963|616906711|FG000|Overall Study|Lost to Follow-up|0|||
170697809|NCT01405963|616906712|FG001|Overall Study|Lost to Follow-up|1|||
170697810|NCT00746941|616906713|FG000|Overall Study|Death|2|||
170697811|NCT00746941|616906714|FG001|Overall Study|Death|0|||
170697812|NCT00746941|616906715|FG002|Overall Study|Death|0|||
170697813|NCT00746941|616906716|FG003|Overall Study|Death|6|||
170697814|NCT00746941|616906713|FG000|Overall Study|Physician Decision|0|||
170697815|NCT00746941|616906714|FG001|Overall Study|Physician Decision|0|||
170697816|NCT00746941|616906715|FG002|Overall Study|Physician Decision|2|||
170697817|NCT00746941|616906716|FG003|Overall Study|Physician Decision|0|||
170697818|NCT00746941|616906713|FG000|Overall Study|Withdrawal by Subject|3|||
170697819|NCT00746941|616906714|FG001|Overall Study|Withdrawal by Subject|0|||
170697820|NCT00746941|616906715|FG002|Overall Study|Withdrawal by Subject|0|||
170697821|NCT00746941|616906716|FG003|Overall Study|Withdrawal by Subject|2|||
170697822|NCT00746941|616906713|FG000|Overall Study|Other, reason not provided|2|||
170697823|NCT00746941|616906714|FG001|Overall Study|Other, reason not provided|4|||
170697824|NCT00746941|616906715|FG002|Overall Study|Other, reason not provided|0|||
170697825|NCT00746941|616906716|FG003|Overall Study|Other, reason not provided|4|||
170697826|NCT00746941|616906713|FG000|Overall Study|Adverse Event|0|||
170697827|NCT00746941|616906714|FG001|Overall Study|Adverse Event|0|||
170697828|NCT00746941|616906715|FG002|Overall Study|Adverse Event|0|||
170697829|NCT00746941|616906716|FG003|Overall Study|Adverse Event|1|||
170697830|NCT01498640|616906721|FG000|Overall Study|Lost to Follow-up|1|||
170697831|NCT01498640|616906721|FG000|Overall Study|Death|1|||
170697832|NCT01498640|616906721|FG000|Overall Study|Other|3|||
170697833|NCT01354496|616906722|FG000|Period 1|Adverse Event|0|||
170697834|NCT01354496|616906723|FG001|Period 1|Adverse Event|0|||
170697835|NCT01354496|616906724|FG002|Period 1|Adverse Event|1|||
170697836|NCT01354496|616906725|FG003|Period 1|Adverse Event|0|||
170697837|NCT01354496|616906726|FG004|Period 1|Adverse Event|0|||
170697838|NCT01354496|616906727|FG005|Period 1|Adverse Event|0|||
170697839|NCT01354496|616906722|FG000|Period 1|Physician Decision|0|||
170697840|NCT01354496|616906723|FG001|Period 1|Physician Decision|0|||
170697841|NCT01354496|616906724|FG002|Period 1|Physician Decision|1|||
170697842|NCT01354496|616906725|FG003|Period 1|Physician Decision|0|||
170697843|NCT01354496|616906726|FG004|Period 1|Physician Decision|0|||
170697844|NCT01354496|616906727|FG005|Period 1|Physician Decision|0|||
170697845|NCT01354496|616906722|FG000|Period 2|Adverse Event|0|||
170697846|NCT01354496|616906723|FG001|Period 2|Adverse Event|0|||
170697847|NCT01354496|616906724|FG002|Period 2|Adverse Event|0|||
170697848|NCT01354496|616906725|FG003|Period 2|Adverse Event|1|||
170697849|NCT01354496|616906726|FG004|Period 2|Adverse Event|0|||
170697850|NCT01354496|616906727|FG005|Period 2|Adverse Event|0|||
170697851|NCT01354496|616906722|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
170697852|NCT01354496|616906723|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
170697853|NCT01354496|616906724|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
170697854|NCT01354496|616906725|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
170697855|NCT01354496|616906726|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
170697856|NCT01354496|616906727|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
170697857|NCT01324349|616906734|FG000|Overall Study|Death|1|||
170697858|NCT01324349|616906735|FG001|Overall Study|Death|1|||
170697859|NCT01324349|616906734|FG000|Overall Study|Withdrawal by Subject|0|||
170697860|NCT01324349|616906735|FG001|Overall Study|Withdrawal by Subject|1|||
170697861|NCT01070316|616906736|FG000|Extension Phase|Lack of Efficacy|3|||
170697862|NCT01070316|616906736|FG000|Extension Phase|Withdrawal by Subject|1|||
170697863|NCT00244712|616906737|FG000|Overall Study|Adverse Event|20|||
170697864|NCT00244712|616906738|FG001|Overall Study|Adverse Event|21|||
170697865|NCT00244712|616906737|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
170697866|NCT00244712|616906738|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
170697867|NCT00244712|616906737|FG000|Overall Study|Lack of Compliance|10|||
170697868|NCT00244712|616906738|FG001|Overall Study|Lack of Compliance|11|||
170697869|NCT00244712|616906737|FG000|Overall Study|Lost to Follow-up|45|||
170697870|NCT00244712|616906738|FG001|Overall Study|Lost to Follow-up|52|||
170697871|NCT00244712|616906737|FG000|Overall Study|Withdrawal by Subject|13|||
170697872|NCT00244712|616906738|FG001|Overall Study|Withdrawal by Subject|23|||
170697873|NCT00244712|616906737|FG000|Overall Study|Protocol Violation, disease progression|13|||
170697874|NCT00244712|616906738|FG001|Overall Study|Protocol Violation, disease progression|11|||
170697875|NCT00574405|616908592|FG000|Overall Study|Withdrawal by Subject|3|||
170697876|NCT00574405|616908593|FG001|Overall Study|Withdrawal by Subject|2|||
170697877|NCT01332149|616908595|FG000|Overall Study|Adverse Event|11|||
170697878|NCT01332149|616908596|FG001|Overall Study|Adverse Event|9|||
170697879|NCT01332149|616908595|FG000|Overall Study|Other unspecified|5|||
170697880|NCT01332149|616908596|FG001|Overall Study|Other unspecified|7|||
170697881|NCT01332149|616908595|FG000|Overall Study|Protocol Violation|1|||
170697882|NCT01332149|616908596|FG001|Overall Study|Protocol Violation|3|||
170697883|NCT01332149|616908595|FG000|Overall Study|Withdrawal by Subject|4|||
170697884|NCT01332149|616908596|FG001|Overall Study|Withdrawal by Subject|5|||
170697885|NCT01332149|616908595|FG000|Overall Study|Lost to Follow-up|1|||
170697886|NCT01332149|616908596|FG001|Overall Study|Lost to Follow-up|1|||
170697887|NCT01332149|616908595|FG000|Overall Study|Insufficient clinical response|4|||
170697888|NCT01332149|616908596|FG001|Overall Study|Insufficient clinical response|7|||
170697889|NCT01332149|616908595|FG000|Overall Study|Did not meet entrance criteria|3|||
170697890|NCT01332149|616908596|FG001|Overall Study|Did not meet entrance criteria|4|||
170697891|NCT01332149|616908595|FG000|Overall Study|Randomized but not treated|1|||
170697892|NCT01332149|616908596|FG001|Overall Study|Randomized but not treated|2|||
170697893|NCT04982029|616908597|FG000|Overall Study|Lost to Follow-up|2|||
170697894|NCT04982029|616908598|FG001|Overall Study|Lost to Follow-up|3|||
170697895|NCT01140477|616908601|FG000|Overall Study|Lost to Follow-up|4|||
170697896|NCT01140477|616908602|FG001|Overall Study|Lost to Follow-up|0|||
170697897|NCT01140477|616908601|FG000|Overall Study|Withdrawal by Subject|1|||
170697898|NCT01140477|616908602|FG001|Overall Study|Withdrawal by Subject|4|||
170697899|NCT01140477|616908601|FG000|Overall Study|Surgical complication preventing implant|2|||
170697900|NCT01140477|616908602|FG001|Overall Study|Surgical complication preventing implant|0|||
170697901|NCT01140477|616908601|FG000|Overall Study|Death|1|||
170697902|NCT01140477|616908602|FG001|Overall Study|Death|1|||
170697903|NCT01140477|616908601|FG000|Overall Study|Subject explanted|0|||
170697904|NCT01140477|616908602|FG001|Overall Study|Subject explanted|1|||
170697905|NCT05083442|616908603|FG000|Overall Study|Lost to Follow-up|1|||
170697906|NCT05083442|616908604|FG001|Overall Study|Lost to Follow-up|0|||
170697907|NCT05083442|616908603|FG000|Overall Study|Lack of Efficacy|0|||
170697908|NCT05083442|616908604|FG001|Overall Study|Lack of Efficacy|1|||
170697909|NCT05083442|616908603|FG000|Overall Study|Withdrawal by Subject|1|||
170697910|NCT05083442|616908604|FG001|Overall Study|Withdrawal by Subject|3|||
170697911|NCT05083442|616908603|FG000|Overall Study|scheduling difficulties|1|||
170697912|NCT05083442|616908604|FG001|Overall Study|scheduling difficulties|2|||
170697913|NCT03711162|616908609|FG000|Overall Study|Adverse Event|5|||
170697914|NCT03711162|616908610|FG001|Overall Study|Adverse Event|2|||
170697915|NCT03711162|616908611|FG002|Overall Study|Adverse Event|4|||
170697916|NCT03711162|616908609|FG000|Overall Study|Death|11|||
170697917|NCT03711162|616908610|FG001|Overall Study|Death|7|||
170697918|NCT03711162|616908611|FG002|Overall Study|Death|8|||
170697919|NCT03711162|616908609|FG000|Overall Study|Lost to Follow-up|1|||
170697920|NCT03711162|616908610|FG001|Overall Study|Lost to Follow-up|0|||
170697921|NCT03711162|616908611|FG002|Overall Study|Lost to Follow-up|1|||
170697922|NCT03711162|616908609|FG000|Overall Study|Study Terminated by Sponsor|139|||
170697923|NCT03711162|616908610|FG001|Overall Study|Study Terminated by Sponsor|152|||
170697924|NCT03711162|616908611|FG002|Overall Study|Study Terminated by Sponsor|146|||
170697925|NCT03711162|616908609|FG000|Overall Study|Withdrawal by Subject|17|||
170697926|NCT03711162|616908610|FG001|Overall Study|Withdrawal by Subject|10|||
170697927|NCT03711162|616908611|FG002|Overall Study|Withdrawal by Subject|10|||
170697928|NCT03711162|616908609|FG000|Overall Study|Miscellaneous|1|||
170697929|NCT03711162|616908610|FG001|Overall Study|Miscellaneous|2|||
170697930|NCT03711162|616908611|FG002|Overall Study|Miscellaneous|2|||
170697931|NCT03711162|616908609|FG000|Overall Study|Not Treated|1|||
170697932|NCT03711162|616908610|FG001|Overall Study|Not Treated|0|||
170697933|NCT03711162|616908611|FG002|Overall Study|Not Treated|1|||
170697934|NCT03711162|616908609|FG000|Overall Study|Physician Decision|0|||
170697935|NCT03711162|616908610|FG001|Overall Study|Physician Decision|2|||
170697936|NCT03711162|616908611|FG002|Overall Study|Physician Decision|0|||
170697937|NCT03711162|616908609|FG000|Overall Study|Lack of Efficacy|0|||
170697938|NCT03711162|616908610|FG001|Overall Study|Lack of Efficacy|0|||
170697939|NCT03711162|616908611|FG002|Overall Study|Lack of Efficacy|2|||
170697940|NCT03711162|616908609|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
170697941|NCT03711162|616908610|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
170697942|NCT03711162|616908611|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
170697943|NCT03034954|616908614|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
170823631|NCT00468858|617362848|FG000|Overall Study|Relocation|1|||
170823632|NCT00468858|617362849|FG001|Overall Study|Relocation|3|||
170697944|NCT03034954|616908615|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
170697945|NCT04865354|616908616|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
170697946|NCT04865354|616908617|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
170697947|NCT04865354|616908616|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
170697948|NCT04865354|616908617|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
170697949|NCT04865354|616908616|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
170697950|NCT04865354|616908617|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
170697951|NCT01344369|616908618|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
170697952|NCT01344369|616908619|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
170697953|NCT01344369|616908618|FG000|Washout of 28 Days|Physician Decision|0|||
170697954|NCT01344369|616908619|FG001|Washout of 28 Days|Physician Decision|1|||
170697955|NCT01344369|616908618|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
170697956|NCT01344369|616908619|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
170697957|NCT00110812|616908620|FG000|Main Study|Death|0|||
170697958|NCT00110812|616908621|FG001|Main Study|Death|0|||
170697959|NCT00110812|616908622|FG002|Main Study|Death|2|||
170697960|NCT00110812|616908620|FG000|Main Study|Withdrawal by Subject|0|||
170697961|NCT00110812|616908621|FG001|Main Study|Withdrawal by Subject|0|||
170697962|NCT00110812|616908622|FG002|Main Study|Withdrawal by Subject|1|||
170697963|NCT00110812|616908620|FG000|Main Study|Lost to Follow-up|8|||
170697964|NCT00110812|616908621|FG001|Main Study|Lost to Follow-up|11|||
170697965|NCT00110812|616908622|FG002|Main Study|Lost to Follow-up|10|||
170697966|NCT00110812|616908620|FG000|Extended Follow-up|Death|1|||
170697967|NCT00110812|616908621|FG001|Extended Follow-up|Death|0|||
170697968|NCT00110812|616908622|FG002|Extended Follow-up|Death|3|||
170697969|NCT00110812|616908620|FG000|Extended Follow-up|Withdrawal by Subject|0|||
170697970|NCT00110812|616908621|FG001|Extended Follow-up|Withdrawal by Subject|1|||
170697971|NCT00110812|616908622|FG002|Extended Follow-up|Withdrawal by Subject|0|||
170823633|NCT00468858|617362850|FG002|Overall Study|Relocation|3|||
170823634|NCT00468858|617362848|FG000|Overall Study|Lost to Follow-up|1|||
170823635|NCT00468858|617362849|FG001|Overall Study|Lost to Follow-up|2|||
170823636|NCT00468858|617362850|FG002|Overall Study|Lost to Follow-up|5|||
170823637|NCT00468858|617362848|FG000|Overall Study|Other|0|||
170823638|NCT00468858|617362849|FG001|Overall Study|Other|0|||
170823639|NCT00468858|617362850|FG002|Overall Study|Other|1|||
170823640|NCT00797511|617362851|FG000|Overall Study|Withdrawal by Subject|1|||
170823641|NCT03461211|617362852|FG000|Overall Study|Adverse Event|1|||
170823642|NCT03461211|617362853|FG001|Overall Study|Adverse Event|1|||
170823643|NCT03461211|617362852|FG000|Overall Study|Lack of Efficacy|0|||
170823644|NCT03461211|617362853|FG001|Overall Study|Lack of Efficacy|1|||
170823645|NCT00843115|617362856|FG000|Overall Study|Death|4|||
170823646|NCT00843115|617362856|FG000|Overall Study|Adverse Event|30|||
170823647|NCT00843115|617362856|FG000|Overall Study|Lost to Follow-up|4|||
170823648|NCT00843115|617362856|FG000|Overall Study|Withdrawal by Subject|17|||
170823649|NCT00843115|617362856|FG000|Overall Study|Family wanted meds stopped|1|||
170823650|NCT00843115|617362856|FG000|Overall Study|Family does not want continuation|1|||
170823651|NCT00843115|617362856|FG000|Overall Study|Patient forgot to take meds|1|||
170823652|NCT00843115|617362856|FG000|Overall Study|Does not meet entrance criteria|1|||
170823653|NCT00843115|617362856|FG000|Overall Study|Physician Decision|1|||
170823654|NCT00843115|617362856|FG000|Overall Study|Family discontinued meds|1|||
170823655|NCT00843115|617362856|FG000|Overall Study|patient took for 2 days then stopped|1|||
170823656|NCT00843115|617362856|FG000|Overall Study|patient never took the medication|1|||
170697972|NCT00110812|616908620|FG000|Extended Follow-up|Lost to Follow-up|1|||
170697973|NCT00110812|616908621|FG001|Extended Follow-up|Lost to Follow-up|3|||
170697974|NCT00110812|616908622|FG002|Extended Follow-up|Lost to Follow-up|1|||
170697975|NCT01454726|616908623|FG000|Overall Study|Withdrawal by Subject|0|||
170697976|NCT01454726|616908624|FG001|Overall Study|Withdrawal by Subject|1|||
170697977|NCT01886833|616908625|FG000|Overall Study|IgA not available from both periods|204|||
170697978|NCT02342704|616908628|FG000|Overall Study|Physician Decision|0|||
170823657|NCT00843115|617362856|FG000|Overall Study|hospitalized due to deterioration|1|||
170823658|NCT00843115|617362856|FG000|Overall Study|week 12 not done|1|||
170823659|NCT00843115|617362856|FG000|Overall Study|Syndrome De Glissement|1|||
170697979|NCT02342704|616908629|FG001|Overall Study|Physician Decision|3|||
170697980|NCT02342704|616908628|FG000|Overall Study|Sponsor Termination|49|||
170697981|NCT02342704|616908629|FG001|Overall Study|Sponsor Termination|43|||
170697982|NCT02342704|616908628|FG000|Overall Study|Other|0|||
170697983|NCT02342704|616908629|FG001|Overall Study|Other|1|||
170697984|NCT02342704|616908628|FG000|Overall Study|Withdrawal by Subject|1|||
170697985|NCT02342704|616908629|FG001|Overall Study|Withdrawal by Subject|0|||
170697986|NCT02342704|616908628|FG000|Overall Study|Lost to Follow-up|2|||
170697987|NCT02342704|616908629|FG001|Overall Study|Lost to Follow-up|1|||
170697988|NCT02342704|616908628|FG000|Overall Study|Adverse Event|1|||
170697989|NCT02342704|616908629|FG001|Overall Study|Adverse Event|3|||
170697990|NCT00934544|616908630|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
170697991|NCT00934544|616908631|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
170697992|NCT00934544|616908632|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
170697993|NCT00934544|616908630|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
170697994|NCT00934544|616908631|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
170697995|NCT00934544|616908632|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
170697996|NCT00934544|616908630|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
170697997|NCT00934544|616908631|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
170697998|NCT00934544|616908632|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
170697999|NCT00934544|616908630|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
170698000|NCT00934544|616908631|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
170698001|NCT00934544|616908632|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
170698002|NCT00934544|616908630|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
170698003|NCT00934544|616908631|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
170698004|NCT00934544|616908632|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
170698005|NCT00934544|616908630|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
170698006|NCT00934544|616908631|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
170698007|NCT00934544|616908632|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
170698008|NCT00934544|616908630|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
170698009|NCT00934544|616908631|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
170698010|NCT00934544|616908632|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
170698011|NCT00934544|616908630|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
170698012|NCT00934544|616908631|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
170698013|NCT00934544|616908632|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
170698014|NCT00934544|616908630|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
170698015|NCT00934544|616908631|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
170698016|NCT00934544|616908632|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
170698017|NCT00934544|616908630|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
170698018|NCT00934544|616908631|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
170698019|NCT00934544|616908632|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
170698020|NCT00934544|616908630|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
170698021|NCT00934544|616908631|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
170698022|NCT00934544|616908632|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
170698023|NCT00934544|616908630|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
170698024|NCT00934544|616908631|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
170698025|NCT00934544|616908632|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
170698026|NCT00934544|616908630|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
170698027|NCT00934544|616908631|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
170698028|NCT00934544|616908632|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
170698029|NCT00934544|616908630|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
170698030|NCT00934544|616908631|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
170698031|NCT00934544|616908632|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
170698032|NCT00934544|616908630|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
170698033|NCT00934544|616908631|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
170823660|NCT02621047|617362857|FG000|Overall Study|Adverse Event|0|||
170823661|NCT02621047|617362858|FG001|Overall Study|Adverse Event|0|||
170823662|NCT02621047|617362859|FG002|Overall Study|Adverse Event|1|||
170823663|NCT02853305|617362864|FG000|Overall Study|Death|287|||
170823664|NCT02853305|617362865|FG001|Overall Study|Death|249|||
170823665|NCT02853305|617362866|FG002|Overall Study|Death|300|||
170823666|NCT02853305|617362864|FG000|Overall Study|Withdrawal by Subject|2|||
170823667|NCT02853305|617362865|FG001|Overall Study|Withdrawal by Subject|8|||
170823668|NCT02853305|617362866|FG002|Overall Study|Withdrawal by Subject|3|||
170823669|NCT02853305|617362864|FG000|Overall Study|Transferred to Extension Study|46|||
170823670|NCT02853305|617362865|FG001|Overall Study|Transferred to Extension Study|30|||
170698034|NCT00934544|616908632|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
170698035|NCT00934544|616908630|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
170698036|NCT00934544|616908631|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
170698037|NCT00934544|616908632|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
170698038|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
170698039|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
170698040|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
170698041|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
170698042|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
170698043|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
170698044|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
170698045|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
170698046|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
170698047|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
170698048|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
170698049|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
170698050|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
170698051|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
170698052|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
170698053|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
170698054|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
170698055|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
170698056|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
170698057|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
170698058|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
170698059|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
170698060|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
170698061|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
170698062|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
170698063|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
170698064|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
170698065|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
170698066|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
170698067|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
170698068|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
170698069|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
170698070|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
170698071|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
170698072|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
170698073|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
170698074|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
170698075|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
170698076|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
170698077|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
170698078|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
170698079|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
170698080|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
170698081|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
170698082|NCT01218516|616908633|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
170698083|NCT01218516|616908634|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
170698084|NCT01218516|616908635|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
170698085|NCT01218516|616908636|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
170698086|NCT01632891|616908637|FG000|Overall Study|Lost to Follow-up|0|||
170698087|NCT01632891|616908638|FG001|Overall Study|Lost to Follow-up|1|||
170698088|NCT01632891|616908637|FG000|Overall Study|Withdrawal by Subject|1|||
170698089|NCT01632891|616908638|FG001|Overall Study|Withdrawal by Subject|0|||
170698090|NCT00240071|616908640|FG000|Overall Study|Withdrawal by Subject|3|||
170698091|NCT00192075|616908641|FG000|Overall Study|Disease Progression|23|||
170698092|NCT00192075|616908642|FG001|Overall Study|Disease Progression|6|||
170698093|NCT00192075|616908641|FG000|Overall Study|Adverse Event|1|||
170698094|NCT00192075|616908642|FG001|Overall Study|Adverse Event|3|||
170698095|NCT00192075|616908641|FG000|Overall Study|Death|0|||
170698096|NCT00192075|616908642|FG001|Overall Study|Death|1|||
170698097|NCT00192075|616908641|FG000|Overall Study|Lack of Efficacy|0|||
170823671|NCT02853305|617362866|FG002|Overall Study|Transferred to Extension Study|25|||
170823672|NCT02853305|617362864|FG000|Overall Study|Did Not Continue on Extension Study|16|||
170823673|NCT02853305|617362865|FG001|Overall Study|Did Not Continue on Extension Study|20|||
170823674|NCT02853305|617362866|FG002|Overall Study|Did Not Continue on Extension Study|24|||
170823675|NCT00677092|617362869|FG000|Overall Study|Adverse Event|1|||
170823676|NCT00677092|617362869|FG000|Overall Study|Lost to Follow-up|1|||
170823677|NCT00677092|617362869|FG000|Overall Study|Withdrawal by Subject|3|||
170823678|NCT00677092|617362869|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
170823679|NCT02215954|617362870|FG000|Overall Study|Adverse Event|0|||
170823680|NCT02215954|617362871|FG001|Overall Study|Adverse Event|0|||
170823681|NCT02215954|617362872|FG002|Overall Study|Adverse Event|1|||
170823682|NCT02215954|617362870|FG000|Overall Study|Withdrawal by Subject|0|||
170823683|NCT02215954|617362871|FG001|Overall Study|Withdrawal by Subject|0|||
170823684|NCT02215954|617362872|FG002|Overall Study|Withdrawal by Subject|2|||
170823685|NCT02215954|617362870|FG000|Overall Study|Not exposed|1|||
170823686|NCT02215954|617362871|FG001|Overall Study|Not exposed|1|||
170823687|NCT02215954|617362872|FG002|Overall Study|Not exposed|3|||
170823688|NCT05012397|617362875|FG000|Overall Study|Death|10|||
170823689|NCT05012397|617362875|FG000|Overall Study|Physician Decision|9|||
170823690|NCT05012397|617362875|FG000|Overall Study|Withdrawal by Subject|5|||
170823691|NCT05012397|617362875|FG000|Overall Study|Lost to Follow-up|2|||
170823692|NCT02460562|617362878|FG000|Overall Study|Lost to Follow-up|15|||
170823693|NCT02460562|617362879|FG001|Overall Study|Lost to Follow-up|16|||
170823694|NCT01061775|617362880|FG000|Overall Study|Physician Decision|2|||
170823695|NCT01061775|617362880|FG000|Overall Study|Lost to Follow-up|1|||
170823696|NCT03334747|617362881|FG000|Treatment Phase|Technical problems|0|||
170823697|NCT03334747|617362882|FG001|Treatment Phase|Technical problems|0|||
170823698|NCT03334747|617362883|FG002|Treatment Phase|Technical problems|0|||
170823699|NCT03334747|617362884|FG003|Treatment Phase|Technical problems|0|||
170823700|NCT03334747|617362885|FG004|Treatment Phase|Technical problems|1|||
170823701|NCT03334747|617362886|FG005|Treatment Phase|Technical problems|0|||
170823702|NCT03334747|617362887|FG006|Treatment Phase|Technical problems|0|||
170823703|NCT03334747|617362888|FG007|Treatment Phase|Technical problems|0|||
170823704|NCT03334747|617362889|FG008|Treatment Phase|Technical problems|0|||
170823705|NCT03334747|617362881|FG000|Treatment Phase|Subject/guardian decision|1|||
170698098|NCT00192075|616908642|FG001|Overall Study|Lack of Efficacy|0|||
170698099|NCT00192075|616908641|FG000|Overall Study|Physician Decision|3|||
170698100|NCT00192075|616908642|FG001|Overall Study|Physician Decision|0|||
170698101|NCT00192075|616908641|FG000|Overall Study|Withdrawal by Subject|5|||
170698102|NCT00192075|616908642|FG001|Overall Study|Withdrawal by Subject|5|||
170698103|NCT00192075|616908641|FG000|Overall Study|Patient Non-Compliance|0|||
170698104|NCT00192075|616908642|FG001|Overall Study|Patient Non-Compliance|1|||
170698105|NCT00192075|616908641|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
170698106|NCT00192075|616908642|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
170698107|NCT00192075|616908641|FG000|Overall Study|Other|5|||
170698108|NCT00192075|616908642|FG001|Overall Study|Other|2|||
170698109|NCT01944059|616908643|FG000|Overall Study|Lost to Follow-up|1|||
170698110|NCT01944059|616908643|FG000|Overall Study|Physician Decision|3|||
170698111|NCT01944059|616908643|FG000|Overall Study|Withdrawal by Subject|1|||
170698112|NCT01944059|616908643|FG000|Overall Study|Adverse Event|2|||
170698113|NCT02821962|616908644|FG000|Overall Study|Lost to Follow-up|2|||
170698114|NCT02821962|616908645|FG001|Overall Study|Lost to Follow-up|0|||
170823706|NCT03334747|617362882|FG001|Treatment Phase|Subject/guardian decision|0|||
170823707|NCT03334747|617362883|FG002|Treatment Phase|Subject/guardian decision|0|||
170823708|NCT03334747|617362884|FG003|Treatment Phase|Subject/guardian decision|0|||
170823709|NCT03334747|617362885|FG004|Treatment Phase|Subject/guardian decision|0|||
170823710|NCT03334747|617362886|FG005|Treatment Phase|Subject/guardian decision|1|||
170823711|NCT03334747|617362887|FG006|Treatment Phase|Subject/guardian decision|0|||
170823712|NCT03334747|617362888|FG007|Treatment Phase|Subject/guardian decision|0|||
170823713|NCT03334747|617362889|FG008|Treatment Phase|Subject/guardian decision|0|||
170698115|NCT04206293|616908650|FG000|Overall Study|Consent withdrawal|1|||
170698116|NCT03325166|616908652|FG000|Overall Study|Adverse Event|1|||
170823714|NCT03334747|617362881|FG000|Follow-Up Phase|Subject/guardian decision|0|||
170823715|NCT03334747|617362882|FG001|Follow-Up Phase|Subject/guardian decision|0|||
170823716|NCT03334747|617362883|FG002|Follow-Up Phase|Subject/guardian decision|0|||
170823717|NCT03334747|617362884|FG003|Follow-Up Phase|Subject/guardian decision|0|||
170823718|NCT03334747|617362885|FG004|Follow-Up Phase|Subject/guardian decision|0|||
170698117|NCT02023151|616908656|FG000|Overall Study|Lost to Follow-up|4|||
170698118|NCT02871375|616908657|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
170698119|NCT02871375|616908658|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
170698120|NCT01988571|616908659|FG000|Overall Study|Death|3|||
170823719|NCT03334747|617362886|FG005|Follow-Up Phase|Subject/guardian decision|0|||
170823720|NCT03334747|617362887|FG006|Follow-Up Phase|Subject/guardian decision|1|||
170823721|NCT03334747|617362888|FG007|Follow-Up Phase|Subject/guardian decision|0|||
170823722|NCT03334747|617362889|FG008|Follow-Up Phase|Subject/guardian decision|1|||
170698121|NCT01988571|616908660|FG001|Overall Study|Death|1|||
170698122|NCT01988571|616908659|FG000|Overall Study|Physician Decision|2|||
170698123|NCT01988571|616908660|FG001|Overall Study|Physician Decision|1|||
170698124|NCT01988571|616908659|FG000|Overall Study|Lost to Follow-up|3|||
170698125|NCT01988571|616908660|FG001|Overall Study|Lost to Follow-up|0|||
170698126|NCT01988571|616908659|FG000|Overall Study|Withdrawal by Subject|31|||
170698127|NCT01988571|616908660|FG001|Overall Study|Withdrawal by Subject|33|||
170698128|NCT00004412|616908661|FG000|Randomized Period|Moved to Crossover Period|3|||
170698129|NCT00004412|616908662|FG001|Randomized Period|Moved to Crossover Period|0|||
170698130|NCT00004412|616908663|FG002|Randomized Period|Moved to Crossover Period|0|||
170698131|NCT00337103|616908670|FG000|Overall Study|Progressive Disease|414|||
170698132|NCT00337103|616908671|FG001|Overall Study|Progressive Disease|410|||
170698133|NCT00337103|616908670|FG000|Overall Study|Adverse Event|45|||
170698134|NCT00337103|616908671|FG001|Overall Study|Adverse Event|59|||
170698135|NCT00337103|616908670|FG000|Overall Study|Subject Choice|34|||
170698136|NCT00337103|616908671|FG001|Overall Study|Subject Choice|27|||
170698137|NCT00337103|616908670|FG000|Overall Study|Clinical Progression|27|||
170698138|NCT00337103|616908671|FG001|Overall Study|Clinical Progression|24|||
170698139|NCT00337103|616908670|FG000|Overall Study|Physician Decision|15|||
170698140|NCT00337103|616908671|FG001|Overall Study|Physician Decision|14|||
170698141|NCT00337103|616908670|FG000|Overall Study|Withdrawal by Subject|8|||
170698142|NCT00337103|616908671|FG001|Overall Study|Withdrawal by Subject|5|||
170698143|NCT00337103|616908670|FG000|Overall Study|Other|5|||
170698144|NCT00337103|616908671|FG001|Overall Study|Other|6|||
170698145|NCT00337103|616908670|FG000|Overall Study|Entry Criteria Not Met|4|||
170698146|NCT00337103|616908671|FG001|Overall Study|Entry Criteria Not Met|1|||
170698147|NCT00337103|616908670|FG000|Overall Study|Lost to Follow-up|1|||
170698148|NCT00337103|616908671|FG001|Overall Study|Lost to Follow-up|2|||
170698149|NCT00337103|616908670|FG000|Overall Study|Death|1|||
170698150|NCT00337103|616908671|FG001|Overall Study|Death|0|||
170698151|NCT02016482|616908672|FG000|Period A|Adverse Event|3|||
170698152|NCT02016482|616908673|FG001|Period A|Adverse Event|5|||
170698153|NCT02016482|616908672|FG000|Period A|Withdrawal by Subject|3|||
170698154|NCT02016482|616908673|FG001|Period A|Withdrawal by Subject|4|||
170698155|NCT02016482|616908672|FG000|Period A|Lost to Follow-up|3|||
170698156|NCT02016482|616908673|FG001|Period A|Lost to Follow-up|3|||
170698157|NCT02016482|616908672|FG000|Period A|Lack of Efficacy|2|||
170698158|NCT02016482|616908673|FG001|Period A|Lack of Efficacy|1|||
170698159|NCT02016482|616908672|FG000|Period A|Other|3|||
170698160|NCT02016482|616908673|FG001|Period A|Other|0|||
170698161|NCT02016482|616908672|FG000|Period A|Protocol Violation|0|||
170698162|NCT02016482|616908673|FG001|Period A|Protocol Violation|1|||
170698163|NCT02016482|616908672|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
170698164|NCT02016482|616908673|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
170698165|NCT02016482|616908672|FG000|Period B|Withdrawal by Subject|1|||
170698166|NCT02016482|616908673|FG001|Period B|Withdrawal by Subject|1|||
170698167|NCT02016482|616908672|FG000|Period B|Lost to Follow-up|2|||
170698168|NCT02016482|616908673|FG001|Period B|Lost to Follow-up|0|||
170698169|NCT02016482|616908672|FG000|Period B|Lack of Efficacy|6|||
170698170|NCT02016482|616908673|FG001|Period B|Lack of Efficacy|4|||
170698171|NCT02016482|616908672|FG000|Period B|Other|4|||
170698172|NCT02016482|616908673|FG001|Period B|Other|0|||
170698173|NCT02016482|616908672|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
170698174|NCT02016482|616908673|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
170698175|NCT04225923|616908683|FG000|Overall Study|Protocol Violation|1|||
170698176|NCT04225923|616908684|FG001|Overall Study|Protocol Violation|0|||
170698177|NCT04225923|616908685|FG002|Overall Study|Protocol Violation|1|||
170698178|NCT04225923|616908683|FG000|Overall Study|Withdrawal by Subject|4|||
170698179|NCT04225923|616908684|FG001|Overall Study|Withdrawal by Subject|1|||
170698180|NCT04225923|616908685|FG002|Overall Study|Withdrawal by Subject|3|||
170698181|NCT04225923|616908683|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
170698182|NCT04225923|616908684|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
170823723|NCT00588341|617362890|FG000|Overall Study|Withdrawal by Subject|3|||
170823724|NCT00588341|617362890|FG000|Overall Study|Not treated due to metastatic disease|1|||
170823725|NCT00588341|617362890|FG000|Overall Study|Patient ineligible|1|||
170823726|NCT04194541|617362891|FG000|Day 1 Through 13|Lost to Follow-up|3|||
170823727|NCT04194541|617362891|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
170698183|NCT04225923|616908685|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
170698184|NCT00855309|616908686|FG000|Overall Study|patient never recieved drug|1|||
170698185|NCT00855309|616908687|FG001|Overall Study|patient never recieved drug|0|||
170698186|NCT02547129|616908691|FG000|Overall Study|Difficulty with ongoing infection|1|||
170698187|NCT02547129|616908692|FG001|Overall Study|Difficulty with ongoing infection|0|||
170698188|NCT00794196|616908694|FG000|Overall Study|Lost to Follow-up|5|||
170698189|NCT00794196|616908695|FG001|Overall Study|Lost to Follow-up|23|||
170698190|NCT02129803|616908696|FG000|Overall Study|Protocol Violation|4|||
170698191|NCT02129803|616908697|FG001|Overall Study|Protocol Violation|0|||
170698192|NCT02129803|616908696|FG000|Overall Study|Physician Decision|0|||
170823728|NCT04194541|617362891|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
170698193|NCT02129803|616908697|FG001|Overall Study|Physician Decision|1|||
170698194|NCT02129803|616908696|FG000|Overall Study|Difficulty sleeping|1|||
170698195|NCT02129803|616908697|FG001|Overall Study|Difficulty sleeping|0|||
170698196|NCT02129803|616908696|FG000|Overall Study|Morning headache|0|||
170698197|NCT02129803|616908697|FG001|Overall Study|Morning headache|1|||
170698198|NCT02129803|616908696|FG000|Overall Study|Withdrawal by Subject|1|||
170698199|NCT02129803|616908697|FG001|Overall Study|Withdrawal by Subject|1|||
170698200|NCT02319031|616908698|FG000|Treatment Period|Death|1|||
170698201|NCT02319031|616908699|FG001|Treatment Period|Death|0|||
170698202|NCT02689258|616908700|FG000|Overall Study|Subject Non-Compliance|0|||
170698203|NCT02689258|616908701|FG001|Overall Study|Subject Non-Compliance|1|||
170698204|NCT02689258|616908702|FG002|Overall Study|Subject Non-Compliance|0|||
170698205|NCT02689258|616908703|FG003|Overall Study|Subject Non-Compliance|0|||
170698206|NCT02689258|616908704|FG004|Overall Study|Subject Non-Compliance|0|||
170698207|NCT02689258|616908705|FG005|Overall Study|Subject Non-Compliance|0|||
170698208|NCT02689258|616908706|FG006|Overall Study|Subject Non-Compliance|0|||
170698209|NCT02689258|616908707|FG007|Overall Study|Subject Non-Compliance|0|||
170698210|NCT02689258|616908708|FG008|Overall Study|Subject Non-Compliance|0|||
170698211|NCT02689258|616908709|FG009|Overall Study|Subject Non-Compliance|0|||
170698212|NCT02689258|616908710|FG010|Overall Study|Subject Non-Compliance|0|||
170698213|NCT02689258|616908711|FG011|Overall Study|Subject Non-Compliance|0|||
170698214|NCT02689258|616908700|FG000|Overall Study|Subject Refusal to Continue|0|||
170698215|NCT02689258|616908701|FG001|Overall Study|Subject Refusal to Continue|1|||
170698216|NCT02689258|616908702|FG002|Overall Study|Subject Refusal to Continue|0|||
170698217|NCT02689258|616908703|FG003|Overall Study|Subject Refusal to Continue|0|||
170698218|NCT02689258|616908704|FG004|Overall Study|Subject Refusal to Continue|0|||
170698219|NCT02689258|616908705|FG005|Overall Study|Subject Refusal to Continue|0|||
170698220|NCT02689258|616908706|FG006|Overall Study|Subject Refusal to Continue|0|||
170698221|NCT02689258|616908707|FG007|Overall Study|Subject Refusal to Continue|0|||
170698222|NCT02689258|616908708|FG008|Overall Study|Subject Refusal to Continue|1|||
170698223|NCT02689258|616908709|FG009|Overall Study|Subject Refusal to Continue|0|||
170698224|NCT02689258|616908710|FG010|Overall Study|Subject Refusal to Continue|0|||
170698225|NCT02689258|616908711|FG011|Overall Study|Subject Refusal to Continue|1|||
170698226|NCT02689258|616908700|FG000|Overall Study|Other|0|||
170698227|NCT02689258|616908701|FG001|Overall Study|Other|2|||
170698228|NCT02689258|616908702|FG002|Overall Study|Other|0|||
170698229|NCT02689258|616908703|FG003|Overall Study|Other|0|||
170698230|NCT02689258|616908704|FG004|Overall Study|Other|1|||
170698231|NCT02689258|616908705|FG005|Overall Study|Other|0|||
170698232|NCT02689258|616908706|FG006|Overall Study|Other|0|||
170698233|NCT02689258|616908707|FG007|Overall Study|Other|0|||
170698234|NCT02689258|616908708|FG008|Overall Study|Other|1|||
170698235|NCT02689258|616908709|FG009|Overall Study|Other|0|||
170698236|NCT02689258|616908710|FG010|Overall Study|Other|0|||
170698237|NCT02689258|616908711|FG011|Overall Study|Other|0|||
170698238|NCT02159521|616908712|FG000|Overall Study|Enrolled but not treated|3|||
170698239|NCT02159521|616908712|FG000|Overall Study|Withdrawal by Subject|7|||
170698240|NCT02159521|616908712|FG000|Overall Study|Lost to Follow-up|6|||
170698241|NCT02159521|616908712|FG000|Overall Study|Death|1|||
170698242|NCT02159521|616908712|FG000|Overall Study|Other than specified|1|||
170698243|NCT01465464|616908723|FG000|Overall Study|Adverse Event|96|||
170698244|NCT01465464|616908724|FG001|Overall Study|Adverse Event|49|||
170698245|NCT01465464|616908723|FG000|Overall Study|Lack of Efficacy|139|||
170698246|NCT01465464|616908724|FG001|Overall Study|Lack of Efficacy|190|||
170698247|NCT01465464|616908723|FG000|Overall Study|Physician Decision|13|||
170698248|NCT01465464|616908724|FG001|Overall Study|Physician Decision|5|||
170698249|NCT01465464|616908723|FG000|Overall Study|Protocol Violation|1|||
170698250|NCT01465464|616908724|FG001|Overall Study|Protocol Violation|1|||
170698251|NCT01465464|616908723|FG000|Overall Study|Withdrawal by Subject|46|||
170698252|NCT01465464|616908724|FG001|Overall Study|Withdrawal by Subject|30|||
170698253|NCT01465464|616908723|FG000|Overall Study|Other|9|||
170698254|NCT01465464|616908724|FG001|Overall Study|Other|3|||
170698255|NCT01465464|616908723|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
170698256|NCT01465464|616908724|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
170698257|NCT01183975|616908725|FG000|Overall Study|Lost to Follow-up|73|||
170698258|NCT03131440|616908729|FG000|Overall Study|Withdrawal by Subject|1|||
170698259|NCT03131440|616908730|FG001|Overall Study|Withdrawal by Subject|3|||
170698260|NCT03131440|616908731|FG002|Overall Study|Withdrawal by Subject|0|||
170698261|NCT03131440|616908732|FG003|Overall Study|Withdrawal by Subject|0|||
170698262|NCT03131440|616908733|FG004|Overall Study|Withdrawal by Subject|1|||
170698263|NCT03131440|616908734|FG005|Overall Study|Withdrawal by Subject|0|||
170698264|NCT03131440|616908735|FG006|Overall Study|Withdrawal by Subject|0|||
170698265|NCT03131440|616908736|FG007|Overall Study|Withdrawal by Subject|1|||
170698266|NCT03131440|616908737|FG008|Overall Study|Withdrawal by Subject|1|||
170698267|NCT03131440|616908738|FG009|Overall Study|Withdrawal by Subject|1|||
170698268|NCT03131440|616908739|FG010|Overall Study|Withdrawal by Subject|0|||
170698269|NCT03131440|616908740|FG011|Overall Study|Withdrawal by Subject|1|||
170698270|NCT03131440|616908741|FG012|Overall Study|Withdrawal by Subject|1|||
170823729|NCT01924806|617362898|FG000|Overall Study|Physician Decision|2|||
170823730|NCT01924806|617362899|FG001|Overall Study|Physician Decision|1|||
170823731|NCT02504502|617362900|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
170823732|NCT02504502|617362901|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
170823733|NCT02504502|617362900|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
170823734|NCT02504502|617362901|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
170823735|NCT01485991|617362903|FG000|Overall Study|Adverse Event|0|||
170823736|NCT01485991|617362904|FG001|Overall Study|Adverse Event|4|||
170823737|NCT01485991|617362903|FG000|Overall Study|Lost to Follow-up|13|||
170823738|NCT01485991|617362904|FG001|Overall Study|Lost to Follow-up|10|||
170823739|NCT01485991|617362903|FG000|Overall Study|Withdrawal by Subject|13|||
170823740|NCT01485991|617362904|FG001|Overall Study|Withdrawal by Subject|20|||
170823741|NCT01485991|617362903|FG000|Overall Study|randomized but not treated|6|||
170823742|NCT01485991|617362904|FG001|Overall Study|randomized but not treated|2|||
170823743|NCT01675050|617362905|FG000|Period One Treatment|Withdrawal by Subject|1|||
170823744|NCT01675050|617362906|FG001|Period One Treatment|Withdrawal by Subject|0|||
170823745|NCT00125853|617362907|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
170823746|NCT00125853|617362908|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
170823747|NCT00157209|617362909|FG000|Overall Study|Ongoing at data cut-off|10|||
170823748|NCT00157209|617362910|FG001|Overall Study|Ongoing at data cut-off|0|||
170698271|NCT03131440|616908742|FG013|Overall Study|Withdrawal by Subject|0|||
170698272|NCT03131440|616908743|FG014|Overall Study|Withdrawal by Subject|1|||
170698273|NCT03131440|616908744|FG015|Overall Study|Withdrawal by Subject|0|||
170698274|NCT03131440|616908745|FG016|Overall Study|Withdrawal by Subject|0|||
170698275|NCT03131440|616908746|FG017|Overall Study|Withdrawal by Subject|0|||
170698276|NCT03131440|616908747|FG018|Overall Study|Withdrawal by Subject|1|||
170698277|NCT03131440|616908748|FG019|Overall Study|Withdrawal by Subject|0|||
170698278|NCT03131440|616908749|FG020|Overall Study|Withdrawal by Subject|1|||
170698279|NCT03131440|616908750|FG021|Overall Study|Withdrawal by Subject|1|||
170698280|NCT03131440|616908751|FG022|Overall Study|Withdrawal by Subject|1|||
170698281|NCT03131440|616908752|FG023|Overall Study|Withdrawal by Subject|0|||
170698282|NCT03131440|616908753|FG024|Overall Study|Withdrawal by Subject|0|||
170698283|NCT03131440|616908754|FG025|Overall Study|Withdrawal by Subject|0|||
170698284|NCT03131440|616908755|FG026|Overall Study|Withdrawal by Subject|0|||
170698285|NCT03131440|616908756|FG027|Overall Study|Withdrawal by Subject|0|||
170698286|NCT03131440|616908757|FG028|Overall Study|Withdrawal by Subject|0|||
170698287|NCT03131440|616908758|FG029|Overall Study|Withdrawal by Subject|0|||
170698288|NCT03131440|616908759|FG030|Overall Study|Withdrawal by Subject|1|||
170698289|NCT03131440|616908760|FG031|Overall Study|Withdrawal by Subject|0|||
170698290|NCT03131440|616908729|FG000|Overall Study|Lost to Follow-up|0|||
170698291|NCT03131440|616908730|FG001|Overall Study|Lost to Follow-up|0|||
170698292|NCT03131440|616908731|FG002|Overall Study|Lost to Follow-up|0|||
170698293|NCT03131440|616908732|FG003|Overall Study|Lost to Follow-up|0|||
170698294|NCT03131440|616908733|FG004|Overall Study|Lost to Follow-up|0|||
170698295|NCT03131440|616908734|FG005|Overall Study|Lost to Follow-up|1|||
170698296|NCT03131440|616908735|FG006|Overall Study|Lost to Follow-up|0|||
170698297|NCT03131440|616908736|FG007|Overall Study|Lost to Follow-up|0|||
170698298|NCT03131440|616908737|FG008|Overall Study|Lost to Follow-up|0|||
170698299|NCT03131440|616908738|FG009|Overall Study|Lost to Follow-up|0|||
170698300|NCT03131440|616908739|FG010|Overall Study|Lost to Follow-up|0|||
170698301|NCT03131440|616908740|FG011|Overall Study|Lost to Follow-up|0|||
170698302|NCT03131440|616908741|FG012|Overall Study|Lost to Follow-up|0|||
170698303|NCT03131440|616908742|FG013|Overall Study|Lost to Follow-up|0|||
170698304|NCT03131440|616908743|FG014|Overall Study|Lost to Follow-up|0|||
170698305|NCT03131440|616908744|FG015|Overall Study|Lost to Follow-up|0|||
170823749|NCT00640042|617362913|FG000|Enrollment|Did not receive study drug|83|||
170823750|NCT01747629|617362914|FG000|Overall Study|Adverse Event|1|||
170823751|NCT01747629|617362915|FG001|Overall Study|Adverse Event|2|||
170823752|NCT01747629|617362914|FG000|Overall Study|Withdrawal by Subject|2|||
170823753|NCT01747629|617362915|FG001|Overall Study|Withdrawal by Subject|2|||
170823754|NCT01747629|617362914|FG000|Overall Study|Noncompliance|1|||
170823755|NCT01747629|617362915|FG001|Overall Study|Noncompliance|1|||
170823756|NCT01747629|617362914|FG000|Overall Study|Inclusion criteria not met|1|||
170698306|NCT03131440|616908745|FG016|Overall Study|Lost to Follow-up|0|||
170698307|NCT03131440|616908746|FG017|Overall Study|Lost to Follow-up|0|||
170698308|NCT03131440|616908747|FG018|Overall Study|Lost to Follow-up|0|||
170698309|NCT03131440|616908748|FG019|Overall Study|Lost to Follow-up|2|||
170698310|NCT03131440|616908749|FG020|Overall Study|Lost to Follow-up|1|||
170698311|NCT03131440|616908750|FG021|Overall Study|Lost to Follow-up|0|||
170823757|NCT01747629|617362915|FG001|Overall Study|Inclusion criteria not met|0|||
170823758|NCT01747629|617362914|FG000|Overall Study|Not treated|1|||
170823759|NCT01747629|617362915|FG001|Overall Study|Not treated|0|||
170698312|NCT03131440|616908751|FG022|Overall Study|Lost to Follow-up|1|||
170823760|NCT01747629|617362914|FG000|Overall Study|Other|2|||
170823761|NCT01747629|617362915|FG001|Overall Study|Other|1|||
170823762|NCT02016690|617362916|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
170823763|NCT02016690|617362916|FG000|Overall Study|Excluded from SAS: Duplication|2|||
170823764|NCT02016690|617362916|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
170823765|NCT02016690|617362916|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
170823766|NCT02016690|617362916|FG000|Overall Study|Did not meet inclusion criteria|13|||
170823767|NCT02016690|617362916|FG000|Overall Study|Hospitalized for RSV at study start|3|||
170823768|NCT01222078|617362917|FG000|Overall Study|Early termination of the study|1|||
170823769|NCT04089332|617362918|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
170823770|NCT04089332|617362918|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
170823771|NCT04089332|617362918|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
170823772|NCT01363297|617362919|FG000|Overall Study|Other|0|||
170823773|NCT01363297|617362920|FG001|Overall Study|Other|0|||
170823774|NCT01363297|617362921|FG002|Overall Study|Other|0|||
170823775|NCT01363297|617362922|FG003|Overall Study|Other|0|||
170823776|NCT01363297|617362923|FG004|Overall Study|Other|1|||
170823777|NCT01363297|617362919|FG000|Overall Study|Death|3|||
170823778|NCT01363297|617362920|FG001|Overall Study|Death|6|||
170823779|NCT01363297|617362921|FG002|Overall Study|Death|6|||
170823780|NCT01363297|617362922|FG003|Overall Study|Death|10|||
170823781|NCT01363297|617362923|FG004|Overall Study|Death|30|||
170823782|NCT02038803|617362924|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
170823783|NCT02038803|617362924|FG000|Overall Study|Lost to Follow-up|1|||
170823784|NCT06016127|617362927|FG000|Overall Study|Withdrawal by Subject|4|||
170823785|NCT06016127|617362928|FG001|Overall Study|Withdrawal by Subject|3|||
170823786|NCT02116582|617362929|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
170823787|NCT02116582|617362929|FG000|Overall Study|Adverse Event|22|||
170823788|NCT02116582|617362929|FG000|Overall Study|Death|9|||
170823789|NCT02116582|617362929|FG000|Overall Study|Progressive Disease|148|||
170823790|NCT02116582|617362929|FG000|Overall Study|Protocol Violation|3|||
170823791|NCT02116582|617362929|FG000|Overall Study|Withdrawal by Subject|8|||
170823792|NCT02116582|617362929|FG000|Overall Study|Other: Miscellaneous|11|||
170823793|NCT02116582|617362929|FG000|Overall Study|Lost to Follow-up|1|||
170823794|NCT02116582|617362929|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
170823795|NCT02864147|617362930|FG000|Overall Study|Withdrawal by Subject|3|||
170823796|NCT02864147|617362931|FG001|Overall Study|Withdrawal by Subject|2|||
170823797|NCT02864147|617362932|FG002|Overall Study|Withdrawal by Subject|1|||
170823798|NCT02864147|617362930|FG000|Overall Study|Lost to Follow-up|0|||
170823799|NCT02864147|617362931|FG001|Overall Study|Lost to Follow-up|4|||
170823800|NCT02864147|617362932|FG002|Overall Study|Lost to Follow-up|0|||
170823801|NCT02864147|617362930|FG000|Overall Study|Adverse Event|0|||
170823802|NCT02864147|617362931|FG001|Overall Study|Adverse Event|1|||
170823803|NCT02864147|617362932|FG002|Overall Study|Adverse Event|0|||
170698313|NCT03131440|616908752|FG023|Overall Study|Lost to Follow-up|0|||
170823804|NCT02864147|617362930|FG000|Overall Study|Pregnancy|4|||
170823805|NCT02864147|617362931|FG001|Overall Study|Pregnancy|0|||
170823806|NCT02864147|617362932|FG002|Overall Study|Pregnancy|0|||
170823807|NCT02864147|617362930|FG000|Overall Study|Physician Decision|0|||
170823808|NCT02864147|617362931|FG001|Overall Study|Physician Decision|0|||
170823809|NCT02864147|617362932|FG002|Overall Study|Physician Decision|1|||
170823810|NCT02864147|617362930|FG000|Overall Study|Opted for excisional procedures|0|||
170823811|NCT02864147|617362931|FG001|Overall Study|Opted for excisional procedures|0|||
170698314|NCT03131440|616908753|FG024|Overall Study|Lost to Follow-up|1|||
170698315|NCT03131440|616908754|FG025|Overall Study|Lost to Follow-up|0|||
170698316|NCT03131440|616908755|FG026|Overall Study|Lost to Follow-up|0|||
170698317|NCT03131440|616908756|FG027|Overall Study|Lost to Follow-up|2|||
170698318|NCT03131440|616908757|FG028|Overall Study|Lost to Follow-up|0|||
170698319|NCT03131440|616908758|FG029|Overall Study|Lost to Follow-up|2|||
170698320|NCT03131440|616908759|FG030|Overall Study|Lost to Follow-up|0|||
170698321|NCT03131440|616908760|FG031|Overall Study|Lost to Follow-up|0|||
170698322|NCT03131440|616908729|FG000|Overall Study|Death|0|||
170698323|NCT03131440|616908730|FG001|Overall Study|Death|0|||
170698324|NCT03131440|616908731|FG002|Overall Study|Death|0|||
170698325|NCT03131440|616908732|FG003|Overall Study|Death|0|||
170698326|NCT03131440|616908733|FG004|Overall Study|Death|0|||
170698327|NCT03131440|616908734|FG005|Overall Study|Death|0|||
170698328|NCT03131440|616908735|FG006|Overall Study|Death|0|||
170698329|NCT03131440|616908736|FG007|Overall Study|Death|0|||
170698330|NCT03131440|616908737|FG008|Overall Study|Death|0|||
170698331|NCT03131440|616908738|FG009|Overall Study|Death|0|||
170698332|NCT03131440|616908739|FG010|Overall Study|Death|0|||
170698333|NCT03131440|616908740|FG011|Overall Study|Death|0|||
170698334|NCT03131440|616908741|FG012|Overall Study|Death|0|||
170698335|NCT03131440|616908742|FG013|Overall Study|Death|0|||
170698336|NCT03131440|616908743|FG014|Overall Study|Death|0|||
170698337|NCT03131440|616908744|FG015|Overall Study|Death|0|||
170698338|NCT03131440|616908745|FG016|Overall Study|Death|0|||
170698339|NCT03131440|616908746|FG017|Overall Study|Death|0|||
170698340|NCT03131440|616908747|FG018|Overall Study|Death|0|||
170698341|NCT03131440|616908748|FG019|Overall Study|Death|0|||
170698342|NCT03131440|616908749|FG020|Overall Study|Death|0|||
170698343|NCT03131440|616908750|FG021|Overall Study|Death|0|||
170698344|NCT03131440|616908751|FG022|Overall Study|Death|0|||
170698345|NCT03131440|616908752|FG023|Overall Study|Death|0|||
170698346|NCT03131440|616908753|FG024|Overall Study|Death|0|||
170698347|NCT03131440|616908754|FG025|Overall Study|Death|1|||
170698348|NCT03131440|616908755|FG026|Overall Study|Death|0|||
170698349|NCT03131440|616908756|FG027|Overall Study|Death|0|||
170698350|NCT03131440|616908757|FG028|Overall Study|Death|0|||
170698351|NCT03131440|616908758|FG029|Overall Study|Death|0|||
170698352|NCT03131440|616908759|FG030|Overall Study|Death|0|||
170698353|NCT03131440|616908760|FG031|Overall Study|Death|0|||
170698354|NCT04371380|616908761|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
170698355|NCT04371380|616908762|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
170698356|NCT04371380|616908763|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
170698357|NCT02376166|616908766|FG000|Overall Study|Adverse Event|1|||
170698358|NCT02376166|616908766|FG000|Overall Study|Discontinued metformin early|2|||
170698359|NCT02136576|616908767|FG000|Overall Study|Lost to Follow-up|2|||
170698360|NCT02136576|616908768|FG001|Overall Study|Lost to Follow-up|0|||
170698361|NCT02136576|616908769|FG002|Overall Study|Lost to Follow-up|0|||
170698362|NCT01951157|616908771|FG000|Overall Study|Progressive Disease|12|||
170698363|NCT01951157|616908772|FG001|Overall Study|Progressive Disease|13|||
170698364|NCT01951157|616908773|FG002|Overall Study|Progressive Disease|10|||
170698365|NCT01951157|616908771|FG000|Overall Study|Treatment-unrelated AE|1|||
170698366|NCT01951157|616908772|FG001|Overall Study|Treatment-unrelated AE|0|||
170698367|NCT01951157|616908773|FG002|Overall Study|Treatment-unrelated AE|3|||
170698368|NCT01951157|616908771|FG000|Overall Study|Study Termination|0|||
170698369|NCT01951157|616908772|FG001|Overall Study|Study Termination|0|||
170698370|NCT01951157|616908773|FG002|Overall Study|Study Termination|1|||
170698371|NCT01951157|616908771|FG000|Overall Study|Physician Decision|5|||
170698372|NCT01951157|616908772|FG001|Overall Study|Physician Decision|3|||
170698373|NCT01951157|616908773|FG002|Overall Study|Physician Decision|2|||
170698374|NCT01951157|616908771|FG000|Overall Study|Non-treatmentrelated death|2|||
170698375|NCT01951157|616908772|FG001|Overall Study|Non-treatmentrelated death|2|||
170698376|NCT01951157|616908773|FG002|Overall Study|Non-treatmentrelated death|2|||
170698377|NCT01951157|616908771|FG000|Overall Study|No treated|0|||
170698378|NCT01951157|616908772|FG001|Overall Study|No treated|1|||
170698379|NCT01951157|616908773|FG002|Overall Study|No treated|0|||
170698380|NCT01951157|616908771|FG000|Overall Study|Treatment-related AE|2|||
170698381|NCT01951157|616908772|FG001|Overall Study|Treatment-related AE|0|||
170698382|NCT01951157|616908773|FG002|Overall Study|Treatment-related AE|4|||
170698383|NCT01951157|616908771|FG000|Overall Study|Consent withdrawn by subject|0|||
170698384|NCT01951157|616908772|FG001|Overall Study|Consent withdrawn by subject|1|||
170698385|NCT01951157|616908773|FG002|Overall Study|Consent withdrawn by subject|3|||
170698386|NCT01951157|616908771|FG000|Overall Study|Treatment-related death|0|||
170698387|NCT01951157|616908772|FG001|Overall Study|Treatment-related death|2|||
170698388|NCT01951157|616908773|FG002|Overall Study|Treatment-related death|0|||
170698389|NCT04809220|616908774|FG000|Overall Study|Adverse Event|4|||
170698390|NCT04809220|616908775|FG001|Overall Study|Adverse Event|0|||
170698391|NCT04809220|616908774|FG000|Overall Study|Death|1|||
170698392|NCT04809220|616908775|FG001|Overall Study|Death|0|||
170698393|NCT04809220|616908774|FG000|Overall Study|Lost to Follow-up|3|||
170698394|NCT04809220|616908775|FG001|Overall Study|Lost to Follow-up|0|||
170698395|NCT04809220|616908774|FG000|Overall Study|Physician Decision|0|||
170698396|NCT04809220|616908775|FG001|Overall Study|Physician Decision|1|||
170698397|NCT04809220|616908774|FG000|Overall Study|Withdrawal by Subject|9|||
170698398|NCT04809220|616908775|FG001|Overall Study|Withdrawal by Subject|5|||
170698399|NCT04809220|616908774|FG000|Overall Study|Due to long-term overseas business trips|1|||
170698400|NCT04809220|616908775|FG001|Overall Study|Due to long-term overseas business trips|0|||
170698401|NCT00994240|616908776|FG000|Overall Study|Lost to Follow-up|3|||
170698402|NCT00994240|616908777|FG001|Overall Study|Lost to Follow-up|2|||
170698403|NCT00994240|616908776|FG000|Overall Study|Withdrawal by Subject|1|||
170698404|NCT00994240|616908777|FG001|Overall Study|Withdrawal by Subject|0|||
170698405|NCT00994240|616908776|FG000|Overall Study|study termination|2|||
170698406|NCT00994240|616908777|FG001|Overall Study|study termination|3|||
170698407|NCT03745144|616908780|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
170698408|NCT03745144|616908781|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
170698409|NCT03745144|616908782|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
170698410|NCT03745144|616908780|FG000|Period 1|Other|0|||
170698411|NCT03745144|616908781|FG001|Period 1|Other|0|||
170698412|NCT03745144|616908782|FG002|Period 1|Other|1|||
170698413|NCT01177540|616908783|FG000|Overall Study|Adverse Event|1|||
170698414|NCT01177540|616908784|FG001|Overall Study|Adverse Event|0|||
170698415|NCT04097821|616908785|FG000|Overall Study|Subject Decision|0|||
170698416|NCT04097821|616908786|FG001|Overall Study|Subject Decision|0|||
170698417|NCT04097821|616908787|FG002|Overall Study|Subject Decision|0|||
170698418|NCT04097821|616908788|FG003|Overall Study|Subject Decision|1|||
170698419|NCT04097821|616908789|FG004|Overall Study|Subject Decision|2|||
170698420|NCT04097821|616908790|FG005|Overall Study|Subject Decision|2|||
170698421|NCT04097821|616908791|FG006|Overall Study|Subject Decision|0|||
170698422|NCT04097821|616908792|FG007|Overall Study|Subject Decision|1|||
170698423|NCT04097821|616908785|FG000|Overall Study|Death|0|||
170698424|NCT04097821|616908786|FG001|Overall Study|Death|0|||
170698425|NCT04097821|616908787|FG002|Overall Study|Death|3|||
170698426|NCT04097821|616908788|FG003|Overall Study|Death|1|||
170698427|NCT04097821|616908789|FG004|Overall Study|Death|0|||
170698428|NCT04097821|616908790|FG005|Overall Study|Death|0|||
170698429|NCT04097821|616908791|FG006|Overall Study|Death|0|||
170698430|NCT04097821|616908792|FG007|Overall Study|Death|0|||
170698431|NCT04097821|616908785|FG000|Overall Study|Physician Decision|1|||
170698432|NCT04097821|616908786|FG001|Overall Study|Physician Decision|2|||
170698433|NCT04097821|616908787|FG002|Overall Study|Physician Decision|0|||
170698434|NCT04097821|616908788|FG003|Overall Study|Physician Decision|0|||
170698435|NCT04097821|616908789|FG004|Overall Study|Physician Decision|0|||
170698436|NCT04097821|616908790|FG005|Overall Study|Physician Decision|0|||
170698437|NCT04097821|616908791|FG006|Overall Study|Physician Decision|0|||
170698438|NCT04097821|616908792|FG007|Overall Study|Physician Decision|0|||
170698439|NCT04097821|616908785|FG000|Overall Study|Adverse Event|0|||
170698440|NCT04097821|616908786|FG001|Overall Study|Adverse Event|0|||
170698441|NCT04097821|616908787|FG002|Overall Study|Adverse Event|1|||
170698442|NCT04097821|616908788|FG003|Overall Study|Adverse Event|1|||
170698443|NCT04097821|616908789|FG004|Overall Study|Adverse Event|0|||
170823812|NCT02864147|617362932|FG002|Overall Study|Opted for excisional procedures|3|||
170823813|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
170823814|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
170823815|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
170698444|NCT04097821|616908790|FG005|Overall Study|Adverse Event|0|||
170698445|NCT04097821|616908791|FG006|Overall Study|Adverse Event|0|||
170698446|NCT04097821|616908792|FG007|Overall Study|Adverse Event|0|||
170698447|NCT04097821|616908785|FG000|Overall Study|New Therapy For Study Indication|0|||
170698448|NCT04097821|616908786|FG001|Overall Study|New Therapy For Study Indication|0|||
170698449|NCT04097821|616908787|FG002|Overall Study|New Therapy For Study Indication|0|||
170698450|NCT04097821|616908788|FG003|Overall Study|New Therapy For Study Indication|0|||
170698451|NCT04097821|616908789|FG004|Overall Study|New Therapy For Study Indication|0|||
170698452|NCT04097821|616908790|FG005|Overall Study|New Therapy For Study Indication|0|||
170698453|NCT04097821|616908791|FG006|Overall Study|New Therapy For Study Indication|1|||
170698454|NCT04097821|616908792|FG007|Overall Study|New Therapy For Study Indication|0|||
170698455|NCT01083433|616910549|FG000|Overall Study|Lost to Follow-up|2|||
170698456|NCT01083433|616910550|FG001|Overall Study|Lost to Follow-up|1|||
170698457|NCT01083433|616910551|FG002|Overall Study|Lost to Follow-up|1|||
170823816|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
170823817|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
170823818|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
170823819|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
170823820|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
170698458|NCT01083433|616910549|FG000|Overall Study|Withdrawal by Subject|0|||
170698459|NCT01083433|616910550|FG001|Overall Study|Withdrawal by Subject|5|||
170698460|NCT01083433|616910551|FG002|Overall Study|Withdrawal by Subject|3|||
170698461|NCT01083433|616910549|FG000|Overall Study|Pregnancy|0|||
170698462|NCT01083433|616910550|FG001|Overall Study|Pregnancy|0|||
170698463|NCT01083433|616910551|FG002|Overall Study|Pregnancy|1|||
170698464|NCT02970968|616910552|FG000|Overall Study|Withdrawal by Subject|3|||
170823821|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
170823822|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
170823823|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
170823824|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
170823825|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
170823826|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
170823827|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
170823828|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
170823829|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
170823830|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
170823831|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
170698465|NCT02970968|616910553|FG001|Overall Study|Withdrawal by Subject|3|||
170698466|NCT02970968|616910552|FG000|Overall Study|Adverse Event|1|||
170698467|NCT02970968|616910553|FG001|Overall Study|Adverse Event|2|||
170698468|NCT02970968|616910552|FG000|Overall Study|Lost to Follow-up|1|||
170698469|NCT02970968|616910553|FG001|Overall Study|Lost to Follow-up|1|||
170698470|NCT02970968|616910552|FG000|Overall Study|Non-Compliance|0|||
170698471|NCT02970968|616910553|FG001|Overall Study|Non-Compliance|1|||
170698472|NCT05458856|616910554|FG000|Overall Study|Withdrawal by Subject|5|||
170698473|NCT05458856|616910554|FG000|Overall Study|Death|4|||
170698474|NCT05458856|616910554|FG000|Overall Study|Protocol Deviation|3|||
170698475|NCT05458856|616910554|FG000|Overall Study|Physician Decision|1|||
170698476|NCT00071812|616910555|FG000|24-Week Double-Blind Period|Adverse Event|2|||
170698477|NCT00071812|616910556|FG001|24-Week Double-Blind Period|Adverse Event|3|||
170698478|NCT00071812|616910557|FG002|24-Week Double-Blind Period|Adverse Event|4|||
170698479|NCT00071812|616910558|FG003|24-Week Double-Blind Period|Adverse Event|4|||
170698480|NCT00071812|616910555|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
170698481|NCT00071812|616910556|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
170698482|NCT00071812|616910557|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
170698483|NCT00071812|616910558|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
170698484|NCT00071812|616910555|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
170698485|NCT00071812|616910556|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
170698486|NCT00071812|616910557|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
170698487|NCT00071812|616910558|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
170698488|NCT00071812|616910555|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
170698489|NCT00071812|616910556|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
170698490|NCT00071812|616910557|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
170698491|NCT00071812|616910558|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
170698492|NCT00071812|616910555|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
170698493|NCT00071812|616910556|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
170698494|NCT00071812|616910557|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
170698495|NCT00071812|616910558|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
170698496|NCT00071812|616910555|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
170698497|NCT00071812|616910556|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
170698498|NCT00071812|616910557|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
170698499|NCT00071812|616910558|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
170698500|NCT00071812|616910555|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
170698501|NCT00071812|616910556|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
170698502|NCT00071812|616910557|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
170698503|NCT00071812|616910558|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
170698504|NCT00071812|616910555|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
170698505|NCT00071812|616910556|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
170698506|NCT00071812|616910557|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
170698507|NCT00071812|616910558|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
170698508|NCT00071812|616910555|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170698509|NCT00071812|616910556|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170698510|NCT00071812|616910557|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170698511|NCT00071812|616910558|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
170698512|NCT00071812|616910555|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
170698513|NCT00071812|616910556|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
170698514|NCT00071812|616910557|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
170698515|NCT00071812|616910558|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
170698516|NCT01816139|616910559|FG000|Overall Study|Adverse Event|6|||
170698517|NCT01816139|616910560|FG001|Overall Study|Adverse Event|8|||
170698518|NCT01816139|616910559|FG000|Overall Study|Lack of Efficacy|1|||
170698519|NCT01816139|616910560|FG001|Overall Study|Lack of Efficacy|2|||
170698520|NCT01816139|616910559|FG000|Overall Study|Lost to Follow-up|5|||
170698521|NCT01816139|616910560|FG001|Overall Study|Lost to Follow-up|3|||
170698522|NCT01816139|616910559|FG000|Overall Study|Withdrew Consent|6|||
170698523|NCT01816139|616910560|FG001|Overall Study|Withdrew Consent|4|||
170698524|NCT01816139|616910559|FG000|Overall Study|Protocol Violation|6|||
170698525|NCT01816139|616910560|FG001|Overall Study|Protocol Violation|3|||
170698526|NCT01816139|616910559|FG000|Overall Study|Reason not Specified|4|||
170698527|NCT01816139|616910560|FG001|Overall Study|Reason not Specified|2|||
170698528|NCT01940120|616910561|FG000|Overall Study|Death|40|||
170698529|NCT01940120|616910561|FG000|Overall Study|Withdrawal by Subject|8|||
170698530|NCT01888497|616910563|FG000|Washout Period 1|Withdrawal by Subject|0|||
170698531|NCT01888497|616910564|FG001|Washout Period 1|Withdrawal by Subject|0|||
170698532|NCT01888497|616910565|FG002|Washout Period 1|Withdrawal by Subject|1|||
170698533|NCT01888497|616910566|FG003|Washout Period 1|Withdrawal by Subject|1|||
170698534|NCT01888497|616910563|FG000|Washout Period 2|Adverse Event|0|||
170698535|NCT01888497|616910564|FG001|Washout Period 2|Adverse Event|0|||
170698536|NCT01888497|616910565|FG002|Washout Period 2|Adverse Event|0|||
170698537|NCT01888497|616910566|FG003|Washout Period 2|Adverse Event|1|||
170698538|NCT01888497|616910563|FG000|Washout Period 2|Withdrawal by Subject|0|||
170698539|NCT01888497|616910564|FG001|Washout Period 2|Withdrawal by Subject|0|||
170698540|NCT01888497|616910565|FG002|Washout Period 2|Withdrawal by Subject|0|||
170698541|NCT01888497|616910566|FG003|Washout Period 2|Withdrawal by Subject|1|||
170698542|NCT03240575|616910567|FG000|Overall Study|Adverse Event|0|||
170698543|NCT03240575|616910568|FG001|Overall Study|Adverse Event|2|||
170698544|NCT03240575|616910569|FG002|Overall Study|Adverse Event|0|||
170698545|NCT03240575|616910570|FG003|Overall Study|Adverse Event|1|||
170698546|NCT03240575|616910567|FG000|Overall Study|Withdrawal by Subject|2|||
170698547|NCT03240575|616910568|FG001|Overall Study|Withdrawal by Subject|11|||
170698548|NCT03240575|616910569|FG002|Overall Study|Withdrawal by Subject|0|||
170698549|NCT03240575|616910570|FG003|Overall Study|Withdrawal by Subject|1|||
170698550|NCT03240575|616910567|FG000|Overall Study|Other|0|||
170698551|NCT03240575|616910568|FG001|Overall Study|Other|1|||
170698552|NCT03240575|616910569|FG002|Overall Study|Other|0|||
170698553|NCT03240575|616910570|FG003|Overall Study|Other|0|||
170698554|NCT04144166|616910578|FG000|Overall Study|Discharged before study start|1|||
170698555|NCT04144166|616910578|FG000|Overall Study|Pregnancy|1|||
170698556|NCT04144166|616910578|FG000|Overall Study|Nail polish could not be removed from finger|1|||
170698557|NCT04145895|616910579|FG000|Overall Study|Physician Decision|2|||
170698558|NCT04145895|616910580|FG001|Overall Study|Physician Decision|0|||
170698559|NCT04145895|616910579|FG000|Overall Study|Withdrawal by Subject|0|||
170698560|NCT04145895|616910580|FG001|Overall Study|Withdrawal by Subject|2|||
170698561|NCT01236755|616910581|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
170698562|NCT01236755|616910581|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
170698563|NCT01236755|616910581|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
170698564|NCT01236755|616910581|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
170698565|NCT00913744|616910582|FG000|Overall Study|Adverse Event|2|||
170698566|NCT00913744|616910583|FG001|Overall Study|Adverse Event|0|||
170698567|NCT00913744|616910582|FG000|Overall Study|Withdrawal by Subject|2|||
170698568|NCT00913744|616910583|FG001|Overall Study|Withdrawal by Subject|1|||
170698569|NCT00913744|616910582|FG000|Overall Study|Death|1|||
170698570|NCT00913744|616910583|FG001|Overall Study|Death|0|||
170698571|NCT00116831|616910584|FG000|Overall Study|Adverse Event|14|||
170698572|NCT00116831|616910585|FG001|Overall Study|Adverse Event|16|||
170698573|NCT00116831|616910584|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
170698574|NCT00116831|616910585|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
170698575|NCT00116831|616910584|FG000|Overall Study|Lost to Follow-up|8|||
170698576|NCT00116831|616910585|FG001|Overall Study|Lost to Follow-up|6|||
170698577|NCT00116831|616910584|FG000|Overall Study|Protocol Violation|3|||
170698578|NCT00116831|616910585|FG001|Overall Study|Protocol Violation|6|||
170698579|NCT00116831|616910584|FG000|Overall Study|Hypoglycaemic events|1|||
170698580|NCT00116831|616910585|FG001|Overall Study|Hypoglycaemic events|0|||
170698581|NCT00116831|616910584|FG000|Overall Study|Low haemoglobin on screening|1|||
170698582|NCT00116831|616910585|FG001|Overall Study|Low haemoglobin on screening|0|||
170698583|NCT00116831|616910584|FG000|Overall Study|Withdrawn investigational product|1|||
170698584|NCT00116831|616910585|FG001|Overall Study|Withdrawn investigational product|0|||
170698585|NCT00116831|616910584|FG000|Overall Study|Withdrawal by Subject|32|||
170698586|NCT00116831|616910585|FG001|Overall Study|Withdrawal by Subject|32|||
170698587|NCT00116831|616910584|FG000|Overall Study|Insufficient therapeutic effect|0|||
170698588|NCT00116831|616910585|FG001|Overall Study|Insufficient therapeutic effect|1|||
170698589|NCT00116831|616910584|FG000|Overall Study|Missing data for participant|1|||
170823832|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
170823833|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
170698590|NCT00116831|616910585|FG001|Overall Study|Missing data for participant|0|||
170698591|NCT00805935|616910586|FG000|Overall Study|Stimulation Failure|1|||
170698592|NCT00805935|616910587|FG001|Overall Study|Stimulation Failure|5|||
170698593|NCT00805935|616910588|FG002|Overall Study|Stimulation Failure|2|||
170698594|NCT00805935|616910589|FG003|Overall Study|Stimulation Failure|2|||
170823834|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
170698595|NCT00805935|616910586|FG000|Overall Study|Cycle cancelled|0|||
170698596|NCT00805935|616910587|FG001|Overall Study|Cycle cancelled|0|||
170698597|NCT00805935|616910588|FG002|Overall Study|Cycle cancelled|2|||
170698598|NCT00805935|616910589|FG003|Overall Study|Cycle cancelled|0|||
170698599|NCT00805935|616910586|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
170698600|NCT00805935|616910587|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
170698601|NCT00805935|616910588|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
170698602|NCT00805935|616910589|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
170698603|NCT00805935|616910586|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
170698604|NCT00805935|616910587|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
170698605|NCT00805935|616910588|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
170698606|NCT00805935|616910589|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
170698607|NCT00805935|616910586|FG000|Overall Study|Lost to Follow-up|1|||
170698608|NCT00805935|616910587|FG001|Overall Study|Lost to Follow-up|0|||
170698609|NCT00805935|616910588|FG002|Overall Study|Lost to Follow-up|0|||
170698610|NCT00805935|616910589|FG003|Overall Study|Lost to Follow-up|0|||
170698611|NCT00805935|616910586|FG000|Overall Study|No positive serum pregnancy|8|||
170698612|NCT00805935|616910587|FG001|Overall Study|No positive serum pregnancy|7|||
170698613|NCT00805935|616910588|FG002|Overall Study|No positive serum pregnancy|6|||
170698614|NCT00805935|616910589|FG003|Overall Study|No positive serum pregnancy|5|||
170698615|NCT00805935|616910586|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
170698616|NCT00805935|616910587|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
170698617|NCT00805935|616910588|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
170698618|NCT00805935|616910589|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
170698619|NCT00805935|616910586|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
170698620|NCT00805935|616910587|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
170698621|NCT00805935|616910588|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
170698622|NCT00805935|616910589|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
170698623|NCT00805935|616910586|FG000|Overall Study|Biochemical pregnancy|0|||
170698624|NCT00805935|616910587|FG001|Overall Study|Biochemical pregnancy|1|||
170698625|NCT00805935|616910588|FG002|Overall Study|Biochemical pregnancy|0|||
170698626|NCT00805935|616910589|FG003|Overall Study|Biochemical pregnancy|0|||
170698627|NCT00805935|616910586|FG000|Overall Study|Chemical pregnancy|0|||
170698628|NCT00805935|616910587|FG001|Overall Study|Chemical pregnancy|5|||
170698629|NCT00805935|616910588|FG002|Overall Study|Chemical pregnancy|3|||
170698630|NCT00805935|616910589|FG003|Overall Study|Chemical pregnancy|2|||
170698631|NCT00805935|616910586|FG000|Overall Study|Ectopic pregnancy|0|||
170698632|NCT00805935|616910587|FG001|Overall Study|Ectopic pregnancy|0|||
170698633|NCT00805935|616910588|FG002|Overall Study|Ectopic pregnancy|1|||
170698634|NCT00805935|616910589|FG003|Overall Study|Ectopic pregnancy|0|||
170698635|NCT00805935|616910586|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
170698636|NCT00805935|616910587|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
170698637|NCT00805935|616910588|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
170698638|NCT00805935|616910589|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
170698639|NCT02945410|616910590|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
170698640|NCT02945410|616910591|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
170698641|NCT02945410|616910592|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
170698642|NCT02945410|616910593|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
170698643|NCT02945410|616910594|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
170698644|NCT02945410|616910595|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
170698645|NCT02945410|616910590|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
170698646|NCT02945410|616910591|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
170698647|NCT02945410|616910592|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
170698648|NCT02945410|616910593|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
170698649|NCT02945410|616910594|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
170698650|NCT02945410|616910595|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
170698651|NCT02945410|616910590|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
170698652|NCT02945410|616910591|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
170698653|NCT02945410|616910592|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
170698654|NCT02945410|616910593|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
170698655|NCT02945410|616910594|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
170698656|NCT02945410|616910595|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
170698657|NCT04904185|616910596|FG000|Overall Study|Expansion failure|1|||
170698658|NCT04904185|616910597|FG001|Overall Study|Expansion failure|0|||
170698659|NCT04904185|616910596|FG000|Overall Study|Late response on prior treatment|1|||
170698660|NCT04904185|616910597|FG001|Overall Study|Late response on prior treatment|0|||
170698661|NCT04200248|616910600|FG000|Overall Study|Personal reasons|0|||
170698662|NCT04200248|616910601|FG001|Overall Study|Personal reasons|0|||
170698663|NCT04200248|616910602|FG002|Overall Study|Personal reasons|1|||
170698664|NCT04200248|616910600|FG000|Overall Study|Discontinued prior to treatment|3|||
170698665|NCT04200248|616910601|FG001|Overall Study|Discontinued prior to treatment|3|||
170698666|NCT04200248|616910602|FG002|Overall Study|Discontinued prior to treatment|2|||
170698667|NCT00283439|616910606|FG000|Overall Study|Adverse Event|0|||
170698668|NCT00283439|616910607|FG001|Overall Study|Adverse Event|0|||
170698669|NCT00283439|616910608|FG002|Overall Study|Adverse Event|0|||
170698670|NCT00283439|616910609|FG003|Overall Study|Adverse Event|1|||
170698671|NCT00283439|616910606|FG000|Overall Study|Death|0|||
170698672|NCT00283439|616910607|FG001|Overall Study|Death|0|||
170698673|NCT00283439|616910608|FG002|Overall Study|Death|1|||
170698674|NCT00283439|616910609|FG003|Overall Study|Death|0|||
170698675|NCT00283439|616910606|FG000|Overall Study|Disease progression|0|||
170698676|NCT00283439|616910607|FG001|Overall Study|Disease progression|1|||
170698677|NCT00283439|616910608|FG002|Overall Study|Disease progression|0|||
170698678|NCT00283439|616910609|FG003|Overall Study|Disease progression|0|||
170698679|NCT00283439|616910606|FG000|Overall Study|Requirement for alternative therapy|1|||
170698680|NCT00283439|616910607|FG001|Overall Study|Requirement for alternative therapy|2|||
170698681|NCT00283439|616910608|FG002|Overall Study|Requirement for alternative therapy|5|||
170698682|NCT00283439|616910609|FG003|Overall Study|Requirement for alternative therapy|2|||
170698683|NCT00283439|616910606|FG000|Overall Study|Stem cell transplant|6|||
170698684|NCT00283439|616910607|FG001|Overall Study|Stem cell transplant|6|||
170698685|NCT00283439|616910608|FG002|Overall Study|Stem cell transplant|4|||
170698686|NCT00283439|616910609|FG003|Overall Study|Stem cell transplant|3|||
170698687|NCT00283439|616910606|FG000|Overall Study|Treatment discontinued|0|||
170698688|NCT00283439|616910607|FG001|Overall Study|Treatment discontinued|2|||
170698689|NCT00283439|616910608|FG002|Overall Study|Treatment discontinued|1|||
170698690|NCT00283439|616910609|FG003|Overall Study|Treatment discontinued|3|||
170698691|NCT00283439|616910606|FG000|Overall Study|Other|1|||
170698692|NCT00283439|616910607|FG001|Overall Study|Other|0|||
170698693|NCT00283439|616910608|FG002|Overall Study|Other|0|||
170698694|NCT00283439|616910609|FG003|Overall Study|Other|0|||
170698695|NCT01539226|616910610|FG000|Overall Study|Withdrawal by Subject|24|||
170698696|NCT01539226|616910611|FG001|Overall Study|Withdrawal by Subject|54|||
170698697|NCT01539226|616910610|FG000|Overall Study|Lost to Follow-up|20|||
170698698|NCT01539226|616910611|FG001|Overall Study|Lost to Follow-up|54|||
170698699|NCT01539226|616910610|FG000|Overall Study|Death|1|||
170698700|NCT01539226|616910611|FG001|Overall Study|Death|2|||
170698701|NCT01539226|616910610|FG000|Overall Study|Adverse Event|2|||
170698702|NCT01539226|616910611|FG001|Overall Study|Adverse Event|0|||
170698703|NCT01539226|616910610|FG000|Overall Study|Pregnancy|13|||
170698704|NCT01539226|616910611|FG001|Overall Study|Pregnancy|29|||
170698705|NCT01539226|616910610|FG000|Overall Study|inappropriate enrollment|0|||
170698706|NCT01539226|616910611|FG001|Overall Study|inappropriate enrollment|1|||
170698707|NCT01539226|616910610|FG000|Overall Study|Multiple Reasons|3|||
170698708|NCT01539226|616910611|FG001|Overall Study|Multiple Reasons|1|||
170698709|NCT01539226|616910610|FG000|Overall Study|not HIV seroconversion-related|93|||
170698710|NCT01539226|616910611|FG001|Overall Study|not HIV seroconversion-related|176|||
170698711|NCT01539226|616910610|FG000|Overall Study|HIV seroconversion-related|55|||
170698712|NCT01539226|616910611|FG001|Overall Study|HIV seroconversion-related|80|||
170698713|NCT01539226|616910610|FG000|Overall Study|Non-compliance|6|||
170698714|NCT01539226|616910611|FG001|Overall Study|Non-compliance|8|||
170698715|NCT02643251|616910612|FG000|Overall Study|Adverse Event|3|||
170698716|NCT02643251|616910613|FG001|Overall Study|Adverse Event|1|||
170698717|NCT02643251|616910612|FG000|Overall Study|Withdrawal by Subject|2|||
170698718|NCT02643251|616910613|FG001|Overall Study|Withdrawal by Subject|0|||
170698719|NCT02643251|616910612|FG000|Overall Study|Lost to Follow-up|4|||
170698720|NCT02643251|616910613|FG001|Overall Study|Lost to Follow-up|1|||
170698721|NCT02643251|616910612|FG000|Overall Study|Protocol Violation|1|||
170698722|NCT02643251|616910613|FG001|Overall Study|Protocol Violation|0|||
170698723|NCT02643251|616910612|FG000|Overall Study|PI Decision to terminate patient|1|||
170698724|NCT02643251|616910613|FG001|Overall Study|PI Decision to terminate patient|0|||
170698725|NCT00333229|616910614|FG000|Overall Study|Lack of Efficacy|0|||
170698726|NCT00333229|616910615|FG001|Overall Study|Lack of Efficacy|1|||
170698727|NCT00735371|616910625|FG000|Overall Study|Adverse Event|3|||
170698728|NCT00735371|616910626|FG001|Overall Study|Adverse Event|3|||
170698729|NCT00735371|616910627|FG002|Overall Study|Adverse Event|4|||
170698730|NCT00735371|616910628|FG003|Overall Study|Adverse Event|1|||
170698731|NCT00735371|616910625|FG000|Overall Study|Protocol Violation|2|||
170698732|NCT00735371|616910626|FG001|Overall Study|Protocol Violation|2|||
170698733|NCT00735371|616910627|FG002|Overall Study|Protocol Violation|0|||
170698734|NCT00735371|616910628|FG003|Overall Study|Protocol Violation|3|||
170698735|NCT00735371|616910625|FG000|Overall Study|Withdrawal by Subject|0|||
170698736|NCT00735371|616910626|FG001|Overall Study|Withdrawal by Subject|2|||
170698737|NCT00735371|616910627|FG002|Overall Study|Withdrawal by Subject|2|||
170698738|NCT00735371|616910628|FG003|Overall Study|Withdrawal by Subject|0|||
170698739|NCT00735371|616910625|FG000|Overall Study|Lost to Follow-up|1|||
170698740|NCT00735371|616910626|FG001|Overall Study|Lost to Follow-up|1|||
170698741|NCT00735371|616910627|FG002|Overall Study|Lost to Follow-up|3|||
170698742|NCT00735371|616910628|FG003|Overall Study|Lost to Follow-up|1|||
170698743|NCT00735371|616910625|FG000|Overall Study|Lack of Efficacy|4|||
170698744|NCT00735371|616910626|FG001|Overall Study|Lack of Efficacy|2|||
170698745|NCT00735371|616910627|FG002|Overall Study|Lack of Efficacy|0|||
170698746|NCT00735371|616910628|FG003|Overall Study|Lack of Efficacy|4|||
170698747|NCT00735371|616910625|FG000|Overall Study|Sponsor Decision|3|||
170698748|NCT00735371|616910626|FG001|Overall Study|Sponsor Decision|1|||
170698749|NCT00735371|616910627|FG002|Overall Study|Sponsor Decision|0|||
170698750|NCT00735371|616910628|FG003|Overall Study|Sponsor Decision|1|||
170698751|NCT00735371|616910625|FG000|Overall Study|Protocol Violation|0|||
170698752|NCT00735371|616910626|FG001|Overall Study|Protocol Violation|1|||
170698753|NCT00735371|616910627|FG002|Overall Study|Protocol Violation|2|||
170698754|NCT00735371|616910628|FG003|Overall Study|Protocol Violation|0|||
170698755|NCT00735371|616910625|FG000|Overall Study|Prior Vyvanse Exposure|1|||
170698756|NCT00735371|616910626|FG001|Overall Study|Prior Vyvanse Exposure|1|||
170698757|NCT00735371|616910627|FG002|Overall Study|Prior Vyvanse Exposure|0|||
170698758|NCT00735371|616910628|FG003|Overall Study|Prior Vyvanse Exposure|0|||
170698759|NCT00735371|616910625|FG000|Overall Study|Exclusion criteria|1|||
170698760|NCT00735371|616910626|FG001|Overall Study|Exclusion criteria|0|||
170698761|NCT00735371|616910627|FG002|Overall Study|Exclusion criteria|0|||
170698762|NCT00735371|616910628|FG003|Overall Study|Exclusion criteria|0|||
170698763|NCT02465528|616910629|FG000|Overall Study|Progressive disease|0|||
170698764|NCT02465528|616910630|FG001|Overall Study|Progressive disease|2|||
170698765|NCT02465528|616910631|FG002|Overall Study|Progressive disease|9|||
170698766|NCT02465528|616910632|FG003|Overall Study|Progressive disease|4|||
170698767|NCT02465528|616910629|FG000|Overall Study|Study terminated by sponsor|1|||
170698768|NCT02465528|616910630|FG001|Overall Study|Study terminated by sponsor|2|||
170698769|NCT02465528|616910631|FG002|Overall Study|Study terminated by sponsor|0|||
170698770|NCT02465528|616910632|FG003|Overall Study|Study terminated by sponsor|0|||
170698771|NCT02465528|616910629|FG000|Overall Study|Withdrawal by Subject|0|||
170698772|NCT02465528|616910630|FG001|Overall Study|Withdrawal by Subject|0|||
170698773|NCT02465528|616910631|FG002|Overall Study|Withdrawal by Subject|2|||
170698774|NCT02465528|616910632|FG003|Overall Study|Withdrawal by Subject|0|||
170698775|NCT02465528|616910629|FG000|Overall Study|Adverse Event|0|||
170698776|NCT02465528|616910630|FG001|Overall Study|Adverse Event|0|||
170698777|NCT02465528|616910631|FG002|Overall Study|Adverse Event|0|||
170698778|NCT02465528|616910632|FG003|Overall Study|Adverse Event|1|||
170698779|NCT02465528|616910629|FG000|Overall Study|Physician Decision|0|||
170698780|NCT02465528|616910630|FG001|Overall Study|Physician Decision|0|||
170698781|NCT02465528|616910631|FG002|Overall Study|Physician Decision|1|||
170698782|NCT02465528|616910632|FG003|Overall Study|Physician Decision|0|||
170698783|NCT04098458|616910633|FG000|Overall Study|Death|1|||
170698784|NCT04098458|616910633|FG000|Overall Study|did not meet study inclusion criteria|3|||
170698785|NCT00423891|616910634|FG000|Enrolled|Withdrawal by Subject|0|||
170698786|NCT00423891|616910635|FG001|Enrolled|Withdrawal by Subject|0|||
170698787|NCT00423891|616910636|FG002|Enrolled|Withdrawal by Subject|1|||
170698788|NCT00423891|616910634|FG000|Enrolled|Lost to Follow-up|0|||
170698789|NCT00423891|616910635|FG001|Enrolled|Lost to Follow-up|0|||
170698790|NCT00423891|616910636|FG002|Enrolled|Lost to Follow-up|1|||
170698791|NCT00423891|616910634|FG000|Enrolled|No longer met criteria|11|||
170698792|NCT00423891|616910635|FG001|Enrolled|No longer met criteria|2|||
170698793|NCT00423891|616910636|FG002|Enrolled|No longer met criteria|1|||
170698794|NCT00423891|616910634|FG000|Treatment|Withdrawal by Subject|1|||
170698795|NCT00423891|616910635|FG001|Treatment|Withdrawal by Subject|0|||
170698796|NCT00423891|616910636|FG002|Treatment|Withdrawal by Subject|0|||
170698797|NCT00423891|616910634|FG000|Treatment|Lost to Follow-up|1|||
170698798|NCT00423891|616910635|FG001|Treatment|Lost to Follow-up|0|||
170698799|NCT00423891|616910636|FG002|Treatment|Lost to Follow-up|0|||
170698800|NCT00423891|616910634|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
170698801|NCT00423891|616910635|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
170698802|NCT00423891|616910636|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
170698803|NCT00423891|616910634|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
170698804|NCT00423891|616910635|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
170698805|NCT00423891|616910636|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
170698806|NCT03742141|616910650|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
170698807|NCT01640366|616910659|FG000|Overall Study|Withdrawal by Subject|1|||
170698808|NCT01640366|616910659|FG000|Overall Study|Protocol Violation|16|||
170698809|NCT01640366|616910659|FG000|Overall Study|Lost to Follow-up|5|||
170698810|NCT02739269|616910662|FG000|Overall Study|Protocol Violation|5|||
170698811|NCT02739269|616910663|FG001|Overall Study|Protocol Violation|0|||
170698812|NCT02739269|616910662|FG000|Overall Study|Cycle cancellation|2|||
170698813|NCT02739269|616910663|FG001|Overall Study|Cycle cancellation|2|||
170698814|NCT02739269|616910662|FG000|Overall Study|Withdrawal by Subject|0|||
170698815|NCT02739269|616910663|FG001|Overall Study|Withdrawal by Subject|2|||
170698816|NCT02244580|616910664|FG000|Overall Study|No cancer tissues available|241|||
170698817|NCT03216850|616910665|FG000|Overall Study|Pre-analytical error|6|||
170698818|NCT01228747|616910666|FG000|Overall Study|Adverse Event|8|||
170698819|NCT01228747|616910667|FG001|Overall Study|Adverse Event|4|||
170698820|NCT01228747|616910666|FG000|Overall Study|Lack of Efficacy|40|||
170698821|NCT01228747|616910667|FG001|Overall Study|Lack of Efficacy|27|||
170698822|NCT01228747|616910666|FG000|Overall Study|Protocol Violation|6|||
170698823|NCT01228747|616910667|FG001|Overall Study|Protocol Violation|5|||
170698824|NCT01228747|616910666|FG000|Overall Study|Lost to Follow-up|4|||
170698825|NCT01228747|616910667|FG001|Overall Study|Lost to Follow-up|3|||
170698826|NCT01228747|616910666|FG000|Overall Study|Withdrawal by Subject|5|||
170698827|NCT01228747|616910667|FG001|Overall Study|Withdrawal by Subject|1|||
170698828|NCT01228747|616910666|FG000|Overall Study|Other Reason|2|||
170698829|NCT01228747|616910667|FG001|Overall Study|Other Reason|5|||
170698830|NCT02197806|616910672|FG000|Overall Study|Adverse Event|0|||
170698831|NCT02197806|616910673|FG001|Overall Study|Adverse Event|1|||
170698832|NCT02197806|616910674|FG002|Overall Study|Adverse Event|0|||
170698833|NCT02197806|616910675|FG003|Overall Study|Adverse Event|1|||
170698834|NCT00537381|616910676|FG000|Overall Study|Adverse Event|13|||
170698835|NCT00537381|616910677|FG001|Overall Study|Adverse Event|9|||
170698836|NCT00537381|616910676|FG000|Overall Study|Death|3|||
170698837|NCT00537381|616910677|FG001|Overall Study|Death|3|||
170698838|NCT00537381|616910676|FG000|Overall Study|Withdrawal by Subject|5|||
170698839|NCT00537381|616910677|FG001|Overall Study|Withdrawal by Subject|14|||
170698840|NCT00537381|616910676|FG000|Overall Study|Physician Decision|7|||
170698841|NCT00537381|616910677|FG001|Overall Study|Physician Decision|6|||
170698842|NCT00537381|616910676|FG000|Overall Study|Disease Progression|9|||
170698843|NCT00537381|616910677|FG001|Overall Study|Disease Progression|18|||
170698844|NCT00537381|616910676|FG000|Overall Study|Sponsor decision|14|||
170698845|NCT00537381|616910677|FG001|Overall Study|Sponsor decision|9|||
170698846|NCT00537381|616910676|FG000|Overall Study|Other|5|||
170698847|NCT00537381|616910677|FG001|Overall Study|Other|3|||
170698848|NCT00680901|616910678|FG000|Overall Study|Ongoing: On Study Treatment|1|||
170698849|NCT00680901|616910679|FG001|Overall Study|Ongoing: On Study Treatment|0|||
170698850|NCT00680901|616910678|FG000|Overall Study|Ongoing: In Follow Up|1|||
170698851|NCT00680901|616910679|FG001|Overall Study|Ongoing: In Follow Up|0|||
170698852|NCT00680901|616910678|FG000|Overall Study|Adverse Event|1|||
170698853|NCT00680901|616910679|FG001|Overall Study|Adverse Event|1|||
170698854|NCT00680901|616910678|FG000|Overall Study|Lost to Follow-up|3|||
170698855|NCT00680901|616910679|FG001|Overall Study|Lost to Follow-up|5|||
170698856|NCT00680901|616910678|FG000|Overall Study|Subject decided to withdraw from the study|4|||
170698857|NCT00680901|616910679|FG001|Overall Study|Subject decided to withdraw from the study|15|||
170698858|NCT00680901|616910678|FG000|Overall Study|Sponsor decision|1|||
170698859|NCT00680901|616910679|FG001|Overall Study|Sponsor decision|0|||
170698860|NCT00680901|616910678|FG000|Overall Study|Physician Decision|0|||
170698861|NCT00680901|616910679|FG001|Overall Study|Physician Decision|2|||
170698862|NCT00680901|616910678|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
170698863|NCT00680901|616910679|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
170698864|NCT00680901|616910678|FG000|Overall Study|Other protocol defined stopping criteria|17|||
170698865|NCT00680901|616910679|FG001|Overall Study|Other protocol defined stopping criteria|17|||
170698866|NCT04964128|616910687|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
170698867|NCT04964128|616910687|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
170698868|NCT01200797|616910689|FG000|Overall Study|symptomatic deterioration|2|||
170698869|NCT01200797|616910689|FG000|Overall Study|Adverse Event|4|||
170698870|NCT01200797|616910689|FG000|Overall Study|Disease Progression|13|||
170698871|NCT00642668|616910694|FG000|Overall Study|Lost to Follow-up|1|||
170698872|NCT00642668|616910694|FG000|Overall Study|Adverse Event|2|||
170698873|NCT00642668|616910694|FG000|Overall Study|Death|2|||
170823835|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
170823836|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
170823837|NCT02269917|617362933|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
170823838|NCT02269917|617362934|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
170823839|NCT02269917|617362935|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
170823840|NCT02269917|617362933|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
170823841|NCT02269917|617362934|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
170823842|NCT02269917|617362935|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
170823843|NCT02269917|617362933|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
170823844|NCT02269917|617362934|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
170823845|NCT02269917|617362935|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
170823846|NCT02269917|617362933|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
170823847|NCT02269917|617362934|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
170823848|NCT02269917|617362935|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
170823849|NCT02269917|617362933|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
170823850|NCT02269917|617362934|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
170823851|NCT02269917|617362935|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
170823852|NCT02269917|617362933|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
170823853|NCT02269917|617362934|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
170823854|NCT02269917|617362935|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
170823855|NCT02269917|617362933|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
170823856|NCT02269917|617362934|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
170823857|NCT02269917|617362935|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
170823858|NCT02269917|617362933|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
170823859|NCT02269917|617362934|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
170823860|NCT02269917|617362935|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
170823861|NCT00240097|617362936|FG000|Part I|Adverse Event|1|||
170823862|NCT00240097|617362936|FG000|Part I|Death|1|||
170823863|NCT00240097|617362936|FG000|Part I|histology|1|||
170823864|NCT00240097|617362936|FG000|Part I|unevaluable|1|||
170823865|NCT00240097|617362936|FG000|Part II|did not continue from Part I|23|||
170823866|NCT00577096|617362937|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
170823867|NCT00577096|617362938|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
170823868|NCT00577096|617362937|FG000|Short Term Participation|Withdrawal by Subject|3|||
170823869|NCT00577096|617362938|FG001|Short Term Participation|Withdrawal by Subject|5|||
170823870|NCT00577096|617362937|FG000|Short Term Participation|Death|1|||
170823871|NCT00577096|617362938|FG001|Short Term Participation|Death|1|||
170823872|NCT00832650|617362939|FG000|Overall Study|Randomized but not treated|0|||
170823873|NCT00832650|617362940|FG001|Overall Study|Randomized but not treated|0|||
170823874|NCT00832650|617362941|FG002|Overall Study|Randomized but not treated|1|||
170823875|NCT02865135|617362945|FG000|Overall Study|Death|0|||
170823876|NCT02865135|617362946|FG001|Overall Study|Death|1|||
170823877|NCT02865135|617362947|FG002|Overall Study|Death|0|||
170823878|NCT02865135|617362945|FG000|Overall Study|Progression|6|||
170823879|NCT02865135|617362946|FG001|Overall Study|Progression|2|||
170823880|NCT02865135|617362947|FG002|Overall Study|Progression|2|||
170823881|NCT00985621|617362948|FG000|Overall Study|Adverse Event|2|||
170823882|NCT00985621|617362949|FG001|Overall Study|Adverse Event|3|||
170823883|NCT00985621|617362950|FG002|Overall Study|Adverse Event|4|||
170823884|NCT00985621|617362951|FG003|Overall Study|Adverse Event|16|||
170823885|NCT00985621|617362948|FG000|Overall Study|Lack of Efficacy|10|||
170698874|NCT00642668|616910694|FG000|Overall Study|Insufficient Therapeutic Response|1|||
170698875|NCT00642668|616910694|FG000|Overall Study|Failure to Return|1|||
170823886|NCT00985621|617362949|FG001|Overall Study|Lack of Efficacy|6|||
170823887|NCT00985621|617362950|FG002|Overall Study|Lack of Efficacy|5|||
170823888|NCT00985621|617362951|FG003|Overall Study|Lack of Efficacy|12|||
170823889|NCT00985621|617362948|FG000|Overall Study|Lost to Follow-up|2|||
170823890|NCT00985621|617362949|FG001|Overall Study|Lost to Follow-up|3|||
170823891|NCT00985621|617362950|FG002|Overall Study|Lost to Follow-up|4|||
170698876|NCT00642668|616910694|FG000|Overall Study|Dialysis Initiation|5|||
170698877|NCT00642668|616910694|FG000|Overall Study|Blood Transfusion|2|||
170698878|NCT00896337|616910695|FG000|Overall Study|Death|7|||
170698879|NCT00896337|616910695|FG000|Overall Study|Withdrawal by Subject|7|||
170698880|NCT00896337|616910695|FG000|Overall Study|Lost to Follow-up|11|||
170698881|NCT02013167|616910701|FG000|Overall Study|Withdrawal by Subject|15|||
170698882|NCT02013167|616910702|FG001|Overall Study|Withdrawal by Subject|14|||
170823892|NCT00985621|617362951|FG003|Overall Study|Lost to Follow-up|4|||
170823893|NCT00985621|617362948|FG000|Overall Study|Study Terminated by Sponsor|89|||
170698883|NCT02013167|616910701|FG000|Overall Study|Sponsor Decision|1|||
170823894|NCT00985621|617362949|FG001|Overall Study|Study Terminated by Sponsor|108|||
170823895|NCT00985621|617362950|FG002|Overall Study|Study Terminated by Sponsor|99|||
170698884|NCT02013167|616910702|FG001|Overall Study|Sponsor Decision|3|||
170698885|NCT02013167|616910701|FG000|Overall Study|Lost to Follow-up|0|||
170698886|NCT02013167|616910702|FG001|Overall Study|Lost to Follow-up|1|||
170698887|NCT02013167|616910701|FG000|Overall Study|Death|85|||
170698888|NCT02013167|616910702|FG001|Overall Study|Death|160|||
170698889|NCT02776917|616910712|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
170698890|NCT00560950|616910717|FG000|Overall Study|Lost to Follow-up|1|||
170698891|NCT00560950|616910718|FG001|Overall Study|Lost to Follow-up|0|||
170698892|NCT01336738|616912393|FG000|Overall Study|Adverse Event|0|||
170698893|NCT01336738|616912394|FG001|Overall Study|Adverse Event|3|||
170698894|NCT01336738|616912395|FG002|Overall Study|Adverse Event|2|||
170698895|NCT01336738|616912396|FG003|Overall Study|Adverse Event|1|||
170698896|NCT01336738|616912397|FG004|Overall Study|Adverse Event|3|||
170698897|NCT01336738|616912393|FG000|Overall Study|Lost to Follow-up|2|||
170698898|NCT01336738|616912394|FG001|Overall Study|Lost to Follow-up|1|||
170698899|NCT01336738|616912395|FG002|Overall Study|Lost to Follow-up|2|||
170698900|NCT01336738|616912396|FG003|Overall Study|Lost to Follow-up|2|||
170698901|NCT01336738|616912397|FG004|Overall Study|Lost to Follow-up|2|||
170698902|NCT01336738|616912393|FG000|Overall Study|Did not meet entrance criteria|0|||
170698903|NCT01336738|616912394|FG001|Overall Study|Did not meet entrance criteria|1|||
170698904|NCT01336738|616912395|FG002|Overall Study|Did not meet entrance criteria|0|||
170698905|NCT01336738|616912396|FG003|Overall Study|Did not meet entrance criteria|0|||
170698906|NCT01336738|616912397|FG004|Overall Study|Did not meet entrance criteria|0|||
170698907|NCT01336738|616912393|FG000|Overall Study|Protocol Violation|0|||
170698908|NCT01336738|616912394|FG001|Overall Study|Protocol Violation|1|||
170698909|NCT01336738|616912395|FG002|Overall Study|Protocol Violation|0|||
170698910|NCT01336738|616912396|FG003|Overall Study|Protocol Violation|0|||
170698911|NCT01336738|616912397|FG004|Overall Study|Protocol Violation|0|||
170698912|NCT01336738|616912393|FG000|Overall Study|Withdrawal by Subject|2|||
170698913|NCT01336738|616912394|FG001|Overall Study|Withdrawal by Subject|0|||
170698914|NCT01336738|616912395|FG002|Overall Study|Withdrawal by Subject|2|||
170698915|NCT01336738|616912396|FG003|Overall Study|Withdrawal by Subject|1|||
170698916|NCT01336738|616912397|FG004|Overall Study|Withdrawal by Subject|1|||
170698917|NCT01336738|616912393|FG000|Overall Study|Other|3|||
170698918|NCT01336738|616912394|FG001|Overall Study|Other|3|||
170698919|NCT01336738|616912395|FG002|Overall Study|Other|2|||
170698920|NCT01336738|616912396|FG003|Overall Study|Other|3|||
170698921|NCT01336738|616912397|FG004|Overall Study|Other|4|||
170698922|NCT01581593|616912398|FG000|Overall Study|Withdrawal by Subject|1|||
170698923|NCT02565381|616912399|FG000|Overall Study|Lost to Follow-up|1|||
170698924|NCT02565381|616912400|FG001|Overall Study|Lost to Follow-up|0|||
170698925|NCT02565381|616912401|FG002|Overall Study|Lost to Follow-up|1|||
170698926|NCT02586012|616912404|FG000|Overall Study|Withdrawal by Subject|1|||
170698927|NCT02586012|616912405|FG001|Overall Study|Withdrawal by Subject|1|||
170698928|NCT02586012|616912406|FG002|Overall Study|Withdrawal by Subject|0|||
170698929|NCT02586012|616912407|FG003|Overall Study|Withdrawal by Subject|1|||
170698930|NCT02586012|616912408|FG004|Overall Study|Withdrawal by Subject|0|||
170698931|NCT02586012|616912409|FG005|Overall Study|Withdrawal by Subject|2|||
170698932|NCT02586012|616912404|FG000|Overall Study|Protocol Violation|0|||
170698933|NCT02586012|616912405|FG001|Overall Study|Protocol Violation|0|||
170698934|NCT02586012|616912406|FG002|Overall Study|Protocol Violation|0|||
170698935|NCT02586012|616912407|FG003|Overall Study|Protocol Violation|0|||
170698936|NCT02586012|616912408|FG004|Overall Study|Protocol Violation|0|||
170698937|NCT02586012|616912409|FG005|Overall Study|Protocol Violation|1|||
170698938|NCT02586012|616912404|FG000|Overall Study|study terminated|0|||
170698939|NCT02586012|616912405|FG001|Overall Study|study terminated|2|||
170698940|NCT02586012|616912406|FG002|Overall Study|study terminated|1|||
170698941|NCT02586012|616912407|FG003|Overall Study|study terminated|1|||
170698942|NCT02586012|616912408|FG004|Overall Study|study terminated|1|||
170698943|NCT02586012|616912409|FG005|Overall Study|study terminated|0|||
170698944|NCT02388737|616912412|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
170698945|NCT02388737|616912413|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
170698946|NCT02388737|616912414|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
170698947|NCT02388737|616912412|FG000|Overall Study|Major Protocol Deviation|18|||
170698948|NCT02388737|616912413|FG001|Overall Study|Major Protocol Deviation|25|||
170698949|NCT02388737|616912414|FG002|Overall Study|Major Protocol Deviation|22|||
170698950|NCT02388737|616912412|FG000|Overall Study|Lost to Follow-up|5|||
170698951|NCT02388737|616912413|FG001|Overall Study|Lost to Follow-up|1|||
170823896|NCT00985621|617362951|FG003|Overall Study|Study Terminated by Sponsor|92|||
170698952|NCT02388737|616912414|FG002|Overall Study|Lost to Follow-up|4|||
170698953|NCT02388737|616912412|FG000|Overall Study|Voluntary Withdrawal|10|||
170698954|NCT02388737|616912413|FG001|Overall Study|Voluntary Withdrawal|18|||
170698955|NCT02388737|616912414|FG002|Overall Study|Voluntary Withdrawal|17|||
170698956|NCT02388737|616912412|FG000|Overall Study|Lack of Efficacy|3|||
170698957|NCT02388737|616912413|FG001|Overall Study|Lack of Efficacy|0|||
170698958|NCT02388737|616912414|FG002|Overall Study|Lack of Efficacy|3|||
170698959|NCT02388737|616912412|FG000|Overall Study|Reason Not Specified|5|||
170698960|NCT02388737|616912413|FG001|Overall Study|Reason Not Specified|5|||
170698961|NCT02388737|616912414|FG002|Overall Study|Reason Not Specified|4|||
170698962|NCT03252522|616912415|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
170698963|NCT03252522|616912416|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
170698964|NCT03252522|616912417|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
170698965|NCT03252522|616912415|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
170698966|NCT03252522|616912416|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
170698967|NCT03252522|616912417|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
170698968|NCT03252522|616912415|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
170698969|NCT03252522|616912416|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
170698970|NCT03252522|616912417|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
170698971|NCT03252522|616912415|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
170698972|NCT03252522|616912416|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
170698973|NCT03252522|616912417|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
170698974|NCT03252522|616912415|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
170698975|NCT03252522|616912416|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
170698976|NCT03252522|616912417|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
170698977|NCT03252522|616912415|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
170698978|NCT03252522|616912416|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
170698979|NCT03252522|616912417|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
170698980|NCT03252522|616912415|FG000|Phase 2: Open Label|Adverse Event|0|||
170698981|NCT03252522|616912416|FG001|Phase 2: Open Label|Adverse Event|0|||
170698982|NCT03252522|616912417|FG002|Phase 2: Open Label|Adverse Event|2|||
170698983|NCT03252522|616912415|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
170698984|NCT03252522|616912416|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
170698985|NCT03252522|616912417|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
170698986|NCT01572038|616912419|FG000|Overall Study|Death|648|||
170698987|NCT01572038|616912419|FG000|Overall Study|Withdrawal by Subject|204|||
170698988|NCT01572038|616912419|FG000|Overall Study|Lost to Follow-up|81|||
170698989|NCT01572038|616912419|FG000|Overall Study|Physician Decision|20|||
170698990|NCT01572038|616912419|FG000|Overall Study|Patient Decision|14|||
170698991|NCT01572038|616912419|FG000|Overall Study|Progressive Disease|8|||
170698992|NCT01572038|616912419|FG000|Overall Study|Site Closed Before Completing Form|6|||
170698993|NCT01572038|616912419|FG000|Overall Study|Enrolled into Another Trial|3|||
170698994|NCT01572038|616912419|FG000|Overall Study|Participated in Another Trial|3|||
170698995|NCT01572038|616912419|FG000|Overall Study|Termination by Sponsor|2|||
170698996|NCT01572038|616912419|FG000|Overall Study|Patient Deterioration|1|||
170698997|NCT01572038|616912419|FG000|Overall Study|Sponsor Decision|1|||
170698998|NCT02554656|616912420|FG000|Overall Study|Protocol Violation|3|||
170698999|NCT04013191|616912423|FG000|Overall Study|Adverse Event|1|||
170699000|NCT04013191|616912424|FG001|Overall Study|Adverse Event|0|||
170699001|NCT04482179|616912425|FG000|Overall Study|Death|1|||
170699002|NCT04482179|616912426|FG001|Overall Study|Death|0|||
170699003|NCT04482179|616912425|FG000|Overall Study|Withdrawal by Subject|1|||
170699004|NCT04482179|616912426|FG001|Overall Study|Withdrawal by Subject|0|||
170699005|NCT01904604|616912431|FG000|Overall Study|Withdrew before receiving dosing|0|||
170699006|NCT01904604|616912432|FG001|Overall Study|Withdrew before receiving dosing|1|||
170699007|NCT01904604|616912433|FG002|Overall Study|Withdrew before receiving dosing|0|||
170699008|NCT01904604|616912431|FG000|Overall Study|Non-compliance|1|||
170699009|NCT01904604|616912432|FG001|Overall Study|Non-compliance|0|||
170699010|NCT01904604|616912433|FG002|Overall Study|Non-compliance|0|||
170699011|NCT01904604|616912431|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
170699012|NCT01904604|616912432|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
170699013|NCT01904604|616912433|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
170699014|NCT01904604|616912431|FG000|Overall Study|Patch site reactions|1|||
170699015|NCT01904604|616912432|FG001|Overall Study|Patch site reactions|1|||
170699016|NCT01904604|616912433|FG002|Overall Study|Patch site reactions|0|||
170699017|NCT01904604|616912431|FG000|Overall Study|Increased syncope|0|||
170699018|NCT01904604|616912432|FG001|Overall Study|Increased syncope|1|||
170699019|NCT01904604|616912433|FG002|Overall Study|Increased syncope|0|||
170699020|NCT01904604|616912431|FG000|Overall Study|Unrelated illness|0|||
170699021|NCT01904604|616912432|FG001|Overall Study|Unrelated illness|1|||
170699022|NCT01904604|616912433|FG002|Overall Study|Unrelated illness|0|||
170699023|NCT01904604|616912431|FG000|Overall Study|Passed Week 52 OFC|1|||
170699024|NCT01904604|616912432|FG001|Overall Study|Passed Week 52 OFC|0|||
170699025|NCT01904604|616912433|FG002|Overall Study|Passed Week 52 OFC|0|||
170699026|NCT01904604|616912431|FG000|Overall Study|Withdrawal by Subject|1|||
170699027|NCT01904604|616912432|FG001|Overall Study|Withdrawal by Subject|2|||
170699028|NCT01904604|616912433|FG002|Overall Study|Withdrawal by Subject|0|||
170699029|NCT01904604|616912431|FG000|Overall Study|Participant Relocated|1|||
170699030|NCT01904604|616912432|FG001|Overall Study|Participant Relocated|1|||
170823897|NCT00985621|617362948|FG000|Overall Study|Protocol Violation|1|||
170699031|NCT01904604|616912433|FG002|Overall Study|Participant Relocated|1|||
170699032|NCT01904604|616912431|FG000|Overall Study|Lost to Follow-up|0|||
170823898|NCT00985621|617362949|FG001|Overall Study|Protocol Violation|1|||
170823899|NCT00985621|617362950|FG002|Overall Study|Protocol Violation|1|||
170699033|NCT01904604|616912432|FG001|Overall Study|Lost to Follow-up|0|||
170699034|NCT01904604|616912433|FG002|Overall Study|Lost to Follow-up|1|||
170699035|NCT00588445|616912437|FG000|Overall Study|Protocol Violation|1|||
170699036|NCT00588445|616912437|FG000|Overall Study|Withdrawal by Subject|3|||
170699037|NCT00588445|616912437|FG000|Overall Study|Disease Progression|1|||
170699038|NCT00588445|616912437|FG000|Overall Study|Not Treated|10|||
170699039|NCT03240133|616912438|FG000|Overall Study|Withdrawal by Subject|0|||
170699040|NCT03240133|616912439|FG001|Overall Study|Withdrawal by Subject|1|||
170699041|NCT03240133|616912440|FG002|Overall Study|Withdrawal by Subject|0|||
170699042|NCT03240133|616912438|FG000|Overall Study|Adverse Event|1|||
170699043|NCT03240133|616912439|FG001|Overall Study|Adverse Event|1|||
170699044|NCT03240133|616912440|FG002|Overall Study|Adverse Event|0|||
170699045|NCT03240133|616912438|FG000|Overall Study|Rash|1|||
170699046|NCT03240133|616912439|FG001|Overall Study|Rash|0|||
170699047|NCT03240133|616912440|FG002|Overall Study|Rash|0|||
170699048|NCT03240133|616912438|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
170699049|NCT03240133|616912439|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
170699050|NCT03240133|616912440|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
170699051|NCT03240133|616912438|FG000|Overall Study|Intercurrent illness.|0|||
170699052|NCT03240133|616912439|FG001|Overall Study|Intercurrent illness.|1|||
170699053|NCT03240133|616912440|FG002|Overall Study|Intercurrent illness.|0|||
170699054|NCT03240133|616912438|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
170699055|NCT03240133|616912439|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
170699056|NCT03240133|616912440|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
170699057|NCT01481116|616912443|FG000|Overall Study|Adverse Event|26|||
170699058|NCT01481116|616912444|FG001|Overall Study|Adverse Event|26|||
170699059|NCT01481116|616912445|FG002|Overall Study|Adverse Event|42|||
170699060|NCT01481116|616912443|FG000|Overall Study|Major Protocol Deviation|3|||
170699061|NCT01481116|616912444|FG001|Overall Study|Major Protocol Deviation|7|||
170699062|NCT01481116|616912445|FG002|Overall Study|Major Protocol Deviation|1|||
170699063|NCT01481116|616912443|FG000|Overall Study|Lost to Follow-up|8|||
170699064|NCT01481116|616912444|FG001|Overall Study|Lost to Follow-up|12|||
170699065|NCT01481116|616912445|FG002|Overall Study|Lost to Follow-up|11|||
170699066|NCT01481116|616912443|FG000|Overall Study|Withdrawal by Subject|37|||
170699067|NCT01481116|616912444|FG001|Overall Study|Withdrawal by Subject|33|||
170699068|NCT01481116|616912445|FG002|Overall Study|Withdrawal by Subject|37|||
170699069|NCT01481116|616912443|FG000|Overall Study|Study Termination|730|||
170699070|NCT01481116|616912444|FG001|Overall Study|Study Termination|729|||
170699071|NCT01481116|616912445|FG002|Overall Study|Study Termination|713|||
170699072|NCT01481116|616912443|FG000|Overall Study|Pregnancy|0|||
170699073|NCT01481116|616912444|FG001|Overall Study|Pregnancy|0|||
170699074|NCT01481116|616912445|FG002|Overall Study|Pregnancy|1|||
170699075|NCT01481116|616912443|FG000|Overall Study|Lack of Efficacy|3|||
170699076|NCT01481116|616912444|FG001|Overall Study|Lack of Efficacy|3|||
170699077|NCT01481116|616912445|FG002|Overall Study|Lack of Efficacy|1|||
170699078|NCT01481116|616912443|FG000|Overall Study|Contraindications|1|||
170699079|NCT01481116|616912444|FG001|Overall Study|Contraindications|1|||
170699080|NCT01481116|616912445|FG002|Overall Study|Contraindications|0|||
170699081|NCT01481116|616912443|FG000|Overall Study|Other|1|||
170699082|NCT01481116|616912444|FG001|Overall Study|Other|1|||
170699083|NCT01481116|616912445|FG002|Overall Study|Other|0|||
170699084|NCT01481116|616912443|FG000|Overall Study|Participant Started Taking Glipizide|1|||
170699085|NCT01481116|616912444|FG001|Overall Study|Participant Started Taking Glipizide|0|||
170699086|NCT01481116|616912445|FG002|Overall Study|Participant Started Taking Glipizide|0|||
170699087|NCT01481116|616912443|FG000|Overall Study|Participant Moved Out of Area|2|||
170699088|NCT01481116|616912444|FG001|Overall Study|Participant Moved Out of Area|0|||
170699089|NCT01481116|616912445|FG002|Overall Study|Participant Moved Out of Area|1|||
170699090|NCT01481116|616912443|FG000|Overall Study|Participant Moved Out of Country|1|||
170699091|NCT01481116|616912444|FG001|Overall Study|Participant Moved Out of Country|0|||
170699092|NCT01481116|616912445|FG002|Overall Study|Participant Moved Out of Country|1|||
170699093|NCT01481116|616912443|FG000|Overall Study|Investigator Decision|3|||
170699094|NCT01481116|616912444|FG001|Overall Study|Investigator Decision|2|||
170699095|NCT01481116|616912445|FG002|Overall Study|Investigator Decision|1|||
170699096|NCT01481116|616912443|FG000|Overall Study|Sponsor Decision|0|||
170699097|NCT01481116|616912444|FG001|Overall Study|Sponsor Decision|1|||
170699098|NCT01481116|616912445|FG002|Overall Study|Sponsor Decision|3|||
170699099|NCT01481116|616912443|FG000|Overall Study|Non-Compliant With Study Drug|0|||
170699100|NCT01481116|616912444|FG001|Overall Study|Non-Compliant With Study Drug|1|||
170699101|NCT01481116|616912445|FG002|Overall Study|Non-Compliant With Study Drug|1|||
170699102|NCT01481116|616912443|FG000|Overall Study|Investigator's Discretion|2|||
170699103|NCT01481116|616912444|FG001|Overall Study|Investigator's Discretion|0|||
170699104|NCT01481116|616912445|FG002|Overall Study|Investigator's Discretion|0|||
170699105|NCT01481116|616912443|FG000|Overall Study|Death|2|||
170699106|NCT01481116|616912444|FG001|Overall Study|Death|1|||
170699107|NCT01481116|616912445|FG002|Overall Study|Death|0|||
170699108|NCT01481116|616912443|FG000|Overall Study|Hypoglycemic Event|4|||
170699109|NCT01481116|616912444|FG001|Overall Study|Hypoglycemic Event|0|||
170699110|NCT01481116|616912445|FG002|Overall Study|Hypoglycemic Event|0|||
170699111|NCT03848845|616912446|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
170699112|NCT03848845|616912447|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
170699113|NCT03848845|616912448|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
170699114|NCT03848845|616912449|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
170699115|NCT03848845|616912446|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
170699116|NCT03848845|616912447|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
170699117|NCT03848845|616912448|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
170699118|NCT03848845|616912449|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
170699119|NCT03848845|616912446|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
170699120|NCT03848845|616912447|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
170699121|NCT03848845|616912448|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
170699122|NCT03848845|616912449|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
170699123|NCT03848845|616912446|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
170699124|NCT03848845|616912447|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
170699125|NCT03848845|616912448|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
170699126|NCT03848845|616912449|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
170699127|NCT02433834|616912450|FG000|Overall Study|Protocol-specified criteria|7|||
170699128|NCT02433834|616912450|FG000|Overall Study|Protocol Violation|3|||
170699129|NCT02433834|616912450|FG000|Overall Study|Lost to Follow-up|6|||
170699130|NCT02433834|616912450|FG000|Overall Study|Withdrawal by Subject|14|||
170699131|NCT02433834|616912450|FG000|Overall Study|Adverse Event|6|||
170699132|NCT02433834|616912450|FG000|Overall Study|Physician Decision|1|||
170699133|NCT00348556|616912451|FG000|Overall Study|Adverse Event|1|||
170699134|NCT01869192|616912464|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
170699135|NCT01869192|616912465|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
170699136|NCT01869192|616912464|FG000|Postoperative Chemotherapy|Physician Decision|0|||
170699137|NCT01869192|616912465|FG001|Postoperative Chemotherapy|Physician Decision|2|||
170699138|NCT02286193|616912468|FG000|Overall Study|Referred: CRS unable to make contact|62|||
170699139|NCT02286193|616912468|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
170699140|NCT02286193|616912468|FG000|Overall Study|Referred: Declined service|38|||
170699141|NCT01232296|616912469|FG000|Overall Study|Adverse Event|24|||
170699142|NCT01232296|616912470|FG001|Overall Study|Adverse Event|12|||
170699143|NCT01232296|616912469|FG000|Overall Study|Physician Decision|1|||
170699144|NCT01232296|616912470|FG001|Overall Study|Physician Decision|1|||
170699145|NCT01232296|616912469|FG000|Overall Study|Progressive disease|43|||
170699146|NCT01232296|616912470|FG001|Overall Study|Progressive disease|61|||
170699147|NCT01232296|616912469|FG000|Overall Study|Study terminated by sponsor|0|||
170699148|NCT01232296|616912470|FG001|Overall Study|Study terminated by sponsor|1|||
170699149|NCT01232296|616912469|FG000|Overall Study|Technical problems|3|||
170699150|NCT01232296|616912470|FG001|Overall Study|Technical problems|0|||
170699151|NCT01232296|616912469|FG000|Overall Study|Subject/guardian decision|10|||
170699152|NCT01232296|616912470|FG001|Overall Study|Subject/guardian decision|2|||
170699153|NCT01232296|616912469|FG000|Overall Study|Death|1|||
170699154|NCT01232296|616912470|FG001|Overall Study|Death|6|||
170699155|NCT01907828|616912480|FG000|Overall Study|Exclusion criteria not met|0|||
170699156|NCT01907828|616912481|FG001|Overall Study|Exclusion criteria not met|1|||
170699157|NCT01907828|616912480|FG000|Overall Study|Withdrawal by Subject|3|||
170699158|NCT01907828|616912481|FG001|Overall Study|Withdrawal by Subject|4|||
170699159|NCT01907828|616912480|FG000|Overall Study|Lost to Follow-up|3|||
170699160|NCT01907828|616912481|FG001|Overall Study|Lost to Follow-up|0|||
170699161|NCT01907828|616912480|FG000|Overall Study|Participant refused 24-month follow-up|1|||
170699162|NCT01907828|616912481|FG001|Overall Study|Participant refused 24-month follow-up|0|||
170699163|NCT01907828|616912480|FG000|Overall Study|Participant met exclusion criteria|0|||
170699164|NCT01907828|616912481|FG001|Overall Study|Participant met exclusion criteria|1|||
170699165|NCT01073865|616912482|FG000|Overall Study|Reasons other than below|19|||
170699166|NCT01073865|616912483|FG001|Overall Study|Reasons other than below|31|||
170699167|NCT01073865|616912482|FG000|Overall Study|Lost to Follow-up|1|||
170699168|NCT01073865|616912483|FG001|Overall Study|Lost to Follow-up|1|||
170699169|NCT01073865|616912482|FG000|Overall Study|Death|3|||
170823900|NCT00985621|617362951|FG003|Overall Study|Protocol Violation|0|||
170823901|NCT00985621|617362948|FG000|Overall Study|Withdrawal by Subject|8|||
170699170|NCT01073865|616912483|FG001|Overall Study|Death|2|||
170699171|NCT01073865|616912482|FG000|Overall Study|Withdrawal by Subject|5|||
170699172|NCT01073865|616912483|FG001|Overall Study|Withdrawal by Subject|5|||
170699173|NCT04414553|616912484|FG000|Overall Study|Lost to Follow-up|20|||
170699174|NCT03717480|616912489|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
170699175|NCT01708174|616912490|FG000|Treatment Period|Withdrawal by Subject|1|||
170699176|NCT01708174|616912491|FG001|Treatment Period|Withdrawal by Subject|0|||
170699177|NCT01708174|616912492|FG002|Treatment Period|Withdrawal by Subject|0|||
170699178|NCT01708174|616912490|FG000|Treatment Period|Progressive disease|0|||
170699179|NCT01708174|616912491|FG001|Treatment Period|Progressive disease|1|||
170823902|NCT00985621|617362949|FG001|Overall Study|Withdrawal by Subject|10|||
170699180|NCT01708174|616912492|FG002|Treatment Period|Progressive disease|0|||
170699181|NCT01708174|616912490|FG000|Treatment Period|Death|0|||
170699182|NCT01708174|616912491|FG001|Treatment Period|Death|0|||
170699183|NCT01708174|616912492|FG002|Treatment Period|Death|1|||
170699184|NCT01708174|616912490|FG000|Treatment Period|Adverse Event|0|||
170699185|NCT01708174|616912491|FG001|Treatment Period|Adverse Event|1|||
170699186|NCT01708174|616912492|FG002|Treatment Period|Adverse Event|0|||
170699187|NCT00923559|616912493|FG000|Overall Study|Lost to Follow-up|2|||
170699188|NCT00923559|616912494|FG001|Overall Study|Lost to Follow-up|3|||
170699189|NCT02268812|616912496|FG000|Overall Study|Adverse Event|8|||
170699190|NCT02268812|616912497|FG001|Overall Study|Adverse Event|26|||
170699191|NCT02268812|616912498|FG002|Overall Study|Adverse Event|7|||
170699192|NCT02268812|616912499|FG003|Overall Study|Adverse Event|10|||
170699193|NCT02268812|616912496|FG000|Overall Study|Protocol deviation|0|||
170699194|NCT02268812|616912497|FG001|Overall Study|Protocol deviation|0|||
170699195|NCT02268812|616912498|FG002|Overall Study|Protocol deviation|1|||
170699196|NCT02268812|616912499|FG003|Overall Study|Protocol deviation|0|||
170699197|NCT02268812|616912496|FG000|Overall Study|Withdrawal by Subject|0|||
170699198|NCT02268812|616912497|FG001|Overall Study|Withdrawal by Subject|1|||
170699199|NCT02268812|616912498|FG002|Overall Study|Withdrawal by Subject|0|||
170699200|NCT02268812|616912499|FG003|Overall Study|Withdrawal by Subject|0|||
170699201|NCT02268812|616912496|FG000|Overall Study|Physician Decision|3|||
170699202|NCT02268812|616912497|FG001|Overall Study|Physician Decision|1|||
170699203|NCT02268812|616912498|FG002|Overall Study|Physician Decision|0|||
170699204|NCT02268812|616912499|FG003|Overall Study|Physician Decision|1|||
170699205|NCT02268812|616912496|FG000|Overall Study|Other|5|||
170699206|NCT02268812|616912497|FG001|Overall Study|Other|4|||
170699207|NCT02268812|616912498|FG002|Overall Study|Other|1|||
170699208|NCT02268812|616912499|FG003|Overall Study|Other|3|||
170699209|NCT02385084|616912502|FG000|Period 2|Protocol Violation|0|||
170699210|NCT02385084|616912503|FG001|Period 2|Protocol Violation|0|||
170699211|NCT02385084|616912504|FG002|Period 2|Protocol Violation|1|||
170699212|NCT02385084|616912505|FG003|Period 2|Protocol Violation|0|||
170699213|NCT02385084|616912506|FG004|Period 2|Protocol Violation|0|||
170699214|NCT02385084|616912507|FG005|Period 2|Protocol Violation|0|||
170699215|NCT01148511|616912508|FG000|Exposed to Study Drug|Protocol Violation|2|||
170699216|NCT01148511|616912509|FG001|Exposed to Study Drug|Protocol Violation|0|||
170699217|NCT01148511|616912510|FG002|Exposed to Study Drug|Protocol Violation|0|||
170699218|NCT01148511|616912508|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
170699219|NCT01148511|616912509|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
170699220|NCT01148511|616912510|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
170699221|NCT01148511|616912508|FG000|Randomized|Adverse Event|0|||
170699222|NCT01148511|616912509|FG001|Randomized|Adverse Event|1|||
170699223|NCT01148511|616912510|FG002|Randomized|Adverse Event|0|||
170699224|NCT01148511|616912508|FG000|Randomized|Protocol Violation|0|||
170699225|NCT01148511|616912509|FG001|Randomized|Protocol Violation|2|||
170699226|NCT01148511|616912510|FG002|Randomized|Protocol Violation|1|||
170699227|NCT01148511|616912508|FG000|Randomized|Lost to Follow-up|0|||
170699228|NCT01148511|616912509|FG001|Randomized|Lost to Follow-up|1|||
170699229|NCT01148511|616912510|FG002|Randomized|Lost to Follow-up|1|||
170699230|NCT01148511|616912508|FG000|Randomized|Consent withdrawal|0|||
170699231|NCT01148511|616912509|FG001|Randomized|Consent withdrawal|5|||
170699232|NCT01148511|616912510|FG002|Randomized|Consent withdrawal|3|||
170699233|NCT01148511|616912508|FG000|Randomized|Other|0|||
170699234|NCT01148511|616912509|FG001|Randomized|Other|1|||
170699235|NCT01148511|616912510|FG002|Randomized|Other|1|||
170699236|NCT04258605|616912511|FG000|Overall Study|Death|1|||
170699237|NCT04258605|616912512|FG001|Overall Study|Death|0|||
170699238|NCT04258605|616912511|FG000|Overall Study|Early study termination|21|||
170699239|NCT04258605|616912512|FG001|Overall Study|Early study termination|2|||
170699240|NCT00969553|616912528|FG000|Overall Study|Progressive disease (PD)|2|||
170699241|NCT00969553|616912529|FG001|Overall Study|Progressive disease (PD)|2|||
170699242|NCT00969553|616912530|FG002|Overall Study|Progressive disease (PD)|6|||
170699243|NCT00969553|616912531|FG003|Overall Study|Progressive disease (PD)|9|||
170699244|NCT00969553|616912532|FG004|Overall Study|Progressive disease (PD)|2|||
170699245|NCT00969553|616912533|FG005|Overall Study|Progressive disease (PD)|4|||
170699246|NCT00969553|616912534|FG006|Overall Study|Progressive disease (PD)|2|||
170699247|NCT00969553|616912535|FG007|Overall Study|Progressive disease (PD)|12|||
170699248|NCT00969553|616912536|FG008|Overall Study|Progressive disease (PD)|3|||
170699249|NCT00969553|616912528|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
170699250|NCT00969553|616912529|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
170699251|NCT00969553|616912530|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
170699252|NCT00969553|616912531|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
170699253|NCT00969553|616912532|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
170699254|NCT00969553|616912533|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
170699255|NCT00969553|616912534|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
170699256|NCT00969553|616912535|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
170699257|NCT00969553|616912536|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
170699258|NCT00969553|616912528|FG000|Overall Study|Other Adverse Event|0|||
170699259|NCT00969553|616912529|FG001|Overall Study|Other Adverse Event|0|||
170699260|NCT00969553|616912530|FG002|Overall Study|Other Adverse Event|0|||
170699261|NCT00969553|616912531|FG003|Overall Study|Other Adverse Event|1|||
170699262|NCT00969553|616912532|FG004|Overall Study|Other Adverse Event|0|||
170699263|NCT00969553|616912533|FG005|Overall Study|Other Adverse Event|0|||
170699264|NCT00969553|616912534|FG006|Overall Study|Other Adverse Event|1|||
170699265|NCT00969553|616912535|FG007|Overall Study|Other Adverse Event|0|||
170699266|NCT00969553|616912536|FG008|Overall Study|Other Adverse Event|0|||
170699267|NCT00969553|616912528|FG000|Overall Study|Refused cont. medication|1|||
170699268|NCT00969553|616912529|FG001|Overall Study|Refused cont. medication|1|||
170699269|NCT00969553|616912530|FG002|Overall Study|Refused cont. medication|0|||
170699270|NCT00969553|616912531|FG003|Overall Study|Refused cont. medication|2|||
170699271|NCT00969553|616912532|FG004|Overall Study|Refused cont. medication|0|||
170699272|NCT00969553|616912533|FG005|Overall Study|Refused cont. medication|0|||
170699273|NCT00969553|616912534|FG006|Overall Study|Refused cont. medication|0|||
170699274|NCT00969553|616912535|FG007|Overall Study|Refused cont. medication|1|||
170699275|NCT00969553|616912536|FG008|Overall Study|Refused cont. medication|0|||
170699276|NCT00969553|616912528|FG000|Overall Study|Not specified above|0|||
170699277|NCT00969553|616912529|FG001|Overall Study|Not specified above|0|||
170699278|NCT00969553|616912530|FG002|Overall Study|Not specified above|0|||
170699279|NCT00969553|616912531|FG003|Overall Study|Not specified above|4|||
170699280|NCT00969553|616912532|FG004|Overall Study|Not specified above|0|||
170699281|NCT00969553|616912533|FG005|Overall Study|Not specified above|0|||
170699282|NCT00969553|616912534|FG006|Overall Study|Not specified above|1|||
170699283|NCT00969553|616912535|FG007|Overall Study|Not specified above|1|||
170699284|NCT00969553|616912536|FG008|Overall Study|Not specified above|0|||
170699285|NCT00082433|616912537|FG000|Overall Study|Adverse Event|12|||
170699286|NCT00082433|616912538|FG001|Overall Study|Adverse Event|17|||
170699287|NCT00082433|616912537|FG000|Overall Study|Death|8|||
170699288|NCT00082433|616912538|FG001|Overall Study|Death|18|||
170699289|NCT00082433|616912537|FG000|Overall Study|Disease Progression/Relapse|270|||
170699290|NCT00082433|616912538|FG001|Overall Study|Disease Progression/Relapse|388|||
170699291|NCT00082433|616912537|FG000|Overall Study|Physician Decision|50|||
170699292|NCT00082433|616912538|FG001|Overall Study|Physician Decision|61|||
170699293|NCT00082433|616912537|FG000|Overall Study|Lost to Follow-up|1|||
170699294|NCT00082433|616912538|FG001|Overall Study|Lost to Follow-up|2|||
170699295|NCT00082433|616912537|FG000|Overall Study|Study Drug Toxicity|179|||
170699296|NCT00082433|616912538|FG001|Overall Study|Study Drug Toxicity|66|||
170699297|NCT00082433|616912537|FG000|Overall Study|Withdrawal by Subject|55|||
170699298|NCT00082433|616912538|FG001|Overall Study|Withdrawal by Subject|30|||
170699299|NCT00082433|616912537|FG000|Overall Study|Still On Treatment|2|||
170699300|NCT00082433|616912538|FG001|Overall Study|Still On Treatment|1|||
170699301|NCT00082433|616912537|FG000|Overall Study|Not Treated|12|||
170699302|NCT00082433|616912538|FG001|Overall Study|Not Treated|11|||
170699303|NCT00082433|616912537|FG000|Overall Study|Ineligible|2|||
170699304|NCT00082433|616912538|FG001|Overall Study|Ineligible|1|||
170699305|NCT00082433|616912537|FG000|Overall Study|Noncompliance|2|||
170699306|NCT00082433|616912538|FG001|Overall Study|Noncompliance|1|||
170699307|NCT00082433|616912537|FG000|Overall Study|New primary cancer|1|||
170699308|NCT00082433|616912538|FG001|Overall Study|New primary cancer|0|||
170699309|NCT00082433|616912537|FG000|Overall Study|Impending surgery|0|||
170699310|NCT00082433|616912538|FG001|Overall Study|Impending surgery|1|||
170699311|NCT02276612|616912539|FG000|Overall Study|Death|1|||
170699312|NCT02276612|616912540|FG001|Overall Study|Death|0|||
170699313|NCT02276612|616912539|FG000|Overall Study|Pregnancy|1|||
170699314|NCT02276612|616912540|FG001|Overall Study|Pregnancy|0|||
170699315|NCT02276612|616912539|FG000|Overall Study|Withdrew Consent|1|||
170699316|NCT02276612|616912540|FG001|Overall Study|Withdrew Consent|0|||
170699317|NCT02276612|616912539|FG000|Overall Study|Lost to Follow-up|1|||
170699318|NCT02276612|616912540|FG001|Overall Study|Lost to Follow-up|0|||
170699319|NCT04536727|616912541|FG000|Overall Study|Lost to Follow-up|1|||
170699320|NCT04536727|616912542|FG001|Overall Study|Lost to Follow-up|1|||
170699321|NCT04536727|616912541|FG000|Overall Study|Death|0|||
170699322|NCT04536727|616912542|FG001|Overall Study|Death|1|||
170699323|NCT01077804|616912543|FG000|Overall Study|Unreachable|102|||
170699324|NCT01077804|616912543|FG000|Overall Study|Refused to continue|79|||
170699325|NCT01077804|616912543|FG000|Overall Study|Other|18|||
170699326|NCT02620046|616912545|FG000|Overall Study|Adverse Event|22|||
170699327|NCT02620046|616912546|FG001|Overall Study|Adverse Event|42|||
170699328|NCT02620046|616912545|FG000|Overall Study|Lost to Follow-up|4|||
170699329|NCT02620046|616912546|FG001|Overall Study|Lost to Follow-up|10|||
170699330|NCT02620046|616912545|FG000|Overall Study|Withdrawal by Subject|36|||
170699331|NCT02620046|616912546|FG001|Overall Study|Withdrawal by Subject|66|||
170699332|NCT02620046|616912545|FG000|Overall Study|Site Termination|3|||
170699333|NCT02620046|616912546|FG001|Overall Study|Site Termination|3|||
170699334|NCT02620046|616912545|FG000|Overall Study|Pregnancy|3|||
170699335|NCT02620046|616912546|FG001|Overall Study|Pregnancy|7|||
170699336|NCT02620046|616912545|FG000|Overall Study|Lack of Efficacy|81|||
170823903|NCT00985621|617362950|FG002|Overall Study|Withdrawal by Subject|8|||
170823904|NCT00985621|617362951|FG003|Overall Study|Withdrawal by Subject|12|||
170699337|NCT02620046|616912546|FG001|Overall Study|Lack of Efficacy|146|||
170699338|NCT02620046|616912545|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
170699339|NCT02620046|616912546|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
170699340|NCT02620046|616912545|FG000|Overall Study|Reason Not Specified|13|||
170699341|NCT02620046|616912546|FG001|Overall Study|Reason Not Specified|21|||
170699342|NCT02620046|616912545|FG000|Overall Study|Significant Protocol Deviation|0|||
170699343|NCT02620046|616912546|FG001|Overall Study|Significant Protocol Deviation|1|||
170699344|NCT03003520|616914233|FG000|Overall Study|Adverse Event|9|||
170699345|NCT03003520|616914234|FG001|Overall Study|Adverse Event|0|||
170699346|NCT03003520|616914233|FG000|Overall Study|Death|1|||
170699347|NCT03003520|616914234|FG001|Overall Study|Death|0|||
170699348|NCT03003520|616914233|FG000|Overall Study|Other reasons|4|||
170699349|NCT03003520|616914234|FG001|Overall Study|Other reasons|0|||
170699350|NCT03003520|616914233|FG000|Overall Study|Withdrawal by Subject|6|||
170699351|NCT03003520|616914234|FG001|Overall Study|Withdrawal by Subject|0|||
170699352|NCT03003520|616914233|FG000|Overall Study|Progressive disease|9|||
170699353|NCT03003520|616914234|FG001|Overall Study|Progressive disease|1|||
170699354|NCT00653224|616914235|FG000|Overall Study|Adverse Event|2|||
170699355|NCT00653224|616914236|FG001|Overall Study|Adverse Event|1|||
170699356|NCT00653224|616914235|FG000|Overall Study|Lack of Efficacy|1|||
170699357|NCT00653224|616914236|FG001|Overall Study|Lack of Efficacy|2|||
170699358|NCT00653224|616914235|FG000|Overall Study|Loss of efficacy|1|||
170699359|NCT00653224|616914236|FG001|Overall Study|Loss of efficacy|0|||
170699360|NCT00653224|616914235|FG000|Overall Study|Lost to Follow-up|1|||
170699361|NCT00653224|616914236|FG001|Overall Study|Lost to Follow-up|0|||
170699362|NCT00653224|616914235|FG000|Overall Study|Other|2|||
170699363|NCT00653224|616914236|FG001|Overall Study|Other|4|||
170699364|NCT05308901|616914237|FG000|Overall Study|Death|6|||
170699365|NCT01914666|616914238|FG000|Treatment Period|Lack of Efficacy|0|||
170699366|NCT01914666|616914239|FG001|Treatment Period|Lack of Efficacy|0|||
170699367|NCT01914666|616914240|FG002|Treatment Period|Lack of Efficacy|2|||
170699368|NCT01914666|616914238|FG000|Treatment Period|Adverse Event|10|||
170699369|NCT01914666|616914239|FG001|Treatment Period|Adverse Event|4|||
170699370|NCT01914666|616914240|FG002|Treatment Period|Adverse Event|2|||
170699371|NCT01914666|616914238|FG000|Treatment Period|Withdrawal by Subject|3|||
170699372|NCT01914666|616914239|FG001|Treatment Period|Withdrawal by Subject|2|||
170699373|NCT01914666|616914240|FG002|Treatment Period|Withdrawal by Subject|2|||
170699374|NCT01914666|616914238|FG000|Treatment Period|Physician Decision|0|||
170699375|NCT01914666|616914239|FG001|Treatment Period|Physician Decision|0|||
170699376|NCT01914666|616914240|FG002|Treatment Period|Physician Decision|2|||
170699377|NCT04152447|616914241|FG000|Overall Study|Lost to Follow-up|1|||
170699378|NCT04152447|616914242|FG001|Overall Study|Lost to Follow-up|0|||
170699379|NCT04152447|616914241|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
170699380|NCT04152447|616914242|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
170699381|NCT04152447|616914241|FG000|Overall Study|Withdrawal by Subject|0|||
170699382|NCT04152447|616914242|FG001|Overall Study|Withdrawal by Subject|1|||
170699383|NCT04152447|616914241|FG000|Overall Study|Found ineligible after enrolling|1|||
170699384|NCT04152447|616914242|FG001|Overall Study|Found ineligible after enrolling|1|||
170699385|NCT04152447|616914241|FG000|Overall Study|Did not receive VR headset in time.|0|||
170699386|NCT04152447|616914242|FG001|Overall Study|Did not receive VR headset in time.|2|||
170699387|NCT01302964|616914245|FG000|Overall Study|Adverse Event|1|||
170699388|NCT01302964|616914246|FG001|Overall Study|Adverse Event|0|||
170699389|NCT01633944|616914250|FG000|Open-label Titration Phase|Adverse Event|109|||
170699390|NCT01633944|616914251|FG001|Open-label Titration Phase|Adverse Event|0|||
170699391|NCT01633944|616914252|FG002|Open-label Titration Phase|Adverse Event|0|||
170699392|NCT01633944|616914250|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
170699393|NCT01633944|616914251|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
170699394|NCT01633944|616914252|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
170699395|NCT01633944|616914250|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
170699396|NCT01633944|616914251|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
170823905|NCT00985621|617362948|FG000|Overall Study|Other|1|||
170699397|NCT01633944|616914252|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
170699398|NCT01633944|616914250|FG000|Open-label Titration Phase|Protocol Violation|24|||
170699399|NCT01633944|616914251|FG001|Open-label Titration Phase|Protocol Violation|0|||
170699400|NCT01633944|616914252|FG002|Open-label Titration Phase|Protocol Violation|0|||
170823906|NCT00985621|617362949|FG001|Overall Study|Other|0|||
170823907|NCT00985621|617362950|FG002|Overall Study|Other|0|||
170699401|NCT01633944|616914250|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
170699402|NCT01633944|616914251|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
170699403|NCT01633944|616914252|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
170823908|NCT00985621|617362951|FG003|Overall Study|Other|0|||
170823909|NCT00985621|617362948|FG000|Overall Study|Randomized but not Treated|1|||
170699404|NCT01633944|616914250|FG000|Open-label Titration Phase|Other|68|||
170823910|NCT00985621|617362949|FG001|Overall Study|Randomized but not Treated|0|||
170699405|NCT01633944|616914251|FG001|Open-label Titration Phase|Other|0|||
170699406|NCT01633944|616914252|FG002|Open-label Titration Phase|Other|0|||
170699407|NCT01633944|616914250|FG000|Double-blind Treatment Phase|Adverse Event|0|||
170699408|NCT01633944|616914251|FG001|Double-blind Treatment Phase|Adverse Event|13|||
170699409|NCT01633944|616914252|FG002|Double-blind Treatment Phase|Adverse Event|7|||
170699410|NCT01633944|616914250|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
170699411|NCT01633944|616914251|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
170699412|NCT01633944|616914252|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
170699413|NCT01633944|616914250|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
170699414|NCT01633944|616914251|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
170699415|NCT01633944|616914252|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
170699416|NCT01633944|616914250|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
170699417|NCT01633944|616914251|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
170699418|NCT01633944|616914252|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
170699419|NCT01633944|616914250|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
170699420|NCT01633944|616914251|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
170699421|NCT01633944|616914252|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
170699422|NCT01633944|616914250|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
170699423|NCT01633944|616914251|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
170699424|NCT01633944|616914252|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
170699425|NCT01633944|616914250|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
170699426|NCT01633944|616914251|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
170699427|NCT01633944|616914252|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
170699428|NCT01633944|616914250|FG000|Double-blind Treatment Phase|Other|0|||
170699429|NCT01633944|616914251|FG001|Double-blind Treatment Phase|Other|7|||
170699430|NCT01633944|616914252|FG002|Double-blind Treatment Phase|Other|0|||
170699431|NCT00701129|616914253|FG000|Overall Study|Death|2|||
170699432|NCT01400841|616914254|FG000|Initial Study Phase (6 Months)|Death|1|||
170699433|NCT01400841|616914254|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
170699434|NCT00910715|616914255|FG000|Overall Study|Lost to Follow-up|22|||
170699435|NCT00910715|616914256|FG001|Overall Study|Lost to Follow-up|26|||
170699436|NCT00910715|616914257|FG002|Overall Study|Lost to Follow-up|0|||
170699437|NCT00706966|616914259|FG000|Overall Study|Adverse Event|1|||
170699438|NCT02884089|616914260|FG000|Period 1|Dosing error|2|||
170699439|NCT02884089|616914261|FG001|Period 1|Dosing error|2|||
170699440|NCT02884089|616914262|FG002|Period 1|Dosing error|0|||
170699441|NCT02884089|616914263|FG003|Period 1|Dosing error|0|||
170699442|NCT02884089|616914260|FG000|Washout Period 1|Lost to Follow-up|0|||
170699443|NCT02884089|616914261|FG001|Washout Period 1|Lost to Follow-up|1|||
170699444|NCT02884089|616914262|FG002|Washout Period 1|Lost to Follow-up|0|||
170699445|NCT02884089|616914263|FG003|Washout Period 1|Lost to Follow-up|1|||
170699446|NCT02884089|616914260|FG000|Washout Period 1|Withdrawal by Subject|0|||
170699447|NCT02884089|616914261|FG001|Washout Period 1|Withdrawal by Subject|1|||
170699448|NCT02884089|616914262|FG002|Washout Period 1|Withdrawal by Subject|0|||
170699449|NCT02884089|616914263|FG003|Washout Period 1|Withdrawal by Subject|0|||
170699450|NCT02884089|616914260|FG000|Period 2|Adverse Event|1|||
170699451|NCT02884089|616914261|FG001|Period 2|Adverse Event|0|||
170699452|NCT02884089|616914262|FG002|Period 2|Adverse Event|0|||
170699453|NCT02884089|616914263|FG003|Period 2|Adverse Event|0|||
170699454|NCT02884089|616914260|FG000|Period 3|Withdrawal by Subject|0|||
170699455|NCT02884089|616914261|FG001|Period 3|Withdrawal by Subject|0|||
170699456|NCT02884089|616914262|FG002|Period 3|Withdrawal by Subject|1|||
170699457|NCT02884089|616914263|FG003|Period 3|Withdrawal by Subject|0|||
170699458|NCT02884089|616914260|FG000|Washout Period 3|Withdrawal by Subject|0|||
170699459|NCT02884089|616914261|FG001|Washout Period 3|Withdrawal by Subject|0|||
170699460|NCT02884089|616914262|FG002|Washout Period 3|Withdrawal by Subject|1|||
170699461|NCT02884089|616914263|FG003|Washout Period 3|Withdrawal by Subject|0|||
170699462|NCT02884089|616914260|FG000|Washout Period 3|Lost to Follow-up|0|||
170699463|NCT02884089|616914261|FG001|Washout Period 3|Lost to Follow-up|0|||
170699464|NCT02884089|616914262|FG002|Washout Period 3|Lost to Follow-up|0|||
170699465|NCT02884089|616914263|FG003|Washout Period 3|Lost to Follow-up|1|||
170823911|NCT00985621|617362950|FG002|Overall Study|Randomized but not Treated|2|||
170823912|NCT00985621|617362951|FG003|Overall Study|Randomized but not Treated|1|||
170823913|NCT03873038|617362952|FG000|Part 2|Withdrawal by Subject|0|||
170823914|NCT03873038|617362953|FG001|Part 2|Withdrawal by Subject|0|||
170823915|NCT03873038|617362954|FG002|Part 2|Withdrawal by Subject|0|||
170823916|NCT03873038|617362955|FG003|Part 2|Withdrawal by Subject|0|||
170823917|NCT03873038|617362956|FG004|Part 2|Withdrawal by Subject|0|||
170823918|NCT03873038|617362957|FG005|Part 2|Withdrawal by Subject|1|||
170823919|NCT03873038|617362952|FG000|Part 2|Unknon|0|||
170823920|NCT03873038|617362953|FG001|Part 2|Unknon|0|||
170699466|NCT02884089|616914260|FG000|Period 4|Withdrawal by Subject|0|||
170699467|NCT02884089|616914261|FG001|Period 4|Withdrawal by Subject|1|||
170699468|NCT02884089|616914262|FG002|Period 4|Withdrawal by Subject|0|||
170823921|NCT03873038|617362954|FG002|Part 2|Unknon|0|||
170699469|NCT02884089|616914263|FG003|Period 4|Withdrawal by Subject|0|||
170699470|NCT02884089|616914260|FG000|Period 4|Lost to Follow-up|1|||
170699471|NCT02884089|616914261|FG001|Period 4|Lost to Follow-up|0|||
170699472|NCT02884089|616914262|FG002|Period 4|Lost to Follow-up|0|||
170699473|NCT02884089|616914263|FG003|Period 4|Lost to Follow-up|0|||
170699474|NCT02884089|616914260|FG000|Follow-up Visit|Withdrawal by Subject|1|||
170699475|NCT02884089|616914261|FG001|Follow-up Visit|Withdrawal by Subject|0|||
170699476|NCT02884089|616914262|FG002|Follow-up Visit|Withdrawal by Subject|0|||
170699477|NCT02884089|616914263|FG003|Follow-up Visit|Withdrawal by Subject|1|||
170699478|NCT01631474|616914264|FG000|Overall Study|Lost to Follow-up|8|||
170699479|NCT01631474|616914265|FG001|Overall Study|Lost to Follow-up|5|||
170699480|NCT01631474|616914266|FG002|Overall Study|Lost to Follow-up|7|||
170699481|NCT01631474|616914267|FG003|Overall Study|Lost to Follow-up|5|||
170699482|NCT01631474|616914268|FG004|Overall Study|Lost to Follow-up|5|||
170699483|NCT01631474|616914264|FG000|Overall Study|Withdrawal by Subject|4|||
170699484|NCT01631474|616914265|FG001|Overall Study|Withdrawal by Subject|4|||
170699485|NCT01631474|616914266|FG002|Overall Study|Withdrawal by Subject|2|||
170699486|NCT01631474|616914267|FG003|Overall Study|Withdrawal by Subject|6|||
170699487|NCT01631474|616914268|FG004|Overall Study|Withdrawal by Subject|5|||
170699488|NCT01631474|616914264|FG000|Overall Study|Lack of Efficacy|2|||
170699489|NCT01631474|616914265|FG001|Overall Study|Lack of Efficacy|2|||
170699490|NCT01631474|616914266|FG002|Overall Study|Lack of Efficacy|0|||
170699491|NCT01631474|616914267|FG003|Overall Study|Lack of Efficacy|0|||
170699492|NCT01631474|616914268|FG004|Overall Study|Lack of Efficacy|2|||
170699493|NCT01631474|616914264|FG000|Overall Study|Noncompliance with Study Drug|0|||
170699494|NCT01631474|616914265|FG001|Overall Study|Noncompliance with Study Drug|0|||
170699495|NCT01631474|616914266|FG002|Overall Study|Noncompliance with Study Drug|0|||
170699496|NCT01631474|616914267|FG003|Overall Study|Noncompliance with Study Drug|0|||
170699497|NCT01631474|616914268|FG004|Overall Study|Noncompliance with Study Drug|1|||
170699498|NCT01631474|616914264|FG000|Overall Study|Adverse Event|0|||
170699499|NCT01631474|616914265|FG001|Overall Study|Adverse Event|1|||
170699500|NCT01631474|616914266|FG002|Overall Study|Adverse Event|0|||
170699501|NCT01631474|616914267|FG003|Overall Study|Adverse Event|0|||
170699502|NCT01631474|616914268|FG004|Overall Study|Adverse Event|0|||
170699503|NCT01467076|616914269|FG000|Overall Study|Lost to Follow-up|1|||
170699504|NCT01467076|616914270|FG001|Overall Study|Lost to Follow-up|0|||
170699505|NCT01467076|616914271|FG002|Overall Study|Lost to Follow-up|0|||
170699506|NCT03354429|616914272|FG000|Overall Study|Withdrawal by Subject|8|||
170699507|NCT03354429|616914273|FG001|Overall Study|Withdrawal by Subject|7|||
170699508|NCT03354429|616914272|FG000|Overall Study|Lost to Follow-up|1|||
170699509|NCT03354429|616914273|FG001|Overall Study|Lost to Follow-up|0|||
170699510|NCT00782210|616914279|FG000|Overall Study|Adverse Event|21|||
170699511|NCT00782210|616914280|FG001|Overall Study|Adverse Event|17|||
170699512|NCT00782210|616914281|FG002|Overall Study|Adverse Event|16|||
170699513|NCT00782210|616914279|FG000|Overall Study|Lost to Follow-up|2|||
170699514|NCT00782210|616914280|FG001|Overall Study|Lost to Follow-up|1|||
170699515|NCT00782210|616914281|FG002|Overall Study|Lost to Follow-up|2|||
170699516|NCT00782210|616914279|FG000|Overall Study|Withdrawal by Subject|11|||
170699517|NCT00782210|616914280|FG001|Overall Study|Withdrawal by Subject|8|||
170699518|NCT00782210|616914281|FG002|Overall Study|Withdrawal by Subject|11|||
170699519|NCT00782210|616914279|FG000|Overall Study|Non compliance with protocol|0|||
170699520|NCT00782210|616914280|FG001|Overall Study|Non compliance with protocol|3|||
170699521|NCT00782210|616914281|FG002|Overall Study|Non compliance with protocol|2|||
170699522|NCT00782210|616914279|FG000|Overall Study|Lack of Efficacy|13|||
170699523|NCT00782210|616914280|FG001|Overall Study|Lack of Efficacy|4|||
170699524|NCT00782210|616914281|FG002|Overall Study|Lack of Efficacy|1|||
170699525|NCT00782210|616914279|FG000|Overall Study|Other reason not described above|3|||
170699526|NCT00782210|616914280|FG001|Overall Study|Other reason not described above|2|||
170699527|NCT00782210|616914281|FG002|Overall Study|Other reason not described above|3|||
170699528|NCT01610791|616914285|FG000|Overall Study|Lost to Follow-up|7|||
170699529|NCT01610791|616914285|FG000|Overall Study|Adverse Event|6|||
170699530|NCT01610791|616914285|FG000|Overall Study|Physician Decision|1|||
170699531|NCT01610791|616914285|FG000|Overall Study|Adverse event and Investigator decision|1|||
170699532|NCT01610791|616914285|FG000|Overall Study|Death|1|||
170699533|NCT01610791|616914285|FG000|Overall Study|Not determined|5|||
170699534|NCT05923229|616914288|FG000|Overall Study|Withdrawal by Subject|3|||
170699535|NCT05923229|616914289|FG001|Overall Study|Withdrawal by Subject|0|||
170699536|NCT05923229|616914288|FG000|Overall Study|Health related|2|||
170699537|NCT05923229|616914289|FG001|Overall Study|Health related|1|||
170699538|NCT04164901|616914290|FG000|Overall Study|Withdrawal by Subject|4|||
170699539|NCT04164901|616914291|FG001|Overall Study|Withdrawal by Subject|4|||
170699540|NCT05288556|616914292|FG000|Overall Study|Protocol Violation|1|||
170699541|NCT05288556|616914292|FG000|Overall Study|Withdrawal by Subject|1|||
170699542|NCT05358821|616914293|FG000|Overall Study|Withdrawal by Subject|0|||
170699543|NCT05358821|616914294|FG001|Overall Study|Withdrawal by Subject|1|||
170699544|NCT05358821|616914295|FG002|Overall Study|Withdrawal by Subject|0|||
170699545|NCT05358821|616914293|FG000|Overall Study|Withdrawal of Consent|0|||
170699546|NCT05358821|616914294|FG001|Overall Study|Withdrawal of Consent|0|||
170823922|NCT03873038|617362955|FG003|Part 2|Unknon|0|||
170823923|NCT03873038|617362956|FG004|Part 2|Unknon|1|||
170823924|NCT03873038|617362957|FG005|Part 2|Unknon|0|||
170823925|NCT00603278|617362958|FG000|Overall Study|Lack of Efficacy|35|||
170823926|NCT00603278|617362959|FG001|Overall Study|Lack of Efficacy|10|||
170823927|NCT00603278|617362960|FG002|Overall Study|Lack of Efficacy|11|||
170823928|NCT00603278|617362961|FG003|Overall Study|Lack of Efficacy|8|||
170823929|NCT00603278|617362962|FG004|Overall Study|Lack of Efficacy|7|||
170823930|NCT00603278|617362963|FG005|Overall Study|Lack of Efficacy|14|||
170823931|NCT00603278|617362958|FG000|Overall Study|Adverse Event|0|||
170823932|NCT00603278|617362959|FG001|Overall Study|Adverse Event|3|||
170823933|NCT00603278|617362960|FG002|Overall Study|Adverse Event|1|||
170823934|NCT00603278|617362961|FG003|Overall Study|Adverse Event|0|||
170823935|NCT00603278|617362962|FG004|Overall Study|Adverse Event|2|||
170823936|NCT00603278|617362963|FG005|Overall Study|Adverse Event|1|||
170823937|NCT00603278|617362958|FG000|Overall Study|Withdrawal by Subject|2|||
170823938|NCT00603278|617362959|FG001|Overall Study|Withdrawal by Subject|3|||
170823939|NCT00603278|617362960|FG002|Overall Study|Withdrawal by Subject|1|||
170823940|NCT00603278|617362961|FG003|Overall Study|Withdrawal by Subject|2|||
170823941|NCT00603278|617362962|FG004|Overall Study|Withdrawal by Subject|1|||
170823942|NCT00603278|617362963|FG005|Overall Study|Withdrawal by Subject|2|||
170699547|NCT05358821|616914295|FG002|Overall Study|Withdrawal of Consent|1|||
170699548|NCT05040152|616914298|FG000|Overall Study|Withdrawal by Subject|5|||
170699549|NCT05040152|616914299|FG001|Overall Study|Withdrawal by Subject|0|||
170699550|NCT05040152|616914298|FG000|Overall Study|Lost to Follow-up|0|||
170699551|NCT05040152|616914299|FG001|Overall Study|Lost to Follow-up|2|||
170699552|NCT00006489|616914302|FG000|Overall Study|Adverse Event|3|||
170699553|NCT00006489|616914303|FG001|Overall Study|Adverse Event|2|||
170699554|NCT00006489|616914304|FG002|Overall Study|Adverse Event|4|||
170699555|NCT00006489|616914305|FG003|Overall Study|Adverse Event|3|||
170699556|NCT00006489|616914302|FG000|Overall Study|Withdrawal by Subject|10|||
170699557|NCT00006489|616914303|FG001|Overall Study|Withdrawal by Subject|9|||
170699558|NCT00006489|616914304|FG002|Overall Study|Withdrawal by Subject|9|||
170699559|NCT00006489|616914305|FG003|Overall Study|Withdrawal by Subject|6|||
170699560|NCT00006489|616914302|FG000|Overall Study|Scheduling Conflict|0|||
170699561|NCT00006489|616914303|FG001|Overall Study|Scheduling Conflict|3|||
170699562|NCT00006489|616914304|FG002|Overall Study|Scheduling Conflict|2|||
170699563|NCT00006489|616914305|FG003|Overall Study|Scheduling Conflict|1|||
170699564|NCT00006489|616914302|FG000|Overall Study|Death|0|||
170699565|NCT00006489|616914303|FG001|Overall Study|Death|0|||
170699566|NCT00006489|616914304|FG002|Overall Study|Death|0|||
170699567|NCT00006489|616914305|FG003|Overall Study|Death|1|||
170699568|NCT00578175|616914306|FG000|Overall Study|Adverse Event|0|||
170699569|NCT00578175|616914307|FG001|Overall Study|Adverse Event|1|||
170699570|NCT00578175|616914308|FG002|Overall Study|Adverse Event|1|||
170699571|NCT00578175|616914306|FG000|Overall Study|Other reasons|70|||
170699572|NCT00578175|616914307|FG001|Overall Study|Other reasons|42|||
170699573|NCT00578175|616914308|FG002|Overall Study|Other reasons|23|||
170699574|NCT01461096|616914315|FG000|Overall Study|Death|3|||
170699575|NCT01461096|616914316|FG001|Overall Study|Death|6|||
170699576|NCT01461096|616914315|FG000|Overall Study|Severe debilitation, unable to continue|1|||
170699577|NCT01461096|616914316|FG001|Overall Study|Severe debilitation, unable to continue|1|||
170699578|NCT01461096|616914315|FG000|Overall Study|Subj not able to get to clinic|15|||
170699579|NCT01461096|616914316|FG001|Overall Study|Subj not able to get to clinic|13|||
170699580|NCT01461096|616914315|FG000|Overall Study|Site is closing|27|||
170699581|NCT01461096|616914316|FG001|Overall Study|Site is closing|30|||
170699582|NCT01461096|616914315|FG000|Overall Study|Withdrawal by Subject|5|||
170699583|NCT01461096|616914316|FG001|Overall Study|Withdrawal by Subject|3|||
170699584|NCT01461096|616914315|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
170699585|NCT01461096|616914316|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
170699586|NCT01461096|616914315|FG000|Overall Study|Lost to Follow-up|8|||
170699587|NCT01461096|616914316|FG001|Overall Study|Lost to Follow-up|4|||
170699588|NCT04889625|616914317|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
170699589|NCT04889625|616914318|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
170699590|NCT04889625|616914317|FG000|Period 1|Subject out of window|0|||
170699591|NCT04889625|616914318|FG001|Period 1|Subject out of window|1|||
170699592|NCT04889625|616914317|FG000|Period 1|Wrong add power dispensed|0|||
170699593|NCT04889625|616914318|FG001|Period 1|Wrong add power dispensed|1|||
170823943|NCT00603278|617362958|FG000|Overall Study|Protocol Violation|3|||
170823944|NCT00603278|617362959|FG001|Overall Study|Protocol Violation|0|||
170823945|NCT00603278|617362960|FG002|Overall Study|Protocol Violation|1|||
170823946|NCT00603278|617362961|FG003|Overall Study|Protocol Violation|1|||
170699594|NCT04889625|616914317|FG000|Period 1|Discontinued due to fitting guide error|1|||
170823947|NCT00603278|617362962|FG004|Overall Study|Protocol Violation|0|||
170823948|NCT00603278|617362963|FG005|Overall Study|Protocol Violation|1|||
170823949|NCT00603278|617362958|FG000|Overall Study|Physician Decision|0|||
170823950|NCT00603278|617362959|FG001|Overall Study|Physician Decision|1|||
170699595|NCT04889625|616914318|FG001|Period 1|Discontinued due to fitting guide error|1|||
170699596|NCT04889625|616914317|FG000|Period 2|Test article no longer available|1|||
170699597|NCT04889625|616914318|FG001|Period 2|Test article no longer available|0|||
170699598|NCT04889625|616914317|FG000|Period 2|Incorrect lens dispensed|1|||
170699599|NCT04889625|616914318|FG001|Period 2|Incorrect lens dispensed|0|||
170699600|NCT04889625|616914317|FG000|Period 2|Wrong add power dispensed|0|||
170699601|NCT04889625|616914318|FG001|Period 2|Wrong add power dispensed|1|||
170699602|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
170699603|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
170699604|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
170699605|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
170699606|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
170699607|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
170699608|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
170699609|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
170699610|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
170699611|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
170699612|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
170699613|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
170699614|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
170699615|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
170699616|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
170699617|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
170699618|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
170699619|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
170699620|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Death|0|||
170699621|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Death|0|||
170699622|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Death|1|||
170699623|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Death|0|||
170699624|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Death|0|||
170699625|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Death|0|||
170699626|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Death|0|||
170699627|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Death|0|||
170699628|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Death|0|||
170699629|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
170699630|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
170699631|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
170699632|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
170699633|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
170699634|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
170699635|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
170699636|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
170699637|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
170699638|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
170699639|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
170699640|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
170699641|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
170699642|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
170699643|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
170699644|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
170699645|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
170699646|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
170699647|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
170699648|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
170699649|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
170699650|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
170699651|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
170699652|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
170699653|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
170699654|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
170699655|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
170699656|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
170699657|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
170699658|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
170699659|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
170699660|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
170699661|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
170699662|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
170699663|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
170699664|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
170699665|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
170823951|NCT00603278|617362960|FG002|Overall Study|Physician Decision|0|||
170823952|NCT00603278|617362961|FG003|Overall Study|Physician Decision|0|||
170823953|NCT00603278|617362962|FG004|Overall Study|Physician Decision|2|||
170823954|NCT00603278|617362963|FG005|Overall Study|Physician Decision|1|||
170823955|NCT00603278|617362958|FG000|Overall Study|Lost to Follow-up|1|||
170823956|NCT00603278|617362959|FG001|Overall Study|Lost to Follow-up|0|||
170823957|NCT00603278|617362960|FG002|Overall Study|Lost to Follow-up|0|||
170823958|NCT00603278|617362961|FG003|Overall Study|Lost to Follow-up|0|||
170823959|NCT00603278|617362962|FG004|Overall Study|Lost to Follow-up|1|||
170823960|NCT00603278|617362963|FG005|Overall Study|Lost to Follow-up|0|||
170823961|NCT01332318|617362965|FG000|Overall Study|Adverse Event|0|||
170823962|NCT01332318|617362966|FG001|Overall Study|Adverse Event|3|||
170823963|NCT01332318|617362967|FG002|Overall Study|Adverse Event|0|||
170823964|NCT01332318|617362968|FG003|Overall Study|Adverse Event|0|||
170823965|NCT01332318|617362965|FG000|Overall Study|Withdrawal by Subject|1|||
170823966|NCT01332318|617362966|FG001|Overall Study|Withdrawal by Subject|1|||
170823967|NCT01332318|617362967|FG002|Overall Study|Withdrawal by Subject|0|||
170823968|NCT01332318|617362968|FG003|Overall Study|Withdrawal by Subject|1|||
170823969|NCT01332318|617362965|FG000|Overall Study|Protocol Violation|1|||
170823970|NCT01332318|617362966|FG001|Overall Study|Protocol Violation|0|||
170823971|NCT01332318|617362967|FG002|Overall Study|Protocol Violation|1|||
170823972|NCT01332318|617362968|FG003|Overall Study|Protocol Violation|1|||
170823973|NCT02040532|617362969|FG000|Overall Study|Lost to Follow-up|1|||
170823974|NCT02040532|617362969|FG000|Overall Study|Physician Decision|4|||
170823975|NCT02040532|617362969|FG000|Overall Study|Adverse Event|4|||
170823976|NCT02040532|617362969|FG000|Overall Study|Withdrawal by Subject|3|||
170823977|NCT01544153|617362970|FG000|Overall Study|Under 18|0|||
170823978|NCT01544153|617362971|FG001|Overall Study|Under 18|1|||
170823979|NCT01544153|617362972|FG002|Overall Study|Under 18|0|||
170823980|NCT01544153|617362973|FG003|Overall Study|Under 18|0|||
170823981|NCT01544153|617362970|FG000|Overall Study|Non-smoker|0|||
170823982|NCT01544153|617362971|FG001|Overall Study|Non-smoker|0|||
170823983|NCT01544153|617362972|FG002|Overall Study|Non-smoker|1|||
170823984|NCT01544153|617362973|FG003|Overall Study|Non-smoker|0|||
170823985|NCT03169530|617362976|FG000|Overall Study|Study ended by NIH|15|||
170823986|NCT03169530|617362977|FG001|Overall Study|Study ended by NIH|17|||
170823987|NCT00884793|617362978|FG000|Overall Study|Withdrawal by Subject|1|||
170823988|NCT01032200|617362979|FG000|Overall Study|Death|1|||
170823989|NCT01032200|617362980|FG001|Overall Study|Death|1|||
170823990|NCT01032200|617362979|FG000|Overall Study|Withdrawal by Subject|1|||
170823991|NCT01032200|617362980|FG001|Overall Study|Withdrawal by Subject|3|||
170699666|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
170699667|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
170699668|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
170699669|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
170699670|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
170699671|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
170699672|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
170699673|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
170699674|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
170699675|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
170699676|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
170823992|NCT01032200|617362979|FG000|Overall Study|Toxicity|0|||
170823993|NCT01032200|617362980|FG001|Overall Study|Toxicity|2|||
170823994|NCT01032200|617362979|FG000|Overall Study|Progression|1|||
170823995|NCT01032200|617362980|FG001|Overall Study|Progression|0|||
170823996|NCT01032200|617362979|FG000|Overall Study|Multiple|1|||
170823997|NCT01032200|617362980|FG001|Overall Study|Multiple|1|||
170823998|NCT02273180|617362981|FG000|Overall Study|Adverse Event|2|||
170823999|NCT02273180|617362982|FG001|Overall Study|Adverse Event|2|||
170824000|NCT02273180|617362981|FG000|Overall Study|Lack of Efficacy|1|||
170824001|NCT02273180|617362982|FG001|Overall Study|Lack of Efficacy|0|||
170824002|NCT02273180|617362981|FG000|Overall Study|Protocol Violation|1|||
170824003|NCT02273180|617362982|FG001|Overall Study|Protocol Violation|7|||
170824004|NCT02273180|617362981|FG000|Overall Study|Randomized but not treated|1|||
170824005|NCT02273180|617362982|FG001|Overall Study|Randomized but not treated|0|||
170824006|NCT02273180|617362981|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
170824007|NCT02273180|617362982|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
170824008|NCT02273180|617362981|FG000|Overall Study|Other than specified above|21|||
170824009|NCT02273180|617362982|FG001|Overall Study|Other than specified above|10|||
170824010|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
170824011|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
170824012|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
170824013|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
170824014|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
170824015|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
170824016|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
170824017|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
170824018|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
170824019|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
170824020|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
170824021|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
170824022|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
170824023|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
170824024|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
170824025|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
170824026|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
170824027|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
170824028|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
170824029|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
170824030|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
170824031|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
170824032|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
170824033|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
170824034|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
170824035|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
170824036|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
170824037|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
170824038|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
170824039|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
170824040|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
170824041|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
170824042|NCT00092521|617364933|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
170824043|NCT00092521|617364934|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
170824044|NCT00092521|617364935|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
170824045|NCT00092521|617364936|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
170824046|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
170824047|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
170824048|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
170824049|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
170824050|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
170824051|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
170824052|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
170824053|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
170824054|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
170824055|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
170824056|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
170824057|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
170824058|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Death|2|||
170699677|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
170699678|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
170699679|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
170699680|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
170699681|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
170699682|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
170699683|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
170699684|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
170699685|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
170699686|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
170699687|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
170699688|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
170699689|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
170699690|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
170699691|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
170699692|NCT00404352|616914321|FG000|Double Blind (up to 24 Month)|Other|0|||
170824059|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Death|0|||
170824060|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Death|1|||
170824061|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Death|0|||
170824062|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
170824063|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
170824064|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
170699693|NCT00404352|616914322|FG001|Double Blind (up to 24 Month)|Other|1|||
170699694|NCT00404352|616914323|FG002|Double Blind (up to 24 Month)|Other|0|||
170699695|NCT00404352|616914324|FG003|Double Blind (up to 24 Month)|Other|0|||
170699696|NCT00404352|616914325|FG004|Double Blind (up to 24 Month)|Other|0|||
170699697|NCT00404352|616914326|FG005|Double Blind (up to 24 Month)|Other|0|||
170699698|NCT00404352|616914327|FG006|Double Blind (up to 24 Month)|Other|0|||
170699699|NCT00404352|616914328|FG007|Double Blind (up to 24 Month)|Other|0|||
170699700|NCT00404352|616914329|FG008|Double Blind (up to 24 Month)|Other|0|||
170699701|NCT00404352|616914321|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
170699702|NCT00404352|616914322|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
170699703|NCT00404352|616914323|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
170699704|NCT00404352|616914324|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
170699705|NCT00404352|616914325|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
170699706|NCT00404352|616914326|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
170699707|NCT00404352|616914327|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
170699708|NCT00404352|616914328|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
170699709|NCT00404352|616914329|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
170699710|NCT00404352|616914321|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
170699711|NCT00404352|616914322|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
170699712|NCT00404352|616914323|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
170699713|NCT00404352|616914324|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
170699714|NCT00404352|616914325|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
170699715|NCT00404352|616914326|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
170699716|NCT00404352|616914327|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
170699717|NCT00404352|616914328|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
170699718|NCT00404352|616914329|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
170699719|NCT00404352|616914321|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
170699720|NCT00404352|616914322|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
170699721|NCT00404352|616914323|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
170699722|NCT00404352|616914324|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
170699723|NCT00404352|616914325|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
170699724|NCT00404352|616914326|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
170699725|NCT00404352|616914327|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
170699726|NCT00404352|616914328|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
170699727|NCT00404352|616914329|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
170699728|NCT00404352|616914321|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
170699729|NCT00404352|616914322|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
170699730|NCT00404352|616914323|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
170699731|NCT00404352|616914324|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
170699732|NCT00404352|616914325|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
170699733|NCT00404352|616914326|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
170699734|NCT00404352|616914327|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
170699735|NCT00404352|616914328|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
170699736|NCT00404352|616914329|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
170699737|NCT00404352|616914321|FG000|Open Label (up to 24 Month)|Disease progression|0|||
170699738|NCT00404352|616914322|FG001|Open Label (up to 24 Month)|Disease progression|0|||
170699739|NCT00404352|616914323|FG002|Open Label (up to 24 Month)|Disease progression|0|||
170699740|NCT00404352|616914324|FG003|Open Label (up to 24 Month)|Disease progression|1|||
170699741|NCT00404352|616914325|FG004|Open Label (up to 24 Month)|Disease progression|0|||
170699742|NCT00404352|616914326|FG005|Open Label (up to 24 Month)|Disease progression|0|||
170699743|NCT00404352|616914327|FG006|Open Label (up to 24 Month)|Disease progression|0|||
170699744|NCT00404352|616914328|FG007|Open Label (up to 24 Month)|Disease progression|0|||
170699745|NCT00404352|616914329|FG008|Open Label (up to 24 Month)|Disease progression|0|||
170699746|NCT00404352|616914321|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
170699747|NCT00404352|616914322|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
170699748|NCT00404352|616914323|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
170699749|NCT00404352|616914324|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
170699750|NCT00404352|616914325|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
170824065|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
170824066|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
170699751|NCT00404352|616914326|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
170699752|NCT00404352|616914327|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
170699753|NCT00404352|616914328|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
170699754|NCT00404352|616914329|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
170699755|NCT00404352|616914321|FG000|Open Label Extension (up to 36 Months)|Other|0|||
170699756|NCT00404352|616914322|FG001|Open Label Extension (up to 36 Months)|Other|0|||
170699757|NCT00404352|616914323|FG002|Open Label Extension (up to 36 Months)|Other|0|||
170699758|NCT00404352|616914324|FG003|Open Label Extension (up to 36 Months)|Other|0|||
170699759|NCT00404352|616914325|FG004|Open Label Extension (up to 36 Months)|Other|0|||
170699760|NCT00404352|616914326|FG005|Open Label Extension (up to 36 Months)|Other|0|||
170699761|NCT00404352|616914327|FG006|Open Label Extension (up to 36 Months)|Other|0|||
170699762|NCT00404352|616914328|FG007|Open Label Extension (up to 36 Months)|Other|0|||
170699763|NCT00404352|616914329|FG008|Open Label Extension (up to 36 Months)|Other|2|||
170699764|NCT02308735|616914334|FG000|Overall Study|Physician Decision|2|||
170699765|NCT02308735|616914335|FG001|Overall Study|Physician Decision|0|||
170699766|NCT02308735|616914336|FG002|Overall Study|Physician Decision|0|||
170699767|NCT02308735|616914337|FG003|Overall Study|Physician Decision|2|||
170699768|NCT03792672|616914338|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
170699769|NCT03792672|616914339|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
170699770|NCT03792672|616914340|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
170699771|NCT03792672|616914341|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
170699772|NCT03792672|616914342|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
170699773|NCT03792672|616914343|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
170699774|NCT03792672|616914338|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
170699775|NCT03792672|616914339|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
170699776|NCT03792672|616914340|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
170699777|NCT03792672|616914341|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
170699778|NCT03792672|616914342|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
170699779|NCT03792672|616914343|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
170699780|NCT03792672|616914338|FG000|Treatment Period 4 (2 Days)|Other|1|||
170699781|NCT03792672|616914339|FG001|Treatment Period 4 (2 Days)|Other|0|||
170699782|NCT03792672|616914340|FG002|Treatment Period 4 (2 Days)|Other|0|||
170699783|NCT03792672|616914341|FG003|Treatment Period 4 (2 Days)|Other|0|||
170699784|NCT03792672|616914342|FG004|Treatment Period 4 (2 Days)|Other|0|||
170699785|NCT03792672|616914343|FG005|Treatment Period 4 (2 Days)|Other|0|||
170699786|NCT00453999|616914344|FG000|Overall Study|Adverse Event|1|||
170699787|NCT00453999|616914345|FG001|Overall Study|Adverse Event|2|||
170699788|NCT00453999|616914346|FG002|Overall Study|Adverse Event|1|||
170699789|NCT00453999|616914344|FG000|Overall Study|Lost to Follow-up|0|||
170699790|NCT00453999|616914345|FG001|Overall Study|Lost to Follow-up|1|||
170699791|NCT00453999|616914346|FG002|Overall Study|Lost to Follow-up|1|||
170699792|NCT00453999|616914344|FG000|Overall Study|Withdrawal by Subject|2|||
170699793|NCT00453999|616914345|FG001|Overall Study|Withdrawal by Subject|1|||
170699794|NCT00453999|616914346|FG002|Overall Study|Withdrawal by Subject|1|||
170699795|NCT00453999|616914344|FG000|Overall Study|Subject Request|2|||
170699796|NCT00453999|616914345|FG001|Overall Study|Subject Request|1|||
170699797|NCT00453999|616914346|FG002|Overall Study|Subject Request|0|||
170699798|NCT00323414|616914352|FG000|Overall Study|Withdrawal by Subject|0|||
170699799|NCT00323414|616914353|FG001|Overall Study|Withdrawal by Subject|1|||
170699800|NCT04238728|616914356|FG000|Overall Study|Withdrawal by Subject|1|||
170699801|NCT04238728|616914356|FG000|Overall Study|Lost to Follow-up|2|||
170699802|NCT04382911|616914358|FG000|Overall Study|unable to be imaged prior to surgery|2|||
170699803|NCT01417481|616914359|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
170699804|NCT01417481|616914360|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
170699805|NCT03925324|616914363|FG000|Overall Study|Death|1|||
170699806|NCT03925324|616914364|FG001|Overall Study|Death|1|||
170699807|NCT00582933|616914368|FG000|Overall Study|Physician Decision|3|||
170699808|NCT00974571|616914370|FG000|Overall Study|Adverse Event|31|||
170824067|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
170824068|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
170824069|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
170824070|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
170824071|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
170824072|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
170824073|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
170824074|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Moved|32|||
170824075|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Moved|2|||
170824076|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Moved|28|||
170824077|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Moved|0|||
170824078|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
170699809|NCT00974571|616914371|FG001|Overall Study|Adverse Event|4|||
170699810|NCT00974571|616914372|FG002|Overall Study|Adverse Event|27|||
170824079|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
170699811|NCT00974571|616914370|FG000|Overall Study|Lack of Efficacy|3|||
170699812|NCT00974571|616914371|FG001|Overall Study|Lack of Efficacy|2|||
170699813|NCT00974571|616914372|FG002|Overall Study|Lack of Efficacy|9|||
170699814|NCT00974571|616914370|FG000|Overall Study|Lost to Follow-up|2|||
170699815|NCT00974571|616914371|FG001|Overall Study|Lost to Follow-up|1|||
170699816|NCT00974571|616914372|FG002|Overall Study|Lost to Follow-up|2|||
170699817|NCT00974571|616914370|FG000|Overall Study|Protocol Violation|13|||
170699818|NCT00974571|616914371|FG001|Overall Study|Protocol Violation|4|||
170824080|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
170824081|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
170699819|NCT00974571|616914372|FG002|Overall Study|Protocol Violation|18|||
170699820|NCT00974571|616914370|FG000|Overall Study|Withdrawal by Subject|14|||
170699821|NCT00974571|616914371|FG001|Overall Study|Withdrawal by Subject|5|||
170699822|NCT00974571|616914372|FG002|Overall Study|Withdrawal by Subject|16|||
170699823|NCT00974571|616914370|FG000|Overall Study|Patient Moved|1|||
170699824|NCT00974571|616914371|FG001|Overall Study|Patient Moved|0|||
170699825|NCT00974571|616914372|FG002|Overall Study|Patient Moved|1|||
170699826|NCT00974571|616914370|FG000|Overall Study|Other|4|||
170699827|NCT00974571|616914371|FG001|Overall Study|Other|0|||
170699828|NCT00974571|616914372|FG002|Overall Study|Other|10|||
170699829|NCT01371656|616914373|FG000|Overall Study|Death|7|||
170699830|NCT01371656|616914374|FG001|Overall Study|Death|4|||
170699831|NCT01371656|616914373|FG000|Overall Study|Physician Decision|46|||
170699832|NCT01371656|616914374|FG001|Overall Study|Physician Decision|7|||
170699833|NCT01371656|616914373|FG000|Overall Study|Withdrawal by Subject|7|||
170699834|NCT01371656|616914374|FG001|Overall Study|Withdrawal by Subject|0|||
170699835|NCT01371656|616914373|FG000|Overall Study|Ineligible|4|||
170699836|NCT01371656|616914374|FG001|Overall Study|Ineligible|3|||
170699837|NCT00696137|616914375|FG000|Overall Study|Withdrawal by Subject|2|||
170699838|NCT03778931|616914385|FG000|Overall Study|Withdrawal by Subject|12|||
170699839|NCT03778931|616914386|FG001|Overall Study|Withdrawal by Subject|25|||
170699840|NCT03778931|616914385|FG000|Overall Study|Physician Decision|1|||
170699841|NCT03778931|616914386|FG001|Overall Study|Physician Decision|3|||
170699842|NCT03778931|616914385|FG000|Overall Study|Participant Noncompliance|1|||
170699843|NCT03778931|616914386|FG001|Overall Study|Participant Noncompliance|1|||
170699844|NCT03778931|616914385|FG000|Overall Study|Lost to Follow-up|4|||
170699845|NCT03778931|616914386|FG001|Overall Study|Lost to Follow-up|1|||
170699846|NCT03778931|616914385|FG000|Overall Study|Death|69|||
170699847|NCT03778931|616914386|FG001|Overall Study|Death|79|||
170699848|NCT00775437|616914387|FG000|Overall Study|Loss of efficacy|2|||
170699849|NCT00775437|616914387|FG000|Overall Study|Withdrawal by Subject|3|||
170699850|NCT00775437|616914387|FG000|Overall Study|Lost to Follow-up|1|||
170699851|NCT05045144|616914388|FG000|Overall Study|Lost to Follow-up|3|||
170699852|NCT05045144|616914389|FG001|Overall Study|Lost to Follow-up|2|||
170699853|NCT05045144|616914390|FG002|Overall Study|Lost to Follow-up|3|||
170699854|NCT05045144|616914391|FG003|Overall Study|Lost to Follow-up|5|||
170699855|NCT05045144|616914392|FG004|Overall Study|Lost to Follow-up|13|||
170699856|NCT05045144|616914388|FG000|Overall Study|Withdrawal by Subject|0|||
170699857|NCT05045144|616914389|FG001|Overall Study|Withdrawal by Subject|1|||
170699858|NCT05045144|616914390|FG002|Overall Study|Withdrawal by Subject|0|||
170699859|NCT05045144|616914391|FG003|Overall Study|Withdrawal by Subject|0|||
170699860|NCT05045144|616914392|FG004|Overall Study|Withdrawal by Subject|0|||
170699861|NCT05045144|616914388|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170699862|NCT05045144|616914389|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170699863|NCT05045144|616914390|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170699864|NCT05045144|616914391|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170699865|NCT05045144|616914392|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170699866|NCT04251221|616914393|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
170699867|NCT04251221|616914394|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
170699868|NCT04243538|616914400|FG000|Overall Study|Withdrawal by Subject|0|||
170699869|NCT04243538|616914401|FG001|Overall Study|Withdrawal by Subject|2|||
170699870|NCT04243538|616914400|FG000|Overall Study|Lost to Follow-up|0|||
170699871|NCT04243538|616914401|FG001|Overall Study|Lost to Follow-up|3|||
170699872|NCT00500370|616914402|FG000|Overall Study|Adverse Event|9|||
170699873|NCT00500370|616914403|FG001|Overall Study|Adverse Event|3|||
170699874|NCT00500370|616914402|FG000|Overall Study|Lost to Follow-up|10|||
170699875|NCT00500370|616914403|FG001|Overall Study|Lost to Follow-up|10|||
170699876|NCT00500370|616914402|FG000|Overall Study|Protocol Violation|2|||
170699877|NCT00500370|616914403|FG001|Overall Study|Protocol Violation|4|||
170699878|NCT00500370|616914402|FG000|Overall Study|Sponsor Decision|2|||
170699879|NCT00500370|616914403|FG001|Overall Study|Sponsor Decision|0|||
170699880|NCT00500370|616914402|FG000|Overall Study|Subject Decision|10|||
170699881|NCT00500370|616914403|FG001|Overall Study|Subject Decision|17|||
170699882|NCT01101841|616915839|FG000|Overall Study|Adverse Event|15|||
170699883|NCT01101841|616915840|FG001|Overall Study|Adverse Event|15|||
170699884|NCT01101841|616915839|FG000|Overall Study|Lost to Follow-up|9|||
170699885|NCT01101841|616915840|FG001|Overall Study|Lost to Follow-up|3|||
170699886|NCT01101841|616915839|FG000|Overall Study|Withdrawal by Subject|21|||
170699887|NCT01101841|616915840|FG001|Overall Study|Withdrawal by Subject|40|||
170699888|NCT01101841|616915839|FG000|Overall Study|Protocol Violation|1|||
170699889|NCT01101841|616915840|FG001|Overall Study|Protocol Violation|1|||
170699890|NCT01101841|616915839|FG000|Overall Study|Physician Decision|0|||
170699891|NCT01101841|616915840|FG001|Overall Study|Physician Decision|2|||
170699892|NCT01101841|616915839|FG000|Overall Study|Lack of Efficacy|0|||
170699893|NCT01101841|616915840|FG001|Overall Study|Lack of Efficacy|2|||
170699894|NCT01101841|616915839|FG000|Overall Study|Other|0|||
170699895|NCT01101841|616915840|FG001|Overall Study|Other|1|||
170824082|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Travel|2|||
170824083|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Travel|0|||
170824084|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Travel|0|||
170824085|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Travel|0|||
170824086|NCT00092521|617364933|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
170824087|NCT00092521|617364934|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
170824088|NCT00092521|617364935|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
170824089|NCT00092521|617364936|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
170824090|NCT00092521|617364933|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
170824091|NCT00092521|617364934|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
170824092|NCT00092521|617364935|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
170824093|NCT00092521|617364936|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
170824094|NCT00092521|617364933|FG000|Extension Study (Group 4)|Adverse Event|0|||
170824095|NCT00092521|617364934|FG001|Extension Study (Group 4)|Adverse Event|0|||
170824096|NCT00092521|617364935|FG002|Extension Study (Group 4)|Adverse Event|0|||
170824097|NCT00092521|617364936|FG003|Extension Study (Group 4)|Adverse Event|2|||
170824098|NCT00092521|617364933|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
170824099|NCT00092521|617364934|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
170824100|NCT00092521|617364935|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
170824101|NCT00092521|617364936|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
170824102|NCT00092521|617364933|FG000|Extension Study (Group 4)|Pregnancy|0|||
170824103|NCT00092521|617364934|FG001|Extension Study (Group 4)|Pregnancy|0|||
170699896|NCT01101841|616915839|FG000|Overall Study|Suicidality Tracking Scale|3|||
170824104|NCT00092521|617364935|FG002|Extension Study (Group 4)|Pregnancy|0|||
170824105|NCT00092521|617364936|FG003|Extension Study (Group 4)|Pregnancy|4|||
170699897|NCT01101841|616915840|FG001|Overall Study|Suicidality Tracking Scale|1|||
170699898|NCT01101841|616915839|FG000|Overall Study|Eligibility Criteria|1|||
170699899|NCT01101841|616915840|FG001|Overall Study|Eligibility Criteria|2|||
170699900|NCT03756558|616915841|FG000|Overall Study|Death|1|||
170699901|NCT03756558|616915841|FG000|Overall Study|Lost to Follow-up|2|||
170699902|NCT03756558|616915841|FG000|Overall Study|Withdrawal by Subject|2|||
170699903|NCT02896400|616915842|FG000|1 Month Follow-up|Lost to Follow-up|7|||
170699904|NCT02896400|616915843|FG001|1 Month Follow-up|Lost to Follow-up|7|||
170699905|NCT02896400|616915844|FG002|1 Month Follow-up|Lost to Follow-up|5|||
170699906|NCT02896400|616915845|FG003|1 Month Follow-up|Lost to Follow-up|8|||
170699907|NCT02896400|616915846|FG004|1 Month Follow-up|Lost to Follow-up|9|||
170699908|NCT02896400|616915847|FG005|1 Month Follow-up|Lost to Follow-up|6|||
170699909|NCT02896400|616915848|FG006|1 Month Follow-up|Lost to Follow-up|5|||
170699910|NCT02896400|616915849|FG007|1 Month Follow-up|Lost to Follow-up|6|||
170699911|NCT02896400|616915850|FG008|1 Month Follow-up|Lost to Follow-up|4|||
170699912|NCT02896400|616915851|FG009|1 Month Follow-up|Lost to Follow-up|7|||
170699913|NCT02896400|616915852|FG010|1 Month Follow-up|Lost to Follow-up|5|||
170699914|NCT02896400|616915853|FG011|1 Month Follow-up|Lost to Follow-up|5|||
170699915|NCT02896400|616915854|FG012|1 Month Follow-up|Lost to Follow-up|3|||
170699916|NCT02896400|616915855|FG013|1 Month Follow-up|Lost to Follow-up|4|||
170699917|NCT02896400|616915856|FG014|1 Month Follow-up|Lost to Follow-up|1|||
170699918|NCT02896400|616915857|FG015|1 Month Follow-up|Lost to Follow-up|2|||
170699919|NCT02896400|616915842|FG000|1 Month Follow-up|Death|0|||
170699920|NCT02896400|616915843|FG001|1 Month Follow-up|Death|0|||
170699921|NCT02896400|616915844|FG002|1 Month Follow-up|Death|0|||
170699922|NCT02896400|616915845|FG003|1 Month Follow-up|Death|0|||
170699923|NCT02896400|616915846|FG004|1 Month Follow-up|Death|0|||
170699924|NCT02896400|616915847|FG005|1 Month Follow-up|Death|0|||
170699925|NCT02896400|616915848|FG006|1 Month Follow-up|Death|0|||
170699926|NCT02896400|616915849|FG007|1 Month Follow-up|Death|0|||
170699927|NCT02896400|616915850|FG008|1 Month Follow-up|Death|0|||
170824106|NCT00092521|617364933|FG000|Extension Study (Group 4)|Protocol Violation|0|||
170824107|NCT00092521|617364934|FG001|Extension Study (Group 4)|Protocol Violation|0|||
170824108|NCT00092521|617364935|FG002|Extension Study (Group 4)|Protocol Violation|0|||
170824109|NCT00092521|617364936|FG003|Extension Study (Group 4)|Protocol Violation|2|||
170824110|NCT00092521|617364933|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
170699928|NCT02896400|616915851|FG009|1 Month Follow-up|Death|0|||
170699929|NCT02896400|616915852|FG010|1 Month Follow-up|Death|0|||
170699930|NCT02896400|616915853|FG011|1 Month Follow-up|Death|0|||
170699931|NCT02896400|616915854|FG012|1 Month Follow-up|Death|0|||
170699932|NCT02896400|616915855|FG013|1 Month Follow-up|Death|0|||
170699933|NCT02896400|616915856|FG014|1 Month Follow-up|Death|0|||
170824111|NCT00092521|617364934|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
170699934|NCT02896400|616915857|FG015|1 Month Follow-up|Death|1|||
170699935|NCT02896400|616915842|FG000|3 Month Follow-up|Lost to Follow-up|6|||
170699936|NCT02896400|616915843|FG001|3 Month Follow-up|Lost to Follow-up|3|||
170699937|NCT02896400|616915844|FG002|3 Month Follow-up|Lost to Follow-up|6|||
170699938|NCT02896400|616915845|FG003|3 Month Follow-up|Lost to Follow-up|11|||
170699939|NCT02896400|616915846|FG004|3 Month Follow-up|Lost to Follow-up|12|||
170699940|NCT02896400|616915847|FG005|3 Month Follow-up|Lost to Follow-up|6|||
170699941|NCT02896400|616915848|FG006|3 Month Follow-up|Lost to Follow-up|4|||
170699942|NCT02896400|616915849|FG007|3 Month Follow-up|Lost to Follow-up|3|||
170699943|NCT02896400|616915850|FG008|3 Month Follow-up|Lost to Follow-up|6|||
170699944|NCT02896400|616915851|FG009|3 Month Follow-up|Lost to Follow-up|5|||
170699945|NCT02896400|616915852|FG010|3 Month Follow-up|Lost to Follow-up|6|||
170699946|NCT02896400|616915853|FG011|3 Month Follow-up|Lost to Follow-up|6|||
170699947|NCT02896400|616915854|FG012|3 Month Follow-up|Lost to Follow-up|3|||
170699948|NCT02896400|616915855|FG013|3 Month Follow-up|Lost to Follow-up|5|||
170699949|NCT02896400|616915856|FG014|3 Month Follow-up|Lost to Follow-up|3|||
170699950|NCT02896400|616915857|FG015|3 Month Follow-up|Lost to Follow-up|2|||
170699951|NCT02896400|616915842|FG000|3 Month Follow-up|Death|0|||
170699952|NCT02896400|616915843|FG001|3 Month Follow-up|Death|0|||
170699953|NCT02896400|616915844|FG002|3 Month Follow-up|Death|0|||
170699954|NCT02896400|616915845|FG003|3 Month Follow-up|Death|0|||
170699955|NCT02896400|616915846|FG004|3 Month Follow-up|Death|0|||
170699956|NCT02896400|616915847|FG005|3 Month Follow-up|Death|0|||
170699957|NCT02896400|616915848|FG006|3 Month Follow-up|Death|0|||
170699958|NCT02896400|616915849|FG007|3 Month Follow-up|Death|0|||
170699959|NCT02896400|616915850|FG008|3 Month Follow-up|Death|0|||
170699960|NCT02896400|616915851|FG009|3 Month Follow-up|Death|0|||
170699961|NCT02896400|616915852|FG010|3 Month Follow-up|Death|0|||
170699962|NCT02896400|616915853|FG011|3 Month Follow-up|Death|0|||
170699963|NCT02896400|616915854|FG012|3 Month Follow-up|Death|0|||
170699964|NCT02896400|616915855|FG013|3 Month Follow-up|Death|1|||
170699965|NCT02896400|616915856|FG014|3 Month Follow-up|Death|1|||
170699966|NCT02896400|616915857|FG015|3 Month Follow-up|Death|0|||
170699967|NCT02896400|616915842|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
170699968|NCT02896400|616915843|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
170699969|NCT02896400|616915844|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
170699970|NCT02896400|616915845|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
170699971|NCT02896400|616915846|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
170699972|NCT02896400|616915847|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
170699973|NCT02896400|616915848|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
170699974|NCT02896400|616915849|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
170699975|NCT02896400|616915850|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
170699976|NCT02896400|616915851|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
170699977|NCT02896400|616915852|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
170699978|NCT02896400|616915853|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
170699979|NCT02896400|616915854|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
170699980|NCT02896400|616915855|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
170699981|NCT02896400|616915856|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
170699982|NCT02896400|616915857|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
170699983|NCT02896400|616915842|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
170699984|NCT02896400|616915843|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
170699985|NCT02896400|616915844|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
170699986|NCT02896400|616915845|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
170699987|NCT02896400|616915846|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
170699988|NCT02896400|616915847|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
170699989|NCT02896400|616915848|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
170699990|NCT02896400|616915849|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
170699991|NCT02896400|616915850|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
170699992|NCT02896400|616915851|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
170699993|NCT02896400|616915852|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
170699994|NCT02896400|616915853|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
170699995|NCT02896400|616915854|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
170699996|NCT02896400|616915855|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
170699997|NCT02896400|616915856|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
170699998|NCT02896400|616915857|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
170699999|NCT02984020|616915858|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
170700000|NCT02984020|616915858|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
170700001|NCT02984020|616915858|FG000|Overall Study|Other significant protocol violation|2|||
170700002|NCT00503841|616915859|FG000|Overall Study|All screen failures|44|||
170700003|NCT05723770|616915860|FG000|Overall Study|Lost to Follow-up|4|||
170700004|NCT05723770|616915860|FG000|Overall Study|Withdrawal by Subject|2|||
170700005|NCT01945489|616915861|FG000|Cycle 1|Adverse Event|2|||
170700006|NCT01945489|616915862|FG001|Cycle 1|Adverse Event|0|||
170700007|NCT01945489|616915861|FG000|Cycle 1|Lost to Follow-up|4|||
170700008|NCT01945489|616915862|FG001|Cycle 1|Lost to Follow-up|0|||
170700009|NCT01945489|616915861|FG000|Cycle 1|Personal Reasons|4|||
170700010|NCT01945489|616915862|FG001|Cycle 1|Personal Reasons|2|||
170700011|NCT01945489|616915861|FG000|Cycle 1|Protocol Violation|0|||
170700012|NCT01945489|616915862|FG001|Cycle 1|Protocol Violation|1|||
170700013|NCT01945489|616915861|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
170700014|NCT01945489|616915862|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
170700015|NCT01945489|616915861|FG000|Cycle 2|Adverse Event|1|||
170700016|NCT01945489|616915862|FG001|Cycle 2|Adverse Event|0|||
170700017|NCT01945489|616915861|FG000|Cycle 2|Lost to Follow-up|0|||
170700018|NCT01945489|616915862|FG001|Cycle 2|Lost to Follow-up|1|||
170700019|NCT00394212|616915865|FG000|Overall Study|Lost to Follow-up|3|||
170700020|NCT00394212|616915866|FG001|Overall Study|Lost to Follow-up|0|||
170700021|NCT00394212|616915865|FG000|Overall Study|Withdrawal by Subject|4|||
170700022|NCT00394212|616915866|FG001|Overall Study|Withdrawal by Subject|1|||
170700023|NCT00358527|616915867|FG000|Overall Study|Adverse Event|4|||
170700024|NCT00358527|616915868|FG001|Overall Study|Adverse Event|0|||
170700025|NCT00358527|616915867|FG000|Overall Study|Withdrawal by Subject|1|||
170700026|NCT00358527|616915868|FG001|Overall Study|Withdrawal by Subject|1|||
170700027|NCT00358527|616915867|FG000|Overall Study|Non-compliance with protocol|6|||
170700028|NCT00358527|616915868|FG001|Overall Study|Non-compliance with protocol|1|||
170700029|NCT00358527|616915867|FG000|Overall Study|Administrative|2|||
170700030|NCT00358527|616915868|FG001|Overall Study|Administrative|1|||
170700031|NCT00145509|616915872|FG000|Overall Study|Adverse Event|10|||
170700032|NCT00145509|616915873|FG001|Overall Study|Adverse Event|3|||
170700033|NCT00145509|616915872|FG000|Overall Study|Lack of Efficacy|3|||
170700034|NCT00145509|616915873|FG001|Overall Study|Lack of Efficacy|1|||
170700035|NCT00145509|616915872|FG000|Overall Study|Lost to Follow-up|5|||
170700036|NCT00145509|616915873|FG001|Overall Study|Lost to Follow-up|9|||
170700037|NCT00145509|616915872|FG000|Overall Study|Withdrew Consent|2|||
170700038|NCT00145509|616915873|FG001|Overall Study|Withdrew Consent|7|||
170700039|NCT00145509|616915872|FG000|Overall Study|Reason not provided|2|||
170700040|NCT00145509|616915873|FG001|Overall Study|Reason not provided|1|||
170700041|NCT00697346|616915874|FG000|Overall Study|Adverse Event|4|||
170700042|NCT00697346|616915875|FG001|Overall Study|Adverse Event|5|||
170700043|NCT00697346|616915876|FG002|Overall Study|Adverse Event|0|||
170700044|NCT00697346|616915874|FG000|Overall Study|Progressive Disease|19|||
170700045|NCT00697346|616915875|FG001|Overall Study|Progressive Disease|18|||
170700046|NCT00697346|616915876|FG002|Overall Study|Progressive Disease|0|||
170700047|NCT00697346|616915874|FG000|Overall Study|Symptomatic Deterioration|0|||
170700048|NCT00697346|616915875|FG001|Overall Study|Symptomatic Deterioration|1|||
170700049|NCT00697346|616915876|FG002|Overall Study|Symptomatic Deterioration|0|||
170700050|NCT00697346|616915874|FG000|Overall Study|Withdrawal by Subject|2|||
170700051|NCT00697346|616915875|FG001|Overall Study|Withdrawal by Subject|2|||
170700052|NCT00697346|616915876|FG002|Overall Study|Withdrawal by Subject|0|||
170700053|NCT00697346|616915874|FG000|Overall Study|Reason not Specified|3|||
170700054|NCT00697346|616915875|FG001|Overall Study|Reason not Specified|0|||
170700055|NCT00697346|616915876|FG002|Overall Study|Reason not Specified|1|||
170700056|NCT00430092|616915880|FG000|Overall Study|Adverse Event|0|||
170700057|NCT00430092|616915881|FG001|Overall Study|Adverse Event|0|||
170700058|NCT00430092|616915882|FG002|Overall Study|Adverse Event|1|||
170700059|NCT00430092|616915880|FG000|Overall Study|Lack of Efficacy|5|||
170700060|NCT00430092|616915881|FG001|Overall Study|Lack of Efficacy|2|||
170700061|NCT00430092|616915882|FG002|Overall Study|Lack of Efficacy|54|||
170700062|NCT00430092|616915880|FG000|Overall Study|Lost to Follow-up|1|||
170700063|NCT00430092|616915881|FG001|Overall Study|Lost to Follow-up|0|||
170700064|NCT00430092|616915882|FG002|Overall Study|Lost to Follow-up|0|||
170700065|NCT00430092|616915880|FG000|Overall Study|Protocol Violation|0|||
170700066|NCT00430092|616915881|FG001|Overall Study|Protocol Violation|1|||
170700067|NCT00430092|616915882|FG002|Overall Study|Protocol Violation|1|||
170700068|NCT00430092|616915880|FG000|Overall Study|Withdrawal by Subject|0|||
170700069|NCT00430092|616915881|FG001|Overall Study|Withdrawal by Subject|1|||
170700070|NCT00430092|616915882|FG002|Overall Study|Withdrawal by Subject|1|||
170700071|NCT00463060|616915883|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
170700072|NCT00463060|616915883|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
170700073|NCT04304001|616915890|FG000|Overall Study|Lost to Follow-up|13|||
170700074|NCT04304001|616915891|FG001|Overall Study|Lost to Follow-up|9|||
170700075|NCT04627064|616915892|FG000|Overall Study|Progressive disease|8|||
170700076|NCT04627064|616915893|FG001|Overall Study|Progressive disease|0|||
170700077|NCT04627064|616915892|FG000|Overall Study|Withdrawal by Subject|2|||
170700078|NCT04627064|616915893|FG001|Overall Study|Withdrawal by Subject|0|||
170700079|NCT04627064|616915892|FG000|Overall Study|Physician Decision|1|||
170700080|NCT04627064|616915893|FG001|Overall Study|Physician Decision|0|||
170700081|NCT02086110|616915894|FG000|Overall Study|Withdrawal by Subject|1|||
170700082|NCT02086110|616915895|FG001|Overall Study|Withdrawal by Subject|1|||
170824112|NCT00092521|617364935|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
170824113|NCT00092521|617364936|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
170824114|NCT00092521|617364933|FG000|Extension Study (Group 4)|Moved|0|||
170824115|NCT00092521|617364934|FG001|Extension Study (Group 4)|Moved|0|||
170824116|NCT00092521|617364935|FG002|Extension Study (Group 4)|Moved|0|||
170824117|NCT00092521|617364936|FG003|Extension Study (Group 4)|Moved|16|||
170824118|NCT00092521|617364933|FG000|Extension Study (Group 4)|Site Terminated|0|||
170824119|NCT00092521|617364934|FG001|Extension Study (Group 4)|Site Terminated|0|||
170824120|NCT00092521|617364935|FG002|Extension Study (Group 4)|Site Terminated|0|||
170824121|NCT00092521|617364936|FG003|Extension Study (Group 4)|Site Terminated|4|||
170824122|NCT00092521|617364933|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
170824123|NCT00092521|617364934|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
170824124|NCT00092521|617364935|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
170824125|NCT00092521|617364936|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
170824126|NCT01878383|617364937|FG000|Overall Study|Lost to Follow-up|0|||
170824127|NCT01878383|617364938|FG001|Overall Study|Lost to Follow-up|1499|||
170824128|NCT00684203|617364939|FG000|Overall Study|Adverse Event|6|||
170824129|NCT00684203|617364940|FG001|Overall Study|Adverse Event|4|||
170824130|NCT00684203|617364941|FG002|Overall Study|Adverse Event|8|||
170824131|NCT00684203|617364942|FG003|Overall Study|Adverse Event|0|||
170824132|NCT00684203|617364943|FG004|Overall Study|Adverse Event|0|||
170824133|NCT00684203|617364944|FG005|Overall Study|Adverse Event|0|||
170824134|NCT00684203|617364939|FG000|Overall Study|Protocol-defined clinical event|3|||
170824135|NCT00684203|617364940|FG001|Overall Study|Protocol-defined clinical event|1|||
170824136|NCT00684203|617364941|FG002|Overall Study|Protocol-defined clinical event|0|||
170824137|NCT00684203|617364942|FG003|Overall Study|Protocol-defined clinical event|0|||
170824138|NCT00684203|617364943|FG004|Overall Study|Protocol-defined clinical event|0|||
170824139|NCT00684203|617364944|FG005|Overall Study|Protocol-defined clinical event|0|||
170824140|NCT00684203|617364939|FG000|Overall Study|Withdrawal by Subject|0|||
170824141|NCT00684203|617364940|FG001|Overall Study|Withdrawal by Subject|2|||
170824142|NCT00684203|617364941|FG002|Overall Study|Withdrawal by Subject|1|||
170824143|NCT00684203|617364942|FG003|Overall Study|Withdrawal by Subject|0|||
170824144|NCT00684203|617364943|FG004|Overall Study|Withdrawal by Subject|0|||
170824145|NCT00684203|617364944|FG005|Overall Study|Withdrawal by Subject|0|||
170824146|NCT00684203|617364939|FG000|Overall Study|Did not meet protocol eligibility|0|||
170824147|NCT00684203|617364940|FG001|Overall Study|Did not meet protocol eligibility|1|||
170824148|NCT00684203|617364941|FG002|Overall Study|Did not meet protocol eligibility|0|||
170824149|NCT00684203|617364942|FG003|Overall Study|Did not meet protocol eligibility|0|||
170824150|NCT00684203|617364943|FG004|Overall Study|Did not meet protocol eligibility|0|||
170824151|NCT00684203|617364944|FG005|Overall Study|Did not meet protocol eligibility|0|||
170824152|NCT02624869|617364945|FG000|Overall Study|Lost to Follow-up|0|||
170824153|NCT02624869|617364946|FG001|Overall Study|Lost to Follow-up|0|||
170824154|NCT02624869|617364947|FG002|Overall Study|Lost to Follow-up|1|||
170824155|NCT02624869|617364945|FG000|Overall Study|Withdrawal by Subject|1|||
170824156|NCT02624869|617364946|FG001|Overall Study|Withdrawal by Subject|3|||
170824157|NCT02624869|617364947|FG002|Overall Study|Withdrawal by Subject|1|||
170824158|NCT02499835|617364953|FG000|Overall Study|Withdrawal by Subject|1|||
170824159|NCT02499835|617364954|FG001|Overall Study|Withdrawal by Subject|0|||
170824160|NCT02499835|617364955|FG002|Overall Study|Withdrawal by Subject|0|||
170700083|NCT02272413|616915897|FG000|Randomized Through Treatment Start|Not treated|3|||
170700084|NCT02272413|616915898|FG001|Randomized Through Treatment Start|Not treated|5|||
170700085|NCT02272413|616915897|FG000|Pre-switch Period|Adverse Event|38|||
170700086|NCT02272413|616915898|FG001|Pre-switch Period|Adverse Event|37|||
170700087|NCT02272413|616915897|FG000|Pre-switch Period|Death|26|||
170700088|NCT02272413|616915898|FG001|Pre-switch Period|Death|26|||
170700089|NCT02272413|616915897|FG000|Pre-switch Period|Withdrawal by Subject|27|||
170700090|NCT02272413|616915898|FG001|Pre-switch Period|Withdrawal by Subject|15|||
170824161|NCT02499835|617364956|FG003|Overall Study|Withdrawal by Subject|1|||
170824162|NCT02499835|617364953|FG000|Overall Study|Physician Decision|0|||
170824163|NCT02499835|617364954|FG001|Overall Study|Physician Decision|3|||
170824164|NCT02499835|617364955|FG002|Overall Study|Physician Decision|18|||
170824165|NCT02499835|617364956|FG003|Overall Study|Physician Decision|7|||
170700091|NCT02272413|616915897|FG000|Pre-switch Period|Physician Decision|6|||
170700092|NCT02272413|616915898|FG001|Pre-switch Period|Physician Decision|18|||
170700093|NCT02272413|616915897|FG000|Pre-switch Period|Progressive disease|185|||
170700094|NCT02272413|616915898|FG001|Pre-switch Period|Progressive disease|173|||
170700095|NCT02272413|616915897|FG000|Pre-switch Period|Lost to Follow-up|0|||
170700096|NCT02272413|616915898|FG001|Pre-switch Period|Lost to Follow-up|2|||
170700097|NCT02272413|616915897|FG000|Pre-switch Period|Protocol Violation|1|||
170700098|NCT02272413|616915898|FG001|Pre-switch Period|Protocol Violation|0|||
170700099|NCT02272413|616915897|FG000|Pre-switch Period|Other than listed|10|||
170700100|NCT02272413|616915898|FG001|Pre-switch Period|Other than listed|11|||
170700101|NCT02272413|616915897|FG000|Post-switch Period|Adverse Event|4|||
170700102|NCT02272413|616915898|FG001|Post-switch Period|Adverse Event|4|||
170700103|NCT02272413|616915897|FG000|Post-switch Period|Death|3|||
170700104|NCT02272413|616915898|FG001|Post-switch Period|Death|2|||
170700105|NCT02272413|616915897|FG000|Post-switch Period|Withdrawal by Subject|1|||
170700106|NCT02272413|616915898|FG001|Post-switch Period|Withdrawal by Subject|2|||
170700107|NCT02272413|616915897|FG000|Post-switch Period|Physician Decision|1|||
170700108|NCT02272413|616915898|FG001|Post-switch Period|Physician Decision|1|||
170700109|NCT02272413|616915897|FG000|Post-switch Period|Progressive disease|21|||
170700110|NCT02272413|616915898|FG001|Post-switch Period|Progressive disease|21|||
170700111|NCT02272413|616915897|FG000|Post-switch Period|Study terminated by sponsor|8|||
170700112|NCT02272413|616915898|FG001|Post-switch Period|Study terminated by sponsor|11|||
170700113|NCT02272413|616915897|FG000|Post-switch Period|Other than listed|4|||
170700114|NCT02272413|616915898|FG001|Post-switch Period|Other than listed|5|||
170700115|NCT01533246|616915899|FG000|Overall Study|Adverse Event|1|||
170700116|NCT01533246|616915899|FG000|Overall Study|Withdrawal by Subject|1|||
170700117|NCT01479621|616915901|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
170700118|NCT01479621|616915902|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170700119|NCT01479621|616915903|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170700120|NCT01479621|616915904|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170700121|NCT01479621|616915905|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170700122|NCT01479621|616915906|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170700123|NCT01479621|616915907|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170700124|NCT01479621|616915901|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
170700125|NCT01479621|616915902|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170700126|NCT01479621|616915903|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170700127|NCT01479621|616915904|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170700128|NCT01479621|616915905|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170700129|NCT01479621|616915906|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170700130|NCT01479621|616915907|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170700131|NCT01479621|616915901|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
170700132|NCT01479621|616915902|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170700133|NCT01479621|616915903|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170700134|NCT01479621|616915904|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170700135|NCT01479621|616915905|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170700136|NCT01479621|616915906|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170700137|NCT01479621|616915907|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170700138|NCT01479621|616915901|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
170700139|NCT01479621|616915902|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170700140|NCT01479621|616915903|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170700141|NCT01479621|616915904|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170700142|NCT01479621|616915905|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170700143|NCT01479621|616915906|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170700144|NCT01479621|616915907|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170700145|NCT01479621|616915901|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
170700146|NCT01479621|616915902|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170700147|NCT01479621|616915903|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170700148|NCT01479621|616915904|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170700149|NCT01479621|616915905|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170700150|NCT01479621|616915906|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170700151|NCT01479621|616915907|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170700152|NCT01479621|616915901|FG000|Treatment Period|Adverse Event|0|||
170700153|NCT01479621|616915902|FG001|Treatment Period|Adverse Event|0|||
170700154|NCT01479621|616915903|FG002|Treatment Period|Adverse Event|0|||
170700155|NCT01479621|616915904|FG003|Treatment Period|Adverse Event|0|||
170700156|NCT01479621|616915905|FG004|Treatment Period|Adverse Event|1|||
170700157|NCT01479621|616915906|FG005|Treatment Period|Adverse Event|2|||
170700158|NCT01479621|616915907|FG006|Treatment Period|Adverse Event|2|||
170700159|NCT01479621|616915901|FG000|Treatment Period|Withdrawal by Subject|0|||
170700160|NCT01479621|616915902|FG001|Treatment Period|Withdrawal by Subject|4|||
170700161|NCT01479621|616915903|FG002|Treatment Period|Withdrawal by Subject|2|||
170700162|NCT01479621|616915904|FG003|Treatment Period|Withdrawal by Subject|2|||
170700163|NCT01479621|616915905|FG004|Treatment Period|Withdrawal by Subject|5|||
170700164|NCT01479621|616915906|FG005|Treatment Period|Withdrawal by Subject|5|||
170700165|NCT01479621|616915907|FG006|Treatment Period|Withdrawal by Subject|1|||
170700166|NCT01479621|616915901|FG000|Treatment Period|Physician Decision|0|||
170700167|NCT01479621|616915902|FG001|Treatment Period|Physician Decision|0|||
170700168|NCT01479621|616915903|FG002|Treatment Period|Physician Decision|0|||
170700169|NCT01479621|616915904|FG003|Treatment Period|Physician Decision|0|||
170700170|NCT01479621|616915905|FG004|Treatment Period|Physician Decision|1|||
170700171|NCT01479621|616915906|FG005|Treatment Period|Physician Decision|1|||
170700172|NCT01479621|616915907|FG006|Treatment Period|Physician Decision|0|||
170700173|NCT01479621|616915901|FG000|Treatment Period|Non-compliance to study drug|0|||
170700174|NCT01479621|616915902|FG001|Treatment Period|Non-compliance to study drug|1|||
170700175|NCT01479621|616915903|FG002|Treatment Period|Non-compliance to study drug|0|||
170700176|NCT01479621|616915904|FG003|Treatment Period|Non-compliance to study drug|0|||
170700177|NCT01479621|616915905|FG004|Treatment Period|Non-compliance to study drug|0|||
170700178|NCT01479621|616915906|FG005|Treatment Period|Non-compliance to study drug|0|||
170700179|NCT01479621|616915907|FG006|Treatment Period|Non-compliance to study drug|1|||
170700180|NCT01479621|616915901|FG000|Treatment Period|Protocol Violation|0|||
170700181|NCT01479621|616915902|FG001|Treatment Period|Protocol Violation|9|||
170700182|NCT01479621|616915903|FG002|Treatment Period|Protocol Violation|6|||
170700183|NCT01479621|616915904|FG003|Treatment Period|Protocol Violation|5|||
170700184|NCT01479621|616915905|FG004|Treatment Period|Protocol Violation|2|||
170700185|NCT01479621|616915906|FG005|Treatment Period|Protocol Violation|10|||
170700186|NCT01479621|616915907|FG006|Treatment Period|Protocol Violation|6|||
170700187|NCT01479621|616915901|FG000|Treatment Period|Pregnancy|0|||
170700188|NCT01479621|616915902|FG001|Treatment Period|Pregnancy|0|||
170700189|NCT01479621|616915903|FG002|Treatment Period|Pregnancy|2|||
170700190|NCT01479621|616915904|FG003|Treatment Period|Pregnancy|0|||
170700191|NCT01479621|616915905|FG004|Treatment Period|Pregnancy|0|||
170700192|NCT01479621|616915906|FG005|Treatment Period|Pregnancy|0|||
170700193|NCT01479621|616915907|FG006|Treatment Period|Pregnancy|0|||
170700194|NCT01479621|616915901|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
170700195|NCT01479621|616915902|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
170700196|NCT01479621|616915903|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
170700197|NCT01479621|616915904|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
170700198|NCT01479621|616915905|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
170700199|NCT01479621|616915906|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
170700200|NCT01479621|616915907|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
170700201|NCT01479621|616915901|FG000|Treatment Period|Lost to Follow-up|0|||
170700202|NCT01479621|616915902|FG001|Treatment Period|Lost to Follow-up|0|||
170700203|NCT01479621|616915903|FG002|Treatment Period|Lost to Follow-up|1|||
170700204|NCT01479621|616915904|FG003|Treatment Period|Lost to Follow-up|0|||
170700205|NCT01479621|616915905|FG004|Treatment Period|Lost to Follow-up|2|||
170700206|NCT01479621|616915906|FG005|Treatment Period|Lost to Follow-up|2|||
170700207|NCT01479621|616915907|FG006|Treatment Period|Lost to Follow-up|1|||
170700208|NCT01479621|616915901|FG000|Treatment Period|Met stopping criteria|0|||
170824166|NCT02499835|617364953|FG000|Overall Study|Adverse Event|0|||
170824167|NCT02499835|617364954|FG001|Overall Study|Adverse Event|0|||
170824168|NCT02499835|617364955|FG002|Overall Study|Adverse Event|0|||
170824169|NCT02499835|617364956|FG003|Overall Study|Adverse Event|1|||
170824170|NCT02499835|617364953|FG000|Overall Study|Disease progression|2|||
170824171|NCT02499835|617364954|FG001|Overall Study|Disease progression|1|||
170824172|NCT02499835|617364955|FG002|Overall Study|Disease progression|0|||
170824173|NCT02499835|617364956|FG003|Overall Study|Disease progression|7|||
170824174|NCT03226353|617364960|FG000|Overall Study|Withdrawal by Subject|1|||
170824175|NCT03226353|617364960|FG000|Overall Study|Screen Failure|5|||
170824176|NCT00317603|617364964|FG000|Overall Study|Progressive Disease|3|||
170824177|NCT03371485|617364965|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
170824178|NCT03371485|617364965|FG000|2-year Follow-up|Death|5|||
170824179|NCT01264887|617364966|FG000|Overall Study|Adverse Event|5|||
170824180|NCT01264887|617364966|FG000|Overall Study|Death|7|||
170824181|NCT01264887|617364966|FG000|Overall Study|Lack of Efficacy|5|||
170824182|NCT01264887|617364966|FG000|Overall Study|Physician Decision|4|||
170824183|NCT01264887|617364966|FG000|Overall Study|Withdrawal by Subject|6|||
170824184|NCT01264887|617364966|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
170824185|NCT01264887|617364966|FG000|Overall Study|Other|2|||
170824186|NCT03544229|617364967|FG000|Overall Study|Adverse Event|1|||
170824187|NCT03544229|617364968|FG001|Overall Study|Adverse Event|0|||
170824188|NCT03544229|617364969|FG002|Overall Study|Adverse Event|1|||
170824189|NCT03544229|617364970|FG003|Overall Study|Adverse Event|0|||
170824190|NCT03544229|617364967|FG000|Overall Study|Protocol Deviation|0|||
170824191|NCT03544229|617364968|FG001|Overall Study|Protocol Deviation|0|||
170824192|NCT03544229|617364969|FG002|Overall Study|Protocol Deviation|1|||
170824193|NCT03544229|617364970|FG003|Overall Study|Protocol Deviation|0|||
170824194|NCT03544229|617364967|FG000|Overall Study|Lost to Follow-up|3|||
170824195|NCT03544229|617364968|FG001|Overall Study|Lost to Follow-up|0|||
170824196|NCT03544229|617364969|FG002|Overall Study|Lost to Follow-up|0|||
170824197|NCT03544229|617364970|FG003|Overall Study|Lost to Follow-up|2|||
170824198|NCT03544229|617364967|FG000|Overall Study|Voluntary Withdrawal|2|||
170824199|NCT03544229|617364968|FG001|Overall Study|Voluntary Withdrawal|1|||
170824200|NCT03544229|617364969|FG002|Overall Study|Voluntary Withdrawal|3|||
170824201|NCT03544229|617364970|FG003|Overall Study|Voluntary Withdrawal|0|||
170824202|NCT03544229|617364967|FG000|Overall Study|Lack of Efficacy|0|||
170824203|NCT03544229|617364968|FG001|Overall Study|Lack of Efficacy|1|||
170824204|NCT03544229|617364969|FG002|Overall Study|Lack of Efficacy|0|||
170824205|NCT03544229|617364970|FG003|Overall Study|Lack of Efficacy|0|||
170824206|NCT00827775|617364971|FG000|Overall Study|Withdrawal by Subject|0|||
170824207|NCT00827775|617364972|FG001|Overall Study|Withdrawal by Subject|5|||
170824208|NCT00784277|617364973|FG000|IR Treatment|Adverse Event|4|||
170824209|NCT00784277|617364974|FG001|IR Treatment|Adverse Event|8|||
170824210|NCT00784277|617364975|FG002|IR Treatment|Adverse Event|19|||
170824211|NCT00784277|617364976|FG003|IR Treatment|Adverse Event|35|||
170824212|NCT00784277|617364977|FG004|IR Treatment|Adverse Event|0|||
170824213|NCT00784277|617364978|FG005|IR Treatment|Adverse Event|0|||
170824214|NCT00784277|617364979|FG006|IR Treatment|Adverse Event|0|||
170824215|NCT00784277|617364973|FG000|IR Treatment|Lack of Efficacy|4|||
170824216|NCT00784277|617364974|FG001|IR Treatment|Lack of Efficacy|4|||
170824217|NCT00784277|617364975|FG002|IR Treatment|Lack of Efficacy|1|||
170824218|NCT00784277|617364976|FG003|IR Treatment|Lack of Efficacy|0|||
170824219|NCT00784277|617364977|FG004|IR Treatment|Lack of Efficacy|0|||
170824220|NCT00784277|617364978|FG005|IR Treatment|Lack of Efficacy|0|||
170824221|NCT00784277|617364979|FG006|IR Treatment|Lack of Efficacy|0|||
170824222|NCT00784277|617364973|FG000|IR Treatment|Lost to Follow-up|1|||
170824223|NCT00784277|617364974|FG001|IR Treatment|Lost to Follow-up|0|||
170824224|NCT00784277|617364975|FG002|IR Treatment|Lost to Follow-up|1|||
170824225|NCT00784277|617364976|FG003|IR Treatment|Lost to Follow-up|0|||
170824226|NCT00784277|617364977|FG004|IR Treatment|Lost to Follow-up|0|||
170824227|NCT00784277|617364978|FG005|IR Treatment|Lost to Follow-up|0|||
170824228|NCT00784277|617364979|FG006|IR Treatment|Lost to Follow-up|0|||
170824229|NCT00784277|617364973|FG000|IR Treatment|Withdrawal by Subject|5|||
170824230|NCT00784277|617364974|FG001|IR Treatment|Withdrawal by Subject|1|||
170700209|NCT01479621|616915902|FG001|Treatment Period|Met stopping criteria|8|||
170700210|NCT01479621|616915903|FG002|Treatment Period|Met stopping criteria|7|||
170700211|NCT01479621|616915904|FG003|Treatment Period|Met stopping criteria|4|||
170700212|NCT01479621|616915905|FG004|Treatment Period|Met stopping criteria|9|||
170700213|NCT01479621|616915906|FG005|Treatment Period|Met stopping criteria|20|||
170700214|NCT01479621|616915907|FG006|Treatment Period|Met stopping criteria|6|||
170700215|NCT04327999|616915910|FG000|Overall Study|Protocol Violation|1|||
170700216|NCT02872116|616915911|FG000|Pre-Treatment|Disease Progression|0|||
170700217|NCT02872116|616915912|FG001|Pre-Treatment|Disease Progression|1|||
170700218|NCT02872116|616915913|FG002|Pre-Treatment|Disease Progression|0|||
170700219|NCT02872116|616915911|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
170700220|NCT02872116|616915912|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
170700221|NCT02872116|616915913|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
170700222|NCT02872116|616915911|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
170700223|NCT02872116|616915912|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
170700224|NCT02872116|616915913|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
170700225|NCT02872116|616915911|FG000|Pre-Treatment|Participant withdrew consent|2|||
170700226|NCT02872116|616915912|FG001|Pre-Treatment|Participant withdrew consent|20|||
170700227|NCT02872116|616915913|FG002|Pre-Treatment|Participant withdrew consent|3|||
170700228|NCT02872116|616915911|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
170700229|NCT02872116|616915912|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
170700230|NCT02872116|616915913|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
170700231|NCT02872116|616915911|FG000|Pre-Treatment|Other reasons|1|||
170700232|NCT02872116|616915912|FG001|Pre-Treatment|Other reasons|2|||
170700233|NCT02872116|616915913|FG002|Pre-Treatment|Other reasons|2|||
170700234|NCT02872116|616915911|FG000|Treatment|Death|121|||
170700235|NCT02872116|616915912|FG001|Treatment|Death|94|||
170700236|NCT02872116|616915913|FG002|Treatment|Death|68|||
170700237|NCT02872116|616915911|FG000|Treatment|Lost to Follow-up|5|||
170700238|NCT02872116|616915912|FG001|Treatment|Lost to Follow-up|7|||
170700239|NCT02872116|616915913|FG002|Treatment|Lost to Follow-up|3|||
170700240|NCT02872116|616915911|FG000|Treatment|Participant withdrew consent|20|||
170700241|NCT02872116|616915912|FG001|Treatment|Participant withdrew consent|40|||
170700242|NCT02872116|616915913|FG002|Treatment|Participant withdrew consent|8|||
170700243|NCT02872116|616915911|FG000|Treatment|Other reasons|13|||
170700244|NCT02872116|616915912|FG001|Treatment|Other reasons|12|||
170700245|NCT02872116|616915913|FG002|Treatment|Other reasons|5|||
170700246|NCT04334460|616915925|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
170700247|NCT04334460|616915926|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
170700248|NCT04334460|616915925|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
170700249|NCT04334460|616915926|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
170700250|NCT04180020|616915937|FG000|Overall Study|missed visit|18|||
170700251|NCT04180020|616915938|FG001|Overall Study|missed visit|16|||
170700252|NCT04180020|616915937|FG000|Overall Study|Death|2|||
170700253|NCT04180020|616915938|FG001|Overall Study|Death|3|||
170700254|NCT04180020|616915937|FG000|Overall Study|Withdrawal by Subject|1|||
170700255|NCT04180020|616915938|FG001|Overall Study|Withdrawal by Subject|5|||
170700256|NCT04180020|616915937|FG000|Overall Study|incarcerated|1|||
170700257|NCT04180020|616915938|FG001|Overall Study|incarcerated|1|||
170700258|NCT04180020|616915937|FG000|Overall Study|Physician Decision|0|||
170700259|NCT04180020|616915938|FG001|Overall Study|Physician Decision|2|||
170700260|NCT03554291|616915945|FG000|Overall Study|Death|2|||
170700261|NCT03554291|616915946|FG001|Overall Study|Death|1|||
170700262|NCT03554291|616915945|FG000|Overall Study|Lost to Follow-up|1|||
170700263|NCT03554291|616915946|FG001|Overall Study|Lost to Follow-up|0|||
170700264|NCT03554291|616915945|FG000|Overall Study|Withdrawal by Subject|1|||
170700265|NCT03554291|616915946|FG001|Overall Study|Withdrawal by Subject|0|||
170700266|NCT03554291|616915945|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
170700267|NCT03554291|616915946|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
170700268|NCT02357940|616915947|FG000|Overall Study|Adverse Event|0|||
170700269|NCT02357940|616915948|FG001|Overall Study|Adverse Event|1|||
170700270|NCT02357940|616915947|FG000|Overall Study|Investigator's judgement|0|||
170700271|NCT02357940|616915948|FG001|Overall Study|Investigator's judgement|1|||
170700272|NCT02442778|616915949|FG000|Overall Study|Adverse Event|2|||
170700273|NCT02442778|616915950|FG001|Overall Study|Adverse Event|6|||
170700274|NCT02442778|616915951|FG002|Overall Study|Adverse Event|6|||
170700275|NCT02442778|616915949|FG000|Overall Study|Death|0|||
170700276|NCT02442778|616915950|FG001|Overall Study|Death|2|||
170700277|NCT02442778|616915951|FG002|Overall Study|Death|0|||
170700278|NCT02442778|616915949|FG000|Overall Study|Lack of Efficacy|1|||
170700279|NCT02442778|616915950|FG001|Overall Study|Lack of Efficacy|0|||
170700280|NCT02442778|616915951|FG002|Overall Study|Lack of Efficacy|0|||
170700281|NCT02442778|616915949|FG000|Overall Study|Lost to Follow-up|1|||
170700282|NCT02442778|616915950|FG001|Overall Study|Lost to Follow-up|1|||
170700283|NCT02442778|616915951|FG002|Overall Study|Lost to Follow-up|1|||
170700284|NCT02442778|616915949|FG000|Overall Study|Non-compliance with study drug|2|||
170700285|NCT02442778|616915950|FG001|Overall Study|Non-compliance with study drug|0|||
170700286|NCT02442778|616915951|FG002|Overall Study|Non-compliance with study drug|1|||
170700287|NCT02442778|616915949|FG000|Overall Study|Physician Decision|1|||
170700288|NCT02442778|616915950|FG001|Overall Study|Physician Decision|1|||
170700289|NCT02442778|616915951|FG002|Overall Study|Physician Decision|1|||
170700290|NCT02442778|616915949|FG000|Overall Study|Protocol Deviation|3|||
170700291|NCT02442778|616915950|FG001|Overall Study|Protocol Deviation|0|||
170700292|NCT02442778|616915951|FG002|Overall Study|Protocol Deviation|1|||
170700293|NCT02442778|616915949|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
170700294|NCT02442778|616915950|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
170700295|NCT02442778|616915951|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
170700296|NCT02442778|616915949|FG000|Overall Study|Withdrawal by Subject|4|||
170700297|NCT02442778|616915950|FG001|Overall Study|Withdrawal by Subject|4|||
170700298|NCT02442778|616915951|FG002|Overall Study|Withdrawal by Subject|3|||
170700299|NCT02442778|616915949|FG000|Overall Study|Reason not specified|1|||
170700300|NCT02442778|616915950|FG001|Overall Study|Reason not specified|4|||
170700301|NCT02442778|616915951|FG002|Overall Study|Reason not specified|0|||
170700302|NCT01165138|616915954|FG000|Overall Study|Adverse Event|0|||
170700303|NCT01165138|616915955|FG001|Overall Study|Adverse Event|1|||
170700304|NCT01165138|616915956|FG002|Overall Study|Adverse Event|0|||
170700305|NCT01165138|616915957|FG003|Overall Study|Adverse Event|2|||
170700306|NCT01165138|616915954|FG000|Overall Study|Lack of Efficacy|0|||
170700307|NCT01165138|616915955|FG001|Overall Study|Lack of Efficacy|32|||
170700308|NCT01165138|616915956|FG002|Overall Study|Lack of Efficacy|6|||
170700309|NCT01165138|616915957|FG003|Overall Study|Lack of Efficacy|7|||
170700310|NCT01165138|616915954|FG000|Overall Study|Protocol Violation|0|||
170700311|NCT01165138|616915955|FG001|Overall Study|Protocol Violation|7|||
170700312|NCT01165138|616915956|FG002|Overall Study|Protocol Violation|0|||
170700313|NCT01165138|616915957|FG003|Overall Study|Protocol Violation|2|||
170700314|NCT01165138|616915954|FG000|Overall Study|Lost to Follow-up|0|||
170700315|NCT01165138|616915955|FG001|Overall Study|Lost to Follow-up|0|||
170700316|NCT01165138|616915956|FG002|Overall Study|Lost to Follow-up|1|||
170700317|NCT01165138|616915957|FG003|Overall Study|Lost to Follow-up|2|||
170700318|NCT01165138|616915954|FG000|Overall Study|Physician Decision|0|||
170700319|NCT01165138|616915955|FG001|Overall Study|Physician Decision|6|||
170700320|NCT01165138|616915956|FG002|Overall Study|Physician Decision|7|||
170700321|NCT01165138|616915957|FG003|Overall Study|Physician Decision|6|||
170700322|NCT01165138|616915954|FG000|Overall Study|Withdrawal by Subject|0|||
170700323|NCT01165138|616915955|FG001|Overall Study|Withdrawal by Subject|6|||
170700324|NCT01165138|616915956|FG002|Overall Study|Withdrawal by Subject|6|||
170700325|NCT01165138|616915957|FG003|Overall Study|Withdrawal by Subject|3|||
170700326|NCT02120794|616915958|FG000|Overall Study|Withdrawal by Subject|43|||
170700327|NCT02120794|616915958|FG000|Overall Study|Adverse Event|10|||
170700328|NCT02120794|616915958|FG000|Overall Study|Physician Decision|4|||
170700329|NCT02120794|616915958|FG000|Overall Study|Due to insurance coverage|1|||
170700330|NCT01644175|616915959|FG000|Overall Study|Randomized But Not Treated|0|||
170700331|NCT01644175|616915960|FG001|Overall Study|Randomized But Not Treated|2|||
170700332|NCT01644175|616915959|FG000|Overall Study|Adverse Event|8|||
170700333|NCT01644175|616915960|FG001|Overall Study|Adverse Event|13|||
170700334|NCT01644175|616915959|FG000|Overall Study|Death|1|||
170700335|NCT01644175|616915960|FG001|Overall Study|Death|2|||
170700336|NCT01644175|616915959|FG000|Overall Study|Poor compliance to protocol|9|||
170700337|NCT01644175|616915960|FG001|Overall Study|Poor compliance to protocol|10|||
170700338|NCT01644175|616915959|FG000|Overall Study|Physician Decision|1|||
170700339|NCT01644175|616915960|FG001|Overall Study|Physician Decision|2|||
170700340|NCT01644175|616915959|FG000|Overall Study|Participant Moved|1|||
170700341|NCT01644175|616915960|FG001|Overall Study|Participant Moved|2|||
170700342|NCT01644175|616915959|FG000|Overall Study|Consent withdrawn by participant|3|||
170700343|NCT01644175|616915960|FG001|Overall Study|Consent withdrawn by participant|4|||
170700344|NCT01644175|616915959|FG000|Overall Study|Related to Autoinjector Administration|2|||
170700345|NCT01644175|616915960|FG001|Overall Study|Related to Autoinjector Administration|1|||
170700346|NCT01644175|616915959|FG000|Overall Study|Last visit outside protocol visit window|4|||
170700347|NCT01644175|616915960|FG001|Overall Study|Last visit outside protocol visit window|11|||
170700348|NCT01644175|616915959|FG000|Overall Study|Selection criteria finally not met|0|||
170700349|NCT01644175|616915960|FG001|Overall Study|Selection criteria finally not met|1|||
170700350|NCT01644175|616915959|FG000|Overall Study|Site closure|2|||
170700351|NCT01644175|616915960|FG001|Overall Study|Site closure|2|||
170700352|NCT01644175|616915959|FG000|Overall Study|Lost to Follow-up|1|||
170700353|NCT01644175|616915960|FG001|Overall Study|Lost to Follow-up|0|||
170700354|NCT01644175|616915959|FG000|Overall Study|Other than specified above|0|||
170700355|NCT01644175|616915960|FG001|Overall Study|Other than specified above|3|||
170700356|NCT02910167|616915967|FG000|Overall Study|Adverse Event|1|||
170700357|NCT02910167|616915967|FG000|Overall Study|Lost to Follow-up|18|||
170700358|NCT01418937|616915968|FG000|Overall Study|Lost to Follow-up|5|||
170700359|NCT01418937|616915968|FG000|Overall Study|Protocol Violation|1|||
170700360|NCT01418937|616915968|FG000|Overall Study|Pregnancy|1|||
170700361|NCT01418937|616915968|FG000|Overall Study|Withdrawal by Subject|1|||
170700362|NCT00451035|616915971|FG000|Overall Study|Disease progression|11|||
170700363|NCT00451035|616915971|FG000|Overall Study|Death|3|||
170700364|NCT00451035|616915971|FG000|Overall Study|New anti-neoplastic therapy|3|||
170700365|NCT00842348|616915974|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
170700366|NCT00842348|616915975|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
170700367|NCT00842348|616915974|FG000|Study 729|Disease progression/death|19|||
170700368|NCT00842348|616915975|FG001|Study 729|Disease progression/death|30|||
170700369|NCT00842348|616915974|FG000|Study 729|Adverse Event|1|||
170700370|NCT00842348|616915975|FG001|Study 729|Adverse Event|1|||
170700371|NCT00842348|616915974|FG000|Study 729|Protocol Violation|1|||
170700372|NCT00842348|616915975|FG001|Study 729|Protocol Violation|1|||
170700373|NCT00842348|616915974|FG000|Study 729|Withdrawal by Subject|2|||
170700374|NCT00842348|616915975|FG001|Study 729|Withdrawal by Subject|4|||
170700375|NCT00842348|616915974|FG000|Study 729|Due to Sponsor stopping the study|1|||
170700376|NCT00842348|616915975|FG001|Study 729|Due to Sponsor stopping the study|1|||
170700377|NCT00842348|616915974|FG000|Study 729|Due to non-availability of IP|0|||
170700378|NCT00842348|616915975|FG001|Study 729|Due to non-availability of IP|1|||
170700379|NCT00842348|616915974|FG000|Study 729|Sponsor's decision|1|||
170700380|NCT00842348|616915975|FG001|Study 729|Sponsor's decision|0|||
170700381|NCT00842348|616915974|FG000|Study 729|Surgical resection|1|||
170700382|NCT00842348|616915975|FG001|Study 729|Surgical resection|0|||
170700383|NCT01393405|616915976|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
170700384|NCT01393405|616915977|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
170700385|NCT01393405|616915978|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
170700386|NCT01393405|616915976|FG000|Induction Period (week1-16)|Adverse Event|16|||
170700387|NCT01393405|616915977|FG001|Induction Period (week1-16)|Adverse Event|0|||
170700388|NCT01393405|616915978|FG002|Induction Period (week1-16)|Adverse Event|0|||
170700389|NCT01393405|616915976|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
170700390|NCT01393405|616915977|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
170700391|NCT01393405|616915978|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
170700392|NCT01393405|616915976|FG000|Maintenance Period Week|Lack of Efficacy|0|||
170700393|NCT01393405|616915977|FG001|Maintenance Period Week|Lack of Efficacy|22|||
170700394|NCT01393405|616915978|FG002|Maintenance Period Week|Lack of Efficacy|22|||
170700395|NCT01393405|616915976|FG000|Maintenance Period Week|Adverse Event|0|||
170700396|NCT01393405|616915977|FG001|Maintenance Period Week|Adverse Event|5|||
170700397|NCT01393405|616915978|FG002|Maintenance Period Week|Adverse Event|2|||
170700398|NCT01393405|616915976|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
170700399|NCT01393405|616915977|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
170700400|NCT01393405|616915978|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
170700401|NCT01393405|616915976|FG000|Maintenance Period Week|Lost to Follow-up|0|||
170700402|NCT01393405|616915977|FG001|Maintenance Period Week|Lost to Follow-up|1|||
170700403|NCT01393405|616915978|FG002|Maintenance Period Week|Lost to Follow-up|0|||
170700404|NCT00026793|616915979|FG000|Overall Study|Death on study due to underlying disease|4|||
170700405|NCT00026793|616915979|FG000|Overall Study|Physician Decision|2|||
170700406|NCT00026793|616915979|FG000|Overall Study|Off study|2|||
170700407|NCT03913091|616915980|FG000|Overall Study|Lost to Follow-up|18|||
170700408|NCT03913091|616915981|FG001|Overall Study|Lost to Follow-up|11|||
170700409|NCT03913091|616915980|FG000|Overall Study|Required additional meds/surgery|1|||
170700410|NCT03913091|616915981|FG001|Overall Study|Required additional meds/surgery|2|||
170700411|NCT03913091|616915980|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
170700412|NCT03913091|616915981|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
170700413|NCT00655564|616915988|FG000|Overall Study|Adverse Event|1|||
170700414|NCT00655564|616915988|FG000|Overall Study|Lost to Follow-up|1|||
170700415|NCT00655564|616915988|FG000|Overall Study|Desired Alternate Therapy|1|||
170700416|NCT01399593|616915989|FG000|Overall Study|Physician Decision|1|||
170700417|NCT01399593|616915990|FG001|Overall Study|Physician Decision|0|||
170700418|NCT01399593|616915989|FG000|Overall Study|Adverse Event|1|||
170700419|NCT01399593|616915990|FG001|Overall Study|Adverse Event|0|||
170700420|NCT01399593|616915989|FG000|Overall Study|Death|1|||
170700421|NCT01399593|616915990|FG001|Overall Study|Death|1|||
170700422|NCT01399593|616915989|FG000|Overall Study|Transplantectomy|0|||
170700423|NCT01399593|616915990|FG001|Overall Study|Transplantectomy|1|||
170700424|NCT02849548|616915997|FG000|Overall Study|Lost to Follow-up|1|||
170700425|NCT02849548|616915998|FG001|Overall Study|Lost to Follow-up|2|||
170700426|NCT02849548|616915997|FG000|Overall Study|Protocol Violation|1|||
170700427|NCT02849548|616915998|FG001|Overall Study|Protocol Violation|0|||
170700428|NCT03569371|616918430|FG000|Overall Study|Lack of Efficacy|1|||
170700429|NCT03569371|616918430|FG000|Overall Study|Lost to Follow-up|1|||
170700430|NCT03569371|616918430|FG000|Overall Study|Adverse Event|1|||
170700431|NCT03643562|616918433|FG000|Overall Study|Adverse Event|1|||
170700432|NCT03643562|616918434|FG001|Overall Study|Adverse Event|0|||
170700433|NCT03643562|616918433|FG000|Overall Study|Lack of Efficacy|0|||
170700434|NCT03643562|616918434|FG001|Overall Study|Lack of Efficacy|1|||
170700435|NCT03643562|616918433|FG000|Overall Study|Physician Decision|0|||
170700436|NCT03643562|616918434|FG001|Overall Study|Physician Decision|1|||
170700437|NCT03643562|616918433|FG000|Overall Study|Study Terminated by Sponsor|2|||
170700438|NCT03643562|616918434|FG001|Overall Study|Study Terminated by Sponsor|10|||
170700439|NCT03643562|616918433|FG000|Overall Study|Withdrawal by Subject|2|||
170700440|NCT03643562|616918434|FG001|Overall Study|Withdrawal by Subject|2|||
170700441|NCT03643562|616918433|FG000|Overall Study|Other than specified|3|||
170700442|NCT03643562|616918434|FG001|Overall Study|Other than specified|2|||
170700443|NCT01982253|616918435|FG000|Overall Study|Withdrawal by Subject|1|||
170700444|NCT01982253|616918436|FG001|Overall Study|Withdrawal by Subject|0|||
170700445|NCT01982253|616918437|FG002|Overall Study|Withdrawal by Subject|0|||
170700446|NCT01982253|616918435|FG000|Overall Study|Study terminated by sponsor|1|||
170700447|NCT01982253|616918436|FG001|Overall Study|Study terminated by sponsor|4|||
170700448|NCT01982253|616918437|FG002|Overall Study|Study terminated by sponsor|4|||
170700449|NCT02789176|616918441|FG000|Overall Study|Death|0|||
170700450|NCT02789176|616918442|FG001|Overall Study|Death|0|||
170700451|NCT02789176|616918443|FG002|Overall Study|Death|3|||
170700452|NCT02789176|616918444|FG003|Overall Study|Death|0|||
170700453|NCT02789176|616918441|FG000|Overall Study|Withdrawal by Subject|0|||
170700454|NCT02789176|616918442|FG001|Overall Study|Withdrawal by Subject|0|||
170700455|NCT02789176|616918443|FG002|Overall Study|Withdrawal by Subject|1|||
170700456|NCT02789176|616918444|FG003|Overall Study|Withdrawal by Subject|0|||
170700457|NCT02789176|616918441|FG000|Overall Study|Lost to Follow-up|8|||
170700458|NCT02789176|616918442|FG001|Overall Study|Lost to Follow-up|2|||
170700459|NCT02789176|616918443|FG002|Overall Study|Lost to Follow-up|6|||
170700460|NCT02789176|616918444|FG003|Overall Study|Lost to Follow-up|1|||
170824231|NCT00784277|617364975|FG002|IR Treatment|Withdrawal by Subject|4|||
170824232|NCT00784277|617364976|FG003|IR Treatment|Withdrawal by Subject|6|||
170824233|NCT00784277|617364977|FG004|IR Treatment|Withdrawal by Subject|0|||
170824234|NCT00784277|617364978|FG005|IR Treatment|Withdrawal by Subject|0|||
170824235|NCT00784277|617364979|FG006|IR Treatment|Withdrawal by Subject|0|||
170824236|NCT00784277|617364973|FG000|IR Treatment|Resolution Of Pain|0|||
170824237|NCT00784277|617364974|FG001|IR Treatment|Resolution Of Pain|1|||
170824238|NCT00784277|617364975|FG002|IR Treatment|Resolution Of Pain|0|||
170824239|NCT00784277|617364976|FG003|IR Treatment|Resolution Of Pain|0|||
170824240|NCT00784277|617364977|FG004|IR Treatment|Resolution Of Pain|0|||
170824241|NCT00784277|617364978|FG005|IR Treatment|Resolution Of Pain|0|||
170824242|NCT00784277|617364979|FG006|IR Treatment|Resolution Of Pain|0|||
170824243|NCT00784277|617364973|FG000|IR Treatment|Other|2|||
170824244|NCT00784277|617364974|FG001|IR Treatment|Other|3|||
170824245|NCT00784277|617364975|FG002|IR Treatment|Other|3|||
170824246|NCT00784277|617364976|FG003|IR Treatment|Other|2|||
170824247|NCT00784277|617364977|FG004|IR Treatment|Other|0|||
170824248|NCT00784277|617364978|FG005|IR Treatment|Other|0|||
170824249|NCT00784277|617364979|FG006|IR Treatment|Other|0|||
170824250|NCT00784277|617364973|FG000|ER Treatment|Adverse Event|0|||
170824251|NCT00784277|617364974|FG001|ER Treatment|Adverse Event|0|||
170824252|NCT00784277|617364975|FG002|ER Treatment|Adverse Event|0|||
170824253|NCT00784277|617364976|FG003|ER Treatment|Adverse Event|0|||
170824254|NCT00784277|617364977|FG004|ER Treatment|Adverse Event|1|||
170824255|NCT00784277|617364978|FG005|ER Treatment|Adverse Event|7|||
170824256|NCT00784277|617364979|FG006|ER Treatment|Adverse Event|7|||
170824257|NCT00784277|617364973|FG000|ER Treatment|Lack of Efficacy|0|||
170824258|NCT00784277|617364974|FG001|ER Treatment|Lack of Efficacy|0|||
170824259|NCT00784277|617364975|FG002|ER Treatment|Lack of Efficacy|0|||
170824260|NCT00784277|617364976|FG003|ER Treatment|Lack of Efficacy|0|||
170700461|NCT02223767|616918445|FG000|Overall Study|Withdrawal by Subject|4|||
170700462|NCT02223767|616918446|FG001|Overall Study|Withdrawal by Subject|4|||
170824261|NCT00784277|617364977|FG004|ER Treatment|Lack of Efficacy|3|||
170824262|NCT00784277|617364978|FG005|ER Treatment|Lack of Efficacy|4|||
170824263|NCT00784277|617364979|FG006|ER Treatment|Lack of Efficacy|0|||
170824264|NCT00784277|617364973|FG000|ER Treatment|Lost to Follow-up|0|||
170824265|NCT00784277|617364974|FG001|ER Treatment|Lost to Follow-up|0|||
170824266|NCT00784277|617364975|FG002|ER Treatment|Lost to Follow-up|0|||
170824267|NCT00784277|617364976|FG003|ER Treatment|Lost to Follow-up|0|||
170824268|NCT00784277|617364977|FG004|ER Treatment|Lost to Follow-up|0|||
170700463|NCT02347527|616918449|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
170700464|NCT02347527|616918450|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
170700465|NCT02347527|616918451|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
170700466|NCT02347527|616918452|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
170700467|NCT02347527|616918449|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
170824269|NCT00784277|617364978|FG005|ER Treatment|Lost to Follow-up|2|||
170824270|NCT00784277|617364979|FG006|ER Treatment|Lost to Follow-up|0|||
170824271|NCT00784277|617364973|FG000|ER Treatment|Withdrawal by Subject|0|||
170824272|NCT00784277|617364974|FG001|ER Treatment|Withdrawal by Subject|0|||
170824273|NCT00784277|617364975|FG002|ER Treatment|Withdrawal by Subject|0|||
170824274|NCT00784277|617364976|FG003|ER Treatment|Withdrawal by Subject|0|||
170824275|NCT00784277|617364977|FG004|ER Treatment|Withdrawal by Subject|2|||
170824276|NCT00784277|617364978|FG005|ER Treatment|Withdrawal by Subject|5|||
170824277|NCT00784277|617364979|FG006|ER Treatment|Withdrawal by Subject|3|||
170824278|NCT00784277|617364973|FG000|ER Treatment|Study Medication Non-Compliant|0|||
170824279|NCT00784277|617364974|FG001|ER Treatment|Study Medication Non-Compliant|0|||
170824280|NCT00784277|617364975|FG002|ER Treatment|Study Medication Non-Compliant|0|||
170824281|NCT00784277|617364976|FG003|ER Treatment|Study Medication Non-Compliant|0|||
170824282|NCT00784277|617364977|FG004|ER Treatment|Study Medication Non-Compliant|2|||
170824283|NCT00784277|617364978|FG005|ER Treatment|Study Medication Non-Compliant|3|||
170824284|NCT00784277|617364979|FG006|ER Treatment|Study Medication Non-Compliant|3|||
170700468|NCT02347527|616918450|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
170700469|NCT02347527|616918451|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
170700470|NCT02347527|616918452|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
170700471|NCT02347527|616918449|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
170700472|NCT02347527|616918450|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
170700473|NCT02347527|616918451|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
170700474|NCT02347527|616918452|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
170700475|NCT02347527|616918449|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
170700476|NCT02347527|616918450|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
170700477|NCT02347527|616918451|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
170700478|NCT02347527|616918452|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
170700479|NCT02347527|616918449|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
170700480|NCT02347527|616918450|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
170700481|NCT02347527|616918451|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
170700482|NCT02347527|616918452|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
170700483|NCT00596011|616918453|FG000|Overall Study|Withdrawal by Subject|2|||
170700484|NCT00596011|616918454|FG001|Overall Study|Withdrawal by Subject|3|||
170700485|NCT00596011|616918453|FG000|Overall Study|Adverse Event|11|||
170700486|NCT00596011|616918454|FG001|Overall Study|Adverse Event|7|||
170700487|NCT00779675|616918455|FG000|Treatment Period|Adverse Event|87|||
170700488|NCT00779675|616918455|FG000|Treatment Period|Treatment Failure|80|||
170700489|NCT00779675|616918455|FG000|Treatment Period|Transferred to Another Study|38|||
170700490|NCT00779675|616918455|FG000|Treatment Period|Lost to Follow-up|23|||
170700491|NCT00779675|616918455|FG000|Treatment Period|Withdrawal by Subject|46|||
170700492|NCT00779675|616918455|FG000|Treatment Period|Protocol Violation|54|||
170700493|NCT00779675|616918455|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
170700494|NCT00779675|616918455|FG000|Treatment Period|Administrative|3|||
170700495|NCT00779675|616918455|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
170700496|NCT00779675|616918455|FG000|Extended Treatment Period|Protocol Violation|13|||
170700497|NCT00779675|616918455|FG000|Extended Treatment Period|Adverse Event|6|||
170700498|NCT00779675|616918455|FG000|Extended Treatment Period|Treatment Failure|11|||
170700499|NCT00779675|616918455|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
170700500|NCT00779675|616918455|FG000|Extended Treatment Period|Lost to Follow-up|6|||
170824285|NCT00784277|617364973|FG000|ER Treatment|Other|0|||
170824286|NCT00784277|617364974|FG001|ER Treatment|Other|0|||
170700501|NCT01466270|616918456|FG000|Overall Study|Withdrawal by Subject|4|||
170700502|NCT01466270|616918457|FG001|Overall Study|Withdrawal by Subject|1|||
170700503|NCT01466270|616918456|FG000|Overall Study|Physician Decision|1|||
170700504|NCT01466270|616918457|FG001|Overall Study|Physician Decision|0|||
170824287|NCT00784277|617364975|FG002|ER Treatment|Other|0|||
170824288|NCT00784277|617364976|FG003|ER Treatment|Other|0|||
170824289|NCT00784277|617364977|FG004|ER Treatment|Other|1|||
170824290|NCT00784277|617364978|FG005|ER Treatment|Other|3|||
170824291|NCT00784277|617364979|FG006|ER Treatment|Other|2|||
170824292|NCT01093222|617364980|FG000|Overall Study|Ineligible|6|||
170824293|NCT01093222|617364980|FG000|Overall Study|Adverse Event|7|||
170824294|NCT01093222|617364980|FG000|Overall Study|Progression/relapse|24|||
170824295|NCT01093222|617364980|FG000|Overall Study|Death|2|||
170824296|NCT01093222|617364980|FG000|Overall Study|Not protocol specified|1|||
170824297|NCT02642159|617364981|FG000|Overall Study|Randomized but not treated|1|||
170824298|NCT02642159|617364982|FG001|Overall Study|Randomized but not treated|0|||
170824299|NCT02642159|617364981|FG000|Overall Study|Adverse Event|10|||
170824300|NCT02642159|617364982|FG001|Overall Study|Adverse Event|4|||
170824301|NCT02642159|617364981|FG000|Overall Study|Withdrawal by Subject|9|||
170824302|NCT02642159|617364982|FG001|Overall Study|Withdrawal by Subject|1|||
170824303|NCT02642159|617364981|FG000|Overall Study|Poor compliance to study protocol|1|||
170824304|NCT02642159|617364982|FG001|Overall Study|Poor compliance to study protocol|0|||
170824305|NCT02642159|617364981|FG000|Overall Study|Other than specified above|10|||
170824306|NCT02642159|617364982|FG001|Overall Study|Other than specified above|3|||
170824307|NCT02567227|617364983|FG000|9 Weeks|Adverse Event|5|||
170824308|NCT02567227|617364984|FG001|9 Weeks|Adverse Event|5|||
170824309|NCT02567227|617364983|FG000|9 Weeks|Withdrawal by Subject|18|||
170824310|NCT02567227|617364984|FG001|9 Weeks|Withdrawal by Subject|8|||
170824311|NCT02567227|617364983|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
170824312|NCT02567227|617364984|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
170824313|NCT02567227|617364983|FG000|6 Month|Death|2|||
170824314|NCT02567227|617364984|FG001|6 Month|Death|0|||
170824315|NCT02567227|617364983|FG000|6 Month|Lost to Follow-up|43|||
170824316|NCT02567227|617364984|FG001|6 Month|Lost to Follow-up|40|||
170824317|NCT02567227|617364983|FG000|12 Months|Lost to Follow-up|31|||
170824318|NCT02567227|617364984|FG001|12 Months|Lost to Follow-up|32|||
170824319|NCT02567227|617364983|FG000|12 Months|Death|0|||
170824320|NCT02567227|617364984|FG001|12 Months|Death|2|||
170824321|NCT03635775|617364989|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
170824322|NCT03635775|617364990|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
170824323|NCT03635775|617364991|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
170824324|NCT03635775|617364992|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
170824325|NCT00762502|617364993|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
170824326|NCT00762502|617364994|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
170824327|NCT00762502|617364995|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
170824328|NCT00762502|617364993|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
170824329|NCT00762502|617364994|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
170824330|NCT00762502|617364995|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
170824331|NCT00762502|617364993|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
170824332|NCT00762502|617364994|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
170824333|NCT00762502|617364995|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
170824334|NCT03280108|617365005|FG000|Overall Study|Lost to Follow-up|2|||
170700505|NCT01466270|616918456|FG000|Overall Study|Lost to Follow-up|1|||
170700506|NCT01466270|616918457|FG001|Overall Study|Lost to Follow-up|3|||
170700507|NCT01466270|616918456|FG000|Overall Study|Progression|1|||
170700508|NCT01466270|616918457|FG001|Overall Study|Progression|0|||
170700509|NCT01466270|616918456|FG000|Overall Study|Toxicity|4|||
170700510|NCT01466270|616918457|FG001|Overall Study|Toxicity|1|||
170700511|NCT01466270|616918456|FG000|Overall Study|Multiple|1|||
170700512|NCT01466270|616918457|FG001|Overall Study|Multiple|1|||
170700513|NCT01956110|616918461|FG000|Overall Study|Protocol Violation|25|||
170700514|NCT01956110|616918462|FG001|Overall Study|Protocol Violation|11|||
170700515|NCT01956110|616918461|FG000|Overall Study|Adverse Event|9|||
170824335|NCT03280108|617365006|FG001|Overall Study|Lost to Follow-up|0|||
170700516|NCT01956110|616918462|FG001|Overall Study|Adverse Event|10|||
170700517|NCT01956110|616918461|FG000|Overall Study|Personal reasons|1|||
170700518|NCT01956110|616918462|FG001|Overall Study|Personal reasons|1|||
170700519|NCT02118428|616918465|FG000|Overall Study|Physician Decision|0|||
170824336|NCT02201771|617365007|FG000|Overall Study|Death|3|||
170824337|NCT02201771|617365008|FG001|Overall Study|Death|2|||
170824338|NCT02201771|617365009|FG002|Overall Study|Death|0|||
170824339|NCT02201771|617365007|FG000|Overall Study|Protocol Violation|10|||
170824340|NCT02201771|617365008|FG001|Overall Study|Protocol Violation|8|||
170824341|NCT02201771|617365009|FG002|Overall Study|Protocol Violation|10|||
170824342|NCT01820637|617365010|FG000|Overall Study|Death|2|||
170824343|NCT01820637|617365010|FG000|Overall Study|Withdrawal by Subject|1|||
170824344|NCT00264498|617365011|FG000|Randomized Treatment|Death|0|||
170824345|NCT00264498|617365012|FG001|Randomized Treatment|Death|3|||
170824346|NCT00264498|617365011|FG000|Randomized Treatment|Withdrawal by Subject|0|||
170700520|NCT02118428|616918466|FG001|Overall Study|Physician Decision|1|||
170824347|NCT00264498|617365012|FG001|Randomized Treatment|Withdrawal by Subject|1|||
170824348|NCT00264498|617365011|FG000|Randomized Treatment|Objective disease Progression|13|||
170824349|NCT00264498|617365012|FG001|Randomized Treatment|Objective disease Progression|14|||
170824350|NCT00264498|617365011|FG000|Randomized Treatment|Physician Decision|1|||
170824351|NCT00264498|617365012|FG001|Randomized Treatment|Physician Decision|0|||
170824352|NCT00264498|617365011|FG000|Randomized Treatment|Incorrectly randomized|1|||
170824353|NCT00264498|617365012|FG001|Randomized Treatment|Incorrectly randomized|0|||
170824354|NCT00264498|617365011|FG000|Randomized Treatment|Study Closure|1|||
170824355|NCT00264498|617365012|FG001|Randomized Treatment|Study Closure|0|||
170824356|NCT00264498|617365011|FG000|Randomized Treatment|Protocol Violation|1|||
170824357|NCT00264498|617365012|FG001|Randomized Treatment|Protocol Violation|0|||
170824358|NCT00264498|617365011|FG000|Crossover Treatment|Death|1|||
170824359|NCT00264498|617365012|FG001|Crossover Treatment|Death|3|||
170824360|NCT00264498|617365011|FG000|Crossover Treatment|Objective disease progression|4|||
170824361|NCT00264498|617365012|FG001|Crossover Treatment|Objective disease progression|5|||
170824362|NCT00264498|617365011|FG000|Crossover Treatment|Study closure|0|||
170824363|NCT00264498|617365012|FG001|Crossover Treatment|Study closure|1|||
170824364|NCT00264498|617365011|FG000|Crossover Treatment|Withdrawal by Subject|1|||
170824365|NCT00264498|617365012|FG001|Crossover Treatment|Withdrawal by Subject|0|||
170824366|NCT03794609|617365013|FG000|Overall Study|Other|10|||
170824367|NCT03794609|617365013|FG000|Overall Study|Withdrawal by Subject|66|||
170824368|NCT03794609|617365013|FG000|Overall Study|The child is enrolled in an interventional study|70|||
170824369|NCT03794609|617365013|FG000|Overall Study|Inclusion/exclusion criteria|8|||
170824370|NCT03794609|617365013|FG000|Overall Study|At sponsor's request|151|||
170824371|NCT03794609|617365013|FG000|Overall Study|Physician Decision|1|||
170824372|NCT03794609|617365013|FG000|Overall Study|Lost to Follow-up|5|||
170824373|NCT03569475|617365014|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
170824374|NCT03569475|617365015|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
170824375|NCT03569475|617365016|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
170824376|NCT03569475|617365014|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
170824377|NCT03569475|617365015|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
170824378|NCT03569475|617365016|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
170824379|NCT03569475|617365014|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
170824380|NCT03569475|617365015|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
170824381|NCT03569475|617365016|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
170824382|NCT03569475|617365014|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
170824383|NCT03569475|617365015|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
170824384|NCT03569475|617365016|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
170824385|NCT03569475|617365014|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
170824386|NCT03569475|617365015|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
170824387|NCT03569475|617365016|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
170824388|NCT03569475|617365014|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
170824389|NCT03569475|617365015|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
170824390|NCT03569475|617365016|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
170824391|NCT03569475|617365014|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
170824392|NCT03569475|617365015|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
170824393|NCT03569475|617365016|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
170824394|NCT03569475|617365014|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
170824395|NCT03569475|617365015|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
170824396|NCT03569475|617365016|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
170824397|NCT03569475|617365014|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
170824398|NCT03569475|617365015|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
170824399|NCT03569475|617365016|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
170824400|NCT03638258|617365017|FG000|Overall Study|Adverse Event|1|||
170824401|NCT03638258|617365018|FG001|Overall Study|Adverse Event|0|||
170824402|NCT03638258|617365019|FG002|Overall Study|Adverse Event|2|||
170824403|NCT03638258|617365017|FG000|Overall Study|Lost to Follow-up|2|||
170824404|NCT03638258|617365018|FG001|Overall Study|Lost to Follow-up|4|||
170824405|NCT03638258|617365019|FG002|Overall Study|Lost to Follow-up|5|||
170824406|NCT03638258|617365017|FG000|Overall Study|Pregnancy|0|||
170824407|NCT03638258|617365018|FG001|Overall Study|Pregnancy|0|||
170824408|NCT03638258|617365019|FG002|Overall Study|Pregnancy|1|||
170824409|NCT03638258|617365017|FG000|Overall Study|Protocol Violation|0|||
170824410|NCT03638258|617365018|FG001|Overall Study|Protocol Violation|0|||
170824411|NCT03638258|617365019|FG002|Overall Study|Protocol Violation|1|||
170824412|NCT03638258|617365017|FG000|Overall Study|Withdrawal by Subject|4|||
170824413|NCT03638258|617365018|FG001|Overall Study|Withdrawal by Subject|5|||
170824414|NCT03638258|617365019|FG002|Overall Study|Withdrawal by Subject|12|||
170824415|NCT03638258|617365017|FG000|Overall Study|Lack of Efficacy|0|||
170824416|NCT03638258|617365018|FG001|Overall Study|Lack of Efficacy|0|||
170824417|NCT03638258|617365019|FG002|Overall Study|Lack of Efficacy|2|||
170824418|NCT04543942|617365020|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
170824419|NCT04543942|617365021|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
170824420|NCT04543942|617365020|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
170824421|NCT04543942|617365021|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
170824422|NCT02205476|617365022|FG000|Overall Study|Study termination by Sponsor|7|||
170824423|NCT02205476|617365023|FG001|Overall Study|Study termination by Sponsor|3|||
170824424|NCT00139659|617365028|FG000|Overall Study|Adverse Event|12|||
170824425|NCT00139659|617365029|FG001|Overall Study|Adverse Event|1|||
170824426|NCT00139659|617365028|FG000|Overall Study|Lack of Efficacy|1|||
170824427|NCT00139659|617365029|FG001|Overall Study|Lack of Efficacy|1|||
170824428|NCT00139659|617365028|FG000|Overall Study|Lost to Follow-up|7|||
170824429|NCT00139659|617365029|FG001|Overall Study|Lost to Follow-up|3|||
170824430|NCT00139659|617365028|FG000|Overall Study|Reason not Specified|6|||
170824431|NCT00139659|617365029|FG001|Overall Study|Reason not Specified|3|||
170824432|NCT00139659|617365028|FG000|Overall Study|Withdrawal by Subject|14|||
170824433|NCT00139659|617365029|FG001|Overall Study|Withdrawal by Subject|10|||
170824434|NCT02625922|617365035|FG000|Overall Study|Non-availability of IMP|1|||
170824435|NCT02625922|617365036|FG001|Overall Study|Non-availability of IMP|1|||
170824436|NCT02625922|617365035|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
170824437|NCT02625922|617365036|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
170824438|NCT02109107|617365044|FG000|Overall Study|Lost to Follow-up|2|||
170824439|NCT02506881|617365049|FG000|First Intervention (Day 1)|Protocol Violation|0|||
170824440|NCT02506881|617365050|FG001|First Intervention (Day 1)|Protocol Violation|0|||
170824441|NCT02506881|617365051|FG002|First Intervention (Day 1)|Protocol Violation|1|||
170824442|NCT02506881|617365052|FG003|First Intervention (Day 1)|Protocol Violation|0|||
170824443|NCT02506881|617365049|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
170824444|NCT02506881|617365050|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
170824445|NCT02506881|617365051|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
170824446|NCT02506881|617365052|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
170824447|NCT02506881|617365049|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
170824448|NCT02506881|617365050|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
170824449|NCT02506881|617365051|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
170824450|NCT02506881|617365052|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
170824451|NCT03340766|617365056|FG000|Overall Study|Withdrawal by Subject|2|||
170824452|NCT03340766|617365057|FG001|Overall Study|Withdrawal by Subject|1|||
170824453|NCT03340766|617365058|FG002|Overall Study|Withdrawal by Subject|3|||
170824454|NCT03340766|617365056|FG000|Overall Study|Lost to Follow-up|0|||
170824455|NCT03340766|617365057|FG001|Overall Study|Lost to Follow-up|0|||
170824456|NCT03340766|617365058|FG002|Overall Study|Lost to Follow-up|1|||
170824457|NCT03340766|617365056|FG000|Overall Study|Death|6|||
170824458|NCT03340766|617365057|FG001|Overall Study|Death|7|||
170824459|NCT03340766|617365058|FG002|Overall Study|Death|4|||
170824460|NCT01294358|617365062|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
170824461|NCT01294358|617365063|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
170824462|NCT01294358|617365064|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
170824463|NCT01294358|617365065|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
170824464|NCT01294358|617365066|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
170700521|NCT02118428|616918467|FG002|Overall Study|Physician Decision|0|||
170700522|NCT02118428|616918465|FG000|Overall Study|Withdrawal by Subject|2|||
170700523|NCT02118428|616918466|FG001|Overall Study|Withdrawal by Subject|2|||
170700524|NCT02118428|616918467|FG002|Overall Study|Withdrawal by Subject|0|||
170700525|NCT02118428|616918465|FG000|Overall Study|Death|7|||
170700526|NCT02118428|616918466|FG001|Overall Study|Death|5|||
170700527|NCT02118428|616918467|FG002|Overall Study|Death|0|||
170700528|NCT02118428|616918465|FG000|Overall Study|Lost to Follow-up|3|||
170700529|NCT02118428|616918466|FG001|Overall Study|Lost to Follow-up|1|||
170824465|NCT01294358|617365062|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
170824466|NCT01294358|617365063|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
170824467|NCT01294358|617365064|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
170824468|NCT01294358|617365065|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
170700530|NCT02118428|616918467|FG002|Overall Study|Lost to Follow-up|0|||
170700531|NCT02118428|616918465|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
170700532|NCT02118428|616918466|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
170824469|NCT01294358|617365066|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
170824470|NCT01294358|617365062|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
170824471|NCT01294358|617365063|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
170824472|NCT01294358|617365064|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
170824473|NCT01294358|617365065|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
170824474|NCT01294358|617365066|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
170824475|NCT01294358|617365062|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
170700533|NCT02118428|616918467|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
170700534|NCT00654381|616918470|FG000|1st Stage|Adverse Event|3|||
170700535|NCT00654381|616918471|FG001|1st Stage|Adverse Event|3|||
170700536|NCT00654381|616918472|FG002|1st Stage|Adverse Event|3|||
170700537|NCT00654381|616918473|FG003|1st Stage|Adverse Event|3|||
170700538|NCT00654381|616918474|FG004|1st Stage|Adverse Event|2|||
170700539|NCT00654381|616918475|FG005|1st Stage|Adverse Event|1|||
170700540|NCT00654381|616918470|FG000|1st Stage|Withdrawal by Subject|0|||
170700541|NCT00654381|616918471|FG001|1st Stage|Withdrawal by Subject|0|||
170700542|NCT00654381|616918472|FG002|1st Stage|Withdrawal by Subject|0|||
170700543|NCT00654381|616918473|FG003|1st Stage|Withdrawal by Subject|1|||
170700544|NCT00654381|616918474|FG004|1st Stage|Withdrawal by Subject|0|||
170700545|NCT00654381|616918475|FG005|1st Stage|Withdrawal by Subject|1|||
170700546|NCT00654381|616918470|FG000|1st Stage|Investigator's decision|0|||
170700547|NCT00654381|616918471|FG001|1st Stage|Investigator's decision|0|||
170700548|NCT00654381|616918472|FG002|1st Stage|Investigator's decision|0|||
170700549|NCT00654381|616918473|FG003|1st Stage|Investigator's decision|1|||
170700550|NCT00654381|616918474|FG004|1st Stage|Investigator's decision|0|||
170700551|NCT00654381|616918475|FG005|1st Stage|Investigator's decision|0|||
170700552|NCT00654381|616918470|FG000|2nd Stage|Adverse Event|2|||
170700553|NCT00654381|616918471|FG001|2nd Stage|Adverse Event|0|||
170700554|NCT00654381|616918472|FG002|2nd Stage|Adverse Event|2|||
170700555|NCT00654381|616918473|FG003|2nd Stage|Adverse Event|3|||
170700556|NCT00654381|616918474|FG004|2nd Stage|Adverse Event|7|||
170700557|NCT00654381|616918475|FG005|2nd Stage|Adverse Event|2|||
170700558|NCT00654381|616918470|FG000|2nd Stage|Withdrawal by Subject|0|||
170700559|NCT00654381|616918471|FG001|2nd Stage|Withdrawal by Subject|0|||
170700560|NCT00654381|616918472|FG002|2nd Stage|Withdrawal by Subject|0|||
170700561|NCT00654381|616918473|FG003|2nd Stage|Withdrawal by Subject|0|||
170700562|NCT00654381|616918474|FG004|2nd Stage|Withdrawal by Subject|1|||
170700563|NCT00654381|616918475|FG005|2nd Stage|Withdrawal by Subject|1|||
170700564|NCT00654381|616918470|FG000|2nd Stage|Investigator's decision|0|||
170700565|NCT00654381|616918471|FG001|2nd Stage|Investigator's decision|0|||
170700566|NCT00654381|616918472|FG002|2nd Stage|Investigator's decision|1|||
170700567|NCT00654381|616918473|FG003|2nd Stage|Investigator's decision|1|||
170700568|NCT00654381|616918474|FG004|2nd Stage|Investigator's decision|0|||
170700569|NCT00654381|616918475|FG005|2nd Stage|Investigator's decision|0|||
170700570|NCT00654381|616918470|FG000|Extension Stage|Adverse Event|1|||
170700571|NCT00654381|616918471|FG001|Extension Stage|Adverse Event|2|||
170700572|NCT00654381|616918472|FG002|Extension Stage|Adverse Event|9|||
170700573|NCT00654381|616918473|FG003|Extension Stage|Adverse Event|7|||
170700574|NCT00654381|616918474|FG004|Extension Stage|Adverse Event|1|||
170700575|NCT00654381|616918475|FG005|Extension Stage|Adverse Event|1|||
170700576|NCT00654381|616918470|FG000|Extension Stage|Protocol Violation|0|||
170700577|NCT00654381|616918471|FG001|Extension Stage|Protocol Violation|0|||
170700578|NCT00654381|616918472|FG002|Extension Stage|Protocol Violation|0|||
170700579|NCT00654381|616918473|FG003|Extension Stage|Protocol Violation|1|||
170700580|NCT00654381|616918474|FG004|Extension Stage|Protocol Violation|0|||
170700581|NCT00654381|616918475|FG005|Extension Stage|Protocol Violation|0|||
170700582|NCT00654381|616918470|FG000|Extension Stage|Lack of Efficacy|0|||
170700583|NCT00654381|616918471|FG001|Extension Stage|Lack of Efficacy|0|||
170700584|NCT00654381|616918472|FG002|Extension Stage|Lack of Efficacy|1|||
170700585|NCT00654381|616918473|FG003|Extension Stage|Lack of Efficacy|0|||
170700586|NCT00654381|616918474|FG004|Extension Stage|Lack of Efficacy|0|||
170700587|NCT00654381|616918475|FG005|Extension Stage|Lack of Efficacy|0|||
170700588|NCT00654381|616918470|FG000|Extension Stage|Withdrawal by Subject|0|||
170700589|NCT00654381|616918471|FG001|Extension Stage|Withdrawal by Subject|0|||
170700590|NCT00654381|616918472|FG002|Extension Stage|Withdrawal by Subject|1|||
170700591|NCT00654381|616918473|FG003|Extension Stage|Withdrawal by Subject|1|||
170700592|NCT00654381|616918474|FG004|Extension Stage|Withdrawal by Subject|1|||
170700593|NCT00654381|616918475|FG005|Extension Stage|Withdrawal by Subject|1|||
170700594|NCT00654381|616918470|FG000|Extension Stage|Closure of the trial site|0|||
170700595|NCT00654381|616918471|FG001|Extension Stage|Closure of the trial site|0|||
170700596|NCT00654381|616918472|FG002|Extension Stage|Closure of the trial site|0|||
170700597|NCT00654381|616918473|FG003|Extension Stage|Closure of the trial site|0|||
170700598|NCT00654381|616918474|FG004|Extension Stage|Closure of the trial site|1|||
170700599|NCT00654381|616918475|FG005|Extension Stage|Closure of the trial site|1|||
170700600|NCT03100825|616918476|FG000|Overall Study|Participant/Guardian Decision|7|||
170700601|NCT03100825|616918476|FG000|Overall Study|Physician Decision|1|||
170700602|NCT03219333|616918477|FG000|Overall Study|Withdrawal by Subject|9|||
170700603|NCT03219333|616918478|FG001|Overall Study|Withdrawal by Subject|4|||
170700604|NCT03219333|616918477|FG000|Overall Study|Lost to Follow-up|1|||
170700605|NCT03219333|616918478|FG001|Overall Study|Lost to Follow-up|1|||
170700606|NCT03219333|616918477|FG000|Overall Study|Death|104|||
170700607|NCT03219333|616918478|FG001|Overall Study|Death|72|||
170700608|NCT03219333|616918477|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
170700609|NCT03219333|616918478|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
170700610|NCT03219333|616918477|FG000|Overall Study|Other|2|||
170700611|NCT03219333|616918478|FG001|Overall Study|Other|2|||
170700612|NCT00994448|616918481|FG000|Overall Study|Adverse Event|1|||
170700613|NCT00994448|616918482|FG001|Overall Study|Adverse Event|0|||
170824476|NCT01294358|617365063|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
170824477|NCT01294358|617365064|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
170824478|NCT01294358|617365065|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
170824479|NCT01294358|617365066|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
170824480|NCT03613454|617365067|FG000|Overall Study|Protocol Violation|1|||
170824481|NCT03613454|617365068|FG001|Overall Study|Protocol Violation|0|||
170824482|NCT03613454|617365067|FG000|Overall Study|Protocol Violation|0|||
170824483|NCT03613454|617365068|FG001|Overall Study|Protocol Violation|1|||
170824484|NCT02963922|617365069|FG000|Overall Study|Adverse Event|15|||
170824485|NCT02963922|617365070|FG001|Overall Study|Adverse Event|6|||
170824486|NCT02963922|617365069|FG000|Overall Study|Protocol deviation|6|||
170824487|NCT02963922|617365070|FG001|Overall Study|Protocol deviation|6|||
170824488|NCT02963922|617365069|FG000|Overall Study|Lack of Efficacy|1|||
170824489|NCT02963922|617365070|FG001|Overall Study|Lack of Efficacy|1|||
170824490|NCT02963922|617365069|FG000|Overall Study|Lost to Follow-up|2|||
170824491|NCT02963922|617365070|FG001|Overall Study|Lost to Follow-up|3|||
170824492|NCT02963922|617365069|FG000|Overall Study|Other|8|||
170824493|NCT02963922|617365070|FG001|Overall Study|Other|14|||
170700614|NCT00994448|616918481|FG000|Overall Study|Lost to Follow-up|5|||
170700615|NCT00994448|616918482|FG001|Overall Study|Lost to Follow-up|1|||
170700616|NCT00994448|616918481|FG000|Overall Study|Withdrawal by Subject|1|||
170700617|NCT00994448|616918482|FG001|Overall Study|Withdrawal by Subject|1|||
170700618|NCT00994448|616918481|FG000|Overall Study|Physician Decision|1|||
170700619|NCT00994448|616918482|FG001|Overall Study|Physician Decision|0|||
170700620|NCT02704364|616918484|FG000|Overall Study|Adverse Event|1|||
170700621|NCT02704364|616918485|FG001|Overall Study|Adverse Event|1|||
170700622|NCT02704364|616918486|FG002|Overall Study|Adverse Event|0|||
170700623|NCT02704364|616918484|FG000|Overall Study|Noncompliance with study drug|1|||
170700624|NCT02704364|616918485|FG001|Overall Study|Noncompliance with study drug|1|||
170700625|NCT02704364|616918486|FG002|Overall Study|Noncompliance with study drug|0|||
170700626|NCT02704364|616918484|FG000|Overall Study|Other|0|||
170700627|NCT02704364|616918485|FG001|Overall Study|Other|1|||
170700628|NCT02704364|616918486|FG002|Overall Study|Other|1|||
170700629|NCT03795610|616918488|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
170700630|NCT03795610|616918488|FG000|Overall Study|Withdrawal by Subject|1|||
170700631|NCT03795610|616918488|FG000|Overall Study|Screen Failure (Unknown)|1|||
170700632|NCT00058825|616918494|FG000|Overall Study|Relapse|9|||
170700633|NCT00058825|616918494|FG000|Overall Study|Progressive Disease|5|||
170700634|NCT00058825|616918494|FG000|Overall Study|Graft Failure|5|||
170700635|NCT00058825|616918494|FG000|Overall Study|Death|3|||
170700636|NCT01205165|616918495|FG000|Overall Study|Lost to Follow-up|2|||
170700637|NCT01736696|616918499|FG000|Overall Study|Withdrawal by Subject|0|||
170700638|NCT01736696|616918500|FG001|Overall Study|Withdrawal by Subject|0|||
170700639|NCT01736696|616918501|FG002|Overall Study|Withdrawal by Subject|1|||
170700640|NCT01736696|616918502|FG003|Overall Study|Withdrawal by Subject|0|||
170700641|NCT01736696|616918503|FG004|Overall Study|Withdrawal by Subject|0|||
170700642|NCT01736696|616918504|FG005|Overall Study|Withdrawal by Subject|0|||
170700643|NCT01736696|616918505|FG006|Overall Study|Withdrawal by Subject|0|||
170700644|NCT01116232|616918506|FG000|Overall Study|Progressive diease|4|||
170700645|NCT02036502|616918507|FG000|Part 1:Dose Determination/Escalation|Death|3|||
170700646|NCT02036502|616918508|FG001|Part 1:Dose Determination/Escalation|Death|2|||
170700647|NCT02036502|616918509|FG002|Part 1:Dose Determination/Escalation|Death|0|||
170700648|NCT02036502|616918510|FG003|Part 1:Dose Determination/Escalation|Death|0|||
170700649|NCT02036502|616918511|FG004|Part 1:Dose Determination/Escalation|Death|0|||
170700650|NCT02036502|616918512|FG005|Part 1:Dose Determination/Escalation|Death|0|||
170700651|NCT02036502|616918513|FG006|Part 1:Dose Determination/Escalation|Death|0|||
170700652|NCT02036502|616918514|FG007|Part 1:Dose Determination/Escalation|Death|0|||
170700653|NCT02036502|616918507|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
170700654|NCT02036502|616918508|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
170700655|NCT02036502|616918509|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
170700656|NCT02036502|616918510|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
170700657|NCT02036502|616918511|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
170700658|NCT02036502|616918512|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
170824494|NCT04394624|617365079|FG000|Overall Study|Adverse Event|6|||
170824495|NCT04394624|617365080|FG001|Overall Study|Adverse Event|0|||
170824496|NCT04394624|617365079|FG000|Overall Study|Progressive disease|24|||
170824497|NCT04394624|617365080|FG001|Overall Study|Progressive disease|0|||
170824498|NCT04394624|617365079|FG000|Overall Study|Not related to COVID-19|1|||
170824499|NCT04394624|617365080|FG001|Overall Study|Not related to COVID-19|0|||
170824500|NCT00595764|617365081|FG000|Overall Study|Protocol Violation|24|||
170824501|NCT00595764|617365082|FG001|Overall Study|Protocol Violation|19|||
170824502|NCT00595764|617365081|FG000|Overall Study|Missed Medication >1 week|10|||
170700659|NCT02036502|616918513|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
170700660|NCT02036502|616918514|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
170700661|NCT02036502|616918507|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
170824503|NCT00595764|617365082|FG001|Overall Study|Missed Medication >1 week|17|||
170824504|NCT00595764|617365081|FG000|Overall Study|Missed 3 PM visits|1|||
170824505|NCT00595764|617365082|FG001|Overall Study|Missed 3 PM visits|7|||
170824506|NCT00595764|617365081|FG000|Overall Study|Withdrawal by Subject|4|||
170824507|NCT00595764|617365082|FG001|Overall Study|Withdrawal by Subject|0|||
170824508|NCT04222088|617365083|FG000|Overall Study|Lost to Follow-up|5|||
170824509|NCT04222088|617365084|FG001|Overall Study|Lost to Follow-up|1|||
170824510|NCT04222088|617365083|FG000|Overall Study|Withdrawal by Subject|4|||
170824511|NCT04222088|617365084|FG001|Overall Study|Withdrawal by Subject|0|||
170824512|NCT00905255|617365085|FG000|Overall Study|Adverse Event|7|||
170824513|NCT00905255|617365086|FG001|Overall Study|Adverse Event|5|||
170824514|NCT00905255|617365085|FG000|Overall Study|Withdrawal by Subject|5|||
170824515|NCT00905255|617365086|FG001|Overall Study|Withdrawal by Subject|4|||
170824516|NCT00905255|617365085|FG000|Overall Study|Familial and Personal Reasons|1|||
170824517|NCT00905255|617365086|FG001|Overall Study|Familial and Personal Reasons|0|||
170824518|NCT01774929|617365087|FG000|Overall Study|Adverse Event|3|||
170824519|NCT00676663|617365088|FG000|Overall Study|Death|43|||
170824520|NCT00676663|617365089|FG001|Overall Study|Death|27|||
170824521|NCT00676663|617365088|FG000|Overall Study|Withdrew Consent|1|||
170824522|NCT00676663|617365089|FG001|Overall Study|Withdrew Consent|8|||
170824523|NCT00676663|617365088|FG000|Overall Study|Lost to Follow-up|1|||
170824524|NCT00676663|617365089|FG001|Overall Study|Lost to Follow-up|3|||
170824525|NCT04374253|617365093|FG000|Overall Study|Adverse Event|0|||
170824526|NCT04374253|617365094|FG001|Overall Study|Adverse Event|26|||
170824527|NCT04374253|617365095|FG002|Overall Study|Adverse Event|2|||
170824528|NCT04374253|617365096|FG003|Overall Study|Adverse Event|12|||
170824529|NCT04374253|617365093|FG000|Overall Study|Study terminated by sponsor|13|||
170824530|NCT04374253|617365094|FG001|Overall Study|Study terminated by sponsor|593|||
170824531|NCT04374253|617365095|FG002|Overall Study|Study terminated by sponsor|21|||
170824532|NCT04374253|617365096|FG003|Overall Study|Study terminated by sponsor|567|||
170824533|NCT04374253|617365093|FG000|Overall Study|Withdrawal by Subject|0|||
170824534|NCT04374253|617365094|FG001|Overall Study|Withdrawal by Subject|55|||
170824535|NCT04374253|617365095|FG002|Overall Study|Withdrawal by Subject|3|||
170824536|NCT04374253|617365096|FG003|Overall Study|Withdrawal by Subject|40|||
170824537|NCT04374253|617365093|FG000|Overall Study|Physician Decision|1|||
170824538|NCT04374253|617365094|FG001|Overall Study|Physician Decision|10|||
170824539|NCT04374253|617365095|FG002|Overall Study|Physician Decision|1|||
170824540|NCT04374253|617365096|FG003|Overall Study|Physician Decision|10|||
170824541|NCT04374253|617365093|FG000|Overall Study|Protocol Violation|0|||
170824542|NCT04374253|617365094|FG001|Overall Study|Protocol Violation|0|||
170824543|NCT04374253|617365095|FG002|Overall Study|Protocol Violation|0|||
170824544|NCT04374253|617365096|FG003|Overall Study|Protocol Violation|2|||
170824545|NCT04374253|617365093|FG000|Overall Study|Death|0|||
170824546|NCT04374253|617365094|FG001|Overall Study|Death|3|||
170824547|NCT04374253|617365095|FG002|Overall Study|Death|1|||
170824548|NCT04374253|617365096|FG003|Overall Study|Death|1|||
170824549|NCT04374253|617365093|FG000|Overall Study|Lack of Efficacy|0|||
170824550|NCT04374253|617365094|FG001|Overall Study|Lack of Efficacy|0|||
170824551|NCT04374253|617365095|FG002|Overall Study|Lack of Efficacy|0|||
170824552|NCT04374253|617365096|FG003|Overall Study|Lack of Efficacy|1|||
170824553|NCT04374253|617365093|FG000|Overall Study|Lost to Follow-up|1|||
170824554|NCT04374253|617365094|FG001|Overall Study|Lost to Follow-up|1|||
170824555|NCT04374253|617365095|FG002|Overall Study|Lost to Follow-up|0|||
170824556|NCT04374253|617365096|FG003|Overall Study|Lost to Follow-up|2|||
170824557|NCT04374253|617365093|FG000|Overall Study|Reason Not Specified|0|||
170824558|NCT04374253|617365094|FG001|Overall Study|Reason Not Specified|8|||
170824559|NCT04374253|617365095|FG002|Overall Study|Reason Not Specified|0|||
170824560|NCT04374253|617365096|FG003|Overall Study|Reason Not Specified|8|||
170824561|NCT01021683|617365099|FG000|Overall Study|Lack of Efficacy|12|||
170824562|NCT01021683|617365099|FG000|Overall Study|Recovery of neutrophil count|51|||
170824563|NCT01021683|617365099|FG000|Overall Study|Other|8|||
170824564|NCT00605566|617366439|FG000|Overall Study|Adverse Event|1|||
170824565|NCT00605566|617366439|FG000|Overall Study|Clinical deterioration|1|||
170824566|NCT00605566|617366439|FG000|Overall Study|Poor compliance in run-in period|1|||
170824567|NCT03713281|617366448|FG000|Overall Study|Lens handling difficuluties|2|||
170824568|NCT03713281|617366448|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
170824569|NCT02412111|617366449|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
170824570|NCT02412111|617366450|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
170824571|NCT02412111|617366451|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
170824572|NCT02412111|617366449|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
170824573|NCT02412111|617366450|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
170700662|NCT02036502|616918508|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
170700663|NCT02036502|616918509|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
170700664|NCT02036502|616918510|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
170700665|NCT02036502|616918511|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
170700666|NCT02036502|616918512|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
170700667|NCT02036502|616918513|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
170700668|NCT02036502|616918514|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
170700669|NCT02036502|616918507|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
170700670|NCT02036502|616918508|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
170700671|NCT02036502|616918509|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
170700672|NCT02036502|616918510|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
170700673|NCT02036502|616918511|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
170700674|NCT02036502|616918512|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
170700675|NCT02036502|616918513|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
170700676|NCT02036502|616918514|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
170700677|NCT02036502|616918507|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
170700678|NCT02036502|616918508|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
170700679|NCT02036502|616918509|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
170700680|NCT02036502|616918510|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
170700681|NCT02036502|616918511|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
170700682|NCT02036502|616918512|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
170700683|NCT02036502|616918513|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
170700684|NCT02036502|616918514|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
170700685|NCT02036502|616918507|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
170700686|NCT02036502|616918508|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
170700687|NCT02036502|616918509|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
170700688|NCT02036502|616918510|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
170700689|NCT02036502|616918511|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
170700690|NCT02036502|616918512|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
170700691|NCT02036502|616918513|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
170700692|NCT02036502|616918514|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
170700693|NCT02036502|616918507|FG000|Part 2:Dose Confirmation|Death|0|||
170700694|NCT02036502|616918508|FG001|Part 2:Dose Confirmation|Death|0|||
170700695|NCT02036502|616918509|FG002|Part 2:Dose Confirmation|Death|1|||
170700696|NCT02036502|616918510|FG003|Part 2:Dose Confirmation|Death|0|||
170700697|NCT02036502|616918511|FG004|Part 2:Dose Confirmation|Death|0|||
170700698|NCT02036502|616918512|FG005|Part 2:Dose Confirmation|Death|0|||
170700699|NCT02036502|616918513|FG006|Part 2:Dose Confirmation|Death|0|||
170700700|NCT02036502|616918514|FG007|Part 2:Dose Confirmation|Death|0|||
170700701|NCT02036502|616918507|FG000|Part 2:Dose Confirmation|Not treated|0|||
170700702|NCT02036502|616918508|FG001|Part 2:Dose Confirmation|Not treated|0|||
170700703|NCT02036502|616918509|FG002|Part 2:Dose Confirmation|Not treated|0|||
170700704|NCT02036502|616918510|FG003|Part 2:Dose Confirmation|Not treated|1|||
170700705|NCT02036502|616918511|FG004|Part 2:Dose Confirmation|Not treated|0|||
170700706|NCT02036502|616918512|FG005|Part 2:Dose Confirmation|Not treated|0|||
170700707|NCT02036502|616918513|FG006|Part 2:Dose Confirmation|Not treated|0|||
170700708|NCT02036502|616918514|FG007|Part 2:Dose Confirmation|Not treated|0|||
170700709|NCT02036502|616918507|FG000|Part 3:Dose Expansion|Adverse Event|0|||
170700710|NCT02036502|616918508|FG001|Part 3:Dose Expansion|Adverse Event|0|||
170700711|NCT02036502|616918509|FG002|Part 3:Dose Expansion|Adverse Event|0|||
170700712|NCT02036502|616918510|FG003|Part 3:Dose Expansion|Adverse Event|0|||
170700713|NCT02036502|616918511|FG004|Part 3:Dose Expansion|Adverse Event|0|||
170700714|NCT02036502|616918512|FG005|Part 3:Dose Expansion|Adverse Event|4|||
170700715|NCT02036502|616918513|FG006|Part 3:Dose Expansion|Adverse Event|0|||
170700716|NCT02036502|616918514|FG007|Part 3:Dose Expansion|Adverse Event|2|||
170700717|NCT02036502|616918507|FG000|Part 3:Dose Expansion|Death|0|||
170700718|NCT02036502|616918508|FG001|Part 3:Dose Expansion|Death|0|||
170700719|NCT02036502|616918509|FG002|Part 3:Dose Expansion|Death|0|||
170700720|NCT02036502|616918510|FG003|Part 3:Dose Expansion|Death|0|||
170824574|NCT02412111|617366451|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
170824575|NCT02412111|617366449|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
170700721|NCT02036502|616918511|FG004|Part 3:Dose Expansion|Death|0|||
170700722|NCT02036502|616918512|FG005|Part 3:Dose Expansion|Death|24|||
170700723|NCT02036502|616918513|FG006|Part 3:Dose Expansion|Death|0|||
170700724|NCT02036502|616918514|FG007|Part 3:Dose Expansion|Death|3|||
170700725|NCT02036502|616918507|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
170700726|NCT02036502|616918508|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
170700727|NCT02036502|616918509|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
170700728|NCT02036502|616918510|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
170700729|NCT02036502|616918511|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
170700730|NCT02036502|616918512|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
170700731|NCT02036502|616918513|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
170700732|NCT02036502|616918514|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
170700733|NCT02036502|616918507|FG000|Part 3:Dose Expansion|Physician Decision|0|||
170700734|NCT02036502|616918508|FG001|Part 3:Dose Expansion|Physician Decision|0|||
170700735|NCT02036502|616918509|FG002|Part 3:Dose Expansion|Physician Decision|0|||
170700736|NCT02036502|616918510|FG003|Part 3:Dose Expansion|Physician Decision|0|||
170700737|NCT02036502|616918511|FG004|Part 3:Dose Expansion|Physician Decision|0|||
170700738|NCT02036502|616918512|FG005|Part 3:Dose Expansion|Physician Decision|1|||
170700739|NCT02036502|616918513|FG006|Part 3:Dose Expansion|Physician Decision|0|||
170700740|NCT02036502|616918514|FG007|Part 3:Dose Expansion|Physician Decision|0|||
170700741|NCT02036502|616918507|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
170700742|NCT02036502|616918508|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
170700743|NCT02036502|616918509|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
170700744|NCT02036502|616918510|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
170700745|NCT02036502|616918511|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
170700746|NCT02036502|616918512|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
170700747|NCT02036502|616918513|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
170700748|NCT02036502|616918514|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
170700749|NCT02036502|616918507|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
170700750|NCT02036502|616918508|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
170700751|NCT02036502|616918509|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
170700752|NCT02036502|616918510|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
170700753|NCT02036502|616918511|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
170700754|NCT02036502|616918512|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
170700755|NCT02036502|616918513|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
170700756|NCT02036502|616918514|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
170700757|NCT02036502|616918507|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
170700758|NCT02036502|616918508|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
170700759|NCT02036502|616918509|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
170700760|NCT02036502|616918510|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
170700761|NCT02036502|616918511|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
170700762|NCT02036502|616918512|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
170700763|NCT02036502|616918513|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
170700764|NCT02036502|616918514|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
170700765|NCT02036502|616918507|FG000|Part 3:Dose Expansion|Not Treated|0|||
170700766|NCT02036502|616918508|FG001|Part 3:Dose Expansion|Not Treated|0|||
170700767|NCT02036502|616918509|FG002|Part 3:Dose Expansion|Not Treated|0|||
170700768|NCT02036502|616918510|FG003|Part 3:Dose Expansion|Not Treated|0|||
170700769|NCT02036502|616918511|FG004|Part 3:Dose Expansion|Not Treated|0|||
170700770|NCT02036502|616918512|FG005|Part 3:Dose Expansion|Not Treated|2|||
170700771|NCT02036502|616918513|FG006|Part 3:Dose Expansion|Not Treated|0|||
170700772|NCT02036502|616918514|FG007|Part 3:Dose Expansion|Not Treated|0|||
170700773|NCT00811577|616918520|FG000|Overall Study|Lost to Follow-up|7|||
170700774|NCT00811577|616918521|FG001|Overall Study|Lost to Follow-up|1|||
170700775|NCT00811577|616918520|FG000|Overall Study|Withdrawal by Subject|3|||
170700776|NCT00811577|616918521|FG001|Overall Study|Withdrawal by Subject|0|||
170700777|NCT01068509|616918522|FG000|Overall Study|Death|0|||
170700778|NCT01068509|616918523|FG001|Overall Study|Death|0|||
170700779|NCT01068509|616918524|FG002|Overall Study|Death|1|||
170700780|NCT01068509|616918522|FG000|Overall Study|Disease Progression|5|||
170700781|NCT01068509|616918523|FG001|Overall Study|Disease Progression|20|||
170700782|NCT01068509|616918524|FG002|Overall Study|Disease Progression|18|||
170700783|NCT01068509|616918522|FG000|Overall Study|Lost to Follow-up|1|||
170700784|NCT01068509|616918523|FG001|Overall Study|Lost to Follow-up|0|||
170700785|NCT01068509|616918524|FG002|Overall Study|Lost to Follow-up|0|||
170700786|NCT01068509|616918522|FG000|Overall Study|Withdrew Consent|0|||
170700787|NCT01068509|616918523|FG001|Overall Study|Withdrew Consent|1|||
170700788|NCT01068509|616918524|FG002|Overall Study|Withdrew Consent|2|||
170700789|NCT01068509|616918522|FG000|Overall Study|Reason Not Specified|0|||
170700790|NCT01068509|616918523|FG001|Overall Study|Reason Not Specified|1|||
170824576|NCT02412111|617366450|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
170824577|NCT02412111|617366451|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
170824578|NCT02412111|617366449|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
170824579|NCT02412111|617366450|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
170824580|NCT02412111|617366451|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
170700791|NCT01068509|616918524|FG002|Overall Study|Reason Not Specified|0|||
170700792|NCT02641379|616918529|FG000|Overall Study|Exclusion criterion during screening|1|||
170700793|NCT02641379|616918530|FG001|Overall Study|Exclusion criterion during screening|0|||
170700794|NCT02641379|616918531|FG002|Overall Study|Exclusion criterion during screening|0|||
170700795|NCT02641379|616918532|FG003|Overall Study|Exclusion criterion during screening|1|||
170700796|NCT02641379|616918533|FG004|Overall Study|Exclusion criterion during screening|2|||
170700797|NCT02641379|616918534|FG005|Overall Study|Exclusion criterion during screening|0|||
170700798|NCT02641379|616918535|FG006|Overall Study|Exclusion criterion during screening|0|||
170700799|NCT02641379|616918536|FG007|Overall Study|Exclusion criterion during screening|0|||
170824581|NCT02412111|617366449|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
170824582|NCT02412111|617366450|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
170700800|NCT02641379|616918537|FG008|Overall Study|Exclusion criterion during screening|0|||
170700801|NCT02641379|616918538|FG009|Overall Study|Exclusion criterion during screening|0|||
170700802|NCT02641379|616918539|FG010|Overall Study|Exclusion criterion during screening|0|||
170700803|NCT02641379|616918529|FG000|Overall Study|Withdrawal of informed consent|0|||
170700804|NCT02641379|616918530|FG001|Overall Study|Withdrawal of informed consent|1|||
170700805|NCT02641379|616918531|FG002|Overall Study|Withdrawal of informed consent|0|||
170700806|NCT02641379|616918532|FG003|Overall Study|Withdrawal of informed consent|0|||
170700807|NCT02641379|616918533|FG004|Overall Study|Withdrawal of informed consent|0|||
170700808|NCT02641379|616918534|FG005|Overall Study|Withdrawal of informed consent|0|||
170700809|NCT02641379|616918535|FG006|Overall Study|Withdrawal of informed consent|0|||
170700810|NCT02641379|616918536|FG007|Overall Study|Withdrawal of informed consent|1|||
170700811|NCT02641379|616918537|FG008|Overall Study|Withdrawal of informed consent|0|||
170700812|NCT02641379|616918538|FG009|Overall Study|Withdrawal of informed consent|0|||
170700813|NCT02641379|616918539|FG010|Overall Study|Withdrawal of informed consent|0|||
170700814|NCT02641379|616918529|FG000|Overall Study|Adverse Event|7|||
170700815|NCT02641379|616918530|FG001|Overall Study|Adverse Event|8|||
170700816|NCT02641379|616918531|FG002|Overall Study|Adverse Event|2|||
170700817|NCT02641379|616918532|FG003|Overall Study|Adverse Event|2|||
170700818|NCT02641379|616918533|FG004|Overall Study|Adverse Event|5|||
170700819|NCT02641379|616918534|FG005|Overall Study|Adverse Event|1|||
170700820|NCT02641379|616918535|FG006|Overall Study|Adverse Event|5|||
170700821|NCT02641379|616918536|FG007|Overall Study|Adverse Event|0|||
170700822|NCT02641379|616918537|FG008|Overall Study|Adverse Event|1|||
170700823|NCT02641379|616918538|FG009|Overall Study|Adverse Event|1|||
170700824|NCT02641379|616918539|FG010|Overall Study|Adverse Event|5|||
170700825|NCT02641379|616918529|FG000|Overall Study|Lack of Efficacy|0|||
170700826|NCT02641379|616918530|FG001|Overall Study|Lack of Efficacy|0|||
170700827|NCT02641379|616918531|FG002|Overall Study|Lack of Efficacy|2|||
170700828|NCT02641379|616918532|FG003|Overall Study|Lack of Efficacy|0|||
170700829|NCT02641379|616918533|FG004|Overall Study|Lack of Efficacy|0|||
170700830|NCT02641379|616918534|FG005|Overall Study|Lack of Efficacy|2|||
170700831|NCT02641379|616918535|FG006|Overall Study|Lack of Efficacy|0|||
170700832|NCT02641379|616918536|FG007|Overall Study|Lack of Efficacy|5|||
170700833|NCT02641379|616918537|FG008|Overall Study|Lack of Efficacy|0|||
170700834|NCT02641379|616918538|FG009|Overall Study|Lack of Efficacy|0|||
170700835|NCT02641379|616918539|FG010|Overall Study|Lack of Efficacy|0|||
170700836|NCT02641379|616918529|FG000|Overall Study|Participant unable to attend study visit|4|||
170700837|NCT02641379|616918530|FG001|Overall Study|Participant unable to attend study visit|10|||
170700838|NCT02641379|616918531|FG002|Overall Study|Participant unable to attend study visit|1|||
170700839|NCT02641379|616918532|FG003|Overall Study|Participant unable to attend study visit|2|||
170700840|NCT02641379|616918533|FG004|Overall Study|Participant unable to attend study visit|5|||
170700841|NCT02641379|616918534|FG005|Overall Study|Participant unable to attend study visit|1|||
170700842|NCT02641379|616918535|FG006|Overall Study|Participant unable to attend study visit|1|||
170700843|NCT02641379|616918536|FG007|Overall Study|Participant unable to attend study visit|1|||
170700844|NCT02641379|616918537|FG008|Overall Study|Participant unable to attend study visit|0|||
170700845|NCT02641379|616918538|FG009|Overall Study|Participant unable to attend study visit|2|||
170700846|NCT02641379|616918539|FG010|Overall Study|Participant unable to attend study visit|0|||
170700847|NCT02641379|616918529|FG000|Overall Study|Participant's compliance|0|||
170700848|NCT02641379|616918530|FG001|Overall Study|Participant's compliance|1|||
170700849|NCT02641379|616918531|FG002|Overall Study|Participant's compliance|0|||
170700850|NCT02641379|616918532|FG003|Overall Study|Participant's compliance|1|||
170700851|NCT02641379|616918533|FG004|Overall Study|Participant's compliance|0|||
170700852|NCT02641379|616918534|FG005|Overall Study|Participant's compliance|2|||
170700853|NCT02641379|616918535|FG006|Overall Study|Participant's compliance|0|||
170700854|NCT02641379|616918536|FG007|Overall Study|Participant's compliance|0|||
170700855|NCT02641379|616918537|FG008|Overall Study|Participant's compliance|1|||
170700856|NCT02641379|616918538|FG009|Overall Study|Participant's compliance|1|||
170700857|NCT02641379|616918539|FG010|Overall Study|Participant's compliance|1|||
170700858|NCT02641379|616918529|FG000|Overall Study|Participant cannot be reached|4|||
170700859|NCT02641379|616918530|FG001|Overall Study|Participant cannot be reached|4|||
170700860|NCT02641379|616918531|FG002|Overall Study|Participant cannot be reached|0|||
170700861|NCT02641379|616918532|FG003|Overall Study|Participant cannot be reached|8|||
170700862|NCT02641379|616918533|FG004|Overall Study|Participant cannot be reached|2|||
170824583|NCT02412111|617366451|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
170824584|NCT02412111|617366449|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
170824585|NCT02412111|617366450|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
170700863|NCT02641379|616918534|FG005|Overall Study|Participant cannot be reached|1|||
170700864|NCT02641379|616918535|FG006|Overall Study|Participant cannot be reached|0|||
170700865|NCT02641379|616918536|FG007|Overall Study|Participant cannot be reached|1|||
170700866|NCT02641379|616918537|FG008|Overall Study|Participant cannot be reached|0|||
170824586|NCT02412111|617366451|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
170824587|NCT02412111|617366449|FG000|Active Comparator Period (8 Weeks)|Other|0|||
170700867|NCT02641379|616918538|FG009|Overall Study|Participant cannot be reached|2|||
170700868|NCT02641379|616918539|FG010|Overall Study|Participant cannot be reached|1|||
170700869|NCT02641379|616918529|FG000|Overall Study|PCR positive at Week 24|15|||
170700870|NCT02641379|616918530|FG001|Overall Study|PCR positive at Week 24|21|||
170700871|NCT02641379|616918531|FG002|Overall Study|PCR positive at Week 24|62|||
170700872|NCT02641379|616918532|FG003|Overall Study|PCR positive at Week 24|0|||
170700873|NCT02641379|616918533|FG004|Overall Study|PCR positive at Week 24|0|||
170700874|NCT02641379|616918534|FG005|Overall Study|PCR positive at Week 24|6|||
170700875|NCT02641379|616918535|FG006|Overall Study|PCR positive at Week 24|3|||
170700876|NCT02641379|616918536|FG007|Overall Study|PCR positive at Week 24|8|||
170700877|NCT02641379|616918537|FG008|Overall Study|PCR positive at Week 24|0|||
170700878|NCT02641379|616918538|FG009|Overall Study|PCR positive at Week 24|1|||
170700879|NCT02641379|616918539|FG010|Overall Study|PCR positive at Week 24|0|||
170700880|NCT02641379|616918529|FG000|Overall Study|PCR positive at follow up 2|1|||
170700881|NCT02641379|616918530|FG001|Overall Study|PCR positive at follow up 2|0|||
170700882|NCT02641379|616918531|FG002|Overall Study|PCR positive at follow up 2|0|||
170700883|NCT02641379|616918532|FG003|Overall Study|PCR positive at follow up 2|0|||
170700884|NCT02641379|616918533|FG004|Overall Study|PCR positive at follow up 2|0|||
170700885|NCT02641379|616918534|FG005|Overall Study|PCR positive at follow up 2|0|||
170700886|NCT02641379|616918535|FG006|Overall Study|PCR positive at follow up 2|0|||
170700887|NCT02641379|616918536|FG007|Overall Study|PCR positive at follow up 2|0|||
170700888|NCT02641379|616918537|FG008|Overall Study|PCR positive at follow up 2|0|||
170700889|NCT02641379|616918538|FG009|Overall Study|PCR positive at follow up 2|0|||
170700890|NCT02641379|616918539|FG010|Overall Study|PCR positive at follow up 2|0|||
170700891|NCT02641379|616918529|FG000|Overall Study|Participant showed relapse|1|||
170700892|NCT02641379|616918530|FG001|Overall Study|Participant showed relapse|0|||
170700893|NCT02641379|616918531|FG002|Overall Study|Participant showed relapse|0|||
170700894|NCT02641379|616918532|FG003|Overall Study|Participant showed relapse|0|||
170700895|NCT02641379|616918533|FG004|Overall Study|Participant showed relapse|0|||
170700896|NCT02641379|616918534|FG005|Overall Study|Participant showed relapse|0|||
170700897|NCT02641379|616918535|FG006|Overall Study|Participant showed relapse|1|||
170700898|NCT02641379|616918536|FG007|Overall Study|Participant showed relapse|0|||
170700899|NCT02641379|616918537|FG008|Overall Study|Participant showed relapse|0|||
170700900|NCT02641379|616918538|FG009|Overall Study|Participant showed relapse|0|||
170700901|NCT02641379|616918539|FG010|Overall Study|Participant showed relapse|0|||
170700902|NCT02641379|616918529|FG000|Overall Study|Participant stopped study/treatment|1|||
170700903|NCT02641379|616918530|FG001|Overall Study|Participant stopped study/treatment|3|||
170700904|NCT02641379|616918531|FG002|Overall Study|Participant stopped study/treatment|1|||
170700905|NCT02641379|616918532|FG003|Overall Study|Participant stopped study/treatment|0|||
170700906|NCT02641379|616918533|FG004|Overall Study|Participant stopped study/treatment|0|||
170700907|NCT02641379|616918534|FG005|Overall Study|Participant stopped study/treatment|1|||
170700908|NCT02641379|616918535|FG006|Overall Study|Participant stopped study/treatment|2|||
170700909|NCT02641379|616918536|FG007|Overall Study|Participant stopped study/treatment|0|||
170700910|NCT02641379|616918537|FG008|Overall Study|Participant stopped study/treatment|1|||
170700911|NCT02641379|616918538|FG009|Overall Study|Participant stopped study/treatment|0|||
170700912|NCT02641379|616918539|FG010|Overall Study|Participant stopped study/treatment|0|||
170700913|NCT02641379|616918529|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
170700914|NCT02641379|616918530|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
170700915|NCT02641379|616918531|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
170700916|NCT02641379|616918532|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
170700917|NCT02641379|616918533|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
170700918|NCT02641379|616918534|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
170700919|NCT02641379|616918535|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
170700920|NCT02641379|616918536|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
170700921|NCT02641379|616918537|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
170700922|NCT02641379|616918538|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
170700923|NCT02641379|616918539|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
170700924|NCT02641379|616918529|FG000|Overall Study|Financial problems|0|||
170700925|NCT02641379|616918530|FG001|Overall Study|Financial problems|1|||
170700926|NCT02641379|616918531|FG002|Overall Study|Financial problems|0|||
170824588|NCT02412111|617366450|FG001|Active Comparator Period (8 Weeks)|Other|0|||
170824589|NCT02412111|617366451|FG002|Active Comparator Period (8 Weeks)|Other|2|||
170824590|NCT00721214|617366452|FG000|Overall Study|Chose another center for transplant|1|||
170824591|NCT00721214|617366452|FG000|Overall Study|Death|3|||
170824592|NCT00510198|617366453|FG000|Overall Study|Withdrawal by Subject|5|||
170824593|NCT00510198|617366454|FG001|Overall Study|Withdrawal by Subject|4|||
170824594|NCT00329550|617366456|FG000|Overall Study|Adverse Event|3|||
170824595|NCT00329550|617366457|FG001|Overall Study|Adverse Event|4|||
170700927|NCT02641379|616918532|FG003|Overall Study|Financial problems|0|||
170700928|NCT02641379|616918533|FG004|Overall Study|Financial problems|0|||
170700929|NCT02641379|616918534|FG005|Overall Study|Financial problems|0|||
170700930|NCT02641379|616918535|FG006|Overall Study|Financial problems|0|||
170700931|NCT02641379|616918536|FG007|Overall Study|Financial problems|0|||
170700932|NCT02641379|616918537|FG008|Overall Study|Financial problems|0|||
170700933|NCT02641379|616918538|FG009|Overall Study|Financial problems|0|||
170700934|NCT02641379|616918539|FG010|Overall Study|Financial problems|0|||
170700935|NCT02641379|616918529|FG000|Overall Study|PCR positive at Week 68|0|||
170700936|NCT02641379|616918530|FG001|Overall Study|PCR positive at Week 68|1|||
170700937|NCT02641379|616918531|FG002|Overall Study|PCR positive at Week 68|0|||
170700938|NCT02641379|616918532|FG003|Overall Study|PCR positive at Week 68|0|||
170700939|NCT02641379|616918533|FG004|Overall Study|PCR positive at Week 68|0|||
170700940|NCT02641379|616918534|FG005|Overall Study|PCR positive at Week 68|0|||
170700941|NCT02641379|616918535|FG006|Overall Study|PCR positive at Week 68|0|||
170700942|NCT02641379|616918536|FG007|Overall Study|PCR positive at Week 68|0|||
170700943|NCT02641379|616918537|FG008|Overall Study|PCR positive at Week 68|0|||
170700944|NCT02641379|616918538|FG009|Overall Study|PCR positive at Week 68|0|||
170700945|NCT02641379|616918539|FG010|Overall Study|PCR positive at Week 68|0|||
170700946|NCT02641379|616918529|FG000|Overall Study|PCR positive at Week 48|0|||
170700947|NCT02641379|616918530|FG001|Overall Study|PCR positive at Week 48|1|||
170700948|NCT02641379|616918531|FG002|Overall Study|PCR positive at Week 48|0|||
170700949|NCT02641379|616918532|FG003|Overall Study|PCR positive at Week 48|0|||
170700950|NCT02641379|616918533|FG004|Overall Study|PCR positive at Week 48|0|||
170700951|NCT02641379|616918534|FG005|Overall Study|PCR positive at Week 48|0|||
170700952|NCT02641379|616918535|FG006|Overall Study|PCR positive at Week 48|0|||
170700953|NCT02641379|616918536|FG007|Overall Study|PCR positive at Week 48|0|||
170700954|NCT02641379|616918537|FG008|Overall Study|PCR positive at Week 48|0|||
170700955|NCT02641379|616918538|FG009|Overall Study|PCR positive at Week 48|0|||
170700956|NCT02641379|616918539|FG010|Overall Study|PCR positive at Week 48|0|||
170700957|NCT02641379|616918529|FG000|Overall Study|PCR not performed at Week 12|0|||
170700958|NCT02641379|616918530|FG001|Overall Study|PCR not performed at Week 12|0|||
170700959|NCT02641379|616918531|FG002|Overall Study|PCR not performed at Week 12|1|||
170700960|NCT02641379|616918532|FG003|Overall Study|PCR not performed at Week 12|0|||
170700961|NCT02641379|616918533|FG004|Overall Study|PCR not performed at Week 12|0|||
170700962|NCT02641379|616918534|FG005|Overall Study|PCR not performed at Week 12|0|||
170700963|NCT02641379|616918535|FG006|Overall Study|PCR not performed at Week 12|0|||
170700964|NCT02641379|616918536|FG007|Overall Study|PCR not performed at Week 12|0|||
170700965|NCT02641379|616918537|FG008|Overall Study|PCR not performed at Week 12|0|||
170700966|NCT02641379|616918538|FG009|Overall Study|PCR not performed at Week 12|0|||
170700967|NCT02641379|616918539|FG010|Overall Study|PCR not performed at Week 12|0|||
170700968|NCT02641379|616918529|FG000|Overall Study|No PCR at baseline|0|||
170700969|NCT02641379|616918530|FG001|Overall Study|No PCR at baseline|0|||
170700970|NCT02641379|616918531|FG002|Overall Study|No PCR at baseline|1|||
170700971|NCT02641379|616918532|FG003|Overall Study|No PCR at baseline|0|||
170700972|NCT02641379|616918533|FG004|Overall Study|No PCR at baseline|0|||
170700973|NCT02641379|616918534|FG005|Overall Study|No PCR at baseline|0|||
170700974|NCT02641379|616918535|FG006|Overall Study|No PCR at baseline|0|||
170700975|NCT02641379|616918536|FG007|Overall Study|No PCR at baseline|0|||
170700976|NCT02641379|616918537|FG008|Overall Study|No PCR at baseline|0|||
170700977|NCT02641379|616918538|FG009|Overall Study|No PCR at baseline|0|||
170700978|NCT02641379|616918539|FG010|Overall Study|No PCR at baseline|0|||
170700979|NCT02641379|616918529|FG000|Overall Study|PCR positive at Week 28|0|||
170700980|NCT02641379|616918530|FG001|Overall Study|PCR positive at Week 28|0|||
170824596|NCT00329550|617366458|FG002|Overall Study|Adverse Event|2|||
170824597|NCT00329550|617366456|FG000|Overall Study|Withdrawal of Consent|1|||
170824598|NCT00329550|617366457|FG001|Overall Study|Withdrawal of Consent|0|||
170824599|NCT00329550|617366458|FG002|Overall Study|Withdrawal of Consent|1|||
170824600|NCT00329550|617366456|FG000|Overall Study|Due to Relocation|0|||
170824601|NCT00329550|617366457|FG001|Overall Study|Due to Relocation|0|||
170824602|NCT00329550|617366458|FG002|Overall Study|Due to Relocation|1|||
170824603|NCT02994784|617366459|FG000|6 Months Follow-up|Lost to Follow-up|3|||
170824604|NCT00494026|617366460|FG000|Overall Study|Sponsor Decision|4|||
170824605|NCT02466243|617366461|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
170824606|NCT02466243|617366462|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
170824607|NCT02466243|617366461|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
170824608|NCT02466243|617366462|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
170824609|NCT02466243|617366461|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
170824610|NCT02466243|617366462|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
170824611|NCT02466243|617366461|FG000|Part B Open-label Treatment Period|Missing|2|||
170824612|NCT02466243|617366462|FG001|Part B Open-label Treatment Period|Missing|2|||
170824613|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
170824614|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
170824615|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
170824616|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
170824617|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
170824618|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
170824619|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
170824620|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
170824621|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
170824622|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
170824623|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
170824624|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
170824625|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
170824626|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
170824627|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
170824628|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
170824629|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
170824630|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
170824631|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
170824632|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
170824633|NCT02637856|617366474|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
170824634|NCT02637856|617366475|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
170824635|NCT02637856|617366474|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
170824636|NCT02637856|617366475|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
170824637|NCT02637856|617366474|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
170824638|NCT02637856|617366475|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
170824639|NCT01649557|617366476|FG000|Overall Study|Lost to Follow-up|5|||
170824640|NCT01649557|617366477|FG001|Overall Study|Lost to Follow-up|0|||
170824641|NCT01649557|617366478|FG002|Overall Study|Lost to Follow-up|3|||
170824642|NCT01649557|617366476|FG000|Overall Study|Adverse Event|7|||
170824643|NCT01649557|617366477|FG001|Overall Study|Adverse Event|5|||
170824644|NCT01649557|617366478|FG002|Overall Study|Adverse Event|1|||
170824645|NCT01649557|617366476|FG000|Overall Study|Met withdrawal criteria|4|||
170824646|NCT01649557|617366477|FG001|Overall Study|Met withdrawal criteria|0|||
170824647|NCT01649557|617366478|FG002|Overall Study|Met withdrawal criteria|0|||
170824648|NCT01649557|617366476|FG000|Overall Study|Physician Decision|8|||
170824649|NCT01649557|617366477|FG001|Overall Study|Physician Decision|2|||
170824650|NCT01649557|617366478|FG002|Overall Study|Physician Decision|1|||
170824651|NCT01649557|617366476|FG000|Overall Study|Withdrawal by Subject|15|||
170824652|NCT01649557|617366477|FG001|Overall Study|Withdrawal by Subject|5|||
170824653|NCT01649557|617366478|FG002|Overall Study|Withdrawal by Subject|4|||
170824654|NCT01649557|617366476|FG000|Overall Study|Protocol deviation|0|||
170824655|NCT01649557|617366477|FG001|Overall Study|Protocol deviation|2|||
170824656|NCT01649557|617366478|FG002|Overall Study|Protocol deviation|0|||
170824657|NCT01649557|617366476|FG000|Overall Study|Lack of Efficacy|5|||
170824658|NCT01649557|617366477|FG001|Overall Study|Lack of Efficacy|0|||
170700981|NCT02641379|616918531|FG002|Overall Study|PCR positive at Week 28|1|||
170700982|NCT02641379|616918532|FG003|Overall Study|PCR positive at Week 28|0|||
170700983|NCT02641379|616918533|FG004|Overall Study|PCR positive at Week 28|0|||
170700984|NCT02641379|616918534|FG005|Overall Study|PCR positive at Week 28|0|||
170700985|NCT02641379|616918535|FG006|Overall Study|PCR positive at Week 28|0|||
170700986|NCT02641379|616918536|FG007|Overall Study|PCR positive at Week 28|0|||
170700987|NCT02641379|616918537|FG008|Overall Study|PCR positive at Week 28|0|||
170700988|NCT02641379|616918538|FG009|Overall Study|PCR positive at Week 28|0|||
170700989|NCT02641379|616918539|FG010|Overall Study|PCR positive at Week 28|0|||
170700990|NCT02641379|616918529|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
170700991|NCT02641379|616918530|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
170700992|NCT02641379|616918531|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
170700993|NCT02641379|616918532|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
170700994|NCT02641379|616918533|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
170700995|NCT02641379|616918534|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
170700996|NCT02641379|616918535|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
170700997|NCT02641379|616918536|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
170700998|NCT02641379|616918537|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
170700999|NCT02641379|616918538|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
170701000|NCT02641379|616918539|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
170701001|NCT02641379|616918529|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
170701002|NCT02641379|616918530|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
170701003|NCT02641379|616918531|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
170701004|NCT02641379|616918532|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
170701005|NCT02641379|616918533|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
170701006|NCT02641379|616918534|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
170701007|NCT02641379|616918535|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
170701008|NCT02641379|616918536|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
170701009|NCT02641379|616918537|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
170701010|NCT02641379|616918538|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
170701011|NCT02641379|616918539|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
170701012|NCT02641379|616918529|FG000|Overall Study|Baseline viral load unavailable|0|||
170701013|NCT02641379|616918530|FG001|Overall Study|Baseline viral load unavailable|0|||
170701014|NCT02641379|616918531|FG002|Overall Study|Baseline viral load unavailable|0|||
170701015|NCT02641379|616918532|FG003|Overall Study|Baseline viral load unavailable|1|||
170701016|NCT02641379|616918533|FG004|Overall Study|Baseline viral load unavailable|0|||
170701017|NCT02641379|616918534|FG005|Overall Study|Baseline viral load unavailable|0|||
170701018|NCT02641379|616918535|FG006|Overall Study|Baseline viral load unavailable|0|||
170701019|NCT02641379|616918536|FG007|Overall Study|Baseline viral load unavailable|0|||
170701020|NCT02641379|616918537|FG008|Overall Study|Baseline viral load unavailable|0|||
170701021|NCT02641379|616918538|FG009|Overall Study|Baseline viral load unavailable|0|||
170701022|NCT02641379|616918539|FG010|Overall Study|Baseline viral load unavailable|0|||
170701023|NCT02641379|616918529|FG000|Overall Study|Blood could not be drawn|0|||
170701024|NCT02641379|616918530|FG001|Overall Study|Blood could not be drawn|0|||
170701025|NCT02641379|616918531|FG002|Overall Study|Blood could not be drawn|0|||
170701026|NCT02641379|616918532|FG003|Overall Study|Blood could not be drawn|0|||
170701027|NCT02641379|616918533|FG004|Overall Study|Blood could not be drawn|1|||
170701028|NCT02641379|616918534|FG005|Overall Study|Blood could not be drawn|0|||
170701029|NCT02641379|616918535|FG006|Overall Study|Blood could not be drawn|0|||
170701030|NCT02641379|616918536|FG007|Overall Study|Blood could not be drawn|0|||
170701031|NCT02641379|616918537|FG008|Overall Study|Blood could not be drawn|0|||
170701032|NCT02641379|616918538|FG009|Overall Study|Blood could not be drawn|0|||
170701033|NCT02641379|616918539|FG010|Overall Study|Blood could not be drawn|0|||
170701034|NCT02641379|616918529|FG000|Overall Study|Protocol Violation|0|||
170701035|NCT02641379|616918530|FG001|Overall Study|Protocol Violation|0|||
170701036|NCT02641379|616918531|FG002|Overall Study|Protocol Violation|0|||
170701037|NCT02641379|616918532|FG003|Overall Study|Protocol Violation|0|||
170701038|NCT02641379|616918533|FG004|Overall Study|Protocol Violation|2|||
170701039|NCT02641379|616918534|FG005|Overall Study|Protocol Violation|0|||
170701040|NCT02641379|616918535|FG006|Overall Study|Protocol Violation|0|||
170701041|NCT02641379|616918536|FG007|Overall Study|Protocol Violation|0|||
170701042|NCT02641379|616918537|FG008|Overall Study|Protocol Violation|1|||
170701043|NCT02641379|616918538|FG009|Overall Study|Protocol Violation|0|||
170701044|NCT02641379|616918539|FG010|Overall Study|Protocol Violation|0|||
170701045|NCT02641379|616918529|FG000|Overall Study|Participation in sili rescue study|0|||
170701046|NCT02641379|616918530|FG001|Overall Study|Participation in sili rescue study|0|||
170701047|NCT02641379|616918531|FG002|Overall Study|Participation in sili rescue study|0|||
170701048|NCT02641379|616918532|FG003|Overall Study|Participation in sili rescue study|0|||
170824659|NCT01649557|617366478|FG002|Overall Study|Lack of Efficacy|0|||
170824660|NCT00352053|617366481|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
170824661|NCT00352053|617366482|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
170824662|NCT00352053|617366481|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
170824663|NCT00352053|617366482|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
170824664|NCT00352053|617366481|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
170824665|NCT00352053|617366482|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
170824666|NCT00352053|617366481|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
170824667|NCT00352053|617366482|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
170824668|NCT00352053|617366481|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
170824669|NCT00352053|617366482|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
170824670|NCT00352053|617366481|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
170824671|NCT00352053|617366482|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
170824672|NCT00352053|617366481|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
170824673|NCT00352053|617366482|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
170824674|NCT00352053|617366481|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
170824675|NCT00352053|617366482|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
170824676|NCT00352053|617366481|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
170824677|NCT00352053|617366482|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
170701049|NCT02641379|616918533|FG004|Overall Study|Participation in sili rescue study|0|||
170701050|NCT02641379|616918534|FG005|Overall Study|Participation in sili rescue study|1|||
170701051|NCT02641379|616918535|FG006|Overall Study|Participation in sili rescue study|0|||
170701052|NCT02641379|616918536|FG007|Overall Study|Participation in sili rescue study|0|||
170701053|NCT02641379|616918537|FG008|Overall Study|Participation in sili rescue study|0|||
170701054|NCT02641379|616918538|FG009|Overall Study|Participation in sili rescue study|0|||
170701055|NCT02641379|616918539|FG010|Overall Study|Participation in sili rescue study|0|||
170701056|NCT02641379|616918529|FG000|Overall Study|Lost to Follow-up|0|||
170701057|NCT02641379|616918530|FG001|Overall Study|Lost to Follow-up|0|||
170701058|NCT02641379|616918531|FG002|Overall Study|Lost to Follow-up|0|||
170701059|NCT02641379|616918532|FG003|Overall Study|Lost to Follow-up|0|||
170701060|NCT02641379|616918533|FG004|Overall Study|Lost to Follow-up|0|||
170701061|NCT02641379|616918534|FG005|Overall Study|Lost to Follow-up|0|||
170701062|NCT02641379|616918535|FG006|Overall Study|Lost to Follow-up|0|||
170701063|NCT02641379|616918536|FG007|Overall Study|Lost to Follow-up|0|||
170701064|NCT02641379|616918537|FG008|Overall Study|Lost to Follow-up|1|||
170701065|NCT02641379|616918538|FG009|Overall Study|Lost to Follow-up|0|||
170701066|NCT02641379|616918539|FG010|Overall Study|Lost to Follow-up|0|||
170701067|NCT02641379|616918529|FG000|Overall Study|Source data not found|0|||
170701068|NCT02641379|616918530|FG001|Overall Study|Source data not found|0|||
170701069|NCT02641379|616918531|FG002|Overall Study|Source data not found|0|||
170701070|NCT02641379|616918532|FG003|Overall Study|Source data not found|0|||
170701071|NCT02641379|616918533|FG004|Overall Study|Source data not found|0|||
170701072|NCT02641379|616918534|FG005|Overall Study|Source data not found|1|||
170701073|NCT02641379|616918535|FG006|Overall Study|Source data not found|0|||
170701074|NCT02641379|616918536|FG007|Overall Study|Source data not found|0|||
170701075|NCT02641379|616918537|FG008|Overall Study|Source data not found|0|||
170701076|NCT02641379|616918538|FG009|Overall Study|Source data not found|0|||
170701077|NCT02641379|616918539|FG010|Overall Study|Source data not found|0|||
170701078|NCT02641379|616918529|FG000|Overall Study|Participant showed weight reduction|0|||
170701079|NCT02641379|616918530|FG001|Overall Study|Participant showed weight reduction|0|||
170701080|NCT02641379|616918531|FG002|Overall Study|Participant showed weight reduction|0|||
170701081|NCT02641379|616918532|FG003|Overall Study|Participant showed weight reduction|0|||
170701082|NCT02641379|616918533|FG004|Overall Study|Participant showed weight reduction|0|||
170701083|NCT02641379|616918534|FG005|Overall Study|Participant showed weight reduction|0|||
170701084|NCT02641379|616918535|FG006|Overall Study|Participant showed weight reduction|0|||
170701085|NCT02641379|616918536|FG007|Overall Study|Participant showed weight reduction|1|||
170701086|NCT02641379|616918537|FG008|Overall Study|Participant showed weight reduction|0|||
170701087|NCT02641379|616918538|FG009|Overall Study|Participant showed weight reduction|0|||
170701088|NCT02641379|616918539|FG010|Overall Study|Participant showed weight reduction|0|||
170701089|NCT02641379|616918529|FG000|Overall Study|Non-response Week 12|0|||
170701090|NCT02641379|616918530|FG001|Overall Study|Non-response Week 12|0|||
170701091|NCT02641379|616918531|FG002|Overall Study|Non-response Week 12|0|||
170701092|NCT02641379|616918532|FG003|Overall Study|Non-response Week 12|0|||
170701093|NCT02641379|616918533|FG004|Overall Study|Non-response Week 12|0|||
170701094|NCT02641379|616918534|FG005|Overall Study|Non-response Week 12|0|||
170824678|NCT00352053|617366481|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
170824679|NCT00352053|617366482|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
170701095|NCT02641379|616918535|FG006|Overall Study|Non-response Week 12|0|||
170824680|NCT00352053|617366481|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
170824681|NCT00352053|617366482|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
170824682|NCT00352053|617366481|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
170824683|NCT00352053|617366482|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
170824684|NCT00352053|617366481|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
170824685|NCT00352053|617366482|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
170824686|NCT02435381|617366483|FG000|Overall Study|Lost to Follow-up|2|||
170824687|NCT02435381|617366484|FG001|Overall Study|Lost to Follow-up|1|||
170824688|NCT05109117|617366497|FG000|Overall Study|Lost to Follow-up|1|||
170824689|NCT05109117|617366497|FG000|Overall Study|Discontinued for non-compliance|1|||
170824690|NCT03319719|617366498|FG000|Overall Study|Lost to Follow-up|1|||
170824691|NCT03168425|617366499|FG000|Overall Study|Lost to Follow-up|5|||
170824692|NCT03168425|617366500|FG001|Overall Study|Lost to Follow-up|8|||
170824693|NCT03168425|617366499|FG000|Overall Study|unable to confirm post op opioids|2|||
170824694|NCT03168425|617366500|FG001|Overall Study|unable to confirm post op opioids|3|||
170824695|NCT02490878|617366501|FG000|Overall Study|deemed ineligible|0|||
170824696|NCT02490878|617366502|FG001|Overall Study|deemed ineligible|1|||
170824697|NCT02490878|617366501|FG000|Overall Study|progression prior to treatment|0|||
170824698|NCT02490878|617366502|FG001|Overall Study|progression prior to treatment|1|||
170824699|NCT02490878|617366501|FG000|Overall Study|only submitted baseline QOL|0|||
170824700|NCT02490878|617366502|FG001|Overall Study|only submitted baseline QOL|1|||
170824701|NCT03772041|617366504|FG000|Overall Study|Adverse Event|8|||
170824702|NCT03772041|617366505|FG001|Overall Study|Adverse Event|3|||
170824703|NCT03772041|617366504|FG000|Overall Study|Withdrawal by Subject|0|||
170824704|NCT03772041|617366505|FG001|Overall Study|Withdrawal by Subject|2|||
170824705|NCT03772041|617366504|FG000|Overall Study|Protocol Violation|4|||
170824706|NCT03772041|617366505|FG001|Overall Study|Protocol Violation|2|||
170824707|NCT03772041|617366504|FG000|Overall Study|Physician Decision|2|||
170824708|NCT03772041|617366505|FG001|Overall Study|Physician Decision|3|||
170824709|NCT02959177|617366506|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
170824710|NCT02959177|617366507|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
170824711|NCT02959177|617366508|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
170824712|NCT02959177|617366506|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
170824713|NCT02959177|617366507|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
170824714|NCT02959177|617366508|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
170824715|NCT02959177|617366506|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
170824716|NCT02959177|617366507|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
170824717|NCT02959177|617366508|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
170824718|NCT02959177|617366506|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
170824719|NCT02959177|617366507|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
170824720|NCT02959177|617366508|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
170824721|NCT02959177|617366506|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
170824722|NCT02959177|617366507|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
170824723|NCT02959177|617366508|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
170824724|NCT02959177|617366506|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
170824725|NCT02959177|617366507|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
170824726|NCT02959177|617366508|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
170824727|NCT02959177|617366506|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
170824728|NCT02959177|617366507|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
170824729|NCT02959177|617366508|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
170824730|NCT02171130|617366509|FG000|Overall Study|Death|1|||
170824731|NCT02171130|617366509|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
170824732|NCT02171130|617366509|FG000|Overall Study|Discontinued; Site Termination|5|||
170824733|NCT02171130|617366509|FG000|Overall Study|Withdrawal by Subject|3|||
170824734|NCT02171130|617366509|FG000|Overall Study|Physician Decision|1|||
170824735|NCT02171130|617366509|FG000|Overall Study|Lost to Follow-up|1|||
170824736|NCT02171130|617366509|FG000|Overall Study|Met Exclusion Criteria|1|||
170824737|NCT04772313|617366510|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
170824738|NCT04772313|617366510|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
170824739|NCT01836198|617366511|FG000|Part A, Period 2|Protocol Violation|0|||
170824740|NCT01836198|617366512|FG001|Part A, Period 2|Protocol Violation|1|||
170824741|NCT01836198|617366513|FG002|Part A, Period 2|Protocol Violation|0|||
170824742|NCT01951261|617366515|FG000|Overall Study|Death|1|||
170824743|NCT01951261|617366516|FG001|Overall Study|Death|0|||
170824744|NCT01951261|617366515|FG000|Overall Study|Lost to Follow-up|4|||
170824745|NCT01951261|617366516|FG001|Overall Study|Lost to Follow-up|3|||
170824746|NCT01951261|617366515|FG000|Overall Study|Protocol Violation|4|||
170824747|NCT01951261|617366516|FG001|Overall Study|Protocol Violation|3|||
170824748|NCT01026103|617366520|FG000|Overall Study|Physician Decision|1|||
170824749|NCT01026103|617366520|FG000|Overall Study|did not receive study device bc of error|1|||
170701096|NCT02641379|616918536|FG007|Overall Study|Non-response Week 12|1|||
170701097|NCT02641379|616918537|FG008|Overall Study|Non-response Week 12|0|||
170701098|NCT02641379|616918538|FG009|Overall Study|Non-response Week 12|0|||
170701099|NCT02641379|616918539|FG010|Overall Study|Non-response Week 12|0|||
170701100|NCT02641379|616918529|FG000|Overall Study|No 2 Log drop at Week 12|0|||
170701101|NCT02641379|616918530|FG001|Overall Study|No 2 Log drop at Week 12|0|||
170701102|NCT02641379|616918531|FG002|Overall Study|No 2 Log drop at Week 12|0|||
170701103|NCT02641379|616918532|FG003|Overall Study|No 2 Log drop at Week 12|0|||
170701104|NCT02641379|616918533|FG004|Overall Study|No 2 Log drop at Week 12|0|||
170701105|NCT02641379|616918534|FG005|Overall Study|No 2 Log drop at Week 12|0|||
170701106|NCT02641379|616918535|FG006|Overall Study|No 2 Log drop at Week 12|0|||
170701107|NCT02641379|616918536|FG007|Overall Study|No 2 Log drop at Week 12|0|||
170701108|NCT02641379|616918537|FG008|Overall Study|No 2 Log drop at Week 12|0|||
170701109|NCT02641379|616918538|FG009|Overall Study|No 2 Log drop at Week 12|0|||
170701110|NCT02641379|616918539|FG010|Overall Study|No 2 Log drop at Week 12|1|||
170701111|NCT02641379|616918529|FG000|Overall Study|Negative PCR result|0|||
170701112|NCT02641379|616918530|FG001|Overall Study|Negative PCR result|0|||
170701113|NCT02641379|616918531|FG002|Overall Study|Negative PCR result|0|||
170701114|NCT02641379|616918532|FG003|Overall Study|Negative PCR result|0|||
170701115|NCT02641379|616918533|FG004|Overall Study|Negative PCR result|0|||
170701116|NCT02641379|616918534|FG005|Overall Study|Negative PCR result|0|||
170701117|NCT02641379|616918535|FG006|Overall Study|Negative PCR result|0|||
170701118|NCT02641379|616918536|FG007|Overall Study|Negative PCR result|0|||
170701119|NCT02641379|616918537|FG008|Overall Study|Negative PCR result|0|||
170701120|NCT02641379|616918538|FG009|Overall Study|Negative PCR result|1|||
170701121|NCT02641379|616918539|FG010|Overall Study|Negative PCR result|0|||
170701122|NCT02641379|616918529|FG000|Overall Study|Participant's PCR high|0|||
170701123|NCT02641379|616918530|FG001|Overall Study|Participant's PCR high|0|||
170701124|NCT02641379|616918531|FG002|Overall Study|Participant's PCR high|0|||
170701125|NCT02641379|616918532|FG003|Overall Study|Participant's PCR high|0|||
170701126|NCT02641379|616918533|FG004|Overall Study|Participant's PCR high|0|||
170701127|NCT02641379|616918534|FG005|Overall Study|Participant's PCR high|0|||
170701128|NCT02641379|616918535|FG006|Overall Study|Participant's PCR high|0|||
170701129|NCT02641379|616918536|FG007|Overall Study|Participant's PCR high|1|||
170701130|NCT02641379|616918537|FG008|Overall Study|Participant's PCR high|0|||
170701131|NCT02641379|616918538|FG009|Overall Study|Participant's PCR high|0|||
170701132|NCT02641379|616918539|FG010|Overall Study|Participant's PCR high|0|||
170701133|NCT02641379|616918529|FG000|Overall Study|Participant treated after Week 24|0|||
170701134|NCT02641379|616918530|FG001|Overall Study|Participant treated after Week 24|0|||
170701135|NCT02641379|616918531|FG002|Overall Study|Participant treated after Week 24|0|||
170701136|NCT02641379|616918532|FG003|Overall Study|Participant treated after Week 24|0|||
170701137|NCT02641379|616918533|FG004|Overall Study|Participant treated after Week 24|0|||
170701138|NCT02641379|616918534|FG005|Overall Study|Participant treated after Week 24|0|||
170701139|NCT02641379|616918535|FG006|Overall Study|Participant treated after Week 24|0|||
170701140|NCT02641379|616918536|FG007|Overall Study|Participant treated after Week 24|0|||
170701141|NCT02641379|616918537|FG008|Overall Study|Participant treated after Week 24|1|||
170701142|NCT02641379|616918538|FG009|Overall Study|Participant treated after Week 24|0|||
170701143|NCT02641379|616918539|FG010|Overall Study|Participant treated after Week 24|0|||
170701144|NCT02641379|616918529|FG000|Overall Study|Missing PCR result at Week 8|0|||
170701145|NCT02641379|616918530|FG001|Overall Study|Missing PCR result at Week 8|0|||
170701146|NCT02641379|616918531|FG002|Overall Study|Missing PCR result at Week 8|0|||
170701147|NCT02641379|616918532|FG003|Overall Study|Missing PCR result at Week 8|0|||
170701148|NCT02641379|616918533|FG004|Overall Study|Missing PCR result at Week 8|0|||
170701149|NCT02641379|616918534|FG005|Overall Study|Missing PCR result at Week 8|0|||
170701150|NCT02641379|616918535|FG006|Overall Study|Missing PCR result at Week 8|0|||
170701151|NCT02641379|616918536|FG007|Overall Study|Missing PCR result at Week 8|0|||
170701152|NCT02641379|616918537|FG008|Overall Study|Missing PCR result at Week 8|0|||
170701153|NCT02641379|616918538|FG009|Overall Study|Missing PCR result at Week 8|1|||
170701154|NCT02641379|616918539|FG010|Overall Study|Missing PCR result at Week 8|0|||
170701155|NCT02641379|616918529|FG000|Overall Study|PCR positive|0|||
170701156|NCT02641379|616918530|FG001|Overall Study|PCR positive|0|||
170701157|NCT02641379|616918531|FG002|Overall Study|PCR positive|0|||
170701158|NCT02641379|616918532|FG003|Overall Study|PCR positive|0|||
170701159|NCT02641379|616918533|FG004|Overall Study|PCR positive|0|||
170701160|NCT02641379|616918534|FG005|Overall Study|PCR positive|0|||
170824750|NCT02498418|617366521|FG000|Overall Study|Lack of Efficacy|0|||
170824751|NCT02498418|617366522|FG001|Overall Study|Lack of Efficacy|0|||
170824752|NCT02498418|617366523|FG002|Overall Study|Lack of Efficacy|1|||
170824753|NCT02498418|617366521|FG000|Overall Study|Withdrawal by Subject|2|||
170824754|NCT02498418|617366522|FG001|Overall Study|Withdrawal by Subject|0|||
170824755|NCT02498418|617366523|FG002|Overall Study|Withdrawal by Subject|3|||
170824756|NCT02498418|617366521|FG000|Overall Study|Lost to Follow-up|0|||
170824757|NCT02498418|617366522|FG001|Overall Study|Lost to Follow-up|1|||
170824758|NCT02498418|617366523|FG002|Overall Study|Lost to Follow-up|1|||
170824759|NCT02498418|617366521|FG000|Overall Study|Participant taken prohibited medication|0|||
170824760|NCT02498418|617366522|FG001|Overall Study|Participant taken prohibited medication|1|||
170824761|NCT02498418|617366523|FG002|Overall Study|Participant taken prohibited medication|1|||
170824762|NCT03927222|617366524|FG000|Overall Study|Progression|3|||
170824763|NCT03927222|617366524|FG000|Overall Study|CMV testing results inconclusive|1|||
170824764|NCT03927222|617366524|FG000|Overall Study|Unable to generate enough vaccines|1|||
170824765|NCT03927222|617366524|FG000|Overall Study|Early study termination|1|||
170824766|NCT03723915|617366525|FG000|Screening|Failed to meet screening requirements.|2|||
170824767|NCT03723915|617366525|FG000|On Treatment|Failed to meet treatment requirements|2|||
170824768|NCT02996097|617366526|FG000|Overall Study|Lost to Follow-up|11|||
170701161|NCT02641379|616918535|FG006|Overall Study|PCR positive|1|||
170701162|NCT02641379|616918536|FG007|Overall Study|PCR positive|0|||
170701163|NCT02641379|616918537|FG008|Overall Study|PCR positive|0|||
170701164|NCT02641379|616918538|FG009|Overall Study|PCR positive|0|||
170701165|NCT02641379|616918539|FG010|Overall Study|PCR positive|0|||
170701166|NCT01455012|616918542|FG000|Overall Study|Adverse Event|0|||
170701167|NCT01455012|616918543|FG001|Overall Study|Adverse Event|2|||
170701168|NCT01455012|616918542|FG000|Overall Study|Lack of Efficacy|6|||
170701169|NCT01455012|616918543|FG001|Overall Study|Lack of Efficacy|1|||
170701170|NCT01455012|616918542|FG000|Overall Study|Withdrawal by Subject|3|||
170701171|NCT01455012|616918543|FG001|Overall Study|Withdrawal by Subject|1|||
170701172|NCT01455012|616918542|FG000|Overall Study|Unknown reason|2|||
170701173|NCT01455012|616918543|FG001|Overall Study|Unknown reason|0|||
170701174|NCT01398956|616918546|FG000|Overall Study|Withdrawal by Subject|4|||
170701175|NCT01398956|616918546|FG000|Overall Study|AE, non-serious non-fatal|4|||
170701176|NCT01398956|616918546|FG000|Overall Study|Withdrawal Criteria No.3|1|||
170701177|NCT01398956|616918546|FG000|Overall Study|Subject moved a long distance|1|||
170701178|NCT00856908|616918564|FG000|Overall Study|Lost to Follow-up|1|||
170701179|NCT00856908|616918565|FG001|Overall Study|Lost to Follow-up|0|||
170701180|NCT01063595|616918569|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
170701181|NCT01063595|616918570|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
170701182|NCT01063595|616918569|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
170701183|NCT01063595|616918570|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
170701184|NCT01063595|616918569|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
170701185|NCT01063595|616918570|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
170701186|NCT01063595|616918569|FG000|First Intervention|Adverse Event|1|||
170701187|NCT01063595|616918570|FG001|First Intervention|Adverse Event|4|||
170701188|NCT01063595|616918569|FG000|First Intervention|Withdrawal by Subject|1|||
170701189|NCT01063595|616918570|FG001|First Intervention|Withdrawal by Subject|0|||
170701190|NCT01063595|616918569|FG000|First Intervention|Reason not Specified|0|||
170701191|NCT01063595|616918570|FG001|First Intervention|Reason not Specified|1|||
170701192|NCT01623596|616918577|FG000|Overall Study|Abnormal laboratory values|2|||
170701193|NCT01623596|616918578|FG001|Overall Study|Abnormal laboratory values|0|||
170701194|NCT01623596|616918577|FG000|Overall Study|Administrative problems|9|||
170824769|NCT02996097|617366527|FG001|Overall Study|Lost to Follow-up|11|||
170824770|NCT00495612|617366533|FG000|Overall Study|Lost to Follow-up|1|||
170824771|NCT00495612|617366534|FG001|Overall Study|Lost to Follow-up|0|||
170701195|NCT01623596|616918578|FG001|Overall Study|Administrative problems|13|||
170701196|NCT01623596|616918577|FG000|Overall Study|Adverse Event|20|||
170701197|NCT01623596|616918578|FG001|Overall Study|Adverse Event|29|||
170701198|NCT01623596|616918577|FG000|Overall Study|Death|0|||
170701199|NCT01623596|616918578|FG001|Overall Study|Death|2|||
170701200|NCT01623596|616918577|FG000|Overall Study|Lost to Follow-up|12|||
170701201|NCT01623596|616918578|FG001|Overall Study|Lost to Follow-up|16|||
170701202|NCT01623596|616918577|FG000|Overall Study|Withdrawal by Subject|13|||
170701203|NCT01623596|616918578|FG001|Overall Study|Withdrawal by Subject|31|||
170701204|NCT01623596|616918577|FG000|Overall Study|Patient no longer requires study drug|1|||
170701205|NCT01623596|616918578|FG001|Overall Study|Patient no longer requires study drug|0|||
170701206|NCT01623596|616918577|FG000|Overall Study|Protocol Violation|0|||
170701207|NCT01623596|616918578|FG001|Overall Study|Protocol Violation|6|||
170701208|NCT01623596|616918577|FG000|Overall Study|Lack of Efficacy|5|||
170701209|NCT01623596|616918578|FG001|Overall Study|Lack of Efficacy|3|||
170701210|NCT04059146|616918579|FG000|Overall Study|Withdrawal by Subject|0|||
170701211|NCT04059146|616918580|FG001|Overall Study|Withdrawal by Subject|1|||
170701212|NCT01712256|616918583|FG000|Overall Study|Lost to Follow-up|1|||
170701213|NCT00603746|616918589|FG000|Overall Study|Adverse Event|2|||
170701214|NCT00603746|616918590|FG001|Overall Study|Adverse Event|3|||
170824772|NCT00495612|617366533|FG000|Overall Study|Subject's Decision to Withdraw|3|||
170824773|NCT00495612|617366534|FG001|Overall Study|Subject's Decision to Withdraw|0|||
170824774|NCT02588027|617366539|FG000|Overall Study|Withdrawal by Subject|1|||
170824775|NCT02588027|617366540|FG001|Overall Study|Withdrawal by Subject|3|||
170824776|NCT02588027|617366539|FG000|Overall Study|Protocol Violation|4|||
170824777|NCT02588027|617366540|FG001|Overall Study|Protocol Violation|1|||
170824778|NCT00734851|617366543|FG000|Overall Study|Withdrawal by Subject|2|||
170824779|NCT00734851|617366543|FG000|Overall Study|Lost to Follow-up|1|||
170824780|NCT00734851|617366543|FG000|Overall Study|Physician Decision|18|||
170824781|NCT00818519|617366544|FG000|Overall Study|Adverse Event|2|||
170824782|NCT00818519|617366545|FG001|Overall Study|Adverse Event|2|||
170824783|NCT00818519|617366544|FG000|Overall Study|Lost to Follow-up|4|||
170824784|NCT00818519|617366545|FG001|Overall Study|Lost to Follow-up|6|||
170824785|NCT00818519|617366544|FG000|Overall Study|Protocol Violation|2|||
170824786|NCT00818519|617366545|FG001|Overall Study|Protocol Violation|1|||
170824787|NCT00818519|617366544|FG000|Overall Study|Pregnancy|0|||
170824788|NCT00818519|617366545|FG001|Overall Study|Pregnancy|1|||
170824789|NCT00818519|617366544|FG000|Overall Study|Withdrawal by Subject|4|||
170824790|NCT00818519|617366545|FG001|Overall Study|Withdrawal by Subject|9|||
170824791|NCT00818519|617366544|FG000|Overall Study|participant recovered completely|1|||
170824792|NCT00818519|617366545|FG001|Overall Study|participant recovered completely|0|||
170824793|NCT00818519|617366544|FG000|Overall Study|participant will leave for long tme|1|||
170824794|NCT00818519|617366545|FG001|Overall Study|participant will leave for long tme|0|||
170824795|NCT04853394|617366549|FG000|Follow-up Interviews|Lost to Follow-up|22|||
170824796|NCT04853394|617366550|FG001|Follow-up Interviews|Lost to Follow-up|15|||
170824797|NCT04531813|617366553|FG000|Overall Study|Protocol Violation|1|||
170824798|NCT04531813|617366553|FG000|Overall Study|Withdrawal by Subject|1|||
170824799|NCT01123642|617366554|FG000|Overall Study|Lost to Follow-up|23|||
170824800|NCT01123642|617366554|FG000|Overall Study|Withdrawal by Subject|9|||
170824801|NCT01123642|617366554|FG000|Overall Study|ineligible at baseline assessment|36|||
170824802|NCT04853238|617366555|FG000|Overall Study|Death|4|||
170824803|NCT04853238|617366556|FG001|Overall Study|Death|0|||
170824804|NCT04853238|617366557|FG002|Overall Study|Death|2|||
170824805|NCT04853238|617366555|FG000|Overall Study|Lost to Follow-up|16|||
170824806|NCT04853238|617366556|FG001|Overall Study|Lost to Follow-up|2|||
170824807|NCT04853238|617366557|FG002|Overall Study|Lost to Follow-up|37|||
170824808|NCT04853238|617366555|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
170824809|NCT04853238|617366556|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
170824810|NCT04853238|617366557|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
170824811|NCT04853238|617366555|FG000|Overall Study|Withdrawal by Subject|6|||
170824812|NCT04853238|617366556|FG001|Overall Study|Withdrawal by Subject|0|||
170824813|NCT04853238|617366557|FG002|Overall Study|Withdrawal by Subject|21|||
170824814|NCT04853238|617366555|FG000|Overall Study|Physician Decision|0|||
170824815|NCT04853238|617366556|FG001|Overall Study|Physician Decision|0|||
170824816|NCT04853238|617366557|FG002|Overall Study|Physician Decision|2|||
170824817|NCT04853238|617366555|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
170824818|NCT04853238|617366556|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
170824819|NCT04853238|617366557|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
170824820|NCT03464383|617367847|FG000|Overall Study|Lost to Follow-up|1|||
170824821|NCT03464383|617367848|FG001|Overall Study|Lost to Follow-up|0|||
170824822|NCT03464383|617367849|FG002|Overall Study|Lost to Follow-up|0|||
170824823|NCT03464383|617367847|FG000|Overall Study|Withdrawal by Subject|0|||
170824824|NCT03464383|617367848|FG001|Overall Study|Withdrawal by Subject|1|||
170824825|NCT03464383|617367849|FG002|Overall Study|Withdrawal by Subject|0|||
170824826|NCT00560313|617367851|FG000|Overall Study|Adverse Events or Death|2|||
170824827|NCT00560313|617367851|FG000|Overall Study|Withdrawal by Subject|2|||
170824828|NCT00560313|617367851|FG000|Overall Study|Lost to Follow-up|1|||
170824829|NCT00560313|617367851|FG000|Overall Study|Protocol Violation|1|||
170824830|NCT00746785|617367852|FG000|Overall Study|Lost to Follow-up|29|||
170824831|NCT00746785|617367853|FG001|Overall Study|Lost to Follow-up|25|||
170824832|NCT00746785|617367854|FG002|Overall Study|Lost to Follow-up|27|||
170824833|NCT01231464|617367855|FG000|Overall Study|Adverse Event|0|||
170824834|NCT01231464|617367856|FG001|Overall Study|Adverse Event|1|||
170824835|NCT01231464|617367855|FG000|Overall Study|Protocol Violation|1|||
170824836|NCT01231464|617367856|FG001|Overall Study|Protocol Violation|2|||
170824837|NCT01231464|617367855|FG000|Overall Study|Lost to Follow-up|1|||
170824838|NCT01231464|617367856|FG001|Overall Study|Lost to Follow-up|2|||
170701215|NCT00603746|616918591|FG002|Overall Study|Adverse Event|0|||
170701216|NCT00603746|616918592|FG003|Overall Study|Adverse Event|1|||
170701217|NCT00603746|616918593|FG004|Overall Study|Adverse Event|0|||
170701218|NCT00603746|616918594|FG005|Overall Study|Adverse Event|4|||
170701219|NCT00603746|616918589|FG000|Overall Study|Lack of Efficacy|34|||
170701220|NCT00603746|616918590|FG001|Overall Study|Lack of Efficacy|11|||
170701221|NCT00603746|616918591|FG002|Overall Study|Lack of Efficacy|6|||
170701222|NCT00603746|616918592|FG003|Overall Study|Lack of Efficacy|11|||
170701223|NCT00603746|616918593|FG004|Overall Study|Lack of Efficacy|12|||
170701224|NCT00603746|616918594|FG005|Overall Study|Lack of Efficacy|8|||
170701225|NCT00603746|616918589|FG000|Overall Study|Protocol Violation|0|||
170701226|NCT00603746|616918590|FG001|Overall Study|Protocol Violation|3|||
170701227|NCT00603746|616918591|FG002|Overall Study|Protocol Violation|1|||
170701228|NCT00603746|616918592|FG003|Overall Study|Protocol Violation|0|||
170701229|NCT00603746|616918593|FG004|Overall Study|Protocol Violation|1|||
170701230|NCT00603746|616918594|FG005|Overall Study|Protocol Violation|0|||
170701231|NCT00603746|616918589|FG000|Overall Study|Lost to Follow-up|0|||
170701232|NCT00603746|616918590|FG001|Overall Study|Lost to Follow-up|1|||
170701233|NCT00603746|616918591|FG002|Overall Study|Lost to Follow-up|1|||
170701234|NCT00603746|616918592|FG003|Overall Study|Lost to Follow-up|0|||
170701235|NCT00603746|616918593|FG004|Overall Study|Lost to Follow-up|0|||
170701236|NCT00603746|616918594|FG005|Overall Study|Lost to Follow-up|0|||
170701237|NCT00603746|616918589|FG000|Overall Study|Physician Decision|1|||
170701238|NCT00603746|616918590|FG001|Overall Study|Physician Decision|0|||
170701239|NCT00603746|616918591|FG002|Overall Study|Physician Decision|0|||
170701240|NCT00603746|616918592|FG003|Overall Study|Physician Decision|0|||
170701241|NCT00603746|616918593|FG004|Overall Study|Physician Decision|1|||
170701242|NCT00603746|616918594|FG005|Overall Study|Physician Decision|0|||
170701243|NCT00603746|616918589|FG000|Overall Study|Withdrawal by Subject|1|||
170701244|NCT00603746|616918590|FG001|Overall Study|Withdrawal by Subject|0|||
170701245|NCT00603746|616918591|FG002|Overall Study|Withdrawal by Subject|0|||
170701246|NCT00603746|616918592|FG003|Overall Study|Withdrawal by Subject|1|||
170701247|NCT00603746|616918593|FG004|Overall Study|Withdrawal by Subject|3|||
170701248|NCT00603746|616918594|FG005|Overall Study|Withdrawal by Subject|1|||
170701249|NCT01224639|616918595|FG000|Overall Study|Withdrawal by Subject|0|||
170701250|NCT01224639|616918596|FG001|Overall Study|Withdrawal by Subject|0|||
170701251|NCT01224639|616918597|FG002|Overall Study|Withdrawal by Subject|0|||
170701252|NCT01224639|616918598|FG003|Overall Study|Withdrawal by Subject|0|||
170701253|NCT01224639|616918599|FG004|Overall Study|Withdrawal by Subject|2|||
170701254|NCT01224639|616918600|FG005|Overall Study|Withdrawal by Subject|0|||
170701255|NCT01224639|616918601|FG006|Overall Study|Withdrawal by Subject|1|||
170701256|NCT01224639|616918602|FG007|Overall Study|Withdrawal by Subject|1|||
170701257|NCT01224639|616918595|FG000|Overall Study|Adverse Event|0|||
170701258|NCT01224639|616918596|FG001|Overall Study|Adverse Event|0|||
170701259|NCT01224639|616918597|FG002|Overall Study|Adverse Event|0|||
170701260|NCT01224639|616918598|FG003|Overall Study|Adverse Event|0|||
170701261|NCT01224639|616918599|FG004|Overall Study|Adverse Event|0|||
170701262|NCT01224639|616918600|FG005|Overall Study|Adverse Event|0|||
170701263|NCT01224639|616918601|FG006|Overall Study|Adverse Event|0|||
170701264|NCT01224639|616918602|FG007|Overall Study|Adverse Event|1|||
170701265|NCT01132495|616918603|FG000|Overall Study|Various reasons|40|||
170701266|NCT01132495|616918604|FG001|Overall Study|Various reasons|38|||
170701267|NCT01132495|616918605|FG002|Overall Study|Various reasons|20|||
170701268|NCT01132495|616918606|FG003|Overall Study|Various reasons|12|||
170701269|NCT00692770|616918608|FG000|Overall Study|Protocol Violation|2|||
170701270|NCT00692770|616918609|FG001|Overall Study|Protocol Violation|7|||
170701271|NCT00692770|616918608|FG000|Overall Study|Withdrawal by Subject|97|||
170701272|NCT00692770|616918609|FG001|Overall Study|Withdrawal by Subject|36|||
170701273|NCT00692770|616918608|FG000|Overall Study|Adverse Event|136|||
170701274|NCT00692770|616918609|FG001|Overall Study|Adverse Event|41|||
170701275|NCT00692770|616918608|FG000|Overall Study|Death|10|||
170701276|NCT00692770|616918609|FG001|Overall Study|Death|5|||
170701277|NCT00692770|616918608|FG000|Overall Study|Lost to Follow-up|7|||
170701278|NCT00692770|616918609|FG001|Overall Study|Lost to Follow-up|3|||
170701279|NCT00692770|616918608|FG000|Overall Study|Non-compliant with study medication|11|||
170701280|NCT00692770|616918609|FG001|Overall Study|Non-compliant with study medication|5|||
170701281|NCT00692770|616918608|FG000|Overall Study|Progression by clinical judgment|2|||
170701282|NCT00692770|616918609|FG001|Overall Study|Progression by clinical judgment|3|||
170701283|NCT00692770|616918608|FG000|Overall Study|Physician decision not protocol driven|10|||
170701284|NCT00692770|616918609|FG001|Overall Study|Physician decision not protocol driven|14|||
170701285|NCT00692770|616918608|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
170701286|NCT00692770|616918609|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
170701287|NCT00692770|616918608|FG000|Overall Study|Protocol driven decision point|3|||
170701288|NCT00692770|616918609|FG001|Overall Study|Protocol driven decision point|7|||
170701289|NCT00692770|616918608|FG000|Overall Study|Completed all planned assessments|79|||
170701290|NCT00692770|616918609|FG001|Overall Study|Completed all planned assessments|101|||
170701291|NCT00692770|616918608|FG000|Overall Study|Radiological and clinical progression|8|||
170701292|NCT00692770|616918609|FG001|Overall Study|Radiological and clinical progression|8|||
170701293|NCT00692770|616918608|FG000|Overall Study|Clinical endpoint reached|16|||
170701294|NCT00692770|616918609|FG001|Overall Study|Clinical endpoint reached|43|||
170701295|NCT00692770|616918608|FG000|Overall Study|Study terminated by sponsor|2|||
170701296|NCT00692770|616918609|FG001|Overall Study|Study terminated by sponsor|2|||
170701297|NCT00692770|616918608|FG000|Overall Study|Randomized but not treated|3|||
170701298|NCT00692770|616918609|FG001|Overall Study|Randomized but not treated|4|||
170701299|NCT03350503|616918610|FG000|Overall Study|Adverse Event|5|||
170701300|NCT03350503|616918610|FG000|Overall Study|Withdrawal by Subject|5|||
170701301|NCT03350503|616918610|FG000|Overall Study|Continuation impossible due to move|4|||
170701302|NCT03350503|616918610|FG000|Overall Study|Physician Decision|3|||
170701303|NCT00834912|616918611|FG000|Treatment Period 1|Adverse Event|0|||
170701304|NCT00834912|616918612|FG001|Treatment Period 1|Adverse Event|1|||
170701305|NCT00834912|616918613|FG002|Treatment Period 1|Adverse Event|0|||
170701306|NCT00834912|616918614|FG003|Treatment Period 1|Adverse Event|1|||
170701307|NCT00834912|616918615|FG004|Treatment Period 1|Adverse Event|0|||
170701308|NCT00834912|616918616|FG005|Treatment Period 1|Adverse Event|0|||
170701309|NCT00834912|616918611|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170701310|NCT00834912|616918612|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170701311|NCT00834912|616918613|FG002|Treatment Period 2|Withdrawal by Subject|1|||
170701312|NCT00834912|616918614|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170701313|NCT00834912|616918615|FG004|Treatment Period 2|Withdrawal by Subject|1|||
170701314|NCT00834912|616918616|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170701315|NCT00262067|616918622|FG000|Overall Study|Death|190|||
170701316|NCT00262067|616918623|FG001|Overall Study|Death|89|||
170701317|NCT00262067|616918624|FG002|Overall Study|Death|186|||
170701318|NCT00262067|616918625|FG003|Overall Study|Death|99|||
170701319|NCT00262067|616918622|FG000|Overall Study|Lost to Follow-up|5|||
170701320|NCT00262067|616918623|FG001|Overall Study|Lost to Follow-up|4|||
170701321|NCT00262067|616918624|FG002|Overall Study|Lost to Follow-up|7|||
170701322|NCT00262067|616918625|FG003|Overall Study|Lost to Follow-up|5|||
170701323|NCT00262067|616918622|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
170701324|NCT00262067|616918623|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
170701325|NCT00262067|616918624|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
170701326|NCT00262067|616918625|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
170701327|NCT00262067|616918622|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
170701328|NCT00262067|616918623|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
170701329|NCT00262067|616918624|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
170701330|NCT00262067|616918625|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
170701331|NCT03829046|616918626|FG000|Overall Study|Withdrawal by Subject|1|||
170701332|NCT03829046|616918627|FG001|Overall Study|Withdrawal by Subject|0|||
170701333|NCT00344773|616918629|FG000|Overall Study|Adverse Event|2|||
170701334|NCT00344773|616918629|FG000|Overall Study|Objective Disease Progression|16|||
170701335|NCT00344773|616918629|FG000|Overall Study|Withdrawal by Subject|1|||
170701336|NCT00344773|616918629|FG000|Overall Study|Not Eligible for the study|2|||
170701337|NCT00714259|616918631|FG000|Overall Study|Death|2|||
170701338|NCT05627518|616918633|FG000|Treatment Period 1|Adverse Event|0|||
170701339|NCT05627518|616918634|FG001|Treatment Period 1|Adverse Event|0|||
170701340|NCT05627518|616918635|FG002|Treatment Period 1|Adverse Event|1|||
170701341|NCT05627518|616918636|FG003|Treatment Period 1|Adverse Event|0|||
170701342|NCT05627518|616918637|FG004|Treatment Period 1|Adverse Event|0|||
170701343|NCT05627518|616918638|FG005|Treatment Period 1|Adverse Event|0|||
170701344|NCT05627518|616918639|FG006|Treatment Period 1|Adverse Event|0|||
170701345|NCT05627518|616918640|FG007|Treatment Period 1|Adverse Event|1|||
170701346|NCT05627518|616918633|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170701347|NCT05627518|616918634|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170701348|NCT05627518|616918635|FG002|Treatment Period 1|Withdrawal by Subject|1|||
170701349|NCT05627518|616918636|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170701350|NCT05627518|616918637|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170701351|NCT05627518|616918638|FG005|Treatment Period 1|Withdrawal by Subject|1|||
170701352|NCT05627518|616918639|FG006|Treatment Period 1|Withdrawal by Subject|0|||
170701353|NCT05627518|616918640|FG007|Treatment Period 1|Withdrawal by Subject|0|||
170701354|NCT05627518|616918633|FG000|Treatment Period 1|Protocol Violation|0|||
170701355|NCT05627518|616918634|FG001|Treatment Period 1|Protocol Violation|0|||
170701356|NCT05627518|616918635|FG002|Treatment Period 1|Protocol Violation|0|||
170701357|NCT05627518|616918636|FG003|Treatment Period 1|Protocol Violation|0|||
170701358|NCT05627518|616918637|FG004|Treatment Period 1|Protocol Violation|0|||
170701359|NCT05627518|616918638|FG005|Treatment Period 1|Protocol Violation|0|||
170701360|NCT05627518|616918639|FG006|Treatment Period 1|Protocol Violation|6|||
170701361|NCT05627518|616918640|FG007|Treatment Period 1|Protocol Violation|6|||
170701362|NCT05627518|616918633|FG000|Treatment Period 2|Adverse Event|1|||
170701363|NCT05627518|616918634|FG001|Treatment Period 2|Adverse Event|0|||
170824839|NCT01231464|617367855|FG000|Overall Study|Withdrawal by Subject|3|||
170824840|NCT01231464|617367856|FG001|Overall Study|Withdrawal by Subject|2|||
170824841|NCT03449134|617367857|FG000|52-Week Treatment Period|Death|2|||
170824842|NCT03449134|617367858|FG001|52-Week Treatment Period|Death|1|||
170824843|NCT03449134|617367859|FG002|52-Week Treatment Period|Death|0|||
170824844|NCT03449134|617367857|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
170824845|NCT03449134|617367858|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
170824846|NCT03449134|617367859|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
170824847|NCT03449134|617367857|FG000|52-Week Treatment Period|Physician Decision|2|||
170824848|NCT03449134|617367858|FG001|52-Week Treatment Period|Physician Decision|3|||
170824849|NCT03449134|617367859|FG002|52-Week Treatment Period|Physician Decision|3|||
170824850|NCT03449134|617367857|FG000|52-Week Treatment Period|Screen Failure|1|||
170824851|NCT03449134|617367858|FG001|52-Week Treatment Period|Screen Failure|0|||
170824852|NCT03449134|617367859|FG002|52-Week Treatment Period|Screen Failure|1|||
170824853|NCT03449134|617367857|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
170824854|NCT03449134|617367858|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
170824855|NCT03449134|617367859|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
170824856|NCT03449134|617367857|FG000|52-Week Treatment Period|Site Closure|1|||
170824857|NCT03449134|617367858|FG001|52-Week Treatment Period|Site Closure|0|||
170824858|NCT03449134|617367859|FG002|52-Week Treatment Period|Site Closure|0|||
170824859|NCT03475056|617367860|FG000|Overall Study|Lost to Follow-up|0|||
170824860|NCT03475056|617367861|FG001|Overall Study|Lost to Follow-up|1|||
170824861|NCT03475056|617367860|FG000|Overall Study|Moved from Area|0|||
170824862|NCT03475056|617367861|FG001|Overall Study|Moved from Area|2|||
170824863|NCT00113269|617367864|FG000|Overall Study|Not transplanted, donor issues|4|||
170824864|NCT00113269|617367865|FG001|Overall Study|Not transplanted, donor issues|0|||
170824865|NCT00113269|617367866|FG002|Overall Study|Not transplanted, donor issues|2|||
170824866|NCT00113269|617367867|FG003|Overall Study|Not transplanted, donor issues|2|||
170824867|NCT00113269|617367864|FG000|Overall Study|Not transplanted, recipient issues|2|||
170701364|NCT05627518|616918635|FG002|Treatment Period 2|Adverse Event|0|||
170701365|NCT05627518|616918636|FG003|Treatment Period 2|Adverse Event|0|||
170701366|NCT05627518|616918637|FG004|Treatment Period 2|Adverse Event|0|||
170701367|NCT05627518|616918638|FG005|Treatment Period 2|Adverse Event|0|||
170701368|NCT05627518|616918639|FG006|Treatment Period 2|Adverse Event|0|||
170701369|NCT05627518|616918640|FG007|Treatment Period 2|Adverse Event|0|||
170701370|NCT05627518|616918633|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170701371|NCT05627518|616918634|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170701372|NCT05627518|616918635|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170701373|NCT05627518|616918636|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170701374|NCT05627518|616918637|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170701375|NCT05627518|616918638|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170701376|NCT05627518|616918639|FG006|Treatment Period 2|Withdrawal by Subject|0|||
170701377|NCT05627518|616918640|FG007|Treatment Period 2|Withdrawal by Subject|0|||
170701378|NCT01589822|616920593|FG000|Overall Study|Withdrawal by Subject|1|||
170701379|NCT01589822|616920594|FG001|Overall Study|Withdrawal by Subject|2|||
170701380|NCT01589822|616920595|FG002|Overall Study|Withdrawal by Subject|0|||
170701381|NCT01589822|616920593|FG000|Overall Study|Death|1|||
170701382|NCT01589822|616920594|FG001|Overall Study|Death|0|||
170701383|NCT01589822|616920595|FG002|Overall Study|Death|0|||
170701384|NCT01589822|616920593|FG000|Overall Study|Missed 90 day visit|2|||
170701385|NCT01589822|616920594|FG001|Overall Study|Missed 90 day visit|1|||
170701386|NCT01589822|616920595|FG002|Overall Study|Missed 90 day visit|1|||
170701387|NCT00749775|616920598|FG000|Overall Study|Protocol Violation|24|||
170701388|NCT00749775|616920598|FG000|Overall Study|Lost to Follow-up|36|||
170701389|NCT00749775|616920598|FG000|Overall Study|No visit after first day of treatment|44|||
170701390|NCT00749775|616920598|FG000|Overall Study|No drug administration|3|||
170701391|NCT00519649|616920603|FG000|Overall Study|Withdrawal by Subject|1|||
170701392|NCT02953821|616920604|FG000|Overall Study|Adverse Event|0|||
170701393|NCT02953821|616920605|FG001|Overall Study|Adverse Event|4|||
170701394|NCT02953821|616920604|FG000|Overall Study|Death|1|||
170701395|NCT02953821|616920605|FG001|Overall Study|Death|0|||
170701396|NCT02953821|616920604|FG000|Overall Study|Progressive Disease|5|||
170701397|NCT02953821|616920605|FG001|Overall Study|Progressive Disease|1|||
170701398|NCT02953821|616920604|FG000|Overall Study|Lost to Follow-up|2|||
170701399|NCT02953821|616920605|FG001|Overall Study|Lost to Follow-up|0|||
170701400|NCT02953821|616920604|FG000|Overall Study|Physician Decision|1|||
170701401|NCT02953821|616920605|FG001|Overall Study|Physician Decision|1|||
170701402|NCT02953821|616920604|FG000|Overall Study|Withdrawal by Subject|3|||
170701403|NCT02953821|616920605|FG001|Overall Study|Withdrawal by Subject|3|||
170701404|NCT02953821|616920604|FG000|Overall Study|Change of address|0|||
170824868|NCT00113269|617367865|FG001|Overall Study|Not transplanted, recipient issues|1|||
170824869|NCT00113269|617367866|FG002|Overall Study|Not transplanted, recipient issues|7|||
170824870|NCT00113269|617367867|FG003|Overall Study|Not transplanted, recipient issues|4|||
170824871|NCT00113269|617367864|FG000|Overall Study|Early graft loss, technical|0|||
170701405|NCT02953821|616920605|FG001|Overall Study|Change of address|1|||
170701406|NCT02953821|616920604|FG000|Overall Study|Lack of Efficacy|1|||
170701407|NCT02953821|616920605|FG001|Overall Study|Lack of Efficacy|0|||
170701408|NCT02953821|616920604|FG000|Overall Study|Out of state for indeterminate time|0|||
170701409|NCT02953821|616920605|FG001|Overall Study|Out of state for indeterminate time|1|||
170701410|NCT02953821|616920604|FG000|Overall Study|No improvement|0|||
170701411|NCT02953821|616920605|FG001|Overall Study|No improvement|1|||
170701412|NCT02953821|616920604|FG000|Overall Study|Refused follow-up visit|2|||
170701413|NCT02953821|616920605|FG001|Overall Study|Refused follow-up visit|1|||
170701414|NCT01096784|616920606|FG000|Overall Study|Withdrawal by Subject|2|||
170701415|NCT01096784|616920607|FG001|Overall Study|Withdrawal by Subject|1|||
170701416|NCT01096784|616920606|FG000|Overall Study|Adverse Event|11|||
170701417|NCT01096784|616920607|FG001|Overall Study|Adverse Event|9|||
170701418|NCT01096784|616920606|FG000|Overall Study|Protocol Deviation|2|||
170701419|NCT01096784|616920607|FG001|Overall Study|Protocol Deviation|2|||
170701420|NCT01096784|616920606|FG000|Overall Study|Administrative Decision|0|||
170701421|NCT01096784|616920607|FG001|Overall Study|Administrative Decision|1|||
170701422|NCT01096784|616920606|FG000|Overall Study|Other Unspecified|0|||
170701423|NCT01096784|616920607|FG001|Overall Study|Other Unspecified|1|||
170701424|NCT03761628|616920608|FG000|Overall Study|Withdrawal by Subject|3|||
170701425|NCT03761628|616920608|FG000|Overall Study|Physician Decision|1|||
170701426|NCT03761628|616920608|FG000|Overall Study|Pregnancy|1|||
170701427|NCT03761628|616920608|FG000|Overall Study|Lost to Follow-up|1|||
170701428|NCT01470469|616920611|FG000|Overall Study|Withdrawal by Subject|4|||
170701429|NCT01470469|616920612|FG001|Overall Study|Withdrawal by Subject|6|||
170701430|NCT01470469|616920611|FG000|Overall Study|Lack of Efficacy|1|||
170701431|NCT01470469|616920612|FG001|Overall Study|Lack of Efficacy|7|||
170701432|NCT01470469|616920611|FG000|Overall Study|Adverse Event|0|||
170701433|NCT01470469|616920612|FG001|Overall Study|Adverse Event|7|||
170701434|NCT01470469|616920611|FG000|Overall Study|Lost to Follow-up|2|||
170701435|NCT01470469|616920612|FG001|Overall Study|Lost to Follow-up|2|||
170701436|NCT01470469|616920611|FG000|Overall Study|Protocol Violation|1|||
170701437|NCT01470469|616920612|FG001|Overall Study|Protocol Violation|1|||
170701438|NCT01470469|616920611|FG000|Overall Study|Other|2|||
170701439|NCT01470469|616920612|FG001|Overall Study|Other|1|||
170701440|NCT05459129|616920613|FG000|Overall Study|Death|1|||
170701441|NCT05459129|616920614|FG001|Overall Study|Death|0|||
170701442|NCT05459129|616920613|FG000|Overall Study|Study Terminated By Sponsor|5|||
170701443|NCT05459129|616920614|FG001|Overall Study|Study Terminated By Sponsor|6|||
170701444|NCT03362502|616920626|FG000|Overall Study|Death|0|||
170701445|NCT03362502|616920627|FG001|Overall Study|Death|0|||
170701446|NCT03362502|616920628|FG002|Overall Study|Death|1|||
170701447|NCT04033159|616920637|FG000|Washout Period|Physician Decision|0|||
170701448|NCT04033159|616920638|FG001|Washout Period|Physician Decision|1|||
170701449|NCT04033159|616920639|FG002|Washout Period|Physician Decision|0|||
170701450|NCT04033159|616920637|FG000|Washout Period|Study terminated by Sponsor|0|||
170701451|NCT04033159|616920638|FG001|Washout Period|Study terminated by Sponsor|7|||
170701452|NCT04033159|616920639|FG002|Washout Period|Study terminated by Sponsor|0|||
170701453|NCT04033159|616920637|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
170701454|NCT04033159|616920638|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
170701455|NCT04033159|616920639|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
170701456|NCT02027844|616920642|FG000|Overall Study|Withdrawal by Subject|3|||
170701457|NCT02027844|616920643|FG001|Overall Study|Withdrawal by Subject|2|||
170701458|NCT02027844|616920644|FG002|Overall Study|Withdrawal by Subject|1|||
170701459|NCT02027844|616920642|FG000|Overall Study|Lost to Follow-up|0|||
170701460|NCT02027844|616920643|FG001|Overall Study|Lost to Follow-up|2|||
170701461|NCT02027844|616920644|FG002|Overall Study|Lost to Follow-up|1|||
170701462|NCT02027844|616920642|FG000|Overall Study|Protocol Violation|0|||
170701463|NCT02027844|616920643|FG001|Overall Study|Protocol Violation|2|||
170701464|NCT02027844|616920644|FG002|Overall Study|Protocol Violation|0|||
170701465|NCT02027844|616920642|FG000|Overall Study|Incomlete data|2|||
170701466|NCT02027844|616920643|FG001|Overall Study|Incomlete data|0|||
170701467|NCT02027844|616920644|FG002|Overall Study|Incomlete data|0|||
170701468|NCT00378014|616920645|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
170701469|NCT00378014|616920646|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
170701470|NCT00378014|616920645|FG000|Core (Randomization to Month 11)|Graft loss|1|||
170701471|NCT00378014|616920646|FG001|Core (Randomization to Month 11)|Graft loss|2|||
170701472|NCT00378014|616920645|FG000|Core (Randomization to Month 11)|Death|5|||
170701473|NCT00378014|616920646|FG001|Core (Randomization to Month 11)|Death|3|||
170701474|NCT00378014|616920645|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
170701475|NCT00378014|616920646|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
170701476|NCT00378014|616920645|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
170701477|NCT00378014|616920646|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
170701478|NCT00378014|616920645|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
170701479|NCT00378014|616920646|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
170701480|NCT00378014|616920645|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
170701481|NCT00378014|616920646|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
170701482|NCT00378014|616920645|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
170701483|NCT00378014|616920646|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
170701484|NCT00378014|616920645|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
170701485|NCT00378014|616920646|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
170701486|NCT00378014|616920645|FG000|Extension (Month 12 to Month 59)|Death|1|||
170701487|NCT00378014|616920646|FG001|Extension (Month 12 to Month 59)|Death|2|||
170701488|NCT00378014|616920645|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
170701489|NCT00378014|616920646|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
170701490|NCT00378014|616920645|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
170701491|NCT00378014|616920646|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
170701492|NCT00378014|616920645|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
170701493|NCT00378014|616920646|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
170701494|NCT00378014|616920645|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
170701495|NCT00378014|616920646|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
170701496|NCT00414661|616920647|FG000|Overall Study|Death|2|||
170701497|NCT00414661|616920648|FG001|Overall Study|Death|5|||
170701498|NCT00414661|616920649|FG002|Overall Study|Death|0|||
170701499|NCT00414661|616920650|FG003|Overall Study|Death|0|||
170701500|NCT00414661|616920647|FG000|Overall Study|Lost to Follow-up|1|||
170701501|NCT00414661|616920648|FG001|Overall Study|Lost to Follow-up|4|||
170701502|NCT00414661|616920649|FG002|Overall Study|Lost to Follow-up|0|||
170701503|NCT00414661|616920650|FG003|Overall Study|Lost to Follow-up|1|||
170701504|NCT00414661|616920647|FG000|Overall Study|Withdrawal by Subject|5|||
170701505|NCT00414661|616920648|FG001|Overall Study|Withdrawal by Subject|2|||
170701506|NCT00414661|616920649|FG002|Overall Study|Withdrawal by Subject|2|||
170701507|NCT00414661|616920650|FG003|Overall Study|Withdrawal by Subject|2|||
170701508|NCT00414661|616920647|FG000|Overall Study|Other|6|||
170701509|NCT00414661|616920648|FG001|Overall Study|Other|3|||
170701510|NCT00414661|616920649|FG002|Overall Study|Other|0|||
170701511|NCT00414661|616920650|FG003|Overall Study|Other|0|||
170701512|NCT00559962|616920666|FG000|Overall Study|Adverse Event|1|||
170701513|NCT00559962|616920667|FG001|Overall Study|Adverse Event|7|||
170701514|NCT00559962|616920668|FG002|Overall Study|Adverse Event|8|||
170701515|NCT00559962|616920669|FG003|Overall Study|Adverse Event|5|||
170701516|NCT00559962|616920670|FG004|Overall Study|Adverse Event|11|||
170701517|NCT00559962|616920671|FG005|Overall Study|Adverse Event|4|||
170701518|NCT00559962|616920672|FG006|Overall Study|Adverse Event|4|||
170701519|NCT00559962|616920673|FG007|Overall Study|Adverse Event|2|||
170701520|NCT00559962|616920666|FG000|Overall Study|Lost to Follow-up|0|||
170701521|NCT00559962|616920667|FG001|Overall Study|Lost to Follow-up|1|||
170701522|NCT00559962|616920668|FG002|Overall Study|Lost to Follow-up|0|||
170701523|NCT00559962|616920669|FG003|Overall Study|Lost to Follow-up|0|||
170701524|NCT00559962|616920670|FG004|Overall Study|Lost to Follow-up|0|||
170701525|NCT00559962|616920671|FG005|Overall Study|Lost to Follow-up|0|||
170701526|NCT00559962|616920672|FG006|Overall Study|Lost to Follow-up|0|||
170701527|NCT00559962|616920673|FG007|Overall Study|Lost to Follow-up|0|||
170701528|NCT00559962|616920666|FG000|Overall Study|Withdrawal by Subject|1|||
170701529|NCT00559962|616920667|FG001|Overall Study|Withdrawal by Subject|1|||
170701530|NCT00559962|616920668|FG002|Overall Study|Withdrawal by Subject|2|||
170701531|NCT00559962|616920669|FG003|Overall Study|Withdrawal by Subject|0|||
170701532|NCT00559962|616920670|FG004|Overall Study|Withdrawal by Subject|3|||
170701533|NCT00559962|616920671|FG005|Overall Study|Withdrawal by Subject|1|||
170701534|NCT00559962|616920672|FG006|Overall Study|Withdrawal by Subject|0|||
170701535|NCT00559962|616920673|FG007|Overall Study|Withdrawal by Subject|2|||
170701536|NCT00559962|616920666|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
170701537|NCT00559962|616920667|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
170701538|NCT00559962|616920668|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
170701539|NCT00559962|616920669|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
170701540|NCT00559962|616920670|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
170701541|NCT00559962|616920671|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
170701542|NCT00559962|616920672|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
170701543|NCT00559962|616920673|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
170701544|NCT01639040|616920674|FG000|Overall Study|Adverse Event|1|||
170701545|NCT01639040|616920675|FG001|Overall Study|Adverse Event|0|||
170701546|NCT04370691|616920676|FG000|Overall Study|Pending visit|48|||
170701547|NCT04370691|616920676|FG000|Overall Study|Have Not Reached Lower Window|15|||
170701548|NCT04370691|616920676|FG000|Overall Study|Termination|14|||
170701549|NCT04370691|616920676|FG000|Overall Study|Missed or Overdue|10|||
170701550|NCT01452412|616920680|FG000|Overall Study|Withdrawal by Subject|15|||
170701551|NCT01452412|616920681|FG001|Overall Study|Withdrawal by Subject|11|||
170701552|NCT01452412|616920680|FG000|Overall Study|Adverse Event|4|||
170701553|NCT01452412|616920681|FG001|Overall Study|Adverse Event|3|||
170701554|NCT01452412|616920680|FG000|Overall Study|Lost to Follow-up|5|||
170701555|NCT01452412|616920681|FG001|Overall Study|Lost to Follow-up|3|||
170701556|NCT01452412|616920680|FG000|Overall Study|Death|1|||
170701557|NCT01452412|616920681|FG001|Overall Study|Death|0|||
170701558|NCT01452412|616920680|FG000|Overall Study|Initiated dialysis|1|||
170701559|NCT01452412|616920681|FG001|Overall Study|Initiated dialysis|0|||
170701560|NCT01452412|616920680|FG000|Overall Study|Other|2|||
170701561|NCT01452412|616920681|FG001|Overall Study|Other|0|||
170701562|NCT02346136|616920682|FG000|Overall Study|Withdrawal by Subject|7|||
170701563|NCT02346136|616920683|FG001|Overall Study|Withdrawal by Subject|5|||
170701564|NCT02346136|616920682|FG000|Overall Study|Death|1|||
170701565|NCT02346136|616920683|FG001|Overall Study|Death|0|||
170701566|NCT02346136|616920682|FG000|Overall Study|Study termination|14|||
170701567|NCT02346136|616920683|FG001|Overall Study|Study termination|18|||
170701568|NCT03047135|616920684|FG000|Overall Study|Still being treated|3|||
170701569|NCT03013543|616920685|FG000|Overall Study|Withdrawal by Subject|0|||
170701570|NCT03013543|616920686|FG001|Overall Study|Withdrawal by Subject|2|||
170701571|NCT03013543|616920687|FG002|Overall Study|Withdrawal by Subject|0|||
170701572|NCT03013543|616920688|FG003|Overall Study|Withdrawal by Subject|5|||
170701573|NCT03013543|616920689|FG004|Overall Study|Withdrawal by Subject|6|||
170701574|NCT03013543|616920690|FG005|Overall Study|Withdrawal by Subject|2|||
170701575|NCT03013543|616920691|FG006|Overall Study|Withdrawal by Subject|3|||
170701576|NCT03013543|616920692|FG007|Overall Study|Withdrawal by Subject|1|||
170701577|NCT03013543|616920693|FG008|Overall Study|Withdrawal by Subject|0|||
170701578|NCT03013543|616920694|FG009|Overall Study|Withdrawal by Subject|4|||
170701579|NCT03013543|616920685|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
170701580|NCT03013543|616920686|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
170701581|NCT03013543|616920687|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
170701582|NCT03013543|616920688|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
170701583|NCT03013543|616920689|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
170701584|NCT03013543|616920690|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
170701585|NCT03013543|616920691|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
170701586|NCT03013543|616920692|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
170701587|NCT03013543|616920693|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
170701588|NCT03013543|616920694|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
170701589|NCT03013543|616920685|FG000|Overall Study|Other|0|||
170701590|NCT03013543|616920686|FG001|Overall Study|Other|0|||
170701591|NCT03013543|616920687|FG002|Overall Study|Other|2|||
170701592|NCT03013543|616920688|FG003|Overall Study|Other|0|||
170701593|NCT03013543|616920689|FG004|Overall Study|Other|2|||
170701594|NCT03013543|616920690|FG005|Overall Study|Other|0|||
170701595|NCT03013543|616920691|FG006|Overall Study|Other|0|||
170701596|NCT03013543|616920692|FG007|Overall Study|Other|0|||
170701597|NCT03013543|616920693|FG008|Overall Study|Other|1|||
170701598|NCT03013543|616920694|FG009|Overall Study|Other|0|||
170701599|NCT03013543|616920685|FG000|Overall Study|Adverse Event|0|||
170701600|NCT03013543|616920686|FG001|Overall Study|Adverse Event|0|||
170701601|NCT03013543|616920687|FG002|Overall Study|Adverse Event|0|||
170701602|NCT03013543|616920688|FG003|Overall Study|Adverse Event|3|||
170701603|NCT03013543|616920689|FG004|Overall Study|Adverse Event|2|||
170701604|NCT03013543|616920690|FG005|Overall Study|Adverse Event|1|||
170701605|NCT03013543|616920691|FG006|Overall Study|Adverse Event|3|||
170701606|NCT03013543|616920692|FG007|Overall Study|Adverse Event|8|||
170701607|NCT03013543|616920693|FG008|Overall Study|Adverse Event|0|||
170701608|NCT03013543|616920694|FG009|Overall Study|Adverse Event|2|||
170701609|NCT03013543|616920685|FG000|Overall Study|Death|0|||
170701610|NCT03013543|616920686|FG001|Overall Study|Death|0|||
170701611|NCT03013543|616920687|FG002|Overall Study|Death|0|||
170701612|NCT03013543|616920688|FG003|Overall Study|Death|1|||
170701613|NCT03013543|616920689|FG004|Overall Study|Death|0|||
170701614|NCT03013543|616920690|FG005|Overall Study|Death|0|||
170701615|NCT03013543|616920691|FG006|Overall Study|Death|0|||
170701616|NCT03013543|616920692|FG007|Overall Study|Death|0|||
170701617|NCT03013543|616920693|FG008|Overall Study|Death|0|||
170701618|NCT03013543|616920694|FG009|Overall Study|Death|0|||
170701619|NCT03013543|616920685|FG000|Overall Study|Lack of Efficacy|0|||
170701620|NCT03013543|616920686|FG001|Overall Study|Lack of Efficacy|0|||
170701621|NCT03013543|616920687|FG002|Overall Study|Lack of Efficacy|0|||
170701622|NCT03013543|616920688|FG003|Overall Study|Lack of Efficacy|1|||
170701623|NCT03013543|616920689|FG004|Overall Study|Lack of Efficacy|0|||
170701624|NCT03013543|616920690|FG005|Overall Study|Lack of Efficacy|0|||
170701625|NCT03013543|616920691|FG006|Overall Study|Lack of Efficacy|0|||
170701626|NCT03013543|616920692|FG007|Overall Study|Lack of Efficacy|0|||
170701627|NCT03013543|616920693|FG008|Overall Study|Lack of Efficacy|0|||
170701628|NCT03013543|616920694|FG009|Overall Study|Lack of Efficacy|0|||
170701629|NCT03013543|616920685|FG000|Overall Study|Lost to Follow-up|0|||
170701630|NCT03013543|616920686|FG001|Overall Study|Lost to Follow-up|0|||
170701631|NCT03013543|616920687|FG002|Overall Study|Lost to Follow-up|0|||
170701632|NCT03013543|616920688|FG003|Overall Study|Lost to Follow-up|1|||
170701633|NCT03013543|616920689|FG004|Overall Study|Lost to Follow-up|0|||
170701634|NCT03013543|616920690|FG005|Overall Study|Lost to Follow-up|0|||
170701635|NCT03013543|616920691|FG006|Overall Study|Lost to Follow-up|1|||
170701636|NCT03013543|616920692|FG007|Overall Study|Lost to Follow-up|0|||
170701637|NCT03013543|616920693|FG008|Overall Study|Lost to Follow-up|0|||
170701638|NCT03013543|616920694|FG009|Overall Study|Lost to Follow-up|2|||
170701639|NCT03013543|616920685|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170701640|NCT03013543|616920686|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170701641|NCT03013543|616920687|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170701642|NCT03013543|616920688|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170701643|NCT03013543|616920689|FG004|Overall Study|Non-Compliance With Study Drug|0|||
170701644|NCT03013543|616920690|FG005|Overall Study|Non-Compliance With Study Drug|0|||
170701645|NCT03013543|616920691|FG006|Overall Study|Non-Compliance With Study Drug|0|||
170701646|NCT03013543|616920692|FG007|Overall Study|Non-Compliance With Study Drug|0|||
170701647|NCT03013543|616920693|FG008|Overall Study|Non-Compliance With Study Drug|1|||
170701648|NCT03013543|616920694|FG009|Overall Study|Non-Compliance With Study Drug|0|||
170701649|NCT03013543|616920685|FG000|Overall Study|Physician Decision|0|||
170701650|NCT03013543|616920686|FG001|Overall Study|Physician Decision|0|||
170701651|NCT03013543|616920687|FG002|Overall Study|Physician Decision|0|||
170701652|NCT03013543|616920688|FG003|Overall Study|Physician Decision|0|||
170701653|NCT03013543|616920689|FG004|Overall Study|Physician Decision|1|||
170701654|NCT03013543|616920690|FG005|Overall Study|Physician Decision|0|||
170701655|NCT03013543|616920691|FG006|Overall Study|Physician Decision|0|||
170701656|NCT03013543|616920692|FG007|Overall Study|Physician Decision|0|||
170701657|NCT03013543|616920693|FG008|Overall Study|Physician Decision|0|||
170701658|NCT03013543|616920694|FG009|Overall Study|Physician Decision|0|||
170701659|NCT03013543|616920685|FG000|Overall Study|Protocol Violation|0|||
170701660|NCT03013543|616920686|FG001|Overall Study|Protocol Violation|0|||
170701661|NCT03013543|616920687|FG002|Overall Study|Protocol Violation|0|||
170701662|NCT03013543|616920688|FG003|Overall Study|Protocol Violation|0|||
170701663|NCT03013543|616920689|FG004|Overall Study|Protocol Violation|0|||
170701664|NCT03013543|616920690|FG005|Overall Study|Protocol Violation|0|||
170701665|NCT03013543|616920691|FG006|Overall Study|Protocol Violation|0|||
170701666|NCT03013543|616920692|FG007|Overall Study|Protocol Violation|0|||
170701667|NCT03013543|616920693|FG008|Overall Study|Protocol Violation|0|||
170701668|NCT03013543|616920694|FG009|Overall Study|Protocol Violation|1|||
170701669|NCT03029624|616920695|FG000|Overall Study|Adverse Event|1|||
170701670|NCT03029624|616920695|FG000|Overall Study|Withdrawal by Subject|1|||
170701671|NCT03029624|616920695|FG000|Overall Study|Lack of Efficacy|1|||
170701672|NCT03029624|616920695|FG000|Overall Study|MRI need|2|||
170701673|NCT05619692|616920698|FG000|Overall Study|Adverse Event|2|||
170701674|NCT05619692|616920699|FG001|Overall Study|Adverse Event|2|||
170701675|NCT05619692|616920698|FG000|Overall Study|Withdrawal by Participant|3|||
170701676|NCT05619692|616920699|FG001|Overall Study|Withdrawal by Participant|4|||
170701677|NCT05619692|616920698|FG000|Overall Study|Lost to Follow-up|2|||
170701678|NCT05619692|616920699|FG001|Overall Study|Lost to Follow-up|1|||
170701679|NCT05619692|616920698|FG000|Overall Study|Randomized but not treated|1|||
170701680|NCT05619692|616920699|FG001|Overall Study|Randomized but not treated|3|||
170701681|NCT02457598|616920700|FG000|Overall Study|Progressive Disease|2|||
170701682|NCT02457598|616920701|FG001|Overall Study|Progressive Disease|2|||
170701683|NCT02457598|616920702|FG002|Overall Study|Progressive Disease|1|||
170701684|NCT02457598|616920703|FG003|Overall Study|Progressive Disease|11|||
170701685|NCT02457598|616920704|FG004|Overall Study|Progressive Disease|7|||
170701686|NCT02457598|616920705|FG005|Overall Study|Progressive Disease|3|||
170701687|NCT02457598|616920706|FG006|Overall Study|Progressive Disease|2|||
170701688|NCT02457598|616920707|FG007|Overall Study|Progressive Disease|1|||
170701689|NCT02457598|616920708|FG008|Overall Study|Progressive Disease|1|||
170701690|NCT02457598|616920709|FG009|Overall Study|Progressive Disease|2|||
170701691|NCT02457598|616920710|FG010|Overall Study|Progressive Disease|45|||
170701692|NCT02457598|616920711|FG011|Overall Study|Progressive Disease|6|||
170701693|NCT02457598|616920712|FG012|Overall Study|Progressive Disease|2|||
170701694|NCT02457598|616920713|FG013|Overall Study|Progressive Disease|2|||
170701695|NCT02457598|616920714|FG014|Overall Study|Progressive Disease|10|||
170701696|NCT02457598|616920715|FG015|Overall Study|Progressive Disease|1|||
170701697|NCT02457598|616920716|FG016|Overall Study|Progressive Disease|1|||
170701698|NCT02457598|616920700|FG000|Overall Study|Investigator's Discretion|0|||
170701699|NCT02457598|616920701|FG001|Overall Study|Investigator's Discretion|2|||
170701700|NCT02457598|616920702|FG002|Overall Study|Investigator's Discretion|2|||
170701701|NCT02457598|616920703|FG003|Overall Study|Investigator's Discretion|2|||
170701702|NCT02457598|616920704|FG004|Overall Study|Investigator's Discretion|0|||
170701703|NCT02457598|616920705|FG005|Overall Study|Investigator's Discretion|0|||
170701704|NCT02457598|616920706|FG006|Overall Study|Investigator's Discretion|0|||
170701705|NCT02457598|616920707|FG007|Overall Study|Investigator's Discretion|1|||
170701706|NCT02457598|616920708|FG008|Overall Study|Investigator's Discretion|2|||
170701707|NCT02457598|616920709|FG009|Overall Study|Investigator's Discretion|0|||
170701708|NCT02457598|616920710|FG010|Overall Study|Investigator's Discretion|10|||
170701709|NCT02457598|616920711|FG011|Overall Study|Investigator's Discretion|2|||
170701710|NCT02457598|616920712|FG012|Overall Study|Investigator's Discretion|2|||
170701711|NCT02457598|616920713|FG013|Overall Study|Investigator's Discretion|1|||
170701712|NCT02457598|616920714|FG014|Overall Study|Investigator's Discretion|5|||
170701713|NCT02457598|616920715|FG015|Overall Study|Investigator's Discretion|0|||
170701714|NCT02457598|616920716|FG016|Overall Study|Investigator's Discretion|0|||
170701715|NCT02457598|616920700|FG000|Overall Study|Study Terminated by Sponsor|0|||
170701716|NCT02457598|616920701|FG001|Overall Study|Study Terminated by Sponsor|1|||
170701717|NCT02457598|616920702|FG002|Overall Study|Study Terminated by Sponsor|0|||
170701718|NCT02457598|616920703|FG003|Overall Study|Study Terminated by Sponsor|4|||
170701719|NCT02457598|616920704|FG004|Overall Study|Study Terminated by Sponsor|1|||
170701720|NCT02457598|616920705|FG005|Overall Study|Study Terminated by Sponsor|0|||
170701721|NCT02457598|616920706|FG006|Overall Study|Study Terminated by Sponsor|1|||
170701722|NCT02457598|616920707|FG007|Overall Study|Study Terminated by Sponsor|0|||
170701723|NCT02457598|616920708|FG008|Overall Study|Study Terminated by Sponsor|0|||
170701724|NCT02457598|616920709|FG009|Overall Study|Study Terminated by Sponsor|0|||
170701725|NCT02457598|616920710|FG010|Overall Study|Study Terminated by Sponsor|4|||
170701726|NCT02457598|616920711|FG011|Overall Study|Study Terminated by Sponsor|0|||
170701727|NCT02457598|616920712|FG012|Overall Study|Study Terminated by Sponsor|1|||
170701728|NCT02457598|616920713|FG013|Overall Study|Study Terminated by Sponsor|0|||
170701729|NCT02457598|616920714|FG014|Overall Study|Study Terminated by Sponsor|8|||
170701730|NCT02457598|616920715|FG015|Overall Study|Study Terminated by Sponsor|1|||
170701731|NCT02457598|616920716|FG016|Overall Study|Study Terminated by Sponsor|0|||
170701732|NCT02457598|616920700|FG000|Overall Study|Adverse Event|0|||
170701733|NCT02457598|616920701|FG001|Overall Study|Adverse Event|1|||
170701734|NCT02457598|616920702|FG002|Overall Study|Adverse Event|1|||
170701735|NCT02457598|616920703|FG003|Overall Study|Adverse Event|4|||
170701736|NCT02457598|616920704|FG004|Overall Study|Adverse Event|1|||
170701737|NCT02457598|616920705|FG005|Overall Study|Adverse Event|0|||
170701738|NCT02457598|616920706|FG006|Overall Study|Adverse Event|0|||
170701739|NCT02457598|616920707|FG007|Overall Study|Adverse Event|1|||
170701740|NCT02457598|616920708|FG008|Overall Study|Adverse Event|0|||
170701741|NCT02457598|616920709|FG009|Overall Study|Adverse Event|1|||
170701742|NCT02457598|616920710|FG010|Overall Study|Adverse Event|6|||
170701743|NCT02457598|616920711|FG011|Overall Study|Adverse Event|0|||
170824872|NCT00113269|617367865|FG001|Overall Study|Early graft loss, technical|0|||
170824873|NCT00113269|617367866|FG002|Overall Study|Early graft loss, technical|2|||
170824874|NCT00113269|617367867|FG003|Overall Study|Early graft loss, technical|0|||
170824875|NCT00113269|617367864|FG000|Overall Study|Death in operating room|0|||
170701744|NCT02457598|616920712|FG012|Overall Study|Adverse Event|0|||
170701745|NCT02457598|616920713|FG013|Overall Study|Adverse Event|1|||
170701746|NCT02457598|616920714|FG014|Overall Study|Adverse Event|2|||
170701747|NCT02457598|616920715|FG015|Overall Study|Adverse Event|0|||
170824876|NCT00113269|617367865|FG001|Overall Study|Death in operating room|0|||
170701748|NCT02457598|616920716|FG016|Overall Study|Adverse Event|0|||
170701749|NCT02457598|616920700|FG000|Overall Study|Death|0|||
170701750|NCT02457598|616920701|FG001|Overall Study|Death|0|||
170701751|NCT02457598|616920702|FG002|Overall Study|Death|0|||
170701752|NCT02457598|616920703|FG003|Overall Study|Death|3|||
170701753|NCT02457598|616920704|FG004|Overall Study|Death|0|||
170701754|NCT02457598|616920705|FG005|Overall Study|Death|1|||
170701755|NCT02457598|616920706|FG006|Overall Study|Death|0|||
170701756|NCT02457598|616920707|FG007|Overall Study|Death|0|||
170701757|NCT02457598|616920708|FG008|Overall Study|Death|0|||
170701758|NCT02457598|616920709|FG009|Overall Study|Death|0|||
170701759|NCT02457598|616920710|FG010|Overall Study|Death|3|||
170701760|NCT02457598|616920711|FG011|Overall Study|Death|0|||
170701761|NCT02457598|616920712|FG012|Overall Study|Death|0|||
170701762|NCT02457598|616920713|FG013|Overall Study|Death|1|||
170701763|NCT02457598|616920714|FG014|Overall Study|Death|2|||
170701764|NCT02457598|616920715|FG015|Overall Study|Death|0|||
170701765|NCT02457598|616920716|FG016|Overall Study|Death|1|||
170701766|NCT02457598|616920700|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701767|NCT02457598|616920701|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
170701768|NCT02457598|616920702|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701769|NCT02457598|616920703|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
170701770|NCT02457598|616920704|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701771|NCT02457598|616920705|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701772|NCT02457598|616920706|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701773|NCT02457598|616920707|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
170701774|NCT02457598|616920708|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701775|NCT02457598|616920709|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701776|NCT02457598|616920710|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
170701777|NCT02457598|616920711|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701778|NCT02457598|616920712|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701779|NCT02457598|616920713|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
170701780|NCT02457598|616920714|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
170701781|NCT02457598|616920715|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
170701782|NCT02457598|616920716|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
170701783|NCT02457598|616920700|FG000|Overall Study|Withdrew Consent|0|||
170701784|NCT02457598|616920701|FG001|Overall Study|Withdrew Consent|0|||
170701785|NCT02457598|616920702|FG002|Overall Study|Withdrew Consent|0|||
170701786|NCT02457598|616920703|FG003|Overall Study|Withdrew Consent|0|||
170701787|NCT02457598|616920704|FG004|Overall Study|Withdrew Consent|0|||
170701788|NCT02457598|616920705|FG005|Overall Study|Withdrew Consent|0|||
170701789|NCT02457598|616920706|FG006|Overall Study|Withdrew Consent|0|||
170701790|NCT02457598|616920707|FG007|Overall Study|Withdrew Consent|2|||
170701791|NCT02457598|616920708|FG008|Overall Study|Withdrew Consent|0|||
170701792|NCT02457598|616920709|FG009|Overall Study|Withdrew Consent|0|||
170701793|NCT02457598|616920710|FG010|Overall Study|Withdrew Consent|3|||
170701794|NCT02457598|616920711|FG011|Overall Study|Withdrew Consent|0|||
170701795|NCT02457598|616920712|FG012|Overall Study|Withdrew Consent|0|||
170701796|NCT02457598|616920713|FG013|Overall Study|Withdrew Consent|1|||
170701797|NCT02457598|616920714|FG014|Overall Study|Withdrew Consent|0|||
170701798|NCT02457598|616920715|FG015|Overall Study|Withdrew Consent|0|||
170701799|NCT02457598|616920716|FG016|Overall Study|Withdrew Consent|0|||
170701800|NCT02457598|616920700|FG000|Overall Study|Unacceptable Toxicity|0|||
170701801|NCT02457598|616920701|FG001|Overall Study|Unacceptable Toxicity|0|||
170701802|NCT02457598|616920702|FG002|Overall Study|Unacceptable Toxicity|0|||
170701803|NCT02457598|616920703|FG003|Overall Study|Unacceptable Toxicity|0|||
170701804|NCT02457598|616920704|FG004|Overall Study|Unacceptable Toxicity|0|||
170701805|NCT02457598|616920705|FG005|Overall Study|Unacceptable Toxicity|0|||
170701806|NCT02457598|616920706|FG006|Overall Study|Unacceptable Toxicity|0|||
170701807|NCT02457598|616920707|FG007|Overall Study|Unacceptable Toxicity|0|||
170701808|NCT02457598|616920708|FG008|Overall Study|Unacceptable Toxicity|0|||
170701809|NCT02457598|616920709|FG009|Overall Study|Unacceptable Toxicity|0|||
170701810|NCT02457598|616920710|FG010|Overall Study|Unacceptable Toxicity|1|||
170701811|NCT02457598|616920711|FG011|Overall Study|Unacceptable Toxicity|0|||
170701812|NCT02457598|616920712|FG012|Overall Study|Unacceptable Toxicity|1|||
170701813|NCT02457598|616920713|FG013|Overall Study|Unacceptable Toxicity|1|||
170701814|NCT02457598|616920714|FG014|Overall Study|Unacceptable Toxicity|1|||
170701815|NCT02457598|616920715|FG015|Overall Study|Unacceptable Toxicity|0|||
170701816|NCT02457598|616920716|FG016|Overall Study|Unacceptable Toxicity|0|||
170701817|NCT02457598|616920700|FG000|Overall Study|Intercurrent Illness|0|||
170701818|NCT02457598|616920701|FG001|Overall Study|Intercurrent Illness|0|||
170701819|NCT02457598|616920702|FG002|Overall Study|Intercurrent Illness|0|||
170701820|NCT02457598|616920703|FG003|Overall Study|Intercurrent Illness|0|||
170701821|NCT02457598|616920704|FG004|Overall Study|Intercurrent Illness|0|||
170701822|NCT02457598|616920705|FG005|Overall Study|Intercurrent Illness|0|||
170701823|NCT02457598|616920706|FG006|Overall Study|Intercurrent Illness|0|||
170701824|NCT02457598|616920707|FG007|Overall Study|Intercurrent Illness|0|||
170701825|NCT02457598|616920708|FG008|Overall Study|Intercurrent Illness|0|||
170701826|NCT02457598|616920709|FG009|Overall Study|Intercurrent Illness|0|||
170701827|NCT02457598|616920710|FG010|Overall Study|Intercurrent Illness|1|||
170701828|NCT02457598|616920711|FG011|Overall Study|Intercurrent Illness|0|||
170701829|NCT02457598|616920712|FG012|Overall Study|Intercurrent Illness|0|||
170701830|NCT02457598|616920713|FG013|Overall Study|Intercurrent Illness|0|||
170701831|NCT02457598|616920714|FG014|Overall Study|Intercurrent Illness|0|||
170701832|NCT02457598|616920715|FG015|Overall Study|Intercurrent Illness|0|||
170701833|NCT02457598|616920716|FG016|Overall Study|Intercurrent Illness|0|||
170701834|NCT02457598|616920700|FG000|Overall Study|Protocol Violation|0|||
170701835|NCT02457598|616920701|FG001|Overall Study|Protocol Violation|0|||
170701836|NCT02457598|616920702|FG002|Overall Study|Protocol Violation|0|||
170701837|NCT02457598|616920703|FG003|Overall Study|Protocol Violation|0|||
170701838|NCT02457598|616920704|FG004|Overall Study|Protocol Violation|0|||
170701839|NCT02457598|616920705|FG005|Overall Study|Protocol Violation|0|||
170701840|NCT02457598|616920706|FG006|Overall Study|Protocol Violation|0|||
170701841|NCT02457598|616920707|FG007|Overall Study|Protocol Violation|0|||
170701842|NCT02457598|616920708|FG008|Overall Study|Protocol Violation|0|||
170701843|NCT02457598|616920709|FG009|Overall Study|Protocol Violation|0|||
170701844|NCT02457598|616920710|FG010|Overall Study|Protocol Violation|1|||
170701845|NCT02457598|616920711|FG011|Overall Study|Protocol Violation|0|||
170701846|NCT02457598|616920712|FG012|Overall Study|Protocol Violation|0|||
170701847|NCT02457598|616920713|FG013|Overall Study|Protocol Violation|0|||
170701848|NCT02457598|616920714|FG014|Overall Study|Protocol Violation|0|||
170701849|NCT02457598|616920715|FG015|Overall Study|Protocol Violation|0|||
170701850|NCT02457598|616920716|FG016|Overall Study|Protocol Violation|0|||
170701851|NCT03316885|616920731|FG000|Overall Study|Adverse Event|1|||
170701852|NCT03316885|616920731|FG000|Overall Study|Death|10|||
170701853|NCT03316885|616920731|FG000|Overall Study|Lost to Follow-up|4|||
170701854|NCT03316885|616920731|FG000|Overall Study|Withdrawal by Subject|9|||
170701855|NCT03316885|616920731|FG000|Overall Study|COVID related|8|||
170701856|NCT02948842|616920733|FG000|Overall Study|Withdrawal by Subject|4|||
170701857|NCT01537783|616920735|FG000|Overall Study|Lost to Follow-up|11|||
170701858|NCT01537783|616920736|FG001|Overall Study|Lost to Follow-up|2|||
170701859|NCT02350309|616920738|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
170701860|NCT02350309|616920739|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
170701861|NCT02350309|616920740|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
170701862|NCT02350309|616920741|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
170701863|NCT02350309|616920742|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
170701864|NCT02350309|616920743|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
170701865|NCT02350309|616920738|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
170701866|NCT02350309|616920739|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
170701867|NCT02350309|616920740|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
170701868|NCT02350309|616920741|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
170701869|NCT02350309|616920742|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
170701870|NCT02350309|616920743|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
170701871|NCT00207142|616920744|FG000|Induction Phase|Adverse Event|9|||
170701872|NCT00207142|616920745|FG001|Induction Phase|Adverse Event|0|||
170701873|NCT00207142|616920746|FG002|Induction Phase|Adverse Event|0|||
170701874|NCT00207142|616920747|FG003|Induction Phase|Adverse Event|0|||
170701875|NCT00207142|616920744|FG000|Induction Phase|Death|1|||
170701876|NCT00207142|616920745|FG001|Induction Phase|Death|0|||
170701877|NCT00207142|616920746|FG002|Induction Phase|Death|0|||
170701878|NCT00207142|616920747|FG003|Induction Phase|Death|0|||
170701879|NCT00207142|616920744|FG000|Induction Phase|Lack of Efficacy|1|||
170701880|NCT00207142|616920745|FG001|Induction Phase|Lack of Efficacy|0|||
170701881|NCT00207142|616920746|FG002|Induction Phase|Lack of Efficacy|0|||
170701882|NCT00207142|616920747|FG003|Induction Phase|Lack of Efficacy|0|||
170701883|NCT00207142|616920744|FG000|Induction Phase|Lost to Follow-up|5|||
170701884|NCT00207142|616920745|FG001|Induction Phase|Lost to Follow-up|0|||
170824877|NCT00113269|617367866|FG002|Overall Study|Death in operating room|0|||
170824878|NCT00113269|617367867|FG003|Overall Study|Death in operating room|1|||
170824879|NCT00113269|617367864|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
170824880|NCT00113269|617367865|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
170824881|NCT00113269|617367866|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
170824882|NCT00113269|617367867|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
170701885|NCT00207142|616920746|FG002|Induction Phase|Lost to Follow-up|0|||
170701886|NCT00207142|616920747|FG003|Induction Phase|Lost to Follow-up|0|||
170701887|NCT00207142|616920744|FG000|Induction Phase|Physician Decision|2|||
170701888|NCT00207142|616920745|FG001|Induction Phase|Physician Decision|0|||
170701889|NCT00207142|616920746|FG002|Induction Phase|Physician Decision|0|||
170701890|NCT00207142|616920747|FG003|Induction Phase|Physician Decision|0|||
170701891|NCT00207142|616920744|FG000|Induction Phase|Poor/noncompliance|2|||
170701892|NCT00207142|616920745|FG001|Induction Phase|Poor/noncompliance|0|||
170824883|NCT00113269|617367864|FG000|Overall Study|Adverse Event|2|||
170701893|NCT00207142|616920746|FG002|Induction Phase|Poor/noncompliance|0|||
170701894|NCT00207142|616920747|FG003|Induction Phase|Poor/noncompliance|0|||
170701895|NCT00207142|616920744|FG000|Induction Phase|Pregnancy|1|||
170701896|NCT00207142|616920745|FG001|Induction Phase|Pregnancy|0|||
170701897|NCT00207142|616920746|FG002|Induction Phase|Pregnancy|0|||
170701898|NCT00207142|616920747|FG003|Induction Phase|Pregnancy|0|||
170701899|NCT00207142|616920744|FG000|Induction Phase|Subject no longer meets study criteria|3|||
170701900|NCT00207142|616920745|FG001|Induction Phase|Subject no longer meets study criteria|0|||
170701901|NCT00207142|616920746|FG002|Induction Phase|Subject no longer meets study criteria|0|||
170701902|NCT00207142|616920747|FG003|Induction Phase|Subject no longer meets study criteria|0|||
170701903|NCT00207142|616920744|FG000|Induction Phase|Withdrawal by Subject|4|||
170701904|NCT00207142|616920745|FG001|Induction Phase|Withdrawal by Subject|0|||
170701905|NCT00207142|616920746|FG002|Induction Phase|Withdrawal by Subject|0|||
170701906|NCT00207142|616920747|FG003|Induction Phase|Withdrawal by Subject|0|||
170701907|NCT00207142|616920744|FG000|Induction Phase|Incarceration|1|||
170701908|NCT00207142|616920745|FG001|Induction Phase|Incarceration|0|||
170701909|NCT00207142|616920746|FG002|Induction Phase|Incarceration|0|||
170701910|NCT00207142|616920747|FG003|Induction Phase|Incarceration|0|||
170701911|NCT00207142|616920744|FG000|Induction Phase|Missing lab data|1|||
170701912|NCT00207142|616920745|FG001|Induction Phase|Missing lab data|0|||
170701913|NCT00207142|616920746|FG002|Induction Phase|Missing lab data|0|||
170701914|NCT00207142|616920747|FG003|Induction Phase|Missing lab data|0|||
170701915|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
170701916|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
170701917|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
170701918|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
170701919|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
170701920|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
170701921|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
170701922|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
170701923|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
170701924|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
170701925|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
170701926|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
170701927|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
170701928|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
170701929|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
170701930|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
170701931|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
170701932|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
170701933|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
170701934|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
170701935|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
170701936|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
170701937|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
170701938|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
170701939|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
170701940|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
170701941|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
170701942|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
170701943|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|Death|0|||
170701944|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|Death|0|||
170701945|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|Death|0|||
170701946|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|Death|1|||
170701947|NCT00207142|616920744|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
170701948|NCT00207142|616920745|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
170701949|NCT00207142|616920746|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
170701950|NCT00207142|616920747|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
170701951|NCT01554618|616920748|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
170701952|NCT01554618|616920749|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
170701953|NCT01554618|616920748|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
170701954|NCT01554618|616920749|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
170701955|NCT01554618|616920748|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
170701956|NCT01554618|616920749|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
170701957|NCT01554618|616920748|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
170701958|NCT01554618|616920749|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
170701959|NCT01554618|616920748|FG000|Open-Label Extension Period|Physician Decision|0|||
170701960|NCT01554618|616920749|FG001|Open-Label Extension Period|Physician Decision|1|||
170701961|NCT01554618|616920748|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
170701962|NCT01554618|616920749|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
170701963|NCT00405548|616920750|FG000|Overall Study|Cognitive Memory problems on study day|1|||
170701964|NCT00405548|616920751|FG001|Overall Study|Cognitive Memory problems on study day|0|||
170701965|NCT00405548|616920750|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
170701966|NCT00405548|616920751|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
170701967|NCT00405548|616920750|FG000|Overall Study|Unable to self-administer shots|1|||
170701968|NCT00405548|616920751|FG001|Overall Study|Unable to self-administer shots|0|||
170701969|NCT00405548|616920750|FG000|Overall Study|Venous access failed during study day|1|||
170701970|NCT00405548|616920751|FG001|Overall Study|Venous access failed during study day|0|||
170701971|NCT00405548|616920750|FG000|Overall Study|Withdrawal by Subject|1|||
170701972|NCT00405548|616920751|FG001|Overall Study|Withdrawal by Subject|0|||
170701973|NCT04011410|616920752|FG000|Overall Study|Withdrawal by Subject|1|||
170701974|NCT00962104|616920753|FG000|Overall Study|Adverse Event|10|||
170701975|NCT00962104|616920754|FG001|Overall Study|Adverse Event|3|||
170701976|NCT00962104|616920753|FG000|Overall Study|Entry Criteria Not Met|1|||
170701977|NCT00962104|616920754|FG001|Overall Study|Entry Criteria Not Met|2|||
170701978|NCT00962104|616920753|FG000|Overall Study|Lack of Efficacy|0|||
170701979|NCT00962104|616920754|FG001|Overall Study|Lack of Efficacy|1|||
170701980|NCT00962104|616920753|FG000|Overall Study|Lost to Follow-up|10|||
170701981|NCT00962104|616920754|FG001|Overall Study|Lost to Follow-up|4|||
170701982|NCT00962104|616920753|FG000|Overall Study|Physician Decision|1|||
170701983|NCT00962104|616920754|FG001|Overall Study|Physician Decision|0|||
170701984|NCT00962104|616920753|FG000|Overall Study|Protocol Violation|6|||
170701985|NCT00962104|616920754|FG001|Overall Study|Protocol Violation|8|||
170701986|NCT00962104|616920753|FG000|Overall Study|Sponsor Decision|0|||
170701987|NCT00962104|616920754|FG001|Overall Study|Sponsor Decision|1|||
170701988|NCT00962104|616920753|FG000|Overall Study|Withdrawal by Subject|10|||
170701989|NCT00962104|616920754|FG001|Overall Study|Withdrawal by Subject|6|||
170701990|NCT00962104|616920753|FG000|Overall Study|Other|2|||
170701991|NCT00962104|616920754|FG001|Overall Study|Other|0|||
170701992|NCT03274986|616920755|FG000|Overall Study|Withdrawal by Subject|0|||
170701993|NCT03274986|616920756|FG001|Overall Study|Withdrawal by Subject|1|||
170701994|NCT03274986|616920755|FG000|Overall Study|Lost to Follow-up|0|||
170701995|NCT03274986|616920756|FG001|Overall Study|Lost to Follow-up|1|||
170701996|NCT01434290|616920759|FG000|Overall Study|Protocol Violation|6|||
170701997|NCT01434290|616920760|FG001|Overall Study|Protocol Violation|3|||
170701998|NCT01434290|616920759|FG000|Overall Study|No protocol treatment|2|||
170701999|NCT01434290|616920760|FG001|Overall Study|No protocol treatment|4|||
170702000|NCT02281552|616920761|FG000|Overall Study|Medication error|1|||
170702001|NCT02281552|616920762|FG001|Overall Study|Medication error|0|||
170702002|NCT02281552|616920761|FG000|Overall Study|Insufficient clinical response|0|||
170702003|NCT02281552|616920762|FG001|Overall Study|Insufficient clinical response|1|||
170702004|NCT02281552|616920761|FG000|Overall Study|Adverse Event|3|||
170702005|NCT02281552|616920762|FG001|Overall Study|Adverse Event|9|||
170702006|NCT01524627|616920764|FG000|Overall Study|Physician Decision|0|||
170702007|NCT01524627|616920765|FG001|Overall Study|Physician Decision|1|||
170702008|NCT01524627|616920764|FG000|Overall Study|Lost to Follow-up|1|||
170702009|NCT01524627|616920765|FG001|Overall Study|Lost to Follow-up|1|||
170702010|NCT04656132|616920766|FG000|Overall Study|Lost to Follow-up|4|||
170702011|NCT04656132|616920766|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
170702012|NCT01449526|616920767|FG000|Overall Study|Lost to Follow-up|1|||
170702013|NCT01449526|616920768|FG001|Overall Study|Lost to Follow-up|2|||
170702014|NCT01449526|616920767|FG000|Overall Study|Withdrawal by Subject|1|||
170702015|NCT01449526|616920768|FG001|Overall Study|Withdrawal by Subject|1|||
170702016|NCT01449526|616920767|FG000|Overall Study|Symptoms/complaints|0|||
170702017|NCT01449526|616920768|FG001|Overall Study|Symptoms/complaints|1|||
170702018|NCT01449526|616920767|FG000|Overall Study|Lack of Motivation|0|||
170702019|NCT01449526|616920768|FG001|Overall Study|Lack of Motivation|1|||
170702020|NCT01449526|616920767|FG000|Overall Study|Cannot maintain visits|0|||
170702021|NCT01449526|616920768|FG001|Overall Study|Cannot maintain visits|1|||
170702022|NCT04365699|616920769|FG000|Overall Study|Death|2|||
170702023|NCT04365699|616920770|FG001|Overall Study|Death|5|||
170702024|NCT04365699|616920771|FG002|Overall Study|Death|15|||
170702025|NCT03323658|616920772|FG000|Overall Study|Adverse Event|0|||
170702026|NCT03323658|616920773|FG001|Overall Study|Adverse Event|1|||
170702027|NCT03323658|616920774|FG002|Overall Study|Adverse Event|0|||
170702028|NCT00615056|616920776|FG000|Overall Study|Death|31|||
170702029|NCT00615056|616920777|FG001|Overall Study|Death|31|||
170702030|NCT00615056|616920778|FG002|Overall Study|Death|21|||
170702031|NCT00615056|616920779|FG003|Overall Study|Death|23|||
170702032|NCT00615056|616920776|FG000|Overall Study|Lost to Follow-up|1|||
170702033|NCT00615056|616920777|FG001|Overall Study|Lost to Follow-up|2|||
170702034|NCT00615056|616920778|FG002|Overall Study|Lost to Follow-up|4|||
170702035|NCT00615056|616920779|FG003|Overall Study|Lost to Follow-up|5|||
170702036|NCT00615056|616920776|FG000|Overall Study|Other|13|||
170702037|NCT00615056|616920777|FG001|Overall Study|Other|15|||
170702038|NCT00615056|616920778|FG002|Overall Study|Other|10|||
170702039|NCT00615056|616920779|FG003|Overall Study|Other|7|||
170702040|NCT00615056|616920776|FG000|Overall Study|Objective progression or relapse|0|||
170702041|NCT00615056|616920777|FG001|Overall Study|Objective progression or relapse|2|||
170702042|NCT00615056|616920778|FG002|Overall Study|Objective progression or relapse|0|||
170702043|NCT00615056|616920779|FG003|Overall Study|Objective progression or relapse|0|||
170702044|NCT00615056|616920776|FG000|Overall Study|Withdrawal by Subject|0|||
170702045|NCT00615056|616920777|FG001|Overall Study|Withdrawal by Subject|1|||
170702046|NCT00615056|616920778|FG002|Overall Study|Withdrawal by Subject|1|||
170702047|NCT00615056|616920779|FG003|Overall Study|Withdrawal by Subject|0|||
170702048|NCT00615056|616920776|FG000|Overall Study|Discontinued by Sponsor|1|||
170702049|NCT00615056|616920777|FG001|Overall Study|Discontinued by Sponsor|0|||
170702050|NCT00615056|616920778|FG002|Overall Study|Discontinued by Sponsor|0|||
170702051|NCT00615056|616920779|FG003|Overall Study|Discontinued by Sponsor|0|||
170702052|NCT00615056|616920776|FG000|Overall Study|Randomized but not treated|3|||
170702053|NCT00615056|616920777|FG001|Overall Study|Randomized but not treated|0|||
170702054|NCT00615056|616920778|FG002|Overall Study|Randomized but not treated|0|||
170702055|NCT00615056|616920779|FG003|Overall Study|Randomized but not treated|0|||
170702056|NCT00717769|616920780|FG000|Overall Study|Adverse Event|9|||
170702057|NCT00717769|616920781|FG001|Overall Study|Adverse Event|6|||
170702058|NCT00717769|616920782|FG002|Overall Study|Adverse Event|1|||
170702059|NCT00717769|616920780|FG000|Overall Study|Lack of compliance|0|||
170702060|NCT00717769|616920781|FG001|Overall Study|Lack of compliance|2|||
170702061|NCT00717769|616920782|FG002|Overall Study|Lack of compliance|0|||
170702062|NCT00717769|616920780|FG000|Overall Study|Lost to Follow-up|3|||
170702063|NCT00717769|616920781|FG001|Overall Study|Lost to Follow-up|4|||
170702064|NCT00717769|616920782|FG002|Overall Study|Lost to Follow-up|0|||
170702065|NCT00717769|616920780|FG000|Overall Study|Lack of Efficacy|1|||
170702066|NCT00717769|616920781|FG001|Overall Study|Lack of Efficacy|2|||
170702067|NCT00717769|616920782|FG002|Overall Study|Lack of Efficacy|0|||
170702068|NCT00717769|616920780|FG000|Overall Study|Protocol Violation|0|||
170702069|NCT00717769|616920781|FG001|Overall Study|Protocol Violation|2|||
170702070|NCT00717769|616920782|FG002|Overall Study|Protocol Violation|0|||
170702071|NCT00717769|616920780|FG000|Overall Study|Sponsor decision|1|||
170702072|NCT00717769|616920781|FG001|Overall Study|Sponsor decision|0|||
170702073|NCT00717769|616920782|FG002|Overall Study|Sponsor decision|10|||
170702074|NCT00717769|616920780|FG000|Overall Study|Withdrew consent|2|||
170702075|NCT00717769|616920781|FG001|Overall Study|Withdrew consent|2|||
170702076|NCT00717769|616920782|FG002|Overall Study|Withdrew consent|0|||
170702077|NCT02196324|616920785|FG000|Overall Study|Withdrawal by Subject|8|||
170702078|NCT02196324|616920786|FG001|Overall Study|Withdrawal by Subject|4|||
170702079|NCT02196324|616920785|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
170702080|NCT02196324|616920786|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
170702081|NCT02196324|616920785|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
170702082|NCT02196324|616920786|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
170702083|NCT02196324|616920785|FG000|Overall Study|Other|1|||
170702084|NCT02196324|616920786|FG001|Overall Study|Other|0|||
170702085|NCT01380184|616920787|FG000|Part 1 (19 Days)|Adverse Event|1|||
170702086|NCT01380184|616920787|FG000|Part 2|Adverse Event|5|||
170702087|NCT01380184|616920787|FG000|Part 2|Disease Progression|8|||
170702088|NCT01380184|616920787|FG000|Part 2|Lost to Follow-up|1|||
170702089|NCT04327986|616920788|FG000|Overall Study|Physician Decision|2|||
170702090|NCT04327986|616920789|FG001|Overall Study|Physician Decision|0|||
170702091|NCT04327986|616920790|FG002|Overall Study|Physician Decision|0|||
170702092|NCT04327986|616920788|FG000|Overall Study|Death|1|||
170702093|NCT04327986|616920789|FG001|Overall Study|Death|0|||
170702094|NCT04327986|616920790|FG002|Overall Study|Death|0|||
170702095|NCT04248816|616920791|FG000|Overall Study|Ineligible post-randomization|7|||
170702096|NCT04248816|616920792|FG001|Overall Study|Ineligible post-randomization|21|||
170702097|NCT04248816|616920793|FG002|Overall Study|Ineligible post-randomization|25|||
170702098|NCT01677195|616922538|FG000|Overall Study|Lost to Follow-up|14|||
170702099|NCT01677195|616922539|FG001|Overall Study|Lost to Follow-up|22|||
170702100|NCT01677195|616922540|FG002|Overall Study|Lost to Follow-up|22|||
170702101|NCT01677195|616922538|FG000|Overall Study|Withdrawal by Subject|1|||
170702102|NCT01677195|616922539|FG001|Overall Study|Withdrawal by Subject|0|||
170702103|NCT01677195|616922540|FG002|Overall Study|Withdrawal by Subject|1|||
170702104|NCT01677195|616922538|FG000|Overall Study|Adverse Event|6|||
170702105|NCT01677195|616922539|FG001|Overall Study|Adverse Event|4|||
170702106|NCT01677195|616922540|FG002|Overall Study|Adverse Event|1|||
170702107|NCT01677195|616922538|FG000|Overall Study|Physician Decision|1|||
170702108|NCT01677195|616922539|FG001|Overall Study|Physician Decision|2|||
170702109|NCT01677195|616922540|FG002|Overall Study|Physician Decision|2|||
170702110|NCT01677195|616922538|FG000|Overall Study|Pregnancy|0|||
170702111|NCT01677195|616922539|FG001|Overall Study|Pregnancy|1|||
170702112|NCT01677195|616922540|FG002|Overall Study|Pregnancy|0|||
170702113|NCT01677195|616922538|FG000|Overall Study|Protocol Violation|7|||
170702114|NCT01677195|616922539|FG001|Overall Study|Protocol Violation|3|||
170702115|NCT01677195|616922540|FG002|Overall Study|Protocol Violation|4|||
170702116|NCT01012817|616922541|FG000|Overall Study|Withdrawal by Subject|0|||
170702117|NCT01012817|616922542|FG001|Overall Study|Withdrawal by Subject|0|||
170702118|NCT01012817|616922543|FG002|Overall Study|Withdrawal by Subject|0|||
170702119|NCT01012817|616922544|FG003|Overall Study|Withdrawal by Subject|1|||
170702120|NCT01012817|616922545|FG004|Overall Study|Withdrawal by Subject|0|||
170702121|NCT01012817|616922546|FG005|Overall Study|Withdrawal by Subject|0|||
170702122|NCT01012817|616922547|FG006|Overall Study|Withdrawal by Subject|0|||
170702123|NCT01012817|616922548|FG007|Overall Study|Withdrawal by Subject|1|||
170702124|NCT01012817|616922549|FG008|Overall Study|Withdrawal by Subject|0|||
170702125|NCT01012817|616922550|FG009|Overall Study|Withdrawal by Subject|0|||
170702126|NCT01012817|616922551|FG010|Overall Study|Withdrawal by Subject|1|||
170702127|NCT01012817|616922552|FG011|Overall Study|Withdrawal by Subject|1|||
170702128|NCT01012817|616922553|FG012|Overall Study|Withdrawal by Subject|0|||
170702129|NCT01012817|616922554|FG013|Overall Study|Withdrawal by Subject|1|||
170702130|NCT01012817|616922541|FG000|Overall Study|Adverse Event|0|||
170702131|NCT01012817|616922542|FG001|Overall Study|Adverse Event|0|||
170702132|NCT01012817|616922543|FG002|Overall Study|Adverse Event|0|||
170702133|NCT01012817|616922544|FG003|Overall Study|Adverse Event|0|||
170702134|NCT01012817|616922545|FG004|Overall Study|Adverse Event|0|||
170702135|NCT01012817|616922546|FG005|Overall Study|Adverse Event|1|||
170702136|NCT01012817|616922547|FG006|Overall Study|Adverse Event|0|||
170702137|NCT01012817|616922548|FG007|Overall Study|Adverse Event|0|||
170702138|NCT01012817|616922549|FG008|Overall Study|Adverse Event|0|||
170702139|NCT01012817|616922550|FG009|Overall Study|Adverse Event|0|||
170702140|NCT01012817|616922551|FG010|Overall Study|Adverse Event|1|||
170702141|NCT01012817|616922552|FG011|Overall Study|Adverse Event|0|||
170702142|NCT01012817|616922553|FG012|Overall Study|Adverse Event|0|||
170702143|NCT01012817|616922554|FG013|Overall Study|Adverse Event|1|||
170702144|NCT00023673|616922555|FG000|Overall Study|Ineligible / no protocol treatment|0|||
170702145|NCT00023673|616922556|FG001|Overall Study|Ineligible / no protocol treatment|0|||
170702146|NCT00023673|616922557|FG002|Overall Study|Ineligible / no protocol treatment|0|||
170702147|NCT00023673|616922558|FG003|Overall Study|Ineligible / no protocol treatment|1|||
170702148|NCT00023673|616922555|FG000|Overall Study|Patient withdrew consent|0|||
170702149|NCT00023673|616922556|FG001|Overall Study|Patient withdrew consent|0|||
170702150|NCT00023673|616922557|FG002|Overall Study|Patient withdrew consent|0|||
170702151|NCT00023673|616922558|FG003|Overall Study|Patient withdrew consent|1|||
170702152|NCT00110266|616922559|FG000|Overall Study|Adverse Event|27|||
170702153|NCT00110266|616922559|FG000|Overall Study|Abnormal laboratory value|15|||
170702154|NCT00110266|616922559|FG000|Overall Study|Withdrawal by Subject|16|||
170702155|NCT00110266|616922559|FG000|Overall Study|Death|17|||
170702156|NCT00110266|616922559|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170702157|NCT00110266|616922559|FG000|Overall Study|Participant condition no longer requires study drug|1|||
170702158|NCT00634647|616922564|FG000|Overall Study|death on study|3|||
170702159|NCT00634647|616922564|FG000|Overall Study|refused further treatment|3|||
170702160|NCT00634647|616922564|FG000|Overall Study|declined to participate before treatment|1|||
170702161|NCT01700179|616922565|FG000|Overall Study|Physician Decision|2|||
170702162|NCT03277846|616922566|FG000|Overall Study|Inpatient stay too brief|12|||
170702163|NCT03277846|616922567|FG001|Overall Study|Inpatient stay too brief|11|||
170702164|NCT01207778|616922568|FG000|Overall Study|Lost to Follow-up|0|||
170702165|NCT01207778|616922569|FG001|Overall Study|Lost to Follow-up|3|||
170702166|NCT01207778|616922570|FG002|Overall Study|Lost to Follow-up|3|||
170702167|NCT05168475|616922573|FG000|Period 1|Protocol Violation|1|||
170702168|NCT05168475|616922573|FG000|Period 1|IMP shortage|2|||
170702169|NCT05168475|616922573|FG000|Period 1|Not randomised|2|||
170702170|NCT05168475|616922573|FG000|Period 2|IMP shortage|1|||
170702171|NCT00646204|616922574|FG000|Overall Study|Adverse Event|3|||
170702172|NCT00646204|616922575|FG001|Overall Study|Adverse Event|0|||
170702173|NCT00646204|616922574|FG000|Overall Study|Withdrawal by Subject|1|||
170702174|NCT00646204|616922575|FG001|Overall Study|Withdrawal by Subject|0|||
170702175|NCT00773175|616922579|FG000|Overall Study|Adverse Event|2|||
170702176|NCT00773175|616922580|FG001|Overall Study|Adverse Event|0|||
170702177|NCT00773175|616922579|FG000|Overall Study|Consent Withdrawn|0|||
170702178|NCT00773175|616922580|FG001|Overall Study|Consent Withdrawn|2|||
170702179|NCT01359592|616922581|FG000|Initial Registration|Adverse Event|1|||
170702180|NCT01359592|616922582|FG001|Initial Registration|Adverse Event|0|||
170702181|NCT01359592|616922583|FG002|Initial Registration|Adverse Event|0|||
170702182|NCT01359592|616922584|FG003|Initial Registration|Adverse Event|0|||
170702183|NCT01359592|616922581|FG000|Initial Registration|Death|1|||
170702184|NCT01359592|616922582|FG001|Initial Registration|Death|0|||
170702185|NCT01359592|616922583|FG002|Initial Registration|Death|0|||
170702186|NCT01359592|616922584|FG003|Initial Registration|Death|0|||
170702187|NCT01359592|616922581|FG000|Initial Registration|Other reason not protocol specified|1|||
170702188|NCT01359592|616922582|FG001|Initial Registration|Other reason not protocol specified|0|||
170702189|NCT01359592|616922583|FG002|Initial Registration|Other reason not protocol specified|0|||
170702190|NCT01359592|616922584|FG003|Initial Registration|Other reason not protocol specified|0|||
170702191|NCT01359592|616922581|FG000|Initial Registration|Ineligible|26|||
170702192|NCT01359592|616922582|FG001|Initial Registration|Ineligible|0|||
170702193|NCT01359592|616922583|FG002|Initial Registration|Ineligible|0|||
170702194|NCT01359592|616922584|FG003|Initial Registration|Ineligible|0|||
170702195|NCT01359592|616922581|FG000|PET-Directed Therapy|Adverse Event|0|||
170702196|NCT01359592|616922582|FG001|PET-Directed Therapy|Adverse Event|0|||
170824884|NCT00113269|617367865|FG001|Overall Study|Adverse Event|7|||
170824885|NCT00113269|617367866|FG002|Overall Study|Adverse Event|11|||
170824886|NCT00113269|617367867|FG003|Overall Study|Adverse Event|7|||
170824887|NCT00113269|617367864|FG000|Overall Study|Withdrawal by Subject|4|||
170824888|NCT00113269|617367865|FG001|Overall Study|Withdrawal by Subject|3|||
170824889|NCT00113269|617367866|FG002|Overall Study|Withdrawal by Subject|4|||
170824890|NCT00113269|617367867|FG003|Overall Study|Withdrawal by Subject|2|||
170824891|NCT00113269|617367864|FG000|Overall Study|Graft loss|6|||
170824892|NCT00113269|617367865|FG001|Overall Study|Graft loss|6|||
170824893|NCT00113269|617367866|FG002|Overall Study|Graft loss|4|||
170824894|NCT00113269|617367867|FG003|Overall Study|Graft loss|9|||
170824895|NCT00113269|617367864|FG000|Overall Study|Protocol Violation|1|||
170824896|NCT00113269|617367865|FG001|Overall Study|Protocol Violation|0|||
170824897|NCT00113269|617367866|FG002|Overall Study|Protocol Violation|4|||
170824898|NCT00113269|617367867|FG003|Overall Study|Protocol Violation|2|||
170824899|NCT00113269|617367864|FG000|Overall Study|Lost to Follow-up|2|||
170824900|NCT00113269|617367865|FG001|Overall Study|Lost to Follow-up|3|||
170824901|NCT00113269|617367866|FG002|Overall Study|Lost to Follow-up|6|||
170824902|NCT00113269|617367867|FG003|Overall Study|Lost to Follow-up|3|||
170824903|NCT00113269|617367864|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
170824904|NCT00113269|617367865|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
170824905|NCT00113269|617367866|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
170824906|NCT00113269|617367867|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
170824907|NCT00113269|617367864|FG000|Overall Study|Discontinued due to rejection|0|||
170824908|NCT00113269|617367865|FG001|Overall Study|Discontinued due to rejection|0|||
170824909|NCT00113269|617367866|FG002|Overall Study|Discontinued due to rejection|1|||
170824910|NCT00113269|617367867|FG003|Overall Study|Discontinued due to rejection|0|||
170824911|NCT00113269|617367864|FG000|Overall Study|Moved|0|||
170824912|NCT00113269|617367865|FG001|Overall Study|Moved|1|||
170824913|NCT00113269|617367866|FG002|Overall Study|Moved|0|||
170824914|NCT00113269|617367867|FG003|Overall Study|Moved|3|||
170824915|NCT00113269|617367864|FG000|Overall Study|Received pancreas transplant|0|||
170824916|NCT00113269|617367865|FG001|Overall Study|Received pancreas transplant|0|||
170824917|NCT00113269|617367866|FG002|Overall Study|Received pancreas transplant|0|||
170824918|NCT00113269|617367867|FG003|Overall Study|Received pancreas transplant|2|||
170824919|NCT00113269|617367864|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
170824920|NCT00113269|617367865|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
170824921|NCT00113269|617367866|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
170824922|NCT00113269|617367867|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
170824923|NCT00113269|617367864|FG000|Overall Study|Did not meet eligibility criteria|1|||
170824924|NCT00113269|617367865|FG001|Overall Study|Did not meet eligibility criteria|0|||
170824925|NCT00113269|617367866|FG002|Overall Study|Did not meet eligibility criteria|0|||
170824926|NCT00113269|617367867|FG003|Overall Study|Did not meet eligibility criteria|1|||
170824927|NCT00113269|617367864|FG000|Overall Study|Unable to return for follow up|2|||
170824928|NCT00113269|617367865|FG001|Overall Study|Unable to return for follow up|1|||
170824929|NCT00113269|617367866|FG002|Overall Study|Unable to return for follow up|0|||
170824930|NCT00113269|617367867|FG003|Overall Study|Unable to return for follow up|0|||
170824931|NCT01066936|617367871|FG000|Overall Study|Death|2|||
170824932|NCT01066936|617367871|FG000|Overall Study|Device revised/removed|1|||
170824933|NCT01066936|617367871|FG000|Overall Study|Lost to Follow-up|3|||
170824934|NCT01066936|617367871|FG000|Overall Study|Withdrawal by Subject|4|||
170824935|NCT02517528|617367873|FG000|Overall Study|Withdrawal by Subject|1|||
170824936|NCT02202109|617367877|FG000|Overall Study|Lost to Follow-up|88|||
170824937|NCT02202109|617367878|FG001|Overall Study|Lost to Follow-up|87|||
170824938|NCT02202109|617367877|FG000|Overall Study|Withdrawal by Subject|2|||
170824939|NCT02202109|617367878|FG001|Overall Study|Withdrawal by Subject|0|||
170824940|NCT01268098|617367881|FG000|Overall Study|Adverse Event|1|||
170824941|NCT01268098|617367882|FG001|Overall Study|Adverse Event|0|||
170824942|NCT01093599|617367884|FG000|Overall Study|Lost to Follow-up|32|||
170824943|NCT01093599|617367885|FG001|Overall Study|Lost to Follow-up|46|||
170824944|NCT01845649|617367886|FG000|Overall Study|Adverse Event|7|||
170702197|NCT01359592|616922583|FG002|PET-Directed Therapy|Adverse Event|1|||
170702198|NCT01359592|616922584|FG003|PET-Directed Therapy|Adverse Event|0|||
170702199|NCT01359592|616922581|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
170702200|NCT01359592|616922582|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
170702201|NCT01359592|616922583|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
170702202|NCT01359592|616922584|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
170702203|NCT01359592|616922581|FG000|PET-Directed Therapy|Ineligible|0|||
170702204|NCT01359592|616922582|FG001|PET-Directed Therapy|Ineligible|0|||
170702205|NCT01359592|616922583|FG002|PET-Directed Therapy|Ineligible|24|||
170702206|NCT01359592|616922584|FG003|PET-Directed Therapy|Ineligible|0|||
170702207|NCT00419562|616922587|FG000|Overall Study|Lost to Follow-up|12|||
170702208|NCT00419562|616922588|FG001|Overall Study|Lost to Follow-up|13|||
170702209|NCT00419562|616922587|FG000|Overall Study|Withdrawal by Subject|20|||
170702210|NCT00419562|616922588|FG001|Overall Study|Withdrawal by Subject|18|||
170702211|NCT00419562|616922587|FG000|Overall Study|Participant Institutionalized|1|||
170702212|NCT00419562|616922588|FG001|Overall Study|Participant Institutionalized|0|||
170702213|NCT02412631|616922597|FG000|Overall Study|Adverse Event|1|||
170702214|NCT02412631|616922598|FG001|Overall Study|Adverse Event|2|||
170702215|NCT02412631|616922597|FG000|Overall Study|Lost to Follow-up|5|||
170702216|NCT02412631|616922598|FG001|Overall Study|Lost to Follow-up|9|||
170702217|NCT02412631|616922597|FG000|Overall Study|Withdrawal by Subject|9|||
170702218|NCT02412631|616922598|FG001|Overall Study|Withdrawal by Subject|3|||
170702219|NCT02412631|616922597|FG000|Overall Study|Early stop by FDA|5|||
170702220|NCT02412631|616922598|FG001|Overall Study|Early stop by FDA|2|||
170702221|NCT02412631|616922597|FG000|Overall Study|Unspecified reason|6|||
170702222|NCT02412631|616922598|FG001|Overall Study|Unspecified reason|8|||
170702223|NCT00770120|616922599|FG000|Overall Study|Progression|31|||
170702224|NCT00770120|616922599|FG000|Overall Study|Adverse Event|11|||
170702225|NCT00770120|616922599|FG000|Overall Study|Not Protocol Specified|11|||
170702226|NCT00770120|616922599|FG000|Overall Study|Death|3|||
170702227|NCT00770120|616922599|FG000|Overall Study|Withdrawal by Subject|2|||
170702228|NCT00770120|616922599|FG000|Overall Study|Ineligible|1|||
170702229|NCT00770120|616922599|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
170702230|NCT00770120|616922599|FG000|Overall Study|Reason under Review|1|||
170702231|NCT03064126|616922604|FG000|Overall Study|Death|40|||
170702232|NCT03064126|616922605|FG001|Overall Study|Death|16|||
170702233|NCT03064126|616922606|FG002|Overall Study|Death|4|||
170702234|NCT03064126|616922607|FG003|Overall Study|Death|2|||
170702235|NCT03064126|616922604|FG000|Overall Study|Withdrawal by Subject|17|||
170702236|NCT03064126|616922605|FG001|Overall Study|Withdrawal by Subject|9|||
170702237|NCT03064126|616922606|FG002|Overall Study|Withdrawal by Subject|0|||
170702238|NCT03064126|616922607|FG003|Overall Study|Withdrawal by Subject|2|||
170702239|NCT03064126|616922604|FG000|Overall Study|Lost to Follow-up|7|||
170702240|NCT03064126|616922605|FG001|Overall Study|Lost to Follow-up|3|||
170702241|NCT03064126|616922606|FG002|Overall Study|Lost to Follow-up|0|||
170702242|NCT03064126|616922607|FG003|Overall Study|Lost to Follow-up|0|||
170702243|NCT03064126|616922604|FG000|Overall Study|Adverse Event|2|||
170702244|NCT03064126|616922605|FG001|Overall Study|Adverse Event|0|||
170702245|NCT03064126|616922606|FG002|Overall Study|Adverse Event|0|||
170702246|NCT03064126|616922607|FG003|Overall Study|Adverse Event|0|||
170702247|NCT03064126|616922604|FG000|Overall Study|Physician Decision|3|||
170702248|NCT03064126|616922605|FG001|Overall Study|Physician Decision|0|||
170702249|NCT03064126|616922606|FG002|Overall Study|Physician Decision|0|||
170702250|NCT03064126|616922607|FG003|Overall Study|Physician Decision|0|||
170702251|NCT03064126|616922604|FG000|Overall Study|Other reason for early termination|3|||
170702252|NCT03064126|616922605|FG001|Overall Study|Other reason for early termination|2|||
170702253|NCT03064126|616922606|FG002|Overall Study|Other reason for early termination|0|||
170702254|NCT03064126|616922607|FG003|Overall Study|Other reason for early termination|0|||
170702255|NCT03064126|616922604|FG000|Overall Study|Missed Visit|3|||
170702256|NCT03064126|616922605|FG001|Overall Study|Missed Visit|1|||
170702257|NCT03064126|616922606|FG002|Overall Study|Missed Visit|0|||
170702258|NCT03064126|616922607|FG003|Overall Study|Missed Visit|0|||
170702259|NCT04649151|616922611|FG000|Overall Study|Pregnancy|0|||
170702260|NCT04649151|616922612|FG001|Overall Study|Pregnancy|0|||
170702261|NCT04649151|616922613|FG002|Overall Study|Pregnancy|0|||
170702262|NCT04649151|616922614|FG003|Overall Study|Pregnancy|0|||
170702263|NCT04649151|616922615|FG004|Overall Study|Pregnancy|3|||
170702264|NCT04649151|616922611|FG000|Overall Study|Physician Decision|10|||
170702265|NCT04649151|616922612|FG001|Overall Study|Physician Decision|0|||
170824945|NCT01845649|617367887|FG001|Overall Study|Adverse Event|10|||
170824946|NCT01845649|617367886|FG000|Overall Study|Lack of Efficacy|1|||
170824947|NCT01845649|617367887|FG001|Overall Study|Lack of Efficacy|1|||
170824948|NCT01845649|617367886|FG000|Overall Study|Lost to Follow-up|2|||
170824949|NCT01845649|617367887|FG001|Overall Study|Lost to Follow-up|2|||
170702266|NCT04649151|616922613|FG002|Overall Study|Physician Decision|0|||
170702267|NCT04649151|616922614|FG003|Overall Study|Physician Decision|1|||
170702268|NCT04649151|616922615|FG004|Overall Study|Physician Decision|1|||
170702269|NCT04649151|616922611|FG000|Overall Study|Protocol Deviation|25|||
170824950|NCT01845649|617367886|FG000|Overall Study|Withdrew Consent|12|||
170702270|NCT04649151|616922612|FG001|Overall Study|Protocol Deviation|3|||
170702271|NCT04649151|616922613|FG002|Overall Study|Protocol Deviation|0|||
170702272|NCT04649151|616922614|FG003|Overall Study|Protocol Deviation|0|||
170702273|NCT04649151|616922615|FG004|Overall Study|Protocol Deviation|0|||
170702274|NCT04649151|616922611|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
170702275|NCT04649151|616922612|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
170702276|NCT04649151|616922613|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
170702277|NCT04649151|616922614|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
170702278|NCT04649151|616922615|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
170702279|NCT04649151|616922611|FG000|Overall Study|Withdrawal by Subject|370|||
170702280|NCT04649151|616922612|FG001|Overall Study|Withdrawal by Subject|113|||
170702281|NCT04649151|616922613|FG002|Overall Study|Withdrawal by Subject|2|||
170702282|NCT04649151|616922614|FG003|Overall Study|Withdrawal by Subject|7|||
170702283|NCT04649151|616922615|FG004|Overall Study|Withdrawal by Subject|15|||
170702284|NCT04649151|616922611|FG000|Overall Study|Adverse Event|1|||
170702285|NCT04649151|616922612|FG001|Overall Study|Adverse Event|0|||
170702286|NCT04649151|616922613|FG002|Overall Study|Adverse Event|0|||
170702287|NCT04649151|616922614|FG003|Overall Study|Adverse Event|0|||
170702288|NCT04649151|616922615|FG004|Overall Study|Adverse Event|0|||
170702289|NCT04649151|616922611|FG000|Overall Study|Lost to Follow-up|256|||
170702290|NCT04649151|616922612|FG001|Overall Study|Lost to Follow-up|29|||
170702291|NCT04649151|616922613|FG002|Overall Study|Lost to Follow-up|10|||
170702292|NCT04649151|616922614|FG003|Overall Study|Lost to Follow-up|3|||
170702293|NCT04649151|616922615|FG004|Overall Study|Lost to Follow-up|6|||
170702294|NCT04649151|616922611|FG000|Overall Study|Other than specified|59|||
170702295|NCT04649151|616922612|FG001|Overall Study|Other than specified|294|||
170702296|NCT04649151|616922613|FG002|Overall Study|Other than specified|0|||
170702297|NCT04649151|616922614|FG003|Overall Study|Other than specified|0|||
170702298|NCT04649151|616922615|FG004|Overall Study|Other than specified|4|||
170702299|NCT04649151|616922611|FG000|Overall Study|Death|0|||
170702300|NCT04649151|616922612|FG001|Overall Study|Death|0|||
170702301|NCT04649151|616922613|FG002|Overall Study|Death|0|||
170702302|NCT04649151|616922614|FG003|Overall Study|Death|0|||
170702303|NCT04649151|616922615|FG004|Overall Study|Death|1|||
170702304|NCT03752619|616922616|FG000|Overall Study|Lost to Follow-up|2|||
170702305|NCT03752619|616922617|FG001|Overall Study|Lost to Follow-up|1|||
170702306|NCT03752619|616922616|FG000|Overall Study|Withdrawal by Subject|1|||
170702307|NCT03752619|616922617|FG001|Overall Study|Withdrawal by Subject|1|||
170702308|NCT03752619|616922616|FG000|Overall Study|Adverse Event|0|||
170702309|NCT03752619|616922617|FG001|Overall Study|Adverse Event|1|||
170702310|NCT03400332|616922618|FG000|Pre-Treatment|Other reasons|0|||
170702311|NCT03400332|616922619|FG001|Pre-Treatment|Other reasons|0|||
170702312|NCT03400332|616922620|FG002|Pre-Treatment|Other reasons|0|||
170702313|NCT03400332|616922621|FG003|Pre-Treatment|Other reasons|0|||
170702314|NCT03400332|616922622|FG004|Pre-Treatment|Other reasons|0|||
170702315|NCT03400332|616922623|FG005|Pre-Treatment|Other reasons|0|||
170702316|NCT03400332|616922624|FG006|Pre-Treatment|Other reasons|0|||
170702317|NCT03400332|616922625|FG007|Pre-Treatment|Other reasons|0|||
170702318|NCT03400332|616922626|FG008|Pre-Treatment|Other reasons|1|||
170702319|NCT03400332|616922618|FG000|Pre-Treatment|No longer met study criteria|0|||
170702320|NCT03400332|616922619|FG001|Pre-Treatment|No longer met study criteria|0|||
170702321|NCT03400332|616922620|FG002|Pre-Treatment|No longer met study criteria|0|||
170702322|NCT03400332|616922621|FG003|Pre-Treatment|No longer met study criteria|0|||
170702323|NCT03400332|616922622|FG004|Pre-Treatment|No longer met study criteria|0|||
170702324|NCT03400332|616922623|FG005|Pre-Treatment|No longer met study criteria|0|||
170702325|NCT03400332|616922624|FG006|Pre-Treatment|No longer met study criteria|0|||
170702326|NCT03400332|616922625|FG007|Pre-Treatment|No longer met study criteria|0|||
170702327|NCT03400332|616922626|FG008|Pre-Treatment|No longer met study criteria|1|||
170702328|NCT03400332|616922618|FG000|Pre-Treatment|Withdrawal by Subject|0|||
170702329|NCT03400332|616922619|FG001|Pre-Treatment|Withdrawal by Subject|0|||
170702330|NCT03400332|616922620|FG002|Pre-Treatment|Withdrawal by Subject|0|||
170702331|NCT03400332|616922621|FG003|Pre-Treatment|Withdrawal by Subject|0|||
170702332|NCT03400332|616922622|FG004|Pre-Treatment|Withdrawal by Subject|0|||
170702333|NCT03400332|616922623|FG005|Pre-Treatment|Withdrawal by Subject|0|||
170702334|NCT03400332|616922624|FG006|Pre-Treatment|Withdrawal by Subject|0|||
170702335|NCT03400332|616922625|FG007|Pre-Treatment|Withdrawal by Subject|0|||
170702336|NCT03400332|616922626|FG008|Pre-Treatment|Withdrawal by Subject|1|||
170702337|NCT03400332|616922618|FG000|Treatment|Participant withdrew consent|2|||
170702338|NCT03400332|616922619|FG001|Treatment|Participant withdrew consent|2|||
170702339|NCT03400332|616922620|FG002|Treatment|Participant withdrew consent|0|||
170702340|NCT03400332|616922621|FG003|Treatment|Participant withdrew consent|0|||
170702341|NCT03400332|616922622|FG004|Treatment|Participant withdrew consent|3|||
170702342|NCT03400332|616922623|FG005|Treatment|Participant withdrew consent|3|||
170702343|NCT03400332|616922624|FG006|Treatment|Participant withdrew consent|1|||
170702344|NCT03400332|616922625|FG007|Treatment|Participant withdrew consent|1|||
170702345|NCT03400332|616922626|FG008|Treatment|Participant withdrew consent|1|||
170702346|NCT03400332|616922618|FG000|Treatment|Other reasons|0|||
170702347|NCT03400332|616922619|FG001|Treatment|Other reasons|1|||
170702348|NCT03400332|616922620|FG002|Treatment|Other reasons|1|||
170702349|NCT03400332|616922621|FG003|Treatment|Other reasons|0|||
170702350|NCT03400332|616922622|FG004|Treatment|Other reasons|3|||
170702351|NCT03400332|616922623|FG005|Treatment|Other reasons|1|||
170702352|NCT03400332|616922624|FG006|Treatment|Other reasons|2|||
170702353|NCT03400332|616922625|FG007|Treatment|Other reasons|0|||
170702354|NCT03400332|616922626|FG008|Treatment|Other reasons|1|||
170824951|NCT01845649|617367887|FG001|Overall Study|Withdrew Consent|4|||
170824952|NCT01845649|617367886|FG000|Overall Study|Protocol Deviation|7|||
170824953|NCT01845649|617367887|FG001|Overall Study|Protocol Deviation|4|||
170824954|NCT01845649|617367886|FG000|Overall Study|Reason not Specified|2|||
170824955|NCT01845649|617367887|FG001|Overall Study|Reason not Specified|1|||
170824956|NCT00381797|617367888|FG000|Overall Study|Withdrawal by Subject|1|||
170824957|NCT00381797|617367889|FG001|Overall Study|Withdrawal by Subject|1|||
170824958|NCT00381797|617367890|FG002|Overall Study|Withdrawal by Subject|0|||
170824959|NCT00381797|617367891|FG003|Overall Study|Withdrawal by Subject|0|||
170824960|NCT00381797|617367892|FG004|Overall Study|Withdrawal by Subject|2|||
170824961|NCT00381797|617367888|FG000|Overall Study|Ineligible|0|||
170824962|NCT00381797|617367889|FG001|Overall Study|Ineligible|0|||
170824963|NCT00381797|617367890|FG002|Overall Study|Ineligible|0|||
170824964|NCT00381797|617367891|FG003|Overall Study|Ineligible|1|||
170824965|NCT00381797|617367892|FG004|Overall Study|Ineligible|0|||
170824966|NCT01947517|617367895|FG000|Overall Study|Withdrawal by Subject|1|||
170824967|NCT01947517|617367896|FG001|Overall Study|Withdrawal by Subject|1|||
170824968|NCT02418845|617367901|FG000|Overall Study|Lost to Follow-up|7|||
170824969|NCT02418845|617367902|FG001|Overall Study|Lost to Follow-up|2|||
170824970|NCT02418845|617367901|FG000|Overall Study|Lack of Efficacy|0|||
170824971|NCT02418845|617367902|FG001|Overall Study|Lack of Efficacy|3|||
170824972|NCT02418845|617367901|FG000|Overall Study|Physician Decision|5|||
170824973|NCT02418845|617367902|FG001|Overall Study|Physician Decision|5|||
170824974|NCT02418845|617367901|FG000|Overall Study|Protocol Violation|1|||
170824975|NCT02418845|617367902|FG001|Overall Study|Protocol Violation|0|||
170824976|NCT02418845|617367901|FG000|Overall Study|Withdrawal by Subject|3|||
170824977|NCT02418845|617367902|FG001|Overall Study|Withdrawal by Subject|2|||
170824978|NCT03972137|617367904|FG000|Overall Study|Lost to Follow-up|2|||
170824979|NCT03972137|617367904|FG000|Overall Study|Withdrawal by Subject|4|||
170824980|NCT03029234|617367907|FG000|Overall Study|Sponsor Decision|1|||
170824981|NCT03029234|617367907|FG000|Overall Study|Withdrawal by Subject|5|||
170824982|NCT03029234|617367907|FG000|Overall Study|Death|91|||
170824983|NCT03029234|617367907|FG000|Overall Study|Lost to Follow-up|2|||
170824984|NCT00498433|617367908|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
170824985|NCT00498433|617367909|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
170824986|NCT00498433|617367910|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
170824987|NCT00498433|617367908|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
170824988|NCT00498433|617367909|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
170824989|NCT00498433|617367910|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
170824990|NCT00498433|617367908|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
170824991|NCT00498433|617367909|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
170824992|NCT00498433|617367910|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
170824993|NCT00498433|617367908|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
170824994|NCT00498433|617367909|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
170824995|NCT00498433|617367910|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
170824996|NCT03193216|617367911|FG000|Overall Study|Lost to Follow-up|1|||
170824997|NCT03193216|617367912|FG001|Overall Study|Lost to Follow-up|0|||
170824998|NCT03193216|617367911|FG000|Overall Study|Withdrawal by Subject|5|||
170824999|NCT03193216|617367912|FG001|Overall Study|Withdrawal by Subject|0|||
170825000|NCT03193216|617367911|FG000|Overall Study|Physician Decision|4|||
170825001|NCT03193216|617367912|FG001|Overall Study|Physician Decision|0|||
170825002|NCT03214250|617367918|FG000|Overall Study|Death|5|||
170825003|NCT03214250|617367919|FG001|Overall Study|Death|5|||
170825004|NCT03214250|617367920|FG002|Overall Study|Death|7|||
170825005|NCT03214250|617367921|FG003|Overall Study|Death|4|||
170702355|NCT03400332|616922618|FG000|Treatment|Lost to Follow-up|0|||
170702356|NCT03400332|616922619|FG001|Treatment|Lost to Follow-up|1|||
170702357|NCT03400332|616922620|FG002|Treatment|Lost to Follow-up|0|||
170825006|NCT03214250|617367922|FG004|Overall Study|Death|23|||
170702358|NCT03400332|616922621|FG003|Treatment|Lost to Follow-up|0|||
170825007|NCT03214250|617367923|FG005|Overall Study|Death|23|||
170825008|NCT03214250|617367924|FG006|Overall Study|Death|24|||
170825009|NCT03214250|617367918|FG000|Overall Study|Lost to Follow-up|0|||
170825010|NCT03214250|617367919|FG001|Overall Study|Lost to Follow-up|0|||
170825011|NCT03214250|617367920|FG002|Overall Study|Lost to Follow-up|0|||
170825012|NCT03214250|617367921|FG003|Overall Study|Lost to Follow-up|1|||
170825013|NCT03214250|617367922|FG004|Overall Study|Lost to Follow-up|1|||
170825014|NCT03214250|617367923|FG005|Overall Study|Lost to Follow-up|2|||
170825015|NCT03214250|617367924|FG006|Overall Study|Lost to Follow-up|0|||
170825016|NCT03214250|617367918|FG000|Overall Study|Other|0|||
170825017|NCT03214250|617367919|FG001|Overall Study|Other|0|||
170825018|NCT03214250|617367920|FG002|Overall Study|Other|0|||
170825019|NCT03214250|617367921|FG003|Overall Study|Other|0|||
170825020|NCT03214250|617367922|FG004|Overall Study|Other|1|||
170825021|NCT03214250|617367923|FG005|Overall Study|Other|1|||
170825022|NCT03214250|617367924|FG006|Overall Study|Other|2|||
170825023|NCT03214250|617367918|FG000|Overall Study|Remains on Study|2|||
170825024|NCT03214250|617367919|FG001|Overall Study|Remains on Study|2|||
170825025|NCT03214250|617367920|FG002|Overall Study|Remains on Study|0|||
170825026|NCT03214250|617367921|FG003|Overall Study|Remains on Study|1|||
170825027|NCT03214250|617367922|FG004|Overall Study|Remains on Study|7|||
170825028|NCT03214250|617367923|FG005|Overall Study|Remains on Study|5|||
170825029|NCT03214250|617367924|FG006|Overall Study|Remains on Study|3|||
170825030|NCT03214250|617367918|FG000|Overall Study|Withdrawal by Subject|0|||
170825031|NCT03214250|617367919|FG001|Overall Study|Withdrawal by Subject|0|||
170825032|NCT03214250|617367920|FG002|Overall Study|Withdrawal by Subject|1|||
170825033|NCT03214250|617367921|FG003|Overall Study|Withdrawal by Subject|2|||
170825034|NCT03214250|617367922|FG004|Overall Study|Withdrawal by Subject|5|||
170825035|NCT03214250|617367923|FG005|Overall Study|Withdrawal by Subject|0|||
170825036|NCT03214250|617367924|FG006|Overall Study|Withdrawal by Subject|2|||
170825037|NCT02845375|617367930|FG000|Overall Study|upper airway obstruction|1|||
170825038|NCT02845375|617367931|FG001|Overall Study|upper airway obstruction|2|||
170825039|NCT02845375|617367932|FG002|Overall Study|upper airway obstruction|1|||
170825040|NCT01388478|617367933|FG000|Overall Study|Adverse Event|4|||
170825041|NCT01388478|617367933|FG000|Overall Study|Withdrawal by Subject|1|||
170825042|NCT01990664|617367934|FG000|Overall Study|Lost to Follow-up|2|||
170825043|NCT01990664|617367935|FG001|Overall Study|Lost to Follow-up|6|||
170825044|NCT01990664|617367934|FG000|Overall Study|Withdrawal by Subject|2|||
170825045|NCT01990664|617367935|FG001|Overall Study|Withdrawal by Subject|3|||
170825046|NCT01990664|617367934|FG000|Overall Study|Protocol Violation|1|||
170825047|NCT01990664|617367935|FG001|Overall Study|Protocol Violation|0|||
170825048|NCT01990664|617367934|FG000|Overall Study|Lens Discomfort|1|||
170825049|NCT01990664|617367935|FG001|Overall Study|Lens Discomfort|1|||
170825050|NCT01990664|617367934|FG000|Overall Study|Lens Handling Difficulties|1|||
170825051|NCT01990664|617367935|FG001|Overall Study|Lens Handling Difficulties|0|||
170825052|NCT01990664|617367934|FG000|Overall Study|Unsatisfactory Visual Response|0|||
170825053|NCT01990664|617367935|FG001|Overall Study|Unsatisfactory Visual Response|1|||
170825054|NCT01037413|617367936|FG000|Part A: Skin Testing|Adverse Event|1|||
170825055|NCT01037413|617367937|FG001|Part A: Skin Testing|Adverse Event|0|||
170825056|NCT01037413|617367936|FG000|Part A: Skin Testing|Protocol Violation|1|||
170825057|NCT01037413|617367937|FG001|Part A: Skin Testing|Protocol Violation|0|||
170825058|NCT01037413|617367936|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
170825059|NCT01037413|617367937|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
170825060|NCT01037413|617367936|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
170825061|NCT01037413|617367937|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
170825062|NCT00619983|617367938|FG000|Test Drug Alone|Withdrawal by Subject|1|||
170825063|NCT00619983|617367939|FG001|Test Drug Alone|Withdrawal by Subject|0|||
170825064|NCT00619983|617367940|FG002|Test Drug Alone|Withdrawal by Subject|0|||
170825065|NCT00619983|617367941|FG003|Test Drug Alone|Withdrawal by Subject|1|||
170825066|NCT00619983|617367938|FG000|Test Drug Alone|Failure of daily diary device|1|||
170825067|NCT00619983|617367939|FG001|Test Drug Alone|Failure of daily diary device|1|||
170825068|NCT00619983|617367940|FG002|Test Drug Alone|Failure of daily diary device|2|||
170825069|NCT00619983|617367941|FG003|Test Drug Alone|Failure of daily diary device|2|||
170825070|NCT00809341|617367942|FG000|Overall Study|Physician Decision|0|||
170825071|NCT00809341|617367943|FG001|Overall Study|Physician Decision|1|||
170825072|NCT02630706|617367951|FG000|Overall Study|Adverse Event|2|||
170825073|NCT02630706|617367952|FG001|Overall Study|Adverse Event|1|||
170825074|NCT02630706|617367953|FG002|Overall Study|Adverse Event|1|||
170825075|NCT02630706|617367951|FG000|Overall Study|Lost to Follow-up|0|||
170825076|NCT02630706|617367952|FG001|Overall Study|Lost to Follow-up|1|||
170825077|NCT02630706|617367953|FG002|Overall Study|Lost to Follow-up|2|||
170825078|NCT02630706|617367951|FG000|Overall Study|Physician Decision|1|||
170825079|NCT02630706|617367952|FG001|Overall Study|Physician Decision|1|||
170825080|NCT02630706|617367953|FG002|Overall Study|Physician Decision|0|||
170825081|NCT02630706|617367951|FG000|Overall Study|Pregnancy|0|||
170825082|NCT02630706|617367952|FG001|Overall Study|Pregnancy|1|||
170825083|NCT02630706|617367953|FG002|Overall Study|Pregnancy|0|||
170825084|NCT02630706|617367951|FG000|Overall Study|Withdrawal by Subject|4|||
170825085|NCT02630706|617367952|FG001|Overall Study|Withdrawal by Subject|5|||
170702359|NCT03400332|616922622|FG004|Treatment|Lost to Follow-up|0|||
170702360|NCT03400332|616922623|FG005|Treatment|Lost to Follow-up|0|||
170702361|NCT03400332|616922624|FG006|Treatment|Lost to Follow-up|0|||
170702362|NCT03400332|616922625|FG007|Treatment|Lost to Follow-up|0|||
170702363|NCT03400332|616922626|FG008|Treatment|Lost to Follow-up|0|||
170702364|NCT03400332|616922618|FG000|Treatment|Death|3|||
170702365|NCT03400332|616922619|FG001|Treatment|Death|1|||
170702366|NCT03400332|616922620|FG002|Treatment|Death|2|||
170702367|NCT03400332|616922621|FG003|Treatment|Death|3|||
170702368|NCT03400332|616922622|FG004|Treatment|Death|6|||
170702369|NCT03400332|616922623|FG005|Treatment|Death|2|||
170702370|NCT03400332|616922624|FG006|Treatment|Death|1|||
170702371|NCT03400332|616922625|FG007|Treatment|Death|3|||
170702372|NCT03400332|616922626|FG008|Treatment|Death|6|||
170702373|NCT00048542|616922627|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
170702374|NCT00048542|616922628|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
170702375|NCT00048542|616922629|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
170702376|NCT00048542|616922630|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
170702377|NCT00048542|616922631|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
170702378|NCT00048542|616922632|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
170702379|NCT00048542|616922633|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
170702380|NCT00048542|616922634|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
170702381|NCT00048542|616922627|FG000|Double-Blind Phase|Protocol Violation|0|||
170702382|NCT00048542|616922628|FG001|Double-Blind Phase|Protocol Violation|0|||
170702383|NCT00048542|616922629|FG002|Double-Blind Phase|Protocol Violation|1|||
170702384|NCT00048542|616922630|FG003|Double-Blind Phase|Protocol Violation|0|||
170702385|NCT00048542|616922631|FG004|Double-Blind Phase|Protocol Violation|0|||
170702386|NCT00048542|616922632|FG005|Double-Blind Phase|Protocol Violation|0|||
170702387|NCT00048542|616922633|FG006|Double-Blind Phase|Protocol Violation|0|||
170702388|NCT00048542|616922634|FG007|Double-Blind Phase|Protocol Violation|0|||
170702389|NCT00048542|616922627|FG000|Double-Blind Phase|Sponsor request or decision|2|||
170702390|NCT00048542|616922628|FG001|Double-Blind Phase|Sponsor request or decision|0|||
170702391|NCT00048542|616922629|FG002|Double-Blind Phase|Sponsor request or decision|0|||
170702392|NCT00048542|616922630|FG003|Double-Blind Phase|Sponsor request or decision|0|||
170702393|NCT00048542|616922631|FG004|Double-Blind Phase|Sponsor request or decision|0|||
170702394|NCT00048542|616922632|FG005|Double-Blind Phase|Sponsor request or decision|0|||
170702395|NCT00048542|616922633|FG006|Double-Blind Phase|Sponsor request or decision|0|||
170702396|NCT00048542|616922634|FG007|Double-Blind Phase|Sponsor request or decision|0|||
170702397|NCT00048542|616922627|FG000|Double-Blind Phase|Randomized in error|1|||
170702398|NCT00048542|616922628|FG001|Double-Blind Phase|Randomized in error|0|||
170702399|NCT00048542|616922629|FG002|Double-Blind Phase|Randomized in error|0|||
170702400|NCT00048542|616922630|FG003|Double-Blind Phase|Randomized in error|0|||
170702401|NCT00048542|616922631|FG004|Double-Blind Phase|Randomized in error|0|||
170702402|NCT00048542|616922632|FG005|Double-Blind Phase|Randomized in error|0|||
170702403|NCT00048542|616922633|FG006|Double-Blind Phase|Randomized in error|0|||
170702404|NCT00048542|616922634|FG007|Double-Blind Phase|Randomized in error|0|||
170702405|NCT00048542|616922627|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
170702406|NCT00048542|616922628|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
170702407|NCT00048542|616922629|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
170702408|NCT00048542|616922630|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
170702409|NCT00048542|616922631|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
170702410|NCT00048542|616922632|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
170702411|NCT00048542|616922633|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
170702412|NCT00048542|616922634|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
170702413|NCT00048542|616922627|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
170702414|NCT00048542|616922628|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
170702415|NCT00048542|616922629|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
170702416|NCT00048542|616922630|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
170702417|NCT00048542|616922631|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
170702418|NCT00048542|616922632|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
170702419|NCT00048542|616922633|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
170702420|NCT00048542|616922634|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
170825086|NCT02630706|617367953|FG002|Overall Study|Withdrawal by Subject|7|||
170702421|NCT00048542|616922627|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
170702422|NCT00048542|616922628|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
170825087|NCT01287416|617367956|FG000|Pre-post Training|Withdrawal by Subject|17|||
170702423|NCT00048542|616922629|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
170702424|NCT00048542|616922630|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
170702425|NCT00048542|616922631|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
170702426|NCT00048542|616922632|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
170702427|NCT00048542|616922633|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
170702428|NCT00048542|616922634|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
170702429|NCT00048542|616922627|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
170702430|NCT00048542|616922628|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
170702431|NCT00048542|616922629|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
170702432|NCT00048542|616922630|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
170702433|NCT00048542|616922631|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
170702434|NCT00048542|616922632|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
170702435|NCT00048542|616922633|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
170702436|NCT00048542|616922634|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
170702437|NCT00048542|616922627|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
170702438|NCT00048542|616922628|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
170702439|NCT00048542|616922629|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
170702440|NCT00048542|616922630|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
170702441|NCT00048542|616922631|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
170702442|NCT00048542|616922632|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
170702443|NCT00048542|616922633|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
170702444|NCT00048542|616922634|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
170702445|NCT00048542|616922627|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
170702446|NCT00048542|616922628|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
170702447|NCT00048542|616922629|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
170702448|NCT00048542|616922630|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
170702449|NCT00048542|616922631|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
170702450|NCT00048542|616922632|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
170702451|NCT00048542|616922633|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
170702452|NCT00048542|616922634|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
170702453|NCT00048542|616922627|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
170702454|NCT00048542|616922628|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
170702455|NCT00048542|616922629|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
170702456|NCT00048542|616922630|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
170702457|NCT00048542|616922631|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
170702458|NCT00048542|616922632|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
170702459|NCT00048542|616922633|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
170702460|NCT00048542|616922634|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
170702461|NCT00048542|616922627|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
170702462|NCT00048542|616922628|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
170702463|NCT00048542|616922629|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
170702464|NCT00048542|616922630|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
170702465|NCT00048542|616922631|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
170702466|NCT00048542|616922632|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
170702467|NCT00048542|616922633|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
170702468|NCT00048542|616922634|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
170702469|NCT00048542|616922627|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
170702470|NCT00048542|616922628|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
170702471|NCT00048542|616922629|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
170702472|NCT00048542|616922630|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
170702473|NCT00048542|616922631|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
170702474|NCT00048542|616922632|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
170702475|NCT00048542|616922633|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
170702476|NCT00048542|616922634|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
170702477|NCT00048542|616922627|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
170702478|NCT00048542|616922628|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
170702479|NCT00048542|616922629|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
170702480|NCT00048542|616922630|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
170702481|NCT00048542|616922631|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
170702482|NCT00048542|616922632|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
170702483|NCT00048542|616922633|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
170702484|NCT00048542|616922634|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
170702485|NCT00048542|616922627|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
170702486|NCT00048542|616922628|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
170702487|NCT00048542|616922629|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
170702488|NCT00048542|616922630|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
170702489|NCT00048542|616922631|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
170702490|NCT00048542|616922632|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
170702491|NCT00048542|616922633|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
170702492|NCT00048542|616922634|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
170702493|NCT04476017|616922636|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
170702494|NCT04476017|616922637|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
170825088|NCT01287416|617367957|FG001|Pre-post Training|Withdrawal by Subject|24|||
170702495|NCT02775344|616922638|FG000|Overall Study|No ovarian cyst identified|3|||
170702496|NCT02775344|616922639|FG001|Overall Study|No ovarian cyst identified|2|||
170702497|NCT03909165|616922644|FG000|Overall Study|Physician Decision|0|||
170702498|NCT03909165|616922645|FG001|Overall Study|Physician Decision|1|||
170702499|NCT03909165|616922646|FG002|Overall Study|Physician Decision|0|||
170702500|NCT03909165|616922647|FG003|Overall Study|Physician Decision|0|||
170702501|NCT03909165|616922648|FG004|Overall Study|Physician Decision|0|||
170702502|NCT03909165|616922644|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170702503|NCT03909165|616922645|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170702504|NCT03909165|616922646|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170702505|NCT03909165|616922647|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
170702506|NCT03909165|616922648|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
170702507|NCT03909165|616922644|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
170702508|NCT03909165|616922645|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
170702509|NCT03909165|616922646|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
170702510|NCT03909165|616922647|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
170702511|NCT03909165|616922648|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
170702512|NCT03909165|616922644|FG000|Overall Study|Previous Drug Exposure|0|||
170702513|NCT03909165|616922645|FG001|Overall Study|Previous Drug Exposure|0|||
170702514|NCT03909165|616922646|FG002|Overall Study|Previous Drug Exposure|1|||
170702515|NCT03909165|616922647|FG003|Overall Study|Previous Drug Exposure|0|||
170702516|NCT03909165|616922648|FG004|Overall Study|Previous Drug Exposure|0|||
170702517|NCT03909165|616922644|FG000|Overall Study|Early Discharge|1|||
170702518|NCT03909165|616922645|FG001|Overall Study|Early Discharge|0|||
170702519|NCT03909165|616922646|FG002|Overall Study|Early Discharge|0|||
170702520|NCT03909165|616922647|FG003|Overall Study|Early Discharge|0|||
170702521|NCT03909165|616922648|FG004|Overall Study|Early Discharge|0|||
170702522|NCT02018458|616922649|FG000|Overall Study|Death|4|||
170702523|NCT02852265|616922653|FG000|3-month Follow-up|Lost to Follow-up|1|||
170702524|NCT02852265|616922654|FG001|3-month Follow-up|Lost to Follow-up|1|||
170702525|NCT00727714|616922656|FG000|Overall Study|Lost to Follow-up|2|||
170702526|NCT00325234|616922657|FG000|Overall Study|Adverse Event|10|||
170702527|NCT00325234|616922658|FG001|Overall Study|Adverse Event|7|||
170702528|NCT00325234|616922657|FG000|Overall Study|Death due to Study Disease|1|||
170702529|NCT00325234|616922658|FG001|Overall Study|Death due to Study Disease|0|||
170702530|NCT00325234|616922657|FG000|Overall Study|Entry Criteria Not Met|1|||
170702531|NCT00325234|616922658|FG001|Overall Study|Entry Criteria Not Met|2|||
170702532|NCT00325234|616922657|FG000|Overall Study|Subject Decision|6|||
170702533|NCT00325234|616922658|FG001|Overall Study|Subject Decision|8|||
170702534|NCT00325234|616922657|FG000|Overall Study|Physician Decision|17|||
170702535|NCT00325234|616922658|FG001|Overall Study|Physician Decision|12|||
170702536|NCT00325234|616922657|FG000|Overall Study|Progressive Disease|34|||
170702537|NCT00325234|616922658|FG001|Overall Study|Progressive Disease|37|||
170825089|NCT01287416|617367956|FG000|Pre-post Training|Lost to Follow-up|5|||
170825090|NCT01287416|617367957|FG001|Pre-post Training|Lost to Follow-up|1|||
170825091|NCT01287416|617367956|FG000|6 Month Follow-up|Lost to Follow-up|3|||
170825092|NCT01287416|617367957|FG001|6 Month Follow-up|Lost to Follow-up|2|||
170825093|NCT02359552|617367958|FG000|Overall Study|Lost to Follow-up|3|||
170825094|NCT02359552|617367959|FG001|Overall Study|Lost to Follow-up|4|||
170825095|NCT02391116|617367970|FG000|Treatment|Withdrawal by Subject|1|||
170825096|NCT02391116|617367970|FG000|Treatment|Protocol Violation|1|||
170825097|NCT02391116|617367970|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
170825098|NCT02391116|617367970|FG000|Treatment|AE with Clinical PD|3|||
170825099|NCT02391116|617367970|FG000|Safety Follow-up|Adverse Event|1|||
170825100|NCT02391116|617367970|FG000|Safety Follow-up|Withdrawal by Subject|4|||
170825101|NCT02391116|617367970|FG000|Safety Follow-up|Switching to Other Therapy|4|||
170825102|NCT02391116|617367970|FG000|Safety Follow-up|No Follow Up|1|||
170825103|NCT02391116|617367970|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
170825104|NCT02391116|617367970|FG000|Active Follow-up|Withdrawal by Subject|1|||
170825105|NCT02391116|617367970|FG000|Active Follow-up|Switching to Other Therapy|2|||
170825106|NCT02391116|617367970|FG000|Survival Follow-up|Withdrawal by Subject|3|||
170825107|NCT02391116|617367970|FG000|Survival Follow-up|Switching to Other Therapy|1|||
170825108|NCT00607789|617367971|FG000|Overall Study|Adverse Event|3|||
170825109|NCT00607789|617367972|FG001|Overall Study|Adverse Event|0|||
170825110|NCT00607789|617367971|FG000|Overall Study|Lack of Efficacy|0|||
170825111|NCT00607789|617367972|FG001|Overall Study|Lack of Efficacy|1|||
170825112|NCT00607789|617367971|FG000|Overall Study|Inadequate adherence|3|||
170825113|NCT00607789|617367972|FG001|Overall Study|Inadequate adherence|0|||
170825114|NCT00607789|617367971|FG000|Overall Study|Lost to Follow-up|0|||
170702538|NCT03746522|616922672|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
170702539|NCT03746522|616922673|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
170702540|NCT03746522|616922674|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
170702541|NCT03746522|616922672|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
170702542|NCT03746522|616922673|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
170825115|NCT00607789|617367972|FG001|Overall Study|Lost to Follow-up|5|||
170702543|NCT03746522|616922674|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
170702544|NCT03746522|616922672|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
170702545|NCT03746522|616922673|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
170702546|NCT03746522|616922674|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
170702547|NCT03746522|616922672|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
170702548|NCT03746522|616922673|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
170702549|NCT03746522|616922674|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
170702550|NCT03746522|616922672|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
170702551|NCT03746522|616922673|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
170702552|NCT03746522|616922674|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
170702553|NCT02552316|616922678|FG000|Overall Study|Withdrawal by Subject|1|||
170702554|NCT02552316|616922678|FG000|Overall Study|Withdrawal due to non-compliance|1|||
170702555|NCT02659020|616922679|FG000|Overall Study|Adverse Event|0|||
170702556|NCT02659020|616922680|FG001|Overall Study|Adverse Event|0|||
170702557|NCT02659020|616922681|FG002|Overall Study|Adverse Event|0|||
170702558|NCT02659020|616922682|FG003|Overall Study|Adverse Event|2|||
170702559|NCT02659020|616922683|FG004|Overall Study|Adverse Event|0|||
170702560|NCT02659020|616922684|FG005|Overall Study|Adverse Event|0|||
170702561|NCT02659020|616922685|FG006|Overall Study|Adverse Event|2|||
170702562|NCT02659020|616922679|FG000|Overall Study|Lost to Follow-up|1|||
170702563|NCT02659020|616922680|FG001|Overall Study|Lost to Follow-up|2|||
170702564|NCT02659020|616922681|FG002|Overall Study|Lost to Follow-up|1|||
170702565|NCT02659020|616922682|FG003|Overall Study|Lost to Follow-up|6|||
170702566|NCT02659020|616922683|FG004|Overall Study|Lost to Follow-up|1|||
170702567|NCT02659020|616922684|FG005|Overall Study|Lost to Follow-up|5|||
170702568|NCT02659020|616922685|FG006|Overall Study|Lost to Follow-up|0|||
170702569|NCT02659020|616922679|FG000|Overall Study|Physician Decision|0|||
170702570|NCT02659020|616922680|FG001|Overall Study|Physician Decision|0|||
170702571|NCT02659020|616922681|FG002|Overall Study|Physician Decision|0|||
170702572|NCT02659020|616922682|FG003|Overall Study|Physician Decision|1|||
170702573|NCT02659020|616922683|FG004|Overall Study|Physician Decision|1|||
170702574|NCT02659020|616922684|FG005|Overall Study|Physician Decision|0|||
170702575|NCT02659020|616922685|FG006|Overall Study|Physician Decision|1|||
170702576|NCT02659020|616922679|FG000|Overall Study|Withdrawal by Subject|2|||
170702577|NCT02659020|616922680|FG001|Overall Study|Withdrawal by Subject|1|||
170702578|NCT02659020|616922681|FG002|Overall Study|Withdrawal by Subject|0|||
170702579|NCT02659020|616922682|FG003|Overall Study|Withdrawal by Subject|3|||
170702580|NCT02659020|616922683|FG004|Overall Study|Withdrawal by Subject|3|||
170702581|NCT02659020|616922684|FG005|Overall Study|Withdrawal by Subject|6|||
170702582|NCT02659020|616922685|FG006|Overall Study|Withdrawal by Subject|3|||
170702583|NCT02659020|616922679|FG000|Overall Study|Progressive Disease|0|||
170702584|NCT02659020|616922680|FG001|Overall Study|Progressive Disease|0|||
170702585|NCT02659020|616922681|FG002|Overall Study|Progressive Disease|0|||
170702586|NCT02659020|616922682|FG003|Overall Study|Progressive Disease|4|||
170702587|NCT02659020|616922683|FG004|Overall Study|Progressive Disease|1|||
170702588|NCT02659020|616922684|FG005|Overall Study|Progressive Disease|0|||
170702589|NCT02659020|616922685|FG006|Overall Study|Progressive Disease|2|||
170702590|NCT04116710|616922687|FG000|Overall Study|Death|4|||
170702591|NCT04116710|616922688|FG001|Overall Study|Death|6|||
170702592|NCT04116710|616922689|FG002|Overall Study|Death|3|||
170702593|NCT04116710|616922690|FG003|Overall Study|Death|1|||
170702594|NCT04116710|616922687|FG000|Overall Study|Withdrawal by Subject|0|||
170702595|NCT04116710|616922688|FG001|Overall Study|Withdrawal by Subject|0|||
170702596|NCT04116710|616922689|FG002|Overall Study|Withdrawal by Subject|0|||
170702597|NCT04116710|616922690|FG003|Overall Study|Withdrawal by Subject|1|||
170702598|NCT01256593|616922691|FG000|Overall Study|Protocol Violation|26|||
170702599|NCT01256593|616922691|FG000|Overall Study|No Drug Administration Information|2|||
170702600|NCT01256593|616922691|FG000|Overall Study|No Visit After Treatment|186|||
170702601|NCT02703636|616922692|FG000|Overall Study|Adverse Event|14|||
170825116|NCT00607789|617367971|FG000|Overall Study|Withdrawal by Subject|1|||
170825117|NCT00607789|617367972|FG001|Overall Study|Withdrawal by Subject|0|||
170825118|NCT02154516|617367976|FG000|Overall Study|Withdrawal by Subject|0|||
170702602|NCT02703636|616922692|FG000|Overall Study|Study stopped by sponsor|1|||
170702603|NCT02703636|616922692|FG000|Overall Study|Withdrawal by Subject|1|||
170702604|NCT01494610|616922695|FG000|Period 1|Withdrawal by Subject|1|||
170702605|NCT01494610|616922696|FG001|Period 1|Withdrawal by Subject|1|||
170702606|NCT01494610|616922695|FG000|Period 3|Adverse Event|1|||
170702607|NCT01494610|616922696|FG001|Period 3|Adverse Event|0|||
170702608|NCT01494610|616922695|FG000|Period 3|Withdrawal by Subject|1|||
170702609|NCT01494610|616922696|FG001|Period 3|Withdrawal by Subject|0|||
170702610|NCT01494610|616922695|FG000|Period 4|Protocol Violation|1|||
170825119|NCT02154516|617367977|FG001|Overall Study|Withdrawal by Subject|1|||
170702611|NCT01494610|616922696|FG001|Period 4|Protocol Violation|0|||
170702612|NCT02161718|616922697|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
170702613|NCT02161718|616922698|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
170702614|NCT02161718|616922699|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
170702615|NCT02161718|616922697|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
170702616|NCT02161718|616922698|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
170702617|NCT02161718|616922699|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
170702618|NCT02161718|616922697|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
170702619|NCT02161718|616922698|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
170702620|NCT02161718|616922699|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
170702621|NCT02161718|616922697|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
170702622|NCT02161718|616922698|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
170702623|NCT02161718|616922699|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
170702624|NCT02161718|616922697|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
170702625|NCT02161718|616922698|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
170702626|NCT02161718|616922699|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
170702627|NCT02161718|616922697|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
170702628|NCT02161718|616922698|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
170702629|NCT02161718|616922699|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
170702630|NCT02161718|616922697|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
170702631|NCT02161718|616922698|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
170702632|NCT02161718|616922699|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
170702633|NCT02161718|616922697|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
170702634|NCT02161718|616922698|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
170702635|NCT02161718|616922699|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
170702636|NCT02161718|616922697|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
170702637|NCT02161718|616922698|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
170702638|NCT02161718|616922699|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
170702639|NCT02161718|616922697|FG000|Post- Randomization Period|Lost to Follow-up|0|||
170702640|NCT02161718|616922698|FG001|Post- Randomization Period|Lost to Follow-up|9|||
170702641|NCT02161718|616922699|FG002|Post- Randomization Period|Lost to Follow-up|15|||
170702642|NCT02161718|616922697|FG000|Post- Randomization Period|Adverse Event|0|||
170702643|NCT02161718|616922698|FG001|Post- Randomization Period|Adverse Event|9|||
170702644|NCT02161718|616922699|FG002|Post- Randomization Period|Adverse Event|10|||
170702645|NCT02161718|616922697|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
170702646|NCT02161718|616922698|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
170702647|NCT02161718|616922699|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
170702648|NCT02161718|616922697|FG000|Post- Randomization Period|Physician Decision|0|||
170702649|NCT02161718|616922698|FG001|Post- Randomization Period|Physician Decision|2|||
170702650|NCT02161718|616922699|FG002|Post- Randomization Period|Physician Decision|4|||
170702651|NCT02161718|616922697|FG000|Post- Randomization Period|Protocol Violation|0|||
170702652|NCT02161718|616922698|FG001|Post- Randomization Period|Protocol Violation|2|||
170702653|NCT02161718|616922699|FG002|Post- Randomization Period|Protocol Violation|3|||
170702654|NCT02161718|616922697|FG000|Post- Randomization Period|Lack of Efficacy|0|||
170702655|NCT02161718|616922698|FG001|Post- Randomization Period|Lack of Efficacy|0|||
170702656|NCT02161718|616922699|FG002|Post- Randomization Period|Lack of Efficacy|1|||
170702657|NCT02161718|616922697|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
170702658|NCT02161718|616922698|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
170702659|NCT02161718|616922699|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
170702660|NCT02161718|616922697|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
170825120|NCT02154516|617367976|FG000|Overall Study|Lost to Follow-up|1|||
170825121|NCT02154516|617367977|FG001|Overall Study|Lost to Follow-up|0|||
170825122|NCT02154516|617367976|FG000|Overall Study|Removal/revision of device|1|||
170825123|NCT02154516|617367977|FG001|Overall Study|Removal/revision of device|0|||
170825124|NCT02154516|617367976|FG000|Overall Study|Death|2|||
170825125|NCT02154516|617367977|FG001|Overall Study|Death|1|||
170825126|NCT03406507|617367978|FG000|Extension Period|Lack of Efficacy|0|||
170825127|NCT03406507|617367979|FG001|Extension Period|Lack of Efficacy|1|||
170825128|NCT04435522|617367982|FG000|Overall Study|Withdrawal by Subject|2|||
170825129|NCT04341584|617367985|FG000|Overall Study|Withdrew consent|0|||
170825130|NCT04341584|617367986|FG001|Overall Study|Withdrew consent|2|||
170825131|NCT04341584|617367987|FG002|Overall Study|Withdrew consent|2|||
170825132|NCT04341584|617367988|FG003|Overall Study|Withdrew consent|1|||
170825133|NCT04156399|617370018|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
170825134|NCT04156399|617370018|FG000|Overall Study|study suspension due to COVID pandemic|3|||
170825135|NCT01703845|617370021|FG000|Overall Study|Adverse Event|1|||
170825136|NCT01703845|617370022|FG001|Overall Study|Adverse Event|0|||
170825137|NCT01703845|617370021|FG000|Overall Study|Protocol Violation|1|||
170825138|NCT01703845|617370022|FG001|Overall Study|Protocol Violation|0|||
170825139|NCT01703845|617370021|FG000|Overall Study|other than stated above|1|||
170825140|NCT01703845|617370022|FG001|Overall Study|other than stated above|0|||
170825141|NCT01644188|617370023|FG000|Overall Study|Adverse Event|44|||
170825142|NCT01644188|617370024|FG001|Overall Study|Adverse Event|20|||
170825143|NCT01644188|617370023|FG000|Overall Study|Poor compliance to protocol|26|||
170825144|NCT01644188|617370024|FG001|Overall Study|Poor compliance to protocol|14|||
170825145|NCT01644188|617370023|FG000|Overall Study|Physician Decision|1|||
170702661|NCT02161718|616922698|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
170702662|NCT02161718|616922699|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
170702663|NCT02161718|616922697|FG000|Post- Randomization Period|Relocation|0|||
170702664|NCT02161718|616922698|FG001|Post- Randomization Period|Relocation|3|||
170702665|NCT02161718|616922699|FG002|Post- Randomization Period|Relocation|0|||
170702666|NCT01857063|616922700|FG000|Period 1 (7 Days)|Adverse Event|0|||
170702667|NCT01857063|616922701|FG001|Period 1 (7 Days)|Adverse Event|1|||
170702668|NCT01857063|616922700|FG000|Period 1 (7 Days)|Physician Decision|1|||
170702669|NCT01857063|616922701|FG001|Period 1 (7 Days)|Physician Decision|0|||
170702670|NCT01857063|616922700|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
170825146|NCT01644188|617370024|FG001|Overall Study|Physician Decision|3|||
170825147|NCT01644188|617370023|FG000|Overall Study|Participant moved|7|||
170825148|NCT01644188|617370024|FG001|Overall Study|Participant moved|2|||
170825149|NCT01644188|617370023|FG000|Overall Study|Related to auto-injector administration|2|||
170825150|NCT01644188|617370024|FG001|Overall Study|Related to auto-injector administration|2|||
170825151|NCT01644188|617370023|FG000|Overall Study|Consent withdrawn by participant|14|||
170825152|NCT01644188|617370024|FG001|Overall Study|Consent withdrawn by participant|7|||
170825153|NCT01644188|617370023|FG000|Overall Study|Selection criteria finally not met|2|||
170825154|NCT01644188|617370024|FG001|Overall Study|Selection criteria finally not met|0|||
170825155|NCT01644188|617370023|FG000|Overall Study|Lost to Follow-up|1|||
170825156|NCT01644188|617370024|FG001|Overall Study|Lost to Follow-up|0|||
170825157|NCT01644188|617370023|FG000|Overall Study|Death|4|||
170825158|NCT01644188|617370024|FG001|Overall Study|Death|3|||
170825159|NCT01644188|617370023|FG000|Overall Study|Last visit outside protocol visit window|14|||
170825160|NCT01644188|617370024|FG001|Overall Study|Last visit outside protocol visit window|16|||
170825161|NCT01644188|617370023|FG000|Overall Study|Site closure|1|||
170825162|NCT01644188|617370024|FG001|Overall Study|Site closure|1|||
170825163|NCT01644188|617370023|FG000|Overall Study|Other than specified above|6|||
170825164|NCT01644188|617370024|FG001|Overall Study|Other than specified above|7|||
170825165|NCT01222533|617370029|FG000|Overall Study|Adverse Event|5|||
170825166|NCT01222533|617370029|FG000|Overall Study|Withdrawal by Subject|5|||
170825167|NCT01222533|617370029|FG000|Overall Study|Other|4|||
170825168|NCT03834623|617370030|FG000|Overall Study|Progression|0|||
170825169|NCT03834623|617370031|FG001|Overall Study|Progression|1|||
170825170|NCT03418493|617370032|FG000|Overall Study|Adverse Event|1|||
170825171|NCT03418493|617370033|FG001|Overall Study|Adverse Event|0|||
170825172|NCT03418493|617370034|FG002|Overall Study|Adverse Event|0|||
170825173|NCT03418493|617370035|FG003|Overall Study|Adverse Event|0|||
170825174|NCT03418493|617370036|FG004|Overall Study|Adverse Event|0|||
170825175|NCT03418493|617370037|FG005|Overall Study|Adverse Event|0|||
170825176|NCT03418493|617370038|FG006|Overall Study|Adverse Event|0|||
170825177|NCT03418493|617370039|FG007|Overall Study|Adverse Event|0|||
170825178|NCT03418493|617370040|FG008|Overall Study|Adverse Event|0|||
170825179|NCT03418493|617370041|FG009|Overall Study|Adverse Event|0|||
170825180|NCT03418493|617370042|FG010|Overall Study|Adverse Event|0|||
170825181|NCT03418493|617370032|FG000|Overall Study|Protocol Violation|0|||
170825182|NCT03418493|617370033|FG001|Overall Study|Protocol Violation|0|||
170825183|NCT03418493|617370034|FG002|Overall Study|Protocol Violation|0|||
170825184|NCT03418493|617370035|FG003|Overall Study|Protocol Violation|0|||
170825185|NCT03418493|617370036|FG004|Overall Study|Protocol Violation|0|||
170825186|NCT03418493|617370037|FG005|Overall Study|Protocol Violation|0|||
170825187|NCT03418493|617370038|FG006|Overall Study|Protocol Violation|0|||
170825188|NCT03418493|617370039|FG007|Overall Study|Protocol Violation|0|||
170825189|NCT03418493|617370040|FG008|Overall Study|Protocol Violation|0|||
170825190|NCT03418493|617370041|FG009|Overall Study|Protocol Violation|1|||
170825191|NCT03418493|617370042|FG010|Overall Study|Protocol Violation|0|||
170825192|NCT00719212|617370043|FG000|Overall Study|Death|41|||
170825193|NCT00719212|617370043|FG000|Overall Study|Lost to Follow-up|2|||
170825194|NCT00719212|617370043|FG000|Overall Study|Withdrawal by Subject|1|||
170825195|NCT00460564|617370044|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
170825196|NCT00460564|617370045|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
170825197|NCT00460564|617370046|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170825198|NCT00460564|617370047|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170825199|NCT00460564|617370048|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170825200|NCT00460564|617370049|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170825201|NCT00460564|617370050|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170825202|NCT00460564|617370051|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
170825203|NCT00460564|617370044|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
170825204|NCT00460564|617370045|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170825205|NCT00460564|617370046|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170825206|NCT00460564|617370047|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170825207|NCT00460564|617370048|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170825208|NCT00460564|617370049|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170702671|NCT01857063|616922701|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
170702672|NCT01857063|616922700|FG000|Period 2 (7 Days)|Adverse Event|2|||
170702673|NCT01857063|616922701|FG001|Period 2 (7 Days)|Adverse Event|1|||
170702674|NCT01857063|616922700|FG000|Period 2 (7 Days)|Physician Decision|1|||
170702675|NCT01857063|616922701|FG001|Period 2 (7 Days)|Physician Decision|1|||
170702676|NCT01857063|616922700|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
170702677|NCT01857063|616922701|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
170702678|NCT02346240|616922702|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702679|NCT02346240|616922703|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
170702680|NCT02346240|616922704|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
170702681|NCT02346240|616922705|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
170702682|NCT02346240|616922706|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702683|NCT02346240|616922707|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702684|NCT02346240|616922708|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702685|NCT02346240|616922709|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702686|NCT02346240|616922710|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702687|NCT02346240|616922711|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702688|NCT02346240|616922712|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702689|NCT02346240|616922713|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702690|NCT02346240|616922714|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702691|NCT02346240|616922715|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702692|NCT02346240|616922716|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702693|NCT02346240|616922717|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702694|NCT02346240|616922718|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702695|NCT02346240|616922719|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702696|NCT02346240|616922720|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702697|NCT02346240|616922721|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702698|NCT02346240|616922722|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702699|NCT02346240|616922723|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702700|NCT02346240|616922724|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702701|NCT02346240|616922725|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
170702702|NCT02346240|616922702|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702703|NCT02346240|616922703|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
170702704|NCT02346240|616922704|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702705|NCT02346240|616922705|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702706|NCT02346240|616922706|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702707|NCT02346240|616922707|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702708|NCT02346240|616922708|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702709|NCT02346240|616922709|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702710|NCT02346240|616922710|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702711|NCT02346240|616922711|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702712|NCT02346240|616922712|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702713|NCT02346240|616922713|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702714|NCT02346240|616922714|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702715|NCT02346240|616922715|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702716|NCT02346240|616922716|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702717|NCT02346240|616922717|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702718|NCT02346240|616922718|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702719|NCT02346240|616922719|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702720|NCT02346240|616922720|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702721|NCT02346240|616922721|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702722|NCT02346240|616922722|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702723|NCT02346240|616922723|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702724|NCT02346240|616922724|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702725|NCT02346240|616922725|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
170702726|NCT02346240|616922702|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702727|NCT02346240|616922703|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
170702728|NCT02346240|616922704|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702729|NCT02346240|616922705|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702730|NCT02346240|616922706|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702731|NCT02346240|616922707|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702732|NCT02346240|616922708|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702733|NCT02346240|616922709|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702734|NCT02346240|616922710|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702735|NCT02346240|616922711|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170825209|NCT00460564|617370050|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170825210|NCT00460564|617370051|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
170825211|NCT00460564|617370044|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
170825212|NCT00460564|617370045|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
170702736|NCT02346240|616922712|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170825213|NCT00460564|617370046|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
170825214|NCT00460564|617370047|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
170825215|NCT00460564|617370048|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
170825216|NCT00460564|617370049|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
170825217|NCT00460564|617370050|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
170825218|NCT00460564|617370051|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
170825219|NCT00460564|617370044|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
170825220|NCT00460564|617370045|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
170825221|NCT00460564|617370046|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
170825222|NCT00460564|617370047|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
170825223|NCT00460564|617370048|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
170702737|NCT02346240|616922713|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702738|NCT02346240|616922714|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702739|NCT02346240|616922715|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702740|NCT02346240|616922716|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702741|NCT02346240|616922717|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702742|NCT02346240|616922718|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702743|NCT02346240|616922719|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702744|NCT02346240|616922720|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702745|NCT02346240|616922721|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702746|NCT02346240|616922722|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702747|NCT02346240|616922723|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702748|NCT02346240|616922724|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702749|NCT02346240|616922725|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
170702750|NCT02346240|616922702|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
170702751|NCT02346240|616922703|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
170702752|NCT02346240|616922704|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
170702753|NCT02346240|616922705|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
170702754|NCT02346240|616922706|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702755|NCT02346240|616922707|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702756|NCT02346240|616922708|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702757|NCT02346240|616922709|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702758|NCT02346240|616922710|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702759|NCT02346240|616922711|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702760|NCT02346240|616922712|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702761|NCT02346240|616922713|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702762|NCT02346240|616922714|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702763|NCT02346240|616922715|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702764|NCT02346240|616922716|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702765|NCT02346240|616922717|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702766|NCT02346240|616922718|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702767|NCT02346240|616922719|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702768|NCT02346240|616922720|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702769|NCT02346240|616922721|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702770|NCT02346240|616922722|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702771|NCT02346240|616922723|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702772|NCT02346240|616922724|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702773|NCT02346240|616922725|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
170702774|NCT02346240|616922702|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
170702775|NCT02346240|616922703|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
170702776|NCT02346240|616922704|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
170702777|NCT02346240|616922705|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
170702778|NCT02346240|616922706|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702779|NCT02346240|616922707|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702780|NCT02346240|616922708|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702781|NCT02346240|616922709|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702782|NCT02346240|616922710|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170825224|NCT00460564|617370049|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
170825225|NCT00460564|617370050|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
170825226|NCT00460564|617370051|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
170825227|NCT00460564|617370044|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
170702783|NCT02346240|616922711|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170825228|NCT00460564|617370045|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
170825229|NCT00460564|617370046|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
170825230|NCT00460564|617370047|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
170825231|NCT00460564|617370048|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
170825232|NCT00460564|617370049|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
170825233|NCT00460564|617370050|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
170825234|NCT00460564|617370051|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
170825235|NCT00966979|617370052|FG000|Overall Study|Death|1|||
170825236|NCT00966979|617370052|FG000|Overall Study|Lost to Follow-up|6|||
170825237|NCT00966979|617370052|FG000|Overall Study|Withdrawal by Subject|14|||
170825238|NCT00966979|617370052|FG000|Overall Study|Adverse Event|5|||
170825239|NCT00966979|617370052|FG000|Overall Study|Sponsor terminated early|49|||
170825240|NCT00966979|617370052|FG000|Overall Study|Censored because surgery not done|2|||
170825241|NCT00966979|617370052|FG000|Overall Study|Censored because study device was not implanted|14|||
170825242|NCT00966979|617370052|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
170825243|NCT04140266|617370053|FG000|Overall Study|Physician Decision|2|||
170825244|NCT04140266|617370054|FG001|Overall Study|Physician Decision|0|||
170825245|NCT04140266|617370053|FG000|Overall Study|Withdrawal by Subject|4|||
170825246|NCT04140266|617370054|FG001|Overall Study|Withdrawal by Subject|2|||
170825247|NCT00943618|617370058|FG000|Overall Study|Lost to Follow-up|38|||
170825248|NCT00943618|617370059|FG001|Overall Study|Lost to Follow-up|48|||
170825249|NCT00943618|617370060|FG002|Overall Study|Lost to Follow-up|20|||
170825250|NCT00943618|617370058|FG000|Overall Study|Discontinued Medication|17|||
170825251|NCT00943618|617370059|FG001|Overall Study|Discontinued Medication|29|||
170825252|NCT00943618|617370060|FG002|Overall Study|Discontinued Medication|11|||
170825253|NCT00837096|617370066|FG000|Overall Study|Physician Decision|1|||
170825254|NCT00837096|617370067|FG001|Overall Study|Physician Decision|1|||
170825255|NCT00837096|617370066|FG000|Overall Study|Not reported|9|||
170825256|NCT00837096|617370067|FG001|Overall Study|Not reported|8|||
170825257|NCT03226106|617370068|FG000|Overall Study|Withdrawal by Subject|2|||
170825258|NCT03226106|617370069|FG001|Overall Study|Withdrawal by Subject|0|||
170825259|NCT03226106|617370068|FG000|Overall Study|Adverse Event|1|||
170825260|NCT03226106|617370069|FG001|Overall Study|Adverse Event|0|||
170825261|NCT03226106|617370068|FG000|Overall Study|Lost to Follow-up|2|||
170825262|NCT03226106|617370069|FG001|Overall Study|Lost to Follow-up|0|||
170825263|NCT00983905|617370070|FG000|Theophylline Alone|Adverse Event|1|||
170825264|NCT00983905|617370070|FG000|Colchicine Alone|Adverse Event|2|||
170825265|NCT02815735|617370071|FG000|First Intervention (4 Weeks)|Discomfort|1|||
170825266|NCT02815735|617370072|FG001|First Intervention (4 Weeks)|Discomfort|0|||
170825267|NCT02815735|617370071|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
170825268|NCT02815735|617370072|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
170825269|NCT02815735|617370071|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
170825270|NCT02815735|617370072|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
170825271|NCT02815735|617370071|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
170825272|NCT02815735|617370072|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
170825273|NCT02973802|617370073|FG000|Overall Study|Lost to Follow-up|1|||
170825274|NCT02973802|617370073|FG000|Overall Study|Withdrawal by Subject|1|||
170825275|NCT00706914|617370074|FG000|Overall Study|Lack of Efficacy|0|||
170825276|NCT00706914|617370075|FG001|Overall Study|Lack of Efficacy|1|||
170825277|NCT00706914|617370076|FG002|Overall Study|Lack of Efficacy|0|||
170825278|NCT00706914|617370074|FG000|Overall Study|Lost to Follow-up|1|||
170825279|NCT00706914|617370075|FG001|Overall Study|Lost to Follow-up|0|||
170825280|NCT00706914|617370076|FG002|Overall Study|Lost to Follow-up|0|||
170825281|NCT00706914|617370074|FG000|Overall Study|Adverse Event|2|||
170825282|NCT00706914|617370075|FG001|Overall Study|Adverse Event|2|||
170825283|NCT00706914|617370076|FG002|Overall Study|Adverse Event|0|||
170825284|NCT00706914|617370074|FG000|Overall Study|Protocol Violation|3|||
170825285|NCT00706914|617370075|FG001|Overall Study|Protocol Violation|1|||
170825286|NCT00706914|617370076|FG002|Overall Study|Protocol Violation|1|||
170825287|NCT01402063|617370077|FG000|Overall Study|Withdrawal by Subject|3|||
170825288|NCT01402063|617370078|FG001|Overall Study|Withdrawal by Subject|3|||
170825289|NCT05153499|617370079|FG000|Overall Study|Withdrawal by Subject|1|||
170825290|NCT05153499|617370080|FG001|Overall Study|Withdrawal by Subject|0|||
170825291|NCT05153499|617370079|FG000|Overall Study|Clinical Hold|1|||
170825292|NCT05153499|617370080|FG001|Overall Study|Clinical Hold|0|||
170702784|NCT02346240|616922712|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702785|NCT02346240|616922713|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702786|NCT02346240|616922714|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702787|NCT02346240|616922715|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702788|NCT02346240|616922716|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702789|NCT02346240|616922717|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702790|NCT02346240|616922718|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702791|NCT02346240|616922719|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702792|NCT02346240|616922720|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702793|NCT02346240|616922721|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702794|NCT02346240|616922722|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702795|NCT02346240|616922723|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702796|NCT02346240|616922724|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702797|NCT02346240|616922725|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
170702798|NCT02346240|616922702|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702799|NCT02346240|616922703|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
170702800|NCT02346240|616922704|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702801|NCT02346240|616922705|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
170702802|NCT02346240|616922706|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702803|NCT02346240|616922707|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702804|NCT02346240|616922708|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702805|NCT02346240|616922709|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702806|NCT02346240|616922710|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702807|NCT02346240|616922711|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702808|NCT02346240|616922712|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702809|NCT02346240|616922713|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702810|NCT02346240|616922714|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702811|NCT02346240|616922715|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702812|NCT02346240|616922716|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702813|NCT02346240|616922717|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702814|NCT02346240|616922718|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702815|NCT02346240|616922719|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702816|NCT02346240|616922720|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702817|NCT02346240|616922721|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702818|NCT02346240|616922722|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702819|NCT02346240|616922723|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702820|NCT02346240|616922724|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702821|NCT02346240|616922725|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
170702822|NCT02346240|616922702|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702823|NCT02346240|616922703|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702824|NCT02346240|616922704|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
170702825|NCT02346240|616922705|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702826|NCT02346240|616922706|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702827|NCT02346240|616922707|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702828|NCT02346240|616922708|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702829|NCT02346240|616922709|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702830|NCT02346240|616922710|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702831|NCT02346240|616922711|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702832|NCT02346240|616922712|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702833|NCT02346240|616922713|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702834|NCT02346240|616922714|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702835|NCT02346240|616922715|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702836|NCT02346240|616922716|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702837|NCT02346240|616922717|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702838|NCT02346240|616922718|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702839|NCT02346240|616922719|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702840|NCT02346240|616922720|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702841|NCT02346240|616922721|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702842|NCT02346240|616922722|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702843|NCT02346240|616922723|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702844|NCT02346240|616922724|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702845|NCT02346240|616922725|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
170702846|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170825293|NCT05153499|617370079|FG000|Overall Study|Study Termination|6|||
170825294|NCT05153499|617370080|FG001|Overall Study|Study Termination|5|||
170825295|NCT03220776|617370081|FG000|Overall Study|Claustrophobia|0|||
170825296|NCT03220776|617370082|FG001|Overall Study|Claustrophobia|1|||
170825297|NCT03220776|617370083|FG002|Overall Study|Claustrophobia|1|||
170825298|NCT03220776|617370084|FG003|Overall Study|Claustrophobia|0|||
170825299|NCT03220776|617370085|FG004|Overall Study|Claustrophobia|1|||
170825300|NCT03220776|617370086|FG005|Overall Study|Claustrophobia|0|||
170825301|NCT03220776|617370081|FG000|Overall Study|MRI Equipment Failure|1|||
170825302|NCT03220776|617370082|FG001|Overall Study|MRI Equipment Failure|0|||
170825303|NCT03220776|617370083|FG002|Overall Study|MRI Equipment Failure|0|||
170825304|NCT03220776|617370084|FG003|Overall Study|MRI Equipment Failure|0|||
170825305|NCT03220776|617370085|FG004|Overall Study|MRI Equipment Failure|0|||
170702847|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702848|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702849|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702850|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702851|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702852|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702853|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
170702854|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
170702855|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702856|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702857|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702858|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702859|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
170702860|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
170702861|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
170702862|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
170702863|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702864|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702865|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702866|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702867|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702868|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702869|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
170702870|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702871|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702872|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702873|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702874|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702875|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702876|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702877|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702878|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702879|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702880|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702881|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702882|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702883|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
170702884|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702885|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
170702886|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702887|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170825306|NCT03220776|617370086|FG005|Overall Study|MRI Equipment Failure|0|||
170825307|NCT03220776|617370081|FG000|Overall Study|Inclimate Weather|0|||
170825308|NCT03220776|617370082|FG001|Overall Study|Inclimate Weather|0|||
170825309|NCT03220776|617370083|FG002|Overall Study|Inclimate Weather|0|||
170825310|NCT03220776|617370084|FG003|Overall Study|Inclimate Weather|0|||
170825311|NCT03220776|617370085|FG004|Overall Study|Inclimate Weather|0|||
170825312|NCT03220776|617370086|FG005|Overall Study|Inclimate Weather|1|||
170825313|NCT03220776|617370081|FG000|Overall Study|Physician Decision|0|||
170825314|NCT03220776|617370082|FG001|Overall Study|Physician Decision|0|||
170825315|NCT03220776|617370083|FG002|Overall Study|Physician Decision|0|||
170825316|NCT03220776|617370084|FG003|Overall Study|Physician Decision|1|||
170825317|NCT03220776|617370085|FG004|Overall Study|Physician Decision|0|||
170825318|NCT03220776|617370086|FG005|Overall Study|Physician Decision|0|||
170825319|NCT03220776|617370081|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
170702888|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170825320|NCT03220776|617370082|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
170702889|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702890|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702891|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702892|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702893|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
170702894|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702895|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702896|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702897|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702898|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702899|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702900|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702901|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702902|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702903|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702904|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702905|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702906|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702907|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702908|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
170702909|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702910|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702911|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702912|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702913|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702914|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702915|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702916|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702917|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
170702918|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702919|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702920|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702921|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702922|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702923|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170702924|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170702925|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170702926|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170702927|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702928|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170702929|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
170702930|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702931|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
170702932|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
170702933|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
170702934|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
170702935|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702936|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702937|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702938|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702939|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702940|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170825321|NCT03220776|617370083|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
170702941|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
170702942|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702943|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170825322|NCT03220776|617370084|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
170825323|NCT03220776|617370085|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
170825324|NCT03220776|617370086|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
170825325|NCT03220776|617370081|FG000|Overall Study|Protocol Violation|0|||
170825326|NCT03220776|617370082|FG001|Overall Study|Protocol Violation|0|||
170825327|NCT03220776|617370083|FG002|Overall Study|Protocol Violation|0|||
170702944|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170825328|NCT03220776|617370084|FG003|Overall Study|Protocol Violation|2|||
170702945|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702946|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702947|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702948|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702949|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702950|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702951|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702952|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702953|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702954|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702955|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
170702956|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
170702957|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
170702958|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
170702959|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702960|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702961|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702962|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702963|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702964|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702965|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
170702966|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702967|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702968|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702969|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702970|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702971|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702972|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
170702973|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702974|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702975|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702976|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702977|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702978|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702979|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702980|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702981|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702982|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702983|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702984|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702985|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702986|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702987|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702988|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702989|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
170702990|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170702991|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170702992|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170702993|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170702994|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170702995|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170702996|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170702997|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170702998|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
170702999|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703000|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703001|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
170703002|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170825329|NCT03220776|617370085|FG004|Overall Study|Protocol Violation|0|||
170703003|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
170703004|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
170703005|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703006|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703007|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703008|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703009|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703010|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703011|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703012|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703013|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
170703014|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703015|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703016|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703017|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703018|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703019|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703020|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703021|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703022|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703023|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
170703024|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703025|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703026|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703027|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703028|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703029|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703030|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703031|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703032|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703033|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703034|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703035|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703036|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703037|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
170703038|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703039|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703040|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703041|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703042|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703043|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703044|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703045|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703046|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703047|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703048|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
170703049|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170825330|NCT03220776|617370086|FG005|Overall Study|Protocol Violation|1|||
170825331|NCT03220776|617370081|FG000|Overall Study|Withdrawal by Subject|1|||
170825332|NCT03220776|617370082|FG001|Overall Study|Withdrawal by Subject|0|||
170825333|NCT03220776|617370083|FG002|Overall Study|Withdrawal by Subject|0|||
170825334|NCT03220776|617370084|FG003|Overall Study|Withdrawal by Subject|0|||
170825335|NCT03220776|617370085|FG004|Overall Study|Withdrawal by Subject|0|||
170825336|NCT03220776|617370086|FG005|Overall Study|Withdrawal by Subject|0|||
170825337|NCT04491006|617370087|FG000|Overall Study|Adverse Event|0|||
170825338|NCT04491006|617370088|FG001|Overall Study|Adverse Event|3|||
170825339|NCT04491006|617370089|FG002|Overall Study|Adverse Event|5|||
170825340|NCT04491006|617370087|FG000|Overall Study|Withdrawal by Subject|1|||
170825341|NCT04491006|617370088|FG001|Overall Study|Withdrawal by Subject|0|||
170703050|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703051|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703052|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703053|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703054|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703055|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703056|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703057|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703058|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703059|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703060|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703061|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
170703062|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703063|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703064|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703065|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703066|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703067|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703068|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703069|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703070|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703071|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703072|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703073|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703074|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703075|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703076|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
170703077|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703078|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703079|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703080|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703081|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703082|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703083|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703084|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703085|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
170703086|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703087|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703088|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703089|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703090|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703091|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703092|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703093|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703094|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703095|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703096|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703097|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703098|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703099|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703100|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
170703101|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703102|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703103|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703104|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703105|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703106|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703107|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703108|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703109|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
170703110|NCT02346240|616922702|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703111|NCT02346240|616922703|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703112|NCT02346240|616922704|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703113|NCT02346240|616922705|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703114|NCT02346240|616922706|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703115|NCT02346240|616922707|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703116|NCT02346240|616922708|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703117|NCT02346240|616922709|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703118|NCT02346240|616922710|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703119|NCT02346240|616922711|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703120|NCT02346240|616922712|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703121|NCT02346240|616922713|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703122|NCT02346240|616922714|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703123|NCT02346240|616922715|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703124|NCT02346240|616922716|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
170703125|NCT02346240|616922717|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703126|NCT02346240|616922718|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703127|NCT02346240|616922719|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703128|NCT02346240|616922720|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703129|NCT02346240|616922721|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703130|NCT02346240|616922722|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703131|NCT02346240|616922723|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703132|NCT02346240|616922724|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703133|NCT02346240|616922725|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
170703134|NCT02346240|616922702|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703135|NCT02346240|616922703|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703136|NCT02346240|616922704|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703137|NCT02346240|616922705|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703138|NCT02346240|616922706|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703139|NCT02346240|616922707|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703140|NCT02346240|616922708|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703141|NCT02346240|616922709|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703142|NCT02346240|616922710|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703143|NCT02346240|616922711|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703144|NCT02346240|616922712|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703145|NCT02346240|616922713|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703146|NCT02346240|616922714|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703147|NCT02346240|616922715|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703148|NCT02346240|616922716|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703149|NCT02346240|616922717|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703150|NCT02346240|616922718|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
170703151|NCT02346240|616922719|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
170703152|NCT02346240|616922720|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
170703153|NCT02346240|616922721|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
170703154|NCT02346240|616922722|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
170703155|NCT02346240|616922723|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
170703156|NCT02346240|616922724|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
170703157|NCT02346240|616922725|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
170703158|NCT02346240|616922702|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703159|NCT02346240|616922703|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703160|NCT02346240|616922704|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
170825342|NCT04491006|617370089|FG002|Overall Study|Withdrawal by Subject|2|||
170825343|NCT01960114|617370090|FG000|Overall Study|Adverse Event|1|||
170825344|NCT01960114|617370091|FG001|Overall Study|Adverse Event|0|||
170825345|NCT01960114|617370090|FG000|Overall Study|Could not swallow study medication|0|||
170825346|NCT01960114|617370091|FG001|Overall Study|Could not swallow study medication|1|||
170825347|NCT01004185|617370092|FG000|Overall Study|Adverse Event|1|||
170825348|NCT01004185|617370093|FG001|Overall Study|Adverse Event|1|||
170825349|NCT01004185|617370092|FG000|Overall Study|Lost to Follow-up|0|||
170825350|NCT01004185|617370093|FG001|Overall Study|Lost to Follow-up|1|||
170703161|NCT02346240|616922705|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703162|NCT02346240|616922706|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703163|NCT02346240|616922707|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703164|NCT02346240|616922708|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703165|NCT02346240|616922709|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703166|NCT02346240|616922710|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703167|NCT02346240|616922711|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703168|NCT02346240|616922712|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703169|NCT02346240|616922713|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703170|NCT02346240|616922714|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703171|NCT02346240|616922715|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703172|NCT02346240|616922716|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703173|NCT02346240|616922717|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703174|NCT02346240|616922718|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703175|NCT02346240|616922719|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703176|NCT02346240|616922720|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
170703177|NCT02346240|616922721|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
170703178|NCT02346240|616922722|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703179|NCT02346240|616922723|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
170703180|NCT02346240|616922724|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703181|NCT02346240|616922725|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
170703182|NCT02346240|616922702|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703183|NCT02346240|616922703|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703184|NCT02346240|616922704|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703185|NCT02346240|616922705|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703186|NCT02346240|616922706|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703187|NCT02346240|616922707|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703188|NCT02346240|616922708|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703189|NCT02346240|616922709|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703190|NCT02346240|616922710|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703191|NCT02346240|616922711|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703192|NCT02346240|616922712|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703193|NCT02346240|616922713|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703194|NCT02346240|616922714|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703195|NCT02346240|616922715|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703196|NCT02346240|616922716|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703197|NCT02346240|616922717|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703198|NCT02346240|616922718|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703199|NCT02346240|616922719|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703200|NCT02346240|616922720|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
170703201|NCT02346240|616922721|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703202|NCT02346240|616922722|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703203|NCT02346240|616922723|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
170703204|NCT02346240|616922724|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703205|NCT02346240|616922725|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
170703206|NCT02346240|616922702|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703207|NCT02346240|616922703|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703208|NCT02346240|616922704|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703209|NCT02346240|616922705|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703210|NCT02346240|616922706|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703211|NCT02346240|616922707|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703212|NCT02346240|616922708|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703213|NCT02346240|616922709|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703214|NCT02346240|616922710|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703215|NCT02346240|616922711|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703216|NCT02346240|616922712|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703217|NCT02346240|616922713|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703218|NCT02346240|616922714|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703219|NCT02346240|616922715|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703220|NCT02346240|616922716|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703221|NCT02346240|616922717|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703222|NCT02346240|616922718|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703223|NCT02346240|616922719|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703224|NCT02346240|616922720|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703225|NCT02346240|616922721|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170825351|NCT01004185|617370092|FG000|Overall Study|Lack of Efficacy|2|||
170703226|NCT02346240|616922722|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703227|NCT02346240|616922723|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
170703228|NCT02346240|616922724|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703229|NCT02346240|616922725|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
170703230|NCT02346240|616922702|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703231|NCT02346240|616922703|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703232|NCT02346240|616922704|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703233|NCT02346240|616922705|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703234|NCT02346240|616922706|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703235|NCT02346240|616922707|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703236|NCT02346240|616922708|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703237|NCT02346240|616922709|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703238|NCT02346240|616922710|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703239|NCT02346240|616922711|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703240|NCT02346240|616922712|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703241|NCT02346240|616922713|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703242|NCT02346240|616922714|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703243|NCT02346240|616922715|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703244|NCT02346240|616922716|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703245|NCT02346240|616922717|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703246|NCT02346240|616922718|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703247|NCT02346240|616922719|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
170703248|NCT02346240|616922720|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
170703249|NCT02346240|616922721|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
170703250|NCT02346240|616922722|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
170703251|NCT02346240|616922723|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
170703252|NCT02346240|616922724|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
170703253|NCT02346240|616922725|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
170703254|NCT02346240|616922702|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703255|NCT02346240|616922703|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703256|NCT02346240|616922704|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703257|NCT02346240|616922705|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703258|NCT02346240|616922706|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703259|NCT02346240|616922707|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703260|NCT02346240|616922708|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703261|NCT02346240|616922709|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703262|NCT02346240|616922710|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703263|NCT02346240|616922711|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703264|NCT02346240|616922712|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703265|NCT02346240|616922713|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703266|NCT02346240|616922714|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703267|NCT02346240|616922715|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703268|NCT02346240|616922716|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703269|NCT02346240|616922717|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703270|NCT02346240|616922718|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703271|NCT02346240|616922719|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703272|NCT02346240|616922720|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
170703273|NCT02346240|616922721|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
170703274|NCT02346240|616922722|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
170703275|NCT02346240|616922723|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
170703276|NCT02346240|616922724|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
170703277|NCT02346240|616922725|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
170703278|NCT02346240|616922702|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703279|NCT02346240|616922703|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703280|NCT02346240|616922704|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703281|NCT02346240|616922705|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703282|NCT02346240|616922706|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703283|NCT02346240|616922707|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703284|NCT02346240|616922708|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703285|NCT02346240|616922709|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170825352|NCT01004185|617370093|FG001|Overall Study|Lack of Efficacy|1|||
170825353|NCT01004185|617370092|FG000|Overall Study|Sponsor Terminated Study|4|||
170825354|NCT01004185|617370093|FG001|Overall Study|Sponsor Terminated Study|5|||
170825355|NCT01004185|617370092|FG000|Overall Study|Withdrawal by Subject|2|||
170825356|NCT01004185|617370093|FG001|Overall Study|Withdrawal by Subject|1|||
170825357|NCT00427778|617370098|FG000|First Intervention (4 Weeks)|no longer interested|1|||
170825358|NCT00427778|617370099|FG001|First Intervention (4 Weeks)|no longer interested|0|||
170825359|NCT00427778|617370098|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
170825360|NCT00427778|617370099|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
170825361|NCT00427778|617370098|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
170703286|NCT02346240|616922710|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703287|NCT02346240|616922711|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703288|NCT02346240|616922712|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703289|NCT02346240|616922713|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703290|NCT02346240|616922714|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703291|NCT02346240|616922715|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703292|NCT02346240|616922716|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170825362|NCT00427778|617370099|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
170825363|NCT00427778|617370098|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
170825364|NCT00427778|617370099|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
170825365|NCT00225277|617370101|FG000|Overall Study|Adverse Event|30|||
170825366|NCT00225277|617370102|FG001|Overall Study|Adverse Event|34|||
170825367|NCT00225277|617370101|FG000|Overall Study|Lack of Efficacy|4|||
170825368|NCT00225277|617370102|FG001|Overall Study|Lack of Efficacy|1|||
170825369|NCT00225277|617370101|FG000|Overall Study|Lost to Follow-up|4|||
170825370|NCT00225277|617370102|FG001|Overall Study|Lost to Follow-up|6|||
170703293|NCT02346240|616922717|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703294|NCT02346240|616922718|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703295|NCT02346240|616922719|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703296|NCT02346240|616922720|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
170703297|NCT02346240|616922721|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703298|NCT02346240|616922722|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
170703299|NCT02346240|616922723|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
170703300|NCT02346240|616922724|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
170703301|NCT02346240|616922725|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
170703302|NCT02346240|616922702|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703303|NCT02346240|616922703|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703304|NCT02346240|616922704|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703305|NCT02346240|616922705|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703306|NCT02346240|616922706|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703307|NCT02346240|616922707|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703308|NCT02346240|616922708|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703309|NCT02346240|616922709|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703310|NCT02346240|616922710|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703311|NCT02346240|616922711|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703312|NCT02346240|616922712|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703313|NCT02346240|616922713|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703314|NCT02346240|616922714|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703315|NCT02346240|616922715|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703316|NCT02346240|616922716|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703317|NCT02346240|616922717|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703318|NCT02346240|616922718|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170825371|NCT00225277|617370101|FG000|Overall Study|Physician Decision|6|||
170825372|NCT00225277|617370102|FG001|Overall Study|Physician Decision|8|||
170825373|NCT00225277|617370101|FG000|Overall Study|Protocol Violation|6|||
170825374|NCT00225277|617370102|FG001|Overall Study|Protocol Violation|3|||
170825375|NCT00225277|617370101|FG000|Overall Study|Withdrawal by Subject|40|||
170825376|NCT00225277|617370102|FG001|Overall Study|Withdrawal by Subject|34|||
170825377|NCT00225277|617370101|FG000|Overall Study|Other|7|||
170825378|NCT00225277|617370102|FG001|Overall Study|Other|9|||
170825379|NCT01177137|617370105|FG000|Overall Study|Withdrawal by Subject|10|||
170825380|NCT01177137|617370106|FG001|Overall Study|Withdrawal by Subject|10|||
170825381|NCT01177137|617370107|FG002|Overall Study|Withdrawal by Subject|2|||
170825382|NCT00591409|617370110|FG000|Overall Study|Not Treated|0|||
170825383|NCT00591409|617370111|FG001|Overall Study|Not Treated|0|||
170825384|NCT00591409|617370112|FG002|Overall Study|Not Treated|0|||
170825385|NCT00591409|617370113|FG003|Overall Study|Not Treated|0|||
170825386|NCT00591409|617370114|FG004|Overall Study|Not Treated|1|||
170825387|NCT00591409|617370115|FG005|Overall Study|Not Treated|0|||
170703319|NCT02346240|616922719|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170825388|NCT00591409|617370116|FG006|Overall Study|Not Treated|0|||
170825389|NCT00591409|617370117|FG007|Overall Study|Not Treated|0|||
170825390|NCT00591409|617370118|FG008|Overall Study|Not Treated|0|||
170825391|NCT00591409|617370119|FG009|Overall Study|Not Treated|1|||
170825392|NCT02560389|617370122|FG000|Overall Study|Lost to Follow-up|1|||
170825393|NCT02560389|617370123|FG001|Overall Study|Lost to Follow-up|2|||
170825394|NCT02560389|617370124|FG002|Overall Study|Lost to Follow-up|2|||
170825395|NCT02560389|617370122|FG000|Overall Study|Tested positive for illicit substance|0|||
170825396|NCT02560389|617370123|FG001|Overall Study|Tested positive for illicit substance|1|||
170825397|NCT02560389|617370124|FG002|Overall Study|Tested positive for illicit substance|0|||
170825398|NCT02716298|617370125|FG000|First Intervention (1 Month)|Lens discomfort|1|||
170825399|NCT02716298|617370126|FG001|First Intervention (1 Month)|Lens discomfort|1|||
170825400|NCT02101268|617370135|FG000|Randomized Treatment Phase|Subject Decision|8|||
170825401|NCT02101268|617370136|FG001|Randomized Treatment Phase|Subject Decision|4|||
170825402|NCT02101268|617370137|FG002|Randomized Treatment Phase|Subject Decision|0|||
170825403|NCT02101268|617370138|FG003|Randomized Treatment Phase|Subject Decision|0|||
170703320|NCT02346240|616922720|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
170703321|NCT02346240|616922721|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703322|NCT02346240|616922722|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703323|NCT02346240|616922723|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703324|NCT02346240|616922724|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703325|NCT02346240|616922725|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
170703326|NCT02681302|616922726|FG000|Overall Study|Withdrawal by Subject|1|||
170703327|NCT02681302|616922727|FG001|Overall Study|Withdrawal by Subject|1|||
170703328|NCT02681302|616922728|FG002|Overall Study|Withdrawal by Subject|0|||
170703329|NCT02681302|616922729|FG003|Overall Study|Withdrawal by Subject|0|||
170703330|NCT02681302|616922730|FG004|Overall Study|Withdrawal by Subject|1|||
170703331|NCT02681302|616922731|FG005|Overall Study|Withdrawal by Subject|0|||
170703332|NCT02681302|616922726|FG000|Overall Study|Screen Failure|2|||
170703333|NCT02681302|616922727|FG001|Overall Study|Screen Failure|4|||
170703334|NCT02681302|616922728|FG002|Overall Study|Screen Failure|2|||
170703335|NCT02681302|616922729|FG003|Overall Study|Screen Failure|0|||
170703336|NCT02681302|616922730|FG004|Overall Study|Screen Failure|1|||
170703337|NCT02681302|616922731|FG005|Overall Study|Screen Failure|1|||
170703338|NCT02681302|616922726|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
170703339|NCT02681302|616922727|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
170703340|NCT02681302|616922728|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
170703341|NCT02681302|616922729|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
170703342|NCT02681302|616922730|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
170703343|NCT02681302|616922731|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
170703344|NCT02942017|616922732|FG000|Overall Study|Adverse Event|0|||
170703345|NCT02942017|616922733|FG001|Overall Study|Adverse Event|1|||
170703346|NCT02942017|616922732|FG000|Overall Study|Withdrawal by Subject|0|||
170703347|NCT02942017|616922733|FG001|Overall Study|Withdrawal by Subject|1|||
170703348|NCT02942017|616922732|FG000|Overall Study|Lost to Follow-up|1|||
170703349|NCT02942017|616922733|FG001|Overall Study|Lost to Follow-up|1|||
170825404|NCT02101268|617370135|FG000|Randomized Treatment Phase|Physician Decision|4|||
170825405|NCT02101268|617370136|FG001|Randomized Treatment Phase|Physician Decision|1|||
170825406|NCT02101268|617370137|FG002|Randomized Treatment Phase|Physician Decision|0|||
170825407|NCT02101268|617370138|FG003|Randomized Treatment Phase|Physician Decision|0|||
170825408|NCT02101268|617370135|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
170825409|NCT02101268|617370136|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
170825410|NCT02101268|617370137|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
170825411|NCT02101268|617370138|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
170825412|NCT02101268|617370135|FG000|Randomized Treatment Phase|Adverse Event|6|||
170825413|NCT02101268|617370136|FG001|Randomized Treatment Phase|Adverse Event|0|||
170825414|NCT02101268|617370137|FG002|Randomized Treatment Phase|Adverse Event|0|||
170825415|NCT02101268|617370138|FG003|Randomized Treatment Phase|Adverse Event|0|||
170825416|NCT02101268|617370135|FG000|Randomized Treatment Phase|Death|5|||
170703350|NCT02942017|616922732|FG000|Overall Study|Randomized but not dosed|1|||
170825417|NCT02101268|617370136|FG001|Randomized Treatment Phase|Death|4|||
170825418|NCT02101268|617370137|FG002|Randomized Treatment Phase|Death|0|||
170825419|NCT02101268|617370138|FG003|Randomized Treatment Phase|Death|0|||
170825420|NCT02101268|617370135|FG000|Randomized Treatment Phase|Disease Progression|4|||
170825421|NCT02101268|617370136|FG001|Randomized Treatment Phase|Disease Progression|1|||
170703351|NCT02942017|616922733|FG001|Overall Study|Randomized but not dosed|3|||
170703352|NCT00477672|616922734|FG000|Overall Study|Adverse Event|3|||
170825422|NCT02101268|617370137|FG002|Randomized Treatment Phase|Disease Progression|0|||
170703353|NCT00477672|616922735|FG001|Overall Study|Adverse Event|5|||
170703354|NCT00477672|616922736|FG002|Overall Study|Adverse Event|6|||
170703355|NCT00477672|616922734|FG000|Overall Study|Death|0|||
170703356|NCT00477672|616922735|FG001|Overall Study|Death|1|||
170703357|NCT00477672|616922736|FG002|Overall Study|Death|0|||
170703358|NCT00477672|616922734|FG000|Overall Study|Disease progression|0|||
170703359|NCT00477672|616922735|FG001|Overall Study|Disease progression|1|||
170703360|NCT00477672|616922736|FG002|Overall Study|Disease progression|0|||
170703361|NCT00477672|616922734|FG000|Overall Study|Physician Decision|1|||
170703362|NCT00477672|616922735|FG001|Overall Study|Physician Decision|0|||
170703363|NCT00477672|616922736|FG002|Overall Study|Physician Decision|0|||
170703364|NCT00477672|616922734|FG000|Overall Study|Protocol noncompliance|0|||
170703365|NCT00477672|616922735|FG001|Overall Study|Protocol noncompliance|2|||
170703366|NCT00477672|616922736|FG002|Overall Study|Protocol noncompliance|0|||
170703367|NCT00477672|616922734|FG000|Overall Study|Consent withdrawn|2|||
170703368|NCT00477672|616922735|FG001|Overall Study|Consent withdrawn|5|||
170703369|NCT00477672|616922736|FG002|Overall Study|Consent withdrawn|10|||
170703370|NCT00477672|616922734|FG000|Overall Study|Discretion of Sponsor|1|||
170703371|NCT00477672|616922735|FG001|Overall Study|Discretion of Sponsor|2|||
170703372|NCT00477672|616922736|FG002|Overall Study|Discretion of Sponsor|0|||
170703373|NCT00458484|616922737|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
170703374|NCT00458484|616922738|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
170703375|NCT00458484|616922739|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
170703376|NCT00458484|616922740|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
170703377|NCT00458484|616922741|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
170703378|NCT00458484|616922742|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
170703379|NCT00458484|616922743|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
170703380|NCT00329407|616922744|FG000|Overall Study|Withdrawal by Subject|1|||
170703381|NCT00978068|616922745|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
170703382|NCT00978068|616922746|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
170703383|NCT00978068|616922745|FG000|Overall Study|Death|1|||
170703384|NCT00978068|616922746|FG001|Overall Study|Death|2|||
170703385|NCT00978068|616922745|FG000|Overall Study|Lost to Follow-up|1|||
170703386|NCT00978068|616922746|FG001|Overall Study|Lost to Follow-up|2|||
170703387|NCT00978068|616922745|FG000|Overall Study|Physician Decision|0|||
170703388|NCT00978068|616922746|FG001|Overall Study|Physician Decision|1|||
170703389|NCT00978068|616922745|FG000|Overall Study|Unable to Comply with Study|0|||
170703390|NCT00978068|616922746|FG001|Overall Study|Unable to Comply with Study|2|||
170703391|NCT02275481|616922747|FG000|Overall Study|Death|2|||
170703392|NCT02275481|616922748|FG001|Overall Study|Death|1|||
170703393|NCT02275481|616922747|FG000|Overall Study|Lost to Follow-up|2|||
170703394|NCT02275481|616922748|FG001|Overall Study|Lost to Follow-up|0|||
170703395|NCT02275481|616922747|FG000|Overall Study|Withdrawal by Subject|3|||
170703396|NCT02275481|616922748|FG001|Overall Study|Withdrawal by Subject|0|||
170703397|NCT02275481|616922747|FG000|Overall Study|all other reasons combined|2|||
170703398|NCT02275481|616922748|FG001|Overall Study|all other reasons combined|1|||
170703399|NCT02275481|616922747|FG000|Overall Study|Physician Decision|0|||
170703400|NCT02275481|616922748|FG001|Overall Study|Physician Decision|1|||
170703401|NCT03044197|616922752|FG000|Overall Study|Withdrawal by Subject|3|||
170703402|NCT03044197|616922753|FG001|Overall Study|Withdrawal by Subject|1|||
170703403|NCT01806896|616922756|FG000|Overall Study|Adverse Event|2|||
170703404|NCT01806896|616922757|FG001|Overall Study|Adverse Event|0|||
170703405|NCT01806896|616922756|FG000|Overall Study|Other|1|||
170703406|NCT01806896|616922757|FG001|Overall Study|Other|0|||
170703407|NCT04804813|616922758|FG000|Overall Study|Protocol Violation|2|||
170703408|NCT04804813|616922759|FG001|Overall Study|Protocol Violation|0|||
170703409|NCT04804813|616922758|FG000|Overall Study|Withdrawal by Subject|1|||
170703410|NCT04804813|616922759|FG001|Overall Study|Withdrawal by Subject|0|||
170703411|NCT02357147|616922760|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
170703412|NCT02357147|616922761|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
170825423|NCT02101268|617370138|FG003|Randomized Treatment Phase|Disease Progression|0|||
170825424|NCT02101268|617370135|FG000|Extended Treatment Phase|Subject Decision|0|||
170825425|NCT02101268|617370136|FG001|Extended Treatment Phase|Subject Decision|0|||
170825426|NCT02101268|617370137|FG002|Extended Treatment Phase|Subject Decision|3|||
170825427|NCT02101268|617370138|FG003|Extended Treatment Phase|Subject Decision|2|||
170825428|NCT02101268|617370135|FG000|Extended Treatment Phase|Physician Decision|0|||
170825429|NCT02101268|617370136|FG001|Extended Treatment Phase|Physician Decision|0|||
170825430|NCT02101268|617370137|FG002|Extended Treatment Phase|Physician Decision|5|||
170703413|NCT02357147|616922760|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
170703414|NCT02357147|616922761|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
170703415|NCT02357147|616922760|FG000|Combination Treatment Phase|Investigator Discretion|1|||
170703416|NCT02357147|616922761|FG001|Combination Treatment Phase|Investigator Discretion|1|||
170703417|NCT02357147|616922760|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
170703418|NCT02357147|616922761|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
170703419|NCT02357147|616922760|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
170703420|NCT02357147|616922761|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
170703421|NCT02357147|616922760|FG000|Combination Treatment Phase|Adverse Event|12|||
170703422|NCT02357147|616922761|FG001|Combination Treatment Phase|Adverse Event|4|||
170703423|NCT02357147|616922760|FG000|Combination Treatment Phase|Death|1|||
170703424|NCT02357147|616922761|FG001|Combination Treatment Phase|Death|1|||
170703425|NCT02357147|616922760|FG000|Combination Treatment Phase|Sponsor Decision|0|||
170703426|NCT02357147|616922761|FG001|Combination Treatment Phase|Sponsor Decision|12|||
170703427|NCT02357147|616922760|FG000|Combination Treatment Phase|Other|1|||
170703428|NCT02357147|616922761|FG001|Combination Treatment Phase|Other|0|||
170703429|NCT02357147|616922760|FG000|Combination Treatment Phase|Not treated|0|||
170703430|NCT02357147|616922761|FG001|Combination Treatment Phase|Not treated|2|||
170703431|NCT02357147|616922760|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
170703432|NCT02357147|616922761|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
170703433|NCT02357147|616922760|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
170703434|NCT02357147|616922761|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
170703435|NCT02357147|616922760|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
170703436|NCT02357147|616922761|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
170703437|NCT02357147|616922760|FG000|Maintenance Treatment Phase|Adverse Event|0|||
170703438|NCT02357147|616922761|FG001|Maintenance Treatment Phase|Adverse Event|3|||
170703439|NCT02357147|616922760|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
170703440|NCT02357147|616922761|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
170703441|NCT02357147|616922760|FG000|Maintenance Treatment Phase|Not Treated|1|||
170703442|NCT02357147|616922761|FG001|Maintenance Treatment Phase|Not Treated|0|||
170703443|NCT03548584|616924466|FG000|Overall Study|Lost to Follow-up|0|||
170703444|NCT03548584|616924467|FG001|Overall Study|Lost to Follow-up|0|||
170703445|NCT03548584|616924468|FG002|Overall Study|Lost to Follow-up|1|||
170703446|NCT03548584|616924466|FG000|Overall Study|Adverse Event|1|||
170703447|NCT03548584|616924467|FG001|Overall Study|Adverse Event|11|||
170703448|NCT03548584|616924468|FG002|Overall Study|Adverse Event|5|||
170703449|NCT03548584|616924466|FG000|Overall Study|Site Terminated by Sponsor|1|||
170703450|NCT03548584|616924467|FG001|Overall Study|Site Terminated by Sponsor|3|||
170703451|NCT03548584|616924468|FG002|Overall Study|Site Terminated by Sponsor|2|||
170703452|NCT03548584|616924466|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
170703453|NCT03548584|616924467|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
170703454|NCT03548584|616924468|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
170703455|NCT03548584|616924466|FG000|Overall Study|Lack of Efficacy|0|||
170703456|NCT03548584|616924467|FG001|Overall Study|Lack of Efficacy|1|||
170703457|NCT03548584|616924468|FG002|Overall Study|Lack of Efficacy|0|||
170703458|NCT03548584|616924466|FG000|Overall Study|Non-compliance with Study Drug|0|||
170703459|NCT03548584|616924467|FG001|Overall Study|Non-compliance with Study Drug|1|||
170703460|NCT03548584|616924468|FG002|Overall Study|Non-compliance with Study Drug|0|||
170703461|NCT03548584|616924466|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
170703462|NCT03548584|616924467|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
170703463|NCT03548584|616924468|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
170703464|NCT02096835|616924475|FG000|Overall Study|Withdrawal by Subject|1|||
170703465|NCT02096835|616924476|FG001|Overall Study|Withdrawal by Subject|0|||
170703466|NCT02096835|616924477|FG002|Overall Study|Withdrawal by Subject|0|||
170703467|NCT02096835|616924475|FG000|Overall Study|converted to open procedures|1|||
170703468|NCT02096835|616924476|FG001|Overall Study|converted to open procedures|0|||
170703469|NCT02096835|616924477|FG002|Overall Study|converted to open procedures|0|||
170703470|NCT02096835|616924475|FG000|Overall Study|Lost to Follow-up|1|||
170703471|NCT02096835|616924476|FG001|Overall Study|Lost to Follow-up|0|||
170825431|NCT02101268|617370138|FG003|Extended Treatment Phase|Physician Decision|2|||
170825432|NCT02101268|617370135|FG000|Extended Treatment Phase|Adverse Event|0|||
170825433|NCT02101268|617370136|FG001|Extended Treatment Phase|Adverse Event|0|||
170825434|NCT02101268|617370137|FG002|Extended Treatment Phase|Adverse Event|14|||
170825435|NCT02101268|617370138|FG003|Extended Treatment Phase|Adverse Event|18|||
170825436|NCT02101268|617370135|FG000|Extended Treatment Phase|Death|0|||
170825437|NCT02101268|617370136|FG001|Extended Treatment Phase|Death|0|||
170825438|NCT02101268|617370137|FG002|Extended Treatment Phase|Death|5|||
170825439|NCT02101268|617370138|FG003|Extended Treatment Phase|Death|1|||
170825440|NCT02101268|617370135|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
170825441|NCT02101268|617370136|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
170825442|NCT02101268|617370137|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
170825443|NCT02101268|617370138|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
170825444|NCT02101268|617370135|FG000|Extended Treatment Phase|Disease Progression|0|||
170825445|NCT02101268|617370136|FG001|Extended Treatment Phase|Disease Progression|0|||
170825446|NCT02101268|617370137|FG002|Extended Treatment Phase|Disease Progression|13|||
170825447|NCT02101268|617370138|FG003|Extended Treatment Phase|Disease Progression|6|||
170825448|NCT02101268|617370135|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
170703472|NCT02096835|616924477|FG002|Overall Study|Lost to Follow-up|1|||
170703473|NCT02472756|616924478|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
170703474|NCT02472756|616924478|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
170703475|NCT02472756|616924478|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
170703476|NCT02472756|616924478|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
170703477|NCT02472756|616924478|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
170703478|NCT00293384|616924479|FG000|Overall Study|Non-compliance|2|||
170703479|NCT00293384|616924479|FG000|Overall Study|Missed dosage/study drug|1|||
170703480|NCT00293384|616924479|FG000|Overall Study|Ineligible|2|||
170703481|NCT04709237|616924481|FG000|Overall Study|Lost to Follow-up|1|||
170703482|NCT04709237|616924482|FG001|Overall Study|Lost to Follow-up|0|||
170703483|NCT04709237|616924483|FG002|Overall Study|Lost to Follow-up|0|||
170703484|NCT02610192|616924484|FG000|Overall Study|Received other treatment|8|||
170703485|NCT02610192|616924484|FG000|Overall Study|Physician Decision|1|||
170703486|NCT00640510|616924493|FG000|Overall Study|Lack of Efficacy|0|||
170703487|NCT00640510|616924494|FG001|Overall Study|Lack of Efficacy|1|||
170703488|NCT00640510|616924493|FG000|Overall Study|Protocol Violation|1|||
170703489|NCT00640510|616924494|FG001|Overall Study|Protocol Violation|0|||
170703490|NCT00640510|616924493|FG000|Overall Study|Physician Decision|0|||
170703491|NCT00640510|616924494|FG001|Overall Study|Physician Decision|1|||
170703492|NCT01440322|616924499|FG000|Overall Study|Discomfort|2|||
170703493|NCT01440322|616924500|FG001|Overall Study|Discomfort|0|||
170703494|NCT01440322|616924499|FG000|Overall Study|Biomicroscopy|1|||
170703495|NCT01440322|616924500|FG001|Overall Study|Biomicroscopy|0|||
170703496|NCT01440322|616924499|FG000|Overall Study|Symptoms and Problems|1|||
170703497|NCT01440322|616924500|FG001|Overall Study|Symptoms and Problems|0|||
170703498|NCT01440322|616924499|FG000|Overall Study|Unacceptable Subjective Vision|1|||
170703499|NCT01440322|616924500|FG001|Overall Study|Unacceptable Subjective Vision|0|||
170703500|NCT01440322|616924499|FG000|Overall Study|Other Product Related|1|||
170703501|NCT01440322|616924500|FG001|Overall Study|Other Product Related|0|||
170703502|NCT01440322|616924499|FG000|Overall Study|Unrelated Medical Problem|0|||
170703503|NCT01440322|616924500|FG001|Overall Study|Unrelated Medical Problem|1|||
170703504|NCT01440322|616924499|FG000|Overall Study|Other Non-Product Related|1|||
170703505|NCT01440322|616924500|FG001|Overall Study|Other Non-Product Related|0|||
170703506|NCT02365636|616924501|FG000|Overall Study|Adverse Event|3|||
170703507|NCT02365636|616924502|FG001|Overall Study|Adverse Event|3|||
170703508|NCT02365636|616924503|FG002|Overall Study|Adverse Event|2|||
170703509|NCT02365636|616924501|FG000|Overall Study|Protocol Violation|1|||
170703510|NCT02365636|616924502|FG001|Overall Study|Protocol Violation|4|||
170703511|NCT02365636|616924503|FG002|Overall Study|Protocol Violation|0|||
170703512|NCT02365636|616924501|FG000|Overall Study|Lost to Follow-up|0|||
170703513|NCT02365636|616924502|FG001|Overall Study|Lost to Follow-up|0|||
170703514|NCT02365636|616924503|FG002|Overall Study|Lost to Follow-up|1|||
170703515|NCT02365636|616924501|FG000|Overall Study|Other|2|||
170703516|NCT02365636|616924502|FG001|Overall Study|Other|0|||
170703517|NCT02365636|616924503|FG002|Overall Study|Other|0|||
170703518|NCT00355238|616924504|FG000|Overall Study|Adverse event unrelated to study drug|2|||
170703519|NCT00355238|616924505|FG001|Overall Study|Adverse event unrelated to study drug|2|||
170703520|NCT00355238|616924506|FG002|Overall Study|Adverse event unrelated to study drug|0|||
170703521|NCT00355238|616924507|FG003|Overall Study|Adverse event unrelated to study drug|1|||
170703522|NCT00355238|616924504|FG000|Overall Study|Death|1|||
170703523|NCT00355238|616924505|FG001|Overall Study|Death|0|||
170703524|NCT00355238|616924506|FG002|Overall Study|Death|0|||
170703525|NCT00355238|616924507|FG003|Overall Study|Death|0|||
170703526|NCT00355238|616924504|FG000|Overall Study|Disease progression|37|||
170703527|NCT00355238|616924505|FG001|Overall Study|Disease progression|36|||
170703528|NCT00355238|616924506|FG002|Overall Study|Disease progression|16|||
170703529|NCT00355238|616924507|FG003|Overall Study|Disease progression|11|||
170703530|NCT00355238|616924504|FG000|Overall Study|Study drug toxicity|11|||
170703531|NCT00355238|616924505|FG001|Overall Study|Study drug toxicity|7|||
170703532|NCT00355238|616924506|FG002|Overall Study|Study drug toxicity|5|||
170629004|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
170629005|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
170629006|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
170629007|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
170629008|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
170629009|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
170629010|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
170629011|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
170629012|NCT03773978|616654327|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
170629013|NCT03773978|616654328|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
170629014|NCT03773978|616654327|FG000|DBW Period|Adverse Event|2|||
170629015|NCT03773978|616654328|FG001|DBW Period|Adverse Event|2|||
170825449|NCT02101268|617370136|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
170825450|NCT02101268|617370137|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
170825451|NCT02101268|617370138|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
170825452|NCT02515097|617370140|FG000|Overall Study|Lost to Follow-up|4|||
170825453|NCT02515097|617370141|FG001|Overall Study|Lost to Follow-up|2|||
170825454|NCT02515097|617370140|FG000|Overall Study|Withdrawal by Subject|1|||
170825455|NCT02515097|617370141|FG001|Overall Study|Withdrawal by Subject|3|||
170825456|NCT02515097|617370140|FG000|Overall Study|Adverse Event|2|||
170825457|NCT02515097|617370141|FG001|Overall Study|Adverse Event|1|||
170825458|NCT02383927|617370142|FG000|Overall Study|Disease Progression|8|||
170825459|NCT02383927|617370143|FG001|Overall Study|Disease Progression|8|||
170825460|NCT02383927|617370144|FG002|Overall Study|Disease Progression|15|||
170825461|NCT02383927|617370145|FG003|Overall Study|Disease Progression|4|||
170825462|NCT02383927|617370142|FG000|Overall Study|Physician Decision|0|||
170825463|NCT02383927|617370143|FG001|Overall Study|Physician Decision|0|||
170825464|NCT02383927|617370144|FG002|Overall Study|Physician Decision|2|||
170825465|NCT02383927|617370145|FG003|Overall Study|Physician Decision|0|||
170825466|NCT02383927|617370142|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
170825467|NCT02383927|617370143|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
170825468|NCT02383927|617370144|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
170825469|NCT02383927|617370145|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
170825470|NCT02383927|617370142|FG000|Overall Study|Adverse Event|4|||
170825471|NCT02383927|617370143|FG001|Overall Study|Adverse Event|1|||
170825472|NCT02383927|617370144|FG002|Overall Study|Adverse Event|3|||
170825473|NCT02383927|617370145|FG003|Overall Study|Adverse Event|5|||
170825474|NCT02383927|617370142|FG000|Overall Study|Miscellaneous|1|||
170825475|NCT02383927|617370143|FG001|Overall Study|Miscellaneous|0|||
170825476|NCT02383927|617370144|FG002|Overall Study|Miscellaneous|0|||
170825477|NCT02383927|617370145|FG003|Overall Study|Miscellaneous|1|||
170825478|NCT02383927|617370142|FG000|Overall Study|Withdrawal by Subject|0|||
170825479|NCT02383927|617370143|FG001|Overall Study|Withdrawal by Subject|1|||
170825480|NCT02383927|617370144|FG002|Overall Study|Withdrawal by Subject|4|||
170825481|NCT02383927|617370145|FG003|Overall Study|Withdrawal by Subject|0|||
170629016|NCT03773978|616654327|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
170825482|NCT00981578|617370146|FG000|Overall Study|Death|1|||
170629017|NCT03773978|616654328|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
170629018|NCT03773978|616654327|FG000|DBW Period|Withdrawal by Subject|2|||
170629019|NCT03773978|616654328|FG001|DBW Period|Withdrawal by Subject|1|||
170629020|NCT03773978|616654327|FG000|DBW Period|Due to epidemic or pandemic|5|||
170629021|NCT03773978|616654328|FG001|DBW Period|Due to epidemic or pandemic|6|||
170629022|NCT03773978|616654327|FG000|DBW Period|Study team decision|1|||
170629023|NCT03773978|616654328|FG001|DBW Period|Study team decision|0|||
170629024|NCT01217229|616654329|FG000|Overall Study|Adverse Event|1|||
170629025|NCT01217229|616654329|FG000|Overall Study|Disease progression, deterioration|2|||
170629026|NCT01217229|616654329|FG000|Overall Study|Disease progression, Cheson criteria|14|||
170629027|NCT01217229|616654329|FG000|Overall Study|Protocol Violation|1|||
170629028|NCT01217229|616654329|FG000|Overall Study|Disease progression not confirmed|2|||
170629029|NCT01668784|616654330|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
170629030|NCT01668784|616654331|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
170629031|NCT01668784|616654330|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
170629032|NCT01668784|616654331|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
170629033|NCT01668784|616654330|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
170629034|NCT01668784|616654331|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
170629035|NCT01668784|616654330|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
170629036|NCT01668784|616654331|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
170703533|NCT00355238|616924507|FG003|Overall Study|Study drug toxicity|2|||
170703534|NCT00355238|616924504|FG000|Overall Study|Participant withdrew consent|3|||
170703535|NCT00355238|616924505|FG001|Overall Study|Participant withdrew consent|1|||
170703536|NCT00355238|616924506|FG002|Overall Study|Participant withdrew consent|0|||
170703537|NCT00355238|616924507|FG003|Overall Study|Participant withdrew consent|0|||
170703538|NCT00355238|616924504|FG000|Overall Study|Participant request to discontinue study treatment|1|||
170703539|NCT00355238|616924505|FG001|Overall Study|Participant request to discontinue study treatment|0|||
170703540|NCT00355238|616924506|FG002|Overall Study|Participant request to discontinue study treatment|1|||
170703541|NCT00355238|616924507|FG003|Overall Study|Participant request to discontinue study treatment|0|||
170703542|NCT01454934|616924508|FG000|Overall Study|Clinical progression|28|||
170703543|NCT01454934|616924509|FG001|Overall Study|Clinical progression|25|||
170703544|NCT01454934|616924508|FG000|Overall Study|Other|6|||
170703545|NCT01454934|616924509|FG001|Overall Study|Other|17|||
170703546|NCT01454934|616924508|FG000|Overall Study|Adverse Event|28|||
170703547|NCT01454934|616924509|FG001|Overall Study|Adverse Event|24|||
170703548|NCT01454934|616924508|FG000|Overall Study|Withdrawn consent|2|||
170703549|NCT01454934|616924509|FG001|Overall Study|Withdrawn consent|5|||
170703550|NCT01454934|616924508|FG000|Overall Study|Withdrawal by Subject|11|||
170703551|NCT01454934|616924509|FG001|Overall Study|Withdrawal by Subject|15|||
170703552|NCT01454934|616924508|FG000|Overall Study|Disease progression|194|||
170703553|NCT01454934|616924509|FG001|Overall Study|Disease progression|181|||
170703554|NCT01454934|616924508|FG000|Overall Study|Lost to Follow-up|0|||
170703555|NCT01454934|616924509|FG001|Overall Study|Lost to Follow-up|1|||
170703556|NCT01454934|616924508|FG000|Overall Study|Not treated|1|||
170629037|NCT01668784|616654330|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
170629038|NCT01668784|616654331|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
170629039|NCT01668784|616654330|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
170629040|NCT01668784|616654331|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
170629041|NCT01668784|616654330|FG000|Treatment Period|Disease Progression|316|||
170629042|NCT01668784|616654331|FG001|Treatment Period|Disease Progression|293|||
170629043|NCT01668784|616654330|FG000|Treatment Period|Study Drug Toxicity|46|||
170629044|NCT01668784|616654331|FG001|Treatment Period|Study Drug Toxicity|53|||
170629045|NCT01668784|616654330|FG000|Treatment Period|Death|1|||
170629046|NCT01668784|616654331|FG001|Treatment Period|Death|1|||
170629047|NCT01668784|616654330|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
170629048|NCT01668784|616654331|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
170629049|NCT01668784|616654330|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
170629050|NCT01668784|616654331|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
170629051|NCT01668784|616654330|FG000|Treatment Period|Withdrawal by Subject|5|||
170629052|NCT01668784|616654331|FG001|Treatment Period|Withdrawal by Subject|3|||
170629053|NCT01668784|616654330|FG000|Treatment Period|Maximal Clinical Benefit|3|||
170629054|NCT01668784|616654331|FG001|Treatment Period|Maximal Clinical Benefit|3|||
170629055|NCT01668784|616654330|FG000|Treatment Period|Other|2|||
170629056|NCT01668784|616654331|FG001|Treatment Period|Other|8|||
170629057|NCT01668784|616654330|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
170629058|NCT01668784|616654331|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
170629059|NCT02761330|616654332|FG000|Treatment Week 1|Withdrawal by Subject|0|||
170629060|NCT02761330|616654333|FG001|Treatment Week 1|Withdrawal by Subject|0|||
170629061|NCT02761330|616654334|FG002|Treatment Week 1|Withdrawal by Subject|0|||
170629062|NCT02761330|616654335|FG003|Treatment Week 1|Withdrawal by Subject|1|||
170629063|NCT02761330|616654336|FG004|Treatment Week 1|Withdrawal by Subject|0|||
170629064|NCT02761330|616654337|FG005|Treatment Week 1|Withdrawal by Subject|1|||
170629065|NCT05386329|616654338|FG000|Overall Study|Lost to Follow-up|3|||
170629066|NCT01903460|616654343|FG000|Overall Study|Adverse Event|0|||
170629067|NCT01903460|616654344|FG001|Overall Study|Adverse Event|0|||
170629068|NCT01903460|616654345|FG002|Overall Study|Adverse Event|0|||
170629069|NCT01903460|616654346|FG003|Overall Study|Adverse Event|1|||
170629070|NCT03104868|616654347|FG000|6 Week Follow up|Lost to Follow-up|5|||
170629071|NCT03104868|616654348|FG001|6 Week Follow up|Lost to Follow-up|8|||
170629072|NCT03104868|616654347|FG000|6 Week Follow up|Death|1|||
170629073|NCT03104868|616654348|FG001|6 Week Follow up|Death|1|||
170629074|NCT03104868|616654347|FG000|6 Week Follow up|Withdrawal by Subject|7|||
170629075|NCT03104868|616654348|FG001|6 Week Follow up|Withdrawal by Subject|6|||
170629076|NCT03104868|616654347|FG000|6 Week Follow up|Completed Later Timepoint|24|||
170629077|NCT03104868|616654348|FG001|6 Week Follow up|Completed Later Timepoint|22|||
170629078|NCT03104868|616654347|FG000|6 Month Follow up|Lost to Follow-up|2|||
170629079|NCT03104868|616654348|FG001|6 Month Follow up|Lost to Follow-up|2|||
170629080|NCT03104868|616654347|FG000|6 Month Follow up|Death|0|||
170629081|NCT03104868|616654348|FG001|6 Month Follow up|Death|1|||
170629082|NCT03104868|616654347|FG000|6 Month Follow up|Completed Later Timepoint|22|||
170629083|NCT03104868|616654348|FG001|6 Month Follow up|Completed Later Timepoint|32|||
170629084|NCT03104868|616654347|FG000|12 Month Follow up|Lost to Follow-up|1|||
170629085|NCT03104868|616654348|FG001|12 Month Follow up|Lost to Follow-up|2|||
170629086|NCT03104868|616654347|FG000|12 Month Follow up|Death|0|||
170629087|NCT03104868|616654348|FG001|12 Month Follow up|Death|1|||
170629088|NCT03104868|616654347|FG000|12 Month Follow up|Withdrawal by Subject|0|||
170629089|NCT03104868|616654348|FG001|12 Month Follow up|Withdrawal by Subject|3|||
170629090|NCT03104868|616654347|FG000|12 Month Follow up|Completed Later Timepoint|32|||
170629091|NCT03104868|616654348|FG001|12 Month Follow up|Completed Later Timepoint|29|||
170629092|NCT03104868|616654347|FG000|18 Month Follow up|Lost to Follow-up|7|||
170629093|NCT03104868|616654348|FG001|18 Month Follow up|Lost to Follow-up|11|||
170629094|NCT03104868|616654347|FG000|18 Month Follow up|Death|2|||
170629095|NCT03104868|616654348|FG001|18 Month Follow up|Death|1|||
170629096|NCT03104868|616654347|FG000|18 Month Follow up|Withdrawal by Subject|1|||
170629097|NCT03104868|616654348|FG001|18 Month Follow up|Withdrawal by Subject|2|||
170629098|NCT03104868|616654347|FG000|18 Month Follow up|Graft Loss|1|||
170629099|NCT03104868|616654348|FG001|18 Month Follow up|Graft Loss|1|||
170629100|NCT03104868|616654347|FG000|18 Month Follow up|Completed Later Timepoint|19|||
170629101|NCT03104868|616654348|FG001|18 Month Follow up|Completed Later Timepoint|20|||
170629102|NCT03104868|616654347|FG000|24 Month Follow up|Lost to Follow-up|15|||
170629103|NCT03104868|616654348|FG001|24 Month Follow up|Lost to Follow-up|16|||
170629104|NCT03104868|616654347|FG000|24 Month Follow up|Death|3|||
170629105|NCT03104868|616654348|FG001|24 Month Follow up|Death|2|||
170629106|NCT03104868|616654347|FG000|24 Month Follow up|Withdrawal by Subject|1|||
170629107|NCT03104868|616654348|FG001|24 Month Follow up|Withdrawal by Subject|0|||
170629108|NCT03104868|616654347|FG000|24 Month Follow up|Graft Loss|2|||
170629109|NCT03104868|616654348|FG001|24 Month Follow up|Graft Loss|0|||
170629110|NCT04408989|616654351|FG000|Overall Study|Lost to Follow-up|0|||
170629111|NCT04408989|616654352|FG001|Overall Study|Lost to Follow-up|0|||
170629112|NCT04408989|616654353|FG002|Overall Study|Lost to Follow-up|1|||
170629113|NCT04408989|616654351|FG000|Overall Study|Withdrawal by Subject|0|||
170629114|NCT04408989|616654352|FG001|Overall Study|Withdrawal by Subject|0|||
170629115|NCT04408989|616654353|FG002|Overall Study|Withdrawal by Subject|2|||
170629116|NCT04363320|616654356|FG000|Overall Study|Lost to Follow-up|43|||
170629117|NCT04363320|616654357|FG001|Overall Study|Lost to Follow-up|42|||
170629118|NCT04363320|616654358|FG002|Overall Study|Lost to Follow-up|24|||
170629119|NCT04363320|616654359|FG003|Overall Study|Lost to Follow-up|29|||
170629120|NCT04363320|616654356|FG000|Overall Study|Death|0|||
170629121|NCT04363320|616654357|FG001|Overall Study|Death|0|||
170629122|NCT04363320|616654358|FG002|Overall Study|Death|1|||
170825483|NCT00981578|617370146|FG000|Overall Study|Withdrawal by Subject|2|||
170825484|NCT01592383|617370150|FG000|Overall Study|Adverse Event|1|||
170825485|NCT01180790|617370151|FG000|Overall Study|Adverse Event|1|||
170825486|NCT01180790|617370152|FG001|Overall Study|Adverse Event|1|||
170825487|NCT01180790|617370153|FG002|Overall Study|Adverse Event|2|||
170825488|NCT01180790|617370154|FG003|Overall Study|Adverse Event|0|||
170825489|NCT01180790|617370155|FG004|Overall Study|Adverse Event|1|||
170825490|NCT01180790|617370156|FG005|Overall Study|Adverse Event|3|||
170825491|NCT01180790|617370157|FG006|Overall Study|Adverse Event|0|||
170825492|NCT01180790|617370151|FG000|Overall Study|Withdrawal by Subject|3|||
170825493|NCT01180790|617370152|FG001|Overall Study|Withdrawal by Subject|0|||
170825494|NCT01180790|617370153|FG002|Overall Study|Withdrawal by Subject|5|||
170825495|NCT01180790|617370154|FG003|Overall Study|Withdrawal by Subject|0|||
170825496|NCT01180790|617370155|FG004|Overall Study|Withdrawal by Subject|2|||
170825497|NCT01180790|617370156|FG005|Overall Study|Withdrawal by Subject|1|||
170825498|NCT01180790|617370157|FG006|Overall Study|Withdrawal by Subject|0|||
170825499|NCT01180790|617370151|FG000|Overall Study|Lost to Follow-up|3|||
170825500|NCT01180790|617370152|FG001|Overall Study|Lost to Follow-up|1|||
170825501|NCT01180790|617370153|FG002|Overall Study|Lost to Follow-up|0|||
170825502|NCT01180790|617370154|FG003|Overall Study|Lost to Follow-up|2|||
170825503|NCT01180790|617370155|FG004|Overall Study|Lost to Follow-up|1|||
170825504|NCT01180790|617370156|FG005|Overall Study|Lost to Follow-up|0|||
170825505|NCT01180790|617370157|FG006|Overall Study|Lost to Follow-up|1|||
170825506|NCT01180790|617370151|FG000|Overall Study|Physician Decision|1|||
170825507|NCT01180790|617370152|FG001|Overall Study|Physician Decision|0|||
170825508|NCT01180790|617370153|FG002|Overall Study|Physician Decision|0|||
170825509|NCT01180790|617370154|FG003|Overall Study|Physician Decision|1|||
170825510|NCT01180790|617370155|FG004|Overall Study|Physician Decision|0|||
170825511|NCT01180790|617370156|FG005|Overall Study|Physician Decision|0|||
170825512|NCT01180790|617370157|FG006|Overall Study|Physician Decision|0|||
170825513|NCT01180790|617370151|FG000|Overall Study|Lack of Efficacy|1|||
170825514|NCT01180790|617370152|FG001|Overall Study|Lack of Efficacy|2|||
170825515|NCT01180790|617370153|FG002|Overall Study|Lack of Efficacy|5|||
170825516|NCT01180790|617370154|FG003|Overall Study|Lack of Efficacy|6|||
170825517|NCT01180790|617370155|FG004|Overall Study|Lack of Efficacy|1|||
170825518|NCT01180790|617370156|FG005|Overall Study|Lack of Efficacy|3|||
170825519|NCT01180790|617370157|FG006|Overall Study|Lack of Efficacy|0|||
170825520|NCT01180790|617370151|FG000|Overall Study|compliance|0|||
170825521|NCT01180790|617370152|FG001|Overall Study|compliance|1|||
170825522|NCT01180790|617370153|FG002|Overall Study|compliance|0|||
170825523|NCT01180790|617370154|FG003|Overall Study|compliance|0|||
170825524|NCT01180790|617370155|FG004|Overall Study|compliance|0|||
170825525|NCT01180790|617370156|FG005|Overall Study|compliance|0|||
170825526|NCT01180790|617370157|FG006|Overall Study|compliance|0|||
170825527|NCT01180790|617370151|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
170825528|NCT01180790|617370152|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
170825529|NCT01180790|617370153|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
170825530|NCT01180790|617370154|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
170825531|NCT01180790|617370155|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
170825532|NCT01180790|617370156|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
170825533|NCT01180790|617370157|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
170825534|NCT00655668|617370158|FG000|Overall Study|Adverse Event|6|||
170825535|NCT00655668|617370158|FG000|Overall Study|Death|5|||
170825536|NCT00655668|617370158|FG000|Overall Study|Disease Progression|27|||
170825537|NCT00655668|617370158|FG000|Overall Study|Study Terminated|9|||
170825538|NCT00655668|617370158|FG000|Overall Study|Other|1|||
170825539|NCT00655668|617370158|FG000|Overall Study|New Lymphoma Treatment Started|4|||
170825540|NCT00655668|617370158|FG000|Overall Study|Withdrawal by Subject|2|||
170825541|NCT02335242|617370159|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
170825542|NCT02335242|617370160|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
170825543|NCT02335242|617370159|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
170825544|NCT02335242|617370160|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
170825545|NCT02335242|617370159|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
170825546|NCT02335242|617370160|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
170825547|NCT04167085|617370161|FG000|Baseline|Withdrawal by Subject|2|||
170825548|NCT04167085|617370162|FG001|Baseline|Withdrawal by Subject|1|||
170825549|NCT04167085|617370161|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
170825550|NCT04167085|617370162|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
170825551|NCT03840148|617370163|FG000|Study Drug Disposition|Adverse Event|13|||
170825552|NCT03840148|617370164|FG001|Study Drug Disposition|Adverse Event|2|||
170825553|NCT03840148|617370163|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
170825554|NCT03840148|617370164|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
170825555|NCT03840148|617370163|FG000|Study Drug Disposition|Lack of Efficacy|3|||
170825556|NCT03840148|617370164|FG001|Study Drug Disposition|Lack of Efficacy|0|||
170825557|NCT03840148|617370163|FG000|Study Drug Disposition|Physician Decision|2|||
170825558|NCT03840148|617370164|FG001|Study Drug Disposition|Physician Decision|0|||
170825559|NCT03840148|617370163|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
170629123|NCT04363320|616654359|FG003|Overall Study|Death|0|||
170629124|NCT02260934|616654372|FG000|Overall Study|Lost to Follow-up|2|||
170825560|NCT03840148|617370164|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
170825561|NCT03840148|617370163|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
170825562|NCT03840148|617370164|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
170825563|NCT03840148|617370163|FG000|Study Completion Disposition|Physician Decision|2|||
170825564|NCT03840148|617370164|FG001|Study Completion Disposition|Physician Decision|0|||
170825565|NCT03840148|617370163|FG000|Study Completion Disposition|Covid-19 related|2|||
170825566|NCT03840148|617370164|FG001|Study Completion Disposition|Covid-19 related|0|||
170825567|NCT03840148|617370163|FG000|Study Completion Disposition|Lost to Follow-up|1|||
170825568|NCT03840148|617370164|FG001|Study Completion Disposition|Lost to Follow-up|1|||
170629125|NCT02260934|616654373|FG001|Overall Study|Lost to Follow-up|1|||
170629126|NCT02260934|616654372|FG000|Overall Study|Withdrawal by Subject|0|||
170629127|NCT02260934|616654373|FG001|Overall Study|Withdrawal by Subject|2|||
170629128|NCT02260934|616654372|FG000|Overall Study|Participant Relocated|1|||
170629129|NCT02260934|616654373|FG001|Overall Study|Participant Relocated|0|||
170629130|NCT02260934|616654372|FG000|Overall Study|Site error|0|||
170629131|NCT02260934|616654373|FG001|Overall Study|Site error|1|||
170629132|NCT02002598|616654374|FG000|Dose Level 1|Withdrawal by Subject|1|||
170629133|NCT02002598|616654375|FG001|Dose Level 1|Withdrawal by Subject|0|||
170629134|NCT02002598|616654376|FG002|Dose Level 1|Withdrawal by Subject|0|||
170629135|NCT02002598|616654377|FG003|Dose Level 1|Withdrawal by Subject|0|||
170629136|NCT02002598|616654378|FG004|Dose Level 1|Withdrawal by Subject|0|||
170629137|NCT02079246|616656529|FG000|OLEX|Withdrawal before treatment|1|||
170629138|NCT02079246|616656530|FG001|OLEX|Withdrawal before treatment|0|||
170629139|NCT02079246|616656529|FG000|OLEX|Death|11|||
170825569|NCT03840148|617370163|FG000|Study Completion Disposition|Death|1|||
170629140|NCT02079246|616656530|FG001|OLEX|Death|0|||
170629141|NCT02079246|616656529|FG000|OLEX|Adverse Event|66|||
170825570|NCT03840148|617370164|FG001|Study Completion Disposition|Death|0|||
170629142|NCT02079246|616656530|FG001|OLEX|Adverse Event|0|||
170629143|NCT02079246|616656529|FG000|OLEX|Withdrawal by Subject|60|||
170629144|NCT02079246|616656530|FG001|OLEX|Withdrawal by Subject|0|||
170629145|NCT02079246|616656529|FG000|OLEX|Lost to Follow-up|6|||
170629146|NCT02079246|616656530|FG001|OLEX|Lost to Follow-up|0|||
170629147|NCT02079246|616656529|FG000|OLEX|Protocol Violation|6|||
170629148|NCT02079246|616656530|FG001|OLEX|Protocol Violation|0|||
170629149|NCT02079246|616656529|FG000|OLEX|Lack of Efficacy|3|||
170629150|NCT02079246|616656530|FG001|OLEX|Lack of Efficacy|0|||
170629151|NCT02079246|616656529|FG000|OLEX|Results of the lead-in studies|58|||
170629152|NCT02079246|616656530|FG001|OLEX|Results of the lead-in studies|0|||
170629153|NCT02079246|616656529|FG000|OLEX|Other: Disallowed medication|8|||
170629154|NCT02079246|616656530|FG001|OLEX|Other: Disallowed medication|0|||
170629155|NCT02079246|616656529|FG000|OLEX|Other: Insufficient compliance|2|||
170629156|NCT02079246|616656530|FG001|OLEX|Other: Insufficient compliance|0|||
170629157|NCT02079246|616656529|FG000|OLEX|Other: Caregiver unavailable|3|||
170629158|NCT02079246|616656530|FG001|OLEX|Other: Caregiver unavailable|0|||
170629159|NCT02079246|616656529|FG000|OLEX|Other: Coordinator decision|1|||
170629160|NCT02079246|616656530|FG001|OLEX|Other: Coordinator decision|0|||
170629161|NCT02079246|616656529|FG000|OLEX|Other: Worsening of condition|1|||
170629162|NCT02079246|616656530|FG001|OLEX|Other: Worsening of condition|0|||
170629163|NCT02079246|616656529|FG000|OLEX|Other: Moved to nursing home|1|||
170629164|NCT02079246|616656530|FG001|OLEX|Other: Moved to nursing home|0|||
170629165|NCT02079246|616656529|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
170629166|NCT02079246|616656530|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
170629167|NCT02079246|616656529|FG000|OLEX-MEM|Adverse Event|0|||
170629168|NCT02079246|616656530|FG001|OLEX-MEM|Adverse Event|6|||
170629169|NCT02079246|616656529|FG000|OLEX-MEM|Withdrawal by Subject|0|||
170629170|NCT02079246|616656530|FG001|OLEX-MEM|Withdrawal by Subject|7|||
170629171|NCT02079246|616656529|FG000|OLEX-MEM|Protocol Violation|0|||
170629172|NCT02079246|616656530|FG001|OLEX-MEM|Protocol Violation|2|||
170629173|NCT02079246|616656529|FG000|OLEX-MEM|Lost to Follow-up|0|||
170629174|NCT02079246|616656530|FG001|OLEX-MEM|Lost to Follow-up|1|||
170629175|NCT02079246|616656529|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
170629176|NCT02079246|616656530|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
170629177|NCT03591406|616656535|FG000|Overall Study|Adverse Event|5|||
170629178|NCT03591406|616656536|FG001|Overall Study|Adverse Event|3|||
170629179|NCT03591406|616656535|FG000|Overall Study|Protocol Violation|2|||
170629180|NCT03591406|616656536|FG001|Overall Study|Protocol Violation|1|||
170629181|NCT03591406|616656535|FG000|Overall Study|Withdrawal by Subject|0|||
170629182|NCT03591406|616656536|FG001|Overall Study|Withdrawal by Subject|5|||
170629183|NCT03216226|616656544|FG000|Overall Study|Adverse Event|3|||
170629184|NCT03216226|616656545|FG001|Overall Study|Adverse Event|0|||
170629185|NCT03216226|616656544|FG000|Overall Study|Protocol Violation|1|||
170629186|NCT03216226|616656545|FG001|Overall Study|Protocol Violation|3|||
170629187|NCT03216226|616656544|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
170629188|NCT03216226|616656545|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
170703557|NCT01454934|616924509|FG001|Overall Study|Not treated|2|||
170629189|NCT03216226|616656544|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
170629190|NCT03216226|616656545|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
170629191|NCT03216226|616656544|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
170629192|NCT03216226|616656545|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
170629193|NCT01352715|616656547|FG000|Overall Study|Death|3|||
170629194|NCT01352715|616656548|FG001|Overall Study|Death|3|||
170629195|NCT01352715|616656547|FG000|Overall Study|Lost to Follow-up|5|||
170629196|NCT01352715|616656548|FG001|Overall Study|Lost to Follow-up|7|||
170629197|NCT01352715|616656547|FG000|Overall Study|Withdrawal by Subject|4|||
170629198|NCT01352715|616656548|FG001|Overall Study|Withdrawal by Subject|8|||
170629199|NCT01352715|616656547|FG000|Overall Study|site closure|16|||
170629200|NCT01352715|616656548|FG001|Overall Study|site closure|15|||
170629201|NCT01352715|616656547|FG000|Overall Study|no final visit in closeout period|15|||
170629202|NCT01352715|616656548|FG001|Overall Study|no final visit in closeout period|12|||
170629203|NCT01352715|616656547|FG000|Overall Study|major ineligibility|2|||
170629204|NCT01352715|616656548|FG001|Overall Study|major ineligibility|1|||
170629205|NCT02000440|616656550|FG000|Overall Study|Adverse Event|3|||
170629206|NCT02000440|616656550|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
170629207|NCT02383576|616656551|FG000|Overall Study|Death|53|||
170629208|NCT02383576|616656552|FG001|Overall Study|Death|33|||
170629209|NCT02383576|616656551|FG000|Overall Study|Lost to Follow-up|7|||
170629210|NCT02383576|616656552|FG001|Overall Study|Lost to Follow-up|1|||
170629211|NCT02383576|616656551|FG000|Overall Study|Withdrew Consent|1|||
170629212|NCT02383576|616656552|FG001|Overall Study|Withdrew Consent|6|||
170629213|NCT02383576|616656551|FG000|Overall Study|Investigator's Decision|0|||
170629214|NCT02383576|616656552|FG001|Overall Study|Investigator's Decision|1|||
170629215|NCT02383576|616656551|FG000|Overall Study|Administrative/Other|2|||
170629216|NCT02383576|616656552|FG001|Overall Study|Administrative/Other|4|||
170629217|NCT00871975|616656553|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
170629218|NCT00871975|616656553|FG000|Overall Study|Catheters could not be inserted|1|||
170629219|NCT00871975|616656553|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
170629220|NCT00871975|616656553|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
170629221|NCT05966142|616656554|FG000|Overall Study|Death|3|||
170629222|NCT05966142|616656555|FG001|Overall Study|Death|3|||
170629223|NCT05966142|616656554|FG000|Overall Study|Lost to Follow-up|55|||
170629224|NCT05966142|616656555|FG001|Overall Study|Lost to Follow-up|52|||
170629225|NCT05966142|616656554|FG000|Overall Study|Physician Decision|1|||
170629226|NCT05966142|616656555|FG001|Overall Study|Physician Decision|0|||
170629227|NCT05966142|616656554|FG000|Overall Study|Withdrawal by Subject|9|||
170629228|NCT05966142|616656555|FG001|Overall Study|Withdrawal by Subject|8|||
170629229|NCT05966142|616656554|FG000|Overall Study|Duplicate Enrollment|1|||
170629230|NCT05966142|616656555|FG001|Overall Study|Duplicate Enrollment|0|||
170629231|NCT05966142|616656554|FG000|Overall Study|Study Logistical Reason|1|||
170629232|NCT05966142|616656555|FG001|Overall Study|Study Logistical Reason|0|||
170629233|NCT05966142|616656554|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
170629234|NCT05966142|616656555|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
170629235|NCT01690143|616656556|FG000|Overall Study|Withdrawal by Subject|1|||
170629236|NCT00870740|616656559|FG000|Overall Study|Adverse Event|2|||
170629237|NCT00870740|616656560|FG001|Overall Study|Adverse Event|1|||
170629238|NCT00870740|616656561|FG002|Overall Study|Adverse Event|3|||
170629239|NCT00870740|616656562|FG003|Overall Study|Adverse Event|2|||
170629240|NCT00870740|616656563|FG004|Overall Study|Adverse Event|1|||
170629241|NCT00870740|616656564|FG005|Overall Study|Adverse Event|6|||
170629242|NCT00870740|616656559|FG000|Overall Study|Consent Withdrawn|6|||
170629243|NCT00870740|616656560|FG001|Overall Study|Consent Withdrawn|3|||
170629244|NCT00870740|616656561|FG002|Overall Study|Consent Withdrawn|4|||
170629245|NCT00870740|616656562|FG003|Overall Study|Consent Withdrawn|6|||
170629246|NCT00870740|616656563|FG004|Overall Study|Consent Withdrawn|6|||
170629247|NCT00870740|616656564|FG005|Overall Study|Consent Withdrawn|5|||
170629248|NCT00870740|616656559|FG000|Overall Study|Investigator Decision|2|||
170629249|NCT00870740|616656560|FG001|Overall Study|Investigator Decision|0|||
170629250|NCT00870740|616656561|FG002|Overall Study|Investigator Decision|1|||
170629251|NCT00870740|616656562|FG003|Overall Study|Investigator Decision|0|||
170629252|NCT00870740|616656563|FG004|Overall Study|Investigator Decision|0|||
170629253|NCT00870740|616656564|FG005|Overall Study|Investigator Decision|0|||
170629254|NCT00870740|616656559|FG000|Overall Study|Subject Non-compliance|0|||
170629255|NCT00870740|616656560|FG001|Overall Study|Subject Non-compliance|0|||
170629256|NCT00870740|616656561|FG002|Overall Study|Subject Non-compliance|0|||
170629257|NCT00870740|616656562|FG003|Overall Study|Subject Non-compliance|0|||
170629258|NCT00870740|616656563|FG004|Overall Study|Subject Non-compliance|0|||
170629259|NCT00870740|616656564|FG005|Overall Study|Subject Non-compliance|1|||
170629260|NCT00870740|616656559|FG000|Overall Study|Death|0|||
170629261|NCT00870740|616656560|FG001|Overall Study|Death|0|||
170629262|NCT00870740|616656561|FG002|Overall Study|Death|0|||
170629263|NCT00870740|616656562|FG003|Overall Study|Death|0|||
170629264|NCT00870740|616656563|FG004|Overall Study|Death|1|||
170629265|NCT00870740|616656564|FG005|Overall Study|Death|0|||
170629266|NCT00870740|616656559|FG000|Overall Study|Other|2|||
170629267|NCT00870740|616656560|FG001|Overall Study|Other|5|||
170629268|NCT00870740|616656561|FG002|Overall Study|Other|2|||
170629269|NCT00870740|616656562|FG003|Overall Study|Other|4|||
170629270|NCT00870740|616656563|FG004|Overall Study|Other|3|||
170629271|NCT00870740|616656564|FG005|Overall Study|Other|5|||
170629272|NCT00449696|616656570|FG000|Overall Study|Other Treatment Required|6|||
170629273|NCT00449696|616656571|FG001|Overall Study|Other Treatment Required|1|||
170629274|NCT00449696|616656570|FG000|Overall Study|Withdrawal by Subject|5|||
170629275|NCT00449696|616656571|FG001|Overall Study|Withdrawal by Subject|5|||
170629276|NCT00449696|616656570|FG000|Overall Study|Lost to Follow-up|2|||
170629277|NCT00449696|616656571|FG001|Overall Study|Lost to Follow-up|3|||
170629278|NCT00449696|616656570|FG000|Overall Study|Others|7|||
170629279|NCT00449696|616656571|FG001|Overall Study|Others|0|||
170629280|NCT01052493|616656572|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
170629281|NCT01052493|616656573|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
170629282|NCT01052493|616656574|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
170629283|NCT00307801|616656575|FG000|Overall Study|Adverse Event|12|||
170825571|NCT03840148|617370163|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
170825572|NCT03840148|617370164|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
170825573|NCT03615404|617370165|FG000|Overall Study|Death|1|||
170825574|NCT03615404|617370165|FG000|Overall Study|vaccine did not pass quality assurance|1|||
170825575|NCT00257556|617370166|FG000|Overall Study|Adverse Event|1|||
170825576|NCT00257556|617370167|FG001|Overall Study|Adverse Event|4|||
170825577|NCT00257556|617370166|FG000|Overall Study|Physician Decision|6|||
170825578|NCT00257556|617370167|FG001|Overall Study|Physician Decision|0|||
170825579|NCT00257556|617370166|FG000|Overall Study|Did not meet hCG criterion|3|||
170629284|NCT00307801|616656576|FG001|Overall Study|Adverse Event|4|||
170825580|NCT00257556|617370167|FG001|Overall Study|Did not meet hCG criterion|0|||
170825581|NCT00257556|617370166|FG000|Overall Study|other reason|4|||
170825582|NCT00257556|617370167|FG001|Overall Study|other reason|6|||
170825583|NCT04839289|617370169|FG000|Overall Study|Withdrawal by Subject|1|||
170825584|NCT04839289|617370170|FG001|Overall Study|Withdrawal by Subject|0|||
170825585|NCT00464737|617370171|FG000|Overall Study|Adverse Event|12|||
170825586|NCT00464737|617370172|FG001|Overall Study|Adverse Event|17|||
170825587|NCT00464737|617370173|FG002|Overall Study|Adverse Event|33|||
170825588|NCT00464737|617370171|FG000|Overall Study|Lack of Efficacy|7|||
170825589|NCT00464737|617370172|FG001|Overall Study|Lack of Efficacy|7|||
170825590|NCT00464737|617370173|FG002|Overall Study|Lack of Efficacy|4|||
170825591|NCT00464737|617370171|FG000|Overall Study|Withdrawal by Subject|5|||
170825592|NCT00464737|617370172|FG001|Overall Study|Withdrawal by Subject|3|||
170825593|NCT00464737|617370173|FG002|Overall Study|Withdrawal by Subject|5|||
170825594|NCT00464737|617370171|FG000|Overall Study|Protocol Violation|1|||
170825595|NCT00464737|617370172|FG001|Overall Study|Protocol Violation|1|||
170825596|NCT00464737|617370173|FG002|Overall Study|Protocol Violation|5|||
170825597|NCT00464737|617370171|FG000|Overall Study|Non-compliance|0|||
170825598|NCT00464737|617370172|FG001|Overall Study|Non-compliance|1|||
170825599|NCT00464737|617370173|FG002|Overall Study|Non-compliance|1|||
170825600|NCT00464737|617370171|FG000|Overall Study|Lost to Follow-up|5|||
170825601|NCT00464737|617370172|FG001|Overall Study|Lost to Follow-up|2|||
170825602|NCT00464737|617370173|FG002|Overall Study|Lost to Follow-up|5|||
170825603|NCT00464737|617370171|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
170825604|NCT00464737|617370172|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
170825605|NCT00464737|617370173|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
170825606|NCT00464737|617370171|FG000|Overall Study|Other: Subject left town; family illness|1|||
170629285|NCT00307801|616656575|FG000|Overall Study|Withdrawal by Subject|9|||
170629286|NCT00307801|616656576|FG001|Overall Study|Withdrawal by Subject|4|||
170629287|NCT00307801|616656575|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
170629288|NCT00307801|616656576|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
170629289|NCT00307801|616656575|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
170629290|NCT00307801|616656576|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
170629291|NCT00307801|616656575|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
170629292|NCT00307801|616656576|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
170629293|NCT00307801|616656575|FG000|Overall Study|Wrong Randomization|1|||
170629294|NCT00307801|616656576|FG001|Overall Study|Wrong Randomization|0|||
170825607|NCT00464737|617370172|FG001|Overall Study|Other: Subject left town; family illness|0|||
170825608|NCT00464737|617370173|FG002|Overall Study|Other: Subject left town; family illness|0|||
170825609|NCT00464737|617370171|FG000|Overall Study|Other: Study demands too great|0|||
170629295|NCT00307801|616656575|FG000|Overall Study|Lack of Efficacy|0|||
170825610|NCT00464737|617370172|FG001|Overall Study|Other: Study demands too great|1|||
170629296|NCT00307801|616656576|FG001|Overall Study|Lack of Efficacy|2|||
170629297|NCT00307801|616656575|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
170825611|NCT00464737|617370173|FG002|Overall Study|Other: Study demands too great|0|||
170629298|NCT00307801|616656576|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
170629299|NCT00307801|616656575|FG000|Overall Study|Frustration with e-diary|1|||
170629300|NCT00307801|616656576|FG001|Overall Study|Frustration with e-diary|0|||
170629301|NCT00307801|616656575|FG000|Overall Study|Protocol Violation|3|||
170629302|NCT00307801|616656576|FG001|Overall Study|Protocol Violation|2|||
170629303|NCT00307801|616656575|FG000|Overall Study|No reason specified|2|||
170629304|NCT00307801|616656576|FG001|Overall Study|No reason specified|0|||
170629305|NCT00307801|616656575|FG000|Overall Study|Pregnancy|0|||
170629306|NCT00307801|616656576|FG001|Overall Study|Pregnancy|1|||
170629307|NCT03337308|616656577|FG000|Overall Study|Adverse Event|2|||
170629308|NCT03337308|616656578|FG001|Overall Study|Adverse Event|3|||
170629309|NCT03337308|616656579|FG002|Overall Study|Adverse Event|3|||
170629310|NCT03337308|616656580|FG003|Overall Study|Adverse Event|1|||
170629311|NCT03337308|616656577|FG000|Overall Study|Lost to Follow-up|1|||
170629312|NCT03337308|616656578|FG001|Overall Study|Lost to Follow-up|2|||
170629313|NCT03337308|616656579|FG002|Overall Study|Lost to Follow-up|0|||
170629314|NCT03337308|616656580|FG003|Overall Study|Lost to Follow-up|0|||
170629315|NCT03337308|616656577|FG000|Overall Study|Withdrawal by Subject|2|||
170629316|NCT03337308|616656578|FG001|Overall Study|Withdrawal by Subject|1|||
170629317|NCT03337308|616656579|FG002|Overall Study|Withdrawal by Subject|2|||
170629318|NCT03337308|616656580|FG003|Overall Study|Withdrawal by Subject|1|||
170629319|NCT03337308|616656577|FG000|Overall Study|Protocol Violation|0|||
170629320|NCT03337308|616656578|FG001|Overall Study|Protocol Violation|1|||
170629321|NCT03337308|616656579|FG002|Overall Study|Protocol Violation|0|||
170629322|NCT03337308|616656580|FG003|Overall Study|Protocol Violation|0|||
170629323|NCT00391586|616656582|FG000|Overall Study|Progressive disease|13|||
170629324|NCT00391586|616656582|FG000|Overall Study|Adverse Event|5|||
170629325|NCT00391586|616656582|FG000|Overall Study|Physician Decision|2|||
170629326|NCT00391586|616656582|FG000|Overall Study|Death|4|||
170629327|NCT00198822|616656583|FG000|Overall Study|Lost to Follow-up|14|||
170629328|NCT00198822|616656584|FG001|Overall Study|Lost to Follow-up|20|||
170629329|NCT00198822|616656585|FG002|Overall Study|Lost to Follow-up|21|||
170629330|NCT03558737|616656586|FG000|Overall Study|Death|1|||
170629331|NCT03558737|616656587|FG001|Overall Study|Death|1|||
170629332|NCT01409707|616656588|FG000|Overall Study|Withdrawal by Subject|5|||
170629333|NCT01409707|616656589|FG001|Overall Study|Withdrawal by Subject|17|||
170629334|NCT01409707|616656590|FG002|Overall Study|Withdrawal by Subject|16|||
170629335|NCT01294553|616656591|FG000|Overall Study|Duplicated Participants|1|||
170629336|NCT01294553|616656591|FG000|Overall Study|Protocol Violation|268|||
170629337|NCT01467960|616656592|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
170629338|NCT01467960|616656593|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
170629339|NCT01467960|616656594|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
170629340|NCT01467960|616656595|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
170629341|NCT01467960|616656596|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
170629342|NCT01467960|616656597|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
170629343|NCT00474812|616656600|FG000|Overall Study|Withdrawal by Subject|5|||
170629344|NCT00474812|616656600|FG000|Overall Study|No Initiation of treatment|2|||
170629345|NCT01506596|616656601|FG000|Overall Study|ineligible pathology|1|||
170629346|NCT00737672|616656610|FG000|Overall Study|Graft Abandonment|48|||
170629347|NCT00737672|616656611|FG001|Overall Study|Graft Abandonment|56|||
170825612|NCT00464737|617370171|FG000|Overall Study|Other: Personal family reasons|0|||
170825613|NCT00464737|617370172|FG001|Overall Study|Other: Personal family reasons|0|||
170825614|NCT00464737|617370173|FG002|Overall Study|Other: Personal family reasons|1|||
170825615|NCT00464737|617370171|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
170825616|NCT00464737|617370172|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
170825617|NCT00464737|617370173|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
170825618|NCT00580047|617370178|FG000|Overall Study|Lost to Follow-up|1|||
170825619|NCT00580047|617370179|FG001|Overall Study|Lost to Follow-up|1|||
170825620|NCT00580047|617370180|FG002|Overall Study|Lost to Follow-up|0|||
170825621|NCT00580047|617370178|FG000|Overall Study|Withdrawal by Subject|1|||
170825622|NCT00580047|617370179|FG001|Overall Study|Withdrawal by Subject|1|||
170825623|NCT00580047|617370180|FG002|Overall Study|Withdrawal by Subject|2|||
170825624|NCT00580047|617370178|FG000|Overall Study|Withdrawal by Subject|1|||
170825625|NCT00580047|617370179|FG001|Overall Study|Withdrawal by Subject|0|||
170825626|NCT00580047|617370180|FG002|Overall Study|Withdrawal by Subject|0|||
170629348|NCT00737672|616656610|FG000|Overall Study|Death|23|||
170629349|NCT00737672|616656611|FG001|Overall Study|Death|22|||
170629350|NCT00737672|616656610|FG000|Overall Study|Withdrawal by Subject|1|||
170629351|NCT00737672|616656611|FG001|Overall Study|Withdrawal by Subject|2|||
170629352|NCT00737672|616656610|FG000|Overall Study|Lost to Follow-up|1|||
170629353|NCT00737672|616656611|FG001|Overall Study|Lost to Follow-up|0|||
170629354|NCT00737672|616656610|FG000|Overall Study|Miscellaneous|7|||
170629355|NCT00737672|616656611|FG001|Overall Study|Miscellaneous|1|||
170629356|NCT00737672|616656610|FG000|Overall Study|Physician Decision|0|||
170629357|NCT00737672|616656611|FG001|Overall Study|Physician Decision|2|||
170629358|NCT00829426|616656616|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
170825627|NCT02820298|617370183|FG000|Overall Study|Withdrawal by Subject|0|||
170825628|NCT02820298|617370184|FG001|Overall Study|Withdrawal by Subject|1|||
170825629|NCT02820298|617370183|FG000|Overall Study|Physician Decision|1|||
170825630|NCT02820298|617370184|FG001|Overall Study|Physician Decision|0|||
170825631|NCT02820298|617370183|FG000|Overall Study|Protocol Violation|0|||
170825632|NCT02820298|617370184|FG001|Overall Study|Protocol Violation|1|||
170825633|NCT01894256|617370185|FG000|Part A|Adverse Event|0|||
170825634|NCT01894256|617370186|FG001|Part A|Adverse Event|1|||
170825635|NCT01894256|617370187|FG002|Part A|Adverse Event|0|||
170825636|NCT01894256|617370185|FG000|Part B|Death|0|||
170825637|NCT01894256|617370186|FG001|Part B|Death|1|||
170825638|NCT01894256|617370187|FG002|Part B|Death|1|||
170825639|NCT01894256|617370185|FG000|Part B|Withdrawal by Subject|0|||
170825640|NCT01894256|617370186|FG001|Part B|Withdrawal by Subject|1|||
170825641|NCT01894256|617370187|FG002|Part B|Withdrawal by Subject|0|||
170825642|NCT01894256|617370185|FG000|Part B|Lack of Efficacy|15|||
170825643|NCT01894256|617370186|FG001|Part B|Lack of Efficacy|12|||
170825644|NCT01894256|617370187|FG002|Part B|Lack of Efficacy|13|||
170825645|NCT01780584|617370188|FG000|Overall Study|Death|1|||
170825646|NCT01780584|617370189|FG001|Overall Study|Death|0|||
170825647|NCT01780584|617370190|FG002|Overall Study|Death|1|||
170825648|NCT01780584|617370188|FG000|Overall Study|Adverse Event|0|||
170825649|NCT01780584|617370189|FG001|Overall Study|Adverse Event|1|||
170825650|NCT01780584|617370190|FG002|Overall Study|Adverse Event|0|||
170825651|NCT01780584|617370188|FG000|Overall Study|Protocol Violation|0|||
170825652|NCT01780584|617370189|FG001|Overall Study|Protocol Violation|0|||
170825653|NCT01780584|617370190|FG002|Overall Study|Protocol Violation|1|||
170825654|NCT00141271|617370193|FG000|Overall Study|Adverse Event|31|||
170825655|NCT00141271|617370194|FG001|Overall Study|Adverse Event|19|||
170825656|NCT00141271|617370195|FG002|Overall Study|Adverse Event|17|||
170825657|NCT00141271|617370193|FG000|Overall Study|Laboratory Abnormality|2|||
170825658|NCT00141271|617370194|FG001|Overall Study|Laboratory Abnormality|1|||
170825659|NCT00141271|617370195|FG002|Overall Study|Laboratory Abnormality|1|||
170825660|NCT00141271|617370193|FG000|Overall Study|Lack of Efficacy|7|||
170825661|NCT00141271|617370194|FG001|Overall Study|Lack of Efficacy|7|||
170825662|NCT00141271|617370195|FG002|Overall Study|Lack of Efficacy|3|||
170825663|NCT00141271|617370193|FG000|Overall Study|Lost to Follow-up|15|||
170825664|NCT00141271|617370194|FG001|Overall Study|Lost to Follow-up|15|||
170825665|NCT00141271|617370195|FG002|Overall Study|Lost to Follow-up|21|||
170825666|NCT00141271|617370193|FG000|Overall Study|Withdrawal by Subject|14|||
170825667|NCT00141271|617370194|FG001|Overall Study|Withdrawal by Subject|9|||
170825668|NCT00141271|617370195|FG002|Overall Study|Withdrawal by Subject|10|||
170825669|NCT00141271|617370193|FG000|Overall Study|Other|11|||
170825670|NCT00141271|617370194|FG001|Overall Study|Other|12|||
170825671|NCT00141271|617370195|FG002|Overall Study|Other|5|||
170825672|NCT00390806|617370199|FG000|Overall Study|Lost to Follow-up|7|||
170825673|NCT00390806|617370200|FG001|Overall Study|Lost to Follow-up|6|||
170825674|NCT00390806|617370199|FG000|Overall Study|Protocol Violation|2|||
170825675|NCT00390806|617370200|FG001|Overall Study|Protocol Violation|2|||
170825676|NCT00390806|617370199|FG000|Overall Study|Withdrawal by Subject|12|||
170825677|NCT00390806|617370200|FG001|Overall Study|Withdrawal by Subject|15|||
170825678|NCT00390806|617370199|FG000|Overall Study|Investigator Decision|4|||
170825679|NCT00390806|617370200|FG001|Overall Study|Investigator Decision|6|||
170825680|NCT00390806|617370199|FG000|Overall Study|Death|1|||
170825681|NCT00390806|617370200|FG001|Overall Study|Death|0|||
170629359|NCT00829426|616656617|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
170629360|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
170629361|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
170629362|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
170629363|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
170629364|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Adverse Event|2|||
170629365|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Adverse Event|5|||
170629366|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Adverse Event|1|||
170629367|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Adverse Event|2|||
170629368|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Death|13|||
170629369|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Death|17|||
170825682|NCT00390806|617370199|FG000|Overall Study|Physician Decision|0|||
170825683|NCT00390806|617370200|FG001|Overall Study|Physician Decision|1|||
170825684|NCT00390806|617370199|FG000|Overall Study|Ongoing|4|||
170825685|NCT00390806|617370200|FG001|Overall Study|Ongoing|2|||
170825686|NCT04783519|617370201|FG000|Overall Study|Withdrawal by Subject|2|||
170825687|NCT04783519|617370202|FG001|Overall Study|Withdrawal by Subject|7|||
170825688|NCT04783519|617370203|FG002|Overall Study|Withdrawal by Subject|3|||
170825689|NCT04783519|617370201|FG000|Overall Study|Lost to Follow-up|9|||
170825690|NCT04783519|617370202|FG001|Overall Study|Lost to Follow-up|7|||
170825691|NCT04783519|617370203|FG002|Overall Study|Lost to Follow-up|6|||
170825692|NCT02316171|617370206|FG000|Overall Study|difficulties with urinary catheter|1|||
170825693|NCT02316171|617370207|FG001|Overall Study|difficulties with urinary catheter|0|||
170825694|NCT02316171|617370208|FG002|Overall Study|difficulties with urinary catheter|0|||
170825695|NCT02316171|617370209|FG003|Overall Study|difficulties with urinary catheter|0|||
170825696|NCT01804140|617370210|FG000|Overall Study|No sampling or biopsy procedures done|114|||
170629370|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Death|1|||
170629371|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Death|0|||
170629372|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
170629373|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
170629374|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
170629375|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
170629376|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Disease Progression|2|||
170629377|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Disease Progression|0|||
170629378|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Disease Progression|0|||
170629379|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Disease Progression|0|||
170629380|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
170629381|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
170629382|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
170629383|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
170629384|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
170629385|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
170629386|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
170629387|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
170629388|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
170629389|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
170629390|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
170629391|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
170629392|NCT03955146|616656618|FG000|DB Period (48 Weeks)|Participant Decision|9|||
170629393|NCT03955146|616656619|FG001|DB Period (48 Weeks)|Participant Decision|12|||
170629394|NCT03955146|616656620|FG002|DB Period (48 Weeks)|Participant Decision|1|||
170629395|NCT03955146|616656621|FG003|DB Period (48 Weeks)|Participant Decision|1|||
170629396|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
170629397|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
170629398|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
170629399|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
170629400|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
170629401|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
170629402|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
170629403|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
170629404|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
170629405|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
170629406|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
170629407|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
170629408|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
170629409|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
170629410|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
170629411|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
170629412|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
170629413|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
170629414|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
170629415|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
170629416|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
170629417|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
170629418|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
170629419|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
170629420|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
170629421|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
170629422|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
170629423|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
170629424|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
170629425|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
170629426|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
170629427|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
170629428|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
170629429|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
170629430|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
170629431|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
170629432|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
170629433|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
170629434|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
170629435|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
170629436|NCT03955146|616656618|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
170629437|NCT03955146|616656619|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
170629438|NCT03955146|616656620|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
170629439|NCT03955146|616656621|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
170629440|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
170629441|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
170629442|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
170629443|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
170629444|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
170629445|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
170629446|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
170629447|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
170629448|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
170629449|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
170629450|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
170629451|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
170629452|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
170629453|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
170629454|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
170629455|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
170629456|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
170629457|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
170629458|NCT03605667|616656624|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
170629459|NCT03605667|616656625|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
170629460|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
170629461|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
170629462|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Other|6|||
170629463|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Other|8|||
170629464|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
170629465|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
170629466|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
170629467|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
170629468|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
170629469|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
170629470|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
170629471|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
170703558|NCT02624284|616924512|FG000|Overall Study|Withdrawal by Subject|3|||
170703559|NCT02624284|616924513|FG001|Overall Study|Withdrawal by Subject|6|||
170703560|NCT02624284|616924514|FG002|Overall Study|Withdrawal by Subject|3|||
170703561|NCT02624284|616924512|FG000|Overall Study|Protocol Violation|9|||
170703562|NCT02624284|616924513|FG001|Overall Study|Protocol Violation|10|||
170703563|NCT02624284|616924514|FG002|Overall Study|Protocol Violation|7|||
170703564|NCT02624284|616924512|FG000|Overall Study|Revealed exclusionary condition|2|||
170703565|NCT02624284|616924513|FG001|Overall Study|Revealed exclusionary condition|2|||
170703566|NCT02624284|616924514|FG002|Overall Study|Revealed exclusionary condition|0|||
170703567|NCT02624284|616924512|FG000|Overall Study|Adverse Event|0|||
170703568|NCT02624284|616924513|FG001|Overall Study|Adverse Event|0|||
170825697|NCT00547300|617370213|FG000|Overall Study|Study was Administratively Terminated|25|||
170629472|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
170629473|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
170629474|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
170629475|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
170629476|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Death|0|||
170629477|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Death|2|||
170629478|NCT03605667|616656624|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
170629479|NCT03605667|616656625|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
170629480|NCT05632211|616656626|FG000|Overall Study|Withdrawal by Subject|2|||
170629481|NCT05632211|616656627|FG001|Overall Study|Withdrawal by Subject|0|||
170629482|NCT05632211|616656628|FG002|Overall Study|Withdrawal by Subject|2|||
170629483|NCT05632211|616656626|FG000|Overall Study|Other reasons|1|||
170629484|NCT05632211|616656627|FG001|Overall Study|Other reasons|1|||
170629485|NCT05632211|616656628|FG002|Overall Study|Other reasons|1|||
170629486|NCT04123470|616656634|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
170629487|NCT04123470|616656635|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
170629488|NCT04123470|616656634|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
170629489|NCT04123470|616656635|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
170629490|NCT04123470|616656634|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
170629491|NCT04123470|616656635|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
170629492|NCT04123470|616656634|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
170629493|NCT04123470|616656635|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
170629494|NCT02018562|616656639|FG000|Overall Study|Withdrawal by Subject|2|||
170629495|NCT02018562|616656640|FG001|Overall Study|Withdrawal by Subject|0|||
170629496|NCT02018562|616656639|FG000|Overall Study|Discharged prior to study completion|1|||
170629497|NCT02018562|616656640|FG001|Overall Study|Discharged prior to study completion|0|||
170629498|NCT05194124|616656647|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
170629499|NCT05194124|616656648|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
170629500|NCT05194124|616656649|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
170629501|NCT05194124|616656650|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
170629502|NCT05194124|616656651|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
170629503|NCT05194124|616656652|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
170629504|NCT05194124|616656653|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
170629505|NCT05194124|616656654|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
170629506|NCT05194124|616656655|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
170629507|NCT05194124|616656656|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
170629508|NCT05194124|616656647|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629509|NCT05194124|616656648|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629510|NCT05194124|616656649|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629511|NCT05194124|616656650|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629512|NCT05194124|616656651|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629513|NCT05194124|616656652|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629514|NCT05194124|616656653|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629515|NCT05194124|616656654|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629516|NCT05194124|616656655|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
170629517|NCT05194124|616656656|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
170629518|NCT05408429|616656661|FG000|Overall Study|Lost to Follow-up|1|||
170629519|NCT05408429|616656662|FG001|Overall Study|Lost to Follow-up|1|||
170629520|NCT05408429|616656663|FG002|Overall Study|Lost to Follow-up|0|||
170629521|NCT05408429|616656661|FG000|Overall Study|Withdrawal by Subject|5|||
170629522|NCT05408429|616656662|FG001|Overall Study|Withdrawal by Subject|0|||
170629523|NCT05408429|616656663|FG002|Overall Study|Withdrawal by Subject|1|||
170629524|NCT03137992|616656664|FG000|Washout Period 1|Adverse Event|1|||
170629525|NCT03137992|616656665|FG001|Washout Period 1|Adverse Event|1|||
170629526|NCT03137992|616656666|FG002|Washout Period 1|Adverse Event|0|||
170629527|NCT03137992|616656667|FG003|Washout Period 1|Adverse Event|0|||
170629528|NCT03137992|616656668|FG004|Washout Period 1|Adverse Event|0|||
170629529|NCT03137992|616656669|FG005|Washout Period 1|Adverse Event|1|||
170629530|NCT03137992|616656664|FG000|Washout Period 1|Withdrawal by Subject|0|||
170629531|NCT03137992|616656665|FG001|Washout Period 1|Withdrawal by Subject|1|||
170629532|NCT03137992|616656666|FG002|Washout Period 1|Withdrawal by Subject|1|||
170629533|NCT03137992|616656667|FG003|Washout Period 1|Withdrawal by Subject|0|||
170629534|NCT03137992|616656668|FG004|Washout Period 1|Withdrawal by Subject|0|||
170629535|NCT03137992|616656669|FG005|Washout Period 1|Withdrawal by Subject|0|||
170629536|NCT03137992|616656664|FG000|Washout Period 1|Principal Investigator Discretion|0|||
170629537|NCT03137992|616656665|FG001|Washout Period 1|Principal Investigator Discretion|1|||
170629538|NCT03137992|616656666|FG002|Washout Period 1|Principal Investigator Discretion|0|||
170629539|NCT03137992|616656667|FG003|Washout Period 1|Principal Investigator Discretion|0|||
170629540|NCT03137992|616656668|FG004|Washout Period 1|Principal Investigator Discretion|0|||
170629541|NCT03137992|616656669|FG005|Washout Period 1|Principal Investigator Discretion|0|||
170629542|NCT03137992|616656664|FG000|Washout Period 1|COPD Exacerbation|1|||
170629543|NCT03137992|616656665|FG001|Washout Period 1|COPD Exacerbation|1|||
170629544|NCT03137992|616656666|FG002|Washout Period 1|COPD Exacerbation|1|||
170629545|NCT03137992|616656667|FG003|Washout Period 1|COPD Exacerbation|0|||
170629546|NCT03137992|616656668|FG004|Washout Period 1|COPD Exacerbation|1|||
170629547|NCT03137992|616656669|FG005|Washout Period 1|COPD Exacerbation|1|||
170629548|NCT03137992|616656664|FG000|Washout Period 1|Subject Noncompliance|1|||
170629549|NCT03137992|616656665|FG001|Washout Period 1|Subject Noncompliance|0|||
170629550|NCT03137992|616656666|FG002|Washout Period 1|Subject Noncompliance|0|||
170629551|NCT03137992|616656667|FG003|Washout Period 1|Subject Noncompliance|0|||
170629552|NCT03137992|616656668|FG004|Washout Period 1|Subject Noncompliance|1|||
170629553|NCT03137992|616656669|FG005|Washout Period 1|Subject Noncompliance|0|||
170629554|NCT03137992|616656664|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
170629555|NCT03137992|616656665|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
170629556|NCT03137992|616656666|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
170629557|NCT03137992|616656667|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
170629558|NCT03137992|616656668|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
170629559|NCT03137992|616656669|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
170629560|NCT03137992|616656664|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
170629561|NCT03137992|616656665|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
170629562|NCT03137992|616656666|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
170629563|NCT03137992|616656667|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
170629564|NCT03137992|616656668|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
170825698|NCT00547300|617370214|FG001|Overall Study|Study was Administratively Terminated|24|||
170825699|NCT00547300|617370213|FG000|Overall Study|Did not Meet Entry Criteria|0|||
170825700|NCT00547300|617370214|FG001|Overall Study|Did not Meet Entry Criteria|2|||
170825701|NCT02785900|617370215|FG000|Overall Study|Study Termination by Sponsor|64|||
170825702|NCT02785900|617370216|FG001|Overall Study|Study Termination by Sponsor|81|||
170825703|NCT02785900|617370215|FG000|Overall Study|Death|46|||
170825704|NCT02785900|617370216|FG001|Overall Study|Death|32|||
170825705|NCT02785900|617370215|FG000|Overall Study|Withdrawal by Subject|4|||
170825706|NCT02785900|617370216|FG001|Overall Study|Withdrawal by Subject|8|||
170825707|NCT02785900|617370215|FG000|Overall Study|Physician Decision|3|||
170825708|NCT02785900|617370216|FG001|Overall Study|Physician Decision|2|||
170825709|NCT03864341|617372132|FG000|Overall Study|Withdrawal by Subject|1|||
170825710|NCT01904136|617372133|FG000|Overall Study|Physician Decision|0|||
170825711|NCT01904136|617372134|FG001|Overall Study|Physician Decision|0|||
170825712|NCT01904136|617372135|FG002|Overall Study|Physician Decision|0|||
170825713|NCT01904136|617372136|FG003|Overall Study|Physician Decision|0|||
170825714|NCT01904136|617372137|FG004|Overall Study|Physician Decision|0|||
170825715|NCT01904136|617372138|FG005|Overall Study|Physician Decision|1|||
170825716|NCT01904136|617372139|FG006|Overall Study|Physician Decision|0|||
170825717|NCT01904136|617372140|FG007|Overall Study|Physician Decision|0|||
170825718|NCT01904136|617372141|FG008|Overall Study|Physician Decision|0|||
170825719|NCT01960348|617372143|FG000|Overall Study|Adverse event, not serious|2|||
170825720|NCT01960348|617372144|FG001|Overall Study|Adverse event, not serious|2|||
170825721|NCT01960348|617372143|FG000|Overall Study|Adverse event, serious fatal|6|||
170825722|NCT01960348|617372144|FG001|Overall Study|Adverse event, serious fatal|5|||
170825723|NCT01960348|617372143|FG000|Overall Study|Adverse event, serious non-fatal|0|||
170629565|NCT03137992|616656669|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
170629566|NCT03137992|616656664|FG000|Period 2 (Visit 3)|Adverse Event|0|||
170629567|NCT03137992|616656665|FG001|Period 2 (Visit 3)|Adverse Event|1|||
170629568|NCT03137992|616656666|FG002|Period 2 (Visit 3)|Adverse Event|0|||
170629569|NCT03137992|616656667|FG003|Period 2 (Visit 3)|Adverse Event|0|||
170629570|NCT03137992|616656668|FG004|Period 2 (Visit 3)|Adverse Event|0|||
170629571|NCT03137992|616656669|FG005|Period 2 (Visit 3)|Adverse Event|0|||
170629572|NCT03137992|616656664|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
170629573|NCT03137992|616656665|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
170629574|NCT03137992|616656666|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
170629575|NCT03137992|616656667|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
170629576|NCT03137992|616656668|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
170629577|NCT03137992|616656669|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
170629578|NCT03137992|616656664|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
170629579|NCT03137992|616656665|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
170629580|NCT03137992|616656666|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
170629581|NCT03137992|616656667|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
170629582|NCT03137992|616656668|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
170629583|NCT03137992|616656669|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
170629584|NCT03137992|616656664|FG000|Washout Period 2|COPD Exacerbation|1|||
170629585|NCT03137992|616656665|FG001|Washout Period 2|COPD Exacerbation|1|||
170629586|NCT03137992|616656666|FG002|Washout Period 2|COPD Exacerbation|0|||
170629587|NCT03137992|616656667|FG003|Washout Period 2|COPD Exacerbation|0|||
170629588|NCT03137992|616656668|FG004|Washout Period 2|COPD Exacerbation|1|||
170629589|NCT03137992|616656669|FG005|Washout Period 2|COPD Exacerbation|0|||
170629590|NCT03137992|616656664|FG000|Washout Period 2|Subject Non-compliance|0|||
170629591|NCT03137992|616656665|FG001|Washout Period 2|Subject Non-compliance|1|||
170629592|NCT03137992|616656666|FG002|Washout Period 2|Subject Non-compliance|0|||
170629593|NCT03137992|616656667|FG003|Washout Period 2|Subject Non-compliance|0|||
170629594|NCT03137992|616656668|FG004|Washout Period 2|Subject Non-compliance|0|||
170629595|NCT03137992|616656669|FG005|Washout Period 2|Subject Non-compliance|0|||
170629596|NCT03137992|616656664|FG000|Washout Period 2|Adverse Event|0|||
170629597|NCT03137992|616656665|FG001|Washout Period 2|Adverse Event|0|||
170629598|NCT03137992|616656666|FG002|Washout Period 2|Adverse Event|0|||
170629599|NCT03137992|616656667|FG003|Washout Period 2|Adverse Event|1|||
170629600|NCT03137992|616656668|FG004|Washout Period 2|Adverse Event|1|||
170629601|NCT03137992|616656669|FG005|Washout Period 2|Adverse Event|0|||
170629602|NCT03137992|616656664|FG000|Washout Period 2|Withdrawal by Subject|1|||
170825724|NCT01960348|617372144|FG001|Overall Study|Adverse event, serious non-fatal|3|||
170825725|NCT01960348|617372143|FG000|Overall Study|Withdrawal by Subject|1|||
170825726|NCT01960348|617372144|FG001|Overall Study|Withdrawal by Subject|11|||
170825727|NCT01960348|617372143|FG000|Overall Study|Physician Decision|0|||
170825728|NCT01960348|617372144|FG001|Overall Study|Physician Decision|1|||
170825729|NCT01960348|617372143|FG000|Overall Study|Protocol Violation|1|||
170825730|NCT01960348|617372144|FG001|Overall Study|Protocol Violation|0|||
170629603|NCT03137992|616656665|FG001|Washout Period 2|Withdrawal by Subject|0|||
170629604|NCT03137992|616656666|FG002|Washout Period 2|Withdrawal by Subject|0|||
170629605|NCT03137992|616656667|FG003|Washout Period 2|Withdrawal by Subject|0|||
170825731|NCT00853372|617372145|FG000|Overall Study|Death|30|||
170629606|NCT03137992|616656668|FG004|Washout Period 2|Withdrawal by Subject|1|||
170629607|NCT03137992|616656669|FG005|Washout Period 2|Withdrawal by Subject|0|||
170629608|NCT03137992|616656664|FG000|Washout Period 2|Sponsor Decision|0|||
170629609|NCT03137992|616656665|FG001|Washout Period 2|Sponsor Decision|0|||
170629610|NCT03137992|616656666|FG002|Washout Period 2|Sponsor Decision|0|||
170629611|NCT03137992|616656667|FG003|Washout Period 2|Sponsor Decision|0|||
170629612|NCT03137992|616656668|FG004|Washout Period 2|Sponsor Decision|0|||
170629613|NCT03137992|616656669|FG005|Washout Period 2|Sponsor Decision|1|||
170629614|NCT03137992|616656664|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
170629615|NCT03137992|616656665|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
170629616|NCT03137992|616656666|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
170629617|NCT03137992|616656667|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
170629618|NCT03137992|616656668|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
170629619|NCT03137992|616656669|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
170629620|NCT03137992|616656664|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
170629621|NCT03137992|616656665|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
170629622|NCT03137992|616656666|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
170629623|NCT03137992|616656667|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
170629624|NCT03137992|616656668|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
170629625|NCT03137992|616656669|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
170629626|NCT03137992|616656664|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
170629627|NCT03137992|616656665|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
170629628|NCT03137992|616656666|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
170629629|NCT03137992|616656667|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
170629630|NCT03137992|616656668|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
170629631|NCT03137992|616656669|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
170629632|NCT03137992|616656664|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
170629633|NCT03137992|616656665|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
170629634|NCT03137992|616656666|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
170629635|NCT03137992|616656667|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
170629636|NCT03137992|616656668|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
170629637|NCT03137992|616656669|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
170629638|NCT03137992|616656664|FG000|Part 2 (Open-label Extension)|Per study team|1|||
170629639|NCT03137992|616656665|FG001|Part 2 (Open-label Extension)|Per study team|0|||
170629640|NCT03137992|616656666|FG002|Part 2 (Open-label Extension)|Per study team|0|||
170629641|NCT03137992|616656667|FG003|Part 2 (Open-label Extension)|Per study team|0|||
170629642|NCT03137992|616656668|FG004|Part 2 (Open-label Extension)|Per study team|0|||
170629643|NCT03137992|616656669|FG005|Part 2 (Open-label Extension)|Per study team|0|||
170629644|NCT03137992|616656664|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
170629645|NCT03137992|616656665|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
170629646|NCT03137992|616656666|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
170629647|NCT03137992|616656667|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
170629648|NCT03137992|616656668|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
170629649|NCT03137992|616656669|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
170629650|NCT04609319|616656670|FG000|Overall Study|Death|64|||
170629651|NCT04609319|616656671|FG001|Overall Study|Death|49|||
170629652|NCT04609319|616656672|FG002|Overall Study|Death|1|||
170629653|NCT04609319|616656670|FG000|Overall Study|Withdrawal of consent|15|||
170629654|NCT04609319|616656671|FG001|Overall Study|Withdrawal of consent|3|||
170629655|NCT04609319|616656672|FG002|Overall Study|Withdrawal of consent|0|||
170629656|NCT04609319|616656670|FG000|Overall Study|Lost to Follow-up|20|||
170629657|NCT04609319|616656671|FG001|Overall Study|Lost to Follow-up|33|||
170629658|NCT04609319|616656672|FG002|Overall Study|Lost to Follow-up|0|||
170629659|NCT04609319|616656670|FG000|Overall Study|Alive until end of follow-up|60|||
170629660|NCT04609319|616656671|FG001|Overall Study|Alive until end of follow-up|53|||
170629661|NCT04609319|616656672|FG002|Overall Study|Alive until end of follow-up|1|||
170629662|NCT01253291|616656674|FG000|Overall Study|Withdrawal by Subject|1|||
170629663|NCT01253291|616656675|FG001|Overall Study|Withdrawal by Subject|1|||
170629664|NCT01253291|616656676|FG002|Overall Study|Withdrawal by Subject|0|||
170629665|NCT01253291|616656677|FG003|Overall Study|Withdrawal by Subject|0|||
170629666|NCT01253291|616656678|FG004|Overall Study|Withdrawal by Subject|0|||
170629667|NCT01253291|616656674|FG000|Overall Study|Adverse Event|0|||
170703569|NCT02624284|616924514|FG002|Overall Study|Adverse Event|1|||
170703570|NCT01782313|616924515|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
170703571|NCT01782313|616924515|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
170629668|NCT01253291|616656675|FG001|Overall Study|Adverse Event|1|||
170629669|NCT01253291|616656676|FG002|Overall Study|Adverse Event|0|||
170629670|NCT01253291|616656677|FG003|Overall Study|Adverse Event|0|||
170629671|NCT01253291|616656678|FG004|Overall Study|Adverse Event|0|||
170629672|NCT01253291|616656674|FG000|Overall Study|Lack of Efficacy|1|||
170629673|NCT01253291|616656675|FG001|Overall Study|Lack of Efficacy|0|||
170629674|NCT01253291|616656676|FG002|Overall Study|Lack of Efficacy|0|||
170629675|NCT01253291|616656677|FG003|Overall Study|Lack of Efficacy|0|||
170629676|NCT01253291|616656678|FG004|Overall Study|Lack of Efficacy|0|||
170629677|NCT01253291|616656674|FG000|Overall Study|Physician Decision|2|||
170629678|NCT01253291|616656675|FG001|Overall Study|Physician Decision|0|||
170629679|NCT01253291|616656676|FG002|Overall Study|Physician Decision|0|||
170629680|NCT01253291|616656677|FG003|Overall Study|Physician Decision|0|||
170629681|NCT01253291|616656678|FG004|Overall Study|Physician Decision|2|||
170629682|NCT01838395|616656682|FG000|Overall Study|Withdrawal by Subject|0|||
170629683|NCT01838395|616656683|FG001|Overall Study|Withdrawal by Subject|0|||
170629684|NCT01838395|616656684|FG002|Overall Study|Withdrawal by Subject|0|||
170629685|NCT01838395|616656685|FG003|Overall Study|Withdrawal by Subject|0|||
170629686|NCT01838395|616656686|FG004|Overall Study|Withdrawal by Subject|1|||
170629687|NCT01838395|616656687|FG005|Overall Study|Withdrawal by Subject|0|||
170629688|NCT01838395|616656682|FG000|Overall Study|Death|0|||
170629689|NCT01838395|616656683|FG001|Overall Study|Death|0|||
170629690|NCT01838395|616656684|FG002|Overall Study|Death|1|||
170629691|NCT01838395|616656685|FG003|Overall Study|Death|0|||
170629692|NCT01838395|616656686|FG004|Overall Study|Death|0|||
170629693|NCT01838395|616656687|FG005|Overall Study|Death|0|||
170629694|NCT01838395|616656682|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
170629695|NCT01838395|616656683|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
170629696|NCT01838395|616656684|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
170629697|NCT01838395|616656685|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
170629698|NCT01838395|616656686|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
170629699|NCT01838395|616656687|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
170629700|NCT05972993|616656688|FG000|Overall Study|Lost to Follow-up|2|||
170629701|NCT05972993|616656689|FG001|Overall Study|Lost to Follow-up|0|||
170629702|NCT05972993|616656690|FG002|Overall Study|Lost to Follow-up|1|||
170629703|NCT05972993|616656691|FG003|Overall Study|Lost to Follow-up|0|||
170629704|NCT05972993|616656692|FG004|Overall Study|Lost to Follow-up|0|||
170629705|NCT05972993|616656693|FG005|Overall Study|Lost to Follow-up|0|||
170629706|NCT05972993|616656694|FG006|Overall Study|Lost to Follow-up|0|||
170629707|NCT05972993|616656695|FG007|Overall Study|Lost to Follow-up|2|||
170629708|NCT05972993|616656696|FG008|Overall Study|Lost to Follow-up|0|||
170629709|NCT03312231|616656697|FG000|Overall Study|Lost to Follow-up|2|||
170629710|NCT03312231|616656698|FG001|Overall Study|Lost to Follow-up|6|||
170629711|NCT03312231|616656699|FG002|Overall Study|Lost to Follow-up|1|||
170629712|NCT03312231|616656700|FG003|Overall Study|Lost to Follow-up|3|||
170629713|NCT03312231|616656701|FG004|Overall Study|Lost to Follow-up|1|||
170629714|NCT03312231|616656697|FG000|Overall Study|Withdrawal by Subject|0|||
170629715|NCT03312231|616656698|FG001|Overall Study|Withdrawal by Subject|3|||
170629716|NCT03312231|616656699|FG002|Overall Study|Withdrawal by Subject|1|||
170629717|NCT03312231|616656700|FG003|Overall Study|Withdrawal by Subject|0|||
170629718|NCT03312231|616656701|FG004|Overall Study|Withdrawal by Subject|0|||
170629719|NCT03312231|616656697|FG000|Overall Study|Death|0|||
170629720|NCT03312231|616656698|FG001|Overall Study|Death|1|||
170629721|NCT03312231|616656699|FG002|Overall Study|Death|1|||
170629722|NCT03312231|616656700|FG003|Overall Study|Death|0|||
170629723|NCT03312231|616656701|FG004|Overall Study|Death|0|||
170629724|NCT03312231|616656697|FG000|Overall Study|Study Vaccination not Received|1|||
170629725|NCT03312231|616656698|FG001|Overall Study|Study Vaccination not Received|1|||
170629726|NCT03312231|616656699|FG002|Overall Study|Study Vaccination not Received|1|||
170629727|NCT03312231|616656700|FG003|Overall Study|Study Vaccination not Received|0|||
170629728|NCT03312231|616656701|FG004|Overall Study|Study Vaccination not Received|0|||
170629729|NCT03804528|616656710|FG000|Overall Study|Time Commitment|18|||
170629730|NCT03804528|616656710|FG000|Overall Study|Health Reasons|5|||
170825732|NCT00853372|617372146|FG001|Overall Study|Death|26|||
170629731|NCT00651742|616656712|FG000|Overall Study|Objective Disease Progression|22|||
170629732|NCT00651742|616656712|FG000|Overall Study|Toxicity|3|||
170629733|NCT00651742|616656712|FG000|Overall Study|Investigator Judgment|1|||
170629734|NCT00651742|616656712|FG000|Overall Study|Withdrawal of Consent|1|||
170629735|NCT00651742|616656712|FG000|Overall Study|Enrolled but not treated|1|||
170629736|NCT05720897|616656713|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
170629737|NCT05720897|616656714|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
170825733|NCT00853372|617372145|FG000|Overall Study|Lost to Follow-up|1|||
170825734|NCT00853372|617372146|FG001|Overall Study|Lost to Follow-up|2|||
170825735|NCT00853372|617372145|FG000|Overall Study|Full Consent Withdrawn|1|||
170629738|NCT02749422|616656720|FG000|Overall Study|Lost to Follow-up|0|||
170629739|NCT02749422|616656721|FG001|Overall Study|Lost to Follow-up|2|||
170629740|NCT02749422|616656720|FG000|Overall Study|Ineligible|0|||
170629741|NCT02749422|616656721|FG001|Overall Study|Ineligible|1|||
170629742|NCT02201953|616656722|FG000|Overall Study|Randomized but Never Treated|1|||
170629743|NCT02201953|616656723|FG001|Overall Study|Randomized but Never Treated|5|||
170629744|NCT02201953|616656722|FG000|Overall Study|Lack of Efficacy|9|||
170825736|NCT00853372|617372146|FG001|Overall Study|Full Consent Withdrawn|1|||
170629745|NCT02201953|616656723|FG001|Overall Study|Lack of Efficacy|30|||
170629746|NCT02201953|616656722|FG000|Overall Study|Lost to Follow-up|8|||
170629747|NCT02201953|616656723|FG001|Overall Study|Lost to Follow-up|8|||
170629748|NCT02201953|616656722|FG000|Overall Study|Withdrew Consent|2|||
170629749|NCT02201953|616656723|FG001|Overall Study|Withdrew Consent|5|||
170629750|NCT02201953|616656722|FG000|Overall Study|Adverse Event|0|||
170629751|NCT02201953|616656723|FG001|Overall Study|Adverse Event|5|||
170629752|NCT02201953|616656722|FG000|Overall Study|Death|0|||
170629753|NCT02201953|616656723|FG001|Overall Study|Death|3|||
170629754|NCT04272242|616656724|FG000|Overall Study|Withdrawal by Subject|3|||
170629755|NCT04272242|616656724|FG000|Overall Study|Lost to Follow-up|1|||
170629756|NCT04272242|616656724|FG000|Overall Study|Adverse Event|1|||
170629757|NCT01824836|616656725|FG000|Overall Study|Adverse Event|48|||
170629758|NCT01824836|616656725|FG000|Overall Study|Withdrawal by Subject|63|||
170629759|NCT01824836|616656725|FG000|Overall Study|Other complicating disease|116|||
170629760|NCT01824836|616656725|FG000|Overall Study|Disease progression|5|||
170629761|NCT01824836|616656725|FG000|Overall Study|Alternative therapy|2|||
170629762|NCT01824836|616656725|FG000|Overall Study|Depression|1|||
170629763|NCT01824836|616656725|FG000|Overall Study|Non-compliance|3|||
170629764|NCT01824836|616656725|FG000|Overall Study|Patient regained ovarian function|3|||
170629765|NCT01824836|616656725|FG000|Overall Study|Lost to Follow-up|8|||
170629766|NCT01824836|616656725|FG000|Overall Study|Physician Decision|2|||
170629767|NCT01824836|616656725|FG000|Overall Study|Research office was closed|3|||
170629768|NCT01824836|616656725|FG000|Overall Study|Relocation|3|||
170629769|NCT01824836|616656725|FG000|Overall Study|Insurance-related issue|1|||
170629770|NCT01824836|616656725|FG000|Overall Study|Transportation issue|1|||
170629771|NCT01824836|616656725|FG000|Overall Study|Patient transferred care|1|||
170629772|NCT01824836|616656725|FG000|Overall Study|Unknown reasons|4|||
170629773|NCT01824836|616656725|FG000|Overall Study|Never started treatment|16|||
170629774|NCT02681523|616656726|FG000|Overall Study|Adverse Event|1|||
170629775|NCT02681523|616656726|FG000|Overall Study|Patient Non-compliance|1|||
170629776|NCT04040933|616658237|FG000|Overall Study|Protocol Violation|1|||
170629777|NCT04040933|616658237|FG000|Overall Study|Withdrawal by Subject|2|||
170629778|NCT02536976|616658238|FG000|Overall Study|Physician Decision|0|||
170629779|NCT02536976|616658239|FG001|Overall Study|Physician Decision|1|||
170629780|NCT00214201|616658240|FG000|Overall Study|Withdrawal by Subject|2|||
170629781|NCT00214201|616658241|FG001|Overall Study|Withdrawal by Subject|0|||
170629782|NCT00214201|616658240|FG000|Overall Study|Death|0|||
170629783|NCT00214201|616658241|FG001|Overall Study|Death|2|||
170629784|NCT01432730|616658245|FG000|Period 1|Adverse Event|2|||
170629785|NCT01432730|616658246|FG001|Period 1|Adverse Event|0|||
170629786|NCT01432730|616658245|FG000|Period 2|Adverse Event|0|||
170629787|NCT01432730|616658246|FG001|Period 2|Adverse Event|4|||
170629788|NCT01124006|616658247|FG000|Overall Study|Withdrawal by Subject|2|||
170629789|NCT01124006|616658248|FG001|Overall Study|Withdrawal by Subject|2|||
170629790|NCT01124006|616658249|FG002|Overall Study|Withdrawal by Subject|0|||
170629791|NCT01124006|616658247|FG000|Overall Study|Lost to Follow-up|1|||
170629792|NCT01124006|616658248|FG001|Overall Study|Lost to Follow-up|0|||
170629793|NCT01124006|616658249|FG002|Overall Study|Lost to Follow-up|1|||
170629794|NCT01124006|616658247|FG000|Overall Study|Other|0|||
170629795|NCT01124006|616658248|FG001|Overall Study|Other|0|||
170629796|NCT01124006|616658249|FG002|Overall Study|Other|1|||
170629797|NCT01712399|616658250|FG000|Overall Study|Lost to Follow-up|1|||
170629798|NCT01712399|616658250|FG000|Overall Study|Withdrawal by Subject|39|||
170629799|NCT01712399|616658250|FG000|Overall Study|Death|1|||
170629800|NCT01712399|616658250|FG000|Overall Study|Adverse Event|11|||
170629801|NCT01712399|616658250|FG000|Overall Study|Study closure|345|||
170629802|NCT01705509|616658256|FG000|Inclusion CPET|Screen Failure|5|||
170629803|NCT01705509|616658256|FG000|Inclusion CPET|Withdrawal by Subject|2|||
170629804|NCT01705509|616658256|FG000|CPET w/ Ranexa|Screen Failure|2|||
170629805|NCT00904033|616658257|FG000|Overall Study|Withdrawal by Subject|1|||
170629806|NCT00904033|616658258|FG001|Overall Study|Withdrawal by Subject|1|||
170629807|NCT00904033|616658259|FG002|Overall Study|Withdrawal by Subject|0|||
170629808|NCT00904033|616658260|FG003|Overall Study|Withdrawal by Subject|0|||
170629809|NCT00904033|616658257|FG000|Overall Study|Physician Decision|0|||
170629810|NCT00904033|616658258|FG001|Overall Study|Physician Decision|0|||
170629811|NCT00904033|616658259|FG002|Overall Study|Physician Decision|1|||
170629812|NCT00904033|616658260|FG003|Overall Study|Physician Decision|0|||
170629813|NCT00904033|616658257|FG000|Overall Study|Unable to obtain final blood draw|0|||
170629814|NCT00904033|616658258|FG001|Overall Study|Unable to obtain final blood draw|0|||
170629815|NCT00904033|616658259|FG002|Overall Study|Unable to obtain final blood draw|0|||
170629816|NCT00904033|616658260|FG003|Overall Study|Unable to obtain final blood draw|2|||
170629817|NCT02351856|616658261|FG000|Overall Study|Adverse Event|2|||
170629818|NCT02351856|616658261|FG000|Overall Study|Physician Decision|5|||
170629819|NCT02351856|616658261|FG000|Overall Study|Study terminated by sponsor|1|||
170629820|NCT01281124|616658272|FG000|Overall Study|Death|1|||
170629821|NCT03038100|616658273|FG000|Overall Study|Death|289|||
170629822|NCT03038100|616658274|FG001|Overall Study|Death|272|||
170629823|NCT03038100|616658273|FG000|Overall Study|Lost to Follow-up|9|||
170629824|NCT03038100|616658274|FG001|Overall Study|Lost to Follow-up|10|||
170629825|NCT03038100|616658273|FG000|Overall Study|Protocol Deviation|1|||
170629826|NCT03038100|616658274|FG001|Overall Study|Protocol Deviation|4|||
170629827|NCT03038100|616658273|FG000|Overall Study|Withdrawal by Subject|45|||
170629828|NCT03038100|616658274|FG001|Overall Study|Withdrawal by Subject|51|||
170629829|NCT03038100|616658273|FG000|Overall Study|Study Terminated By Sponsor|305|||
170629830|NCT03038100|616658274|FG001|Overall Study|Study Terminated By Sponsor|311|||
170629831|NCT03038100|616658273|FG000|Overall Study|Physician Decision|1|||
170629832|NCT03038100|616658274|FG001|Overall Study|Physician Decision|3|||
170629833|NCT00918255|616658275|FG000|Overall Study|Adverse Event|1|||
170629834|NCT00918255|616658276|FG001|Overall Study|Adverse Event|0|||
170629835|NCT00918255|616658277|FG002|Overall Study|Adverse Event|0|||
170629836|NCT00918255|616658275|FG000|Overall Study|Withdrawal by Subject|1|||
170629837|NCT00918255|616658276|FG001|Overall Study|Withdrawal by Subject|0|||
170629838|NCT00918255|616658277|FG002|Overall Study|Withdrawal by Subject|2|||
170629839|NCT00918255|616658275|FG000|Overall Study|Lack of Efficacy|1|||
170629840|NCT00918255|616658276|FG001|Overall Study|Lack of Efficacy|0|||
170629841|NCT00918255|616658277|FG002|Overall Study|Lack of Efficacy|0|||
170825737|NCT01580995|617372147|FG000|Overall Study|Lost to Follow-up|2|||
170825738|NCT01580995|617372148|FG001|Overall Study|Lost to Follow-up|2|||
170825739|NCT00526097|617372151|FG000|Overall Study|Adverse Event|6|||
170825740|NCT00526097|617372152|FG001|Overall Study|Adverse Event|44|||
170825741|NCT00526097|617372151|FG000|Overall Study|Protocol Violation|4|||
170825742|NCT00526097|617372152|FG001|Overall Study|Protocol Violation|10|||
170825743|NCT00526097|617372151|FG000|Overall Study|Withdrawal by Subject|3|||
170825744|NCT00526097|617372152|FG001|Overall Study|Withdrawal by Subject|1|||
170825745|NCT00526097|617372151|FG000|Overall Study|Other|2|||
170825746|NCT00526097|617372152|FG001|Overall Study|Other|1|||
170825747|NCT01990313|617372155|FG000|Overall Study|Lost to Follow-up|1|||
170825748|NCT01169636|617372157|FG000|Overall Study|Adverse Event|0|||
170825749|NCT01169636|617372158|FG001|Overall Study|Adverse Event|0|||
170825750|NCT01169636|617372159|FG002|Overall Study|Adverse Event|1|||
170825751|NCT01169636|617372160|FG003|Overall Study|Adverse Event|1|||
170825752|NCT01169636|617372161|FG004|Overall Study|Adverse Event|0|||
170825753|NCT01169636|617372157|FG000|Overall Study|Screen failure|0|||
170825754|NCT01169636|617372158|FG001|Overall Study|Screen failure|0|||
170825755|NCT01169636|617372159|FG002|Overall Study|Screen failure|2|||
170825756|NCT01169636|617372160|FG003|Overall Study|Screen failure|0|||
170825757|NCT01169636|617372161|FG004|Overall Study|Screen failure|0|||
170825758|NCT01169636|617372157|FG000|Overall Study|Withdrawal by Subject|0|||
170825759|NCT01169636|617372158|FG001|Overall Study|Withdrawal by Subject|0|||
170825760|NCT01169636|617372159|FG002|Overall Study|Withdrawal by Subject|0|||
170825761|NCT01169636|617372160|FG003|Overall Study|Withdrawal by Subject|0|||
170825762|NCT01169636|617372161|FG004|Overall Study|Withdrawal by Subject|3|||
170629842|NCT00918255|616658275|FG000|Overall Study|Lost to Follow-up|1|||
170629843|NCT00918255|616658276|FG001|Overall Study|Lost to Follow-up|0|||
170629844|NCT00918255|616658277|FG002|Overall Study|Lost to Follow-up|2|||
170629845|NCT00918255|616658275|FG000|Overall Study|Exceeded allowed number of interventions|0|||
170629846|NCT00918255|616658276|FG001|Overall Study|Exceeded allowed number of interventions|0|||
170629847|NCT00918255|616658277|FG002|Overall Study|Exceeded allowed number of interventions|1|||
170629848|NCT00918255|616658275|FG000|Overall Study|Non-compliance|1|||
170629849|NCT00918255|616658276|FG001|Overall Study|Non-compliance|0|||
170629850|NCT00918255|616658277|FG002|Overall Study|Non-compliance|0|||
170629851|NCT00918255|616658275|FG000|Overall Study|Investigator discretion|1|||
170629852|NCT00918255|616658276|FG001|Overall Study|Investigator discretion|0|||
170629853|NCT00918255|616658277|FG002|Overall Study|Investigator discretion|0|||
170629854|NCT02392624|616658278|FG000|Overall Study|Withdrawal by Subject|15|||
170825763|NCT02396953|617372162|FG000|Overall Study|Withdrawal by Subject|0|||
170825764|NCT02396953|617372163|FG001|Overall Study|Withdrawal by Subject|0|||
170825765|NCT02396953|617372164|FG002|Overall Study|Withdrawal by Subject|1|||
170825766|NCT02396953|617372162|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
170825767|NCT02396953|617372163|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
170825768|NCT02396953|617372164|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
170629855|NCT02392624|616658279|FG001|Overall Study|Withdrawal by Subject|12|||
170629856|NCT02392624|616658280|FG002|Overall Study|Withdrawal by Subject|9|||
170629857|NCT02392624|616658278|FG000|Overall Study|Adverse Event|4|||
170629858|NCT02392624|616658279|FG001|Overall Study|Adverse Event|1|||
170629859|NCT02392624|616658280|FG002|Overall Study|Adverse Event|2|||
170629860|NCT02392624|616658278|FG000|Overall Study|Pregnancy|1|||
170629861|NCT02392624|616658279|FG001|Overall Study|Pregnancy|0|||
170629862|NCT02392624|616658280|FG002|Overall Study|Pregnancy|0|||
170629863|NCT02392624|616658278|FG000|Overall Study|Protocol Violation|0|||
170629864|NCT02392624|616658279|FG001|Overall Study|Protocol Violation|0|||
170629865|NCT02392624|616658280|FG002|Overall Study|Protocol Violation|1|||
170629866|NCT02392624|616658278|FG000|Overall Study|Sponsor/Investigator Decision|2|||
170629867|NCT02392624|616658279|FG001|Overall Study|Sponsor/Investigator Decision|1|||
170629868|NCT02392624|616658280|FG002|Overall Study|Sponsor/Investigator Decision|0|||
170629869|NCT02392624|616658278|FG000|Overall Study|Other|49|||
170825769|NCT02396953|617372162|FG000|Overall Study|Personal Reasons|1|||
170825770|NCT02396953|617372163|FG001|Overall Study|Personal Reasons|1|||
170825771|NCT02396953|617372164|FG002|Overall Study|Personal Reasons|0|||
170825772|NCT00784147|617372165|FG000|Overall Study|Lost to Follow-up|2|||
170825773|NCT00784147|617372166|FG001|Overall Study|Lost to Follow-up|4|||
170825774|NCT00784147|617372165|FG000|Overall Study|Withdrawal by Subject|1|||
170825775|NCT00784147|617372166|FG001|Overall Study|Withdrawal by Subject|3|||
170825776|NCT00784147|617372165|FG000|Overall Study|Physician Decision|2|||
170825777|NCT00784147|617372166|FG001|Overall Study|Physician Decision|1|||
170825778|NCT00784147|617372165|FG000|Overall Study|Protocol Violation|1|||
170629870|NCT02392624|616658279|FG001|Overall Study|Other|1|||
170629871|NCT02392624|616658280|FG002|Overall Study|Other|1|||
170629872|NCT03819114|616658281|FG000|Overall Study|Protocol Violation|0|||
170629873|NCT03819114|616658282|FG001|Overall Study|Protocol Violation|1|||
170629874|NCT03819114|616658283|FG002|Overall Study|Protocol Violation|1|||
170629875|NCT03819114|616658284|FG003|Overall Study|Protocol Violation|0|||
170629876|NCT03819114|616658281|FG000|Overall Study|Lost to Follow-up|0|||
170629877|NCT03819114|616658282|FG001|Overall Study|Lost to Follow-up|0|||
170629878|NCT03819114|616658283|FG002|Overall Study|Lost to Follow-up|1|||
170629879|NCT03819114|616658284|FG003|Overall Study|Lost to Follow-up|0|||
170703572|NCT01782313|616924515|FG000|Treated Cycle 3|Progressive Disease|21|||
170629880|NCT04226742|616658285|FG000|Overall Study|Lost to Follow-up|16|||
170629881|NCT04226742|616658286|FG001|Overall Study|Lost to Follow-up|13|||
170629882|NCT04226742|616658285|FG000|Overall Study|Withdrawal by Subject|5|||
170629883|NCT04226742|616658286|FG001|Overall Study|Withdrawal by Subject|3|||
170629884|NCT03841604|616658287|FG000|Overall Study|Withdrawal by Subject|3|||
170629885|NCT03841604|616658288|FG001|Overall Study|Withdrawal by Subject|1|||
170629886|NCT03841604|616658287|FG000|Overall Study|Adverse Event|4|||
170629887|NCT03841604|616658288|FG001|Overall Study|Adverse Event|2|||
170629888|NCT03841604|616658287|FG000|Overall Study|Physician Decision|1|||
170629889|NCT03841604|616658288|FG001|Overall Study|Physician Decision|0|||
170629890|NCT03877510|616658291|FG000|Overall Study|Death|6|||
170629891|NCT03877510|616658291|FG000|Overall Study|Lost to Follow-up|2|||
170629892|NCT03877510|616658291|FG000|Overall Study|Non-compliance with study drug|2|||
170629893|NCT03877510|616658291|FG000|Overall Study|Lack of Efficacy|14|||
170629894|NCT03877510|616658291|FG000|Overall Study|Adverse Event|20|||
170629895|NCT03877510|616658291|FG000|Overall Study|Withdrawal by Subject|22|||
170629896|NCT03877510|616658291|FG000|Overall Study|Miscellaneous|1|||
170629897|NCT01936870|616658299|FG000|Overall Study|No Visit After Treatment|176|||
170825779|NCT00784147|617372166|FG001|Overall Study|Protocol Violation|1|||
170825780|NCT00784147|617372165|FG000|Overall Study|Death|2|||
170825781|NCT00784147|617372166|FG001|Overall Study|Death|0|||
170825782|NCT03596242|617372167|FG000|Overall Study|Lost to Follow-up|2|||
170825783|NCT03596242|617372168|FG001|Overall Study|Lost to Follow-up|2|||
170825784|NCT01011049|617372172|FG000|Overall Study|Protocol Violation|0|||
170825785|NCT01011049|617372173|FG001|Overall Study|Protocol Violation|0|||
170825786|NCT01011049|617372174|FG002|Overall Study|Protocol Violation|2|||
170825787|NCT01011049|617372175|FG003|Overall Study|Protocol Violation|0|||
170629898|NCT01936870|616658299|FG000|Overall Study|Protocol Violation|12|||
170629899|NCT01936870|616658299|FG000|Overall Study|No Drug Administration|1|||
170629900|NCT00248040|616658301|FG000|Overall Study|transplantectomy|2|||
170629901|NCT00248040|616658302|FG001|Overall Study|transplantectomy|1|||
170703573|NCT01782313|616924515|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
170703574|NCT01782313|616924515|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
170703575|NCT01782313|616924515|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
170703576|NCT01782313|616924515|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
170703577|NCT01782313|616924515|FG000|Survival Follow up|Lost to Follow-up|1|||
170703578|NCT02940691|616924516|FG000|Overall Study|Lost to Follow-up|5|||
170703579|NCT02940691|616924516|FG000|Overall Study|Incarceration|1|||
170703580|NCT00958776|616924517|FG000|Overall Study|Adverse Event|0|||
170825788|NCT01011049|617372172|FG000|Overall Study|Lost to Follow-up|1|||
170825789|NCT01011049|617372173|FG001|Overall Study|Lost to Follow-up|2|||
170825790|NCT01011049|617372174|FG002|Overall Study|Lost to Follow-up|1|||
170825791|NCT01011049|617372175|FG003|Overall Study|Lost to Follow-up|0|||
170703581|NCT00958776|616924518|FG001|Overall Study|Adverse Event|1|||
170703582|NCT00958776|616924517|FG000|Overall Study|Physician Decision|1|||
170703583|NCT00958776|616924518|FG001|Overall Study|Physician Decision|0|||
170703584|NCT00958776|616924517|FG000|Overall Study|Lost to Follow-up|2|||
170703585|NCT00958776|616924518|FG001|Overall Study|Lost to Follow-up|6|||
170703586|NCT00958776|616924517|FG000|Overall Study|Withdrawal by Subject|7|||
170703587|NCT00958776|616924518|FG001|Overall Study|Withdrawal by Subject|16|||
170703588|NCT00958776|616924517|FG000|Overall Study|Protocol Violation|1|||
170703589|NCT00958776|616924518|FG001|Overall Study|Protocol Violation|1|||
170703590|NCT00958776|616924517|FG000|Overall Study|Death|2|||
170629902|NCT00248040|616658303|FG002|Overall Study|transplantectomy|3|||
170629903|NCT00248040|616658301|FG000|Overall Study|transplant cancelled post treat start|1|||
170629904|NCT00248040|616658302|FG001|Overall Study|transplant cancelled post treat start|0|||
170629905|NCT00248040|616658303|FG002|Overall Study|transplant cancelled post treat start|0|||
170629906|NCT00248040|616658301|FG000|Overall Study|Death|0|||
170629907|NCT00248040|616658302|FG001|Overall Study|Death|0|||
170629908|NCT00248040|616658303|FG002|Overall Study|Death|1|||
170629909|NCT00118417|616658307|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
170629910|NCT00118417|616658308|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
170629911|NCT00118417|616658307|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
170629912|NCT00118417|616658308|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
170629913|NCT00118417|616658307|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
170629914|NCT00118417|616658308|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
170629915|NCT00118417|616658307|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
170629916|NCT00118417|616658308|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
170629917|NCT00118417|616658307|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
170629918|NCT00118417|616658308|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
170629919|NCT02978781|616658309|FG000|Part A|Adverse Event|1|||
170629920|NCT02978781|616658310|FG001|Part A|Adverse Event|1|||
170629921|NCT02978781|616658311|FG002|Part A|Adverse Event|0|||
170629922|NCT02978781|616658312|FG003|Part A|Adverse Event|0|||
170629923|NCT02978781|616658313|FG004|Part A|Adverse Event|0|||
170629924|NCT02978781|616658309|FG000|Part A|Withdrawal by Subject|0|||
170629925|NCT02978781|616658310|FG001|Part A|Withdrawal by Subject|1|||
170629926|NCT02978781|616658311|FG002|Part A|Withdrawal by Subject|0|||
170629927|NCT02978781|616658312|FG003|Part A|Withdrawal by Subject|0|||
170629928|NCT02978781|616658313|FG004|Part A|Withdrawal by Subject|0|||
170629929|NCT02978781|616658309|FG000|Part B|Withdrawal by Subject|0|||
170629930|NCT02978781|616658310|FG001|Part B|Withdrawal by Subject|0|||
170629931|NCT02978781|616658311|FG002|Part B|Withdrawal by Subject|0|||
170629932|NCT02978781|616658312|FG003|Part B|Withdrawal by Subject|1|||
170629933|NCT02978781|616658313|FG004|Part B|Withdrawal by Subject|0|||
170629934|NCT02978781|616658309|FG000|Part C|Adverse Event|0|||
170629935|NCT02978781|616658310|FG001|Part C|Adverse Event|0|||
170629936|NCT02978781|616658311|FG002|Part C|Adverse Event|0|||
170629937|NCT02978781|616658312|FG003|Part C|Adverse Event|0|||
170629938|NCT02978781|616658313|FG004|Part C|Adverse Event|2|||
170629939|NCT02978781|616658309|FG000|Part C|Withdrawal by Subject|0|||
170629940|NCT02978781|616658310|FG001|Part C|Withdrawal by Subject|0|||
170629941|NCT02978781|616658311|FG002|Part C|Withdrawal by Subject|0|||
170629942|NCT02978781|616658312|FG003|Part C|Withdrawal by Subject|0|||
170629943|NCT02978781|616658313|FG004|Part C|Withdrawal by Subject|1|||
170629944|NCT02978781|616658309|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
170629945|NCT02978781|616658310|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
170629946|NCT02978781|616658311|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
170629947|NCT02978781|616658312|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
170629948|NCT02978781|616658313|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
170629949|NCT00084136|616658314|FG000|PI Comparison|Death|10|||
170629950|NCT00084136|616658315|FG001|PI Comparison|Death|9|||
170629951|NCT00084136|616658316|FG002|PI Comparison|Death|0|||
170629952|NCT00084136|616658314|FG000|PI Comparison|Lost to Follow-up|11|||
170629953|NCT00084136|616658315|FG001|PI Comparison|Lost to Follow-up|8|||
170629954|NCT00084136|616658316|FG002|PI Comparison|Lost to Follow-up|0|||
170629955|NCT00084136|616658314|FG000|PI Comparison|Withdrawal by Subject|33|||
170629956|NCT00084136|616658315|FG001|PI Comparison|Withdrawal by Subject|30|||
170629957|NCT00084136|616658316|FG002|PI Comparison|Withdrawal by Subject|0|||
170629958|NCT00084136|616658314|FG000|PI Comparison|Clinic site closed|1|||
170629959|NCT00084136|616658315|FG001|PI Comparison|Clinic site closed|0|||
170629960|NCT00084136|616658316|FG002|PI Comparison|Clinic site closed|0|||
170629961|NCT00084136|616658314|FG000|NRTI Comparison|Death|20|||
170629962|NCT00084136|616658315|FG001|NRTI Comparison|Death|0|||
170629963|NCT00084136|616658316|FG002|NRTI Comparison|Death|18|||
170629964|NCT00084136|616658314|FG000|NRTI Comparison|Lost to Follow-up|14|||
170629965|NCT00084136|616658315|FG001|NRTI Comparison|Lost to Follow-up|0|||
170629966|NCT00084136|616658316|FG002|NRTI Comparison|Lost to Follow-up|12|||
170629967|NCT00084136|616658314|FG000|NRTI Comparison|Withdrawal by Subject|54|||
170629968|NCT00084136|616658315|FG001|NRTI Comparison|Withdrawal by Subject|0|||
170703591|NCT00958776|616924518|FG001|Overall Study|Death|1|||
170629969|NCT00084136|616658316|FG002|NRTI Comparison|Withdrawal by Subject|38|||
170629970|NCT00084136|616658314|FG000|NRTI Comparison|Clinic site closed|12|||
170629971|NCT00084136|616658315|FG001|NRTI Comparison|Clinic site closed|0|||
170629972|NCT00084136|616658316|FG002|NRTI Comparison|Clinic site closed|14|||
170629973|NCT00084136|616658314|FG000|NRTI Comparison|Not reason above|1|||
170629974|NCT00084136|616658315|FG001|NRTI Comparison|Not reason above|0|||
170629975|NCT00084136|616658316|FG002|NRTI Comparison|Not reason above|0|||
170629976|NCT00389610|616658317|FG000|Overall Study|Disease Progression|0|||
170629977|NCT00389610|616658318|FG001|Overall Study|Disease Progression|19|||
170629978|NCT00389610|616658317|FG000|Overall Study|Death|0|||
170629979|NCT00389610|616658318|FG001|Overall Study|Death|1|||
170629980|NCT00389610|616658317|FG000|Overall Study|Physician Decision|0|||
170629981|NCT00389610|616658318|FG001|Overall Study|Physician Decision|1|||
170629982|NCT00389610|616658317|FG000|Overall Study|Withdrawal by Subject|0|||
170629983|NCT00389610|616658318|FG001|Overall Study|Withdrawal by Subject|1|||
170629984|NCT00887809|616658319|FG000|Overall Study|Patient Not Treated|3|||
170629985|NCT00887809|616658320|FG001|Overall Study|Patient Not Treated|0|||
170629986|NCT00887809|616658319|FG000|Overall Study|Death|1|||
170629987|NCT00887809|616658320|FG001|Overall Study|Death|0|||
170629988|NCT04849364|616658327|FG000|Overall Study|Eligibility criteria not meet|0|||
170629989|NCT04849364|616658328|FG001|Overall Study|Eligibility criteria not meet|1|||
170629990|NCT04849364|616658329|FG002|Overall Study|Eligibility criteria not meet|0|||
170629991|NCT01210313|616658338|FG000|Overall Study|Withdrawal by Subject|3|||
170629992|NCT01210313|616658338|FG000|Overall Study|Adverse Event|2|||
170629993|NCT01210313|616658338|FG000|Overall Study|Distant recurrence|4|||
170629994|NCT01210313|616658338|FG000|Overall Study|Non-compliance|7|||
170629995|NCT03777982|616658339|FG000|Overall Study|Physician Decision|0|||
170629996|NCT03777982|616658340|FG001|Overall Study|Physician Decision|1|||
170629997|NCT00627393|616658352|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
170629998|NCT00627393|616658353|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
170629999|NCT00627393|616658352|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
170630000|NCT00627393|616658353|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
170630001|NCT00627393|616658352|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
170630002|NCT00627393|616658353|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
170630003|NCT00627393|616658352|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
170630004|NCT00627393|616658353|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
170630005|NCT04973449|616658357|FG000|Overall Study|Withdrawal by Subject|3|||
170630006|NCT04973449|616658358|FG001|Overall Study|Withdrawal by Subject|3|||
170630007|NCT04973449|616658359|FG002|Overall Study|Withdrawal by Subject|2|||
170630008|NCT04973449|616658360|FG003|Overall Study|Withdrawal by Subject|5|||
170630009|NCT04973449|616658361|FG004|Overall Study|Withdrawal by Subject|5|||
170630010|NCT04973449|616658362|FG005|Overall Study|Withdrawal by Subject|4|||
170630011|NCT04973449|616658363|FG006|Overall Study|Withdrawal by Subject|7|||
170630012|NCT04973449|616658364|FG007|Overall Study|Withdrawal by Subject|5|||
170630013|NCT04973449|616658357|FG000|Overall Study|Lost to Follow-up|15|||
170630014|NCT04973449|616658358|FG001|Overall Study|Lost to Follow-up|16|||
170630015|NCT04973449|616658359|FG002|Overall Study|Lost to Follow-up|16|||
170630016|NCT04973449|616658360|FG003|Overall Study|Lost to Follow-up|13|||
170630017|NCT04973449|616658361|FG004|Overall Study|Lost to Follow-up|5|||
170630018|NCT04973449|616658362|FG005|Overall Study|Lost to Follow-up|6|||
170630019|NCT04973449|616658363|FG006|Overall Study|Lost to Follow-up|10|||
170630020|NCT04973449|616658364|FG007|Overall Study|Lost to Follow-up|6|||
170630021|NCT04973449|616658357|FG000|Overall Study|Death|1|||
170630022|NCT04973449|616658358|FG001|Overall Study|Death|0|||
170630023|NCT04973449|616658359|FG002|Overall Study|Death|0|||
170630024|NCT04973449|616658360|FG003|Overall Study|Death|0|||
170630025|NCT04973449|616658361|FG004|Overall Study|Death|0|||
170630026|NCT04973449|616658362|FG005|Overall Study|Death|1|||
170630027|NCT04973449|616658363|FG006|Overall Study|Death|0|||
170630028|NCT04973449|616658364|FG007|Overall Study|Death|0|||
170630029|NCT04973449|616658357|FG000|Overall Study|Other|1|||
170630030|NCT04973449|616658358|FG001|Overall Study|Other|1|||
170630031|NCT04973449|616658359|FG002|Overall Study|Other|2|||
170630032|NCT04973449|616658360|FG003|Overall Study|Other|1|||
170630033|NCT04973449|616658361|FG004|Overall Study|Other|4|||
170630034|NCT04973449|616658362|FG005|Overall Study|Other|0|||
170630035|NCT04973449|616658363|FG006|Overall Study|Other|2|||
170630036|NCT04973449|616658364|FG007|Overall Study|Other|2|||
170630037|NCT00604565|616658365|FG000|Overall Study|Study terminated|0|||
170630038|NCT00604565|616658366|FG001|Overall Study|Study terminated|3|||
170630039|NCT03642873|616658367|FG000|Third Intervention (1 Day)|Screen failure|0|||
170630040|NCT03642873|616658368|FG001|Third Intervention (1 Day)|Screen failure|0|||
170630041|NCT03642873|616658369|FG002|Third Intervention (1 Day)|Screen failure|0|||
170630042|NCT03642873|616658370|FG003|Third Intervention (1 Day)|Screen failure|0|||
170630043|NCT03642873|616658371|FG004|Third Intervention (1 Day)|Screen failure|1|||
170630044|NCT03642873|616658372|FG005|Third Intervention (1 Day)|Screen failure|0|||
170630045|NCT02195518|616658373|FG000|Overall Study|Adverse Event|1|||
170630046|NCT02195518|616658373|FG000|Overall Study|Protocol Violation|4|||
170630047|NCT02195518|616658373|FG000|Overall Study|Pregnancy|2|||
170630048|NCT02195518|616658373|FG000|Overall Study|Withdrawal by Subject|1|||
170630049|NCT02195518|616658373|FG000|Overall Study|Lost to Follow-up|1|||
170630050|NCT03472885|616658378|FG000|24-Week Treatment Period|Adverse Event|1|||
170630051|NCT05417438|616658379|FG000|Overall Study|Withdrawal by Subject|3|||
170630052|NCT00911170|616658384|FG000|Treatment Period|Randomized in error|1|||
170630053|NCT00911170|616658385|FG001|Treatment Period|Randomized in error|1|||
170630054|NCT00911170|616658384|FG000|Treatment Period|Ineligibility determined|1|||
170630055|NCT00911170|616658385|FG001|Treatment Period|Ineligibility determined|3|||
170630056|NCT00911170|616658384|FG000|Treatment Period|Protocol deviation|1|||
170630057|NCT00911170|616658385|FG001|Treatment Period|Protocol deviation|2|||
170630058|NCT00911170|616658384|FG000|Treatment Period|Adverse Event|9|||
170630059|NCT00911170|616658385|FG001|Treatment Period|Adverse Event|10|||
170630060|NCT00911170|616658384|FG000|Treatment Period|Withdrawal by Subject|4|||
170630061|NCT00911170|616658385|FG001|Treatment Period|Withdrawal by Subject|4|||
170630062|NCT00911170|616658384|FG000|Treatment Period|Disease progression|0|||
170630063|NCT00911170|616658385|FG001|Treatment Period|Disease progression|2|||
170630064|NCT00911170|616658384|FG000|Treatment Period|Physician Decision|5|||
170630065|NCT00911170|616658385|FG001|Treatment Period|Physician Decision|5|||
170630066|NCT00911170|616658384|FG000|Treatment Period|Lost to Follow-up|0|||
170630067|NCT00911170|616658385|FG001|Treatment Period|Lost to Follow-up|1|||
170630068|NCT00911170|616658384|FG000|Treatment Period|Death|6|||
170630069|NCT00911170|616658385|FG001|Treatment Period|Death|9|||
170630070|NCT00911170|616658384|FG000|Long Term Follow-Up|Continuing in study|274|||
170630071|NCT00911170|616658385|FG001|Long Term Follow-Up|Continuing in study|269|||
170630072|NCT00911170|616658384|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
170630073|NCT00911170|616658385|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
170630074|NCT00911170|616658384|FG000|Long Term Follow-Up|Physician Decision|5|||
170630075|NCT00911170|616658385|FG001|Long Term Follow-Up|Physician Decision|4|||
170630076|NCT00911170|616658384|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
170630077|NCT00911170|616658385|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
170630078|NCT00911170|616658384|FG000|Long Term Follow-Up|Death|116|||
170630079|NCT00911170|616658385|FG001|Long Term Follow-Up|Death|121|||
170703592|NCT00958776|616924517|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
170703593|NCT00958776|616924518|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
170703594|NCT00958776|616924517|FG000|Overall Study|Missing|1|||
170703595|NCT00958776|616924518|FG001|Overall Study|Missing|1|||
170703596|NCT00480636|616924519|FG000|Overall Study|Death|12|||
170703597|NCT00480636|616924519|FG000|Overall Study|Lost to Follow-up|4|||
170703598|NCT00480636|616924519|FG000|Overall Study|Other|2|||
170703599|NCT00480636|616924519|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
170703600|NCT02506816|616924524|FG000|Overall Study|Adverse Event|3|||
170703601|NCT02177266|616924528|FG000|Overall Study|Adverse Event|0|||
170703602|NCT02177266|616924529|FG001|Overall Study|Adverse Event|1|||
170703603|NCT02177266|616924528|FG000|Overall Study|Withdrawal by Subject|1|||
170703604|NCT02177266|616924529|FG001|Overall Study|Withdrawal by Subject|0|||
170703605|NCT01023659|616924530|FG000|Overall Study|Lost to Follow-up|73|||
170703606|NCT01023659|616924531|FG001|Overall Study|Lost to Follow-up|228|||
170703607|NCT01023659|616924532|FG002|Overall Study|Lost to Follow-up|99|||
170703608|NCT04537806|616924533|FG000|Overall Study|Randomized but not treated|1|||
170703609|NCT04537806|616924534|FG001|Overall Study|Randomized but not treated|0|||
170703610|NCT04537806|616924533|FG000|Overall Study|Adverse Event|1|||
170703611|NCT04537806|616924534|FG001|Overall Study|Adverse Event|1|||
170703612|NCT03019627|616924539|FG000|Overall Study|Adverse Event|8|||
170703613|NCT03019627|616924540|FG001|Overall Study|Adverse Event|0|||
170703614|NCT03019627|616924539|FG000|Overall Study|Unrelated to adverse event|1|||
170703615|NCT03019627|616924540|FG001|Overall Study|Unrelated to adverse event|3|||
170703616|NCT03019627|616924539|FG000|Overall Study|Lost to Follow-up|2|||
170703617|NCT03019627|616924540|FG001|Overall Study|Lost to Follow-up|1|||
170703618|NCT03019627|616924539|FG000|Overall Study|not compliance|2|||
170703619|NCT03019627|616924540|FG001|Overall Study|not compliance|2|||
170703620|NCT03019627|616924539|FG000|Overall Study|Other|2|||
170703621|NCT03019627|616924540|FG001|Overall Study|Other|2|||
170703622|NCT03364049|616924541|FG000|Overall Study|Death|6|||
170703623|NCT03364049|616924542|FG001|Overall Study|Death|4|||
170703624|NCT03364049|616924543|FG002|Overall Study|Death|5|||
170703625|NCT03364049|616924544|FG003|Overall Study|Death|14|||
170703626|NCT03364049|616924541|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
170703627|NCT03364049|616924542|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
170703628|NCT03364049|616924543|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
170703629|NCT03364049|616924544|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
170703630|NCT03364049|616924541|FG000|Overall Study|Withdrawal by Subject|0|||
170703631|NCT03364049|616924542|FG001|Overall Study|Withdrawal by Subject|1|||
170703632|NCT03364049|616924543|FG002|Overall Study|Withdrawal by Subject|1|||
170703633|NCT03364049|616924544|FG003|Overall Study|Withdrawal by Subject|1|||
170703634|NCT01340976|616924547|FG000|Overall Study|Physician Decision|2|||
170703635|NCT01340976|616924548|FG001|Overall Study|Physician Decision|0|||
170703636|NCT01340976|616924549|FG002|Overall Study|Physician Decision|1|||
170703637|NCT01340976|616924550|FG003|Overall Study|Physician Decision|1|||
170703638|NCT01340976|616924551|FG004|Overall Study|Physician Decision|1|||
170703639|NCT01340976|616924552|FG005|Overall Study|Physician Decision|0|||
170703640|NCT01340976|616924547|FG000|Overall Study|Death|0|||
170703641|NCT01340976|616924548|FG001|Overall Study|Death|1|||
170703642|NCT01340976|616924549|FG002|Overall Study|Death|0|||
170703643|NCT01340976|616924550|FG003|Overall Study|Death|0|||
170703644|NCT01340976|616924551|FG004|Overall Study|Death|0|||
170703645|NCT01340976|616924552|FG005|Overall Study|Death|0|||
170703646|NCT01340976|616924547|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
170703647|NCT01340976|616924548|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
170703648|NCT01340976|616924549|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
170703649|NCT01340976|616924550|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
170703650|NCT01340976|616924551|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
170703651|NCT01340976|616924552|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
170703652|NCT01340976|616924547|FG000|Overall Study|Withdrawal by Subject|0|||
170703653|NCT01340976|616924548|FG001|Overall Study|Withdrawal by Subject|0|||
170703654|NCT01340976|616924549|FG002|Overall Study|Withdrawal by Subject|0|||
170703655|NCT01340976|616924550|FG003|Overall Study|Withdrawal by Subject|1|||
170703656|NCT01340976|616924551|FG004|Overall Study|Withdrawal by Subject|1|||
170703657|NCT01340976|616924552|FG005|Overall Study|Withdrawal by Subject|0|||
170703658|NCT01340976|616924547|FG000|Overall Study|Other anemia treatment|1|||
170703659|NCT01340976|616924548|FG001|Overall Study|Other anemia treatment|0|||
170703660|NCT01340976|616924549|FG002|Overall Study|Other anemia treatment|2|||
170703661|NCT01340976|616924550|FG003|Overall Study|Other anemia treatment|1|||
170703662|NCT01340976|616924551|FG004|Overall Study|Other anemia treatment|0|||
170703663|NCT01340976|616924552|FG005|Overall Study|Other anemia treatment|1|||
170703664|NCT01340976|616924547|FG000|Overall Study|Adverse Event|0|||
170703665|NCT01340976|616924548|FG001|Overall Study|Adverse Event|1|||
170703666|NCT01340976|616924549|FG002|Overall Study|Adverse Event|0|||
170703667|NCT01340976|616924550|FG003|Overall Study|Adverse Event|0|||
170703668|NCT01340976|616924551|FG004|Overall Study|Adverse Event|0|||
170703669|NCT01340976|616924552|FG005|Overall Study|Adverse Event|0|||
170703670|NCT02103478|616924553|FG000|Overall Study|Adverse Event|0|||
170703671|NCT02103478|616924554|FG001|Overall Study|Adverse Event|0|||
170703672|NCT02103478|616924555|FG002|Overall Study|Adverse Event|1|||
170703673|NCT02103478|616924556|FG003|Overall Study|Adverse Event|1|||
170703674|NCT02103478|616924557|FG004|Overall Study|Adverse Event|2|||
170703675|NCT02103478|616924558|FG005|Overall Study|Adverse Event|1|||
170703676|NCT02103478|616924559|FG006|Overall Study|Adverse Event|0|||
170703677|NCT02103478|616924560|FG007|Overall Study|Adverse Event|0|||
170703678|NCT02103478|616924561|FG008|Overall Study|Adverse Event|0|||
170703679|NCT02103478|616924553|FG000|Overall Study|Death|2|||
170703680|NCT02103478|616924554|FG001|Overall Study|Death|2|||
170703681|NCT02103478|616924555|FG002|Overall Study|Death|1|||
170703682|NCT02103478|616924556|FG003|Overall Study|Death|1|||
170703683|NCT02103478|616924557|FG004|Overall Study|Death|5|||
170703684|NCT02103478|616924558|FG005|Overall Study|Death|15|||
170703685|NCT02103478|616924559|FG006|Overall Study|Death|14|||
170703686|NCT02103478|616924560|FG007|Overall Study|Death|10|||
170703687|NCT02103478|616924561|FG008|Overall Study|Death|11|||
170703688|NCT02103478|616924553|FG000|Overall Study|Progressive Disease|2|||
170703689|NCT02103478|616924554|FG001|Overall Study|Progressive Disease|1|||
170703690|NCT02103478|616924555|FG002|Overall Study|Progressive Disease|2|||
170703691|NCT02103478|616924556|FG003|Overall Study|Progressive Disease|0|||
170703692|NCT02103478|616924557|FG004|Overall Study|Progressive Disease|9|||
170703693|NCT02103478|616924558|FG005|Overall Study|Progressive Disease|1|||
170703694|NCT02103478|616924559|FG006|Overall Study|Progressive Disease|2|||
170703695|NCT02103478|616924560|FG007|Overall Study|Progressive Disease|0|||
170703696|NCT02103478|616924561|FG008|Overall Study|Progressive Disease|1|||
170703697|NCT02103478|616924553|FG000|Overall Study|Withdrawal by Subject|2|||
170703698|NCT02103478|616924554|FG001|Overall Study|Withdrawal by Subject|0|||
170703699|NCT02103478|616924555|FG002|Overall Study|Withdrawal by Subject|0|||
170703700|NCT02103478|616924556|FG003|Overall Study|Withdrawal by Subject|4|||
170703701|NCT02103478|616924557|FG004|Overall Study|Withdrawal by Subject|0|||
170703702|NCT02103478|616924558|FG005|Overall Study|Withdrawal by Subject|0|||
170703703|NCT02103478|616924559|FG006|Overall Study|Withdrawal by Subject|1|||
170703704|NCT02103478|616924560|FG007|Overall Study|Withdrawal by Subject|1|||
170703705|NCT02103478|616924561|FG008|Overall Study|Withdrawal by Subject|0|||
170703706|NCT02103478|616924553|FG000|Overall Study|Lost to Follow-up|0|||
170703707|NCT02103478|616924554|FG001|Overall Study|Lost to Follow-up|0|||
170703708|NCT02103478|616924555|FG002|Overall Study|Lost to Follow-up|0|||
170703709|NCT02103478|616924556|FG003|Overall Study|Lost to Follow-up|0|||
170703710|NCT02103478|616924557|FG004|Overall Study|Lost to Follow-up|0|||
170703711|NCT02103478|616924558|FG005|Overall Study|Lost to Follow-up|0|||
170703712|NCT02103478|616924559|FG006|Overall Study|Lost to Follow-up|0|||
170703713|NCT02103478|616924560|FG007|Overall Study|Lost to Follow-up|1|||
170703714|NCT02103478|616924561|FG008|Overall Study|Lost to Follow-up|0|||
170703715|NCT02103478|616924553|FG000|Overall Study|Other|1|||
170703716|NCT02103478|616924554|FG001|Overall Study|Other|3|||
170703717|NCT02103478|616924555|FG002|Overall Study|Other|2|||
170703718|NCT02103478|616924556|FG003|Overall Study|Other|0|||
170703719|NCT02103478|616924557|FG004|Overall Study|Other|3|||
170703720|NCT02103478|616924558|FG005|Overall Study|Other|8|||
170703721|NCT02103478|616924559|FG006|Overall Study|Other|8|||
170703722|NCT02103478|616924560|FG007|Overall Study|Other|4|||
170703723|NCT02103478|616924561|FG008|Overall Study|Other|2|||
170703724|NCT03762083|616924562|FG000|Overall Study|Withdrawal by Subject|2|||
170703725|NCT03762083|616924562|FG000|Overall Study|Physician Decision|1|||
170703726|NCT01203072|616924563|FG000|Overall Study|Adverse Event|5|||
170703727|NCT01203072|616924564|FG001|Overall Study|Adverse Event|3|||
170703728|NCT01203072|616924565|FG002|Overall Study|Adverse Event|2|||
170703729|NCT01203072|616924566|FG003|Overall Study|Adverse Event|4|||
170703730|NCT01203072|616924567|FG004|Overall Study|Adverse Event|2|||
170703731|NCT01203072|616924563|FG000|Overall Study|Lack of Efficacy|1|||
170703732|NCT01203072|616924564|FG001|Overall Study|Lack of Efficacy|0|||
170703733|NCT01203072|616924565|FG002|Overall Study|Lack of Efficacy|0|||
170703734|NCT01203072|616924566|FG003|Overall Study|Lack of Efficacy|0|||
170703735|NCT01203072|616924567|FG004|Overall Study|Lack of Efficacy|0|||
170703736|NCT01203072|616924563|FG000|Overall Study|Lost to Follow-up|0|||
170703737|NCT01203072|616924564|FG001|Overall Study|Lost to Follow-up|1|||
170703738|NCT01203072|616924565|FG002|Overall Study|Lost to Follow-up|0|||
170703739|NCT01203072|616924566|FG003|Overall Study|Lost to Follow-up|0|||
170703740|NCT01203072|616924567|FG004|Overall Study|Lost to Follow-up|0|||
170703741|NCT01203072|616924563|FG000|Overall Study|Protocol Violation|2|||
170703742|NCT01203072|616924564|FG001|Overall Study|Protocol Violation|0|||
170703743|NCT01203072|616924565|FG002|Overall Study|Protocol Violation|0|||
170703744|NCT01203072|616924566|FG003|Overall Study|Protocol Violation|0|||
170703745|NCT01203072|616924567|FG004|Overall Study|Protocol Violation|1|||
170703746|NCT01203072|616924563|FG000|Overall Study|Withdrawal by Subject|2|||
170703747|NCT01203072|616924564|FG001|Overall Study|Withdrawal by Subject|2|||
170703748|NCT01203072|616924565|FG002|Overall Study|Withdrawal by Subject|1|||
170703749|NCT01203072|616924566|FG003|Overall Study|Withdrawal by Subject|2|||
170703750|NCT01203072|616924567|FG004|Overall Study|Withdrawal by Subject|3|||
170703751|NCT00116558|616924568|FG000|Overall Study|Death|11|||
170703752|NCT00116558|616924569|FG001|Overall Study|Death|5|||
170703753|NCT00116558|616924570|FG002|Overall Study|Death|3|||
170703754|NCT00116558|616924568|FG000|Overall Study|Withdrawal by Subject|17|||
170703755|NCT00116558|616924569|FG001|Overall Study|Withdrawal by Subject|3|||
170703756|NCT00116558|616924570|FG002|Overall Study|Withdrawal by Subject|12|||
170703757|NCT00116558|616924568|FG000|Overall Study|disease progression|3|||
170703758|NCT00116558|616924569|FG001|Overall Study|disease progression|7|||
170703759|NCT00116558|616924570|FG002|Overall Study|disease progression|18|||
170825792|NCT01011049|617372172|FG000|Overall Study|Withdrawal by Subject|0|||
170825793|NCT01011049|617372173|FG001|Overall Study|Withdrawal by Subject|0|||
170703760|NCT00235872|616924571|FG000|Overall Study|Adverse Event|34|||
170703761|NCT00235872|616924571|FG000|Overall Study|Death|1|||
170703762|NCT00235872|616924571|FG000|Overall Study|Lost to Follow-up|1|||
170825794|NCT01011049|617372174|FG002|Overall Study|Withdrawal by Subject|1|||
170703763|NCT00235872|616924571|FG000|Overall Study|Withdrawal by Subject|50|||
170703764|NCT00235872|616924571|FG000|Overall Study|Administrative reason|61|||
170703765|NCT01143090|616924572|FG000|Overall Study|Lack of Efficacy|2|||
170703766|NCT01143090|616924572|FG000|Overall Study|Adverse Event|17|||
170703767|NCT01143090|616924572|FG000|Overall Study|Lost to Follow-up|9|||
170703768|NCT01143090|616924572|FG000|Overall Study|Protocol Violation|2|||
170825795|NCT01011049|617372175|FG003|Overall Study|Withdrawal by Subject|0|||
170825796|NCT00875615|617372178|FG000|Overall Study|Withdrawal by Subject|1|||
170825797|NCT00702650|617372179|FG000|Overall Study|Withdrawal by Subject|9|||
170825798|NCT00702650|617372179|FG000|Overall Study|Non-Compliance of Study Drug|3|||
170825799|NCT00702650|617372179|FG000|Overall Study|Lost to Follow-up|2|||
170825800|NCT00702650|617372179|FG000|Overall Study|Non-Compliance with Site Directives|1|||
170825801|NCT00702650|617372179|FG000|Overall Study|Sponsor Request|1|||
170825802|NCT00702650|617372179|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
170825803|NCT00702650|617372179|FG000|Overall Study|Adverse Event|3|||
170825804|NCT00405912|617372181|FG000|Overall Study|Withdrawal by Subject|12|||
170703769|NCT01143090|616924572|FG000|Overall Study|Withdrawal by Subject|18|||
170703770|NCT01143090|616924572|FG000|Overall Study|Non-compliance with study drug|1|||
170703771|NCT01143090|616924572|FG000|Overall Study|Failure to meet eligibility criteria|1|||
170703772|NCT01143090|616924572|FG000|Overall Study|Administrative|1|||
170703773|NCT01800916|616924575|FG000|Test Period 1 (1 Week)|Convex product user|0|||
170703774|NCT01800916|616924576|FG001|Test Period 1 (1 Week)|Convex product user|0|||
170703775|NCT01800916|616924577|FG002|Test Period 1 (1 Week)|Convex product user|0|||
170703776|NCT01800916|616924578|FG003|Test Period 1 (1 Week)|Convex product user|1|||
170703777|NCT01800916|616924579|FG004|Test Period 1 (1 Week)|Convex product user|0|||
170703778|NCT01800916|616924580|FG005|Test Period 1 (1 Week)|Convex product user|0|||
170703779|NCT01800916|616924581|FG006|Test Period 1 (1 Week)|Convex product user|0|||
170703780|NCT01800916|616924582|FG007|Test Period 1 (1 Week)|Convex product user|0|||
170703781|NCT01800916|616924583|FG008|Test Period 1 (1 Week)|Convex product user|0|||
170703782|NCT01800916|616924575|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
170703783|NCT01800916|616924576|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
170703784|NCT01800916|616924577|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
170703785|NCT01800916|616924578|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
170703786|NCT01800916|616924579|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
170703787|NCT01800916|616924580|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
170703788|NCT01800916|616924581|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
170703789|NCT01800916|616924582|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
170703790|NCT01800916|616924583|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
170703791|NCT01234467|616924584|FG000|Overall Study|Adverse Event|3|||
170703792|NCT01234467|616924584|FG000|Overall Study|Death|2|||
170703793|NCT01234467|616924584|FG000|Overall Study|Withdrawal by Subject|2|||
170703794|NCT01234467|616924584|FG000|Overall Study|Disease Progression|2|||
170703795|NCT01234467|616924584|FG000|Overall Study|Clinical deterioration|1|||
170703796|NCT01234467|616924584|FG000|Overall Study|Physician Decision|1|||
170703797|NCT01234467|616924584|FG000|Overall Study|Other complicating disease (stroke)|1|||
170703798|NCT05179421|616924585|FG000|First Infusion Day|Adverse Event|1|||
170703799|NCT05179421|616924586|FG001|First Infusion Day|Adverse Event|0|||
170703800|NCT03323099|616924587|FG000|Overall Study|Withdrawal by Subject|6|||
170703801|NCT03323099|616924588|FG001|Overall Study|Withdrawal by Subject|12|||
170703802|NCT03323099|616924587|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
170703803|NCT03323099|616924588|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
170703804|NCT01120210|616924591|FG000|MAIN INFUSION|Adverse Event|1|||
170703805|NCT01120210|616924592|FG001|MAIN INFUSION|Adverse Event|0|||
170703806|NCT01120210|616924591|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
170703807|NCT01120210|616924592|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
170703808|NCT02043015|616924599|FG000|Overall Study|Lost to Follow-up|4|||
170703809|NCT02043015|616924599|FG000|Overall Study|Withdrawal by Subject|4|||
170703810|NCT02043015|616924599|FG000|Overall Study|Removed once target enrollment reached|15|||
170703811|NCT02043015|616924599|FG000|Overall Study|Participant moved away from study city|4|||
170703812|NCT02043015|616924599|FG000|Overall Study|Incarceration|1|||
170703813|NCT03837899|616924604|FG000|Overall Study|Death|6|||
170703814|NCT03837899|616924605|FG001|Overall Study|Death|8|||
170703815|NCT03837899|616924606|FG002|Overall Study|Death|3|||
170703816|NCT03837899|616924607|FG003|Overall Study|Death|7|||
170703817|NCT03837899|616924608|FG004|Overall Study|Death|8|||
170703818|NCT03837899|616924609|FG005|Overall Study|Death|7|||
170703819|NCT03837899|616924604|FG000|Overall Study|Moved to post-trial access program|0|||
170703820|NCT03837899|616924605|FG001|Overall Study|Moved to post-trial access program|1|||
170703821|NCT03837899|616924606|FG002|Overall Study|Moved to post-trial access program|0|||
170703822|NCT03837899|616924607|FG003|Overall Study|Moved to post-trial access program|0|||
170703823|NCT03837899|616924608|FG004|Overall Study|Moved to post-trial access program|0|||
170703824|NCT03837899|616924609|FG005|Overall Study|Moved to post-trial access program|0|||
170703825|NCT03837899|616924604|FG000|Overall Study|Other|0|||
170703826|NCT03837899|616924605|FG001|Overall Study|Other|0|||
170703827|NCT03837899|616924606|FG002|Overall Study|Other|0|||
170703828|NCT03837899|616924607|FG003|Overall Study|Other|0|||
170703829|NCT03837899|616924608|FG004|Overall Study|Other|0|||
170703830|NCT03837899|616924609|FG005|Overall Study|Other|2|||
170703831|NCT03837899|616924604|FG000|Overall Study|Lost to Follow-up|0|||
170703832|NCT03837899|616924605|FG001|Overall Study|Lost to Follow-up|1|||
170703833|NCT03837899|616924606|FG002|Overall Study|Lost to Follow-up|0|||
170703834|NCT03837899|616924607|FG003|Overall Study|Lost to Follow-up|0|||
170703835|NCT03837899|616924608|FG004|Overall Study|Lost to Follow-up|0|||
170703836|NCT03837899|616924609|FG005|Overall Study|Lost to Follow-up|0|||
170703837|NCT03837899|616924604|FG000|Overall Study|Withdrawal by Subject|0|||
170703838|NCT03837899|616924605|FG001|Overall Study|Withdrawal by Subject|0|||
170703839|NCT03837899|616924606|FG002|Overall Study|Withdrawal by Subject|0|||
170703840|NCT03837899|616924607|FG003|Overall Study|Withdrawal by Subject|1|||
170703841|NCT03837899|616924608|FG004|Overall Study|Withdrawal by Subject|0|||
170703842|NCT03837899|616924609|FG005|Overall Study|Withdrawal by Subject|0|||
170703843|NCT03837899|616924604|FG000|Overall Study|Study specific discontinuation criteria|0|||
170703844|NCT03837899|616924605|FG001|Overall Study|Study specific discontinuation criteria|1|||
170703845|NCT03837899|616924606|FG002|Overall Study|Study specific discontinuation criteria|0|||
170703846|NCT03837899|616924607|FG003|Overall Study|Study specific discontinuation criteria|0|||
170703847|NCT03837899|616924608|FG004|Overall Study|Study specific discontinuation criteria|3|||
170703848|NCT03837899|616924609|FG005|Overall Study|Study specific discontinuation criteria|1|||
170703849|NCT00393939|616924615|FG000|Overall Study|Protocol Violation|1|||
170703850|NCT00393939|616924616|FG001|Overall Study|Protocol Violation|1|||
170703851|NCT00393939|616924615|FG000|Overall Study|Lost to Follow-up|2|||
170703852|NCT00393939|616924616|FG001|Overall Study|Lost to Follow-up|4|||
170703853|NCT00393939|616924615|FG000|Overall Study|Death|10|||
170703854|NCT00393939|616924616|FG001|Overall Study|Death|4|||
170825805|NCT00405912|617372182|FG001|Overall Study|Withdrawal by Subject|11|||
170825806|NCT00405912|617372183|FG002|Overall Study|Withdrawal by Subject|12|||
170825807|NCT00405912|617372181|FG000|Overall Study|Lost to Follow-up|4|||
170825808|NCT00405912|617372182|FG001|Overall Study|Lost to Follow-up|8|||
170825809|NCT00405912|617372183|FG002|Overall Study|Lost to Follow-up|4|||
170825810|NCT03730662|617372184|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
170825811|NCT03730662|617372185|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
170825812|NCT03730662|617372186|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
170825813|NCT03730662|617372187|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
170825814|NCT03730662|617372184|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
170825815|NCT03730662|617372185|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
170825816|NCT03730662|617372186|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
170825817|NCT03730662|617372187|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
170825818|NCT03730662|617372184|FG000|Treatment Period (52 Weeks)|Death|6|||
170825819|NCT03730662|617372185|FG001|Treatment Period (52 Weeks)|Death|2|||
170825820|NCT03730662|617372186|FG002|Treatment Period (52 Weeks)|Death|2|||
170825821|NCT03730662|617372187|FG003|Treatment Period (52 Weeks)|Death|9|||
170825822|NCT03730662|617372184|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
170825823|NCT03730662|617372185|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
170825824|NCT03730662|617372186|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
170825825|NCT03730662|617372187|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
170825826|NCT03730662|617372184|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
170825827|NCT03730662|617372185|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
170825828|NCT03730662|617372186|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
170825829|NCT03730662|617372187|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
170825830|NCT03730662|617372184|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
170825831|NCT03730662|617372185|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
170825832|NCT03730662|617372186|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
170825833|NCT03730662|617372187|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
170825834|NCT03730662|617372184|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
170825835|NCT03730662|617372185|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
170825836|NCT03730662|617372186|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
170825837|NCT03730662|617372187|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
170825838|NCT03730662|617372184|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
170825839|NCT03730662|617372185|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
170825840|NCT03730662|617372186|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
170825841|NCT03730662|617372187|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
170825842|NCT03730662|617372184|FG000|Variable Treatment Period|Adverse Event|1|||
170825843|NCT03730662|617372185|FG001|Variable Treatment Period|Adverse Event|2|||
170825844|NCT03730662|617372186|FG002|Variable Treatment Period|Adverse Event|0|||
170825845|NCT03730662|617372187|FG003|Variable Treatment Period|Adverse Event|7|||
170825846|NCT03730662|617372184|FG000|Variable Treatment Period|Death|9|||
170825847|NCT03730662|617372185|FG001|Variable Treatment Period|Death|0|||
170825848|NCT03730662|617372186|FG002|Variable Treatment Period|Death|6|||
170825849|NCT03730662|617372187|FG003|Variable Treatment Period|Death|26|||
170825850|NCT03730662|617372184|FG000|Variable Treatment Period|Lost to Follow-up|2|||
170825851|NCT03730662|617372185|FG001|Variable Treatment Period|Lost to Follow-up|1|||
170825852|NCT03730662|617372186|FG002|Variable Treatment Period|Lost to Follow-up|4|||
170825853|NCT03730662|617372187|FG003|Variable Treatment Period|Lost to Follow-up|11|||
170825854|NCT03730662|617372184|FG000|Variable Treatment Period|Personal Reason|0|||
170825855|NCT03730662|617372185|FG001|Variable Treatment Period|Personal Reason|2|||
170825856|NCT03730662|617372186|FG002|Variable Treatment Period|Personal Reason|1|||
170825857|NCT03730662|617372187|FG003|Variable Treatment Period|Personal Reason|6|||
170825858|NCT03730662|617372184|FG000|Variable Treatment Period|Physician Decision|0|||
170825859|NCT03730662|617372185|FG001|Variable Treatment Period|Physician Decision|0|||
170825860|NCT03730662|617372186|FG002|Variable Treatment Period|Physician Decision|0|||
170825861|NCT03730662|617372187|FG003|Variable Treatment Period|Physician Decision|3|||
170703855|NCT00393939|616924615|FG000|Overall Study|Sponsor|5|||
170825862|NCT03730662|617372184|FG000|Variable Treatment Period|Protocol Violation|0|||
170825863|NCT03730662|617372185|FG001|Variable Treatment Period|Protocol Violation|1|||
170825864|NCT03730662|617372186|FG002|Variable Treatment Period|Protocol Violation|1|||
170825865|NCT03730662|617372187|FG003|Variable Treatment Period|Protocol Violation|1|||
170825866|NCT03730662|617372184|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
170825867|NCT03730662|617372185|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
170825868|NCT03730662|617372186|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
170825869|NCT03730662|617372187|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
170825870|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
170825871|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
170825872|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
170825873|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
170825874|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Death|0|||
170825875|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Death|1|||
170825876|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
170825877|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
170825878|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
170825879|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
170825880|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
170825881|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
170825882|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
170825883|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
170825884|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
170825885|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
170825886|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
170825887|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
170825888|NCT01309243|617372188|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
170825889|NCT01309243|617372189|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
170825890|NCT01309243|617372188|FG000|Extension Phase|Lost to Follow-up|6|||
170825891|NCT01309243|617372189|FG001|Extension Phase|Lost to Follow-up|0|||
170825892|NCT01850823|617372190|FG000|Overall Study|Early Visit Window|0|||
170825893|NCT01850823|617372191|FG001|Overall Study|Early Visit Window|1|||
170825894|NCT01850823|617372192|FG002|Overall Study|Early Visit Window|4|||
170825895|NCT01850823|617372190|FG000|Overall Study|Enrolled in Error|0|||
170825896|NCT01850823|617372191|FG001|Overall Study|Enrolled in Error|1|||
170825897|NCT01850823|617372192|FG002|Overall Study|Enrolled in Error|2|||
170825898|NCT01850823|617372190|FG000|Overall Study|Lack of Efficacy|1|||
170825899|NCT01850823|617372191|FG001|Overall Study|Lack of Efficacy|0|||
170825900|NCT01850823|617372192|FG002|Overall Study|Lack of Efficacy|0|||
170825901|NCT01850823|617372190|FG000|Overall Study|Lost to Follow-up|0|||
170825902|NCT01850823|617372191|FG001|Overall Study|Lost to Follow-up|0|||
170825903|NCT01850823|617372192|FG002|Overall Study|Lost to Follow-up|1|||
170825904|NCT01850823|617372190|FG000|Overall Study|Restricted Medication|0|||
170825905|NCT01850823|617372191|FG001|Overall Study|Restricted Medication|0|||
170825906|NCT01850823|617372192|FG002|Overall Study|Restricted Medication|2|||
170825907|NCT01850823|617372190|FG000|Overall Study|Significant worstening of SAR|0|||
170825908|NCT01850823|617372191|FG001|Overall Study|Significant worstening of SAR|1|||
170825909|NCT01850823|617372192|FG002|Overall Study|Significant worstening of SAR|0|||
170825910|NCT01850823|617372190|FG000|Overall Study|Withdrawal by Subject|2|||
170825911|NCT01850823|617372191|FG001|Overall Study|Withdrawal by Subject|0|||
170825912|NCT01850823|617372192|FG002|Overall Study|Withdrawal by Subject|1|||
170825913|NCT02895360|617372193|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
170825914|NCT02895360|617372194|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
170825915|NCT02895360|617372195|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
170825916|NCT02895360|617372196|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
170825917|NCT02895360|617372197|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
170825918|NCT02895360|617372198|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
170825919|NCT02895360|617372193|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
170825920|NCT02895360|617372194|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
170825921|NCT02895360|617372195|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
170825922|NCT02895360|617372196|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
170825923|NCT02895360|617372197|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
170825924|NCT02895360|617372198|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
170825925|NCT02895360|617372193|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
170825926|NCT02895360|617372194|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
170825927|NCT02895360|617372195|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
170825928|NCT02895360|617372196|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
170825929|NCT02895360|617372197|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
170825930|NCT02895360|617372198|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
170825931|NCT02895360|617372193|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
170825932|NCT02895360|617372194|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
170825933|NCT02895360|617372195|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
170825934|NCT02895360|617372196|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
170825935|NCT02895360|617372197|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
170825936|NCT02895360|617372198|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
170825937|NCT02895360|617372193|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
170703856|NCT00393939|616924616|FG001|Overall Study|Sponsor|13|||
170703857|NCT00393939|616924615|FG000|Overall Study|Objective progression or relapse|239|||
170703858|NCT00393939|616924616|FG001|Overall Study|Objective progression or relapse|223|||
170703859|NCT00393939|616924615|FG000|Overall Study|Withdrawal by Subject|2|||
170703860|NCT00393939|616924616|FG001|Overall Study|Withdrawal by Subject|7|||
170703861|NCT00393939|616924615|FG000|Overall Study|Other|37|||
170703862|NCT00393939|616924616|FG001|Overall Study|Other|45|||
170703863|NCT02385799|616924617|FG000|Overall Study|Lost to Follow-up|1|||
170703864|NCT02385799|616924618|FG001|Overall Study|Lost to Follow-up|2|||
170703865|NCT02385799|616924617|FG000|Overall Study|Adverse Event|4|||
170703866|NCT02385799|616924618|FG001|Overall Study|Adverse Event|2|||
170825938|NCT02895360|617372194|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
170825939|NCT02895360|617372195|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
170825940|NCT02895360|617372196|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
170825941|NCT02895360|617372197|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
170825942|NCT02895360|617372198|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
170825943|NCT02895360|617372193|FG000|Phase 2a|Adverse Event|0|||
170825944|NCT02895360|617372194|FG001|Phase 2a|Adverse Event|0|||
170825945|NCT02895360|617372195|FG002|Phase 2a|Adverse Event|0|||
170825946|NCT02895360|617372196|FG003|Phase 2a|Adverse Event|0|||
170825947|NCT02895360|617372197|FG004|Phase 2a|Adverse Event|0|||
170825948|NCT02895360|617372198|FG005|Phase 2a|Adverse Event|1|||
170825949|NCT02895360|617372193|FG000|Phase 2a|Progressive disease|0|||
170825950|NCT02895360|617372194|FG001|Phase 2a|Progressive disease|0|||
170825951|NCT02895360|617372195|FG002|Phase 2a|Progressive disease|0|||
170825952|NCT02895360|617372196|FG003|Phase 2a|Progressive disease|0|||
170825953|NCT02895360|617372197|FG004|Phase 2a|Progressive disease|11|||
170825954|NCT02895360|617372198|FG005|Phase 2a|Progressive disease|11|||
170825955|NCT00666198|617372201|FG000|Overall Study|Protocol Violation|10|||
170825956|NCT00666198|617372201|FG000|Overall Study|No Visit After First Day of Treatment|13|||
170825957|NCT00666198|617372201|FG000|Overall Study|Safety Not Assessable|6|||
170825958|NCT00666198|617372201|FG000|Overall Study|No Drug Administration|4|||
170825959|NCT02166047|617372205|FG000|Overall Study|Withdrawal by Participant|0|||
170825960|NCT02166047|617372206|FG001|Overall Study|Withdrawal by Participant|1|||
170825961|NCT02166047|617372207|FG002|Overall Study|Withdrawal by Participant|2|||
170825962|NCT02166047|617372208|FG003|Overall Study|Withdrawal by Participant|0|||
170825963|NCT02166047|617372209|FG004|Overall Study|Withdrawal by Participant|0|||
170825964|NCT02166047|617372210|FG005|Overall Study|Withdrawal by Participant|0|||
170825965|NCT02166047|617372211|FG006|Overall Study|Withdrawal by Participant|1|||
170825966|NCT02166047|617372212|FG007|Overall Study|Withdrawal by Participant|0|||
170825967|NCT02166047|617372213|FG008|Overall Study|Withdrawal by Participant|0|||
170825968|NCT02166047|617372214|FG009|Overall Study|Withdrawal by Participant|0|||
170825969|NCT02166047|617372215|FG010|Overall Study|Withdrawal by Participant|0|||
170825970|NCT02166047|617372216|FG011|Overall Study|Withdrawal by Participant|0|||
170825971|NCT02166047|617372205|FG000|Overall Study|Adverse Event|0|||
170825972|NCT02166047|617372206|FG001|Overall Study|Adverse Event|0|||
170825973|NCT02166047|617372207|FG002|Overall Study|Adverse Event|0|||
170825974|NCT02166047|617372208|FG003|Overall Study|Adverse Event|0|||
170825975|NCT02166047|617372209|FG004|Overall Study|Adverse Event|1|||
170825976|NCT02166047|617372210|FG005|Overall Study|Adverse Event|0|||
170825977|NCT02166047|617372211|FG006|Overall Study|Adverse Event|1|||
170825978|NCT02166047|617372212|FG007|Overall Study|Adverse Event|0|||
170825979|NCT02166047|617372213|FG008|Overall Study|Adverse Event|0|||
170825980|NCT02166047|617372214|FG009|Overall Study|Adverse Event|0|||
170825981|NCT02166047|617372215|FG010|Overall Study|Adverse Event|2|||
170825982|NCT02166047|617372216|FG011|Overall Study|Adverse Event|0|||
170825983|NCT01885936|617372227|FG000|Overall Study|Withdrawal by Subject|1|||
170825984|NCT01885936|617372228|FG001|Overall Study|Withdrawal by Subject|0|||
170825985|NCT00053352|617372232|FG000|Overall Study|Lost to Follow-up|0|||
170703867|NCT02385799|616924617|FG000|Overall Study|Withdrawal by Subject|0|||
170825986|NCT00053352|617372233|FG001|Overall Study|Lost to Follow-up|1|||
170825987|NCT00053352|617372232|FG000|Overall Study|Physician Decision|11|||
170825988|NCT00053352|617372233|FG001|Overall Study|Physician Decision|1|||
170825989|NCT00053352|617372232|FG000|Overall Study|Withdrawal by Subject|1|||
170825990|NCT00053352|617372233|FG001|Overall Study|Withdrawal by Subject|0|||
170825991|NCT00053352|617372232|FG000|Overall Study|Ineligible|8|||
170825992|NCT00053352|617372233|FG001|Overall Study|Ineligible|8|||
170825993|NCT00053352|617372232|FG000|Overall Study|Disease at new site|1|||
170825994|NCT00053352|617372233|FG001|Overall Study|Disease at new site|0|||
170703868|NCT02385799|616924618|FG001|Overall Study|Withdrawal by Subject|4|||
170703869|NCT02388997|616924619|FG000|Overall Study|Adverse Event|1|||
170825995|NCT01340300|617372234|FG000|Overall Study|Lost to Follow-up|3|||
170703870|NCT02388997|616924620|FG001|Overall Study|Adverse Event|2|||
170825996|NCT01340300|617372235|FG001|Overall Study|Lost to Follow-up|0|||
170825997|NCT01340300|617372236|FG002|Overall Study|Lost to Follow-up|5|||
170825998|NCT01340300|617372237|FG003|Overall Study|Lost to Follow-up|10|||
170825999|NCT01340300|617372234|FG000|Overall Study|Withdrawal by Subject|5|||
170826000|NCT01340300|617372235|FG001|Overall Study|Withdrawal by Subject|6|||
170826001|NCT01340300|617372236|FG002|Overall Study|Withdrawal by Subject|6|||
170826002|NCT01340300|617372237|FG003|Overall Study|Withdrawal by Subject|3|||
170826003|NCT01340300|617372234|FG000|Overall Study|Adverse Event|1|||
170826004|NCT01340300|617372235|FG001|Overall Study|Adverse Event|0|||
170826005|NCT01340300|617372236|FG002|Overall Study|Adverse Event|4|||
170826006|NCT01340300|617372237|FG003|Overall Study|Adverse Event|0|||
170826007|NCT01340300|617372234|FG000|Overall Study|Physician Decision|0|||
170826008|NCT01340300|617372235|FG001|Overall Study|Physician Decision|1|||
170826009|NCT01340300|617372236|FG002|Overall Study|Physician Decision|0|||
170826010|NCT01340300|617372237|FG003|Overall Study|Physician Decision|0|||
170826011|NCT01340300|617372234|FG000|Overall Study|Unrelated sickness|0|||
170826012|NCT01340300|617372235|FG001|Overall Study|Unrelated sickness|2|||
170826013|NCT01340300|617372236|FG002|Overall Study|Unrelated sickness|0|||
170826014|NCT01340300|617372237|FG003|Overall Study|Unrelated sickness|1|||
170826015|NCT00297778|617372238|FG000|Overall Study|Adverse Event|16|||
170826016|NCT00297778|617372239|FG001|Overall Study|Adverse Event|10|||
170826017|NCT00297778|617372238|FG000|Overall Study|Withdrawal by Subject|1|||
170826018|NCT00297778|617372239|FG001|Overall Study|Withdrawal by Subject|5|||
170826019|NCT00297778|617372238|FG000|Overall Study|Lack of Efficacy|2|||
170826020|NCT00297778|617372239|FG001|Overall Study|Lack of Efficacy|1|||
170826021|NCT00297778|617372238|FG000|Overall Study|Non-compliant with trial protocol|0|||
170826022|NCT00297778|617372239|FG001|Overall Study|Non-compliant with trial protocol|3|||
170826023|NCT00297778|617372238|FG000|Overall Study|Other|0|||
170826024|NCT00297778|617372239|FG001|Overall Study|Other|1|||
170826025|NCT00802438|617372240|FG000|Overall Study|Screen Failure|20|||
170826026|NCT00802438|617372240|FG000|Overall Study|Withdrawal by Subject|7|||
170826027|NCT00802438|617372240|FG000|Overall Study|Physician Decision|1|||
170826028|NCT00510146|617372241|FG000|Double-Blind Treatment|Adverse Event|30|||
170826029|NCT00510146|617372242|FG001|Double-Blind Treatment|Adverse Event|13|||
170826030|NCT00510146|617372241|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
170826031|NCT00510146|617372242|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
170826032|NCT00510146|617372241|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
170826033|NCT00510146|617372242|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
170826034|NCT00510146|617372241|FG000|Double-Blind Treatment|Physician Decision|6|||
170826035|NCT00510146|617372242|FG001|Double-Blind Treatment|Physician Decision|0|||
170826036|NCT00510146|617372241|FG000|Double-Blind Treatment|Protocol Violation|1|||
170826037|NCT00510146|617372242|FG001|Double-Blind Treatment|Protocol Violation|2|||
170826038|NCT00510146|617372241|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
170826039|NCT00510146|617372242|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
170703871|NCT02388997|616924619|FG000|Overall Study|Withdrawal by Subject|2|||
170703872|NCT02388997|616924620|FG001|Overall Study|Withdrawal by Subject|1|||
170703873|NCT02388997|616924619|FG000|Overall Study|Lung function exclusion criteria|0|||
170703874|NCT02388997|616924620|FG001|Overall Study|Lung function exclusion criteria|2|||
170703875|NCT02388997|616924619|FG000|Overall Study|Tested positive for virus during run-in|0|||
170703876|NCT02388997|616924620|FG001|Overall Study|Tested positive for virus during run-in|1|||
170703877|NCT02130765|616924621|FG000|Overall Study|Did not receive treatment|4|||
170703878|NCT02130765|616924622|FG001|Overall Study|Did not receive treatment|0|||
170703879|NCT02130765|616924623|FG002|Overall Study|Did not receive treatment|0|||
170703880|NCT02130765|616924624|FG003|Overall Study|Did not receive treatment|0|||
170703881|NCT00006184|616924626|FG000|Overall Study|Death|1|||
170703882|NCT00006184|616924627|FG001|Overall Study|Death|0|||
170703883|NCT01110915|616924628|FG000|Overall Study|Death|2|||
170703884|NCT01110915|616924629|FG001|Overall Study|Death|1|||
170703885|NCT01110915|616924628|FG000|Overall Study|Lost to Follow-up|1|||
170703886|NCT01110915|616924629|FG001|Overall Study|Lost to Follow-up|0|||
170703887|NCT01110915|616924628|FG000|Overall Study|Withdrawal by Subject|7|||
170703888|NCT01110915|616924629|FG001|Overall Study|Withdrawal by Subject|1|||
170703889|NCT02253810|616924634|FG000|Overall Study|Withdrawal by Subject|2|||
170703890|NCT02253810|616924635|FG001|Overall Study|Withdrawal by Subject|1|||
170703891|NCT02253810|616924634|FG000|Overall Study|Unknown concomitant procedure|3|||
170703892|NCT02253810|616924635|FG001|Overall Study|Unknown concomitant procedure|2|||
170703893|NCT00291668|616924636|FG000|Overall Study|Lack of Efficacy|1|||
170703894|NCT00291668|616924637|FG001|Overall Study|Lack of Efficacy|0|||
170703895|NCT00291668|616924638|FG002|Overall Study|Lack of Efficacy|0|||
170703896|NCT00291668|616924636|FG000|Overall Study|SAE, non-fatal|1|||
170703897|NCT00291668|616924637|FG001|Overall Study|SAE, non-fatal|1|||
170703898|NCT00291668|616924638|FG002|Overall Study|SAE, non-fatal|1|||
170703899|NCT00291668|616924636|FG000|Overall Study|AE, non-serious non-fatal|1|||
170703900|NCT00291668|616924637|FG001|Overall Study|AE, non-serious non-fatal|0|||
170703901|NCT00291668|616924638|FG002|Overall Study|AE, non-serious non-fatal|0|||
170703902|NCT00291668|616924636|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
170703903|NCT00291668|616924637|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
170703904|NCT00291668|616924638|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
170703905|NCT01557400|616924639|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
170703906|NCT01557400|616924639|FG000|Overall Study|Adverse Event|3|||
170703907|NCT01557400|616924639|FG000|Overall Study|Lost to Follow-up|5|||
170703908|NCT01557400|616924639|FG000|Overall Study|Withdrawal by Subject|9|||
170703909|NCT04019041|616924640|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
170703910|NCT04019041|616924641|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
170703911|NCT04019041|616924642|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
170703912|NCT04019041|616924643|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
170703913|NCT04019041|616924644|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
170703914|NCT04019041|616924645|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
170703915|NCT04019041|616924640|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
170826040|NCT00510146|617372241|FG000|Double-Blind Treatment|Clinical Relapse|0|||
170826041|NCT00510146|617372242|FG001|Double-Blind Treatment|Clinical Relapse|1|||
170826042|NCT00510146|617372241|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
170826043|NCT00510146|617372242|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
170826044|NCT00510146|617372241|FG000|Open-Label Treatment|Adverse Event|22|||
170826045|NCT00510146|617372242|FG001|Open-Label Treatment|Adverse Event|8|||
170826046|NCT00510146|617372241|FG000|Open-Label Treatment|Death|1|||
170826047|NCT00510146|617372242|FG001|Open-Label Treatment|Death|1|||
170826048|NCT00510146|617372241|FG000|Open-Label Treatment|Lack of Efficacy|4|||
170826049|NCT00510146|617372242|FG001|Open-Label Treatment|Lack of Efficacy|0|||
170826050|NCT00510146|617372241|FG000|Open-Label Treatment|Lost to Follow-up|10|||
170826051|NCT00510146|617372242|FG001|Open-Label Treatment|Lost to Follow-up|1|||
170826052|NCT00510146|617372241|FG000|Open-Label Treatment|Physician Decision|3|||
170826053|NCT00510146|617372242|FG001|Open-Label Treatment|Physician Decision|1|||
170826054|NCT00510146|617372241|FG000|Open-Label Treatment|Protocol Violation|4|||
170826055|NCT00510146|617372242|FG001|Open-Label Treatment|Protocol Violation|2|||
170703916|NCT04019041|616924641|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
170703917|NCT04019041|616924642|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
170703918|NCT04019041|616924643|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
170703919|NCT04019041|616924644|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
170703920|NCT04019041|616924645|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
170703921|NCT04019041|616924640|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
170703922|NCT04019041|616924641|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
170703923|NCT04019041|616924642|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
170703924|NCT04019041|616924643|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
170703925|NCT04019041|616924644|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
170703926|NCT04019041|616924645|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
170703927|NCT04019041|616924640|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
170703928|NCT04019041|616924641|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
170703929|NCT04019041|616924642|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
170703930|NCT04019041|616924643|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
170703931|NCT04019041|616924644|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
170703932|NCT04019041|616924645|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
170703933|NCT04019041|616924640|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
170703934|NCT04019041|616924641|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
170703935|NCT04019041|616924642|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
170703936|NCT04019041|616924643|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
170703937|NCT04019041|616924644|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
170703938|NCT04019041|616924645|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
170703939|NCT04019041|616924640|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
170703940|NCT04019041|616924641|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
170703941|NCT04019041|616924642|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
170703942|NCT04019041|616924643|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
170703943|NCT04019041|616924644|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
170703944|NCT04019041|616924645|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
170703945|NCT04019041|616924640|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
170703946|NCT04019041|616924641|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
170703947|NCT04019041|616924642|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
170703948|NCT04019041|616924643|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
170703949|NCT04019041|616924644|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
170703950|NCT04019041|616924645|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
170703951|NCT04019041|616924640|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
170703952|NCT04019041|616924641|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
170703953|NCT04019041|616924642|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
170826056|NCT00510146|617372241|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
170826057|NCT00510146|617372242|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
170826058|NCT00510146|617372241|FG000|Open-Label Treatment|Clinical Relapse|1|||
170826059|NCT00510146|617372242|FG001|Open-Label Treatment|Clinical Relapse|1|||
170826060|NCT00510146|617372241|FG000|Open-Label Treatment|Sponsor Decision|2|||
170826061|NCT00510146|617372242|FG001|Open-Label Treatment|Sponsor Decision|0|||
170826062|NCT01200485|617372243|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
170826063|NCT01200485|617372244|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
170703954|NCT04019041|616924643|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
170703955|NCT04019041|616924644|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
170703956|NCT04019041|616924645|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
170826064|NCT01200485|617372245|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
170826065|NCT01200485|617372243|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
170703957|NCT04019041|616924640|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
170703958|NCT04019041|616924641|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
170703959|NCT04019041|616924642|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
170703960|NCT04019041|616924643|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
170703961|NCT04019041|616924644|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
170703962|NCT04019041|616924645|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
170703963|NCT02434770|616924649|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
170703964|NCT02434770|616924650|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
170703965|NCT02434770|616924651|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
170703966|NCT02434770|616924649|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
170703967|NCT02434770|616924650|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
170703968|NCT02434770|616924651|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
170703969|NCT02434770|616924649|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
170703970|NCT02434770|616924650|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
170703971|NCT02434770|616924651|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
170703972|NCT02434770|616924649|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
170703973|NCT02434770|616924650|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
170703974|NCT02434770|616924651|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
170703975|NCT02434770|616924649|FG000|Week 1 to Week 18|Death|1|||
170703976|NCT02434770|616924650|FG001|Week 1 to Week 18|Death|0|||
170703977|NCT02434770|616924651|FG002|Week 1 to Week 18|Death|0|||
170703978|NCT02434770|616924649|FG000|Week 18 to Week|Lost to Follow-up|2|||
170703979|NCT02434770|616924650|FG001|Week 18 to Week|Lost to Follow-up|2|||
170703980|NCT02434770|616924651|FG002|Week 18 to Week|Lost to Follow-up|1|||
170703981|NCT02434770|616924649|FG000|Week 18 to Week|Withdrawal by Subject|0|||
170703982|NCT02434770|616924650|FG001|Week 18 to Week|Withdrawal by Subject|0|||
170703983|NCT02434770|616924651|FG002|Week 18 to Week|Withdrawal by Subject|2|||
170703984|NCT02434770|616924649|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
170703985|NCT02434770|616924650|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
170703986|NCT02434770|616924651|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
170703987|NCT01574352|616924652|FG000|Overall Study|Withdrawal by Subject|6|||
170703988|NCT01574352|616924653|FG001|Overall Study|Withdrawal by Subject|13|||
170703989|NCT01574352|616924652|FG000|Overall Study|Injury in non-camp related sport|1|||
170703990|NCT01574352|616924653|FG001|Overall Study|Injury in non-camp related sport|0|||
170703991|NCT00245765|616924654|FG000|Overall Study|Adverse Event|1|||
170703992|NCT00245765|616924655|FG001|Overall Study|Adverse Event|1|||
170703993|NCT00245765|616924656|FG002|Overall Study|Adverse Event|0|||
170703994|NCT00245765|616924654|FG000|Overall Study|Lack of Efficacy|14|||
170703995|NCT00245765|616924655|FG001|Overall Study|Lack of Efficacy|7|||
170703996|NCT00245765|616924656|FG002|Overall Study|Lack of Efficacy|0|||
170703997|NCT00245765|616924654|FG000|Overall Study|Lost to Follow-up|1|||
170703998|NCT00245765|616924655|FG001|Overall Study|Lost to Follow-up|2|||
170703999|NCT00245765|616924656|FG002|Overall Study|Lost to Follow-up|0|||
170704000|NCT00245765|616924654|FG000|Overall Study|Withdrawal by Subject|1|||
170704001|NCT00245765|616924655|FG001|Overall Study|Withdrawal by Subject|0|||
170704002|NCT00245765|616924656|FG002|Overall Study|Withdrawal by Subject|3|||
170704003|NCT00245765|616924654|FG000|Overall Study|Other reason|2|||
170704004|NCT00245765|616924655|FG001|Overall Study|Other reason|0|||
170704005|NCT00245765|616924656|FG002|Overall Study|Other reason|1|||
170704006|NCT00245765|616924654|FG000|Overall Study|Other|13|||
170704007|NCT00245765|616924655|FG001|Overall Study|Other|4|||
170704008|NCT00245765|616924656|FG002|Overall Study|Other|4|||
170704009|NCT00660348|616924657|FG000|Overall Study|Withdrawal by Subject|1|||
170704010|NCT00660348|616924658|FG001|Overall Study|Withdrawal by Subject|0|||
170704011|NCT02917031|616924664|FG000|Overall Study|Reason not specified|7|||
170704012|NCT02917031|616924665|FG001|Overall Study|Reason not specified|5|||
170704013|NCT02917031|616924666|FG002|Overall Study|Reason not specified|6|||
170704014|NCT02917031|616924664|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
170704015|NCT02917031|616924665|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
170704016|NCT02917031|616924666|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
170704017|NCT02917031|616924664|FG000|Overall Study|Withdrawal by Subject|3|||
170704018|NCT02917031|616924665|FG001|Overall Study|Withdrawal by Subject|3|||
170704019|NCT02917031|616924666|FG002|Overall Study|Withdrawal by Subject|0|||
170704020|NCT02917031|616924664|FG000|Overall Study|Physician Decision|1|||
170704021|NCT02917031|616924665|FG001|Overall Study|Physician Decision|0|||
170704022|NCT02917031|616924666|FG002|Overall Study|Physician Decision|0|||
170704023|NCT02917031|616924664|FG000|Overall Study|Adverse Event|4|||
170704024|NCT02917031|616924665|FG001|Overall Study|Adverse Event|1|||
170704025|NCT02917031|616924666|FG002|Overall Study|Adverse Event|5|||
170704026|NCT02917031|616924664|FG000|Overall Study|Death|2|||
170826066|NCT01200485|617372244|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
170826067|NCT01200485|617372245|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
170826068|NCT04947436|617372246|FG000|Overall Study|Lost to Follow-up|3|||
170826069|NCT04947436|617372247|FG001|Overall Study|Lost to Follow-up|7|||
170826070|NCT04947436|617372248|FG002|Overall Study|Lost to Follow-up|5|||
170826071|NCT04947436|617372246|FG000|Overall Study|Death|1|||
170704027|NCT02917031|616924665|FG001|Overall Study|Death|3|||
170704028|NCT02917031|616924666|FG002|Overall Study|Death|4|||
170704029|NCT04269161|616925958|FG000|Overall Study|Change of modality and no longer eligible|3|||
170704030|NCT04269161|616925959|FG001|Overall Study|Change of modality and no longer eligible|3|||
170704031|NCT04269161|616925958|FG000|Overall Study|Required procedure outside of NICU|1|||
170704032|NCT04269161|616925959|FG001|Overall Study|Required procedure outside of NICU|0|||
170704033|NCT04269161|616925958|FG000|Overall Study|Equipment issue|1|||
170704034|NCT04269161|616925959|FG001|Overall Study|Equipment issue|1|||
170704035|NCT01896895|616925960|FG000|Double-blind MP|Physician Decision|0|||
170704036|NCT01896895|616925961|FG001|Double-blind MP|Physician Decision|0|||
170826072|NCT04947436|617372247|FG001|Overall Study|Death|1|||
170826073|NCT04947436|617372248|FG002|Overall Study|Death|1|||
170826074|NCT00808899|617372251|FG000|Overall Study|Death|1|||
170826075|NCT00808899|617372251|FG000|Overall Study|Physician Decision|3|||
170826076|NCT01196741|617372256|FG000|Overall Study|Disease progression|34|||
170826077|NCT01196741|617372257|FG001|Overall Study|Disease progression|14|||
170826078|NCT01196741|617372256|FG000|Overall Study|Adverse Event|10|||
170826079|NCT01196741|617372257|FG001|Overall Study|Adverse Event|6|||
170826080|NCT01196741|617372256|FG000|Overall Study|Serious Adverse Event|3|||
170826081|NCT01196741|617372257|FG001|Overall Study|Serious Adverse Event|1|||
170826082|NCT01196741|617372256|FG000|Overall Study|Dose limiting Adverse Event|2|||
170826083|NCT01196741|617372257|FG001|Overall Study|Dose limiting Adverse Event|1|||
170826084|NCT01196741|617372256|FG000|Overall Study|Withdrawal by Subject|3|||
170826085|NCT01196741|617372257|FG001|Overall Study|Withdrawal by Subject|0|||
170826086|NCT01196741|617372256|FG000|Overall Study|Other reason|3|||
170826087|NCT01196741|617372257|FG001|Overall Study|Other reason|3|||
170826088|NCT01196741|617372256|FG000|Overall Study|Other|3|||
170826089|NCT01196741|617372257|FG001|Overall Study|Other|2|||
170826090|NCT01196741|617372256|FG000|Overall Study|Protocol Violation|2|||
170826091|NCT01196741|617372257|FG001|Overall Study|Protocol Violation|1|||
170826092|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
170826093|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
170826094|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
170826095|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Other|1|||
170826096|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Other|0|||
170826097|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Other|0|||
170826098|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Physician Decision|3|||
170826099|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Physician Decision|0|||
170826100|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Physician Decision|0|||
170826101|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
170826102|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
170826103|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
170826104|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
170826105|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
170826106|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
170826107|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Adverse Event|18|||
170826108|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Adverse Event|0|||
170826109|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Adverse Event|0|||
170826110|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
170826111|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
170826112|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
170826113|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
170826114|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
170826115|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
170826116|NCT03030599|617372258|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
170826117|NCT03030599|617372259|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
170826118|NCT03030599|617372260|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
170826119|NCT03030599|617372258|FG000|Stable Dose|Protocol deviation|3|||
170826120|NCT03030599|617372259|FG001|Stable Dose|Protocol deviation|0|||
170826121|NCT03030599|617372260|FG002|Stable Dose|Protocol deviation|0|||
170826122|NCT03030599|617372258|FG000|Stable Dose|Adverse Event|1|||
170826123|NCT03030599|617372259|FG001|Stable Dose|Adverse Event|0|||
170826124|NCT03030599|617372260|FG002|Stable Dose|Adverse Event|0|||
170704037|NCT01896895|616925962|FG002|Double-blind MP|Physician Decision|1|||
170704038|NCT01896895|616925963|FG003|Double-blind MP|Physician Decision|0|||
170826125|NCT03030599|617372258|FG000|Stable Dose|Lost to Follow-up|1|||
170826126|NCT03030599|617372259|FG001|Stable Dose|Lost to Follow-up|0|||
170826127|NCT03030599|617372260|FG002|Stable Dose|Lost to Follow-up|0|||
170704039|NCT01896895|616925960|FG000|Double-blind MP|Withdrawal by Subject|0|||
170704040|NCT01896895|616925961|FG001|Double-blind MP|Withdrawal by Subject|2|||
170704041|NCT01896895|616925962|FG002|Double-blind MP|Withdrawal by Subject|1|||
170704042|NCT01896895|616925963|FG003|Double-blind MP|Withdrawal by Subject|0|||
170704043|NCT01896895|616925960|FG000|Double-blind MP|Lost to Follow-up|1|||
170704044|NCT01896895|616925961|FG001|Double-blind MP|Lost to Follow-up|0|||
170704045|NCT01896895|616925962|FG002|Double-blind MP|Lost to Follow-up|1|||
170704046|NCT01896895|616925963|FG003|Double-blind MP|Lost to Follow-up|0|||
170704047|NCT04300296|616925964|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
170704048|NCT04300296|616925965|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
170704049|NCT04300296|616925966|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
170704050|NCT04300296|616925967|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
170704051|NCT04300296|616925968|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
170704052|NCT04300296|616925969|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
170704053|NCT04300296|616925964|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
170704054|NCT04300296|616925965|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
170704055|NCT04300296|616925966|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
170704056|NCT04300296|616925967|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
170704057|NCT04300296|616925968|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
170704058|NCT04300296|616925969|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
170704059|NCT04300296|616925964|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
170704060|NCT04300296|616925965|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
170704061|NCT04300296|616925966|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
170704062|NCT04300296|616925967|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
170704063|NCT04300296|616925968|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
170704064|NCT04300296|616925969|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
170704065|NCT04300296|616925964|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
170704066|NCT04300296|616925965|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
170704067|NCT04300296|616925966|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
170704068|NCT04300296|616925967|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
170704069|NCT04300296|616925968|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
170704070|NCT04300296|616925969|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
170704071|NCT04300296|616925964|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
170704072|NCT04300296|616925965|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
170704073|NCT04300296|616925966|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
170704074|NCT04300296|616925967|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
170704075|NCT04300296|616925968|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
170704076|NCT04300296|616925969|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
170704077|NCT04300296|616925964|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
170704078|NCT04300296|616925965|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
170704079|NCT04300296|616925966|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
170704080|NCT04300296|616925967|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
170704081|NCT04300296|616925968|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
170704082|NCT04300296|616925969|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
170704083|NCT04300296|616925964|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
170704084|NCT04300296|616925965|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
170704085|NCT04300296|616925966|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
170704086|NCT04300296|616925967|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
170704087|NCT04300296|616925968|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
170704088|NCT04300296|616925969|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
170704089|NCT05044234|616925970|FG000|Overall Study|Lost to Follow-up|2|||
170704090|NCT05044234|616925971|FG001|Overall Study|Lost to Follow-up|1|||
170704091|NCT05044234|616925972|FG002|Overall Study|Lost to Follow-up|1|||
170704092|NCT05044234|616925973|FG003|Overall Study|Lost to Follow-up|2|||
170704093|NCT05044234|616925970|FG000|Overall Study|Withdrawal by Subject|6|||
170704094|NCT05044234|616925971|FG001|Overall Study|Withdrawal by Subject|4|||
170704095|NCT05044234|616925972|FG002|Overall Study|Withdrawal by Subject|5|||
170704096|NCT05044234|616925973|FG003|Overall Study|Withdrawal by Subject|8|||
170704097|NCT05044234|616925970|FG000|Overall Study|Study terminated by Sponsor|21|||
170704098|NCT05044234|616925971|FG001|Overall Study|Study terminated by Sponsor|21|||
170704099|NCT05044234|616925972|FG002|Overall Study|Study terminated by Sponsor|20|||
170826128|NCT03030599|617372258|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
170704100|NCT05044234|616925973|FG003|Overall Study|Study terminated by Sponsor|14|||
170704101|NCT05044234|616925970|FG000|Overall Study|Other, not specified|0|||
170704102|NCT05044234|616925971|FG001|Overall Study|Other, not specified|0|||
170704103|NCT05044234|616925972|FG002|Overall Study|Other, not specified|1|||
170704104|NCT05044234|616925973|FG003|Overall Study|Other, not specified|2|||
170704105|NCT05044234|616925970|FG000|Overall Study|Delayed data entry|0|||
170826129|NCT03030599|617372259|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
170704106|NCT05044234|616925971|FG001|Overall Study|Delayed data entry|0|||
170704107|NCT05044234|616925972|FG002|Overall Study|Delayed data entry|0|||
170704108|NCT05044234|616925973|FG003|Overall Study|Delayed data entry|1|||
170704109|NCT02896127|616925979|FG000|COMPLETED WEEK 52|Adverse Event|9|||
170704110|NCT02896127|616925980|FG001|COMPLETED WEEK 52|Adverse Event|2|||
170704111|NCT02896127|616925979|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
170704112|NCT02896127|616925980|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
170826130|NCT03030599|617372260|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
170826131|NCT03030599|617372258|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
170826132|NCT03030599|617372259|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
170826133|NCT03030599|617372260|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
170704113|NCT02896127|616925979|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
170704114|NCT02896127|616925980|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
170704115|NCT02896127|616925979|FG000|COMPLETED WEEK 52|Physician Decision|1|||
170704116|NCT02896127|616925980|FG001|COMPLETED WEEK 52|Physician Decision|1|||
170704117|NCT02896127|616925979|FG000|COMPLETED WEEK 52|Pregnancy|2|||
170704118|NCT02896127|616925980|FG001|COMPLETED WEEK 52|Pregnancy|0|||
170704119|NCT02896127|616925979|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
170704120|NCT02896127|616925980|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
170704121|NCT02896127|616925979|FG000|COMPLETED WEEK 52|Technical problems|1|||
170704122|NCT02896127|616925980|FG001|COMPLETED WEEK 52|Technical problems|0|||
170704123|NCT02896127|616925979|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
170704124|NCT02896127|616925980|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
170704125|NCT02896127|616925979|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
170704126|NCT02896127|616925980|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
170704127|NCT02896127|616925979|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
170704128|NCT02896127|616925980|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
170704129|NCT02896127|616925979|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
170704130|NCT02896127|616925980|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
170704131|NCT02896127|616925979|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
170704132|NCT02896127|616925980|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
170704133|NCT00279708|616925981|FG000|Overall Study|Withdrawal by Subject|2|||
170704134|NCT00279708|616925982|FG001|Overall Study|Withdrawal by Subject|3|||
170704135|NCT00279708|616925981|FG000|Overall Study|Adverse Event|1|||
170704136|NCT00279708|616925982|FG001|Overall Study|Adverse Event|1|||
170704137|NCT03912233|616925983|FG000|Overall Study|Adverse Event|1|||
170704138|NCT03912233|616925984|FG001|Overall Study|Adverse Event|0|||
170704139|NCT03912233|616925985|FG002|Overall Study|Adverse Event|0|||
170704140|NCT03912233|616925986|FG003|Overall Study|Adverse Event|0|||
170704141|NCT03912233|616925987|FG004|Overall Study|Adverse Event|0|||
170704142|NCT03912233|616925988|FG005|Overall Study|Adverse Event|0|||
170704143|NCT03912233|616925983|FG000|Overall Study|Physician Decision|1|||
170704144|NCT03912233|616925984|FG001|Overall Study|Physician Decision|0|||
170704145|NCT03912233|616925985|FG002|Overall Study|Physician Decision|0|||
170704146|NCT03912233|616925986|FG003|Overall Study|Physician Decision|0|||
170704147|NCT03912233|616925987|FG004|Overall Study|Physician Decision|0|||
170704148|NCT03912233|616925988|FG005|Overall Study|Physician Decision|0|||
170704149|NCT03912233|616925983|FG000|Overall Study|Other|0|||
170704150|NCT03912233|616925984|FG001|Overall Study|Other|0|||
170704151|NCT03912233|616925985|FG002|Overall Study|Other|0|||
170704152|NCT03912233|616925986|FG003|Overall Study|Other|0|||
170704153|NCT03912233|616925987|FG004|Overall Study|Other|7|||
170826134|NCT03030599|617372258|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
170826135|NCT03030599|617372259|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
170826136|NCT03030599|617372260|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
170826137|NCT03030599|617372258|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
170826138|NCT03030599|617372259|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
170826139|NCT03030599|617372260|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
170826140|NCT03030599|617372258|FG000|Open-label Extension|Adverse Event|3|||
170826141|NCT03030599|617372259|FG001|Open-label Extension|Adverse Event|0|||
170704154|NCT03912233|616925988|FG005|Overall Study|Other|12|||
170704155|NCT02583256|616925989|FG000|Overall Study|Withdrawal by Subject|0|||
170704156|NCT02583256|616925990|FG001|Overall Study|Withdrawal by Subject|1|||
170704157|NCT02583256|616925991|FG002|Overall Study|Withdrawal by Subject|1|||
170704158|NCT02583256|616925992|FG003|Overall Study|Withdrawal by Subject|0|||
170704159|NCT02583256|616925989|FG000|Overall Study|Lost to Follow-up|1|||
170704160|NCT02583256|616925990|FG001|Overall Study|Lost to Follow-up|1|||
170826142|NCT03030599|617372260|FG002|Open-label Extension|Adverse Event|0|||
170704161|NCT02583256|616925991|FG002|Overall Study|Lost to Follow-up|0|||
170704162|NCT02583256|616925992|FG003|Overall Study|Lost to Follow-up|1|||
170704163|NCT02583256|616925989|FG000|Overall Study|Administrative/Other|2|||
170704164|NCT02583256|616925990|FG001|Overall Study|Administrative/Other|0|||
170704165|NCT02583256|616925991|FG002|Overall Study|Administrative/Other|1|||
170704166|NCT02583256|616925992|FG003|Overall Study|Administrative/Other|2|||
170704167|NCT03852316|616926001|FG000|Overall Study|Protocol Violation|1|||
170704168|NCT03852316|616926001|FG000|Overall Study|Withdrawal by Subject|2|||
170704169|NCT03852316|616926001|FG000|Overall Study|Enrolled but Device not Utilized|1|||
170704170|NCT03907683|616926002|FG000|Overall Study|Pregnancy|1|||
170704171|NCT03907683|616926002|FG000|Overall Study|Withdrawal by Subject|1|||
170704172|NCT02075840|616926004|FG000|Overall Study|Withdrawal by Subject|13|||
170704173|NCT02075840|616926005|FG001|Overall Study|Withdrawal by Subject|22|||
170704174|NCT02075840|616926004|FG000|Overall Study|Reason not specified|1|||
170704175|NCT02075840|616926005|FG001|Overall Study|Reason not specified|0|||
170704176|NCT02075840|616926004|FG000|Overall Study|Adverse Event|0|||
170704177|NCT02075840|616926005|FG001|Overall Study|Adverse Event|2|||
170704178|NCT02075840|616926004|FG000|Overall Study|Death|35|||
170704179|NCT02075840|616926005|FG001|Overall Study|Death|40|||
170826143|NCT03030599|617372258|FG000|Open-label Extension|Lost to Follow-up|2|||
170826144|NCT03030599|617372259|FG001|Open-label Extension|Lost to Follow-up|0|||
170826145|NCT03030599|617372260|FG002|Open-label Extension|Lost to Follow-up|0|||
170826146|NCT03030599|617372258|FG000|Open-label Extension|Lack of Efficacy|1|||
170826147|NCT03030599|617372259|FG001|Open-label Extension|Lack of Efficacy|0|||
170826148|NCT03030599|617372260|FG002|Open-label Extension|Lack of Efficacy|0|||
170826149|NCT03030599|617372258|FG000|Open-label Extension|Other Reason|1|||
170826150|NCT03030599|617372259|FG001|Open-label Extension|Other Reason|0|||
170826151|NCT03030599|617372260|FG002|Open-label Extension|Other Reason|0|||
170826152|NCT00356759|617372261|FG000|Overall Study|Death|5|||
170826153|NCT00356759|617372262|FG001|Overall Study|Death|2|||
170826154|NCT00356759|617372261|FG000|Overall Study|Withdrawal by Subject|2|||
170826155|NCT00356759|617372262|FG001|Overall Study|Withdrawal by Subject|2|||
170826156|NCT00356759|617372261|FG000|Overall Study|Adverse Event|1|||
170826157|NCT00356759|617372262|FG001|Overall Study|Adverse Event|3|||
170826158|NCT00356759|617372261|FG000|Overall Study|Lost to Follow-up|1|||
170826159|NCT00356759|617372262|FG001|Overall Study|Lost to Follow-up|1|||
170826160|NCT00356759|617372261|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
170826161|NCT00356759|617372262|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
170826162|NCT04582864|617372263|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
170826163|NCT04582864|617372263|FG000|Overall Study|Death|1|||
170826164|NCT03849300|617372264|FG000|Overall Study|move out to different area|1|||
170826165|NCT03849300|617372265|FG001|Overall Study|move out to different area|3|||
170826166|NCT03849300|617372266|FG002|Overall Study|move out to different area|1|||
170826167|NCT03849300|617372267|FG003|Overall Study|move out to different area|4|||
170826168|NCT03849300|617372264|FG000|Overall Study|scheduling/transportation conflict|4|||
170826169|NCT03849300|617372265|FG001|Overall Study|scheduling/transportation conflict|4|||
170826170|NCT03849300|617372266|FG002|Overall Study|scheduling/transportation conflict|3|||
170826171|NCT03849300|617372267|FG003|Overall Study|scheduling/transportation conflict|2|||
170826172|NCT03640754|617372269|FG000|Overall Study|Withdrawal by Subject|1|||
170826173|NCT03640754|617372270|FG001|Overall Study|Withdrawal by Subject|0|||
170826174|NCT03640754|617372269|FG000|Overall Study|Lost to Follow-up|0|||
170826175|NCT03640754|617372270|FG001|Overall Study|Lost to Follow-up|1|||
170826176|NCT02133131|617372273|FG000|Overall Study|Adverse Event|0|||
170826177|NCT02133131|617372274|FG001|Overall Study|Adverse Event|0|||
170826178|NCT02133131|617372275|FG002|Overall Study|Adverse Event|0|||
170826179|NCT02133131|617372276|FG003|Overall Study|Adverse Event|1|||
170826180|NCT02133131|617372277|FG004|Overall Study|Adverse Event|0|||
170826181|NCT02133131|617372278|FG005|Overall Study|Adverse Event|0|||
170826182|NCT02133131|617372279|FG006|Overall Study|Adverse Event|0|||
170826183|NCT02133131|617372273|FG000|Overall Study|Lost to Follow-up|1|||
170826184|NCT02133131|617372274|FG001|Overall Study|Lost to Follow-up|0|||
170826185|NCT02133131|617372275|FG002|Overall Study|Lost to Follow-up|0|||
170826186|NCT02133131|617372276|FG003|Overall Study|Lost to Follow-up|1|||
170826187|NCT02133131|617372277|FG004|Overall Study|Lost to Follow-up|0|||
170826188|NCT02133131|617372278|FG005|Overall Study|Lost to Follow-up|0|||
170826189|NCT02133131|617372279|FG006|Overall Study|Lost to Follow-up|0|||
170826190|NCT02133131|617372273|FG000|Overall Study|Status not recorded|4|||
170826191|NCT02133131|617372274|FG001|Overall Study|Status not recorded|5|||
170826192|NCT02133131|617372275|FG002|Overall Study|Status not recorded|1|||
170826193|NCT02133131|617372276|FG003|Overall Study|Status not recorded|4|||
170826194|NCT02133131|617372277|FG004|Overall Study|Status not recorded|0|||
170826195|NCT02133131|617372278|FG005|Overall Study|Status not recorded|0|||
170826196|NCT02133131|617372279|FG006|Overall Study|Status not recorded|0|||
170826197|NCT02133131|617372273|FG000|Overall Study|Ongoing in study|0|||
170704180|NCT02075840|616926004|FG000|Overall Study|Lost to Follow-up|3|||
170826198|NCT02133131|617372274|FG001|Overall Study|Ongoing in study|0|||
170826199|NCT02133131|617372275|FG002|Overall Study|Ongoing in study|0|||
170704181|NCT02075840|616926005|FG001|Overall Study|Lost to Follow-up|2|||
170826200|NCT02133131|617372276|FG003|Overall Study|Ongoing in study|0|||
170826201|NCT02133131|617372277|FG004|Overall Study|Ongoing in study|15|||
170826202|NCT02133131|617372278|FG005|Overall Study|Ongoing in study|14|||
170826203|NCT02133131|617372279|FG006|Overall Study|Ongoing in study|11|||
170826204|NCT02133131|617372273|FG000|Overall Study|Protocol Violation|0|||
170704182|NCT02075840|616926004|FG000|Overall Study|Physician Decision|1|||
170704183|NCT02075840|616926005|FG001|Overall Study|Physician Decision|3|||
170826205|NCT02133131|617372274|FG001|Overall Study|Protocol Violation|0|||
170826206|NCT02133131|617372275|FG002|Overall Study|Protocol Violation|0|||
170826207|NCT02133131|617372276|FG003|Overall Study|Protocol Violation|0|||
170826208|NCT02133131|617372277|FG004|Overall Study|Protocol Violation|0|||
170826209|NCT02133131|617372278|FG005|Overall Study|Protocol Violation|0|||
170826210|NCT02133131|617372279|FG006|Overall Study|Protocol Violation|1|||
170826211|NCT01204775|617372284|FG000|Overall Study|Poor/non-compliance|0|||
170826212|NCT01204775|617372285|FG001|Overall Study|Poor/non-compliance|1|||
170826213|NCT01204775|617372284|FG000|Overall Study|Withdrawal by Subject|1|||
170826214|NCT01204775|617372285|FG001|Overall Study|Withdrawal by Subject|0|||
170826215|NCT01679613|617372290|FG000|Overall Study|other than stated above|0|||
170826216|NCT01679613|617372291|FG001|Overall Study|other than stated above|1|||
170826217|NCT01679613|617372292|FG002|Overall Study|other than stated above|2|||
170826218|NCT01679613|617372293|FG003|Overall Study|other than stated above|2|||
170826219|NCT00727259|617372294|FG000|Overall Study|Not all questionnaires completed|1055|||
170826220|NCT00509925|617372295|FG000|Overall Study|Personal reasons|0|||
170826221|NCT00509925|617372296|FG001|Overall Study|Personal reasons|1|||
170826222|NCT00645099|617372297|FG000|Overall Study|Lack of Efficacy|15|||
170826223|NCT00645099|617372298|FG001|Overall Study|Lack of Efficacy|6|||
170826224|NCT00645099|617372297|FG000|Overall Study|Withdrawal by Subject|30|||
170826225|NCT00645099|617372298|FG001|Overall Study|Withdrawal by Subject|22|||
170704184|NCT02075840|616926004|FG000|Overall Study|Ongoing at CCOD|99|||
170704185|NCT02075840|616926005|FG001|Overall Study|Ongoing at CCOD|82|||
170704186|NCT06034496|616926006|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
170704187|NCT06034496|616926007|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
170704188|NCT06034496|616926006|FG000|Overall Study|Withdrawal by Subject|5|||
170704189|NCT06034496|616926007|FG001|Overall Study|Withdrawal by Subject|4|||
170704190|NCT01428193|616926033|FG000|Overall Study|Physician Decision|1|||
170704191|NCT01428193|616926033|FG000|Overall Study|Elevated screening liver enzymes|1|||
170704192|NCT03277261|616926040|FG000|Overall Study|Adverse Event|17|||
170704193|NCT03277261|616926041|FG001|Overall Study|Adverse Event|1|||
170704194|NCT03277261|616926040|FG000|Overall Study|Participant Withdrawal of Consent|6|||
170704195|NCT03277261|616926041|FG001|Overall Study|Participant Withdrawal of Consent|15|||
170704196|NCT03277261|616926040|FG000|Overall Study|Investigator / Sponsor Decision|4|||
170704197|NCT03277261|616926041|FG001|Overall Study|Investigator / Sponsor Decision|2|||
170704198|NCT03277261|616926040|FG000|Overall Study|Pregnancy|2|||
170704199|NCT03277261|616926041|FG001|Overall Study|Pregnancy|0|||
170704200|NCT03277261|616926040|FG000|Overall Study|Lost to Follow-up|2|||
170704201|NCT03277261|616926041|FG001|Overall Study|Lost to Follow-up|2|||
170704202|NCT03277261|616926040|FG000|Overall Study|Lack of Efficacy|2|||
170704203|NCT03277261|616926041|FG001|Overall Study|Lack of Efficacy|2|||
170704204|NCT03277261|616926040|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
170704205|NCT03277261|616926041|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
170704206|NCT00486265|616926042|FG000|Overall Study|Adverse Event|1|||
170704207|NCT00486265|616926042|FG000|Overall Study|Lack of Efficacy|8|||
170704208|NCT01256710|616926046|FG000|Overall Study|Death|449|||
170704209|NCT01256710|616926046|FG000|Overall Study|System Explant|67|||
170704210|NCT01256710|616926046|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
170704211|NCT01256710|616926046|FG000|Overall Study|Lost to Follow-up|67|||
170704212|NCT01256710|616926046|FG000|Overall Study|Withdrawal by Subject|29|||
170704213|NCT01256710|616926046|FG000|Overall Study|Physician Decision|9|||
170704214|NCT01256710|616926046|FG000|Overall Study|Subject Noncompliance|2|||
170704215|NCT01256710|616926046|FG000|Overall Study|Study Terminated by Sponsor|273|||
170704216|NCT00715793|616926047|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
170704217|NCT00715793|616926048|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
170826226|NCT00645099|617372297|FG000|Overall Study|Lost to Follow-up|6|||
170826227|NCT00645099|617372298|FG001|Overall Study|Lost to Follow-up|4|||
170704218|NCT00715793|616926047|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
170704219|NCT00715793|616926048|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
170704220|NCT00838565|616926051|FG000|Overall Study|Withdrawal by Subject|0|||
170704221|NCT00838565|616926052|FG001|Overall Study|Withdrawal by Subject|0|||
170704222|NCT00838565|616926053|FG002|Overall Study|Withdrawal by Subject|1|||
170704223|NCT00838565|616926054|FG003|Overall Study|Withdrawal by Subject|0|||
170826228|NCT00645099|617372297|FG000|Overall Study|Adverse Event|11|||
170826229|NCT00645099|617372298|FG001|Overall Study|Adverse Event|5|||
170826230|NCT00645099|617372297|FG000|Overall Study|Other|9|||
170826231|NCT00645099|617372298|FG001|Overall Study|Other|5|||
170826232|NCT01201915|617372299|FG000|Overall Study|Adverse Event|2|||
170826233|NCT01201915|617372300|FG001|Overall Study|Adverse Event|1|||
170826234|NCT01201915|617372301|FG002|Overall Study|Adverse Event|1|||
170704224|NCT00838565|616926055|FG004|Overall Study|Withdrawal by Subject|0|||
170704225|NCT00838565|616926056|FG005|Overall Study|Withdrawal by Subject|2|||
170704226|NCT00838565|616926051|FG000|Overall Study|Other|0|||
170704227|NCT00838565|616926052|FG001|Overall Study|Other|2|||
170704228|NCT00838565|616926053|FG002|Overall Study|Other|0|||
170704229|NCT00838565|616926054|FG003|Overall Study|Other|0|||
170704230|NCT00838565|616926055|FG004|Overall Study|Other|0|||
170704231|NCT00838565|616926056|FG005|Overall Study|Other|0|||
170704232|NCT00838565|616926051|FG000|Overall Study|Randomized but not Treated|0|||
170704233|NCT00838565|616926052|FG001|Overall Study|Randomized but not Treated|1|||
170704234|NCT00838565|616926053|FG002|Overall Study|Randomized but not Treated|0|||
170704235|NCT00838565|616926054|FG003|Overall Study|Randomized but not Treated|0|||
170704236|NCT00838565|616926055|FG004|Overall Study|Randomized but not Treated|0|||
170704237|NCT00838565|616926056|FG005|Overall Study|Randomized but not Treated|0|||
170704238|NCT01838642|616926057|FG000|Overall Study|Died on study|1|||
170704239|NCT01215227|616926058|FG000|Overall Study|Adverse Event|11|||
170704240|NCT01215227|616926059|FG001|Overall Study|Adverse Event|11|||
170704241|NCT01215227|616926060|FG002|Overall Study|Adverse Event|4|||
170704242|NCT01215227|616926061|FG003|Overall Study|Adverse Event|8|||
170704243|NCT01215227|616926062|FG004|Overall Study|Adverse Event|7|||
170704244|NCT01215227|616926063|FG005|Overall Study|Adverse Event|6|||
170704245|NCT01215227|616926058|FG000|Overall Study|Treatment Failure|8|||
170704246|NCT01215227|616926059|FG001|Overall Study|Treatment Failure|4|||
170704247|NCT01215227|616926060|FG002|Overall Study|Treatment Failure|1|||
170704248|NCT01215227|616926061|FG003|Overall Study|Treatment Failure|5|||
170704249|NCT01215227|616926062|FG004|Overall Study|Treatment Failure|1|||
170704250|NCT01215227|616926063|FG005|Overall Study|Treatment Failure|1|||
170704251|NCT01215227|616926058|FG000|Overall Study|Lost to Follow-up|1|||
170704252|NCT01215227|616926059|FG001|Overall Study|Lost to Follow-up|4|||
170704253|NCT01215227|616926060|FG002|Overall Study|Lost to Follow-up|1|||
170704254|NCT01215227|616926061|FG003|Overall Study|Lost to Follow-up|1|||
170704255|NCT01215227|616926062|FG004|Overall Study|Lost to Follow-up|1|||
170704256|NCT01215227|616926063|FG005|Overall Study|Lost to Follow-up|2|||
170704257|NCT01215227|616926058|FG000|Overall Study|Subject Withdrew Consent|16|||
170704258|NCT01215227|616926059|FG001|Overall Study|Subject Withdrew Consent|20|||
170704259|NCT01215227|616926060|FG002|Overall Study|Subject Withdrew Consent|7|||
170704260|NCT01215227|616926061|FG003|Overall Study|Subject Withdrew Consent|10|||
170704261|NCT01215227|616926062|FG004|Overall Study|Subject Withdrew Consent|11|||
170704262|NCT01215227|616926063|FG005|Overall Study|Subject Withdrew Consent|8|||
170704263|NCT01215227|616926058|FG000|Overall Study|Non-Compliance With Protocol|2|||
170704264|NCT01215227|616926059|FG001|Overall Study|Non-Compliance With Protocol|6|||
170704265|NCT01215227|616926060|FG002|Overall Study|Non-Compliance With Protocol|1|||
170704266|NCT01215227|616926061|FG003|Overall Study|Non-Compliance With Protocol|0|||
170704267|NCT01215227|616926062|FG004|Overall Study|Non-Compliance With Protocol|0|||
170704268|NCT01215227|616926063|FG005|Overall Study|Non-Compliance With Protocol|0|||
170704269|NCT01215227|616926058|FG000|Overall Study|Administrative|83|||
170704270|NCT01215227|616926059|FG001|Overall Study|Administrative|73|||
170704271|NCT01215227|616926060|FG002|Overall Study|Administrative|42|||
170704272|NCT01215227|616926061|FG003|Overall Study|Administrative|24|||
170704273|NCT01215227|616926062|FG004|Overall Study|Administrative|28|||
170704274|NCT01215227|616926063|FG005|Overall Study|Administrative|40|||
170704275|NCT01215227|616926058|FG000|Overall Study|Missing Status|0|||
170704276|NCT01215227|616926059|FG001|Overall Study|Missing Status|1|||
170704277|NCT01215227|616926060|FG002|Overall Study|Missing Status|0|||
170704278|NCT01215227|616926061|FG003|Overall Study|Missing Status|0|||
170704279|NCT01215227|616926062|FG004|Overall Study|Missing Status|0|||
170704280|NCT01215227|616926063|FG005|Overall Study|Missing Status|0|||
170704281|NCT01215227|616926058|FG000|Overall Study|Randomized but not treated|0|||
170704282|NCT01215227|616926059|FG001|Overall Study|Randomized but not treated|0|||
170704283|NCT01215227|616926060|FG002|Overall Study|Randomized but not treated|1|||
170704284|NCT01215227|616926061|FG003|Overall Study|Randomized but not treated|1|||
170704285|NCT01215227|616926062|FG004|Overall Study|Randomized but not treated|0|||
170704286|NCT01215227|616926063|FG005|Overall Study|Randomized but not treated|1|||
170826235|NCT01201915|617372299|FG000|Overall Study|Lost to Follow-up|0|||
170826236|NCT01201915|617372300|FG001|Overall Study|Lost to Follow-up|4|||
170826237|NCT01201915|617372301|FG002|Overall Study|Lost to Follow-up|0|||
170826238|NCT01201915|617372299|FG000|Overall Study|Physician Decision|3|||
170826239|NCT01201915|617372300|FG001|Overall Study|Physician Decision|0|||
170826240|NCT01201915|617372301|FG002|Overall Study|Physician Decision|0|||
170826241|NCT01201915|617372299|FG000|Overall Study|Subject Decision|3|||
170826242|NCT01201915|617372300|FG001|Overall Study|Subject Decision|3|||
170826243|NCT01201915|617372301|FG002|Overall Study|Subject Decision|5|||
170826244|NCT01201915|617372299|FG000|Overall Study|Target Lesion Progression|0|||
170826245|NCT01201915|617372300|FG001|Overall Study|Target Lesion Progression|3|||
170826246|NCT01201915|617372301|FG002|Overall Study|Target Lesion Progression|0|||
170826247|NCT00663923|617372302|FG000|Overall Study|Lost to Follow-up|2|||
170704287|NCT00213148|616926066|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
170704288|NCT00213148|616926067|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
170826248|NCT00230971|617372304|FG000|Randomization|No study drug administered|3|||
170704289|NCT00213148|616926068|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
170704290|NCT00213148|616926069|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
170704291|NCT00213148|616926070|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
170704292|NCT00213148|616926066|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
170704293|NCT00213148|616926067|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
170704294|NCT00213148|616926068|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
170704295|NCT00213148|616926069|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
170704296|NCT00213148|616926070|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
170704297|NCT00213148|616926066|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
170704298|NCT00213148|616926067|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
170704299|NCT00213148|616926068|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
170704300|NCT00213148|616926069|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
170704301|NCT00213148|616926070|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
170704302|NCT00213148|616926066|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
170704303|NCT00213148|616926067|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
170704304|NCT00213148|616926068|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
170704305|NCT00213148|616926069|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
170704306|NCT00213148|616926070|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
170704307|NCT00213148|616926066|FG000|Cycle 1 (1 Month)|Other|3|||
170704308|NCT00213148|616926067|FG001|Cycle 1 (1 Month)|Other|0|||
170704309|NCT00213148|616926068|FG002|Cycle 1 (1 Month)|Other|2|||
170704310|NCT00213148|616926069|FG003|Cycle 1 (1 Month)|Other|2|||
170704311|NCT00213148|616926070|FG004|Cycle 1 (1 Month)|Other|7|||
170704312|NCT00213148|616926066|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
170704313|NCT00213148|616926067|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
170704314|NCT00213148|616926068|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
170704315|NCT00213148|616926069|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
170704316|NCT00213148|616926070|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
170704317|NCT00213148|616926066|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
170704318|NCT00213148|616926067|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
170704319|NCT00213148|616926068|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
170704320|NCT00213148|616926069|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
170704321|NCT00213148|616926070|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
170704322|NCT00213148|616926066|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
170704323|NCT00213148|616926067|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
170704324|NCT00213148|616926068|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
170704325|NCT00213148|616926069|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
170704326|NCT00213148|616926070|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
170704327|NCT00213148|616926066|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
170704328|NCT00213148|616926067|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
170704329|NCT00213148|616926068|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
170704330|NCT00213148|616926069|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
170704331|NCT00213148|616926070|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
170704332|NCT00213148|616926066|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
170704333|NCT00213148|616926067|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
170704334|NCT00213148|616926068|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
170704335|NCT00213148|616926069|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
170704336|NCT00213148|616926070|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
170704337|NCT00213148|616926066|FG000|Cycle 2 (1 Month)|Other|2|||
170704338|NCT00213148|616926067|FG001|Cycle 2 (1 Month)|Other|1|||
170704339|NCT00213148|616926068|FG002|Cycle 2 (1 Month)|Other|2|||
170704340|NCT00213148|616926069|FG003|Cycle 2 (1 Month)|Other|8|||
170704341|NCT00213148|616926070|FG004|Cycle 2 (1 Month)|Other|7|||
170704342|NCT00213148|616926066|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
170704343|NCT00213148|616926067|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
170704344|NCT00213148|616926068|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
170704345|NCT00213148|616926069|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
170704346|NCT00213148|616926070|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
170704347|NCT00213148|616926066|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
170704348|NCT00213148|616926067|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
170704349|NCT00213148|616926068|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
170704350|NCT00213148|616926069|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
170704351|NCT00213148|616926070|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
170704352|NCT00213148|616926066|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
170704353|NCT00213148|616926067|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
170704354|NCT00213148|616926068|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
170704355|NCT00213148|616926069|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
170704356|NCT00213148|616926070|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
170704357|NCT00213148|616926066|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
170704358|NCT00213148|616926067|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
170704359|NCT00213148|616926068|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
170704360|NCT00213148|616926069|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
170704361|NCT00213148|616926070|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
170704362|NCT00213148|616926066|FG000|Cycle 3 (1 Month)|Other|0|||
170704363|NCT00213148|616926067|FG001|Cycle 3 (1 Month)|Other|0|||
170704364|NCT00213148|616926068|FG002|Cycle 3 (1 Month)|Other|1|||
170704365|NCT00213148|616926069|FG003|Cycle 3 (1 Month)|Other|1|||
170704366|NCT00213148|616926070|FG004|Cycle 3 (1 Month)|Other|0|||
170704367|NCT02448875|616926071|FG000|Overall Study|Adverse Event|2|||
170704368|NCT02448875|616926072|FG001|Overall Study|Adverse Event|1|||
170704369|NCT02448875|616926073|FG002|Overall Study|Adverse Event|0|||
170704370|NCT02448875|616926071|FG000|Overall Study|Lost to Follow-up|1|||
170704371|NCT02448875|616926072|FG001|Overall Study|Lost to Follow-up|0|||
170704372|NCT02448875|616926073|FG002|Overall Study|Lost to Follow-up|0|||
170704373|NCT02448875|616926071|FG000|Overall Study|Investigator Decision|3|||
170704374|NCT02448875|616926072|FG001|Overall Study|Investigator Decision|0|||
170704375|NCT02448875|616926073|FG002|Overall Study|Investigator Decision|1|||
170704376|NCT02448875|616926071|FG000|Overall Study|Withdrawal by Subject|1|||
170704377|NCT02448875|616926072|FG001|Overall Study|Withdrawal by Subject|0|||
170704378|NCT02448875|616926073|FG002|Overall Study|Withdrawal by Subject|0|||
170704379|NCT01282424|616926076|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
170704380|NCT01282424|616926076|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
170704381|NCT01282424|616926076|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
170704382|NCT01282424|616926076|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
170704383|NCT01282424|616926076|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
170704384|NCT01282424|616926076|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
170704385|NCT01282424|616926076|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
170704386|NCT01282424|616926076|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
170704387|NCT02741115|616926077|FG000|Overall Study|Adverse Event|1|||
170704388|NCT02741115|616926078|FG001|Overall Study|Adverse Event|0|||
170704389|NCT02741115|616926077|FG000|Overall Study|Lost to Follow-up|7|||
170704390|NCT02741115|616926078|FG001|Overall Study|Lost to Follow-up|4|||
170704391|NCT02741115|616926077|FG000|Overall Study|Withdrawal by Subject|4|||
170704392|NCT02741115|616926078|FG001|Overall Study|Withdrawal by Subject|2|||
170704393|NCT06425458|616926079|FG000|Overall Study|Removed by study team|2|||
170704394|NCT06425458|616926079|FG000|Overall Study|Lost to Follow-up|5|||
170704395|NCT03945981|616926080|FG000|Overall Study|Lost to Follow-up|12|||
170704396|NCT03945981|616926080|FG000|Overall Study|Physician Decision|4|||
170704397|NCT03945981|616926080|FG000|Overall Study|Withdrawal by Subject|6|||
170704398|NCT03945981|616926080|FG000|Overall Study|Protocol Violation|1|||
170704399|NCT00256698|616926081|FG000|Overall Study|Withdrawal by Subject|7|||
170704400|NCT00256698|616926082|FG001|Overall Study|Withdrawal by Subject|7|||
170704401|NCT00256698|616926081|FG000|Overall Study|Adverse Event|13|||
170704402|NCT00256698|616926082|FG001|Overall Study|Adverse Event|6|||
170704403|NCT00256698|616926081|FG000|Overall Study|Protocol Violation|6|||
170704404|NCT00256698|616926082|FG001|Overall Study|Protocol Violation|5|||
170704405|NCT00256698|616926081|FG000|Overall Study|Lost to Follow-up|1|||
170704406|NCT00256698|616926082|FG001|Overall Study|Lost to Follow-up|3|||
170704407|NCT00256698|616926081|FG000|Overall Study|disease progression|97|||
170704408|NCT00256698|616926082|FG001|Overall Study|disease progression|105|||
170704409|NCT00256698|616926081|FG000|Overall Study|still ongoing at data cut-off|41|||
170704410|NCT00256698|616926082|FG001|Overall Study|still ongoing at data cut-off|46|||
170826249|NCT00230971|617372305|FG001|Randomization|No study drug administered|3|||
170826250|NCT00230971|617372304|FG000|Baseline Participants|Lost to Follow-up|5|||
170826251|NCT00230971|617372305|FG001|Baseline Participants|Lost to Follow-up|12|||
170826252|NCT00230971|617372304|FG000|Baseline Participants|Death|6|||
170826253|NCT00230971|617372305|FG001|Baseline Participants|Death|5|||
170826254|NCT00230971|617372304|FG000|Baseline Participants|Withdrawal by Subject|7|||
170826255|NCT00230971|617372305|FG001|Baseline Participants|Withdrawal by Subject|1|||
170826256|NCT00230971|617372304|FG000|Baseline Participants|Adverse Event|1|||
170826257|NCT00230971|617372305|FG001|Baseline Participants|Adverse Event|0|||
170826258|NCT00230971|617372304|FG000|Baseline Participants|No bacteria observed|1|||
170826259|NCT00230971|617372305|FG001|Baseline Participants|No bacteria observed|0|||
170826260|NCT00230971|617372304|FG000|Baseline Participants|Failure to return|1|||
170826261|NCT00230971|617372305|FG001|Baseline Participants|Failure to return|1|||
170826262|NCT00230971|617372304|FG000|Baseline Participants|Reintervention|1|||
170826263|NCT00230971|617372305|FG001|Baseline Participants|Reintervention|0|||
170826264|NCT01932762|617374291|FG000|Overall Study|Withdrawal by Subject|1|||
170826265|NCT01932762|617374292|FG001|Overall Study|Withdrawal by Subject|2|||
170826266|NCT01932762|617374293|FG002|Overall Study|Withdrawal by Subject|0|||
170826267|NCT01932762|617374294|FG003|Overall Study|Withdrawal by Subject|0|||
170826268|NCT01932762|617374291|FG000|Overall Study|Lost to Follow-up|4|||
170826269|NCT01932762|617374292|FG001|Overall Study|Lost to Follow-up|0|||
170826270|NCT01932762|617374293|FG002|Overall Study|Lost to Follow-up|0|||
170826271|NCT01932762|617374294|FG003|Overall Study|Lost to Follow-up|1|||
170826272|NCT01932762|617374291|FG000|Overall Study|Physician Decision|1|||
170704411|NCT00256698|616926081|FG000|Overall Study|withdrawn due to osteoporosis|1|||
170704412|NCT00256698|616926082|FG001|Overall Study|withdrawn due to osteoporosis|0|||
170704413|NCT00256698|616926081|FG000|Overall Study|Prematurely Discontinued|1|||
170704414|NCT00256698|616926082|FG001|Overall Study|Prematurely Discontinued|0|||
170704415|NCT03962543|616926085|FG000|Treatment Phase|Death|0|||
170704416|NCT03962543|616926086|FG001|Treatment Phase|Death|1|||
170704417|NCT03962543|616926085|FG000|Treatment Phase|Withdrawal by Subject|3|||
170704418|NCT03962543|616926086|FG001|Treatment Phase|Withdrawal by Subject|0|||
170704419|NCT03962543|616926085|FG000|Treatment Phase|Adverse Event|3|||
170704420|NCT03962543|616926086|FG001|Treatment Phase|Adverse Event|12|||
170704421|NCT03962543|616926085|FG000|Treatment Phase|Lost to Follow-up|1|||
170704422|NCT03962543|616926086|FG001|Treatment Phase|Lost to Follow-up|2|||
170704423|NCT03962543|616926085|FG000|Treatment Phase|Radiographic PD|9|||
170704424|NCT03962543|616926086|FG001|Treatment Phase|Radiographic PD|3|||
170704425|NCT03962543|616926085|FG000|Treatment Phase|Participant Decision|3|||
170704426|NCT03962543|616926086|FG001|Treatment Phase|Participant Decision|8|||
170704427|NCT03962543|616926085|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
170704428|NCT03962543|616926086|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
170704429|NCT03962543|616926085|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
170704430|NCT03962543|616926086|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
170704431|NCT03962543|616926085|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
170704432|NCT03962543|616926086|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
170704433|NCT03962543|616926085|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
170704434|NCT03962543|616926086|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
170704435|NCT03962543|616926085|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
170704436|NCT03962543|616926086|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
170704437|NCT03962543|616926085|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
170704438|NCT03962543|616926086|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
170704439|NCT03962543|616926085|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
170704440|NCT03962543|616926086|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
170704441|NCT03962543|616926085|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
170704442|NCT03962543|616926086|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
170704443|NCT03962543|616926085|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
170704444|NCT03962543|616926086|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
170704445|NCT03962543|616926085|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
170704446|NCT03962543|616926086|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
170704447|NCT03316872|616926087|FG000|Overall Study|Death|1|||
170704448|NCT02777125|616926088|FG000|Overall Study|Consent form violation|14|||
170704449|NCT02777125|616926089|FG001|Overall Study|Consent form violation|12|||
170704450|NCT02777125|616926088|FG000|Overall Study|Assent form violation|21|||
170704451|NCT02777125|616926089|FG001|Overall Study|Assent form violation|23|||
170704452|NCT02777125|616926088|FG000|Overall Study|Protocol Violation|8|||
170704453|NCT02777125|616926089|FG001|Overall Study|Protocol Violation|12|||
170704454|NCT01038778|616926090|FG000|Overall Study|Withdrawal by Subject|0|||
170704455|NCT01038778|616926091|FG001|Overall Study|Withdrawal by Subject|2|||
170704456|NCT01038778|616926092|FG002|Overall Study|Withdrawal by Subject|3|||
170704457|NCT02742103|616927581|FG000|Overall Study|Protocol Violation|1|||
170704458|NCT02742103|616927582|FG001|Overall Study|Protocol Violation|0|||
170704459|NCT02742103|616927581|FG000|Overall Study|Death|2|||
170704460|NCT02742103|616927582|FG001|Overall Study|Death|2|||
170704461|NCT02742103|616927581|FG000|Overall Study|Adverse Event|1|||
170704462|NCT02742103|616927582|FG001|Overall Study|Adverse Event|0|||
170704463|NCT02742103|616927581|FG000|Overall Study|Moved to another town|0|||
170704464|NCT02742103|616927582|FG001|Overall Study|Moved to another town|1|||
170704465|NCT02742103|616927581|FG000|Overall Study|Withdrawal by Subject|5|||
170704466|NCT02742103|616927582|FG001|Overall Study|Withdrawal by Subject|2|||
170704467|NCT04346615|616927585|FG000|Overall Study|Lost to Follow-up|0|||
170826273|NCT01932762|617374292|FG001|Overall Study|Physician Decision|0|||
170826274|NCT01932762|617374293|FG002|Overall Study|Physician Decision|0|||
170826275|NCT01932762|617374294|FG003|Overall Study|Physician Decision|0|||
170826276|NCT00863798|617374295|FG000|Overall Study|Adverse Event|5|||
170826277|NCT00863798|617374296|FG001|Overall Study|Adverse Event|2|||
170826278|NCT00863798|617374297|FG002|Overall Study|Adverse Event|4|||
170826279|NCT00863798|617374295|FG000|Overall Study|Participant failed to return|2|||
170826280|NCT00863798|617374296|FG001|Overall Study|Participant failed to return|1|||
170826281|NCT00863798|617374297|FG002|Overall Study|Participant failed to return|0|||
170826282|NCT00863798|617374295|FG000|Overall Study|Investigator request|1|||
170826283|NCT00863798|617374296|FG001|Overall Study|Investigator request|2|||
170826284|NCT00863798|617374297|FG002|Overall Study|Investigator request|1|||
170704468|NCT04346615|616927586|FG001|Overall Study|Lost to Follow-up|2|||
170704469|NCT04346615|616927585|FG000|Overall Study|Withdrawal by Subject|1|||
170704470|NCT04346615|616927586|FG001|Overall Study|Withdrawal by Subject|0|||
170704471|NCT04346615|616927585|FG000|Overall Study|Death|5|||
170704472|NCT04346615|616927586|FG001|Overall Study|Death|1|||
170704473|NCT04346615|616927585|FG000|Overall Study|Other|0|||
170704474|NCT04346615|616927586|FG001|Overall Study|Other|2|||
170704475|NCT04346615|616927585|FG000|Overall Study|Randomized not treated|1|||
170704476|NCT04346615|616927586|FG001|Overall Study|Randomized not treated|0|||
170704477|NCT00533949|616927589|FG000|Overall Study|Protocol Violation|12|||
170704478|NCT00533949|616927590|FG001|Overall Study|Protocol Violation|12|||
170704479|NCT00533949|616927591|FG002|Overall Study|Protocol Violation|9|||
170704480|NCT00533949|616927592|FG003|Overall Study|Protocol Violation|9|||
170704481|NCT00533949|616927589|FG000|Overall Study|Withdrawal by Subject|3|||
170704482|NCT00533949|616927590|FG001|Overall Study|Withdrawal by Subject|2|||
170704483|NCT00533949|616927591|FG002|Overall Study|Withdrawal by Subject|1|||
170704484|NCT00533949|616927592|FG003|Overall Study|Withdrawal by Subject|1|||
170704485|NCT00727194|616927593|FG000|Screening Period|Low QMG scores|0|||
170704486|NCT00727194|616927594|FG001|Screening Period|Low QMG scores|0|||
170704487|NCT00727194|616927595|FG002|Screening Period|Low QMG scores|6|||
170704488|NCT00727194|616927593|FG000|Screening Period|Lacked AChR antibodies|0|||
170704489|NCT00727194|616927594|FG001|Screening Period|Lacked AChR antibodies|0|||
170704490|NCT00727194|616927595|FG002|Screening Period|Lacked AChR antibodies|5|||
170704491|NCT00727194|616927593|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
170704492|NCT00727194|616927594|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
170704493|NCT00727194|616927595|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
170704494|NCT00727194|616927593|FG000|Screening Period|Severe infections|0|||
170704495|NCT00727194|616927594|FG001|Screening Period|Severe infections|0|||
170704496|NCT00727194|616927595|FG002|Screening Period|Severe infections|2|||
170704497|NCT00727194|616927593|FG000|Screening Period|History of thymoma|0|||
170704498|NCT00727194|616927594|FG001|Screening Period|History of thymoma|0|||
170704499|NCT00727194|616927595|FG002|Screening Period|History of thymoma|1|||
170704500|NCT00727194|616927593|FG000|Treatment Period 2|Lack of Efficacy|0|||
170704501|NCT00727194|616927594|FG001|Treatment Period 2|Lack of Efficacy|1|||
170704502|NCT00727194|616927595|FG002|Treatment Period 2|Lack of Efficacy|0|||
170704503|NCT02349711|616927596|FG000|Overall Study|Withdrawal by Subject|2|||
170704504|NCT02349711|616927597|FG001|Overall Study|Withdrawal by Subject|1|||
170704505|NCT02349711|616927596|FG000|Overall Study|Lost to Follow-up|1|||
170704506|NCT02349711|616927597|FG001|Overall Study|Lost to Follow-up|1|||
170704507|NCT04368429|616927602|FG000|Overall Study|Adverse Event|1|||
170704508|NCT04368429|616927603|FG001|Overall Study|Adverse Event|0|||
170704509|NCT03633396|616927606|FG000|Overall Study|Withdrawal by Subject|4|||
170704510|NCT03633396|616927607|FG001|Overall Study|Withdrawal by Subject|4|||
170704511|NCT03633396|616927606|FG000|Overall Study|Adverse Event|1|||
170704512|NCT03633396|616927607|FG001|Overall Study|Adverse Event|1|||
170704513|NCT03633396|616927606|FG000|Overall Study|Lack of Efficacy|1|||
170704514|NCT03633396|616927607|FG001|Overall Study|Lack of Efficacy|0|||
170704515|NCT03633396|616927606|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
170704516|NCT03633396|616927607|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
170704517|NCT00667342|616927608|FG000|Overall Study|Protocol Violation|1|||
170704518|NCT00667342|616927609|FG001|Overall Study|Protocol Violation|0|||
170704519|NCT00667342|616927610|FG002|Overall Study|Protocol Violation|0|||
170704520|NCT00667342|616927608|FG000|Overall Study|Withdrawal by Subject|1|||
170704521|NCT00667342|616927609|FG001|Overall Study|Withdrawal by Subject|0|||
170704522|NCT00667342|616927610|FG002|Overall Study|Withdrawal by Subject|0|||
170704523|NCT00667342|616927608|FG000|Overall Study|Physician Decision|3|||
170704524|NCT00667342|616927609|FG001|Overall Study|Physician Decision|0|||
170704525|NCT00667342|616927610|FG002|Overall Study|Physician Decision|0|||
170704526|NCT00667342|616927608|FG000|Overall Study|Relapse or tumor progression|9|||
170704527|NCT00667342|616927609|FG001|Overall Study|Relapse or tumor progression|0|||
170704528|NCT00667342|616927610|FG002|Overall Study|Relapse or tumor progression|7|||
170704529|NCT00667342|616927608|FG000|Overall Study|Adverse Event|0|||
170704530|NCT00667342|616927609|FG001|Overall Study|Adverse Event|0|||
170704531|NCT00667342|616927610|FG002|Overall Study|Adverse Event|1|||
170704532|NCT00667342|616927608|FG000|Overall Study|Ineligible|0|||
170704533|NCT00667342|616927609|FG001|Overall Study|Ineligible|0|||
170704534|NCT00667342|616927610|FG002|Overall Study|Ineligible|1|||
170704535|NCT01433263|616927611|FG000|Overall Study|Adverse Event|3|||
170704536|NCT01433263|616927612|FG001|Overall Study|Adverse Event|1|||
170704537|NCT01433263|616927611|FG000|Overall Study|Death|5|||
170704538|NCT01433263|616927612|FG001|Overall Study|Death|3|||
170704539|NCT01433263|616927611|FG000|Overall Study|Lost to Follow-up|0|||
170704540|NCT01433263|616927612|FG001|Overall Study|Lost to Follow-up|1|||
170704541|NCT01433263|616927611|FG000|Overall Study|Protocol Deviation|1|||
170704542|NCT01433263|616927612|FG001|Overall Study|Protocol Deviation|0|||
170704543|NCT01433263|616927611|FG000|Overall Study|Withdrawal by Subject|10|||
170704544|NCT01433263|616927612|FG001|Overall Study|Withdrawal by Subject|7|||
170704545|NCT02649972|616927617|FG000|Overall Study|Not treated|1|||
170704546|NCT00326612|616927618|FG000|Overall Study|They did not have a seizure requiring tx|129|||
170704547|NCT00326612|616927619|FG001|Overall Study|They did not have a seizure requiring tx|137|||
170704548|NCT00326911|616927624|FG000|Overall Study|Hospitalization prior to treatment|0|||
170704549|NCT00326911|616927625|FG001|Overall Study|Hospitalization prior to treatment|1|||
170704550|NCT00326911|616927624|FG000|Overall Study|Physician decision prior to treatment|1|||
170704551|NCT00326911|616927625|FG001|Overall Study|Physician decision prior to treatment|0|||
170704552|NCT00326911|616927624|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
170704553|NCT00326911|616927625|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
170704554|NCT00546715|616927626|FG000|Overall Study|Withdrawal by Subject|0|||
170704555|NCT00546715|616927627|FG001|Overall Study|Withdrawal by Subject|1|||
170704556|NCT00546715|616927628|FG002|Overall Study|Withdrawal by Subject|0|||
170704557|NCT00546715|616927629|FG003|Overall Study|Withdrawal by Subject|0|||
170704558|NCT00418691|616927630|FG000|Overall Study|Lost to Follow-up|1|||
170704559|NCT00418691|616927631|FG001|Overall Study|Lost to Follow-up|2|||
170704560|NCT00418691|616927632|FG002|Overall Study|Lost to Follow-up|3|||
170704561|NCT00418691|616927630|FG000|Overall Study|Started new medication voiding entry|0|||
170704562|NCT00418691|616927631|FG001|Overall Study|Started new medication voiding entry|0|||
170704563|NCT00418691|616927632|FG002|Overall Study|Started new medication voiding entry|1|||
170704564|NCT00418691|616927630|FG000|Overall Study|Progressive Disease|1|||
170704565|NCT00418691|616927631|FG001|Overall Study|Progressive Disease|0|||
170704566|NCT00418691|616927632|FG002|Overall Study|Progressive Disease|1|||
170704567|NCT02477020|616927637|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
170704568|NCT02477020|616927638|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
170704569|NCT02477020|616927637|FG000|Overall Study|Voluntary Withdrawal|7|||
170704570|NCT02477020|616927638|FG001|Overall Study|Voluntary Withdrawal|16|||
170704571|NCT02477020|616927637|FG000|Overall Study|Reason not Specified|3|||
170704572|NCT02477020|616927638|FG001|Overall Study|Reason not Specified|1|||
170704573|NCT02477020|616927637|FG000|Overall Study|Lack of Efficacy|14|||
170704574|NCT02477020|616927638|FG001|Overall Study|Lack of Efficacy|5|||
170704575|NCT01802775|616927640|FG000|Overall Study|Death|0|||
170704576|NCT01802775|616927641|FG001|Overall Study|Death|3|||
170704577|NCT01802775|616927640|FG000|Overall Study|Reason not provided|0|||
170704578|NCT01802775|616927641|FG001|Overall Study|Reason not provided|1|||
170704579|NCT01802775|616927640|FG000|Overall Study|Physician Decision|1|||
170704580|NCT01802775|616927641|FG001|Overall Study|Physician Decision|0|||
170704581|NCT01802775|616927640|FG000|Overall Study|Adverse Event|1|||
170704582|NCT01802775|616927641|FG001|Overall Study|Adverse Event|1|||
170704583|NCT01802775|616927640|FG000|Overall Study|Withdrawal by Subject|3|||
170704584|NCT01802775|616927641|FG001|Overall Study|Withdrawal by Subject|5|||
170704585|NCT01802775|616927640|FG000|Overall Study|Lost to Follow-up|1|||
170704586|NCT01802775|616927641|FG001|Overall Study|Lost to Follow-up|2|||
170704587|NCT00501540|616927642|FG000|Overall Study|Death|5|||
170704588|NCT01465802|616927643|FG000|Overall Study|Study terminated by sponsor|1|||
170704589|NCT01465802|616927644|FG001|Overall Study|Study terminated by sponsor|0|||
170704590|NCT01465802|616927645|FG002|Overall Study|Study terminated by sponsor|0|||
170704591|NCT01465802|616927646|FG003|Overall Study|Study terminated by sponsor|1|||
170704592|NCT01465802|616927647|FG004|Overall Study|Study terminated by sponsor|7|||
170704593|NCT01465802|616927643|FG000|Overall Study|Withdrawal by Subject|7|||
170704594|NCT01465802|616927644|FG001|Overall Study|Withdrawal by Subject|7|||
170704595|NCT01465802|616927645|FG002|Overall Study|Withdrawal by Subject|0|||
170704596|NCT01465802|616927646|FG003|Overall Study|Withdrawal by Subject|8|||
170704597|NCT01465802|616927647|FG004|Overall Study|Withdrawal by Subject|1|||
170704598|NCT01465802|616927643|FG000|Overall Study|Lost to Follow-up|1|||
170704599|NCT01465802|616927644|FG001|Overall Study|Lost to Follow-up|1|||
170704600|NCT01465802|616927645|FG002|Overall Study|Lost to Follow-up|0|||
170704601|NCT01465802|616927646|FG003|Overall Study|Lost to Follow-up|0|||
170704602|NCT01465802|616927647|FG004|Overall Study|Lost to Follow-up|0|||
170704603|NCT01465802|616927643|FG000|Overall Study|Reason not specified|9|||
170704604|NCT01465802|616927644|FG001|Overall Study|Reason not specified|4|||
170704605|NCT01465802|616927645|FG002|Overall Study|Reason not specified|0|||
170704606|NCT01465802|616927646|FG003|Overall Study|Reason not specified|10|||
170704607|NCT01465802|616927647|FG004|Overall Study|Reason not specified|2|||
170704608|NCT01465802|616927643|FG000|Overall Study|Death|15|||
170704609|NCT01465802|616927644|FG001|Overall Study|Death|12|||
170704610|NCT01465802|616927645|FG002|Overall Study|Death|0|||
170704611|NCT01465802|616927646|FG003|Overall Study|Death|10|||
170704612|NCT01465802|616927647|FG004|Overall Study|Death|2|||
170704613|NCT02331446|616927648|FG000|Overall Study|Lost to Follow-up|2|||
170704614|NCT02331446|616927649|FG001|Overall Study|Lost to Follow-up|1|||
170704615|NCT02331446|616927650|FG002|Overall Study|Lost to Follow-up|0|||
170704616|NCT02331446|616927651|FG003|Overall Study|Lost to Follow-up|1|||
170704617|NCT02331446|616927648|FG000|Overall Study|Personal Problem|2|||
170704618|NCT02331446|616927649|FG001|Overall Study|Personal Problem|0|||
170704619|NCT02331446|616927650|FG002|Overall Study|Personal Problem|0|||
170704620|NCT02331446|616927651|FG003|Overall Study|Personal Problem|0|||
170704621|NCT02331446|616927648|FG000|Overall Study|Disease|0|||
170704622|NCT02331446|616927649|FG001|Overall Study|Disease|2|||
170704623|NCT02331446|616927650|FG002|Overall Study|Disease|2|||
170704624|NCT02331446|616927651|FG003|Overall Study|Disease|1|||
170704625|NCT02331446|616927648|FG000|Overall Study|Physician Decision|0|||
170704626|NCT02331446|616927649|FG001|Overall Study|Physician Decision|1|||
170704627|NCT02331446|616927650|FG002|Overall Study|Physician Decision|0|||
170704628|NCT02331446|616927651|FG003|Overall Study|Physician Decision|1|||
170704629|NCT02331446|616927648|FG000|Overall Study|Lost before baseline analysis|0|||
170704630|NCT02331446|616927649|FG001|Overall Study|Lost before baseline analysis|1|||
170826285|NCT00863798|617374295|FG000|Overall Study|Lack of Efficacy|4|||
170826286|NCT00863798|617374296|FG001|Overall Study|Lack of Efficacy|3|||
170826287|NCT00863798|617374297|FG002|Overall Study|Lack of Efficacy|6|||
170826288|NCT00863798|617374295|FG000|Overall Study|Lost to Follow-up|6|||
170826289|NCT00863798|617374296|FG001|Overall Study|Lost to Follow-up|9|||
170826290|NCT00863798|617374297|FG002|Overall Study|Lost to Follow-up|5|||
170826291|NCT00863798|617374295|FG000|Overall Study|Other|2|||
170826292|NCT00863798|617374296|FG001|Overall Study|Other|3|||
170826293|NCT00863798|617374297|FG002|Overall Study|Other|1|||
170826294|NCT00863798|617374295|FG000|Overall Study|Protocol Violation|0|||
170826295|NCT00863798|617374296|FG001|Overall Study|Protocol Violation|1|||
170826296|NCT00863798|617374297|FG002|Overall Study|Protocol Violation|1|||
170826297|NCT00863798|617374295|FG000|Overall Study|Withdrawal by Subject|8|||
170826298|NCT00863798|617374296|FG001|Overall Study|Withdrawal by Subject|7|||
170826299|NCT00863798|617374297|FG002|Overall Study|Withdrawal by Subject|4|||
170826300|NCT00863798|617374295|FG000|Overall Study|Randomized not treated|4|||
170826301|NCT00863798|617374296|FG001|Overall Study|Randomized not treated|2|||
170826302|NCT00863798|617374297|FG002|Overall Study|Randomized not treated|3|||
170826303|NCT04238520|617374298|FG000|Overall Study|Withdrawal by Subject|1|||
170826304|NCT04238520|617374299|FG001|Overall Study|Withdrawal by Subject|1|||
170826305|NCT04238520|617374298|FG000|Overall Study|Lost to Follow-up|1|||
170826306|NCT04238520|617374299|FG001|Overall Study|Lost to Follow-up|2|||
170826307|NCT04238520|617374298|FG000|Overall Study|Death|0|||
170826308|NCT04238520|617374299|FG001|Overall Study|Death|2|||
170826309|NCT04238520|617374298|FG000|Overall Study|Unsafe home environment for research staff|0|||
170826310|NCT04238520|617374299|FG001|Overall Study|Unsafe home environment for research staff|1|||
170826311|NCT01470599|617374300|FG000|Overall Study|Did not meet entrance criteria|1|||
170826312|NCT01470599|617374301|FG001|Overall Study|Did not meet entrance criteria|0|||
170826313|NCT01470599|617374300|FG000|Overall Study|Lost to Follow-up|2|||
170826314|NCT01470599|617374301|FG001|Overall Study|Lost to Follow-up|1|||
170826315|NCT01470599|617374300|FG000|Overall Study|Withdrawal by Subject|3|||
170826316|NCT01470599|617374301|FG001|Overall Study|Withdrawal by Subject|4|||
170826317|NCT01470599|617374300|FG000|Overall Study|Other|1|||
170826318|NCT01470599|617374301|FG001|Overall Study|Other|0|||
170826319|NCT01470599|617374300|FG000|Overall Study|Protocol Violation|3|||
170826320|NCT01470599|617374301|FG001|Overall Study|Protocol Violation|1|||
170826321|NCT01470599|617374300|FG000|Overall Study|Adverse event related to study drug|2|||
170826322|NCT01470599|617374301|FG001|Overall Study|Adverse event related to study drug|5|||
170826323|NCT01470599|617374300|FG000|Overall Study|Insufficient clinical response|6|||
170826324|NCT01470599|617374301|FG001|Overall Study|Insufficient clinical response|27|||
170826325|NCT01470599|617374300|FG000|Overall Study|Adverse event not related to study drug|1|||
170826326|NCT01470599|617374301|FG001|Overall Study|Adverse event not related to study drug|5|||
170826327|NCT01917006|617374302|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
170826328|NCT01917006|617374303|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
170826329|NCT01917006|617374304|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
170826330|NCT01917006|617374305|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
170826331|NCT01917006|617374306|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
170826332|NCT01917006|617374307|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
170826333|NCT01917006|617374308|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
170826334|NCT01917006|617374309|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
170826335|NCT01917006|617374302|FG000|Randomized-treatment Period|Personal Reasons|0|||
170826336|NCT01917006|617374303|FG001|Randomized-treatment Period|Personal Reasons|0|||
170704631|NCT02331446|616927650|FG002|Overall Study|Lost before baseline analysis|1|||
170704632|NCT02331446|616927651|FG003|Overall Study|Lost before baseline analysis|0|||
170704633|NCT04879745|616927652|FG000|Overall Study|Lost to Follow-up|4|||
170704634|NCT04879745|616927653|FG001|Overall Study|Lost to Follow-up|1|||
170704635|NCT00120042|616927654|FG000|Overall Study|all completed protocl|0|||
170704636|NCT00120042|616927655|FG001|Overall Study|all completed protocl|0|||
170704637|NCT00120042|616927656|FG002|Overall Study|all completed protocl|0|||
170704638|NCT00529386|616927659|FG000|Overall Study|Lost to Follow-up|1|||
170704639|NCT04532112|616927660|FG000|Overall Study|Adverse Event|3|||
170704640|NCT04532112|616927661|FG001|Overall Study|Adverse Event|0|||
170826337|NCT01917006|617374304|FG002|Randomized-treatment Period|Personal Reasons|0|||
170704641|NCT03592641|616927662|FG000|Overall Study|Withdrawal by Subject|1|||
170704642|NCT01067352|616927663|FG000|Overall Study|Withdrawal by Subject|1|||
170826338|NCT01917006|617374305|FG003|Randomized-treatment Period|Personal Reasons|0|||
170826339|NCT01917006|617374306|FG004|Randomized-treatment Period|Personal Reasons|0|||
170826340|NCT01917006|617374307|FG005|Randomized-treatment Period|Personal Reasons|1|||
170826341|NCT01917006|617374308|FG006|Randomized-treatment Period|Personal Reasons|0|||
170826342|NCT01917006|617374309|FG007|Randomized-treatment Period|Personal Reasons|0|||
170704643|NCT01067352|616927664|FG001|Overall Study|Withdrawal by Subject|2|||
170704644|NCT01067352|616927665|FG002|Overall Study|Withdrawal by Subject|1|||
170704645|NCT01067352|616927663|FG000|Overall Study|Physician Decision|0|||
170704646|NCT01067352|616927664|FG001|Overall Study|Physician Decision|1|||
170704647|NCT01067352|616927665|FG002|Overall Study|Physician Decision|0|||
170704648|NCT01049919|616927667|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
170704649|NCT01049919|616927668|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
170704650|NCT01049919|616927667|FG000|Overall Study|Withdrawal by Subject|5|||
170704651|NCT01049919|616927668|FG001|Overall Study|Withdrawal by Subject|0|||
170704652|NCT01049919|616927667|FG000|Overall Study|Lost to Follow-up|6|||
170704653|NCT01049919|616927668|FG001|Overall Study|Lost to Follow-up|1|||
170704654|NCT01049919|616927667|FG000|Overall Study|Physician Decision|2|||
170704655|NCT01049919|616927668|FG001|Overall Study|Physician Decision|0|||
170704656|NCT01049919|616927667|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
170704657|NCT01049919|616927668|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
170704658|NCT01049919|616927667|FG000|Overall Study|Early study termination by sponsor.|2|||
170704659|NCT01049919|616927668|FG001|Overall Study|Early study termination by sponsor.|0|||
170704660|NCT03491150|616927669|FG000|Overall Study|Adverse Event|1|||
170704661|NCT03491150|616927670|FG001|Overall Study|Adverse Event|0|||
170704662|NCT03491150|616927669|FG000|Overall Study|Study Terminated by Sponsor|74|||
170704663|NCT03491150|616927670|FG001|Overall Study|Study Terminated by Sponsor|70|||
170704664|NCT03491150|616927669|FG000|Overall Study|Other|0|||
170704665|NCT03491150|616927670|FG001|Overall Study|Other|1|||
170704666|NCT03491150|616927669|FG000|Overall Study|Withdrawal by Subject|1|||
170704667|NCT03491150|616927670|FG001|Overall Study|Withdrawal by Subject|2|||
170704668|NCT00937547|616927672|FG000|Overall Study|misdiagnosis|1|||
170704669|NCT00937547|616927673|FG001|Overall Study|misdiagnosis|6|||
170704670|NCT00937547|616927674|FG002|Overall Study|misdiagnosis|7|||
170704671|NCT04439240|616927675|FG000|Overall Study|Ineligible|2|||
170704672|NCT04439240|616927675|FG000|Overall Study|Never started treatment|2|||
170704673|NCT04439240|616927675|FG000|Overall Study|Adverse Event|12|||
170704674|NCT04439240|616927675|FG000|Overall Study|Death|2|||
170704675|NCT04439240|616927675|FG000|Overall Study|Disease progression|25|||
170704676|NCT04439240|616927675|FG000|Overall Study|Other diseases|2|||
170704677|NCT04439240|616927675|FG000|Overall Study|Withdrawal by Subject|3|||
170704678|NCT04439240|616927675|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
170704679|NCT04439240|616927675|FG000|Overall Study|Symptomatic decline|1|||
170704680|NCT04439240|616927675|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
170704681|NCT04439240|616927675|FG000|Overall Study|Clinical progression|1|||
170704682|NCT02287896|616927677|FG000|Second Injection Visit|Withdrawal by Subject|0|||
170704683|NCT02287896|616927678|FG001|Second Injection Visit|Withdrawal by Subject|1|||
170704684|NCT00079274|616927680|FG000|Overall Study|Withdrawal by Subject|111|||
170704685|NCT00079274|616927681|FG001|Overall Study|Withdrawal by Subject|10|||
170704686|NCT00079274|616927682|FG002|Overall Study|Withdrawal by Subject|12|||
170704687|NCT00079274|616927683|FG003|Overall Study|Withdrawal by Subject|163|||
170704688|NCT00079274|616927684|FG004|Overall Study|Withdrawal by Subject|7|||
170704689|NCT00079274|616927685|FG005|Overall Study|Withdrawal by Subject|8|||
170704690|NCT00079274|616927686|FG006|Overall Study|Withdrawal by Subject|0|||
170704691|NCT00079274|616927680|FG000|Overall Study|Adverse Event|130|||
170704692|NCT00079274|616927681|FG001|Overall Study|Adverse Event|8|||
170704693|NCT00079274|616927682|FG002|Overall Study|Adverse Event|8|||
170704694|NCT00079274|616927683|FG003|Overall Study|Adverse Event|184|||
170704695|NCT00079274|616927684|FG004|Overall Study|Adverse Event|7|||
170704696|NCT00079274|616927685|FG005|Overall Study|Adverse Event|8|||
170704697|NCT00079274|616927686|FG006|Overall Study|Adverse Event|0|||
170704698|NCT00079274|616927680|FG000|Overall Study|Recurrence|21|||
170704699|NCT00079274|616927681|FG001|Overall Study|Recurrence|0|||
170704700|NCT00079274|616927682|FG002|Overall Study|Recurrence|1|||
170704701|NCT00079274|616927683|FG003|Overall Study|Recurrence|15|||
170704702|NCT00079274|616927684|FG004|Overall Study|Recurrence|0|||
170704703|NCT00079274|616927685|FG005|Overall Study|Recurrence|2|||
170704704|NCT00079274|616927686|FG006|Overall Study|Recurrence|0|||
170704705|NCT00079274|616927680|FG000|Overall Study|Alternate Treatment|6|||
170704706|NCT00079274|616927681|FG001|Overall Study|Alternate Treatment|1|||
170704707|NCT00079274|616927682|FG002|Overall Study|Alternate Treatment|0|||
170704708|NCT00079274|616927683|FG003|Overall Study|Alternate Treatment|3|||
170704709|NCT00079274|616927684|FG004|Overall Study|Alternate Treatment|0|||
170704710|NCT00079274|616927685|FG005|Overall Study|Alternate Treatment|0|||
170704711|NCT00079274|616927686|FG006|Overall Study|Alternate Treatment|0|||
170704712|NCT00079274|616927680|FG000|Overall Study|Other Medical Problems|6|||
170704713|NCT00079274|616927681|FG001|Overall Study|Other Medical Problems|1|||
170704714|NCT00079274|616927682|FG002|Overall Study|Other Medical Problems|0|||
170704715|NCT00079274|616927683|FG003|Overall Study|Other Medical Problems|7|||
170704716|NCT00079274|616927684|FG004|Overall Study|Other Medical Problems|0|||
170704717|NCT00079274|616927685|FG005|Overall Study|Other Medical Problems|0|||
170704718|NCT00079274|616927686|FG006|Overall Study|Other Medical Problems|0|||
170704719|NCT00079274|616927680|FG000|Overall Study|Death|4|||
170704720|NCT00079274|616927681|FG001|Overall Study|Death|0|||
170704721|NCT00079274|616927682|FG002|Overall Study|Death|1|||
170704722|NCT00079274|616927683|FG003|Overall Study|Death|15|||
170704723|NCT00079274|616927684|FG004|Overall Study|Death|0|||
170704724|NCT00079274|616927685|FG005|Overall Study|Death|0|||
170704725|NCT00079274|616927686|FG006|Overall Study|Death|0|||
170704726|NCT00079274|616927680|FG000|Overall Study|Cytogenetic resistance|0|||
170704727|NCT00079274|616927681|FG001|Overall Study|Cytogenetic resistance|0|||
170704728|NCT00079274|616927682|FG002|Overall Study|Cytogenetic resistance|0|||
170704729|NCT00079274|616927683|FG003|Overall Study|Cytogenetic resistance|2|||
170704730|NCT00079274|616927684|FG004|Overall Study|Cytogenetic resistance|0|||
170704731|NCT00079274|616927685|FG005|Overall Study|Cytogenetic resistance|0|||
170704732|NCT00079274|616927686|FG006|Overall Study|Cytogenetic resistance|0|||
170704733|NCT00079274|616927680|FG000|Overall Study|Other|43|||
170704734|NCT00079274|616927681|FG001|Overall Study|Other|7|||
170704735|NCT00079274|616927682|FG002|Overall Study|Other|5|||
170704736|NCT00079274|616927683|FG003|Overall Study|Other|55|||
170704737|NCT00079274|616927684|FG004|Overall Study|Other|1|||
170704738|NCT00079274|616927685|FG005|Overall Study|Other|2|||
170704739|NCT00079274|616927686|FG006|Overall Study|Other|0|||
170704740|NCT05132127|616927693|FG000|Overall Study|Adverse Event|1|||
170704741|NCT05220397|616927694|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
170704742|NCT05220397|616927695|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
170704743|NCT05220397|616927696|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
170704744|NCT05220397|616927697|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
170704745|NCT05220397|616927698|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
170704746|NCT01526889|616927699|FG000|Treatment Period|Adverse Event|2|||
170704747|NCT01526889|616927700|FG001|Treatment Period|Adverse Event|0|||
170704748|NCT01526889|616927699|FG000|Treatment Extension Period|Administrative problems|1|||
170704749|NCT01526889|616927700|FG001|Treatment Extension Period|Administrative problems|0|||
170704750|NCT03417141|616927706|FG000|Overall Study|Withdrawal by Subject|1|||
170704751|NCT03417141|616927706|FG000|Overall Study|Protocol Violation|3|||
170704752|NCT03571516|616927707|FG000|Overall Study|Severe diarrhea|1|||
170704753|NCT03571516|616927708|FG001|Overall Study|Severe diarrhea|0|||
170704754|NCT03571516|616927707|FG000|Overall Study|Withdrawal by Subject|0|||
170704755|NCT03571516|616927708|FG001|Overall Study|Withdrawal by Subject|1|||
170704756|NCT04907032|616927711|FG000|Overall Study|Withdrawal by Subject|7|||
170704757|NCT04907032|616927712|FG001|Overall Study|Withdrawal by Subject|1|||
170704758|NCT00613509|616927713|FG000|Cycle 1|Adverse Event|2|||
170704759|NCT00613509|616927714|FG001|Cycle 1|Adverse Event|1|||
170704760|NCT00613509|616927713|FG000|Cycle 1|Disease Progression|2|||
170704761|NCT00613509|616927714|FG001|Cycle 1|Disease Progression|6|||
170704762|NCT00613509|616927713|FG000|Cycle 1|Unacceptable Toxicity|1|||
170704763|NCT00613509|616927714|FG001|Cycle 1|Unacceptable Toxicity|0|||
170704764|NCT00613509|616927713|FG000|Cycle 1|Other administrative reason|0|||
170704765|NCT00613509|616927714|FG001|Cycle 1|Other administrative reason|1|||
170704766|NCT03465878|616927721|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
170704767|NCT03465878|616927722|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
170704768|NCT03465878|616927723|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
170704769|NCT03465878|616927724|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
170704770|NCT03465878|616927721|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
170704771|NCT03465878|616927722|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
170704772|NCT03465878|616927723|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
170704773|NCT03465878|616927724|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
170704774|NCT03465878|616927721|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
170704775|NCT03465878|616927722|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
170704776|NCT03465878|616927723|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
170704777|NCT03465878|616927724|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
170704778|NCT02702401|616927726|FG000|Overall Study|Death|242|||
170704779|NCT02702401|616927727|FG001|Overall Study|Death|125|||
170704780|NCT02702401|616927726|FG000|Overall Study|Withdrawal by Subject|15|||
170704781|NCT02702401|616927727|FG001|Overall Study|Withdrawal by Subject|5|||
170704782|NCT02702401|616927726|FG000|Overall Study|Sponsor Decision|19|||
170704783|NCT02702401|616927727|FG001|Overall Study|Sponsor Decision|3|||
170704784|NCT02702401|616927726|FG000|Overall Study|Physician Decision|1|||
170704785|NCT02702401|616927727|FG001|Overall Study|Physician Decision|2|||
170704786|NCT02702401|616927726|FG000|Overall Study|Lost to Follow-up|1|||
170704787|NCT02702401|616927727|FG001|Overall Study|Lost to Follow-up|0|||
170704788|NCT00677807|616927728|FG000|Overall Study|Adverse Event|4|||
170704789|NCT00677807|616927729|FG001|Overall Study|Adverse Event|1|||
170704790|NCT00677807|616927730|FG002|Overall Study|Adverse Event|6|||
170704791|NCT00677807|616927728|FG000|Overall Study|Lack of Efficacy|0|||
170704792|NCT00677807|616927729|FG001|Overall Study|Lack of Efficacy|0|||
170704793|NCT00677807|616927730|FG002|Overall Study|Lack of Efficacy|2|||
170704794|NCT00677807|616927728|FG000|Overall Study|Participant no longer needs study drug|0|||
170704795|NCT00677807|616927729|FG001|Overall Study|Participant no longer needs study drug|0|||
170704796|NCT00677807|616927730|FG002|Overall Study|Participant no longer needs study drug|1|||
170704797|NCT00677807|616927728|FG000|Overall Study|Withdrawal by Subject|10|||
170704798|NCT00677807|616927729|FG001|Overall Study|Withdrawal by Subject|3|||
170704799|NCT00677807|616927730|FG002|Overall Study|Withdrawal by Subject|6|||
170704800|NCT00677807|616927728|FG000|Overall Study|Lost to Follow-up|2|||
170704801|NCT00677807|616927729|FG001|Overall Study|Lost to Follow-up|2|||
170704802|NCT00677807|616927730|FG002|Overall Study|Lost to Follow-up|2|||
170704803|NCT00677807|616927728|FG000|Overall Study|Administrative problems|1|||
170704804|NCT00677807|616927729|FG001|Overall Study|Administrative problems|1|||
170704805|NCT00677807|616927730|FG002|Overall Study|Administrative problems|2|||
170704806|NCT00677807|616927728|FG000|Overall Study|Death|0|||
170704807|NCT00677807|616927729|FG001|Overall Study|Death|1|||
170704808|NCT00677807|616927730|FG002|Overall Study|Death|1|||
170704809|NCT00677807|616927728|FG000|Overall Study|Protocol Deviation|1|||
170704810|NCT00677807|616927729|FG001|Overall Study|Protocol Deviation|3|||
170704811|NCT00677807|616927730|FG002|Overall Study|Protocol Deviation|0|||
170704812|NCT02540954|616927736|FG000|Overall Study|Physician Decision|3|||
170704813|NCT02540954|616927737|FG001|Overall Study|Physician Decision|1|||
170704814|NCT02540954|616927736|FG000|Overall Study|Withdrawal by Subject|6|||
170704815|NCT02540954|616927737|FG001|Overall Study|Withdrawal by Subject|5|||
170704816|NCT02540954|616927736|FG000|Overall Study|Lost to Follow-up|1|||
170704817|NCT02540954|616927737|FG001|Overall Study|Lost to Follow-up|1|||
170704818|NCT02540954|616927736|FG000|Overall Study|Adverse Event|4|||
170704819|NCT02540954|616927737|FG001|Overall Study|Adverse Event|2|||
170704820|NCT02540954|616927736|FG000|Overall Study|Death|0|||
170704821|NCT02540954|616927737|FG001|Overall Study|Death|3|||
170704822|NCT02540954|616927736|FG000|Overall Study|Treatment failure|1|||
170704823|NCT02540954|616927737|FG001|Overall Study|Treatment failure|0|||
170704824|NCT02540954|616927736|FG000|Overall Study|Other reason|4|||
170704825|NCT02540954|616927737|FG001|Overall Study|Other reason|2|||
170704826|NCT03925727|616927738|FG000|Overall Study|Adverse Event|4|||
170704827|NCT03925727|616927739|FG001|Overall Study|Adverse Event|0|||
170704828|NCT03925727|616927740|FG002|Overall Study|Adverse Event|3|||
170704829|NCT03925727|616927738|FG000|Overall Study|Protocol Violation|1|||
170704830|NCT03925727|616927739|FG001|Overall Study|Protocol Violation|2|||
170704831|NCT03925727|616927740|FG002|Overall Study|Protocol Violation|2|||
170704832|NCT03925727|616927738|FG000|Overall Study|Withdrawal by Subject|3|||
170704833|NCT03925727|616927739|FG001|Overall Study|Withdrawal by Subject|2|||
170704834|NCT03925727|616927740|FG002|Overall Study|Withdrawal by Subject|4|||
170704835|NCT03925727|616927738|FG000|Overall Study|Administrative Reasons|3|||
170704836|NCT03925727|616927739|FG001|Overall Study|Administrative Reasons|1|||
170704837|NCT03925727|616927740|FG002|Overall Study|Administrative Reasons|2|||
170704838|NCT03925727|616927738|FG000|Overall Study|Randomized in error or Disqualified|8|||
170704839|NCT03925727|616927739|FG001|Overall Study|Randomized in error or Disqualified|1|||
170704840|NCT03925727|616927740|FG002|Overall Study|Randomized in error or Disqualified|7|||
170704841|NCT01420081|616927744|FG000|Overall Study|Death|1|||
170704842|NCT01420081|616927745|FG001|Overall Study|Death|0|||
170704843|NCT01420081|616927746|FG002|Overall Study|Death|8|||
170704844|NCT01420081|616927747|FG003|Overall Study|Death|0|||
170704845|NCT01420081|616927748|FG004|Overall Study|Death|7|||
170704846|NCT01420081|616927749|FG005|Overall Study|Death|12|||
170704847|NCT01420081|616927750|FG006|Overall Study|Death|0|||
170704848|NCT01420081|616927751|FG007|Overall Study|Death|1|||
170704849|NCT01420081|616927752|FG008|Overall Study|Death|1|||
170704850|NCT01420081|616927744|FG000|Overall Study|Lost to Follow-up|0|||
170704851|NCT01420081|616927745|FG001|Overall Study|Lost to Follow-up|0|||
170704852|NCT01420081|616927746|FG002|Overall Study|Lost to Follow-up|0|||
170704853|NCT01420081|616927747|FG003|Overall Study|Lost to Follow-up|0|||
170704854|NCT01420081|616927748|FG004|Overall Study|Lost to Follow-up|1|||
170704855|NCT01420081|616927749|FG005|Overall Study|Lost to Follow-up|1|||
170704856|NCT01420081|616927750|FG006|Overall Study|Lost to Follow-up|0|||
170704857|NCT01420081|616927751|FG007|Overall Study|Lost to Follow-up|0|||
170704858|NCT01420081|616927752|FG008|Overall Study|Lost to Follow-up|0|||
170704859|NCT01420081|616927744|FG000|Overall Study|Study Terminated by Sponsor|2|||
170704860|NCT01420081|616927745|FG001|Overall Study|Study Terminated by Sponsor|1|||
170704861|NCT01420081|616927746|FG002|Overall Study|Study Terminated by Sponsor|1|||
170704862|NCT01420081|616927747|FG003|Overall Study|Study Terminated by Sponsor|3|||
170704863|NCT01420081|616927748|FG004|Overall Study|Study Terminated by Sponsor|11|||
170704864|NCT01420081|616927749|FG005|Overall Study|Study Terminated by Sponsor|7|||
170704865|NCT01420081|616927750|FG006|Overall Study|Study Terminated by Sponsor|3|||
170704866|NCT01420081|616927751|FG007|Overall Study|Study Terminated by Sponsor|2|||
170704867|NCT01420081|616927752|FG008|Overall Study|Study Terminated by Sponsor|2|||
170704868|NCT01420081|616927744|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
170704869|NCT01420081|616927745|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
170704870|NCT01420081|616927746|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
170704871|NCT01420081|616927747|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
170704872|NCT01420081|616927748|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
170704873|NCT01420081|616927749|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
170704874|NCT01420081|616927750|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
170704875|NCT01420081|616927751|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
170704876|NCT01420081|616927752|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
170704877|NCT01420081|616927744|FG000|Overall Study|Other Reasons|0|||
170704878|NCT01420081|616927745|FG001|Overall Study|Other Reasons|0|||
170704879|NCT01420081|616927746|FG002|Overall Study|Other Reasons|1|||
170704880|NCT01420081|616927747|FG003|Overall Study|Other Reasons|0|||
170704881|NCT01420081|616927748|FG004|Overall Study|Other Reasons|0|||
170704882|NCT01420081|616927749|FG005|Overall Study|Other Reasons|0|||
170704883|NCT01420081|616927750|FG006|Overall Study|Other Reasons|0|||
170704884|NCT01420081|616927751|FG007|Overall Study|Other Reasons|0|||
170704885|NCT01420081|616927752|FG008|Overall Study|Other Reasons|0|||
170704886|NCT04466891|616927754|FG000|Overall Study|Death|60|||
170704887|NCT04466891|616927755|FG001|Overall Study|Death|6|||
170704888|NCT04466891|616927754|FG000|Overall Study|Withdrawal by Subject|8|||
170704889|NCT04466891|616927755|FG001|Overall Study|Withdrawal by Subject|1|||
170704890|NCT04466891|616927754|FG000|Overall Study|Study terminated by sponsor|5|||
170704891|NCT04466891|616927755|FG001|Overall Study|Study terminated by sponsor|0|||
170704892|NCT04466891|616927754|FG000|Overall Study|Lost to Follow-up|2|||
170704893|NCT04466891|616927755|FG001|Overall Study|Lost to Follow-up|0|||
170704894|NCT04466891|616927754|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
170704895|NCT04466891|616927755|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
170704896|NCT03107988|616930053|FG000|Overall Study|Adverse Event|0|||
170704897|NCT03107988|616930054|FG001|Overall Study|Adverse Event|0|||
170704898|NCT03107988|616930055|FG002|Overall Study|Adverse Event|0|||
170704899|NCT03107988|616930056|FG003|Overall Study|Adverse Event|1|||
170704900|NCT03107988|616930057|FG004|Overall Study|Adverse Event|0|||
170704901|NCT03107988|616930058|FG005|Overall Study|Adverse Event|1|||
170704902|NCT03107988|616930059|FG006|Overall Study|Adverse Event|0|||
170704903|NCT03107988|616930060|FG007|Overall Study|Adverse Event|1|||
170704904|NCT03107988|616930061|FG008|Overall Study|Adverse Event|0|||
170704905|NCT03107988|616930062|FG009|Overall Study|Adverse Event|0|||
170704906|NCT03107988|616930063|FG010|Overall Study|Adverse Event|0|||
170704907|NCT03107988|616930064|FG011|Overall Study|Adverse Event|0|||
170704908|NCT03107988|616930065|FG012|Overall Study|Adverse Event|0|||
170704909|NCT03107988|616930053|FG000|Overall Study|Disease Progression or Relapse|1|||
170704910|NCT03107988|616930054|FG001|Overall Study|Disease Progression or Relapse|2|||
170704911|NCT03107988|616930055|FG002|Overall Study|Disease Progression or Relapse|2|||
170704912|NCT03107988|616930056|FG003|Overall Study|Disease Progression or Relapse|5|||
170704913|NCT03107988|616930057|FG004|Overall Study|Disease Progression or Relapse|1|||
170704914|NCT03107988|616930058|FG005|Overall Study|Disease Progression or Relapse|1|||
170704915|NCT03107988|616930059|FG006|Overall Study|Disease Progression or Relapse|0|||
170704916|NCT03107988|616930060|FG007|Overall Study|Disease Progression or Relapse|0|||
170704917|NCT03107988|616930061|FG008|Overall Study|Disease Progression or Relapse|0|||
170704918|NCT03107988|616930062|FG009|Overall Study|Disease Progression or Relapse|1|||
170704919|NCT03107988|616930063|FG010|Overall Study|Disease Progression or Relapse|4|||
170704920|NCT03107988|616930064|FG011|Overall Study|Disease Progression or Relapse|0|||
170704921|NCT03107988|616930065|FG012|Overall Study|Disease Progression or Relapse|0|||
170704922|NCT03107988|616930053|FG000|Overall Study|Ineligible|0|||
170704923|NCT03107988|616930054|FG001|Overall Study|Ineligible|0|||
170704924|NCT03107988|616930055|FG002|Overall Study|Ineligible|0|||
170704925|NCT03107988|616930056|FG003|Overall Study|Ineligible|0|||
170704926|NCT03107988|616930057|FG004|Overall Study|Ineligible|0|||
170704927|NCT03107988|616930058|FG005|Overall Study|Ineligible|0|||
170704928|NCT03107988|616930059|FG006|Overall Study|Ineligible|0|||
170704929|NCT03107988|616930060|FG007|Overall Study|Ineligible|0|||
170704930|NCT03107988|616930061|FG008|Overall Study|Ineligible|1|||
170704931|NCT03107988|616930062|FG009|Overall Study|Ineligible|0|||
170704932|NCT03107988|616930063|FG010|Overall Study|Ineligible|0|||
170704933|NCT03107988|616930064|FG011|Overall Study|Ineligible|0|||
170704934|NCT03107988|616930065|FG012|Overall Study|Ineligible|0|||
170704935|NCT04101526|616930066|FG000|Overall Study|Did not complete all sleep diary entries|0|||
170704936|NCT04101526|616930067|FG001|Overall Study|Did not complete all sleep diary entries|1|||
170704937|NCT00844545|616930068|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
170704938|NCT00844545|616930068|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
170704939|NCT00844545|616930068|FG000|Extension Treatment Period|Adverse Event|2|||
170704940|NCT00844545|616930068|FG000|Post Treatment Period|Withdrawal by Subject|1|||
170704941|NCT00723606|616930069|FG000|Overall Study|Adverse Event|2|||
170704942|NCT00723606|616930070|FG001|Overall Study|Adverse Event|5|||
170704943|NCT00723606|616930069|FG000|Overall Study|Other|2|||
170704944|NCT00723606|616930070|FG001|Overall Study|Other|0|||
170704945|NCT00723606|616930069|FG000|Overall Study|Withdrawal by Subject|0|||
170704946|NCT00723606|616930070|FG001|Overall Study|Withdrawal by Subject|2|||
170704947|NCT02566759|616930071|FG000|All Parts|Withdrawal by Subject|0|||
170704948|NCT02566759|616930072|FG001|All Parts|Withdrawal by Subject|1|||
170704949|NCT02566759|616930073|FG002|All Parts|Withdrawal by Subject|0|||
170704950|NCT02566759|616930074|FG003|All Parts|Withdrawal by Subject|0|||
170704951|NCT02566759|616930075|FG004|All Parts|Withdrawal by Subject|0|||
170704952|NCT02566759|616930076|FG005|All Parts|Withdrawal by Subject|0|||
170704953|NCT02566759|616930077|FG006|All Parts|Withdrawal by Subject|0|||
170704954|NCT02566759|616930078|FG007|All Parts|Withdrawal by Subject|0|||
170704955|NCT02566759|616930079|FG008|All Parts|Withdrawal by Subject|0|||
170704956|NCT02566759|616930080|FG009|All Parts|Withdrawal by Subject|0|||
170704957|NCT02566759|616930081|FG010|All Parts|Withdrawal by Subject|0|||
170704958|NCT02566759|616930082|FG011|All Parts|Withdrawal by Subject|0|||
170704959|NCT02566759|616930083|FG012|All Parts|Withdrawal by Subject|0|||
170704960|NCT02566759|616930084|FG013|All Parts|Withdrawal by Subject|0|||
170704961|NCT02566759|616930085|FG014|All Parts|Withdrawal by Subject|0|||
170704962|NCT02566759|616930086|FG015|All Parts|Withdrawal by Subject|0|||
170704963|NCT02566759|616930087|FG016|All Parts|Withdrawal by Subject|0|||
170704964|NCT02566759|616930071|FG000|All Parts|Adverse Event|0|||
170704965|NCT02566759|616930072|FG001|All Parts|Adverse Event|0|||
170704966|NCT02566759|616930073|FG002|All Parts|Adverse Event|0|||
170704967|NCT02566759|616930074|FG003|All Parts|Adverse Event|0|||
170704968|NCT02566759|616930075|FG004|All Parts|Adverse Event|0|||
170704969|NCT02566759|616930076|FG005|All Parts|Adverse Event|0|||
170704970|NCT02566759|616930077|FG006|All Parts|Adverse Event|0|||
170704971|NCT02566759|616930078|FG007|All Parts|Adverse Event|0|||
170704972|NCT02566759|616930079|FG008|All Parts|Adverse Event|0|||
170704973|NCT02566759|616930080|FG009|All Parts|Adverse Event|0|||
170704974|NCT02566759|616930081|FG010|All Parts|Adverse Event|0|||
170704975|NCT02566759|616930082|FG011|All Parts|Adverse Event|0|||
170704976|NCT02566759|616930083|FG012|All Parts|Adverse Event|1|||
170704977|NCT02566759|616930084|FG013|All Parts|Adverse Event|3|||
170704978|NCT02566759|616930085|FG014|All Parts|Adverse Event|0|||
170704979|NCT02566759|616930086|FG015|All Parts|Adverse Event|0|||
170704980|NCT02566759|616930087|FG016|All Parts|Adverse Event|0|||
170704981|NCT02566759|616930071|FG000|All Parts|Other|0|||
170704982|NCT02566759|616930072|FG001|All Parts|Other|0|||
170704983|NCT02566759|616930073|FG002|All Parts|Other|0|||
170704984|NCT02566759|616930074|FG003|All Parts|Other|0|||
170704985|NCT02566759|616930075|FG004|All Parts|Other|0|||
170704986|NCT02566759|616930076|FG005|All Parts|Other|0|||
170704987|NCT02566759|616930077|FG006|All Parts|Other|0|||
170704988|NCT02566759|616930078|FG007|All Parts|Other|0|||
170704989|NCT02566759|616930079|FG008|All Parts|Other|0|||
170704990|NCT02566759|616930080|FG009|All Parts|Other|0|||
170704991|NCT02566759|616930081|FG010|All Parts|Other|0|||
170704992|NCT02566759|616930082|FG011|All Parts|Other|0|||
170704993|NCT02566759|616930083|FG012|All Parts|Other|0|||
170704994|NCT02566759|616930084|FG013|All Parts|Other|2|||
170704995|NCT02566759|616930085|FG014|All Parts|Other|0|||
170704996|NCT02566759|616930086|FG015|All Parts|Other|0|||
170704997|NCT02566759|616930087|FG016|All Parts|Other|0|||
170704998|NCT02566759|616930071|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170704999|NCT02566759|616930072|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705000|NCT02566759|616930073|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705001|NCT02566759|616930074|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705002|NCT02566759|616930075|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705003|NCT02566759|616930076|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705004|NCT02566759|616930077|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705005|NCT02566759|616930078|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705006|NCT02566759|616930079|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705007|NCT02566759|616930080|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705008|NCT02566759|616930081|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705009|NCT02566759|616930082|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705010|NCT02566759|616930083|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705011|NCT02566759|616930084|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705012|NCT02566759|616930085|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705013|NCT02566759|616930086|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
170705014|NCT02566759|616930087|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
170705015|NCT01126541|616930088|FG000|Overall Study|Adverse Event|0|||
170705016|NCT01126541|616930089|FG001|Overall Study|Adverse Event|2|||
170705017|NCT01126541|616930090|FG002|Overall Study|Adverse Event|4|||
170705018|NCT01126541|616930088|FG000|Overall Study|Death|0|||
170705019|NCT01126541|616930089|FG001|Overall Study|Death|1|||
170705020|NCT01126541|616930090|FG002|Overall Study|Death|0|||
170705021|NCT01126541|616930088|FG000|Overall Study|Lack of Efficacy|6|||
170705022|NCT01126541|616930089|FG001|Overall Study|Lack of Efficacy|1|||
170705023|NCT01126541|616930090|FG002|Overall Study|Lack of Efficacy|11|||
170705024|NCT01126541|616930088|FG000|Overall Study|Lost to Follow-up|1|||
170705025|NCT01126541|616930089|FG001|Overall Study|Lost to Follow-up|2|||
170705026|NCT01126541|616930090|FG002|Overall Study|Lost to Follow-up|2|||
170705027|NCT01126541|616930088|FG000|Overall Study|Withdrawal by Subject|2|||
170705028|NCT01126541|616930089|FG001|Overall Study|Withdrawal by Subject|5|||
170705029|NCT01126541|616930090|FG002|Overall Study|Withdrawal by Subject|6|||
170705030|NCT01126541|616930088|FG000|Overall Study|Protocol Violation|0|||
170705031|NCT01126541|616930089|FG001|Overall Study|Protocol Violation|0|||
170705032|NCT01126541|616930090|FG002|Overall Study|Protocol Violation|1|||
170705033|NCT01126541|616930088|FG000|Overall Study|Administrative reason or other|1|||
170705034|NCT01126541|616930089|FG001|Overall Study|Administrative reason or other|1|||
170705035|NCT01126541|616930090|FG002|Overall Study|Administrative reason or other|2|||
170705036|NCT00976898|616930091|FG000|Overall Study|Protocol Violation|1|||
170705037|NCT00976898|616930091|FG000|Overall Study|Adverse Event|1|||
170705038|NCT00976898|616930091|FG000|Overall Study|Physician Decision|1|||
170705039|NCT00976898|616930091|FG000|Overall Study|Liver Transplant|1|||
170705040|NCT00976898|616930091|FG000|Overall Study|Progressive Disease|1|||
170705041|NCT02984995|616930092|FG000|Overall Study|Required stem cell transplant|13|||
170705042|NCT02984995|616930093|FG001|Overall Study|Required stem cell transplant|2|||
170705043|NCT02984995|616930092|FG000|Overall Study|Progressive disease|11|||
170705044|NCT02984995|616930093|FG001|Overall Study|Progressive disease|1|||
170705045|NCT02984995|616930092|FG000|Overall Study|Adverse Event|1|||
170705046|NCT02984995|616930093|FG001|Overall Study|Adverse Event|0|||
170705047|NCT05107128|616930094|FG000|Overall Study|Adverse Event|2|||
170705048|NCT05107128|616930095|FG001|Overall Study|Adverse Event|0|||
170705049|NCT05107128|616930094|FG000|Overall Study|Withdrawal by Subject|3|||
170705050|NCT05107128|616930095|FG001|Overall Study|Withdrawal by Subject|3|||
170705051|NCT05107128|616930094|FG000|Overall Study|Withdrawal of Consent|0|||
170705052|NCT05107128|616930095|FG001|Overall Study|Withdrawal of Consent|1|||
170705053|NCT05107128|616930094|FG000|Overall Study|Reason Not Specified|2|||
170705054|NCT05107128|616930095|FG001|Overall Study|Reason Not Specified|0|||
170705055|NCT04354831|616930096|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
170705056|NCT04354831|616930097|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
170705057|NCT01018264|616930098|FG000|Overall Study|Withdrawal by Subject|1|||
170705058|NCT01018264|616930099|FG001|Overall Study|Withdrawal by Subject|0|||
170705059|NCT01018264|616930098|FG000|Overall Study|Lost to Follow-up|0|||
170705060|NCT01018264|616930099|FG001|Overall Study|Lost to Follow-up|1|||
170705061|NCT00812929|616930100|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
170705062|NCT00812929|616930101|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
170705063|NCT00812929|616930102|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
170705064|NCT00812929|616930103|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
170705065|NCT00812929|616930104|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
170705066|NCT00812929|616930105|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
170705067|NCT00812929|616930106|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
170705068|NCT00812929|616930107|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
170705069|NCT00812929|616930108|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
170705070|NCT00812929|616930109|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
170705071|NCT00812929|616930100|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
170705072|NCT00812929|616930101|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
170705073|NCT00812929|616930102|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
170705074|NCT00812929|616930103|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
170705075|NCT00812929|616930104|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
170705076|NCT00812929|616930105|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
170705077|NCT00812929|616930106|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
170705078|NCT00812929|616930107|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
170705079|NCT00812929|616930108|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
170705080|NCT00812929|616930109|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
170705081|NCT00812929|616930100|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
170705082|NCT00812929|616930101|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
170705083|NCT00812929|616930102|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
170705084|NCT00812929|616930103|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
170705085|NCT00812929|616930104|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
170705086|NCT00812929|616930105|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
170705087|NCT00812929|616930106|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
170705088|NCT00812929|616930107|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
170705089|NCT00812929|616930108|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
170705090|NCT00812929|616930109|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
170705091|NCT02939404|616930110|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
170705092|NCT02939404|616930111|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
170705093|NCT02939404|616930110|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
170705094|NCT02939404|616930111|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
170705095|NCT04182100|616930112|FG000|Overall Study|Adverse Event|1|||
170705096|NCT04182100|616930112|FG000|Overall Study|Withdrawal by Subject|1|||
170705097|NCT02504372|616930114|FG000|Overall Study|Death|136|||
170705098|NCT02504372|616930115|FG001|Overall Study|Death|154|||
170705099|NCT02504372|616930114|FG000|Overall Study|Lost to Follow-up|0|||
170705100|NCT02504372|616930115|FG001|Overall Study|Lost to Follow-up|2|||
170705101|NCT02504372|616930114|FG000|Overall Study|Withdrawal of consent|25|||
170705102|NCT02504372|616930115|FG001|Overall Study|Withdrawal of consent|16|||
170705103|NCT02504372|616930114|FG000|Overall Study|Participants ongoing|429|||
170705104|NCT02504372|616930115|FG001|Overall Study|Participants ongoing|415|||
170705105|NCT02975934|616930116|FG000|Treatment Phase|Never initiated study drug|0|||
170705106|NCT02975934|616930117|FG001|Treatment Phase|Never initiated study drug|5|||
170705107|NCT02975934|616930118|FG002|Treatment Phase|Never initiated study drug|0|||
170705108|NCT00433654|616930122|FG000|Overall Study|Death|4|||
170705109|NCT00433654|616930123|FG001|Overall Study|Death|0|||
170705110|NCT00433654|616930122|FG000|Overall Study|Missed visit|6|||
170705111|NCT00433654|616930123|FG001|Overall Study|Missed visit|3|||
170705112|NCT00433654|616930122|FG000|Overall Study|Subject not yet due for visit|4|||
170705113|NCT00433654|616930123|FG001|Overall Study|Subject not yet due for visit|0|||
170705114|NCT00433654|616930122|FG000|Overall Study|Withdrawal by Subject|1|||
170705115|NCT00433654|616930123|FG001|Overall Study|Withdrawal by Subject|2|||
170705116|NCT00357370|616930124|FG000|Cohort 2|Lack of Efficacy|0|||
170705117|NCT00357370|616930125|FG001|Cohort 2|Lack of Efficacy|2|||
170705118|NCT00357370|616930126|FG002|Cohort 2|Lack of Efficacy|1|||
170705119|NCT00357370|616930124|FG000|Cohort 2|Adverse Event|1|||
170705120|NCT00357370|616930125|FG001|Cohort 2|Adverse Event|1|||
170705121|NCT00357370|616930126|FG002|Cohort 2|Adverse Event|1|||
170705122|NCT00357370|616930124|FG000|Cohort 2|Lost to Follow-up|0|||
170705123|NCT00357370|616930125|FG001|Cohort 2|Lost to Follow-up|1|||
170705124|NCT00357370|616930126|FG002|Cohort 2|Lost to Follow-up|0|||
170705125|NCT00357370|616930124|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
170705126|NCT00357370|616930125|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
170705127|NCT00357370|616930126|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
170705128|NCT00357370|616930124|FG000|Cohort 2|Withdrawal by Subject|0|||
170705129|NCT00357370|616930125|FG001|Cohort 2|Withdrawal by Subject|2|||
170705130|NCT00357370|616930126|FG002|Cohort 2|Withdrawal by Subject|0|||
170705131|NCT02075437|616930127|FG000|Overall Study|Withdrawal by Subject|5|||
170705132|NCT02075437|616930127|FG000|Overall Study|Lost to Follow-up|1|||
170705133|NCT00499603|616930128|FG000|Overall Study|Adverse Event|0|||
170705134|NCT00499603|616930129|FG001|Overall Study|Adverse Event|1|||
170705135|NCT01632800|616930130|FG000|Overall Study|Subject did not fit in apparatus|1|||
170705136|NCT02644967|616930131|FG000|Overall Study|Death|26|||
170705137|NCT02644967|616930131|FG000|Overall Study|Physician Decision|1|||
170705138|NCT02644967|616930131|FG000|Overall Study|Withdrawal by Subject|2|||
170705139|NCT02644967|616930131|FG000|Overall Study|Protocol Violation|1|||
170705140|NCT02644967|616930131|FG000|Overall Study|Progressive Disease|1|||
170705141|NCT02644967|616930131|FG000|Overall Study|Study Terminated by Sponsor|4|||
170705142|NCT00813124|616930132|FG000|Overall Study|Death|2|||
170705143|NCT00813124|616930132|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
170705144|NCT00813124|616930132|FG000|Overall Study|Withdrawal by Subject|1|||
170705145|NCT00767676|616930133|FG000|Overall Study|Investigator error|54|||
170705146|NCT00280566|616930135|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
170705147|NCT00280566|616930136|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
170705148|NCT00280566|616930137|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
170705149|NCT00280566|616930135|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
170705150|NCT00280566|616930136|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
170705151|NCT00280566|616930137|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
170705152|NCT00280566|616930135|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
170705153|NCT00280566|616930136|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
170705154|NCT00280566|616930137|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
170705155|NCT00280566|616930135|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
170705156|NCT00280566|616930136|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
170705157|NCT00280566|616930137|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
170705158|NCT00280566|616930135|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
170705159|NCT00280566|616930136|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
170705160|NCT00280566|616930137|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
170705161|NCT00280566|616930135|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
170705162|NCT00280566|616930136|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
170705163|NCT00280566|616930137|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
170705164|NCT00280566|616930135|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
170705165|NCT00280566|616930136|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
170705166|NCT00280566|616930137|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
170705167|NCT00280566|616930135|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
170705168|NCT00280566|616930136|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
170705169|NCT00280566|616930137|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
170705170|NCT00280566|616930135|FG000|Period 2 Double Blind|Adverse Event|0|||
170705171|NCT00280566|616930136|FG001|Period 2 Double Blind|Adverse Event|11|||
170705172|NCT00280566|616930137|FG002|Period 2 Double Blind|Adverse Event|15|||
170705173|NCT00280566|616930135|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
170705174|NCT00280566|616930136|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
170705175|NCT00280566|616930137|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
170705176|NCT00280566|616930135|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
170705177|NCT00280566|616930136|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
170705178|NCT00280566|616930137|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
170705179|NCT00280566|616930135|FG000|Period 2 Double Blind|miscellaneous|0|||
170705180|NCT00280566|616930136|FG001|Period 2 Double Blind|miscellaneous|10|||
170705181|NCT00280566|616930137|FG002|Period 2 Double Blind|miscellaneous|5|||
170705182|NCT01147653|616930138|FG000|Year 2|Withdrawal by Subject|2|||
170705183|NCT01147653|616930139|FG001|Year 2|Withdrawal by Subject|3|||
170705184|NCT01502644|616930140|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
170705185|NCT01502644|616930141|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
170705186|NCT01502644|616930142|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
170705187|NCT01502644|616930143|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
170705188|NCT01502644|616930140|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
170705189|NCT01502644|616930141|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
170705190|NCT01502644|616930142|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
170705191|NCT01502644|616930143|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
170705192|NCT01502644|616930140|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
170705193|NCT01502644|616930141|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
170705194|NCT01502644|616930142|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
170705195|NCT01502644|616930143|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
170705196|NCT01502644|616930140|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
170705197|NCT01502644|616930141|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
170705198|NCT01502644|616930142|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
170705199|NCT01502644|616930143|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
170705200|NCT01502644|616930140|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
170705201|NCT01502644|616930141|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
170705202|NCT01502644|616930142|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
170705203|NCT01502644|616930143|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
170705204|NCT02052739|616930146|FG000|Overall Study|Withdrew due to Adverse Event|3|||
170705205|NCT02052739|616930147|FG001|Overall Study|Withdrew due to Adverse Event|0|||
170705206|NCT02052739|616930146|FG000|Overall Study|Participant Died|2|||
170705207|NCT02052739|616930147|FG001|Overall Study|Participant Died|1|||
170705208|NCT01302392|616930148|FG000|Overall Study|Lost to Follow-up|1|||
170705209|NCT01302392|616930149|FG001|Overall Study|Lost to Follow-up|0|||
170705210|NCT01302392|616930148|FG000|Overall Study|Withdrawal by Subject|6|||
170705211|NCT01302392|616930149|FG001|Overall Study|Withdrawal by Subject|1|||
170705212|NCT00670228|616930150|FG000|Overall Study|Adverse Event|1|||
170705213|NCT00670228|616930151|FG001|Overall Study|Adverse Event|0|||
170705214|NCT00670228|616930150|FG000|Overall Study|Death or MACE|0|||
170705215|NCT00670228|616930151|FG001|Overall Study|Death or MACE|1|||
170705216|NCT00670228|616930150|FG000|Overall Study|Not treated|2|||
170705217|NCT00670228|616930151|FG001|Overall Study|Not treated|2|||
170705218|NCT00670228|616930150|FG000|Overall Study|Not meeting the selection criteria|2|||
170705219|NCT00670228|616930151|FG001|Overall Study|Not meeting the selection criteria|0|||
170705220|NCT01077960|616930152|FG000|Overall Study|Adverse Event|6|||
170705221|NCT01077960|616930152|FG000|Overall Study|Protocol Violation|3|||
170705222|NCT01077960|616930152|FG000|Overall Study|Lost to Follow-up|5|||
170705223|NCT01077960|616930152|FG000|Overall Study|Subject decision|1|||
170705224|NCT01077960|616930152|FG000|Overall Study|Reason unspecified|1|||
170705225|NCT01403974|616930153|FG000|Overall Study|Progressive disease according to RECIST|3|||
170705226|NCT01403974|616930154|FG001|Overall Study|Progressive disease according to RECIST|3|||
170705227|NCT01403974|616930155|FG002|Overall Study|Progressive disease according to RECIST|2|||
170705228|NCT01403974|616930156|FG003|Overall Study|Progressive disease according to RECIST|3|||
170705229|NCT01403974|616930157|FG004|Overall Study|Progressive disease according to RECIST|3|||
170705230|NCT01403974|616930158|FG005|Overall Study|Progressive disease according to RECIST|2|||
170705231|NCT01403974|616930159|FG006|Overall Study|Progressive disease according to RECIST|3|||
170705232|NCT01403974|616930160|FG007|Overall Study|Progressive disease according to RECIST|2|||
170705233|NCT01403974|616930161|FG008|Overall Study|Progressive disease according to RECIST|6|||
170705234|NCT01403974|616930162|FG009|Overall Study|Progressive disease according to RECIST|2|||
170705235|NCT01403974|616930163|FG010|Overall Study|Progressive disease according to RECIST|3|||
170705236|NCT01403974|616930164|FG011|Overall Study|Progressive disease according to RECIST|2|||
170705237|NCT01403974|616930165|FG012|Overall Study|Progressive disease according to RECIST|2|||
170705238|NCT01403974|616930166|FG013|Overall Study|Progressive disease according to RECIST|3|||
170705239|NCT01403974|616930167|FG014|Overall Study|Progressive disease according to RECIST|1|||
170705240|NCT01403974|616930168|FG015|Overall Study|Progressive disease according to RECIST|8|||
170705241|NCT01403974|616930153|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
170705242|NCT01403974|616930154|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
170705243|NCT01403974|616930155|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
170705244|NCT01403974|616930156|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
170705245|NCT01403974|616930157|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
170705246|NCT01403974|616930158|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
170705247|NCT01403974|616930159|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
170705248|NCT01403974|616930160|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
170705249|NCT01403974|616930161|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
170705250|NCT01403974|616930162|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
170705251|NCT01403974|616930163|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
170705252|NCT01403974|616930164|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
170705253|NCT01403974|616930165|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
170705254|NCT01403974|616930166|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
170705255|NCT01403974|616930167|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
170705256|NCT01403974|616930168|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
170705257|NCT01403974|616930153|FG000|Overall Study|Refused to continue study medication|0|||
170705258|NCT01403974|616930154|FG001|Overall Study|Refused to continue study medication|0|||
170705259|NCT01403974|616930155|FG002|Overall Study|Refused to continue study medication|0|||
170705260|NCT01403974|616930156|FG003|Overall Study|Refused to continue study medication|0|||
170705261|NCT01403974|616930157|FG004|Overall Study|Refused to continue study medication|0|||
170705262|NCT01403974|616930158|FG005|Overall Study|Refused to continue study medication|1|||
170705263|NCT01403974|616930159|FG006|Overall Study|Refused to continue study medication|0|||
170705264|NCT01403974|616930160|FG007|Overall Study|Refused to continue study medication|0|||
170705265|NCT01403974|616930161|FG008|Overall Study|Refused to continue study medication|1|||
170705266|NCT01403974|616930162|FG009|Overall Study|Refused to continue study medication|0|||
170705267|NCT01403974|616930163|FG010|Overall Study|Refused to continue study medication|1|||
170705268|NCT01403974|616930164|FG011|Overall Study|Refused to continue study medication|0|||
170705269|NCT01403974|616930165|FG012|Overall Study|Refused to continue study medication|0|||
170705270|NCT01403974|616930166|FG013|Overall Study|Refused to continue study medication|0|||
170705271|NCT01403974|616930167|FG014|Overall Study|Refused to continue study medication|0|||
170705272|NCT01403974|616930168|FG015|Overall Study|Refused to continue study medication|4|||
170705273|NCT01403974|616930153|FG000|Overall Study|Adverse Event|0|||
170705274|NCT01403974|616930154|FG001|Overall Study|Adverse Event|0|||
170705275|NCT01403974|616930155|FG002|Overall Study|Adverse Event|1|||
170705276|NCT01403974|616930156|FG003|Overall Study|Adverse Event|0|||
170705277|NCT01403974|616930157|FG004|Overall Study|Adverse Event|0|||
170705278|NCT01403974|616930158|FG005|Overall Study|Adverse Event|0|||
170705279|NCT01403974|616930159|FG006|Overall Study|Adverse Event|0|||
170705280|NCT01403974|616930160|FG007|Overall Study|Adverse Event|1|||
170705281|NCT01403974|616930161|FG008|Overall Study|Adverse Event|0|||
170705282|NCT01403974|616930162|FG009|Overall Study|Adverse Event|0|||
170705283|NCT01403974|616930163|FG010|Overall Study|Adverse Event|0|||
170705284|NCT01403974|616930164|FG011|Overall Study|Adverse Event|0|||
170705285|NCT01403974|616930165|FG012|Overall Study|Adverse Event|1|||
170705286|NCT01403974|616930166|FG013|Overall Study|Adverse Event|0|||
170705287|NCT01403974|616930167|FG014|Overall Study|Adverse Event|0|||
170705288|NCT01403974|616930168|FG015|Overall Study|Adverse Event|0|||
170705289|NCT01403974|616930153|FG000|Overall Study|Other than specified|0|||
170705290|NCT01403974|616930154|FG001|Overall Study|Other than specified|0|||
170705291|NCT01403974|616930155|FG002|Overall Study|Other than specified|0|||
170705292|NCT01403974|616930156|FG003|Overall Study|Other than specified|0|||
170705293|NCT01403974|616930157|FG004|Overall Study|Other than specified|0|||
170705294|NCT01403974|616930158|FG005|Overall Study|Other than specified|0|||
170705295|NCT01403974|616930159|FG006|Overall Study|Other than specified|0|||
170705296|NCT01403974|616930160|FG007|Overall Study|Other than specified|0|||
170705297|NCT01403974|616930161|FG008|Overall Study|Other than specified|0|||
170705298|NCT01403974|616930162|FG009|Overall Study|Other than specified|1|||
170705299|NCT01403974|616930163|FG010|Overall Study|Other than specified|0|||
170705300|NCT01403974|616930164|FG011|Overall Study|Other than specified|1|||
170705301|NCT01403974|616930165|FG012|Overall Study|Other than specified|0|||
170705302|NCT01403974|616930166|FG013|Overall Study|Other than specified|0|||
170705303|NCT01403974|616930167|FG014|Overall Study|Other than specified|0|||
170705304|NCT01403974|616930168|FG015|Overall Study|Other than specified|0|||
170705305|NCT03995953|616930169|FG000|Overall Study|Death|3|||
170705306|NCT03995953|616930170|FG001|Overall Study|Death|0|||
170705307|NCT03995953|616930171|FG002|Overall Study|Death|3|||
170705308|NCT03995953|616930172|FG003|Overall Study|Death|0|||
170705309|NCT03995953|616930173|FG004|Overall Study|Death|3|||
170705310|NCT03995953|616930174|FG005|Overall Study|Death|0|||
170705311|NCT03995953|616930175|FG006|Overall Study|Death|0|||
170705312|NCT03995953|616930176|FG007|Overall Study|Death|0|||
170705313|NCT03995953|616930177|FG008|Overall Study|Death|1|||
170705314|NCT03995953|616930178|FG009|Overall Study|Death|0|||
170705315|NCT03995953|616930179|FG010|Overall Study|Death|0|||
170705316|NCT03995953|616930180|FG011|Overall Study|Death|0|||
170705317|NCT03995953|616930169|FG000|Overall Study|Lost to Follow-up|6|||
170705318|NCT03995953|616930170|FG001|Overall Study|Lost to Follow-up|54|||
170705319|NCT03995953|616930171|FG002|Overall Study|Lost to Follow-up|3|||
170705320|NCT03995953|616930172|FG003|Overall Study|Lost to Follow-up|32|||
170705321|NCT03995953|616930173|FG004|Overall Study|Lost to Follow-up|5|||
170705322|NCT03995953|616930174|FG005|Overall Study|Lost to Follow-up|44|||
170705323|NCT03995953|616930175|FG006|Overall Study|Lost to Follow-up|0|||
170705324|NCT03995953|616930176|FG007|Overall Study|Lost to Follow-up|31|||
170705325|NCT03995953|616930177|FG008|Overall Study|Lost to Follow-up|8|||
170705326|NCT03995953|616930178|FG009|Overall Study|Lost to Follow-up|36|||
170705327|NCT03995953|616930179|FG010|Overall Study|Lost to Follow-up|5|||
170705328|NCT03995953|616930180|FG011|Overall Study|Lost to Follow-up|41|||
170705329|NCT03995953|616930169|FG000|Overall Study|Withdrawal by Subject|4|||
170705330|NCT03995953|616930170|FG001|Overall Study|Withdrawal by Subject|0|||
170705331|NCT03995953|616930171|FG002|Overall Study|Withdrawal by Subject|1|||
170705332|NCT03995953|616930172|FG003|Overall Study|Withdrawal by Subject|0|||
170705333|NCT03995953|616930173|FG004|Overall Study|Withdrawal by Subject|1|||
170705334|NCT03995953|616930174|FG005|Overall Study|Withdrawal by Subject|0|||
170705335|NCT03995953|616930175|FG006|Overall Study|Withdrawal by Subject|1|||
170705336|NCT03995953|616930176|FG007|Overall Study|Withdrawal by Subject|0|||
170705337|NCT03995953|616930177|FG008|Overall Study|Withdrawal by Subject|3|||
170705338|NCT03995953|616930178|FG009|Overall Study|Withdrawal by Subject|0|||
170705339|NCT03995953|616930179|FG010|Overall Study|Withdrawal by Subject|3|||
170705340|NCT03995953|616930180|FG011|Overall Study|Withdrawal by Subject|0|||
170705341|NCT03995953|616930169|FG000|Overall Study|Health Issues|0|||
170705342|NCT03995953|616930170|FG001|Overall Study|Health Issues|0|||
170705343|NCT03995953|616930171|FG002|Overall Study|Health Issues|0|||
170705344|NCT03995953|616930172|FG003|Overall Study|Health Issues|0|||
170705345|NCT03995953|616930173|FG004|Overall Study|Health Issues|1|||
170705346|NCT03995953|616930174|FG005|Overall Study|Health Issues|0|||
170705347|NCT03995953|616930175|FG006|Overall Study|Health Issues|0|||
170705348|NCT03995953|616930176|FG007|Overall Study|Health Issues|0|||
170705349|NCT03995953|616930177|FG008|Overall Study|Health Issues|4|||
170705350|NCT03995953|616930178|FG009|Overall Study|Health Issues|0|||
170705351|NCT03995953|616930179|FG010|Overall Study|Health Issues|0|||
170705352|NCT03995953|616930180|FG011|Overall Study|Health Issues|0|||
170705353|NCT03995953|616930169|FG000|Overall Study|Relocated|11|||
170705354|NCT03995953|616930170|FG001|Overall Study|Relocated|0|||
170705355|NCT03995953|616930171|FG002|Overall Study|Relocated|16|||
170705356|NCT03995953|616930172|FG003|Overall Study|Relocated|0|||
170705357|NCT03995953|616930173|FG004|Overall Study|Relocated|14|||
170705358|NCT03995953|616930174|FG005|Overall Study|Relocated|0|||
170705359|NCT03995953|616930175|FG006|Overall Study|Relocated|16|||
170705360|NCT03995953|616930176|FG007|Overall Study|Relocated|0|||
170705361|NCT03995953|616930177|FG008|Overall Study|Relocated|14|||
170705362|NCT03995953|616930178|FG009|Overall Study|Relocated|0|||
170705363|NCT03995953|616930179|FG010|Overall Study|Relocated|15|||
170705364|NCT03995953|616930180|FG011|Overall Study|Relocated|0|||
170705365|NCT01193556|616930181|FG000|Overall Study|Study termination|26|||
170705366|NCT01193556|616930182|FG001|Overall Study|Study termination|25|||
170705367|NCT01696032|616930183|FG000|Overall Study|Withdrawal by Subject|0|||
170705368|NCT01696032|616930184|FG001|Overall Study|Withdrawal by Subject|0|||
170705369|NCT01696032|616930185|FG002|Overall Study|Withdrawal by Subject|1|||
170705370|NCT01696032|616930186|FG003|Overall Study|Withdrawal by Subject|2|||
170705371|NCT01696032|616930183|FG000|Overall Study|Death|14|||
170705372|NCT01696032|616930184|FG001|Overall Study|Death|4|||
170705373|NCT01696032|616930185|FG002|Overall Study|Death|43|||
170705374|NCT01696032|616930186|FG003|Overall Study|Death|18|||
170705375|NCT01696032|616930183|FG000|Overall Study|Lost to Follow-up|0|||
170705376|NCT01696032|616930184|FG001|Overall Study|Lost to Follow-up|1|||
170705377|NCT01696032|616930185|FG002|Overall Study|Lost to Follow-up|0|||
170705378|NCT01696032|616930186|FG003|Overall Study|Lost to Follow-up|0|||
170705379|NCT01696032|616930183|FG000|Overall Study|Database lock|0|||
170705380|NCT01696032|616930184|FG001|Overall Study|Database lock|1|||
170705381|NCT01696032|616930185|FG002|Overall Study|Database lock|7|||
170705382|NCT01696032|616930186|FG003|Overall Study|Database lock|2|||
170705383|NCT00376168|616930189|FG000|Overall Study|Adverse Event|1|||
170705384|NCT00376168|616930190|FG001|Overall Study|Adverse Event|1|||
170826343|NCT01917006|617374302|FG000|Randomized-treatment Period|Protocol Violation|1|||
170826344|NCT01917006|617374303|FG001|Randomized-treatment Period|Protocol Violation|0|||
170705385|NCT00376168|616930189|FG000|Overall Study|Pregnancy|1|||
170705386|NCT00376168|616930190|FG001|Overall Study|Pregnancy|0|||
170705387|NCT01020019|616930191|FG000|Overall Study|Lost to Follow-up|21|||
170705388|NCT01020019|616930192|FG001|Overall Study|Lost to Follow-up|18|||
170705389|NCT01020019|616930191|FG000|Overall Study|Adverse Event|1|||
170705390|NCT01020019|616930192|FG001|Overall Study|Adverse Event|5|||
170705391|NCT01020019|616930191|FG000|Overall Study|not interested in treatment|4|||
170705392|NCT01020019|616930192|FG001|Overall Study|not interested in treatment|4|||
170705393|NCT01020019|616930191|FG000|Overall Study|moving|0|||
170705394|NCT01020019|616930192|FG001|Overall Study|moving|2|||
170705395|NCT05091528|616930193|FG000|Overall Study|Study Termination by Sponsor|0|||
170705396|NCT05091528|616930194|FG001|Overall Study|Study Termination by Sponsor|1|||
170705397|NCT05091528|616930195|FG002|Overall Study|Study Termination by Sponsor|0|||
170705398|NCT05091528|616930196|FG003|Overall Study|Study Termination by Sponsor|1|||
170705399|NCT04958109|616930197|FG000|Overall Study|Withdrawal by Subject|0|||
170705400|NCT04958109|616930198|FG001|Overall Study|Withdrawal by Subject|1|||
170705401|NCT04958109|616930197|FG000|Overall Study|Lost to Follow-up|0|||
170705402|NCT04958109|616930198|FG001|Overall Study|Lost to Follow-up|1|||
170705403|NCT02214121|616930201|FG000|Part A|Patient decision|2|||
170705404|NCT02214121|616930202|FG001|Part A|Patient decision|0|||
170705405|NCT02214121|616930203|FG002|Part A|Patient decision|0|||
170705406|NCT02214121|616930201|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
170705407|NCT02214121|616930202|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
170705408|NCT02214121|616930203|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
170705409|NCT02214121|616930201|FG000|Part A|Other|1|||
170705410|NCT02214121|616930202|FG001|Part A|Other|0|||
170705411|NCT02214121|616930203|FG002|Part A|Other|0|||
170705412|NCT02214121|616930201|FG000|Part B|Patient decision|0|||
170705413|NCT02214121|616930202|FG001|Part B|Patient decision|1|||
170705414|NCT02214121|616930203|FG002|Part B|Patient decision|0|||
170705415|NCT02214121|616930201|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
170705416|NCT02214121|616930202|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
170705417|NCT02214121|616930203|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
170705418|NCT02214121|616930201|FG000|Part B|Lost to Follow-up|0|||
170705419|NCT02214121|616930202|FG001|Part B|Lost to Follow-up|0|||
170705420|NCT02214121|616930203|FG002|Part B|Lost to Follow-up|1|||
170705421|NCT02375672|616930204|FG000|Overall Study|remain on follow up|20|||
170705422|NCT02203591|616930205|FG000|Overall Study|Did not meet treatment day baseline|147|||
170705423|NCT02203591|616930206|FG001|Overall Study|Did not meet treatment day baseline|141|||
170705424|NCT02203591|616930207|FG002|Overall Study|Did not meet treatment day baseline|150|||
170705425|NCT02203591|616930208|FG003|Overall Study|Did not meet treatment day baseline|45|||
170705426|NCT02203591|616930209|FG004|Overall Study|Did not meet treatment day baseline|33|||
170705427|NCT02203591|616930210|FG005|Overall Study|Did not meet treatment day baseline|35|||
170705428|NCT02203591|616930211|FG006|Overall Study|Did not meet treatment day baseline|29|||
170705429|NCT02203591|616930212|FG007|Overall Study|Did not meet treatment day baseline|12|||
170705430|NCT02203591|616930205|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
170705431|NCT02203591|616930206|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
170705432|NCT02203591|616930207|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
170705433|NCT02203591|616930208|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
170705434|NCT02203591|616930209|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
170705435|NCT02203591|616930210|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
170705436|NCT02203591|616930211|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
170705437|NCT02203591|616930212|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
170705438|NCT04115358|616930213|FG000|Overall Study|exfoliation|0|||
170705439|NCT04115358|616930214|FG001|Overall Study|exfoliation|0|||
170705440|NCT04115358|616930215|FG002|Overall Study|exfoliation|1|||
170705441|NCT01573624|616930216|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
170705442|NCT01573624|616930217|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
170705443|NCT01573624|616930218|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
170705444|NCT01573624|616930219|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
170705445|NCT01573624|616930220|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
170705446|NCT01573624|616930221|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
170705447|NCT01573624|616930222|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
170705448|NCT01573624|616930216|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
170705449|NCT01573624|616930217|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
170705450|NCT01573624|616930218|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
170705451|NCT01573624|616930219|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
170705452|NCT01573624|616930220|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
170705453|NCT01573624|616930221|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
170705454|NCT01573624|616930222|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
170705455|NCT01573624|616930216|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
170705456|NCT01573624|616930217|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
170705457|NCT01573624|616930218|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
170705458|NCT01573624|616930219|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
170705459|NCT01573624|616930220|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
170705460|NCT01573624|616930221|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
170705461|NCT01573624|616930222|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
170705462|NCT01573624|616930216|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170705463|NCT01573624|616930217|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170705464|NCT01573624|616930218|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
170705465|NCT01573624|616930219|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170705466|NCT01573624|616930220|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170705467|NCT01573624|616930221|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
170826345|NCT01917006|617374304|FG002|Randomized-treatment Period|Protocol Violation|0|||
170826346|NCT01917006|617374305|FG003|Randomized-treatment Period|Protocol Violation|0|||
170826347|NCT01917006|617374306|FG004|Randomized-treatment Period|Protocol Violation|0|||
170826348|NCT01917006|617374307|FG005|Randomized-treatment Period|Protocol Violation|0|||
170826349|NCT01917006|617374308|FG006|Randomized-treatment Period|Protocol Violation|0|||
170826350|NCT01917006|617374309|FG007|Randomized-treatment Period|Protocol Violation|0|||
170826351|NCT01917006|617374302|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
170826352|NCT01917006|617374303|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
170826353|NCT01917006|617374304|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
170826354|NCT01917006|617374305|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
170826355|NCT01917006|617374306|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
170826356|NCT01917006|617374307|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
170826357|NCT01917006|617374308|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
170826358|NCT01917006|617374309|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
170826359|NCT01917006|617374302|FG000|Open-label Period|Adverse Event|0|||
170826360|NCT01917006|617374303|FG001|Open-label Period|Adverse Event|0|||
170826361|NCT01917006|617374304|FG002|Open-label Period|Adverse Event|0|||
170826362|NCT01917006|617374305|FG003|Open-label Period|Adverse Event|0|||
170826363|NCT01917006|617374306|FG004|Open-label Period|Adverse Event|0|||
170826364|NCT01917006|617374307|FG005|Open-label Period|Adverse Event|0|||
170826365|NCT01917006|617374308|FG006|Open-label Period|Adverse Event|0|||
170826366|NCT01917006|617374309|FG007|Open-label Period|Adverse Event|1|||
170826367|NCT01917006|617374302|FG000|Open-label Period|Lost to Follow-up|0|||
170826368|NCT01917006|617374303|FG001|Open-label Period|Lost to Follow-up|0|||
170826369|NCT01917006|617374304|FG002|Open-label Period|Lost to Follow-up|0|||
170826370|NCT01917006|617374305|FG003|Open-label Period|Lost to Follow-up|0|||
170826371|NCT01917006|617374306|FG004|Open-label Period|Lost to Follow-up|0|||
170826372|NCT01917006|617374307|FG005|Open-label Period|Lost to Follow-up|0|||
170826373|NCT01917006|617374308|FG006|Open-label Period|Lost to Follow-up|0|||
170826374|NCT01917006|617374309|FG007|Open-label Period|Lost to Follow-up|1|||
170826375|NCT02158247|617374315|FG000|Overall Study|Invisible vocal cords|5|||
170826376|NCT01057251|617374317|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
170826377|NCT01057251|617374318|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
170826378|NCT01057251|617374317|FG000|Overall Study|Adverse Event|4|||
170826379|NCT01057251|617374318|FG001|Overall Study|Adverse Event|2|||
170826380|NCT01057251|617374317|FG000|Overall Study|Lack of Efficacy|2|||
170826381|NCT01057251|617374318|FG001|Overall Study|Lack of Efficacy|11|||
170826382|NCT01057251|617374317|FG000|Overall Study|Protocol Violation|6|||
170826383|NCT01057251|617374318|FG001|Overall Study|Protocol Violation|2|||
170826384|NCT01057251|617374317|FG000|Overall Study|Withdrawal by Subject|4|||
170826385|NCT01057251|617374318|FG001|Overall Study|Withdrawal by Subject|5|||
170826386|NCT01057251|617374317|FG000|Overall Study|Lost to Follow-up|7|||
170826387|NCT01057251|617374318|FG001|Overall Study|Lost to Follow-up|6|||
170826388|NCT01057251|617374317|FG000|Overall Study|Other Reason|1|||
170826389|NCT01057251|617374318|FG001|Overall Study|Other Reason|1|||
170826390|NCT04150341|617374322|FG000|Overall Study|Physician Decision|0|||
170826391|NCT04150341|617374323|FG001|Overall Study|Physician Decision|0|||
170826392|NCT04150341|617374324|FG002|Overall Study|Physician Decision|1|||
170826393|NCT04150341|617374325|FG003|Overall Study|Physician Decision|0|||
170826394|NCT04150341|617374326|FG004|Overall Study|Physician Decision|0|||
170826395|NCT04150341|617374327|FG005|Overall Study|Physician Decision|0|||
170826396|NCT04150341|617374322|FG000|Overall Study|Adverse Event|0|||
170826397|NCT04150341|617374323|FG001|Overall Study|Adverse Event|0|||
170826398|NCT04150341|617374324|FG002|Overall Study|Adverse Event|0|||
170826399|NCT04150341|617374325|FG003|Overall Study|Adverse Event|0|||
170826400|NCT04150341|617374326|FG004|Overall Study|Adverse Event|1|||
170826401|NCT04150341|617374327|FG005|Overall Study|Adverse Event|0|||
170826402|NCT00833898|617374328|FG000|Overall Study|Withdrawal by Subject|33|||
170826403|NCT00833898|617374329|FG001|Overall Study|Withdrawal by Subject|27|||
170826404|NCT00833898|617374328|FG000|Overall Study|Lost to Follow-up|7|||
170826405|NCT00833898|617374329|FG001|Overall Study|Lost to Follow-up|7|||
170826406|NCT00833898|617374328|FG000|Overall Study|Patient did not receive transplant|0|||
170826407|NCT00833898|617374329|FG001|Overall Study|Patient did not receive transplant|2|||
170826408|NCT00943722|617374330|FG000|Base Study|Adverse Event|0|||
170826409|NCT00943722|617374331|FG001|Base Study|Adverse Event|0|||
170826410|NCT00943722|617374332|FG002|Base Study|Adverse Event|0|||
170826411|NCT00943722|617374333|FG003|Base Study|Adverse Event|1|||
170826412|NCT00943722|617374334|FG004|Base Study|Adverse Event|0|||
170826413|NCT00943722|617374335|FG005|Base Study|Adverse Event|0|||
170826414|NCT00943722|617374336|FG006|Base Study|Adverse Event|0|||
170826415|NCT00943722|617374330|FG000|Base Study|Lost to Follow-up|12|||
170826416|NCT00943722|617374331|FG001|Base Study|Lost to Follow-up|8|||
170826417|NCT00943722|617374332|FG002|Base Study|Lost to Follow-up|10|||
170826418|NCT00943722|617374333|FG003|Base Study|Lost to Follow-up|8|||
170826419|NCT00943722|617374334|FG004|Base Study|Lost to Follow-up|11|||
170826420|NCT00943722|617374335|FG005|Base Study|Lost to Follow-up|0|||
170826421|NCT00943722|617374336|FG006|Base Study|Lost to Follow-up|0|||
170705468|NCT01573624|616930222|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
170705469|NCT01573624|616930216|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
170705470|NCT01573624|616930217|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
170705471|NCT01573624|616930218|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
170705472|NCT01573624|616930219|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
170705473|NCT01573624|616930220|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
170705474|NCT01573624|616930221|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
170705475|NCT01573624|616930222|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
170705476|NCT01573624|616930216|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
170705477|NCT01573624|616930217|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
170705478|NCT01573624|616930218|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
170705479|NCT01573624|616930219|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
170705480|NCT01573624|616930220|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
170705481|NCT01573624|616930221|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
170705482|NCT01573624|616930222|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
170705483|NCT01573624|616930216|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
170705484|NCT01573624|616930217|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
170705485|NCT01573624|616930218|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
170705486|NCT01573624|616930219|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
170705487|NCT01573624|616930220|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
170705488|NCT01573624|616930221|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
170705489|NCT01573624|616930222|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
170705490|NCT01573624|616930216|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
170705491|NCT01573624|616930217|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170705492|NCT01573624|616930218|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
170705493|NCT01573624|616930219|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
170705494|NCT01573624|616930220|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170705495|NCT01573624|616930221|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170705496|NCT01573624|616930222|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
170705497|NCT01573624|616930216|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
170705498|NCT01573624|616930217|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
170705499|NCT01573624|616930218|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
170705500|NCT01573624|616930219|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
170705501|NCT01573624|616930220|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
170705502|NCT01573624|616930221|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
170705503|NCT01573624|616930222|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
170705504|NCT01573624|616930216|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
170705505|NCT01573624|616930217|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
170705506|NCT01573624|616930218|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
170705507|NCT01573624|616930219|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
170705508|NCT01573624|616930220|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
170705509|NCT01573624|616930221|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
170705510|NCT01573624|616930222|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
170705511|NCT01573624|616930216|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
170705512|NCT01573624|616930217|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
170705513|NCT01573624|616930218|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
170705514|NCT01573624|616930219|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
170705515|NCT01573624|616930220|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
170705516|NCT01573624|616930221|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
170705517|NCT01573624|616930222|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
170705518|NCT01573624|616930216|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
170705519|NCT01573624|616930217|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
170826422|NCT00943722|617374330|FG000|Base Study|Physician Decision|1|||
170826423|NCT00943722|617374331|FG001|Base Study|Physician Decision|0|||
170826424|NCT00943722|617374332|FG002|Base Study|Physician Decision|0|||
170826425|NCT00943722|617374333|FG003|Base Study|Physician Decision|0|||
170826426|NCT00943722|617374334|FG004|Base Study|Physician Decision|1|||
170705520|NCT01573624|616930218|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
170705521|NCT01573624|616930219|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
170705522|NCT01573624|616930220|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
170705523|NCT01573624|616930221|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
170705524|NCT01573624|616930222|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
170826427|NCT00943722|617374335|FG005|Base Study|Physician Decision|0|||
170826428|NCT00943722|617374336|FG006|Base Study|Physician Decision|0|||
170826429|NCT00943722|617374330|FG000|Base Study|Pregnancy|0|||
170826430|NCT00943722|617374331|FG001|Base Study|Pregnancy|0|||
170826431|NCT00943722|617374332|FG002|Base Study|Pregnancy|1|||
170826432|NCT00943722|617374333|FG003|Base Study|Pregnancy|0|||
170826433|NCT00943722|617374334|FG004|Base Study|Pregnancy|2|||
170826434|NCT00943722|617374335|FG005|Base Study|Pregnancy|0|||
170826435|NCT00943722|617374336|FG006|Base Study|Pregnancy|0|||
170826436|NCT00943722|617374330|FG000|Base Study|Protocol Violation|0|||
170826437|NCT00943722|617374331|FG001|Base Study|Protocol Violation|1|||
170826438|NCT00943722|617374332|FG002|Base Study|Protocol Violation|0|||
170826439|NCT00943722|617374333|FG003|Base Study|Protocol Violation|0|||
170826440|NCT00943722|617374334|FG004|Base Study|Protocol Violation|2|||
170826441|NCT00943722|617374335|FG005|Base Study|Protocol Violation|0|||
170826442|NCT00943722|617374336|FG006|Base Study|Protocol Violation|0|||
170826443|NCT00943722|617374330|FG000|Base Study|Withdrawal by Subject|12|||
170826444|NCT00943722|617374331|FG001|Base Study|Withdrawal by Subject|13|||
170826445|NCT00943722|617374332|FG002|Base Study|Withdrawal by Subject|2|||
170826446|NCT00943722|617374333|FG003|Base Study|Withdrawal by Subject|13|||
170826447|NCT00943722|617374334|FG004|Base Study|Withdrawal by Subject|8|||
170826448|NCT00943722|617374335|FG005|Base Study|Withdrawal by Subject|0|||
170826449|NCT00943722|617374336|FG006|Base Study|Withdrawal by Subject|0|||
170826450|NCT00943722|617374330|FG000|Base Study|Month 12 visit not completed|0|||
170826451|NCT00943722|617374331|FG001|Base Study|Month 12 visit not completed|0|||
170826452|NCT00943722|617374332|FG002|Base Study|Month 12 visit not completed|0|||
170826453|NCT00943722|617374333|FG003|Base Study|Month 12 visit not completed|0|||
170826454|NCT00943722|617374334|FG004|Base Study|Month 12 visit not completed|2|||
170826455|NCT00943722|617374335|FG005|Base Study|Month 12 visit not completed|0|||
170826456|NCT00943722|617374336|FG006|Base Study|Month 12 visit not completed|0|||
170826457|NCT00943722|617374330|FG000|First Extension Study: EXT 1|Adverse Event|0|||
170826458|NCT00943722|617374331|FG001|First Extension Study: EXT 1|Adverse Event|0|||
170826459|NCT00943722|617374332|FG002|First Extension Study: EXT 1|Adverse Event|0|||
170826460|NCT00943722|617374333|FG003|First Extension Study: EXT 1|Adverse Event|0|||
170826461|NCT00943722|617374334|FG004|First Extension Study: EXT 1|Adverse Event|0|||
170826462|NCT00943722|617374335|FG005|First Extension Study: EXT 1|Adverse Event|1|||
170826463|NCT00943722|617374336|FG006|First Extension Study: EXT 1|Adverse Event|0|||
170826464|NCT00943722|617374330|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
170826465|NCT00943722|617374331|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
170826466|NCT00943722|617374332|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
170826467|NCT00943722|617374333|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
170826468|NCT00943722|617374334|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
170826469|NCT00943722|617374335|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
170826470|NCT00943722|617374336|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
170826471|NCT00943722|617374330|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
170826472|NCT00943722|617374331|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
170826473|NCT00943722|617374332|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
170826474|NCT00943722|617374333|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
170826475|NCT00943722|617374334|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
170826476|NCT00943722|617374335|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
170826477|NCT00943722|617374336|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
170826478|NCT00943722|617374330|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
170826479|NCT00943722|617374331|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
170826480|NCT00943722|617374332|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
170826481|NCT00943722|617374333|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
170826482|NCT00943722|617374334|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
170826483|NCT00943722|617374335|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
170826484|NCT00943722|617374336|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
170826485|NCT00943722|617374330|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
170826486|NCT00943722|617374331|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
170826487|NCT00943722|617374332|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
170826488|NCT00943722|617374333|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
170826489|NCT00943722|617374334|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
170826490|NCT00943722|617374335|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
170826491|NCT00943722|617374336|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
170826492|NCT00943722|617374330|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
170826493|NCT00943722|617374331|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
170826494|NCT00943722|617374332|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
170826495|NCT00943722|617374333|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
170826496|NCT00943722|617374334|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
170826497|NCT00943722|617374335|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
170826498|NCT00943722|617374336|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
170826499|NCT00943722|617374330|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
170826500|NCT00943722|617374331|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
170705525|NCT01573624|616930216|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
170705526|NCT01573624|616930217|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
170705527|NCT01573624|616930218|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
170705528|NCT01573624|616930219|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
170705529|NCT01573624|616930220|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
170705530|NCT01573624|616930221|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
170705531|NCT01573624|616930222|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
170705532|NCT01573624|616930216|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
170705533|NCT01573624|616930217|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
170705534|NCT01573624|616930218|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
170705535|NCT01573624|616930219|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
170705536|NCT01573624|616930220|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
170705537|NCT01573624|616930221|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
170705538|NCT01573624|616930222|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
170705539|NCT01573624|616930216|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
170705540|NCT01573624|616930217|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
170705541|NCT01573624|616930218|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
170705542|NCT01573624|616930219|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
170705543|NCT01573624|616930220|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
170705544|NCT01573624|616930221|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
170705545|NCT01573624|616930222|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
170705546|NCT01573624|616930216|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
170705547|NCT01573624|616930217|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
170705548|NCT01573624|616930218|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
170705549|NCT01573624|616930219|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
170705550|NCT01573624|616930220|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
170705551|NCT01573624|616930221|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
170705552|NCT01573624|616930222|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
170705553|NCT01573624|616930216|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
170705554|NCT01573624|616930217|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
170705555|NCT01573624|616930218|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
170705556|NCT01573624|616930219|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
170705557|NCT01573624|616930220|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
170705558|NCT01573624|616930221|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
170705559|NCT01573624|616930222|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
170705560|NCT01573624|616930216|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
170705561|NCT01573624|616930217|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
170705562|NCT01573624|616930218|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
170705563|NCT01573624|616930219|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
170705564|NCT01573624|616930220|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
170705565|NCT01573624|616930221|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
170705566|NCT01573624|616930222|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
170705567|NCT01573624|616930216|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
170705568|NCT01573624|616930217|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
170705569|NCT01573624|616930218|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
170705570|NCT01573624|616930219|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
170705571|NCT01573624|616930220|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
170705572|NCT01573624|616930221|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
170705573|NCT01573624|616930222|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
170705574|NCT01573624|616930216|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
170705575|NCT01573624|616930217|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
170705576|NCT01573624|616930218|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
170705577|NCT01573624|616930219|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
170705578|NCT01573624|616930220|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
170826501|NCT00943722|617374332|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
170826502|NCT00943722|617374333|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
170826503|NCT00943722|617374334|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
170826504|NCT00943722|617374335|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
170826505|NCT00943722|617374336|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
170826506|NCT00943722|617374330|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
170826507|NCT00943722|617374331|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
170826508|NCT00943722|617374332|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
170826509|NCT00943722|617374333|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
170705579|NCT01573624|616930221|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
170705580|NCT01573624|616930222|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
170705581|NCT01573624|616930216|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170705582|NCT01573624|616930217|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170705583|NCT01573624|616930218|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170705584|NCT01573624|616930219|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170705585|NCT01573624|616930220|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
170705586|NCT01573624|616930221|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
170705587|NCT01573624|616930222|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
170705588|NCT01573624|616930216|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
170705589|NCT01573624|616930217|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
170705590|NCT01573624|616930218|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
170705591|NCT01573624|616930219|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
170705592|NCT01573624|616930220|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
170705593|NCT01573624|616930221|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
170705594|NCT01573624|616930222|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
170705595|NCT01573624|616930216|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
170705596|NCT01573624|616930217|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170705597|NCT01573624|616930218|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170705598|NCT01573624|616930219|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
170705599|NCT01573624|616930220|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
170705600|NCT01573624|616930221|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
170705601|NCT01573624|616930222|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
170705602|NCT01573624|616930216|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
170705603|NCT01573624|616930217|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
170705604|NCT01573624|616930218|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
170705605|NCT01573624|616930219|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
170705606|NCT01573624|616930220|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
170705607|NCT01573624|616930221|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
170705608|NCT01573624|616930222|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
170705609|NCT01573624|616930216|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
170705610|NCT01573624|616930217|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
170705611|NCT01573624|616930218|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
170705612|NCT01573624|616930219|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
170705613|NCT01573624|616930220|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
170705614|NCT01573624|616930221|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
170705615|NCT01573624|616930222|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
170705616|NCT01573624|616930216|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
170705617|NCT01573624|616930217|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
170705618|NCT01573624|616930218|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
170705619|NCT01573624|616930219|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
170705620|NCT01573624|616930220|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
170705621|NCT01573624|616930221|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
170705622|NCT01573624|616930222|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
170705623|NCT01573624|616930216|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
170705624|NCT01573624|616930217|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
170705625|NCT01573624|616930218|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
170705626|NCT01573624|616930219|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
170705627|NCT01573624|616930220|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
170705628|NCT01573624|616930221|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
170705629|NCT01573624|616930222|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
170705630|NCT03306264|616930225|FG000|Overall Study|Death|33|||
170705631|NCT03306264|616930226|FG001|Overall Study|Death|25|||
170705632|NCT03306264|616930227|FG002|Overall Study|Death|34|||
170705633|NCT03306264|616930228|FG003|Overall Study|Death|34|||
170705634|NCT03306264|616930225|FG000|Overall Study|Complete Consent Withdrawal|4|||
170705635|NCT03306264|616930226|FG001|Overall Study|Complete Consent Withdrawal|4|||
170705636|NCT03306264|616930227|FG002|Overall Study|Complete Consent Withdrawal|1|||
170705637|NCT03306264|616930228|FG003|Overall Study|Complete Consent Withdrawal|8|||
170705638|NCT03306264|616930225|FG000|Overall Study|Lost to Follow-up|1|||
170705639|NCT03306264|616930226|FG001|Overall Study|Lost to Follow-up|0|||
170705640|NCT03306264|616930227|FG002|Overall Study|Lost to Follow-up|1|||
170705641|NCT03306264|616930228|FG003|Overall Study|Lost to Follow-up|0|||
170705642|NCT03306264|616930225|FG000|Overall Study|Rollover to ASTX727-06|10|||
170705643|NCT03306264|616930226|FG001|Overall Study|Rollover to ASTX727-06|18|||
170705644|NCT03306264|616930227|FG002|Overall Study|Rollover to ASTX727-06|4|||
170705645|NCT03306264|616930228|FG003|Overall Study|Rollover to ASTX727-06|2|||
170705646|NCT03306264|616930225|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
170705647|NCT03306264|616930226|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
170705648|NCT03306264|616930227|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
170705649|NCT03306264|616930228|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
170705650|NCT04399161|616930229|FG000|Overall Study|Withdrawal by Subject|1|||
170705651|NCT04399161|616930230|FG001|Overall Study|Withdrawal by Subject|0|||
170705652|NCT04399161|616930231|FG002|Overall Study|Withdrawal by Subject|2|||
170705653|NCT04399161|616930229|FG000|Overall Study|Protocol Violation|1|||
170705654|NCT04399161|616930230|FG001|Overall Study|Protocol Violation|2|||
170705655|NCT04399161|616930231|FG002|Overall Study|Protocol Violation|0|||
170705656|NCT02722928|616930236|FG000|Overall Study|Standard CT was not as required per prot|5|||
170705657|NCT02722928|616930237|FG001|Overall Study|Standard CT was not as required per prot|13|||
170705658|NCT02722928|616930236|FG000|Overall Study|Required Intraoperative MRI|5|||
170705659|NCT02722928|616930237|FG001|Overall Study|Required Intraoperative MRI|7|||
170705660|NCT02114879|616930238|FG000|Overall Study|Withdrawal by Subject|9|||
170705661|NCT02114879|616930239|FG001|Overall Study|Withdrawal by Subject|5|||
170705662|NCT02114879|616930238|FG000|Overall Study|Death|6|||
170705663|NCT02114879|616930239|FG001|Overall Study|Death|11|||
170705664|NCT02114879|616930238|FG000|Overall Study|Lost to Follow-up|4|||
170705665|NCT02114879|616930239|FG001|Overall Study|Lost to Follow-up|6|||
170705666|NCT02114879|616930238|FG000|Overall Study|Physician Decision|0|||
170705667|NCT02114879|616930239|FG001|Overall Study|Physician Decision|2|||
170705668|NCT03120013|616930243|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
170705669|NCT03120013|616930244|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
170705670|NCT01723228|616930249|FG000|Overall Study|Adverse Event|2|||
170705671|NCT01723228|616930250|FG001|Overall Study|Adverse Event|6|||
170705672|NCT01723228|616930249|FG000|Overall Study|Withdrawal by Subject|2|||
170705673|NCT01723228|616930250|FG001|Overall Study|Withdrawal by Subject|1|||
170705674|NCT01723228|616930249|FG000|Overall Study|Protocol Violation|0|||
170705675|NCT01723228|616930250|FG001|Overall Study|Protocol Violation|2|||
170705676|NCT01723228|616930249|FG000|Overall Study|Lost to Follow-up|2|||
170705677|NCT01723228|616930250|FG001|Overall Study|Lost to Follow-up|1|||
170705678|NCT01723228|616930249|FG000|Overall Study|Other|2|||
170705679|NCT01723228|616930250|FG001|Overall Study|Other|1|||
170705680|NCT01864291|616930251|FG000|Overall Study|need for revision surgery|2|||
170705681|NCT01282216|616930252|FG000|Overall Study|Graft failure|0|||
170705682|NCT01282216|616930253|FG001|Overall Study|Graft failure|0|||
170705683|NCT01282216|616930254|FG002|Overall Study|Graft failure|3|||
170705684|NCT01282216|616930255|FG003|Overall Study|Graft failure|2|||
170705685|NCT01282216|616930252|FG000|Overall Study|Physician Decision|0|||
170705686|NCT01282216|616930253|FG001|Overall Study|Physician Decision|0|||
170705687|NCT01282216|616930254|FG002|Overall Study|Physician Decision|11|||
170705688|NCT01282216|616930255|FG003|Overall Study|Physician Decision|0|||
170705689|NCT01282216|616930252|FG000|Overall Study|Relapse|0|||
170705690|NCT01282216|616930253|FG001|Overall Study|Relapse|0|||
170705691|NCT01282216|616930254|FG002|Overall Study|Relapse|17|||
170705692|NCT01282216|616930255|FG003|Overall Study|Relapse|6|||
170705693|NCT01282216|616930252|FG000|Overall Study|Death|0|||
170705694|NCT01282216|616930253|FG001|Overall Study|Death|0|||
170705695|NCT01282216|616930254|FG002|Overall Study|Death|2|||
170705696|NCT01282216|616930255|FG003|Overall Study|Death|0|||
170705697|NCT04074317|616930262|FG000|Third Period|Withdrawal by Subject|0|||
170705698|NCT04074317|616930263|FG001|Third Period|Withdrawal by Subject|0|||
170705699|NCT04074317|616930264|FG002|Third Period|Withdrawal by Subject|0|||
170705700|NCT04074317|616930265|FG003|Third Period|Withdrawal by Subject|1|||
170705701|NCT04074317|616930266|FG004|Third Period|Withdrawal by Subject|0|||
170705702|NCT04074317|616930267|FG005|Third Period|Withdrawal by Subject|0|||
170705703|NCT02573324|616931686|FG000|Overall Study|Withdrawal by Subject|26|||
170705704|NCT02573324|616931687|FG001|Overall Study|Withdrawal by Subject|23|||
170705705|NCT02573324|616931688|FG002|Overall Study|Withdrawal by Subject|3|||
170705706|NCT02573324|616931686|FG000|Overall Study|Lost to Follow-up|4|||
170705707|NCT02573324|616931687|FG001|Overall Study|Lost to Follow-up|5|||
170705708|NCT02573324|616931688|FG002|Overall Study|Lost to Follow-up|0|||
170705709|NCT02573324|616931686|FG000|Overall Study|Study Terminated by Sponsor|107|||
170705710|NCT02573324|616931687|FG001|Overall Study|Study Terminated by Sponsor|89|||
170705711|NCT02573324|616931688|FG002|Overall Study|Study Terminated by Sponsor|2|||
170705712|NCT02573324|616931686|FG000|Overall Study|Death|182|||
170705713|NCT02573324|616931687|FG001|Overall Study|Death|200|||
170705714|NCT02573324|616931688|FG002|Overall Study|Death|1|||
170705715|NCT02573324|616931686|FG000|Overall Study|Other, Not Specified|20|||
170705716|NCT02573324|616931687|FG001|Overall Study|Other, Not Specified|27|||
170705717|NCT02573324|616931688|FG002|Overall Study|Other, Not Specified|0|||
170705718|NCT02573324|616931686|FG000|Overall Study|Unknown Reason|2|||
170705719|NCT02573324|616931687|FG001|Overall Study|Unknown Reason|0|||
170705720|NCT02573324|616931688|FG002|Overall Study|Unknown Reason|0|||
170705721|NCT01607905|616931689|FG000|Overall Study|Withdrawal by participant|7|||
170705722|NCT01607905|616931690|FG001|Overall Study|Withdrawal by participant|2|||
170705723|NCT01607905|616931691|FG002|Overall Study|Withdrawal by participant|4|||
170705724|NCT01607905|616931692|FG003|Overall Study|Withdrawal by participant|6|||
170705725|NCT01607905|616931693|FG004|Overall Study|Withdrawal by participant|0|||
170705726|NCT01607905|616931694|FG005|Overall Study|Withdrawal by participant|4|||
170705727|NCT01607905|616931695|FG006|Overall Study|Withdrawal by participant|12|||
170705728|NCT01607905|616931689|FG000|Overall Study|Incidence or severity of AEs|5|||
170705729|NCT01607905|616931690|FG001|Overall Study|Incidence or severity of AEs|1|||
170705730|NCT01607905|616931691|FG002|Overall Study|Incidence or severity of AEs|1|||
170705731|NCT01607905|616931692|FG003|Overall Study|Incidence or severity of AEs|3|||
170705732|NCT01607905|616931693|FG004|Overall Study|Incidence or severity of AEs|0|||
170705733|NCT01607905|616931694|FG005|Overall Study|Incidence or severity of AEs|2|||
170705734|NCT01607905|616931695|FG006|Overall Study|Incidence or severity of AEs|8|||
170705735|NCT01607905|616931689|FG000|Overall Study|Disease progression|44|||
170705736|NCT01607905|616931690|FG001|Overall Study|Disease progression|16|||
170705737|NCT01607905|616931691|FG002|Overall Study|Disease progression|15|||
170705738|NCT01607905|616931692|FG003|Overall Study|Disease progression|11|||
170705739|NCT01607905|616931693|FG004|Overall Study|Disease progression|6|||
170705740|NCT01607905|616931694|FG005|Overall Study|Disease progression|7|||
170705741|NCT01607905|616931695|FG006|Overall Study|Disease progression|21|||
170705742|NCT01607905|616931689|FG000|Overall Study|Non-compliance with study procedures|0|||
170705743|NCT01607905|616931690|FG001|Overall Study|Non-compliance with study procedures|0|||
170705744|NCT01607905|616931691|FG002|Overall Study|Non-compliance with study procedures|0|||
170705745|NCT01607905|616931692|FG003|Overall Study|Non-compliance with study procedures|0|||
170705746|NCT01607905|616931693|FG004|Overall Study|Non-compliance with study procedures|0|||
170705747|NCT01607905|616931694|FG005|Overall Study|Non-compliance with study procedures|0|||
170705748|NCT01607905|616931695|FG006|Overall Study|Non-compliance with study procedures|1|||
170705749|NCT01607905|616931689|FG000|Overall Study|Death|1|||
170705750|NCT01607905|616931690|FG001|Overall Study|Death|1|||
170705751|NCT01607905|616931691|FG002|Overall Study|Death|1|||
170705752|NCT01607905|616931692|FG003|Overall Study|Death|1|||
170705753|NCT01607905|616931693|FG004|Overall Study|Death|0|||
170705754|NCT01607905|616931694|FG005|Overall Study|Death|0|||
170705755|NCT01607905|616931695|FG006|Overall Study|Death|3|||
170705756|NCT01607905|616931689|FG000|Overall Study|Other treatments become available|1|||
170705757|NCT01607905|616931690|FG001|Overall Study|Other treatments become available|0|||
170705758|NCT01607905|616931691|FG002|Overall Study|Other treatments become available|0|||
170705759|NCT01607905|616931692|FG003|Overall Study|Other treatments become available|0|||
170705760|NCT01607905|616931693|FG004|Overall Study|Other treatments become available|0|||
170705761|NCT01607905|616931694|FG005|Overall Study|Other treatments become available|0|||
170705762|NCT01607905|616931695|FG006|Overall Study|Other treatments become available|1|||
170705763|NCT01607905|616931689|FG000|Overall Study|Investigator discretion|0|||
170705764|NCT01607905|616931690|FG001|Overall Study|Investigator discretion|0|||
170705765|NCT01607905|616931691|FG002|Overall Study|Investigator discretion|0|||
170705766|NCT01607905|616931692|FG003|Overall Study|Investigator discretion|0|||
170705767|NCT01607905|616931693|FG004|Overall Study|Investigator discretion|0|||
170705768|NCT01607905|616931694|FG005|Overall Study|Investigator discretion|1|||
170705769|NCT01607905|616931695|FG006|Overall Study|Investigator discretion|0|||
170705770|NCT01607905|616931689|FG000|Overall Study|Other|1|||
170705771|NCT01607905|616931690|FG001|Overall Study|Other|0|||
170705772|NCT01607905|616931691|FG002|Overall Study|Other|0|||
170705773|NCT01607905|616931692|FG003|Overall Study|Other|0|||
170705774|NCT01607905|616931693|FG004|Overall Study|Other|0|||
170705775|NCT01607905|616931694|FG005|Overall Study|Other|0|||
170705776|NCT01607905|616931695|FG006|Overall Study|Other|1|||
170705777|NCT01607905|616931689|FG000|Overall Study|Randomized but not treated|1|||
170705778|NCT01607905|616931690|FG001|Overall Study|Randomized but not treated|0|||
170705779|NCT01607905|616931691|FG002|Overall Study|Randomized but not treated|0|||
170705780|NCT01607905|616931692|FG003|Overall Study|Randomized but not treated|0|||
170705781|NCT01607905|616931693|FG004|Overall Study|Randomized but not treated|1|||
170705782|NCT01607905|616931694|FG005|Overall Study|Randomized but not treated|1|||
170705783|NCT01607905|616931695|FG006|Overall Study|Randomized but not treated|0|||
170705784|NCT00941733|616931696|FG000|Overall Study|Death|24|||
170705785|NCT00941733|616931697|FG001|Overall Study|Death|10|||
170705786|NCT00941733|616931696|FG000|Overall Study|Withdrawal by Subject|14|||
170705787|NCT00941733|616931697|FG001|Overall Study|Withdrawal by Subject|6|||
170705788|NCT00941733|616931696|FG000|Overall Study|Adverse Event|20|||
170705789|NCT00941733|616931697|FG001|Overall Study|Adverse Event|4|||
170705790|NCT00941733|616931696|FG000|Overall Study|Lost to Follow-up|1|||
170705791|NCT00941733|616931697|FG001|Overall Study|Lost to Follow-up|2|||
170705792|NCT00941733|616931696|FG000|Overall Study|Protocol Violation|15|||
170705793|NCT00941733|616931697|FG001|Overall Study|Protocol Violation|6|||
170705794|NCT01610700|616931699|FG000|Overall Study|Adverse Event|3|||
170705795|NCT01610700|616931700|FG001|Overall Study|Adverse Event|1|||
170705796|NCT01610700|616931699|FG000|Overall Study|Withdrawal by Subject|0|||
170705797|NCT01610700|616931700|FG001|Overall Study|Withdrawal by Subject|1|||
170705798|NCT01610700|616931699|FG000|Overall Study|subject took one dose of street cannabis|0|||
170705799|NCT01610700|616931700|FG001|Overall Study|subject took one dose of street cannabis|1|||
170705800|NCT00978731|616931705|FG000|Overall Study|Death|4|||
170705801|NCT00978731|616931706|FG001|Overall Study|Death|1|||
170705802|NCT00978731|616931707|FG002|Overall Study|Death|1|||
170705803|NCT00978731|616931708|FG003|Overall Study|Death|0|||
170705804|NCT00978731|616931705|FG000|Overall Study|Lost to Follow-up|0|||
170705805|NCT00978731|616931706|FG001|Overall Study|Lost to Follow-up|0|||
170705806|NCT00978731|616931707|FG002|Overall Study|Lost to Follow-up|0|||
170705807|NCT00978731|616931708|FG003|Overall Study|Lost to Follow-up|1|||
170705808|NCT00978731|616931705|FG000|Overall Study|Adverse Event|5|||
170705809|NCT00978731|616931706|FG001|Overall Study|Adverse Event|2|||
170705810|NCT00978731|616931707|FG002|Overall Study|Adverse Event|0|||
170705811|NCT00978731|616931708|FG003|Overall Study|Adverse Event|0|||
170705812|NCT00978731|616931705|FG000|Overall Study|Participant's request|1|||
170705813|NCT00978731|616931706|FG001|Overall Study|Participant's request|0|||
170705814|NCT00978731|616931707|FG002|Overall Study|Participant's request|0|||
170705815|NCT00978731|616931708|FG003|Overall Study|Participant's request|0|||
170705816|NCT00978731|616931705|FG000|Overall Study|Administrative reason|3|||
170705817|NCT00978731|616931706|FG001|Overall Study|Administrative reason|3|||
170705818|NCT00978731|616931707|FG002|Overall Study|Administrative reason|1|||
170705819|NCT00978731|616931708|FG003|Overall Study|Administrative reason|0|||
170705820|NCT00978731|616931705|FG000|Overall Study|Deterioration without progression|0|||
170705821|NCT00978731|616931706|FG001|Overall Study|Deterioration without progression|1|||
170705822|NCT00978731|616931707|FG002|Overall Study|Deterioration without progression|0|||
170705823|NCT00978731|616931708|FG003|Overall Study|Deterioration without progression|0|||
170705824|NCT00978731|616931705|FG000|Overall Study|Disease progression/relapse|5|||
170705825|NCT00978731|616931706|FG001|Overall Study|Disease progression/relapse|4|||
170705826|NCT00978731|616931707|FG002|Overall Study|Disease progression/relapse|2|||
170705827|NCT00978731|616931708|FG003|Overall Study|Disease progression/relapse|2|||
170705828|NCT00978731|616931705|FG000|Overall Study|Study closure|3|||
170705829|NCT00978731|616931706|FG001|Overall Study|Study closure|4|||
170705830|NCT00978731|616931707|FG002|Overall Study|Study closure|1|||
170705831|NCT00978731|616931708|FG003|Overall Study|Study closure|1|||
170705832|NCT00978731|616931705|FG000|Overall Study|No response|1|||
170705833|NCT00978731|616931706|FG001|Overall Study|No response|0|||
170705834|NCT00978731|616931707|FG002|Overall Study|No response|0|||
170705835|NCT00978731|616931708|FG003|Overall Study|No response|0|||
170705836|NCT02097134|616931709|FG000|Overall Study|Physician Decision|4|||
170705837|NCT02097134|616931709|FG000|Overall Study|Non-Protocol Therapy|1|||
170705838|NCT02097134|616931709|FG000|Overall Study|Progressive Disease|3|||
170705839|NCT02097134|616931709|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
170705840|NCT04027686|616931710|FG000|Overall Study|Lost to Follow-up|2|||
170705841|NCT04027686|616931711|FG001|Overall Study|Lost to Follow-up|0|||
170705842|NCT04027686|616931710|FG000|Overall Study|Withdrawal by Subject|0|||
170705843|NCT04027686|616931711|FG001|Overall Study|Withdrawal by Subject|1|||
170705844|NCT04456699|616931713|FG000|Overall Study|Death|48|||
170705845|NCT04456699|616931714|FG001|Overall Study|Death|50|||
170705846|NCT04456699|616931715|FG002|Overall Study|Death|52|||
170705847|NCT04456699|616931713|FG000|Overall Study|Physician Decision|0|||
170705848|NCT04456699|616931714|FG001|Overall Study|Physician Decision|0|||
170705849|NCT04456699|616931715|FG002|Overall Study|Physician Decision|2|||
170705850|NCT04456699|616931713|FG000|Overall Study|Sponsor Decision|55|||
170705851|NCT04456699|616931714|FG001|Overall Study|Sponsor Decision|61|||
170705852|NCT04456699|616931715|FG002|Overall Study|Sponsor Decision|50|||
170705853|NCT04456699|616931713|FG000|Overall Study|Withdrawal by Subject|8|||
170705854|NCT04456699|616931714|FG001|Overall Study|Withdrawal by Subject|4|||
170705855|NCT04456699|616931715|FG002|Overall Study|Withdrawal by Subject|5|||
170705856|NCT03604692|616931718|FG000|Overall Study|Investigator's Decision|0|||
170705857|NCT03604692|616931719|FG001|Overall Study|Investigator's Decision|0|||
170705858|NCT03604692|616931720|FG002|Overall Study|Investigator's Decision|0|||
170705859|NCT03604692|616931721|FG003|Overall Study|Investigator's Decision|1|||
170705860|NCT03604692|616931722|FG004|Overall Study|Investigator's Decision|0|||
170705861|NCT03604692|616931723|FG005|Overall Study|Investigator's Decision|7|||
170705862|NCT03604692|616931718|FG000|Overall Study|Withdrawal by Subject|0|||
170705863|NCT03604692|616931719|FG001|Overall Study|Withdrawal by Subject|0|||
170705864|NCT03604692|616931720|FG002|Overall Study|Withdrawal by Subject|0|||
170705865|NCT03604692|616931721|FG003|Overall Study|Withdrawal by Subject|0|||
170705866|NCT03604692|616931722|FG004|Overall Study|Withdrawal by Subject|0|||
170705867|NCT03604692|616931723|FG005|Overall Study|Withdrawal by Subject|2|||
170705868|NCT03604692|616931718|FG000|Overall Study|Progressive Disease|1|||
170705869|NCT03604692|616931719|FG001|Overall Study|Progressive Disease|0|||
170705870|NCT03604692|616931720|FG002|Overall Study|Progressive Disease|1|||
170705871|NCT03604692|616931721|FG003|Overall Study|Progressive Disease|0|||
170705872|NCT03604692|616931722|FG004|Overall Study|Progressive Disease|3|||
170705873|NCT03604692|616931723|FG005|Overall Study|Progressive Disease|4|||
170705874|NCT03604692|616931718|FG000|Overall Study|Difficulty Coming into Site|0|||
170705875|NCT03604692|616931719|FG001|Overall Study|Difficulty Coming into Site|0|||
170705876|NCT03604692|616931720|FG002|Overall Study|Difficulty Coming into Site|0|||
170705877|NCT03604692|616931721|FG003|Overall Study|Difficulty Coming into Site|0|||
170705878|NCT03604692|616931722|FG004|Overall Study|Difficulty Coming into Site|0|||
170705879|NCT03604692|616931723|FG005|Overall Study|Difficulty Coming into Site|1|||
170705880|NCT03604692|616931718|FG000|Overall Study|Death|0|||
170705881|NCT03604692|616931719|FG001|Overall Study|Death|0|||
170705882|NCT03604692|616931720|FG002|Overall Study|Death|1|||
170705883|NCT03604692|616931721|FG003|Overall Study|Death|0|||
170705884|NCT03604692|616931722|FG004|Overall Study|Death|0|||
170705885|NCT03604692|616931723|FG005|Overall Study|Death|0|||
170705886|NCT03604692|616931718|FG000|Overall Study|Drug Intolerance|0|||
170705887|NCT03604692|616931719|FG001|Overall Study|Drug Intolerance|0|||
170705888|NCT03604692|616931720|FG002|Overall Study|Drug Intolerance|0|||
170705889|NCT03604692|616931721|FG003|Overall Study|Drug Intolerance|1|||
170705890|NCT03604692|616931722|FG004|Overall Study|Drug Intolerance|0|||
170705891|NCT03604692|616931723|FG005|Overall Study|Drug Intolerance|0|||
170705892|NCT03604692|616931718|FG000|Overall Study|Noncompliance with follow-up visit|0|||
170705893|NCT03604692|616931719|FG001|Overall Study|Noncompliance with follow-up visit|0|||
170705894|NCT03604692|616931720|FG002|Overall Study|Noncompliance with follow-up visit|0|||
170705895|NCT03604692|616931721|FG003|Overall Study|Noncompliance with follow-up visit|1|||
170705896|NCT03604692|616931722|FG004|Overall Study|Noncompliance with follow-up visit|0|||
170705897|NCT03604692|616931723|FG005|Overall Study|Noncompliance with follow-up visit|0|||
170705898|NCT03604692|616931718|FG000|Overall Study|Not Treated|0|||
170705899|NCT03604692|616931719|FG001|Overall Study|Not Treated|0|||
170705900|NCT03604692|616931720|FG002|Overall Study|Not Treated|0|||
170705901|NCT03604692|616931721|FG003|Overall Study|Not Treated|0|||
170705902|NCT03604692|616931722|FG004|Overall Study|Not Treated|1|||
170705903|NCT03604692|616931723|FG005|Overall Study|Not Treated|0|||
170705904|NCT00637195|616931724|FG000|Overall Study|Lost to Follow-up|1|||
170705905|NCT00637195|616931725|FG001|Overall Study|Lost to Follow-up|0|||
170705906|NCT00637195|616931724|FG000|Overall Study|Other|2|||
170705907|NCT00637195|616931725|FG001|Overall Study|Other|0|||
170705908|NCT00637195|616931724|FG000|Overall Study|Withdrawal by Subject|0|||
170705909|NCT00637195|616931725|FG001|Overall Study|Withdrawal by Subject|1|||
170705910|NCT00547703|616931728|FG000|Overall Study|Lost to Follow-up|1|||
170705911|NCT00547703|616931729|FG001|Overall Study|Lost to Follow-up|0|||
170705912|NCT03075644|616931733|FG000|Overall Study|Withdrawal by Subject|1|||
170705913|NCT03075644|616931734|FG001|Overall Study|Withdrawal by Subject|1|||
170705914|NCT00439140|616931735|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
170705915|NCT00439140|616931736|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
170705916|NCT00439140|616931737|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
170705917|NCT00439140|616931735|FG000|Treatment Cycle 1|Personal reasons|0|||
170705918|NCT00439140|616931736|FG001|Treatment Cycle 1|Personal reasons|2|||
170705919|NCT00439140|616931737|FG002|Treatment Cycle 1|Personal reasons|0|||
170705920|NCT00439140|616931735|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
170705921|NCT00439140|616931736|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
170705922|NCT00439140|616931737|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
170705923|NCT00439140|616931735|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
170705924|NCT00439140|616931736|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
170705925|NCT00439140|616931737|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
170705926|NCT00439140|616931735|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
170705927|NCT00439140|616931736|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
170705928|NCT00439140|616931737|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
170705929|NCT01458171|616931741|FG000|Overall Study|Adverse Event|1|||
170705930|NCT00578565|616931746|FG000|Overall Study|Adverse Event|3|||
170705931|NCT03025828|616931747|FG000|Overall Study|Lost to Follow-up|1|||
170705932|NCT05059600|616931748|FG000|Overall Study|Enrolled but not Treated|10|||
170705933|NCT02152995|616931749|FG000|Overall Study|Withdrawal by Subject|1|||
170705934|NCT02152995|616931750|FG001|Overall Study|Withdrawal by Subject|0|||
170705935|NCT02098109|616931751|FG000|Overall Study|Protocol Violation|3|||
170705936|NCT02098109|616931752|FG001|Overall Study|Protocol Violation|0|||
170705937|NCT01541826|616931753|FG000|Overall Study|Lost to Follow-up|2|||
170705938|NCT01541826|616931754|FG001|Overall Study|Lost to Follow-up|3|||
170705939|NCT01541826|616931755|FG002|Overall Study|Lost to Follow-up|0|||
170705940|NCT01541826|616931753|FG000|Overall Study|Withdrawal by Subject|2|||
170705941|NCT01541826|616931754|FG001|Overall Study|Withdrawal by Subject|0|||
170705942|NCT01541826|616931755|FG002|Overall Study|Withdrawal by Subject|0|||
170705943|NCT00313612|616931763|FG000|Overall Study|Patient never received treatment|0|||
170705944|NCT00313612|616931764|FG001|Overall Study|Patient never received treatment|1|||
170705945|NCT02321462|616931765|FG000|Overall Study|Withdrawal by Subject|5|||
170705946|NCT02321462|616931766|FG001|Overall Study|Withdrawal by Subject|2|||
170705947|NCT02321462|616931765|FG000|Overall Study|Subject withdrawn before any treatment|1|||
170705948|NCT02321462|616931766|FG001|Overall Study|Subject withdrawn before any treatment|1|||
170705949|NCT01524770|616931774|FG000|First Intervention|Withdrawal by Subject|1|||
170705950|NCT01524770|616931775|FG001|First Intervention|Withdrawal by Subject|0|||
170705951|NCT01524770|616931774|FG000|First Intervention|Adverse Event|1|||
170705952|NCT01524770|616931775|FG001|First Intervention|Adverse Event|1|||
170826510|NCT00943722|617374334|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
170826511|NCT00943722|617374335|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
170826512|NCT00943722|617374336|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
170826513|NCT00943722|617374330|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
170826514|NCT00943722|617374331|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
170826515|NCT00943722|617374332|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
170826516|NCT00943722|617374333|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
170826517|NCT00943722|617374334|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
170826518|NCT00943722|617374335|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
170826519|NCT00943722|617374336|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
170826520|NCT01772823|617374341|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
170826521|NCT01772823|617374342|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
170826522|NCT01772823|617374341|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
170826523|NCT01772823|617374342|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
170826524|NCT01772823|617374341|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
170826525|NCT01772823|617374342|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
170826526|NCT01772823|617374341|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
170826527|NCT01772823|617374342|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
170826528|NCT01772823|617374341|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
170826529|NCT01772823|617374342|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
170826530|NCT01772823|617374341|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
170826531|NCT01772823|617374342|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
170826532|NCT01772823|617374341|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
170826533|NCT01772823|617374342|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
170826534|NCT01772823|617374341|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
170826535|NCT01772823|617374342|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
170826536|NCT01772823|617374341|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
170826537|NCT01772823|617374342|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
170826538|NCT01772823|617374341|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
170826539|NCT01772823|617374342|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
170826540|NCT01772823|617374341|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
170826541|NCT01772823|617374342|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
170826542|NCT01772823|617374341|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
170826543|NCT01772823|617374342|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
170826544|NCT01772823|617374341|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
170826545|NCT01772823|617374342|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
170826546|NCT01772823|617374341|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
170826547|NCT01772823|617374342|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
170705953|NCT01524770|616931774|FG000|First Intervention|Protocol Violation|1|||
170705954|NCT01524770|616931775|FG001|First Intervention|Protocol Violation|0|||
170705955|NCT00989833|616931776|FG000|Overall Study|Lost to Follow-up|0|||
170705956|NCT00989833|616931777|FG001|Overall Study|Lost to Follow-up|1|||
170705957|NCT00989833|616931778|FG002|Overall Study|Lost to Follow-up|0|||
170705958|NCT00989833|616931776|FG000|Overall Study|Protocol Violation|1|||
170705959|NCT00989833|616931777|FG001|Overall Study|Protocol Violation|2|||
170705960|NCT00989833|616931778|FG002|Overall Study|Protocol Violation|1|||
170705961|NCT00989833|616931776|FG000|Overall Study|Withdrawal by Subject|0|||
170705962|NCT00989833|616931777|FG001|Overall Study|Withdrawal by Subject|0|||
170705963|NCT00989833|616931778|FG002|Overall Study|Withdrawal by Subject|1|||
170705964|NCT00989833|616931776|FG000|Overall Study|Incorrectly randomized|1|||
170705965|NCT00989833|616931777|FG001|Overall Study|Incorrectly randomized|0|||
170705966|NCT00989833|616931778|FG002|Overall Study|Incorrectly randomized|0|||
170705967|NCT03080961|616931780|FG000|Overall Study|Withdrawal by Subject|3|||
170705968|NCT03238911|616931781|FG000|Overall Study|Withdrawal by Subject|1|||
170705969|NCT03238911|616931782|FG001|Overall Study|Withdrawal by Subject|2|||
170705970|NCT03238911|616931781|FG000|Overall Study|Lost to Follow-up|2|||
170705971|NCT03238911|616931782|FG001|Overall Study|Lost to Follow-up|1|||
170705972|NCT02239536|616931783|FG000|Overall Study|Non-neoplastic polyp|23|||
170705973|NCT02239536|616931784|FG001|Overall Study|Non-neoplastic polyp|17|||
170705974|NCT05645432|616931788|FG000|Overall Study|Withdrawal by Subject|1|||
170705975|NCT03195478|616931789|FG000|Overall Study|Disease Progression|5|||
170705976|NCT03195478|616931790|FG001|Overall Study|Disease Progression|4|||
170705977|NCT03195478|616931791|FG002|Overall Study|Disease Progression|6|||
170705978|NCT03195478|616931792|FG003|Overall Study|Disease Progression|1|||
170705979|NCT03195478|616931789|FG000|Overall Study|Study Drug Toxicity|2|||
170705980|NCT03195478|616931790|FG001|Overall Study|Study Drug Toxicity|0|||
170705981|NCT03195478|616931791|FG002|Overall Study|Study Drug Toxicity|0|||
170705982|NCT03195478|616931792|FG003|Overall Study|Study Drug Toxicity|1|||
170705983|NCT03195478|616931789|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
170705984|NCT03195478|616931790|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
170705985|NCT03195478|616931791|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
170705986|NCT03195478|616931792|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
170705987|NCT03195478|616931789|FG000|Overall Study|Participant Withdrew Consent|1|||
170705988|NCT03195478|616931790|FG001|Overall Study|Participant Withdrew Consent|0|||
170705989|NCT03195478|616931791|FG002|Overall Study|Participant Withdrew Consent|0|||
170705990|NCT03195478|616931792|FG003|Overall Study|Participant Withdrew Consent|0|||
170705991|NCT03195478|616931789|FG000|Overall Study|Maximum Clinical benefit|0|||
170705992|NCT03195478|616931790|FG001|Overall Study|Maximum Clinical benefit|0|||
170705993|NCT03195478|616931791|FG002|Overall Study|Maximum Clinical benefit|1|||
170705994|NCT03195478|616931792|FG003|Overall Study|Maximum Clinical benefit|0|||
170705995|NCT03195478|616931789|FG000|Overall Study|Other Reasons|0|||
170705996|NCT03195478|616931790|FG001|Overall Study|Other Reasons|0|||
170705997|NCT03195478|616931791|FG002|Overall Study|Other Reasons|1|||
170705998|NCT03195478|616931792|FG003|Overall Study|Other Reasons|0|||
170705999|NCT02283788|616931793|FG000|Overall Study|Adverse Event|1|||
170706000|NCT02283788|616931794|FG001|Overall Study|Adverse Event|3|||
170706001|NCT02283788|616931795|FG002|Overall Study|Adverse Event|5|||
170706002|NCT02283788|616931796|FG003|Overall Study|Adverse Event|1|||
170706003|NCT02283788|616931793|FG000|Overall Study|Withdrawal by Subject|0|||
170706004|NCT02283788|616931794|FG001|Overall Study|Withdrawal by Subject|1|||
170706005|NCT02283788|616931795|FG002|Overall Study|Withdrawal by Subject|0|||
170706006|NCT02283788|616931796|FG003|Overall Study|Withdrawal by Subject|1|||
170706007|NCT02664038|616933650|FG000|13 Week|Lost to Follow-up|7|||
170706008|NCT02664038|616933651|FG001|13 Week|Lost to Follow-up|14|||
170706009|NCT02664038|616933650|FG000|13 Week|Withdrawal by Subject|1|||
170706010|NCT02664038|616933651|FG001|13 Week|Withdrawal by Subject|0|||
170706011|NCT02664038|616933650|FG000|26 Week|Lost to Follow-up|5|||
170706012|NCT02664038|616933651|FG001|26 Week|Lost to Follow-up|4|||
170706013|NCT06640829|616933658|FG000|Overall Study|Withdrawal by Subject|1|||
170706014|NCT06640829|616933658|FG000|Overall Study|Lost to Follow-up|1|||
170706015|NCT01192152|616933659|FG000|Period 1|left prematurely (while on treatment B)|0|||
170826548|NCT01772823|617374341|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
170826549|NCT01772823|617374342|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
170826550|NCT01772823|617374341|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
170826551|NCT01772823|617374342|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
170826552|NCT00451555|617374348|FG000|Overall Study|Protocol Violation|2|||
170826553|NCT00451555|617374349|FG001|Overall Study|Protocol Violation|2|||
170826554|NCT00451555|617374348|FG000|Overall Study|Adverse Event|3|||
170826555|NCT00451555|617374349|FG001|Overall Study|Adverse Event|1|||
170706016|NCT01192152|616933660|FG001|Period 1|left prematurely (while on treatment B)|1|||
170706017|NCT01192152|616933659|FG000|Period 3|family emergency|1|||
170706018|NCT01192152|616933660|FG001|Period 3|family emergency|0|||
170826556|NCT00451555|617374348|FG000|Overall Study|Withdrawal by Subject|6|||
170706019|NCT00094653|616933664|FG000|Overall Study|Death|306|||
170706020|NCT00094653|616933665|FG001|Overall Study|Death|100|||
170706021|NCT00094653|616933666|FG002|Overall Study|Death|119|||
170706022|NCT00094653|616933664|FG000|Overall Study|Subject Withdrew Consent|10|||
170706023|NCT00094653|616933665|FG001|Overall Study|Subject Withdrew Consent|2|||
170706024|NCT00094653|616933666|FG002|Overall Study|Subject Withdrew Consent|3|||
170706025|NCT00094653|616933664|FG000|Overall Study|Other|2|||
170706026|NCT00094653|616933665|FG001|Overall Study|Other|2|||
170706027|NCT00094653|616933666|FG002|Overall Study|Other|2|||
170706028|NCT00094653|616933664|FG000|Overall Study|Lost to Follow-up|3|||
170706029|NCT00094653|616933665|FG001|Overall Study|Lost to Follow-up|2|||
170706030|NCT00094653|616933666|FG002|Overall Study|Lost to Follow-up|1|||
170706031|NCT00094653|616933664|FG000|Overall Study|Protocol Violation|0|||
170706032|NCT00094653|616933665|FG001|Overall Study|Protocol Violation|0|||
170706033|NCT00094653|616933666|FG002|Overall Study|Protocol Violation|1|||
170706034|NCT03921411|616933667|FG000|Overall Study|Withdrawal by Subject|1|||
170706035|NCT03921411|616933667|FG000|Overall Study|Protocol Deviation|2|||
170706036|NCT03921411|616933667|FG000|Overall Study|Enrolled, but never treated|2|||
170706037|NCT01565291|616933669|FG000|Overall Study|Withdrawal by Subject|1|||
170706038|NCT01565291|616933670|FG001|Overall Study|Withdrawal by Subject|0|||
170706039|NCT02143843|616933671|FG000|Overall Study|Adverse Event|8|||
170706040|NCT02143843|616933671|FG000|Overall Study|Lack of Efficacy|2|||
170706041|NCT02143843|616933671|FG000|Overall Study|Withdrawal by Subject|2|||
170706042|NCT04552587|616933673|FG000|Overall Study|Lost to Follow-up|4|||
170706043|NCT00480779|616933674|FG000|Overall Study|Other|2|||
170706044|NCT00480779|616933675|FG001|Overall Study|Other|0|||
170706045|NCT00480779|616933674|FG000|Overall Study|Job and Health-related|0|||
170706046|NCT00480779|616933675|FG001|Overall Study|Job and Health-related|3|||
170706047|NCT01822132|616933678|FG000|Overall Study|Lost to Follow-up|4|||
170706048|NCT01822132|616933679|FG001|Overall Study|Lost to Follow-up|2|||
170706049|NCT02519712|616933682|FG000|Overall Study|Disease Relapse|1|||
170706050|NCT02519712|616933682|FG000|Overall Study|Disease Progression|1|||
170706051|NCT02519712|616933682|FG000|Overall Study|Accruals are donors|2|||
170706052|NCT00854581|616933693|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
170706053|NCT00854581|616933693|FG000|Induction (Up to Day 21)|Death|1|||
170706054|NCT00854581|616933693|FG000|Induction (Up to Day 21)|Physician Decision|1|||
170706055|NCT00854581|616933693|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
170706056|NCT01339390|616933694|FG000|Overall Study|Death|32|||
170706057|NCT01339390|616933695|FG001|Overall Study|Death|29|||
170706058|NCT01339390|616933694|FG000|Overall Study|Lost to Follow-up|125|||
170706059|NCT01339390|616933695|FG001|Overall Study|Lost to Follow-up|127|||
170706060|NCT04847674|616933696|FG000|Overall Study|Withdrawal by Subject|0|||
170706061|NCT04847674|616933697|FG001|Overall Study|Withdrawal by Subject|1|||
170706062|NCT04847674|616933698|FG002|Overall Study|Withdrawal by Subject|0|||
170706063|NCT04847674|616933696|FG000|Overall Study|Lost to Follow-up|0|||
170706064|NCT04847674|616933697|FG001|Overall Study|Lost to Follow-up|0|||
170706065|NCT04847674|616933698|FG002|Overall Study|Lost to Follow-up|2|||
170706066|NCT04847674|616933696|FG000|Overall Study|Other than specified|21|||
170706067|NCT04847674|616933697|FG001|Overall Study|Other than specified|20|||
170706068|NCT04847674|616933698|FG002|Overall Study|Other than specified|20|||
170706069|NCT00378703|616933701|FG000|Overall Study|Disease progression|59|||
170706070|NCT00378703|616933702|FG001|Overall Study|Disease progression|43|||
170706071|NCT00378703|616933703|FG002|Overall Study|Disease progression|48|||
170706072|NCT00378703|616933704|FG003|Overall Study|Disease progression|49|||
170706073|NCT00378703|616933701|FG000|Overall Study|Adverse Event|11|||
170706074|NCT00378703|616933702|FG001|Overall Study|Adverse Event|17|||
170706075|NCT00378703|616933703|FG002|Overall Study|Adverse Event|20|||
170706076|NCT00378703|616933704|FG003|Overall Study|Adverse Event|18|||
170706077|NCT00378703|616933701|FG000|Overall Study|Death|2|||
170706078|NCT00378703|616933702|FG001|Overall Study|Death|2|||
170706079|NCT00378703|616933703|FG002|Overall Study|Death|4|||
170706080|NCT00378703|616933704|FG003|Overall Study|Death|3|||
170706081|NCT00378703|616933701|FG000|Overall Study|Withdrawal by Subject|4|||
170706082|NCT00378703|616933702|FG001|Overall Study|Withdrawal by Subject|8|||
170706083|NCT00378703|616933703|FG002|Overall Study|Withdrawal by Subject|5|||
170706084|NCT00378703|616933704|FG003|Overall Study|Withdrawal by Subject|7|||
170706085|NCT00378703|616933701|FG000|Overall Study|Physician Decision|1|||
170706086|NCT00378703|616933702|FG001|Overall Study|Physician Decision|4|||
170706087|NCT00378703|616933703|FG002|Overall Study|Physician Decision|1|||
170706088|NCT00378703|616933704|FG003|Overall Study|Physician Decision|0|||
170706089|NCT00378703|616933701|FG000|Overall Study|Alternative therapy|4|||
170706090|NCT00378703|616933702|FG001|Overall Study|Alternative therapy|2|||
170706091|NCT00378703|616933703|FG002|Overall Study|Alternative therapy|0|||
170706092|NCT00378703|616933704|FG003|Overall Study|Alternative therapy|0|||
170706093|NCT00378703|616933701|FG000|Overall Study|Other complicated disease|0|||
170706094|NCT00378703|616933702|FG001|Overall Study|Other complicated disease|2|||
170706095|NCT00378703|616933703|FG002|Overall Study|Other complicated disease|2|||
170706096|NCT00378703|616933704|FG003|Overall Study|Other complicated disease|0|||
170706097|NCT00378703|616933701|FG000|Overall Study|Symptomatic deterioration|0|||
170706098|NCT00378703|616933702|FG001|Overall Study|Symptomatic deterioration|1|||
170706099|NCT00378703|616933703|FG002|Overall Study|Symptomatic deterioration|0|||
170706100|NCT00378703|616933704|FG003|Overall Study|Symptomatic deterioration|2|||
170706101|NCT00378703|616933701|FG000|Overall Study|Surgery|1|||
170706102|NCT00378703|616933702|FG001|Overall Study|Surgery|0|||
170706103|NCT00378703|616933703|FG002|Overall Study|Surgery|0|||
170706104|NCT00378703|616933704|FG003|Overall Study|Surgery|1|||
170706105|NCT00378703|616933701|FG000|Overall Study|Joint decision of physician and patient|1|||
170706106|NCT00378703|616933702|FG001|Overall Study|Joint decision of physician and patient|0|||
170706107|NCT00378703|616933703|FG002|Overall Study|Joint decision of physician and patient|0|||
170706108|NCT00378703|616933704|FG003|Overall Study|Joint decision of physician and patient|0|||
170706109|NCT00378703|616933701|FG000|Overall Study|Adverse events and progressive disease|0|||
170706110|NCT00378703|616933702|FG001|Overall Study|Adverse events and progressive disease|0|||
170706111|NCT00378703|616933703|FG002|Overall Study|Adverse events and progressive disease|0|||
170706112|NCT00378703|616933704|FG003|Overall Study|Adverse events and progressive disease|1|||
170706113|NCT00378703|616933701|FG000|Overall Study|Relocation|0|||
170706114|NCT00378703|616933702|FG001|Overall Study|Relocation|0|||
170706115|NCT00378703|616933703|FG002|Overall Study|Relocation|1|||
170706116|NCT00378703|616933704|FG003|Overall Study|Relocation|0|||
170706117|NCT00378703|616933701|FG000|Overall Study|Ineligible|4|||
170706118|NCT00378703|616933702|FG001|Overall Study|Ineligible|7|||
170706119|NCT00378703|616933703|FG002|Overall Study|Ineligible|7|||
170706120|NCT00378703|616933704|FG003|Overall Study|Ineligible|7|||
170706121|NCT00378703|616933701|FG000|Overall Study|Never started treatment|1|||
170706122|NCT00378703|616933702|FG001|Overall Study|Never started treatment|4|||
170706123|NCT00378703|616933703|FG002|Overall Study|Never started treatment|0|||
170706124|NCT00378703|616933704|FG003|Overall Study|Never started treatment|0|||
170706125|NCT00378703|616933701|FG000|Overall Study|Other|1|||
170706126|NCT00378703|616933702|FG001|Overall Study|Other|1|||
170706127|NCT00378703|616933703|FG002|Overall Study|Other|2|||
170706128|NCT00378703|616933704|FG003|Overall Study|Other|3|||
170706129|NCT02705820|616933705|FG000|Overall Study|Death|2|||
170706130|NCT02705820|616933705|FG000|Overall Study|Disease Progression|34|||
170706131|NCT02705820|616933705|FG000|Overall Study|Clinical Deterioration|3|||
170706132|NCT03181542|616933709|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
170706133|NCT03181542|616933710|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
170706134|NCT01462357|616933717|FG000|Overall Study|Death|0|||
170706135|NCT01462357|616933718|FG001|Overall Study|Death|0|||
170706136|NCT01462357|616933719|FG002|Overall Study|Death|1|||
170706137|NCT01462357|616933717|FG000|Overall Study|Withdrawal by Subject|3|||
170706138|NCT01462357|616933718|FG001|Overall Study|Withdrawal by Subject|11|||
170706139|NCT01462357|616933719|FG002|Overall Study|Withdrawal by Subject|3|||
170706140|NCT01462357|616933717|FG000|Overall Study|Migrated/moved from study area|2|||
170706141|NCT01462357|616933718|FG001|Overall Study|Migrated/moved from study area|3|||
170706142|NCT01462357|616933719|FG002|Overall Study|Migrated/moved from study area|1|||
170706143|NCT01462357|616933717|FG000|Overall Study|Lost to Follow-up|3|||
170706144|NCT01462357|616933718|FG001|Overall Study|Lost to Follow-up|5|||
170706145|NCT01462357|616933719|FG002|Overall Study|Lost to Follow-up|7|||
170706146|NCT01527292|616933728|FG000|Overall Study|Physician Decision|0|||
170706147|NCT01527292|616933729|FG001|Overall Study|Physician Decision|3|||
170706148|NCT01482767|616933730|FG000|Overall Study|Death|1|||
170706149|NCT01482767|616933731|FG001|Overall Study|Death|1|||
170706150|NCT01482767|616933730|FG000|Overall Study|Withdrawal by Subject|7|||
170706151|NCT01482767|616933731|FG001|Overall Study|Withdrawal by Subject|5|||
170706152|NCT01482767|616933730|FG000|Overall Study|Lost to Follow-up|12|||
170706153|NCT01482767|616933731|FG001|Overall Study|Lost to Follow-up|6|||
170706154|NCT01482767|616933730|FG000|Overall Study|Adverse Event|0|||
170706155|NCT01482767|616933731|FG001|Overall Study|Adverse Event|3|||
170706156|NCT01482767|616933730|FG000|Overall Study|Site closure|22|||
170706157|NCT01482767|616933731|FG001|Overall Study|Site closure|14|||
170706158|NCT01482767|616933730|FG000|Overall Study|Non-adherence to study requirements|4|||
170706159|NCT01482767|616933731|FG001|Overall Study|Non-adherence to study requirements|7|||
170706160|NCT01482767|616933730|FG000|Overall Study|Alternate HCV treatment|7|||
170706161|NCT01482767|616933731|FG001|Overall Study|Alternate HCV treatment|8|||
170706162|NCT01482767|616933730|FG000|Overall Study|Ineligible|0|||
170706163|NCT01482767|616933731|FG001|Overall Study|Ineligible|5|||
170706164|NCT01482767|616933730|FG000|Overall Study|Nurse error|1|||
170706165|NCT01482767|616933731|FG001|Overall Study|Nurse error|0|||
170706166|NCT01393743|616933732|FG000|Core Study|Adverse Event|5|||
170706167|NCT01393743|616933733|FG001|Core Study|Adverse Event|9|||
170706168|NCT01393743|616933734|FG002|Core Study|Adverse Event|0|||
170706169|NCT01393743|616933732|FG000|Core Study|Lost to Follow-up|1|||
170706170|NCT01393743|616933733|FG001|Core Study|Lost to Follow-up|1|||
170706171|NCT01393743|616933734|FG002|Core Study|Lost to Follow-up|0|||
170706172|NCT01393743|616933732|FG000|Core Study|Participant's Choice|2|||
170706173|NCT01393743|616933733|FG001|Core Study|Participant's Choice|3|||
170706174|NCT01393743|616933734|FG002|Core Study|Participant's Choice|0|||
170706175|NCT01393743|616933732|FG000|Core Study|Inadequate therapeutic effect|2|||
170706176|NCT01393743|616933733|FG001|Core Study|Inadequate therapeutic effect|0|||
170706177|NCT01393743|616933734|FG002|Core Study|Inadequate therapeutic effect|0|||
170706178|NCT01393743|616933732|FG000|Extension Phase|Adverse Event|0|||
170706179|NCT01393743|616933733|FG001|Extension Phase|Adverse Event|0|||
170706180|NCT01393743|616933734|FG002|Extension Phase|Adverse Event|12|||
170706181|NCT01393743|616933732|FG000|Extension Phase|Lost to Follow-up|0|||
170706182|NCT01393743|616933733|FG001|Extension Phase|Lost to Follow-up|0|||
170706183|NCT01393743|616933734|FG002|Extension Phase|Lost to Follow-up|2|||
170706184|NCT01393743|616933732|FG000|Extension Phase|Participant choice|0|||
170706185|NCT01393743|616933733|FG001|Extension Phase|Participant choice|0|||
170706186|NCT01393743|616933734|FG002|Extension Phase|Participant choice|16|||
170706187|NCT01393743|616933732|FG000|Extension Phase|Inadequate therapeutic effect|0|||
170706188|NCT01393743|616933733|FG001|Extension Phase|Inadequate therapeutic effect|0|||
170706189|NCT01393743|616933734|FG002|Extension Phase|Inadequate therapeutic effect|7|||
170706190|NCT01393743|616933732|FG000|Extension Phase|Withdrawal by Subject|0|||
170706191|NCT01393743|616933733|FG001|Extension Phase|Withdrawal by Subject|0|||
170706192|NCT01393743|616933734|FG002|Extension Phase|Withdrawal by Subject|8|||
170706193|NCT01393743|616933732|FG000|Extension Phase|Pregnancy|0|||
170706194|NCT01393743|616933733|FG001|Extension Phase|Pregnancy|0|||
170706195|NCT01393743|616933734|FG002|Extension Phase|Pregnancy|1|||
170706196|NCT01393743|616933732|FG000|Extension Phase|Other|0|||
170706197|NCT01393743|616933733|FG001|Extension Phase|Other|0|||
170706198|NCT01393743|616933734|FG002|Extension Phase|Other|14|||
170706199|NCT03400033|616933744|FG000|Overall Study|Withdrawal by Subject|1|||
170706200|NCT03400033|616933745|FG001|Overall Study|Withdrawal by Subject|2|||
170706201|NCT01247090|616933746|FG000|Overall Study|Physician Decision|1|||
170706202|NCT01247090|616933747|FG001|Overall Study|Physician Decision|0|||
170706203|NCT01247090|616933748|FG002|Overall Study|Physician Decision|0|||
170706204|NCT01247090|616933746|FG000|Overall Study|Withdrawal by Subject|0|||
170706205|NCT01247090|616933747|FG001|Overall Study|Withdrawal by Subject|1|||
170706206|NCT01247090|616933748|FG002|Overall Study|Withdrawal by Subject|0|||
170706207|NCT02751983|616933755|FG000|Treatment|Stopped ACT, but Remained in study|2|||
170706208|NCT02751983|616933756|FG001|Treatment|Stopped ACT, but Remained in study|0|||
170706209|NCT02751983|616933755|FG000|Treatment|Discharged prior to beginning ACT|2|||
170706210|NCT02751983|616933756|FG001|Treatment|Discharged prior to beginning ACT|0|||
170706211|NCT02751983|616933755|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
170706212|NCT02751983|616933756|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
170706213|NCT02751983|616933755|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
170706214|NCT02751983|616933756|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
170706215|NCT02751983|616933755|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
170706216|NCT02751983|616933756|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
170706217|NCT03467425|616933757|FG000|Overall Study|Adverse Event|9|||
170706218|NCT03467425|616933758|FG001|Overall Study|Adverse Event|9|||
170706219|NCT03467425|616933757|FG000|Overall Study|Lack of Efficacy|3|||
170706220|NCT03467425|616933758|FG001|Overall Study|Lack of Efficacy|1|||
170706221|NCT03467425|616933757|FG000|Overall Study|Protocol Violation|0|||
170706222|NCT03467425|616933758|FG001|Overall Study|Protocol Violation|1|||
170706223|NCT03467425|616933757|FG000|Overall Study|Lost to Follow-up|18|||
170706224|NCT03467425|616933758|FG001|Overall Study|Lost to Follow-up|25|||
170706225|NCT03467425|616933757|FG000|Overall Study|Physician Decision|2|||
170706226|NCT03467425|616933758|FG001|Overall Study|Physician Decision|1|||
170706227|NCT03467425|616933757|FG000|Overall Study|Withdrawal by Subject|15|||
170706228|NCT03467425|616933758|FG001|Overall Study|Withdrawal by Subject|17|||
170706229|NCT00678561|616933759|FG000|Overall Study|Adverse Event|0|||
170706230|NCT00678561|616933760|FG001|Overall Study|Adverse Event|1|||
170706231|NCT00678561|616933761|FG002|Overall Study|Adverse Event|1|||
170706232|NCT00678561|616933762|FG003|Overall Study|Adverse Event|0|||
170706233|NCT00678561|616933763|FG004|Overall Study|Adverse Event|1|||
170706234|NCT00678561|616933764|FG005|Overall Study|Adverse Event|0|||
170706235|NCT00678561|616933765|FG006|Overall Study|Adverse Event|0|||
170706236|NCT00678561|616933766|FG007|Overall Study|Adverse Event|0|||
170706237|NCT00678561|616933759|FG000|Overall Study|Protocol Violation|0|||
170706238|NCT00678561|616933760|FG001|Overall Study|Protocol Violation|0|||
170706239|NCT00678561|616933761|FG002|Overall Study|Protocol Violation|0|||
170706240|NCT00678561|616933762|FG003|Overall Study|Protocol Violation|0|||
170706241|NCT00678561|616933763|FG004|Overall Study|Protocol Violation|1|||
170706242|NCT00678561|616933764|FG005|Overall Study|Protocol Violation|1|||
170706243|NCT00678561|616933765|FG006|Overall Study|Protocol Violation|0|||
170706244|NCT00678561|616933766|FG007|Overall Study|Protocol Violation|0|||
170706245|NCT00678561|616933759|FG000|Overall Study|Withdrawal by Subject|0|||
170706246|NCT00678561|616933760|FG001|Overall Study|Withdrawal by Subject|0|||
170706247|NCT00678561|616933761|FG002|Overall Study|Withdrawal by Subject|0|||
170706248|NCT00678561|616933762|FG003|Overall Study|Withdrawal by Subject|0|||
170706249|NCT00678561|616933763|FG004|Overall Study|Withdrawal by Subject|0|||
170706250|NCT00678561|616933764|FG005|Overall Study|Withdrawal by Subject|0|||
170706251|NCT00678561|616933765|FG006|Overall Study|Withdrawal by Subject|0|||
170706252|NCT00678561|616933766|FG007|Overall Study|Withdrawal by Subject|1|||
170706253|NCT02920983|616933768|FG000|Dispense 1|Unacceptable Lens Fit|0|||
170706254|NCT02920983|616933769|FG001|Dispense 1|Unacceptable Lens Fit|0|||
170706255|NCT02920983|616933770|FG002|Dispense 1|Unacceptable Lens Fit|0|||
170706256|NCT02920983|616933771|FG003|Dispense 1|Unacceptable Lens Fit|0|||
170706257|NCT02920983|616933772|FG004|Dispense 1|Unacceptable Lens Fit|1|||
170706258|NCT02920983|616933773|FG005|Dispense 1|Unacceptable Lens Fit|0|||
170706259|NCT02920983|616933768|FG000|Dispense 2|Unscceptable lens fit|1|||
170706260|NCT02920983|616933769|FG001|Dispense 2|Unscceptable lens fit|0|||
170706261|NCT02920983|616933770|FG002|Dispense 2|Unscceptable lens fit|0|||
170706262|NCT02920983|616933771|FG003|Dispense 2|Unscceptable lens fit|0|||
170706263|NCT02920983|616933772|FG004|Dispense 2|Unscceptable lens fit|1|||
170706264|NCT02920983|616933773|FG005|Dispense 2|Unscceptable lens fit|0|||
170706265|NCT02920983|616933768|FG000|Dispense 3|Unacceptable Lens Fit|1|||
170706266|NCT02920983|616933769|FG001|Dispense 3|Unacceptable Lens Fit|1|||
170706267|NCT02920983|616933770|FG002|Dispense 3|Unacceptable Lens Fit|0|||
170706268|NCT02920983|616933771|FG003|Dispense 3|Unacceptable Lens Fit|0|||
170706269|NCT02920983|616933772|FG004|Dispense 3|Unacceptable Lens Fit|1|||
170706270|NCT02920983|616933773|FG005|Dispense 3|Unacceptable Lens Fit|0|||
170706271|NCT00689481|616933774|FG000|Overall Study|Adverse Event|7|||
170706272|NCT00689481|616933775|FG001|Overall Study|Adverse Event|1|||
170706273|NCT00689481|616933774|FG000|Overall Study|Lost to Follow-up|4|||
170706274|NCT00689481|616933775|FG001|Overall Study|Lost to Follow-up|3|||
170706275|NCT00689481|616933774|FG000|Overall Study|Lack of Efficacy|4|||
170706276|NCT00689481|616933775|FG001|Overall Study|Lack of Efficacy|3|||
170706277|NCT00689481|616933774|FG000|Overall Study|Non-compliance with study treatment|1|||
170706278|NCT00689481|616933775|FG001|Overall Study|Non-compliance with study treatment|1|||
170706279|NCT00689481|616933774|FG000|Overall Study|Withdrawal by Subject|8|||
170706280|NCT00689481|616933775|FG001|Overall Study|Withdrawal by Subject|4|||
170706281|NCT00689481|616933774|FG000|Overall Study|Excluded medication started during study|0|||
170706282|NCT00689481|616933775|FG001|Overall Study|Excluded medication started during study|1|||
170706283|NCT00689481|616933774|FG000|Overall Study|Subject early term, left on vacation|0|||
170706284|NCT00689481|616933775|FG001|Overall Study|Subject early term, left on vacation|1|||
170706285|NCT03337724|616933780|FG000|Overall Study|Reason not Specified|12|||
170706286|NCT03337724|616933781|FG001|Overall Study|Reason not Specified|21|||
170706287|NCT03337724|616933782|FG002|Overall Study|Reason not Specified|9|||
170706288|NCT03337724|616933783|FG003|Overall Study|Reason not Specified|9|||
170706289|NCT03337724|616933784|FG004|Overall Study|Reason not Specified|29|||
170706290|NCT03337724|616933780|FG000|Overall Study|Withdrawal by Subject|13|||
170706291|NCT03337724|616933781|FG001|Overall Study|Withdrawal by Subject|15|||
170706292|NCT03337724|616933782|FG002|Overall Study|Withdrawal by Subject|4|||
170706293|NCT03337724|616933783|FG003|Overall Study|Withdrawal by Subject|15|||
170706294|NCT03337724|616933784|FG004|Overall Study|Withdrawal by Subject|6|||
170706295|NCT03337724|616933780|FG000|Overall Study|Protocol Deviation|0|||
170706296|NCT03337724|616933781|FG001|Overall Study|Protocol Deviation|1|||
170706297|NCT03337724|616933782|FG002|Overall Study|Protocol Deviation|1|||
170706298|NCT03337724|616933783|FG003|Overall Study|Protocol Deviation|1|||
170706299|NCT03337724|616933784|FG004|Overall Study|Protocol Deviation|0|||
170706300|NCT03337724|616933780|FG000|Overall Study|Adverse Event|1|||
170706301|NCT03337724|616933781|FG001|Overall Study|Adverse Event|1|||
170706302|NCT03337724|616933782|FG002|Overall Study|Adverse Event|0|||
170826557|NCT00451555|617374349|FG001|Overall Study|Withdrawal by Subject|0|||
170826558|NCT00451555|617374348|FG000|Overall Study|Physician Decision|2|||
170826559|NCT00451555|617374349|FG001|Overall Study|Physician Decision|1|||
170826560|NCT03036150|617374350|FG000|Overall Study|Withdrawal by Subject|8|||
170826561|NCT03036150|617374351|FG001|Overall Study|Withdrawal by Subject|3|||
170826562|NCT03036150|617374350|FG000|Overall Study|Lost to Follow-up|2|||
170826563|NCT03036150|617374351|FG001|Overall Study|Lost to Follow-up|2|||
170826564|NCT02741713|617374352|FG000|Overall Study|Surgery type changed intra-operatively|2|||
170826565|NCT02741713|617374353|FG001|Overall Study|Surgery type changed intra-operatively|1|||
170826566|NCT00931918|617374356|FG000|Overall Study|Adverse Event|4|||
170826567|NCT00931918|617374357|FG001|Overall Study|Adverse Event|6|||
170826568|NCT00931918|617374356|FG000|Overall Study|Progressive Disease|2|||
170826569|NCT00931918|617374357|FG001|Overall Study|Progressive Disease|1|||
170826570|NCT00931918|617374356|FG000|Overall Study|Symptomatic Deterioration|1|||
170826571|NCT00931918|617374357|FG001|Overall Study|Symptomatic Deterioration|0|||
170826572|NCT00931918|617374356|FG000|Overall Study|Withdrawal by Patient|3|||
170826573|NCT00931918|617374357|FG001|Overall Study|Withdrawal by Patient|4|||
170826574|NCT00931918|617374356|FG000|Overall Study|Other Reason not Specified|4|||
170826575|NCT00931918|617374357|FG001|Overall Study|Other Reason not Specified|4|||
170826576|NCT00931918|617374356|FG000|Overall Study|Did not receive study drug|3|||
170826577|NCT00931918|617374357|FG001|Overall Study|Did not receive study drug|2|||
170706303|NCT03337724|616933783|FG003|Overall Study|Adverse Event|1|||
170706304|NCT03337724|616933784|FG004|Overall Study|Adverse Event|0|||
170706305|NCT03337724|616933780|FG000|Overall Study|Death|40|||
170826578|NCT01274559|617374358|FG000|Overall Study|Adverse Event|57|||
170826579|NCT01274559|617374359|FG001|Overall Study|Adverse Event|13|||
170826580|NCT01274559|617374358|FG000|Overall Study|Death|1|||
170826581|NCT01274559|617374359|FG001|Overall Study|Death|1|||
170706306|NCT03337724|616933781|FG001|Overall Study|Death|89|||
170706307|NCT03337724|616933782|FG002|Overall Study|Death|43|||
170706308|NCT03337724|616933783|FG003|Overall Study|Death|76|||
170706309|NCT03337724|616933784|FG004|Overall Study|Death|50|||
170706310|NCT03337724|616933780|FG000|Overall Study|Lost to Follow-up|5|||
170706311|NCT03337724|616933781|FG001|Overall Study|Lost to Follow-up|5|||
170706312|NCT03337724|616933782|FG002|Overall Study|Lost to Follow-up|4|||
170706313|NCT03337724|616933783|FG003|Overall Study|Lost to Follow-up|7|||
170706314|NCT03337724|616933784|FG004|Overall Study|Lost to Follow-up|4|||
170706315|NCT03337724|616933780|FG000|Overall Study|Physician Decision|16|||
170706316|NCT03337724|616933781|FG001|Overall Study|Physician Decision|34|||
170706317|NCT03337724|616933782|FG002|Overall Study|Physician Decision|14|||
170706318|NCT03337724|616933783|FG003|Overall Study|Physician Decision|34|||
170706319|NCT03337724|616933784|FG004|Overall Study|Physician Decision|13|||
170706320|NCT03337724|616933780|FG000|Overall Study|Progressive Disease|0|||
170706321|NCT03337724|616933781|FG001|Overall Study|Progressive Disease|2|||
170706322|NCT03337724|616933782|FG002|Overall Study|Progressive Disease|1|||
170706323|NCT03337724|616933783|FG003|Overall Study|Progressive Disease|2|||
170706324|NCT03337724|616933784|FG004|Overall Study|Progressive Disease|0|||
170706325|NCT03337724|616933780|FG000|Overall Study|Symptomatic Deterioration|0|||
170706326|NCT03337724|616933781|FG001|Overall Study|Symptomatic Deterioration|0|||
170706327|NCT03337724|616933782|FG002|Overall Study|Symptomatic Deterioration|0|||
170706328|NCT03337724|616933783|FG003|Overall Study|Symptomatic Deterioration|1|||
170706329|NCT03337724|616933784|FG004|Overall Study|Symptomatic Deterioration|0|||
170706330|NCT00528528|616933785|FG000|Overall Study|Lost to Follow-up|0|||
170706331|NCT00528528|616933786|FG001|Overall Study|Lost to Follow-up|0|||
170706332|NCT00528528|616933787|FG002|Overall Study|Lost to Follow-up|1|||
170706333|NCT00528528|616933788|FG003|Overall Study|Lost to Follow-up|1|||
170706334|NCT00528528|616933785|FG000|Overall Study|Ineligible to continue the trial|0|||
170706335|NCT00528528|616933786|FG001|Overall Study|Ineligible to continue the trial|0|||
170706336|NCT00528528|616933787|FG002|Overall Study|Ineligible to continue the trial|0|||
170706337|NCT00528528|616933788|FG003|Overall Study|Ineligible to continue the trial|1|||
170706338|NCT00528528|616933785|FG000|Overall Study|Other|0|||
170706339|NCT00528528|616933786|FG001|Overall Study|Other|1|||
170706340|NCT00528528|616933787|FG002|Overall Study|Other|0|||
170706341|NCT00528528|616933788|FG003|Overall Study|Other|0|||
170706342|NCT00528528|616933785|FG000|Overall Study|Withdrawal by Subject|3|||
170706343|NCT00528528|616933786|FG001|Overall Study|Withdrawal by Subject|2|||
170706344|NCT00528528|616933787|FG002|Overall Study|Withdrawal by Subject|1|||
170706345|NCT00528528|616933788|FG003|Overall Study|Withdrawal by Subject|1|||
170706346|NCT00528528|616933785|FG000|Overall Study|Ongoing participant|0|||
170706347|NCT00528528|616933786|FG001|Overall Study|Ongoing participant|0|||
170706348|NCT00528528|616933787|FG002|Overall Study|Ongoing participant|1|||
170706349|NCT00528528|616933788|FG003|Overall Study|Ongoing participant|0|||
170706350|NCT00773097|616933789|FG000|Overall Study|Withdrawal by Subject|1|||
170706351|NCT00773097|616933789|FG000|Overall Study|Physician Decision|6|||
170706352|NCT04602624|616933798|FG000|Overall Study|Protocol Deviation|1|||
170706353|NCT04602624|616933798|FG000|Overall Study|Withdrawal by Participant|1|||
170706354|NCT04084769|616933799|FG000|Overall Study|Protocol Violation|1|||
170706355|NCT04084769|616933800|FG001|Overall Study|Protocol Violation|3|||
170706356|NCT04084769|616933801|FG002|Overall Study|Protocol Violation|0|||
170706357|NCT04084769|616933802|FG003|Overall Study|Protocol Violation|1|||
170706358|NCT04084769|616933799|FG000|Overall Study|Withdrawal by Subject|0|||
170706359|NCT04084769|616933800|FG001|Overall Study|Withdrawal by Subject|1|||
170706360|NCT04084769|616933801|FG002|Overall Study|Withdrawal by Subject|0|||
170706361|NCT04084769|616933802|FG003|Overall Study|Withdrawal by Subject|0|||
170706362|NCT04084769|616933799|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170706363|NCT04084769|616933800|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170706364|NCT04084769|616933801|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170706365|NCT04084769|616933802|FG003|Overall Study|Withdrawal by parent/guardian|1|||
170706366|NCT04084769|616933799|FG000|Overall Study|Lost to Follow-up|2|||
170706367|NCT04084769|616933800|FG001|Overall Study|Lost to Follow-up|0|||
170706368|NCT04084769|616933801|FG002|Overall Study|Lost to Follow-up|0|||
170706369|NCT04084769|616933802|FG003|Overall Study|Lost to Follow-up|0|||
170706370|NCT03508219|616933803|FG000|Overall Study|Death|2|||
170706371|NCT03508219|616933803|FG000|Overall Study|Withdrawal by Subject|1|||
170826582|NCT01274559|617374358|FG000|Overall Study|Lost to Follow-up|3|||
170826583|NCT01274559|617374359|FG001|Overall Study|Lost to Follow-up|3|||
170826584|NCT01274559|617374358|FG000|Overall Study|Non-compliance with Study Drug|2|||
170826585|NCT01274559|617374359|FG001|Overall Study|Non-compliance with Study Drug|4|||
170826586|NCT01274559|617374358|FG000|Overall Study|Physician Decision|2|||
170706372|NCT03508219|616933803|FG000|Overall Study|Lost to Follow-up|4|||
170706373|NCT03508219|616933803|FG000|Overall Study|Missed visit|2|||
170826587|NCT01274559|617374359|FG001|Overall Study|Physician Decision|1|||
170826588|NCT01274559|617374358|FG000|Overall Study|Protocol Violation|28|||
170706374|NCT03665038|616933804|FG000|Overall Study|Lost to Follow-up|0|||
170706375|NCT03665038|616933805|FG001|Overall Study|Lost to Follow-up|0|||
170706376|NCT03665038|616933806|FG002|Overall Study|Lost to Follow-up|1|||
170706377|NCT00445328|616933807|FG000|Overall Study|Death|0|||
170706378|NCT00445328|616933808|FG001|Overall Study|Death|1|||
170706379|NCT00445328|616933807|FG000|Overall Study|Adverse Event|0|||
170706380|NCT00445328|616933808|FG001|Overall Study|Adverse Event|3|||
170706381|NCT00445328|616933807|FG000|Overall Study|Other|0|||
170706382|NCT00445328|616933808|FG001|Overall Study|Other|2|||
170706383|NCT00445328|616933807|FG000|Overall Study|Withdrawal by Subject|2|||
170706384|NCT00445328|616933808|FG001|Overall Study|Withdrawal by Subject|0|||
170706385|NCT00445328|616933807|FG000|Overall Study|Protocol Violation|1|||
170706386|NCT00445328|616933808|FG001|Overall Study|Protocol Violation|0|||
170706387|NCT00316199|616933809|FG000|Overall Study|Adverse Event|2|||
170706388|NCT00316199|616933809|FG000|Overall Study|Death|8|||
170706389|NCT00316199|616933809|FG000|Overall Study|Lost to Follow-up|2|||
170706390|NCT00590954|616933810|FG000|Overall Study|Inevaluable|2|||
170706391|NCT04477304|616933811|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
170706392|NCT04477304|616933812|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
170706393|NCT02782949|616933814|FG000|Overall Study|Protocol Violation|1|||
170706394|NCT02782949|616933815|FG001|Overall Study|Protocol Violation|0|||
170706395|NCT02782949|616933814|FG000|Overall Study|Withdrawal by Subject|0|||
170706396|NCT02782949|616933815|FG001|Overall Study|Withdrawal by Subject|1|||
170706397|NCT01707004|616935297|FG000|Overall Study|Physician Decision|3|||
170706398|NCT00646958|616935300|FG000|Overall Study|Lack of Efficacy|1|||
170706399|NCT00646958|616935301|FG001|Overall Study|Lack of Efficacy|0|||
170706400|NCT00646958|616935302|FG002|Overall Study|Lack of Efficacy|0|||
170706401|NCT00646958|616935300|FG000|Overall Study|Adverse Event|4|||
170706402|NCT00646958|616935301|FG001|Overall Study|Adverse Event|0|||
170706403|NCT00646958|616935302|FG002|Overall Study|Adverse Event|0|||
170706404|NCT00646958|616935300|FG000|Overall Study|Lost to Follow-up|1|||
170706405|NCT00646958|616935301|FG001|Overall Study|Lost to Follow-up|5|||
170706406|NCT00646958|616935302|FG002|Overall Study|Lost to Follow-up|7|||
170706407|NCT00646958|616935300|FG000|Overall Study|Protocol Violation|1|||
170706408|NCT00646958|616935301|FG001|Overall Study|Protocol Violation|1|||
170706409|NCT00646958|616935302|FG002|Overall Study|Protocol Violation|0|||
170706410|NCT00646958|616935300|FG000|Overall Study|Abnormal screening lab tests|1|||
170706411|NCT00646958|616935301|FG001|Overall Study|Abnormal screening lab tests|1|||
170706412|NCT00646958|616935302|FG002|Overall Study|Abnormal screening lab tests|0|||
170706413|NCT00646958|616935300|FG000|Overall Study|Withdrawal by Subject|1|||
170706414|NCT00646958|616935301|FG001|Overall Study|Withdrawal by Subject|2|||
170706415|NCT00646958|616935302|FG002|Overall Study|Withdrawal by Subject|0|||
170706416|NCT00646958|616935300|FG000|Overall Study|Did not receive study drug|2|||
170706417|NCT00646958|616935301|FG001|Overall Study|Did not receive study drug|0|||
170706418|NCT00646958|616935302|FG002|Overall Study|Did not receive study drug|2|||
170706419|NCT00827372|616935303|FG000|Overall Study|Adverse Event|5|||
170706420|NCT00827372|616935303|FG000|Overall Study|Lack of Efficacy|3|||
170706421|NCT00194012|616935306|FG000|Randomized Phase|Lack of Efficacy|8|||
170706422|NCT00194012|616935307|FG001|Randomized Phase|Lack of Efficacy|18|||
170706423|NCT00194012|616935306|FG000|Randomized Phase|Study nonadherence|2|||
170706424|NCT00194012|616935307|FG001|Randomized Phase|Study nonadherence|1|||
170706425|NCT00194012|616935306|FG000|Randomized Phase|Withdrawal by Subject|3|||
170706426|NCT00194012|616935307|FG001|Randomized Phase|Withdrawal by Subject|3|||
170706427|NCT00194012|616935306|FG000|Randomized Phase|Adverse Event|2|||
170706428|NCT00194012|616935307|FG001|Randomized Phase|Adverse Event|1|||
170706429|NCT00194012|616935306|FG000|Randomized Phase|Participant reported having a rash|1|||
170706430|NCT00194012|616935307|FG001|Randomized Phase|Participant reported having a rash|0|||
170706431|NCT00194012|616935306|FG000|Randomized Phase|Emesis and enuresis|0|||
170706432|NCT00194012|616935307|FG001|Randomized Phase|Emesis and enuresis|1|||
170706433|NCT00194012|616935306|FG000|Randomized Phase|Oral/nasal twitching|0|||
170706434|NCT00194012|616935307|FG001|Randomized Phase|Oral/nasal twitching|1|||
170706435|NCT00194012|616935306|FG000|Open Label Extension (OLE)|Weight Gain|1|||
170706436|NCT00194012|616935307|FG001|Open Label Extension (OLE)|Weight Gain|0|||
170706437|NCT00194012|616935306|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
170706438|NCT00194012|616935307|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
170706439|NCT00194012|616935306|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
170706440|NCT00194012|616935307|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
170706441|NCT00194012|616935306|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
170706442|NCT00194012|616935307|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
170706443|NCT01105533|616935308|FG000|Overall Study|Death|0|||
170706444|NCT01105533|616935309|FG001|Overall Study|Death|0|||
170826589|NCT01274559|617374359|FG001|Overall Study|Protocol Violation|23|||
170826590|NCT01274559|617374358|FG000|Overall Study|Study Terminated by Sponsor|79|||
170826591|NCT01274559|617374359|FG001|Overall Study|Study Terminated by Sponsor|87|||
170826592|NCT01274559|617374358|FG000|Overall Study|Withdrawal by Subject|25|||
170826593|NCT01274559|617374359|FG001|Overall Study|Withdrawal by Subject|13|||
170706445|NCT01105533|616935310|FG002|Overall Study|Death|0|||
170706446|NCT01105533|616935311|FG003|Overall Study|Death|0|||
170706447|NCT01105533|616935312|FG004|Overall Study|Death|1|||
170706448|NCT01105533|616935313|FG005|Overall Study|Death|0|||
170706449|NCT01105533|616935314|FG006|Overall Study|Death|0|||
170706450|NCT01105533|616935315|FG007|Overall Study|Death|0|||
170706451|NCT01105533|616935316|FG008|Overall Study|Death|0|||
170706452|NCT01105533|616935308|FG000|Overall Study|Lack of Efficacy|1|||
170706453|NCT01105533|616935309|FG001|Overall Study|Lack of Efficacy|1|||
170706454|NCT01105533|616935310|FG002|Overall Study|Lack of Efficacy|3|||
170706455|NCT01105533|616935311|FG003|Overall Study|Lack of Efficacy|3|||
170706456|NCT01105533|616935312|FG004|Overall Study|Lack of Efficacy|4|||
170706457|NCT01105533|616935313|FG005|Overall Study|Lack of Efficacy|5|||
170706458|NCT01105533|616935314|FG006|Overall Study|Lack of Efficacy|3|||
170706459|NCT01105533|616935315|FG007|Overall Study|Lack of Efficacy|2|||
170706460|NCT01105533|616935316|FG008|Overall Study|Lack of Efficacy|9|||
170706461|NCT01105533|616935308|FG000|Overall Study|Adverse Event|0|||
170706462|NCT01105533|616935309|FG001|Overall Study|Adverse Event|0|||
170706463|NCT01105533|616935310|FG002|Overall Study|Adverse Event|0|||
170706464|NCT01105533|616935311|FG003|Overall Study|Adverse Event|0|||
170706465|NCT01105533|616935312|FG004|Overall Study|Adverse Event|1|||
170706466|NCT01105533|616935313|FG005|Overall Study|Adverse Event|2|||
170706467|NCT01105533|616935314|FG006|Overall Study|Adverse Event|2|||
170706468|NCT01105533|616935315|FG007|Overall Study|Adverse Event|0|||
170706469|NCT01105533|616935316|FG008|Overall Study|Adverse Event|1|||
170706470|NCT01105533|616935308|FG000|Overall Study|Other|0|||
170706471|NCT01105533|616935309|FG001|Overall Study|Other|0|||
170706472|NCT01105533|616935310|FG002|Overall Study|Other|0|||
170706473|NCT01105533|616935311|FG003|Overall Study|Other|0|||
170706474|NCT01105533|616935312|FG004|Overall Study|Other|1|||
170706475|NCT01105533|616935313|FG005|Overall Study|Other|0|||
170706476|NCT01105533|616935314|FG006|Overall Study|Other|3|||
170706477|NCT01105533|616935315|FG007|Overall Study|Other|1|||
170706478|NCT01105533|616935316|FG008|Overall Study|Other|2|||
170706479|NCT01105533|616935308|FG000|Overall Study|Physician Decision|0|||
170706480|NCT01105533|616935309|FG001|Overall Study|Physician Decision|0|||
170706481|NCT01105533|616935310|FG002|Overall Study|Physician Decision|0|||
170706482|NCT01105533|616935311|FG003|Overall Study|Physician Decision|0|||
170706483|NCT01105533|616935312|FG004|Overall Study|Physician Decision|0|||
170706484|NCT01105533|616935313|FG005|Overall Study|Physician Decision|0|||
170706485|NCT01105533|616935314|FG006|Overall Study|Physician Decision|0|||
170706486|NCT01105533|616935315|FG007|Overall Study|Physician Decision|1|||
170706487|NCT01105533|616935316|FG008|Overall Study|Physician Decision|0|||
170706488|NCT03892889|616935317|FG000|Overall Study|Adverse Event|17|||
170706489|NCT03892889|616935317|FG000|Overall Study|Lack of Efficacy|1|||
170706490|NCT03892889|616935317|FG000|Overall Study|Lost to Follow-up|46|||
170706491|NCT03892889|616935317|FG000|Overall Study|Non-compliance with study drug|22|||
170706492|NCT03892889|616935317|FG000|Overall Study|Pregnancy|1|||
170706493|NCT03892889|616935317|FG000|Overall Study|Protocol Deviation|3|||
170706494|NCT03892889|616935317|FG000|Overall Study|Withdrawal by Subject|50|||
170706495|NCT03892889|616935317|FG000|Overall Study|Withdrawal by Caregiver|1|||
170706496|NCT03892889|616935317|FG000|Overall Study|Study Terminated by Sponsor|50|||
170706497|NCT03892889|616935317|FG000|Overall Study|Physician Decision|8|||
170706498|NCT03892889|616935317|FG000|Overall Study|Reason not Specified|5|||
170706499|NCT00630877|616935320|FG000|Overall Study|Adverse Event|11|||
170706500|NCT00630877|616935321|FG001|Overall Study|Adverse Event|8|||
170706501|NCT00630877|616935322|FG002|Overall Study|Adverse Event|7|||
170826594|NCT00550446|617374360|FG000|Up To Week 12|Adverse Event|2|||
170826595|NCT00550446|617374361|FG001|Up To Week 12|Adverse Event|2|||
170826596|NCT00550446|617374362|FG002|Up To Week 12|Adverse Event|0|||
170826597|NCT00550446|617374363|FG003|Up To Week 12|Adverse Event|0|||
170826598|NCT00550446|617374364|FG004|Up To Week 12|Adverse Event|2|||
170826599|NCT00550446|617374365|FG005|Up To Week 12|Adverse Event|2|||
170826600|NCT00550446|617374366|FG006|Up To Week 12|Adverse Event|1|||
170826601|NCT00550446|617374367|FG007|Up To Week 12|Adverse Event|0|||
170826602|NCT00550446|617374368|FG008|Up To Week 12|Adverse Event|0|||
170826603|NCT00550446|617374369|FG009|Up To Week 12|Adverse Event|0|||
170826604|NCT00550446|617374370|FG010|Up To Week 12|Adverse Event|0|||
170826605|NCT00550446|617374360|FG000|Up To Week 12|Lack of Efficacy|3|||
170826606|NCT00550446|617374361|FG001|Up To Week 12|Lack of Efficacy|1|||
170826607|NCT00550446|617374362|FG002|Up To Week 12|Lack of Efficacy|0|||
170826608|NCT00550446|617374363|FG003|Up To Week 12|Lack of Efficacy|1|||
170826609|NCT00550446|617374364|FG004|Up To Week 12|Lack of Efficacy|0|||
170826610|NCT00550446|617374365|FG005|Up To Week 12|Lack of Efficacy|3|||
170826611|NCT00550446|617374366|FG006|Up To Week 12|Lack of Efficacy|3|||
170706502|NCT00630877|616935320|FG000|Overall Study|Withdrawal by Subject|3|||
170706503|NCT00630877|616935321|FG001|Overall Study|Withdrawal by Subject|4|||
170706504|NCT00630877|616935322|FG002|Overall Study|Withdrawal by Subject|0|||
170706505|NCT00630877|616935320|FG000|Overall Study|Lost to Follow-up|2|||
170706506|NCT00630877|616935321|FG001|Overall Study|Lost to Follow-up|0|||
170706507|NCT00630877|616935322|FG002|Overall Study|Lost to Follow-up|0|||
170706508|NCT00630877|616935320|FG000|Overall Study|Noncompliance|2|||
170706509|NCT00630877|616935321|FG001|Overall Study|Noncompliance|3|||
170826612|NCT00550446|617374367|FG007|Up To Week 12|Lack of Efficacy|0|||
170826613|NCT00550446|617374368|FG008|Up To Week 12|Lack of Efficacy|0|||
170706510|NCT00630877|616935322|FG002|Overall Study|Noncompliance|1|||
170826614|NCT00550446|617374369|FG009|Up To Week 12|Lack of Efficacy|0|||
170706511|NCT00630877|616935320|FG000|Overall Study|Protocol violation|1|||
170706512|NCT00630877|616935321|FG001|Overall Study|Protocol violation|0|||
170706513|NCT00630877|616935322|FG002|Overall Study|Protocol violation|1|||
170706514|NCT00630877|616935320|FG000|Overall Study|Personal reasons|0|||
170706515|NCT00630877|616935321|FG001|Overall Study|Personal reasons|0|||
170706516|NCT00630877|616935322|FG002|Overall Study|Personal reasons|1|||
170706517|NCT01639001|616935331|FG000|Overall Study|Refused further follow-up|9|||
170706518|NCT01639001|616935332|FG001|Overall Study|Refused further follow-up|12|||
170706519|NCT01639001|616935331|FG000|Overall Study|Lost to Follow-up|3|||
170706520|NCT01639001|616935332|FG001|Overall Study|Lost to Follow-up|0|||
170706521|NCT01639001|616935331|FG000|Overall Study|Death|62|||
170706522|NCT01639001|616935332|FG001|Overall Study|Death|61|||
170706523|NCT01639001|616935331|FG000|Overall Study|Randomized but not treated|0|||
170706524|NCT01639001|616935332|FG001|Overall Study|Randomized but not treated|2|||
170706525|NCT01639001|616935331|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
170706526|NCT01639001|616935332|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
170706527|NCT02453594|616935333|FG000|Overall Study|Protocol Violation|0|||
170706528|NCT02453594|616935334|FG001|Overall Study|Protocol Violation|0|||
170706529|NCT02453594|616935335|FG002|Overall Study|Protocol Violation|1|||
170706530|NCT02453594|616935333|FG000|Overall Study|Cohort Was Closed|17|||
170706531|NCT02453594|616935334|FG001|Overall Study|Cohort Was Closed|21|||
170706532|NCT02453594|616935335|FG002|Overall Study|Cohort Was Closed|14|||
170706533|NCT02453594|616935333|FG000|Overall Study|Death|20|||
170706534|NCT02453594|616935334|FG001|Overall Study|Death|24|||
170706535|NCT02453594|616935335|FG002|Overall Study|Death|16|||
170706536|NCT02453594|616935333|FG000|Overall Study|Lost to Follow-up|6|||
170706537|NCT02453594|616935334|FG001|Overall Study|Lost to Follow-up|14|||
170706538|NCT02453594|616935335|FG002|Overall Study|Lost to Follow-up|2|||
170706539|NCT02453594|616935333|FG000|Overall Study|Physician Decision|2|||
170706540|NCT02453594|616935334|FG001|Overall Study|Physician Decision|4|||
170706541|NCT02453594|616935335|FG002|Overall Study|Physician Decision|0|||
170706542|NCT02453594|616935333|FG000|Overall Study|Site Terminated by Sponsor|1|||
170706543|NCT02453594|616935334|FG001|Overall Study|Site Terminated by Sponsor|0|||
170706544|NCT02453594|616935335|FG002|Overall Study|Site Terminated by Sponsor|1|||
170706545|NCT02453594|616935333|FG000|Overall Study|Transitioned to Extension Study|16|||
170826615|NCT00550446|617374370|FG010|Up To Week 12|Lack of Efficacy|0|||
170826616|NCT00550446|617374360|FG000|Up To Week 12|Lost to Follow-up|0|||
170826617|NCT00550446|617374361|FG001|Up To Week 12|Lost to Follow-up|1|||
170826618|NCT00550446|617374362|FG002|Up To Week 12|Lost to Follow-up|0|||
170826619|NCT00550446|617374363|FG003|Up To Week 12|Lost to Follow-up|0|||
170826620|NCT00550446|617374364|FG004|Up To Week 12|Lost to Follow-up|1|||
170826621|NCT00550446|617374365|FG005|Up To Week 12|Lost to Follow-up|1|||
170826622|NCT00550446|617374366|FG006|Up To Week 12|Lost to Follow-up|2|||
170826623|NCT00550446|617374367|FG007|Up To Week 12|Lost to Follow-up|0|||
170826624|NCT00550446|617374368|FG008|Up To Week 12|Lost to Follow-up|0|||
170826625|NCT00550446|617374369|FG009|Up To Week 12|Lost to Follow-up|0|||
170826626|NCT00550446|617374370|FG010|Up To Week 12|Lost to Follow-up|0|||
170826627|NCT00550446|617374360|FG000|Up To Week 12|Withdrawal by Subject|2|||
170826628|NCT00550446|617374361|FG001|Up To Week 12|Withdrawal by Subject|0|||
170826629|NCT00550446|617374362|FG002|Up To Week 12|Withdrawal by Subject|3|||
170826630|NCT00550446|617374363|FG003|Up To Week 12|Withdrawal by Subject|2|||
170826631|NCT00550446|617374364|FG004|Up To Week 12|Withdrawal by Subject|0|||
170826632|NCT00550446|617374365|FG005|Up To Week 12|Withdrawal by Subject|1|||
170826633|NCT00550446|617374366|FG006|Up To Week 12|Withdrawal by Subject|3|||
170826634|NCT00550446|617374367|FG007|Up To Week 12|Withdrawal by Subject|0|||
170826635|NCT00550446|617374368|FG008|Up To Week 12|Withdrawal by Subject|0|||
170826636|NCT00550446|617374369|FG009|Up To Week 12|Withdrawal by Subject|0|||
170826637|NCT00550446|617374370|FG010|Up To Week 12|Withdrawal by Subject|0|||
170826638|NCT00550446|617374360|FG000|Up To Week 12|Other|3|||
170826639|NCT00550446|617374361|FG001|Up To Week 12|Other|0|||
170826640|NCT00550446|617374362|FG002|Up To Week 12|Other|0|||
170826641|NCT00550446|617374363|FG003|Up To Week 12|Other|0|||
170826642|NCT00550446|617374364|FG004|Up To Week 12|Other|0|||
170826643|NCT00550446|617374365|FG005|Up To Week 12|Other|1|||
170826644|NCT00550446|617374366|FG006|Up To Week 12|Other|4|||
170826645|NCT00550446|617374367|FG007|Up To Week 12|Other|0|||
170826646|NCT00550446|617374368|FG008|Up To Week 12|Other|0|||
170826647|NCT00550446|617374369|FG009|Up To Week 12|Other|0|||
170706546|NCT02453594|616935334|FG001|Overall Study|Transitioned to Extension Study|9|||
170706547|NCT02453594|616935335|FG002|Overall Study|Transitioned to Extension Study|16|||
170706548|NCT02453594|616935333|FG000|Overall Study|Withdrawal by Subject|7|||
170706549|NCT02453594|616935334|FG001|Overall Study|Withdrawal by Subject|9|||
170706550|NCT02453594|616935335|FG002|Overall Study|Withdrawal by Subject|11|||
170706551|NCT00679341|616935337|FG000|Overall Study|Disease progression|42|||
170706552|NCT00679341|616935338|FG001|Overall Study|Disease progression|36|||
170706553|NCT00679341|616935337|FG000|Overall Study|Adverse Event|5|||
170826648|NCT00550446|617374370|FG010|Up To Week 12|Other|0|||
170826649|NCT00550446|617374360|FG000|Up To Week 12|Randomized not treated|0|||
170826650|NCT00550446|617374361|FG001|Up To Week 12|Randomized not treated|1|||
170706554|NCT00679341|616935338|FG001|Overall Study|Adverse Event|6|||
170706555|NCT00679341|616935337|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
170706556|NCT00679341|616935338|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
170706557|NCT00679341|616935337|FG000|Overall Study|Death|1|||
170706558|NCT00679341|616935338|FG001|Overall Study|Death|1|||
170706559|NCT00679341|616935337|FG000|Overall Study|Other|1|||
170706560|NCT00679341|616935338|FG001|Overall Study|Other|0|||
170706561|NCT00679341|616935337|FG000|Overall Study|Physician Decision|1|||
170706562|NCT00679341|616935338|FG001|Overall Study|Physician Decision|0|||
170706563|NCT00679341|616935337|FG000|Overall Study|Not treated|0|||
170706564|NCT00679341|616935338|FG001|Overall Study|Not treated|2|||
170706565|NCT00679341|616935337|FG000|Overall Study|Physician/patient decision to withdraw|0|||
170706566|NCT00679341|616935338|FG001|Overall Study|Physician/patient decision to withdraw|6|||
170706567|NCT00298896|616935342|FG000|Overall Study|Death|3|||
170706568|NCT00298896|616935342|FG000|Overall Study|Physician Decision|2|||
170706569|NCT00298896|616935342|FG000|Overall Study|Intercurrent Illness|1|||
170706570|NCT00298896|616935342|FG000|Overall Study|Disease Progression|41|||
170706571|NCT00298896|616935342|FG000|Overall Study|Withdrawal by Subject|2|||
170706572|NCT00298896|616935342|FG000|Overall Study|Assigned to treatment in error|1|||
170706573|NCT02880371|616935343|FG000|Phase 1b|Lost to Follow-up|1|||
170706574|NCT02880371|616935344|FG001|Phase 1b|Lost to Follow-up|0|||
170706575|NCT02880371|616935345|FG002|Phase 1b|Lost to Follow-up|0|||
170706576|NCT02880371|616935346|FG003|Phase 1b|Lost to Follow-up|0|||
170706577|NCT02880371|616935347|FG004|Phase 1b|Lost to Follow-up|0|||
170706578|NCT02880371|616935348|FG005|Phase 1b|Lost to Follow-up|0|||
170706579|NCT02880371|616935349|FG006|Phase 1b|Lost to Follow-up|0|||
170706580|NCT02880371|616935350|FG007|Phase 1b|Lost to Follow-up|0|||
170706581|NCT02880371|616935343|FG000|Phase 1b|Participants terminated by Sponsor|1|||
170706582|NCT02880371|616935344|FG001|Phase 1b|Participants terminated by Sponsor|0|||
170706583|NCT02880371|616935345|FG002|Phase 1b|Participants terminated by Sponsor|0|||
170706584|NCT02880371|616935346|FG003|Phase 1b|Participants terminated by Sponsor|0|||
170706585|NCT02880371|616935347|FG004|Phase 1b|Participants terminated by Sponsor|0|||
170706586|NCT02880371|616935348|FG005|Phase 1b|Participants terminated by Sponsor|0|||
170706587|NCT02880371|616935349|FG006|Phase 1b|Participants terminated by Sponsor|0|||
170706588|NCT02880371|616935350|FG007|Phase 1b|Participants terminated by Sponsor|0|||
170706589|NCT02880371|616935343|FG000|Phase 1b|Withdrawal by Subject|0|||
170706590|NCT02880371|616935344|FG001|Phase 1b|Withdrawal by Subject|0|||
170706591|NCT02880371|616935345|FG002|Phase 1b|Withdrawal by Subject|1|||
170706592|NCT02880371|616935346|FG003|Phase 1b|Withdrawal by Subject|0|||
170706593|NCT02880371|616935347|FG004|Phase 1b|Withdrawal by Subject|0|||
170706594|NCT02880371|616935348|FG005|Phase 1b|Withdrawal by Subject|0|||
170706595|NCT02880371|616935349|FG006|Phase 1b|Withdrawal by Subject|0|||
170706596|NCT02880371|616935350|FG007|Phase 1b|Withdrawal by Subject|0|||
170706597|NCT02880371|616935343|FG000|Phase 1b|Death|4|||
170706598|NCT02880371|616935344|FG001|Phase 1b|Death|6|||
170706599|NCT02880371|616935345|FG002|Phase 1b|Death|5|||
170706600|NCT02880371|616935346|FG003|Phase 1b|Death|1|||
170706601|NCT02880371|616935347|FG004|Phase 1b|Death|0|||
170706602|NCT02880371|616935348|FG005|Phase 1b|Death|0|||
170706603|NCT02880371|616935349|FG006|Phase 1b|Death|0|||
170706604|NCT02880371|616935350|FG007|Phase 1b|Death|0|||
170706605|NCT02880371|616935343|FG000|Phase 1b|Enrolled but not Treated|0|||
170706606|NCT02880371|616935344|FG001|Phase 1b|Enrolled but not Treated|1|||
170706607|NCT02880371|616935345|FG002|Phase 1b|Enrolled but not Treated|0|||
170706608|NCT02880371|616935346|FG003|Phase 1b|Enrolled but not Treated|0|||
170706609|NCT02880371|616935347|FG004|Phase 1b|Enrolled but not Treated|0|||
170706610|NCT02880371|616935348|FG005|Phase 1b|Enrolled but not Treated|0|||
170706611|NCT02880371|616935349|FG006|Phase 1b|Enrolled but not Treated|0|||
170706612|NCT02880371|616935350|FG007|Phase 1b|Enrolled but not Treated|0|||
170706613|NCT02880371|616935343|FG000|Phase 2|Enrolled but not Treated|0|||
170706614|NCT02880371|616935344|FG001|Phase 2|Enrolled but not Treated|0|||
170706615|NCT02880371|616935345|FG002|Phase 2|Enrolled but not Treated|0|||
170706616|NCT02880371|616935346|FG003|Phase 2|Enrolled but not Treated|0|||
170706617|NCT02880371|616935347|FG004|Phase 2|Enrolled but not Treated|0|||
170706618|NCT02880371|616935348|FG005|Phase 2|Enrolled but not Treated|1|||
170706619|NCT02880371|616935349|FG006|Phase 2|Enrolled but not Treated|1|||
170706620|NCT02880371|616935350|FG007|Phase 2|Enrolled but not Treated|0|||
170706621|NCT02880371|616935343|FG000|Phase 2|Other|0|||
170706622|NCT02880371|616935344|FG001|Phase 2|Other|0|||
170706623|NCT02880371|616935345|FG002|Phase 2|Other|0|||
170706624|NCT02880371|616935346|FG003|Phase 2|Other|0|||
170706625|NCT02880371|616935347|FG004|Phase 2|Other|0|||
170706626|NCT02880371|616935348|FG005|Phase 2|Other|1|||
170706627|NCT02880371|616935349|FG006|Phase 2|Other|2|||
170706628|NCT02880371|616935350|FG007|Phase 2|Other|1|||
170706629|NCT02880371|616935343|FG000|Phase 2|Participants terminated by Sponsor|0|||
170706630|NCT02880371|616935344|FG001|Phase 2|Participants terminated by Sponsor|0|||
170706631|NCT02880371|616935345|FG002|Phase 2|Participants terminated by Sponsor|0|||
170706632|NCT02880371|616935346|FG003|Phase 2|Participants terminated by Sponsor|0|||
170706633|NCT02880371|616935347|FG004|Phase 2|Participants terminated by Sponsor|1|||
170706634|NCT02880371|616935348|FG005|Phase 2|Participants terminated by Sponsor|6|||
170706635|NCT02880371|616935349|FG006|Phase 2|Participants terminated by Sponsor|1|||
170706636|NCT02880371|616935350|FG007|Phase 2|Participants terminated by Sponsor|5|||
170706637|NCT02880371|616935343|FG000|Phase 2|Death|0|||
170706638|NCT02880371|616935344|FG001|Phase 2|Death|0|||
170706639|NCT02880371|616935345|FG002|Phase 2|Death|0|||
170706640|NCT02880371|616935346|FG003|Phase 2|Death|0|||
170706641|NCT02880371|616935347|FG004|Phase 2|Death|1|||
170706642|NCT02880371|616935348|FG005|Phase 2|Death|10|||
170706643|NCT02880371|616935349|FG006|Phase 2|Death|20|||
170706644|NCT02880371|616935350|FG007|Phase 2|Death|5|||
170706645|NCT02880371|616935343|FG000|Phase 2|Lost to Follow-up|0|||
170706646|NCT02880371|616935344|FG001|Phase 2|Lost to Follow-up|0|||
170706647|NCT02880371|616935345|FG002|Phase 2|Lost to Follow-up|0|||
170706648|NCT02880371|616935346|FG003|Phase 2|Lost to Follow-up|0|||
170706649|NCT02880371|616935347|FG004|Phase 2|Lost to Follow-up|0|||
170706650|NCT02880371|616935348|FG005|Phase 2|Lost to Follow-up|0|||
170706651|NCT02880371|616935349|FG006|Phase 2|Lost to Follow-up|3|||
170706652|NCT02880371|616935350|FG007|Phase 2|Lost to Follow-up|0|||
170706653|NCT02880371|616935343|FG000|Phase 2|Withdrawal by Subject|0|||
170706654|NCT02880371|616935344|FG001|Phase 2|Withdrawal by Subject|0|||
170706655|NCT02880371|616935345|FG002|Phase 2|Withdrawal by Subject|0|||
170706656|NCT02880371|616935346|FG003|Phase 2|Withdrawal by Subject|0|||
170706657|NCT02880371|616935347|FG004|Phase 2|Withdrawal by Subject|0|||
170706658|NCT02880371|616935348|FG005|Phase 2|Withdrawal by Subject|1|||
170706659|NCT02880371|616935349|FG006|Phase 2|Withdrawal by Subject|1|||
170706660|NCT02880371|616935350|FG007|Phase 2|Withdrawal by Subject|0|||
170706661|NCT02880371|616935343|FG000|Phase 2|End of Study page not completed by error|0|||
170706662|NCT02880371|616935344|FG001|Phase 2|End of Study page not completed by error|0|||
170706663|NCT02880371|616935345|FG002|Phase 2|End of Study page not completed by error|0|||
170706664|NCT02880371|616935346|FG003|Phase 2|End of Study page not completed by error|0|||
170706665|NCT02880371|616935347|FG004|Phase 2|End of Study page not completed by error|0|||
170706666|NCT02880371|616935348|FG005|Phase 2|End of Study page not completed by error|1|||
170706667|NCT02880371|616935349|FG006|Phase 2|End of Study page not completed by error|0|||
170706668|NCT02880371|616935350|FG007|Phase 2|End of Study page not completed by error|0|||
170706669|NCT01344057|616935360|FG000|Overall Study|Premature Withdrawal|1|||
170706670|NCT00306592|616935364|FG000|Overall Study|Adverse Event|8|||
170706671|NCT00306592|616935365|FG001|Overall Study|Adverse Event|15|||
170706672|NCT00306592|616935364|FG000|Overall Study|Lost to Follow-up|1|||
170706673|NCT00306592|616935365|FG001|Overall Study|Lost to Follow-up|0|||
170706674|NCT00306592|616935364|FG000|Overall Study|Noncompliance|0|||
170706675|NCT00306592|616935365|FG001|Overall Study|Noncompliance|2|||
170706676|NCT00306592|616935364|FG000|Overall Study|Persistent Antibodies|6|||
170706677|NCT00306592|616935365|FG001|Overall Study|Persistent Antibodies|3|||
170706678|NCT00306592|616935364|FG000|Overall Study|Voluntary|10|||
170706679|NCT00306592|616935365|FG001|Overall Study|Voluntary|6|||
170706680|NCT00306592|616935364|FG000|Overall Study|Other|5|||
170706681|NCT00306592|616935365|FG001|Overall Study|Other|10|||
170706682|NCT00306592|616935364|FG000|Overall Study|Other|1|||
170706683|NCT00306592|616935365|FG001|Overall Study|Other|2|||
170706684|NCT00306592|616935364|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
170706685|NCT00306592|616935365|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
170706686|NCT00424372|616935373|FG000|Overall Study|Death|1|||
170706687|NCT00424372|616935373|FG000|Overall Study|Adverse Event|18|||
170706688|NCT00424372|616935373|FG000|Overall Study|Lack of Efficacy|6|||
170706689|NCT00424372|616935373|FG000|Overall Study|Withdrawal by Subject|4|||
170706690|NCT00424372|616935373|FG000|Overall Study|Protocol Violation|1|||
170706691|NCT00424372|616935373|FG000|Overall Study|Health deterioration|1|||
170706692|NCT02167035|616935374|FG000|Overall Study|Adverse Event|2|||
170706693|NCT02167035|616935375|FG001|Overall Study|Adverse Event|2|||
170706694|NCT02167035|616935374|FG000|Overall Study|Lost to Follow-up|3|||
170706695|NCT02167035|616935375|FG001|Overall Study|Lost to Follow-up|3|||
170706696|NCT02167035|616935374|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
170826651|NCT00550446|617374362|FG002|Up To Week 12|Randomized not treated|1|||
170706697|NCT02167035|616935375|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
170706698|NCT00796861|616935376|FG000|Overall Study|Withdrawal by Subject|2|||
170826652|NCT00550446|617374363|FG003|Up To Week 12|Randomized not treated|0|||
170826653|NCT00550446|617374364|FG004|Up To Week 12|Randomized not treated|0|||
170826654|NCT00550446|617374365|FG005|Up To Week 12|Randomized not treated|0|||
170706699|NCT00796861|616935376|FG000|Overall Study|Death|2|||
170706700|NCT02039427|616935386|FG000|Overall Study|Duration of surgery > 3h|1|||
170706701|NCT02039427|616935387|FG001|Overall Study|Duration of surgery > 3h|1|||
170706702|NCT02039427|616935388|FG002|Overall Study|Duration of surgery > 3h|0|||
170706703|NCT02039427|616935389|FG003|Overall Study|Duration of surgery > 3h|0|||
170706704|NCT02039427|616935386|FG000|Overall Study|Withdrawal on concent|0|||
170706705|NCT02039427|616935387|FG001|Overall Study|Withdrawal on concent|0|||
170706706|NCT02039427|616935388|FG002|Overall Study|Withdrawal on concent|0|||
170706707|NCT02039427|616935389|FG003|Overall Study|Withdrawal on concent|1|||
170706708|NCT02039427|616935386|FG000|Overall Study|Cancellation of surgery|0|||
170706709|NCT02039427|616935387|FG001|Overall Study|Cancellation of surgery|0|||
170706710|NCT02039427|616935388|FG002|Overall Study|Cancellation of surgery|1|||
170706711|NCT02039427|616935389|FG003|Overall Study|Cancellation of surgery|0|||
170706712|NCT02039427|616935386|FG000|Overall Study|Loss of follow - up|1|||
170706713|NCT02039427|616935387|FG001|Overall Study|Loss of follow - up|0|||
170706714|NCT02039427|616935388|FG002|Overall Study|Loss of follow - up|2|||
170706715|NCT02039427|616935389|FG003|Overall Study|Loss of follow - up|4|||
170706716|NCT02039427|616935386|FG000|Overall Study|Steroid Use|1|||
170706717|NCT02039427|616935387|FG001|Overall Study|Steroid Use|0|||
170706718|NCT02039427|616935388|FG002|Overall Study|Steroid Use|0|||
170706719|NCT02039427|616935389|FG003|Overall Study|Steroid Use|0|||
170706720|NCT02399085|616935398|FG000|Overall Study|Adverse Event|16|||
170706721|NCT02399085|616935398|FG000|Overall Study|Death|2|||
170706722|NCT02399085|616935398|FG000|Overall Study|Withdrawal by Subject|8|||
170706723|NCT02399085|616935398|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
170706724|NCT02399085|616935398|FG000|Overall Study|Physician Decision|5|||
170706725|NCT00086580|616935399|FG000|Treatment Period|Disease progression|9|||
170706726|NCT00086580|616935400|FG001|Treatment Period|Disease progression|8|||
170706727|NCT00086580|616935399|FG000|Treatment Period|Unable to comply with protocol|3|||
170706728|NCT00086580|616935400|FG001|Treatment Period|Unable to comply with protocol|1|||
170706729|NCT00086580|616935399|FG000|Treatment Period|Withdrawal by Subject|7|||
170706730|NCT00086580|616935400|FG001|Treatment Period|Withdrawal by Subject|8|||
170706731|NCT00086580|616935399|FG000|Treatment Period|Physician Decision|13|||
170706732|NCT00086580|616935400|FG001|Treatment Period|Physician Decision|7|||
170706733|NCT00086580|616935399|FG000|Treatment Period|AE - not treatment related|7|||
170706734|NCT00086580|616935400|FG001|Treatment Period|AE - not treatment related|7|||
170706735|NCT00086580|616935399|FG000|Treatment Period|Toxicity - treatment related|15|||
170706736|NCT00086580|616935400|FG001|Treatment Period|Toxicity - treatment related|15|||
170706737|NCT00086580|616935399|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
170706738|NCT00086580|616935400|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
170706739|NCT00086580|616935399|FG000|Treatment Period|Death|5|||
170706740|NCT00086580|616935400|FG001|Treatment Period|Death|7|||
170706741|NCT00086580|616935399|FG000|Treatment Period|Other|5|||
170706742|NCT00086580|616935400|FG001|Treatment Period|Other|3|||
170706743|NCT00086580|616935399|FG000|Follow-up Period|Disease progression|72|||
170706744|NCT00086580|616935400|FG001|Follow-up Period|Disease progression|99|||
170706745|NCT00086580|616935399|FG000|Follow-up Period|Unable to comply with protocol|5|||
170706746|NCT00086580|616935400|FG001|Follow-up Period|Unable to comply with protocol|0|||
170706747|NCT00086580|616935399|FG000|Follow-up Period|Withdrawal by Subject|6|||
170706748|NCT00086580|616935400|FG001|Follow-up Period|Withdrawal by Subject|6|||
170706749|NCT00086580|616935399|FG000|Follow-up Period|Physician Decision|0|||
170706750|NCT00086580|616935400|FG001|Follow-up Period|Physician Decision|1|||
170706751|NCT00086580|616935399|FG000|Follow-up Period|AE - not related|1|||
170706752|NCT00086580|616935400|FG001|Follow-up Period|AE - not related|0|||
170706753|NCT00086580|616935399|FG000|Follow-up Period|Death|13|||
170706754|NCT00086580|616935400|FG001|Follow-up Period|Death|7|||
170706755|NCT00086580|616935399|FG000|Follow-up Period|Other|7|||
170706756|NCT00086580|616935400|FG001|Follow-up Period|Other|6|||
170706757|NCT00086580|616935399|FG000|Observation Period|Unable to comply with protocol|1|||
170706758|NCT00086580|616935400|FG001|Observation Period|Unable to comply with protocol|1|||
170706759|NCT00086580|616935399|FG000|Observation Period|Withdrawal by Subject|4|||
170706760|NCT00086580|616935400|FG001|Observation Period|Withdrawal by Subject|2|||
170706761|NCT00086580|616935399|FG000|Observation Period|Death|33|||
170706762|NCT00086580|616935400|FG001|Observation Period|Death|55|||
170706763|NCT00086580|616935399|FG000|Observation Period|Other|8|||
170706764|NCT00086580|616935400|FG001|Observation Period|Other|7|||
170706765|NCT02247349|616935401|FG000|Overall Study|Disease Progression|7|||
170706766|NCT02247349|616935402|FG001|Overall Study|Disease Progression|4|||
170706767|NCT02247349|616935403|FG002|Overall Study|Disease Progression|26|||
170706768|NCT02247349|616935404|FG003|Overall Study|Disease Progression|31|||
170706769|NCT02247349|616935405|FG004|Overall Study|Disease Progression|16|||
170706770|NCT02247349|616935406|FG005|Overall Study|Disease Progression|6|||
170706771|NCT02247349|616935401|FG000|Overall Study|Study drug toxicity|0|||
170706772|NCT02247349|616935402|FG001|Overall Study|Study drug toxicity|1|||
170706773|NCT02247349|616935403|FG002|Overall Study|Study drug toxicity|1|||
170706774|NCT02247349|616935404|FG003|Overall Study|Study drug toxicity|1|||
170706775|NCT02247349|616935405|FG004|Overall Study|Study drug toxicity|2|||
170706776|NCT02247349|616935406|FG005|Overall Study|Study drug toxicity|2|||
170706777|NCT02247349|616935401|FG000|Overall Study|Death|0|||
170706778|NCT02247349|616935402|FG001|Overall Study|Death|0|||
170706779|NCT02247349|616935403|FG002|Overall Study|Death|0|||
170706780|NCT02247349|616935404|FG003|Overall Study|Death|1|||
170706781|NCT02247349|616935405|FG004|Overall Study|Death|0|||
170706782|NCT02247349|616935406|FG005|Overall Study|Death|0|||
170706783|NCT02247349|616935401|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
170706784|NCT02247349|616935402|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
170706785|NCT02247349|616935403|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
170706786|NCT02247349|616935404|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
170706787|NCT02247349|616935405|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
170706788|NCT02247349|616935406|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
170706789|NCT02247349|616935401|FG000|Overall Study|Participant request to discontinue study treatment|0|||
170706790|NCT02247349|616935402|FG001|Overall Study|Participant request to discontinue study treatment|0|||
170706791|NCT02247349|616935403|FG002|Overall Study|Participant request to discontinue study treatment|1|||
170706792|NCT02247349|616935404|FG003|Overall Study|Participant request to discontinue study treatment|2|||
170706793|NCT02247349|616935405|FG004|Overall Study|Participant request to discontinue study treatment|1|||
170706794|NCT02247349|616935406|FG005|Overall Study|Participant request to discontinue study treatment|0|||
170706795|NCT02247349|616935401|FG000|Overall Study|Withdrawal by Subject|0|||
170706796|NCT02247349|616935402|FG001|Overall Study|Withdrawal by Subject|1|||
170706797|NCT02247349|616935403|FG002|Overall Study|Withdrawal by Subject|0|||
170706798|NCT02247349|616935404|FG003|Overall Study|Withdrawal by Subject|0|||
170706799|NCT02247349|616935405|FG004|Overall Study|Withdrawal by Subject|0|||
170706800|NCT02247349|616935406|FG005|Overall Study|Withdrawal by Subject|0|||
170706801|NCT02247349|616935401|FG000|Overall Study|Administrative reason by sponsor|0|||
170706802|NCT02247349|616935402|FG001|Overall Study|Administrative reason by sponsor|0|||
170706803|NCT02247349|616935403|FG002|Overall Study|Administrative reason by sponsor|0|||
170706804|NCT02247349|616935404|FG003|Overall Study|Administrative reason by sponsor|0|||
170706805|NCT02247349|616935405|FG004|Overall Study|Administrative reason by sponsor|1|||
170706806|NCT02247349|616935406|FG005|Overall Study|Administrative reason by sponsor|0|||
170706807|NCT02247349|616935401|FG000|Overall Study|Other reasons|0|||
170706808|NCT02247349|616935402|FG001|Overall Study|Other reasons|0|||
170706809|NCT02247349|616935403|FG002|Overall Study|Other reasons|1|||
170706810|NCT02247349|616935404|FG003|Overall Study|Other reasons|0|||
170706811|NCT02247349|616935405|FG004|Overall Study|Other reasons|0|||
170706812|NCT02247349|616935406|FG005|Overall Study|Other reasons|0|||
170706813|NCT00673452|616935408|FG000|Acute Double-Blind Phase|Adverse Event|41|||
170706814|NCT00673452|616935409|FG001|Acute Double-Blind Phase|Adverse Event|24|||
170706815|NCT00673452|616935408|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
170706816|NCT00673452|616935409|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
170706817|NCT00673452|616935408|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
170706818|NCT00673452|616935409|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
170706819|NCT00673452|616935408|FG000|Acute Double-Blind Phase|Physician Decision|0|||
170706820|NCT00673452|616935409|FG001|Acute Double-Blind Phase|Physician Decision|6|||
170706821|NCT00673452|616935408|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
170706822|NCT00673452|616935409|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
170706823|NCT00673452|616935408|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
170706824|NCT00673452|616935409|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
170706825|NCT00673452|616935408|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
170706826|NCT00673452|616935409|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
170706827|NCT00673452|616935408|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
170706828|NCT00673452|616935409|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
170706829|NCT00673452|616935408|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
170706830|NCT00673452|616935409|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
170706831|NCT00673452|616935408|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
170706832|NCT00673452|616935409|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
170706833|NCT00673452|616935408|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
170706834|NCT00673452|616935409|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
170706835|NCT00673452|616935408|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
170706836|NCT00673452|616935409|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
170706837|NCT00673452|616935408|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
170706838|NCT00673452|616935409|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
170706839|NCT00673452|616935408|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
170706840|NCT00673452|616935409|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
170706841|NCT00673452|616935408|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
170706842|NCT00673452|616935409|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
170706843|NCT01611259|616935410|FG000|Overall Study|Physician Decision|1|||
170706844|NCT01611259|616935410|FG000|Overall Study|Lack of Efficacy|2|||
170706845|NCT01611259|616935410|FG000|Overall Study|Adverse Event|4|||
170706846|NCT01611259|616935410|FG000|Overall Study|Withdrawal by Subject|7|||
170706847|NCT01365273|616935413|FG000|Overall Study|Lost to Follow-up|1|||
170706848|NCT01365273|616935414|FG001|Overall Study|Lost to Follow-up|0|||
170706849|NCT01365273|616935413|FG000|Overall Study|Protocol Violation|0|||
170706850|NCT01365273|616935414|FG001|Overall Study|Protocol Violation|1|||
170706851|NCT01365273|616935413|FG000|Overall Study|Physician Decision|1|||
170706852|NCT01365273|616935414|FG001|Overall Study|Physician Decision|0|||
170706853|NCT00314366|616935419|FG000|Overall Study|not treated due to patient medical condi|1|||
170826655|NCT00550446|617374366|FG006|Up To Week 12|Randomized not treated|0|||
170706854|NCT00314366|616935420|FG001|Overall Study|not treated due to patient medical condi|0|||
170706855|NCT00006916|616935424|FG000|Overall Study|Device not inserted|4|||
170706856|NCT00006916|616935424|FG000|Overall Study|Complication of device insertion|1|||
170706857|NCT01541930|616935425|FG000|Overall Study|Withdrawal by Subject|1|||
170706858|NCT06023394|616935426|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
170706859|NCT06023394|616935427|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
170706860|NCT06023394|616935426|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
170706861|NCT06023394|616935427|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
170706862|NCT06023394|616935426|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
170706863|NCT06023394|616935427|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
170706864|NCT06023394|616935426|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
170706865|NCT06023394|616935427|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
170706866|NCT02556710|616937443|FG000|Overall Study|Surgical treatment|3|||
170706867|NCT02556710|616937444|FG001|Overall Study|Surgical treatment|0|||
170706868|NCT02556710|616937443|FG000|Overall Study|Required proscribed pain medication|2|||
170706869|NCT02556710|616937444|FG001|Overall Study|Required proscribed pain medication|1|||
170706870|NCT02556710|616937443|FG000|Overall Study|Lack of Efficacy|1|||
170706871|NCT02556710|616937444|FG001|Overall Study|Lack of Efficacy|0|||
170706872|NCT02556710|616937443|FG000|Overall Study|Worsening osteoarthritis|1|||
170706873|NCT02556710|616937444|FG001|Overall Study|Worsening osteoarthritis|0|||
170706874|NCT02556710|616937443|FG000|Overall Study|Moved out of state|1|||
170706875|NCT02556710|616937444|FG001|Overall Study|Moved out of state|0|||
170706876|NCT02556710|616937443|FG000|Overall Study|Missing reason|3|||
170706877|NCT02556710|616937444|FG001|Overall Study|Missing reason|1|||
170706878|NCT02556710|616937443|FG000|Overall Study|Pain as lack of efficacy|0|||
170706879|NCT02556710|616937444|FG001|Overall Study|Pain as lack of efficacy|4|||
170706880|NCT04524403|616937447|FG000|Overall Study|Withdrawal by Subject|10|||
170706881|NCT04524403|616937448|FG001|Overall Study|Withdrawal by Subject|3|||
170706882|NCT04524403|616937449|FG002|Overall Study|Withdrawal by Subject|8|||
170706883|NCT04524403|616937447|FG000|Overall Study|Lost to Follow-up|3|||
170706884|NCT04524403|616937448|FG001|Overall Study|Lost to Follow-up|4|||
170706885|NCT04524403|616937449|FG002|Overall Study|Lost to Follow-up|3|||
170706886|NCT04524403|616937447|FG000|Overall Study|Adverse Event|3|||
170706887|NCT04524403|616937448|FG001|Overall Study|Adverse Event|1|||
170706888|NCT04524403|616937449|FG002|Overall Study|Adverse Event|4|||
170706889|NCT04524403|616937447|FG000|Overall Study|Non-compliant with study drug|1|||
170706890|NCT04524403|616937448|FG001|Overall Study|Non-compliant with study drug|2|||
170706891|NCT04524403|616937449|FG002|Overall Study|Non-compliant with study drug|3|||
170706892|NCT04524403|616937447|FG000|Overall Study|Moved|0|||
170706893|NCT04524403|616937448|FG001|Overall Study|Moved|1|||
170706894|NCT04524403|616937449|FG002|Overall Study|Moved|0|||
170706895|NCT00991302|616937452|FG000|Overall Study|Death|0|||
170706896|NCT00991302|616937453|FG001|Overall Study|Death|1|||
170706897|NCT00991302|616937452|FG000|Overall Study|Lost to Follow-up|14|||
170706898|NCT00991302|616937453|FG001|Overall Study|Lost to Follow-up|12|||
170706899|NCT01709318|616937454|FG000|Overall Study|Adverse Event|3|||
170706900|NCT01709318|616937455|FG001|Overall Study|Adverse Event|4|||
170706901|NCT01709318|616937456|FG002|Overall Study|Adverse Event|2|||
170706902|NCT01709318|616937457|FG003|Overall Study|Adverse Event|2|||
170706903|NCT01709318|616937458|FG004|Overall Study|Adverse Event|0|||
170706904|NCT01709318|616937459|FG005|Overall Study|Adverse Event|1|||
170706905|NCT01709318|616937460|FG006|Overall Study|Adverse Event|2|||
170706906|NCT01709318|616937454|FG000|Overall Study|Lost to Follow-up|2|||
170706907|NCT01709318|616937455|FG001|Overall Study|Lost to Follow-up|0|||
170706908|NCT01709318|616937456|FG002|Overall Study|Lost to Follow-up|0|||
170706909|NCT01709318|616937457|FG003|Overall Study|Lost to Follow-up|0|||
170706910|NCT01709318|616937458|FG004|Overall Study|Lost to Follow-up|1|||
170706911|NCT01709318|616937459|FG005|Overall Study|Lost to Follow-up|1|||
170706912|NCT01709318|616937460|FG006|Overall Study|Lost to Follow-up|1|||
170706913|NCT01709318|616937454|FG000|Overall Study|Non-compliance with Study Drug|0|||
170706914|NCT01709318|616937455|FG001|Overall Study|Non-compliance with Study Drug|2|||
170706915|NCT01709318|616937456|FG002|Overall Study|Non-compliance with Study Drug|1|||
170706916|NCT01709318|616937457|FG003|Overall Study|Non-compliance with Study Drug|1|||
170706917|NCT01709318|616937458|FG004|Overall Study|Non-compliance with Study Drug|0|||
170706918|NCT01709318|616937459|FG005|Overall Study|Non-compliance with Study Drug|0|||
170706919|NCT01709318|616937460|FG006|Overall Study|Non-compliance with Study Drug|2|||
170706920|NCT01709318|616937454|FG000|Overall Study|Physician Decision|0|||
170706921|NCT01709318|616937455|FG001|Overall Study|Physician Decision|0|||
170706922|NCT01709318|616937456|FG002|Overall Study|Physician Decision|0|||
170706923|NCT01709318|616937457|FG003|Overall Study|Physician Decision|0|||
170826656|NCT00550446|617374367|FG007|Up To Week 12|Randomized not treated|0|||
170826657|NCT00550446|617374368|FG008|Up To Week 12|Randomized not treated|0|||
170826658|NCT00550446|617374369|FG009|Up To Week 12|Randomized not treated|0|||
170826659|NCT00550446|617374370|FG010|Up To Week 12|Randomized not treated|0|||
170826660|NCT00550446|617374360|FG000|Post Week 12|Adverse Event|2|||
170826661|NCT00550446|617374361|FG001|Post Week 12|Adverse Event|1|||
170706924|NCT01709318|616937458|FG004|Overall Study|Physician Decision|0|||
170706925|NCT01709318|616937459|FG005|Overall Study|Physician Decision|0|||
170706926|NCT01709318|616937460|FG006|Overall Study|Physician Decision|1|||
170706927|NCT01709318|616937454|FG000|Overall Study|Pregnancy|0|||
170706928|NCT01709318|616937455|FG001|Overall Study|Pregnancy|0|||
170706929|NCT01709318|616937456|FG002|Overall Study|Pregnancy|0|||
170706930|NCT01709318|616937457|FG003|Overall Study|Pregnancy|0|||
170706931|NCT01709318|616937458|FG004|Overall Study|Pregnancy|1|||
170706932|NCT01709318|616937459|FG005|Overall Study|Pregnancy|0|||
170706933|NCT01709318|616937460|FG006|Overall Study|Pregnancy|0|||
170706934|NCT01709318|616937454|FG000|Overall Study|Protocol Violation|0|||
170706935|NCT01709318|616937455|FG001|Overall Study|Protocol Violation|0|||
170706936|NCT01709318|616937456|FG002|Overall Study|Protocol Violation|0|||
170706937|NCT01709318|616937457|FG003|Overall Study|Protocol Violation|0|||
170706938|NCT01709318|616937458|FG004|Overall Study|Protocol Violation|2|||
170706939|NCT01709318|616937459|FG005|Overall Study|Protocol Violation|0|||
170706940|NCT01709318|616937460|FG006|Overall Study|Protocol Violation|1|||
170706941|NCT01709318|616937454|FG000|Overall Study|Technical Problems|1|||
170706942|NCT01709318|616937455|FG001|Overall Study|Technical Problems|0|||
170706943|NCT01709318|616937456|FG002|Overall Study|Technical Problems|0|||
170706944|NCT01709318|616937457|FG003|Overall Study|Technical Problems|0|||
170706945|NCT01709318|616937458|FG004|Overall Study|Technical Problems|0|||
170706946|NCT01709318|616937459|FG005|Overall Study|Technical Problems|0|||
170706947|NCT01709318|616937460|FG006|Overall Study|Technical Problems|0|||
170706948|NCT01709318|616937454|FG000|Overall Study|Withdrawal by Subject|3|||
170706949|NCT01709318|616937455|FG001|Overall Study|Withdrawal by Subject|0|||
170706950|NCT01709318|616937456|FG002|Overall Study|Withdrawal by Subject|3|||
170706951|NCT01709318|616937457|FG003|Overall Study|Withdrawal by Subject|3|||
170706952|NCT01709318|616937458|FG004|Overall Study|Withdrawal by Subject|0|||
170706953|NCT01709318|616937459|FG005|Overall Study|Withdrawal by Subject|2|||
170706954|NCT01709318|616937460|FG006|Overall Study|Withdrawal by Subject|4|||
170706955|NCT01709318|616937454|FG000|Overall Study|Other Protocol Specified Criteria|0|||
170706956|NCT01709318|616937455|FG001|Overall Study|Other Protocol Specified Criteria|1|||
170706957|NCT01709318|616937456|FG002|Overall Study|Other Protocol Specified Criteria|0|||
170706958|NCT01709318|616937457|FG003|Overall Study|Other Protocol Specified Criteria|0|||
170706959|NCT01709318|616937458|FG004|Overall Study|Other Protocol Specified Criteria|0|||
170706960|NCT01709318|616937459|FG005|Overall Study|Other Protocol Specified Criteria|0|||
170706961|NCT01709318|616937460|FG006|Overall Study|Other Protocol Specified Criteria|0|||
170706962|NCT03370341|616937461|FG000|Overall Study|Lost to Follow-up|0|||
170706963|NCT03370341|616937462|FG001|Overall Study|Lost to Follow-up|1|||
170706964|NCT02602288|616937463|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
170706965|NCT02602288|616937464|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
170706966|NCT02602288|616937463|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
170706967|NCT02602288|616937464|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
170706968|NCT02602288|616937463|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
170706969|NCT02602288|616937464|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
170706970|NCT02602288|616937463|FG000|12 Month Follow-up|Lost to Follow-up|0|||
170706971|NCT02602288|616937464|FG001|12 Month Follow-up|Lost to Follow-up|4|||
170706972|NCT02602288|616937463|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
170706973|NCT02602288|616937464|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
170706974|NCT01310413|616937465|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
170706975|NCT01310413|616937466|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
170706976|NCT01310413|616937467|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
170706977|NCT01310413|616937468|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
170706978|NCT01310413|616937469|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
170706979|NCT01310413|616937470|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
170706980|NCT01310413|616937471|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
170706981|NCT01310413|616937465|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
170706982|NCT01310413|616937466|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
170826662|NCT00550446|617374362|FG002|Post Week 12|Adverse Event|1|||
170826663|NCT00550446|617374363|FG003|Post Week 12|Adverse Event|1|||
170826664|NCT00550446|617374364|FG004|Post Week 12|Adverse Event|1|||
170826665|NCT00550446|617374365|FG005|Post Week 12|Adverse Event|1|||
170826666|NCT00550446|617374366|FG006|Post Week 12|Adverse Event|0|||
170826667|NCT00550446|617374367|FG007|Post Week 12|Adverse Event|0|||
170826668|NCT00550446|617374368|FG008|Post Week 12|Adverse Event|0|||
170826669|NCT00550446|617374369|FG009|Post Week 12|Adverse Event|4|||
170826670|NCT00550446|617374370|FG010|Post Week 12|Adverse Event|0|||
170826671|NCT00550446|617374360|FG000|Post Week 12|Lack of Efficacy|0|||
170706983|NCT01310413|616937467|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
170706984|NCT01310413|616937468|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
170706985|NCT01310413|616937469|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
170706986|NCT01310413|616937470|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
170706987|NCT01310413|616937471|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
170706988|NCT01310413|616937465|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
170706989|NCT01310413|616937466|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
170706990|NCT01310413|616937467|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
170706991|NCT01310413|616937468|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
170706992|NCT01310413|616937469|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
170826672|NCT00550446|617374361|FG001|Post Week 12|Lack of Efficacy|0|||
170706993|NCT01310413|616937470|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
170706994|NCT01310413|616937471|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
170706995|NCT01310413|616937465|FG000|Day 0 to Day 385|Other|1|||
170706996|NCT01310413|616937466|FG001|Day 0 to Day 385|Other|0|||
170706997|NCT01310413|616937467|FG002|Day 0 to Day 385|Other|3|||
170706998|NCT01310413|616937468|FG003|Day 0 to Day 385|Other|0|||
170706999|NCT01310413|616937469|FG004|Day 0 to Day 385|Other|0|||
170707000|NCT01310413|616937470|FG005|Day 0 to Day 385|Other|0|||
170707001|NCT01310413|616937471|FG006|Day 0 to Day 385|Other|0|||
170707002|NCT01310413|616937465|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
170707003|NCT01310413|616937466|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
170707004|NCT01310413|616937467|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
170707005|NCT01310413|616937468|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
170707006|NCT01310413|616937469|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
170707007|NCT01310413|616937470|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
170707008|NCT01310413|616937471|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
170707009|NCT01310413|616937465|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
170707010|NCT01310413|616937466|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
170707011|NCT01310413|616937467|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
170707012|NCT01310413|616937468|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
170707013|NCT01310413|616937469|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
170707014|NCT01310413|616937470|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
170707015|NCT01310413|616937471|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
170707016|NCT01312909|616937474|FG000|Overall Study|Randomized but not treated|1|||
170707017|NCT01312909|616937475|FG001|Overall Study|Randomized but not treated|3|||
170707018|NCT01312909|616937476|FG002|Overall Study|Randomized but not treated|1|||
170707019|NCT01312909|616937474|FG000|Overall Study|Adverse Event|1|||
170707020|NCT01312909|616937475|FG001|Overall Study|Adverse Event|0|||
170707021|NCT01312909|616937476|FG002|Overall Study|Adverse Event|3|||
170707022|NCT01312909|616937474|FG000|Overall Study|Protocol Violation|2|||
170707023|NCT01312909|616937475|FG001|Overall Study|Protocol Violation|0|||
170707024|NCT01312909|616937476|FG002|Overall Study|Protocol Violation|2|||
170707025|NCT01312909|616937474|FG000|Overall Study|Other|9|||
170707026|NCT01312909|616937475|FG001|Overall Study|Other|6|||
170707027|NCT01312909|616937476|FG002|Overall Study|Other|11|||
170707028|NCT01312909|616937474|FG000|Overall Study|Withdrawal by Subject|8|||
170707029|NCT01312909|616937475|FG001|Overall Study|Withdrawal by Subject|10|||
170707030|NCT01312909|616937476|FG002|Overall Study|Withdrawal by Subject|7|||
170707031|NCT01312909|616937474|FG000|Overall Study|Lost to Follow-up|21|||
170707032|NCT01312909|616937475|FG001|Overall Study|Lost to Follow-up|17|||
170707033|NCT01312909|616937476|FG002|Overall Study|Lost to Follow-up|20|||
170707034|NCT01312909|616937474|FG000|Overall Study|Insufficient clinical response|0|||
170707035|NCT01312909|616937475|FG001|Overall Study|Insufficient clinical response|0|||
170707036|NCT01312909|616937476|FG002|Overall Study|Insufficient clinical response|1|||
170707037|NCT01312909|616937474|FG000|Overall Study|Entrance criteria not met|0|||
170707038|NCT01312909|616937475|FG001|Overall Study|Entrance criteria not met|0|||
170707039|NCT01312909|616937476|FG002|Overall Study|Entrance criteria not met|2|||
170707040|NCT01640301|616937477|FG000|Overall Study|Death|0|||
170707041|NCT01640301|616937478|FG001|Overall Study|Death|8|||
170707042|NCT02391948|616937482|FG000|6-month Assessment|Death|0|||
170707043|NCT02391948|616937483|FG001|6-month Assessment|Death|0|||
170707044|NCT02391948|616937484|FG002|6-month Assessment|Death|0|||
170707045|NCT02391948|616937485|FG003|6-month Assessment|Death|0|||
170707046|NCT02391948|616937486|FG004|6-month Assessment|Death|1|||
170707047|NCT02391948|616937482|FG000|6-month Assessment|Withdrawal by Subject|0|||
170707048|NCT02391948|616937483|FG001|6-month Assessment|Withdrawal by Subject|0|||
170707049|NCT02391948|616937484|FG002|6-month Assessment|Withdrawal by Subject|1|||
170707050|NCT02391948|616937485|FG003|6-month Assessment|Withdrawal by Subject|2|||
170707051|NCT02391948|616937486|FG004|6-month Assessment|Withdrawal by Subject|0|||
170707052|NCT02391948|616937482|FG000|6-month Assessment|Lost to Follow-up|4|||
170707053|NCT02391948|616937483|FG001|6-month Assessment|Lost to Follow-up|5|||
170707054|NCT02391948|616937484|FG002|6-month Assessment|Lost to Follow-up|2|||
170707055|NCT02391948|616937485|FG003|6-month Assessment|Lost to Follow-up|3|||
170826673|NCT00550446|617374362|FG002|Post Week 12|Lack of Efficacy|1|||
170826674|NCT00550446|617374363|FG003|Post Week 12|Lack of Efficacy|0|||
170707056|NCT02391948|616937486|FG004|6-month Assessment|Lost to Follow-up|1|||
170826675|NCT00550446|617374364|FG004|Post Week 12|Lack of Efficacy|0|||
170707057|NCT02391948|616937482|FG000|6-month Assessment|Medical issue/illness|1|||
170707058|NCT02391948|616937483|FG001|6-month Assessment|Medical issue/illness|1|||
170707059|NCT02391948|616937484|FG002|6-month Assessment|Medical issue/illness|0|||
170707060|NCT02391948|616937485|FG003|6-month Assessment|Medical issue/illness|0|||
170707061|NCT02391948|616937486|FG004|6-month Assessment|Medical issue/illness|0|||
170707062|NCT02391948|616937482|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
170707063|NCT02391948|616937483|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
170707064|NCT02391948|616937484|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
170826676|NCT00550446|617374365|FG005|Post Week 12|Lack of Efficacy|0|||
170707065|NCT02391948|616937485|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
170707066|NCT02391948|616937486|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
170707067|NCT02391948|616937482|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
170707068|NCT02391948|616937483|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
170707069|NCT02391948|616937484|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
170707070|NCT02391948|616937485|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
170707071|NCT02391948|616937486|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
170707072|NCT02391948|616937482|FG000|12-month Assessment|Death|0|||
170707073|NCT02391948|616937483|FG001|12-month Assessment|Death|0|||
170707074|NCT02391948|616937484|FG002|12-month Assessment|Death|0|||
170707075|NCT02391948|616937485|FG003|12-month Assessment|Death|1|||
170707076|NCT02391948|616937486|FG004|12-month Assessment|Death|0|||
170707077|NCT02391948|616937482|FG000|12-month Assessment|Withdrawal by Subject|1|||
170707078|NCT02391948|616937483|FG001|12-month Assessment|Withdrawal by Subject|0|||
170707079|NCT02391948|616937484|FG002|12-month Assessment|Withdrawal by Subject|0|||
170707080|NCT02391948|616937485|FG003|12-month Assessment|Withdrawal by Subject|1|||
170707081|NCT02391948|616937486|FG004|12-month Assessment|Withdrawal by Subject|0|||
170707082|NCT02391948|616937482|FG000|12-month Assessment|Lost to Follow-up|5|||
170707083|NCT02391948|616937483|FG001|12-month Assessment|Lost to Follow-up|4|||
170707084|NCT02391948|616937484|FG002|12-month Assessment|Lost to Follow-up|4|||
170707085|NCT02391948|616937485|FG003|12-month Assessment|Lost to Follow-up|4|||
170707086|NCT02391948|616937486|FG004|12-month Assessment|Lost to Follow-up|5|||
170707087|NCT02391948|616937482|FG000|12-month Assessment|Medical issue/illness|0|||
170707088|NCT02391948|616937483|FG001|12-month Assessment|Medical issue/illness|1|||
170707089|NCT02391948|616937484|FG002|12-month Assessment|Medical issue/illness|0|||
170707090|NCT02391948|616937485|FG003|12-month Assessment|Medical issue/illness|1|||
170707091|NCT02391948|616937486|FG004|12-month Assessment|Medical issue/illness|0|||
170707092|NCT02391948|616937482|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
170707093|NCT02391948|616937483|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
170707094|NCT02391948|616937484|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
170707095|NCT02391948|616937485|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
170707096|NCT02391948|616937486|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
170707097|NCT02391948|616937482|FG000|18-month Assessment|Death|0|||
170707098|NCT02391948|616937483|FG001|18-month Assessment|Death|0|||
170707099|NCT02391948|616937484|FG002|18-month Assessment|Death|0|||
170707100|NCT02391948|616937485|FG003|18-month Assessment|Death|1|||
170707101|NCT02391948|616937486|FG004|18-month Assessment|Death|1|||
170707102|NCT02391948|616937482|FG000|18-month Assessment|Withdrawal by Subject|1|||
170707103|NCT02391948|616937483|FG001|18-month Assessment|Withdrawal by Subject|0|||
170707104|NCT02391948|616937484|FG002|18-month Assessment|Withdrawal by Subject|0|||
170707105|NCT02391948|616937485|FG003|18-month Assessment|Withdrawal by Subject|1|||
170707106|NCT02391948|616937486|FG004|18-month Assessment|Withdrawal by Subject|0|||
170707107|NCT02391948|616937482|FG000|18-month Assessment|Lost to Follow-up|2|||
170707108|NCT02391948|616937483|FG001|18-month Assessment|Lost to Follow-up|6|||
170707109|NCT02391948|616937484|FG002|18-month Assessment|Lost to Follow-up|2|||
170707110|NCT02391948|616937485|FG003|18-month Assessment|Lost to Follow-up|2|||
170707111|NCT02391948|616937486|FG004|18-month Assessment|Lost to Follow-up|3|||
170707112|NCT02391948|616937482|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
170707113|NCT02391948|616937483|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
170707114|NCT02391948|616937484|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
170707115|NCT02391948|616937485|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
170707116|NCT02391948|616937486|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
170707117|NCT02391948|616937482|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
170707118|NCT02391948|616937483|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
170707119|NCT02391948|616937484|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
170707120|NCT02391948|616937485|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
170707121|NCT02391948|616937486|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
170707122|NCT02391948|616937482|FG000|24-month Assessment|Death|0|||
170707123|NCT02391948|616937483|FG001|24-month Assessment|Death|0|||
170707124|NCT02391948|616937484|FG002|24-month Assessment|Death|0|||
170707125|NCT02391948|616937485|FG003|24-month Assessment|Death|0|||
170707126|NCT02391948|616937486|FG004|24-month Assessment|Death|1|||
170707127|NCT02391948|616937482|FG000|24-month Assessment|Withdrawal by Subject|1|||
170707128|NCT02391948|616937483|FG001|24-month Assessment|Withdrawal by Subject|1|||
170707129|NCT02391948|616937484|FG002|24-month Assessment|Withdrawal by Subject|0|||
170707130|NCT02391948|616937485|FG003|24-month Assessment|Withdrawal by Subject|0|||
170707131|NCT02391948|616937486|FG004|24-month Assessment|Withdrawal by Subject|1|||
170707132|NCT02391948|616937482|FG000|24-month Assessment|Lost to Follow-up|5|||
170707133|NCT02391948|616937483|FG001|24-month Assessment|Lost to Follow-up|4|||
170707134|NCT02391948|616937484|FG002|24-month Assessment|Lost to Follow-up|0|||
170707135|NCT02391948|616937485|FG003|24-month Assessment|Lost to Follow-up|0|||
170707136|NCT02391948|616937486|FG004|24-month Assessment|Lost to Follow-up|0|||
170707137|NCT02391948|616937482|FG000|24-month Assessment|Medical issue/illness|0|||
170707138|NCT02391948|616937483|FG001|24-month Assessment|Medical issue/illness|0|||
170707139|NCT02391948|616937484|FG002|24-month Assessment|Medical issue/illness|1|||
170707140|NCT02391948|616937485|FG003|24-month Assessment|Medical issue/illness|0|||
170707141|NCT02391948|616937486|FG004|24-month Assessment|Medical issue/illness|0|||
170707142|NCT02391948|616937482|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
170707143|NCT02391948|616937483|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
170707144|NCT02391948|616937484|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
170707145|NCT02391948|616937485|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
170707146|NCT02391948|616937486|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
170707147|NCT02200042|616937487|FG000|Overall Study|Withdrawal by Subject|0|||
170707148|NCT02200042|616937488|FG001|Overall Study|Withdrawal by Subject|1|||
170707149|NCT01969838|616937489|FG000|Double-blind Phase|Adverse Event|10|||
170707150|NCT01969838|616937490|FG001|Double-blind Phase|Adverse Event|4|||
170707151|NCT01969838|616937491|FG002|Double-blind Phase|Adverse Event|0|||
170707152|NCT01969838|616937492|FG003|Double-blind Phase|Adverse Event|0|||
170707153|NCT01969838|616937489|FG000|Double-blind Phase|Death|5|||
170707154|NCT01969838|616937490|FG001|Double-blind Phase|Death|2|||
170707155|NCT01969838|616937491|FG002|Double-blind Phase|Death|0|||
170707156|NCT01969838|616937492|FG003|Double-blind Phase|Death|0|||
170707157|NCT01969838|616937489|FG000|Double-blind Phase|Physician Decision|5|||
170707158|NCT01969838|616937490|FG001|Double-blind Phase|Physician Decision|1|||
170707159|NCT01969838|616937491|FG002|Double-blind Phase|Physician Decision|0|||
170707160|NCT01969838|616937492|FG003|Double-blind Phase|Physician Decision|0|||
170707161|NCT01969838|616937489|FG000|Double-blind Phase|Subject Decision|4|||
170707162|NCT01969838|616937490|FG001|Double-blind Phase|Subject Decision|2|||
170707163|NCT01969838|616937491|FG002|Double-blind Phase|Subject Decision|0|||
170707164|NCT01969838|616937492|FG003|Double-blind Phase|Subject Decision|0|||
170707165|NCT01969838|616937489|FG000|Double-blind Phase|Disease Progression|2|||
170707166|NCT01969838|616937490|FG001|Double-blind Phase|Disease Progression|0|||
170707167|NCT01969838|616937491|FG002|Double-blind Phase|Disease Progression|0|||
170707168|NCT01969838|616937492|FG003|Double-blind Phase|Disease Progression|0|||
170826677|NCT00550446|617374366|FG006|Post Week 12|Lack of Efficacy|0|||
170826678|NCT00550446|617374367|FG007|Post Week 12|Lack of Efficacy|1|||
170826679|NCT00550446|617374368|FG008|Post Week 12|Lack of Efficacy|1|||
170826680|NCT00550446|617374369|FG009|Post Week 12|Lack of Efficacy|2|||
170826681|NCT00550446|617374370|FG010|Post Week 12|Lack of Efficacy|1|||
170826682|NCT00550446|617374360|FG000|Post Week 12|Lost to Follow-up|0|||
170826683|NCT00550446|617374361|FG001|Post Week 12|Lost to Follow-up|0|||
170826684|NCT00550446|617374362|FG002|Post Week 12|Lost to Follow-up|1|||
170826685|NCT00550446|617374363|FG003|Post Week 12|Lost to Follow-up|1|||
170826686|NCT00550446|617374364|FG004|Post Week 12|Lost to Follow-up|0|||
170826687|NCT00550446|617374365|FG005|Post Week 12|Lost to Follow-up|0|||
170826688|NCT00550446|617374366|FG006|Post Week 12|Lost to Follow-up|1|||
170826689|NCT00550446|617374367|FG007|Post Week 12|Lost to Follow-up|0|||
170826690|NCT00550446|617374368|FG008|Post Week 12|Lost to Follow-up|0|||
170826691|NCT00550446|617374369|FG009|Post Week 12|Lost to Follow-up|0|||
170826692|NCT00550446|617374370|FG010|Post Week 12|Lost to Follow-up|0|||
170826693|NCT00550446|617374360|FG000|Post Week 12|Withdrawal by Subject|0|||
170826694|NCT00550446|617374361|FG001|Post Week 12|Withdrawal by Subject|0|||
170826695|NCT00550446|617374362|FG002|Post Week 12|Withdrawal by Subject|0|||
170826696|NCT00550446|617374363|FG003|Post Week 12|Withdrawal by Subject|0|||
170826697|NCT00550446|617374364|FG004|Post Week 12|Withdrawal by Subject|1|||
170826698|NCT00550446|617374365|FG005|Post Week 12|Withdrawal by Subject|0|||
170826699|NCT00550446|617374366|FG006|Post Week 12|Withdrawal by Subject|0|||
170826700|NCT00550446|617374367|FG007|Post Week 12|Withdrawal by Subject|0|||
170826701|NCT00550446|617374368|FG008|Post Week 12|Withdrawal by Subject|0|||
170826702|NCT00550446|617374369|FG009|Post Week 12|Withdrawal by Subject|0|||
170826703|NCT00550446|617374370|FG010|Post Week 12|Withdrawal by Subject|0|||
170826704|NCT00550446|617374360|FG000|Post Week 12|Other|1|||
170707169|NCT01969838|616937489|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
170707170|NCT01969838|616937490|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
170826705|NCT00550446|617374361|FG001|Post Week 12|Other|1|||
170707171|NCT01969838|616937491|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
170707172|NCT01969838|616937492|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
170707173|NCT01969838|616937489|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
170707174|NCT01969838|616937490|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
170707175|NCT01969838|616937491|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
170707176|NCT01969838|616937492|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
170826706|NCT00550446|617374362|FG002|Post Week 12|Other|0|||
170826707|NCT00550446|617374363|FG003|Post Week 12|Other|1|||
170707177|NCT01969838|616937489|FG000|Open-label Phase|Adverse Event|0|||
170707178|NCT01969838|616937490|FG001|Open-label Phase|Adverse Event|0|||
170826708|NCT00550446|617374364|FG004|Post Week 12|Other|0|||
170707179|NCT01969838|616937491|FG002|Open-label Phase|Adverse Event|37|||
170707180|NCT01969838|616937492|FG003|Open-label Phase|Adverse Event|49|||
170707181|NCT01969838|616937489|FG000|Open-label Phase|Disease Progression|0|||
170707182|NCT01969838|616937490|FG001|Open-label Phase|Disease Progression|0|||
170707183|NCT01969838|616937491|FG002|Open-label Phase|Disease Progression|26|||
170707184|NCT01969838|616937492|FG003|Open-label Phase|Disease Progression|27|||
170707185|NCT01969838|616937489|FG000|Open-label Phase|Lack of Efficacy|0|||
170707186|NCT01969838|616937490|FG001|Open-label Phase|Lack of Efficacy|0|||
170707187|NCT01969838|616937491|FG002|Open-label Phase|Lack of Efficacy|17|||
170707188|NCT01969838|616937492|FG003|Open-label Phase|Lack of Efficacy|19|||
170707189|NCT01969838|616937489|FG000|Open-label Phase|Subject Decision|0|||
170707190|NCT01969838|616937490|FG001|Open-label Phase|Subject Decision|0|||
170707191|NCT01969838|616937491|FG002|Open-label Phase|Subject Decision|14|||
170707192|NCT01969838|616937492|FG003|Open-label Phase|Subject Decision|15|||
170707193|NCT01969838|616937489|FG000|Open-label Phase|Death|0|||
170707194|NCT01969838|616937490|FG001|Open-label Phase|Death|0|||
170707195|NCT01969838|616937491|FG002|Open-label Phase|Death|13|||
170707196|NCT01969838|616937492|FG003|Open-label Phase|Death|11|||
170707197|NCT01969838|616937489|FG000|Open-label Phase|Physician Decision|0|||
170707198|NCT01969838|616937490|FG001|Open-label Phase|Physician Decision|0|||
170707199|NCT01969838|616937491|FG002|Open-label Phase|Physician Decision|9|||
170707200|NCT01969838|616937492|FG003|Open-label Phase|Physician Decision|14|||
170707201|NCT01969838|616937489|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
170707202|NCT01969838|616937490|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
170707203|NCT01969838|616937491|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
170707204|NCT01969838|616937492|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
170707205|NCT00456092|616937495|FG000|Extension Phase|Grade 2 or Greater AE|2|||
170707206|NCT00456092|616937496|FG001|Extension Phase|Grade 2 or Greater AE|2|||
170707207|NCT00456092|616937497|FG002|Extension Phase|Grade 2 or Greater AE|0|||
170707208|NCT00456092|616937498|FG003|Extension Phase|Grade 2 or Greater AE|0|||
170707209|NCT00456092|616937499|FG004|Extension Phase|Grade 2 or Greater AE|2|||
170707210|NCT00456092|616937495|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
170707211|NCT00456092|616937496|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
170707212|NCT00456092|616937497|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
170707213|NCT00456092|616937498|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
170707214|NCT00456092|616937499|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
170707215|NCT00456092|616937495|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
170707216|NCT00456092|616937496|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
170707217|NCT00456092|616937497|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
170707218|NCT00456092|616937498|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
170707219|NCT00456092|616937499|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
170707220|NCT00456092|616937495|FG000|Extension Phase|Withdrew Consent|2|||
170707221|NCT00456092|616937496|FG001|Extension Phase|Withdrew Consent|0|||
170707222|NCT00456092|616937497|FG002|Extension Phase|Withdrew Consent|0|||
170707223|NCT00456092|616937498|FG003|Extension Phase|Withdrew Consent|0|||
170707224|NCT00456092|616937499|FG004|Extension Phase|Withdrew Consent|0|||
170707225|NCT00456092|616937495|FG000|Extension Phase|Lost to Follow-up|1|||
170707226|NCT00456092|616937496|FG001|Extension Phase|Lost to Follow-up|1|||
170707227|NCT00456092|616937497|FG002|Extension Phase|Lost to Follow-up|0|||
170707228|NCT00456092|616937498|FG003|Extension Phase|Lost to Follow-up|0|||
170707229|NCT00456092|616937499|FG004|Extension Phase|Lost to Follow-up|1|||
170707230|NCT00456092|616937495|FG000|Extension Phase|Other|2|||
170707231|NCT00456092|616937496|FG001|Extension Phase|Other|0|||
170707232|NCT00456092|616937497|FG002|Extension Phase|Other|0|||
170826709|NCT00550446|617374365|FG005|Post Week 12|Other|0|||
170826710|NCT00550446|617374366|FG006|Post Week 12|Other|1|||
170826711|NCT00550446|617374367|FG007|Post Week 12|Other|0|||
170826712|NCT00550446|617374368|FG008|Post Week 12|Other|1|||
170826713|NCT00550446|617374369|FG009|Post Week 12|Other|1|||
170826714|NCT00550446|617374370|FG010|Post Week 12|Other|0|||
170826715|NCT00578318|617374373|FG000|Overall Study|Lost to Follow-up|2|||
170826716|NCT00578318|617374374|FG001|Overall Study|Lost to Follow-up|0|||
170826717|NCT00578318|617374373|FG000|Overall Study|Physician Decision|1|||
170826718|NCT00578318|617374374|FG001|Overall Study|Physician Decision|0|||
170826719|NCT00527514|617374375|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
170826720|NCT00527514|617374375|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
170826721|NCT00527514|617374375|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
170826722|NCT00527514|617374375|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
170826723|NCT00527514|617374375|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
170826724|NCT00527514|617374375|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
170826725|NCT00527514|617374375|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
170826726|NCT03041701|617374376|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
170826727|NCT03041701|617374377|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
170707233|NCT00456092|616937498|FG003|Extension Phase|Other|1|||
170707234|NCT00456092|616937499|FG004|Extension Phase|Other|1|||
170707235|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
170707236|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
170707237|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
170707238|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
170707239|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
170707240|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
170707241|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
170707242|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
170707243|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
170707244|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
170707245|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
170707246|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
170707247|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
170707248|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
170707249|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
170707250|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
170707251|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
170707252|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
170707253|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
170707254|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
170707255|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
170707256|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
170707257|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
170707258|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
170707259|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
170707260|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
170707261|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
170707262|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
170707263|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
170707264|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
170707265|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
170707266|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
170707267|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
170707268|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
170707269|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
170707270|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
170707271|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
170707272|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
170707273|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
170707274|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
170707275|NCT00456092|616937495|FG000|Treatment Phase (12 Weeks)|Other|1|||
170707276|NCT00456092|616937496|FG001|Treatment Phase (12 Weeks)|Other|0|||
170707277|NCT00456092|616937497|FG002|Treatment Phase (12 Weeks)|Other|1|||
170707278|NCT00456092|616937498|FG003|Treatment Phase (12 Weeks)|Other|0|||
170707279|NCT00456092|616937499|FG004|Treatment Phase (12 Weeks)|Other|0|||
170707280|NCT03228680|616937500|FG000|Overall Study|Adverse Event|13|||
170707281|NCT03228680|616937501|FG001|Overall Study|Adverse Event|18|||
170707282|NCT03228680|616937500|FG000|Overall Study|Randomization failure|0|||
170707283|NCT03228680|616937501|FG001|Overall Study|Randomization failure|1|||
170707284|NCT03228680|616937500|FG000|Overall Study|Withdrawal by Subject|1|||
170707285|NCT03228680|616937501|FG001|Overall Study|Withdrawal by Subject|0|||
170707286|NCT03228680|616937500|FG000|Overall Study|Other|9|||
170707287|NCT03228680|616937501|FG001|Overall Study|Other|16|||
170707288|NCT02252081|616937508|FG000|Overall Study|Withdrawal by Subject|2|||
170707289|NCT02252081|616937509|FG001|Overall Study|Withdrawal by Subject|1|||
170707290|NCT02252081|616937508|FG000|Overall Study|Adverse Event|4|||
170707291|NCT02252081|616937509|FG001|Overall Study|Adverse Event|1|||
170707292|NCT02252081|616937508|FG000|Overall Study|non compliance & others|0|||
170707293|NCT02252081|616937509|FG001|Overall Study|non compliance & others|2|||
170707294|NCT00403455|616937510|FG000|Overall Study|Withdrawal by Subject|1|||
170707295|NCT00087568|616937511|FG000|Overall Study|Adverse Event|4|||
170707296|NCT00087568|616937512|FG001|Overall Study|Adverse Event|0|||
170707297|NCT00087568|616937511|FG000|Overall Study|Withdrawal by Subject|1|||
170707298|NCT00087568|616937512|FG001|Overall Study|Withdrawal by Subject|1|||
170707299|NCT00087568|616937511|FG000|Overall Study|Lost to Follow-up|1|||
170707300|NCT00087568|616937512|FG001|Overall Study|Lost to Follow-up|0|||
170707301|NCT00087568|616937511|FG000|Overall Study|Lack of Efficacy|24|||
170707302|NCT00087568|616937512|FG001|Overall Study|Lack of Efficacy|1|||
170707303|NCT01332305|616937513|FG000|Overall Study|Adverse Event|1|||
170707304|NCT01332305|616937514|FG001|Overall Study|Adverse Event|4|||
170707305|NCT01332305|616937515|FG002|Overall Study|Adverse Event|6|||
170707306|NCT01332305|616937516|FG003|Overall Study|Adverse Event|3|||
170707307|NCT01332305|616937517|FG004|Overall Study|Adverse Event|5|||
170707308|NCT01332305|616937513|FG000|Overall Study|Withdrawal by Subject|6|||
170707309|NCT01332305|616937514|FG001|Overall Study|Withdrawal by Subject|5|||
170707310|NCT01332305|616937515|FG002|Overall Study|Withdrawal by Subject|4|||
170707311|NCT01332305|616937516|FG003|Overall Study|Withdrawal by Subject|1|||
170707312|NCT01332305|616937517|FG004|Overall Study|Withdrawal by Subject|0|||
170707313|NCT01332305|616937513|FG000|Overall Study|Lost to Follow-up|0|||
170707314|NCT01332305|616937514|FG001|Overall Study|Lost to Follow-up|2|||
170707315|NCT01332305|616937515|FG002|Overall Study|Lost to Follow-up|3|||
170707316|NCT01332305|616937516|FG003|Overall Study|Lost to Follow-up|2|||
170707317|NCT01332305|616937517|FG004|Overall Study|Lost to Follow-up|3|||
170707318|NCT01332305|616937513|FG000|Overall Study|Protocol Violation|1|||
170707319|NCT01332305|616937514|FG001|Overall Study|Protocol Violation|2|||
170707320|NCT01332305|616937515|FG002|Overall Study|Protocol Violation|1|||
170707321|NCT01332305|616937516|FG003|Overall Study|Protocol Violation|0|||
170707322|NCT01332305|616937517|FG004|Overall Study|Protocol Violation|3|||
170707323|NCT01332305|616937513|FG000|Overall Study|Withdrawal by Sponsor|1|||
170707324|NCT01332305|616937514|FG001|Overall Study|Withdrawal by Sponsor|0|||
170707325|NCT01332305|616937515|FG002|Overall Study|Withdrawal by Sponsor|0|||
170707326|NCT01332305|616937516|FG003|Overall Study|Withdrawal by Sponsor|1|||
170707327|NCT01332305|616937517|FG004|Overall Study|Withdrawal by Sponsor|1|||
170707328|NCT01332305|616937513|FG000|Overall Study|Treatment Failure|1|||
170707329|NCT01332305|616937514|FG001|Overall Study|Treatment Failure|1|||
170707330|NCT01332305|616937515|FG002|Overall Study|Treatment Failure|0|||
170707331|NCT01332305|616937516|FG003|Overall Study|Treatment Failure|0|||
170707332|NCT01332305|616937517|FG004|Overall Study|Treatment Failure|0|||
170707333|NCT01332305|616937513|FG000|Overall Study|Physician Decision|0|||
170707334|NCT01332305|616937514|FG001|Overall Study|Physician Decision|0|||
170707335|NCT01332305|616937515|FG002|Overall Study|Physician Decision|0|||
170707336|NCT01332305|616937516|FG003|Overall Study|Physician Decision|1|||
170707337|NCT01332305|616937517|FG004|Overall Study|Physician Decision|0|||
170707338|NCT00642304|616937522|FG000|Overall Study|Adverse Event|1|||
170707339|NCT00642304|616937522|FG000|Overall Study|Death|1|||
170707340|NCT00642304|616937522|FG000|Overall Study|Blood transfusion|2|||
170707341|NCT00642304|616937522|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
170707342|NCT00642304|616937522|FG000|Overall Study|Transplantation|1|||
170707343|NCT01401530|616937523|FG000|Overall Study|Disease Progression|1|||
170707344|NCT01401530|616937524|FG001|Overall Study|Disease Progression|2|||
170707345|NCT01401530|616937525|FG002|Overall Study|Disease Progression|1|||
170707346|NCT01401530|616937523|FG000|Overall Study|Adverse Event|1|||
170707347|NCT01401530|616937524|FG001|Overall Study|Adverse Event|1|||
170707348|NCT01401530|616937525|FG002|Overall Study|Adverse Event|1|||
170707349|NCT01401530|616937523|FG000|Overall Study|Participant Choice|1|||
170707350|NCT01401530|616937524|FG001|Overall Study|Participant Choice|2|||
170707351|NCT01401530|616937525|FG002|Overall Study|Participant Choice|1|||
170707352|NCT01401530|616937523|FG000|Overall Study|Physician Decision|0|||
170707353|NCT01401530|616937524|FG001|Overall Study|Physician Decision|1|||
170707354|NCT01401530|616937525|FG002|Overall Study|Physician Decision|0|||
170707355|NCT03670810|616937526|FG000|Main Study|Adverse Event|37|||
170707356|NCT03670810|616937527|FG001|Main Study|Adverse Event|38|||
170707357|NCT03670810|616937528|FG002|Main Study|Adverse Event|3|||
170707358|NCT03670810|616937529|FG003|Main Study|Adverse Event|4|||
170707359|NCT03670810|616937530|FG004|Main Study|Adverse Event|4|||
170707360|NCT03670810|616937531|FG005|Main Study|Adverse Event|5|||
170707361|NCT03670810|616937532|FG006|Main Study|Adverse Event|0|||
170707362|NCT03670810|616937533|FG007|Main Study|Adverse Event|0|||
170707363|NCT03670810|616937534|FG008|Main Study|Adverse Event|0|||
170707364|NCT03670810|616937526|FG000|Main Study|Lack of Efficacy|8|||
170707365|NCT03670810|616937527|FG001|Main Study|Lack of Efficacy|9|||
170707366|NCT03670810|616937528|FG002|Main Study|Lack of Efficacy|3|||
170707367|NCT03670810|616937529|FG003|Main Study|Lack of Efficacy|4|||
170707368|NCT03670810|616937530|FG004|Main Study|Lack of Efficacy|0|||
170707369|NCT03670810|616937531|FG005|Main Study|Lack of Efficacy|0|||
170707370|NCT03670810|616937532|FG006|Main Study|Lack of Efficacy|0|||
170707371|NCT03670810|616937533|FG007|Main Study|Lack of Efficacy|0|||
170707372|NCT03670810|616937534|FG008|Main Study|Lack of Efficacy|0|||
170707373|NCT03670810|616937526|FG000|Main Study|Lost to Follow-up|9|||
170707374|NCT03670810|616937527|FG001|Main Study|Lost to Follow-up|7|||
170707375|NCT03670810|616937528|FG002|Main Study|Lost to Follow-up|4|||
170707376|NCT03670810|616937529|FG003|Main Study|Lost to Follow-up|6|||
170707377|NCT03670810|616937530|FG004|Main Study|Lost to Follow-up|1|||
170707378|NCT03670810|616937531|FG005|Main Study|Lost to Follow-up|0|||
170707379|NCT03670810|616937532|FG006|Main Study|Lost to Follow-up|0|||
170707380|NCT03670810|616937533|FG007|Main Study|Lost to Follow-up|0|||
170707381|NCT03670810|616937534|FG008|Main Study|Lost to Follow-up|0|||
170707382|NCT03670810|616937526|FG000|Main Study|Non-compliance with Study Drug|0|||
170707383|NCT03670810|616937527|FG001|Main Study|Non-compliance with Study Drug|2|||
170707384|NCT03670810|616937528|FG002|Main Study|Non-compliance with Study Drug|3|||
170707385|NCT03670810|616937529|FG003|Main Study|Non-compliance with Study Drug|0|||
170707386|NCT03670810|616937530|FG004|Main Study|Non-compliance with Study Drug|0|||
170707387|NCT03670810|616937531|FG005|Main Study|Non-compliance with Study Drug|0|||
170707388|NCT03670810|616937532|FG006|Main Study|Non-compliance with Study Drug|0|||
170707389|NCT03670810|616937533|FG007|Main Study|Non-compliance with Study Drug|1|||
170707390|NCT03670810|616937534|FG008|Main Study|Non-compliance with Study Drug|0|||
170707391|NCT03670810|616937526|FG000|Main Study|Physician Decision|3|||
170707392|NCT03670810|616937527|FG001|Main Study|Physician Decision|0|||
170707393|NCT03670810|616937528|FG002|Main Study|Physician Decision|1|||
170707394|NCT03670810|616937529|FG003|Main Study|Physician Decision|0|||
170707395|NCT03670810|616937530|FG004|Main Study|Physician Decision|0|||
170707396|NCT03670810|616937531|FG005|Main Study|Physician Decision|0|||
170707397|NCT03670810|616937532|FG006|Main Study|Physician Decision|1|||
170707398|NCT03670810|616937533|FG007|Main Study|Physician Decision|1|||
170707399|NCT03670810|616937534|FG008|Main Study|Physician Decision|0|||
170707400|NCT03670810|616937526|FG000|Main Study|Pregnancy|1|||
170707401|NCT03670810|616937527|FG001|Main Study|Pregnancy|2|||
170707402|NCT03670810|616937528|FG002|Main Study|Pregnancy|0|||
170707403|NCT03670810|616937529|FG003|Main Study|Pregnancy|0|||
170707404|NCT03670810|616937530|FG004|Main Study|Pregnancy|0|||
170707405|NCT03670810|616937531|FG005|Main Study|Pregnancy|0|||
170707406|NCT03670810|616937532|FG006|Main Study|Pregnancy|0|||
170707407|NCT03670810|616937533|FG007|Main Study|Pregnancy|0|||
170707408|NCT03670810|616937534|FG008|Main Study|Pregnancy|0|||
170707409|NCT03670810|616937526|FG000|Main Study|Protocol Deviation|2|||
170707410|NCT03670810|616937527|FG001|Main Study|Protocol Deviation|12|||
170707411|NCT03670810|616937528|FG002|Main Study|Protocol Deviation|8|||
170707412|NCT03670810|616937529|FG003|Main Study|Protocol Deviation|4|||
170707413|NCT03670810|616937530|FG004|Main Study|Protocol Deviation|0|||
170707414|NCT03670810|616937531|FG005|Main Study|Protocol Deviation|0|||
170707415|NCT03670810|616937532|FG006|Main Study|Protocol Deviation|0|||
170707416|NCT03670810|616937533|FG007|Main Study|Protocol Deviation|0|||
170707417|NCT03670810|616937534|FG008|Main Study|Protocol Deviation|0|||
170707418|NCT03670810|616937526|FG000|Main Study|Withdrawal by Subject|21|||
170707419|NCT03670810|616937527|FG001|Main Study|Withdrawal by Subject|21|||
170707420|NCT03670810|616937528|FG002|Main Study|Withdrawal by Subject|8|||
170707421|NCT03670810|616937529|FG003|Main Study|Withdrawal by Subject|9|||
170707422|NCT03670810|616937530|FG004|Main Study|Withdrawal by Subject|5|||
170707423|NCT03670810|616937531|FG005|Main Study|Withdrawal by Subject|2|||
170707424|NCT03670810|616937532|FG006|Main Study|Withdrawal by Subject|1|||
170707425|NCT03670810|616937533|FG007|Main Study|Withdrawal by Subject|1|||
170707426|NCT03670810|616937534|FG008|Main Study|Withdrawal by Subject|0|||
170707427|NCT03670810|616937526|FG000|Main Study|Participant did not want to take the three other treatments|1|||
170707428|NCT03670810|616937527|FG001|Main Study|Participant did not want to take the three other treatments|0|||
170826728|NCT03041701|617374378|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
170826729|NCT03041701|617374376|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
170826730|NCT03041701|617374377|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
170826731|NCT03041701|617374378|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
170826732|NCT00920699|617374381|FG000|Overall Study|Withdrawal by Subject|2|||
170826733|NCT00920699|617374382|FG001|Overall Study|Withdrawal by Subject|0|||
170707429|NCT03670810|616937528|FG002|Main Study|Participant did not want to take the three other treatments|0|||
170707430|NCT03670810|616937529|FG003|Main Study|Participant did not want to take the three other treatments|0|||
170707431|NCT03670810|616937530|FG004|Main Study|Participant did not want to take the three other treatments|0|||
170707432|NCT03670810|616937531|FG005|Main Study|Participant did not want to take the three other treatments|0|||
170707433|NCT03670810|616937532|FG006|Main Study|Participant did not want to take the three other treatments|0|||
170707434|NCT03670810|616937533|FG007|Main Study|Participant did not want to take the three other treatments|0|||
170707435|NCT03670810|616937534|FG008|Main Study|Participant did not want to take the three other treatments|0|||
170707436|NCT03670810|616937526|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
170707437|NCT03670810|616937527|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
170707438|NCT03670810|616937528|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
170707439|NCT03670810|616937529|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
170707440|NCT03670810|616937530|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
170707441|NCT03670810|616937531|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
170707442|NCT03670810|616937532|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
170707443|NCT03670810|616937533|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
170707444|NCT03670810|616937534|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
170707445|NCT03670810|616937526|FG000|Main Study|Travel and Coronavirus issues|0|||
170707446|NCT03670810|616937527|FG001|Main Study|Travel and Coronavirus issues|0|||
170707447|NCT03670810|616937528|FG002|Main Study|Travel and Coronavirus issues|0|||
170707448|NCT03670810|616937529|FG003|Main Study|Travel and Coronavirus issues|1|||
170707449|NCT03670810|616937530|FG004|Main Study|Travel and Coronavirus issues|0|||
170707450|NCT03670810|616937531|FG005|Main Study|Travel and Coronavirus issues|0|||
170707451|NCT03670810|616937532|FG006|Main Study|Travel and Coronavirus issues|0|||
170707452|NCT03670810|616937533|FG007|Main Study|Travel and Coronavirus issues|0|||
170707453|NCT03670810|616937534|FG008|Main Study|Travel and Coronavirus issues|0|||
170707454|NCT03670810|616937526|FG000|Open Label Extension|Protocol Deviation|0|||
170707455|NCT03670810|616937527|FG001|Open Label Extension|Protocol Deviation|0|||
170707456|NCT03670810|616937528|FG002|Open Label Extension|Protocol Deviation|0|||
170707457|NCT03670810|616937529|FG003|Open Label Extension|Protocol Deviation|0|||
170707458|NCT03670810|616937530|FG004|Open Label Extension|Protocol Deviation|0|||
170707459|NCT03670810|616937531|FG005|Open Label Extension|Protocol Deviation|0|||
170707460|NCT03670810|616937532|FG006|Open Label Extension|Protocol Deviation|0|||
170707461|NCT03670810|616937533|FG007|Open Label Extension|Protocol Deviation|0|||
170707462|NCT03670810|616937534|FG008|Open Label Extension|Protocol Deviation|5|||
170707463|NCT03670810|616937526|FG000|Open Label Extension|Death|0|||
170707464|NCT03670810|616937527|FG001|Open Label Extension|Death|0|||
170707465|NCT03670810|616937528|FG002|Open Label Extension|Death|0|||
170707466|NCT03670810|616937529|FG003|Open Label Extension|Death|0|||
170707467|NCT03670810|616937530|FG004|Open Label Extension|Death|0|||
170707468|NCT03670810|616937531|FG005|Open Label Extension|Death|0|||
170707469|NCT03670810|616937532|FG006|Open Label Extension|Death|0|||
170707470|NCT03670810|616937533|FG007|Open Label Extension|Death|0|||
170707471|NCT03670810|616937534|FG008|Open Label Extension|Death|1|||
170707472|NCT03670810|616937526|FG000|Open Label Extension|COVID-19|0|||
170707473|NCT03670810|616937527|FG001|Open Label Extension|COVID-19|0|||
170707474|NCT03670810|616937528|FG002|Open Label Extension|COVID-19|0|||
170707475|NCT03670810|616937529|FG003|Open Label Extension|COVID-19|0|||
170707476|NCT03670810|616937530|FG004|Open Label Extension|COVID-19|0|||
170707477|NCT03670810|616937531|FG005|Open Label Extension|COVID-19|0|||
170707478|NCT03670810|616937532|FG006|Open Label Extension|COVID-19|0|||
170707479|NCT03670810|616937533|FG007|Open Label Extension|COVID-19|0|||
170707480|NCT03670810|616937534|FG008|Open Label Extension|COVID-19|1|||
170707481|NCT03670810|616937526|FG000|Open Label Extension|Lack of Efficacy|0|||
170707482|NCT03670810|616937527|FG001|Open Label Extension|Lack of Efficacy|0|||
170707483|NCT03670810|616937528|FG002|Open Label Extension|Lack of Efficacy|0|||
170707484|NCT03670810|616937529|FG003|Open Label Extension|Lack of Efficacy|0|||
170707485|NCT03670810|616937530|FG004|Open Label Extension|Lack of Efficacy|0|||
170707486|NCT03670810|616937531|FG005|Open Label Extension|Lack of Efficacy|0|||
170707487|NCT03670810|616937532|FG006|Open Label Extension|Lack of Efficacy|0|||
170707488|NCT03670810|616937533|FG007|Open Label Extension|Lack of Efficacy|0|||
170707489|NCT03670810|616937534|FG008|Open Label Extension|Lack of Efficacy|39|||
170707490|NCT03670810|616937526|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
170707491|NCT03670810|616937527|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
170707492|NCT03670810|616937528|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
170707493|NCT03670810|616937529|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
170707494|NCT03670810|616937530|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
170707495|NCT03670810|616937531|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
170707496|NCT03670810|616937532|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
170707497|NCT03670810|616937533|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
170707498|NCT03670810|616937534|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
170707499|NCT03670810|616937526|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
170707500|NCT03670810|616937527|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
170707501|NCT03670810|616937528|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
170707502|NCT03670810|616937529|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
170707503|NCT03670810|616937530|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
170707504|NCT03670810|616937531|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
170707505|NCT03670810|616937532|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
170707506|NCT03670810|616937533|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
170707507|NCT03670810|616937534|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
170707508|NCT03670810|616937526|FG000|Open Label Extension|Withdrawal by Subject|0|||
170707509|NCT03670810|616937527|FG001|Open Label Extension|Withdrawal by Subject|0|||
170707510|NCT03670810|616937528|FG002|Open Label Extension|Withdrawal by Subject|0|||
170707511|NCT03670810|616937529|FG003|Open Label Extension|Withdrawal by Subject|0|||
170707512|NCT03670810|616937530|FG004|Open Label Extension|Withdrawal by Subject|0|||
170707513|NCT03670810|616937531|FG005|Open Label Extension|Withdrawal by Subject|0|||
170707514|NCT03670810|616937532|FG006|Open Label Extension|Withdrawal by Subject|0|||
170707515|NCT03670810|616937533|FG007|Open Label Extension|Withdrawal by Subject|0|||
170707516|NCT03670810|616937534|FG008|Open Label Extension|Withdrawal by Subject|46|||
170707517|NCT03670810|616937526|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
170707518|NCT03670810|616937527|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
170707519|NCT03670810|616937528|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
170707520|NCT03670810|616937529|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
170707521|NCT03670810|616937530|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
170707522|NCT03670810|616937531|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
170707523|NCT03670810|616937532|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
170707524|NCT03670810|616937533|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
170707525|NCT03670810|616937534|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
170707526|NCT03670810|616937526|FG000|Open Label Extension|Physician Decision|0|||
170707527|NCT03670810|616937527|FG001|Open Label Extension|Physician Decision|0|||
170707528|NCT03670810|616937528|FG002|Open Label Extension|Physician Decision|0|||
170707529|NCT03670810|616937529|FG003|Open Label Extension|Physician Decision|0|||
170707530|NCT03670810|616937530|FG004|Open Label Extension|Physician Decision|0|||
170707531|NCT03670810|616937531|FG005|Open Label Extension|Physician Decision|0|||
170707532|NCT03670810|616937532|FG006|Open Label Extension|Physician Decision|0|||
170707533|NCT03670810|616937533|FG007|Open Label Extension|Physician Decision|0|||
170707534|NCT03670810|616937534|FG008|Open Label Extension|Physician Decision|2|||
170707535|NCT03670810|616937526|FG000|Open Label Extension|Non-compliance with study drug|0|||
170707536|NCT03670810|616937527|FG001|Open Label Extension|Non-compliance with study drug|0|||
170707537|NCT03670810|616937528|FG002|Open Label Extension|Non-compliance with study drug|0|||
170707538|NCT03670810|616937529|FG003|Open Label Extension|Non-compliance with study drug|0|||
170707539|NCT03670810|616937530|FG004|Open Label Extension|Non-compliance with study drug|0|||
170707540|NCT03670810|616937531|FG005|Open Label Extension|Non-compliance with study drug|0|||
170707541|NCT03670810|616937532|FG006|Open Label Extension|Non-compliance with study drug|0|||
170707542|NCT03670810|616937533|FG007|Open Label Extension|Non-compliance with study drug|0|||
170707543|NCT03670810|616937534|FG008|Open Label Extension|Non-compliance with study drug|5|||
170707544|NCT03670810|616937526|FG000|Open Label Extension|Pregnancy|0|||
170707545|NCT03670810|616937527|FG001|Open Label Extension|Pregnancy|0|||
170707546|NCT03670810|616937528|FG002|Open Label Extension|Pregnancy|0|||
170707547|NCT03670810|616937529|FG003|Open Label Extension|Pregnancy|0|||
170707548|NCT03670810|616937530|FG004|Open Label Extension|Pregnancy|0|||
170707549|NCT03670810|616937531|FG005|Open Label Extension|Pregnancy|0|||
170707550|NCT03670810|616937532|FG006|Open Label Extension|Pregnancy|0|||
170707551|NCT03670810|616937533|FG007|Open Label Extension|Pregnancy|0|||
170707552|NCT03670810|616937534|FG008|Open Label Extension|Pregnancy|3|||
170707553|NCT03670810|616937526|FG000|Open Label Extension|Adverse Event|0|||
170707554|NCT03670810|616937527|FG001|Open Label Extension|Adverse Event|0|||
170707555|NCT03670810|616937528|FG002|Open Label Extension|Adverse Event|0|||
170707556|NCT03670810|616937529|FG003|Open Label Extension|Adverse Event|0|||
170707557|NCT03670810|616937530|FG004|Open Label Extension|Adverse Event|0|||
170707558|NCT03670810|616937531|FG005|Open Label Extension|Adverse Event|0|||
170707559|NCT03670810|616937532|FG006|Open Label Extension|Adverse Event|0|||
170707560|NCT03670810|616937533|FG007|Open Label Extension|Adverse Event|0|||
170707561|NCT03670810|616937534|FG008|Open Label Extension|Adverse Event|24|||
170707562|NCT03670810|616937526|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
170707563|NCT03670810|616937527|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
170707564|NCT03670810|616937528|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
170707565|NCT03670810|616937529|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
170707566|NCT03670810|616937530|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
170826734|NCT00920699|617374383|FG002|Overall Study|Withdrawal by Subject|2|||
170826735|NCT00920699|617374381|FG000|Overall Study|no longer met eligibility|0|||
170826736|NCT00920699|617374382|FG001|Overall Study|no longer met eligibility|1|||
170826737|NCT00920699|617374383|FG002|Overall Study|no longer met eligibility|0|||
170826738|NCT00920699|617374381|FG000|Overall Study|Lost to Follow-up|0|||
170826739|NCT00920699|617374382|FG001|Overall Study|Lost to Follow-up|0|||
170826740|NCT00920699|617374383|FG002|Overall Study|Lost to Follow-up|2|||
170826741|NCT02287883|617374392|FG000|Overall Study|Death|8|||
170826742|NCT02287883|617374393|FG001|Overall Study|Death|7|||
170707567|NCT03670810|616937531|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
170707568|NCT03670810|616937532|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
170707569|NCT03670810|616937533|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
170707570|NCT03670810|616937534|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
170707571|NCT03670810|616937526|FG000|Open Label Extension|Lost to Follow-up|0|||
170707572|NCT03670810|616937527|FG001|Open Label Extension|Lost to Follow-up|0|||
170707573|NCT03670810|616937528|FG002|Open Label Extension|Lost to Follow-up|0|||
170707574|NCT03670810|616937529|FG003|Open Label Extension|Lost to Follow-up|0|||
170707575|NCT03670810|616937530|FG004|Open Label Extension|Lost to Follow-up|0|||
170707576|NCT03670810|616937531|FG005|Open Label Extension|Lost to Follow-up|0|||
170707577|NCT03670810|616937532|FG006|Open Label Extension|Lost to Follow-up|0|||
170707578|NCT03670810|616937533|FG007|Open Label Extension|Lost to Follow-up|0|||
170707579|NCT03670810|616937534|FG008|Open Label Extension|Lost to Follow-up|23|||
170707580|NCT00678691|616937535|FG000|Overall Study|Adverse Event|6|||
170707581|NCT00678691|616937536|FG001|Overall Study|Adverse Event|4|||
170707582|NCT03192150|616937543|FG000|Overall Study|Adverse Event|14|||
170707583|NCT03192150|616937544|FG001|Overall Study|Adverse Event|12|||
170707584|NCT03192150|616937543|FG000|Overall Study|Lack of Efficacy|23|||
170707585|NCT03192150|616937544|FG001|Overall Study|Lack of Efficacy|30|||
170707586|NCT03192150|616937543|FG000|Overall Study|Lost to Follow-up|1|||
170707587|NCT03192150|616937544|FG001|Overall Study|Lost to Follow-up|1|||
170707588|NCT03192150|616937543|FG000|Overall Study|Withdrawal by Subject|4|||
170707589|NCT03192150|616937544|FG001|Overall Study|Withdrawal by Subject|2|||
170707590|NCT03192150|616937543|FG000|Overall Study|Protocol Violation|5|||
170707591|NCT03192150|616937544|FG001|Overall Study|Protocol Violation|2|||
170707592|NCT03192150|616937543|FG000|Overall Study|Surgery Canceled|6|||
170707593|NCT03192150|616937544|FG001|Overall Study|Surgery Canceled|2|||
170707594|NCT03192150|616937543|FG000|Overall Study|Other-Various Administrative Reasons|2|||
170707595|NCT03192150|616937544|FG001|Overall Study|Other-Various Administrative Reasons|5|||
170707596|NCT01274637|616937549|FG000|Overall Study|Withdrawal by Subject|0|||
170707597|NCT01274637|616937550|FG001|Overall Study|Withdrawal by Subject|1|||
170707598|NCT01274637|616937549|FG000|Overall Study|Lost to Follow-up|0|||
170707599|NCT01274637|616937550|FG001|Overall Study|Lost to Follow-up|1|||
170707600|NCT01824303|616937556|FG000|Randomized Study|Withdrawal by Subject|1|||
170707601|NCT01824303|616937557|FG001|Randomized Study|Withdrawal by Subject|1|||
170707602|NCT01824303|616937556|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
170707603|NCT01824303|616937557|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
170707604|NCT02606136|616937561|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
170707605|NCT02606136|616937561|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
170707606|NCT02606136|616937561|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
170707607|NCT02606136|616937561|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
170707608|NCT03296696|616937562|FG000|Overall Study|Started Other Antitumor Therapy|1|||
170707609|NCT03296696|616937563|FG001|Overall Study|Started Other Antitumor Therapy|2|||
170707610|NCT03296696|616937564|FG002|Overall Study|Started Other Antitumor Therapy|1|||
170707611|NCT03296696|616937565|FG003|Overall Study|Started Other Antitumor Therapy|2|||
170707612|NCT03296696|616937566|FG004|Overall Study|Started Other Antitumor Therapy|1|||
170707613|NCT03296696|616937567|FG005|Overall Study|Started Other Antitumor Therapy|1|||
170707614|NCT03296696|616937568|FG006|Overall Study|Started Other Antitumor Therapy|2|||
170707615|NCT03296696|616937569|FG007|Overall Study|Started Other Antitumor Therapy|3|||
170707616|NCT03296696|616937570|FG008|Overall Study|Started Other Antitumor Therapy|1|||
170707617|NCT03296696|616937571|FG009|Overall Study|Started Other Antitumor Therapy|0|||
170707618|NCT03296696|616937562|FG000|Overall Study|Death|0|||
170707619|NCT03296696|616937563|FG001|Overall Study|Death|1|||
170707620|NCT03296696|616937564|FG002|Overall Study|Death|1|||
170707621|NCT03296696|616937565|FG003|Overall Study|Death|2|||
170707622|NCT03296696|616937566|FG004|Overall Study|Death|2|||
170707623|NCT03296696|616937567|FG005|Overall Study|Death|3|||
170707624|NCT03296696|616937568|FG006|Overall Study|Death|1|||
170707625|NCT03296696|616937569|FG007|Overall Study|Death|2|||
170707626|NCT03296696|616937570|FG008|Overall Study|Death|0|||
170707627|NCT03296696|616937571|FG009|Overall Study|Death|0|||
170707628|NCT03296696|616937562|FG000|Overall Study|Withdrawal by Subject|0|||
170707629|NCT03296696|616937563|FG001|Overall Study|Withdrawal by Subject|0|||
170707630|NCT03296696|616937564|FG002|Overall Study|Withdrawal by Subject|1|||
170707631|NCT03296696|616937565|FG003|Overall Study|Withdrawal by Subject|0|||
170707632|NCT03296696|616937566|FG004|Overall Study|Withdrawal by Subject|1|||
170707633|NCT03296696|616937567|FG005|Overall Study|Withdrawal by Subject|0|||
170707634|NCT03296696|616937568|FG006|Overall Study|Withdrawal by Subject|0|||
170707635|NCT03296696|616937569|FG007|Overall Study|Withdrawal by Subject|0|||
170707636|NCT03296696|616937570|FG008|Overall Study|Withdrawal by Subject|0|||
170707637|NCT03296696|616937571|FG009|Overall Study|Withdrawal by Subject|1|||
170707638|NCT04694131|616937574|FG000|Overall Study|Withdrawal by Subject|7|||
170707639|NCT04694131|616937574|FG000|Overall Study|Screen Failure|1|||
170707640|NCT04694131|616937574|FG000|Overall Study|High stimulation threshold|3|||
170826743|NCT02287883|617374392|FG000|Overall Study|No longer eligible|222|||
170707641|NCT00617240|616937575|FG000|Overall Study|Lack of Efficacy|1|||
170707642|NCT00617240|616937576|FG001|Overall Study|Lack of Efficacy|0|||
170707643|NCT04936685|616937577|FG000|Overall Study|Protocol Violation|1|||
170707644|NCT04936685|616937578|FG001|Overall Study|Protocol Violation|0|||
170707645|NCT02410811|616937582|FG000|Overall Study|Withdrawal by Subject|0|||
170707646|NCT02410811|616937583|FG001|Overall Study|Withdrawal by Subject|0|||
170707647|NCT02410811|616937584|FG002|Overall Study|Withdrawal by Subject|1|||
170707648|NCT02410811|616937585|FG003|Overall Study|Withdrawal by Subject|0|||
170707649|NCT00353366|616937586|FG000|Overall Study|Adverse Event|8|||
170707650|NCT00353366|616937586|FG000|Overall Study|Protocol Violation|12|||
170707651|NCT00353366|616937586|FG000|Overall Study|Withdrawal by Subject|12|||
170707652|NCT00353366|616937586|FG000|Overall Study|Lost to Follow-up|92|||
170707653|NCT00353366|616937586|FG000|Overall Study|Other|19|||
170707654|NCT00259857|616937587|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
170707655|NCT00259857|616937588|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
170707656|NCT00259857|616937587|FG000|24 Months Treatment|Lost to Follow-up|0|||
170707657|NCT00259857|616937588|FG001|24 Months Treatment|Lost to Follow-up|3|||
170707658|NCT02457325|616937602|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
170707659|NCT02457325|616937603|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
170707660|NCT03385239|616937606|FG000|Overall Study|Voluntary Withdrawal|2|||
170707661|NCT03385239|616937607|FG001|Overall Study|Voluntary Withdrawal|3|||
170707662|NCT03385239|616937608|FG002|Overall Study|Voluntary Withdrawal|2|||
170707663|NCT03385239|616937609|FG003|Overall Study|Voluntary Withdrawal|3|||
170707664|NCT03385239|616937610|FG004|Overall Study|Voluntary Withdrawal|0|||
170707665|NCT03385239|616937606|FG000|Overall Study|Adverse Event|0|||
170707666|NCT03385239|616937607|FG001|Overall Study|Adverse Event|0|||
170707667|NCT03385239|616937608|FG002|Overall Study|Adverse Event|1|||
170707668|NCT03385239|616937609|FG003|Overall Study|Adverse Event|0|||
170707669|NCT03385239|616937610|FG004|Overall Study|Adverse Event|0|||
170707670|NCT03385239|616937606|FG000|Overall Study|Other|0|||
170707671|NCT03385239|616937607|FG001|Overall Study|Other|0|||
170707672|NCT03385239|616937608|FG002|Overall Study|Other|0|||
170707673|NCT03385239|616937609|FG003|Overall Study|Other|1|||
170707674|NCT03385239|616937610|FG004|Overall Study|Other|0|||
170707675|NCT01574703|616937611|FG000|Overall Study|Adverse Event|0|||
170707676|NCT01574703|616937612|FG001|Overall Study|Adverse Event|2|||
170707677|NCT01574703|616937613|FG002|Overall Study|Adverse Event|1|||
170707678|NCT01574703|616937614|FG003|Overall Study|Adverse Event|1|||
170707679|NCT01574703|616937611|FG000|Overall Study|Protocol Violation|0|||
170707680|NCT01574703|616937612|FG001|Overall Study|Protocol Violation|0|||
170707681|NCT01574703|616937613|FG002|Overall Study|Protocol Violation|0|||
170707682|NCT01574703|616937614|FG003|Overall Study|Protocol Violation|1|||
170707683|NCT01574703|616937611|FG000|Overall Study|Unspecified Reason|27|||
170707684|NCT01574703|616937612|FG001|Overall Study|Unspecified Reason|15|||
170707685|NCT01574703|616937613|FG002|Overall Study|Unspecified Reason|20|||
170707686|NCT01574703|616937614|FG003|Overall Study|Unspecified Reason|16|||
170707687|NCT01574703|616937611|FG000|Overall Study|Withdrawal by Subject|53|||
170707688|NCT01574703|616937612|FG001|Overall Study|Withdrawal by Subject|52|||
170707689|NCT01574703|616937613|FG002|Overall Study|Withdrawal by Subject|36|||
170707690|NCT01574703|616937614|FG003|Overall Study|Withdrawal by Subject|61|||
170707691|NCT01574703|616937611|FG000|Overall Study|Met Withdrawal Criteria|0|||
170707692|NCT01574703|616937612|FG001|Overall Study|Met Withdrawal Criteria|1|||
170707693|NCT01574703|616937613|FG002|Overall Study|Met Withdrawal Criteria|1|||
170707694|NCT01574703|616937614|FG003|Overall Study|Met Withdrawal Criteria|0|||
170707695|NCT01574703|616937611|FG000|Overall Study|Lost to Follow-up|43|||
170707696|NCT01574703|616937612|FG001|Overall Study|Lost to Follow-up|41|||
170707697|NCT01574703|616937613|FG002|Overall Study|Lost to Follow-up|46|||
170707698|NCT01574703|616937614|FG003|Overall Study|Lost to Follow-up|35|||
170707699|NCT01574703|616937611|FG000|Overall Study|Death|2|||
170707700|NCT01574703|616937612|FG001|Overall Study|Death|1|||
170707701|NCT01574703|616937613|FG002|Overall Study|Death|1|||
170707702|NCT01574703|616937614|FG003|Overall Study|Death|0|||
170707703|NCT02167256|616937615|FG000|Overall Study|Adverse Event|13|||
170707704|NCT02167256|616937616|FG001|Overall Study|Adverse Event|6|||
170707705|NCT02167256|616937615|FG000|Overall Study|Withdrawal by Subject|4|||
170707706|NCT02167256|616937616|FG001|Overall Study|Withdrawal by Subject|4|||
170707707|NCT02167256|616937615|FG000|Overall Study|non-compliance|3|||
170707708|NCT02167256|616937616|FG001|Overall Study|non-compliance|0|||
170707709|NCT02167256|616937615|FG000|Overall Study|Study partner unable to participate|1|||
170707710|NCT02167256|616937616|FG001|Overall Study|Study partner unable to participate|0|||
170707711|NCT00025883|616937617|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
170707712|NCT00025883|616937617|FG000|Overall Study|no baseline data|1|||
170707713|NCT00025883|616937617|FG000|Overall Study|Death|1|||
170707714|NCT00025883|616937617|FG000|Overall Study|Adverse Event|1|||
170707715|NCT00025883|616937617|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
170707716|NCT01451424|616937618|FG000|Overall Study|Withdrawal by Subject|1|||
170707717|NCT01451424|616937619|FG001|Overall Study|Withdrawal by Subject|1|||
170707718|NCT01451424|616937620|FG002|Overall Study|Withdrawal by Subject|0|||
170707719|NCT01451424|616937621|FG003|Overall Study|Withdrawal by Subject|2|||
170707720|NCT01451424|616937618|FG000|Overall Study|Lost to Follow-up|0|||
170707721|NCT01451424|616937619|FG001|Overall Study|Lost to Follow-up|1|||
170707722|NCT01451424|616937620|FG002|Overall Study|Lost to Follow-up|0|||
170707723|NCT01451424|616937621|FG003|Overall Study|Lost to Follow-up|1|||
170707724|NCT01451424|616937618|FG000|Overall Study|Physician Decision|0|||
170707725|NCT01451424|616937619|FG001|Overall Study|Physician Decision|0|||
170707726|NCT01451424|616937620|FG002|Overall Study|Physician Decision|1|||
170707727|NCT01451424|616937621|FG003|Overall Study|Physician Decision|1|||
170707728|NCT01451424|616937618|FG000|Overall Study|Adverse Event|0|||
170707729|NCT01451424|616937619|FG001|Overall Study|Adverse Event|0|||
170707730|NCT01451424|616937620|FG002|Overall Study|Adverse Event|0|||
170707731|NCT01451424|616937621|FG003|Overall Study|Adverse Event|1|||
170707732|NCT01387607|616937622|FG000|Overall Study|Adverse Event|23|||
170707733|NCT01387607|616937623|FG001|Overall Study|Adverse Event|11|||
170707734|NCT01387607|616937622|FG000|Overall Study|Lack of Efficacy|8|||
170707735|NCT01387607|616937623|FG001|Overall Study|Lack of Efficacy|6|||
170707736|NCT01387607|616937622|FG000|Overall Study|Lost to Follow-up|2|||
170707737|NCT01387607|616937623|FG001|Overall Study|Lost to Follow-up|1|||
170707738|NCT01387607|616937622|FG000|Overall Study|No longer meets eligibility criteria|0|||
170707739|NCT01387607|616937623|FG001|Overall Study|No longer meets eligibility criteria|1|||
170707740|NCT01387607|616937622|FG000|Overall Study|Protocol Violation|1|||
170707741|NCT01387607|616937623|FG001|Overall Study|Protocol Violation|5|||
170707742|NCT01387607|616937622|FG000|Overall Study|Withdrawal by Subject|13|||
170707743|NCT01387607|616937623|FG001|Overall Study|Withdrawal by Subject|14|||
170707744|NCT01387607|616937622|FG000|Overall Study|Other|1|||
170707745|NCT01387607|616937623|FG001|Overall Study|Other|1|||
170707746|NCT01387607|616937622|FG000|Overall Study|Randomized, not treated|3|||
170707747|NCT01387607|616937623|FG001|Overall Study|Randomized, not treated|6|||
170707748|NCT02553421|616937626|FG000|Overall Study|Lost to Follow-up|21|||
170707749|NCT02553421|616937627|FG001|Overall Study|Lost to Follow-up|1|||
170707750|NCT02553421|616937626|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
170707751|NCT02553421|616937627|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
170707752|NCT02553421|616937626|FG000|Overall Study|Improper Device Placement|3|||
170707753|NCT02553421|616937627|FG001|Overall Study|Improper Device Placement|0|||
170707754|NCT03013491|616937630|FG000|Main Study|Death|2|||
170707755|NCT03013491|616937631|FG001|Main Study|Death|2|||
170707756|NCT03013491|616937632|FG002|Main Study|Death|5|||
170707757|NCT03013491|616937633|FG003|Main Study|Death|3|||
170707758|NCT03013491|616937634|FG004|Main Study|Death|9|||
170707759|NCT03013491|616937635|FG005|Main Study|Death|12|||
170707760|NCT03013491|616937636|FG006|Main Study|Death|3|||
170707761|NCT03013491|616937637|FG007|Main Study|Death|5|||
170707762|NCT03013491|616937638|FG008|Main Study|Death|1|||
170707763|NCT03013491|616937639|FG009|Main Study|Death|2|||
170707764|NCT03013491|616937640|FG010|Main Study|Death|4|||
170707765|NCT03013491|616937641|FG011|Main Study|Death|1|||
170707766|NCT03013491|616937642|FG012|Main Study|Death|1|||
170707767|NCT03013491|616937643|FG013|Main Study|Death|4|||
170707768|NCT03013491|616937644|FG014|Main Study|Death|0|||
170707769|NCT03013491|616937645|FG015|Main Study|Death|3|||
170707770|NCT03013491|616937646|FG016|Main Study|Death|5|||
170707771|NCT03013491|616937647|FG017|Main Study|Death|1|||
170707772|NCT03013491|616937648|FG018|Main Study|Death|47|||
170707773|NCT03013491|616937630|FG000|Main Study|Lost to Follow-up|0|||
170707774|NCT03013491|616937631|FG001|Main Study|Lost to Follow-up|0|||
170707775|NCT03013491|616937632|FG002|Main Study|Lost to Follow-up|1|||
170707776|NCT03013491|616937633|FG003|Main Study|Lost to Follow-up|0|||
170707777|NCT03013491|616937634|FG004|Main Study|Lost to Follow-up|1|||
170826744|NCT02287883|617374393|FG001|Overall Study|No longer eligible|182|||
170707778|NCT03013491|616937635|FG005|Main Study|Lost to Follow-up|0|||
170707779|NCT03013491|616937636|FG006|Main Study|Lost to Follow-up|0|||
170707780|NCT03013491|616937637|FG007|Main Study|Lost to Follow-up|0|||
170707781|NCT03013491|616937638|FG008|Main Study|Lost to Follow-up|0|||
170707782|NCT03013491|616937639|FG009|Main Study|Lost to Follow-up|0|||
170707783|NCT03013491|616937640|FG010|Main Study|Lost to Follow-up|0|||
170707784|NCT03013491|616937641|FG011|Main Study|Lost to Follow-up|0|||
170707785|NCT03013491|616937642|FG012|Main Study|Lost to Follow-up|0|||
170707786|NCT03013491|616937643|FG013|Main Study|Lost to Follow-up|0|||
170707787|NCT03013491|616937644|FG014|Main Study|Lost to Follow-up|0|||
170707788|NCT03013491|616937645|FG015|Main Study|Lost to Follow-up|0|||
170707789|NCT03013491|616937646|FG016|Main Study|Lost to Follow-up|0|||
170707790|NCT03013491|616937647|FG017|Main Study|Lost to Follow-up|0|||
170707791|NCT03013491|616937648|FG018|Main Study|Lost to Follow-up|3|||
170707792|NCT03013491|616937630|FG000|Main Study|Termination of the study by Sponsor|0|||
170707793|NCT03013491|616937631|FG001|Main Study|Termination of the study by Sponsor|0|||
170707794|NCT03013491|616937632|FG002|Main Study|Termination of the study by Sponsor|2|||
170707795|NCT03013491|616937633|FG003|Main Study|Termination of the study by Sponsor|0|||
170707796|NCT03013491|616937634|FG004|Main Study|Termination of the study by Sponsor|1|||
170707797|NCT03013491|616937635|FG005|Main Study|Termination of the study by Sponsor|2|||
170707798|NCT03013491|616937636|FG006|Main Study|Termination of the study by Sponsor|0|||
170707799|NCT03013491|616937637|FG007|Main Study|Termination of the study by Sponsor|0|||
170707800|NCT03013491|616937638|FG008|Main Study|Termination of the study by Sponsor|1|||
170707801|NCT03013491|616937639|FG009|Main Study|Termination of the study by Sponsor|1|||
170707802|NCT03013491|616937640|FG010|Main Study|Termination of the study by Sponsor|1|||
170707803|NCT03013491|616937641|FG011|Main Study|Termination of the study by Sponsor|2|||
170707804|NCT03013491|616937642|FG012|Main Study|Termination of the study by Sponsor|0|||
170707805|NCT03013491|616937643|FG013|Main Study|Termination of the study by Sponsor|0|||
170707806|NCT03013491|616937644|FG014|Main Study|Termination of the study by Sponsor|0|||
170707807|NCT03013491|616937645|FG015|Main Study|Termination of the study by Sponsor|0|||
170707808|NCT03013491|616937646|FG016|Main Study|Termination of the study by Sponsor|0|||
170707809|NCT03013491|616937647|FG017|Main Study|Termination of the study by Sponsor|1|||
170707810|NCT03013491|616937648|FG018|Main Study|Termination of the study by Sponsor|13|||
170707811|NCT03013491|616937630|FG000|Main Study|Withdrawal by Subject|0|||
170707812|NCT03013491|616937631|FG001|Main Study|Withdrawal by Subject|0|||
170707813|NCT03013491|616937632|FG002|Main Study|Withdrawal by Subject|0|||
170707814|NCT03013491|616937633|FG003|Main Study|Withdrawal by Subject|4|||
170707815|NCT03013491|616937634|FG004|Main Study|Withdrawal by Subject|2|||
170707816|NCT03013491|616937635|FG005|Main Study|Withdrawal by Subject|1|||
170707817|NCT03013491|616937636|FG006|Main Study|Withdrawal by Subject|0|||
170707818|NCT03013491|616937637|FG007|Main Study|Withdrawal by Subject|0|||
170707819|NCT03013491|616937638|FG008|Main Study|Withdrawal by Subject|0|||
170707820|NCT03013491|616937639|FG009|Main Study|Withdrawal by Subject|0|||
170707821|NCT03013491|616937640|FG010|Main Study|Withdrawal by Subject|1|||
170707822|NCT03013491|616937641|FG011|Main Study|Withdrawal by Subject|2|||
170707823|NCT03013491|616937642|FG012|Main Study|Withdrawal by Subject|0|||
170707824|NCT03013491|616937643|FG013|Main Study|Withdrawal by Subject|2|||
170707825|NCT03013491|616937644|FG014|Main Study|Withdrawal by Subject|0|||
170707826|NCT03013491|616937645|FG015|Main Study|Withdrawal by Subject|0|||
170707827|NCT03013491|616937646|FG016|Main Study|Withdrawal by Subject|0|||
170707828|NCT03013491|616937647|FG017|Main Study|Withdrawal by Subject|0|||
170707829|NCT03013491|616937648|FG018|Main Study|Withdrawal by Subject|18|||
170707830|NCT03013491|616937630|FG000|Main Study|Disease progression|0|||
170707831|NCT03013491|616937631|FG001|Main Study|Disease progression|0|||
170707832|NCT03013491|616937632|FG002|Main Study|Disease progression|0|||
170707833|NCT03013491|616937633|FG003|Main Study|Disease progression|1|||
170707834|NCT03013491|616937634|FG004|Main Study|Disease progression|0|||
170707835|NCT03013491|616937635|FG005|Main Study|Disease progression|0|||
170707836|NCT03013491|616937636|FG006|Main Study|Disease progression|0|||
170707837|NCT03013491|616937637|FG007|Main Study|Disease progression|0|||
170707838|NCT03013491|616937638|FG008|Main Study|Disease progression|1|||
170707839|NCT03013491|616937639|FG009|Main Study|Disease progression|0|||
170707840|NCT03013491|616937640|FG010|Main Study|Disease progression|1|||
170707841|NCT03013491|616937641|FG011|Main Study|Disease progression|0|||
170707842|NCT03013491|616937642|FG012|Main Study|Disease progression|0|||
170707843|NCT03013491|616937643|FG013|Main Study|Disease progression|0|||
170707844|NCT03013491|616937644|FG014|Main Study|Disease progression|0|||
170707845|NCT03013491|616937645|FG015|Main Study|Disease progression|0|||
170707846|NCT03013491|616937646|FG016|Main Study|Disease progression|0|||
170707847|NCT03013491|616937647|FG017|Main Study|Disease progression|0|||
170707848|NCT03013491|616937648|FG018|Main Study|Disease progression|4|||
170707849|NCT03013491|616937630|FG000|Main Study|Symptomatic deterioration|0|||
170707850|NCT03013491|616937631|FG001|Main Study|Symptomatic deterioration|0|||
170707851|NCT03013491|616937632|FG002|Main Study|Symptomatic deterioration|0|||
170707852|NCT03013491|616937633|FG003|Main Study|Symptomatic deterioration|0|||
170707853|NCT03013491|616937634|FG004|Main Study|Symptomatic deterioration|0|||
170707854|NCT03013491|616937635|FG005|Main Study|Symptomatic deterioration|1|||
170707855|NCT03013491|616937636|FG006|Main Study|Symptomatic deterioration|0|||
170707856|NCT03013491|616937637|FG007|Main Study|Symptomatic deterioration|0|||
170707857|NCT03013491|616937638|FG008|Main Study|Symptomatic deterioration|0|||
170707858|NCT03013491|616937639|FG009|Main Study|Symptomatic deterioration|0|||
170707859|NCT03013491|616937640|FG010|Main Study|Symptomatic deterioration|0|||
170707860|NCT03013491|616937641|FG011|Main Study|Symptomatic deterioration|0|||
170707861|NCT03013491|616937642|FG012|Main Study|Symptomatic deterioration|0|||
170826745|NCT02287883|617374392|FG000|Overall Study|Non-response to survey|229|||
170707862|NCT03013491|616937643|FG013|Main Study|Symptomatic deterioration|0|||
170707863|NCT03013491|616937644|FG014|Main Study|Symptomatic deterioration|0|||
170707864|NCT03013491|616937645|FG015|Main Study|Symptomatic deterioration|0|||
170707865|NCT03013491|616937646|FG016|Main Study|Symptomatic deterioration|0|||
170707866|NCT03013491|616937647|FG017|Main Study|Symptomatic deterioration|0|||
170707867|NCT03013491|616937648|FG018|Main Study|Symptomatic deterioration|0|||
170707868|NCT03013491|616937630|FG000|Main Study|Protocol version 8.0 approval|0|||
170707869|NCT03013491|616937631|FG001|Main Study|Protocol version 8.0 approval|0|||
170707870|NCT03013491|616937632|FG002|Main Study|Protocol version 8.0 approval|0|||
170707871|NCT03013491|616937633|FG003|Main Study|Protocol version 8.0 approval|0|||
170707872|NCT03013491|616937634|FG004|Main Study|Protocol version 8.0 approval|0|||
170707873|NCT03013491|616937635|FG005|Main Study|Protocol version 8.0 approval|0|||
170707874|NCT03013491|616937636|FG006|Main Study|Protocol version 8.0 approval|0|||
170707875|NCT03013491|616937637|FG007|Main Study|Protocol version 8.0 approval|0|||
170707876|NCT03013491|616937638|FG008|Main Study|Protocol version 8.0 approval|0|||
170707877|NCT03013491|616937639|FG009|Main Study|Protocol version 8.0 approval|0|||
170707878|NCT03013491|616937640|FG010|Main Study|Protocol version 8.0 approval|1|||
170707879|NCT03013491|616937641|FG011|Main Study|Protocol version 8.0 approval|0|||
170707880|NCT03013491|616937642|FG012|Main Study|Protocol version 8.0 approval|0|||
170707881|NCT03013491|616937643|FG013|Main Study|Protocol version 8.0 approval|0|||
170707882|NCT03013491|616937644|FG014|Main Study|Protocol version 8.0 approval|0|||
170707883|NCT03013491|616937645|FG015|Main Study|Protocol version 8.0 approval|0|||
170707884|NCT03013491|616937646|FG016|Main Study|Protocol version 8.0 approval|0|||
170707885|NCT03013491|616937647|FG017|Main Study|Protocol version 8.0 approval|0|||
170707886|NCT03013491|616937648|FG018|Main Study|Protocol version 8.0 approval|0|||
170707887|NCT03013491|616937630|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
170707888|NCT03013491|616937631|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
170707889|NCT03013491|616937632|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
170707890|NCT03013491|616937633|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
170707891|NCT03013491|616937634|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
170707892|NCT03013491|616937635|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
170707893|NCT03013491|616937636|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
170707894|NCT03013491|616937637|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
170707895|NCT03013491|616937638|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
170707896|NCT03013491|616937639|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
170707897|NCT03013491|616937640|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
170707898|NCT03013491|616937641|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
170707899|NCT03013491|616937642|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
170707900|NCT03013491|616937643|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
170707901|NCT03013491|616937644|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
170707902|NCT03013491|616937645|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
170707903|NCT03013491|616937646|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
170707904|NCT03013491|616937647|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
170707905|NCT03013491|616937648|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
170707906|NCT03013491|616937630|FG000|Main Study|Start of new anticancer therapy|0|||
170707907|NCT03013491|616937631|FG001|Main Study|Start of new anticancer therapy|0|||
170707908|NCT03013491|616937632|FG002|Main Study|Start of new anticancer therapy|0|||
170707909|NCT03013491|616937633|FG003|Main Study|Start of new anticancer therapy|0|||
170707910|NCT03013491|616937634|FG004|Main Study|Start of new anticancer therapy|0|||
170707911|NCT03013491|616937635|FG005|Main Study|Start of new anticancer therapy|0|||
170707912|NCT03013491|616937636|FG006|Main Study|Start of new anticancer therapy|0|||
170707913|NCT03013491|616937637|FG007|Main Study|Start of new anticancer therapy|0|||
170707914|NCT03013491|616937638|FG008|Main Study|Start of new anticancer therapy|0|||
170707915|NCT03013491|616937639|FG009|Main Study|Start of new anticancer therapy|0|||
170707916|NCT03013491|616937640|FG010|Main Study|Start of new anticancer therapy|0|||
170707917|NCT03013491|616937641|FG011|Main Study|Start of new anticancer therapy|0|||
170707918|NCT03013491|616937642|FG012|Main Study|Start of new anticancer therapy|0|||
170707919|NCT03013491|616937643|FG013|Main Study|Start of new anticancer therapy|0|||
170707920|NCT03013491|616937644|FG014|Main Study|Start of new anticancer therapy|0|||
170707921|NCT03013491|616937645|FG015|Main Study|Start of new anticancer therapy|0|||
170707922|NCT03013491|616937646|FG016|Main Study|Start of new anticancer therapy|0|||
170707923|NCT03013491|616937647|FG017|Main Study|Start of new anticancer therapy|0|||
170707924|NCT03013491|616937648|FG018|Main Study|Start of new anticancer therapy|2|||
170707925|NCT03013491|616937630|FG000|Long-term Extension|Disease progression|0|||
170707926|NCT03013491|616937631|FG001|Long-term Extension|Disease progression|0|||
170707927|NCT03013491|616937632|FG002|Long-term Extension|Disease progression|0|||
170707928|NCT03013491|616937633|FG003|Long-term Extension|Disease progression|1|||
170707929|NCT03013491|616937634|FG004|Long-term Extension|Disease progression|0|||
170707930|NCT03013491|616937635|FG005|Long-term Extension|Disease progression|0|||
170707931|NCT03013491|616937636|FG006|Long-term Extension|Disease progression|0|||
170707932|NCT03013491|616937637|FG007|Long-term Extension|Disease progression|0|||
170707933|NCT03013491|616937638|FG008|Long-term Extension|Disease progression|0|||
170707934|NCT03013491|616937639|FG009|Long-term Extension|Disease progression|0|||
170707935|NCT03013491|616937640|FG010|Long-term Extension|Disease progression|0|||
170707936|NCT03013491|616937641|FG011|Long-term Extension|Disease progression|0|||
170707937|NCT03013491|616937642|FG012|Long-term Extension|Disease progression|0|||
170707938|NCT03013491|616937643|FG013|Long-term Extension|Disease progression|0|||
170707939|NCT03013491|616937644|FG014|Long-term Extension|Disease progression|0|||
170707940|NCT03013491|616937645|FG015|Long-term Extension|Disease progression|0|||
170707941|NCT03013491|616937646|FG016|Long-term Extension|Disease progression|0|||
170826746|NCT02287883|617374393|FG001|Overall Study|Non-response to survey|237|||
170707942|NCT03013491|616937647|FG017|Long-term Extension|Disease progression|0|||
170707943|NCT03013491|616937648|FG018|Long-term Extension|Disease progression|1|||
170707944|NCT03013491|616937630|FG000|Long-term Extension|Withdrawal by Subject|0|||
170707945|NCT03013491|616937631|FG001|Long-term Extension|Withdrawal by Subject|0|||
170707946|NCT03013491|616937632|FG002|Long-term Extension|Withdrawal by Subject|0|||
170707947|NCT03013491|616937633|FG003|Long-term Extension|Withdrawal by Subject|0|||
170707948|NCT03013491|616937634|FG004|Long-term Extension|Withdrawal by Subject|0|||
170707949|NCT03013491|616937635|FG005|Long-term Extension|Withdrawal by Subject|0|||
170707950|NCT03013491|616937636|FG006|Long-term Extension|Withdrawal by Subject|0|||
170707951|NCT03013491|616937637|FG007|Long-term Extension|Withdrawal by Subject|1|||
170707952|NCT03013491|616937638|FG008|Long-term Extension|Withdrawal by Subject|0|||
170707953|NCT03013491|616937639|FG009|Long-term Extension|Withdrawal by Subject|0|||
170707954|NCT03013491|616937640|FG010|Long-term Extension|Withdrawal by Subject|0|||
170707955|NCT03013491|616937641|FG011|Long-term Extension|Withdrawal by Subject|0|||
170707956|NCT03013491|616937642|FG012|Long-term Extension|Withdrawal by Subject|0|||
170707957|NCT03013491|616937643|FG013|Long-term Extension|Withdrawal by Subject|0|||
170707958|NCT03013491|616937644|FG014|Long-term Extension|Withdrawal by Subject|0|||
170707959|NCT03013491|616937645|FG015|Long-term Extension|Withdrawal by Subject|0|||
170707960|NCT03013491|616937646|FG016|Long-term Extension|Withdrawal by Subject|0|||
170707961|NCT03013491|616937647|FG017|Long-term Extension|Withdrawal by Subject|0|||
170707962|NCT03013491|616937648|FG018|Long-term Extension|Withdrawal by Subject|0|||
170707963|NCT03013491|616937630|FG000|Long-term Extension|Adverse Event|0|||
170707964|NCT03013491|616937631|FG001|Long-term Extension|Adverse Event|0|||
170707965|NCT03013491|616937632|FG002|Long-term Extension|Adverse Event|0|||
170707966|NCT03013491|616937633|FG003|Long-term Extension|Adverse Event|0|||
170707967|NCT03013491|616937634|FG004|Long-term Extension|Adverse Event|0|||
170707968|NCT03013491|616937635|FG005|Long-term Extension|Adverse Event|0|||
170707969|NCT03013491|616937636|FG006|Long-term Extension|Adverse Event|0|||
170707970|NCT03013491|616937637|FG007|Long-term Extension|Adverse Event|0|||
170707971|NCT03013491|616937638|FG008|Long-term Extension|Adverse Event|0|||
170707972|NCT03013491|616937639|FG009|Long-term Extension|Adverse Event|0|||
170707973|NCT03013491|616937640|FG010|Long-term Extension|Adverse Event|0|||
170707974|NCT03013491|616937641|FG011|Long-term Extension|Adverse Event|0|||
170707975|NCT03013491|616937642|FG012|Long-term Extension|Adverse Event|0|||
170707976|NCT03013491|616937643|FG013|Long-term Extension|Adverse Event|0|||
170707977|NCT03013491|616937644|FG014|Long-term Extension|Adverse Event|0|||
170707978|NCT03013491|616937645|FG015|Long-term Extension|Adverse Event|0|||
170707979|NCT03013491|616937646|FG016|Long-term Extension|Adverse Event|0|||
170707980|NCT03013491|616937647|FG017|Long-term Extension|Adverse Event|0|||
170707981|NCT03013491|616937648|FG018|Long-term Extension|Adverse Event|1|||
170707982|NCT03013491|616937630|FG000|Long-term Extension|Death|0|||
170707983|NCT03013491|616937631|FG001|Long-term Extension|Death|0|||
170707984|NCT03013491|616937632|FG002|Long-term Extension|Death|0|||
170707985|NCT03013491|616937633|FG003|Long-term Extension|Death|0|||
170707986|NCT03013491|616937634|FG004|Long-term Extension|Death|0|||
170707987|NCT03013491|616937635|FG005|Long-term Extension|Death|0|||
170707988|NCT03013491|616937636|FG006|Long-term Extension|Death|0|||
170707989|NCT03013491|616937637|FG007|Long-term Extension|Death|0|||
170707990|NCT03013491|616937638|FG008|Long-term Extension|Death|0|||
170707991|NCT03013491|616937639|FG009|Long-term Extension|Death|0|||
170707992|NCT03013491|616937640|FG010|Long-term Extension|Death|0|||
170707993|NCT03013491|616937641|FG011|Long-term Extension|Death|0|||
170707994|NCT03013491|616937642|FG012|Long-term Extension|Death|0|||
170707995|NCT03013491|616937643|FG013|Long-term Extension|Death|0|||
170707996|NCT03013491|616937644|FG014|Long-term Extension|Death|0|||
170707997|NCT03013491|616937645|FG015|Long-term Extension|Death|0|||
170707998|NCT03013491|616937646|FG016|Long-term Extension|Death|0|||
170707999|NCT03013491|616937647|FG017|Long-term Extension|Death|0|||
170708000|NCT03013491|616937648|FG018|Long-term Extension|Death|1|||
170708001|NCT02564471|616939340|FG000|Overall Study|Adverse Event|1|||
170708002|NCT02564471|616939341|FG001|Overall Study|Adverse Event|0|||
170708003|NCT02564471|616939342|FG002|Overall Study|Adverse Event|0|||
170708004|NCT02564471|616939343|FG003|Overall Study|Adverse Event|0|||
170708005|NCT02564471|616939340|FG000|Overall Study|Withdrawal by Subject|2|||
170708006|NCT02564471|616939341|FG001|Overall Study|Withdrawal by Subject|1|||
170708007|NCT02564471|616939342|FG002|Overall Study|Withdrawal by Subject|3|||
170708008|NCT02564471|616939343|FG003|Overall Study|Withdrawal by Subject|0|||
170708009|NCT02564471|616939340|FG000|Overall Study|Lost to Follow-up|0|||
170708010|NCT02564471|616939341|FG001|Overall Study|Lost to Follow-up|2|||
170708011|NCT02564471|616939342|FG002|Overall Study|Lost to Follow-up|0|||
170708012|NCT02564471|616939343|FG003|Overall Study|Lost to Follow-up|0|||
170708013|NCT01643473|616939344|FG000|Overall Study|Lost to Follow-up|1|||
170708014|NCT01643473|616939345|FG001|Overall Study|Lost to Follow-up|0|||
170708015|NCT01513317|616939352|FG000|Overall Study|Withdrawal by Subject|15|||
170708016|NCT01513317|616939353|FG001|Overall Study|Withdrawal by Subject|4|||
170708017|NCT01513317|616939352|FG000|Overall Study|Death|1|||
170708018|NCT01513317|616939353|FG001|Overall Study|Death|1|||
170708019|NCT01513317|616939352|FG000|Overall Study|Study terminated by sponsor|18|||
170708020|NCT01513317|616939353|FG001|Overall Study|Study terminated by sponsor|18|||
170708021|NCT01513317|616939352|FG000|Overall Study|Other|0|||
170708022|NCT01513317|616939353|FG001|Overall Study|Other|1|||
170708023|NCT01265953|616939354|FG000|Overall Study|Non compliance|5|||
170708024|NCT01265953|616939355|FG001|Overall Study|Non compliance|3|||
170708025|NCT00182689|616939357|FG000|Overall Study|Adverse Event|8|||
170708026|NCT00182689|616939358|FG001|Overall Study|Adverse Event|11|||
170708027|NCT00182689|616939357|FG000|Overall Study|Withdrawal by Subject|2|||
170708028|NCT00182689|616939358|FG001|Overall Study|Withdrawal by Subject|2|||
170708029|NCT00182689|616939357|FG000|Overall Study|Progression|27|||
170708030|NCT00182689|616939358|FG001|Overall Study|Progression|29|||
170708031|NCT00182689|616939357|FG000|Overall Study|Death|1|||
170708032|NCT00182689|616939358|FG001|Overall Study|Death|0|||
170708033|NCT00182689|616939357|FG000|Overall Study|not protocol specified|0|||
170708034|NCT00182689|616939358|FG001|Overall Study|not protocol specified|3|||
170708035|NCT00182689|616939357|FG000|Overall Study|Ineligible|1|||
170708036|NCT00182689|616939358|FG001|Overall Study|Ineligible|4|||
170708037|NCT00182689|616939357|FG000|Overall Study|Never received treatment|1|||
170708038|NCT00182689|616939358|FG001|Overall Study|Never received treatment|0|||
170708039|NCT02564198|616939361|FG000|Overall Study|Withdrawal by Subject|2|||
170708040|NCT02564198|616939362|FG001|Overall Study|Withdrawal by Subject|4|||
170708041|NCT02564198|616939363|FG002|Overall Study|Withdrawal by Subject|0|||
170708042|NCT02564198|616939361|FG000|Overall Study|Adverse Event|0|||
170708043|NCT02564198|616939362|FG001|Overall Study|Adverse Event|1|||
170708044|NCT02564198|616939363|FG002|Overall Study|Adverse Event|0|||
170708045|NCT01777997|616939368|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
170708046|NCT01777997|616939368|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
170708047|NCT01777997|616939368|FG000|Weeks 48 to 72/96 on ART|Death|1|||
170708048|NCT01777997|616939368|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
170708049|NCT03285646|616939369|FG000|Overall Study|Adverse Event|1|||
170708050|NCT03285646|616939370|FG001|Overall Study|Adverse Event|0|||
170708051|NCT03285646|616939369|FG000|Overall Study|Withdrawal by Subject|10|||
170708052|NCT03285646|616939370|FG001|Overall Study|Withdrawal by Subject|2|||
170708053|NCT03285646|616939369|FG000|Overall Study|Lost to Follow-up|2|||
170708054|NCT03285646|616939370|FG001|Overall Study|Lost to Follow-up|1|||
170708055|NCT03285646|616939369|FG000|Overall Study|Investigator/Sponsor Decision|0|||
170708056|NCT03285646|616939370|FG001|Overall Study|Investigator/Sponsor Decision|1|||
170708057|NCT02660359|616939371|FG000|Overall Study|Protocol Deviation|0|||
170708058|NCT02660359|616939372|FG001|Overall Study|Protocol Deviation|0|||
170708059|NCT02660359|616939373|FG002|Overall Study|Protocol Deviation|1|||
170708060|NCT02660359|616939371|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
170708061|NCT02660359|616939372|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
170708062|NCT02660359|616939373|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
170708063|NCT02660359|616939371|FG000|Overall Study|Lack of Efficacy|1|||
170708064|NCT02660359|616939372|FG001|Overall Study|Lack of Efficacy|1|||
170708065|NCT02660359|616939373|FG002|Overall Study|Lack of Efficacy|1|||
170708066|NCT02660359|616939371|FG000|Overall Study|Adverse Event|0|||
170708067|NCT02660359|616939372|FG001|Overall Study|Adverse Event|1|||
170708068|NCT02660359|616939373|FG002|Overall Study|Adverse Event|0|||
170708069|NCT02660359|616939371|FG000|Overall Study|Other|2|||
170708070|NCT02660359|616939372|FG001|Overall Study|Other|1|||
170708071|NCT02660359|616939373|FG002|Overall Study|Other|3|||
170708072|NCT02660359|616939371|FG000|Overall Study|Withdrawal by Subject|7|||
170708073|NCT02660359|616939372|FG001|Overall Study|Withdrawal by Subject|5|||
170708074|NCT02660359|616939373|FG002|Overall Study|Withdrawal by Subject|8|||
170708075|NCT02660359|616939371|FG000|Overall Study|Lost to Follow-up|3|||
170708076|NCT02660359|616939372|FG001|Overall Study|Lost to Follow-up|3|||
170708077|NCT02660359|616939373|FG002|Overall Study|Lost to Follow-up|0|||
170708078|NCT01694706|616939374|FG000|Overall Study|Adverse Event|0|||
170708079|NCT01694706|616939375|FG001|Overall Study|Adverse Event|1|||
170708080|NCT01694706|616939376|FG002|Overall Study|Adverse Event|0|||
170708081|NCT01694706|616939374|FG000|Overall Study|other reason not defined above|1|||
170708082|NCT01694706|616939375|FG001|Overall Study|other reason not defined above|0|||
170708083|NCT01694706|616939376|FG002|Overall Study|other reason not defined above|0|||
170708084|NCT01923181|616939377|FG000|Overall Study|Protocol Violation|2|||
170708085|NCT01923181|616939378|FG001|Overall Study|Protocol Violation|2|||
170708086|NCT01923181|616939379|FG002|Overall Study|Protocol Violation|0|||
170708087|NCT01923181|616939380|FG003|Overall Study|Protocol Violation|2|||
170708088|NCT01923181|616939381|FG004|Overall Study|Protocol Violation|2|||
170708089|NCT01923181|616939382|FG005|Overall Study|Protocol Violation|1|||
170708090|NCT01923181|616939383|FG006|Overall Study|Protocol Violation|1|||
170708091|NCT01923181|616939384|FG007|Overall Study|Protocol Violation|2|||
170708092|NCT01923181|616939385|FG008|Overall Study|Protocol Violation|1|||
170708093|NCT01923181|616939377|FG000|Overall Study|Withdrawal by Subject|0|||
170708094|NCT01923181|616939378|FG001|Overall Study|Withdrawal by Subject|1|||
170708095|NCT01923181|616939379|FG002|Overall Study|Withdrawal by Subject|0|||
170708096|NCT01923181|616939380|FG003|Overall Study|Withdrawal by Subject|1|||
170708097|NCT01923181|616939381|FG004|Overall Study|Withdrawal by Subject|4|||
170708098|NCT01923181|616939382|FG005|Overall Study|Withdrawal by Subject|2|||
170708099|NCT01923181|616939383|FG006|Overall Study|Withdrawal by Subject|4|||
170708100|NCT01923181|616939384|FG007|Overall Study|Withdrawal by Subject|3|||
170708101|NCT01923181|616939385|FG008|Overall Study|Withdrawal by Subject|1|||
170708102|NCT01923181|616939377|FG000|Overall Study|Other|1|||
170708103|NCT01923181|616939378|FG001|Overall Study|Other|0|||
170708104|NCT01923181|616939379|FG002|Overall Study|Other|0|||
170708105|NCT01923181|616939380|FG003|Overall Study|Other|1|||
170708106|NCT01923181|616939381|FG004|Overall Study|Other|0|||
170708107|NCT01923181|616939382|FG005|Overall Study|Other|0|||
170708108|NCT01923181|616939383|FG006|Overall Study|Other|0|||
170708109|NCT01923181|616939384|FG007|Overall Study|Other|0|||
170708110|NCT01923181|616939385|FG008|Overall Study|Other|0|||
170708111|NCT01923181|616939377|FG000|Overall Study|Lost to Follow-up|0|||
170708112|NCT01923181|616939378|FG001|Overall Study|Lost to Follow-up|3|||
170708113|NCT01923181|616939379|FG002|Overall Study|Lost to Follow-up|2|||
170708114|NCT01923181|616939380|FG003|Overall Study|Lost to Follow-up|1|||
170708115|NCT01923181|616939381|FG004|Overall Study|Lost to Follow-up|2|||
170708116|NCT01923181|616939382|FG005|Overall Study|Lost to Follow-up|1|||
170708117|NCT01923181|616939383|FG006|Overall Study|Lost to Follow-up|3|||
170708118|NCT01923181|616939384|FG007|Overall Study|Lost to Follow-up|3|||
170708119|NCT01923181|616939385|FG008|Overall Study|Lost to Follow-up|1|||
170708120|NCT02944578|616939386|FG000|Overall Study|Physician Decision|1|||
170708121|NCT02944578|616939387|FG001|Overall Study|Physician Decision|0|||
170708122|NCT01257204|616939388|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
170708123|NCT01257204|616939389|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
170708124|NCT01257204|616939390|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
170708125|NCT01257204|616939388|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
170708126|NCT01257204|616939389|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
170826747|NCT00819013|617374395|FG000|Overall Study|Not meeting continuing study eligibility|2|||
170826748|NCT00819013|617374396|FG001|Overall Study|Not meeting continuing study eligibility|1|||
170826749|NCT00819013|617374397|FG002|Overall Study|Not meeting continuing study eligibility|2|||
170826750|NCT00819013|617374398|FG003|Overall Study|Not meeting continuing study eligibility|1|||
170826751|NCT00819013|617374395|FG000|Overall Study|Adverse Event|0|||
170826752|NCT00819013|617374396|FG001|Overall Study|Adverse Event|0|||
170826753|NCT00819013|617374397|FG002|Overall Study|Adverse Event|1|||
170826754|NCT00819013|617374398|FG003|Overall Study|Adverse Event|0|||
170826755|NCT00819013|617374395|FG000|Overall Study|Withdrawal by Subject|1|||
170826756|NCT00819013|617374396|FG001|Overall Study|Withdrawal by Subject|0|||
170826757|NCT00819013|617374397|FG002|Overall Study|Withdrawal by Subject|1|||
170826758|NCT00819013|617374398|FG003|Overall Study|Withdrawal by Subject|0|||
170826759|NCT00819013|617374395|FG000|Overall Study|Lost to Follow-up|0|||
170826760|NCT00819013|617374396|FG001|Overall Study|Lost to Follow-up|0|||
170826761|NCT00819013|617374397|FG002|Overall Study|Lost to Follow-up|1|||
170826762|NCT00819013|617374398|FG003|Overall Study|Lost to Follow-up|2|||
170826763|NCT00819013|617374395|FG000|Overall Study|Death|0|||
170826764|NCT00819013|617374396|FG001|Overall Study|Death|0|||
170826765|NCT00819013|617374397|FG002|Overall Study|Death|0|||
170826766|NCT00819013|617374398|FG003|Overall Study|Death|1|||
170826767|NCT00002597|617374400|FG000|Overall Study|Protocol Violation|19|||
170826768|NCT00002597|617374401|FG001|Overall Study|Protocol Violation|17|||
170826769|NCT00002597|617374400|FG000|Overall Study|Withdrawal by Subject|7|||
170826770|NCT00002597|617374401|FG001|Overall Study|Withdrawal by Subject|6|||
170826771|NCT00839332|617374402|FG000|Phase 1|Disease Progression|38|||
170826772|NCT00839332|617374403|FG001|Phase 1|Disease Progression|0|||
170826773|NCT00839332|617374404|FG002|Phase 1|Disease Progression|0|||
170826774|NCT00839332|617374402|FG000|Phase 1|Adverse Event|6|||
170826775|NCT00839332|617374403|FG001|Phase 1|Adverse Event|0|||
170826776|NCT00839332|617374404|FG002|Phase 1|Adverse Event|0|||
170826777|NCT00839332|617374402|FG000|Phase 1|Withdrawal by Subject|4|||
170826778|NCT00839332|617374403|FG001|Phase 1|Withdrawal by Subject|0|||
170826779|NCT00839332|617374404|FG002|Phase 1|Withdrawal by Subject|0|||
170826780|NCT00839332|617374402|FG000|Phase 1|Physician Decision|2|||
170826781|NCT00839332|617374403|FG001|Phase 1|Physician Decision|0|||
170826782|NCT00839332|617374404|FG002|Phase 1|Physician Decision|0|||
170826783|NCT00839332|617374402|FG000|Phase 2|Protocol Violation|0|||
170826784|NCT00839332|617374403|FG001|Phase 2|Protocol Violation|1|||
170826785|NCT00839332|617374404|FG002|Phase 2|Protocol Violation|0|||
170826786|NCT00839332|617374402|FG000|Phase 2|Disease Progression|0|||
170826787|NCT00839332|617374403|FG001|Phase 2|Disease Progression|46|||
170826788|NCT00839332|617374404|FG002|Phase 2|Disease Progression|21|||
170826789|NCT00839332|617374402|FG000|Phase 2|Adverse Event|0|||
170826790|NCT00839332|617374403|FG001|Phase 2|Adverse Event|8|||
170826791|NCT00839332|617374404|FG002|Phase 2|Adverse Event|6|||
170826792|NCT00839332|617374402|FG000|Phase 2|Death|0|||
170826793|NCT00839332|617374403|FG001|Phase 2|Death|4|||
170826794|NCT00839332|617374404|FG002|Phase 2|Death|2|||
170826795|NCT00839332|617374402|FG000|Phase 2|Withdrawal by Subject|0|||
170826796|NCT00839332|617374403|FG001|Phase 2|Withdrawal by Subject|5|||
170708127|NCT01257204|616939390|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
170708128|NCT01257204|616939388|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
170708129|NCT01257204|616939389|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
170708130|NCT01257204|616939390|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
170708131|NCT01257204|616939388|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
170708132|NCT01257204|616939389|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
170708133|NCT01257204|616939390|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
170708134|NCT01257204|616939388|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
170708135|NCT01257204|616939389|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
170708136|NCT01257204|616939390|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
170708137|NCT01257204|616939388|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
170708138|NCT01257204|616939389|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
170708139|NCT01257204|616939390|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
170708140|NCT01257204|616939388|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
170708141|NCT01257204|616939389|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
170708142|NCT01257204|616939390|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
170708143|NCT01257204|616939388|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
170708144|NCT01257204|616939389|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
170708145|NCT01257204|616939390|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
170708146|NCT01257204|616939388|FG000|Follow-up Period (up to Week 48)|Other|0|||
170708147|NCT01257204|616939389|FG001|Follow-up Period (up to Week 48)|Other|0|||
170708148|NCT01257204|616939390|FG002|Follow-up Period (up to Week 48)|Other|5|||
170708149|NCT00548808|616939391|FG000|Overall Study|Lost to Follow-up|9|||
170708150|NCT00548808|616939392|FG001|Overall Study|Lost to Follow-up|3|||
170708151|NCT00548808|616939391|FG000|Overall Study|Protocol Violation|8|||
170708152|NCT00548808|616939392|FG001|Overall Study|Protocol Violation|8|||
170708153|NCT00548808|616939391|FG000|Overall Study|Withdrawal by Subject|8|||
170708154|NCT00548808|616939392|FG001|Overall Study|Withdrawal by Subject|4|||
170708155|NCT00548808|616939391|FG000|Overall Study|Physician Decision|6|||
170708156|NCT00548808|616939392|FG001|Overall Study|Physician Decision|3|||
170708157|NCT00548808|616939391|FG000|Overall Study|Adverse Event|4|||
170708158|NCT00548808|616939392|FG001|Overall Study|Adverse Event|5|||
170708159|NCT00548808|616939391|FG000|Overall Study|Death|2|||
170708160|NCT00548808|616939392|FG001|Overall Study|Death|0|||
170708161|NCT00548808|616939391|FG000|Overall Study|Entry Criteria Not Met|2|||
170708162|NCT00548808|616939392|FG001|Overall Study|Entry Criteria Not Met|2|||
170708163|NCT00548808|616939391|FG000|Overall Study|Lack of Efficacy|2|||
170708164|NCT00548808|616939392|FG001|Overall Study|Lack of Efficacy|0|||
170708165|NCT00548808|616939391|FG000|Overall Study|Sponsor Decision|1|||
170708166|NCT00548808|616939392|FG001|Overall Study|Sponsor Decision|1|||
170708167|NCT02488629|616939393|FG000|Overall Study|Lack of Efficacy|3|||
170708168|NCT02488629|616939394|FG001|Overall Study|Lack of Efficacy|1|||
170708169|NCT02488629|616939395|FG002|Overall Study|Lack of Efficacy|0|||
170708170|NCT02488629|616939396|FG003|Overall Study|Lack of Efficacy|0|||
170708171|NCT02488629|616939393|FG000|Overall Study|Withdrawal by Subject|0|||
170708172|NCT02488629|616939394|FG001|Overall Study|Withdrawal by Subject|1|||
170708173|NCT02488629|616939395|FG002|Overall Study|Withdrawal by Subject|0|||
170708174|NCT02488629|616939396|FG003|Overall Study|Withdrawal by Subject|0|||
170708175|NCT02932891|616939397|FG000|Overall Study|Lost to Follow-up|2|||
170708176|NCT02932891|616939397|FG000|Overall Study|HPA Suppress|2|||
170708177|NCT04622254|616939398|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
170708178|NCT04622254|616939399|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
170708179|NCT04622254|616939400|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
170708180|NCT04622254|616939401|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
170708181|NCT04622254|616939402|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
170708182|NCT04622254|616939403|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
170708183|NCT04622254|616939398|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
170708184|NCT04622254|616939399|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
170708185|NCT04622254|616939400|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
170708186|NCT04622254|616939401|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
170708187|NCT04622254|616939402|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
170708188|NCT04622254|616939403|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
170708189|NCT04622254|616939398|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
170708190|NCT04622254|616939399|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
170826797|NCT00839332|617374404|FG002|Phase 2|Withdrawal by Subject|8|||
170826798|NCT00839332|617374402|FG000|Phase 2|Physician Decision|0|||
170826799|NCT00839332|617374403|FG001|Phase 2|Physician Decision|4|||
170826800|NCT00839332|617374404|FG002|Phase 2|Physician Decision|1|||
170826801|NCT00839332|617374402|FG000|Phase 2|Lost to Follow-up|0|||
170826802|NCT00839332|617374403|FG001|Phase 2|Lost to Follow-up|0|||
170826803|NCT00839332|617374404|FG002|Phase 2|Lost to Follow-up|1|||
170826804|NCT02132117|617374406|FG000|Overall Study|Adverse Event|6|||
170708191|NCT04622254|616939400|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
170826805|NCT02132117|617374407|FG001|Overall Study|Adverse Event|1|||
170708192|NCT04622254|616939401|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
170708193|NCT04622254|616939402|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
170708194|NCT04622254|616939403|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
170708195|NCT04622254|616939398|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
170708196|NCT04622254|616939399|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
170708197|NCT04622254|616939400|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
170708198|NCT04622254|616939401|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
170708199|NCT04622254|616939402|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
170708200|NCT04622254|616939403|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
170708201|NCT04622254|616939398|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170708202|NCT04622254|616939399|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170708203|NCT04622254|616939400|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170708204|NCT04622254|616939401|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
170708205|NCT04622254|616939402|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170708206|NCT04622254|616939403|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170708207|NCT04622254|616939398|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
170708208|NCT04622254|616939399|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
170708209|NCT04622254|616939400|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
170708210|NCT04622254|616939401|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
170708211|NCT04622254|616939402|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
170708212|NCT04622254|616939403|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
170708213|NCT04622254|616939398|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170708214|NCT04622254|616939399|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170708215|NCT04622254|616939400|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170708216|NCT04622254|616939401|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
170708217|NCT04622254|616939402|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170708218|NCT04622254|616939403|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170708219|NCT04622254|616939398|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170708220|NCT04622254|616939399|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170708221|NCT04622254|616939400|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170708222|NCT04622254|616939401|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
170708223|NCT04622254|616939402|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170708224|NCT04622254|616939403|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170708225|NCT04622254|616939398|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
170708226|NCT04622254|616939399|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
170708227|NCT04622254|616939400|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
170708228|NCT04622254|616939401|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
170708229|NCT04622254|616939402|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
170708230|NCT04622254|616939403|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
170708231|NCT04622254|616939398|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
170708232|NCT04622254|616939399|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
170708233|NCT04622254|616939400|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
170708234|NCT04622254|616939401|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
170708235|NCT04622254|616939402|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
170708236|NCT04622254|616939403|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
170708237|NCT04622254|616939398|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
170708238|NCT04622254|616939399|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
170708239|NCT04622254|616939400|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
170708240|NCT04622254|616939401|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
170708241|NCT04622254|616939402|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
170708242|NCT04622254|616939403|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
170708243|NCT02652624|616939404|FG000|Randomized Phase|Pregnancy|3|||
170826806|NCT02132117|617374406|FG000|Overall Study|Lost to Follow-up|2|||
170826807|NCT02132117|617374407|FG001|Overall Study|Lost to Follow-up|2|||
170826808|NCT02132117|617374406|FG000|Overall Study|Personal Reasons|1|||
170826809|NCT02132117|617374407|FG001|Overall Study|Personal Reasons|2|||
170826810|NCT02132117|617374406|FG000|Overall Study|Other Miscellaneous Reasons|2|||
170826811|NCT02132117|617374407|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170826812|NCT01678898|617374412|FG000|PB-102-F01|Adverse Event|0|||
170826813|NCT01678898|617374413|FG001|PB-102-F01|Adverse Event|1|||
170826814|NCT01678898|617374414|FG002|PB-102-F01|Adverse Event|0|||
170826815|NCT01678898|617374412|FG000|PB-102-F01|Physician Decision|0|||
170826816|NCT01678898|617374413|FG001|PB-102-F01|Physician Decision|1|||
170708244|NCT02652624|616939405|FG001|Randomized Phase|Pregnancy|1|||
170708245|NCT02652624|616939404|FG000|Randomized Phase|Investigator's Discretion|0|||
170708246|NCT02652624|616939405|FG001|Randomized Phase|Investigator's Discretion|2|||
170708247|NCT02652624|616939404|FG000|Randomized Phase|Death|0|||
170826817|NCT01678898|617374414|FG002|PB-102-F01|Physician Decision|0|||
170826818|NCT03078751|617374418|FG000|Overall Study|Adverse Event|4|||
170826819|NCT03078751|617374419|FG001|Overall Study|Adverse Event|0|||
170826820|NCT03078751|617374418|FG000|Overall Study|Physician Decision|1|||
170826821|NCT03078751|617374419|FG001|Overall Study|Physician Decision|0|||
170826822|NCT03078751|617374418|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
170826823|NCT03078751|617374419|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
170826824|NCT03078751|617374418|FG000|Overall Study|Subject/guardian decision|8|||
170826825|NCT03078751|617374419|FG001|Overall Study|Subject/guardian decision|1|||
170826826|NCT03078751|617374418|FG000|Overall Study|Untreated|0|||
170826827|NCT03078751|617374419|FG001|Overall Study|Untreated|4|||
170826828|NCT04088500|617374421|FG000|Overall Study|Reason unknown|1|||
170826829|NCT04088500|617374421|FG000|Overall Study|Participant withdrew consent|1|||
170826830|NCT04088500|617374421|FG000|Overall Study|Disease progression|3|||
170826831|NCT01064856|617374422|FG000|Double-blind (DB) Period|Adverse Event|1|||
170708248|NCT02652624|616939405|FG001|Randomized Phase|Death|1|||
170708249|NCT02652624|616939404|FG000|Randomized Phase|Lost to Follow-up|0|||
170708250|NCT02652624|616939405|FG001|Randomized Phase|Lost to Follow-up|1|||
170708251|NCT02652624|616939404|FG000|Extension Phase|Lost to Follow-up|3|||
170826832|NCT01064856|617374423|FG001|Double-blind (DB) Period|Adverse Event|0|||
170826833|NCT01064856|617374424|FG002|Double-blind (DB) Period|Adverse Event|0|||
170826834|NCT01064856|617374425|FG003|Double-blind (DB) Period|Adverse Event|0|||
170826835|NCT01064856|617374422|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
170826836|NCT01064856|617374423|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
170826837|NCT01064856|617374424|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
170826838|NCT01064856|617374425|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
170826839|NCT01064856|617374422|FG000|Open-label (OL) Period|Adverse Event|0|||
170826840|NCT01064856|617374423|FG001|Open-label (OL) Period|Adverse Event|0|||
170826841|NCT01064856|617374424|FG002|Open-label (OL) Period|Adverse Event|12|||
170826842|NCT01064856|617374425|FG003|Open-label (OL) Period|Adverse Event|6|||
170826843|NCT01064856|617374422|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
170826844|NCT01064856|617374423|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
170826845|NCT01064856|617374424|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
170826846|NCT01064856|617374425|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
170826847|NCT01064856|617374422|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
170826848|NCT01064856|617374423|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
170826849|NCT01064856|617374424|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
170826850|NCT01064856|617374425|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
170826851|NCT01064856|617374422|FG000|Open-label (OL) Period|Other|0|||
170826852|NCT01064856|617374423|FG001|Open-label (OL) Period|Other|0|||
170826853|NCT01064856|617374424|FG002|Open-label (OL) Period|Other|7|||
170826854|NCT01064856|617374425|FG003|Open-label (OL) Period|Other|7|||
170826855|NCT01374971|617374426|FG000|Overall Study|Withdrawal by Subject|1|||
170826856|NCT02965599|617374428|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
170826857|NCT02965599|617374429|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
170826858|NCT00951171|617374431|FG000|Overall Study|Adverse Event|2|||
170826859|NCT00951171|617374432|FG001|Overall Study|Adverse Event|0|||
170826860|NCT04130061|617374435|FG000|Overall Study|OR team forgot to request membrane|1|||
170826861|NCT04130061|617374436|FG001|Overall Study|OR team forgot to request membrane|0|||
170826862|NCT04267393|617374439|FG000|Randomization|Adverse Event|1|||
170826863|NCT04267393|617374440|FG001|Randomization|Adverse Event|0|||
170826864|NCT04267393|617374441|FG002|Randomization|Adverse Event|0|||
170826865|NCT04267393|617374439|FG000|Randomization|Administrative Reasons by Sponsor|0|||
170826866|NCT04267393|617374440|FG001|Randomization|Administrative Reasons by Sponsor|1|||
170826867|NCT04267393|617374441|FG002|Randomization|Administrative Reasons by Sponsor|0|||
170826868|NCT04267393|617374439|FG000|Treatment Period|Adverse Event|0|||
170826869|NCT04267393|617374440|FG001|Treatment Period|Adverse Event|2|||
170826870|NCT04267393|617374441|FG002|Treatment Period|Adverse Event|3|||
170826871|NCT04267393|617374439|FG000|Treatment Period|Participant Withdrew Consent|0|||
170826872|NCT04267393|617374440|FG001|Treatment Period|Participant Withdrew Consent|0|||
170826873|NCT04267393|617374441|FG002|Treatment Period|Participant Withdrew Consent|1|||
170826874|NCT04267393|617374439|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
170826875|NCT04267393|617374440|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
170708252|NCT02652624|616939405|FG001|Extension Phase|Lost to Follow-up|1|||
170708253|NCT02652624|616939404|FG000|Extension Phase|Pregnancy|1|||
170708254|NCT02652624|616939405|FG001|Extension Phase|Pregnancy|1|||
170708255|NCT02652624|616939404|FG000|Extension Phase|Adverse Event|0|||
170708256|NCT02652624|616939405|FG001|Extension Phase|Adverse Event|1|||
170708257|NCT02652624|616939404|FG000|Extension Phase|Withdrew Consent|0|||
170826876|NCT04267393|617374441|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
170826877|NCT02388347|617376012|FG000|Overall Study|Withdrawal by Subject|0|||
170826878|NCT02388347|617376013|FG001|Overall Study|Withdrawal by Subject|0|||
170826879|NCT02388347|617376014|FG002|Overall Study|Withdrawal by Subject|1|||
170708258|NCT02652624|616939405|FG001|Extension Phase|Withdrew Consent|1|||
170826880|NCT02388347|617376015|FG003|Overall Study|Withdrawal by Subject|0|||
170826881|NCT02388347|617376016|FG004|Overall Study|Withdrawal by Subject|0|||
170708259|NCT00654628|616939406|FG000|6-week Active Treatment Period|Adverse Event|9|||
170708260|NCT00654628|616939406|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
170708261|NCT00654628|616939406|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
170708262|NCT00654628|616939406|FG000|6-week Active Treatment Period|Out of window period|1|||
170708263|NCT00654628|616939406|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
170708264|NCT00654628|616939406|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
170708265|NCT00912405|616939409|FG000|Overall Study|Lost to Follow-up|5|||
170708266|NCT00953329|616939410|FG000|Overall Study|Lack of Efficacy|1|||
170708267|NCT01434823|616939411|FG000|Overall Study|Incomplete data in medical record|4|||
170708268|NCT01434823|616939412|FG001|Overall Study|Incomplete data in medical record|7|||
170708269|NCT00451282|616939415|FG000|Overall Study|Lost to Follow-up|6|||
170708270|NCT00451282|616939416|FG001|Overall Study|Lost to Follow-up|5|||
170708271|NCT01797536|616939417|FG000|Overall Study|Adverse Event|0|||
170708272|NCT01797536|616939418|FG001|Overall Study|Adverse Event|1|||
170708273|NCT01797536|616939419|FG002|Overall Study|Adverse Event|0|||
170708274|NCT01797536|616939420|FG003|Overall Study|Adverse Event|0|||
170708275|NCT00098839|616939421|FG000|Overall Study|Adverse Event|5|||
170708276|NCT00098839|616939422|FG001|Overall Study|Adverse Event|2|||
170708277|NCT00098839|616939421|FG000|Overall Study|Death|1|||
170708278|NCT00098839|616939422|FG001|Overall Study|Death|2|||
170708279|NCT00098839|616939421|FG000|Overall Study|Physician Decision|4|||
170708280|NCT00098839|616939422|FG001|Overall Study|Physician Decision|14|||
170708281|NCT00098839|616939421|FG000|Overall Study|Withdrawal by Subject|1|||
170708282|NCT00098839|616939422|FG001|Overall Study|Withdrawal by Subject|0|||
170708283|NCT00098839|616939421|FG000|Overall Study|Refusal of further protocol therapy|3|||
170708284|NCT00098839|616939422|FG001|Overall Study|Refusal of further protocol therapy|1|||
170708285|NCT00098839|616939421|FG000|Overall Study|Relapse|6|||
170708286|NCT00098839|616939422|FG001|Overall Study|Relapse|3|||
170708287|NCT00098839|616939421|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
170708288|NCT00098839|616939422|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
170708289|NCT00098839|616939421|FG000|Overall Study|Ineligible|2|||
170708290|NCT00098839|616939422|FG001|Overall Study|Ineligible|0|||
170708291|NCT00577122|616939423|FG000|Overall Study|Adverse Event|0|||
170708292|NCT00577122|616939424|FG001|Overall Study|Adverse Event|2|||
170708293|NCT00577122|616939423|FG000|Overall Study|Progression, relapse during active trt|6|||
170708294|NCT00577122|616939424|FG001|Overall Study|Progression, relapse during active trt|8|||
170708295|NCT00577122|616939423|FG000|Overall Study|Prog, refract disease during active trt|8|||
170708296|NCT00577122|616939424|FG001|Overall Study|Prog, refract disease during active trt|5|||
170708297|NCT00577122|616939423|FG000|Overall Study|Alternative Therapy|0|||
170708298|NCT00577122|616939424|FG001|Overall Study|Alternative Therapy|1|||
170708299|NCT00436280|616939426|FG000|Period 1: Induction|Adverse Event|8|||
170708300|NCT00436280|616939426|FG000|Period 1: Induction|Progressive Disease|12|||
170708301|NCT00436280|616939426|FG000|Period 1: Induction|Stable Disease|6|||
170708302|NCT00436280|616939426|FG000|Period 1: Induction|Withdrawal by Subject|1|||
170708303|NCT00436280|616939426|FG000|Period 1: Induction|Death|1|||
170708304|NCT00436280|616939426|FG000|Period 2: Consolidation|Adverse Event|1|||
170708305|NCT00436280|616939426|FG000|Period 2: Consolidation|Progressive Disease|10|||
170708306|NCT00436280|616939426|FG000|Period 2: Consolidation|Stable Disease|1|||
170708307|NCT00436280|616939426|FG000|Period 2: Consolidation|Physician Decision|2|||
170708308|NCT00436280|616939426|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
170708309|NCT00436280|616939426|FG000|Period 2: Consolidation|Death|1|||
170708310|NCT00436280|616939426|FG000|Period 3: Maintenance|Adverse Event|6|||
170708311|NCT00436280|616939426|FG000|Period 3: Maintenance|Progressive Disease|12|||
170708312|NCT03732638|616939435|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
170708313|NCT03732638|616939436|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
170708314|NCT03732638|616939435|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
170708315|NCT03732638|616939436|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
170708316|NCT03732638|616939435|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
170708317|NCT03732638|616939436|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
170708318|NCT03732638|616939435|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
170708319|NCT03732638|616939436|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
170708320|NCT03732638|616939435|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
170708321|NCT03732638|616939436|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
170708322|NCT03732638|616939435|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
170708323|NCT03732638|616939436|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
170708324|NCT03732638|616939435|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
170708325|NCT03732638|616939436|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
170708326|NCT03732638|616939435|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
170708327|NCT03732638|616939436|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
170708328|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
170708329|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
170708330|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
170708331|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
170708332|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
170708333|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
170708334|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
170708335|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
170708336|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
170708337|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
170708338|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
170708339|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
170708340|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
170708341|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
170708342|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
170708343|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
170708344|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
170708345|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
170708346|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
170708347|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
170708348|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
170708349|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
170708350|NCT03732638|616939435|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
170708351|NCT03732638|616939436|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
170708352|NCT03732638|616939435|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
170708353|NCT03732638|616939436|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
170708354|NCT03732638|616939435|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
170708355|NCT03732638|616939436|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
170708356|NCT03732638|616939435|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
170708357|NCT03732638|616939436|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
170708358|NCT03732638|616939435|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
170708359|NCT03732638|616939436|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
170708360|NCT01358981|616939437|FG000|Period 1|Withdrawal by Subject|0|||
170708361|NCT01358981|616939438|FG001|Period 1|Withdrawal by Subject|0|||
170708362|NCT01358981|616939439|FG002|Period 1|Withdrawal by Subject|0|||
170708363|NCT01358981|616939440|FG003|Period 1|Withdrawal by Subject|1|||
170708364|NCT01358981|616939441|FG004|Period 1|Withdrawal by Subject|0|||
170708365|NCT01358981|616939442|FG005|Period 1|Withdrawal by Subject|0|||
170708366|NCT01358981|616939443|FG006|Period 1|Withdrawal by Subject|0|||
170708367|NCT03728582|616939448|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
170708368|NCT03728582|616939449|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
170708369|NCT03728582|616939448|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
170708370|NCT03728582|616939449|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
170708371|NCT01430585|616939450|FG000|Overall Study|Death|1|||
170708372|NCT01430585|616939450|FG000|Overall Study|Objective Progression or Relapse|3|||
170708373|NCT01430585|616939450|FG000|Overall Study|Study Terminated by Sponsor|3|||
170708374|NCT01430585|616939450|FG000|Overall Study|Other|7|||
170708375|NCT01448850|616939451|FG000|Overall Study|Death|3|||
170708376|NCT01448850|616939452|FG001|Overall Study|Death|6|||
170708377|NCT01448850|616939451|FG000|Overall Study|Withdrawal by Subject|13|||
170708378|NCT01448850|616939452|FG001|Overall Study|Withdrawal by Subject|21|||
170708379|NCT01448850|616939451|FG000|Overall Study|Lost to Follow-up|3|||
170708380|NCT01448850|616939452|FG001|Overall Study|Lost to Follow-up|1|||
170708381|NCT01448850|616939451|FG000|Overall Study|Other|15|||
170708382|NCT01448850|616939452|FG001|Overall Study|Other|12|||
170708383|NCT00482391|616939453|FG000|Overall Study|Withdrawal by Subject|1|||
170708384|NCT00482391|616939453|FG000|Overall Study|Adverse Event|1|||
170708385|NCT00482391|616939453|FG000|Overall Study|Death|1|||
170708386|NCT00779766|616939454|FG000|Month 24|Serious Adverse Event|2|||
170708387|NCT00779766|616939455|FG001|Month 24|Serious Adverse Event|3|||
170708388|NCT00779766|616939454|FG000|Month 24|Adverse Event|3|||
170708389|NCT00779766|616939455|FG001|Month 24|Adverse Event|3|||
170708390|NCT00779766|616939454|FG000|Month 24|Protocol Violation|3|||
170708391|NCT00779766|616939455|FG001|Month 24|Protocol Violation|1|||
170708392|NCT00779766|616939454|FG000|Month 24|Withdrawal by Subject|159|||
170708393|NCT00779766|616939455|FG001|Month 24|Withdrawal by Subject|127|||
170708394|NCT00779766|616939454|FG000|Month 24|Migrated/moved from study area|138|||
170708395|NCT00779766|616939455|FG001|Month 24|Migrated/moved from study area|162|||
170708396|NCT00779766|616939454|FG000|Month 24|Lost to Follow-up|9|||
170708397|NCT00779766|616939455|FG001|Month 24|Lost to Follow-up|9|||
170826882|NCT02210208|617376017|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
170826883|NCT02210208|617376017|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
170826884|NCT02210208|617376017|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
170826885|NCT00695136|617376018|FG000|Overall Study|Withdrawal by Subject|1|||
170826886|NCT00695136|617376018|FG000|Overall Study|unrelated adverse event|1|||
170826887|NCT01726049|617376020|FG000|Overall Study|Death|1|||
170826888|NCT01726049|617376021|FG001|Overall Study|Death|1|||
170826889|NCT01726049|617376020|FG000|Overall Study|Adverse Event|4|||
170826890|NCT01726049|617376021|FG001|Overall Study|Adverse Event|1|||
170826891|NCT01726049|617376020|FG000|Overall Study|refused second HC|0|||
170826892|NCT01726049|617376021|FG001|Overall Study|refused second HC|2|||
170826893|NCT01181609|617376022|FG000|Overall Study|Adverse Event|1|||
170826894|NCT01181609|617376022|FG000|Overall Study|Withdrawal by Subject|1|||
170826895|NCT01181609|617376022|FG000|Overall Study|Lost to Follow-up|1|||
170826896|NCT01181609|617376022|FG000|Overall Study|Death|50|||
170826897|NCT01333111|617376025|FG000|Overall Study|patient undergoing major surgery|0|||
170826898|NCT01333111|617376026|FG001|Overall Study|patient undergoing major surgery|2|||
170826899|NCT01333111|617376027|FG002|Overall Study|patient undergoing major surgery|0|||
170826900|NCT01333111|617376025|FG000|Overall Study|personal reasons|0|||
170826901|NCT01333111|617376026|FG001|Overall Study|personal reasons|0|||
170826902|NCT01333111|617376027|FG002|Overall Study|personal reasons|1|||
170826903|NCT01333111|617376025|FG000|Overall Study|unclassified|1|||
170826904|NCT01333111|617376026|FG001|Overall Study|unclassified|0|||
170826905|NCT01333111|617376027|FG002|Overall Study|unclassified|0|||
170826906|NCT01333111|617376025|FG000|Overall Study|withdrawal criteria|0|||
170826907|NCT01333111|617376026|FG001|Overall Study|withdrawal criteria|1|||
170826908|NCT01333111|617376027|FG002|Overall Study|withdrawal criteria|0|||
170826909|NCT01333111|617376025|FG000|Overall Study|Non-compliance|1|||
170826910|NCT01333111|617376026|FG001|Overall Study|Non-compliance|0|||
170826911|NCT01333111|617376027|FG002|Overall Study|Non-compliance|0|||
170826912|NCT01333111|617376025|FG000|Overall Study|Ineffective therapy|0|||
170826913|NCT01333111|617376026|FG001|Overall Study|Ineffective therapy|0|||
170826914|NCT01333111|617376027|FG002|Overall Study|Ineffective therapy|1|||
170826915|NCT02161406|617376028|FG000|Overall Study|Death|2|||
170826916|NCT02161406|617376029|FG001|Overall Study|Death|1|||
170826917|NCT02161406|617376028|FG000|Overall Study|Lost to Follow-up|2|||
170826918|NCT02161406|617376029|FG001|Overall Study|Lost to Follow-up|1|||
170826919|NCT02161406|617376028|FG000|Overall Study|Withdrawal by Subject|2|||
170826920|NCT02161406|617376029|FG001|Overall Study|Withdrawal by Subject|4|||
170826921|NCT02161406|617376028|FG000|Overall Study|investigator withdrew subject|3|||
170826922|NCT02161406|617376029|FG001|Overall Study|investigator withdrew subject|1|||
170826923|NCT02161406|617376028|FG000|Overall Study|Lack of Efficacy|1|||
170826924|NCT02161406|617376029|FG001|Overall Study|Lack of Efficacy|1|||
170826925|NCT02161406|617376028|FG000|Overall Study|relocation|0|||
170826926|NCT02161406|617376029|FG001|Overall Study|relocation|1|||
170826927|NCT00664105|617376032|FG000|Overall Study|Death|3|||
170826928|NCT00664105|617376032|FG000|Overall Study|Withdrawal by Subject|5|||
170826929|NCT00664105|617376032|FG000|Overall Study|Adverse Event|9|||
170826930|NCT00664105|617376032|FG000|Overall Study|Disease progression|7|||
170826931|NCT00263211|617376033|FG000|Overall Study|Death|1|||
170826932|NCT00263211|617376034|FG001|Overall Study|Death|0|||
170826933|NCT00263211|617376033|FG000|Overall Study|Withdrawal by Subject|3|||
170826934|NCT00263211|617376034|FG001|Overall Study|Withdrawal by Subject|0|||
170826935|NCT00263211|617376033|FG000|Overall Study|Protocol Violation|1|||
170826936|NCT00263211|617376034|FG001|Overall Study|Protocol Violation|0|||
170826937|NCT00263211|617376033|FG000|Overall Study|Disease Progression|0|||
170826938|NCT00263211|617376034|FG001|Overall Study|Disease Progression|1|||
170826939|NCT01929876|617376035|FG000|Period 2|Non-Compliance|1|||
170826940|NCT00478647|617376039|FG000|Overall Study|Adverse Event|1|||
170826941|NCT00478647|617376039|FG000|Overall Study|Withdrawal by Subject|1|||
170826942|NCT04333147|617376040|FG000|Overall Study|Adverse Event|43|||
170826943|NCT04333147|617376041|FG001|Overall Study|Adverse Event|40|||
170826944|NCT04333147|617376040|FG000|Overall Study|Lack of Efficacy|49|||
170826945|NCT04333147|617376041|FG001|Overall Study|Lack of Efficacy|48|||
170826946|NCT04333147|617376040|FG000|Overall Study|Lost to Follow-up|19|||
170826947|NCT04333147|617376041|FG001|Overall Study|Lost to Follow-up|16|||
170826948|NCT04333147|617376040|FG000|Overall Study|Physician Decision|17|||
170826949|NCT04333147|617376041|FG001|Overall Study|Physician Decision|20|||
170826950|NCT04333147|617376040|FG000|Overall Study|Withdrawal by Subject|65|||
170826951|NCT04333147|617376041|FG001|Overall Study|Withdrawal by Subject|68|||
170826952|NCT04333147|617376040|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
170826953|NCT04333147|617376041|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
170826954|NCT04333147|617376040|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
170826955|NCT04333147|617376041|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
170826956|NCT04333147|617376040|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
170826957|NCT04333147|617376041|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
170826958|NCT00487552|617376051|FG000|Overall Study|Unsuccessful magnet placements|3|||
170826959|NCT00487552|617376051|FG000|Overall Study|Death due to progressive malignancy|2|||
170826960|NCT00487552|617376051|FG000|Overall Study|Stent not placed|1|||
170826961|NCT03119688|617376052|FG000|Overall Study|Adverse Event|4|||
170826962|NCT00320398|617376053|FG000|Overall Study|Adverse Event|1|||
170826963|NCT00320398|617376054|FG001|Overall Study|Adverse Event|4|||
170826964|NCT00320398|617376053|FG000|Overall Study|Other|1|||
170826965|NCT00320398|617376054|FG001|Overall Study|Other|0|||
170826966|NCT00630552|617376055|FG000|Overall Study|Adverse Event|0|||
170826967|NCT00630552|617376056|FG001|Overall Study|Adverse Event|1|||
170826968|NCT00630552|617376057|FG002|Overall Study|Adverse Event|5|||
170826969|NCT00630552|617376058|FG003|Overall Study|Adverse Event|4|||
170826970|NCT00630552|617376059|FG004|Overall Study|Adverse Event|2|||
170826971|NCT00630552|617376055|FG000|Overall Study|Disease progression|5|||
170826972|NCT00630552|617376056|FG001|Overall Study|Disease progression|6|||
170826973|NCT00630552|617376057|FG002|Overall Study|Disease progression|27|||
170826974|NCT00630552|617376058|FG003|Overall Study|Disease progression|22|||
170826975|NCT00630552|617376059|FG004|Overall Study|Disease progression|31|||
170826976|NCT00630552|617376055|FG000|Overall Study|Never received IP|0|||
170826977|NCT00630552|617376056|FG001|Overall Study|Never received IP|0|||
170826978|NCT00630552|617376057|FG002|Overall Study|Never received IP|0|||
170826979|NCT00630552|617376058|FG003|Overall Study|Never received IP|2|||
170826980|NCT00630552|617376059|FG004|Overall Study|Never received IP|2|||
170826981|NCT00630552|617376055|FG000|Overall Study|Ineligibility determined|0|||
170826982|NCT00630552|617376056|FG001|Overall Study|Ineligibility determined|0|||
170826983|NCT00630552|617376057|FG002|Overall Study|Ineligibility determined|0|||
170826984|NCT00630552|617376058|FG003|Overall Study|Ineligibility determined|0|||
170826985|NCT00630552|617376059|FG004|Overall Study|Ineligibility determined|1|||
170826986|NCT00630552|617376055|FG000|Overall Study|Protocol Violation|0|||
170826987|NCT00630552|617376056|FG001|Overall Study|Protocol Violation|0|||
170826988|NCT00630552|617376057|FG002|Overall Study|Protocol Violation|0|||
170826989|NCT00630552|617376058|FG003|Overall Study|Protocol Violation|1|||
170826990|NCT00630552|617376059|FG004|Overall Study|Protocol Violation|0|||
170826991|NCT00630552|617376055|FG000|Overall Study|Physician Decision|0|||
170826992|NCT00630552|617376056|FG001|Overall Study|Physician Decision|0|||
170826993|NCT00630552|617376057|FG002|Overall Study|Physician Decision|0|||
170826994|NCT00630552|617376058|FG003|Overall Study|Physician Decision|0|||
170826995|NCT00630552|617376059|FG004|Overall Study|Physician Decision|1|||
170826996|NCT00630552|617376055|FG000|Overall Study|Death|0|||
170826997|NCT00630552|617376056|FG001|Overall Study|Death|0|||
170826998|NCT00630552|617376057|FG002|Overall Study|Death|1|||
170826999|NCT00630552|617376058|FG003|Overall Study|Death|2|||
170827000|NCT00630552|617376059|FG004|Overall Study|Death|2|||
170827001|NCT00630552|617376055|FG000|Overall Study|Withdrawal by Subject|0|||
170827002|NCT00630552|617376056|FG001|Overall Study|Withdrawal by Subject|0|||
170827003|NCT00630552|617376057|FG002|Overall Study|Withdrawal by Subject|0|||
170827004|NCT00630552|617376058|FG003|Overall Study|Withdrawal by Subject|1|||
170827005|NCT00630552|617376059|FG004|Overall Study|Withdrawal by Subject|0|||
170827006|NCT00630552|617376055|FG000|Overall Study|Other|0|||
170827007|NCT00630552|617376056|FG001|Overall Study|Other|0|||
170827008|NCT00630552|617376057|FG002|Overall Study|Other|4|||
170827009|NCT00630552|617376058|FG003|Overall Study|Other|2|||
170827010|NCT00630552|617376059|FG004|Overall Study|Other|0|||
170827011|NCT05006417|617376062|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
170827012|NCT00570921|617376063|FG000|Overall Study|Protocol Violation|1|||
170827013|NCT00570921|617376063|FG000|Overall Study|Physician Decision|1|||
170827014|NCT03503162|617376086|FG000|Overall Study|did not meet eligibility|1|||
170827015|NCT02835092|617376087|FG000|Overall Study|Withdrawal by Subject|3|||
170827016|NCT02835092|617376088|FG001|Overall Study|Withdrawal by Subject|6|||
170827017|NCT02835092|617376089|FG002|Overall Study|Withdrawal by Subject|3|||
170827018|NCT02835092|617376087|FG000|Overall Study|Lost to Follow-up|0|||
170827019|NCT02835092|617376088|FG001|Overall Study|Lost to Follow-up|2|||
170827020|NCT02835092|617376089|FG002|Overall Study|Lost to Follow-up|0|||
170827021|NCT00025506|617376090|FG000|Overall Study|Ineligible: clerical error|1|||
170827022|NCT00025506|617376090|FG000|Overall Study|Ineligible: wrong cell type|5|||
170827023|NCT00025506|617376090|FG000|Overall Study|Ineligible: inadequate pathology|2|||
170827024|NCT00025506|617376090|FG000|Overall Study|Never Treated|2|||
170827025|NCT02246218|617376091|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170827026|NCT02246218|617376092|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170827027|NCT02246218|617376091|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
170827028|NCT02246218|617376092|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
170827029|NCT02246218|617376091|FG000|Overall Study|Adverse Event|1|||
170827030|NCT02246218|617376092|FG001|Overall Study|Adverse Event|1|||
170827031|NCT02246218|617376091|FG000|Overall Study|Lost to Follow-up|1|||
170827032|NCT02246218|617376092|FG001|Overall Study|Lost to Follow-up|0|||
170827033|NCT01321723|617376093|FG000|Overall Study|Adverse Event|3|||
170827034|NCT01321723|617376094|FG001|Overall Study|Adverse Event|5|||
170827035|NCT01321723|617376095|FG002|Overall Study|Adverse Event|2|||
170827036|NCT01321723|617376093|FG000|Overall Study|Withdrawal by Subject|2|||
170827037|NCT01321723|617376094|FG001|Overall Study|Withdrawal by Subject|0|||
170827038|NCT01321723|617376095|FG002|Overall Study|Withdrawal by Subject|2|||
170827039|NCT00713206|617376096|FG000|Overall Study|Lost to Follow-up|4|||
170827040|NCT00713206|617376097|FG001|Overall Study|Lost to Follow-up|4|||
170827041|NCT00713206|617376096|FG000|Overall Study|Death|1|||
170827042|NCT00713206|617376097|FG001|Overall Study|Death|0|||
170827043|NCT02561806|617376098|FG000|Induction Period|Adverse Event|0|||
170827044|NCT02561806|617376099|FG001|Induction Period|Adverse Event|2|||
170827045|NCT02561806|617376098|FG000|Induction Period|Lack of Efficacy|1|||
170827046|NCT02561806|617376099|FG001|Induction Period|Lack of Efficacy|0|||
170827047|NCT02561806|617376098|FG000|Induction Period|Withdrawal by Subject|0|||
170827048|NCT02561806|617376099|FG001|Induction Period|Withdrawal by Subject|2|||
170827049|NCT02561806|617376098|FG000|Induction Period|Site staff became unblinded|1|||
170827050|NCT02561806|617376099|FG001|Induction Period|Site staff became unblinded|0|||
170827051|NCT02561806|617376098|FG000|Induction Period|Randomized but not treated|0|||
170827052|NCT02561806|617376099|FG001|Induction Period|Randomized but not treated|1|||
170827053|NCT02561806|617376098|FG000|Maintenance Period|Adverse Event|2|||
170827054|NCT02561806|617376099|FG001|Maintenance Period|Adverse Event|1|||
170827055|NCT02561806|617376098|FG000|Maintenance Period|Lack of Efficacy|3|||
170827056|NCT02561806|617376099|FG001|Maintenance Period|Lack of Efficacy|1|||
170827057|NCT02561806|617376098|FG000|Maintenance Period|Lost to Follow-up|2|||
170827058|NCT02561806|617376099|FG001|Maintenance Period|Lost to Follow-up|2|||
170827059|NCT02561806|617376098|FG000|Maintenance Period|Protocol Violation|1|||
170827060|NCT02561806|617376099|FG001|Maintenance Period|Protocol Violation|0|||
170827061|NCT02561806|617376098|FG000|Maintenance Period|Withdrawal by Subject|5|||
170827062|NCT02561806|617376099|FG001|Maintenance Period|Withdrawal by Subject|3|||
170827063|NCT02561806|617376098|FG000|Maintenance Period|Site staff became unblinded|0|||
170827064|NCT02561806|617376099|FG001|Maintenance Period|Site staff became unblinded|1|||
170827065|NCT02561806|617376098|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
170827066|NCT02561806|617376099|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
170827067|NCT02561806|617376098|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
170827068|NCT02561806|617376099|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
170827069|NCT00905034|617376101|FG000|Overall Study|Withdrawal by Subject|1|||
170827070|NCT00394589|617376102|FG000|Overall Study|Adverse Event|2|||
170827071|NCT00394589|617376103|FG001|Overall Study|Adverse Event|1|||
170827072|NCT00394589|617376104|FG002|Overall Study|Adverse Event|2|||
170827073|NCT00394589|617376102|FG000|Overall Study|Lack of Efficacy|2|||
170827074|NCT00394589|617376103|FG001|Overall Study|Lack of Efficacy|2|||
170827075|NCT00394589|617376104|FG002|Overall Study|Lack of Efficacy|3|||
170827076|NCT00394589|617376102|FG000|Overall Study|Protocol Violation|4|||
170827077|NCT00394589|617376103|FG001|Overall Study|Protocol Violation|0|||
170827078|NCT00394589|617376104|FG002|Overall Study|Protocol Violation|2|||
170827079|NCT04081389|617376106|FG000|Overall Study|Withdrawal by Subject|0|||
170827080|NCT04081389|617376107|FG001|Overall Study|Withdrawal by Subject|0|||
170827081|NCT04081389|617376108|FG002|Overall Study|Withdrawal by Subject|1|||
170827082|NCT04081389|617376109|FG003|Overall Study|Withdrawal by Subject|0|||
170827083|NCT01114672|617376111|FG000|Overall Study|Death|0|||
170827084|NCT01114672|617376112|FG001|Overall Study|Death|1|||
170827085|NCT01114672|617376111|FG000|Overall Study|Withdrawal by Subject|2|||
170827086|NCT01114672|617376112|FG001|Overall Study|Withdrawal by Subject|1|||
170827087|NCT01114672|617376111|FG000|Overall Study|Lost to Follow-up|1|||
170827088|NCT01114672|617376112|FG001|Overall Study|Lost to Follow-up|0|||
170827089|NCT01114672|617376111|FG000|Overall Study|transplanted|1|||
170827090|NCT01114672|617376112|FG001|Overall Study|transplanted|0|||
170827091|NCT01710800|617376119|FG000|Overall Study|Withdrawal by Subject|21|||
170827092|NCT01710800|617376119|FG000|Overall Study|Protocol Violation|1|||
170827093|NCT03891641|617376120|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
170827094|NCT03891641|617376121|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
170827095|NCT01670188|617376127|FG000|Overall Study|Death|0|||
170827096|NCT01670188|617376128|FG001|Overall Study|Death|1|||
170827097|NCT02212301|617376129|FG000|Period 1|Lost to Follow-up|0|||
170827098|NCT02212301|617376130|FG001|Period 1|Lost to Follow-up|1|||
170827099|NCT02427958|617376131|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
170827100|NCT02427958|617376131|FG000|Overall Study|Lost to Follow-up|6|||
170827101|NCT02427958|617376131|FG000|Overall Study|Withdrawal by Subject|14|||
170827102|NCT02427958|617376131|FG000|Overall Study|Lack of Efficacy|1|||
170827103|NCT00866918|617376132|FG000|Overall Study|Death|1|||
170827104|NCT00866918|617376133|FG001|Overall Study|Death|5|||
170827105|NCT00866918|617376132|FG000|Overall Study|Lack of Efficacy|1|||
170827106|NCT00866918|617376133|FG001|Overall Study|Lack of Efficacy|1|||
170827107|NCT00866918|617376132|FG000|Overall Study|Physician Decision|10|||
170827108|NCT00866918|617376133|FG001|Overall Study|Physician Decision|2|||
170827109|NCT00866918|617376132|FG000|Overall Study|Ineligible|2|||
170827110|NCT00866918|617376133|FG001|Overall Study|Ineligible|4|||
170827111|NCT00866918|617376132|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
170827112|NCT00866918|617376133|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
170827113|NCT00866918|617376132|FG000|Overall Study|Secondary malignancy|1|||
170827114|NCT00866918|617376133|FG001|Overall Study|Secondary malignancy|0|||
170827115|NCT06080438|617376140|FG000|Overall Study|Lost to Follow-up|2|||
170827116|NCT01527500|617376141|FG000|Part A|Administrative|11|||
170827117|NCT01527500|617376142|FG001|Part A|Administrative|7|||
170827118|NCT01527500|617376141|FG000|Part A|Adverse Event|4|||
170827119|NCT01527500|617376142|FG001|Part A|Adverse Event|2|||
170827120|NCT01527500|617376141|FG000|Part A|Death|4|||
170827121|NCT01527500|617376142|FG001|Part A|Death|1|||
170827122|NCT01527500|617376141|FG000|Part A|Lost to Follow-up|0|||
170827123|NCT01527500|617376142|FG001|Part A|Lost to Follow-up|1|||
170827124|NCT01527500|617376141|FG000|Part A|Protocol Deviation|9|||
170827125|NCT01527500|617376142|FG001|Part A|Protocol Deviation|2|||
170827126|NCT01527500|617376141|FG000|Part A|Withdrawal by Subject|2|||
170827127|NCT01527500|617376142|FG001|Part A|Withdrawal by Subject|0|||
170827128|NCT01527500|617376141|FG000|Part B|Adverse Event|1|||
170827129|NCT01527500|617376142|FG001|Part B|Adverse Event|0|||
170827130|NCT00372255|617376143|FG000|Overall Study|Withdrawn for other reasons|2|||
170827131|NCT00372255|617376144|FG001|Overall Study|Withdrawn for other reasons|1|||
170827132|NCT00776984|617376145|FG000|Overall Study|Adverse Event|8|||
170827133|NCT00776984|617376146|FG001|Overall Study|Adverse Event|2|||
170827134|NCT00776984|617376145|FG000|Overall Study|Protocol Violation|4|||
170827135|NCT00776984|617376146|FG001|Overall Study|Protocol Violation|2|||
170827136|NCT00776984|617376145|FG000|Overall Study|Lost to Follow-up|2|||
170827137|NCT00776984|617376146|FG001|Overall Study|Lost to Follow-up|0|||
170827138|NCT00776984|617376145|FG000|Overall Study|Withdrawal by Subject|12|||
170827139|NCT00776984|617376146|FG001|Overall Study|Withdrawal by Subject|7|||
170827140|NCT00776984|617376145|FG000|Overall Study|Lack of Efficacy|0|||
170827141|NCT00776984|617376146|FG001|Overall Study|Lack of Efficacy|1|||
170827142|NCT00776984|617376145|FG000|Overall Study|Other|5|||
170827143|NCT00776984|617376146|FG001|Overall Study|Other|9|||
170827144|NCT01544309|617376152|FG000|Overall Study|Withdrawal by Subject|12|||
170827145|NCT01544309|617376153|FG001|Overall Study|Withdrawal by Subject|7|||
170827146|NCT01544309|617376152|FG000|Overall Study|Protocol Violation|2|||
170827147|NCT01544309|617376153|FG001|Overall Study|Protocol Violation|1|||
170827148|NCT01544309|617376152|FG000|Overall Study|Physician Decision|4|||
170827149|NCT01544309|617376153|FG001|Overall Study|Physician Decision|1|||
170827150|NCT01544309|617376152|FG000|Overall Study|Not performed pre-dose examination|1|||
170827151|NCT01544309|617376153|FG001|Overall Study|Not performed pre-dose examination|2|||
170827152|NCT01544309|617376152|FG000|Overall Study|Administered prohibit prior medication|1|||
170827153|NCT01544309|617376153|FG001|Overall Study|Administered prohibit prior medication|0|||
170827154|NCT04414397|617376154|FG000|Control Period|Withdrawal by Subject|2|||
170827155|NCT04414397|617376155|FG001|Control Period|Withdrawal by Subject|2|||
170827156|NCT04414397|617376154|FG000|Control Period|Lost to Follow-up|0|||
170827157|NCT04414397|617376155|FG001|Control Period|Lost to Follow-up|4|||
170827158|NCT04414397|617376154|FG000|Control Period|Protocol deviation|0|||
170827159|NCT04414397|617376155|FG001|Control Period|Protocol deviation|1|||
170827160|NCT04414397|617376154|FG000|Post-Control Period|Withdrawal by Subject|3|||
170827161|NCT04414397|617376155|FG001|Post-Control Period|Withdrawal by Subject|6|||
170827162|NCT04414397|617376154|FG000|Post-Control Period|Lost to Follow-up|4|||
170827163|NCT04414397|617376155|FG001|Post-Control Period|Lost to Follow-up|9|||
170827164|NCT04414397|617376154|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
170827165|NCT04414397|617376155|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
170827166|NCT04414397|617376154|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
170827167|NCT04414397|617376155|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
170827168|NCT02551692|617376160|FG000|Overall Study|Lost to Follow-up|0|||
170827169|NCT02551692|617376161|FG001|Overall Study|Lost to Follow-up|1|||
170827170|NCT02551692|617376162|FG002|Overall Study|Lost to Follow-up|4|||
170827171|NCT02551692|617376160|FG000|Overall Study|Withdrawal by Subject|1|||
170827172|NCT02551692|617376161|FG001|Overall Study|Withdrawal by Subject|0|||
170827173|NCT02551692|617376162|FG002|Overall Study|Withdrawal by Subject|1|||
170827174|NCT02799745|617376163|FG000|Overall Study|Participant moved out of state|1|||
170827175|NCT02799745|617376164|FG001|Overall Study|Participant moved out of state|0|||
170827176|NCT02799745|617376163|FG000|Overall Study|Discontinued due to planned surgery|1|||
170827177|NCT02799745|617376164|FG001|Overall Study|Discontinued due to planned surgery|0|||
170827178|NCT02799745|617376163|FG000|Overall Study|Withdrawal by Subject|16|||
170827179|NCT02799745|617376164|FG001|Overall Study|Withdrawal by Subject|25|||
170827180|NCT02799745|617376163|FG000|Overall Study|Protocol Deviation|4|||
170708398|NCT00779766|616939454|FG000|Month 24|Other|18|||
170708399|NCT00779766|616939455|FG001|Month 24|Other|27|||
170708400|NCT00779766|616939454|FG000|Month 48|Withdrawal by Subject|68|||
170708401|NCT00779766|616939455|FG001|Month 48|Withdrawal by Subject|63|||
170708402|NCT00779766|616939454|FG000|Month 48|Migrated/moved from study area|76|||
170708403|NCT00779766|616939455|FG001|Month 48|Migrated/moved from study area|75|||
170708404|NCT00779766|616939454|FG000|Month 48|Lost to Follow-up|29|||
170708405|NCT00779766|616939455|FG001|Month 48|Lost to Follow-up|30|||
170708406|NCT00779766|616939454|FG000|Month 48|Other|1|||
170708407|NCT00779766|616939455|FG001|Month 48|Other|0|||
170708408|NCT00779766|616939454|FG000|Month 72|Withdrawal by Subject|55|||
170708409|NCT00779766|616939455|FG001|Month 72|Withdrawal by Subject|71|||
170708410|NCT00779766|616939454|FG000|Month 72|Migrated/moved from study area|124|||
170708411|NCT00779766|616939455|FG001|Month 72|Migrated/moved from study area|109|||
170708412|NCT00779766|616939454|FG000|Month 72|Lost to Follow-up|6|||
170708413|NCT00779766|616939455|FG001|Month 72|Lost to Follow-up|8|||
170708414|NCT00779766|616939454|FG000|Month 72|Other|0|||
170708415|NCT00779766|616939455|FG001|Month 72|Other|1|||
170708416|NCT01412424|616939458|FG000|Core Treatment Period|Treatment Failure|24|||
170708417|NCT01412424|616939458|FG000|Core Treatment Period|Adverse Event|21|||
170708418|NCT01412424|616939458|FG000|Core Treatment Period|Patient Request|5|||
170708419|NCT01412424|616939458|FG000|Core Treatment Period|Lost to Follow-up|2|||
170708420|NCT01412424|616939458|FG000|Core Treatment Period|Sponsor Request|1|||
170708421|NCT01412424|616939458|FG000|Extension Treatment Period|Adverse Event|2|||
170708422|NCT01412424|616939458|FG000|Extension Treatment Period|Treatment Failure|2|||
170708423|NCT01412424|616939458|FG000|Extension Treatment Period|Patient Request|2|||
170708424|NCT02075320|616939467|FG000|Overall Study|Withdrawal by Subject|2|||
170708425|NCT03773757|616939468|FG000|Overall Study|Withdrawal by Subject|2|||
170708426|NCT03773757|616939469|FG001|Overall Study|Withdrawal by Subject|4|||
170708427|NCT00057746|616939470|FG000|Overall Study|Withdrawal by Subject|0|||
170708428|NCT00057746|616939471|FG001|Overall Study|Withdrawal by Subject|0|||
170708429|NCT00057746|616939472|FG002|Overall Study|Withdrawal by Subject|1|||
170708430|NCT01469065|616939473|FG000|Overall Study|Lack of Efficacy|0|||
170708431|NCT01469065|616939474|FG001|Overall Study|Lack of Efficacy|0|||
170708432|NCT01469065|616939475|FG002|Overall Study|Lack of Efficacy|0|||
170708433|NCT01469065|616939476|FG003|Overall Study|Lack of Efficacy|0|||
170708434|NCT01469065|616939477|FG004|Overall Study|Lack of Efficacy|1|||
170708435|NCT01469065|616939473|FG000|Overall Study|Other|0|||
170708436|NCT01469065|616939474|FG001|Overall Study|Other|1|||
170708437|NCT01469065|616939475|FG002|Overall Study|Other|0|||
170708438|NCT01469065|616939476|FG003|Overall Study|Other|0|||
170708439|NCT01469065|616939477|FG004|Overall Study|Other|0|||
170708440|NCT04542070|616939478|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
170708441|NCT04542070|616939479|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
170708442|NCT04542070|616939480|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
170708443|NCT04542070|616939481|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
170708444|NCT04542070|616939478|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
170708445|NCT04542070|616939479|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
170708446|NCT04542070|616939480|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
170708447|NCT04542070|616939481|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
170708448|NCT04542070|616939478|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
170708449|NCT04542070|616939479|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
170708450|NCT04542070|616939480|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
170708451|NCT04542070|616939481|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
170708452|NCT04542070|616939478|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
170708453|NCT04542070|616939479|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
170708454|NCT04542070|616939480|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
170708455|NCT04542070|616939481|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
170708456|NCT04542070|616939478|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
170708457|NCT04542070|616939479|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
170708458|NCT04542070|616939480|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
170708459|NCT04542070|616939481|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
170708460|NCT04542070|616939478|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
170708461|NCT04542070|616939479|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
170708462|NCT04542070|616939480|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
170708463|NCT04542070|616939481|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
170708464|NCT04542070|616939478|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
170708465|NCT04542070|616939479|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
170827181|NCT02799745|617376164|FG001|Overall Study|Protocol Deviation|5|||
170827182|NCT02799745|617376163|FG000|Overall Study|Progressive Disease|28|||
170827183|NCT02799745|617376164|FG001|Overall Study|Progressive Disease|38|||
170827184|NCT02799745|617376163|FG000|Overall Study|Lost to Follow-up|3|||
170827185|NCT02799745|617376164|FG001|Overall Study|Lost to Follow-up|2|||
170827186|NCT02799745|617376163|FG000|Overall Study|Death|3|||
170827187|NCT02799745|617376164|FG001|Overall Study|Death|0|||
170827188|NCT02799745|617376163|FG000|Overall Study|Adverse Event|0|||
170827189|NCT02799745|617376164|FG001|Overall Study|Adverse Event|1|||
170827190|NCT02056873|617376165|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
170827191|NCT00497874|617377984|FG000|Overall Study|Withdrawal by Subject|48|||
170827192|NCT00497874|617377985|FG001|Overall Study|Withdrawal by Subject|17|||
170827193|NCT00497874|617377984|FG000|Overall Study|Illness|8|||
170827194|NCT00497874|617377985|FG001|Overall Study|Illness|4|||
170827195|NCT00497874|617377984|FG000|Overall Study|Death|2|||
170827196|NCT00497874|617377985|FG001|Overall Study|Death|4|||
170827197|NCT00497874|617377984|FG000|Overall Study|Unable to contact|52|||
170827198|NCT00497874|617377985|FG001|Overall Study|Unable to contact|67|||
170827199|NCT00497874|617377984|FG000|Overall Study|Unable to schedule|37|||
170827200|NCT00497874|617377985|FG001|Overall Study|Unable to schedule|24|||
170827201|NCT01101334|617377986|FG000|Overall Study|Adverse Event|9|||
170827202|NCT01101334|617377987|FG001|Overall Study|Adverse Event|4|||
170827203|NCT01101334|617377986|FG000|Overall Study|Death|7|||
170827204|NCT01101334|617377987|FG001|Overall Study|Death|1|||
170827205|NCT01101334|617377986|FG000|Overall Study|Withdrawal by Subject|4|||
170827206|NCT01101334|617377987|FG001|Overall Study|Withdrawal by Subject|3|||
170827207|NCT01101334|617377986|FG000|Overall Study|Withdrawal by Sponsor|1|||
170827208|NCT01101334|617377987|FG001|Overall Study|Withdrawal by Sponsor|1|||
170827209|NCT01101334|617377986|FG000|Overall Study|Progressive Disease|22|||
170827210|NCT01101334|617377987|FG001|Overall Study|Progressive Disease|35|||
170827211|NCT01101334|617377986|FG000|Overall Study|Other|2|||
170827212|NCT01101334|617377987|FG001|Overall Study|Other|1|||
170827213|NCT01722045|617377988|FG000|Overall Study|Adverse Event|8|||
170827214|NCT01722045|617377988|FG000|Overall Study|Death|3|||
170827215|NCT01722045|617377988|FG000|Overall Study|Withdrawal by Subject|8|||
170827216|NCT01722045|617377988|FG000|Overall Study|Lost to Follow-up|4|||
170827217|NCT01722045|617377988|FG000|Overall Study|Protocol Deviation|1|||
170827218|NCT01722045|617377988|FG000|Overall Study|Physician Decision|3|||
170827219|NCT01722045|617377988|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
170827220|NCT00612352|617377989|FG000|Overall Study|Adverse Event|1|||
170827221|NCT00612352|617377990|FG001|Overall Study|Adverse Event|0|||
170827222|NCT00612352|617377989|FG000|Overall Study|Withdrawal by Subject|3|||
170827223|NCT00612352|617377990|FG001|Overall Study|Withdrawal by Subject|5|||
170827224|NCT00612352|617377989|FG000|Overall Study|moved out of state|1|||
170827225|NCT00612352|617377990|FG001|Overall Study|moved out of state|0|||
170827226|NCT00612352|617377989|FG000|Overall Study|didn't return calls/show up on test date|4|||
170827227|NCT00612352|617377990|FG001|Overall Study|didn't return calls/show up on test date|1|||
170827228|NCT01053247|617377991|FG000|Overall Study|Withdrawal by Subject|9|||
170827229|NCT01053247|617377992|FG001|Overall Study|Withdrawal by Subject|4|||
170827230|NCT01053247|617377993|FG002|Overall Study|Withdrawal by Subject|15|||
170827231|NCT01053247|617377991|FG000|Overall Study|Lack of Efficacy|1|||
170827232|NCT01053247|617377992|FG001|Overall Study|Lack of Efficacy|0|||
170827233|NCT01053247|617377993|FG002|Overall Study|Lack of Efficacy|1|||
170827234|NCT01053247|617377991|FG000|Overall Study|Protocol Violation|2|||
170827235|NCT01053247|617377992|FG001|Overall Study|Protocol Violation|1|||
170827236|NCT01053247|617377993|FG002|Overall Study|Protocol Violation|2|||
170827237|NCT01053247|617377991|FG000|Overall Study|Lost to Follow-up|8|||
170827238|NCT01053247|617377992|FG001|Overall Study|Lost to Follow-up|5|||
170827239|NCT01053247|617377993|FG002|Overall Study|Lost to Follow-up|7|||
170827240|NCT01053247|617377991|FG000|Overall Study|Adverse Event|0|||
170827241|NCT01053247|617377992|FG001|Overall Study|Adverse Event|9|||
170827242|NCT01053247|617377993|FG002|Overall Study|Adverse Event|3|||
170827243|NCT03458728|617377994|FG000|Overall Study|Adverse Event|1|||
170827244|NCT03458728|617377995|FG001|Overall Study|Adverse Event|0|||
170827245|NCT03458728|617377994|FG000|Overall Study|Physician Decision|1|||
170827246|NCT03458728|617377995|FG001|Overall Study|Physician Decision|0|||
170827247|NCT03458728|617377994|FG000|Overall Study|Progressive disease - clinical assessment|1|||
170827248|NCT03458728|617377995|FG001|Overall Study|Progressive disease - clinical assessment|0|||
170827249|NCT03458728|617377994|FG000|Overall Study|Progressive disease - radiological progression|21|||
170827250|NCT03458728|617377995|FG001|Overall Study|Progressive disease - radiological progression|6|||
170827251|NCT03458728|617377994|FG000|Overall Study|Withdrawal by Subject|0|||
170827252|NCT03458728|617377995|FG001|Overall Study|Withdrawal by Subject|1|||
170827253|NCT00908349|617377998|FG000|Overall Study|Adverse Event|10|||
170827254|NCT00908349|617377998|FG000|Overall Study|Withdrawal by Subject|9|||
170708466|NCT04542070|616939480|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
170708467|NCT04542070|616939481|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
170708468|NCT04542070|616939478|FG000|Maintenance + Extension Period|Adverse Event|10|||
170708469|NCT04542070|616939479|FG001|Maintenance + Extension Period|Adverse Event|2|||
170708470|NCT04542070|616939480|FG002|Maintenance + Extension Period|Adverse Event|0|||
170708471|NCT04542070|616939481|FG003|Maintenance + Extension Period|Adverse Event|0|||
170708472|NCT04542070|616939478|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
170708473|NCT04542070|616939479|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
170708474|NCT04542070|616939480|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
170708475|NCT04542070|616939481|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
170708476|NCT04542070|616939478|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
170708477|NCT04542070|616939479|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
170708478|NCT04542070|616939480|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
170708479|NCT04542070|616939481|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
170708480|NCT04542070|616939478|FG000|Maintenance + Extension Period|Physician Decision|1|||
170708481|NCT04542070|616939479|FG001|Maintenance + Extension Period|Physician Decision|1|||
170708482|NCT04542070|616939480|FG002|Maintenance + Extension Period|Physician Decision|0|||
170708483|NCT04542070|616939481|FG003|Maintenance + Extension Period|Physician Decision|0|||
170708484|NCT04542070|616939478|FG000|Maintenance + Extension Period|Protocol Violation|2|||
170708485|NCT04542070|616939479|FG001|Maintenance + Extension Period|Protocol Violation|5|||
170708486|NCT04542070|616939480|FG002|Maintenance + Extension Period|Protocol Violation|0|||
170708487|NCT04542070|616939481|FG003|Maintenance + Extension Period|Protocol Violation|0|||
170708488|NCT04542070|616939478|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
170708489|NCT04542070|616939479|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
170708490|NCT04542070|616939480|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
170708491|NCT04542070|616939481|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
170708492|NCT04542070|616939478|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
170708493|NCT04542070|616939479|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
170708494|NCT04542070|616939480|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
170708495|NCT04542070|616939481|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
170708496|NCT04542070|616939478|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
170708497|NCT04542070|616939479|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
170708498|NCT04542070|616939480|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
170708499|NCT04542070|616939481|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
170708500|NCT04542070|616939478|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
170708501|NCT04542070|616939479|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
170708502|NCT04542070|616939480|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
170708503|NCT04542070|616939481|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
170708504|NCT04542070|616939478|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
170708505|NCT04542070|616939479|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
170708506|NCT04542070|616939480|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
170708507|NCT04542070|616939481|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
170708508|NCT04542070|616939478|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
170708509|NCT04542070|616939479|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
170708510|NCT04542070|616939480|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
170708511|NCT04542070|616939481|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
170708512|NCT04542070|616939478|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
170708513|NCT04542070|616939479|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
170708514|NCT04542070|616939480|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
170708515|NCT04542070|616939481|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
170708516|NCT04292730|616939485|FG000|Overall Study|Lost to Follow-up|8|||
170708517|NCT04292730|616939486|FG001|Overall Study|Lost to Follow-up|12|||
170708518|NCT04292730|616939487|FG002|Overall Study|Lost to Follow-up|12|||
170708519|NCT04292730|616939488|FG003|Overall Study|Lost to Follow-up|48|||
170708520|NCT04292730|616939485|FG000|Overall Study|Death|2|||
170708521|NCT04292730|616939486|FG001|Overall Study|Death|2|||
170708522|NCT04292730|616939487|FG002|Overall Study|Death|4|||
170708523|NCT04292730|616939488|FG003|Overall Study|Death|12|||
170708524|NCT04292730|616939485|FG000|Overall Study|Withdrew Consent|2|||
170708525|NCT04292730|616939486|FG001|Overall Study|Withdrew Consent|2|||
170708526|NCT04292730|616939487|FG002|Overall Study|Withdrew Consent|5|||
170708527|NCT04292730|616939488|FG003|Overall Study|Withdrew Consent|6|||
170708528|NCT04292730|616939485|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170708529|NCT04292730|616939486|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170708530|NCT04292730|616939487|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170708531|NCT04292730|616939488|FG003|Overall Study|Non-Compliance with Study Drug|0|||
170708532|NCT04292730|616939485|FG000|Overall Study|Protocol Violation|0|||
170708533|NCT04292730|616939486|FG001|Overall Study|Protocol Violation|0|||
170708534|NCT04292730|616939487|FG002|Overall Study|Protocol Violation|1|||
170708535|NCT04292730|616939488|FG003|Overall Study|Protocol Violation|0|||
170708536|NCT04292730|616939485|FG000|Overall Study|Randomized but not Treated|8|||
170708537|NCT04292730|616939486|FG001|Overall Study|Randomized but not Treated|4|||
170708538|NCT04292730|616939487|FG002|Overall Study|Randomized but not Treated|0|||
170708539|NCT04292730|616939488|FG003|Overall Study|Randomized but not Treated|14|||
170708540|NCT01856543|616939489|FG000|Overall Study|Treatment discontinued|6|||
170708541|NCT01856543|616939490|FG001|Overall Study|Treatment discontinued|3|||
170708542|NCT01856543|616939489|FG000|Overall Study|Withdrawn before start|7|||
170708543|NCT01856543|616939490|FG001|Overall Study|Withdrawn before start|3|||
170708544|NCT00806546|616939491|FG000|Overall Study|Enrolled, not treated|35|||
170708545|NCT00806546|616939491|FG000|Overall Study|Lost to Follow-up|32|||
170708546|NCT00806546|616939491|FG000|Overall Study|Adverse Event|74|||
170708547|NCT00806546|616939491|FG000|Overall Study|Withdrawal by Subject|75|||
170708548|NCT00806546|616939491|FG000|Overall Study|Protocol Violation|49|||
170708549|NCT00806546|616939491|FG000|Overall Study|Various|42|||
170708550|NCT00558103|616939492|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
170708551|NCT00558103|616939493|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
170708552|NCT00558103|616939494|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
170708553|NCT00558103|616939495|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
170708554|NCT00558103|616939496|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
170708555|NCT00558103|616939497|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
170708556|NCT00558103|616939492|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
170708557|NCT00558103|616939493|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
170708558|NCT00558103|616939494|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
170708559|NCT00558103|616939495|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
170708560|NCT00558103|616939496|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
170708561|NCT00558103|616939497|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
170708562|NCT00558103|616939492|FG000|Randomized Treatment Phase|Disease Progression|1|||
170708563|NCT00558103|616939493|FG001|Randomized Treatment Phase|Disease Progression|0|||
170708564|NCT00558103|616939494|FG002|Randomized Treatment Phase|Disease Progression|1|||
170708565|NCT00558103|616939495|FG003|Randomized Treatment Phase|Disease Progression|0|||
170708566|NCT00558103|616939496|FG004|Randomized Treatment Phase|Disease Progression|0|||
170708567|NCT00558103|616939497|FG005|Randomized Treatment Phase|Disease Progression|0|||
170708568|NCT00558103|616939492|FG000|Randomized Treatment Phase|Adverse Event|0|||
170708569|NCT00558103|616939493|FG001|Randomized Treatment Phase|Adverse Event|0|||
170708570|NCT00558103|616939494|FG002|Randomized Treatment Phase|Adverse Event|0|||
170708571|NCT00558103|616939495|FG003|Randomized Treatment Phase|Adverse Event|1|||
170708572|NCT00558103|616939496|FG004|Randomized Treatment Phase|Adverse Event|1|||
170708573|NCT00558103|616939497|FG005|Randomized Treatment Phase|Adverse Event|0|||
170708574|NCT00558103|616939492|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
170708575|NCT00558103|616939493|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
170708576|NCT00558103|616939494|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
170708577|NCT00558103|616939495|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
170708578|NCT00558103|616939496|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
170708579|NCT00558103|616939497|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
170708580|NCT00558103|616939492|FG000|Monotherapy Extension Phase|Disease Progression|0|||
170708581|NCT00558103|616939493|FG001|Monotherapy Extension Phase|Disease Progression|0|||
170708582|NCT00558103|616939494|FG002|Monotherapy Extension Phase|Disease Progression|0|||
170708583|NCT00558103|616939495|FG003|Monotherapy Extension Phase|Disease Progression|0|||
170708584|NCT00558103|616939496|FG004|Monotherapy Extension Phase|Disease Progression|0|||
170708585|NCT00558103|616939497|FG005|Monotherapy Extension Phase|Disease Progression|8|||
170708586|NCT01552772|616939503|FG000|Overall Study|Lost to Follow-up|2|||
170708587|NCT01552772|616939503|FG000|Overall Study|Adverse Event|1|||
170708588|NCT01552772|616939503|FG000|Overall Study|Protocol Deviation|1|||
170708589|NCT00414388|616939504|FG000|Overall Study|Adverse Event|1|||
170708590|NCT02318693|616939505|FG000|Overall Study|Protocol Violation|0|||
170708591|NCT02318693|616939506|FG001|Overall Study|Protocol Violation|1|||
170827255|NCT00908349|617377998|FG000|Overall Study|Physician Decision|5|||
170827256|NCT00908349|617377998|FG000|Overall Study|Lost to Follow-up|5|||
170827257|NCT00908349|617377998|FG000|Overall Study|Various|6|||
170827258|NCT01468077|617378001|FG000|Overall Study|Adverse Event|2|||
170827259|NCT01468077|617378002|FG001|Overall Study|Adverse Event|2|||
170827260|NCT01468077|617378001|FG000|Overall Study|Lack of Efficacy|1|||
170827261|NCT01468077|617378002|FG001|Overall Study|Lack of Efficacy|1|||
170827262|NCT01468077|617378001|FG000|Overall Study|Physician Decision|1|||
170827263|NCT01468077|617378002|FG001|Overall Study|Physician Decision|0|||
170827264|NCT04009629|617378003|FG000|Overall Study|Withdrawal by Subject|2|||
170827265|NCT04009629|617378004|FG001|Overall Study|Withdrawal by Subject|0|||
170827266|NCT03991988|617378006|FG000|Overall Study|Withdrawal by Subject|2|||
170827267|NCT03991988|617378007|FG001|Overall Study|Withdrawal by Subject|2|||
170827268|NCT05446714|617378008|FG000|Overall Study|Lost to Follow-up|1|||
170827269|NCT05446714|617378009|FG001|Overall Study|Lost to Follow-up|3|||
170827270|NCT05446714|617378010|FG002|Overall Study|Lost to Follow-up|2|||
170827271|NCT05446714|617378008|FG000|Overall Study|Protocol Violation|2|||
170827272|NCT05446714|617378009|FG001|Overall Study|Protocol Violation|0|||
170827273|NCT05446714|617378010|FG002|Overall Study|Protocol Violation|0|||
170827274|NCT03024996|617378014|FG000|Overall Study|Death|57|||
170827275|NCT03024996|617378015|FG001|Overall Study|Death|55|||
170827276|NCT03024996|617378014|FG000|Overall Study|Disease relapse|1|||
170827277|NCT03024996|617378015|FG001|Overall Study|Disease relapse|0|||
170827278|NCT03024996|617378014|FG000|Overall Study|Lost to Follow-up|5|||
170827279|NCT03024996|617378015|FG001|Overall Study|Lost to Follow-up|10|||
170827280|NCT03024996|617378014|FG000|Overall Study|Other|3|||
170827281|NCT03024996|617378015|FG001|Overall Study|Other|3|||
170827282|NCT03024996|617378014|FG000|Overall Study|Physician Decision|0|||
170827283|NCT03024996|617378015|FG001|Overall Study|Physician Decision|1|||
170827284|NCT03024996|617378014|FG000|Overall Study|Study terminated by sponsor|303|||
170827285|NCT03024996|617378015|FG001|Overall Study|Study terminated by sponsor|283|||
170827286|NCT03024996|617378014|FG000|Overall Study|Withdrawal by Subject|21|||
170827287|NCT03024996|617378015|FG001|Overall Study|Withdrawal by Subject|36|||
170827288|NCT01084239|617378018|FG000|28-Day Follow-up|Lost to Follow-up|4|||
170827289|NCT01084239|617378019|FG001|28-Day Follow-up|Lost to Follow-up|9|||
170827290|NCT02705625|617378021|FG000|Overall Study|Protocol Violation|1|||
170827291|NCT02705625|617378022|FG001|Overall Study|Protocol Violation|0|||
170827292|NCT02705625|617378023|FG002|Overall Study|Protocol Violation|0|||
170827293|NCT02705625|617378021|FG000|Overall Study|Adverse Event|6|||
170827294|NCT02705625|617378022|FG001|Overall Study|Adverse Event|5|||
170827295|NCT02705625|617378023|FG002|Overall Study|Adverse Event|2|||
170827296|NCT02705625|617378021|FG000|Overall Study|Death|0|||
170827297|NCT02705625|617378022|FG001|Overall Study|Death|0|||
170827298|NCT02705625|617378023|FG002|Overall Study|Death|1|||
170827299|NCT02705625|617378021|FG000|Overall Study|Withdrawal by Subject|1|||
170827300|NCT02705625|617378022|FG001|Overall Study|Withdrawal by Subject|4|||
170827301|NCT02705625|617378023|FG002|Overall Study|Withdrawal by Subject|5|||
170827302|NCT02705625|617378021|FG000|Overall Study|Lost to Follow-up|0|||
170827303|NCT02705625|617378022|FG001|Overall Study|Lost to Follow-up|0|||
170827304|NCT02705625|617378023|FG002|Overall Study|Lost to Follow-up|1|||
170827305|NCT02705625|617378021|FG000|Overall Study|Non-compliance|0|||
170827306|NCT02705625|617378022|FG001|Overall Study|Non-compliance|1|||
170827307|NCT02705625|617378023|FG002|Overall Study|Non-compliance|1|||
170827308|NCT02705625|617378021|FG000|Overall Study|Overdosing|0|||
170827309|NCT02705625|617378022|FG001|Overall Study|Overdosing|0|||
170827310|NCT02705625|617378023|FG002|Overall Study|Overdosing|1|||
170827311|NCT00639769|617378025|FG000|Overall Study|Death|2|||
170827312|NCT00639769|617378025|FG000|Overall Study|Adverse Event|7|||
170827313|NCT00639769|617378025|FG000|Overall Study|Lack of Efficacy|1|||
170827314|NCT00639769|617378025|FG000|Overall Study|Disease progression|26|||
170827315|NCT00639769|617378025|FG000|Overall Study|Withdrawal by Subject|4|||
170827316|NCT00634842|617378026|FG000|Overall Study|Adverse Event|2|||
170827317|NCT00634842|617378027|FG001|Overall Study|Adverse Event|3|||
170827318|NCT00634842|617378026|FG000|Overall Study|Protocol Violation|8|||
170827319|NCT00634842|617378027|FG001|Overall Study|Protocol Violation|4|||
170827320|NCT00634842|617378026|FG000|Overall Study|Move to another state|1|||
170827321|NCT00634842|617378027|FG001|Overall Study|Move to another state|0|||
170827322|NCT00634842|617378026|FG000|Overall Study|Inclusion criteria were not met|1|||
170827323|NCT00634842|617378027|FG001|Overall Study|Inclusion criteria were not met|0|||
170827324|NCT00634842|617378026|FG000|Overall Study|Lost to Follow-up|1|||
170827325|NCT00634842|617378027|FG001|Overall Study|Lost to Follow-up|2|||
170827326|NCT00634842|617378026|FG000|Overall Study|Physician Decision|1|||
170827327|NCT00634842|617378027|FG001|Overall Study|Physician Decision|0|||
170827328|NCT00634842|617378026|FG000|Overall Study|Withdrawal by Subject|1|||
170827329|NCT00634842|617378027|FG001|Overall Study|Withdrawal by Subject|3|||
170827330|NCT00634842|617378026|FG000|Overall Study|Lack of time and intolerance to drug|0|||
170827331|NCT00634842|617378027|FG001|Overall Study|Lack of time and intolerance to drug|1|||
170827332|NCT00634842|617378026|FG000|Overall Study|Discontinued due to injection|0|||
170827333|NCT00634842|617378027|FG001|Overall Study|Discontinued due to injection|2|||
170708592|NCT03591575|616939509|FG000|Overall Study|Adverse Event|2|||
170708593|NCT03591575|616939510|FG001|Overall Study|Adverse Event|0|||
170708594|NCT03591575|616939509|FG000|Overall Study|Withdrawal by Subject|4|||
170708595|NCT03591575|616939510|FG001|Overall Study|Withdrawal by Subject|1|||
170708596|NCT00813358|616939511|FG000|Overall Study|Death|32|||
170708597|NCT00813358|616939511|FG000|Overall Study|Lost to Follow-up|12|||
170708598|NCT00813358|616939511|FG000|Overall Study|other endpoints|5|||
170708599|NCT00813358|616939511|FG000|Overall Study|Withdrawal by Subject|20|||
170708600|NCT02293005|616941206|FG000|Overall Study|Adverse Event|2|||
170708601|NCT02293005|616941206|FG000|Overall Study|Death|4|||
170708602|NCT02293005|616941206|FG000|Overall Study|Lost to Follow-up|1|||
170708603|NCT02293005|616941206|FG000|Overall Study|Withdrawal by Subject|2|||
170708604|NCT02293005|616941206|FG000|Overall Study|Progression|17|||
170708605|NCT00659646|616941211|FG000|Overall Study|Protocol Violation|12|||
170708606|NCT00659646|616941212|FG001|Overall Study|Protocol Violation|8|||
170708607|NCT00659646|616941211|FG000|Overall Study|Adverse Event|1|||
170708608|NCT00659646|616941212|FG001|Overall Study|Adverse Event|0|||
170708609|NCT00659646|616941211|FG000|Overall Study|Lost to Follow-up|1|||
170708610|NCT00659646|616941212|FG001|Overall Study|Lost to Follow-up|0|||
170708611|NCT00659646|616941211|FG000|Overall Study|protocol noncompliance after randomized|1|||
170708612|NCT00659646|616941212|FG001|Overall Study|protocol noncompliance after randomized|0|||
170708613|NCT02086591|616941215|FG000|Overall Study|Adverse Event|1|||
170708614|NCT02086591|616941215|FG000|Overall Study|Withdrawal by Subject|1|||
170708615|NCT02086591|616941215|FG000|Overall Study|protocol terminated|3|||
170708616|NCT00274716|616941220|FG000|Phase A|Other non-reported reason|4|||
170708617|NCT00274716|616941221|FG001|Phase A|Other non-reported reason|2|||
170708618|NCT00274716|616941222|FG002|Phase A|Other non-reported reason|1|||
170708619|NCT00274716|616941223|FG003|Phase A|Other non-reported reason|2|||
170708620|NCT00274716|616941224|FG004|Phase A|Other non-reported reason|0|||
170708621|NCT00274716|616941225|FG005|Phase A|Other non-reported reason|1|||
170708622|NCT00274716|616941220|FG000|Phase A|Participant moved|0|||
170708623|NCT00274716|616941221|FG001|Phase A|Participant moved|0|||
170708624|NCT00274716|616941222|FG002|Phase A|Participant moved|1|||
170708625|NCT00274716|616941223|FG003|Phase A|Participant moved|0|||
170708626|NCT00274716|616941224|FG004|Phase A|Participant moved|0|||
170708627|NCT00274716|616941225|FG005|Phase A|Participant moved|1|||
170708628|NCT00274716|616941220|FG000|Phase A|Site Terminated|0|||
170708629|NCT00274716|616941221|FG001|Phase A|Site Terminated|0|||
170708630|NCT00274716|616941222|FG002|Phase A|Site Terminated|0|||
170708631|NCT00274716|616941223|FG003|Phase A|Site Terminated|1|||
170708632|NCT00274716|616941224|FG004|Phase A|Site Terminated|0|||
170708633|NCT00274716|616941225|FG005|Phase A|Site Terminated|0|||
170708634|NCT00274716|616941220|FG000|Phase A|Protocol Violation|1|||
170708635|NCT00274716|616941221|FG001|Phase A|Protocol Violation|0|||
170708636|NCT00274716|616941222|FG002|Phase A|Protocol Violation|0|||
170708637|NCT00274716|616941223|FG003|Phase A|Protocol Violation|1|||
170708638|NCT00274716|616941224|FG004|Phase A|Protocol Violation|0|||
170708639|NCT00274716|616941225|FG005|Phase A|Protocol Violation|0|||
170708640|NCT00274716|616941220|FG000|Phase A|Met criteria for discontinuation|1|||
170708641|NCT00274716|616941221|FG001|Phase A|Met criteria for discontinuation|1|||
170708642|NCT00274716|616941222|FG002|Phase A|Met criteria for discontinuation|0|||
170708643|NCT00274716|616941223|FG003|Phase A|Met criteria for discontinuation|0|||
170708644|NCT00274716|616941224|FG004|Phase A|Met criteria for discontinuation|0|||
170708645|NCT00274716|616941225|FG005|Phase A|Met criteria for discontinuation|0|||
170708646|NCT00274716|616941220|FG000|Phase A|Withdrawal by Subject|2|||
170708647|NCT00274716|616941221|FG001|Phase A|Withdrawal by Subject|2|||
170708648|NCT00274716|616941222|FG002|Phase A|Withdrawal by Subject|1|||
170708649|NCT00274716|616941223|FG003|Phase A|Withdrawal by Subject|3|||
170708650|NCT00274716|616941224|FG004|Phase A|Withdrawal by Subject|0|||
170708651|NCT00274716|616941225|FG005|Phase A|Withdrawal by Subject|1|||
170708652|NCT00274716|616941220|FG000|Phase A|Adverse Event|2|||
170708653|NCT00274716|616941221|FG001|Phase A|Adverse Event|3|||
170708654|NCT00274716|616941222|FG002|Phase A|Adverse Event|3|||
170708655|NCT00274716|616941223|FG003|Phase A|Adverse Event|0|||
170708656|NCT00274716|616941224|FG004|Phase A|Adverse Event|2|||
170708657|NCT00274716|616941225|FG005|Phase A|Adverse Event|0|||
170708658|NCT00274716|616941220|FG000|Phase A|Completed but did not enter Phase B|1|||
170708659|NCT00274716|616941221|FG001|Phase A|Completed but did not enter Phase B|2|||
170708660|NCT00274716|616941222|FG002|Phase A|Completed but did not enter Phase B|2|||
170708661|NCT00274716|616941223|FG003|Phase A|Completed but did not enter Phase B|2|||
170708662|NCT00274716|616941224|FG004|Phase A|Completed but did not enter Phase B|1|||
170708663|NCT00274716|616941225|FG005|Phase A|Completed but did not enter Phase B|1|||
170708664|NCT00274716|616941220|FG000|Phase B|Adverse Event|0|||
170708665|NCT00274716|616941221|FG001|Phase B|Adverse Event|0|||
170708666|NCT00274716|616941222|FG002|Phase B|Adverse Event|2|||
170708667|NCT00274716|616941223|FG003|Phase B|Adverse Event|0|||
170708668|NCT00274716|616941224|FG004|Phase B|Adverse Event|0|||
170708669|NCT00274716|616941225|FG005|Phase B|Adverse Event|1|||
170708670|NCT00274716|616941220|FG000|Phase B|Protocol Violation|0|||
170708671|NCT00274716|616941221|FG001|Phase B|Protocol Violation|2|||
170708672|NCT00274716|616941222|FG002|Phase B|Protocol Violation|0|||
170708673|NCT00274716|616941223|FG003|Phase B|Protocol Violation|0|||
170708674|NCT00274716|616941224|FG004|Phase B|Protocol Violation|0|||
170708675|NCT00274716|616941225|FG005|Phase B|Protocol Violation|0|||
170708676|NCT00274716|616941220|FG000|Phase B|Withdrawal by Subject|0|||
170708677|NCT00274716|616941221|FG001|Phase B|Withdrawal by Subject|1|||
170708678|NCT00274716|616941222|FG002|Phase B|Withdrawal by Subject|0|||
170708679|NCT00274716|616941223|FG003|Phase B|Withdrawal by Subject|0|||
170708680|NCT00274716|616941224|FG004|Phase B|Withdrawal by Subject|0|||
170708681|NCT00274716|616941225|FG005|Phase B|Withdrawal by Subject|0|||
170708682|NCT00274716|616941220|FG000|Phase B|Participant moved|1|||
170708683|NCT00274716|616941221|FG001|Phase B|Participant moved|0|||
170708684|NCT00274716|616941222|FG002|Phase B|Participant moved|0|||
170708685|NCT00274716|616941223|FG003|Phase B|Participant moved|0|||
170708686|NCT00274716|616941224|FG004|Phase B|Participant moved|0|||
170827334|NCT00634842|617378026|FG000|Overall Study|No need of study drug to treat diabetes|0|||
170827335|NCT00634842|617378027|FG001|Overall Study|No need of study drug to treat diabetes|1|||
170827336|NCT00634842|617378026|FG000|Overall Study|No wish to keep taking Avandia|0|||
170827337|NCT00634842|617378027|FG001|Overall Study|No wish to keep taking Avandia|1|||
170827338|NCT00634842|617378026|FG000|Overall Study|Subject off study drug for too long|0|||
170827339|NCT00634842|617378027|FG001|Overall Study|Subject off study drug for too long|1|||
170827340|NCT00195442|617378028|FG000|Overall Study|Less than expected therapeutic effect|38|||
170827341|NCT00195442|617378028|FG000|Overall Study|Lost to Follow-up|27|||
170827342|NCT00195442|617378028|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
170827343|NCT00195442|617378028|FG000|Overall Study|Intermittent product shortage|21|||
170827344|NCT00195442|617378028|FG000|Overall Study|Death|7|||
170827345|NCT00195442|617378028|FG000|Overall Study|No reason specified|4|||
170827346|NCT00195442|617378028|FG000|Overall Study|Poor cooperation|2|||
170827347|NCT00195442|617378028|FG000|Overall Study|Other|14|||
170708687|NCT00274716|616941225|FG005|Phase B|Participant moved|0|||
170708688|NCT00274716|616941220|FG000|Phase B|Other non-reported reason|0|||
170708689|NCT00274716|616941221|FG001|Phase B|Other non-reported reason|0|||
170708690|NCT00274716|616941222|FG002|Phase B|Other non-reported reason|1|||
170708691|NCT00274716|616941223|FG003|Phase B|Other non-reported reason|1|||
170708692|NCT00274716|616941224|FG004|Phase B|Other non-reported reason|0|||
170708693|NCT00274716|616941225|FG005|Phase B|Other non-reported reason|0|||
170708694|NCT00274716|616941220|FG000|Phase B|Lost to Follow-up|0|||
170708695|NCT00274716|616941221|FG001|Phase B|Lost to Follow-up|1|||
170708696|NCT00274716|616941222|FG002|Phase B|Lost to Follow-up|0|||
170708697|NCT00274716|616941223|FG003|Phase B|Lost to Follow-up|0|||
170708698|NCT00274716|616941224|FG004|Phase B|Lost to Follow-up|0|||
170708699|NCT00274716|616941225|FG005|Phase B|Lost to Follow-up|0|||
170708700|NCT04193202|616941226|FG000|Overall Study|Adverse Event|2|||
170708701|NCT04193202|616941227|FG001|Overall Study|Adverse Event|1|||
170708702|NCT04193202|616941226|FG000|Overall Study|Death|0|||
170708703|NCT04193202|616941227|FG001|Overall Study|Death|1|||
170708704|NCT04193202|616941226|FG000|Overall Study|Physician Decision|1|||
170708705|NCT04193202|616941227|FG001|Overall Study|Physician Decision|1|||
170708706|NCT04193202|616941226|FG000|Overall Study|Protocol Violation|2|||
170708707|NCT04193202|616941227|FG001|Overall Study|Protocol Violation|2|||
170708708|NCT04193202|616941226|FG000|Overall Study|Withdrawal by Subject|11|||
170708709|NCT04193202|616941227|FG001|Overall Study|Withdrawal by Subject|5|||
170708710|NCT02148003|616941231|FG000|Overall Study|Failed inclusion criteria|1|||
170708711|NCT02148003|616941232|FG001|Overall Study|Failed inclusion criteria|0|||
170708712|NCT02148003|616941231|FG000|Overall Study|Met exclusion criteria|0|||
170708713|NCT02148003|616941232|FG001|Overall Study|Met exclusion criteria|1|||
170708714|NCT02148003|616941231|FG000|Overall Study|Withdrawal by Subject|0|||
170708715|NCT02148003|616941232|FG001|Overall Study|Withdrawal by Subject|1|||
170708716|NCT02489981|616941233|FG000|Overall Study|Adverse Event|21|||
170708717|NCT02489981|616941233|FG000|Overall Study|Insufficient effectiveness|16|||
170708718|NCT02489981|616941233|FG000|Overall Study|Improved|31|||
170708719|NCT02489981|616941233|FG000|Overall Study|Lost to Follow-up|31|||
170827348|NCT00847132|617378029|FG000|Overall Study|Death|1|||
170827349|NCT00847132|617378030|FG001|Overall Study|Death|1|||
170827350|NCT02509312|617378031|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
170708720|NCT02489981|616941233|FG000|Overall Study|Other than listed|28|||
170708721|NCT01565993|616941234|FG000|Overall Study|Physician Decision|0|||
170708722|NCT01565993|616941235|FG001|Overall Study|Physician Decision|3|||
170708723|NCT03348904|616941236|FG000|Overall Study|Administrative reason by the sponsor|0|||
170708724|NCT03348904|616941237|FG001|Overall Study|Administrative reason by the sponsor|1|||
170708725|NCT03348904|616941238|FG002|Overall Study|Administrative reason by the sponsor|0|||
170708726|NCT03160703|616941243|FG000|Overall Study|Withdrawal by Subject|0|||
170827351|NCT02509312|617378032|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
170827352|NCT02509312|617378031|FG000|Overall Study|Obstetrician refusal|0|||
170827353|NCT02509312|617378032|FG001|Overall Study|Obstetrician refusal|1|||
170827354|NCT02509312|617378031|FG000|Overall Study|Patient elected for TOLAC|1|||
170708727|NCT03160703|616941244|FG001|Overall Study|Withdrawal by Subject|0|||
170708728|NCT03160703|616941245|FG002|Overall Study|Withdrawal by Subject|0|||
170708729|NCT03160703|616941246|FG003|Overall Study|Withdrawal by Subject|1|||
170827355|NCT02509312|617378032|FG001|Overall Study|Patient elected for TOLAC|0|||
170827356|NCT02509312|617378031|FG000|Overall Study|Cesarean deemed stat|1|||
170827357|NCT02509312|617378032|FG001|Overall Study|Cesarean deemed stat|0|||
170827358|NCT02509312|617378031|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
170827359|NCT02509312|617378032|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
170827360|NCT04544865|617378033|FG000|Overall Study|Death|0|||
170827361|NCT04544865|617378034|FG001|Overall Study|Death|2|||
170827362|NCT04544865|617378033|FG000|Overall Study|Lost to Follow-up|11|||
170827363|NCT04544865|617378034|FG001|Overall Study|Lost to Follow-up|7|||
170827364|NCT04544865|617378033|FG000|Overall Study|Withdrawal by Subject|0|||
170827365|NCT04544865|617378034|FG001|Overall Study|Withdrawal by Subject|1|||
170827366|NCT04544865|617378033|FG000|Overall Study|Other|0|||
170827367|NCT04544865|617378034|FG001|Overall Study|Other|1|||
170827368|NCT01513330|617378035|FG000|SenSura Mio First,|Adverse Event|2|||
170708730|NCT01513291|616941247|FG000|Treatment Period|Adverse Event|8|||
170708731|NCT01513291|616941248|FG001|Treatment Period|Adverse Event|4|||
170708732|NCT01513291|616941249|FG002|Treatment Period|Adverse Event|0|||
170708733|NCT01513291|616941250|FG003|Treatment Period|Adverse Event|0|||
170708734|NCT01513291|616941251|FG004|Treatment Period|Adverse Event|0|||
170708735|NCT01513291|616941247|FG000|Treatment Period|Lack of Efficacy|3|||
170708736|NCT01513291|616941248|FG001|Treatment Period|Lack of Efficacy|0|||
170708737|NCT01513291|616941249|FG002|Treatment Period|Lack of Efficacy|0|||
170708738|NCT01513291|616941250|FG003|Treatment Period|Lack of Efficacy|0|||
170708739|NCT01513291|616941251|FG004|Treatment Period|Lack of Efficacy|0|||
170827369|NCT01513330|617378036|FG001|SenSura Mio First,|Adverse Event|0|||
170708740|NCT01513291|616941247|FG000|Treatment Period|Lost to Follow-up|2|||
170708741|NCT01513291|616941248|FG001|Treatment Period|Lost to Follow-up|3|||
170708742|NCT01513291|616941249|FG002|Treatment Period|Lost to Follow-up|0|||
170708743|NCT01513291|616941250|FG003|Treatment Period|Lost to Follow-up|0|||
170708744|NCT01513291|616941251|FG004|Treatment Period|Lost to Follow-up|0|||
170708745|NCT01513291|616941247|FG000|Treatment Period|Physician Decision|1|||
170708746|NCT01513291|616941248|FG001|Treatment Period|Physician Decision|0|||
170708747|NCT01513291|616941249|FG002|Treatment Period|Physician Decision|0|||
170708748|NCT01513291|616941250|FG003|Treatment Period|Physician Decision|0|||
170708749|NCT01513291|616941251|FG004|Treatment Period|Physician Decision|0|||
170708750|NCT01513291|616941247|FG000|Treatment Period|Protocol Violation|1|||
170708751|NCT01513291|616941248|FG001|Treatment Period|Protocol Violation|2|||
170708752|NCT01513291|616941249|FG002|Treatment Period|Protocol Violation|0|||
170708753|NCT01513291|616941250|FG003|Treatment Period|Protocol Violation|0|||
170708754|NCT01513291|616941251|FG004|Treatment Period|Protocol Violation|0|||
170708755|NCT01513291|616941247|FG000|Treatment Period|Withdrawal by Subject|8|||
170708756|NCT01513291|616941248|FG001|Treatment Period|Withdrawal by Subject|5|||
170708757|NCT01513291|616941249|FG002|Treatment Period|Withdrawal by Subject|0|||
170708758|NCT01513291|616941250|FG003|Treatment Period|Withdrawal by Subject|0|||
170708759|NCT01513291|616941251|FG004|Treatment Period|Withdrawal by Subject|0|||
170708760|NCT01513291|616941247|FG000|Treatment Period|Randomized not treated|0|||
170708761|NCT01513291|616941248|FG001|Treatment Period|Randomized not treated|2|||
170708762|NCT01513291|616941249|FG002|Treatment Period|Randomized not treated|0|||
170708763|NCT01513291|616941250|FG003|Treatment Period|Randomized not treated|0|||
170708764|NCT01513291|616941251|FG004|Treatment Period|Randomized not treated|0|||
170827370|NCT01513330|617378035|FG000|SenSura Mio First,|Lack of Efficacy|0|||
170827371|NCT01513330|617378036|FG001|SenSura Mio First,|Lack of Efficacy|1|||
170827372|NCT01513330|617378035|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
170708765|NCT01513291|616941247|FG000|Run-out Period|Lost to Follow-up|0|||
170708766|NCT01513291|616941248|FG001|Run-out Period|Lost to Follow-up|0|||
170708767|NCT01513291|616941249|FG002|Run-out Period|Lost to Follow-up|0|||
170708768|NCT01513291|616941250|FG003|Run-out Period|Lost to Follow-up|1|||
170708769|NCT01513291|616941251|FG004|Run-out Period|Lost to Follow-up|0|||
170708770|NCT01513291|616941247|FG000|Run-out Period|Withdrawal by Subject|0|||
170708771|NCT01513291|616941248|FG001|Run-out Period|Withdrawal by Subject|0|||
170708772|NCT01513291|616941249|FG002|Run-out Period|Withdrawal by Subject|0|||
170708773|NCT01513291|616941250|FG003|Run-out Period|Withdrawal by Subject|1|||
170708774|NCT01513291|616941251|FG004|Run-out Period|Withdrawal by Subject|0|||
170708775|NCT02992899|616941252|FG000|Overall Study|Withdrawal by Subject|1|||
170708776|NCT02992899|616941253|FG001|Overall Study|Withdrawal by Subject|0|||
170708777|NCT02992899|616941252|FG000|Overall Study|Lost to Follow-up|1|||
170708778|NCT02992899|616941253|FG001|Overall Study|Lost to Follow-up|3|||
170708779|NCT02738775|616941254|FG000|Overall Study|Withdrawal by Subject|0|||
170708780|NCT02738775|616941255|FG001|Overall Study|Withdrawal by Subject|1|||
170708781|NCT02738775|616941256|FG002|Overall Study|Withdrawal by Subject|0|||
170708782|NCT02738775|616941257|FG003|Overall Study|Withdrawal by Subject|0|||
170708783|NCT02738775|616941258|FG004|Overall Study|Withdrawal by Subject|0|||
170708784|NCT02738775|616941259|FG005|Overall Study|Withdrawal by Subject|0|||
170708785|NCT02738775|616941254|FG000|Overall Study|Adverse Event|0|||
170708786|NCT02738775|616941255|FG001|Overall Study|Adverse Event|0|||
170708787|NCT02738775|616941256|FG002|Overall Study|Adverse Event|0|||
170708788|NCT02738775|616941257|FG003|Overall Study|Adverse Event|1|||
170708789|NCT02738775|616941258|FG004|Overall Study|Adverse Event|0|||
170708790|NCT02738775|616941259|FG005|Overall Study|Adverse Event|0|||
170708791|NCT02738775|616941254|FG000|Overall Study|Pregnancy|0|||
170708792|NCT02738775|616941255|FG001|Overall Study|Pregnancy|1|||
170708793|NCT02738775|616941256|FG002|Overall Study|Pregnancy|0|||
170708794|NCT02738775|616941257|FG003|Overall Study|Pregnancy|0|||
170708795|NCT02738775|616941258|FG004|Overall Study|Pregnancy|0|||
170708796|NCT02738775|616941259|FG005|Overall Study|Pregnancy|0|||
170708797|NCT02738775|616941254|FG000|Overall Study|Missing|0|||
170708798|NCT02738775|616941255|FG001|Overall Study|Missing|0|||
170708799|NCT02738775|616941256|FG002|Overall Study|Missing|0|||
170708800|NCT02738775|616941257|FG003|Overall Study|Missing|0|||
170708801|NCT02738775|616941258|FG004|Overall Study|Missing|0|||
170708802|NCT02738775|616941259|FG005|Overall Study|Missing|1|||
170708803|NCT02370888|616941260|FG000|Overall Study|disease progression|2|||
170708804|NCT02370888|616941260|FG000|Overall Study|did not meet chimerism criteria|6|||
170708805|NCT01034397|616941261|FG000|Overall Study|Lack of compliance|0|||
170708806|NCT01034397|616941262|FG001|Overall Study|Lack of compliance|1|||
170708807|NCT01034397|616941261|FG000|Overall Study|Lack of Efficacy|3|||
170708808|NCT01034397|616941262|FG001|Overall Study|Lack of Efficacy|0|||
170708809|NCT01034397|616941261|FG000|Overall Study|Adverse Event|4|||
170708810|NCT01034397|616941262|FG001|Overall Study|Adverse Event|0|||
170708811|NCT01034397|616941261|FG000|Overall Study|Other|0|||
170708812|NCT01034397|616941262|FG001|Overall Study|Other|1|||
170708813|NCT04574362|616941263|FG000|Overall Study|Other|0|||
170708814|NCT04574362|616941264|FG001|Overall Study|Other|5|||
170708815|NCT04574362|616941263|FG000|Overall Study|COVID-19|0|||
170708816|NCT04574362|616941264|FG001|Overall Study|COVID-19|1|||
170708817|NCT04574362|616941263|FG000|Overall Study|Adverse Event|1|||
170708818|NCT04574362|616941264|FG001|Overall Study|Adverse Event|1|||
170708819|NCT04574362|616941263|FG000|Overall Study|Withdrawal by Subject|2|||
170708820|NCT04574362|616941264|FG001|Overall Study|Withdrawal by Subject|4|||
170708821|NCT04574362|616941263|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
170708822|NCT04574362|616941264|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
170708823|NCT04574362|616941263|FG000|Overall Study|Participant refused to come to the hospital|1|||
170708824|NCT04574362|616941264|FG001|Overall Study|Participant refused to come to the hospital|0|||
170708825|NCT04574362|616941263|FG000|Overall Study|Participant refused the visit|1|||
170708826|NCT04574362|616941264|FG001|Overall Study|Participant refused the visit|0|||
170708827|NCT04574362|616941263|FG000|Overall Study|Participant quit early because of business trip|1|||
170708828|NCT04574362|616941264|FG001|Overall Study|Participant quit early because of business trip|0|||
170827373|NCT01513330|617378036|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
170708829|NCT01785524|616941265|FG000|Overall Study|Withdrawal by Subject|2|||
170708830|NCT01785524|616941266|FG001|Overall Study|Withdrawal by Subject|2|||
170708831|NCT01060384|616941267|FG000|Overall Study|Withdrawal by Subject|0|||
170708832|NCT01060384|616941268|FG001|Overall Study|Withdrawal by Subject|1|||
170708833|NCT01060384|616941269|FG002|Overall Study|Withdrawal by Subject|0|||
170708834|NCT01060384|616941270|FG003|Overall Study|Withdrawal by Subject|0|||
170708835|NCT01060384|616941271|FG004|Overall Study|Withdrawal by Subject|0|||
170708836|NCT01060384|616941267|FG000|Overall Study|Death|0|||
170708837|NCT01060384|616941268|FG001|Overall Study|Death|0|||
170708838|NCT01060384|616941269|FG002|Overall Study|Death|0|||
170708839|NCT01060384|616941270|FG003|Overall Study|Death|0|||
170708840|NCT01060384|616941271|FG004|Overall Study|Death|1|||
170708841|NCT01060384|616941267|FG000|Overall Study|Intercurrent illness|0|||
170708842|NCT01060384|616941268|FG001|Overall Study|Intercurrent illness|0|||
170708843|NCT01060384|616941269|FG002|Overall Study|Intercurrent illness|0|||
170708844|NCT01060384|616941270|FG003|Overall Study|Intercurrent illness|0|||
170708845|NCT01060384|616941271|FG004|Overall Study|Intercurrent illness|1|||
170708846|NCT00211081|616941273|FG000|Overall Study|Withdrawal by Subject|2|||
170708847|NCT01600040|616941274|FG000|Overall Study|Withdrawal by Subject|1|||
170708848|NCT00047463|616941275|FG000|Overall Study|Withdrawal by Subject|0|||
170708849|NCT00047463|616941276|FG001|Overall Study|Withdrawal by Subject|3|||
170708850|NCT03217136|616941277|FG000|Overall Study|Lost to Follow-up|2|||
170708851|NCT03217136|616941278|FG001|Overall Study|Lost to Follow-up|1|||
170708852|NCT03217136|616941277|FG000|Overall Study|Site Randomized Participant in Error|0|||
170708853|NCT03217136|616941278|FG001|Overall Study|Site Randomized Participant in Error|1|||
170708854|NCT03217136|616941277|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
170708855|NCT03217136|616941278|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
170708856|NCT03217136|616941277|FG000|Overall Study|Dispensing Error|1|||
170708857|NCT03217136|616941278|FG001|Overall Study|Dispensing Error|0|||
170708858|NCT03217136|616941277|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170708859|NCT03217136|616941278|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170708860|NCT03755765|616941279|FG000|Overall Study|Withdrawal by Subject|2|||
170708861|NCT03755765|616941280|FG001|Overall Study|Withdrawal by Subject|4|||
170708862|NCT03755765|616941281|FG002|Overall Study|Withdrawal by Subject|4|||
170708863|NCT00111228|616941282|FG000|Overall Study|Withdrawal by Subject|5|||
170708864|NCT00111228|616941283|FG001|Overall Study|Withdrawal by Subject|1|||
170827374|NCT01513330|617378035|FG000|SenSura Mio First,|Other|1|||
170827375|NCT01513330|617378036|FG001|SenSura Mio First,|Other|0|||
170827376|NCT01513330|617378035|FG000|Standard Care First,|Lack of Efficacy|2|||
170827377|NCT01513330|617378036|FG001|Standard Care First,|Lack of Efficacy|2|||
170827378|NCT01513330|617378035|FG000|Standard Care First,|Withdrawal by Subject|1|||
170827379|NCT01513330|617378036|FG001|Standard Care First,|Withdrawal by Subject|2|||
170827380|NCT01513330|617378035|FG000|Standard Care First,|Other|1|||
170827381|NCT01513330|617378036|FG001|Standard Care First,|Other|0|||
170827382|NCT03357471|617378037|FG000|Overall Study|Adverse Event|1|||
170827383|NCT03357471|617378038|FG001|Overall Study|Adverse Event|0|||
170827384|NCT03357471|617378037|FG000|Overall Study|Lost to Follow-up|1|||
170827385|NCT03357471|617378038|FG001|Overall Study|Lost to Follow-up|0|||
170827386|NCT01751165|617378040|FG000|Overall Study|Adverse event, serious fatal|1|||
170827387|NCT01751165|617378041|FG001|Overall Study|Adverse event, serious fatal|0|||
170827388|NCT01751165|617378042|FG002|Overall Study|Adverse event, serious fatal|1|||
170827389|NCT01751165|617378040|FG000|Overall Study|Withdrawal by Subject|0|||
170827390|NCT01751165|617378041|FG001|Overall Study|Withdrawal by Subject|0|||
170827391|NCT01751165|617378042|FG002|Overall Study|Withdrawal by Subject|1|||
170827392|NCT01751165|617378040|FG000|Overall Study|Serious adverse event|0|||
170827393|NCT01751165|617378041|FG001|Overall Study|Serious adverse event|2|||
170827394|NCT01751165|617378042|FG002|Overall Study|Serious adverse event|0|||
170827395|NCT01751165|617378040|FG000|Overall Study|Lost to Follow-up|1|||
170827396|NCT01751165|617378041|FG001|Overall Study|Lost to Follow-up|1|||
170827397|NCT01751165|617378042|FG002|Overall Study|Lost to Follow-up|1|||
170827398|NCT00988533|617378043|FG000|Overall Study|Lost to Follow-up|3|||
170827399|NCT01036165|617378044|FG000|Overall Study|Adverse Event|6|||
170827400|NCT01036165|617378044|FG000|Overall Study|Lost to Follow-up|2|||
170827401|NCT01036165|617378044|FG000|Overall Study|Withdrawal by Subject|3|||
170827402|NCT01036165|617378044|FG000|Overall Study|Device Related Issues|3|||
170827403|NCT01036165|617378044|FG000|Overall Study|Problems finding proper area to inject|1|||
170827404|NCT01475461|617378049|FG000|Run-in Period|Not meet eligibility criteria|16|||
170827405|NCT01475461|617378050|FG001|Run-in Period|Not meet eligibility criteria|0|||
170827406|NCT01475461|617378051|FG002|Run-in Period|Not meet eligibility criteria|0|||
170827407|NCT01475461|617378052|FG003|Run-in Period|Not meet eligibility criteria|0|||
170827408|NCT01475461|617378053|FG004|Run-in Period|Not meet eligibility criteria|0|||
170827409|NCT01475461|617378054|FG005|Run-in Period|Not meet eligibility criteria|0|||
170827410|NCT01475461|617378055|FG006|Run-in Period|Not meet eligibility criteria|0|||
170827411|NCT01475461|617378049|FG000|Run-in Period|Lost to Follow-up|7|||
170827412|NCT01475461|617378050|FG001|Run-in Period|Lost to Follow-up|0|||
170827413|NCT01475461|617378051|FG002|Run-in Period|Lost to Follow-up|0|||
170708865|NCT00111228|616941284|FG002|Overall Study|Withdrawal by Subject|0|||
170827414|NCT01475461|617378052|FG003|Run-in Period|Lost to Follow-up|0|||
170827415|NCT01475461|617378053|FG004|Run-in Period|Lost to Follow-up|0|||
170827416|NCT01475461|617378054|FG005|Run-in Period|Lost to Follow-up|0|||
170827417|NCT01475461|617378055|FG006|Run-in Period|Lost to Follow-up|0|||
170827418|NCT01475461|617378049|FG000|Run-in Period|Withdrawal by Subject|11|||
170708866|NCT02579616|616941285|FG000|Overall Study|Participants did not receive treatment|3|||
170708867|NCT03969212|616941293|FG000|Overall Study|Adverse Event|1|||
170708868|NCT03969212|616941294|FG001|Overall Study|Adverse Event|0|||
170708869|NCT03969212|616941295|FG002|Overall Study|Adverse Event|0|||
170708870|NCT03969212|616941296|FG003|Overall Study|Adverse Event|0|||
170708871|NCT03969212|616941293|FG000|Overall Study|Lost to Follow-up|2|||
170708872|NCT03969212|616941294|FG001|Overall Study|Lost to Follow-up|2|||
170708873|NCT03969212|616941295|FG002|Overall Study|Lost to Follow-up|2|||
170708874|NCT03969212|616941296|FG003|Overall Study|Lost to Follow-up|2|||
170708875|NCT03969212|616941293|FG000|Overall Study|Protocol Violation|0|||
170708876|NCT03969212|616941294|FG001|Overall Study|Protocol Violation|0|||
170708877|NCT03969212|616941295|FG002|Overall Study|Protocol Violation|0|||
170708878|NCT03969212|616941296|FG003|Overall Study|Protocol Violation|1|||
170708879|NCT03969212|616941293|FG000|Overall Study|Withdrawal by Subject|7|||
170708880|NCT03969212|616941294|FG001|Overall Study|Withdrawal by Subject|13|||
170708881|NCT03969212|616941295|FG002|Overall Study|Withdrawal by Subject|5|||
170708882|NCT03969212|616941296|FG003|Overall Study|Withdrawal by Subject|11|||
170708883|NCT03969212|616941293|FG000|Overall Study|Physician Decision|0|||
170708884|NCT03969212|616941294|FG001|Overall Study|Physician Decision|0|||
170708885|NCT03969212|616941295|FG002|Overall Study|Physician Decision|1|||
170708886|NCT03969212|616941296|FG003|Overall Study|Physician Decision|0|||
170708887|NCT03969212|616941293|FG000|Overall Study|Reason not Specified|22|||
170708888|NCT03969212|616941294|FG001|Overall Study|Reason not Specified|23|||
170708889|NCT03969212|616941295|FG002|Overall Study|Reason not Specified|28|||
170708890|NCT03969212|616941296|FG003|Overall Study|Reason not Specified|26|||
170708891|NCT01109316|616941297|FG000|Study Period 1|Adverse Event|0|||
170708892|NCT01109316|616941298|FG001|Study Period 1|Adverse Event|0|||
170708893|NCT01109316|616941299|FG002|Study Period 1|Adverse Event|1|||
170708894|NCT01109316|616941300|FG003|Study Period 1|Adverse Event|0|||
170708895|NCT01109316|616941301|FG004|Study Period 1|Adverse Event|0|||
170708896|NCT01109316|616941302|FG005|Study Period 1|Adverse Event|0|||
170708897|NCT01109316|616941297|FG000|Study Period 1|Lost to Follow-up|0|||
170708898|NCT01109316|616941298|FG001|Study Period 1|Lost to Follow-up|0|||
170708899|NCT01109316|616941299|FG002|Study Period 1|Lost to Follow-up|1|||
170708900|NCT01109316|616941300|FG003|Study Period 1|Lost to Follow-up|1|||
170708901|NCT01109316|616941301|FG004|Study Period 1|Lost to Follow-up|0|||
170708902|NCT01109316|616941302|FG005|Study Period 1|Lost to Follow-up|0|||
170708903|NCT01109316|616941297|FG000|Study Period 1|Withdrawal by Subject|0|||
170708904|NCT01109316|616941298|FG001|Study Period 1|Withdrawal by Subject|0|||
170708905|NCT01109316|616941299|FG002|Study Period 1|Withdrawal by Subject|1|||
170708906|NCT01109316|616941300|FG003|Study Period 1|Withdrawal by Subject|0|||
170708907|NCT01109316|616941301|FG004|Study Period 1|Withdrawal by Subject|2|||
170708908|NCT01109316|616941302|FG005|Study Period 1|Withdrawal by Subject|0|||
170708909|NCT01109316|616941297|FG000|Study Period 1|Sponsor Decision|0|||
170708910|NCT01109316|616941298|FG001|Study Period 1|Sponsor Decision|0|||
170708911|NCT01109316|616941299|FG002|Study Period 1|Sponsor Decision|0|||
170708912|NCT01109316|616941300|FG003|Study Period 1|Sponsor Decision|0|||
170708913|NCT01109316|616941301|FG004|Study Period 1|Sponsor Decision|0|||
170708914|NCT01109316|616941302|FG005|Study Period 1|Sponsor Decision|2|||
170708915|NCT01109316|616941297|FG000|Study Period 2|Entry Criteria Not Met|0|||
170708916|NCT01109316|616941298|FG001|Study Period 2|Entry Criteria Not Met|1|||
170708917|NCT01109316|616941299|FG002|Study Period 2|Entry Criteria Not Met|0|||
170708918|NCT01109316|616941300|FG003|Study Period 2|Entry Criteria Not Met|0|||
170708919|NCT01109316|616941301|FG004|Study Period 2|Entry Criteria Not Met|0|||
170708920|NCT01109316|616941302|FG005|Study Period 2|Entry Criteria Not Met|0|||
170708921|NCT01109316|616941297|FG000|Study Period 2|Physician Decision|0|||
170708922|NCT01109316|616941298|FG001|Study Period 2|Physician Decision|0|||
170708923|NCT01109316|616941299|FG002|Study Period 2|Physician Decision|0|||
170708924|NCT01109316|616941300|FG003|Study Period 2|Physician Decision|1|||
170708925|NCT01109316|616941301|FG004|Study Period 2|Physician Decision|0|||
170708926|NCT01109316|616941302|FG005|Study Period 2|Physician Decision|0|||
170708927|NCT01109316|616941297|FG000|Study Period 2|Protocol Violation|1|||
170708928|NCT01109316|616941298|FG001|Study Period 2|Protocol Violation|0|||
170708929|NCT01109316|616941299|FG002|Study Period 2|Protocol Violation|0|||
170708930|NCT01109316|616941300|FG003|Study Period 2|Protocol Violation|0|||
170708931|NCT01109316|616941301|FG004|Study Period 2|Protocol Violation|0|||
170708932|NCT01109316|616941302|FG005|Study Period 2|Protocol Violation|0|||
170708933|NCT01109316|616941297|FG000|Study Period 2|Withdrawal by Subject|0|||
170708934|NCT01109316|616941298|FG001|Study Period 2|Withdrawal by Subject|0|||
170708935|NCT01109316|616941299|FG002|Study Period 2|Withdrawal by Subject|1|||
170708936|NCT01109316|616941300|FG003|Study Period 2|Withdrawal by Subject|0|||
170708937|NCT01109316|616941301|FG004|Study Period 2|Withdrawal by Subject|0|||
170708938|NCT01109316|616941302|FG005|Study Period 2|Withdrawal by Subject|1|||
170708939|NCT01109316|616941297|FG000|Study Period 3|Lost to Follow-up|0|||
170708940|NCT01109316|616941298|FG001|Study Period 3|Lost to Follow-up|0|||
170708941|NCT01109316|616941299|FG002|Study Period 3|Lost to Follow-up|0|||
170708942|NCT01109316|616941300|FG003|Study Period 3|Lost to Follow-up|0|||
170708943|NCT01109316|616941301|FG004|Study Period 3|Lost to Follow-up|1|||
170708944|NCT01109316|616941302|FG005|Study Period 3|Lost to Follow-up|0|||
170708945|NCT01109316|616941297|FG000|Study Period 3|Withdrawal by Subject|1|||
170708946|NCT01109316|616941298|FG001|Study Period 3|Withdrawal by Subject|0|||
170708947|NCT01109316|616941299|FG002|Study Period 3|Withdrawal by Subject|0|||
170708948|NCT01109316|616941300|FG003|Study Period 3|Withdrawal by Subject|0|||
170708949|NCT01109316|616941301|FG004|Study Period 3|Withdrawal by Subject|1|||
170708950|NCT01109316|616941302|FG005|Study Period 3|Withdrawal by Subject|0|||
170708951|NCT05267054|616941307|FG000|Overall Study|Death|13|||
170708952|NCT05267054|616941308|FG001|Overall Study|Death|14|||
170708953|NCT05267054|616941307|FG000|Overall Study|Study Ended by Sponsor|9|||
170708954|NCT05267054|616941308|FG001|Overall Study|Study Ended by Sponsor|13|||
170708955|NCT05267054|616941307|FG000|Overall Study|Lost to Follow-up|1|||
170708956|NCT05267054|616941308|FG001|Overall Study|Lost to Follow-up|1|||
170708957|NCT05267054|616941307|FG000|Overall Study|Withdrawal by Subject|1|||
170708958|NCT05267054|616941308|FG001|Overall Study|Withdrawal by Subject|1|||
170708959|NCT01552226|616941311|FG000|Overall Study|Withdrawal by Subject|4|||
170708960|NCT01552226|616941312|FG001|Overall Study|Withdrawal by Subject|4|||
170708961|NCT03511560|616941315|FG000|Overall Study|Death|0|||
170708962|NCT03511560|616941316|FG001|Overall Study|Death|1|||
170708963|NCT03511560|616941315|FG000|Overall Study|Adverse Event|0|||
170708964|NCT03511560|616941316|FG001|Overall Study|Adverse Event|2|||
170708965|NCT03511560|616941315|FG000|Overall Study|Transplant cancelled|0|||
170708966|NCT03511560|616941316|FG001|Overall Study|Transplant cancelled|1|||
170708967|NCT03511560|616941315|FG000|Overall Study|Patient switched to another drug|1|||
170708968|NCT03511560|616941316|FG001|Overall Study|Patient switched to another drug|0|||
170708969|NCT00382733|616941322|FG000|Overall Study|Withdrawal by Subject|0|||
170708970|NCT00382733|616941323|FG001|Overall Study|Withdrawal by Subject|1|||
170708971|NCT00382733|616941324|FG002|Overall Study|Withdrawal by Subject|0|||
170708972|NCT00382733|616941325|FG003|Overall Study|Withdrawal by Subject|0|||
170708973|NCT00382733|616941326|FG004|Overall Study|Withdrawal by Subject|0|||
170708974|NCT03049813|616941327|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
170708975|NCT03049813|616941328|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
170708976|NCT03049813|616941329|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
170708977|NCT03049813|616941330|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
170708978|NCT03049813|616941327|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
170708979|NCT03049813|616941328|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
170708980|NCT03049813|616941329|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
170708981|NCT03049813|616941330|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
170708982|NCT03049813|616941327|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
170708983|NCT03049813|616941328|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
170708984|NCT03049813|616941329|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
170708985|NCT03049813|616941330|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
170708986|NCT03049813|616941327|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
170708987|NCT03049813|616941328|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
170708988|NCT03049813|616941329|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
170708989|NCT03049813|616941330|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
170708990|NCT00179413|616941331|FG000|Overall Study|Adverse Event|38|||
170708991|NCT00179413|616941332|FG001|Overall Study|Adverse Event|20|||
170708992|NCT00179413|616941331|FG000|Overall Study|Withdrawal by Subject|87|||
170708993|NCT00179413|616941332|FG001|Overall Study|Withdrawal by Subject|95|||
170708994|NCT01813019|616941335|FG000|Overall Study|Adverse Event|0|||
170708995|NCT01813019|616941336|FG001|Overall Study|Adverse Event|3|||
170708996|NCT01813019|616941335|FG000|Overall Study|Withdrawal by Subject|3|||
170708997|NCT01813019|616941336|FG001|Overall Study|Withdrawal by Subject|2|||
170708998|NCT01813019|616941335|FG000|Overall Study|administrative problems|2|||
170708999|NCT01813019|616941336|FG001|Overall Study|administrative problems|0|||
170709000|NCT01813019|616941335|FG000|Overall Study|Protocol Deviation|2|||
170709001|NCT01813019|616941336|FG001|Overall Study|Protocol Deviation|1|||
170709002|NCT01559311|616941337|FG000|Overall Study|Protocol Violation|0|||
170709003|NCT01559311|616941338|FG001|Overall Study|Protocol Violation|0|||
170827419|NCT01475461|617378050|FG001|Run-in Period|Withdrawal by Subject|0|||
170827420|NCT01475461|617378051|FG002|Run-in Period|Withdrawal by Subject|0|||
170827421|NCT01475461|617378052|FG003|Run-in Period|Withdrawal by Subject|0|||
170827422|NCT01475461|617378053|FG004|Run-in Period|Withdrawal by Subject|0|||
170827423|NCT01475461|617378054|FG005|Run-in Period|Withdrawal by Subject|0|||
170827424|NCT01475461|617378055|FG006|Run-in Period|Withdrawal by Subject|0|||
170709004|NCT01559311|616941339|FG002|Overall Study|Protocol Violation|2|||
170709005|NCT01559311|616941337|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
170709006|NCT01559311|616941338|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
170709007|NCT01559311|616941339|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
170709008|NCT01559311|616941337|FG000|Overall Study|Withdrawal by Subject|2|||
170709009|NCT01559311|616941338|FG001|Overall Study|Withdrawal by Subject|1|||
170827425|NCT01475461|617378049|FG000|Run-in Period|Other|3|||
170827426|NCT01475461|617378050|FG001|Run-in Period|Other|0|||
170709010|NCT01559311|616941339|FG002|Overall Study|Withdrawal by Subject|0|||
170709011|NCT01559311|616941337|FG000|Overall Study|Death|0|||
170709012|NCT01559311|616941338|FG001|Overall Study|Death|2|||
170709013|NCT01559311|616941339|FG002|Overall Study|Death|3|||
170709014|NCT01559311|616941337|FG000|Overall Study|Lost to Follow-up|0|||
170709015|NCT01559311|616941338|FG001|Overall Study|Lost to Follow-up|3|||
170709016|NCT01559311|616941339|FG002|Overall Study|Lost to Follow-up|2|||
170709017|NCT01559311|616941337|FG000|Overall Study|Adverse Event|0|||
170709018|NCT01559311|616941338|FG001|Overall Study|Adverse Event|0|||
170709019|NCT01559311|616941339|FG002|Overall Study|Adverse Event|1|||
170709020|NCT01858194|616941341|FG000|Overall Study|Total Artificial Heart Implant|0|||
170709021|NCT01858194|616941342|FG001|Overall Study|Total Artificial Heart Implant|1|||
170709022|NCT01858194|616941341|FG000|Overall Study|Lost to Follow-up|0|||
170709023|NCT01858194|616941342|FG001|Overall Study|Lost to Follow-up|1|||
170709024|NCT02563028|616941343|FG000|Overall Study|Lack of equipment|1|||
170709025|NCT02563028|616941343|FG000|Overall Study|Unable to elicit VEP post induction|1|||
170709026|NCT04545515|616941344|FG000|Overall Study|Adverse Event|1|||
170709027|NCT04545515|616941344|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
170709028|NCT04545515|616941344|FG000|Overall Study|Commercial drug is available for participant|7|||
170709029|NCT00853658|616941347|FG000|Overall Study|Death|713|||
170709030|NCT00853658|616941348|FG001|Overall Study|Death|768|||
170709031|NCT00853658|616941349|FG002|Overall Study|Death|753|||
170709032|NCT00853658|616941347|FG000|Overall Study|Lost to Follow-up|11|||
170709033|NCT00853658|616941348|FG001|Overall Study|Lost to Follow-up|6|||
170709034|NCT00853658|616941349|FG002|Overall Study|Lost to Follow-up|11|||
170709035|NCT00853658|616941347|FG000|Overall Study|H.A. Request|26|||
170709036|NCT00853658|616941348|FG001|Overall Study|H.A. Request|23|||
170709037|NCT00853658|616941349|FG002|Overall Study|H.A. Request|19|||
170709038|NCT00853658|616941347|FG000|Overall Study|IRB request|0|||
170709039|NCT00853658|616941348|FG001|Overall Study|IRB request|0|||
170709040|NCT00853658|616941349|FG002|Overall Study|IRB request|2|||
170709041|NCT00853658|616941347|FG000|Overall Study|Vital Status known (alive) at study end|2|||
170709042|NCT00853658|616941348|FG001|Overall Study|Vital Status known (alive) at study end|3|||
170709043|NCT00853658|616941349|FG002|Overall Study|Vital Status known (alive) at study end|3|||
170709044|NCT00853658|616941347|FG000|Overall Study|Vital Status unknown at study end|1|||
170709045|NCT00853658|616941348|FG001|Overall Study|Vital Status unknown at study end|1|||
170709046|NCT00853658|616941349|FG002|Overall Study|Vital Status unknown at study end|0|||
170709047|NCT00853658|616941347|FG000|Overall Study|Vital Status at study end N/A|8|||
170709048|NCT00853658|616941348|FG001|Overall Study|Vital Status at study end N/A|10|||
170709049|NCT00853658|616941349|FG002|Overall Study|Vital Status at study end N/A|10|||
170709050|NCT00853658|616941347|FG000|Overall Study|Patient's request|21|||
170709051|NCT00853658|616941348|FG001|Overall Study|Patient's request|17|||
170709052|NCT00853658|616941349|FG002|Overall Study|Patient's request|11|||
170709053|NCT00853658|616941347|FG000|Overall Study|Missing study completion information|5|||
170709054|NCT00853658|616941348|FG001|Overall Study|Missing study completion information|4|||
170709055|NCT00853658|616941349|FG002|Overall Study|Missing study completion information|6|||
170709056|NCT02908529|616941350|FG000|Overall Study|Lost to Follow-up|0|||
170709057|NCT02908529|616941351|FG001|Overall Study|Lost to Follow-up|2|||
170709058|NCT04497987|616941352|FG000|Overall Study|Adverse Event|1|||
170709059|NCT04497987|616941353|FG001|Overall Study|Adverse Event|0|||
170709060|NCT04497987|616941352|FG000|Overall Study|Death|21|||
170709061|NCT04497987|616941353|FG001|Overall Study|Death|13|||
170709062|NCT04497987|616941352|FG000|Overall Study|Lost to Follow-up|19|||
170709063|NCT04497987|616941353|FG001|Overall Study|Lost to Follow-up|17|||
170709064|NCT04497987|616941352|FG000|Overall Study|Other - as reported by the investigator|22|||
170709065|NCT04497987|616941353|FG001|Overall Study|Other - as reported by the investigator|16|||
170709066|NCT04497987|616941352|FG000|Overall Study|Physician Decision|1|||
170709067|NCT04497987|616941353|FG001|Overall Study|Physician Decision|0|||
170709068|NCT04497987|616941352|FG000|Overall Study|Withdrawal by Subject|35|||
170709069|NCT04497987|616941353|FG001|Overall Study|Withdrawal by Subject|21|||
170709070|NCT02696096|616941354|FG000|Overall Study|ruled out at screening|1|||
170709071|NCT02696096|616941354|FG000|Overall Study|did not attend second fMRI|1|||
170709072|NCT03265119|616941355|FG000|Overall Study|Adverse Event|2|||
170709073|NCT03265119|616941356|FG001|Overall Study|Adverse Event|1|||
170709074|NCT03265119|616941355|FG000|Overall Study|Lack of Efficacy|3|||
170709075|NCT03265119|616941356|FG001|Overall Study|Lack of Efficacy|0|||
170709076|NCT03265119|616941355|FG000|Overall Study|Protocol Violation|1|||
170709077|NCT03265119|616941356|FG001|Overall Study|Protocol Violation|2|||
170709078|NCT03265119|616941355|FG000|Overall Study|Withdrawal by Subject|2|||
170709079|NCT03265119|616941356|FG001|Overall Study|Withdrawal by Subject|4|||
170709080|NCT03265119|616941355|FG000|Overall Study|Lost to Follow-up|1|||
170709081|NCT03265119|616941356|FG001|Overall Study|Lost to Follow-up|0|||
170709082|NCT03265119|616941355|FG000|Overall Study|Lack of Compliance|1|||
170709083|NCT03265119|616941356|FG001|Overall Study|Lack of Compliance|0|||
170709084|NCT04579679|616941357|FG000|Overall Study|New Antitumor Therapy|6|||
170709085|NCT04579679|616941358|FG001|Overall Study|New Antitumor Therapy|4|||
170709086|NCT04579679|616941359|FG002|Overall Study|New Antitumor Therapy|7|||
170709087|NCT04579679|616941360|FG003|Overall Study|New Antitumor Therapy|0|||
170709088|NCT04579679|616941357|FG000|Overall Study|Withdrawal of Consent|1|||
170709089|NCT04579679|616941358|FG001|Overall Study|Withdrawal of Consent|1|||
170709090|NCT04579679|616941359|FG002|Overall Study|Withdrawal of Consent|2|||
170709091|NCT04579679|616941360|FG003|Overall Study|Withdrawal of Consent|4|||
170709092|NCT04579679|616941357|FG000|Overall Study|Death|2|||
170709093|NCT04579679|616941358|FG001|Overall Study|Death|2|||
170709094|NCT04579679|616941359|FG002|Overall Study|Death|2|||
170709095|NCT04579679|616941360|FG003|Overall Study|Death|0|||
170709096|NCT04579679|616941357|FG000|Overall Study|Adverse Event|0|||
170709097|NCT04579679|616941358|FG001|Overall Study|Adverse Event|4|||
170709098|NCT04579679|616941359|FG002|Overall Study|Adverse Event|0|||
170709099|NCT04579679|616941360|FG003|Overall Study|Adverse Event|0|||
170709100|NCT04579679|616941357|FG000|Overall Study|Disease Progression|9|||
170709101|NCT04579679|616941358|FG001|Overall Study|Disease Progression|13|||
170709102|NCT04579679|616941359|FG002|Overall Study|Disease Progression|7|||
170709103|NCT04579679|616941360|FG003|Overall Study|Disease Progression|0|||
170709104|NCT04579679|616941357|FG000|Overall Study|Physician Decision|0|||
170709105|NCT04579679|616941358|FG001|Overall Study|Physician Decision|0|||
170709106|NCT04579679|616941359|FG002|Overall Study|Physician Decision|1|||
170709107|NCT04579679|616941360|FG003|Overall Study|Physician Decision|0|||
170709108|NCT04579679|616941357|FG000|Overall Study|Study Terminated by Sponsor|2|||
170709109|NCT04579679|616941358|FG001|Overall Study|Study Terminated by Sponsor|7|||
170709110|NCT04579679|616941359|FG002|Overall Study|Study Terminated by Sponsor|1|||
170709111|NCT04579679|616941360|FG003|Overall Study|Study Terminated by Sponsor|0|||
170709112|NCT03890367|616941369|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170709113|NCT03890367|616941370|FG001|Overall Study|Withdrawal by parent/guardian|3|||
170709114|NCT03890367|616941371|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170709115|NCT03890367|616941369|FG000|Overall Study|Protocol deviation|2|||
170709116|NCT03890367|616941370|FG001|Overall Study|Protocol deviation|2|||
170709117|NCT03890367|616941371|FG002|Overall Study|Protocol deviation|1|||
170709118|NCT03890367|616941369|FG000|Overall Study|Lost to Follow-up|1|||
170709119|NCT03890367|616941370|FG001|Overall Study|Lost to Follow-up|1|||
170709120|NCT03890367|616941371|FG002|Overall Study|Lost to Follow-up|0|||
170709121|NCT03085927|616943118|FG000|Overall Study|Withdrawal by Subject|1|||
170709122|NCT03085927|616943119|FG001|Overall Study|Withdrawal by Subject|4|||
170709123|NCT03085927|616943118|FG000|Overall Study|Lost to Follow-up|3|||
170709124|NCT03085927|616943119|FG001|Overall Study|Lost to Follow-up|1|||
170709125|NCT03085927|616943118|FG000|Overall Study|Death|1|||
170709126|NCT03085927|616943119|FG001|Overall Study|Death|0|||
170709127|NCT03085927|616943118|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
170709128|NCT03085927|616943119|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
170709129|NCT03085927|616943118|FG000|Overall Study|Dyad Became Ineligible|0|||
170709130|NCT03085927|616943119|FG001|Overall Study|Dyad Became Ineligible|1|||
170709131|NCT02139644|616943120|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
170709132|NCT02139644|616943121|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170709133|NCT02139644|616943122|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170709134|NCT02139644|616943123|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170709135|NCT02139644|616943124|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170709136|NCT02139644|616943125|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170709137|NCT02139644|616943120|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
170709138|NCT02139644|616943121|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170709139|NCT02139644|616943122|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170709140|NCT02139644|616943123|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170709141|NCT02139644|616943124|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170709142|NCT02139644|616943125|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170709143|NCT02139644|616943120|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
170709144|NCT02139644|616943121|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170709145|NCT02139644|616943122|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170827427|NCT01475461|617378051|FG002|Run-in Period|Other|0|||
170827428|NCT01475461|617378052|FG003|Run-in Period|Other|0|||
170827429|NCT01475461|617378053|FG004|Run-in Period|Other|0|||
170827430|NCT01475461|617378054|FG005|Run-in Period|Other|0|||
170827431|NCT01475461|617378055|FG006|Run-in Period|Other|0|||
170827432|NCT01475461|617378049|FG000|Run-in Period|Protocol Violation|4|||
170827433|NCT01475461|617378050|FG001|Run-in Period|Protocol Violation|0|||
170827434|NCT01475461|617378051|FG002|Run-in Period|Protocol Violation|0|||
170827435|NCT01475461|617378052|FG003|Run-in Period|Protocol Violation|0|||
170827436|NCT01475461|617378053|FG004|Run-in Period|Protocol Violation|0|||
170827437|NCT01475461|617378054|FG005|Run-in Period|Protocol Violation|0|||
170827438|NCT01475461|617378055|FG006|Run-in Period|Protocol Violation|0|||
170827439|NCT01475461|617378049|FG000|Treatment Period|Death|0|||
170827440|NCT01475461|617378050|FG001|Treatment Period|Death|0|||
170827441|NCT01475461|617378051|FG002|Treatment Period|Death|0|||
170827442|NCT01475461|617378052|FG003|Treatment Period|Death|1|||
170827443|NCT01475461|617378053|FG004|Treatment Period|Death|0|||
170827444|NCT01475461|617378054|FG005|Treatment Period|Death|0|||
170827445|NCT01475461|617378055|FG006|Treatment Period|Death|0|||
170827446|NCT01475461|617378049|FG000|Treatment Period|Lost to Follow-up|0|||
170827447|NCT01475461|617378050|FG001|Treatment Period|Lost to Follow-up|3|||
170827448|NCT01475461|617378051|FG002|Treatment Period|Lost to Follow-up|2|||
170827449|NCT01475461|617378052|FG003|Treatment Period|Lost to Follow-up|3|||
170827450|NCT01475461|617378053|FG004|Treatment Period|Lost to Follow-up|1|||
170827451|NCT01475461|617378054|FG005|Treatment Period|Lost to Follow-up|2|||
170827452|NCT01475461|617378055|FG006|Treatment Period|Lost to Follow-up|1|||
170827453|NCT01475461|617378049|FG000|Treatment Period|Withdrawal by Subject|0|||
170827454|NCT01475461|617378050|FG001|Treatment Period|Withdrawal by Subject|2|||
170827455|NCT01475461|617378051|FG002|Treatment Period|Withdrawal by Subject|2|||
170827456|NCT01475461|617378052|FG003|Treatment Period|Withdrawal by Subject|0|||
170827457|NCT01475461|617378053|FG004|Treatment Period|Withdrawal by Subject|2|||
170827458|NCT01475461|617378054|FG005|Treatment Period|Withdrawal by Subject|2|||
170827459|NCT01475461|617378055|FG006|Treatment Period|Withdrawal by Subject|0|||
170827460|NCT01475461|617378049|FG000|Treatment Period|Other|0|||
170827461|NCT01475461|617378050|FG001|Treatment Period|Other|1|||
170827462|NCT01475461|617378051|FG002|Treatment Period|Other|0|||
170827463|NCT01475461|617378052|FG003|Treatment Period|Other|0|||
170827464|NCT01475461|617378053|FG004|Treatment Period|Other|0|||
170827465|NCT01475461|617378054|FG005|Treatment Period|Other|0|||
170827466|NCT01475461|617378055|FG006|Treatment Period|Other|0|||
170827467|NCT01475461|617378049|FG000|Treatment Period|Protocol Violation|0|||
170827468|NCT01475461|617378050|FG001|Treatment Period|Protocol Violation|1|||
170827469|NCT01475461|617378051|FG002|Treatment Period|Protocol Violation|0|||
170827470|NCT01475461|617378052|FG003|Treatment Period|Protocol Violation|0|||
170827471|NCT01475461|617378053|FG004|Treatment Period|Protocol Violation|0|||
170827472|NCT01475461|617378054|FG005|Treatment Period|Protocol Violation|0|||
170827473|NCT01475461|617378055|FG006|Treatment Period|Protocol Violation|1|||
170827474|NCT01475461|617378049|FG000|Treatment Period|Lack of Efficacy|0|||
170827475|NCT01475461|617378050|FG001|Treatment Period|Lack of Efficacy|2|||
170827476|NCT01475461|617378051|FG002|Treatment Period|Lack of Efficacy|0|||
170827477|NCT01475461|617378052|FG003|Treatment Period|Lack of Efficacy|2|||
170827478|NCT01475461|617378053|FG004|Treatment Period|Lack of Efficacy|1|||
170827479|NCT01475461|617378054|FG005|Treatment Period|Lack of Efficacy|1|||
170827480|NCT01475461|617378055|FG006|Treatment Period|Lack of Efficacy|0|||
170827481|NCT01475461|617378049|FG000|Treatment Period|Medication Error|0|||
170827482|NCT01475461|617378050|FG001|Treatment Period|Medication Error|0|||
170827483|NCT01475461|617378051|FG002|Treatment Period|Medication Error|0|||
170827484|NCT01475461|617378052|FG003|Treatment Period|Medication Error|1|||
170827485|NCT01475461|617378053|FG004|Treatment Period|Medication Error|0|||
170827486|NCT01475461|617378054|FG005|Treatment Period|Medication Error|0|||
170827487|NCT01475461|617378055|FG006|Treatment Period|Medication Error|0|||
170827488|NCT01475461|617378049|FG000|Treatment Period|Adverse Event|0|||
170827489|NCT01475461|617378050|FG001|Treatment Period|Adverse Event|0|||
170827490|NCT01475461|617378051|FG002|Treatment Period|Adverse Event|0|||
170827491|NCT01475461|617378052|FG003|Treatment Period|Adverse Event|1|||
170827492|NCT01475461|617378053|FG004|Treatment Period|Adverse Event|0|||
170827493|NCT01475461|617378054|FG005|Treatment Period|Adverse Event|0|||
170827494|NCT01475461|617378055|FG006|Treatment Period|Adverse Event|0|||
170827495|NCT04051242|617378056|FG000|Overall Study|Withdrawal by Subject|1|||
170827496|NCT04051242|617378056|FG000|Overall Study|Physician Decision|1|||
170827497|NCT01085812|617378062|FG000|Open-Label Period|Adverse Event|0|||
170709146|NCT02139644|616943123|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170709147|NCT02139644|616943124|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170709148|NCT02139644|616943125|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170709149|NCT02139644|616943120|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
170709150|NCT02139644|616943121|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170709151|NCT02139644|616943122|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170709152|NCT02139644|616943123|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170709153|NCT02139644|616943124|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170709154|NCT02139644|616943125|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170709155|NCT02139644|616943120|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
170709156|NCT02139644|616943121|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170709157|NCT02139644|616943122|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170709158|NCT02139644|616943123|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170709159|NCT02139644|616943124|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170709160|NCT02139644|616943125|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170709161|NCT02139644|616943120|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
170709162|NCT02139644|616943121|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
170709163|NCT02139644|616943122|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
170709164|NCT02139644|616943123|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
170709165|NCT02139644|616943124|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
170709166|NCT02139644|616943125|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
170709167|NCT02139644|616943120|FG000|Run-In Period (Pre-assignment)|Other|6|||
170709168|NCT02139644|616943121|FG001|Run-In Period (Pre-assignment)|Other|0|||
170709169|NCT02139644|616943122|FG002|Run-In Period (Pre-assignment)|Other|0|||
170709170|NCT02139644|616943123|FG003|Run-In Period (Pre-assignment)|Other|0|||
170709171|NCT02139644|616943124|FG004|Run-In Period (Pre-assignment)|Other|0|||
170709172|NCT02139644|616943125|FG005|Run-In Period (Pre-assignment)|Other|0|||
170709173|NCT02139644|616943120|FG000|Treatment Period|Adverse Event|0|||
170709174|NCT02139644|616943121|FG001|Treatment Period|Adverse Event|0|||
170709175|NCT02139644|616943122|FG002|Treatment Period|Adverse Event|3|||
170709176|NCT02139644|616943123|FG003|Treatment Period|Adverse Event|2|||
170709177|NCT02139644|616943124|FG004|Treatment Period|Adverse Event|1|||
170709178|NCT02139644|616943125|FG005|Treatment Period|Adverse Event|6|||
170709179|NCT02139644|616943120|FG000|Treatment Period|Withdrawal by Subject|0|||
170709180|NCT02139644|616943121|FG001|Treatment Period|Withdrawal by Subject|0|||
170709181|NCT02139644|616943122|FG002|Treatment Period|Withdrawal by Subject|2|||
170709182|NCT02139644|616943123|FG003|Treatment Period|Withdrawal by Subject|2|||
170709183|NCT02139644|616943124|FG004|Treatment Period|Withdrawal by Subject|3|||
170709184|NCT02139644|616943125|FG005|Treatment Period|Withdrawal by Subject|2|||
170709185|NCT02139644|616943120|FG000|Treatment Period|Non-compliance|0|||
170709186|NCT02139644|616943121|FG001|Treatment Period|Non-compliance|0|||
170709187|NCT02139644|616943122|FG002|Treatment Period|Non-compliance|0|||
170709188|NCT02139644|616943123|FG003|Treatment Period|Non-compliance|1|||
170709189|NCT02139644|616943124|FG004|Treatment Period|Non-compliance|0|||
170709190|NCT02139644|616943125|FG005|Treatment Period|Non-compliance|0|||
170709191|NCT02139644|616943120|FG000|Treatment Period|Protocol Violation|0|||
170709192|NCT02139644|616943121|FG001|Treatment Period|Protocol Violation|0|||
170709193|NCT02139644|616943122|FG002|Treatment Period|Protocol Violation|0|||
170709194|NCT02139644|616943123|FG003|Treatment Period|Protocol Violation|1|||
170709195|NCT02139644|616943124|FG004|Treatment Period|Protocol Violation|1|||
170709196|NCT02139644|616943125|FG005|Treatment Period|Protocol Violation|1|||
170709197|NCT02139644|616943120|FG000|Treatment Period|Disease progression|0|||
170709198|NCT02139644|616943121|FG001|Treatment Period|Disease progression|0|||
170709199|NCT02139644|616943122|FG002|Treatment Period|Disease progression|0|||
170709200|NCT02139644|616943123|FG003|Treatment Period|Disease progression|1|||
170709201|NCT02139644|616943124|FG004|Treatment Period|Disease progression|1|||
170709202|NCT02139644|616943125|FG005|Treatment Period|Disease progression|2|||
170709203|NCT02139644|616943120|FG000|Treatment Period|Lost to Follow-up|0|||
170709204|NCT02139644|616943121|FG001|Treatment Period|Lost to Follow-up|0|||
170709205|NCT02139644|616943122|FG002|Treatment Period|Lost to Follow-up|1|||
170709206|NCT02139644|616943123|FG003|Treatment Period|Lost to Follow-up|1|||
170709207|NCT02139644|616943124|FG004|Treatment Period|Lost to Follow-up|1|||
170709208|NCT02139644|616943125|FG005|Treatment Period|Lost to Follow-up|1|||
170709209|NCT02139644|616943120|FG000|Treatment Period|Lack of Efficacy|0|||
170709210|NCT02139644|616943121|FG001|Treatment Period|Lack of Efficacy|0|||
170709211|NCT02139644|616943122|FG002|Treatment Period|Lack of Efficacy|1|||
170709212|NCT02139644|616943123|FG003|Treatment Period|Lack of Efficacy|0|||
170709213|NCT02139644|616943124|FG004|Treatment Period|Lack of Efficacy|1|||
170709214|NCT02139644|616943125|FG005|Treatment Period|Lack of Efficacy|4|||
170709215|NCT02139644|616943120|FG000|Treatment Period|Other|0|||
170709216|NCT02139644|616943121|FG001|Treatment Period|Other|3|||
170709217|NCT02139644|616943122|FG002|Treatment Period|Other|1|||
170709218|NCT02139644|616943123|FG003|Treatment Period|Other|1|||
170709219|NCT02139644|616943124|FG004|Treatment Period|Other|0|||
170709220|NCT02139644|616943125|FG005|Treatment Period|Other|1|||
170709221|NCT00600821|616943126|FG000|Overall Study|Death|45|||
170709222|NCT00600821|616943127|FG001|Overall Study|Death|46|||
170709223|NCT00600821|616943126|FG000|Overall Study|Lost to Follow-up|2|||
170709224|NCT00600821|616943127|FG001|Overall Study|Lost to Follow-up|2|||
170709225|NCT00600821|616943126|FG000|Overall Study|Withdrawal by Subject|1|||
170709226|NCT00600821|616943127|FG001|Overall Study|Withdrawal by Subject|1|||
170709227|NCT00600821|616943126|FG000|Overall Study|Terminated by sponsor|8|||
170709228|NCT00600821|616943127|FG001|Overall Study|Terminated by sponsor|6|||
170709229|NCT00600821|616943126|FG000|Overall Study|Objective progression or relapse|0|||
170709230|NCT00600821|616943127|FG001|Overall Study|Objective progression or relapse|1|||
170709231|NCT00600821|616943126|FG000|Overall Study|Randomized but not treated|0|||
170709232|NCT00600821|616943127|FG001|Overall Study|Randomized but not treated|1|||
170709233|NCT00600821|616943126|FG000|Overall Study|Other|2|||
170709234|NCT00600821|616943127|FG001|Overall Study|Other|3|||
170709235|NCT01076400|616943131|FG000|Overall Study|Adverse Event|2|||
170709236|NCT01076400|616943132|FG001|Overall Study|Adverse Event|0|||
170709237|NCT01076400|616943133|FG002|Overall Study|Adverse Event|0|||
170709238|NCT01076400|616943131|FG000|Overall Study|Progressive Disease|5|||
170709239|NCT01076400|616943132|FG001|Overall Study|Progressive Disease|0|||
170709240|NCT01076400|616943133|FG002|Overall Study|Progressive Disease|0|||
170709241|NCT02766608|616943136|FG000|Overall Study|Adverse Event|27|||
170709242|NCT02766608|616943137|FG001|Overall Study|Adverse Event|22|||
170709243|NCT02766608|616943138|FG002|Overall Study|Adverse Event|17|||
170709244|NCT02766608|616943139|FG003|Overall Study|Adverse Event|13|||
170709245|NCT02766608|616943140|FG004|Overall Study|Adverse Event|12|||
170709246|NCT02766608|616943136|FG000|Overall Study|Withdrawal by Subject|21|||
170709247|NCT02766608|616943137|FG001|Overall Study|Withdrawal by Subject|20|||
170709248|NCT02766608|616943138|FG002|Overall Study|Withdrawal by Subject|24|||
170827498|NCT01085812|617378063|FG001|Open-Label Period|Adverse Event|80|||
170827499|NCT01085812|617378062|FG000|Open-Label Period|Lack of Efficacy|0|||
170827500|NCT01085812|617378063|FG001|Open-Label Period|Lack of Efficacy|26|||
170827501|NCT01085812|617378062|FG000|Open-Label Period|Protocol Violation|0|||
170827502|NCT01085812|617378063|FG001|Open-Label Period|Protocol Violation|39|||
170827503|NCT01085812|617378062|FG000|Open-Label Period|Withdrawal by Subject|0|||
170827504|NCT01085812|617378063|FG001|Open-Label Period|Withdrawal by Subject|53|||
170827505|NCT01085812|617378062|FG000|Open-Label Period|Lost to Follow-up|0|||
170827506|NCT01085812|617378063|FG001|Open-Label Period|Lost to Follow-up|42|||
170827507|NCT01085812|617378062|FG000|Double-Blind Period|Adverse Event|3|||
170827508|NCT01085812|617378063|FG001|Double-Blind Period|Adverse Event|8|||
170827509|NCT01085812|617378062|FG000|Double-Blind Period|Protocol Violation|2|||
170827510|NCT01085812|617378063|FG001|Double-Blind Period|Protocol Violation|7|||
170827511|NCT01085812|617378062|FG000|Double-Blind Period|Withdrawal by Subject|11|||
170827512|NCT01085812|617378063|FG001|Double-Blind Period|Withdrawal by Subject|24|||
170827513|NCT01085812|617378062|FG000|Double-Blind Period|Lost to Follow-up|5|||
170827514|NCT01085812|617378063|FG001|Double-Blind Period|Lost to Follow-up|17|||
170827515|NCT01085812|617378062|FG000|Double-Blind Period|Other Reasons|0|||
170827516|NCT01085812|617378063|FG001|Double-Blind Period|Other Reasons|2|||
170827517|NCT01085812|617378062|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
170827518|NCT01085812|617378063|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
170827519|NCT01085812|617378062|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
170827520|NCT01085812|617378063|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
170827521|NCT01085812|617378062|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
170827522|NCT01085812|617378063|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
170827523|NCT01085812|617378062|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
170827524|NCT01085812|617378063|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
170827525|NCT01085812|617378062|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
170827526|NCT01085812|617378063|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
170827527|NCT00594178|617378066|FG000|Overall Study|Physician Decision|5|||
170827528|NCT00496626|617378070|FG000|Overall Study|Lost to Follow-up|0|||
170827529|NCT00496626|617378071|FG001|Overall Study|Lost to Follow-up|1|||
170827530|NCT00496626|617378070|FG000|Overall Study|Protocol Violation|1|||
170827531|NCT00496626|617378071|FG001|Overall Study|Protocol Violation|0|||
170827532|NCT00496626|617378070|FG000|Overall Study|Withdrawal by Subject|5|||
170827533|NCT00496626|617378071|FG001|Overall Study|Withdrawal by Subject|4|||
170709249|NCT02766608|616943139|FG003|Overall Study|Withdrawal by Subject|13|||
170709250|NCT02766608|616943140|FG004|Overall Study|Withdrawal by Subject|10|||
170709251|NCT02766608|616943136|FG000|Overall Study|Lack of Efficacy|16|||
170709252|NCT02766608|616943137|FG001|Overall Study|Lack of Efficacy|15|||
170709253|NCT02766608|616943138|FG002|Overall Study|Lack of Efficacy|32|||
170709254|NCT02766608|616943139|FG003|Overall Study|Lack of Efficacy|8|||
170709255|NCT02766608|616943140|FG004|Overall Study|Lack of Efficacy|2|||
170709256|NCT02766608|616943136|FG000|Overall Study|Lost to Follow-up|6|||
170709257|NCT02766608|616943137|FG001|Overall Study|Lost to Follow-up|3|||
170827534|NCT00496626|617378070|FG000|Overall Study|Relocated|0|||
170827535|NCT00496626|617378071|FG001|Overall Study|Relocated|1|||
170827536|NCT04191148|617378081|FG000|Overall Study|Withdrawal by Subject|1|||
170709258|NCT02766608|616943138|FG002|Overall Study|Lost to Follow-up|5|||
170709259|NCT02766608|616943139|FG003|Overall Study|Lost to Follow-up|2|||
170709260|NCT02766608|616943140|FG004|Overall Study|Lost to Follow-up|2|||
170709261|NCT02766608|616943136|FG000|Overall Study|Physician Decision|3|||
170709262|NCT02766608|616943137|FG001|Overall Study|Physician Decision|2|||
170709263|NCT02766608|616943138|FG002|Overall Study|Physician Decision|3|||
170709264|NCT02766608|616943139|FG003|Overall Study|Physician Decision|1|||
170709265|NCT02766608|616943140|FG004|Overall Study|Physician Decision|2|||
170709266|NCT02766608|616943136|FG000|Overall Study|Protocol disc criteria|3|||
170709267|NCT02766608|616943137|FG001|Overall Study|Protocol disc criteria|3|||
170709268|NCT02766608|616943138|FG002|Overall Study|Protocol disc criteria|4|||
170709269|NCT02766608|616943139|FG003|Overall Study|Protocol disc criteria|0|||
170709270|NCT02766608|616943140|FG004|Overall Study|Protocol disc criteria|0|||
170709271|NCT02766608|616943136|FG000|Overall Study|Protocol Violation|0|||
170709272|NCT02766608|616943137|FG001|Overall Study|Protocol Violation|4|||
170709273|NCT02766608|616943138|FG002|Overall Study|Protocol Violation|4|||
170709274|NCT02766608|616943139|FG003|Overall Study|Protocol Violation|0|||
170709275|NCT02766608|616943140|FG004|Overall Study|Protocol Violation|1|||
170709276|NCT02766608|616943136|FG000|Overall Study|Administrative Reasons|3|||
170709277|NCT02766608|616943137|FG001|Overall Study|Administrative Reasons|1|||
170709278|NCT02766608|616943138|FG002|Overall Study|Administrative Reasons|1|||
170709279|NCT02766608|616943139|FG003|Overall Study|Administrative Reasons|0|||
170709280|NCT02766608|616943140|FG004|Overall Study|Administrative Reasons|0|||
170709281|NCT02066298|616943141|FG000|Overall Study|Lost to Follow-up|3|||
170709282|NCT02066298|616943142|FG001|Overall Study|Lost to Follow-up|2|||
170709283|NCT02066298|616943143|FG002|Overall Study|Lost to Follow-up|3|||
170709284|NCT02066298|616943144|FG003|Overall Study|Lost to Follow-up|2|||
170709285|NCT02066298|616943145|FG004|Overall Study|Lost to Follow-up|3|||
170709286|NCT02066298|616943146|FG005|Overall Study|Lost to Follow-up|4|||
170709287|NCT02066298|616943141|FG000|Overall Study|Withdrawal by Subject|6|||
170709288|NCT02066298|616943142|FG001|Overall Study|Withdrawal by Subject|6|||
170709289|NCT02066298|616943143|FG002|Overall Study|Withdrawal by Subject|6|||
170709290|NCT02066298|616943144|FG003|Overall Study|Withdrawal by Subject|4|||
170709291|NCT02066298|616943145|FG004|Overall Study|Withdrawal by Subject|5|||
170709292|NCT02066298|616943146|FG005|Overall Study|Withdrawal by Subject|8|||
170709293|NCT02066298|616943141|FG000|Overall Study|Physician Decision|0|||
170709294|NCT02066298|616943142|FG001|Overall Study|Physician Decision|0|||
170709295|NCT02066298|616943143|FG002|Overall Study|Physician Decision|1|||
170709296|NCT02066298|616943144|FG003|Overall Study|Physician Decision|0|||
170709297|NCT02066298|616943145|FG004|Overall Study|Physician Decision|1|||
170709298|NCT02066298|616943146|FG005|Overall Study|Physician Decision|0|||
170709299|NCT04260191|616943147|FG000|Overall Study|Decision by Sponsor|0|||
170709300|NCT04260191|616943148|FG001|Overall Study|Decision by Sponsor|1|||
170709301|NCT04260191|616943149|FG002|Overall Study|Decision by Sponsor|0|||
170709302|NCT04260191|616943147|FG000|Overall Study|Withdrawal by Subject|1|||
170709303|NCT04260191|616943148|FG001|Overall Study|Withdrawal by Subject|0|||
170709304|NCT04260191|616943149|FG002|Overall Study|Withdrawal by Subject|3|||
170709305|NCT04260191|616943147|FG000|Overall Study|Death|4|||
170709306|NCT04260191|616943148|FG001|Overall Study|Death|3|||
170709307|NCT04260191|616943149|FG002|Overall Study|Death|2|||
170709308|NCT01519518|616943150|FG000|Overall Study|Consent not available|7|||
170709309|NCT01519518|616943151|FG001|Overall Study|Consent not available|10|||
170709310|NCT02033889|616943152|FG000|Overall Study|Adverse Event|3|||
170709311|NCT02033889|616943153|FG001|Overall Study|Adverse Event|1|||
170709312|NCT02033889|616943154|FG002|Overall Study|Adverse Event|3|||
170709313|NCT02033889|616943152|FG000|Overall Study|Death|3|||
170709314|NCT02033889|616943153|FG001|Overall Study|Death|1|||
170709315|NCT02033889|616943154|FG002|Overall Study|Death|2|||
170709316|NCT02033889|616943152|FG000|Overall Study|Excluded Medication|1|||
170709317|NCT02033889|616943153|FG001|Overall Study|Excluded Medication|1|||
170709318|NCT02033889|616943154|FG002|Overall Study|Excluded Medication|0|||
170709319|NCT02033889|616943152|FG000|Overall Study|Lost to Follow-up|8|||
170709320|NCT02033889|616943153|FG001|Overall Study|Lost to Follow-up|5|||
170709321|NCT02033889|616943154|FG002|Overall Study|Lost to Follow-up|6|||
170709322|NCT02033889|616943152|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170709323|NCT02033889|616943153|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170709324|NCT02033889|616943154|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170709325|NCT02033889|616943152|FG000|Overall Study|Physician Decision|0|||
170709326|NCT02033889|616943153|FG001|Overall Study|Physician Decision|1|||
170709327|NCT02033889|616943154|FG002|Overall Study|Physician Decision|1|||
170709328|NCT02033889|616943152|FG000|Overall Study|Participant moved|0|||
170709329|NCT02033889|616943153|FG001|Overall Study|Participant moved|1|||
170709330|NCT02033889|616943154|FG002|Overall Study|Participant moved|0|||
170709331|NCT02033889|616943152|FG000|Overall Study|Withdrawal by Subject|18|||
170709332|NCT02033889|616943153|FG001|Overall Study|Withdrawal by Subject|10|||
170709333|NCT02033889|616943154|FG002|Overall Study|Withdrawal by Subject|13|||
170709334|NCT02343458|616943155|FG000|Overall Study|Adverse Event|15|||
170709335|NCT02343458|616943156|FG001|Overall Study|Adverse Event|14|||
170709336|NCT02343458|616943157|FG002|Overall Study|Adverse Event|15|||
170827537|NCT04191148|617378082|FG001|Overall Study|Withdrawal by Subject|0|||
170827538|NCT04191148|617378081|FG000|Overall Study|Adverse Event|1|||
170827539|NCT04191148|617378082|FG001|Overall Study|Adverse Event|0|||
170827540|NCT01874665|617378083|FG000|Overall Study|Adverse Event|6|||
170827541|NCT01874665|617378084|FG001|Overall Study|Adverse Event|2|||
170827542|NCT01874665|617378083|FG000|Overall Study|Withdrawal by Subject|4|||
170827543|NCT01874665|617378084|FG001|Overall Study|Withdrawal by Subject|1|||
170827544|NCT01874665|617378083|FG000|Overall Study|Physician Decision|3|||
170827545|NCT01874665|617378084|FG001|Overall Study|Physician Decision|0|||
170827546|NCT01874665|617378083|FG000|Overall Study|Clinical Progressive Disease|4|||
170827547|NCT01874665|617378084|FG001|Overall Study|Clinical Progressive Disease|3|||
170827548|NCT01874665|617378083|FG000|Overall Study|Study Terminated by Sponsor|0|||
170827549|NCT01874665|617378084|FG001|Overall Study|Study Terminated by Sponsor|2|||
170827550|NCT01874665|617378083|FG000|Overall Study|Documented Progressive Disease|11|||
170827551|NCT01874665|617378084|FG001|Overall Study|Documented Progressive Disease|7|||
170827552|NCT01874665|617378083|FG000|Overall Study|Other|2|||
170827553|NCT01874665|617378084|FG001|Overall Study|Other|0|||
170827554|NCT02647788|617378087|FG000|Overall Study|Lost to Follow-up|13|||
170827555|NCT02647788|617378088|FG001|Overall Study|Lost to Follow-up|11|||
170827556|NCT02647788|617378087|FG000|Overall Study|Did not want opiate|0|||
170827557|NCT02647788|617378088|FG001|Overall Study|Did not want opiate|1|||
170827558|NCT02647788|617378087|FG000|Overall Study|Withdrawal by Subject|1|||
170827559|NCT02647788|617378088|FG001|Overall Study|Withdrawal by Subject|0|||
170827560|NCT02647788|617378087|FG000|Overall Study|Felt itchy with assigned medication|1|||
170827561|NCT02647788|617378088|FG001|Overall Study|Felt itchy with assigned medication|0|||
170827562|NCT02647788|617378087|FG000|Overall Study|Felt nauseous with assigned medication|1|||
170827563|NCT02647788|617378088|FG001|Overall Study|Felt nauseous with assigned medication|1|||
170827564|NCT02447432|617378089|FG000|Epoch 001|Adverse Event|1|||
170827565|NCT02447432|617378090|FG001|Epoch 001|Adverse Event|1|||
170827566|NCT02447432|617378089|FG000|Epoch 001|Withdrawal by Subject|0|||
170827567|NCT02447432|617378090|FG001|Epoch 001|Withdrawal by Subject|4|||
170827568|NCT02447432|617378089|FG000|Epoch 001|Migrated/moved from study area|3|||
170827569|NCT02447432|617378090|FG001|Epoch 001|Migrated/moved from study area|5|||
170827570|NCT02447432|617378089|FG000|Epoch 001|Lost to Follow-up|1|||
170827571|NCT02447432|617378090|FG001|Epoch 001|Lost to Follow-up|3|||
170827572|NCT03470545|617378094|FG000|Overall Study|Death|0|||
170827573|NCT03470545|617378095|FG001|Overall Study|Death|1|||
170827574|NCT03470545|617378094|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
170827575|NCT03470545|617378095|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
170827576|NCT03470545|617378094|FG000|Overall Study|Adverse Event|2|||
170827577|NCT03470545|617378095|FG001|Overall Study|Adverse Event|0|||
170827578|NCT03470545|617378094|FG000|Overall Study|Withdrawal by Subject|1|||
170827579|NCT03470545|617378095|FG001|Overall Study|Withdrawal by Subject|1|||
170827580|NCT03470545|617378094|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
170709337|NCT02343458|616943158|FG003|Overall Study|Adverse Event|3|||
170709338|NCT02343458|616943155|FG000|Overall Study|Lack of Efficacy|3|||
170709339|NCT02343458|616943156|FG001|Overall Study|Lack of Efficacy|8|||
170709340|NCT02343458|616943157|FG002|Overall Study|Lack of Efficacy|4|||
170709341|NCT02343458|616943158|FG003|Overall Study|Lack of Efficacy|8|||
170709342|NCT02343458|616943155|FG000|Overall Study|Withdrawal by Subject|18|||
170827581|NCT03470545|617378095|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
170709343|NCT02343458|616943156|FG001|Overall Study|Withdrawal by Subject|17|||
170709344|NCT02343458|616943157|FG002|Overall Study|Withdrawal by Subject|23|||
170709345|NCT02343458|616943158|FG003|Overall Study|Withdrawal by Subject|14|||
170709346|NCT02343458|616943155|FG000|Overall Study|Physician Decision|1|||
170709347|NCT02343458|616943156|FG001|Overall Study|Physician Decision|4|||
170709348|NCT02343458|616943157|FG002|Overall Study|Physician Decision|2|||
170709349|NCT02343458|616943158|FG003|Overall Study|Physician Decision|2|||
170709350|NCT02343458|616943155|FG000|Overall Study|Lost to Follow-up|5|||
170709351|NCT02343458|616943156|FG001|Overall Study|Lost to Follow-up|5|||
170709352|NCT02343458|616943157|FG002|Overall Study|Lost to Follow-up|3|||
170709353|NCT02343458|616943158|FG003|Overall Study|Lost to Follow-up|1|||
170709354|NCT02343458|616943155|FG000|Overall Study|Protocol Violation|2|||
170709355|NCT02343458|616943156|FG001|Overall Study|Protocol Violation|5|||
170709356|NCT02343458|616943157|FG002|Overall Study|Protocol Violation|2|||
170709357|NCT02343458|616943158|FG003|Overall Study|Protocol Violation|2|||
170709358|NCT02343458|616943155|FG000|Overall Study|Protocol Specified Criteria|17|||
170709359|NCT02343458|616943156|FG001|Overall Study|Protocol Specified Criteria|13|||
170827582|NCT00776659|617378096|FG000|Overall Study|Lost to Follow-up|15|||
170827583|NCT00776659|617378096|FG000|Overall Study|Withdrawal by Subject|10|||
170827584|NCT00776659|617378096|FG000|Overall Study|Study Terminated by Sponsor|1|||
170827585|NCT02971228|617378097|FG000|Overall Study|Withdrawal by Subject|1|||
170827586|NCT02971228|617378098|FG001|Overall Study|Withdrawal by Subject|1|||
170827587|NCT02971228|617378099|FG002|Overall Study|Withdrawal by Subject|0|||
170827588|NCT02971228|617378100|FG003|Overall Study|Withdrawal by Subject|0|||
170827589|NCT02971228|617378101|FG004|Overall Study|Withdrawal by Subject|0|||
170709360|NCT02343458|616943157|FG002|Overall Study|Protocol Specified Criteria|14|||
170709361|NCT02343458|616943158|FG003|Overall Study|Protocol Specified Criteria|8|||
170709362|NCT01913041|616943161|FG000|Overall Study|Protocol Violation|35|||
170709363|NCT01913041|616943161|FG000|Overall Study|Withdrawal by Subject|3|||
170709364|NCT01913041|616943161|FG000|Overall Study|Physician Decision|1|||
170709365|NCT02348489|616943166|FG000|Overall Study|Death|336|||
170709366|NCT02348489|616943167|FG001|Overall Study|Death|335|||
170709367|NCT02348489|616943166|FG000|Overall Study|Withdrawal by Subject|14|||
170709368|NCT02348489|616943167|FG001|Overall Study|Withdrawal by Subject|27|||
170709369|NCT02348489|616943166|FG000|Overall Study|Lost to Follow-up|3|||
170709370|NCT02348489|616943167|FG001|Overall Study|Lost to Follow-up|5|||
170709371|NCT00201006|616943168|FG000|Overall Study|Withdrawal by Subject|7|||
170709372|NCT00201006|616943169|FG001|Overall Study|Withdrawal by Subject|2|||
170709373|NCT00201006|616943170|FG002|Overall Study|Withdrawal by Subject|3|||
170709374|NCT00201006|616943168|FG000|Overall Study|Adverse Event|1|||
170709375|NCT00201006|616943169|FG001|Overall Study|Adverse Event|0|||
170709376|NCT00201006|616943170|FG002|Overall Study|Adverse Event|1|||
170709377|NCT01490060|616943173|FG000|Cycle 1|Change of Treatment|0|||
170709378|NCT01490060|616943174|FG001|Cycle 1|Change of Treatment|1|||
170709379|NCT01490060|616943175|FG002|Cycle 1|Change of Treatment|1|||
170709380|NCT01490060|616943176|FG003|Cycle 1|Change of Treatment|1|||
170709381|NCT01490060|616943173|FG000|Cycle 1|Insurance Denied|0|||
170709382|NCT01490060|616943174|FG001|Cycle 1|Insurance Denied|0|||
170709383|NCT01490060|616943175|FG002|Cycle 1|Insurance Denied|2|||
170709384|NCT01490060|616943176|FG003|Cycle 1|Insurance Denied|0|||
170709385|NCT01490060|616943173|FG000|Cycle 1|Withdrawal by Subject|0|||
170709386|NCT01490060|616943174|FG001|Cycle 1|Withdrawal by Subject|0|||
170709387|NCT01490060|616943175|FG002|Cycle 1|Withdrawal by Subject|0|||
170709388|NCT01490060|616943176|FG003|Cycle 1|Withdrawal by Subject|1|||
170709389|NCT01490060|616943173|FG000|Cycle 1|Treatment at Another Facility|0|||
170709390|NCT01490060|616943174|FG001|Cycle 1|Treatment at Another Facility|0|||
170709391|NCT01490060|616943175|FG002|Cycle 1|Treatment at Another Facility|0|||
170709392|NCT01490060|616943176|FG003|Cycle 1|Treatment at Another Facility|1|||
170709393|NCT01490060|616943173|FG000|Cycle 2|Change of Treatment|1|||
170709394|NCT01490060|616943174|FG001|Cycle 2|Change of Treatment|1|||
170709395|NCT01490060|616943175|FG002|Cycle 2|Change of Treatment|0|||
170709396|NCT01490060|616943176|FG003|Cycle 2|Change of Treatment|0|||
170709397|NCT01490060|616943173|FG000|Cycle 2|Non-Compliance|0|||
170709398|NCT01490060|616943174|FG001|Cycle 2|Non-Compliance|0|||
170709399|NCT01490060|616943175|FG002|Cycle 2|Non-Compliance|1|||
170709400|NCT01490060|616943176|FG003|Cycle 2|Non-Compliance|0|||
170709401|NCT01490060|616943173|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
170709402|NCT01490060|616943174|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
170709403|NCT01490060|616943175|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
170709404|NCT01490060|616943176|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
170709405|NCT02464969|616943180|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
170709406|NCT02464969|616943181|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
170709407|NCT02464969|616943180|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
170709408|NCT02464969|616943181|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
170709409|NCT02464969|616943180|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
170709410|NCT02464969|616943181|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
170709411|NCT02464969|616943180|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
170709412|NCT02464969|616943181|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
170709413|NCT02464969|616943180|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
170709414|NCT02464969|616943181|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
170709415|NCT02464969|616943180|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
170709416|NCT02464969|616943181|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
170709417|NCT02464969|616943180|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
170709418|NCT02464969|616943181|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
170709419|NCT02464969|616943180|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
170709420|NCT02464969|616943181|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
170709421|NCT02464969|616943180|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
170709422|NCT02464969|616943181|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
170709423|NCT02464969|616943180|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
170827590|NCT02971228|617378097|FG000|Overall Study|Logistical challenges|0|||
170827591|NCT02971228|617378098|FG001|Overall Study|Logistical challenges|1|||
170827592|NCT02971228|617378099|FG002|Overall Study|Logistical challenges|0|||
170827593|NCT02971228|617378100|FG003|Overall Study|Logistical challenges|0|||
170827594|NCT02971228|617378101|FG004|Overall Study|Logistical challenges|0|||
170827595|NCT01167192|617378102|FG000|Overall Study|Adverse Event|1|||
170709424|NCT02464969|616943181|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
170709425|NCT02464969|616943180|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
170709426|NCT02464969|616943181|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
170709427|NCT02863354|616943185|FG000|Year 1|Lost to Follow-up|1|||
170827596|NCT01167192|617378102|FG000|Overall Study|Death|1|||
170827597|NCT01167192|617378102|FG000|Overall Study|Withdrawal by Subject|1|||
170709428|NCT02863354|616943186|FG001|Year 1|Lost to Follow-up|1|||
170709429|NCT02863354|616943185|FG000|Year 1|Withdrawal by Subject|3|||
170709430|NCT02863354|616943186|FG001|Year 1|Withdrawal by Subject|0|||
170709431|NCT02863354|616943185|FG000|Year 1|Death|0|||
170709432|NCT02863354|616943186|FG001|Year 1|Death|1|||
170709433|NCT02863354|616943185|FG000|Year 2|Lost to Follow-up|2|||
170709434|NCT02863354|616943186|FG001|Year 2|Lost to Follow-up|2|||
170709435|NCT01350128|616943196|FG000|Overall Study|Withdrawal by Subject|3|||
170709436|NCT01350128|616943196|FG000|Overall Study|Protocol discontinuation criteria|8|||
170709437|NCT01350128|616943196|FG000|Overall Study|Physician Decision|1|||
170709438|NCT01350128|616943196|FG000|Overall Study|Lost to Follow-up|2|||
170709439|NCT01859715|616943197|FG000|Overall Study|No 2nd VAS|16|||
170709440|NCT01859715|616943198|FG001|Overall Study|No 2nd VAS|8|||
170709441|NCT01859715|616943199|FG002|Overall Study|No 2nd VAS|23|||
170709442|NCT01252290|616943200|FG000|Overall Study|Withdrawal by Subject|1|||
170709443|NCT03235024|616943205|FG000|Overall Study|Adverse Event|2|||
170709444|NCT03235024|616943206|FG001|Overall Study|Adverse Event|2|||
170709445|NCT03235024|616943205|FG000|Overall Study|Death|1|||
170709446|NCT03235024|616943206|FG001|Overall Study|Death|0|||
170709447|NCT03235024|616943205|FG000|Overall Study|Lost to Follow-up|2|||
170709448|NCT03235024|616943206|FG001|Overall Study|Lost to Follow-up|5|||
170709449|NCT03235024|616943205|FG000|Overall Study|Protocol Violation|1|||
170709450|NCT03235024|616943206|FG001|Overall Study|Protocol Violation|0|||
170709451|NCT03235024|616943205|FG000|Overall Study|Withdrawal by Subject|0|||
170709452|NCT03235024|616943206|FG001|Overall Study|Withdrawal by Subject|3|||
170709453|NCT02357576|616943207|FG000|Treatment Period|Withdrawal by Subject|0|||
170709454|NCT02357576|616943208|FG001|Treatment Period|Withdrawal by Subject|1|||
170709455|NCT02357576|616943207|FG000|Treatment Period|Physician Decision|0|||
170709456|NCT02357576|616943208|FG001|Treatment Period|Physician Decision|1|||
170709457|NCT02357576|616943207|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
170709458|NCT02357576|616943208|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
170709459|NCT02357576|616943207|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
170709460|NCT02357576|616943208|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
170709461|NCT02357576|616943207|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
170709462|NCT02357576|616943208|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
170709463|NCT02357576|616943207|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
170709464|NCT02357576|616943208|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
170709465|NCT00261716|616943209|FG000|Overall Study|Withdrawal by Subject|6|||
170709466|NCT00261716|616943210|FG001|Overall Study|Withdrawal by Subject|8|||
170709467|NCT00261716|616943209|FG000|Overall Study|Lost to Follow-up|0|||
170709468|NCT00261716|616943210|FG001|Overall Study|Lost to Follow-up|2|||
170709469|NCT02047110|616943213|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
170709470|NCT02047110|616943214|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
170709471|NCT02047110|616943215|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
170709472|NCT02047110|616943216|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
170709473|NCT02047110|616943213|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
170709474|NCT02047110|616943214|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
170709475|NCT02047110|616943215|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
170709476|NCT02047110|616943216|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
170709477|NCT02047110|616943213|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
170709478|NCT02047110|616943214|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
170709479|NCT02047110|616943215|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
170709480|NCT02047110|616943216|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
170709481|NCT02047110|616943213|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
170709482|NCT02047110|616943214|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
170709483|NCT02047110|616943215|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
170709484|NCT02047110|616943216|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
170709485|NCT02047110|616943213|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
170709486|NCT02047110|616943214|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
170709487|NCT02047110|616943215|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
170709488|NCT02047110|616943216|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
170709489|NCT02047110|616943213|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
170709490|NCT02047110|616943214|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
170709491|NCT02047110|616943215|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
170709492|NCT02047110|616943216|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
170709493|NCT02047110|616943213|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
170709494|NCT02047110|616943214|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
170709495|NCT02047110|616943215|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
170709496|NCT02047110|616943216|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
170709497|NCT02047110|616943213|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
170709498|NCT02047110|616943214|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
170827598|NCT01167192|617378102|FG000|Overall Study|Insurance denial|1|||
170827599|NCT01336205|617378103|FG000|Overall Study|Other|22|||
170827600|NCT01336205|617378104|FG001|Overall Study|Other|9|||
170827601|NCT01336205|617378103|FG000|Overall Study|Lost to Follow-up|40|||
170827602|NCT01336205|617378104|FG001|Overall Study|Lost to Follow-up|20|||
170827603|NCT01336205|617378103|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
170827604|NCT01336205|617378104|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
170827605|NCT01336205|617378103|FG000|Overall Study|Lack of Efficacy|4|||
170827606|NCT01336205|617378104|FG001|Overall Study|Lack of Efficacy|0|||
170827607|NCT01336205|617378103|FG000|Overall Study|Severe noncompliance with protocol|9|||
170827608|NCT01336205|617378104|FG001|Overall Study|Severe noncompliance with protocol|2|||
170827609|NCT01336205|617378103|FG000|Overall Study|Adverse Event|56|||
170827610|NCT01336205|617378104|FG001|Overall Study|Adverse Event|6|||
170827611|NCT01336205|617378103|FG000|Overall Study|Death|1|||
170827612|NCT01336205|617378104|FG001|Overall Study|Death|1|||
170827613|NCT01336205|617378103|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
170827614|NCT01336205|617378104|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
170827615|NCT01336205|617378103|FG000|Overall Study|Withdrawal by Subject|72|||
170827616|NCT01336205|617378104|FG001|Overall Study|Withdrawal by Subject|38|||
170827617|NCT01336205|617378103|FG000|Overall Study|Did not receive treatment|4|||
170827618|NCT01336205|617378104|FG001|Overall Study|Did not receive treatment|0|||
170827619|NCT00001941|617378113|FG000|Overall Study|not treated- rapidly progressing disease|0|||
170827620|NCT00001941|617378114|FG001|Overall Study|not treated- rapidly progressing disease|0|||
170709499|NCT02047110|616943215|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
170709500|NCT02047110|616943216|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
170709501|NCT02047110|616943213|FG000|Escape Treatment Period|Adverse Event|1|||
170709502|NCT02047110|616943214|FG001|Escape Treatment Period|Adverse Event|2|||
170709503|NCT02047110|616943215|FG002|Escape Treatment Period|Adverse Event|2|||
170709504|NCT02047110|616943216|FG003|Escape Treatment Period|Adverse Event|0|||
170709505|NCT02047110|616943213|FG000|Escape Treatment Period|Other than specified|1|||
170709506|NCT02047110|616943214|FG001|Escape Treatment Period|Other than specified|2|||
170827621|NCT00001941|617378115|FG002|Overall Study|not treated- rapidly progressing disease|0|||
170827622|NCT00001941|617378116|FG003|Overall Study|not treated- rapidly progressing disease|0|||
170827623|NCT00001941|617378117|FG004|Overall Study|not treated- rapidly progressing disease|1|||
170827624|NCT01281917|617378122|FG000|Overall Study|Withdrawal by Subject|1|||
170827625|NCT04016805|617378123|FG000|Overall Study|Sponsor's Discretion|30|||
170827626|NCT04016805|617378124|FG001|Overall Study|Sponsor's Discretion|6|||
170827627|NCT04016805|617378125|FG002|Overall Study|Sponsor's Discretion|5|||
170827628|NCT00545571|617378126|FG000|Overall Study|Administrative Reasons|1|||
170827629|NCT00545571|617378126|FG000|Overall Study|Adverse Event|2|||
170827630|NCT00545571|617378126|FG000|Overall Study|Death|5|||
170827631|NCT00545571|617378126|FG000|Overall Study|Lack of Efficacy|1|||
170827632|NCT00545571|617378126|FG000|Overall Study|Protocol Violation|2|||
170827633|NCT00545571|617378126|FG000|Overall Study|Refused Treatment|1|||
170827634|NCT00545571|617378126|FG000|Overall Study|Screen Failure|16|||
170827635|NCT00545571|617378126|FG000|Overall Study|Transfusion|12|||
170827636|NCT00545571|617378126|FG000|Overall Study|Early Termination of Study|24|||
170827637|NCT00545571|617378126|FG000|Overall Study|Kidney Transplantation|3|||
170827638|NCT00874497|617378127|FG000|Overall Study|Lost to Follow-up|2|||
170827639|NCT00874497|617378128|FG001|Overall Study|Lost to Follow-up|4|||
170827640|NCT00874497|617378127|FG000|Overall Study|Adverse Event|9|||
170827641|NCT00874497|617378128|FG001|Overall Study|Adverse Event|4|||
170827642|NCT00874497|617378127|FG000|Overall Study|Sponsor Discontinued Trial|7|||
170827643|NCT00874497|617378128|FG001|Overall Study|Sponsor Discontinued Trial|3|||
170827644|NCT00874497|617378127|FG000|Overall Study|Met Withdrawal Criteria|4|||
170827645|NCT00874497|617378128|FG001|Overall Study|Met Withdrawal Criteria|2|||
170827646|NCT00874497|617378127|FG000|Overall Study|Physician Decision|1|||
170827647|NCT00874497|617378128|FG001|Overall Study|Physician Decision|1|||
170709507|NCT02047110|616943215|FG002|Escape Treatment Period|Other than specified|0|||
170709508|NCT02047110|616943216|FG003|Escape Treatment Period|Other than specified|1|||
170709509|NCT02047110|616943213|FG000|OLE Treatment Period|Other than specified|0|||
170827648|NCT00874497|617378127|FG000|Overall Study|Withdrawal by Subject|5|||
170827649|NCT00874497|617378128|FG001|Overall Study|Withdrawal by Subject|4|||
170827650|NCT00505414|617378130|FG000|Titration Phase|Adverse Event|0|||
170827651|NCT00505414|617378131|FG001|Titration Phase|Adverse Event|0|||
170827652|NCT00505414|617378132|FG002|Titration Phase|Adverse Event|0|||
170827653|NCT00505414|617378133|FG003|Titration Phase|Adverse Event|8|||
170709510|NCT02047110|616943214|FG001|OLE Treatment Period|Other than specified|0|||
170709511|NCT02047110|616943215|FG002|OLE Treatment Period|Other than specified|1|||
170709512|NCT02047110|616943216|FG003|OLE Treatment Period|Other than specified|0|||
170709513|NCT00699699|616943217|FG000|Overall Study|Adverse Event|36|||
170709514|NCT00699699|616943217|FG000|Overall Study|Individual different reasons|21|||
170827654|NCT00505414|617378134|FG004|Titration Phase|Adverse Event|3|||
170827655|NCT00505414|617378130|FG000|Titration Phase|Death|0|||
170827656|NCT00505414|617378131|FG001|Titration Phase|Death|0|||
170827657|NCT00505414|617378132|FG002|Titration Phase|Death|0|||
170827658|NCT00505414|617378133|FG003|Titration Phase|Death|2|||
170827659|NCT00505414|617378134|FG004|Titration Phase|Death|0|||
170709515|NCT00705575|616943218|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170709516|NCT00705575|616943219|FG001|Overall Study|Abnormal laboratory value(s)|3|||
170709517|NCT00705575|616943218|FG000|Overall Study|Abnormal test procedure result(s)|2|||
170709518|NCT00705575|616943219|FG001|Overall Study|Abnormal test procedure result(s)|12|||
170709519|NCT00705575|616943218|FG000|Overall Study|Adverse Event|11|||
170709520|NCT00705575|616943219|FG001|Overall Study|Adverse Event|15|||
170709521|NCT00705575|616943218|FG000|Overall Study|Lost to Follow-up|3|||
170709522|NCT00705575|616943219|FG001|Overall Study|Lost to Follow-up|4|||
170709523|NCT00705575|616943218|FG000|Overall Study|Protocol Violation|2|||
170709524|NCT00705575|616943219|FG001|Overall Study|Protocol Violation|2|||
170709525|NCT00705575|616943218|FG000|Overall Study|Withdrawal by Subject|5|||
170709526|NCT00705575|616943219|FG001|Overall Study|Withdrawal by Subject|10|||
170709527|NCT00724451|616943222|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
170709528|NCT00724451|616943222|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
170709529|NCT00724451|616943222|FG000|Overall Study|Not Eligible for Treatment|431|||
170709530|NCT00724451|616943222|FG000|Overall Study|Participant Refused Treatment|89|||
170709531|NCT00724451|616943222|FG000|Overall Study|Never Started Treatment|89|||
170709532|NCT00724451|616943222|FG000|Overall Study|Unknown; No Data Sources Available|9|||
170709533|NCT00724451|616943222|FG000|Overall Study|Physician Decision|116|||
170709534|NCT00724451|616943222|FG000|Overall Study|Withdrawal by Subject|45|||
170709535|NCT00724451|616943222|FG000|Overall Study|Investigator + Participant Decision|13|||
170709536|NCT02170727|616943223|FG000|Overall Study|Lost to Follow-up|1|||
170709537|NCT02170727|616943224|FG001|Overall Study|Lost to Follow-up|0|||
170709538|NCT02170727|616943223|FG000|Overall Study|Withdrawal by Subject|2|||
170709539|NCT02170727|616943224|FG001|Overall Study|Withdrawal by Subject|0|||
170709540|NCT01959581|616943229|FG000|Overall Study|Lost to Follow-up|5|||
170709541|NCT00720876|616943240|FG000|Overall Study|found to be ineligible after starting tx|2|||
170709542|NCT03495908|616943242|FG000|Overall Study|Withdrawal by Subject|3|||
170709543|NCT03495908|616943243|FG001|Overall Study|Withdrawal by Subject|1|||
170709544|NCT03495908|616943242|FG000|Overall Study|Lost to Follow-up|1|||
170709545|NCT03495908|616943243|FG001|Overall Study|Lost to Follow-up|4|||
170709546|NCT03495908|616943242|FG000|Overall Study|Adverse Event|0|||
170709547|NCT03495908|616943243|FG001|Overall Study|Adverse Event|2|||
170709548|NCT03495908|616943242|FG000|Overall Study|Death|1|||
170709549|NCT03495908|616943243|FG001|Overall Study|Death|0|||
170709550|NCT03495908|616943242|FG000|Overall Study|Physician Decision|5|||
170709551|NCT03495908|616943243|FG001|Overall Study|Physician Decision|4|||
170709552|NCT03495908|616943242|FG000|Overall Study|No documented reason|0|||
170709553|NCT03495908|616943243|FG001|Overall Study|No documented reason|2|||
170709554|NCT03304379|616943244|FG000|Overall Study|Protocol Violation|8|||
170709555|NCT03304379|616943245|FG001|Overall Study|Protocol Violation|10|||
170709556|NCT03304379|616943246|FG002|Overall Study|Protocol Violation|5|||
170709557|NCT03304379|616943247|FG003|Overall Study|Protocol Violation|0|||
170709558|NCT03304379|616943248|FG004|Overall Study|Protocol Violation|2|||
170709559|NCT03304379|616943244|FG000|Overall Study|Adverse Event|4|||
170709560|NCT03304379|616943245|FG001|Overall Study|Adverse Event|20|||
170709561|NCT03304379|616943246|FG002|Overall Study|Adverse Event|17|||
170709562|NCT03304379|616943247|FG003|Overall Study|Adverse Event|1|||
170709563|NCT03304379|616943248|FG004|Overall Study|Adverse Event|0|||
170709564|NCT03304379|616943244|FG000|Overall Study|Lack of Efficacy|17|||
170709565|NCT03304379|616943245|FG001|Overall Study|Lack of Efficacy|16|||
170709566|NCT03304379|616943246|FG002|Overall Study|Lack of Efficacy|20|||
170709567|NCT03304379|616943247|FG003|Overall Study|Lack of Efficacy|0|||
170709568|NCT03304379|616943248|FG004|Overall Study|Lack of Efficacy|0|||
170709569|NCT03304379|616943244|FG000|Overall Study|Physician Decision|6|||
170709570|NCT03304379|616943245|FG001|Overall Study|Physician Decision|10|||
170709571|NCT03304379|616943246|FG002|Overall Study|Physician Decision|6|||
170709572|NCT03304379|616943247|FG003|Overall Study|Physician Decision|9|||
170709573|NCT03304379|616943248|FG004|Overall Study|Physician Decision|10|||
170709574|NCT03304379|616943244|FG000|Overall Study|Withdrawal by Subject|26|||
170709575|NCT03304379|616943245|FG001|Overall Study|Withdrawal by Subject|58|||
170827660|NCT00505414|617378130|FG000|Titration Phase|Lack of Efficacy|0|||
170827661|NCT00505414|617378131|FG001|Titration Phase|Lack of Efficacy|0|||
170827662|NCT00505414|617378132|FG002|Titration Phase|Lack of Efficacy|0|||
170827663|NCT00505414|617378133|FG003|Titration Phase|Lack of Efficacy|10|||
170827664|NCT00505414|617378134|FG004|Titration Phase|Lack of Efficacy|1|||
170827665|NCT00505414|617378130|FG000|Titration Phase|Protocol Violation|0|||
170827666|NCT00505414|617378131|FG001|Titration Phase|Protocol Violation|0|||
170827667|NCT00505414|617378132|FG002|Titration Phase|Protocol Violation|0|||
170827668|NCT00505414|617378133|FG003|Titration Phase|Protocol Violation|0|||
170827669|NCT00505414|617378134|FG004|Titration Phase|Protocol Violation|1|||
170827670|NCT00505414|617378130|FG000|Titration Phase|Withdrawal by Subject|0|||
170827671|NCT00505414|617378131|FG001|Titration Phase|Withdrawal by Subject|0|||
170827672|NCT00505414|617378132|FG002|Titration Phase|Withdrawal by Subject|0|||
170827673|NCT00505414|617378133|FG003|Titration Phase|Withdrawal by Subject|3|||
170827674|NCT00505414|617378134|FG004|Titration Phase|Withdrawal by Subject|4|||
170827675|NCT00505414|617378130|FG000|Titration Phase|Underlying disease and therapy required|0|||
170827676|NCT00505414|617378131|FG001|Titration Phase|Underlying disease and therapy required|0|||
170827677|NCT00505414|617378132|FG002|Titration Phase|Underlying disease and therapy required|0|||
170827678|NCT00505414|617378133|FG003|Titration Phase|Underlying disease and therapy required|7|||
170827679|NCT00505414|617378134|FG004|Titration Phase|Underlying disease and therapy required|3|||
170827680|NCT00505414|617378130|FG000|Maintenance Phase|Adverse Event|2|||
170827681|NCT00505414|617378131|FG001|Maintenance Phase|Adverse Event|2|||
170827682|NCT00505414|617378132|FG002|Maintenance Phase|Adverse Event|3|||
170827683|NCT00505414|617378133|FG003|Maintenance Phase|Adverse Event|0|||
170827684|NCT00505414|617378134|FG004|Maintenance Phase|Adverse Event|0|||
170827685|NCT00505414|617378130|FG000|Maintenance Phase|Death|2|||
170827686|NCT00505414|617378131|FG001|Maintenance Phase|Death|0|||
170827687|NCT00505414|617378132|FG002|Maintenance Phase|Death|1|||
170827688|NCT00505414|617378133|FG003|Maintenance Phase|Death|0|||
170827689|NCT00505414|617378134|FG004|Maintenance Phase|Death|0|||
170827690|NCT00505414|617378130|FG000|Maintenance Phase|Lack of Efficacy|2|||
170827691|NCT00505414|617378131|FG001|Maintenance Phase|Lack of Efficacy|1|||
170827692|NCT00505414|617378132|FG002|Maintenance Phase|Lack of Efficacy|1|||
170827693|NCT00505414|617378133|FG003|Maintenance Phase|Lack of Efficacy|0|||
170827694|NCT00505414|617378134|FG004|Maintenance Phase|Lack of Efficacy|0|||
170827695|NCT00505414|617378130|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170709576|NCT03304379|616943246|FG002|Overall Study|Withdrawal by Subject|66|||
170709577|NCT03304379|616943247|FG003|Overall Study|Withdrawal by Subject|3|||
170709578|NCT03304379|616943248|FG004|Overall Study|Withdrawal by Subject|5|||
170709579|NCT03304379|616943244|FG000|Overall Study|Lost to Follow-up|8|||
170709580|NCT03304379|616943245|FG001|Overall Study|Lost to Follow-up|24|||
170709581|NCT03304379|616943246|FG002|Overall Study|Lost to Follow-up|35|||
170709582|NCT03304379|616943247|FG003|Overall Study|Lost to Follow-up|4|||
170709583|NCT03304379|616943248|FG004|Overall Study|Lost to Follow-up|0|||
170709584|NCT03304379|616943244|FG000|Overall Study|Death|1|||
170709585|NCT03304379|616943245|FG001|Overall Study|Death|2|||
170709586|NCT03304379|616943246|FG002|Overall Study|Death|0|||
170709587|NCT03304379|616943247|FG003|Overall Study|Death|0|||
170709588|NCT03304379|616943248|FG004|Overall Study|Death|0|||
170709589|NCT03304379|616943244|FG000|Overall Study|Other|0|||
170709590|NCT03304379|616943245|FG001|Overall Study|Other|1|||
170709591|NCT03304379|616943246|FG002|Overall Study|Other|0|||
170709592|NCT03304379|616943247|FG003|Overall Study|Other|0|||
170709593|NCT03304379|616943248|FG004|Overall Study|Other|0|||
170709594|NCT02802345|616943251|FG000|Overall Study|Not Treated|0|||
170709595|NCT02802345|616943252|FG001|Overall Study|Not Treated|1|||
170709596|NCT02802345|616943251|FG000|Overall Study|Adverse Event|28|||
170709597|NCT02802345|616943252|FG001|Overall Study|Adverse Event|20|||
170709598|NCT02802345|616943251|FG000|Overall Study|Withdrawal by Subject|3|||
170709599|NCT02802345|616943252|FG001|Overall Study|Withdrawal by Subject|3|||
170709600|NCT02802345|616943251|FG000|Overall Study|Protocol Violation|0|||
170709601|NCT02802345|616943252|FG001|Overall Study|Protocol Violation|1|||
170709602|NCT02802345|616943251|FG000|Overall Study|Other than listed|1|||
170709603|NCT02802345|616943252|FG001|Overall Study|Other than listed|5|||
170709604|NCT02985736|616943255|FG000|Overall Study|Lost to Follow-up|3|||
170827696|NCT00505414|617378131|FG001|Maintenance Phase|Withdrawal by Subject|0|||
170709605|NCT00550836|616943256|FG000|Overall Study|Withdrawal by Subject|3|||
170709606|NCT00550836|616943257|FG001|Overall Study|Withdrawal by Subject|9|||
170709607|NCT03027466|616943258|FG000|Overall Study|Opting out of the app|1869|||
170709608|NCT03027466|616943259|FG001|Overall Study|Opting out of the app|1819|||
170709609|NCT03027466|616943260|FG002|Overall Study|Opting out of the app|1743|||
170709610|NCT03027466|616943261|FG003|Overall Study|Opting out of the app|1821|||
170827697|NCT00505414|617378132|FG002|Maintenance Phase|Withdrawal by Subject|1|||
170827698|NCT00505414|617378133|FG003|Maintenance Phase|Withdrawal by Subject|0|||
170827699|NCT00505414|617378134|FG004|Maintenance Phase|Withdrawal by Subject|0|||
170827700|NCT00505414|617378130|FG000|Maintenance Phase|underlying disease and therapy required|0|||
170827701|NCT00505414|617378131|FG001|Maintenance Phase|underlying disease and therapy required|2|||
170827702|NCT00505414|617378132|FG002|Maintenance Phase|underlying disease and therapy required|2|||
170709611|NCT01826825|616943262|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
170709612|NCT01826825|616943263|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
170709613|NCT02158039|616943264|FG000|Overall Study|Withdrawal by Subject|1|||
170709614|NCT02158039|616943264|FG000|Overall Study|Screen Failure|9|||
170709615|NCT00515827|616943265|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
170709616|NCT00515827|616943266|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
170709617|NCT00515827|616943265|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
170709618|NCT00515827|616943266|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
170709619|NCT03254134|616943268|FG000|Overall Study|Not eligible patients|599|||
170709620|NCT03254134|616943269|FG001|Overall Study|Not eligible patients|3630|||
170709621|NCT00205712|616943270|FG000|Overall Study|Lost to Follow-up|0|||
170709622|NCT00205712|616943271|FG001|Overall Study|Lost to Follow-up|1|||
170709623|NCT01071512|616943272|FG000|Overall Study|Adverse Event|1|||
170709624|NCT01071512|616943272|FG000|Overall Study|Development of antibodies to drug|2|||
170709625|NCT01071512|616943272|FG000|Overall Study|positive anti-JC virus antibody test|2|||
170709626|NCT02188485|616943273|FG000|Overall Study|Withdrawal by Subject|2|||
170709627|NCT02188485|616943274|FG001|Overall Study|Withdrawal by Subject|1|||
170709628|NCT02188485|616943273|FG000|Overall Study|PI withdrew, lack of capacity|0|||
170709629|NCT02188485|616943274|FG001|Overall Study|PI withdrew, lack of capacity|2|||
170709630|NCT00308711|616943275|FG000|Overall Study|Withdrawal by Subject|1|||
170709631|NCT00308711|616943276|FG001|Overall Study|Withdrawal by Subject|0|||
170709632|NCT00308711|616943277|FG002|Overall Study|Withdrawal by Subject|1|||
170709633|NCT00308711|616943275|FG000|Overall Study|Protocol Violation|0|||
170709634|NCT00308711|616943276|FG001|Overall Study|Protocol Violation|1|||
170709635|NCT00308711|616943277|FG002|Overall Study|Protocol Violation|1|||
170709636|NCT00308711|616943275|FG000|Overall Study|Lost to Follow-up|0|||
170709637|NCT00308711|616943276|FG001|Overall Study|Lost to Follow-up|1|||
170709638|NCT00308711|616943277|FG002|Overall Study|Lost to Follow-up|0|||
170709639|NCT00308711|616943275|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
170709640|NCT00308711|616943276|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
170709641|NCT00308711|616943277|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
170709642|NCT00308711|616943275|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
170709643|NCT00308711|616943276|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
170709644|NCT00308711|616943277|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
170709645|NCT03139916|616943278|FG000|Overall Study|Withdrawal by Subject|2|||
170709646|NCT03139916|616943278|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
170709647|NCT01957475|616943279|FG000|Test Period 1|Withdrawal by Subject|1|||
170709648|NCT01957475|616943280|FG001|Test Period 1|Withdrawal by Subject|0|||
170709649|NCT01957475|616943279|FG000|Test Period 1|Other|1|||
170709650|NCT01957475|616943280|FG001|Test Period 1|Other|0|||
170709651|NCT01957475|616943279|FG000|Test Period 1|Lack of Efficacy|0|||
170709652|NCT01957475|616943280|FG001|Test Period 1|Lack of Efficacy|1|||
170709653|NCT01957475|616943279|FG000|Test Period 2|Adverse Event|1|||
170709654|NCT01957475|616943280|FG001|Test Period 2|Adverse Event|0|||
170709655|NCT02469610|616943281|FG000|Overall Study|Death|1|||
170709656|NCT02469610|616943282|FG001|Overall Study|Death|0|||
170709657|NCT02469610|616943281|FG000|Overall Study|Lost to Follow-up|1|||
170709658|NCT02469610|616943282|FG001|Overall Study|Lost to Follow-up|0|||
170709659|NCT02469610|616943281|FG000|Overall Study|exclusion criteria|2|||
170709660|NCT02469610|616943282|FG001|Overall Study|exclusion criteria|1|||
170709661|NCT01848990|616943284|FG000|Overall Study|Adverse Event|6|||
170709662|NCT01848990|616943285|FG001|Overall Study|Adverse Event|2|||
170709663|NCT01848990|616943286|FG002|Overall Study|Adverse Event|0|||
170709664|NCT01848990|616943284|FG000|Overall Study|Lost to Follow-up|6|||
170709665|NCT01848990|616943285|FG001|Overall Study|Lost to Follow-up|2|||
170709666|NCT01848990|616943286|FG002|Overall Study|Lost to Follow-up|2|||
170709667|NCT01848990|616943284|FG000|Overall Study|Protocol Violation|1|||
170709668|NCT01848990|616943285|FG001|Overall Study|Protocol Violation|1|||
170709669|NCT01848990|616943286|FG002|Overall Study|Protocol Violation|0|||
170709670|NCT01848990|616943284|FG000|Overall Study|Withdrawal by Subject|29|||
170709671|NCT01848990|616943285|FG001|Overall Study|Withdrawal by Subject|10|||
170709672|NCT01848990|616943286|FG002|Overall Study|Withdrawal by Subject|11|||
170709673|NCT01848990|616943284|FG000|Overall Study|Physician Decision|1|||
170709674|NCT01848990|616943285|FG001|Overall Study|Physician Decision|1|||
170709675|NCT01848990|616943286|FG002|Overall Study|Physician Decision|0|||
170709676|NCT01848990|616943284|FG000|Overall Study|Non Compliance|1|||
170709677|NCT01848990|616943285|FG001|Overall Study|Non Compliance|0|||
170709678|NCT01848990|616943286|FG002|Overall Study|Non Compliance|0|||
170709679|NCT01848990|616943284|FG000|Overall Study|Death|1|||
170709680|NCT01848990|616943285|FG001|Overall Study|Death|0|||
170709681|NCT01848990|616943286|FG002|Overall Study|Death|1|||
170709682|NCT01848990|616943284|FG000|Overall Study|Other|1|||
170709683|NCT01848990|616943285|FG001|Overall Study|Other|4|||
170709684|NCT01848990|616943286|FG002|Overall Study|Other|2|||
170709685|NCT00218543|616943287|FG000|Overall Study|Lost to Follow-up|8|||
170709686|NCT00218543|616943287|FG000|Overall Study|relocated|1|||
170709687|NCT00218543|616943287|FG000|Overall Study|Withdrawal by Subject|1|||
170709688|NCT00218543|616943287|FG000|Overall Study|Physician Decision|3|||
170709689|NCT00218543|616943287|FG000|Overall Study|Adverse Event|2|||
170709690|NCT00586469|616943291|FG000|Overall Study|Adverse Event|0|||
170709691|NCT00586469|616943292|FG001|Overall Study|Adverse Event|1|||
170709692|NCT00298038|616943297|FG000|Overall Study|Lost to Follow-up|0|||
170709693|NCT00298038|616943298|FG001|Overall Study|Lost to Follow-up|1|||
170709694|NCT00298038|616943297|FG000|Overall Study|Liver Transplant|0|||
170709695|NCT00298038|616943298|FG001|Overall Study|Liver Transplant|1|||
170709696|NCT00298038|616943297|FG000|Overall Study|Protocol Violation|1|||
170709697|NCT00298038|616943298|FG001|Overall Study|Protocol Violation|3|||
170709698|NCT00298038|616943297|FG000|Overall Study|Death|6|||
170709699|NCT00298038|616943298|FG001|Overall Study|Death|3|||
170709700|NCT00298038|616943297|FG000|Overall Study|Withdrawal by Subject|6|||
170709701|NCT00298038|616943298|FG001|Overall Study|Withdrawal by Subject|9|||
170709702|NCT00298038|616943297|FG000|Overall Study|Adverse Event|8|||
170709703|NCT00298038|616943298|FG001|Overall Study|Adverse Event|7|||
170709704|NCT00298038|616943297|FG000|Overall Study|Breakthrough overt HE episode|28|||
170709705|NCT00298038|616943298|FG001|Overall Study|Breakthrough overt HE episode|69|||
170709706|NCT00298038|616943297|FG000|Overall Study|Noncompliance|1|||
170709707|NCT00298038|616943298|FG001|Overall Study|Noncompliance|0|||
170709708|NCT00298038|616943297|FG000|Overall Study|Cocaine Abuse|1|||
170709709|NCT00298038|616943298|FG001|Overall Study|Cocaine Abuse|0|||
170709710|NCT00298038|616943297|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
170709711|NCT00298038|616943298|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
170709712|NCT01818336|616944931|FG000|Overall Study|Declined retest visit|0|||
170709713|NCT01818336|616944932|FG001|Overall Study|Declined retest visit|11|||
170709714|NCT01818336|616944931|FG000|Overall Study|Lost to Follow-up|0|||
170709715|NCT01818336|616944932|FG001|Overall Study|Lost to Follow-up|1|||
170709716|NCT03042312|616944933|FG000|Overall Study|Administrative Reason|1|||
170709717|NCT03042312|616944934|FG001|Overall Study|Administrative Reason|1|||
170709718|NCT03042312|616944933|FG000|Overall Study|Adverse Event|0|||
170709719|NCT03042312|616944934|FG001|Overall Study|Adverse Event|1|||
170709720|NCT03042312|616944933|FG000|Overall Study|Lost to Follow-up|1|||
170709721|NCT03042312|616944934|FG001|Overall Study|Lost to Follow-up|3|||
170709722|NCT03042312|616944933|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
170709723|NCT03042312|616944934|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
170709724|NCT03042312|616944933|FG000|Overall Study|Withdrawal by Subject|4|||
170709725|NCT03042312|616944934|FG001|Overall Study|Withdrawal by Subject|5|||
170709726|NCT02383758|616944935|FG000|Overall Study|Withdrawal by Subject|0|||
170709727|NCT02383758|616944936|FG001|Overall Study|Withdrawal by Subject|2|||
170709728|NCT04258839|616944937|FG000|Overall Study|Adverse Event|2|||
170709729|NCT04258839|616944938|FG001|Overall Study|Adverse Event|4|||
170709730|NCT04258839|616944937|FG000|Overall Study|Lack of Efficacy|0|||
170709731|NCT04258839|616944938|FG001|Overall Study|Lack of Efficacy|2|||
170709732|NCT04258839|616944937|FG000|Overall Study|Lost to Follow-up|2|||
170709733|NCT04258839|616944938|FG001|Overall Study|Lost to Follow-up|0|||
170709734|NCT04258839|616944937|FG000|Overall Study|Withdrawal by Subject|1|||
170709735|NCT04258839|616944938|FG001|Overall Study|Withdrawal by Subject|2|||
170709736|NCT04258839|616944937|FG000|Overall Study|Withdrawal by Caregiver|5|||
170709737|NCT04258839|616944938|FG001|Overall Study|Withdrawal by Caregiver|6|||
170709738|NCT04258839|616944937|FG000|Overall Study|Reason not Specified|0|||
170709739|NCT04258839|616944938|FG001|Overall Study|Reason not Specified|1|||
170709740|NCT02648698|616944939|FG000|Overall Study|Protocol Violation|1|||
170709741|NCT02648698|616944940|FG001|Overall Study|Protocol Violation|5|||
170709742|NCT00672477|616944943|FG000|Overall Study|Adverse Event|10|||
170709743|NCT00672477|616944944|FG001|Overall Study|Adverse Event|7|||
170709744|NCT00672477|616944943|FG000|Overall Study|Death|7|||
170709745|NCT00672477|616944944|FG001|Overall Study|Death|11|||
170709746|NCT00672477|616944943|FG000|Overall Study|Physician Decision|2|||
170709747|NCT00672477|616944944|FG001|Overall Study|Physician Decision|0|||
170709748|NCT00672477|616944943|FG000|Overall Study|Protocol Violation|1|||
170709749|NCT00672477|616944944|FG001|Overall Study|Protocol Violation|1|||
170709750|NCT00672477|616944943|FG000|Overall Study|Withdrawal by Subject|5|||
170709751|NCT00672477|616944944|FG001|Overall Study|Withdrawal by Subject|3|||
170709752|NCT00672477|616944943|FG000|Overall Study|Lack of Efficacy|1|||
170709753|NCT00672477|616944944|FG001|Overall Study|Lack of Efficacy|1|||
170709754|NCT00672477|616944943|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
170709755|NCT00672477|616944944|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
170709756|NCT02866682|616944948|FG000|Overall Study|Death|0|||
170709757|NCT02866682|616944949|FG001|Overall Study|Death|1|||
170709758|NCT02866682|616944948|FG000|Overall Study|Lost to Follow-up|0|||
170709759|NCT02866682|616944949|FG001|Overall Study|Lost to Follow-up|4|||
170709760|NCT02866682|616944948|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
170709761|NCT02866682|616944949|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
170709762|NCT02866682|616944948|FG000|Overall Study|Other|0|||
170709763|NCT02866682|616944949|FG001|Overall Study|Other|1|||
170709764|NCT01750268|616944950|FG000|Overall Study|Lost to Follow-up|0|||
170709765|NCT01750268|616944951|FG001|Overall Study|Lost to Follow-up|2|||
170709766|NCT01750268|616944950|FG000|Overall Study|Physician Decision|0|||
170709767|NCT01750268|616944951|FG001|Overall Study|Physician Decision|3|||
170709768|NCT01750268|616944950|FG000|Overall Study|Withdrawal by Subject|2|||
170709769|NCT01750268|616944951|FG001|Overall Study|Withdrawal by Subject|0|||
170709770|NCT00966940|616944952|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
170709771|NCT00966940|616944953|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
170709772|NCT00966940|616944952|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
170709773|NCT00966940|616944953|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
170709774|NCT01040871|616944956|FG000|Overall Study|Adverse Event|6|||
170709775|NCT01040871|616944957|FG001|Overall Study|Adverse Event|2|||
170709776|NCT01040871|616944956|FG000|Overall Study|Withdrawal by Subject|2|||
170709777|NCT01040871|616944957|FG001|Overall Study|Withdrawal by Subject|0|||
170709778|NCT01040871|616944956|FG000|Overall Study|Death|1|||
170709779|NCT01040871|616944957|FG001|Overall Study|Death|3|||
170709780|NCT01040871|616944956|FG000|Overall Study|Lack of Efficacy|1|||
170709781|NCT01040871|616944957|FG001|Overall Study|Lack of Efficacy|1|||
170709782|NCT01040871|616944956|FG000|Overall Study|drug supply issue|1|||
170709783|NCT01040871|616944957|FG001|Overall Study|drug supply issue|0|||
170709784|NCT01040871|616944956|FG000|Overall Study|Randomized and Not Treated|2|||
170709785|NCT01040871|616944957|FG001|Overall Study|Randomized and Not Treated|1|||
170709786|NCT02886572|616944958|FG000|Overall Study|Death|8|||
170709787|NCT03087591|616944963|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
170709788|NCT03087591|616944963|FG000|Overall Study|Withdrawal by Subject|1|||
170709789|NCT00408993|616944964|FG000|Overall Study|Adverse Event|15|||
170709790|NCT00408993|616944965|FG001|Overall Study|Adverse Event|4|||
170709791|NCT00408993|616944964|FG000|Overall Study|Protocol Violation|1|||
170709792|NCT00408993|616944965|FG001|Overall Study|Protocol Violation|6|||
170709793|NCT00408993|616944964|FG000|Overall Study|Lack of Efficacy|1|||
170709794|NCT00408993|616944965|FG001|Overall Study|Lack of Efficacy|4|||
170709795|NCT00408993|616944964|FG000|Overall Study|Withdrawal by Subject|2|||
170709796|NCT00408993|616944965|FG001|Overall Study|Withdrawal by Subject|3|||
170709797|NCT02212730|616944966|FG000|Overall Study|Tumor not of the required cell histology|1|||
170827703|NCT00505414|617378133|FG003|Maintenance Phase|underlying disease and therapy required|0|||
170827704|NCT00505414|617378134|FG004|Maintenance Phase|underlying disease and therapy required|0|||
170827705|NCT00583115|617378135|FG000|Overall Study|Death|1|||
170827706|NCT00740870|617378136|FG000|Overall Study|Not Catheterized|4|||
170827707|NCT00740870|617378136|FG000|Overall Study|Further testing contraindicated implant|17|||
170827708|NCT00591591|617378137|FG000|Overall Study|Withdrawal by Subject|1|||
170827709|NCT00591591|617378138|FG001|Overall Study|Withdrawal by Subject|37|||
170827710|NCT00591591|617378137|FG000|Overall Study|Lack of Efficacy|10|||
170827711|NCT00591591|617378138|FG001|Overall Study|Lack of Efficacy|2|||
170827712|NCT01013740|617378139|FG000|Overall Study|Lost to Follow-up|3|||
170827713|NCT01013740|617378140|FG001|Overall Study|Lost to Follow-up|5|||
170827714|NCT01013740|617378139|FG000|Overall Study|Physician Decision|2|||
170827715|NCT01013740|617378140|FG001|Overall Study|Physician Decision|0|||
170827716|NCT01013740|617378139|FG000|Overall Study|Withdrawal by Subject|2|||
170827717|NCT01013740|617378140|FG001|Overall Study|Withdrawal by Subject|10|||
170827718|NCT01013740|617378139|FG000|Overall Study|study close / terminated : done in error|2|||
170827719|NCT01013740|617378140|FG001|Overall Study|study close / terminated : done in error|1|||
170827720|NCT01013740|617378139|FG000|Overall Study|Missing|2|||
170827721|NCT01013740|617378140|FG001|Overall Study|Missing|1|||
170827722|NCT01013740|617378139|FG000|Overall Study|Ongoing: Study records not completed|0|||
170827723|NCT01013740|617378140|FG001|Overall Study|Ongoing: Study records not completed|2|||
170827724|NCT00607997|617378141|FG000|Overall Study|Lack of Efficacy|6|||
170827725|NCT00607997|617378142|FG001|Overall Study|Lack of Efficacy|20|||
170827726|NCT00607997|617378143|FG002|Overall Study|Lack of Efficacy|14|||
170827727|NCT00607997|617378144|FG003|Overall Study|Lack of Efficacy|10|||
170827728|NCT00607997|617378141|FG000|Overall Study|Death|8|||
170827729|NCT00607997|617378142|FG001|Overall Study|Death|5|||
170827730|NCT00607997|617378143|FG002|Overall Study|Death|2|||
170827731|NCT00607997|617378144|FG003|Overall Study|Death|5|||
170827732|NCT00607997|617378141|FG000|Overall Study|Adverse Event|3|||
170827733|NCT00607997|617378142|FG001|Overall Study|Adverse Event|1|||
170709798|NCT02212730|616944967|FG001|Overall Study|Tumor not of the required cell histology|0|||
170709799|NCT02212730|616944966|FG000|Overall Study|Withdrawal by Subject|1|||
170827734|NCT00607997|617378143|FG002|Overall Study|Adverse Event|2|||
170827735|NCT00607997|617378144|FG003|Overall Study|Adverse Event|0|||
170827736|NCT00607997|617378141|FG000|Overall Study|Physician Decision|4|||
170827737|NCT00607997|617378142|FG001|Overall Study|Physician Decision|1|||
170709800|NCT02212730|616944967|FG001|Overall Study|Withdrawal by Subject|0|||
170709801|NCT02212730|616944966|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
170709802|NCT02212730|616944967|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
170709803|NCT04086472|616944968|FG000|Overall Study|Lost to Follow-up|1|||
170709804|NCT04086472|616944969|FG001|Overall Study|Lost to Follow-up|0|||
170709805|NCT04086472|616944970|FG002|Overall Study|Lost to Follow-up|0|||
170709806|NCT04086472|616944971|FG003|Overall Study|Lost to Follow-up|0|||
170709807|NCT04086472|616944972|FG004|Overall Study|Lost to Follow-up|1|||
170709808|NCT04086472|616944968|FG000|Overall Study|Physician Decision|0|||
170709809|NCT04086472|616944969|FG001|Overall Study|Physician Decision|1|||
170709810|NCT04086472|616944970|FG002|Overall Study|Physician Decision|1|||
170709811|NCT04086472|616944971|FG003|Overall Study|Physician Decision|0|||
170709812|NCT04086472|616944972|FG004|Overall Study|Physician Decision|0|||
170709813|NCT04086472|616944968|FG000|Overall Study|Withdrawal by Subject|1|||
170709814|NCT04086472|616944969|FG001|Overall Study|Withdrawal by Subject|1|||
170709815|NCT04086472|616944970|FG002|Overall Study|Withdrawal by Subject|1|||
170709816|NCT04086472|616944971|FG003|Overall Study|Withdrawal by Subject|0|||
170709817|NCT04086472|616944972|FG004|Overall Study|Withdrawal by Subject|0|||
170709818|NCT04086472|616944968|FG000|Overall Study|Various reasons|2|||
170709819|NCT04086472|616944969|FG001|Overall Study|Various reasons|0|||
170709820|NCT04086472|616944970|FG002|Overall Study|Various reasons|0|||
170709821|NCT04086472|616944971|FG003|Overall Study|Various reasons|3|||
170709822|NCT04086472|616944972|FG004|Overall Study|Various reasons|1|||
170709823|NCT01743092|616944973|FG000|Overall Study|Lost to Follow-up|14|||
170709824|NCT01743092|616944974|FG001|Overall Study|Lost to Follow-up|15|||
170709825|NCT01532687|616944978|FG000|Overall Study|Death|2|||
170709826|NCT01532687|616944979|FG001|Overall Study|Death|0|||
170709827|NCT01532687|616944978|FG000|Overall Study|Adverse Event|6|||
170709828|NCT01532687|616944979|FG001|Overall Study|Adverse Event|1|||
170709829|NCT01532687|616944978|FG000|Overall Study|Withdrawal by Subject|1|||
170709830|NCT01532687|616944979|FG001|Overall Study|Withdrawal by Subject|0|||
170709831|NCT01532687|616944978|FG000|Overall Study|Physician Decision|2|||
170709832|NCT01532687|616944979|FG001|Overall Study|Physician Decision|1|||
170709833|NCT01532687|616944978|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
170709834|NCT01532687|616944979|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
170709835|NCT04116229|616944980|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
170709836|NCT04116229|616944981|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
170709837|NCT04116229|616944980|FG000|Overall Study|Scheduling not possible.|0|||
170709838|NCT04116229|616944981|FG001|Overall Study|Scheduling not possible.|1|||
170709839|NCT01931839|616944985|FG000|Overall Study|Death|0|||
170709840|NCT01931839|616944986|FG001|Overall Study|Death|1|||
170709841|NCT01931839|616944987|FG002|Overall Study|Death|2|||
170709842|NCT01931839|616944988|FG003|Overall Study|Death|0|||
170709843|NCT01931839|616944989|FG004|Overall Study|Death|0|||
170709844|NCT01931839|616944990|FG005|Overall Study|Death|0|||
170709845|NCT01931839|616944991|FG006|Overall Study|Death|0|||
170709846|NCT01931839|616944985|FG000|Overall Study|Physician Decision|1|||
170709847|NCT01931839|616944986|FG001|Overall Study|Physician Decision|0|||
170709848|NCT01931839|616944987|FG002|Overall Study|Physician Decision|1|||
170709849|NCT01931839|616944988|FG003|Overall Study|Physician Decision|0|||
170709850|NCT01931839|616944989|FG004|Overall Study|Physician Decision|0|||
170709851|NCT01931839|616944990|FG005|Overall Study|Physician Decision|0|||
170709852|NCT01931839|616944991|FG006|Overall Study|Physician Decision|1|||
170709853|NCT01931839|616944985|FG000|Overall Study|Withdrawal of consent|0|||
170709854|NCT01931839|616944986|FG001|Overall Study|Withdrawal of consent|0|||
170709855|NCT01931839|616944987|FG002|Overall Study|Withdrawal of consent|0|||
170709856|NCT01931839|616944988|FG003|Overall Study|Withdrawal of consent|0|||
170709857|NCT01931839|616944989|FG004|Overall Study|Withdrawal of consent|1|||
170709858|NCT01931839|616944990|FG005|Overall Study|Withdrawal of consent|0|||
170709859|NCT01931839|616944991|FG006|Overall Study|Withdrawal of consent|0|||
170709860|NCT01931839|616944985|FG000|Overall Study|Adverse Event|9|||
170709861|NCT01931839|616944986|FG001|Overall Study|Adverse Event|4|||
170709862|NCT01931839|616944987|FG002|Overall Study|Adverse Event|1|||
170709863|NCT01931839|616944988|FG003|Overall Study|Adverse Event|3|||
170709864|NCT01931839|616944989|FG004|Overall Study|Adverse Event|0|||
170709865|NCT01931839|616944990|FG005|Overall Study|Adverse Event|0|||
170709866|NCT01931839|616944991|FG006|Overall Study|Adverse Event|1|||
170709867|NCT01931839|616944985|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
170709868|NCT01931839|616944986|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
170709869|NCT01931839|616944987|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
170709870|NCT01931839|616944988|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
170709871|NCT01931839|616944989|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
170709872|NCT01931839|616944990|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
170709873|NCT01931839|616944991|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
170709874|NCT01931839|616944985|FG000|Overall Study|Other non-compliance|15|||
170709875|NCT01931839|616944986|FG001|Overall Study|Other non-compliance|9|||
170709876|NCT01931839|616944987|FG002|Overall Study|Other non-compliance|12|||
170709877|NCT01931839|616944988|FG003|Overall Study|Other non-compliance|3|||
170709878|NCT01931839|616944989|FG004|Overall Study|Other non-compliance|0|||
170709879|NCT01931839|616944990|FG005|Overall Study|Other non-compliance|3|||
170709880|NCT01931839|616944991|FG006|Overall Study|Other non-compliance|0|||
170709881|NCT01931839|616944985|FG000|Overall Study|Lost to Follow-up|1|||
170709882|NCT01931839|616944986|FG001|Overall Study|Lost to Follow-up|2|||
170709883|NCT01931839|616944987|FG002|Overall Study|Lost to Follow-up|4|||
170709884|NCT01931839|616944988|FG003|Overall Study|Lost to Follow-up|5|||
170709885|NCT01931839|616944989|FG004|Overall Study|Lost to Follow-up|0|||
170709886|NCT01931839|616944990|FG005|Overall Study|Lost to Follow-up|0|||
170709887|NCT01931839|616944991|FG006|Overall Study|Lost to Follow-up|0|||
170709888|NCT01931839|616944985|FG000|Overall Study|Other|4|||
170709889|NCT01931839|616944986|FG001|Overall Study|Other|2|||
170709890|NCT01931839|616944987|FG002|Overall Study|Other|6|||
170709891|NCT01931839|616944988|FG003|Overall Study|Other|0|||
170709892|NCT01931839|616944989|FG004|Overall Study|Other|0|||
170709893|NCT01931839|616944990|FG005|Overall Study|Other|0|||
170709894|NCT01931839|616944991|FG006|Overall Study|Other|0|||
170709895|NCT01263873|616944992|FG000|Overall Study|One provider unable to complete numbers|1|||
170709896|NCT01263873|616944993|FG001|Overall Study|One provider unable to complete numbers|1|||
170709897|NCT02104557|616945004|FG000|Overall Study|Adverse Event|24|||
170709898|NCT02104557|616945004|FG000|Overall Study|Lost to Follow-up|34|||
170709899|NCT02104557|616945004|FG000|Overall Study|Violated the usage and dosage|14|||
170709900|NCT02104557|616945004|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
170709901|NCT02104557|616945004|FG000|Overall Study|Administered Sayana prior to the contract|1|||
170709902|NCT02104557|616945004|FG000|Overall Study|Other|17|||
170709903|NCT02104557|616945004|FG000|Overall Study|Change to other contraception methods|5|||
170709904|NCT02104557|616945004|FG000|Overall Study|Discontinuation due to no pain|1|||
170709905|NCT02104557|616945004|FG000|Overall Study|Withdrawal consent|2|||
170709906|NCT02104557|616945004|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
170709907|NCT02104557|616945004|FG000|Overall Study|Discontinuation of contraception|9|||
170709908|NCT01158222|616945008|FG000|Overall Study|Not eligible for intermediate phase|17|||
170709909|NCT01000051|616945012|FG000|Overall Study|Withdrawal by Subject|1|||
170709910|NCT01000051|616945013|FG001|Overall Study|Withdrawal by Subject|1|||
170709911|NCT01000051|616945012|FG000|Overall Study|Disease Progression|1|||
170709912|NCT01000051|616945013|FG001|Overall Study|Disease Progression|0|||
170709913|NCT01000051|616945012|FG000|Overall Study|Serious noncompliance|1|||
170709914|NCT01000051|616945013|FG001|Overall Study|Serious noncompliance|0|||
170709915|NCT01260922|616945014|FG000|First Intervention|Withdrawal by Subject|0|||
170709916|NCT01260922|616945015|FG001|First Intervention|Withdrawal by Subject|1|||
170709917|NCT01260922|616945014|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
170709918|NCT01260922|616945015|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
170709919|NCT01260922|616945014|FG000|Second Intervention|Emesis|0|||
170709920|NCT01260922|616945015|FG001|Second Intervention|Emesis|2|||
170709921|NCT01416805|616945018|FG000|Overall Study|Lost to Follow-up|4|||
170709922|NCT01416805|616945019|FG001|Overall Study|Lost to Follow-up|4|||
170709923|NCT02604589|616945024|FG000|Overall Study|catheter dislodgement|0|||
170709924|NCT02604589|616945025|FG001|Overall Study|catheter dislodgement|0|||
170709925|NCT02604589|616945026|FG002|Overall Study|catheter dislodgement|1|||
170709926|NCT04632940|616945035|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
170709927|NCT04632940|616945036|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
170709928|NCT04632940|616945035|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
170709929|NCT04632940|616945036|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
170709930|NCT04632940|616945035|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
170709931|NCT04632940|616945036|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
170709932|NCT04632940|616945035|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
170709933|NCT04632940|616945036|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
170709934|NCT04632940|616945035|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
170709935|NCT04632940|616945036|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
170709936|NCT04632940|616945035|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
170709937|NCT04632940|616945036|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
170709938|NCT04632940|616945035|FG000|OLE Period (52 Weeks)|Other than specified|0|||
170709939|NCT04632940|616945036|FG001|OLE Period (52 Weeks)|Other than specified|1|||
170709940|NCT04632940|616945035|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
170709941|NCT04632940|616945036|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
170709942|NCT00281840|616945039|FG000|Overall Study|Adverse Event|12|||
170709943|NCT00281840|616945039|FG000|Overall Study|Physician Decision|6|||
170709944|NCT00281840|616945039|FG000|Overall Study|Withdrawal by Subject|3|||
170709945|NCT00281840|616945039|FG000|Overall Study|Disease Progression|2|||
170709946|NCT00281840|616945039|FG000|Overall Study|exceed maximum delay in treatment|1|||
170709947|NCT00281840|616945039|FG000|Overall Study|Complicating Disease|1|||
170709948|NCT00835406|616945040|FG000|Period: First Intervention|Adverse Event|0|||
170709949|NCT00835406|616945041|FG001|Period: First Intervention|Adverse Event|1|||
170709950|NCT00835406|616945040|FG000|Period: First Intervention|Withdrawal by Subject|2|||
170709951|NCT00835406|616945041|FG001|Period: First Intervention|Withdrawal by Subject|0|||
170709952|NCT00835406|616945040|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
170709953|NCT00835406|616945041|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
170709954|NCT05013905|616945044|FG000|Overall Study|Adverse Event|1|||
170709955|NCT05013905|616945044|FG000|Overall Study|Lack of Efficacy|1|||
170709956|NCT01849588|616945046|FG000|Overall Study|Lack of Efficacy|3|||
170709957|NCT02550652|616945056|FG000|Overall Study|Death|1|||
170709958|NCT02550652|616945057|FG001|Overall Study|Death|4|||
170709959|NCT02550652|616945056|FG000|Overall Study|Lack of Efficacy|1|||
170709960|NCT02550652|616945057|FG001|Overall Study|Lack of Efficacy|0|||
170709961|NCT02550652|616945056|FG000|Overall Study|Withdrawal by Subject|4|||
170709962|NCT02550652|616945057|FG001|Overall Study|Withdrawal by Subject|7|||
170709963|NCT02550652|616945056|FG000|Overall Study|Post Trial Access|1|||
170709964|NCT02550652|616945057|FG001|Overall Study|Post Trial Access|0|||
170709965|NCT02550652|616945056|FG000|Overall Study|Lost to Follow-up|1|||
170709966|NCT02550652|616945057|FG001|Overall Study|Lost to Follow-up|3|||
170709967|NCT02550652|616945056|FG000|Overall Study|Physician Decision|0|||
170709968|NCT02550652|616945057|FG001|Overall Study|Physician Decision|2|||
170709969|NCT02550652|616945056|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
170709970|NCT02550652|616945057|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
170709971|NCT01706250|616945058|FG000|Overall Study|Lost to Follow-up|2|||
170709972|NCT03286140|616945059|FG000|Overall Study|Withdrawal by Subject|10|||
170709973|NCT03286140|616945060|FG001|Overall Study|Withdrawal by Subject|5|||
170709974|NCT03286140|616945059|FG000|Overall Study|Lost to Follow-up|5|||
170709975|NCT03286140|616945060|FG001|Overall Study|Lost to Follow-up|10|||
170827738|NCT00607997|617378143|FG002|Overall Study|Physician Decision|0|||
170827739|NCT00607997|617378144|FG003|Overall Study|Physician Decision|0|||
170827740|NCT00607997|617378141|FG000|Overall Study|Relapse, recurrent illness|4|||
170827741|NCT00607997|617378142|FG001|Overall Study|Relapse, recurrent illness|0|||
170827742|NCT00607997|617378143|FG002|Overall Study|Relapse, recurrent illness|2|||
170827743|NCT00607997|617378144|FG003|Overall Study|Relapse, recurrent illness|0|||
170827744|NCT00607997|617378141|FG000|Overall Study|Other without explanation|2|||
170827745|NCT00607997|617378142|FG001|Overall Study|Other without explanation|0|||
170827746|NCT00607997|617378143|FG002|Overall Study|Other without explanation|4|||
170709976|NCT03286140|616945059|FG000|Overall Study|Failure to comply|0|||
170709977|NCT03286140|616945060|FG001|Overall Study|Failure to comply|1|||
170709978|NCT02486406|616945065|FG000|Overall Study|Withdrew consent|1|||
170709979|NCT02486406|616945066|FG001|Overall Study|Withdrew consent|0|||
170709980|NCT02486406|616945067|FG002|Overall Study|Withdrew consent|0|||
170709981|NCT02486406|616945068|FG003|Overall Study|Withdrew consent|1|||
170709982|NCT02486406|616945065|FG000|Overall Study|Lost to Follow-up|1|||
170709983|NCT02486406|616945066|FG001|Overall Study|Lost to Follow-up|3|||
170709984|NCT02486406|616945067|FG002|Overall Study|Lost to Follow-up|1|||
170709985|NCT02486406|616945068|FG003|Overall Study|Lost to Follow-up|3|||
170709986|NCT02486406|616945065|FG000|Overall Study|Other, not specified|0|||
170709987|NCT02486406|616945066|FG001|Overall Study|Other, not specified|0|||
170709988|NCT02486406|616945067|FG002|Overall Study|Other, not specified|1|||
170709989|NCT02486406|616945068|FG003|Overall Study|Other, not specified|0|||
170709990|NCT00096044|616945075|FG000|Overall Study|Withdrawal by Subject|9|||
170709991|NCT00096044|616945075|FG000|Overall Study|Adverse Event|21|||
170709992|NCT00096044|616945075|FG000|Overall Study|Disease Progression|4|||
170709993|NCT03149237|616945076|FG000|Overall Study|Withdrawal by Subject|4|||
170709994|NCT03149237|616945077|FG001|Overall Study|Withdrawal by Subject|5|||
170709995|NCT02442830|616945078|FG000|Overall Study|Technical Failure|0|||
170709996|NCT02442830|616945079|FG001|Overall Study|Technical Failure|1|||
170709997|NCT02052466|616945080|FG000|Overall Study|Withdrawal by Subject|1|||
170709998|NCT02052466|616945080|FG000|Overall Study|Acromial fracture|1|||
170709999|NCT03851016|616945082|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
170710000|NCT03851016|616945083|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
170710001|NCT03878134|616945084|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
170710002|NCT02797262|616945085|FG000|Overall Study|Withdrawal by Subject|5|||
170710003|NCT02797262|616945086|FG001|Overall Study|Withdrawal by Subject|1|||
170827747|NCT00607997|617378144|FG003|Overall Study|Other without explanation|1|||
170827748|NCT03811834|617378145|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
170827749|NCT01242371|617378149|FG000|Overall Study|Withdrawal by Subject|2|||
170827750|NCT01242371|617378150|FG001|Overall Study|Withdrawal by Subject|2|||
170827751|NCT01242371|617378149|FG000|Overall Study|Protocol Violation|0|||
170710004|NCT02797262|616945085|FG000|Overall Study|Lost to Follow-up|10|||
170710005|NCT02797262|616945086|FG001|Overall Study|Lost to Follow-up|7|||
170710006|NCT02797262|616945085|FG000|Overall Study|Death|1|||
170710007|NCT02797262|616945086|FG001|Overall Study|Death|2|||
170710008|NCT02797262|616945085|FG000|Overall Study|Adverse Event|1|||
170710009|NCT02797262|616945086|FG001|Overall Study|Adverse Event|0|||
170710010|NCT02797262|616945085|FG000|Overall Study|COVID-19|2|||
170710011|NCT02797262|616945086|FG001|Overall Study|COVID-19|1|||
170710012|NCT02797262|616945085|FG000|Overall Study|Out-of-country|1|||
170827752|NCT01242371|617378150|FG001|Overall Study|Protocol Violation|3|||
170827753|NCT03294941|617380131|FG000|Overall Study|Withdrawal by Subject|0|||
170827754|NCT03294941|617380132|FG001|Overall Study|Withdrawal by Subject|2|||
170827755|NCT04629443|617380133|FG000|Overall Study|Adverse Event|2|||
170827756|NCT04629443|617380134|FG001|Overall Study|Adverse Event|1|||
170710013|NCT02797262|616945086|FG001|Overall Study|Out-of-country|0|||
170710014|NCT00512096|616945089|FG000|Overall Study|Adverse Event|2|||
170710015|NCT00512096|616945089|FG000|Overall Study|Withdrawal by Subject|2|||
170710016|NCT00512096|616945089|FG000|Overall Study|Lack of Efficacy|3|||
170710017|NCT04740034|616945093|FG000|Overall Study|Death|0|||
170710018|NCT04740034|616945094|FG001|Overall Study|Death|1|||
170710019|NCT04740034|616945095|FG002|Overall Study|Death|2|||
170710020|NCT04740034|616945096|FG003|Overall Study|Death|3|||
170710021|NCT04740034|616945097|FG004|Overall Study|Death|4|||
170710022|NCT04740034|616945098|FG005|Overall Study|Death|4|||
170710023|NCT04740034|616945099|FG006|Overall Study|Death|2|||
170710024|NCT04740034|616945100|FG007|Overall Study|Death|2|||
170710025|NCT04740034|616945101|FG008|Overall Study|Death|2|||
170710026|NCT04740034|616945102|FG009|Overall Study|Death|4|||
170710027|NCT04740034|616945103|FG010|Overall Study|Death|0|||
170710028|NCT04740034|616945093|FG000|Overall Study|Lost to Follow-up|0|||
170710029|NCT04740034|616945094|FG001|Overall Study|Lost to Follow-up|0|||
170710030|NCT04740034|616945095|FG002|Overall Study|Lost to Follow-up|0|||
170710031|NCT04740034|616945096|FG003|Overall Study|Lost to Follow-up|1|||
170710032|NCT04740034|616945097|FG004|Overall Study|Lost to Follow-up|2|||
170710033|NCT04740034|616945098|FG005|Overall Study|Lost to Follow-up|2|||
170710034|NCT04740034|616945099|FG006|Overall Study|Lost to Follow-up|0|||
170710035|NCT04740034|616945100|FG007|Overall Study|Lost to Follow-up|0|||
170710036|NCT04740034|616945101|FG008|Overall Study|Lost to Follow-up|0|||
170710037|NCT04740034|616945102|FG009|Overall Study|Lost to Follow-up|1|||
170710038|NCT04740034|616945103|FG010|Overall Study|Lost to Follow-up|0|||
170710039|NCT04740034|616945093|FG000|Overall Study|Withdrawal by Subject|1|||
170710040|NCT04740034|616945094|FG001|Overall Study|Withdrawal by Subject|0|||
170710041|NCT04740034|616945095|FG002|Overall Study|Withdrawal by Subject|0|||
170710042|NCT04740034|616945096|FG003|Overall Study|Withdrawal by Subject|0|||
170710043|NCT04740034|616945097|FG004|Overall Study|Withdrawal by Subject|0|||
170710044|NCT04740034|616945098|FG005|Overall Study|Withdrawal by Subject|0|||
170710045|NCT04740034|616945099|FG006|Overall Study|Withdrawal by Subject|0|||
170710046|NCT04740034|616945100|FG007|Overall Study|Withdrawal by Subject|1|||
170710047|NCT04740034|616945101|FG008|Overall Study|Withdrawal by Subject|0|||
170710048|NCT04740034|616945102|FG009|Overall Study|Withdrawal by Subject|1|||
170710049|NCT04740034|616945103|FG010|Overall Study|Withdrawal by Subject|0|||
170710050|NCT04740034|616945093|FG000|Overall Study|Decision by sponsor|0|||
170710051|NCT04740034|616945094|FG001|Overall Study|Decision by sponsor|0|||
170710052|NCT04740034|616945095|FG002|Overall Study|Decision by sponsor|1|||
170710053|NCT04740034|616945096|FG003|Overall Study|Decision by sponsor|0|||
170710054|NCT04740034|616945097|FG004|Overall Study|Decision by sponsor|0|||
170710055|NCT04740034|616945098|FG005|Overall Study|Decision by sponsor|0|||
170710056|NCT04740034|616945099|FG006|Overall Study|Decision by sponsor|1|||
170710057|NCT04740034|616945100|FG007|Overall Study|Decision by sponsor|2|||
170710058|NCT04740034|616945101|FG008|Overall Study|Decision by sponsor|1|||
170710059|NCT04740034|616945102|FG009|Overall Study|Decision by sponsor|1|||
170710060|NCT04740034|616945103|FG010|Overall Study|Decision by sponsor|2|||
170710061|NCT00608829|616946571|FG000|Overall Study|Death|6|||
170710062|NCT00608829|616946571|FG000|Overall Study|Withdrawal by Subject|4|||
170710063|NCT00608829|616946571|FG000|Overall Study|Subject refuses to follow up or return.|5|||
170710064|NCT00432380|616946572|FG000|Overall Study|Migrated/moved from study area|3|||
170710065|NCT00432380|616946573|FG001|Overall Study|Migrated/moved from study area|4|||
170710066|NCT00432380|616946574|FG002|Overall Study|Migrated/moved from study area|1|||
170710067|NCT00432380|616946572|FG000|Overall Study|Adverse Event|1|||
170710068|NCT00432380|616946573|FG001|Overall Study|Adverse Event|0|||
170710069|NCT00432380|616946574|FG002|Overall Study|Adverse Event|0|||
170710070|NCT02805257|616946575|FG000|Overall Study|Lost to Follow-up|7|||
170710071|NCT02805257|616946576|FG001|Overall Study|Lost to Follow-up|6|||
170710072|NCT02805257|616946575|FG000|Overall Study|Death|0|||
170710073|NCT02805257|616946576|FG001|Overall Study|Death|1|||
170710074|NCT00612066|616946577|FG000|Overall Study|Adverse Event|1|||
170710075|NCT03019536|616946579|FG000|Overall Study|Withdrawal by Subject|1|||
170710076|NCT03019536|616946580|FG001|Overall Study|Withdrawal by Subject|1|||
170710077|NCT03019536|616946581|FG002|Overall Study|Withdrawal by Subject|0|||
170710078|NCT03019536|616946579|FG000|Overall Study|Adverse Event|0|||
170710079|NCT03019536|616946580|FG001|Overall Study|Adverse Event|0|||
170710080|NCT03019536|616946581|FG002|Overall Study|Adverse Event|2|||
170710081|NCT01043874|616946582|FG000|Overall Study|Adverse Event|3|||
170710082|NCT01043874|616946582|FG000|Overall Study|Withdrawal by Subject|1|||
170710083|NCT01043874|616946582|FG000|Overall Study|Lack of Efficacy|1|||
170710084|NCT01043874|616946582|FG000|Overall Study|Administrative Problems|1|||
170710085|NCT01337089|616946583|FG000|Overall Study|Adverse Event|237|||
170710086|NCT01337089|616946583|FG000|Overall Study|Withdrawal by Subject|129|||
170710087|NCT01337089|616946583|FG000|Overall Study|Withdrawal by Investigator|33|||
170710088|NCT01337089|616946583|FG000|Overall Study|Met Withdrawal Criteria|3|||
170710089|NCT01337089|616946583|FG000|Overall Study|Lost to Follow-up|2|||
170710090|NCT01404312|616946584|FG000|Overall Study|Death|21|||
170710091|NCT01404312|616946585|FG001|Overall Study|Death|27|||
170710092|NCT01404312|616946584|FG000|Overall Study|Withdrawal by Subject|15|||
170710093|NCT01404312|616946585|FG001|Overall Study|Withdrawal by Subject|18|||
170710094|NCT01404312|616946584|FG000|Overall Study|Participant Unable to get to clinic|93|||
170710095|NCT01404312|616946585|FG001|Overall Study|Participant Unable to get to clinic|103|||
170710096|NCT01404312|616946584|FG000|Overall Study|Lost to Follow-up|115|||
170710097|NCT01404312|616946585|FG001|Overall Study|Lost to Follow-up|111|||
170710098|NCT01404312|616946584|FG000|Overall Study|Site closed|22|||
170710099|NCT01404312|616946585|FG001|Overall Study|Site closed|21|||
170710100|NCT01404312|616946584|FG000|Overall Study|Participant not willing to adhere to req|31|||
170710101|NCT01404312|616946585|FG001|Overall Study|Participant not willing to adhere to req|29|||
170710102|NCT01404312|616946584|FG000|Overall Study|Severe debilitation, unable to continue|1|||
170710103|NCT01404312|616946585|FG001|Overall Study|Severe debilitation, unable to continue|2|||
170710104|NCT03143829|616946586|FG000|Overall Study|Withdrawal by Subject|2|||
170710105|NCT03143829|616946587|FG001|Overall Study|Withdrawal by Subject|5|||
170710106|NCT03143829|616946586|FG000|Overall Study|Lost to Follow-up|0|||
170710107|NCT03143829|616946587|FG001|Overall Study|Lost to Follow-up|2|||
170710108|NCT03143829|616946586|FG000|Overall Study|Death|1|||
170710109|NCT03143829|616946587|FG001|Overall Study|Death|1|||
170710110|NCT03143829|616946586|FG000|Overall Study|changed treatment, no longer eligible|2|||
170710111|NCT03143829|616946587|FG001|Overall Study|changed treatment, no longer eligible|2|||
170710112|NCT02627677|616946588|FG000|Overall Study|Adverse event (not progressive disease)|1|||
170710113|NCT02627677|616946589|FG001|Overall Study|Adverse event (not progressive disease)|4|||
170710114|NCT02627677|616946590|FG002|Overall Study|Adverse event (not progressive disease)|1|||
170710115|NCT02627677|616946588|FG000|Overall Study|Progressive disease|1|||
170710116|NCT02627677|616946589|FG001|Overall Study|Progressive disease|3|||
170710117|NCT02627677|616946590|FG002|Overall Study|Progressive disease|0|||
170710118|NCT02627677|616946588|FG000|Overall Study|Lack of Efficacy|1|||
170710119|NCT02627677|616946589|FG001|Overall Study|Lack of Efficacy|2|||
170710120|NCT02627677|616946590|FG002|Overall Study|Lack of Efficacy|0|||
170710121|NCT02627677|616946588|FG000|Overall Study|Lost to Follow-up|0|||
170710122|NCT02627677|616946589|FG001|Overall Study|Lost to Follow-up|0|||
170710123|NCT02627677|616946590|FG002|Overall Study|Lost to Follow-up|1|||
170710124|NCT02627677|616946588|FG000|Overall Study|Pregnancy|0|||
170710125|NCT02627677|616946589|FG001|Overall Study|Pregnancy|1|||
170710126|NCT02627677|616946590|FG002|Overall Study|Pregnancy|0|||
170710127|NCT02627677|616946588|FG000|Overall Study|Study Terminated by Sponsor|5|||
170710128|NCT02627677|616946589|FG001|Overall Study|Study Terminated by Sponsor|10|||
170710129|NCT02627677|616946590|FG002|Overall Study|Study Terminated by Sponsor|6|||
170710130|NCT02627677|616946588|FG000|Overall Study|Physician Decision|0|||
170710131|NCT02627677|616946589|FG001|Overall Study|Physician Decision|0|||
170710132|NCT02627677|616946590|FG002|Overall Study|Physician Decision|2|||
170710133|NCT02627677|616946588|FG000|Overall Study|Withdrawal by Subject|2|||
170710134|NCT02627677|616946589|FG001|Overall Study|Withdrawal by Subject|1|||
170710135|NCT02627677|616946590|FG002|Overall Study|Withdrawal by Subject|1|||
170710136|NCT02627677|616946588|FG000|Overall Study|Reason not Specified|0|||
170710137|NCT02627677|616946589|FG001|Overall Study|Reason not Specified|0|||
170710138|NCT02627677|616946590|FG002|Overall Study|Reason not Specified|1|||
170710139|NCT02627677|616946588|FG000|Overall Study|Randomized but not Treated|1|||
170710140|NCT02627677|616946589|FG001|Overall Study|Randomized but not Treated|0|||
170710141|NCT02627677|616946590|FG002|Overall Study|Randomized but not Treated|0|||
170710142|NCT00317772|616946592|FG000|Overall Study|Adverse Event|0|||
170710143|NCT00317772|616946593|FG001|Overall Study|Adverse Event|0|||
170710144|NCT00317772|616946594|FG002|Overall Study|Adverse Event|0|||
170710145|NCT00317772|616946595|FG003|Overall Study|Adverse Event|2|||
170710146|NCT00317772|616946592|FG000|Overall Study|Disease Progression|2|||
170710147|NCT00317772|616946593|FG001|Overall Study|Disease Progression|2|||
170710148|NCT00317772|616946594|FG002|Overall Study|Disease Progression|1|||
170710149|NCT00317772|616946595|FG003|Overall Study|Disease Progression|7|||
170710150|NCT00938431|616946598|FG000|Overall Study|Adverse Event|5|||
170710151|NCT00938431|616946599|FG001|Overall Study|Adverse Event|8|||
170710152|NCT00938431|616946600|FG002|Overall Study|Adverse Event|6|||
170710153|NCT00938431|616946598|FG000|Overall Study|Lack of Efficacy|0|||
170710154|NCT00938431|616946599|FG001|Overall Study|Lack of Efficacy|1|||
170710155|NCT00938431|616946600|FG002|Overall Study|Lack of Efficacy|0|||
170710156|NCT00938431|616946598|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
170710157|NCT00938431|616946599|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
170710158|NCT00938431|616946600|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
170710159|NCT00938431|616946598|FG000|Overall Study|Dosing compliance issue|0|||
170710160|NCT00938431|616946599|FG001|Overall Study|Dosing compliance issue|0|||
170710161|NCT00938431|616946600|FG002|Overall Study|Dosing compliance issue|1|||
170710162|NCT00938431|616946598|FG000|Overall Study|Reached maximum dose early|0|||
170710163|NCT00938431|616946599|FG001|Overall Study|Reached maximum dose early|0|||
170710164|NCT00938431|616946600|FG002|Overall Study|Reached maximum dose early|1|||
170710165|NCT00673049|616946603|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
170710166|NCT00673049|616946604|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
170710167|NCT00673049|616946605|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
170710168|NCT00673049|616946606|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
170710169|NCT00673049|616946603|FG000|Before Progression on Erlotinib|Death|235|||
170710170|NCT00673049|616946604|FG001|Before Progression on Erlotinib|Death|167|||
170710171|NCT00673049|616946605|FG002|Before Progression on Erlotinib|Death|1|||
170710172|NCT00673049|616946606|FG003|Before Progression on Erlotinib|Death|0|||
170710173|NCT00673049|616946603|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
170710174|NCT00673049|616946604|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
170710175|NCT00673049|616946605|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
170710176|NCT00673049|616946606|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
170710177|NCT00673049|616946603|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
170710178|NCT00673049|616946604|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
170710179|NCT00673049|616946605|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
170710180|NCT00673049|616946606|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
170710181|NCT00673049|616946603|FG000|Before Progression on Erlotinib|Other|1|||
170710182|NCT00673049|616946604|FG001|Before Progression on Erlotinib|Other|2|||
170710183|NCT00673049|616946605|FG002|Before Progression on Erlotinib|Other|0|||
170710184|NCT00673049|616946606|FG003|Before Progression on Erlotinib|Other|0|||
170710185|NCT00673049|616946603|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
170710186|NCT00673049|616946604|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
170710187|NCT00673049|616946605|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
170710188|NCT00673049|616946606|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
170710189|NCT00673049|616946603|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
170710190|NCT00673049|616946604|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
170710191|NCT00673049|616946605|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
170710192|NCT00673049|616946606|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
170710193|NCT00673049|616946603|FG000|After Progression on Erlotinib|Death|0|||
170710194|NCT00673049|616946604|FG001|After Progression on Erlotinib|Death|0|||
170710195|NCT00673049|616946605|FG002|After Progression on Erlotinib|Death|0|||
170710196|NCT00673049|616946606|FG003|After Progression on Erlotinib|Death|71|||
170710197|NCT00673049|616946603|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
170710198|NCT00673049|616946604|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
170710199|NCT00673049|616946605|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
170710200|NCT00673049|616946606|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
170710201|NCT00673049|616946603|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
170710202|NCT00673049|616946604|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
170710203|NCT00673049|616946605|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
170710204|NCT00673049|616946606|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
170710205|NCT00673049|616946603|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
170710206|NCT00673049|616946604|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
170710207|NCT00673049|616946605|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
170710208|NCT00673049|616946606|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
170710209|NCT03738865|616946609|FG000|Overall Study|Withdrawal by Subject|3|||
170710210|NCT03738865|616946610|FG001|Overall Study|Withdrawal by Subject|3|||
170710211|NCT03738865|616946609|FG000|Overall Study|Adverse Event|2|||
170710212|NCT03738865|616946610|FG001|Overall Study|Adverse Event|0|||
170710213|NCT03738865|616946609|FG000|Overall Study|Physician Decision|0|||
170710214|NCT03738865|616946610|FG001|Overall Study|Physician Decision|1|||
170710215|NCT02621606|616946611|FG000|Overall Study|Withdrawal by Subject|0|||
170710216|NCT02621606|616946612|FG001|Overall Study|Withdrawal by Subject|1|||
170710217|NCT02621606|616946613|FG002|Overall Study|Withdrawal by Subject|0|||
170710218|NCT01529645|616946614|FG000|Overall Study|Lost to Follow-up|0|||
170710219|NCT01529645|616946615|FG001|Overall Study|Lost to Follow-up|1|||
170710220|NCT01529645|616946616|FG002|Overall Study|Lost to Follow-up|1|||
170710221|NCT01529645|616946617|FG003|Overall Study|Lost to Follow-up|1|||
170710222|NCT01529645|616946618|FG004|Overall Study|Lost to Follow-up|1|||
170710223|NCT01529645|616946619|FG005|Overall Study|Lost to Follow-up|0|||
170710224|NCT01529645|616946620|FG006|Overall Study|Lost to Follow-up|2|||
170710225|NCT01529645|616946621|FG007|Overall Study|Lost to Follow-up|0|||
170710226|NCT01529645|616946622|FG008|Overall Study|Lost to Follow-up|1|||
170710227|NCT01529645|616946623|FG009|Overall Study|Lost to Follow-up|0|||
170710228|NCT01529645|616946614|FG000|Overall Study|SAE - Premature contractions|0|||
170710229|NCT01529645|616946615|FG001|Overall Study|SAE - Premature contractions|0|||
170710230|NCT01529645|616946616|FG002|Overall Study|SAE - Premature contractions|1|||
170710231|NCT01529645|616946617|FG003|Overall Study|SAE - Premature contractions|0|||
170710232|NCT01529645|616946618|FG004|Overall Study|SAE - Premature contractions|0|||
170827757|NCT04629443|617380135|FG002|Overall Study|Adverse Event|2|||
170710233|NCT01529645|616946619|FG005|Overall Study|SAE - Premature contractions|0|||
170710234|NCT01529645|616946620|FG006|Overall Study|SAE - Premature contractions|0|||
170710235|NCT01529645|616946621|FG007|Overall Study|SAE - Premature contractions|0|||
170710236|NCT01529645|616946622|FG008|Overall Study|SAE - Premature contractions|0|||
170710237|NCT01529645|616946623|FG009|Overall Study|SAE - Premature contractions|0|||
170710238|NCT01529645|616946614|FG000|Overall Study|Withdrawal by Subject|2|||
170710239|NCT01529645|616946615|FG001|Overall Study|Withdrawal by Subject|0|||
170710240|NCT01529645|616946616|FG002|Overall Study|Withdrawal by Subject|0|||
170710241|NCT01529645|616946617|FG003|Overall Study|Withdrawal by Subject|1|||
170710242|NCT01529645|616946618|FG004|Overall Study|Withdrawal by Subject|1|||
170710243|NCT01529645|616946619|FG005|Overall Study|Withdrawal by Subject|1|||
170710244|NCT01529645|616946620|FG006|Overall Study|Withdrawal by Subject|0|||
170710245|NCT01529645|616946621|FG007|Overall Study|Withdrawal by Subject|0|||
170710246|NCT01529645|616946622|FG008|Overall Study|Withdrawal by Subject|0|||
170710247|NCT01529645|616946623|FG009|Overall Study|Withdrawal by Subject|0|||
170710248|NCT01774903|616946624|FG000|Overall Study|Adverse Event|7|||
170710249|NCT01774903|616946624|FG000|Overall Study|Withdrawal by Subject|2|||
170710250|NCT01774903|616946624|FG000|Overall Study|Lack of Efficacy|1|||
170710251|NCT01774903|616946624|FG000|Overall Study|Ineligible to continue the trial|1|||
170710252|NCT00097591|616946638|FG000|Overall Study|Withdrawal of consent|342|||
170710253|NCT00097591|616946639|FG001|Overall Study|Withdrawal of consent|323|||
170710254|NCT00097591|616946638|FG000|Overall Study|Less than 6 months on study drug|9|||
170710255|NCT00097591|616946639|FG001|Overall Study|Less than 6 months on study drug|7|||
170710256|NCT00097591|616946638|FG000|Overall Study|Unable to attend termination visit|53|||
170710257|NCT00097591|616946639|FG001|Overall Study|Unable to attend termination visit|51|||
170710258|NCT00097591|616946638|FG000|Overall Study|Lost to follow up|6|||
170710259|NCT00097591|616946639|FG001|Overall Study|Lost to follow up|10|||
170710260|NCT00097591|616946638|FG000|Overall Study|Other|0|||
170710261|NCT00097591|616946639|FG001|Overall Study|Other|3|||
170710262|NCT00048724|616946644|FG000|Overall Study|Adverse Event|53|||
170710263|NCT00048724|616946645|FG001|Overall Study|Adverse Event|12|||
170710264|NCT00048724|616946644|FG000|Overall Study|Withdrawal by Subject|34|||
170710265|NCT00048724|616946645|FG001|Overall Study|Withdrawal by Subject|54|||
170710266|NCT00048724|616946644|FG000|Overall Study|Lost to Follow-up|5|||
170710267|NCT00048724|616946645|FG001|Overall Study|Lost to Follow-up|5|||
170710268|NCT00048724|616946644|FG000|Overall Study|Protocol-defined Clinical Event|17|||
170710269|NCT00048724|616946645|FG001|Overall Study|Protocol-defined Clinical Event|32|||
170710270|NCT00048724|616946644|FG000|Overall Study|Noncompliance With Protocol|4|||
170710271|NCT00048724|616946645|FG001|Overall Study|Noncompliance With Protocol|12|||
170710272|NCT00048724|616946644|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
170710273|NCT00048724|616946645|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
170710274|NCT00048724|616946644|FG000|Overall Study|Administrative|1|||
170710275|NCT00048724|616946645|FG001|Overall Study|Administrative|1|||
170710276|NCT02809976|616946646|FG000|Overall Study|Lost to Follow-up|1|||
170710277|NCT02809976|616946646|FG000|Overall Study|Withdrawal by Subject|1|||
170710278|NCT00226941|616946647|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
170710279|NCT00226941|616946648|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
170710280|NCT00226941|616946649|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
170710281|NCT00226941|616946650|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
170710282|NCT00226941|616946647|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
170710283|NCT00226941|616946648|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
170710284|NCT00226941|616946649|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
170710285|NCT00226941|616946650|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
170710286|NCT01163682|616946653|FG000|Overall Study|Lost to Follow-up|6|||
170710287|NCT01163682|616946654|FG001|Overall Study|Lost to Follow-up|9|||
170710288|NCT00530023|616946655|FG000|Overall Study|Withdrawal by Subject|0|||
170710289|NCT00530023|616946656|FG001|Overall Study|Withdrawal by Subject|1|||
170710290|NCT01877421|616946659|FG000|Phase 2|Lost to Follow-up|0|||
170710291|NCT01877421|616946660|FG001|Phase 2|Lost to Follow-up|0|||
170710292|NCT01877421|616946661|FG002|Phase 2|Lost to Follow-up|0|||
170710293|NCT01877421|616946662|FG003|Phase 2|Lost to Follow-up|0|||
170710294|NCT01877421|616946663|FG004|Phase 2|Lost to Follow-up|0|||
170710295|NCT01877421|616946664|FG005|Phase 2|Lost to Follow-up|0|||
170710296|NCT01877421|616946665|FG006|Phase 2|Lost to Follow-up|1|||
170710297|NCT01877421|616946666|FG007|Phase 2|Lost to Follow-up|0|||
170710298|NCT01877421|616946667|FG008|Phase 2|Lost to Follow-up|0|||
170710299|NCT01877421|616946668|FG009|Phase 2|Lost to Follow-up|0|||
170710300|NCT01877421|616946669|FG010|Phase 2|Lost to Follow-up|0|||
170710301|NCT01877421|616946670|FG011|Phase 2|Lost to Follow-up|0|||
170710302|NCT01877421|616946671|FG012|Phase 2|Lost to Follow-up|0|||
170827758|NCT04629443|617380133|FG000|Overall Study|Progressive Disease|2|||
170827759|NCT04629443|617380134|FG001|Overall Study|Progressive Disease|3|||
170827760|NCT04629443|617380135|FG002|Overall Study|Progressive Disease|3|||
170827761|NCT04629443|617380133|FG000|Overall Study|Physician Decision|1|||
170827762|NCT04629443|617380134|FG001|Overall Study|Physician Decision|3|||
170827763|NCT04629443|617380135|FG002|Overall Study|Physician Decision|0|||
170827764|NCT00913523|617380139|FG000|Overall Study|Withdrawal by Subject|3|||
170710303|NCT01877421|616946672|FG013|Phase 2|Lost to Follow-up|0|||
170710304|NCT01877421|616946673|FG014|Phase 2|Lost to Follow-up|0|||
170827765|NCT00913523|617380140|FG001|Overall Study|Withdrawal by Subject|2|||
170710305|NCT01877421|616946674|FG015|Phase 2|Lost to Follow-up|0|||
170710306|NCT01877421|616946675|FG016|Phase 2|Lost to Follow-up|0|||
170710307|NCT01877421|616946676|FG017|Phase 2|Lost to Follow-up|0|||
170827766|NCT00913523|617380141|FG002|Overall Study|Withdrawal by Subject|2|||
170710308|NCT01877421|616946659|FG000|Phase 2|Withdrawal by Subject|0|||
170710309|NCT01877421|616946660|FG001|Phase 2|Withdrawal by Subject|0|||
170710310|NCT01877421|616946661|FG002|Phase 2|Withdrawal by Subject|0|||
170710311|NCT01877421|616946662|FG003|Phase 2|Withdrawal by Subject|0|||
170710312|NCT01877421|616946663|FG004|Phase 2|Withdrawal by Subject|0|||
170710313|NCT01877421|616946664|FG005|Phase 2|Withdrawal by Subject|0|||
170710314|NCT01877421|616946665|FG006|Phase 2|Withdrawal by Subject|0|||
170710315|NCT01877421|616946666|FG007|Phase 2|Withdrawal by Subject|0|||
170710316|NCT01877421|616946667|FG008|Phase 2|Withdrawal by Subject|1|||
170710317|NCT01877421|616946668|FG009|Phase 2|Withdrawal by Subject|0|||
170710318|NCT01877421|616946669|FG010|Phase 2|Withdrawal by Subject|1|||
170710319|NCT01877421|616946670|FG011|Phase 2|Withdrawal by Subject|0|||
170710320|NCT01877421|616946671|FG012|Phase 2|Withdrawal by Subject|1|||
170710321|NCT01877421|616946672|FG013|Phase 2|Withdrawal by Subject|0|||
170710322|NCT01877421|616946673|FG014|Phase 2|Withdrawal by Subject|0|||
170710323|NCT01877421|616946674|FG015|Phase 2|Withdrawal by Subject|1|||
170710324|NCT01877421|616946675|FG016|Phase 2|Withdrawal by Subject|0|||
170710325|NCT01877421|616946676|FG017|Phase 2|Withdrawal by Subject|0|||
170710326|NCT01877421|616946659|FG000|Phase 2|Protocol Violation|0|||
170710327|NCT01877421|616946660|FG001|Phase 2|Protocol Violation|0|||
170710328|NCT01877421|616946661|FG002|Phase 2|Protocol Violation|0|||
170710329|NCT01877421|616946662|FG003|Phase 2|Protocol Violation|0|||
170710330|NCT01877421|616946663|FG004|Phase 2|Protocol Violation|0|||
170710331|NCT01877421|616946664|FG005|Phase 2|Protocol Violation|0|||
170710332|NCT01877421|616946665|FG006|Phase 2|Protocol Violation|0|||
170710333|NCT01877421|616946666|FG007|Phase 2|Protocol Violation|0|||
170710334|NCT01877421|616946667|FG008|Phase 2|Protocol Violation|0|||
170710335|NCT01877421|616946668|FG009|Phase 2|Protocol Violation|0|||
170710336|NCT01877421|616946669|FG010|Phase 2|Protocol Violation|1|||
170710337|NCT01877421|616946670|FG011|Phase 2|Protocol Violation|0|||
170710338|NCT01877421|616946671|FG012|Phase 2|Protocol Violation|0|||
170710339|NCT01877421|616946672|FG013|Phase 2|Protocol Violation|0|||
170710340|NCT01877421|616946673|FG014|Phase 2|Protocol Violation|0|||
170710341|NCT01877421|616946674|FG015|Phase 2|Protocol Violation|0|||
170710342|NCT01877421|616946675|FG016|Phase 2|Protocol Violation|0|||
170710343|NCT01877421|616946676|FG017|Phase 2|Protocol Violation|0|||
170710344|NCT00414050|616946681|FG000|Overall Study|Adverse Event|1|||
170710345|NCT00414050|616946682|FG001|Overall Study|Adverse Event|1|||
170710346|NCT00414050|616946683|FG002|Overall Study|Adverse Event|1|||
170710347|NCT00414050|616946684|FG003|Overall Study|Adverse Event|1|||
170710348|NCT00414050|616946681|FG000|Overall Study|Lost to Follow-up|2|||
170710349|NCT00414050|616946682|FG001|Overall Study|Lost to Follow-up|2|||
170710350|NCT00414050|616946683|FG002|Overall Study|Lost to Follow-up|1|||
170710351|NCT00414050|616946684|FG003|Overall Study|Lost to Follow-up|1|||
170710352|NCT00414050|616946681|FG000|Overall Study|Withdrawal by Subject|5|||
170710353|NCT00414050|616946682|FG001|Overall Study|Withdrawal by Subject|3|||
170710354|NCT00414050|616946683|FG002|Overall Study|Withdrawal by Subject|2|||
170710355|NCT00414050|616946684|FG003|Overall Study|Withdrawal by Subject|4|||
170710356|NCT00414050|616946681|FG000|Overall Study|Subject discontinued for other reason|1|||
170710357|NCT00414050|616946682|FG001|Overall Study|Subject discontinued for other reason|2|||
170710358|NCT00414050|616946683|FG002|Overall Study|Subject discontinued for other reason|2|||
170710359|NCT00414050|616946684|FG003|Overall Study|Subject discontinued for other reason|1|||
170710360|NCT00414050|616946681|FG000|Overall Study|Subject Moved|0|||
170710361|NCT00414050|616946682|FG001|Overall Study|Subject Moved|0|||
170710362|NCT00414050|616946683|FG002|Overall Study|Subject Moved|0|||
170710363|NCT00414050|616946684|FG003|Overall Study|Subject Moved|1|||
170710364|NCT02138214|616946685|FG000|Overall Study|Withdrawal by Subject|0|||
170710365|NCT02138214|616946686|FG001|Overall Study|Withdrawal by Subject|1|||
170710366|NCT02138214|616946687|FG002|Overall Study|Withdrawal by Subject|0|||
170710367|NCT02138214|616946685|FG000|Overall Study|Lost to Follow-up|0|||
170710368|NCT02138214|616946686|FG001|Overall Study|Lost to Follow-up|2|||
170710369|NCT02138214|616946687|FG002|Overall Study|Lost to Follow-up|4|||
170710370|NCT02138214|616946685|FG000|Overall Study|Screen Failure|0|||
170710371|NCT02138214|616946686|FG001|Overall Study|Screen Failure|1|||
170710372|NCT02138214|616946687|FG002|Overall Study|Screen Failure|0|||
170710373|NCT01079234|616946698|FG000|Main: Week 0 to 26|Adverse Event|5|||
170710374|NCT01079234|616946699|FG001|Main: Week 0 to 26|Adverse Event|4|||
170710375|NCT01079234|616946700|FG002|Main: Week 0 to 26|Adverse Event|1|||
170710376|NCT01079234|616946701|FG003|Main: Week 0 to 26|Adverse Event|0|||
170710377|NCT01079234|616946698|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
170710378|NCT01079234|616946699|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
170710379|NCT01079234|616946700|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
170710380|NCT01079234|616946701|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
170710381|NCT01079234|616946698|FG000|Main: Week 0 to 26|Protocol Violation|6|||
170710382|NCT01079234|616946699|FG001|Main: Week 0 to 26|Protocol Violation|2|||
170710383|NCT01079234|616946700|FG002|Main: Week 0 to 26|Protocol Violation|4|||
170710384|NCT01079234|616946701|FG003|Main: Week 0 to 26|Protocol Violation|0|||
170710385|NCT01079234|616946698|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
170710386|NCT01079234|616946699|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
170710387|NCT01079234|616946700|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
170710388|NCT01079234|616946701|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
170710389|NCT01079234|616946698|FG000|Main: Week 0 to 26|Unclassified|7|||
170710390|NCT01079234|616946699|FG001|Main: Week 0 to 26|Unclassified|13|||
170710391|NCT01079234|616946700|FG002|Main: Week 0 to 26|Unclassified|4|||
170710392|NCT01079234|616946701|FG003|Main: Week 0 to 26|Unclassified|0|||
170710393|NCT01079234|616946698|FG000|Extension: Week 27 to 52|Adverse Event|0|||
170710394|NCT01079234|616946699|FG001|Extension: Week 27 to 52|Adverse Event|0|||
170710395|NCT01079234|616946700|FG002|Extension: Week 27 to 52|Adverse Event|1|||
170710396|NCT01079234|616946701|FG003|Extension: Week 27 to 52|Adverse Event|0|||
170710397|NCT01079234|616946698|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
170710398|NCT01079234|616946699|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
170710399|NCT01079234|616946700|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
170710400|NCT01079234|616946701|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
170710401|NCT01079234|616946698|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
170710402|NCT01079234|616946699|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
170710403|NCT01079234|616946700|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
170710404|NCT01079234|616946701|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
170710405|NCT01079234|616946698|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
170710406|NCT01079234|616946699|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
170710407|NCT01079234|616946700|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
170710408|NCT01079234|616946701|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
170710409|NCT01079234|616946698|FG000|Extension: Week 27 to 52|Unclassified|0|||
170710410|NCT01079234|616946699|FG001|Extension: Week 27 to 52|Unclassified|0|||
170710411|NCT01079234|616946700|FG002|Extension: Week 27 to 52|Unclassified|4|||
170710412|NCT01079234|616946701|FG003|Extension: Week 27 to 52|Unclassified|7|||
170710413|NCT03509948|616946706|FG000|Overall Study|Protocol Violation|0|||
170710414|NCT03509948|616946707|FG001|Overall Study|Protocol Violation|1|||
170710415|NCT00799617|616946712|FG000|Main Testosterone Trial|Randomized in error|1|||
170710416|NCT00799617|616946713|FG001|Main Testosterone Trial|Randomized in error|1|||
170710417|NCT00799617|616946712|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
170710418|NCT00799617|616946713|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
170710419|NCT00799617|616946712|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
170710420|NCT00799617|616946713|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
170710421|NCT00799617|616946712|FG000|Sexual Funtion Trial|No Baseline Data|4|||
170710422|NCT00799617|616946713|FG001|Sexual Funtion Trial|No Baseline Data|7|||
170710423|NCT00799617|616946712|FG000|Physical Function Trial|Lost to Follow-up|6|||
170710424|NCT00799617|616946713|FG001|Physical Function Trial|Lost to Follow-up|11|||
170710425|NCT00799617|616946712|FG000|Vitality Trial|Lost to Follow-up|7|||
170710426|NCT00799617|616946713|FG001|Vitality Trial|Lost to Follow-up|22|||
170710427|NCT00799617|616946712|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
170710428|NCT00799617|616946713|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
170710429|NCT00799617|616946712|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
170710430|NCT00799617|616946713|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
170710431|NCT00799617|616946712|FG000|Bone Trial|Month 12 scan not available|6|||
170710432|NCT00799617|616946713|FG001|Bone Trial|Month 12 scan not available|16|||
170710433|NCT00799617|616946712|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
170710434|NCT00799617|616946713|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
170710435|NCT00799617|616946712|FG000|Anemia Trial|Withdrawal by Subject|3|||
170710436|NCT00799617|616946713|FG001|Anemia Trial|Withdrawal by Subject|3|||
170710437|NCT01687166|616946716|FG000|Overall Study|Attempt subject|2|||
170710438|NCT01687166|616946717|FG001|Overall Study|Attempt subject|3|||
170710439|NCT01687166|616946718|FG002|Overall Study|Attempt subject|2|||
170710440|NCT01687166|616946719|FG003|Overall Study|Attempt subject|0|||
170710441|NCT01687166|616946716|FG000|Overall Study|Did not meet eligibility criteria|4|||
170710442|NCT01687166|616946717|FG001|Overall Study|Did not meet eligibility criteria|6|||
170710443|NCT01687166|616946718|FG002|Overall Study|Did not meet eligibility criteria|1|||
170710444|NCT01687166|616946719|FG003|Overall Study|Did not meet eligibility criteria|1|||
170710445|NCT01687166|616946716|FG000|Overall Study|Adverse Event|2|||
170710446|NCT01687166|616946717|FG001|Overall Study|Adverse Event|1|||
170710447|NCT01687166|616946718|FG002|Overall Study|Adverse Event|0|||
170710448|NCT01687166|616946719|FG003|Overall Study|Adverse Event|0|||
170710449|NCT01687166|616946716|FG000|Overall Study|Physician Decision|3|||
170710450|NCT01687166|616946717|FG001|Overall Study|Physician Decision|2|||
170710451|NCT01687166|616946718|FG002|Overall Study|Physician Decision|1|||
170710452|NCT01687166|616946719|FG003|Overall Study|Physician Decision|0|||
170710453|NCT01687166|616946716|FG000|Overall Study|Withdrawal by Subject|11|||
170710454|NCT01687166|616946717|FG001|Overall Study|Withdrawal by Subject|4|||
170710455|NCT01687166|616946718|FG002|Overall Study|Withdrawal by Subject|3|||
170710456|NCT01687166|616946719|FG003|Overall Study|Withdrawal by Subject|0|||
170710457|NCT01687166|616946716|FG000|Overall Study|Lost to Follow-up|2|||
170710458|NCT01687166|616946717|FG001|Overall Study|Lost to Follow-up|5|||
170710459|NCT01687166|616946718|FG002|Overall Study|Lost to Follow-up|1|||
170710460|NCT01687166|616946719|FG003|Overall Study|Lost to Follow-up|0|||
170710461|NCT01687166|616946716|FG000|Overall Study|Equipment/Device Availability|0|||
170710462|NCT01687166|616946717|FG001|Overall Study|Equipment/Device Availability|1|||
170710463|NCT01687166|616946718|FG002|Overall Study|Equipment/Device Availability|0|||
170710464|NCT01687166|616946719|FG003|Overall Study|Equipment/Device Availability|0|||
170710465|NCT01687166|616946716|FG000|Overall Study|Death|1|||
170710466|NCT01687166|616946717|FG001|Overall Study|Death|1|||
170710467|NCT01687166|616946718|FG002|Overall Study|Death|0|||
170710468|NCT01687166|616946719|FG003|Overall Study|Death|0|||
170710469|NCT01687166|616946716|FG000|Overall Study|Protocol Violation|1|||
170710470|NCT01687166|616946717|FG001|Overall Study|Protocol Violation|1|||
170710471|NCT01687166|616946718|FG002|Overall Study|Protocol Violation|1|||
170710472|NCT01687166|616946719|FG003|Overall Study|Protocol Violation|0|||
170710473|NCT01687166|616946716|FG000|Overall Study|Subject moved out of state|0|||
170710474|NCT01687166|616946717|FG001|Overall Study|Subject moved out of state|1|||
170710475|NCT01687166|616946718|FG002|Overall Study|Subject moved out of state|0|||
170710476|NCT01687166|616946719|FG003|Overall Study|Subject moved out of state|0|||
170710477|NCT01687166|616946716|FG000|Overall Study|Patient unable to be compliant|1|||
170710478|NCT01687166|616946717|FG001|Overall Study|Patient unable to be compliant|0|||
170710479|NCT01687166|616946718|FG002|Overall Study|Patient unable to be compliant|0|||
170710480|NCT01687166|616946719|FG003|Overall Study|Patient unable to be compliant|0|||
170710481|NCT01687166|616946716|FG000|Overall Study|Physician choice to use different device|1|||
170710482|NCT01687166|616946717|FG001|Overall Study|Physician choice to use different device|2|||
170710483|NCT01687166|616946718|FG002|Overall Study|Physician choice to use different device|4|||
170710484|NCT01687166|616946719|FG003|Overall Study|Physician choice to use different device|0|||
170710485|NCT01687166|616946716|FG000|Overall Study|Insurance|0|||
170710486|NCT01687166|616946717|FG001|Overall Study|Insurance|0|||
170710487|NCT01687166|616946718|FG002|Overall Study|Insurance|1|||
170710488|NCT01687166|616946719|FG003|Overall Study|Insurance|1|||
170710489|NCT00183872|616946720|FG000|Overall Study|Death|3|||
170710490|NCT00183872|616946720|FG000|Overall Study|Adverse Event|9|||
170710491|NCT00183872|616946720|FG000|Overall Study|Withdrawal by Subject|2|||
170710492|NCT00183872|616946720|FG000|Overall Study|Drug delayed more than 28 days|2|||
170710493|NCT00700011|616946721|FG000|Overall Study|Death|0|||
170710494|NCT00700011|616946722|FG001|Overall Study|Death|1|||
170710495|NCT00004031|616946723|FG000|Overall Study|Adverse Event|5|||
170710496|NCT00004031|616946724|FG001|Overall Study|Adverse Event|0|||
170710497|NCT00004031|616946723|FG000|Overall Study|Refusal unrelated to adverse events|2|||
170710498|NCT00004031|616946724|FG001|Overall Study|Refusal unrelated to adverse events|11|||
170710499|NCT00004031|616946723|FG000|Overall Study|Progression/relapse|9|||
170710500|NCT00004031|616946724|FG001|Overall Study|Progression/relapse|4|||
170710501|NCT00004031|616946723|FG000|Overall Study|Death|3|||
170710502|NCT00004031|616946724|FG001|Overall Study|Death|1|||
170710503|NCT00004031|616946723|FG000|Overall Study|Other- not protocol specified|3|||
170710504|NCT00004031|616946724|FG001|Overall Study|Other- not protocol specified|3|||
170710505|NCT00004031|616946723|FG000|Overall Study|Reason under review|3|||
170710506|NCT00004031|616946724|FG001|Overall Study|Reason under review|2|||
170710507|NCT00437034|616946725|FG000|Overall Study|Adverse Event|1|||
170710508|NCT00437034|616946725|FG000|Overall Study|Disease progression during treatment|5|||
170710509|NCT04055116|616946726|FG000|First Intervention|Physician Decision|2|||
170710510|NCT04055116|616946727|FG001|First Intervention|Physician Decision|7|||
170710511|NCT02707640|616946730|FG000|Overall Study|Adverse Event|4|||
170710512|NCT02707640|616946731|FG001|Overall Study|Adverse Event|2|||
170710513|NCT02707640|616946730|FG000|Overall Study|Death|1|||
170710514|NCT02707640|616946731|FG001|Overall Study|Death|2|||
170710515|NCT02707640|616946730|FG000|Overall Study|Physician Decision|2|||
170710516|NCT02707640|616946731|FG001|Overall Study|Physician Decision|0|||
170710517|NCT02707640|616946730|FG000|Overall Study|Withdrawal by Subject|0|||
170710518|NCT02707640|616946731|FG001|Overall Study|Withdrawal by Subject|1|||
170710519|NCT02707640|616946730|FG000|Overall Study|Participant's Personal Decision|1|||
170710520|NCT02707640|616946731|FG001|Overall Study|Participant's Personal Decision|2|||
170710521|NCT02707640|616946730|FG000|Overall Study|Sponsor Discretion|1|||
170710522|NCT02707640|616946731|FG001|Overall Study|Sponsor Discretion|0|||
170710523|NCT00023452|616946732|FG000|Overall Study|Ineligible for Study|163|||
170710524|NCT00023452|616946733|FG001|Overall Study|Ineligible for Study|159|||
170710525|NCT00023452|616946732|FG000|Overall Study|Out of Window|129|||
170710526|NCT00023452|616946733|FG001|Overall Study|Out of Window|69|||
170710527|NCT00023452|616946732|FG000|Overall Study|Death|2|||
170710528|NCT00023452|616946733|FG001|Overall Study|Death|0|||
170710529|NCT00023452|616946732|FG000|Overall Study|Withdrawal by Subject|66|||
170710530|NCT00023452|616946733|FG001|Overall Study|Withdrawal by Subject|54|||
170710531|NCT00023452|616946732|FG000|Overall Study|Adverse Event|139|||
170710532|NCT00023452|616946733|FG001|Overall Study|Adverse Event|196|||
170710533|NCT00023452|616946732|FG000|Overall Study|Lost to Follow-up|293|||
170710534|NCT00023452|616946733|FG001|Overall Study|Lost to Follow-up|60|||
170710535|NCT00023452|616946732|FG000|Overall Study|Physician Decision|49|||
170710536|NCT00023452|616946733|FG001|Overall Study|Physician Decision|21|||
170710537|NCT00023452|616946732|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
170710538|NCT00023452|616946733|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
170710539|NCT00023452|616946732|FG000|Overall Study|Pregnant|53|||
170710540|NCT00023452|616946733|FG001|Overall Study|Pregnant|20|||
170710541|NCT00023452|616946732|FG000|Overall Study|Other|204|||
170710542|NCT00023452|616946733|FG001|Overall Study|Other|69|||
170710543|NCT05789875|616946734|FG000|Overall Study|Lost to Follow-up|6|||
170710544|NCT01940705|616946738|FG000|Overall Study|Lost to Follow-up|1|||
170710545|NCT01940705|616946739|FG001|Overall Study|Lost to Follow-up|3|||
170710546|NCT01940705|616946740|FG002|Overall Study|Lost to Follow-up|2|||
170710547|NCT01940705|616946741|FG003|Overall Study|Lost to Follow-up|2|||
170710548|NCT01940705|616946738|FG000|Overall Study|Withdrawal by Subject|2|||
170710549|NCT01940705|616946739|FG001|Overall Study|Withdrawal by Subject|2|||
170710550|NCT01940705|616946740|FG002|Overall Study|Withdrawal by Subject|3|||
170710551|NCT01940705|616946741|FG003|Overall Study|Withdrawal by Subject|2|||
170710552|NCT01940705|616946738|FG000|Overall Study|Intervention not given|0|||
170710553|NCT01940705|616946739|FG001|Overall Study|Intervention not given|3|||
170710554|NCT01940705|616946740|FG002|Overall Study|Intervention not given|3|||
170710555|NCT01940705|616946741|FG003|Overall Study|Intervention not given|0|||
170710556|NCT01940705|616946738|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
170710557|NCT01940705|616946739|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
170710558|NCT01940705|616946740|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
170710559|NCT01940705|616946741|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
170710560|NCT03328897|616948286|FG000|Randomized-treatment Epoch|Adverse Event|4|||
170710561|NCT03328897|616948287|FG001|Randomized-treatment Epoch|Adverse Event|1|||
170710562|NCT03328897|616948288|FG002|Randomized-treatment Epoch|Adverse Event|1|||
170710563|NCT03328897|616948286|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
170710564|NCT03328897|616948287|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
170710565|NCT03328897|616948288|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
170710566|NCT03328897|616948286|FG000|Randomized-treatment Epoch|Pregnancy|3|||
170710567|NCT03328897|616948287|FG001|Randomized-treatment Epoch|Pregnancy|0|||
170710568|NCT03328897|616948288|FG002|Randomized-treatment Epoch|Pregnancy|0|||
170710569|NCT03328897|616948286|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
170710570|NCT03328897|616948287|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
170710571|NCT03328897|616948288|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
170710572|NCT03328897|616948286|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
170710573|NCT03328897|616948287|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
170710574|NCT03328897|616948288|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
170710575|NCT03328897|616948286|FG000|Follow-up Epoch|Adverse Event|4|||
170710576|NCT03328897|616948287|FG001|Follow-up Epoch|Adverse Event|0|||
170710577|NCT03328897|616948288|FG002|Follow-up Epoch|Adverse Event|1|||
170710578|NCT03328897|616948286|FG000|Follow-up Epoch|Lack of Efficacy|1|||
170710579|NCT03328897|616948287|FG001|Follow-up Epoch|Lack of Efficacy|1|||
170710580|NCT03328897|616948288|FG002|Follow-up Epoch|Lack of Efficacy|1|||
170710581|NCT03328897|616948286|FG000|Follow-up Epoch|Lost to Follow-up|0|||
170710582|NCT03328897|616948287|FG001|Follow-up Epoch|Lost to Follow-up|1|||
170710583|NCT03328897|616948288|FG002|Follow-up Epoch|Lost to Follow-up|0|||
170710584|NCT03328897|616948286|FG000|Follow-up Epoch|Pregnancy|1|||
170710585|NCT03328897|616948287|FG001|Follow-up Epoch|Pregnancy|0|||
170710586|NCT03328897|616948288|FG002|Follow-up Epoch|Pregnancy|0|||
170710587|NCT03328897|616948286|FG000|Follow-up Epoch|Patient/guardian decision|2|||
170710588|NCT03328897|616948287|FG001|Follow-up Epoch|Patient/guardian decision|1|||
170710589|NCT03328897|616948288|FG002|Follow-up Epoch|Patient/guardian decision|0|||
170710590|NCT01175824|616948293|FG000|Overall Study|Adverse Event|2|||
170710591|NCT01175824|616948294|FG001|Overall Study|Adverse Event|1|||
170710592|NCT01175824|616948293|FG000|Overall Study|Lack of Efficacy|2|||
170710593|NCT01175824|616948294|FG001|Overall Study|Lack of Efficacy|0|||
170710594|NCT01175824|616948293|FG000|Overall Study|Lost to Follow-up|0|||
170710595|NCT01175824|616948294|FG001|Overall Study|Lost to Follow-up|1|||
170710596|NCT01175824|616948293|FG000|Overall Study|Physician Decision|0|||
170710597|NCT01175824|616948294|FG001|Overall Study|Physician Decision|4|||
170710598|NCT01175824|616948293|FG000|Overall Study|Protocol Violation|2|||
170710599|NCT01175824|616948294|FG001|Overall Study|Protocol Violation|5|||
170710600|NCT01175824|616948293|FG000|Overall Study|Withdrawal by Subject|3|||
170710601|NCT01175824|616948294|FG001|Overall Study|Withdrawal by Subject|7|||
170710602|NCT01175824|616948293|FG000|Overall Study|Sponsor Decision|1|||
170710603|NCT01175824|616948294|FG001|Overall Study|Sponsor Decision|0|||
170827767|NCT00913523|617380139|FG000|Overall Study|Lost to Follow-up|1|||
170710604|NCT01175824|616948293|FG000|Overall Study|Entry Criteria Not Met|6|||
170710605|NCT01175824|616948294|FG001|Overall Study|Entry Criteria Not Met|4|||
170827768|NCT00913523|617380140|FG001|Overall Study|Lost to Follow-up|1|||
170827769|NCT00913523|617380141|FG002|Overall Study|Lost to Follow-up|1|||
170710606|NCT03455855|616948295|FG000|Overall Study|Lost to Follow-up|4|||
170710607|NCT03455855|616948296|FG001|Overall Study|Lost to Follow-up|2|||
170710608|NCT00767000|616948299|FG000|54-week Study|Adverse Event|4|||
170710609|NCT00767000|616948300|FG001|54-week Study|Adverse Event|6|||
170827770|NCT00913523|617380139|FG000|Overall Study|Adverse Event|1|||
170710610|NCT00767000|616948301|FG002|54-week Study|Adverse Event|6|||
170710611|NCT00767000|616948302|FG003|54-week Study|Adverse Event|8|||
170710612|NCT00767000|616948303|FG004|54-week Study|Adverse Event|4|||
170710613|NCT00767000|616948299|FG000|54-week Study|Creaninine/creatinine clearance|2|||
170710614|NCT00767000|616948300|FG001|54-week Study|Creaninine/creatinine clearance|1|||
170710615|NCT00767000|616948301|FG002|54-week Study|Creaninine/creatinine clearance|2|||
170710616|NCT00767000|616948302|FG003|54-week Study|Creaninine/creatinine clearance|2|||
170710617|NCT00767000|616948303|FG004|54-week Study|Creaninine/creatinine clearance|4|||
170710618|NCT00767000|616948299|FG000|54-week Study|Hyperglycemia|0|||
170710619|NCT00767000|616948300|FG001|54-week Study|Hyperglycemia|0|||
170710620|NCT00767000|616948301|FG002|54-week Study|Hyperglycemia|1|||
170710621|NCT00767000|616948302|FG003|54-week Study|Hyperglycemia|0|||
170710622|NCT00767000|616948303|FG004|54-week Study|Hyperglycemia|1|||
170710623|NCT00767000|616948299|FG000|54-week Study|Hypoglycemia|0|||
170710624|NCT00767000|616948300|FG001|54-week Study|Hypoglycemia|1|||
170710625|NCT00767000|616948301|FG002|54-week Study|Hypoglycemia|0|||
170710626|NCT00767000|616948302|FG003|54-week Study|Hypoglycemia|0|||
170710627|NCT00767000|616948303|FG004|54-week Study|Hypoglycemia|0|||
170710628|NCT00767000|616948299|FG000|54-week Study|Interruption of study medication|0|||
170710629|NCT00767000|616948300|FG001|54-week Study|Interruption of study medication|0|||
170710630|NCT00767000|616948301|FG002|54-week Study|Interruption of study medication|1|||
170710631|NCT00767000|616948302|FG003|54-week Study|Interruption of study medication|0|||
170710632|NCT00767000|616948303|FG004|54-week Study|Interruption of study medication|0|||
170710633|NCT00767000|616948299|FG000|54-week Study|Lack of Efficacy|2|||
170710634|NCT00767000|616948300|FG001|54-week Study|Lack of Efficacy|0|||
170710635|NCT00767000|616948301|FG002|54-week Study|Lack of Efficacy|1|||
170710636|NCT00767000|616948302|FG003|54-week Study|Lack of Efficacy|0|||
170710637|NCT00767000|616948303|FG004|54-week Study|Lack of Efficacy|5|||
170710638|NCT00767000|616948299|FG000|54-week Study|Lost to Follow-up|4|||
170710639|NCT00767000|616948300|FG001|54-week Study|Lost to Follow-up|0|||
170710640|NCT00767000|616948301|FG002|54-week Study|Lost to Follow-up|1|||
170710641|NCT00767000|616948302|FG003|54-week Study|Lost to Follow-up|4|||
170710642|NCT00767000|616948303|FG004|54-week Study|Lost to Follow-up|2|||
170710643|NCT00767000|616948299|FG000|54-week Study|Physician Decision|4|||
170710644|NCT00767000|616948300|FG001|54-week Study|Physician Decision|0|||
170710645|NCT00767000|616948301|FG002|54-week Study|Physician Decision|1|||
170710646|NCT00767000|616948302|FG003|54-week Study|Physician Decision|1|||
170710647|NCT00767000|616948303|FG004|54-week Study|Physician Decision|1|||
170710648|NCT00767000|616948299|FG000|54-week Study|Progressive disease|0|||
170710649|NCT00767000|616948300|FG001|54-week Study|Progressive disease|0|||
170710650|NCT00767000|616948301|FG002|54-week Study|Progressive disease|1|||
170710651|NCT00767000|616948302|FG003|54-week Study|Progressive disease|0|||
170710652|NCT00767000|616948303|FG004|54-week Study|Progressive disease|0|||
170710653|NCT00767000|616948299|FG000|54-week Study|Protocol Violation|0|||
170710654|NCT00767000|616948300|FG001|54-week Study|Protocol Violation|0|||
170710655|NCT00767000|616948301|FG002|54-week Study|Protocol Violation|1|||
170710656|NCT00767000|616948302|FG003|54-week Study|Protocol Violation|2|||
170710657|NCT00767000|616948303|FG004|54-week Study|Protocol Violation|0|||
170710658|NCT00767000|616948299|FG000|54-week Study|Withdrawal by Subject|2|||
170710659|NCT00767000|616948300|FG001|54-week Study|Withdrawal by Subject|3|||
170710660|NCT00767000|616948301|FG002|54-week Study|Withdrawal by Subject|5|||
170710661|NCT00767000|616948302|FG003|54-week Study|Withdrawal by Subject|11|||
170710662|NCT00767000|616948303|FG004|54-week Study|Withdrawal by Subject|13|||
170710663|NCT00767000|616948299|FG000|54-week Study|Study terminated by sponsor|90|||
170710664|NCT00767000|616948300|FG001|54-week Study|Study terminated by sponsor|102|||
170710665|NCT00767000|616948301|FG002|54-week Study|Study terminated by sponsor|89|||
170710666|NCT00767000|616948302|FG003|54-week Study|Study terminated by sponsor|196|||
170710667|NCT00767000|616948303|FG004|54-week Study|Study terminated by sponsor|194|||
170710668|NCT00767000|616948299|FG000|54-week Study|Reason not reported|0|||
170710669|NCT00767000|616948300|FG001|54-week Study|Reason not reported|0|||
170710670|NCT00767000|616948301|FG002|54-week Study|Reason not reported|0|||
170710671|NCT00767000|616948302|FG003|54-week Study|Reason not reported|1|||
170710672|NCT00767000|616948303|FG004|54-week Study|Reason not reported|0|||
170710673|NCT00767000|616948299|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
170710674|NCT00767000|616948300|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
170710675|NCT00767000|616948301|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
170710676|NCT00767000|616948302|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
170827771|NCT00913523|617380140|FG001|Overall Study|Adverse Event|0|||
170710677|NCT00767000|616948303|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
170710678|NCT00961259|616948309|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
170710679|NCT00961259|616948310|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
170710680|NCT00961259|616948311|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
170827772|NCT00913523|617380141|FG002|Overall Study|Adverse Event|0|||
170827773|NCT00913523|617380139|FG000|Overall Study|Protocol Violation|5|||
170827774|NCT00913523|617380140|FG001|Overall Study|Protocol Violation|8|||
170827775|NCT00913523|617380141|FG002|Overall Study|Protocol Violation|8|||
170827776|NCT00913523|617380139|FG000|Overall Study|Pregnancy|1|||
170710681|NCT02691455|616948314|FG000|Overall Study|Withdrawal by Subject|1|||
170710682|NCT02691455|616948315|FG001|Overall Study|Withdrawal by Subject|2|||
170710683|NCT02691455|616948314|FG000|Overall Study|Lost to Follow-up|15|||
170710684|NCT02691455|616948315|FG001|Overall Study|Lost to Follow-up|15|||
170710685|NCT02057757|616948316|FG000|Overall Study|Withdrawal by Subject|3|||
170710686|NCT02057757|616948317|FG001|Overall Study|Withdrawal by Subject|5|||
170710687|NCT02057757|616948316|FG000|Overall Study|Death|2|||
170710688|NCT02057757|616948317|FG001|Overall Study|Death|0|||
170710689|NCT02057757|616948316|FG000|Overall Study|Lost to Follow-up|8|||
170710690|NCT02057757|616948317|FG001|Overall Study|Lost to Follow-up|3|||
170710691|NCT02057757|616948316|FG000|Overall Study|Non-compliance|1|||
170710692|NCT02057757|616948317|FG001|Overall Study|Non-compliance|0|||
170710693|NCT03586869|616948321|FG000|Overall Study|Progressive Disease|3|||
170710694|NCT02732847|616948324|FG000|Overall Study|some filled early|42|||
170710695|NCT02732847|616948325|FG001|Overall Study|some filled early|42|||
170710696|NCT00009737|616948326|FG000|Overall Study|Adverse Event|112|||
170710697|NCT00009737|616948327|FG001|Overall Study|Adverse Event|75|||
170710698|NCT00009737|616948326|FG000|Overall Study|Death|4|||
170710699|NCT00009737|616948327|FG001|Overall Study|Death|6|||
170710700|NCT00009737|616948326|FG000|Overall Study|Lack of Efficacy|17|||
170710701|NCT00009737|616948327|FG001|Overall Study|Lack of Efficacy|15|||
170710702|NCT00009737|616948326|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
170710703|NCT00009737|616948327|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
170710704|NCT00009737|616948326|FG000|Overall Study|Other Protocol Violation|1|||
170710705|NCT00009737|616948327|FG001|Overall Study|Other Protocol Violation|0|||
170710706|NCT00009737|616948326|FG000|Overall Study|Refused Treatment|15|||
170710707|NCT00009737|616948327|FG001|Overall Study|Refused Treatment|16|||
170710708|NCT00009737|616948326|FG000|Overall Study|Lost to Follow-up|1|||
170710709|NCT00009737|616948327|FG001|Overall Study|Lost to Follow-up|1|||
170710710|NCT00009737|616948326|FG000|Overall Study|Administrative/Other Reasons|7|||
170710711|NCT00009737|616948327|FG001|Overall Study|Administrative/Other Reasons|1|||
170710712|NCT00003498|616948329|FG000|Overall Study|Not evaluable.|4|||
170710713|NCT02956629|616948330|FG000|Overall Study|Adverse Event|0|||
170710714|NCT02956629|616948331|FG001|Overall Study|Adverse Event|0|||
170710715|NCT02956629|616948332|FG002|Overall Study|Adverse Event|1|||
170710716|NCT02956629|616948333|FG003|Overall Study|Adverse Event|0|||
170710717|NCT02956629|616948334|FG004|Overall Study|Adverse Event|0|||
170710718|NCT02956629|616948335|FG005|Overall Study|Adverse Event|0|||
170710719|NCT02956629|616948330|FG000|Overall Study|Lost to Follow-up|2|||
170710720|NCT02956629|616948331|FG001|Overall Study|Lost to Follow-up|5|||
170710721|NCT02956629|616948332|FG002|Overall Study|Lost to Follow-up|3|||
170710722|NCT02956629|616948333|FG003|Overall Study|Lost to Follow-up|1|||
170710723|NCT02956629|616948334|FG004|Overall Study|Lost to Follow-up|0|||
170710724|NCT02956629|616948335|FG005|Overall Study|Lost to Follow-up|1|||
170710725|NCT02956629|616948330|FG000|Overall Study|Withdrawal by Subject|3|||
170710726|NCT02956629|616948331|FG001|Overall Study|Withdrawal by Subject|1|||
170710727|NCT02956629|616948332|FG002|Overall Study|Withdrawal by Subject|0|||
170710728|NCT02956629|616948333|FG003|Overall Study|Withdrawal by Subject|0|||
170710729|NCT02956629|616948334|FG004|Overall Study|Withdrawal by Subject|0|||
170710730|NCT02956629|616948335|FG005|Overall Study|Withdrawal by Subject|0|||
170710731|NCT03224468|616948342|FG000|Overall Study|Did not obtain MM card|53|||
170710732|NCT03224468|616948343|FG001|Overall Study|Did not obtain MM card|0|||
170710733|NCT03224468|616948342|FG000|Overall Study|Lost to Follow-up|4|||
170710734|NCT03224468|616948343|FG001|Overall Study|Lost to Follow-up|11|||
170710735|NCT03224468|616948342|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
170710736|NCT03224468|616948343|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
170710737|NCT04713748|616948344|FG000|Overall Study|Not enough kits allocated|35|||
170710738|NCT00406029|616948345|FG000|Overall Study|Adverse Event|12|||
170710739|NCT00406029|616948346|FG001|Overall Study|Adverse Event|2|||
170710740|NCT00406029|616948347|FG002|Overall Study|Adverse Event|5|||
170710741|NCT00406029|616948348|FG003|Overall Study|Adverse Event|10|||
170710742|NCT00406029|616948349|FG004|Overall Study|Adverse Event|7|||
170710743|NCT00406029|616948345|FG000|Overall Study|Withdrawal by Subject|3|||
170710744|NCT00406029|616948346|FG001|Overall Study|Withdrawal by Subject|4|||
170710745|NCT00406029|616948347|FG002|Overall Study|Withdrawal by Subject|2|||
170710746|NCT00406029|616948348|FG003|Overall Study|Withdrawal by Subject|2|||
170710747|NCT00406029|616948349|FG004|Overall Study|Withdrawal by Subject|0|||
170710748|NCT00406029|616948345|FG000|Overall Study|Protocol Violation|1|||
170710749|NCT00406029|616948346|FG001|Overall Study|Protocol Violation|2|||
170710750|NCT00406029|616948347|FG002|Overall Study|Protocol Violation|0|||
170710751|NCT00406029|616948348|FG003|Overall Study|Protocol Violation|2|||
170710752|NCT00406029|616948349|FG004|Overall Study|Protocol Violation|0|||
170710753|NCT00406029|616948345|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
170710754|NCT00406029|616948346|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
170710755|NCT00406029|616948347|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
170710756|NCT00406029|616948348|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
170710757|NCT00406029|616948349|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
170827777|NCT00913523|617380140|FG001|Overall Study|Pregnancy|3|||
170710758|NCT00406029|616948345|FG000|Overall Study|Randomized in Error|0|||
170710759|NCT00406029|616948346|FG001|Overall Study|Randomized in Error|0|||
170710760|NCT00406029|616948347|FG002|Overall Study|Randomized in Error|2|||
170710761|NCT00406029|616948348|FG003|Overall Study|Randomized in Error|3|||
170710762|NCT00406029|616948349|FG004|Overall Study|Randomized in Error|1|||
170710763|NCT00113516|616948350|FG000|Part 1|Adverse Event|6|||
170710764|NCT00113516|616948351|FG001|Part 1|Adverse Event|0|||
170710765|NCT00113516|616948350|FG000|Part 1|Death|3|||
170710766|NCT00113516|616948351|FG001|Part 1|Death|0|||
170710767|NCT00113516|616948350|FG000|Part 1|Other|3|||
170710768|NCT00113516|616948351|FG001|Part 1|Other|0|||
170710769|NCT00113516|616948350|FG000|Part 1|Withdrawal by Subject|2|||
170710770|NCT00113516|616948351|FG001|Part 1|Withdrawal by Subject|0|||
170710771|NCT00113516|616948350|FG000|Part 1|Lack of Efficacy|2|||
170710772|NCT00113516|616948351|FG001|Part 1|Lack of Efficacy|0|||
170710773|NCT00113516|616948350|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
170710774|NCT00113516|616948351|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
170710775|NCT00113516|616948350|FG000|Part 1|Laboratory Abnormality|1|||
170710776|NCT00113516|616948351|FG001|Part 1|Laboratory Abnormality|0|||
170710777|NCT00113516|616948350|FG000|Part 1|Ongoing|1|||
170710778|NCT00113516|616948351|FG001|Part 1|Ongoing|0|||
170710779|NCT00113516|616948350|FG000|Part 1|Missing|65|||
170710780|NCT00113516|616948351|FG001|Part 1|Missing|0|||
170710781|NCT00113516|616948350|FG000|Part 2|Adverse Event|0|||
170710782|NCT00113516|616948351|FG001|Part 2|Adverse Event|16|||
170710783|NCT00113516|616948350|FG000|Part 2|Death|0|||
170710784|NCT00113516|616948351|FG001|Part 2|Death|5|||
170710785|NCT00113516|616948350|FG000|Part 2|Lack of Efficacy|0|||
170710786|NCT00113516|616948351|FG001|Part 2|Lack of Efficacy|37|||
170710787|NCT00113516|616948350|FG000|Part 2|Withdrawal by Subject|0|||
170710788|NCT00113516|616948351|FG001|Part 2|Withdrawal by Subject|3|||
170710789|NCT00113516|616948350|FG000|Part 2|Other|0|||
170710790|NCT00113516|616948351|FG001|Part 2|Other|3|||
170710791|NCT00113516|616948350|FG000|Part 2|Laboratory Abnormality|0|||
170710792|NCT00113516|616948351|FG001|Part 2|Laboratory Abnormality|1|||
170710793|NCT00113516|616948350|FG000|Part 2|Ongoing|0|||
170710794|NCT00113516|616948351|FG001|Part 2|Ongoing|1|||
170710795|NCT01557946|616948352|FG000|Overall Study|Adverse Event|3|||
170710796|NCT01557946|616948353|FG001|Overall Study|Adverse Event|0|||
170710797|NCT00812812|616948355|FG000|Overall Study|Adverse Event|2|||
170710798|NCT00812812|616948356|FG001|Overall Study|Adverse Event|1|||
170710799|NCT00812812|616948355|FG000|Overall Study|Lack of Efficacy|1|||
170710800|NCT00812812|616948356|FG001|Overall Study|Lack of Efficacy|0|||
170710801|NCT00812812|616948355|FG000|Overall Study|Lost to Follow-up|0|||
170710802|NCT00812812|616948356|FG001|Overall Study|Lost to Follow-up|1|||
170710803|NCT00812812|616948355|FG000|Overall Study|Withdrawal by Subject|0|||
170710804|NCT00812812|616948356|FG001|Overall Study|Withdrawal by Subject|2|||
170710805|NCT04327934|616948357|FG000|Overall Study|Did not qualify|7|||
170710806|NCT04327934|616948358|FG001|Overall Study|Did not qualify|4|||
170710807|NCT04327934|616948357|FG000|Overall Study|Physician Decision|0|||
170710808|NCT04327934|616948358|FG001|Overall Study|Physician Decision|1|||
170710809|NCT03732248|616948362|FG000|Overall Study|Withdrawal by Subject|1|||
170710810|NCT03732248|616948363|FG001|Overall Study|Withdrawal by Subject|0|||
170710811|NCT01649856|616948368|FG000|Overall Study|Withdrawal by Subject|14|||
170710812|NCT01649856|616948369|FG001|Overall Study|Withdrawal by Subject|14|||
170710813|NCT01649856|616948368|FG000|Overall Study|Protocol Violation|4|||
170710814|NCT01649856|616948369|FG001|Overall Study|Protocol Violation|4|||
170710815|NCT01649856|616948368|FG000|Overall Study|Treatment Failure|1|||
170710816|NCT01649856|616948369|FG001|Overall Study|Treatment Failure|1|||
170827778|NCT00913523|617380141|FG002|Overall Study|Pregnancy|0|||
170827779|NCT00913523|617380139|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
170827780|NCT00913523|617380140|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
170827781|NCT00913523|617380141|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
170827782|NCT01649297|617380144|FG000|Overall Study|Adverse Event|5|||
170710817|NCT01649856|616948368|FG000|Overall Study|Death|69|||
170710818|NCT01649856|616948369|FG001|Overall Study|Death|34|||
170710819|NCT01649856|616948368|FG000|Overall Study|Stable or Progressed Disease|5|||
170710820|NCT01649856|616948369|FG001|Overall Study|Stable or Progressed Disease|3|||
170710821|NCT01649856|616948368|FG000|Overall Study|Lost to Follow-up|20|||
170710822|NCT01649856|616948369|FG001|Overall Study|Lost to Follow-up|16|||
170710823|NCT01649856|616948368|FG000|Overall Study|Lack of Compliance|6|||
170710824|NCT01649856|616948369|FG001|Overall Study|Lack of Compliance|1|||
170710825|NCT01649856|616948368|FG000|Overall Study|Other|20|||
170827783|NCT01649297|617380145|FG001|Overall Study|Adverse Event|5|||
170827784|NCT01649297|617380146|FG002|Overall Study|Adverse Event|4|||
170827785|NCT01649297|617380147|FG003|Overall Study|Adverse Event|13|||
170710826|NCT01649856|616948369|FG001|Overall Study|Other|5|||
170710827|NCT00179647|616948370|FG000|Overall Study|Adverse Event|294|||
170710828|NCT00179647|616948370|FG000|Overall Study|Lack of Efficacy|478|||
170710829|NCT00179647|616948370|FG000|Overall Study|Withdrawal by Subject|83|||
170710830|NCT00179647|616948370|FG000|Overall Study|Lost to Follow-up|4|||
170710831|NCT00179647|616948370|FG000|Overall Study|Death|94|||
170710832|NCT00179647|616948370|FG000|Overall Study|Other|960|||
170710833|NCT00622635|616948371|FG000|Treatment Period 1|Adverse Event|0|||
170710834|NCT00622635|616948372|FG001|Treatment Period 1|Adverse Event|0|||
170710835|NCT00622635|616948373|FG002|Treatment Period 1|Adverse Event|1|||
170710836|NCT00622635|616948374|FG003|Treatment Period 1|Adverse Event|0|||
170710837|NCT00622635|616948375|FG004|Treatment Period 1|Adverse Event|0|||
170710838|NCT00622635|616948376|FG005|Treatment Period 1|Adverse Event|0|||
170710839|NCT00622635|616948371|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170710840|NCT00622635|616948372|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170710841|NCT00622635|616948373|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170710842|NCT00622635|616948374|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170710843|NCT00622635|616948375|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170827786|NCT01649297|617380148|FG004|Overall Study|Adverse Event|1|||
170710844|NCT00622635|616948376|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170710845|NCT00622635|616948371|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
170710846|NCT00622635|616948372|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
170710847|NCT00622635|616948373|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
170710848|NCT00622635|616948374|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
170710849|NCT00622635|616948375|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
170710850|NCT00622635|616948376|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
170710851|NCT00622635|616948371|FG000|Treatment Period 2|Adverse Event|1|||
170710852|NCT00622635|616948372|FG001|Treatment Period 2|Adverse Event|0|||
170710853|NCT00622635|616948373|FG002|Treatment Period 2|Adverse Event|0|||
170710854|NCT00622635|616948374|FG003|Treatment Period 2|Adverse Event|0|||
170710855|NCT00622635|616948375|FG004|Treatment Period 2|Adverse Event|0|||
170710856|NCT00622635|616948376|FG005|Treatment Period 2|Adverse Event|0|||
170710857|NCT00622635|616948371|FG000|Treatment Period 3|Adverse Event|0|||
170710858|NCT00622635|616948372|FG001|Treatment Period 3|Adverse Event|0|||
170710859|NCT00622635|616948373|FG002|Treatment Period 3|Adverse Event|0|||
170710860|NCT00622635|616948374|FG003|Treatment Period 3|Adverse Event|2|||
170710861|NCT00622635|616948375|FG004|Treatment Period 3|Adverse Event|0|||
170710862|NCT00622635|616948376|FG005|Treatment Period 3|Adverse Event|0|||
170710863|NCT00622635|616948371|FG000|Treatment Period 3|Withdrawal by Subject|0|||
170710864|NCT00622635|616948372|FG001|Treatment Period 3|Withdrawal by Subject|0|||
170710865|NCT00622635|616948373|FG002|Treatment Period 3|Withdrawal by Subject|0|||
170710866|NCT00622635|616948374|FG003|Treatment Period 3|Withdrawal by Subject|1|||
170710867|NCT00622635|616948375|FG004|Treatment Period 3|Withdrawal by Subject|0|||
170710868|NCT00622635|616948376|FG005|Treatment Period 3|Withdrawal by Subject|0|||
170710869|NCT02755831|616948381|FG000|Overall Study|Lost to Follow-up|3|||
170710870|NCT02755831|616948382|FG001|Overall Study|Lost to Follow-up|3|||
170710871|NCT02501096|616948383|FG000|Overall Study|Lost to Follow-up|0|||
170710872|NCT02501096|616948384|FG001|Overall Study|Lost to Follow-up|0|||
170710873|NCT02501096|616948385|FG002|Overall Study|Lost to Follow-up|0|||
170710874|NCT02501096|616948386|FG003|Overall Study|Lost to Follow-up|0|||
170710875|NCT02501096|616948387|FG004|Overall Study|Lost to Follow-up|1|||
170710876|NCT02501096|616948388|FG005|Overall Study|Lost to Follow-up|1|||
170710877|NCT02501096|616948389|FG006|Overall Study|Lost to Follow-up|3|||
170710878|NCT02501096|616948390|FG007|Overall Study|Lost to Follow-up|0|||
170710879|NCT02501096|616948391|FG008|Overall Study|Lost to Follow-up|0|||
170710880|NCT02501096|616948383|FG000|Overall Study|Withdrawal by Subject|1|||
170710881|NCT02501096|616948384|FG001|Overall Study|Withdrawal by Subject|0|||
170710882|NCT02501096|616948385|FG002|Overall Study|Withdrawal by Subject|7|||
170710883|NCT02501096|616948386|FG003|Overall Study|Withdrawal by Subject|13|||
170710884|NCT02501096|616948387|FG004|Overall Study|Withdrawal by Subject|2|||
170710885|NCT02501096|616948388|FG005|Overall Study|Withdrawal by Subject|2|||
170710886|NCT02501096|616948389|FG006|Overall Study|Withdrawal by Subject|2|||
170710887|NCT02501096|616948390|FG007|Overall Study|Withdrawal by Subject|3|||
170710888|NCT02501096|616948391|FG008|Overall Study|Withdrawal by Subject|0|||
170710889|NCT02501096|616948383|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
170710890|NCT02501096|616948384|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
170710891|NCT02501096|616948385|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
170710892|NCT02501096|616948386|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
170710893|NCT02501096|616948387|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
170710894|NCT02501096|616948388|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
170710895|NCT02501096|616948389|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
170710896|NCT02501096|616948390|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
170710897|NCT02501096|616948391|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
170710898|NCT02501096|616948383|FG000|Overall Study|Death|1|||
170710899|NCT02501096|616948384|FG001|Overall Study|Death|1|||
170710900|NCT02501096|616948385|FG002|Overall Study|Death|88|||
170710901|NCT02501096|616948386|FG003|Overall Study|Death|74|||
170710902|NCT02501096|616948387|FG004|Overall Study|Death|15|||
170710903|NCT02501096|616948388|FG005|Overall Study|Death|16|||
170710904|NCT02501096|616948389|FG006|Overall Study|Death|15|||
170710905|NCT02501096|616948390|FG007|Overall Study|Death|16|||
170710906|NCT02501096|616948391|FG008|Overall Study|Death|1|||
170710907|NCT01916304|616948392|FG000|Overall Study|Screening failure|17|||
170710908|NCT01069289|616948397|FG000|Overall Study|Withdrawal by Subject|15|||
170710909|NCT01069289|616948398|FG001|Overall Study|Withdrawal by Subject|26|||
170710910|NCT01069289|616948397|FG000|Overall Study|Adverse Event|21|||
170710911|NCT01069289|616948398|FG001|Overall Study|Adverse Event|28|||
170710912|NCT01069289|616948397|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
170710913|NCT01069289|616948398|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170710914|NCT01069289|616948397|FG000|Overall Study|Severe non-compliance to protocol|3|||
170710915|NCT01069289|616948398|FG001|Overall Study|Severe non-compliance to protocol|2|||
170710916|NCT01069289|616948397|FG000|Overall Study|Due to deteriorating health condition|1|||
170710917|NCT01069289|616948398|FG001|Overall Study|Due to deteriorating health condition|0|||
170710918|NCT00965848|616948399|FG000|Overall Study|Protocol Violation|3|||
170710919|NCT00965848|616948400|FG001|Overall Study|Protocol Violation|0|||
170710920|NCT00965848|616948401|FG002|Overall Study|Protocol Violation|1|||
170710921|NCT00965848|616948399|FG000|Overall Study|Death|11|||
170710922|NCT00965848|616948400|FG001|Overall Study|Death|1|||
170710923|NCT00965848|616948401|FG002|Overall Study|Death|5|||
170710924|NCT00965848|616948399|FG000|Overall Study|Lost to Follow-up|0|||
170710925|NCT00965848|616948400|FG001|Overall Study|Lost to Follow-up|0|||
170710926|NCT00965848|616948401|FG002|Overall Study|Lost to Follow-up|1|||
170710927|NCT00965848|616948399|FG000|Overall Study|Withdrawal by Subject|1|||
170710928|NCT00965848|616948400|FG001|Overall Study|Withdrawal by Subject|0|||
170710929|NCT00965848|616948401|FG002|Overall Study|Withdrawal by Subject|0|||
170710930|NCT00965848|616948399|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
170710931|NCT00965848|616948400|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
170710932|NCT00965848|616948401|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
170710933|NCT00965848|616948399|FG000|Overall Study|Not Clinically Evaluable|7|||
170710934|NCT00965848|616948400|FG001|Overall Study|Not Clinically Evaluable|1|||
170710935|NCT00965848|616948401|FG002|Overall Study|Not Clinically Evaluable|1|||
170710936|NCT00965848|616948399|FG000|Overall Study|Other|5|||
170710937|NCT00965848|616948400|FG001|Overall Study|Other|0|||
170710938|NCT00965848|616948401|FG002|Overall Study|Other|1|||
170710939|NCT00691210|616948402|FG000|Overall Study|Progression of Disease|0|||
170710940|NCT00691210|616948403|FG001|Overall Study|Progression of Disease|0|||
170710941|NCT00691210|616948404|FG002|Overall Study|Progression of Disease|0|||
170710942|NCT00691210|616948405|FG003|Overall Study|Progression of Disease|2|||
170710943|NCT00691210|616948406|FG004|Overall Study|Progression of Disease|0|||
170710944|NCT00691210|616948407|FG005|Overall Study|Progression of Disease|0|||
170710945|NCT00691210|616948408|FG006|Overall Study|Progression of Disease|0|||
170710946|NCT00691210|616948409|FG007|Overall Study|Progression of Disease|0|||
170710947|NCT00691210|616948402|FG000|Overall Study|Lack of Efficacy|0|||
170710948|NCT00691210|616948403|FG001|Overall Study|Lack of Efficacy|0|||
170710949|NCT00691210|616948404|FG002|Overall Study|Lack of Efficacy|0|||
170710950|NCT00691210|616948405|FG003|Overall Study|Lack of Efficacy|1|||
170710951|NCT00691210|616948406|FG004|Overall Study|Lack of Efficacy|0|||
170710952|NCT00691210|616948407|FG005|Overall Study|Lack of Efficacy|1|||
170710953|NCT00691210|616948408|FG006|Overall Study|Lack of Efficacy|0|||
170710954|NCT00691210|616948409|FG007|Overall Study|Lack of Efficacy|0|||
170710955|NCT01994395|616948411|FG000|Overall Study|Withdrawal by Subject|1|||
170710956|NCT01994395|616948412|FG001|Overall Study|Withdrawal by Subject|2|||
170710957|NCT02447991|616948415|FG000|Overall Study|Withdrawn by subject - no data|0|||
170710958|NCT02447991|616948416|FG001|Overall Study|Withdrawn by subject - no data|2|||
170710959|NCT02447991|616948415|FG000|Overall Study|Withdrawn by Subject - with data|4|||
170710960|NCT02447991|616948416|FG001|Overall Study|Withdrawn by Subject - with data|4|||
170710961|NCT02447991|616948415|FG000|Overall Study|Lost to Follow-up - no data|3|||
170710962|NCT02447991|616948416|FG001|Overall Study|Lost to Follow-up - no data|6|||
170710963|NCT02447991|616948415|FG000|Overall Study|Lost to follow-up - with data|0|||
170827787|NCT01649297|617380144|FG000|Overall Study|Lack of Efficacy|0|||
170827788|NCT01649297|617380145|FG001|Overall Study|Lack of Efficacy|0|||
170827789|NCT01649297|617380146|FG002|Overall Study|Lack of Efficacy|0|||
170827790|NCT01649297|617380147|FG003|Overall Study|Lack of Efficacy|0|||
170827791|NCT01649297|617380148|FG004|Overall Study|Lack of Efficacy|1|||
170827792|NCT01649297|617380144|FG000|Overall Study|Non compliant with Protocol|1|||
170827793|NCT01649297|617380145|FG001|Overall Study|Non compliant with Protocol|0|||
170827794|NCT01649297|617380146|FG002|Overall Study|Non compliant with Protocol|3|||
170827795|NCT01649297|617380147|FG003|Overall Study|Non compliant with Protocol|2|||
170827796|NCT01649297|617380148|FG004|Overall Study|Non compliant with Protocol|1|||
170827797|NCT01649297|617380144|FG000|Overall Study|Lost to Follow-up|1|||
170827798|NCT01649297|617380145|FG001|Overall Study|Lost to Follow-up|1|||
170827799|NCT01649297|617380146|FG002|Overall Study|Lost to Follow-up|4|||
170827800|NCT01649297|617380147|FG003|Overall Study|Lost to Follow-up|3|||
170827801|NCT01649297|617380148|FG004|Overall Study|Lost to Follow-up|0|||
170827802|NCT01649297|617380144|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
170827803|NCT01649297|617380145|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
170827804|NCT01649297|617380146|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
170827805|NCT01649297|617380147|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
170827806|NCT01649297|617380148|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
170827807|NCT01649297|617380144|FG000|Overall Study|For other reason|4|||
170827808|NCT01649297|617380145|FG001|Overall Study|For other reason|1|||
170827809|NCT01649297|617380146|FG002|Overall Study|For other reason|2|||
170827810|NCT01649297|617380147|FG003|Overall Study|For other reason|0|||
170827811|NCT01649297|617380148|FG004|Overall Study|For other reason|0|||
170827812|NCT01685047|617380149|FG000|Overall Study|Withdrawal by Subject|20|||
170827813|NCT01685047|617380149|FG000|Overall Study|Death|26|||
170710964|NCT02447991|616948416|FG001|Overall Study|Lost to follow-up - with data|3|||
170710965|NCT02447991|616948415|FG000|Overall Study|End of study - no treatment results|3|||
170710966|NCT02447991|616948416|FG001|Overall Study|End of study - no treatment results|6|||
170710967|NCT02447991|616948415|FG000|Overall Study|End of study - partial treatment results|0|||
170710968|NCT02447991|616948416|FG001|Overall Study|End of study - partial treatment results|9|||
170710969|NCT00459134|616948421|FG000|Overall Study|Physician Decision|1|||
170710970|NCT00459134|616948422|FG001|Overall Study|Physician Decision|1|||
170710971|NCT00459134|616948421|FG000|Overall Study|Withdrawal by Subject|8|||
170710972|NCT00459134|616948422|FG001|Overall Study|Withdrawal by Subject|7|||
170710973|NCT00459134|616948421|FG000|Overall Study|Lost to Follow-up|6|||
170710974|NCT00459134|616948422|FG001|Overall Study|Lost to Follow-up|7|||
170710975|NCT00459134|616948421|FG000|Overall Study|Surgery|1|||
170710976|NCT00459134|616948422|FG001|Overall Study|Surgery|2|||
170710977|NCT00459134|616948421|FG000|Overall Study|Toxicity|4|||
170710978|NCT00459134|616948422|FG001|Overall Study|Toxicity|5|||
170710979|NCT00459134|616948421|FG000|Overall Study|Progression|1|||
170710980|NCT00459134|616948422|FG001|Overall Study|Progression|0|||
170710981|NCT00459134|616948421|FG000|Overall Study|Multiple Reasons|2|||
170710982|NCT00459134|616948422|FG001|Overall Study|Multiple Reasons|3|||
170710983|NCT00829621|616948423|FG000|Overall Study|Death|1|||
170710984|NCT00829621|616948424|FG001|Overall Study|Death|0|||
170710985|NCT00829621|616948423|FG000|Overall Study|Lost to Follow-up|3|||
170710986|NCT00829621|616948424|FG001|Overall Study|Lost to Follow-up|4|||
170710987|NCT02770391|616948427|FG000|Overall Study|Lost to Follow-up|2|||
170710988|NCT02770391|616948427|FG000|Overall Study|Withdrawal by Subject|1|||
170710989|NCT02770391|616948427|FG000|Overall Study|Surgery delayed unevaluable|2|||
170710990|NCT02770391|616948427|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
170710991|NCT01976845|616948431|FG000|Overall Study|Physician Decision|8|||
170710992|NCT01976845|616948432|FG001|Overall Study|Physician Decision|8|||
170710993|NCT01976845|616948433|FG002|Overall Study|Physician Decision|3|||
170710994|NCT01660412|616948436|FG000|Overall Study|Protocol Violation|0|||
170710995|NCT01660412|616948437|FG001|Overall Study|Protocol Violation|3|||
170710996|NCT03551210|616948444|FG000|Overall Study|Adverse Event|5|||
170710997|NCT03551210|616948445|FG001|Overall Study|Adverse Event|6|||
170710998|NCT03551210|616948444|FG000|Overall Study|Withdrawal by Subject|1|||
170710999|NCT03551210|616948445|FG001|Overall Study|Withdrawal by Subject|7|||
170711000|NCT03551210|616948444|FG000|Overall Study|Needed in other antibiotic treatment|2|||
170711001|NCT03551210|616948445|FG001|Overall Study|Needed in other antibiotic treatment|5|||
170711002|NCT03551210|616948444|FG000|Overall Study|Lost to Follow-up|1|||
170711003|NCT03551210|616948445|FG001|Overall Study|Lost to Follow-up|1|||
170711004|NCT03551210|616948444|FG000|Overall Study|Absence of visit 4 and 5|1|||
170711005|NCT03551210|616948445|FG001|Overall Study|Absence of visit 4 and 5|0|||
170711006|NCT03551210|616948444|FG000|Overall Study|No drug for dispensing|0|||
170711007|NCT03551210|616948445|FG001|Overall Study|No drug for dispensing|1|||
170711008|NCT01782131|616950066|FG000|Overall Study|Death|93|||
170711009|NCT01782131|616950067|FG001|Overall Study|Death|96|||
170711010|NCT01782131|616950066|FG000|Overall Study|Lost to Follow-up|1|||
170711011|NCT01782131|616950067|FG001|Overall Study|Lost to Follow-up|3|||
170711012|NCT01782131|616950066|FG000|Overall Study|Withdrawal by Subject|10|||
170711013|NCT01782131|616950067|FG001|Overall Study|Withdrawal by Subject|10|||
170711014|NCT01782131|616950066|FG000|Overall Study|Randomized but not treated|5|||
170711015|NCT01782131|616950067|FG001|Overall Study|Randomized but not treated|5|||
170711016|NCT01782131|616950066|FG000|Overall Study|Reason not provided|0|||
170711017|NCT01782131|616950067|FG001|Overall Study|Reason not provided|1|||
170711018|NCT03266588|616950068|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
170711019|NCT03266588|616950069|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
170711020|NCT03266588|616950070|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
170711021|NCT03266588|616950068|FG000|Observational Period|Withdrawal by Subject|44|||
170711022|NCT03266588|616950069|FG001|Observational Period|Withdrawal by Subject|22|||
170711023|NCT03266588|616950070|FG002|Observational Period|Withdrawal by Subject|13|||
170711024|NCT03266588|616950068|FG000|Observational Period|Non-compliance|18|||
170711025|NCT03266588|616950069|FG001|Observational Period|Non-compliance|12|||
170711026|NCT03266588|616950070|FG002|Observational Period|Non-compliance|10|||
170711027|NCT03266588|616950068|FG000|Observational Period|Lost to Follow-up|8|||
170711028|NCT03266588|616950069|FG001|Observational Period|Lost to Follow-up|12|||
170711029|NCT03266588|616950070|FG002|Observational Period|Lost to Follow-up|4|||
170711030|NCT03266588|616950068|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
170711031|NCT03266588|616950069|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
170711032|NCT03266588|616950070|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
170711033|NCT03266588|616950068|FG000|Observational Period|Protocol Deviation|1|||
170711034|NCT03266588|616950069|FG001|Observational Period|Protocol Deviation|0|||
170711035|NCT03266588|616950070|FG002|Observational Period|Protocol Deviation|0|||
170711036|NCT03266588|616950068|FG000|Observational Period|Other Reasons|3|||
170711037|NCT03266588|616950069|FG001|Observational Period|Other Reasons|0|||
170711038|NCT03266588|616950070|FG002|Observational Period|Other Reasons|1|||
170711039|NCT03266588|616950068|FG000|Long-term Treatment Period|Adverse Event|33|||
170711040|NCT03266588|616950069|FG001|Long-term Treatment Period|Adverse Event|17|||
170711041|NCT03266588|616950070|FG002|Long-term Treatment Period|Adverse Event|8|||
170711042|NCT03266588|616950068|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
170711043|NCT03266588|616950069|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
170711044|NCT03266588|616950070|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
170711045|NCT03266588|616950068|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
170711046|NCT03266588|616950069|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
170711047|NCT03266588|616950070|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
170711048|NCT03266588|616950068|FG000|Long-term Treatment Period|Non-Compliance|126|||
170711049|NCT03266588|616950069|FG001|Long-term Treatment Period|Non-Compliance|57|||
170711050|NCT03266588|616950070|FG002|Long-term Treatment Period|Non-Compliance|7|||
170711051|NCT03266588|616950068|FG000|Long-term Treatment Period|Pregnancy|11|||
170711052|NCT03266588|616950069|FG001|Long-term Treatment Period|Pregnancy|5|||
170711053|NCT03266588|616950070|FG002|Long-term Treatment Period|Pregnancy|0|||
170711054|NCT03266588|616950068|FG000|Long-term Treatment Period|Protocol Deviation|17|||
170711055|NCT03266588|616950069|FG001|Long-term Treatment Period|Protocol Deviation|10|||
170711056|NCT03266588|616950070|FG002|Long-term Treatment Period|Protocol Deviation|4|||
170711057|NCT03266588|616950068|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
170827814|NCT01685047|617380149|FG000|Overall Study|Lost to Follow-up|8|||
170827815|NCT01685047|617380149|FG000|Overall Study|Physician Decision|25|||
170827816|NCT01685047|617380149|FG000|Overall Study|Adverse Event|5|||
170827817|NCT01685047|617380149|FG000|Overall Study|patient withdrawn by sponsor|1|||
170827818|NCT01202409|617380150|FG000|Overall Study|Adverse Event|1|||
170827819|NCT01202409|617380150|FG000|Overall Study|Ineligible - KRAS mutants|7|||
170827820|NCT01732926|617380153|FG000|Overall Study|Study Terminated by Sponsor|168|||
170827821|NCT01732926|617380154|FG001|Overall Study|Study Terminated by Sponsor|80|||
170827822|NCT01732926|617380153|FG000|Overall Study|Withdrawal by Subject|46|||
170827823|NCT01732926|617380154|FG001|Overall Study|Withdrawal by Subject|8|||
170827824|NCT01732926|617380153|FG000|Overall Study|Physician Decision|24|||
170827825|NCT01732926|617380154|FG001|Overall Study|Physician Decision|11|||
170827826|NCT01732926|617380153|FG000|Overall Study|Other Reason|21|||
170827827|NCT01732926|617380154|FG001|Overall Study|Other Reason|4|||
170827828|NCT01732926|617380153|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
170827829|NCT01732926|617380154|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
170827830|NCT01732926|617380153|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
170711058|NCT03266588|616950069|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
170711059|NCT03266588|616950070|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
170711060|NCT03266588|616950068|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
170711061|NCT03266588|616950069|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
170711062|NCT03266588|616950070|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
170827831|NCT01732926|617380154|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
170827832|NCT02544113|617380155|FG000|Overall Study|Death|3|||
170827833|NCT02544113|617380156|FG001|Overall Study|Death|4|||
170827834|NCT02262364|617380160|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
170827835|NCT01049984|617380161|FG000|Overall Study|Withdrawal by Subject|1|||
170827836|NCT01049984|617380162|FG001|Overall Study|Withdrawal by Subject|5|||
170711063|NCT03266588|616950068|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
170711064|NCT03266588|616950069|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
170711065|NCT03266588|616950070|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
170711066|NCT03266588|616950068|FG000|Long-term Treatment Period|Other Reasons|5|||
170711067|NCT03266588|616950069|FG001|Long-term Treatment Period|Other Reasons|0|||
170711068|NCT03266588|616950070|FG002|Long-term Treatment Period|Other Reasons|0|||
170711069|NCT03266588|616950068|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
170711070|NCT03266588|616950069|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
170711071|NCT03266588|616950070|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
170711072|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Adverse Event|5|||
170711073|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Adverse Event|8|||
170711074|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Adverse Event|4|||
170711075|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Adverse Event|8|||
170711076|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
170711077|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
170711078|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
170711079|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
170711080|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
170711081|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
170711082|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
170711083|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
170711084|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Physician Decision|1|||
170711085|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Physician Decision|0|||
170711086|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Physician Decision|0|||
170711087|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Physician Decision|0|||
170711088|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
170711089|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
170711090|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
170711091|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
170711092|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Pregnancy|0|||
170711093|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Pregnancy|1|||
170711094|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Pregnancy|0|||
170711095|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Pregnancy|0|||
170711096|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
170711097|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
170711098|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
170711099|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
170711100|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Death|0|||
170711101|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Death|1|||
170711102|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Death|0|||
170711103|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Death|0|||
170711104|NCT00071487|616950075|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
170711105|NCT00071487|616950076|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
170711106|NCT00071487|616950077|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
170711107|NCT00071487|616950078|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
170711108|NCT00071487|616950075|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
170711109|NCT00071487|616950076|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
170711110|NCT00071487|616950077|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
170711111|NCT00071487|616950078|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
170711112|NCT00071487|616950075|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
170711113|NCT00071487|616950076|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
170711114|NCT00071487|616950077|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
170711115|NCT00071487|616950078|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
170711116|NCT00071487|616950075|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170711117|NCT00071487|616950076|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170711118|NCT00071487|616950077|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170711119|NCT00071487|616950078|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
170711120|NCT00071487|616950075|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
170711121|NCT00071487|616950076|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
170711122|NCT00071487|616950077|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
170711123|NCT00071487|616950078|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
170711124|NCT00071487|616950075|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
170711125|NCT00071487|616950076|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
170711126|NCT00071487|616950077|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
170711127|NCT00071487|616950078|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
170711128|NCT00071487|616950075|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
170711129|NCT00071487|616950076|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
170711130|NCT00071487|616950077|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
170711131|NCT00071487|616950078|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
170711132|NCT01073618|616950081|FG000|Overall Study|Death|208|||
170711133|NCT01073618|616950081|FG000|Overall Study|Adverse Event|19|||
170711134|NCT01073618|616950081|FG000|Overall Study|Other|80|||
170711135|NCT02696850|616950082|FG000|Overall Study|Withdrawal by Subject|3|||
170711136|NCT02696850|616950083|FG001|Overall Study|Withdrawal by Subject|3|||
170711137|NCT02696850|616950082|FG000|Overall Study|Lost to Follow-up|8|||
170711138|NCT02696850|616950083|FG001|Overall Study|Lost to Follow-up|5|||
170711139|NCT02044510|616950084|FG000|Overall Study|Adverse Event|1|||
170711140|NCT02044510|616950085|FG001|Overall Study|Adverse Event|2|||
170711141|NCT00924950|616950086|FG000|Overall Study|Lost to Follow-up|2|||
170711142|NCT01602315|616950087|FG000|Overall Study|Protocol Violation|0|||
170711143|NCT01602315|616950088|FG001|Overall Study|Protocol Violation|0|||
170711144|NCT01602315|616950089|FG002|Overall Study|Protocol Violation|0|||
170711145|NCT01602315|616950090|FG003|Overall Study|Protocol Violation|0|||
170711146|NCT01602315|616950091|FG004|Overall Study|Protocol Violation|0|||
170711147|NCT01602315|616950092|FG005|Overall Study|Protocol Violation|1|||
170711148|NCT01602315|616950093|FG006|Overall Study|Protocol Violation|0|||
170711149|NCT01602315|616950087|FG000|Overall Study|Physician Decision|2|||
170711150|NCT01602315|616950088|FG001|Overall Study|Physician Decision|0|||
170711151|NCT01602315|616950089|FG002|Overall Study|Physician Decision|0|||
170711152|NCT01602315|616950090|FG003|Overall Study|Physician Decision|0|||
170711153|NCT01602315|616950091|FG004|Overall Study|Physician Decision|2|||
170711154|NCT01602315|616950092|FG005|Overall Study|Physician Decision|1|||
170711155|NCT01602315|616950093|FG006|Overall Study|Physician Decision|1|||
170711156|NCT01602315|616950087|FG000|Overall Study|Disease progression|6|||
170711157|NCT01602315|616950088|FG001|Overall Study|Disease progression|3|||
170711158|NCT01602315|616950089|FG002|Overall Study|Disease progression|10|||
170711159|NCT01602315|616950090|FG003|Overall Study|Disease progression|1|||
170711160|NCT01602315|616950091|FG004|Overall Study|Disease progression|41|||
170711161|NCT01602315|616950092|FG005|Overall Study|Disease progression|12|||
170711162|NCT01602315|616950093|FG006|Overall Study|Disease progression|15|||
170711163|NCT01602315|616950087|FG000|Overall Study|Death|1|||
170711164|NCT01602315|616950088|FG001|Overall Study|Death|1|||
170711165|NCT01602315|616950089|FG002|Overall Study|Death|1|||
170711166|NCT01602315|616950090|FG003|Overall Study|Death|1|||
170711167|NCT01602315|616950091|FG004|Overall Study|Death|7|||
170711168|NCT01602315|616950092|FG005|Overall Study|Death|2|||
170711169|NCT01602315|616950093|FG006|Overall Study|Death|2|||
170711170|NCT01602315|616950087|FG000|Overall Study|Withdrawal by Subject|2|||
170711171|NCT01602315|616950088|FG001|Overall Study|Withdrawal by Subject|0|||
170711172|NCT01602315|616950089|FG002|Overall Study|Withdrawal by Subject|2|||
170711173|NCT01602315|616950090|FG003|Overall Study|Withdrawal by Subject|0|||
170711174|NCT01602315|616950091|FG004|Overall Study|Withdrawal by Subject|6|||
170711175|NCT01602315|616950092|FG005|Overall Study|Withdrawal by Subject|0|||
170711176|NCT01602315|616950093|FG006|Overall Study|Withdrawal by Subject|1|||
170711177|NCT01602315|616950087|FG000|Overall Study|Adverse Event|5|||
170711178|NCT01602315|616950088|FG001|Overall Study|Adverse Event|1|||
170711179|NCT01602315|616950089|FG002|Overall Study|Adverse Event|5|||
170711180|NCT01602315|616950090|FG003|Overall Study|Adverse Event|4|||
170711181|NCT01602315|616950091|FG004|Overall Study|Adverse Event|15|||
170711182|NCT01602315|616950092|FG005|Overall Study|Adverse Event|3|||
170711183|NCT01602315|616950093|FG006|Overall Study|Adverse Event|9|||
170711184|NCT01602315|616950087|FG000|Overall Study|Subject/guardian decision|0|||
170711185|NCT01602315|616950088|FG001|Overall Study|Subject/guardian decision|0|||
170711186|NCT01602315|616950089|FG002|Overall Study|Subject/guardian decision|0|||
170711187|NCT01602315|616950090|FG003|Overall Study|Subject/guardian decision|0|||
170711188|NCT01602315|616950091|FG004|Overall Study|Subject/guardian decision|0|||
170711189|NCT01602315|616950092|FG005|Overall Study|Subject/guardian decision|0|||
170711190|NCT01602315|616950093|FG006|Overall Study|Subject/guardian decision|1|||
170827837|NCT01049984|617380161|FG000|Overall Study|Protocol Violation|3|||
170827838|NCT01049984|617380162|FG001|Overall Study|Protocol Violation|4|||
170827839|NCT01049984|617380161|FG000|Overall Study|Lost to Follow-up|2|||
170827840|NCT01049984|617380162|FG001|Overall Study|Lost to Follow-up|1|||
170827841|NCT01049984|617380161|FG000|Overall Study|Adverse Event|13|||
170827842|NCT01049984|617380162|FG001|Overall Study|Adverse Event|7|||
170827843|NCT01049984|617380161|FG000|Overall Study|Treatment failure|0|||
170827844|NCT01049984|617380162|FG001|Overall Study|Treatment failure|2|||
170827845|NCT02847637|617380163|FG000|Overall Study|Withdrawal by Subject|0|||
170827846|NCT02847637|617380164|FG001|Overall Study|Withdrawal by Subject|1|||
170827847|NCT02847637|617380165|FG002|Overall Study|Withdrawal by Subject|1|||
170827848|NCT02847637|617380166|FG003|Overall Study|Withdrawal by Subject|0|||
170827849|NCT02847637|617380163|FG000|Overall Study|Lost to Follow-up|1|||
170827850|NCT02847637|617380164|FG001|Overall Study|Lost to Follow-up|1|||
170827851|NCT02847637|617380165|FG002|Overall Study|Lost to Follow-up|0|||
170827852|NCT02847637|617380166|FG003|Overall Study|Lost to Follow-up|0|||
170827853|NCT02512861|617380169|FG000|Overall Study|Protocol Violation|3|||
170827854|NCT02512861|617380170|FG001|Overall Study|Protocol Violation|7|||
170827855|NCT02512861|617380169|FG000|Overall Study|Physician Decision|3|||
170827856|NCT02512861|617380170|FG001|Overall Study|Physician Decision|1|||
170827857|NCT02512861|617380169|FG000|Overall Study|Withdrawal by Subject|0|||
170827858|NCT02512861|617380170|FG001|Overall Study|Withdrawal by Subject|1|||
170711191|NCT01602315|616950087|FG000|Overall Study|Cross-over patients to combo treatment|0|||
170711192|NCT01602315|616950088|FG001|Overall Study|Cross-over patients to combo treatment|0|||
170711193|NCT01602315|616950089|FG002|Overall Study|Cross-over patients to combo treatment|0|||
170711194|NCT01602315|616950090|FG003|Overall Study|Cross-over patients to combo treatment|0|||
170711195|NCT01602315|616950091|FG004|Overall Study|Cross-over patients to combo treatment|0|||
170711196|NCT01602315|616950092|FG005|Overall Study|Cross-over patients to combo treatment|16|||
170711197|NCT01602315|616950093|FG006|Overall Study|Cross-over patients to combo treatment|0|||
170711198|NCT00982319|616950099|FG000|Overall Study|Surgery date change|1|||
170711199|NCT00982319|616950100|FG001|Overall Study|Surgery date change|0|||
170711200|NCT00982319|616950099|FG000|Overall Study|Preop values out of acceptable range|1|||
170711201|NCT00982319|616950100|FG001|Overall Study|Preop values out of acceptable range|1|||
170711202|NCT00982319|616950099|FG000|Overall Study|Pregnancy|0|||
170711203|NCT00982319|616950100|FG001|Overall Study|Pregnancy|1|||
170711204|NCT00975975|616950101|FG000|Overall Study|Death|6|||
170711205|NCT01722331|616950104|FG000|Part 1|Adverse Event|5|||
170711206|NCT01722331|616950105|FG001|Part 1|Adverse Event|0|||
170711207|NCT01722331|616950106|FG002|Part 1|Adverse Event|0|||
170711208|NCT01722331|616950107|FG003|Part 1|Adverse Event|0|||
170711209|NCT01722331|616950108|FG004|Part 1|Adverse Event|0|||
170711210|NCT01722331|616950109|FG005|Part 1|Adverse Event|0|||
170711211|NCT01722331|616950110|FG006|Part 1|Adverse Event|0|||
170711212|NCT01722331|616950104|FG000|Part 1|Lack of Efficacy|0|||
170711213|NCT01722331|616950105|FG001|Part 1|Lack of Efficacy|0|||
170711214|NCT01722331|616950106|FG002|Part 1|Lack of Efficacy|1|||
170711215|NCT01722331|616950107|FG003|Part 1|Lack of Efficacy|0|||
170711216|NCT01722331|616950108|FG004|Part 1|Lack of Efficacy|2|||
170711217|NCT01722331|616950109|FG005|Part 1|Lack of Efficacy|0|||
170711218|NCT01722331|616950110|FG006|Part 1|Lack of Efficacy|0|||
170711219|NCT01722331|616950104|FG000|Part 1|Lost to Follow-up|1|||
170711220|NCT01722331|616950105|FG001|Part 1|Lost to Follow-up|0|||
170711221|NCT01722331|616950106|FG002|Part 1|Lost to Follow-up|2|||
170711222|NCT01722331|616950107|FG003|Part 1|Lost to Follow-up|0|||
170711223|NCT01722331|616950108|FG004|Part 1|Lost to Follow-up|1|||
170711224|NCT01722331|616950109|FG005|Part 1|Lost to Follow-up|0|||
170711225|NCT01722331|616950110|FG006|Part 1|Lost to Follow-up|0|||
170711226|NCT01722331|616950104|FG000|Part 1|Physician Decision|0|||
170711227|NCT01722331|616950105|FG001|Part 1|Physician Decision|0|||
170711228|NCT01722331|616950106|FG002|Part 1|Physician Decision|3|||
170711229|NCT01722331|616950107|FG003|Part 1|Physician Decision|0|||
170711230|NCT01722331|616950108|FG004|Part 1|Physician Decision|1|||
170711231|NCT01722331|616950109|FG005|Part 1|Physician Decision|0|||
170711232|NCT01722331|616950110|FG006|Part 1|Physician Decision|0|||
170711233|NCT01722331|616950104|FG000|Part 1|Pregnancy|1|||
170711234|NCT01722331|616950105|FG001|Part 1|Pregnancy|0|||
170711235|NCT01722331|616950106|FG002|Part 1|Pregnancy|0|||
170711236|NCT01722331|616950107|FG003|Part 1|Pregnancy|0|||
170711237|NCT01722331|616950108|FG004|Part 1|Pregnancy|0|||
170711238|NCT01722331|616950109|FG005|Part 1|Pregnancy|0|||
170711239|NCT01722331|616950110|FG006|Part 1|Pregnancy|0|||
170711240|NCT01722331|616950104|FG000|Part 1|Progressive Disease|0|||
170711241|NCT01722331|616950105|FG001|Part 1|Progressive Disease|0|||
170711242|NCT01722331|616950106|FG002|Part 1|Progressive Disease|0|||
170711243|NCT01722331|616950107|FG003|Part 1|Progressive Disease|0|||
170711244|NCT01722331|616950108|FG004|Part 1|Progressive Disease|1|||
170711245|NCT01722331|616950109|FG005|Part 1|Progressive Disease|0|||
170827859|NCT00337285|617380171|FG000|Overall Study|Withdrawal by Subject|42|||
170827860|NCT00337285|617380171|FG000|Overall Study|Lost to Follow-up|41|||
170827861|NCT00337285|617380171|FG000|Overall Study|Adverse Event|28|||
170827862|NCT00337285|617380171|FG000|Overall Study|Protocol Violation|27|||
170827863|NCT00337285|617380171|FG000|Overall Study|Lack of Efficacy|11|||
170827864|NCT00337285|617380171|FG000|Overall Study|Death|1|||
170827865|NCT00337285|617380171|FG000|Overall Study|Physician Decision|1|||
170711246|NCT01722331|616950110|FG006|Part 1|Progressive Disease|0|||
170711247|NCT01722331|616950104|FG000|Part 1|Protocol Violation|1|||
170711248|NCT01722331|616950105|FG001|Part 1|Protocol Violation|0|||
170711249|NCT01722331|616950106|FG002|Part 1|Protocol Violation|0|||
170711250|NCT01722331|616950107|FG003|Part 1|Protocol Violation|0|||
170711251|NCT01722331|616950108|FG004|Part 1|Protocol Violation|1|||
170711252|NCT01722331|616950109|FG005|Part 1|Protocol Violation|0|||
170711253|NCT01722331|616950110|FG006|Part 1|Protocol Violation|0|||
170827866|NCT00337285|617380171|FG000|Overall Study|Lack of protocol compliance|7|||
170827867|NCT01746108|617380172|FG000|Overall Study|Migrated /moved from study area|0|||
170827868|NCT01746108|617380173|FG001|Overall Study|Migrated /moved from study area|1|||
170711254|NCT01722331|616950104|FG000|Part 1|Withdrawal by Subject|2|||
170711255|NCT01722331|616950105|FG001|Part 1|Withdrawal by Subject|0|||
170711256|NCT01722331|616950106|FG002|Part 1|Withdrawal by Subject|3|||
170711257|NCT01722331|616950107|FG003|Part 1|Withdrawal by Subject|0|||
170711258|NCT01722331|616950108|FG004|Part 1|Withdrawal by Subject|3|||
170711259|NCT01722331|616950109|FG005|Part 1|Withdrawal by Subject|0|||
170711260|NCT01722331|616950110|FG006|Part 1|Withdrawal by Subject|0|||
170711261|NCT01722331|616950104|FG000|Part 2|Adverse Event|3|||
170711262|NCT01722331|616950105|FG001|Part 2|Adverse Event|0|||
170711263|NCT01722331|616950106|FG002|Part 2|Adverse Event|0|||
170711264|NCT01722331|616950107|FG003|Part 2|Adverse Event|0|||
170711265|NCT01722331|616950108|FG004|Part 2|Adverse Event|0|||
170711266|NCT01722331|616950109|FG005|Part 2|Adverse Event|1|||
170711267|NCT01722331|616950110|FG006|Part 2|Adverse Event|0|||
170711268|NCT01722331|616950104|FG000|Part 2|Lack of Efficacy|3|||
170711269|NCT01722331|616950105|FG001|Part 2|Lack of Efficacy|0|||
170711270|NCT01722331|616950106|FG002|Part 2|Lack of Efficacy|11|||
170711271|NCT01722331|616950107|FG003|Part 2|Lack of Efficacy|0|||
170711272|NCT01722331|616950108|FG004|Part 2|Lack of Efficacy|0|||
170711273|NCT01722331|616950109|FG005|Part 2|Lack of Efficacy|3|||
170711274|NCT01722331|616950110|FG006|Part 2|Lack of Efficacy|3|||
170711275|NCT01722331|616950104|FG000|Part 2|Lost to Follow-up|0|||
170711276|NCT01722331|616950105|FG001|Part 2|Lost to Follow-up|0|||
170711277|NCT01722331|616950106|FG002|Part 2|Lost to Follow-up|3|||
170711278|NCT01722331|616950107|FG003|Part 2|Lost to Follow-up|0|||
170711279|NCT01722331|616950108|FG004|Part 2|Lost to Follow-up|0|||
170711280|NCT01722331|616950109|FG005|Part 2|Lost to Follow-up|1|||
170711281|NCT01722331|616950110|FG006|Part 2|Lost to Follow-up|1|||
170711282|NCT01722331|616950104|FG000|Part 2|Non-Compliance with Study Drug|1|||
170711283|NCT01722331|616950105|FG001|Part 2|Non-Compliance with Study Drug|0|||
170711284|NCT01722331|616950106|FG002|Part 2|Non-Compliance with Study Drug|1|||
170711285|NCT01722331|616950107|FG003|Part 2|Non-Compliance with Study Drug|0|||
170711286|NCT01722331|616950108|FG004|Part 2|Non-Compliance with Study Drug|0|||
170711287|NCT01722331|616950109|FG005|Part 2|Non-Compliance with Study Drug|0|||
170711288|NCT01722331|616950110|FG006|Part 2|Non-Compliance with Study Drug|0|||
170711289|NCT01722331|616950104|FG000|Part 2|Physician Decision|0|||
170711290|NCT01722331|616950105|FG001|Part 2|Physician Decision|0|||
170711291|NCT01722331|616950106|FG002|Part 2|Physician Decision|2|||
170711292|NCT01722331|616950107|FG003|Part 2|Physician Decision|0|||
170711293|NCT01722331|616950108|FG004|Part 2|Physician Decision|0|||
170711294|NCT01722331|616950109|FG005|Part 2|Physician Decision|0|||
170711295|NCT01722331|616950110|FG006|Part 2|Physician Decision|0|||
170711296|NCT01722331|616950104|FG000|Part 2|Pregnancy|0|||
170711297|NCT01722331|616950105|FG001|Part 2|Pregnancy|0|||
170711298|NCT01722331|616950106|FG002|Part 2|Pregnancy|0|||
170711299|NCT01722331|616950107|FG003|Part 2|Pregnancy|0|||
170711300|NCT01722331|616950108|FG004|Part 2|Pregnancy|0|||
170711301|NCT01722331|616950109|FG005|Part 2|Pregnancy|1|||
170711302|NCT01722331|616950110|FG006|Part 2|Pregnancy|0|||
170711303|NCT01722331|616950104|FG000|Part 2|Progressive Disease|0|||
170711304|NCT01722331|616950105|FG001|Part 2|Progressive Disease|0|||
170711305|NCT01722331|616950106|FG002|Part 2|Progressive Disease|1|||
170711306|NCT01722331|616950107|FG003|Part 2|Progressive Disease|0|||
170711307|NCT01722331|616950108|FG004|Part 2|Progressive Disease|0|||
170711308|NCT01722331|616950109|FG005|Part 2|Progressive Disease|0|||
170711309|NCT01722331|616950110|FG006|Part 2|Progressive Disease|0|||
170711310|NCT01722331|616950104|FG000|Part 2|Protocol Violation|1|||
170711311|NCT01722331|616950105|FG001|Part 2|Protocol Violation|0|||
170711312|NCT01722331|616950106|FG002|Part 2|Protocol Violation|0|||
170711313|NCT01722331|616950107|FG003|Part 2|Protocol Violation|0|||
170711314|NCT01722331|616950108|FG004|Part 2|Protocol Violation|0|||
170711315|NCT01722331|616950109|FG005|Part 2|Protocol Violation|0|||
170711316|NCT01722331|616950110|FG006|Part 2|Protocol Violation|0|||
170711317|NCT01722331|616950104|FG000|Part 2|Withdrawal by Subject|5|||
170711318|NCT01722331|616950105|FG001|Part 2|Withdrawal by Subject|0|||
170711319|NCT01722331|616950106|FG002|Part 2|Withdrawal by Subject|3|||
170711320|NCT01722331|616950107|FG003|Part 2|Withdrawal by Subject|0|||
170711321|NCT01722331|616950108|FG004|Part 2|Withdrawal by Subject|0|||
170711322|NCT01722331|616950109|FG005|Part 2|Withdrawal by Subject|2|||
170711323|NCT01722331|616950110|FG006|Part 2|Withdrawal by Subject|2|||
170711324|NCT01722331|616950104|FG000|Part 2|Other Protocol Specified Criteria|6|||
170711325|NCT01722331|616950105|FG001|Part 2|Other Protocol Specified Criteria|0|||
170711326|NCT01722331|616950106|FG002|Part 2|Other Protocol Specified Criteria|10|||
170711327|NCT01722331|616950107|FG003|Part 2|Other Protocol Specified Criteria|0|||
170711328|NCT01722331|616950108|FG004|Part 2|Other Protocol Specified Criteria|0|||
170711329|NCT01722331|616950109|FG005|Part 2|Other Protocol Specified Criteria|2|||
170711330|NCT01722331|616950110|FG006|Part 2|Other Protocol Specified Criteria|1|||
170711331|NCT01722331|616950104|FG000|Part 3|Adverse Event|2|||
170711332|NCT01722331|616950105|FG001|Part 3|Adverse Event|2|||
170711333|NCT01722331|616950106|FG002|Part 3|Adverse Event|0|||
170711334|NCT01722331|616950107|FG003|Part 3|Adverse Event|1|||
170711335|NCT01722331|616950108|FG004|Part 3|Adverse Event|0|||
170711336|NCT01722331|616950109|FG005|Part 3|Adverse Event|0|||
170711337|NCT01722331|616950110|FG006|Part 3|Adverse Event|0|||
170711338|NCT01722331|616950104|FG000|Part 3|Death|1|||
170711339|NCT01722331|616950105|FG001|Part 3|Death|0|||
170711340|NCT01722331|616950106|FG002|Part 3|Death|0|||
170711341|NCT01722331|616950107|FG003|Part 3|Death|0|||
170711342|NCT01722331|616950108|FG004|Part 3|Death|0|||
170711343|NCT01722331|616950109|FG005|Part 3|Death|0|||
170711344|NCT01722331|616950110|FG006|Part 3|Death|0|||
170711345|NCT01722331|616950104|FG000|Part 3|Lack of Efficacy|1|||
170711346|NCT01722331|616950105|FG001|Part 3|Lack of Efficacy|0|||
170711347|NCT01722331|616950106|FG002|Part 3|Lack of Efficacy|0|||
170711348|NCT01722331|616950107|FG003|Part 3|Lack of Efficacy|0|||
170711349|NCT01722331|616950108|FG004|Part 3|Lack of Efficacy|0|||
170711350|NCT01722331|616950109|FG005|Part 3|Lack of Efficacy|0|||
170711351|NCT01722331|616950110|FG006|Part 3|Lack of Efficacy|0|||
170711352|NCT01722331|616950104|FG000|Part 3|Lost to Follow-up|3|||
170711353|NCT01722331|616950105|FG001|Part 3|Lost to Follow-up|4|||
170711354|NCT01722331|616950106|FG002|Part 3|Lost to Follow-up|0|||
170711355|NCT01722331|616950107|FG003|Part 3|Lost to Follow-up|0|||
170711356|NCT01722331|616950108|FG004|Part 3|Lost to Follow-up|0|||
170711357|NCT01722331|616950109|FG005|Part 3|Lost to Follow-up|1|||
170711358|NCT01722331|616950110|FG006|Part 3|Lost to Follow-up|0|||
170711359|NCT01722331|616950104|FG000|Part 3|Non-Compliance with Study Drug|0|||
170711360|NCT01722331|616950105|FG001|Part 3|Non-Compliance with Study Drug|1|||
170711361|NCT01722331|616950106|FG002|Part 3|Non-Compliance with Study Drug|0|||
170711362|NCT01722331|616950107|FG003|Part 3|Non-Compliance with Study Drug|0|||
170711363|NCT01722331|616950108|FG004|Part 3|Non-Compliance with Study Drug|0|||
170711364|NCT01722331|616950109|FG005|Part 3|Non-Compliance with Study Drug|0|||
170711365|NCT01722331|616950110|FG006|Part 3|Non-Compliance with Study Drug|0|||
170711366|NCT01722331|616950104|FG000|Part 3|Physician Decision|1|||
170711367|NCT01722331|616950105|FG001|Part 3|Physician Decision|1|||
170711368|NCT01722331|616950106|FG002|Part 3|Physician Decision|0|||
170711369|NCT01722331|616950107|FG003|Part 3|Physician Decision|0|||
170711370|NCT01722331|616950108|FG004|Part 3|Physician Decision|0|||
170711371|NCT01722331|616950109|FG005|Part 3|Physician Decision|0|||
170711372|NCT01722331|616950110|FG006|Part 3|Physician Decision|1|||
170711373|NCT01722331|616950104|FG000|Part 3|Protocol Violation|2|||
170711374|NCT01722331|616950105|FG001|Part 3|Protocol Violation|1|||
170827869|NCT01746108|617380174|FG002|Overall Study|Migrated /moved from study area|0|||
170827870|NCT01746108|617380172|FG000|Overall Study|Adverse event, non-fatal|0|||
170827871|NCT01746108|617380173|FG001|Overall Study|Adverse event, non-fatal|1|||
170827872|NCT01746108|617380174|FG002|Overall Study|Adverse event, non-fatal|0|||
170827873|NCT01746108|617380172|FG000|Overall Study|Withdrawal by Subject|0|||
170827874|NCT01746108|617380173|FG001|Overall Study|Withdrawal by Subject|1|||
170827875|NCT01746108|617380174|FG002|Overall Study|Withdrawal by Subject|0|||
170827876|NCT01746108|617380172|FG000|Overall Study|Lost to Follow-up|0|||
170711375|NCT01722331|616950106|FG002|Part 3|Protocol Violation|0|||
170711376|NCT01722331|616950107|FG003|Part 3|Protocol Violation|0|||
170711377|NCT01722331|616950108|FG004|Part 3|Protocol Violation|0|||
170711378|NCT01722331|616950109|FG005|Part 3|Protocol Violation|0|||
170711379|NCT01722331|616950110|FG006|Part 3|Protocol Violation|0|||
170711380|NCT01722331|616950104|FG000|Part 3|Withdrawal by Subject|4|||
170711381|NCT01722331|616950105|FG001|Part 3|Withdrawal by Subject|7|||
170711382|NCT01722331|616950106|FG002|Part 3|Withdrawal by Subject|0|||
170711383|NCT01722331|616950107|FG003|Part 3|Withdrawal by Subject|0|||
170711384|NCT01722331|616950108|FG004|Part 3|Withdrawal by Subject|0|||
170711385|NCT01722331|616950109|FG005|Part 3|Withdrawal by Subject|2|||
170711386|NCT01722331|616950110|FG006|Part 3|Withdrawal by Subject|1|||
170711387|NCT01722331|616950104|FG000|Part 3|Other Protocol Specified Criteria|1|||
170711388|NCT01722331|616950105|FG001|Part 3|Other Protocol Specified Criteria|1|||
170711389|NCT01722331|616950106|FG002|Part 3|Other Protocol Specified Criteria|0|||
170711390|NCT01722331|616950107|FG003|Part 3|Other Protocol Specified Criteria|0|||
170711391|NCT01722331|616950108|FG004|Part 3|Other Protocol Specified Criteria|0|||
170711392|NCT01722331|616950109|FG005|Part 3|Other Protocol Specified Criteria|0|||
170827877|NCT01746108|617380173|FG001|Overall Study|Lost to Follow-up|1|||
170711393|NCT01722331|616950110|FG006|Part 3|Other Protocol Specified Criteria|0|||
170711394|NCT00353704|616950115|FG000|Overall Study|Protocol Violation|3|||
170711395|NCT00353704|616950116|FG001|Overall Study|Protocol Violation|1|||
170711396|NCT02807948|616950117|FG000|Overall Study|Physician Decision|1|||
170711397|NCT02807948|616950118|FG001|Overall Study|Physician Decision|0|||
170711398|NCT03727750|616950119|FG000|Overall Study|Death|45|||
170711399|NCT03727750|616950119|FG000|Overall Study|Withdrawal by Subject|2|||
170711400|NCT03727750|616950119|FG000|Overall Study|Lost to Follow-up|1|||
170711401|NCT03727750|616950119|FG000|Overall Study|Other|1|||
170711402|NCT01375049|616950121|FG000|Overall Study|Adverse Event|2|||
170711403|NCT01375049|616950121|FG000|Overall Study|Lost to Follow-up|1|||
170711404|NCT01375049|616950121|FG000|Overall Study|Withdrawal by Subject|2|||
170711405|NCT01375049|616950121|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
170711406|NCT03394391|616950122|FG000|Overall Study|Lost to Follow-up|1|||
170711407|NCT03394391|616950123|FG001|Overall Study|Lost to Follow-up|2|||
170711408|NCT03614793|616950126|FG000|Overall Study|Lost to Follow-up|1|||
170711409|NCT03614793|616950127|FG001|Overall Study|Lost to Follow-up|2|||
170711410|NCT03614793|616950126|FG000|Overall Study|Lack of Efficacy|0|||
170711411|NCT03614793|616950127|FG001|Overall Study|Lack of Efficacy|5|||
170711412|NCT03614793|616950126|FG000|Overall Study|Withdrawal by Subject|0|||
170711413|NCT03614793|616950127|FG001|Overall Study|Withdrawal by Subject|1|||
170711414|NCT03614793|616950126|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
170711415|NCT03614793|616950127|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
170711416|NCT02082522|616950128|FG000|Overall Study|Sponsor termination|5|||
170711417|NCT02082522|616950129|FG001|Overall Study|Sponsor termination|3|||
170711418|NCT02082522|616950128|FG000|Overall Study|Withdrawal by Subject|2|||
170711419|NCT02082522|616950129|FG001|Overall Study|Withdrawal by Subject|4|||
170711420|NCT02082522|616950128|FG000|Overall Study|Death|1|||
170711421|NCT02082522|616950129|FG001|Overall Study|Death|0|||
170711422|NCT02082522|616950128|FG000|Overall Study|Lost to Follow-up|1|||
170711423|NCT02082522|616950129|FG001|Overall Study|Lost to Follow-up|0|||
170711424|NCT02082522|616950128|FG000|Overall Study|Physician Decision|3|||
170711425|NCT02082522|616950129|FG001|Overall Study|Physician Decision|1|||
170711426|NCT02082522|616950128|FG000|Overall Study|Disease progression|2|||
170711427|NCT02082522|616950129|FG001|Overall Study|Disease progression|2|||
170711428|NCT02082522|616950128|FG000|Overall Study|Chemotherapy change|1|||
170711429|NCT02082522|616950129|FG001|Overall Study|Chemotherapy change|3|||
170711430|NCT00440271|616950130|FG000|Overall Study|Protocol Violation|1|||
170711431|NCT00440271|616950131|FG001|Overall Study|Protocol Violation|1|||
170711432|NCT00440271|616950130|FG000|Overall Study|Adverse Event|0|||
170711433|NCT00440271|616950131|FG001|Overall Study|Adverse Event|1|||
170711434|NCT00440271|616950130|FG000|Overall Study|Lost to Follow-up|1|||
170711435|NCT00440271|616950131|FG001|Overall Study|Lost to Follow-up|0|||
170711436|NCT00440271|616950130|FG000|Overall Study|Withdrawal by Subject|0|||
170711437|NCT00440271|616950131|FG001|Overall Study|Withdrawal by Subject|2|||
170711438|NCT00440271|616950130|FG000|Overall Study|Lack of Efficacy|0|||
170711439|NCT00440271|616950131|FG001|Overall Study|Lack of Efficacy|1|||
170711440|NCT00440271|616950130|FG000|Overall Study|Due to closure of trial|8|||
170711441|NCT00440271|616950131|FG001|Overall Study|Due to closure of trial|10|||
170711442|NCT00440271|616950130|FG000|Overall Study|Other|2|||
170711443|NCT00440271|616950131|FG001|Overall Study|Other|0|||
170711444|NCT00723801|616950134|FG000|Overall Study|Lost to Follow-up|1|||
170711445|NCT00723801|616950135|FG001|Overall Study|Lost to Follow-up|2|||
170711446|NCT00723801|616950134|FG000|Overall Study|Protocol Violation|2|||
170711447|NCT00723801|616950135|FG001|Overall Study|Protocol Violation|1|||
170711448|NCT01863446|616950136|FG000|Overall Study|Withdrawal by Subject|1|||
170711449|NCT01863446|616950137|FG001|Overall Study|Withdrawal by Subject|0|||
170711450|NCT01863446|616950138|FG002|Overall Study|Withdrawal by Subject|1|||
170711451|NCT01863446|616950139|FG003|Overall Study|Withdrawal by Subject|2|||
170711452|NCT01863446|616950136|FG000|Overall Study|Physician Decision|0|||
170711453|NCT01863446|616950137|FG001|Overall Study|Physician Decision|0|||
170711454|NCT01863446|616950138|FG002|Overall Study|Physician Decision|1|||
170711455|NCT01863446|616950139|FG003|Overall Study|Physician Decision|0|||
170711456|NCT02114892|616950140|FG000|Overall Study|Lost to Follow-up|1|||
170711457|NCT02114892|616950141|FG001|Overall Study|Lost to Follow-up|2|||
170711458|NCT02178475|616950147|FG000|Overall Study|Withdrawal by Subject|7|||
170711459|NCT02178475|616950147|FG000|Overall Study|Lost to Follow-up|10|||
170711460|NCT02178475|616950147|FG000|Overall Study|Death|13|||
170711461|NCT02178475|616950147|FG000|Overall Study|Protocol-specified Criteria|99|||
170711462|NCT00718042|616950148|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
170711463|NCT00718042|616950149|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
170711464|NCT00718042|616950150|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
170711465|NCT00718042|616950151|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
170711466|NCT00718042|616950152|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
170711467|NCT00718042|616950153|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
170711468|NCT00718042|616950148|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
170711469|NCT00718042|616950149|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
170711470|NCT00718042|616950150|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
170711471|NCT00718042|616950151|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
170711472|NCT00718042|616950152|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
170711473|NCT00718042|616950153|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
170711474|NCT00718042|616950148|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
170711475|NCT00718042|616950149|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
170711476|NCT00718042|616950150|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
170711477|NCT00718042|616950151|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
170711478|NCT00718042|616950152|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
170711479|NCT00718042|616950153|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
170711480|NCT00718042|616950148|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
170711481|NCT00718042|616950149|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
170827878|NCT01746108|617380174|FG002|Overall Study|Lost to Follow-up|0|||
170827879|NCT01774019|617380175|FG000|Overall Study|No longer meets protocol criteria|2|||
170827880|NCT01774019|617380176|FG001|Overall Study|No longer meets protocol criteria|0|||
170827881|NCT01774019|617380175|FG000|Overall Study|Withdrawal by Subject|1|||
170827882|NCT01774019|617380176|FG001|Overall Study|Withdrawal by Subject|0|||
170711482|NCT00718042|616950150|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
170711483|NCT00718042|616950151|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
170711484|NCT00718042|616950152|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
170711485|NCT00718042|616950153|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
170711486|NCT00718042|616950148|FG000|Donor Follow-up|Lost to Follow-up|13|||
170711487|NCT00718042|616950149|FG001|Donor Follow-up|Lost to Follow-up|0|||
170711488|NCT00718042|616950150|FG002|Donor Follow-up|Lost to Follow-up|0|||
170711489|NCT00718042|616950151|FG003|Donor Follow-up|Lost to Follow-up|0|||
170711490|NCT00718042|616950152|FG004|Donor Follow-up|Lost to Follow-up|19|||
170711491|NCT00718042|616950153|FG005|Donor Follow-up|Lost to Follow-up|0|||
170711492|NCT02443298|616950154|FG000|Overall Study|Adverse Event|3|||
170711493|NCT02443298|616950155|FG001|Overall Study|Adverse Event|3|||
170711494|NCT02443298|616950154|FG000|Overall Study|Withdrawal by Subject|1|||
170711495|NCT02443298|616950155|FG001|Overall Study|Withdrawal by Subject|2|||
170711496|NCT03095417|616950156|FG000|Overall Study|missed|1|||
170711497|NCT03095417|616950157|FG001|Overall Study|missed|2|||
170711498|NCT03095417|616950158|FG002|Overall Study|missed|0|||
170711499|NCT03095417|616950159|FG003|Overall Study|missed|1|||
170711500|NCT03095417|616950156|FG000|Overall Study|Lost to Follow-up|2|||
170711501|NCT03095417|616950157|FG001|Overall Study|Lost to Follow-up|2|||
170711502|NCT03095417|616950158|FG002|Overall Study|Lost to Follow-up|1|||
170711503|NCT03095417|616950159|FG003|Overall Study|Lost to Follow-up|0|||
170711504|NCT03095417|616950156|FG000|Overall Study|refusal|0|||
170711505|NCT03095417|616950157|FG001|Overall Study|refusal|1|||
170711506|NCT03095417|616950158|FG002|Overall Study|refusal|0|||
170711507|NCT03095417|616950159|FG003|Overall Study|refusal|1|||
170711508|NCT03095417|616950156|FG000|Overall Study|Withdrawal by Subject|8|||
170711509|NCT03095417|616950157|FG001|Overall Study|Withdrawal by Subject|2|||
170711510|NCT03095417|616950158|FG002|Overall Study|Withdrawal by Subject|5|||
170711511|NCT03095417|616950159|FG003|Overall Study|Withdrawal by Subject|4|||
170711512|NCT03095417|616950156|FG000|Overall Study|Physician Decision|1|||
170711513|NCT03095417|616950157|FG001|Overall Study|Physician Decision|2|||
170711514|NCT03095417|616950158|FG002|Overall Study|Physician Decision|2|||
170711515|NCT03095417|616950159|FG003|Overall Study|Physician Decision|2|||
170711516|NCT03095417|616950156|FG000|Overall Study|Death|1|||
170711517|NCT03095417|616950157|FG001|Overall Study|Death|2|||
170711518|NCT03095417|616950158|FG002|Overall Study|Death|1|||
170711519|NCT03095417|616950159|FG003|Overall Study|Death|3|||
170711520|NCT02571452|616950160|FG000|Overall Study Treatment|Protocol Violation|0|||
170711521|NCT02571452|616950161|FG001|Overall Study Treatment|Protocol Violation|1|||
170711522|NCT02571452|616950160|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
170711523|NCT02571452|616950161|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
170711524|NCT02571452|616950160|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
170711525|NCT02571452|616950161|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
170711526|NCT01158924|616950162|FG000|Overall Study|Withdrawal by Subject|1|||
170711527|NCT01158924|616950163|FG001|Overall Study|Withdrawal by Subject|2|||
170711528|NCT01158924|616950162|FG000|Overall Study|Lost to Follow-up|0|||
170711529|NCT01158924|616950163|FG001|Overall Study|Lost to Follow-up|1|||
170711530|NCT02822794|616950164|FG000|Overall Study|Withdrew Consent|1|||
170711531|NCT02822794|616950165|FG001|Overall Study|Withdrew Consent|0|||
170711532|NCT04788147|616950166|FG000|Overall Study|Screen Failure|3|||
170711533|NCT04788147|616950167|FG001|Overall Study|Screen Failure|10|||
170711534|NCT04788147|616950166|FG000|Overall Study|Incomplete RMRS image session|2|||
170711535|NCT04788147|616950167|FG001|Overall Study|Incomplete RMRS image session|0|||
170711536|NCT01731171|616950168|FG000|Overall Study|Withdrawal by Subject|4|||
170711537|NCT01731171|616950169|FG001|Overall Study|Withdrawal by Subject|1|||
170711538|NCT01731171|616950168|FG000|Overall Study|Lost to Follow-up|3|||
170711539|NCT01731171|616950169|FG001|Overall Study|Lost to Follow-up|2|||
170711540|NCT01731171|616950168|FG000|Overall Study|Moved out of Area|0|||
170711541|NCT01731171|616950169|FG001|Overall Study|Moved out of Area|2|||
170711542|NCT01731171|616950168|FG000|Overall Study|Terminated for Lack of Adherence|0|||
170711543|NCT01731171|616950169|FG001|Overall Study|Terminated for Lack of Adherence|1|||
170711544|NCT01731171|616950168|FG000|Overall Study|Terminated for Safety Reasons|0|||
170711545|NCT01731171|616950169|FG001|Overall Study|Terminated for Safety Reasons|1|||
170711546|NCT01410110|616950170|FG000|Overall Study|Withdrawal by Subject|4|||
170711547|NCT01410110|616950171|FG001|Overall Study|Withdrawal by Subject|2|||
170711548|NCT02520531|616950174|FG000|Overall Study|Revision of study device components|2|||
170711549|NCT02520531|616950175|FG001|Overall Study|Revision of study device components|2|||
170711550|NCT02520531|616950174|FG000|Overall Study|Death|1|||
170711551|NCT02520531|616950175|FG001|Overall Study|Death|2|||
170711552|NCT02520531|616950174|FG000|Overall Study|Lost to Follow-up|1|||
170711553|NCT02520531|616950175|FG001|Overall Study|Lost to Follow-up|1|||
170711554|NCT02520531|616950174|FG000|Overall Study|Meet exclusion criterion|0|||
170711555|NCT02520531|616950175|FG001|Overall Study|Meet exclusion criterion|1|||
170711556|NCT02520531|616950174|FG000|Overall Study|Withdrawal by Subject|1|||
170711557|NCT02520531|616950175|FG001|Overall Study|Withdrawal by Subject|0|||
170711558|NCT02520531|616950174|FG000|Overall Study|Not study device|1|||
170711559|NCT02520531|616950175|FG001|Overall Study|Not study device|0|||
170711560|NCT02617589|616950178|FG000|Randomization|Request to Discontinue Study Treatment|1|||
170711561|NCT02617589|616950179|FG001|Randomization|Request to Discontinue Study Treatment|3|||
170711562|NCT02617589|616950178|FG000|Randomization|Participant Withdrew Consent|1|||
170711563|NCT02617589|616950179|FG001|Randomization|Participant Withdrew Consent|2|||
170711564|NCT02617589|616950178|FG000|Treatment|Other Reasons|3|||
170711565|NCT02617589|616950179|FG001|Treatment|Other Reasons|3|||
170711566|NCT02617589|616950178|FG000|Treatment|Poor/Non Compliance|1|||
170711567|NCT02617589|616950179|FG001|Treatment|Poor/Non Compliance|1|||
170711568|NCT02617589|616950178|FG000|Treatment|Maximum Clinical Benefit|0|||
170711569|NCT02617589|616950179|FG001|Treatment|Maximum Clinical Benefit|2|||
170711570|NCT02617589|616950178|FG000|Treatment|Participant Withdrew Consent|2|||
170711571|NCT02617589|616950179|FG001|Treatment|Participant Withdrew Consent|6|||
170711572|NCT02617589|616950178|FG000|Treatment|Participant Request to Discontinue|12|||
170711573|NCT02617589|616950179|FG001|Treatment|Participant Request to Discontinue|21|||
170711574|NCT02617589|616950178|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
170711575|NCT02617589|616950179|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
170711576|NCT02617589|616950178|FG000|Treatment|Death|1|||
170711577|NCT02617589|616950179|FG001|Treatment|Death|1|||
170711578|NCT02617589|616950178|FG000|Treatment|Study Drug Toxicity|27|||
170711579|NCT02617589|616950179|FG001|Treatment|Study Drug Toxicity|20|||
170711580|NCT02617589|616950178|FG000|Treatment|Disease Progression|216|||
170711581|NCT02617589|616950179|FG001|Treatment|Disease Progression|136|||
170711582|NCT02185768|616950183|FG000|Overall Study|Patients were not treated|2|||
170711583|NCT03221257|616950185|FG000|Overall Study|Lost to Follow-up|0|||
170711584|NCT03221257|616950186|FG001|Overall Study|Lost to Follow-up|1|||
170711585|NCT03221257|616950185|FG000|Overall Study|Withdrawal by Subject|1|||
170711586|NCT03221257|616950186|FG001|Overall Study|Withdrawal by Subject|1|||
170711587|NCT01009099|616950187|FG000|Overall Study|Lost to Follow-up|1|||
170711588|NCT01009099|616950188|FG001|Overall Study|Lost to Follow-up|0|||
170711589|NCT01009099|616950187|FG000|Overall Study|Physician Decision|3|||
170711590|NCT01009099|616950188|FG001|Overall Study|Physician Decision|2|||
170711591|NCT01009099|616950187|FG000|Overall Study|Withdrawal by Subject|1|||
170711592|NCT01009099|616950188|FG001|Overall Study|Withdrawal by Subject|1|||
170711593|NCT01009099|616950187|FG000|Overall Study|Death|0|||
170711594|NCT01009099|616950188|FG001|Overall Study|Death|1|||
170711595|NCT01516879|616950196|FG000|Overall Study|Withdrawal by Subject|9|||
170711596|NCT01516879|616950197|FG001|Overall Study|Withdrawal by Subject|11|||
170711597|NCT01516879|616950196|FG000|Overall Study|Death|0|||
170711598|NCT01516879|616950197|FG001|Overall Study|Death|2|||
170711599|NCT01516879|616950196|FG000|Overall Study|Lost to Follow-up|2|||
170711600|NCT01516879|616950197|FG001|Overall Study|Lost to Follow-up|11|||
170711601|NCT01516879|616950196|FG000|Overall Study|Other|5|||
170711602|NCT01516879|616950197|FG001|Overall Study|Other|10|||
170711603|NCT04587193|616950198|FG000|Overall Study|Screen failure after consent|3|||
170711604|NCT04587193|616950199|FG001|Overall Study|Screen failure after consent|0|||
170711605|NCT04587193|616950198|FG000|Overall Study|Device broke during study|3|||
170711606|NCT04587193|616950199|FG001|Overall Study|Device broke during study|2|||
170711607|NCT00508742|616950200|FG000|Period 1: Infant Series|Adverse Event|5|||
170711608|NCT00508742|616950201|FG001|Period 1: Infant Series|Adverse Event|4|||
170711609|NCT00508742|616950200|FG000|Period 1: Infant Series|Protocol Violation|1|||
170711610|NCT00508742|616950201|FG001|Period 1: Infant Series|Protocol Violation|0|||
170711611|NCT00508742|616950200|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
170711612|NCT00508742|616950201|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
170711613|NCT00508742|616950200|FG000|Period 1: Infant Series|Physician Decision|1|||
170711614|NCT00508742|616950201|FG001|Period 1: Infant Series|Physician Decision|0|||
170711615|NCT00508742|616950200|FG000|Period 1: Infant Series|Other|4|||
170711616|NCT00508742|616950201|FG001|Period 1: Infant Series|Other|1|||
170711617|NCT00508742|616950200|FG000|Period 2: After Infant Series|Adverse Event|2|||
170711618|NCT00508742|616950201|FG001|Period 2: After Infant Series|Adverse Event|6|||
170711619|NCT00508742|616950200|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
170711620|NCT00508742|616950201|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
170711621|NCT00508742|616950200|FG000|Period 2: After Infant Series|Protocol Violation|1|||
170711622|NCT00508742|616950201|FG001|Period 2: After Infant Series|Protocol Violation|0|||
170711623|NCT00508742|616950200|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
170711624|NCT00508742|616950201|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
170711625|NCT00508742|616950200|FG000|Period 2: After Infant Series|Failed to Return|1|||
170711626|NCT00508742|616950201|FG001|Period 2: After Infant Series|Failed to Return|0|||
170711627|NCT00508742|616950200|FG000|Period 2: After Infant Series|Other|2|||
170711628|NCT00508742|616950201|FG001|Period 2: After Infant Series|Other|1|||
170711629|NCT00508742|616950200|FG000|Period 3: Toddler Dose|Adverse Event|1|||
170711630|NCT00508742|616950201|FG001|Period 3: Toddler Dose|Adverse Event|0|||
170711631|NCT00508742|616950200|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
170711632|NCT00508742|616950201|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
170711633|NCT00508742|616950200|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
170711634|NCT00508742|616950201|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
170711635|NCT00508742|616950200|FG000|Period 3: Toddler Dose|Other|5|||
170711636|NCT00508742|616950201|FG001|Period 3: Toddler Dose|Other|4|||
170711637|NCT00595582|616950205|FG000|Overall Study|Pilot study that PI terminated|2|||
170711638|NCT00595582|616950205|FG000|Overall Study|Lost to Follow-up|1|||
170711639|NCT00595582|616950205|FG000|Overall Study|Adverse Event|2|||
170711640|NCT00595582|616950205|FG000|Overall Study|Physician Decision|5|||
170711641|NCT01600586|616950206|FG000|Overall Study|Physician Decision|3|||
170711642|NCT01600586|616950207|FG001|Overall Study|Physician Decision|3|||
170711643|NCT01227512|616950209|FG000|Overall Study|Physician Decision|6|||
170711644|NCT01227512|616950210|FG001|Overall Study|Physician Decision|6|||
170711645|NCT01227512|616950209|FG000|Overall Study|Adverse Event|4|||
170711646|NCT01227512|616950210|FG001|Overall Study|Adverse Event|3|||
170711647|NCT01227512|616950209|FG000|Overall Study|Withdrawal by Subject|3|||
170711648|NCT01227512|616950210|FG001|Overall Study|Withdrawal by Subject|0|||
170711649|NCT01227512|616950209|FG000|Overall Study|Participant met withdrawal criteria|0|||
170711650|NCT01227512|616950210|FG001|Overall Study|Participant met withdrawal criteria|1|||
170711651|NCT01978184|616950212|FG000|Overall Study|Progressive disease|5|||
170711652|NCT01978184|616950213|FG001|Overall Study|Progressive disease|5|||
170711653|NCT01978184|616950212|FG000|Overall Study|Other than PDA|2|||
170711654|NCT01978184|616950213|FG001|Overall Study|Other than PDA|2|||
170711655|NCT01978184|616950212|FG000|Overall Study|Physician Decision|0|||
170711656|NCT01978184|616950213|FG001|Overall Study|Physician Decision|3|||
170711657|NCT01978184|616950212|FG000|Overall Study|Noncompliance|1|||
170711658|NCT01978184|616950213|FG001|Overall Study|Noncompliance|2|||
170711659|NCT01978184|616950212|FG000|Overall Study|Death|1|||
170711660|NCT01978184|616950213|FG001|Overall Study|Death|0|||
170711661|NCT01978184|616950212|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
170711662|NCT01978184|616950213|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
170711663|NCT03146650|616950215|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
170711664|NCT03146650|616950215|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
170711665|NCT03146650|616950215|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
170711666|NCT03146650|616950215|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
170711667|NCT03146650|616950215|FG000|2 Year Follow-up|Death|11|||
170711668|NCT03146650|616950215|FG000|2 Year Follow-up|Still in follow-up|7|||
170711669|NCT03146650|616950215|FG000|2 Year Follow-up|Lost to Follow-up|1|||
170711670|NCT00931307|616950216|FG000|Overall Study|Lack of Efficacy|12|||
170711671|NCT00931307|616950216|FG000|Overall Study|Biomicroscopy|1|||
170711672|NCT04666441|616950217|FG000|Overall Study|Lost to Follow-up|1|||
170711673|NCT04666441|616950218|FG001|Overall Study|Lost to Follow-up|4|||
170711674|NCT04666441|616950219|FG002|Overall Study|Lost to Follow-up|1|||
170711675|NCT04666441|616950220|FG003|Overall Study|Lost to Follow-up|3|||
170711676|NCT04666441|616950221|FG004|Overall Study|Lost to Follow-up|0|||
170711677|NCT04666441|616950222|FG005|Overall Study|Lost to Follow-up|2|||
170711678|NCT04666441|616950223|FG006|Overall Study|Lost to Follow-up|2|||
170711679|NCT04666441|616950224|FG007|Overall Study|Lost to Follow-up|2|||
170711680|NCT04666441|616950217|FG000|Overall Study|Subject Decision|1|||
170711681|NCT04666441|616950218|FG001|Overall Study|Subject Decision|1|||
170711682|NCT04666441|616950219|FG002|Overall Study|Subject Decision|3|||
170711683|NCT04666441|616950220|FG003|Overall Study|Subject Decision|1|||
170711684|NCT04666441|616950221|FG004|Overall Study|Subject Decision|0|||
170711685|NCT04666441|616950222|FG005|Overall Study|Subject Decision|1|||
170711686|NCT04666441|616950223|FG006|Overall Study|Subject Decision|3|||
170711687|NCT04666441|616950224|FG007|Overall Study|Subject Decision|2|||
170711688|NCT00555438|616950231|FG000|10 Days Post-operative|Death|4|||
170711689|NCT00555438|616950231|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
170711690|NCT02517905|616950232|FG000|Overall Study|Lost to Follow-up|4|||
170711691|NCT02517905|616950233|FG001|Overall Study|Lost to Follow-up|0|||
170711692|NCT02517905|616950232|FG000|Overall Study|Withdrawal by Subject|4|||
170711693|NCT02517905|616950233|FG001|Overall Study|Withdrawal by Subject|0|||
170711694|NCT02517905|616950232|FG000|Overall Study|Screen failure|2|||
170711695|NCT02517905|616950233|FG001|Overall Study|Screen failure|2|||
170711696|NCT00766415|616950234|FG000|Overall Study|Withdrawal by Subject|0|||
170711697|NCT00766415|616950235|FG001|Overall Study|Withdrawal by Subject|1|||
170711698|NCT01114516|616950236|FG000|Overall Study|Lost to Follow-up|2|||
170711699|NCT01114516|616950237|FG001|Overall Study|Lost to Follow-up|1|||
170711700|NCT00132769|616950240|FG000|Overall Study|Withdrawal by Subject|1|||
170711701|NCT00132769|616950241|FG001|Overall Study|Withdrawal by Subject|3|||
170711702|NCT00132769|616950240|FG000|Overall Study|Lack of Efficacy|7|||
170711703|NCT00132769|616950241|FG001|Overall Study|Lack of Efficacy|6|||
170711704|NCT00132769|616950240|FG000|Overall Study|Adverse Event|2|||
170711705|NCT00132769|616950241|FG001|Overall Study|Adverse Event|1|||
170711706|NCT00132769|616950240|FG000|Overall Study|Protocol Violation|1|||
170711707|NCT00132769|616950241|FG001|Overall Study|Protocol Violation|1|||
170711708|NCT01431508|616950242|FG000|Overall Study|Lack of Efficacy|1|||
170711709|NCT01431508|616950242|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
170711710|NCT02758236|616950243|FG000|Overall Study|Investigator discretion|43|||
170711711|NCT03136068|616952806|FG000|Overall Study|Lost to Follow-up|1|||
170711712|NCT03136068|616952807|FG001|Overall Study|Lost to Follow-up|1|||
170711713|NCT03136068|616952806|FG000|Overall Study|Protocol Violation|1|||
170711714|NCT03136068|616952807|FG001|Overall Study|Protocol Violation|0|||
170711715|NCT01071395|616952817|FG000|Overall Study|Withdrawal by Subject|2|||
170711716|NCT01071395|616952818|FG001|Overall Study|Withdrawal by Subject|1|||
170711717|NCT01071395|616952817|FG000|Overall Study|Adverse Event|3|||
170711718|NCT01071395|616952818|FG001|Overall Study|Adverse Event|1|||
170711719|NCT03422003|616952820|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
170711720|NCT03422003|616952821|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
170711721|NCT03422003|616952820|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
170711722|NCT03422003|616952821|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
170711723|NCT04419493|616952824|FG000|Wash-out After Period 1|Adverse Event|1|||
170711724|NCT04419493|616952825|FG001|Wash-out After Period 1|Adverse Event|2|||
170711725|NCT04419493|616952826|FG002|Wash-out After Period 1|Adverse Event|1|||
170711726|NCT04419493|616952827|FG003|Wash-out After Period 1|Adverse Event|0|||
170711727|NCT00116805|616952836|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
170711728|NCT00116805|616952837|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
170711729|NCT00116805|616952836|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
170711730|NCT00116805|616952837|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
170711731|NCT00116805|616952836|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
170711732|NCT00116805|616952837|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
170711733|NCT00116805|616952836|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
170711734|NCT00116805|616952837|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
170711735|NCT00116805|616952836|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
170711736|NCT00116805|616952837|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
170711737|NCT00116805|616952836|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
170711738|NCT00116805|616952837|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
170711739|NCT00116805|616952836|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
170711740|NCT00116805|616952837|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
170711741|NCT00116805|616952836|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
170711742|NCT00116805|616952837|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
170711743|NCT00116805|616952836|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
170711744|NCT00116805|616952837|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
170711745|NCT00116805|616952836|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
170711746|NCT00116805|616952837|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
170711747|NCT00116805|616952836|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
170711748|NCT00116805|616952837|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
170711749|NCT00116805|616952836|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
170711750|NCT00116805|616952837|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
170711751|NCT00116805|616952836|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
170711752|NCT00116805|616952837|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
170711753|NCT00116805|616952836|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
170711754|NCT00116805|616952837|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
170711755|NCT00116805|616952836|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
170711756|NCT00116805|616952837|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
170711757|NCT00116805|616952836|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
170711758|NCT00116805|616952837|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
170711759|NCT00116805|616952836|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
170711760|NCT00116805|616952837|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
170711761|NCT00116805|616952836|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
170711762|NCT00116805|616952837|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
170711763|NCT00116805|616952836|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
170711764|NCT00116805|616952837|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
170711765|NCT00116805|616952836|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
170711766|NCT00116805|616952837|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
170711767|NCT00116805|616952836|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
170711768|NCT00116805|616952837|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
170711769|NCT00116805|616952836|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
170711770|NCT00116805|616952837|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
170711771|NCT00116805|616952836|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
170711772|NCT00116805|616952837|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
170711773|NCT00116805|616952836|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
170711774|NCT00116805|616952837|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
170711775|NCT00116805|616952836|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
170711776|NCT00116805|616952837|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
170711777|NCT00116805|616952836|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
170711778|NCT00116805|616952837|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
170711779|NCT00116805|616952836|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
170711780|NCT00116805|616952837|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
170711781|NCT00116805|616952836|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
170711782|NCT00116805|616952837|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
170711783|NCT00116805|616952836|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
170711784|NCT00116805|616952837|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
170711785|NCT00116805|616952836|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
170711786|NCT00116805|616952837|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
170711787|NCT00116805|616952836|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
170711788|NCT00116805|616952837|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
170711789|NCT00116805|616952836|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
170711790|NCT00116805|616952837|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
170711791|NCT00116805|616952836|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
170711792|NCT00116805|616952837|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
170711793|NCT00116805|616952836|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
170827883|NCT01774019|617380175|FG000|Overall Study|Surgery delayed > 120 days|1|||
170827884|NCT01774019|617380176|FG001|Overall Study|Surgery delayed > 120 days|0|||
170827885|NCT01774019|617380175|FG000|Overall Study|Patient refused surgery|1|||
170827886|NCT01774019|617380176|FG001|Overall Study|Patient refused surgery|1|||
170827887|NCT01774019|617380175|FG000|Overall Study|Unable to implant study device|1|||
170827888|NCT01774019|617380176|FG001|Overall Study|Unable to implant study device|0|||
170827889|NCT01774019|617380175|FG000|Overall Study|Lost to Follow-up|0|||
170827890|NCT01774019|617380176|FG001|Overall Study|Lost to Follow-up|3|||
170827891|NCT00553605|617380177|FG000|Overall Study|Did not meet entrance criteria|1|||
170827892|NCT00553605|617380178|FG001|Overall Study|Did not meet entrance criteria|3|||
170827893|NCT00553605|617380177|FG000|Overall Study|Did not receive full dose|1|||
170827894|NCT00553605|617380178|FG001|Overall Study|Did not receive full dose|0|||
170827895|NCT00553605|617380177|FG000|Overall Study|Randomized but not treated|2|||
170827896|NCT00553605|617380178|FG001|Overall Study|Randomized but not treated|0|||
170827897|NCT01040403|617380182|FG000|Overall Study|Adverse Event|10|||
170827898|NCT01040403|617380182|FG000|Overall Study|Protocol Violation|2|||
170827899|NCT01040403|617380182|FG000|Overall Study|Lost to Follow-up|1|||
170827900|NCT01040403|617380182|FG000|Overall Study|Not treated|1|||
170827901|NCT01040403|617380182|FG000|Overall Study|Other reason not defined above|6|||
170827902|NCT03463577|617380185|FG000|Overall Study|Lost to Follow-up|238|||
170827903|NCT03463577|617380186|FG001|Overall Study|Lost to Follow-up|435|||
170827904|NCT03463577|617380187|FG002|Overall Study|Lost to Follow-up|0|||
170827905|NCT03463577|617380188|FG003|Overall Study|Lost to Follow-up|0|||
170827906|NCT03463577|617380189|FG004|Overall Study|Lost to Follow-up|0|||
170827907|NCT03463577|617380190|FG005|Overall Study|Lost to Follow-up|0|||
170827908|NCT03463577|617380185|FG000|Overall Study|With unknown pregnancy outcome|0|||
170827909|NCT03463577|617380186|FG001|Overall Study|With unknown pregnancy outcome|5|||
170827910|NCT03463577|617380187|FG002|Overall Study|With unknown pregnancy outcome|0|||
170827911|NCT03463577|617380188|FG003|Overall Study|With unknown pregnancy outcome|0|||
170827912|NCT03463577|617380189|FG004|Overall Study|With unknown pregnancy outcome|0|||
170827913|NCT03463577|617380190|FG005|Overall Study|With unknown pregnancy outcome|0|||
170827914|NCT03463577|617380185|FG000|Overall Study|Maternal death|2|||
170827915|NCT03463577|617380186|FG001|Overall Study|Maternal death|0|||
170827916|NCT03463577|617380187|FG002|Overall Study|Maternal death|0|||
170827917|NCT03463577|617380188|FG003|Overall Study|Maternal death|0|||
170827918|NCT03463577|617380189|FG004|Overall Study|Maternal death|0|||
170827919|NCT03463577|617380190|FG005|Overall Study|Maternal death|0|||
170827920|NCT03463577|617380185|FG000|Overall Study|Neonatal death|0|||
170827921|NCT03463577|617380186|FG001|Overall Study|Neonatal death|0|||
170827922|NCT03463577|617380187|FG002|Overall Study|Neonatal death|0|||
170827923|NCT03463577|617380188|FG003|Overall Study|Neonatal death|15|||
170827924|NCT03463577|617380189|FG004|Overall Study|Neonatal death|17|||
170827925|NCT03463577|617380190|FG005|Overall Study|Neonatal death|0|||
170827926|NCT00236184|617380191|FG000|Overall Study|Adverse Event|5|||
170827927|NCT00236184|617380192|FG001|Overall Study|Adverse Event|2|||
170827928|NCT00236184|617380191|FG000|Overall Study|Lack of Efficacy|0|||
170827929|NCT00236184|617380192|FG001|Overall Study|Lack of Efficacy|1|||
170827930|NCT00236184|617380191|FG000|Overall Study|Lost to Follow-up|3|||
170827931|NCT00236184|617380192|FG001|Overall Study|Lost to Follow-up|4|||
170827932|NCT00236184|617380191|FG000|Overall Study|Physician Decision|1|||
170827933|NCT00236184|617380192|FG001|Overall Study|Physician Decision|1|||
170827934|NCT00236184|617380191|FG000|Overall Study|Withdrawal by Subject|3|||
170827935|NCT00236184|617380192|FG001|Overall Study|Withdrawal by Subject|0|||
170827936|NCT00236184|617380191|FG000|Overall Study|Protocol Violation|3|||
170827937|NCT00236184|617380192|FG001|Overall Study|Protocol Violation|0|||
170827938|NCT00236184|617380191|FG000|Overall Study|non-compliance with study drug|2|||
170827939|NCT00236184|617380192|FG001|Overall Study|non-compliance with study drug|1|||
170827940|NCT00236184|617380191|FG000|Overall Study|other|1|||
170827941|NCT00236184|617380192|FG001|Overall Study|other|2|||
170827942|NCT00292981|617380193|FG000|Overall Study|Adverse Event|1|||
170827943|NCT00292981|617380193|FG000|Overall Study|Lost to Follow-up|13|||
170827944|NCT00292981|617380193|FG000|Overall Study|Withdrawal by Subject|22|||
170827945|NCT00292981|617380193|FG000|Overall Study|Other|3|||
170827946|NCT04582669|617380194|FG000|Overall Study|Subject missed appointment(s).|1|||
170711794|NCT00116805|616952837|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
170711795|NCT00116805|616952836|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
170711796|NCT00116805|616952837|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
170711797|NCT00116805|616952836|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
170711798|NCT00116805|616952837|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
170711799|NCT00116805|616952836|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
170711800|NCT00116805|616952837|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
170711801|NCT00116805|616952836|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
170711802|NCT00116805|616952837|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
170711803|NCT00116805|616952836|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
170711804|NCT00116805|616952837|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
170711805|NCT00116805|616952836|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
170711806|NCT00116805|616952837|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
170711807|NCT00116805|616952836|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
170711808|NCT00116805|616952837|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
170711809|NCT00116805|616952836|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
170711810|NCT00116805|616952837|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
170711811|NCT00116805|616952836|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
170711812|NCT00116805|616952837|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
170711813|NCT00116805|616952836|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
170711814|NCT00116805|616952837|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
170711815|NCT00116805|616952836|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
170711816|NCT00116805|616952837|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
170711817|NCT01627249|616952838|FG000|Overall Study|Death|3|||
170711818|NCT01627249|616952839|FG001|Overall Study|Death|5|||
170711819|NCT01627249|616952840|FG002|Overall Study|Death|3|||
170711820|NCT01627249|616952838|FG000|Overall Study|Withdrawal by Subject|12|||
170711821|NCT01627249|616952839|FG001|Overall Study|Withdrawal by Subject|6|||
170711822|NCT01627249|616952840|FG002|Overall Study|Withdrawal by Subject|9|||
170711823|NCT01627249|616952838|FG000|Overall Study|Missed Visit|1|||
170711824|NCT01627249|616952839|FG001|Overall Study|Missed Visit|1|||
170711825|NCT01627249|616952840|FG002|Overall Study|Missed Visit|0|||
170711826|NCT00796718|616952841|FG000|Overall Study|Adverse Event|2|||
170711827|NCT00796718|616952841|FG000|Overall Study|Exclusion Criteria|1|||
170711828|NCT00796718|616952841|FG000|Overall Study|Lost to Follow-up|5|||
170711829|NCT00796718|616952841|FG000|Overall Study|Withdrawal by Informed Consent|1|||
170711830|NCT01159938|616952842|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
170711831|NCT01159938|616952843|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
170711832|NCT01159938|616952844|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
170711833|NCT01159938|616952845|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
170711834|NCT01159938|616952846|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
170711835|NCT02105116|616952848|FG000|Overall Study|not eligible for step 2 of trial|5|||
170711836|NCT02105116|616952848|FG000|Overall Study|Death|1|||
170711837|NCT01933334|616952855|FG000|Overall Study|Adverse Event|5|||
170711838|NCT01933334|616952856|FG001|Overall Study|Adverse Event|1|||
170711839|NCT01933334|616952855|FG000|Overall Study|Withdrawal by Subject|0|||
170711840|NCT01933334|616952856|FG001|Overall Study|Withdrawal by Subject|1|||
170711841|NCT01252251|616952857|FG000|Overall Study|Withdrawal by Subject|1|||
170711842|NCT02039505|616952858|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
170711843|NCT02039505|616952859|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
170711844|NCT02039505|616952860|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
170711845|NCT02039505|616952861|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
170711846|NCT02039505|616952862|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
170711847|NCT02039505|616952863|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
170711848|NCT02039505|616952864|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
170711849|NCT02039505|616952858|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
170711850|NCT02039505|616952859|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
170711851|NCT02039505|616952860|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
170711852|NCT02039505|616952861|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
170711853|NCT02039505|616952862|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
170711854|NCT02039505|616952863|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
170711855|NCT02039505|616952864|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
170711856|NCT02039505|616952858|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
170711857|NCT02039505|616952859|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
170711858|NCT02039505|616952860|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
170711859|NCT02039505|616952861|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
170711860|NCT02039505|616952862|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
170711861|NCT02039505|616952863|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
170711862|NCT02039505|616952864|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
170711863|NCT02039505|616952858|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
170711864|NCT02039505|616952859|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
170711865|NCT02039505|616952860|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
170711866|NCT02039505|616952861|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
170711867|NCT02039505|616952862|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
170711868|NCT02039505|616952863|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
170711869|NCT02039505|616952864|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
170711870|NCT02039505|616952858|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
170711871|NCT02039505|616952859|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
170827947|NCT04582669|617380195|FG001|Overall Study|Subject missed appointment(s).|0|||
170827948|NCT04582669|617380196|FG002|Overall Study|Subject missed appointment(s).|1|||
170827949|NCT04582669|617380197|FG003|Overall Study|Subject missed appointment(s).|2|||
170827950|NCT04582669|617380194|FG000|Overall Study|Protocol Violation|0|||
170827951|NCT04582669|617380195|FG001|Overall Study|Protocol Violation|1|||
170827952|NCT04582669|617380196|FG002|Overall Study|Protocol Violation|1|||
170827953|NCT04582669|617380197|FG003|Overall Study|Protocol Violation|0|||
170827954|NCT03245619|617380198|FG000|Part A (Up to Day 22)|Physician Decision|4|||
170827955|NCT03245619|617380199|FG001|Part A (Up to Day 22)|Physician Decision|6|||
170827956|NCT03245619|617380200|FG002|Part A (Up to Day 22)|Physician Decision|6|||
170827957|NCT03245619|617380201|FG003|Part A (Up to Day 22)|Physician Decision|0|||
170827958|NCT03245619|617380202|FG004|Part A (Up to Day 22)|Physician Decision|0|||
170827959|NCT03245619|617380203|FG005|Part A (Up to Day 22)|Physician Decision|0|||
170827960|NCT03245619|617380204|FG006|Part A (Up to Day 22)|Physician Decision|0|||
170827961|NCT03245619|617380205|FG007|Part A (Up to Day 22)|Physician Decision|0|||
170827962|NCT03245619|617380206|FG008|Part A (Up to Day 22)|Physician Decision|0|||
170827963|NCT03245619|617380207|FG009|Part A (Up to Day 22)|Physician Decision|0|||
170827964|NCT03245619|617380208|FG010|Part A (Up to Day 22)|Physician Decision|0|||
170827965|NCT03245619|617380209|FG011|Part A (Up to Day 22)|Physician Decision|0|||
170827966|NCT03245619|617380210|FG012|Part A (Up to Day 22)|Physician Decision|0|||
170827967|NCT03245619|617380211|FG013|Part A (Up to Day 22)|Physician Decision|0|||
170827968|NCT03245619|617380212|FG014|Part A (Up to Day 22)|Physician Decision|0|||
170827969|NCT03245619|617380213|FG015|Part A (Up to Day 22)|Physician Decision|0|||
170827970|NCT03245619|617380214|FG016|Part A (Up to Day 22)|Physician Decision|0|||
170827971|NCT03201900|617380215|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
170827972|NCT03201900|617380215|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
170827973|NCT03201900|617380215|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
170827974|NCT03201900|617380215|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
170827975|NCT03201900|617380215|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
170827976|NCT03201900|617380215|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
170827977|NCT03201900|617380215|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
170827978|NCT03201900|617380215|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
170827979|NCT03201900|617380215|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
170827980|NCT03201900|617380215|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
170827981|NCT03201900|617380215|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
170827982|NCT03201900|617380215|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
170827983|NCT03201900|617380215|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
170827984|NCT01664923|617380216|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
170827985|NCT01664923|617380217|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
170827986|NCT01664923|617380216|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
170827987|NCT01664923|617380217|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
170827988|NCT01664923|617380216|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
170827989|NCT01664923|617380217|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
170827990|NCT01664923|617380216|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
170827991|NCT01664923|617380217|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
170827992|NCT01664923|617380216|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
170827993|NCT01664923|617380217|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
170827994|NCT01664923|617380216|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
170827995|NCT01664923|617380217|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
170827996|NCT01664923|617380216|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
170827997|NCT01664923|617380217|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
170827998|NCT01664923|617380216|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
170827999|NCT01664923|617380217|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
170828000|NCT01664923|617380216|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
170828001|NCT01664923|617380217|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
170828002|NCT01664923|617380216|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
170828003|NCT01664923|617380217|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
170828004|NCT01664923|617380216|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
170828005|NCT01664923|617380217|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
170828006|NCT01664923|617380216|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
170828007|NCT01664923|617380217|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
170828008|NCT01664923|617380216|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
170828009|NCT01664923|617380217|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
170828010|NCT01664923|617380216|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
170828011|NCT01664923|617380217|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
170828012|NCT01233999|617380220|FG000|Overall Study|Withdrawal by Subject|1|||
170828013|NCT01233999|617380220|FG000|Overall Study|Lost to Follow-up|1|||
170828014|NCT00129649|617380221|FG000|Overall Study|Withdrawal by Subject|76|||
170828015|NCT00129649|617380222|FG001|Overall Study|Withdrawal by Subject|65|||
170828016|NCT02482935|617380223|FG000|Period 1|Withdrawal by Subject|1|||
170828017|NCT02482935|617380224|FG001|Period 1|Withdrawal by Subject|0|||
170828018|NCT04952701|617380225|FG000|Control Lens|Physician Decision|4|||
170711872|NCT02039505|616952860|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
170828019|NCT04952701|617380225|FG000|Test Lens|Physician Decision|1|||
170828020|NCT02547441|617380229|FG000|Double-Blind Study Period|Adverse Event|4|||
170828021|NCT02547441|617380230|FG001|Double-Blind Study Period|Adverse Event|9|||
170828022|NCT02547441|617380229|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
170828023|NCT02547441|617380230|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
170828024|NCT02547441|617380229|FG000|Double-Blind Study Period|Physician Decision|1|||
170828025|NCT02547441|617380230|FG001|Double-Blind Study Period|Physician Decision|0|||
170828026|NCT02547441|617380229|FG000|Double-Blind Study Period|Protocol Violation|1|||
170828027|NCT02547441|617380230|FG001|Double-Blind Study Period|Protocol Violation|2|||
170828028|NCT02547441|617380229|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
170828029|NCT02547441|617380230|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
170828030|NCT02547441|617380229|FG000|Double-Blind Study Period|Sponsor Decision|1|||
170828031|NCT02547441|617380230|FG001|Double-Blind Study Period|Sponsor Decision|0|||
170828032|NCT02547441|617380229|FG000|Open-Label Study Period|Adverse Event|10|||
170828033|NCT02547441|617380230|FG001|Open-Label Study Period|Adverse Event|11|||
170828034|NCT02547441|617380229|FG000|Open-Label Study Period|Lack of Efficacy|3|||
170828035|NCT02547441|617380230|FG001|Open-Label Study Period|Lack of Efficacy|2|||
170828036|NCT02547441|617380229|FG000|Open-Label Study Period|Lost to Follow-up|7|||
170828037|NCT02547441|617380230|FG001|Open-Label Study Period|Lost to Follow-up|8|||
170828038|NCT02547441|617380229|FG000|Open-Label Study Period|Physician Decision|1|||
170828039|NCT02547441|617380230|FG001|Open-Label Study Period|Physician Decision|0|||
170828040|NCT02547441|617380229|FG000|Open-Label Study Period|Protocol Violation|2|||
170828041|NCT02547441|617380230|FG001|Open-Label Study Period|Protocol Violation|0|||
170828042|NCT02547441|617380229|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
170828043|NCT02547441|617380230|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
170828044|NCT02547441|617380229|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
170828045|NCT02547441|617380230|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
170828046|NCT01322009|617380231|FG000|Overall Study|Death|0|||
170828047|NCT01322009|617380232|FG001|Overall Study|Death|1|||
170828048|NCT01322009|617380231|FG000|Overall Study|Adverse Event|0|||
170828049|NCT01322009|617380232|FG001|Overall Study|Adverse Event|1|||
170828050|NCT01322009|617380231|FG000|Overall Study|ng tube discontinued|0|||
170828051|NCT01322009|617380232|FG001|Overall Study|ng tube discontinued|1|||
170828052|NCT01657877|617380233|FG000|Overall Study|Withdrawal by Subject|4|||
170828053|NCT01657877|617380233|FG000|Overall Study|Protocol Violation|6|||
170828054|NCT01657877|617380233|FG000|Overall Study|Adverse Event|2|||
170828055|NCT01657877|617380233|FG000|Overall Study|Other Reason|2|||
170828056|NCT03409731|617380235|FG000|Overall Study|Withdrawal by Subject|17|||
170828057|NCT03409731|617380235|FG000|Overall Study|Death|4|||
170828058|NCT01585298|617380236|FG000|Overall Study|Study completion was not documented.|1|||
170828059|NCT01585298|617380236|FG000|Overall Study|Protocol deviation|1|||
170828060|NCT01585298|617380236|FG000|Overall Study|Administrative problems|4|||
170828061|NCT01585298|617380236|FG000|Overall Study|Lost to Follow-up|2|||
170828062|NCT01585298|617380236|FG000|Overall Study|Withdrawal by Subject|4|||
170828063|NCT01585298|617380236|FG000|Overall Study|Abnormal test procedure results|1|||
170828064|NCT01585298|617380236|FG000|Overall Study|Adverse Event|24|||
170828065|NCT04545476|617380237|FG000|Overall Study|Lost to Follow-up|1|||
170828066|NCT04545476|617380238|FG001|Overall Study|Lost to Follow-up|1|||
170828067|NCT04545476|617380239|FG002|Overall Study|Lost to Follow-up|0|||
170828068|NCT04545476|617380240|FG003|Overall Study|Lost to Follow-up|0|||
170828069|NCT02025985|617380245|FG000|Overall Study|Consent withdrawn|0|||
170828070|NCT02025985|617380246|FG001|Overall Study|Consent withdrawn|0|||
170828071|NCT02025985|617380247|FG002|Overall Study|Consent withdrawn|1|||
170828072|NCT02025985|617380248|FG003|Overall Study|Consent withdrawn|0|||
170828073|NCT02025985|617380249|FG004|Overall Study|Consent withdrawn|0|||
170828074|NCT02025985|617380245|FG000|Overall Study|Termination of study by Sponsor|4|||
170828075|NCT02025985|617380246|FG001|Overall Study|Termination of study by Sponsor|3|||
170828076|NCT02025985|617380247|FG002|Overall Study|Termination of study by Sponsor|1|||
170828077|NCT02025985|617380248|FG003|Overall Study|Termination of study by Sponsor|1|||
170828078|NCT02025985|617380249|FG004|Overall Study|Termination of study by Sponsor|3|||
170828079|NCT02025985|617380245|FG000|Overall Study|Death|21|||
170828080|NCT02025985|617380246|FG001|Overall Study|Death|20|||
170828081|NCT02025985|617380247|FG002|Overall Study|Death|23|||
170828082|NCT02025985|617380248|FG003|Overall Study|Death|20|||
170828083|NCT02025985|617380249|FG004|Overall Study|Death|17|||
170828084|NCT00937521|617380254|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
170828085|NCT00937521|617380255|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
170828086|NCT00937521|617380256|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
170828087|NCT00937521|617380257|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
170828088|NCT00937521|617380258|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
170828089|NCT00937521|617380259|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
170711873|NCT02039505|616952861|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
170711874|NCT02039505|616952862|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
170711875|NCT02039505|616952863|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
170711876|NCT02039505|616952864|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
170711877|NCT02039505|616952858|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
170711878|NCT02039505|616952859|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
170711879|NCT02039505|616952860|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
170711880|NCT02039505|616952861|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
170711881|NCT02039505|616952862|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
170711882|NCT02039505|616952863|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
170711883|NCT02039505|616952864|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
170711884|NCT02039505|616952858|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
170711885|NCT02039505|616952859|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
170711886|NCT02039505|616952860|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
170711887|NCT02039505|616952861|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
170711888|NCT02039505|616952862|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
170711889|NCT02039505|616952863|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
170711890|NCT02039505|616952864|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
170711891|NCT02039505|616952858|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
170711892|NCT02039505|616952859|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
170711893|NCT02039505|616952860|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
170711894|NCT02039505|616952861|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
170711895|NCT02039505|616952862|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
170711896|NCT02039505|616952863|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
170711897|NCT02039505|616952864|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
170711898|NCT02039505|616952858|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
170711899|NCT02039505|616952859|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
170711900|NCT02039505|616952860|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
170711901|NCT02039505|616952861|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
170711902|NCT02039505|616952862|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
170711903|NCT02039505|616952863|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
170711904|NCT02039505|616952864|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
170711905|NCT02039505|616952858|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
170711906|NCT02039505|616952859|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
170711907|NCT02039505|616952860|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
170711908|NCT02039505|616952861|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
170711909|NCT02039505|616952862|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
170711910|NCT02039505|616952863|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
170711911|NCT02039505|616952864|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
170711912|NCT02039505|616952858|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
170711913|NCT02039505|616952859|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
170711914|NCT02039505|616952860|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
170711915|NCT02039505|616952861|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
170711916|NCT02039505|616952862|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
170711917|NCT02039505|616952863|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
170711918|NCT02039505|616952864|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
170711919|NCT01324024|616952865|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
170711920|NCT01324024|616952866|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
170711921|NCT02473614|616952872|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
170711922|NCT02473614|616952873|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
170711923|NCT01343082|616952874|FG000|The run-in Period|Not meeting criteria|3|||
170711924|NCT01343082|616952875|FG001|The run-in Period|Not meeting criteria|4|||
170711925|NCT01343082|616952876|FG002|The run-in Period|Not meeting criteria|5|||
170711926|NCT01343082|616952874|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
170711927|NCT01343082|616952875|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
170711928|NCT01343082|616952876|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
170711929|NCT01343082|616952874|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
170711930|NCT01343082|616952875|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
170711931|NCT01343082|616952876|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
170711932|NCT01343082|616952874|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
170711933|NCT01343082|616952875|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
170711934|NCT01343082|616952876|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
170711935|NCT01343082|616952874|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
170711936|NCT01343082|616952875|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
170711937|NCT01343082|616952876|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
170711938|NCT01154166|616952877|FG000|Overall Study|Adverse Event|14|||
170711939|NCT01154166|616952878|FG001|Overall Study|Adverse Event|9|||
170711940|NCT01154166|616952877|FG000|Overall Study|Lost to Follow-up|1|||
170711941|NCT01154166|616952878|FG001|Overall Study|Lost to Follow-up|1|||
170711942|NCT01154166|616952877|FG000|Overall Study|Protocol Violation|4|||
170711943|NCT01154166|616952878|FG001|Overall Study|Protocol Violation|1|||
170711944|NCT01154166|616952877|FG000|Overall Study|Withdrawal by Subject|10|||
170711945|NCT01154166|616952878|FG001|Overall Study|Withdrawal by Subject|1|||
170711946|NCT01154166|616952877|FG000|Overall Study|Lack of Efficacy|3|||
170711947|NCT01154166|616952878|FG001|Overall Study|Lack of Efficacy|0|||
170711948|NCT01154166|616952877|FG000|Overall Study|Disease Progression|1|||
170711949|NCT01154166|616952878|FG001|Overall Study|Disease Progression|0|||
170711950|NCT01154166|616952877|FG000|Overall Study|Poor Compliance|1|||
170711951|NCT01154166|616952878|FG001|Overall Study|Poor Compliance|0|||
170711952|NCT04265755|616952879|FG000|Overall Study|Withdrawal by Subject|39|||
170711953|NCT04265755|616952879|FG000|Overall Study|Decision by sponsor|2|||
170711954|NCT04265755|616952879|FG000|Overall Study|Lost to Follow-up|11|||
170711955|NCT04265755|616952879|FG000|Overall Study|Death|1|||
170711956|NCT00633984|616952880|FG000|Overall Study|Lost to Follow-up|0|||
170711957|NCT00633984|616952881|FG001|Overall Study|Lost to Follow-up|6|||
170711958|NCT00633984|616952880|FG000|Overall Study|Withdrawal by Subject|8|||
170711959|NCT00633984|616952881|FG001|Overall Study|Withdrawal by Subject|7|||
170711960|NCT00633984|616952880|FG000|Overall Study|Hospitalized|1|||
170711961|NCT00633984|616952881|FG001|Overall Study|Hospitalized|0|||
170711962|NCT02554773|616952882|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
170711963|NCT02554773|616952883|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
170711964|NCT02554773|616952882|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
170711965|NCT02554773|616952883|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
170711966|NCT02554773|616952882|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
170711967|NCT02554773|616952883|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
170711968|NCT02554773|616952882|FG000|Original Dose Regimen (SAS 1)|Death|1|||
170711969|NCT02554773|616952883|FG001|Original Dose Regimen (SAS 1)|Death|0|||
170711970|NCT02554773|616952882|FG000|Original Dose Regimen (SAS 1)|Other|4|||
170711971|NCT02554773|616952883|FG001|Original Dose Regimen (SAS 1)|Other|0|||
170711972|NCT02554773|616952882|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
170711973|NCT02554773|616952883|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
170711974|NCT02554773|616952882|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
170711975|NCT02554773|616952883|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
170711976|NCT02554773|616952882|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
170711977|NCT02554773|616952883|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
170711978|NCT02554773|616952882|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
170711979|NCT02554773|616952883|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
170711980|NCT02840877|616952886|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
170711981|NCT02840877|616952886|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
170711982|NCT02840877|616952886|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
170711983|NCT02840877|616952886|FG000|Baseline to 12 Weeks|Death|1|||
170711984|NCT02840877|616952886|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
170711985|NCT02840877|616952886|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
170711986|NCT02840877|616952886|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
170711987|NCT02840877|616952886|FG000|12 Weeks to 6 Months|Treatment failure|1|||
170711988|NCT02840877|616952886|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
170711989|NCT02840877|616952886|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
170711990|NCT02840877|616952886|FG000|12 Weeks to 6 Months|Death|1|||
170711991|NCT02840877|616952886|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
170711992|NCT02840877|616952886|FG000|6 Months to 18 Months|Treatment failure|7|||
170711993|NCT02840877|616952886|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
170711994|NCT02840877|616952886|FG000|6 Months to 18 Months|Moved/transferred out|6|||
170711995|NCT02840877|616952886|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
170711996|NCT02840877|616952886|FG000|6 Months to 18 Months|Death|4|||
170711997|NCT02840877|616952886|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
170711998|NCT02840877|616952886|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
170711999|NCT02840877|616952886|FG000|6 Months to 18 Months|Still in study.|14|||
170712000|NCT02496884|616952887|FG000|Overall Study|Counted twice as enrolled|2|||
170712001|NCT02496884|616952888|FG001|Overall Study|Counted twice as enrolled|0|||
170712002|NCT02496884|616952889|FG002|Overall Study|Counted twice as enrolled|0|||
170712003|NCT02496884|616952890|FG003|Overall Study|Counted twice as enrolled|0|||
170712004|NCT02496884|616952887|FG000|Overall Study|Withdrawal by Subject|0|||
170712005|NCT02496884|616952888|FG001|Overall Study|Withdrawal by Subject|3|||
170712006|NCT02496884|616952889|FG002|Overall Study|Withdrawal by Subject|0|||
170712007|NCT02496884|616952890|FG003|Overall Study|Withdrawal by Subject|0|||
170712008|NCT01168999|616952891|FG000|Overall Study|Lost to Follow-up|2|||
170712009|NCT01168999|616952892|FG001|Overall Study|Lost to Follow-up|1|||
170712010|NCT01168999|616952893|FG002|Overall Study|Lost to Follow-up|0|||
170712011|NCT01168999|616952894|FG003|Overall Study|Lost to Follow-up|0|||
170712012|NCT03603964|616952895|FG000|Overall Study|Death|9|||
170712013|NCT03603964|616952895|FG000|Overall Study|Withdrawal by participant|7|||
170712014|NCT03603964|616952895|FG000|Overall Study|Study terminated by Sponsor|19|||
170712015|NCT00563797|616952896|FG000|Overall Study|Lost to Follow-up|7|||
170712016|NCT00563797|616952897|FG001|Overall Study|Lost to Follow-up|2|||
170712017|NCT04317586|616952898|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
170712018|NCT04317586|616952898|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
170712019|NCT01276327|616952899|FG000|Overall Study|Adverse Event|1|||
170712020|NCT01276327|616952900|FG001|Overall Study|Adverse Event|3|||
170712021|NCT01276327|616952899|FG000|Overall Study|Withdrawal by Subject|1|||
170712022|NCT01276327|616952900|FG001|Overall Study|Withdrawal by Subject|0|||
170712023|NCT00807092|616952901|FG000|Overall Study|Adverse Event|0|||
170712024|NCT00807092|616952902|FG001|Overall Study|Adverse Event|1|||
170712025|NCT00807092|616952901|FG000|Overall Study|Protocol Violation|0|||
170712026|NCT00807092|616952902|FG001|Overall Study|Protocol Violation|2|||
170712027|NCT00807092|616952901|FG000|Overall Study|Withdrawal by Subject|1|||
170712028|NCT00807092|616952902|FG001|Overall Study|Withdrawal by Subject|0|||
170712029|NCT00807092|616952901|FG000|Overall Study|CGMS data collection failed|0|||
170712030|NCT00807092|616952902|FG001|Overall Study|CGMS data collection failed|1|||
170712031|NCT01794949|616952903|FG000|Overall Study|Lost to Follow-up|1|||
170712032|NCT01794949|616952904|FG001|Overall Study|Lost to Follow-up|0|||
170712033|NCT02530619|616952905|FG000|Registered for Study|Withdrawal by Subject|2|||
170712034|NCT02530619|616952905|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
170712035|NCT02530619|616952905|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
170712036|NCT02530619|616952905|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
170712037|NCT02530619|616952905|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
170712038|NCT02530619|616952905|FG000|Follow-up Period (6 Months)|Death|4|||
170712039|NCT02530619|616952905|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
170712040|NCT02530619|616952905|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
170712041|NCT01854554|616952915|FG000|Overall Study|Denial of Insurance Coverage|12|||
170712042|NCT01854554|616952916|FG001|Overall Study|Denial of Insurance Coverage|0|||
170712043|NCT01854554|616952915|FG000|Overall Study|Decided to get treatment locally|1|||
170712044|NCT01854554|616952916|FG001|Overall Study|Decided to get treatment locally|5|||
170712045|NCT01854554|616952915|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
170712046|NCT01854554|616952916|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
170712047|NCT01854554|616952915|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
170712048|NCT01854554|616952916|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
170712049|NCT01854554|616952915|FG000|Overall Study|Progression|0|||
170712050|NCT01854554|616952916|FG001|Overall Study|Progression|1|||
170712051|NCT01854554|616952915|FG000|Overall Study|Lost to Follow-up|0|||
170712052|NCT01854554|616952916|FG001|Overall Study|Lost to Follow-up|1|||
170712053|NCT02461589|616952919|FG000|Overall Study|Withdrawal by Subject|5|||
170712054|NCT02461589|616952920|FG001|Overall Study|Withdrawal by Subject|1|||
170712055|NCT02461589|616952921|FG002|Overall Study|Withdrawal by Subject|3|||
170712056|NCT02461589|616952922|FG003|Overall Study|Withdrawal by Subject|2|||
170712057|NCT02461589|616952923|FG004|Overall Study|Withdrawal by Subject|1|||
170712058|NCT02461589|616952924|FG005|Overall Study|Withdrawal by Subject|2|||
170712059|NCT02461589|616952925|FG006|Overall Study|Withdrawal by Subject|1|||
170712060|NCT02461589|616952926|FG007|Overall Study|Withdrawal by Subject|3|||
170712061|NCT02461589|616952927|FG008|Overall Study|Withdrawal by Subject|3|||
170712062|NCT02461589|616952928|FG009|Overall Study|Withdrawal by Subject|1|||
170712063|NCT02461589|616952919|FG000|Overall Study|Lost to Follow-up|0|||
170712064|NCT02461589|616952920|FG001|Overall Study|Lost to Follow-up|0|||
170712065|NCT02461589|616952921|FG002|Overall Study|Lost to Follow-up|2|||
170712066|NCT02461589|616952922|FG003|Overall Study|Lost to Follow-up|3|||
170712067|NCT02461589|616952923|FG004|Overall Study|Lost to Follow-up|1|||
170712068|NCT02461589|616952924|FG005|Overall Study|Lost to Follow-up|1|||
170712069|NCT02461589|616952925|FG006|Overall Study|Lost to Follow-up|3|||
170712070|NCT02461589|616952926|FG007|Overall Study|Lost to Follow-up|1|||
170712071|NCT02461589|616952927|FG008|Overall Study|Lost to Follow-up|3|||
170712072|NCT02461589|616952928|FG009|Overall Study|Lost to Follow-up|1|||
170712073|NCT02461589|616952919|FG000|Overall Study|Death|0|||
170712074|NCT02461589|616952920|FG001|Overall Study|Death|0|||
170712075|NCT02461589|616952921|FG002|Overall Study|Death|0|||
170712076|NCT02461589|616952922|FG003|Overall Study|Death|0|||
170712077|NCT02461589|616952923|FG004|Overall Study|Death|0|||
170712078|NCT02461589|616952924|FG005|Overall Study|Death|0|||
170712079|NCT02461589|616952925|FG006|Overall Study|Death|0|||
170712080|NCT02461589|616952926|FG007|Overall Study|Death|1|||
170712081|NCT02461589|616952927|FG008|Overall Study|Death|0|||
170712082|NCT02461589|616952928|FG009|Overall Study|Death|0|||
170712083|NCT02461589|616952919|FG000|Overall Study|Unclassified|0|||
170712084|NCT02461589|616952920|FG001|Overall Study|Unclassified|0|||
170712085|NCT02461589|616952921|FG002|Overall Study|Unclassified|0|||
170712086|NCT02461589|616952922|FG003|Overall Study|Unclassified|0|||
170712087|NCT02461589|616952923|FG004|Overall Study|Unclassified|0|||
170712088|NCT02461589|616952924|FG005|Overall Study|Unclassified|0|||
170712089|NCT02461589|616952925|FG006|Overall Study|Unclassified|1|||
170712090|NCT02461589|616952926|FG007|Overall Study|Unclassified|0|||
170712091|NCT02461589|616952927|FG008|Overall Study|Unclassified|0|||
170712092|NCT02461589|616952928|FG009|Overall Study|Unclassified|2|||
170712093|NCT02461589|616952919|FG000|Overall Study|Missing follow-up information|1|||
170712094|NCT02461589|616952920|FG001|Overall Study|Missing follow-up information|1|||
170712095|NCT02461589|616952921|FG002|Overall Study|Missing follow-up information|0|||
170712096|NCT02461589|616952922|FG003|Overall Study|Missing follow-up information|0|||
170712097|NCT02461589|616952923|FG004|Overall Study|Missing follow-up information|0|||
170712098|NCT02461589|616952924|FG005|Overall Study|Missing follow-up information|0|||
170712099|NCT02461589|616952925|FG006|Overall Study|Missing follow-up information|1|||
170712100|NCT02461589|616952926|FG007|Overall Study|Missing follow-up information|0|||
170712101|NCT02461589|616952927|FG008|Overall Study|Missing follow-up information|0|||
170712102|NCT02461589|616952928|FG009|Overall Study|Missing follow-up information|0|||
170712103|NCT02461589|616952919|FG000|Overall Study|Withdrawal from trial before exposure|0|||
170712104|NCT02461589|616952920|FG001|Overall Study|Withdrawal from trial before exposure|0|||
170712105|NCT02461589|616952921|FG002|Overall Study|Withdrawal from trial before exposure|0|||
170712106|NCT02461589|616952922|FG003|Overall Study|Withdrawal from trial before exposure|0|||
170712107|NCT02461589|616952923|FG004|Overall Study|Withdrawal from trial before exposure|0|||
170712108|NCT02461589|616952924|FG005|Overall Study|Withdrawal from trial before exposure|0|||
170712109|NCT02461589|616952925|FG006|Overall Study|Withdrawal from trial before exposure|0|||
170712110|NCT02461589|616952926|FG007|Overall Study|Withdrawal from trial before exposure|0|||
170712111|NCT02461589|616952927|FG008|Overall Study|Withdrawal from trial before exposure|0|||
170712112|NCT02461589|616952928|FG009|Overall Study|Withdrawal from trial before exposure|1|||
170712113|NCT04067141|616952929|FG000|First Intervention|Withdrawal by Subject|0|||
170712114|NCT04067141|616952930|FG001|First Intervention|Withdrawal by Subject|1|||
170712115|NCT04067141|616952929|FG000|Second Intervention|Adverse Event|0|||
170712116|NCT04067141|616952930|FG001|Second Intervention|Adverse Event|2|||
170712117|NCT01978119|616952932|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
170712118|NCT01978119|616952933|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
170712119|NCT01978119|616952932|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
170712120|NCT01978119|616952933|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170712121|NCT01978119|616952932|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170712122|NCT01978119|616952933|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
170712123|NCT02162810|616952934|FG000|Overall Study|Protocol Violation|1|||
170712124|NCT02162810|616952935|FG001|Overall Study|Protocol Violation|0|||
170712125|NCT02162810|616952934|FG000|Overall Study|patients did not report compliance|4|||
170712126|NCT02162810|616952935|FG001|Overall Study|patients did not report compliance|1|||
170712127|NCT01958918|616952939|FG000|Overall Study|Death|1|||
170712128|NCT01958918|616952940|FG001|Overall Study|Death|3|||
170712129|NCT01958918|616952939|FG000|Overall Study|Lost to Follow-up|4|||
170712130|NCT01958918|616952940|FG001|Overall Study|Lost to Follow-up|7|||
170712131|NCT01958918|616952939|FG000|Overall Study|Withdrawal by Subject|13|||
170712132|NCT01958918|616952940|FG001|Overall Study|Withdrawal by Subject|8|||
170712133|NCT01958918|616952939|FG000|Overall Study|Lack of Efficacy|13|||
170712134|NCT01958918|616952940|FG001|Overall Study|Lack of Efficacy|10|||
170712135|NCT01958918|616952939|FG000|Overall Study|Adverse Event|12|||
170712136|NCT01958918|616952940|FG001|Overall Study|Adverse Event|12|||
170712137|NCT01958918|616952939|FG000|Overall Study|administrative problems|0|||
170712138|NCT01958918|616952940|FG001|Overall Study|administrative problems|2|||
170712139|NCT03698773|616952952|FG000|Overall Study|Lost to Follow-up|2|||
170712140|NCT03698773|616952953|FG001|Overall Study|Lost to Follow-up|1|||
170712141|NCT02266381|616952954|FG000|Overall Study|Physician Decision|3|||
170712142|NCT02266381|616952955|FG001|Overall Study|Physician Decision|5|||
170712143|NCT02266381|616952956|FG002|Overall Study|Physician Decision|4|||
170712144|NCT01599650|616952957|FG000|Overall Study|Administrative issue|1|||
170712145|NCT01599650|616952958|FG001|Overall Study|Administrative issue|0|||
170712146|NCT01599650|616952959|FG002|Overall Study|Administrative issue|1|||
170712147|NCT01599650|616952957|FG000|Overall Study|Physician Decision|2|||
170712148|NCT01599650|616952958|FG001|Overall Study|Physician Decision|0|||
170712149|NCT01599650|616952959|FG002|Overall Study|Physician Decision|7|||
170712150|NCT01599650|616952957|FG000|Overall Study|Protocol Violation|0|||
170712151|NCT01599650|616952958|FG001|Overall Study|Protocol Violation|3|||
170712152|NCT01599650|616952959|FG002|Overall Study|Protocol Violation|0|||
170712153|NCT01599650|616952957|FG000|Overall Study|Death|2|||
170712154|NCT01599650|616952958|FG001|Overall Study|Death|1|||
170712155|NCT01599650|616952959|FG002|Overall Study|Death|2|||
170712156|NCT01599650|616952957|FG000|Overall Study|Lost to Follow-up|3|||
170712157|NCT01599650|616952958|FG001|Overall Study|Lost to Follow-up|3|||
170712158|NCT01599650|616952959|FG002|Overall Study|Lost to Follow-up|3|||
170712159|NCT01599650|616952957|FG000|Overall Study|Withdrawal by Subject|11|||
170712160|NCT01599650|616952958|FG001|Overall Study|Withdrawal by Subject|11|||
170712161|NCT01599650|616952959|FG002|Overall Study|Withdrawal by Subject|10|||
170712162|NCT01599650|616952957|FG000|Overall Study|Adverse Event|3|||
170712163|NCT01599650|616952958|FG001|Overall Study|Adverse Event|8|||
170712164|NCT01599650|616952959|FG002|Overall Study|Adverse Event|4|||
170712165|NCT01334866|616952964|FG000|Overall Study|Withdrawal by Subject|10|||
170712166|NCT01334866|616952964|FG000|Overall Study|Lost to Follow-up|3|||
170712167|NCT01334866|616952964|FG000|Overall Study|Physician Decision|3|||
170712168|NCT01334866|616952964|FG000|Overall Study|medically necessary prior to procedure|2|||
170712169|NCT01334866|616952964|FG000|Overall Study|medically necessary post-procedure|1|||
170712170|NCT00958880|616952971|FG000|Overall Study|Lost to Follow-up|2|||
170712171|NCT00958880|616952972|FG001|Overall Study|Lost to Follow-up|2|||
170712172|NCT01971346|616952973|FG000|Overall Study|Protocol Violation|3|||
170712173|NCT01971346|616952973|FG000|Overall Study|Lost to Follow-up|2|||
170712174|NCT01971346|616952973|FG000|Overall Study|Withdrawal by Subject|2|||
170712175|NCT01971346|616952973|FG000|Overall Study|Physician Decision|1|||
170712176|NCT01712984|616952974|FG000|Overall Study|Adverse Event|0|||
170712177|NCT01712984|616952975|FG001|Overall Study|Adverse Event|0|||
170712178|NCT01712984|616952976|FG002|Overall Study|Adverse Event|1|||
170712179|NCT01712984|616952974|FG000|Overall Study|Protocol Violation|2|||
170712180|NCT01712984|616952975|FG001|Overall Study|Protocol Violation|0|||
170712181|NCT01712984|616952976|FG002|Overall Study|Protocol Violation|1|||
170712182|NCT01712984|616952974|FG000|Overall Study|Lost to Follow-up|8|||
170712183|NCT01712984|616952975|FG001|Overall Study|Lost to Follow-up|10|||
170712184|NCT01712984|616952976|FG002|Overall Study|Lost to Follow-up|1|||
170712185|NCT01712984|616952974|FG000|Overall Study|Withdrawal by Subject|6|||
170712186|NCT01712984|616952975|FG001|Overall Study|Withdrawal by Subject|6|||
170712187|NCT01712984|616952976|FG002|Overall Study|Withdrawal by Subject|7|||
170712188|NCT04187196|616952977|FG000|Overall Study|Screen Failure|2|||
170712189|NCT04187196|616952978|FG001|Overall Study|Screen Failure|0|||
170712190|NCT02316717|616952979|FG000|Overall Study|Adverse Event|2|||
170712191|NCT02316717|616952980|FG001|Overall Study|Adverse Event|2|||
170712192|NCT02316717|616952981|FG002|Overall Study|Adverse Event|0|||
170712193|NCT02316717|616952979|FG000|Overall Study|Lost to Follow-up|1|||
170712194|NCT02316717|616952980|FG001|Overall Study|Lost to Follow-up|2|||
170712195|NCT02316717|616952981|FG002|Overall Study|Lost to Follow-up|1|||
170712196|NCT02316717|616952979|FG000|Overall Study|Non compliance|3|||
170712197|NCT02316717|616952980|FG001|Overall Study|Non compliance|1|||
170712198|NCT02316717|616952981|FG002|Overall Study|Non compliance|0|||
170712199|NCT02316717|616952979|FG000|Overall Study|Protocol Violation|2|||
170712200|NCT02316717|616952980|FG001|Overall Study|Protocol Violation|0|||
170712201|NCT02316717|616952981|FG002|Overall Study|Protocol Violation|0|||
170712202|NCT02316717|616952979|FG000|Overall Study|Withdrawal by Subject|2|||
170712203|NCT02316717|616952980|FG001|Overall Study|Withdrawal by Subject|1|||
170712204|NCT02316717|616952981|FG002|Overall Study|Withdrawal by Subject|1|||
170712205|NCT02316717|616952979|FG000|Overall Study|Death|0|||
170712206|NCT02316717|616952980|FG001|Overall Study|Death|0|||
170712207|NCT02316717|616952981|FG002|Overall Study|Death|1|||
170712208|NCT02316717|616952979|FG000|Overall Study|Physician Decision|0|||
170712209|NCT02316717|616952980|FG001|Overall Study|Physician Decision|1|||
170712210|NCT02316717|616952981|FG002|Overall Study|Physician Decision|0|||
170712211|NCT02316717|616952979|FG000|Overall Study|TBC|1|||
170712212|NCT02316717|616952980|FG001|Overall Study|TBC|0|||
170712213|NCT02316717|616952981|FG002|Overall Study|TBC|0|||
170712214|NCT00298831|616952982|FG000|Overall Study|Adverse Event|1|||
170712215|NCT00298831|616952982|FG000|Overall Study|Lost to Follow-up|3|||
170712216|NCT00298831|616952982|FG000|Overall Study|Withdrawal by Subject|1|||
170712217|NCT00298831|616952982|FG000|Overall Study|Participants did not receive treatment|27|||
170712218|NCT04568122|616952983|FG000|Overall Study|Lost to Follow-up|48|||
170712219|NCT04568122|616952984|FG001|Overall Study|Lost to Follow-up|44|||
170712220|NCT04568122|616952985|FG002|Overall Study|Lost to Follow-up|4|||
170712221|NCT04568122|616952986|FG003|Overall Study|Lost to Follow-up|0|||
170712222|NCT04568122|616952987|FG004|Overall Study|Lost to Follow-up|0|||
170712223|NCT02460224|616952990|FG000|Overall Study|Adverse Event|0|||
170828090|NCT00937521|617380260|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
170828091|NCT00937521|617380261|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
170828092|NCT00937521|617380254|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
170828093|NCT00937521|617380255|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
170828094|NCT00937521|617380256|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
170712224|NCT02460224|616952991|FG001|Overall Study|Adverse Event|0|||
170712225|NCT02460224|616952992|FG002|Overall Study|Adverse Event|0|||
170828095|NCT00937521|617380257|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
170712226|NCT02460224|616952993|FG003|Overall Study|Adverse Event|0|||
170712227|NCT02460224|616952994|FG004|Overall Study|Adverse Event|0|||
170712228|NCT02460224|616952995|FG005|Overall Study|Adverse Event|0|||
170712229|NCT02460224|616952996|FG006|Overall Study|Adverse Event|1|||
170712230|NCT02460224|616952997|FG007|Overall Study|Adverse Event|0|||
170712231|NCT02460224|616952998|FG008|Overall Study|Adverse Event|0|||
170712232|NCT02460224|616952999|FG009|Overall Study|Adverse Event|0|||
170712233|NCT02460224|616953000|FG010|Overall Study|Adverse Event|0|||
170712234|NCT02460224|616953001|FG011|Overall Study|Adverse Event|0|||
170712235|NCT02460224|616953002|FG012|Overall Study|Adverse Event|1|||
170712236|NCT02460224|616953003|FG013|Overall Study|Adverse Event|0|||
170712237|NCT02460224|616953004|FG014|Overall Study|Adverse Event|0|||
170712238|NCT02460224|616953005|FG015|Overall Study|Adverse Event|0|||
170712239|NCT02460224|616953006|FG016|Overall Study|Adverse Event|1|||
170712240|NCT02460224|616953007|FG017|Overall Study|Adverse Event|0|||
170712241|NCT02460224|616953008|FG018|Overall Study|Adverse Event|1|||
170712242|NCT02460224|616953009|FG019|Overall Study|Adverse Event|0|||
170712243|NCT02460224|616953010|FG020|Overall Study|Adverse Event|1|||
170712244|NCT02460224|616953011|FG021|Overall Study|Adverse Event|1|||
170712245|NCT02460224|616953012|FG022|Overall Study|Adverse Event|1|||
170712246|NCT02460224|616953013|FG023|Overall Study|Adverse Event|0|||
170712247|NCT02460224|616953014|FG024|Overall Study|Adverse Event|0|||
170712248|NCT02460224|616953015|FG025|Overall Study|Adverse Event|0|||
170712249|NCT02460224|616953016|FG026|Overall Study|Adverse Event|11|||
170712250|NCT02460224|616953017|FG027|Overall Study|Adverse Event|1|||
170712251|NCT02460224|616953018|FG028|Overall Study|Adverse Event|6|||
170712252|NCT02460224|616952990|FG000|Overall Study|Death|0|||
170712253|NCT02460224|616952991|FG001|Overall Study|Death|0|||
170712254|NCT02460224|616952992|FG002|Overall Study|Death|0|||
170712255|NCT02460224|616952993|FG003|Overall Study|Death|0|||
170712256|NCT02460224|616952994|FG004|Overall Study|Death|0|||
170712257|NCT02460224|616952995|FG005|Overall Study|Death|2|||
170712258|NCT02460224|616952996|FG006|Overall Study|Death|1|||
170712259|NCT02460224|616952997|FG007|Overall Study|Death|0|||
170712260|NCT02460224|616952998|FG008|Overall Study|Death|0|||
170712261|NCT02460224|616952999|FG009|Overall Study|Death|1|||
170712262|NCT02460224|616953000|FG010|Overall Study|Death|0|||
170712263|NCT02460224|616953001|FG011|Overall Study|Death|0|||
170712264|NCT02460224|616953002|FG012|Overall Study|Death|0|||
170712265|NCT02460224|616953003|FG013|Overall Study|Death|1|||
170712266|NCT02460224|616953004|FG014|Overall Study|Death|0|||
170712267|NCT02460224|616953005|FG015|Overall Study|Death|0|||
170712268|NCT02460224|616953006|FG016|Overall Study|Death|2|||
170712269|NCT02460224|616953007|FG017|Overall Study|Death|1|||
170712270|NCT02460224|616953008|FG018|Overall Study|Death|0|||
170712271|NCT02460224|616953009|FG019|Overall Study|Death|2|||
170712272|NCT02460224|616953010|FG020|Overall Study|Death|0|||
170712273|NCT02460224|616953011|FG021|Overall Study|Death|0|||
170712274|NCT02460224|616953012|FG022|Overall Study|Death|0|||
170712275|NCT02460224|616953013|FG023|Overall Study|Death|0|||
170712276|NCT02460224|616953014|FG024|Overall Study|Death|1|||
170712277|NCT02460224|616953015|FG025|Overall Study|Death|1|||
170712278|NCT02460224|616953016|FG026|Overall Study|Death|5|||
170712279|NCT02460224|616953017|FG027|Overall Study|Death|0|||
170712280|NCT02460224|616953018|FG028|Overall Study|Death|1|||
170712281|NCT02460224|616952990|FG000|Overall Study|Lost to Follow-up|0|||
170712282|NCT02460224|616952991|FG001|Overall Study|Lost to Follow-up|0|||
170712283|NCT02460224|616952992|FG002|Overall Study|Lost to Follow-up|0|||
170712284|NCT02460224|616952993|FG003|Overall Study|Lost to Follow-up|0|||
170712285|NCT02460224|616952994|FG004|Overall Study|Lost to Follow-up|0|||
170712286|NCT02460224|616952995|FG005|Overall Study|Lost to Follow-up|0|||
170712287|NCT02460224|616952996|FG006|Overall Study|Lost to Follow-up|0|||
170712288|NCT02460224|616952997|FG007|Overall Study|Lost to Follow-up|0|||
170712289|NCT02460224|616952998|FG008|Overall Study|Lost to Follow-up|0|||
170712290|NCT02460224|616952999|FG009|Overall Study|Lost to Follow-up|0|||
170712291|NCT02460224|616953000|FG010|Overall Study|Lost to Follow-up|0|||
170712292|NCT02460224|616953001|FG011|Overall Study|Lost to Follow-up|0|||
170712293|NCT02460224|616953002|FG012|Overall Study|Lost to Follow-up|0|||
170712294|NCT02460224|616953003|FG013|Overall Study|Lost to Follow-up|0|||
170712295|NCT02460224|616953004|FG014|Overall Study|Lost to Follow-up|0|||
170828096|NCT00937521|617380258|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
170828097|NCT00937521|617380259|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
170828098|NCT00937521|617380260|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
170828099|NCT00937521|617380261|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
170828100|NCT00937521|617380254|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
170828101|NCT00937521|617380255|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
170712296|NCT02460224|616953005|FG015|Overall Study|Lost to Follow-up|0|||
170712297|NCT02460224|616953006|FG016|Overall Study|Lost to Follow-up|0|||
170712298|NCT02460224|616953007|FG017|Overall Study|Lost to Follow-up|0|||
170712299|NCT02460224|616953008|FG018|Overall Study|Lost to Follow-up|0|||
170712300|NCT02460224|616953009|FG019|Overall Study|Lost to Follow-up|0|||
170712301|NCT02460224|616953010|FG020|Overall Study|Lost to Follow-up|0|||
170712302|NCT02460224|616953011|FG021|Overall Study|Lost to Follow-up|0|||
170712303|NCT02460224|616953012|FG022|Overall Study|Lost to Follow-up|1|||
170712304|NCT02460224|616953013|FG023|Overall Study|Lost to Follow-up|0|||
170712305|NCT02460224|616953014|FG024|Overall Study|Lost to Follow-up|0|||
170712306|NCT02460224|616953015|FG025|Overall Study|Lost to Follow-up|0|||
170712307|NCT02460224|616953016|FG026|Overall Study|Lost to Follow-up|0|||
170712308|NCT02460224|616953017|FG027|Overall Study|Lost to Follow-up|0|||
170712309|NCT02460224|616953018|FG028|Overall Study|Lost to Follow-up|0|||
170712310|NCT02460224|616952990|FG000|Overall Study|Physician Decision|0|||
170712311|NCT02460224|616952991|FG001|Overall Study|Physician Decision|1|||
170712312|NCT02460224|616952992|FG002|Overall Study|Physician Decision|0|||
170712313|NCT02460224|616952993|FG003|Overall Study|Physician Decision|0|||
170712314|NCT02460224|616952994|FG004|Overall Study|Physician Decision|1|||
170712315|NCT02460224|616952995|FG005|Overall Study|Physician Decision|0|||
170712316|NCT02460224|616952996|FG006|Overall Study|Physician Decision|0|||
170712317|NCT02460224|616952997|FG007|Overall Study|Physician Decision|1|||
170712318|NCT02460224|616952998|FG008|Overall Study|Physician Decision|0|||
170712319|NCT02460224|616952999|FG009|Overall Study|Physician Decision|0|||
170712320|NCT02460224|616953000|FG010|Overall Study|Physician Decision|0|||
170712321|NCT02460224|616953001|FG011|Overall Study|Physician Decision|1|||
170712322|NCT02460224|616953002|FG012|Overall Study|Physician Decision|0|||
170712323|NCT02460224|616953003|FG013|Overall Study|Physician Decision|1|||
170712324|NCT02460224|616953004|FG014|Overall Study|Physician Decision|0|||
170712325|NCT02460224|616953005|FG015|Overall Study|Physician Decision|0|||
170712326|NCT02460224|616953006|FG016|Overall Study|Physician Decision|2|||
170712327|NCT02460224|616953007|FG017|Overall Study|Physician Decision|1|||
170712328|NCT02460224|616953008|FG018|Overall Study|Physician Decision|1|||
170712329|NCT02460224|616953009|FG019|Overall Study|Physician Decision|2|||
170712330|NCT02460224|616953010|FG020|Overall Study|Physician Decision|1|||
170712331|NCT02460224|616953011|FG021|Overall Study|Physician Decision|1|||
170712332|NCT02460224|616953012|FG022|Overall Study|Physician Decision|0|||
170712333|NCT02460224|616953013|FG023|Overall Study|Physician Decision|0|||
170712334|NCT02460224|616953014|FG024|Overall Study|Physician Decision|1|||
170712335|NCT02460224|616953015|FG025|Overall Study|Physician Decision|0|||
170712336|NCT02460224|616953016|FG026|Overall Study|Physician Decision|14|||
170712337|NCT02460224|616953017|FG027|Overall Study|Physician Decision|1|||
170712338|NCT02460224|616953018|FG028|Overall Study|Physician Decision|6|||
170712339|NCT02460224|616952990|FG000|Overall Study|Progressive disease|15|||
170712340|NCT02460224|616952991|FG001|Overall Study|Progressive disease|11|||
170712341|NCT02460224|616952992|FG002|Overall Study|Progressive disease|5|||
170712342|NCT02460224|616952993|FG003|Overall Study|Progressive disease|6|||
170712343|NCT02460224|616952994|FG004|Overall Study|Progressive disease|3|||
170712344|NCT02460224|616952995|FG005|Overall Study|Progressive disease|26|||
170712345|NCT02460224|616952996|FG006|Overall Study|Progressive disease|28|||
170712346|NCT02460224|616952997|FG007|Overall Study|Progressive disease|4|||
170712347|NCT02460224|616952998|FG008|Overall Study|Progressive disease|5|||
170712348|NCT02460224|616952999|FG009|Overall Study|Progressive disease|9|||
170712349|NCT02460224|616953000|FG010|Overall Study|Progressive disease|5|||
170712350|NCT02460224|616953001|FG011|Overall Study|Progressive disease|4|||
170712351|NCT02460224|616953002|FG012|Overall Study|Progressive disease|5|||
170712352|NCT02460224|616953003|FG013|Overall Study|Progressive disease|4|||
170712353|NCT02460224|616953004|FG014|Overall Study|Progressive disease|5|||
170712354|NCT02460224|616953005|FG015|Overall Study|Progressive disease|5|||
170712355|NCT02460224|616953006|FG016|Overall Study|Progressive disease|15|||
170712356|NCT02460224|616953007|FG017|Overall Study|Progressive disease|3|||
170712357|NCT02460224|616953008|FG018|Overall Study|Progressive disease|8|||
170712358|NCT02460224|616953009|FG019|Overall Study|Progressive disease|3|||
170712359|NCT02460224|616953010|FG020|Overall Study|Progressive disease|4|||
170712360|NCT02460224|616953011|FG021|Overall Study|Progressive disease|9|||
170712361|NCT02460224|616953012|FG022|Overall Study|Progressive disease|4|||
170712362|NCT02460224|616953013|FG023|Overall Study|Progressive disease|11|||
170712363|NCT02460224|616953014|FG024|Overall Study|Progressive disease|4|||
170712364|NCT02460224|616953015|FG025|Overall Study|Progressive disease|5|||
170712365|NCT02460224|616953016|FG026|Overall Study|Progressive disease|85|||
170712366|NCT02460224|616953017|FG027|Overall Study|Progressive disease|17|||
170712367|NCT02460224|616953018|FG028|Overall Study|Progressive disease|77|||
170712368|NCT02460224|616952990|FG000|Overall Study|Subject/guardian decision|2|||
170712369|NCT02460224|616952991|FG001|Overall Study|Subject/guardian decision|0|||
170712370|NCT02460224|616952992|FG002|Overall Study|Subject/guardian decision|1|||
170712371|NCT02460224|616952993|FG003|Overall Study|Subject/guardian decision|0|||
170712372|NCT02460224|616952994|FG004|Overall Study|Subject/guardian decision|2|||
170712373|NCT02460224|616952995|FG005|Overall Study|Subject/guardian decision|2|||
170712374|NCT02460224|616952996|FG006|Overall Study|Subject/guardian decision|0|||
170712375|NCT02460224|616952997|FG007|Overall Study|Subject/guardian decision|0|||
170712376|NCT02460224|616952998|FG008|Overall Study|Subject/guardian decision|1|||
170712377|NCT02460224|616952999|FG009|Overall Study|Subject/guardian decision|1|||
170712378|NCT02460224|616953000|FG010|Overall Study|Subject/guardian decision|0|||
170712379|NCT02460224|616953001|FG011|Overall Study|Subject/guardian decision|1|||
170712380|NCT02460224|616953002|FG012|Overall Study|Subject/guardian decision|0|||
170712381|NCT02460224|616953003|FG013|Overall Study|Subject/guardian decision|0|||
170712382|NCT02460224|616953004|FG014|Overall Study|Subject/guardian decision|0|||
170712383|NCT02460224|616953005|FG015|Overall Study|Subject/guardian decision|1|||
170712384|NCT02460224|616953006|FG016|Overall Study|Subject/guardian decision|0|||
170712385|NCT02460224|616953007|FG017|Overall Study|Subject/guardian decision|1|||
170712386|NCT02460224|616953008|FG018|Overall Study|Subject/guardian decision|2|||
170712387|NCT02460224|616953009|FG019|Overall Study|Subject/guardian decision|0|||
170712388|NCT02460224|616953010|FG020|Overall Study|Subject/guardian decision|0|||
170712389|NCT02460224|616953011|FG021|Overall Study|Subject/guardian decision|1|||
170712390|NCT02460224|616953012|FG022|Overall Study|Subject/guardian decision|0|||
170712391|NCT02460224|616953013|FG023|Overall Study|Subject/guardian decision|0|||
170712392|NCT02460224|616953014|FG024|Overall Study|Subject/guardian decision|0|||
170712393|NCT02460224|616953015|FG025|Overall Study|Subject/guardian decision|0|||
170712394|NCT02460224|616953016|FG026|Overall Study|Subject/guardian decision|6|||
170712395|NCT02460224|616953017|FG027|Overall Study|Subject/guardian decision|2|||
170712396|NCT02460224|616953018|FG028|Overall Study|Subject/guardian decision|3|||
170712397|NCT01181895|616953027|FG000|Overall Study|Adverse Event|3|||
170712398|NCT01181895|616953028|FG001|Overall Study|Adverse Event|1|||
170712399|NCT01181895|616953029|FG002|Overall Study|Adverse Event|1|||
170712400|NCT01181895|616953027|FG000|Overall Study|Lack of Efficacy|8|||
170712401|NCT01181895|616953028|FG001|Overall Study|Lack of Efficacy|9|||
170712402|NCT01181895|616953029|FG002|Overall Study|Lack of Efficacy|9|||
170712403|NCT01181895|616953027|FG000|Overall Study|Protocol Violation|2|||
170712404|NCT01181895|616953028|FG001|Overall Study|Protocol Violation|1|||
170712405|NCT01181895|616953029|FG002|Overall Study|Protocol Violation|0|||
170712406|NCT01181895|616953027|FG000|Overall Study|Lost to Follow-up|0|||
170712407|NCT01181895|616953028|FG001|Overall Study|Lost to Follow-up|1|||
170712408|NCT01181895|616953029|FG002|Overall Study|Lost to Follow-up|2|||
170712409|NCT01181895|616953027|FG000|Overall Study|Investigator Discretion|1|||
170712410|NCT01181895|616953028|FG001|Overall Study|Investigator Discretion|2|||
170712411|NCT01181895|616953029|FG002|Overall Study|Investigator Discretion|1|||
170712412|NCT01181895|616953027|FG000|Overall Study|Withdrawal by Subject|3|||
170712413|NCT01181895|616953028|FG001|Overall Study|Withdrawal by Subject|0|||
170712414|NCT01181895|616953029|FG002|Overall Study|Withdrawal by Subject|5|||
170712415|NCT02080091|616954912|FG000|Overall Study|Study Terminated|22|||
170712416|NCT02080091|616954912|FG000|Overall Study|Death|1|||
170712417|NCT02080091|616954912|FG000|Overall Study|Withdrawal by Subject|1|||
170712418|NCT02080091|616954912|FG000|Overall Study|Other|1|||
170712419|NCT02055352|616954913|FG000|Overall Study|Adverse Event|0|||
170712420|NCT02055352|616954914|FG001|Overall Study|Adverse Event|1|||
170712421|NCT02055352|616954913|FG000|Overall Study|Non-eligible|0|||
170712422|NCT02055352|616954914|FG001|Overall Study|Non-eligible|1|||
170712423|NCT02055352|616954913|FG000|Overall Study|Poor compliance|1|||
170712424|NCT02055352|616954914|FG001|Overall Study|Poor compliance|1|||
170712425|NCT02055352|616954913|FG000|Overall Study|Death|1|||
170712426|NCT02055352|616954914|FG001|Overall Study|Death|2|||
170712427|NCT02055352|616954913|FG000|Overall Study|Patient decision|1|||
170712428|NCT02055352|616954914|FG001|Overall Study|Patient decision|1|||
170712429|NCT02055352|616954913|FG000|Overall Study|Use of prohibited treatment|0|||
170712430|NCT02055352|616954914|FG001|Overall Study|Use of prohibited treatment|3|||
170712431|NCT02055352|616954913|FG000|Overall Study|AE, study drug would be detrimental|1|||
170712432|NCT02055352|616954914|FG001|Overall Study|AE, study drug would be detrimental|3|||
170712433|NCT02055352|616954913|FG000|Overall Study|Withdrawal of informed consent|1|||
170712434|NCT02055352|616954914|FG001|Overall Study|Withdrawal of informed consent|0|||
170712435|NCT02055352|616954913|FG000|Overall Study|Reason unknown|1|||
170712436|NCT02055352|616954914|FG001|Overall Study|Reason unknown|5|||
170712437|NCT00524134|616954915|FG000|Overall Study|Withdrawal by Subject|1|||
170712438|NCT00524134|616954915|FG000|Overall Study|Physician Decision|1|||
170712439|NCT03794089|616954916|FG000|Overall Study|Lost to Follow-up|4|||
170712440|NCT03794089|616954917|FG001|Overall Study|Lost to Follow-up|1|||
170712441|NCT03794089|616954916|FG000|Overall Study|Withdrawal by Subject|2|||
170712442|NCT03794089|616954917|FG001|Overall Study|Withdrawal by Subject|0|||
170712443|NCT03985423|616954918|FG000|Overall Study|Adverse Event|1|||
170712444|NCT03985423|616954918|FG000|Overall Study|Death|2|||
170712445|NCT03985423|616954918|FG000|Overall Study|Physician Decision|1|||
170712446|NCT03985423|616954918|FG000|Overall Study|Withdrawal by Subject|2|||
170712447|NCT03985423|616954918|FG000|Overall Study|Lack of insurance and citizenship|1|||
170712448|NCT01045447|616954919|FG000|Overall Study|Adverse Event|0|||
170712449|NCT01045447|616954920|FG001|Overall Study|Adverse Event|1|||
170712450|NCT01045447|616954919|FG000|Overall Study|Lack of Efficacy|3|||
170712451|NCT01045447|616954920|FG001|Overall Study|Lack of Efficacy|1|||
170712452|NCT01045447|616954919|FG000|Overall Study|Protocol Violation|6|||
170712453|NCT01045447|616954920|FG001|Overall Study|Protocol Violation|3|||
170712454|NCT01045447|616954919|FG000|Overall Study|Withdrawal Criteria|10|||
170712455|NCT01045447|616954920|FG001|Overall Study|Withdrawal Criteria|10|||
170712456|NCT01045447|616954919|FG000|Overall Study|Unclassified|17|||
170712457|NCT01045447|616954920|FG001|Overall Study|Unclassified|13|||
170712458|NCT02525133|616954925|FG000|Overall Study|Adverse Event|0|||
170712459|NCT02525133|616954926|FG001|Overall Study|Adverse Event|1|||
170712460|NCT02525133|616954925|FG000|Overall Study|Death|0|||
170712461|NCT02525133|616954926|FG001|Overall Study|Death|1|||
170712462|NCT02525133|616954925|FG000|Overall Study|did not meet randomization criteria|1|||
170712463|NCT02525133|616954926|FG001|Overall Study|did not meet randomization criteria|0|||
170712464|NCT02525133|616954925|FG000|Overall Study|Lost to Follow-up|5|||
170712465|NCT02525133|616954926|FG001|Overall Study|Lost to Follow-up|1|||
170712466|NCT02525133|616954925|FG000|Overall Study|randomized not enrolled|3|||
170712467|NCT02525133|616954926|FG001|Overall Study|randomized not enrolled|0|||
170712468|NCT02525133|616954925|FG000|Overall Study|Withdrawal by Subject|1|||
170712469|NCT02525133|616954926|FG001|Overall Study|Withdrawal by Subject|0|||
170712470|NCT01075074|616954927|FG000|Overall Study|Surgeon changed to open incisional case|1|||
170712471|NCT01075074|616954928|FG001|Overall Study|Surgeon changed to open incisional case|2|||
170712472|NCT01075074|616954929|FG002|Overall Study|Surgeon changed to open incisional case|2|||
170712473|NCT01575561|616954930|FG000|Overall Study|Adverse Event|9|||
170712474|NCT01575561|616954930|FG000|Overall Study|Lack of Efficacy|8|||
170712475|NCT01575561|616954930|FG000|Overall Study|Lost to Follow-up|6|||
170712476|NCT01575561|616954930|FG000|Overall Study|Protocol Violation|4|||
170712477|NCT01575561|616954930|FG000|Overall Study|Withdrawal by Subject|11|||
170712478|NCT01575561|616954930|FG000|Overall Study|administration|1|||
170712479|NCT00359762|616954938|FG000|Period II|Adverse Event|17|||
170712480|NCT00359762|616954939|FG001|Period II|Adverse Event|0|||
170712481|NCT00359762|616954940|FG002|Period II|Adverse Event|0|||
170712482|NCT00359762|616954941|FG003|Period II|Adverse Event|0|||
170712483|NCT00359762|616954942|FG004|Period II|Adverse Event|49|||
170712484|NCT00359762|616954938|FG000|Period II|Protocol Violation|18|||
170712485|NCT00359762|616954939|FG001|Period II|Protocol Violation|0|||
170712486|NCT00359762|616954940|FG002|Period II|Protocol Violation|0|||
170712487|NCT00359762|616954941|FG003|Period II|Protocol Violation|0|||
170712488|NCT00359762|616954942|FG004|Period II|Protocol Violation|11|||
170712489|NCT00359762|616954938|FG000|Period II|Physician Decision|17|||
170712490|NCT00359762|616954939|FG001|Period II|Physician Decision|0|||
170712491|NCT00359762|616954940|FG002|Period II|Physician Decision|0|||
170712492|NCT00359762|616954941|FG003|Period II|Physician Decision|0|||
170712493|NCT00359762|616954942|FG004|Period II|Physician Decision|23|||
170712494|NCT00359762|616954938|FG000|Period II|Death|2|||
170712495|NCT00359762|616954939|FG001|Period II|Death|0|||
170712496|NCT00359762|616954940|FG002|Period II|Death|0|||
170712497|NCT00359762|616954941|FG003|Period II|Death|0|||
170712498|NCT00359762|616954942|FG004|Period II|Death|4|||
170828102|NCT00937521|617380256|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
170828103|NCT00937521|617380257|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
170828104|NCT00937521|617380258|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
170828105|NCT00937521|617380259|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
170828106|NCT00937521|617380260|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
170712499|NCT00359762|616954938|FG000|Period II|Lack of Efficacy|11|||
170712500|NCT00359762|616954939|FG001|Period II|Lack of Efficacy|0|||
170712501|NCT00359762|616954940|FG002|Period II|Lack of Efficacy|0|||
170712502|NCT00359762|616954941|FG003|Period II|Lack of Efficacy|0|||
170712503|NCT00359762|616954942|FG004|Period II|Lack of Efficacy|8|||
170712504|NCT00359762|616954938|FG000|Period II|Lost to follow up|5|||
170712505|NCT00359762|616954939|FG001|Period II|Lost to follow up|0|||
170712506|NCT00359762|616954940|FG002|Period II|Lost to follow up|0|||
170712507|NCT00359762|616954941|FG003|Period II|Lost to follow up|0|||
170712508|NCT00359762|616954942|FG004|Period II|Lost to follow up|5|||
170712509|NCT00359762|616954938|FG000|Period II|Entry Criteria Not Met|8|||
170712510|NCT00359762|616954939|FG001|Period II|Entry Criteria Not Met|0|||
170712511|NCT00359762|616954940|FG002|Period II|Entry Criteria Not Met|0|||
170712512|NCT00359762|616954941|FG003|Period II|Entry Criteria Not Met|0|||
170712513|NCT00359762|616954942|FG004|Period II|Entry Criteria Not Met|4|||
170712514|NCT00359762|616954938|FG000|Period II|Subject Decision|50|||
170712515|NCT00359762|616954939|FG001|Period II|Subject Decision|0|||
170712516|NCT00359762|616954940|FG002|Period II|Subject Decision|0|||
170712517|NCT00359762|616954941|FG003|Period II|Subject Decision|0|||
170712518|NCT00359762|616954942|FG004|Period II|Subject Decision|70|||
170712519|NCT00359762|616954938|FG000|Period III|Protocol Violation|0|||
170712520|NCT00359762|616954939|FG001|Period III|Protocol Violation|5|||
170712521|NCT00359762|616954940|FG002|Period III|Protocol Violation|3|||
170712522|NCT00359762|616954941|FG003|Period III|Protocol Violation|8|||
170712523|NCT00359762|616954942|FG004|Period III|Protocol Violation|0|||
170712524|NCT00359762|616954938|FG000|Period III|Adverse Event|0|||
170712525|NCT00359762|616954939|FG001|Period III|Adverse Event|3|||
170712526|NCT00359762|616954940|FG002|Period III|Adverse Event|4|||
170712527|NCT00359762|616954941|FG003|Period III|Adverse Event|10|||
170712528|NCT00359762|616954942|FG004|Period III|Adverse Event|0|||
170712529|NCT00359762|616954938|FG000|Period III|Physician Decision|0|||
170712530|NCT00359762|616954939|FG001|Period III|Physician Decision|5|||
170712531|NCT00359762|616954940|FG002|Period III|Physician Decision|9|||
170712532|NCT00359762|616954941|FG003|Period III|Physician Decision|15|||
170712533|NCT00359762|616954942|FG004|Period III|Physician Decision|0|||
170712534|NCT00359762|616954938|FG000|Period III|Lack of Efficacy|0|||
170712535|NCT00359762|616954939|FG001|Period III|Lack of Efficacy|7|||
170712536|NCT00359762|616954940|FG002|Period III|Lack of Efficacy|5|||
170712537|NCT00359762|616954941|FG003|Period III|Lack of Efficacy|9|||
170712538|NCT00359762|616954942|FG004|Period III|Lack of Efficacy|0|||
170712539|NCT00359762|616954938|FG000|Period III|Lost to follow up|0|||
170712540|NCT00359762|616954939|FG001|Period III|Lost to follow up|1|||
170712541|NCT00359762|616954940|FG002|Period III|Lost to follow up|1|||
170712542|NCT00359762|616954941|FG003|Period III|Lost to follow up|2|||
170712543|NCT00359762|616954942|FG004|Period III|Lost to follow up|0|||
170712544|NCT00359762|616954938|FG000|Period III|Entry Criteria Not Met|0|||
170712545|NCT00359762|616954939|FG001|Period III|Entry Criteria Not Met|1|||
170712546|NCT00359762|616954940|FG002|Period III|Entry Criteria Not Met|0|||
170712547|NCT00359762|616954941|FG003|Period III|Entry Criteria Not Met|1|||
170712548|NCT00359762|616954942|FG004|Period III|Entry Criteria Not Met|0|||
170712549|NCT00359762|616954938|FG000|Period III|Subject Decision|0|||
170712550|NCT00359762|616954939|FG001|Period III|Subject Decision|7|||
170712551|NCT00359762|616954940|FG002|Period III|Subject Decision|8|||
170712552|NCT00359762|616954941|FG003|Period III|Subject Decision|20|||
170712553|NCT00359762|616954942|FG004|Period III|Subject Decision|0|||
170712554|NCT00803023|616954947|FG000|Overall Study|Adverse Event|5|||
170712555|NCT00803023|616954948|FG001|Overall Study|Adverse Event|4|||
170712556|NCT00803023|616954949|FG002|Overall Study|Adverse Event|8|||
170712557|NCT00803023|616954950|FG003|Overall Study|Adverse Event|6|||
170712558|NCT00803023|616954947|FG000|Overall Study|Withdrawal by Subject|0|||
170712559|NCT00803023|616954948|FG001|Overall Study|Withdrawal by Subject|2|||
170712560|NCT00803023|616954949|FG002|Overall Study|Withdrawal by Subject|0|||
170712561|NCT00803023|616954950|FG003|Overall Study|Withdrawal by Subject|0|||
170712562|NCT00803023|616954947|FG000|Overall Study|Lost to Follow-up|0|||
170712563|NCT00803023|616954948|FG001|Overall Study|Lost to Follow-up|1|||
170712564|NCT00803023|616954949|FG002|Overall Study|Lost to Follow-up|2|||
170712565|NCT00803023|616954950|FG003|Overall Study|Lost to Follow-up|1|||
170712566|NCT00803023|616954947|FG000|Overall Study|Lack of Efficacy|0|||
170712567|NCT00803023|616954948|FG001|Overall Study|Lack of Efficacy|1|||
170712568|NCT00803023|616954949|FG002|Overall Study|Lack of Efficacy|1|||
170712569|NCT00803023|616954950|FG003|Overall Study|Lack of Efficacy|1|||
170712570|NCT01542528|616954951|FG000|Overall Study|Lost to Follow-up|2|||
170712571|NCT01542528|616954952|FG001|Overall Study|Lost to Follow-up|1|||
170712572|NCT01542528|616954951|FG000|Overall Study|Physician Decision|1|||
170712573|NCT01542528|616954952|FG001|Overall Study|Physician Decision|0|||
170712574|NCT01542528|616954951|FG000|Overall Study|Withdrawal by Subject|9|||
170712575|NCT01542528|616954952|FG001|Overall Study|Withdrawal by Subject|6|||
170712576|NCT05282004|616954953|FG000|Overall Study|Adverse Event|2|||
170712577|NCT04808609|616954954|FG000|Overall Study|Lost to Follow-up|0|||
170712578|NCT04808609|616954955|FG001|Overall Study|Lost to Follow-up|2|||
170712579|NCT04808609|616954954|FG000|Overall Study|Administrative Withdrawal|0|||
170712580|NCT04808609|616954955|FG001|Overall Study|Administrative Withdrawal|1|||
170712581|NCT00562159|616954956|FG000|Overall Study|Adverse Event|11|||
170712582|NCT00562159|616954957|FG001|Overall Study|Adverse Event|8|||
170712583|NCT00562159|616954956|FG000|Overall Study|Lost to Follow-up|5|||
170712584|NCT00562159|616954957|FG001|Overall Study|Lost to Follow-up|4|||
170712585|NCT00562159|616954956|FG000|Overall Study|Withdrawal by Subject|9|||
170712586|NCT00562159|616954957|FG001|Overall Study|Withdrawal by Subject|8|||
170712587|NCT00562159|616954956|FG000|Overall Study|Protocol Violation|12|||
170712588|NCT00562159|616954957|FG001|Overall Study|Protocol Violation|12|||
170712589|NCT00562159|616954956|FG000|Overall Study|Did not meet protocol eligibility|1|||
170712590|NCT00562159|616954957|FG001|Overall Study|Did not meet protocol eligibility|1|||
170712591|NCT01762761|616954967|FG000|Overall Study|Adverse Event|15|||
170712592|NCT01762761|616954968|FG001|Overall Study|Adverse Event|17|||
170712593|NCT01762761|616954967|FG000|Overall Study|Lack of Efficacy|9|||
170712594|NCT01762761|616954968|FG001|Overall Study|Lack of Efficacy|25|||
170712595|NCT01762761|616954967|FG000|Overall Study|Protocol Violation|1|||
170712596|NCT01762761|616954968|FG001|Overall Study|Protocol Violation|1|||
170712597|NCT01762761|616954967|FG000|Overall Study|Study closed/terminated|0|||
170712598|NCT01762761|616954968|FG001|Overall Study|Study closed/terminated|2|||
170712599|NCT01762761|616954967|FG000|Overall Study|Lost to Follow-up|3|||
170712600|NCT01762761|616954968|FG001|Overall Study|Lost to Follow-up|6|||
170712601|NCT01762761|616954967|FG000|Overall Study|Physician Decision|4|||
170712602|NCT01762761|616954968|FG001|Overall Study|Physician Decision|6|||
170712603|NCT01762761|616954967|FG000|Overall Study|Withdrawal by Subject|7|||
170712604|NCT01762761|616954968|FG001|Overall Study|Withdrawal by Subject|8|||
170712605|NCT01992536|616954969|FG000|Overall Study|Administrative Reason|0|||
170712606|NCT01992536|616954970|FG001|Overall Study|Administrative Reason|0|||
170712607|NCT01992536|616954971|FG002|Overall Study|Administrative Reason|0|||
170712608|NCT01992536|616954972|FG003|Overall Study|Administrative Reason|0|||
170712609|NCT01992536|616954973|FG004|Overall Study|Administrative Reason|0|||
170712610|NCT01992536|616954974|FG005|Overall Study|Administrative Reason|0|||
170712611|NCT01992536|616954975|FG006|Overall Study|Administrative Reason|7|||
170712612|NCT01992536|616954976|FG007|Overall Study|Administrative Reason|0|||
170712613|NCT01992536|616954977|FG008|Overall Study|Administrative Reason|0|||
170712614|NCT01992536|616954978|FG009|Overall Study|Administrative Reason|0|||
170712615|NCT01992536|616954969|FG000|Overall Study|Lost to Follow-up|4|||
170712616|NCT01992536|616954970|FG001|Overall Study|Lost to Follow-up|2|||
170712617|NCT01992536|616954971|FG002|Overall Study|Lost to Follow-up|1|||
170712618|NCT01992536|616954972|FG003|Overall Study|Lost to Follow-up|0|||
170712619|NCT01992536|616954973|FG004|Overall Study|Lost to Follow-up|0|||
170712620|NCT01992536|616954974|FG005|Overall Study|Lost to Follow-up|1|||
170712621|NCT01992536|616954975|FG006|Overall Study|Lost to Follow-up|0|||
170712622|NCT01992536|616954976|FG007|Overall Study|Lost to Follow-up|0|||
170712623|NCT01992536|616954977|FG008|Overall Study|Lost to Follow-up|1|||
170712624|NCT01992536|616954978|FG009|Overall Study|Lost to Follow-up|1|||
170712625|NCT01992536|616954969|FG000|Overall Study|Withdrawal by Subject|0|||
170712626|NCT01992536|616954970|FG001|Overall Study|Withdrawal by Subject|1|||
170712627|NCT01992536|616954971|FG002|Overall Study|Withdrawal by Subject|0|||
170712628|NCT01992536|616954972|FG003|Overall Study|Withdrawal by Subject|2|||
170712629|NCT01992536|616954973|FG004|Overall Study|Withdrawal by Subject|0|||
170712630|NCT01992536|616954974|FG005|Overall Study|Withdrawal by Subject|0|||
170712631|NCT01992536|616954975|FG006|Overall Study|Withdrawal by Subject|0|||
170712632|NCT01992536|616954976|FG007|Overall Study|Withdrawal by Subject|0|||
170712633|NCT01992536|616954977|FG008|Overall Study|Withdrawal by Subject|0|||
170712634|NCT01992536|616954978|FG009|Overall Study|Withdrawal by Subject|0|||
170712635|NCT01038921|616954979|FG000|Overall Study|Withdrawal by Subject|1|||
170712636|NCT01038921|616954980|FG001|Overall Study|Withdrawal by Subject|0|||
170712637|NCT01038921|616954979|FG000|Overall Study|Physician Decision|1|||
170712638|NCT01038921|616954980|FG001|Overall Study|Physician Decision|0|||
170712639|NCT02352493|616954982|FG000|Overall Study|Pregnancy|0|||
170712640|NCT02352493|616954983|FG001|Overall Study|Pregnancy|0|||
170712641|NCT02352493|616954984|FG002|Overall Study|Pregnancy|0|||
170712642|NCT02352493|616954985|FG003|Overall Study|Pregnancy|0|||
170712643|NCT02352493|616954986|FG004|Overall Study|Pregnancy|0|||
170712644|NCT02352493|616954987|FG005|Overall Study|Pregnancy|0|||
170712645|NCT02352493|616954988|FG006|Overall Study|Pregnancy|1|||
170712646|NCT02352493|616954989|FG007|Overall Study|Pregnancy|0|||
170712647|NCT02352493|616954990|FG008|Overall Study|Pregnancy|1|||
170712648|NCT02352493|616954991|FG009|Overall Study|Pregnancy|0|||
170712649|NCT02352493|616954992|FG010|Overall Study|Pregnancy|0|||
170712650|NCT02352493|616954993|FG011|Overall Study|Pregnancy|0|||
170712651|NCT02352493|616954994|FG012|Overall Study|Pregnancy|0|||
170712652|NCT02352493|616954995|FG013|Overall Study|Pregnancy|0|||
170712653|NCT02352493|616954996|FG014|Overall Study|Pregnancy|0|||
170712654|NCT02352493|616954997|FG015|Overall Study|Pregnancy|0|||
170712655|NCT02352493|616954998|FG016|Overall Study|Pregnancy|0|||
170712656|NCT02352493|616954999|FG017|Overall Study|Pregnancy|0|||
170712657|NCT02352493|616954982|FG000|Overall Study|Withdrawal by Subject|0|||
170712658|NCT02352493|616954983|FG001|Overall Study|Withdrawal by Subject|0|||
170712659|NCT02352493|616954984|FG002|Overall Study|Withdrawal by Subject|0|||
170712660|NCT02352493|616954985|FG003|Overall Study|Withdrawal by Subject|0|||
170712661|NCT02352493|616954986|FG004|Overall Study|Withdrawal by Subject|0|||
170712662|NCT02352493|616954987|FG005|Overall Study|Withdrawal by Subject|0|||
170712663|NCT02352493|616954988|FG006|Overall Study|Withdrawal by Subject|0|||
170712664|NCT02352493|616954989|FG007|Overall Study|Withdrawal by Subject|0|||
170712665|NCT02352493|616954990|FG008|Overall Study|Withdrawal by Subject|1|||
170712666|NCT02352493|616954991|FG009|Overall Study|Withdrawal by Subject|0|||
170712667|NCT02352493|616954992|FG010|Overall Study|Withdrawal by Subject|0|||
170712668|NCT02352493|616954993|FG011|Overall Study|Withdrawal by Subject|0|||
170712669|NCT02352493|616954994|FG012|Overall Study|Withdrawal by Subject|0|||
170712670|NCT02352493|616954995|FG013|Overall Study|Withdrawal by Subject|0|||
170712671|NCT02352493|616954996|FG014|Overall Study|Withdrawal by Subject|1|||
170712672|NCT02352493|616954997|FG015|Overall Study|Withdrawal by Subject|0|||
170712673|NCT02352493|616954998|FG016|Overall Study|Withdrawal by Subject|0|||
170712674|NCT02352493|616954999|FG017|Overall Study|Withdrawal by Subject|0|||
170828107|NCT00937521|617380261|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
170828108|NCT00937521|617380254|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
170828109|NCT00937521|617380255|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
170828110|NCT00937521|617380256|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
170828111|NCT00937521|617380257|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
170828112|NCT00937521|617380258|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
170828113|NCT00937521|617380259|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
170828114|NCT00937521|617380260|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
170828115|NCT00937521|617380261|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
170828116|NCT00937521|617380254|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
170828117|NCT00937521|617380255|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
170828118|NCT00937521|617380256|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
170828119|NCT00937521|617380257|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
170828120|NCT00937521|617380258|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
170828121|NCT00937521|617380259|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
170828122|NCT00937521|617380260|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
170828123|NCT00937521|617380261|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
170828124|NCT00937521|617380254|FG000|Booster Phase|Adverse Event|0|||
170828125|NCT00937521|617380255|FG001|Booster Phase|Adverse Event|0|||
170828126|NCT00937521|617380256|FG002|Booster Phase|Adverse Event|0|||
170828127|NCT00937521|617380257|FG003|Booster Phase|Adverse Event|0|||
170828128|NCT00937521|617380258|FG004|Booster Phase|Adverse Event|0|||
170828129|NCT00937521|617380259|FG005|Booster Phase|Adverse Event|0|||
170828130|NCT00937521|617380260|FG006|Booster Phase|Adverse Event|1|||
170828131|NCT00937521|617380261|FG007|Booster Phase|Adverse Event|0|||
170828132|NCT00937521|617380254|FG000|Booster Phase|Withdrawal by Subject|1|||
170828133|NCT00937521|617380255|FG001|Booster Phase|Withdrawal by Subject|0|||
170828134|NCT00937521|617380256|FG002|Booster Phase|Withdrawal by Subject|0|||
170828135|NCT00937521|617380257|FG003|Booster Phase|Withdrawal by Subject|1|||
170828136|NCT00937521|617380258|FG004|Booster Phase|Withdrawal by Subject|0|||
170828137|NCT00937521|617380259|FG005|Booster Phase|Withdrawal by Subject|0|||
170828138|NCT00937521|617380260|FG006|Booster Phase|Withdrawal by Subject|0|||
170828139|NCT00937521|617380261|FG007|Booster Phase|Withdrawal by Subject|2|||
170828140|NCT00937521|617380254|FG000|Booster Phase|Lost to Follow-up|2|||
170828141|NCT00937521|617380255|FG001|Booster Phase|Lost to Follow-up|2|||
170828142|NCT00937521|617380256|FG002|Booster Phase|Lost to Follow-up|4|||
170828143|NCT00937521|617380257|FG003|Booster Phase|Lost to Follow-up|2|||
170828144|NCT00937521|617380258|FG004|Booster Phase|Lost to Follow-up|4|||
170828145|NCT00937521|617380259|FG005|Booster Phase|Lost to Follow-up|4|||
170828146|NCT00937521|617380260|FG006|Booster Phase|Lost to Follow-up|3|||
170828147|NCT00937521|617380261|FG007|Booster Phase|Lost to Follow-up|0|||
170828148|NCT00937521|617380254|FG000|Booster Phase|Administrative Reason|0|||
170828149|NCT00937521|617380255|FG001|Booster Phase|Administrative Reason|0|||
170828150|NCT00937521|617380256|FG002|Booster Phase|Administrative Reason|1|||
170828151|NCT00937521|617380257|FG003|Booster Phase|Administrative Reason|0|||
170828152|NCT00937521|617380258|FG004|Booster Phase|Administrative Reason|1|||
170828153|NCT00937521|617380259|FG005|Booster Phase|Administrative Reason|1|||
170828154|NCT00937521|617380260|FG006|Booster Phase|Administrative Reason|0|||
170828155|NCT00937521|617380261|FG007|Booster Phase|Administrative Reason|0|||
170828156|NCT00937521|617380254|FG000|Booster Phase|Protocol Deviation|0|||
170828157|NCT00937521|617380255|FG001|Booster Phase|Protocol Deviation|0|||
170828158|NCT00937521|617380256|FG002|Booster Phase|Protocol Deviation|0|||
170828159|NCT00937521|617380257|FG003|Booster Phase|Protocol Deviation|0|||
170828160|NCT00937521|617380258|FG004|Booster Phase|Protocol Deviation|0|||
170828161|NCT00937521|617380259|FG005|Booster Phase|Protocol Deviation|0|||
170828162|NCT00937521|617380260|FG006|Booster Phase|Protocol Deviation|1|||
170828163|NCT00937521|617380261|FG007|Booster Phase|Protocol Deviation|0|||
170712675|NCT02352493|616954982|FG000|Overall Study|Lost to Follow-up|0|||
170712676|NCT02352493|616954983|FG001|Overall Study|Lost to Follow-up|0|||
170712677|NCT02352493|616954984|FG002|Overall Study|Lost to Follow-up|0|||
170712678|NCT02352493|616954985|FG003|Overall Study|Lost to Follow-up|0|||
170712679|NCT02352493|616954986|FG004|Overall Study|Lost to Follow-up|0|||
170712680|NCT02352493|616954987|FG005|Overall Study|Lost to Follow-up|0|||
170712681|NCT02352493|616954988|FG006|Overall Study|Lost to Follow-up|0|||
170712682|NCT02352493|616954989|FG007|Overall Study|Lost to Follow-up|0|||
170712683|NCT02352493|616954990|FG008|Overall Study|Lost to Follow-up|0|||
170712684|NCT02352493|616954991|FG009|Overall Study|Lost to Follow-up|1|||
170712685|NCT02352493|616954992|FG010|Overall Study|Lost to Follow-up|0|||
170712686|NCT02352493|616954993|FG011|Overall Study|Lost to Follow-up|0|||
170712687|NCT02352493|616954994|FG012|Overall Study|Lost to Follow-up|1|||
170712688|NCT02352493|616954995|FG013|Overall Study|Lost to Follow-up|2|||
170712689|NCT02352493|616954996|FG014|Overall Study|Lost to Follow-up|0|||
170712690|NCT02352493|616954997|FG015|Overall Study|Lost to Follow-up|0|||
170712691|NCT02352493|616954998|FG016|Overall Study|Lost to Follow-up|0|||
170712692|NCT02352493|616954999|FG017|Overall Study|Lost to Follow-up|0|||
170712693|NCT02519504|616955000|FG000|Overall Study|Protocol Violation|6|||
170712694|NCT02519504|616955001|FG001|Overall Study|Protocol Violation|5|||
170712695|NCT02519504|616955000|FG000|Overall Study|Ineligible for direct testing|12|||
170712696|NCT02519504|616955001|FG001|Overall Study|Ineligible for direct testing|12|||
170712697|NCT02519504|616955000|FG000|Overall Study|Did not participate in direct testing|95|||
170712698|NCT02519504|616955001|FG001|Overall Study|Did not participate in direct testing|86|||
170712699|NCT02317575|616955002|FG000|Period 1|Difficulty with venous cannulation|0|||
170712700|NCT02317575|616955003|FG001|Period 1|Difficulty with venous cannulation|1|||
170712701|NCT02317575|616955004|FG002|Period 1|Difficulty with venous cannulation|0|||
170712702|NCT02317575|616955005|FG003|Period 1|Difficulty with venous cannulation|0|||
170712703|NCT02317575|616955006|FG004|Period 1|Difficulty with venous cannulation|0|||
170712704|NCT02317575|616955002|FG000|Period 1|Withdrawal by Subject|1|||
170712705|NCT02317575|616955003|FG001|Period 1|Withdrawal by Subject|0|||
170712706|NCT02317575|616955004|FG002|Period 1|Withdrawal by Subject|0|||
170712707|NCT02317575|616955005|FG003|Period 1|Withdrawal by Subject|0|||
170712708|NCT02317575|616955006|FG004|Period 1|Withdrawal by Subject|0|||
170712709|NCT02548962|616955007|FG000|Overall Study|Withdrawal by Subject|1|||
170712710|NCT02548962|616955008|FG001|Overall Study|Withdrawal by Subject|0|||
170712711|NCT03936244|616955012|FG000|Overall Study|Lost to Follow-up|5|||
170712712|NCT03936244|616955013|FG001|Overall Study|Lost to Follow-up|1|||
170712713|NCT03936244|616955012|FG000|Overall Study|Physician Decision|7|||
170712714|NCT03936244|616955013|FG001|Overall Study|Physician Decision|3|||
170712715|NCT00403546|616955017|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
170712716|NCT00403546|616955018|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
170712717|NCT00403546|616955019|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
170712718|NCT00403546|616955017|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
170712719|NCT00403546|616955018|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
170712720|NCT00403546|616955019|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
170712721|NCT00403546|616955017|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
170712722|NCT00403546|616955018|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
170712723|NCT00403546|616955019|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
170712724|NCT00403546|616955017|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
170712725|NCT00403546|616955018|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
170712726|NCT00403546|616955019|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
170712727|NCT00403546|616955017|FG000|Screening Phase|Screening Failure|22|||
170712728|NCT00403546|616955018|FG001|Screening Phase|Screening Failure|0|||
170712729|NCT00403546|616955019|FG002|Screening Phase|Screening Failure|0|||
170712730|NCT00403546|616955017|FG000|Screening Phase|Adverse Event|1|||
170712731|NCT00403546|616955018|FG001|Screening Phase|Adverse Event|0|||
170712732|NCT00403546|616955019|FG002|Screening Phase|Adverse Event|0|||
170712733|NCT00403546|616955017|FG000|Screening Phase|Terminated Prior to Randomization|5|||
170712734|NCT00403546|616955018|FG001|Screening Phase|Terminated Prior to Randomization|0|||
170712735|NCT00403546|616955019|FG002|Screening Phase|Terminated Prior to Randomization|0|||
170712736|NCT00403546|616955017|FG000|Randomized Trial|Early Terminations|0|||
170712737|NCT00403546|616955018|FG001|Randomized Trial|Early Terminations|17|||
170712738|NCT00403546|616955019|FG002|Randomized Trial|Early Terminations|16|||
170712739|NCT02480621|616955025|FG000|Randomization|Withdrawal by Subject|1|||
170712740|NCT02480621|616955026|FG001|Randomization|Withdrawal by Subject|0|||
170712741|NCT02480621|616955025|FG000|Randomization|Surgeon did not give intervention|0|||
170712742|NCT02480621|616955026|FG001|Randomization|Surgeon did not give intervention|1|||
170712743|NCT02480621|616955025|FG000|Follow Up|Lost to Follow-up|4|||
170712744|NCT02480621|616955026|FG001|Follow Up|Lost to Follow-up|2|||
170712745|NCT05061446|616955027|FG000|Overall Study|Adverse Event|2|||
170712746|NCT05061446|616955028|FG001|Overall Study|Adverse Event|0|||
170712747|NCT05061446|616955029|FG002|Overall Study|Adverse Event|0|||
170712748|NCT05061446|616955027|FG000|Overall Study|Participant no longer available due to personal reason|0|||
170712749|NCT05061446|616955028|FG001|Overall Study|Participant no longer available due to personal reason|1|||
170712750|NCT05061446|616955029|FG002|Overall Study|Participant no longer available due to personal reason|0|||
170712751|NCT04111497|616955030|FG000|Overall Study|relapse of primary disease|1|||
170712752|NCT04111497|616955030|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
170712753|NCT00684424|616955033|FG000|Overall Study|Adverse Event|1|||
170712754|NCT00684424|616955033|FG000|Overall Study|Lost to Follow-up|2|||
170712755|NCT00684424|616955033|FG000|Overall Study|Other|2|||
170712756|NCT05857527|616955034|FG000|Overall Study|Withdrawal by Subject|0|||
170712757|NCT05857527|616955035|FG001|Overall Study|Withdrawal by Subject|1|||
170712758|NCT01592708|616955036|FG000|Overall Study|Protocol Violation|3|||
170712759|NCT01592708|616955037|FG001|Overall Study|Protocol Violation|0|||
170712760|NCT01723904|616955040|FG000|Overall Study|Noncompliant|3|||
170712761|NCT01723904|616955040|FG000|Overall Study|Adverse Event|5|||
170712762|NCT01723904|616955040|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
170712763|NCT02610140|616955049|FG000|Randomization and Treatment Period|Radiological progression|23|||
170712764|NCT02610140|616955050|FG001|Randomization and Treatment Period|Radiological progression|15|||
170712765|NCT02610140|616955049|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
170712766|NCT02610140|616955050|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
170712767|NCT02610140|616955049|FG000|Randomization and Treatment Period|Protocol Violation|1|||
170712768|NCT02610140|616955050|FG001|Randomization and Treatment Period|Protocol Violation|0|||
170712769|NCT02610140|616955049|FG000|Randomization and Treatment Period|Physician Decision|0|||
170712770|NCT02610140|616955050|FG001|Randomization and Treatment Period|Physician Decision|1|||
170712771|NCT02610140|616955049|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
170712772|NCT02610140|616955050|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
170712773|NCT02610140|616955049|FG000|Randomization and Treatment Period|Death|7|||
170712774|NCT02610140|616955050|FG001|Randomization and Treatment Period|Death|1|||
170712775|NCT02610140|616955049|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
170712776|NCT02610140|616955050|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
170712777|NCT02610140|616955049|FG000|Randomization and Treatment Period|Adverse Event|44|||
170712778|NCT02610140|616955050|FG001|Randomization and Treatment Period|Adverse Event|13|||
170712779|NCT02610140|616955049|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
170712780|NCT02610140|616955050|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
170712781|NCT02610140|616955049|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
170712782|NCT02610140|616955050|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
170712783|NCT02610140|616955049|FG000|Randomization and Treatment Period|Not treated|3|||
170712784|NCT02610140|616955050|FG001|Randomization and Treatment Period|Not treated|10|||
170712785|NCT02610140|616955049|FG000|Safety Follow-up|Other|0|||
170712786|NCT02610140|616955050|FG001|Safety Follow-up|Other|2|||
170712787|NCT02610140|616955049|FG000|Safety Follow-up|Lost to Follow-up|1|||
170712788|NCT02610140|616955050|FG001|Safety Follow-up|Lost to Follow-up|0|||
170712789|NCT02610140|616955049|FG000|Safety Follow-up|No follow-up|5|||
170712790|NCT02610140|616955050|FG001|Safety Follow-up|No follow-up|3|||
170712791|NCT02610140|616955049|FG000|Safety Follow-up|Death|12|||
170712792|NCT02610140|616955050|FG001|Safety Follow-up|Death|2|||
170712793|NCT02610140|616955049|FG000|Safety Follow-up|Deterioration of general conditions|15|||
170712794|NCT02610140|616955050|FG001|Safety Follow-up|Deterioration of general conditions|5|||
170712795|NCT02610140|616955049|FG000|Safety Follow-up|Withdrawal by Subject|12|||
170712796|NCT02610140|616955050|FG001|Safety Follow-up|Withdrawal by Subject|12|||
170712797|NCT02610140|616955049|FG000|Active Follow-up|Progressive disease - radiological|30|||
170712798|NCT02610140|616955050|FG001|Active Follow-up|Progressive disease - radiological|22|||
170712799|NCT02610140|616955049|FG000|Active Follow-up|Death|8|||
170712800|NCT02610140|616955050|FG001|Active Follow-up|Death|1|||
170712801|NCT02610140|616955049|FG000|Active Follow-up|Withdrawal by Subject|4|||
170712802|NCT02610140|616955050|FG001|Active Follow-up|Withdrawal by Subject|0|||
170712803|NCT02610140|616955049|FG000|Active Follow-up|Progressive disease - clinical|1|||
170712804|NCT02610140|616955050|FG001|Active Follow-up|Progressive disease - clinical|2|||
170712805|NCT02610140|616955049|FG000|Active Follow-up|Deterioration of general conditions|1|||
170712806|NCT02610140|616955050|FG001|Active Follow-up|Deterioration of general conditions|0|||
170712807|NCT02610140|616955049|FG000|Active Follow-up|Ongoing but not completed|4|||
170712808|NCT02610140|616955050|FG001|Active Follow-up|Ongoing but not completed|1|||
170712809|NCT02610140|616955049|FG000|Long-term Follow-up|Death|86|||
170712810|NCT02610140|616955050|FG001|Long-term Follow-up|Death|44|||
170712811|NCT02610140|616955049|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
170712812|NCT02610140|616955050|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
170712813|NCT02610140|616955049|FG000|Long-term Follow-up|Lost to Follow-up|1|||
170712814|NCT02610140|616955050|FG001|Long-term Follow-up|Lost to Follow-up|2|||
170712815|NCT02610140|616955049|FG000|Long-term Follow-up|Ongoing but not completed|30|||
170712816|NCT02610140|616955050|FG001|Long-term Follow-up|Ongoing but not completed|17|||
170712817|NCT00887341|616955051|FG000|Overall Study|Refused treatment|1|||
170712818|NCT00887341|616955052|FG001|Overall Study|Refused treatment|0|||
170712819|NCT00887341|616955051|FG000|Overall Study|Withdrawal by Subject|1|||
170712820|NCT00887341|616955052|FG001|Overall Study|Withdrawal by Subject|1|||
170712821|NCT00887341|616955051|FG000|Overall Study|Adverse Event|0|||
170712822|NCT00887341|616955052|FG001|Overall Study|Adverse Event|1|||
170712823|NCT00887341|616955051|FG000|Overall Study|Lost to Follow-up|0|||
170712824|NCT00887341|616955052|FG001|Overall Study|Lost to Follow-up|1|||
170712825|NCT01591681|616955055|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
170712826|NCT01591681|616955055|FG000|Overall Study|Failed to use system during run-in|1|||
170712827|NCT01440946|616955056|FG000|Overall Study|Lost to Follow-up|1|||
170712828|NCT01440946|616955057|FG001|Overall Study|Lost to Follow-up|1|||
170712829|NCT01440946|616955056|FG000|Overall Study|Physician Decision|1|||
170712830|NCT01440946|616955057|FG001|Overall Study|Physician Decision|0|||
170712831|NCT01312961|616955062|FG000|Overall Study|Adverse Event|3|||
170712832|NCT01312961|616955063|FG001|Overall Study|Adverse Event|3|||
170712833|NCT01312961|616955062|FG000|Overall Study|Lack of Efficacy|11|||
170712834|NCT01312961|616955063|FG001|Overall Study|Lack of Efficacy|1|||
170712835|NCT01312961|616955062|FG000|Overall Study|Poor compliance to protocol|1|||
170712836|NCT01312961|616955063|FG001|Overall Study|Poor compliance to protocol|0|||
170712837|NCT01312961|616955062|FG000|Overall Study|Other than specified above|2|||
170712838|NCT01312961|616955063|FG001|Overall Study|Other than specified above|3|||
170712839|NCT05402995|616955064|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
170712840|NCT05402995|616955065|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
170712841|NCT05402995|616955066|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
170712842|NCT05402995|616955067|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
170712843|NCT02774681|616955068|FG000|Treatment on Study|Progressive Disease|7|||
170712844|NCT02774681|616955068|FG000|Follow-Up for 3 Years|Death|11|||
170712845|NCT02774681|616955068|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
170712846|NCT02460198|616955072|FG000|Overall Study|Adverse Event|1|||
170712847|NCT02460198|616955073|FG001|Overall Study|Adverse Event|3|||
170712848|NCT02460198|616955072|FG000|Overall Study|Death|36|||
170712849|NCT02460198|616955073|FG001|Overall Study|Death|28|||
170712850|NCT02460198|616955072|FG000|Overall Study|Lost to Follow-up|1|||
170712851|NCT02460198|616955073|FG001|Overall Study|Lost to Follow-up|1|||
170712852|NCT02460198|616955072|FG000|Overall Study|Transferred to Extension Study|15|||
170712853|NCT02460198|616955073|FG001|Overall Study|Transferred to Extension Study|15|||
170712854|NCT02460198|616955072|FG000|Overall Study|Withdrawal by Subject|2|||
170712855|NCT02460198|616955073|FG001|Overall Study|Withdrawal by Subject|4|||
170712856|NCT02460198|616955072|FG000|Overall Study|Site Terminated By Sponsor|0|||
170712857|NCT02460198|616955073|FG001|Overall Study|Site Terminated By Sponsor|1|||
170712858|NCT02460198|616955072|FG000|Overall Study|Did Not Continue on Extension Study|6|||
170712859|NCT02460198|616955073|FG001|Overall Study|Did Not Continue on Extension Study|11|||
170712860|NCT00813761|616955074|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
170712861|NCT00813761|616955075|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
170712862|NCT00813761|616955076|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
170712863|NCT00813761|616955077|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
170712864|NCT00813761|616955074|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
170712865|NCT00813761|616955075|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
170712866|NCT00813761|616955076|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
170712867|NCT00813761|616955077|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
170712868|NCT00813761|616955074|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
170712869|NCT00813761|616955075|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
170712870|NCT00813761|616955076|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
170712871|NCT00813761|616955077|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
170712872|NCT00813761|616955074|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
170712873|NCT00813761|616955075|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
170712874|NCT00813761|616955076|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
170712875|NCT00813761|616955077|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
170712876|NCT00813761|616955074|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
170712877|NCT00813761|616955075|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
170712878|NCT00813761|616955076|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
170712879|NCT00813761|616955077|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
170712880|NCT00813761|616955074|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
170712881|NCT00813761|616955075|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
170712882|NCT00813761|616955076|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
170712883|NCT00813761|616955077|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
170712884|NCT00813761|616955074|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
170712885|NCT00813761|616955075|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
170712886|NCT00813761|616955076|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
170712887|NCT00813761|616955077|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
170712888|NCT00813761|616955074|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
170712889|NCT00813761|616955075|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
170712890|NCT00813761|616955076|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
170712891|NCT00813761|616955077|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
170712892|NCT00813761|616955074|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
170712893|NCT00813761|616955075|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
170712894|NCT00813761|616955076|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
170712895|NCT00813761|616955077|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
170712896|NCT00813761|616955074|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
170712897|NCT00813761|616955075|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
170712898|NCT00813761|616955076|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
170712899|NCT00813761|616955077|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
170712900|NCT00813761|616955074|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
170712901|NCT00813761|616955075|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
170712902|NCT00813761|616955076|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
170712903|NCT00813761|616955077|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
170712904|NCT00813761|616955074|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
170712905|NCT00813761|616955075|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
170712906|NCT00813761|616955076|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
170712907|NCT00813761|616955077|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
170712908|NCT02047604|616955080|FG000|Overall Study|Withdrawal by Subject|0|||
170712909|NCT02047604|616955081|FG001|Overall Study|Withdrawal by Subject|0|||
170712910|NCT02047604|616955082|FG002|Overall Study|Withdrawal by Subject|0|||
170712911|NCT02047604|616955083|FG003|Overall Study|Withdrawal by Subject|0|||
170712912|NCT02047604|616955084|FG004|Overall Study|Withdrawal by Subject|1|||
170712913|NCT02047604|616955085|FG005|Overall Study|Withdrawal by Subject|1|||
170712914|NCT03333486|616955088|FG000|Overall Study|Withdrawal by Subject|1|||
170712915|NCT03333486|616955088|FG000|Overall Study|Lost to Follow-up|1|||
170712916|NCT01755416|616955091|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
170712917|NCT01755416|616955092|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
170712918|NCT06748040|616955096|FG000|Overall Study|Death|3|||
170712919|NCT06748040|616955097|FG001|Overall Study|Death|4|||
170712920|NCT06748040|616955096|FG000|Overall Study|Lost to Follow-up|134|||
170712921|NCT06748040|616955097|FG001|Overall Study|Lost to Follow-up|132|||
170712922|NCT06748040|616955096|FG000|Overall Study|Withdrawal by Subject|3|||
170712923|NCT06748040|616955097|FG001|Overall Study|Withdrawal by Subject|5|||
170712924|NCT01539291|616956759|FG000|Study GS-US-312-0116|Adverse Event|9|||
170712925|NCT01539291|616956760|FG001|Study GS-US-312-0116|Adverse Event|0|||
170712926|NCT01539291|616956761|FG002|Study GS-US-312-0116|Adverse Event|0|||
170712927|NCT01539291|616956762|FG003|Study GS-US-312-0116|Adverse Event|0|||
170712928|NCT01539291|616956759|FG000|Study GS-US-312-0116|Physician Decision|1|||
170712929|NCT01539291|616956760|FG001|Study GS-US-312-0116|Physician Decision|0|||
170712930|NCT01539291|616956761|FG002|Study GS-US-312-0116|Physician Decision|0|||
170712931|NCT01539291|616956762|FG003|Study GS-US-312-0116|Physician Decision|0|||
170712932|NCT01539291|616956759|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
170712933|NCT01539291|616956760|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
170712934|NCT01539291|616956761|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
170712935|NCT01539291|616956762|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
170712936|NCT01539291|616956759|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
170712937|NCT01539291|616956760|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
170712938|NCT01539291|616956761|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
170712939|NCT01539291|616956762|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
170712940|NCT01539291|616956759|FG000|Study GS-US-312-0116|Other|1|||
170712941|NCT01539291|616956760|FG001|Study GS-US-312-0116|Other|0|||
170712942|NCT01539291|616956761|FG002|Study GS-US-312-0116|Other|0|||
170712943|NCT01539291|616956762|FG003|Study GS-US-312-0116|Other|0|||
170712944|NCT01539291|616956759|FG000|Study GS-US-312-0117|Adverse Event|22|||
170712945|NCT01539291|616956760|FG001|Study GS-US-312-0117|Adverse Event|1|||
170712946|NCT01539291|616956761|FG002|Study GS-US-312-0117|Adverse Event|9|||
170712947|NCT01539291|616956762|FG003|Study GS-US-312-0117|Adverse Event|12|||
170712948|NCT01539291|616956759|FG000|Study GS-US-312-0117|Physician Decision|9|||
170712949|NCT01539291|616956760|FG001|Study GS-US-312-0117|Physician Decision|0|||
170712950|NCT01539291|616956761|FG002|Study GS-US-312-0117|Physician Decision|6|||
170712951|NCT01539291|616956762|FG003|Study GS-US-312-0117|Physician Decision|4|||
170712952|NCT01539291|616956759|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
170712953|NCT01539291|616956760|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
170712954|NCT01539291|616956761|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
170712955|NCT01539291|616956762|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
170712956|NCT01539291|616956759|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
170712957|NCT01539291|616956760|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
170712958|NCT01539291|616956761|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
170712959|NCT01539291|616956762|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
170712960|NCT01539291|616956759|FG000|Study GS-US-312-0117|Other|2|||
170712961|NCT01539291|616956760|FG001|Study GS-US-312-0117|Other|1|||
170712962|NCT01539291|616956761|FG002|Study GS-US-312-0117|Other|1|||
170712963|NCT01539291|616956762|FG003|Study GS-US-312-0117|Other|1|||
170712964|NCT04450264|616956763|FG000|Overall Study|Incomplete survey|13|||
170712965|NCT04450264|616956764|FG001|Overall Study|Incomplete survey|19|||
170712966|NCT02239510|616956765|FG000|Overall Study|Lost to Follow-up|2|||
170712967|NCT02239510|616956766|FG001|Overall Study|Lost to Follow-up|1|||
170712968|NCT00074282|616956772|FG000|Step 1|Adverse Event|32|||
170712969|NCT00074282|616956773|FG001|Step 1|Adverse Event|0|||
170712970|NCT00074282|616956774|FG002|Step 1|Adverse Event|0|||
170712971|NCT00074282|616956772|FG000|Step 1|Death|6|||
170712972|NCT00074282|616956773|FG001|Step 1|Death|0|||
170712973|NCT00074282|616956774|FG002|Step 1|Death|0|||
170712974|NCT00074282|616956772|FG000|Step 1|Withdrawal by Subject|7|||
170712975|NCT00074282|616956773|FG001|Step 1|Withdrawal by Subject|0|||
170712976|NCT00074282|616956774|FG002|Step 1|Withdrawal by Subject|0|||
170712977|NCT00074282|616956772|FG000|Step 1|Disease progression|2|||
170712978|NCT00074282|616956773|FG001|Step 1|Disease progression|0|||
170712979|NCT00074282|616956774|FG002|Step 1|Disease progression|0|||
170712980|NCT00074282|616956772|FG000|Step 1|Alternative therapy|2|||
170712981|NCT00074282|616956773|FG001|Step 1|Alternative therapy|0|||
170712982|NCT00074282|616956774|FG002|Step 1|Alternative therapy|0|||
170712983|NCT00074282|616956772|FG000|Step 1|Other complicating disease|2|||
170712984|NCT00074282|616956773|FG001|Step 1|Other complicating disease|0|||
170712985|NCT00074282|616956774|FG002|Step 1|Other complicating disease|0|||
170712986|NCT00074282|616956772|FG000|Step 1|Physician Decision|1|||
170712987|NCT00074282|616956773|FG001|Step 1|Physician Decision|0|||
170712988|NCT00074282|616956774|FG002|Step 1|Physician Decision|0|||
170712989|NCT00074282|616956772|FG000|Step 1|Ineligible|4|||
170712990|NCT00074282|616956773|FG001|Step 1|Ineligible|0|||
170712991|NCT00074282|616956774|FG002|Step 1|Ineligible|0|||
170712992|NCT00074282|616956772|FG000|Step 1|Never started treatment|2|||
170712993|NCT00074282|616956773|FG001|Step 1|Never started treatment|0|||
170712994|NCT00074282|616956774|FG002|Step 1|Never started treatment|0|||
170712995|NCT00074282|616956772|FG000|Step 2|Adverse Event|0|||
170712996|NCT00074282|616956773|FG001|Step 2|Adverse Event|2|||
170712997|NCT00074282|616956774|FG002|Step 2|Adverse Event|12|||
170712998|NCT00074282|616956772|FG000|Step 2|Disease progression|0|||
170712999|NCT00074282|616956773|FG001|Step 2|Disease progression|0|||
170713000|NCT00074282|616956774|FG002|Step 2|Disease progression|5|||
170713001|NCT00074282|616956772|FG000|Step 2|Death|0|||
170713002|NCT00074282|616956773|FG001|Step 2|Death|0|||
170713003|NCT00074282|616956774|FG002|Step 2|Death|3|||
170713004|NCT00074282|616956772|FG000|Step 2|Withdrawal by Subject|0|||
170713005|NCT00074282|616956773|FG001|Step 2|Withdrawal by Subject|0|||
170713006|NCT00074282|616956774|FG002|Step 2|Withdrawal by Subject|2|||
170713007|NCT00074282|616956772|FG000|Step 2|Physician Decision|0|||
170713008|NCT00074282|616956773|FG001|Step 2|Physician Decision|0|||
170713009|NCT00074282|616956774|FG002|Step 2|Physician Decision|1|||
170713010|NCT00074282|616956772|FG000|Step 2|Ineligible|0|||
170713011|NCT00074282|616956773|FG001|Step 2|Ineligible|0|||
170713012|NCT00074282|616956774|FG002|Step 2|Ineligible|1|||
170713013|NCT05349617|616956778|FG000|Overall Study|Death|1|||
170713014|NCT05349617|616956779|FG001|Overall Study|Death|1|||
170713015|NCT05349617|616956778|FG000|Overall Study|Lost to Follow-up|3|||
170713016|NCT05349617|616956779|FG001|Overall Study|Lost to Follow-up|8|||
170713017|NCT05349617|616956778|FG000|Overall Study|Withdrawal by Subject|2|||
170713018|NCT05349617|616956779|FG001|Overall Study|Withdrawal by Subject|10|||
170713019|NCT02707055|616956780|FG000|Phase 1|Withdrawal by Subject|1|||
170713020|NCT02707055|616956781|FG001|Phase 1|Withdrawal by Subject|2|||
170713021|NCT02707055|616956780|FG000|Phase 1|Physician Decision|0|||
170713022|NCT02707055|616956781|FG001|Phase 1|Physician Decision|1|||
170713023|NCT02707055|616956780|FG000|Phase 2|Adverse Event|1|||
170713024|NCT02707055|616956781|FG001|Phase 2|Adverse Event|2|||
170713025|NCT01880424|616956782|FG000|Overall Study|Adverse Event|7|||
170713026|NCT01880424|616956783|FG001|Overall Study|Adverse Event|6|||
170713027|NCT01880424|616956782|FG000|Overall Study|Lack of Efficacy|1|||
170713028|NCT01880424|616956783|FG001|Overall Study|Lack of Efficacy|4|||
170713029|NCT01880424|616956782|FG000|Overall Study|Lost to Follow-up|3|||
170713030|NCT01880424|616956783|FG001|Overall Study|Lost to Follow-up|2|||
170713031|NCT01880424|616956782|FG000|Overall Study|Protocol Violation|11|||
170713032|NCT01880424|616956783|FG001|Overall Study|Protocol Violation|13|||
170713033|NCT01880424|616956782|FG000|Overall Study|Withdrawal by Subject|10|||
170713034|NCT01880424|616956783|FG001|Overall Study|Withdrawal by Subject|30|||
170713035|NCT01880424|616956782|FG000|Overall Study|Other|1|||
170713036|NCT01880424|616956783|FG001|Overall Study|Other|0|||
170713037|NCT00982020|616956786|FG000|Overall Study|Adverse Event|19|||
170713038|NCT00982020|616956787|FG001|Overall Study|Adverse Event|15|||
170713039|NCT00982020|616956786|FG000|Overall Study|Withdrawal by Subject|11|||
170713040|NCT00982020|616956787|FG001|Overall Study|Withdrawal by Subject|14|||
170713041|NCT00982020|616956786|FG000|Overall Study|Lost to Follow-up|5|||
170713042|NCT00982020|616956787|FG001|Overall Study|Lost to Follow-up|11|||
170713043|NCT00982020|616956786|FG000|Overall Study|Lack of Efficacy|10|||
170713044|NCT00982020|616956787|FG001|Overall Study|Lack of Efficacy|4|||
170713045|NCT00982020|616956786|FG000|Overall Study|Parent/Caregiver Decision|5|||
170713046|NCT00982020|616956787|FG001|Overall Study|Parent/Caregiver Decision|5|||
170713047|NCT00982020|616956786|FG000|Overall Study|Treatment Non-compliance|3|||
170713048|NCT00982020|616956787|FG001|Overall Study|Treatment Non-compliance|6|||
170713049|NCT00982020|616956786|FG000|Overall Study|Physician Decision|2|||
170713050|NCT00982020|616956787|FG001|Overall Study|Physician Decision|5|||
170713051|NCT00982020|616956786|FG000|Overall Study|Entry Criteria Not Met|2|||
170713052|NCT00982020|616956787|FG001|Overall Study|Entry Criteria Not Met|1|||
170713053|NCT00982020|616956786|FG000|Overall Study|Protocol Violation|0|||
170713054|NCT00982020|616956787|FG001|Overall Study|Protocol Violation|2|||
170713055|NCT00982020|616956786|FG000|Overall Study|Clinical Relapse|0|||
170713056|NCT00982020|616956787|FG001|Overall Study|Clinical Relapse|1|||
170713057|NCT00086346|616956795|FG000|Randomization|Did not receive test article|4|||
170713058|NCT00086346|616956796|FG001|Randomization|Did not receive test article|4|||
170713059|NCT00086346|616956795|FG000|Patients Dosed With Test Article|Adverse Event|94|||
170713060|NCT00086346|616956796|FG001|Patients Dosed With Test Article|Adverse Event|11|||
170713061|NCT00086346|616956795|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
170713062|NCT00086346|616956796|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
170713063|NCT00086346|616956795|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
170713064|NCT00086346|616956796|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
170713065|NCT00086346|616956795|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
170713066|NCT00086346|616956796|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
170713067|NCT00086346|616956795|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
170713068|NCT00086346|616956796|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
170713069|NCT00086346|616956795|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
170713070|NCT00086346|616956796|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
170713071|NCT04495374|616956797|FG000|Overall Study|Protocol Violation|2|||
170713072|NCT04495374|616956798|FG001|Overall Study|Protocol Violation|1|||
170713073|NCT03489304|616956799|FG000|Overall Study|Lost to Follow-up|4|||
170713074|NCT03003676|616956800|FG000|Overall Study|Lack of Efficacy|5|||
170713075|NCT03003676|616956801|FG001|Overall Study|Lack of Efficacy|7|||
170713076|NCT03003676|616956800|FG000|Overall Study|Withdrawal by Subject|0|||
170713077|NCT03003676|616956801|FG001|Overall Study|Withdrawal by Subject|1|||
170713078|NCT03003676|616956800|FG000|Overall Study|Hepatitis B infection|1|||
170713079|NCT03003676|616956801|FG001|Overall Study|Hepatitis B infection|0|||
170713080|NCT03766646|616956803|FG000|Overall Study|Withdrawal by Subject|1|||
170713081|NCT03766646|616956804|FG001|Overall Study|Withdrawal by Subject|0|||
170713082|NCT03766646|616956803|FG000|Overall Study|Protocol Violation|0|||
170713083|NCT03766646|616956804|FG001|Overall Study|Protocol Violation|3|||
170713084|NCT02819726|616956819|FG000|Part A (All Participants)|Lost to Follow-up|0|||
170713085|NCT02819726|616956820|FG001|Part A (All Participants)|Lost to Follow-up|1|||
170713086|NCT02819726|616956821|FG002|Part A (All Participants)|Lost to Follow-up|0|||
170713087|NCT02819726|616956822|FG003|Part A (All Participants)|Lost to Follow-up|0|||
170713088|NCT02819726|616956819|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
170713089|NCT02819726|616956820|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
170713090|NCT02819726|616956821|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
170713091|NCT02819726|616956822|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
170713092|NCT02819726|616956819|FG000|Part A (All Participants)|Protocol non-compliance|3|||
170713093|NCT02819726|616956820|FG001|Part A (All Participants)|Protocol non-compliance|4|||
170713094|NCT02819726|616956821|FG002|Part A (All Participants)|Protocol non-compliance|5|||
170713095|NCT02819726|616956822|FG003|Part A (All Participants)|Protocol non-compliance|0|||
170713096|NCT02819726|616956819|FG000|Part B (All Participants)|Lost to Follow-up|1|||
170713097|NCT02819726|616956820|FG001|Part B (All Participants)|Lost to Follow-up|1|||
170713098|NCT02819726|616956821|FG002|Part B (All Participants)|Lost to Follow-up|2|||
170713099|NCT02819726|616956822|FG003|Part B (All Participants)|Lost to Follow-up|2|||
170713100|NCT02819726|616956819|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
170713101|NCT02819726|616956820|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
170713102|NCT02819726|616956821|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
170713103|NCT02819726|616956822|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
170713104|NCT02819726|616956819|FG000|Part B (All Participants)|Protocol non-compliance|0|||
170713105|NCT02819726|616956820|FG001|Part B (All Participants)|Protocol non-compliance|0|||
170713106|NCT02819726|616956821|FG002|Part B (All Participants)|Protocol non-compliance|1|||
170713107|NCT02819726|616956822|FG003|Part B (All Participants)|Protocol non-compliance|0|||
170713108|NCT02613481|616956823|FG000|Overall Study|Lost to Follow-up|7|||
170713109|NCT02613481|616956823|FG000|Overall Study|Withdrawal by Subject|2|||
170713110|NCT01033747|616956824|FG000|Overall Study|Adverse Event|9|||
170713111|NCT01033747|616956825|FG001|Overall Study|Adverse Event|4|||
170713112|NCT01033747|616956824|FG000|Overall Study|Abnormal Laboratory Value|1|||
170713113|NCT01033747|616956825|FG001|Overall Study|Abnormal Laboratory Value|0|||
170713114|NCT01033747|616956824|FG000|Overall Study|Abnormal test procedure|0|||
170713115|NCT01033747|616956825|FG001|Overall Study|Abnormal test procedure|1|||
170713116|NCT01033747|616956824|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
170713117|NCT01033747|616956825|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
170713118|NCT01033747|616956824|FG000|Overall Study|Protocol Violation|1|||
170713119|NCT01033747|616956825|FG001|Overall Study|Protocol Violation|0|||
170713120|NCT01033747|616956824|FG000|Overall Study|Withdrawal by Subject|9|||
170713121|NCT01033747|616956825|FG001|Overall Study|Withdrawal by Subject|6|||
170713122|NCT01033747|616956824|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
170713123|NCT01033747|616956825|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
170713124|NCT01033747|616956824|FG000|Overall Study|Stopped at end of Extension 1|2|||
170713125|NCT01033747|616956825|FG001|Overall Study|Stopped at end of Extension 1|0|||
170713126|NCT00844194|616956826|FG000|Overall Study|Adverse Event|17|||
170713127|NCT00844194|616956827|FG001|Overall Study|Adverse Event|5|||
170713128|NCT00844194|616956826|FG000|Overall Study|Protocol Violation|1|||
170713129|NCT00844194|616956827|FG001|Overall Study|Protocol Violation|1|||
170713130|NCT00844194|616956826|FG000|Overall Study|Lost to Follow-up|1|||
170713131|NCT00844194|616956827|FG001|Overall Study|Lost to Follow-up|1|||
170713132|NCT00844194|616956826|FG000|Overall Study|Withdrawal by Subject|2|||
170713133|NCT00844194|616956827|FG001|Overall Study|Withdrawal by Subject|1|||
170713134|NCT00844194|616956826|FG000|Overall Study|Lack of Efficacy|3|||
170713135|NCT00844194|616956827|FG001|Overall Study|Lack of Efficacy|0|||
170713136|NCT00844194|616956826|FG000|Overall Study|Other reason (not specified)|1|||
170713137|NCT00844194|616956827|FG001|Overall Study|Other reason (not specified)|0|||
170713138|NCT02647658|616956828|FG000|Overall Study|Consent refusal|15|||
170713139|NCT02647658|616956829|FG001|Overall Study|Consent refusal|24|||
170713140|NCT04382326|616956833|FG000|Overall Study|Adverse Event, not serious|1|||
170713141|NCT04382326|616956834|FG001|Overall Study|Adverse Event, not serious|2|||
170713142|NCT04382326|616956833|FG000|Overall Study|Other|1|||
170713143|NCT04382326|616956834|FG001|Overall Study|Other|0|||
170713144|NCT04382326|616956833|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
170713145|NCT04382326|616956834|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
170713146|NCT04382326|616956833|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
170713147|NCT04382326|616956834|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
170713148|NCT04382326|616956833|FG000|Overall Study|Protocol Violation|29|||
170713149|NCT04382326|616956834|FG001|Overall Study|Protocol Violation|23|||
170713150|NCT04382326|616956833|FG000|Overall Study|Physician Decision|0|||
170713151|NCT04382326|616956834|FG001|Overall Study|Physician Decision|1|||
170713152|NCT04382326|616956833|FG000|Overall Study|Lost to Follow-up|48|||
170713153|NCT04382326|616956834|FG001|Overall Study|Lost to Follow-up|63|||
170713154|NCT04382326|616956833|FG000|Overall Study|Adverse Event, non-fatal|1|||
170713155|NCT04382326|616956834|FG001|Overall Study|Adverse Event, non-fatal|1|||
170713156|NCT01181921|616956835|FG000|Overall Study|Lost to Follow-up|1|||
170713157|NCT00389324|616956843|FG000|Run-In Phase|Adverse Event|1|||
170713158|NCT00389324|616956843|FG000|Run-In Phase|Lost to Follow-up|1|||
170713159|NCT00389324|616956843|FG000|Run-In Phase|Withdrawal by Subject|1|||
170713160|NCT00389324|616956843|FG000|Subcutaneous Phase|Adverse Event|2|||
170713161|NCT00389324|616956843|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
170713162|NCT00389324|616956843|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
170713163|NCT00389324|616956843|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
170713164|NCT03295201|616956844|FG000|Overall Study|Lost to Follow-up|1|||
170713165|NCT03295201|616956845|FG001|Overall Study|Lost to Follow-up|1|||
170713166|NCT03295201|616956844|FG000|Overall Study|Hospital admission|0|||
170713167|NCT03295201|616956845|FG001|Overall Study|Hospital admission|1|||
170713168|NCT01831089|616956846|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
170713169|NCT01831089|616956847|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
170713170|NCT01831089|616956848|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
170713171|NCT01831089|616956849|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
170713172|NCT01831089|616956850|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
170713173|NCT01831089|616956851|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
170713174|NCT01831089|616956846|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
170713175|NCT01831089|616956847|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
170713176|NCT01831089|616956848|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
170713177|NCT01831089|616956849|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
170713178|NCT01831089|616956850|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
170713179|NCT01831089|616956851|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
170713180|NCT01831089|616956846|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
170713181|NCT01831089|616956847|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
170713182|NCT01831089|616956848|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
170713183|NCT01831089|616956849|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
170713184|NCT01831089|616956850|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
170713185|NCT01831089|616956851|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
170713186|NCT01831089|616956846|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
170713187|NCT01831089|616956847|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
170713188|NCT01831089|616956848|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
170713189|NCT01831089|616956849|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
170713190|NCT01831089|616956850|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
170713191|NCT01831089|616956851|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
170713192|NCT01831089|616956846|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
170713193|NCT01831089|616956847|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
170713194|NCT01831089|616956848|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
170713195|NCT01831089|616956849|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
170713196|NCT01831089|616956850|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
170713197|NCT01831089|616956851|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
170713198|NCT01831089|616956846|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
170713199|NCT01831089|616956847|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
170713200|NCT01831089|616956848|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
170713201|NCT01831089|616956849|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
170713202|NCT01831089|616956850|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
170713203|NCT01831089|616956851|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
170713204|NCT01831089|616956846|FG000|Cohort III: Dose Level 3|Global end of study|0|||
170713205|NCT01831089|616956847|FG001|Cohort III: Dose Level 3|Global end of study|0|||
170713206|NCT01831089|616956848|FG002|Cohort III: Dose Level 3|Global end of study|1|||
170713207|NCT01831089|616956849|FG003|Cohort III: Dose Level 3|Global end of study|0|||
170713208|NCT01831089|616956850|FG004|Cohort III: Dose Level 3|Global end of study|0|||
170713209|NCT01831089|616956851|FG005|Cohort III: Dose Level 3|Global end of study|0|||
170713210|NCT01831089|616956846|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
170713211|NCT01831089|616956847|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
170713212|NCT01831089|616956848|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
170713213|NCT01831089|616956849|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
170713214|NCT01831089|616956850|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
170713215|NCT01831089|616956851|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
170713216|NCT01831089|616956846|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
170713217|NCT01831089|616956847|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
170713218|NCT01831089|616956848|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
170713219|NCT01831089|616956849|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
170713220|NCT01831089|616956850|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
170713221|NCT01831089|616956851|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
170713222|NCT01831089|616956846|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
170713223|NCT01831089|616956847|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
170713224|NCT01831089|616956848|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
170713225|NCT01831089|616956849|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
170713226|NCT01831089|616956850|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
170713227|NCT01831089|616956851|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
170713228|NCT01831089|616956846|FG000|Cohort V: Dose Level 5|Death|0|||
170713229|NCT01831089|616956847|FG001|Cohort V: Dose Level 5|Death|0|||
170713230|NCT01831089|616956848|FG002|Cohort V: Dose Level 5|Death|0|||
170713231|NCT01831089|616956849|FG003|Cohort V: Dose Level 5|Death|0|||
170713232|NCT01831089|616956850|FG004|Cohort V: Dose Level 5|Death|1|||
170713233|NCT01831089|616956851|FG005|Cohort V: Dose Level 5|Death|0|||
170713234|NCT01831089|616956846|FG000|Cohort V: Dose Level 5|Global end of study|0|||
170713235|NCT01831089|616956847|FG001|Cohort V: Dose Level 5|Global end of study|0|||
170713236|NCT01831089|616956848|FG002|Cohort V: Dose Level 5|Global end of study|0|||
170713237|NCT01831089|616956849|FG003|Cohort V: Dose Level 5|Global end of study|0|||
170713238|NCT01831089|616956850|FG004|Cohort V: Dose Level 5|Global end of study|2|||
170713239|NCT01831089|616956851|FG005|Cohort V: Dose Level 5|Global end of study|0|||
170713240|NCT01831089|616956846|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
170713241|NCT01831089|616956847|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
170713242|NCT01831089|616956848|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
170713243|NCT01831089|616956849|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
170713244|NCT01831089|616956850|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
170713245|NCT01831089|616956851|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
170713246|NCT01831089|616956846|FG000|Cohort B: Arm B|Progressive disease|0|||
170713247|NCT01831089|616956847|FG001|Cohort B: Arm B|Progressive disease|0|||
170713248|NCT01831089|616956848|FG002|Cohort B: Arm B|Progressive disease|0|||
170713249|NCT01831089|616956849|FG003|Cohort B: Arm B|Progressive disease|0|||
170713250|NCT01831089|616956850|FG004|Cohort B: Arm B|Progressive disease|0|||
170713251|NCT01831089|616956851|FG005|Cohort B: Arm B|Progressive disease|8|||
170713252|NCT01831089|616956846|FG000|Cohort B: Arm B|Physician Decision|0|||
170713253|NCT01831089|616956847|FG001|Cohort B: Arm B|Physician Decision|0|||
170713254|NCT01831089|616956848|FG002|Cohort B: Arm B|Physician Decision|0|||
170713255|NCT01831089|616956849|FG003|Cohort B: Arm B|Physician Decision|0|||
170713256|NCT01831089|616956850|FG004|Cohort B: Arm B|Physician Decision|0|||
170713257|NCT01831089|616956851|FG005|Cohort B: Arm B|Physician Decision|2|||
170713258|NCT01831089|616956846|FG000|Cohort B: Arm B|Never treated|0|||
170713259|NCT01831089|616956847|FG001|Cohort B: Arm B|Never treated|0|||
170713260|NCT01831089|616956848|FG002|Cohort B: Arm B|Never treated|0|||
170713261|NCT01831089|616956849|FG003|Cohort B: Arm B|Never treated|0|||
170713262|NCT01831089|616956850|FG004|Cohort B: Arm B|Never treated|0|||
170713263|NCT01831089|616956851|FG005|Cohort B: Arm B|Never treated|2|||
170713264|NCT01831089|616956846|FG000|Cohort B: Arm B|Adverse Event|0|||
170713265|NCT01831089|616956847|FG001|Cohort B: Arm B|Adverse Event|0|||
170713266|NCT01831089|616956848|FG002|Cohort B: Arm B|Adverse Event|0|||
170713267|NCT01831089|616956849|FG003|Cohort B: Arm B|Adverse Event|0|||
170713268|NCT01831089|616956850|FG004|Cohort B: Arm B|Adverse Event|0|||
170713269|NCT01831089|616956851|FG005|Cohort B: Arm B|Adverse Event|1|||
170713270|NCT01831089|616956846|FG000|Cohort B: Arm B|Global end of study|0|||
170713271|NCT01831089|616956847|FG001|Cohort B: Arm B|Global end of study|0|||
170713272|NCT01831089|616956848|FG002|Cohort B: Arm B|Global end of study|0|||
170713273|NCT01831089|616956849|FG003|Cohort B: Arm B|Global end of study|0|||
170713274|NCT01831089|616956850|FG004|Cohort B: Arm B|Global end of study|0|||
170713275|NCT01831089|616956851|FG005|Cohort B: Arm B|Global end of study|1|||
170713276|NCT03551938|616956854|FG000|3-Month Follow Up|Lost to Follow-up|39|||
170713277|NCT03551938|616956855|FG001|3-Month Follow Up|Lost to Follow-up|38|||
170713278|NCT03551938|616956854|FG000|6-Month Follow Up|Lost to Follow-up|46|||
170713279|NCT03551938|616956855|FG001|6-Month Follow Up|Lost to Follow-up|42|||
170713280|NCT03551938|616956854|FG000|9-Month Follow Up|Lost to Follow-up|44|||
170713281|NCT03551938|616956855|FG001|9-Month Follow Up|Lost to Follow-up|43|||
170713282|NCT01925183|616956859|FG000|Overall Study|Adverse Event|1|||
170713283|NCT01925183|616956860|FG001|Overall Study|Adverse Event|0|||
170713284|NCT01046110|616956861|FG000|Overall Study|Adverse Event|9|||
170713285|NCT01046110|616956862|FG001|Overall Study|Adverse Event|2|||
170713286|NCT01046110|616956861|FG000|Overall Study|Lack of Efficacy|0|||
170713287|NCT01046110|616956862|FG001|Overall Study|Lack of Efficacy|1|||
170713288|NCT01046110|616956861|FG000|Overall Study|Protocol Violation|7|||
170713289|NCT01046110|616956862|FG001|Overall Study|Protocol Violation|12|||
170713290|NCT01046110|616956861|FG000|Overall Study|Withdrawal Criteria|3|||
170713291|NCT01046110|616956862|FG001|Overall Study|Withdrawal Criteria|5|||
170713292|NCT01046110|616956861|FG000|Overall Study|Unclassified|36|||
170713293|NCT01046110|616956862|FG001|Overall Study|Unclassified|35|||
170713294|NCT01114646|616956863|FG000|Overall Study|Withdrawal by Subject|3|||
170713295|NCT01114646|616956864|FG001|Overall Study|Withdrawal by Subject|2|||
170713296|NCT02667912|616956873|FG000|Overall Study|Death|3|||
170713297|NCT02667912|616956874|FG001|Overall Study|Death|1|||
170713298|NCT02667912|616956873|FG000|Overall Study|Withdrawal by Subject|1|||
170713299|NCT02667912|616956874|FG001|Overall Study|Withdrawal by Subject|2|||
170713300|NCT02667912|616956873|FG000|Overall Study|Withdrawal by Subject|1|||
170713301|NCT02667912|616956874|FG001|Overall Study|Withdrawal by Subject|0|||
170713302|NCT05101252|616956875|FG000|Overall Study|Unsatisfactory Test Article|1|||
170713303|NCT05101252|616956876|FG001|Overall Study|Unsatisfactory Test Article|0|||
170713304|NCT05101252|616956875|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
170713305|NCT05101252|616956876|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
170713306|NCT05101252|616956875|FG000|Overall Study|Withdrew Consent during study|0|||
170713307|NCT05101252|616956876|FG001|Overall Study|Withdrew Consent during study|1|||
170713308|NCT05101252|616956875|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
170713309|NCT05101252|616956876|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
170713310|NCT00793910|616956877|FG000|Overall Study|discarded study pills|0|||
170713311|NCT00793910|616956878|FG001|Overall Study|discarded study pills|1|||
170713312|NCT00793910|616956877|FG000|Overall Study|did not pick up medications|1|||
170713313|NCT00793910|616956878|FG001|Overall Study|did not pick up medications|1|||
170713314|NCT00793910|616956877|FG000|Overall Study|ineligible based on entry criteria|2|||
170713315|NCT00793910|616956878|FG001|Overall Study|ineligible based on entry criteria|3|||
170713316|NCT00793910|616956877|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
170713317|NCT00793910|616956878|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
170713318|NCT00793910|616956877|FG000|Overall Study|Withdrawal by Subject|0|||
170713319|NCT00793910|616956878|FG001|Overall Study|Withdrawal by Subject|1|||
170713320|NCT01700946|616956879|FG000|Overall Study|Lost to Follow-up|1|||
170713321|NCT01700946|616956880|FG001|Overall Study|Lost to Follow-up|0|||
170713322|NCT01700946|616956879|FG000|Overall Study|Physician Decision|7|||
170713323|NCT01700946|616956880|FG001|Overall Study|Physician Decision|12|||
170713324|NCT01700946|616956879|FG000|Overall Study|Withdrawal by Subject|0|||
170713325|NCT01700946|616956880|FG001|Overall Study|Withdrawal by Subject|2|||
170713326|NCT01700946|616956879|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
170713327|NCT01700946|616956880|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
170713328|NCT01700946|616956879|FG000|Overall Study|Relapse|2|||
170713329|NCT01700946|616956880|FG001|Overall Study|Relapse|1|||
170713330|NCT01700946|616956879|FG000|Overall Study|Unacceptable toxicity|1|||
170713331|NCT01700946|616956880|FG001|Overall Study|Unacceptable toxicity|0|||
170713332|NCT03634579|616956883|FG000|Overall Study|study termination|9|||
170713333|NCT01993719|616956884|FG000|First Drug Administration|Not treated|1|||
170713334|NCT01993719|616956885|FG001|First Drug Administration|Not treated|0|||
170713335|NCT01993719|616956886|FG002|First Drug Administration|Not treated|0|||
170713336|NCT01993719|616956887|FG003|First Drug Administration|Not treated|0|||
170713337|NCT01993719|616956888|FG004|First Drug Administration|Not treated|0|||
170713338|NCT02799082|616956890|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
170713339|NCT02799082|616956891|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
170713340|NCT02799082|616956890|FG000|Overall Study|Protocol Violation|0|||
170713341|NCT02799082|616956891|FG001|Overall Study|Protocol Violation|1|||
170713342|NCT01208233|616956894|FG000|Overall Study|Adverse Event|0|||
170713343|NCT01208233|616956895|FG001|Overall Study|Adverse Event|1|||
170713344|NCT01208233|616956896|FG002|Overall Study|Adverse Event|2|||
170713345|NCT01208233|616956897|FG003|Overall Study|Adverse Event|0|||
170713346|NCT01208233|616956898|FG004|Overall Study|Adverse Event|3|||
170713347|NCT01208233|616956899|FG005|Overall Study|Adverse Event|5|||
170713348|NCT01208233|616956894|FG000|Overall Study|Death|0|||
170713349|NCT01208233|616956895|FG001|Overall Study|Death|0|||
170713350|NCT01208233|616956896|FG002|Overall Study|Death|0|||
170713351|NCT01208233|616956897|FG003|Overall Study|Death|0|||
170713352|NCT01208233|616956898|FG004|Overall Study|Death|3|||
170713353|NCT01208233|616956899|FG005|Overall Study|Death|5|||
170713354|NCT01208233|616956894|FG000|Overall Study|Did not meet entrance criteria|2|||
170713355|NCT01208233|616956895|FG001|Overall Study|Did not meet entrance criteria|1|||
170713356|NCT01208233|616956896|FG002|Overall Study|Did not meet entrance criteria|1|||
170713357|NCT01208233|616956897|FG003|Overall Study|Did not meet entrance criteria|0|||
170713358|NCT01208233|616956898|FG004|Overall Study|Did not meet entrance criteria|1|||
170713359|NCT01208233|616956899|FG005|Overall Study|Did not meet entrance criteria|0|||
170713360|NCT01208233|616956894|FG000|Overall Study|Medication error without adverse event|0|||
170713361|NCT01208233|616956895|FG001|Overall Study|Medication error without adverse event|0|||
170713362|NCT01208233|616956896|FG002|Overall Study|Medication error without adverse event|0|||
170713363|NCT01208233|616956897|FG003|Overall Study|Medication error without adverse event|0|||
170713364|NCT01208233|616956898|FG004|Overall Study|Medication error without adverse event|0|||
170713365|NCT01208233|616956899|FG005|Overall Study|Medication error without adverse event|1|||
170713366|NCT01208233|616956894|FG000|Overall Study|Study terminated by sponsor|0|||
170713367|NCT01208233|616956895|FG001|Overall Study|Study terminated by sponsor|0|||
170713368|NCT01208233|616956896|FG002|Overall Study|Study terminated by sponsor|0|||
170713369|NCT01208233|616956897|FG003|Overall Study|Study terminated by sponsor|0|||
170713370|NCT01208233|616956898|FG004|Overall Study|Study terminated by sponsor|10|||
170713371|NCT01208233|616956899|FG005|Overall Study|Study terminated by sponsor|7|||
170713372|NCT01208233|616956894|FG000|Overall Study|Protocol Violation|0|||
170713373|NCT01208233|616956895|FG001|Overall Study|Protocol Violation|0|||
170713374|NCT01208233|616956896|FG002|Overall Study|Protocol Violation|0|||
170713375|NCT01208233|616956897|FG003|Overall Study|Protocol Violation|0|||
170713376|NCT01208233|616956898|FG004|Overall Study|Protocol Violation|3|||
170713377|NCT01208233|616956899|FG005|Overall Study|Protocol Violation|0|||
170713378|NCT01208233|616956894|FG000|Overall Study|Other|2|||
170713379|NCT01208233|616956895|FG001|Overall Study|Other|1|||
170713380|NCT01208233|616956896|FG002|Overall Study|Other|0|||
170713381|NCT01208233|616956897|FG003|Overall Study|Other|0|||
170713382|NCT01208233|616956898|FG004|Overall Study|Other|0|||
170713383|NCT01208233|616956899|FG005|Overall Study|Other|1|||
170713384|NCT01208233|616956894|FG000|Overall Study|Withdrawal by Subject|1|||
170713385|NCT01208233|616956895|FG001|Overall Study|Withdrawal by Subject|0|||
170713386|NCT01208233|616956896|FG002|Overall Study|Withdrawal by Subject|1|||
170713387|NCT01208233|616956897|FG003|Overall Study|Withdrawal by Subject|1|||
170713388|NCT01208233|616956898|FG004|Overall Study|Withdrawal by Subject|4|||
170713389|NCT01208233|616956899|FG005|Overall Study|Withdrawal by Subject|2|||
170713390|NCT00983814|616956900|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
170713391|NCT00983814|616956901|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
170713392|NCT00983814|616956902|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
170713393|NCT00983814|616956900|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
170713394|NCT00983814|616956901|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
170713395|NCT00983814|616956902|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
170713396|NCT00983814|616956900|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
170713397|NCT00983814|616956901|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
170713398|NCT00983814|616956902|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
170713399|NCT00983814|616956900|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
170713400|NCT00983814|616956901|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
170713401|NCT00983814|616956902|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
170713402|NCT00983814|616956900|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
170713403|NCT00983814|616956901|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
170713404|NCT00983814|616956902|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
170713405|NCT00129259|616956906|FG000|Overall Study|Lost to Follow-up|1|||
170713406|NCT00129259|616956907|FG001|Overall Study|Lost to Follow-up|1|||
170713407|NCT00129259|616956906|FG000|Overall Study|Withdrawal by Subject|2|||
170713408|NCT00129259|616956907|FG001|Overall Study|Withdrawal by Subject|1|||
170713409|NCT00129259|616956906|FG000|Overall Study|Only available minimal phone assessments|0|||
170713410|NCT00129259|616956907|FG001|Overall Study|Only available minimal phone assessments|1|||
170713411|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
170713412|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
170713413|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
170713414|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Death|1|||
170713415|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Death|0|||
170713416|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Death|0|||
170713417|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
170713418|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
170713419|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
170713420|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
170713421|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
170713422|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
170713423|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
170713424|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
170713425|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
170713426|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
170713427|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
170713428|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
170713429|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
170713430|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
170713431|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
170713432|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
170713433|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
170713434|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
170713435|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
170713436|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
170713437|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
170713438|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
170713439|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
170713440|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
170713441|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
170713442|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
170713443|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
170713444|NCT03655236|616956911|FG000|Subject Disposition in Part 1 Period|Other|0|||
170713445|NCT03655236|616956912|FG001|Subject Disposition in Part 1 Period|Other|2|||
170713446|NCT03655236|616956913|FG002|Subject Disposition in Part 1 Period|Other|2|||
170713447|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
170713448|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
170713449|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
170713450|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
170713451|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
170713452|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
170713453|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
170713454|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
170713455|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
170713456|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
170713457|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
170713458|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
170713459|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
170713460|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
170828164|NCT03175198|617380262|FG000|Overall Study|Adverse Event|480|||
170828165|NCT03175198|617380262|FG000|Overall Study|No actual visit|120|||
170828166|NCT03175198|617380262|FG000|Overall Study|Registration rule not followed|4|||
170828167|NCT03175198|617380262|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
170828168|NCT03175198|617380262|FG000|Overall Study|Other personal reason|509|||
170828169|NCT03175198|617380262|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
170828170|NCT03175198|617380262|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
170828171|NCT03175198|617380262|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
170828172|NCT03175198|617380262|FG000|Overall Study|To conduct invasive treatment of operation|53|||
170828173|NCT03175198|617380262|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
170828174|NCT01978236|617380263|FG000|Overall Study|Discontinued due to study close|2|||
170713461|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
170713462|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
170713463|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
170713464|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
170713465|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
170713466|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
170713467|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
170713468|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
170713469|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
170713470|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
170713471|NCT03655236|616956911|FG000|Subject Disposition in Part 2 Period|Other|1|||
170713472|NCT03655236|616956912|FG001|Subject Disposition in Part 2 Period|Other|0|||
170713473|NCT03655236|616956913|FG002|Subject Disposition in Part 2 Period|Other|0|||
170713474|NCT00464542|616958880|FG000|Pre-treatment|Withdrawal by Subject|2|||
170713475|NCT04745169|616958881|FG000|Overall Study|Kidney transplantation|1|||
170713476|NCT04745169|616958881|FG000|Overall Study|Participant health problems|3|||
170713477|NCT04745169|616958881|FG000|Overall Study|Physician Decision|2|||
170713478|NCT00129987|616958882|FG000|1st Educational Session|Withdrawal by Subject|141|||
170713479|NCT00129987|616958883|FG001|1st Educational Session|Withdrawal by Subject|109|||
170713480|NCT00129987|616958882|FG000|1 Year|Withdrawal by Subject|32|||
170713481|NCT00129987|616958883|FG001|1 Year|Withdrawal by Subject|21|||
170713482|NCT00489970|616958884|FG000|Persistence Year 9|Lost to Follow-up|2|||
170713483|NCT00489970|616958885|FG001|Persistence Year 9|Lost to Follow-up|2|||
170713484|NCT00489970|616958886|FG002|Persistence Year 9|Lost to Follow-up|3|||
170713485|NCT00489970|616958884|FG000|Persistence Year 9|Other|1|||
170713486|NCT00489970|616958885|FG001|Persistence Year 9|Other|0|||
170713487|NCT00489970|616958886|FG002|Persistence Year 9|Other|2|||
170713488|NCT02280044|616958887|FG000|Overall Study|Planned alternate|0|||
170713489|NCT02280044|616958888|FG001|Overall Study|Planned alternate|2|||
170713490|NCT02318329|616958890|FG000|Overall Study|Progressive Disease|2|||
170713491|NCT02318329|616958891|FG001|Overall Study|Progressive Disease|3|||
170713492|NCT02318329|616958892|FG002|Overall Study|Progressive Disease|2|||
170713493|NCT02318329|616958893|FG003|Overall Study|Progressive Disease|3|||
170713494|NCT02318329|616958894|FG004|Overall Study|Progressive Disease|3|||
170713495|NCT02318329|616958895|FG005|Overall Study|Progressive Disease|3|||
170713496|NCT02318329|616958896|FG006|Overall Study|Progressive Disease|1|||
170713497|NCT02318329|616958897|FG007|Overall Study|Progressive Disease|1|||
170713498|NCT02318329|616958898|FG008|Overall Study|Progressive Disease|5|||
170713499|NCT02318329|616958899|FG009|Overall Study|Progressive Disease|39|||
170713500|NCT02318329|616958890|FG000|Overall Study|Death|0|||
170713501|NCT02318329|616958891|FG001|Overall Study|Death|0|||
170713502|NCT02318329|616958892|FG002|Overall Study|Death|0|||
170713503|NCT02318329|616958893|FG003|Overall Study|Death|0|||
170713504|NCT02318329|616958894|FG004|Overall Study|Death|0|||
170713505|NCT02318329|616958895|FG005|Overall Study|Death|0|||
170713506|NCT02318329|616958896|FG006|Overall Study|Death|0|||
170713507|NCT02318329|616958897|FG007|Overall Study|Death|0|||
170713508|NCT02318329|616958898|FG008|Overall Study|Death|0|||
170713509|NCT02318329|616958899|FG009|Overall Study|Death|5|||
170713510|NCT02318329|616958890|FG000|Overall Study|Lost to Follow-up|0|||
170713511|NCT02318329|616958891|FG001|Overall Study|Lost to Follow-up|0|||
170713512|NCT02318329|616958892|FG002|Overall Study|Lost to Follow-up|0|||
170713513|NCT02318329|616958893|FG003|Overall Study|Lost to Follow-up|0|||
170713514|NCT02318329|616958894|FG004|Overall Study|Lost to Follow-up|0|||
170713515|NCT02318329|616958895|FG005|Overall Study|Lost to Follow-up|0|||
170713516|NCT02318329|616958896|FG006|Overall Study|Lost to Follow-up|0|||
170713517|NCT02318329|616958897|FG007|Overall Study|Lost to Follow-up|0|||
170713518|NCT02318329|616958898|FG008|Overall Study|Lost to Follow-up|0|||
170713519|NCT02318329|616958899|FG009|Overall Study|Lost to Follow-up|1|||
170713520|NCT02318329|616958890|FG000|Overall Study|Withdrawal by Subject|0|||
170713521|NCT02318329|616958891|FG001|Overall Study|Withdrawal by Subject|0|||
170713522|NCT02318329|616958892|FG002|Overall Study|Withdrawal by Subject|0|||
170713523|NCT02318329|616958893|FG003|Overall Study|Withdrawal by Subject|0|||
170713524|NCT02318329|616958894|FG004|Overall Study|Withdrawal by Subject|0|||
170713525|NCT02318329|616958895|FG005|Overall Study|Withdrawal by Subject|0|||
170713526|NCT02318329|616958896|FG006|Overall Study|Withdrawal by Subject|0|||
170713527|NCT02318329|616958897|FG007|Overall Study|Withdrawal by Subject|0|||
170713528|NCT02318329|616958898|FG008|Overall Study|Withdrawal by Subject|0|||
170713529|NCT02318329|616958899|FG009|Overall Study|Withdrawal by Subject|6|||
170713530|NCT02318329|616958890|FG000|Overall Study|Other|1|||
170713531|NCT02318329|616958891|FG001|Overall Study|Other|1|||
170713532|NCT02318329|616958892|FG002|Overall Study|Other|1|||
170713533|NCT02318329|616958893|FG003|Overall Study|Other|0|||
170713534|NCT02318329|616958894|FG004|Overall Study|Other|0|||
170713535|NCT02318329|616958895|FG005|Overall Study|Other|0|||
170713536|NCT02318329|616958896|FG006|Overall Study|Other|0|||
170713537|NCT02318329|616958897|FG007|Overall Study|Other|0|||
170713538|NCT02318329|616958898|FG008|Overall Study|Other|1|||
170713539|NCT02318329|616958899|FG009|Overall Study|Other|1|||
170713540|NCT04837482|616958900|FG000|Period 2|Withdrawal by Subject|0|||
170713541|NCT04837482|616958901|FG001|Period 2|Withdrawal by Subject|1|||
170713542|NCT00581945|616958902|FG000|Overall Study|Adverse Event|4|||
170713543|NCT00581945|616958903|FG001|Overall Study|Adverse Event|4|||
170713544|NCT00581945|616958902|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170713545|NCT00581945|616958903|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170713546|NCT00581945|616958902|FG000|Overall Study|Withdrawal by Subject|2|||
170713547|NCT00581945|616958903|FG001|Overall Study|Withdrawal by Subject|6|||
170713548|NCT00581945|616958902|FG000|Overall Study|Death|1|||
170713549|NCT00581945|616958903|FG001|Overall Study|Death|0|||
170713550|NCT02979535|616958904|FG000|Overall Study|Non compliance with the protocol|78|||
170713551|NCT02979535|616958905|FG001|Overall Study|Non compliance with the protocol|82|||
170713552|NCT02979535|616958904|FG000|Overall Study|Consent withdrawn by participant|11|||
170713553|NCT02979535|616958905|FG001|Overall Study|Consent withdrawn by participant|18|||
170713554|NCT02979535|616958904|FG000|Overall Study|Lost to Follow-up|6|||
170713555|NCT02979535|616958905|FG001|Overall Study|Lost to Follow-up|1|||
170713556|NCT04820673|616958906|FG000|Overall Study|Adverse Event|6|||
170713557|NCT04820673|616958906|FG000|Overall Study|Due to Lack of Effectiveness|1|||
170713558|NCT04820673|616958906|FG000|Overall Study|Pregnancy|1|||
170713559|NCT04820673|616958906|FG000|Overall Study|Voluntary Withdrawal|20|||
170713560|NCT04820673|616958906|FG000|Overall Study|Lost to Follow-up|10|||
170713561|NCT00587587|616958907|FG000|Overall Study|Lost to Follow-up|6|||
170713562|NCT00587587|616958908|FG001|Overall Study|Lost to Follow-up|1|||
170713563|NCT02032901|616958909|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
170713564|NCT02032901|616958910|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
170713565|NCT02032901|616958909|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
170713566|NCT02032901|616958910|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
170713567|NCT02646423|616958911|FG000|Overall Study|Adverse Event|5|||
170713568|NCT02646423|616958912|FG001|Overall Study|Adverse Event|7|||
170713569|NCT02646423|616958911|FG000|Overall Study|Ineligible|2|||
170713570|NCT02646423|616958912|FG001|Overall Study|Ineligible|1|||
170713571|NCT00466193|616958913|FG000|Overall Study|Adverse Event|0|||
170713572|NCT00466193|616958914|FG001|Overall Study|Adverse Event|1|||
170713573|NCT00466193|616958913|FG000|Overall Study|Lost to Follow-up|2|||
170713574|NCT00466193|616958914|FG001|Overall Study|Lost to Follow-up|4|||
170713575|NCT00466193|616958913|FG000|Overall Study|Physician Decision|1|||
170713576|NCT00466193|616958914|FG001|Overall Study|Physician Decision|0|||
170713577|NCT00466193|616958913|FG000|Overall Study|Protocol Violation|1|||
170713578|NCT00466193|616958914|FG001|Overall Study|Protocol Violation|1|||
170713579|NCT00466193|616958913|FG000|Overall Study|Withdrawal by Subject|7|||
170713580|NCT00466193|616958914|FG001|Overall Study|Withdrawal by Subject|2|||
170713581|NCT00466193|616958913|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
170713582|NCT00466193|616958914|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
170713583|NCT02246998|616958915|FG000|Overall Study|Adverse Event|0|||
170713584|NCT02246998|616958916|FG001|Overall Study|Adverse Event|1|||
170713585|NCT02246998|616958917|FG002|Overall Study|Adverse Event|1|||
170713586|NCT02246998|616958918|FG003|Overall Study|Adverse Event|0|||
170713587|NCT02246998|616958915|FG000|Overall Study|Lost to Follow-up|1|||
170713588|NCT02246998|616958916|FG001|Overall Study|Lost to Follow-up|0|||
170713589|NCT02246998|616958917|FG002|Overall Study|Lost to Follow-up|0|||
170713590|NCT02246998|616958918|FG003|Overall Study|Lost to Follow-up|1|||
170713591|NCT02246998|616958915|FG000|Overall Study|Randomized but Never Dosed|1|||
170713592|NCT02246998|616958916|FG001|Overall Study|Randomized but Never Dosed|2|||
170713593|NCT02246998|616958917|FG002|Overall Study|Randomized but Never Dosed|2|||
170713594|NCT02246998|616958918|FG003|Overall Study|Randomized but Never Dosed|1|||
170713595|NCT01303627|616958919|FG000|Overall Study|the failure while performing URS|0|||
170713596|NCT01303627|616958920|FG001|Overall Study|the failure while performing URS|1|||
170713597|NCT00659269|616958924|FG000|Overall Study|Physician Decision|1|||
170713598|NCT00659269|616958925|FG001|Overall Study|Physician Decision|1|||
170713599|NCT03447769|616958926|FG000|Overall Study|Progressive disease|138|||
170713600|NCT03447769|616958927|FG001|Overall Study|Progressive disease|148|||
170713601|NCT03447769|616958926|FG000|Overall Study|Study terminated by Sponsor|60|||
170713602|NCT03447769|616958927|FG001|Overall Study|Study terminated by Sponsor|44|||
170713603|NCT03447769|616958926|FG000|Overall Study|Adverse Event|34|||
170713604|NCT03447769|616958927|FG001|Overall Study|Adverse Event|31|||
170713605|NCT03447769|616958926|FG000|Overall Study|Patient decision|27|||
170713606|NCT03447769|616958927|FG001|Overall Study|Patient decision|27|||
170713607|NCT03447769|616958926|FG000|Overall Study|Protocol deviation|4|||
170713608|NCT03447769|616958927|FG001|Overall Study|Protocol deviation|6|||
170713609|NCT03447769|616958926|FG000|Overall Study|Death|2|||
170713610|NCT03447769|616958927|FG001|Overall Study|Death|7|||
170713611|NCT03447769|616958926|FG000|Overall Study|Technical problems|1|||
170713612|NCT03447769|616958927|FG001|Overall Study|Technical problems|0|||
170713613|NCT03447769|616958926|FG000|Overall Study|Lost to Follow-up|0|||
170713614|NCT03447769|616958927|FG001|Overall Study|Lost to Follow-up|1|||
170713615|NCT03447769|616958926|FG000|Overall Study|Physician Decision|13|||
170828175|NCT04358068|617380264|FG000|Overall Study|Did not initiate study treatment|2|||
170828176|NCT04358068|617380265|FG001|Overall Study|Did not initiate study treatment|2|||
170828177|NCT01193218|617380266|FG000|0-12 Weeks|Adverse Event|6|||
170828178|NCT01193218|617380267|FG001|0-12 Weeks|Adverse Event|0|||
170828179|NCT01193218|617380268|FG002|0-12 Weeks|Adverse Event|1|||
170828180|NCT01193218|617380269|FG003|0-12 Weeks|Adverse Event|0|||
170828181|NCT01193218|617380270|FG004|0-12 Weeks|Adverse Event|0|||
170828182|NCT01193218|617380271|FG005|0-12 Weeks|Adverse Event|2|||
170828183|NCT01193218|617380272|FG006|0-12 Weeks|Adverse Event|2|||
170828184|NCT01193218|617380273|FG007|0-12 Weeks|Adverse Event|0|||
170828185|NCT01193218|617380266|FG000|0-12 Weeks|Protocol Violation|0|||
170828186|NCT01193218|617380267|FG001|0-12 Weeks|Protocol Violation|0|||
170828187|NCT01193218|617380268|FG002|0-12 Weeks|Protocol Violation|0|||
170828188|NCT01193218|617380269|FG003|0-12 Weeks|Protocol Violation|0|||
170828189|NCT01193218|617380270|FG004|0-12 Weeks|Protocol Violation|1|||
170828190|NCT01193218|617380271|FG005|0-12 Weeks|Protocol Violation|1|||
170828191|NCT01193218|617380272|FG006|0-12 Weeks|Protocol Violation|0|||
170828192|NCT01193218|617380273|FG007|0-12 Weeks|Protocol Violation|0|||
170828193|NCT01193218|617380266|FG000|0-12 Weeks|Withdrawal by Subject|3|||
170828194|NCT01193218|617380267|FG001|0-12 Weeks|Withdrawal by Subject|0|||
170828195|NCT01193218|617380268|FG002|0-12 Weeks|Withdrawal by Subject|2|||
170828196|NCT01193218|617380269|FG003|0-12 Weeks|Withdrawal by Subject|0|||
170828197|NCT01193218|617380270|FG004|0-12 Weeks|Withdrawal by Subject|0|||
170828198|NCT01193218|617380271|FG005|0-12 Weeks|Withdrawal by Subject|0|||
170828199|NCT01193218|617380272|FG006|0-12 Weeks|Withdrawal by Subject|1|||
170828200|NCT01193218|617380273|FG007|0-12 Weeks|Withdrawal by Subject|0|||
170828201|NCT01193218|617380266|FG000|12-52 Weeks|Adverse Event|1|||
170828202|NCT01193218|617380267|FG001|12-52 Weeks|Adverse Event|0|||
170828203|NCT01193218|617380268|FG002|12-52 Weeks|Adverse Event|1|||
170828204|NCT01193218|617380269|FG003|12-52 Weeks|Adverse Event|2|||
170828205|NCT01193218|617380270|FG004|12-52 Weeks|Adverse Event|3|||
170828206|NCT01193218|617380271|FG005|12-52 Weeks|Adverse Event|3|||
170828207|NCT01193218|617380272|FG006|12-52 Weeks|Adverse Event|1|||
170828208|NCT01193218|617380273|FG007|12-52 Weeks|Adverse Event|2|||
170828209|NCT01193218|617380266|FG000|12-52 Weeks|Lack of Efficacy|0|||
170828210|NCT01193218|617380267|FG001|12-52 Weeks|Lack of Efficacy|0|||
170828211|NCT01193218|617380268|FG002|12-52 Weeks|Lack of Efficacy|0|||
170828212|NCT01193218|617380269|FG003|12-52 Weeks|Lack of Efficacy|0|||
170828213|NCT01193218|617380270|FG004|12-52 Weeks|Lack of Efficacy|0|||
170828214|NCT01193218|617380271|FG005|12-52 Weeks|Lack of Efficacy|0|||
170828215|NCT01193218|617380272|FG006|12-52 Weeks|Lack of Efficacy|1|||
170828216|NCT01193218|617380273|FG007|12-52 Weeks|Lack of Efficacy|0|||
170828217|NCT01193218|617380266|FG000|12-52 Weeks|Withdrawal by Subject|3|||
170828218|NCT01193218|617380267|FG001|12-52 Weeks|Withdrawal by Subject|0|||
170828219|NCT01193218|617380268|FG002|12-52 Weeks|Withdrawal by Subject|3|||
170828220|NCT01193218|617380269|FG003|12-52 Weeks|Withdrawal by Subject|0|||
170828221|NCT01193218|617380270|FG004|12-52 Weeks|Withdrawal by Subject|0|||
170828222|NCT01193218|617380271|FG005|12-52 Weeks|Withdrawal by Subject|2|||
170828223|NCT01193218|617380272|FG006|12-52 Weeks|Withdrawal by Subject|1|||
170828224|NCT01193218|617380273|FG007|12-52 Weeks|Withdrawal by Subject|2|||
170828225|NCT01193218|617380266|FG000|12-52 Weeks|Other reason than above|1|||
170828226|NCT01193218|617380267|FG001|12-52 Weeks|Other reason than above|0|||
170828227|NCT01193218|617380268|FG002|12-52 Weeks|Other reason than above|0|||
170828228|NCT01193218|617380269|FG003|12-52 Weeks|Other reason than above|1|||
170828229|NCT01193218|617380270|FG004|12-52 Weeks|Other reason than above|1|||
170828230|NCT01193218|617380271|FG005|12-52 Weeks|Other reason than above|0|||
170828231|NCT01193218|617380272|FG006|12-52 Weeks|Other reason than above|0|||
170828232|NCT01193218|617380273|FG007|12-52 Weeks|Other reason than above|0|||
170828233|NCT00912223|617380274|FG000|Overall Study|Withdrawal by Subject|1|||
170828234|NCT00912223|617380274|FG000|Overall Study|Not transplanted|1|||
170828235|NCT00912223|617380274|FG000|Overall Study|Transformed disease|1|||
170828236|NCT00576823|617380275|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
170828237|NCT00576823|617380276|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
170828238|NCT00576823|617380277|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
170828239|NCT00576823|617380275|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
170828240|NCT00576823|617380276|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
170828241|NCT00576823|617380277|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
170828242|NCT00025662|617380278|FG000|Overall Study|Withdrawal by Subject|2|||
170828243|NCT00025662|617380278|FG000|Overall Study|Technical failure of manipulation|1|||
170828244|NCT00130728|617380279|FG000|Overall Study|Death|258|||
170828245|NCT00130728|617380280|FG001|Overall Study|Death|258|||
170828246|NCT00130728|617380279|FG000|Overall Study|Lost to Follow-up|4|||
170828247|NCT00130728|617380280|FG001|Overall Study|Lost to Follow-up|0|||
170828248|NCT00130728|617380279|FG000|Overall Study|Withdrawal by Subject|0|||
170828249|NCT00130728|617380280|FG001|Overall Study|Withdrawal by Subject|2|||
170828250|NCT01161628|617380282|FG000|Overall Study|Death|6|||
170828251|NCT01161628|617380282|FG000|Overall Study|Lack of Efficacy|2|||
170828252|NCT02970305|617380283|FG000|Overall Study|Adverse Event|10|||
170828253|NCT02970305|617380284|FG001|Overall Study|Adverse Event|6|||
170828254|NCT02970305|617380283|FG000|Overall Study|Lack of Efficacy|1|||
170713616|NCT03447769|616958927|FG001|Overall Study|Physician Decision|5|||
170713617|NCT00908960|616958930|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
170713618|NCT00908960|616958931|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
170713619|NCT00908960|616958932|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
170713620|NCT03795922|616958933|FG000|Overall Study|Adverse Event|2|||
170713621|NCT03795922|616958934|FG001|Overall Study|Adverse Event|1|||
170713622|NCT03795922|616958933|FG000|Overall Study|Withdrawal by Subject|5|||
170713623|NCT03795922|616958934|FG001|Overall Study|Withdrawal by Subject|13|||
170713624|NCT03795922|616958933|FG000|Overall Study|Lost to Follow-up|2|||
170713625|NCT03795922|616958934|FG001|Overall Study|Lost to Follow-up|3|||
170713626|NCT03795922|616958933|FG000|Overall Study|Pregnancy|0|||
170713627|NCT03795922|616958934|FG001|Overall Study|Pregnancy|1|||
170713628|NCT03795922|616958933|FG000|Overall Study|Physician Decision|1|||
170713629|NCT03795922|616958934|FG001|Overall Study|Physician Decision|2|||
170713630|NCT03795922|616958933|FG000|Overall Study|Protocol Violation|0|||
170713631|NCT03795922|616958934|FG001|Overall Study|Protocol Violation|1|||
170713632|NCT03795922|616958933|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
170713633|NCT03795922|616958934|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
170713634|NCT00781326|616958939|FG000|Phase I|Adverse Event|1|||
170713635|NCT00781326|616958939|FG000|Phase I|Withdrawal by Subject|1|||
170713636|NCT00781326|616958939|FG000|Phase I|Physician Decision|2|||
170713637|NCT00096941|616958940|FG000|Overall Study|disease progression|3|||
170713638|NCT04796610|616958941|FG000|Overall Study|Withdrawal by Subject|1|||
170713639|NCT04796610|616958942|FG001|Overall Study|Withdrawal by Subject|0|||
170713640|NCT04796610|616958943|FG002|Overall Study|Withdrawal by Subject|0|||
170713641|NCT04796610|616958944|FG003|Overall Study|Withdrawal by Subject|0|||
170713642|NCT04796610|616958941|FG000|Overall Study|Lost to Follow-up|2|||
170713643|NCT04796610|616958942|FG001|Overall Study|Lost to Follow-up|0|||
170713644|NCT04796610|616958943|FG002|Overall Study|Lost to Follow-up|1|||
170713645|NCT04796610|616958944|FG003|Overall Study|Lost to Follow-up|1|||
170713646|NCT02401672|616958945|FG000|Overall Study|Withdrawal by Subject|1|||
170713647|NCT02401672|616958946|FG001|Overall Study|Withdrawal by Subject|3|||
170713648|NCT01459796|616958947|FG000|Overall Study|Non compliance with protocol|2|||
170713649|NCT01459796|616958948|FG001|Overall Study|Non compliance with protocol|4|||
170713650|NCT01459796|616958947|FG000|Overall Study|Adverse Event|5|||
170713651|NCT01459796|616958948|FG001|Overall Study|Adverse Event|5|||
170713652|NCT01459796|616958947|FG000|Overall Study|Withdrawal by Subject|6|||
170713653|NCT01459796|616958948|FG001|Overall Study|Withdrawal by Subject|3|||
170713654|NCT01459796|616958947|FG000|Overall Study|Lost to Follow-up|5|||
170713655|NCT01459796|616958948|FG001|Overall Study|Lost to Follow-up|4|||
170713656|NCT01459796|616958947|FG000|Overall Study|Reason unspecified|1|||
170713657|NCT01459796|616958948|FG001|Overall Study|Reason unspecified|2|||
170713658|NCT01459796|616958947|FG000|Overall Study|Decision by the sponsor|75|||
170713659|NCT01459796|616958948|FG001|Overall Study|Decision by the sponsor|108|||
170713660|NCT03653429|616958959|FG000|Overall Study|Physician Decision|4|||
170713661|NCT03653429|616958960|FG001|Overall Study|Physician Decision|10|||
170713662|NCT03029208|616958961|FG000|Overall Study|Withdrawal by Subject|2|||
170713663|NCT03029208|616958962|FG001|Overall Study|Withdrawal by Subject|3|||
170713664|NCT03029208|616958961|FG000|Overall Study|Lost to Follow-up|0|||
170713665|NCT03029208|616958962|FG001|Overall Study|Lost to Follow-up|1|||
170713666|NCT03893448|616958963|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
170713667|NCT03893448|616958964|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
170713668|NCT03893448|616958963|FG000|Overall Study|Physician Decision|8|||
170713669|NCT03893448|616958964|FG001|Overall Study|Physician Decision|14|||
170713670|NCT03893448|616958963|FG000|Overall Study|Lost to Follow-up|34|||
170713671|NCT03893448|616958964|FG001|Overall Study|Lost to Follow-up|27|||
170713672|NCT03893448|616958963|FG000|Overall Study|Death|1|||
170713673|NCT03893448|616958964|FG001|Overall Study|Death|0|||
170713674|NCT01525082|616958973|FG000|Overall Study|Death|1|||
170713675|NCT03056690|616958975|FG000|Overall Study|Adverse Event|3|||
170713676|NCT03056690|616958976|FG001|Overall Study|Adverse Event|2|||
170713677|NCT03056690|616958975|FG000|Overall Study|Lack of Efficacy|1|||
170713678|NCT03056690|616958976|FG001|Overall Study|Lack of Efficacy|2|||
170713679|NCT03056690|616958975|FG000|Overall Study|Lost to Follow-up|3|||
170828255|NCT02970305|617380284|FG001|Overall Study|Lack of Efficacy|1|||
170828256|NCT02970305|617380283|FG000|Overall Study|Noncompliance with study drug|2|||
170828257|NCT02970305|617380284|FG001|Overall Study|Noncompliance with study drug|4|||
170828258|NCT02970305|617380283|FG000|Overall Study|Protocol Violation|2|||
170713680|NCT03056690|616958976|FG001|Overall Study|Lost to Follow-up|2|||
170713681|NCT03056690|616958975|FG000|Overall Study|Protocol Violation|2|||
170713682|NCT03056690|616958976|FG001|Overall Study|Protocol Violation|2|||
170713683|NCT03056690|616958975|FG000|Overall Study|Withdrawal by Subject|3|||
170713684|NCT03056690|616958976|FG001|Overall Study|Withdrawal by Subject|6|||
170713685|NCT03056690|616958975|FG000|Overall Study|Non-compliance with Study Drug|1|||
170713686|NCT03056690|616958976|FG001|Overall Study|Non-compliance with Study Drug|0|||
170713687|NCT03056690|616958975|FG000|Overall Study|Miscellaneous|1|||
170713688|NCT03056690|616958976|FG001|Overall Study|Miscellaneous|2|||
170713689|NCT01944046|616958985|FG000|Randomized to DB|Adverse Event|5|||
170713690|NCT01944046|616958986|FG001|Randomized to DB|Adverse Event|2|||
170713691|NCT01944046|616958985|FG000|Randomized to DB|Clinical Worsening|3|||
170713692|NCT01944046|616958986|FG001|Randomized to DB|Clinical Worsening|2|||
170713693|NCT01944046|616958985|FG000|Randomized to DB|Lost to Follow-up|3|||
170713694|NCT01944046|616958986|FG001|Randomized to DB|Lost to Follow-up|3|||
170713695|NCT01944046|616958985|FG000|Randomized to DB|Withdrawal by Subject|2|||
170713696|NCT01944046|616958986|FG001|Randomized to DB|Withdrawal by Subject|4|||
170713697|NCT01944046|616958985|FG000|Randomized to DB|Physician Decision|1|||
170713698|NCT01944046|616958986|FG001|Randomized to DB|Physician Decision|2|||
170713699|NCT01944046|616958985|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
170713700|NCT01944046|616958986|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
170713701|NCT01944046|616958985|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
170713702|NCT01944046|616958986|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
170713703|NCT01944046|616958985|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
170713704|NCT01944046|616958986|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
170713705|NCT01944046|616958985|FG000|Open Label Eligible and Consented|Adverse Event|6|||
170713706|NCT01944046|616958986|FG001|Open Label Eligible and Consented|Adverse Event|1|||
170713707|NCT01944046|616958985|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
170713708|NCT01944046|616958986|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
170713709|NCT01944046|616958985|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
170713710|NCT01944046|616958986|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
170713711|NCT02543346|616958987|FG000|Second Priming Visit|Withdrawal by Subject|0|||
170713712|NCT02543346|616958988|FG001|Second Priming Visit|Withdrawal by Subject|2|||
170713713|NCT02543346|616958989|FG002|Second Priming Visit|Withdrawal by Subject|2|||
170713714|NCT02543346|616958990|FG003|Second Priming Visit|Withdrawal by Subject|2|||
170713715|NCT02543346|616958987|FG000|Second Priming Visit|Adverse Event|1|||
170713716|NCT02543346|616958988|FG001|Second Priming Visit|Adverse Event|0|||
170713717|NCT02543346|616958989|FG002|Second Priming Visit|Adverse Event|0|||
170713718|NCT02543346|616958990|FG003|Second Priming Visit|Adverse Event|0|||
170713719|NCT02209324|616958994|FG000|Overall Study|Adverse Event|2|||
170713720|NCT02209324|616958994|FG000|Overall Study|Lack of Efficacy|1|||
170713721|NCT02209324|616958994|FG000|Overall Study|Lost to Follow-up|1|||
170713722|NCT02209324|616958994|FG000|Overall Study|Physician Decision|3|||
170713723|NCT02209324|616958994|FG000|Overall Study|Protocol Violation|14|||
170713724|NCT02209324|616958994|FG000|Overall Study|Withdrawal by Subject|8|||
170713725|NCT02209324|616958994|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
170713726|NCT02209324|616958994|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
170713727|NCT02209324|616958994|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
170713728|NCT01985126|616958995|FG000|Overall Study|Death|15|||
170713729|NCT01985126|616958996|FG001|Overall Study|Death|69|||
170713730|NCT01985126|616958995|FG000|Overall Study|Lost to Follow-up|0|||
170713731|NCT01985126|616958996|FG001|Overall Study|Lost to Follow-up|8|||
170713732|NCT01985126|616958995|FG000|Overall Study|Study Terminated By Sponsor|1|||
170713733|NCT01985126|616958996|FG001|Overall Study|Study Terminated By Sponsor|22|||
170713734|NCT01985126|616958995|FG000|Overall Study|Withdrawal by Subject|2|||
170713735|NCT01985126|616958996|FG001|Overall Study|Withdrawal by Subject|7|||
170713736|NCT03433456|616958999|FG000|Overall Study|Death|1|||
170713737|NCT03433456|616959000|FG001|Overall Study|Death|1|||
170713738|NCT03433456|616958999|FG000|Overall Study|Lost to Follow-up|14|||
170713739|NCT03433456|616959000|FG001|Overall Study|Lost to Follow-up|11|||
170713740|NCT03433456|616958999|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
170713741|NCT03433456|616959000|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
170713742|NCT00153101|616959001|FG000|Overall Study|Lost to Follow-up|14|||
170713743|NCT00153101|616959002|FG001|Overall Study|Lost to Follow-up|14|||
170713744|NCT00153101|616959003|FG002|Overall Study|Lost to Follow-up|12|||
170713745|NCT00153101|616959004|FG003|Overall Study|Lost to Follow-up|5|||
170713746|NCT00153101|616959005|FG004|Overall Study|Lost to Follow-up|5|||
170713747|NCT00153101|616959001|FG000|Overall Study|Withdrawal by Subject|3|||
170713748|NCT00153101|616959002|FG001|Overall Study|Withdrawal by Subject|4|||
170713749|NCT00153101|616959003|FG002|Overall Study|Withdrawal by Subject|3|||
170828259|NCT02970305|617380284|FG001|Overall Study|Protocol Violation|2|||
170828260|NCT02970305|617380283|FG000|Overall Study|Withdrawal by Subject|12|||
170713750|NCT00153101|616959004|FG003|Overall Study|Withdrawal by Subject|3|||
170713751|NCT00153101|616959005|FG004|Overall Study|Withdrawal by Subject|5|||
170713752|NCT01752933|616959006|FG000|Treatment|Disease Progression|3|||
170713753|NCT01752933|616959007|FG001|Treatment|Disease Progression|29|||
170713754|NCT01752933|616959006|FG000|Treatment|Withdrawal by Subject|0|||
170713755|NCT01752933|616959007|FG001|Treatment|Withdrawal by Subject|5|||
170713756|NCT01752933|616959006|FG000|Treatment|Adverse Event|1|||
170713757|NCT01752933|616959007|FG001|Treatment|Adverse Event|4|||
170713758|NCT01752933|616959006|FG000|Treatment|Physician Decision|0|||
170713759|NCT01752933|616959007|FG001|Treatment|Physician Decision|3|||
170713760|NCT01752933|616959006|FG000|Treatment|Death|0|||
170713761|NCT01752933|616959007|FG001|Treatment|Death|2|||
170713762|NCT01752933|616959006|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
170828261|NCT02970305|617380284|FG001|Overall Study|Withdrawal by Subject|11|||
170828262|NCT02970305|617380283|FG000|Overall Study|Not further specified|1|||
170828263|NCT02970305|617380284|FG001|Overall Study|Not further specified|2|||
170828264|NCT02970305|617380283|FG000|Overall Study|Lost to Follow-up|1|||
170828265|NCT02970305|617380284|FG001|Overall Study|Lost to Follow-up|2|||
170828266|NCT02212197|617380285|FG000|Overall Study|Need for radiotherapy|1|||
170828267|NCT02212197|617380286|FG001|Overall Study|Need for radiotherapy|0|||
170828268|NCT02212197|617380287|FG002|Overall Study|Need for radiotherapy|0|||
170828269|NCT01121185|617380288|FG000|Overall Study|Not infused|0|||
170828270|NCT01121185|617380289|FG001|Overall Study|Not infused|1|||
170828271|NCT01121185|617380288|FG000|Overall Study|Not transplanted|1|||
170828272|NCT01121185|617380289|FG001|Overall Study|Not transplanted|0|||
170828273|NCT00496834|617380299|FG000|Overall Study|Withdrawal by Subject|4|||
170828274|NCT00496834|617380300|FG001|Overall Study|Withdrawal by Subject|6|||
170828275|NCT00496834|617380299|FG000|Overall Study|Contraindicated medication administered|0|||
170828276|NCT00496834|617380300|FG001|Overall Study|Contraindicated medication administered|1|||
170828277|NCT00496834|617380299|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
170828278|NCT00496834|617380300|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
170828279|NCT00496834|617380299|FG000|Overall Study|Adverse Event|5|||
170828280|NCT00496834|617380300|FG001|Overall Study|Adverse Event|3|||
170713763|NCT01752933|616959007|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
170713764|NCT01752933|616959006|FG000|Treatment|Patient noncompliant|0|||
170713765|NCT01752933|616959007|FG001|Treatment|Patient noncompliant|1|||
170713766|NCT01752933|616959006|FG000|Treatment|Patient unable to travel to appointments|0|||
170713767|NCT01752933|616959007|FG001|Treatment|Patient unable to travel to appointments|1|||
170713768|NCT01752933|616959006|FG000|Overall Study and Follow-up|Death|4|||
170713769|NCT01752933|616959007|FG001|Overall Study and Follow-up|Death|34|||
170713770|NCT01752933|616959006|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
170713771|NCT01752933|616959007|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
170713772|NCT01752933|616959006|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
170713773|NCT01752933|616959007|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
170713774|NCT01752933|616959006|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
170713775|NCT01752933|616959007|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
170713776|NCT00861341|616959008|FG000|Overall Study|Withdrawal by Subject|2|||
170713777|NCT01975389|616959009|FG000|Overall Study|Adverse Event|10|||
170713778|NCT01975389|616959010|FG001|Overall Study|Adverse Event|6|||
170713779|NCT01975389|616959009|FG000|Overall Study|Death|61|||
170713780|NCT01975389|616959010|FG001|Overall Study|Death|54|||
170713781|NCT01975389|616959009|FG000|Overall Study|Lost to Follow-up|81|||
170713782|NCT01975389|616959010|FG001|Overall Study|Lost to Follow-up|86|||
170713783|NCT01975389|616959009|FG000|Overall Study|Withdrawal by Subject|90|||
170713784|NCT01975389|616959010|FG001|Overall Study|Withdrawal by Subject|76|||
170713785|NCT01975389|616959009|FG000|Overall Study|Other|6|||
170713786|NCT01975389|616959010|FG001|Overall Study|Other|9|||
170713787|NCT01975389|616959009|FG000|Overall Study|Randomized, not treated|4|||
170713788|NCT01975389|616959010|FG001|Overall Study|Randomized, not treated|5|||
170713789|NCT00360334|616959011|FG000|Overall Study|Adverse Event|7|||
170713790|NCT00360334|616959012|FG001|Overall Study|Adverse Event|4|||
170713791|NCT00360334|616959011|FG000|Overall Study|Protocol Violation|1|||
170713792|NCT00360334|616959012|FG001|Overall Study|Protocol Violation|1|||
170713793|NCT00360334|616959011|FG000|Overall Study|Physician Decision|2|||
170713794|NCT00360334|616959012|FG001|Overall Study|Physician Decision|3|||
170713795|NCT00360334|616959011|FG000|Overall Study|Lack of Efficacy|0|||
170713796|NCT00360334|616959012|FG001|Overall Study|Lack of Efficacy|1|||
170713797|NCT00360334|616959011|FG000|Overall Study|Entry criterion not met|1|||
170713798|NCT00360334|616959012|FG001|Overall Study|Entry criterion not met|2|||
170713799|NCT00360334|616959011|FG000|Overall Study|Subject decision|8|||
170713800|NCT00360334|616959012|FG001|Overall Study|Subject decision|2|||
170713801|NCT02752048|616959019|FG000|Overall Study|Withdrawal by Subject|0|||
170828281|NCT00496834|617380299|FG000|Overall Study|IP administration violation|2|||
170828282|NCT00496834|617380300|FG001|Overall Study|IP administration violation|0|||
170828283|NCT00496834|617380299|FG000|Overall Study|Lost to Follow-up|2|||
170828284|NCT00496834|617380300|FG001|Overall Study|Lost to Follow-up|0|||
170828285|NCT00496834|617380299|FG000|Overall Study|Blood Pressure control failure|2|||
170828286|NCT00496834|617380300|FG001|Overall Study|Blood Pressure control failure|1|||
170828287|NCT01393613|617380305|FG000|Overall Study|Adverse Event|11|||
170828288|NCT01393613|617380306|FG001|Overall Study|Adverse Event|11|||
170713802|NCT02752048|616959020|FG001|Overall Study|Withdrawal by Subject|0|||
170713803|NCT02752048|616959021|FG002|Overall Study|Withdrawal by Subject|3|||
170713804|NCT01609556|616959024|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713805|NCT01609556|616959025|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713806|NCT01609556|616959026|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713807|NCT01609556|616959027|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713808|NCT01609556|616959028|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
170828289|NCT01393613|617380307|FG002|Overall Study|Adverse Event|13|||
170828290|NCT01393613|617380308|FG003|Overall Study|Adverse Event|22|||
170828291|NCT01393613|617380305|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
170828292|NCT01393613|617380306|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
170828293|NCT01393613|617380307|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
170828294|NCT01393613|617380308|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
170828295|NCT01393613|617380305|FG000|Overall Study|Physician Decision|2|||
170828296|NCT01393613|617380306|FG001|Overall Study|Physician Decision|0|||
170828297|NCT01393613|617380307|FG002|Overall Study|Physician Decision|0|||
170828298|NCT01393613|617380308|FG003|Overall Study|Physician Decision|1|||
170828299|NCT01393613|617380305|FG000|Overall Study|Withdrawal by Subject|15|||
170828300|NCT01393613|617380306|FG001|Overall Study|Withdrawal by Subject|25|||
170828301|NCT01393613|617380307|FG002|Overall Study|Withdrawal by Subject|23|||
170828302|NCT01393613|617380308|FG003|Overall Study|Withdrawal by Subject|21|||
170828303|NCT01393613|617380305|FG000|Overall Study|Protocol Deviation|2|||
170828304|NCT01393613|617380306|FG001|Overall Study|Protocol Deviation|1|||
170828305|NCT01393613|617380307|FG002|Overall Study|Protocol Deviation|0|||
170828306|NCT01393613|617380308|FG003|Overall Study|Protocol Deviation|0|||
170828307|NCT01393613|617380305|FG000|Overall Study|Lack of Efficacy|9|||
170828308|NCT01393613|617380306|FG001|Overall Study|Lack of Efficacy|20|||
170828309|NCT01393613|617380307|FG002|Overall Study|Lack of Efficacy|16|||
170828310|NCT01393613|617380308|FG003|Overall Study|Lack of Efficacy|21|||
170828311|NCT02154347|617380313|FG000|Double-blind Period|Adverse Event|1|||
170828312|NCT02154347|617380314|FG001|Double-blind Period|Adverse Event|2|||
170828313|NCT02154347|617380313|FG000|Double-blind Period|Lack of Efficacy|1|||
170828314|NCT02154347|617380314|FG001|Double-blind Period|Lack of Efficacy|0|||
170828315|NCT02154347|617380313|FG000|Double-blind Period|Physician Decision|0|||
170828316|NCT02154347|617380314|FG001|Double-blind Period|Physician Decision|1|||
170828317|NCT02154347|617380313|FG000|Double-blind Period|Withdrawal by Subject|1|||
170828318|NCT02154347|617380314|FG001|Double-blind Period|Withdrawal by Subject|1|||
170828319|NCT02154347|617380313|FG000|Open-label Period|Adverse Event|3|||
170828320|NCT02154347|617380314|FG001|Open-label Period|Adverse Event|4|||
170828321|NCT02154347|617380313|FG000|Open-label Period|Lack of Efficacy|4|||
170828322|NCT02154347|617380314|FG001|Open-label Period|Lack of Efficacy|19|||
170828323|NCT02154347|617380313|FG000|Open-label Period|Protocol Violation|0|||
170828324|NCT02154347|617380314|FG001|Open-label Period|Protocol Violation|1|||
170828325|NCT02154347|617380313|FG000|Open-label Period|Withdrawal by Subject|0|||
170828326|NCT02154347|617380314|FG001|Open-label Period|Withdrawal by Subject|1|||
170828327|NCT02820597|617381895|FG000|Overall Study|Lost to Follow-up|12|||
170828328|NCT00761956|617381896|FG000|Overall Study|Lost to Follow-up|6|||
170828329|NCT00761956|617381897|FG001|Overall Study|Lost to Follow-up|11|||
170828330|NCT00761956|617381896|FG000|Overall Study|Withdrawal by Subject|3|||
170828331|NCT00761956|617381897|FG001|Overall Study|Withdrawal by Subject|8|||
170828332|NCT00761956|617381896|FG000|Overall Study|Death|0|||
170828333|NCT00761956|617381897|FG001|Overall Study|Death|1|||
170828334|NCT00761956|617381896|FG000|Overall Study|Adverse Event|26|||
170828335|NCT00761956|617381897|FG001|Overall Study|Adverse Event|34|||
170828336|NCT04398368|617381901|FG000|Overall Study|Withdrawal by Subject|2|||
170828337|NCT02166476|617381902|FG000|Overall Study|Withdrawal by Subject|5|||
170828338|NCT02166476|617381903|FG001|Overall Study|Withdrawal by Subject|7|||
170828339|NCT02166476|617381902|FG000|Overall Study|Adverse Event|3|||
170713809|NCT01609556|616959029|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713810|NCT01609556|616959030|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713811|NCT01609556|616959031|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
170713812|NCT01609556|616959032|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
170713813|NCT01609556|616959033|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713814|NCT01609556|616959034|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
170713815|NCT01609556|616959035|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
170713816|NCT01609556|616959036|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713817|NCT01609556|616959037|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713818|NCT01609556|616959038|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713819|NCT01609556|616959039|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
170713820|NCT01609556|616959024|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
170713821|NCT01609556|616959025|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
170713822|NCT01609556|616959026|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
170713823|NCT01609556|616959027|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
170713824|NCT01609556|616959028|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
170713825|NCT01609556|616959029|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
170713826|NCT01609556|616959030|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
170713827|NCT01609556|616959031|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
170713828|NCT01609556|616959032|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
170713829|NCT01609556|616959033|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
170713830|NCT01609556|616959034|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
170713831|NCT01609556|616959035|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
170713832|NCT01609556|616959036|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
170713833|NCT01609556|616959037|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
170713834|NCT01609556|616959038|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
170713835|NCT01609556|616959039|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
170713836|NCT01609556|616959024|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713837|NCT01609556|616959025|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713838|NCT01609556|616959026|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713839|NCT01609556|616959027|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713840|NCT01609556|616959028|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713841|NCT01609556|616959029|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
170713842|NCT01609556|616959030|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
170713843|NCT01609556|616959031|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713844|NCT01609556|616959032|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713845|NCT01609556|616959033|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
170713846|NCT01609556|616959034|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
170713847|NCT01609556|616959035|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
170713848|NCT01609556|616959036|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713849|NCT01609556|616959037|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713850|NCT01609556|616959038|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713851|NCT01609556|616959039|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
170713852|NCT01609556|616959024|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713853|NCT01609556|616959025|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713854|NCT01609556|616959026|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713855|NCT01609556|616959027|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713856|NCT01609556|616959028|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713857|NCT01609556|616959029|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
170713858|NCT01609556|616959030|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713859|NCT01609556|616959031|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713860|NCT01609556|616959032|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713861|NCT01609556|616959033|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713862|NCT01609556|616959034|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713863|NCT01609556|616959035|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
170713864|NCT01609556|616959036|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713865|NCT01609556|616959037|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713866|NCT01609556|616959038|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713867|NCT01609556|616959039|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
170713868|NCT01609556|616959024|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713869|NCT01609556|616959025|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713870|NCT01609556|616959026|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170828340|NCT02166476|617381903|FG001|Overall Study|Adverse Event|3|||
170828341|NCT02166476|617381902|FG000|Overall Study|Lost to Follow-up|5|||
170828342|NCT02166476|617381903|FG001|Overall Study|Lost to Follow-up|10|||
170828343|NCT02166476|617381902|FG000|Overall Study|Physician Decision|1|||
170828344|NCT02166476|617381903|FG001|Overall Study|Physician Decision|0|||
170828345|NCT02166476|617381902|FG000|Overall Study|Unable to Come for Visit|0|||
170828346|NCT02166476|617381903|FG001|Overall Study|Unable to Come for Visit|3|||
170828347|NCT04035577|617381906|FG000|Overall Study|Lost to Follow-up|1|||
170828348|NCT04035577|617381906|FG000|Overall Study|Withdrawal by Subject|1|||
170828349|NCT00846768|617381908|FG000|Overall Study|Adverse Event|0|||
170828350|NCT00846768|617381909|FG001|Overall Study|Adverse Event|1|||
170828351|NCT00846768|617381910|FG002|Overall Study|Adverse Event|0|||
170828352|NCT00846768|617381911|FG003|Overall Study|Adverse Event|0|||
170828353|NCT00634920|617381913|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
170828354|NCT00634920|617381914|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
170828355|NCT00634920|617381915|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
170828356|NCT00634920|617381913|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
170828357|NCT00634920|617381914|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
170828358|NCT00634920|617381915|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
170828359|NCT00634920|617381913|FG000|Period 1 - Pre-Randomization|Rejections|0|||
170828360|NCT00634920|617381914|FG001|Period 1 - Pre-Randomization|Rejections|0|||
170828361|NCT00634920|617381915|FG002|Period 1 - Pre-Randomization|Rejections|55|||
170713871|NCT01609556|616959027|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713872|NCT01609556|616959028|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713873|NCT01609556|616959029|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
170713874|NCT01609556|616959030|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713875|NCT01609556|616959031|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713876|NCT01609556|616959032|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713877|NCT01609556|616959033|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713878|NCT01609556|616959034|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713879|NCT01609556|616959035|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713880|NCT01609556|616959036|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713881|NCT01609556|616959037|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713882|NCT01609556|616959038|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713883|NCT01609556|616959039|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
170713884|NCT01609556|616959024|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713885|NCT01609556|616959025|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713886|NCT01609556|616959026|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713887|NCT01609556|616959027|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713888|NCT01609556|616959028|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713889|NCT01609556|616959029|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713890|NCT01609556|616959030|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713891|NCT01609556|616959031|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713892|NCT01609556|616959032|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
170713893|NCT01609556|616959033|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713894|NCT01609556|616959034|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713895|NCT01609556|616959035|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713896|NCT01609556|616959036|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713897|NCT01609556|616959037|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713898|NCT01609556|616959038|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713899|NCT01609556|616959039|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
170713900|NCT01609556|616959024|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
170713901|NCT01609556|616959025|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713902|NCT01609556|616959026|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713903|NCT01609556|616959027|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713904|NCT01609556|616959028|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713905|NCT01609556|616959029|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
170713906|NCT01609556|616959030|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713907|NCT01609556|616959031|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713908|NCT01609556|616959032|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713909|NCT01609556|616959033|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713910|NCT01609556|616959034|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
170713911|NCT01609556|616959035|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713912|NCT01609556|616959036|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713913|NCT01609556|616959037|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713914|NCT01609556|616959038|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713915|NCT01609556|616959039|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
170713916|NCT01609556|616959024|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170828362|NCT00634920|617381913|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
170828363|NCT00634920|617381914|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
170828364|NCT00634920|617381915|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
170828365|NCT00634920|617381913|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
170828366|NCT00634920|617381914|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
170828367|NCT00634920|617381915|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
170828368|NCT00634920|617381913|FG000|Period 1 - Pre-Randomization|Other issues|0|||
170828369|NCT00634920|617381914|FG001|Period 1 - Pre-Randomization|Other issues|0|||
170828370|NCT00634920|617381915|FG002|Period 1 - Pre-Randomization|Other issues|6|||
170828371|NCT00634920|617381913|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
170828372|NCT00634920|617381914|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
170828373|NCT00634920|617381915|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
170828374|NCT00634920|617381913|FG000|Period 2 - Post-Randomization|Rejection|11|||
170828375|NCT00634920|617381914|FG001|Period 2 - Post-Randomization|Rejection|5|||
170828376|NCT00634920|617381915|FG002|Period 2 - Post-Randomization|Rejection|0|||
170828377|NCT00634920|617381913|FG000|Period 2 - Post-Randomization|Death|2|||
170828378|NCT00634920|617381914|FG001|Period 2 - Post-Randomization|Death|5|||
170828379|NCT00634920|617381915|FG002|Period 2 - Post-Randomization|Death|0|||
170828380|NCT00634920|617381913|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
170828381|NCT00634920|617381914|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
170828382|NCT00634920|617381915|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
170828383|NCT00634920|617381913|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
170828384|NCT00634920|617381914|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
170828385|NCT00634920|617381915|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
170828386|NCT00644878|617381916|FG000|Overall Study|Adverse Event|2|||
170828387|NCT00644878|617381916|FG000|Overall Study|Abnormal laboratory value|3|||
170828388|NCT00644878|617381916|FG000|Overall Study|Protocol deviation|2|||
170828389|NCT00644878|617381916|FG000|Overall Study|Treatment duration completed as per protocol|11|||
170828390|NCT04353817|617381917|FG000|Overall Study|Adverse Event|0|||
170828391|NCT04353817|617381918|FG001|Overall Study|Adverse Event|1|||
170828392|NCT00665223|617381921|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
170828393|NCT00665223|617381922|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
170828394|NCT00665223|617381923|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
170828395|NCT00665223|617381921|FG000|Randomized Phase (26 Weeks)|Death|0|||
170828396|NCT00665223|617381922|FG001|Randomized Phase (26 Weeks)|Death|0|||
170828397|NCT00665223|617381923|FG002|Randomized Phase (26 Weeks)|Death|1|||
170828398|NCT00665223|617381921|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
170828399|NCT00665223|617381922|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
170828400|NCT00665223|617381923|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
170828401|NCT00665223|617381921|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
170828402|NCT00665223|617381922|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
170828403|NCT00665223|617381923|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
170828404|NCT00665223|617381921|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
170828405|NCT00665223|617381922|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
170828406|NCT00665223|617381923|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
170828407|NCT00665223|617381921|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
170828408|NCT00665223|617381922|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
170828409|NCT00665223|617381923|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
170828410|NCT00665223|617381921|FG000|Open-Label Period (26 Weeks)|Death|0|||
170828411|NCT00665223|617381922|FG001|Open-Label Period (26 Weeks)|Death|1|||
170828412|NCT00665223|617381923|FG002|Open-Label Period (26 Weeks)|Death|0|||
170828413|NCT00665223|617381921|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
170828414|NCT00665223|617381922|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
170828415|NCT00665223|617381923|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
170828416|NCT00665223|617381921|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
170828417|NCT00665223|617381922|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
170828418|NCT00665223|617381923|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
170828419|NCT00665223|617381921|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
170828420|NCT00665223|617381922|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
170828421|NCT00665223|617381923|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
170828422|NCT00665223|617381921|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
170828423|NCT00665223|617381922|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
170828424|NCT00665223|617381923|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
170828425|NCT00363649|617381924|FG000|Overall Study|Withdrawal by Subject|1|||
170828426|NCT00363649|617381925|FG001|Overall Study|Withdrawal by Subject|1|||
170828427|NCT00363649|617381924|FG000|Overall Study|Adverse Event|6|||
170828428|NCT00363649|617381925|FG001|Overall Study|Adverse Event|0|||
170828429|NCT02143063|617381930|FG000|Overall Study|Lost to Follow-up|16|||
170828430|NCT02143063|617381931|FG001|Overall Study|Lost to Follow-up|28|||
170828431|NCT02143063|617381932|FG002|Overall Study|Lost to Follow-up|29|||
170828432|NCT02143063|617381930|FG000|Overall Study|Withdrawal by Subject|0|||
170828433|NCT02143063|617381931|FG001|Overall Study|Withdrawal by Subject|1|||
170828434|NCT02143063|617381932|FG002|Overall Study|Withdrawal by Subject|0|||
170828435|NCT02143063|617381930|FG000|Overall Study|Death|0|||
170828436|NCT02143063|617381931|FG001|Overall Study|Death|1|||
170828437|NCT02143063|617381932|FG002|Overall Study|Death|1|||
170828438|NCT00878553|617381933|FG000|Sleep Study|Withdrawal by Subject|2|||
170828439|NCT00878553|617381934|FG001|Sleep Study|Withdrawal by Subject|0|||
170828440|NCT00878553|617381935|FG002|Sleep Study|Withdrawal by Subject|0|||
170828441|NCT00878553|617381936|FG003|Sleep Study|Withdrawal by Subject|0|||
170828442|NCT00878553|617381937|FG004|Sleep Study|Withdrawal by Subject|0|||
170828443|NCT00878553|617381933|FG000|Sleep Study|Lost to Follow-up|1|||
170828444|NCT00878553|617381934|FG001|Sleep Study|Lost to Follow-up|0|||
170828445|NCT00878553|617381935|FG002|Sleep Study|Lost to Follow-up|0|||
170828446|NCT00878553|617381936|FG003|Sleep Study|Lost to Follow-up|0|||
170828447|NCT00878553|617381937|FG004|Sleep Study|Lost to Follow-up|0|||
170828448|NCT00878553|617381933|FG000|Sleep Study|car accident|1|||
170828449|NCT00878553|617381934|FG001|Sleep Study|car accident|0|||
170828450|NCT00878553|617381935|FG002|Sleep Study|car accident|0|||
170828451|NCT00878553|617381936|FG003|Sleep Study|car accident|0|||
170828452|NCT00878553|617381937|FG004|Sleep Study|car accident|0|||
170828453|NCT00878553|617381933|FG000|Sleep Study|family emergency|1|||
170828454|NCT00878553|617381934|FG001|Sleep Study|family emergency|0|||
170828455|NCT00878553|617381935|FG002|Sleep Study|family emergency|0|||
170828456|NCT00878553|617381936|FG003|Sleep Study|family emergency|0|||
170828457|NCT00878553|617381937|FG004|Sleep Study|family emergency|0|||
170828458|NCT00878553|617381933|FG000|PK Study|Withdrawal by Subject|0|||
170828459|NCT00878553|617381934|FG001|PK Study|Withdrawal by Subject|0|||
170828460|NCT00878553|617381935|FG002|PK Study|Withdrawal by Subject|0|||
170828461|NCT00878553|617381936|FG003|PK Study|Withdrawal by Subject|1|||
170828462|NCT00878553|617381937|FG004|PK Study|Withdrawal by Subject|0|||
170828463|NCT03589300|617381938|FG000|Overall Study|Adverse Event|2|||
170828464|NCT03589300|617381938|FG000|Overall Study|Death|4|||
170828465|NCT03589300|617381938|FG000|Overall Study|Lost to Follow-up|12|||
170828466|NCT03589300|617381938|FG000|Overall Study|Withdrawal by Subject|5|||
170828467|NCT02161185|617381939|FG000|Treatment Phase|Administrative/Other|7|||
170828468|NCT02573883|617381943|FG000|Six Month Follow Up|Lost to Follow-up|1|||
170828469|NCT02573883|617381944|FG001|Six Month Follow Up|Lost to Follow-up|0|||
170828470|NCT02573883|617381945|FG002|Six Month Follow Up|Lost to Follow-up|0|||
170828471|NCT02573883|617381946|FG003|Six Month Follow Up|Lost to Follow-up|0|||
170828472|NCT02573883|617381943|FG000|One Year Follow Up|Lost to Follow-up|2|||
170828473|NCT02573883|617381944|FG001|One Year Follow Up|Lost to Follow-up|1|||
170828474|NCT02573883|617381945|FG002|One Year Follow Up|Lost to Follow-up|0|||
170828475|NCT02573883|617381946|FG003|One Year Follow Up|Lost to Follow-up|0|||
170828476|NCT00582114|617381947|FG000|Overall Study|Death|4|||
170828477|NCT00582114|617381948|FG001|Overall Study|Death|4|||
170828478|NCT00582114|617381947|FG000|Overall Study|Kidney Transplant|3|||
170828479|NCT00582114|617381948|FG001|Overall Study|Kidney Transplant|1|||
170828480|NCT00582114|617381947|FG000|Overall Study|Lost to Follow-up|7|||
170828481|NCT00582114|617381948|FG001|Overall Study|Lost to Follow-up|6|||
170828482|NCT00582114|617381947|FG000|Overall Study|Withdrawal by Subject|8|||
170828483|NCT00582114|617381948|FG001|Overall Study|Withdrawal by Subject|16|||
170828484|NCT00582114|617381947|FG000|Overall Study|Adverse Event|1|||
170828485|NCT00582114|617381948|FG001|Overall Study|Adverse Event|1|||
170828486|NCT00582114|617381947|FG000|Overall Study|Physician Decision|0|||
170828487|NCT00582114|617381948|FG001|Overall Study|Physician Decision|6|||
170828488|NCT00582114|617381947|FG000|Overall Study|Stopped by data safety monitoring board|19|||
170828489|NCT00582114|617381948|FG001|Overall Study|Stopped by data safety monitoring board|20|||
170828490|NCT03796208|617381956|FG000|Overall Study|Withdrawal by Subject|3|||
170828491|NCT03796208|617381957|FG001|Overall Study|Withdrawal by Subject|0|||
170828492|NCT03796208|617381956|FG000|Overall Study|Loss of pregnancy|1|||
170828493|NCT03796208|617381957|FG001|Overall Study|Loss of pregnancy|1|||
170828494|NCT03796208|617381956|FG000|Overall Study|Changed prenatal clinics|0|||
170828495|NCT03796208|617381957|FG001|Overall Study|Changed prenatal clinics|5|||
170828496|NCT03796208|617381956|FG000|Overall Study|Lost to Follow-up|20|||
170828497|NCT03796208|617381957|FG001|Overall Study|Lost to Follow-up|16|||
170828498|NCT01263925|617381958|FG000|Overall Study|Protocol Violation|1|||
170828499|NCT01263925|617381959|FG001|Overall Study|Protocol Violation|0|||
170828500|NCT01263925|617381958|FG000|Overall Study|Lack of Efficacy|0|||
170828501|NCT01263925|617381959|FG001|Overall Study|Lack of Efficacy|1|||
170828502|NCT01263925|617381958|FG000|Overall Study|Adverse Event|23|||
170828503|NCT01263925|617381959|FG001|Overall Study|Adverse Event|22|||
170828504|NCT01263925|617381958|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
170828505|NCT01263925|617381959|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
170828506|NCT01263925|617381958|FG000|Overall Study|Withdrawal by Subject|6|||
170828507|NCT01263925|617381959|FG001|Overall Study|Withdrawal by Subject|8|||
170828508|NCT01263925|617381958|FG000|Overall Study|Other|4|||
170828509|NCT01263925|617381959|FG001|Overall Study|Other|4|||
170828510|NCT01263925|617381958|FG000|Overall Study|Lost to Follow-up|3|||
170828511|NCT01263925|617381959|FG001|Overall Study|Lost to Follow-up|1|||
170828512|NCT01263925|617381958|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
170828513|NCT01263925|617381959|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
170828514|NCT01263925|617381958|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
170828515|NCT01263925|617381959|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
170828516|NCT01263925|617381958|FG000|Overall Study|AE/ Withdrawal|1|||
170828517|NCT01263925|617381959|FG001|Overall Study|AE/ Withdrawal|4|||
170828518|NCT01263925|617381958|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
170828519|NCT01263925|617381959|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
170828520|NCT01263925|617381958|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
170828521|NCT01263925|617381959|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
170828522|NCT01263925|617381958|FG000|Overall Study|Withdrawal/ Not specified|0|||
170828523|NCT01263925|617381959|FG001|Overall Study|Withdrawal/ Not specified|1|||
170828524|NCT03028012|617381965|FG000|Overall Study|Lost to Follow-up|2|||
170828525|NCT03028012|617381966|FG001|Overall Study|Lost to Follow-up|3|||
170828526|NCT03028012|617381967|FG002|Overall Study|Lost to Follow-up|3|||
170828527|NCT01726517|617381968|FG000|Overall Study|Withdrawal by Subject|0|||
170828528|NCT01726517|617381969|FG001|Overall Study|Withdrawal by Subject|0|||
170828529|NCT01726517|617381970|FG002|Overall Study|Withdrawal by Subject|1|||
170828530|NCT01726517|617381971|FG003|Overall Study|Withdrawal by Subject|0|||
170828531|NCT01726517|617381972|FG004|Overall Study|Withdrawal by Subject|0|||
170828532|NCT03765164|617381978|FG000|Pre-intervention|Withdrawal by Subject|5|||
170828533|NCT03765164|617381979|FG001|Pre-intervention|Withdrawal by Subject|6|||
170828534|NCT02484547|617381980|FG000|Placebo-Controlled Period|Adverse Event|10|||
170828535|NCT02484547|617381981|FG001|Placebo-Controlled Period|Adverse Event|13|||
170828536|NCT02484547|617381982|FG002|Placebo-Controlled Period|Adverse Event|20|||
170828537|NCT02484547|617381983|FG003|Placebo-Controlled Period|Adverse Event|0|||
170828538|NCT02484547|617381984|FG004|Placebo-Controlled Period|Adverse Event|0|||
170828539|NCT02484547|617381985|FG005|Placebo-Controlled Period|Adverse Event|0|||
170828540|NCT02484547|617381986|FG006|Placebo-Controlled Period|Adverse Event|0|||
170828541|NCT02484547|617381980|FG000|Placebo-Controlled Period|Change of Treatment|0|||
170828542|NCT02484547|617381981|FG001|Placebo-Controlled Period|Change of Treatment|0|||
170828543|NCT02484547|617381982|FG002|Placebo-Controlled Period|Change of Treatment|1|||
170828544|NCT02484547|617381983|FG003|Placebo-Controlled Period|Change of Treatment|0|||
170828545|NCT02484547|617381984|FG004|Placebo-Controlled Period|Change of Treatment|0|||
170828546|NCT02484547|617381985|FG005|Placebo-Controlled Period|Change of Treatment|0|||
170828547|NCT02484547|617381986|FG006|Placebo-Controlled Period|Change of Treatment|0|||
170828548|NCT02484547|617381980|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
170828549|NCT02484547|617381981|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
170828550|NCT02484547|617381982|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
170828551|NCT02484547|617381983|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
170828552|NCT02484547|617381984|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
170828553|NCT02484547|617381985|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
170828554|NCT02484547|617381986|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
170828555|NCT02484547|617381980|FG000|Placebo-Controlled Period|Death|5|||
170828556|NCT02484547|617381981|FG001|Placebo-Controlled Period|Death|0|||
170828557|NCT02484547|617381982|FG002|Placebo-Controlled Period|Death|6|||
170828558|NCT02484547|617381983|FG003|Placebo-Controlled Period|Death|0|||
170828559|NCT02484547|617381984|FG004|Placebo-Controlled Period|Death|0|||
170828560|NCT02484547|617381985|FG005|Placebo-Controlled Period|Death|0|||
170828561|NCT02484547|617381986|FG006|Placebo-Controlled Period|Death|0|||
170828562|NCT02484547|617381980|FG000|Placebo-Controlled Period|Disease Progression|2|||
170828563|NCT02484547|617381981|FG001|Placebo-Controlled Period|Disease Progression|0|||
170828564|NCT02484547|617381982|FG002|Placebo-Controlled Period|Disease Progression|1|||
170828565|NCT02484547|617381983|FG003|Placebo-Controlled Period|Disease Progression|0|||
170828566|NCT02484547|617381984|FG004|Placebo-Controlled Period|Disease Progression|0|||
170828567|NCT02484547|617381985|FG005|Placebo-Controlled Period|Disease Progression|0|||
170828568|NCT02484547|617381986|FG006|Placebo-Controlled Period|Disease Progression|0|||
170828569|NCT02484547|617381980|FG000|Placebo-Controlled Period|Investigator Decision|2|||
170828570|NCT02484547|617381981|FG001|Placebo-Controlled Period|Investigator Decision|2|||
170828571|NCT02484547|617381982|FG002|Placebo-Controlled Period|Investigator Decision|5|||
170828572|NCT02484547|617381983|FG003|Placebo-Controlled Period|Investigator Decision|0|||
170828573|NCT02484547|617381984|FG004|Placebo-Controlled Period|Investigator Decision|0|||
170828574|NCT02484547|617381985|FG005|Placebo-Controlled Period|Investigator Decision|0|||
170828575|NCT02484547|617381986|FG006|Placebo-Controlled Period|Investigator Decision|0|||
170828576|NCT02484547|617381980|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
170828577|NCT02484547|617381981|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
170828578|NCT02484547|617381982|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
170828579|NCT02484547|617381983|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
170828580|NCT02484547|617381984|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
170828581|NCT02484547|617381985|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
170828582|NCT02484547|617381986|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
170828583|NCT02484547|617381980|FG000|Placebo-Controlled Period|Relocation|1|||
170828584|NCT02484547|617381981|FG001|Placebo-Controlled Period|Relocation|1|||
170828585|NCT02484547|617381982|FG002|Placebo-Controlled Period|Relocation|1|||
170828586|NCT02484547|617381983|FG003|Placebo-Controlled Period|Relocation|0|||
170828587|NCT02484547|617381984|FG004|Placebo-Controlled Period|Relocation|0|||
170828588|NCT02484547|617381985|FG005|Placebo-Controlled Period|Relocation|0|||
170828589|NCT02484547|617381986|FG006|Placebo-Controlled Period|Relocation|0|||
170828590|NCT02484547|617381980|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
170828591|NCT02484547|617381981|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
170828592|NCT02484547|617381982|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
170828593|NCT02484547|617381983|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
170828594|NCT02484547|617381984|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
170828595|NCT02484547|617381985|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
170828596|NCT02484547|617381986|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
170828597|NCT02484547|617381980|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
170828598|NCT02484547|617381981|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
170828599|NCT02484547|617381982|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
170828600|NCT02484547|617381983|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170828601|NCT02484547|617381984|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170828602|NCT02484547|617381985|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170828603|NCT02484547|617381986|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170828604|NCT02484547|617381980|FG000|Placebo-Controlled Period|Reason not Specified|216|||
170828605|NCT02484547|617381981|FG001|Placebo-Controlled Period|Reason not Specified|194|||
170828606|NCT02484547|617381982|FG002|Placebo-Controlled Period|Reason not Specified|183|||
170828607|NCT02484547|617381983|FG003|Placebo-Controlled Period|Reason not Specified|0|||
170828608|NCT02484547|617381984|FG004|Placebo-Controlled Period|Reason not Specified|0|||
170828609|NCT02484547|617381985|FG005|Placebo-Controlled Period|Reason not Specified|0|||
170828610|NCT02484547|617381986|FG006|Placebo-Controlled Period|Reason not Specified|0|||
170828611|NCT02484547|617381980|FG000|Long-Term Extension Period|Adverse Event|0|||
170828612|NCT02484547|617381981|FG001|Long-Term Extension Period|Adverse Event|0|||
170828613|NCT02484547|617381982|FG002|Long-Term Extension Period|Adverse Event|0|||
170828614|NCT02484547|617381983|FG003|Long-Term Extension Period|Adverse Event|0|||
170828615|NCT02484547|617381984|FG004|Long-Term Extension Period|Adverse Event|1|||
170828616|NCT02484547|617381985|FG005|Long-Term Extension Period|Adverse Event|3|||
170828617|NCT02484547|617381986|FG006|Long-Term Extension Period|Adverse Event|2|||
170828618|NCT02484547|617381980|FG000|Long-Term Extension Period|Death|0|||
170828619|NCT02484547|617381981|FG001|Long-Term Extension Period|Death|0|||
170828620|NCT02484547|617381982|FG002|Long-Term Extension Period|Death|0|||
170828621|NCT02484547|617381983|FG003|Long-Term Extension Period|Death|0|||
170828622|NCT02484547|617381984|FG004|Long-Term Extension Period|Death|0|||
170828623|NCT02484547|617381985|FG005|Long-Term Extension Period|Death|3|||
170828624|NCT02484547|617381986|FG006|Long-Term Extension Period|Death|0|||
170828625|NCT02484547|617381980|FG000|Long-Term Extension Period|Disease Progression|0|||
170713917|NCT01609556|616959025|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713918|NCT01609556|616959026|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713919|NCT01609556|616959027|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713920|NCT01609556|616959028|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713921|NCT01609556|616959029|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713922|NCT01609556|616959030|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713923|NCT01609556|616959031|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713924|NCT01609556|616959032|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713925|NCT01609556|616959033|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713926|NCT01609556|616959034|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713927|NCT01609556|616959035|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
170713928|NCT01609556|616959036|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
170713929|NCT01609556|616959037|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
170713930|NCT01609556|616959038|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
170713931|NCT01609556|616959039|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
170713932|NCT01609556|616959024|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713933|NCT01609556|616959025|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713934|NCT01609556|616959026|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713935|NCT01609556|616959027|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713936|NCT01609556|616959028|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713937|NCT01609556|616959029|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713938|NCT01609556|616959030|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713939|NCT01609556|616959031|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713940|NCT01609556|616959032|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713941|NCT01609556|616959033|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713942|NCT01609556|616959034|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713943|NCT01609556|616959035|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
170713944|NCT01609556|616959036|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
170713945|NCT01609556|616959037|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
170713946|NCT01609556|616959038|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
170713947|NCT01609556|616959039|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
170713948|NCT01609556|616959024|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713949|NCT01609556|616959025|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713950|NCT01609556|616959026|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713951|NCT01609556|616959027|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713952|NCT01609556|616959028|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713953|NCT01609556|616959029|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713954|NCT01609556|616959030|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713955|NCT01609556|616959031|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713956|NCT01609556|616959032|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713957|NCT01609556|616959033|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713958|NCT01609556|616959034|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713959|NCT01609556|616959035|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
170713960|NCT01609556|616959036|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
170713961|NCT01609556|616959037|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
170713962|NCT01609556|616959038|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
170713963|NCT01609556|616959039|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
170713964|NCT01609556|616959024|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713965|NCT01609556|616959025|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713966|NCT01609556|616959026|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713967|NCT01609556|616959027|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713968|NCT01609556|616959028|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713969|NCT01609556|616959029|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713970|NCT01609556|616959030|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713971|NCT01609556|616959031|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713972|NCT01609556|616959032|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713973|NCT01609556|616959033|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713974|NCT01609556|616959034|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713975|NCT01609556|616959035|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713976|NCT01609556|616959036|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
170713977|NCT01609556|616959037|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713978|NCT01609556|616959038|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713979|NCT01609556|616959039|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
170713980|NCT01609556|616959024|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713981|NCT01609556|616959025|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713982|NCT01609556|616959026|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713983|NCT01609556|616959027|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713984|NCT01609556|616959028|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713985|NCT01609556|616959029|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713986|NCT01609556|616959030|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713987|NCT01609556|616959031|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713988|NCT01609556|616959032|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170828626|NCT02484547|617381981|FG001|Long-Term Extension Period|Disease Progression|0|||
170828627|NCT02484547|617381982|FG002|Long-Term Extension Period|Disease Progression|0|||
170828628|NCT02484547|617381983|FG003|Long-Term Extension Period|Disease Progression|0|||
170828629|NCT02484547|617381984|FG004|Long-Term Extension Period|Disease Progression|2|||
170828630|NCT02484547|617381985|FG005|Long-Term Extension Period|Disease Progression|4|||
170828631|NCT02484547|617381986|FG006|Long-Term Extension Period|Disease Progression|0|||
170828632|NCT02484547|617381980|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
170828633|NCT02484547|617381981|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
170828634|NCT02484547|617381982|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
170828635|NCT02484547|617381983|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
170828636|NCT02484547|617381984|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
170828637|NCT02484547|617381985|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
170828638|NCT02484547|617381986|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
170828639|NCT02484547|617381980|FG000|Long-Term Extension Period|Loss of Capacity|0|||
170828640|NCT02484547|617381981|FG001|Long-Term Extension Period|Loss of Capacity|0|||
170828641|NCT02484547|617381982|FG002|Long-Term Extension Period|Loss of Capacity|0|||
170828642|NCT02484547|617381983|FG003|Long-Term Extension Period|Loss of Capacity|0|||
170828643|NCT02484547|617381984|FG004|Long-Term Extension Period|Loss of Capacity|1|||
170828644|NCT02484547|617381985|FG005|Long-Term Extension Period|Loss of Capacity|0|||
170828645|NCT02484547|617381986|FG006|Long-Term Extension Period|Loss of Capacity|0|||
170828646|NCT02484547|617381980|FG000|Long-Term Extension Period|Change of Treatment|0|||
170828647|NCT02484547|617381981|FG001|Long-Term Extension Period|Change of Treatment|0|||
170828648|NCT02484547|617381982|FG002|Long-Term Extension Period|Change of Treatment|0|||
170828649|NCT02484547|617381983|FG003|Long-Term Extension Period|Change of Treatment|0|||
170828650|NCT02484547|617381984|FG004|Long-Term Extension Period|Change of Treatment|0|||
170828651|NCT02484547|617381985|FG005|Long-Term Extension Period|Change of Treatment|0|||
170828652|NCT02484547|617381986|FG006|Long-Term Extension Period|Change of Treatment|1|||
170828653|NCT02484547|617381980|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
170828654|NCT02484547|617381981|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
170828655|NCT02484547|617381982|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
170828656|NCT02484547|617381983|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
170828657|NCT02484547|617381984|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
170828658|NCT02484547|617381985|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
170828659|NCT02484547|617381986|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
170828660|NCT02484547|617381980|FG000|Long-Term Extension Period|Investigator Decision|0|||
170828661|NCT02484547|617381981|FG001|Long-Term Extension Period|Investigator Decision|0|||
170828662|NCT02484547|617381982|FG002|Long-Term Extension Period|Investigator Decision|0|||
170828663|NCT02484547|617381983|FG003|Long-Term Extension Period|Investigator Decision|2|||
170828664|NCT02484547|617381984|FG004|Long-Term Extension Period|Investigator Decision|1|||
170828665|NCT02484547|617381985|FG005|Long-Term Extension Period|Investigator Decision|0|||
170828666|NCT02484547|617381986|FG006|Long-Term Extension Period|Investigator Decision|1|||
170828667|NCT02484547|617381980|FG000|Long-Term Extension Period|Relocation|0|||
170828668|NCT02484547|617381981|FG001|Long-Term Extension Period|Relocation|0|||
170828669|NCT02484547|617381982|FG002|Long-Term Extension Period|Relocation|0|||
170828670|NCT02484547|617381983|FG003|Long-Term Extension Period|Relocation|1|||
170828671|NCT02484547|617381984|FG004|Long-Term Extension Period|Relocation|1|||
170828672|NCT02484547|617381985|FG005|Long-Term Extension Period|Relocation|0|||
170828673|NCT02484547|617381986|FG006|Long-Term Extension Period|Relocation|0|||
170828674|NCT02484547|617381980|FG000|Long-Term Extension Period|Study Visit Burden|0|||
170828675|NCT02484547|617381981|FG001|Long-Term Extension Period|Study Visit Burden|0|||
170828676|NCT02484547|617381982|FG002|Long-Term Extension Period|Study Visit Burden|0|||
170828677|NCT02484547|617381983|FG003|Long-Term Extension Period|Study Visit Burden|2|||
170828678|NCT02484547|617381984|FG004|Long-Term Extension Period|Study Visit Burden|0|||
170828679|NCT02484547|617381985|FG005|Long-Term Extension Period|Study Visit Burden|0|||
170828680|NCT02484547|617381986|FG006|Long-Term Extension Period|Study Visit Burden|3|||
170828681|NCT02484547|617381980|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
170828682|NCT02484547|617381981|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
170828683|NCT02484547|617381982|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
170828684|NCT02484547|617381983|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
170828685|NCT02484547|617381984|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
170828686|NCT02484547|617381985|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
170828687|NCT02484547|617381986|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
170828688|NCT02484547|617381980|FG000|Long-Term Extension Period|Reason not Specified|0|||
170828689|NCT02484547|617381981|FG001|Long-Term Extension Period|Reason not Specified|0|||
170828690|NCT02484547|617381982|FG002|Long-Term Extension Period|Reason not Specified|0|||
170828691|NCT02484547|617381983|FG003|Long-Term Extension Period|Reason not Specified|119|||
170828692|NCT02484547|617381984|FG004|Long-Term Extension Period|Reason not Specified|117|||
170828693|NCT02484547|617381985|FG005|Long-Term Extension Period|Reason not Specified|223|||
170828694|NCT02484547|617381986|FG006|Long-Term Extension Period|Reason not Specified|231|||
170828695|NCT04206384|617381988|FG000|Overall Study|Withdrawal by Subject|8|||
170828696|NCT04206384|617381988|FG000|Overall Study|Adverse Event|2|||
170828697|NCT01078584|617381989|FG000|Overall Study|Final Status Unknown|1073|||
170828698|NCT01078584|617381989|FG000|Overall Study|Lost to Follow-up|670|||
170828699|NCT01078584|617381989|FG000|Overall Study|Non-serious Adverse Event|577|||
170828700|NCT01078584|617381989|FG000|Overall Study|Withdrawal of Consent|244|||
170828701|NCT01078584|617381989|FG000|Overall Study|Physician Withdrew from Study|90|||
170828702|NCT01078584|617381989|FG000|Overall Study|Non-compliance|67|||
170828703|NCT01078584|617381989|FG000|Overall Study|Blood Pressure Controlled|49|||
170828704|NCT01078584|617381989|FG000|Overall Study|Physician Switched Medication|26|||
170828705|NCT01078584|617381989|FG000|Overall Study|Physician Discontinued Patient|12|||
170828706|NCT01078584|617381989|FG000|Overall Study|Lack of Efficacy|98|||
170828707|NCT01078584|617381989|FG000|Overall Study|Protocol Violation|75|||
170828708|NCT01078584|617381989|FG000|Overall Study|Serious Adverse Event|27|||
170828709|NCT01078584|617381989|FG000|Overall Study|Multiple Reasons|2|||
170828710|NCT01208870|617381992|FG000|Overall Study|Lost to Follow-up|2|||
170828711|NCT01208870|617381993|FG001|Overall Study|Lost to Follow-up|8|||
170828712|NCT01260142|617381994|FG000|Treatment Period 1|Study on hold|1|||
170828713|NCT01260142|617381995|FG001|Treatment Period 1|Study on hold|1|||
170828714|NCT01260142|617381996|FG002|Treatment Period 1|Study on hold|0|||
170713989|NCT01609556|616959033|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713990|NCT01609556|616959034|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713991|NCT01609556|616959035|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
170713992|NCT01609556|616959036|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
170713993|NCT01609556|616959037|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
170713994|NCT01609556|616959038|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
170713995|NCT01609556|616959039|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
170713996|NCT01609556|616959024|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170713997|NCT01609556|616959025|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170713998|NCT01609556|616959026|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170713999|NCT01609556|616959027|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714000|NCT01609556|616959028|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714001|NCT01609556|616959029|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714002|NCT01609556|616959030|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714003|NCT01609556|616959031|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714004|NCT01609556|616959032|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714005|NCT01609556|616959033|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714006|NCT01609556|616959034|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714007|NCT01609556|616959035|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714008|NCT01609556|616959036|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714009|NCT01609556|616959037|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714010|NCT01609556|616959038|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
170714011|NCT01609556|616959039|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
170714012|NCT01609556|616959024|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714013|NCT01609556|616959025|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714014|NCT01609556|616959026|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714015|NCT01609556|616959027|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714016|NCT01609556|616959028|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714017|NCT01609556|616959029|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714018|NCT01609556|616959030|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714019|NCT01609556|616959031|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714020|NCT01609556|616959032|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714021|NCT01609556|616959033|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714022|NCT01609556|616959034|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714023|NCT01609556|616959035|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714024|NCT01609556|616959036|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
170714025|NCT01609556|616959037|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
170714026|NCT01609556|616959038|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
170714027|NCT01609556|616959039|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
170714028|NCT01609556|616959024|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714029|NCT01609556|616959025|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714030|NCT01609556|616959026|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714031|NCT01609556|616959027|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714032|NCT01609556|616959028|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714033|NCT01609556|616959029|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714034|NCT01609556|616959030|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714035|NCT01609556|616959031|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714036|NCT01609556|616959032|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714037|NCT01609556|616959033|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714038|NCT01609556|616959034|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714039|NCT01609556|616959035|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714040|NCT01609556|616959036|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
170714041|NCT01609556|616959037|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714042|NCT01609556|616959038|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714043|NCT01609556|616959039|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
170714044|NCT00852397|616959040|FG000|Overall Study|Adverse Event|4|||
170714045|NCT00852397|616959041|FG001|Overall Study|Adverse Event|6|||
170714046|NCT00852397|616959042|FG002|Overall Study|Adverse Event|4|||
170714047|NCT00852397|616959040|FG000|Overall Study|Death|0|||
170714048|NCT00852397|616959041|FG001|Overall Study|Death|0|||
170714049|NCT00852397|616959042|FG002|Overall Study|Death|1|||
170714050|NCT00852397|616959040|FG000|Overall Study|Withdrawal by Subject|4|||
170714051|NCT00852397|616959041|FG001|Overall Study|Withdrawal by Subject|1|||
170714052|NCT00852397|616959042|FG002|Overall Study|Withdrawal by Subject|2|||
170714053|NCT00852397|616959040|FG000|Overall Study|Study terminated by sponsor|2|||
170714054|NCT00852397|616959041|FG001|Overall Study|Study terminated by sponsor|1|||
170714055|NCT00852397|616959042|FG002|Overall Study|Study terminated by sponsor|6|||
170714056|NCT00852397|616959040|FG000|Overall Study|Difficulty in study site visit|1|||
170714057|NCT00852397|616959041|FG001|Overall Study|Difficulty in study site visit|0|||
170714058|NCT00852397|616959042|FG002|Overall Study|Difficulty in study site visit|0|||
170714059|NCT00852397|616959040|FG000|Overall Study|Protocol Violation|0|||
170714060|NCT00852397|616959041|FG001|Overall Study|Protocol Violation|0|||
170714061|NCT00852397|616959042|FG002|Overall Study|Protocol Violation|1|||
170714062|NCT00774995|616959047|FG000|Overall Study|Protocol Violation|0|||
170714063|NCT00774995|616959048|FG001|Overall Study|Protocol Violation|0|||
170714064|NCT00774995|616959049|FG002|Overall Study|Protocol Violation|1|||
170714065|NCT00774995|616959050|FG003|Overall Study|Protocol Violation|0|||
170714066|NCT00441337|616959054|FG000|Overall Study|Disease Progression|6|||
170714067|NCT00441337|616959055|FG001|Overall Study|Disease Progression|6|||
170714068|NCT00441337|616959056|FG002|Overall Study|Disease Progression|4|||
170714069|NCT00441337|616959057|FG003|Overall Study|Disease Progression|18|||
170714070|NCT00441337|616959054|FG000|Overall Study|Lost to Follow-up|0|||
170714071|NCT00441337|616959055|FG001|Overall Study|Lost to Follow-up|0|||
170714072|NCT00441337|616959056|FG002|Overall Study|Lost to Follow-up|0|||
170714073|NCT00441337|616959057|FG003|Overall Study|Lost to Follow-up|1|||
170714074|NCT00441337|616959054|FG000|Overall Study|Sponsor Decision|0|||
170714075|NCT00441337|616959055|FG001|Overall Study|Sponsor Decision|0|||
170714076|NCT00441337|616959056|FG002|Overall Study|Sponsor Decision|1|||
170714077|NCT00441337|616959057|FG003|Overall Study|Sponsor Decision|2|||
170714078|NCT00441337|616959054|FG000|Overall Study|Did not meet inclusion criteria|0|||
170714079|NCT00441337|616959055|FG001|Overall Study|Did not meet inclusion criteria|0|||
170714080|NCT00441337|616959056|FG002|Overall Study|Did not meet inclusion criteria|1|||
170714081|NCT00441337|616959057|FG003|Overall Study|Did not meet inclusion criteria|0|||
170714082|NCT03964454|616959061|FG000|Overall Study|Lost to Follow-up|13|||
170714083|NCT03964454|616959062|FG001|Overall Study|Lost to Follow-up|7|||
170714084|NCT03964454|616959061|FG000|Overall Study|Withdrawal by Subject|4|||
170714085|NCT03964454|616959062|FG001|Overall Study|Withdrawal by Subject|11|||
170714086|NCT00993447|616960839|FG000|Overall Study|Withdrawal by Subject|23|||
170714087|NCT00993447|616960840|FG001|Overall Study|Withdrawal by Subject|8|||
170714088|NCT00993447|616960839|FG000|Overall Study|Protocol Violation|12|||
170714089|NCT00993447|616960840|FG001|Overall Study|Protocol Violation|8|||
170714090|NCT00993447|616960839|FG000|Overall Study|Lost to Follow-up|1|||
170714091|NCT00993447|616960840|FG001|Overall Study|Lost to Follow-up|3|||
170714092|NCT00993447|616960839|FG000|Overall Study|Adverse Event|1|||
170714093|NCT00993447|616960840|FG001|Overall Study|Adverse Event|0|||
170714094|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
170714095|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
170714096|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
170828715|NCT01260142|617381997|FG003|Treatment Period 1|Study on hold|0|||
170828716|NCT01260142|617381998|FG004|Treatment Period 1|Study on hold|1|||
170828717|NCT01260142|617381999|FG005|Treatment Period 1|Study on hold|2|||
170828718|NCT01260142|617381994|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
170828719|NCT01260142|617381995|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
170828720|NCT01260142|617381996|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
170828721|NCT01260142|617381997|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
170828722|NCT01260142|617381998|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
170828723|NCT01260142|617381999|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
170828724|NCT01260142|617381994|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170828725|NCT01260142|617381995|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170828726|NCT01260142|617381996|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170828727|NCT01260142|617381997|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170828728|NCT01260142|617381998|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170828729|NCT01260142|617381999|FG005|Treatment Period 1|Withdrawal by Subject|1|||
170828730|NCT00424177|617382000|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
170828731|NCT00424177|617382000|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
170828732|NCT00424177|617382000|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
170828733|NCT00424177|617382000|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
170828734|NCT00424177|617382000|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
170828735|NCT00424177|617382000|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
170828736|NCT00424177|617382000|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
170828737|NCT00424177|617382000|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
170828738|NCT00424177|617382000|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
170828739|NCT00424177|617382000|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
170828740|NCT01503164|617382005|FG000|Overall Study|Withdrawal by Subject|2|||
170828741|NCT01503164|617382006|FG001|Overall Study|Withdrawal by Subject|1|||
170828742|NCT01227928|617382007|FG000|Overall Study|Lost to Follow-up|4|||
170828743|NCT01227928|617382008|FG001|Overall Study|Lost to Follow-up|2|||
170714097|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
170714098|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Adverse Event|5|||
170714099|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Adverse Event|3|||
170714100|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Adverse Event|4|||
170714101|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Adverse Event|10|||
170714102|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
170714103|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
170714104|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
170714105|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
170714106|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
170714107|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
170714108|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
170714109|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
170714110|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Pregnancy|5|||
170714111|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Pregnancy|0|||
170714112|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Pregnancy|3|||
170714113|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Pregnancy|2|||
170714114|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Non-compliance|1|||
170714115|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Non-compliance|4|||
170714116|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Non-compliance|0|||
170714117|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Non-compliance|3|||
170714118|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Other|0|||
170714119|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Other|3|||
170714120|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Other|3|||
170714121|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Other|1|||
170714122|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
170714123|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
170714124|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
170714125|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
170714126|NCT01760954|616960841|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
170714127|NCT01760954|616960842|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
170714128|NCT01760954|616960843|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
170714129|NCT01760954|616960844|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
170714130|NCT01760954|616960841|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
170714131|NCT01760954|616960842|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
170714132|NCT01760954|616960843|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
170714133|NCT01760954|616960844|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
170714134|NCT01760954|616960841|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
170714135|NCT01760954|616960842|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
170714136|NCT01760954|616960843|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
170714137|NCT01760954|616960844|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
170714138|NCT01760954|616960841|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
170714139|NCT01760954|616960842|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
170714140|NCT01760954|616960843|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
170714141|NCT01760954|616960844|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
170714142|NCT01760954|616960841|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
170714143|NCT01760954|616960842|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
170714144|NCT01760954|616960843|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
170714145|NCT01760954|616960844|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
170714146|NCT01760954|616960841|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
170714147|NCT01760954|616960842|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
170714148|NCT01760954|616960843|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
170714149|NCT01760954|616960844|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
170714150|NCT01760954|616960841|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
170714151|NCT01760954|616960842|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
170714152|NCT01760954|616960843|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
170714153|NCT01760954|616960844|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
170714154|NCT00902304|616960847|FG000|Overall Study|Adverse Event|4|||
170714155|NCT00902304|616960848|FG001|Overall Study|Adverse Event|10|||
170714156|NCT00902304|616960849|FG002|Overall Study|Adverse Event|25|||
170714157|NCT00902304|616960847|FG000|Overall Study|Investigator discretion|3|||
170714158|NCT00902304|616960848|FG001|Overall Study|Investigator discretion|5|||
170714159|NCT00902304|616960849|FG002|Overall Study|Investigator discretion|13|||
170714160|NCT00902304|616960847|FG000|Overall Study|Lost to Follow-up|7|||
170714161|NCT00902304|616960848|FG001|Overall Study|Lost to Follow-up|7|||
170714162|NCT00902304|616960849|FG002|Overall Study|Lost to Follow-up|7|||
170714163|NCT00902304|616960847|FG000|Overall Study|Protocol Violation|9|||
170714164|NCT00902304|616960848|FG001|Overall Study|Protocol Violation|18|||
170714165|NCT00902304|616960849|FG002|Overall Study|Protocol Violation|20|||
170714166|NCT00902304|616960847|FG000|Overall Study|Withdrawal by Subject|32|||
170714167|NCT00902304|616960848|FG001|Overall Study|Withdrawal by Subject|22|||
170714168|NCT00902304|616960849|FG002|Overall Study|Withdrawal by Subject|43|||
170714169|NCT00902304|616960847|FG000|Overall Study|includes pregnancy|3|||
170714170|NCT00902304|616960848|FG001|Overall Study|includes pregnancy|9|||
170714171|NCT00902304|616960849|FG002|Overall Study|includes pregnancy|2|||
170714172|NCT05706506|616960850|FG000|Overall Study|Adverse Event|1|||
170714173|NCT05706506|616960850|FG000|Overall Study|Withdrawal by Subject|4|||
170714174|NCT05706506|616960850|FG000|Overall Study|Lost to Follow-up|2|||
170714175|NCT05706506|616960850|FG000|Overall Study|Inadvertent Enrolment|12|||
170714176|NCT05706506|616960850|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
170714177|NCT05706506|616960850|FG000|Overall Study|Participant Moved Out of State|1|||
170714178|NCT01075321|616960853|FG000|Overall Study|Withdrawal by Subject|0|||
170714179|NCT01075321|616960854|FG001|Overall Study|Withdrawal by Subject|0|||
170714180|NCT01075321|616960855|FG002|Overall Study|Withdrawal by Subject|1|||
170714181|NCT01075321|616960856|FG003|Overall Study|Withdrawal by Subject|1|||
170714182|NCT01075321|616960853|FG000|Overall Study|Protocol Violation|0|||
170714183|NCT01075321|616960854|FG001|Overall Study|Protocol Violation|0|||
170714184|NCT01075321|616960855|FG002|Overall Study|Protocol Violation|1|||
170714185|NCT01075321|616960856|FG003|Overall Study|Protocol Violation|0|||
170714186|NCT01075321|616960853|FG000|Overall Study|Treatment Incomplete due to progression|1|||
170714187|NCT01075321|616960854|FG001|Overall Study|Treatment Incomplete due to progression|0|||
170714188|NCT01075321|616960855|FG002|Overall Study|Treatment Incomplete due to progression|0|||
170714189|NCT01075321|616960856|FG003|Overall Study|Treatment Incomplete due to progression|0|||
170714190|NCT01075321|616960853|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
170714191|NCT01075321|616960854|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
170714192|NCT01075321|616960855|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
170714193|NCT01075321|616960856|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
170714194|NCT00003457|616960857|FG000|Overall Study|Not evaluable|9|||
170714195|NCT01172938|616960861|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
170714196|NCT01172938|616960862|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
170714197|NCT01172938|616960863|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
170714198|NCT01172938|616960864|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170714199|NCT01172938|616960865|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170714200|NCT01172938|616960866|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170714201|NCT01172938|616960867|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170714202|NCT01172938|616960868|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170714203|NCT01172938|616960869|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
170714204|NCT01172938|616960861|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
170714205|NCT01172938|616960862|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
170714206|NCT01172938|616960863|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
170714207|NCT01172938|616960864|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170714208|NCT01172938|616960865|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170714209|NCT01172938|616960866|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170714210|NCT01172938|616960867|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170714211|NCT01172938|616960868|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170714212|NCT01172938|616960869|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
170714213|NCT01172938|616960861|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170714214|NCT01172938|616960862|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
170714215|NCT01172938|616960863|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
170714216|NCT01172938|616960864|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170714217|NCT01172938|616960865|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170714218|NCT01172938|616960866|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170714219|NCT01172938|616960867|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170714220|NCT01172938|616960868|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170714221|NCT01172938|616960869|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
170714222|NCT01172938|616960861|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
170714223|NCT01172938|616960862|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
170714224|NCT01172938|616960863|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
170714225|NCT01172938|616960864|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170714226|NCT01172938|616960865|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170714227|NCT01172938|616960866|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170714228|NCT01172938|616960867|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170714229|NCT01172938|616960868|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170714230|NCT01172938|616960869|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
170714231|NCT01172938|616960861|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
170714232|NCT01172938|616960862|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
170714233|NCT01172938|616960863|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
170714234|NCT01172938|616960864|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
170714235|NCT01172938|616960865|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
170714236|NCT01172938|616960866|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
170714237|NCT01172938|616960867|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
170714238|NCT01172938|616960868|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
170714239|NCT01172938|616960869|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
170714240|NCT01172938|616960861|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
170714241|NCT01172938|616960862|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170714242|NCT01172938|616960863|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170714243|NCT01172938|616960864|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170714244|NCT01172938|616960865|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170714245|NCT01172938|616960866|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170714246|NCT01172938|616960867|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170714247|NCT01172938|616960868|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170714248|NCT01172938|616960869|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
170714249|NCT01172938|616960861|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
170714250|NCT01172938|616960862|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
170714251|NCT01172938|616960863|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
170714252|NCT01172938|616960864|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
170714253|NCT01172938|616960865|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
170714254|NCT01172938|616960866|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
170714255|NCT01172938|616960867|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
170714256|NCT01172938|616960868|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
170714257|NCT01172938|616960869|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
170714258|NCT01172938|616960861|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
170714259|NCT01172938|616960862|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
170714260|NCT01172938|616960863|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
170714261|NCT01172938|616960864|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
170714262|NCT01172938|616960865|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
170714263|NCT01172938|616960866|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
170714264|NCT01172938|616960867|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
170714265|NCT01172938|616960868|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
170714266|NCT01172938|616960869|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
170714267|NCT01172938|616960861|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
170714268|NCT01172938|616960862|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
170714269|NCT01172938|616960863|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
170714270|NCT01172938|616960864|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
170714271|NCT01172938|616960865|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
170714272|NCT01172938|616960866|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
170714273|NCT01172938|616960867|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
170714274|NCT01172938|616960868|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
170714275|NCT01172938|616960869|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
170714276|NCT01172938|616960861|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
170714277|NCT01172938|616960862|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
170714278|NCT01172938|616960863|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
170714279|NCT01172938|616960864|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
170714280|NCT01172938|616960865|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
170714281|NCT01172938|616960866|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
170714282|NCT01172938|616960867|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
170714283|NCT01172938|616960868|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
170714284|NCT01172938|616960869|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
170714285|NCT01172938|616960861|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
170714286|NCT01172938|616960862|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
170714287|NCT01172938|616960863|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
170714288|NCT01172938|616960864|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
170714289|NCT01172938|616960865|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
170714290|NCT01172938|616960866|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
170714291|NCT01172938|616960867|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
170714292|NCT01172938|616960868|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
170714293|NCT01172938|616960869|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
170714294|NCT01172938|616960861|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
170714295|NCT01172938|616960862|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
170714296|NCT01172938|616960863|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
170714297|NCT01172938|616960864|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
170714298|NCT01172938|616960865|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
170714299|NCT01172938|616960866|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
170714300|NCT01172938|616960867|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
170714301|NCT01172938|616960868|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
170714302|NCT01172938|616960869|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
170714303|NCT01172938|616960861|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
170714304|NCT01172938|616960862|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
170714305|NCT01172938|616960863|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
170714306|NCT01172938|616960864|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
170714307|NCT01172938|616960865|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
170714308|NCT01172938|616960866|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
170714309|NCT01172938|616960867|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
170714310|NCT01172938|616960868|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
170714311|NCT01172938|616960869|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
170714312|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
170714313|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
170828744|NCT01227928|617382007|FG000|Overall Study|Withdrawal by Subject|4|||
170714314|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
170714315|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
170714316|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
170714317|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
170714318|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
170714319|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
170714320|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
170714321|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
170714322|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
170714323|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
170714324|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
170714325|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
170714326|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
170714327|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
170714328|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
170714329|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
170714330|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
170714331|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
170714332|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
170714333|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
170714334|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
170714335|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
170714336|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
170714337|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
170714338|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
170714339|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
170714340|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
170714341|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
170714342|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
170714343|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
170714344|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
170714345|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
170714346|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
170714347|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
170714348|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
170714349|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
170714350|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
170714351|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
170714352|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
170714353|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
170714354|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
170714355|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
170714356|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
170714357|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
170714358|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
170714359|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
170714360|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
170714361|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
170714362|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
170714363|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
170714364|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
170714365|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
170714366|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
170714367|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
170714368|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
170714369|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
170714370|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
170714371|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
170714372|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
170714373|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
170714374|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
170714375|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
170714376|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
170714377|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
170714378|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
170714379|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
170714380|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
170714381|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
170714382|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
170714383|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
170714384|NCT01172938|616960861|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
170714385|NCT01172938|616960862|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
170714386|NCT01172938|616960863|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
170714387|NCT01172938|616960864|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
170714388|NCT01172938|616960865|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
170714389|NCT01172938|616960866|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
170714390|NCT01172938|616960867|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
170714391|NCT01172938|616960868|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
170714392|NCT01172938|616960869|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
170714393|NCT01172938|616960861|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
170714394|NCT01172938|616960862|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
170714395|NCT01172938|616960863|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
170714396|NCT01172938|616960864|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
170714397|NCT01172938|616960865|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
170714398|NCT01172938|616960866|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
170714399|NCT01172938|616960867|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
170714400|NCT01172938|616960868|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
170714401|NCT01172938|616960869|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
170714402|NCT01172938|616960861|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
170714403|NCT01172938|616960862|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
170714404|NCT01172938|616960863|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
170714405|NCT01172938|616960864|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
170714406|NCT01172938|616960865|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
170714407|NCT01172938|616960866|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
170714408|NCT01172938|616960867|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
170714409|NCT01172938|616960868|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
170714410|NCT01172938|616960869|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
170714411|NCT01172938|616960861|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
170714412|NCT01172938|616960862|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
170714413|NCT01172938|616960863|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
170714414|NCT01172938|616960864|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
170714415|NCT01172938|616960865|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
170714416|NCT01172938|616960866|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
170714417|NCT01172938|616960867|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
170714418|NCT01172938|616960868|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
170714419|NCT01172938|616960869|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
170714420|NCT01172938|616960861|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
170714421|NCT01172938|616960862|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
170714422|NCT01172938|616960863|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
170714423|NCT01172938|616960864|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
170714424|NCT01172938|616960865|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
170714425|NCT01172938|616960866|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
170714426|NCT01172938|616960867|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
170714427|NCT01172938|616960868|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
170828745|NCT01227928|617382008|FG001|Overall Study|Withdrawal by Subject|3|||
170828746|NCT01227928|617382007|FG000|Overall Study|Death|14|||
170828747|NCT01227928|617382008|FG001|Overall Study|Death|12|||
170828748|NCT04088136|617382009|FG000|Overall Study|Withdrawal by Subject|5|||
170828749|NCT04088136|617382010|FG001|Overall Study|Withdrawal by Subject|0|||
170714428|NCT01172938|616960869|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
170714429|NCT01172938|616960861|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
170714430|NCT01172938|616960862|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
170714431|NCT01172938|616960863|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
170714432|NCT01172938|616960864|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
170714433|NCT01172938|616960865|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
170714434|NCT01172938|616960866|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
170714435|NCT01172938|616960867|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
170714436|NCT01172938|616960868|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
170714437|NCT01172938|616960869|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
170714438|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
170714439|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
170714440|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
170714441|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
170714442|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
170714443|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
170714444|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
170714445|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
170714446|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
170714447|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
170714448|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
170714449|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
170714450|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
170714451|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
170714452|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
170714453|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
170714454|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
170714455|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
170714456|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
170714457|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
170714458|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
170714459|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
170714460|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
170714461|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
170714462|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
170714463|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
170714464|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
170714465|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
170714466|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
170714467|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
170714468|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
170714469|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
170714470|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
170714471|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
170714472|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
170714473|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
170714474|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
170714475|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
170714476|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
170714477|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
170714478|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
170714479|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
170714480|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
170714481|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
170714482|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
170714483|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
170714484|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
170714485|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
170714486|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
170714487|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
170714488|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
170828750|NCT04088136|617382009|FG000|Overall Study|Lack of Efficacy|0|||
170828751|NCT04088136|617382010|FG001|Overall Study|Lack of Efficacy|1|||
170828752|NCT01177228|617382011|FG000|Overall Study|Positive tuberculosis test|0|||
170714489|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
170714490|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
170714491|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
170714492|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
170714493|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
170714494|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
170714495|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
170714496|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
170714497|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
170714498|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
170714499|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
170714500|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
170714501|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
170714502|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
170714503|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
170714504|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
170714505|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
170714506|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
170714507|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
170714508|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
170714509|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
170714510|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
170714511|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
170714512|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
170714513|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
170714514|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
170714515|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
170714516|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
170714517|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
170714518|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
170714519|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
170714520|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
170714521|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
170714522|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
170714523|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
170714524|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
170714525|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
170714526|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
170714527|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
170714528|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
170714529|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
170714530|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
170714531|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
170714532|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
170714533|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
170714534|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
170714535|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
170714536|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
170714537|NCT01172938|616960861|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
170714538|NCT01172938|616960862|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
170714539|NCT01172938|616960863|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
170714540|NCT01172938|616960864|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
170714541|NCT01172938|616960865|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
170714542|NCT01172938|616960866|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
170714543|NCT01172938|616960867|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
170714544|NCT01172938|616960868|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
170714545|NCT01172938|616960869|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
170714546|NCT01709227|616960871|FG000|Overall Study|Physician Decision|1|||
170714547|NCT01709227|616960872|FG001|Overall Study|Physician Decision|0|||
170714548|NCT01709227|616960871|FG000|Overall Study|Pleural Peritoneal communication|0|||
170714549|NCT01709227|616960872|FG001|Overall Study|Pleural Peritoneal communication|9|||
170714550|NCT01465334|616960873|FG000|Overall Study|Disease Progression|1|||
170714551|NCT01465334|616960874|FG001|Overall Study|Disease Progression|0|||
170714552|NCT01465334|616960873|FG000|Overall Study|Adverse Event|1|||
170714553|NCT01465334|616960874|FG001|Overall Study|Adverse Event|0|||
170714554|NCT01465334|616960873|FG000|Overall Study|Richter's transformation|0|||
170714555|NCT01465334|616960874|FG001|Overall Study|Richter's transformation|3|||
170714556|NCT01465334|616960873|FG000|Overall Study|Refractory Disease|0|||
170714557|NCT01465334|616960874|FG001|Overall Study|Refractory Disease|3|||
170714558|NCT00572572|616960875|FG000|Overall Study|Withdrawal by Subject|3|||
170714559|NCT00572572|616960876|FG001|Overall Study|Withdrawal by Subject|6|||
170714560|NCT00889421|616960877|FG000|Overall Study|Lack of Efficacy|3|||
170714561|NCT02013765|616960881|FG000|Overall Study|Trial was terminated by sponsor|1|||
170714562|NCT01430130|616960882|FG000|Overall Study|Lost to Follow-up|1|||
170714563|NCT01430130|616960882|FG000|Overall Study|Infection on Control Side of Incision|1|||
170714564|NCT04443218|616960883|FG000|Overall Study|Exited study for other reasons|9|||
170714565|NCT04443218|616960883|FG000|Overall Study|Withdrawal by Subject|1|||
170714566|NCT04443218|616960883|FG000|Overall Study|Lost to Follow-up|4|||
170714567|NCT04443218|616960883|FG000|Overall Study|Death|19|||
170714568|NCT00797667|616960884|FG000|Overall Study|Lack of Efficacy|0|||
170714569|NCT00797667|616960885|FG001|Overall Study|Lack of Efficacy|1|||
170714570|NCT00797667|616960886|FG002|Overall Study|Lack of Efficacy|0|||
170714571|NCT00797667|616960884|FG000|Overall Study|Lost to Follow-up|8|||
170714572|NCT00797667|616960885|FG001|Overall Study|Lost to Follow-up|12|||
170714573|NCT00797667|616960886|FG002|Overall Study|Lost to Follow-up|2|||
170714574|NCT00797667|616960884|FG000|Overall Study|Physician Decision|3|||
170714575|NCT00797667|616960885|FG001|Overall Study|Physician Decision|1|||
170714576|NCT00797667|616960886|FG002|Overall Study|Physician Decision|0|||
170714577|NCT00797667|616960884|FG000|Overall Study|Pregnancy|2|||
170714578|NCT00797667|616960885|FG001|Overall Study|Pregnancy|0|||
170714579|NCT00797667|616960886|FG002|Overall Study|Pregnancy|0|||
170714580|NCT00797667|616960884|FG000|Overall Study|Protocol Violation|2|||
170714581|NCT00797667|616960885|FG001|Overall Study|Protocol Violation|7|||
170714582|NCT00797667|616960886|FG002|Overall Study|Protocol Violation|0|||
170714583|NCT00797667|616960884|FG000|Overall Study|Study Terminated by Sponsor|217|||
170714584|NCT00797667|616960885|FG001|Overall Study|Study Terminated by Sponsor|216|||
170714585|NCT00797667|616960886|FG002|Overall Study|Study Terminated by Sponsor|115|||
170714586|NCT00797667|616960884|FG000|Overall Study|Withdrawal by Subject|9|||
170714587|NCT00797667|616960885|FG001|Overall Study|Withdrawal by Subject|14|||
170714588|NCT00797667|616960886|FG002|Overall Study|Withdrawal by Subject|2|||
170714589|NCT00797667|616960884|FG000|Overall Study|Adverse Event|19|||
170714590|NCT00797667|616960885|FG001|Overall Study|Adverse Event|8|||
170714591|NCT00797667|616960886|FG002|Overall Study|Adverse Event|8|||
170714592|NCT01485861|616960887|FG000|Phase Ib|Death|1|||
170714593|NCT01485861|616960888|FG001|Phase Ib|Death|0|||
170714594|NCT01485861|616960889|FG002|Phase Ib|Death|0|||
170714595|NCT01485861|616960890|FG003|Phase Ib|Death|0|||
170714596|NCT01485861|616960891|FG004|Phase Ib|Death|0|||
170714597|NCT01485861|616960892|FG005|Phase Ib|Death|0|||
170714598|NCT01485861|616960887|FG000|Phase Ib|Physician Decision|1|||
170714599|NCT01485861|616960888|FG001|Phase Ib|Physician Decision|1|||
170714600|NCT01485861|616960889|FG002|Phase Ib|Physician Decision|0|||
170714601|NCT01485861|616960890|FG003|Phase Ib|Physician Decision|0|||
170714602|NCT01485861|616960891|FG004|Phase Ib|Physician Decision|0|||
170714603|NCT01485861|616960892|FG005|Phase Ib|Physician Decision|0|||
170714604|NCT01485861|616960887|FG000|Phase Ib|Adverse Event|0|||
170714605|NCT01485861|616960888|FG001|Phase Ib|Adverse Event|4|||
170714606|NCT01485861|616960889|FG002|Phase Ib|Adverse Event|0|||
170714607|NCT01485861|616960890|FG003|Phase Ib|Adverse Event|0|||
170714608|NCT01485861|616960891|FG004|Phase Ib|Adverse Event|0|||
170714609|NCT01485861|616960892|FG005|Phase Ib|Adverse Event|0|||
170714610|NCT01485861|616960887|FG000|Phase Ib|Progression of disease|5|||
170714611|NCT01485861|616960888|FG001|Phase Ib|Progression of disease|0|||
170714612|NCT01485861|616960889|FG002|Phase Ib|Progression of disease|0|||
170714613|NCT01485861|616960890|FG003|Phase Ib|Progression of disease|0|||
170714614|NCT01485861|616960891|FG004|Phase Ib|Progression of disease|0|||
170714615|NCT01485861|616960892|FG005|Phase Ib|Progression of disease|0|||
170714616|NCT01485861|616960887|FG000|Phase Ib|Other|3|||
170714617|NCT01485861|616960888|FG001|Phase Ib|Other|0|||
170714618|NCT01485861|616960889|FG002|Phase Ib|Other|0|||
170714619|NCT01485861|616960890|FG003|Phase Ib|Other|0|||
170714620|NCT01485861|616960891|FG004|Phase Ib|Other|0|||
170714621|NCT01485861|616960892|FG005|Phase Ib|Other|0|||
170714622|NCT01485861|616960887|FG000|Phase Ib|Withdrawal by Subject|4|||
170714623|NCT01485861|616960888|FG001|Phase Ib|Withdrawal by Subject|1|||
170714624|NCT01485861|616960889|FG002|Phase Ib|Withdrawal by Subject|0|||
170714625|NCT01485861|616960890|FG003|Phase Ib|Withdrawal by Subject|0|||
170714626|NCT01485861|616960891|FG004|Phase Ib|Withdrawal by Subject|0|||
170714627|NCT01485861|616960892|FG005|Phase Ib|Withdrawal by Subject|0|||
170714628|NCT01485861|616960887|FG000|Phase II|Death|0|||
170714629|NCT01485861|616960888|FG001|Phase II|Death|0|||
170714630|NCT01485861|616960889|FG002|Phase II|Death|67|||
170714631|NCT01485861|616960890|FG003|Phase II|Death|71|||
170714632|NCT01485861|616960891|FG004|Phase II|Death|68|||
170714633|NCT01485861|616960892|FG005|Phase II|Death|0|||
170714634|NCT01485861|616960887|FG000|Phase II|Progression of Disease|0|||
170714635|NCT01485861|616960888|FG001|Phase II|Progression of Disease|0|||
170714636|NCT01485861|616960889|FG002|Phase II|Progression of Disease|1|||
170714637|NCT01485861|616960890|FG003|Phase II|Progression of Disease|0|||
170714638|NCT01485861|616960891|FG004|Phase II|Progression of Disease|0|||
170714639|NCT01485861|616960892|FG005|Phase II|Progression of Disease|0|||
170714640|NCT01485861|616960887|FG000|Phase II|Other|0|||
170714641|NCT01485861|616960888|FG001|Phase II|Other|0|||
170714642|NCT01485861|616960889|FG002|Phase II|Other|0|||
170714643|NCT01485861|616960890|FG003|Phase II|Other|1|||
170714644|NCT01485861|616960891|FG004|Phase II|Other|0|||
170714645|NCT01485861|616960892|FG005|Phase II|Other|0|||
170714646|NCT01485861|616960887|FG000|Phase II|Withdrawal by Subject|0|||
170714647|NCT01485861|616960888|FG001|Phase II|Withdrawal by Subject|0|||
170714648|NCT01485861|616960889|FG002|Phase II|Withdrawal by Subject|6|||
170714649|NCT01485861|616960890|FG003|Phase II|Withdrawal by Subject|3|||
170714650|NCT01485861|616960891|FG004|Phase II|Withdrawal by Subject|4|||
170714651|NCT01485861|616960892|FG005|Phase II|Withdrawal by Subject|0|||
170714652|NCT01485861|616960887|FG000|Phase II|Lost to Follow-up|0|||
170714653|NCT01485861|616960888|FG001|Phase II|Lost to Follow-up|0|||
170714654|NCT01485861|616960889|FG002|Phase II|Lost to Follow-up|2|||
170714655|NCT01485861|616960890|FG003|Phase II|Lost to Follow-up|3|||
170714656|NCT01485861|616960891|FG004|Phase II|Lost to Follow-up|5|||
170714657|NCT01485861|616960892|FG005|Phase II|Lost to Follow-up|0|||
170714658|NCT01485861|616960887|FG000|Phase II|Study Ended|0|||
170714659|NCT01485861|616960888|FG001|Phase II|Study Ended|0|||
170714660|NCT01485861|616960889|FG002|Phase II|Study Ended|7|||
170714661|NCT01485861|616960890|FG003|Phase II|Study Ended|8|||
170714662|NCT01485861|616960891|FG004|Phase II|Study Ended|6|||
170714663|NCT01485861|616960892|FG005|Phase II|Study Ended|0|||
170714664|NCT01485861|616960887|FG000|Safety Phase|Death|0|||
170714665|NCT01485861|616960888|FG001|Safety Phase|Death|0|||
170714666|NCT01485861|616960889|FG002|Safety Phase|Death|0|||
170714667|NCT01485861|616960890|FG003|Safety Phase|Death|0|||
170714668|NCT01485861|616960891|FG004|Safety Phase|Death|0|||
170714669|NCT01485861|616960892|FG005|Safety Phase|Death|2|||
170714670|NCT01485861|616960887|FG000|Safety Phase|Adverse Event|0|||
170714671|NCT01485861|616960888|FG001|Safety Phase|Adverse Event|0|||
170714672|NCT01485861|616960889|FG002|Safety Phase|Adverse Event|0|||
170714673|NCT01485861|616960890|FG003|Safety Phase|Adverse Event|0|||
170714674|NCT01485861|616960891|FG004|Safety Phase|Adverse Event|0|||
170714675|NCT01485861|616960892|FG005|Safety Phase|Adverse Event|1|||
170714676|NCT01485861|616960887|FG000|Safety Phase|Other|0|||
170714677|NCT01485861|616960888|FG001|Safety Phase|Other|0|||
170714678|NCT01485861|616960889|FG002|Safety Phase|Other|0|||
170714679|NCT01485861|616960890|FG003|Safety Phase|Other|0|||
170714680|NCT01485861|616960891|FG004|Safety Phase|Other|0|||
170714681|NCT01485861|616960892|FG005|Safety Phase|Other|5|||
170714682|NCT01485861|616960887|FG000|Safety Phase|Progression of Disease|0|||
170714683|NCT01485861|616960888|FG001|Safety Phase|Progression of Disease|0|||
170714684|NCT01485861|616960889|FG002|Safety Phase|Progression of Disease|0|||
170714685|NCT01485861|616960890|FG003|Safety Phase|Progression of Disease|0|||
170714686|NCT01485861|616960891|FG004|Safety Phase|Progression of Disease|0|||
170714687|NCT01485861|616960892|FG005|Safety Phase|Progression of Disease|9|||
170714688|NCT01485861|616960887|FG000|Safety Phase|Withdrawal by Subject|0|||
170714689|NCT01485861|616960888|FG001|Safety Phase|Withdrawal by Subject|0|||
170714690|NCT01485861|616960889|FG002|Safety Phase|Withdrawal by Subject|0|||
170714691|NCT01485861|616960890|FG003|Safety Phase|Withdrawal by Subject|0|||
170714692|NCT01485861|616960891|FG004|Safety Phase|Withdrawal by Subject|0|||
170714693|NCT01485861|616960892|FG005|Safety Phase|Withdrawal by Subject|6|||
170828753|NCT01177228|617382012|FG001|Overall Study|Positive tuberculosis test|1|||
170828754|NCT01177228|617382013|FG002|Overall Study|Positive tuberculosis test|0|||
170828755|NCT01177228|617382014|FG003|Overall Study|Positive tuberculosis test|0|||
170828756|NCT01177228|617382011|FG000|Overall Study|Worsening disease activity|1|||
170828757|NCT01177228|617382012|FG001|Overall Study|Worsening disease activity|0|||
170828758|NCT01177228|617382013|FG002|Overall Study|Worsening disease activity|0|||
170828759|NCT01177228|617382014|FG003|Overall Study|Worsening disease activity|0|||
170828760|NCT01177228|617382011|FG000|Overall Study|Withdrawal by Subject|0|||
170828761|NCT01177228|617382012|FG001|Overall Study|Withdrawal by Subject|1|||
170828762|NCT01177228|617382013|FG002|Overall Study|Withdrawal by Subject|0|||
170828763|NCT01177228|617382014|FG003|Overall Study|Withdrawal by Subject|0|||
170828764|NCT01494298|617382015|FG000|Overall Study|Protocol Violation|2|||
170714694|NCT01485861|616960887|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
170714695|NCT01485861|616960888|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
170714696|NCT01485861|616960889|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
170714697|NCT01485861|616960890|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
170714698|NCT01485861|616960891|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
170714699|NCT01485861|616960892|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
170828765|NCT01494298|617382016|FG001|Overall Study|Protocol Violation|8|||
170828766|NCT04159805|617382017|FG000|Overall Study|Withdrawal by Subject|0|||
170714700|NCT01775137|616960897|FG000|Overall Study|Death|1|||
170714701|NCT01775137|616960897|FG000|Overall Study|Protocol deviation|2|||
170714702|NCT01775137|616960897|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170714703|NCT01775137|616960897|FG000|Overall Study|Adverse Event|1|||
170714704|NCT01775137|616960897|FG000|Overall Study|Withdrawal by participants|5|||
170714705|NCT00701051|616960898|FG000|Screening|Failed Screening|40|||
170714706|NCT00701051|616960899|FG001|Screening|Failed Screening|0|||
170714707|NCT00701051|616960900|FG002|Screening|Failed Screening|0|||
170714708|NCT00701051|616960898|FG000|Screening|Time conflicts|19|||
170714709|NCT00701051|616960899|FG001|Screening|Time conflicts|0|||
170714710|NCT00701051|616960900|FG002|Screening|Time conflicts|0|||
170714711|NCT00701051|616960898|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
170714712|NCT00701051|616960899|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
170714713|NCT00701051|616960900|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
170714714|NCT00437489|616960903|FG000|Overall Study|Study terminated by sponsor|23|||
170714715|NCT00437489|616960904|FG001|Overall Study|Study terminated by sponsor|21|||
170714716|NCT00437489|616960903|FG000|Overall Study|Lost to Follow-up|0|||
170714717|NCT00437489|616960904|FG001|Overall Study|Lost to Follow-up|1|||
170714718|NCT01748994|616960908|FG000|Overall Study|Lost to Follow-up|8|||
170714719|NCT01748994|616960909|FG001|Overall Study|Lost to Follow-up|6|||
170714720|NCT03105362|616960916|FG000|Overall Study|Withdrawal by Subject|1|||
170714721|NCT03105362|616960916|FG000|Overall Study|Lost to Follow-up|1|||
170714722|NCT01198600|616960921|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
170714723|NCT01198600|616960922|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
170714724|NCT01198600|616960923|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
170714725|NCT01198600|616960924|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
170714726|NCT01198600|616960921|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
170714727|NCT01198600|616960922|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
170714728|NCT01198600|616960923|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
170714729|NCT01198600|616960924|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
170714730|NCT01198600|616960921|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
170714731|NCT01198600|616960922|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
170714732|NCT01198600|616960923|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
170714733|NCT01198600|616960924|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
170714734|NCT01198600|616960921|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
170714735|NCT01198600|616960922|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
170714736|NCT01198600|616960923|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
170714737|NCT01198600|616960924|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
170714738|NCT01198600|616960921|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
170714739|NCT01198600|616960922|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
170714740|NCT01198600|616960923|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
170714741|NCT01198600|616960924|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
170714742|NCT01198600|616960921|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
170714743|NCT01198600|616960922|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
170714744|NCT01198600|616960923|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
170714745|NCT01198600|616960924|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
170714746|NCT01198600|616960921|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
170714747|NCT01198600|616960922|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
170714748|NCT01198600|616960923|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
170714749|NCT01198600|616960924|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
170714750|NCT01785602|616960925|FG000|Overall Study|Withdrawal by Subject|2|||
170714751|NCT01785602|616960926|FG001|Overall Study|Withdrawal by Subject|0|||
170714752|NCT01785602|616960925|FG000|Overall Study|Lost to Follow-up|1|||
170714753|NCT01785602|616960926|FG001|Overall Study|Lost to Follow-up|1|||
170714754|NCT01785602|616960925|FG000|Overall Study|Adverse Event|3|||
170714755|NCT01785602|616960926|FG001|Overall Study|Adverse Event|5|||
170714756|NCT01785602|616960925|FG000|Overall Study|Administrative problems|7|||
170714757|NCT01785602|616960926|FG001|Overall Study|Administrative problems|3|||
170714758|NCT04496258|616960929|FG000|Overall Study|Withdrawal by Subject|2|||
170714759|NCT04496258|616960930|FG001|Overall Study|Withdrawal by Subject|1|||
170714760|NCT02141516|616960931|FG000|Overall Study|Adverse Event|0|||
170828767|NCT04159805|617382018|FG001|Overall Study|Withdrawal by Subject|2|||
170828768|NCT04159805|617382019|FG002|Overall Study|Withdrawal by Subject|2|||
170828769|NCT02930837|617382020|FG000|Overall Study|Adverse Event|6|||
170828770|NCT02930837|617382020|FG000|Overall Study|Lost to Follow-up|5|||
170828771|NCT02930837|617382020|FG000|Overall Study|Withdrawal by Subject|1|||
170828772|NCT01071317|617382024|FG000|Overall Study|Lost to Follow-up|2|||
170828773|NCT01071317|617382025|FG001|Overall Study|Lost to Follow-up|2|||
170828774|NCT00316589|617382026|FG000|Overall Study|Withdrawal by Subject|0|||
170828775|NCT00316589|617382027|FG001|Overall Study|Withdrawal by Subject|5|||
170714761|NCT02141516|616960932|FG001|Overall Study|Adverse Event|1|||
170828776|NCT00316589|617382028|FG002|Overall Study|Withdrawal by Subject|0|||
170828777|NCT00316589|617382029|FG003|Overall Study|Withdrawal by Subject|1|||
170714762|NCT02141516|616960933|FG002|Overall Study|Adverse Event|0|||
170828778|NCT00316589|617382026|FG000|Overall Study|Subject unwilling/unable to comply|0|||
170828779|NCT00316589|617382027|FG001|Overall Study|Subject unwilling/unable to comply|6|||
170714763|NCT02141516|616960931|FG000|Overall Study|Lost to Follow-up|0|||
170714764|NCT02141516|616960932|FG001|Overall Study|Lost to Follow-up|1|||
170714765|NCT02141516|616960933|FG002|Overall Study|Lost to Follow-up|0|||
170714766|NCT02141516|616960931|FG000|Overall Study|Other|0|||
170714767|NCT02141516|616960932|FG001|Overall Study|Other|3|||
170714768|NCT02141516|616960933|FG002|Overall Study|Other|0|||
170714769|NCT02041429|616960934|FG000|Overall Study|Progressive Disease|2|||
170714770|NCT02041429|616960935|FG001|Overall Study|Progressive Disease|2|||
170714771|NCT02041429|616960936|FG002|Overall Study|Progressive Disease|3|||
170714772|NCT02041429|616960937|FG003|Overall Study|Progressive Disease|2|||
170714773|NCT02041429|616960934|FG000|Overall Study|Toxicity|0|||
170714774|NCT02041429|616960935|FG001|Overall Study|Toxicity|1|||
170714775|NCT02041429|616960936|FG002|Overall Study|Toxicity|4|||
170714776|NCT02041429|616960937|FG003|Overall Study|Toxicity|2|||
170714777|NCT02041429|616960934|FG000|Overall Study|Withdrawal by Subject|0|||
170714778|NCT02041429|616960935|FG001|Overall Study|Withdrawal by Subject|1|||
170714779|NCT02041429|616960936|FG002|Overall Study|Withdrawal by Subject|0|||
170714780|NCT02041429|616960937|FG003|Overall Study|Withdrawal by Subject|0|||
170714781|NCT02041429|616960934|FG000|Overall Study|On Maintenance Therapy|1|||
170714782|NCT02041429|616960935|FG001|Overall Study|On Maintenance Therapy|0|||
170714783|NCT02041429|616960936|FG002|Overall Study|On Maintenance Therapy|0|||
170714784|NCT02041429|616960937|FG003|Overall Study|On Maintenance Therapy|2|||
170714785|NCT03251924|616960938|FG000|Overall Study|Disease Progression|6|||
170714786|NCT03251924|616960939|FG001|Overall Study|Disease Progression|6|||
170714787|NCT03251924|616960940|FG002|Overall Study|Disease Progression|7|||
170714788|NCT03251924|616960941|FG003|Overall Study|Disease Progression|8|||
170714789|NCT03251924|616960942|FG004|Overall Study|Disease Progression|8|||
170714790|NCT03251924|616960943|FG005|Overall Study|Disease Progression|7|||
170714791|NCT03251924|616960944|FG006|Overall Study|Disease Progression|6|||
170714792|NCT03251924|616960945|FG007|Overall Study|Disease Progression|10|||
170714793|NCT03251924|616960946|FG008|Overall Study|Disease Progression|6|||
170714794|NCT03251924|616960938|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
170714795|NCT03251924|616960939|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
170714796|NCT03251924|616960940|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
170714797|NCT03251924|616960941|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
170714798|NCT03251924|616960942|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
170714799|NCT03251924|616960943|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
170714800|NCT03251924|616960944|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
170714801|NCT03251924|616960945|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
170714802|NCT03251924|616960946|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
170714803|NCT03251924|616960938|FG000|Overall Study|Death|0|||
170714804|NCT03251924|616960939|FG001|Overall Study|Death|1|||
170714805|NCT03251924|616960940|FG002|Overall Study|Death|0|||
170714806|NCT03251924|616960941|FG003|Overall Study|Death|1|||
170714807|NCT03251924|616960942|FG004|Overall Study|Death|1|||
170714808|NCT03251924|616960943|FG005|Overall Study|Death|1|||
170714809|NCT03251924|616960944|FG006|Overall Study|Death|0|||
170714810|NCT03251924|616960945|FG007|Overall Study|Death|0|||
170714811|NCT03251924|616960946|FG008|Overall Study|Death|0|||
170714812|NCT03251924|616960938|FG000|Overall Study|Study Drug Toxicity|0|||
170714813|NCT03251924|616960939|FG001|Overall Study|Study Drug Toxicity|0|||
170714814|NCT03251924|616960940|FG002|Overall Study|Study Drug Toxicity|0|||
170714815|NCT03251924|616960941|FG003|Overall Study|Study Drug Toxicity|1|||
170714816|NCT03251924|616960942|FG004|Overall Study|Study Drug Toxicity|0|||
170714817|NCT03251924|616960943|FG005|Overall Study|Study Drug Toxicity|0|||
170714818|NCT03251924|616960944|FG006|Overall Study|Study Drug Toxicity|0|||
170714819|NCT03251924|616960945|FG007|Overall Study|Study Drug Toxicity|0|||
170714820|NCT03251924|616960946|FG008|Overall Study|Study Drug Toxicity|1|||
170714821|NCT03251924|616960938|FG000|Overall Study|Other Reasons|0|||
170714822|NCT03251924|616960939|FG001|Overall Study|Other Reasons|0|||
170714823|NCT03251924|616960940|FG002|Overall Study|Other Reasons|0|||
170714824|NCT03251924|616960941|FG003|Overall Study|Other Reasons|0|||
170714825|NCT03251924|616960942|FG004|Overall Study|Other Reasons|0|||
170714826|NCT03251924|616960943|FG005|Overall Study|Other Reasons|0|||
170714827|NCT03251924|616960944|FG006|Overall Study|Other Reasons|0|||
170714828|NCT03251924|616960945|FG007|Overall Study|Other Reasons|0|||
170714829|NCT03251924|616960946|FG008|Overall Study|Other Reasons|1|||
170714830|NCT03251924|616960938|FG000|Overall Study|Participant request to discontinue study treatment|0|||
170714831|NCT03251924|616960939|FG001|Overall Study|Participant request to discontinue study treatment|0|||
170714832|NCT03251924|616960940|FG002|Overall Study|Participant request to discontinue study treatment|0|||
170714833|NCT03251924|616960941|FG003|Overall Study|Participant request to discontinue study treatment|0|||
170714834|NCT03251924|616960942|FG004|Overall Study|Participant request to discontinue study treatment|0|||
170714835|NCT03251924|616960943|FG005|Overall Study|Participant request to discontinue study treatment|0|||
170714836|NCT03251924|616960944|FG006|Overall Study|Participant request to discontinue study treatment|0|||
170714837|NCT03251924|616960945|FG007|Overall Study|Participant request to discontinue study treatment|1|||
170714838|NCT03251924|616960946|FG008|Overall Study|Participant request to discontinue study treatment|0|||
170714839|NCT01427712|616960947|FG000|Overall Study|Transfer to a different hospital|2|||
170714840|NCT01427712|616960947|FG000|Overall Study|Lost to Follow-up|1|||
170714841|NCT01427712|616960947|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
170714842|NCT01427712|616960947|FG000|Overall Study|Failure to visit|1|||
170714843|NCT03169153|616960948|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
170714844|NCT03169153|616960949|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
170714845|NCT03169153|616960948|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
170714846|NCT03169153|616960949|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
170714847|NCT03169153|616960948|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
170714848|NCT03169153|616960949|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
170714849|NCT03169153|616960948|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
170714850|NCT03169153|616960949|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
170714851|NCT00439777|616960950|FG000|Treatment Period|Death|29|||
170714852|NCT00439777|616960951|FG001|Treatment Period|Death|21|||
170714853|NCT00439777|616960950|FG000|Treatment Period|Study terminated by sponsor|125|||
170714854|NCT00439777|616960951|FG001|Treatment Period|Study terminated by sponsor|132|||
170714855|NCT00439777|616960950|FG000|Treatment Period|Site closed by investigator|0|||
170714856|NCT00439777|616960951|FG001|Treatment Period|Site closed by investigator|1|||
170714857|NCT00439777|616960950|FG000|Treatment Period|Did not take study treatment|7|||
170714858|NCT00439777|616960951|FG001|Treatment Period|Did not take study treatment|8|||
170714859|NCT00439777|616960950|FG000|Treatment Period|Adverse Event|111|||
170714860|NCT00439777|616960951|FG001|Treatment Period|Adverse Event|92|||
170714861|NCT00439777|616960950|FG000|Treatment Period|Protocol Violation|23|||
170714862|NCT00439777|616960951|FG001|Treatment Period|Protocol Violation|30|||
170714863|NCT00439777|616960950|FG000|Treatment Period|Withdrawal by Subject|66|||
170714864|NCT00439777|616960951|FG001|Treatment Period|Withdrawal by Subject|118|||
170714865|NCT00439777|616960950|FG000|Treatment Period|Lack of Efficacy|1|||
170714866|NCT00439777|616960951|FG001|Treatment Period|Lack of Efficacy|4|||
170714867|NCT00439777|616960950|FG000|Treatment Period|Lost to Follow-up|8|||
170714868|NCT00439777|616960951|FG001|Treatment Period|Lost to Follow-up|10|||
170714869|NCT00439777|616960950|FG000|Treatment Period|Protocol driven decision point|1|||
170714870|NCT00439777|616960951|FG001|Treatment Period|Protocol driven decision point|3|||
170714871|NCT00439777|616960950|FG000|Treatment Period|Physician Decision|7|||
170714872|NCT00439777|616960951|FG001|Treatment Period|Physician Decision|18|||
170714873|NCT00439777|616960950|FG000|Treatment Period|Clinical endpoint reached|26|||
170714874|NCT00439777|616960951|FG001|Treatment Period|Clinical endpoint reached|13|||
170714875|NCT00439777|616960950|FG000|Treatment Period|Technical problems|3|||
170714876|NCT00439777|616960951|FG001|Treatment Period|Technical problems|1|||
170714877|NCT00439777|616960950|FG000|Treatment Period|Participant convenience|12|||
170714878|NCT00439777|616960951|FG001|Treatment Period|Participant convenience|8|||
170828780|NCT00316589|617382028|FG002|Overall Study|Subject unwilling/unable to comply|0|||
170828781|NCT00316589|617382029|FG003|Overall Study|Subject unwilling/unable to comply|2|||
170828782|NCT00316589|617382026|FG000|Overall Study|Adverse Event|1|||
170828783|NCT00316589|617382027|FG001|Overall Study|Adverse Event|0|||
170828784|NCT00316589|617382028|FG002|Overall Study|Adverse Event|0|||
170828785|NCT00316589|617382029|FG003|Overall Study|Adverse Event|1|||
170828786|NCT00316589|617382026|FG000|Overall Study|Physician Decision|0|||
170828787|NCT00316589|617382027|FG001|Overall Study|Physician Decision|1|||
170828788|NCT00316589|617382028|FG002|Overall Study|Physician Decision|0|||
170828789|NCT00316589|617382029|FG003|Overall Study|Physician Decision|0|||
170828790|NCT00316589|617382026|FG000|Overall Study|Other reason|0|||
170828791|NCT00316589|617382027|FG001|Overall Study|Other reason|12|||
170828792|NCT00316589|617382028|FG002|Overall Study|Other reason|1|||
170828793|NCT00316589|617382029|FG003|Overall Study|Other reason|1|||
170828794|NCT02481934|617382034|FG000|Overall Study|Death|2|||
170828795|NCT00276016|617382035|FG000|Intervention 1|Withdrawal by Subject|0|||
170828796|NCT00276016|617382036|FG001|Intervention 1|Withdrawal by Subject|1|||
170828797|NCT00276016|617382037|FG002|Intervention 1|Withdrawal by Subject|0|||
170714879|NCT00439777|616960950|FG000|Observational Period|Protocol Violation|0|||
170828798|NCT00276016|617382038|FG003|Intervention 1|Withdrawal by Subject|0|||
170714880|NCT00439777|616960951|FG001|Observational Period|Protocol Violation|2|||
170714881|NCT00439777|616960950|FG000|Observational Period|Withdrawal by Subject|9|||
170828799|NCT00276016|617382039|FG004|Intervention 1|Withdrawal by Subject|0|||
170828800|NCT00276016|617382040|FG005|Intervention 1|Withdrawal by Subject|0|||
170714882|NCT00439777|616960951|FG001|Observational Period|Withdrawal by Subject|5|||
170714883|NCT00439777|616960950|FG000|Observational Period|Lost to Follow-up|1|||
170828801|NCT02473913|617382041|FG000|Overall Study|Lost to Follow-up|3|||
170714884|NCT00439777|616960951|FG001|Observational Period|Lost to Follow-up|11|||
170714885|NCT00439777|616960950|FG000|Observational Period|Death|27|||
170714886|NCT00439777|616960951|FG001|Observational Period|Death|20|||
170714887|NCT00439777|616960950|FG000|Observational Period|Study terminated by sponsor|3|||
170714888|NCT00439777|616960951|FG001|Observational Period|Study terminated by sponsor|1|||
170714889|NCT00439777|616960950|FG000|Observational Period|Protocol driven decision point|0|||
170714890|NCT00439777|616960951|FG001|Observational Period|Protocol driven decision point|1|||
170714891|NCT00439777|616960950|FG000|Observational Period|Lack of Efficacy|1|||
170714892|NCT00439777|616960951|FG001|Observational Period|Lack of Efficacy|0|||
170714893|NCT00439777|616960950|FG000|Observational Period|Technical problems|0|||
170714894|NCT00439777|616960951|FG001|Observational Period|Technical problems|1|||
170714895|NCT03062891|616960956|FG000|Overall Study|Withdrawal by Subject|2|||
170714896|NCT03062891|616960957|FG001|Overall Study|Withdrawal by Subject|0|||
170714897|NCT03062891|616960956|FG000|Overall Study|Lost to Follow-up|50|||
170714898|NCT03062891|616960957|FG001|Overall Study|Lost to Follow-up|38|||
170714899|NCT02127307|616960958|FG000|Overall Study|Protocol Violation|36|||
170714900|NCT02127307|616960958|FG000|Overall Study|Lost to Follow-up|2|||
170714901|NCT02127307|616960958|FG000|Overall Study|Death|101|||
170714902|NCT02127307|616960958|FG000|Overall Study|Other than specified above|169|||
170714903|NCT00235989|616960959|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
170714904|NCT00235989|616960960|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
170714905|NCT00235989|616960961|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
170714906|NCT00235989|616960962|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
170714907|NCT00235989|616960963|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
170714908|NCT00235989|616960964|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
170714909|NCT00235989|616960959|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
170714910|NCT00235989|616960960|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
170828802|NCT02473913|617382042|FG001|Overall Study|Lost to Follow-up|3|||
170828803|NCT05041439|617382043|FG000|Overall Study|Withdrawal by Subject|1|||
170828804|NCT05041439|617382044|FG001|Overall Study|Withdrawal by Subject|1|||
170828805|NCT05041439|617382043|FG000|Overall Study|Death|1|||
170828806|NCT05041439|617382044|FG001|Overall Study|Death|0|||
170828807|NCT02979613|617382045|FG000|Double-Blind Phase|Withdrew Consent|2|||
170828808|NCT02979613|617382046|FG001|Double-Blind Phase|Withdrew Consent|4|||
170828809|NCT02979613|617382045|FG000|Double-Blind Phase|Pregnancy|2|||
170828810|NCT02979613|617382046|FG001|Double-Blind Phase|Pregnancy|2|||
170828811|NCT02979613|617382045|FG000|Double-Blind Phase|Adverse Event|2|||
170828812|NCT02979613|617382046|FG001|Double-Blind Phase|Adverse Event|0|||
170828813|NCT02979613|617382045|FG000|Double-Blind Phase|Lost to Follow-up|1|||
170828814|NCT02979613|617382046|FG001|Double-Blind Phase|Lost to Follow-up|1|||
170828815|NCT02979613|617382045|FG000|Double-Blind Phase|Protocol Violation|1|||
170828816|NCT02979613|617382046|FG001|Double-Blind Phase|Protocol Violation|1|||
170828817|NCT02979613|617382045|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
170828818|NCT02979613|617382046|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
170828819|NCT02979613|617382045|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
170828820|NCT02979613|617382046|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
170828821|NCT02979613|617382045|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
170828822|NCT02979613|617382046|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
170828823|NCT02979613|617382045|FG000|Open-Label Extension (OLE) Phase|Death|0|||
170828824|NCT02979613|617382046|FG001|Open-Label Extension (OLE) Phase|Death|1|||
170828825|NCT02979613|617382045|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
170828826|NCT02979613|617382046|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
170828827|NCT04843579|617383833|FG000|Overall Study|Adverse Event|1|||
170828828|NCT04843579|617383833|FG000|Overall Study|Disease Progression|1|||
170828829|NCT00477464|617383835|FG000|Overall Study|Lost to Follow-up|1|||
170828830|NCT00477464|617383835|FG000|Overall Study|Death|36|||
170828831|NCT00477464|617383835|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
170828832|NCT03568812|617383836|FG000|Overall Study|Physician Decision|0|||
170828833|NCT03568812|617383837|FG001|Overall Study|Physician Decision|1|||
170828834|NCT01172639|617383842|FG000|Overall Study|Death|1|||
170828835|NCT01172639|617383843|FG001|Overall Study|Death|1|||
170828836|NCT01172639|617383844|FG002|Overall Study|Death|0|||
170828837|NCT01172639|617383845|FG003|Overall Study|Death|0|||
170828838|NCT01172639|617383846|FG004|Overall Study|Death|0|||
170714911|NCT00235989|616960961|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
170714912|NCT00235989|616960962|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
170828839|NCT01172639|617383842|FG000|Overall Study|Lost to Follow-up|9|||
170828840|NCT01172639|617383843|FG001|Overall Study|Lost to Follow-up|7|||
170828841|NCT01172639|617383844|FG002|Overall Study|Lost to Follow-up|11|||
170828842|NCT01172639|617383845|FG003|Overall Study|Lost to Follow-up|6|||
170828843|NCT01172639|617383846|FG004|Overall Study|Lost to Follow-up|6|||
170828844|NCT01172639|617383842|FG000|Overall Study|Withdrawal by Subject|3|||
170828845|NCT01172639|617383843|FG001|Overall Study|Withdrawal by Subject|3|||
170714913|NCT00235989|616960963|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
170714914|NCT00235989|616960964|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
170714915|NCT00235989|616960959|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
170714916|NCT00235989|616960960|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
170714917|NCT00235989|616960961|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
170714918|NCT00235989|616960962|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
170714919|NCT00235989|616960963|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
170714920|NCT00235989|616960964|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
170714921|NCT00235989|616960959|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
170714922|NCT00235989|616960960|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
170714923|NCT00235989|616960961|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
170714924|NCT00235989|616960962|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
170714925|NCT00235989|616960963|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
170828846|NCT01172639|617383844|FG002|Overall Study|Withdrawal by Subject|5|||
170828847|NCT01172639|617383845|FG003|Overall Study|Withdrawal by Subject|5|||
170828848|NCT01172639|617383846|FG004|Overall Study|Withdrawal by Subject|0|||
170828849|NCT01316887|617383847|FG000|Overall Study|Adverse Event|13|||
170828850|NCT01316887|617383848|FG001|Overall Study|Adverse Event|21|||
170828851|NCT01316887|617383849|FG002|Overall Study|Adverse Event|17|||
170828852|NCT01316887|617383847|FG000|Overall Study|Lack of Efficacy|9|||
170828853|NCT01316887|617383848|FG001|Overall Study|Lack of Efficacy|3|||
170828854|NCT01316887|617383849|FG002|Overall Study|Lack of Efficacy|1|||
170828855|NCT01316887|617383847|FG000|Overall Study|Protocol Violation|2|||
170828856|NCT01316887|617383848|FG001|Overall Study|Protocol Violation|6|||
170828857|NCT01316887|617383849|FG002|Overall Study|Protocol Violation|6|||
170828858|NCT01316887|617383847|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
170828859|NCT01316887|617383848|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
170828860|NCT01316887|617383849|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
170828861|NCT01316887|617383847|FG000|Overall Study|Study Closed/Terminated|2|||
170828862|NCT01316887|617383848|FG001|Overall Study|Study Closed/Terminated|4|||
170828863|NCT01316887|617383849|FG002|Overall Study|Study Closed/Terminated|3|||
170828864|NCT01316887|617383847|FG000|Overall Study|Lost to Follow-up|1|||
170828865|NCT01316887|617383848|FG001|Overall Study|Lost to Follow-up|7|||
170828866|NCT01316887|617383849|FG002|Overall Study|Lost to Follow-up|5|||
170828867|NCT01316887|617383847|FG000|Overall Study|Withdrawal by Subject|8|||
170828868|NCT01316887|617383848|FG001|Overall Study|Withdrawal by Subject|16|||
170828869|NCT01316887|617383849|FG002|Overall Study|Withdrawal by Subject|15|||
170828870|NCT02172950|617383850|FG000|Overall Study|Physician Decision|3|||
170828871|NCT02172950|617383851|FG001|Overall Study|Physician Decision|3|||
170828872|NCT02172950|617383850|FG000|Overall Study|Lack of Efficacy|1|||
170828873|NCT02172950|617383851|FG001|Overall Study|Lack of Efficacy|0|||
170828874|NCT02172950|617383850|FG000|Overall Study|Adverse Event|4|||
170828875|NCT02172950|617383851|FG001|Overall Study|Adverse Event|1|||
170828876|NCT02172950|617383850|FG000|Overall Study|Withdrawal by Subject|10|||
170828877|NCT02172950|617383851|FG001|Overall Study|Withdrawal by Subject|0|||
170828878|NCT02172950|617383850|FG000|Overall Study|Protocol Violation|1|||
170828879|NCT02172950|617383851|FG001|Overall Study|Protocol Violation|0|||
170828880|NCT02172950|617383850|FG000|Overall Study|Lost to Follow-up|1|||
170828881|NCT02172950|617383851|FG001|Overall Study|Lost to Follow-up|0|||
170828882|NCT02172950|617383850|FG000|Overall Study|Death|1|||
170828883|NCT02172950|617383851|FG001|Overall Study|Death|0|||
170828884|NCT02172950|617383850|FG000|Overall Study|Patient traveling|1|||
170828885|NCT02172950|617383851|FG001|Overall Study|Patient traveling|0|||
170828886|NCT02172950|617383850|FG000|Overall Study|Patient went to other country|1|||
170828887|NCT02172950|617383851|FG001|Overall Study|Patient went to other country|0|||
170828888|NCT02172950|617383850|FG000|Overall Study|Patient relocated overseas|1|||
170828889|NCT02172950|617383851|FG001|Overall Study|Patient relocated overseas|1|||
170828890|NCT02172950|617383850|FG000|Overall Study|Patient moving|1|||
170828891|NCT02172950|617383851|FG001|Overall Study|Patient moving|0|||
170828892|NCT00813098|617383856|FG000|Overall Study|Adverse Event|2|||
170828893|NCT00813098|617383857|FG001|Overall Study|Adverse Event|4|||
170828894|NCT00813098|617383858|FG002|Overall Study|Adverse Event|1|||
170828895|NCT00813098|617383856|FG000|Overall Study|Withdrawal by Subject|0|||
170828896|NCT00813098|617383857|FG001|Overall Study|Withdrawal by Subject|1|||
170828897|NCT00813098|617383858|FG002|Overall Study|Withdrawal by Subject|0|||
170828898|NCT00813098|617383856|FG000|Overall Study|Inability to complete study procedures|1|||
170828899|NCT00813098|617383857|FG001|Overall Study|Inability to complete study procedures|0|||
170828900|NCT00813098|617383858|FG002|Overall Study|Inability to complete study procedures|0|||
170828901|NCT00813098|617383856|FG000|Overall Study|Lost to Follow-up|0|||
170828902|NCT00813098|617383857|FG001|Overall Study|Lost to Follow-up|1|||
170828903|NCT00813098|617383858|FG002|Overall Study|Lost to Follow-up|0|||
170828904|NCT00813098|617383856|FG000|Overall Study|Protocol Violation|0|||
170828905|NCT00813098|617383857|FG001|Overall Study|Protocol Violation|0|||
170828906|NCT00813098|617383858|FG002|Overall Study|Protocol Violation|1|||
170828907|NCT00813098|617383856|FG000|Overall Study|Principal Investigator decision|0|||
170828908|NCT00813098|617383857|FG001|Overall Study|Principal Investigator decision|1|||
170714926|NCT00235989|616960964|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
170714927|NCT00235989|616960959|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
170714928|NCT00235989|616960960|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
170714929|NCT00235989|616960961|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
170714930|NCT00235989|616960962|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
170714931|NCT00235989|616960963|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
170714932|NCT00235989|616960964|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
170714933|NCT01337297|616960985|FG000|Overall Study|They entered to single anodal tDCS|4|||
170714934|NCT01337297|616960986|FG001|Overall Study|They entered to single anodal tDCS|3|||
170714935|NCT01337297|616960985|FG000|Overall Study|Lost to Follow-up|1|||
170714936|NCT01337297|616960986|FG001|Overall Study|Lost to Follow-up|3|||
170714937|NCT01800903|616960987|FG000|Second Test Period|unable to catheterise|1|||
170714938|NCT01800903|616960988|FG001|Second Test Period|unable to catheterise|0|||
170714939|NCT01800903|616960989|FG002|Second Test Period|unable to catheterise|0|||
170714940|NCT01800903|616960990|FG003|Second Test Period|unable to catheterise|0|||
170714941|NCT01800903|616960991|FG004|Second Test Period|unable to catheterise|0|||
170714942|NCT01800903|616960992|FG005|Second Test Period|unable to catheterise|0|||
170714943|NCT02296112|616960993|FG000|Overall Study|Disease progression|7|||
170714944|NCT02296112|616960993|FG000|Overall Study|Toxicity|1|||
170714945|NCT02296112|616960993|FG000|Overall Study|Began an alternate therapy|1|||
170714946|NCT02778204|616960994|FG000|Overall Study|Adverse Event|1|||
170714947|NCT02778204|616960995|FG001|Overall Study|Adverse Event|0|||
170714948|NCT02778204|616960996|FG002|Overall Study|Adverse Event|0|||
170714949|NCT02778204|616960997|FG003|Overall Study|Adverse Event|0|||
170714950|NCT02778204|616960994|FG000|Overall Study|Withdrawal by Subject|0|||
170714951|NCT02778204|616960995|FG001|Overall Study|Withdrawal by Subject|0|||
170714952|NCT02778204|616960996|FG002|Overall Study|Withdrawal by Subject|1|||
170714953|NCT02778204|616960997|FG003|Overall Study|Withdrawal by Subject|2|||
170714954|NCT02778204|616960994|FG000|Overall Study|Lost to Follow-up|1|||
170714955|NCT02778204|616960995|FG001|Overall Study|Lost to Follow-up|0|||
170714956|NCT02778204|616960996|FG002|Overall Study|Lost to Follow-up|2|||
170714957|NCT02778204|616960997|FG003|Overall Study|Lost to Follow-up|1|||
170714958|NCT02778204|616960994|FG000|Overall Study|Protocol Violation|0|||
170714959|NCT02778204|616960995|FG001|Overall Study|Protocol Violation|0|||
170714960|NCT02778204|616960996|FG002|Overall Study|Protocol Violation|1|||
170714961|NCT02778204|616960997|FG003|Overall Study|Protocol Violation|0|||
170714962|NCT02778204|616960994|FG000|Overall Study|Eligibility Violation|0|||
170714963|NCT02778204|616960995|FG001|Overall Study|Eligibility Violation|0|||
170714964|NCT02778204|616960996|FG002|Overall Study|Eligibility Violation|0|||
170714965|NCT02778204|616960997|FG003|Overall Study|Eligibility Violation|1|||
170714966|NCT01072201|616960998|FG000|Overall Study|Lost to Follow-up|0|||
170714967|NCT01072201|616960999|FG001|Overall Study|Lost to Follow-up|1|||
170714968|NCT01720069|616961000|FG000|Overall Study|Could not use e-diary correctly|0|||
170714969|NCT01720069|616961001|FG001|Overall Study|Could not use e-diary correctly|1|||
170714970|NCT01720069|616961002|FG002|Overall Study|Could not use e-diary correctly|1|||
170714971|NCT01720069|616961000|FG000|Overall Study|Randomised without baseline values|0|||
170714972|NCT01720069|616961001|FG001|Overall Study|Randomised without baseline values|0|||
170714973|NCT01720069|616961002|FG002|Overall Study|Randomised without baseline values|1|||
170714974|NCT01720069|616961000|FG000|Overall Study|Adverse Event|0|||
170714975|NCT01720069|616961001|FG001|Overall Study|Adverse Event|0|||
170714976|NCT01720069|616961002|FG002|Overall Study|Adverse Event|1|||
170714977|NCT01720069|616961000|FG000|Overall Study|Lack of Efficacy|0|||
170714978|NCT01720069|616961001|FG001|Overall Study|Lack of Efficacy|4|||
170714979|NCT01720069|616961002|FG002|Overall Study|Lack of Efficacy|0|||
170714980|NCT01720069|616961000|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
170714981|NCT01720069|616961001|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
170714982|NCT01720069|616961002|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
170714983|NCT01720069|616961000|FG000|Overall Study|Withdrawal by Subject|0|||
170714984|NCT01720069|616961001|FG001|Overall Study|Withdrawal by Subject|2|||
170714985|NCT01720069|616961002|FG002|Overall Study|Withdrawal by Subject|1|||
170714986|NCT01720069|616961000|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
170714987|NCT01720069|616961001|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
170714988|NCT01720069|616961002|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
170714989|NCT01720069|616961000|FG000|Overall Study|Non-compliance on using e-diary|0|||
170714990|NCT01720069|616961001|FG001|Overall Study|Non-compliance on using e-diary|0|||
170714991|NCT01720069|616961002|FG002|Overall Study|Non-compliance on using e-diary|1|||
170714992|NCT01720069|616961000|FG000|Overall Study|Lost to Follow-up|0|||
170714993|NCT01720069|616961001|FG001|Overall Study|Lost to Follow-up|0|||
170714994|NCT01720069|616961002|FG002|Overall Study|Lost to Follow-up|1|||
170714995|NCT04028388|616961003|FG000|Overall Study|Evaluations missing|3|||
170714996|NCT04028388|616961004|FG001|Overall Study|Evaluations missing|6|||
170714997|NCT04028388|616961003|FG000|Overall Study|Not started|2|||
170714998|NCT04028388|616961004|FG001|Overall Study|Not started|0|||
170714999|NCT03779841|616961005|FG000|Randomized Population|Did Not Receive Treatment|3|||
170715000|NCT03779841|616961006|FG001|Randomized Population|Did Not Receive Treatment|1|||
170715001|NCT03779841|616961007|FG002|Randomized Population|Did Not Receive Treatment|0|||
170715002|NCT03779841|616961005|FG000|Treated (Safety) Population|Adverse Event|1|||
170715003|NCT03779841|616961006|FG001|Treated (Safety) Population|Adverse Event|1|||
170715004|NCT03779841|616961007|FG002|Treated (Safety) Population|Adverse Event|0|||
170715005|NCT03779841|616961005|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
170715006|NCT03779841|616961006|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
170715007|NCT03779841|616961007|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
170715008|NCT03779841|616961005|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
170715009|NCT03779841|616961006|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
170715010|NCT03779841|616961007|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
170715011|NCT03779841|616961005|FG000|Treated (Safety) Population|Death|1|||
170715012|NCT03779841|616961006|FG001|Treated (Safety) Population|Death|0|||
170715013|NCT03779841|616961007|FG002|Treated (Safety) Population|Death|2|||
170715014|NCT02348216|616962427|FG000|Overall Study|Death|5|||
170715015|NCT02348216|616962428|FG001|Overall Study|Death|53|||
170715016|NCT02348216|616962429|FG002|Overall Study|Death|11|||
170715017|NCT02348216|616962430|FG003|Overall Study|Death|20|||
170715018|NCT02348216|616962431|FG004|Overall Study|Death|16|||
170715019|NCT02348216|616962432|FG005|Overall Study|Death|32|||
170715020|NCT02348216|616962433|FG006|Overall Study|Death|17|||
170715021|NCT02348216|616962427|FG000|Overall Study|Full consent withdrawal|0|||
170715022|NCT02348216|616962428|FG001|Overall Study|Full consent withdrawal|0|||
170715023|NCT02348216|616962429|FG002|Overall Study|Full consent withdrawal|0|||
170715024|NCT02348216|616962430|FG003|Overall Study|Full consent withdrawal|1|||
170715025|NCT02348216|616962431|FG004|Overall Study|Full consent withdrawal|3|||
170715026|NCT02348216|616962432|FG005|Overall Study|Full consent withdrawal|0|||
170715027|NCT02348216|616962433|FG006|Overall Study|Full consent withdrawal|3|||
170715028|NCT02348216|616962427|FG000|Overall Study|Lost to Follow-up|0|||
170715029|NCT02348216|616962428|FG001|Overall Study|Lost to Follow-up|5|||
170715030|NCT02348216|616962429|FG002|Overall Study|Lost to Follow-up|2|||
170715031|NCT02348216|616962430|FG003|Overall Study|Lost to Follow-up|0|||
170715032|NCT02348216|616962431|FG004|Overall Study|Lost to Follow-up|1|||
170715033|NCT02348216|616962432|FG005|Overall Study|Lost to Follow-up|1|||
170715034|NCT02348216|616962433|FG006|Overall Study|Lost to Follow-up|1|||
170715035|NCT02348216|616962427|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
170715036|NCT02348216|616962428|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
170715037|NCT02348216|616962429|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
170715038|NCT02348216|616962430|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
170715039|NCT02348216|616962431|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
170715040|NCT02348216|616962432|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
170715041|NCT02348216|616962433|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
170715042|NCT02348216|616962427|FG000|Overall Study|Reason not specified|2|||
170715043|NCT02348216|616962428|FG001|Overall Study|Reason not specified|19|||
170715044|NCT02348216|616962429|FG002|Overall Study|Reason not specified|11|||
170715045|NCT02348216|616962430|FG003|Overall Study|Reason not specified|17|||
170715046|NCT02348216|616962431|FG004|Overall Study|Reason not specified|21|||
170715047|NCT02348216|616962432|FG005|Overall Study|Reason not specified|17|||
170715048|NCT02348216|616962433|FG006|Overall Study|Reason not specified|19|||
170715049|NCT00795600|616962434|FG000|Overall Study|Adverse Event|1|||
170715050|NCT00795600|616962435|FG001|Overall Study|Adverse Event|1|||
170715051|NCT00795600|616962434|FG000|Overall Study|Protocol Violation|1|||
170715052|NCT00795600|616962435|FG001|Overall Study|Protocol Violation|2|||
170715053|NCT00795600|616962434|FG000|Overall Study|Withdrawal by Subject|1|||
170715054|NCT00795600|616962435|FG001|Overall Study|Withdrawal by Subject|0|||
170715055|NCT00795600|616962434|FG000|Overall Study|Unclassified|1|||
170715056|NCT00795600|616962435|FG001|Overall Study|Unclassified|1|||
170715057|NCT02159482|616962436|FG000|Overall Study|Withdrawal by Subject|2|||
170715058|NCT02159482|616962436|FG000|Overall Study|Physician Decision|3|||
170715059|NCT01248884|616962437|FG000|Overall Study|Withdrawal by Subject|1|||
170715060|NCT01248884|616962438|FG001|Overall Study|Withdrawal by Subject|3|||
170715061|NCT01248884|616962439|FG002|Overall Study|Withdrawal by Subject|1|||
170715062|NCT01248884|616962437|FG000|Overall Study|Adverse Event|1|||
170715063|NCT01248884|616962438|FG001|Overall Study|Adverse Event|0|||
170715064|NCT01248884|616962439|FG002|Overall Study|Adverse Event|0|||
170715065|NCT02511431|616962440|FG000|Treatment|Lost to Follow-up|0|||
170715066|NCT02511431|616962441|FG001|Treatment|Lost to Follow-up|0|||
170715067|NCT02511431|616962442|FG002|Treatment|Lost to Follow-up|1|||
170715068|NCT02511431|616962443|FG003|Treatment|Lost to Follow-up|0|||
170715069|NCT02511431|616962444|FG004|Treatment|Lost to Follow-up|0|||
170715070|NCT02511431|616962445|FG005|Treatment|Lost to Follow-up|1|||
170715071|NCT00840970|616962450|FG000|Overall Study|Adverse Event|0|||
170715072|NCT00840970|616962451|FG001|Overall Study|Adverse Event|0|||
170715073|NCT00840970|616962452|FG002|Overall Study|Adverse Event|1|||
170715074|NCT00736996|616962453|FG000|Overall Study|Lost to Follow-up|1|||
170715075|NCT00736996|616962454|FG001|Overall Study|Lost to Follow-up|9|||
170715076|NCT00736996|616962455|FG002|Overall Study|Lost to Follow-up|2|||
170715077|NCT02660944|616962456|FG000|Overall Study|Adverse Event|3|||
170715078|NCT02660944|616962457|FG001|Overall Study|Adverse Event|4|||
170715079|NCT02660944|616962456|FG000|Overall Study|Physician Decision|3|||
170715080|NCT02660944|616962457|FG001|Overall Study|Physician Decision|1|||
170715081|NCT02660944|616962456|FG000|Overall Study|Withdrawal by Subject|5|||
170715082|NCT02660944|616962457|FG001|Overall Study|Withdrawal by Subject|3|||
170715083|NCT02660944|616962456|FG000|Overall Study|Lost to Follow-up|4|||
170715084|NCT02660944|616962457|FG001|Overall Study|Lost to Follow-up|1|||
170715085|NCT02660944|616962456|FG000|Overall Study|Subject schedule|0|||
170715086|NCT02660944|616962457|FG001|Overall Study|Subject schedule|1|||
170715087|NCT02660944|616962456|FG000|Overall Study|Exclusion criteria met|2|||
170715088|NCT02660944|616962457|FG001|Overall Study|Exclusion criteria met|0|||
170715089|NCT01343056|616962460|FG000|Overall Study|Lost to Follow-up|7|||
170715090|NCT01343056|616962461|FG001|Overall Study|Lost to Follow-up|5|||
170715091|NCT01343056|616962462|FG002|Overall Study|Lost to Follow-up|3|||
170715092|NCT01343056|616962463|FG003|Overall Study|Lost to Follow-up|9|||
170715093|NCT03231371|616962464|FG000|Overall Study|Withdrawal by Subject|1|||
170715094|NCT03231371|616962464|FG000|Overall Study|chose or were ineligible to have MRI|12|||
170715095|NCT01243944|616962467|FG000|Overall Study|Adverse Event|15|||
170715096|NCT01243944|616962468|FG001|Overall Study|Adverse Event|13|||
170715097|NCT01243944|616962467|FG000|Overall Study|Lost to Follow-up|2|||
170715098|NCT01243944|616962468|FG001|Overall Study|Lost to Follow-up|1|||
170715099|NCT01243944|616962467|FG000|Overall Study|Physician Decision|2|||
170715100|NCT01243944|616962468|FG001|Overall Study|Physician Decision|7|||
170715101|NCT01243944|616962467|FG000|Overall Study|Disease progression|12|||
170715102|NCT01243944|616962468|FG001|Overall Study|Disease progression|11|||
170715103|NCT01243944|616962467|FG000|Overall Study|Protocol deviation|1|||
170715104|NCT01243944|616962468|FG001|Overall Study|Protocol deviation|1|||
170715105|NCT01243944|616962467|FG000|Overall Study|Participant decision|10|||
170715106|NCT01243944|616962468|FG001|Overall Study|Participant decision|15|||
170715107|NCT01243944|616962467|FG000|Overall Study|Death|2|||
170715108|NCT01243944|616962468|FG001|Overall Study|Death|3|||
170715109|NCT01243944|616962467|FG000|Overall Study|Non-compliance with study treatment|1|||
170715110|NCT01243944|616962468|FG001|Overall Study|Non-compliance with study treatment|0|||
170715111|NCT02673697|616962473|FG000|Overall Study|Adverse Event|2|||
170715112|NCT02673697|616962474|FG001|Overall Study|Adverse Event|0|||
170715113|NCT02673697|616962473|FG000|Overall Study|Death|32|||
170715114|NCT02673697|616962474|FG001|Overall Study|Death|24|||
170715115|NCT02673697|616962473|FG000|Overall Study|Lost to Follow-up|5|||
170715116|NCT02673697|616962474|FG001|Overall Study|Lost to Follow-up|2|||
170715117|NCT02673697|616962473|FG000|Overall Study|Physician Decision|2|||
170715118|NCT02673697|616962474|FG001|Overall Study|Physician Decision|1|||
170715119|NCT02673697|616962473|FG000|Overall Study|Withdrawal by Subject|10|||
170715120|NCT02673697|616962474|FG001|Overall Study|Withdrawal by Subject|7|||
170715121|NCT02673697|616962473|FG000|Overall Study|Change subj medical status|1|||
170715122|NCT02673697|616962474|FG001|Overall Study|Change subj medical status|2|||
170715123|NCT02673697|616962473|FG000|Overall Study|Explant|10|||
170715124|NCT02673697|616962474|FG001|Overall Study|Explant|5|||
170715125|NCT02673697|616962473|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
170715126|NCT02673697|616962474|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
170715127|NCT03321981|616962484|FG000|Overall Study|Progressive Disease (PD)|15|||
170715128|NCT03321981|616962485|FG001|Overall Study|Progressive Disease (PD)|30|||
170715129|NCT03321981|616962486|FG002|Overall Study|Progressive Disease (PD)|47|||
170828909|NCT00813098|617383858|FG002|Overall Study|Principal Investigator decision|0|||
170715130|NCT03321981|616962484|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
170715131|NCT03321981|616962485|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
170715132|NCT03321981|616962486|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
170715133|NCT03321981|616962484|FG000|Overall Study|Adverse Event|0|||
170715134|NCT03321981|616962485|FG001|Overall Study|Adverse Event|0|||
170715135|NCT03321981|616962486|FG002|Overall Study|Adverse Event|2|||
170715136|NCT03321981|616962484|FG000|Overall Study|symptomatic deterioration|0|||
170715137|NCT03321981|616962485|FG001|Overall Study|symptomatic deterioration|1|||
170715138|NCT03321981|616962486|FG002|Overall Study|symptomatic deterioration|1|||
170715139|NCT03321981|616962484|FG000|Overall Study|Lack of compliance|0|||
170715140|NCT03321981|616962485|FG001|Overall Study|Lack of compliance|1|||
170715141|NCT03321981|616962486|FG002|Overall Study|Lack of compliance|0|||
170715142|NCT03321981|616962484|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
170715143|NCT03321981|616962485|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
170715144|NCT03321981|616962486|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
170715145|NCT03321981|616962484|FG000|Overall Study|Death|0|||
170715146|NCT03321981|616962485|FG001|Overall Study|Death|1|||
170715147|NCT03321981|616962486|FG002|Overall Study|Death|0|||
170715148|NCT03321981|616962484|FG000|Overall Study|Subject withdrawal of investigational product|0|||
170715149|NCT03321981|616962485|FG001|Overall Study|Subject withdrawal of investigational product|1|||
170715150|NCT03321981|616962486|FG002|Overall Study|Subject withdrawal of investigational product|0|||
170715151|NCT03321981|616962484|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
170715152|NCT03321981|616962485|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
170715153|NCT03321981|616962486|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
170715154|NCT03321981|616962484|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
170715155|NCT03321981|616962485|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
170715156|NCT03321981|616962486|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
170715157|NCT00022516|616962489|FG000|Overall Study|Adverse Event|0|||
170715158|NCT00022516|616962490|FG001|Overall Study|Adverse Event|59|||
170715159|NCT00022516|616962489|FG000|Overall Study|Lack of Efficacy|0|||
170715160|NCT00022516|616962490|FG001|Overall Study|Lack of Efficacy|27|||
170715161|NCT00022516|616962489|FG000|Overall Study|Physician Decision|0|||
170715162|NCT00022516|616962490|FG001|Overall Study|Physician Decision|1|||
170715163|NCT00022516|616962489|FG000|Overall Study|Protocol Violation|1|||
170715164|NCT00022516|616962490|FG001|Overall Study|Protocol Violation|3|||
170715165|NCT00022516|616962489|FG000|Overall Study|Withdrawal by Subject|2|||
170715166|NCT00022516|616962490|FG001|Overall Study|Withdrawal by Subject|113|||
170715167|NCT00022516|616962489|FG000|Overall Study|Incomplete documentation|0|||
170715168|NCT00022516|616962490|FG001|Overall Study|Incomplete documentation|27|||
170715169|NCT03321019|616962491|FG000|Overall Study|Withdrawal by Subject|0|||
170715170|NCT03321019|616962492|FG001|Overall Study|Withdrawal by Subject|6|||
170715171|NCT03321019|616962491|FG000|Overall Study|Lost to Follow-up|0|||
170715172|NCT03321019|616962492|FG001|Overall Study|Lost to Follow-up|22|||
170715173|NCT04934670|616962493|FG000|Overall Study|Death|4|||
170715174|NCT04934670|616962494|FG001|Overall Study|Death|0|||
170715175|NCT04934670|616962493|FG000|Overall Study|Lost to Follow-up|1|||
170715176|NCT04934670|616962494|FG001|Overall Study|Lost to Follow-up|4|||
170715177|NCT01568047|616962495|FG000|Overall Study|Ineligibility|1|||
170715178|NCT01568047|616962496|FG001|Overall Study|Ineligibility|0|||
170715179|NCT01568047|616962497|FG002|Overall Study|Ineligibility|0|||
170715180|NCT01568047|616962498|FG003|Overall Study|Ineligibility|0|||
170715181|NCT01568047|616962495|FG000|Overall Study|Withdrawal by Subject|0|||
170715182|NCT01568047|616962496|FG001|Overall Study|Withdrawal by Subject|1|||
170715183|NCT01568047|616962497|FG002|Overall Study|Withdrawal by Subject|0|||
170715184|NCT01568047|616962498|FG003|Overall Study|Withdrawal by Subject|0|||
170828910|NCT00813098|617383856|FG000|Overall Study|Withdrew Consent|0|||
170828911|NCT00813098|617383857|FG001|Overall Study|Withdrew Consent|1|||
170828912|NCT00813098|617383858|FG002|Overall Study|Withdrew Consent|0|||
170828913|NCT01086384|617383861|FG000|2-week Run-in Period|Adverse Event|1|||
170828914|NCT01086384|617383862|FG001|2-week Run-in Period|Adverse Event|0|||
170828915|NCT01086384|617383863|FG002|2-week Run-in Period|Adverse Event|0|||
170828916|NCT01086384|617383861|FG000|2-week Run-in Period|Protocol Violation|1|||
170828917|NCT01086384|617383862|FG001|2-week Run-in Period|Protocol Violation|0|||
170828918|NCT01086384|617383863|FG002|2-week Run-in Period|Protocol Violation|0|||
170828919|NCT01086384|617383861|FG000|2-week Run-in Period|Lost to Follow-up|1|||
170828920|NCT01086384|617383862|FG001|2-week Run-in Period|Lost to Follow-up|0|||
170828921|NCT01086384|617383863|FG002|2-week Run-in Period|Lost to Follow-up|0|||
170828922|NCT01086384|617383861|FG000|2-week Run-in Period|Physician Decision|6|||
170828923|NCT01086384|617383862|FG001|2-week Run-in Period|Physician Decision|0|||
170715185|NCT01568047|616962495|FG000|Overall Study|Adverse Event|0|||
170715186|NCT01568047|616962496|FG001|Overall Study|Adverse Event|0|||
170715187|NCT01568047|616962497|FG002|Overall Study|Adverse Event|1|||
170715188|NCT01568047|616962498|FG003|Overall Study|Adverse Event|1|||
170715189|NCT03783923|616962499|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
170715190|NCT03783923|616962500|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
170715191|NCT03783923|616962499|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
170715192|NCT03783923|616962500|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
170715193|NCT03783923|616962499|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
170715194|NCT03783923|616962500|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
170715195|NCT03783923|616962499|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
170715196|NCT03783923|616962500|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
170715197|NCT03783923|616962499|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
170715198|NCT03783923|616962500|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
170715199|NCT03067441|616962501|FG000|Overall Study|Withdrawal by Subject|16|||
170715200|NCT03067441|616962502|FG001|Overall Study|Withdrawal by Subject|34|||
170715201|NCT03067441|616962501|FG000|Overall Study|Lost to Follow-up|7|||
170715202|NCT03067441|616962502|FG001|Overall Study|Lost to Follow-up|5|||
170715203|NCT03067441|616962501|FG000|Overall Study|Adverse Event|7|||
170715204|NCT03067441|616962502|FG001|Overall Study|Adverse Event|14|||
170715205|NCT03067441|616962501|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
170715206|NCT03067441|616962502|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
170715207|NCT03067441|616962501|FG000|Overall Study|Physician Decision|1|||
170715208|NCT03067441|616962502|FG001|Overall Study|Physician Decision|3|||
170715209|NCT03067441|616962501|FG000|Overall Study|Other|1|||
170715210|NCT03067441|616962502|FG001|Overall Study|Other|1|||
170715211|NCT00856583|616962506|FG000|Overall Study|Lack of Efficacy|389|||
170715212|NCT00856583|616962507|FG001|Overall Study|Lack of Efficacy|377|||
170715213|NCT00856583|616962506|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
170715214|NCT00856583|616962507|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
170715215|NCT00856583|616962506|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
170715216|NCT00856583|616962507|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
170715217|NCT00856583|616962506|FG000|Overall Study|Non-compliance|305|||
170715218|NCT00856583|616962507|FG001|Overall Study|Non-compliance|262|||
170715219|NCT00856583|616962506|FG000|Overall Study|Withdrawal by Subject|1092|||
170715220|NCT00856583|616962507|FG001|Overall Study|Withdrawal by Subject|919|||
170715221|NCT00856583|616962506|FG000|Overall Study|Physician Decision|59|||
170715222|NCT00856583|616962507|FG001|Overall Study|Physician Decision|82|||
170715223|NCT00856583|616962506|FG000|Overall Study|Pregnancy|14|||
170715224|NCT00856583|616962507|FG001|Overall Study|Pregnancy|5|||
170715225|NCT00856583|616962506|FG000|Overall Study|Other|92|||
170715226|NCT00856583|616962507|FG001|Overall Study|Other|104|||
170715227|NCT00856583|616962506|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
170715228|NCT00856583|616962507|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
170715229|NCT02328326|616962508|FG000|Overall Study|Withdrawal by Subject|10|||
170715230|NCT02328326|616962509|FG001|Overall Study|Withdrawal by Subject|3|||
170715231|NCT02328326|616962508|FG000|Overall Study|Death|2|||
170715232|NCT02328326|616962509|FG001|Overall Study|Death|1|||
170715233|NCT02328326|616962508|FG000|Overall Study|Lost to Follow-up|10|||
170715234|NCT02328326|616962509|FG001|Overall Study|Lost to Follow-up|4|||
170715235|NCT02056301|616962510|FG000|Overall Study|Protocol Violation|1|||
170715236|NCT02056301|616962511|FG001|Overall Study|Protocol Violation|2|||
170715237|NCT02056301|616962510|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
170715238|NCT02056301|616962511|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
170715239|NCT02056301|616962510|FG000|Overall Study|Withdrawal by Subject|0|||
170715240|NCT02056301|616962511|FG001|Overall Study|Withdrawal by Subject|1|||
170715241|NCT02056301|616962510|FG000|Overall Study|Issues with epidural|0|||
170715242|NCT02056301|616962511|FG001|Overall Study|Issues with epidural|3|||
170715243|NCT00661492|616962512|FG000|Overall Study|Adverse Event|16|||
170715244|NCT00661492|616962513|FG001|Overall Study|Adverse Event|13|||
170715245|NCT00661492|616962512|FG000|Overall Study|Disease Progression|44|||
170715246|NCT00661492|616962513|FG001|Overall Study|Disease Progression|14|||
170715247|NCT00661492|616962512|FG000|Overall Study|Patient Request|6|||
170715248|NCT00661492|616962513|FG001|Overall Study|Patient Request|1|||
170715249|NCT00661492|616962512|FG000|Overall Study|Investigator Request|1|||
170715250|NCT00661492|616962513|FG001|Overall Study|Investigator Request|0|||
170715251|NCT00661492|616962512|FG000|Overall Study|Lost to Follow-up|0|||
170715252|NCT00661492|616962513|FG001|Overall Study|Lost to Follow-up|1|||
170715253|NCT00661492|616962512|FG000|Overall Study|Other|1|||
170715254|NCT00661492|616962513|FG001|Overall Study|Other|0|||
170715255|NCT00499889|616962514|FG000|Overall Study|Infection prior to treatment|1|||
170715256|NCT01418209|616962515|FG000|Overall Study|Withdrawal by Subject|1|||
170715257|NCT01418209|616962516|FG001|Overall Study|Withdrawal by Subject|0|||
170715258|NCT01418209|616962517|FG002|Overall Study|Withdrawal by Subject|1|||
170715259|NCT01418209|616962515|FG000|Overall Study|Did not provide hot flash diary data|1|||
170715260|NCT01418209|616962516|FG001|Overall Study|Did not provide hot flash diary data|3|||
170715261|NCT01418209|616962517|FG002|Overall Study|Did not provide hot flash diary data|3|||
170715262|NCT01603875|616962518|FG000|Overall Study|Preexisting rabies antibody|3|||
170715263|NCT01603875|616962519|FG001|Overall Study|Preexisting rabies antibody|4|||
170715264|NCT01603875|616962520|FG002|Overall Study|Preexisting rabies antibody|3|||
170715265|NCT01603875|616962518|FG000|Overall Study|Lost to Follow-up|4|||
170715266|NCT01603875|616962519|FG001|Overall Study|Lost to Follow-up|3|||
170715267|NCT01603875|616962520|FG002|Overall Study|Lost to Follow-up|6|||
170715268|NCT01603875|616962518|FG000|Overall Study|Protocol Violation|0|||
170715269|NCT01603875|616962519|FG001|Overall Study|Protocol Violation|1|||
170715270|NCT01603875|616962520|FG002|Overall Study|Protocol Violation|0|||
170828924|NCT01086384|617383863|FG002|2-week Run-in Period|Physician Decision|0|||
170828925|NCT01086384|617383861|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
170828926|NCT01086384|617383862|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
170828927|NCT01086384|617383863|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
170828928|NCT01086384|617383861|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
170715271|NCT01898793|616962521|FG000|Overall Study|Death|2|||
170828929|NCT01086384|617383862|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
170828930|NCT01086384|617383863|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
170828931|NCT01086384|617383861|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
170828932|NCT01086384|617383862|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
170828933|NCT01086384|617383863|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
170828934|NCT01086384|617383861|FG000|2-week Run-in Period|Randomized in Error|1|||
170828935|NCT01086384|617383862|FG001|2-week Run-in Period|Randomized in Error|0|||
170828936|NCT01086384|617383863|FG002|2-week Run-in Period|Randomized in Error|0|||
170828937|NCT01086384|617383861|FG000|Treatment Period|Withdrawal by Subject|0|||
170828938|NCT01086384|617383862|FG001|Treatment Period|Withdrawal by Subject|53|||
170828939|NCT01086384|617383863|FG002|Treatment Period|Withdrawal by Subject|55|||
170828940|NCT01086384|617383861|FG000|Treatment Period|Protocol Violation|0|||
170828941|NCT01086384|617383862|FG001|Treatment Period|Protocol Violation|26|||
170828942|NCT01086384|617383863|FG002|Treatment Period|Protocol Violation|17|||
170828943|NCT01086384|617383861|FG000|Treatment Period|Lack of Efficacy|0|||
170828944|NCT01086384|617383862|FG001|Treatment Period|Lack of Efficacy|22|||
170828945|NCT01086384|617383863|FG002|Treatment Period|Lack of Efficacy|13|||
170828946|NCT01086384|617383861|FG000|Treatment Period|Adverse Event|0|||
170828947|NCT01086384|617383862|FG001|Treatment Period|Adverse Event|19|||
170828948|NCT01086384|617383863|FG002|Treatment Period|Adverse Event|15|||
170828949|NCT01086384|617383861|FG000|Treatment Period|Lost to Follow-up|0|||
170828950|NCT01086384|617383862|FG001|Treatment Period|Lost to Follow-up|11|||
170828951|NCT01086384|617383863|FG002|Treatment Period|Lost to Follow-up|9|||
170828952|NCT01086384|617383861|FG000|Treatment Period|Physician Decision|0|||
170828953|NCT01086384|617383862|FG001|Treatment Period|Physician Decision|9|||
170828954|NCT01086384|617383863|FG002|Treatment Period|Physician Decision|6|||
170828955|NCT01086384|617383861|FG000|Treatment Period|Study Closed/Terminated|0|||
170828956|NCT01086384|617383862|FG001|Treatment Period|Study Closed/Terminated|7|||
170828957|NCT01086384|617383863|FG002|Treatment Period|Study Closed/Terminated|8|||
170828958|NCT01086384|617383861|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
170828959|NCT01086384|617383862|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
170828960|NCT01086384|617383863|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
170828961|NCT01086384|617383861|FG000|Treatment Period|Received Treatment in Error|0|||
170828962|NCT01086384|617383862|FG001|Treatment Period|Received Treatment in Error|1|||
170828963|NCT01086384|617383863|FG002|Treatment Period|Received Treatment in Error|0|||
170828964|NCT02586415|617383866|FG000|Overall Study|Death|13|||
170828965|NCT02586415|617383867|FG001|Overall Study|Death|23|||
170828966|NCT02586415|617383866|FG000|Overall Study|Lost to Follow-up|1|||
170828967|NCT02586415|617383867|FG001|Overall Study|Lost to Follow-up|2|||
170828968|NCT01841112|617383868|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
170828969|NCT01841112|617383869|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
170828970|NCT01841112|617383870|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
170828971|NCT01841112|617383871|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
170828972|NCT01841112|617383872|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
170828973|NCT03517111|617383873|FG000|Enrolled|Withdrawal by Subject|0|||
170828974|NCT03517111|617383874|FG001|Enrolled|Withdrawal by Subject|1|||
170828975|NCT03517111|617383875|FG002|Enrolled|Withdrawal by Subject|0|||
170828976|NCT03517111|617383873|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
170828977|NCT03517111|617383874|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
170828978|NCT03517111|617383875|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
170828979|NCT03517111|617383873|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
170715272|NCT01898793|616962522|FG001|Overall Study|Death|1|||
170715273|NCT01898793|616962523|FG002|Overall Study|Death|4|||
170715274|NCT01898793|616962524|FG003|Overall Study|Death|0|||
170715275|NCT01898793|616962525|FG004|Overall Study|Death|0|||
170715276|NCT01898793|616962526|FG005|Overall Study|Death|0|||
170715277|NCT01898793|616962527|FG006|Overall Study|Death|0|||
170715278|NCT04382612|616962530|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
170715279|NCT01328002|616962531|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
170715280|NCT01328002|616962532|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
170715281|NCT01328002|616962531|FG000|Open-Label Period|Adverse Event|8|||
170715282|NCT01328002|616962532|FG001|Open-Label Period|Adverse Event|0|||
170715283|NCT01328002|616962531|FG000|Open-Label Period|Lack of Efficacy|3|||
170715284|NCT01328002|616962532|FG001|Open-Label Period|Lack of Efficacy|0|||
170715285|NCT01328002|616962531|FG000|Open-Label Period|Protocol Violation|2|||
170715286|NCT01328002|616962532|FG001|Open-Label Period|Protocol Violation|0|||
170715287|NCT01328002|616962531|FG000|Open-Label Period|Withdrawal by Subject|9|||
170715288|NCT01328002|616962532|FG001|Open-Label Period|Withdrawal by Subject|0|||
170715289|NCT01328002|616962531|FG000|Open-Label Period|Lost to Follow-up|6|||
170715290|NCT01328002|616962532|FG001|Open-Label Period|Lost to Follow-up|0|||
170715291|NCT01328002|616962531|FG000|Open-Label Period|Other Reason|2|||
170715292|NCT01328002|616962532|FG001|Open-Label Period|Other Reason|0|||
170715293|NCT01328002|616962531|FG000|Double-Blind Period|Adverse Event|1|||
170715294|NCT01328002|616962532|FG001|Double-Blind Period|Adverse Event|0|||
170715295|NCT01328002|616962531|FG000|Double-Blind Period|Lack of Efficacy|1|||
170715296|NCT01328002|616962532|FG001|Double-Blind Period|Lack of Efficacy|0|||
170715297|NCT01306617|616962534|FG000|Overall Study|Adverse Event|1|||
170715298|NCT01306617|616962535|FG001|Overall Study|Adverse Event|0|||
170715299|NCT01306617|616962536|FG002|Overall Study|Adverse Event|0|||
170715300|NCT01306617|616962534|FG000|Overall Study|Virologic Failure|0|||
170715301|NCT01306617|616962535|FG001|Overall Study|Virologic Failure|0|||
170715302|NCT01306617|616962536|FG002|Overall Study|Virologic Failure|5|||
170715303|NCT01306617|616962534|FG000|Overall Study|Non-compliance|0|||
170715304|NCT01306617|616962535|FG001|Overall Study|Non-compliance|1|||
170715305|NCT01306617|616962536|FG002|Overall Study|Non-compliance|0|||
170715306|NCT01578551|616962538|FG000|Overall Study|Adverse Event|1|||
170715307|NCT01578551|616962539|FG001|Overall Study|Adverse Event|0|||
170715308|NCT00061048|616962543|FG000|Overall Study|Adverse Event|2|||
170715309|NCT00061048|616962543|FG000|Overall Study|disease progression|20|||
170715310|NCT01632579|616962545|FG000|Washout Period|Adverse Event|1|||
170715311|NCT01632579|616962546|FG001|Washout Period|Adverse Event|0|||
170715312|NCT01632579|616962547|FG002|Washout Period|Adverse Event|0|||
170715313|NCT01632579|616962548|FG003|Washout Period|Adverse Event|0|||
170715314|NCT01632579|616962549|FG004|Washout Period|Adverse Event|0|||
170715315|NCT01632579|616962550|FG005|Washout Period|Adverse Event|0|||
170715316|NCT01632579|616962551|FG006|Washout Period|Adverse Event|0|||
170715317|NCT01632579|616962552|FG007|Washout Period|Adverse Event|0|||
170715318|NCT01632579|616962553|FG008|Washout Period|Adverse Event|0|||
170715319|NCT01632579|616962545|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
170715320|NCT01632579|616962546|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
170715321|NCT01632579|616962547|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
170715322|NCT01632579|616962548|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
170715323|NCT01632579|616962549|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
170715324|NCT01632579|616962550|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
170715325|NCT01632579|616962551|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
170715326|NCT01632579|616962552|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
170715327|NCT01632579|616962553|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
170715328|NCT00162136|616962554|FG000|Overall Study|Adverse Event|1|||
170715329|NCT00162136|616962554|FG000|Overall Study|Death|1|||
170715330|NCT00162136|616962554|FG000|Overall Study|Disease Progression/Relapse|23|||
170715331|NCT00162136|616962554|FG000|Overall Study|Investigator Request|5|||
170715332|NCT00162136|616962554|FG000|Overall Study|Study Drug Toxicity|4|||
170715333|NCT00162136|616962554|FG000|Overall Study|Withdrawal by Subject|1|||
170715334|NCT02788175|616962555|FG000|Overall Study|Protocol Violation|3|||
170715335|NCT02788175|616962555|FG000|Overall Study|Withdrawal by Subject|4|||
170715336|NCT02788175|616962555|FG000|Overall Study|Ineligible prior to study agent|6|||
170715337|NCT00818441|616962556|FG000|Overall Study|Death|69|||
170715338|NCT00818441|616962557|FG001|Overall Study|Death|26|||
170715339|NCT00818441|616962556|FG000|Overall Study|Other|5|||
170715340|NCT00818441|616962557|FG001|Overall Study|Other|0|||
170715341|NCT00818441|616962556|FG000|Overall Study|Lost to Follow-up|2|||
170715342|NCT00818441|616962557|FG001|Overall Study|Lost to Follow-up|1|||
170715343|NCT00818441|616962556|FG000|Overall Study|Withdrawal by Subject|2|||
170715344|NCT00818441|616962557|FG001|Overall Study|Withdrawal by Subject|0|||
170715345|NCT00818441|616962556|FG000|Overall Study|Adverse Event|0|||
170715346|NCT00818441|616962557|FG001|Overall Study|Adverse Event|1|||
170715347|NCT00818441|616962556|FG000|Overall Study|Study terminated by sponsor|11|||
170715348|NCT00818441|616962557|FG001|Overall Study|Study terminated by sponsor|2|||
170715349|NCT03283670|616962558|FG000|Placebo Gas|Withdrawal by Subject|2|||
170715350|NCT03283670|616962558|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
170715351|NCT03283670|616962558|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
170715352|NCT00898677|616962561|FG000|Overall Study|Adverse Event|0|||
170715353|NCT00898677|616962562|FG001|Overall Study|Adverse Event|0|||
170715354|NCT00898677|616962563|FG002|Overall Study|Adverse Event|1|||
170715355|NCT00898677|616962564|FG003|Overall Study|Adverse Event|0|||
170715356|NCT00898677|616962561|FG000|Overall Study|Lost to Follow-up|0|||
170715357|NCT00898677|616962562|FG001|Overall Study|Lost to Follow-up|0|||
170715358|NCT00898677|616962563|FG002|Overall Study|Lost to Follow-up|2|||
170715359|NCT00898677|616962564|FG003|Overall Study|Lost to Follow-up|0|||
170715360|NCT00898677|616962561|FG000|Overall Study|Protocol Violation|1|||
170715361|NCT00898677|616962562|FG001|Overall Study|Protocol Violation|1|||
170715362|NCT00898677|616962563|FG002|Overall Study|Protocol Violation|2|||
170828980|NCT03517111|617383874|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
170828981|NCT03517111|617383875|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
170828982|NCT03517111|617383873|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
170828983|NCT03517111|617383874|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
170828984|NCT03517111|617383875|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
170828985|NCT03517111|617383873|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
170828986|NCT03517111|617383874|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
170828987|NCT03517111|617383875|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
170828988|NCT02024750|617383879|FG000|Overall Study|Withdrawal by Subject|2|||
170828989|NCT02024750|617383880|FG001|Overall Study|Withdrawal by Subject|1|||
170828990|NCT02261285|617383881|FG000|Overall Study|Disease progression|0|||
170828991|NCT02261285|617383882|FG001|Overall Study|Disease progression|0|||
170828992|NCT02261285|617383883|FG002|Overall Study|Disease progression|1|||
170828993|NCT00927901|617383884|FG000|Treatment Period 1|Subject withdrew consent|0|||
170828994|NCT00927901|617383885|FG001|Treatment Period 1|Subject withdrew consent|0|||
170828995|NCT00927901|617383886|FG002|Treatment Period 1|Subject withdrew consent|1|||
170828996|NCT00927901|617383887|FG003|Treatment Period 1|Subject withdrew consent|0|||
170828997|NCT00927901|617383884|FG000|Treatment Period 4|Adverse Event|0|||
170828998|NCT00927901|617383885|FG001|Treatment Period 4|Adverse Event|0|||
170828999|NCT00927901|617383886|FG002|Treatment Period 4|Adverse Event|0|||
170829000|NCT00927901|617383887|FG003|Treatment Period 4|Adverse Event|1|||
170829001|NCT00927901|617383884|FG000|Treatment Period 4|Subject withdrew consent|0|||
170829002|NCT00927901|617383885|FG001|Treatment Period 4|Subject withdrew consent|0|||
170829003|NCT00927901|617383886|FG002|Treatment Period 4|Subject withdrew consent|1|||
170829004|NCT00927901|617383887|FG003|Treatment Period 4|Subject withdrew consent|0|||
170829005|NCT02344173|617383888|FG000|Procedure|Ablation Procedure Not Performed|7|||
170829006|NCT02344173|617383888|FG000|12-month Visit|Death|8|||
170829007|NCT02344173|617383888|FG000|12-month Visit|Withdrawal by Subject|30|||
170829008|NCT02344173|617383888|FG000|12-month Visit|Lost to Follow-up|58|||
170829009|NCT01209286|617383889|FG000|Overall Study|Adverse Event|4|||
170829010|NCT01209286|617383890|FG001|Overall Study|Adverse Event|3|||
170829011|NCT01209286|617383891|FG002|Overall Study|Adverse Event|1|||
170829012|NCT01209286|617383889|FG000|Overall Study|Hematological Relapse After Remission|0|||
170829013|NCT01209286|617383890|FG001|Overall Study|Hematological Relapse After Remission|1|||
170829014|NCT01209286|617383891|FG002|Overall Study|Hematological Relapse After Remission|1|||
170829015|NCT01209286|617383889|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
170829016|NCT01209286|617383890|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
170829017|NCT01209286|617383891|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
170829018|NCT01209286|617383889|FG000|Overall Study|Physician Decision|0|||
170829019|NCT01209286|617383890|FG001|Overall Study|Physician Decision|2|||
170829020|NCT01209286|617383891|FG002|Overall Study|Physician Decision|0|||
170829021|NCT01209286|617383889|FG000|Overall Study|Other|0|||
170829022|NCT01209286|617383890|FG001|Overall Study|Other|1|||
170829023|NCT01209286|617383891|FG002|Overall Study|Other|0|||
170829024|NCT01891890|617383892|FG000|Overall Study|Lost to Follow-up|0|||
170829025|NCT01891890|617383893|FG001|Overall Study|Lost to Follow-up|0|||
170829026|NCT01891890|617383894|FG002|Overall Study|Lost to Follow-up|1|||
170829027|NCT01891890|617383892|FG000|Overall Study|Study ended before endpoint reached|7|||
170829028|NCT01891890|617383893|FG001|Overall Study|Study ended before endpoint reached|3|||
170829029|NCT01891890|617383894|FG002|Overall Study|Study ended before endpoint reached|6|||
170715363|NCT00898677|616962564|FG003|Overall Study|Protocol Violation|0|||
170829030|NCT00746356|617383900|FG000|Overall Study|Withdrawal by Subject|2|||
170715364|NCT00898677|616962561|FG000|Overall Study|Withdrawal by Subject|0|||
170715365|NCT00898677|616962562|FG001|Overall Study|Withdrawal by Subject|0|||
170715366|NCT00898677|616962563|FG002|Overall Study|Withdrawal by Subject|0|||
170715367|NCT00898677|616962564|FG003|Overall Study|Withdrawal by Subject|1|||
170715368|NCT00898677|616962561|FG000|Overall Study|Not Treated: Adverse Event|0|||
170715369|NCT00898677|616962562|FG001|Overall Study|Not Treated: Adverse Event|2|||
170715370|NCT00898677|616962563|FG002|Overall Study|Not Treated: Adverse Event|1|||
170715371|NCT00898677|616962564|FG003|Overall Study|Not Treated: Adverse Event|0|||
170715372|NCT00898677|616962561|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
170829031|NCT00746356|617383901|FG001|Overall Study|Withdrawal by Subject|3|||
170829032|NCT00746356|617383900|FG000|Overall Study|Death|7|||
170829033|NCT00746356|617383901|FG001|Overall Study|Death|3|||
170829034|NCT00746356|617383900|FG000|Overall Study|Lost to Follow-up|1|||
170829035|NCT00746356|617383901|FG001|Overall Study|Lost to Follow-up|0|||
170829036|NCT00746356|617383900|FG000|Overall Study|Removal of Device|0|||
170829037|NCT00746356|617383901|FG001|Overall Study|Removal of Device|1|||
170829038|NCT00746356|617383900|FG000|Overall Study|Patient relocated|1|||
170829039|NCT00746356|617383901|FG001|Overall Study|Patient relocated|0|||
170829040|NCT03029819|617383902|FG000|Overall Study|Lost to Follow-up|3|||
170829041|NCT03029819|617383903|FG001|Overall Study|Lost to Follow-up|5|||
170829042|NCT03029819|617383902|FG000|Overall Study|Removed due to disruptive behavior|0|||
170715373|NCT00898677|616962562|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
170715374|NCT00898677|616962563|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
170715375|NCT00898677|616962564|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
170715376|NCT00898677|616962561|FG000|Overall Study|Not Treated: Pregnancy|0|||
170715377|NCT00898677|616962562|FG001|Overall Study|Not Treated: Pregnancy|0|||
170715378|NCT00898677|616962563|FG002|Overall Study|Not Treated: Pregnancy|1|||
170715379|NCT00898677|616962564|FG003|Overall Study|Not Treated: Pregnancy|0|||
170715380|NCT00898677|616962561|FG000|Overall Study|Not Treated: Protocol Violation|2|||
170715381|NCT00898677|616962562|FG001|Overall Study|Not Treated: Protocol Violation|0|||
170715382|NCT00898677|616962563|FG002|Overall Study|Not Treated: Protocol Violation|2|||
170715383|NCT00898677|616962564|FG003|Overall Study|Not Treated: Protocol Violation|0|||
170715384|NCT00898677|616962561|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
170715385|NCT00898677|616962562|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
170715386|NCT00898677|616962563|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
170715387|NCT00898677|616962564|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
170715388|NCT00898677|616962561|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
170715389|NCT00898677|616962562|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
170715390|NCT00898677|616962563|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
170715391|NCT00898677|616962564|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
170715392|NCT00898677|616962561|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
170715393|NCT00898677|616962562|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
170715394|NCT00898677|616962563|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
170715395|NCT00898677|616962564|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
170715396|NCT00898677|616962561|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
170715397|NCT00898677|616962562|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
170715398|NCT00898677|616962563|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
170715399|NCT00898677|616962564|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
170715400|NCT00898677|616962561|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
170715401|NCT00898677|616962562|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
170715402|NCT00898677|616962563|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
170715403|NCT00898677|616962564|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
170715404|NCT00898677|616962561|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
170715405|NCT00898677|616962562|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
170715406|NCT00898677|616962563|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
170715407|NCT00898677|616962564|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
170715408|NCT00898677|616962561|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
170715409|NCT00898677|616962562|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
170715410|NCT00898677|616962563|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
170715411|NCT00898677|616962564|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
170715412|NCT02199691|616962570|FG000|Overall Study|Protocol Violation|3|||
170715413|NCT02199691|616962571|FG001|Overall Study|Protocol Violation|3|||
170715414|NCT02199691|616962572|FG002|Overall Study|Protocol Violation|6|||
170715415|NCT02199691|616962573|FG003|Overall Study|Protocol Violation|7|||
170715416|NCT02199691|616962570|FG000|Overall Study|Withdrawal by Subject|5|||
170715417|NCT02199691|616962571|FG001|Overall Study|Withdrawal by Subject|3|||
170715418|NCT02199691|616962572|FG002|Overall Study|Withdrawal by Subject|12|||
170715419|NCT02199691|616962573|FG003|Overall Study|Withdrawal by Subject|13|||
170715420|NCT02199691|616962570|FG000|Overall Study|Lost to Follow-up|2|||
170715421|NCT02199691|616962571|FG001|Overall Study|Lost to Follow-up|1|||
170715422|NCT02199691|616962572|FG002|Overall Study|Lost to Follow-up|9|||
170715423|NCT02199691|616962573|FG003|Overall Study|Lost to Follow-up|10|||
170715424|NCT00136955|616964833|FG000|Overall Study|Adverse Event|8|||
170715425|NCT00136955|616964833|FG000|Overall Study|Lost to Follow-up|1|||
170715426|NCT00136955|616964833|FG000|Overall Study|Withdrawal by Subject|2|||
170715427|NCT00136955|616964833|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
170715428|NCT04827576|616964834|FG000|Overall Study|Death|5|||
170715429|NCT04827576|616964835|FG001|Overall Study|Death|17|||
170715430|NCT04827576|616964836|FG002|Overall Study|Death|17|||
170715431|NCT04827576|616964837|FG003|Overall Study|Death|32|||
170715432|NCT04827576|616964834|FG000|Overall Study|Study Terminated by Sponsor|2|||
170715433|NCT04827576|616964835|FG001|Overall Study|Study Terminated by Sponsor|9|||
170715434|NCT04827576|616964836|FG002|Overall Study|Study Terminated by Sponsor|7|||
170715435|NCT04827576|616964837|FG003|Overall Study|Study Terminated by Sponsor|5|||
170715436|NCT04827576|616964834|FG000|Overall Study|Investigator's Discretion|1|||
170715437|NCT04827576|616964835|FG001|Overall Study|Investigator's Discretion|0|||
170715438|NCT04827576|616964836|FG002|Overall Study|Investigator's Discretion|2|||
170715439|NCT04827576|616964837|FG003|Overall Study|Investigator's Discretion|5|||
170715440|NCT04827576|616964834|FG000|Overall Study|Withdrew Consent|0|||
170715441|NCT04827576|616964835|FG001|Overall Study|Withdrew Consent|3|||
170715442|NCT04827576|616964836|FG002|Overall Study|Withdrew Consent|0|||
170715443|NCT04827576|616964837|FG003|Overall Study|Withdrew Consent|0|||
170715444|NCT04827576|616964834|FG000|Overall Study|Lost to Follow-up|1|||
170715445|NCT04827576|616964835|FG001|Overall Study|Lost to Follow-up|0|||
170715446|NCT04827576|616964836|FG002|Overall Study|Lost to Follow-up|0|||
170829043|NCT03029819|617383903|FG001|Overall Study|Removed due to disruptive behavior|1|||
170829044|NCT01560585|617383904|FG000|Overall Study|Physician Decision|3|||
170829045|NCT00519285|617383905|FG000|Overall Study|Adverse Event|127|||
170829046|NCT00519285|617383906|FG001|Overall Study|Adverse Event|266|||
170829047|NCT00519285|617383905|FG000|Overall Study|Disease progression|334|||
170829048|NCT00519285|617383906|FG001|Overall Study|Disease progression|186|||
170829049|NCT00519285|617383905|FG000|Overall Study|Physician Decision|75|||
170829050|NCT00519285|617383906|FG001|Overall Study|Physician Decision|47|||
170829051|NCT00519285|617383905|FG000|Overall Study|Participant's request|53|||
170829052|NCT00519285|617383906|FG001|Overall Study|Participant's request|84|||
170829053|NCT00519285|617383905|FG000|Overall Study|Consent withdrawn|4|||
170829054|NCT00519285|617383906|FG001|Overall Study|Consent withdrawn|5|||
170829055|NCT00519285|617383905|FG000|Overall Study|Poor compliance to protocol|5|||
170829056|NCT00519285|617383906|FG001|Overall Study|Poor compliance to protocol|7|||
170829057|NCT00519285|617383905|FG000|Overall Study|Reason unspecified|5|||
170829058|NCT00519285|617383906|FG001|Overall Study|Reason unspecified|8|||
170829059|NCT00519285|617383905|FG000|Overall Study|Not treated|8|||
170829060|NCT00519285|617383906|FG001|Overall Study|Not treated|7|||
170829061|NCT00519285|617383905|FG000|Overall Study|Treatment ongoing|1|||
170829062|NCT00519285|617383906|FG001|Overall Study|Treatment ongoing|2|||
170829063|NCT01482429|617383907|FG000|Care Usual|Protocol Violation|0|||
170829064|NCT01482429|617383908|FG001|Care Usual|Protocol Violation|172|||
170829065|NCT01482429|617383907|FG000|Care Usual|Lost to Follow-up|0|||
170829066|NCT01482429|617383908|FG001|Care Usual|Lost to Follow-up|1|||
170829067|NCT01482429|617383907|FG000|Protocol|Protocol Violation|275|||
170829068|NCT01482429|617383908|FG001|Protocol|Protocol Violation|0|||
170829069|NCT00983892|617383909|FG000|Overall Study|Withdrawal by Subject|10|||
170829070|NCT00983892|617383910|FG001|Overall Study|Withdrawal by Subject|12|||
170829071|NCT02175745|617383911|FG000|Overall Study|Not Eligible|1|||
170829072|NCT02881047|617383912|FG000|Overall Study|Adverse Event|1|||
170829073|NCT02881047|617383912|FG000|Overall Study|Withdrawal by Subject|1|||
170829074|NCT01813305|617383915|FG000|Overall Study|Withdrawal by Subject|12|||
170829075|NCT01813305|617383916|FG001|Overall Study|Withdrawal by Subject|5|||
170829076|NCT01813305|617383915|FG000|Overall Study|Safety Concern|4|||
170829077|NCT01813305|617383916|FG001|Overall Study|Safety Concern|0|||
170829078|NCT01813305|617383915|FG000|Overall Study|Ulcer became worse|4|||
170829079|NCT01813305|617383916|FG001|Overall Study|Ulcer became worse|0|||
170829080|NCT01813305|617383915|FG000|Overall Study|Physician Decision|4|||
170829081|NCT01813305|617383916|FG001|Overall Study|Physician Decision|0|||
170829082|NCT01813305|617383915|FG000|Overall Study|Lost to Follow-up|3|||
170829083|NCT01813305|617383916|FG001|Overall Study|Lost to Follow-up|1|||
170829084|NCT01813305|617383915|FG000|Overall Study|Protocol Violation|1|||
170829085|NCT01813305|617383916|FG001|Overall Study|Protocol Violation|0|||
170829086|NCT01813305|617383915|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
170829087|NCT01813305|617383916|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
170829088|NCT03448536|617383917|FG000|Overall Study|Protocol Violation|2|||
170829089|NCT03448536|617383918|FG001|Overall Study|Protocol Violation|0|||
170829090|NCT03448536|617383917|FG000|Overall Study|Pregnancy|1|||
170829091|NCT03448536|617383918|FG001|Overall Study|Pregnancy|0|||
170829092|NCT03448536|617383917|FG000|Overall Study|Withdrawal by Subject|1|||
170829093|NCT03448536|617383918|FG001|Overall Study|Withdrawal by Subject|2|||
170829094|NCT03448536|617383917|FG000|Overall Study|Lost to Follow-up|3|||
170829095|NCT03448536|617383918|FG001|Overall Study|Lost to Follow-up|2|||
170829096|NCT03448536|617383917|FG000|Overall Study|Inadequate pain reporter|1|||
170829097|NCT03448536|617383918|FG001|Overall Study|Inadequate pain reporter|0|||
170829098|NCT03448536|617383917|FG000|Overall Study|Other|3|||
170829099|NCT03448536|617383918|FG001|Overall Study|Other|0|||
170829100|NCT03448536|617383917|FG000|Overall Study|Physician Decision|1|||
170829101|NCT03448536|617383918|FG001|Overall Study|Physician Decision|0|||
170829102|NCT01665599|617383922|FG000|Overall Study|Adverse Event|1|||
170829103|NCT01665599|617383922|FG000|Overall Study|Consent Withdrawn|1|||
170829104|NCT01665599|617383922|FG000|Overall Study|Investigator/Sponsor decision|1|||
170829105|NCT01665599|617383922|FG000|Overall Study|Death|1|||
170829106|NCT01665599|617383922|FG000|Overall Study|Lost to Follow-up|2|||
170829107|NCT01665599|617383922|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
170829108|NCT01665599|617383922|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
170829109|NCT00770588|617383925|FG000|Overall Study|Adverse Event|9|||
170829110|NCT00770588|617383926|FG001|Overall Study|Adverse Event|2|||
170829111|NCT00770588|617383925|FG000|Overall Study|Death caused by progression of disease|70|||
170829112|NCT00770588|617383926|FG001|Overall Study|Death caused by progression of disease|91|||
170829113|NCT00770588|617383925|FG000|Overall Study|Lost to Follow-up|1|||
170829114|NCT00770588|617383926|FG001|Overall Study|Lost to Follow-up|1|||
170829115|NCT00770588|617383925|FG000|Overall Study|Withdrawal by Subject|1|||
170715447|NCT04827576|616964837|FG003|Overall Study|Lost to Follow-up|0|||
170715448|NCT04295564|616964838|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
170715449|NCT04295564|616964839|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
170715450|NCT01773226|616964840|FG000|Overall Study|Withdrawal by Subject|1|||
170715451|NCT04401579|616964845|FG000|Overall Study|Death|23|||
170715452|NCT04401579|616964846|FG001|Overall Study|Death|36|||
170715453|NCT04401579|616964845|FG000|Overall Study|Lost to Follow-up|40|||
170715454|NCT04401579|616964846|FG001|Overall Study|Lost to Follow-up|41|||
170715455|NCT04401579|616964845|FG000|Overall Study|Withdrawal by Subject|8|||
170715456|NCT04401579|616964846|FG001|Overall Study|Withdrawal by Subject|16|||
170715457|NCT04401579|616964845|FG000|Overall Study|Physician Decision|1|||
170715458|NCT04401579|616964846|FG001|Overall Study|Physician Decision|2|||
170715459|NCT04401579|616964845|FG000|Overall Study|Became ineligible after enrollment|1|||
170715460|NCT04401579|616964846|FG001|Overall Study|Became ineligible after enrollment|1|||
170715461|NCT04401579|616964845|FG000|Overall Study|Enrolled but treatment not administered|7|||
170715462|NCT04401579|616964846|FG001|Overall Study|Enrolled but treatment not administered|9|||
170715463|NCT04401579|616964845|FG000|Overall Study|Adverse Event|2|||
170715464|NCT04401579|616964846|FG001|Overall Study|Adverse Event|1|||
170715465|NCT04401579|616964845|FG000|Overall Study|Scheduling error|1|||
170715466|NCT04401579|616964846|FG001|Overall Study|Scheduling error|2|||
170715467|NCT04401579|616964845|FG000|Overall Study|Transferred to another hospital|1|||
170715468|NCT04401579|616964846|FG001|Overall Study|Transferred to another hospital|2|||
170715469|NCT03320070|616964847|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
170715470|NCT03320070|616964848|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
170715471|NCT03320070|616964847|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
170715472|NCT03320070|616964848|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
170715473|NCT03320070|616964847|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
170715474|NCT03320070|616964848|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
170715475|NCT03320070|616964847|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
170715476|NCT03320070|616964848|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
170715477|NCT03320070|616964847|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
170715478|NCT03320070|616964848|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
170715479|NCT03320070|616964847|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
170715480|NCT03320070|616964848|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
170715481|NCT02367911|616964849|FG000|Overall Study|Withdrawal by Subject|3|||
170715482|NCT02367911|616964850|FG001|Overall Study|Withdrawal by Subject|2|||
170715483|NCT02367911|616964849|FG000|Overall Study|Lost to Follow-up|2|||
170715484|NCT02367911|616964850|FG001|Overall Study|Lost to Follow-up|2|||
170715485|NCT00896168|616964851|FG000|Overall Study|Adverse Event|4|||
170715486|NCT00896168|616964852|FG001|Overall Study|Adverse Event|7|||
170715487|NCT00896168|616964851|FG000|Overall Study|Treatment failure|8|||
170715488|NCT00896168|616964852|FG001|Overall Study|Treatment failure|10|||
170715489|NCT00896168|616964851|FG000|Overall Study|Lost to Follow-up|1|||
170715490|NCT00896168|616964852|FG001|Overall Study|Lost to Follow-up|1|||
170715491|NCT00896168|616964851|FG000|Overall Study|Other|1|||
170715492|NCT00896168|616964852|FG001|Overall Study|Other|1|||
170715493|NCT03832010|616964853|FG000|Overall Study|Withdrawal by Subject|2|||
170715494|NCT03832010|616964854|FG001|Overall Study|Withdrawal by Subject|1|||
170715495|NCT03832010|616964855|FG002|Overall Study|Withdrawal by Subject|0|||
170715496|NCT03832010|616964853|FG000|Overall Study|Lost to Follow-up|2|||
170715497|NCT03832010|616964854|FG001|Overall Study|Lost to Follow-up|1|||
170715498|NCT03832010|616964855|FG002|Overall Study|Lost to Follow-up|1|||
170715499|NCT01003899|616964856|FG000|Overall Study|Other Adverse Event|8|||
170715500|NCT01003899|616964856|FG000|Overall Study|Not entered|4|||
170829116|NCT00770588|617383926|FG001|Overall Study|Withdrawal by Subject|1|||
170829117|NCT01424189|617383927|FG000|Overall Study|Adverse Event|1|||
170829118|NCT01424189|617383928|FG001|Overall Study|Adverse Event|0|||
170715501|NCT01003899|616964856|FG000|Overall Study|Not treated|1|||
170715502|NCT01003899|616964856|FG000|Overall Study|Progressive disease|34|||
170715503|NCT00987467|616964857|FG000|Overall Study|Lost to Follow-up|2|||
170715504|NCT01054729|616964861|FG000|Overall Study|Randomized but Not Treated|0|||
170715505|NCT01054729|616964862|FG001|Overall Study|Randomized but Not Treated|1|||
170715506|NCT01054729|616964863|FG002|Overall Study|Randomized but Not Treated|0|||
170715507|NCT01054729|616964864|FG003|Overall Study|Randomized but Not Treated|0|||
170715508|NCT01054729|616964861|FG000|Overall Study|Adverse Event|1|||
170715509|NCT01054729|616964862|FG001|Overall Study|Adverse Event|1|||
170715510|NCT01054729|616964863|FG002|Overall Study|Adverse Event|2|||
170715511|NCT01054729|616964864|FG003|Overall Study|Adverse Event|1|||
170715512|NCT01054729|616964861|FG000|Overall Study|Withdrawal by Subject|1|||
170715513|NCT01054729|616964862|FG001|Overall Study|Withdrawal by Subject|0|||
170715514|NCT01054729|616964863|FG002|Overall Study|Withdrawal by Subject|1|||
170715515|NCT01054729|616964864|FG003|Overall Study|Withdrawal by Subject|0|||
170715516|NCT01054729|616964861|FG000|Overall Study|Lost to Follow-up|0|||
170715517|NCT01054729|616964862|FG001|Overall Study|Lost to Follow-up|1|||
170715518|NCT01054729|616964863|FG002|Overall Study|Lost to Follow-up|0|||
170715519|NCT01054729|616964864|FG003|Overall Study|Lost to Follow-up|0|||
170715520|NCT01054729|616964861|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
170715521|NCT01054729|616964862|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
170715522|NCT01054729|616964863|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
170715523|NCT01054729|616964864|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
170715524|NCT01054729|616964861|FG000|Overall Study|Non-responder|1|||
170715525|NCT01054729|616964862|FG001|Overall Study|Non-responder|0|||
170715526|NCT01054729|616964863|FG002|Overall Study|Non-responder|1|||
170715527|NCT01054729|616964864|FG003|Overall Study|Non-responder|1|||
170715528|NCT01054729|616964861|FG000|Overall Study|PEG/RBV Non-responder|1|||
170715529|NCT01054729|616964862|FG001|Overall Study|PEG/RBV Non-responder|0|||
170715530|NCT01054729|616964863|FG002|Overall Study|PEG/RBV Non-responder|1|||
170715531|NCT01054729|616964864|FG003|Overall Study|PEG/RBV Non-responder|0|||
170715532|NCT01054729|616964861|FG000|Overall Study|Personal/Obligations|0|||
170715533|NCT01054729|616964862|FG001|Overall Study|Personal/Obligations|1|||
170715534|NCT01054729|616964863|FG002|Overall Study|Personal/Obligations|0|||
170715535|NCT01054729|616964864|FG003|Overall Study|Personal/Obligations|0|||
170715536|NCT01054729|616964861|FG000|Overall Study|Subject moved|0|||
170715537|NCT01054729|616964862|FG001|Overall Study|Subject moved|0|||
170715538|NCT01054729|616964863|FG002|Overall Study|Subject moved|1|||
170715539|NCT01054729|616964864|FG003|Overall Study|Subject moved|0|||
170715540|NCT01054729|616964861|FG000|Overall Study|Lack of Efficacy|0|||
170715541|NCT01054729|616964862|FG001|Overall Study|Lack of Efficacy|0|||
170715542|NCT01054729|616964863|FG002|Overall Study|Lack of Efficacy|0|||
170715543|NCT01054729|616964864|FG003|Overall Study|Lack of Efficacy|1|||
170715544|NCT00321919|616964865|FG000|Overall Study|Adverse Event|17|||
170715545|NCT00321919|616964866|FG001|Overall Study|Adverse Event|10|||
170715546|NCT00321919|616964865|FG000|Overall Study|Death|21|||
170715547|NCT00321919|616964866|FG001|Overall Study|Death|17|||
170715548|NCT00321919|616964865|FG000|Overall Study|Insufficient Therapeutic Response|1|||
170715549|NCT00321919|616964866|FG001|Overall Study|Insufficient Therapeutic Response|0|||
170715550|NCT00321919|616964865|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
170715551|NCT00321919|616964866|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
170715552|NCT00321919|616964865|FG000|Overall Study|Refused Treatment|23|||
170715553|NCT00321919|616964866|FG001|Overall Study|Refused Treatment|14|||
170715554|NCT00321919|616964865|FG000|Overall Study|Other Protocol Violation|2|||
170715555|NCT00321919|616964866|FG001|Overall Study|Other Protocol Violation|3|||
170715556|NCT00321919|616964865|FG000|Overall Study|Failure to Return|3|||
170715557|NCT00321919|616964866|FG001|Overall Study|Failure to Return|1|||
170715558|NCT00321919|616964865|FG000|Overall Study|Other withdrawal reason|7|||
170715559|NCT00321919|616964866|FG001|Overall Study|Other withdrawal reason|6|||
170715560|NCT02624804|616964867|FG000|Overall Study|Screen Failure|5|||
170715561|NCT02590354|616964868|FG000|Phase 1|Active hepatitis B or C infection|1|||
170715562|NCT02590354|616964868|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
170715563|NCT02590354|616964868|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
170715564|NCT02590354|616964868|FG000|Phase 1|Subject does not want to participate|20|||
170715565|NCT02590354|616964868|FG000|Phase 1|Lost to Follow-up|1|||
170715566|NCT02590354|616964868|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
170715567|NCT01148810|616964869|FG000|Overall Study|Adverse Event|0|||
170715568|NCT01148810|616964870|FG001|Overall Study|Adverse Event|2|||
170715569|NCT01148810|616964869|FG000|Overall Study|Lack of Efficacy|0|||
170715570|NCT01148810|616964870|FG001|Overall Study|Lack of Efficacy|1|||
170715571|NCT01148810|616964869|FG000|Overall Study|Withdrawal by Subject|0|||
170715572|NCT01148810|616964870|FG001|Overall Study|Withdrawal by Subject|2|||
170715573|NCT01148810|616964869|FG000|Overall Study|Protocol Violation|1|||
170715574|NCT01148810|616964870|FG001|Overall Study|Protocol Violation|0|||
170715575|NCT04408469|616964884|FG000|Overall Study|Lost to Follow-up|6|||
170715576|NCT04408469|616964885|FG001|Overall Study|Lost to Follow-up|9|||
170715577|NCT04408469|616964884|FG000|Overall Study|Withdrawal by Subject|6|||
170715578|NCT04408469|616964885|FG001|Overall Study|Withdrawal by Subject|1|||
170715579|NCT04408469|616964884|FG000|Overall Study|Dismissal due to ineligibility|0|||
170715580|NCT04408469|616964885|FG001|Overall Study|Dismissal due to ineligibility|1|||
170715581|NCT04321460|616964886|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
170715582|NCT04321460|616964887|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
170715583|NCT02223390|616964888|FG000|Overall Study|Lost to Follow-up|9|||
170715584|NCT02223390|616964889|FG001|Overall Study|Lost to Follow-up|4|||
170715585|NCT02553330|616964892|FG000|Overall Study|Study Terminated by Sponsor|2|||
170715586|NCT02553330|616964893|FG001|Overall Study|Study Terminated by Sponsor|13|||
170715587|NCT02553330|616964894|FG002|Overall Study|Study Terminated by Sponsor|12|||
170715588|NCT02553330|616964892|FG000|Overall Study|Withdrawal by Subject|3|||
170715589|NCT02553330|616964893|FG001|Overall Study|Withdrawal by Subject|19|||
170715590|NCT02553330|616964894|FG002|Overall Study|Withdrawal by Subject|21|||
170715591|NCT02553330|616964892|FG000|Overall Study|Other|0|||
170715592|NCT02553330|616964893|FG001|Overall Study|Other|1|||
170715593|NCT02553330|616964894|FG002|Overall Study|Other|0|||
170715594|NCT02553330|616964892|FG000|Overall Study|Non compliance to study treatment|0|||
170715595|NCT02553330|616964893|FG001|Overall Study|Non compliance to study treatment|1|||
170715596|NCT02553330|616964894|FG002|Overall Study|Non compliance to study treatment|0|||
170715597|NCT02553330|616964892|FG000|Overall Study|Adverse Event|0|||
170715598|NCT02553330|616964893|FG001|Overall Study|Adverse Event|1|||
170715599|NCT02553330|616964894|FG002|Overall Study|Adverse Event|0|||
170715600|NCT02553330|616964892|FG000|Overall Study|Lost to Follow-up|0|||
170715601|NCT02553330|616964893|FG001|Overall Study|Lost to Follow-up|4|||
170715602|NCT02553330|616964894|FG002|Overall Study|Lost to Follow-up|4|||
170715603|NCT01659021|616964895|FG000|Main Study|Adverse Event|2|||
170715604|NCT01659021|616964896|FG001|Main Study|Adverse Event|3|||
170715605|NCT01659021|616964895|FG000|Main Study|Lost to Follow-up|1|||
170715606|NCT01659021|616964896|FG001|Main Study|Lost to Follow-up|0|||
170715607|NCT01659021|616964895|FG000|Main Study|Unknown Reasons|2|||
170715608|NCT01659021|616964896|FG001|Main Study|Unknown Reasons|1|||
170715609|NCT01659021|616964895|FG000|Main Study|Physician Decision|34|||
170715610|NCT01659021|616964896|FG001|Main Study|Physician Decision|16|||
170715611|NCT01659021|616964895|FG000|Main Study|Withdrawal by Subject|19|||
170715612|NCT01659021|616964896|FG001|Main Study|Withdrawal by Subject|16|||
170715613|NCT01659021|616964895|FG000|Main Study|Study Terminated by Sponsor|16|||
170715614|NCT01659021|616964896|FG001|Main Study|Study Terminated by Sponsor|1|||
170715615|NCT01659021|616964895|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
170715616|NCT01659021|616964896|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
170715617|NCT01659021|616964895|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
170715618|NCT01659021|616964896|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
170715619|NCT01666002|616964897|FG000|Overall Study|Lost to Follow-up|5|||
170715620|NCT01666002|616964898|FG001|Overall Study|Lost to Follow-up|0|||
170715621|NCT01233817|616964899|FG000|Overall Study|Lost to Follow-up|1|||
170715622|NCT01233817|616964899|FG000|Overall Study|Withdrawal by Subject|2|||
170715623|NCT04479618|616964900|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
170715624|NCT04479618|616964901|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
170715625|NCT04479618|616964902|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
170715626|NCT04479618|616964900|FG000|Overall Study|Lack of Efficacy|1|||
170715627|NCT04479618|616964901|FG001|Overall Study|Lack of Efficacy|0|||
170715628|NCT04479618|616964902|FG002|Overall Study|Lack of Efficacy|0|||
170715629|NCT04479618|616964900|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
170715630|NCT04479618|616964901|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
170715631|NCT04479618|616964902|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
170715632|NCT04479618|616964900|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
170715633|NCT04479618|616964901|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
170715634|NCT04479618|616964902|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
170715635|NCT04479618|616964900|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
170715636|NCT04479618|616964901|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
170715637|NCT04479618|616964902|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
170715638|NCT04479618|616964900|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
170715639|NCT04479618|616964901|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
170715640|NCT04479618|616964902|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
170715641|NCT01202773|616964903|FG000|Overall Study|Adverse Event|4|||
170715642|NCT01202773|616964904|FG001|Overall Study|Adverse Event|5|||
170715643|NCT01202773|616964905|FG002|Overall Study|Adverse Event|5|||
170829119|NCT01424189|617383927|FG000|Overall Study|Lost to Follow-up|4|||
170829120|NCT01424189|617383928|FG001|Overall Study|Lost to Follow-up|1|||
170829121|NCT01424189|617383927|FG000|Overall Study|Withdrawal by Subject|4|||
170715644|NCT01202773|616964903|FG000|Overall Study|Lack of Efficacy|5|||
170715645|NCT01202773|616964904|FG001|Overall Study|Lack of Efficacy|4|||
170715646|NCT01202773|616964905|FG002|Overall Study|Lack of Efficacy|9|||
170715647|NCT01202773|616964903|FG000|Overall Study|Entry Criteria Not Met|2|||
170715648|NCT01202773|616964904|FG001|Overall Study|Entry Criteria Not Met|0|||
170715649|NCT01202773|616964905|FG002|Overall Study|Entry Criteria Not Met|1|||
170715650|NCT01202773|616964903|FG000|Overall Study|Lost to Follow-up|1|||
170715651|NCT01202773|616964904|FG001|Overall Study|Lost to Follow-up|2|||
170715652|NCT01202773|616964905|FG002|Overall Study|Lost to Follow-up|2|||
170715653|NCT01202773|616964903|FG000|Overall Study|Withdrawal by Subject|13|||
170715654|NCT01202773|616964904|FG001|Overall Study|Withdrawal by Subject|6|||
170715655|NCT01202773|616964905|FG002|Overall Study|Withdrawal by Subject|5|||
170715656|NCT01202773|616964903|FG000|Overall Study|Physician Decision|2|||
170715657|NCT01202773|616964904|FG001|Overall Study|Physician Decision|0|||
170715658|NCT01202773|616964905|FG002|Overall Study|Physician Decision|0|||
170715659|NCT01202773|616964903|FG000|Overall Study|Protocol Violation|11|||
170715660|NCT01202773|616964904|FG001|Overall Study|Protocol Violation|6|||
170715661|NCT01202773|616964905|FG002|Overall Study|Protocol Violation|10|||
170715662|NCT01202773|616964903|FG000|Overall Study|Sponsor Decision|19|||
170715663|NCT01202773|616964904|FG001|Overall Study|Sponsor Decision|20|||
170715664|NCT01202773|616964905|FG002|Overall Study|Sponsor Decision|23|||
170715665|NCT03058679|616964911|FG000|Baseline to Week 6|Lost to Follow-up|3|||
170715666|NCT03058679|616964912|FG001|Baseline to Week 6|Lost to Follow-up|2|||
170715667|NCT03058679|616964911|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
170715668|NCT03058679|616964912|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
170715669|NCT03058679|616964911|FG000|Baseline to Week 6|Adverse Event|6|||
170715670|NCT03058679|616964912|FG001|Baseline to Week 6|Adverse Event|6|||
170715671|NCT03058679|616964911|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
170715672|NCT03058679|616964912|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
170715673|NCT03058679|616964911|FG000|Baseline to Week 6|Difficulty following the diet|0|||
170715674|NCT03058679|616964912|FG001|Baseline to Week 6|Difficulty following the diet|2|||
170715675|NCT03058679|616964911|FG000|Baseline to Week 6|Physician Decision|1|||
170715676|NCT03058679|616964912|FG001|Baseline to Week 6|Physician Decision|0|||
170715677|NCT03058679|616964911|FG000|Week 6 to Week 12|Change in medication|5|||
170715678|NCT03058679|616964912|FG001|Week 6 to Week 12|Change in medication|7|||
170715679|NCT03058679|616964911|FG000|Week 6 to Week 12|Adverse Event|4|||
170715680|NCT03058679|616964912|FG001|Week 6 to Week 12|Adverse Event|3|||
170715681|NCT03058679|616964911|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
170715682|NCT03058679|616964912|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
170715683|NCT03058679|616964911|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
170715684|NCT03058679|616964912|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
170715685|NCT00614939|616964920|FG000|Overall Study|Withdrawal by Subject|10|||
170715686|NCT00614939|616964921|FG001|Overall Study|Withdrawal by Subject|17|||
170715687|NCT00614939|616964920|FG000|Overall Study|Study specific discontinuation criteris|13|||
170715688|NCT00614939|616964921|FG001|Overall Study|Study specific discontinuation criteris|16|||
170715689|NCT00614939|616964920|FG000|Overall Study|Adverse Event|2|||
170715690|NCT00614939|616964921|FG001|Overall Study|Adverse Event|5|||
170715691|NCT00614939|616964920|FG000|Overall Study|Incorrect enrollment|1|||
170715692|NCT00614939|616964921|FG001|Overall Study|Incorrect enrollment|2|||
170715693|NCT00614939|616964920|FG000|Overall Study|Death|4|||
170715694|NCT00614939|616964921|FG001|Overall Study|Death|3|||
170715695|NCT00614939|616964920|FG000|Overall Study|Poor/non-compliance|4|||
170715696|NCT00614939|616964921|FG001|Overall Study|Poor/non-compliance|0|||
170715697|NCT00614939|616964920|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
170715698|NCT00614939|616964921|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
170715699|NCT00504829|616964922|FG000|Overall Study|Protocol Violation|6|||
170715700|NCT00504829|616964923|FG001|Overall Study|Protocol Violation|4|||
170715701|NCT00504829|616964924|FG002|Overall Study|Protocol Violation|10|||
170715702|NCT01854827|616964925|FG000|Overall Study|Death|1|||
170715703|NCT04000165|616964926|FG000|Overall Study|Physician Decision|1|||
170715704|NCT04000165|616964926|FG000|Overall Study|Withdrawal by Subject|1|||
170715705|NCT02079805|616964930|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
170715706|NCT02079805|616964931|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
170715707|NCT02079805|616964930|FG000|Overall Study|Voluntary Withdrawal|0|||
170715708|NCT02079805|616964931|FG001|Overall Study|Voluntary Withdrawal|1|||
170715709|NCT04079933|616964939|FG000|Overall Study|Withdrawal by Subject|3|||
170715710|NCT04079933|616964940|FG001|Overall Study|Withdrawal by Subject|4|||
170715711|NCT04079933|616964939|FG000|Overall Study|Lost to Follow-up|0|||
170715712|NCT04079933|616964940|FG001|Overall Study|Lost to Follow-up|1|||
170715713|NCT01986829|616964941|FG000|Overall Study|Death|1|||
170715714|NCT02504866|616964942|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
170715715|NCT02504866|616964943|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
170715716|NCT02504866|616964944|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
170715717|NCT01229436|616964945|FG000|Overall Study|Withdrawal by Subject|2|||
170715718|NCT01229436|616964945|FG000|Overall Study|Lost to Follow-up|3|||
170715719|NCT00733824|616964948|FG000|Phase I|Withdrawal by Subject|1|||
170715720|NCT00733824|616964949|FG001|Phase I|Withdrawal by Subject|0|||
170715721|NCT00733824|616964950|FG002|Phase I|Withdrawal by Subject|0|||
170715722|NCT00733824|616964951|FG003|Phase I|Withdrawal by Subject|0|||
170715723|NCT00733824|616964952|FG004|Phase I|Withdrawal by Subject|0|||
170715724|NCT02059148|616964953|FG000|Treatment 1|Protocol Violation|0|||
170715725|NCT02059148|616964954|FG001|Treatment 1|Protocol Violation|0|||
170715726|NCT02059148|616964955|FG002|Treatment 1|Protocol Violation|0|||
170715727|NCT02059148|616964956|FG003|Treatment 1|Protocol Violation|0|||
170715728|NCT02059148|616964957|FG004|Treatment 1|Protocol Violation|0|||
170715729|NCT02059148|616964958|FG005|Treatment 1|Protocol Violation|1|||
170715730|NCT05799495|616964970|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
170715731|NCT05799495|616964971|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
170715732|NCT05799495|616964972|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
170715733|NCT05799495|616964973|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
170715734|NCT05799495|616964970|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
170715735|NCT05799495|616964971|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
170715736|NCT05799495|616964972|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
170715737|NCT05799495|616964973|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
170715738|NCT05799495|616964970|FG000|Treatment (Up to 5 Days)|Other|0|||
170715739|NCT05799495|616964971|FG001|Treatment (Up to 5 Days)|Other|1|||
170715740|NCT05799495|616964972|FG002|Treatment (Up to 5 Days)|Other|0|||
170715741|NCT05799495|616964973|FG003|Treatment (Up to 5 Days)|Other|0|||
170715742|NCT05799495|616964970|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
170715743|NCT05799495|616964971|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
170715744|NCT05799495|616964972|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
170715745|NCT05799495|616964973|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
170715746|NCT05799495|616964970|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
170715747|NCT05799495|616964971|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
170715748|NCT05799495|616964972|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
170715749|NCT05799495|616964973|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
170715750|NCT05799495|616964970|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
170715751|NCT05799495|616964971|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
170715752|NCT05799495|616964972|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
170715753|NCT05799495|616964973|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
170715754|NCT03694548|616964977|FG000|Part A Survey|Protocol Violation|3|||
170715755|NCT03694548|616964978|FG001|Part A Survey|Protocol Violation|3|||
170715756|NCT03694548|616964979|FG002|Part A Survey|Protocol Violation|0|||
170715757|NCT03694548|616964977|FG000|Part B Yoga Program|Protocol Violation|0|||
170715758|NCT03694548|616964978|FG001|Part B Yoga Program|Protocol Violation|0|||
170715759|NCT03694548|616964979|FG002|Part B Yoga Program|Protocol Violation|3|||
170715760|NCT03694548|616964977|FG000|Part B Yoga Program|Did not attend intervention|0|||
170715761|NCT03694548|616964978|FG001|Part B Yoga Program|Did not attend intervention|0|||
170715762|NCT03694548|616964979|FG002|Part B Yoga Program|Did not attend intervention|8|||
170715763|NCT04177108|616964980|FG000|Overall Study|Withdrawal by Subject|4|||
170715764|NCT04177108|616964981|FG001|Overall Study|Withdrawal by Subject|8|||
170715765|NCT04177108|616964982|FG002|Overall Study|Withdrawal by Subject|9|||
170715766|NCT04177108|616964983|FG003|Overall Study|Withdrawal by Subject|11|||
170715767|NCT04177108|616964984|FG004|Overall Study|Withdrawal by Subject|13|||
170715768|NCT04177108|616964980|FG000|Overall Study|Physician Decision|23|||
170715769|NCT04177108|616964981|FG001|Overall Study|Physician Decision|15|||
170715770|NCT04177108|616964982|FG002|Overall Study|Physician Decision|18|||
170715771|NCT04177108|616964983|FG003|Overall Study|Physician Decision|29|||
170715772|NCT04177108|616964984|FG004|Overall Study|Physician Decision|23|||
170715773|NCT04177108|616964980|FG000|Overall Study|Reason Not Specified|0|||
170715774|NCT04177108|616964981|FG001|Overall Study|Reason Not Specified|1|||
170715775|NCT04177108|616964982|FG002|Overall Study|Reason Not Specified|0|||
170715776|NCT04177108|616964983|FG003|Overall Study|Reason Not Specified|0|||
170715777|NCT04177108|616964984|FG004|Overall Study|Reason Not Specified|2|||
170715778|NCT04177108|616964980|FG000|Overall Study|Lost to Follow-up|0|||
170715779|NCT04177108|616964981|FG001|Overall Study|Lost to Follow-up|0|||
170715780|NCT04177108|616964982|FG002|Overall Study|Lost to Follow-up|1|||
170715781|NCT04177108|616964983|FG003|Overall Study|Lost to Follow-up|1|||
170715782|NCT04177108|616964984|FG004|Overall Study|Lost to Follow-up|1|||
170715783|NCT04177108|616964980|FG000|Overall Study|Death|16|||
170829122|NCT01424189|617383928|FG001|Overall Study|Withdrawal by Subject|4|||
170829123|NCT01424189|617383927|FG000|Overall Study|Subject moved|1|||
170829124|NCT01424189|617383928|FG001|Overall Study|Subject moved|0|||
170829125|NCT01424189|617383927|FG000|Overall Study|Death|3|||
170829126|NCT01424189|617383928|FG001|Overall Study|Death|1|||
170829127|NCT01203956|617383929|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
170829128|NCT01203956|617383930|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
170829129|NCT02230306|617383933|FG000|Overall Study|Did not receive study treatment|1|||
170829130|NCT00312845|617383934|FG000|Overall Study|Adverse Event|19|||
170829131|NCT00312845|617383935|FG001|Overall Study|Adverse Event|5|||
170829132|NCT00312845|617383934|FG000|Overall Study|Death|2|||
170829133|NCT00312845|617383935|FG001|Overall Study|Death|2|||
170829134|NCT00312845|617383934|FG000|Overall Study|Withdrawal by Subject|14|||
170829135|NCT00312845|617383935|FG001|Overall Study|Withdrawal by Subject|6|||
170829136|NCT00312845|617383934|FG000|Overall Study|Disease Progression|56|||
170829137|NCT00312845|617383935|FG001|Overall Study|Disease Progression|77|||
170829138|NCT00312845|617383934|FG000|Overall Study|Lost to Follow-up|2|||
170829139|NCT00312845|617383935|FG001|Overall Study|Lost to Follow-up|0|||
170829140|NCT00312845|617383934|FG000|Overall Study|Other|6|||
170829141|NCT00312845|617383935|FG001|Overall Study|Other|5|||
170829142|NCT03015181|617383936|FG000|Overall Study|Enrolled, but product never administered|1|||
170829143|NCT03015181|617383937|FG001|Overall Study|Enrolled, but product never administered|0|||
170829144|NCT03015181|617383938|FG002|Overall Study|Enrolled, but product never administered|0|||
170829145|NCT03015181|617383939|FG003|Overall Study|Enrolled, but product never administered|0|||
170829146|NCT03015181|617383940|FG004|Overall Study|Enrolled, but product never administered|0|||
170829147|NCT03015181|617383941|FG005|Overall Study|Enrolled, but product never administered|0|||
170829148|NCT03015181|617383942|FG006|Overall Study|Enrolled, but product never administered|0|||
170829149|NCT03015181|617383936|FG000|Overall Study|Withdrawal by Subject|0|||
170829150|NCT03015181|617383937|FG001|Overall Study|Withdrawal by Subject|0|||
170829151|NCT03015181|617383938|FG002|Overall Study|Withdrawal by Subject|0|||
170829152|NCT03015181|617383939|FG003|Overall Study|Withdrawal by Subject|0|||
170829153|NCT03015181|617383940|FG004|Overall Study|Withdrawal by Subject|0|||
170829154|NCT03015181|617383941|FG005|Overall Study|Withdrawal by Subject|1|||
170829155|NCT03015181|617383942|FG006|Overall Study|Withdrawal by Subject|0|||
170829156|NCT03015181|617383936|FG000|Overall Study|Physician Decision|0|||
170829157|NCT03015181|617383937|FG001|Overall Study|Physician Decision|0|||
170829158|NCT03015181|617383938|FG002|Overall Study|Physician Decision|0|||
170829159|NCT03015181|617383939|FG003|Overall Study|Physician Decision|0|||
170829160|NCT03015181|617383940|FG004|Overall Study|Physician Decision|0|||
170829161|NCT03015181|617383941|FG005|Overall Study|Physician Decision|0|||
170829162|NCT03015181|617383942|FG006|Overall Study|Physician Decision|1|||
170829163|NCT01077622|617383943|FG000|Overall Study|Physician Decision|2|||
170829164|NCT01077622|617383943|FG000|Overall Study|Withdrawal by Subject|1|||
170829165|NCT01091519|617383946|FG000|Overall Study|Adverse Event|12|||
170829166|NCT01091519|617383947|FG001|Overall Study|Adverse Event|16|||
170829167|NCT01091519|617383946|FG000|Overall Study|Death|1|||
170829168|NCT01091519|617383947|FG001|Overall Study|Death|0|||
170829169|NCT01091519|617383946|FG000|Overall Study|Lack of Efficacy|16|||
170829170|NCT01091519|617383947|FG001|Overall Study|Lack of Efficacy|19|||
170829171|NCT01091519|617383946|FG000|Overall Study|Lost to Follow-up|14|||
170829172|NCT01091519|617383947|FG001|Overall Study|Lost to Follow-up|24|||
170829173|NCT01091519|617383946|FG000|Overall Study|Withdrawal by Subject|2|||
170829174|NCT01091519|617383947|FG001|Overall Study|Withdrawal by Subject|2|||
170829175|NCT01091519|617383946|FG000|Overall Study|Other|6|||
170829176|NCT01091519|617383947|FG001|Overall Study|Other|8|||
170829177|NCT01091519|617383946|FG000|Overall Study|Randomized not treated|4|||
170829178|NCT01091519|617383947|FG001|Overall Study|Randomized not treated|4|||
170829179|NCT01251887|617383950|FG000|Overall Study|Scheduling conflict|1|||
170829180|NCT01251887|617383951|FG001|Overall Study|Scheduling conflict|2|||
170829181|NCT01251887|617383952|FG002|Overall Study|Scheduling conflict|2|||
170829182|NCT01251887|617383950|FG000|Overall Study|Physician Decision|0|||
170829183|NCT01251887|617383951|FG001|Overall Study|Physician Decision|1|||
170829184|NCT01251887|617383952|FG002|Overall Study|Physician Decision|0|||
170829185|NCT02998918|617383954|FG000|Overall Study|Withdrawal by Subject|1|||
170829186|NCT02998918|617383955|FG001|Overall Study|Withdrawal by Subject|0|||
170829187|NCT01283971|617383956|FG000|Overall Study|Adverse Event|3|||
170829188|NCT01283971|617383957|FG001|Overall Study|Adverse Event|5|||
170829189|NCT01283971|617383956|FG000|Overall Study|Insufficient therapeutic responses|3|||
170715784|NCT04177108|616964981|FG001|Overall Study|Death|19|||
170715785|NCT04177108|616964982|FG002|Overall Study|Death|13|||
170715786|NCT04177108|616964983|FG003|Overall Study|Death|17|||
170715787|NCT04177108|616964984|FG004|Overall Study|Death|18|||
170715788|NCT00784043|616964985|FG000|Overall Study|Withdrawal by Subject|8|||
170715789|NCT00784043|616964986|FG001|Overall Study|Withdrawal by Subject|5|||
170715790|NCT00784043|616964985|FG000|Overall Study|Protocol Terminated|23|||
170715791|NCT00784043|616964986|FG001|Overall Study|Protocol Terminated|1|||
170715792|NCT00099983|616964987|FG000|Overall Study|Lost to Follow-up|2|||
170715793|NCT00099983|616964988|FG001|Overall Study|Lost to Follow-up|3|||
170829190|NCT01283971|617383957|FG001|Overall Study|Insufficient therapeutic responses|3|||
170829191|NCT01283971|617383956|FG000|Overall Study|Protocol Violation|5|||
170715794|NCT00099983|616964987|FG000|Overall Study|Missing Source Documents|14|||
170715795|NCT00099983|616964988|FG001|Overall Study|Missing Source Documents|15|||
170715796|NCT00099983|616964987|FG000|Overall Study|Withdrawal by Subject|3|||
170829192|NCT01283971|617383957|FG001|Overall Study|Protocol Violation|1|||
170829193|NCT01283971|617383956|FG000|Overall Study|Refused treatment|3|||
170829194|NCT01283971|617383957|FG001|Overall Study|Refused treatment|1|||
170829195|NCT01283971|617383956|FG000|Overall Study|Failure to return|0|||
170829196|NCT01283971|617383957|FG001|Overall Study|Failure to return|1|||
170829197|NCT01283971|617383956|FG000|Overall Study|Administrative reasons|1|||
170829198|NCT01283971|617383957|FG001|Overall Study|Administrative reasons|1|||
170829199|NCT04811339|617383965|FG000|Overall Study|lack of transportation not wanting to return|4|||
170829200|NCT04811339|617383966|FG001|Overall Study|lack of transportation not wanting to return|8|||
170829201|NCT04811339|617383967|FG002|Overall Study|lack of transportation not wanting to return|0|||
170715797|NCT00099983|616964988|FG001|Overall Study|Withdrawal by Subject|2|||
170715798|NCT00099983|616964987|FG000|Overall Study|Adverse Event|1|||
170715799|NCT00099983|616964988|FG001|Overall Study|Adverse Event|1|||
170715800|NCT00099983|616964987|FG000|Overall Study|Lack of Efficacy|0|||
170715801|NCT00099983|616964988|FG001|Overall Study|Lack of Efficacy|1|||
170715802|NCT00099983|616964987|FG000|Overall Study|Unable to return for appointments|1|||
170715803|NCT00099983|616964988|FG001|Overall Study|Unable to return for appointments|1|||
170715804|NCT00099983|616964987|FG000|Overall Study|Moved|1|||
170715805|NCT00099983|616964988|FG001|Overall Study|Moved|0|||
170715806|NCT00099983|616964987|FG000|Overall Study|Other psychiatric problem|1|||
170715807|NCT00099983|616964988|FG001|Overall Study|Other psychiatric problem|0|||
170715808|NCT00099983|616964987|FG000|Overall Study|Incarcerated|0|||
170715809|NCT00099983|616964988|FG001|Overall Study|Incarcerated|1|||
170715810|NCT00099983|616964987|FG000|Overall Study|Intolerant of burden of visits|0|||
170715811|NCT00099983|616964988|FG001|Overall Study|Intolerant of burden of visits|1|||
170715812|NCT00099983|616964987|FG000|Overall Study|Other issue|1|||
170715813|NCT00099983|616964988|FG001|Overall Study|Other issue|0|||
170715814|NCT00803634|616964989|FG000|Overall Study|Withdrew Consent|1|||
170715815|NCT00803634|616964990|FG001|Overall Study|Withdrew Consent|0|||
170715816|NCT00803634|616964989|FG000|Overall Study|Lost to Follow-up|2|||
170715817|NCT00803634|616964990|FG001|Overall Study|Lost to Follow-up|3|||
170715818|NCT00803634|616964989|FG000|Overall Study|Death|3|||
170715819|NCT00803634|616964990|FG001|Overall Study|Death|2|||
170715820|NCT03791398|616964995|FG000|Overall Study|Progression of Disease Under Study|2|||
170715821|NCT03791398|616964996|FG001|Overall Study|Progression of Disease Under Study|0|||
170715822|NCT03791398|616964997|FG002|Overall Study|Progression of Disease Under Study|0|||
170715823|NCT00766376|616964998|FG000|Overall Study|Withdrawal by Subject|27|||
170715824|NCT03299192|616964999|FG000|Overall Study|Fell before classes started|1|||
170715825|NCT03299192|616965000|FG001|Overall Study|Fell before classes started|0|||
170715826|NCT03299192|616965001|FG002|Overall Study|Fell before classes started|0|||
170715827|NCT03299192|616964999|FG000|Overall Study|Other|0|||
170715828|NCT03299192|616965000|FG001|Overall Study|Other|2|||
170715829|NCT03299192|616965001|FG002|Overall Study|Other|1|||
170715830|NCT00101101|616965003|FG000|Overall Study|never received vaccine|20|||
170715831|NCT00983580|616965004|FG000|Overall Study|Cancel Prior to treatment|1|||
170715832|NCT00983580|616965005|FG001|Overall Study|Cancel Prior to treatment|3|||
170715833|NCT00983580|616965004|FG000|Overall Study|Protocol Violation|1|||
170715834|NCT00983580|616965005|FG001|Overall Study|Protocol Violation|1|||
170715835|NCT00983580|616965004|FG000|Overall Study|Ineligible|3|||
170715836|NCT00983580|616965005|FG001|Overall Study|Ineligible|0|||
170715837|NCT01652716|616965006|FG000|Overall Study|Loss of glucose control|1|||
170715838|NCT01652716|616965007|FG001|Overall Study|Loss of glucose control|0|||
170715839|NCT01652716|616965006|FG000|Overall Study|Administrative|0|||
170715840|NCT01652716|616965007|FG001|Overall Study|Administrative|2|||
170715841|NCT01652716|616965006|FG000|Overall Study|Investigator decision|1|||
170715842|NCT01652716|616965007|FG001|Overall Study|Investigator decision|4|||
170715843|NCT01652716|616965006|FG000|Overall Study|Lost to Follow-up|12|||
170715844|NCT01652716|616965007|FG001|Overall Study|Lost to Follow-up|11|||
170715845|NCT01652716|616965006|FG000|Overall Study|Protocol Violation|2|||
170715846|NCT01652716|616965007|FG001|Overall Study|Protocol Violation|1|||
170715847|NCT01652716|616965006|FG000|Overall Study|Adverse Event|7|||
170715848|NCT01652716|616965007|FG001|Overall Study|Adverse Event|10|||
170715849|NCT01652716|616965006|FG000|Overall Study|Withdrawal by Subject|33|||
170715850|NCT01652716|616965007|FG001|Overall Study|Withdrawal by Subject|18|||
170715851|NCT05204134|616965009|FG000|Overall Study|Withdrawal by Subject|3|||
170715852|NCT05204134|616965009|FG000|Overall Study|Physician Decision|1|||
170715853|NCT01059617|616965013|FG000|Overall Study|Other|7|||
170715854|NCT01059617|616965014|FG001|Overall Study|Other|1|||
170715855|NCT01059617|616965015|FG002|Overall Study|Other|8|||
170715856|NCT01059617|616965016|FG003|Overall Study|Other|6|||
170715857|NCT01968434|616965017|FG000|Overall Study|Lost to Follow-up|3|||
170715858|NCT01968434|616965018|FG001|Overall Study|Lost to Follow-up|6|||
170715859|NCT00612313|616965019|FG000|Overall Study|Withdrawal by Subject|6|||
170715860|NCT00612313|616965020|FG001|Overall Study|Withdrawal by Subject|9|||
170715861|NCT00612313|616965019|FG000|Overall Study|Lost to Follow-up|11|||
170715862|NCT00612313|616965020|FG001|Overall Study|Lost to Follow-up|4|||
170715863|NCT00791765|616967217|FG000|Weeks 1 to 12|Adverse Event|0|||
170715864|NCT00791765|616967218|FG001|Weeks 1 to 12|Adverse Event|1|||
170715865|NCT00791765|616967217|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
170715866|NCT00791765|616967218|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
170715867|NCT00791765|616967217|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
170715868|NCT00791765|616967218|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
170715869|NCT00791765|616967217|FG000|Weeks 1 to 12|Physician Decision|1|||
170715870|NCT00791765|616967218|FG001|Weeks 1 to 12|Physician Decision|0|||
170715871|NCT00791765|616967217|FG000|Weeks 1 to 12|Disease progression|3|||
170715872|NCT00791765|616967218|FG001|Weeks 1 to 12|Disease progression|0|||
170715873|NCT00791765|616967217|FG000|Weeks 1 to 12|Ineligibility determined|0|||
170715874|NCT00791765|616967218|FG001|Weeks 1 to 12|Ineligibility determined|3|||
170715875|NCT00791765|616967217|FG000|Weeks 13 to 24|Protocol deviation|2|||
170715876|NCT00791765|616967218|FG001|Weeks 13 to 24|Protocol deviation|0|||
170715877|NCT00791765|616967217|FG000|Weeks 13 to 24|Adverse Event|0|||
170715878|NCT00791765|616967218|FG001|Weeks 13 to 24|Adverse Event|3|||
170715879|NCT00791765|616967217|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
170715880|NCT00791765|616967218|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
170715881|NCT00791765|616967217|FG000|Weeks 13 to 24|Disease progression|0|||
170715882|NCT00791765|616967218|FG001|Weeks 13 to 24|Disease progression|1|||
170715883|NCT00791765|616967217|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
170715884|NCT00791765|616967218|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
170715885|NCT00791765|616967217|FG000|Weeks 13 to 24|Other|0|||
170715886|NCT00791765|616967218|FG001|Weeks 13 to 24|Other|1|||
170715887|NCT04537923|616967219|FG000|Overall Study|Adverse Event|2|||
170715888|NCT04537923|616967220|FG001|Overall Study|Adverse Event|1|||
170715889|NCT04537923|616967221|FG002|Overall Study|Adverse Event|2|||
170715890|NCT04537923|616967222|FG003|Overall Study|Adverse Event|4|||
170715891|NCT04537923|616967219|FG000|Overall Study|Death|3|||
170715892|NCT04537923|616967220|FG001|Overall Study|Death|3|||
170715893|NCT04537923|616967221|FG002|Overall Study|Death|1|||
170715894|NCT04537923|616967222|FG003|Overall Study|Death|11|||
170715895|NCT04537923|616967219|FG000|Overall Study|Lost to Follow-up|1|||
170715896|NCT04537923|616967220|FG001|Overall Study|Lost to Follow-up|2|||
170715897|NCT04537923|616967221|FG002|Overall Study|Lost to Follow-up|1|||
170715898|NCT04537923|616967222|FG003|Overall Study|Lost to Follow-up|6|||
170715899|NCT04537923|616967219|FG000|Overall Study|Physician Decision|1|||
170715900|NCT04537923|616967220|FG001|Overall Study|Physician Decision|0|||
170715901|NCT04537923|616967221|FG002|Overall Study|Physician Decision|2|||
170715902|NCT04537923|616967222|FG003|Overall Study|Physician Decision|5|||
170715903|NCT04537923|616967219|FG000|Overall Study|Pregnancy|1|||
170715904|NCT04537923|616967220|FG001|Overall Study|Pregnancy|0|||
170715905|NCT04537923|616967221|FG002|Overall Study|Pregnancy|0|||
170715906|NCT04537923|616967222|FG003|Overall Study|Pregnancy|0|||
170715907|NCT04537923|616967219|FG000|Overall Study|Withdrawal by Subject|4|||
170715908|NCT04537923|616967220|FG001|Overall Study|Withdrawal by Subject|4|||
170715909|NCT04537923|616967221|FG002|Overall Study|Withdrawal by Subject|4|||
170715910|NCT04537923|616967222|FG003|Overall Study|Withdrawal by Subject|58|||
170715911|NCT04537923|616967219|FG000|Overall Study|Missed study visits|2|||
170715912|NCT04537923|616967220|FG001|Overall Study|Missed study visits|0|||
170715913|NCT04537923|616967221|FG002|Overall Study|Missed study visits|0|||
170715914|NCT04537923|616967222|FG003|Overall Study|Missed study visits|3|||
170715915|NCT04537923|616967219|FG000|Overall Study|Sponsor's decision|0|||
170715916|NCT04537923|616967220|FG001|Overall Study|Sponsor's decision|0|||
170715917|NCT04537923|616967221|FG002|Overall Study|Sponsor's decision|1|||
170715918|NCT04537923|616967222|FG003|Overall Study|Sponsor's decision|1|||
170715919|NCT04537923|616967219|FG000|Overall Study|Safety reasons|1|||
170715920|NCT04537923|616967220|FG001|Overall Study|Safety reasons|0|||
170715921|NCT04537923|616967221|FG002|Overall Study|Safety reasons|0|||
170715922|NCT04537923|616967222|FG003|Overall Study|Safety reasons|0|||
170715923|NCT01261611|616967223|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
170715924|NCT01261611|616967224|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
170715925|NCT01261611|616967225|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
170715926|NCT01261611|616967223|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
170715927|NCT01261611|616967224|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
170715928|NCT01261611|616967225|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
170715929|NCT01261611|616967223|FG000|Treatment Cycle 1|Adverse Event|0|||
170715930|NCT01261611|616967224|FG001|Treatment Cycle 1|Adverse Event|1|||
170715931|NCT01261611|616967225|FG002|Treatment Cycle 1|Adverse Event|0|||
170715932|NCT01261611|616967223|FG000|Treatment Cycle 1|Protocol Violation|0|||
170715933|NCT01261611|616967224|FG001|Treatment Cycle 1|Protocol Violation|0|||
170715934|NCT01261611|616967225|FG002|Treatment Cycle 1|Protocol Violation|2|||
170715935|NCT01261611|616967223|FG000|Treatment Cycle 2|Completed study|4|||
170715936|NCT01261611|616967224|FG001|Treatment Cycle 2|Completed study|0|||
170715937|NCT01261611|616967225|FG002|Treatment Cycle 2|Completed study|0|||
170715938|NCT01261611|616967223|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
170715939|NCT01261611|616967224|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
170715940|NCT01261611|616967225|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
170715941|NCT01261611|616967223|FG000|Treatment Cycle 2|Adverse Event|1|||
170715942|NCT01261611|616967224|FG001|Treatment Cycle 2|Adverse Event|0|||
170715943|NCT01261611|616967225|FG002|Treatment Cycle 2|Adverse Event|0|||
170715944|NCT01261611|616967223|FG000|Treatment Cycle 2|Protocol Violation|2|||
170715945|NCT01261611|616967224|FG001|Treatment Cycle 2|Protocol Violation|0|||
170715946|NCT01261611|616967225|FG002|Treatment Cycle 2|Protocol Violation|0|||
170715947|NCT01261611|616967223|FG000|Treatment Cycle 2|Not otherwise specified|2|||
170715948|NCT01261611|616967224|FG001|Treatment Cycle 2|Not otherwise specified|0|||
170715949|NCT01261611|616967225|FG002|Treatment Cycle 2|Not otherwise specified|0|||
170715950|NCT01261611|616967223|FG000|Treatment Cycle 3|Completed study|24|||
170715951|NCT01261611|616967224|FG001|Treatment Cycle 3|Completed study|0|||
170715952|NCT01261611|616967225|FG002|Treatment Cycle 3|Completed study|0|||
170715953|NCT01261611|616967223|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
170715954|NCT01261611|616967224|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
170715955|NCT01261611|616967225|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
170715956|NCT01261611|616967223|FG000|Treatment Cycle 3|Adverse Event|1|||
170715957|NCT01261611|616967224|FG001|Treatment Cycle 3|Adverse Event|0|||
170715958|NCT01261611|616967225|FG002|Treatment Cycle 3|Adverse Event|0|||
170715959|NCT01261611|616967223|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
170715960|NCT01261611|616967224|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
170715961|NCT01261611|616967225|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
170715962|NCT01261611|616967223|FG000|Treatment Cycle 4|Completed study|87|||
170715963|NCT01261611|616967224|FG001|Treatment Cycle 4|Completed study|0|||
170715964|NCT01261611|616967225|FG002|Treatment Cycle 4|Completed study|0|||
170715965|NCT01261611|616967223|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
170715966|NCT01261611|616967224|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
170715967|NCT01261611|616967225|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
170715968|NCT01261611|616967223|FG000|Treatment Cycle 4|Adverse Event|1|||
170715969|NCT01261611|616967224|FG001|Treatment Cycle 4|Adverse Event|0|||
170715970|NCT01261611|616967225|FG002|Treatment Cycle 4|Adverse Event|0|||
170715971|NCT01261611|616967223|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
170715972|NCT01261611|616967224|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
170715973|NCT01261611|616967225|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
170715974|NCT01261611|616967223|FG000|Treatment Cycle 4|Not otherwise specified|3|||
170715975|NCT01261611|616967224|FG001|Treatment Cycle 4|Not otherwise specified|0|||
170715976|NCT01261611|616967225|FG002|Treatment Cycle 4|Not otherwise specified|0|||
170715977|NCT01261611|616967223|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
170715978|NCT01261611|616967224|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
170715979|NCT01261611|616967225|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
170715980|NCT01261611|616967223|FG000|Treatment Cycle 5|Adverse Event|1|||
170715981|NCT01261611|616967224|FG001|Treatment Cycle 5|Adverse Event|0|||
170715982|NCT01261611|616967225|FG002|Treatment Cycle 5|Adverse Event|0|||
170715983|NCT01261611|616967223|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
170715984|NCT01261611|616967224|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
170715985|NCT01261611|616967225|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
170715986|NCT02527798|616967226|FG000|Overall Study|Physician Decision|1|||
170715987|NCT02527798|616967227|FG001|Overall Study|Physician Decision|0|||
170715988|NCT02527798|616967228|FG002|Overall Study|Physician Decision|1|||
170715989|NCT02527798|616967229|FG003|Overall Study|Physician Decision|1|||
170715990|NCT02527798|616967230|FG004|Overall Study|Physician Decision|0|||
170715991|NCT02527798|616967231|FG005|Overall Study|Physician Decision|0|||
170715992|NCT02527798|616967226|FG000|Overall Study|Death|0|||
170715993|NCT02527798|616967227|FG001|Overall Study|Death|0|||
170715994|NCT02527798|616967228|FG002|Overall Study|Death|1|||
170715995|NCT02527798|616967229|FG003|Overall Study|Death|0|||
170715996|NCT02527798|616967230|FG004|Overall Study|Death|0|||
170715997|NCT02527798|616967231|FG005|Overall Study|Death|0|||
170715998|NCT02527798|616967226|FG000|Overall Study|Withdrawal by Subject|0|||
170715999|NCT02527798|616967227|FG001|Overall Study|Withdrawal by Subject|1|||
170716000|NCT02527798|616967228|FG002|Overall Study|Withdrawal by Subject|2|||
170716001|NCT02527798|616967229|FG003|Overall Study|Withdrawal by Subject|0|||
170716002|NCT02527798|616967230|FG004|Overall Study|Withdrawal by Subject|0|||
170716003|NCT02527798|616967231|FG005|Overall Study|Withdrawal by Subject|0|||
170716004|NCT02527798|616967226|FG000|Overall Study|Reason undisclosed|1|||
170716005|NCT02527798|616967227|FG001|Overall Study|Reason undisclosed|0|||
170716006|NCT02527798|616967228|FG002|Overall Study|Reason undisclosed|1|||
170716007|NCT02527798|616967229|FG003|Overall Study|Reason undisclosed|0|||
170716008|NCT02527798|616967230|FG004|Overall Study|Reason undisclosed|0|||
170716009|NCT02527798|616967231|FG005|Overall Study|Reason undisclosed|0|||
170716010|NCT02527798|616967226|FG000|Overall Study|Did not receive intervention|1|||
170716011|NCT02527798|616967227|FG001|Overall Study|Did not receive intervention|1|||
170716012|NCT02527798|616967228|FG002|Overall Study|Did not receive intervention|0|||
170716013|NCT02527798|616967229|FG003|Overall Study|Did not receive intervention|0|||
170716014|NCT02527798|616967230|FG004|Overall Study|Did not receive intervention|0|||
170716015|NCT02527798|616967231|FG005|Overall Study|Did not receive intervention|0|||
170716016|NCT03859323|616967237|FG000|Overall Study|Lost to Follow-up|0|||
170716017|NCT03859323|616967238|FG001|Overall Study|Lost to Follow-up|0|||
170716018|NCT03859323|616967239|FG002|Overall Study|Lost to Follow-up|0|||
170716019|NCT03859323|616967240|FG003|Overall Study|Lost to Follow-up|0|||
170716020|NCT03859323|616967241|FG004|Overall Study|Lost to Follow-up|0|||
170716021|NCT03859323|616967242|FG005|Overall Study|Lost to Follow-up|0|||
170716022|NCT03859323|616967243|FG006|Overall Study|Lost to Follow-up|1|||
170716023|NCT03859323|616967244|FG007|Overall Study|Lost to Follow-up|0|||
170716024|NCT03859323|616967245|FG008|Overall Study|Lost to Follow-up|0|||
170716025|NCT03859323|616967246|FG009|Overall Study|Lost to Follow-up|0|||
170716026|NCT03859323|616967247|FG010|Overall Study|Lost to Follow-up|0|||
170716027|NCT03859323|616967248|FG011|Overall Study|Lost to Follow-up|0|||
170716028|NCT03859323|616967249|FG012|Overall Study|Lost to Follow-up|0|||
170716029|NCT03859323|616967237|FG000|Overall Study|Withdrawal by Subject|0|||
170716030|NCT03859323|616967238|FG001|Overall Study|Withdrawal by Subject|0|||
170716031|NCT03859323|616967239|FG002|Overall Study|Withdrawal by Subject|1|||
170716032|NCT03859323|616967240|FG003|Overall Study|Withdrawal by Subject|0|||
170716033|NCT03859323|616967241|FG004|Overall Study|Withdrawal by Subject|0|||
170716034|NCT03859323|616967242|FG005|Overall Study|Withdrawal by Subject|1|||
170716035|NCT03859323|616967243|FG006|Overall Study|Withdrawal by Subject|0|||
170716036|NCT03859323|616967244|FG007|Overall Study|Withdrawal by Subject|0|||
170716037|NCT03859323|616967245|FG008|Overall Study|Withdrawal by Subject|0|||
170716038|NCT03859323|616967246|FG009|Overall Study|Withdrawal by Subject|1|||
170716039|NCT03859323|616967247|FG010|Overall Study|Withdrawal by Subject|1|||
170716040|NCT03859323|616967248|FG011|Overall Study|Withdrawal by Subject|2|||
170716041|NCT03859323|616967249|FG012|Overall Study|Withdrawal by Subject|1|||
170716042|NCT03859323|616967237|FG000|Overall Study|Pregnancy|0|||
170716043|NCT03859323|616967238|FG001|Overall Study|Pregnancy|0|||
170716044|NCT03859323|616967239|FG002|Overall Study|Pregnancy|0|||
170716045|NCT03859323|616967240|FG003|Overall Study|Pregnancy|0|||
170716046|NCT03859323|616967241|FG004|Overall Study|Pregnancy|0|||
170716047|NCT03859323|616967242|FG005|Overall Study|Pregnancy|0|||
170716048|NCT03859323|616967243|FG006|Overall Study|Pregnancy|0|||
170716049|NCT03859323|616967244|FG007|Overall Study|Pregnancy|0|||
170716050|NCT03859323|616967245|FG008|Overall Study|Pregnancy|0|||
170716051|NCT03859323|616967246|FG009|Overall Study|Pregnancy|1|||
170716052|NCT03859323|616967247|FG010|Overall Study|Pregnancy|0|||
170716053|NCT03859323|616967248|FG011|Overall Study|Pregnancy|0|||
170716054|NCT03859323|616967249|FG012|Overall Study|Pregnancy|0|||
170829202|NCT04811339|617383965|FG000|Overall Study|Adverse Event|3|||
170829203|NCT04811339|617383966|FG001|Overall Study|Adverse Event|0|||
170829204|NCT04811339|617383967|FG002|Overall Study|Adverse Event|0|||
170829205|NCT04811339|617383965|FG000|Overall Study|Lost to Follow-up|1|||
170829206|NCT04811339|617383966|FG001|Overall Study|Lost to Follow-up|0|||
170829207|NCT04811339|617383967|FG002|Overall Study|Lost to Follow-up|0|||
170829208|NCT04811339|617383965|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
170829209|NCT04811339|617383966|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
170829210|NCT04811339|617383967|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
170829211|NCT04811339|617383965|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
170829212|NCT04811339|617383966|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
170829213|NCT04811339|617383967|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
170829214|NCT04811339|617383965|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
170829215|NCT04811339|617383966|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
170829216|NCT04811339|617383967|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
170829217|NCT04811339|617383965|FG000|Overall Study|Withdrawal by Subject|0|||
170829218|NCT04811339|617383966|FG001|Overall Study|Withdrawal by Subject|3|||
170829219|NCT04811339|617383967|FG002|Overall Study|Withdrawal by Subject|0|||
170829220|NCT04811339|617383965|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
170829221|NCT04811339|617383966|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
170829222|NCT04811339|617383967|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
170829223|NCT04811339|617383965|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
170829224|NCT04811339|617383966|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
170829225|NCT04811339|617383967|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
170829226|NCT04380688|617383971|FG000|Overall Study|Death|2|||
170829227|NCT04380688|617383972|FG001|Overall Study|Death|2|||
170829228|NCT04380688|617383971|FG000|Overall Study|Lost to Follow-up|2|||
170829229|NCT04380688|617383972|FG001|Overall Study|Lost to Follow-up|4|||
170829230|NCT04380688|617383971|FG000|Overall Study|Withdrawal by Subject|3|||
170829231|NCT04380688|617383972|FG001|Overall Study|Withdrawal by Subject|3|||
170829232|NCT02250183|617383975|FG000|Overall Study|Withdrawal by Subject|2|||
170829233|NCT02250183|617383975|FG000|Overall Study|Adverse Event|5|||
170829234|NCT02250183|617383975|FG000|Overall Study|Lost to Follow-up|1|||
170829235|NCT03282799|617383976|FG000|Overall Study|Pregnancy|1|||
170829236|NCT03282799|617383977|FG001|Overall Study|Pregnancy|0|||
170829237|NCT03282799|617383976|FG000|Overall Study|Physician Decision|1|||
170829238|NCT03282799|617383977|FG001|Overall Study|Physician Decision|0|||
170829239|NCT03749616|617383981|FG000|Overall Study|Lost to Follow-up|4|||
170829240|NCT03749616|617383982|FG001|Overall Study|Lost to Follow-up|7|||
170829241|NCT03749616|617383981|FG000|Overall Study|Screen Failure|1|||
170829242|NCT03749616|617383982|FG001|Overall Study|Screen Failure|1|||
170829243|NCT03749616|617383981|FG000|Overall Study|Withdrawal by Subject|2|||
170829244|NCT03749616|617383982|FG001|Overall Study|Withdrawal by Subject|0|||
170829245|NCT03302559|617383985|FG000|Overall Study|Adverse Event|2|||
170829246|NCT03302559|617383985|FG000|Overall Study|Lost to Follow-up|1|||
170829247|NCT03302559|617383985|FG000|Overall Study|Withdrew Consent|3|||
170829248|NCT00919061|617383988|FG000|Overall Study|Adverse Event|1|||
170829249|NCT00919061|617383988|FG000|Overall Study|Withdrawal by Subject|1|||
170829250|NCT05294328|617383991|FG000|Overall Study|Adverse Event|1|||
170829251|NCT05294328|617383992|FG001|Overall Study|Adverse Event|0|||
170829252|NCT05294328|617383993|FG002|Overall Study|Adverse Event|0|||
170829253|NCT05294328|617383991|FG000|Overall Study|Physician Decision|1|||
170829254|NCT05294328|617383992|FG001|Overall Study|Physician Decision|1|||
170829255|NCT05294328|617383993|FG002|Overall Study|Physician Decision|0|||
170829256|NCT05294328|617383991|FG000|Overall Study|Withdrawal by Subject|0|||
170829257|NCT05294328|617383992|FG001|Overall Study|Withdrawal by Subject|2|||
170829258|NCT05294328|617383993|FG002|Overall Study|Withdrawal by Subject|1|||
170829259|NCT05294328|617383991|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
170829260|NCT05294328|617383992|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
170829261|NCT05294328|617383993|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
170829262|NCT03614676|617385360|FG000|Overall Study|Delivery before planned visit|2|||
170829263|NCT03614676|617385361|FG001|Overall Study|Delivery before planned visit|0|||
170829264|NCT03614676|617385360|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
170829265|NCT03614676|617385361|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
170829266|NCT03614676|617385360|FG000|Overall Study|Migrated / moved from the study area|30|||
170716055|NCT00724282|616967255|FG000|Overall Study|Withdrawal by Subject|3|||
170716056|NCT00724282|616967255|FG000|Overall Study|Physician Decision|1|||
170716057|NCT01432366|616967256|FG000|Overall Study|Non-Responder|7|||
170716058|NCT01432366|616967256|FG000|Overall Study|Adverse Event|8|||
170716059|NCT01432366|616967256|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
170716060|NCT01432366|616967256|FG000|Overall Study|Pregnancy|1|||
170716061|NCT01432366|616967256|FG000|Overall Study|Lost to Follow-up|13|||
170716062|NCT01432366|616967256|FG000|Overall Study|Lack of Efficacy|1|||
170716063|NCT01432366|616967256|FG000|Overall Study|Site Closed|20|||
170716064|NCT01432366|616967256|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
170716065|NCT01432366|616967256|FG000|Overall Study|Other|14|||
170716066|NCT00970502|616967257|FG000|Overall Study|Withdrawal by Subject|1|||
170716067|NCT01808690|616967258|FG000|Overall Study|Withdrawal by Subject|1|||
170716068|NCT01808690|616967259|FG001|Overall Study|Withdrawal by Subject|2|||
170716069|NCT03811912|616967260|FG000|Overall Study|Withdrew Consent|4|||
170716070|NCT03811912|616967261|FG001|Overall Study|Withdrew Consent|2|||
170716071|NCT01863680|616967262|FG000|Overall Study|Adverse Event|17|||
170716072|NCT01863680|616967262|FG000|Overall Study|Risk of OHSS|17|||
170716073|NCT01863680|616967262|FG000|Overall Study|Spontaneous pregnancy|2|||
170716074|NCT01863680|616967262|FG000|Overall Study|Withdrawal by Subject|1|||
170716075|NCT01863680|616967262|FG000|Overall Study|Did not undergo IVF/ET|14|||
170829267|NCT03614676|617385361|FG001|Overall Study|Migrated / moved from the study area|22|||
170829268|NCT03614676|617385360|FG000|Overall Study|Lost to Follow-up|17|||
170829269|NCT03614676|617385361|FG001|Overall Study|Lost to Follow-up|42|||
170829270|NCT03614676|617385360|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
170829271|NCT03614676|617385361|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
170829272|NCT03614676|617385360|FG000|Overall Study|Other|16|||
170829273|NCT03614676|617385361|FG001|Overall Study|Other|47|||
170829274|NCT03614676|617385360|FG000|Overall Study|Protocol Violation|0|||
170829275|NCT03614676|617385361|FG001|Overall Study|Protocol Violation|2|||
170829276|NCT03614676|617385360|FG000|Overall Study|Neonatal event of interest|0|||
170829277|NCT03614676|617385361|FG001|Overall Study|Neonatal event of interest|6|||
170829278|NCT03614676|617385360|FG000|Overall Study|Death in infant greater than 28 days old|0|||
170829279|NCT03614676|617385361|FG001|Overall Study|Death in infant greater than 28 days old|12|||
170829280|NCT03614676|617385360|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
170829281|NCT03614676|617385361|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
170829282|NCT02080403|617385362|FG000|Overall Study|Adverse Event|5|||
170829283|NCT02080403|617385363|FG001|Overall Study|Adverse Event|1|||
170829284|NCT02080403|617385362|FG000|Overall Study|Death|0|||
170829285|NCT02080403|617385363|FG001|Overall Study|Death|2|||
170829286|NCT02080403|617385362|FG000|Overall Study|Lost to Follow-up|2|||
170829287|NCT02080403|617385363|FG001|Overall Study|Lost to Follow-up|0|||
170829288|NCT02080403|617385362|FG000|Overall Study|Pregnancy|0|||
170829289|NCT02080403|617385363|FG001|Overall Study|Pregnancy|1|||
170829290|NCT02080403|617385362|FG000|Overall Study|Protocol Violation|3|||
170829291|NCT02080403|617385363|FG001|Overall Study|Protocol Violation|7|||
170829292|NCT02080403|617385362|FG000|Overall Study|Withdrawal by Subject|5|||
170829293|NCT02080403|617385363|FG001|Overall Study|Withdrawal by Subject|1|||
170829294|NCT01999972|617385364|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
170829295|NCT01999972|617385365|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
170829296|NCT01999972|617385366|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
170829297|NCT01999972|617385367|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
170829298|NCT01999972|617385368|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
170829299|NCT01999972|617385369|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
170829300|NCT01999972|617385364|FG000|Dose Escalation Part|Death|0|||
170829301|NCT01999972|617385365|FG001|Dose Escalation Part|Death|1|||
170829302|NCT01999972|617385366|FG002|Dose Escalation Part|Death|0|||
170829303|NCT01999972|617385367|FG003|Dose Escalation Part|Death|0|||
170829304|NCT01999972|617385368|FG004|Dose Escalation Part|Death|0|||
170829305|NCT01999972|617385369|FG005|Dose Escalation Part|Death|0|||
170829306|NCT01999972|617385364|FG000|Dose Escalation Part|Enrolled but not treated|0|||
170829307|NCT01999972|617385365|FG001|Dose Escalation Part|Enrolled but not treated|0|||
170829308|NCT01999972|617385366|FG002|Dose Escalation Part|Enrolled but not treated|1|||
170829309|NCT01999972|617385367|FG003|Dose Escalation Part|Enrolled but not treated|1|||
170829310|NCT01999972|617385368|FG004|Dose Escalation Part|Enrolled but not treated|0|||
170716076|NCT01863680|616967262|FG000|Overall Study|Other|6|||
170716077|NCT03586648|616967265|FG000|Period 1|Withdrawal by Subject|0|||
170716078|NCT03586648|616967266|FG001|Period 1|Withdrawal by Subject|1|||
170716079|NCT03586648|616967265|FG000|Period 1|Lost to Follow-up|1|||
170829311|NCT01999972|617385369|FG005|Dose Escalation Part|Enrolled but not treated|0|||
170829312|NCT01999972|617385364|FG000|Dose Escalation Part|Disease progression|3|||
170829313|NCT01999972|617385365|FG001|Dose Escalation Part|Disease progression|2|||
170829314|NCT01999972|617385366|FG002|Dose Escalation Part|Disease progression|3|||
170829315|NCT01999972|617385367|FG003|Dose Escalation Part|Disease progression|6|||
170716080|NCT03586648|616967266|FG001|Period 1|Lost to Follow-up|1|||
170716081|NCT03586648|616967265|FG000|Period 1|Adverse Event|1|||
170716082|NCT03586648|616967266|FG001|Period 1|Adverse Event|0|||
170716083|NCT03586648|616967265|FG000|Period 1|Study related symptoms or complaints|2|||
170716084|NCT03586648|616967266|FG001|Period 1|Study related symptoms or complaints|1|||
170716085|NCT03586648|616967265|FG000|Period 1|Physician Decision|0|||
170716086|NCT03586648|616967266|FG001|Period 1|Physician Decision|1|||
170716087|NCT03586648|616967265|FG000|Period 2|Adverse Event|1|||
170716088|NCT03586648|616967266|FG001|Period 2|Adverse Event|0|||
170716089|NCT02041195|616967267|FG000|Overall Study|Adverse Event|1|||
170716090|NCT02041195|616967268|FG001|Overall Study|Adverse Event|2|||
170716091|NCT02041195|616967269|FG002|Overall Study|Adverse Event|0|||
170716092|NCT02041195|616967270|FG003|Overall Study|Adverse Event|0|||
170716093|NCT02041195|616967271|FG004|Overall Study|Adverse Event|0|||
170716094|NCT02041195|616967272|FG005|Overall Study|Adverse Event|0|||
170716095|NCT02041195|616967273|FG006|Overall Study|Adverse Event|3|||
170716096|NCT02041195|616967274|FG007|Overall Study|Adverse Event|0|||
170716097|NCT02041195|616967267|FG000|Overall Study|Withdrawal by Subject|1|||
170716098|NCT02041195|616967268|FG001|Overall Study|Withdrawal by Subject|0|||
170716099|NCT02041195|616967269|FG002|Overall Study|Withdrawal by Subject|0|||
170716100|NCT02041195|616967270|FG003|Overall Study|Withdrawal by Subject|0|||
170716101|NCT02041195|616967271|FG004|Overall Study|Withdrawal by Subject|0|||
170716102|NCT02041195|616967272|FG005|Overall Study|Withdrawal by Subject|0|||
170716103|NCT02041195|616967273|FG006|Overall Study|Withdrawal by Subject|4|||
170716104|NCT02041195|616967274|FG007|Overall Study|Withdrawal by Subject|3|||
170716105|NCT02041195|616967267|FG000|Overall Study|Unable to comply with study visits|0|||
170716106|NCT02041195|616967268|FG001|Overall Study|Unable to comply with study visits|1|||
170716107|NCT02041195|616967269|FG002|Overall Study|Unable to comply with study visits|0|||
170716108|NCT02041195|616967270|FG003|Overall Study|Unable to comply with study visits|0|||
170716109|NCT02041195|616967271|FG004|Overall Study|Unable to comply with study visits|1|||
170716110|NCT02041195|616967272|FG005|Overall Study|Unable to comply with study visits|0|||
170716111|NCT02041195|616967273|FG006|Overall Study|Unable to comply with study visits|0|||
170716112|NCT02041195|616967274|FG007|Overall Study|Unable to comply with study visits|0|||
170716113|NCT02395120|616967275|FG000|Overall Study|Missed follow-up dental exam|57|||
170716114|NCT02395120|616967276|FG001|Overall Study|Missed follow-up dental exam|62|||
170716115|NCT02395120|616967277|FG002|Overall Study|Missed follow-up dental exam|6|||
170716116|NCT02395120|616967278|FG003|Overall Study|Missed follow-up dental exam|6|||
170716117|NCT02395120|616967279|FG004|Overall Study|Missed follow-up dental exam|51|||
170716118|NCT00674986|616967280|FG000|Overall Study|Adverse Event|2|||
170716119|NCT00674986|616967281|FG001|Overall Study|Adverse Event|1|||
170716120|NCT00674986|616967280|FG000|Overall Study|Subject withdrew consent|12|||
170716121|NCT00674986|616967281|FG001|Overall Study|Subject withdrew consent|19|||
170716122|NCT00674986|616967280|FG000|Overall Study|Lost to Follow-up|25|||
170716123|NCT00674986|616967281|FG001|Overall Study|Lost to Follow-up|53|||
170716124|NCT00674986|616967280|FG000|Overall Study|Other reasons|4|||
170716125|NCT00674986|616967281|FG001|Overall Study|Other reasons|8|||
170716126|NCT02053350|616967283|FG000|Overall Study|Withdrawal by Subject|1|||
170716127|NCT02053350|616967283|FG000|Overall Study|Adverse Event|4|||
170716128|NCT04546581|616967284|FG000|Overall Study|Adverse Event|9|||
170716129|NCT04546581|616967285|FG001|Overall Study|Adverse Event|3|||
170716130|NCT04546581|616967284|FG000|Overall Study|Physician Decision|0|||
170716131|NCT04546581|616967285|FG001|Overall Study|Physician Decision|1|||
170716132|NCT04546581|616967284|FG000|Overall Study|Protocol Violation|1|||
170716133|NCT04546581|616967285|FG001|Overall Study|Protocol Violation|2|||
170716134|NCT04546581|616967284|FG000|Overall Study|Withdrawal by Subject|3|||
170716135|NCT04546581|616967285|FG001|Overall Study|Withdrawal by Subject|7|||
170716136|NCT02526693|616967286|FG000|Overall Study|Physician Decision|3|||
170716137|NCT02526693|616967287|FG001|Overall Study|Physician Decision|1|||
170716138|NCT01275625|616967288|FG000|Overall Study|Death|1|||
170829316|NCT01999972|617385368|FG004|Dose Escalation Part|Disease progression|0|||
170829317|NCT01999972|617385369|FG005|Dose Escalation Part|Disease progression|0|||
170829318|NCT01999972|617385364|FG000|Dose Escalation Part|Adverse Event|0|||
170829319|NCT01999972|617385365|FG001|Dose Escalation Part|Adverse Event|0|||
170829320|NCT01999972|617385366|FG002|Dose Escalation Part|Adverse Event|0|||
170829321|NCT01999972|617385367|FG003|Dose Escalation Part|Adverse Event|2|||
170829322|NCT01999972|617385368|FG004|Dose Escalation Part|Adverse Event|0|||
170829323|NCT01999972|617385369|FG005|Dose Escalation Part|Adverse Event|0|||
170829324|NCT01999972|617385364|FG000|Dose Escalation Part|Global deterioration of health status|1|||
170829325|NCT01999972|617385365|FG001|Dose Escalation Part|Global deterioration of health status|0|||
170829326|NCT01999972|617385366|FG002|Dose Escalation Part|Global deterioration of health status|0|||
170829327|NCT01999972|617385367|FG003|Dose Escalation Part|Global deterioration of health status|1|||
170829328|NCT01999972|617385368|FG004|Dose Escalation Part|Global deterioration of health status|0|||
170716139|NCT01275625|616967288|FG000|Overall Study|Lack of Efficacy|2|||
170716140|NCT01275625|616967288|FG000|Overall Study|Lost to Follow-up|1|||
170829329|NCT01999972|617385369|FG005|Dose Escalation Part|Global deterioration of health status|0|||
170829330|NCT01999972|617385364|FG000|Dose Expansion Part|Death|0|||
170829331|NCT01999972|617385365|FG001|Dose Expansion Part|Death|0|||
170829332|NCT01999972|617385366|FG002|Dose Expansion Part|Death|0|||
170829333|NCT01999972|617385367|FG003|Dose Expansion Part|Death|0|||
170829334|NCT01999972|617385368|FG004|Dose Expansion Part|Death|2|||
170829335|NCT01999972|617385369|FG005|Dose Expansion Part|Death|1|||
170829336|NCT01999972|617385364|FG000|Dose Expansion Part|Disease progression|0|||
170829337|NCT01999972|617385365|FG001|Dose Expansion Part|Disease progression|0|||
170829338|NCT01999972|617385366|FG002|Dose Expansion Part|Disease progression|0|||
170829339|NCT01999972|617385367|FG003|Dose Expansion Part|Disease progression|0|||
170829340|NCT01999972|617385368|FG004|Dose Expansion Part|Disease progression|9|||
170829341|NCT01999972|617385369|FG005|Dose Expansion Part|Disease progression|3|||
170829342|NCT01999972|617385364|FG000|Dose Expansion Part|Sponsor decision|0|||
170829343|NCT01999972|617385365|FG001|Dose Expansion Part|Sponsor decision|0|||
170829344|NCT01999972|617385366|FG002|Dose Expansion Part|Sponsor decision|0|||
170829345|NCT01999972|617385367|FG003|Dose Expansion Part|Sponsor decision|0|||
170829346|NCT01999972|617385368|FG004|Dose Expansion Part|Sponsor decision|1|||
170829347|NCT01999972|617385369|FG005|Dose Expansion Part|Sponsor decision|0|||
170829348|NCT01999972|617385364|FG000|Dose Expansion Part|Adverse Event|0|||
170829349|NCT01999972|617385365|FG001|Dose Expansion Part|Adverse Event|0|||
170829350|NCT01999972|617385366|FG002|Dose Expansion Part|Adverse Event|0|||
170829351|NCT01999972|617385367|FG003|Dose Expansion Part|Adverse Event|0|||
170829352|NCT01999972|617385368|FG004|Dose Expansion Part|Adverse Event|4|||
170829353|NCT01999972|617385369|FG005|Dose Expansion Part|Adverse Event|2|||
170829354|NCT01999972|617385364|FG000|Dose Expansion Part|Participant's non-compliance|0|||
170829355|NCT01999972|617385365|FG001|Dose Expansion Part|Participant's non-compliance|0|||
170829356|NCT01999972|617385366|FG002|Dose Expansion Part|Participant's non-compliance|0|||
170829357|NCT01999972|617385367|FG003|Dose Expansion Part|Participant's non-compliance|0|||
170829358|NCT01999972|617385368|FG004|Dose Expansion Part|Participant's non-compliance|0|||
170829359|NCT01999972|617385369|FG005|Dose Expansion Part|Participant's non-compliance|1|||
170829360|NCT01999972|617385364|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
170829361|NCT01999972|617385365|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
170829362|NCT01999972|617385366|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
170829363|NCT01999972|617385367|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
170829364|NCT01999972|617385368|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
170829365|NCT01999972|617385369|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
170829366|NCT01999972|617385364|FG000|Dose Expansion Part|Changed to standard of care|0|||
170829367|NCT01999972|617385365|FG001|Dose Expansion Part|Changed to standard of care|0|||
170829368|NCT01999972|617385366|FG002|Dose Expansion Part|Changed to standard of care|0|||
170829369|NCT01999972|617385367|FG003|Dose Expansion Part|Changed to standard of care|0|||
170829370|NCT01999972|617385368|FG004|Dose Expansion Part|Changed to standard of care|1|||
170829371|NCT01999972|617385369|FG005|Dose Expansion Part|Changed to standard of care|0|||
170829372|NCT01171183|617385370|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
170829373|NCT01171183|617385371|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
170829374|NCT01171183|617385370|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
170829375|NCT01171183|617385371|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
170829376|NCT01171183|617385370|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
170829377|NCT01171183|617385371|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
170829378|NCT01171183|617385370|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
170829379|NCT01171183|617385371|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
170829380|NCT01171183|617385370|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
170716141|NCT01275625|616967288|FG000|Overall Study|Withdrawal by Subject|3|||
170716142|NCT01275625|616967288|FG000|Overall Study|Protocol Violation|1|||
170716143|NCT01275625|616967288|FG000|Overall Study|Adverse Event|4|||
170716144|NCT01275625|616967288|FG000|Overall Study|Other|1|||
170716145|NCT01585103|616967290|FG000|Overall Study|Unable to swallow Cytosponge|6|||
170716146|NCT01349569|616967291|FG000|Overall Study|Lack of Efficacy|4|||
170716147|NCT03581305|616967292|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
170716148|NCT03581305|616967293|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
170716149|NCT03581305|616967292|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
170716150|NCT03581305|616967293|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
170716151|NCT03581305|616967292|FG000|Serotonergic Study|Withdrawal by Subject|5|||
170716152|NCT03581305|616967293|FG001|Serotonergic Study|Withdrawal by Subject|1|||
170716153|NCT02244944|616967294|FG000|Overall Study|Withdrawal by Subject|1|||
170716154|NCT02244944|616967294|FG000|Overall Study|Study Terminated|1|||
170716155|NCT02492100|616967299|FG000|Overall Study|Death|1|||
170716156|NCT00352365|616967302|FG000|Induction Therapy|Adverse Event|7|||
170829381|NCT01171183|617385371|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
170829382|NCT01171183|617385370|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
170829383|NCT01171183|617385371|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
170829384|NCT03898700|617385379|FG000|Overall Study|Withdrawal by Subject|2|||
170829385|NCT00511836|617385383|FG000|Double-blind Period|Lost to Follow-up|1|||
170716157|NCT00352365|616967302|FG000|Induction Therapy|Progression/Relapse|8|||
170716158|NCT00352365|616967302|FG000|Induction Therapy|Death|7|||
170716159|NCT00352365|616967302|FG000|Induction Therapy|Not protocol specified|1|||
170716160|NCT00352365|616967302|FG000|Induction Therapy|Not eligible|3|||
170716161|NCT00352365|616967302|FG000|Induction Therapy|Death before starting protocol therapy|1|||
170716162|NCT00352365|616967302|FG000|Maintenance Therapy|Progression/Relapse|3|||
170716163|NCT00352365|616967302|FG000|Maintenance Therapy|Death|2|||
170716164|NCT00352365|616967302|FG000|Maintenance Therapy|Not protocol specified|3|||
170716165|NCT00352365|616967302|FG000|Maintenance Therapy|Not eligible|4|||
170716166|NCT03822533|616967303|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
170716167|NCT03822533|616967304|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
170716168|NCT03822533|616967303|FG000|3 Month Follow-up|Lost to Follow-up|2|||
170716169|NCT03822533|616967304|FG001|3 Month Follow-up|Lost to Follow-up|2|||
170716170|NCT03822533|616967303|FG000|6 Month Follow-up|Lost to Follow-up|3|||
170716171|NCT03822533|616967304|FG001|6 Month Follow-up|Lost to Follow-up|0|||
170716172|NCT03822533|616967303|FG000|12 Month Follow-up|Lost to Follow-up|2|||
170716173|NCT03822533|616967304|FG001|12 Month Follow-up|Lost to Follow-up|3|||
170716174|NCT03822533|616967303|FG000|12 Month Follow-up|Pregnancy|0|||
170716175|NCT03822533|616967304|FG001|12 Month Follow-up|Pregnancy|1|||
170716176|NCT03822533|616967303|FG000|12 Month Follow-up|Surgery|2|||
170716177|NCT03822533|616967304|FG001|12 Month Follow-up|Surgery|0|||
170716178|NCT03822533|616967303|FG000|12 Month Follow-up|Wrong address|1|||
170716179|NCT03822533|616967304|FG001|12 Month Follow-up|Wrong address|0|||
170716180|NCT03822533|616967303|FG000|12 Month Follow-up|No symptoms|1|||
170716181|NCT03822533|616967304|FG001|12 Month Follow-up|No symptoms|0|||
170716182|NCT03822533|616967303|FG000|12 Month Follow-up|Changed primary care center|0|||
170716183|NCT03822533|616967304|FG001|12 Month Follow-up|Changed primary care center|1|||
170716184|NCT04969783|616967305|FG000|Overall Study|Lost to Follow-up|2|||
170716185|NCT04969783|616967306|FG001|Overall Study|Lost to Follow-up|0|||
170716186|NCT04969783|616967305|FG000|Overall Study|Withdrawal by Subject|4|||
170716187|NCT04969783|616967306|FG001|Overall Study|Withdrawal by Subject|0|||
170716188|NCT04969783|616967305|FG000|Overall Study|Physician Decision|6|||
170716189|NCT04969783|616967306|FG001|Overall Study|Physician Decision|0|||
170716190|NCT02489500|616967307|FG000|Overall Study|Death|1|||
170716191|NCT02489500|616967308|FG001|Overall Study|Death|1|||
170716192|NCT00512135|616967316|FG000|Overall Study|Not Treated|5|||
170716193|NCT00512135|616967316|FG000|Overall Study|Lack of Efficacy|2|||
170716194|NCT00512135|616967316|FG000|Overall Study|Adverse Event|6|||
170716195|NCT00512135|616967316|FG000|Overall Study|Withdrawal by Subject|22|||
170716196|NCT00512135|616967316|FG000|Overall Study|Lost to Follow-up|27|||
170716197|NCT00512135|616967316|FG000|Overall Study|Other|22|||
170716198|NCT00262834|616967317|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
170716199|NCT00262834|616967318|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
170716200|NCT03422250|616967319|FG000|Intervention|Adverse Event|0|||
170716201|NCT03422250|616967320|FG001|Intervention|Adverse Event|1|||
170716202|NCT03422250|616967321|FG002|Intervention|Adverse Event|0|||
170716203|NCT03422250|616967322|FG003|Intervention|Adverse Event|1|||
170716204|NCT03422250|616967319|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
170716205|NCT03422250|616967320|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
170716206|NCT03422250|616967321|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
170716207|NCT03422250|616967322|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
170716208|NCT03422250|616967319|FG000|Follow-up|Withdrawal by Subject|0|||
170716209|NCT03422250|616967320|FG001|Follow-up|Withdrawal by Subject|0|||
170716210|NCT03422250|616967321|FG002|Follow-up|Withdrawal by Subject|0|||
170716211|NCT03422250|616967322|FG003|Follow-up|Withdrawal by Subject|1|||
170716212|NCT03422250|616967319|FG000|Follow-up|Adverse Event|0|||
170716213|NCT03422250|616967320|FG001|Follow-up|Adverse Event|0|||
170716214|NCT03422250|616967321|FG002|Follow-up|Adverse Event|0|||
170716215|NCT03422250|616967322|FG003|Follow-up|Adverse Event|1|||
170716216|NCT00377819|616967323|FG000|Overall Study|Adverse Event|2|||
170716217|NCT00377819|616967324|FG001|Overall Study|Adverse Event|3|||
170716218|NCT00377819|616967323|FG000|Overall Study|Withdrawal by Subject|10|||
170716219|NCT00377819|616967324|FG001|Overall Study|Withdrawal by Subject|4|||
170716220|NCT00377819|616967323|FG000|Overall Study|Death|0|||
170716221|NCT00377819|616967324|FG001|Overall Study|Death|1|||
170716222|NCT00377819|616967323|FG000|Overall Study|Lost to Follow-up|0|||
170716223|NCT00377819|616967324|FG001|Overall Study|Lost to Follow-up|1|||
170716224|NCT00377819|616967323|FG000|Overall Study|Protocol Violation|1|||
170716225|NCT00377819|616967324|FG001|Overall Study|Protocol Violation|1|||
170716226|NCT00996996|616967325|FG000|Overall Study|Progressive Disease|10|||
170716227|NCT00996996|616967325|FG000|Overall Study|Non-compliance|8|||
170716228|NCT00996996|616967325|FG000|Overall Study|Lost to Follow-up|9|||
170716229|NCT00996996|616967325|FG000|Overall Study|Death|5|||
170716230|NCT00996996|616967325|FG000|Overall Study|Did Not Receive Study Medications|1|||
170716231|NCT01227889|616967326|FG000|Randomized Phase (RP)|Adverse Event|13|||
170716232|NCT01227889|616967327|FG001|Randomized Phase (RP)|Adverse Event|0|||
170716233|NCT01227889|616967326|FG000|Randomized Phase (RP)|Physician Decision|13|||
170716234|NCT01227889|616967327|FG001|Randomized Phase (RP)|Physician Decision|5|||
170716235|NCT01227889|616967326|FG000|Randomized Phase (RP)|Progressive Disease|135|||
170829386|NCT00511836|617385384|FG001|Double-blind Period|Lost to Follow-up|0|||
170829387|NCT00416598|617385385|FG000|Induction & Intensification|Adverse Event|38|||
170829388|NCT00416598|617385385|FG000|Induction & Intensification|Death|32|||
170829389|NCT00416598|617385385|FG000|Induction & Intensification|Withdrawal by Subject|46|||
170829390|NCT00416598|617385385|FG000|Induction & Intensification|Alternative Treatment|135|||
170829391|NCT00416598|617385385|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
170829392|NCT00416598|617385385|FG000|Induction & Intensification|Relapse/progression|29|||
170829393|NCT00416598|617385385|FG000|Induction & Intensification|Failed induction|87|||
170829394|NCT00416598|617385385|FG000|Decitabine Maintenance|Adverse Event|5|||
170829395|NCT00416598|617385385|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
170829396|NCT00416598|617385385|FG000|Decitabine Maintenance|Progression/relapse|38|||
170829397|NCT00416598|617385385|FG000|Decitabine Maintenance|Alternative treatment|2|||
170829398|NCT00416598|617385385|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
170829399|NCT00030823|617385388|FG000|Overall Study|Withdrawal by Subject|1|||
170829400|NCT01755546|617385390|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
170829401|NCT01755546|617385390|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
170829402|NCT01755546|617385390|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
170829403|NCT01755546|617385390|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
170829404|NCT01755546|617385390|FG000|Titration Phase|Adverse Event|11|||
170829405|NCT01755546|617385390|FG000|Titration Phase|Lack of Efficacy|18|||
170829406|NCT01755546|617385390|FG000|Titration Phase|Protocol Violation|9|||
170829407|NCT01755546|617385390|FG000|Titration Phase|Lost to Follow-up|2|||
170829408|NCT01755546|617385390|FG000|Titration Phase|Other and Continuing|22|||
170829409|NCT01755546|617385390|FG000|Titration Phase|Withdrawal by Subject|8|||
170829410|NCT01755546|617385390|FG000|Long Term Treatment|Adverse Event|12|||
170829411|NCT01755546|617385390|FG000|Long Term Treatment|Lack of Efficacy|6|||
170829412|NCT01755546|617385390|FG000|Long Term Treatment|Protocol Violation|10|||
170829413|NCT01755546|617385390|FG000|Long Term Treatment|Withdrawal by Subject|35|||
170829414|NCT01755546|617385390|FG000|Long Term Treatment|Lost to Follow-up|17|||
170829415|NCT01755546|617385390|FG000|Long Term Treatment|other and ongoing|41|||
170829416|NCT00891046|617385401|FG000|Overall Study|Protocol Violation|1|||
170829417|NCT00891046|617385402|FG001|Overall Study|Protocol Violation|1|||
170829418|NCT00891046|617385403|FG002|Overall Study|Protocol Violation|0|||
170829419|NCT00891046|617385404|FG003|Overall Study|Protocol Violation|0|||
170829420|NCT00891046|617385405|FG004|Overall Study|Protocol Violation|1|||
170829421|NCT00891046|617385401|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
170829422|NCT00891046|617385402|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170829423|NCT00891046|617385403|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
170829424|NCT00891046|617385404|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
170829425|NCT00891046|617385405|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
170829426|NCT00891046|617385401|FG000|Overall Study|Administrative problems|0|||
170829427|NCT00891046|617385402|FG001|Overall Study|Administrative problems|0|||
170829428|NCT00891046|617385403|FG002|Overall Study|Administrative problems|0|||
170829429|NCT00891046|617385404|FG003|Overall Study|Administrative problems|0|||
170829430|NCT00891046|617385405|FG004|Overall Study|Administrative problems|1|||
170829431|NCT00891046|617385401|FG000|Overall Study|Participant no longer required drug|0|||
170829432|NCT00891046|617385402|FG001|Overall Study|Participant no longer required drug|2|||
170829433|NCT00891046|617385403|FG002|Overall Study|Participant no longer required drug|0|||
170829434|NCT00891046|617385404|FG003|Overall Study|Participant no longer required drug|0|||
170829435|NCT00891046|617385405|FG004|Overall Study|Participant no longer required drug|1|||
170829436|NCT00891046|617385401|FG000|Overall Study|Adverse Event|4|||
170829437|NCT00891046|617385402|FG001|Overall Study|Adverse Event|3|||
170829438|NCT00891046|617385403|FG002|Overall Study|Adverse Event|2|||
170829439|NCT00891046|617385404|FG003|Overall Study|Adverse Event|0|||
170829440|NCT00891046|617385405|FG004|Overall Study|Adverse Event|14|||
170829441|NCT00891046|617385401|FG000|Overall Study|Withdrawal by Subject|2|||
170829442|NCT00891046|617385402|FG001|Overall Study|Withdrawal by Subject|1|||
170829443|NCT00891046|617385403|FG002|Overall Study|Withdrawal by Subject|2|||
170829444|NCT00891046|617385404|FG003|Overall Study|Withdrawal by Subject|1|||
170829445|NCT00891046|617385405|FG004|Overall Study|Withdrawal by Subject|1|||
170829446|NCT00891046|617385401|FG000|Overall Study|Lost to Follow-up|0|||
170829447|NCT00891046|617385402|FG001|Overall Study|Lost to Follow-up|0|||
170829448|NCT00891046|617385403|FG002|Overall Study|Lost to Follow-up|0|||
170829449|NCT00891046|617385404|FG003|Overall Study|Lost to Follow-up|0|||
170829450|NCT00891046|617385405|FG004|Overall Study|Lost to Follow-up|1|||
170829451|NCT02106195|617385406|FG000|Overall Study|Adverse Event|2|||
170829452|NCT02106195|617385406|FG000|Overall Study|Protocol Violation|1|||
170829453|NCT04367480|617385407|FG000|Overall Study|Adverse Event|1|||
170829454|NCT04367480|617385408|FG001|Overall Study|Adverse Event|1|||
170716236|NCT01227889|616967327|FG001|Randomized Phase (RP)|Progressive Disease|52|||
170716237|NCT01227889|616967326|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
170716238|NCT01227889|616967327|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
170716239|NCT01227889|616967326|FG000|Randomized Phase (RP)|Missing|1|||
170716240|NCT01227889|616967327|FG001|Randomized Phase (RP)|Missing|3|||
170716241|NCT01227889|616967326|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
170716242|NCT01227889|616967327|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
170716243|NCT01227889|616967326|FG000|Crossover Phase|Adverse Event|0|||
170716244|NCT01227889|616967327|FG001|Crossover Phase|Adverse Event|1|||
170716245|NCT01227889|616967326|FG000|Crossover Phase|Physician Decision|0|||
170716246|NCT01227889|616967327|FG001|Crossover Phase|Physician Decision|3|||
170716247|NCT01227889|616967326|FG000|Crossover Phase|Progressive Disease|0|||
170716248|NCT01227889|616967327|FG001|Crossover Phase|Progressive Disease|31|||
170716249|NCT01227889|616967326|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
170716250|NCT01227889|616967327|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
170716251|NCT01227889|616967326|FG000|Crossover Phase|Withdrawal by Subject|0|||
170716252|NCT01227889|616967327|FG001|Crossover Phase|Withdrawal by Subject|1|||
170716253|NCT04535037|616967330|FG000|Overall Study|Protocol Violation|1|||
170716254|NCT04535037|616967331|FG001|Overall Study|Protocol Violation|0|||
170716255|NCT04535037|616967330|FG000|Overall Study|Withdrawal by Subject|8|||
170716256|NCT04535037|616967331|FG001|Overall Study|Withdrawal by Subject|9|||
170716257|NCT04535037|616967330|FG000|Overall Study|Migrated / moved from the study area|1|||
170716258|NCT04535037|616967331|FG001|Overall Study|Migrated / moved from the study area|4|||
170716259|NCT04535037|616967330|FG000|Overall Study|Other|2|||
170716260|NCT04535037|616967331|FG001|Overall Study|Other|5|||
170716261|NCT02031276|616967332|FG000|Period 1 Double-blind IV|Adverse Event|6|||
170716262|NCT02031276|616967333|FG001|Period 1 Double-blind IV|Adverse Event|5|||
170716263|NCT02031276|616967334|FG002|Period 1 Double-blind IV|Adverse Event|1|||
170716264|NCT02031276|616967332|FG000|Period 1 Double-blind IV|Other|0|||
170716265|NCT02031276|616967333|FG001|Period 1 Double-blind IV|Other|1|||
170716266|NCT02031276|616967334|FG002|Period 1 Double-blind IV|Other|0|||
170716267|NCT02031276|616967332|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
170716268|NCT02031276|616967333|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
170716269|NCT02031276|616967334|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
170716270|NCT02031276|616967332|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
170716271|NCT02031276|616967333|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
170716272|NCT02031276|616967334|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
170716273|NCT02031276|616967332|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
170716274|NCT02031276|616967333|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
170716275|NCT02031276|616967334|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
170716276|NCT02031276|616967332|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
170716277|NCT02031276|616967333|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
170716278|NCT02031276|616967334|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
170716279|NCT02031276|616967332|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
170716280|NCT02031276|616967333|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
170716281|NCT02031276|616967334|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
170716282|NCT02031276|616967332|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
170716283|NCT02031276|616967333|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
170716284|NCT02031276|616967334|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
170716285|NCT02031276|616967332|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
170716286|NCT02031276|616967333|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
170716287|NCT02031276|616967334|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
170716288|NCT02731131|616967337|FG000|Overall Study|Psychiatric Disorder|0|||
170716289|NCT02731131|616967338|FG001|Overall Study|Psychiatric Disorder|1|||
170716290|NCT02731131|616967337|FG000|Overall Study|Refused Therapy|0|||
170716291|NCT02731131|616967338|FG001|Overall Study|Refused Therapy|1|||
170716292|NCT01055639|616967339|FG000|Overall Study|Adverse Event|0|||
170716293|NCT01055639|616967340|FG001|Overall Study|Adverse Event|1|||
170716294|NCT01055639|616967339|FG000|Overall Study|Lack of Efficacy|0|||
170716295|NCT01055639|616967340|FG001|Overall Study|Lack of Efficacy|1|||
170716296|NCT01055639|616967339|FG000|Overall Study|Lost to Follow-up|8|||
170716297|NCT01055639|616967340|FG001|Overall Study|Lost to Follow-up|11|||
170716298|NCT01055639|616967339|FG000|Overall Study|Protocol Violation|5|||
170716299|NCT01055639|616967340|FG001|Overall Study|Protocol Violation|5|||
170716300|NCT01055639|616967339|FG000|Overall Study|Withdrawal by Subject|8|||
170716301|NCT01055639|616967340|FG001|Overall Study|Withdrawal by Subject|11|||
170716302|NCT00765245|616967341|FG000|Overall Study|disease progression|3|||
170716303|NCT00765245|616967342|FG001|Overall Study|disease progression|2|||
170716304|NCT00765245|616967341|FG000|Overall Study|Withdrawal by Subject|3|||
170716305|NCT00765245|616967342|FG001|Overall Study|Withdrawal by Subject|0|||
170716306|NCT00765245|616967341|FG000|Overall Study|Adverse Event|5|||
170716307|NCT00765245|616967342|FG001|Overall Study|Adverse Event|0|||
170716308|NCT00765245|616967341|FG000|Overall Study|Physician Decision|1|||
170716309|NCT00765245|616967342|FG001|Overall Study|Physician Decision|0|||
170716310|NCT00765245|616967341|FG000|Overall Study|Death|1|||
170716311|NCT00765245|616967342|FG001|Overall Study|Death|0|||
170829455|NCT04367480|617385407|FG000|Overall Study|Death|1|||
170829456|NCT04367480|617385408|FG001|Overall Study|Death|0|||
170716312|NCT03669081|616967347|FG000|Overall Study|Data could not be validated|1|||
170716313|NCT03669081|616967348|FG001|Overall Study|Data could not be validated|1|||
170716314|NCT01308749|616967349|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
170716315|NCT01308749|616967350|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
170716316|NCT01308749|616967349|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
170716317|NCT01308749|616967350|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
170716318|NCT01308749|616967349|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
170716319|NCT01308749|616967350|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
170829457|NCT04367480|617385407|FG000|Overall Study|Lost to Follow-up|1|||
170829458|NCT04367480|617385408|FG001|Overall Study|Lost to Follow-up|1|||
170829459|NCT04367480|617385407|FG000|Overall Study|Withdrawal by Subject|0|||
170829460|NCT04367480|617385408|FG001|Overall Study|Withdrawal by Subject|3|||
170829461|NCT04367480|617385407|FG000|Overall Study|App glitch during the study|1|||
170829462|NCT04367480|617385408|FG001|Overall Study|App glitch during the study|0|||
170829463|NCT04367480|617385407|FG000|Overall Study|Device Distribution Error|0|||
170829464|NCT04367480|617385408|FG001|Overall Study|Device Distribution Error|2|||
170829465|NCT04367480|617385407|FG000|Overall Study|Ineligible after Randomization|0|||
170829466|NCT04367480|617385408|FG001|Overall Study|Ineligible after Randomization|1|||
170829467|NCT04367480|617385407|FG000|Overall Study|Other Medical Reasons|0|||
170829468|NCT04367480|617385408|FG001|Overall Study|Other Medical Reasons|2|||
170829469|NCT01131104|617385409|FG000|Overall Study|Withdrawal by Subject|3|||
170829470|NCT01131104|617385409|FG000|Overall Study|Physician Decision|4|||
170829471|NCT01131104|617385409|FG000|Overall Study|Information Not Available|5|||
170829472|NCT01131104|617385409|FG000|Overall Study|No Information on Index Date of Onset|1|||
170829473|NCT04702893|617385412|FG000|Overall Study|Other reasons than listed|11|||
170829474|NCT04702893|617385412|FG000|Overall Study|Withdrawal by Subject|3|||
170829475|NCT04702893|617385412|FG000|Overall Study|Lost to Follow-up|7|||
170829476|NCT04702893|617385412|FG000|Overall Study|Death|10|||
170829477|NCT04702893|617385412|FG000|Overall Study|Not treated|6|||
170829478|NCT04606199|617385413|FG000|Overall Study|Withdrawal by Subject|2|||
170829479|NCT00408928|617385414|FG000|Overall Study|Withdrawal by Subject|1|||
170829480|NCT00408928|617385414|FG000|Overall Study|Death|1|||
170829481|NCT00408928|617385414|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
170829482|NCT01114139|617385416|FG000|Overall Study|Adverse Event|3|||
170829483|NCT01114139|617385417|FG001|Overall Study|Adverse Event|2|||
170716320|NCT02546544|616967351|FG000|Overall Study|Disease Progression|14|||
170716321|NCT02546544|616967351|FG000|Overall Study|Adverse Event|1|||
170716322|NCT02546544|616967351|FG000|Overall Study|Withdrawal by Subject|1|||
170829484|NCT01114139|617385416|FG000|Overall Study|Lost to Follow-up|15|||
170829485|NCT01114139|617385417|FG001|Overall Study|Lost to Follow-up|3|||
170829486|NCT01114139|617385416|FG000|Overall Study|Withdrawal by Subject|17|||
170829487|NCT01114139|617385417|FG001|Overall Study|Withdrawal by Subject|6|||
170829488|NCT01114139|617385416|FG000|Overall Study|Other-Missed 1 visit|1|||
170829489|NCT01114139|617385417|FG001|Overall Study|Other-Missed 1 visit|0|||
170829490|NCT01114139|617385416|FG000|Overall Study|Other-Protocol Violation|1|||
170716323|NCT02828111|616967352|FG000|Overall Study|Withdrawal by Subject|0|||
170716324|NCT02828111|616967353|FG001|Overall Study|Withdrawal by Subject|0|||
170716325|NCT02828111|616967354|FG002|Overall Study|Withdrawal by Subject|2|||
170716326|NCT02828111|616967355|FG003|Overall Study|Withdrawal by Subject|0|||
170716327|NCT02828111|616967356|FG004|Overall Study|Withdrawal by Subject|0|||
170716328|NCT02828111|616967352|FG000|Overall Study|Lost to Follow-up|0|||
170716329|NCT02828111|616967353|FG001|Overall Study|Lost to Follow-up|0|||
170716330|NCT02828111|616967354|FG002|Overall Study|Lost to Follow-up|0|||
170716331|NCT02828111|616967355|FG003|Overall Study|Lost to Follow-up|1|||
170716332|NCT02828111|616967356|FG004|Overall Study|Lost to Follow-up|1|||
170716333|NCT03465540|616967357|FG000|Overall Study|Withdrawal by Subject|0|||
170716334|NCT03465540|616967358|FG001|Overall Study|Withdrawal by Subject|0|||
170716335|NCT03465540|616967359|FG002|Overall Study|Withdrawal by Subject|1|||
170716336|NCT03465540|616967360|FG003|Overall Study|Withdrawal by Subject|1|||
170716337|NCT03465540|616967361|FG004|Overall Study|Withdrawal by Subject|1|||
170716338|NCT03465540|616967362|FG005|Overall Study|Withdrawal by Subject|0|||
170716339|NCT03465540|616967357|FG000|Overall Study|Lost to Follow-up|0|||
170716340|NCT03465540|616967358|FG001|Overall Study|Lost to Follow-up|1|||
170716341|NCT03465540|616967359|FG002|Overall Study|Lost to Follow-up|0|||
170716342|NCT03465540|616967360|FG003|Overall Study|Lost to Follow-up|0|||
170716343|NCT03465540|616967361|FG004|Overall Study|Lost to Follow-up|1|||
170716344|NCT03465540|616967362|FG005|Overall Study|Lost to Follow-up|0|||
170716345|NCT03465540|616967357|FG000|Overall Study|Death|1|||
170716346|NCT03465540|616967358|FG001|Overall Study|Death|1|||
170716347|NCT03465540|616967359|FG002|Overall Study|Death|0|||
170716348|NCT03465540|616967360|FG003|Overall Study|Death|2|||
170716349|NCT03465540|616967361|FG004|Overall Study|Death|0|||
170716350|NCT03465540|616967362|FG005|Overall Study|Death|2|||
170716351|NCT03465540|616967357|FG000|Overall Study|Protocol specified criteria|0|||
170716352|NCT03465540|616967358|FG001|Overall Study|Protocol specified criteria|2|||
170716353|NCT03465540|616967359|FG002|Overall Study|Protocol specified criteria|2|||
170716354|NCT03465540|616967360|FG003|Overall Study|Protocol specified criteria|0|||
170716355|NCT03465540|616967361|FG004|Overall Study|Protocol specified criteria|2|||
170716356|NCT03465540|616967362|FG005|Overall Study|Protocol specified criteria|0|||
170716357|NCT00462384|616967363|FG000|Overall Study|Adverse Event|2|||
170716358|NCT00462384|616967363|FG000|Overall Study|Death|2|||
170716359|NCT00462384|616967363|FG000|Overall Study|Withdrawal by Subject|1|||
170716360|NCT00462384|616967363|FG000|Overall Study|Other|4|||
170716361|NCT00346034|616967364|FG000|Overall Study|Adverse Event|34|||
170716362|NCT00346034|616967364|FG000|Overall Study|Lack of Efficacy|8|||
170716363|NCT00346034|616967364|FG000|Overall Study|Withdrawal by Subject|13|||
170716364|NCT00346034|616967364|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
170716365|NCT00346034|616967364|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
170716366|NCT01753193|616967365|FG000|Overall Study|Withdrawal by Subject|23|||
170716367|NCT01753193|616967365|FG000|Overall Study|Lost to Follow-up|6|||
170716368|NCT01753193|616967365|FG000|Overall Study|Death|1|||
170716369|NCT01753193|616967365|FG000|Overall Study|Other|16|||
170716370|NCT00383435|616967366|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
170716371|NCT00383435|616967367|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
170716372|NCT00383435|616967368|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
170716373|NCT00383435|616967369|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
170716374|NCT00383435|616967370|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
170716375|NCT00383435|616967366|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
170716376|NCT00383435|616967367|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
170716377|NCT00383435|616967368|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
170716378|NCT00383435|616967369|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
170716379|NCT00383435|616967370|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
170716380|NCT00383435|616967366|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
170716381|NCT00383435|616967367|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
170716382|NCT00383435|616967368|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
170716383|NCT00383435|616967369|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
170716384|NCT00383435|616967370|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
170716385|NCT00383435|616967366|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
170716386|NCT00383435|616967367|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
170829491|NCT01114139|617385417|FG001|Overall Study|Other-Protocol Violation|0|||
170716387|NCT00383435|616967368|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
170716388|NCT00383435|616967369|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
170716389|NCT00383435|616967370|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
170829492|NCT01114139|617385416|FG000|Overall Study|Other-Out of window for study drug dose|1|||
170829493|NCT01114139|617385417|FG001|Overall Study|Other-Out of window for study drug dose|0|||
170829494|NCT01114139|617385416|FG000|Overall Study|Other-Participant falsified records|0|||
170829495|NCT01114139|617385417|FG001|Overall Study|Other-Participant falsified records|1|||
170716390|NCT00383435|616967366|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
170716391|NCT00383435|616967367|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
170716392|NCT00383435|616967368|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
170716393|NCT00383435|616967369|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
170716394|NCT00383435|616967370|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
170716395|NCT00383435|616967366|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
170716396|NCT00383435|616967367|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
170716397|NCT00383435|616967368|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
170716398|NCT00383435|616967369|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
170716399|NCT00383435|616967370|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
170716400|NCT00383435|616967366|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
170716401|NCT00383435|616967367|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
170716402|NCT00383435|616967368|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
170716403|NCT00383435|616967369|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
170716404|NCT00383435|616967370|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
170716405|NCT00383435|616967366|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
170716406|NCT00383435|616967367|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
170716407|NCT00383435|616967368|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
170716408|NCT00383435|616967369|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
170716409|NCT00383435|616967370|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
170716410|NCT00383435|616967366|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
170716411|NCT00383435|616967367|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
170716412|NCT00383435|616967368|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
170716413|NCT00383435|616967369|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
170716414|NCT00383435|616967370|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
170716415|NCT00383435|616967366|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
170716416|NCT00383435|616967367|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
170716417|NCT00383435|616967368|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
170716418|NCT00383435|616967369|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
170716419|NCT00383435|616967370|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
170716420|NCT00383435|616967366|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
170716421|NCT00383435|616967367|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
170716422|NCT00383435|616967368|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
170716423|NCT00383435|616967369|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
170716424|NCT00383435|616967370|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
170716425|NCT00383435|616967366|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
170716426|NCT00383435|616967367|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
170829496|NCT01114139|617385416|FG000|Overall Study|Other-Participant went on hospice|0|||
170829497|NCT01114139|617385417|FG001|Overall Study|Other-Participant went on hospice|1|||
170829498|NCT01114139|617385416|FG000|Overall Study|Other-Physician changed treatment|1|||
170829499|NCT01114139|617385417|FG001|Overall Study|Other-Physician changed treatment|0|||
170829500|NCT01114139|617385416|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
170829501|NCT01114139|617385417|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
170829502|NCT01951378|617385418|FG000|Overall Study|Study Terminated-Not completed|23|||
170829503|NCT01951378|617385419|FG001|Overall Study|Study Terminated-Not completed|17|||
170829504|NCT04120376|617385420|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
170829505|NCT04120376|617385421|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
170829506|NCT01150045|617385422|FG000|Overall Study|Protocol Violation|0|||
170829507|NCT01150045|617385423|FG001|Overall Study|Protocol Violation|1|||
170829508|NCT01150045|617385424|FG002|Overall Study|Protocol Violation|0|||
170829509|NCT01150045|617385425|FG003|Overall Study|Protocol Violation|1|||
170829510|NCT01519778|617385427|FG000|Overall Study|Withdrawal by Subject|3|||
170829511|NCT01519778|617385427|FG000|Overall Study|Lost to Follow-up|10|||
170829512|NCT01519778|617385427|FG000|Overall Study|Physician Decision|1|||
170829513|NCT00704171|617385430|FG000|Overall Study|Withdrawal by Subject|1|||
170829514|NCT00704171|617385431|FG001|Overall Study|Withdrawal by Subject|0|||
170829515|NCT03974100|617385435|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
170829516|NCT03974100|617385436|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
170829517|NCT03974100|617385437|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
170829518|NCT03974100|617385438|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
170829519|NCT03974100|617385439|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
170829520|NCT03974100|617385435|FG000|TP1 - Day 1 to Week 52|Death|1|||
170829521|NCT03974100|617385436|FG001|TP1 - Day 1 to Week 52|Death|0|||
170829522|NCT03974100|617385437|FG002|TP1 - Day 1 to Week 52|Death|0|||
170829523|NCT03974100|617385438|FG003|TP1 - Day 1 to Week 52|Death|0|||
170829524|NCT03974100|617385439|FG004|TP1 - Day 1 to Week 52|Death|0|||
170829525|NCT03974100|617385435|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
170829526|NCT03974100|617385436|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
170829527|NCT03974100|617385437|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
170829528|NCT03974100|617385438|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
170829529|NCT03974100|617385439|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
170829530|NCT03974100|617385435|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
170829531|NCT03974100|617385436|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
170829532|NCT03974100|617385437|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
170829533|NCT03974100|617385438|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
170829534|NCT03974100|617385439|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
170829535|NCT03974100|617385435|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
170829536|NCT03974100|617385436|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
170829537|NCT03974100|617385437|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
170829538|NCT03974100|617385438|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
170716427|NCT00383435|616967368|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
170716428|NCT00383435|616967369|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
170716429|NCT00383435|616967370|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
170716430|NCT00383435|616967366|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
170716431|NCT00383435|616967367|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
170716432|NCT00383435|616967368|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
170716433|NCT00383435|616967369|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
170716434|NCT00383435|616967370|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
170716435|NCT00383435|616967366|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
170716436|NCT00383435|616967367|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
170716437|NCT00383435|616967368|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
170716438|NCT00383435|616967369|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
170716439|NCT00383435|616967370|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
170716440|NCT00383435|616967366|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
170716441|NCT00383435|616967367|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
170716442|NCT00383435|616967368|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
170716443|NCT00383435|616967369|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
170716444|NCT00383435|616967370|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
170716445|NCT00383435|616967366|FG000|26-Week Treatment Safety Extension|Administrative|1|||
170716446|NCT00383435|616967367|FG001|26-Week Treatment Safety Extension|Administrative|1|||
170716447|NCT00383435|616967368|FG002|26-Week Treatment Safety Extension|Administrative|0|||
170716448|NCT00383435|616967369|FG003|26-Week Treatment Safety Extension|Administrative|1|||
170716449|NCT00383435|616967370|FG004|26-Week Treatment Safety Extension|Administrative|0|||
170716450|NCT00583557|616967371|FG000|Overall Study|Withdrawal by Subject|18|||
170716451|NCT00583557|616967371|FG000|Overall Study|Adverse Event|9|||
170716452|NCT00583557|616967371|FG000|Overall Study|Lack of Efficacy|31|||
170716453|NCT00583557|616967371|FG000|Overall Study|Lack of Compliance|5|||
170716454|NCT00583557|616967371|FG000|Overall Study|Other|5|||
170716455|NCT00583557|616967371|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
170716456|NCT02682264|616967372|FG000|Overall Study|Withdrawal by Subject|56|||
170716457|NCT02682264|616967373|FG001|Overall Study|Withdrawal by Subject|45|||
170716458|NCT02682264|616967372|FG000|Overall Study|Lost to Follow-up|49|||
170716459|NCT02682264|616967373|FG001|Overall Study|Lost to Follow-up|41|||
170716460|NCT02682264|616967372|FG000|Overall Study|Lack of Efficacy|14|||
170716461|NCT02682264|616967373|FG001|Overall Study|Lack of Efficacy|16|||
170716462|NCT02682264|616967372|FG000|Overall Study|Withdrawal by Parent|6|||
170716463|NCT02682264|616967373|FG001|Overall Study|Withdrawal by Parent|7|||
170716464|NCT02682264|616967372|FG000|Overall Study|Adverse Event|9|||
170716465|NCT02682264|616967373|FG001|Overall Study|Adverse Event|0|||
170716466|NCT02682264|616967372|FG000|Overall Study|Noncompliance with study drug|1|||
170829539|NCT03974100|617385439|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
170829540|NCT03974100|617385435|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
170829541|NCT03974100|617385436|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
170716467|NCT02682264|616967373|FG001|Overall Study|Noncompliance with study drug|4|||
170716468|NCT02682264|616967372|FG000|Overall Study|Pregnancy|1|||
170716469|NCT02682264|616967373|FG001|Overall Study|Pregnancy|2|||
170716470|NCT02682264|616967372|FG000|Overall Study|Recovery|1|||
170716471|NCT02682264|616967373|FG001|Overall Study|Recovery|2|||
170716472|NCT02682264|616967372|FG000|Overall Study|Progressive Disease|1|||
170829542|NCT03974100|617385437|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
170829543|NCT03974100|617385438|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
170829544|NCT03974100|617385439|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
170829545|NCT03974100|617385435|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
170716473|NCT02682264|616967373|FG001|Overall Study|Progressive Disease|0|||
170716474|NCT02682264|616967372|FG000|Overall Study|Technical Problems|0|||
170716475|NCT02682264|616967373|FG001|Overall Study|Technical Problems|1|||
170716476|NCT02682264|616967372|FG000|Overall Study|Moved abroad and unable to continue|0|||
170716477|NCT02682264|616967373|FG001|Overall Study|Moved abroad and unable to continue|3|||
170716478|NCT02682264|616967372|FG000|Overall Study|Stopped test article application|0|||
170716479|NCT02682264|616967373|FG001|Overall Study|Stopped test article application|1|||
170716480|NCT01131312|616967374|FG000|Overall Study|Lost to Follow-up|425|||
170716481|NCT01131312|616967375|FG001|Overall Study|Lost to Follow-up|229|||
170716482|NCT01131312|616967376|FG002|Overall Study|Lost to Follow-up|351|||
170716483|NCT02347761|616967377|FG000|All Collected|Death|1|||
170716484|NCT02347761|616967378|FG001|All Collected|Death|0|||
170716485|NCT02347761|616967379|FG002|All Collected|Death|0|||
170716486|NCT02347761|616967377|FG000|All Collected|Lost to Follow-up|3|||
170716487|NCT02347761|616967378|FG001|All Collected|Lost to Follow-up|2|||
170716488|NCT02347761|616967379|FG002|All Collected|Lost to Follow-up|3|||
170716489|NCT02347761|616967377|FG000|All Collected|Withdrawal by Subject|11|||
170716490|NCT02347761|616967378|FG001|All Collected|Withdrawal by Subject|11|||
170716491|NCT02347761|616967379|FG002|All Collected|Withdrawal by Subject|22|||
170716492|NCT02347761|616967377|FG000|All Collected|invetigator disretion|2|||
170716493|NCT02347761|616967378|FG001|All Collected|invetigator disretion|0|||
170716494|NCT02347761|616967379|FG002|All Collected|invetigator disretion|0|||
170716495|NCT02347761|616967377|FG000|All Collected|instillation site pain|0|||
170716496|NCT02347761|616967378|FG001|All Collected|instillation site pain|0|||
170716497|NCT02347761|616967379|FG002|All Collected|instillation site pain|1|||
170716498|NCT02347761|616967377|FG000|All Collected|exacerbation of COPD|0|||
170716499|NCT02347761|616967378|FG001|All Collected|exacerbation of COPD|0|||
170716500|NCT02347761|616967379|FG002|All Collected|exacerbation of COPD|1|||
170716501|NCT02347761|616967377|FG000|All Collected|moved/travel|0|||
170716502|NCT02347761|616967378|FG001|All Collected|moved/travel|1|||
170716503|NCT02347761|616967379|FG002|All Collected|moved/travel|0|||
170716504|NCT02347761|616967377|FG000|On Study Treatment|Lack of Efficacy|2|||
170716505|NCT02347761|616967378|FG001|On Study Treatment|Lack of Efficacy|3|||
170716506|NCT02347761|616967379|FG002|On Study Treatment|Lack of Efficacy|4|||
170716507|NCT02347761|616967377|FG000|On Study Treatment|non-compliance with study medication|0|||
170716508|NCT02347761|616967378|FG001|On Study Treatment|non-compliance with study medication|0|||
170716509|NCT02347761|616967379|FG002|On Study Treatment|non-compliance with study medication|2|||
170716510|NCT02347761|616967377|FG000|On Study Treatment|Withdrawal by Subject|7|||
170829546|NCT03974100|617385436|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
170829547|NCT03974100|617385437|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
170716511|NCT02347761|616967378|FG001|On Study Treatment|Withdrawal by Subject|3|||
170716512|NCT02347761|616967379|FG002|On Study Treatment|Withdrawal by Subject|5|||
170716513|NCT02347761|616967377|FG000|On Study Treatment|move/travel|2|||
170716514|NCT02347761|616967378|FG001|On Study Treatment|move/travel|6|||
170716515|NCT02347761|616967379|FG002|On Study Treatment|move/travel|5|||
170716516|NCT02347761|616967377|FG000|On Study Treatment|dissastisfaction with device|2|||
170716517|NCT02347761|616967378|FG001|On Study Treatment|dissastisfaction with device|1|||
170716518|NCT02347761|616967379|FG002|On Study Treatment|dissastisfaction with device|4|||
170716519|NCT02347761|616967377|FG000|On Study Treatment|Lost to Follow-up|2|||
170716520|NCT02347761|616967378|FG001|On Study Treatment|Lost to Follow-up|1|||
170829548|NCT03974100|617385438|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
170829549|NCT03974100|617385439|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
170829550|NCT00263575|617385442|FG000|Titration Period|Adverse Event|14|||
170829551|NCT00263575|617385442|FG000|Titration Period|Withdrawal by Subject|10|||
170829552|NCT00263575|617385442|FG000|Titration Period|Protocol Violation|9|||
170829553|NCT00263575|617385442|FG000|Titration Period|Sponsor Decision|2|||
170829554|NCT00263575|617385442|FG000|Titration Period|Other|2|||
170829555|NCT00263575|617385442|FG000|Titration Period|Lack of Efficacy|6|||
170829556|NCT00263575|617385442|FG000|Maintence Period|Adverse Event|23|||
170829557|NCT00263575|617385442|FG000|Maintence Period|Withdrawal by Subject|8|||
170829558|NCT00263575|617385442|FG000|Maintence Period|Protocol Violation|4|||
170829559|NCT00263575|617385442|FG000|Maintence Period|Lack of Efficacy|4|||
170829560|NCT00263575|617385442|FG000|Maintence Period|Physician Decision|6|||
170829561|NCT00263575|617385442|FG000|Maintence Period|Lost to Follow-up|1|||
170829562|NCT00263575|617385442|FG000|Maintence Period|Sponsor Decision|24|||
170829563|NCT00263575|617385442|FG000|Maintence Period|Other|7|||
170829564|NCT03188536|617385449|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
170829565|NCT03188536|617385449|FG000|Overall Study|Not participated/met inclusion criteria|1|||
170829566|NCT02719743|617385450|FG000|Overall Study|Consent withdrawal|0|||
170829567|NCT02719743|617385451|FG001|Overall Study|Consent withdrawal|2|||
170829568|NCT02719743|617385452|FG002|Overall Study|Consent withdrawal|0|||
170829569|NCT02719743|617385453|FG003|Overall Study|Consent withdrawal|1|||
170716521|NCT02347761|616967379|FG002|On Study Treatment|Lost to Follow-up|1|||
170716522|NCT02347761|616967377|FG000|On Study Treatment|investigator discretion|2|||
170716523|NCT02347761|616967378|FG001|On Study Treatment|investigator discretion|0|||
170716524|NCT02347761|616967379|FG002|On Study Treatment|investigator discretion|0|||
170716525|NCT02347761|616967377|FG000|On Study Treatment|durg not working|0|||
170716526|NCT02347761|616967378|FG001|On Study Treatment|durg not working|1|||
170716527|NCT02347761|616967379|FG002|On Study Treatment|durg not working|1|||
170716528|NCT02347761|616967377|FG000|On Study Treatment|Adverse Event|10|||
170716529|NCT02347761|616967378|FG001|On Study Treatment|Adverse Event|8|||
170716530|NCT02347761|616967379|FG002|On Study Treatment|Adverse Event|20|||
170716531|NCT01047683|616967380|FG000|Overall Study|Adverse Event|3|||
170716532|NCT01047683|616967381|FG001|Overall Study|Adverse Event|1|||
170716533|NCT01047683|616967382|FG002|Overall Study|Adverse Event|0|||
170716534|NCT01047683|616967380|FG000|Overall Study|Withdrew Consent|1|||
170716535|NCT01047683|616967381|FG001|Overall Study|Withdrew Consent|4|||
170716536|NCT01047683|616967382|FG002|Overall Study|Withdrew Consent|2|||
170716537|NCT01047683|616967380|FG000|Overall Study|Lost to Follow-up|0|||
170716538|NCT01047683|616967381|FG001|Overall Study|Lost to Follow-up|1|||
170716539|NCT01047683|616967382|FG002|Overall Study|Lost to Follow-up|0|||
170716540|NCT01047683|616967380|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
170716541|NCT01047683|616967381|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
170716542|NCT01047683|616967382|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
170716543|NCT01751568|616967387|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
170716544|NCT01751568|616967388|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
170716545|NCT01751568|616967389|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
170716546|NCT03586999|616967399|FG000|Overall Study|Lack of Efficacy|2|||
170716547|NCT04096560|616967400|FG000|Overall Study|Reason not Specified|1|||
170716548|NCT04096560|616967401|FG001|Overall Study|Reason not Specified|0|||
170716549|NCT04096560|616967402|FG002|Overall Study|Reason not Specified|0|||
170716550|NCT04096560|616967403|FG003|Overall Study|Reason not Specified|0|||
170716551|NCT04096560|616967404|FG004|Overall Study|Reason not Specified|1|||
170716552|NCT04096560|616967405|FG005|Overall Study|Reason not Specified|1|||
170716553|NCT04096560|616967406|FG006|Overall Study|Reason not Specified|1|||
170716554|NCT04096560|616967407|FG007|Overall Study|Reason not Specified|0|||
170716555|NCT04096560|616967400|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
170716556|NCT04096560|616967401|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
170716557|NCT04096560|616967402|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
170716558|NCT04096560|616967403|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
170716559|NCT04096560|616967404|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
170716560|NCT04096560|616967405|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
170716561|NCT04096560|616967406|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
170716562|NCT04096560|616967407|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
170716563|NCT04096560|616967400|FG000|Overall Study|Study Terminated by Sponsor|0|||
170716564|NCT04096560|616967401|FG001|Overall Study|Study Terminated by Sponsor|0|||
170716565|NCT04096560|616967402|FG002|Overall Study|Study Terminated by Sponsor|0|||
170716566|NCT04096560|616967403|FG003|Overall Study|Study Terminated by Sponsor|5|||
170716567|NCT04096560|616967404|FG004|Overall Study|Study Terminated by Sponsor|6|||
170716568|NCT04096560|616967405|FG005|Overall Study|Study Terminated by Sponsor|4|||
170716569|NCT04096560|616967406|FG006|Overall Study|Study Terminated by Sponsor|6|||
170716570|NCT04096560|616967407|FG007|Overall Study|Study Terminated by Sponsor|1|||
170716571|NCT04096560|616967400|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
170716572|NCT04096560|616967401|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
170716573|NCT04096560|616967402|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
170716574|NCT04096560|616967403|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
170716575|NCT04096560|616967404|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
170716576|NCT04096560|616967405|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
170829570|NCT02719743|617385454|FG004|Overall Study|Consent withdrawal|0|||
170716577|NCT04096560|616967406|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
170716578|NCT04096560|616967407|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
170716579|NCT01255358|616967408|FG000|Overall Study|Adverse Event|2|||
170716580|NCT01255358|616967408|FG000|Overall Study|Protocol Violation|2|||
170716581|NCT00534352|616967409|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
170716582|NCT00534352|616967409|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
170716583|NCT00534352|616967409|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
170716584|NCT00534352|616967409|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
170716585|NCT00534352|616967409|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
170829571|NCT02719743|617385450|FG000|Overall Study|Migrated/moved from study area|0|||
170829572|NCT02719743|617385451|FG001|Overall Study|Migrated/moved from study area|0|||
170829573|NCT02719743|617385452|FG002|Overall Study|Migrated/moved from study area|0|||
170829574|NCT02719743|617385453|FG003|Overall Study|Migrated/moved from study area|0|||
170829575|NCT02719743|617385454|FG004|Overall Study|Migrated/moved from study area|2|||
170829576|NCT02719743|617385450|FG000|Overall Study|Lost to Follow-up|1|||
170829577|NCT02719743|617385451|FG001|Overall Study|Lost to Follow-up|1|||
170829578|NCT02719743|617385452|FG002|Overall Study|Lost to Follow-up|0|||
170829579|NCT02719743|617385453|FG003|Overall Study|Lost to Follow-up|0|||
170829580|NCT02719743|617385454|FG004|Overall Study|Lost to Follow-up|0|||
170829581|NCT01930214|617385455|FG000|Overall Study|Death|4|||
170829582|NCT01930214|617385456|FG001|Overall Study|Death|4|||
170829583|NCT01930214|617385457|FG002|Overall Study|Death|11|||
170829584|NCT01930214|617385455|FG000|Overall Study|Lost to Follow-up|12|||
170829585|NCT01930214|617385456|FG001|Overall Study|Lost to Follow-up|13|||
170829586|NCT01930214|617385457|FG002|Overall Study|Lost to Follow-up|12|||
170829587|NCT01930214|617385455|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
170829588|NCT01930214|617385456|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
170829589|NCT01930214|617385457|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
170829590|NCT01930214|617385455|FG000|Overall Study|Physician Decision|2|||
170829591|NCT01930214|617385456|FG001|Overall Study|Physician Decision|0|||
170829592|NCT01930214|617385457|FG002|Overall Study|Physician Decision|0|||
170829593|NCT02601209|617385458|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
170829594|NCT02601209|617385459|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
170829595|NCT02601209|617385460|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
170829596|NCT02601209|617385461|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
170829597|NCT02601209|617385462|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
170829598|NCT02601209|617385463|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
170716586|NCT00534352|616967409|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
170716587|NCT03264989|616967410|FG000|Overall Study|Lost to Follow-up|1|||
170716588|NCT03264989|616967411|FG001|Overall Study|Lost to Follow-up|0|||
170716589|NCT03264989|616967410|FG000|Overall Study|New Therapy for study Indication|1|||
170716590|NCT03264989|616967411|FG001|Overall Study|New Therapy for study Indication|0|||
170716591|NCT03264989|616967410|FG000|Overall Study|Protocol Violation|0|||
170716592|NCT03264989|616967411|FG001|Overall Study|Protocol Violation|1|||
170716593|NCT03264989|616967410|FG000|Overall Study|Patient decision|13|||
170716594|NCT03264989|616967411|FG001|Overall Study|Patient decision|0|||
170716595|NCT03264989|616967410|FG000|Overall Study|Physician Decision|6|||
170716596|NCT03264989|616967411|FG001|Overall Study|Physician Decision|4|||
170716597|NCT03264989|616967410|FG000|Overall Study|Adverse Event|2|||
170716598|NCT03264989|616967411|FG001|Overall Study|Adverse Event|1|||
170716599|NCT03264989|616967410|FG000|Overall Study|Death|1|||
170716600|NCT03264989|616967411|FG001|Overall Study|Death|1|||
170716601|NCT03264989|616967410|FG000|Overall Study|Pregnancy|2|||
170716602|NCT03264989|616967411|FG001|Overall Study|Pregnancy|0|||
170716603|NCT03264989|616967410|FG000|Overall Study|End of Study|19|||
170716604|NCT03264989|616967411|FG001|Overall Study|End of Study|5|||
170829599|NCT02601209|617385464|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
170716605|NCT03880578|616967412|FG000|Overall Study|Withdrawal by Subject|0|||
170716606|NCT03880578|616967413|FG001|Overall Study|Withdrawal by Subject|3|||
170716607|NCT03880578|616967414|FG002|Overall Study|Withdrawal by Subject|1|||
170716608|NCT03880578|616967412|FG000|Overall Study|Death|0|||
170716609|NCT03880578|616967413|FG001|Overall Study|Death|1|||
170829600|NCT02601209|617385465|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
170829601|NCT02601209|617385466|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
170829602|NCT02601209|617385458|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
170716610|NCT03880578|616967414|FG002|Overall Study|Death|0|||
170716611|NCT02504294|616967418|FG000|Overall Study|Adverse Event|15|||
170716612|NCT02504294|616967419|FG001|Overall Study|Adverse Event|12|||
170716613|NCT02504294|616967418|FG000|Overall Study|Withdrawal by Subject|7|||
170716614|NCT02504294|616967419|FG001|Overall Study|Withdrawal by Subject|1|||
170716615|NCT02504294|616967418|FG000|Overall Study|Protocol Violation|27|||
170716616|NCT02504294|616967419|FG001|Overall Study|Protocol Violation|26|||
170716617|NCT02504294|616967418|FG000|Overall Study|Physician Decision|1|||
170716618|NCT02504294|616967419|FG001|Overall Study|Physician Decision|2|||
170716619|NCT02504294|616967418|FG000|Overall Study|Lost to Follow-up|6|||
170716620|NCT02504294|616967419|FG001|Overall Study|Lost to Follow-up|7|||
170716621|NCT02252211|616967420|FG000|Overall Study|Adverse Event|0|||
170716622|NCT02252211|616967421|FG001|Overall Study|Adverse Event|1|||
170716623|NCT02252211|616967422|FG002|Overall Study|Adverse Event|0|||
170716624|NCT02252211|616967420|FG000|Overall Study|Progressive disease|3|||
170716625|NCT02252211|616967421|FG001|Overall Study|Progressive disease|2|||
170716626|NCT02252211|616967422|FG002|Overall Study|Progressive disease|0|||
170716627|NCT02252211|616967420|FG000|Overall Study|Withdrawal by Subject|1|||
170716628|NCT02252211|616967421|FG001|Overall Study|Withdrawal by Subject|0|||
170716629|NCT02252211|616967422|FG002|Overall Study|Withdrawal by Subject|0|||
170716630|NCT02252211|616967420|FG000|Overall Study|Serious Adverse Event During Screening|1|||
170716631|NCT02252211|616967421|FG001|Overall Study|Serious Adverse Event During Screening|0|||
170716632|NCT02252211|616967422|FG002|Overall Study|Serious Adverse Event During Screening|1|||
170716633|NCT01024387|616967423|FG000|Overall Study|Radiographic Progression|29|||
170716634|NCT01024387|616967423|FG000|Overall Study|Symptomatic Progression|10|||
170716635|NCT01024387|616967423|FG000|Overall Study|Physician Decision|5|||
170716636|NCT01024387|616967423|FG000|Overall Study|Withdrawal by Subject|5|||
170716637|NCT01024387|616967423|FG000|Overall Study|Death|2|||
170716638|NCT01024387|616967423|FG000|Overall Study|Prolonged Treatment Delay|1|||
170716639|NCT01024387|616967423|FG000|Overall Study|Adverse Event|3|||
170716640|NCT01024387|616967423|FG000|Overall Study|Other|5|||
170716641|NCT03855189|616967424|FG000|Overall Study|Adverse Event|5|||
170716642|NCT03855189|616967425|FG001|Overall Study|Adverse Event|2|||
170716643|NCT03855189|616967426|FG002|Overall Study|Adverse Event|4|||
170716644|NCT03855189|616967424|FG000|Overall Study|Treatment Failure|1|||
170716645|NCT03855189|616967425|FG001|Overall Study|Treatment Failure|1|||
170716646|NCT03855189|616967426|FG002|Overall Study|Treatment Failure|2|||
170716647|NCT03855189|616967424|FG000|Overall Study|Noncompliance with Protocol|0|||
170716648|NCT03855189|616967425|FG001|Overall Study|Noncompliance with Protocol|1|||
170716649|NCT03855189|616967426|FG002|Overall Study|Noncompliance with Protocol|0|||
170716650|NCT03855189|616967424|FG000|Overall Study|Did Not Return|4|||
170716651|NCT03855189|616967425|FG001|Overall Study|Did Not Return|3|||
170716652|NCT03855189|616967426|FG002|Overall Study|Did Not Return|0|||
170716653|NCT02641080|616967427|FG000|Overall Study|Physician Decision|2|||
170829603|NCT02601209|617385459|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
170829604|NCT02601209|617385460|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
170829605|NCT02601209|617385461|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
170829606|NCT02601209|617385462|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
170829607|NCT02601209|617385463|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
170829608|NCT02601209|617385464|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
170829609|NCT02601209|617385465|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
170829610|NCT02601209|617385466|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
170829611|NCT02062645|617385469|FG000|Overall Study|Adverse Event|2|||
170829612|NCT02062645|617385469|FG000|Overall Study|Protocol Violation|8|||
170829613|NCT02062645|617385469|FG000|Overall Study|Lost to Follow-up|5|||
170829614|NCT02864342|617385471|FG000|Overall Study|Eligibility Criteria Deviation|2|||
170829615|NCT02864342|617385472|FG001|Overall Study|Eligibility Criteria Deviation|3|||
170829616|NCT02864342|617385471|FG000|Overall Study|Withdrawal by Subject|4|||
170829617|NCT02864342|617385472|FG001|Overall Study|Withdrawal by Subject|2|||
170829618|NCT02864342|617385471|FG000|Overall Study|Device Technology Issue|6|||
170829619|NCT02864342|617385472|FG001|Overall Study|Device Technology Issue|7|||
170829620|NCT02864342|617385471|FG000|Overall Study|Death|0|||
170716654|NCT02641080|616967428|FG001|Overall Study|Physician Decision|0|||
170716655|NCT02641080|616967427|FG000|Overall Study|Withdrawal by Subject|0|||
170716656|NCT02641080|616967428|FG001|Overall Study|Withdrawal by Subject|1|||
170716657|NCT02641080|616967427|FG000|Overall Study|Rehab Center denied use of pumps|0|||
170716658|NCT02641080|616967428|FG001|Overall Study|Rehab Center denied use of pumps|3|||
170829621|NCT02864342|617385472|FG001|Overall Study|Death|1|||
170829622|NCT02864342|617385471|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
170829623|NCT02864342|617385472|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
170829624|NCT02864342|617385471|FG000|Overall Study|Lost to Follow-up|1|||
170829625|NCT02864342|617385472|FG001|Overall Study|Lost to Follow-up|5|||
170829626|NCT02864342|617385471|FG000|Overall Study|Lost Device|1|||
170829627|NCT02864342|617385472|FG001|Overall Study|Lost Device|0|||
170829628|NCT02864342|617385471|FG000|Overall Study|Adverse Event|1|||
170829629|NCT02864342|617385472|FG001|Overall Study|Adverse Event|0|||
170829630|NCT00118703|617385473|FG000|Overall Study|Protocol Violation|1|||
170829631|NCT00118703|617385474|FG001|Overall Study|Protocol Violation|0|||
170829632|NCT00118703|617385473|FG000|Overall Study|Adverse Event|1|||
170829633|NCT00118703|617385474|FG001|Overall Study|Adverse Event|1|||
170829634|NCT00118703|617385473|FG000|Overall Study|Participant took two different treatment|0|||
170829635|NCT00118703|617385474|FG001|Overall Study|Participant took two different treatment|1|||
170829636|NCT00118703|617385473|FG000|Overall Study|Withdrawal by Subject|2|||
170829637|NCT00118703|617385474|FG001|Overall Study|Withdrawal by Subject|5|||
170829638|NCT00118703|617385473|FG000|Overall Study|Lost to Follow-up|1|||
170829639|NCT00118703|617385474|FG001|Overall Study|Lost to Follow-up|2|||
170829640|NCT00461123|617385475|FG000|Overall Study|Adverse Event|1|||
170829641|NCT00461123|617385476|FG001|Overall Study|Adverse Event|0|||
170829642|NCT00461123|617385475|FG000|Overall Study|Lost to Follow-up|1|||
170829643|NCT00461123|617385476|FG001|Overall Study|Lost to Follow-up|1|||
170829644|NCT00461123|617385475|FG000|Overall Study|Protocol Violation|3|||
170829645|NCT00461123|617385476|FG001|Overall Study|Protocol Violation|2|||
170829646|NCT00461123|617385475|FG000|Overall Study|Withdrawal by Subject|1|||
170829647|NCT00461123|617385476|FG001|Overall Study|Withdrawal by Subject|3|||
170829648|NCT01349036|617385478|FG000|Overall Study|Disease progression|13|||
170829649|NCT01349036|617385479|FG001|Overall Study|Disease progression|22|||
170829650|NCT01349036|617385478|FG000|Overall Study|Other|1|||
170829651|NCT01349036|617385479|FG001|Overall Study|Other|0|||
170829652|NCT01349036|617385478|FG000|Overall Study|Withdrawal by Subject|0|||
170829653|NCT01349036|617385479|FG001|Overall Study|Withdrawal by Subject|2|||
170829654|NCT03605368|617385487|FG000|Overall Study|Lost to Follow-up|2|||
170829655|NCT03605368|617385488|FG001|Overall Study|Lost to Follow-up|1|||
170829656|NCT03605368|617385489|FG002|Overall Study|Lost to Follow-up|3|||
170829657|NCT03605368|617385490|FG003|Overall Study|Lost to Follow-up|2|||
170829658|NCT03605368|617385487|FG000|Overall Study|Withdrawal by Subject|0|||
170829659|NCT03605368|617385488|FG001|Overall Study|Withdrawal by Subject|0|||
170829660|NCT03605368|617385489|FG002|Overall Study|Withdrawal by Subject|4|||
170829661|NCT03605368|617385490|FG003|Overall Study|Withdrawal by Subject|3|||
170716659|NCT02641080|616967427|FG000|Overall Study|Lost to Follow-up|0|||
170716660|NCT02641080|616967428|FG001|Overall Study|Lost to Follow-up|3|||
170716661|NCT04307186|616967431|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
170716662|NCT04307186|616967431|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
170716663|NCT04307186|616967431|FG000|Washout 3-14 Days|Progressive disease|1|||
170716664|NCT04307186|616967431|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
170716665|NCT04307186|616967431|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
170716666|NCT06281548|616967434|FG000|Overall Study|Lost to Follow-up|3|||
170716667|NCT00759109|616967435|FG000|Overall Study|Adverse Event|17|||
170716668|NCT00759109|616967436|FG001|Overall Study|Adverse Event|12|||
170716669|NCT00759109|616967435|FG000|Overall Study|Inability to comply|1|||
170716670|NCT00759109|616967436|FG001|Overall Study|Inability to comply|1|||
170716671|NCT00759109|616967435|FG000|Overall Study|Withdrawal by Subject|9|||
170716672|NCT00759109|616967436|FG001|Overall Study|Withdrawal by Subject|5|||
170716673|NCT00759109|616967435|FG000|Overall Study|Death|4|||
170716674|NCT00759109|616967436|FG001|Overall Study|Death|3|||
170829662|NCT01215032|617385491|FG000|Overall Study|Adverse Event|3|||
170829663|NCT01215032|617385491|FG000|Overall Study|Lack of Efficacy|17|||
170829664|NCT01125566|617385492|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
170829665|NCT01125566|617385493|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
170829666|NCT01125566|617385494|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
170829667|NCT01125566|617385492|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
170716675|NCT00759109|616967435|FG000|Overall Study|Lost to Follow-up|4|||
170829668|NCT01125566|617385493|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
170829669|NCT01125566|617385494|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
170829670|NCT01125566|617385492|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
170829671|NCT01125566|617385493|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
170716676|NCT00759109|616967436|FG001|Overall Study|Lost to Follow-up|6|||
170716677|NCT00759109|616967435|FG000|Overall Study|Started new therapy|2|||
170716678|NCT00759109|616967436|FG001|Overall Study|Started new therapy|6|||
170829672|NCT01125566|617385494|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
170829673|NCT01125566|617385492|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
170829674|NCT01125566|617385493|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
170829675|NCT01125566|617385494|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
170829676|NCT01125566|617385492|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
170829677|NCT01125566|617385493|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
170829678|NCT01125566|617385494|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
170829679|NCT01125566|617385492|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
170829680|NCT01125566|617385493|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
170829681|NCT01125566|617385494|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
170829682|NCT01125566|617385492|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
170829683|NCT01125566|617385493|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
170829684|NCT01125566|617385494|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
170829685|NCT01125566|617385492|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
170829686|NCT01125566|617385493|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
170829687|NCT01125566|617385494|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
170829688|NCT01125566|617385492|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
170829689|NCT01125566|617385493|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
170829690|NCT01125566|617385494|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
170829691|NCT01125566|617385492|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
170829692|NCT01125566|617385493|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
170829693|NCT01125566|617385494|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
170829694|NCT01125566|617385492|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
170829695|NCT01125566|617385493|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
170829696|NCT01125566|617385494|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
170829697|NCT01125566|617385492|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
170829698|NCT01125566|617385493|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
170829699|NCT01125566|617385494|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
170829700|NCT02598934|617385500|FG000|Overall Study|Adverse Event|11|||
170829701|NCT02598934|617385501|FG001|Overall Study|Adverse Event|13|||
170829702|NCT02598934|617385500|FG000|Overall Study|Failure to Return|3|||
170829703|NCT02598934|617385501|FG001|Overall Study|Failure to Return|3|||
170829704|NCT02598934|617385500|FG000|Overall Study|Withdrawal by Subject|2|||
170829705|NCT02598934|617385501|FG001|Overall Study|Withdrawal by Subject|3|||
170829706|NCT02598934|617385500|FG000|Overall Study|Administrative|2|||
170829707|NCT02598934|617385501|FG001|Overall Study|Administrative|1|||
170829708|NCT02598934|617385500|FG000|Overall Study|Protocol Violation|1|||
170829709|NCT02598934|617385501|FG001|Overall Study|Protocol Violation|2|||
170829710|NCT03440047|617386937|FG000|Overall Study|Withdrawal by Subject|2|||
170829711|NCT00701909|617386941|FG000|Overall Study|Withdrawal by Subject|0|||
170829712|NCT00701909|617386942|FG001|Overall Study|Withdrawal by Subject|1|||
170829713|NCT02808975|617386943|FG000|Overall Study|Adverse Event|3|||
170829714|NCT02808975|617386944|FG001|Overall Study|Adverse Event|4|||
170829715|NCT02808975|617386943|FG000|Overall Study|Withdrew consent|9|||
170829716|NCT02808975|617386944|FG001|Overall Study|Withdrew consent|8|||
170829717|NCT02808975|617386943|FG000|Overall Study|Lost to Follow-up|4|||
170829718|NCT02808975|617386944|FG001|Overall Study|Lost to Follow-up|6|||
170829719|NCT02808975|617386943|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
170829720|NCT02808975|617386944|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
170829721|NCT02808975|617386943|FG000|Overall Study|Other, not specified|5|||
170829722|NCT02808975|617386944|FG001|Overall Study|Other, not specified|1|||
170829723|NCT03602586|617386945|FG000|Overall Study|Withdrawal by Subject|3|||
170829724|NCT00362375|617386946|FG000|Overall Study|Lost to Follow-up|40|||
170829725|NCT00362375|617386947|FG001|Overall Study|Lost to Follow-up|35|||
170829726|NCT04984239|617386948|FG000|Overall Study|Lost to Follow-up|1|||
170829727|NCT04523207|617386949|FG000|Overall Study|Adverse Event|5|||
170829728|NCT04523207|617386950|FG001|Overall Study|Adverse Event|1|||
170829729|NCT04523207|617386949|FG000|Overall Study|Lost to Follow-up|2|||
170829730|NCT04523207|617386950|FG001|Overall Study|Lost to Follow-up|0|||
170829731|NCT04523207|617386949|FG000|Overall Study|Withdrawal by Subject|2|||
170829732|NCT04523207|617386950|FG001|Overall Study|Withdrawal by Subject|0|||
170829733|NCT04523207|617386949|FG000|Overall Study|Progressive Disease|2|||
170829734|NCT04523207|617386950|FG001|Overall Study|Progressive Disease|1|||
170829735|NCT04523207|617386949|FG000|Overall Study|Other|7|||
170829736|NCT04523207|617386950|FG001|Overall Study|Other|1|||
170829737|NCT03113383|617386951|FG000|Overall Study|Death|4|||
170829738|NCT03113383|617386952|FG001|Overall Study|Death|0|||
170829739|NCT02370251|617386953|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
170829740|NCT02370251|617386953|FG000|Overall Study|Death|4|||
170829741|NCT04469465|617386954|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
170829742|NCT04469465|617386955|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
170829743|NCT04469465|617386954|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
170829744|NCT04469465|617386955|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
170829745|NCT04469465|617386954|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
170829746|NCT04469465|617386955|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
170829747|NCT04469465|617386954|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
170829748|NCT04469465|617386955|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
170829749|NCT04469465|617386954|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
170829750|NCT04469465|617386955|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
170829751|NCT04469465|617386954|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
170829752|NCT04469465|617386955|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
170829753|NCT04469465|617386954|FG000|Long-Term Extension (LTE)|Death|0|||
170829754|NCT04469465|617386955|FG001|Long-Term Extension (LTE)|Death|1|||
170829755|NCT04469465|617386954|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
170829756|NCT04469465|617386955|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
170829757|NCT01010204|617386956|FG000|Overall Study|Lost to Follow-up|2|||
170829758|NCT01010204|617386957|FG001|Overall Study|Lost to Follow-up|2|||
170716679|NCT00759109|616967435|FG000|Overall Study|HCV RNA negative|1|||
170716680|NCT00759109|616967436|FG001|Overall Study|HCV RNA negative|0|||
170716681|NCT00759109|616967435|FG000|Overall Study|Participant moved to a different city|0|||
170716682|NCT00759109|616967436|FG001|Overall Study|Participant moved to a different city|1|||
170716683|NCT00759109|616967435|FG000|Overall Study|Participant had a liver transplant|0|||
170716684|NCT00759109|616967436|FG001|Overall Study|Participant had a liver transplant|1|||
170716685|NCT00759109|616967435|FG000|Overall Study|Lost during study|1|||
170716686|NCT00759109|616967436|FG001|Overall Study|Lost during study|0|||
170716687|NCT01866709|616967440|FG000|Overall Study|Adverse Event|1|||
170716688|NCT01866709|616967441|FG001|Overall Study|Adverse Event|0|||
170716689|NCT02265237|616967445|FG000|As Treated (Overall Study)|Adverse Event|1|||
170716690|NCT02265237|616967446|FG001|As Treated (Overall Study)|Adverse Event|1|||
170716691|NCT02265237|616967447|FG002|As Treated (Overall Study)|Adverse Event|0|||
170716692|NCT02265237|616967448|FG003|As Treated (Overall Study)|Adverse Event|0|||
170716693|NCT02265237|616967445|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
170716694|NCT02265237|616967446|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
170716695|NCT02265237|616967447|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
170716696|NCT02265237|616967448|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
170716697|NCT02265237|616967445|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
170716698|NCT02265237|616967446|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
170716699|NCT02265237|616967447|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
170716700|NCT02265237|616967448|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
170716701|NCT02265237|616967445|FG000|As Treated (Overall Study)|Other|2|||
170716702|NCT02265237|616967446|FG001|As Treated (Overall Study)|Other|0|||
170716703|NCT02265237|616967447|FG002|As Treated (Overall Study)|Other|3|||
170716704|NCT02265237|616967448|FG003|As Treated (Overall Study)|Other|1|||
170716705|NCT03550313|616967450|FG000|Overall Study|Adverse Event|0|||
170716706|NCT03550313|616967451|FG001|Overall Study|Adverse Event|1|||
170716707|NCT03550313|616967452|FG002|Overall Study|Adverse Event|0|||
170716708|NCT03550313|616967450|FG000|Overall Study|Lost to Follow-up|5|||
170716709|NCT03550313|616967451|FG001|Overall Study|Lost to Follow-up|7|||
170716710|NCT03550313|616967452|FG002|Overall Study|Lost to Follow-up|12|||
170716711|NCT03550313|616967450|FG000|Overall Study|Study terminated by sponsor|44|||
170716712|NCT03550313|616967451|FG001|Overall Study|Study terminated by sponsor|37|||
170716713|NCT03550313|616967452|FG002|Overall Study|Study terminated by sponsor|48|||
170716714|NCT03550313|616967450|FG000|Overall Study|No longer met eligibility criteria|3|||
170716715|NCT03550313|616967451|FG001|Overall Study|No longer met eligibility criteria|5|||
170716716|NCT03550313|616967452|FG002|Overall Study|No longer met eligibility criteria|6|||
170716717|NCT03550313|616967450|FG000|Overall Study|Withdrawal by parent/guardian|20|||
170716718|NCT03550313|616967451|FG001|Overall Study|Withdrawal by parent/guardian|18|||
170716719|NCT03550313|616967452|FG002|Overall Study|Withdrawal by parent/guardian|26|||
170829759|NCT01010204|617386956|FG000|Overall Study|Adverse Event|1|||
170829760|NCT01010204|617386957|FG001|Overall Study|Adverse Event|3|||
170829761|NCT01010204|617386956|FG000|Overall Study|Withdrawal by Subject|2|||
170716720|NCT03550313|616967450|FG000|Overall Study|Other|4|||
170829762|NCT01010204|617386957|FG001|Overall Study|Withdrawal by Subject|3|||
170829763|NCT01010204|617386956|FG000|Overall Study|psychiatric hospitalization|2|||
170716721|NCT03550313|616967451|FG001|Overall Study|Other|2|||
170716722|NCT03550313|616967452|FG002|Overall Study|Other|2|||
170829764|NCT01010204|617386957|FG001|Overall Study|psychiatric hospitalization|1|||
170829765|NCT00916305|617386962|FG000|Overall Study|Lost to Follow-up|21|||
170829766|NCT00916305|617386963|FG001|Overall Study|Lost to Follow-up|27|||
170829767|NCT00916305|617386962|FG000|Overall Study|Withdrawal by Subject|0|||
170829768|NCT00916305|617386963|FG001|Overall Study|Withdrawal by Subject|1|||
170829769|NCT02229578|617386964|FG000|Overall Study|Withdrawal by Subject|1|||
170829770|NCT02229578|617386965|FG001|Overall Study|Withdrawal by Subject|3|||
170829771|NCT02229578|617386964|FG000|Overall Study|Protocol Violation|2|||
170829772|NCT02229578|617386965|FG001|Overall Study|Protocol Violation|0|||
170829773|NCT01288209|617386966|FG000|Overall Study|Withdrawal by Subject|1|||
170829774|NCT01288209|617386967|FG001|Overall Study|Withdrawal by Subject|3|||
170829775|NCT01288209|617386966|FG000|Overall Study|Other|1|||
170829776|NCT01288209|617386967|FG001|Overall Study|Other|0|||
170829777|NCT01015677|617386968|FG000|Overall Study|Adverse Event|0|||
170829778|NCT01015677|617386969|FG001|Overall Study|Adverse Event|1|||
170829779|NCT01015677|617386970|FG002|Overall Study|Adverse Event|0|||
170829780|NCT01015677|617386968|FG000|Overall Study|Lack of Efficacy|0|||
170829781|NCT01015677|617386969|FG001|Overall Study|Lack of Efficacy|1|||
170829782|NCT01015677|617386970|FG002|Overall Study|Lack of Efficacy|0|||
170829783|NCT01015677|617386968|FG000|Overall Study|Protocol Violation|0|||
170829784|NCT01015677|617386969|FG001|Overall Study|Protocol Violation|1|||
170829785|NCT01015677|617386970|FG002|Overall Study|Protocol Violation|0|||
170829786|NCT01015677|617386968|FG000|Overall Study|Withdrawal by Subject|1|||
170829787|NCT01015677|617386969|FG001|Overall Study|Withdrawal by Subject|1|||
170829788|NCT01015677|617386970|FG002|Overall Study|Withdrawal by Subject|0|||
170829789|NCT03603639|617386974|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
170829790|NCT03603639|617386975|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
170829791|NCT03603639|617386976|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
170829792|NCT03603639|617386977|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
170829793|NCT03603639|617386978|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
170829794|NCT03603639|617386979|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
170829795|NCT03603639|617386974|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
170829796|NCT03603639|617386975|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
170829797|NCT03603639|617386976|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
170829798|NCT03603639|617386977|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
170829799|NCT03603639|617386978|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
170829800|NCT03603639|617386979|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
170829801|NCT04599855|617386981|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
170829802|NCT04599855|617386982|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
170829803|NCT04599855|617386983|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
170829804|NCT04599855|617386981|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
170829805|NCT04599855|617386982|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
170829806|NCT04599855|617386983|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
170829807|NCT04599855|617386981|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
170829808|NCT04599855|617386982|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
170829809|NCT04599855|617386983|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
170829810|NCT04599855|617386981|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
170829811|NCT04599855|617386982|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
170829812|NCT04599855|617386983|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
170829813|NCT04599855|617386981|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
170829814|NCT04599855|617386982|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
170829815|NCT04599855|617386983|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
170829816|NCT04599855|617386981|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
170829817|NCT04599855|617386982|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
170829818|NCT04599855|617386983|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
170829819|NCT04599855|617386981|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
170829820|NCT04599855|617386982|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
170829821|NCT04599855|617386983|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
170829822|NCT04599855|617386981|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
170829823|NCT04599855|617386982|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
170829824|NCT04599855|617386983|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
170829825|NCT04599855|617386981|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
170829826|NCT04599855|617386982|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
170829827|NCT04599855|617386983|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
170829828|NCT04599855|617386981|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
170829829|NCT04599855|617386982|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
170829830|NCT04599855|617386983|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
170829831|NCT04599855|617386981|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
170829832|NCT04599855|617386982|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
170829833|NCT04599855|617386983|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
170829834|NCT04599855|617386981|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
170829835|NCT04599855|617386982|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
170829836|NCT04599855|617386983|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
170829837|NCT04599855|617386981|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
170829838|NCT04599855|617386982|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
170829839|NCT04599855|617386983|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
170829840|NCT04599855|617386981|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
170829841|NCT04599855|617386982|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
170829842|NCT04599855|617386983|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
170829843|NCT00858247|617386984|FG000|Baseline Assessment|Withdrawal by Subject|1|||
170829844|NCT00858247|617386985|FG001|Baseline Assessment|Withdrawal by Subject|1|||
170829845|NCT00858247|617386984|FG000|Baseline Assessment|Poor IV access|1|||
170829846|NCT00858247|617386985|FG001|Baseline Assessment|Poor IV access|0|||
170829847|NCT00858247|617386984|FG000|Baseline Assessment|Protocol Violation|0|||
170829848|NCT00858247|617386985|FG001|Baseline Assessment|Protocol Violation|1|||
170829849|NCT00858247|617386984|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
170829850|NCT00858247|617386985|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
170829851|NCT02165397|617386986|FG000|Overall Study|Death|7|||
170829852|NCT02165397|617386987|FG001|Overall Study|Death|10|||
170716723|NCT03550313|616967450|FG000|Overall Study|Randomized but not vaccinated|3|||
170716724|NCT03550313|616967451|FG001|Overall Study|Randomized but not vaccinated|23|||
170716725|NCT03550313|616967452|FG002|Overall Study|Randomized but not vaccinated|2|||
170716726|NCT03550313|616967450|FG000|Overall Study|Sites terminated due to quality issues|18|||
170716727|NCT03550313|616967451|FG001|Overall Study|Sites terminated due to quality issues|17|||
170716728|NCT03550313|616967452|FG002|Overall Study|Sites terminated due to quality issues|18|||
170716729|NCT02207829|616967453|FG000|Overall Study|Adverse Event|10|||
170716730|NCT02207829|616967454|FG001|Overall Study|Adverse Event|9|||
170716731|NCT02207829|616967453|FG000|Overall Study|Lack of Efficacy|7|||
170716732|NCT02207829|616967454|FG001|Overall Study|Lack of Efficacy|5|||
170716733|NCT02207829|616967453|FG000|Overall Study|Lost to Follow-up|2|||
170716734|NCT02207829|616967454|FG001|Overall Study|Lost to Follow-up|2|||
170716735|NCT02207829|616967453|FG000|Overall Study|Protocol deviation|5|||
170716736|NCT02207829|616967454|FG001|Overall Study|Protocol deviation|4|||
170716737|NCT02207829|616967453|FG000|Overall Study|Withdrew consent|18|||
170716738|NCT02207829|616967454|FG001|Overall Study|Withdrew consent|14|||
170716739|NCT04122443|616967459|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
170716740|NCT04122443|616967460|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
170716741|NCT04122443|616967461|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
170716742|NCT04122443|616967459|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
170716743|NCT04122443|616967460|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
170716744|NCT04122443|616967461|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
170716745|NCT00836875|616967462|FG000|Overall Study|Death|3|||
170716746|NCT00836875|616967463|FG001|Overall Study|Death|2|||
170716747|NCT00836875|616967462|FG000|Overall Study|Withdrawal by Subject|0|||
170716748|NCT00836875|616967463|FG001|Overall Study|Withdrawal by Subject|1|||
170829853|NCT02165397|617386988|FG002|Overall Study|Death|8|||
170829854|NCT02165397|617386986|FG000|Overall Study|Lost to Follow-up|1|||
170829855|NCT02165397|617386987|FG001|Overall Study|Lost to Follow-up|3|||
170829856|NCT02165397|617386988|FG002|Overall Study|Lost to Follow-up|0|||
170829857|NCT02165397|617386986|FG000|Overall Study|Withdrawal by Subject|6|||
170829858|NCT02165397|617386987|FG001|Overall Study|Withdrawal by Subject|6|||
170829859|NCT02165397|617386988|FG002|Overall Study|Withdrawal by Subject|1|||
170829860|NCT02165397|617386986|FG000|Overall Study|Other, Not Specified|0|||
170829861|NCT02165397|617386987|FG001|Overall Study|Other, Not Specified|0|||
170829862|NCT02165397|617386988|FG002|Overall Study|Other, Not Specified|1|||
170829863|NCT03898960|617386991|FG000|Overall Study|Death|10|||
170829864|NCT01379703|617386994|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
170829865|NCT01379703|617386995|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
170829866|NCT01379703|617386996|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
170829867|NCT01379703|617386994|FG000|Study Start Through 9 Months|Adverse Event|0|||
170829868|NCT01379703|617386995|FG001|Study Start Through 9 Months|Adverse Event|14|||
170829869|NCT01379703|617386996|FG002|Study Start Through 9 Months|Adverse Event|10|||
170829870|NCT01379703|617386994|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
170829871|NCT01379703|617386995|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
170829872|NCT01379703|617386996|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
170829873|NCT01379703|617386994|FG000|Study Start Through 9 Months|Treatment Failure|0|||
170829874|NCT01379703|617386995|FG001|Study Start Through 9 Months|Treatment Failure|2|||
170829875|NCT01379703|617386996|FG002|Study Start Through 9 Months|Treatment Failure|2|||
170829876|NCT01379703|617386994|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
170829877|NCT01379703|617386995|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
170829878|NCT01379703|617386996|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
170829879|NCT01379703|617386994|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
170829880|NCT01379703|617386995|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
170829881|NCT01379703|617386996|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
170829882|NCT01379703|617386994|FG000|Study Start Through 9 Months|Medication not available|0|||
170829883|NCT01379703|617386995|FG001|Study Start Through 9 Months|Medication not available|2|||
170829884|NCT01379703|617386996|FG002|Study Start Through 9 Months|Medication not available|1|||
170829885|NCT01379703|617386994|FG000|Study Start Through 9 Months|Poor general condition|0|||
170829886|NCT01379703|617386995|FG001|Study Start Through 9 Months|Poor general condition|1|||
170829887|NCT01379703|617386996|FG002|Study Start Through 9 Months|Poor general condition|0|||
170829888|NCT01379703|617386994|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
170829889|NCT01379703|617386995|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
170829890|NCT01379703|617386996|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
170829891|NCT01379703|617386994|FG000|Study Start Through 9 Months|Reason unknown|2|||
170829892|NCT01379703|617386995|FG001|Study Start Through 9 Months|Reason unknown|31|||
170829893|NCT01379703|617386996|FG002|Study Start Through 9 Months|Reason unknown|24|||
170829894|NCT01379703|617386994|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
170829895|NCT01379703|617386995|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
170829896|NCT01379703|617386996|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
170829897|NCT01379703|617386994|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
170829898|NCT01379703|617386995|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
170829899|NCT01379703|617386996|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
170829900|NCT01379703|617386994|FG000|9 Months Through 18 Months|Adverse Event|0|||
170829901|NCT01379703|617386995|FG001|9 Months Through 18 Months|Adverse Event|6|||
170829902|NCT01379703|617386996|FG002|9 Months Through 18 Months|Adverse Event|0|||
170829903|NCT01379703|617386994|FG000|9 Months Through 18 Months|Treatment failure|0|||
170829904|NCT01379703|617386995|FG001|9 Months Through 18 Months|Treatment failure|5|||
170829905|NCT01379703|617386996|FG002|9 Months Through 18 Months|Treatment failure|0|||
170829906|NCT01379703|617386994|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
170829907|NCT01379703|617386995|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
170829908|NCT01379703|617386996|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
170829909|NCT01379703|617386994|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
170829910|NCT01379703|617386995|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
170829911|NCT01379703|617386996|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
170829912|NCT01379703|617386994|FG000|9 Months Through 18 Months|Fatigue|0|||
170716749|NCT00924287|616969474|FG000|Overall Study|Death|1|||
170716750|NCT01682460|616969477|FG000|Overall Study|Withdrawal by Subject|2|||
170716751|NCT01682460|616969477|FG000|Overall Study|Did not meet inclusion criteria|2|||
170716752|NCT00377234|616969478|FG000|Overall Study|Adverse Event|14|||
170716753|NCT00377234|616969479|FG001|Overall Study|Adverse Event|17|||
170716754|NCT00377234|616969478|FG000|Overall Study|Withdrawal by Subject|11|||
170716755|NCT00377234|616969479|FG001|Overall Study|Withdrawal by Subject|9|||
170716756|NCT00377234|616969478|FG000|Overall Study|Lost to Follow-up|4|||
170716757|NCT00377234|616969479|FG001|Overall Study|Lost to Follow-up|2|||
170716758|NCT00377234|616969478|FG000|Overall Study|Administrative|2|||
170716759|NCT00377234|616969479|FG001|Overall Study|Administrative|1|||
170716760|NCT00377234|616969478|FG000|Overall Study|Not assigned|3|||
170716761|NCT00377234|616969479|FG001|Overall Study|Not assigned|2|||
170716762|NCT01747772|616969486|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
170716763|NCT01798927|616969487|FG000|Overall Study|Withdrawal by Subject|1|||
170716764|NCT00626522|616969488|FG000|Overall Study|Protocol Violation|0|||
170716765|NCT00626522|616969489|FG001|Overall Study|Protocol Violation|0|||
170716766|NCT00626522|616969490|FG002|Overall Study|Protocol Violation|0|||
170716767|NCT00626522|616969491|FG003|Overall Study|Protocol Violation|0|||
170716768|NCT00626522|616969492|FG004|Overall Study|Protocol Violation|1|||
170716769|NCT00626522|616969493|FG005|Overall Study|Protocol Violation|0|||
170716770|NCT00626522|616969488|FG000|Overall Study|Adverse Event|2|||
170716771|NCT00626522|616969489|FG001|Overall Study|Adverse Event|1|||
170716772|NCT00626522|616969490|FG002|Overall Study|Adverse Event|2|||
170716773|NCT00626522|616969491|FG003|Overall Study|Adverse Event|0|||
170716774|NCT00626522|616969492|FG004|Overall Study|Adverse Event|1|||
170716775|NCT00626522|616969493|FG005|Overall Study|Adverse Event|1|||
170716776|NCT00626522|616969488|FG000|Overall Study|Withdrawal by Subject|2|||
170716777|NCT00626522|616969489|FG001|Overall Study|Withdrawal by Subject|5|||
170716778|NCT00626522|616969490|FG002|Overall Study|Withdrawal by Subject|5|||
170716779|NCT00626522|616969491|FG003|Overall Study|Withdrawal by Subject|0|||
170716780|NCT00626522|616969492|FG004|Overall Study|Withdrawal by Subject|4|||
170716781|NCT00626522|616969493|FG005|Overall Study|Withdrawal by Subject|1|||
170716782|NCT00626522|616969488|FG000|Overall Study|COPD exacerbation|0|||
170716783|NCT00626522|616969489|FG001|Overall Study|COPD exacerbation|0|||
170716784|NCT00626522|616969490|FG002|Overall Study|COPD exacerbation|0|||
170716785|NCT00626522|616969491|FG003|Overall Study|COPD exacerbation|1|||
170716786|NCT00626522|616969492|FG004|Overall Study|COPD exacerbation|1|||
170716787|NCT00626522|616969493|FG005|Overall Study|COPD exacerbation|0|||
170716788|NCT00626522|616969488|FG000|Overall Study|Lost to Follow-up|0|||
170716789|NCT00626522|616969489|FG001|Overall Study|Lost to Follow-up|1|||
170716790|NCT00626522|616969490|FG002|Overall Study|Lost to Follow-up|0|||
170716791|NCT00626522|616969491|FG003|Overall Study|Lost to Follow-up|0|||
170716792|NCT00626522|616969492|FG004|Overall Study|Lost to Follow-up|0|||
170716793|NCT00626522|616969493|FG005|Overall Study|Lost to Follow-up|0|||
170716794|NCT00626522|616969488|FG000|Overall Study|Inconsistent reason reported|1|||
170716795|NCT00626522|616969489|FG001|Overall Study|Inconsistent reason reported|0|||
170716796|NCT00626522|616969490|FG002|Overall Study|Inconsistent reason reported|0|||
170716797|NCT00626522|616969491|FG003|Overall Study|Inconsistent reason reported|0|||
170716798|NCT00626522|616969492|FG004|Overall Study|Inconsistent reason reported|0|||
170716799|NCT00626522|616969493|FG005|Overall Study|Inconsistent reason reported|0|||
170716800|NCT00626522|616969488|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
170716801|NCT00626522|616969489|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
170716802|NCT00626522|616969490|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
170716803|NCT00626522|616969491|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
170716804|NCT00626522|616969492|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
170716805|NCT00626522|616969493|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
170716806|NCT01928719|616969494|FG000|Overall Study|Lost to Follow-up|26|||
170716807|NCT01928719|616969495|FG001|Overall Study|Lost to Follow-up|11|||
170716808|NCT01928719|616969494|FG000|Overall Study|Withdrawal by Subject|22|||
170716809|NCT01928719|616969495|FG001|Overall Study|Withdrawal by Subject|7|||
170716810|NCT01928719|616969494|FG000|Overall Study|Protocol Violation|3|||
170716811|NCT01928719|616969495|FG001|Overall Study|Protocol Violation|1|||
170716812|NCT01928719|616969494|FG000|Overall Study|Adverse Event|1|||
170716813|NCT01928719|616969495|FG001|Overall Study|Adverse Event|0|||
170716814|NCT00263666|616969498|FG000|Overall Study|Adverse Event|6|||
170716815|NCT00263666|616969499|FG001|Overall Study|Adverse Event|8|||
170716816|NCT00263666|616969498|FG000|Overall Study|Lost to Follow-up|1|||
170716817|NCT00263666|616969499|FG001|Overall Study|Lost to Follow-up|2|||
170716818|NCT00263666|616969498|FG000|Overall Study|Withdrawal by Subject|0|||
170716819|NCT00263666|616969499|FG001|Overall Study|Withdrawal by Subject|1|||
170716820|NCT01490632|616969500|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
170716821|NCT01490632|616969501|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
170716822|NCT01490632|616969502|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
170716823|NCT01490632|616969503|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
170716824|NCT01490632|616969504|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
170716825|NCT01490632|616969505|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
170716826|NCT01490632|616969506|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
170716827|NCT01490632|616969507|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
170716828|NCT01490632|616969508|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
170716829|NCT01490632|616969509|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
170716830|NCT01490632|616969510|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
170716831|NCT01490632|616969511|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
170716832|NCT01490632|616969512|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
170716833|NCT01490632|616969513|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
170716834|NCT01490632|616969514|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
170716835|NCT01490632|616969515|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
170716836|NCT01490632|616969516|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
170716837|NCT01490632|616969517|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
170716838|NCT01490632|616969518|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
170716839|NCT01490632|616969519|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
170716840|NCT01490632|616969500|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
170716841|NCT01490632|616969501|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
170716842|NCT01490632|616969502|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
170716843|NCT01490632|616969503|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
170716844|NCT01490632|616969504|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716845|NCT01490632|616969505|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716846|NCT01490632|616969506|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716847|NCT01490632|616969507|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716848|NCT01490632|616969508|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716849|NCT01490632|616969509|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716850|NCT01490632|616969510|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716851|NCT01490632|616969511|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716852|NCT01490632|616969512|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716853|NCT01490632|616969513|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716854|NCT01490632|616969514|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716855|NCT01490632|616969515|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716856|NCT01490632|616969516|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716857|NCT01490632|616969517|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716858|NCT01490632|616969518|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716859|NCT01490632|616969519|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
170716860|NCT01490632|616969500|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716861|NCT01490632|616969501|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716862|NCT01490632|616969502|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
170829913|NCT01379703|617386995|FG001|9 Months Through 18 Months|Fatigue|1|||
170829914|NCT01379703|617386996|FG002|9 Months Through 18 Months|Fatigue|0|||
170829915|NCT01379703|617386994|FG000|9 Months Through 18 Months|Reason Unknown|0|||
170829916|NCT01379703|617386995|FG001|9 Months Through 18 Months|Reason Unknown|23|||
170829917|NCT01379703|617386996|FG002|9 Months Through 18 Months|Reason Unknown|0|||
170829918|NCT03481556|617386997|FG000|Overall Study|Adverse Event|1|||
170829919|NCT03481556|617386998|FG001|Overall Study|Adverse Event|0|||
170829920|NCT03481556|617386999|FG002|Overall Study|Adverse Event|0|||
170829921|NCT03481556|617387000|FG003|Overall Study|Adverse Event|0|||
170829922|NCT03481556|617386997|FG000|Overall Study|Death|4|||
170829923|NCT03481556|617386998|FG001|Overall Study|Death|2|||
170829924|NCT03481556|617386999|FG002|Overall Study|Death|3|||
170829925|NCT03481556|617387000|FG003|Overall Study|Death|16|||
170829926|NCT03481556|617386997|FG000|Overall Study|Study Terminated by Sponsor|10|||
170829927|NCT03481556|617386998|FG001|Overall Study|Study Terminated by Sponsor|5|||
170829928|NCT03481556|617386999|FG002|Overall Study|Study Terminated by Sponsor|2|||
170829929|NCT03481556|617387000|FG003|Overall Study|Study Terminated by Sponsor|9|||
170829930|NCT00469456|617387001|FG000|Overall Study|Adverse Event|4|||
170829931|NCT00469456|617387002|FG001|Overall Study|Adverse Event|3|||
170829932|NCT00469456|617387001|FG000|Overall Study|Protocol Violation|1|||
170829933|NCT00469456|617387002|FG001|Overall Study|Protocol Violation|0|||
170829934|NCT00469456|617387001|FG000|Overall Study|Withdrawal by Subject|4|||
170829935|NCT00469456|617387002|FG001|Overall Study|Withdrawal by Subject|1|||
170829936|NCT01841697|617387003|FG000|Overall Study|Death|0|||
170829937|NCT01841697|617387004|FG001|Overall Study|Death|1|||
170829938|NCT01841697|617387003|FG000|Overall Study|Lost to Follow-up|4|||
170829939|NCT01841697|617387004|FG001|Overall Study|Lost to Follow-up|1|||
170716863|NCT01490632|616969503|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
170716864|NCT01490632|616969504|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
170716865|NCT01490632|616969505|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716866|NCT01490632|616969506|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716867|NCT01490632|616969507|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716868|NCT01490632|616969508|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716869|NCT01490632|616969509|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716870|NCT01490632|616969510|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716871|NCT01490632|616969511|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716872|NCT01490632|616969512|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716873|NCT01490632|616969513|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716874|NCT01490632|616969514|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716875|NCT01490632|616969515|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716876|NCT01490632|616969516|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716877|NCT01490632|616969517|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716878|NCT01490632|616969518|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716879|NCT01490632|616969519|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
170716880|NCT01490632|616969500|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
170716881|NCT01490632|616969501|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
170716882|NCT01490632|616969502|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
170716883|NCT01490632|616969503|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
170716884|NCT01490632|616969504|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
170716885|NCT01490632|616969505|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
170716886|NCT01490632|616969506|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
170716887|NCT01490632|616969507|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
170716888|NCT01490632|616969508|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
170716889|NCT01490632|616969509|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
170716890|NCT01490632|616969510|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
170716891|NCT01490632|616969511|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
170716892|NCT01490632|616969512|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
170716893|NCT01490632|616969513|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
170716894|NCT01490632|616969514|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
170716895|NCT01490632|616969515|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
170716896|NCT01490632|616969516|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
170716897|NCT01490632|616969517|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
170716898|NCT01490632|616969518|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
170716899|NCT01490632|616969519|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
170716900|NCT01490632|616969500|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
170716901|NCT01490632|616969501|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716902|NCT01490632|616969502|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716903|NCT01490632|616969503|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716904|NCT01490632|616969504|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716905|NCT01490632|616969505|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716906|NCT01490632|616969506|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716907|NCT01490632|616969507|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716908|NCT01490632|616969508|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716909|NCT01490632|616969509|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716910|NCT01490632|616969510|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716911|NCT01490632|616969511|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716912|NCT01490632|616969512|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716913|NCT01490632|616969513|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716914|NCT01490632|616969514|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716915|NCT01490632|616969515|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716916|NCT01490632|616969516|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716917|NCT01490632|616969517|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716918|NCT01490632|616969518|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716919|NCT01490632|616969519|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
170716920|NCT01490632|616969500|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
170716921|NCT01490632|616969501|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
170716922|NCT01490632|616969502|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716923|NCT01490632|616969503|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
170716924|NCT01490632|616969504|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
170716925|NCT01490632|616969505|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716926|NCT01490632|616969506|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716927|NCT01490632|616969507|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716928|NCT01490632|616969508|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716929|NCT01490632|616969509|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716930|NCT01490632|616969510|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716931|NCT01490632|616969511|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716932|NCT01490632|616969512|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716933|NCT01490632|616969513|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716934|NCT01490632|616969514|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716935|NCT01490632|616969515|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716936|NCT01490632|616969516|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716937|NCT01490632|616969517|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716938|NCT01490632|616969518|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716939|NCT01490632|616969519|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
170716940|NCT01490632|616969500|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716941|NCT01490632|616969501|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716942|NCT01490632|616969502|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716943|NCT01490632|616969503|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716944|NCT01490632|616969504|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
170716945|NCT01490632|616969505|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716946|NCT01490632|616969506|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716947|NCT01490632|616969507|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716948|NCT01490632|616969508|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716949|NCT01490632|616969509|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716950|NCT01490632|616969510|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716951|NCT01490632|616969511|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716952|NCT01490632|616969512|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716953|NCT01490632|616969513|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716954|NCT01490632|616969514|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716955|NCT01490632|616969515|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716956|NCT01490632|616969516|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716957|NCT01490632|616969517|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716958|NCT01490632|616969518|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716959|NCT01490632|616969519|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
170716960|NCT01490632|616969500|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716961|NCT01490632|616969501|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716962|NCT01490632|616969502|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716963|NCT01490632|616969503|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716964|NCT01490632|616969504|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716965|NCT01490632|616969505|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
170716966|NCT01490632|616969506|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
170716967|NCT01490632|616969507|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716968|NCT01490632|616969508|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716969|NCT01490632|616969509|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
170829940|NCT01841697|617387003|FG000|Overall Study|Withdrawal by Subject|16|||
170829941|NCT01841697|617387004|FG001|Overall Study|Withdrawal by Subject|16|||
170829942|NCT00832000|617387009|FG000|Overall Study|Adverse Event|2|||
170829943|NCT00832000|617387010|FG001|Overall Study|Adverse Event|0|||
170829944|NCT00832000|617387009|FG000|Overall Study|Withdrawal by Subject|1|||
170829945|NCT00832000|617387010|FG001|Overall Study|Withdrawal by Subject|0|||
170829946|NCT00832000|617387009|FG000|Overall Study|No calls to IVR in either period|1|||
170829947|NCT00832000|617387010|FG001|Overall Study|No calls to IVR in either period|1|||
170829948|NCT00832000|617387009|FG000|Overall Study|No calls to IVR in period 2|2|||
170829949|NCT00832000|617387010|FG001|Overall Study|No calls to IVR in period 2|0|||
170829950|NCT00255944|617387011|FG000|Overall Study|Lost to Follow-up|797|||
170829951|NCT00255944|617387012|FG001|Overall Study|Lost to Follow-up|834|||
170829952|NCT01121913|617387013|FG000|First Intervention Period|Adverse Event|0|||
170829953|NCT01121913|617387014|FG001|First Intervention Period|Adverse Event|0|||
170829954|NCT01121913|617387015|FG002|First Intervention Period|Adverse Event|1|||
170829955|NCT01121913|617387016|FG003|First Intervention Period|Adverse Event|0|||
170829956|NCT01121913|617387013|FG000|First Washout Period|Withdrawal by Subject|1|||
170829957|NCT01121913|617387014|FG001|First Washout Period|Withdrawal by Subject|0|||
170829958|NCT01121913|617387015|FG002|First Washout Period|Withdrawal by Subject|0|||
170829959|NCT01121913|617387016|FG003|First Washout Period|Withdrawal by Subject|0|||
170829960|NCT01121913|617387013|FG000|Second Intervention Period|Adverse Event|0|||
170829961|NCT01121913|617387014|FG001|Second Intervention Period|Adverse Event|0|||
170829962|NCT01121913|617387015|FG002|Second Intervention Period|Adverse Event|1|||
170829963|NCT01121913|617387016|FG003|Second Intervention Period|Adverse Event|0|||
170829964|NCT01121913|617387013|FG000|Second Washout Period|Withdrawal by Subject|0|||
170829965|NCT01121913|617387014|FG001|Second Washout Period|Withdrawal by Subject|0|||
170829966|NCT01121913|617387015|FG002|Second Washout Period|Withdrawal by Subject|1|||
170829967|NCT01121913|617387016|FG003|Second Washout Period|Withdrawal by Subject|0|||
170829968|NCT01121913|617387013|FG000|Third Washout Period|Adverse Event|1|||
170829969|NCT01121913|617387014|FG001|Third Washout Period|Adverse Event|0|||
170829970|NCT01121913|617387015|FG002|Third Washout Period|Adverse Event|0|||
170829971|NCT01121913|617387016|FG003|Third Washout Period|Adverse Event|0|||
170829972|NCT03318783|617387023|FG000|Overall Study|Withdrawal by Subject|0|||
170829973|NCT03318783|617387024|FG001|Overall Study|Withdrawal by Subject|1|||
170829974|NCT03318783|617387023|FG000|Overall Study|Death|0|||
170829975|NCT03318783|617387024|FG001|Overall Study|Death|1|||
170829976|NCT03856047|617387025|FG000|Overall Study|Withdrawal by Subject|0|||
170829977|NCT03856047|617387026|FG001|Overall Study|Withdrawal by Subject|1|||
170829978|NCT03856047|617387027|FG002|Overall Study|Withdrawal by Subject|1|||
170829979|NCT03856047|617387028|FG003|Overall Study|Withdrawal by Subject|0|||
170829980|NCT03856047|617387029|FG004|Overall Study|Withdrawal by Subject|3|||
170829981|NCT03856047|617387030|FG005|Overall Study|Withdrawal by Subject|0|||
170829982|NCT03856047|617387031|FG006|Overall Study|Withdrawal by Subject|2|||
170829983|NCT03856047|617387025|FG000|Overall Study|Lost to Follow-up|4|||
170829984|NCT03856047|617387026|FG001|Overall Study|Lost to Follow-up|2|||
170829985|NCT03856047|617387027|FG002|Overall Study|Lost to Follow-up|3|||
170829986|NCT03856047|617387028|FG003|Overall Study|Lost to Follow-up|1|||
170829987|NCT03856047|617387029|FG004|Overall Study|Lost to Follow-up|4|||
170829988|NCT03856047|617387030|FG005|Overall Study|Lost to Follow-up|4|||
170829989|NCT03856047|617387031|FG006|Overall Study|Lost to Follow-up|4|||
170829990|NCT02447718|617387038|FG000|Overall Study|Lost to Follow-up|8|||
170829991|NCT02447718|617387039|FG001|Overall Study|Lost to Follow-up|0|||
170829992|NCT02447718|617387038|FG000|Overall Study|Withdrawal by Subject|3|||
170716970|NCT01490632|616969510|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
170716971|NCT01490632|616969511|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
170716972|NCT01490632|616969512|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716973|NCT01490632|616969513|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716974|NCT01490632|616969514|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716975|NCT01490632|616969515|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716976|NCT01490632|616969516|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716977|NCT01490632|616969517|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716978|NCT01490632|616969518|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716979|NCT01490632|616969519|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
170716980|NCT01490632|616969500|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716981|NCT01490632|616969501|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716982|NCT01490632|616969502|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716983|NCT01490632|616969503|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716984|NCT01490632|616969504|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716985|NCT01490632|616969505|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716986|NCT01490632|616969506|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
170716987|NCT01490632|616969507|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716988|NCT01490632|616969508|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
170716989|NCT01490632|616969509|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
170716990|NCT01490632|616969510|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
170716991|NCT01490632|616969511|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716992|NCT01490632|616969512|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716993|NCT01490632|616969513|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716994|NCT01490632|616969514|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170829993|NCT02447718|617387039|FG001|Overall Study|Withdrawal by Subject|0|||
170716995|NCT01490632|616969515|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716996|NCT01490632|616969516|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716997|NCT01490632|616969517|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170829994|NCT02447718|617387038|FG000|Overall Study|Screen Failure|1|||
170829995|NCT02447718|617387039|FG001|Overall Study|Screen Failure|0|||
170829996|NCT00239681|617387040|FG000|Overall Study|Adverse Event|100|||
170829997|NCT00239681|617387041|FG001|Overall Study|Adverse Event|99|||
170829998|NCT00239681|617387040|FG000|Overall Study|Withdrawal by Subject|458|||
170829999|NCT00239681|617387041|FG001|Overall Study|Withdrawal by Subject|489|||
170830000|NCT00239681|617387040|FG000|Overall Study|Lost to Follow-up|28|||
170830001|NCT00239681|617387041|FG001|Overall Study|Lost to Follow-up|22|||
170716998|NCT01490632|616969518|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170716999|NCT01490632|616969519|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
170717000|NCT01490632|616969500|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717001|NCT01490632|616969501|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717002|NCT01490632|616969502|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717003|NCT01490632|616969503|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717004|NCT01490632|616969504|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717005|NCT01490632|616969505|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717006|NCT01490632|616969506|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
170717007|NCT01490632|616969507|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717008|NCT01490632|616969508|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717009|NCT01490632|616969509|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
170717010|NCT01490632|616969510|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717011|NCT01490632|616969511|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717012|NCT01490632|616969512|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717013|NCT01490632|616969513|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717014|NCT01490632|616969514|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717015|NCT01490632|616969515|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717016|NCT01490632|616969516|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717017|NCT01490632|616969517|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717018|NCT01490632|616969518|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717019|NCT01490632|616969519|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
170717020|NCT01490632|616969500|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717021|NCT01490632|616969501|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717022|NCT01490632|616969502|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717023|NCT01490632|616969503|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717024|NCT01490632|616969504|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717025|NCT01490632|616969505|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717026|NCT01490632|616969506|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
170717027|NCT01490632|616969507|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717028|NCT01490632|616969508|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717029|NCT01490632|616969509|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717030|NCT01490632|616969510|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717031|NCT01490632|616969511|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717032|NCT01490632|616969512|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717033|NCT01490632|616969513|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717034|NCT01490632|616969514|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717035|NCT01490632|616969515|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717036|NCT01490632|616969516|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717037|NCT01490632|616969517|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717038|NCT01490632|616969518|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717039|NCT01490632|616969519|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
170717040|NCT01490632|616969500|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717041|NCT01490632|616969501|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717042|NCT01490632|616969502|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717043|NCT01490632|616969503|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717044|NCT01490632|616969504|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717045|NCT01490632|616969505|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
170717046|NCT01490632|616969506|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717047|NCT01490632|616969507|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717048|NCT01490632|616969508|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717049|NCT01490632|616969509|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717050|NCT01490632|616969510|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717051|NCT01490632|616969511|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717052|NCT01490632|616969512|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717053|NCT01490632|616969513|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717054|NCT01490632|616969514|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717055|NCT01490632|616969515|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717056|NCT01490632|616969516|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717057|NCT01490632|616969517|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717058|NCT01490632|616969518|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717059|NCT01490632|616969519|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
170717060|NCT01490632|616969500|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717061|NCT01490632|616969501|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717062|NCT01490632|616969502|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170830002|NCT00239681|617387040|FG000|Overall Study|Protocol Violation|4|||
170830003|NCT00239681|617387041|FG001|Overall Study|Protocol Violation|4|||
170830004|NCT00239681|617387040|FG000|Overall Study|Physician Decision|13|||
170830005|NCT00239681|617387041|FG001|Overall Study|Physician Decision|17|||
170830006|NCT00239681|617387040|FG000|Overall Study|No information chacked on CaseReportForm|90|||
170830007|NCT00239681|617387041|FG001|Overall Study|No information chacked on CaseReportForm|84|||
170830008|NCT00436956|617387046|FG000|Overall Study|Not evaluable|1|||
170830009|NCT00436956|617387047|FG001|Overall Study|Not evaluable|0|||
170830010|NCT02725528|617387052|FG000|Overall Study|Lost to Follow-up|1|||
170830011|NCT02725528|617387053|FG001|Overall Study|Lost to Follow-up|4|||
170830012|NCT02725528|617387052|FG000|Overall Study|Withdrawal by Subject|0|||
170830013|NCT02725528|617387053|FG001|Overall Study|Withdrawal by Subject|1|||
170830014|NCT02706847|617387054|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
170830015|NCT02706847|617387055|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
170830016|NCT02706847|617387056|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
170830017|NCT02706847|617387057|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
170830018|NCT02706847|617387054|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
170830019|NCT02706847|617387055|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
170830020|NCT02706847|617387056|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
170830021|NCT02706847|617387057|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
170830022|NCT02706847|617387054|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
170830023|NCT02706847|617387055|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
170830024|NCT02706847|617387056|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
170830025|NCT02706847|617387057|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
170830026|NCT02706847|617387054|FG000|Period 1: Day 1 to Week 12|Other|4|||
170830027|NCT02706847|617387055|FG001|Period 1: Day 1 to Week 12|Other|4|||
170830028|NCT02706847|617387056|FG002|Period 1: Day 1 to Week 12|Other|2|||
170830029|NCT02706847|617387057|FG003|Period 1: Day 1 to Week 12|Other|2|||
170830030|NCT02706847|617387054|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
170830031|NCT02706847|617387055|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
170830032|NCT02706847|617387056|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
170830033|NCT02706847|617387057|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
170830034|NCT02706847|617387054|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
170830035|NCT02706847|617387055|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
170830036|NCT02706847|617387056|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
170830037|NCT02706847|617387057|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
170830038|NCT02706847|617387054|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
170830039|NCT02706847|617387055|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
170830040|NCT02706847|617387056|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
170830041|NCT02706847|617387057|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
170830042|NCT02706847|617387054|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
170830043|NCT02706847|617387055|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
170830044|NCT02706847|617387056|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
170830045|NCT02706847|617387057|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
170830046|NCT02706847|617387054|FG000|Period 1: Week 12 to Week 24|Other|1|||
170830047|NCT02706847|617387055|FG001|Period 1: Week 12 to Week 24|Other|0|||
170830048|NCT02706847|617387056|FG002|Period 1: Week 12 to Week 24|Other|1|||
170830049|NCT02706847|617387057|FG003|Period 1: Week 12 to Week 24|Other|4|||
170830050|NCT02706847|617387054|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
170830051|NCT02706847|617387055|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
170830052|NCT02706847|617387056|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
170830053|NCT02706847|617387057|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
170830054|NCT02706847|617387054|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
170830055|NCT02706847|617387055|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
170830056|NCT02706847|617387056|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
170830057|NCT02706847|617387057|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
170830058|NCT02706847|617387054|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
170830059|NCT02706847|617387055|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
170830060|NCT02706847|617387056|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
170830061|NCT02706847|617387057|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
170830062|NCT02706847|617387054|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
170830063|NCT02706847|617387055|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
170830064|NCT02706847|617387056|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
170830065|NCT02706847|617387057|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
170830066|NCT02706847|617387054|FG000|Period 2: Week 24 to Week 260|Other|8|||
170830067|NCT02706847|617387055|FG001|Period 2: Week 24 to Week 260|Other|5|||
170717063|NCT01490632|616969503|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717064|NCT01490632|616969504|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717065|NCT01490632|616969505|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717066|NCT01490632|616969506|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
170717067|NCT01490632|616969507|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717068|NCT01490632|616969508|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
170717069|NCT01490632|616969509|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717070|NCT01490632|616969510|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
170717071|NCT01490632|616969511|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
170717072|NCT01490632|616969512|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717073|NCT01490632|616969513|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717074|NCT01490632|616969514|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717075|NCT01490632|616969515|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717076|NCT01490632|616969516|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717077|NCT01490632|616969517|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717078|NCT01490632|616969518|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717079|NCT01490632|616969519|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
170717080|NCT01490632|616969500|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170830068|NCT02706847|617387056|FG002|Period 2: Week 24 to Week 260|Other|15|||
170830069|NCT02706847|617387057|FG003|Period 2: Week 24 to Week 260|Other|15|||
170830070|NCT01174264|617387058|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
170830071|NCT01174264|617387059|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
170830072|NCT01174264|617387060|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
170830073|NCT01174264|617387058|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
170830074|NCT01174264|617387059|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
170830075|NCT01174264|617387060|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
170830076|NCT01174264|617387058|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
170830077|NCT01174264|617387059|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
170830078|NCT01174264|617387060|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
170830079|NCT00562484|617387071|FG000|Overall Study|Adverse Event|6|||
170830080|NCT00562484|617387072|FG001|Overall Study|Adverse Event|1|||
170830081|NCT00562484|617387071|FG000|Overall Study|Protocol Violation|11|||
170830082|NCT00562484|617387072|FG001|Overall Study|Protocol Violation|2|||
170830083|NCT00562484|617387071|FG000|Overall Study|Withdrawal by Subject|12|||
170830084|NCT00562484|617387072|FG001|Overall Study|Withdrawal by Subject|9|||
170830085|NCT00562484|617387071|FG000|Overall Study|Moved away from the study area|20|||
170830086|NCT00562484|617387072|FG001|Overall Study|Moved away from the study area|9|||
170830087|NCT00562484|617387071|FG000|Overall Study|Lost to Follow-up|132|||
170830088|NCT00562484|617387072|FG001|Overall Study|Lost to Follow-up|71|||
170830089|NCT00562484|617387071|FG000|Overall Study|Reason not provided or not specified|25|||
170830090|NCT00562484|617387072|FG001|Overall Study|Reason not provided or not specified|12|||
170830091|NCT00702520|617387074|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
170830092|NCT00702520|617387075|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
170830093|NCT00702520|617387076|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
170830094|NCT00702520|617387077|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
170830095|NCT00702520|617387074|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
170830096|NCT00702520|617387075|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
170830097|NCT00702520|617387076|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
170830098|NCT00702520|617387077|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
170830099|NCT00702520|617387074|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
170830100|NCT00702520|617387075|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
170830101|NCT00702520|617387076|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
170830102|NCT00702520|617387077|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
170830103|NCT00514813|617387080|FG000|Overall Study|Study terminated|14|||
170830104|NCT00514813|617387081|FG001|Overall Study|Study terminated|74|||
170830105|NCT00514813|617387082|FG002|Overall Study|Study terminated|40|||
170830106|NCT00514813|617387083|FG003|Overall Study|Study terminated|2|||
170830107|NCT00514813|617387080|FG000|Overall Study|Adverse Event|0|||
170830108|NCT00514813|617387081|FG001|Overall Study|Adverse Event|2|||
170830109|NCT00514813|617387082|FG002|Overall Study|Adverse Event|2|||
170830110|NCT00514813|617387083|FG003|Overall Study|Adverse Event|0|||
170830111|NCT00514813|617387080|FG000|Overall Study|Protocol Violation|1|||
170830112|NCT00514813|617387081|FG001|Overall Study|Protocol Violation|0|||
170830113|NCT00514813|617387082|FG002|Overall Study|Protocol Violation|0|||
170830114|NCT00514813|617387083|FG003|Overall Study|Protocol Violation|0|||
170830115|NCT00514813|617387080|FG000|Overall Study|Withdrawal by Subject|0|||
170830116|NCT00514813|617387081|FG001|Overall Study|Withdrawal by Subject|1|||
170830117|NCT00514813|617387082|FG002|Overall Study|Withdrawal by Subject|0|||
170830118|NCT00514813|617387083|FG003|Overall Study|Withdrawal by Subject|0|||
170830119|NCT00514813|617387080|FG000|Overall Study|Lack of Efficacy|0|||
170830120|NCT00514813|617387081|FG001|Overall Study|Lack of Efficacy|1|||
170830121|NCT00514813|617387082|FG002|Overall Study|Lack of Efficacy|0|||
170830122|NCT00514813|617387083|FG003|Overall Study|Lack of Efficacy|0|||
170830123|NCT00514813|617387080|FG000|Overall Study|Kidney transplant|0|||
170830124|NCT00514813|617387081|FG001|Overall Study|Kidney transplant|6|||
170830125|NCT00514813|617387082|FG002|Overall Study|Kidney transplant|2|||
170830126|NCT00514813|617387083|FG003|Overall Study|Kidney transplant|0|||
170830127|NCT00514813|617387080|FG000|Overall Study|Death|0|||
170830128|NCT00514813|617387081|FG001|Overall Study|Death|2|||
170830129|NCT00514813|617387082|FG002|Overall Study|Death|3|||
170830130|NCT00514813|617387083|FG003|Overall Study|Death|2|||
170830131|NCT01075100|617387084|FG000|Overall Study|Adverse Event|15|||
170830132|NCT01075100|617387085|FG001|Overall Study|Adverse Event|18|||
170830133|NCT01075100|617387084|FG000|Overall Study|Patient Request|4|||
170830134|NCT01075100|617387085|FG001|Overall Study|Patient Request|4|||
170830135|NCT01075100|617387084|FG000|Overall Study|Investigator Request|2|||
170830136|NCT01075100|617387085|FG001|Overall Study|Investigator Request|1|||
170830137|NCT01075100|617387084|FG000|Overall Study|Disease Progression|25|||
170830138|NCT01075100|617387085|FG001|Overall Study|Disease Progression|29|||
170830139|NCT01075100|617387084|FG000|Overall Study|Other|3|||
170830140|NCT01075100|617387085|FG001|Overall Study|Other|1|||
170830141|NCT04944784|617387086|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
170830142|NCT04944784|617387087|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
170830143|NCT04944784|617387088|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
170830144|NCT04944784|617387089|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
170830145|NCT04944784|617387086|FG000|Double-blind Period|Adverse Event|20|||
170830146|NCT04944784|617387087|FG001|Double-blind Period|Adverse Event|4|||
170830147|NCT04944784|617387088|FG002|Double-blind Period|Adverse Event|0|||
170830148|NCT04944784|617387089|FG003|Double-blind Period|Adverse Event|0|||
170830149|NCT04944784|617387086|FG000|Double-blind Period|Withdrawal by Subject|15|||
170830150|NCT04944784|617387087|FG001|Double-blind Period|Withdrawal by Subject|4|||
170830151|NCT04944784|617387088|FG002|Double-blind Period|Withdrawal by Subject|0|||
170830152|NCT04944784|617387089|FG003|Double-blind Period|Withdrawal by Subject|0|||
170830153|NCT04944784|617387086|FG000|Double-blind Period|Death|7|||
170830154|NCT04944784|617387087|FG001|Double-blind Period|Death|2|||
170830155|NCT04944784|617387088|FG002|Double-blind Period|Death|0|||
170830156|NCT04944784|617387089|FG003|Double-blind Period|Death|0|||
170830157|NCT04944784|617387086|FG000|Double-blind Period|Physician Decision|2|||
170830158|NCT04944784|617387087|FG001|Double-blind Period|Physician Decision|1|||
170830159|NCT04944784|617387088|FG002|Double-blind Period|Physician Decision|0|||
170830160|NCT04944784|617387089|FG003|Double-blind Period|Physician Decision|0|||
170830161|NCT04944784|617387086|FG000|Double-blind Period|Lack of Efficacy|0|||
170830162|NCT04944784|617387087|FG001|Double-blind Period|Lack of Efficacy|1|||
170830163|NCT04944784|617387088|FG002|Double-blind Period|Lack of Efficacy|0|||
170830164|NCT04944784|617387089|FG003|Double-blind Period|Lack of Efficacy|0|||
170830165|NCT04944784|617387086|FG000|Double-blind Period|Sponsor Request|2|||
170830166|NCT04944784|617387087|FG001|Double-blind Period|Sponsor Request|1|||
170830167|NCT04944784|617387088|FG002|Double-blind Period|Sponsor Request|0|||
170830168|NCT04944784|617387089|FG003|Double-blind Period|Sponsor Request|0|||
170830169|NCT04944784|617387086|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
170830170|NCT04944784|617387087|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
170830171|NCT04944784|617387088|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
170830172|NCT04944784|617387089|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
170830173|NCT04944784|617387086|FG000|Double-blind Period|Participant Choice|1|||
170830174|NCT04944784|617387087|FG001|Double-blind Period|Participant Choice|1|||
170830175|NCT04944784|617387088|FG002|Double-blind Period|Participant Choice|0|||
170830176|NCT04944784|617387089|FG003|Double-blind Period|Participant Choice|0|||
170830177|NCT04944784|617387086|FG000|Double-blind Period|Progressive Disease|2|||
170830178|NCT04944784|617387087|FG001|Double-blind Period|Progressive Disease|2|||
170830179|NCT04944784|617387088|FG002|Double-blind Period|Progressive Disease|0|||
170830180|NCT04944784|617387089|FG003|Double-blind Period|Progressive Disease|0|||
170830181|NCT04944784|617387086|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
170830182|NCT04944784|617387087|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
170830183|NCT04944784|617387088|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
170830184|NCT04944784|617387089|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
170830185|NCT04944784|617387086|FG000|Active Drug Period|Adverse Event|0|||
170830186|NCT04944784|617387087|FG001|Active Drug Period|Adverse Event|0|||
170717081|NCT01490632|616969501|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717082|NCT01490632|616969502|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717083|NCT01490632|616969503|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717084|NCT01490632|616969504|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717085|NCT01490632|616969505|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
170717086|NCT01490632|616969506|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
170717087|NCT01490632|616969507|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
170717088|NCT01490632|616969508|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
170717089|NCT01490632|616969509|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
170717090|NCT01490632|616969510|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
170717091|NCT01490632|616969511|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
170717092|NCT01490632|616969512|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717093|NCT01490632|616969513|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717094|NCT01490632|616969514|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717095|NCT01490632|616969515|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717096|NCT01490632|616969516|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717097|NCT01490632|616969517|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717098|NCT01490632|616969518|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717099|NCT01490632|616969519|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
170717100|NCT01490632|616969500|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717101|NCT01490632|616969501|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717102|NCT01490632|616969502|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717103|NCT01490632|616969503|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717104|NCT01490632|616969504|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717105|NCT01490632|616969505|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717106|NCT01490632|616969506|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717107|NCT01490632|616969507|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717108|NCT01490632|616969508|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717109|NCT01490632|616969509|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717110|NCT01490632|616969510|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717111|NCT01490632|616969511|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717112|NCT01490632|616969512|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717113|NCT01490632|616969513|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717114|NCT01490632|616969514|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
170717115|NCT01490632|616969515|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
170717116|NCT01490632|616969516|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717117|NCT01490632|616969517|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717118|NCT01490632|616969518|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717119|NCT01490632|616969519|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
170717120|NCT01490632|616969500|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717121|NCT01490632|616969501|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717122|NCT01490632|616969502|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717123|NCT01490632|616969503|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717124|NCT01490632|616969504|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717125|NCT01490632|616969505|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717126|NCT01490632|616969506|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717127|NCT01490632|616969507|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717128|NCT01490632|616969508|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717129|NCT01490632|616969509|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717130|NCT01490632|616969510|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717131|NCT01490632|616969511|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717132|NCT01490632|616969512|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717133|NCT01490632|616969513|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
170717134|NCT01490632|616969514|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717135|NCT01490632|616969515|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717136|NCT01490632|616969516|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717137|NCT01490632|616969517|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717138|NCT01490632|616969518|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717139|NCT01490632|616969519|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
170717140|NCT01490632|616969500|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717141|NCT01490632|616969501|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717142|NCT01490632|616969502|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717143|NCT01490632|616969503|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717144|NCT01490632|616969504|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717145|NCT01490632|616969505|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717146|NCT01490632|616969506|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717147|NCT01490632|616969507|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717148|NCT01490632|616969508|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717149|NCT01490632|616969509|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717150|NCT01490632|616969510|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717151|NCT01490632|616969511|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717152|NCT01490632|616969512|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717153|NCT01490632|616969513|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717154|NCT01490632|616969514|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
170717155|NCT01490632|616969515|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
170717156|NCT01490632|616969516|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717157|NCT01490632|616969517|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717158|NCT01490632|616969518|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717159|NCT01490632|616969519|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
170717160|NCT01490632|616969500|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717161|NCT01490632|616969501|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717162|NCT01490632|616969502|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717163|NCT01490632|616969503|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717164|NCT01490632|616969504|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717165|NCT01490632|616969505|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717166|NCT01490632|616969506|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717167|NCT01490632|616969507|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717168|NCT01490632|616969508|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717169|NCT01490632|616969509|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717170|NCT01490632|616969510|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717171|NCT01490632|616969511|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717172|NCT01490632|616969512|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
170717173|NCT01490632|616969513|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
170717174|NCT01490632|616969514|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
170717175|NCT01490632|616969515|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
170717176|NCT01490632|616969516|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717177|NCT01490632|616969517|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717178|NCT01490632|616969518|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717179|NCT01490632|616969519|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
170717180|NCT01490632|616969500|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
170717181|NCT01490632|616969501|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
170717182|NCT01490632|616969502|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
170717183|NCT01490632|616969503|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
170717184|NCT01490632|616969504|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
170717185|NCT01490632|616969505|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
170717186|NCT01490632|616969506|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
170717187|NCT01490632|616969507|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
170717188|NCT01490632|616969508|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
170717189|NCT01490632|616969509|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
170717190|NCT01490632|616969510|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
170717191|NCT01490632|616969511|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
170717192|NCT01490632|616969512|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
170717193|NCT01490632|616969513|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
170717194|NCT01490632|616969514|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
170717195|NCT01490632|616969515|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
170717196|NCT01490632|616969516|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
170717197|NCT01490632|616969517|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
170717198|NCT01490632|616969518|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
170717199|NCT01490632|616969519|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
170717200|NCT01490632|616969500|FG000|Part D: Re-Treatment Period|Death|0|||
170717201|NCT01490632|616969501|FG001|Part D: Re-Treatment Period|Death|0|||
170717202|NCT01490632|616969502|FG002|Part D: Re-Treatment Period|Death|0|||
170717203|NCT01490632|616969503|FG003|Part D: Re-Treatment Period|Death|0|||
170717204|NCT01490632|616969504|FG004|Part D: Re-Treatment Period|Death|0|||
170717205|NCT01490632|616969505|FG005|Part D: Re-Treatment Period|Death|0|||
170717206|NCT01490632|616969506|FG006|Part D: Re-Treatment Period|Death|0|||
170717207|NCT01490632|616969507|FG007|Part D: Re-Treatment Period|Death|0|||
170717208|NCT01490632|616969508|FG008|Part D: Re-Treatment Period|Death|0|||
170717209|NCT01490632|616969509|FG009|Part D: Re-Treatment Period|Death|0|||
170717210|NCT01490632|616969510|FG010|Part D: Re-Treatment Period|Death|0|||
170717211|NCT01490632|616969511|FG011|Part D: Re-Treatment Period|Death|0|||
170717212|NCT01490632|616969512|FG012|Part D: Re-Treatment Period|Death|0|||
170717213|NCT01490632|616969513|FG013|Part D: Re-Treatment Period|Death|0|||
170717214|NCT01490632|616969514|FG014|Part D: Re-Treatment Period|Death|0|||
170717215|NCT01490632|616969515|FG015|Part D: Re-Treatment Period|Death|0|||
170717216|NCT01490632|616969516|FG016|Part D: Re-Treatment Period|Death|0|||
170717217|NCT01490632|616969517|FG017|Part D: Re-Treatment Period|Death|0|||
170717218|NCT01490632|616969518|FG018|Part D: Re-Treatment Period|Death|1|||
170717219|NCT01490632|616969519|FG019|Part D: Re-Treatment Period|Death|0|||
170717220|NCT01490632|616969500|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717221|NCT01490632|616969501|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717222|NCT01490632|616969502|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717223|NCT01490632|616969503|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717224|NCT01490632|616969504|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717225|NCT01490632|616969505|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717226|NCT01490632|616969506|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717227|NCT01490632|616969507|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717228|NCT01490632|616969508|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717229|NCT01490632|616969509|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717230|NCT01490632|616969510|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717231|NCT01490632|616969511|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717232|NCT01490632|616969512|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717233|NCT01490632|616969513|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717234|NCT01490632|616969514|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717235|NCT01490632|616969515|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717236|NCT01490632|616969516|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
170717237|NCT01490632|616969517|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
170717238|NCT01490632|616969518|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
170717239|NCT01490632|616969519|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
170717240|NCT01490632|616969500|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717241|NCT01490632|616969501|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717242|NCT01490632|616969502|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717243|NCT01490632|616969503|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717244|NCT01490632|616969504|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717245|NCT01490632|616969505|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717246|NCT01490632|616969506|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717247|NCT01490632|616969507|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717248|NCT01490632|616969508|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717249|NCT01490632|616969509|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717250|NCT01490632|616969510|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717251|NCT01490632|616969511|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717252|NCT01490632|616969512|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717253|NCT01490632|616969513|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717254|NCT01490632|616969514|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717255|NCT01490632|616969515|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717256|NCT01490632|616969516|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717257|NCT01490632|616969517|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717258|NCT01490632|616969518|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
170717259|NCT01490632|616969519|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
170717260|NCT01490632|616969500|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
170717261|NCT01490632|616969501|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
170717262|NCT01490632|616969502|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
170717263|NCT01490632|616969503|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
170717264|NCT01490632|616969504|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
170717265|NCT01490632|616969505|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
170717266|NCT01490632|616969506|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
170717267|NCT01490632|616969507|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
170717268|NCT01490632|616969508|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
170717269|NCT01490632|616969509|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
170717270|NCT01490632|616969510|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
170717271|NCT01490632|616969511|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
170717272|NCT01490632|616969512|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
170717273|NCT01490632|616969513|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
170717274|NCT01490632|616969514|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
170717275|NCT01490632|616969515|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
170717276|NCT01490632|616969516|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
170717277|NCT01490632|616969517|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
170717278|NCT01490632|616969518|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
170717279|NCT01490632|616969519|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
170717280|NCT01490632|616969500|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
170717281|NCT01490632|616969501|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
170717282|NCT01490632|616969502|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
170717283|NCT01490632|616969503|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
170717284|NCT01490632|616969504|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
170717285|NCT01490632|616969505|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
170717286|NCT01490632|616969506|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
170717287|NCT01490632|616969507|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
170717288|NCT01490632|616969508|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
170717289|NCT01490632|616969509|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
170717290|NCT01490632|616969510|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
170717291|NCT01490632|616969511|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
170717292|NCT01490632|616969512|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
170717293|NCT01490632|616969513|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
170717294|NCT01490632|616969514|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
170717295|NCT01490632|616969515|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
170717296|NCT01490632|616969516|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
170717297|NCT01490632|616969517|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
170717298|NCT01490632|616969518|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
170717299|NCT01490632|616969519|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
170717300|NCT01490632|616969500|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717301|NCT01490632|616969501|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717302|NCT01490632|616969502|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717303|NCT01490632|616969503|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717304|NCT01490632|616969504|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717305|NCT01490632|616969505|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717306|NCT01490632|616969506|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717307|NCT01490632|616969507|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717308|NCT01490632|616969508|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717309|NCT01490632|616969509|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717310|NCT01490632|616969510|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717311|NCT01490632|616969511|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717312|NCT01490632|616969512|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717313|NCT01490632|616969513|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717314|NCT01490632|616969514|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717315|NCT01490632|616969515|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717316|NCT01490632|616969516|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
170717317|NCT01490632|616969517|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
170717318|NCT01490632|616969518|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
170717319|NCT01490632|616969519|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
170717320|NCT05732454|616969520|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
170717321|NCT05732454|616969521|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
170717322|NCT05732454|616969520|FG000|Part 1: DB Period|Adverse Event|1|||
170717323|NCT05732454|616969521|FG001|Part 1: DB Period|Adverse Event|0|||
170717324|NCT05732454|616969520|FG000|Part 1: DB Period|Lost to Follow-up|1|||
170717325|NCT05732454|616969521|FG001|Part 1: DB Period|Lost to Follow-up|0|||
170717326|NCT05732454|616969520|FG000|Part 1: DB Period|Protocol Violation|0|||
170717327|NCT05732454|616969521|FG001|Part 1: DB Period|Protocol Violation|1|||
170717328|NCT05732454|616969520|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
170717329|NCT05732454|616969521|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
170717330|NCT05732454|616969520|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
170717331|NCT05732454|616969521|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
170717332|NCT05732454|616969520|FG000|Part 1: OLE Period|Adverse Event|0|||
170717333|NCT05732454|616969521|FG001|Part 1: OLE Period|Adverse Event|1|||
170717334|NCT05732454|616969520|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
170717335|NCT05732454|616969521|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
170717336|NCT01153633|616969522|FG000|Overall Study|Protocol Violation|1|||
170717337|NCT01153633|616969523|FG001|Overall Study|Protocol Violation|1|||
170717338|NCT01153633|616969522|FG000|Overall Study|Therapeutic failure|3|||
170717339|NCT01153633|616969523|FG001|Overall Study|Therapeutic failure|3|||
170717340|NCT00838110|616969524|FG000|Overall Study|Death|0|||
170717341|NCT00838110|616969525|FG001|Overall Study|Death|0|||
170717342|NCT00838110|616969526|FG002|Overall Study|Death|1|||
170717343|NCT00838110|616969527|FG003|Overall Study|Death|2|||
170717344|NCT00838110|616969524|FG000|Overall Study|Adverse Event|11|||
170717345|NCT00838110|616969525|FG001|Overall Study|Adverse Event|10|||
170717346|NCT00838110|616969526|FG002|Overall Study|Adverse Event|8|||
170717347|NCT00838110|616969527|FG003|Overall Study|Adverse Event|7|||
170717348|NCT00838110|616969524|FG000|Overall Study|Withdrawal by Subject|5|||
170717349|NCT00838110|616969525|FG001|Overall Study|Withdrawal by Subject|6|||
170717350|NCT00838110|616969526|FG002|Overall Study|Withdrawal by Subject|3|||
170717351|NCT00838110|616969527|FG003|Overall Study|Withdrawal by Subject|4|||
170717352|NCT00838110|616969524|FG000|Overall Study|Other|3|||
170717353|NCT00838110|616969525|FG001|Overall Study|Other|3|||
170717354|NCT00838110|616969526|FG002|Overall Study|Other|3|||
170717355|NCT00838110|616969527|FG003|Overall Study|Other|2|||
170717356|NCT00838110|616969524|FG000|Overall Study|Protocol Violation|0|||
170717357|NCT00838110|616969525|FG001|Overall Study|Protocol Violation|2|||
170717358|NCT00838110|616969526|FG002|Overall Study|Protocol Violation|1|||
170717359|NCT00838110|616969527|FG003|Overall Study|Protocol Violation|1|||
170717360|NCT00838110|616969524|FG000|Overall Study|Lost to Follow-up|3|||
170717361|NCT00838110|616969525|FG001|Overall Study|Lost to Follow-up|0|||
170717362|NCT00838110|616969526|FG002|Overall Study|Lost to Follow-up|0|||
170717363|NCT00838110|616969527|FG003|Overall Study|Lost to Follow-up|0|||
170717364|NCT00838110|616969524|FG000|Overall Study|Did not meet eligibility criteria|0|||
170717365|NCT00838110|616969525|FG001|Overall Study|Did not meet eligibility criteria|0|||
170717366|NCT00838110|616969526|FG002|Overall Study|Did not meet eligibility criteria|1|||
170717367|NCT00838110|616969527|FG003|Overall Study|Did not meet eligibility criteria|2|||
170717368|NCT00838110|616969524|FG000|Overall Study|Randomized but not treated|0|||
170830187|NCT04944784|617387088|FG002|Active Drug Period|Adverse Event|3|||
170830188|NCT04944784|617387089|FG003|Active Drug Period|Adverse Event|6|||
170830189|NCT04944784|617387086|FG000|Active Drug Period|Withdrawal by Subject|0|||
170830190|NCT04944784|617387087|FG001|Active Drug Period|Withdrawal by Subject|0|||
170830191|NCT04944784|617387088|FG002|Active Drug Period|Withdrawal by Subject|4|||
170830192|NCT04944784|617387089|FG003|Active Drug Period|Withdrawal by Subject|7|||
170830193|NCT04944784|617387086|FG000|Active Drug Period|Death|0|||
170830194|NCT04944784|617387087|FG001|Active Drug Period|Death|0|||
170830195|NCT04944784|617387088|FG002|Active Drug Period|Death|3|||
170830196|NCT04944784|617387089|FG003|Active Drug Period|Death|4|||
170830197|NCT04944784|617387086|FG000|Active Drug Period|Lack of Efficacy|0|||
170830198|NCT04944784|617387087|FG001|Active Drug Period|Lack of Efficacy|0|||
170830199|NCT04944784|617387088|FG002|Active Drug Period|Lack of Efficacy|2|||
170830200|NCT04944784|617387089|FG003|Active Drug Period|Lack of Efficacy|2|||
170830201|NCT04944784|617387086|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
170830202|NCT04944784|617387087|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
170830203|NCT04944784|617387088|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
170830204|NCT04944784|617387089|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
170830205|NCT04944784|617387086|FG000|Active Drug Period|Participant Choice|0|||
170830206|NCT04944784|617387087|FG001|Active Drug Period|Participant Choice|0|||
170830207|NCT04944784|617387088|FG002|Active Drug Period|Participant Choice|0|||
170830208|NCT04944784|617387089|FG003|Active Drug Period|Participant Choice|1|||
170830209|NCT04944784|617387086|FG000|Active Drug Period|Progressive Disease|0|||
170830210|NCT04944784|617387087|FG001|Active Drug Period|Progressive Disease|0|||
170830211|NCT04944784|617387088|FG002|Active Drug Period|Progressive Disease|4|||
170830212|NCT04944784|617387089|FG003|Active Drug Period|Progressive Disease|4|||
170830213|NCT04944784|617387086|FG000|Active Drug Period|Lost to Follow-up|0|||
170830214|NCT04944784|617387087|FG001|Active Drug Period|Lost to Follow-up|0|||
170830215|NCT04944784|617387088|FG002|Active Drug Period|Lost to Follow-up|0|||
170830216|NCT04944784|617387089|FG003|Active Drug Period|Lost to Follow-up|1|||
170830217|NCT00966264|617388568|FG000|Overall Study|Lost to Follow-up|4|||
170830218|NCT00966264|617388569|FG001|Overall Study|Lost to Follow-up|3|||
170830219|NCT00903760|617388570|FG000|Overall Study|Disease Progression/Death|8|||
170830220|NCT00903760|617388571|FG001|Overall Study|Disease Progression/Death|6|||
170830221|NCT00903760|617388570|FG000|Overall Study|Stem Cell Transplant|8|||
170830222|NCT00903760|617388571|FG001|Overall Study|Stem Cell Transplant|4|||
170830223|NCT00903760|617388570|FG000|Overall Study|Physician Decision|1|||
170830224|NCT00903760|617388571|FG001|Overall Study|Physician Decision|2|||
170830225|NCT00903760|617388570|FG000|Overall Study|Death|0|||
170830226|NCT00903760|617388571|FG001|Overall Study|Death|1|||
170830227|NCT00903760|617388570|FG000|Overall Study|Lost to Follow-up|1|||
170830228|NCT00903760|617388571|FG001|Overall Study|Lost to Follow-up|0|||
170830229|NCT00903760|617388570|FG000|Overall Study|Withdrawal by Subject|1|||
170830230|NCT00903760|617388571|FG001|Overall Study|Withdrawal by Subject|2|||
170830231|NCT00903760|617388570|FG000|Overall Study|Off treatment for long period|0|||
170830232|NCT00903760|617388571|FG001|Overall Study|Off treatment for long period|1|||
170830233|NCT00487825|617388573|FG000|Overall Study|Adverse Event|2|||
170830234|NCT00487825|617388574|FG001|Overall Study|Adverse Event|2|||
170830235|NCT00487825|617388573|FG000|Overall Study|Lack of Efficacy|1|||
170830236|NCT00487825|617388574|FG001|Overall Study|Lack of Efficacy|1|||
170830237|NCT00487825|617388573|FG000|Overall Study|Other|3|||
170830238|NCT00487825|617388574|FG001|Overall Study|Other|2|||
170830239|NCT01639742|617388577|FG000|Overall Study|Study Ongoing|17|||
170830240|NCT01639742|617388577|FG000|Overall Study|Lost to Follow-up|1|||
170830241|NCT02826798|617388578|FG000|Overall Study|Withdrawal by Subject|0|||
170830242|NCT02826798|617388579|FG001|Overall Study|Withdrawal by Subject|1|||
170830243|NCT02826798|617388580|FG002|Overall Study|Withdrawal by Subject|0|||
170830244|NCT02826798|617388581|FG003|Overall Study|Withdrawal by Subject|1|||
170830245|NCT02826798|617388582|FG004|Overall Study|Withdrawal by Subject|0|||
170830246|NCT02806505|617388584|FG000|Overall Study|Adverse event/intercurrent illness|1|||
170830247|NCT02806505|617388585|FG001|Overall Study|Adverse event/intercurrent illness|3|||
170830248|NCT02806505|617388584|FG000|Overall Study|Death|4|||
170830249|NCT02806505|617388585|FG001|Overall Study|Death|0|||
170830250|NCT02806505|617388584|FG000|Overall Study|Did not cooperate/refused treatment|3|||
170830251|NCT02806505|617388585|FG001|Overall Study|Did not cooperate/refused treatment|3|||
170830252|NCT02806505|617388584|FG000|Overall Study|Failure to return|0|||
170830253|NCT02806505|617388585|FG001|Overall Study|Failure to return|1|||
170830254|NCT02806505|617388584|FG000|Overall Study|Insufficient therapeutic response|2|||
170830255|NCT02806505|617388585|FG001|Overall Study|Insufficient therapeutic response|4|||
170830256|NCT01256671|617388589|FG000|Overall Study|Adverse Event|29|||
170830257|NCT01256671|617388589|FG000|Overall Study|Lost to Follow-up|16|||
170830258|NCT01256671|617388589|FG000|Overall Study|Withdrawal by Subject|31|||
170830259|NCT01256671|617388589|FG000|Overall Study|Physician Decision|3|||
170830260|NCT01256671|617388589|FG000|Overall Study|Lack of Efficacy|4|||
170830261|NCT01256671|617388589|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
170830262|NCT01986114|617388590|FG000|Overall Study|Adverse Event|59|||
170830263|NCT01986114|617388590|FG000|Overall Study|Lack of Efficacy|23|||
170717369|NCT00838110|616969525|FG001|Overall Study|Randomized but not treated|1|||
170717370|NCT00838110|616969526|FG002|Overall Study|Randomized but not treated|0|||
170717371|NCT00838110|616969527|FG003|Overall Study|Randomized but not treated|0|||
170717372|NCT02416791|616969532|FG000|6 Months|Lost to Follow-up|0|||
170717373|NCT02416791|616969533|FG001|6 Months|Lost to Follow-up|0|||
170717374|NCT02416791|616969534|FG002|6 Months|Lost to Follow-up|1|||
170717375|NCT01054820|616969535|FG000|Overall Study|Withdrawal by Subject|2|||
170717376|NCT00467870|616969536|FG000|Overall Study|Adverse Event|13|||
170717377|NCT00467870|616969537|FG001|Overall Study|Adverse Event|9|||
170717378|NCT00467870|616969538|FG002|Overall Study|Adverse Event|1|||
170717379|NCT00467870|616969539|FG003|Overall Study|Adverse Event|15|||
170717380|NCT00467870|616969540|FG004|Overall Study|Adverse Event|15|||
170717381|NCT00467870|616969541|FG005|Overall Study|Adverse Event|1|||
170717382|NCT00467870|616969536|FG000|Overall Study|Protocol Violation|2|||
170717383|NCT00467870|616969537|FG001|Overall Study|Protocol Violation|1|||
170717384|NCT00467870|616969538|FG002|Overall Study|Protocol Violation|1|||
170717385|NCT00467870|616969539|FG003|Overall Study|Protocol Violation|2|||
170717386|NCT00467870|616969540|FG004|Overall Study|Protocol Violation|0|||
170717387|NCT00467870|616969541|FG005|Overall Study|Protocol Violation|0|||
170717388|NCT00467870|616969536|FG000|Overall Study|Withdrawal by Subject|14|||
170717389|NCT00467870|616969537|FG001|Overall Study|Withdrawal by Subject|21|||
170717390|NCT00467870|616969538|FG002|Overall Study|Withdrawal by Subject|0|||
170717391|NCT00467870|616969539|FG003|Overall Study|Withdrawal by Subject|9|||
170717392|NCT00467870|616969540|FG004|Overall Study|Withdrawal by Subject|10|||
170717393|NCT00467870|616969541|FG005|Overall Study|Withdrawal by Subject|1|||
170717394|NCT00467870|616969536|FG000|Overall Study|Lost to Follow-up|5|||
170717395|NCT00467870|616969537|FG001|Overall Study|Lost to Follow-up|3|||
170717396|NCT00467870|616969538|FG002|Overall Study|Lost to Follow-up|1|||
170717397|NCT00467870|616969539|FG003|Overall Study|Lost to Follow-up|1|||
170717398|NCT00467870|616969540|FG004|Overall Study|Lost to Follow-up|3|||
170717399|NCT00467870|616969541|FG005|Overall Study|Lost to Follow-up|0|||
170717400|NCT00467870|616969536|FG000|Overall Study|Subject Non-compliance|3|||
170717401|NCT00467870|616969537|FG001|Overall Study|Subject Non-compliance|4|||
170717402|NCT00467870|616969538|FG002|Overall Study|Subject Non-compliance|0|||
170717403|NCT00467870|616969539|FG003|Overall Study|Subject Non-compliance|1|||
170717404|NCT00467870|616969540|FG004|Overall Study|Subject Non-compliance|5|||
170717405|NCT00467870|616969541|FG005|Overall Study|Subject Non-compliance|0|||
170717406|NCT00467870|616969536|FG000|Overall Study|Other/Unknown|8|||
170717407|NCT00467870|616969537|FG001|Overall Study|Other/Unknown|5|||
170717408|NCT00467870|616969538|FG002|Overall Study|Other/Unknown|1|||
170717409|NCT00467870|616969539|FG003|Overall Study|Other/Unknown|5|||
170717410|NCT00467870|616969540|FG004|Overall Study|Other/Unknown|4|||
170717411|NCT00467870|616969541|FG005|Overall Study|Other/Unknown|0|||
170717412|NCT00760929|616969545|FG000|Overall Study|Adverse Event|2|||
170717413|NCT00760929|616969546|FG001|Overall Study|Adverse Event|0|||
170717414|NCT00760929|616969547|FG002|Overall Study|Adverse Event|6|||
170717415|NCT00760929|616969548|FG003|Overall Study|Adverse Event|10|||
170717416|NCT00760929|616969545|FG000|Overall Study|Lack of Efficacy|0|||
170717417|NCT00760929|616969546|FG001|Overall Study|Lack of Efficacy|2|||
170717418|NCT00760929|616969547|FG002|Overall Study|Lack of Efficacy|1|||
170717419|NCT00760929|616969548|FG003|Overall Study|Lack of Efficacy|0|||
170717420|NCT00760929|616969545|FG000|Overall Study|Withdrawal by Subject|1|||
170717421|NCT00760929|616969546|FG001|Overall Study|Withdrawal by Subject|0|||
170717422|NCT00760929|616969547|FG002|Overall Study|Withdrawal by Subject|9|||
170717423|NCT00760929|616969548|FG003|Overall Study|Withdrawal by Subject|1|||
170717424|NCT00760929|616969545|FG000|Overall Study|Lost to Follow-up|0|||
170717425|NCT00760929|616969546|FG001|Overall Study|Lost to Follow-up|0|||
170717426|NCT00760929|616969547|FG002|Overall Study|Lost to Follow-up|1|||
170717427|NCT00760929|616969548|FG003|Overall Study|Lost to Follow-up|0|||
170717428|NCT00760929|616969545|FG000|Overall Study|Progression of Disease|21|||
170717429|NCT00760929|616969546|FG001|Overall Study|Progression of Disease|26|||
170717430|NCT00760929|616969547|FG002|Overall Study|Progression of Disease|38|||
170717431|NCT00760929|616969548|FG003|Overall Study|Progression of Disease|42|||
170717432|NCT00760929|616969545|FG000|Overall Study|Other|2|||
170717433|NCT00760929|616969546|FG001|Overall Study|Other|0|||
170717434|NCT00760929|616969547|FG002|Overall Study|Other|2|||
170717435|NCT00760929|616969548|FG003|Overall Study|Other|1|||
170717436|NCT00760929|616969545|FG000|Overall Study|Death|0|||
170717437|NCT00760929|616969546|FG001|Overall Study|Death|0|||
170717438|NCT00760929|616969547|FG002|Overall Study|Death|1|||
170717439|NCT00760929|616969548|FG003|Overall Study|Death|0|||
170717440|NCT00760929|616969545|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
170717441|NCT00760929|616969546|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
170717442|NCT00760929|616969547|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
170717443|NCT00760929|616969548|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
170717444|NCT04121962|616969549|FG000|Overall Study|Lost to Follow-up|42|||
170717445|NCT04121962|616969550|FG001|Overall Study|Lost to Follow-up|39|||
170717446|NCT01175382|616969551|FG000|Overall Study|Lost to Follow-up|4|||
170717447|NCT01175382|616969552|FG001|Overall Study|Lost to Follow-up|3|||
170830264|NCT01986114|617388590|FG000|Overall Study|Withdrawal by Subject|58|||
170830265|NCT01986114|617388590|FG000|Overall Study|Noncompliance|3|||
170830266|NCT01986114|617388590|FG000|Overall Study|Protocol Violation|1|||
170830267|NCT01986114|617388590|FG000|Overall Study|Lost to Follow-up|5|||
170830268|NCT01986114|617388590|FG000|Overall Study|Other reason|7|||
170830269|NCT01190644|617388591|FG000|Overall Study|Death|2|||
170830270|NCT01190644|617388591|FG000|Overall Study|Disease progression|1|||
170830271|NCT02366143|617388592|FG000|Overall Study|Death|307|||
170830272|NCT02366143|617388593|FG001|Overall Study|Death|278|||
170830273|NCT02366143|617388594|FG002|Overall Study|Death|280|||
170830274|NCT02366143|617388592|FG000|Overall Study|Lost to Follow-up|2|||
170830275|NCT02366143|617388593|FG001|Overall Study|Lost to Follow-up|4|||
170830276|NCT02366143|617388594|FG002|Overall Study|Lost to Follow-up|2|||
170830277|NCT02366143|617388592|FG000|Overall Study|Physician Decision|1|||
170830278|NCT02366143|617388593|FG001|Overall Study|Physician Decision|2|||
170830279|NCT02366143|617388594|FG002|Overall Study|Physician Decision|1|||
170830280|NCT02366143|617388592|FG000|Overall Study|Protocol Violation|0|||
170830281|NCT02366143|617388593|FG001|Overall Study|Protocol Violation|0|||
170830282|NCT02366143|617388594|FG002|Overall Study|Protocol Violation|2|||
170830283|NCT02366143|617388592|FG000|Overall Study|Withdrawal by Subject|16|||
170830284|NCT02366143|617388593|FG001|Overall Study|Withdrawal by Subject|17|||
170830285|NCT02366143|617388594|FG002|Overall Study|Withdrawal by Subject|22|||
170830286|NCT02366143|617388592|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
170830287|NCT02366143|617388593|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
170830288|NCT02366143|617388594|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
170830289|NCT02366143|617388592|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
170830290|NCT02366143|617388593|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
170830291|NCT02366143|617388594|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
170830292|NCT02366143|617388592|FG000|Overall Study|Randomization Error|1|||
170830293|NCT02366143|617388593|FG001|Overall Study|Randomization Error|0|||
170830294|NCT02366143|617388594|FG002|Overall Study|Randomization Error|0|||
170830295|NCT02366143|617388592|FG000|Overall Study|PI Move and Site Closure|1|||
170830296|NCT02366143|617388593|FG001|Overall Study|PI Move and Site Closure|0|||
170830297|NCT02366143|617388594|FG002|Overall Study|PI Move and Site Closure|1|||
170830298|NCT02366143|617388592|FG000|Overall Study|Study Terminated By Sponsor|0|||
170830299|NCT02366143|617388593|FG001|Overall Study|Study Terminated By Sponsor|0|||
170830300|NCT02366143|617388594|FG002|Overall Study|Study Terminated By Sponsor|2|||
170830301|NCT02366143|617388592|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
170830302|NCT02366143|617388593|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
170830303|NCT02366143|617388594|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
170830304|NCT02366143|617388592|FG000|Overall Study|Patient moved to roll-over study|1|||
170830305|NCT02366143|617388593|FG001|Overall Study|Patient moved to roll-over study|19|||
170830306|NCT02366143|617388594|FG002|Overall Study|Patient moved to roll-over study|28|||
170830307|NCT02366143|617388592|FG000|Overall Study|Patient moved to commercial stock|0|||
170830308|NCT02366143|617388593|FG001|Overall Study|Patient moved to commercial stock|0|||
170830309|NCT02366143|617388594|FG002|Overall Study|Patient moved to commercial stock|1|||
170830310|NCT02366143|617388592|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
170830311|NCT02366143|617388593|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
170830312|NCT02366143|617388594|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
170830313|NCT02366143|617388592|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
170830314|NCT02366143|617388593|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
170830315|NCT02366143|617388594|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
170830316|NCT02366143|617388592|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
170717448|NCT01175382|616969553|FG002|Overall Study|Lost to Follow-up|1|||
170717449|NCT01175382|616969551|FG000|Overall Study|Physician Decision|0|||
170717450|NCT01175382|616969552|FG001|Overall Study|Physician Decision|1|||
170717451|NCT01175382|616969553|FG002|Overall Study|Physician Decision|0|||
170717452|NCT01175382|616969551|FG000|Overall Study|Withdrawal by Subject|0|||
170717453|NCT01175382|616969552|FG001|Overall Study|Withdrawal by Subject|0|||
170717454|NCT01175382|616969553|FG002|Overall Study|Withdrawal by Subject|1|||
170717455|NCT01175382|616969551|FG000|Overall Study|No longer having problem|1|||
170717456|NCT01175382|616969552|FG001|Overall Study|No longer having problem|0|||
170717457|NCT01175382|616969553|FG002|Overall Study|No longer having problem|1|||
170717458|NCT01175382|616969551|FG000|Overall Study|Unable/unwilling to attend visits|3|||
170717459|NCT01175382|616969552|FG001|Overall Study|Unable/unwilling to attend visits|1|||
170717460|NCT01175382|616969553|FG002|Overall Study|Unable/unwilling to attend visits|2|||
170717461|NCT01175382|616969551|FG000|Overall Study|Unwilling to follow protocol|0|||
170717462|NCT01175382|616969552|FG001|Overall Study|Unwilling to follow protocol|1|||
170717463|NCT01175382|616969553|FG002|Overall Study|Unwilling to follow protocol|0|||
170717464|NCT01175382|616969551|FG000|Overall Study|Unable to tolerate study meds|0|||
170717465|NCT01175382|616969552|FG001|Overall Study|Unable to tolerate study meds|1|||
170717466|NCT01175382|616969553|FG002|Overall Study|Unable to tolerate study meds|1|||
170717467|NCT00774787|616969554|FG000|Overall Study|Lost to Follow-up|1|||
170717468|NCT04831736|616969560|FG000|Overall Study|Withdrawal by Subject|0|||
170717469|NCT04831736|616969561|FG001|Overall Study|Withdrawal by Subject|1|||
170717470|NCT04004611|616969576|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
170717471|NCT04004611|616969577|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
170717472|NCT04004611|616969578|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
170717473|NCT04004611|616969579|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
170717474|NCT04004611|616969580|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
170717475|NCT04004611|616969581|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
170717476|NCT04004611|616969582|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
170717477|NCT04004611|616969583|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
170717478|NCT04004611|616969584|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
170717479|NCT04004611|616969576|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
170717480|NCT04004611|616969577|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
170717481|NCT04004611|616969578|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
170717482|NCT04004611|616969579|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
170717483|NCT04004611|616969580|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
170717484|NCT04004611|616969581|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
170717485|NCT04004611|616969582|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
170717486|NCT04004611|616969583|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
170717487|NCT04004611|616969584|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
170717488|NCT04004611|616969576|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
170717489|NCT04004611|616969577|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
170717490|NCT04004611|616969578|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
170717491|NCT04004611|616969579|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
170717492|NCT04004611|616969580|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
170717493|NCT04004611|616969581|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
170717494|NCT04004611|616969582|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
170717495|NCT04004611|616969583|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
170717496|NCT04004611|616969584|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
170717497|NCT04004611|616969576|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
170717498|NCT04004611|616969577|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
170717499|NCT04004611|616969578|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
170717500|NCT04004611|616969579|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
170717501|NCT04004611|616969580|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
170717502|NCT04004611|616969581|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
170717503|NCT04004611|616969582|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
170717504|NCT04004611|616969583|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
170717505|NCT04004611|616969584|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
170717506|NCT04004611|616969576|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
170717507|NCT04004611|616969577|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
170717508|NCT04004611|616969578|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
170717509|NCT04004611|616969579|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
170717510|NCT04004611|616969580|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
170717511|NCT04004611|616969581|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
170717512|NCT04004611|616969582|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
170717513|NCT04004611|616969583|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
170717514|NCT04004611|616969584|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
170717515|NCT04004611|616969576|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
170830317|NCT02366143|617388593|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
170717516|NCT04004611|616969577|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
170717517|NCT04004611|616969578|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
170717518|NCT04004611|616969579|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
170717519|NCT04004611|616969580|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
170717520|NCT04004611|616969581|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
170717521|NCT04004611|616969582|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
170717522|NCT04004611|616969583|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
170717523|NCT04004611|616969584|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
170717524|NCT00575588|616969585|FG000|Overall Study|Adverse Event|11|||
170717525|NCT00575588|616969586|FG001|Overall Study|Adverse Event|13|||
170717526|NCT00575588|616969585|FG000|Overall Study|Withdrawal by Subject|27|||
170717527|NCT00575588|616969586|FG001|Overall Study|Withdrawal by Subject|31|||
170717528|NCT00575588|616969585|FG000|Overall Study|Lost to Follow-up|1|||
170717529|NCT00575588|616969586|FG001|Overall Study|Lost to Follow-up|3|||
170717530|NCT00575588|616969585|FG000|Overall Study|Death|4|||
170717531|NCT00575588|616969586|FG001|Overall Study|Death|2|||
170717532|NCT00575588|616969585|FG000|Overall Study|Incorrect enrollment|8|||
170717533|NCT00575588|616969586|FG001|Overall Study|Incorrect enrollment|4|||
170717534|NCT00575588|616969585|FG000|Overall Study|Study specific discontinuation criteria|203|||
170717535|NCT00575588|616969586|FG001|Overall Study|Study specific discontinuation criteria|218|||
170717536|NCT00575588|616969585|FG000|Overall Study|Severe non-compliance to protocol|5|||
170717537|NCT00575588|616969586|FG001|Overall Study|Severe non-compliance to protocol|7|||
170717538|NCT00575588|616969585|FG000|Overall Study|Safety reasons|2|||
170717539|NCT00575588|616969586|FG001|Overall Study|Safety reasons|1|||
170717540|NCT00575588|616969585|FG000|Overall Study|Elevated triglyceride|1|||
170717541|NCT00575588|616969586|FG001|Overall Study|Elevated triglyceride|0|||
170717542|NCT00575588|616969585|FG000|Overall Study|Patient moved|1|||
170717543|NCT00575588|616969586|FG001|Overall Study|Patient moved|3|||
170717544|NCT00575588|616969585|FG000|Overall Study|Impossible to determine HbA1c|0|||
170717545|NCT00575588|616969586|FG001|Overall Study|Impossible to determine HbA1c|1|||
170717546|NCT00148343|616969592|FG000|Overall Study|Withdrawal by Subject|12|||
170717547|NCT00148343|616969593|FG001|Overall Study|Withdrawal by Subject|7|||
170717548|NCT00148343|616969592|FG000|Overall Study|Physician Decision|3|||
170717549|NCT00148343|616969593|FG001|Overall Study|Physician Decision|4|||
170717550|NCT00941603|616969594|FG000|Overall Study|Adverse Event|10|||
170717551|NCT00941603|616969595|FG001|Overall Study|Adverse Event|15|||
170717552|NCT00941603|616969596|FG002|Overall Study|Adverse Event|5|||
170717553|NCT00941603|616969597|FG003|Overall Study|Adverse Event|1|||
170717554|NCT00941603|616969598|FG004|Overall Study|Adverse Event|4|||
170717555|NCT00941603|616969599|FG005|Overall Study|Adverse Event|0|||
170717556|NCT00941603|616969594|FG000|Overall Study|Lost to Follow-up|0|||
170717557|NCT00941603|616969595|FG001|Overall Study|Lost to Follow-up|0|||
170717558|NCT00941603|616969596|FG002|Overall Study|Lost to Follow-up|0|||
170717559|NCT00941603|616969597|FG003|Overall Study|Lost to Follow-up|1|||
170717560|NCT00941603|616969598|FG004|Overall Study|Lost to Follow-up|0|||
170717561|NCT00941603|616969599|FG005|Overall Study|Lost to Follow-up|2|||
170717562|NCT00941603|616969594|FG000|Overall Study|Withdrawal by Subject|0|||
170717563|NCT00941603|616969595|FG001|Overall Study|Withdrawal by Subject|0|||
170717564|NCT00941603|616969596|FG002|Overall Study|Withdrawal by Subject|0|||
170717565|NCT00941603|616969597|FG003|Overall Study|Withdrawal by Subject|2|||
170717566|NCT00941603|616969598|FG004|Overall Study|Withdrawal by Subject|0|||
170717567|NCT00941603|616969599|FG005|Overall Study|Withdrawal by Subject|1|||
170717568|NCT00941603|616969594|FG000|Overall Study|Protocol Violation|0|||
170717569|NCT00941603|616969595|FG001|Overall Study|Protocol Violation|1|||
170717570|NCT00941603|616969596|FG002|Overall Study|Protocol Violation|0|||
170717571|NCT00941603|616969597|FG003|Overall Study|Protocol Violation|0|||
170717572|NCT00941603|616969598|FG004|Overall Study|Protocol Violation|0|||
170717573|NCT00941603|616969599|FG005|Overall Study|Protocol Violation|0|||
170717574|NCT00941603|616969594|FG000|Overall Study|Did not meet protocol eligibility|1|||
170717575|NCT00941603|616969595|FG001|Overall Study|Did not meet protocol eligibility|0|||
170717576|NCT00941603|616969596|FG002|Overall Study|Did not meet protocol eligibility|0|||
170717577|NCT00941603|616969597|FG003|Overall Study|Did not meet protocol eligibility|0|||
170717578|NCT00941603|616969598|FG004|Overall Study|Did not meet protocol eligibility|0|||
170717579|NCT00941603|616969599|FG005|Overall Study|Did not meet protocol eligibility|0|||
170717580|NCT02843568|616969600|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
170717581|NCT02843568|616969601|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
170717582|NCT02843568|616969600|FG000|Overall Study|Death|3|||
170717583|NCT02843568|616969601|FG001|Overall Study|Death|3|||
170717584|NCT02843568|616969600|FG000|Overall Study|Withdrawal by Subject|1|||
170717585|NCT02843568|616969601|FG001|Overall Study|Withdrawal by Subject|1|||
170717586|NCT02843568|616969600|FG000|Overall Study|Lost to Follow-up|2|||
170717587|NCT02843568|616969601|FG001|Overall Study|Lost to Follow-up|0|||
170717588|NCT01343407|616969604|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
170717589|NCT01343407|616969605|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
170717590|NCT01343407|616969606|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
170717591|NCT01343407|616969607|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
170717592|NCT01343407|616969608|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
170717593|NCT01343407|616969609|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
170717594|NCT01343407|616969604|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
170717595|NCT01343407|616969605|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
170717596|NCT01343407|616969606|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
170717597|NCT01343407|616969607|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
170717598|NCT01343407|616969608|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
170717599|NCT01343407|616969609|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
170717600|NCT00833924|616969611|FG000|Overall Study|Death|21|||
170717601|NCT00833924|616969611|FG000|Overall Study|Conversion|2|||
170717602|NCT00833924|616969611|FG000|Overall Study|Lost to Follow-up|2|||
170717603|NCT00833924|616969611|FG000|Overall Study|Withdrawal by Subject|13|||
170717604|NCT00833924|616969611|FG000|Overall Study|In study follow-up|71|||
170717605|NCT03646513|616969615|FG000|Overall Study|Premature study termination|4|||
170717606|NCT00782340|616969616|FG000|Open Label Titration|Adverse Event|12|||
170717607|NCT00782340|616969617|FG001|Open Label Titration|Adverse Event|0|||
170717608|NCT00782340|616969618|FG002|Open Label Titration|Adverse Event|0|||
170717609|NCT00782340|616969616|FG000|Open Label Titration|Treatment failure|50|||
170717610|NCT00782340|616969617|FG001|Open Label Titration|Treatment failure|0|||
170717611|NCT00782340|616969618|FG002|Open Label Titration|Treatment failure|0|||
170717612|NCT00782340|616969616|FG000|Open Label Titration|Protocol Violation|5|||
170717613|NCT00782340|616969617|FG001|Open Label Titration|Protocol Violation|0|||
170717614|NCT00782340|616969618|FG002|Open Label Titration|Protocol Violation|0|||
170717615|NCT00782340|616969616|FG000|Open Label Titration|Withdrawal by Subject|5|||
170717616|NCT00782340|616969617|FG001|Open Label Titration|Withdrawal by Subject|0|||
170717617|NCT00782340|616969618|FG002|Open Label Titration|Withdrawal by Subject|0|||
170717618|NCT00782340|616969616|FG000|Open Label Titration|Enrollment capped|16|||
170717619|NCT00782340|616969617|FG001|Open Label Titration|Enrollment capped|0|||
170717620|NCT00782340|616969618|FG002|Open Label Titration|Enrollment capped|0|||
170717621|NCT00782340|616969616|FG000|Open Label Titration|Did not meet responder criteria|2|||
170717622|NCT00782340|616969617|FG001|Open Label Titration|Did not meet responder criteria|0|||
170717623|NCT00782340|616969618|FG002|Open Label Titration|Did not meet responder criteria|0|||
170717624|NCT00782340|616969616|FG000|Open Label Titration|Lost to Follow-up|5|||
170717625|NCT00782340|616969617|FG001|Open Label Titration|Lost to Follow-up|0|||
170717626|NCT00782340|616969618|FG002|Open Label Titration|Lost to Follow-up|0|||
170717627|NCT00782340|616969616|FG000|Open Label Titration|Randomized in error|6|||
170717628|NCT00782340|616969617|FG001|Open Label Titration|Randomized in error|0|||
170717629|NCT00782340|616969618|FG002|Open Label Titration|Randomized in error|0|||
170717630|NCT01732835|616969619|FG000|6-month Primary Endpoint|Did not receive device|19|||
170717631|NCT01732835|616969619|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
170717632|NCT01732835|616969619|FG000|6-month Primary Endpoint|Adverse Event|3|||
170717633|NCT01732835|616969619|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
170717634|NCT01732835|616969619|FG000|2-year Extended Follow-up|Adverse Event|3|||
170717635|NCT01732835|616969619|FG000|2-year Extended Follow-up|Death|1|||
170717636|NCT03207750|616969620|FG000|Overall Study|Adverse Event|3|||
170717637|NCT03207750|616969621|FG001|Overall Study|Adverse Event|2|||
170717638|NCT03207750|616969620|FG000|Overall Study|Lost to Follow-up|21|||
170717639|NCT03207750|616969621|FG001|Overall Study|Lost to Follow-up|29|||
170717640|NCT03207750|616969620|FG000|Overall Study|Protocol Violation|0|||
170717641|NCT03207750|616969621|FG001|Overall Study|Protocol Violation|1|||
170717642|NCT03207750|616969620|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
170717643|NCT03207750|616969621|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
170717644|NCT03207750|616969620|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
170717645|NCT03207750|616969621|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
170717646|NCT03207750|616969620|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
170717647|NCT03207750|616969621|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
170717648|NCT03207750|616969620|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
170717649|NCT03207750|616969621|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
170717650|NCT03207750|616969620|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
170717651|NCT03207750|616969621|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
170717652|NCT00093145|616969628|FG000|Overall Study|Unacceptable Toxicity Only|2|||
170717653|NCT00093145|616969628|FG000|Overall Study|Physician Decision|5|||
170717654|NCT00093145|616969628|FG000|Overall Study|Withdrawal by Subject|9|||
170717655|NCT00093145|616969628|FG000|Overall Study|Other|1|||
170830318|NCT02366143|617388594|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
170830319|NCT02366143|617388592|FG000|Overall Study|Requester's instructions|1|||
170830320|NCT02366143|617388593|FG001|Overall Study|Requester's instructions|1|||
170717656|NCT01310036|616969629|FG000|Overall Study|Administrative/other|10|||
170717657|NCT01310036|616969629|FG000|Overall Study|Withdrew Consent|11|||
170717658|NCT01310036|616969629|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
170717659|NCT01310036|616969629|FG000|Overall Study|Progression of Disease|164|||
170717660|NCT01310036|616969629|FG000|Overall Study|Death|1|||
170717661|NCT01310036|616969629|FG000|Overall Study|Adverse event or intercurrent illness|12|||
170717662|NCT04667117|616969630|FG000|Investigational Period|Lost to Follow-up|0|||
170717663|NCT04667117|616969631|FG001|Investigational Period|Lost to Follow-up|0|||
170717664|NCT04667117|616969632|FG002|Investigational Period|Lost to Follow-up|1|||
170717665|NCT04667117|616969630|FG000|Investigational Period|Protocol Deviation|0|||
170717666|NCT04667117|616969631|FG001|Investigational Period|Protocol Deviation|1|||
170717667|NCT04667117|616969632|FG002|Investigational Period|Protocol Deviation|0|||
170717668|NCT04667117|616969630|FG000|Extension Period|Lost to Follow-up|1|||
170717669|NCT04667117|616969631|FG001|Extension Period|Lost to Follow-up|0|||
170717670|NCT04667117|616969632|FG002|Extension Period|Lost to Follow-up|0|||
170717671|NCT00968617|616969637|FG000|Overall Study|Study terminated by sponsor|6|||
170717672|NCT04433767|616969638|FG000|Overall Study|Adverse Event|1|||
170717673|NCT02371369|616969643|FG000|Part 1|Physician Decision|0|||
170717674|NCT02371369|616969644|FG001|Part 1|Physician Decision|3|||
170717675|NCT02371369|616969643|FG000|Part 1|Adverse Event|8|||
170717676|NCT02371369|616969644|FG001|Part 1|Adverse Event|0|||
170717677|NCT02371369|616969643|FG000|Part 1|Withdrawal by Subject|1|||
170717678|NCT02371369|616969644|FG001|Part 1|Withdrawal by Subject|6|||
170717679|NCT02371369|616969643|FG000|Part 1|Disease progression|0|||
170717680|NCT02371369|616969644|FG001|Part 1|Disease progression|1|||
170717681|NCT02371369|616969643|FG000|Part 1|Protocol Violation|0|||
170717682|NCT02371369|616969644|FG001|Part 1|Protocol Violation|1|||
170717683|NCT02371369|616969643|FG000|Part 2|Adverse Event|6|||
170717684|NCT02371369|616969644|FG001|Part 2|Adverse Event|5|||
170717685|NCT02371369|616969643|FG000|Part 2|Withdrawal by Subject|16|||
170717686|NCT02371369|616969644|FG001|Part 2|Withdrawal by Subject|6|||
170717687|NCT02371369|616969643|FG000|Part 2|Investigator decision|1|||
170717688|NCT02371369|616969644|FG001|Part 2|Investigator decision|2|||
170717689|NCT02371369|616969643|FG000|Part 2|Death|0|||
170717690|NCT02371369|616969644|FG001|Part 2|Death|1|||
170717691|NCT02371369|616969643|FG000|Part 2|Disease progression|1|||
170717692|NCT02371369|616969644|FG001|Part 2|Disease progression|0|||
170717693|NCT02371369|616969643|FG000|Part 2|Subject Noncompliance|1|||
170717694|NCT02371369|616969644|FG001|Part 2|Subject Noncompliance|0|||
170717695|NCT02371369|616969643|FG000|Part 2|Lost to Follow-up|1|||
170717696|NCT02371369|616969644|FG001|Part 2|Lost to Follow-up|1|||
170717697|NCT02371369|616969643|FG000|Part 2|Subject transitioned to commercial supply|6|||
170717698|NCT02371369|616969644|FG001|Part 2|Subject transitioned to commercial supply|4|||
170717699|NCT02371369|616969643|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
170717700|NCT02371369|616969644|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
170717701|NCT02371369|616969643|FG000|Part 2|Surgical resection of tumor|1|||
170717702|NCT02371369|616969644|FG001|Part 2|Surgical resection of tumor|1|||
170717703|NCT02371369|616969643|FG000|Part 2|Other|0|||
170717704|NCT02371369|616969644|FG001|Part 2|Other|1|||
170717705|NCT01143259|616969645|FG000|Overall Study|Withdrawal by Subject|3|||
170717706|NCT01143259|616969646|FG001|Overall Study|Withdrawal by Subject|2|||
170717707|NCT01143259|616969645|FG000|Overall Study|Protocol Violation|13|||
170717708|NCT01143259|616969646|FG001|Overall Study|Protocol Violation|9|||
170717709|NCT01143259|616969645|FG000|Overall Study|Screen Failure|7|||
170717710|NCT01143259|616969646|FG001|Overall Study|Screen Failure|9|||
170717711|NCT03864900|616969647|FG000|Overall Study|Withdrawal by Subject|1|||
170717712|NCT03864900|616969648|FG001|Overall Study|Withdrawal by Subject|1|||
170717713|NCT03864900|616969647|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
170717714|NCT03864900|616969648|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
170717715|NCT03238001|616969649|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
170717716|NCT03238001|616969649|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
170717717|NCT03238001|616969649|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
170717718|NCT03238001|616969649|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
170717719|NCT03238001|616969649|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
170717720|NCT03238001|616969649|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
170717721|NCT03238001|616969649|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
170717722|NCT03238001|616969649|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
170717723|NCT00839072|616969653|FG000|First Intervention Period|Withdrawal by Subject|1|||
170717724|NCT00839072|616969654|FG001|First Intervention Period|Withdrawal by Subject|0|||
170717725|NCT00839072|616969653|FG000|First Intervention Period|Adverse Event|1|||
170717726|NCT00839072|616969654|FG001|First Intervention Period|Adverse Event|1|||
170717727|NCT00839072|616969653|FG000|Second Intervention Period|Withdrawal by Subject|1|||
170717728|NCT00839072|616969654|FG001|Second Intervention Period|Withdrawal by Subject|0|||
170717729|NCT00503685|616969656|FG000|Overall Study|Adverse Event|0|||
170717730|NCT00503685|616969657|FG001|Overall Study|Adverse Event|0|||
170717731|NCT00503685|616969658|FG002|Overall Study|Adverse Event|2|||
170717732|NCT00503685|616969656|FG000|Overall Study|Withdrawal by Subject|0|||
170717733|NCT00503685|616969657|FG001|Overall Study|Withdrawal by Subject|1|||
170717734|NCT00503685|616969658|FG002|Overall Study|Withdrawal by Subject|0|||
170717735|NCT00503685|616969656|FG000|Overall Study|Protocol Violation|0|||
170717736|NCT00503685|616969657|FG001|Overall Study|Protocol Violation|1|||
170717737|NCT00503685|616969658|FG002|Overall Study|Protocol Violation|0|||
170717738|NCT00503685|616969656|FG000|Overall Study|Eligibility Criteria Not Met|0|||
170717739|NCT00503685|616969657|FG001|Overall Study|Eligibility Criteria Not Met|1|||
170717740|NCT00503685|616969658|FG002|Overall Study|Eligibility Criteria Not Met|0|||
170717741|NCT01110239|616969659|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
170717742|NCT01110239|616969660|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
170717743|NCT01110239|616969661|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
170717744|NCT01110239|616969662|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
170717745|NCT01110239|616969659|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
170717746|NCT01110239|616969660|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
170717747|NCT01110239|616969661|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
170717748|NCT01110239|616969662|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
170717749|NCT00156065|616971433|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
170717750|NCT00156065|616971434|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
170717751|NCT00156065|616971435|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
170717752|NCT00156065|616971433|FG000|Overall Study|Adverse Event|8|||
170717753|NCT00156065|616971434|FG001|Overall Study|Adverse Event|11|||
170717754|NCT00156065|616971435|FG002|Overall Study|Adverse Event|4|||
170717755|NCT00156065|616971433|FG000|Overall Study|Lack of Efficacy|2|||
170717756|NCT00156065|616971434|FG001|Overall Study|Lack of Efficacy|9|||
170717757|NCT00156065|616971435|FG002|Overall Study|Lack of Efficacy|3|||
170717758|NCT00156065|616971433|FG000|Overall Study|Withdrawal by Subject|13|||
170717759|NCT00156065|616971434|FG001|Overall Study|Withdrawal by Subject|26|||
170717760|NCT00156065|616971435|FG002|Overall Study|Withdrawal by Subject|16|||
170717761|NCT00156065|616971433|FG000|Overall Study|Lost to Follow-up|5|||
170717762|NCT00156065|616971434|FG001|Overall Study|Lost to Follow-up|7|||
170717763|NCT00156065|616971435|FG002|Overall Study|Lost to Follow-up|1|||
170717764|NCT00156065|616971433|FG000|Overall Study|Other|2|||
170717765|NCT00156065|616971434|FG001|Overall Study|Other|9|||
170717766|NCT00156065|616971435|FG002|Overall Study|Other|3|||
170717767|NCT02891187|616971438|FG000|Overall Study|Lost to Follow-up|1|||
170717768|NCT02891187|616971439|FG001|Overall Study|Lost to Follow-up|2|||
170717769|NCT01438411|616971440|FG000|Overall Study|Adverse Event|8|||
170717770|NCT01438411|616971440|FG000|Overall Study|Lost to Follow-up|1|||
170717771|NCT01438411|616971440|FG000|Overall Study|Lack of Efficacy|1|||
170717772|NCT01438411|616971440|FG000|Overall Study|Withdrawal by Subject|3|||
170717773|NCT00566228|616971445|FG000|Overall Study|Withdrawal by Subject|1|||
170717774|NCT00566228|616971446|FG001|Overall Study|Withdrawal by Subject|0|||
170717775|NCT00566228|616971445|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
170717776|NCT00566228|616971446|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
170717777|NCT00566228|616971445|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
170717778|NCT00566228|616971446|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
170717779|NCT00566228|616971445|FG000|Overall Study|progressed before infusion could occur|0|||
170717780|NCT00566228|616971446|FG001|Overall Study|progressed before infusion could occur|1|||
170717781|NCT03521635|616971449|FG000|Overall Study|Adverse Event|1|||
170717782|NCT03521635|616971450|FG001|Overall Study|Adverse Event|1|||
170717783|NCT03521635|616971449|FG000|Overall Study|Refused to complete study visit|1|||
170717784|NCT03521635|616971450|FG001|Overall Study|Refused to complete study visit|0|||
170717785|NCT03521635|616971449|FG000|Overall Study|Refused to continue trial medication|2|||
170717786|NCT03521635|616971450|FG001|Overall Study|Refused to continue trial medication|2|||
170717787|NCT03521635|616971449|FG000|Overall Study|Lost to Follow-up|0|||
170717788|NCT03521635|616971450|FG001|Overall Study|Lost to Follow-up|1|||
170717789|NCT03521635|616971449|FG000|Overall Study|Meet exclusion criteria|0|||
170717790|NCT03521635|616971450|FG001|Overall Study|Meet exclusion criteria|1|||
170717791|NCT03521635|616971449|FG000|Overall Study|Patient not taken study medicine|0|||
170717792|NCT03521635|616971450|FG001|Overall Study|Patient not taken study medicine|1|||
170717793|NCT01159691|616971451|FG000|Overall Study|Lost to Follow-up|2|||
170717794|NCT01159691|616971451|FG000|Overall Study|Unknown reasons|1|||
170717795|NCT01159691|616971451|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
170717796|NCT01159691|616971451|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
170717797|NCT01159691|616971451|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
170717798|NCT01159691|616971451|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
170717799|NCT01159691|616971451|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
170717800|NCT01159691|616971451|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
170717801|NCT01843192|616971458|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
170717802|NCT01843192|616971459|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
170717803|NCT01843192|616971460|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
170717804|NCT04743908|616971462|FG000|Overall Study|Death|1|||
170717805|NCT04743908|616971463|FG001|Overall Study|Death|0|||
170717806|NCT04743908|616971462|FG000|Overall Study|Lost to Follow-up|181|||
170717807|NCT04743908|616971463|FG001|Overall Study|Lost to Follow-up|180|||
170717808|NCT04743908|616971462|FG000|Overall Study|Withdrawal by Subject|1|||
170717809|NCT04743908|616971463|FG001|Overall Study|Withdrawal by Subject|2|||
170717810|NCT00328510|616971465|FG000|Overall Study|Gag disorder, could not use frame|4|||
170717811|NCT00328510|616971466|FG001|Overall Study|Gag disorder, could not use frame|0|||
170717812|NCT00328510|616971465|FG000|Overall Study|Dentition problems, could not use frame|1|||
170717813|NCT00328510|616971466|FG001|Overall Study|Dentition problems, could not use frame|0|||
170717814|NCT00328510|616971465|FG000|Overall Study|Withdrawal by Subject|4|||
170717815|NCT00328510|616971466|FG001|Overall Study|Withdrawal by Subject|2|||
170717816|NCT00328510|616971465|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
170717817|NCT00328510|616971466|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
170717818|NCT00328510|616971465|FG000|Overall Study|Treatment changed to a single fraction|1|||
170717819|NCT00328510|616971466|FG001|Overall Study|Treatment changed to a single fraction|1|||
170717820|NCT01412944|616971467|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
170717821|NCT01412944|616971468|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
170717822|NCT01412944|616971469|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
170717823|NCT01412944|616971470|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
170717824|NCT01412944|616971471|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
170717825|NCT01412944|616971472|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
170717826|NCT01412944|616971467|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
170717827|NCT01412944|616971468|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
170717828|NCT01412944|616971469|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
170717829|NCT01412944|616971470|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
170717830|NCT01412944|616971471|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
170717831|NCT01412944|616971472|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
170717832|NCT01412944|616971467|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
170717833|NCT01412944|616971468|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
170717834|NCT01412944|616971469|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
170717835|NCT01412944|616971470|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
170717836|NCT01412944|616971471|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
170717837|NCT01412944|616971472|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
170717838|NCT01412944|616971467|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
170717839|NCT01412944|616971468|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
170717840|NCT01412944|616971469|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
170717841|NCT01412944|616971470|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
170717842|NCT01412944|616971471|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
170717843|NCT01412944|616971472|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
170717844|NCT01412944|616971467|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
170717845|NCT01412944|616971468|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
170717846|NCT01412944|616971469|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
170717847|NCT01412944|616971470|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
170717848|NCT01412944|616971471|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
170717849|NCT01412944|616971472|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
170717850|NCT01412944|616971467|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
170717851|NCT01412944|616971468|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
170717852|NCT01412944|616971469|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
170717853|NCT01412944|616971470|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
170717854|NCT01412944|616971471|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
170717855|NCT01412944|616971472|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
170717856|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
170717857|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
170717858|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
170717859|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
170717860|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
170717861|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
170717862|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Adverse Event|0|||
170717863|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Adverse Event|0|||
170717864|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Adverse Event|0|||
170717865|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Adverse Event|0|||
170717866|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Adverse Event|1|||
170717867|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Adverse Event|0|||
170717868|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
170717869|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
170717870|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
170717871|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
170717872|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
170717873|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
170717874|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717875|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717876|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717877|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717878|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717879|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
170717880|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717881|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717882|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717883|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717884|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
170717885|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717886|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
170717887|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
170717888|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
170717889|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
170717890|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
170717891|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
170717892|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
170717893|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
170717894|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
170717895|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
170717896|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
170717897|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
170717898|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717899|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
170717900|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717901|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717902|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717903|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
170717904|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717905|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
170717906|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717907|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717908|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717909|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
170717910|NCT01412944|616971467|FG000|Entire: IV + Maintenance|Adverse Event|0|||
170717911|NCT01412944|616971468|FG001|Entire: IV + Maintenance|Adverse Event|1|||
170717912|NCT01412944|616971469|FG002|Entire: IV + Maintenance|Adverse Event|0|||
170717913|NCT01412944|616971470|FG003|Entire: IV + Maintenance|Adverse Event|0|||
170717914|NCT01412944|616971471|FG004|Entire: IV + Maintenance|Adverse Event|0|||
170717915|NCT01412944|616971472|FG005|Entire: IV + Maintenance|Adverse Event|0|||
170717916|NCT01990950|616971473|FG000|Overall Study|Death|3|||
170717917|NCT01990950|616971473|FG000|Overall Study|Lost to Follow-up|2|||
170717918|NCT01990950|616971473|FG000|Overall Study|Withdrawal by Subject|6|||
170717919|NCT02863926|616971474|FG000|Overall Study|Physician Decision|1|||
170717920|NCT02863926|616971475|FG001|Overall Study|Physician Decision|0|||
170717921|NCT02863926|616971474|FG000|Overall Study|Lost to Follow-up|1|||
170717922|NCT02863926|616971475|FG001|Overall Study|Lost to Follow-up|1|||
170717923|NCT02239679|616971477|FG000|Overall Study|Lost to Follow-up|1|||
170717924|NCT02239679|616971478|FG001|Overall Study|Lost to Follow-up|0|||
170717925|NCT02239679|616971479|FG002|Overall Study|Lost to Follow-up|0|||
170717926|NCT02239679|616971477|FG000|Overall Study|Withdrawal by Subject|2|||
170717927|NCT02239679|616971478|FG001|Overall Study|Withdrawal by Subject|3|||
170717928|NCT02239679|616971479|FG002|Overall Study|Withdrawal by Subject|1|||
170717929|NCT01917526|616971480|FG000|Overall Study|Protocol Violation|1|||
170717930|NCT01917526|616971481|FG001|Overall Study|Protocol Violation|1|||
170717931|NCT02099838|616971482|FG000|Overall Study|Death|1|||
170717932|NCT02099838|616971483|FG001|Overall Study|Death|0|||
170717933|NCT02099838|616971482|FG000|Overall Study|Lost to Follow-up|3|||
170717934|NCT02099838|616971483|FG001|Overall Study|Lost to Follow-up|1|||
170717935|NCT02099838|616971482|FG000|Overall Study|Withdrawal by Subject|0|||
170717936|NCT02099838|616971483|FG001|Overall Study|Withdrawal by Subject|1|||
170717937|NCT02417246|616971484|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
170717938|NCT02417246|616971485|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
170717939|NCT02417246|616971484|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
170717940|NCT02417246|616971485|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
170717941|NCT02417246|616971484|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
170717942|NCT02417246|616971485|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
170717943|NCT02417246|616971484|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
170717944|NCT02417246|616971485|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
170717945|NCT01921348|616971490|FG000|Overall Study|Withdrawal by Subject|1|||
170717946|NCT01921348|616971491|FG001|Overall Study|Withdrawal by Subject|0|||
170717947|NCT01921348|616971490|FG000|Overall Study|Lost to Follow-up|0|||
170717948|NCT01921348|616971491|FG001|Overall Study|Lost to Follow-up|2|||
170717949|NCT01197950|616971497|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
170717950|NCT01197950|616971498|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
170717951|NCT01197950|616971499|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
170717952|NCT00455195|616971500|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
170717953|NCT00455195|616971501|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
170717954|NCT00455195|616971500|FG000|Double-blind Study AGLU02704|Death|1|||
170717955|NCT00455195|616971501|FG001|Double-blind Study AGLU02704|Death|0|||
170717956|NCT00455195|616971500|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
170717957|NCT00455195|616971501|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
170717958|NCT00455195|616971500|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
170717959|NCT00455195|616971501|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
170717960|NCT01286779|616971513|FG000|Overall Study|Withdrawal by Subject|9|||
170717961|NCT01286779|616971513|FG000|Overall Study|Protocol Violation|5|||
170717962|NCT01286779|616971513|FG000|Overall Study|Physician Decision|2|||
170717963|NCT01286779|616971513|FG000|Overall Study|Participant had scheduled surgery|1|||
170717964|NCT01286779|616971513|FG000|Overall Study|Participant moved to another country|1|||
170717965|NCT01286779|616971513|FG000|Overall Study|Discontinued by sponsor|1|||
170717966|NCT04447404|616971514|FG000|Overall Study|Death|2|||
170717967|NCT04447404|616971515|FG001|Overall Study|Death|0|||
170717968|NCT00574080|616971516|FG000|Overall Study|Death|10|||
170717969|NCT00574080|616971517|FG001|Overall Study|Death|10|||
170717970|NCT04137380|616971518|FG000|Overall Study|Physician Decision|0|||
170717971|NCT04137380|616971519|FG001|Overall Study|Physician Decision|0|||
170717972|NCT04137380|616971520|FG002|Overall Study|Physician Decision|0|||
170717973|NCT04137380|616971521|FG003|Overall Study|Physician Decision|1|||
170717974|NCT04137380|616971522|FG004|Overall Study|Physician Decision|0|||
170717975|NCT04137380|616971523|FG005|Overall Study|Physician Decision|0|||
170717976|NCT04137380|616971524|FG006|Overall Study|Physician Decision|0|||
170717977|NCT00563784|616971525|FG000|Overall Study|Withdrawal by Subject|2|||
170717978|NCT00563784|616971525|FG000|Overall Study|Screen Failures|20|||
170717979|NCT02265705|616971526|FG000|Treatment Period Week 0-24|Adverse Event|3|||
170717980|NCT02265705|616971527|FG001|Treatment Period Week 0-24|Adverse Event|2|||
170717981|NCT02265705|616971528|FG002|Treatment Period Week 0-24|Adverse Event|0|||
170717982|NCT02265705|616971529|FG003|Treatment Period Week 0-24|Adverse Event|0|||
170717983|NCT02265705|616971530|FG004|Treatment Period Week 0-24|Adverse Event|0|||
170717984|NCT02265705|616971531|FG005|Treatment Period Week 0-24|Adverse Event|0|||
170717985|NCT02265705|616971532|FG006|Treatment Period Week 0-24|Adverse Event|0|||
170717986|NCT02265705|616971526|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
170717987|NCT02265705|616971527|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
170717988|NCT02265705|616971528|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
170717989|NCT02265705|616971529|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
170717990|NCT02265705|616971530|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
170717991|NCT02265705|616971531|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
170717992|NCT02265705|616971532|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
170717993|NCT02265705|616971526|FG000|Treatment Period Week 0-24|Physician Decision|1|||
170717994|NCT02265705|616971527|FG001|Treatment Period Week 0-24|Physician Decision|0|||
170717995|NCT02265705|616971528|FG002|Treatment Period Week 0-24|Physician Decision|0|||
170717996|NCT02265705|616971529|FG003|Treatment Period Week 0-24|Physician Decision|0|||
170717997|NCT02265705|616971530|FG004|Treatment Period Week 0-24|Physician Decision|0|||
170717998|NCT02265705|616971531|FG005|Treatment Period Week 0-24|Physician Decision|0|||
170717999|NCT02265705|616971532|FG006|Treatment Period Week 0-24|Physician Decision|0|||
170718000|NCT02265705|616971526|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
170718001|NCT02265705|616971527|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
170718002|NCT02265705|616971528|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
170718003|NCT02265705|616971529|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
170718004|NCT02265705|616971530|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
170830321|NCT02366143|617388594|FG002|Overall Study|Requester's instructions|1|||
170830322|NCT02366143|617388592|FG000|Overall Study|Uneligible|0|||
170830323|NCT02366143|617388593|FG001|Overall Study|Uneligible|1|||
170830324|NCT02366143|617388594|FG002|Overall Study|Uneligible|0|||
170830325|NCT02366143|617388592|FG000|Overall Study|Post Trial Migration|0|||
170830326|NCT02366143|617388593|FG001|Overall Study|Post Trial Migration|1|||
170830327|NCT02366143|617388594|FG002|Overall Study|Post Trial Migration|0|||
170718005|NCT02265705|616971531|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
170718006|NCT02265705|616971532|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
170718007|NCT02265705|616971526|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
170718008|NCT02265705|616971527|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
170718009|NCT02265705|616971528|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
170718010|NCT02265705|616971529|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
170718011|NCT02265705|616971530|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
170718012|NCT02265705|616971531|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
170718013|NCT02265705|616971532|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
170718014|NCT02265705|616971526|FG000|Rescue Period|Withdrawal by Subject|0|||
170718015|NCT02265705|616971527|FG001|Rescue Period|Withdrawal by Subject|0|||
170718016|NCT02265705|616971528|FG002|Rescue Period|Withdrawal by Subject|1|||
170718017|NCT02265705|616971529|FG003|Rescue Period|Withdrawal by Subject|0|||
170718018|NCT02265705|616971530|FG004|Rescue Period|Withdrawal by Subject|0|||
170718019|NCT02265705|616971531|FG005|Rescue Period|Withdrawal by Subject|0|||
170718020|NCT02265705|616971532|FG006|Rescue Period|Withdrawal by Subject|0|||
170718021|NCT02265705|616971526|FG000|Rescue Period|Death|0|||
170718022|NCT02265705|616971527|FG001|Rescue Period|Death|0|||
170718023|NCT02265705|616971528|FG002|Rescue Period|Death|1|||
170718024|NCT02265705|616971529|FG003|Rescue Period|Death|0|||
170718025|NCT02265705|616971530|FG004|Rescue Period|Death|0|||
170718026|NCT02265705|616971531|FG005|Rescue Period|Death|0|||
170718027|NCT02265705|616971532|FG006|Rescue Period|Death|0|||
170718028|NCT02265705|616971526|FG000|Rescue Period|Lack of Efficacy|0|||
170718029|NCT02265705|616971527|FG001|Rescue Period|Lack of Efficacy|0|||
170718030|NCT02265705|616971528|FG002|Rescue Period|Lack of Efficacy|1|||
170718031|NCT02265705|616971529|FG003|Rescue Period|Lack of Efficacy|0|||
170718032|NCT02265705|616971530|FG004|Rescue Period|Lack of Efficacy|0|||
170718033|NCT02265705|616971531|FG005|Rescue Period|Lack of Efficacy|0|||
170718034|NCT02265705|616971532|FG006|Rescue Period|Lack of Efficacy|0|||
170718035|NCT02265705|616971526|FG000|Open Label Period|Adverse Event|0|||
170718036|NCT02265705|616971527|FG001|Open Label Period|Adverse Event|0|||
170718037|NCT02265705|616971528|FG002|Open Label Period|Adverse Event|0|||
170718038|NCT02265705|616971529|FG003|Open Label Period|Adverse Event|2|||
170718039|NCT02265705|616971530|FG004|Open Label Period|Adverse Event|2|||
170718040|NCT02265705|616971531|FG005|Open Label Period|Adverse Event|0|||
170718041|NCT02265705|616971532|FG006|Open Label Period|Adverse Event|0|||
170718042|NCT02265705|616971526|FG000|Open Label Period|Physician Decision|0|||
170718043|NCT02265705|616971527|FG001|Open Label Period|Physician Decision|0|||
170718044|NCT02265705|616971528|FG002|Open Label Period|Physician Decision|0|||
170718045|NCT02265705|616971529|FG003|Open Label Period|Physician Decision|0|||
170718046|NCT02265705|616971530|FG004|Open Label Period|Physician Decision|1|||
170718047|NCT02265705|616971531|FG005|Open Label Period|Physician Decision|0|||
170718048|NCT02265705|616971532|FG006|Open Label Period|Physician Decision|0|||
170718049|NCT02265705|616971526|FG000|Open Label Period|Withdrawal by Subject|0|||
170718050|NCT02265705|616971527|FG001|Open Label Period|Withdrawal by Subject|0|||
170830328|NCT02366143|617388592|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
170830329|NCT02366143|617388593|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
170830330|NCT02366143|617388594|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
170830331|NCT02366143|617388592|FG000|Overall Study|Patient switched to PTAP|0|||
170830332|NCT02366143|617388593|FG001|Overall Study|Patient switched to PTAP|1|||
170830333|NCT02366143|617388594|FG002|Overall Study|Patient switched to PTAP|0|||
170830334|NCT02366143|617388592|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
170830335|NCT02366143|617388593|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
170830336|NCT02366143|617388594|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
170830337|NCT04411186|617388595|FG000|Overall Study|Withdrawn due to protocol violation|0|||
170718051|NCT02265705|616971528|FG002|Open Label Period|Withdrawal by Subject|0|||
170718052|NCT02265705|616971529|FG003|Open Label Period|Withdrawal by Subject|0|||
170718053|NCT02265705|616971530|FG004|Open Label Period|Withdrawal by Subject|2|||
170718054|NCT02265705|616971531|FG005|Open Label Period|Withdrawal by Subject|0|||
170718055|NCT02265705|616971532|FG006|Open Label Period|Withdrawal by Subject|0|||
170830338|NCT04411186|617388596|FG001|Overall Study|Withdrawn due to protocol violation|1|||
170830339|NCT02034162|617388597|FG000|Double-blind|Lost to Follow-up|3|||
170718056|NCT02265705|616971526|FG000|Follow-up Period|Sponsor Decision|0|||
170718057|NCT02265705|616971527|FG001|Follow-up Period|Sponsor Decision|0|||
170718058|NCT02265705|616971528|FG002|Follow-up Period|Sponsor Decision|0|||
170718059|NCT02265705|616971529|FG003|Follow-up Period|Sponsor Decision|0|||
170718060|NCT02265705|616971530|FG004|Follow-up Period|Sponsor Decision|0|||
170830340|NCT02034162|617388598|FG001|Double-blind|Lost to Follow-up|0|||
170830341|NCT02034162|617388599|FG002|Double-blind|Lost to Follow-up|0|||
170830342|NCT02034162|617388597|FG000|Double-blind|Physician Decision|1|||
170718061|NCT02265705|616971531|FG005|Follow-up Period|Sponsor Decision|1|||
170718062|NCT02265705|616971532|FG006|Follow-up Period|Sponsor Decision|6|||
170718063|NCT02265705|616971526|FG000|Follow-up Period|Adverse Event|0|||
170718064|NCT02265705|616971527|FG001|Follow-up Period|Adverse Event|0|||
170718065|NCT02265705|616971528|FG002|Follow-up Period|Adverse Event|0|||
170718066|NCT02265705|616971529|FG003|Follow-up Period|Adverse Event|0|||
170718067|NCT02265705|616971530|FG004|Follow-up Period|Adverse Event|0|||
170718068|NCT02265705|616971531|FG005|Follow-up Period|Adverse Event|0|||
170718069|NCT02265705|616971532|FG006|Follow-up Period|Adverse Event|3|||
170718070|NCT02265705|616971526|FG000|Follow-up Period|Physician Decision|0|||
170718071|NCT02265705|616971527|FG001|Follow-up Period|Physician Decision|0|||
170718072|NCT02265705|616971528|FG002|Follow-up Period|Physician Decision|0|||
170718073|NCT02265705|616971529|FG003|Follow-up Period|Physician Decision|0|||
170718074|NCT02265705|616971530|FG004|Follow-up Period|Physician Decision|0|||
170718075|NCT02265705|616971531|FG005|Follow-up Period|Physician Decision|0|||
170718076|NCT02265705|616971532|FG006|Follow-up Period|Physician Decision|1|||
170718077|NCT02265705|616971526|FG000|Follow-up Period|Withdrawal by Subject|0|||
170718078|NCT02265705|616971527|FG001|Follow-up Period|Withdrawal by Subject|0|||
170718079|NCT02265705|616971528|FG002|Follow-up Period|Withdrawal by Subject|0|||
170718080|NCT02265705|616971529|FG003|Follow-up Period|Withdrawal by Subject|0|||
170718081|NCT02265705|616971530|FG004|Follow-up Period|Withdrawal by Subject|0|||
170718082|NCT02265705|616971531|FG005|Follow-up Period|Withdrawal by Subject|0|||
170718083|NCT02265705|616971532|FG006|Follow-up Period|Withdrawal by Subject|1|||
170718084|NCT06027216|616971537|FG000|Overall Study|Did not qualify|8|||
170830343|NCT02034162|617388598|FG001|Double-blind|Physician Decision|0|||
170830344|NCT02034162|617388599|FG002|Double-blind|Physician Decision|0|||
170830345|NCT02034162|617388597|FG000|Double-blind|Protocol Violation|0|||
170830346|NCT02034162|617388598|FG001|Double-blind|Protocol Violation|1|||
170830347|NCT02034162|617388599|FG002|Double-blind|Protocol Violation|0|||
170830348|NCT02034162|617388597|FG000|Double-blind|Withdrawal by Subject|5|||
170830349|NCT02034162|617388598|FG001|Double-blind|Withdrawal by Subject|7|||
170830350|NCT02034162|617388599|FG002|Double-blind|Withdrawal by Subject|0|||
170830351|NCT00760513|617388600|FG000|Overall Study|Withdrawal by Subject|5|||
170830352|NCT00760513|617388601|FG001|Overall Study|Withdrawal by Subject|7|||
170830353|NCT02172911|617388602|FG000|Overall Study|Serious Adverse Event|0|||
170830354|NCT02172911|617388603|FG001|Overall Study|Serious Adverse Event|1|||
170830355|NCT02172911|617388602|FG000|Overall Study|Progression of Disease|0|||
170830356|NCT02172911|617388603|FG001|Overall Study|Progression of Disease|1|||
170830357|NCT02172911|617388602|FG000|Overall Study|Loss of insurance coverage|1|||
170830358|NCT02172911|617388603|FG001|Overall Study|Loss of insurance coverage|0|||
170830359|NCT00575042|617388606|FG000|Overall Study|Adverse Event|2|||
170830360|NCT00575042|617388606|FG000|Overall Study|Lost to Follow-up|1|||
170830361|NCT04795336|617388609|FG000|Overall Study|Withdrawal by Subject|3|||
170830362|NCT04795336|617388610|FG001|Overall Study|Withdrawal by Subject|4|||
170830363|NCT04795336|617388611|FG002|Overall Study|Withdrawal by Subject|3|||
170830364|NCT04795336|617388612|FG003|Overall Study|Withdrawal by Subject|12|||
170830365|NCT04795336|617388609|FG000|Overall Study|Lost study logs|0|||
170830366|NCT04795336|617388610|FG001|Overall Study|Lost study logs|1|||
170830367|NCT04795336|617388611|FG002|Overall Study|Lost study logs|0|||
170830368|NCT04795336|617388612|FG003|Overall Study|Lost study logs|2|||
170830369|NCT04795336|617388609|FG000|Overall Study|Did not take study medication|2|||
170830370|NCT04795336|617388610|FG001|Overall Study|Did not take study medication|0|||
170830371|NCT04795336|617388611|FG002|Overall Study|Did not take study medication|0|||
170830372|NCT04795336|617388612|FG003|Overall Study|Did not take study medication|0|||
170830373|NCT02666664|617388617|FG000|Overall Study|Physician Decision|0|||
170830374|NCT02666664|617388618|FG001|Overall Study|Physician Decision|1|||
170830375|NCT02666664|617388617|FG000|Overall Study|Protocol Violation|0|||
170830376|NCT02666664|617388618|FG001|Overall Study|Protocol Violation|2|||
170718085|NCT00345579|616971538|FG000|Overall Study|Adverse Event|9|||
170830377|NCT02666664|617388617|FG000|Overall Study|Other|0|||
170830378|NCT02666664|617388618|FG001|Overall Study|Other|1|||
170830379|NCT02666664|617388617|FG000|Overall Study|Adverse Event|12|||
170830380|NCT02666664|617388618|FG001|Overall Study|Adverse Event|37|||
170830381|NCT02666664|617388617|FG000|Overall Study|Withdrawal by participant|23|||
170830382|NCT02666664|617388618|FG001|Overall Study|Withdrawal by participant|40|||
170830383|NCT02666664|617388617|FG000|Overall Study|Sponsor decision|0|||
170830384|NCT02666664|617388618|FG001|Overall Study|Sponsor decision|1|||
170830385|NCT02666664|617388617|FG000|Overall Study|Lost to Follow-up|1|||
170830386|NCT02666664|617388618|FG001|Overall Study|Lost to Follow-up|2|||
170830387|NCT00971997|617388621|FG000|Overall Study|Adverse Event|2|||
170830388|NCT00971997|617388621|FG000|Overall Study|Death|1|||
170830389|NCT00971997|617388621|FG000|Overall Study|Protocol Violation|4|||
170830390|NCT00971997|617388621|FG000|Overall Study|Withdrawal by Subject|5|||
170830391|NCT00971997|617388621|FG000|Overall Study|Physician Decision|7|||
170830392|NCT03382561|617388624|FG000|Overall Study|Disease progression|47|||
170830393|NCT03382561|617388625|FG001|Overall Study|Disease progression|6|||
170830394|NCT03382561|617388624|FG000|Overall Study|Adverse Event|10|||
170718086|NCT00345579|616971539|FG001|Overall Study|Adverse Event|6|||
170718087|NCT00345579|616971538|FG000|Overall Study|Protocol Violation|14|||
170718088|NCT00345579|616971539|FG001|Overall Study|Protocol Violation|5|||
170718089|NCT00345579|616971538|FG000|Overall Study|Withdrawal by Subject|50|||
170718090|NCT00345579|616971539|FG001|Overall Study|Withdrawal by Subject|17|||
170830395|NCT03382561|617388625|FG001|Overall Study|Adverse Event|2|||
170718091|NCT00345579|616971538|FG000|Overall Study|Lost to Follow-up|82|||
170718092|NCT00345579|616971539|FG001|Overall Study|Lost to Follow-up|36|||
170718093|NCT00345579|616971538|FG000|Overall Study|Other|9|||
170718094|NCT00345579|616971539|FG001|Overall Study|Other|1|||
170718095|NCT02334748|616971540|FG000|Overall Study|Adverse Event|1|||
170718096|NCT02334748|616971540|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
170718097|NCT02334748|616971540|FG000|Overall Study|Patient no longer required study drug|2|||
170718098|NCT02334748|616971540|FG000|Overall Study|Lack of Efficacy|4|||
170718099|NCT02493361|616971541|FG000|Overall Study|Withdrawal by Subject|3|||
170718100|NCT01046643|616971542|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
170718101|NCT01046643|616971543|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
170718102|NCT01046643|616971544|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
170718103|NCT01046643|616971545|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
170718104|NCT01175668|616971546|FG000|Overall Study|Withdrawal by Subject|2|||
170718105|NCT01175668|616971547|FG001|Overall Study|Withdrawal by Subject|0|||
170718106|NCT00874029|616971548|FG000|Overall Study|Withdrawal by Subject|10|||
170718107|NCT00874029|616971548|FG000|Overall Study|Pregnancy|4|||
170718108|NCT00874029|616971548|FG000|Overall Study|Physician Decision|1|||
170718109|NCT00874029|616971548|FG000|Overall Study|Adverse Event|1|||
170718110|NCT00874029|616971548|FG000|Overall Study|Lost to Follow-up|5|||
170718111|NCT02937545|616971551|FG000|Overall Study|Withdrawal by Subject|1|||
170718112|NCT02937545|616971552|FG001|Overall Study|Withdrawal by Subject|2|||
170718113|NCT02937545|616971553|FG002|Overall Study|Withdrawal by Subject|6|||
170718114|NCT02937545|616971554|FG003|Overall Study|Withdrawal by Subject|7|||
170718115|NCT02937545|616971551|FG000|Overall Study|Lost to Follow-up|1|||
170718116|NCT02937545|616971552|FG001|Overall Study|Lost to Follow-up|0|||
170718117|NCT02937545|616971553|FG002|Overall Study|Lost to Follow-up|0|||
170718118|NCT02937545|616971554|FG003|Overall Study|Lost to Follow-up|0|||
170718119|NCT01767116|616971555|FG000|Overall Study|Lost to Follow-up|2|||
170718120|NCT01767116|616971556|FG001|Overall Study|Lost to Follow-up|2|||
170718121|NCT00968669|616971557|FG000|Overall Study|Lost to Follow-up|5|||
170718122|NCT00968669|616971558|FG001|Overall Study|Lost to Follow-up|2|||
170718123|NCT00968669|616971559|FG002|Overall Study|Lost to Follow-up|1|||
170718124|NCT00968669|616971560|FG003|Overall Study|Lost to Follow-up|4|||
170718125|NCT00968669|616971557|FG000|Overall Study|Withdrawal by Subject|9|||
170718126|NCT00968669|616971558|FG001|Overall Study|Withdrawal by Subject|7|||
170718127|NCT00968669|616971559|FG002|Overall Study|Withdrawal by Subject|5|||
170718128|NCT00968669|616971560|FG003|Overall Study|Withdrawal by Subject|3|||
170718129|NCT00968669|616971557|FG000|Overall Study|Pregnancy|0|||
170718130|NCT00968669|616971558|FG001|Overall Study|Pregnancy|0|||
170718131|NCT00968669|616971559|FG002|Overall Study|Pregnancy|2|||
170718132|NCT00968669|616971560|FG003|Overall Study|Pregnancy|0|||
170718133|NCT00968669|616971557|FG000|Overall Study|AE|1|||
170718134|NCT00968669|616971558|FG001|Overall Study|AE|0|||
170718135|NCT00968669|616971559|FG002|Overall Study|AE|0|||
170718136|NCT00968669|616971560|FG003|Overall Study|AE|0|||
170718137|NCT00968669|616971557|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
170718138|NCT00968669|616971558|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
170718139|NCT00968669|616971559|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
170718140|NCT00968669|616971560|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
170718141|NCT00968669|616971557|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
170718142|NCT00968669|616971558|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
170718143|NCT00968669|616971559|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
170718144|NCT00968669|616971560|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
170718145|NCT00968669|616971557|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
170718146|NCT00968669|616971558|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
170718147|NCT00968669|616971559|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
170718148|NCT00968669|616971560|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
170718149|NCT00968669|616971557|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
170718150|NCT00968669|616971558|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
170718151|NCT00968669|616971559|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
170718152|NCT00968669|616971560|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
170718153|NCT00968669|616971557|FG000|Overall Study|EARLY WITHDRAWAL|0|||
170718154|NCT00968669|616971558|FG001|Overall Study|EARLY WITHDRAWAL|1|||
170718155|NCT00968669|616971559|FG002|Overall Study|EARLY WITHDRAWAL|0|||
170718156|NCT00968669|616971560|FG003|Overall Study|EARLY WITHDRAWAL|0|||
170718157|NCT00968669|616971557|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
170830396|NCT03382561|617388624|FG000|Overall Study|Death|8|||
170830397|NCT03382561|617388625|FG001|Overall Study|Death|3|||
170830398|NCT03382561|617388624|FG000|Overall Study|Withdrawal by Subject|6|||
170830399|NCT03382561|617388625|FG001|Overall Study|Withdrawal by Subject|5|||
170830400|NCT03382561|617388624|FG000|Overall Study|Alternative therapy|2|||
170830401|NCT03382561|617388625|FG001|Overall Study|Alternative therapy|8|||
170830402|NCT03382561|617388624|FG000|Overall Study|Never started treatment|3|||
170830403|NCT03382561|617388625|FG001|Overall Study|Never started treatment|6|||
170830404|NCT03382561|617388624|FG000|Overall Study|Lack of Efficacy|0|||
170830405|NCT03382561|617388625|FG001|Overall Study|Lack of Efficacy|1|||
170830406|NCT03382561|617388624|FG000|Overall Study|Physician Decision|0|||
170830407|NCT03382561|617388625|FG001|Overall Study|Physician Decision|1|||
170830408|NCT03382561|617388624|FG000|Overall Study|Other complicating disease|0|||
170830409|NCT03382561|617388625|FG001|Overall Study|Other complicating disease|1|||
170830410|NCT02438371|617388627|FG000|Overall Study|Lost to Follow-up|3|||
170830411|NCT02438371|617388628|FG001|Overall Study|Lost to Follow-up|2|||
170830412|NCT02438371|617388627|FG000|Overall Study|Withdrawal by Subject|1|||
170830413|NCT02438371|617388628|FG001|Overall Study|Withdrawal by Subject|1|||
170830414|NCT03065933|617388629|FG000|Overall Study|study terminated|5|||
170830415|NCT01101997|617388630|FG000|Overall Study|Withdrawal by Subject|2|||
170830416|NCT00690378|617388633|FG000|Overall Study|Adverse Event|1|||
170830417|NCT00690378|617388634|FG001|Overall Study|Adverse Event|0|||
170830418|NCT00690378|617388633|FG000|Overall Study|Withdrawal by Subject|2|||
170830419|NCT00690378|617388634|FG001|Overall Study|Withdrawal by Subject|0|||
170830420|NCT00690378|617388633|FG000|Overall Study|Protocol Violation|1|||
170830421|NCT00690378|617388634|FG001|Overall Study|Protocol Violation|0|||
170830422|NCT00690378|617388633|FG000|Overall Study|Lost to Follow-up|2|||
170830423|NCT00690378|617388634|FG001|Overall Study|Lost to Follow-up|3|||
170830424|NCT00690378|617388633|FG000|Overall Study|Did not meet inc/exc criteria|13|||
170830425|NCT00690378|617388634|FG001|Overall Study|Did not meet inc/exc criteria|11|||
170830426|NCT00690378|617388633|FG000|Overall Study|Social problem|1|||
170830427|NCT00690378|617388634|FG001|Overall Study|Social problem|0|||
170830428|NCT00935259|617388638|FG000|Period 1|Administrative (scheduling conflict)|1|||
170830429|NCT00935259|617388639|FG001|Period 1|Administrative (scheduling conflict)|1|||
170830430|NCT03410108|617388640|FG000|Overall Study|Ongoing|41|||
170830431|NCT03410108|617388640|FG000|Overall Study|Adverse Event|4|||
170830432|NCT03410108|617388640|FG000|Overall Study|Progressive Disease|58|||
170830433|NCT03410108|617388640|FG000|Overall Study|Withdrawal by Subject|1|||
170830434|NCT03269695|617388645|FG000|Overall Study|Adverse Event|2|||
170830435|NCT03269695|617388646|FG001|Overall Study|Adverse Event|1|||
170830436|NCT03269695|617388645|FG000|Overall Study|Lack of Efficacy|0|||
170718158|NCT00968669|616971558|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
170718159|NCT00968669|616971559|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
170718160|NCT00968669|616971560|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
170718161|NCT00968669|616971557|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
170718162|NCT00968669|616971558|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
170718163|NCT00968669|616971559|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
170718164|NCT00968669|616971560|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
170718165|NCT00968669|616971557|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
170718166|NCT00968669|616971558|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
170718167|NCT00968669|616971559|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
170718168|NCT00968669|616971560|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
170718169|NCT00968669|616971557|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
170718170|NCT00968669|616971558|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
170718171|NCT00968669|616971559|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
170718172|NCT00968669|616971560|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
170718173|NCT00968669|616971557|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
170830437|NCT03269695|617388646|FG001|Overall Study|Lack of Efficacy|1|||
170830438|NCT03269695|617388645|FG000|Overall Study|Withdrawal by Subject|0|||
170830439|NCT03269695|617388646|FG001|Overall Study|Withdrawal by Subject|1|||
170830440|NCT05043883|617388647|FG000|Overall Study|Minimum required measurements could not be taken|4|||
170830441|NCT02980705|617388648|FG000|Overall Study|Adverse Event|0|||
170718174|NCT00968669|616971558|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
170718175|NCT00968669|616971559|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
170718176|NCT00968669|616971560|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
170830442|NCT02980705|617388649|FG001|Overall Study|Adverse Event|1|||
170830443|NCT02980705|617388648|FG000|Overall Study|Withdrawal by Subject|6|||
170830444|NCT02980705|617388649|FG001|Overall Study|Withdrawal by Subject|9|||
170830445|NCT02980705|617388648|FG000|Overall Study|withdrew participation|0|||
170830446|NCT02980705|617388649|FG001|Overall Study|withdrew participation|1|||
170830447|NCT02980705|617388648|FG000|Overall Study|Lost to Follow-up|2|||
170830448|NCT02980705|617388649|FG001|Overall Study|Lost to Follow-up|0|||
170718177|NCT00968669|616971557|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
170718178|NCT00968669|616971558|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
170718179|NCT00968669|616971559|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
170718180|NCT00968669|616971560|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
170718181|NCT00968669|616971557|FG000|Overall Study|SPONSOR DECISION|0|||
170718182|NCT00968669|616971558|FG001|Overall Study|SPONSOR DECISION|1|||
170718183|NCT00968669|616971559|FG002|Overall Study|SPONSOR DECISION|0|||
170718184|NCT00968669|616971560|FG003|Overall Study|SPONSOR DECISION|0|||
170718185|NCT00968669|616971557|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
170718186|NCT00968669|616971558|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
170718187|NCT00968669|616971559|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
170718188|NCT00968669|616971560|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
170718189|NCT00968669|616971557|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
170718190|NCT00968669|616971558|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
170718191|NCT00968669|616971559|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
170718192|NCT00968669|616971560|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
170718193|NCT00968669|616971557|FG000|Overall Study|SUBJECT INCARCERATED|0|||
170718194|NCT00968669|616971558|FG001|Overall Study|SUBJECT INCARCERATED|1|||
170718195|NCT00968669|616971559|FG002|Overall Study|SUBJECT INCARCERATED|0|||
170718196|NCT00968669|616971560|FG003|Overall Study|SUBJECT INCARCERATED|0|||
170718197|NCT00968669|616971557|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
170718198|NCT00968669|616971558|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
170718199|NCT00968669|616971559|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
170718200|NCT00968669|616971560|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
170718201|NCT00968669|616971557|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
170718202|NCT00968669|616971558|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
170718203|NCT00968669|616971559|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
170718204|NCT00968669|616971560|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
170718205|NCT01949480|616971563|FG000|Overall Study|Physician Decision|5|||
170718206|NCT01949480|616971564|FG001|Overall Study|Physician Decision|8|||
170718207|NCT04102501|616971566|FG000|Overall Study|Withdrawal by Subject|7|||
170718208|NCT04102501|616971567|FG001|Overall Study|Withdrawal by Subject|9|||
170718209|NCT04102501|616971566|FG000|Overall Study|Adverse Event|1|||
170718210|NCT04102501|616971567|FG001|Overall Study|Adverse Event|3|||
170718211|NCT02338362|616971569|FG000|Overall Study|Withdrawal by Subject|1|||
170718212|NCT02338362|616971570|FG001|Overall Study|Withdrawal by Subject|1|||
170718213|NCT03835533|616971572|FG000|Overall Study|Death|5|||
170718214|NCT03835533|616971573|FG001|Overall Study|Death|10|||
170718215|NCT03835533|616971574|FG002|Overall Study|Death|9|||
170830449|NCT01721746|617388650|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
170830450|NCT01721746|617388651|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
170830451|NCT01721746|617388650|FG000|Pre-Treatment|Withdrawal by Subject|1|||
170830452|NCT01721746|617388651|FG001|Pre-Treatment|Withdrawal by Subject|16|||
170830453|NCT01721746|617388650|FG000|Pre-Treatment|Poor/Non-compliance|1|||
170830454|NCT01721746|617388651|FG001|Pre-Treatment|Poor/Non-compliance|0|||
170830455|NCT01721746|617388650|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
170830456|NCT01721746|617388651|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
170830457|NCT01721746|617388650|FG000|Treatment|Disease Progression|192|||
170830458|NCT01721746|617388651|FG001|Treatment|Disease Progression|74|||
170830459|NCT01721746|617388650|FG000|Treatment|Study Drug Toxicity|19|||
170830460|NCT01721746|617388651|FG001|Treatment|Study Drug Toxicity|11|||
170830461|NCT01721746|617388650|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
170830462|NCT01721746|617388651|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
170830463|NCT01721746|617388650|FG000|Treatment|Participant request to discontinue Study treatment|26|||
170830464|NCT01721746|617388651|FG001|Treatment|Participant request to discontinue Study treatment|7|||
170830465|NCT01721746|617388650|FG000|Treatment|Participant withdrew consent|4|||
170830466|NCT01721746|617388651|FG001|Treatment|Participant withdrew consent|2|||
170830467|NCT01721746|617388650|FG000|Treatment|Maximum Clinical Benefit|9|||
170830468|NCT01721746|617388651|FG001|Treatment|Maximum Clinical Benefit|3|||
170830469|NCT01721746|617388650|FG000|Treatment|Poor/Non-compliance|2|||
170830470|NCT01721746|617388651|FG001|Treatment|Poor/Non-compliance|0|||
170830471|NCT01721746|617388650|FG000|Treatment|Participant no longer met Study criteria|4|||
170830472|NCT01721746|617388651|FG001|Treatment|Participant no longer met Study criteria|0|||
170830473|NCT01721746|617388650|FG000|Treatment|Other reasons|6|||
170830474|NCT01721746|617388651|FG001|Treatment|Other reasons|2|||
170830475|NCT03599622|617388654|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
170830476|NCT03599622|617388655|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
170718216|NCT03835533|616971572|FG000|Overall Study|Withdrawal by Subject|2|||
170718217|NCT03835533|616971573|FG001|Overall Study|Withdrawal by Subject|2|||
170718218|NCT03835533|616971574|FG002|Overall Study|Withdrawal by Subject|2|||
170718219|NCT03835533|616971572|FG000|Overall Study|Lost to Follow-up|1|||
170718220|NCT03835533|616971573|FG001|Overall Study|Lost to Follow-up|0|||
170718221|NCT03835533|616971574|FG002|Overall Study|Lost to Follow-up|0|||
170718222|NCT01178853|616971582|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
170718223|NCT01178853|616971583|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
170718224|NCT01178853|616971582|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
170718225|NCT01178853|616971583|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
170718226|NCT01178853|616971582|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
170718227|NCT01178853|616971583|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
170718228|NCT01178853|616971582|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
170718229|NCT01178853|616971583|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
170718230|NCT01178853|616971582|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
170718231|NCT01178853|616971583|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
170718232|NCT00927927|616971584|FG000|Overall Study|Withdrawal by Subject|0|||
170718233|NCT00927927|616971585|FG001|Overall Study|Withdrawal by Subject|0|||
170718234|NCT00927927|616971586|FG002|Overall Study|Withdrawal by Subject|0|||
170718235|NCT00927927|616971587|FG003|Overall Study|Withdrawal by Subject|0|||
170718236|NCT00927927|616971588|FG004|Overall Study|Withdrawal by Subject|0|||
170718237|NCT00927927|616971589|FG005|Overall Study|Withdrawal by Subject|0|||
170718238|NCT00927927|616971590|FG006|Overall Study|Withdrawal by Subject|0|||
170718239|NCT00927927|616971591|FG007|Overall Study|Withdrawal by Subject|2|||
170718240|NCT00927927|616971592|FG008|Overall Study|Withdrawal by Subject|0|||
170718241|NCT00927927|616971593|FG009|Overall Study|Withdrawal by Subject|0|||
170718242|NCT00927927|616971594|FG010|Overall Study|Withdrawal by Subject|0|||
170718243|NCT00927927|616971595|FG011|Overall Study|Withdrawal by Subject|2|||
170718244|NCT00927927|616971596|FG012|Overall Study|Withdrawal by Subject|0|||
170718245|NCT00927927|616971597|FG013|Overall Study|Withdrawal by Subject|0|||
170718246|NCT00927927|616971598|FG014|Overall Study|Withdrawal by Subject|0|||
170718247|NCT00080223|616971601|FG000|Overall Study|Adverse Event|23|||
170718248|NCT00080223|616971601|FG000|Overall Study|Death|21|||
170718249|NCT00080223|616971601|FG000|Overall Study|Withdrawal by Subject|13|||
170718250|NCT00080223|616971601|FG000|Overall Study|Lung Transplantation|9|||
170718251|NCT00080223|616971601|FG000|Overall Study|Non-compliance With Study Treatment|7|||
170718252|NCT00080223|616971601|FG000|Overall Study|Participant unwilling to continue|2|||
170718253|NCT00080223|616971601|FG000|Overall Study|Physician Decision|1|||
170718254|NCT01312467|616971608|FG000|Overall Study|Adverse Event|4|||
170718255|NCT01312467|616971608|FG000|Overall Study|Lost to Follow-up|1|||
170718256|NCT01312467|616971608|FG000|Overall Study|Withdrawal by Subject|2|||
170718257|NCT01312467|616971608|FG000|Overall Study|Deported to country of origin|1|||
170718258|NCT01312467|616971608|FG000|Overall Study|Another medical condition|1|||
170718259|NCT01312467|616971608|FG000|Overall Study|Ineligible|4|||
170718260|NCT03285477|616971609|FG000|Treatment and Response Assessment Period|Death|1|||
170718261|NCT03285477|616971610|FG001|Treatment and Response Assessment Period|Death|0|||
170718262|NCT03285477|616971609|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
170718263|NCT03285477|616971610|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
170718264|NCT03285477|616971609|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
170718265|NCT03285477|616971610|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
170718266|NCT03285477|616971609|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
170718267|NCT03285477|616971610|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
170718268|NCT03285477|616971609|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
170718269|NCT03285477|616971610|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
170718270|NCT00560833|616971611|FG000|Overall Study|Adverse Event|16|||
170718271|NCT00560833|616971612|FG001|Overall Study|Adverse Event|10|||
170830477|NCT03599622|617388656|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
170830478|NCT03599622|617388657|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
170830479|NCT03599622|617388654|FG000|Pre-Treatment Period|Other reasons|1|||
170830480|NCT03599622|617388655|FG001|Pre-Treatment Period|Other reasons|1|||
170830481|NCT03599622|617388656|FG002|Pre-Treatment Period|Other reasons|1|||
170830482|NCT03599622|617388657|FG003|Pre-Treatment Period|Other reasons|0|||
170830483|NCT03599622|617388654|FG000|Treatment Period|Adverse Event|11|||
170830484|NCT03599622|617388655|FG001|Treatment Period|Adverse Event|20|||
170830485|NCT03599622|617388656|FG002|Treatment Period|Adverse Event|18|||
170830486|NCT03599622|617388657|FG003|Treatment Period|Adverse Event|2|||
170830487|NCT03599622|617388654|FG000|Treatment Period|Lack of Efficacy|18|||
170830488|NCT03599622|617388655|FG001|Treatment Period|Lack of Efficacy|12|||
170830489|NCT03599622|617388656|FG002|Treatment Period|Lack of Efficacy|13|||
170830490|NCT03599622|617388657|FG003|Treatment Period|Lack of Efficacy|2|||
170830491|NCT03599622|617388654|FG000|Treatment Period|Withdrawal by Subject|5|||
170830492|NCT03599622|617388655|FG001|Treatment Period|Withdrawal by Subject|11|||
170718272|NCT00560833|616971613|FG002|Overall Study|Adverse Event|25|||
170718273|NCT00560833|616971614|FG003|Overall Study|Adverse Event|23|||
170718274|NCT00560833|616971615|FG004|Overall Study|Adverse Event|35|||
170830493|NCT03599622|617388656|FG002|Treatment Period|Withdrawal by Subject|16|||
170830494|NCT03599622|617388657|FG003|Treatment Period|Withdrawal by Subject|1|||
170830495|NCT03599622|617388654|FG000|Treatment Period|Other reasons|4|||
170830496|NCT03599622|617388655|FG001|Treatment Period|Other reasons|6|||
170718275|NCT00560833|616971611|FG000|Overall Study|Lost to Follow-up|0|||
170718276|NCT00560833|616971612|FG001|Overall Study|Lost to Follow-up|0|||
170718277|NCT00560833|616971613|FG002|Overall Study|Lost to Follow-up|1|||
170718278|NCT00560833|616971614|FG003|Overall Study|Lost to Follow-up|0|||
170718279|NCT00560833|616971615|FG004|Overall Study|Lost to Follow-up|0|||
170718280|NCT00560833|616971611|FG000|Overall Study|Lack of Efficacy|22|||
170718281|NCT00560833|616971612|FG001|Overall Study|Lack of Efficacy|9|||
170718282|NCT00560833|616971613|FG002|Overall Study|Lack of Efficacy|6|||
170718283|NCT00560833|616971614|FG003|Overall Study|Lack of Efficacy|4|||
170718284|NCT00560833|616971615|FG004|Overall Study|Lack of Efficacy|4|||
170718285|NCT00560833|616971611|FG000|Overall Study|Participant uncooperative|5|||
170718286|NCT00560833|616971612|FG001|Overall Study|Participant uncooperative|5|||
170718287|NCT00560833|616971613|FG002|Overall Study|Participant uncooperative|4|||
170718288|NCT00560833|616971614|FG003|Overall Study|Participant uncooperative|4|||
170718289|NCT00560833|616971615|FG004|Overall Study|Participant uncooperative|2|||
170718290|NCT00560833|616971611|FG000|Overall Study|Other|1|||
170718291|NCT00560833|616971612|FG001|Overall Study|Other|1|||
170718292|NCT00560833|616971613|FG002|Overall Study|Other|3|||
170718293|NCT00560833|616971614|FG003|Overall Study|Other|0|||
170718294|NCT00560833|616971615|FG004|Overall Study|Other|0|||
170718295|NCT00560833|616971611|FG000|Overall Study|Never received drug|0|||
170718296|NCT00560833|616971612|FG001|Overall Study|Never received drug|1|||
170718297|NCT00560833|616971613|FG002|Overall Study|Never received drug|0|||
170718298|NCT00560833|616971614|FG003|Overall Study|Never received drug|0|||
170718299|NCT00560833|616971615|FG004|Overall Study|Never received drug|1|||
170718300|NCT01307501|616971618|FG000|Overall Study|Treatment Failure|1|||
170718301|NCT01307501|616971618|FG000|Overall Study|Death|20|||
170718302|NCT01307501|616971618|FG000|Overall Study|Lost to Follow-up|1|||
170718303|NCT01307501|616971618|FG000|Overall Study|Starting Hospice|1|||
170718304|NCT01209624|616971625|FG000|Overall Study|Death|2|||
170718305|NCT01209624|616971625|FG000|Overall Study|Adverse Event|13|||
170718306|NCT01209624|616971625|FG000|Overall Study|Lack of Efficacy|17|||
170718307|NCT01209624|616971625|FG000|Overall Study|Lost to Follow-up|290|||
170718308|NCT01209624|616971625|FG000|Overall Study|Other|4|||
170718309|NCT00428610|616971626|FG000|Overall Study|Death Due to Adverse Event|3|||
170718310|NCT00428610|616971627|FG001|Overall Study|Death Due to Adverse Event|0|||
170718311|NCT00428610|616971628|FG002|Overall Study|Death Due to Adverse Event|5|||
170718312|NCT00428610|616971626|FG000|Overall Study|Death Due to Progressive Disease|0|||
170718313|NCT00428610|616971627|FG001|Overall Study|Death Due to Progressive Disease|0|||
170718314|NCT00428610|616971628|FG002|Overall Study|Death Due to Progressive Disease|2|||
170718315|NCT00428610|616971626|FG000|Overall Study|Adverse Event|2|||
170718316|NCT00428610|616971627|FG001|Overall Study|Adverse Event|3|||
170718317|NCT00428610|616971628|FG002|Overall Study|Adverse Event|2|||
170718318|NCT00428610|616971626|FG000|Overall Study|Investigator Decision|2|||
170718319|NCT00428610|616971627|FG001|Overall Study|Investigator Decision|1|||
170718320|NCT00428610|616971628|FG002|Overall Study|Investigator Decision|1|||
170718321|NCT00428610|616971626|FG000|Overall Study|Progressive Disease|42|||
170830497|NCT03599622|617388656|FG002|Treatment Period|Other reasons|7|||
170830498|NCT03599622|617388657|FG003|Treatment Period|Other reasons|0|||
170830499|NCT03599622|617388654|FG000|Treatment Period|Lost to Follow-up|1|||
170830500|NCT03599622|617388655|FG001|Treatment Period|Lost to Follow-up|0|||
170830501|NCT03599622|617388656|FG002|Treatment Period|Lost to Follow-up|0|||
170830502|NCT03599622|617388657|FG003|Treatment Period|Lost to Follow-up|0|||
170830503|NCT03599622|617388654|FG000|Treatment Period|Study terminated by sponsor|7|||
170830504|NCT03599622|617388655|FG001|Treatment Period|Study terminated by sponsor|20|||
170830505|NCT03599622|617388656|FG002|Treatment Period|Study terminated by sponsor|15|||
170830506|NCT03599622|617388657|FG003|Treatment Period|Study terminated by sponsor|0|||
170830507|NCT03599622|617388654|FG000|Treatment Period|Site terminated by sponsor|0|||
170830508|NCT03599622|617388655|FG001|Treatment Period|Site terminated by sponsor|1|||
170830509|NCT03599622|617388656|FG002|Treatment Period|Site terminated by sponsor|0|||
170830510|NCT03599622|617388657|FG003|Treatment Period|Site terminated by sponsor|0|||
170830511|NCT01426113|617388660|FG000|Overall Study|Study Discontinued|1|||
170830512|NCT01426113|617388661|FG001|Overall Study|Study Discontinued|1|||
170830513|NCT01426113|617388660|FG000|Overall Study|Adverse Event|0|||
170830514|NCT01426113|617388661|FG001|Overall Study|Adverse Event|1|||
170830515|NCT00338949|617388662|FG000|Subject Screening|Screen failures|11|||
170830516|NCT00338949|617388663|FG001|Subject Screening|Screen failures|11|||
170830517|NCT00338949|617388662|FG000|Randomization|Withdrawal by Subject|1|||
170830518|NCT00338949|617388663|FG001|Randomization|Withdrawal by Subject|0|||
170830519|NCT00338949|617388662|FG000|Randomization|Adverse Event|0|||
170830520|NCT00338949|617388663|FG001|Randomization|Adverse Event|5|||
170830521|NCT00468130|617388665|FG000|Overall Study|Adverse Event|2|||
170830522|NCT00468130|617388666|FG001|Overall Study|Adverse Event|1|||
170830523|NCT00468130|617388665|FG000|Overall Study|Withdrawal by Subject|0|||
170830524|NCT00468130|617388666|FG001|Overall Study|Withdrawal by Subject|1|||
170830525|NCT01880437|617388668|FG000|Overall Study|Death|12|||
170830526|NCT01880437|617388669|FG001|Overall Study|Death|4|||
170830527|NCT01880437|617388670|FG002|Overall Study|Death|17|||
170830528|NCT01880437|617388668|FG000|Overall Study|Study terminated by Sponsor|3|||
170830529|NCT01880437|617388669|FG001|Overall Study|Study terminated by Sponsor|0|||
170830530|NCT01880437|617388670|FG002|Overall Study|Study terminated by Sponsor|2|||
170830531|NCT03713320|617388671|FG000|Randomized Period|Adverse Event|1|||
170830532|NCT03713320|617388672|FG001|Randomized Period|Adverse Event|5|||
170830533|NCT03713320|617388673|FG002|Randomized Period|Adverse Event|0|||
170830534|NCT03713320|617388671|FG000|Randomized Period|Physician Decision|1|||
170830535|NCT03713320|617388672|FG001|Randomized Period|Physician Decision|1|||
170830536|NCT03713320|617388673|FG002|Randomized Period|Physician Decision|0|||
170830537|NCT03713320|617388671|FG000|Randomized Period|Withdrawal by Subject|4|||
170830538|NCT03713320|617388672|FG001|Randomized Period|Withdrawal by Subject|0|||
170830539|NCT03713320|617388673|FG002|Randomized Period|Withdrawal by Subject|0|||
170830540|NCT03713320|617388671|FG000|Randomized Period|Participant decision|3|||
170830541|NCT03713320|617388672|FG001|Randomized Period|Participant decision|1|||
170830542|NCT03713320|617388673|FG002|Randomized Period|Participant decision|0|||
170830543|NCT03713320|617388671|FG000|Randomized Period|Study terminated by sponsor|6|||
170830544|NCT03713320|617388672|FG001|Randomized Period|Study terminated by sponsor|3|||
170830545|NCT03713320|617388673|FG002|Randomized Period|Study terminated by sponsor|0|||
170830546|NCT03713320|617388671|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
170830547|NCT03713320|617388672|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
170830548|NCT03713320|617388673|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
170830549|NCT03713320|617388671|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
170830550|NCT03713320|617388672|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
170830551|NCT03713320|617388673|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
170830552|NCT00909532|617388674|FG000|Overall Study|Adverse Event|4|||
170830553|NCT00909532|617388675|FG001|Overall Study|Adverse Event|1|||
170830554|NCT00909532|617388674|FG000|Overall Study|Pregnancy|0|||
170830555|NCT00909532|617388675|FG001|Overall Study|Pregnancy|1|||
170830556|NCT00909532|617388674|FG000|Overall Study|Prohibited Medication|2|||
170718322|NCT00428610|616971627|FG001|Overall Study|Progressive Disease|14|||
170718323|NCT00428610|616971628|FG002|Overall Study|Progressive Disease|22|||
170718324|NCT00428610|616971626|FG000|Overall Study|Withdrawal by Subject|4|||
170718325|NCT00428610|616971627|FG001|Overall Study|Withdrawal by Subject|0|||
170718326|NCT00428610|616971628|FG002|Overall Study|Withdrawal by Subject|0|||
170718327|NCT00618514|616973420|FG000|Overall Study|Lost to Follow-up|11|||
170718328|NCT00618514|616973421|FG001|Overall Study|Lost to Follow-up|12|||
170718329|NCT00618514|616973422|FG002|Overall Study|Lost to Follow-up|4|||
170718330|NCT01944631|616973428|FG000|Overall Study|Adverse Event|1|||
170718331|NCT01944631|616973429|FG001|Overall Study|Adverse Event|0|||
170718332|NCT01944631|616973428|FG000|Overall Study|Lost to Follow-up|3|||
170718333|NCT01944631|616973429|FG001|Overall Study|Lost to Follow-up|1|||
170718334|NCT01944631|616973428|FG000|Overall Study|Withdrawal by Subject|0|||
170718335|NCT01944631|616973429|FG001|Overall Study|Withdrawal by Subject|1|||
170718336|NCT01262651|616973430|FG000|Overall Study|Adverse Event|40|||
170718337|NCT01262651|616973431|FG001|Overall Study|Adverse Event|35|||
170718338|NCT01262651|616973430|FG000|Overall Study|Withdrawal by Subject|15|||
170718339|NCT01262651|616973431|FG001|Overall Study|Withdrawal by Subject|11|||
170718340|NCT01262651|616973430|FG000|Overall Study|Withdrawal by Investigator|2|||
170718341|NCT01262651|616973431|FG001|Overall Study|Withdrawal by Investigator|2|||
170718342|NCT01262651|616973430|FG000|Overall Study|Met Withdrawal Criteria|1|||
170718343|NCT01262651|616973431|FG001|Overall Study|Met Withdrawal Criteria|0|||
170718344|NCT02019719|616973434|FG000|Overall Study|Adverse Event|1|||
170718345|NCT02019719|616973435|FG001|Overall Study|Adverse Event|0|||
170718346|NCT02019719|616973436|FG002|Overall Study|Adverse Event|0|||
170718347|NCT02019719|616973437|FG003|Overall Study|Adverse Event|1|||
170718348|NCT02019719|616973438|FG004|Overall Study|Adverse Event|1|||
170718349|NCT02019719|616973434|FG000|Overall Study|Protocol Violation|1|||
170718350|NCT02019719|616973435|FG001|Overall Study|Protocol Violation|1|||
170718351|NCT02019719|616973436|FG002|Overall Study|Protocol Violation|0|||
170718352|NCT02019719|616973437|FG003|Overall Study|Protocol Violation|0|||
170718353|NCT02019719|616973438|FG004|Overall Study|Protocol Violation|0|||
170718354|NCT02019719|616973434|FG000|Overall Study|Protocol defined stopping criteria|2|||
170718355|NCT02019719|616973435|FG001|Overall Study|Protocol defined stopping criteria|0|||
170718356|NCT02019719|616973436|FG002|Overall Study|Protocol defined stopping criteria|0|||
170718357|NCT02019719|616973437|FG003|Overall Study|Protocol defined stopping criteria|1|||
170718358|NCT02019719|616973438|FG004|Overall Study|Protocol defined stopping criteria|1|||
170718359|NCT02019719|616973434|FG000|Overall Study|Physician Decision|2|||
170718360|NCT02019719|616973435|FG001|Overall Study|Physician Decision|0|||
170718361|NCT02019719|616973436|FG002|Overall Study|Physician Decision|0|||
170718362|NCT02019719|616973437|FG003|Overall Study|Physician Decision|0|||
170718363|NCT02019719|616973438|FG004|Overall Study|Physician Decision|0|||
170718364|NCT04726709|616973439|FG000|Overall Study|Withdrawal by Subject|2|||
170718365|NCT04726709|616973440|FG001|Overall Study|Withdrawal by Subject|2|||
170718366|NCT00434057|616973443|FG000|Overall Study|Withdrawal by Subject|1|||
170718367|NCT02896855|616973444|FG000|Overall Study|Death|50|||
170718368|NCT02896855|616973445|FG001|Overall Study|Death|40|||
170718369|NCT02896855|616973444|FG000|Overall Study|Lost to Follow-up|15|||
170718370|NCT02896855|616973445|FG001|Overall Study|Lost to Follow-up|9|||
170830557|NCT00909532|617388675|FG001|Overall Study|Prohibited Medication|1|||
170830558|NCT00909532|617388674|FG000|Overall Study|Withdrawal of Consent|1|||
170830559|NCT00909532|617388675|FG001|Overall Study|Withdrawal of Consent|1|||
170830560|NCT00909532|617388674|FG000|Overall Study|Noncompliance with Study Requirements|0|||
170830561|NCT00909532|617388675|FG001|Overall Study|Noncompliance with Study Requirements|2|||
170830562|NCT00909532|617388674|FG000|Overall Study|Physician Decision|1|||
170830563|NCT00909532|617388675|FG001|Overall Study|Physician Decision|0|||
170830564|NCT00909532|617388674|FG000|Overall Study|Wrong Genotype|1|||
170830565|NCT00909532|617388675|FG001|Overall Study|Wrong Genotype|0|||
170830566|NCT00909532|617388674|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
170830567|NCT00909532|617388675|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
170830568|NCT01209598|617388676|FG000|Overall Study|Withdrawal by Subject|1|||
170830569|NCT01209598|617388677|FG001|Overall Study|Withdrawal by Subject|0|||
170830570|NCT00085566|617388679|FG000|Overall Study|Adverse Event|0|||
170830571|NCT00085566|617388680|FG001|Overall Study|Adverse Event|0|||
170830572|NCT00085566|617388681|FG002|Overall Study|Adverse Event|10|||
170830573|NCT00085566|617388679|FG000|Overall Study|Patient Not treated|0|||
170830574|NCT00085566|617388680|FG001|Overall Study|Patient Not treated|0|||
170830575|NCT00085566|617388681|FG002|Overall Study|Patient Not treated|3|||
170830576|NCT00085566|617388679|FG000|Overall Study|Clinical progression|0|||
170830577|NCT00085566|617388680|FG001|Overall Study|Clinical progression|0|||
170830578|NCT00085566|617388681|FG002|Overall Study|Clinical progression|1|||
170830579|NCT01774305|617388684|FG000|Overall Study|Physician Decision|1|||
170830580|NCT01774305|617388685|FG001|Overall Study|Physician Decision|0|||
170830581|NCT02604342|617388686|FG000|Overall Study|Death|32|||
170830582|NCT02604342|617388687|FG001|Overall Study|Death|16|||
170830583|NCT02604342|617388686|FG000|Overall Study|Progression of disease|1|||
170830584|NCT02604342|617388687|FG001|Overall Study|Progression of disease|0|||
170830585|NCT02604342|617388686|FG000|Overall Study|Withdrawal by Subject|5|||
170718371|NCT02896855|616973444|FG000|Overall Study|Withdrawal by Subject|7|||
170830586|NCT02604342|617388687|FG001|Overall Study|Withdrawal by Subject|6|||
170830587|NCT02604342|617388686|FG000|Overall Study|Other|1|||
170830588|NCT02604342|617388687|FG001|Overall Study|Other|0|||
170830589|NCT02604342|617388686|FG000|Overall Study|Study Termination by Sponsor|1|||
170830590|NCT02604342|617388687|FG001|Overall Study|Study Termination by Sponsor|0|||
170830591|NCT02604342|617388686|FG000|Overall Study|Lost to Follow-up|1|||
170830592|NCT02604342|617388687|FG001|Overall Study|Lost to Follow-up|1|||
170830593|NCT02604342|617388686|FG000|Overall Study|Physician Decision|2|||
170830594|NCT02604342|617388687|FG001|Overall Study|Physician Decision|0|||
170830595|NCT01702519|617388688|FG000|Washout Period|Lost to Follow-up|1|||
170830596|NCT01702519|617388689|FG001|Washout Period|Lost to Follow-up|0|||
170830597|NCT01702519|617388688|FG000|Washout Period|Withdrawal by Subject|0|||
170830598|NCT01702519|617388689|FG001|Washout Period|Withdrawal by Subject|2|||
170830599|NCT03772613|617388690|FG000|Overall Study|Lost to Follow-up|0|||
170830600|NCT03772613|617388691|FG001|Overall Study|Lost to Follow-up|1|||
170830601|NCT03772613|617388692|FG002|Overall Study|Lost to Follow-up|1|||
170830602|NCT02725008|617388695|FG000|Overall Study|Lost to Follow-up|7|||
170830603|NCT02725008|617388696|FG001|Overall Study|Lost to Follow-up|9|||
170830604|NCT02725008|617388695|FG000|Overall Study|Withdrawal by Subject|2|||
170830605|NCT02725008|617388696|FG001|Overall Study|Withdrawal by Subject|2|||
170830606|NCT02725008|617388695|FG000|Overall Study|Admitted to hospital|0|||
170830607|NCT02725008|617388696|FG001|Overall Study|Admitted to hospital|1|||
170830608|NCT01020747|617388697|FG000|Overall Study|Withdrawal by Subject|1|||
170830609|NCT04688086|617388702|FG000|Overall Study|Lost to Follow-up|164|||
170830610|NCT04688086|617388702|FG000|Overall Study|Imaging error;|64|||
170830611|NCT03120949|617388703|FG000|Overall Study|randomized in error|1|||
170830612|NCT03120949|617388704|FG001|Overall Study|randomized in error|0|||
170830613|NCT03120949|617388703|FG000|Overall Study|Death|13|||
170830614|NCT03120949|617388704|FG001|Overall Study|Death|13|||
170830615|NCT03120949|617388703|FG000|Overall Study|Lost to Follow-up|23|||
170830616|NCT03120949|617388704|FG001|Overall Study|Lost to Follow-up|13|||
170830617|NCT03120949|617388703|FG000|Overall Study|Withdrawal by Subject|139|||
170830618|NCT03120949|617388704|FG001|Overall Study|Withdrawal by Subject|124|||
170830619|NCT03120949|617388703|FG000|Overall Study|Covid-19|43|||
170830620|NCT03120949|617388704|FG001|Overall Study|Covid-19|34|||
170830621|NCT03120949|617388703|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
170830622|NCT03120949|617388704|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
170830623|NCT03120949|617388703|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
170830624|NCT03120949|617388704|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
170830625|NCT03120949|617388703|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
170830626|NCT03120949|617388704|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
170830627|NCT03120949|617388703|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
170830628|NCT03120949|617388704|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
170830629|NCT03120949|617388703|FG000|Overall Study|Site was closed|2|||
170830630|NCT03120949|617388704|FG001|Overall Study|Site was closed|3|||
170830631|NCT03120949|617388703|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
170830632|NCT03120949|617388704|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
170830633|NCT03120949|617388703|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
170830634|NCT03120949|617388704|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
170830635|NCT03120949|617388703|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
170830636|NCT03120949|617388704|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
170830637|NCT03120949|617388703|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
170830638|NCT03120949|617388704|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
170830639|NCT03120949|617388703|FG000|Overall Study|Other: Adverse Event|0|||
170830640|NCT03120949|617388704|FG001|Overall Study|Other: Adverse Event|1|||
170830641|NCT03120949|617388703|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
170830642|NCT03120949|617388704|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
170830643|NCT03120949|617388703|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
170830644|NCT03120949|617388704|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
170830645|NCT03120949|617388703|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
170830646|NCT03120949|617388704|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
170830647|NCT03120949|617388703|FG000|Overall Study|Personal Reasons|0|||
170830648|NCT03120949|617388704|FG001|Overall Study|Personal Reasons|1|||
170830649|NCT03120949|617388703|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
170830650|NCT03120949|617388704|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
170718372|NCT02896855|616973445|FG001|Overall Study|Withdrawal by Subject|4|||
170718373|NCT01205685|616973446|FG000|Overall Study|Disease Progression|10|||
170718374|NCT01205685|616973446|FG000|Overall Study|Withdrawal by Subject|1|||
170718375|NCT02169674|616973447|FG000|Overall Study|Withdrawal by Subject|2|||
170718376|NCT02169674|616973448|FG001|Overall Study|Withdrawal by Subject|1|||
170718377|NCT02169674|616973447|FG000|Overall Study|Seroprotected|30|||
170718378|NCT02169674|616973448|FG001|Overall Study|Seroprotected|76|||
170718379|NCT02169674|616973447|FG000|Overall Study|Lost to Follow-up|0|||
170718380|NCT02169674|616973448|FG001|Overall Study|Lost to Follow-up|1|||
170718381|NCT00304070|616973451|FG000|Overall Study|Death|0|||
170718382|NCT00304070|616973452|FG001|Overall Study|Death|0|||
170718383|NCT00304070|616973453|FG002|Overall Study|Death|3|||
170718384|NCT00304070|616973451|FG000|Overall Study|Lost to Follow-up|0|||
170718385|NCT00304070|616973452|FG001|Overall Study|Lost to Follow-up|0|||
170718386|NCT00304070|616973453|FG002|Overall Study|Lost to Follow-up|1|||
170718387|NCT00304070|616973451|FG000|Overall Study|Physician Decision|0|||
170718388|NCT00304070|616973452|FG001|Overall Study|Physician Decision|0|||
170718389|NCT00304070|616973453|FG002|Overall Study|Physician Decision|3|||
170718390|NCT00304070|616973451|FG000|Overall Study|Withdrawal by Subject|0|||
170718391|NCT00304070|616973452|FG001|Overall Study|Withdrawal by Subject|0|||
170718392|NCT00304070|616973453|FG002|Overall Study|Withdrawal by Subject|1|||
170718393|NCT00304070|616973451|FG000|Overall Study|Progressive Disease|3|||
170718394|NCT00304070|616973452|FG001|Overall Study|Progressive Disease|7|||
170718395|NCT00304070|616973453|FG002|Overall Study|Progressive Disease|4|||
170718396|NCT00320216|616973454|FG000|Overall Study|Adverse Event|0|||
170718397|NCT00320216|616973455|FG001|Overall Study|Adverse Event|6|||
170718398|NCT00320216|616973456|FG002|Overall Study|Adverse Event|0|||
170718399|NCT00320216|616973457|FG003|Overall Study|Adverse Event|2|||
170718400|NCT00320216|616973458|FG004|Overall Study|Adverse Event|2|||
170718401|NCT00320216|616973454|FG000|Overall Study|Lack of Efficacy|6|||
170718402|NCT00320216|616973455|FG001|Overall Study|Lack of Efficacy|2|||
170718403|NCT00320216|616973456|FG002|Overall Study|Lack of Efficacy|1|||
170718404|NCT00320216|616973457|FG003|Overall Study|Lack of Efficacy|0|||
170718405|NCT00320216|616973458|FG004|Overall Study|Lack of Efficacy|1|||
170718406|NCT00320216|616973454|FG000|Overall Study|Lost to Follow-up|3|||
170718407|NCT00320216|616973455|FG001|Overall Study|Lost to Follow-up|0|||
170718408|NCT00320216|616973456|FG002|Overall Study|Lost to Follow-up|0|||
170718409|NCT00320216|616973457|FG003|Overall Study|Lost to Follow-up|0|||
170718410|NCT00320216|616973458|FG004|Overall Study|Lost to Follow-up|0|||
170718411|NCT00320216|616973454|FG000|Overall Study|Other|7|||
170718412|NCT00320216|616973455|FG001|Overall Study|Other|2|||
170718413|NCT00320216|616973456|FG002|Overall Study|Other|5|||
170718414|NCT00320216|616973457|FG003|Overall Study|Other|1|||
170718415|NCT00320216|616973458|FG004|Overall Study|Other|3|||
170718416|NCT03525834|616973459|FG000|Overall Study|Progressive disease|1|||
170718417|NCT00779246|616973460|FG000|Overall Study|Missing sufficient data for analysis|33|||
170718418|NCT00779246|616973461|FG001|Overall Study|Missing sufficient data for analysis|53|||
170718419|NCT02806986|616973472|FG000|Treatment Stage 1|Adverse Event|1|||
170718420|NCT02806986|616973472|FG000|Treatment Stage 2|Adverse Event|3|||
170718421|NCT02806986|616973472|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
170718422|NCT02384759|616973473|FG000|Overall Study|Patients not treated|3|||
170718423|NCT02384759|616973474|FG001|Overall Study|Patients not treated|2|||
170718424|NCT00121238|616973475|FG000|Overall Study|disease progression before intervention|1|||
170718425|NCT00121238|616973475|FG000|Overall Study|Protocol Violation|2|||
170718426|NCT01380327|616973476|FG000|Overall Study|Lost to Follow-up|0|||
170718427|NCT01380327|616973477|FG001|Overall Study|Lost to Follow-up|1|||
170718428|NCT01380327|616973478|FG002|Overall Study|Lost to Follow-up|1|||
170718429|NCT01380327|616973476|FG000|Overall Study|Protocol Violation|3|||
170718430|NCT01380327|616973477|FG001|Overall Study|Protocol Violation|2|||
170718431|NCT01380327|616973478|FG002|Overall Study|Protocol Violation|3|||
170718432|NCT01380327|616973476|FG000|Overall Study|Withdrawal by Subject|0|||
170718433|NCT01380327|616973477|FG001|Overall Study|Withdrawal by Subject|0|||
170718434|NCT01380327|616973478|FG002|Overall Study|Withdrawal by Subject|1|||
170718435|NCT01380327|616973476|FG000|Overall Study|Housing situation precluded ability to k|0|||
170718436|NCT01380327|616973477|FG001|Overall Study|Housing situation precluded ability to k|0|||
170718437|NCT01380327|616973478|FG002|Overall Study|Housing situation precluded ability to k|1|||
170718438|NCT01380327|616973476|FG000|Overall Study|Questionable onset of epilepsy|0|||
170718439|NCT01380327|616973477|FG001|Overall Study|Questionable onset of epilepsy|0|||
170718440|NCT01380327|616973478|FG002|Overall Study|Questionable onset of epilepsy|1|||
170718441|NCT00325468|616973479|FG000|Overall Study|Adverse Event|1|||
170718442|NCT00325468|616973480|FG001|Overall Study|Adverse Event|1|||
170718443|NCT00325468|616973481|FG002|Overall Study|Adverse Event|0|||
170718444|NCT00325468|616973482|FG003|Overall Study|Adverse Event|5|||
170718445|NCT00325468|616973483|FG004|Overall Study|Adverse Event|1|||
170718446|NCT00325468|616973479|FG000|Overall Study|Death|2|||
170718447|NCT00325468|616973480|FG001|Overall Study|Death|0|||
170718448|NCT00325468|616973481|FG002|Overall Study|Death|2|||
170718449|NCT00325468|616973482|FG003|Overall Study|Death|4|||
170718450|NCT00325468|616973483|FG004|Overall Study|Death|0|||
170718451|NCT00325468|616973479|FG000|Overall Study|Lost to Follow-up|0|||
170718452|NCT00325468|616973480|FG001|Overall Study|Lost to Follow-up|0|||
170718453|NCT00325468|616973481|FG002|Overall Study|Lost to Follow-up|1|||
170718454|NCT00325468|616973482|FG003|Overall Study|Lost to Follow-up|2|||
170718455|NCT00325468|616973483|FG004|Overall Study|Lost to Follow-up|2|||
170718456|NCT00325468|616973479|FG000|Overall Study|Physician Decision|1|||
170718457|NCT00325468|616973480|FG001|Overall Study|Physician Decision|1|||
170718458|NCT00325468|616973481|FG002|Overall Study|Physician Decision|0|||
170718459|NCT00325468|616973482|FG003|Overall Study|Physician Decision|1|||
170718460|NCT00325468|616973483|FG004|Overall Study|Physician Decision|0|||
170718461|NCT00325468|616973479|FG000|Overall Study|Withdrawal by Subject|3|||
170718462|NCT00325468|616973480|FG001|Overall Study|Withdrawal by Subject|1|||
170718463|NCT00325468|616973481|FG002|Overall Study|Withdrawal by Subject|0|||
170718464|NCT00325468|616973482|FG003|Overall Study|Withdrawal by Subject|14|||
170718465|NCT00325468|616973483|FG004|Overall Study|Withdrawal by Subject|4|||
170718466|NCT00325468|616973479|FG000|Overall Study|site closure etc|4|||
170718467|NCT00325468|616973480|FG001|Overall Study|site closure etc|2|||
170718468|NCT00325468|616973481|FG002|Overall Study|site closure etc|1|||
170718469|NCT00325468|616973482|FG003|Overall Study|site closure etc|8|||
170718470|NCT00325468|616973483|FG004|Overall Study|site closure etc|1|||
170718471|NCT03732209|616973484|FG000|Overall Study|Lost to Follow-up|4|||
170718472|NCT03732209|616973485|FG001|Overall Study|Lost to Follow-up|4|||
170718473|NCT03732209|616973484|FG000|Overall Study|Withdrawal by Subject|8|||
170718474|NCT03732209|616973485|FG001|Overall Study|Withdrawal by Subject|9|||
170718475|NCT03879798|616973486|FG000|Overall Study|Adverse Event|0|||
170718476|NCT03879798|616973487|FG001|Overall Study|Adverse Event|0|||
170718477|NCT03879798|616973488|FG002|Overall Study|Adverse Event|0|||
170718478|NCT03879798|616973489|FG003|Overall Study|Adverse Event|0|||
170718479|NCT03879798|616973490|FG004|Overall Study|Adverse Event|0|||
170718480|NCT03879798|616973491|FG005|Overall Study|Adverse Event|1|||
170718481|NCT03879798|616973486|FG000|Overall Study|Lack of Efficacy|0|||
170718482|NCT03879798|616973487|FG001|Overall Study|Lack of Efficacy|0|||
170718483|NCT03879798|616973488|FG002|Overall Study|Lack of Efficacy|0|||
170718484|NCT03879798|616973489|FG003|Overall Study|Lack of Efficacy|0|||
170718485|NCT03879798|616973490|FG004|Overall Study|Lack of Efficacy|0|||
170718486|NCT03879798|616973491|FG005|Overall Study|Lack of Efficacy|1|||
170718487|NCT03879798|616973486|FG000|Overall Study|Withdrawal by Subject|0|||
170718488|NCT03879798|616973487|FG001|Overall Study|Withdrawal by Subject|0|||
170718489|NCT03879798|616973488|FG002|Overall Study|Withdrawal by Subject|0|||
170718490|NCT03879798|616973489|FG003|Overall Study|Withdrawal by Subject|0|||
170718491|NCT03879798|616973490|FG004|Overall Study|Withdrawal by Subject|0|||
170718492|NCT03879798|616973491|FG005|Overall Study|Withdrawal by Subject|1|||
170718493|NCT01127178|616973492|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
170718494|NCT01127178|616973493|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
170718495|NCT01127178|616973492|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
170718496|NCT01127178|616973493|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
170718497|NCT01127178|616973492|FG000|Dose Escalation: Treatment Phase|Other|2|||
170718498|NCT01127178|616973493|FG001|Dose Escalation: Treatment Phase|Other|0|||
170718499|NCT01127178|616973492|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
170718500|NCT01127178|616973493|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
170718501|NCT01127178|616973492|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
170718502|NCT01127178|616973493|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
170718503|NCT01127178|616973492|FG000|Dose Escalation: Extension Phase|Other|1|||
170718504|NCT01127178|616973493|FG001|Dose Escalation: Extension Phase|Other|0|||
170718505|NCT03950739|616973494|FG000|Treatment Phase|Adverse Event|2|||
170718506|NCT03950739|616973494|FG000|Optional Extension Phase|Death|1|||
170718507|NCT03950739|616973494|FG000|Optional Extension Phase|Progressive Disease|5|||
170718508|NCT03950739|616973494|FG000|Optional Extension Phase|Adverse Event|7|||
170718509|NCT03950739|616973494|FG000|Optional Extension Phase|Lost to Follow-up|2|||
170718510|NCT03950739|616973494|FG000|Optional Extension Phase|Site Closure|2|||
170718511|NCT03950739|616973494|FG000|Optional Extension Phase|Pregnancy|1|||
170718512|NCT03625570|616973495|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
170718513|NCT03625570|616973496|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
170718514|NCT03625570|616973495|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
170718515|NCT03625570|616973496|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
170718516|NCT03625570|616973495|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
170718517|NCT03625570|616973496|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
170718518|NCT04139317|616973497|FG000|Overall Study|Adverse Event|10|||
170718519|NCT04139317|616973498|FG001|Overall Study|Adverse Event|2|||
170718520|NCT04139317|616973497|FG000|Overall Study|Death|6|||
170718521|NCT04139317|616973498|FG001|Overall Study|Death|4|||
170718522|NCT04139317|616973497|FG000|Overall Study|Lost to Follow-up|1|||
170718523|NCT04139317|616973498|FG001|Overall Study|Lost to Follow-up|0|||
170718524|NCT04139317|616973497|FG000|Overall Study|Physician Decision|3|||
170718525|NCT04139317|616973498|FG001|Overall Study|Physician Decision|1|||
170718526|NCT04139317|616973497|FG000|Overall Study|Progressive Disease|19|||
170718527|NCT04139317|616973498|FG001|Overall Study|Progressive Disease|9|||
170718528|NCT04139317|616973497|FG000|Overall Study|Subject Decision|2|||
170718529|NCT04139317|616973498|FG001|Overall Study|Subject Decision|2|||
170718530|NCT02043782|616973501|FG000|Period 1|Adverse Event|0|||
170718531|NCT02043782|616973502|FG001|Period 1|Adverse Event|0|||
170718532|NCT02043782|616973503|FG002|Period 1|Adverse Event|1|||
170718533|NCT02043782|616973504|FG003|Period 1|Adverse Event|0|||
170718534|NCT02043782|616973505|FG004|Period 1|Adverse Event|0|||
170718535|NCT02043782|616973506|FG005|Period 1|Adverse Event|0|||
170718536|NCT03359096|616973507|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
170718537|NCT03359096|616973508|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
170718538|NCT03359096|616973507|FG000|First Intervention (4 Weeks)|Death|1|||
170718539|NCT03359096|616973508|FG001|First Intervention (4 Weeks)|Death|0|||
170718540|NCT03359096|616973507|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
170718541|NCT03359096|616973508|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
170718542|NCT02007577|616973514|FG000|Overall Study|Adverse Event|1|||
170718543|NCT02007577|616973515|FG001|Overall Study|Adverse Event|0|||
170718544|NCT02007577|616973514|FG000|Overall Study|Withdrawal by Subject|0|||
170718545|NCT02007577|616973515|FG001|Overall Study|Withdrawal by Subject|1|||
170718546|NCT00144339|616973517|FG000|Overall Study|Adverse Event|746|||
170718547|NCT00144339|616973518|FG001|Overall Study|Adverse Event|627|||
170718548|NCT00144339|616973517|FG000|Overall Study|Protocol Violation|75|||
170718549|NCT00144339|616973518|FG001|Overall Study|Protocol Violation|48|||
170718550|NCT00144339|616973517|FG000|Overall Study|Withdrawal by Subject|403|||
170718551|NCT00144339|616973518|FG001|Overall Study|Withdrawal by Subject|300|||
170718552|NCT00144339|616973517|FG000|Overall Study|Lost to Follow-up|76|||
170718553|NCT00144339|616973518|FG001|Overall Study|Lost to Follow-up|64|||
170718554|NCT00144339|616973517|FG000|Overall Study|Other|58|||
170718555|NCT00144339|616973518|FG001|Overall Study|Other|60|||
170718556|NCT01669343|616973519|FG000|Part A: All Patients|Withdrawal by Subject|7|||
170718557|NCT01669343|616973519|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
170718558|NCT01669343|616973519|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
170718559|NCT01669343|616973519|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
170718560|NCT01669343|616973519|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
170718561|NCT04798586|616973520|FG000|Overall Study|Death|2|||
170718562|NCT01618838|616973521|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
170718563|NCT03538626|616973523|FG000|Overall Study|Withdrawal by Subject|0|||
170718564|NCT03538626|616973524|FG001|Overall Study|Withdrawal by Subject|1|||
170718565|NCT03538626|616973525|FG002|Overall Study|Withdrawal by Subject|0|||
170718566|NCT03538626|616973526|FG003|Overall Study|Withdrawal by Subject|0|||
170718567|NCT03538626|616973527|FG004|Overall Study|Withdrawal by Subject|0|||
170718568|NCT03538626|616973528|FG005|Overall Study|Withdrawal by Subject|0|||
170718569|NCT03538626|616973529|FG006|Overall Study|Withdrawal by Subject|0|||
170718570|NCT03538626|616973530|FG007|Overall Study|Withdrawal by Subject|0|||
170718571|NCT03538626|616973523|FG000|Overall Study|Lost to Follow-up|0|||
170718572|NCT03538626|616973524|FG001|Overall Study|Lost to Follow-up|0|||
170718573|NCT03538626|616973525|FG002|Overall Study|Lost to Follow-up|0|||
170718574|NCT03538626|616973526|FG003|Overall Study|Lost to Follow-up|0|||
170718575|NCT03538626|616973527|FG004|Overall Study|Lost to Follow-up|0|||
170718576|NCT03538626|616973528|FG005|Overall Study|Lost to Follow-up|0|||
170718577|NCT03538626|616973529|FG006|Overall Study|Lost to Follow-up|1|||
170718578|NCT03538626|616973530|FG007|Overall Study|Lost to Follow-up|0|||
170718579|NCT01434602|616973535|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
170718580|NCT01434602|616973536|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
170718581|NCT01434602|616973537|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
170718582|NCT01434602|616973538|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
170718583|NCT01434602|616973539|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
170718584|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
170830651|NCT03120949|617388703|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
170718585|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
170718586|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
170718587|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
170718588|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
170718589|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
170718590|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
170718591|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
170718592|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
170718593|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
170718594|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
170718595|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
170718596|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
170718597|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
170718598|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
170718599|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
170718600|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
170718601|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
170718602|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
170718603|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
170718604|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
170718605|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
170718606|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
170718607|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
170718608|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
170718609|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
170718610|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
170718611|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
170718612|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
170718613|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
170718614|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
170718615|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
170718616|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
170718617|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
170718618|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
170718619|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
170718620|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
170718621|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
170718622|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
170718623|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
170718624|NCT01434602|616973535|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
170718625|NCT01434602|616973536|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
170718626|NCT01434602|616973537|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
170718627|NCT01434602|616973538|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
170718628|NCT01434602|616973539|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
170718629|NCT02232893|616973541|FG000|Overall Study|Withdrawal by Subject|4|||
170718630|NCT02232893|616973542|FG001|Overall Study|Withdrawal by Subject|1|||
170718631|NCT02232893|616973541|FG000|Overall Study|Adverse Event|0|||
170718632|NCT02232893|616973542|FG001|Overall Study|Adverse Event|1|||
170718633|NCT02232893|616973541|FG000|Overall Study|Sponsor request early termination|0|||
170718634|NCT02232893|616973542|FG001|Overall Study|Sponsor request early termination|1|||
170718635|NCT02232893|616973541|FG000|Overall Study|Developed exclusion criteria|0|||
170718636|NCT02232893|616973542|FG001|Overall Study|Developed exclusion criteria|1|||
170718637|NCT02232893|616973541|FG000|Overall Study|Other|0|||
170718638|NCT02232893|616973542|FG001|Overall Study|Other|3|||
170718639|NCT01764945|616973547|FG000|Overall Study|Adverse Event|0|||
170718640|NCT01764945|616973548|FG001|Overall Study|Adverse Event|1|||
170718641|NCT01764945|616973549|FG002|Overall Study|Adverse Event|0|||
170718642|NCT01764945|616973550|FG003|Overall Study|Adverse Event|0|||
170718643|NCT01764945|616973551|FG004|Overall Study|Adverse Event|0|||
170718644|NCT01764945|616973552|FG005|Overall Study|Adverse Event|0|||
170718645|NCT01764945|616973553|FG006|Overall Study|Adverse Event|1|||
170718646|NCT01764945|616973554|FG007|Overall Study|Adverse Event|0|||
170718647|NCT02911948|616973557|FG000|Overall Study|Protocol Violation|0|||
170718648|NCT02911948|616973558|FG001|Overall Study|Protocol Violation|1|||
170718649|NCT02911948|616973557|FG000|Overall Study|Withdrawal by Subject|0|||
170718650|NCT02911948|616973558|FG001|Overall Study|Withdrawal by Subject|2|||
170718651|NCT02911948|616973557|FG000|Overall Study|Lack of Efficacy|0|||
170718652|NCT02911948|616973558|FG001|Overall Study|Lack of Efficacy|1|||
170718653|NCT02911948|616973557|FG000|Overall Study|Unclassified|0|||
170718654|NCT02911948|616973558|FG001|Overall Study|Unclassified|3|||
170718655|NCT01587651|616973563|FG000|Overall Study|Adverse Event|0|||
170718656|NCT01587651|616973564|FG001|Overall Study|Adverse Event|1|||
170718657|NCT01587651|616973565|FG002|Overall Study|Adverse Event|0|||
170718658|NCT01587651|616973563|FG000|Overall Study|Protocol Violation|0|||
170718659|NCT01587651|616973564|FG001|Overall Study|Protocol Violation|1|||
170718660|NCT01587651|616973565|FG002|Overall Study|Protocol Violation|1|||
170718661|NCT01587651|616973563|FG000|Overall Study|Withdrawal by Subject|0|||
170718662|NCT01587651|616973564|FG001|Overall Study|Withdrawal by Subject|1|||
170718663|NCT01587651|616973565|FG002|Overall Study|Withdrawal by Subject|0|||
170718664|NCT03965052|616973568|FG000|Overall Study|Protocol Violation|1|||
170718665|NCT03965052|616973569|FG001|Overall Study|Protocol Violation|0|||
170718666|NCT03165045|616973573|FG000|Visit 1|No registration after visit 1|9|||
170718667|NCT03165045|616973573|FG000|Visit 1|No treatment documented|10|||
170718668|NCT03165045|616973573|FG000|Visit 1|No visit 1|10|||
170718669|NCT03165045|616973573|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
170718670|NCT03165045|616973573|FG000|Visit 2|No available total CCQ score at all|29|||
170718671|NCT03165045|616973573|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
170718672|NCT03325712|616973574|FG000|Overall Study|Protocol Violation|0|||
170718673|NCT03325712|616973575|FG001|Overall Study|Protocol Violation|0|||
170718674|NCT03325712|616973576|FG002|Overall Study|Protocol Violation|0|||
170718675|NCT03325712|616973577|FG003|Overall Study|Protocol Violation|0|||
170718676|NCT03325712|616973578|FG004|Overall Study|Protocol Violation|1|||
170718677|NCT03325712|616973579|FG005|Overall Study|Protocol Violation|0|||
170718678|NCT03325712|616973580|FG006|Overall Study|Protocol Violation|0|||
170718679|NCT03325712|616973581|FG007|Overall Study|Protocol Violation|0|||
170718680|NCT03325712|616973574|FG000|Overall Study|Adverse Event|0|||
170718681|NCT03325712|616973575|FG001|Overall Study|Adverse Event|0|||
170718682|NCT03325712|616973576|FG002|Overall Study|Adverse Event|0|||
170718683|NCT03325712|616973577|FG003|Overall Study|Adverse Event|0|||
170718684|NCT03325712|616973578|FG004|Overall Study|Adverse Event|1|||
170718685|NCT03325712|616973579|FG005|Overall Study|Adverse Event|0|||
170718686|NCT03325712|616973580|FG006|Overall Study|Adverse Event|0|||
170718687|NCT03325712|616973581|FG007|Overall Study|Adverse Event|0|||
170718688|NCT00380068|616973582|FG000|Overall Study|Adverse Event|40|||
170718689|NCT00380068|616973582|FG000|Overall Study|Withdrawal by Subject|10|||
170718690|NCT00380068|616973582|FG000|Overall Study|Not compliant|6|||
170718691|NCT00380068|616973582|FG000|Overall Study|Lost to Follow-up|1|||
170718692|NCT00380068|616973582|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
170718693|NCT00380068|616973582|FG000|Overall Study|Lung transplant|3|||
170718694|NCT00380068|616973582|FG000|Overall Study|Physician Decision|2|||
170718695|NCT00380068|616973582|FG000|Overall Study|Partipant moved away|1|||
170718696|NCT00380068|616973582|FG000|Overall Study|Lack of Efficacy|5|||
170718697|NCT01297062|616973583|FG000|Overall Study|Adverse Event|2|||
170718698|NCT01297062|616973584|FG001|Overall Study|Adverse Event|0|||
170718699|NCT01297062|616973585|FG002|Overall Study|Adverse Event|1|||
170718700|NCT01297062|616973586|FG003|Overall Study|Adverse Event|0|||
170718701|NCT01297062|616973587|FG004|Overall Study|Adverse Event|0|||
170718702|NCT01297062|616973588|FG005|Overall Study|Adverse Event|0|||
170718703|NCT01297062|616973589|FG006|Overall Study|Adverse Event|0|||
170718704|NCT01297062|616973583|FG000|Overall Study|Physician Decision|1|||
170718705|NCT01297062|616973584|FG001|Overall Study|Physician Decision|0|||
170718706|NCT01297062|616973585|FG002|Overall Study|Physician Decision|1|||
170718707|NCT01297062|616973586|FG003|Overall Study|Physician Decision|0|||
170718708|NCT01297062|616973587|FG004|Overall Study|Physician Decision|0|||
170718709|NCT01297062|616973588|FG005|Overall Study|Physician Decision|0|||
170718710|NCT01297062|616973589|FG006|Overall Study|Physician Decision|6|||
170718711|NCT01297062|616973583|FG000|Overall Study|Protocol Violation|0|||
170718712|NCT01297062|616973584|FG001|Overall Study|Protocol Violation|0|||
170718713|NCT01297062|616973585|FG002|Overall Study|Protocol Violation|0|||
170718714|NCT01297062|616973586|FG003|Overall Study|Protocol Violation|0|||
170718715|NCT01297062|616973587|FG004|Overall Study|Protocol Violation|1|||
170718716|NCT01297062|616973588|FG005|Overall Study|Protocol Violation|0|||
170718717|NCT01297062|616973589|FG006|Overall Study|Protocol Violation|0|||
170718718|NCT01297062|616973583|FG000|Overall Study|Subject Decision|1|||
170718719|NCT01297062|616973584|FG001|Overall Study|Subject Decision|1|||
170718720|NCT01297062|616973585|FG002|Overall Study|Subject Decision|0|||
170718721|NCT01297062|616973586|FG003|Overall Study|Subject Decision|1|||
170718722|NCT01297062|616973587|FG004|Overall Study|Subject Decision|1|||
170718723|NCT01297062|616973588|FG005|Overall Study|Subject Decision|1|||
170718724|NCT01297062|616973589|FG006|Overall Study|Subject Decision|2|||
170718725|NCT03191903|616973590|FG000|Overall Study|Withdrawal by Subject|6|||
170718726|NCT03191903|616973591|FG001|Overall Study|Withdrawal by Subject|5|||
170718727|NCT03191903|616973592|FG002|Overall Study|Withdrawal by Subject|4|||
170718728|NCT03191903|616973590|FG000|Overall Study|Adverse Event|1|||
170718729|NCT03191903|616973591|FG001|Overall Study|Adverse Event|0|||
170718730|NCT03191903|616973592|FG002|Overall Study|Adverse Event|0|||
170718731|NCT03564496|616973605|FG000|Overall Study|Withdrawal by Subject|1|||
170718732|NCT03564496|616973606|FG001|Overall Study|Withdrawal by Subject|1|||
170718733|NCT03564496|616973607|FG002|Overall Study|Withdrawal by Subject|0|||
170718734|NCT03564496|616973605|FG000|Overall Study|Screen failure|0|||
170718735|NCT03564496|616973606|FG001|Overall Study|Screen failure|3|||
170718736|NCT03564496|616973607|FG002|Overall Study|Screen failure|0|||
170718737|NCT03823651|616973608|FG000|Overall Study|Death|5|||
170718738|NCT03823651|616973609|FG001|Overall Study|Death|0|||
170718739|NCT03823651|616973608|FG000|Overall Study|Physician Decision|1|||
170718740|NCT03823651|616973609|FG001|Overall Study|Physician Decision|0|||
170718741|NCT03823651|616973608|FG000|Overall Study|Caregiver to patient who died|0|||
170718742|NCT03823651|616973609|FG001|Overall Study|Caregiver to patient who died|5|||
170718743|NCT03823651|616973608|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
170718744|NCT03823651|616973609|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
170718745|NCT04579757|616975048|FG000|Overall Study|Adverse Event|0|||
170718746|NCT04579757|616975049|FG001|Overall Study|Adverse Event|0|||
170718747|NCT04579757|616975050|FG002|Overall Study|Adverse Event|0|||
170718748|NCT04579757|616975051|FG003|Overall Study|Adverse Event|2|||
170718749|NCT04579757|616975052|FG004|Overall Study|Adverse Event|1|||
170718750|NCT04579757|616975053|FG005|Overall Study|Adverse Event|1|||
170718751|NCT04579757|616975054|FG006|Overall Study|Adverse Event|0|||
170718752|NCT04579757|616975055|FG007|Overall Study|Adverse Event|0|||
170718753|NCT04579757|616975056|FG008|Overall Study|Adverse Event|0|||
170718754|NCT04579757|616975048|FG000|Overall Study|Death|4|||
170718755|NCT04579757|616975049|FG001|Overall Study|Death|1|||
170718756|NCT04579757|616975050|FG002|Overall Study|Death|14|||
170718757|NCT04579757|616975051|FG003|Overall Study|Death|3|||
170718758|NCT04579757|616975052|FG004|Overall Study|Death|2|||
170718759|NCT04579757|616975053|FG005|Overall Study|Death|7|||
170718760|NCT04579757|616975054|FG006|Overall Study|Death|0|||
170718761|NCT04579757|616975055|FG007|Overall Study|Death|1|||
170718762|NCT04579757|616975056|FG008|Overall Study|Death|3|||
170718763|NCT04579757|616975048|FG000|Overall Study|Physician Decision|0|||
170830652|NCT03120949|617388704|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
170830653|NCT03120949|617388703|FG000|Overall Study|Compliance With Medication|0|||
170830654|NCT03120949|617388704|FG001|Overall Study|Compliance With Medication|1|||
170830655|NCT03120949|617388703|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
170830656|NCT03120949|617388704|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
170830657|NCT03120949|617388703|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
170830658|NCT03120949|617388704|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
170830659|NCT03120949|617388703|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
170830660|NCT03120949|617388704|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
170830661|NCT01705145|617388705|FG000|Part B|Adverse Event|1|||
170830662|NCT00988117|617388706|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
170830663|NCT00988117|617388706|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
170830664|NCT04522778|617388708|FG000|Overall Study|Patient did not want to wear the device|1|||
170830665|NCT04522778|617388709|FG001|Overall Study|Patient did not want to wear the device|0|||
170830666|NCT04522778|617388708|FG000|Overall Study|Lost to Follow-up|0|||
170830667|NCT04522778|617388709|FG001|Overall Study|Lost to Follow-up|1|||
170830668|NCT00069277|617388710|FG000|Overall Study|Adverse Event|3|||
170830669|NCT00069277|617388710|FG000|Overall Study|Withdrawal by Subject|1|||
170830670|NCT00069277|617388710|FG000|Overall Study|Progressive Disease|15|||
170830671|NCT00069277|617388710|FG000|Overall Study|Physician Decision|2|||
170830672|NCT00361842|617388711|FG000|Overall Study|Withdrawal by Subject|2|||
170830673|NCT00361842|617388712|FG001|Overall Study|Withdrawal by Subject|3|||
170830674|NCT00361842|617388711|FG000|Overall Study|Death|2|||
170830675|NCT00361842|617388712|FG001|Overall Study|Death|1|||
170830676|NCT00361842|617388711|FG000|Overall Study|Disease progression|19|||
170830677|NCT00361842|617388712|FG001|Overall Study|Disease progression|20|||
170830678|NCT00361842|617388711|FG000|Overall Study|Adverse Event|2|||
170830679|NCT00361842|617388712|FG001|Overall Study|Adverse Event|3|||
170718764|NCT04579757|616975049|FG001|Overall Study|Physician Decision|0|||
170830680|NCT00361842|617388711|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
170830681|NCT00361842|617388712|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
170830682|NCT00361842|617388711|FG000|Overall Study|Other|1|||
170718765|NCT04579757|616975050|FG002|Overall Study|Physician Decision|0|||
170718766|NCT04579757|616975051|FG003|Overall Study|Physician Decision|2|||
170718767|NCT04579757|616975052|FG004|Overall Study|Physician Decision|1|||
170718768|NCT04579757|616975053|FG005|Overall Study|Physician Decision|1|||
170718769|NCT04579757|616975054|FG006|Overall Study|Physician Decision|1|||
170718770|NCT04579757|616975055|FG007|Overall Study|Physician Decision|0|||
170718771|NCT04579757|616975056|FG008|Overall Study|Physician Decision|0|||
170718772|NCT04579757|616975048|FG000|Overall Study|Study Terminated By Sponsor|0|||
170830683|NCT00361842|617388712|FG001|Overall Study|Other|0|||
170830684|NCT00361842|617388711|FG000|Overall Study|Other|0|||
170830685|NCT00361842|617388712|FG001|Overall Study|Other|2|||
170830686|NCT03821064|617388713|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
170830687|NCT01482819|617388714|FG000|Overall Study|Lost to Follow-up|2|||
170830688|NCT00942188|617388717|FG000|Overall Study|Adverse Event|0|||
170830689|NCT00942188|617388718|FG001|Overall Study|Adverse Event|3|||
170830690|NCT00942188|617388719|FG002|Overall Study|Adverse Event|2|||
170830691|NCT00942188|617388720|FG003|Overall Study|Adverse Event|0|||
170830692|NCT00942188|617388717|FG000|Overall Study|Lack of Efficacy|0|||
170830693|NCT00942188|617388718|FG001|Overall Study|Lack of Efficacy|0|||
170830694|NCT00942188|617388719|FG002|Overall Study|Lack of Efficacy|0|||
170830695|NCT00942188|617388720|FG003|Overall Study|Lack of Efficacy|1|||
170830696|NCT00942188|617388717|FG000|Overall Study|Protocol Violation|1|||
170830697|NCT00942188|617388718|FG001|Overall Study|Protocol Violation|1|||
170830698|NCT00942188|617388719|FG002|Overall Study|Protocol Violation|0|||
170830699|NCT00942188|617388720|FG003|Overall Study|Protocol Violation|0|||
170830700|NCT00942188|617388717|FG000|Overall Study|Lost to Follow-up|2|||
170830701|NCT00942188|617388718|FG001|Overall Study|Lost to Follow-up|1|||
170830702|NCT00942188|617388719|FG002|Overall Study|Lost to Follow-up|2|||
170830703|NCT00942188|617388720|FG003|Overall Study|Lost to Follow-up|0|||
170830704|NCT00942188|617388717|FG000|Overall Study|Withdrawal by Subject|1|||
170830705|NCT00942188|617388718|FG001|Overall Study|Withdrawal by Subject|3|||
170830706|NCT00942188|617388719|FG002|Overall Study|Withdrawal by Subject|4|||
170830707|NCT00942188|617388720|FG003|Overall Study|Withdrawal by Subject|2|||
170830708|NCT00942188|617388717|FG000|Overall Study|Physician Decision|0|||
170830709|NCT00942188|617388718|FG001|Overall Study|Physician Decision|0|||
170830710|NCT00942188|617388719|FG002|Overall Study|Physician Decision|1|||
170830711|NCT00942188|617388720|FG003|Overall Study|Physician Decision|0|||
170830712|NCT00942188|617388717|FG000|Overall Study|Sponsor Decision|0|||
170830713|NCT00942188|617388718|FG001|Overall Study|Sponsor Decision|2|||
170830714|NCT00942188|617388719|FG002|Overall Study|Sponsor Decision|0|||
170830715|NCT00942188|617388720|FG003|Overall Study|Sponsor Decision|1|||
170830716|NCT01536587|617390117|FG000|Overall Study|Adverse Event|2|||
170830717|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
170830718|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
170830719|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
170830720|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Death|4|||
170830721|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Death|2|||
170830722|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Death|3|||
170830723|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
170830724|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
170830725|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
170830726|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
170830727|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
170830728|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
170830729|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
170830730|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
170830731|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
170830732|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
170830733|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
170830734|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
170830735|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
170830736|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
170830737|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
170830738|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
170830739|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
170830740|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
170830741|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
170830742|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
170830743|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
170830744|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
170830745|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
170830746|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
170830747|NCT02783573|617390118|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
170830748|NCT02783573|617390119|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
170830749|NCT02783573|617390120|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
170830750|NCT02783573|617390118|FG000|Delayed-Start Period|Sponsor Decision|0|||
170830751|NCT02783573|617390119|FG001|Delayed-Start Period|Sponsor Decision|17|||
170830752|NCT02783573|617390120|FG002|Delayed-Start Period|Sponsor Decision|12|||
170830753|NCT00590564|617390121|FG000|Overall Study|Withdrawal by Subject|4|||
170830754|NCT00590564|617390121|FG000|Overall Study|Lost to Follow-up|6|||
170718773|NCT04579757|616975049|FG001|Overall Study|Study Terminated By Sponsor|0|||
170718774|NCT04579757|616975050|FG002|Overall Study|Study Terminated By Sponsor|0|||
170718775|NCT04579757|616975051|FG003|Overall Study|Study Terminated By Sponsor|0|||
170718776|NCT04579757|616975052|FG004|Overall Study|Study Terminated By Sponsor|2|||
170718777|NCT04579757|616975053|FG005|Overall Study|Study Terminated By Sponsor|0|||
170718778|NCT04579757|616975054|FG006|Overall Study|Study Terminated By Sponsor|0|||
170718779|NCT04579757|616975055|FG007|Overall Study|Study Terminated By Sponsor|2|||
170718780|NCT04579757|616975056|FG008|Overall Study|Study Terminated By Sponsor|0|||
170718781|NCT04579757|616975048|FG000|Overall Study|Withdrawal by Subject|1|||
170718782|NCT04579757|616975049|FG001|Overall Study|Withdrawal by Subject|1|||
170718783|NCT04579757|616975050|FG002|Overall Study|Withdrawal by Subject|0|||
170718784|NCT04579757|616975051|FG003|Overall Study|Withdrawal by Subject|0|||
170718785|NCT04579757|616975052|FG004|Overall Study|Withdrawal by Subject|2|||
170718786|NCT04579757|616975053|FG005|Overall Study|Withdrawal by Subject|1|||
170718787|NCT04579757|616975054|FG006|Overall Study|Withdrawal by Subject|0|||
170718788|NCT04579757|616975055|FG007|Overall Study|Withdrawal by Subject|3|||
170718789|NCT04579757|616975056|FG008|Overall Study|Withdrawal by Subject|0|||
170718790|NCT04579757|616975048|FG000|Overall Study|Radiological or Clinical PD|1|||
170718791|NCT04579757|616975049|FG001|Overall Study|Radiological or Clinical PD|4|||
170718792|NCT04579757|616975050|FG002|Overall Study|Radiological or Clinical PD|1|||
170718793|NCT04579757|616975051|FG003|Overall Study|Radiological or Clinical PD|3|||
170718794|NCT04579757|616975052|FG004|Overall Study|Radiological or Clinical PD|9|||
170718795|NCT04579757|616975053|FG005|Overall Study|Radiological or Clinical PD|4|||
170718796|NCT04579757|616975054|FG006|Overall Study|Radiological or Clinical PD|2|||
170718797|NCT04579757|616975055|FG007|Overall Study|Radiological or Clinical PD|2|||
170718798|NCT04579757|616975056|FG008|Overall Study|Radiological or Clinical PD|0|||
170718799|NCT04579757|616975048|FG000|Overall Study|Start of New Therapy|0|||
170718800|NCT04579757|616975049|FG001|Overall Study|Start of New Therapy|0|||
170718801|NCT04579757|616975050|FG002|Overall Study|Start of New Therapy|0|||
170718802|NCT04579757|616975051|FG003|Overall Study|Start of New Therapy|0|||
170718803|NCT04579757|616975052|FG004|Overall Study|Start of New Therapy|2|||
170718804|NCT04579757|616975053|FG005|Overall Study|Start of New Therapy|1|||
170718805|NCT04579757|616975054|FG006|Overall Study|Start of New Therapy|0|||
170718806|NCT04579757|616975055|FG007|Overall Study|Start of New Therapy|0|||
170718807|NCT04579757|616975056|FG008|Overall Study|Start of New Therapy|0|||
170718808|NCT02332720|616975057|FG000|Part A and Part B|Lost to Follow-up|1|||
170718809|NCT02332720|616975058|FG001|Part A and Part B|Lost to Follow-up|0|||
170718810|NCT02332720|616975059|FG002|Part A and Part B|Lost to Follow-up|0|||
170718811|NCT02332720|616975060|FG003|Part A and Part B|Lost to Follow-up|0|||
170718812|NCT02332720|616975061|FG004|Part A and Part B|Lost to Follow-up|0|||
170718813|NCT02332720|616975062|FG005|Part A and Part B|Lost to Follow-up|2|||
170718814|NCT02332720|616975063|FG006|Part A and Part B|Lost to Follow-up|1|||
170718815|NCT02332720|616975064|FG007|Part A and Part B|Lost to Follow-up|1|||
170718816|NCT02332720|616975065|FG008|Part A and Part B|Lost to Follow-up|0|||
170718817|NCT02332720|616975066|FG009|Part A and Part B|Lost to Follow-up|0|||
170718818|NCT02332720|616975067|FG010|Part A and Part B|Lost to Follow-up|0|||
170718819|NCT02332720|616975068|FG011|Part A and Part B|Lost to Follow-up|0|||
170718820|NCT02332720|616975069|FG012|Part A and Part B|Lost to Follow-up|0|||
170718821|NCT02332720|616975070|FG013|Part A and Part B|Lost to Follow-up|0|||
170718822|NCT02332720|616975071|FG014|Part A and Part B|Lost to Follow-up|0|||
170718823|NCT02332720|616975072|FG015|Part A and Part B|Lost to Follow-up|1|||
170718824|NCT02332720|616975073|FG016|Part A and Part B|Lost to Follow-up|0|||
170718825|NCT02332720|616975074|FG017|Part A and Part B|Lost to Follow-up|0|||
170718826|NCT02332720|616975075|FG018|Part A and Part B|Lost to Follow-up|0|||
170718827|NCT02332720|616975076|FG019|Part A and Part B|Lost to Follow-up|0|||
170718828|NCT02332720|616975077|FG020|Part A and Part B|Lost to Follow-up|0|||
170718829|NCT02332720|616975078|FG021|Part A and Part B|Lost to Follow-up|0|||
170718830|NCT02332720|616975079|FG022|Part A and Part B|Lost to Follow-up|0|||
170718831|NCT02332720|616975057|FG000|Part A and Part B|Adverse Event|0|||
170718832|NCT02332720|616975058|FG001|Part A and Part B|Adverse Event|0|||
170718833|NCT02332720|616975059|FG002|Part A and Part B|Adverse Event|0|||
170718834|NCT02332720|616975060|FG003|Part A and Part B|Adverse Event|0|||
170718835|NCT02332720|616975061|FG004|Part A and Part B|Adverse Event|0|||
170718836|NCT02332720|616975062|FG005|Part A and Part B|Adverse Event|0|||
170718837|NCT02332720|616975063|FG006|Part A and Part B|Adverse Event|0|||
170718838|NCT02332720|616975064|FG007|Part A and Part B|Adverse Event|0|||
170718839|NCT02332720|616975065|FG008|Part A and Part B|Adverse Event|0|||
170718840|NCT02332720|616975066|FG009|Part A and Part B|Adverse Event|0|||
170718841|NCT02332720|616975067|FG010|Part A and Part B|Adverse Event|0|||
170718842|NCT02332720|616975068|FG011|Part A and Part B|Adverse Event|0|||
170718843|NCT02332720|616975069|FG012|Part A and Part B|Adverse Event|0|||
170718844|NCT02332720|616975070|FG013|Part A and Part B|Adverse Event|0|||
170718845|NCT02332720|616975071|FG014|Part A and Part B|Adverse Event|0|||
170718846|NCT02332720|616975072|FG015|Part A and Part B|Adverse Event|0|||
170718847|NCT02332720|616975073|FG016|Part A and Part B|Adverse Event|0|||
170718848|NCT02332720|616975074|FG017|Part A and Part B|Adverse Event|1|||
170718849|NCT02332720|616975075|FG018|Part A and Part B|Adverse Event|0|||
170718850|NCT02332720|616975076|FG019|Part A and Part B|Adverse Event|0|||
170718851|NCT02332720|616975077|FG020|Part A and Part B|Adverse Event|0|||
170718852|NCT02332720|616975078|FG021|Part A and Part B|Adverse Event|0|||
170718853|NCT02332720|616975079|FG022|Part A and Part B|Adverse Event|0|||
170718854|NCT02332720|616975057|FG000|Part A and Part B|Physician Decision|0|||
170718855|NCT02332720|616975058|FG001|Part A and Part B|Physician Decision|0|||
170718856|NCT02332720|616975059|FG002|Part A and Part B|Physician Decision|0|||
170718857|NCT02332720|616975060|FG003|Part A and Part B|Physician Decision|0|||
170718858|NCT02332720|616975061|FG004|Part A and Part B|Physician Decision|0|||
170718859|NCT02332720|616975062|FG005|Part A and Part B|Physician Decision|0|||
170718860|NCT02332720|616975063|FG006|Part A and Part B|Physician Decision|0|||
170718861|NCT02332720|616975064|FG007|Part A and Part B|Physician Decision|0|||
170718862|NCT02332720|616975065|FG008|Part A and Part B|Physician Decision|0|||
170718863|NCT02332720|616975066|FG009|Part A and Part B|Physician Decision|0|||
170718864|NCT02332720|616975067|FG010|Part A and Part B|Physician Decision|0|||
170718865|NCT02332720|616975068|FG011|Part A and Part B|Physician Decision|0|||
170718866|NCT02332720|616975069|FG012|Part A and Part B|Physician Decision|0|||
170718867|NCT02332720|616975070|FG013|Part A and Part B|Physician Decision|0|||
170718868|NCT02332720|616975071|FG014|Part A and Part B|Physician Decision|0|||
170718869|NCT02332720|616975072|FG015|Part A and Part B|Physician Decision|0|||
170718870|NCT02332720|616975073|FG016|Part A and Part B|Physician Decision|0|||
170718871|NCT02332720|616975074|FG017|Part A and Part B|Physician Decision|0|||
170718872|NCT02332720|616975075|FG018|Part A and Part B|Physician Decision|1|||
170718873|NCT02332720|616975076|FG019|Part A and Part B|Physician Decision|0|||
170718874|NCT02332720|616975077|FG020|Part A and Part B|Physician Decision|0|||
170718875|NCT02332720|616975078|FG021|Part A and Part B|Physician Decision|0|||
170718876|NCT02332720|616975079|FG022|Part A and Part B|Physician Decision|0|||
170718877|NCT02332720|616975057|FG000|Part A and Part B|Withdrawal by Subject|0|||
170718878|NCT02332720|616975058|FG001|Part A and Part B|Withdrawal by Subject|0|||
170718879|NCT02332720|616975059|FG002|Part A and Part B|Withdrawal by Subject|0|||
170718880|NCT02332720|616975060|FG003|Part A and Part B|Withdrawal by Subject|0|||
170718881|NCT02332720|616975061|FG004|Part A and Part B|Withdrawal by Subject|0|||
170718882|NCT02332720|616975062|FG005|Part A and Part B|Withdrawal by Subject|1|||
170718883|NCT02332720|616975063|FG006|Part A and Part B|Withdrawal by Subject|0|||
170718884|NCT02332720|616975064|FG007|Part A and Part B|Withdrawal by Subject|0|||
170718885|NCT02332720|616975065|FG008|Part A and Part B|Withdrawal by Subject|0|||
170718886|NCT02332720|616975066|FG009|Part A and Part B|Withdrawal by Subject|0|||
170718887|NCT02332720|616975067|FG010|Part A and Part B|Withdrawal by Subject|0|||
170718888|NCT02332720|616975068|FG011|Part A and Part B|Withdrawal by Subject|0|||
170718889|NCT02332720|616975069|FG012|Part A and Part B|Withdrawal by Subject|0|||
170718890|NCT02332720|616975070|FG013|Part A and Part B|Withdrawal by Subject|0|||
170718891|NCT02332720|616975071|FG014|Part A and Part B|Withdrawal by Subject|0|||
170718892|NCT02332720|616975072|FG015|Part A and Part B|Withdrawal by Subject|0|||
170718893|NCT02332720|616975073|FG016|Part A and Part B|Withdrawal by Subject|0|||
170718894|NCT02332720|616975074|FG017|Part A and Part B|Withdrawal by Subject|0|||
170718895|NCT02332720|616975075|FG018|Part A and Part B|Withdrawal by Subject|0|||
170718896|NCT02332720|616975076|FG019|Part A and Part B|Withdrawal by Subject|1|||
170718897|NCT02332720|616975077|FG020|Part A and Part B|Withdrawal by Subject|0|||
170718898|NCT02332720|616975078|FG021|Part A and Part B|Withdrawal by Subject|0|||
170718899|NCT02332720|616975079|FG022|Part A and Part B|Withdrawal by Subject|0|||
170718900|NCT00384085|616975080|FG000|Overall Study|Adverse Event|5|||
170718901|NCT00384085|616975081|FG001|Overall Study|Adverse Event|5|||
170718902|NCT00384085|616975082|FG002|Overall Study|Adverse Event|4|||
170718903|NCT00384085|616975080|FG000|Overall Study|Lack of Efficacy|0|||
170718904|NCT00384085|616975081|FG001|Overall Study|Lack of Efficacy|3|||
170718905|NCT00384085|616975082|FG002|Overall Study|Lack of Efficacy|2|||
170718906|NCT00384085|616975080|FG000|Overall Study|No longer Requires Study Treatment|1|||
170718907|NCT00384085|616975081|FG001|Overall Study|No longer Requires Study Treatment|0|||
170718908|NCT00384085|616975082|FG002|Overall Study|No longer Requires Study Treatment|1|||
170718909|NCT00384085|616975080|FG000|Overall Study|Protocol Violation|2|||
170718910|NCT00384085|616975081|FG001|Overall Study|Protocol Violation|2|||
170718911|NCT00384085|616975082|FG002|Overall Study|Protocol Violation|2|||
170718912|NCT00384085|616975080|FG000|Overall Study|Lost to Follow-up|9|||
170830755|NCT00590564|617390121|FG000|Overall Study|Protocol Violation|1|||
170718913|NCT00384085|616975081|FG001|Overall Study|Lost to Follow-up|9|||
170718914|NCT00384085|616975082|FG002|Overall Study|Lost to Follow-up|10|||
170718915|NCT00384085|616975080|FG000|Overall Study|Progressive Disease|0|||
170718916|NCT00384085|616975081|FG001|Overall Study|Progressive Disease|1|||
170718917|NCT00384085|616975082|FG002|Overall Study|Progressive Disease|0|||
170718918|NCT00384085|616975080|FG000|Overall Study|Withdrawal by Subject|14|||
170718919|NCT00384085|616975081|FG001|Overall Study|Withdrawal by Subject|19|||
170718920|NCT00384085|616975082|FG002|Overall Study|Withdrawal by Subject|29|||
170718921|NCT00384085|616975080|FG000|Overall Study|Patient non-compliant|4|||
170718922|NCT00384085|616975081|FG001|Overall Study|Patient non-compliant|4|||
170718923|NCT00384085|616975082|FG002|Overall Study|Patient non-compliant|5|||
170830756|NCT00590564|617390121|FG000|Overall Study|Patient Found to be Ineligible|1|||
170718924|NCT00384085|616975080|FG000|Overall Study|Physician Decision|1|||
170718925|NCT00384085|616975081|FG001|Overall Study|Physician Decision|0|||
170718926|NCT00384085|616975082|FG002|Overall Study|Physician Decision|0|||
170718927|NCT00384085|616975080|FG000|Overall Study|Loss of site personnel|1|||
170718928|NCT00384085|616975081|FG001|Overall Study|Loss of site personnel|0|||
170718929|NCT00384085|616975082|FG002|Overall Study|Loss of site personnel|1|||
170718930|NCT00384085|616975080|FG000|Overall Study|Sponsor decision|1|||
170718931|NCT00384085|616975081|FG001|Overall Study|Sponsor decision|2|||
170718932|NCT00384085|616975082|FG002|Overall Study|Sponsor decision|1|||
170718933|NCT00384085|616975080|FG000|Overall Study|Patient moved|1|||
170718934|NCT00384085|616975081|FG001|Overall Study|Patient moved|0|||
170718935|NCT00384085|616975082|FG002|Overall Study|Patient moved|1|||
170718936|NCT00384085|616975080|FG000|Overall Study|Patient required surgery|0|||
170718937|NCT00384085|616975081|FG001|Overall Study|Patient required surgery|1|||
170718938|NCT00384085|616975082|FG002|Overall Study|Patient required surgery|0|||
170718939|NCT03725982|616975085|FG000|First Intervention|Withdrawal by Subject|0|||
170718940|NCT03725982|616975086|FG001|First Intervention|Withdrawal by Subject|1|||
170718941|NCT03725982|616975085|FG000|First Intervention|Physician Decision|1|||
170718942|NCT03725982|616975086|FG001|First Intervention|Physician Decision|1|||
170718943|NCT05912400|616975087|FG000|Overall Study|Lost to Follow-up|1|||
170718944|NCT05912400|616975088|FG001|Overall Study|Lost to Follow-up|0|||
170718945|NCT05912400|616975087|FG000|Overall Study|Physician Decision|6|||
170718946|NCT05912400|616975088|FG001|Overall Study|Physician Decision|0|||
170718947|NCT05912400|616975087|FG000|Overall Study|Withdrawal by Subject|1|||
170718948|NCT05912400|616975088|FG001|Overall Study|Withdrawal by Subject|0|||
170718949|NCT02261363|616975090|FG000|Overall Study|Lost to Follow-up|21|||
170718950|NCT01517802|616975091|FG000|Overall Study|Death|1|||
170718951|NCT02605954|616975092|FG000|Overall Study|Adverse Event|5|||
170718952|NCT02605954|616975093|FG001|Overall Study|Adverse Event|1|||
170718953|NCT02605954|616975092|FG000|Overall Study|Investigator's Discretion|1|||
170718954|NCT02605954|616975093|FG001|Overall Study|Investigator's Discretion|0|||
170718955|NCT02605954|616975092|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170718956|NCT02605954|616975093|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170718957|NCT02605954|616975092|FG000|Overall Study|Withdrew Consent|2|||
170718958|NCT02605954|616975093|FG001|Overall Study|Withdrew Consent|2|||
170718959|NCT02605954|616975092|FG000|Overall Study|Lost to Follow-up|3|||
170718960|NCT02605954|616975093|FG001|Overall Study|Lost to Follow-up|0|||
170718961|NCT02605954|616975092|FG000|Overall Study|Randomized but not treated|0|||
170718962|NCT02605954|616975093|FG001|Overall Study|Randomized but not treated|1|||
170718963|NCT02301143|616975094|FG000|Induction Period|Enrolled But Not Treated|1|||
170718964|NCT02301143|616975095|FG001|Induction Period|Enrolled But Not Treated|0|||
170718965|NCT02301143|616975094|FG000|Induction Period|Death|1|||
170718966|NCT02301143|616975095|FG001|Induction Period|Death|0|||
170718967|NCT02301143|616975094|FG000|Induction Period|Adverse Event|22|||
170718968|NCT02301143|616975095|FG001|Induction Period|Adverse Event|0|||
170718969|NCT02301143|616975094|FG000|Induction Period|Progressive Disease|8|||
170718970|NCT02301143|616975095|FG001|Induction Period|Progressive Disease|0|||
170718971|NCT02301143|616975094|FG000|Induction Period|Withdrawal by Subject|3|||
170718972|NCT02301143|616975095|FG001|Induction Period|Withdrawal by Subject|0|||
170718973|NCT02301143|616975094|FG000|Induction Period|Noncompliance with Study Drug|1|||
170718974|NCT02301143|616975095|FG001|Induction Period|Noncompliance with Study Drug|0|||
170718975|NCT02301143|616975094|FG000|Induction Period|Physician Decision|4|||
170718976|NCT02301143|616975095|FG001|Induction Period|Physician Decision|0|||
170718977|NCT02301143|616975094|FG000|Induction Period|Symptomatic Deterioration|2|||
170718978|NCT02301143|616975095|FG001|Induction Period|Symptomatic Deterioration|0|||
170718979|NCT02301143|616975094|FG000|Induction Period|Protocol Violation|2|||
170718980|NCT02301143|616975095|FG001|Induction Period|Protocol Violation|0|||
170718981|NCT02301143|616975094|FG000|Induction Period|Other|1|||
170718982|NCT02301143|616975095|FG001|Induction Period|Other|0|||
170718983|NCT02301143|616975094|FG000|Investigator's Choice|Adverse Event|0|||
170718984|NCT02301143|616975095|FG001|Investigator's Choice|Adverse Event|3|||
170718985|NCT02301143|616975094|FG000|Investigator's Choice|Progressive Disease|0|||
170718986|NCT02301143|616975095|FG001|Investigator's Choice|Progressive Disease|3|||
170718987|NCT02301143|616975094|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
170718988|NCT02301143|616975095|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
170718989|NCT02301143|616975094|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
170718990|NCT02301143|616975095|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
170718991|NCT02301143|616975094|FG000|Investigator's Choice|Other|0|||
170718992|NCT02301143|616975095|FG001|Investigator's Choice|Other|1|||
170718993|NCT02301143|616975094|FG000|Investigator's Choice|Unresectable Surgery|0|||
170718994|NCT02301143|616975095|FG001|Investigator's Choice|Unresectable Surgery|1|||
170718995|NCT03268811|616975098|FG000|Overall Study|Adverse Event|0|||
170718996|NCT03268811|616975099|FG001|Overall Study|Adverse Event|1|||
170718997|NCT03966157|616975103|FG000|Overall Study|Physician Decision|1|||
170718998|NCT03966157|616975104|FG001|Overall Study|Physician Decision|0|||
170718999|NCT01221597|616975109|FG000|Overall Study|Adverse Event|4|||
170719000|NCT01221597|616975110|FG001|Overall Study|Adverse Event|1|||
170719001|NCT01221597|616975109|FG000|Overall Study|Withdrawal by Subject|20|||
170719002|NCT01221597|616975110|FG001|Overall Study|Withdrawal by Subject|6|||
170719003|NCT01221597|616975109|FG000|Overall Study|Lost to Follow-up|6|||
170719004|NCT01221597|616975110|FG001|Overall Study|Lost to Follow-up|5|||
170719005|NCT01221597|616975109|FG000|Overall Study|Protocol Violation|1|||
170719006|NCT01221597|616975110|FG001|Overall Study|Protocol Violation|0|||
170719007|NCT01221597|616975109|FG000|Overall Study|Other|3|||
170719008|NCT01221597|616975110|FG001|Overall Study|Other|4|||
170719009|NCT01221597|616975109|FG000|Overall Study|Death|2|||
170719010|NCT01221597|616975110|FG001|Overall Study|Death|0|||
170719011|NCT03305016|616975111|FG000|Overall Study|Withdrawal by Subject|2|||
170719012|NCT03434119|616975112|FG000|Overall Study|Randomized but not treated|1|||
170719013|NCT03434119|616975113|FG001|Overall Study|Randomized but not treated|0|||
170719014|NCT03434119|616975112|FG000|Overall Study|Adverse Event|1|||
170719015|NCT03434119|616975113|FG001|Overall Study|Adverse Event|0|||
170719016|NCT03434119|616975112|FG000|Overall Study|Poor Compliance to Protocol|0|||
170719017|NCT03434119|616975113|FG001|Overall Study|Poor Compliance to Protocol|1|||
170719018|NCT03434119|616975112|FG000|Overall Study|Study Terminated by Sponsor|91|||
170719019|NCT03434119|616975113|FG001|Overall Study|Study Terminated by Sponsor|102|||
170719020|NCT03434119|616975112|FG000|Overall Study|Withdrawal by Subject|7|||
170719021|NCT03434119|616975113|FG001|Overall Study|Withdrawal by Subject|5|||
170719022|NCT03434119|616975112|FG000|Overall Study|Other than specified|7|||
170719023|NCT03434119|616975113|FG001|Overall Study|Other than specified|5|||
170719024|NCT00305058|616975114|FG000|Overall Study|Participant too young|1|||
170719025|NCT00305058|616975115|FG001|Overall Study|Participant too young|0|||
170719026|NCT00305058|616975114|FG000|Overall Study|Missing data collection instrument|3|||
170719027|NCT00305058|616975115|FG001|Overall Study|Missing data collection instrument|2|||
170719028|NCT00305058|616975114|FG000|Overall Study|Missing outcome data|3|||
170719029|NCT00305058|616975115|FG001|Overall Study|Missing outcome data|2|||
170719030|NCT01109992|616975116|FG000|Overall Study|Withdrawal by Subject|0|||
170719031|NCT01109992|616975117|FG001|Overall Study|Withdrawal by Subject|1|||
170719032|NCT01109992|616975116|FG000|Overall Study|Movement during rest scan.|0|||
170719033|NCT01109992|616975117|FG001|Overall Study|Movement during rest scan.|1|||
170719034|NCT00690755|616975120|FG000|Overall Study|Physician Decision|2|||
170719035|NCT00690755|616975121|FG001|Overall Study|Physician Decision|0|||
170719036|NCT00690755|616975122|FG002|Overall Study|Physician Decision|46|||
170719037|NCT00690755|616975123|FG003|Overall Study|Physician Decision|5|||
170719038|NCT00690755|616975124|FG004|Overall Study|Physician Decision|0|||
170719039|NCT00690755|616975125|FG005|Overall Study|Physician Decision|4|||
170719040|NCT00690755|616975126|FG006|Overall Study|Physician Decision|0|||
170719041|NCT00288587|616975136|FG000|Overall Study|Death|4|||
170719042|NCT00288587|616975137|FG001|Overall Study|Death|4|||
170719043|NCT00288587|616975136|FG000|Overall Study|Transplant|0|||
170719044|NCT00288587|616975137|FG001|Overall Study|Transplant|3|||
170719045|NCT00288587|616975136|FG000|Overall Study|Adverse Event|0|||
170719046|NCT00288587|616975137|FG001|Overall Study|Adverse Event|1|||
170719047|NCT00288587|616975136|FG000|Overall Study|Physician Decision|0|||
170719048|NCT00288587|616975137|FG001|Overall Study|Physician Decision|2|||
170719049|NCT00288587|616975136|FG000|Overall Study|Severe Aortic Stenosis|1|||
170719050|NCT00288587|616975137|FG001|Overall Study|Severe Aortic Stenosis|0|||
170719051|NCT01934218|616975138|FG000|Double-blind Phase|Adverse Event|8|||
170719052|NCT01934218|616975139|FG001|Double-blind Phase|Adverse Event|8|||
170719053|NCT01934218|616975138|FG000|Double-blind Phase|Lack of Efficacy|6|||
170719054|NCT01934218|616975139|FG001|Double-blind Phase|Lack of Efficacy|7|||
170719055|NCT01934218|616975138|FG000|Double-blind Phase|Lost to Follow-up|7|||
170719056|NCT01934218|616975139|FG001|Double-blind Phase|Lost to Follow-up|14|||
170719057|NCT01934218|616975138|FG000|Double-blind Phase|Physician Decision|1|||
170719058|NCT01934218|616975139|FG001|Double-blind Phase|Physician Decision|2|||
170719059|NCT01934218|616975138|FG000|Double-blind Phase|Protocol Violation|4|||
170719060|NCT01934218|616975139|FG001|Double-blind Phase|Protocol Violation|0|||
170719061|NCT01934218|616975138|FG000|Double-blind Phase|Withdrawal by Subject|16|||
170719062|NCT01934218|616975139|FG001|Double-blind Phase|Withdrawal by Subject|13|||
170719063|NCT01934218|616975138|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
170719064|NCT01934218|616975139|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
170719065|NCT01934218|616975138|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
170719066|NCT01934218|616975139|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
170719067|NCT01934218|616975138|FG000|Open-Label Phase|Adverse Event|2|||
170719068|NCT01934218|616975139|FG001|Open-Label Phase|Adverse Event|4|||
170719069|NCT01934218|616975138|FG000|Open-Label Phase|Lack of Efficacy|1|||
170830757|NCT00590564|617390121|FG000|Overall Study|Patient Non-compliance|6|||
170719070|NCT01934218|616975139|FG001|Open-Label Phase|Lack of Efficacy|4|||
170719071|NCT01934218|616975138|FG000|Open-Label Phase|Lost to Follow-up|4|||
170719072|NCT01934218|616975139|FG001|Open-Label Phase|Lost to Follow-up|2|||
170719073|NCT01934218|616975138|FG000|Open-Label Phase|Physician Decision|1|||
170719074|NCT01934218|616975139|FG001|Open-Label Phase|Physician Decision|0|||
170719075|NCT01934218|616975138|FG000|Open-Label Phase|Protocol Violation|1|||
170830758|NCT01266018|617390122|FG000|Overall Study|Physician Decision|1|||
170719076|NCT01934218|616975139|FG001|Open-Label Phase|Protocol Violation|0|||
170719077|NCT01934218|616975138|FG000|Open-Label Phase|Withdrawal by Subject|13|||
170719078|NCT01934218|616975139|FG001|Open-Label Phase|Withdrawal by Subject|11|||
170719079|NCT01934218|616975138|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
170719080|NCT01934218|616975139|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
170719081|NCT01934218|616975138|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
170719082|NCT01934218|616975139|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
170719083|NCT03273946|616975144|FG000|Overall Study|Withdrawal by Subject|5|||
170719084|NCT03273946|616975144|FG000|Overall Study|Unwillingness of the guardian|1|||
170719085|NCT03273946|616975144|FG000|Overall Study|Participant refused to use the drug|2|||
170719086|NCT03273946|616975144|FG000|Overall Study|Participant relative refused to use drug|1|||
170719087|NCT01220557|616975145|FG000|Overall Study|Lost to Follow-up|5|||
170719088|NCT01220557|616975146|FG001|Overall Study|Lost to Follow-up|3|||
170719089|NCT01220557|616975145|FG000|Overall Study|attended less than 6 lessons|1|||
170719090|NCT01220557|616975146|FG001|Overall Study|attended less than 6 lessons|2|||
170719091|NCT05077267|616975147|FG000|Treatment Period|Lost to Follow-up|0|||
170719092|NCT05077267|616975148|FG001|Treatment Period|Lost to Follow-up|1|||
170719093|NCT05077267|616975149|FG002|Treatment Period|Lost to Follow-up|0|||
170719094|NCT05077267|616975147|FG000|Treatment Period|Withdrawal by Subject|0|||
170719095|NCT05077267|616975148|FG001|Treatment Period|Withdrawal by Subject|1|||
170719096|NCT05077267|616975149|FG002|Treatment Period|Withdrawal by Subject|0|||
170719097|NCT05077267|616975147|FG000|Follow-up Period|Lost to Follow-up|0|||
170719098|NCT05077267|616975148|FG001|Follow-up Period|Lost to Follow-up|5|||
170719099|NCT05077267|616975149|FG002|Follow-up Period|Lost to Follow-up|7|||
170719100|NCT05077267|616975147|FG000|Follow-up Period|Withdrawal by Subject|0|||
170719101|NCT05077267|616975148|FG001|Follow-up Period|Withdrawal by Subject|2|||
170719102|NCT05077267|616975149|FG002|Follow-up Period|Withdrawal by Subject|5|||
170719103|NCT05077267|616975147|FG000|Follow-up Period|Study terminated by sponsor|0|||
170719104|NCT05077267|616975148|FG001|Follow-up Period|Study terminated by sponsor|27|||
170719105|NCT05077267|616975149|FG002|Follow-up Period|Study terminated by sponsor|23|||
170719106|NCT05077267|616975147|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
170719107|NCT05077267|616975148|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
170719108|NCT05077267|616975149|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
170719109|NCT05077267|616975147|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
170719110|NCT05077267|616975148|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
170719111|NCT05077267|616975149|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
170719112|NCT00586105|616975157|FG000|Overall Study|Adverse Event|4|||
170719113|NCT00586105|616975157|FG000|Overall Study|Death|2|||
170719114|NCT00586105|616975157|FG000|Overall Study|Protocol Violation|1|||
170719115|NCT00586105|616975157|FG000|Overall Study|Withdrawal by Subject|3|||
170719116|NCT00586105|616975157|FG000|Overall Study|Disease progression|19|||
170719117|NCT00586105|616975157|FG000|Overall Study|Switched to commercial drug|9|||
170719118|NCT00586105|616975157|FG000|Overall Study|Reason not reported|1|||
170719119|NCT05045625|616975160|FG000|Overall Study|Lost to Follow-up|3|||
170719120|NCT03867734|616975162|FG000|Overall Study|Lost to Follow-up|2|||
170719121|NCT01136291|616975163|FG000|Overall Study|Lost to Follow-up|1|||
170719122|NCT01136291|616975164|FG001|Overall Study|Lost to Follow-up|1|||
170719123|NCT02308033|616975170|FG000|Overall Study|Normal Gram stain at Baseline|13|||
170719124|NCT02308033|616975171|FG001|Overall Study|Normal Gram stain at Baseline|10|||
170719125|NCT02308033|616975170|FG000|Overall Study|Positive for STD at Baseline|7|||
170719126|NCT02308033|616975171|FG001|Overall Study|Positive for STD at Baseline|4|||
170719127|NCT02308033|616975170|FG000|Overall Study|Lost to Follow-up|6|||
170719128|NCT02308033|616975171|FG001|Overall Study|Lost to Follow-up|5|||
170719129|NCT04964089|616975177|FG000|Overall Study|Adverse Event|8|||
170719130|NCT04964089|616975178|FG001|Overall Study|Adverse Event|6|||
170719131|NCT04964089|616975177|FG000|Overall Study|Non-compliance with study schedule|1|||
170719132|NCT04964089|616975178|FG001|Overall Study|Non-compliance with study schedule|0|||
170719133|NCT04964089|616975177|FG000|Overall Study|Withdrawal by Subject|6|||
170719134|NCT04964089|616975178|FG001|Overall Study|Withdrawal by Subject|5|||
170719135|NCT04964089|616975177|FG000|Overall Study|Lost to Follow-up|1|||
170719136|NCT04964089|616975178|FG001|Overall Study|Lost to Follow-up|1|||
170719137|NCT04964089|616975177|FG000|Overall Study|Progressive disease|4|||
170719138|NCT04964089|616975178|FG001|Overall Study|Progressive disease|0|||
170719139|NCT04964089|616975177|FG000|Overall Study|Physician Decision|1|||
170719140|NCT04964089|616975178|FG001|Overall Study|Physician Decision|0|||
170719141|NCT04964089|616975177|FG000|Overall Study|Participant did not want to continue study treatment|1|||
170719142|NCT04964089|616975178|FG001|Overall Study|Participant did not want to continue study treatment|0|||
170719143|NCT04964089|616975177|FG000|Overall Study|Participant moved to different state|1|||
170719144|NCT04964089|616975178|FG001|Overall Study|Participant moved to different state|0|||
170719145|NCT04964089|616975177|FG000|Overall Study|Participant decided to discontinue|0|||
170719146|NCT04964089|616975178|FG001|Overall Study|Participant decided to discontinue|1|||
170719147|NCT01664078|616975179|FG000|Overall Study|Death|9|||
170719148|NCT01664078|616975179|FG000|Overall Study|Withdrawal by Subject|4|||
170719149|NCT01664078|616975179|FG000|Overall Study|Lost to Follow-up|2|||
170719150|NCT01664078|616975179|FG000|Overall Study|missed 5 year visit|1|||
170719151|NCT01664078|616975179|FG000|Overall Study|Other|53|||
170719152|NCT03149328|616975180|FG000|Overall Study|Withdrawal by Subject|30|||
170719153|NCT03149328|616975181|FG001|Overall Study|Withdrawal by Subject|26|||
170719154|NCT03149328|616975180|FG000|Overall Study|Changed Dialysis Modality|18|||
170719155|NCT03149328|616975181|FG001|Overall Study|Changed Dialysis Modality|1|||
170719156|NCT03149328|616975180|FG000|Overall Study|Transplant|9|||
170719157|NCT03149328|616975181|FG001|Overall Study|Transplant|1|||
170719158|NCT03149328|616975180|FG000|Overall Study|Lost to Follow-up|25|||
170719159|NCT03149328|616975181|FG001|Overall Study|Lost to Follow-up|16|||
170719160|NCT03149328|616975180|FG000|Overall Study|Left Study Site|1|||
170719161|NCT03149328|616975181|FG001|Overall Study|Left Study Site|2|||
170719162|NCT03149328|616975180|FG000|Overall Study|Language Barrier|1|||
170719163|NCT03149328|616975181|FG001|Overall Study|Language Barrier|0|||
170719164|NCT03135522|616975193|FG000|Overall Study|Adverse Event|1|||
170719165|NCT03135522|616975194|FG001|Overall Study|Adverse Event|0|||
170719166|NCT03832192|616975195|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
170719167|NCT03832192|616975196|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
170719168|NCT00499369|616975199|FG000|Overall Study|Adverse Event|2|||
170719169|NCT00499369|616975200|FG001|Overall Study|Adverse Event|2|||
170719170|NCT00499369|616975201|FG002|Overall Study|Adverse Event|3|||
170719171|NCT00499369|616975202|FG003|Overall Study|Adverse Event|1|||
170719172|NCT00499369|616975203|FG004|Overall Study|Adverse Event|2|||
170719173|NCT00499369|616975199|FG000|Overall Study|Withdrawal by Subject|0|||
170719174|NCT00499369|616975200|FG001|Overall Study|Withdrawal by Subject|1|||
170719175|NCT00499369|616975201|FG002|Overall Study|Withdrawal by Subject|1|||
170719176|NCT00499369|616975202|FG003|Overall Study|Withdrawal by Subject|0|||
170719177|NCT00499369|616975203|FG004|Overall Study|Withdrawal by Subject|0|||
170719178|NCT00499369|616975199|FG000|Overall Study|Progression|10|||
170719179|NCT00499369|616975200|FG001|Overall Study|Progression|12|||
170719180|NCT00499369|616975201|FG002|Overall Study|Progression|9|||
170719181|NCT00499369|616975202|FG003|Overall Study|Progression|6|||
170719182|NCT00499369|616975203|FG004|Overall Study|Progression|10|||
170719183|NCT00499369|616975199|FG000|Overall Study|Death|0|||
170719184|NCT00499369|616975200|FG001|Overall Study|Death|1|||
170719185|NCT00499369|616975201|FG002|Overall Study|Death|0|||
170719186|NCT00499369|616975202|FG003|Overall Study|Death|0|||
170719187|NCT00499369|616975203|FG004|Overall Study|Death|0|||
170719188|NCT00499369|616975199|FG000|Overall Study|Not protocol specified|2|||
170719189|NCT00499369|616975200|FG001|Overall Study|Not protocol specified|0|||
170719190|NCT00499369|616975201|FG002|Overall Study|Not protocol specified|3|||
170719191|NCT00499369|616975202|FG003|Overall Study|Not protocol specified|1|||
170719192|NCT00499369|616975203|FG004|Overall Study|Not protocol specified|0|||
170719193|NCT00499369|616975199|FG000|Overall Study|Ineligible|2|||
170719194|NCT00499369|616975200|FG001|Overall Study|Ineligible|2|||
170830759|NCT01266018|617390123|FG001|Overall Study|Physician Decision|0|||
170719195|NCT00499369|616975201|FG002|Overall Study|Ineligible|1|||
170719196|NCT00499369|616975202|FG003|Overall Study|Ineligible|1|||
170719197|NCT00499369|616975203|FG004|Overall Study|Ineligible|0|||
170719198|NCT01898195|616975204|FG000|Smoking Abstinence|Did not have good measurements|35|||
170719199|NCT01898195|616975205|FG001|Smoking Abstinence|Did not have good measurements|38|||
170719200|NCT01898195|616975206|FG002|Smoking Abstinence|Did not have good measurements|36|||
170719201|NCT01337245|616975207|FG000|Overall Study|Lost to Follow-up|1|||
170719202|NCT01692197|616975208|FG000|Overall Study|Failed Screening|3|||
170719203|NCT03588572|616975215|FG000|Visitation 1|Lack of Efficacy|1|||
170719204|NCT03588572|616975216|FG001|Visitation 1|Lack of Efficacy|1|||
170719205|NCT03588572|616975215|FG000|Visitation 2|Lost to Follow-up|1|||
170719206|NCT03588572|616975216|FG001|Visitation 2|Lost to Follow-up|1|||
170719207|NCT03588572|616975215|FG000|Visitation 2|Lack of Efficacy|0|||
170719208|NCT03588572|616975216|FG001|Visitation 2|Lack of Efficacy|1|||
170719209|NCT03588572|616975215|FG000|Visitation 2|Withdrawal by Subject|1|||
170830760|NCT01266018|617390122|FG000|Overall Study|Progressive disease|0|||
170830761|NCT01266018|617390123|FG001|Overall Study|Progressive disease|1|||
170830762|NCT03167151|617390124|FG000|Overall Study|Withdrawal by Subject|1|||
170830763|NCT03167151|617390125|FG001|Overall Study|Withdrawal by Subject|0|||
170830764|NCT03167151|617390126|FG002|Overall Study|Withdrawal by Subject|0|||
170830765|NCT03167151|617390124|FG000|Overall Study|No evidence of tumour at surgery|0|||
170719210|NCT03588572|616975216|FG001|Visitation 2|Withdrawal by Subject|0|||
170719211|NCT03588572|616975215|FG000|Visitation 3|Lost to Follow-up|1|||
170719212|NCT03588572|616975216|FG001|Visitation 3|Lost to Follow-up|1|||
170719213|NCT03588572|616975215|FG000|Visitation 3|Physician Decision|1|||
170830766|NCT03167151|617390125|FG001|Overall Study|No evidence of tumour at surgery|1|||
170719214|NCT03588572|616975216|FG001|Visitation 3|Physician Decision|1|||
170719215|NCT03588572|616975215|FG000|Visitation 3|Withdrawal by Subject|1|||
170719216|NCT03588572|616975216|FG001|Visitation 3|Withdrawal by Subject|0|||
170719217|NCT02345512|616975221|FG000|Overall Study|Adverse Event|1|||
170719218|NCT02345512|616975221|FG000|Overall Study|Withdrawal by Subject|1|||
170719219|NCT01912612|616977661|FG000|Overall Study|Adverse Event|4|||
170719220|NCT01912612|616977662|FG001|Overall Study|Adverse Event|0|||
170719221|NCT01912612|616977663|FG002|Overall Study|Adverse Event|0|||
170719222|NCT01912612|616977661|FG000|Overall Study|Withdrew consent|1|||
170719223|NCT01912612|616977662|FG001|Overall Study|Withdrew consent|0|||
170719224|NCT01912612|616977663|FG002|Overall Study|Withdrew consent|0|||
170719225|NCT01912612|616977661|FG000|Overall Study|Study design change|0|||
170719226|NCT01912612|616977662|FG001|Overall Study|Study design change|0|||
170719227|NCT01912612|616977663|FG002|Overall Study|Study design change|3|||
170719228|NCT01588184|616977664|FG000|Overall Study|Death|1|||
170719229|NCT01588184|616977665|FG001|Overall Study|Death|0|||
170719230|NCT01588184|616977666|FG002|Overall Study|Death|0|||
170719231|NCT01588184|616977667|FG003|Overall Study|Death|1|||
170719232|NCT01588184|616977668|FG004|Overall Study|Death|1|||
170719233|NCT01588184|616977669|FG005|Overall Study|Death|1|||
170719234|NCT01588184|616977664|FG000|Overall Study|Withdrawal by Subject|2|||
170719235|NCT01588184|616977665|FG001|Overall Study|Withdrawal by Subject|4|||
170719236|NCT01588184|616977666|FG002|Overall Study|Withdrawal by Subject|0|||
170719237|NCT01588184|616977667|FG003|Overall Study|Withdrawal by Subject|1|||
170719238|NCT01588184|616977668|FG004|Overall Study|Withdrawal by Subject|0|||
170719239|NCT01588184|616977669|FG005|Overall Study|Withdrawal by Subject|0|||
170719240|NCT01588184|616977664|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
170719241|NCT01588184|616977665|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
170719242|NCT01588184|616977666|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
170719243|NCT01588184|616977667|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
170719244|NCT01588184|616977668|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
170719245|NCT01588184|616977669|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
170719246|NCT01588184|616977664|FG000|Overall Study|multiple reasons|0|||
170719247|NCT01588184|616977665|FG001|Overall Study|multiple reasons|3|||
170719248|NCT01588184|616977666|FG002|Overall Study|multiple reasons|0|||
170719249|NCT01588184|616977667|FG003|Overall Study|multiple reasons|1|||
170719250|NCT01588184|616977668|FG004|Overall Study|multiple reasons|0|||
170719251|NCT01588184|616977669|FG005|Overall Study|multiple reasons|0|||
170719252|NCT01914926|616977674|FG000|Overall Study|Adverse Event|1|||
170719253|NCT01914926|616977675|FG001|Overall Study|Adverse Event|0|||
170719254|NCT01914926|616977674|FG000|Overall Study|uncooperative, agitated and removed|0|||
170719255|NCT01914926|616977675|FG001|Overall Study|uncooperative, agitated and removed|1|||
170719256|NCT00620750|616977681|FG000|Overall Study|Lost to Follow-up|25|||
170719257|NCT03214367|616977684|FG000|Lead-in Period|Withdrawal by Subject|50|||
170719258|NCT03214367|616977685|FG001|Lead-in Period|Withdrawal by Subject|0|||
170719259|NCT03214367|616977686|FG002|Lead-in Period|Withdrawal by Subject|0|||
170719260|NCT03214367|616977687|FG003|Lead-in Period|Withdrawal by Subject|0|||
170719261|NCT03214367|616977688|FG004|Lead-in Period|Withdrawal by Subject|2|||
170719262|NCT03214367|616977689|FG005|Lead-in Period|Withdrawal by Subject|0|||
170719263|NCT03214367|616977690|FG006|Lead-in Period|Withdrawal by Subject|0|||
170719264|NCT03214367|616977691|FG007|Lead-in Period|Withdrawal by Subject|0|||
170719265|NCT03214367|616977684|FG000|Lead-in Period|Adverse Event|3|||
170719266|NCT03214367|616977685|FG001|Lead-in Period|Adverse Event|0|||
170719267|NCT03214367|616977686|FG002|Lead-in Period|Adverse Event|0|||
170719268|NCT03214367|616977687|FG003|Lead-in Period|Adverse Event|0|||
170719269|NCT03214367|616977688|FG004|Lead-in Period|Adverse Event|0|||
170719270|NCT03214367|616977689|FG005|Lead-in Period|Adverse Event|0|||
170719271|NCT03214367|616977690|FG006|Lead-in Period|Adverse Event|0|||
170719272|NCT03214367|616977691|FG007|Lead-in Period|Adverse Event|0|||
170719273|NCT03214367|616977684|FG000|Lead-in Period|Lost to Follow-up|12|||
170719274|NCT03214367|616977685|FG001|Lead-in Period|Lost to Follow-up|0|||
170719275|NCT03214367|616977686|FG002|Lead-in Period|Lost to Follow-up|0|||
170719276|NCT03214367|616977687|FG003|Lead-in Period|Lost to Follow-up|0|||
170719277|NCT03214367|616977688|FG004|Lead-in Period|Lost to Follow-up|0|||
170719278|NCT03214367|616977689|FG005|Lead-in Period|Lost to Follow-up|0|||
170719279|NCT03214367|616977690|FG006|Lead-in Period|Lost to Follow-up|0|||
170719280|NCT03214367|616977691|FG007|Lead-in Period|Lost to Follow-up|0|||
170719281|NCT03214367|616977684|FG000|Lead-in Period|Sponsor Decision|11|||
170719282|NCT03214367|616977685|FG001|Lead-in Period|Sponsor Decision|0|||
170719283|NCT03214367|616977686|FG002|Lead-in Period|Sponsor Decision|0|||
170719284|NCT03214367|616977687|FG003|Lead-in Period|Sponsor Decision|0|||
170719285|NCT03214367|616977688|FG004|Lead-in Period|Sponsor Decision|0|||
170719286|NCT03214367|616977689|FG005|Lead-in Period|Sponsor Decision|0|||
170719287|NCT03214367|616977690|FG006|Lead-in Period|Sponsor Decision|0|||
170719288|NCT03214367|616977691|FG007|Lead-in Period|Sponsor Decision|0|||
170719289|NCT03214367|616977684|FG000|Lead-in Period|Physician Decision|12|||
170719290|NCT03214367|616977685|FG001|Lead-in Period|Physician Decision|0|||
170719291|NCT03214367|616977686|FG002|Lead-in Period|Physician Decision|0|||
170719292|NCT03214367|616977687|FG003|Lead-in Period|Physician Decision|0|||
170719293|NCT03214367|616977688|FG004|Lead-in Period|Physician Decision|0|||
170719294|NCT03214367|616977689|FG005|Lead-in Period|Physician Decision|0|||
170719295|NCT03214367|616977690|FG006|Lead-in Period|Physician Decision|0|||
170719296|NCT03214367|616977691|FG007|Lead-in Period|Physician Decision|0|||
170719297|NCT03214367|616977684|FG000|Lead-in Period|Protocol Violation|5|||
170719298|NCT03214367|616977685|FG001|Lead-in Period|Protocol Violation|0|||
170719299|NCT03214367|616977686|FG002|Lead-in Period|Protocol Violation|0|||
170719300|NCT03214367|616977687|FG003|Lead-in Period|Protocol Violation|0|||
170719301|NCT03214367|616977688|FG004|Lead-in Period|Protocol Violation|0|||
170719302|NCT03214367|616977689|FG005|Lead-in Period|Protocol Violation|0|||
170719303|NCT03214367|616977690|FG006|Lead-in Period|Protocol Violation|0|||
170719304|NCT03214367|616977691|FG007|Lead-in Period|Protocol Violation|0|||
170719305|NCT03214367|616977684|FG000|Lead-in Period|Treatment Interruption|1|||
170719306|NCT03214367|616977685|FG001|Lead-in Period|Treatment Interruption|0|||
170719307|NCT03214367|616977686|FG002|Lead-in Period|Treatment Interruption|0|||
170719308|NCT03214367|616977687|FG003|Lead-in Period|Treatment Interruption|0|||
170719309|NCT03214367|616977688|FG004|Lead-in Period|Treatment Interruption|0|||
170719310|NCT03214367|616977689|FG005|Lead-in Period|Treatment Interruption|0|||
170719311|NCT03214367|616977690|FG006|Lead-in Period|Treatment Interruption|0|||
170719312|NCT03214367|616977691|FG007|Lead-in Period|Treatment Interruption|0|||
170719313|NCT03214367|616977684|FG000|Treatment Period|Adverse Event|0|||
170719314|NCT03214367|616977685|FG001|Treatment Period|Adverse Event|1|||
170719315|NCT03214367|616977686|FG002|Treatment Period|Adverse Event|4|||
170719316|NCT03214367|616977687|FG003|Treatment Period|Adverse Event|2|||
170719317|NCT03214367|616977688|FG004|Treatment Period|Adverse Event|0|||
170719318|NCT03214367|616977689|FG005|Treatment Period|Adverse Event|0|||
170719319|NCT03214367|616977690|FG006|Treatment Period|Adverse Event|0|||
170719320|NCT03214367|616977691|FG007|Treatment Period|Adverse Event|0|||
170719321|NCT03214367|616977684|FG000|Treatment Period|Death|0|||
170719322|NCT03214367|616977685|FG001|Treatment Period|Death|1|||
170719323|NCT03214367|616977686|FG002|Treatment Period|Death|1|||
170719324|NCT03214367|616977687|FG003|Treatment Period|Death|1|||
170719325|NCT03214367|616977688|FG004|Treatment Period|Death|0|||
170719326|NCT03214367|616977689|FG005|Treatment Period|Death|0|||
170719327|NCT03214367|616977690|FG006|Treatment Period|Death|0|||
170719328|NCT03214367|616977691|FG007|Treatment Period|Death|0|||
170719329|NCT03214367|616977684|FG000|Treatment Period|Lost to Follow-up|0|||
170719330|NCT03214367|616977685|FG001|Treatment Period|Lost to Follow-up|5|||
170719331|NCT03214367|616977686|FG002|Treatment Period|Lost to Follow-up|3|||
170719332|NCT03214367|616977687|FG003|Treatment Period|Lost to Follow-up|2|||
170719333|NCT03214367|616977688|FG004|Treatment Period|Lost to Follow-up|0|||
170719334|NCT03214367|616977689|FG005|Treatment Period|Lost to Follow-up|2|||
170719335|NCT03214367|616977690|FG006|Treatment Period|Lost to Follow-up|1|||
170719336|NCT03214367|616977691|FG007|Treatment Period|Lost to Follow-up|0|||
170719337|NCT03214367|616977684|FG000|Treatment Period|Sponsor Decision|0|||
170719338|NCT03214367|616977685|FG001|Treatment Period|Sponsor Decision|3|||
170719339|NCT03214367|616977686|FG002|Treatment Period|Sponsor Decision|0|||
170719340|NCT03214367|616977687|FG003|Treatment Period|Sponsor Decision|0|||
170719341|NCT03214367|616977688|FG004|Treatment Period|Sponsor Decision|0|||
170719342|NCT03214367|616977689|FG005|Treatment Period|Sponsor Decision|0|||
170719343|NCT03214367|616977690|FG006|Treatment Period|Sponsor Decision|0|||
170719344|NCT03214367|616977691|FG007|Treatment Period|Sponsor Decision|0|||
170719345|NCT03214367|616977684|FG000|Treatment Period|Physician Decision|0|||
170719346|NCT03214367|616977685|FG001|Treatment Period|Physician Decision|1|||
170719347|NCT03214367|616977686|FG002|Treatment Period|Physician Decision|2|||
170719348|NCT03214367|616977687|FG003|Treatment Period|Physician Decision|0|||
170719349|NCT03214367|616977688|FG004|Treatment Period|Physician Decision|0|||
170719350|NCT03214367|616977689|FG005|Treatment Period|Physician Decision|0|||
170719351|NCT03214367|616977690|FG006|Treatment Period|Physician Decision|0|||
170719352|NCT03214367|616977691|FG007|Treatment Period|Physician Decision|0|||
170719353|NCT03214367|616977684|FG000|Treatment Period|Protocol Violation|0|||
170719354|NCT03214367|616977685|FG001|Treatment Period|Protocol Violation|3|||
170719355|NCT03214367|616977686|FG002|Treatment Period|Protocol Violation|0|||
170719356|NCT03214367|616977687|FG003|Treatment Period|Protocol Violation|0|||
170719357|NCT03214367|616977688|FG004|Treatment Period|Protocol Violation|0|||
170719358|NCT03214367|616977689|FG005|Treatment Period|Protocol Violation|0|||
170719359|NCT03214367|616977690|FG006|Treatment Period|Protocol Violation|0|||
170719360|NCT03214367|616977691|FG007|Treatment Period|Protocol Violation|0|||
170719361|NCT03214367|616977684|FG000|Treatment Period|Withdrawal by Subject|0|||
170719362|NCT03214367|616977685|FG001|Treatment Period|Withdrawal by Subject|20|||
170719363|NCT03214367|616977686|FG002|Treatment Period|Withdrawal by Subject|23|||
170719364|NCT03214367|616977687|FG003|Treatment Period|Withdrawal by Subject|14|||
170719365|NCT03214367|616977688|FG004|Treatment Period|Withdrawal by Subject|0|||
170719366|NCT03214367|616977689|FG005|Treatment Period|Withdrawal by Subject|1|||
170719367|NCT03214367|616977690|FG006|Treatment Period|Withdrawal by Subject|1|||
170719368|NCT03214367|616977691|FG007|Treatment Period|Withdrawal by Subject|1|||
170719369|NCT02536508|616977694|FG000|Overall Study|Withdrawal by Subject|18|||
170719370|NCT02536508|616977695|FG001|Overall Study|Withdrawal by Subject|13|||
170719371|NCT02536508|616977696|FG002|Overall Study|Withdrawal by Subject|7|||
170719372|NCT02536508|616977694|FG000|Overall Study|Adverse Event|14|||
170719373|NCT02536508|616977695|FG001|Overall Study|Adverse Event|13|||
170719374|NCT02536508|616977696|FG002|Overall Study|Adverse Event|6|||
170719375|NCT02536508|616977694|FG000|Overall Study|Lost to Follow-up|12|||
170719376|NCT02536508|616977695|FG001|Overall Study|Lost to Follow-up|4|||
170719377|NCT02536508|616977696|FG002|Overall Study|Lost to Follow-up|0|||
170719378|NCT02536508|616977694|FG000|Overall Study|Lack of Efficacy|3|||
170719379|NCT02536508|616977695|FG001|Overall Study|Lack of Efficacy|5|||
170719380|NCT02536508|616977696|FG002|Overall Study|Lack of Efficacy|4|||
170719381|NCT02536508|616977694|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
170719382|NCT02536508|616977695|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
170719383|NCT02536508|616977696|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
170719384|NCT02536508|616977694|FG000|Overall Study|Physician Decision|0|||
170719385|NCT02536508|616977695|FG001|Overall Study|Physician Decision|4|||
170719386|NCT02536508|616977696|FG002|Overall Study|Physician Decision|2|||
170719387|NCT02536508|616977694|FG000|Overall Study|Major Protocol Deviation|2|||
170719388|NCT02536508|616977695|FG001|Overall Study|Major Protocol Deviation|2|||
170719389|NCT02536508|616977696|FG002|Overall Study|Major Protocol Deviation|2|||
170719390|NCT02536508|616977694|FG000|Overall Study|Administrative Reasons|0|||
170719391|NCT02536508|616977695|FG001|Overall Study|Administrative Reasons|1|||
170719392|NCT02536508|616977696|FG002|Overall Study|Administrative Reasons|0|||
170719393|NCT00856856|616977697|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
170719394|NCT00856856|616977697|FG000|4-year Clinical Follow-up|Missed visit|1|||
170719395|NCT00823719|616977702|FG000|Overall Study|Adverse Event|1|||
170719396|NCT00823719|616977703|FG001|Overall Study|Adverse Event|2|||
170719397|NCT00823719|616977702|FG000|Overall Study|Physician Decision|1|||
170719398|NCT00823719|616977703|FG001|Overall Study|Physician Decision|4|||
170719399|NCT00823719|616977702|FG000|Overall Study|Withdrawal by Subject|0|||
170719400|NCT00823719|616977703|FG001|Overall Study|Withdrawal by Subject|1|||
170719401|NCT00823719|616977702|FG000|Overall Study|Disease Progression|4|||
170719402|NCT00823719|616977703|FG001|Overall Study|Disease Progression|4|||
170719403|NCT02117570|616977704|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
170719404|NCT02117570|616977705|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
170719405|NCT02117570|616977706|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
170719406|NCT02117570|616977704|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
170719407|NCT02117570|616977705|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
170719408|NCT02117570|616977706|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
170719409|NCT02117570|616977704|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
170719410|NCT02117570|616977705|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
170719411|NCT02117570|616977706|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
170719412|NCT02117570|616977704|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
170719413|NCT02117570|616977705|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
170719414|NCT02117570|616977706|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
170719415|NCT02117570|616977704|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
170719416|NCT02117570|616977705|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
170719417|NCT02117570|616977706|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
170719418|NCT02117570|616977704|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
170719419|NCT02117570|616977705|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
170719420|NCT02117570|616977706|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
170719421|NCT02117570|616977704|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
170719422|NCT02117570|616977705|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
170719423|NCT02117570|616977706|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
170719424|NCT02148250|616977707|FG000|Screening|Withdrawal by Subject|5|||
170719425|NCT02148250|616977708|FG001|Screening|Withdrawal by Subject|0|||
170719426|NCT02508311|616977716|FG000|Overall Study|Withdrawal by Subject|1|||
170719427|NCT02508311|616977717|FG001|Overall Study|Withdrawal by Subject|0|||
170719428|NCT04862143|616977718|FG000|Overall Study|Adverse Event|1|||
170719429|NCT04862143|616977718|FG000|Overall Study|Study terminated by sponsor|1|||
170719430|NCT02370602|616977720|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
170719431|NCT02370602|616977721|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
170719432|NCT02370602|616977722|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
170719433|NCT02370602|616977723|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
170830767|NCT03167151|617390126|FG002|Overall Study|No evidence of tumour at surgery|1|||
170830768|NCT01458522|617390127|FG000|Overall Study|Withdrawal by Subject|2|||
170830769|NCT01458522|617390128|FG001|Overall Study|Withdrawal by Subject|2|||
170830770|NCT01458522|617390127|FG000|Overall Study|Physician Decision|1|||
170830771|NCT01458522|617390128|FG001|Overall Study|Physician Decision|9|||
170719434|NCT02370602|616977724|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
170719435|NCT02370602|616977725|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
170830772|NCT00516139|617390129|FG000|Overall Study|Adverse Event|27|||
170830773|NCT00516139|617390129|FG000|Overall Study|Lost to Follow-up|1|||
170719436|NCT02103439|616977726|FG000|Overall Study|Adverse Event|0|||
170719437|NCT02103439|616977727|FG001|Overall Study|Adverse Event|2|||
170719438|NCT02103439|616977726|FG000|Overall Study|Withdrawal by Subject|3|||
170719439|NCT02103439|616977727|FG001|Overall Study|Withdrawal by Subject|1|||
170719440|NCT04955639|616977728|FG000|Overall Study|Withdrawal by Subject|2|||
170719441|NCT04955639|616977729|FG001|Overall Study|Withdrawal by Subject|2|||
170719442|NCT04955639|616977728|FG000|Overall Study|Week 26 survey not completed|2|||
170719443|NCT04955639|616977729|FG001|Overall Study|Week 26 survey not completed|2|||
170719444|NCT03905655|616977730|FG000|Overall Study|Adverse Event|1|||
170719445|NCT03905655|616977731|FG001|Overall Study|Adverse Event|0|||
170719446|NCT03905655|616977732|FG002|Overall Study|Adverse Event|1|||
170719447|NCT03905655|616977733|FG003|Overall Study|Adverse Event|1|||
170719448|NCT00413153|616977734|FG000|Overall Study|Withdrawal by Subject|1|||
170719449|NCT00413153|616977735|FG001|Overall Study|Withdrawal by Subject|1|||
170719450|NCT00413153|616977734|FG000|Overall Study|Adverse Event|1|||
170719451|NCT00413153|616977735|FG001|Overall Study|Adverse Event|0|||
170719452|NCT04969250|616977736|FG000|Overall Study|Protocol Violation|0|||
170719453|NCT04969250|616977737|FG001|Overall Study|Protocol Violation|2|||
170719454|NCT04969250|616977738|FG002|Overall Study|Protocol Violation|3|||
170719455|NCT04969250|616977739|FG003|Overall Study|Protocol Violation|8|||
170719456|NCT04969250|616977736|FG000|Overall Study|Withdrawal by Subject|0|||
170719457|NCT04969250|616977737|FG001|Overall Study|Withdrawal by Subject|1|||
170719458|NCT04969250|616977738|FG002|Overall Study|Withdrawal by Subject|0|||
170719459|NCT04969250|616977739|FG003|Overall Study|Withdrawal by Subject|0|||
170719460|NCT02119416|616977741|FG000|Overall Study|Protocol Violation|1|||
170719461|NCT02119416|616977742|FG001|Overall Study|Protocol Violation|1|||
170719462|NCT02119416|616977743|FG002|Overall Study|Protocol Violation|1|||
170719463|NCT02119416|616977741|FG000|Overall Study|wrong pubertal stage|1|||
170719464|NCT02119416|616977742|FG001|Overall Study|wrong pubertal stage|0|||
170719465|NCT02119416|616977743|FG002|Overall Study|wrong pubertal stage|1|||
170719466|NCT01605617|616977744|FG000|First Intervention|Adverse Event|0|||
170719467|NCT01605617|616977745|FG001|First Intervention|Adverse Event|1|||
170719468|NCT01605617|616977744|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
170719469|NCT01605617|616977745|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
170719470|NCT03043664|616977746|FG000|Overall Study|Lost to Follow-up|1|||
170719471|NCT01540851|616977747|FG000|Overall Study|Lost to Follow-up|14|||
170719472|NCT01540851|616977748|FG001|Overall Study|Lost to Follow-up|15|||
170719473|NCT01540851|616977747|FG000|Overall Study|Withdrawal by Subject|7|||
170719474|NCT01540851|616977748|FG001|Overall Study|Withdrawal by Subject|3|||
170719475|NCT03593655|616977749|FG000|First Product Use Period|Withdrawal by Subject|1|||
170719476|NCT03593655|616977750|FG001|First Product Use Period|Withdrawal by Subject|1|||
170719477|NCT03593655|616977749|FG000|First Product Use Period|Lost to Follow-up|1|||
170719478|NCT03593655|616977750|FG001|First Product Use Period|Lost to Follow-up|3|||
170719479|NCT03593655|616977749|FG000|Second Product Use Period|Withdrawal by Subject|1|||
170719480|NCT03593655|616977750|FG001|Second Product Use Period|Withdrawal by Subject|1|||
170719481|NCT03593655|616977749|FG000|Second Product Use Period|Lost to Follow-up|1|||
170719482|NCT03593655|616977750|FG001|Second Product Use Period|Lost to Follow-up|0|||
170719483|NCT03593655|616977749|FG000|Third Product Use Period|Lost to Follow-up|1|||
170719484|NCT03593655|616977750|FG001|Third Product Use Period|Lost to Follow-up|2|||
170719485|NCT03593655|616977749|FG000|Third Product Use Period|Physician Decision|0|||
170719486|NCT03593655|616977750|FG001|Third Product Use Period|Physician Decision|1|||
170719487|NCT03593655|616977749|FG000|Third Product Use Period|Withdrawal by Subject|0|||
170719488|NCT03593655|616977750|FG001|Third Product Use Period|Withdrawal by Subject|1|||
170719489|NCT01953926|616977754|FG000|Overall Study|Withdrawal by Subject|23|||
170719490|NCT01953926|616977755|FG001|Overall Study|Withdrawal by Subject|3|||
170719491|NCT01953926|616977756|FG002|Overall Study|Withdrawal by Subject|3|||
170719492|NCT01953926|616977757|FG003|Overall Study|Withdrawal by Subject|5|||
170719493|NCT01953926|616977758|FG004|Overall Study|Withdrawal by Subject|6|||
170719494|NCT01953926|616977759|FG005|Overall Study|Withdrawal by Subject|0|||
170719495|NCT01953926|616977760|FG006|Overall Study|Withdrawal by Subject|1|||
170719496|NCT01953926|616977754|FG000|Overall Study|Physician Decision|1|||
170830774|NCT00516139|617390129|FG000|Overall Study|Protocol Violation|1|||
170830775|NCT00516139|617390129|FG000|Overall Study|Withdrawal by Subject|8|||
170830776|NCT00516139|617390129|FG000|Overall Study|Lack of Efficacy|1|||
170719497|NCT01953926|616977755|FG001|Overall Study|Physician Decision|0|||
170719498|NCT01953926|616977756|FG002|Overall Study|Physician Decision|0|||
170719499|NCT01953926|616977757|FG003|Overall Study|Physician Decision|0|||
170719500|NCT01953926|616977758|FG004|Overall Study|Physician Decision|2|||
170719501|NCT01953926|616977759|FG005|Overall Study|Physician Decision|0|||
170719502|NCT01953926|616977760|FG006|Overall Study|Physician Decision|0|||
170719503|NCT01953926|616977754|FG000|Overall Study|Lost to Follow-up|18|||
170719504|NCT01953926|616977755|FG001|Overall Study|Lost to Follow-up|3|||
170719505|NCT01953926|616977756|FG002|Overall Study|Lost to Follow-up|0|||
170719506|NCT01953926|616977757|FG003|Overall Study|Lost to Follow-up|5|||
170719507|NCT01953926|616977758|FG004|Overall Study|Lost to Follow-up|3|||
170719508|NCT01953926|616977759|FG005|Overall Study|Lost to Follow-up|0|||
170719509|NCT01953926|616977760|FG006|Overall Study|Lost to Follow-up|0|||
170719510|NCT01953926|616977754|FG000|Overall Study|Protocol Violation|1|||
170719511|NCT01953926|616977755|FG001|Overall Study|Protocol Violation|0|||
170719512|NCT01953926|616977756|FG002|Overall Study|Protocol Violation|0|||
170719513|NCT01953926|616977757|FG003|Overall Study|Protocol Violation|0|||
170719514|NCT01953926|616977758|FG004|Overall Study|Protocol Violation|0|||
170719515|NCT01953926|616977759|FG005|Overall Study|Protocol Violation|0|||
170719516|NCT01953926|616977760|FG006|Overall Study|Protocol Violation|0|||
170719517|NCT01953926|616977754|FG000|Overall Study|Other, Disease progression|2|||
170719518|NCT01953926|616977755|FG001|Overall Study|Other, Disease progression|1|||
170719519|NCT01953926|616977756|FG002|Overall Study|Other, Disease progression|0|||
170719520|NCT01953926|616977757|FG003|Overall Study|Other, Disease progression|0|||
170719521|NCT01953926|616977758|FG004|Overall Study|Other, Disease progression|1|||
170719522|NCT01953926|616977759|FG005|Overall Study|Other, Disease progression|0|||
170719523|NCT01953926|616977760|FG006|Overall Study|Other, Disease progression|0|||
170719524|NCT01953926|616977754|FG000|Overall Study|Discontinuation of study by sponsor|41|||
170719525|NCT01953926|616977755|FG001|Overall Study|Discontinuation of study by sponsor|7|||
170719526|NCT01953926|616977756|FG002|Overall Study|Discontinuation of study by sponsor|5|||
170719527|NCT01953926|616977757|FG003|Overall Study|Discontinuation of study by sponsor|12|||
170719528|NCT01953926|616977758|FG004|Overall Study|Discontinuation of study by sponsor|46|||
170719529|NCT01953926|616977759|FG005|Overall Study|Discontinuation of study by sponsor|5|||
170719530|NCT01953926|616977760|FG006|Overall Study|Discontinuation of study by sponsor|6|||
170719531|NCT01953926|616977754|FG000|Overall Study|Not Treated|1|||
170719532|NCT01953926|616977755|FG001|Overall Study|Not Treated|0|||
170719533|NCT01953926|616977756|FG002|Overall Study|Not Treated|1|||
170719534|NCT01953926|616977757|FG003|Overall Study|Not Treated|0|||
170719535|NCT01953926|616977758|FG004|Overall Study|Not Treated|0|||
170719536|NCT01953926|616977759|FG005|Overall Study|Not Treated|0|||
170719537|NCT01953926|616977760|FG006|Overall Study|Not Treated|0|||
170719538|NCT04287920|616977761|FG000|Overall Study|Lost to Follow-up|1|||
170719539|NCT04287920|616977762|FG001|Overall Study|Lost to Follow-up|1|||
170719540|NCT04287920|616977761|FG000|Overall Study|Withdrawal by Subject|0|||
170719541|NCT04287920|616977762|FG001|Overall Study|Withdrawal by Subject|3|||
170719542|NCT02952924|616977763|FG000|Overall Study|Protocol Violation|0|||
170719543|NCT02952924|616977764|FG001|Overall Study|Protocol Violation|0|||
170719544|NCT02952924|616977765|FG002|Overall Study|Protocol Violation|0|||
170719545|NCT02952924|616977766|FG003|Overall Study|Protocol Violation|0|||
170719546|NCT02952924|616977767|FG004|Overall Study|Protocol Violation|0|||
170719547|NCT02952924|616977768|FG005|Overall Study|Protocol Violation|0|||
170719548|NCT02952924|616977769|FG006|Overall Study|Protocol Violation|0|||
170719549|NCT02952924|616977770|FG007|Overall Study|Protocol Violation|0|||
170719550|NCT02952924|616977771|FG008|Overall Study|Protocol Violation|0|||
170719551|NCT02952924|616977772|FG009|Overall Study|Protocol Violation|0|||
170719552|NCT02952924|616977773|FG010|Overall Study|Protocol Violation|0|||
170719553|NCT02952924|616977774|FG011|Overall Study|Protocol Violation|0|||
170719554|NCT02952924|616977775|FG012|Overall Study|Protocol Violation|0|||
170719555|NCT02952924|616977776|FG013|Overall Study|Protocol Violation|0|||
170719556|NCT02952924|616977777|FG014|Overall Study|Protocol Violation|0|||
170719557|NCT02952924|616977778|FG015|Overall Study|Protocol Violation|0|||
170719558|NCT02952924|616977779|FG016|Overall Study|Protocol Violation|0|||
170719559|NCT02952924|616977780|FG017|Overall Study|Protocol Violation|0|||
170719560|NCT02952924|616977781|FG018|Overall Study|Protocol Violation|0|||
170719561|NCT02952924|616977782|FG019|Overall Study|Protocol Violation|1|||
170719562|NCT02952924|616977783|FG020|Overall Study|Protocol Violation|0|||
170719563|NCT02952924|616977784|FG021|Overall Study|Protocol Violation|0|||
170719564|NCT02952924|616977763|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
170719565|NCT02952924|616977764|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
170719566|NCT02952924|616977765|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
170719567|NCT02952924|616977766|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
170830777|NCT00589303|617390134|FG000|Overall Study|Withdrawal by Subject|2|||
170830778|NCT00589303|617390135|FG001|Overall Study|Withdrawal by Subject|1|||
170830779|NCT00730015|617390136|FG000|Overall Study|Adverse Event|11|||
170830780|NCT00730015|617390137|FG001|Overall Study|Adverse Event|10|||
170830781|NCT00730015|617390138|FG002|Overall Study|Adverse Event|8|||
170830782|NCT00730015|617390136|FG000|Overall Study|Protocol Violation|2|||
170830783|NCT00730015|617390137|FG001|Overall Study|Protocol Violation|6|||
170830784|NCT00730015|617390138|FG002|Overall Study|Protocol Violation|4|||
170830785|NCT00730015|617390136|FG000|Overall Study|Withdrawal by Subject|12|||
170830786|NCT00730015|617390137|FG001|Overall Study|Withdrawal by Subject|12|||
170719568|NCT02952924|616977767|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
170719569|NCT02952924|616977768|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
170719570|NCT02952924|616977769|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
170719571|NCT02952924|616977770|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
170830787|NCT00730015|617390138|FG002|Overall Study|Withdrawal by Subject|8|||
170830788|NCT00730015|617390136|FG000|Overall Study|Lost to Follow-up|4|||
170830789|NCT00730015|617390137|FG001|Overall Study|Lost to Follow-up|10|||
170719572|NCT02952924|616977771|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
170719573|NCT02952924|616977772|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
170719574|NCT02952924|616977773|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
170719575|NCT02952924|616977774|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
170719576|NCT02952924|616977775|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
170719577|NCT02952924|616977776|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
170719578|NCT02952924|616977777|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
170719579|NCT02952924|616977778|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
170719580|NCT02952924|616977779|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
170719581|NCT02952924|616977780|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
170719582|NCT02952924|616977781|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
170719583|NCT02952924|616977782|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
170719584|NCT02952924|616977783|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
170719585|NCT02952924|616977784|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
170719586|NCT02952924|616977763|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719587|NCT02952924|616977764|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719588|NCT02952924|616977765|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719589|NCT02952924|616977766|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719590|NCT02952924|616977767|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719591|NCT02952924|616977768|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719592|NCT02952924|616977769|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719593|NCT02952924|616977770|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719594|NCT02952924|616977771|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719595|NCT02952924|616977772|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719596|NCT02952924|616977773|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719597|NCT02952924|616977774|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719598|NCT02952924|616977775|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719599|NCT02952924|616977776|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719600|NCT02952924|616977777|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719601|NCT02952924|616977778|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719602|NCT02952924|616977779|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719603|NCT02952924|616977780|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719604|NCT02952924|616977781|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719605|NCT02952924|616977782|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719606|NCT02952924|616977783|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
170719607|NCT02952924|616977784|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
170719608|NCT02952924|616977763|FG000|Overall Study|Noncompliance with study drug|0|||
170719609|NCT02952924|616977764|FG001|Overall Study|Noncompliance with study drug|0|||
170719610|NCT02952924|616977765|FG002|Overall Study|Noncompliance with study drug|0|||
170719611|NCT02952924|616977766|FG003|Overall Study|Noncompliance with study drug|0|||
170719612|NCT02952924|616977767|FG004|Overall Study|Noncompliance with study drug|0|||
170719613|NCT02952924|616977768|FG005|Overall Study|Noncompliance with study drug|0|||
170719614|NCT02952924|616977769|FG006|Overall Study|Noncompliance with study drug|0|||
170719615|NCT02952924|616977770|FG007|Overall Study|Noncompliance with study drug|0|||
170719616|NCT02952924|616977771|FG008|Overall Study|Noncompliance with study drug|0|||
170719617|NCT02952924|616977772|FG009|Overall Study|Noncompliance with study drug|0|||
170719618|NCT02952924|616977773|FG010|Overall Study|Noncompliance with study drug|0|||
170719619|NCT02952924|616977774|FG011|Overall Study|Noncompliance with study drug|0|||
170719620|NCT02952924|616977775|FG012|Overall Study|Noncompliance with study drug|0|||
170719621|NCT02952924|616977776|FG013|Overall Study|Noncompliance with study drug|0|||
170719622|NCT02952924|616977777|FG014|Overall Study|Noncompliance with study drug|0|||
170719623|NCT02952924|616977778|FG015|Overall Study|Noncompliance with study drug|0|||
170719624|NCT02952924|616977779|FG016|Overall Study|Noncompliance with study drug|0|||
170719625|NCT02952924|616977780|FG017|Overall Study|Noncompliance with study drug|0|||
170719626|NCT02952924|616977781|FG018|Overall Study|Noncompliance with study drug|0|||
170830790|NCT00730015|617390138|FG002|Overall Study|Lost to Follow-up|3|||
170830791|NCT00730015|617390136|FG000|Overall Study|Lack of Efficacy|1|||
170719627|NCT02952924|616977782|FG019|Overall Study|Noncompliance with study drug|0|||
170719628|NCT02952924|616977783|FG020|Overall Study|Noncompliance with study drug|0|||
170719629|NCT02952924|616977784|FG021|Overall Study|Noncompliance with study drug|1|||
170719630|NCT01435577|616977785|FG000|Overall Study|Adverse Event|10|||
170719631|NCT01435577|616977786|FG001|Overall Study|Adverse Event|0|||
170719632|NCT01435577|616977785|FG000|Overall Study|Lack of Efficacy|7|||
170719633|NCT01435577|616977786|FG001|Overall Study|Lack of Efficacy|51|||
170719634|NCT01435577|616977785|FG000|Overall Study|Alternative treatment started|0|||
170719635|NCT01435577|616977786|FG001|Overall Study|Alternative treatment started|1|||
170719636|NCT01458574|616977787|FG000|Overall Study|Adverse Event|5|||
170719637|NCT01458574|616977788|FG001|Overall Study|Adverse Event|9|||
170719638|NCT01458574|616977789|FG002|Overall Study|Adverse Event|7|||
170719639|NCT01458574|616977787|FG000|Overall Study|Lack of Efficacy|70|||
170719640|NCT01458574|616977788|FG001|Overall Study|Lack of Efficacy|53|||
170719641|NCT01458574|616977789|FG002|Overall Study|Lack of Efficacy|132|||
170719642|NCT01458574|616977787|FG000|Overall Study|Lost to Follow-up|3|||
170719643|NCT01458574|616977788|FG001|Overall Study|Lost to Follow-up|2|||
170719644|NCT01458574|616977789|FG002|Overall Study|Lost to Follow-up|1|||
170719645|NCT01458574|616977787|FG000|Overall Study|Pregnancy|1|||
170719646|NCT01458574|616977788|FG001|Overall Study|Pregnancy|1|||
170719647|NCT01458574|616977789|FG002|Overall Study|Pregnancy|0|||
170719648|NCT01458574|616977787|FG000|Overall Study|Protocol Violation|0|||
170719649|NCT01458574|616977788|FG001|Overall Study|Protocol Violation|1|||
170719650|NCT01458574|616977789|FG002|Overall Study|Protocol Violation|0|||
170719651|NCT01458574|616977787|FG000|Overall Study|Withdrawal by Subject|6|||
170719652|NCT01458574|616977788|FG001|Overall Study|Withdrawal by Subject|3|||
170719653|NCT01458574|616977789|FG002|Overall Study|Withdrawal by Subject|5|||
170719654|NCT01458574|616977787|FG000|Overall Study|Other|2|||
170719655|NCT01458574|616977788|FG001|Overall Study|Other|1|||
170719656|NCT01458574|616977789|FG002|Overall Study|Other|0|||
170719657|NCT01458574|616977787|FG000|Overall Study|Randomized but not treated|0|||
170719658|NCT01458574|616977788|FG001|Overall Study|Randomized but not treated|1|||
170719659|NCT01458574|616977789|FG002|Overall Study|Randomized but not treated|0|||
170719660|NCT02125786|616977790|FG000|Overall Study|Still in Follow-up|3|||
170719661|NCT02125786|616977790|FG000|Overall Study|Screen Failure|2|||
170719662|NCT02125786|616977790|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
170719663|NCT02125786|616977790|FG000|Overall Study|Progressive Disease|44|||
170719664|NCT02125786|616977790|FG000|Overall Study|Death|8|||
170719665|NCT01682837|616977794|FG000|Baseline|Withdrawal by Subject|5|||
170719666|NCT01365494|616977797|FG000|Overall Study|Adverse Event|1|||
170719667|NCT01365494|616977798|FG001|Overall Study|Adverse Event|0|||
170719668|NCT01365494|616977797|FG000|Overall Study|Withdrawal by Subject|0|||
170719669|NCT01365494|616977798|FG001|Overall Study|Withdrawal by Subject|1|||
170719670|NCT01365494|616977797|FG000|Overall Study|Lost to Follow-up|1|||
170719671|NCT01365494|616977798|FG001|Overall Study|Lost to Follow-up|2|||
170719672|NCT03021187|616977799|FG000|Overall Study|Death|0|||
170719673|NCT03021187|616977800|FG001|Overall Study|Death|0|||
170719674|NCT03021187|616977801|FG002|Overall Study|Death|3|||
170719675|NCT03021187|616977802|FG003|Overall Study|Death|0|||
170719676|NCT03021187|616977799|FG000|Overall Study|Withdrawal by Subject|0|||
170719677|NCT03021187|616977800|FG001|Overall Study|Withdrawal by Subject|6|||
170719678|NCT03021187|616977801|FG002|Overall Study|Withdrawal by Subject|2|||
170719679|NCT03021187|616977802|FG003|Overall Study|Withdrawal by Subject|5|||
170719680|NCT03021187|616977799|FG000|Overall Study|Lost to Follow-up|10|||
170719681|NCT03021187|616977800|FG001|Overall Study|Lost to Follow-up|3|||
170719682|NCT03021187|616977801|FG002|Overall Study|Lost to Follow-up|1|||
170719683|NCT03021187|616977802|FG003|Overall Study|Lost to Follow-up|4|||
170719684|NCT04782323|616977803|FG000|Overall Study|Death|1|||
170719685|NCT04782323|616977804|FG001|Overall Study|Death|0|||
170719686|NCT04782323|616977805|FG002|Overall Study|Death|0|||
170719687|NCT04782323|616977806|FG003|Overall Study|Death|0|||
170719688|NCT04782323|616977807|FG004|Overall Study|Death|1|||
170830792|NCT00730015|617390137|FG001|Overall Study|Lack of Efficacy|2|||
170830793|NCT00730015|617390138|FG002|Overall Study|Lack of Efficacy|8|||
170830794|NCT00730015|617390136|FG000|Overall Study|Other Reason|1|||
170830795|NCT00730015|617390137|FG001|Overall Study|Other Reason|0|||
170830796|NCT00730015|617390138|FG002|Overall Study|Other Reason|1|||
170719689|NCT04782323|616977808|FG005|Overall Study|Death|1|||
170719690|NCT04782323|616977809|FG006|Overall Study|Death|1|||
170719691|NCT04782323|616977810|FG007|Overall Study|Death|0|||
170719692|NCT04782323|616977803|FG000|Overall Study|Withdrawal by Subject|0|||
170719693|NCT04782323|616977804|FG001|Overall Study|Withdrawal by Subject|0|||
170719694|NCT04782323|616977805|FG002|Overall Study|Withdrawal by Subject|1|||
170719695|NCT04782323|616977806|FG003|Overall Study|Withdrawal by Subject|0|||
170719696|NCT04782323|616977807|FG004|Overall Study|Withdrawal by Subject|0|||
170719697|NCT04782323|616977808|FG005|Overall Study|Withdrawal by Subject|1|||
170719698|NCT04782323|616977809|FG006|Overall Study|Withdrawal by Subject|0|||
170719699|NCT04782323|616977810|FG007|Overall Study|Withdrawal by Subject|1|||
170719700|NCT04782323|616977803|FG000|Overall Study|Lost to Follow-up|0|||
170830797|NCT03062449|617390140|FG000|Overall Study|Withdrawal by Subject|7|||
170719701|NCT04782323|616977804|FG001|Overall Study|Lost to Follow-up|1|||
170719702|NCT04782323|616977805|FG002|Overall Study|Lost to Follow-up|1|||
170719703|NCT04782323|616977806|FG003|Overall Study|Lost to Follow-up|0|||
170719704|NCT04782323|616977807|FG004|Overall Study|Lost to Follow-up|0|||
170719705|NCT04782323|616977808|FG005|Overall Study|Lost to Follow-up|1|||
170719706|NCT04782323|616977809|FG006|Overall Study|Lost to Follow-up|1|||
170719707|NCT04782323|616977810|FG007|Overall Study|Lost to Follow-up|2|||
170719708|NCT04782323|616977803|FG000|Overall Study|randomization in error|1|||
170719709|NCT04782323|616977804|FG001|Overall Study|randomization in error|0|||
170719710|NCT04782323|616977805|FG002|Overall Study|randomization in error|0|||
170719711|NCT04782323|616977806|FG003|Overall Study|randomization in error|0|||
170719712|NCT04782323|616977807|FG004|Overall Study|randomization in error|0|||
170719713|NCT04782323|616977808|FG005|Overall Study|randomization in error|0|||
170719714|NCT04782323|616977809|FG006|Overall Study|randomization in error|0|||
170719715|NCT04782323|616977810|FG007|Overall Study|randomization in error|0|||
170719716|NCT03351049|616977811|FG000|Overall Study|Withdrawal|26|||
170719717|NCT03351049|616977812|FG001|Overall Study|Withdrawal|22|||
170719718|NCT00718718|616977813|FG000|Prior to Week 12|Adverse Event|0|||
170719719|NCT00718718|616977814|FG001|Prior to Week 12|Adverse Event|0|||
170719720|NCT00718718|616977815|FG002|Prior to Week 12|Adverse Event|0|||
170719721|NCT00718718|616977816|FG003|Prior to Week 12|Adverse Event|0|||
170719722|NCT00718718|616977817|FG004|Prior to Week 12|Adverse Event|0|||
170719723|NCT00718718|616977818|FG005|Prior to Week 12|Adverse Event|0|||
170719724|NCT00718718|616977819|FG006|Prior to Week 12|Adverse Event|0|||
170719725|NCT00718718|616977820|FG007|Prior to Week 12|Adverse Event|1|||
170719726|NCT00718718|616977821|FG008|Prior to Week 12|Adverse Event|1|||
170719727|NCT00718718|616977822|FG009|Prior to Week 12|Adverse Event|0|||
170719728|NCT00718718|616977813|FG000|Prior to Week 12|Withdrawal by Subject|0|||
170719729|NCT00718718|616977814|FG001|Prior to Week 12|Withdrawal by Subject|0|||
170719730|NCT00718718|616977815|FG002|Prior to Week 12|Withdrawal by Subject|0|||
170719731|NCT00718718|616977816|FG003|Prior to Week 12|Withdrawal by Subject|0|||
170719732|NCT00718718|616977817|FG004|Prior to Week 12|Withdrawal by Subject|3|||
170719733|NCT00718718|616977818|FG005|Prior to Week 12|Withdrawal by Subject|0|||
170719734|NCT00718718|616977819|FG006|Prior to Week 12|Withdrawal by Subject|1|||
170719735|NCT00718718|616977820|FG007|Prior to Week 12|Withdrawal by Subject|1|||
170719736|NCT00718718|616977821|FG008|Prior to Week 12|Withdrawal by Subject|1|||
170719737|NCT00718718|616977822|FG009|Prior to Week 12|Withdrawal by Subject|0|||
170719738|NCT00718718|616977813|FG000|Prior to Week 12|Other|1|||
170719739|NCT00718718|616977814|FG001|Prior to Week 12|Other|0|||
170719740|NCT00718718|616977815|FG002|Prior to Week 12|Other|1|||
170719741|NCT00718718|616977816|FG003|Prior to Week 12|Other|0|||
170719742|NCT00718718|616977817|FG004|Prior to Week 12|Other|0|||
170719743|NCT00718718|616977818|FG005|Prior to Week 12|Other|0|||
170719744|NCT00718718|616977819|FG006|Prior to Week 12|Other|0|||
170719745|NCT00718718|616977820|FG007|Prior to Week 12|Other|0|||
170719746|NCT00718718|616977821|FG008|Prior to Week 12|Other|0|||
170719747|NCT00718718|616977822|FG009|Prior to Week 12|Other|0|||
170719748|NCT00718718|616977813|FG000|Week 12 to End of Study|Adverse Event|0|||
170719749|NCT00718718|616977814|FG001|Week 12 to End of Study|Adverse Event|0|||
170719750|NCT00718718|616977815|FG002|Week 12 to End of Study|Adverse Event|0|||
170719751|NCT00718718|616977816|FG003|Week 12 to End of Study|Adverse Event|0|||
170719752|NCT00718718|616977817|FG004|Week 12 to End of Study|Adverse Event|0|||
170719753|NCT00718718|616977818|FG005|Week 12 to End of Study|Adverse Event|0|||
170719754|NCT00718718|616977819|FG006|Week 12 to End of Study|Adverse Event|0|||
170719755|NCT00718718|616977820|FG007|Week 12 to End of Study|Adverse Event|1|||
170719756|NCT00718718|616977821|FG008|Week 12 to End of Study|Adverse Event|0|||
170719757|NCT00718718|616977822|FG009|Week 12 to End of Study|Adverse Event|0|||
170719758|NCT00718718|616977813|FG000|Week 12 to End of Study|Death|0|||
170719759|NCT00718718|616977814|FG001|Week 12 to End of Study|Death|0|||
170719760|NCT00718718|616977815|FG002|Week 12 to End of Study|Death|0|||
170719761|NCT00718718|616977816|FG003|Week 12 to End of Study|Death|0|||
170719762|NCT00718718|616977817|FG004|Week 12 to End of Study|Death|0|||
170719763|NCT00718718|616977818|FG005|Week 12 to End of Study|Death|1|||
170719764|NCT00718718|616977819|FG006|Week 12 to End of Study|Death|0|||
170719765|NCT00718718|616977820|FG007|Week 12 to End of Study|Death|0|||
170719766|NCT00718718|616977821|FG008|Week 12 to End of Study|Death|0|||
170719767|NCT00718718|616977822|FG009|Week 12 to End of Study|Death|0|||
170719768|NCT00718718|616977813|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
170719769|NCT00718718|616977814|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
170719770|NCT00718718|616977815|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
170719771|NCT00718718|616977816|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
170719772|NCT00718718|616977817|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
170719773|NCT00718718|616977818|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
170719774|NCT00718718|616977819|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
170719775|NCT00718718|616977820|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
170719776|NCT00718718|616977821|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
170719777|NCT00718718|616977822|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
170719778|NCT00718718|616977813|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
170719779|NCT00718718|616977814|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
170719780|NCT00718718|616977815|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
170719781|NCT00718718|616977816|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
170719782|NCT00718718|616977817|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
170719783|NCT00718718|616977818|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
170719784|NCT00718718|616977819|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
170719785|NCT00718718|616977820|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
170719786|NCT00718718|616977821|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
170719787|NCT00718718|616977822|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
170719788|NCT00718718|616977813|FG000|Week 12 to End of Study|Other|0|||
170719789|NCT00718718|616977814|FG001|Week 12 to End of Study|Other|1|||
170719790|NCT00718718|616977815|FG002|Week 12 to End of Study|Other|0|||
170719791|NCT00718718|616977816|FG003|Week 12 to End of Study|Other|1|||
170719792|NCT00718718|616977817|FG004|Week 12 to End of Study|Other|0|||
170719793|NCT00718718|616977818|FG005|Week 12 to End of Study|Other|0|||
170719794|NCT00718718|616977819|FG006|Week 12 to End of Study|Other|1|||
170719795|NCT00718718|616977820|FG007|Week 12 to End of Study|Other|0|||
170719796|NCT00718718|616977821|FG008|Week 12 to End of Study|Other|0|||
170719797|NCT00718718|616977822|FG009|Week 12 to End of Study|Other|0|||
170719798|NCT04369469|616977823|FG000|Overall Study|Lost to Follow-up|2|||
170719799|NCT04369469|616977824|FG001|Overall Study|Lost to Follow-up|4|||
170719800|NCT04369469|616977823|FG000|Overall Study|Physician Decision|2|||
170719801|NCT04369469|616977824|FG001|Overall Study|Physician Decision|1|||
170719802|NCT04369469|616977823|FG000|Overall Study|Withdrawal by Subject|2|||
170830798|NCT03062449|617390141|FG001|Overall Study|Withdrawal by Subject|1|||
170830799|NCT05923112|617390143|FG000|Overall Study|Protocol Violation|4|||
170719803|NCT04369469|616977824|FG001|Overall Study|Withdrawal by Subject|3|||
170830800|NCT05923112|617390143|FG000|Overall Study|No informed consent on publication of study results|243|||
170830801|NCT02053610|617390144|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
170830802|NCT02053610|617390145|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
170830803|NCT02053610|617390144|FG000|Overall Study|Withdrew Consent|2|||
170830804|NCT02053610|617390145|FG001|Overall Study|Withdrew Consent|9|||
170830805|NCT02053610|617390144|FG000|Overall Study|Death|5|||
170830806|NCT02053610|617390145|FG001|Overall Study|Death|5|||
170830807|NCT02053610|617390144|FG000|Overall Study|Administrative/Other|1|||
170830808|NCT02053610|617390145|FG001|Overall Study|Administrative/Other|1|||
170830809|NCT02053610|617390144|FG000|Overall Study|Disease Progression|2|||
170830810|NCT02053610|617390145|FG001|Overall Study|Disease Progression|3|||
170830811|NCT02053610|617390144|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
170830812|NCT02053610|617390145|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
170830813|NCT02053610|617390144|FG000|Overall Study|Did not Receive Treatment|4|||
170830814|NCT02053610|617390145|FG001|Overall Study|Did not Receive Treatment|2|||
170830815|NCT02053610|617390144|FG000|Overall Study|Insufficient Therapeutic Response|1|||
170830816|NCT02053610|617390145|FG001|Overall Study|Insufficient Therapeutic Response|1|||
170719804|NCT04369469|616977823|FG000|Overall Study|Adverse Event|1|||
170719805|NCT04369469|616977824|FG001|Overall Study|Adverse Event|0|||
170719806|NCT04369469|616977823|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
170719807|NCT04369469|616977824|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
170719808|NCT04369469|616977823|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
170719809|NCT04369469|616977824|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
170719810|NCT04369469|616977823|FG000|Overall Study|Unable to Provide Consent|0|||
170830817|NCT02053610|617390144|FG000|Overall Study|Violation of Selection Criteria|1|||
170830818|NCT02053610|617390145|FG001|Overall Study|Violation of Selection Criteria|0|||
170830819|NCT02641587|617390146|FG000|Confinement Period|Adverse Event|1|||
170719811|NCT04369469|616977824|FG001|Overall Study|Unable to Provide Consent|1|||
170719812|NCT03099382|616977827|FG000|Overall Study|Protocol Violation|2|||
170719813|NCT03099382|616977828|FG001|Overall Study|Protocol Violation|3|||
170719814|NCT01802411|616977830|FG000|Overall Study|Death|2|||
170830820|NCT02641587|617390147|FG001|Confinement Period|Adverse Event|0|||
170830821|NCT02641587|617390146|FG000|Confinement Period|Withdrawal by Subject|2|||
170830822|NCT02641587|617390147|FG001|Confinement Period|Withdrawal by Subject|1|||
170830823|NCT02641587|617390146|FG000|Ambulatory Period|Withdrawal by Subject|1|||
170830824|NCT02641587|617390147|FG001|Ambulatory Period|Withdrawal by Subject|0|||
170719815|NCT01802411|616977831|FG001|Overall Study|Death|1|||
170719816|NCT01802411|616977830|FG000|Overall Study|Adverse Event|2|||
170719817|NCT01802411|616977831|FG001|Overall Study|Adverse Event|7|||
170719818|NCT01802411|616977830|FG000|Overall Study|Lack of Efficacy|8|||
170719819|NCT01802411|616977831|FG001|Overall Study|Lack of Efficacy|10|||
170719820|NCT01802411|616977830|FG000|Overall Study|Withdrawal by Subject|0|||
170719821|NCT01802411|616977831|FG001|Overall Study|Withdrawal by Subject|2|||
170719822|NCT01802411|616977830|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
170719823|NCT01802411|616977831|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
170719824|NCT01802411|616977830|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
170719825|NCT01802411|616977831|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
170719826|NCT01802411|616977830|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
170719827|NCT01802411|616977831|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
170719828|NCT02663128|616977832|FG000|Period 2|Physician Decision|0|||
170719829|NCT02663128|616977833|FG001|Period 2|Physician Decision|0|||
170719830|NCT02663128|616977834|FG002|Period 2|Physician Decision|0|||
170719831|NCT02663128|616977835|FG003|Period 2|Physician Decision|0|||
170719832|NCT02663128|616977836|FG004|Period 2|Physician Decision|1|||
170719833|NCT02663128|616977837|FG005|Period 2|Physician Decision|0|||
170719834|NCT02715765|616977845|FG000|Overall Study|Study Termination|3|||
170719835|NCT02715765|616977846|FG001|Overall Study|Study Termination|0|||
170719836|NCT02715765|616977847|FG002|Overall Study|Study Termination|0|||
170719837|NCT04095858|616977848|FG000|Overall Study|Death|1|||
170719838|NCT04095858|616977849|FG001|Overall Study|Death|0|||
170719839|NCT04095858|616977848|FG000|Overall Study|Study terminated by Sponsor|2|||
170719840|NCT04095858|616977849|FG001|Overall Study|Study terminated by Sponsor|4|||
170719841|NCT01344460|616977850|FG000|Overall Study|Withdrawal by Subject|1|||
170719842|NCT01344460|616977850|FG000|Overall Study|Lost to Follow-up|2|||
170719843|NCT02120924|616977852|FG000|Overall Study|Lack of Efficacy|1|||
170719844|NCT02120924|616977853|FG001|Overall Study|Lack of Efficacy|2|||
170719845|NCT02120924|616977854|FG002|Overall Study|Lack of Efficacy|3|||
170719846|NCT02120924|616977852|FG000|Overall Study|Adverse Event|0|||
170719847|NCT02120924|616977853|FG001|Overall Study|Adverse Event|1|||
170719848|NCT02120924|616977854|FG002|Overall Study|Adverse Event|3|||
170719849|NCT02120924|616977852|FG000|Overall Study|Withdrawal by Subject|16|||
170719850|NCT02120924|616977853|FG001|Overall Study|Withdrawal by Subject|20|||
170719851|NCT02120924|616977854|FG002|Overall Study|Withdrawal by Subject|8|||
170719852|NCT02120924|616977852|FG000|Overall Study|Lost to Follow-up|14|||
170719853|NCT02120924|616977853|FG001|Overall Study|Lost to Follow-up|14|||
170719854|NCT02120924|616977854|FG002|Overall Study|Lost to Follow-up|11|||
170719855|NCT02120924|616977852|FG000|Overall Study|Pregnancy|2|||
170719856|NCT02120924|616977853|FG001|Overall Study|Pregnancy|0|||
170719857|NCT02120924|616977854|FG002|Overall Study|Pregnancy|0|||
170719858|NCT02120924|616977852|FG000|Overall Study|Protocol Violation|3|||
170719859|NCT02120924|616977853|FG001|Overall Study|Protocol Violation|7|||
170719860|NCT02120924|616977854|FG002|Overall Study|Protocol Violation|2|||
170719861|NCT02120924|616977852|FG000|Overall Study|Physician Decision|0|||
170719862|NCT02120924|616977853|FG001|Overall Study|Physician Decision|1|||
170719863|NCT02120924|616977854|FG002|Overall Study|Physician Decision|1|||
170719864|NCT02120924|616977852|FG000|Overall Study|Death|1|||
170719865|NCT02120924|616977853|FG001|Overall Study|Death|0|||
170719866|NCT02120924|616977854|FG002|Overall Study|Death|0|||
170719867|NCT02120924|616977852|FG000|Overall Study|Compliance with IP|5|||
170719868|NCT02120924|616977853|FG001|Overall Study|Compliance with IP|1|||
170719869|NCT02120924|616977854|FG002|Overall Study|Compliance with IP|1|||
170719870|NCT03483623|616977855|FG000|Overall Study|43 complete sets achieved|1|||
170719871|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
170719872|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
170719873|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
170719874|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
170719875|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
170719876|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
170719877|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
170719878|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
170719879|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
170719880|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
170719881|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
170719882|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
170719883|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
170719884|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
170719885|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
170719886|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
170719887|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
170719888|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
170719889|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
170719890|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
170719891|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
170719892|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
170719893|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
170719894|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
170719895|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
170719896|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
170719897|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
170719898|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
170719899|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
170719900|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
170719901|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
170719902|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
170719903|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
170719904|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
170719905|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
170719906|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
170719907|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
170719908|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
170719909|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
170719910|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
170719911|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
170719912|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
170719913|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
170719914|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
170719915|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
170719916|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
170719917|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
170719918|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
170719919|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
170719920|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
170719921|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
170719922|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
170719923|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
170719924|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
170719925|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
170719926|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
170719927|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
170719928|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
170719929|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
170719930|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
170719931|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
170719932|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
170719933|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
170719934|NCT01884350|616977856|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
170719935|NCT01884350|616977857|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
170719936|NCT01884350|616977858|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
170719937|NCT03277313|616977859|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
170719938|NCT03277313|616977860|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
170719939|NCT03277313|616977859|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
170719940|NCT03277313|616977860|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
170719941|NCT03277313|616977859|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
170719942|NCT03277313|616977860|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
170719943|NCT03277313|616977859|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
170719944|NCT03277313|616977860|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
170719945|NCT03277313|616977859|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
170719946|NCT03277313|616977860|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
170719947|NCT00363766|616977861|FG000|Overall Study|Progressive Disease|15|||
170719948|NCT00363766|616977862|FG001|Overall Study|Progressive Disease|9|||
170830825|NCT00781937|617390149|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
170830826|NCT00781937|617390150|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
170830827|NCT00781937|617390149|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
170830828|NCT00781937|617390150|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
170830829|NCT00781937|617390149|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
170719949|NCT00363766|616977861|FG000|Overall Study|Adverse Event|10|||
170719950|NCT00363766|616977862|FG001|Overall Study|Adverse Event|2|||
170719951|NCT00363766|616977861|FG000|Overall Study|Disease Related Death|1|||
170719952|NCT00363766|616977862|FG001|Overall Study|Disease Related Death|3|||
170719953|NCT00363766|616977861|FG000|Overall Study|Not Disease Related Death|3|||
170719954|NCT00363766|616977862|FG001|Overall Study|Not Disease Related Death|4|||
170719955|NCT00363766|616977861|FG000|Overall Study|Withdrawal by Subject|2|||
170719956|NCT00363766|616977862|FG001|Overall Study|Withdrawal by Subject|0|||
170719957|NCT00363766|616977861|FG000|Overall Study|Physician Decision|1|||
170719958|NCT00363766|616977862|FG001|Overall Study|Physician Decision|2|||
170719959|NCT02730819|616977866|FG000|Overall Study|Lost to Follow-up|9|||
170719960|NCT01983293|616979731|FG000|Overall Study|Withdrawal by Subject|29|||
170719961|NCT01983293|616979732|FG001|Overall Study|Withdrawal by Subject|15|||
170719962|NCT01983293|616979731|FG000|Overall Study|Missing 12-month visit|3|||
170719963|NCT01983293|616979732|FG001|Overall Study|Missing 12-month visit|3|||
170719964|NCT01983293|616979731|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
170719965|NCT01983293|616979732|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
170719966|NCT03147248|616979734|FG000|Overall Study|Adverse Event|0|||
170719967|NCT03147248|616979735|FG001|Overall Study|Adverse Event|2|||
170719968|NCT03147248|616979736|FG002|Overall Study|Adverse Event|2|||
170719969|NCT03147248|616979737|FG003|Overall Study|Adverse Event|2|||
170719970|NCT03147248|616979738|FG004|Overall Study|Adverse Event|6|||
170719971|NCT03147248|616979739|FG005|Overall Study|Adverse Event|11|||
170719972|NCT03147248|616979734|FG000|Overall Study|Disease progression|1|||
170719973|NCT03147248|616979735|FG001|Overall Study|Disease progression|0|||
170719974|NCT03147248|616979736|FG002|Overall Study|Disease progression|0|||
170719975|NCT03147248|616979737|FG003|Overall Study|Disease progression|0|||
170719976|NCT03147248|616979738|FG004|Overall Study|Disease progression|0|||
170719977|NCT03147248|616979739|FG005|Overall Study|Disease progression|2|||
170719978|NCT03147248|616979734|FG000|Overall Study|Withdrawal by Subject|0|||
170719979|NCT03147248|616979735|FG001|Overall Study|Withdrawal by Subject|0|||
170719980|NCT03147248|616979736|FG002|Overall Study|Withdrawal by Subject|0|||
170719981|NCT03147248|616979737|FG003|Overall Study|Withdrawal by Subject|0|||
170719982|NCT03147248|616979738|FG004|Overall Study|Withdrawal by Subject|12|||
170719983|NCT03147248|616979739|FG005|Overall Study|Withdrawal by Subject|9|||
170719984|NCT03147248|616979734|FG000|Overall Study|Protocol Violation|0|||
170719985|NCT03147248|616979735|FG001|Overall Study|Protocol Violation|0|||
170719986|NCT03147248|616979736|FG002|Overall Study|Protocol Violation|0|||
170719987|NCT03147248|616979737|FG003|Overall Study|Protocol Violation|0|||
170719988|NCT03147248|616979738|FG004|Overall Study|Protocol Violation|2|||
170719989|NCT03147248|616979739|FG005|Overall Study|Protocol Violation|0|||
170719990|NCT03147248|616979734|FG000|Overall Study|Lost to Follow-up|0|||
170719991|NCT03147248|616979735|FG001|Overall Study|Lost to Follow-up|0|||
170719992|NCT03147248|616979736|FG002|Overall Study|Lost to Follow-up|0|||
170719993|NCT03147248|616979737|FG003|Overall Study|Lost to Follow-up|0|||
170719994|NCT03147248|616979738|FG004|Overall Study|Lost to Follow-up|2|||
170719995|NCT03147248|616979739|FG005|Overall Study|Lost to Follow-up|0|||
170719996|NCT03147248|616979734|FG000|Overall Study|Pregnancy|0|||
170719997|NCT03147248|616979735|FG001|Overall Study|Pregnancy|0|||
170719998|NCT03147248|616979736|FG002|Overall Study|Pregnancy|0|||
170719999|NCT03147248|616979737|FG003|Overall Study|Pregnancy|0|||
170720000|NCT03147248|616979738|FG004|Overall Study|Pregnancy|1|||
170720001|NCT03147248|616979739|FG005|Overall Study|Pregnancy|0|||
170720002|NCT03147248|616979734|FG000|Overall Study|Death|0|||
170720003|NCT03147248|616979735|FG001|Overall Study|Death|0|||
170720004|NCT03147248|616979736|FG002|Overall Study|Death|0|||
170720005|NCT03147248|616979737|FG003|Overall Study|Death|0|||
170720006|NCT03147248|616979738|FG004|Overall Study|Death|0|||
170720007|NCT03147248|616979739|FG005|Overall Study|Death|4|||
170720008|NCT03147248|616979734|FG000|Overall Study|Physician Decision|0|||
170720009|NCT03147248|616979735|FG001|Overall Study|Physician Decision|0|||
170720010|NCT03147248|616979736|FG002|Overall Study|Physician Decision|0|||
170720011|NCT03147248|616979737|FG003|Overall Study|Physician Decision|0|||
170720012|NCT03147248|616979738|FG004|Overall Study|Physician Decision|2|||
170720013|NCT03147248|616979739|FG005|Overall Study|Physician Decision|4|||
170720014|NCT03147248|616979734|FG000|Overall Study|Prolonged Dosing Interval|0|||
170720015|NCT03147248|616979735|FG001|Overall Study|Prolonged Dosing Interval|0|||
170720016|NCT03147248|616979736|FG002|Overall Study|Prolonged Dosing Interval|0|||
170720017|NCT03147248|616979737|FG003|Overall Study|Prolonged Dosing Interval|0|||
170720018|NCT03147248|616979738|FG004|Overall Study|Prolonged Dosing Interval|1|||
170720019|NCT03147248|616979739|FG005|Overall Study|Prolonged Dosing Interval|1|||
170720020|NCT03750552|616979740|FG000|Overall Study|Adverse Event|5|||
170720021|NCT03750552|616979741|FG001|Overall Study|Adverse Event|1|||
170720022|NCT03750552|616979740|FG000|Overall Study|Withdrawal by Subject|1|||
170720023|NCT03750552|616979741|FG001|Overall Study|Withdrawal by Subject|1|||
170720024|NCT03750552|616979740|FG000|Overall Study|Other|2|||
170720025|NCT03750552|616979741|FG001|Overall Study|Other|0|||
170720026|NCT00773968|616979744|FG000|Overall Study|Adverse Event|2|||
170720027|NCT00773968|616979744|FG000|Overall Study|Death|1|||
170720028|NCT00773968|616979744|FG000|Overall Study|Failure to Return|2|||
170720029|NCT00773968|616979744|FG000|Overall Study|Lack of Efficacy|3|||
170720030|NCT00773968|616979744|FG000|Overall Study|Protocol Violation|1|||
170720031|NCT00773968|616979744|FG000|Overall Study|Withdrawal by Subject|11|||
170720032|NCT00773968|616979744|FG000|Overall Study|Screen Failure|17|||
170720033|NCT00773968|616979744|FG000|Overall Study|Other|8|||
170720034|NCT01949311|616979746|FG000|Overall Study|Lost to Follow-up|73|||
170720035|NCT01949311|616979746|FG000|Overall Study|Terminated by Sponsor|708|||
170720036|NCT01949311|616979746|FG000|Overall Study|Withdrawal by Subject|375|||
170720037|NCT01949311|616979746|FG000|Overall Study|Lack of Efficacy|50|||
170720038|NCT01949311|616979746|FG000|Overall Study|Protocol Deviation|34|||
170720039|NCT01949311|616979746|FG000|Overall Study|Pregnancy|20|||
170720040|NCT01949311|616979746|FG000|Overall Study|Physician Decision|9|||
170720041|NCT01949311|616979746|FG000|Overall Study|Other|4|||
170720042|NCT01949311|616979746|FG000|Overall Study|Adverse Event|107|||
170720043|NCT03461003|616979751|FG000|Overall Study|Lost to Follow-up|2|||
170720044|NCT03461003|616979752|FG001|Overall Study|Lost to Follow-up|2|||
170720045|NCT03461003|616979751|FG000|Overall Study|Withdrawal by Subject|3|||
170720046|NCT03461003|616979752|FG001|Overall Study|Withdrawal by Subject|1|||
170720047|NCT03508843|616979753|FG000|Overall Study|Withdrawal by Subject|1|||
170720048|NCT03508843|616979753|FG000|Overall Study|technical difficulties|2|||
170720049|NCT04757649|616979756|FG000|Overall Study|Withdrawal by Subject|1|||
170720050|NCT04757649|616979756|FG000|Overall Study|Adverse Event|1|||
170720051|NCT03349710|616979757|FG000|Treatment Period|Death|0|||
170720052|NCT03349710|616979758|FG001|Treatment Period|Death|0|||
170720053|NCT03349710|616979759|FG002|Treatment Period|Death|1|||
170720054|NCT03349710|616979760|FG003|Treatment Period|Death|0|||
170720055|NCT03349710|616979757|FG000|Treatment Period|Disease Progression|0|||
170720056|NCT03349710|616979758|FG001|Treatment Period|Disease Progression|2|||
170720057|NCT03349710|616979759|FG002|Treatment Period|Disease Progression|0|||
170720058|NCT03349710|616979760|FG003|Treatment Period|Disease Progression|1|||
170720059|NCT03349710|616979757|FG000|Treatment Period|Study Drug Toxicity|1|||
170720060|NCT03349710|616979758|FG001|Treatment Period|Study Drug Toxicity|0|||
170720061|NCT03349710|616979759|FG002|Treatment Period|Study Drug Toxicity|1|||
170720062|NCT03349710|616979760|FG003|Treatment Period|Study Drug Toxicity|1|||
170720063|NCT03349710|616979757|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
170720064|NCT03349710|616979758|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
170720065|NCT03349710|616979759|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
170720066|NCT03349710|616979760|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
170720067|NCT03349710|616979757|FG000|Treatment Period|admin reason by sponsor|0|||
170720068|NCT03349710|616979758|FG001|Treatment Period|admin reason by sponsor|7|||
170720069|NCT03349710|616979759|FG002|Treatment Period|admin reason by sponsor|0|||
170720070|NCT03349710|616979760|FG003|Treatment Period|admin reason by sponsor|19|||
170720071|NCT03349710|616979757|FG000|Treatment Period|Other Reason|2|||
170720072|NCT03349710|616979758|FG001|Treatment Period|Other Reason|0|||
170720073|NCT03349710|616979759|FG002|Treatment Period|Other Reason|2|||
170720074|NCT03349710|616979760|FG003|Treatment Period|Other Reason|1|||
170720075|NCT03349710|616979757|FG000|Treatment Period|completed|6|||
170720076|NCT03349710|616979758|FG001|Treatment Period|completed|0|||
170720077|NCT03349710|616979759|FG002|Treatment Period|completed|18|||
170720078|NCT03349710|616979760|FG003|Treatment Period|completed|1|||
170720079|NCT03349710|616979757|FG000|Treatment Period|participant request to discontinue|0|||
170720080|NCT03349710|616979758|FG001|Treatment Period|participant request to discontinue|0|||
170720081|NCT03349710|616979759|FG002|Treatment Period|participant request to discontinue|4|||
170720082|NCT03349710|616979760|FG003|Treatment Period|participant request to discontinue|0|||
170720083|NCT03349710|616979757|FG000|Treatment Period|participant withdrew consent|1|||
170720084|NCT03349710|616979758|FG001|Treatment Period|participant withdrew consent|0|||
170720085|NCT03349710|616979759|FG002|Treatment Period|participant withdrew consent|0|||
170720086|NCT03349710|616979760|FG003|Treatment Period|participant withdrew consent|0|||
170720087|NCT00695903|616979761|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
170720088|NCT00695903|616979762|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
170720089|NCT00695903|616979761|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
170720090|NCT00695903|616979762|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
170720091|NCT00695903|616979761|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
170720092|NCT00695903|616979762|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
170720093|NCT00695903|616979761|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
170720094|NCT00695903|616979762|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
170720095|NCT00695903|616979761|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
170720096|NCT00695903|616979762|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
170720097|NCT00695903|616979761|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
170720098|NCT00695903|616979762|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
170720099|NCT00695903|616979761|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
170720100|NCT00695903|616979762|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
170720101|NCT00695903|616979761|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
170720102|NCT00695903|616979762|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
170720103|NCT00695903|616979761|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
170720104|NCT00695903|616979762|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
170720105|NCT01296568|616979768|FG000|Continued Access Phase|Lost to Follow-up|1|||
170720106|NCT01296568|616979768|FG000|Continued Access Phase|Withdrawal by Subject|1|||
170720107|NCT01296568|616979768|FG000|Continued Access Phase|Disease Progression|1|||
170720108|NCT04723576|616979769|FG000|Overall Study|Withdrawal by Subject|2133|||
170720109|NCT04723576|616979770|FG001|Overall Study|Withdrawal by Subject|3234|||
170720110|NCT00784810|616979773|FG000|Overall Study|Adverse Event|32|||
170720111|NCT00784810|616979774|FG001|Overall Study|Adverse Event|20|||
170720112|NCT00784810|616979773|FG000|Overall Study|Lack of Efficacy|14|||
170720113|NCT00784810|616979774|FG001|Overall Study|Lack of Efficacy|11|||
170720114|NCT00784810|616979773|FG000|Overall Study|Withdrawal by Subject|11|||
170720115|NCT00784810|616979774|FG001|Overall Study|Withdrawal by Subject|9|||
170720116|NCT00784810|616979773|FG000|Overall Study|Administrative|5|||
170720117|NCT00784810|616979774|FG001|Overall Study|Administrative|8|||
170720118|NCT00784810|616979773|FG000|Overall Study|Lost to Follow-up|1|||
170720119|NCT00784810|616979774|FG001|Overall Study|Lost to Follow-up|1|||
170720120|NCT02862106|616979775|FG000|Overall Study|Adverse Event|4|||
170720121|NCT02862106|616979776|FG001|Overall Study|Adverse Event|0|||
170720122|NCT02862106|616979775|FG000|Overall Study|Protocol Violation|16|||
170720123|NCT02862106|616979776|FG001|Overall Study|Protocol Violation|1|||
170720124|NCT02862106|616979775|FG000|Overall Study|Lost to Follow-up|15|||
170720125|NCT02862106|616979776|FG001|Overall Study|Lost to Follow-up|5|||
170720126|NCT02862106|616979775|FG000|Overall Study|Withdrawal by Subject|2|||
170720127|NCT02862106|616979776|FG001|Overall Study|Withdrawal by Subject|0|||
170720128|NCT02862106|616979775|FG000|Overall Study|Subjects moved to other city|1|||
170720129|NCT02862106|616979776|FG001|Overall Study|Subjects moved to other city|0|||
170720130|NCT04420689|616979779|FG000|Overall Study|COVID-19 related hospitalization|0|||
170720131|NCT04420689|616979780|FG001|Overall Study|COVID-19 related hospitalization|0|||
170720132|NCT04420689|616979781|FG002|Overall Study|COVID-19 related hospitalization|0|||
170720133|NCT04420689|616979782|FG003|Overall Study|COVID-19 related hospitalization|0|||
170720134|NCT04420689|616979783|FG004|Overall Study|COVID-19 related hospitalization|1|||
170720135|NCT04420689|616979784|FG005|Overall Study|COVID-19 related hospitalization|0|||
170720136|NCT04420689|616979785|FG006|Overall Study|COVID-19 related hospitalization|0|||
170720137|NCT04420689|616979779|FG000|Overall Study|Physician Decision|0|||
170720138|NCT04420689|616979780|FG001|Overall Study|Physician Decision|0|||
170720139|NCT04420689|616979781|FG002|Overall Study|Physician Decision|0|||
170720140|NCT04420689|616979782|FG003|Overall Study|Physician Decision|0|||
170720141|NCT04420689|616979783|FG004|Overall Study|Physician Decision|0|||
170720142|NCT04420689|616979784|FG005|Overall Study|Physician Decision|1|||
170720143|NCT04420689|616979785|FG006|Overall Study|Physician Decision|0|||
170720144|NCT04360824|616979788|FG000|Overall Study|Withdrawal by Subject|2|||
170720145|NCT04360824|616979789|FG001|Overall Study|Withdrawal by Subject|1|||
170720146|NCT04360824|616979788|FG000|Overall Study|Did not receive assigned treatment|1|||
170720147|NCT04360824|616979789|FG001|Overall Study|Did not receive assigned treatment|3|||
170720148|NCT00377676|616979793|FG000|Overall Study|Adverse Event|498|||
170720149|NCT00377676|616979794|FG001|Overall Study|Adverse Event|107|||
170720150|NCT00377676|616979793|FG000|Overall Study|Protocol Violation|33|||
170720151|NCT00377676|616979794|FG001|Overall Study|Protocol Violation|27|||
170720152|NCT00377676|616979793|FG000|Overall Study|Death|5|||
170720153|NCT00377676|616979794|FG001|Overall Study|Death|2|||
170720154|NCT00377676|616979793|FG000|Overall Study|Withdrawal by Subject|187|||
170720155|NCT00377676|616979794|FG001|Overall Study|Withdrawal by Subject|72|||
170720156|NCT00377676|616979793|FG000|Overall Study|Lost to Follow-up|120|||
170720157|NCT00377676|616979794|FG001|Overall Study|Lost to Follow-up|56|||
170720158|NCT00377676|616979793|FG000|Overall Study|Other|118|||
170720159|NCT00377676|616979794|FG001|Overall Study|Other|58|||
170720160|NCT03834779|616979800|FG000|Overall Study|Death|1|||
170830830|NCT00781937|617390150|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
170830831|NCT00781937|617390149|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
170830832|NCT00781937|617390150|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
170830833|NCT00781937|617390149|FG000|Main Trial Period Through Week 56|Unclassified|10|||
170830834|NCT00781937|617390150|FG001|Main Trial Period Through Week 56|Unclassified|15|||
170830835|NCT00781937|617390149|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
170830836|NCT00781937|617390150|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
170720161|NCT03834779|616979801|FG001|Overall Study|Death|2|||
170720162|NCT03834779|616979800|FG000|Overall Study|Lost to Follow-up|6|||
170720163|NCT03834779|616979801|FG001|Overall Study|Lost to Follow-up|4|||
170720164|NCT02844946|616979807|FG000|Overall Study|Lost to Follow-up|7|||
170720165|NCT02844946|616979808|FG001|Overall Study|Lost to Follow-up|0|||
170720166|NCT03927950|616979810|FG000|Overall Study|Adverse Event|9|||
170720167|NCT02528214|616979815|FG000|Overall Study|Protocol Violation|0|||
170720168|NCT02528214|616979816|FG001|Overall Study|Protocol Violation|1|||
170720169|NCT02528214|616979815|FG000|Overall Study|Adverse Event|0|||
170720170|NCT02528214|616979816|FG001|Overall Study|Adverse Event|1|||
170720171|NCT02528214|616979815|FG000|Overall Study|Other than specified above|0|||
170720172|NCT02528214|616979816|FG001|Overall Study|Other than specified above|1|||
170720173|NCT00407537|616979817|FG000|Overall Study|Death|5|||
170720174|NCT00407537|616979818|FG001|Overall Study|Death|2|||
170720175|NCT00407537|616979817|FG000|Overall Study|Adverse Event|36|||
170720176|NCT00407537|616979818|FG001|Overall Study|Adverse Event|0|||
170720177|NCT00407537|616979817|FG000|Overall Study|Lost to Follow-up|12|||
170720178|NCT00407537|616979818|FG001|Overall Study|Lost to Follow-up|19|||
170720179|NCT00407537|616979817|FG000|Overall Study|Other|6|||
170720180|NCT00407537|616979818|FG001|Overall Study|Other|7|||
170720181|NCT00407537|616979817|FG000|Overall Study|Withdrawal by Subject|34|||
170720182|NCT00407537|616979818|FG001|Overall Study|Withdrawal by Subject|16|||
170720183|NCT05046795|616979823|FG000|Overall Study|Adverse Event|13|||
170720184|NCT05046795|616979824|FG001|Overall Study|Adverse Event|15|||
170720185|NCT05046795|616979823|FG000|Overall Study|Withdrawal by Subject|4|||
170720186|NCT05046795|616979824|FG001|Overall Study|Withdrawal by Subject|7|||
170720187|NCT05046795|616979823|FG000|Overall Study|Physician Decision|1|||
170720188|NCT05046795|616979824|FG001|Overall Study|Physician Decision|2|||
170720189|NCT05046795|616979823|FG000|Overall Study|Protocol Violation|1|||
170720190|NCT05046795|616979824|FG001|Overall Study|Protocol Violation|2|||
170720191|NCT05046795|616979823|FG000|Overall Study|Death|1|||
170720192|NCT05046795|616979824|FG001|Overall Study|Death|0|||
170720193|NCT05046795|616979823|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
170720194|NCT05046795|616979824|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
170720195|NCT00553267|616979826|FG000|Overall Study|Adverse Event|8|||
170720196|NCT00553267|616979827|FG001|Overall Study|Adverse Event|10|||
170720197|NCT00553267|616979828|FG002|Overall Study|Adverse Event|5|||
170720198|NCT00553267|616979826|FG000|Overall Study|Non compliant with protocol|3|||
170720199|NCT00553267|616979827|FG001|Overall Study|Non compliant with protocol|3|||
170720200|NCT00553267|616979828|FG002|Overall Study|Non compliant with protocol|2|||
170720201|NCT00553267|616979826|FG000|Overall Study|Lost to Follow-up|0|||
170720202|NCT00553267|616979827|FG001|Overall Study|Lost to Follow-up|0|||
170720203|NCT00553267|616979828|FG002|Overall Study|Lost to Follow-up|1|||
170720204|NCT00553267|616979826|FG000|Overall Study|Consent withdrawn|2|||
170720205|NCT00553267|616979827|FG001|Overall Study|Consent withdrawn|3|||
170720206|NCT00553267|616979828|FG002|Overall Study|Consent withdrawn|1|||
170720207|NCT00553267|616979826|FG000|Overall Study|Specified category|1|||
170720208|NCT00553267|616979827|FG001|Overall Study|Specified category|2|||
170720209|NCT00553267|616979828|FG002|Overall Study|Specified category|1|||
170720210|NCT04389840|616979829|FG000|Overall Study|Adverse Event|0|||
170720211|NCT04389840|616979830|FG001|Overall Study|Adverse Event|0|||
170720212|NCT04389840|616979831|FG002|Overall Study|Adverse Event|0|||
170720213|NCT04389840|616979832|FG003|Overall Study|Adverse Event|1|||
170720214|NCT04389840|616979833|FG004|Overall Study|Adverse Event|0|||
170720215|NCT04389840|616979834|FG005|Overall Study|Adverse Event|0|||
170720216|NCT04389840|616979829|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
170720217|NCT04389840|616979830|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
170720218|NCT04389840|616979831|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
170720219|NCT04389840|616979832|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
170720220|NCT04389840|616979833|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
170720221|NCT04389840|616979834|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
170720222|NCT04389840|616979829|FG000|Overall Study|Death|0|||
170720223|NCT04389840|616979830|FG001|Overall Study|Death|1|||
170720224|NCT04389840|616979831|FG002|Overall Study|Death|0|||
170720225|NCT04389840|616979832|FG003|Overall Study|Death|0|||
170720226|NCT04389840|616979833|FG004|Overall Study|Death|0|||
170720227|NCT04389840|616979834|FG005|Overall Study|Death|0|||
170720228|NCT01618864|616979835|FG000|Overall Study|Withdrawal by Subject|2|||
170720229|NCT01618864|616979835|FG000|Overall Study|Lost to Follow-up|2|||
170720230|NCT00817089|616979836|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
170720231|NCT00817089|616979837|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
170720232|NCT00817089|616979838|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
170720233|NCT00817089|616979839|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
170720234|NCT00817089|616979836|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
170720235|NCT00817089|616979837|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
170720236|NCT00817089|616979838|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
170720237|NCT00817089|616979839|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
170720238|NCT00709722|616979840|FG000|Overall Study|Adverse Event|1|||
170720239|NCT01306162|616979841|FG000|Period 1|Adverse Event|0|||
170720240|NCT01306162|616979842|FG001|Period 1|Adverse Event|0|||
170720241|NCT01306162|616979843|FG002|Period 1|Adverse Event|0|||
170720242|NCT01306162|616979844|FG003|Period 1|Adverse Event|1|||
170830837|NCT00781937|617390149|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
170830838|NCT00781937|617390150|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
170830839|NCT03305809|617390154|FG000|Overall Study|Adverse Event|2|||
170830840|NCT03305809|617390155|FG001|Overall Study|Adverse Event|2|||
170830841|NCT03305809|617390156|FG002|Overall Study|Adverse Event|6|||
170830842|NCT03305809|617390157|FG003|Overall Study|Adverse Event|6|||
170830843|NCT03305809|617390154|FG000|Overall Study|Death|0|||
170830844|NCT03305809|617390155|FG001|Overall Study|Death|0|||
170830845|NCT03305809|617390156|FG002|Overall Study|Death|1|||
170830846|NCT03305809|617390157|FG003|Overall Study|Death|1|||
170830847|NCT03305809|617390154|FG000|Overall Study|Lost to Follow-up|1|||
170830848|NCT03305809|617390155|FG001|Overall Study|Lost to Follow-up|2|||
170830849|NCT03305809|617390156|FG002|Overall Study|Lost to Follow-up|0|||
170830850|NCT03305809|617390157|FG003|Overall Study|Lost to Follow-up|0|||
170830851|NCT03305809|617390154|FG000|Overall Study|Sponsor Decision|1|||
170830852|NCT03305809|617390155|FG001|Overall Study|Sponsor Decision|0|||
170830853|NCT03305809|617390156|FG002|Overall Study|Sponsor Decision|1|||
170830854|NCT03305809|617390157|FG003|Overall Study|Sponsor Decision|8|||
170830855|NCT03305809|617390154|FG000|Overall Study|Physician Decision|0|||
170830856|NCT03305809|617390155|FG001|Overall Study|Physician Decision|0|||
170830857|NCT03305809|617390156|FG002|Overall Study|Physician Decision|2|||
170830858|NCT03305809|617390157|FG003|Overall Study|Physician Decision|4|||
170830859|NCT03305809|617390154|FG000|Overall Study|Progressive Disease|0|||
170830860|NCT03305809|617390155|FG001|Overall Study|Progressive Disease|0|||
170830861|NCT03305809|617390156|FG002|Overall Study|Progressive Disease|1|||
170830862|NCT03305809|617390157|FG003|Overall Study|Progressive Disease|0|||
170830863|NCT03305809|617390154|FG000|Overall Study|Protocol Violation|1|||
170830864|NCT03305809|617390155|FG001|Overall Study|Protocol Violation|0|||
170830865|NCT03305809|617390156|FG002|Overall Study|Protocol Violation|2|||
170830866|NCT03305809|617390157|FG003|Overall Study|Protocol Violation|3|||
170830867|NCT03305809|617390154|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
170830868|NCT03305809|617390155|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
170830869|NCT03305809|617390156|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
170830870|NCT03305809|617390157|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
170830871|NCT03305809|617390154|FG000|Overall Study|Withdrawal by Subject|2|||
170830872|NCT03305809|617390155|FG001|Overall Study|Withdrawal by Subject|4|||
170830873|NCT03305809|617390156|FG002|Overall Study|Withdrawal by Subject|5|||
170830874|NCT03305809|617390157|FG003|Overall Study|Withdrawal by Subject|2|||
170830875|NCT03305809|617390154|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
170830876|NCT03305809|617390155|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
170720243|NCT01306162|616979841|FG000|Washout 1|Non-compliance to protocol|0|||
170720244|NCT01306162|616979842|FG001|Washout 1|Non-compliance to protocol|1|||
170720245|NCT01306162|616979843|FG002|Washout 1|Non-compliance to protocol|0|||
170720246|NCT01306162|616979844|FG003|Washout 1|Non-compliance to protocol|0|||
170720247|NCT04323436|616979845|FG000|Overall Study|Adverse Event|7|||
170720248|NCT04323436|616979846|FG001|Overall Study|Adverse Event|0|||
170720249|NCT04323436|616979847|FG002|Overall Study|Adverse Event|0|||
170720250|NCT04323436|616979845|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
170720251|NCT04323436|616979846|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
170720252|NCT04323436|616979847|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
170720253|NCT04323436|616979845|FG000|Overall Study|Death|1|||
170720254|NCT04323436|616979846|FG001|Overall Study|Death|0|||
170720255|NCT04323436|616979847|FG002|Overall Study|Death|0|||
170720256|NCT04323436|616979845|FG000|Overall Study|Physician Decision|2|||
170720257|NCT04323436|616979846|FG001|Overall Study|Physician Decision|0|||
170720258|NCT04323436|616979847|FG002|Overall Study|Physician Decision|0|||
170720259|NCT04323436|616979845|FG000|Overall Study|Progressive disease|10|||
170720260|NCT04323436|616979846|FG001|Overall Study|Progressive disease|0|||
170720261|NCT04323436|616979847|FG002|Overall Study|Progressive disease|0|||
170830877|NCT03305809|617390156|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
170830878|NCT03305809|617390157|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
170830879|NCT02536742|617390160|FG000|Overall Study|Did not start protocol therapy|1|||
170830880|NCT02536742|617390160|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
170830881|NCT01547117|617390162|FG000|Overall Study|Physician Decision|0|||
170830882|NCT01547117|617390163|FG001|Overall Study|Physician Decision|1|||
170830883|NCT01547117|617390164|FG002|Overall Study|Physician Decision|1|||
170830884|NCT01547117|617390165|FG003|Overall Study|Physician Decision|3|||
170830885|NCT01547117|617390162|FG000|Overall Study|Withdrawal by Subject|1|||
170830886|NCT01547117|617390163|FG001|Overall Study|Withdrawal by Subject|2|||
170830887|NCT01547117|617390164|FG002|Overall Study|Withdrawal by Subject|1|||
170830888|NCT01547117|617390165|FG003|Overall Study|Withdrawal by Subject|2|||
170830889|NCT01844726|617390166|FG000|Overall Study|Withdrawal by Subject|0|||
170830890|NCT01844726|617390167|FG001|Overall Study|Withdrawal by Subject|1|||
170830891|NCT01844726|617390166|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
170830892|NCT01844726|617390167|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
170830893|NCT01496365|617390168|FG000|Overall Study|Adverse Event|2|||
170830894|NCT01496365|617390169|FG001|Overall Study|Adverse Event|3|||
170830895|NCT01496365|617390170|FG002|Overall Study|Adverse Event|3|||
170830896|NCT01496365|617390171|FG003|Overall Study|Adverse Event|2|||
170830897|NCT01496365|617390172|FG004|Overall Study|Adverse Event|5|||
170830898|NCT01496365|617390173|FG005|Overall Study|Adverse Event|6|||
170830899|NCT01496365|617390174|FG006|Overall Study|Adverse Event|4|||
170830900|NCT01496365|617390168|FG000|Overall Study|Withdrawal by Subject|6|||
170830901|NCT01496365|617390169|FG001|Overall Study|Withdrawal by Subject|6|||
170830902|NCT01496365|617390170|FG002|Overall Study|Withdrawal by Subject|0|||
170830903|NCT01496365|617390171|FG003|Overall Study|Withdrawal by Subject|1|||
170830904|NCT01496365|617390172|FG004|Overall Study|Withdrawal by Subject|3|||
170830905|NCT01496365|617390173|FG005|Overall Study|Withdrawal by Subject|2|||
170830906|NCT01496365|617390174|FG006|Overall Study|Withdrawal by Subject|1|||
170830907|NCT01496365|617390168|FG000|Overall Study|Protocol Violation|2|||
170830908|NCT01496365|617390169|FG001|Overall Study|Protocol Violation|1|||
170830909|NCT01496365|617390170|FG002|Overall Study|Protocol Violation|1|||
170830910|NCT01496365|617390171|FG003|Overall Study|Protocol Violation|0|||
170830911|NCT01496365|617390172|FG004|Overall Study|Protocol Violation|0|||
170830912|NCT01496365|617390173|FG005|Overall Study|Protocol Violation|1|||
170830913|NCT01496365|617390174|FG006|Overall Study|Protocol Violation|0|||
170830914|NCT01496365|617390168|FG000|Overall Study|Lack of Efficacy|1|||
170720262|NCT04323436|616979845|FG000|Overall Study|Subject decision|3|||
170720263|NCT04323436|616979846|FG001|Overall Study|Subject decision|0|||
170720264|NCT04323436|616979847|FG002|Overall Study|Subject decision|0|||
170720265|NCT00142909|616979848|FG000|Randomization|Various Reasons|7|||
170720266|NCT00142909|616979849|FG001|Randomization|Various Reasons|10|||
170720267|NCT00142909|616979848|FG000|Medications Begin|Protocol Violation|2|||
170720268|NCT00142909|616979849|FG001|Medications Begin|Protocol Violation|0|||
170720269|NCT00142909|616979848|FG000|Medications Begin|Withdrawal by Subject|5|||
170720270|NCT00142909|616979849|FG001|Medications Begin|Withdrawal by Subject|3|||
170720271|NCT00142909|616979848|FG000|Medications Begin|Withdrawal by Subject|2|||
170720272|NCT00142909|616979849|FG001|Medications Begin|Withdrawal by Subject|0|||
170720273|NCT01660763|616979853|FG000|Overall Study|Lack of Efficacy|45|||
170720274|NCT01660763|616979854|FG001|Overall Study|Lack of Efficacy|50|||
170720275|NCT01660763|616979853|FG000|Overall Study|Adverse Event|22|||
170720276|NCT01660763|616979854|FG001|Overall Study|Adverse Event|7|||
170720277|NCT01660763|616979853|FG000|Overall Study|Protocol Violation|1|||
170720278|NCT01660763|616979854|FG001|Overall Study|Protocol Violation|0|||
170720279|NCT01660763|616979853|FG000|Overall Study|Withdrawal by Subject|4|||
170720280|NCT01660763|616979854|FG001|Overall Study|Withdrawal by Subject|0|||
170720281|NCT01660763|616979853|FG000|Overall Study|Patient ready for early discharge|28|||
170720282|NCT01660763|616979854|FG001|Overall Study|Patient ready for early discharge|4|||
170720283|NCT00345397|616979855|FG000|Overall Study|Death|1|||
170720284|NCT01870843|616979856|FG000|Overall Study|Adverse Event|10|||
170720285|NCT01870843|616979856|FG000|Overall Study|Lost to Follow-up|24|||
170720286|NCT01870843|616979856|FG000|Overall Study|Death|1|||
170720287|NCT01870843|616979856|FG000|Overall Study|Withdrawal by Subject|18|||
170720288|NCT01910519|616979857|FG000|Overall Study|Withdrawal by Subject|2|||
170720289|NCT01910519|616979858|FG001|Overall Study|Withdrawal by Subject|0|||
170720290|NCT01910519|616979857|FG000|Overall Study|Adverse Event|2|||
170720291|NCT01910519|616979858|FG001|Overall Study|Adverse Event|0|||
170720292|NCT04266028|616979859|FG000|Overall Study|Adverse Event|0|||
170720293|NCT04266028|616979860|FG001|Overall Study|Adverse Event|0|||
170720294|NCT04266028|616979861|FG002|Overall Study|Adverse Event|1|||
170720295|NCT04266028|616979862|FG003|Overall Study|Adverse Event|0|||
170720296|NCT04266028|616979863|FG004|Overall Study|Adverse Event|1|||
170720297|NCT04266028|616979864|FG005|Overall Study|Adverse Event|0|||
170720298|NCT04266028|616979865|FG006|Overall Study|Adverse Event|2|||
170720299|NCT04266028|616979866|FG007|Overall Study|Adverse Event|0|||
170720300|NCT04266028|616979859|FG000|Overall Study|temporary halt of the study|0|||
170720301|NCT04266028|616979860|FG001|Overall Study|temporary halt of the study|0|||
170720302|NCT04266028|616979861|FG002|Overall Study|temporary halt of the study|0|||
170720303|NCT04266028|616979862|FG003|Overall Study|temporary halt of the study|0|||
170720304|NCT04266028|616979863|FG004|Overall Study|temporary halt of the study|0|||
170720305|NCT04266028|616979864|FG005|Overall Study|temporary halt of the study|0|||
170720306|NCT04266028|616979865|FG006|Overall Study|temporary halt of the study|2|||
170720307|NCT04266028|616979866|FG007|Overall Study|temporary halt of the study|1|||
170720308|NCT04266028|616979859|FG000|Overall Study|Onset of birch pollen season|0|||
170720309|NCT04266028|616979860|FG001|Overall Study|Onset of birch pollen season|0|||
170720310|NCT04266028|616979861|FG002|Overall Study|Onset of birch pollen season|0|||
170720311|NCT04266028|616979862|FG003|Overall Study|Onset of birch pollen season|0|||
170720312|NCT04266028|616979863|FG004|Overall Study|Onset of birch pollen season|1|||
170720313|NCT04266028|616979864|FG005|Overall Study|Onset of birch pollen season|0|||
170720314|NCT04266028|616979865|FG006|Overall Study|Onset of birch pollen season|0|||
170720315|NCT04266028|616979866|FG007|Overall Study|Onset of birch pollen season|0|||
170720316|NCT01617629|616979870|FG000|Overall Study|Death|2|||
170720317|NCT01617629|616979870|FG000|Overall Study|Investigator's Clinical Judgement|1|||
170720318|NCT01617629|616979870|FG000|Overall Study|Reason Not Specified|1|||
170720319|NCT01617629|616979870|FG000|Overall Study|Participant Withdrew Consent|2|||
170830915|NCT01496365|617390169|FG001|Overall Study|Lack of Efficacy|0|||
170720320|NCT01663636|616979871|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
170720321|NCT01663636|616979872|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
170720322|NCT03930745|616979873|FG000|Overall Study|Lost to Follow-up|10|||
170720323|NCT03930745|616979874|FG001|Overall Study|Lost to Follow-up|5|||
170720324|NCT03930745|616979873|FG000|Overall Study|Withdrawal by Subject|1|||
170720325|NCT03930745|616979874|FG001|Overall Study|Withdrawal by Subject|2|||
170720326|NCT03930745|616979873|FG000|Overall Study|Protocol Violation|2|||
170720327|NCT03930745|616979874|FG001|Overall Study|Protocol Violation|2|||
170720328|NCT03930745|616979873|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
170720329|NCT03930745|616979874|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
170720330|NCT03930745|616979873|FG000|Overall Study|Adverse Event|0|||
170720331|NCT03930745|616979874|FG001|Overall Study|Adverse Event|1|||
170720332|NCT03930745|616979873|FG000|Overall Study|Pregnancy|0|||
170720333|NCT03930745|616979874|FG001|Overall Study|Pregnancy|1|||
170720334|NCT02838017|616979875|FG000|Overall Study|Lost to Follow-up|14|||
170720335|NCT02838017|616979876|FG001|Overall Study|Lost to Follow-up|11|||
170720336|NCT02276482|616979877|FG000|Overall Study|Adverse Event|1|||
170720337|NCT02276482|616979878|FG001|Overall Study|Adverse Event|0|||
170720338|NCT02276482|616979877|FG000|Overall Study|Withdrawal by Subject|1|||
170720339|NCT02276482|616979878|FG001|Overall Study|Withdrawal by Subject|0|||
170720340|NCT02276482|616979877|FG000|Overall Study|Gram-negative infection|1|||
170720341|NCT02276482|616979878|FG001|Overall Study|Gram-negative infection|0|||
170720342|NCT02276482|616979877|FG000|Overall Study|Reason not specified|0|||
170720343|NCT02276482|616979878|FG001|Overall Study|Reason not specified|1|||
170720344|NCT01165281|616979884|FG000|Overall Study|Adverse Event|12|||
170720345|NCT01165281|616979885|FG001|Overall Study|Adverse Event|14|||
170720346|NCT01165281|616979884|FG000|Overall Study|Death|3|||
170720347|NCT01165281|616979885|FG001|Overall Study|Death|4|||
170720348|NCT01165281|616979884|FG000|Overall Study|Lack of Efficacy|4|||
170720349|NCT01165281|616979885|FG001|Overall Study|Lack of Efficacy|1|||
170720350|NCT01165281|616979884|FG000|Overall Study|Lost to Follow-up|0|||
170720351|NCT01165281|616979885|FG001|Overall Study|Lost to Follow-up|1|||
170720352|NCT01165281|616979884|FG000|Overall Study|Physician Decision|8|||
170720353|NCT01165281|616979885|FG001|Overall Study|Physician Decision|1|||
170720354|NCT01165281|616979884|FG000|Overall Study|Protocol Violation|6|||
170720355|NCT01165281|616979885|FG001|Overall Study|Protocol Violation|5|||
170720356|NCT01165281|616979884|FG000|Overall Study|Withdrawal by Subject|8|||
170720357|NCT01165281|616979885|FG001|Overall Study|Withdrawal by Subject|7|||
170720358|NCT01165281|616979884|FG000|Overall Study|Noncompliance with Study Drug|1|||
170720359|NCT01165281|616979885|FG001|Overall Study|Noncompliance with Study Drug|4|||
170720360|NCT01165281|616979884|FG000|Overall Study|Progressive Disease|10|||
170720361|NCT01165281|616979885|FG001|Overall Study|Progressive Disease|14|||
170720362|NCT01165281|616979884|FG000|Overall Study|Other|6|||
170720363|NCT01165281|616979885|FG001|Overall Study|Other|0|||
170720364|NCT02863991|616979886|FG000|Overall Study|Death|0|||
170720365|NCT02863991|616979887|FG001|Overall Study|Death|3|||
170720366|NCT02863991|616979886|FG000|Overall Study|Lack of Efficacy|0|||
170720367|NCT02863991|616979887|FG001|Overall Study|Lack of Efficacy|1|||
170720368|NCT02863991|616979886|FG000|Overall Study|Study Terminated|2|||
170720369|NCT02863991|616979887|FG001|Overall Study|Study Terminated|8|||
170720370|NCT02121847|616979888|FG000|Overall Study|Administrative Reasons|1|||
170720371|NCT02121847|616979888|FG000|Overall Study|Adverse Event|2|||
170720372|NCT03712917|616979892|FG000|Overall Study|Pregnancy|0|||
170720373|NCT03712917|616979893|FG001|Overall Study|Pregnancy|0|||
170720374|NCT03712917|616979894|FG002|Overall Study|Pregnancy|1|||
170720375|NCT03712917|616979892|FG000|Overall Study|Adverse Event|0|||
170720376|NCT03712917|616979893|FG001|Overall Study|Adverse Event|4|||
170720377|NCT03712917|616979894|FG002|Overall Study|Adverse Event|3|||
170720378|NCT03712917|616979892|FG000|Overall Study|Lost to Follow-up|9|||
170720379|NCT03712917|616979893|FG001|Overall Study|Lost to Follow-up|4|||
170720380|NCT03712917|616979894|FG002|Overall Study|Lost to Follow-up|5|||
170720381|NCT02091167|616979895|FG000|Overall Study|Lost to Follow-up|0|||
170720382|NCT02091167|616979896|FG001|Overall Study|Lost to Follow-up|2|||
170720383|NCT03403634|616979901|FG000|Overall Study|Disease progression|3|||
170720384|NCT03403634|616979901|FG000|Overall Study|Did not meet eligibility criteria|4|||
170720385|NCT03864614|616979905|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
170720386|NCT03864614|616979906|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
170720387|NCT03864614|616979907|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
170720388|NCT03864614|616979908|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
170720389|NCT03864614|616979905|FG000|Overall Study|Withdrawal by Subject|72|||
170720390|NCT03864614|616979906|FG001|Overall Study|Withdrawal by Subject|100|||
170720391|NCT03864614|616979907|FG002|Overall Study|Withdrawal by Subject|1|||
170720392|NCT03864614|616979908|FG003|Overall Study|Withdrawal by Subject|21|||
170720393|NCT03864614|616979905|FG000|Overall Study|Lost to Follow-up|45|||
170720394|NCT03864614|616979906|FG001|Overall Study|Lost to Follow-up|54|||
170720395|NCT03864614|616979907|FG002|Overall Study|Lost to Follow-up|0|||
170720396|NCT03864614|616979908|FG003|Overall Study|Lost to Follow-up|9|||
170720397|NCT03864614|616979905|FG000|Overall Study|Adverse Event|42|||
170720398|NCT03864614|616979906|FG001|Overall Study|Adverse Event|30|||
170720399|NCT03864614|616979907|FG002|Overall Study|Adverse Event|1|||
170720400|NCT03864614|616979908|FG003|Overall Study|Adverse Event|9|||
170720401|NCT03864614|616979905|FG000|Overall Study|Protocol Deviation|6|||
170720402|NCT03864614|616979906|FG001|Overall Study|Protocol Deviation|26|||
170720403|NCT03864614|616979907|FG002|Overall Study|Protocol Deviation|0|||
170720404|NCT03864614|616979908|FG003|Overall Study|Protocol Deviation|1|||
170720405|NCT03864614|616979905|FG000|Overall Study|Physician Decision|7|||
170720406|NCT03864614|616979906|FG001|Overall Study|Physician Decision|10|||
170720407|NCT03864614|616979907|FG002|Overall Study|Physician Decision|1|||
170720408|NCT03864614|616979908|FG003|Overall Study|Physician Decision|5|||
170720409|NCT03864614|616979905|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
170720410|NCT03864614|616979906|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
170720411|NCT03864614|616979907|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
170720412|NCT03864614|616979908|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
170720413|NCT03864614|616979905|FG000|Overall Study|Sponsor Decision|1|||
170720414|NCT03864614|616979906|FG001|Overall Study|Sponsor Decision|2|||
170720415|NCT03864614|616979907|FG002|Overall Study|Sponsor Decision|0|||
170720416|NCT03864614|616979908|FG003|Overall Study|Sponsor Decision|0|||
170720417|NCT03864614|616979905|FG000|Overall Study|Pregnancy|0|||
170720418|NCT03864614|616979906|FG001|Overall Study|Pregnancy|1|||
170720419|NCT03864614|616979907|FG002|Overall Study|Pregnancy|0|||
170720420|NCT03864614|616979908|FG003|Overall Study|Pregnancy|0|||
170720421|NCT03864614|616979905|FG000|Overall Study|Other|7|||
170720422|NCT03864614|616979906|FG001|Overall Study|Other|9|||
170720423|NCT03864614|616979907|FG002|Overall Study|Other|1|||
170720424|NCT03864614|616979908|FG003|Overall Study|Other|4|||
170720425|NCT03864614|616979905|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
170720426|NCT03864614|616979906|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
170720427|NCT03864614|616979907|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
170720428|NCT03864614|616979908|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
170720429|NCT00932893|616979909|FG000|Overall Study|Death|115|||
170720430|NCT00932893|616979910|FG001|Overall Study|Death|24|||
170720431|NCT00932893|616979909|FG000|Overall Study|Lost to Follow-up|8|||
170720432|NCT00932893|616979910|FG001|Overall Study|Lost to Follow-up|0|||
170720433|NCT00932893|616979909|FG000|Overall Study|Withdrawal by Subject|5|||
170720434|NCT00932893|616979910|FG001|Overall Study|Withdrawal by Subject|2|||
170720435|NCT00932893|616979909|FG000|Overall Study|Other|5|||
170720436|NCT00932893|616979910|FG001|Overall Study|Other|144|||
170720437|NCT01850004|616979911|FG000|Overall Study|Poor/Non-compliance|1|||
170720438|NCT01850004|616979911|FG000|Overall Study|Participant Withdrew Consent|9|||
170720439|NCT01850004|616979911|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
170720440|NCT01850004|616979911|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
170720441|NCT01850004|616979911|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
170720442|NCT01850004|616979911|FG000|Overall Study|Other Reasons|2|||
170720443|NCT01850004|616979911|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
170720444|NCT01850004|616979911|FG000|Overall Study|Maximum Clinical Benefit|4|||
170720445|NCT02207816|616982388|FG000|Overall Study|Serious Adverse Event|0|||
170720446|NCT02207816|616982389|FG001|Overall Study|Serious Adverse Event|5|||
170720447|NCT02207816|616982390|FG002|Overall Study|Serious Adverse Event|2|||
170720448|NCT02207816|616982388|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
170720449|NCT02207816|616982389|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
170720450|NCT02207816|616982390|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
170720451|NCT02207816|616982388|FG000|Overall Study|Withdrawal by Subject|4|||
170720452|NCT02207816|616982389|FG001|Overall Study|Withdrawal by Subject|9|||
170720453|NCT02207816|616982390|FG002|Overall Study|Withdrawal by Subject|7|||
170720454|NCT02207816|616982388|FG000|Overall Study|Migrated/Moved From Study Area|41|||
170720455|NCT02207816|616982389|FG001|Overall Study|Migrated/Moved From Study Area|60|||
170720456|NCT02207816|616982390|FG002|Overall Study|Migrated/Moved From Study Area|51|||
170720457|NCT02207816|616982388|FG000|Overall Study|Lost to Follow-up|3|||
170720458|NCT02207816|616982389|FG001|Overall Study|Lost to Follow-up|9|||
170720459|NCT02207816|616982390|FG002|Overall Study|Lost to Follow-up|1|||
170720460|NCT02207816|616982388|FG000|Overall Study|Other|1|||
170720461|NCT02207816|616982389|FG001|Overall Study|Other|2|||
170720462|NCT02207816|616982390|FG002|Overall Study|Other|4|||
170720463|NCT06111742|616982391|FG000|Overall Study|Did not receive intervention|1|||
170720464|NCT06111742|616982392|FG001|Overall Study|Did not receive intervention|0|||
170720465|NCT06111742|616982393|FG002|Overall Study|Did not receive intervention|0|||
170720466|NCT06111742|616982391|FG000|Overall Study|Withdrawal by Subject|2|||
170720467|NCT06111742|616982392|FG001|Overall Study|Withdrawal by Subject|0|||
170720468|NCT06111742|616982393|FG002|Overall Study|Withdrawal by Subject|0|||
170720469|NCT01925950|616982394|FG000|Part 2|Withdrawal by Subject|1|||
170720470|NCT01925950|616982395|FG001|Part 2|Withdrawal by Subject|0|||
170720471|NCT00713648|616982396|FG000|Overall Study|Adverse Event|1|||
170720472|NCT00713648|616982396|FG000|Overall Study|Unclassified|2|||
170720473|NCT00713648|616982396|FG000|Overall Study|According to Protocol|2|||
170720474|NCT00713648|616982396|FG000|Overall Study|Development of antibodies|3|||
170720475|NCT04717596|616982397|FG000|Overall Study|Withdrawal by Subject|4|||
170720476|NCT03555396|616982398|FG000|Overall Study|Death|3|||
170720477|NCT03555396|616982399|FG001|Overall Study|Death|1|||
170720478|NCT03555396|616982398|FG000|Overall Study|Lost to Follow-up|0|||
170720479|NCT03555396|616982399|FG001|Overall Study|Lost to Follow-up|2|||
170720480|NCT02460991|616982404|FG000|Overall Study|Withdrawal by Subject|0|||
170720481|NCT02460991|616982405|FG001|Overall Study|Withdrawal by Subject|2|||
170720482|NCT03073603|616982407|FG000|Overall Study|Noncompliance|3|||
170720483|NCT03073603|616982408|FG001|Overall Study|Noncompliance|1|||
170720484|NCT03073603|616982407|FG000|Overall Study|Adverse Event|5|||
170720485|NCT03073603|616982408|FG001|Overall Study|Adverse Event|3|||
170720486|NCT03073603|616982407|FG000|Overall Study|Physician Decision|1|||
170720487|NCT03073603|616982408|FG001|Overall Study|Physician Decision|2|||
170720488|NCT03073603|616982407|FG000|Overall Study|Required treatment not allowed by protocol|1|||
170720489|NCT03073603|616982408|FG001|Overall Study|Required treatment not allowed by protocol|0|||
170720490|NCT03073603|616982407|FG000|Overall Study|Financial or insurance-related|8|||
170720491|NCT03073603|616982408|FG001|Overall Study|Financial or insurance-related|0|||
170720492|NCT03073603|616982407|FG000|Overall Study|Withdrawal by Subject|0|||
170720493|NCT03073603|616982408|FG001|Overall Study|Withdrawal by Subject|1|||
170720494|NCT03073603|616982407|FG000|Overall Study|Discontinued DMT|4|||
170720495|NCT03073603|616982408|FG001|Overall Study|Discontinued DMT|0|||
170720496|NCT03073603|616982407|FG000|Overall Study|Restarted DMT|0|||
170720497|NCT03073603|616982408|FG001|Overall Study|Restarted DMT|1|||
170720498|NCT02564523|616982409|FG000|Overall Study|Withdrawal by Subject|3|||
170720499|NCT02564523|616982410|FG001|Overall Study|Withdrawal by Subject|0|||
170720500|NCT02564523|616982411|FG002|Overall Study|Withdrawal by Subject|1|||
170720501|NCT02564523|616982412|FG003|Overall Study|Withdrawal by Subject|0|||
170720502|NCT02564523|616982413|FG004|Overall Study|Withdrawal by Subject|1|||
170720503|NCT02564523|616982414|FG005|Overall Study|Withdrawal by Subject|0|||
170720504|NCT02564523|616982415|FG006|Overall Study|Withdrawal by Subject|1|||
170720505|NCT02564523|616982416|FG007|Overall Study|Withdrawal by Subject|0|||
170720506|NCT02564523|616982417|FG008|Overall Study|Withdrawal by Subject|0|||
170720507|NCT02564523|616982418|FG009|Overall Study|Withdrawal by Subject|0|||
170720508|NCT02564523|616982419|FG010|Overall Study|Withdrawal by Subject|1|||
170720509|NCT02564523|616982420|FG011|Overall Study|Withdrawal by Subject|0|||
170720510|NCT02564523|616982421|FG012|Overall Study|Withdrawal by Subject|1|||
170720511|NCT02564523|616982422|FG013|Overall Study|Withdrawal by Subject|0|||
170720512|NCT02564523|616982423|FG014|Overall Study|Withdrawal by Subject|0|||
170720513|NCT02564523|616982424|FG015|Overall Study|Withdrawal by Subject|0|||
170720514|NCT02564523|616982425|FG016|Overall Study|Withdrawal by Subject|0|||
170720515|NCT02564523|616982426|FG017|Overall Study|Withdrawal by Subject|0|||
170720516|NCT02564523|616982409|FG000|Overall Study|Adverse Event|0|||
170720517|NCT02564523|616982410|FG001|Overall Study|Adverse Event|0|||
170720518|NCT02564523|616982411|FG002|Overall Study|Adverse Event|0|||
170720519|NCT02564523|616982412|FG003|Overall Study|Adverse Event|0|||
170720520|NCT02564523|616982413|FG004|Overall Study|Adverse Event|0|||
170720521|NCT02564523|616982414|FG005|Overall Study|Adverse Event|0|||
170720522|NCT02564523|616982415|FG006|Overall Study|Adverse Event|0|||
170720523|NCT02564523|616982416|FG007|Overall Study|Adverse Event|0|||
170720524|NCT02564523|616982417|FG008|Overall Study|Adverse Event|0|||
170720525|NCT02564523|616982418|FG009|Overall Study|Adverse Event|0|||
170720526|NCT02564523|616982419|FG010|Overall Study|Adverse Event|0|||
170720527|NCT02564523|616982420|FG011|Overall Study|Adverse Event|0|||
170720528|NCT02564523|616982421|FG012|Overall Study|Adverse Event|0|||
170720529|NCT02564523|616982422|FG013|Overall Study|Adverse Event|0|||
170720530|NCT02564523|616982423|FG014|Overall Study|Adverse Event|0|||
170720531|NCT02564523|616982424|FG015|Overall Study|Adverse Event|0|||
170720532|NCT02564523|616982425|FG016|Overall Study|Adverse Event|0|||
170720533|NCT02564523|616982426|FG017|Overall Study|Adverse Event|1|||
170720534|NCT02564523|616982409|FG000|Overall Study|Death|0|||
170720535|NCT02564523|616982410|FG001|Overall Study|Death|0|||
170720536|NCT02564523|616982411|FG002|Overall Study|Death|0|||
170720537|NCT02564523|616982412|FG003|Overall Study|Death|0|||
170720538|NCT02564523|616982413|FG004|Overall Study|Death|0|||
170720539|NCT02564523|616982414|FG005|Overall Study|Death|0|||
170720540|NCT02564523|616982415|FG006|Overall Study|Death|1|||
170720541|NCT02564523|616982416|FG007|Overall Study|Death|0|||
170720542|NCT02564523|616982417|FG008|Overall Study|Death|0|||
170720543|NCT02564523|616982418|FG009|Overall Study|Death|0|||
170720544|NCT02564523|616982419|FG010|Overall Study|Death|1|||
170720545|NCT02564523|616982420|FG011|Overall Study|Death|0|||
170720546|NCT02564523|616982421|FG012|Overall Study|Death|0|||
170720547|NCT02564523|616982422|FG013|Overall Study|Death|0|||
170720548|NCT02564523|616982423|FG014|Overall Study|Death|0|||
170720549|NCT02564523|616982424|FG015|Overall Study|Death|0|||
170720550|NCT02564523|616982425|FG016|Overall Study|Death|0|||
170720551|NCT02564523|616982426|FG017|Overall Study|Death|0|||
170720552|NCT02564523|616982409|FG000|Overall Study|Lost to Follow-up|2|||
170720553|NCT02564523|616982410|FG001|Overall Study|Lost to Follow-up|1|||
170720554|NCT02564523|616982411|FG002|Overall Study|Lost to Follow-up|4|||
170720555|NCT02564523|616982412|FG003|Overall Study|Lost to Follow-up|0|||
170830916|NCT01496365|617390170|FG002|Overall Study|Lack of Efficacy|0|||
170720556|NCT02564523|616982413|FG004|Overall Study|Lost to Follow-up|1|||
170720557|NCT02564523|616982414|FG005|Overall Study|Lost to Follow-up|0|||
170720558|NCT02564523|616982415|FG006|Overall Study|Lost to Follow-up|1|||
170720559|NCT02564523|616982416|FG007|Overall Study|Lost to Follow-up|0|||
170720560|NCT02564523|616982417|FG008|Overall Study|Lost to Follow-up|0|||
170720561|NCT02564523|616982418|FG009|Overall Study|Lost to Follow-up|0|||
170720562|NCT02564523|616982419|FG010|Overall Study|Lost to Follow-up|0|||
170720563|NCT02564523|616982420|FG011|Overall Study|Lost to Follow-up|1|||
170720564|NCT02564523|616982421|FG012|Overall Study|Lost to Follow-up|1|||
170720565|NCT02564523|616982422|FG013|Overall Study|Lost to Follow-up|0|||
170720566|NCT02564523|616982423|FG014|Overall Study|Lost to Follow-up|0|||
170720567|NCT02564523|616982424|FG015|Overall Study|Lost to Follow-up|0|||
170720568|NCT02564523|616982425|FG016|Overall Study|Lost to Follow-up|0|||
170720569|NCT02564523|616982426|FG017|Overall Study|Lost to Follow-up|0|||
170720570|NCT02564523|616982409|FG000|Overall Study|Physician Decision|0|||
170720571|NCT02564523|616982410|FG001|Overall Study|Physician Decision|0|||
170720572|NCT02564523|616982411|FG002|Overall Study|Physician Decision|0|||
170720573|NCT02564523|616982412|FG003|Overall Study|Physician Decision|0|||
170720574|NCT02564523|616982413|FG004|Overall Study|Physician Decision|1|||
170720575|NCT02564523|616982414|FG005|Overall Study|Physician Decision|0|||
170720576|NCT02564523|616982415|FG006|Overall Study|Physician Decision|0|||
170720577|NCT02564523|616982416|FG007|Overall Study|Physician Decision|0|||
170720578|NCT02564523|616982417|FG008|Overall Study|Physician Decision|0|||
170720579|NCT02564523|616982418|FG009|Overall Study|Physician Decision|0|||
170720580|NCT02564523|616982419|FG010|Overall Study|Physician Decision|1|||
170720581|NCT02564523|616982420|FG011|Overall Study|Physician Decision|0|||
170720582|NCT02564523|616982421|FG012|Overall Study|Physician Decision|0|||
170720583|NCT02564523|616982422|FG013|Overall Study|Physician Decision|0|||
170720584|NCT02564523|616982423|FG014|Overall Study|Physician Decision|0|||
170720585|NCT02564523|616982424|FG015|Overall Study|Physician Decision|0|||
170720586|NCT02564523|616982425|FG016|Overall Study|Physician Decision|0|||
170720587|NCT02564523|616982426|FG017|Overall Study|Physician Decision|0|||
170720588|NCT02564523|616982409|FG000|Overall Study|Protocol Violation|2|||
170720589|NCT02564523|616982410|FG001|Overall Study|Protocol Violation|2|||
170720590|NCT02564523|616982411|FG002|Overall Study|Protocol Violation|5|||
170720591|NCT02564523|616982412|FG003|Overall Study|Protocol Violation|0|||
170720592|NCT02564523|616982413|FG004|Overall Study|Protocol Violation|1|||
170720593|NCT02564523|616982414|FG005|Overall Study|Protocol Violation|0|||
170720594|NCT02564523|616982415|FG006|Overall Study|Protocol Violation|0|||
170720595|NCT02564523|616982416|FG007|Overall Study|Protocol Violation|0|||
170720596|NCT02564523|616982417|FG008|Overall Study|Protocol Violation|0|||
170720597|NCT02564523|616982418|FG009|Overall Study|Protocol Violation|0|||
170720598|NCT02564523|616982419|FG010|Overall Study|Protocol Violation|0|||
170720599|NCT02564523|616982420|FG011|Overall Study|Protocol Violation|0|||
170720600|NCT02564523|616982421|FG012|Overall Study|Protocol Violation|0|||
170720601|NCT02564523|616982422|FG013|Overall Study|Protocol Violation|0|||
170720602|NCT02564523|616982423|FG014|Overall Study|Protocol Violation|0|||
170720603|NCT02564523|616982424|FG015|Overall Study|Protocol Violation|0|||
170720604|NCT02564523|616982425|FG016|Overall Study|Protocol Violation|0|||
170720605|NCT02564523|616982426|FG017|Overall Study|Protocol Violation|0|||
170720606|NCT02564523|616982409|FG000|Overall Study|Other|3|||
170720607|NCT02564523|616982410|FG001|Overall Study|Other|0|||
170720608|NCT02564523|616982411|FG002|Overall Study|Other|0|||
170720609|NCT02564523|616982412|FG003|Overall Study|Other|1|||
170720610|NCT02564523|616982413|FG004|Overall Study|Other|0|||
170720611|NCT02564523|616982414|FG005|Overall Study|Other|0|||
170720612|NCT02564523|616982415|FG006|Overall Study|Other|0|||
170720613|NCT02564523|616982416|FG007|Overall Study|Other|0|||
170720614|NCT02564523|616982417|FG008|Overall Study|Other|0|||
170720615|NCT02564523|616982418|FG009|Overall Study|Other|0|||
170720616|NCT02564523|616982419|FG010|Overall Study|Other|0|||
170720617|NCT02564523|616982420|FG011|Overall Study|Other|0|||
170720618|NCT02564523|616982421|FG012|Overall Study|Other|0|||
170720619|NCT02564523|616982422|FG013|Overall Study|Other|0|||
170720620|NCT02564523|616982423|FG014|Overall Study|Other|0|||
170720621|NCT02564523|616982424|FG015|Overall Study|Other|0|||
170720622|NCT02564523|616982425|FG016|Overall Study|Other|0|||
170720623|NCT02564523|616982426|FG017|Overall Study|Other|0|||
170720624|NCT00922428|616982427|FG000|Overall Study|retrospective/extremely implausible data|2|||
170720625|NCT00922428|616982427|FG000|Overall Study|no medication use or questionable use|13|||
170720626|NCT01369342|616982428|FG000|Overall Study|Withdrawal by Subject|7|||
170720627|NCT01369342|616982429|FG001|Overall Study|Withdrawal by Subject|7|||
170720628|NCT01369342|616982430|FG002|Overall Study|Withdrawal by Subject|2|||
170720629|NCT01369342|616982428|FG000|Overall Study|Lost to Follow-up|5|||
170720630|NCT01369342|616982429|FG001|Overall Study|Lost to Follow-up|2|||
170720631|NCT01369342|616982430|FG002|Overall Study|Lost to Follow-up|1|||
170720632|NCT01369342|616982428|FG000|Overall Study|Not Treated|1|||
170720633|NCT01369342|616982429|FG001|Overall Study|Not Treated|0|||
170720634|NCT01369342|616982430|FG002|Overall Study|Not Treated|0|||
170720635|NCT03204279|616982432|FG000|Overall Study|Withdrawal by Subject|0|||
170720636|NCT03204279|616982433|FG001|Overall Study|Withdrawal by Subject|1|||
170720637|NCT01064739|616982434|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
170720638|NCT04827212|616982437|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
170720639|NCT04827212|616982438|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
170720640|NCT04827212|616982437|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
170830917|NCT01496365|617390171|FG003|Overall Study|Lack of Efficacy|0|||
170830918|NCT01496365|617390172|FG004|Overall Study|Lack of Efficacy|0|||
170830919|NCT01496365|617390173|FG005|Overall Study|Lack of Efficacy|1|||
170830920|NCT01496365|617390174|FG006|Overall Study|Lack of Efficacy|0|||
170830921|NCT01496365|617390168|FG000|Overall Study|Lost to Follow-up|0|||
170830922|NCT01496365|617390169|FG001|Overall Study|Lost to Follow-up|1|||
170830923|NCT01496365|617390170|FG002|Overall Study|Lost to Follow-up|0|||
170720641|NCT04827212|616982438|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
170720642|NCT02479412|616982439|FG000|Overall Study|Adverse Event|0|||
170720643|NCT02479412|616982440|FG001|Overall Study|Adverse Event|0|||
170720644|NCT02479412|616982441|FG002|Overall Study|Adverse Event|1|||
170720645|NCT02479412|616982442|FG003|Overall Study|Adverse Event|0|||
170720646|NCT02479412|616982443|FG004|Overall Study|Adverse Event|0|||
170720647|NCT02479412|616982444|FG005|Overall Study|Adverse Event|0|||
170830924|NCT01496365|617390171|FG003|Overall Study|Lost to Follow-up|0|||
170830925|NCT01496365|617390172|FG004|Overall Study|Lost to Follow-up|2|||
170830926|NCT01496365|617390173|FG005|Overall Study|Lost to Follow-up|0|||
170830927|NCT01496365|617390174|FG006|Overall Study|Lost to Follow-up|0|||
170830928|NCT01496365|617390168|FG000|Overall Study|Other|4|||
170830929|NCT01496365|617390169|FG001|Overall Study|Other|4|||
170830930|NCT01496365|617390170|FG002|Overall Study|Other|2|||
170830931|NCT01496365|617390171|FG003|Overall Study|Other|1|||
170830932|NCT01496365|617390172|FG004|Overall Study|Other|3|||
170830933|NCT01496365|617390173|FG005|Overall Study|Other|0|||
170830934|NCT01496365|617390174|FG006|Overall Study|Other|1|||
170830935|NCT01660256|617390175|FG000|Overall Study|Adverse Event|4|||
170830936|NCT01660256|617390176|FG001|Overall Study|Adverse Event|0|||
170830937|NCT01660256|617390177|FG002|Overall Study|Adverse Event|2|||
170830938|NCT01660256|617390175|FG000|Overall Study|Withdrawal by Subject|1|||
170830939|NCT01660256|617390176|FG001|Overall Study|Withdrawal by Subject|0|||
170830940|NCT01660256|617390177|FG002|Overall Study|Withdrawal by Subject|2|||
170830941|NCT01646385|617390178|FG000|Overall Study|Death|202|||
170830942|NCT01646385|617390179|FG001|Overall Study|Death|222|||
170830943|NCT01646385|617390178|FG000|Overall Study|Switched to alternate biologic|636|||
170830944|NCT01646385|617390179|FG001|Overall Study|Switched to alternate biologic|649|||
170830945|NCT00107978|617390182|FG000|Overall Study|Adverse Event|1|||
170830946|NCT00107978|617390183|FG001|Overall Study|Adverse Event|5|||
170830947|NCT00107978|617390182|FG000|Overall Study|Death|3|||
170830948|NCT00107978|617390183|FG001|Overall Study|Death|3|||
170830949|NCT00107978|617390182|FG000|Overall Study|Lost to Follow-up|20|||
170830950|NCT00107978|617390183|FG001|Overall Study|Lost to Follow-up|28|||
170830951|NCT00107978|617390182|FG000|Overall Study|Withdrawal by Subject|4|||
170830952|NCT00107978|617390183|FG001|Overall Study|Withdrawal by Subject|9|||
170830953|NCT00107978|617390182|FG000|Overall Study|Protocol Violation|0|||
170830954|NCT00107978|617390183|FG001|Overall Study|Protocol Violation|1|||
170830955|NCT00107978|617390182|FG000|Overall Study|Other|5|||
170830956|NCT00107978|617390183|FG001|Overall Study|Other|4|||
170830957|NCT02669407|617390184|FG000|Overall Study|Physician Decision|3|||
170830958|NCT00727415|617390185|FG000|Phase I|Dose Limiting Toxicity|2|||
170830959|NCT01747837|617390186|FG000|Overall Study|Lost to Follow-up|5|||
170830960|NCT01747837|617390187|FG001|Overall Study|Lost to Follow-up|2|||
170830961|NCT01747837|617390186|FG000|Overall Study|Death|4|||
170830962|NCT01747837|617390187|FG001|Overall Study|Death|4|||
170830963|NCT01704547|617390189|FG000|Overall Study|Physician Decision|4|||
170830964|NCT01704547|617390189|FG000|Overall Study|Withdrawal by Subject|1|||
170830965|NCT02413593|617390190|FG000|Overall Study|Lost to Follow-up|3|||
170830966|NCT02413593|617390190|FG000|Overall Study|Adverse Event|1|||
170830967|NCT02564718|617390191|FG000|Overall Study|Withdrew from treatment|0|||
170830968|NCT02564718|617390192|FG001|Overall Study|Withdrew from treatment|1|||
170830969|NCT03845075|617390193|FG000|Part 1 - DB|Withdrawal by Subject|1|||
170830970|NCT03845075|617390194|FG001|Part 1 - DB|Withdrawal by Subject|1|||
170830971|NCT03845075|617390195|FG002|Part 1 - DB|Withdrawal by Subject|0|||
170830972|NCT03845075|617390196|FG003|Part 1 - DB|Withdrawal by Subject|0|||
170720648|NCT02479412|616982445|FG006|Overall Study|Adverse Event|0|||
170720649|NCT02479412|616982446|FG007|Overall Study|Adverse Event|0|||
170720650|NCT02479412|616982447|FG008|Overall Study|Adverse Event|0|||
170830973|NCT03845075|617390193|FG000|Part 1 - DB|Adverse Event|0|||
170830974|NCT03845075|617390194|FG001|Part 1 - DB|Adverse Event|1|||
170830975|NCT03845075|617390195|FG002|Part 1 - DB|Adverse Event|0|||
170830976|NCT03845075|617390196|FG003|Part 1 - DB|Adverse Event|0|||
170830977|NCT03845075|617390193|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
170830978|NCT03845075|617390194|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
170830979|NCT03845075|617390195|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
170830980|NCT03845075|617390196|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
170830981|NCT02019641|617390197|FG000|10-Week Follow up|Withdrawal by investigator|2|||
170830982|NCT02019641|617390198|FG001|10-Week Follow up|Withdrawal by investigator|0|||
170830983|NCT02019641|617390199|FG002|10-Week Follow up|Withdrawal by investigator|0|||
170830984|NCT02019641|617390197|FG000|10-Week Follow up|Withdrawal by Subject|1|||
170720651|NCT02479412|616982439|FG000|Overall Study|Study-specific withdrawal criteria|0|||
170720652|NCT02479412|616982440|FG001|Overall Study|Study-specific withdrawal criteria|0|||
170720653|NCT02479412|616982441|FG002|Overall Study|Study-specific withdrawal criteria|1|||
170720654|NCT02479412|616982442|FG003|Overall Study|Study-specific withdrawal criteria|1|||
170720655|NCT02479412|616982443|FG004|Overall Study|Study-specific withdrawal criteria|0|||
170720656|NCT02479412|616982444|FG005|Overall Study|Study-specific withdrawal criteria|0|||
170720657|NCT02479412|616982445|FG006|Overall Study|Study-specific withdrawal criteria|0|||
170720658|NCT02479412|616982446|FG007|Overall Study|Study-specific withdrawal criteria|1|||
170720659|NCT02479412|616982447|FG008|Overall Study|Study-specific withdrawal criteria|1|||
170720660|NCT02479412|616982439|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
170720661|NCT02479412|616982440|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
170720662|NCT02479412|616982441|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
170720663|NCT02479412|616982442|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
170720664|NCT02479412|616982443|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
170720665|NCT02479412|616982444|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
170720666|NCT02479412|616982445|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
170720667|NCT02479412|616982446|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
170720668|NCT02479412|616982447|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
170720669|NCT00454051|616982448|FG000|Overall Study|Adverse Event|1|||
170720670|NCT00454051|616982449|FG001|Overall Study|Adverse Event|2|||
170720671|NCT00454051|616982448|FG000|Overall Study|Withdrawal by Subject|1|||
170720672|NCT00454051|616982449|FG001|Overall Study|Withdrawal by Subject|0|||
170720673|NCT00454051|616982448|FG000|Overall Study|Protocol Violation|1|||
170720674|NCT00454051|616982449|FG001|Overall Study|Protocol Violation|1|||
170720675|NCT01571362|616982450|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
170720676|NCT01571362|616982451|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
170720677|NCT01571362|616982452|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
170720678|NCT01571362|616982450|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
170720679|NCT01571362|616982451|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
170720680|NCT01571362|616982452|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
170720681|NCT01571362|616982450|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
170720682|NCT01571362|616982451|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
170720683|NCT01571362|616982452|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
170720684|NCT01571362|616982450|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
170720685|NCT01571362|616982451|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
170720686|NCT01571362|616982452|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
170720687|NCT01571362|616982450|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
170720688|NCT01571362|616982451|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
170720689|NCT01571362|616982452|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
170720690|NCT01571362|616982450|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
170720691|NCT01571362|616982451|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
170720692|NCT01571362|616982452|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
170720693|NCT01571362|616982450|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170720694|NCT01571362|616982451|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
170720695|NCT01571362|616982452|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
170720696|NCT01571362|616982450|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
170720697|NCT01571362|616982451|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
170720698|NCT01571362|616982452|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
170720699|NCT01571362|616982450|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170720700|NCT01571362|616982451|FG001|Double-Blind Treatment Period|Adverse Event|9|||
170720701|NCT01571362|616982452|FG002|Double-Blind Treatment Period|Adverse Event|14|||
170720702|NCT01571362|616982450|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170720703|NCT01571362|616982451|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
170720704|NCT01571362|616982452|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
170720705|NCT01571362|616982450|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
170720706|NCT01571362|616982451|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
170720707|NCT01571362|616982452|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
170720708|NCT01571362|616982450|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
170720709|NCT01571362|616982451|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
170720710|NCT01571362|616982452|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
170720711|NCT04258020|616982453|FG000|Overall Study|Withdrawal by Subject|1|||
170720712|NCT04258020|616982454|FG001|Overall Study|Withdrawal by Subject|0|||
170720713|NCT00599326|616982455|FG000|Overall Study|Lost to Follow-up|1|||
170720714|NCT00599326|616982455|FG000|Overall Study|Noncompliant|1|||
170720715|NCT02097472|616982458|FG000|Received Vaccination 2|Adverse Event|0|||
170720716|NCT02097472|616982459|FG001|Received Vaccination 2|Adverse Event|0|||
170720717|NCT02097472|616982460|FG002|Received Vaccination 2|Adverse Event|0|||
170720718|NCT02097472|616982461|FG003|Received Vaccination 2|Adverse Event|0|||
170720719|NCT02097472|616982462|FG004|Received Vaccination 2|Adverse Event|0|||
170720720|NCT02097472|616982463|FG005|Received Vaccination 2|Adverse Event|0|||
170720721|NCT02097472|616982464|FG006|Received Vaccination 2|Adverse Event|1|||
170720722|NCT02097472|616982465|FG007|Received Vaccination 2|Adverse Event|0|||
170720723|NCT01669629|616982466|FG000|Period 1|protocol deviation|1|||
170720724|NCT01669629|616982467|FG001|Period 1|protocol deviation|2|||
170720725|NCT04402866|616982468|FG000|Overall Study|Discontinued Prior to Treatment|0|||
170720726|NCT04402866|616982469|FG001|Overall Study|Discontinued Prior to Treatment|0|||
170720727|NCT04402866|616982470|FG002|Overall Study|Discontinued Prior to Treatment|0|||
170720728|NCT04402866|616982471|FG003|Overall Study|Discontinued Prior to Treatment|0|||
170720729|NCT04402866|616982472|FG004|Overall Study|Discontinued Prior to Treatment|2|||
170720730|NCT04402866|616982473|FG005|Overall Study|Discontinued Prior to Treatment|3|||
170720731|NCT04402866|616982468|FG000|Overall Study|Adverse Event|2|||
170720732|NCT04402866|616982469|FG001|Overall Study|Adverse Event|1|||
170720733|NCT04402866|616982470|FG002|Overall Study|Adverse Event|0|||
170720734|NCT04402866|616982471|FG003|Overall Study|Adverse Event|0|||
170720735|NCT04402866|616982472|FG004|Overall Study|Adverse Event|13|||
170720736|NCT04402866|616982473|FG005|Overall Study|Adverse Event|8|||
170720737|NCT04402866|616982468|FG000|Overall Study|Miscellaneous|0|||
170720738|NCT04402866|616982469|FG001|Overall Study|Miscellaneous|0|||
170720739|NCT04402866|616982470|FG002|Overall Study|Miscellaneous|1|||
170720740|NCT04402866|616982471|FG003|Overall Study|Miscellaneous|0|||
170720741|NCT04402866|616982472|FG004|Overall Study|Miscellaneous|0|||
170720742|NCT04402866|616982473|FG005|Overall Study|Miscellaneous|0|||
170720743|NCT04402866|616982468|FG000|Overall Study|Lost to Follow-up|0|||
170720744|NCT04402866|616982469|FG001|Overall Study|Lost to Follow-up|0|||
170720745|NCT04402866|616982470|FG002|Overall Study|Lost to Follow-up|0|||
170720746|NCT04402866|616982471|FG003|Overall Study|Lost to Follow-up|0|||
170720747|NCT04402866|616982472|FG004|Overall Study|Lost to Follow-up|0|||
170720748|NCT04402866|616982473|FG005|Overall Study|Lost to Follow-up|1|||
170720749|NCT04402866|616982468|FG000|Overall Study|Withdrawal by Subject|0|||
170720750|NCT04402866|616982469|FG001|Overall Study|Withdrawal by Subject|0|||
170720751|NCT04402866|616982470|FG002|Overall Study|Withdrawal by Subject|0|||
170720752|NCT04402866|616982471|FG003|Overall Study|Withdrawal by Subject|0|||
170720753|NCT04402866|616982472|FG004|Overall Study|Withdrawal by Subject|0|||
170720754|NCT04402866|616982473|FG005|Overall Study|Withdrawal by Subject|2|||
170720755|NCT02278328|616982475|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
170720756|NCT02278328|616982476|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
170720757|NCT02278328|616982477|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
170720758|NCT02278328|616982475|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
170720759|NCT02278328|616982476|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
170720760|NCT02278328|616982477|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
170720761|NCT02278328|616982475|FG000|Neuropsych Screening|incomplete consent|0|||
170720762|NCT02278328|616982476|FG001|Neuropsych Screening|incomplete consent|0|||
170720763|NCT02278328|616982477|FG002|Neuropsych Screening|incomplete consent|2|||
170720764|NCT01292928|616982478|FG000|Overall Study|Death|8|||
170720765|NCT01292928|616982478|FG000|Overall Study|Withdrawal by Subject|8|||
170720766|NCT01292928|616982478|FG000|Overall Study|Lost to Follow-up|6|||
170720767|NCT01292928|616982478|FG000|Overall Study|Physician Decision|2|||
170720768|NCT03579459|616982479|FG000|Overall Study|Adverse Event|7|||
170720769|NCT03579459|616982480|FG001|Overall Study|Adverse Event|6|||
170720770|NCT03579459|616982481|FG002|Overall Study|Adverse Event|2|||
170720771|NCT03579459|616982482|FG003|Overall Study|Adverse Event|6|||
170720772|NCT03579459|616982479|FG000|Overall Study|Death|1|||
170720773|NCT03579459|616982480|FG001|Overall Study|Death|0|||
170720774|NCT03579459|616982481|FG002|Overall Study|Death|1|||
170720775|NCT03579459|616982482|FG003|Overall Study|Death|2|||
170720776|NCT03579459|616982479|FG000|Overall Study|Lost to Follow-up|6|||
170720777|NCT03579459|616982480|FG001|Overall Study|Lost to Follow-up|2|||
170720778|NCT03579459|616982481|FG002|Overall Study|Lost to Follow-up|4|||
170720779|NCT03579459|616982482|FG003|Overall Study|Lost to Follow-up|1|||
170720780|NCT03579459|616982479|FG000|Overall Study|Physician Decision|0|||
170720781|NCT03579459|616982480|FG001|Overall Study|Physician Decision|1|||
170720782|NCT03579459|616982481|FG002|Overall Study|Physician Decision|0|||
170720783|NCT03579459|616982482|FG003|Overall Study|Physician Decision|1|||
170720784|NCT03579459|616982479|FG000|Overall Study|Protocol Violation|1|||
170720785|NCT03579459|616982480|FG001|Overall Study|Protocol Violation|2|||
170720786|NCT03579459|616982481|FG002|Overall Study|Protocol Violation|3|||
170720787|NCT03579459|616982482|FG003|Overall Study|Protocol Violation|5|||
170720788|NCT03579459|616982479|FG000|Overall Study|Withdrawal by Subject|12|||
170720789|NCT03579459|616982480|FG001|Overall Study|Withdrawal by Subject|8|||
170720790|NCT03579459|616982481|FG002|Overall Study|Withdrawal by Subject|11|||
170720791|NCT03579459|616982482|FG003|Overall Study|Withdrawal by Subject|8|||
170720792|NCT03579459|616982479|FG000|Overall Study|Medication error without associated adverse event|2|||
170720793|NCT03579459|616982480|FG001|Overall Study|Medication error without associated adverse event|1|||
170720794|NCT03579459|616982481|FG002|Overall Study|Medication error without associated adverse event|1|||
170720795|NCT03579459|616982482|FG003|Overall Study|Medication error without associated adverse event|0|||
170720796|NCT03579459|616982479|FG000|Overall Study|Other|0|||
170720797|NCT03579459|616982480|FG001|Overall Study|Other|1|||
170720798|NCT03579459|616982481|FG002|Overall Study|Other|1|||
170720799|NCT03579459|616982482|FG003|Overall Study|Other|0|||
170720800|NCT03579459|616982479|FG000|Overall Study|Randomized not vaccinated|0|||
170720801|NCT03579459|616982480|FG001|Overall Study|Randomized not vaccinated|2|||
170720802|NCT03579459|616982481|FG002|Overall Study|Randomized not vaccinated|0|||
170720803|NCT03579459|616982482|FG003|Overall Study|Randomized not vaccinated|1|||
170720804|NCT02732938|616982483|FG000|Overall Study|Death|0|||
170720805|NCT02732938|616982484|FG001|Overall Study|Death|11|||
170720806|NCT02732938|616982485|FG002|Overall Study|Death|0|||
170720807|NCT02732938|616982483|FG000|Overall Study|Randomized but did not receive treatment|0|||
170720808|NCT02732938|616982484|FG001|Overall Study|Randomized but did not receive treatment|1|||
170720809|NCT02732938|616982485|FG002|Overall Study|Randomized but did not receive treatment|0|||
170720810|NCT02732938|616982483|FG000|Overall Study|Refused further follow-up|1|||
170720811|NCT02732938|616982484|FG001|Overall Study|Refused further follow-up|0|||
170720812|NCT02732938|616982485|FG002|Overall Study|Refused further follow-up|0|||
170720813|NCT02732938|616982483|FG000|Overall Study|Study terminated by sponsor|3|||
170720814|NCT02732938|616982484|FG001|Overall Study|Study terminated by sponsor|6|||
170720815|NCT02732938|616982485|FG002|Overall Study|Study terminated by sponsor|0|||
170720816|NCT03263429|616982486|FG000|Overall Study|Withdrawal by Subject|0|||
170720817|NCT03263429|616982487|FG001|Overall Study|Withdrawal by Subject|1|||
170720818|NCT03263429|616982488|FG002|Overall Study|Withdrawal by Subject|0|||
170720819|NCT03263429|616982486|FG000|Overall Study|Follow-Up Period Completed|0|||
170720820|NCT03263429|616982487|FG001|Overall Study|Follow-Up Period Completed|2|||
170720821|NCT03263429|616982488|FG002|Overall Study|Follow-Up Period Completed|0|||
170720822|NCT03263429|616982486|FG000|Overall Study|Death|3|||
170720823|NCT03263429|616982487|FG001|Overall Study|Death|5|||
170720824|NCT03263429|616982488|FG002|Overall Study|Death|16|||
170720825|NCT03263429|616982486|FG000|Overall Study|Participant unable to return|0|||
170720826|NCT03263429|616982487|FG001|Overall Study|Participant unable to return|0|||
170720827|NCT03263429|616982488|FG002|Overall Study|Participant unable to return|1|||
170720828|NCT03263429|616982486|FG000|Overall Study|Study Closed|0|||
170720829|NCT03263429|616982487|FG001|Overall Study|Study Closed|0|||
170720830|NCT03263429|616982488|FG002|Overall Study|Study Closed|1|||
170720831|NCT01519206|616982489|FG000|Overall Study|Lost to Follow-up|3|||
170720832|NCT01519206|616982489|FG000|Overall Study|Missed Visit|2|||
170720833|NCT01491854|616982491|FG000|Overall Study|mainly due to premature termination|93|||
170720834|NCT01491854|616982491|FG000|Overall Study|Death|1|||
170720835|NCT01491854|616982491|FG000|Overall Study|Withdrawal by Subject|3|||
170720836|NCT01491854|616982491|FG000|Overall Study|Lost to Follow-up|33|||
170720837|NCT02014116|616982492|FG000|Overall Study|Progressive Disease|3|||
170720838|NCT02014116|616982493|FG001|Overall Study|Progressive Disease|4|||
170720839|NCT02014116|616982494|FG002|Overall Study|Progressive Disease|2|||
170720840|NCT02014116|616982495|FG003|Overall Study|Progressive Disease|6|||
170720841|NCT02014116|616982496|FG004|Overall Study|Progressive Disease|1|||
170720842|NCT02014116|616982497|FG005|Overall Study|Progressive Disease|13|||
170720843|NCT02014116|616982498|FG006|Overall Study|Progressive Disease|1|||
170720844|NCT02014116|616982499|FG007|Overall Study|Progressive Disease|3|||
170720845|NCT02014116|616982500|FG008|Overall Study|Progressive Disease|7|||
170720846|NCT02014116|616982492|FG000|Overall Study|Adverse Event|0|||
170720847|NCT02014116|616982493|FG001|Overall Study|Adverse Event|0|||
170720848|NCT02014116|616982494|FG002|Overall Study|Adverse Event|0|||
170720849|NCT02014116|616982495|FG003|Overall Study|Adverse Event|0|||
170720850|NCT02014116|616982496|FG004|Overall Study|Adverse Event|1|||
170720851|NCT02014116|616982497|FG005|Overall Study|Adverse Event|0|||
170720852|NCT02014116|616982498|FG006|Overall Study|Adverse Event|0|||
170720853|NCT02014116|616982499|FG007|Overall Study|Adverse Event|1|||
170720854|NCT02014116|616982500|FG008|Overall Study|Adverse Event|0|||
170720855|NCT02014116|616982492|FG000|Overall Study|Lost to Follow-up|0|||
170720856|NCT02014116|616982493|FG001|Overall Study|Lost to Follow-up|0|||
170720857|NCT02014116|616982494|FG002|Overall Study|Lost to Follow-up|0|||
170720858|NCT02014116|616982495|FG003|Overall Study|Lost to Follow-up|0|||
170720859|NCT02014116|616982496|FG004|Overall Study|Lost to Follow-up|0|||
170720860|NCT02014116|616982497|FG005|Overall Study|Lost to Follow-up|1|||
170720861|NCT02014116|616982498|FG006|Overall Study|Lost to Follow-up|0|||
170720862|NCT02014116|616982499|FG007|Overall Study|Lost to Follow-up|0|||
170720863|NCT02014116|616982500|FG008|Overall Study|Lost to Follow-up|1|||
170720864|NCT02014116|616982492|FG000|Overall Study|Death|0|||
170720865|NCT02014116|616982493|FG001|Overall Study|Death|0|||
170720866|NCT02014116|616982494|FG002|Overall Study|Death|0|||
170720867|NCT02014116|616982495|FG003|Overall Study|Death|0|||
170720868|NCT02014116|616982496|FG004|Overall Study|Death|0|||
170720869|NCT02014116|616982497|FG005|Overall Study|Death|0|||
170720870|NCT02014116|616982498|FG006|Overall Study|Death|0|||
170720871|NCT02014116|616982499|FG007|Overall Study|Death|1|||
170720872|NCT02014116|616982500|FG008|Overall Study|Death|1|||
170720873|NCT02014116|616982492|FG000|Overall Study|Withdrawal by Subject|0|||
170720874|NCT02014116|616982493|FG001|Overall Study|Withdrawal by Subject|0|||
170720875|NCT02014116|616982494|FG002|Overall Study|Withdrawal by Subject|1|||
170720876|NCT02014116|616982495|FG003|Overall Study|Withdrawal by Subject|1|||
170720877|NCT02014116|616982496|FG004|Overall Study|Withdrawal by Subject|0|||
170720878|NCT02014116|616982497|FG005|Overall Study|Withdrawal by Subject|1|||
170720879|NCT02014116|616982498|FG006|Overall Study|Withdrawal by Subject|0|||
170720880|NCT02014116|616982499|FG007|Overall Study|Withdrawal by Subject|0|||
170720881|NCT02014116|616982500|FG008|Overall Study|Withdrawal by Subject|0|||
170720882|NCT02014116|616982492|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
170720883|NCT02014116|616982493|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
170720884|NCT02014116|616982494|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
170720885|NCT02014116|616982495|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
170720886|NCT02014116|616982496|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
170720887|NCT02014116|616982497|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
170720888|NCT02014116|616982498|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
170720889|NCT02014116|616982499|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
170720890|NCT02014116|616982500|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
170720891|NCT02014116|616982492|FG000|Overall Study|Physician Decision|0|||
170720892|NCT02014116|616982493|FG001|Overall Study|Physician Decision|0|||
170720893|NCT02014116|616982494|FG002|Overall Study|Physician Decision|0|||
170720894|NCT02014116|616982495|FG003|Overall Study|Physician Decision|0|||
170720895|NCT02014116|616982496|FG004|Overall Study|Physician Decision|0|||
170720896|NCT02014116|616982497|FG005|Overall Study|Physician Decision|0|||
170720897|NCT02014116|616982498|FG006|Overall Study|Physician Decision|0|||
170720898|NCT02014116|616982499|FG007|Overall Study|Physician Decision|0|||
170720899|NCT02014116|616982500|FG008|Overall Study|Physician Decision|1|||
170720900|NCT01026974|616982509|FG000|Overall Study|Withdrawal by Subject|0|||
170720901|NCT01026974|616982510|FG001|Overall Study|Withdrawal by Subject|1|||
170720902|NCT01026974|616982511|FG002|Overall Study|Withdrawal by Subject|7|||
170720903|NCT01026974|616982512|FG003|Overall Study|Withdrawal by Subject|2|||
170720904|NCT01026974|616982509|FG000|Overall Study|Lost to Follow-up|1|||
170720905|NCT01026974|616982510|FG001|Overall Study|Lost to Follow-up|1|||
170720906|NCT01026974|616982511|FG002|Overall Study|Lost to Follow-up|4|||
170720907|NCT01026974|616982512|FG003|Overall Study|Lost to Follow-up|0|||
170720908|NCT01026974|616982509|FG000|Overall Study|Adverse Event|0|||
170720909|NCT01026974|616982510|FG001|Overall Study|Adverse Event|0|||
170720910|NCT01026974|616982511|FG002|Overall Study|Adverse Event|0|||
170720911|NCT01026974|616982512|FG003|Overall Study|Adverse Event|1|||
170720912|NCT01026974|616982509|FG000|Overall Study|Inappropriate enrollment|0|||
170720913|NCT01026974|616982510|FG001|Overall Study|Inappropriate enrollment|0|||
170720914|NCT01026974|616982511|FG002|Overall Study|Inappropriate enrollment|1|||
170720915|NCT01026974|616982512|FG003|Overall Study|Inappropriate enrollment|0|||
170720916|NCT02864082|616982515|FG000|Overall Study|Adverse Event|1|||
170720917|NCT02864082|616982516|FG001|Overall Study|Adverse Event|1|||
170720918|NCT02864082|616982515|FG000|Overall Study|Lost to Follow-up|0|||
170720919|NCT02864082|616982516|FG001|Overall Study|Lost to Follow-up|1|||
170720920|NCT02864082|616982515|FG000|Overall Study|Withdrawal by Subject|2|||
170720921|NCT02864082|616982516|FG001|Overall Study|Withdrawal by Subject|2|||
170720922|NCT03621696|616982524|FG000|Overall Study|Not eligible|0|||
170720923|NCT03621696|616982525|FG001|Overall Study|Not eligible|0|||
170720924|NCT03621696|616982526|FG002|Overall Study|Not eligible|0|||
170720925|NCT03621696|616982527|FG003|Overall Study|Not eligible|5|||
170720926|NCT03621696|616982524|FG000|Overall Study|Withdrawal by Subject|1|||
170720927|NCT03621696|616982525|FG001|Overall Study|Withdrawal by Subject|1|||
170720928|NCT03621696|616982526|FG002|Overall Study|Withdrawal by Subject|1|||
170720929|NCT03621696|616982527|FG003|Overall Study|Withdrawal by Subject|0|||
170720930|NCT03621696|616982524|FG000|Overall Study|Physician Decision|0|||
170720931|NCT03621696|616982525|FG001|Overall Study|Physician Decision|0|||
170720932|NCT03621696|616982526|FG002|Overall Study|Physician Decision|1|||
170720933|NCT03621696|616982527|FG003|Overall Study|Physician Decision|0|||
170720934|NCT03526250|616982528|FG000|Overall Study|Adverse Event|4|||
170720935|NCT03526250|616982528|FG000|Overall Study|Progressive Disease|16|||
170720936|NCT03526250|616982528|FG000|Overall Study|No Treatment|3|||
170720937|NCT04420221|616982529|FG000|Overall Study|Withdrawal by Subject|0|||
170720938|NCT04420221|616982530|FG001|Overall Study|Withdrawal by Subject|0|||
170720939|NCT04420221|616982531|FG002|Overall Study|Withdrawal by Subject|0|||
170720940|NCT04420221|616982532|FG003|Overall Study|Withdrawal by Subject|0|||
170720941|NCT04420221|616982533|FG004|Overall Study|Withdrawal by Subject|0|||
170720942|NCT04420221|616982534|FG005|Overall Study|Withdrawal by Subject|20|||
170720943|NCT04420221|616982535|FG006|Overall Study|Withdrawal by Subject|5|||
170720944|NCT04420221|616982529|FG000|Overall Study|Other|0|||
170720945|NCT04420221|616982530|FG001|Overall Study|Other|0|||
170720946|NCT04420221|616982531|FG002|Overall Study|Other|0|||
170720947|NCT04420221|616982532|FG003|Overall Study|Other|0|||
170720948|NCT04420221|616982533|FG004|Overall Study|Other|0|||
170720949|NCT04420221|616982534|FG005|Overall Study|Other|1|||
170720950|NCT04420221|616982535|FG006|Overall Study|Other|1|||
170720951|NCT04420221|616982529|FG000|Overall Study|Lost to Follow-up|0|||
170720952|NCT04420221|616982530|FG001|Overall Study|Lost to Follow-up|0|||
170720953|NCT04420221|616982531|FG002|Overall Study|Lost to Follow-up|0|||
170720954|NCT04420221|616982532|FG003|Overall Study|Lost to Follow-up|0|||
170720955|NCT04420221|616982533|FG004|Overall Study|Lost to Follow-up|0|||
170720956|NCT04420221|616982534|FG005|Overall Study|Lost to Follow-up|3|||
170720957|NCT04420221|616982535|FG006|Overall Study|Lost to Follow-up|2|||
170720958|NCT04420221|616982529|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
170720959|NCT04420221|616982530|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
170720960|NCT04420221|616982531|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
170720961|NCT04420221|616982532|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
170720962|NCT04420221|616982533|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
170720963|NCT04420221|616982534|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
170720964|NCT04420221|616982535|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
170720965|NCT05348681|616982536|FG000|Overall Study|Study terminated by Sponsor|8|||
170720966|NCT05348681|616982537|FG001|Overall Study|Study terminated by Sponsor|3|||
170720967|NCT05348681|616982536|FG000|Overall Study|Withdrawal by Subject|1|||
170720968|NCT05348681|616982537|FG001|Overall Study|Withdrawal by Subject|1|||
170720969|NCT05348681|616982536|FG000|Overall Study|Lost to Follow-up|1|||
170720970|NCT05348681|616982537|FG001|Overall Study|Lost to Follow-up|1|||
170720971|NCT05348681|616982536|FG000|Overall Study|Adverse Event|1|||
170720972|NCT05348681|616982537|FG001|Overall Study|Adverse Event|0|||
170720973|NCT05348681|616982536|FG000|Overall Study|Other|2|||
170720974|NCT05348681|616982537|FG001|Overall Study|Other|1|||
170720975|NCT01040130|616982538|FG000|Overall Study|Adverse Event|1|||
170720976|NCT01040130|616982539|FG001|Overall Study|Adverse Event|1|||
170720977|NCT01040130|616982540|FG002|Overall Study|Adverse Event|0|||
170720978|NCT01040130|616982541|FG003|Overall Study|Adverse Event|5|||
170720979|NCT01040130|616982542|FG004|Overall Study|Adverse Event|0|||
170720980|NCT01040130|616982543|FG005|Overall Study|Adverse Event|3|||
170720981|NCT01040130|616982538|FG000|Overall Study|Protocol Violation|0|||
170720982|NCT01040130|616982539|FG001|Overall Study|Protocol Violation|0|||
170720983|NCT01040130|616982540|FG002|Overall Study|Protocol Violation|2|||
170720984|NCT01040130|616982541|FG003|Overall Study|Protocol Violation|0|||
170720985|NCT01040130|616982542|FG004|Overall Study|Protocol Violation|0|||
170720986|NCT01040130|616982543|FG005|Overall Study|Protocol Violation|0|||
170720987|NCT01040130|616982538|FG000|Overall Study|Withdrawal by Subject|0|||
170720988|NCT01040130|616982539|FG001|Overall Study|Withdrawal by Subject|2|||
170720989|NCT01040130|616982540|FG002|Overall Study|Withdrawal by Subject|0|||
170720990|NCT01040130|616982541|FG003|Overall Study|Withdrawal by Subject|0|||
170720991|NCT01040130|616982542|FG004|Overall Study|Withdrawal by Subject|0|||
170720992|NCT01040130|616982543|FG005|Overall Study|Withdrawal by Subject|1|||
170720993|NCT01040130|616982538|FG000|Overall Study|Other reasons not listed above|2|||
170720994|NCT01040130|616982539|FG001|Overall Study|Other reasons not listed above|0|||
170720995|NCT01040130|616982540|FG002|Overall Study|Other reasons not listed above|0|||
170720996|NCT01040130|616982541|FG003|Overall Study|Other reasons not listed above|0|||
170720997|NCT01040130|616982542|FG004|Overall Study|Other reasons not listed above|0|||
170720998|NCT01040130|616982543|FG005|Overall Study|Other reasons not listed above|0|||
170720999|NCT02365467|616982544|FG000|Overall Study|Death|3|||
170721000|NCT03585244|616982550|FG000|Overall Study|Withdrawal by Subject|15|||
170721001|NCT02199028|616982556|FG000|Week 1|Adverse Event|1|||
170721002|NCT02199028|616982557|FG001|Week 1|Adverse Event|0|||
170721003|NCT02199028|616982556|FG000|Week 3|Adverse Event|1|||
170721004|NCT02199028|616982557|FG001|Week 3|Adverse Event|0|||
170721005|NCT01881126|616982558|FG000|Overall Study|Non-compliance|1|||
170721006|NCT01881126|616982559|FG001|Overall Study|Non-compliance|1|||
170721007|NCT01881126|616982558|FG000|Overall Study|Adverse Event|0|||
170721008|NCT01881126|616982559|FG001|Overall Study|Adverse Event|1|||
170721009|NCT01090453|616982560|FG000|Overall Study|Withdrawal by Subject|1|||
170721010|NCT01090453|616982561|FG001|Overall Study|Withdrawal by Subject|2|||
170721011|NCT01090453|616982560|FG000|Overall Study|Lost to Follow-up|7|||
170721012|NCT01090453|616982561|FG001|Overall Study|Lost to Follow-up|7|||
170721013|NCT01090453|616982560|FG000|Overall Study|Non serious AEs|1|||
170721014|NCT01090453|616982561|FG001|Overall Study|Non serious AEs|0|||
170721015|NCT01090453|616982560|FG000|Overall Study|Protocol Violation|2|||
170721016|NCT01090453|616982561|FG001|Overall Study|Protocol Violation|0|||
170721017|NCT01090453|616982560|FG000|Overall Study|Other|2|||
170721018|NCT01090453|616982561|FG001|Overall Study|Other|4|||
170721019|NCT01090453|616982560|FG000|Overall Study|Eligibility Criteria|0|||
170721020|NCT01090453|616982561|FG001|Overall Study|Eligibility Criteria|1|||
170721021|NCT01827904|616982564|FG000|Main Study|Withdrawal by Subject|1|||
170721022|NCT01827904|616982565|FG001|Main Study|Withdrawal by Subject|0|||
170721023|NCT01827904|616982566|FG002|Main Study|Withdrawal by Subject|0|||
170721024|NCT01827904|616982564|FG000|Main Study|Adverse Event|1|||
170721025|NCT01827904|616982565|FG001|Main Study|Adverse Event|0|||
170721026|NCT01827904|616982566|FG002|Main Study|Adverse Event|0|||
170721027|NCT01827904|616982564|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
170721028|NCT01827904|616982565|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
170721029|NCT01827904|616982566|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
170721030|NCT01827904|616982564|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
170721031|NCT01827904|616982565|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
170721032|NCT01827904|616982566|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
170721033|NCT01827904|616982564|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
170721034|NCT01827904|616982565|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
170721035|NCT01827904|616982566|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
170721036|NCT01827904|616982564|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
170721037|NCT01827904|616982565|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
170721038|NCT01827904|616982566|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
170721039|NCT01827904|616982564|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
170721040|NCT01827904|616982565|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
170721041|NCT01827904|616982566|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
170721042|NCT01827904|616982564|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
170721043|NCT01827904|616982565|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
170721044|NCT01827904|616982566|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
170721045|NCT01827904|616982564|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
170721046|NCT01827904|616982565|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
170721047|NCT01827904|616982566|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
170721048|NCT01827904|616982564|FG000|Long-term Annual Follow-up|Physician Decision|1|||
170721049|NCT01827904|616982565|FG001|Long-term Annual Follow-up|Physician Decision|0|||
170721050|NCT01827904|616982566|FG002|Long-term Annual Follow-up|Physician Decision|0|||
170721051|NCT01827904|616982564|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
170721052|NCT01827904|616982565|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
170721053|NCT01827904|616982566|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
170721054|NCT01827904|616982564|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
170721055|NCT01827904|616982565|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
170721056|NCT01827904|616982566|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
170721057|NCT02720484|616982576|FG000|Treatment on Study|Adverse Event|1|||
170721058|NCT02720484|616982576|FG000|Treatment on Study|Withdrawal by Subject|1|||
170721059|NCT02720484|616982576|FG000|Treatment on Study|Progressive Disease|4|||
170721060|NCT02720484|616982576|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
170721061|NCT02720484|616982576|FG000|Follow Up for 2 Years|Death|3|||
170721062|NCT02720484|616982576|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
170721063|NCT05070897|616982579|FG000|Overall Study|Protocol Violation|123|||
170721064|NCT05070897|616982580|FG001|Overall Study|Protocol Violation|68|||
170721065|NCT01292603|616985235|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
170721066|NCT01292603|616985236|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
170721067|NCT01292603|616985237|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
170721068|NCT01292603|616985238|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
170721069|NCT01292603|616985239|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
170721070|NCT01292603|616985240|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
170721071|NCT01292603|616985235|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
170721072|NCT01292603|616985236|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
170830985|NCT02019641|617390198|FG001|10-Week Follow up|Withdrawal by Subject|1|||
170830986|NCT02019641|617390199|FG002|10-Week Follow up|Withdrawal by Subject|0|||
170830987|NCT02019641|617390197|FG000|20-Week Follow up|Withdrawal by investigator|0|||
170830988|NCT02019641|617390198|FG001|20-Week Follow up|Withdrawal by investigator|0|||
170830989|NCT02019641|617390199|FG002|20-Week Follow up|Withdrawal by investigator|1|||
170830990|NCT01313624|617390202|FG000|Double-Blind Phase|Adverse Event|27|||
170721073|NCT01292603|616985237|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
170721074|NCT01292603|616985238|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
170721075|NCT01292603|616985239|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
170721076|NCT01292603|616985240|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
170721077|NCT01292603|616985235|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
170830991|NCT01313624|617390203|FG001|Double-Blind Phase|Adverse Event|4|||
170721078|NCT01292603|616985236|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
170721079|NCT01292603|616985237|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
170721080|NCT01292603|616985238|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
170721081|NCT01292603|616985239|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
170721082|NCT01292603|616985240|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
170721083|NCT01292603|616985235|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
170721084|NCT01292603|616985236|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
170721085|NCT01292603|616985237|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
170721086|NCT01292603|616985238|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
170721087|NCT01292603|616985239|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
170721088|NCT01292603|616985240|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
170721089|NCT01292603|616985235|FG000|Part 1: Regular Follow-Up Period|Death|3|||
170721090|NCT01292603|616985236|FG001|Part 1: Regular Follow-Up Period|Death|1|||
170721091|NCT01292603|616985237|FG002|Part 1: Regular Follow-Up Period|Death|3|||
170721092|NCT01292603|616985238|FG003|Part 1: Regular Follow-Up Period|Death|1|||
170721093|NCT01292603|616985239|FG004|Part 1: Regular Follow-Up Period|Death|0|||
170721094|NCT01292603|616985240|FG005|Part 1: Regular Follow-Up Period|Death|0|||
170721095|NCT01292603|616985235|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
170721096|NCT01292603|616985236|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
170721097|NCT01292603|616985237|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
170721098|NCT01292603|616985238|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
170721099|NCT01292603|616985239|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
170721100|NCT01292603|616985240|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
170721101|NCT01292603|616985235|FG000|Part 2: Dose Confirmation Period|Death|0|||
170721102|NCT01292603|616985236|FG001|Part 2: Dose Confirmation Period|Death|0|||
170721103|NCT01292603|616985237|FG002|Part 2: Dose Confirmation Period|Death|0|||
170721104|NCT01292603|616985238|FG003|Part 2: Dose Confirmation Period|Death|0|||
170721105|NCT01292603|616985239|FG004|Part 2: Dose Confirmation Period|Death|1|||
170721106|NCT01292603|616985240|FG005|Part 2: Dose Confirmation Period|Death|0|||
170721107|NCT01292603|616985235|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
170721108|NCT01292603|616985236|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
170721109|NCT01292603|616985237|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
170721110|NCT01292603|616985238|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
170721111|NCT01292603|616985239|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
170721112|NCT01292603|616985240|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
170721113|NCT01292603|616985235|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
170721114|NCT01292603|616985236|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
170721115|NCT01292603|616985237|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
170721116|NCT01292603|616985238|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
170721117|NCT01292603|616985239|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
170721118|NCT01292603|616985240|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
170721119|NCT01292603|616985235|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
170721120|NCT01292603|616985236|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
170721121|NCT01292603|616985237|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
170721122|NCT01292603|616985238|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
170721123|NCT01292603|616985239|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
170721124|NCT01292603|616985240|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
170721125|NCT01292603|616985235|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
170721126|NCT01292603|616985236|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
170721127|NCT01292603|616985237|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
170721128|NCT01292603|616985238|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
170721129|NCT01292603|616985239|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
170721130|NCT01292603|616985240|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
170721131|NCT01292603|616985235|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
170721132|NCT01292603|616985236|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
170721133|NCT01292603|616985237|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
170721134|NCT01292603|616985238|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
170721135|NCT01292603|616985239|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
170721136|NCT01292603|616985240|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
170721137|NCT01292603|616985235|FG000|Part 2: Regular Follow-Up|Death|0|||
170721138|NCT01292603|616985236|FG001|Part 2: Regular Follow-Up|Death|0|||
170721139|NCT01292603|616985237|FG002|Part 2: Regular Follow-Up|Death|0|||
170721140|NCT01292603|616985238|FG003|Part 2: Regular Follow-Up|Death|0|||
170721141|NCT01292603|616985239|FG004|Part 2: Regular Follow-Up|Death|6|||
170721142|NCT01292603|616985240|FG005|Part 2: Regular Follow-Up|Death|3|||
170721143|NCT01292603|616985235|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
170721144|NCT01292603|616985236|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
170721145|NCT01292603|616985237|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
170721146|NCT01292603|616985238|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
170721147|NCT01292603|616985239|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
170721148|NCT01292603|616985240|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
170721149|NCT01292603|616985235|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
170721150|NCT01292603|616985236|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
170721151|NCT01292603|616985237|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
170721152|NCT01292603|616985238|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
170721153|NCT01292603|616985239|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
170721154|NCT01292603|616985240|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
170721155|NCT01292603|616985235|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
170721156|NCT01292603|616985236|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
170721157|NCT01292603|616985237|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
170721158|NCT01292603|616985238|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
170721159|NCT01292603|616985239|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
170721160|NCT01292603|616985240|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
170721161|NCT01292603|616985235|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
170721162|NCT01292603|616985236|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
170721163|NCT01292603|616985237|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
170721164|NCT01292603|616985238|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
170721165|NCT01292603|616985239|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
170721166|NCT01292603|616985240|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
170721167|NCT01292603|616985235|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
170721168|NCT01292603|616985236|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
170721169|NCT01292603|616985237|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
170721170|NCT01292603|616985238|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
170721171|NCT01292603|616985239|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
170721172|NCT01292603|616985240|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
170721173|NCT01292603|616985235|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
170721174|NCT01292603|616985236|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
170721175|NCT01292603|616985237|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
170721176|NCT01292603|616985238|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
170721177|NCT01292603|616985239|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
170721178|NCT01292603|616985240|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
170721179|NCT01292603|616985235|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
170721180|NCT01292603|616985236|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
170721181|NCT01292603|616985237|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
170721182|NCT01292603|616985238|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
170721183|NCT01292603|616985239|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
170721184|NCT01292603|616985240|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
170721185|NCT01292603|616985235|FG000|Overall Survival Status|Death|3|||
170721186|NCT01292603|616985236|FG001|Overall Survival Status|Death|1|||
170721187|NCT01292603|616985237|FG002|Overall Survival Status|Death|3|||
170721188|NCT01292603|616985238|FG003|Overall Survival Status|Death|1|||
170721189|NCT01292603|616985239|FG004|Overall Survival Status|Death|16|||
170721190|NCT01292603|616985240|FG005|Overall Survival Status|Death|10|||
170721191|NCT02062632|616985245|FG000|Overall Study|No treatment data|1|||
170721192|NCT02338154|616985246|FG000|Overall Study|Death|46|||
170721193|NCT02338154|616985246|FG000|Overall Study|Valve Implant Failure|17|||
170721194|NCT02338154|616985246|FG000|Overall Study|Valve Explant|11|||
170721195|NCT02338154|616985246|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
170721196|NCT02338154|616985246|FG000|Overall Study|Lost to Follow-up|8|||
170721197|NCT02338154|616985246|FG000|Overall Study|Other Reason|3|||
170721198|NCT02338154|616985246|FG000|Overall Study|Patients Without Exit Form|47|||
170721199|NCT02338154|616985246|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
170721200|NCT02008890|616985247|FG000|Period 1|Withdrawal by Subject|7|||
170721201|NCT02008890|616985248|FG001|Period 1|Withdrawal by Subject|7|||
170721202|NCT02008890|616985249|FG002|Period 1|Withdrawal by Subject|5|||
170721203|NCT02008890|616985250|FG003|Period 1|Withdrawal by Subject|0|||
170721204|NCT02008890|616985251|FG004|Period 1|Withdrawal by Subject|0|||
170721205|NCT02008890|616985247|FG000|Period 1|Pregnancy|1|||
170721206|NCT02008890|616985248|FG001|Period 1|Pregnancy|0|||
170721207|NCT02008890|616985249|FG002|Period 1|Pregnancy|0|||
170721208|NCT02008890|616985250|FG003|Period 1|Pregnancy|0|||
170721209|NCT02008890|616985251|FG004|Period 1|Pregnancy|0|||
170721210|NCT02008890|616985247|FG000|Period 1|Physician Decision|1|||
170721211|NCT02008890|616985248|FG001|Period 1|Physician Decision|0|||
170721212|NCT02008890|616985249|FG002|Period 1|Physician Decision|1|||
170721213|NCT02008890|616985250|FG003|Period 1|Physician Decision|0|||
170721214|NCT02008890|616985251|FG004|Period 1|Physician Decision|0|||
170721215|NCT02008890|616985247|FG000|Period 1|Adverse Event|6|||
170721216|NCT02008890|616985248|FG001|Period 1|Adverse Event|8|||
170721217|NCT02008890|616985249|FG002|Period 1|Adverse Event|6|||
170721218|NCT02008890|616985250|FG003|Period 1|Adverse Event|0|||
170721219|NCT02008890|616985251|FG004|Period 1|Adverse Event|0|||
170721220|NCT02008890|616985247|FG000|Period 2|Adverse Event|12|||
170721221|NCT02008890|616985248|FG001|Period 2|Adverse Event|7|||
170830992|NCT01313624|617390202|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
170830993|NCT01313624|617390203|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
170830994|NCT01313624|617390202|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170830995|NCT01313624|617390203|FG001|Double-Blind Phase|Lost to Follow-up|2|||
170830996|NCT01313624|617390202|FG000|Double-Blind Phase|Physician Decision|1|||
170830997|NCT01313624|617390203|FG001|Double-Blind Phase|Physician Decision|0|||
170830998|NCT01313624|617390202|FG000|Double-Blind Phase|Lack of Efficacy|1|||
170830999|NCT01313624|617390203|FG001|Double-Blind Phase|Lack of Efficacy|0|||
170831000|NCT01313624|617390202|FG000|Open-Label Phase|Adverse Event|1|||
170831001|NCT01313624|617390203|FG001|Open-Label Phase|Adverse Event|10|||
170831002|NCT01313624|617390202|FG000|Open-Label Phase|Withdrawal by Subject|2|||
170831003|NCT01313624|617390203|FG001|Open-Label Phase|Withdrawal by Subject|2|||
170831004|NCT01313624|617390202|FG000|Open-Label Phase|Lost to Follow-up|1|||
170831005|NCT01313624|617390203|FG001|Open-Label Phase|Lost to Follow-up|1|||
170831006|NCT01017263|617390204|FG000|Overall Study|not eligible|12|||
170831007|NCT00905359|617390205|FG000|Overall Study|Lost to Follow-up|17|||
170831008|NCT00905359|617390206|FG001|Overall Study|Lost to Follow-up|10|||
170831009|NCT00905359|617390205|FG000|Overall Study|Death|2|||
170831010|NCT00905359|617390206|FG001|Overall Study|Death|0|||
170831011|NCT00905359|617390205|FG000|Overall Study|Withdrawal consent|5|||
170831012|NCT00905359|617390206|FG001|Overall Study|Withdrawal consent|6|||
170831013|NCT01006889|617390207|FG000|Overall Study|Withdrawal by Subject|3|||
170831014|NCT01130168|617390208|FG000|Period 1|Withdrawal by Subject|0|||
170831015|NCT01130168|617390209|FG001|Period 1|Withdrawal by Subject|1|||
170721222|NCT02008890|616985249|FG002|Period 2|Adverse Event|0|||
170721223|NCT02008890|616985250|FG003|Period 2|Adverse Event|5|||
170721224|NCT02008890|616985251|FG004|Period 2|Adverse Event|5|||
170721225|NCT02008890|616985247|FG000|Period 2|Withdrawal by Subject|11|||
170721226|NCT02008890|616985248|FG001|Period 2|Withdrawal by Subject|8|||
170721227|NCT02008890|616985249|FG002|Period 2|Withdrawal by Subject|0|||
170721228|NCT02008890|616985250|FG003|Period 2|Withdrawal by Subject|7|||
170721229|NCT02008890|616985251|FG004|Period 2|Withdrawal by Subject|2|||
170721230|NCT02008890|616985247|FG000|Period 2|Physician Decision|4|||
170721231|NCT02008890|616985248|FG001|Period 2|Physician Decision|0|||
170721232|NCT02008890|616985249|FG002|Period 2|Physician Decision|0|||
170721233|NCT02008890|616985250|FG003|Period 2|Physician Decision|2|||
170721234|NCT02008890|616985251|FG004|Period 2|Physician Decision|1|||
170721235|NCT02008890|616985247|FG000|Period 2|Lost to Follow-up|0|||
170721236|NCT02008890|616985248|FG001|Period 2|Lost to Follow-up|0|||
170721237|NCT02008890|616985249|FG002|Period 2|Lost to Follow-up|1|||
170721238|NCT02008890|616985250|FG003|Period 2|Lost to Follow-up|0|||
170721239|NCT02008890|616985251|FG004|Period 2|Lost to Follow-up|0|||
170721240|NCT02008890|616985247|FG000|Extension Period|Withdrawal by Subject|3|||
170721241|NCT02008890|616985248|FG001|Extension Period|Withdrawal by Subject|2|||
170721242|NCT02008890|616985249|FG002|Extension Period|Withdrawal by Subject|0|||
170721243|NCT02008890|616985250|FG003|Extension Period|Withdrawal by Subject|4|||
170721244|NCT02008890|616985251|FG004|Extension Period|Withdrawal by Subject|2|||
170721245|NCT02008890|616985247|FG000|Extension Period|Lost to Follow-up|1|||
170721246|NCT02008890|616985248|FG001|Extension Period|Lost to Follow-up|0|||
170721247|NCT02008890|616985249|FG002|Extension Period|Lost to Follow-up|0|||
170721248|NCT02008890|616985250|FG003|Extension Period|Lost to Follow-up|0|||
170721249|NCT02008890|616985251|FG004|Extension Period|Lost to Follow-up|0|||
170721250|NCT02008890|616985247|FG000|Extension Period|Adverse Event|1|||
170721251|NCT02008890|616985248|FG001|Extension Period|Adverse Event|3|||
170721252|NCT02008890|616985249|FG002|Extension Period|Adverse Event|0|||
170721253|NCT02008890|616985250|FG003|Extension Period|Adverse Event|0|||
170721254|NCT02008890|616985251|FG004|Extension Period|Adverse Event|2|||
170721255|NCT01773070|616985254|FG000|Overall Study|Withdrawal by Subject|24|||
170721256|NCT01773070|616985254|FG000|Overall Study|Lost to Follow-up|39|||
170721257|NCT01773070|616985254|FG000|Overall Study|Other|15|||
170721258|NCT01773070|616985254|FG000|Overall Study|Death (unrelated to study procedures)|3|||
170721259|NCT02522494|616985255|FG000|Overall Study|Lost to Follow-up|6|||
170721260|NCT02522494|616985256|FG001|Overall Study|Lost to Follow-up|2|||
170721261|NCT02522494|616985255|FG000|Overall Study|Withdrawal by Subject|1|||
170721262|NCT02522494|616985256|FG001|Overall Study|Withdrawal by Subject|0|||
170721263|NCT02522494|616985255|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
170721264|NCT02522494|616985256|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
170721265|NCT02522494|616985255|FG000|Overall Study|Participant did not watch the video|1|||
170721266|NCT02522494|616985256|FG001|Overall Study|Participant did not watch the video|0|||
170721267|NCT02522494|616985255|FG000|Overall Study|Death|0|||
170721268|NCT02522494|616985256|FG001|Overall Study|Death|1|||
170721269|NCT01559844|616985259|FG000|Overall Study|Consent Withdrawn|7|||
170721270|NCT01559844|616985259|FG000|Overall Study|Death|5|||
170721271|NCT01559844|616985259|FG000|Overall Study|Efficacy Failure|10|||
170721272|NCT01559844|616985259|FG000|Overall Study|No Longer A Transplant Candidate|3|||
170721273|NCT02181803|616985260|FG000|Overall Study|Withdrawal by Subject|0|||
170721274|NCT02181803|616985261|FG001|Overall Study|Withdrawal by Subject|2|||
170721275|NCT02181803|616985262|FG002|Overall Study|Withdrawal by Subject|0|||
170721276|NCT02181803|616985263|FG003|Overall Study|Withdrawal by Subject|0|||
170721277|NCT02181803|616985264|FG004|Overall Study|Withdrawal by Subject|0|||
170721278|NCT02181803|616985265|FG005|Overall Study|Withdrawal by Subject|0|||
170721279|NCT02181803|616985266|FG006|Overall Study|Withdrawal by Subject|0|||
170721280|NCT02181803|616985267|FG007|Overall Study|Withdrawal by Subject|0|||
170721281|NCT02181803|616985268|FG008|Overall Study|Withdrawal by Subject|0|||
170721282|NCT02181803|616985260|FG000|Overall Study|Physician Decision|0|||
170721283|NCT02181803|616985261|FG001|Overall Study|Physician Decision|0|||
170721284|NCT02181803|616985262|FG002|Overall Study|Physician Decision|0|||
170721285|NCT02181803|616985263|FG003|Overall Study|Physician Decision|1|||
170721286|NCT02181803|616985264|FG004|Overall Study|Physician Decision|0|||
170721287|NCT02181803|616985265|FG005|Overall Study|Physician Decision|0|||
170721288|NCT02181803|616985266|FG006|Overall Study|Physician Decision|0|||
170721289|NCT02181803|616985267|FG007|Overall Study|Physician Decision|1|||
170721290|NCT02181803|616985268|FG008|Overall Study|Physician Decision|0|||
170721291|NCT02181803|616985260|FG000|Overall Study|Adverse Event|0|||
170721292|NCT02181803|616985261|FG001|Overall Study|Adverse Event|2|||
170721293|NCT02181803|616985262|FG002|Overall Study|Adverse Event|0|||
170721294|NCT02181803|616985263|FG003|Overall Study|Adverse Event|1|||
170721295|NCT02181803|616985264|FG004|Overall Study|Adverse Event|0|||
170721296|NCT02181803|616985265|FG005|Overall Study|Adverse Event|0|||
170721297|NCT02181803|616985266|FG006|Overall Study|Adverse Event|1|||
170721298|NCT02181803|616985267|FG007|Overall Study|Adverse Event|0|||
170721299|NCT02181803|616985268|FG008|Overall Study|Adverse Event|0|||
170721300|NCT00951041|616985269|FG000|Overall Study|Withdrawal by Subject|1|||
170721301|NCT00951041|616985270|FG001|Overall Study|Withdrawal by Subject|1|||
170721302|NCT00951041|616985269|FG000|Overall Study|Lost to Follow-up|1|||
170721303|NCT00951041|616985270|FG001|Overall Study|Lost to Follow-up|0|||
170721304|NCT00951041|616985269|FG000|Overall Study|Other|3|||
170721305|NCT00951041|616985270|FG001|Overall Study|Other|0|||
170721306|NCT02349295|616985273|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
170721307|NCT02349295|616985274|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
170721308|NCT02349295|616985275|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
170721309|NCT02349295|616985276|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721310|NCT02349295|616985277|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721311|NCT02349295|616985278|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721312|NCT02349295|616985279|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721313|NCT02349295|616985280|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721314|NCT02349295|616985281|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721315|NCT02349295|616985282|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721316|NCT02349295|616985283|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721317|NCT02349295|616985284|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721318|NCT02349295|616985285|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721319|NCT02349295|616985286|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
170721320|NCT02349295|616985273|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
170721321|NCT02349295|616985274|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
170721322|NCT02349295|616985275|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
170721323|NCT02349295|616985276|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721324|NCT02349295|616985277|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721325|NCT02349295|616985278|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721326|NCT02349295|616985279|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721327|NCT02349295|616985280|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721328|NCT02349295|616985281|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721329|NCT02349295|616985282|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721330|NCT02349295|616985283|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721331|NCT02349295|616985284|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721332|NCT02349295|616985285|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721333|NCT02349295|616985286|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
170721334|NCT02349295|616985273|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
170721335|NCT02349295|616985274|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
170721336|NCT02349295|616985275|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
170721337|NCT02349295|616985276|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721338|NCT02349295|616985277|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721339|NCT02349295|616985278|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721340|NCT02349295|616985279|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721341|NCT02349295|616985280|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721342|NCT02349295|616985281|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721343|NCT02349295|616985282|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721344|NCT02349295|616985283|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721345|NCT02349295|616985284|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721346|NCT02349295|616985285|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721347|NCT02349295|616985286|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
170721348|NCT02349295|616985273|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
170721349|NCT02349295|616985274|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
170721350|NCT02349295|616985275|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
170721351|NCT02349295|616985276|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721352|NCT02349295|616985277|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721353|NCT02349295|616985278|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721354|NCT02349295|616985279|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721355|NCT02349295|616985280|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721356|NCT02349295|616985281|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721357|NCT02349295|616985282|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721358|NCT02349295|616985283|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721359|NCT02349295|616985284|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721360|NCT02349295|616985285|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721361|NCT02349295|616985286|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
170721362|NCT02349295|616985273|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721363|NCT02349295|616985274|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
170721364|NCT02349295|616985275|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
170721365|NCT02349295|616985276|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721366|NCT02349295|616985277|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721367|NCT02349295|616985278|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721368|NCT02349295|616985279|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721369|NCT02349295|616985280|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721370|NCT02349295|616985281|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721371|NCT02349295|616985282|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721372|NCT02349295|616985283|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721373|NCT02349295|616985284|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721374|NCT02349295|616985285|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721375|NCT02349295|616985286|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
170721376|NCT02349295|616985273|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
170721377|NCT02349295|616985274|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
170721378|NCT02349295|616985275|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
170721379|NCT02349295|616985276|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
170721380|NCT02349295|616985277|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
170721381|NCT02349295|616985278|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
170721382|NCT02349295|616985279|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
170721383|NCT02349295|616985280|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
170721384|NCT02349295|616985281|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
170721385|NCT02349295|616985282|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
170721386|NCT02349295|616985283|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
170721387|NCT02349295|616985284|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
170721388|NCT02349295|616985285|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
170721389|NCT02349295|616985286|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
170721390|NCT02349295|616985273|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721391|NCT02349295|616985274|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721392|NCT02349295|616985275|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721393|NCT02349295|616985276|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721394|NCT02349295|616985277|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721395|NCT02349295|616985278|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721396|NCT02349295|616985279|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721397|NCT02349295|616985280|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
170831016|NCT01130168|617390210|FG002|Period 1|Withdrawal by Subject|0|||
170831017|NCT01130168|617390211|FG003|Period 1|Withdrawal by Subject|1|||
170831018|NCT01130168|617390212|FG004|Period 1|Withdrawal by Subject|0|||
170831019|NCT01130168|617390213|FG005|Period 1|Withdrawal by Subject|0|||
170831020|NCT01130168|617390208|FG000|Period 1|Discontinued For Other Reason|0|||
170831021|NCT01130168|617390209|FG001|Period 1|Discontinued For Other Reason|0|||
170831022|NCT01130168|617390210|FG002|Period 1|Discontinued For Other Reason|1|||
170831023|NCT01130168|617390211|FG003|Period 1|Discontinued For Other Reason|1|||
170831024|NCT01130168|617390212|FG004|Period 1|Discontinued For Other Reason|0|||
170831025|NCT01130168|617390213|FG005|Period 1|Discontinued For Other Reason|0|||
170831026|NCT01130168|617390208|FG000|Period 1|Adverse Event|0|||
170831027|NCT01130168|617390209|FG001|Period 1|Adverse Event|0|||
170831028|NCT01130168|617390210|FG002|Period 1|Adverse Event|0|||
170831029|NCT01130168|617390211|FG003|Period 1|Adverse Event|1|||
170831030|NCT01130168|617390212|FG004|Period 1|Adverse Event|0|||
170831031|NCT01130168|617390213|FG005|Period 1|Adverse Event|0|||
170831032|NCT01185171|617390214|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
170831033|NCT01185171|617390214|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
170831034|NCT01185171|617390214|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
170831035|NCT01185171|617390214|FG000|Maintenance|Elevated liver transaminases|3|||
170831036|NCT01185171|617390214|FG000|Maintenance|Rush|2|||
170831037|NCT01185171|617390214|FG000|Maintenance|Diarrhea|1|||
170831038|NCT01185171|617390214|FG000|Maintenance|Xerostomia|1|||
170831039|NCT01185171|617390214|FG000|Maintenance|Nausea|1|||
170831040|NCT01185171|617390214|FG000|Maintenance|Comorbid Illness|2|||
170831041|NCT01185171|617390214|FG000|Maintenance|Withdrawal by Subject|1|||
170831042|NCT01185171|617390214|FG000|Maintenance|Disease Recurrence|1|||
170831043|NCT01329419|617390215|FG000|Overall Study|Protocol Violation|235|||
170831044|NCT04052997|617390216|FG000|Overall Study|Withdrawal by Subject|17|||
170831045|NCT04052997|617390216|FG000|Overall Study|Physician Decision|50|||
170831046|NCT04052997|617390216|FG000|Overall Study|Death|43|||
170831047|NCT04052997|617390216|FG000|Overall Study|Lost to Follow-up|5|||
170831048|NCT04052997|617390216|FG000|Overall Study|Progression of Disease|1|||
170831049|NCT01024036|617390223|FG000|Blinded Treatment|Adverse Event|1|||
170831050|NCT01024036|617390224|FG001|Blinded Treatment|Adverse Event|1|||
170831051|NCT01024036|617390223|FG000|Blinded Treatment|Lack of Efficacy|16|||
170831052|NCT01024036|617390224|FG001|Blinded Treatment|Lack of Efficacy|14|||
170831053|NCT01024036|617390223|FG000|Blinded Treatment|Physician Decision|1|||
170831054|NCT01024036|617390224|FG001|Blinded Treatment|Physician Decision|0|||
170831055|NCT01024036|617390223|FG000|Blinded Treatment|Death|0|||
170721398|NCT02349295|616985281|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
170721399|NCT02349295|616985282|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
170721400|NCT02349295|616985283|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
170721401|NCT02349295|616985284|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721402|NCT02349295|616985285|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721403|NCT02349295|616985286|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
170721404|NCT02349295|616985273|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721405|NCT02349295|616985274|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721406|NCT02349295|616985275|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721407|NCT02349295|616985276|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721408|NCT02349295|616985277|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721409|NCT02349295|616985278|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721410|NCT02349295|616985279|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721411|NCT02349295|616985280|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
170721412|NCT02349295|616985281|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
170721413|NCT02349295|616985282|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
170721414|NCT02349295|616985283|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
170721415|NCT02349295|616985284|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721416|NCT02349295|616985285|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721417|NCT02349295|616985286|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
170721418|NCT02349295|616985273|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721419|NCT02349295|616985274|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721420|NCT02349295|616985275|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721421|NCT02349295|616985276|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721422|NCT02349295|616985277|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721423|NCT02349295|616985278|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721424|NCT02349295|616985279|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721425|NCT02349295|616985280|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
170721426|NCT02349295|616985281|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721427|NCT02349295|616985282|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
170721428|NCT02349295|616985283|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721429|NCT02349295|616985284|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721430|NCT02349295|616985285|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721431|NCT02349295|616985286|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
170721432|NCT02349295|616985273|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
170721433|NCT02349295|616985274|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
170721434|NCT02349295|616985275|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
170721435|NCT02349295|616985276|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
170721436|NCT02349295|616985277|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
170721437|NCT02349295|616985278|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
170721438|NCT02349295|616985279|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
170721439|NCT02349295|616985280|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
170721440|NCT02349295|616985281|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
170721441|NCT02349295|616985282|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
170721442|NCT02349295|616985283|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
170721443|NCT02349295|616985284|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
170721444|NCT02349295|616985285|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
170721445|NCT02349295|616985286|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
170721446|NCT02349295|616985273|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721447|NCT02349295|616985274|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721448|NCT02349295|616985275|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721449|NCT02349295|616985276|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721450|NCT02349295|616985277|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721451|NCT02349295|616985278|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721452|NCT02349295|616985279|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721453|NCT02349295|616985280|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
170721454|NCT02349295|616985281|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
170721455|NCT02349295|616985282|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
170721456|NCT02349295|616985283|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
170721457|NCT02349295|616985284|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721458|NCT02349295|616985285|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721459|NCT02349295|616985286|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
170721460|NCT02349295|616985273|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721461|NCT02349295|616985274|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721462|NCT02349295|616985275|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721463|NCT02349295|616985276|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721464|NCT02349295|616985277|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721465|NCT02349295|616985278|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721466|NCT02349295|616985279|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721467|NCT02349295|616985280|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
170721468|NCT02349295|616985281|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
170721469|NCT02349295|616985282|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721470|NCT02349295|616985283|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721471|NCT02349295|616985284|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721472|NCT02349295|616985285|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721473|NCT02349295|616985286|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
170721474|NCT02349295|616985273|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721475|NCT02349295|616985274|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721476|NCT02349295|616985275|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721477|NCT02349295|616985276|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721478|NCT02349295|616985277|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721479|NCT02349295|616985278|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721480|NCT02349295|616985279|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721481|NCT02349295|616985280|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
170721482|NCT02349295|616985281|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
170721483|NCT02349295|616985282|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721484|NCT02349295|616985283|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721485|NCT02349295|616985284|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721486|NCT02349295|616985285|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721487|NCT02349295|616985286|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
170721488|NCT02349295|616985273|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721489|NCT02349295|616985274|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721490|NCT02349295|616985275|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721491|NCT02349295|616985276|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721492|NCT02349295|616985277|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721493|NCT02349295|616985278|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721494|NCT02349295|616985279|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721495|NCT02349295|616985280|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721496|NCT02349295|616985281|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721497|NCT02349295|616985282|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721498|NCT02349295|616985283|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
170721499|NCT02349295|616985284|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
170721500|NCT02349295|616985285|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
170721501|NCT02349295|616985286|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
170721502|NCT02349295|616985273|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721503|NCT02349295|616985274|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721504|NCT02349295|616985275|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721505|NCT02349295|616985276|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721506|NCT02349295|616985277|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721507|NCT02349295|616985278|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721508|NCT02349295|616985279|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721509|NCT02349295|616985280|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721510|NCT02349295|616985281|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721511|NCT02349295|616985282|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721512|NCT02349295|616985283|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721513|NCT02349295|616985284|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
170721514|NCT02349295|616985285|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
170721515|NCT02349295|616985286|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
170721516|NCT02349295|616985273|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721517|NCT02349295|616985274|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721518|NCT02349295|616985275|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170831056|NCT01024036|617390224|FG001|Blinded Treatment|Death|2|||
170831057|NCT01024036|617390223|FG000|Blinded Treatment|Withdrawal by Subject|4|||
170831058|NCT01024036|617390224|FG001|Blinded Treatment|Withdrawal by Subject|3|||
170831059|NCT01024036|617390223|FG000|Unblinded Treatment|Adverse Event|0|||
170831060|NCT01024036|617390224|FG001|Unblinded Treatment|Adverse Event|1|||
170831061|NCT01024036|617390223|FG000|Unblinded Treatment|Lack of Efficacy|0|||
170831062|NCT01024036|617390224|FG001|Unblinded Treatment|Lack of Efficacy|2|||
170831063|NCT01024036|617390223|FG000|Follow-Up Period|Lost to Follow-up|1|||
170831064|NCT01024036|617390224|FG001|Follow-Up Period|Lost to Follow-up|1|||
170831065|NCT01024036|617390223|FG000|Follow-Up Period|Withdrawal by Subject|0|||
170831066|NCT01024036|617390224|FG001|Follow-Up Period|Withdrawal by Subject|1|||
170831067|NCT01024036|617390223|FG000|Follow-Up Period|Adverse Event|4|||
170831068|NCT01024036|617390224|FG001|Follow-Up Period|Adverse Event|1|||
170831069|NCT03512288|617390225|FG000|Overall Study|Adverse Event|1|||
170831070|NCT03512288|617390226|FG001|Overall Study|Adverse Event|0|||
170831071|NCT03512288|617390225|FG000|Overall Study|Lost to Follow-up|12|||
170831072|NCT03512288|617390226|FG001|Overall Study|Lost to Follow-up|15|||
170831073|NCT03512288|617390225|FG000|Overall Study|Physician Decision|0|||
170831074|NCT03512288|617390226|FG001|Overall Study|Physician Decision|2|||
170831075|NCT03512288|617390225|FG000|Overall Study|Protocol Violation|6|||
170831076|NCT03512288|617390226|FG001|Overall Study|Protocol Violation|4|||
170831077|NCT03512288|617390225|FG000|Overall Study|Medication error without associated adverse event|1|||
170831078|NCT03512288|617390226|FG001|Overall Study|Medication error without associated adverse event|0|||
170831079|NCT03512288|617390225|FG000|Overall Study|No longer met eligibility criteria|5|||
170831080|NCT03512288|617390226|FG001|Overall Study|No longer met eligibility criteria|2|||
170831081|NCT03512288|617390225|FG000|Overall Study|Withdrawal by parent/guardian|14|||
170831082|NCT03512288|617390226|FG001|Overall Study|Withdrawal by parent/guardian|18|||
170831083|NCT03512288|617390225|FG000|Overall Study|Other|1|||
170831084|NCT03512288|617390226|FG001|Overall Study|Other|1|||
170831085|NCT03512288|617390225|FG000|Overall Study|Randomized but not treated|1|||
170831086|NCT03512288|617390226|FG001|Overall Study|Randomized but not treated|1|||
170831087|NCT00691678|617390227|FG000|Overall Study|Adverse Event|5|||
170831088|NCT00691678|617390227|FG000|Overall Study|life events, pain|11|||
170831089|NCT00934700|617390230|FG000|Overall Study|missing scan|5|||
170831090|NCT00934700|617390231|FG001|Overall Study|missing scan|9|||
170831091|NCT00934700|617390230|FG000|Overall Study|Death|8|||
170831092|NCT00934700|617390231|FG001|Overall Study|Death|3|||
170831093|NCT01831726|617390232|FG000|Overall Study|Adverse Event|16|||
170831094|NCT01831726|617390232|FG000|Overall Study|Death|7|||
170831095|NCT01831726|617390232|FG000|Overall Study|Disease Progression|49|||
170831096|NCT01831726|617390232|FG000|Overall Study|Physician Decision|1|||
170831097|NCT01831726|617390232|FG000|Overall Study|Subject/guardian decision|7|||
170831098|NCT00474383|617390233|FG000|Main Study|Adverse Event|11|||
170831099|NCT00474383|617390234|FG001|Main Study|Adverse Event|0|||
170831100|NCT00474383|617390233|FG000|Main Study|Symptomatic Deterioration|1|||
170831101|NCT00474383|617390234|FG001|Main Study|Symptomatic Deterioration|0|||
170831102|NCT00474383|617390233|FG000|Main Study|Progressive Disease|23|||
170831103|NCT00474383|617390234|FG001|Main Study|Progressive Disease|0|||
170831104|NCT00474383|617390233|FG000|Main Study|Other|1|||
170831105|NCT00474383|617390234|FG001|Main Study|Other|0|||
170831106|NCT00474383|617390233|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
170831107|NCT00474383|617390234|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
170831108|NCT00474383|617390233|FG000|Extension|Progressive Disease|0|||
170831109|NCT00474383|617390234|FG001|Extension|Progressive Disease|5|||
170831110|NCT01502371|617390239|FG000|Overall Study|Withdrawal by Subject|1|||
170831111|NCT01502371|617390240|FG001|Overall Study|Withdrawal by Subject|2|||
170831112|NCT01502371|617390241|FG002|Overall Study|Withdrawal by Subject|1|||
170831113|NCT01502371|617390242|FG003|Overall Study|Withdrawal by Subject|1|||
170831114|NCT01502371|617390243|FG004|Overall Study|Withdrawal by Subject|1|||
170831115|NCT01502371|617390239|FG000|Overall Study|Adverse Event|2|||
170831116|NCT01502371|617390240|FG001|Overall Study|Adverse Event|1|||
170831117|NCT01502371|617390241|FG002|Overall Study|Adverse Event|0|||
170831118|NCT01502371|617390242|FG003|Overall Study|Adverse Event|4|||
170831119|NCT01502371|617390243|FG004|Overall Study|Adverse Event|3|||
170831120|NCT01502371|617390239|FG000|Overall Study|Treatment Failure|22|||
170831121|NCT01502371|617390240|FG001|Overall Study|Treatment Failure|20|||
170721519|NCT02349295|616985276|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721520|NCT02349295|616985277|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721521|NCT02349295|616985278|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721522|NCT02349295|616985279|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721523|NCT02349295|616985280|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721524|NCT02349295|616985281|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721525|NCT02349295|616985282|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721526|NCT02349295|616985283|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721527|NCT02349295|616985284|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
170721528|NCT02349295|616985285|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
170721529|NCT02349295|616985286|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
170721530|NCT02349295|616985273|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721531|NCT02349295|616985274|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721532|NCT02349295|616985275|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721533|NCT02349295|616985276|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721534|NCT02349295|616985277|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721535|NCT02349295|616985278|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721536|NCT02349295|616985279|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721537|NCT02349295|616985280|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721538|NCT02349295|616985281|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721539|NCT02349295|616985282|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721540|NCT02349295|616985283|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721541|NCT02349295|616985284|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
170721542|NCT02349295|616985285|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721543|NCT02349295|616985286|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
170721544|NCT02349295|616985273|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721545|NCT02349295|616985274|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721546|NCT02349295|616985275|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721547|NCT02349295|616985276|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721548|NCT02349295|616985277|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721549|NCT02349295|616985278|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721550|NCT02349295|616985279|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721551|NCT02349295|616985280|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721552|NCT02349295|616985281|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721553|NCT02349295|616985282|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721554|NCT02349295|616985283|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721555|NCT02349295|616985284|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
170721556|NCT02349295|616985285|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721557|NCT02349295|616985286|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
170721558|NCT01259713|616985287|FG000|Overall Study|Adverse Event|54|||
170721559|NCT01259713|616985288|FG001|Overall Study|Adverse Event|23|||
170721560|NCT01259713|616985287|FG000|Overall Study|Death Not Related to IFI|8|||
170721561|NCT01259713|616985288|FG001|Overall Study|Death Not Related to IFI|1|||
170721562|NCT01259713|616985287|FG000|Overall Study|Investigators Discretion|14|||
170721563|NCT01259713|616985288|FG001|Overall Study|Investigators Discretion|6|||
170721564|NCT01259713|616985287|FG000|Overall Study|Lack of Efficacy|2|||
170721565|NCT01259713|616985288|FG001|Overall Study|Lack of Efficacy|0|||
170721566|NCT01259713|616985287|FG000|Overall Study|Protocol Violation|5|||
170721567|NCT01259713|616985288|FG001|Overall Study|Protocol Violation|4|||
170721568|NCT01259713|616985287|FG000|Overall Study|Subject Withdrew Consent|12|||
170721569|NCT01259713|616985288|FG001|Overall Study|Subject Withdrew Consent|7|||
170721570|NCT02091726|616985289|FG000|Overall Study|Lost to Follow-up|6|||
170721571|NCT02388724|616985290|FG000|Overall Study|Reason not Specified|0|||
170721572|NCT02388724|616985291|FG001|Overall Study|Reason not Specified|1|||
170721573|NCT02388724|616985290|FG000|Overall Study|Major Protocol Deviation|3|||
170721574|NCT02388724|616985291|FG001|Overall Study|Major Protocol Deviation|3|||
170721575|NCT02388724|616985290|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
170721576|NCT02388724|616985291|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
170721577|NCT02388724|616985290|FG000|Overall Study|Voluntary Withdrawal|6|||
170721578|NCT02388724|616985291|FG001|Overall Study|Voluntary Withdrawal|5|||
170721579|NCT02388724|616985290|FG000|Overall Study|Randomized but not Treated|0|||
170721580|NCT02388724|616985291|FG001|Overall Study|Randomized but not Treated|2|||
170721581|NCT04786444|616985292|FG000|Overall Study|Withdrawal by Subject|4|||
170721582|NCT04786444|616985293|FG001|Overall Study|Withdrawal by Subject|7|||
170721583|NCT04786444|616985294|FG002|Overall Study|Withdrawal by Subject|2|||
170721584|NCT04786444|616985292|FG000|Overall Study|Lost to Follow-up|11|||
170721585|NCT04786444|616985293|FG001|Overall Study|Lost to Follow-up|9|||
170721586|NCT04786444|616985294|FG002|Overall Study|Lost to Follow-up|10|||
170721587|NCT04786444|616985292|FG000|Overall Study|Subject would like to become pregnant|0|||
170831122|NCT01502371|617390241|FG002|Overall Study|Treatment Failure|12|||
170831123|NCT01502371|617390242|FG003|Overall Study|Treatment Failure|19|||
170831124|NCT01502371|617390243|FG004|Overall Study|Treatment Failure|30|||
170831125|NCT01502371|617390239|FG000|Overall Study|Lack of Efficacy|3|||
170831126|NCT01502371|617390240|FG001|Overall Study|Lack of Efficacy|3|||
170831127|NCT01502371|617390241|FG002|Overall Study|Lack of Efficacy|2|||
170831128|NCT01502371|617390242|FG003|Overall Study|Lack of Efficacy|2|||
170831129|NCT01502371|617390243|FG004|Overall Study|Lack of Efficacy|4|||
170831130|NCT01502371|617390239|FG000|Overall Study|Physician Decision|3|||
170831131|NCT01502371|617390240|FG001|Overall Study|Physician Decision|0|||
170831132|NCT01502371|617390241|FG002|Overall Study|Physician Decision|0|||
170831133|NCT01502371|617390242|FG003|Overall Study|Physician Decision|0|||
170831134|NCT01502371|617390243|FG004|Overall Study|Physician Decision|1|||
170831135|NCT01502371|617390239|FG000|Overall Study|Noncompliance with Study Drug|0|||
170831136|NCT01502371|617390240|FG001|Overall Study|Noncompliance with Study Drug|0|||
170831137|NCT01502371|617390241|FG002|Overall Study|Noncompliance with Study Drug|1|||
170831138|NCT01502371|617390242|FG003|Overall Study|Noncompliance with Study Drug|2|||
170831139|NCT01502371|617390243|FG004|Overall Study|Noncompliance with Study Drug|1|||
170831140|NCT01502371|617390239|FG000|Overall Study|Technical Problems|1|||
170831141|NCT01502371|617390240|FG001|Overall Study|Technical Problems|0|||
170831142|NCT01502371|617390241|FG002|Overall Study|Technical Problems|2|||
170831143|NCT01502371|617390242|FG003|Overall Study|Technical Problems|4|||
170831144|NCT01502371|617390243|FG004|Overall Study|Technical Problems|1|||
170831145|NCT01502371|617390239|FG000|Overall Study|Protocol Violation|9|||
170721588|NCT04786444|616985293|FG001|Overall Study|Subject would like to become pregnant|1|||
170721589|NCT04786444|616985294|FG002|Overall Study|Subject would like to become pregnant|0|||
170721590|NCT03137303|616985304|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
170721591|NCT03137303|616985305|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
170721592|NCT03137303|616985304|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
170721593|NCT03137303|616985305|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
170721594|NCT03137303|616985304|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
170721595|NCT03137303|616985305|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
170721596|NCT03137303|616985304|FG000|T3: 9-month Follow-up|Death|1|||
170721597|NCT03137303|616985305|FG001|T3: 9-month Follow-up|Death|0|||
170721598|NCT03137303|616985304|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
170721599|NCT03137303|616985305|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
170721600|NCT03137303|616985304|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
170721601|NCT03137303|616985305|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
170721602|NCT03137303|616985304|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
170721603|NCT03137303|616985305|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
170721604|NCT04477187|616985313|FG000|Overall Study|Lost to Follow-up|2|||
170721605|NCT00765843|616985315|FG000|Overall Study|Lost to Follow-up|1|||
170721606|NCT00765843|616985316|FG001|Overall Study|Lost to Follow-up|3|||
170721607|NCT00765843|616985317|FG002|Overall Study|Lost to Follow-up|2|||
170721608|NCT00765843|616985315|FG000|Overall Study|did not return to receive intervention|0|||
170721609|NCT00765843|616985316|FG001|Overall Study|did not return to receive intervention|1|||
170721610|NCT00765843|616985317|FG002|Overall Study|did not return to receive intervention|0|||
170721611|NCT00765843|616985315|FG000|Overall Study|Adverse Event|0|||
170721612|NCT00765843|616985316|FG001|Overall Study|Adverse Event|0|||
170721613|NCT00765843|616985317|FG002|Overall Study|Adverse Event|1|||
170721614|NCT04066114|616985318|FG000|Overall Study|Adverse Event|1|||
170721615|NCT04066114|616985319|FG001|Overall Study|Adverse Event|0|||
170721616|NCT04066114|616985320|FG002|Overall Study|Adverse Event|0|||
170721617|NCT04066114|616985318|FG000|Overall Study|Withdrawal by Subject|1|||
170721618|NCT04066114|616985319|FG001|Overall Study|Withdrawal by Subject|0|||
170721619|NCT04066114|616985320|FG002|Overall Study|Withdrawal by Subject|0|||
170721620|NCT04066114|616985318|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
170721621|NCT04066114|616985319|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
170721622|NCT04066114|616985320|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
170721623|NCT02473952|616985321|FG000|Overall Study|Adverse Event|2|||
170721624|NCT02473952|616985322|FG001|Overall Study|Adverse Event|2|||
170721625|NCT02473952|616985321|FG000|Overall Study|Withdrawal by Subject|0|||
170721626|NCT02473952|616985322|FG001|Overall Study|Withdrawal by Subject|6|||
170831146|NCT01502371|617390240|FG001|Overall Study|Protocol Violation|5|||
170831147|NCT01502371|617390241|FG002|Overall Study|Protocol Violation|6|||
170831148|NCT01502371|617390242|FG003|Overall Study|Protocol Violation|5|||
170831149|NCT01502371|617390243|FG004|Overall Study|Protocol Violation|10|||
170831150|NCT01502371|617390239|FG000|Overall Study|Excluded Medication|0|||
170831151|NCT01502371|617390240|FG001|Overall Study|Excluded Medication|1|||
170831152|NCT01502371|617390241|FG002|Overall Study|Excluded Medication|1|||
170831153|NCT01502371|617390242|FG003|Overall Study|Excluded Medication|0|||
170721627|NCT02277106|616985327|FG000|Stage 2|Adverse Event|0|||
170721628|NCT02277106|616985328|FG001|Stage 2|Adverse Event|0|||
170721629|NCT02277106|616985329|FG002|Stage 2|Adverse Event|1|||
170721630|NCT03031938|616985330|FG000|Overall Study|Death|1|||
170721631|NCT03031938|616985331|FG001|Overall Study|Death|0|||
170721632|NCT00130533|616985332|FG000|Overall Study|Withdrawal by Subject|33|||
170721633|NCT00130533|616985333|FG001|Overall Study|Withdrawal by Subject|6|||
170721634|NCT00130533|616985332|FG000|Overall Study|Adverse Event|34|||
170721635|NCT00130533|616985333|FG001|Overall Study|Adverse Event|1|||
170721636|NCT00130533|616985332|FG000|Overall Study|Disease relapse|9|||
170721637|NCT00130533|616985333|FG001|Overall Study|Disease relapse|13|||
170721638|NCT00130533|616985332|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
170721639|NCT00130533|616985333|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
170721640|NCT00130533|616985332|FG000|Overall Study|Death|4|||
170721641|NCT00130533|616985333|FG001|Overall Study|Death|2|||
170721642|NCT00130533|616985332|FG000|Overall Study|Protocol Violation|5|||
170721643|NCT00130533|616985333|FG001|Overall Study|Protocol Violation|1|||
170721644|NCT00130533|616985332|FG000|Overall Study|Lost to Follow-up|1|||
170721645|NCT00130533|616985333|FG001|Overall Study|Lost to Follow-up|1|||
170721646|NCT00130533|616985332|FG000|Overall Study|Sponsor´s decision|2|||
170721647|NCT00130533|616985333|FG001|Overall Study|Sponsor´s decision|0|||
170721648|NCT00130533|616985332|FG000|Overall Study|Second Primary Malignancy|0|||
170721649|NCT00130533|616985333|FG001|Overall Study|Second Primary Malignancy|1|||
170721650|NCT00130533|616985332|FG000|Overall Study|Other|12|||
170721651|NCT00130533|616985333|FG001|Overall Study|Other|5|||
170721652|NCT04530448|616985335|FG000|Overall Study|Physician Decision|3|||
170721653|NCT04530448|616985336|FG001|Overall Study|Physician Decision|0|||
170721654|NCT00476476|616985337|FG000|Overall Study|Adverse Event|2|||
170721655|NCT00476476|616985338|FG001|Overall Study|Adverse Event|7|||
170721656|NCT00476476|616985337|FG000|Overall Study|Progressive Disease|0|||
170721657|NCT00476476|616985338|FG001|Overall Study|Progressive Disease|17|||
170721658|NCT05545072|616985342|FG000|Overall Study|Lost to Follow-up|1|||
170721659|NCT05545072|616985343|FG001|Overall Study|Lost to Follow-up|0|||
170721660|NCT05545072|616985342|FG000|Overall Study|Study ended prematurely due to funding|2|||
170721661|NCT05545072|616985343|FG001|Overall Study|Study ended prematurely due to funding|2|||
170721662|NCT02395042|616985344|FG000|Treatment 1 Period|Adverse Event|1|||
170721663|NCT02395042|616985345|FG001|Treatment 1 Period|Adverse Event|3|||
170721664|NCT02395042|616985346|FG002|Treatment 1 Period|Adverse Event|1|||
170721665|NCT02395042|616985344|FG000|Treatment 1 Period|Lack of Efficacy|1|||
170721666|NCT02395042|616985345|FG001|Treatment 1 Period|Lack of Efficacy|1|||
170721667|NCT02395042|616985346|FG002|Treatment 1 Period|Lack of Efficacy|0|||
170831154|NCT01502371|617390243|FG004|Overall Study|Excluded Medication|1|||
170831155|NCT03325608|617390244|FG000|Overall Study|Lost to Follow-up|23|||
170831156|NCT03325608|617390245|FG001|Overall Study|Lost to Follow-up|23|||
170831157|NCT03325608|617390246|FG002|Overall Study|Lost to Follow-up|30|||
170831158|NCT03325608|617390247|FG003|Overall Study|Lost to Follow-up|30|||
170831159|NCT03325608|617390244|FG000|Overall Study|Death of Caregiver|0|||
170831160|NCT03325608|617390245|FG001|Overall Study|Death of Caregiver|0|||
170831161|NCT03325608|617390246|FG002|Overall Study|Death of Caregiver|2|||
170831162|NCT03325608|617390247|FG003|Overall Study|Death of Caregiver|2|||
170721668|NCT02395042|616985344|FG000|Treatment 1 Period|Lost to Follow-up|1|||
170721669|NCT02395042|616985345|FG001|Treatment 1 Period|Lost to Follow-up|0|||
170721670|NCT02395042|616985346|FG002|Treatment 1 Period|Lost to Follow-up|0|||
170721671|NCT02395042|616985344|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
170721672|NCT02395042|616985345|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
170721673|NCT02395042|616985346|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
170721674|NCT02395042|616985344|FG000|Treatment 2 Period|Lack of Efficacy|1|||
170721675|NCT02395042|616985345|FG001|Treatment 2 Period|Lack of Efficacy|1|||
170721676|NCT02395042|616985346|FG002|Treatment 2 Period|Lack of Efficacy|0|||
170721677|NCT03638141|616985347|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
170721678|NCT03996473|616985348|FG000|Treatment Assignment|Withdrawal by Subject|1|||
170721679|NCT03996473|616985348|FG000|Treatment Assignment|Progressive disease|6|||
170721680|NCT03996473|616985348|FG000|Treatment Assignment|Study drug never administered|1|||
170721681|NCT03996473|616985348|FG000|Active Follow-up|Death|1|||
170721682|NCT03996473|616985348|FG000|Long-term Follow-up|Death|5|||
170721683|NCT03759873|616985349|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
170721684|NCT03759873|616985350|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
170721685|NCT03759873|616985351|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
170721686|NCT03759873|616985352|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
170721687|NCT03759873|616985349|FG000|Overall Study|Moved outside eligible area|0|||
170721688|NCT03759873|616985350|FG001|Overall Study|Moved outside eligible area|2|||
170721689|NCT03759873|616985351|FG002|Overall Study|Moved outside eligible area|0|||
170721690|NCT03759873|616985352|FG003|Overall Study|Moved outside eligible area|0|||
170721691|NCT03759873|616985349|FG000|Overall Study|Withdrawal by Subject|0|||
170721692|NCT03759873|616985350|FG001|Overall Study|Withdrawal by Subject|0|||
170721693|NCT03759873|616985351|FG002|Overall Study|Withdrawal by Subject|1|||
170721694|NCT03759873|616985352|FG003|Overall Study|Withdrawal by Subject|0|||
170721695|NCT03579563|616985353|FG000|Overall Study|Lost to Follow-up|0|||
170721696|NCT03579563|616985354|FG001|Overall Study|Lost to Follow-up|0|||
170721697|NCT03579563|616985355|FG002|Overall Study|Lost to Follow-up|0|||
170721698|NCT03579563|616985356|FG003|Overall Study|Lost to Follow-up|0|||
170721699|NCT03579563|616985357|FG004|Overall Study|Lost to Follow-up|1|||
170721700|NCT03579563|616985358|FG005|Overall Study|Lost to Follow-up|0|||
170721701|NCT03579563|616985353|FG000|Overall Study|Lack of Efficacy|1|||
170721702|NCT03579563|616985354|FG001|Overall Study|Lack of Efficacy|1|||
170721703|NCT03579563|616985355|FG002|Overall Study|Lack of Efficacy|4|||
170721704|NCT03579563|616985356|FG003|Overall Study|Lack of Efficacy|1|||
170721705|NCT03579563|616985357|FG004|Overall Study|Lack of Efficacy|2|||
170721706|NCT03579563|616985358|FG005|Overall Study|Lack of Efficacy|3|||
170721707|NCT03579563|616985353|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
170721708|NCT03579563|616985354|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
170721709|NCT03579563|616985355|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
170721710|NCT03579563|616985356|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
170721711|NCT03579563|616985357|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
170721712|NCT03579563|616985358|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
170721713|NCT03579563|616985353|FG000|Overall Study|Time/distance concern|0|||
170721714|NCT03579563|616985354|FG001|Overall Study|Time/distance concern|0|||
170721715|NCT03579563|616985355|FG002|Overall Study|Time/distance concern|1|||
170721716|NCT03579563|616985356|FG003|Overall Study|Time/distance concern|0|||
170721717|NCT03579563|616985357|FG004|Overall Study|Time/distance concern|0|||
170721718|NCT03579563|616985358|FG005|Overall Study|Time/distance concern|1|||
170721719|NCT03579563|616985353|FG000|Overall Study|COVID shutdown|2|||
170721720|NCT03579563|616985354|FG001|Overall Study|COVID shutdown|3|||
170721721|NCT03579563|616985355|FG002|Overall Study|COVID shutdown|4|||
170831163|NCT03325608|617390244|FG000|Overall Study|Death of Care Recipient|34|||
170721722|NCT03579563|616985356|FG003|Overall Study|COVID shutdown|3|||
170721723|NCT03579563|616985357|FG004|Overall Study|COVID shutdown|1|||
170721724|NCT03579563|616985358|FG005|Overall Study|COVID shutdown|2|||
170721725|NCT03579563|616985353|FG000|Overall Study|Protocol administration error|1|||
170721726|NCT03579563|616985354|FG001|Overall Study|Protocol administration error|0|||
170721727|NCT03579563|616985355|FG002|Overall Study|Protocol administration error|1|||
170721728|NCT03579563|616985356|FG003|Overall Study|Protocol administration error|0|||
170721729|NCT03579563|616985357|FG004|Overall Study|Protocol administration error|1|||
170721730|NCT03579563|616985358|FG005|Overall Study|Protocol administration error|5|||
170721731|NCT04349553|616985359|FG000|Overall Study|Withdrawal by Subject|1|||
170721732|NCT04349553|616985360|FG001|Overall Study|Withdrawal by Subject|0|||
170721733|NCT04349553|616985361|FG002|Overall Study|Withdrawal by Subject|1|||
170721734|NCT04349553|616985362|FG003|Overall Study|Withdrawal by Subject|0|||
170831164|NCT03325608|617390245|FG001|Overall Study|Death of Care Recipient|34|||
170721735|NCT04642638|616985366|FG000|Overall Study|Withdrawal by Subject|23|||
170721736|NCT04642638|616985367|FG001|Overall Study|Withdrawal by Subject|29|||
170721737|NCT04642638|616985368|FG002|Overall Study|Withdrawal by Subject|9|||
170721738|NCT04642638|616985369|FG003|Overall Study|Withdrawal by Subject|7|||
170721739|NCT04642638|616985370|FG004|Overall Study|Withdrawal by Subject|61|||
170721740|NCT04642638|616985371|FG005|Overall Study|Withdrawal by Subject|27|||
170721741|NCT04642638|616985366|FG000|Overall Study|Lost to Follow-up|17|||
170721742|NCT04642638|616985367|FG001|Overall Study|Lost to Follow-up|18|||
170721743|NCT04642638|616985368|FG002|Overall Study|Lost to Follow-up|5|||
170721744|NCT04642638|616985369|FG003|Overall Study|Lost to Follow-up|5|||
170721745|NCT04642638|616985370|FG004|Overall Study|Lost to Follow-up|6|||
170721746|NCT04642638|616985371|FG005|Overall Study|Lost to Follow-up|3|||
170721747|NCT04642638|616985366|FG000|Overall Study|Adverse Event|0|||
170721748|NCT04642638|616985367|FG001|Overall Study|Adverse Event|0|||
170721749|NCT04642638|616985368|FG002|Overall Study|Adverse Event|1|||
170721750|NCT04642638|616985369|FG003|Overall Study|Adverse Event|0|||
170721751|NCT04642638|616985370|FG004|Overall Study|Adverse Event|10|||
170721752|NCT04642638|616985371|FG005|Overall Study|Adverse Event|3|||
170721753|NCT04642638|616985366|FG000|Overall Study|Reason Not Specified|1|||
170721754|NCT04642638|616985367|FG001|Overall Study|Reason Not Specified|4|||
170721755|NCT04642638|616985368|FG002|Overall Study|Reason Not Specified|0|||
170721756|NCT04642638|616985369|FG003|Overall Study|Reason Not Specified|0|||
170721757|NCT04642638|616985370|FG004|Overall Study|Reason Not Specified|38|||
170721758|NCT04642638|616985371|FG005|Overall Study|Reason Not Specified|16|||
170721759|NCT04642638|616985366|FG000|Overall Study|Physician Decision|0|||
170721760|NCT04642638|616985367|FG001|Overall Study|Physician Decision|0|||
170721761|NCT04642638|616985368|FG002|Overall Study|Physician Decision|0|||
170721762|NCT04642638|616985369|FG003|Overall Study|Physician Decision|0|||
170721763|NCT04642638|616985370|FG004|Overall Study|Physician Decision|2|||
170721764|NCT04642638|616985371|FG005|Overall Study|Physician Decision|1|||
170721765|NCT04642638|616985366|FG000|Overall Study|Protocol Deviation|0|||
170721766|NCT04642638|616985367|FG001|Overall Study|Protocol Deviation|0|||
170721767|NCT04642638|616985368|FG002|Overall Study|Protocol Deviation|0|||
170721768|NCT04642638|616985369|FG003|Overall Study|Protocol Deviation|0|||
170721769|NCT04642638|616985370|FG004|Overall Study|Protocol Deviation|1|||
170721770|NCT04642638|616985371|FG005|Overall Study|Protocol Deviation|3|||
170721771|NCT04642638|616985366|FG000|Overall Study|Study Terminated|0|||
170721772|NCT04642638|616985367|FG001|Overall Study|Study Terminated|0|||
170721773|NCT04642638|616985368|FG002|Overall Study|Study Terminated|0|||
170721774|NCT04642638|616985369|FG003|Overall Study|Study Terminated|0|||
170721775|NCT04642638|616985370|FG004|Overall Study|Study Terminated|484|||
170721776|NCT04642638|616985371|FG005|Overall Study|Study Terminated|250|||
170721777|NCT04642638|616985366|FG000|Overall Study|Pregnancy|0|||
170721778|NCT04642638|616985367|FG001|Overall Study|Pregnancy|0|||
170721779|NCT04642638|616985368|FG002|Overall Study|Pregnancy|0|||
170721780|NCT04642638|616985369|FG003|Overall Study|Pregnancy|0|||
170721781|NCT04642638|616985370|FG004|Overall Study|Pregnancy|1|||
170721782|NCT04642638|616985371|FG005|Overall Study|Pregnancy|0|||
170721783|NCT00511004|616985372|FG000|Overall Study|Lost to Follow-up|0|||
170721784|NCT00511004|616985373|FG001|Overall Study|Lost to Follow-up|0|||
170721785|NCT00511004|616985374|FG002|Overall Study|Lost to Follow-up|4|||
170721786|NCT00096135|616985380|FG000|Overall Study|Physician Decision|20|||
170721787|NCT00096135|616985381|FG001|Overall Study|Physician Decision|4|||
170721788|NCT00096135|616985380|FG000|Overall Study|Refusal of further protocol therapy|4|||
170721789|NCT00096135|616985381|FG001|Overall Study|Refusal of further protocol therapy|1|||
170721790|NCT00096135|616985380|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
170721791|NCT00096135|616985381|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
170721792|NCT00096135|616985380|FG000|Overall Study|Other, specify|15|||
170721793|NCT00096135|616985381|FG001|Overall Study|Other, specify|3|||
170721794|NCT00096135|616985380|FG000|Overall Study|Ineligible|2|||
170721795|NCT00096135|616985381|FG001|Overall Study|Ineligible|0|||
170721796|NCT02310750|616985383|FG000|HP Period 1|Lost to Follow-up|0|||
170721797|NCT02310750|616985384|FG001|HP Period 1|Lost to Follow-up|0|||
170721798|NCT02310750|616985385|FG002|HP Period 1|Lost to Follow-up|0|||
170721799|NCT02310750|616985386|FG003|HP Period 1|Lost to Follow-up|0|||
170721800|NCT02310750|616985387|FG004|HP Period 1|Lost to Follow-up|0|||
170721801|NCT02310750|616985388|FG005|HP Period 1|Lost to Follow-up|0|||
170721802|NCT02310750|616985389|FG006|HP Period 1|Lost to Follow-up|1|||
170721803|NCT02310750|616985390|FG007|HP Period 1|Lost to Follow-up|0|||
170721804|NCT02310750|616985391|FG008|HP Period 1|Lost to Follow-up|0|||
170721805|NCT02310750|616985392|FG009|HP Period 1|Lost to Follow-up|0|||
170721806|NCT02310750|616985393|FG010|HP Period 1|Lost to Follow-up|0|||
170721807|NCT02310750|616985394|FG011|HP Period 1|Lost to Follow-up|0|||
170831165|NCT03325608|617390246|FG002|Overall Study|Death of Care Recipient|28|||
170721808|NCT02310750|616985395|FG012|HP Period 1|Lost to Follow-up|0|||
170721809|NCT02310750|616985396|FG013|HP Period 1|Lost to Follow-up|0|||
170721810|NCT02310750|616985397|FG014|HP Period 1|Lost to Follow-up|0|||
170721811|NCT02310750|616985398|FG015|HP Period 1|Lost to Follow-up|0|||
170721812|NCT02310750|616985383|FG000|HP Period 1|Withdrawal by Subject|1|||
170721813|NCT02310750|616985384|FG001|HP Period 1|Withdrawal by Subject|0|||
170721814|NCT02310750|616985385|FG002|HP Period 1|Withdrawal by Subject|0|||
170721815|NCT02310750|616985386|FG003|HP Period 1|Withdrawal by Subject|1|||
170721816|NCT02310750|616985387|FG004|HP Period 1|Withdrawal by Subject|0|||
170721817|NCT02310750|616985388|FG005|HP Period 1|Withdrawal by Subject|0|||
170721818|NCT02310750|616985389|FG006|HP Period 1|Withdrawal by Subject|0|||
170721819|NCT02310750|616985390|FG007|HP Period 1|Withdrawal by Subject|0|||
170721820|NCT02310750|616985391|FG008|HP Period 1|Withdrawal by Subject|0|||
170721821|NCT02310750|616985392|FG009|HP Period 1|Withdrawal by Subject|0|||
170721822|NCT02310750|616985393|FG010|HP Period 1|Withdrawal by Subject|0|||
170721823|NCT02310750|616985394|FG011|HP Period 1|Withdrawal by Subject|0|||
170721824|NCT02310750|616985395|FG012|HP Period 1|Withdrawal by Subject|0|||
170721825|NCT02310750|616985396|FG013|HP Period 1|Withdrawal by Subject|0|||
170721826|NCT02310750|616985397|FG014|HP Period 1|Withdrawal by Subject|0|||
170721827|NCT02310750|616985398|FG015|HP Period 1|Withdrawal by Subject|0|||
170721828|NCT02310750|616985383|FG000|HP Washout 1|Lost to Follow-up|0|||
170721829|NCT02310750|616985384|FG001|HP Washout 1|Lost to Follow-up|0|||
170721830|NCT02310750|616985385|FG002|HP Washout 1|Lost to Follow-up|1|||
170721831|NCT02310750|616985386|FG003|HP Washout 1|Lost to Follow-up|1|||
170721832|NCT02310750|616985387|FG004|HP Washout 1|Lost to Follow-up|2|||
170721833|NCT02310750|616985388|FG005|HP Washout 1|Lost to Follow-up|2|||
170721834|NCT02310750|616985389|FG006|HP Washout 1|Lost to Follow-up|3|||
170721835|NCT02310750|616985390|FG007|HP Washout 1|Lost to Follow-up|0|||
170721836|NCT02310750|616985391|FG008|HP Washout 1|Lost to Follow-up|0|||
170721837|NCT02310750|616985392|FG009|HP Washout 1|Lost to Follow-up|0|||
170721838|NCT02310750|616985393|FG010|HP Washout 1|Lost to Follow-up|0|||
170721839|NCT02310750|616985394|FG011|HP Washout 1|Lost to Follow-up|0|||
170721840|NCT02310750|616985395|FG012|HP Washout 1|Lost to Follow-up|0|||
170721841|NCT02310750|616985396|FG013|HP Washout 1|Lost to Follow-up|0|||
170721842|NCT02310750|616985397|FG014|HP Washout 1|Lost to Follow-up|0|||
170721843|NCT02310750|616985398|FG015|HP Washout 1|Lost to Follow-up|0|||
170721844|NCT02310750|616985383|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721845|NCT02310750|616985384|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721846|NCT02310750|616985385|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721847|NCT02310750|616985386|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
170721848|NCT02310750|616985387|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721849|NCT02310750|616985388|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
170721850|NCT02310750|616985389|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721851|NCT02310750|616985390|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721852|NCT02310750|616985391|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
170721853|NCT02310750|616985392|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
170721854|NCT02310750|616985393|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721855|NCT02310750|616985394|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721856|NCT02310750|616985395|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721857|NCT02310750|616985396|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721858|NCT02310750|616985397|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721859|NCT02310750|616985398|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
170721860|NCT02310750|616985383|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721861|NCT02310750|616985384|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721862|NCT02310750|616985385|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721863|NCT02310750|616985386|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721864|NCT02310750|616985387|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721865|NCT02310750|616985388|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721866|NCT02310750|616985389|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721867|NCT02310750|616985390|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721868|NCT02310750|616985391|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721869|NCT02310750|616985392|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
170721870|NCT02310750|616985393|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721871|NCT02310750|616985394|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721872|NCT02310750|616985395|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721873|NCT02310750|616985396|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721874|NCT02310750|616985397|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721875|NCT02310750|616985398|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
170721876|NCT02310750|616985383|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721877|NCT02310750|616985384|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721878|NCT02310750|616985385|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721879|NCT02310750|616985386|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170831166|NCT03325608|617390247|FG003|Overall Study|Death of Care Recipient|28|||
170831167|NCT03325608|617390244|FG000|Overall Study|Withdrawal by Subject|49|||
170831168|NCT03325608|617390245|FG001|Overall Study|Withdrawal by Subject|49|||
170831169|NCT03325608|617390246|FG002|Overall Study|Withdrawal by Subject|35|||
170831170|NCT03325608|617390247|FG003|Overall Study|Withdrawal by Subject|35|||
170831171|NCT03325608|617390244|FG000|Overall Study|Ineligible|7|||
170831172|NCT03325608|617390245|FG001|Overall Study|Ineligible|7|||
170831173|NCT03325608|617390246|FG002|Overall Study|Ineligible|5|||
170721880|NCT02310750|616985387|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721881|NCT02310750|616985388|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721882|NCT02310750|616985389|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721883|NCT02310750|616985390|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
170721884|NCT02310750|616985391|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
170721885|NCT02310750|616985392|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
170721886|NCT02310750|616985393|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721887|NCT02310750|616985394|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721888|NCT02310750|616985395|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721889|NCT02310750|616985396|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721890|NCT02310750|616985397|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721891|NCT02310750|616985398|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
170721892|NCT02310750|616985383|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721893|NCT02310750|616985384|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721894|NCT02310750|616985385|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721895|NCT02310750|616985386|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721896|NCT02310750|616985387|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721897|NCT02310750|616985388|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721898|NCT02310750|616985389|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721899|NCT02310750|616985390|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
170721900|NCT02310750|616985391|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
170721901|NCT02310750|616985392|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721902|NCT02310750|616985393|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721903|NCT02310750|616985394|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721904|NCT02310750|616985395|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721905|NCT02310750|616985396|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721906|NCT02310750|616985397|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721907|NCT02310750|616985398|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
170721908|NCT02310750|616985383|FG000|HP Washout 2|Lost to Follow-up|0|||
170721909|NCT02310750|616985384|FG001|HP Washout 2|Lost to Follow-up|0|||
170721910|NCT02310750|616985385|FG002|HP Washout 2|Lost to Follow-up|0|||
170721911|NCT02310750|616985386|FG003|HP Washout 2|Lost to Follow-up|0|||
170721912|NCT02310750|616985387|FG004|HP Washout 2|Lost to Follow-up|1|||
170721913|NCT02310750|616985388|FG005|HP Washout 2|Lost to Follow-up|0|||
170721914|NCT02310750|616985389|FG006|HP Washout 2|Lost to Follow-up|7|||
170721915|NCT02310750|616985390|FG007|HP Washout 2|Lost to Follow-up|0|||
170721916|NCT02310750|616985391|FG008|HP Washout 2|Lost to Follow-up|0|||
170721917|NCT02310750|616985392|FG009|HP Washout 2|Lost to Follow-up|0|||
170721918|NCT02310750|616985393|FG010|HP Washout 2|Lost to Follow-up|0|||
170721919|NCT02310750|616985394|FG011|HP Washout 2|Lost to Follow-up|0|||
170721920|NCT02310750|616985395|FG012|HP Washout 2|Lost to Follow-up|0|||
170721921|NCT02310750|616985396|FG013|HP Washout 2|Lost to Follow-up|0|||
170721922|NCT02310750|616985397|FG014|HP Washout 2|Lost to Follow-up|0|||
170721923|NCT02310750|616985398|FG015|HP Washout 2|Lost to Follow-up|0|||
170721924|NCT03832946|616985399|FG000|Overall Study|Adverse Event|3|||
170721925|NCT03832946|616985400|FG001|Overall Study|Adverse Event|1|||
170721926|NCT03832946|616985399|FG000|Overall Study|Lost to Follow-up|1|||
170721927|NCT03832946|616985400|FG001|Overall Study|Lost to Follow-up|0|||
170721928|NCT03832946|616985399|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
170721929|NCT03832946|616985400|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
170721930|NCT03832946|616985399|FG000|Overall Study|Lack of Efficacy|1|||
170721931|NCT03832946|616985400|FG001|Overall Study|Lack of Efficacy|0|||
170721932|NCT03832946|616985399|FG000|Overall Study|Withdrawal by Subject|12|||
170721933|NCT03832946|616985400|FG001|Overall Study|Withdrawal by Subject|9|||
170721934|NCT01003249|616985401|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170721935|NCT01003249|616985402|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
170721936|NCT01003249|616985401|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
170721937|NCT01003249|616985402|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
170721938|NCT01003249|616985401|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
170721939|NCT01003249|616985402|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
170721940|NCT01003249|616985401|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
170721941|NCT01003249|616985402|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
170721942|NCT03394924|616985405|FG000|Overall Study|Adverse Event|0|||
170721943|NCT03394924|616985406|FG001|Overall Study|Adverse Event|5|||
170721944|NCT03394924|616985407|FG002|Overall Study|Adverse Event|0|||
170721945|NCT03394924|616985405|FG000|Overall Study|Withdrawal by Subject|2|||
170831174|NCT03325608|617390247|FG003|Overall Study|Ineligible|5|||
170831175|NCT02188784|617390248|FG000|Overall Study|Death|3|||
170831176|NCT02188784|617390249|FG001|Overall Study|Death|1|||
170721946|NCT03394924|616985406|FG001|Overall Study|Withdrawal by Subject|0|||
170721947|NCT03394924|616985407|FG002|Overall Study|Withdrawal by Subject|0|||
170721948|NCT03394924|616985405|FG000|Overall Study|Lost to Follow-up|0|||
170721949|NCT03394924|616985406|FG001|Overall Study|Lost to Follow-up|1|||
170721950|NCT03394924|616985407|FG002|Overall Study|Lost to Follow-up|0|||
170721951|NCT03394924|616985405|FG000|Overall Study|Did not meet all inclusion criteria|1|||
170721952|NCT03394924|616985406|FG001|Overall Study|Did not meet all inclusion criteria|0|||
170721953|NCT03394924|616985407|FG002|Overall Study|Did not meet all inclusion criteria|0|||
170721954|NCT00364858|616985418|FG000|Overall Study|Adverse Event|1|||
170721955|NCT00364858|616985419|FG001|Overall Study|Adverse Event|5|||
170721956|NCT00364858|616985418|FG000|Overall Study|Withdrawal by Subject|1|||
170721957|NCT00364858|616985419|FG001|Overall Study|Withdrawal by Subject|1|||
170721958|NCT00364858|616985418|FG000|Overall Study|Pregnancy|1|||
170721959|NCT00364858|616985419|FG001|Overall Study|Pregnancy|1|||
170721960|NCT00364858|616985418|FG000|Overall Study|Clinical failure|2|||
170721961|NCT00364858|616985419|FG001|Overall Study|Clinical failure|13|||
170721962|NCT00364858|616985418|FG000|Overall Study|Discontinuation at baseline|1|||
170721963|NCT00364858|616985419|FG001|Overall Study|Discontinuation at baseline|0|||
170721964|NCT00364858|616985418|FG000|Overall Study|Non-compliant|1|||
170721965|NCT00364858|616985419|FG001|Overall Study|Non-compliant|0|||
170721966|NCT00364858|616985418|FG000|Overall Study|Return to Q2 regimen|0|||
170721967|NCT00364858|616985419|FG001|Overall Study|Return to Q2 regimen|1|||
170831177|NCT02188784|617390248|FG000|Overall Study|Lost to Follow-up|1|||
170831178|NCT02188784|617390249|FG001|Overall Study|Lost to Follow-up|0|||
170831179|NCT02188784|617390248|FG000|Overall Study|Withdrawal by Subject|3|||
170831180|NCT02188784|617390249|FG001|Overall Study|Withdrawal by Subject|9|||
170831181|NCT02188784|617390248|FG000|Overall Study|Physician Decision|2|||
170831182|NCT02188784|617390249|FG001|Overall Study|Physician Decision|3|||
170831183|NCT03900715|617390253|FG000|Overall Study|Protocol Deviation|1|||
170831184|NCT03900715|617390253|FG000|Overall Study|Lack of Efficacy|1|||
170831185|NCT03900715|617390253|FG000|Overall Study|Progressive Disease|6|||
170831186|NCT03900715|617390253|FG000|Overall Study|Adverse Event|2|||
170831187|NCT03900715|617390253|FG000|Overall Study|Other reasons|11|||
170831188|NCT03467919|617392053|FG000|Overall Study|Withdrawal by Subject|3|||
170831189|NCT03467919|617392054|FG001|Overall Study|Withdrawal by Subject|2|||
170831190|NCT01638390|617392055|FG000|Overall Study|screening failures|21|||
170831191|NCT04991766|617392061|FG000|Overall Study|Withdrawal by Subject|2|||
170831192|NCT04991766|617392062|FG001|Overall Study|Withdrawal by Subject|0|||
170831193|NCT01165177|617392063|FG000|Overall Study|Serious Adverse Event|227|||
170831194|NCT01165177|617392064|FG001|Overall Study|Serious Adverse Event|235|||
170831195|NCT01165177|617392063|FG000|Overall Study|Withdrawal by Subject|368|||
170831196|NCT01165177|617392064|FG001|Overall Study|Withdrawal by Subject|354|||
170831197|NCT01165177|617392063|FG000|Overall Study|Protocol Violation|19|||
170831198|NCT01165177|617392064|FG001|Overall Study|Protocol Violation|21|||
170831199|NCT01165177|617392063|FG000|Overall Study|Non-serious adverse event|30|||
170831200|NCT01165177|617392064|FG001|Overall Study|Non-serious adverse event|18|||
170831201|NCT01165177|617392063|FG000|Overall Study|Other unspecified reasons|47|||
170831202|NCT01165177|617392064|FG001|Overall Study|Other unspecified reasons|35|||
170831203|NCT01165177|617392063|FG000|Overall Study|Suspected HZ episode|0|||
170831204|NCT01165177|617392064|FG001|Overall Study|Suspected HZ episode|2|||
170831205|NCT01165177|617392063|FG000|Overall Study|Lost to Follow-up|183|||
170831206|NCT01165177|617392064|FG001|Overall Study|Lost to Follow-up|194|||
170831207|NCT01165177|617392063|FG000|Overall Study|Migrated/ moved from study area|48|||
170831208|NCT01165177|617392064|FG001|Overall Study|Migrated/ moved from study area|43|||
170831209|NCT05499130|617392065|FG000|Overall Study|Adverse Event|2|||
170831210|NCT05499130|617392066|FG001|Overall Study|Adverse Event|0|||
170831211|NCT05499130|617392067|FG002|Overall Study|Adverse Event|1|||
170831212|NCT05499130|617392068|FG003|Overall Study|Adverse Event|0|||
170831213|NCT05499130|617392069|FG004|Overall Study|Adverse Event|1|||
170831214|NCT05499130|617392070|FG005|Overall Study|Adverse Event|4|||
170831215|NCT05499130|617392071|FG006|Overall Study|Adverse Event|1|||
170831216|NCT05499130|617392072|FG007|Overall Study|Adverse Event|0|||
170831217|NCT05499130|617392065|FG000|Overall Study|Lack of Efficacy|1|||
170831218|NCT05499130|617392066|FG001|Overall Study|Lack of Efficacy|0|||
170831219|NCT05499130|617392067|FG002|Overall Study|Lack of Efficacy|0|||
170831220|NCT05499130|617392068|FG003|Overall Study|Lack of Efficacy|0|||
170831221|NCT05499130|617392069|FG004|Overall Study|Lack of Efficacy|5|||
170831222|NCT05499130|617392070|FG005|Overall Study|Lack of Efficacy|0|||
170831223|NCT05499130|617392071|FG006|Overall Study|Lack of Efficacy|1|||
170721968|NCT00364858|616985418|FG000|Overall Study|Clinical baseline issue|0|||
170721969|NCT00364858|616985419|FG001|Overall Study|Clinical baseline issue|1|||
170721970|NCT02005471|616985420|FG000|Main Study|Adverse Event|0|||
170721971|NCT02005471|616985421|FG001|Main Study|Adverse Event|1|||
170831224|NCT05499130|617392072|FG007|Overall Study|Lack of Efficacy|0|||
170831225|NCT05499130|617392065|FG000|Overall Study|Withdrawal by Subject|2|||
170831226|NCT05499130|617392066|FG001|Overall Study|Withdrawal by Subject|0|||
170831227|NCT05499130|617392067|FG002|Overall Study|Withdrawal by Subject|0|||
170831228|NCT05499130|617392068|FG003|Overall Study|Withdrawal by Subject|0|||
170831229|NCT05499130|617392069|FG004|Overall Study|Withdrawal by Subject|1|||
170831230|NCT05499130|617392070|FG005|Overall Study|Withdrawal by Subject|2|||
170831231|NCT05499130|617392071|FG006|Overall Study|Withdrawal by Subject|0|||
170831232|NCT05499130|617392072|FG007|Overall Study|Withdrawal by Subject|0|||
170831233|NCT05499130|617392065|FG000|Overall Study|Lost to Follow-up|0|||
170831234|NCT05499130|617392066|FG001|Overall Study|Lost to Follow-up|0|||
170831235|NCT05499130|617392067|FG002|Overall Study|Lost to Follow-up|0|||
170831236|NCT05499130|617392068|FG003|Overall Study|Lost to Follow-up|0|||
170831237|NCT05499130|617392069|FG004|Overall Study|Lost to Follow-up|0|||
170831238|NCT05499130|617392070|FG005|Overall Study|Lost to Follow-up|2|||
170831239|NCT05499130|617392071|FG006|Overall Study|Lost to Follow-up|0|||
170831240|NCT05499130|617392072|FG007|Overall Study|Lost to Follow-up|0|||
170831241|NCT05499130|617392065|FG000|Overall Study|Other Than Specified|0|||
170831242|NCT05499130|617392066|FG001|Overall Study|Other Than Specified|0|||
170831243|NCT05499130|617392067|FG002|Overall Study|Other Than Specified|0|||
170831244|NCT05499130|617392068|FG003|Overall Study|Other Than Specified|0|||
170831245|NCT05499130|617392069|FG004|Overall Study|Other Than Specified|1|||
170831246|NCT05499130|617392070|FG005|Overall Study|Other Than Specified|1|||
170831247|NCT05499130|617392071|FG006|Overall Study|Other Than Specified|2|||
170831248|NCT05499130|617392072|FG007|Overall Study|Other Than Specified|0|||
170831249|NCT05499130|617392065|FG000|Overall Study|Protocol Violation|0|||
170831250|NCT05499130|617392066|FG001|Overall Study|Protocol Violation|0|||
170831251|NCT05499130|617392067|FG002|Overall Study|Protocol Violation|0|||
170831252|NCT05499130|617392068|FG003|Overall Study|Protocol Violation|0|||
170831253|NCT05499130|617392069|FG004|Overall Study|Protocol Violation|1|||
170831254|NCT05499130|617392070|FG005|Overall Study|Protocol Violation|0|||
170831255|NCT05499130|617392071|FG006|Overall Study|Protocol Violation|0|||
170831256|NCT05499130|617392072|FG007|Overall Study|Protocol Violation|0|||
170831257|NCT00013611|617392073|FG000|Overall Study|Lost to Follow-up|91|||
170831258|NCT00013611|617392074|FG001|Overall Study|Lost to Follow-up|100|||
170831259|NCT03194867|617392075|FG000|Overall Study|Incorrect completion of end of study form|0|||
170831260|NCT03194867|617392076|FG001|Overall Study|Incorrect completion of end of study form|0|||
170831261|NCT03194867|617392077|FG002|Overall Study|Incorrect completion of end of study form|1|||
170831262|NCT03194867|617392078|FG003|Overall Study|Incorrect completion of end of study form|0|||
170831263|NCT00464945|617392079|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
170831264|NCT00464945|617392080|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
170831265|NCT00464945|617392079|FG000|Infant Series|Protocol Violation|1|||
170721972|NCT02005471|616985422|FG002|Main Study|Adverse Event|0|||
170721973|NCT02005471|616985423|FG003|Main Study|Adverse Event|0|||
170721974|NCT02005471|616985420|FG000|Main Study|Death|83|||
170721975|NCT02005471|616985421|FG001|Main Study|Death|52|||
170721976|NCT02005471|616985422|FG002|Main Study|Death|0|||
170721977|NCT02005471|616985423|FG003|Main Study|Death|0|||
170721978|NCT02005471|616985420|FG000|Main Study|Lost to Follow-up|4|||
170721979|NCT02005471|616985421|FG001|Main Study|Lost to Follow-up|5|||
170721980|NCT02005471|616985422|FG002|Main Study|Lost to Follow-up|0|||
170721981|NCT02005471|616985423|FG003|Main Study|Lost to Follow-up|0|||
170721982|NCT02005471|616985420|FG000|Main Study|Physician Decision|3|||
170721983|NCT02005471|616985421|FG001|Main Study|Physician Decision|1|||
170831266|NCT00464945|617392080|FG001|Infant Series|Protocol Violation|0|||
170831267|NCT00464945|617392079|FG000|Infant Series|Lost to Follow-up|1|||
170831268|NCT00464945|617392080|FG001|Infant Series|Lost to Follow-up|0|||
170831269|NCT00464945|617392079|FG000|After Infant Series|Withdrawal by Subject|0|||
170831270|NCT00464945|617392080|FG001|After Infant Series|Withdrawal by Subject|2|||
170721984|NCT02005471|616985422|FG002|Main Study|Physician Decision|0|||
170721985|NCT02005471|616985423|FG003|Main Study|Physician Decision|0|||
170831271|NCT00464945|617392079|FG000|Toddler Dose|Lost to Follow-up|0|||
170831272|NCT00464945|617392080|FG001|Toddler Dose|Lost to Follow-up|1|||
170831273|NCT00543062|617392081|FG000|Overall Study|Withdrawal by Subject|1|||
170831274|NCT00543062|617392082|FG001|Overall Study|Withdrawal by Subject|0|||
170831275|NCT00543062|617392083|FG002|Overall Study|Withdrawal by Subject|2|||
170831276|NCT00543062|617392084|FG003|Overall Study|Withdrawal by Subject|0|||
170831277|NCT00543062|617392081|FG000|Overall Study|Adverse Event|0|||
170831278|NCT00543062|617392082|FG001|Overall Study|Adverse Event|1|||
170831279|NCT00543062|617392083|FG002|Overall Study|Adverse Event|1|||
170831280|NCT00543062|617392084|FG003|Overall Study|Adverse Event|1|||
170831281|NCT00543062|617392081|FG000|Overall Study|Protocol Violation|1|||
170831282|NCT00543062|617392082|FG001|Overall Study|Protocol Violation|0|||
170831283|NCT00543062|617392083|FG002|Overall Study|Protocol Violation|0|||
170831284|NCT00543062|617392084|FG003|Overall Study|Protocol Violation|0|||
170831285|NCT01663506|617392088|FG000|Overall Study|Lack of Efficacy|3|||
170831286|NCT01663506|617392088|FG000|Overall Study|Consent Withdrawal by Subject|1|||
170831287|NCT01663506|617392088|FG000|Overall Study|Lost to Follow-up|1|||
170831288|NCT01663506|617392088|FG000|Overall Study|Adverse Event|1|||
170831289|NCT01663506|617392088|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
170831290|NCT02094898|617392094|FG000|Overall Study|Clinical Worsening|2|||
170831291|NCT02094898|617392094|FG000|Overall Study|Adverse Event|2|||
170831292|NCT02094898|617392094|FG000|Overall Study|Lack of Efficacy|1|||
170831293|NCT03771898|617392095|FG000|Overall Study|Adverse Event|1|||
170831294|NCT03771898|617392096|FG001|Overall Study|Adverse Event|0|||
170831295|NCT03771898|617392097|FG002|Overall Study|Adverse Event|0|||
170831296|NCT03771898|617392098|FG003|Overall Study|Adverse Event|0|||
170831297|NCT03771898|617392099|FG004|Overall Study|Adverse Event|0|||
170831298|NCT03771898|617392095|FG000|Overall Study|Lost to Follow-up|1|||
170831299|NCT03771898|617392096|FG001|Overall Study|Lost to Follow-up|1|||
170831300|NCT03771898|617392097|FG002|Overall Study|Lost to Follow-up|1|||
170831301|NCT03771898|617392098|FG003|Overall Study|Lost to Follow-up|0|||
170831302|NCT03771898|617392099|FG004|Overall Study|Lost to Follow-up|0|||
170831303|NCT03771898|617392095|FG000|Overall Study|Withdrawal by parent/guardian|1|||
170831304|NCT03771898|617392096|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170831305|NCT03771898|617392097|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170831306|NCT03771898|617392098|FG003|Overall Study|Withdrawal by parent/guardian|0|||
170831307|NCT03771898|617392099|FG004|Overall Study|Withdrawal by parent/guardian|0|||
170831308|NCT03771898|617392095|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
170831309|NCT03771898|617392096|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
170721986|NCT02005471|616985420|FG000|Main Study|Withdrawal by Subject|26|||
170721987|NCT02005471|616985421|FG001|Main Study|Withdrawal by Subject|11|||
170721988|NCT02005471|616985422|FG002|Main Study|Withdrawal by Subject|0|||
170721989|NCT02005471|616985423|FG003|Main Study|Withdrawal by Subject|0|||
170721990|NCT02005471|616985420|FG000|Main Study|Reason not Specified|0|||
170721991|NCT02005471|616985421|FG001|Main Study|Reason not Specified|6|||
170721992|NCT02005471|616985422|FG002|Main Study|Reason not Specified|0|||
170721993|NCT02005471|616985423|FG003|Main Study|Reason not Specified|0|||
170721994|NCT02005471|616985420|FG000|Main Study|Randomized but not Dosed|8|||
170721995|NCT02005471|616985421|FG001|Main Study|Randomized but not Dosed|0|||
170721996|NCT02005471|616985422|FG002|Main Study|Randomized but not Dosed|0|||
170721997|NCT02005471|616985423|FG003|Main Study|Randomized but not Dosed|0|||
170721998|NCT02005471|616985420|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
170721999|NCT02005471|616985421|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
170722000|NCT02005471|616985422|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
170722001|NCT02005471|616985423|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
170722002|NCT02005471|616985420|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
170722003|NCT02005471|616985421|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
170722004|NCT02005471|616985422|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
170722005|NCT02005471|616985423|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
170722006|NCT02005471|616985420|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
170722007|NCT02005471|616985421|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
170722008|NCT02005471|616985422|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
170722009|NCT02005471|616985423|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
170722010|NCT00558285|616985424|FG000|Overall Study|Adverse Event|1|||
170722011|NCT00558285|616985425|FG001|Overall Study|Adverse Event|1|||
170722012|NCT00558285|616985426|FG002|Overall Study|Adverse Event|4|||
170722013|NCT00558285|616985427|FG003|Overall Study|Adverse Event|1|||
170722014|NCT00558285|616985428|FG004|Overall Study|Adverse Event|2|||
170722015|NCT00558285|616985424|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170722016|NCT00558285|616985425|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170722017|NCT00558285|616985426|FG002|Overall Study|Abnormal test procedure result(s)|0|||
170722018|NCT00558285|616985427|FG003|Overall Study|Abnormal test procedure result(s)|0|||
170831310|NCT03771898|617392097|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
170722019|NCT00558285|616985428|FG004|Overall Study|Abnormal test procedure result(s)|0|||
170722020|NCT00558285|616985424|FG000|Overall Study|Subject withdrew consent|2|||
170722021|NCT00558285|616985425|FG001|Overall Study|Subject withdrew consent|0|||
170722022|NCT00558285|616985426|FG002|Overall Study|Subject withdrew consent|1|||
170722023|NCT00558285|616985427|FG003|Overall Study|Subject withdrew consent|1|||
170722024|NCT00558285|616985428|FG004|Overall Study|Subject withdrew consent|1|||
170722025|NCT00558285|616985424|FG000|Overall Study|Lost to Follow-up|1|||
170722026|NCT00558285|616985425|FG001|Overall Study|Lost to Follow-up|1|||
170722027|NCT00558285|616985426|FG002|Overall Study|Lost to Follow-up|0|||
170722028|NCT00558285|616985427|FG003|Overall Study|Lost to Follow-up|0|||
170722029|NCT00558285|616985428|FG004|Overall Study|Lost to Follow-up|0|||
170722030|NCT00558285|616985424|FG000|Overall Study|Administrative problems|0|||
170722031|NCT00558285|616985425|FG001|Overall Study|Administrative problems|0|||
170722032|NCT00558285|616985426|FG002|Overall Study|Administrative problems|0|||
170722033|NCT00558285|616985427|FG003|Overall Study|Administrative problems|1|||
170722034|NCT00558285|616985428|FG004|Overall Study|Administrative problems|1|||
170722035|NCT00558285|616985424|FG000|Overall Study|Protocol deviation|1|||
170722036|NCT00558285|616985425|FG001|Overall Study|Protocol deviation|1|||
170722037|NCT00558285|616985426|FG002|Overall Study|Protocol deviation|0|||
170722038|NCT00558285|616985427|FG003|Overall Study|Protocol deviation|1|||
170722039|NCT00558285|616985428|FG004|Overall Study|Protocol deviation|0|||
170722040|NCT01660906|616985429|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
170722041|NCT03478891|616985435|FG000|Overall Study|Enrolled, but product never administered|0|||
170722042|NCT03478891|616985436|FG001|Overall Study|Enrolled, but product never administered|0|||
170722043|NCT03478891|616985437|FG002|Overall Study|Enrolled, but product never administered|1|||
170722044|NCT03478891|616985435|FG000|Overall Study|Moved from area|0|||
170722045|NCT03478891|616985436|FG001|Overall Study|Moved from area|0|||
170722046|NCT03478891|616985437|FG002|Overall Study|Moved from area|1|||
170722047|NCT03478891|616985435|FG000|Overall Study|Lost to Follow-up|1|||
170722048|NCT03478891|616985436|FG001|Overall Study|Lost to Follow-up|0|||
170722049|NCT03478891|616985437|FG002|Overall Study|Lost to Follow-up|1|||
170722050|NCT01308580|616985441|FG000|Overall Study|Lost to Follow-up|12|||
170831311|NCT03771898|617392098|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
170831312|NCT03771898|617392099|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
170831313|NCT03520075|617392100|FG000|Phase 1 (Dose Escalation)|Death|2|||
170831314|NCT03520075|617392101|FG001|Phase 1 (Dose Escalation)|Death|2|||
170831315|NCT03520075|617392102|FG002|Phase 1 (Dose Escalation)|Death|3|||
170831316|NCT03520075|617392103|FG003|Phase 1 (Dose Escalation)|Death|2|||
170831317|NCT03520075|617392104|FG004|Phase 1 (Dose Escalation)|Death|6|||
170831318|NCT03520075|617392105|FG005|Phase 1 (Dose Escalation)|Death|5|||
170831319|NCT03520075|617392106|FG006|Phase 1 (Dose Escalation)|Death|3|||
170831320|NCT03520075|617392107|FG007|Phase 1 (Dose Escalation)|Death|2|||
170831321|NCT03520075|617392108|FG008|Phase 1 (Dose Escalation)|Death|3|||
170831322|NCT03520075|617392109|FG009|Phase 1 (Dose Escalation)|Death|1|||
170831323|NCT03520075|617392110|FG010|Phase 1 (Dose Escalation)|Death|5|||
170831324|NCT03520075|617392111|FG011|Phase 1 (Dose Escalation)|Death|7|||
170831325|NCT03520075|617392112|FG012|Phase 1 (Dose Escalation)|Death|11|||
170831326|NCT03520075|617392113|FG013|Phase 1 (Dose Escalation)|Death|0|||
170831327|NCT03520075|617392114|FG014|Phase 1 (Dose Escalation)|Death|0|||
170831328|NCT03520075|617392115|FG015|Phase 1 (Dose Escalation)|Death|0|||
170831329|NCT03520075|617392116|FG016|Phase 1 (Dose Escalation)|Death|0|||
170831330|NCT03520075|617392117|FG017|Phase 1 (Dose Escalation)|Death|0|||
170831331|NCT03520075|617392118|FG018|Phase 1 (Dose Escalation)|Death|0|||
170831332|NCT03520075|617392100|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
170831333|NCT03520075|617392101|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831334|NCT03520075|617392102|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831335|NCT03520075|617392103|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
170831336|NCT03520075|617392104|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
170831337|NCT03520075|617392105|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
170831338|NCT03520075|617392106|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831339|NCT03520075|617392107|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
170831340|NCT03520075|617392108|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170722051|NCT01308580|616985442|FG001|Overall Study|Lost to Follow-up|7|||
170722052|NCT00110617|616985444|FG000|Overall Study|Adverse Event|2|||
170722053|NCT00110617|616985445|FG001|Overall Study|Adverse Event|4|||
170722054|NCT00110617|616985444|FG000|Overall Study|Abnormal Laboratory Value|4|||
170722055|NCT00110617|616985445|FG001|Overall Study|Abnormal Laboratory Value|2|||
170722056|NCT00110617|616985444|FG000|Overall Study|Lack of Efficacy|1|||
170722057|NCT00110617|616985445|FG001|Overall Study|Lack of Efficacy|0|||
170722058|NCT00110617|616985444|FG000|Overall Study|Patient no longer requires study drug|1|||
170722059|NCT00110617|616985445|FG001|Overall Study|Patient no longer requires study drug|0|||
170722060|NCT00110617|616985444|FG000|Overall Study|Protocol Violation|5|||
170722061|NCT00110617|616985445|FG001|Overall Study|Protocol Violation|0|||
170831341|NCT03520075|617392109|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
170831342|NCT03520075|617392110|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831343|NCT03520075|617392111|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831344|NCT03520075|617392112|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
170831345|NCT03520075|617392113|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831346|NCT03520075|617392114|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831347|NCT03520075|617392115|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831348|NCT03520075|617392116|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831349|NCT03520075|617392117|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831350|NCT03520075|617392118|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
170831351|NCT03520075|617392100|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831352|NCT03520075|617392101|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
170831353|NCT03520075|617392102|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831354|NCT03520075|617392103|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
170831355|NCT03520075|617392104|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
170831356|NCT03520075|617392105|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170722062|NCT00110617|616985444|FG000|Overall Study|Withdrawal by Subject|10|||
170722063|NCT00110617|616985445|FG001|Overall Study|Withdrawal by Subject|4|||
170722064|NCT00110617|616985444|FG000|Overall Study|Lost to Follow-up|9|||
170722065|NCT00110617|616985445|FG001|Overall Study|Lost to Follow-up|1|||
170722066|NCT00110617|616985444|FG000|Overall Study|Administrative problems|6|||
170722067|NCT00110617|616985445|FG001|Overall Study|Administrative problems|5|||
170722068|NCT00110617|616985444|FG000|Overall Study|Death|1|||
170722069|NCT00110617|616985445|FG001|Overall Study|Death|1|||
170722070|NCT00110617|616985444|FG000|Overall Study|Did not receive study drug|0|||
170722071|NCT00110617|616985445|FG001|Overall Study|Did not receive study drug|12|||
170722072|NCT02010060|616985447|FG000|Overall Study|Lost to Follow-up|1|||
170722073|NCT02010060|616985448|FG001|Overall Study|Lost to Follow-up|2|||
170722074|NCT02010060|616985449|FG002|Overall Study|Lost to Follow-up|2|||
170722075|NCT02010060|616985447|FG000|Overall Study|Injury|0|||
170722076|NCT02010060|616985448|FG001|Overall Study|Injury|1|||
170722077|NCT02010060|616985449|FG002|Overall Study|Injury|0|||
170722078|NCT05819749|616985450|FG000|Overall Study|Lost to Follow-up|1|||
170722079|NCT00844857|616988271|FG000|Overall Study|Adverse Event|24|||
170722080|NCT00844857|616988272|FG001|Overall Study|Adverse Event|5|||
170722081|NCT00844857|616988271|FG000|Overall Study|Sponsor Decision|1|||
170722082|NCT00844857|616988272|FG001|Overall Study|Sponsor Decision|1|||
170722083|NCT00844857|616988271|FG000|Overall Study|Physician Decision|2|||
170722084|NCT00844857|616988272|FG001|Overall Study|Physician Decision|0|||
170722085|NCT00844857|616988271|FG000|Overall Study|Parent/Caregiver Decision|6|||
170722086|NCT00844857|616988272|FG001|Overall Study|Parent/Caregiver Decision|2|||
170722087|NCT00844857|616988271|FG000|Overall Study|Withdrawal by Subject|8|||
170722088|NCT00844857|616988272|FG001|Overall Study|Withdrawal by Subject|7|||
170722089|NCT00844857|616988271|FG000|Overall Study|Protocol Violation|6|||
170722090|NCT00844857|616988272|FG001|Overall Study|Protocol Violation|0|||
170722091|NCT00844857|616988271|FG000|Overall Study|Lack of Efficacy|5|||
170722092|NCT00844857|616988272|FG001|Overall Study|Lack of Efficacy|5|||
170722093|NCT00844857|616988271|FG000|Overall Study|Clinical Relapse|0|||
170722094|NCT00844857|616988272|FG001|Overall Study|Clinical Relapse|1|||
170722095|NCT00844857|616988271|FG000|Overall Study|Entry Criteria Not Met|0|||
170722096|NCT00844857|616988272|FG001|Overall Study|Entry Criteria Not Met|1|||
170722097|NCT00844857|616988271|FG000|Overall Study|Lost to Follow-up|2|||
170722098|NCT00844857|616988272|FG001|Overall Study|Lost to Follow-up|3|||
170722099|NCT00844857|616988271|FG000|Overall Study|Did Not Take Study Drug|3|||
170722100|NCT00844857|616988272|FG001|Overall Study|Did Not Take Study Drug|1|||
170722101|NCT00844857|616988271|FG000|Overall Study|Good Clinical Practice Violations|21|||
170722102|NCT00844857|616988272|FG001|Overall Study|Good Clinical Practice Violations|11|||
170722103|NCT00570674|616988273|FG000|Overall Study|Withdrawal by Subject|0|||
170722104|NCT00570674|616988274|FG001|Overall Study|Withdrawal by Subject|0|||
170722105|NCT00570674|616988275|FG002|Overall Study|Withdrawal by Subject|1|||
170722106|NCT00570674|616988276|FG003|Overall Study|Withdrawal by Subject|0|||
170722107|NCT00570674|616988277|FG004|Overall Study|Withdrawal by Subject|0|||
170722108|NCT00570674|616988278|FG005|Overall Study|Withdrawal by Subject|0|||
170722109|NCT00570674|616988279|FG006|Overall Study|Withdrawal by Subject|0|||
170722110|NCT03069482|616988280|FG000|Overall Study|Lost to Follow-up|0|||
170722111|NCT03069482|616988281|FG001|Overall Study|Lost to Follow-up|1|||
170722112|NCT03069482|616988280|FG000|Overall Study|Physician Decision|1|||
170722113|NCT03069482|616988281|FG001|Overall Study|Physician Decision|0|||
170722114|NCT00907153|616988283|FG000|Overall Study|Lost to Follow-up|1|||
170722115|NCT00907153|616988284|FG001|Overall Study|Lost to Follow-up|1|||
170722116|NCT00907153|616988283|FG000|Overall Study|Withdrawal by Subject|1|||
170722117|NCT00907153|616988284|FG001|Overall Study|Withdrawal by Subject|3|||
170722118|NCT03393000|616988289|FG000|Overall Study|Death|11|||
170722119|NCT03393000|616988289|FG000|Overall Study|Withdrawal by Subject|2|||
170722120|NCT03393000|616988289|FG000|Overall Study|Physician Decision|1|||
170722121|NCT03240588|616988290|FG000|Overall Study|Death|3|||
170722122|NCT03240588|616988291|FG001|Overall Study|Death|0|||
170722123|NCT03240588|616988292|FG002|Overall Study|Death|0|||
170722124|NCT03240588|616988290|FG000|Overall Study|Adverse Event|5|||
170722125|NCT03240588|616988291|FG001|Overall Study|Adverse Event|4|||
170722126|NCT03240588|616988292|FG002|Overall Study|Adverse Event|0|||
170722127|NCT03240588|616988290|FG000|Overall Study|Lost to Follow-up|9|||
170722128|NCT03240588|616988291|FG001|Overall Study|Lost to Follow-up|4|||
170722129|NCT03240588|616988292|FG002|Overall Study|Lost to Follow-up|0|||
170722130|NCT03240588|616988290|FG000|Overall Study|Physician Decision|3|||
170722131|NCT03240588|616988291|FG001|Overall Study|Physician Decision|2|||
170722132|NCT03240588|616988292|FG002|Overall Study|Physician Decision|0|||
170722133|NCT03240588|616988290|FG000|Overall Study|Did not meet eligibility criteria|0|||
170722134|NCT03240588|616988291|FG001|Overall Study|Did not meet eligibility criteria|6|||
170722135|NCT03240588|616988292|FG002|Overall Study|Did not meet eligibility criteria|0|||
170722136|NCT03240588|616988290|FG000|Overall Study|No longer meets protocol criteria|12|||
170722137|NCT03240588|616988291|FG001|Overall Study|No longer meets protocol criteria|7|||
170722138|NCT03240588|616988292|FG002|Overall Study|No longer meets protocol criteria|0|||
170722139|NCT03240588|616988290|FG000|Overall Study|Withdrawal by Subject|60|||
170722140|NCT03240588|616988291|FG001|Overall Study|Withdrawal by Subject|52|||
170722141|NCT03240588|616988292|FG002|Overall Study|Withdrawal by Subject|7|||
170722142|NCT03240588|616988290|FG000|Overall Study|Other, additional details not available.|0|||
170722143|NCT03240588|616988291|FG001|Overall Study|Other, additional details not available.|12|||
170722144|NCT03240588|616988292|FG002|Overall Study|Other, additional details not available.|1|||
170722145|NCT03240588|616988290|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
170722146|NCT03240588|616988291|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
170722147|NCT03240588|616988292|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
170722148|NCT03240588|616988290|FG000|Overall Study|Closure of study|55|||
170722149|NCT03240588|616988291|FG001|Overall Study|Closure of study|3|||
170722150|NCT03240588|616988292|FG002|Overall Study|Closure of study|0|||
170722151|NCT03240588|616988290|FG000|Overall Study|Subject non-compliance|23|||
170722152|NCT03240588|616988291|FG001|Overall Study|Subject non-compliance|2|||
170722153|NCT03240588|616988292|FG002|Overall Study|Subject non-compliance|1|||
170722154|NCT03240588|616988290|FG000|Overall Study|Device Deficiency|1|||
170722155|NCT03240588|616988291|FG001|Overall Study|Device Deficiency|0|||
170722156|NCT03240588|616988292|FG002|Overall Study|Device Deficiency|0|||
170722157|NCT03240588|616988290|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
170722158|NCT03240588|616988291|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
170722159|NCT03240588|616988292|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
170722160|NCT03912259|616988293|FG000|Overall Study|Adverse Event (AE)|2|||
170722161|NCT03912259|616988294|FG001|Overall Study|Adverse Event (AE)|4|||
170722162|NCT03912259|616988293|FG000|Overall Study|Lack of Efficacy|4|||
170722163|NCT03912259|616988294|FG001|Overall Study|Lack of Efficacy|1|||
170722164|NCT03912259|616988293|FG000|Overall Study|Withdrawal by Subject|11|||
170722165|NCT03912259|616988294|FG001|Overall Study|Withdrawal by Subject|1|||
170722166|NCT03166618|616988296|FG000|Overall Study|Study was Terminated|0|||
170722167|NCT03166618|616988297|FG001|Overall Study|Study was Terminated|1|||
170722168|NCT00381940|616988298|FG000|Overall Study|Lack of Efficacy|3|||
170722169|NCT00381940|616988298|FG000|Overall Study|Protocol Violation|1|||
170722170|NCT00381940|616988298|FG000|Overall Study|Ineligible|1|||
170722171|NCT03162224|616988299|FG000|Overall Study|Death|4|||
170722172|NCT03162224|616988300|FG001|Overall Study|Death|5|||
170722173|NCT03162224|616988301|FG002|Overall Study|Death|8|||
170722174|NCT03162224|616988299|FG000|Overall Study|Withdrawal by Subject|1|||
170722175|NCT03162224|616988300|FG001|Overall Study|Withdrawal by Subject|0|||
170722176|NCT03162224|616988301|FG002|Overall Study|Withdrawal by Subject|1|||
170722177|NCT03162224|616988299|FG000|Overall Study|Lost to Follow-up|0|||
170722178|NCT03162224|616988300|FG001|Overall Study|Lost to Follow-up|1|||
170722179|NCT03162224|616988301|FG002|Overall Study|Lost to Follow-up|0|||
170722180|NCT03162224|616988299|FG000|Overall Study|Other|6|||
170722181|NCT03162224|616988300|FG001|Overall Study|Other|2|||
170722182|NCT03162224|616988301|FG002|Overall Study|Other|1|||
170722183|NCT01217073|616988302|FG000|Base Period|Adverse Event|1|||
170722184|NCT01217073|616988303|FG001|Base Period|Adverse Event|0|||
170722185|NCT01217073|616988304|FG002|Base Period|Adverse Event|1|||
170722186|NCT01217073|616988305|FG003|Base Period|Adverse Event|0|||
170722187|NCT01217073|616988306|FG004|Base Period|Adverse Event|4|||
170722188|NCT01217073|616988307|FG005|Base Period|Adverse Event|1|||
170831357|NCT03520075|617392106|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831358|NCT03520075|617392107|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170722189|NCT01217073|616988308|FG006|Base Period|Adverse Event|0|||
170722190|NCT01217073|616988309|FG007|Base Period|Adverse Event|0|||
170722191|NCT01217073|616988302|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
170722192|NCT01217073|616988303|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
170722193|NCT01217073|616988304|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
170831359|NCT03520075|617392108|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831360|NCT03520075|617392109|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831361|NCT03520075|617392110|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
170831362|NCT03520075|617392111|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831363|NCT03520075|617392112|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
170831364|NCT03520075|617392113|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831365|NCT03520075|617392114|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831366|NCT03520075|617392115|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831367|NCT03520075|617392116|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831368|NCT03520075|617392117|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831369|NCT03520075|617392118|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
170831370|NCT03520075|617392100|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831371|NCT03520075|617392101|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831372|NCT03520075|617392102|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831373|NCT03520075|617392103|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831374|NCT03520075|617392104|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831375|NCT03520075|617392105|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831376|NCT03520075|617392106|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831377|NCT03520075|617392107|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831378|NCT03520075|617392108|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831379|NCT03520075|617392109|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
170722194|NCT01217073|616988305|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
170722195|NCT01217073|616988306|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
170722196|NCT01217073|616988307|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
170722197|NCT01217073|616988308|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
170722198|NCT01217073|616988309|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
170722199|NCT01217073|616988302|FG000|Base Period|Excluded medication|0|||
170722200|NCT01217073|616988303|FG001|Base Period|Excluded medication|0|||
170722201|NCT01217073|616988304|FG002|Base Period|Excluded medication|0|||
170722202|NCT01217073|616988305|FG003|Base Period|Excluded medication|0|||
170722203|NCT01217073|616988306|FG004|Base Period|Excluded medication|1|||
170722204|NCT01217073|616988307|FG005|Base Period|Excluded medication|0|||
170722205|NCT01217073|616988308|FG006|Base Period|Excluded medication|0|||
170722206|NCT01217073|616988309|FG007|Base Period|Excluded medication|0|||
170722207|NCT01217073|616988302|FG000|Base Period|Lack of Efficacy|0|||
170722208|NCT01217073|616988303|FG001|Base Period|Lack of Efficacy|0|||
170722209|NCT01217073|616988304|FG002|Base Period|Lack of Efficacy|0|||
170722210|NCT01217073|616988305|FG003|Base Period|Lack of Efficacy|0|||
170722211|NCT01217073|616988306|FG004|Base Period|Lack of Efficacy|0|||
170722212|NCT01217073|616988307|FG005|Base Period|Lack of Efficacy|1|||
170722213|NCT01217073|616988308|FG006|Base Period|Lack of Efficacy|0|||
170722214|NCT01217073|616988309|FG007|Base Period|Lack of Efficacy|0|||
170722215|NCT01217073|616988302|FG000|Base Period|Lost to Follow-up|0|||
170722216|NCT01217073|616988303|FG001|Base Period|Lost to Follow-up|0|||
170722217|NCT01217073|616988304|FG002|Base Period|Lost to Follow-up|1|||
170722218|NCT01217073|616988305|FG003|Base Period|Lost to Follow-up|1|||
170722219|NCT01217073|616988306|FG004|Base Period|Lost to Follow-up|3|||
170722220|NCT01217073|616988307|FG005|Base Period|Lost to Follow-up|0|||
170722221|NCT01217073|616988308|FG006|Base Period|Lost to Follow-up|0|||
170722222|NCT01217073|616988309|FG007|Base Period|Lost to Follow-up|0|||
170722223|NCT01217073|616988302|FG000|Base Period|Physician Decision|0|||
170722224|NCT01217073|616988303|FG001|Base Period|Physician Decision|0|||
170722225|NCT01217073|616988304|FG002|Base Period|Physician Decision|0|||
170722226|NCT01217073|616988305|FG003|Base Period|Physician Decision|0|||
170831380|NCT03520075|617392110|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831381|NCT03520075|617392111|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831382|NCT03520075|617392112|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
170831383|NCT03520075|617392113|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170722227|NCT01217073|616988306|FG004|Base Period|Physician Decision|1|||
170722228|NCT01217073|616988307|FG005|Base Period|Physician Decision|0|||
170722229|NCT01217073|616988308|FG006|Base Period|Physician Decision|0|||
170722230|NCT01217073|616988309|FG007|Base Period|Physician Decision|0|||
170722231|NCT01217073|616988302|FG000|Base Period|Protocol Violation|1|||
170722232|NCT01217073|616988303|FG001|Base Period|Protocol Violation|0|||
170722233|NCT01217073|616988304|FG002|Base Period|Protocol Violation|0|||
170722234|NCT01217073|616988305|FG003|Base Period|Protocol Violation|0|||
170722235|NCT01217073|616988306|FG004|Base Period|Protocol Violation|1|||
170722236|NCT01217073|616988307|FG005|Base Period|Protocol Violation|2|||
170722237|NCT01217073|616988308|FG006|Base Period|Protocol Violation|0|||
170722238|NCT01217073|616988309|FG007|Base Period|Protocol Violation|0|||
170722239|NCT01217073|616988302|FG000|Base Period|Withdrawal by Subject|4|||
170722240|NCT01217073|616988303|FG001|Base Period|Withdrawal by Subject|5|||
170722241|NCT01217073|616988304|FG002|Base Period|Withdrawal by Subject|5|||
170722242|NCT01217073|616988305|FG003|Base Period|Withdrawal by Subject|1|||
170722243|NCT01217073|616988306|FG004|Base Period|Withdrawal by Subject|5|||
170722244|NCT01217073|616988307|FG005|Base Period|Withdrawal by Subject|5|||
170722245|NCT01217073|616988308|FG006|Base Period|Withdrawal by Subject|0|||
170722246|NCT01217073|616988309|FG007|Base Period|Withdrawal by Subject|0|||
170722247|NCT01217073|616988302|FG000|Extension Period|Adverse Event|0|||
170722248|NCT01217073|616988303|FG001|Extension Period|Adverse Event|0|||
170722249|NCT01217073|616988304|FG002|Extension Period|Adverse Event|0|||
170722250|NCT01217073|616988305|FG003|Extension Period|Adverse Event|0|||
170722251|NCT01217073|616988306|FG004|Extension Period|Adverse Event|0|||
170722252|NCT01217073|616988307|FG005|Extension Period|Adverse Event|0|||
170722253|NCT01217073|616988308|FG006|Extension Period|Adverse Event|19|||
170722254|NCT01217073|616988309|FG007|Extension Period|Adverse Event|5|||
170722255|NCT01217073|616988302|FG000|Extension Period|ALT/AST|0|||
170722256|NCT01217073|616988303|FG001|Extension Period|ALT/AST|0|||
170722257|NCT01217073|616988304|FG002|Extension Period|ALT/AST|0|||
170722258|NCT01217073|616988305|FG003|Extension Period|ALT/AST|0|||
170722259|NCT01217073|616988306|FG004|Extension Period|ALT/AST|0|||
170722260|NCT01217073|616988307|FG005|Extension Period|ALT/AST|0|||
170722261|NCT01217073|616988308|FG006|Extension Period|ALT/AST|2|||
170722262|NCT01217073|616988309|FG007|Extension Period|ALT/AST|0|||
170722263|NCT01217073|616988302|FG000|Extension Period|Contraindication to study medication|0|||
170722264|NCT01217073|616988303|FG001|Extension Period|Contraindication to study medication|0|||
170722265|NCT01217073|616988304|FG002|Extension Period|Contraindication to study medication|0|||
170722266|NCT01217073|616988305|FG003|Extension Period|Contraindication to study medication|0|||
170722267|NCT01217073|616988306|FG004|Extension Period|Contraindication to study medication|0|||
170722268|NCT01217073|616988307|FG005|Extension Period|Contraindication to study medication|0|||
170722269|NCT01217073|616988308|FG006|Extension Period|Contraindication to study medication|1|||
170722270|NCT01217073|616988309|FG007|Extension Period|Contraindication to study medication|0|||
170722271|NCT01217073|616988302|FG000|Extension Period|Creatinine/eGFR|0|||
170722272|NCT01217073|616988303|FG001|Extension Period|Creatinine/eGFR|0|||
170722273|NCT01217073|616988304|FG002|Extension Period|Creatinine/eGFR|0|||
170722274|NCT01217073|616988305|FG003|Extension Period|Creatinine/eGFR|0|||
170722275|NCT01217073|616988306|FG004|Extension Period|Creatinine/eGFR|0|||
170722276|NCT01217073|616988307|FG005|Extension Period|Creatinine/eGFR|0|||
170722277|NCT01217073|616988308|FG006|Extension Period|Creatinine/eGFR|11|||
170722278|NCT01217073|616988309|FG007|Extension Period|Creatinine/eGFR|1|||
170722279|NCT01217073|616988302|FG000|Extension Period|Death|0|||
170722280|NCT01217073|616988303|FG001|Extension Period|Death|0|||
170722281|NCT01217073|616988304|FG002|Extension Period|Death|0|||
170722282|NCT01217073|616988305|FG003|Extension Period|Death|0|||
170722283|NCT01217073|616988306|FG004|Extension Period|Death|0|||
170722284|NCT01217073|616988307|FG005|Extension Period|Death|0|||
170722285|NCT01217073|616988308|FG006|Extension Period|Death|1|||
170722286|NCT01217073|616988309|FG007|Extension Period|Death|0|||
170722287|NCT01217073|616988302|FG000|Extension Period|Excluded medication|0|||
170722288|NCT01217073|616988303|FG001|Extension Period|Excluded medication|0|||
170722289|NCT01217073|616988304|FG002|Extension Period|Excluded medication|0|||
170722290|NCT01217073|616988305|FG003|Extension Period|Excluded medication|0|||
170722291|NCT01217073|616988306|FG004|Extension Period|Excluded medication|0|||
170722292|NCT01217073|616988307|FG005|Extension Period|Excluded medication|0|||
170722293|NCT01217073|616988308|FG006|Extension Period|Excluded medication|2|||
170722294|NCT01217073|616988309|FG007|Extension Period|Excluded medication|0|||
170722295|NCT01217073|616988302|FG000|Extension Period|Lack of Efficacy|0|||
170722296|NCT01217073|616988303|FG001|Extension Period|Lack of Efficacy|0|||
170722297|NCT01217073|616988304|FG002|Extension Period|Lack of Efficacy|0|||
170722298|NCT01217073|616988305|FG003|Extension Period|Lack of Efficacy|0|||
170722299|NCT01217073|616988306|FG004|Extension Period|Lack of Efficacy|0|||
170722300|NCT01217073|616988307|FG005|Extension Period|Lack of Efficacy|0|||
170722301|NCT01217073|616988308|FG006|Extension Period|Lack of Efficacy|3|||
170722302|NCT01217073|616988309|FG007|Extension Period|Lack of Efficacy|0|||
170722303|NCT01217073|616988302|FG000|Extension Period|Lost to Follow-up|0|||
170722304|NCT01217073|616988303|FG001|Extension Period|Lost to Follow-up|0|||
170722305|NCT01217073|616988304|FG002|Extension Period|Lost to Follow-up|0|||
170722306|NCT01217073|616988305|FG003|Extension Period|Lost to Follow-up|0|||
170722307|NCT01217073|616988306|FG004|Extension Period|Lost to Follow-up|0|||
170722308|NCT01217073|616988307|FG005|Extension Period|Lost to Follow-up|0|||
170722309|NCT01217073|616988308|FG006|Extension Period|Lost to Follow-up|9|||
170722310|NCT01217073|616988309|FG007|Extension Period|Lost to Follow-up|1|||
170722311|NCT01217073|616988302|FG000|Extension Period|Non-compliance with study drug|0|||
170722312|NCT01217073|616988303|FG001|Extension Period|Non-compliance with study drug|0|||
170722313|NCT01217073|616988304|FG002|Extension Period|Non-compliance with study drug|0|||
170722314|NCT01217073|616988305|FG003|Extension Period|Non-compliance with study drug|0|||
170722315|NCT01217073|616988306|FG004|Extension Period|Non-compliance with study drug|0|||
170722316|NCT01217073|616988307|FG005|Extension Period|Non-compliance with study drug|0|||
170722317|NCT01217073|616988308|FG006|Extension Period|Non-compliance with study drug|0|||
170722318|NCT01217073|616988309|FG007|Extension Period|Non-compliance with study drug|1|||
170722319|NCT01217073|616988302|FG000|Extension Period|Physician Decision|0|||
170722320|NCT01217073|616988303|FG001|Extension Period|Physician Decision|0|||
170722321|NCT01217073|616988304|FG002|Extension Period|Physician Decision|0|||
170722322|NCT01217073|616988305|FG003|Extension Period|Physician Decision|0|||
170722323|NCT01217073|616988306|FG004|Extension Period|Physician Decision|0|||
170722324|NCT01217073|616988307|FG005|Extension Period|Physician Decision|0|||
170722325|NCT01217073|616988308|FG006|Extension Period|Physician Decision|4|||
170722326|NCT01217073|616988309|FG007|Extension Period|Physician Decision|1|||
170722327|NCT01217073|616988302|FG000|Extension Period|Protocol Violation|0|||
170722328|NCT01217073|616988303|FG001|Extension Period|Protocol Violation|0|||
170722329|NCT01217073|616988304|FG002|Extension Period|Protocol Violation|0|||
170722330|NCT01217073|616988305|FG003|Extension Period|Protocol Violation|0|||
170722331|NCT01217073|616988306|FG004|Extension Period|Protocol Violation|0|||
170722332|NCT01217073|616988307|FG005|Extension Period|Protocol Violation|0|||
170722333|NCT01217073|616988308|FG006|Extension Period|Protocol Violation|2|||
170722334|NCT01217073|616988309|FG007|Extension Period|Protocol Violation|1|||
170722335|NCT01217073|616988302|FG000|Extension Period|Site discontinued study participation|0|||
170722336|NCT01217073|616988303|FG001|Extension Period|Site discontinued study participation|0|||
170722337|NCT01217073|616988304|FG002|Extension Period|Site discontinued study participation|0|||
170722338|NCT01217073|616988305|FG003|Extension Period|Site discontinued study participation|0|||
170722339|NCT01217073|616988306|FG004|Extension Period|Site discontinued study participation|0|||
170722340|NCT01217073|616988307|FG005|Extension Period|Site discontinued study participation|0|||
170722341|NCT01217073|616988308|FG006|Extension Period|Site discontinued study participation|7|||
170722342|NCT01217073|616988309|FG007|Extension Period|Site discontinued study participation|2|||
170722343|NCT01217073|616988302|FG000|Extension Period|Withdrawal by Subject|0|||
170722344|NCT01217073|616988303|FG001|Extension Period|Withdrawal by Subject|0|||
170722345|NCT01217073|616988304|FG002|Extension Period|Withdrawal by Subject|0|||
170831384|NCT03520075|617392114|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831385|NCT03520075|617392115|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831386|NCT03520075|617392116|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831387|NCT03520075|617392117|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831388|NCT03520075|617392118|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
170831389|NCT03520075|617392100|FG000|Phase 2 (Dose Expansion)|Death|0|||
170831390|NCT03520075|617392101|FG001|Phase 2 (Dose Expansion)|Death|0|||
170831391|NCT03520075|617392102|FG002|Phase 2 (Dose Expansion)|Death|0|||
170831392|NCT03520075|617392103|FG003|Phase 2 (Dose Expansion)|Death|0|||
170831393|NCT03520075|617392104|FG004|Phase 2 (Dose Expansion)|Death|0|||
170831394|NCT03520075|617392105|FG005|Phase 2 (Dose Expansion)|Death|0|||
170831395|NCT03520075|617392106|FG006|Phase 2 (Dose Expansion)|Death|0|||
170831396|NCT03520075|617392107|FG007|Phase 2 (Dose Expansion)|Death|0|||
170831397|NCT03520075|617392108|FG008|Phase 2 (Dose Expansion)|Death|0|||
170831398|NCT03520075|617392109|FG009|Phase 2 (Dose Expansion)|Death|0|||
170831399|NCT03520075|617392110|FG010|Phase 2 (Dose Expansion)|Death|0|||
170831400|NCT03520075|617392111|FG011|Phase 2 (Dose Expansion)|Death|0|||
170831401|NCT03520075|617392112|FG012|Phase 2 (Dose Expansion)|Death|0|||
170831402|NCT03520075|617392113|FG013|Phase 2 (Dose Expansion)|Death|20|||
170831403|NCT03520075|617392114|FG014|Phase 2 (Dose Expansion)|Death|13|||
170831404|NCT03520075|617392115|FG015|Phase 2 (Dose Expansion)|Death|9|||
170831405|NCT03520075|617392116|FG016|Phase 2 (Dose Expansion)|Death|5|||
170831406|NCT03520075|617392117|FG017|Phase 2 (Dose Expansion)|Death|14|||
170831407|NCT03520075|617392118|FG018|Phase 2 (Dose Expansion)|Death|12|||
170831408|NCT03520075|617392100|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831409|NCT03520075|617392101|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831410|NCT03520075|617392102|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831411|NCT03520075|617392103|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831412|NCT03520075|617392104|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831413|NCT03520075|617392105|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831414|NCT03520075|617392106|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831415|NCT03520075|617392107|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831416|NCT03520075|617392108|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170722346|NCT01217073|616988305|FG003|Extension Period|Withdrawal by Subject|0|||
170722347|NCT01217073|616988306|FG004|Extension Period|Withdrawal by Subject|0|||
170722348|NCT01217073|616988307|FG005|Extension Period|Withdrawal by Subject|0|||
170831417|NCT03520075|617392109|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831418|NCT03520075|617392110|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831419|NCT03520075|617392111|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831420|NCT03520075|617392112|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831421|NCT03520075|617392113|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
170831422|NCT03520075|617392114|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
170831423|NCT03520075|617392115|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
170831424|NCT03520075|617392116|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
170831425|NCT03520075|617392117|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
170831426|NCT03520075|617392118|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
170831427|NCT03520075|617392100|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831428|NCT03520075|617392101|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831429|NCT03520075|617392102|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831430|NCT03520075|617392103|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831431|NCT03520075|617392104|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831432|NCT03520075|617392105|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831433|NCT03520075|617392106|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831434|NCT03520075|617392107|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831435|NCT03520075|617392108|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831436|NCT03520075|617392109|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831437|NCT03520075|617392110|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831438|NCT03520075|617392111|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831439|NCT03520075|617392112|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831440|NCT03520075|617392113|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831441|NCT03520075|617392114|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
170831442|NCT03520075|617392115|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
170831443|NCT03520075|617392116|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831444|NCT03520075|617392117|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
170831445|NCT03520075|617392118|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
170831446|NCT03520075|617392100|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831447|NCT03520075|617392101|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831448|NCT03520075|617392102|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831449|NCT03520075|617392103|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831450|NCT03520075|617392104|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831451|NCT03520075|617392105|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831452|NCT03520075|617392106|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831453|NCT03520075|617392107|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831454|NCT03520075|617392108|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831455|NCT03520075|617392109|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831456|NCT03520075|617392110|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831457|NCT03520075|617392111|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831458|NCT03520075|617392112|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831459|NCT03520075|617392113|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
170831460|NCT03520075|617392114|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831461|NCT03520075|617392115|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831462|NCT03520075|617392116|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
170831463|NCT03520075|617392117|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
170831464|NCT03520075|617392118|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
170831465|NCT01432626|617392121|FG000|Overall Study|LV function recovered|2|||
170831466|NCT01432626|617392121|FG000|Overall Study|Withdrawal by Subject|2|||
170722349|NCT01217073|616988308|FG006|Extension Period|Withdrawal by Subject|30|||
170722350|NCT01217073|616988309|FG007|Extension Period|Withdrawal by Subject|8|||
170722351|NCT03561090|616988310|FG000|Overall Study|Adverse Event|11|||
170722352|NCT03561090|616988311|FG001|Overall Study|Adverse Event|7|||
170722353|NCT03561090|616988310|FG000|Overall Study|Non-Compliance With Study Drug|2|||
170722354|NCT03561090|616988311|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170722355|NCT03561090|616988310|FG000|Overall Study|Protocol Violation|2|||
170722356|NCT03561090|616988311|FG001|Overall Study|Protocol Violation|2|||
170722357|NCT03561090|616988310|FG000|Overall Study|Withdrawal by Subject|7|||
170722358|NCT03561090|616988311|FG001|Overall Study|Withdrawal by Subject|7|||
170722359|NCT03561090|616988310|FG000|Overall Study|Lost to Follow-up|7|||
170722360|NCT03561090|616988311|FG001|Overall Study|Lost to Follow-up|2|||
170722361|NCT03561090|616988310|FG000|Overall Study|Study Terminated by Sponsor|10|||
170722362|NCT03561090|616988311|FG001|Overall Study|Study Terminated by Sponsor|15|||
170722363|NCT03561090|616988310|FG000|Overall Study|Randomized by Mistake|1|||
170722364|NCT03561090|616988311|FG001|Overall Study|Randomized by Mistake|1|||
170722365|NCT03561090|616988310|FG000|Overall Study|Other Not Specified|0|||
170722366|NCT03561090|616988311|FG001|Overall Study|Other Not Specified|2|||
170722367|NCT00725452|616988312|FG000|Overall Study|Adverse Event|3|||
170722368|NCT00725452|616988312|FG000|Overall Study|Lack of Efficacy|2|||
170722369|NCT00725452|616988312|FG000|Overall Study|Reason not specified|1|||
170722370|NCT00725452|616988312|FG000|Overall Study|Physician Decision|1|||
170722371|NCT00725452|616988312|FG000|Overall Study|Withdrawal by Subject|3|||
170722372|NCT00725452|616988312|FG000|Overall Study|Lost to Follow-up|1|||
170722373|NCT02047045|616988313|FG000|Baseline|Withdrawal by Subject|3|||
170722374|NCT02047045|616988314|FG001|Baseline|Withdrawal by Subject|2|||
170722375|NCT02047045|616988313|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
170722376|NCT02047045|616988314|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
170722377|NCT02047045|616988313|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
170722378|NCT02047045|616988314|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
170722379|NCT02047045|616988313|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
170722380|NCT02047045|616988314|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
170722381|NCT02047045|616988313|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
170722382|NCT02047045|616988314|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
170722383|NCT02047045|616988313|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
170722384|NCT02047045|616988314|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
170722385|NCT02047045|616988313|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
170722386|NCT02047045|616988314|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
170722387|NCT02047045|616988313|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
170722388|NCT02047045|616988314|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
170722389|NCT02047045|616988313|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
170722390|NCT02047045|616988314|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
170722391|NCT03701555|616988320|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
170722392|NCT03701555|616988321|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
170722393|NCT03701555|616988322|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
170722394|NCT03701555|616988323|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
170722395|NCT03701555|616988324|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
170722396|NCT03701555|616988325|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
170722397|NCT03701555|616988326|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
170722398|NCT03701555|616988327|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
170722399|NCT03701555|616988328|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
170722400|NCT03701555|616988329|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
170722401|NCT03701555|616988330|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
170722402|NCT03701555|616988331|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
170722403|NCT03701555|616988332|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
170722404|NCT03701555|616988333|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
170722405|NCT03701555|616988334|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
170722406|NCT03701555|616988335|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
170722407|NCT03701555|616988336|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
170722408|NCT03701555|616988337|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
170722409|NCT03701555|616988338|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
170722410|NCT03701555|616988339|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
170722411|NCT03701555|616988340|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
170722412|NCT03701555|616988341|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
170722413|NCT03701555|616988342|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
170722414|NCT03701555|616988343|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
170722415|NCT03701555|616988344|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
170722416|NCT03701555|616988345|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
170722417|NCT03701555|616988346|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
170722418|NCT03701555|616988347|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
170722419|NCT03701555|616988348|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
170722420|NCT03701555|616988349|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
170722421|NCT03701555|616988350|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
170722422|NCT03701555|616988351|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
170722423|NCT03701555|616988352|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
170722424|NCT03701555|616988353|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
170722425|NCT03701555|616988354|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
170722426|NCT03701555|616988355|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
170722427|NCT03701555|616988320|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
170722428|NCT03701555|616988321|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
170722429|NCT03701555|616988322|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
170722430|NCT03701555|616988323|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
170722431|NCT03701555|616988324|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
170722432|NCT03701555|616988325|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
170722433|NCT03701555|616988326|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
170722434|NCT03701555|616988327|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
170722435|NCT03701555|616988328|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
170722436|NCT03701555|616988329|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
170722437|NCT03701555|616988330|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
170722438|NCT03701555|616988331|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
170722439|NCT03701555|616988332|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
170722440|NCT03701555|616988333|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
170722441|NCT03701555|616988334|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
170722442|NCT03701555|616988335|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
170722443|NCT03701555|616988336|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
170722444|NCT03701555|616988337|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
170722445|NCT03701555|616988338|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
170722446|NCT03701555|616988339|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
170722447|NCT03701555|616988340|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
170722448|NCT03701555|616988341|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
170722449|NCT03701555|616988342|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
170722450|NCT03701555|616988343|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
170722451|NCT03701555|616988344|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
170722452|NCT03701555|616988345|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
170722453|NCT03701555|616988346|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
170722454|NCT03701555|616988347|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
170722455|NCT03701555|616988348|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
170722456|NCT03701555|616988349|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
170722457|NCT03701555|616988350|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
170722458|NCT03701555|616988351|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
170722459|NCT03701555|616988352|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
170722460|NCT03701555|616988353|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
170722461|NCT03701555|616988354|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
170722462|NCT03701555|616988355|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
170722463|NCT03701555|616988320|FG000|Part 2 (Day 1)|Other|0|||
170722464|NCT03701555|616988321|FG001|Part 2 (Day 1)|Other|0|||
170722465|NCT03701555|616988322|FG002|Part 2 (Day 1)|Other|0|||
170722466|NCT03701555|616988323|FG003|Part 2 (Day 1)|Other|0|||
170722467|NCT03701555|616988324|FG004|Part 2 (Day 1)|Other|0|||
170722468|NCT03701555|616988325|FG005|Part 2 (Day 1)|Other|0|||
170722469|NCT03701555|616988326|FG006|Part 2 (Day 1)|Other|0|||
170722470|NCT03701555|616988327|FG007|Part 2 (Day 1)|Other|0|||
170722471|NCT03701555|616988328|FG008|Part 2 (Day 1)|Other|0|||
170722472|NCT03701555|616988329|FG009|Part 2 (Day 1)|Other|0|||
170722473|NCT03701555|616988330|FG010|Part 2 (Day 1)|Other|3|||
170722474|NCT03701555|616988331|FG011|Part 2 (Day 1)|Other|1|||
170722475|NCT03701555|616988332|FG012|Part 2 (Day 1)|Other|0|||
170722476|NCT03701555|616988333|FG013|Part 2 (Day 1)|Other|1|||
170722477|NCT03701555|616988334|FG014|Part 2 (Day 1)|Other|0|||
170722478|NCT03701555|616988335|FG015|Part 2 (Day 1)|Other|2|||
170722479|NCT03701555|616988336|FG016|Part 2 (Day 1)|Other|2|||
170722480|NCT03701555|616988337|FG017|Part 2 (Day 1)|Other|0|||
170722481|NCT03701555|616988338|FG018|Part 2 (Day 1)|Other|0|||
170722482|NCT03701555|616988339|FG019|Part 2 (Day 1)|Other|0|||
170722483|NCT03701555|616988340|FG020|Part 2 (Day 1)|Other|0|||
170722484|NCT03701555|616988341|FG021|Part 2 (Day 1)|Other|0|||
170722485|NCT03701555|616988342|FG022|Part 2 (Day 1)|Other|0|||
170722486|NCT03701555|616988343|FG023|Part 2 (Day 1)|Other|0|||
170722487|NCT03701555|616988344|FG024|Part 2 (Day 1)|Other|0|||
170722488|NCT03701555|616988345|FG025|Part 2 (Day 1)|Other|0|||
170722489|NCT03701555|616988346|FG026|Part 2 (Day 1)|Other|0|||
170722490|NCT03701555|616988347|FG027|Part 2 (Day 1)|Other|0|||
170722491|NCT03701555|616988348|FG028|Part 2 (Day 1)|Other|0|||
170722492|NCT03701555|616988349|FG029|Part 2 (Day 1)|Other|0|||
170722493|NCT03701555|616988350|FG030|Part 2 (Day 1)|Other|0|||
170722494|NCT03701555|616988351|FG031|Part 2 (Day 1)|Other|0|||
170722495|NCT03701555|616988352|FG032|Part 2 (Day 1)|Other|0|||
170722496|NCT03701555|616988353|FG033|Part 2 (Day 1)|Other|0|||
170722497|NCT03701555|616988354|FG034|Part 2 (Day 1)|Other|0|||
170722498|NCT03701555|616988355|FG035|Part 2 (Day 1)|Other|0|||
170722499|NCT03701555|616988320|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
170722500|NCT03701555|616988321|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
170722501|NCT03701555|616988322|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
170722502|NCT03701555|616988323|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
170722503|NCT03701555|616988324|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
170722504|NCT03701555|616988325|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
170831467|NCT01432626|617392121|FG000|Overall Study|Only 1 image competed|2|||
170831468|NCT01432626|617392121|FG000|Overall Study|Imaging agent not available|1|||
170831469|NCT00328562|617392122|FG000|Overall Study|Disease progression|1|||
170831470|NCT04014790|617392123|FG000|Overall Study|Death|4|||
170831471|NCT04014790|617392123|FG000|Overall Study|Adverse Event|1|||
170831472|NCT04014790|617392123|FG000|Overall Study|Withdrawal by Subject|1|||
170831473|NCT00816556|617392126|FG000|Overall Study|Adverse Event|1|||
170831474|NCT00816556|617392127|FG001|Overall Study|Adverse Event|1|||
170831475|NCT00816556|617392128|FG002|Overall Study|Adverse Event|1|||
170831476|NCT00816556|617392126|FG000|Overall Study|Withdrawal by Subject|1|||
170831477|NCT00816556|617392127|FG001|Overall Study|Withdrawal by Subject|1|||
170831478|NCT00816556|617392128|FG002|Overall Study|Withdrawal by Subject|1|||
170831479|NCT00816556|617392126|FG000|Overall Study|Lost to Follow-up|0|||
170831480|NCT00816556|617392127|FG001|Overall Study|Lost to Follow-up|0|||
170831481|NCT00816556|617392128|FG002|Overall Study|Lost to Follow-up|1|||
170831482|NCT03546816|617392129|FG000|Overall Study|Adverse Event|5|||
170831483|NCT03546816|617392130|FG001|Overall Study|Adverse Event|3|||
170831484|NCT03546816|617392129|FG000|Overall Study|Lack of Efficacy|2|||
170831485|NCT03546816|617392130|FG001|Overall Study|Lack of Efficacy|4|||
170831486|NCT03546816|617392129|FG000|Overall Study|Pregnancy|1|||
170831487|NCT03546816|617392130|FG001|Overall Study|Pregnancy|0|||
170831488|NCT03546816|617392129|FG000|Overall Study|Physician Decision|2|||
170831489|NCT03546816|617392130|FG001|Overall Study|Physician Decision|0|||
170831490|NCT03546816|617392129|FG000|Overall Study|Withdrawal by Subject|8|||
170831491|NCT03546816|617392130|FG001|Overall Study|Withdrawal by Subject|10|||
170831492|NCT03546816|617392129|FG000|Overall Study|Lost to Follow-up|3|||
170831493|NCT03546816|617392130|FG001|Overall Study|Lost to Follow-up|2|||
170831494|NCT01161446|617392131|FG000|Overall Study|Lost to Follow-up|18|||
170831495|NCT01161446|617392132|FG001|Overall Study|Lost to Follow-up|14|||
170831496|NCT01161446|617392131|FG000|Overall Study|Withdrawal by Subject|0|||
170831497|NCT01161446|617392132|FG001|Overall Study|Withdrawal by Subject|1|||
170831498|NCT00810342|617392133|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
170831499|NCT00810342|617392134|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
170831500|NCT00810342|617392133|FG000|Month 1 Follow-up|Pregnancy|1|||
170831501|NCT00810342|617392134|FG001|Month 1 Follow-up|Pregnancy|0|||
170831502|NCT00810342|617392133|FG000|6-month Follow-up|Lost to Follow-up|18|||
170831503|NCT00810342|617392134|FG001|6-month Follow-up|Lost to Follow-up|6|||
170831504|NCT00810342|617392133|FG000|6-month Follow-up|Pregnancy|6|||
170831505|NCT00810342|617392134|FG001|6-month Follow-up|Pregnancy|2|||
170831506|NCT00810342|617392133|FG000|12-month Followup|Pregnancy|9|||
170831507|NCT00810342|617392134|FG001|12-month Followup|Pregnancy|10|||
170831508|NCT00810342|617392133|FG000|12-month Followup|Lost to Follow-up|3|||
170831509|NCT00810342|617392134|FG001|12-month Followup|Lost to Follow-up|1|||
170831510|NCT03210519|617392135|FG000|Overall Study|Adverse Event|2|||
170831511|NCT03210519|617392136|FG001|Overall Study|Adverse Event|0|||
170831512|NCT02270671|617392137|FG000|Overall Study|Withdrawal by Subject|1|||
170831513|NCT02270671|617392138|FG001|Overall Study|Withdrawal by Subject|1|||
170831514|NCT02270671|617392137|FG000|Overall Study|Protocol Violation|0|||
170831515|NCT02270671|617392138|FG001|Overall Study|Protocol Violation|1|||
170831516|NCT02270671|617392137|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
170831517|NCT02270671|617392138|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
170831518|NCT02270671|617392137|FG000|Overall Study|Lost to Follow-up|2|||
170831519|NCT02270671|617392138|FG001|Overall Study|Lost to Follow-up|1|||
170831520|NCT02330562|617392143|FG000|Overall Study|Adverse Event|0|||
170831521|NCT02330562|617392144|FG001|Overall Study|Adverse Event|0|||
170831522|NCT02330562|617392145|FG002|Overall Study|Adverse Event|3|||
170831523|NCT02330562|617392146|FG003|Overall Study|Adverse Event|0|||
170831524|NCT02330562|617392147|FG004|Overall Study|Adverse Event|3|||
170831525|NCT02330562|617392148|FG005|Overall Study|Adverse Event|1|||
170831526|NCT02330562|617392149|FG006|Overall Study|Adverse Event|0|||
170831527|NCT02330562|617392150|FG007|Overall Study|Adverse Event|0|||
170831528|NCT02330562|617392151|FG008|Overall Study|Adverse Event|0|||
170831529|NCT02330562|617392152|FG009|Overall Study|Adverse Event|1|||
170831530|NCT02330562|617392153|FG010|Overall Study|Adverse Event|1|||
170831531|NCT02330562|617392143|FG000|Overall Study|Participant decision|1|||
170831532|NCT02330562|617392144|FG001|Overall Study|Participant decision|0|||
170831533|NCT02330562|617392145|FG002|Overall Study|Participant decision|4|||
170831534|NCT02330562|617392146|FG003|Overall Study|Participant decision|1|||
170831535|NCT02330562|617392147|FG004|Overall Study|Participant decision|5|||
170831536|NCT02330562|617392148|FG005|Overall Study|Participant decision|2|||
170831537|NCT02330562|617392149|FG006|Overall Study|Participant decision|0|||
170831538|NCT02330562|617392150|FG007|Overall Study|Participant decision|0|||
170831539|NCT02330562|617392151|FG008|Overall Study|Participant decision|0|||
170831540|NCT02330562|617392152|FG009|Overall Study|Participant decision|3|||
170831541|NCT02330562|617392153|FG010|Overall Study|Participant decision|0|||
170831542|NCT02330562|617392143|FG000|Overall Study|Disease progression|5|||
170831543|NCT02330562|617392144|FG001|Overall Study|Disease progression|3|||
170831544|NCT02330562|617392145|FG002|Overall Study|Disease progression|20|||
170831545|NCT02330562|617392146|FG003|Overall Study|Disease progression|28|||
170831546|NCT02330562|617392147|FG004|Overall Study|Disease progression|23|||
170831547|NCT02330562|617392148|FG005|Overall Study|Disease progression|7|||
170831548|NCT02330562|617392149|FG006|Overall Study|Disease progression|1|||
170831549|NCT02330562|617392150|FG007|Overall Study|Disease progression|1|||
170831550|NCT02330562|617392151|FG008|Overall Study|Disease progression|1|||
170831551|NCT02330562|617392152|FG009|Overall Study|Disease progression|0|||
170831552|NCT02330562|617392153|FG010|Overall Study|Disease progression|5|||
170831553|NCT02330562|617392143|FG000|Overall Study|Other reasons|0|||
170831554|NCT02330562|617392144|FG001|Overall Study|Other reasons|0|||
170722505|NCT03701555|616988326|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
170722506|NCT03701555|616988327|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
170722507|NCT03701555|616988328|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
170722508|NCT03701555|616988329|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
170722509|NCT03701555|616988330|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
170722510|NCT03701555|616988331|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
170722511|NCT03701555|616988332|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
170722512|NCT03701555|616988333|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
170722513|NCT03701555|616988334|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
170722514|NCT03701555|616988335|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
170722515|NCT03701555|616988336|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
170722516|NCT03701555|616988337|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
170722517|NCT03701555|616988338|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
170722518|NCT03701555|616988339|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
170722519|NCT03701555|616988340|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
170722520|NCT03701555|616988341|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
170722521|NCT03701555|616988342|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
170722522|NCT03701555|616988343|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
170722523|NCT03701555|616988344|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
170722524|NCT03701555|616988345|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
170722525|NCT03701555|616988346|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
170722526|NCT03701555|616988347|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
170722527|NCT03701555|616988348|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
170722528|NCT03701555|616988349|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
170722529|NCT03701555|616988350|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
170722530|NCT03701555|616988351|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
170722531|NCT03701555|616988352|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
170722532|NCT03701555|616988353|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
170722533|NCT03701555|616988354|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
170722534|NCT03701555|616988355|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
170722535|NCT03701555|616988320|FG000|Part 3 (Day 1)|Subject Decision|0|||
170722536|NCT03701555|616988321|FG001|Part 3 (Day 1)|Subject Decision|0|||
170722537|NCT03701555|616988322|FG002|Part 3 (Day 1)|Subject Decision|0|||
170722538|NCT03701555|616988323|FG003|Part 3 (Day 1)|Subject Decision|0|||
170722539|NCT03701555|616988324|FG004|Part 3 (Day 1)|Subject Decision|0|||
170722540|NCT03701555|616988325|FG005|Part 3 (Day 1)|Subject Decision|0|||
170722541|NCT03701555|616988326|FG006|Part 3 (Day 1)|Subject Decision|0|||
170722542|NCT03701555|616988327|FG007|Part 3 (Day 1)|Subject Decision|0|||
170722543|NCT03701555|616988328|FG008|Part 3 (Day 1)|Subject Decision|0|||
170722544|NCT03701555|616988329|FG009|Part 3 (Day 1)|Subject Decision|0|||
170722545|NCT03701555|616988330|FG010|Part 3 (Day 1)|Subject Decision|0|||
170722546|NCT03701555|616988331|FG011|Part 3 (Day 1)|Subject Decision|0|||
170722547|NCT03701555|616988332|FG012|Part 3 (Day 1)|Subject Decision|0|||
170722548|NCT03701555|616988333|FG013|Part 3 (Day 1)|Subject Decision|0|||
170722549|NCT03701555|616988334|FG014|Part 3 (Day 1)|Subject Decision|0|||
170722550|NCT03701555|616988335|FG015|Part 3 (Day 1)|Subject Decision|0|||
170722551|NCT03701555|616988336|FG016|Part 3 (Day 1)|Subject Decision|0|||
170722552|NCT03701555|616988337|FG017|Part 3 (Day 1)|Subject Decision|0|||
170722553|NCT03701555|616988338|FG018|Part 3 (Day 1)|Subject Decision|0|||
170722554|NCT03701555|616988339|FG019|Part 3 (Day 1)|Subject Decision|0|||
170722555|NCT03701555|616988340|FG020|Part 3 (Day 1)|Subject Decision|0|||
170722556|NCT03701555|616988341|FG021|Part 3 (Day 1)|Subject Decision|0|||
170722557|NCT03701555|616988342|FG022|Part 3 (Day 1)|Subject Decision|0|||
170722558|NCT03701555|616988343|FG023|Part 3 (Day 1)|Subject Decision|0|||
170722559|NCT03701555|616988344|FG024|Part 3 (Day 1)|Subject Decision|0|||
170722560|NCT03701555|616988345|FG025|Part 3 (Day 1)|Subject Decision|0|||
170722561|NCT03701555|616988346|FG026|Part 3 (Day 1)|Subject Decision|1|||
170722562|NCT03701555|616988347|FG027|Part 3 (Day 1)|Subject Decision|0|||
170722563|NCT03701555|616988348|FG028|Part 3 (Day 1)|Subject Decision|0|||
170722564|NCT03701555|616988349|FG029|Part 3 (Day 1)|Subject Decision|0|||
170722565|NCT03701555|616988350|FG030|Part 3 (Day 1)|Subject Decision|0|||
170722566|NCT03701555|616988351|FG031|Part 3 (Day 1)|Subject Decision|2|||
170722567|NCT03701555|616988352|FG032|Part 3 (Day 1)|Subject Decision|1|||
170722568|NCT03701555|616988353|FG033|Part 3 (Day 1)|Subject Decision|1|||
170722569|NCT03701555|616988354|FG034|Part 3 (Day 1)|Subject Decision|0|||
170722570|NCT03701555|616988355|FG035|Part 3 (Day 1)|Subject Decision|0|||
170722571|NCT03701555|616988320|FG000|Part 3 (Day 1)|Other|0|||
170722572|NCT03701555|616988321|FG001|Part 3 (Day 1)|Other|0|||
170722573|NCT03701555|616988322|FG002|Part 3 (Day 1)|Other|0|||
170722574|NCT03701555|616988323|FG003|Part 3 (Day 1)|Other|0|||
170722575|NCT03701555|616988324|FG004|Part 3 (Day 1)|Other|0|||
170722576|NCT03701555|616988325|FG005|Part 3 (Day 1)|Other|0|||
170722577|NCT03701555|616988326|FG006|Part 3 (Day 1)|Other|0|||
170722578|NCT03701555|616988327|FG007|Part 3 (Day 1)|Other|0|||
170722579|NCT03701555|616988328|FG008|Part 3 (Day 1)|Other|0|||
170722580|NCT03701555|616988329|FG009|Part 3 (Day 1)|Other|0|||
170722581|NCT03701555|616988330|FG010|Part 3 (Day 1)|Other|0|||
170722582|NCT03701555|616988331|FG011|Part 3 (Day 1)|Other|0|||
170722583|NCT03701555|616988332|FG012|Part 3 (Day 1)|Other|0|||
170722584|NCT03701555|616988333|FG013|Part 3 (Day 1)|Other|0|||
170722585|NCT03701555|616988334|FG014|Part 3 (Day 1)|Other|0|||
170722586|NCT03701555|616988335|FG015|Part 3 (Day 1)|Other|0|||
170722587|NCT03701555|616988336|FG016|Part 3 (Day 1)|Other|0|||
170722588|NCT03701555|616988337|FG017|Part 3 (Day 1)|Other|0|||
170722589|NCT03701555|616988338|FG018|Part 3 (Day 1)|Other|0|||
170722590|NCT03701555|616988339|FG019|Part 3 (Day 1)|Other|0|||
170722591|NCT03701555|616988340|FG020|Part 3 (Day 1)|Other|0|||
170722592|NCT03701555|616988341|FG021|Part 3 (Day 1)|Other|0|||
170722593|NCT03701555|616988342|FG022|Part 3 (Day 1)|Other|0|||
170831555|NCT02330562|617392145|FG002|Overall Study|Other reasons|0|||
170831556|NCT02330562|617392146|FG003|Overall Study|Other reasons|1|||
170831557|NCT02330562|617392147|FG004|Overall Study|Other reasons|0|||
170831558|NCT02330562|617392148|FG005|Overall Study|Other reasons|0|||
170831559|NCT02330562|617392149|FG006|Overall Study|Other reasons|0|||
170831560|NCT02330562|617392150|FG007|Overall Study|Other reasons|0|||
170831561|NCT02330562|617392151|FG008|Overall Study|Other reasons|0|||
170831562|NCT02330562|617392152|FG009|Overall Study|Other reasons|0|||
170831563|NCT02330562|617392153|FG010|Overall Study|Other reasons|0|||
170831564|NCT02330562|617392143|FG000|Overall Study|Withdrawal by Subject|0|||
170831565|NCT02330562|617392144|FG001|Overall Study|Withdrawal by Subject|0|||
170831566|NCT02330562|617392145|FG002|Overall Study|Withdrawal by Subject|0|||
170831567|NCT02330562|617392146|FG003|Overall Study|Withdrawal by Subject|0|||
170831568|NCT02330562|617392147|FG004|Overall Study|Withdrawal by Subject|0|||
170831569|NCT02330562|617392148|FG005|Overall Study|Withdrawal by Subject|0|||
170831570|NCT02330562|617392149|FG006|Overall Study|Withdrawal by Subject|0|||
170831571|NCT02330562|617392150|FG007|Overall Study|Withdrawal by Subject|0|||
170831572|NCT02330562|617392151|FG008|Overall Study|Withdrawal by Subject|0|||
170831573|NCT02330562|617392152|FG009|Overall Study|Withdrawal by Subject|1|||
170831574|NCT02330562|617392153|FG010|Overall Study|Withdrawal by Subject|0|||
170831575|NCT01657799|617392155|FG000|Overall Study|Adverse Event Related to progression|6|||
170831576|NCT01657799|617392156|FG001|Overall Study|Adverse Event Related to progression|8|||
170831577|NCT01657799|617392157|FG002|Overall Study|Adverse Event Related to progression|12|||
170831578|NCT01657799|617392155|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
170831579|NCT01657799|617392156|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
170831580|NCT01657799|617392157|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
170831581|NCT01657799|617392155|FG000|Overall Study|Withdrawal by Subject|13|||
170831582|NCT01657799|617392156|FG001|Overall Study|Withdrawal by Subject|10|||
170831583|NCT01657799|617392157|FG002|Overall Study|Withdrawal by Subject|10|||
170831584|NCT01657799|617392155|FG000|Overall Study|Lost to Follow-up|1|||
170831585|NCT01657799|617392156|FG001|Overall Study|Lost to Follow-up|0|||
170831586|NCT01657799|617392157|FG002|Overall Study|Lost to Follow-up|1|||
170831587|NCT01657799|617392155|FG000|Overall Study|Disease Progression|2|||
170831588|NCT01657799|617392156|FG001|Overall Study|Disease Progression|4|||
170831589|NCT01657799|617392157|FG002|Overall Study|Disease Progression|4|||
170831590|NCT01657799|617392155|FG000|Overall Study|Progressive Disease Clinical|7|||
170831591|NCT01657799|617392156|FG001|Overall Study|Progressive Disease Clinical|4|||
170831592|NCT01657799|617392157|FG002|Overall Study|Progressive Disease Clinical|7|||
170831593|NCT01657799|617392155|FG000|Overall Study|Radiographic & Clinical Progression|16|||
170831594|NCT01657799|617392156|FG001|Overall Study|Radiographic & Clinical Progression|11|||
170831595|NCT01657799|617392157|FG002|Overall Study|Radiographic & Clinical Progression|15|||
170831596|NCT01657799|617392155|FG000|Overall Study|Other|52|||
170831597|NCT01657799|617392156|FG001|Overall Study|Other|62|||
170831598|NCT01657799|617392157|FG002|Overall Study|Other|49|||
170831599|NCT00126659|617392160|FG000|Overall Study|Adverse Event|0|||
170831600|NCT00126659|617392161|FG001|Overall Study|Adverse Event|0|||
170831601|NCT00126659|617392162|FG002|Overall Study|Adverse Event|2|||
170831602|NCT00174447|617392167|FG000|Overall Study|Adverse Event|19|||
170831603|NCT00174447|617392167|FG000|Overall Study|Withdrawal by Subject|15|||
170831604|NCT00174447|617392167|FG000|Overall Study|Protocol Violation|1|||
170831605|NCT00174447|617392167|FG000|Overall Study|Lack of Efficacy|1|||
170831606|NCT00174447|617392167|FG000|Overall Study|Administrative reason/Other|2|||
170831607|NCT03634839|617392174|FG000|First Intervention (2 Hours)|Adverse Event|0|||
170831608|NCT03634839|617392175|FG001|First Intervention (2 Hours)|Adverse Event|2|||
170831609|NCT01777490|617392178|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
170831610|NCT01777490|617392179|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
170831611|NCT01777490|617392180|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
170831612|NCT01777490|617392181|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
170831613|NCT03414047|617392184|FG000|Overall Study|Adverse Event|0|||
170831614|NCT03414047|617392185|FG001|Overall Study|Adverse Event|0|||
170831615|NCT03414047|617392186|FG002|Overall Study|Adverse Event|1|||
170831616|NCT03414047|617392187|FG003|Overall Study|Adverse Event|1|||
170831617|NCT03414047|617392184|FG000|Overall Study|Physician Decision|1|||
170831618|NCT03414047|617392185|FG001|Overall Study|Physician Decision|0|||
170831619|NCT03414047|617392186|FG002|Overall Study|Physician Decision|0|||
170831620|NCT03414047|617392187|FG003|Overall Study|Physician Decision|1|||
170831621|NCT03414047|617392184|FG000|Overall Study|Withdrawal by Subject|1|||
170831622|NCT03414047|617392185|FG001|Overall Study|Withdrawal by Subject|0|||
170831623|NCT03414047|617392186|FG002|Overall Study|Withdrawal by Subject|2|||
170831624|NCT03414047|617392187|FG003|Overall Study|Withdrawal by Subject|0|||
170831625|NCT01772563|617392188|FG000|Cycle 1|Dose limiting toxicity|2|||
170831626|NCT01772563|617392188|FG000|Cycle 1|Progressive disease|2|||
170831627|NCT01772563|617392188|FG000|Cycle 2 and Beyond|Progressive disease|17|||
170831628|NCT01772563|617392188|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
170831629|NCT01772563|617392188|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
170831630|NCT01898442|617392191|FG000|Overall Study|Hemolysis/technical problems|1|||
170831631|NCT01898442|617392192|FG001|Overall Study|Hemolysis/technical problems|2|||
170831632|NCT01898442|617392193|FG002|Overall Study|Hemolysis/technical problems|2|||
170831633|NCT01898442|617392191|FG000|Overall Study|Patient vomited pills|0|||
170831634|NCT01898442|617392192|FG001|Overall Study|Patient vomited pills|0|||
170831635|NCT01898442|617392193|FG002|Overall Study|Patient vomited pills|1|||
170831636|NCT01129115|617392195|FG000|Overall Study|Adverse Event|1|||
170831637|NCT01129115|617392196|FG001|Overall Study|Adverse Event|2|||
170831638|NCT01129115|617392197|FG002|Overall Study|Adverse Event|3|||
170831639|NCT01129115|617392198|FG003|Overall Study|Adverse Event|3|||
170831640|NCT01129115|617392195|FG000|Overall Study|Withdrawal by Subject|1|||
170831641|NCT01129115|617392196|FG001|Overall Study|Withdrawal by Subject|3|||
170831642|NCT01129115|617392197|FG002|Overall Study|Withdrawal by Subject|1|||
170831643|NCT01129115|617392198|FG003|Overall Study|Withdrawal by Subject|4|||
170831644|NCT01129115|617392195|FG000|Overall Study|Protocol Violation|0|||
170831645|NCT01129115|617392196|FG001|Overall Study|Protocol Violation|2|||
170831646|NCT01129115|617392197|FG002|Overall Study|Protocol Violation|2|||
170831647|NCT01129115|617392198|FG003|Overall Study|Protocol Violation|2|||
170831648|NCT02635386|617392200|FG000|Overall Study|Pregnancy|2|||
170831649|NCT02635386|617392201|FG001|Overall Study|Pregnancy|0|||
170831650|NCT02635386|617392202|FG002|Overall Study|Pregnancy|0|||
170831651|NCT02635386|617392203|FG003|Overall Study|Pregnancy|0|||
170831652|NCT02635386|617392204|FG004|Overall Study|Pregnancy|2|||
170831653|NCT02635386|617392200|FG000|Overall Study|Withdrawal by Subject|1|||
170831654|NCT02635386|617392201|FG001|Overall Study|Withdrawal by Subject|1|||
170831655|NCT02635386|617392202|FG002|Overall Study|Withdrawal by Subject|0|||
170831656|NCT02635386|617392203|FG003|Overall Study|Withdrawal by Subject|1|||
170831657|NCT02635386|617392204|FG004|Overall Study|Withdrawal by Subject|0|||
170831658|NCT02635386|617392200|FG000|Overall Study|Physician Decision|0|||
170831659|NCT02635386|617392201|FG001|Overall Study|Physician Decision|1|||
170831660|NCT02635386|617392202|FG002|Overall Study|Physician Decision|0|||
170831661|NCT02635386|617392203|FG003|Overall Study|Physician Decision|0|||
170722594|NCT03701555|616988343|FG023|Part 3 (Day 1)|Other|0|||
170722595|NCT03701555|616988344|FG024|Part 3 (Day 1)|Other|1|||
170722596|NCT03701555|616988345|FG025|Part 3 (Day 1)|Other|1|||
170722597|NCT03701555|616988346|FG026|Part 3 (Day 1)|Other|0|||
170722598|NCT03701555|616988347|FG027|Part 3 (Day 1)|Other|0|||
170722599|NCT03701555|616988348|FG028|Part 3 (Day 1)|Other|0|||
170722600|NCT03701555|616988349|FG029|Part 3 (Day 1)|Other|1|||
170722601|NCT03701555|616988350|FG030|Part 3 (Day 1)|Other|1|||
170722602|NCT03701555|616988351|FG031|Part 3 (Day 1)|Other|0|||
170722603|NCT03701555|616988352|FG032|Part 3 (Day 1)|Other|1|||
170722604|NCT03701555|616988353|FG033|Part 3 (Day 1)|Other|1|||
170722605|NCT03701555|616988354|FG034|Part 3 (Day 1)|Other|0|||
170722606|NCT03701555|616988355|FG035|Part 3 (Day 1)|Other|0|||
170722607|NCT00448539|616988356|FG000|Overall Study|Medication non-compliance|4|||
170722608|NCT00448539|616988357|FG001|Overall Study|Medication non-compliance|1|||
170722609|NCT00448539|616988356|FG000|Overall Study|Protocol Violation|1|||
170722610|NCT00448539|616988357|FG001|Overall Study|Protocol Violation|0|||
170722611|NCT00448539|616988356|FG000|Overall Study|Request of the investigator or sponsor|67|||
170722612|NCT00448539|616988357|FG001|Overall Study|Request of the investigator or sponsor|54|||
170722613|NCT00448539|616988356|FG000|Overall Study|Withdrawal by Subject|20|||
170722614|NCT00448539|616988357|FG001|Overall Study|Withdrawal by Subject|24|||
170722615|NCT00448539|616988356|FG000|Overall Study|Diary non-compliance|1|||
170831662|NCT02635386|617392204|FG004|Overall Study|Physician Decision|0|||
170831663|NCT02635386|617392200|FG000|Overall Study|Moved Out of State|0|||
170831664|NCT02635386|617392201|FG001|Overall Study|Moved Out of State|1|||
170831665|NCT02635386|617392202|FG002|Overall Study|Moved Out of State|0|||
170831666|NCT02635386|617392203|FG003|Overall Study|Moved Out of State|0|||
170831667|NCT02635386|617392204|FG004|Overall Study|Moved Out of State|0|||
170831668|NCT02635386|617392200|FG000|Overall Study|Noncompliant|0|||
170831669|NCT02635386|617392201|FG001|Overall Study|Noncompliant|2|||
170831670|NCT02635386|617392202|FG002|Overall Study|Noncompliant|1|||
170831671|NCT02635386|617392203|FG003|Overall Study|Noncompliant|1|||
170722616|NCT00448539|616988357|FG001|Overall Study|Diary non-compliance|0|||
170831672|NCT02635386|617392204|FG004|Overall Study|Noncompliant|1|||
170831673|NCT02635386|617392200|FG000|Overall Study|side effects|0|||
170831674|NCT02635386|617392201|FG001|Overall Study|side effects|0|||
170831675|NCT02635386|617392202|FG002|Overall Study|side effects|1|||
170831676|NCT02635386|617392203|FG003|Overall Study|side effects|4|||
170831677|NCT02635386|617392204|FG004|Overall Study|side effects|6|||
170722617|NCT00448539|616988356|FG000|Overall Study|Adverse Event|9|||
170722618|NCT00448539|616988357|FG001|Overall Study|Adverse Event|26|||
170722619|NCT00448539|616988356|FG000|Overall Study|Lack of Efficacy|27|||
170722620|NCT00448539|616988357|FG001|Overall Study|Lack of Efficacy|40|||
170722621|NCT00448539|616988356|FG000|Overall Study|Miscellaneous|2|||
170722622|NCT00448539|616988357|FG001|Overall Study|Miscellaneous|1|||
170722623|NCT00448539|616988356|FG000|Overall Study|Change of meds|2|||
170722624|NCT00448539|616988357|FG001|Overall Study|Change of meds|3|||
170722625|NCT00448539|616988356|FG000|Overall Study|Lost to Follow-up|1|||
170722626|NCT00448539|616988357|FG001|Overall Study|Lost to Follow-up|3|||
170722627|NCT00237744|616988358|FG000|Overall Study|Withdrawal by Subject|3|||
170722628|NCT00237744|616988359|FG001|Overall Study|Withdrawal by Subject|1|||
170722629|NCT00237744|616988360|FG002|Overall Study|Withdrawal by Subject|0|||
170722630|NCT00321854|616988361|FG000|Overall Study|Adverse Event|41|||
170722631|NCT00321854|616988362|FG001|Overall Study|Adverse Event|43|||
170722632|NCT00321854|616988361|FG000|Overall Study|Lack of Efficacy|9|||
170722633|NCT00321854|616988362|FG001|Overall Study|Lack of Efficacy|14|||
170722634|NCT00321854|616988361|FG000|Overall Study|Protocol Violation|6|||
170722635|NCT00321854|616988362|FG001|Overall Study|Protocol Violation|5|||
170722636|NCT00321854|616988361|FG000|Overall Study|Lost to Follow-up|0|||
170722637|NCT00321854|616988362|FG001|Overall Study|Lost to Follow-up|2|||
170722638|NCT00321854|616988361|FG000|Overall Study|Withdrawal by Subject|6|||
170722639|NCT00321854|616988362|FG001|Overall Study|Withdrawal by Subject|17|||
170722640|NCT00321854|616988361|FG000|Overall Study|Other|1|||
170722641|NCT00321854|616988362|FG001|Overall Study|Other|1|||
170722642|NCT01816594|616988363|FG000|Overall Study|Local Progress|0|||
170722643|NCT01816594|616988364|FG001|Overall Study|Local Progress|2|||
170722644|NCT01816594|616988363|FG000|Overall Study|Adverse Event|9|||
170722645|NCT01816594|616988364|FG001|Overall Study|Adverse Event|0|||
170722646|NCT01816594|616988363|FG000|Overall Study|Withdrawal by Subject|1|||
170722647|NCT01816594|616988364|FG001|Overall Study|Withdrawal by Subject|0|||
170722648|NCT01816594|616988363|FG000|Overall Study|Physician Decision|1|||
170722649|NCT01816594|616988364|FG001|Overall Study|Physician Decision|0|||
170722650|NCT02566031|616988365|FG000|Overall Study|Patient/guardian decision|14|||
170722651|NCT02566031|616988366|FG001|Overall Study|Patient/guardian decision|7|||
170722652|NCT02566031|616988365|FG000|Overall Study|Protocol deviation|2|||
170722653|NCT02566031|616988366|FG001|Overall Study|Protocol deviation|3|||
170722654|NCT02566031|616988365|FG000|Overall Study|Adverse Event|3|||
170722655|NCT02566031|616988366|FG001|Overall Study|Adverse Event|1|||
170722656|NCT02566031|616988365|FG000|Overall Study|Lost to Follow-up|1|||
170722657|NCT02566031|616988366|FG001|Overall Study|Lost to Follow-up|1|||
170722658|NCT01059565|616988367|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
170722659|NCT01059565|616988368|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
170722660|NCT01059565|616988367|FG000|24-Week Randomized Phase|Adverse Event|5|||
170831678|NCT02635386|617392200|FG000|Overall Study|needed other major surgery|0|||
170831679|NCT02635386|617392201|FG001|Overall Study|needed other major surgery|1|||
170831680|NCT02635386|617392202|FG002|Overall Study|needed other major surgery|0|||
170831681|NCT02635386|617392203|FG003|Overall Study|needed other major surgery|0|||
170831682|NCT02635386|617392204|FG004|Overall Study|needed other major surgery|0|||
170831683|NCT02635386|617392200|FG000|Overall Study|Other medical problems not drug related|0|||
170831684|NCT02635386|617392201|FG001|Overall Study|Other medical problems not drug related|0|||
170831685|NCT02635386|617392202|FG002|Overall Study|Other medical problems not drug related|0|||
170831686|NCT02635386|617392203|FG003|Overall Study|Other medical problems not drug related|1|||
170831687|NCT02635386|617392204|FG004|Overall Study|Other medical problems not drug related|0|||
170831688|NCT01781832|617392205|FG000|Overall Study|Withdrawal by Subject|1|||
170831689|NCT01438840|617392206|FG000|Core Study|Adverse Event|0|||
170831690|NCT01438840|617392207|FG001|Core Study|Adverse Event|3|||
170831691|NCT01438840|617392208|FG002|Core Study|Adverse Event|0|||
170722661|NCT01059565|616988368|FG001|24-Week Randomized Phase|Adverse Event|0|||
170722662|NCT01059565|616988367|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
170831692|NCT01438840|617392206|FG000|Core Study|Lack of Efficacy|15|||
170831693|NCT01438840|617392207|FG001|Core Study|Lack of Efficacy|7|||
170831694|NCT01438840|617392208|FG002|Core Study|Lack of Efficacy|0|||
170722663|NCT01059565|616988368|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
170722664|NCT01059565|616988367|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
170722665|NCT01059565|616988368|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
170722666|NCT01059565|616988367|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
170722667|NCT01059565|616988368|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
170722668|NCT01059565|616988367|FG000|24-Week Open-Label Phase|Adverse Event|2|||
170722669|NCT01059565|616988368|FG001|24-Week Open-Label Phase|Adverse Event|0|||
170722670|NCT01059565|616988367|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
170722671|NCT01059565|616988368|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
170722672|NCT01059565|616988367|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
170722673|NCT01059565|616988368|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
170722674|NCT01059565|616988367|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
170722675|NCT01059565|616988368|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
170722676|NCT01059565|616988367|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
170722677|NCT01059565|616988368|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
170722678|NCT01059565|616988367|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
170722679|NCT01059565|616988368|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
170722680|NCT02219932|616988371|FG000|Overall Study|Other|5|||
170722681|NCT02219932|616988372|FG001|Overall Study|Other|11|||
170722682|NCT02219932|616988371|FG000|Overall Study|Death|1|||
170722683|NCT02219932|616988372|FG001|Overall Study|Death|1|||
170722684|NCT02219932|616988371|FG000|Overall Study|Investigator Decision|0|||
170722685|NCT02219932|616988372|FG001|Overall Study|Investigator Decision|1|||
170722686|NCT02219932|616988371|FG000|Overall Study|Consent Withdrawn|11|||
170722687|NCT02219932|616988372|FG001|Overall Study|Consent Withdrawn|7|||
170722688|NCT02219932|616988371|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
170722689|NCT02219932|616988372|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
170722690|NCT02219932|616988371|FG000|Overall Study|Protocol Violation|10|||
170722691|NCT02219932|616988372|FG001|Overall Study|Protocol Violation|6|||
170722692|NCT02219932|616988371|FG000|Overall Study|Pregnancy|1|||
170722693|NCT02219932|616988372|FG001|Overall Study|Pregnancy|0|||
170722694|NCT02219932|616988371|FG000|Overall Study|Lost to Follow-up|4|||
170722695|NCT02219932|616988372|FG001|Overall Study|Lost to Follow-up|2|||
170722696|NCT02219932|616988371|FG000|Overall Study|Adverse Event|23|||
170722697|NCT02219932|616988372|FG001|Overall Study|Adverse Event|21|||
170722698|NCT01869491|616988377|FG000|Overall Study|Adverse Event|3|||
170722699|NCT01869491|616988378|FG001|Overall Study|Adverse Event|5|||
170722700|NCT01869491|616988377|FG000|Overall Study|Lack of Efficacy|0|||
170722701|NCT01869491|616988378|FG001|Overall Study|Lack of Efficacy|3|||
170722702|NCT01869491|616988377|FG000|Overall Study|Withdrawal by Subject|6|||
170722703|NCT01869491|616988378|FG001|Overall Study|Withdrawal by Subject|7|||
170722704|NCT01869491|616988377|FG000|Overall Study|Lost to Follow-up|11|||
170722705|NCT01869491|616988378|FG001|Overall Study|Lost to Follow-up|9|||
170722706|NCT01869491|616988377|FG000|Overall Study|No further need of investigational product|1|||
170722707|NCT01869491|616988378|FG001|Overall Study|No further need of investigational product|0|||
170722708|NCT05177770|616988379|FG000|Overall Study|Death|4|||
170722709|NCT05177770|616988379|FG000|Overall Study|Withdrawal by Subject|1|||
170722710|NCT05177770|616988379|FG000|Overall Study|Adverse Event prior to dosing|1|||
170722711|NCT01672801|616988383|FG000|Overall Study|Screen Failure|0|||
170722712|NCT01672801|616988384|FG001|Overall Study|Screen Failure|1|||
170722713|NCT00833989|616988386|FG000|Overall Study|Physician Decision|0|||
170722714|NCT00833989|616988387|FG001|Overall Study|Physician Decision|0|||
170722715|NCT00833989|616988388|FG002|Overall Study|Physician Decision|0|||
170722716|NCT00833989|616988389|FG003|Overall Study|Physician Decision|1|||
170722717|NCT00833989|616988386|FG000|Overall Study|Withdrawal by Subject|3|||
170722718|NCT00833989|616988387|FG001|Overall Study|Withdrawal by Subject|0|||
170722719|NCT00833989|616988388|FG002|Overall Study|Withdrawal by Subject|1|||
170722720|NCT00833989|616988389|FG003|Overall Study|Withdrawal by Subject|1|||
170722721|NCT04313881|616988393|FG000|Overall Study|Death|138|||
170722722|NCT04313881|616988394|FG001|Overall Study|Death|126|||
170722723|NCT04313881|616988393|FG000|Overall Study|Study terminated by sponsor|108|||
170722724|NCT04313881|616988394|FG001|Overall Study|Study terminated by sponsor|129|||
170722725|NCT04313881|616988393|FG000|Overall Study|Consent withdrawn|19|||
170722726|NCT04313881|616988394|FG001|Overall Study|Consent withdrawn|15|||
170722727|NCT04313881|616988393|FG000|Overall Study|Reason not Specified|3|||
170722728|NCT04313881|616988394|FG001|Overall Study|Reason not Specified|1|||
170722729|NCT01272934|616988395|FG000|Overall Study|Adverse Event|0|||
170722730|NCT01272934|616988396|FG001|Overall Study|Adverse Event|1|||
170831695|NCT01438840|617392206|FG000|Core Study|Withdrawal of consent|1|||
170831696|NCT01438840|617392207|FG001|Core Study|Withdrawal of consent|0|||
170831697|NCT01438840|617392208|FG002|Core Study|Withdrawal of consent|0|||
170831698|NCT01438840|617392206|FG000|Extension Phase|Adverse Event|0|||
170831699|NCT01438840|617392207|FG001|Extension Phase|Adverse Event|0|||
170831700|NCT01438840|617392208|FG002|Extension Phase|Adverse Event|3|||
170831701|NCT01438840|617392206|FG000|Extension Phase|Lost to Follow-up|0|||
170831702|NCT01438840|617392207|FG001|Extension Phase|Lost to Follow-up|0|||
170831703|NCT01438840|617392208|FG002|Extension Phase|Lost to Follow-up|1|||
170831704|NCT01438840|617392206|FG000|Extension Phase|Withdrawal by Subject|0|||
170831705|NCT01438840|617392207|FG001|Extension Phase|Withdrawal by Subject|0|||
170831706|NCT01438840|617392208|FG002|Extension Phase|Withdrawal by Subject|3|||
170831707|NCT01438840|617392206|FG000|Extension Phase|Lack of Efficacy|0|||
170831708|NCT01438840|617392207|FG001|Extension Phase|Lack of Efficacy|0|||
170831709|NCT01438840|617392208|FG002|Extension Phase|Lack of Efficacy|2|||
170831710|NCT01438840|617392206|FG000|Extension Phase|Other|0|||
170831711|NCT01438840|617392207|FG001|Extension Phase|Other|0|||
170831712|NCT01438840|617392208|FG002|Extension Phase|Other|1|||
170831713|NCT02804399|617392209|FG000|Period 2|Adverse Event|0|||
170831714|NCT02804399|617392210|FG001|Period 2|Adverse Event|1|||
170831715|NCT03432390|617392211|FG000|Apnea Period|Protocol Violation|2|||
170831716|NCT03432390|617392212|FG001|Apnea Period|Protocol Violation|2|||
170831717|NCT02058836|617392213|FG000|Overall Study|Withdrawal by Subject|1|||
170831718|NCT02058836|617392214|FG001|Overall Study|Withdrawal by Subject|1|||
170831719|NCT00904722|617392216|FG000|Overall Study|Physician Decision|1|||
170831720|NCT01801982|617392217|FG000|Overall Study|Lost to Follow-up|1|||
170831721|NCT01214421|617392224|FG000|Overall Study|Lost to Follow-up|7|||
170831722|NCT01214421|617392225|FG001|Overall Study|Lost to Follow-up|3|||
170831723|NCT01214421|617392226|FG002|Overall Study|Lost to Follow-up|7|||
170831724|NCT01214421|617392227|FG003|Overall Study|Lost to Follow-up|3|||
170831725|NCT01214421|617392224|FG000|Overall Study|Adverse Event|16|||
170831726|NCT01214421|617392225|FG001|Overall Study|Adverse Event|35|||
170831727|NCT01214421|617392226|FG002|Overall Study|Adverse Event|14|||
170831728|NCT01214421|617392227|FG003|Overall Study|Adverse Event|3|||
170831729|NCT01214421|617392224|FG000|Overall Study|Sponsor Discontinued Site|1|||
170831730|NCT01214421|617392225|FG001|Overall Study|Sponsor Discontinued Site|2|||
170831731|NCT01214421|617392226|FG002|Overall Study|Sponsor Discontinued Site|0|||
170831732|NCT01214421|617392227|FG003|Overall Study|Sponsor Discontinued Site|0|||
170831733|NCT01214421|617392224|FG000|Overall Study|Withdrawal Criteria Met|3|||
170831734|NCT01214421|617392225|FG001|Overall Study|Withdrawal Criteria Met|0|||
170831735|NCT01214421|617392226|FG002|Overall Study|Withdrawal Criteria Met|2|||
170831736|NCT01214421|617392227|FG003|Overall Study|Withdrawal Criteria Met|1|||
170831737|NCT01214421|617392224|FG000|Overall Study|Physician Decision|2|||
170831738|NCT01214421|617392225|FG001|Overall Study|Physician Decision|0|||
170831739|NCT01214421|617392226|FG002|Overall Study|Physician Decision|4|||
170831740|NCT01214421|617392227|FG003|Overall Study|Physician Decision|0|||
170831741|NCT01214421|617392224|FG000|Overall Study|Withdrawal by Subject|21|||
170831742|NCT01214421|617392225|FG001|Overall Study|Withdrawal by Subject|18|||
170831743|NCT01214421|617392226|FG002|Overall Study|Withdrawal by Subject|11|||
170831744|NCT01214421|617392227|FG003|Overall Study|Withdrawal by Subject|2|||
170831745|NCT01837797|617392231|FG000|Period 1|Adverse Event|9|||
170831746|NCT01837797|617392232|FG001|Period 1|Adverse Event|0|||
170831747|NCT01837797|617392233|FG002|Period 1|Adverse Event|0|||
170831748|NCT01837797|617392234|FG003|Period 1|Adverse Event|0|||
170831749|NCT01837797|617392235|FG004|Period 1|Adverse Event|0|||
170831750|NCT01837797|617392231|FG000|Period 1|Withdrawal by Subject|6|||
170831751|NCT01837797|617392232|FG001|Period 1|Withdrawal by Subject|0|||
170831752|NCT01837797|617392233|FG002|Period 1|Withdrawal by Subject|0|||
170831753|NCT01837797|617392234|FG003|Period 1|Withdrawal by Subject|0|||
170831754|NCT01837797|617392235|FG004|Period 1|Withdrawal by Subject|0|||
170831755|NCT01837797|617392231|FG000|Period 1|Administrative reasons|76|||
170831756|NCT01837797|617392232|FG001|Period 1|Administrative reasons|0|||
170831757|NCT01837797|617392233|FG002|Period 1|Administrative reasons|0|||
170831758|NCT01837797|617392234|FG003|Period 1|Administrative reasons|0|||
170831759|NCT01837797|617392235|FG004|Period 1|Administrative reasons|0|||
170831760|NCT01837797|617392231|FG000|Period 1|Withdrawal of consent before treatment|1|||
170831761|NCT01837797|617392232|FG001|Period 1|Withdrawal of consent before treatment|0|||
170831762|NCT01837797|617392233|FG002|Period 1|Withdrawal of consent before treatment|0|||
170831763|NCT01837797|617392234|FG003|Period 1|Withdrawal of consent before treatment|0|||
170831764|NCT01837797|617392235|FG004|Period 1|Withdrawal of consent before treatment|0|||
170831765|NCT01837797|617392231|FG000|Period 1|Other|10|||
170831766|NCT01837797|617392232|FG001|Period 1|Other|0|||
170831767|NCT01837797|617392233|FG002|Period 1|Other|0|||
170831768|NCT01837797|617392234|FG003|Period 1|Other|0|||
170831769|NCT01837797|617392235|FG004|Period 1|Other|0|||
170831770|NCT01837797|617392231|FG000|Period 2|Administrative or other reasons|0|||
170831771|NCT01837797|617392232|FG001|Period 2|Administrative or other reasons|5|||
170831772|NCT01837797|617392233|FG002|Period 2|Administrative or other reasons|2|||
170831773|NCT01837797|617392234|FG003|Period 2|Administrative or other reasons|4|||
170722731|NCT01272934|616988395|FG000|Overall Study|Abnormal Laboratory Value|0|||
170722732|NCT01272934|616988396|FG001|Overall Study|Abnormal Laboratory Value|1|||
170722733|NCT00214136|616988397|FG000|Overall Study|Death|5|||
170722734|NCT04313634|616988398|FG000|Overall Study|Adverse Event|2|||
170722735|NCT04313634|616988399|FG001|Overall Study|Adverse Event|2|||
170722736|NCT04313634|616988400|FG002|Overall Study|Adverse Event|0|||
170722737|NCT04313634|616988398|FG000|Overall Study|Withdrawal by Subject|1|||
170722738|NCT04313634|616988399|FG001|Overall Study|Withdrawal by Subject|0|||
170722739|NCT04313634|616988400|FG002|Overall Study|Withdrawal by Subject|1|||
170722740|NCT04313634|616988398|FG000|Overall Study|Protocol Violation|0|||
170722741|NCT04313634|616988399|FG001|Overall Study|Protocol Violation|0|||
170722742|NCT04313634|616988400|FG002|Overall Study|Protocol Violation|1|||
170722743|NCT00319098|616988403|FG000|Overall Study|Serious adverse event|3|||
170722744|NCT00319098|616988404|FG001|Overall Study|Serious adverse event|0|||
170722745|NCT00319098|616988403|FG000|Overall Study|Adverse Event|20|||
170722746|NCT00319098|616988404|FG001|Overall Study|Adverse Event|1|||
170722747|NCT00319098|616988403|FG000|Overall Study|Withdrawal by Subject|37|||
170722748|NCT00319098|616988404|FG001|Overall Study|Withdrawal by Subject|8|||
170722749|NCT00319098|616988403|FG000|Overall Study|Migrated/moved from study area|2|||
170722750|NCT00319098|616988404|FG001|Overall Study|Migrated/moved from study area|1|||
170722751|NCT00319098|616988403|FG000|Overall Study|Lost to Follow-up|37|||
170722752|NCT00319098|616988404|FG001|Overall Study|Lost to Follow-up|13|||
170722753|NCT00319098|616988403|FG000|Overall Study|Others|33|||
170722754|NCT00319098|616988404|FG001|Overall Study|Others|8|||
170722755|NCT00319098|616988403|FG000|Overall Study|Protocol Violation|3|||
170722756|NCT00319098|616988404|FG001|Overall Study|Protocol Violation|1|||
170722757|NCT01226745|616988405|FG000|Overall Study|Did not complete schedule of assessments|8|||
170722758|NCT01226745|616988406|FG001|Overall Study|Did not complete schedule of assessments|3|||
170722759|NCT01226745|616988407|FG002|Overall Study|Did not complete schedule of assessments|6|||
170722760|NCT01226745|616988408|FG003|Overall Study|Did not complete schedule of assessments|0|||
170722761|NCT01226745|616988409|FG004|Overall Study|Did not complete schedule of assessments|0|||
170722762|NCT01226745|616988410|FG005|Overall Study|Did not complete schedule of assessments|1|||
170722763|NCT01226745|616988405|FG000|Overall Study|Lost to Follow-up|2|||
170722764|NCT01226745|616988406|FG001|Overall Study|Lost to Follow-up|6|||
170722765|NCT01226745|616988407|FG002|Overall Study|Lost to Follow-up|6|||
170722766|NCT01226745|616988408|FG003|Overall Study|Lost to Follow-up|1|||
170722767|NCT01226745|616988409|FG004|Overall Study|Lost to Follow-up|1|||
170722768|NCT01226745|616988410|FG005|Overall Study|Lost to Follow-up|2|||
170722769|NCT01226745|616988405|FG000|Overall Study|Death|1|||
170722770|NCT01226745|616988406|FG001|Overall Study|Death|0|||
170722771|NCT01226745|616988407|FG002|Overall Study|Death|0|||
170722772|NCT01226745|616988408|FG003|Overall Study|Death|0|||
170722773|NCT01226745|616988409|FG004|Overall Study|Death|0|||
170722774|NCT01226745|616988410|FG005|Overall Study|Death|1|||
170722775|NCT01226745|616988405|FG000|Overall Study|Other|6|||
170722776|NCT01226745|616988406|FG001|Overall Study|Other|7|||
170722777|NCT01226745|616988407|FG002|Overall Study|Other|8|||
170722778|NCT01226745|616988408|FG003|Overall Study|Other|4|||
170722779|NCT01226745|616988409|FG004|Overall Study|Other|3|||
170722780|NCT01226745|616988410|FG005|Overall Study|Other|1|||
170722781|NCT02270450|616988413|FG000|Overall Study|Refusal unrelated to adverse event|3|||
170722782|NCT02270450|616988414|FG001|Overall Study|Refusal unrelated to adverse event|1|||
170722783|NCT02270450|616988415|FG002|Overall Study|Refusal unrelated to adverse event|5|||
170722784|NCT02270450|616988416|FG003|Overall Study|Refusal unrelated to adverse event|14|||
170722785|NCT02270450|616988413|FG000|Overall Study|Progression/relapse|1|||
170722786|NCT02270450|616988414|FG001|Overall Study|Progression/relapse|2|||
170722787|NCT02270450|616988415|FG002|Overall Study|Progression/relapse|4|||
170722788|NCT02270450|616988416|FG003|Overall Study|Progression/relapse|9|||
170722789|NCT02270450|616988413|FG000|Overall Study|Death|19|||
170722790|NCT02270450|616988414|FG001|Overall Study|Death|19|||
170722791|NCT02270450|616988415|FG002|Overall Study|Death|31|||
170722792|NCT02270450|616988416|FG003|Overall Study|Death|59|||
170722793|NCT02363738|616988417|FG000|Overall Study|Adverse Event|5|||
170722794|NCT02363738|616988418|FG001|Overall Study|Adverse Event|2|||
170722795|NCT02363738|616988417|FG000|Overall Study|Lack of Efficacy|1|||
170722796|NCT02363738|616988418|FG001|Overall Study|Lack of Efficacy|2|||
170722797|NCT02363738|616988417|FG000|Overall Study|Lost to Follow-up|2|||
170831774|NCT01837797|617392235|FG004|Period 2|Administrative or other reasons|0|||
170831775|NCT01837797|617392231|FG000|Period 2|Adverse Event|0|||
170831776|NCT01837797|617392232|FG001|Period 2|Adverse Event|0|||
170722798|NCT02363738|616988418|FG001|Overall Study|Lost to Follow-up|1|||
170722799|NCT03595904|616988427|FG000|Overall Study|Protocol Violation|3|||
170722800|NCT03595904|616988428|FG001|Overall Study|Protocol Violation|1|||
170722801|NCT03595904|616988427|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
170722802|NCT03595904|616988428|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
170722803|NCT03595904|616988427|FG000|Overall Study|Insurance complications|1|||
170831777|NCT01837797|617392233|FG002|Period 2|Adverse Event|0|||
170831778|NCT01837797|617392234|FG003|Period 2|Adverse Event|1|||
170831779|NCT01837797|617392235|FG004|Period 2|Adverse Event|0|||
170831780|NCT01837797|617392231|FG000|Period 3|Adverse Event|0|||
170831781|NCT01837797|617392232|FG001|Period 3|Adverse Event|0|||
170831782|NCT01837797|617392233|FG002|Period 3|Adverse Event|0|||
170831783|NCT01837797|617392234|FG003|Period 3|Adverse Event|0|||
170831784|NCT01837797|617392235|FG004|Period 3|Adverse Event|1|||
170831785|NCT01837797|617392231|FG000|Period 3|Administrative reasons|0|||
170722804|NCT03595904|616988428|FG001|Overall Study|Insurance complications|0|||
170722805|NCT03595904|616988427|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
170722806|NCT03595904|616988428|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
170722807|NCT02187991|616988429|FG000|Overall Study|Adverse Event|13|||
170722808|NCT02187991|616988430|FG001|Overall Study|Adverse Event|14|||
170722809|NCT02187991|616988431|FG002|Overall Study|Adverse Event|3|||
170722810|NCT02187991|616988432|FG003|Overall Study|Adverse Event|2|||
170722811|NCT02187991|616988429|FG000|Overall Study|Withdrawal by Subject|9|||
170722812|NCT02187991|616988430|FG001|Overall Study|Withdrawal by Subject|6|||
170722813|NCT02187991|616988431|FG002|Overall Study|Withdrawal by Subject|3|||
170722814|NCT02187991|616988432|FG003|Overall Study|Withdrawal by Subject|2|||
170722815|NCT02187991|616988429|FG000|Overall Study|Physician Decision|4|||
170722816|NCT02187991|616988430|FG001|Overall Study|Physician Decision|4|||
170722817|NCT02187991|616988431|FG002|Overall Study|Physician Decision|0|||
170722818|NCT02187991|616988432|FG003|Overall Study|Physician Decision|2|||
170722819|NCT02187991|616988429|FG000|Overall Study|Other, unrelated complication|7|||
170722820|NCT02187991|616988430|FG001|Overall Study|Other, unrelated complication|1|||
170722821|NCT02187991|616988431|FG002|Overall Study|Other, unrelated complication|1|||
170722822|NCT02187991|616988432|FG003|Overall Study|Other, unrelated complication|2|||
170722823|NCT02187991|616988429|FG000|Overall Study|Death|1|||
170722824|NCT02187991|616988430|FG001|Overall Study|Death|3|||
170722825|NCT02187991|616988431|FG002|Overall Study|Death|0|||
170722826|NCT02187991|616988432|FG003|Overall Study|Death|0|||
170722827|NCT01392560|616988433|FG000|Overall Study|Adverse Event|2|||
170722828|NCT01392560|616988433|FG000|Overall Study|not entered|8|||
170722829|NCT01392560|616988433|FG000|Overall Study|discontinued during placebo run-in|2|||
170722830|NCT00047879|616988437|FG000|Overall Study|Progressive disease|4|||
170722831|NCT00047879|616988438|FG001|Overall Study|Progressive disease|3|||
170722832|NCT01196975|616988439|FG000|Overall Study|Adverse Event|2|||
170722833|NCT01196975|616988440|FG001|Overall Study|Adverse Event|2|||
170722834|NCT01196975|616988441|FG002|Overall Study|Adverse Event|0|||
170722835|NCT01196975|616988442|FG003|Overall Study|Adverse Event|0|||
170722836|NCT01196975|616988443|FG004|Overall Study|Adverse Event|2|||
170722837|NCT01196975|616988439|FG000|Overall Study|Withdrawal by Subject|2|||
170722838|NCT01196975|616988440|FG001|Overall Study|Withdrawal by Subject|1|||
170722839|NCT01196975|616988441|FG002|Overall Study|Withdrawal by Subject|0|||
170722840|NCT01196975|616988442|FG003|Overall Study|Withdrawal by Subject|1|||
170722841|NCT01196975|616988443|FG004|Overall Study|Withdrawal by Subject|0|||
170722842|NCT01196975|616988439|FG000|Overall Study|Lost to Follow-up|11|||
170722843|NCT01196975|616988440|FG001|Overall Study|Lost to Follow-up|6|||
170722844|NCT01196975|616988441|FG002|Overall Study|Lost to Follow-up|5|||
170722845|NCT01196975|616988442|FG003|Overall Study|Lost to Follow-up|5|||
170722846|NCT01196975|616988443|FG004|Overall Study|Lost to Follow-up|11|||
170722847|NCT02663817|616988447|FG000|Overall Study|Screen failure|2|||
170722848|NCT02535065|616988450|FG000|Overall Study|Death|13|||
170722849|NCT02535065|616988450|FG000|Overall Study|Lost to Follow-up|1|||
170722850|NCT02535065|616988450|FG000|Overall Study|Withdrawal by Subject|6|||
170722851|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
170722852|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
170722853|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
170722854|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
170722855|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
170722856|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
170722857|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
170722858|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
170722859|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
170722860|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
170831786|NCT01837797|617392232|FG001|Period 3|Administrative reasons|0|||
170831787|NCT01837797|617392233|FG002|Period 3|Administrative reasons|0|||
170831788|NCT01837797|617392234|FG003|Period 3|Administrative reasons|0|||
170831789|NCT01837797|617392235|FG004|Period 3|Administrative reasons|20|||
170831790|NCT01837797|617392231|FG000|Period 3|Other|0|||
170831791|NCT01837797|617392232|FG001|Period 3|Other|0|||
170831792|NCT01837797|617392233|FG002|Period 3|Other|0|||
170831793|NCT01837797|617392234|FG003|Period 3|Other|0|||
170831794|NCT01837797|617392235|FG004|Period 3|Other|2|||
170831795|NCT03797989|617392240|FG000|VAC069A|Withdrawal by Subject|0|||
170831796|NCT03797989|617392241|FG001|VAC069A|Withdrawal by Subject|0|||
170831797|NCT03797989|617392242|FG002|VAC069A|Withdrawal by Subject|1|||
170831798|NCT03797989|617392243|FG003|VAC069A|Withdrawal by Subject|0|||
170831799|NCT03797989|617392244|FG004|VAC069A|Withdrawal by Subject|0|||
170831800|NCT03797989|617392245|FG005|VAC069A|Withdrawal by Subject|0|||
170831801|NCT03797989|617392246|FG006|VAC069A|Withdrawal by Subject|0|||
170831802|NCT03797989|617392247|FG007|VAC069A|Withdrawal by Subject|0|||
170831803|NCT03797989|617392248|FG008|VAC069A|Withdrawal by Subject|0|||
170831804|NCT03797989|617392249|FG009|VAC069A|Withdrawal by Subject|0|||
170831805|NCT03797989|617392250|FG010|VAC069A|Withdrawal by Subject|0|||
170831806|NCT03797989|617392251|FG011|VAC069A|Withdrawal by Subject|0|||
170831807|NCT04594733|617392254|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
170831808|NCT04594733|617392255|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
170831809|NCT04594733|617392254|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
170831810|NCT04594733|617392255|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
170831811|NCT04594733|617392254|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
170831812|NCT04594733|617392255|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
170831813|NCT01225159|617392258|FG000|Overall Study|Change operation|1|||
170831814|NCT01225159|617392259|FG001|Overall Study|Change operation|0|||
170831815|NCT03865953|617394628|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
170831816|NCT03865953|617394629|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
170831817|NCT03865953|617394628|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
170831818|NCT03865953|617394629|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
170831819|NCT03865953|617394628|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
170831820|NCT03865953|617394629|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
170831821|NCT00490945|617394632|FG000|Overall Study|Adverse Event|0|||
170831822|NCT00490945|617394633|FG001|Overall Study|Adverse Event|1|||
170831823|NCT00490945|617394634|FG002|Overall Study|Adverse Event|0|||
170831824|NCT00490945|617394635|FG003|Overall Study|Adverse Event|0|||
170831825|NCT00490945|617394636|FG004|Overall Study|Adverse Event|0|||
170831826|NCT00412880|617394637|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
170831827|NCT00412880|617394637|FG000|Overall Study|Consent withdrawn|1|||
170831828|NCT00412880|617394637|FG000|Overall Study|Adverse Event|1|||
170831829|NCT00412880|617394637|FG000|Overall Study|Progressive disease|20|||
170831830|NCT02232399|617394639|FG000|Overall Study|Adverse Event|1|||
170831831|NCT02232399|617394640|FG001|Overall Study|Adverse Event|0|||
170831832|NCT02232399|617394639|FG000|Overall Study|Withdrawal by Subject|0|||
170831833|NCT02232399|617394640|FG001|Overall Study|Withdrawal by Subject|1|||
170831834|NCT02706951|617394648|FG000|Period 1|Adverse Event|1|||
170831835|NCT02706951|617394649|FG001|Period 1|Adverse Event|5|||
170831836|NCT02706951|617394650|FG002|Period 1|Adverse Event|3|||
170831837|NCT02706951|617394651|FG003|Period 1|Adverse Event|0|||
170831838|NCT02706951|617394652|FG004|Period 1|Adverse Event|0|||
170831839|NCT02706951|617394648|FG000|Period 1|Withdrawal by Subject|10|||
170831840|NCT02706951|617394649|FG001|Period 1|Withdrawal by Subject|6|||
170831841|NCT02706951|617394650|FG002|Period 1|Withdrawal by Subject|6|||
170831842|NCT02706951|617394651|FG003|Period 1|Withdrawal by Subject|0|||
170831843|NCT02706951|617394652|FG004|Period 1|Withdrawal by Subject|0|||
170831844|NCT02706951|617394648|FG000|Period 1|Lost to Follow-up|0|||
170831845|NCT02706951|617394649|FG001|Period 1|Lost to Follow-up|4|||
170831846|NCT02706951|617394650|FG002|Period 1|Lost to Follow-up|1|||
170831847|NCT02706951|617394651|FG003|Period 1|Lost to Follow-up|0|||
170831848|NCT02706951|617394652|FG004|Period 1|Lost to Follow-up|0|||
170831849|NCT02706951|617394648|FG000|Period 1|Other|2|||
170831850|NCT02706951|617394649|FG001|Period 1|Other|1|||
170831851|NCT02706951|617394650|FG002|Period 1|Other|0|||
170831852|NCT02706951|617394651|FG003|Period 1|Other|0|||
170831853|NCT02706951|617394652|FG004|Period 1|Other|0|||
170831854|NCT02706951|617394648|FG000|Period 2|Adverse Event|0|||
170831855|NCT02706951|617394649|FG001|Period 2|Adverse Event|0|||
170831856|NCT02706951|617394650|FG002|Period 2|Adverse Event|0|||
170831857|NCT02706951|617394651|FG003|Period 2|Adverse Event|25|||
170831858|NCT02706951|617394652|FG004|Period 2|Adverse Event|34|||
170831859|NCT02706951|617394648|FG000|Period 2|Withdrawal by Subject|0|||
170831860|NCT02706951|617394649|FG001|Period 2|Withdrawal by Subject|0|||
170831861|NCT02706951|617394650|FG002|Period 2|Withdrawal by Subject|0|||
170831862|NCT02706951|617394651|FG003|Period 2|Withdrawal by Subject|38|||
170831863|NCT02706951|617394652|FG004|Period 2|Withdrawal by Subject|44|||
170831864|NCT02706951|617394648|FG000|Period 2|Lost to Follow-up|0|||
170831865|NCT02706951|617394649|FG001|Period 2|Lost to Follow-up|0|||
170831866|NCT02706951|617394650|FG002|Period 2|Lost to Follow-up|0|||
170831867|NCT02706951|617394651|FG003|Period 2|Lost to Follow-up|17|||
170831868|NCT02706951|617394652|FG004|Period 2|Lost to Follow-up|9|||
170831869|NCT02706951|617394648|FG000|Period 2|COVID-19 Related|0|||
170831870|NCT02706951|617394649|FG001|Period 2|COVID-19 Related|0|||
170831871|NCT02706951|617394650|FG002|Period 2|COVID-19 Related|0|||
170831872|NCT02706951|617394651|FG003|Period 2|COVID-19 Related|1|||
170831873|NCT02706951|617394652|FG004|Period 2|COVID-19 Related|2|||
170831874|NCT02706951|617394648|FG000|Period 2|Other|0|||
170831875|NCT02706951|617394649|FG001|Period 2|Other|0|||
170831876|NCT02706951|617394650|FG002|Period 2|Other|0|||
170831877|NCT02706951|617394651|FG003|Period 2|Other|37|||
170831878|NCT02706951|617394652|FG004|Period 2|Other|31|||
170831879|NCT03491215|617394653|FG000|Overall Study|Death|6|||
170831880|NCT03491215|617394654|FG001|Overall Study|Death|2|||
170722861|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
170722862|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
170722863|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
170722864|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
170722865|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
170722866|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
170722867|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
170722868|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
170722869|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
170722870|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
170722871|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
170722872|NCT01781572|616988451|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
170722873|NCT01781572|616988452|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
170722874|NCT01781572|616988453|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
170722875|NCT01781572|616988451|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
170722876|NCT01781572|616988452|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
170722877|NCT01781572|616988453|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
170722878|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
170722879|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
170722880|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
170722881|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
170722882|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
170722883|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
170722884|NCT01781572|616988451|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
170722885|NCT01781572|616988452|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
170722886|NCT01781572|616988453|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
170722887|NCT01781572|616988451|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
170722888|NCT01781572|616988452|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
170722889|NCT01781572|616988453|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
170831881|NCT03491215|617394655|FG002|Overall Study|Death|1|||
170831882|NCT03491215|617394656|FG003|Overall Study|Death|0|||
170831883|NCT03491215|617394653|FG000|Overall Study|Physician Decision|1|||
170831884|NCT03491215|617394654|FG001|Overall Study|Physician Decision|0|||
170831885|NCT03491215|617394655|FG002|Overall Study|Physician Decision|0|||
170722890|NCT01781572|616988451|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
170722891|NCT01781572|616988452|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
170722892|NCT01781572|616988453|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
170722893|NCT01781572|616988451|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
170831886|NCT03491215|617394656|FG003|Overall Study|Physician Decision|0|||
170831887|NCT01162135|617394660|FG000|Overall Study|Withdrawal by Subject|1|||
170831888|NCT01162135|617394660|FG000|Overall Study|Severe back pain|1|||
170831889|NCT01162135|617394660|FG000|Overall Study|Ineligible|1|||
170831890|NCT00551135|617394666|FG000|Overall Study|Adverse Event|1|||
170831891|NCT00551135|617394667|FG001|Overall Study|Adverse Event|0|||
170831892|NCT00551135|617394668|FG002|Overall Study|Adverse Event|1|||
170831893|NCT00551135|617394669|FG003|Overall Study|Adverse Event|1|||
170831894|NCT00551135|617394666|FG000|Overall Study|Lost to Follow-up|0|||
170831895|NCT00551135|617394667|FG001|Overall Study|Lost to Follow-up|0|||
170831896|NCT00551135|617394668|FG002|Overall Study|Lost to Follow-up|0|||
170831897|NCT00551135|617394669|FG003|Overall Study|Lost to Follow-up|1|||
170831898|NCT00551135|617394666|FG000|Overall Study|Other|3|||
170831899|NCT00551135|617394667|FG001|Overall Study|Other|2|||
170831900|NCT00551135|617394668|FG002|Overall Study|Other|1|||
170831901|NCT00551135|617394669|FG003|Overall Study|Other|2|||
170831902|NCT00551135|617394666|FG000|Overall Study|Withdrawal by Subject|1|||
170831903|NCT00551135|617394667|FG001|Overall Study|Withdrawal by Subject|0|||
170831904|NCT00551135|617394668|FG002|Overall Study|Withdrawal by Subject|3|||
170831905|NCT00551135|617394669|FG003|Overall Study|Withdrawal by Subject|1|||
170831906|NCT04294667|617394670|FG000|Overall Study|Lack of Efficacy|4|||
170831907|NCT04294667|617394671|FG001|Overall Study|Lack of Efficacy|4|||
170831908|NCT04294667|617394670|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
170831909|NCT04294667|617394671|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
170831910|NCT04294667|617394670|FG000|Overall Study|Patient has a Renal Flare|1|||
170831911|NCT04294667|617394671|FG001|Overall Study|Patient has a Renal Flare|0|||
170831912|NCT04294667|617394670|FG000|Overall Study|SLE Worsening|0|||
170831913|NCT04294667|617394671|FG001|Overall Study|SLE Worsening|1|||
170831914|NCT04294667|617394670|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
170831915|NCT04294667|617394671|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
170831916|NCT04294667|617394670|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
170831917|NCT04294667|617394671|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
170831918|NCT04294667|617394670|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
170831919|NCT04294667|617394671|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
170831920|NCT04294667|617394670|FG000|Overall Study|Subject Moved to Another State|0|||
170831921|NCT04294667|617394671|FG001|Overall Study|Subject Moved to Another State|1|||
170831922|NCT04294667|617394670|FG000|Overall Study|Adverse event, serious fatal|0|||
170831923|NCT04294667|617394671|FG001|Overall Study|Adverse event, serious fatal|1|||
170831924|NCT04294667|617394670|FG000|Overall Study|Adverse event, non-fatal|3|||
170831925|NCT04294667|617394671|FG001|Overall Study|Adverse event, non-fatal|4|||
170831926|NCT03297398|617394672|FG000|Overall Study|Sponsor's decision|6|||
170831927|NCT03297398|617394673|FG001|Overall Study|Sponsor's decision|9|||
170831928|NCT03297398|617394674|FG002|Overall Study|Sponsor's decision|7|||
170831929|NCT03297398|617394672|FG000|Overall Study|Adverse Event|1|||
170831930|NCT03297398|617394673|FG001|Overall Study|Adverse Event|4|||
170831931|NCT03297398|617394674|FG002|Overall Study|Adverse Event|4|||
170831932|NCT03297398|617394672|FG000|Overall Study|Withdrawal by Subject|1|||
170831933|NCT03297398|617394673|FG001|Overall Study|Withdrawal by Subject|2|||
170831934|NCT03297398|617394674|FG002|Overall Study|Withdrawal by Subject|2|||
170831935|NCT03297398|617394672|FG000|Overall Study|Protocol Violation|0|||
170831936|NCT03297398|617394673|FG001|Overall Study|Protocol Violation|2|||
170831937|NCT03297398|617394674|FG002|Overall Study|Protocol Violation|0|||
170831938|NCT03297398|617394672|FG000|Overall Study|Physician Decision|0|||
170831939|NCT03297398|617394673|FG001|Overall Study|Physician Decision|0|||
170831940|NCT03297398|617394674|FG002|Overall Study|Physician Decision|1|||
170831941|NCT03297398|617394672|FG000|Overall Study|Lost to Follow-up|0|||
170831942|NCT03297398|617394673|FG001|Overall Study|Lost to Follow-up|0|||
170831943|NCT03297398|617394674|FG002|Overall Study|Lost to Follow-up|1|||
170831944|NCT00611715|617394675|FG000|Overall Study|Disease Progression|24|||
170831945|NCT00611715|617394676|FG001|Overall Study|Disease Progression|4|||
170831946|NCT00611715|617394675|FG000|Overall Study|Withdrawal by Subject|5|||
170831947|NCT00611715|617394676|FG001|Overall Study|Withdrawal by Subject|1|||
170831948|NCT00611715|617394675|FG000|Overall Study|Adverse Event|9|||
170831949|NCT00611715|617394676|FG001|Overall Study|Adverse Event|1|||
170831950|NCT00611715|617394675|FG000|Overall Study|Death|1|||
170831951|NCT00611715|617394676|FG001|Overall Study|Death|0|||
170831952|NCT00611715|617394675|FG000|Overall Study|two patients are still on treatment|2|||
170831953|NCT00611715|617394676|FG001|Overall Study|two patients are still on treatment|0|||
170831954|NCT00756457|617394680|FG000|Overall Study|Lost to Follow-up|1|||
170831955|NCT00756457|617394681|FG001|Overall Study|Lost to Follow-up|2|||
170831956|NCT00233389|617394684|FG000|Overall Study|Adverse Event|5|||
170722894|NCT01781572|616988452|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
170722895|NCT01781572|616988453|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
170722896|NCT01781572|616988451|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
170722897|NCT01781572|616988452|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
170722898|NCT01781572|616988453|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
170722899|NCT01781572|616988451|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
170722900|NCT01781572|616988452|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
170722901|NCT01781572|616988453|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
170722902|NCT01781572|616988451|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
170722903|NCT01781572|616988452|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
170722904|NCT01781572|616988453|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
170722905|NCT01453595|616988455|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
170722906|NCT01453595|616988456|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
170722907|NCT01453595|616988457|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
170722908|NCT01218438|616988458|FG000|Epoch 1|Physician Decision|2|||
170722909|NCT01218438|616988458|FG000|Epoch 1|Adverse Event|1|||
170722910|NCT01218438|616988458|FG000|Epoch 3|Withdrawal by Subject|3|||
170722911|NCT01218438|616988458|FG000|Epoch 3|Adverse Event|1|||
170722912|NCT01218438|616988458|FG000|Epoch 4|Physician Decision|1|||
170722913|NCT01218438|616988458|FG000|Epoch 4|Withdrawal by Subject|2|||
170722914|NCT03762473|616988459|FG000|Overall Study|Death|1|||
170722915|NCT03762473|616988460|FG001|Overall Study|Death|0|||
170722916|NCT00045110|616988461|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
170722917|NCT00045110|616988462|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
170722918|NCT00045110|616988463|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
170722919|NCT00045110|616988461|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
170722920|NCT00045110|616988462|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
170722921|NCT00045110|616988463|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
170722922|NCT00045110|616988461|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
170722923|NCT00045110|616988462|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
170722924|NCT00045110|616988463|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
170722925|NCT01438541|616988464|FG000|Overall Study|Physician Decision|1|||
170722926|NCT01438541|616988464|FG000|Overall Study|Withdrawal by Subject|1|||
170722927|NCT01438541|616988464|FG000|Overall Study|discharge from the hospital|5|||
170722928|NCT01218646|616988465|FG000|Overall Study|Adverse Event|0|||
170722929|NCT01218646|616988466|FG001|Overall Study|Adverse Event|0|||
170722930|NCT01218646|616988467|FG002|Overall Study|Adverse Event|1|||
170722931|NCT01218646|616988468|FG003|Overall Study|Adverse Event|0|||
170722932|NCT01218646|616988465|FG000|Overall Study|Lost to Follow-up|1|||
170722933|NCT01218646|616988466|FG001|Overall Study|Lost to Follow-up|0|||
170722934|NCT01218646|616988467|FG002|Overall Study|Lost to Follow-up|0|||
170722935|NCT01218646|616988468|FG003|Overall Study|Lost to Follow-up|0|||
170722936|NCT01218646|616988465|FG000|Overall Study|Protocol Violation|0|||
170722937|NCT01218646|616988466|FG001|Overall Study|Protocol Violation|0|||
170722938|NCT01218646|616988467|FG002|Overall Study|Protocol Violation|1|||
170722939|NCT01218646|616988468|FG003|Overall Study|Protocol Violation|1|||
170722940|NCT00722761|616988469|FG000|Overall Study|Lost to Follow-up|1|||
170722941|NCT00722761|616988470|FG001|Overall Study|Lost to Follow-up|4|||
170722942|NCT00722761|616988469|FG000|Overall Study|Withdrawal by Subject|5|||
170722943|NCT00722761|616988470|FG001|Overall Study|Withdrawal by Subject|2|||
170722944|NCT02693665|616988477|FG000|Overall Study|Death|3|||
170722945|NCT02693665|616988478|FG001|Overall Study|Death|2|||
170722946|NCT02693665|616988477|FG000|Overall Study|Lost to Follow-up|7|||
170722947|NCT02693665|616988478|FG001|Overall Study|Lost to Follow-up|3|||
170722948|NCT02693665|616988477|FG000|Overall Study|Protocol Violation|1|||
170722949|NCT02693665|616988478|FG001|Overall Study|Protocol Violation|0|||
170722950|NCT02693665|616988477|FG000|Overall Study|Withdrawal by Subject|2|||
170722951|NCT02693665|616988478|FG001|Overall Study|Withdrawal by Subject|0|||
170722952|NCT02693665|616988477|FG000|Overall Study|patient wanted to leave it behind|1|||
170722953|NCT02693665|616988478|FG001|Overall Study|patient wanted to leave it behind|0|||
170722954|NCT02693665|616988477|FG000|Overall Study|anxiety|1|||
170722955|NCT02693665|616988478|FG001|Overall Study|anxiety|0|||
170722956|NCT02693665|616988477|FG000|Overall Study|family issues|1|||
170722957|NCT02693665|616988478|FG001|Overall Study|family issues|0|||
170722958|NCT02693665|616988477|FG000|Overall Study|no reason given|1|||
170722959|NCT02693665|616988478|FG001|Overall Study|no reason given|0|||
170722960|NCT03662750|616988479|FG000|Overall Study|Withdrawal by Subject|1|||
170722961|NCT03096782|616988480|FG000|Overall Study|Death|1|||
170722962|NCT03096782|616988480|FG000|Overall Study|Participant Relapsed|1|||
170722963|NCT03156023|616988481|FG000|Overall Study|Withdrawal by Subject|1|||
170722964|NCT03156023|616988482|FG001|Overall Study|Withdrawal by Subject|0|||
170722965|NCT03156023|616988483|FG002|Overall Study|Withdrawal by Subject|2|||
170722966|NCT03156023|616988484|FG003|Overall Study|Withdrawal by Subject|1|||
170722967|NCT03156023|616988485|FG004|Overall Study|Withdrawal by Subject|1|||
170722968|NCT03156023|616988481|FG000|Overall Study|Lost to Follow-up|0|||
170722969|NCT03156023|616988482|FG001|Overall Study|Lost to Follow-up|0|||
170722970|NCT03156023|616988483|FG002|Overall Study|Lost to Follow-up|0|||
170722971|NCT03156023|616988484|FG003|Overall Study|Lost to Follow-up|0|||
170722972|NCT03156023|616988485|FG004|Overall Study|Lost to Follow-up|1|||
170722973|NCT00660010|616988490|FG000|Overall Study|Withdrawal by Subject|2|||
170722974|NCT00660010|616988490|FG000|Overall Study|Lost to Follow-up|3|||
170722975|NCT00660010|616988490|FG000|Overall Study|Adverse Event|1|||
170722976|NCT00660010|616988490|FG000|Overall Study|Noncompliance with visit schedule|3|||
170722977|NCT05350449|616988491|FG000|Overall Study|Withdrawal by Subject|4|||
170722978|NCT05350449|616988492|FG001|Overall Study|Withdrawal by Subject|8|||
170722979|NCT01877408|616990302|FG000|Overall Study|Lost to Follow-up|0|||
170722980|NCT01877408|616990303|FG001|Overall Study|Lost to Follow-up|2|||
170722981|NCT03870763|616990304|FG000|Overall Study|Study terminated by sponsor|0|||
170722982|NCT03870763|616990305|FG001|Overall Study|Study terminated by sponsor|2|||
170722983|NCT03870763|616990306|FG002|Overall Study|Study terminated by sponsor|0|||
170722984|NCT03870763|616990304|FG000|Overall Study|Withdrawal by Subject|0|||
170722985|NCT03870763|616990305|FG001|Overall Study|Withdrawal by Subject|1|||
170722986|NCT03870763|616990306|FG002|Overall Study|Withdrawal by Subject|0|||
170722987|NCT03870763|616990304|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
170722988|NCT03870763|616990305|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
170722989|NCT03870763|616990306|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
170722990|NCT00686166|616990310|FG000|Overall Study|Adverse Event|7|||
170722991|NCT00686166|616990310|FG000|Overall Study|Withdrawal by Subject|1|||
170722992|NCT00686166|616990310|FG000|Overall Study|Progression/Relapse|1|||
170722993|NCT00686166|616990310|FG000|Overall Study|Death|1|||
170722994|NCT00686166|616990310|FG000|Overall Study|Not Protocol Specified|1|||
170722995|NCT00686166|616990310|FG000|Overall Study|Ineligible|5|||
170722996|NCT00686166|616990310|FG000|Overall Study|Did not begin protocol therapy|4|||
170722997|NCT02696317|616990313|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
170722998|NCT02696317|616990314|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
170722999|NCT02696317|616990313|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
170723000|NCT02696317|616990314|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
170723001|NCT01343368|616990315|FG000|Overall Study|Death|1|||
170723002|NCT01343368|616990316|FG001|Overall Study|Death|0|||
170723003|NCT01343368|616990315|FG000|Overall Study|Lost to Follow-up|1|||
170723004|NCT01343368|616990316|FG001|Overall Study|Lost to Follow-up|0|||
170723005|NCT03117738|616990323|FG000|Overall Study|Withdrawal by Subject|3|||
170723006|NCT03117738|616990324|FG001|Overall Study|Withdrawal by Subject|1|||
170723007|NCT03117738|616990323|FG000|Overall Study|Lost to Follow-up|1|||
170723008|NCT03117738|616990324|FG001|Overall Study|Lost to Follow-up|4|||
170723009|NCT03667053|616990325|FG000|Overall Study|Withdrawal by Subject|1|||
170723010|NCT03667053|616990326|FG001|Overall Study|Withdrawal by Subject|0|||
170723011|NCT03667053|616990327|FG002|Overall Study|Withdrawal by Subject|0|||
170723012|NCT02015676|616990328|FG000|Overall Study|Adverse Event|2|||
170723013|NCT02015676|616990329|FG001|Overall Study|Adverse Event|18|||
170723014|NCT02015676|616990330|FG002|Overall Study|Adverse Event|0|||
170723015|NCT02015676|616990328|FG000|Overall Study|Lack of Efficacy|2|||
170723016|NCT02015676|616990329|FG001|Overall Study|Lack of Efficacy|4|||
170723017|NCT02015676|616990330|FG002|Overall Study|Lack of Efficacy|0|||
170723018|NCT02015676|616990328|FG000|Overall Study|Protocol Violation|1|||
170723019|NCT02015676|616990329|FG001|Overall Study|Protocol Violation|0|||
170723020|NCT02015676|616990330|FG002|Overall Study|Protocol Violation|0|||
170723021|NCT02015676|616990328|FG000|Overall Study|Withdrawal by Subject|1|||
170723022|NCT02015676|616990329|FG001|Overall Study|Withdrawal by Subject|7|||
170723023|NCT02015676|616990330|FG002|Overall Study|Withdrawal by Subject|1|||
170723024|NCT02015676|616990328|FG000|Overall Study|Administrative reasons|0|||
170723025|NCT02015676|616990329|FG001|Overall Study|Administrative reasons|3|||
170723026|NCT02015676|616990330|FG002|Overall Study|Administrative reasons|1|||
170723027|NCT02015676|616990328|FG000|Overall Study|Death|0|||
170723028|NCT02015676|616990329|FG001|Overall Study|Death|1|||
170723029|NCT02015676|616990330|FG002|Overall Study|Death|0|||
170723030|NCT02015676|616990328|FG000|Overall Study|Disease progression|3|||
170723031|NCT02015676|616990329|FG001|Overall Study|Disease progression|1|||
170723032|NCT02015676|616990330|FG002|Overall Study|Disease progression|1|||
170723033|NCT00971048|616990335|FG000|Overall Study|Protocol Violation|1|||
170723034|NCT00971048|616990336|FG001|Overall Study|Protocol Violation|2|||
170723035|NCT00971048|616990337|FG002|Overall Study|Protocol Violation|0|||
170723036|NCT00971048|616990338|FG003|Overall Study|Protocol Violation|1|||
170723037|NCT00971048|616990335|FG000|Overall Study|Adverse Event|0|||
170723038|NCT00971048|616990336|FG001|Overall Study|Adverse Event|0|||
170723039|NCT00971048|616990337|FG002|Overall Study|Adverse Event|1|||
170723040|NCT00971048|616990338|FG003|Overall Study|Adverse Event|0|||
170723041|NCT00971048|616990335|FG000|Overall Study|Physician Decision|0|||
170723042|NCT00971048|616990336|FG001|Overall Study|Physician Decision|0|||
170723043|NCT00971048|616990337|FG002|Overall Study|Physician Decision|0|||
170723044|NCT00971048|616990338|FG003|Overall Study|Physician Decision|1|||
170723045|NCT02633137|616990345|FG000|Overall Study|Adverse Event|1|||
170723046|NCT02633137|616990345|FG000|Overall Study|Lack of Efficacy|2|||
170723047|NCT02633137|616990345|FG000|Overall Study|Withdrawal by Subject|1|||
170723048|NCT04307004|616990346|FG000|Randomization 1|Withdrawal by Subject|25|||
170723049|NCT04307004|616990347|FG001|Randomization 1|Withdrawal by Subject|26|||
170723050|NCT04307004|616990348|FG002|Randomization 1|Withdrawal by Subject|0|||
170723051|NCT04307004|616990349|FG003|Randomization 1|Withdrawal by Subject|0|||
170723052|NCT04307004|616990346|FG000|Randomization 2|Withdrawal by Subject|0|||
170723053|NCT04307004|616990347|FG001|Randomization 2|Withdrawal by Subject|0|||
170723054|NCT04307004|616990348|FG002|Randomization 2|Withdrawal by Subject|28|||
170723055|NCT04307004|616990349|FG003|Randomization 2|Withdrawal by Subject|23|||
170723056|NCT02807558|616990352|FG000|Overall Study|Consent withdrawn by participant|4|||
170723057|NCT02807558|616990353|FG001|Overall Study|Consent withdrawn by participant|0|||
170723058|NCT02807558|616990354|FG002|Overall Study|Consent withdrawn by participant|4|||
170723059|NCT02807558|616990355|FG003|Overall Study|Consent withdrawn by participant|2|||
170723060|NCT02807558|616990356|FG004|Overall Study|Consent withdrawn by participant|1|||
170723061|NCT02807558|616990357|FG005|Overall Study|Consent withdrawn by participant|0|||
170723062|NCT02807558|616990352|FG000|Overall Study|Non-compliance with Study Drug|0|||
170723063|NCT02807558|616990353|FG001|Overall Study|Non-compliance with Study Drug|0|||
170723064|NCT02807558|616990354|FG002|Overall Study|Non-compliance with Study Drug|1|||
170723065|NCT02807558|616990355|FG003|Overall Study|Non-compliance with Study Drug|0|||
170723066|NCT02807558|616990356|FG004|Overall Study|Non-compliance with Study Drug|0|||
170723067|NCT02807558|616990357|FG005|Overall Study|Non-compliance with Study Drug|0|||
170723068|NCT02807558|616990352|FG000|Overall Study|Adverse Event|0|||
170723069|NCT02807558|616990353|FG001|Overall Study|Adverse Event|0|||
170723070|NCT02807558|616990354|FG002|Overall Study|Adverse Event|9|||
170723071|NCT02807558|616990355|FG003|Overall Study|Adverse Event|0|||
170723072|NCT02807558|616990356|FG004|Overall Study|Adverse Event|0|||
170723073|NCT02807558|616990357|FG005|Overall Study|Adverse Event|0|||
170723074|NCT02807558|616990352|FG000|Overall Study|Death|23|||
170723075|NCT02807558|616990353|FG001|Overall Study|Death|2|||
170723076|NCT02807558|616990354|FG002|Overall Study|Death|3|||
170723077|NCT02807558|616990355|FG003|Overall Study|Death|43|||
170723078|NCT02807558|616990356|FG004|Overall Study|Death|24|||
170723079|NCT02807558|616990357|FG005|Overall Study|Death|15|||
170723080|NCT02807558|616990352|FG000|Overall Study|Progressive Disease|0|||
170723081|NCT02807558|616990353|FG001|Overall Study|Progressive Disease|0|||
170723082|NCT02807558|616990354|FG002|Overall Study|Progressive Disease|1|||
170723083|NCT02807558|616990355|FG003|Overall Study|Progressive Disease|0|||
170723084|NCT02807558|616990356|FG004|Overall Study|Progressive Disease|0|||
170723085|NCT02807558|616990357|FG005|Overall Study|Progressive Disease|0|||
170723086|NCT02807558|616990352|FG000|Overall Study|Other than specified|1|||
170723087|NCT02807558|616990353|FG001|Overall Study|Other than specified|0|||
170723088|NCT02807558|616990354|FG002|Overall Study|Other than specified|2|||
170723089|NCT02807558|616990355|FG003|Overall Study|Other than specified|0|||
170723090|NCT02807558|616990356|FG004|Overall Study|Other than specified|1|||
170723091|NCT02807558|616990357|FG005|Overall Study|Other than specified|1|||
170723092|NCT02807558|616990352|FG000|Overall Study|Lack of Efficacy|0|||
170723093|NCT02807558|616990353|FG001|Overall Study|Lack of Efficacy|0|||
170723094|NCT02807558|616990354|FG002|Overall Study|Lack of Efficacy|9|||
170723095|NCT02807558|616990355|FG003|Overall Study|Lack of Efficacy|0|||
170723096|NCT02807558|616990356|FG004|Overall Study|Lack of Efficacy|0|||
170723097|NCT02807558|616990357|FG005|Overall Study|Lack of Efficacy|0|||
170723098|NCT02647359|616990360|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
170723099|NCT02647359|616990361|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
170723100|NCT02647359|616990360|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
170723101|NCT02647359|616990361|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
170723102|NCT02647359|616990360|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
170723103|NCT02647359|616990361|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
170723104|NCT02647359|616990360|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
170723105|NCT02647359|616990361|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
170723106|NCT02647359|616990360|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
170723107|NCT02647359|616990361|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
170723108|NCT02647359|616990360|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
170723109|NCT02647359|616990361|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
170723110|NCT00413413|616990362|FG000|Single-Blind|Adverse Event|0|||
170723111|NCT00413413|616990363|FG001|Single-Blind|Adverse Event|9|||
170723112|NCT00413413|616990364|FG002|Single-Blind|Adverse Event|0|||
170723113|NCT00413413|616990362|FG000|Single-Blind|Lack of Efficacy|0|||
170723114|NCT00413413|616990363|FG001|Single-Blind|Lack of Efficacy|5|||
170723115|NCT00413413|616990364|FG002|Single-Blind|Lack of Efficacy|0|||
170723116|NCT00413413|616990362|FG000|Single-Blind|Subject no longer requires study drug|0|||
170723117|NCT00413413|616990363|FG001|Single-Blind|Subject no longer requires study drug|151|||
170723118|NCT00413413|616990364|FG002|Single-Blind|Subject no longer requires study drug|0|||
170723119|NCT00413413|616990362|FG000|Single-Blind|Protocol Violation|0|||
170723120|NCT00413413|616990363|FG001|Single-Blind|Protocol Violation|16|||
170723121|NCT00413413|616990364|FG002|Single-Blind|Protocol Violation|0|||
170723122|NCT00413413|616990362|FG000|Single-Blind|Withdrawal by Subject|0|||
170723123|NCT00413413|616990363|FG001|Single-Blind|Withdrawal by Subject|27|||
170723124|NCT00413413|616990364|FG002|Single-Blind|Withdrawal by Subject|0|||
170723125|NCT00413413|616990362|FG000|Single-Blind|Lost to Follow-up|0|||
170723126|NCT00413413|616990363|FG001|Single-Blind|Lost to Follow-up|8|||
170723127|NCT00413413|616990364|FG002|Single-Blind|Lost to Follow-up|0|||
170723128|NCT00413413|616990362|FG000|Double-Blind|Adverse Event|6|||
170723129|NCT00413413|616990363|FG001|Double-Blind|Adverse Event|0|||
170723130|NCT00413413|616990364|FG002|Double-Blind|Adverse Event|5|||
170723131|NCT00413413|616990362|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
170723132|NCT00413413|616990363|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
170723133|NCT00413413|616990364|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
170723134|NCT00413413|616990362|FG000|Double-Blind|Protocol deviation|1|||
170723135|NCT00413413|616990363|FG001|Double-Blind|Protocol deviation|2|||
170723136|NCT00413413|616990364|FG002|Double-Blind|Protocol deviation|1|||
170723137|NCT00413413|616990362|FG000|Double-Blind|Subject withdrew consent|4|||
170723138|NCT00413413|616990363|FG001|Double-Blind|Subject withdrew consent|6|||
170723139|NCT00413413|616990364|FG002|Double-Blind|Subject withdrew consent|9|||
170723140|NCT00413413|616990362|FG000|Double-Blind|Lost to Follow-up|3|||
170723141|NCT00413413|616990363|FG001|Double-Blind|Lost to Follow-up|4|||
170723142|NCT00413413|616990364|FG002|Double-Blind|Lost to Follow-up|2|||
170723143|NCT00990652|616990368|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
170723144|NCT00990652|616990368|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
170723145|NCT04391023|616990369|FG000|Overall Study|Withdrawal by Subject|2|||
170723146|NCT04391023|616990370|FG001|Overall Study|Withdrawal by Subject|2|||
170723147|NCT01270347|616990371|FG000|Core Phase|Adverse Event|1|||
170723148|NCT01270347|616990372|FG001|Core Phase|Adverse Event|6|||
170723149|NCT01270347|616990371|FG000|Core Phase|Withdrawal by Subject|1|||
170723150|NCT01270347|616990372|FG001|Core Phase|Withdrawal by Subject|2|||
170723151|NCT01270347|616990371|FG000|Core Phase|Lost to Follow-up|0|||
170723152|NCT01270347|616990372|FG001|Core Phase|Lost to Follow-up|1|||
170723153|NCT01270347|616990371|FG000|Core Phase|Miscellaneous|8|||
170723154|NCT01270347|616990372|FG001|Core Phase|Miscellaneous|14|||
170723155|NCT01270347|616990371|FG000|Extension Phase|Adverse Event|1|||
170723156|NCT01270347|616990372|FG001|Extension Phase|Adverse Event|3|||
170723157|NCT01270347|616990371|FG000|Extension Phase|Withdrawal by Subject|3|||
170723158|NCT01270347|616990372|FG001|Extension Phase|Withdrawal by Subject|4|||
170723159|NCT01270347|616990371|FG000|Extension Phase|Miscellaneous|2|||
170723160|NCT01270347|616990372|FG001|Extension Phase|Miscellaneous|2|||
170723161|NCT02085408|616990373|FG000|Step 1: Induction|Disease Progression|19|||
170723162|NCT02085408|616990374|FG001|Step 1: Induction|Disease Progression|19|||
170723163|NCT02085408|616990373|FG000|Step 1: Induction|Adverse Event|18|||
170723164|NCT02085408|616990374|FG001|Step 1: Induction|Adverse Event|17|||
170723165|NCT02085408|616990373|FG000|Step 1: Induction|Death|33|||
170723166|NCT02085408|616990374|FG001|Step 1: Induction|Death|30|||
170723167|NCT02085408|616990373|FG000|Step 1: Induction|Withdrawal by Subject|16|||
170723168|NCT02085408|616990374|FG001|Step 1: Induction|Withdrawal by Subject|8|||
170723169|NCT02085408|616990373|FG000|Step 1: Induction|Alternative Therapy|15|||
170723170|NCT02085408|616990374|FG001|Step 1: Induction|Alternative Therapy|19|||
170723171|NCT02085408|616990373|FG000|Step 1: Induction|Complicating Disease|2|||
170723172|NCT02085408|616990374|FG001|Step 1: Induction|Complicating Disease|3|||
170723173|NCT02085408|616990373|FG000|Step 1: Induction|Other|27|||
170723174|NCT02085408|616990374|FG001|Step 1: Induction|Other|39|||
170723175|NCT02085408|616990373|FG000|Step 1: Induction|Never started treatment|6|||
170723176|NCT02085408|616990374|FG001|Step 1: Induction|Never started treatment|4|||
170723177|NCT02085408|616990373|FG000|Step 2: Consolidation|Disease Progression|5|||
170723178|NCT02085408|616990374|FG001|Step 2: Consolidation|Disease Progression|20|||
170723179|NCT02085408|616990373|FG000|Step 2: Consolidation|Adverse Event|9|||
170723180|NCT02085408|616990374|FG001|Step 2: Consolidation|Adverse Event|8|||
170723181|NCT02085408|616990373|FG000|Step 2: Consolidation|Death|4|||
170723182|NCT02085408|616990374|FG001|Step 2: Consolidation|Death|3|||
170723183|NCT02085408|616990373|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
170723184|NCT02085408|616990374|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
170723185|NCT02085408|616990373|FG000|Step 2: Consolidation|Alternative Therapy|9|||
170723186|NCT02085408|616990374|FG001|Step 2: Consolidation|Alternative Therapy|3|||
170723187|NCT02085408|616990373|FG000|Step 2: Consolidation|Complicating Disease|0|||
170723188|NCT02085408|616990374|FG001|Step 2: Consolidation|Complicating Disease|2|||
170723189|NCT02085408|616990373|FG000|Step 2: Consolidation|Other|6|||
170723190|NCT02085408|616990374|FG001|Step 2: Consolidation|Other|6|||
170723191|NCT02085408|616990373|FG000|Step 2: Consolidation|Never started treatment|4|||
170723192|NCT02085408|616990374|FG001|Step 2: Consolidation|Never started treatment|3|||
170723193|NCT02085408|616990373|FG000|Step 3: Maintenance|Disease Progression|13|||
170723194|NCT02085408|616990374|FG001|Step 3: Maintenance|Disease Progression|11|||
170723195|NCT02085408|616990373|FG000|Step 3: Maintenance|Adverse Event|2|||
170723196|NCT02085408|616990374|FG001|Step 3: Maintenance|Adverse Event|4|||
170723197|NCT02085408|616990373|FG000|Step 3: Maintenance|Death|1|||
170723198|NCT02085408|616990374|FG001|Step 3: Maintenance|Death|2|||
170723199|NCT02085408|616990373|FG000|Step 3: Maintenance|Alternative Therapy|1|||
170723200|NCT02085408|616990374|FG001|Step 3: Maintenance|Alternative Therapy|1|||
170723201|NCT02085408|616990373|FG000|Step 3: Maintenance|Complicating Disease|0|||
170723202|NCT02085408|616990374|FG001|Step 3: Maintenance|Complicating Disease|1|||
170723203|NCT02085408|616990373|FG000|Step 3: Maintenance|Other|3|||
170723204|NCT02085408|616990374|FG001|Step 3: Maintenance|Other|2|||
170723205|NCT02085408|616990373|FG000|Step 3: Maintenance|Never started treatment|5|||
170723206|NCT02085408|616990374|FG001|Step 3: Maintenance|Never started treatment|1|||
170723207|NCT04732286|616990377|FG000|Overall Study|Progressive Disease|2|||
170723208|NCT04732286|616990377|FG000|Overall Study|Physician Decision|1|||
170723209|NCT04732286|616990377|FG000|Overall Study|Study Terminated by Sponsor|31|||
170723210|NCT04732286|616990377|FG000|Overall Study|Withdrawal by Subject|10|||
170723211|NCT04732286|616990377|FG000|Overall Study|Non-compliance With Study Drug|1|||
170723212|NCT04732286|616990377|FG000|Overall Study|Lost to Follow-up|4|||
170723213|NCT04732286|616990377|FG000|Overall Study|Death|51|||
170723214|NCT03449030|616990378|FG000|Overall Study|Withdrawal by Subject|0|||
170723215|NCT03449030|616990379|FG001|Overall Study|Withdrawal by Subject|0|||
170723216|NCT03449030|616990380|FG002|Overall Study|Withdrawal by Subject|0|||
170723217|NCT03449030|616990381|FG003|Overall Study|Withdrawal by Subject|1|||
170723218|NCT03449030|616990382|FG004|Overall Study|Withdrawal by Subject|1|||
170723219|NCT03449030|616990383|FG005|Overall Study|Withdrawal by Subject|1|||
170723220|NCT03449030|616990384|FG006|Overall Study|Withdrawal by Subject|1|||
170723221|NCT03449030|616990385|FG007|Overall Study|Withdrawal by Subject|2|||
170723222|NCT03449030|616990386|FG008|Overall Study|Withdrawal by Subject|0|||
170723223|NCT03449030|616990387|FG009|Overall Study|Withdrawal by Subject|0|||
170723224|NCT03449030|616990378|FG000|Overall Study|Symptomatic Deterioration|0|||
170723225|NCT03449030|616990379|FG001|Overall Study|Symptomatic Deterioration|1|||
170723226|NCT03449030|616990380|FG002|Overall Study|Symptomatic Deterioration|0|||
170723227|NCT03449030|616990381|FG003|Overall Study|Symptomatic Deterioration|0|||
170723228|NCT03449030|616990382|FG004|Overall Study|Symptomatic Deterioration|0|||
170723229|NCT03449030|616990383|FG005|Overall Study|Symptomatic Deterioration|1|||
170723230|NCT03449030|616990384|FG006|Overall Study|Symptomatic Deterioration|1|||
170723231|NCT03449030|616990385|FG007|Overall Study|Symptomatic Deterioration|0|||
170723232|NCT03449030|616990386|FG008|Overall Study|Symptomatic Deterioration|2|||
170723233|NCT03449030|616990387|FG009|Overall Study|Symptomatic Deterioration|0|||
170723234|NCT03449030|616990378|FG000|Overall Study|Progressive Disease|1|||
170723235|NCT03449030|616990379|FG001|Overall Study|Progressive Disease|0|||
170723236|NCT03449030|616990380|FG002|Overall Study|Progressive Disease|1|||
170723237|NCT03449030|616990381|FG003|Overall Study|Progressive Disease|4|||
170723238|NCT03449030|616990382|FG004|Overall Study|Progressive Disease|5|||
170723239|NCT03449030|616990383|FG005|Overall Study|Progressive Disease|3|||
170723240|NCT03449030|616990384|FG006|Overall Study|Progressive Disease|0|||
170723241|NCT03449030|616990385|FG007|Overall Study|Progressive Disease|1|||
170723242|NCT03449030|616990386|FG008|Overall Study|Progressive Disease|1|||
170831957|NCT00233389|617394685|FG001|Overall Study|Adverse Event|5|||
170723243|NCT03449030|616990387|FG009|Overall Study|Progressive Disease|1|||
170723244|NCT03449030|616990378|FG000|Overall Study|Adverse Event|0|||
170723245|NCT03449030|616990379|FG001|Overall Study|Adverse Event|0|||
170723246|NCT03449030|616990380|FG002|Overall Study|Adverse Event|0|||
170723247|NCT03449030|616990381|FG003|Overall Study|Adverse Event|0|||
170723248|NCT03449030|616990382|FG004|Overall Study|Adverse Event|0|||
170723249|NCT03449030|616990383|FG005|Overall Study|Adverse Event|2|||
170723250|NCT03449030|616990384|FG006|Overall Study|Adverse Event|0|||
170723251|NCT03449030|616990385|FG007|Overall Study|Adverse Event|0|||
170723252|NCT03449030|616990386|FG008|Overall Study|Adverse Event|0|||
170723253|NCT03449030|616990387|FG009|Overall Study|Adverse Event|0|||
170723254|NCT03449030|616990378|FG000|Overall Study|Death|0|||
170723255|NCT03449030|616990379|FG001|Overall Study|Death|0|||
170723256|NCT03449030|616990380|FG002|Overall Study|Death|0|||
170831958|NCT00233389|617394684|FG000|Overall Study|Lack of Efficacy|11|||
170831959|NCT00233389|617394685|FG001|Overall Study|Lack of Efficacy|8|||
170831960|NCT00233389|617394684|FG000|Overall Study|Lost to Follow-up|1|||
170831961|NCT00233389|617394685|FG001|Overall Study|Lost to Follow-up|1|||
170831962|NCT00233389|617394684|FG000|Overall Study|Physician Decision|1|||
170831963|NCT00233389|617394685|FG001|Overall Study|Physician Decision|0|||
170831964|NCT00233389|617394684|FG000|Overall Study|Protocol Violation|0|||
170831965|NCT00233389|617394685|FG001|Overall Study|Protocol Violation|1|||
170831966|NCT00233389|617394684|FG000|Overall Study|Withdrawal by Subject|0|||
170831967|NCT00233389|617394685|FG001|Overall Study|Withdrawal by Subject|1|||
170831968|NCT01588366|617394691|FG000|Overall Study|Adverse Event|0|||
170831969|NCT01588366|617394692|FG001|Overall Study|Adverse Event|1|||
170831970|NCT01588366|617394693|FG002|Overall Study|Adverse Event|0|||
170831971|NCT01588366|617394694|FG003|Overall Study|Adverse Event|1|||
170831972|NCT01588366|617394695|FG004|Overall Study|Adverse Event|0|||
170831973|NCT01588366|617394696|FG005|Overall Study|Adverse Event|2|||
170831974|NCT00302159|617394697|FG000|Overall Study|pt declined before treatment started|1|||
170831975|NCT00302159|617394697|FG000|Overall Study|pt started Avastin|1|||
170831976|NCT02648997|617394698|FG000|Overall Study|Still receiving active study tx|0|||
170831977|NCT02648997|617394699|FG001|Overall Study|Still receiving active study tx|0|||
170831978|NCT02648997|617394700|FG002|Overall Study|Still receiving active study tx|1|||
170831979|NCT04962698|617394701|FG000|Motor Imagery|Technical difficulty|1|||
170831980|NCT04962698|617394702|FG001|Motor Imagery|Technical difficulty|0|||
170831981|NCT04962698|617394701|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
170831982|NCT04962698|617394702|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
170831983|NCT04962698|617394701|FG000|Kinesthetic MI|Technical difficulty|1|||
170831984|NCT04962698|617394702|FG001|Kinesthetic MI|Technical difficulty|0|||
170831985|NCT04962698|617394701|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
170831986|NCT04962698|617394702|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
170831987|NCT04962698|617394701|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
170831988|NCT04962698|617394702|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
170831989|NCT04962698|617394701|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
170831990|NCT04962698|617394702|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
170831991|NCT04962698|617394701|FG000|Virtual-hand Interaction|Technical difficulty|1|||
170831992|NCT04962698|617394702|FG001|Virtual-hand Interaction|Technical difficulty|0|||
170831993|NCT04962698|617394701|FG000|Robotic Action Observation|Technical difficulty|1|||
170831994|NCT04962698|617394702|FG001|Robotic Action Observation|Technical difficulty|0|||
170831995|NCT04962698|617394701|FG000|Rest|Technical difficulty|1|||
170831996|NCT04962698|617394702|FG001|Rest|Technical difficulty|0|||
170831997|NCT04962698|617394701|FG000|Rest|Exclusion criteria met after enrollment|0|||
170831998|NCT04962698|617394702|FG001|Rest|Exclusion criteria met after enrollment|2|||
170831999|NCT02312206|617394709|FG000|Overall Study|Adverse Event|3|||
170832000|NCT02312206|617394710|FG001|Overall Study|Adverse Event|6|||
170832001|NCT02312206|617394709|FG000|Overall Study|Withdrawal by Subject|6|||
170832002|NCT02312206|617394710|FG001|Overall Study|Withdrawal by Subject|6|||
170832003|NCT02312206|617394709|FG000|Overall Study|Physician Decision|7|||
170832004|NCT02312206|617394710|FG001|Overall Study|Physician Decision|6|||
170832005|NCT02312206|617394709|FG000|Overall Study|Death|31|||
170832006|NCT02312206|617394710|FG001|Overall Study|Death|36|||
170832007|NCT02312206|617394709|FG000|Overall Study|Study Terminated by Sponsor|81|||
170832008|NCT02312206|617394710|FG001|Overall Study|Study Terminated by Sponsor|74|||
170832009|NCT02312206|617394709|FG000|Overall Study|Patient transferred to hospice|0|||
170832010|NCT02312206|617394710|FG001|Overall Study|Patient transferred to hospice|1|||
170832011|NCT02312206|617394709|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
170832012|NCT02312206|617394710|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
170832013|NCT02312206|617394709|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
170832014|NCT02312206|617394710|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
170832015|NCT02312206|617394709|FG000|Overall Study|Disease Progression|1|||
170832016|NCT02312206|617394710|FG001|Overall Study|Disease Progression|0|||
170832017|NCT00585975|617394711|FG000|Overall Study|Withdrawal by Subject|3|||
170832018|NCT00585975|617394712|FG001|Overall Study|Withdrawal by Subject|3|||
170832019|NCT00585975|617394711|FG000|Overall Study|Lost to Follow-up|2|||
170832020|NCT00585975|617394712|FG001|Overall Study|Lost to Follow-up|1|||
170832021|NCT00585975|617394711|FG000|Overall Study|Enrollment met/over-enrolled|10|||
170832022|NCT00585975|617394712|FG001|Overall Study|Enrollment met/over-enrolled|9|||
170832023|NCT03082612|617394715|FG000|Overall Study|Lost to Follow-up|2|||
170832024|NCT03082612|617394716|FG001|Overall Study|Lost to Follow-up|0|||
170832025|NCT00822770|617394717|FG000|Overall Study|Not treated|1|||
170832026|NCT00822770|617394718|FG001|Overall Study|Not treated|0|||
170832027|NCT00822770|617394717|FG000|Overall Study|Complication/Incomplete treatment|1|||
170832028|NCT00822770|617394718|FG001|Overall Study|Complication/Incomplete treatment|0|||
170832029|NCT00822770|617394717|FG000|Overall Study|Death|1|||
170723257|NCT03449030|616990381|FG003|Overall Study|Death|0|||
170723258|NCT03449030|616990382|FG004|Overall Study|Death|1|||
170723259|NCT03449030|616990383|FG005|Overall Study|Death|0|||
170723260|NCT03449030|616990384|FG006|Overall Study|Death|0|||
170723261|NCT03449030|616990385|FG007|Overall Study|Death|0|||
170723262|NCT03449030|616990386|FG008|Overall Study|Death|0|||
170723263|NCT03449030|616990387|FG009|Overall Study|Death|0|||
170723264|NCT00965523|616990388|FG000|Study 221|Progressive Disease|4|||
170723265|NCT00965523|616990388|FG000|Study 221|Physician Decision|3|||
170723266|NCT00965523|616990388|FG000|Study 224|Progressive Disease|5|||
170723267|NCT00965523|616990388|FG000|Study 224|Physician Decision|1|||
170723268|NCT02105948|616990392|FG000|Overall Study|Adverse Event|10|||
170723269|NCT02105948|616990393|FG001|Overall Study|Adverse Event|7|||
170723270|NCT02105948|616990394|FG002|Overall Study|Adverse Event|11|||
170723271|NCT02105948|616990395|FG003|Overall Study|Adverse Event|11|||
170723272|NCT02105948|616990392|FG000|Overall Study|Lack of Efficacy|0|||
170723273|NCT02105948|616990393|FG001|Overall Study|Lack of Efficacy|1|||
170723274|NCT02105948|616990394|FG002|Overall Study|Lack of Efficacy|3|||
170723275|NCT02105948|616990395|FG003|Overall Study|Lack of Efficacy|2|||
170723276|NCT02105948|616990392|FG000|Overall Study|Lost to Follow-up|0|||
170723277|NCT02105948|616990393|FG001|Overall Study|Lost to Follow-up|0|||
170723278|NCT02105948|616990394|FG002|Overall Study|Lost to Follow-up|2|||
170723279|NCT02105948|616990395|FG003|Overall Study|Lost to Follow-up|1|||
170723280|NCT02105948|616990392|FG000|Overall Study|Physician Decision|2|||
170723281|NCT02105948|616990393|FG001|Overall Study|Physician Decision|2|||
170723282|NCT02105948|616990394|FG002|Overall Study|Physician Decision|2|||
170723283|NCT02105948|616990395|FG003|Overall Study|Physician Decision|2|||
170723284|NCT02105948|616990392|FG000|Overall Study|Withdrawal by Subject|15|||
170723285|NCT02105948|616990393|FG001|Overall Study|Withdrawal by Subject|10|||
170723286|NCT02105948|616990394|FG002|Overall Study|Withdrawal by Subject|10|||
170723287|NCT02105948|616990395|FG003|Overall Study|Withdrawal by Subject|11|||
170723288|NCT01581281|616990396|FG000|Overall Study|Early Study Closure|15|||
170723289|NCT01581281|616990397|FG001|Overall Study|Early Study Closure|6|||
170723290|NCT01581281|616990398|FG002|Overall Study|Early Study Closure|12|||
170723291|NCT00584727|616990400|FG000|First Intervention|Discontinuation|0|||
170723292|NCT00584727|616990401|FG001|First Intervention|Discontinuation|0|||
170723293|NCT00584727|616990402|FG002|First Intervention|Discontinuation|1|||
170723294|NCT00584727|616990403|FG003|First Intervention|Discontinuation|0|||
170723295|NCT00584727|616990404|FG004|First Intervention|Discontinuation|0|||
170723296|NCT00584727|616990405|FG005|First Intervention|Discontinuation|0|||
170723297|NCT00584727|616990400|FG000|Third Intervention|Protocol Violation|0|||
170723298|NCT00584727|616990401|FG001|Third Intervention|Protocol Violation|0|||
170723299|NCT00584727|616990402|FG002|Third Intervention|Protocol Violation|1|||
170723300|NCT00584727|616990403|FG003|Third Intervention|Protocol Violation|0|||
170723301|NCT00584727|616990404|FG004|Third Intervention|Protocol Violation|4|||
170723302|NCT00584727|616990405|FG005|Third Intervention|Protocol Violation|2|||
170723303|NCT03301051|616990407|FG000|Overall Study|Adverse Event|0|||
170723304|NCT03301051|616990408|FG001|Overall Study|Adverse Event|4|||
170832030|NCT00822770|617394718|FG001|Overall Study|Death|1|||
170832031|NCT01006616|617394719|FG000|Period 1 (6 Months)|Adverse Event|10|||
170832032|NCT01006616|617394720|FG001|Period 1 (6 Months)|Adverse Event|31|||
170832033|NCT01006616|617394721|FG002|Period 1 (6 Months)|Adverse Event|37|||
170832034|NCT01006616|617394722|FG003|Period 1 (6 Months)|Adverse Event|9|||
170832035|NCT01006616|617394719|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
170832036|NCT01006616|617394720|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
170832037|NCT01006616|617394721|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
170832038|NCT01006616|617394722|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
170832039|NCT01006616|617394719|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
170832040|NCT01006616|617394720|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
170832041|NCT01006616|617394721|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
170832042|NCT01006616|617394722|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
170832043|NCT01006616|617394719|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
170832044|NCT01006616|617394720|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
170723305|NCT03301051|616990407|FG000|Overall Study|Withdrawal by Subject|59|||
170723306|NCT03301051|616990408|FG001|Overall Study|Withdrawal by Subject|65|||
170723307|NCT03301051|616990407|FG000|Overall Study|Lost to Follow-up|263|||
170723308|NCT03301051|616990408|FG001|Overall Study|Lost to Follow-up|282|||
170723309|NCT03301051|616990407|FG000|Overall Study|Protocol Violation|1|||
170723310|NCT03301051|616990408|FG001|Overall Study|Protocol Violation|3|||
170723311|NCT03301051|616990407|FG000|Overall Study|Physician Decision|1|||
170723312|NCT03301051|616990408|FG001|Overall Study|Physician Decision|3|||
170723313|NCT03301051|616990407|FG000|Overall Study|Death|1|||
170832045|NCT01006616|617394721|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
170832046|NCT01006616|617394722|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
170723314|NCT03301051|616990408|FG001|Overall Study|Death|1|||
170723315|NCT03301051|616990407|FG000|Overall Study|Miscellaneous|8|||
170723316|NCT03301051|616990408|FG001|Overall Study|Miscellaneous|4|||
170723317|NCT03301051|616990407|FG000|Overall Study|Randomized, not vaccinated|13|||
170832047|NCT01006616|617394719|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
170832048|NCT01006616|617394720|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
170832049|NCT01006616|617394721|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
170832050|NCT01006616|617394722|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
170832051|NCT01006616|617394719|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
170832052|NCT01006616|617394720|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
170832053|NCT01006616|617394721|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
170832054|NCT01006616|617394722|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
170832055|NCT01006616|617394719|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
170832056|NCT01006616|617394720|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
170832057|NCT01006616|617394721|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
170832058|NCT01006616|617394722|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
170832059|NCT01006616|617394719|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
170832060|NCT01006616|617394720|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
170832061|NCT01006616|617394721|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
170832062|NCT01006616|617394722|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
170832063|NCT01006616|617394719|FG000|Period 1 (6 Months)|Not Treated|0|||
170832064|NCT01006616|617394720|FG001|Period 1 (6 Months)|Not Treated|0|||
170832065|NCT01006616|617394721|FG002|Period 1 (6 Months)|Not Treated|1|||
170832066|NCT01006616|617394722|FG003|Period 1 (6 Months)|Not Treated|1|||
170832067|NCT01006616|617394719|FG000|Period 2 (18 Months)|Adverse Event|6|||
170832068|NCT01006616|617394720|FG001|Period 2 (18 Months)|Adverse Event|6|||
170832069|NCT01006616|617394721|FG002|Period 2 (18 Months)|Adverse Event|6|||
170832070|NCT01006616|617394722|FG003|Period 2 (18 Months)|Adverse Event|4|||
170832071|NCT01006616|617394719|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
170832072|NCT01006616|617394720|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
170832073|NCT01006616|617394721|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
170832074|NCT01006616|617394722|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
170832075|NCT01006616|617394719|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
170832076|NCT01006616|617394720|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
170832077|NCT01006616|617394721|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
170832078|NCT01006616|617394722|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
170832079|NCT01006616|617394719|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
170832080|NCT01006616|617394720|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
170832081|NCT01006616|617394721|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
170832082|NCT01006616|617394722|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
170832083|NCT01006616|617394719|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
170832084|NCT01006616|617394720|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
170832085|NCT01006616|617394721|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
170832086|NCT01006616|617394722|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
170832087|NCT01006616|617394719|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
170832088|NCT01006616|617394720|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
170832089|NCT01006616|617394721|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
170832090|NCT01006616|617394722|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
170832091|NCT01006616|617394719|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
170832092|NCT01006616|617394720|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
170832093|NCT01006616|617394721|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
170832094|NCT01006616|617394722|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
170832095|NCT01006616|617394719|FG000|Period 2 (18 Months)|Study Terminated|63|||
170832096|NCT01006616|617394720|FG001|Period 2 (18 Months)|Study Terminated|46|||
170832097|NCT01006616|617394721|FG002|Period 2 (18 Months)|Study Terminated|44|||
170832098|NCT01006616|617394722|FG003|Period 2 (18 Months)|Study Terminated|70|||
170832099|NCT03672175|617394723|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
170832100|NCT03672175|617394724|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
170832101|NCT03672175|617394725|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
170832102|NCT03672175|617394723|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
170832103|NCT03672175|617394724|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
170832104|NCT03672175|617394725|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
170832105|NCT03672175|617394723|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
170832106|NCT03672175|617394724|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
170832107|NCT03672175|617394725|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
170832108|NCT03672175|617394723|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
170832109|NCT03672175|617394724|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
170832110|NCT03672175|617394725|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
170832111|NCT03672175|617394723|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
170832112|NCT03672175|617394724|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
170832113|NCT03672175|617394725|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
170832114|NCT03672175|617394723|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
170832115|NCT03672175|617394724|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
170832116|NCT03672175|617394725|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
170832117|NCT03672175|617394723|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
170832118|NCT03672175|617394724|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
170832119|NCT03672175|617394725|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
170832120|NCT03672175|617394723|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
170832121|NCT03672175|617394724|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
170832122|NCT03672175|617394725|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
170832123|NCT03672175|617394723|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
170832124|NCT03672175|617394724|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
170832125|NCT03672175|617394725|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
170832126|NCT03672175|617394723|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
170832127|NCT03672175|617394724|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
170832128|NCT03672175|617394725|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
170832129|NCT03672175|617394723|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
170832130|NCT03672175|617394724|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
170832131|NCT03672175|617394725|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
170832132|NCT03672175|617394723|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
170832133|NCT03672175|617394724|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
170832134|NCT03672175|617394725|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
170832135|NCT05720949|617394729|FG000|Overall Study|Withdrawal by Subject|0|||
170832136|NCT05720949|617394730|FG001|Overall Study|Withdrawal by Subject|1|||
170832137|NCT05720949|617394729|FG000|Overall Study|Lost to Follow-up|11|||
170832138|NCT05720949|617394730|FG001|Overall Study|Lost to Follow-up|13|||
170832139|NCT00992992|617394731|FG000|Overall Study|Lost to Follow-up|3|||
170832140|NCT00992992|617394731|FG000|Overall Study|Death|16|||
170832141|NCT00992992|617394731|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
170832142|NCT00992992|617394731|FG000|Overall Study|Sponsor Closed the Study|4|||
170832143|NCT00458393|617394732|FG000|Overall Study|Withdrawal by Subject|67|||
170832144|NCT00458393|617394733|FG001|Overall Study|Withdrawal by Subject|80|||
170832145|NCT00458393|617394732|FG000|Overall Study|Physician Decision|31|||
170832146|NCT00458393|617394733|FG001|Overall Study|Physician Decision|22|||
170832147|NCT00458393|617394732|FG000|Overall Study|Relocated|77|||
170832148|NCT00458393|617394733|FG001|Overall Study|Relocated|81|||
170832149|NCT00458393|617394732|FG000|Overall Study|Lost to Follow-up|115|||
170832150|NCT00458393|617394733|FG001|Overall Study|Lost to Follow-up|92|||
170832151|NCT00458393|617394732|FG000|Overall Study|Sites marked other on the form.|19|||
170832152|NCT00458393|617394733|FG001|Overall Study|Sites marked other on the form.|20|||
170832153|NCT02725567|617394734|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
170832154|NCT02725567|617394735|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
170832155|NCT02725567|617394734|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
170832156|NCT02725567|617394735|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
170832157|NCT02725567|617394734|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
170832158|NCT02725567|617394735|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
170832159|NCT01182181|617394745|FG000|First Intervention|Adverse Event|1|||
170832160|NCT01182181|617394746|FG001|First Intervention|Adverse Event|0|||
170832161|NCT01182181|617394745|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
170832162|NCT01182181|617394746|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
170832163|NCT00511797|617394747|FG000|Overall Study|Adverse Event|1|||
170832164|NCT00511797|617394748|FG001|Overall Study|Adverse Event|2|||
170832165|NCT00511797|617394749|FG002|Overall Study|Adverse Event|2|||
170832166|NCT00511797|617394750|FG003|Overall Study|Adverse Event|2|||
170832167|NCT00511797|617394747|FG000|Overall Study|Lost to Follow-up|1|||
170832168|NCT00511797|617394748|FG001|Overall Study|Lost to Follow-up|0|||
170832169|NCT00511797|617394749|FG002|Overall Study|Lost to Follow-up|0|||
170832170|NCT00511797|617394750|FG003|Overall Study|Lost to Follow-up|1|||
170832171|NCT00511797|617394747|FG000|Overall Study|Pregnancy|0|||
170832172|NCT00511797|617394748|FG001|Overall Study|Pregnancy|0|||
170832173|NCT00511797|617394749|FG002|Overall Study|Pregnancy|0|||
170832174|NCT00511797|617394750|FG003|Overall Study|Pregnancy|1|||
170832175|NCT00511797|617394747|FG000|Overall Study|Protocol Violation|0|||
170832176|NCT00511797|617394748|FG001|Overall Study|Protocol Violation|2|||
170832177|NCT00511797|617394749|FG002|Overall Study|Protocol Violation|2|||
170832178|NCT00511797|617394750|FG003|Overall Study|Protocol Violation|3|||
170832179|NCT00511797|617394747|FG000|Overall Study|Withdrawal by Subject|3|||
170832180|NCT00511797|617394748|FG001|Overall Study|Withdrawal by Subject|3|||
170832181|NCT00511797|617394749|FG002|Overall Study|Withdrawal by Subject|4|||
170832182|NCT00511797|617394750|FG003|Overall Study|Withdrawal by Subject|2|||
170832183|NCT00511797|617394747|FG000|Overall Study|Never dispensed|1|||
170832184|NCT00511797|617394748|FG001|Overall Study|Never dispensed|0|||
170832185|NCT00511797|617394749|FG002|Overall Study|Never dispensed|1|||
170832186|NCT00511797|617394750|FG003|Overall Study|Never dispensed|3|||
170832187|NCT00511797|617394747|FG000|Overall Study|Study drug not taken|0|||
170832188|NCT00511797|617394748|FG001|Overall Study|Study drug not taken|1|||
170832189|NCT00511797|617394749|FG002|Overall Study|Study drug not taken|0|||
170832190|NCT00511797|617394750|FG003|Overall Study|Study drug not taken|1|||
170832191|NCT00511797|617394747|FG000|Overall Study|Partially missing diary|0|||
170832192|NCT00511797|617394748|FG001|Overall Study|Partially missing diary|0|||
170832193|NCT00511797|617394749|FG002|Overall Study|Partially missing diary|1|||
170832194|NCT00511797|617394750|FG003|Overall Study|Partially missing diary|0|||
170832195|NCT00511797|617394747|FG000|Overall Study|Other (moving etc)|1|||
170832196|NCT00511797|617394748|FG001|Overall Study|Other (moving etc)|0|||
170832197|NCT00511797|617394749|FG002|Overall Study|Other (moving etc)|1|||
170832198|NCT00511797|617394750|FG003|Overall Study|Other (moving etc)|2|||
170832199|NCT00104637|617394751|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
170832200|NCT00104637|617394752|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
170832201|NCT01278615|617394753|FG000|Overall Study|Withdrawal by Subject|2|||
170832202|NCT02654132|617394757|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
170832203|NCT02654132|617394758|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
170832204|NCT02654132|617394757|FG000|Treatment Period|Disease progression|43|||
170832205|NCT02654132|617394758|FG001|Treatment Period|Disease progression|38|||
170832206|NCT02654132|617394757|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
170832207|NCT02654132|617394758|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
170832208|NCT02654132|617394757|FG000|Treatment Period|Other reasons|4|||
170832209|NCT02654132|617394758|FG001|Treatment Period|Other reasons|2|||
170832210|NCT02654132|617394757|FG000|Treatment Period|Study drug toxicity|2|||
170832211|NCT02654132|617394758|FG001|Treatment Period|Study drug toxicity|2|||
170832212|NCT02654132|617394757|FG000|Treatment Period|Withdrawal by Subject|2|||
170832213|NCT02654132|617394758|FG001|Treatment Period|Withdrawal by Subject|1|||
170832214|NCT02654132|617394757|FG000|Treatment Period|Maximum Clinical Benefit|0|||
170832215|NCT02654132|617394758|FG001|Treatment Period|Maximum Clinical Benefit|2|||
170832216|NCT02654132|617394757|FG000|Treatment Period|Participant request to discontinue|2|||
170832217|NCT02654132|617394758|FG001|Treatment Period|Participant request to discontinue|0|||
170832218|NCT02654132|617394757|FG000|Treatment Period|Administrative reasons by sponsor|0|||
170832219|NCT02654132|617394758|FG001|Treatment Period|Administrative reasons by sponsor|1|||
170832220|NCT02654132|617394757|FG000|Treatment Period|Death|1|||
170832221|NCT02654132|617394758|FG001|Treatment Period|Death|0|||
170832222|NCT01390441|617394763|FG000|Treatment Period|Protocol Violation|0|||
170832223|NCT01390441|617394764|FG001|Treatment Period|Protocol Violation|1|||
170832224|NCT01390441|617394765|FG002|Treatment Period|Protocol Violation|0|||
170832225|NCT01390441|617394766|FG003|Treatment Period|Protocol Violation|0|||
170832226|NCT01390441|617394767|FG004|Treatment Period|Protocol Violation|0|||
170832227|NCT01390441|617394763|FG000|Treatment Period|Physician Decision|0|||
170832228|NCT01390441|617394764|FG001|Treatment Period|Physician Decision|0|||
170832229|NCT01390441|617394765|FG002|Treatment Period|Physician Decision|0|||
170832230|NCT01390441|617394766|FG003|Treatment Period|Physician Decision|1|||
170832231|NCT01390441|617394767|FG004|Treatment Period|Physician Decision|0|||
170832232|NCT01390441|617394763|FG000|Treatment Period|Lack of Efficacy|0|||
170832233|NCT01390441|617394764|FG001|Treatment Period|Lack of Efficacy|0|||
170832234|NCT01390441|617394765|FG002|Treatment Period|Lack of Efficacy|0|||
170832235|NCT01390441|617394766|FG003|Treatment Period|Lack of Efficacy|0|||
170832236|NCT01390441|617394767|FG004|Treatment Period|Lack of Efficacy|1|||
170832237|NCT01390441|617394763|FG000|Treatment Period|Unknown due to early stopping of study|0|||
170832238|NCT01390441|617394764|FG001|Treatment Period|Unknown due to early stopping of study|0|||
170832239|NCT01390441|617394765|FG002|Treatment Period|Unknown due to early stopping of study|8|||
170832240|NCT01390441|617394766|FG003|Treatment Period|Unknown due to early stopping of study|11|||
170832241|NCT01390441|617394767|FG004|Treatment Period|Unknown due to early stopping of study|7|||
170832242|NCT01390441|617394763|FG000|Treatment Period|Adverse Event|0|||
170832243|NCT01390441|617394764|FG001|Treatment Period|Adverse Event|0|||
170832244|NCT01390441|617394765|FG002|Treatment Period|Adverse Event|1|||
170832245|NCT01390441|617394766|FG003|Treatment Period|Adverse Event|1|||
170832246|NCT01390441|617394767|FG004|Treatment Period|Adverse Event|2|||
170832247|NCT01390441|617394763|FG000|Treatment Period|Withdrawal by Subject|0|||
170832248|NCT01390441|617394764|FG001|Treatment Period|Withdrawal by Subject|0|||
170832249|NCT01390441|617394765|FG002|Treatment Period|Withdrawal by Subject|1|||
170832250|NCT01390441|617394766|FG003|Treatment Period|Withdrawal by Subject|0|||
170832251|NCT01390441|617394767|FG004|Treatment Period|Withdrawal by Subject|1|||
170832252|NCT01390441|617394763|FG000|Treatment Period|Lost to Follow-up|1|||
170832253|NCT01390441|617394764|FG001|Treatment Period|Lost to Follow-up|0|||
170832254|NCT01390441|617394765|FG002|Treatment Period|Lost to Follow-up|0|||
170832255|NCT01390441|617394766|FG003|Treatment Period|Lost to Follow-up|0|||
170832256|NCT01390441|617394767|FG004|Treatment Period|Lost to Follow-up|0|||
170832257|NCT01390441|617394763|FG000|Extension Period|Protocol Violation|3|||
170832258|NCT01390441|617394764|FG001|Extension Period|Protocol Violation|1|||
170832259|NCT01390441|617394765|FG002|Extension Period|Protocol Violation|0|||
170832260|NCT01390441|617394766|FG003|Extension Period|Protocol Violation|1|||
170832261|NCT01390441|617394767|FG004|Extension Period|Protocol Violation|0|||
170832262|NCT00623363|617394768|FG000|Overall Study|Adverse Event|2|||
170832263|NCT00623363|617394769|FG001|Overall Study|Adverse Event|2|||
170832264|NCT03802617|617394770|FG000|Overall Study|Adverse Event|0|||
170832265|NCT03802617|617394771|FG001|Overall Study|Adverse Event|4|||
170832266|NCT03802617|617394772|FG002|Overall Study|Adverse Event|5|||
170832267|NCT03802617|617394773|FG003|Overall Study|Adverse Event|1|||
170832268|NCT03802617|617394770|FG000|Overall Study|Lack of Efficacy|0|||
170832269|NCT03802617|617394771|FG001|Overall Study|Lack of Efficacy|1|||
170832270|NCT03802617|617394772|FG002|Overall Study|Lack of Efficacy|0|||
170832271|NCT03802617|617394773|FG003|Overall Study|Lack of Efficacy|2|||
170832272|NCT03802617|617394770|FG000|Overall Study|Protocol Violation|1|||
170832273|NCT03802617|617394771|FG001|Overall Study|Protocol Violation|1|||
170832274|NCT03802617|617394772|FG002|Overall Study|Protocol Violation|1|||
170832275|NCT03802617|617394773|FG003|Overall Study|Protocol Violation|0|||
170832276|NCT03802617|617394770|FG000|Overall Study|Withdrawal by Subject|1|||
170832277|NCT03802617|617394771|FG001|Overall Study|Withdrawal by Subject|1|||
170832278|NCT03802617|617394772|FG002|Overall Study|Withdrawal by Subject|1|||
170832279|NCT03802617|617394773|FG003|Overall Study|Withdrawal by Subject|0|||
170832280|NCT03802617|617394770|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
170832281|NCT03802617|617394771|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
170832282|NCT03802617|617394772|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
170832283|NCT03802617|617394773|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
170832284|NCT00823836|617394777|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
170832285|NCT00823836|617394778|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
170832286|NCT00823836|617394777|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
170832287|NCT00823836|617394778|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
170832288|NCT00823836|617394777|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
170832289|NCT00823836|617394778|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
170832290|NCT00823836|617394777|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
170832291|NCT00823836|617394778|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
170832292|NCT00823836|617394777|FG000|Long-term Phase|Adverse Event|3|||
170832293|NCT00823836|617394778|FG001|Long-term Phase|Adverse Event|2|||
170832294|NCT00823836|617394777|FG000|Long-term Phase|Physician Decision|1|||
170832295|NCT00823836|617394778|FG001|Long-term Phase|Physician Decision|2|||
170832296|NCT00823836|617394777|FG000|Long-term Phase|Withdrawal by Subject|1|||
170832297|NCT00823836|617394778|FG001|Long-term Phase|Withdrawal by Subject|1|||
170832298|NCT01157377|617394779|FG000|Overall Study|Lost to Follow-up|0|||
170832299|NCT01157377|617394780|FG001|Overall Study|Lost to Follow-up|0|||
170832300|NCT01157377|617394781|FG002|Overall Study|Lost to Follow-up|1|||
170832301|NCT01157377|617394782|FG003|Overall Study|Lost to Follow-up|0|||
170832302|NCT01157377|617394783|FG004|Overall Study|Lost to Follow-up|1|||
170832303|NCT01157377|617394784|FG005|Overall Study|Lost to Follow-up|1|||
170832304|NCT01157377|617394785|FG006|Overall Study|Lost to Follow-up|0|||
170832305|NCT01157377|617394779|FG000|Overall Study|Personal Reasons|2|||
170832306|NCT01157377|617394780|FG001|Overall Study|Personal Reasons|1|||
170832307|NCT01157377|617394781|FG002|Overall Study|Personal Reasons|0|||
170832308|NCT01157377|617394782|FG003|Overall Study|Personal Reasons|1|||
170832309|NCT01157377|617394783|FG004|Overall Study|Personal Reasons|0|||
170832310|NCT01157377|617394784|FG005|Overall Study|Personal Reasons|0|||
170832311|NCT01157377|617394785|FG006|Overall Study|Personal Reasons|0|||
170832312|NCT01157377|617394779|FG000|Overall Study|Protocol Violation|0|||
170832313|NCT01157377|617394780|FG001|Overall Study|Protocol Violation|0|||
170832314|NCT01157377|617394781|FG002|Overall Study|Protocol Violation|0|||
170832315|NCT01157377|617394782|FG003|Overall Study|Protocol Violation|0|||
170832316|NCT01157377|617394783|FG004|Overall Study|Protocol Violation|0|||
170832317|NCT01157377|617394784|FG005|Overall Study|Protocol Violation|1|||
170832318|NCT01157377|617394785|FG006|Overall Study|Protocol Violation|0|||
170832319|NCT01157377|617394779|FG000|Overall Study|Lack of Efficacy|0|||
170832320|NCT01157377|617394780|FG001|Overall Study|Lack of Efficacy|0|||
170832321|NCT01157377|617394781|FG002|Overall Study|Lack of Efficacy|0|||
170832322|NCT01157377|617394782|FG003|Overall Study|Lack of Efficacy|0|||
170832323|NCT01157377|617394783|FG004|Overall Study|Lack of Efficacy|0|||
170832324|NCT01157377|617394784|FG005|Overall Study|Lack of Efficacy|0|||
170832325|NCT01157377|617394785|FG006|Overall Study|Lack of Efficacy|1|||
170832326|NCT01157377|617394779|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170832327|NCT01157377|617394780|FG001|Overall Study|Other Miscellaneous Reasons|2|||
170832328|NCT01157377|617394781|FG002|Overall Study|Other Miscellaneous Reasons|0|||
170832329|NCT01157377|617394782|FG003|Overall Study|Other Miscellaneous Reasons|0|||
170832330|NCT01157377|617394783|FG004|Overall Study|Other Miscellaneous Reasons|1|||
170832331|NCT01157377|617394784|FG005|Overall Study|Other Miscellaneous Reasons|1|||
170832332|NCT01157377|617394785|FG006|Overall Study|Other Miscellaneous Reasons|1|||
170832333|NCT01182207|617394788|FG000|First Intervention|Positive Hepatitis Results|0|||
170832334|NCT01182207|617394789|FG001|First Intervention|Positive Hepatitis Results|1|||
170832335|NCT01182207|617394788|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
170832336|NCT01182207|617394789|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
170832337|NCT02554383|617394790|FG000|Overall Study|Ineligible|3|||
170832338|NCT02554383|617394791|FG001|Overall Study|Ineligible|2|||
170832339|NCT02554383|617394790|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
170832340|NCT02554383|617394791|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
170832341|NCT02554383|617394790|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
170832342|NCT02554383|617394791|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
170832343|NCT02554383|617394790|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
170832344|NCT02554383|617394791|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
170832345|NCT00727506|617394792|FG000|Overall Study|Adverse Event|0|||
170832346|NCT00727506|617394793|FG001|Overall Study|Adverse Event|0|||
170832347|NCT00727506|617394794|FG002|Overall Study|Adverse Event|4|||
170832348|NCT00727506|617394795|FG003|Overall Study|Adverse Event|4|||
170832349|NCT00727506|617394796|FG004|Overall Study|Adverse Event|1|||
170832350|NCT00727506|617394797|FG005|Overall Study|Adverse Event|8|||
170832351|NCT00727506|617394792|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
170832352|NCT00727506|617394793|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170832353|NCT00727506|617394794|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
170832354|NCT00727506|617394795|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170832355|NCT00727506|617394796|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170832356|NCT00727506|617394797|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170832357|NCT00727506|617394792|FG000|Overall Study|Progressive disease|4|||
170832358|NCT00727506|617394793|FG001|Overall Study|Progressive disease|7|||
170723318|NCT03301051|616990408|FG001|Overall Study|Randomized, not vaccinated|10|||
170723319|NCT01358526|616990412|FG000|Open-label Titration Period|Adverse Event|95|||
170723320|NCT01358526|616990413|FG001|Open-label Titration Period|Adverse Event|0|||
170723321|NCT01358526|616990414|FG002|Open-label Titration Period|Adverse Event|0|||
170723322|NCT01358526|616990412|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
170723323|NCT01358526|616990413|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
170723324|NCT01358526|616990414|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
170723325|NCT01358526|616990412|FG000|Open-label Titration Period|Lost to Follow-up|25|||
170723326|NCT01358526|616990413|FG001|Open-label Titration Period|Lost to Follow-up|0|||
170723327|NCT01358526|616990414|FG002|Open-label Titration Period|Lost to Follow-up|0|||
170723328|NCT01358526|616990412|FG000|Open-label Titration Period|Lack of Efficacy|107|||
170723329|NCT01358526|616990413|FG001|Open-label Titration Period|Lack of Efficacy|0|||
170723330|NCT01358526|616990414|FG002|Open-label Titration Period|Lack of Efficacy|0|||
170723331|NCT01358526|616990412|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
170723332|NCT01358526|616990413|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
170723333|NCT01358526|616990414|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
170723334|NCT01358526|616990412|FG000|Open-label Titration Period|Administrative|8|||
170723335|NCT01358526|616990413|FG001|Open-label Titration Period|Administrative|0|||
170723336|NCT01358526|616990414|FG002|Open-label Titration Period|Administrative|0|||
170723337|NCT01358526|616990412|FG000|Open-label Titration Period|Did not qualify|178|||
170723338|NCT01358526|616990413|FG001|Open-label Titration Period|Did not qualify|0|||
170723339|NCT01358526|616990414|FG002|Open-label Titration Period|Did not qualify|0|||
170723340|NCT01358526|616990412|FG000|Double-blind Phase|Adverse Event|0|||
170723341|NCT01358526|616990413|FG001|Double-blind Phase|Adverse Event|24|||
170723342|NCT01358526|616990414|FG002|Double-blind Phase|Adverse Event|23|||
170723343|NCT01358526|616990412|FG000|Double-blind Phase|Withdrawal by Subject|0|||
170723344|NCT01358526|616990413|FG001|Double-blind Phase|Withdrawal by Subject|10|||
170723345|NCT01358526|616990414|FG002|Double-blind Phase|Withdrawal by Subject|8|||
170723346|NCT01358526|616990412|FG000|Double-blind Phase|Lost to Follow-up|0|||
170723347|NCT01358526|616990413|FG001|Double-blind Phase|Lost to Follow-up|4|||
170723348|NCT01358526|616990414|FG002|Double-blind Phase|Lost to Follow-up|1|||
170723349|NCT01358526|616990412|FG000|Double-blind Phase|Lack of Efficacy|0|||
170723350|NCT01358526|616990413|FG001|Double-blind Phase|Lack of Efficacy|31|||
170832359|NCT00727506|617394794|FG002|Overall Study|Progressive disease|9|||
170832360|NCT00727506|617394795|FG003|Overall Study|Progressive disease|28|||
170832361|NCT00727506|617394796|FG004|Overall Study|Progressive disease|38|||
170832362|NCT00727506|617394797|FG005|Overall Study|Progressive disease|28|||
170832363|NCT00727506|617394792|FG000|Overall Study|Refused to continue medication|0|||
170832364|NCT00727506|617394793|FG001|Overall Study|Refused to continue medication|1|||
170832365|NCT00727506|617394794|FG002|Overall Study|Refused to continue medication|2|||
170832366|NCT00727506|617394795|FG003|Overall Study|Refused to continue medication|3|||
170832367|NCT00727506|617394796|FG004|Overall Study|Refused to continue medication|1|||
170832368|NCT00727506|617394797|FG005|Overall Study|Refused to continue medication|2|||
170832369|NCT00727506|617394792|FG000|Overall Study|Other reason not described above|0|||
170832370|NCT00727506|617394793|FG001|Overall Study|Other reason not described above|0|||
170832371|NCT00727506|617394794|FG002|Overall Study|Other reason not described above|1|||
170832372|NCT00727506|617394795|FG003|Overall Study|Other reason not described above|4|||
170832373|NCT00727506|617394796|FG004|Overall Study|Other reason not described above|1|||
170832374|NCT00727506|617394797|FG005|Overall Study|Other reason not described above|1|||
170832375|NCT04814992|617394802|FG000|Overall Study|Withdrawal by Subject|6|||
170832376|NCT04814992|617394803|FG001|Overall Study|Withdrawal by Subject|3|||
170832377|NCT04814992|617394802|FG000|Overall Study|Lost to Follow-up|1|||
170832378|NCT04814992|617394803|FG001|Overall Study|Lost to Follow-up|4|||
170832379|NCT00143598|617394808|FG000|Overall Study|Lost to Follow-up|23|||
170832380|NCT00143598|617394809|FG001|Overall Study|Lost to Follow-up|21|||
170832381|NCT00143598|617394808|FG000|Overall Study|Withdrawal by Subject|33|||
170832382|NCT00143598|617394809|FG001|Overall Study|Withdrawal by Subject|37|||
170832383|NCT00143598|617394808|FG000|Overall Study|Death|36|||
170832384|NCT00143598|617394809|FG001|Overall Study|Death|36|||
170832385|NCT01568112|617394812|FG000|Overall Study|Randomized But Not Treated|0|||
170832386|NCT01568112|617394813|FG001|Overall Study|Randomized But Not Treated|1|||
170832387|NCT01568112|617394814|FG002|Overall Study|Randomized But Not Treated|0|||
170832388|NCT01568112|617394815|FG003|Overall Study|Randomized But Not Treated|0|||
170723351|NCT01358526|616990414|FG002|Double-blind Phase|Lack of Efficacy|73|||
170723352|NCT01358526|616990412|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
170723353|NCT01358526|616990413|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
170723354|NCT01358526|616990414|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
170832389|NCT01568112|617394812|FG000|Overall Study|Withdrew due to Adverse Event|2|||
170832390|NCT01568112|617394813|FG001|Overall Study|Withdrew due to Adverse Event|4|||
170832391|NCT01568112|617394814|FG002|Overall Study|Withdrew due to Adverse Event|6|||
170832392|NCT01568112|617394815|FG003|Overall Study|Withdrew due to Adverse Event|3|||
170832393|NCT01568112|617394812|FG000|Overall Study|Lost to Follow-up|0|||
170832394|NCT01568112|617394813|FG001|Overall Study|Lost to Follow-up|0|||
170832395|NCT01568112|617394814|FG002|Overall Study|Lost to Follow-up|0|||
170723355|NCT01358526|616990412|FG000|Double-blind Phase|Administrative|0|||
170723356|NCT01358526|616990413|FG001|Double-blind Phase|Administrative|6|||
170723357|NCT01358526|616990414|FG002|Double-blind Phase|Administrative|10|||
170723358|NCT00724971|616990415|FG000|Overall Study|Adverse Event|5|||
170723359|NCT00724971|616990415|FG000|Overall Study|Withdrawal by Subject|1|||
170723360|NCT01962974|616990416|FG000|Overall Study|Study termination|7|||
170723361|NCT02132611|616990417|FG000|Overall Study|Death|2|||
170723362|NCT01965834|616990419|FG000|Overall Study|Lack of Efficacy|4|||
170723363|NCT03674177|616990423|FG000|Overall Study|Lost to Follow-up|2|||
170723364|NCT03674177|616990424|FG001|Overall Study|Lost to Follow-up|1|||
170723365|NCT03674177|616990425|FG002|Overall Study|Lost to Follow-up|0|||
170723366|NCT03674177|616990426|FG003|Overall Study|Lost to Follow-up|2|||
170723367|NCT00627705|616990427|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
170723368|NCT00627705|616990428|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
170723369|NCT00627705|616990427|FG000|Overall Study|Adverse Event|1|||
170723370|NCT00627705|616990428|FG001|Overall Study|Adverse Event|0|||
170723371|NCT00627705|616990427|FG000|Overall Study|Withdrawal by Subject|0|||
170723372|NCT00627705|616990428|FG001|Overall Study|Withdrawal by Subject|2|||
170723373|NCT00627705|616990427|FG000|Overall Study|Lost to Follow-up|0|||
170723374|NCT00627705|616990428|FG001|Overall Study|Lost to Follow-up|1|||
170723375|NCT03387852|616990429|FG000|Overall Study|Adverse event (AE)|3|||
170723376|NCT03387852|616990430|FG001|Overall Study|Adverse event (AE)|0|||
170723377|NCT03387852|616990431|FG002|Overall Study|Adverse event (AE)|2|||
170723378|NCT03387852|616990432|FG003|Overall Study|Adverse event (AE)|0|||
170723379|NCT03387852|616990429|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
170723380|NCT03387852|616990430|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
170723381|NCT03387852|616990431|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
170723382|NCT03387852|616990432|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
170723383|NCT03387852|616990429|FG000|Overall Study|Withdrawal by participant|1|||
170723384|NCT03387852|616990430|FG001|Overall Study|Withdrawal by participant|1|||
170723385|NCT03387852|616990431|FG002|Overall Study|Withdrawal by participant|3|||
170723386|NCT03387852|616990432|FG003|Overall Study|Withdrawal by participant|2|||
170723387|NCT03387852|616990429|FG000|Overall Study|Other- Unspecified|1|||
170723388|NCT03387852|616990430|FG001|Overall Study|Other- Unspecified|1|||
170723389|NCT03387852|616990431|FG002|Overall Study|Other- Unspecified|2|||
170723390|NCT03387852|616990432|FG003|Overall Study|Other- Unspecified|1|||
170723391|NCT03387852|616990429|FG000|Overall Study|Poor compliance to protocol|0|||
170723392|NCT03387852|616990430|FG001|Overall Study|Poor compliance to protocol|0|||
170723393|NCT03387852|616990431|FG002|Overall Study|Poor compliance to protocol|0|||
170723394|NCT03387852|616990432|FG003|Overall Study|Poor compliance to protocol|1|||
170723395|NCT03387852|616990429|FG000|Overall Study|Randomized and not treated|0|||
170723396|NCT03387852|616990430|FG001|Overall Study|Randomized and not treated|0|||
170723397|NCT03387852|616990431|FG002|Overall Study|Randomized and not treated|0|||
170832396|NCT01568112|617394815|FG003|Overall Study|Lost to Follow-up|1|||
170832397|NCT01568112|617394812|FG000|Overall Study|Withdrawal by Subject|2|||
170832398|NCT01568112|617394813|FG001|Overall Study|Withdrawal by Subject|3|||
170832399|NCT01568112|617394814|FG002|Overall Study|Withdrawal by Subject|0|||
170832400|NCT01568112|617394815|FG003|Overall Study|Withdrawal by Subject|7|||
170832401|NCT01568112|617394812|FG000|Overall Study|Withdrawal by Physician|1|||
170832402|NCT01568112|617394813|FG001|Overall Study|Withdrawal by Physician|0|||
170832403|NCT01568112|617394814|FG002|Overall Study|Withdrawal by Physician|1|||
170832404|NCT01568112|617394815|FG003|Overall Study|Withdrawal by Physician|1|||
170723398|NCT03387852|616990432|FG003|Overall Study|Randomized and not treated|1|||
170723399|NCT02493127|616990433|FG000|Overall Study|Lost to Follow-up|1|||
170832405|NCT02825251|617396903|FG000|Overall Study|Adverse Event|0|||
170832406|NCT02825251|617396904|FG001|Overall Study|Adverse Event|1|||
170832407|NCT02825251|617396903|FG000|Overall Study|Lost to Follow-up|0|||
170832408|NCT02825251|617396904|FG001|Overall Study|Lost to Follow-up|1|||
170832409|NCT02825251|617396903|FG000|Overall Study|Withdrawal by Subject|1|||
170832410|NCT02825251|617396904|FG001|Overall Study|Withdrawal by Subject|4|||
170832411|NCT02825251|617396903|FG000|Overall Study|Unclassified|2|||
170832412|NCT02825251|617396904|FG001|Overall Study|Unclassified|0|||
170832413|NCT03927690|617396912|FG000|Overall Study|Withdrawal by Subject|3|||
170832414|NCT03927690|617396913|FG001|Overall Study|Withdrawal by Subject|1|||
170832415|NCT03927690|617396914|FG002|Overall Study|Withdrawal by Subject|1|||
170832416|NCT03927690|617396912|FG000|Overall Study|Adverse Event|1|||
170832417|NCT03927690|617396913|FG001|Overall Study|Adverse Event|0|||
170832418|NCT03927690|617396914|FG002|Overall Study|Adverse Event|0|||
170832419|NCT03927690|617396912|FG000|Overall Study|Death|1|||
170832420|NCT03927690|617396913|FG001|Overall Study|Death|0|||
170832421|NCT03927690|617396914|FG002|Overall Study|Death|0|||
170832422|NCT03927690|617396912|FG000|Overall Study|Lost to Follow-up|2|||
170832423|NCT03927690|617396913|FG001|Overall Study|Lost to Follow-up|2|||
170832424|NCT03927690|617396914|FG002|Overall Study|Lost to Follow-up|1|||
170832425|NCT05208905|617396926|FG000|Overall Study|Death|1|||
170832426|NCT01777334|617396929|FG000|Overall Study|Adverse Event|18|||
170832427|NCT01777334|617396930|FG001|Overall Study|Adverse Event|14|||
170832428|NCT01777334|617396929|FG000|Overall Study|Lack of Efficacy|15|||
170832429|NCT01777334|617396930|FG001|Overall Study|Lack of Efficacy|29|||
170832430|NCT01777334|617396929|FG000|Overall Study|Protocol Violation|3|||
170832431|NCT01777334|617396930|FG001|Overall Study|Protocol Violation|7|||
170832432|NCT01777334|617396929|FG000|Overall Study|Lost to Follow-up|3|||
170832433|NCT01777334|617396930|FG001|Overall Study|Lost to Follow-up|2|||
170832434|NCT01777334|617396929|FG000|Overall Study|Withdrawal by Subject|14|||
170832435|NCT01777334|617396930|FG001|Overall Study|Withdrawal by Subject|11|||
170832436|NCT00548847|617396940|FG000|Overall Study|Disease progression|7|||
170832437|NCT02599688|617396945|FG000|Overall Study|Lack of Efficacy|1|||
170832438|NCT02599688|617396945|FG000|Overall Study|Withdrawal by Subject|1|||
170832439|NCT02599688|617396945|FG000|Overall Study|Termination by Sponsor|2|||
170832440|NCT06136897|617396948|FG000|Overall Study|Ineligible|3|||
170832441|NCT06136897|617396948|FG000|Overall Study|Mutation status not confirmed|7|||
170832442|NCT06136897|617396948|FG000|Overall Study|Adverse Event|2|||
170832443|NCT06136897|617396948|FG000|Overall Study|Death|1|||
170832444|NCT06136897|617396948|FG000|Overall Study|Disease progression|18|||
170832445|NCT06136897|617396948|FG000|Overall Study|Other complicating disease|1|||
170832446|NCT06136897|617396948|FG000|Overall Study|Withdrawal by Subject|1|||
170832447|NCT06136897|617396948|FG000|Overall Study|Still on treatment|1|||
170832448|NCT06136897|617396948|FG000|Overall Study|Lost to Follow-up|1|||
170832449|NCT00350298|617396950|FG000|Overall Study|Death|7|||
170832450|NCT00350298|617396951|FG001|Overall Study|Death|8|||
170832451|NCT00350298|617396950|FG000|Overall Study|Lost to Follow-up|1|||
170832452|NCT00350298|617396951|FG001|Overall Study|Lost to Follow-up|2|||
170832453|NCT00350298|617396950|FG000|Overall Study|Withdrawal by Subject|1|||
170832454|NCT00350298|617396951|FG001|Overall Study|Withdrawal by Subject|3|||
170723400|NCT02493127|616990434|FG001|Overall Study|Lost to Follow-up|1|||
170723401|NCT00714168|616990435|FG000|Overall Study|Pregnancy|5|||
170723402|NCT00714168|616990436|FG001|Overall Study|Pregnancy|4|||
170723403|NCT00714168|616990435|FG000|Overall Study|Lost to Follow-up|32|||
170723404|NCT00714168|616990436|FG001|Overall Study|Lost to Follow-up|50|||
170723405|NCT00714168|616990435|FG000|Overall Study|Relocation|4|||
170723406|NCT00714168|616990436|FG001|Overall Study|Relocation|3|||
170723407|NCT00714168|616990435|FG000|Overall Study|Non-study medical condition|3|||
170723408|NCT00714168|616990436|FG001|Overall Study|Non-study medical condition|2|||
170723409|NCT01410448|616990438|FG000|Overall Study|No conversion to everolimus|0|||
170723410|NCT01410448|616990439|FG001|Overall Study|No conversion to everolimus|24|||
170723411|NCT01410448|616990438|FG000|Overall Study|Graft loss|4|||
170723412|NCT01410448|616990439|FG001|Overall Study|Graft loss|1|||
170723413|NCT01410448|616990438|FG000|Overall Study|Administrative issues|2|||
170723414|NCT01410448|616990439|FG001|Overall Study|Administrative issues|1|||
170723415|NCT01410448|616990438|FG000|Overall Study|Lost to Follow-up|1|||
170723416|NCT01410448|616990439|FG001|Overall Study|Lost to Follow-up|0|||
170723417|NCT01410448|616990438|FG000|Overall Study|Withdrawal by Subject|3|||
170723418|NCT01410448|616990439|FG001|Overall Study|Withdrawal by Subject|2|||
170723419|NCT01410448|616990438|FG000|Overall Study|Protocol Violation|0|||
170723420|NCT01410448|616990439|FG001|Overall Study|Protocol Violation|4|||
170723421|NCT01410448|616990438|FG000|Overall Study|Death|2|||
170723422|NCT01410448|616990439|FG001|Overall Study|Death|3|||
170723423|NCT04764396|616990440|FG000|Overall Study|Physician Decision|1|||
170723424|NCT04764396|616990441|FG001|Overall Study|Physician Decision|0|||
170723425|NCT03230916|616990447|FG000|Overall Study|Withdrawal by Subject|0|||
170723426|NCT03230916|616990448|FG001|Overall Study|Withdrawal by Subject|0|||
170723427|NCT03230916|616990449|FG002|Overall Study|Withdrawal by Subject|0|||
170723428|NCT03230916|616990450|FG003|Overall Study|Withdrawal by Subject|0|||
170723429|NCT03230916|616990451|FG004|Overall Study|Withdrawal by Subject|0|||
170723430|NCT03230916|616990452|FG005|Overall Study|Withdrawal by Subject|1|||
170723431|NCT03230916|616990453|FG006|Overall Study|Withdrawal by Subject|0|||
170723432|NCT03230916|616990454|FG007|Overall Study|Withdrawal by Subject|0|||
170723433|NCT03230916|616990455|FG008|Overall Study|Withdrawal by Subject|0|||
170723434|NCT03230916|616990456|FG009|Overall Study|Withdrawal by Subject|0|||
170723435|NCT03230916|616990457|FG010|Overall Study|Withdrawal by Subject|0|||
170723436|NCT01128413|616990459|FG000|Overall Study|Withdrawal by Subject|1|||
170723437|NCT01128413|616990460|FG001|Overall Study|Withdrawal by Subject|0|||
170723438|NCT01128413|616990459|FG000|Overall Study|NICOM Monitor Problems|2|||
170723439|NCT01128413|616990460|FG001|Overall Study|NICOM Monitor Problems|1|||
170723440|NCT01128413|616990459|FG000|Overall Study|Pt made DNR|1|||
170723441|NCT01128413|616990460|FG001|Overall Study|Pt made DNR|0|||
170723442|NCT02075593|616990464|FG000|Overall Study|Withdrawal by Subject|1|||
170723443|NCT00726752|616990465|FG000|Overall Study|Lack of Efficacy|6|||
170723444|NCT04279314|616992168|FG000|Overall Study|Adverse Event|55|||
170723445|NCT04279314|616992168|FG000|Overall Study|Withdrawal by Subject|5|||
170723446|NCT04279314|616992168|FG000|Overall Study|Lack of Efficacy|5|||
170723447|NCT04279314|616992168|FG000|Overall Study|Protocol Violation|3|||
170723448|NCT04279314|616992168|FG000|Overall Study|Other (not COVID-19 related)|2|||
170723449|NCT02120027|616992169|FG000|Overall Study|Adverse Event|4|||
170723450|NCT02120027|616992170|FG001|Overall Study|Adverse Event|5|||
170723451|NCT02120027|616992169|FG000|Overall Study|Lack of Efficacy|3|||
170723452|NCT02120027|616992170|FG001|Overall Study|Lack of Efficacy|5|||
170723453|NCT02120027|616992169|FG000|Overall Study|Lost to Follow-up|5|||
170723454|NCT02120027|616992170|FG001|Overall Study|Lost to Follow-up|13|||
170723455|NCT02120027|616992169|FG000|Overall Study|Other|4|||
170723456|NCT02120027|616992170|FG001|Overall Study|Other|0|||
170723457|NCT02120027|616992169|FG000|Overall Study|Physician Decision|4|||
170832455|NCT00719043|617396952|FG000|Overall Study|Adverse Event|5|||
170832456|NCT00719043|617396953|FG001|Overall Study|Adverse Event|1|||
170832457|NCT00719043|617396954|FG002|Overall Study|Adverse Event|2|||
170832458|NCT00719043|617396955|FG003|Overall Study|Adverse Event|2|||
170832459|NCT00719043|617396956|FG004|Overall Study|Adverse Event|1|||
170832460|NCT00719043|617396957|FG005|Overall Study|Adverse Event|4|||
170832461|NCT00719043|617396958|FG006|Overall Study|Adverse Event|4|||
170832462|NCT00719043|617396952|FG000|Overall Study|Lost to Follow-up|14|||
170723458|NCT02120027|616992170|FG001|Overall Study|Physician Decision|3|||
170723459|NCT02120027|616992169|FG000|Overall Study|Protocol Violation|18|||
170723460|NCT02120027|616992170|FG001|Overall Study|Protocol Violation|21|||
170832463|NCT00719043|617396953|FG001|Overall Study|Lost to Follow-up|10|||
170832464|NCT00719043|617396954|FG002|Overall Study|Lost to Follow-up|8|||
170832465|NCT00719043|617396955|FG003|Overall Study|Lost to Follow-up|9|||
170723461|NCT02120027|616992169|FG000|Overall Study|Study terminated by Sponsor|45|||
170723462|NCT02120027|616992170|FG001|Overall Study|Study terminated by Sponsor|47|||
170723463|NCT02120027|616992169|FG000|Overall Study|Withdrawal by Subject|33|||
170723464|NCT02120027|616992170|FG001|Overall Study|Withdrawal by Subject|25|||
170723465|NCT01471054|616992175|FG000|Overall Study|Study terminated prematurely|4|||
170723466|NCT01471054|616992176|FG001|Overall Study|Study terminated prematurely|0|||
170723467|NCT00985725|616992178|FG000|Overall Study|Adverse Event|4|||
170723468|NCT00985725|616992179|FG001|Overall Study|Adverse Event|1|||
170723469|NCT00985725|616992178|FG000|Overall Study|Protocol Violation|1|||
170723470|NCT00985725|616992179|FG001|Overall Study|Protocol Violation|3|||
170723471|NCT00985725|616992178|FG000|Overall Study|Withdrawal by Subject|4|||
170723472|NCT00985725|616992179|FG001|Overall Study|Withdrawal by Subject|4|||
170723473|NCT00985725|616992178|FG000|Overall Study|Lost to Follow-up|1|||
170723474|NCT00985725|616992179|FG001|Overall Study|Lost to Follow-up|1|||
170723475|NCT00985725|616992178|FG000|Overall Study|Lack of Efficacy|0|||
170723476|NCT00985725|616992179|FG001|Overall Study|Lack of Efficacy|1|||
170723477|NCT00985725|616992178|FG000|Overall Study|Non-compliance|1|||
170723478|NCT00985725|616992179|FG001|Overall Study|Non-compliance|2|||
170723479|NCT00985725|616992178|FG000|Overall Study|Out-of-window visits|0|||
170723480|NCT00985725|616992179|FG001|Overall Study|Out-of-window visits|1|||
170723481|NCT02314624|616992183|FG000|Overall Study|No participating patient|16|||
170723482|NCT02314624|616992184|FG001|Overall Study|No participating patient|13|||
170723483|NCT02314624|616992183|FG000|Overall Study|Participant withdrew|7|||
170723484|NCT02314624|616992184|FG001|Overall Study|Participant withdrew|2|||
170723485|NCT02314624|616992183|FG000|Overall Study|Lost to Follow-up|2|||
170723486|NCT02314624|616992184|FG001|Overall Study|Lost to Follow-up|5|||
170723487|NCT02314624|616992183|FG000|Overall Study|Dropped/Excluded by PI|6|||
170723488|NCT02314624|616992184|FG001|Overall Study|Dropped/Excluded by PI|6|||
170723489|NCT03151005|616992185|FG000|Overall Study|Lost to Follow-up|5|||
170723490|NCT03151005|616992186|FG001|Overall Study|Lost to Follow-up|5|||
170723491|NCT01549613|616992189|FG000|Overall Study|Lost to Follow-up|11|||
170723492|NCT01549613|616992190|FG001|Overall Study|Lost to Follow-up|11|||
170723493|NCT02131272|616992191|FG000|Overall Study|Withdrawal by parent|0|||
170723494|NCT02131272|616992192|FG001|Overall Study|Withdrawal by parent|1|||
170723495|NCT02131272|616992191|FG000|Overall Study|Withdrawal by Subject|0|||
170723496|NCT02131272|616992192|FG001|Overall Study|Withdrawal by Subject|1|||
170723497|NCT02131272|616992191|FG000|Overall Study|Withdrawal Criteria|1|||
170723498|NCT02131272|616992192|FG001|Overall Study|Withdrawal Criteria|0|||
170723499|NCT04162769|616992193|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
170723500|NCT04162769|616992194|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
170723501|NCT04162769|616992195|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
170723502|NCT04162769|616992196|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
170723503|NCT04162769|616992193|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
170723504|NCT04162769|616992194|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
170723505|NCT04162769|616992195|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
170723506|NCT04162769|616992196|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
170723507|NCT04162769|616992193|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
170723508|NCT04162769|616992194|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
170723509|NCT04162769|616992195|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
170723510|NCT04162769|616992196|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
170723511|NCT04162769|616992193|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
170723512|NCT04162769|616992194|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
170723513|NCT04162769|616992195|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
170723514|NCT04162769|616992196|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
170723515|NCT04162769|616992193|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
170723516|NCT04162769|616992194|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
170723517|NCT04162769|616992195|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
170723518|NCT04162769|616992196|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
170723519|NCT04162769|616992193|FG000|Double-blind Treatment (12-Week)|Other|0|||
170723520|NCT04162769|616992194|FG001|Double-blind Treatment (12-Week)|Other|1|||
170723521|NCT04162769|616992195|FG002|Double-blind Treatment (12-Week)|Other|1|||
170723522|NCT04162769|616992196|FG003|Double-blind Treatment (12-Week)|Other|0|||
170723523|NCT04162769|616992193|FG000|OLE Period (52-Week)|Adverse Event|0|||
170723524|NCT04162769|616992194|FG001|OLE Period (52-Week)|Adverse Event|0|||
170723525|NCT04162769|616992195|FG002|OLE Period (52-Week)|Adverse Event|0|||
170723526|NCT04162769|616992196|FG003|OLE Period (52-Week)|Adverse Event|5|||
170723527|NCT04162769|616992193|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
170832466|NCT00719043|617396956|FG004|Overall Study|Lost to Follow-up|10|||
170832467|NCT00719043|617396957|FG005|Overall Study|Lost to Follow-up|9|||
170832468|NCT00719043|617396958|FG006|Overall Study|Lost to Follow-up|9|||
170832469|NCT00719043|617396952|FG000|Overall Study|Protocol Violation|0|||
170832470|NCT00719043|617396953|FG001|Overall Study|Protocol Violation|0|||
170832471|NCT00719043|617396954|FG002|Overall Study|Protocol Violation|0|||
170832472|NCT00719043|617396955|FG003|Overall Study|Protocol Violation|0|||
170832473|NCT00719043|617396956|FG004|Overall Study|Protocol Violation|0|||
170832474|NCT00719043|617396957|FG005|Overall Study|Protocol Violation|1|||
170832475|NCT00719043|617396958|FG006|Overall Study|Protocol Violation|0|||
170832476|NCT00719043|617396952|FG000|Overall Study|Other|1|||
170832477|NCT00719043|617396953|FG001|Overall Study|Other|0|||
170832478|NCT00719043|617396954|FG002|Overall Study|Other|1|||
170723528|NCT04162769|616992194|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
170723529|NCT04162769|616992195|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
170832479|NCT00719043|617396955|FG003|Overall Study|Other|2|||
170832480|NCT00719043|617396956|FG004|Overall Study|Other|0|||
170832481|NCT00719043|617396957|FG005|Overall Study|Other|2|||
170832482|NCT00719043|617396958|FG006|Overall Study|Other|1|||
170832483|NCT00719043|617396952|FG000|Overall Study|Withdrawal by Subject|12|||
170832484|NCT00719043|617396953|FG001|Overall Study|Withdrawal by Subject|14|||
170832485|NCT00719043|617396954|FG002|Overall Study|Withdrawal by Subject|9|||
170832486|NCT00719043|617396955|FG003|Overall Study|Withdrawal by Subject|10|||
170723530|NCT04162769|616992196|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
170723531|NCT04162769|616992193|FG000|OLE Period (52-Week)|Physician Decision|0|||
170723532|NCT04162769|616992194|FG001|OLE Period (52-Week)|Physician Decision|0|||
170723533|NCT04162769|616992195|FG002|OLE Period (52-Week)|Physician Decision|0|||
170723534|NCT04162769|616992196|FG003|OLE Period (52-Week)|Physician Decision|1|||
170723535|NCT04162769|616992193|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
170723536|NCT04162769|616992194|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
170723537|NCT04162769|616992195|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
170723538|NCT04162769|616992196|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
170723539|NCT04162769|616992193|FG000|OLE Period (52-Week)|Protocol deviation|0|||
170723540|NCT04162769|616992194|FG001|OLE Period (52-Week)|Protocol deviation|0|||
170723541|NCT04162769|616992195|FG002|OLE Period (52-Week)|Protocol deviation|0|||
170723542|NCT04162769|616992196|FG003|OLE Period (52-Week)|Protocol deviation|2|||
170723543|NCT00082173|616992197|FG000|Overall Study|Withdrawal by Subject|3|||
170723544|NCT00082173|616992198|FG001|Overall Study|Withdrawal by Subject|5|||
170723545|NCT00082173|616992197|FG000|Overall Study|Lost to Follow-up|1|||
170723546|NCT00082173|616992198|FG001|Overall Study|Lost to Follow-up|0|||
170723547|NCT00082173|616992197|FG000|Overall Study|Adverse Event|1|||
170723548|NCT00082173|616992198|FG001|Overall Study|Adverse Event|0|||
170723549|NCT00082173|616992197|FG000|Overall Study|Culture negative or resistant at baselin|5|||
170723550|NCT00082173|616992198|FG001|Overall Study|Culture negative or resistant at baselin|6|||
170723551|NCT01733732|616992199|FG000|Overall Study|Adverse Event|1|||
170723552|NCT01733732|616992200|FG001|Overall Study|Adverse Event|0|||
170723553|NCT01733732|616992199|FG000|Overall Study|Did not attend all study visits|1|||
170723554|NCT01733732|616992200|FG001|Overall Study|Did not attend all study visits|0|||
170723555|NCT06476366|616992201|FG000|Overall Study|Lost to Follow-up|1|||
170723556|NCT06476366|616992202|FG001|Overall Study|Lost to Follow-up|3|||
170723557|NCT06476366|616992201|FG000|Overall Study|Adverse Event|1|||
170723558|NCT06476366|616992202|FG001|Overall Study|Adverse Event|0|||
170723559|NCT00727272|616992206|FG000|Washout Period A|Adverse Event|0|||
170723560|NCT00727272|616992207|FG001|Washout Period A|Adverse Event|0|||
170723561|NCT00727272|616992208|FG002|Washout Period A|Adverse Event|1|||
170723562|NCT00727272|616992206|FG000|Washout Period B|Withdrawal by Subject|0|||
170723563|NCT00727272|616992207|FG001|Washout Period B|Withdrawal by Subject|0|||
170723564|NCT00727272|616992208|FG002|Washout Period B|Withdrawal by Subject|1|||
170723565|NCT00651664|616992209|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
170723566|NCT00651664|616992210|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
170832487|NCT00719043|617396956|FG004|Overall Study|Withdrawal by Subject|16|||
170832488|NCT00719043|617396957|FG005|Overall Study|Withdrawal by Subject|18|||
170832489|NCT00719043|617396958|FG006|Overall Study|Withdrawal by Subject|14|||
170832490|NCT00853229|617396959|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
170832491|NCT00853229|617396960|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
170832492|NCT04593823|617396966|FG000|Overall Study|Withdrawal by Subject|1|||
170832493|NCT04593823|617396967|FG001|Overall Study|Withdrawal by Subject|1|||
170832494|NCT04593823|617396966|FG000|Overall Study|Lost to Follow-up|0|||
170832495|NCT04593823|617396967|FG001|Overall Study|Lost to Follow-up|1|||
170832496|NCT01296555|617396972|FG000|Overall Study|Adverse Event|0|||
170832497|NCT01296555|617396973|FG001|Overall Study|Adverse Event|0|||
170832498|NCT01296555|617396974|FG002|Overall Study|Adverse Event|1|||
170832499|NCT01296555|617396975|FG003|Overall Study|Adverse Event|1|||
170832500|NCT01296555|617396976|FG004|Overall Study|Adverse Event|2|||
170832501|NCT01296555|617396977|FG005|Overall Study|Adverse Event|4|||
170832502|NCT01296555|617396978|FG006|Overall Study|Adverse Event|1|||
170832503|NCT01296555|617396979|FG007|Overall Study|Adverse Event|4|||
170832504|NCT01296555|617396980|FG008|Overall Study|Adverse Event|3|||
170832505|NCT01296555|617396981|FG009|Overall Study|Adverse Event|1|||
170832506|NCT01296555|617396982|FG010|Overall Study|Adverse Event|0|||
170832507|NCT01296555|617396983|FG011|Overall Study|Adverse Event|4|||
170832508|NCT01296555|617396984|FG012|Overall Study|Adverse Event|1|||
170832509|NCT01296555|617396985|FG013|Overall Study|Adverse Event|4|||
170832510|NCT01296555|617396986|FG014|Overall Study|Adverse Event|0|||
170832511|NCT01296555|617396987|FG015|Overall Study|Adverse Event|0|||
170832512|NCT01296555|617396988|FG016|Overall Study|Adverse Event|0|||
170832513|NCT01296555|617396989|FG017|Overall Study|Adverse Event|0|||
170832514|NCT01296555|617396990|FG018|Overall Study|Adverse Event|0|||
170832515|NCT01296555|617396991|FG019|Overall Study|Adverse Event|1|||
170832516|NCT01296555|617396992|FG020|Overall Study|Adverse Event|0|||
170832517|NCT01296555|617396993|FG021|Overall Study|Adverse Event|0|||
170832518|NCT01296555|617396994|FG022|Overall Study|Adverse Event|0|||
170832519|NCT01296555|617396995|FG023|Overall Study|Adverse Event|0|||
170832520|NCT01296555|617396996|FG024|Overall Study|Adverse Event|0|||
170832521|NCT01296555|617396997|FG025|Overall Study|Adverse Event|0|||
170832522|NCT01296555|617396998|FG026|Overall Study|Adverse Event|0|||
170832523|NCT01296555|617396999|FG027|Overall Study|Adverse Event|0|||
170832524|NCT01296555|617397000|FG028|Overall Study|Adverse Event|0|||
170832525|NCT01296555|617396972|FG000|Overall Study|Reason Not Specified|0|||
170832526|NCT01296555|617396973|FG001|Overall Study|Reason Not Specified|0|||
170832527|NCT01296555|617396974|FG002|Overall Study|Reason Not Specified|0|||
170832528|NCT01296555|617396975|FG003|Overall Study|Reason Not Specified|0|||
170832529|NCT01296555|617396976|FG004|Overall Study|Reason Not Specified|0|||
170832530|NCT01296555|617396977|FG005|Overall Study|Reason Not Specified|0|||
170832531|NCT01296555|617396978|FG006|Overall Study|Reason Not Specified|0|||
170832532|NCT01296555|617396979|FG007|Overall Study|Reason Not Specified|0|||
170832533|NCT01296555|617396980|FG008|Overall Study|Reason Not Specified|0|||
170832534|NCT01296555|617396981|FG009|Overall Study|Reason Not Specified|0|||
170832535|NCT01296555|617396982|FG010|Overall Study|Reason Not Specified|0|||
170832536|NCT01296555|617396983|FG011|Overall Study|Reason Not Specified|0|||
170832537|NCT01296555|617396984|FG012|Overall Study|Reason Not Specified|0|||
170832538|NCT01296555|617396985|FG013|Overall Study|Reason Not Specified|1|||
170832539|NCT01296555|617396986|FG014|Overall Study|Reason Not Specified|2|||
170832540|NCT01296555|617396987|FG015|Overall Study|Reason Not Specified|3|||
170832541|NCT01296555|617396988|FG016|Overall Study|Reason Not Specified|7|||
170832542|NCT01296555|617396989|FG017|Overall Study|Reason Not Specified|4|||
170832543|NCT01296555|617396990|FG018|Overall Study|Reason Not Specified|3|||
170832544|NCT01296555|617396991|FG019|Overall Study|Reason Not Specified|7|||
170832545|NCT01296555|617396992|FG020|Overall Study|Reason Not Specified|11|||
170832546|NCT01296555|617396993|FG021|Overall Study|Reason Not Specified|5|||
170832547|NCT01296555|617396994|FG022|Overall Study|Reason Not Specified|5|||
170832548|NCT01296555|617396995|FG023|Overall Study|Reason Not Specified|7|||
170832549|NCT01296555|617396996|FG024|Overall Study|Reason Not Specified|2|||
170832550|NCT01296555|617396997|FG025|Overall Study|Reason Not Specified|2|||
170832551|NCT01296555|617396998|FG026|Overall Study|Reason Not Specified|19|||
170832552|NCT01296555|617396999|FG027|Overall Study|Reason Not Specified|11|||
170832553|NCT01296555|617397000|FG028|Overall Study|Reason Not Specified|9|||
170832554|NCT01296555|617396972|FG000|Overall Study|Physician Decision|0|||
170832555|NCT01296555|617396973|FG001|Overall Study|Physician Decision|0|||
170832556|NCT01296555|617396974|FG002|Overall Study|Physician Decision|0|||
170832557|NCT01296555|617396975|FG003|Overall Study|Physician Decision|0|||
170832558|NCT01296555|617396976|FG004|Overall Study|Physician Decision|1|||
170832559|NCT01296555|617396977|FG005|Overall Study|Physician Decision|0|||
170832560|NCT01296555|617396978|FG006|Overall Study|Physician Decision|0|||
170832561|NCT01296555|617396979|FG007|Overall Study|Physician Decision|0|||
170832562|NCT01296555|617396980|FG008|Overall Study|Physician Decision|0|||
170832563|NCT01296555|617396981|FG009|Overall Study|Physician Decision|0|||
170832564|NCT01296555|617396982|FG010|Overall Study|Physician Decision|0|||
170832565|NCT01296555|617396983|FG011|Overall Study|Physician Decision|0|||
170832566|NCT01296555|617396984|FG012|Overall Study|Physician Decision|0|||
170832567|NCT01296555|617396985|FG013|Overall Study|Physician Decision|1|||
170832568|NCT01296555|617396986|FG014|Overall Study|Physician Decision|0|||
170832569|NCT01296555|617396987|FG015|Overall Study|Physician Decision|0|||
170832570|NCT01296555|617396988|FG016|Overall Study|Physician Decision|0|||
170832571|NCT01296555|617396989|FG017|Overall Study|Physician Decision|0|||
170832572|NCT01296555|617396990|FG018|Overall Study|Physician Decision|0|||
170832573|NCT01296555|617396991|FG019|Overall Study|Physician Decision|1|||
170832574|NCT01296555|617396992|FG020|Overall Study|Physician Decision|0|||
170832575|NCT01296555|617396993|FG021|Overall Study|Physician Decision|0|||
170832576|NCT01296555|617396994|FG022|Overall Study|Physician Decision|0|||
170832577|NCT01296555|617396995|FG023|Overall Study|Physician Decision|0|||
170832578|NCT01296555|617396996|FG024|Overall Study|Physician Decision|0|||
170832579|NCT01296555|617396997|FG025|Overall Study|Physician Decision|0|||
170832580|NCT01296555|617396998|FG026|Overall Study|Physician Decision|0|||
170832581|NCT01296555|617396999|FG027|Overall Study|Physician Decision|0|||
170832582|NCT01296555|617397000|FG028|Overall Study|Physician Decision|0|||
170832583|NCT01296555|617396972|FG000|Overall Study|Progressive Disease|6|||
170832584|NCT01296555|617396973|FG001|Overall Study|Progressive Disease|3|||
170832585|NCT01296555|617396974|FG002|Overall Study|Progressive Disease|3|||
170832586|NCT01296555|617396975|FG003|Overall Study|Progressive Disease|7|||
170832587|NCT01296555|617396976|FG004|Overall Study|Progressive Disease|6|||
170832588|NCT01296555|617396977|FG005|Overall Study|Progressive Disease|16|||
170832589|NCT01296555|617396978|FG006|Overall Study|Progressive Disease|16|||
170832590|NCT01296555|617396979|FG007|Overall Study|Progressive Disease|8|||
170832591|NCT01296555|617396980|FG008|Overall Study|Progressive Disease|7|||
170832592|NCT01296555|617396981|FG009|Overall Study|Progressive Disease|18|||
170832593|NCT01296555|617396982|FG010|Overall Study|Progressive Disease|7|||
170832594|NCT01296555|617396983|FG011|Overall Study|Progressive Disease|14|||
170832595|NCT01296555|617396984|FG012|Overall Study|Progressive Disease|5|||
170832596|NCT01296555|617396985|FG013|Overall Study|Progressive Disease|12|||
170832597|NCT01296555|617396986|FG014|Overall Study|Progressive Disease|1|||
170832598|NCT01296555|617396987|FG015|Overall Study|Progressive Disease|1|||
170832599|NCT01296555|617396988|FG016|Overall Study|Progressive Disease|0|||
170832600|NCT01296555|617396989|FG017|Overall Study|Progressive Disease|0|||
170832601|NCT01296555|617396990|FG018|Overall Study|Progressive Disease|0|||
170832602|NCT01296555|617396991|FG019|Overall Study|Progressive Disease|1|||
170832603|NCT01296555|617396992|FG020|Overall Study|Progressive Disease|0|||
170832604|NCT01296555|617396993|FG021|Overall Study|Progressive Disease|0|||
170832605|NCT01296555|617396994|FG022|Overall Study|Progressive Disease|0|||
170832606|NCT01296555|617396995|FG023|Overall Study|Progressive Disease|0|||
170832607|NCT01296555|617396996|FG024|Overall Study|Progressive Disease|1|||
170832608|NCT01296555|617396997|FG025|Overall Study|Progressive Disease|0|||
170832609|NCT01296555|617396998|FG026|Overall Study|Progressive Disease|5|||
170832610|NCT01296555|617396999|FG027|Overall Study|Progressive Disease|1|||
170832611|NCT01296555|617397000|FG028|Overall Study|Progressive Disease|0|||
170832612|NCT01296555|617396972|FG000|Overall Study|Protocol Violation|0|||
170832613|NCT01296555|617396973|FG001|Overall Study|Protocol Violation|0|||
170832614|NCT01296555|617396974|FG002|Overall Study|Protocol Violation|0|||
170832615|NCT01296555|617396975|FG003|Overall Study|Protocol Violation|0|||
170832616|NCT01296555|617396976|FG004|Overall Study|Protocol Violation|0|||
170832617|NCT01296555|617396977|FG005|Overall Study|Protocol Violation|0|||
170832618|NCT01296555|617396978|FG006|Overall Study|Protocol Violation|0|||
170832619|NCT01296555|617396979|FG007|Overall Study|Protocol Violation|0|||
170832620|NCT01296555|617396980|FG008|Overall Study|Protocol Violation|0|||
170832621|NCT01296555|617396981|FG009|Overall Study|Protocol Violation|0|||
170832622|NCT01296555|617396982|FG010|Overall Study|Protocol Violation|0|||
170832623|NCT01296555|617396983|FG011|Overall Study|Protocol Violation|0|||
170832624|NCT01296555|617396984|FG012|Overall Study|Protocol Violation|0|||
170832625|NCT01296555|617396985|FG013|Overall Study|Protocol Violation|1|||
170832626|NCT01296555|617396986|FG014|Overall Study|Protocol Violation|0|||
170832627|NCT01296555|617396987|FG015|Overall Study|Protocol Violation|0|||
170832628|NCT01296555|617396988|FG016|Overall Study|Protocol Violation|0|||
170832629|NCT01296555|617396989|FG017|Overall Study|Protocol Violation|0|||
170832630|NCT01296555|617396990|FG018|Overall Study|Protocol Violation|0|||
170832631|NCT01296555|617396991|FG019|Overall Study|Protocol Violation|0|||
170832632|NCT01296555|617396992|FG020|Overall Study|Protocol Violation|0|||
170832633|NCT01296555|617396993|FG021|Overall Study|Protocol Violation|0|||
170832634|NCT01296555|617396994|FG022|Overall Study|Protocol Violation|0|||
170832635|NCT01296555|617396995|FG023|Overall Study|Protocol Violation|0|||
170832636|NCT01296555|617396996|FG024|Overall Study|Protocol Violation|0|||
170832637|NCT01296555|617396997|FG025|Overall Study|Protocol Violation|0|||
170832638|NCT01296555|617396998|FG026|Overall Study|Protocol Violation|0|||
170832639|NCT01296555|617396999|FG027|Overall Study|Protocol Violation|0|||
170832640|NCT01296555|617397000|FG028|Overall Study|Protocol Violation|0|||
170832641|NCT01296555|617396972|FG000|Overall Study|Study Terminated By Sponsor|0|||
170832642|NCT01296555|617396973|FG001|Overall Study|Study Terminated By Sponsor|0|||
170832643|NCT01296555|617396974|FG002|Overall Study|Study Terminated By Sponsor|0|||
170832644|NCT01296555|617396975|FG003|Overall Study|Study Terminated By Sponsor|0|||
170832645|NCT01296555|617396976|FG004|Overall Study|Study Terminated By Sponsor|0|||
170832646|NCT01296555|617396977|FG005|Overall Study|Study Terminated By Sponsor|0|||
170832647|NCT01296555|617396978|FG006|Overall Study|Study Terminated By Sponsor|0|||
170832648|NCT01296555|617396979|FG007|Overall Study|Study Terminated By Sponsor|0|||
170832649|NCT01296555|617396980|FG008|Overall Study|Study Terminated By Sponsor|0|||
170832650|NCT01296555|617396981|FG009|Overall Study|Study Terminated By Sponsor|0|||
170832651|NCT01296555|617396982|FG010|Overall Study|Study Terminated By Sponsor|0|||
170832652|NCT01296555|617396983|FG011|Overall Study|Study Terminated By Sponsor|0|||
170832653|NCT01296555|617396984|FG012|Overall Study|Study Terminated By Sponsor|0|||
170832654|NCT01296555|617396985|FG013|Overall Study|Study Terminated By Sponsor|0|||
170832655|NCT01296555|617396986|FG014|Overall Study|Study Terminated By Sponsor|0|||
170832656|NCT01296555|617396987|FG015|Overall Study|Study Terminated By Sponsor|0|||
170832657|NCT01296555|617396988|FG016|Overall Study|Study Terminated By Sponsor|0|||
170832658|NCT01296555|617396989|FG017|Overall Study|Study Terminated By Sponsor|0|||
170832659|NCT01296555|617396990|FG018|Overall Study|Study Terminated By Sponsor|0|||
170832660|NCT01296555|617396991|FG019|Overall Study|Study Terminated By Sponsor|0|||
170832661|NCT01296555|617396992|FG020|Overall Study|Study Terminated By Sponsor|0|||
170832662|NCT01296555|617396993|FG021|Overall Study|Study Terminated By Sponsor|0|||
170832663|NCT01296555|617396994|FG022|Overall Study|Study Terminated By Sponsor|0|||
170832664|NCT01296555|617396995|FG023|Overall Study|Study Terminated By Sponsor|0|||
170832665|NCT01296555|617396996|FG024|Overall Study|Study Terminated By Sponsor|0|||
170832666|NCT01296555|617396997|FG025|Overall Study|Study Terminated By Sponsor|1|||
170832667|NCT01296555|617396998|FG026|Overall Study|Study Terminated By Sponsor|0|||
170832668|NCT01296555|617396999|FG027|Overall Study|Study Terminated By Sponsor|0|||
170832669|NCT01296555|617397000|FG028|Overall Study|Study Terminated By Sponsor|0|||
170832670|NCT01296555|617396972|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832671|NCT01296555|617396973|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832672|NCT01296555|617396974|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832673|NCT01296555|617396975|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832674|NCT01296555|617396976|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832675|NCT01296555|617396977|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832676|NCT01296555|617396978|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832677|NCT01296555|617396979|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832678|NCT01296555|617396980|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832679|NCT01296555|617396981|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832680|NCT01296555|617396982|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832681|NCT01296555|617396983|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832682|NCT01296555|617396984|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832683|NCT01296555|617396985|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832684|NCT01296555|617396986|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832685|NCT01296555|617396987|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832686|NCT01296555|617396988|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832687|NCT01296555|617396989|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832688|NCT01296555|617396990|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832689|NCT01296555|617396991|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
170832690|NCT01296555|617396992|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832691|NCT01296555|617396993|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832692|NCT01296555|617396994|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832693|NCT01296555|617396995|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832694|NCT01296555|617396996|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832695|NCT01296555|617396997|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832696|NCT01296555|617396998|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832697|NCT01296555|617396999|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832698|NCT01296555|617397000|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
170832699|NCT01296555|617396972|FG000|Overall Study|Death|0|||
170832700|NCT01296555|617396973|FG001|Overall Study|Death|0|||
170832701|NCT01296555|617396974|FG002|Overall Study|Death|0|||
170832702|NCT01296555|617396975|FG003|Overall Study|Death|2|||
170832703|NCT01296555|617396976|FG004|Overall Study|Death|1|||
170832704|NCT01296555|617396977|FG005|Overall Study|Death|0|||
170832705|NCT01296555|617396978|FG006|Overall Study|Death|2|||
170832706|NCT01296555|617396979|FG007|Overall Study|Death|0|||
170832707|NCT01296555|617396980|FG008|Overall Study|Death|0|||
170832708|NCT01296555|617396981|FG009|Overall Study|Death|1|||
170832709|NCT01296555|617396982|FG010|Overall Study|Death|0|||
170832710|NCT01296555|617396983|FG011|Overall Study|Death|1|||
170832711|NCT01296555|617396984|FG012|Overall Study|Death|0|||
170832712|NCT01296555|617396985|FG013|Overall Study|Death|2|||
170832713|NCT01296555|617396986|FG014|Overall Study|Death|27|||
170832714|NCT01296555|617396987|FG015|Overall Study|Death|15|||
170832715|NCT01296555|617396988|FG016|Overall Study|Death|11|||
170723567|NCT00651664|616992211|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
170723568|NCT00651664|616992212|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
170723569|NCT00651664|616992213|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
170723570|NCT00651664|616992214|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
170723571|NCT00651664|616992215|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
170723572|NCT00651664|616992216|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
170723573|NCT00651664|616992217|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
170723574|NCT00651664|616992218|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
170723575|NCT00651664|616992209|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
170723576|NCT00651664|616992210|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
170723577|NCT00651664|616992211|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
170723578|NCT00651664|616992212|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
170723579|NCT00651664|616992213|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
170723580|NCT00651664|616992214|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
170723581|NCT00651664|616992215|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
170723582|NCT00651664|616992216|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
170723583|NCT00651664|616992217|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
170723584|NCT00651664|616992218|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
170723585|NCT00651664|616992209|FG000|Overall Study|Progressive Disease|3|||
170723586|NCT00651664|616992210|FG001|Overall Study|Progressive Disease|3|||
170723587|NCT00651664|616992211|FG002|Overall Study|Progressive Disease|3|||
170723588|NCT00651664|616992212|FG003|Overall Study|Progressive Disease|12|||
170723589|NCT00651664|616992213|FG004|Overall Study|Progressive Disease|4|||
170723590|NCT00651664|616992214|FG005|Overall Study|Progressive Disease|1|||
170723591|NCT00651664|616992215|FG006|Overall Study|Progressive Disease|3|||
170723592|NCT00651664|616992216|FG007|Overall Study|Progressive Disease|6|||
170723593|NCT00651664|616992217|FG008|Overall Study|Progressive Disease|5|||
170723594|NCT00651664|616992218|FG009|Overall Study|Progressive Disease|5|||
170723595|NCT00651664|616992209|FG000|Overall Study|Patient Declined Further Treatment|0|||
170723596|NCT00651664|616992210|FG001|Overall Study|Patient Declined Further Treatment|0|||
170723597|NCT00651664|616992211|FG002|Overall Study|Patient Declined Further Treatment|0|||
170723598|NCT00651664|616992212|FG003|Overall Study|Patient Declined Further Treatment|1|||
170723599|NCT00651664|616992213|FG004|Overall Study|Patient Declined Further Treatment|1|||
170723600|NCT00651664|616992214|FG005|Overall Study|Patient Declined Further Treatment|1|||
170723601|NCT00651664|616992215|FG006|Overall Study|Patient Declined Further Treatment|0|||
170723602|NCT00651664|616992216|FG007|Overall Study|Patient Declined Further Treatment|0|||
170723603|NCT00651664|616992217|FG008|Overall Study|Patient Declined Further Treatment|0|||
170723604|NCT00651664|616992218|FG009|Overall Study|Patient Declined Further Treatment|1|||
170723605|NCT00651664|616992209|FG000|Overall Study|Symptomatic Deterioration|0|||
170723606|NCT00651664|616992210|FG001|Overall Study|Symptomatic Deterioration|0|||
170723607|NCT00651664|616992211|FG002|Overall Study|Symptomatic Deterioration|0|||
170723608|NCT00651664|616992212|FG003|Overall Study|Symptomatic Deterioration|1|||
170723609|NCT00651664|616992213|FG004|Overall Study|Symptomatic Deterioration|0|||
170723610|NCT00651664|616992214|FG005|Overall Study|Symptomatic Deterioration|0|||
170723611|NCT00651664|616992215|FG006|Overall Study|Symptomatic Deterioration|1|||
170723612|NCT00651664|616992216|FG007|Overall Study|Symptomatic Deterioration|0|||
170723613|NCT00651664|616992217|FG008|Overall Study|Symptomatic Deterioration|1|||
170723614|NCT00651664|616992218|FG009|Overall Study|Symptomatic Deterioration|0|||
170723615|NCT00651664|616992209|FG000|Overall Study|Reason not Specified|0|||
170723616|NCT00651664|616992210|FG001|Overall Study|Reason not Specified|0|||
170723617|NCT00651664|616992211|FG002|Overall Study|Reason not Specified|0|||
170723618|NCT00651664|616992212|FG003|Overall Study|Reason not Specified|0|||
170723619|NCT00651664|616992213|FG004|Overall Study|Reason not Specified|0|||
170723620|NCT00651664|616992214|FG005|Overall Study|Reason not Specified|0|||
170723621|NCT00651664|616992215|FG006|Overall Study|Reason not Specified|1|||
170723622|NCT00651664|616992216|FG007|Overall Study|Reason not Specified|0|||
170723623|NCT00651664|616992217|FG008|Overall Study|Reason not Specified|0|||
170723624|NCT00651664|616992218|FG009|Overall Study|Reason not Specified|0|||
170723625|NCT02384954|616992219|FG000|Phase 1|Progressive Disease|2|||
170723626|NCT02384954|616992220|FG001|Phase 1|Progressive Disease|0|||
170723627|NCT02384954|616992221|FG002|Phase 1|Progressive Disease|1|||
170723628|NCT02384954|616992222|FG003|Phase 1|Progressive Disease|1|||
170723629|NCT02384954|616992223|FG004|Phase 1|Progressive Disease|0|||
170723630|NCT02384954|616992224|FG005|Phase 1|Progressive Disease|0|||
170723631|NCT02384954|616992225|FG006|Phase 1|Progressive Disease|0|||
170723632|NCT02384954|616992226|FG007|Phase 1|Progressive Disease|0|||
170723633|NCT02384954|616992227|FG008|Phase 1|Progressive Disease|0|||
170723634|NCT02384954|616992219|FG000|Phase 1|Adverse Event|0|||
170723635|NCT02384954|616992220|FG001|Phase 1|Adverse Event|0|||
170723636|NCT02384954|616992221|FG002|Phase 1|Adverse Event|1|||
170723637|NCT02384954|616992222|FG003|Phase 1|Adverse Event|0|||
170723638|NCT02384954|616992223|FG004|Phase 1|Adverse Event|0|||
170723639|NCT02384954|616992224|FG005|Phase 1|Adverse Event|0|||
170723640|NCT02384954|616992225|FG006|Phase 1|Adverse Event|0|||
170723641|NCT02384954|616992226|FG007|Phase 1|Adverse Event|0|||
170723642|NCT02384954|616992227|FG008|Phase 1|Adverse Event|0|||
170723643|NCT02384954|616992219|FG000|Phase 2|Progressive Disease|0|||
170723644|NCT02384954|616992220|FG001|Phase 2|Progressive Disease|0|||
170723645|NCT02384954|616992221|FG002|Phase 2|Progressive Disease|0|||
170723646|NCT02384954|616992222|FG003|Phase 2|Progressive Disease|0|||
170723647|NCT02384954|616992223|FG004|Phase 2|Progressive Disease|0|||
170723648|NCT02384954|616992224|FG005|Phase 2|Progressive Disease|0|||
170723649|NCT02384954|616992225|FG006|Phase 2|Progressive Disease|0|||
170723650|NCT02384954|616992226|FG007|Phase 2|Progressive Disease|1|||
170723651|NCT02384954|616992227|FG008|Phase 2|Progressive Disease|2|||
170723652|NCT02384954|616992219|FG000|Phase 2|Adverse Event|0|||
170723653|NCT02384954|616992220|FG001|Phase 2|Adverse Event|0|||
170723654|NCT02384954|616992221|FG002|Phase 2|Adverse Event|0|||
170723655|NCT02384954|616992222|FG003|Phase 2|Adverse Event|0|||
170723656|NCT02384954|616992223|FG004|Phase 2|Adverse Event|0|||
170723657|NCT02384954|616992224|FG005|Phase 2|Adverse Event|0|||
170723658|NCT02384954|616992225|FG006|Phase 2|Adverse Event|0|||
170723659|NCT02384954|616992226|FG007|Phase 2|Adverse Event|1|||
170723660|NCT02384954|616992227|FG008|Phase 2|Adverse Event|1|||
170723661|NCT02384954|616992219|FG000|Phase 2|Failure to meet continuation criteria|0|||
170723662|NCT02384954|616992220|FG001|Phase 2|Failure to meet continuation criteria|0|||
170723663|NCT02384954|616992221|FG002|Phase 2|Failure to meet continuation criteria|0|||
170723664|NCT02384954|616992222|FG003|Phase 2|Failure to meet continuation criteria|0|||
170723665|NCT02384954|616992223|FG004|Phase 2|Failure to meet continuation criteria|0|||
170723666|NCT02384954|616992224|FG005|Phase 2|Failure to meet continuation criteria|0|||
170723667|NCT02384954|616992225|FG006|Phase 2|Failure to meet continuation criteria|0|||
170723668|NCT02384954|616992226|FG007|Phase 2|Failure to meet continuation criteria|1|||
170723669|NCT02384954|616992227|FG008|Phase 2|Failure to meet continuation criteria|0|||
170723670|NCT02372396|616992235|FG000|Overall Study|Lost to Follow-up|7|||
170723671|NCT02372396|616992236|FG001|Overall Study|Lost to Follow-up|9|||
170723672|NCT01483924|616992237|FG000|Overall Study|Withdrawal by Subject|2|||
170723673|NCT01483924|616992238|FG001|Overall Study|Withdrawal by Subject|0|||
170723674|NCT01483924|616992239|FG002|Overall Study|Withdrawal by Subject|0|||
170723675|NCT01483924|616992240|FG003|Overall Study|Withdrawal by Subject|1|||
170723676|NCT01483924|616992241|FG004|Overall Study|Withdrawal by Subject|1|||
170723677|NCT01483924|616992237|FG000|Overall Study|Adverse Event|0|||
170723678|NCT01483924|616992238|FG001|Overall Study|Adverse Event|0|||
170723679|NCT01483924|616992239|FG002|Overall Study|Adverse Event|1|||
170723680|NCT01483924|616992240|FG003|Overall Study|Adverse Event|1|||
170723681|NCT01483924|616992241|FG004|Overall Study|Adverse Event|0|||
170723682|NCT01483924|616992237|FG000|Overall Study|Non-compliance|0|||
170723683|NCT01483924|616992238|FG001|Overall Study|Non-compliance|0|||
170723684|NCT01483924|616992239|FG002|Overall Study|Non-compliance|0|||
170723685|NCT01483924|616992240|FG003|Overall Study|Non-compliance|1|||
170723686|NCT01483924|616992241|FG004|Overall Study|Non-compliance|1|||
170723687|NCT01483924|616992237|FG000|Overall Study|Sponsor concern over ECG result|0|||
170723688|NCT01483924|616992238|FG001|Overall Study|Sponsor concern over ECG result|0|||
170723689|NCT01483924|616992239|FG002|Overall Study|Sponsor concern over ECG result|0|||
170723690|NCT01483924|616992240|FG003|Overall Study|Sponsor concern over ECG result|1|||
170723691|NCT01483924|616992241|FG004|Overall Study|Sponsor concern over ECG result|0|||
170723692|NCT00003298|616992244|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
170723693|NCT00003298|616992244|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
170723694|NCT00003298|616992244|FG000|Surgery|Unresectable at surgery|3|||
170723695|NCT00003298|616992244|FG000|Surgery|Progression before surgery|2|||
170723696|NCT00003298|616992244|FG000|Surgery|Unevaluable and off study|2|||
170723697|NCT00003298|616992244|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
170723698|NCT00003298|616992244|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
170723699|NCT00003298|616992244|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
170723700|NCT00003298|616992244|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
170723701|NCT00003298|616992244|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
170723702|NCT00003298|616992244|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
170723703|NCT00003298|616992244|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
170723704|NCT00003298|616992244|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
170723705|NCT00003298|616992244|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
170723706|NCT00003298|616992244|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
170723707|NCT01910129|616992245|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
170723708|NCT01910129|616992246|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
170723709|NCT01910129|616992247|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
170723710|NCT01910129|616992245|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
170723711|NCT01910129|616992246|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
170723712|NCT01910129|616992247|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
170723713|NCT00335322|616992249|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
170723714|NCT00335322|616992250|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
170723715|NCT00335322|616992251|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
170723716|NCT02834780|616992254|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
170723717|NCT02834780|616992255|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
170723718|NCT02834780|616992256|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
170723719|NCT02834780|616992257|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
170723720|NCT02834780|616992258|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
170723721|NCT02834780|616992259|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
170723722|NCT02834780|616992260|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
170723723|NCT02834780|616992261|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
170723724|NCT02834780|616992262|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
170723725|NCT02834780|616992263|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
170832716|NCT01296555|617396989|FG017|Overall Study|Death|11|||
170832717|NCT01296555|617396990|FG018|Overall Study|Death|17|||
170832718|NCT01296555|617396991|FG019|Overall Study|Death|12|||
170832719|NCT01296555|617396992|FG020|Overall Study|Death|13|||
170832720|NCT01296555|617396993|FG021|Overall Study|Death|12|||
170832721|NCT01296555|617396994|FG022|Overall Study|Death|12|||
170832722|NCT01296555|617396995|FG023|Overall Study|Death|13|||
170832723|NCT01296555|617396996|FG024|Overall Study|Death|7|||
170832724|NCT01296555|617396997|FG025|Overall Study|Death|7|||
170832725|NCT01296555|617396998|FG026|Overall Study|Death|35|||
170832726|NCT01296555|617396999|FG027|Overall Study|Death|92|||
170832727|NCT01296555|617397000|FG028|Overall Study|Death|44|||
170832728|NCT01296555|617396972|FG000|Overall Study|Lost to Follow-up|0|||
170832729|NCT01296555|617396973|FG001|Overall Study|Lost to Follow-up|0|||
170723726|NCT02834780|616992264|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
170723727|NCT02834780|616992265|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
170723728|NCT02834780|616992266|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
170723729|NCT02834780|616992254|FG000|Overall Study|Withdrawal by Subject|0|||
170832730|NCT01296555|617396974|FG002|Overall Study|Lost to Follow-up|0|||
170832731|NCT01296555|617396975|FG003|Overall Study|Lost to Follow-up|0|||
170832732|NCT01296555|617396976|FG004|Overall Study|Lost to Follow-up|0|||
170723730|NCT02834780|616992255|FG001|Overall Study|Withdrawal by Subject|0|||
170723731|NCT02834780|616992256|FG002|Overall Study|Withdrawal by Subject|1|||
170723732|NCT02834780|616992257|FG003|Overall Study|Withdrawal by Subject|0|||
170723733|NCT02834780|616992258|FG004|Overall Study|Withdrawal by Subject|0|||
170723734|NCT02834780|616992259|FG005|Overall Study|Withdrawal by Subject|0|||
170723735|NCT02834780|616992260|FG006|Overall Study|Withdrawal by Subject|0|||
170723736|NCT02834780|616992261|FG007|Overall Study|Withdrawal by Subject|0|||
170723737|NCT02834780|616992262|FG008|Overall Study|Withdrawal by Subject|0|||
170723738|NCT02834780|616992263|FG009|Overall Study|Withdrawal by Subject|0|||
170723739|NCT02834780|616992264|FG010|Overall Study|Withdrawal by Subject|1|||
170723740|NCT02834780|616992265|FG011|Overall Study|Withdrawal by Subject|0|||
170723741|NCT02834780|616992266|FG012|Overall Study|Withdrawal by Subject|0|||
170723742|NCT02834780|616992254|FG000|Overall Study|Adverse Event|0|||
170723743|NCT02834780|616992255|FG001|Overall Study|Adverse Event|0|||
170723744|NCT02834780|616992256|FG002|Overall Study|Adverse Event|0|||
170723745|NCT02834780|616992257|FG003|Overall Study|Adverse Event|0|||
170723746|NCT02834780|616992258|FG004|Overall Study|Adverse Event|1|||
170723747|NCT02834780|616992259|FG005|Overall Study|Adverse Event|0|||
170723748|NCT02834780|616992260|FG006|Overall Study|Adverse Event|1|||
170723749|NCT02834780|616992261|FG007|Overall Study|Adverse Event|1|||
170723750|NCT02834780|616992262|FG008|Overall Study|Adverse Event|0|||
170723751|NCT02834780|616992263|FG009|Overall Study|Adverse Event|2|||
170723752|NCT02834780|616992264|FG010|Overall Study|Adverse Event|0|||
170723753|NCT02834780|616992265|FG011|Overall Study|Adverse Event|3|||
170723754|NCT02834780|616992266|FG012|Overall Study|Adverse Event|2|||
170723755|NCT02834780|616992254|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
170832733|NCT01296555|617396977|FG005|Overall Study|Lost to Follow-up|0|||
170832734|NCT01296555|617396978|FG006|Overall Study|Lost to Follow-up|0|||
170723756|NCT02834780|616992255|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
170832735|NCT01296555|617396979|FG007|Overall Study|Lost to Follow-up|0|||
170832736|NCT01296555|617396980|FG008|Overall Study|Lost to Follow-up|0|||
170832737|NCT01296555|617396981|FG009|Overall Study|Lost to Follow-up|0|||
170832738|NCT01296555|617396982|FG010|Overall Study|Lost to Follow-up|0|||
170832739|NCT01296555|617396983|FG011|Overall Study|Lost to Follow-up|0|||
170832740|NCT01296555|617396984|FG012|Overall Study|Lost to Follow-up|0|||
170832741|NCT01296555|617396985|FG013|Overall Study|Lost to Follow-up|0|||
170723757|NCT02834780|616992256|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
170723758|NCT02834780|616992257|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
170723759|NCT02834780|616992258|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
170723760|NCT02834780|616992259|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
170723761|NCT02834780|616992260|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
170723762|NCT02834780|616992261|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
170723763|NCT02834780|616992262|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
170723764|NCT02834780|616992263|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
170723765|NCT02834780|616992264|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
170723766|NCT02834780|616992265|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
170723767|NCT02834780|616992266|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
170723768|NCT02834780|616992254|FG000|Overall Study|Other|1|||
170723769|NCT02834780|616992255|FG001|Overall Study|Other|0|||
170723770|NCT02834780|616992256|FG002|Overall Study|Other|1|||
170723771|NCT02834780|616992257|FG003|Overall Study|Other|2|||
170723772|NCT02834780|616992258|FG004|Overall Study|Other|0|||
170723773|NCT02834780|616992259|FG005|Overall Study|Other|0|||
170723774|NCT02834780|616992260|FG006|Overall Study|Other|0|||
170723775|NCT02834780|616992261|FG007|Overall Study|Other|0|||
170723776|NCT02834780|616992262|FG008|Overall Study|Other|0|||
170723777|NCT02834780|616992263|FG009|Overall Study|Other|0|||
170723778|NCT02834780|616992264|FG010|Overall Study|Other|0|||
170723779|NCT02834780|616992265|FG011|Overall Study|Other|0|||
170723780|NCT02834780|616992266|FG012|Overall Study|Other|1|||
170723781|NCT02415400|616992267|FG000|Overall Study|Adverse Event|0|||
170723782|NCT02415400|616992268|FG001|Overall Study|Adverse Event|1|||
170723783|NCT02415400|616992269|FG002|Overall Study|Adverse Event|1|||
170723784|NCT02415400|616992270|FG003|Overall Study|Adverse Event|2|||
170723785|NCT02415400|616992267|FG000|Overall Study|Participant request to stop therapy|4|||
170723786|NCT02415400|616992268|FG001|Overall Study|Participant request to stop therapy|3|||
170723787|NCT02415400|616992269|FG002|Overall Study|Participant request to stop therapy|8|||
170723788|NCT02415400|616992270|FG003|Overall Study|Participant request to stop therapy|6|||
170723789|NCT02415400|616992267|FG000|Overall Study|Participant withdrew consent|14|||
170723790|NCT02415400|616992268|FG001|Overall Study|Participant withdrew consent|12|||
170723791|NCT02415400|616992269|FG002|Overall Study|Participant withdrew consent|30|||
170723792|NCT02415400|616992270|FG003|Overall Study|Participant withdrew consent|21|||
170723793|NCT02415400|616992267|FG000|Overall Study|Death|39|||
170723794|NCT02415400|616992268|FG001|Overall Study|Death|41|||
170723795|NCT02415400|616992269|FG002|Overall Study|Death|35|||
170723796|NCT02415400|616992270|FG003|Overall Study|Death|42|||
170723797|NCT02415400|616992267|FG000|Overall Study|Lost to Follow-up|3|||
170723798|NCT02415400|616992268|FG001|Overall Study|Lost to Follow-up|3|||
170723799|NCT02415400|616992269|FG002|Overall Study|Lost to Follow-up|2|||
170723800|NCT02415400|616992270|FG003|Overall Study|Lost to Follow-up|5|||
170723801|NCT02415400|616992267|FG000|Overall Study|Poor/Non-Compliance|0|||
170723802|NCT02415400|616992268|FG001|Overall Study|Poor/Non-Compliance|1|||
170723803|NCT02415400|616992269|FG002|Overall Study|Poor/Non-Compliance|3|||
170723804|NCT02415400|616992270|FG003|Overall Study|Poor/Non-Compliance|4|||
170723805|NCT02415400|616992267|FG000|Overall Study|Participant no longer meets criteria|2|||
170723806|NCT02415400|616992268|FG001|Overall Study|Participant no longer meets criteria|0|||
170723807|NCT02415400|616992269|FG002|Overall Study|Participant no longer meets criteria|0|||
170723808|NCT02415400|616992270|FG003|Overall Study|Participant no longer meets criteria|1|||
170723809|NCT02415400|616992267|FG000|Overall Study|Participant doesn't answer phone|1|||
170723810|NCT02415400|616992268|FG001|Overall Study|Participant doesn't answer phone|0|||
170723811|NCT02415400|616992269|FG002|Overall Study|Participant doesn't answer phone|0|||
170723812|NCT02415400|616992270|FG003|Overall Study|Participant doesn't answer phone|0|||
170723813|NCT02415400|616992267|FG000|Overall Study|Participant wanted home visits|1|||
170723814|NCT02415400|616992268|FG001|Overall Study|Participant wanted home visits|0|||
170723815|NCT02415400|616992269|FG002|Overall Study|Participant wanted home visits|0|||
170723816|NCT02415400|616992270|FG003|Overall Study|Participant wanted home visits|0|||
170723817|NCT02415400|616992267|FG000|Overall Study|Randomized in error|2|||
170723818|NCT02415400|616992268|FG001|Overall Study|Randomized in error|0|||
170723819|NCT02415400|616992269|FG002|Overall Study|Randomized in error|0|||
170723820|NCT02415400|616992270|FG003|Overall Study|Randomized in error|0|||
170723821|NCT02415400|616992267|FG000|Overall Study|No study drug on site|0|||
170723822|NCT02415400|616992268|FG001|Overall Study|No study drug on site|1|||
170723823|NCT02415400|616992269|FG002|Overall Study|No study drug on site|0|||
170723824|NCT02415400|616992270|FG003|Overall Study|No study drug on site|0|||
170723825|NCT02415400|616992267|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
170723826|NCT02415400|616992268|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
170723827|NCT02415400|616992269|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
170723828|NCT02415400|616992270|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
170832742|NCT01296555|617396986|FG014|Overall Study|Lost to Follow-up|2|||
170832743|NCT01296555|617396987|FG015|Overall Study|Lost to Follow-up|1|||
170832744|NCT01296555|617396988|FG016|Overall Study|Lost to Follow-up|0|||
170832745|NCT01296555|617396989|FG017|Overall Study|Lost to Follow-up|2|||
170832746|NCT01296555|617396990|FG018|Overall Study|Lost to Follow-up|0|||
170832747|NCT01296555|617396991|FG019|Overall Study|Lost to Follow-up|2|||
170832748|NCT01296555|617396992|FG020|Overall Study|Lost to Follow-up|3|||
170832749|NCT01296555|617396993|FG021|Overall Study|Lost to Follow-up|2|||
170832750|NCT01296555|617396994|FG022|Overall Study|Lost to Follow-up|0|||
170832751|NCT01296555|617396995|FG023|Overall Study|Lost to Follow-up|0|||
170832752|NCT01296555|617396996|FG024|Overall Study|Lost to Follow-up|0|||
170832753|NCT01296555|617396997|FG025|Overall Study|Lost to Follow-up|0|||
170832754|NCT01296555|617396998|FG026|Overall Study|Lost to Follow-up|3|||
170832755|NCT01296555|617396999|FG027|Overall Study|Lost to Follow-up|13|||
170832756|NCT01296555|617397000|FG028|Overall Study|Lost to Follow-up|5|||
170832757|NCT01296555|617396972|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170832758|NCT01296555|617396973|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170832759|NCT01296555|617396974|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170832760|NCT01296555|617396975|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170832761|NCT01296555|617396976|FG004|Overall Study|Non-Compliance With Study Drug|0|||
170832762|NCT01296555|617396977|FG005|Overall Study|Non-Compliance With Study Drug|0|||
170832763|NCT01296555|617396978|FG006|Overall Study|Non-Compliance With Study Drug|0|||
170832764|NCT01296555|617396979|FG007|Overall Study|Non-Compliance With Study Drug|1|||
170832765|NCT01296555|617396980|FG008|Overall Study|Non-Compliance With Study Drug|0|||
170832766|NCT01296555|617396981|FG009|Overall Study|Non-Compliance With Study Drug|0|||
170832767|NCT01296555|617396982|FG010|Overall Study|Non-Compliance With Study Drug|0|||
170832768|NCT01296555|617396983|FG011|Overall Study|Non-Compliance With Study Drug|0|||
170832769|NCT01296555|617396984|FG012|Overall Study|Non-Compliance With Study Drug|0|||
170832770|NCT01296555|617396985|FG013|Overall Study|Non-Compliance With Study Drug|0|||
170832771|NCT01296555|617396986|FG014|Overall Study|Non-Compliance With Study Drug|0|||
170832772|NCT01296555|617396987|FG015|Overall Study|Non-Compliance With Study Drug|0|||
170832773|NCT01296555|617396988|FG016|Overall Study|Non-Compliance With Study Drug|0|||
170832774|NCT01296555|617396989|FG017|Overall Study|Non-Compliance With Study Drug|0|||
170832775|NCT01296555|617396990|FG018|Overall Study|Non-Compliance With Study Drug|0|||
170832776|NCT01296555|617396991|FG019|Overall Study|Non-Compliance With Study Drug|0|||
170832777|NCT01296555|617396992|FG020|Overall Study|Non-Compliance With Study Drug|0|||
170832778|NCT01296555|617396993|FG021|Overall Study|Non-Compliance With Study Drug|0|||
170832779|NCT01296555|617396994|FG022|Overall Study|Non-Compliance With Study Drug|0|||
170832780|NCT01296555|617396995|FG023|Overall Study|Non-Compliance With Study Drug|0|||
170832781|NCT01296555|617396996|FG024|Overall Study|Non-Compliance With Study Drug|0|||
170832782|NCT01296555|617396997|FG025|Overall Study|Non-Compliance With Study Drug|0|||
170832783|NCT01296555|617396998|FG026|Overall Study|Non-Compliance With Study Drug|0|||
170832784|NCT01296555|617396999|FG027|Overall Study|Non-Compliance With Study Drug|0|||
170832785|NCT01296555|617397000|FG028|Overall Study|Non-Compliance With Study Drug|0|||
170832786|NCT01296555|617396972|FG000|Overall Study|Withdrawal by Subject|0|||
170832787|NCT01296555|617396973|FG001|Overall Study|Withdrawal by Subject|0|||
170832788|NCT01296555|617396974|FG002|Overall Study|Withdrawal by Subject|0|||
170832789|NCT01296555|617396975|FG003|Overall Study|Withdrawal by Subject|0|||
170832790|NCT01296555|617396976|FG004|Overall Study|Withdrawal by Subject|1|||
170832791|NCT01296555|617396977|FG005|Overall Study|Withdrawal by Subject|0|||
170832792|NCT01296555|617396978|FG006|Overall Study|Withdrawal by Subject|1|||
170832793|NCT01296555|617396979|FG007|Overall Study|Withdrawal by Subject|0|||
170832794|NCT01296555|617396980|FG008|Overall Study|Withdrawal by Subject|0|||
170832795|NCT01296555|617396981|FG009|Overall Study|Withdrawal by Subject|0|||
170832796|NCT01296555|617396982|FG010|Overall Study|Withdrawal by Subject|1|||
170832797|NCT01296555|617396983|FG011|Overall Study|Withdrawal by Subject|1|||
170832798|NCT01296555|617396984|FG012|Overall Study|Withdrawal by Subject|0|||
170832799|NCT01296555|617396985|FG013|Overall Study|Withdrawal by Subject|0|||
170832800|NCT01296555|617396986|FG014|Overall Study|Withdrawal by Subject|3|||
170832801|NCT01296555|617396987|FG015|Overall Study|Withdrawal by Subject|0|||
170832802|NCT01296555|617396988|FG016|Overall Study|Withdrawal by Subject|2|||
170832803|NCT01296555|617396989|FG017|Overall Study|Withdrawal by Subject|1|||
170832804|NCT01296555|617396990|FG018|Overall Study|Withdrawal by Subject|0|||
170832805|NCT01296555|617396991|FG019|Overall Study|Withdrawal by Subject|1|||
170832806|NCT01296555|617396992|FG020|Overall Study|Withdrawal by Subject|1|||
170832807|NCT01296555|617396993|FG021|Overall Study|Withdrawal by Subject|1|||
170832808|NCT01296555|617396994|FG022|Overall Study|Withdrawal by Subject|3|||
170832809|NCT01296555|617396995|FG023|Overall Study|Withdrawal by Subject|0|||
170832810|NCT01296555|617396996|FG024|Overall Study|Withdrawal by Subject|0|||
170832811|NCT01296555|617396997|FG025|Overall Study|Withdrawal by Subject|0|||
170832812|NCT01296555|617396998|FG026|Overall Study|Withdrawal by Subject|8|||
170832813|NCT01296555|617396999|FG027|Overall Study|Withdrawal by Subject|4|||
170832814|NCT01296555|617397000|FG028|Overall Study|Withdrawal by Subject|2|||
170832815|NCT00217022|617397002|FG000|Overall Study|Withdrawal by Subject|1|||
170832816|NCT00217022|617397003|FG001|Overall Study|Withdrawal by Subject|1|||
170832817|NCT02777242|617397004|FG000|Overall Study|Other|2|||
170832818|NCT02777242|617397004|FG000|Overall Study|Lost to Follow-up|1|||
170832819|NCT02777242|617397004|FG000|Overall Study|Multiple|1|||
170832820|NCT02777242|617397004|FG000|Overall Study|Sponsor's request|1|||
170832821|NCT02777242|617397004|FG000|Overall Study|Withdrawal by Subject|1|||
170832822|NCT05178979|617397005|FG000|Overall Study|Death|0|||
170832823|NCT05178979|617397006|FG001|Overall Study|Death|5|||
170832824|NCT05178979|617397007|FG002|Overall Study|Death|0|||
170832825|NCT05178979|617397008|FG003|Overall Study|Death|3|||
170832826|NCT05178979|617397005|FG000|Overall Study|Adverse Event|0|||
170832827|NCT05178979|617397006|FG001|Overall Study|Adverse Event|1|||
170832828|NCT05178979|617397007|FG002|Overall Study|Adverse Event|0|||
170832829|NCT05178979|617397008|FG003|Overall Study|Adverse Event|0|||
170832830|NCT05178979|617397005|FG000|Overall Study|Lost to Follow-up|1|||
170832831|NCT05178979|617397006|FG001|Overall Study|Lost to Follow-up|8|||
170832832|NCT05178979|617397007|FG002|Overall Study|Lost to Follow-up|3|||
170832833|NCT05178979|617397008|FG003|Overall Study|Lost to Follow-up|8|||
170832834|NCT00817336|617397009|FG000|Overall Study|Withdrawal by Subject|1|||
170832835|NCT00817336|617397010|FG001|Overall Study|Withdrawal by Subject|1|||
170832836|NCT02299427|617397011|FG000|Overall Study|Withdrawal by Subject|1|||
170723829|NCT02415400|616992267|FG000|Overall Study|Coagulation values cannot be set|0|||
170723830|NCT02415400|616992268|FG001|Overall Study|Coagulation values cannot be set|0|||
170723831|NCT02415400|616992269|FG002|Overall Study|Coagulation values cannot be set|1|||
170723832|NCT02415400|616992270|FG003|Overall Study|Coagulation values cannot be set|0|||
170723833|NCT02415400|616992267|FG000|Overall Study|State regulations prevent participation|0|||
170723834|NCT02415400|616992268|FG001|Overall Study|State regulations prevent participation|0|||
170723835|NCT02415400|616992269|FG002|Overall Study|State regulations prevent participation|1|||
170723836|NCT02415400|616992270|FG003|Overall Study|State regulations prevent participation|0|||
170723837|NCT02415400|616992267|FG000|Overall Study|Poor treatment monitoring|0|||
170723838|NCT02415400|616992268|FG001|Overall Study|Poor treatment monitoring|0|||
170723839|NCT02415400|616992269|FG002|Overall Study|Poor treatment monitoring|1|||
170723840|NCT02415400|616992270|FG003|Overall Study|Poor treatment monitoring|0|||
170723841|NCT02415400|616992267|FG000|Overall Study|Participant in jail|0|||
170723842|NCT02415400|616992268|FG001|Overall Study|Participant in jail|0|||
170723843|NCT02415400|616992269|FG002|Overall Study|Participant in jail|1|||
170723844|NCT02415400|616992270|FG003|Overall Study|Participant in jail|0|||
170723845|NCT02415400|616992267|FG000|Overall Study|Investigator decision|0|||
170723846|NCT02415400|616992268|FG001|Overall Study|Investigator decision|0|||
170723847|NCT02415400|616992269|FG002|Overall Study|Investigator decision|1|||
170723848|NCT02415400|616992270|FG003|Overall Study|Investigator decision|1|||
170723849|NCT02415400|616992267|FG000|Overall Study|Site closure; participant won't transfer|0|||
170723850|NCT02415400|616992268|FG001|Overall Study|Site closure; participant won't transfer|0|||
170723851|NCT02415400|616992269|FG002|Overall Study|Site closure; participant won't transfer|0|||
170723852|NCT02415400|616992270|FG003|Overall Study|Site closure; participant won't transfer|1|||
170723853|NCT01939028|616992274|FG000|Overall Study|Withdrawal by Subject|5|||
170723854|NCT01939028|616992274|FG000|Overall Study|Physician Decision|7|||
170723855|NCT02081846|616992275|FG000|Overall Study|Withdrawal by Subject|1|||
170723856|NCT02081846|616992276|FG001|Overall Study|Withdrawal by Subject|0|||
170723857|NCT02081846|616992275|FG000|Overall Study|invalid consent|1|||
170723858|NCT02081846|616992276|FG001|Overall Study|invalid consent|0|||
170723859|NCT03282227|616992277|FG000|Overall Study|Exposure Goals Achieved|60|||
170723860|NCT03282227|616992277|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
170723861|NCT03282227|616992277|FG000|Overall Study|Adverse Event|15|||
170723862|NCT03282227|616992277|FG000|Overall Study|Lost to Follow-up|21|||
170723863|NCT03282227|616992277|FG000|Overall Study|Withdrawal by Subject|20|||
170723864|NCT03282227|616992277|FG000|Overall Study|Lack of Efficacy|12|||
170723865|NCT03282227|616992277|FG000|Overall Study|Sponsor decision|3|||
170723866|NCT03282227|616992277|FG000|Overall Study|Physician Decision|2|||
170723867|NCT03282227|616992277|FG000|Overall Study|Pregnancy|2|||
170723868|NCT03282227|616992277|FG000|Overall Study|Other|1|||
170723869|NCT02576678|616992278|FG000|Overall Study|Adverse Event|0|||
170723870|NCT02576678|616992279|FG001|Overall Study|Adverse Event|0|||
170723871|NCT02576678|616992280|FG002|Overall Study|Adverse Event|2|||
170723872|NCT02576678|616992278|FG000|Overall Study|Withdrawal by Subject|3|||
170723873|NCT02576678|616992279|FG001|Overall Study|Withdrawal by Subject|1|||
170723874|NCT02576678|616992280|FG002|Overall Study|Withdrawal by Subject|2|||
170723875|NCT02576678|616992278|FG000|Overall Study|Lost to Follow-up|0|||
170723876|NCT02576678|616992279|FG001|Overall Study|Lost to Follow-up|0|||
170723877|NCT02576678|616992280|FG002|Overall Study|Lost to Follow-up|1|||
170723878|NCT02576678|616992278|FG000|Overall Study|Miscellaneous|2|||
170723879|NCT02576678|616992279|FG001|Overall Study|Miscellaneous|0|||
170723880|NCT02576678|616992280|FG002|Overall Study|Miscellaneous|0|||
170723881|NCT03265600|616992281|FG000|Overall Study|Lost to Follow-up|17|||
170723882|NCT03265600|616992282|FG001|Overall Study|Lost to Follow-up|5|||
170723883|NCT03265600|616992281|FG000|Overall Study|Withdrawal by Subject|4|||
170723884|NCT03265600|616992282|FG001|Overall Study|Withdrawal by Subject|2|||
170723885|NCT03265600|616992281|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
170723886|NCT03265600|616992282|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
170723887|NCT02341417|616992284|FG000|Overall Study|Withdrawal by Subject|0|||
170723888|NCT02341417|616992285|FG001|Overall Study|Withdrawal by Subject|2|||
170723889|NCT02341417|616992286|FG002|Overall Study|Withdrawal by Subject|0|||
170723890|NCT02341417|616992284|FG000|Overall Study|Decision by sponsor|2|||
170723891|NCT02341417|616992285|FG001|Overall Study|Decision by sponsor|0|||
170723892|NCT02341417|616992286|FG002|Overall Study|Decision by sponsor|0|||
170723893|NCT02341417|616992284|FG000|Overall Study|Death|0|||
170723894|NCT02341417|616992285|FG001|Overall Study|Death|0|||
170723895|NCT02341417|616992286|FG002|Overall Study|Death|1|||
170723896|NCT01922076|616992291|FG000|Overall Study|Adverse Event|0|||
170723897|NCT01922076|616992292|FG001|Overall Study|Adverse Event|0|||
170723898|NCT01922076|616992293|FG002|Overall Study|Adverse Event|0|||
170723899|NCT01922076|616992294|FG003|Overall Study|Adverse Event|0|||
170723900|NCT01922076|616992295|FG004|Overall Study|Adverse Event|1|||
170723901|NCT01922076|616992296|FG005|Overall Study|Adverse Event|0|||
170723902|NCT01922076|616992297|FG006|Overall Study|Adverse Event|0|||
170723903|NCT01922076|616992291|FG000|Overall Study|Physician Decision|0|||
170723904|NCT01922076|616992292|FG001|Overall Study|Physician Decision|0|||
170832837|NCT02299427|617397012|FG001|Overall Study|Withdrawal by Subject|0|||
170832838|NCT02299427|617397011|FG000|Overall Study|Lost to Follow-up|1|||
170832839|NCT02299427|617397012|FG001|Overall Study|Lost to Follow-up|3|||
170832840|NCT02299427|617397011|FG000|Overall Study|not adherent to dog website use|21|||
170832841|NCT02299427|617397012|FG001|Overall Study|not adherent to dog website use|0|||
170832842|NCT02108652|617397013|FG000|Overall Study|Death|253|||
170832843|NCT02108652|617397013|FG000|Overall Study|Lost to Follow-up|2|||
170832844|NCT02108652|617397013|FG000|Overall Study|Withdrawal by Subject|16|||
170832845|NCT02108652|617397013|FG000|Overall Study|Study Terminated By Sponsor|31|||
170832846|NCT02108652|617397013|FG000|Overall Study|Non-Compliance|1|||
170832847|NCT02108652|617397013|FG000|Overall Study|Physician Decision|6|||
170832848|NCT02108652|617397013|FG000|Overall Study|Progression Of Disease|1|||
170832849|NCT00409409|617397014|FG000|Overall Study|Adverse Event|7|||
170832850|NCT00409409|617397015|FG001|Overall Study|Adverse Event|2|||
170832851|NCT00409409|617397014|FG000|Overall Study|Withdrawal by Subject|1|||
170832852|NCT00409409|617397015|FG001|Overall Study|Withdrawal by Subject|1|||
170832853|NCT00409409|617397014|FG000|Overall Study|Any other reason not above-mentioned|0|||
170832854|NCT00409409|617397015|FG001|Overall Study|Any other reason not above-mentioned|1|||
170832855|NCT02138253|617397016|FG000|Overall Study|Adverse Event|3|||
170832856|NCT02138253|617397017|FG001|Overall Study|Adverse Event|3|||
170832857|NCT02138253|617397016|FG000|Overall Study|Lost to Follow-up|2|||
170832858|NCT02138253|617397017|FG001|Overall Study|Lost to Follow-up|1|||
170832859|NCT02138253|617397016|FG000|Overall Study|Physician Decision|2|||
170832860|NCT02138253|617397017|FG001|Overall Study|Physician Decision|0|||
170832861|NCT02138253|617397016|FG000|Overall Study|Non compliance|1|||
170832862|NCT02138253|617397017|FG001|Overall Study|Non compliance|0|||
170832863|NCT02138253|617397016|FG000|Overall Study|Withdrawal by Subject|1|||
170832864|NCT02138253|617397017|FG001|Overall Study|Withdrawal by Subject|0|||
170832865|NCT02485899|617397018|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
170832866|NCT02485899|617397019|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170832867|NCT02485899|617397018|FG000|Overall Study|Withdrawal by Subject|1|||
170832868|NCT02485899|617397019|FG001|Overall Study|Withdrawal by Subject|0|||
170832869|NCT02485899|617397018|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
170832870|NCT02485899|617397019|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
170832871|NCT01918371|617397020|FG000|Overall Study|Missing Data|1|||
170832872|NCT01918371|617397021|FG001|Overall Study|Missing Data|1|||
170832873|NCT00621192|617397022|FG000|Overall Study|Withdrawal by Subject|0|||
170832874|NCT00621192|617397023|FG001|Overall Study|Withdrawal by Subject|0|||
170832875|NCT00621192|617397024|FG002|Overall Study|Withdrawal by Subject|2|||
170832876|NCT00621192|617397025|FG003|Overall Study|Withdrawal by Subject|0|||
170832877|NCT00621192|617397022|FG000|Overall Study|Physician Decision|1|||
170832878|NCT00621192|617397023|FG001|Overall Study|Physician Decision|3|||
170832879|NCT00621192|617397024|FG002|Overall Study|Physician Decision|0|||
170832880|NCT00621192|617397025|FG003|Overall Study|Physician Decision|0|||
170832881|NCT00621192|617397022|FG000|Overall Study|Protocol Violation|1|||
170832882|NCT00621192|617397023|FG001|Overall Study|Protocol Violation|0|||
170832883|NCT00621192|617397024|FG002|Overall Study|Protocol Violation|0|||
170832884|NCT00621192|617397025|FG003|Overall Study|Protocol Violation|1|||
170832885|NCT00621192|617397022|FG000|Overall Study|Adverse Event|0|||
170832886|NCT00621192|617397023|FG001|Overall Study|Adverse Event|1|||
170832887|NCT00621192|617397024|FG002|Overall Study|Adverse Event|0|||
170832888|NCT00621192|617397025|FG003|Overall Study|Adverse Event|1|||
170832889|NCT00621192|617397022|FG000|Overall Study|Death|2|||
170832890|NCT00621192|617397023|FG001|Overall Study|Death|5|||
170832891|NCT00621192|617397024|FG002|Overall Study|Death|0|||
170832892|NCT00621192|617397025|FG003|Overall Study|Death|0|||
170832893|NCT00621192|617397022|FG000|Overall Study|Final Assessments not Completed|0|||
170832894|NCT00621192|617397023|FG001|Overall Study|Final Assessments not Completed|0|||
170832895|NCT00621192|617397024|FG002|Overall Study|Final Assessments not Completed|3|||
170832896|NCT00621192|617397025|FG003|Overall Study|Final Assessments not Completed|1|||
170832897|NCT04706793|617397026|FG000|Treatment|Disease worsening|10|||
170832898|NCT04706793|617397027|FG001|Treatment|Disease worsening|10|||
170832899|NCT04706793|617397026|FG000|Follow-up|Lack of Efficacy|1|||
170832900|NCT04706793|617397027|FG001|Follow-up|Lack of Efficacy|0|||
170832901|NCT04706793|617397026|FG000|Follow-up|Disease worsening|8|||
170832902|NCT04706793|617397027|FG001|Follow-up|Disease worsening|10|||
170832903|NCT04706793|617397026|FG000|Follow-up|Adverse Event|1|||
170832904|NCT04706793|617397027|FG001|Follow-up|Adverse Event|0|||
170832905|NCT04354168|617397028|FG000|Overall Study|Lost to Follow-up|22|||
170832906|NCT02287233|617397031|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
170832907|NCT02287233|617397032|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
170832908|NCT02287233|617397033|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
170832909|NCT02287233|617397031|FG000|Overall Study|Adverse Event Related to Progression|0|||
170832910|NCT02287233|617397032|FG001|Overall Study|Adverse Event Related to Progression|2|||
170832911|NCT02287233|617397033|FG002|Overall Study|Adverse Event Related to Progression|8|||
170832912|NCT02287233|617397031|FG000|Overall Study|Physician Decision|1|||
170832913|NCT02287233|617397032|FG001|Overall Study|Physician Decision|2|||
170832914|NCT02287233|617397033|FG002|Overall Study|Physician Decision|4|||
170832915|NCT02287233|617397031|FG000|Overall Study|Progressive Disease with Death|0|||
170832916|NCT02287233|617397032|FG001|Overall Study|Progressive Disease with Death|0|||
170832917|NCT02287233|617397033|FG002|Overall Study|Progressive Disease with Death|10|||
170832918|NCT02287233|617397031|FG000|Overall Study|Progressive Disease Without Death|2|||
170832919|NCT02287233|617397032|FG001|Overall Study|Progressive Disease Without Death|3|||
170832920|NCT02287233|617397033|FG002|Overall Study|Progressive Disease Without Death|20|||
170832921|NCT02287233|617397031|FG000|Overall Study|Withdrawal by Subject|1|||
170832922|NCT02287233|617397032|FG001|Overall Study|Withdrawal by Subject|1|||
170832923|NCT02287233|617397033|FG002|Overall Study|Withdrawal by Subject|7|||
170832924|NCT02287233|617397031|FG000|Overall Study|Other|3|||
170832925|NCT02287233|617397032|FG001|Overall Study|Other|0|||
170832926|NCT02287233|617397033|FG002|Overall Study|Other|15|||
170832927|NCT02287233|617397031|FG000|Overall Study|Did Not Receive Treatment|0|||
170832928|NCT02287233|617397032|FG001|Overall Study|Did Not Receive Treatment|0|||
170832929|NCT02287233|617397033|FG002|Overall Study|Did Not Receive Treatment|2|||
170832930|NCT00745498|617397034|FG000|Overall Study|Lost to Follow-up|1|||
170832931|NCT00745498|617397035|FG001|Overall Study|Lost to Follow-up|1|||
170832932|NCT00745498|617397036|FG002|Overall Study|Lost to Follow-up|3|||
170832933|NCT00745498|617397034|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
170832934|NCT00745498|617397035|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
170832935|NCT00745498|617397036|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
170832936|NCT00745498|617397034|FG000|Overall Study|Non-PDR related VH|0|||
170832937|NCT00745498|617397035|FG001|Overall Study|Non-PDR related VH|1|||
170832938|NCT00745498|617397036|FG002|Overall Study|Non-PDR related VH|1|||
170832939|NCT00745498|617397034|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
170832940|NCT00745498|617397035|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
170832941|NCT00745498|617397036|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
170832942|NCT04788511|617397039|FG000|Overall Study|Withdrawal by Subject|2|||
170832943|NCT04788511|617397040|FG001|Overall Study|Withdrawal by Subject|1|||
170832944|NCT04788511|617397039|FG000|Overall Study|Lost to Follow-up|2|||
170832945|NCT04788511|617397040|FG001|Overall Study|Lost to Follow-up|7|||
170832946|NCT04788511|617397039|FG000|Overall Study|Death|3|||
170832947|NCT04788511|617397040|FG001|Overall Study|Death|4|||
170832948|NCT03174782|617397041|FG000|Overall Study|Protocol Violation|1|||
170832949|NCT03174782|617397042|FG001|Overall Study|Protocol Violation|0|||
170832950|NCT03174782|617397041|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
170832951|NCT03174782|617397042|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
170832952|NCT00778921|617397043|FG000|Overall Study|Adverse Event|9|||
170832953|NCT00778921|617397044|FG001|Overall Study|Adverse Event|10|||
170832954|NCT00778921|617397045|FG002|Overall Study|Adverse Event|14|||
170832955|NCT00778921|617397043|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
170832956|NCT00778921|617397044|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
170832957|NCT00778921|617397045|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
170832958|NCT00778921|617397043|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
170832959|NCT00778921|617397044|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
170832960|NCT00778921|617397045|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
170832961|NCT00778921|617397043|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
170832962|NCT00778921|617397044|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
170832963|NCT00778921|617397045|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
170832964|NCT00778921|617397043|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
170832965|NCT00778921|617397044|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
170832966|NCT00778921|617397045|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
170832967|NCT00778921|617397043|FG000|Overall Study|Patient withdrew request|3|||
170832968|NCT00778921|617397044|FG001|Overall Study|Patient withdrew request|1|||
170832969|NCT00778921|617397045|FG002|Overall Study|Patient withdrew request|6|||
170723905|NCT01922076|616992293|FG002|Overall Study|Physician Decision|1|||
170723906|NCT01922076|616992294|FG003|Overall Study|Physician Decision|0|||
170723907|NCT01922076|616992295|FG004|Overall Study|Physician Decision|0|||
170723908|NCT01922076|616992296|FG005|Overall Study|Physician Decision|0|||
170723909|NCT01922076|616992297|FG006|Overall Study|Physician Decision|0|||
170723910|NCT01922076|616992291|FG000|Overall Study|Withdrawal by Subject|0|||
170723911|NCT01922076|616992292|FG001|Overall Study|Withdrawal by Subject|0|||
170723912|NCT01922076|616992293|FG002|Overall Study|Withdrawal by Subject|0|||
170723913|NCT01922076|616992294|FG003|Overall Study|Withdrawal by Subject|1|||
170723914|NCT01922076|616992295|FG004|Overall Study|Withdrawal by Subject|0|||
170723915|NCT01922076|616992296|FG005|Overall Study|Withdrawal by Subject|1|||
170723916|NCT01922076|616992297|FG006|Overall Study|Withdrawal by Subject|1|||
170723917|NCT03570619|616992304|FG000|Overall Study|Adverse Event|2|||
170723918|NCT03570619|616992305|FG001|Overall Study|Adverse Event|0|||
170723919|NCT03570619|616992306|FG002|Overall Study|Adverse Event|1|||
170723920|NCT03570619|616992304|FG000|Overall Study|new diagnosis of new malignancy|1|||
170723921|NCT03570619|616992305|FG001|Overall Study|new diagnosis of new malignancy|0|||
170723922|NCT03570619|616992306|FG002|Overall Study|new diagnosis of new malignancy|0|||
170723923|NCT03570619|616992304|FG000|Overall Study|Physician Decision|1|||
170723924|NCT03570619|616992305|FG001|Overall Study|Physician Decision|1|||
170723925|NCT03570619|616992306|FG002|Overall Study|Physician Decision|0|||
170723926|NCT03570619|616992304|FG000|Overall Study|Withdrawal by Subject|0|||
170723927|NCT03570619|616992305|FG001|Overall Study|Withdrawal by Subject|2|||
170723928|NCT03570619|616992306|FG002|Overall Study|Withdrawal by Subject|0|||
170723929|NCT04773587|616992307|FG000|Overall Study|Lost to Follow-up|11|||
170723930|NCT04773587|616992308|FG001|Overall Study|Lost to Follow-up|3|||
170723931|NCT04773587|616992307|FG000|Overall Study|Adverse Event|6|||
170723932|NCT04773587|616992308|FG001|Overall Study|Adverse Event|3|||
170723933|NCT04773587|616992307|FG000|Overall Study|Lack of Efficacy|5|||
170723934|NCT04773587|616992308|FG001|Overall Study|Lack of Efficacy|2|||
170723935|NCT04773587|616992307|FG000|Overall Study|Withdrawal by Subject|4|||
170723936|NCT04773587|616992308|FG001|Overall Study|Withdrawal by Subject|5|||
170723937|NCT04773587|616992307|FG000|Overall Study|Noncompliance|1|||
170723938|NCT04773587|616992308|FG001|Overall Study|Noncompliance|0|||
170723939|NCT04773587|616992307|FG000|Overall Study|Protocol Violation|1|||
170723940|NCT04773587|616992308|FG001|Overall Study|Protocol Violation|0|||
170723941|NCT04773587|616992307|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
170723942|NCT04773587|616992308|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
170723943|NCT02372409|616992309|FG000|Overall Study|Lost to Follow-up|1|||
170723944|NCT02372409|616992310|FG001|Overall Study|Lost to Follow-up|0|||
170723945|NCT02372409|616992309|FG000|Overall Study|Disease progression|1|||
170723946|NCT02372409|616992310|FG001|Overall Study|Disease progression|1|||
170723947|NCT01808313|616992313|FG000|Overall Study|Adverse Event|5|||
170723948|NCT01808313|616992313|FG000|Overall Study|Protocol Violation|2|||
170723949|NCT01808313|616992313|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
170723950|NCT01808313|616992313|FG000|Overall Study|Lost to Follow-up|1|||
170723951|NCT01808313|616992313|FG000|Overall Study|Physician Decision|1|||
170723952|NCT04656847|616992314|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
170723953|NCT00622167|616992315|FG000|Overall Study|Did not meet angiographic criteria|20|||
170723954|NCT04558346|616992320|FG000|Overall Study|Withdrawal by Subject|2|||
170723955|NCT04558346|616992321|FG001|Overall Study|Withdrawal by Subject|0|||
170723956|NCT04558346|616992320|FG000|Overall Study|Lost to Follow-up|0|||
170723957|NCT04558346|616992321|FG001|Overall Study|Lost to Follow-up|1|||
170723958|NCT04558346|616992320|FG000|Overall Study|Adverse Event|0|||
170723959|NCT04558346|616992321|FG001|Overall Study|Adverse Event|1|||
170723960|NCT01462344|616992322|FG000|Overall Study|Withdrawal by Subject|245|||
170723961|NCT01462344|616992323|FG001|Overall Study|Withdrawal by Subject|226|||
170723962|NCT01462344|616992322|FG000|Overall Study|Adverse Event|24|||
170723963|NCT01462344|616992323|FG001|Overall Study|Adverse Event|23|||
170723964|NCT01462344|616992322|FG000|Overall Study|Asthma Exacerbation|34|||
170723965|NCT01462344|616992323|FG001|Overall Study|Asthma Exacerbation|35|||
170723966|NCT01462344|616992322|FG000|Overall Study|Lack of Efficacy|5|||
170723967|NCT01462344|616992323|FG001|Overall Study|Lack of Efficacy|6|||
170723968|NCT01462344|616992322|FG000|Overall Study|Protocol Violation|68|||
170723969|NCT01462344|616992323|FG001|Overall Study|Protocol Violation|53|||
170723970|NCT01462344|616992322|FG000|Overall Study|Lost to Follow-up|7|||
170723971|NCT01462344|616992323|FG001|Overall Study|Lost to Follow-up|7|||
170723972|NCT03086447|616992325|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
170723973|NCT03086447|616992326|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
170723974|NCT03086447|616992325|FG000|Overall Study|Lost Lens|2|||
170723975|NCT03086447|616992326|FG001|Overall Study|Lost Lens|5|||
170723976|NCT03086447|616992325|FG000|Overall Study|Product quality complaint|0|||
170723977|NCT03086447|616992326|FG001|Overall Study|Product quality complaint|1|||
170723978|NCT03086447|616992325|FG000|Overall Study|Lens Damage|1|||
170723979|NCT03086447|616992326|FG001|Overall Study|Lens Damage|6|||
170723980|NCT03086447|616992325|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
170723981|NCT03086447|616992326|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
170723982|NCT03086447|616992325|FG000|Overall Study|Test Article No Longer Available|1|||
170723983|NCT03086447|616992326|FG001|Overall Study|Test Article No Longer Available|0|||
170723984|NCT03086447|616992325|FG000|Overall Study|Protocol Violation|2|||
170723985|NCT03086447|616992326|FG001|Overall Study|Protocol Violation|4|||
170723986|NCT03086447|616992325|FG000|Overall Study|Lost to Follow-up|0|||
170723987|NCT03086447|616992326|FG001|Overall Study|Lost to Follow-up|1|||
170723988|NCT03086447|616992325|FG000|Overall Study|Adverse Event|3|||
170723989|NCT03086447|616992326|FG001|Overall Study|Adverse Event|0|||
170723990|NCT03086447|616992325|FG000|Overall Study|Lens Discomfort|2|||
170723991|NCT03086447|616992326|FG001|Overall Study|Lens Discomfort|1|||
170723992|NCT00435370|616992330|FG000|Overall Study|Adverse Event|8|||
170723993|NCT00435370|616992331|FG001|Overall Study|Adverse Event|8|||
170723994|NCT00435370|616992330|FG000|Overall Study|Withdrawal by Subject|10|||
170723995|NCT00435370|616992331|FG001|Overall Study|Withdrawal by Subject|10|||
170723996|NCT00435370|616992330|FG000|Overall Study|Antipsychotic medication changed|4|||
170723997|NCT00435370|616992331|FG001|Overall Study|Antipsychotic medication changed|2|||
170723998|NCT03034577|616992333|FG000|Overall Study|Withdrawal by Subject|6|||
170723999|NCT03034577|616992334|FG001|Overall Study|Withdrawal by Subject|9|||
170724000|NCT03034577|616992333|FG000|Overall Study|Lost to Follow-up|25|||
170724001|NCT03034577|616992334|FG001|Overall Study|Lost to Follow-up|26|||
170724002|NCT01174342|616992335|FG000|Overall Study|Conversion to cesarean section|4|||
170724003|NCT02625623|616992336|FG000|Overall Study|Participants randomized but not treated|9|||
170724004|NCT02625623|616992337|FG001|Overall Study|Participants randomized but not treated|1|||
170724005|NCT00744653|616992341|FG000|Overall Study|antineoplastic treatment|11|||
170724006|NCT00744653|616992341|FG000|Overall Study|Death|1|||
170724007|NCT00744653|616992341|FG000|Overall Study|Lost to Follow-up|1|||
170724008|NCT00744653|616992341|FG000|Overall Study|Physician Decision|3|||
170724009|NCT00360529|616992342|FG000|Overall Study|Adverse Event|10|||
170724010|NCT00360529|616992343|FG001|Overall Study|Adverse Event|23|||
170724011|NCT00360529|616992344|FG002|Overall Study|Adverse Event|33|||
170724012|NCT00360529|616992342|FG000|Overall Study|Protocol Violation|3|||
170724013|NCT00360529|616992343|FG001|Overall Study|Protocol Violation|3|||
170724014|NCT00360529|616992344|FG002|Overall Study|Protocol Violation|11|||
170724015|NCT00360529|616992342|FG000|Overall Study|Lost to Follow-up|14|||
170724016|NCT00360529|616992343|FG001|Overall Study|Lost to Follow-up|10|||
170724017|NCT00360529|616992344|FG002|Overall Study|Lost to Follow-up|13|||
170724018|NCT00360529|616992342|FG000|Overall Study|Withdrawal by Subject|22|||
170724019|NCT00360529|616992343|FG001|Overall Study|Withdrawal by Subject|14|||
170724020|NCT00360529|616992344|FG002|Overall Study|Withdrawal by Subject|18|||
170724021|NCT00360529|616992342|FG000|Overall Study|Lack of Efficacy|8|||
170724022|NCT00360529|616992343|FG001|Overall Study|Lack of Efficacy|6|||
170724023|NCT00360529|616992344|FG002|Overall Study|Lack of Efficacy|5|||
170724024|NCT00360529|616992342|FG000|Overall Study|Reason discontinued not explained above|4|||
170724025|NCT00360529|616992343|FG001|Overall Study|Reason discontinued not explained above|9|||
170724026|NCT00360529|616992344|FG002|Overall Study|Reason discontinued not explained above|11|||
170724027|NCT03826667|616992347|FG000|Overall Study|Protocol deviation|21|||
170724028|NCT00808808|616992350|FG000|Overall Study|Vaccinated; survey not completed|131|||
170724029|NCT00808808|616992351|FG001|Overall Study|Vaccinated; survey not completed|169|||
170724030|NCT00808808|616992352|FG002|Overall Study|Vaccinated; survey not completed|302|||
170724031|NCT00808808|616992350|FG000|Overall Study|Employee was not vaccinated.|2686|||
170724032|NCT00808808|616992351|FG001|Overall Study|Employee was not vaccinated.|2268|||
170724033|NCT00808808|616992352|FG002|Overall Study|Employee was not vaccinated.|2255|||
170724034|NCT02298192|616992356|FG000|Overall Study|Unclassified|3|||
170724035|NCT02298192|616992357|FG001|Overall Study|Unclassified|2|||
170724036|NCT02298192|616992356|FG000|Overall Study|Withdrawal criteria|2|||
170724037|NCT02298192|616992357|FG001|Overall Study|Withdrawal criteria|0|||
170724038|NCT02298192|616992356|FG000|Overall Study|Withdrawal by Subject|6|||
170724039|NCT02298192|616992357|FG001|Overall Study|Withdrawal by Subject|1|||
170724040|NCT02298192|616992356|FG000|Overall Study|Lost to Follow-up|2|||
170724041|NCT02298192|616992357|FG001|Overall Study|Lost to Follow-up|1|||
170724042|NCT02298192|616992356|FG000|Overall Study|Adverse Event|6|||
170724043|NCT02298192|616992357|FG001|Overall Study|Adverse Event|2|||
170724044|NCT02313428|616992361|FG000|Overall Study|Lost to Follow-up|1|||
170724045|NCT02313428|616992362|FG001|Overall Study|Lost to Follow-up|1|||
170724046|NCT05374421|616992363|FG000|Overall Study|Withdrawal by Subject|3|||
170724047|NCT05374421|616992364|FG001|Overall Study|Withdrawal by Subject|4|||
170724048|NCT02763384|616992365|FG000|Overall Study|Physician Decision|1|||
170724049|NCT02763384|616992365|FG000|Overall Study|Rapid decline - went on hospice|1|||
170724050|NCT04657211|616992366|FG000|Overall Study|Withdrawal by Subject|21|||
170724051|NCT04657211|616992366|FG000|Overall Study|Lost to Follow-up|113|||
170724052|NCT04657211|616992366|FG000|Overall Study|Death|47|||
170724053|NCT04657211|616992366|FG000|Overall Study|Transfer to another institution|21|||
170724054|NCT04657211|616992366|FG000|Overall Study|Other|29|||
170724055|NCT06167031|616992367|FG000|Overall Study|Lost to Follow-up|5|||
170724056|NCT06167031|616992368|FG001|Overall Study|Lost to Follow-up|1|||
170724057|NCT00003508|616994335|FG000|Overall Study|Not evaluable|5|||
170724058|NCT02160314|616994336|FG000|Overall Study|Adverse Event|0|||
170832970|NCT00778921|617397043|FG000|Overall Study|Lost to Follow-up|0|||
170832971|NCT00778921|617397044|FG001|Overall Study|Lost to Follow-up|2|||
170832972|NCT00778921|617397045|FG002|Overall Study|Lost to Follow-up|1|||
170832973|NCT00778921|617397043|FG000|Overall Study|Administrative Problems|1|||
170832974|NCT00778921|617397044|FG001|Overall Study|Administrative Problems|2|||
170832975|NCT00778921|617397045|FG002|Overall Study|Administrative Problems|0|||
170832976|NCT00778921|617397043|FG000|Overall Study|Protocol Violation|3|||
170832977|NCT00778921|617397044|FG001|Overall Study|Protocol Violation|0|||
170832978|NCT00778921|617397045|FG002|Overall Study|Protocol Violation|2|||
170832979|NCT00778921|617397043|FG000|Overall Study|Not treated|0|||
170832980|NCT00778921|617397044|FG001|Overall Study|Not treated|2|||
170832981|NCT00778921|617397045|FG002|Overall Study|Not treated|2|||
170832982|NCT03178045|617397046|FG000|Overall Study|Withdrawal by Subject|5|||
170832983|NCT03178045|617397047|FG001|Overall Study|Withdrawal by Subject|7|||
170832984|NCT03178045|617397046|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
170832985|NCT03178045|617397047|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
170832986|NCT03178045|617397046|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
170832987|NCT03178045|617397047|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
170832988|NCT00572533|617397048|FG000|Overall Study|Death|4|||
170832989|NCT00572533|617397049|FG001|Overall Study|Death|1|||
170832990|NCT00572533|617397048|FG000|Overall Study|Received Kidney Transplant|2|||
170832991|NCT00572533|617397049|FG001|Overall Study|Received Kidney Transplant|1|||
170832992|NCT00572533|617397048|FG000|Overall Study|Social Issues|1|||
170832993|NCT00572533|617397049|FG001|Overall Study|Social Issues|0|||
170832994|NCT00572533|617397048|FG000|Overall Study|Transfer out of Facility|0|||
170832995|NCT00572533|617397049|FG001|Overall Study|Transfer out of Facility|1|||
170832996|NCT01078922|617397050|FG000|Overall Study|Adverse Event|1|||
170832997|NCT02353468|617397051|FG000|Overall Study|Study terminated|3|||
170832998|NCT00003477|617397053|FG000|Overall Study|Not evalauable|4|||
170832999|NCT00267098|617397054|FG000|Overall Study|Death|0|||
170833000|NCT00267098|617397055|FG001|Overall Study|Death|0|||
170833001|NCT00267098|617397056|FG002|Overall Study|Death|57|||
170833002|NCT00267098|617397057|FG003|Overall Study|Death|66|||
170833003|NCT00267098|617397058|FG004|Overall Study|Death|14|||
170833004|NCT00267098|617397059|FG005|Overall Study|Death|23|||
170833005|NCT00267098|617397060|FG006|Overall Study|Death|28|||
170833006|NCT00267098|617397061|FG007|Overall Study|Death|9|||
170833007|NCT00267098|617397054|FG000|Overall Study|Lost to Follow-up|0|||
170833008|NCT00267098|617397055|FG001|Overall Study|Lost to Follow-up|0|||
170833009|NCT00267098|617397056|FG002|Overall Study|Lost to Follow-up|6|||
170833010|NCT00267098|617397057|FG003|Overall Study|Lost to Follow-up|5|||
170833011|NCT00267098|617397058|FG004|Overall Study|Lost to Follow-up|2|||
170833012|NCT00267098|617397059|FG005|Overall Study|Lost to Follow-up|3|||
170833013|NCT00267098|617397060|FG006|Overall Study|Lost to Follow-up|1|||
170833014|NCT00267098|617397061|FG007|Overall Study|Lost to Follow-up|1|||
170833015|NCT00267098|617397054|FG000|Overall Study|Withdrawal by Subject|8|||
170833016|NCT00267098|617397055|FG001|Overall Study|Withdrawal by Subject|0|||
170833017|NCT00267098|617397056|FG002|Overall Study|Withdrawal by Subject|24|||
170833018|NCT00267098|617397057|FG003|Overall Study|Withdrawal by Subject|21|||
170833019|NCT00267098|617397058|FG004|Overall Study|Withdrawal by Subject|12|||
170833020|NCT00267098|617397059|FG005|Overall Study|Withdrawal by Subject|9|||
170833021|NCT00267098|617397060|FG006|Overall Study|Withdrawal by Subject|12|||
170833022|NCT00267098|617397061|FG007|Overall Study|Withdrawal by Subject|5|||
170833023|NCT00267098|617397054|FG000|Overall Study|Physician Decision|5|||
170833024|NCT00267098|617397055|FG001|Overall Study|Physician Decision|0|||
170833025|NCT00267098|617397056|FG002|Overall Study|Physician Decision|7|||
170833026|NCT00267098|617397057|FG003|Overall Study|Physician Decision|11|||
170833027|NCT00267098|617397058|FG004|Overall Study|Physician Decision|5|||
170833028|NCT00267098|617397059|FG005|Overall Study|Physician Decision|4|||
170833029|NCT00267098|617397060|FG006|Overall Study|Physician Decision|3|||
170833030|NCT00267098|617397061|FG007|Overall Study|Physician Decision|0|||
170833031|NCT00267098|617397054|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
170833032|NCT00267098|617397055|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170833033|NCT00267098|617397056|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170724059|NCT02160314|616994337|FG001|Overall Study|Adverse Event|6|||
170724060|NCT02160314|616994336|FG000|Overall Study|Protocol Violation|0|||
170724061|NCT02160314|616994337|FG001|Overall Study|Protocol Violation|4|||
170724062|NCT02160314|616994336|FG000|Overall Study|Withdrawal by Subject|1|||
170724063|NCT02160314|616994337|FG001|Overall Study|Withdrawal by Subject|2|||
170724064|NCT02160314|616994336|FG000|Overall Study|Lost to Follow-up|0|||
170724065|NCT02160314|616994337|FG001|Overall Study|Lost to Follow-up|1|||
170724066|NCT00593567|616994338|FG000|Overall Study|Adverse Event|2|||
170724067|NCT00593567|616994339|FG001|Overall Study|Adverse Event|0|||
170724068|NCT00593567|616994338|FG000|Overall Study|Physician Decision|2|||
170724069|NCT00593567|616994339|FG001|Overall Study|Physician Decision|0|||
170724070|NCT00593567|616994338|FG000|Overall Study|Protocol Violation|13|||
170724071|NCT00593567|616994339|FG001|Overall Study|Protocol Violation|7|||
170724072|NCT00593567|616994338|FG000|Overall Study|Lack of Efficacy|2|||
170724073|NCT00593567|616994339|FG001|Overall Study|Lack of Efficacy|1|||
170724074|NCT00593567|616994338|FG000|Overall Study|Withdrawal by Subject|1|||
170724075|NCT00593567|616994339|FG001|Overall Study|Withdrawal by Subject|2|||
170724076|NCT00785291|616994343|FG000|Overall Study|Never began treatment|8|||
170724077|NCT00785291|616994344|FG001|Overall Study|Never began treatment|4|||
170724078|NCT00785291|616994345|FG002|Overall Study|Never began treatment|4|||
170724079|NCT00785291|616994343|FG000|Overall Study|Adverse Event|39|||
170724080|NCT00785291|616994344|FG001|Overall Study|Adverse Event|70|||
170724081|NCT00785291|616994345|FG002|Overall Study|Adverse Event|56|||
170724082|NCT00785291|616994343|FG000|Overall Study|Death|7|||
170724083|NCT00785291|616994344|FG001|Overall Study|Death|4|||
170724084|NCT00785291|616994345|FG002|Overall Study|Death|3|||
170724085|NCT00785291|616994343|FG000|Overall Study|Withdrawal by Subject|35|||
170724086|NCT00785291|616994344|FG001|Overall Study|Withdrawal by Subject|36|||
170724087|NCT00785291|616994345|FG002|Overall Study|Withdrawal by Subject|17|||
170724088|NCT00785291|616994343|FG000|Overall Study|Alternative Therapy|12|||
170724089|NCT00785291|616994344|FG001|Overall Study|Alternative Therapy|6|||
170724090|NCT00785291|616994345|FG002|Overall Study|Alternative Therapy|7|||
170724091|NCT00785291|616994343|FG000|Overall Study|Complicating illness|6|||
170724092|NCT00785291|616994344|FG001|Overall Study|Complicating illness|4|||
170724093|NCT00785291|616994345|FG002|Overall Study|Complicating illness|4|||
170724094|NCT00785291|616994343|FG000|Overall Study|Other Medical Reasons|29|||
170724095|NCT00785291|616994344|FG001|Overall Study|Other Medical Reasons|25|||
170724096|NCT00785291|616994345|FG002|Overall Study|Other Medical Reasons|15|||
170724097|NCT02119260|616994346|FG000|Overall Study|Adverse Event|1|||
170724098|NCT02119260|616994347|FG001|Overall Study|Adverse Event|0|||
170724099|NCT02119260|616994348|FG002|Overall Study|Adverse Event|0|||
170724100|NCT02119260|616994349|FG003|Overall Study|Adverse Event|0|||
170724101|NCT02119260|616994350|FG004|Overall Study|Adverse Event|0|||
170724102|NCT02119260|616994351|FG005|Overall Study|Adverse Event|0|||
170724103|NCT02119260|616994352|FG006|Overall Study|Adverse Event|0|||
170724104|NCT02119260|616994346|FG000|Overall Study|Withdrew consent|0|||
170724105|NCT02119260|616994347|FG001|Overall Study|Withdrew consent|1|||
170724106|NCT02119260|616994348|FG002|Overall Study|Withdrew consent|1|||
170724107|NCT02119260|616994349|FG003|Overall Study|Withdrew consent|0|||
170724108|NCT02119260|616994350|FG004|Overall Study|Withdrew consent|0|||
170724109|NCT02119260|616994351|FG005|Overall Study|Withdrew consent|0|||
170724110|NCT02119260|616994352|FG006|Overall Study|Withdrew consent|0|||
170724111|NCT00920426|616994354|FG000|ITZ111451|Adverse Event|1|||
170724112|NCT00920426|616994355|FG001|ITZ111451|Adverse Event|0|||
170724113|NCT00920426|616994356|FG002|ITZ111451|Adverse Event|0|||
170724114|NCT00920426|616994357|FG003|ITZ111451|Adverse Event|0|||
170724115|NCT00886340|616994362|FG000|Overall Study|Withdrawal by Subject|0|||
170724116|NCT00886340|616994363|FG001|Overall Study|Withdrawal by Subject|7|||
170724117|NCT03224182|616994364|FG000|Overall Study|Study Drug Not Instilled|6|||
170724118|NCT03224182|616994365|FG001|Overall Study|Study Drug Not Instilled|1|||
170724119|NCT03224182|616994364|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
170724120|NCT03224182|616994365|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
170724121|NCT03224182|616994364|FG000|Overall Study|Withdrew of Consent|4|||
170724122|NCT03224182|616994365|FG001|Overall Study|Withdrew of Consent|2|||
170724123|NCT03224182|616994364|FG000|Overall Study|Investigator Decision|3|||
170724124|NCT03224182|616994365|FG001|Overall Study|Investigator Decision|1|||
170724125|NCT03224182|616994364|FG000|Overall Study|Sponsor Decision|26|||
170724126|NCT03224182|616994365|FG001|Overall Study|Sponsor Decision|12|||
170724127|NCT03224182|616994364|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
170724128|NCT03224182|616994365|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
170724129|NCT03224182|616994364|FG000|Overall Study|Lost to Follow-up|1|||
170833034|NCT00267098|617397057|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170833035|NCT00267098|617397058|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
170833036|NCT00267098|617397059|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170833037|NCT00267098|617397060|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170833038|NCT00267098|617397061|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170833039|NCT00267098|617397054|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
170833040|NCT00267098|617397055|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
170833041|NCT00267098|617397056|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
170833042|NCT00267098|617397057|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
170833043|NCT00267098|617397058|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
170833044|NCT00267098|617397059|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
170833045|NCT00267098|617397060|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
170833046|NCT00267098|617397061|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
170833047|NCT00267098|617397054|FG000|Overall Study|Site closure|0|||
170833048|NCT00267098|617397055|FG001|Overall Study|Site closure|0|||
170833049|NCT00267098|617397056|FG002|Overall Study|Site closure|0|||
170833050|NCT00267098|617397057|FG003|Overall Study|Site closure|1|||
170833051|NCT00267098|617397058|FG004|Overall Study|Site closure|0|||
170833052|NCT00267098|617397059|FG005|Overall Study|Site closure|1|||
170833053|NCT00267098|617397060|FG006|Overall Study|Site closure|1|||
170833054|NCT00267098|617397061|FG007|Overall Study|Site closure|0|||
170833055|NCT00267098|617397054|FG000|Overall Study|Explanted Medtronic device|0|||
170833056|NCT00267098|617397055|FG001|Overall Study|Explanted Medtronic device|0|||
170833057|NCT00267098|617397056|FG002|Overall Study|Explanted Medtronic device|0|||
170833058|NCT00267098|617397057|FG003|Overall Study|Explanted Medtronic device|1|||
170833059|NCT00267098|617397058|FG004|Overall Study|Explanted Medtronic device|0|||
170833060|NCT00267098|617397059|FG005|Overall Study|Explanted Medtronic device|0|||
170833061|NCT00267098|617397060|FG006|Overall Study|Explanted Medtronic device|0|||
170833062|NCT00267098|617397061|FG007|Overall Study|Explanted Medtronic device|0|||
170833063|NCT00267098|617397054|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
170833064|NCT00267098|617397055|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
170833065|NCT00267098|617397056|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
170833066|NCT00267098|617397057|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
170833067|NCT00267098|617397058|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
170833068|NCT00267098|617397059|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
170833069|NCT00267098|617397060|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
170833070|NCT00267098|617397061|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
170833071|NCT00267098|617397054|FG000|Overall Study|Subject listed for heart transplant|0|||
170833072|NCT00267098|617397055|FG001|Overall Study|Subject listed for heart transplant|0|||
170833073|NCT00267098|617397056|FG002|Overall Study|Subject listed for heart transplant|0|||
170833074|NCT00267098|617397057|FG003|Overall Study|Subject listed for heart transplant|0|||
170833075|NCT00267098|617397058|FG004|Overall Study|Subject listed for heart transplant|0|||
170833076|NCT00267098|617397059|FG005|Overall Study|Subject listed for heart transplant|0|||
170833077|NCT00267098|617397060|FG006|Overall Study|Subject listed for heart transplant|1|||
170833078|NCT00267098|617397061|FG007|Overall Study|Subject listed for heart transplant|0|||
170833079|NCT00267098|617397054|FG000|Overall Study|Sponsor withdrew subject|0|||
170833080|NCT00267098|617397055|FG001|Overall Study|Sponsor withdrew subject|0|||
170833081|NCT00267098|617397056|FG002|Overall Study|Sponsor withdrew subject|0|||
170833082|NCT00267098|617397057|FG003|Overall Study|Sponsor withdrew subject|1|||
170833083|NCT00267098|617397058|FG004|Overall Study|Sponsor withdrew subject|0|||
170833084|NCT00267098|617397059|FG005|Overall Study|Sponsor withdrew subject|0|||
170833085|NCT00267098|617397060|FG006|Overall Study|Sponsor withdrew subject|0|||
170833086|NCT00267098|617397061|FG007|Overall Study|Sponsor withdrew subject|0|||
170833087|NCT04211389|617397064|FG000|Overall Study|Adverse Event|1|||
170833088|NCT04211389|617397065|FG001|Overall Study|Adverse Event|2|||
170833089|NCT04211389|617397064|FG000|Overall Study|Lost to Follow-up|15|||
170833090|NCT04211389|617397065|FG001|Overall Study|Lost to Follow-up|7|||
170833091|NCT04211389|617397064|FG000|Overall Study|Protocol Violation|0|||
170833092|NCT04211389|617397065|FG001|Overall Study|Protocol Violation|1|||
170833093|NCT04211389|617397064|FG000|Overall Study|Withdrawal by Subject|10|||
170833094|NCT04211389|617397065|FG001|Overall Study|Withdrawal by Subject|11|||
170833095|NCT00547534|617397066|FG000|Overall Study|Adverse Event|7|||
170833096|NCT00547534|617397066|FG000|Overall Study|Disease Progression|4|||
170833097|NCT02168478|617397067|FG000|Overall Study|Withdrawal by Subject|1|||
170833098|NCT02168478|617397067|FG000|Overall Study|Did Not Consent to Participation|2|||
170833099|NCT02168478|617397067|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
170833100|NCT01062971|617397068|FG000|Overall Study|Protocol Violation|1|||
170833101|NCT01062971|617397069|FG001|Overall Study|Protocol Violation|3|||
170833102|NCT01062971|617397068|FG000|Overall Study|Lost to Follow-up|3|||
170724130|NCT03224182|616994365|FG001|Overall Study|Lost to Follow-up|0|||
170724131|NCT03224182|616994364|FG000|Overall Study|Participant Had Recurrence|11|||
170724132|NCT03224182|616994365|FG001|Overall Study|Participant Had Recurrence|5|||
170724133|NCT03224182|616994364|FG000|Overall Study|Death|0|||
170724134|NCT03224182|616994365|FG001|Overall Study|Death|1|||
170724135|NCT03224182|616994364|FG000|Overall Study|Reason not Specified|3|||
170724136|NCT03224182|616994365|FG001|Overall Study|Reason not Specified|3|||
170724137|NCT03224182|616994364|FG000|Overall Study|Other|1|||
170724138|NCT03224182|616994365|FG001|Overall Study|Other|0|||
170724139|NCT00360308|616994366|FG000|Overall Study|Adverse Event|15|||
170724140|NCT00360308|616994367|FG001|Overall Study|Adverse Event|14|||
170724141|NCT00360308|616994368|FG002|Overall Study|Adverse Event|25|||
170724142|NCT00360308|616994366|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
170724143|NCT00360308|616994367|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
170724144|NCT00360308|616994368|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
170724145|NCT00360308|616994366|FG000|Overall Study|Protocol Violation|2|||
170724146|NCT00360308|616994367|FG001|Overall Study|Protocol Violation|1|||
170724147|NCT00360308|616994368|FG002|Overall Study|Protocol Violation|2|||
170724148|NCT00360308|616994366|FG000|Overall Study|Withdrawal by Subject|11|||
170724149|NCT00360308|616994367|FG001|Overall Study|Withdrawal by Subject|7|||
170724150|NCT00360308|616994368|FG002|Overall Study|Withdrawal by Subject|14|||
170724151|NCT00360308|616994366|FG000|Overall Study|Lack of Efficacy|3|||
170724152|NCT00360308|616994367|FG001|Overall Study|Lack of Efficacy|0|||
170724153|NCT00360308|616994368|FG002|Overall Study|Lack of Efficacy|2|||
170724154|NCT00360308|616994366|FG000|Overall Study|Other|2|||
170724155|NCT00360308|616994367|FG001|Overall Study|Other|1|||
170724156|NCT00360308|616994368|FG002|Overall Study|Other|1|||
170724157|NCT00360308|616994366|FG000|Overall Study|Study termination by sponsor|43|||
170724158|NCT00360308|616994367|FG001|Overall Study|Study termination by sponsor|55|||
170724159|NCT00360308|616994368|FG002|Overall Study|Study termination by sponsor|44|||
170724160|NCT00464815|616994369|FG000|Overall Study|Withdrawal by Subject|6|||
170724161|NCT00464815|616994370|FG001|Overall Study|Withdrawal by Subject|3|||
170724162|NCT05554237|616994371|FG000|Part 2 (7 Days)|Adverse Event|0|||
170724163|NCT05554237|616994372|FG001|Part 2 (7 Days)|Adverse Event|0|||
170724164|NCT05554237|616994373|FG002|Part 2 (7 Days)|Adverse Event|0|||
170724165|NCT05554237|616994374|FG003|Part 2 (7 Days)|Adverse Event|0|||
170724166|NCT05554237|616994375|FG004|Part 2 (7 Days)|Adverse Event|2|||
170724167|NCT05554237|616994376|FG005|Part 2 (7 Days)|Adverse Event|0|||
170724168|NCT05554237|616994377|FG006|Part 2 (7 Days)|Adverse Event|0|||
170724169|NCT05554237|616994378|FG007|Part 2 (7 Days)|Adverse Event|0|||
170724170|NCT05554237|616994379|FG008|Part 2 (7 Days)|Adverse Event|0|||
170724171|NCT05554237|616994380|FG009|Part 2 (7 Days)|Adverse Event|1|||
170724172|NCT05554237|616994381|FG010|Part 2 (7 Days)|Adverse Event|0|||
170724173|NCT05554237|616994382|FG011|Part 2 (7 Days)|Adverse Event|0|||
170724174|NCT05554237|616994383|FG012|Part 2 (7 Days)|Adverse Event|1|||
170724175|NCT05554237|616994384|FG013|Part 2 (7 Days)|Adverse Event|0|||
170724176|NCT06116591|616994385|FG000|Overall Study|No longer met eligibility criteria|0|||
170724177|NCT06116591|616994386|FG001|Overall Study|No longer met eligibility criteria|1|||
170724178|NCT06116591|616994385|FG000|Overall Study|Other: Change in life situation|0|||
170724179|NCT06116591|616994386|FG001|Overall Study|Other: Change in life situation|1|||
170724180|NCT03644186|616994387|FG000|Overall Study|Withdrawal by Subject|1|||
170724181|NCT03644186|616994388|FG001|Overall Study|Withdrawal by Subject|1|||
170724182|NCT01715805|616994393|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
170724183|NCT01715805|616994394|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
170724184|NCT01715805|616994395|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
170724185|NCT01715805|616994396|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
170724186|NCT01715805|616994393|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
170724187|NCT01715805|616994394|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
170724188|NCT01715805|616994395|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
170724189|NCT01715805|616994396|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
170724190|NCT01715805|616994393|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
170724191|NCT01715805|616994394|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
170724192|NCT01715805|616994395|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
170724193|NCT01715805|616994396|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
170724194|NCT01715805|616994393|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
170724195|NCT01715805|616994394|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
170724196|NCT01715805|616994395|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
170724197|NCT01715805|616994396|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
170724198|NCT01715805|616994393|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
170833103|NCT01062971|617397069|FG001|Overall Study|Lost to Follow-up|4|||
170833104|NCT01087814|617397070|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
170833105|NCT01087814|617397071|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
170833106|NCT01087814|617397070|FG000|Second Intervention (5 Days)|Physician Decision|1|||
170833107|NCT01087814|617397071|FG001|Second Intervention (5 Days)|Physician Decision|0|||
170833108|NCT01427738|617397072|FG000|Overall Study|Death|12|||
170833109|NCT01427738|617397073|FG001|Overall Study|Death|9|||
170833110|NCT01427738|617397072|FG000|Overall Study|Severe debilitation, unable to continue|0|||
170833111|NCT01427738|617397073|FG001|Overall Study|Severe debilitation, unable to continue|1|||
170833112|NCT01427738|617397072|FG000|Overall Study|Subject unable to get to clinic|5|||
170833113|NCT01427738|617397073|FG001|Overall Study|Subject unable to get to clinic|2|||
170833114|NCT01427738|617397072|FG000|Overall Study|Withdrawal by Subject|0|||
170833115|NCT01427738|617397073|FG001|Overall Study|Withdrawal by Subject|2|||
170833116|NCT01427738|617397072|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
170833117|NCT01427738|617397073|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
170833118|NCT01427738|617397072|FG000|Overall Study|Lost to Follow-up|1|||
170833119|NCT01427738|617397073|FG001|Overall Study|Lost to Follow-up|5|||
170833120|NCT00661713|617397074|FG000|Overall Study|Death|1|||
170833121|NCT00661713|617397075|FG001|Overall Study|Death|0|||
170833122|NCT00661713|617397076|FG002|Overall Study|Death|0|||
170833123|NCT00661713|617397077|FG003|Overall Study|Death|0|||
170833124|NCT00661713|617397078|FG004|Overall Study|Death|1|||
170833125|NCT00661713|617397079|FG005|Overall Study|Death|0|||
170833126|NCT00661713|617397080|FG006|Overall Study|Death|0|||
170833127|NCT00661713|617397081|FG007|Overall Study|Death|0|||
170833128|NCT00661713|617397074|FG000|Overall Study|Unable to Classify|1|||
170833129|NCT00661713|617397075|FG001|Overall Study|Unable to Classify|0|||
170833130|NCT00661713|617397076|FG002|Overall Study|Unable to Classify|0|||
170833131|NCT00661713|617397077|FG003|Overall Study|Unable to Classify|0|||
170833132|NCT00661713|617397078|FG004|Overall Study|Unable to Classify|0|||
170833133|NCT00661713|617397079|FG005|Overall Study|Unable to Classify|0|||
170833134|NCT00661713|617397080|FG006|Overall Study|Unable to Classify|0|||
170833135|NCT00661713|617397081|FG007|Overall Study|Unable to Classify|0|||
170833136|NCT00661713|617397074|FG000|Overall Study|Protocol Violation|1|||
170833137|NCT00661713|617397075|FG001|Overall Study|Protocol Violation|6|||
170833138|NCT00661713|617397076|FG002|Overall Study|Protocol Violation|3|||
170833139|NCT00661713|617397077|FG003|Overall Study|Protocol Violation|3|||
170833140|NCT00661713|617397078|FG004|Overall Study|Protocol Violation|0|||
170833141|NCT00661713|617397079|FG005|Overall Study|Protocol Violation|2|||
170833142|NCT00661713|617397080|FG006|Overall Study|Protocol Violation|2|||
170833143|NCT00661713|617397081|FG007|Overall Study|Protocol Violation|1|||
170833144|NCT00661713|617397074|FG000|Overall Study|Withdrawal by Subject|11|||
170833145|NCT00661713|617397075|FG001|Overall Study|Withdrawal by Subject|25|||
170833146|NCT00661713|617397076|FG002|Overall Study|Withdrawal by Subject|12|||
170833147|NCT00661713|617397077|FG003|Overall Study|Withdrawal by Subject|21|||
170833148|NCT00661713|617397078|FG004|Overall Study|Withdrawal by Subject|12|||
170833149|NCT00661713|617397079|FG005|Overall Study|Withdrawal by Subject|26|||
170833150|NCT00661713|617397080|FG006|Overall Study|Withdrawal by Subject|45|||
170833151|NCT00661713|617397081|FG007|Overall Study|Withdrawal by Subject|9|||
170833152|NCT00661713|617397074|FG000|Overall Study|Lost to Follow-up|2|||
170833153|NCT00661713|617397075|FG001|Overall Study|Lost to Follow-up|7|||
170833154|NCT00661713|617397076|FG002|Overall Study|Lost to Follow-up|2|||
170833155|NCT00661713|617397077|FG003|Overall Study|Lost to Follow-up|2|||
170833156|NCT00661713|617397078|FG004|Overall Study|Lost to Follow-up|5|||
170833157|NCT00661713|617397079|FG005|Overall Study|Lost to Follow-up|7|||
170833158|NCT00661713|617397080|FG006|Overall Study|Lost to Follow-up|14|||
170833159|NCT00661713|617397081|FG007|Overall Study|Lost to Follow-up|1|||
170833160|NCT00661713|617397074|FG000|Overall Study|Administrative Reason|0|||
170833161|NCT00661713|617397075|FG001|Overall Study|Administrative Reason|1|||
170833162|NCT00661713|617397076|FG002|Overall Study|Administrative Reason|0|||
170833163|NCT00661713|617397077|FG003|Overall Study|Administrative Reason|2|||
170833164|NCT00661713|617397078|FG004|Overall Study|Administrative Reason|2|||
170833165|NCT00661713|617397079|FG005|Overall Study|Administrative Reason|2|||
170833166|NCT00661713|617397080|FG006|Overall Study|Administrative Reason|1|||
170833167|NCT00661713|617397081|FG007|Overall Study|Administrative Reason|0|||
170833168|NCT00661713|617397074|FG000|Overall Study|Adverse Event|0|||
170833169|NCT00661713|617397075|FG001|Overall Study|Adverse Event|0|||
170833170|NCT00661713|617397076|FG002|Overall Study|Adverse Event|0|||
170833171|NCT00661713|617397077|FG003|Overall Study|Adverse Event|0|||
170833172|NCT00661713|617397078|FG004|Overall Study|Adverse Event|0|||
170724199|NCT01715805|616994394|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
170724200|NCT01715805|616994395|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
170724201|NCT01715805|616994396|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
170724202|NCT01715805|616994393|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
170724203|NCT01715805|616994394|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
170724204|NCT01715805|616994395|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
170724205|NCT01715805|616994396|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
170724206|NCT01715805|616994393|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
170724207|NCT01715805|616994394|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
170724208|NCT01715805|616994395|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
170833173|NCT00661713|617397079|FG005|Overall Study|Adverse Event|0|||
170833174|NCT00661713|617397080|FG006|Overall Study|Adverse Event|1|||
170833175|NCT00661713|617397081|FG007|Overall Study|Adverse Event|0|||
170833176|NCT00661713|617397074|FG000|Overall Study|Inappropriate Enrollment|0|||
170833177|NCT00661713|617397075|FG001|Overall Study|Inappropriate Enrollment|0|||
170833178|NCT00661713|617397076|FG002|Overall Study|Inappropriate Enrollment|0|||
170833179|NCT00661713|617397077|FG003|Overall Study|Inappropriate Enrollment|0|||
170833180|NCT00661713|617397078|FG004|Overall Study|Inappropriate Enrollment|0|||
170833181|NCT00661713|617397079|FG005|Overall Study|Inappropriate Enrollment|0|||
170833182|NCT00661713|617397080|FG006|Overall Study|Inappropriate Enrollment|1|||
170833183|NCT00661713|617397081|FG007|Overall Study|Inappropriate Enrollment|0|||
170833184|NCT03156114|617397082|FG000|Overall Study|Other than listed|0|||
170833185|NCT03156114|617397083|FG001|Overall Study|Other than listed|0|||
170833186|NCT03156114|617397084|FG002|Overall Study|Other than listed|0|||
170833187|NCT03156114|617397085|FG003|Overall Study|Other than listed|0|||
170833188|NCT03156114|617397086|FG004|Overall Study|Other than listed|0|||
170833189|NCT03156114|617397087|FG005|Overall Study|Other than listed|0|||
170833190|NCT03156114|617397088|FG006|Overall Study|Other than listed|0|||
170833191|NCT03156114|617397089|FG007|Overall Study|Other than listed|0|||
170833192|NCT03156114|617397090|FG008|Overall Study|Other than listed|0|||
170833193|NCT03156114|617397091|FG009|Overall Study|Other than listed|1|||
170833194|NCT03156114|617397092|FG010|Overall Study|Other than listed|1|||
170833195|NCT03156114|617397082|FG000|Overall Study|Subject decision|0|||
170833196|NCT03156114|617397083|FG001|Overall Study|Subject decision|0|||
170833197|NCT03156114|617397084|FG002|Overall Study|Subject decision|0|||
170833198|NCT03156114|617397085|FG003|Overall Study|Subject decision|0|||
170833199|NCT03156114|617397086|FG004|Overall Study|Subject decision|0|||
170833200|NCT03156114|617397087|FG005|Overall Study|Subject decision|0|||
170833201|NCT03156114|617397088|FG006|Overall Study|Subject decision|0|||
170833202|NCT03156114|617397089|FG007|Overall Study|Subject decision|1|||
170833203|NCT03156114|617397090|FG008|Overall Study|Subject decision|1|||
170833204|NCT03156114|617397091|FG009|Overall Study|Subject decision|3|||
170833205|NCT03156114|617397092|FG010|Overall Study|Subject decision|1|||
170833206|NCT03156114|617397082|FG000|Overall Study|Physician Decision|0|||
170833207|NCT03156114|617397083|FG001|Overall Study|Physician Decision|0|||
170833208|NCT03156114|617397084|FG002|Overall Study|Physician Decision|0|||
170833209|NCT03156114|617397085|FG003|Overall Study|Physician Decision|1|||
170724209|NCT01715805|616994396|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
170724210|NCT01715805|616994393|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
170724211|NCT01715805|616994394|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
170724212|NCT01715805|616994395|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
170724213|NCT01715805|616994396|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
170724214|NCT01715805|616994393|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
170724215|NCT01715805|616994394|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
170724216|NCT01715805|616994395|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
170724217|NCT01715805|616994396|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
170724218|NCT01715805|616994393|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
170724219|NCT01715805|616994394|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
170724220|NCT01715805|616994395|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
170724221|NCT01715805|616994396|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
170724222|NCT01715805|616994393|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
170724223|NCT01715805|616994394|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
170724224|NCT01715805|616994395|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
170724225|NCT01715805|616994396|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
170724226|NCT01715805|616994393|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
170724227|NCT01715805|616994394|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
170724228|NCT01715805|616994395|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
170724229|NCT01715805|616994396|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
170724230|NCT01715805|616994393|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
170724231|NCT01715805|616994394|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
170724232|NCT01715805|616994395|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
170724233|NCT01715805|616994396|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
170724234|NCT01715805|616994393|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
170724235|NCT01715805|616994394|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
170724236|NCT01715805|616994395|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
170724237|NCT01715805|616994396|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
170724238|NCT04009291|616994398|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
170724239|NCT04009291|616994399|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
170724240|NCT04009291|616994400|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
170724241|NCT04009291|616994401|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
170724242|NCT04009291|616994402|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
170724243|NCT04009291|616994398|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
170724244|NCT04009291|616994399|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
170724245|NCT04009291|616994400|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
170724246|NCT04009291|616994401|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
170724247|NCT04009291|616994402|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
170724248|NCT00492284|616994408|FG000|Overall Study|Adverse Event|0|||
170724249|NCT00492284|616994409|FG001|Overall Study|Adverse Event|1|||
170724250|NCT00492284|616994410|FG002|Overall Study|Adverse Event|1|||
170724251|NCT00492284|616994411|FG003|Overall Study|Adverse Event|2|||
170724252|NCT00492284|616994408|FG000|Overall Study|Lost to Follow-up|0|||
170724253|NCT00492284|616994409|FG001|Overall Study|Lost to Follow-up|0|||
170724254|NCT00492284|616994410|FG002|Overall Study|Lost to Follow-up|3|||
170724255|NCT00492284|616994411|FG003|Overall Study|Lost to Follow-up|1|||
170724256|NCT00492284|616994408|FG000|Overall Study|Death|0|||
170724257|NCT00492284|616994409|FG001|Overall Study|Death|3|||
170724258|NCT00492284|616994410|FG002|Overall Study|Death|2|||
170724259|NCT00492284|616994411|FG003|Overall Study|Death|5|||
170724260|NCT00492284|616994408|FG000|Overall Study|Withdrawal by Subject|1|||
170724261|NCT00492284|616994409|FG001|Overall Study|Withdrawal by Subject|0|||
170724262|NCT00492284|616994410|FG002|Overall Study|Withdrawal by Subject|0|||
170724263|NCT00492284|616994411|FG003|Overall Study|Withdrawal by Subject|2|||
170724264|NCT00688636|616994414|FG000|Overall Study|Adverse Event|2|||
170724265|NCT00688636|616994415|FG001|Overall Study|Adverse Event|1|||
170724266|NCT01572727|616994416|FG000|Overall Study|Adverse Event|43|||
170724267|NCT01572727|616994417|FG001|Overall Study|Adverse Event|15|||
170724268|NCT01572727|616994416|FG000|Overall Study|Lost to Follow-up|1|||
170724269|NCT01572727|616994417|FG001|Overall Study|Lost to Follow-up|1|||
170724270|NCT01572727|616994416|FG000|Overall Study|Physician Decision|23|||
170724271|NCT01572727|616994417|FG001|Overall Study|Physician Decision|9|||
170724272|NCT01572727|616994416|FG000|Overall Study|Progressive disease|59|||
170724273|NCT01572727|616994417|FG001|Overall Study|Progressive disease|82|||
170724274|NCT01572727|616994416|FG000|Overall Study|Protocol Violation|0|||
170724275|NCT01572727|616994417|FG001|Overall Study|Protocol Violation|1|||
170724276|NCT01572727|616994416|FG000|Overall Study|Study terminated by sponsor|61|||
170724277|NCT01572727|616994417|FG001|Overall Study|Study terminated by sponsor|83|||
170724278|NCT01572727|616994416|FG000|Overall Study|Parent/guardian decision|14|||
170724279|NCT01572727|616994417|FG001|Overall Study|Parent/guardian decision|9|||
170833210|NCT03156114|617397086|FG004|Overall Study|Physician Decision|1|||
170833211|NCT03156114|617397087|FG005|Overall Study|Physician Decision|0|||
170833212|NCT03156114|617397088|FG006|Overall Study|Physician Decision|0|||
170833213|NCT03156114|617397089|FG007|Overall Study|Physician Decision|0|||
170833214|NCT03156114|617397090|FG008|Overall Study|Physician Decision|1|||
170833215|NCT03156114|617397091|FG009|Overall Study|Physician Decision|1|||
170833216|NCT03156114|617397092|FG010|Overall Study|Physician Decision|2|||
170833217|NCT03156114|617397082|FG000|Overall Study|Non-compliant with study drug|0|||
170833218|NCT03156114|617397083|FG001|Overall Study|Non-compliant with study drug|0|||
170833219|NCT03156114|617397084|FG002|Overall Study|Non-compliant with study drug|0|||
170833220|NCT03156114|617397085|FG003|Overall Study|Non-compliant with study drug|1|||
170833221|NCT03156114|617397086|FG004|Overall Study|Non-compliant with study drug|0|||
170833222|NCT03156114|617397087|FG005|Overall Study|Non-compliant with study drug|0|||
170833223|NCT03156114|617397088|FG006|Overall Study|Non-compliant with study drug|0|||
170833224|NCT03156114|617397089|FG007|Overall Study|Non-compliant with study drug|0|||
170833225|NCT03156114|617397090|FG008|Overall Study|Non-compliant with study drug|0|||
170833226|NCT03156114|617397091|FG009|Overall Study|Non-compliant with study drug|0|||
170833227|NCT03156114|617397092|FG010|Overall Study|Non-compliant with study drug|0|||
170833228|NCT03156114|617397082|FG000|Overall Study|Death|0|||
170833229|NCT03156114|617397083|FG001|Overall Study|Death|0|||
170833230|NCT03156114|617397084|FG002|Overall Study|Death|0|||
170833231|NCT03156114|617397085|FG003|Overall Study|Death|0|||
170833232|NCT03156114|617397086|FG004|Overall Study|Death|0|||
170833233|NCT03156114|617397087|FG005|Overall Study|Death|0|||
170833234|NCT03156114|617397088|FG006|Overall Study|Death|0|||
170833235|NCT03156114|617397089|FG007|Overall Study|Death|0|||
170833236|NCT03156114|617397090|FG008|Overall Study|Death|0|||
170833237|NCT03156114|617397091|FG009|Overall Study|Death|0|||
170833238|NCT03156114|617397092|FG010|Overall Study|Death|1|||
170833239|NCT03156114|617397082|FG000|Overall Study|Adverse Event|0|||
170833240|NCT03156114|617397083|FG001|Overall Study|Adverse Event|1|||
170833241|NCT03156114|617397084|FG002|Overall Study|Adverse Event|1|||
170833242|NCT03156114|617397085|FG003|Overall Study|Adverse Event|2|||
170833243|NCT03156114|617397086|FG004|Overall Study|Adverse Event|0|||
170833244|NCT03156114|617397087|FG005|Overall Study|Adverse Event|3|||
170833245|NCT03156114|617397088|FG006|Overall Study|Adverse Event|1|||
170833246|NCT03156114|617397089|FG007|Overall Study|Adverse Event|3|||
170833247|NCT03156114|617397090|FG008|Overall Study|Adverse Event|7|||
170833248|NCT03156114|617397091|FG009|Overall Study|Adverse Event|5|||
170833249|NCT03156114|617397092|FG010|Overall Study|Adverse Event|4|||
170833250|NCT03156114|617397082|FG000|Overall Study|Progressive disease|4|||
170833251|NCT03156114|617397083|FG001|Overall Study|Progressive disease|8|||
170833252|NCT03156114|617397084|FG002|Overall Study|Progressive disease|8|||
170833253|NCT03156114|617397085|FG003|Overall Study|Progressive disease|5|||
170833254|NCT03156114|617397086|FG004|Overall Study|Progressive disease|8|||
170833255|NCT03156114|617397087|FG005|Overall Study|Progressive disease|6|||
170833256|NCT03156114|617397088|FG006|Overall Study|Progressive disease|5|||
170833257|NCT03156114|617397089|FG007|Overall Study|Progressive disease|17|||
170833258|NCT03156114|617397090|FG008|Overall Study|Progressive disease|31|||
170833259|NCT03156114|617397091|FG009|Overall Study|Progressive disease|27|||
170833260|NCT03156114|617397092|FG010|Overall Study|Progressive disease|7|||
170833261|NCT03156114|617397082|FG000|Overall Study|Currently on treatment|0|||
170833262|NCT03156114|617397083|FG001|Overall Study|Currently on treatment|0|||
170833263|NCT03156114|617397084|FG002|Overall Study|Currently on treatment|0|||
170833264|NCT03156114|617397085|FG003|Overall Study|Currently on treatment|0|||
170833265|NCT03156114|617397086|FG004|Overall Study|Currently on treatment|0|||
170833266|NCT03156114|617397087|FG005|Overall Study|Currently on treatment|0|||
170833267|NCT03156114|617397088|FG006|Overall Study|Currently on treatment|0|||
170833268|NCT03156114|617397089|FG007|Overall Study|Currently on treatment|0|||
170833269|NCT03156114|617397090|FG008|Overall Study|Currently on treatment|0|||
170833270|NCT03156114|617397091|FG009|Overall Study|Currently on treatment|2|||
170833271|NCT03156114|617397092|FG010|Overall Study|Currently on treatment|1|||
170833272|NCT02650466|617397093|FG000|Overall Study|Physician Decision|1|||
170833273|NCT02650466|617397093|FG000|Overall Study|Withdrawal by Subject|5|||
170833274|NCT02650466|617397093|FG000|Overall Study|Lost to Follow-up|1|||
170833275|NCT03561597|617397094|FG000|Overall Study|Lost to Follow-up|20|||
170833276|NCT00573651|617397095|FG000|Overall Study|Lost to Follow-up|3|||
170833277|NCT00573651|617397095|FG000|Overall Study|Withdrawal by Subject|1|||
170833278|NCT00443599|617397096|FG000|Overall Study|Physician Decision|2|||
170833279|NCT00443599|617397097|FG001|Overall Study|Physician Decision|1|||
170833280|NCT00443599|617397096|FG000|Overall Study|Death|1|||
170833281|NCT00443599|617397097|FG001|Overall Study|Death|1|||
170833282|NCT00443599|617397096|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
170833283|NCT00443599|617397097|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
170833284|NCT03049306|617397100|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
170833285|NCT03049306|617397101|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
170833286|NCT05093504|617397102|FG000|Overall Study|Death|0|||
170833287|NCT05093504|617397103|FG001|Overall Study|Death|1|||
170833288|NCT03151551|617397104|FG000|Open-Label Treatment Period|Adverse Event|0|||
170833289|NCT03151551|617397105|FG001|Open-Label Treatment Period|Adverse Event|2|||
170833290|NCT03151551|617397104|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
170833291|NCT03151551|617397105|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
170833292|NCT03151551|617397104|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
170833293|NCT03151551|617397105|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
170833294|NCT03151551|617397104|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
170833295|NCT03151551|617397105|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
170833296|NCT03151551|617397104|FG000|Open-Label Treatment Period|Physician Decision|3|||
170833297|NCT03151551|617397105|FG001|Open-Label Treatment Period|Physician Decision|0|||
170833298|NCT03151551|617397104|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
170833299|NCT03151551|617397105|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
170833300|NCT03151551|617397104|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
170833301|NCT03151551|617397105|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
170833302|NCT03151551|617397104|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
170833303|NCT03151551|617397105|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
170833304|NCT03151551|617397104|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
170833305|NCT03151551|617397105|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
170833306|NCT03151551|617397104|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
170833307|NCT03151551|617397105|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
170833308|NCT05347485|617397107|FG000|Overall Study|Death|14|||
170833309|NCT05347485|617397107|FG000|Overall Study|Lost to Follow-up|2|||
170833310|NCT05347485|617397107|FG000|Overall Study|Withdrawal by Subject|13|||
170833311|NCT05347485|617397107|FG000|Overall Study|Progressive Disease|1|||
170833312|NCT05347485|617397107|FG000|Overall Study|Study Terminated by Sponsor|49|||
170833313|NCT05347485|617397107|FG000|Overall Study|Other|1|||
170833314|NCT05347485|617397107|FG000|Overall Study|Enrolled (consented) but not treated|4|||
170833315|NCT05347485|617397107|FG000|Overall Study|Disease Relapse|2|||
170833316|NCT05896696|617397108|FG000|Overall Study|Screening Failure|7|||
170833317|NCT05896696|617397108|FG000|Overall Study|Withdrawal by Subject|2|||
170833318|NCT04021043|617398502|FG000|Overall Study|Adverse Event|3|||
170833319|NCT04021043|617398503|FG001|Overall Study|Adverse Event|1|||
170833320|NCT04021043|617398504|FG002|Overall Study|Adverse Event|1|||
170833321|NCT04021043|617398505|FG003|Overall Study|Adverse Event|0|||
170833322|NCT04021043|617398502|FG000|Overall Study|Death|2|||
170833323|NCT04021043|617398503|FG001|Overall Study|Death|3|||
170833324|NCT04021043|617398504|FG002|Overall Study|Death|1|||
170833325|NCT04021043|617398505|FG003|Overall Study|Death|3|||
170833326|NCT04021043|617398502|FG000|Overall Study|Withdrawal by Subject|1|||
170833327|NCT04021043|617398503|FG001|Overall Study|Withdrawal by Subject|1|||
170833328|NCT04021043|617398504|FG002|Overall Study|Withdrawal by Subject|1|||
170833329|NCT04021043|617398505|FG003|Overall Study|Withdrawal by Subject|6|||
170833330|NCT04021043|617398502|FG000|Overall Study|Discontinued due to disease progression|4|||
170833331|NCT04021043|617398503|FG001|Overall Study|Discontinued due to disease progression|5|||
170833332|NCT04021043|617398504|FG002|Overall Study|Discontinued due to disease progression|7|||
170833333|NCT04021043|617398505|FG003|Overall Study|Discontinued due to disease progression|10|||
170833334|NCT00826228|617398506|FG000|Overall Study|Withdrawal by Subject|1|||
170833335|NCT03526679|617398507|FG000|Overall Study|still under treatment|2|||
170833336|NCT01246999|617398508|FG000|Overall Study|Lost to Follow-up|0|||
170833337|NCT01246999|617398509|FG001|Overall Study|Lost to Follow-up|1|||
170833338|NCT01246999|617398510|FG002|Overall Study|Lost to Follow-up|0|||
170833339|NCT01246999|617398511|FG003|Overall Study|Lost to Follow-up|0|||
170833340|NCT01246999|617398508|FG000|Overall Study|Withdrawal by Subject|0|||
170833341|NCT01246999|617398509|FG001|Overall Study|Withdrawal by Subject|0|||
170833342|NCT01246999|617398510|FG002|Overall Study|Withdrawal by Subject|0|||
170833343|NCT01246999|617398511|FG003|Overall Study|Withdrawal by Subject|2|||
170833344|NCT03616964|617398512|FG000|Overall Study|Adverse Event|15|||
170833345|NCT03616964|617398513|FG001|Overall Study|Adverse Event|10|||
170833346|NCT03616964|617398514|FG002|Overall Study|Adverse Event|16|||
170833347|NCT03616964|617398512|FG000|Overall Study|Death|3|||
170833348|NCT03616964|617398513|FG001|Overall Study|Death|0|||
170833349|NCT03616964|617398514|FG002|Overall Study|Death|4|||
170833350|NCT03616964|617398512|FG000|Overall Study|Lack of Efficacy|4|||
170833351|NCT03616964|617398513|FG001|Overall Study|Lack of Efficacy|8|||
170833352|NCT03616964|617398514|FG002|Overall Study|Lack of Efficacy|8|||
170833353|NCT03616964|617398512|FG000|Overall Study|Lost to Follow-up|2|||
170833354|NCT03616964|617398513|FG001|Overall Study|Lost to Follow-up|1|||
170833355|NCT03616964|617398514|FG002|Overall Study|Lost to Follow-up|3|||
170833356|NCT03616964|617398512|FG000|Overall Study|Withdrawal by Subject|18|||
170833357|NCT03616964|617398513|FG001|Overall Study|Withdrawal by Subject|14|||
170833358|NCT03616964|617398514|FG002|Overall Study|Withdrawal by Subject|21|||
170833359|NCT03616964|617398512|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
170833360|NCT03616964|617398513|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
170833361|NCT03616964|617398514|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
170833362|NCT03616964|617398512|FG000|Overall Study|Sponsor's Decision|1|||
170833363|NCT03616964|617398513|FG001|Overall Study|Sponsor's Decision|0|||
170833364|NCT03616964|617398514|FG002|Overall Study|Sponsor's Decision|0|||
170833365|NCT03616964|617398512|FG000|Overall Study|Physician Decision|0|||
170833366|NCT03616964|617398513|FG001|Overall Study|Physician Decision|2|||
170833367|NCT03616964|617398514|FG002|Overall Study|Physician Decision|0|||
170833368|NCT03616964|617398512|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
170833369|NCT03616964|617398513|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
170833370|NCT03616964|617398514|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
170833371|NCT03616964|617398512|FG000|Overall Study|Protocol Violation|0|||
170833372|NCT03616964|617398513|FG001|Overall Study|Protocol Violation|1|||
170833373|NCT03616964|617398514|FG002|Overall Study|Protocol Violation|0|||
170833374|NCT03616964|617398512|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
170833375|NCT03616964|617398513|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
170833376|NCT03616964|617398514|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
170833377|NCT03616964|617398512|FG000|Overall Study|Randomized but Never Treated|1|||
170833378|NCT03616964|617398513|FG001|Overall Study|Randomized but Never Treated|1|||
170833379|NCT03616964|617398514|FG002|Overall Study|Randomized but Never Treated|1|||
170833380|NCT01434680|617398515|FG000|Overall Study|Withdrawal by Subject|1|||
170833381|NCT01434680|617398516|FG001|Overall Study|Withdrawal by Subject|0|||
170833382|NCT01434680|617398517|FG002|Overall Study|Withdrawal by Subject|2|||
170833383|NCT01434680|617398518|FG003|Overall Study|Withdrawal by Subject|0|||
170833384|NCT01434680|617398515|FG000|Overall Study|Lost to Follow-up|1|||
170833385|NCT01434680|617398516|FG001|Overall Study|Lost to Follow-up|1|||
170833386|NCT01434680|617398517|FG002|Overall Study|Lost to Follow-up|0|||
170833387|NCT01434680|617398518|FG003|Overall Study|Lost to Follow-up|0|||
170833388|NCT01434680|617398515|FG000|Overall Study|Protocol Violation|1|||
170833389|NCT01434680|617398516|FG001|Overall Study|Protocol Violation|1|||
170833390|NCT01434680|617398517|FG002|Overall Study|Protocol Violation|0|||
170833391|NCT01434680|617398518|FG003|Overall Study|Protocol Violation|0|||
170833392|NCT01367847|617398520|FG000|Overall Study|Withdrawal by Subject|2|||
170833393|NCT01367847|617398521|FG001|Overall Study|Withdrawal by Subject|2|||
170833394|NCT02635360|617398522|FG000|Overall Study|Adverse Event|0|||
170833395|NCT02635360|617398523|FG001|Overall Study|Adverse Event|3|||
170833396|NCT02635360|617398522|FG000|Overall Study|Withdrawal by Subject|2|||
170833397|NCT02635360|617398523|FG001|Overall Study|Withdrawal by Subject|0|||
170833398|NCT02635360|617398522|FG000|Overall Study|Non-Compliance|3|||
170833399|NCT02635360|617398523|FG001|Overall Study|Non-Compliance|1|||
170833400|NCT02635360|617398522|FG000|Overall Study|Disease Progression|0|||
170833401|NCT02635360|617398523|FG001|Overall Study|Disease Progression|2|||
170833402|NCT02635360|617398522|FG000|Overall Study|Lost to Follow-up|1|||
170833403|NCT02635360|617398523|FG001|Overall Study|Lost to Follow-up|1|||
170833404|NCT05765344|617398524|FG000|Overall Study|Protocol Violation|1|||
170833405|NCT05765344|617398525|FG001|Overall Study|Protocol Violation|1|||
170833406|NCT05765344|617398526|FG002|Overall Study|Protocol Violation|0|||
170833407|NCT05765344|617398527|FG003|Overall Study|Protocol Violation|0|||
170833408|NCT05765344|617398528|FG004|Overall Study|Protocol Violation|0|||
170833409|NCT05765344|617398529|FG005|Overall Study|Protocol Violation|0|||
170833410|NCT05765344|617398530|FG006|Overall Study|Protocol Violation|0|||
170833411|NCT05765344|617398531|FG007|Overall Study|Protocol Violation|0|||
170833412|NCT04978350|617398532|FG000|Overall Study|Lost to Follow-up|6|||
170833413|NCT00334542|617398533|FG000|Overall Study|Adverse Event|3|||
170833414|NCT00334542|617398533|FG000|Overall Study|Withdrawal by Subject|1|||
170833415|NCT00334542|617398533|FG000|Overall Study|New cancer diagnosis|1|||
170833416|NCT02577003|617398534|FG000|Overall Study|Adverse Event|2|||
170833417|NCT02577003|617398535|FG001|Overall Study|Adverse Event|4|||
170833418|NCT02577003|617398534|FG000|Overall Study|Withdrawal by Subject|0|||
170833419|NCT02577003|617398535|FG001|Overall Study|Withdrawal by Subject|1|||
170833420|NCT02786004|617398536|FG000|Overall Study|Withdrawal by Subject|0|||
170833421|NCT02786004|617398537|FG001|Overall Study|Withdrawal by Subject|1|||
170833422|NCT01234883|617398539|FG000|Overall Study|Early treatment release|8|||
170833423|NCT01234883|617398540|FG001|Overall Study|Early treatment release|10|||
170833424|NCT01234883|617398539|FG000|Overall Study|Parent/guardian withdrew consent|1|||
170833425|NCT01234883|617398540|FG001|Overall Study|Parent/guardian withdrew consent|2|||
170833426|NCT01234883|617398539|FG000|Overall Study|Technical difficulties with IV infusion|0|||
170833427|NCT01234883|617398540|FG001|Overall Study|Technical difficulties with IV infusion|1|||
170833428|NCT01234883|617398539|FG000|Overall Study|Inclusion/exclusion failure|1|||
170833429|NCT01234883|617398540|FG001|Overall Study|Inclusion/exclusion failure|0|||
170833430|NCT00798304|617398541|FG000|Overall Study|Adverse Event|0|||
170833431|NCT00798304|617398542|FG001|Overall Study|Adverse Event|1|||
170833432|NCT00798304|617398543|FG002|Overall Study|Adverse Event|1|||
170833433|NCT00798304|617398541|FG000|Overall Study|Discontinuation by Sponsor|14|||
170833434|NCT00798304|617398542|FG001|Overall Study|Discontinuation by Sponsor|21|||
170833435|NCT00798304|617398543|FG002|Overall Study|Discontinuation by Sponsor|9|||
170724280|NCT01572727|616994416|FG000|Overall Study|Death|2|||
170724281|NCT01572727|616994417|FG001|Overall Study|Death|2|||
170724282|NCT01572727|616994416|FG000|Overall Study|Untreated|4|||
170724283|NCT01572727|616994417|FG001|Overall Study|Untreated|7|||
170724284|NCT04053764|616994418|FG000|Overall Study|Withdrawal by Subject|6|||
170724285|NCT04053764|616994419|FG001|Overall Study|Withdrawal by Subject|2|||
170724286|NCT04053764|616994418|FG000|Overall Study|Physician Decision|2|||
170724287|NCT04053764|616994419|FG001|Overall Study|Physician Decision|1|||
170724288|NCT04053764|616994418|FG000|Overall Study|Adverse Event|1|||
170724289|NCT04053764|616994419|FG001|Overall Study|Adverse Event|0|||
170724290|NCT04053764|616994418|FG000|Overall Study|Pregnancy|1|||
170724291|NCT04053764|616994419|FG001|Overall Study|Pregnancy|0|||
170724292|NCT01474681|616994426|FG000|Overall Study|Death|0|||
170724293|NCT01474681|616994427|FG001|Overall Study|Death|3|||
170724294|NCT01474681|616994428|FG002|Overall Study|Death|2|||
170724295|NCT01474681|616994429|FG003|Overall Study|Death|6|||
170724296|NCT03206203|616994430|FG000|Treatment|Death|38|||
170724297|NCT03206203|616994431|FG001|Treatment|Death|26|||
170724298|NCT03206203|616994432|FG002|Treatment|Death|0|||
170724299|NCT03206203|616994430|FG000|Treatment|Withdrawal by Subject|1|||
170724300|NCT03206203|616994431|FG001|Treatment|Withdrawal by Subject|0|||
170724301|NCT03206203|616994432|FG002|Treatment|Withdrawal by Subject|0|||
170724302|NCT03206203|616994430|FG000|Treatment|Lost to Follow-up|4|||
170724303|NCT03206203|616994431|FG001|Treatment|Lost to Follow-up|0|||
170724304|NCT03206203|616994432|FG002|Treatment|Lost to Follow-up|0|||
170724305|NCT03206203|616994430|FG000|Treatment|N/A in Follow-Up|8|||
170724306|NCT03206203|616994431|FG001|Treatment|N/A in Follow-Up|1|||
170724307|NCT03206203|616994432|FG002|Treatment|N/A in Follow-Up|0|||
170724308|NCT03206203|616994430|FG000|Treatment|Disease progression|0|||
170724309|NCT03206203|616994431|FG001|Treatment|Disease progression|1|||
170724310|NCT03206203|616994432|FG002|Treatment|Disease progression|0|||
170724311|NCT03206203|616994430|FG000|Treatment|Refused follow-up|0|||
170724312|NCT03206203|616994431|FG001|Treatment|Refused follow-up|1|||
170724313|NCT03206203|616994432|FG002|Treatment|Refused follow-up|0|||
170724314|NCT03206203|616994430|FG000|Treatment|Cross over to Arm 1|0|||
170724315|NCT03206203|616994431|FG001|Treatment|Cross over to Arm 1|19|||
170724316|NCT03206203|616994432|FG002|Treatment|Cross over to Arm 1|0|||
170724317|NCT03206203|616994430|FG000|Optional Cross-Over|Death|0|||
170724318|NCT03206203|616994431|FG001|Optional Cross-Over|Death|0|||
170724319|NCT03206203|616994432|FG002|Optional Cross-Over|Death|14|||
170724320|NCT03206203|616994430|FG000|Optional Cross-Over|Refused follow-up|0|||
170724321|NCT03206203|616994431|FG001|Optional Cross-Over|Refused follow-up|0|||
170724322|NCT03206203|616994432|FG002|Optional Cross-Over|Refused follow-up|2|||
170724323|NCT02195986|616994435|FG000|Overall Study|Adverse Event|3|||
170724324|NCT02195986|616994436|FG001|Overall Study|Adverse Event|0|||
170724325|NCT02195986|616994437|FG002|Overall Study|Adverse Event|0|||
170724326|NCT02195986|616994435|FG000|Overall Study|Withdrawal by Subject|0|||
170724327|NCT02195986|616994436|FG001|Overall Study|Withdrawal by Subject|3|||
170724328|NCT02195986|616994437|FG002|Overall Study|Withdrawal by Subject|0|||
170724329|NCT02195986|616994435|FG000|Overall Study|Family Emergency|0|||
170724330|NCT02195986|616994436|FG001|Overall Study|Family Emergency|0|||
170724331|NCT02195986|616994437|FG002|Overall Study|Family Emergency|1|||
170724332|NCT02195986|616994435|FG000|Overall Study|Protocol Violation|0|||
170724333|NCT02195986|616994436|FG001|Overall Study|Protocol Violation|1|||
170724334|NCT02195986|616994437|FG002|Overall Study|Protocol Violation|1|||
170724335|NCT02195986|616994435|FG000|Overall Study|Non-compliance|0|||
170724336|NCT02195986|616994436|FG001|Overall Study|Non-compliance|1|||
170724337|NCT02195986|616994437|FG002|Overall Study|Non-compliance|0|||
170724338|NCT00700401|616994449|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
170724339|NCT00700401|616994449|FG000|Overall Study|Adverse Event|5|||
170724340|NCT00700401|616994449|FG000|Overall Study|Refused Treatment|2|||
170724341|NCT00700401|616994449|FG000|Overall Study|Lost to Follow-up|1|||
170724342|NCT00700401|616994449|FG000|Overall Study|Treatment never started|1|||
170724343|NCT00700401|616994449|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
170724344|NCT00700401|616994449|FG000|Overall Study|Withdrawal by Subject|2|||
170724345|NCT01454583|616994450|FG000|1st Year|Lost to Follow-up|1057|||
170724346|NCT01454583|616994451|FG001|1st Year|Lost to Follow-up|318|||
170724347|NCT01454583|616994452|FG002|1st Year|Lost to Follow-up|180|||
170724348|NCT01454583|616994450|FG000|2nd Year|Lost to Follow-up|3965|||
170724349|NCT01454583|616994451|FG001|2nd Year|Lost to Follow-up|1049|||
170724350|NCT01454583|616994452|FG002|2nd Year|Lost to Follow-up|737|||
170724351|NCT01454583|616994450|FG000|3rd Year|Lost to Follow-up|1959|||
170724352|NCT01454583|616994451|FG001|3rd Year|Lost to Follow-up|512|||
170724353|NCT01454583|616994452|FG002|3rd Year|Lost to Follow-up|297|||
170724354|NCT02251990|616994456|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
170724355|NCT02251990|616994457|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
170724356|NCT02251990|616994456|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
170724357|NCT02251990|616994457|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
170724358|NCT02251990|616994456|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
170724359|NCT02251990|616994457|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
170724360|NCT02251990|616994456|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
170724361|NCT02251990|616994457|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
170724362|NCT02251990|616994456|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
170724363|NCT02251990|616994457|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
170724364|NCT02251990|616994456|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
170724365|NCT02251990|616994457|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
170724366|NCT00535730|616994458|FG000|Overall Study|Adverse Event|1|||
170724367|NCT00535730|616994459|FG001|Overall Study|Adverse Event|1|||
170724368|NCT00535730|616994458|FG000|Overall Study|Lost to Follow-up|0|||
170724369|NCT00535730|616994459|FG001|Overall Study|Lost to Follow-up|1|||
170724370|NCT00535730|616994458|FG000|Overall Study|Physician Decision|0|||
170724371|NCT00535730|616994459|FG001|Overall Study|Physician Decision|1|||
170724372|NCT00535730|616994458|FG000|Overall Study|Protocol Violation|1|||
170724373|NCT00535730|616994459|FG001|Overall Study|Protocol Violation|0|||
170724374|NCT00535730|616994458|FG000|Overall Study|Withdrawal by Subject|0|||
170724375|NCT00535730|616994459|FG001|Overall Study|Withdrawal by Subject|4|||
170724376|NCT00322348|616994460|FG000|Overall Study|Adverse Event|0|||
170724377|NCT00322348|616994461|FG001|Overall Study|Adverse Event|1|||
170724378|NCT00322348|616994460|FG000|Overall Study|Withdrawal by Subject|1|||
170724379|NCT00322348|616994461|FG001|Overall Study|Withdrawal by Subject|4|||
170724380|NCT00322348|616994460|FG000|Overall Study|Lost to Follow-up|1|||
170724381|NCT00322348|616994461|FG001|Overall Study|Lost to Follow-up|0|||
170724382|NCT00322348|616994460|FG000|Overall Study|Death|0|||
170724383|NCT00322348|616994461|FG001|Overall Study|Death|2|||
170724384|NCT00322348|616994460|FG000|Overall Study|Disease Progression|30|||
170724385|NCT00322348|616994461|FG001|Overall Study|Disease Progression|25|||
170724386|NCT00322348|616994460|FG000|Overall Study|Reasons not specified|5|||
170724387|NCT00322348|616994461|FG001|Overall Study|Reasons not specified|1|||
170724388|NCT00522275|616994468|FG000|Overall Study|Adverse Event|35|||
170724389|NCT00522275|616994468|FG000|Overall Study|Lack of Efficacy|80|||
170724390|NCT00522275|616994468|FG000|Overall Study|Subject withdrew consent|16|||
170724391|NCT00522275|616994468|FG000|Overall Study|Protocol deviation|1|||
170724392|NCT00522275|616994468|FG000|Overall Study|Unsatisfactory compliance|11|||
170724393|NCT00522275|616994468|FG000|Overall Study|Lost to Follow-up|8|||
170724394|NCT00522275|616994468|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
170724395|NCT00522275|616994468|FG000|Overall Study|Other: Subject is pregnant|2|||
170724396|NCT00522275|616994468|FG000|Overall Study|Other: Subject relocated|2|||
170724397|NCT00522275|616994468|FG000|Overall Study|Other: Subject arrested|1|||
170724398|NCT00522275|616994468|FG000|Overall Study|Other: Site / clinic closed|4|||
170724399|NCT00522275|616994468|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
170724400|NCT00522275|616994468|FG000|Overall Study|Other: Sponsor request|2|||
170724401|NCT00522275|616994468|FG000|Overall Study|Other: Subject ran out of medication|1|||
170724402|NCT00522275|616994468|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
170724403|NCT00695669|616994469|FG000|Overall Study|Adverse Event|0|||
170724404|NCT00695669|616994470|FG001|Overall Study|Adverse Event|0|||
170724405|NCT00695669|616994471|FG002|Overall Study|Adverse Event|2|||
170724406|NCT00695669|616994472|FG003|Overall Study|Adverse Event|0|||
170724407|NCT00695669|616994469|FG000|Overall Study|Lost to Follow-up|4|||
170724408|NCT00695669|616994470|FG001|Overall Study|Lost to Follow-up|4|||
170724409|NCT00695669|616994471|FG002|Overall Study|Lost to Follow-up|1|||
170724410|NCT00695669|616994472|FG003|Overall Study|Lost to Follow-up|4|||
170833436|NCT02031536|617398545|FG000|Overall Study|ineligible|1|||
170833437|NCT02031536|617398546|FG001|Overall Study|ineligible|0|||
170833438|NCT02688530|617398549|FG000|Overall Study|Withdrawal by Subject|0|||
170833439|NCT02688530|617398550|FG001|Overall Study|Withdrawal by Subject|1|||
170833440|NCT02688530|617398551|FG002|Overall Study|Withdrawal by Subject|0|||
170833441|NCT02688530|617398552|FG003|Overall Study|Withdrawal by Subject|0|||
170833442|NCT02688530|617398549|FG000|Overall Study|Lost to Follow-up|0|||
170833443|NCT02688530|617398550|FG001|Overall Study|Lost to Follow-up|0|||
170833444|NCT02688530|617398551|FG002|Overall Study|Lost to Follow-up|2|||
170833445|NCT02688530|617398552|FG003|Overall Study|Lost to Follow-up|0|||
170833446|NCT00725543|617398553|FG000|Overall Study|Adverse Event|10|||
170833447|NCT00725543|617398553|FG000|Overall Study|Lack of Efficacy|3|||
170833448|NCT00725543|617398553|FG000|Overall Study|Withdrawal by Subject|10|||
170833449|NCT00725543|617398553|FG000|Overall Study|Physician Decision|5|||
170833450|NCT00725543|617398553|FG000|Overall Study|Lost to Follow-up|4|||
170833451|NCT00725543|617398553|FG000|Overall Study|Non-compliance|2|||
170833452|NCT00725543|617398553|FG000|Overall Study|Other|119|||
170833453|NCT02353871|617398554|FG000|Overall Study|Protocol deviation|0|||
170833454|NCT02353871|617398555|FG001|Overall Study|Protocol deviation|1|||
170833455|NCT02353871|617398554|FG000|Overall Study|Consent withdrawn|1|||
170833456|NCT02353871|617398555|FG001|Overall Study|Consent withdrawn|8|||
170833457|NCT02353871|617398554|FG000|Overall Study|Lost to Follow-up|2|||
170833458|NCT02353871|617398555|FG001|Overall Study|Lost to Follow-up|0|||
170833459|NCT05314374|617398556|FG000|Overall Study|Adverse Event|2|||
170833460|NCT05314374|617398557|FG001|Overall Study|Adverse Event|2|||
170833461|NCT02918292|617398562|FG000|Study Enrollment Prior to Transplant|Death|1|||
170833462|NCT02918292|617398562|FG000|Study Follow up After Transplant|Death|6|||
170833463|NCT04447989|617398563|FG000|Overall Study|Withdrawal by Subject|1|||
170833464|NCT04447989|617398564|FG001|Overall Study|Withdrawal by Subject|1|||
170833465|NCT04447989|617398565|FG002|Overall Study|Withdrawal by Subject|0|||
170833466|NCT04447989|617398566|FG003|Overall Study|Withdrawal by Subject|0|||
170833467|NCT04447989|617398563|FG000|Overall Study|Physician Decision|0|||
170833468|NCT04447989|617398564|FG001|Overall Study|Physician Decision|0|||
170833469|NCT04447989|617398565|FG002|Overall Study|Physician Decision|0|||
170833470|NCT04447989|617398566|FG003|Overall Study|Physician Decision|1|||
170833471|NCT04447989|617398563|FG000|Overall Study|Transfer|0|||
170833472|NCT04447989|617398564|FG001|Overall Study|Transfer|1|||
170833473|NCT04447989|617398565|FG002|Overall Study|Transfer|0|||
170833474|NCT04447989|617398566|FG003|Overall Study|Transfer|0|||
170833475|NCT04447989|617398563|FG000|Overall Study|Discharge|0|||
170833476|NCT04447989|617398564|FG001|Overall Study|Discharge|1|||
170833477|NCT04447989|617398565|FG002|Overall Study|Discharge|1|||
170833478|NCT04447989|617398566|FG003|Overall Study|Discharge|3|||
170833479|NCT04447989|617398563|FG000|Overall Study|Ineligibility|0|||
170833480|NCT04447989|617398564|FG001|Overall Study|Ineligibility|0|||
170833481|NCT04447989|617398565|FG002|Overall Study|Ineligibility|0|||
170833482|NCT04447989|617398566|FG003|Overall Study|Ineligibility|1|||
170833483|NCT03779334|617398567|FG000|Overall Study|Withdrawal by Subject|3|||
170833484|NCT03779334|617398568|FG001|Overall Study|Withdrawal by Subject|0|||
170833485|NCT03779334|617398569|FG002|Overall Study|Withdrawal by Subject|0|||
170833486|NCT03779334|617398567|FG000|Overall Study|Ongoing in Study|5|||
170833487|NCT03779334|617398568|FG001|Overall Study|Ongoing in Study|13|||
170833488|NCT03779334|617398569|FG002|Overall Study|Ongoing in Study|5|||
170833489|NCT03912532|617398570|FG000|Overall Study|Adverse Event|3|||
170833490|NCT03912532|617398571|FG001|Overall Study|Adverse Event|3|||
170833491|NCT03912532|617398572|FG002|Overall Study|Adverse Event|2|||
170833492|NCT03912532|617398573|FG003|Overall Study|Adverse Event|2|||
170833493|NCT03912532|617398570|FG000|Overall Study|Lost to Follow-up|3|||
170833494|NCT03912532|617398571|FG001|Overall Study|Lost to Follow-up|2|||
170833495|NCT03912532|617398572|FG002|Overall Study|Lost to Follow-up|1|||
170833496|NCT03912532|617398573|FG003|Overall Study|Lost to Follow-up|2|||
170833497|NCT03912532|617398570|FG000|Overall Study|Withdrawal by Subject|1|||
170833498|NCT03912532|617398571|FG001|Overall Study|Withdrawal by Subject|1|||
170833499|NCT03912532|617398572|FG002|Overall Study|Withdrawal by Subject|2|||
170833500|NCT03912532|617398573|FG003|Overall Study|Withdrawal by Subject|0|||
170833501|NCT03912532|617398570|FG000|Overall Study|Physician Decision|1|||
170833502|NCT03912532|617398571|FG001|Overall Study|Physician Decision|0|||
170833503|NCT03912532|617398572|FG002|Overall Study|Physician Decision|0|||
170833504|NCT03912532|617398573|FG003|Overall Study|Physician Decision|3|||
170833505|NCT03912532|617398570|FG000|Overall Study|Other|0|||
170833506|NCT03912532|617398571|FG001|Overall Study|Other|1|||
170833507|NCT03912532|617398572|FG002|Overall Study|Other|1|||
170833508|NCT03912532|617398573|FG003|Overall Study|Other|0|||
170833509|NCT01321073|617398581|FG000|Overall Study|Did not attempt implant|4|||
170833510|NCT01321073|617398581|FG000|Overall Study|Death|3|||
170833511|NCT06552871|617398584|FG000|Overall Study|Withdrawal by Subject|2|||
170833512|NCT03522389|617398593|FG000|Overall Study|Lost to Follow-up|1|||
170833513|NCT03522389|617398594|FG001|Overall Study|Lost to Follow-up|1|||
170833514|NCT03522389|617398595|FG002|Overall Study|Lost to Follow-up|2|||
170833515|NCT03522389|617398593|FG000|Overall Study|had herniated nucleus pulposus|0|||
170833516|NCT03522389|617398594|FG001|Overall Study|had herniated nucleus pulposus|1|||
170833517|NCT03522389|617398595|FG002|Overall Study|had herniated nucleus pulposus|0|||
170833518|NCT03522389|617398593|FG000|Overall Study|go to work in other province|1|||
170833519|NCT03522389|617398594|FG001|Overall Study|go to work in other province|0|||
170833520|NCT03522389|617398595|FG002|Overall Study|go to work in other province|0|||
170833521|NCT01220856|617398596|FG000|Overall Study|graft loss|3|||
170833522|NCT01220856|617398597|FG001|Overall Study|graft loss|3|||
170833523|NCT01220856|617398596|FG000|Overall Study|Lost to Follow-up|1|||
170833524|NCT01220856|617398597|FG001|Overall Study|Lost to Follow-up|0|||
170833525|NCT02473042|617398599|FG000|Overall Study|Withdrawal by Subject|1|||
170833526|NCT02473042|617398600|FG001|Overall Study|Withdrawal by Subject|0|||
170833527|NCT02473042|617398599|FG000|Overall Study|Patient became ineligible after enrollment|2|||
170833528|NCT02473042|617398600|FG001|Overall Study|Patient became ineligible after enrollment|5|||
170833529|NCT02473042|617398599|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
170833530|NCT02473042|617398600|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
170833531|NCT02473042|617398599|FG000|Overall Study|PACU data unable to be collected|3|||
170833532|NCT02473042|617398600|FG001|Overall Study|PACU data unable to be collected|0|||
170833533|NCT04680637|617398603|FG000|Overall Study|Lost to Follow-up|0|||
170833534|NCT04680637|617398604|FG001|Overall Study|Lost to Follow-up|1|||
170833535|NCT04680637|617398605|FG002|Overall Study|Lost to Follow-up|0|||
170833536|NCT04680637|617398606|FG003|Overall Study|Lost to Follow-up|1|||
170833537|NCT04680637|617398603|FG000|Overall Study|Death|1|||
170833538|NCT04680637|617398604|FG001|Overall Study|Death|0|||
170833539|NCT04680637|617398605|FG002|Overall Study|Death|0|||
170833540|NCT04680637|617398606|FG003|Overall Study|Death|0|||
170833541|NCT04680637|617398603|FG000|Overall Study|Withdrawal by Subject|7|||
170833542|NCT04680637|617398604|FG001|Overall Study|Withdrawal by Subject|10|||
170833543|NCT04680637|617398605|FG002|Overall Study|Withdrawal by Subject|17|||
170833544|NCT04680637|617398606|FG003|Overall Study|Withdrawal by Subject|15|||
170833545|NCT04680637|617398603|FG000|Overall Study|Decision by Sponsor|21|||
170833546|NCT04680637|617398604|FG001|Overall Study|Decision by Sponsor|15|||
170833547|NCT04680637|617398605|FG002|Overall Study|Decision by Sponsor|7|||
170833548|NCT04680637|617398606|FG003|Overall Study|Decision by Sponsor|32|||
170833549|NCT00604188|617398607|FG000|Overall Study|Adverse Event|1|||
170833550|NCT00604188|617398608|FG001|Overall Study|Adverse Event|4|||
170833551|NCT00604188|617398607|FG000|Overall Study|Lost to Follow-up|17|||
170833552|NCT00604188|617398608|FG001|Overall Study|Lost to Follow-up|15|||
170833553|NCT00604188|617398607|FG000|Overall Study|Withdrawal by Subject|5|||
170833554|NCT00604188|617398608|FG001|Overall Study|Withdrawal by Subject|1|||
170833555|NCT00604188|617398607|FG000|Overall Study|Non-compliance with protocol|4|||
170833556|NCT00604188|617398608|FG001|Overall Study|Non-compliance with protocol|4|||
170833557|NCT00604188|617398607|FG000|Overall Study|Did not receive study drug|0|||
170833558|NCT00604188|617398608|FG001|Overall Study|Did not receive study drug|1|||
170833559|NCT05622682|617398610|FG000|Overall Study|Lost to Follow-up|2|||
170833560|NCT05622682|617398610|FG000|Overall Study|Censored Due to ALL Relapse|3|||
170833561|NCT02242643|617398615|FG000|Overall Study|Protocol Violation|1|||
170833562|NCT02242643|617398616|FG001|Overall Study|Protocol Violation|2|||
170833563|NCT02242643|617398615|FG000|Overall Study|Withdrawal by Subject|15|||
170833564|NCT02242643|617398616|FG001|Overall Study|Withdrawal by Subject|10|||
170833565|NCT02242643|617398615|FG000|Overall Study|Migrated/moved from study area|1|||
170833566|NCT02242643|617398616|FG001|Overall Study|Migrated/moved from study area|3|||
170833567|NCT02242643|617398615|FG000|Overall Study|Lost to Follow-up|54|||
170833568|NCT02242643|617398616|FG001|Overall Study|Lost to Follow-up|61|||
170833569|NCT02242643|617398615|FG000|Overall Study|Child placed in foster care by family|0|||
170833570|NCT02242643|617398616|FG001|Overall Study|Child placed in foster care by family|1|||
170833571|NCT02242643|617398615|FG000|Overall Study|Non-compliance|1|||
170833572|NCT02242643|617398616|FG001|Overall Study|Non-compliance|0|||
170833573|NCT02242643|617398615|FG000|Overall Study|Consent withdrawal by parent|1|||
170724411|NCT03240692|616994488|FG000|Overall Study|Physician Decision|1|||
170724412|NCT03240692|616994488|FG000|Overall Study|Withdrawal by Subject|1|||
170724413|NCT00683644|616994489|FG000|Overall Study|Withdrawal by Subject|4|||
170724414|NCT00683644|616994490|FG001|Overall Study|Withdrawal by Subject|2|||
170724415|NCT00683644|616994489|FG000|Overall Study|Lost to Follow-up|1|||
170724416|NCT00683644|616994490|FG001|Overall Study|Lost to Follow-up|4|||
170724417|NCT00683644|616994489|FG000|Overall Study|Adverse Event|1|||
170724418|NCT00683644|616994490|FG001|Overall Study|Adverse Event|2|||
170724419|NCT00683644|616994489|FG000|Overall Study|Low copper, other health problems,|7|||
170724420|NCT00683644|616994490|FG001|Overall Study|Low copper, other health problems,|6|||
170724421|NCT01857531|616994491|FG000|Overall Study|Withdrawal by Subject|4|||
170724422|NCT00355082|616994492|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
170724423|NCT00355082|616994493|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
170724424|NCT00355082|616994494|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
170724425|NCT00355082|616994492|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
170724426|NCT00355082|616994493|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
170724427|NCT00355082|616994494|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
170724428|NCT00355082|616994492|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
170724429|NCT00355082|616994493|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
170724430|NCT00355082|616994494|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
170724431|NCT00355082|616994492|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
170724432|NCT00355082|616994493|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
170724433|NCT00355082|616994494|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
170724434|NCT00355082|616994492|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
170724435|NCT00355082|616994493|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
170724436|NCT00355082|616994494|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
170724437|NCT00355082|616994492|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
170724438|NCT00355082|616994493|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
170724439|NCT00355082|616994494|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
170724440|NCT00355082|616994492|FG000|Continuation Phase|Adverse Event|2|||
170724441|NCT00355082|616994493|FG001|Continuation Phase|Adverse Event|0|||
170724442|NCT00355082|616994494|FG002|Continuation Phase|Adverse Event|1|||
170724443|NCT00355082|616994492|FG000|Continuation Phase|Lost to Follow-up|2|||
170724444|NCT00355082|616994493|FG001|Continuation Phase|Lost to Follow-up|0|||
170724445|NCT00355082|616994494|FG002|Continuation Phase|Lost to Follow-up|1|||
170724446|NCT00355082|616994492|FG000|Continuation Phase|Protocol Violation|1|||
170724447|NCT00355082|616994493|FG001|Continuation Phase|Protocol Violation|0|||
170724448|NCT00355082|616994494|FG002|Continuation Phase|Protocol Violation|1|||
170724449|NCT00355082|616994492|FG000|Continuation Phase|Withdrawal by Subject|4|||
170724450|NCT00355082|616994493|FG001|Continuation Phase|Withdrawal by Subject|0|||
170724451|NCT00355082|616994494|FG002|Continuation Phase|Withdrawal by Subject|0|||
170724452|NCT00355082|616994492|FG000|Continuation Phase|Lack of Efficacy|5|||
170724453|NCT00355082|616994493|FG001|Continuation Phase|Lack of Efficacy|0|||
170724454|NCT00355082|616994494|FG002|Continuation Phase|Lack of Efficacy|0|||
170724455|NCT00355082|616994492|FG000|Continuation Phase|Site Closed by Sponsor|8|||
170724456|NCT00355082|616994493|FG001|Continuation Phase|Site Closed by Sponsor|0|||
170724457|NCT00355082|616994494|FG002|Continuation Phase|Site Closed by Sponsor|0|||
170724458|NCT00355082|616994492|FG000|Continuation Phase|Scheduling Error|1|||
170724459|NCT00355082|616994493|FG001|Continuation Phase|Scheduling Error|0|||
170724460|NCT00355082|616994494|FG002|Continuation Phase|Scheduling Error|0|||
170724461|NCT00355082|616994492|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
170724462|NCT00355082|616994493|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
170724463|NCT00355082|616994494|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
170724464|NCT02576067|616994495|FG000|Overall Study|Death|0|||
170724465|NCT02576067|616994496|FG001|Overall Study|Death|1|||
170724466|NCT02576067|616994495|FG000|Overall Study|Lack of Efficacy|1|||
170724467|NCT02576067|616994496|FG001|Overall Study|Lack of Efficacy|0|||
170724468|NCT02576067|616994495|FG000|Overall Study|Lost to Follow-up|11|||
170724469|NCT02576067|616994496|FG001|Overall Study|Lost to Follow-up|0|||
170724470|NCT02576067|616994495|FG000|Overall Study|Withdrawal by Subject|11|||
170724471|NCT02576067|616994496|FG001|Overall Study|Withdrawal by Subject|2|||
170724472|NCT02576067|616994495|FG000|Overall Study|study closure of main CIRT trial)|0|||
170724473|NCT02576067|616994496|FG001|Overall Study|study closure of main CIRT trial)|8|||
170833574|NCT02242643|617398616|FG001|Overall Study|Consent withdrawal by parent|0|||
170833575|NCT02242643|617398615|FG000|Overall Study|Protocol requirements not followed|1|||
170833576|NCT02242643|617398616|FG001|Overall Study|Protocol requirements not followed|0|||
170833577|NCT02242643|617398615|FG000|Overall Study|Language barrier|1|||
170833578|NCT02242643|617398616|FG001|Overall Study|Language barrier|0|||
170833579|NCT02242643|617398615|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
170833580|NCT02242643|617398616|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
170833581|NCT03306277|617398617|FG000|Overall Study|Death|1|||
170833582|NCT03306277|617398617|FG000|Overall Study|Adverse Event|1|||
170833583|NCT03306277|617398617|FG000|Overall Study|Withdrawal by Subject|1|||
170833584|NCT01103232|617398621|FG000|Overall Study|Withdrawal by Subject|1|||
170724474|NCT02576067|616994495|FG000|Overall Study|not randomized, failed run-in|7|||
170724475|NCT02576067|616994496|FG001|Overall Study|not randomized, failed run-in|0|||
170724476|NCT02576067|616994495|FG000|Overall Study|screen failure/ re-enrolled|0|||
170724477|NCT02576067|616994496|FG001|Overall Study|screen failure/ re-enrolled|25|||
170724478|NCT02576067|616994495|FG000|Overall Study|Physician Decision|4|||
170724479|NCT02576067|616994496|FG001|Overall Study|Physician Decision|0|||
170724480|NCT03738150|616994506|FG000|Base Study|Withdrawal by Subject|1|||
170724481|NCT03738150|616994506|FG000|Extension Study|Withdrawal by Subject|1|||
170724482|NCT04598152|616994507|FG000|Overall Study|Lost to Follow-up|0|||
170724483|NCT04598152|616994508|FG001|Overall Study|Lost to Follow-up|1|||
170724484|NCT02352948|616994509|FG000|Overall Study|Death|47|||
170724485|NCT02352948|616994510|FG001|Overall Study|Death|48|||
170724486|NCT02352948|616994511|FG002|Overall Study|Death|114|||
170724487|NCT02352948|616994512|FG003|Overall Study|Death|74|||
170724488|NCT02352948|616994513|FG004|Overall Study|Death|77|||
170724489|NCT02352948|616994514|FG005|Overall Study|Death|44|||
170724490|NCT02352948|616994509|FG000|Overall Study|Lost to Follow-up|1|||
170724491|NCT02352948|616994510|FG001|Overall Study|Lost to Follow-up|0|||
170724492|NCT02352948|616994511|FG002|Overall Study|Lost to Follow-up|2|||
170724493|NCT02352948|616994512|FG003|Overall Study|Lost to Follow-up|1|||
170724494|NCT02352948|616994513|FG004|Overall Study|Lost to Follow-up|2|||
170724495|NCT02352948|616994514|FG005|Overall Study|Lost to Follow-up|1|||
170724496|NCT02352948|616994509|FG000|Overall Study|Withdrawal by Subject|1|||
170724497|NCT02352948|616994510|FG001|Overall Study|Withdrawal by Subject|10|||
170724498|NCT02352948|616994511|FG002|Overall Study|Withdrawal by Subject|11|||
170724499|NCT02352948|616994512|FG003|Overall Study|Withdrawal by Subject|23|||
170724500|NCT02352948|616994513|FG004|Overall Study|Withdrawal by Subject|9|||
170724501|NCT02352948|616994514|FG005|Overall Study|Withdrawal by Subject|4|||
170724502|NCT02352948|616994509|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170724503|NCT02352948|616994510|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170724504|NCT02352948|616994511|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
170724505|NCT02352948|616994512|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
170724506|NCT02352948|616994513|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
170724507|NCT02352948|616994514|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
170724508|NCT02352948|616994509|FG000|Overall Study|Other|0|||
170724509|NCT02352948|616994510|FG001|Overall Study|Other|0|||
170724510|NCT02352948|616994511|FG002|Overall Study|Other|2|||
170724511|NCT02352948|616994512|FG003|Overall Study|Other|0|||
170724512|NCT02352948|616994513|FG004|Overall Study|Other|0|||
170724513|NCT02352948|616994514|FG005|Overall Study|Other|0|||
170724514|NCT01864564|616994516|FG000|Overall Study|Lost to Follow-up|17|||
170724515|NCT01864564|616994517|FG001|Overall Study|Lost to Follow-up|23|||
170724516|NCT01864564|616994516|FG000|Overall Study|Withdrawal by Subject|20|||
170724517|NCT01864564|616994517|FG001|Overall Study|Withdrawal by Subject|11|||
170724518|NCT01864564|616994516|FG000|Overall Study|Protocol Violation|0|||
170724519|NCT01864564|616994517|FG001|Overall Study|Protocol Violation|27|||
170724520|NCT01864564|616994516|FG000|Overall Study|not reported|0|||
170724521|NCT01864564|616994517|FG001|Overall Study|not reported|34|||
170724522|NCT03077724|616994518|FG000|Overall Study|Lost to Follow-up|5|||
170724523|NCT03077724|616994519|FG001|Overall Study|Lost to Follow-up|1|||
170724524|NCT03077724|616994518|FG000|Overall Study|Withdrawal by Subject|3|||
170724525|NCT03077724|616994519|FG001|Overall Study|Withdrawal by Subject|1|||
170724526|NCT02269670|616994520|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
170724527|NCT00234065|616994521|FG000|Overall Study|Adverse Event|268|||
170724528|NCT00234065|616994522|FG001|Overall Study|Adverse Event|166|||
170724529|NCT00234065|616994521|FG000|Overall Study|Withdrawal by Subject|73|||
170724530|NCT00234065|616994522|FG001|Overall Study|Withdrawal by Subject|56|||
170724531|NCT00234065|616994521|FG000|Overall Study|Physician Decision|23|||
170724532|NCT00234065|616994522|FG001|Overall Study|Physician Decision|22|||
170724533|NCT00234065|616994521|FG000|Overall Study|Not Classified|111|||
170724534|NCT00234065|616994522|FG001|Overall Study|Not Classified|112|||
170724535|NCT00126438|616994523|FG000|Overall Study|Withdrawal due to adverse event|1|||
170724536|NCT00126438|616994524|FG001|Overall Study|Withdrawal due to adverse event|0|||
170724537|NCT00126438|616994523|FG000|Overall Study|Lost to Follow-up|22|||
170724538|NCT00126438|616994524|FG001|Overall Study|Lost to Follow-up|0|||
170724539|NCT00126438|616994523|FG000|Overall Study|Protocol Violation|8|||
170724540|NCT00126438|616994524|FG001|Overall Study|Protocol Violation|8|||
170724541|NCT00126438|616994523|FG000|Overall Study|Withdrawal by Subject|3|||
170724542|NCT00126438|616994524|FG001|Overall Study|Withdrawal by Subject|2|||
170724543|NCT04414696|616994526|FG000|3-month Follow up|Withdrawal by Subject|1|||
170724544|NCT04414696|616994527|FG001|3-month Follow up|Withdrawal by Subject|0|||
170724545|NCT04414696|616994526|FG000|3-month Follow up|Lost to Follow-up|22|||
170724546|NCT04414696|616994527|FG001|3-month Follow up|Lost to Follow-up|23|||
170724547|NCT04414696|616994526|FG000|6-month Follow up|Withdrawal by Subject|1|||
170724548|NCT04414696|616994527|FG001|6-month Follow up|Withdrawal by Subject|2|||
170724549|NCT04414696|616994526|FG000|6-month Follow up|Lost to Follow-up|5|||
170724550|NCT04414696|616994527|FG001|6-month Follow up|Lost to Follow-up|2|||
170833585|NCT01103232|617398622|FG001|Overall Study|Withdrawal by Subject|1|||
170833586|NCT01103232|617398621|FG000|Overall Study|Protocol Violation|0|||
170833587|NCT01103232|617398622|FG001|Overall Study|Protocol Violation|1|||
170833588|NCT03340675|617398630|FG000|Double Blind|Adverse Event|3|||
170833589|NCT03340675|617398631|FG001|Double Blind|Adverse Event|1|||
170833590|NCT03340675|617398632|FG002|Double Blind|Adverse Event|1|||
170833591|NCT03340675|617398630|FG000|Double Blind|Lost to Follow-up|0|||
170833592|NCT03340675|617398631|FG001|Double Blind|Lost to Follow-up|0|||
170833593|NCT03340675|617398632|FG002|Double Blind|Lost to Follow-up|1|||
170833594|NCT03340675|617398630|FG000|Double Blind|Withdrawal by Subject|1|||
170833595|NCT03340675|617398631|FG001|Double Blind|Withdrawal by Subject|2|||
170833596|NCT03340675|617398632|FG002|Double Blind|Withdrawal by Subject|1|||
170833597|NCT03340675|617398630|FG000|Double Blind|Protocol Violation|1|||
170833598|NCT03340675|617398631|FG001|Double Blind|Protocol Violation|0|||
170833599|NCT03340675|617398632|FG002|Double Blind|Protocol Violation|0|||
170833600|NCT06814470|617398635|FG000|Overall Study|Withdrawal by Subject|1|||
170833601|NCT06814470|617398636|FG001|Overall Study|Withdrawal by Subject|2|||
170833602|NCT03370393|617398639|FG000|Overall Study|Lost to Follow-up|15|||
170833603|NCT03370393|617398640|FG001|Overall Study|Lost to Follow-up|10|||
170833604|NCT03651752|617398641|FG000|Overall Study|Adverse Event|1|||
170833605|NCT03651752|617398641|FG000|Overall Study|Screen failure|3|||
170833606|NCT01867047|617399807|FG000|Overall Study|Lost to Follow-up|3|||
170833607|NCT01867047|617399808|FG001|Overall Study|Lost to Follow-up|3|||
170833608|NCT01867047|617399807|FG000|Overall Study|Withdrawal by Subject|2|||
170833609|NCT01867047|617399808|FG001|Overall Study|Withdrawal by Subject|0|||
170833610|NCT01867047|617399807|FG000|Overall Study|Physician Decision|2|||
170833611|NCT01867047|617399808|FG001|Overall Study|Physician Decision|0|||
170833612|NCT01867047|617399807|FG000|Overall Study|surgery not indicated in protocol|1|||
170833613|NCT01867047|617399808|FG001|Overall Study|surgery not indicated in protocol|2|||
170833614|NCT00307047|617399809|FG000|Overall Study|Lost to Follow-up|35|||
170833615|NCT00307047|617399810|FG001|Overall Study|Lost to Follow-up|24|||
170833616|NCT00307047|617399809|FG000|Overall Study|Withdrawal by Subject|6|||
170833617|NCT00307047|617399810|FG001|Overall Study|Withdrawal by Subject|6|||
170833618|NCT00307047|617399809|FG000|Overall Study|Physician Decision|1|||
170833619|NCT00307047|617399810|FG001|Overall Study|Physician Decision|2|||
170833620|NCT00307047|617399809|FG000|Overall Study|Lost to follow-up for other reasons|0|||
170833621|NCT00307047|617399810|FG001|Overall Study|Lost to follow-up for other reasons|1|||
170833622|NCT00307047|617399809|FG000|Overall Study|All death, all MI, all Revascularization|27|||
170833623|NCT00307047|617399810|FG001|Overall Study|All death, all MI, all Revascularization|16|||
170724551|NCT01738984|616996630|FG000|Overall Study|Pregnancy|4|||
170724552|NCT01738984|616996631|FG001|Overall Study|Pregnancy|0|||
170724553|NCT01738984|616996630|FG000|Overall Study|Withdrawal by Subject|1|||
170724554|NCT01738984|616996631|FG001|Overall Study|Withdrawal by Subject|0|||
170724555|NCT01738984|616996630|FG000|Overall Study|Lost to Follow-up|59|||
170724556|NCT01738984|616996631|FG001|Overall Study|Lost to Follow-up|39|||
170724557|NCT02035332|616996635|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
170724558|NCT00955357|616996641|FG000|Titration Phase|Adverse Event|9|||
170724559|NCT00955357|616996642|FG001|Titration Phase|Adverse Event|46|||
170724560|NCT00955357|616996641|FG000|Titration Phase|Lack of Efficacy|0|||
170724561|NCT00955357|616996642|FG001|Titration Phase|Lack of Efficacy|2|||
170724562|NCT00955357|616996641|FG000|Titration Phase|Protocol Violation|3|||
170724563|NCT00955357|616996642|FG001|Titration Phase|Protocol Violation|7|||
170724564|NCT00955357|616996641|FG000|Titration Phase|Lost to Follow-up|1|||
170724565|NCT00955357|616996642|FG001|Titration Phase|Lost to Follow-up|3|||
170724566|NCT00955357|616996641|FG000|Titration Phase|Withdrawal by Subject|3|||
170724567|NCT00955357|616996642|FG001|Titration Phase|Withdrawal by Subject|5|||
170724568|NCT00955357|616996641|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
170724569|NCT00955357|616996642|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
170724570|NCT00955357|616996641|FG000|Titration Phase|Study medication not tolerated|0|||
170833624|NCT00129935|617399811|FG000|Overall Study|Adverse Event|18|||
170833625|NCT00129935|617399812|FG001|Overall Study|Adverse Event|56|||
170833626|NCT00129935|617399811|FG000|Overall Study|Death|1|||
170724571|NCT00955357|616996642|FG001|Titration Phase|Study medication not tolerated|1|||
170724572|NCT00955357|616996641|FG000|Titration Phase|Non compliance to study procedures|0|||
170724573|NCT00955357|616996642|FG001|Titration Phase|Non compliance to study procedures|1|||
170724574|NCT00955357|616996641|FG000|Maintenance Phase|Adverse Event|3|||
170833627|NCT00129935|617399812|FG001|Overall Study|Death|1|||
170833628|NCT00129935|617399811|FG000|Overall Study|Withdrawal by Subject|7|||
170833629|NCT00129935|617399812|FG001|Overall Study|Withdrawal by Subject|20|||
170833630|NCT00129935|617399811|FG000|Overall Study|Protocol Violation|0|||
170724575|NCT00955357|616996642|FG001|Maintenance Phase|Adverse Event|23|||
170724576|NCT00955357|616996641|FG000|Maintenance Phase|Lack of Efficacy|0|||
170724577|NCT00955357|616996642|FG001|Maintenance Phase|Lack of Efficacy|4|||
170724578|NCT00955357|616996641|FG000|Maintenance Phase|Protocol Violation|2|||
170724579|NCT00955357|616996642|FG001|Maintenance Phase|Protocol Violation|6|||
170724580|NCT00955357|616996641|FG000|Maintenance Phase|Lost to Follow-up|2|||
170724581|NCT00955357|616996642|FG001|Maintenance Phase|Lost to Follow-up|7|||
170724582|NCT00955357|616996641|FG000|Maintenance Phase|Withdrawal by Subject|4|||
170724583|NCT00955357|616996642|FG001|Maintenance Phase|Withdrawal by Subject|4|||
170724584|NCT00955357|616996641|FG000|Maintenance Phase|Patient moving out of area|0|||
170724585|NCT00955357|616996642|FG001|Maintenance Phase|Patient moving out of area|1|||
170724586|NCT00955357|616996641|FG000|Maintenance Phase|Non compliance to study procedures|1|||
170724587|NCT00955357|616996642|FG001|Maintenance Phase|Non compliance to study procedures|0|||
170724588|NCT04205630|616996643|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
170724589|NCT04205630|616996643|FG000|Overall Study|Disease clinical progression|7|||
170724590|NCT04205630|616996643|FG000|Overall Study|Withdrawal by Subject|2|||
170724591|NCT04205630|616996643|FG000|Overall Study|Adverse Event|17|||
170724592|NCT04205630|616996643|FG000|Overall Study|Other|1|||
170724593|NCT02943408|616996647|FG000|Overall Study|Lost to Follow-up|7|||
170724594|NCT02943408|616996648|FG001|Overall Study|Lost to Follow-up|1|||
170724595|NCT02943408|616996647|FG000|Overall Study|Withdrawal by Subject|0|||
170724596|NCT02943408|616996648|FG001|Overall Study|Withdrawal by Subject|1|||
170724597|NCT01621126|616996649|FG000|Overall Study|Physician Decision|6|||
170724598|NCT02985866|616996650|FG000|Overall Study|Poor CGM data|1|||
170724599|NCT02985866|616996651|FG001|Overall Study|Poor CGM data|1|||
170724600|NCT03751631|616996652|FG000|Overall Study|Withdrawal by Subject|0|||
170724601|NCT03751631|616996653|FG001|Overall Study|Withdrawal by Subject|0|||
170724602|NCT03751631|616996654|FG002|Overall Study|Withdrawal by Subject|1|||
170724603|NCT03751631|616996655|FG003|Overall Study|Withdrawal by Subject|1|||
170724604|NCT03751631|616996656|FG004|Overall Study|Withdrawal by Subject|0|||
170724605|NCT03751631|616996657|FG005|Overall Study|Withdrawal by Subject|0|||
170724606|NCT00643916|616996659|FG000|Overall Study|Protocol Violation|0|||
170724607|NCT00643916|616996660|FG001|Overall Study|Protocol Violation|1|||
170724608|NCT00643916|616996661|FG002|Overall Study|Protocol Violation|1|||
170724609|NCT00643916|616996662|FG003|Overall Study|Protocol Violation|1|||
170724610|NCT00643916|616996663|FG004|Overall Study|Protocol Violation|0|||
170724611|NCT00643916|616996664|FG005|Overall Study|Protocol Violation|0|||
170724612|NCT00643916|616996659|FG000|Overall Study|Lost to Follow-up|0|||
170724613|NCT00643916|616996660|FG001|Overall Study|Lost to Follow-up|1|||
170724614|NCT00643916|616996661|FG002|Overall Study|Lost to Follow-up|0|||
170724615|NCT00643916|616996662|FG003|Overall Study|Lost to Follow-up|0|||
170724616|NCT00643916|616996663|FG004|Overall Study|Lost to Follow-up|0|||
170724617|NCT00643916|616996664|FG005|Overall Study|Lost to Follow-up|0|||
170724618|NCT00643916|616996659|FG000|Overall Study|Withdrawal by Subject|2|||
170724619|NCT00643916|616996660|FG001|Overall Study|Withdrawal by Subject|2|||
170724620|NCT00643916|616996661|FG002|Overall Study|Withdrawal by Subject|2|||
170724621|NCT00643916|616996662|FG003|Overall Study|Withdrawal by Subject|1|||
170724622|NCT00643916|616996663|FG004|Overall Study|Withdrawal by Subject|0|||
170724623|NCT00643916|616996664|FG005|Overall Study|Withdrawal by Subject|1|||
170724624|NCT00643916|616996659|FG000|Overall Study|Not Vaccinated|2|||
170724625|NCT00643916|616996660|FG001|Overall Study|Not Vaccinated|2|||
170724626|NCT00643916|616996661|FG002|Overall Study|Not Vaccinated|3|||
170724627|NCT00643916|616996662|FG003|Overall Study|Not Vaccinated|0|||
170724628|NCT00643916|616996663|FG004|Overall Study|Not Vaccinated|2|||
170724629|NCT00643916|616996664|FG005|Overall Study|Not Vaccinated|0|||
170724630|NCT02184611|616996669|FG000|Overall Study|Lack of Efficacy|11|||
170724631|NCT02184611|616996670|FG001|Overall Study|Lack of Efficacy|15|||
170724632|NCT02184611|616996669|FG000|Overall Study|Withdrawal by Subject|5|||
170724633|NCT02184611|616996670|FG001|Overall Study|Withdrawal by Subject|6|||
170724634|NCT02184611|616996669|FG000|Overall Study|Adverse Event|4|||
170724635|NCT02184611|616996670|FG001|Overall Study|Adverse Event|5|||
170724636|NCT02184611|616996669|FG000|Overall Study|Protocol Violation|1|||
170724637|NCT02184611|616996670|FG001|Overall Study|Protocol Violation|1|||
170724638|NCT02184611|616996669|FG000|Overall Study|Protocol defined stopping criteria|0|||
170724639|NCT02184611|616996670|FG001|Overall Study|Protocol defined stopping criteria|1|||
170724640|NCT00160680|616996671|FG000|Overall Study|Adverse Event|0|||
170724641|NCT00160680|616996672|FG001|Overall Study|Adverse Event|1|||
170724642|NCT00160680|616996671|FG000|Overall Study|Lack of Efficacy|2|||
170724643|NCT00160680|616996672|FG001|Overall Study|Lack of Efficacy|1|||
170724644|NCT00160680|616996671|FG000|Overall Study|Lost to Follow-up|3|||
170724645|NCT00160680|616996672|FG001|Overall Study|Lost to Follow-up|2|||
170724646|NCT00160680|616996671|FG000|Overall Study|Withdrawal by Subject|4|||
170724647|NCT00160680|616996672|FG001|Overall Study|Withdrawal by Subject|9|||
170724648|NCT02925455|616996673|FG000|Overall Study|Withdrawal by Subject|2|||
170724649|NCT02925455|616996674|FG001|Overall Study|Withdrawal by Subject|0|||
170724650|NCT02723864|616996680|FG000|Overall Study|Refused further treatment|1|||
170724651|NCT02723864|616996681|FG001|Overall Study|Refused further treatment|0|||
170833631|NCT00129935|617399812|FG001|Overall Study|Protocol Violation|4|||
170833632|NCT00129935|617399811|FG000|Overall Study|Physician Decision|3|||
170833633|NCT00129935|617399812|FG001|Overall Study|Physician Decision|4|||
170833634|NCT00129935|617399811|FG000|Overall Study|Recurrence|1|||
170833635|NCT00129935|617399812|FG001|Overall Study|Recurrence|3|||
170833636|NCT00129935|617399811|FG000|Overall Study|Second primary|0|||
170833637|NCT00129935|617399812|FG001|Overall Study|Second primary|1|||
170833638|NCT00129935|617399811|FG000|Overall Study|Other|3|||
170833639|NCT00129935|617399812|FG001|Overall Study|Other|2|||
170833640|NCT00129935|617399811|FG000|Overall Study|Crossed to the other arm|2|||
170833641|NCT00129935|617399812|FG001|Overall Study|Crossed to the other arm|1|||
170833642|NCT00129935|617399811|FG000|Overall Study|Incorrect study treatment|1|||
170833643|NCT00129935|617399812|FG001|Overall Study|Incorrect study treatment|0|||
170833644|NCT04090528|617399815|FG000|Overall Study|participants still on study|9|||
170833645|NCT04090528|617399816|FG001|Overall Study|participants still on study|13|||
170833646|NCT02550938|617399817|FG000|Overall Study|Lost to Follow-up|8|||
170833647|NCT02550938|617399818|FG001|Overall Study|Lost to Follow-up|7|||
170833648|NCT02550938|617399819|FG002|Overall Study|Lost to Follow-up|12|||
170833649|NCT02550938|617399820|FG003|Overall Study|Lost to Follow-up|11|||
170833650|NCT02056626|617399822|FG000|Overall Study|patient did not follow directions|3|||
170833651|NCT02056626|617399823|FG001|Overall Study|patient did not follow directions|1|||
170833652|NCT02056626|617399824|FG002|Overall Study|patient did not follow directions|0|||
170833653|NCT02056626|617399825|FG003|Overall Study|patient did not follow directions|0|||
170833654|NCT02037477|617399828|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
170833655|NCT02037477|617399829|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
170833656|NCT02037477|617399830|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
170833657|NCT02037477|617399831|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
170833658|NCT01245140|617399832|FG000|Overall Study|Adverse Event|1|||
170833659|NCT01245140|617399833|FG001|Overall Study|Adverse Event|3|||
170833660|NCT01245140|617399832|FG000|Overall Study|Lack of Efficacy|2|||
170833661|NCT01245140|617399833|FG001|Overall Study|Lack of Efficacy|4|||
170833662|NCT01245140|617399832|FG000|Overall Study|Protocol Violation|0|||
170833663|NCT01245140|617399833|FG001|Overall Study|Protocol Violation|1|||
170833664|NCT01245140|617399832|FG000|Overall Study|Withdrawal by Subject|0|||
170833665|NCT01245140|617399833|FG001|Overall Study|Withdrawal by Subject|1|||
170833666|NCT01245140|617399832|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
170833667|NCT01245140|617399833|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
170833668|NCT03118050|617399834|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
170833669|NCT03118050|617399835|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
170833670|NCT03118050|617399836|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
170833671|NCT03118050|617399837|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
170833672|NCT03118050|617399838|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
170833673|NCT03118050|617399839|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
170833674|NCT03118050|617399840|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
170833675|NCT05274750|617399841|FG000|Overall Study|Adverse Event|0|||
170833676|NCT05274750|617399842|FG001|Overall Study|Adverse Event|1|||
170833677|NCT05274750|617399841|FG000|Overall Study|Lost to Follow-up|2|||
170833678|NCT05274750|617399842|FG001|Overall Study|Lost to Follow-up|3|||
170833679|NCT05274750|617399841|FG000|Overall Study|Physician Decision|3|||
170833680|NCT05274750|617399842|FG001|Overall Study|Physician Decision|0|||
170833681|NCT05274750|617399841|FG000|Overall Study|Withdrawal by Subject|10|||
170833682|NCT05274750|617399842|FG001|Overall Study|Withdrawal by Subject|9|||
170833683|NCT05274750|617399841|FG000|Overall Study|GCP Violation|0|||
170833684|NCT05274750|617399842|FG001|Overall Study|GCP Violation|4|||
170833685|NCT05274750|617399841|FG000|Overall Study|Randomized, not treated|0|||
170833686|NCT05274750|617399842|FG001|Overall Study|Randomized, not treated|1|||
170833687|NCT02312557|617399843|FG000|Overall Study|Survival follow-up|4|||
170833688|NCT04545866|617399844|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
170833689|NCT04545866|617399845|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
170833690|NCT04545866|617399844|FG000|Overall Study|Withdrawal by Physician|1|||
170833691|NCT04545866|617399845|FG001|Overall Study|Withdrawal by Physician|0|||
170833692|NCT04486313|617399848|FG000|Overall Study|Lost to Follow-up|7|||
170833693|NCT04486313|617399849|FG001|Overall Study|Lost to Follow-up|9|||
170833694|NCT04486313|617399848|FG000|Overall Study|Withdrawal by Subject|8|||
170833695|NCT04486313|617399849|FG001|Overall Study|Withdrawal by Subject|6|||
170833696|NCT04486313|617399848|FG000|Overall Study|Physician Decision|1|||
170833697|NCT04486313|617399849|FG001|Overall Study|Physician Decision|1|||
170833698|NCT04486313|617399848|FG000|Overall Study|Death|2|||
170833699|NCT04486313|617399849|FG001|Overall Study|Death|0|||
170833700|NCT04486313|617399848|FG000|Overall Study|Protocol Violation|1|||
170833701|NCT04486313|617399849|FG001|Overall Study|Protocol Violation|1|||
170833702|NCT01013961|617399853|FG000|Overall Study|Adverse Event|2|||
170724652|NCT02723864|616996682|FG002|Overall Study|Refused further treatment|0|||
170724653|NCT02723864|616996683|FG003|Overall Study|Refused further treatment|0|||
170724654|NCT02723864|616996684|FG004|Overall Study|Refused further treatment|1|||
170724655|NCT02723864|616996685|FG005|Overall Study|Refused further treatment|2|||
170724656|NCT02723864|616996686|FG006|Overall Study|Refused further treatment|0|||
170724657|NCT02723864|616996680|FG000|Overall Study|Exceed treatment hold time|0|||
170724658|NCT02723864|616996681|FG001|Overall Study|Exceed treatment hold time|1|||
170724659|NCT02723864|616996682|FG002|Overall Study|Exceed treatment hold time|0|||
170724660|NCT02723864|616996683|FG003|Overall Study|Exceed treatment hold time|0|||
170724661|NCT02723864|616996684|FG004|Overall Study|Exceed treatment hold time|0|||
170724662|NCT02723864|616996685|FG005|Overall Study|Exceed treatment hold time|0|||
170724663|NCT02723864|616996686|FG006|Overall Study|Exceed treatment hold time|0|||
170724664|NCT02723864|616996680|FG000|Overall Study|Clinical progression|0|||
170724665|NCT02723864|616996681|FG001|Overall Study|Clinical progression|0|||
170724666|NCT02723864|616996682|FG002|Overall Study|Clinical progression|1|||
170724667|NCT02723864|616996683|FG003|Overall Study|Clinical progression|0|||
170724668|NCT02723864|616996684|FG004|Overall Study|Clinical progression|0|||
170724669|NCT02723864|616996685|FG005|Overall Study|Clinical progression|3|||
170724670|NCT02723864|616996686|FG006|Overall Study|Clinical progression|1|||
170724671|NCT02723864|616996680|FG000|Overall Study|Physician Decision|0|||
170724672|NCT02723864|616996681|FG001|Overall Study|Physician Decision|0|||
170724673|NCT02723864|616996682|FG002|Overall Study|Physician Decision|0|||
170724674|NCT02723864|616996683|FG003|Overall Study|Physician Decision|0|||
170724675|NCT02723864|616996684|FG004|Overall Study|Physician Decision|0|||
170724676|NCT02723864|616996685|FG005|Overall Study|Physician Decision|0|||
170724677|NCT02723864|616996686|FG006|Overall Study|Physician Decision|1|||
170724678|NCT02723864|616996680|FG000|Overall Study|Changes in patient condition|0|||
170724679|NCT02723864|616996681|FG001|Overall Study|Changes in patient condition|0|||
170724680|NCT02723864|616996682|FG002|Overall Study|Changes in patient condition|0|||
170724681|NCT02723864|616996683|FG003|Overall Study|Changes in patient condition|0|||
170724682|NCT02723864|616996684|FG004|Overall Study|Changes in patient condition|0|||
170724683|NCT02723864|616996685|FG005|Overall Study|Changes in patient condition|1|||
170724684|NCT02723864|616996686|FG006|Overall Study|Changes in patient condition|0|||
170724685|NCT02723864|616996680|FG000|Overall Study|Patient choice|0|||
170724686|NCT02723864|616996681|FG001|Overall Study|Patient choice|0|||
170724687|NCT02723864|616996682|FG002|Overall Study|Patient choice|0|||
170724688|NCT02723864|616996683|FG003|Overall Study|Patient choice|0|||
170724689|NCT02723864|616996684|FG004|Overall Study|Patient choice|0|||
170724690|NCT02723864|616996685|FG005|Overall Study|Patient choice|1|||
170724691|NCT02723864|616996686|FG006|Overall Study|Patient choice|0|||
170724692|NCT02723864|616996680|FG000|Overall Study|Adverse Event|0|||
170724693|NCT02723864|616996681|FG001|Overall Study|Adverse Event|0|||
170724694|NCT02723864|616996682|FG002|Overall Study|Adverse Event|0|||
170724695|NCT02723864|616996683|FG003|Overall Study|Adverse Event|0|||
170724696|NCT02723864|616996684|FG004|Overall Study|Adverse Event|0|||
170724697|NCT02723864|616996685|FG005|Overall Study|Adverse Event|1|||
170724698|NCT02723864|616996686|FG006|Overall Study|Adverse Event|0|||
170724699|NCT02723864|616996680|FG000|Overall Study|Started new treatment|0|||
170724700|NCT02723864|616996681|FG001|Overall Study|Started new treatment|0|||
170724701|NCT02723864|616996682|FG002|Overall Study|Started new treatment|0|||
170724702|NCT02723864|616996683|FG003|Overall Study|Started new treatment|0|||
170724703|NCT02723864|616996684|FG004|Overall Study|Started new treatment|0|||
170724704|NCT02723864|616996685|FG005|Overall Study|Started new treatment|1|||
170724705|NCT02723864|616996686|FG006|Overall Study|Started new treatment|0|||
170724706|NCT02723864|616996680|FG000|Overall Study|Switched to alternative treatment|0|||
170724707|NCT02723864|616996681|FG001|Overall Study|Switched to alternative treatment|0|||
170724708|NCT02723864|616996682|FG002|Overall Study|Switched to alternative treatment|0|||
170724709|NCT02723864|616996683|FG003|Overall Study|Switched to alternative treatment|0|||
170724710|NCT02723864|616996684|FG004|Overall Study|Switched to alternative treatment|0|||
170724711|NCT02723864|616996685|FG005|Overall Study|Switched to alternative treatment|1|||
170724712|NCT02723864|616996686|FG006|Overall Study|Switched to alternative treatment|0|||
170724713|NCT02723864|616996680|FG000|Overall Study|Late determination of ineligibility|0|||
170724714|NCT02723864|616996681|FG001|Overall Study|Late determination of ineligibility|0|||
170724715|NCT02723864|616996682|FG002|Overall Study|Late determination of ineligibility|0|||
170724716|NCT02723864|616996683|FG003|Overall Study|Late determination of ineligibility|0|||
170724717|NCT02723864|616996684|FG004|Overall Study|Late determination of ineligibility|0|||
170724718|NCT02723864|616996685|FG005|Overall Study|Late determination of ineligibility|1|||
170724719|NCT02723864|616996686|FG006|Overall Study|Late determination of ineligibility|0|||
170724720|NCT00746590|616996687|FG000|Overall Study|Death|1|||
170724721|NCT03643952|616996693|FG000|Overall Study|Lack of Efficacy|1|||
170724722|NCT00815295|616996696|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
170724723|NCT00815295|616996697|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
170724724|NCT00815295|616996698|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
170724725|NCT00515502|616996702|FG000|Treatment Period 1|Adverse Event|0|||
170724726|NCT00515502|616996703|FG001|Treatment Period 1|Adverse Event|0|||
170833703|NCT01013961|617399854|FG001|Overall Study|Adverse Event|2|||
170833704|NCT01013961|617399853|FG000|Overall Study|Withdrawal by Subject|1|||
170833705|NCT01013961|617399854|FG001|Overall Study|Withdrawal by Subject|0|||
170833706|NCT01013961|617399853|FG000|Overall Study|Physician Decision|0|||
170833707|NCT01013961|617399854|FG001|Overall Study|Physician Decision|1|||
170833708|NCT02980523|617399855|FG000|Overall Study|Lost to Follow-up|1|||
170833709|NCT02980523|617399856|FG001|Overall Study|Lost to Follow-up|4|||
170833710|NCT02980523|617399857|FG002|Overall Study|Lost to Follow-up|1|||
170833711|NCT02980523|617399858|FG003|Overall Study|Lost to Follow-up|2|||
170833712|NCT02980523|617399859|FG004|Overall Study|Lost to Follow-up|1|||
170833713|NCT02980523|617399855|FG000|Overall Study|Excluded from analysis|1|||
170833714|NCT02980523|617399856|FG001|Overall Study|Excluded from analysis|3|||
170833715|NCT02980523|617399857|FG002|Overall Study|Excluded from analysis|1|||
170833716|NCT02980523|617399858|FG003|Overall Study|Excluded from analysis|1|||
170833717|NCT02980523|617399859|FG004|Overall Study|Excluded from analysis|1|||
170833718|NCT02980523|617399855|FG000|Overall Study|Lack of Efficacy|1|||
170833719|NCT02980523|617399856|FG001|Overall Study|Lack of Efficacy|4|||
170833720|NCT02980523|617399857|FG002|Overall Study|Lack of Efficacy|4|||
170833721|NCT02980523|617399858|FG003|Overall Study|Lack of Efficacy|5|||
170833722|NCT02980523|617399859|FG004|Overall Study|Lack of Efficacy|8|||
170833723|NCT02980523|617399855|FG000|Overall Study|Did not receive intervention|0|||
170833724|NCT02980523|617399856|FG001|Overall Study|Did not receive intervention|0|||
170833725|NCT02980523|617399857|FG002|Overall Study|Did not receive intervention|0|||
170833726|NCT02980523|617399858|FG003|Overall Study|Did not receive intervention|1|||
170833727|NCT02980523|617399859|FG004|Overall Study|Did not receive intervention|0|||
170833728|NCT03021551|617399864|FG000|Overall Study|Equipment Issues|2|||
170833729|NCT03021551|617399864|FG000|Overall Study|Protocol Violation|1|||
170833730|NCT01592045|617399868|FG000|Overall Study|Disease Progression|1|||
170833731|NCT01592045|617399869|FG001|Overall Study|Disease Progression|1|||
170833732|NCT01592045|617399868|FG000|Overall Study|Adverse Event|1|||
170833733|NCT01592045|617399869|FG001|Overall Study|Adverse Event|1|||
170833734|NCT01592045|617399868|FG000|Overall Study|Withdrawal by Subject|1|||
170833735|NCT01592045|617399869|FG001|Overall Study|Withdrawal by Subject|0|||
170833736|NCT01592045|617399868|FG000|Overall Study|Moved out of country|2|||
170833737|NCT01592045|617399869|FG001|Overall Study|Moved out of country|0|||
170833738|NCT01216072|617399871|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
170833739|NCT01216072|617399872|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
170833740|NCT01216072|617399871|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
170833741|NCT01216072|617399872|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
170833742|NCT01216072|617399871|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
170833743|NCT01216072|617399872|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
170833744|NCT01216072|617399871|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
170833745|NCT01216072|617399872|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
170833746|NCT01216072|617399871|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
170833747|NCT01216072|617399872|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
170833748|NCT01216072|617399871|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
170833749|NCT01216072|617399872|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
170833750|NCT01216072|617399871|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
170833751|NCT01216072|617399872|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
170833752|NCT01216072|617399871|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
170833753|NCT01216072|617399872|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
170833754|NCT01216072|617399871|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
170833755|NCT01216072|617399872|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
170833756|NCT01216072|617399871|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
170833757|NCT01216072|617399872|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
170833758|NCT04799418|617399873|FG000|Overall Study|Death|1|||
170833759|NCT04799418|617399874|FG001|Overall Study|Death|1|||
170833760|NCT04799418|617399873|FG000|Overall Study|Lack of Efficacy|14|||
170833761|NCT04799418|617399874|FG001|Overall Study|Lack of Efficacy|14|||
170833762|NCT04799418|617399873|FG000|Overall Study|Withdrawal by Subject|10|||
170833763|NCT04799418|617399874|FG001|Overall Study|Withdrawal by Subject|7|||
170833764|NCT04799418|617399873|FG000|Overall Study|Adverse Event|3|||
170833765|NCT04799418|617399874|FG001|Overall Study|Adverse Event|2|||
170833766|NCT02947100|617399875|FG000|Overall Study|study terminated early|3|||
170833767|NCT02947100|617399875|FG000|Overall Study|did not meet inclusion criteria|1|||
170833768|NCT01080326|617399878|FG000|Overall Study|Patient deterioration prior to procedure|3|||
170833769|NCT01080326|617399878|FG000|Overall Study|Surgeon decision|1|||
170833770|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
170833771|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
170833772|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
170833773|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
170833774|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
170833775|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
170833776|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
170833777|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
170833778|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
170833779|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
170833780|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
170833781|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
170833782|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
170833783|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
170833784|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
170724727|NCT00515502|616996704|FG002|Treatment Period 1|Adverse Event|0|||
170724728|NCT00515502|616996705|FG003|Treatment Period 1|Adverse Event|0|||
170724729|NCT00515502|616996706|FG004|Treatment Period 1|Adverse Event|0|||
170724730|NCT00515502|616996707|FG005|Treatment Period 1|Adverse Event|0|||
170724731|NCT00515502|616996708|FG006|Treatment Period 1|Adverse Event|1|||
170724732|NCT00515502|616996709|FG007|Treatment Period 1|Adverse Event|0|||
170724733|NCT00515502|616996710|FG008|Treatment Period 1|Adverse Event|1|||
170724734|NCT00515502|616996711|FG009|Treatment Period 1|Adverse Event|0|||
170724735|NCT00515502|616996712|FG010|Treatment Period 1|Adverse Event|0|||
170724736|NCT00515502|616996713|FG011|Treatment Period 1|Adverse Event|1|||
170724737|NCT00515502|616996702|FG000|Treatment Period 2|Adverse Event|0|||
170724738|NCT00515502|616996703|FG001|Treatment Period 2|Adverse Event|1|||
170724739|NCT00515502|616996704|FG002|Treatment Period 2|Adverse Event|0|||
170724740|NCT00515502|616996705|FG003|Treatment Period 2|Adverse Event|0|||
170724741|NCT00515502|616996706|FG004|Treatment Period 2|Adverse Event|0|||
170724742|NCT00515502|616996707|FG005|Treatment Period 2|Adverse Event|0|||
170724743|NCT00515502|616996708|FG006|Treatment Period 2|Adverse Event|0|||
170724744|NCT00515502|616996709|FG007|Treatment Period 2|Adverse Event|0|||
170724745|NCT00515502|616996710|FG008|Treatment Period 2|Adverse Event|0|||
170724746|NCT00515502|616996711|FG009|Treatment Period 2|Adverse Event|0|||
170724747|NCT00515502|616996712|FG010|Treatment Period 2|Adverse Event|0|||
170724748|NCT00515502|616996713|FG011|Treatment Period 2|Adverse Event|0|||
170724749|NCT04052204|616996714|FG000|Overall Study|Death|1|||
170724750|NCT04052204|616996715|FG001|Overall Study|Death|0|||
170724751|NCT04052204|616996716|FG002|Overall Study|Death|0|||
170724752|NCT04052204|616996714|FG000|Overall Study|Progressive disease|1|||
170724753|NCT04052204|616996715|FG001|Overall Study|Progressive disease|0|||
170724754|NCT04052204|616996716|FG002|Overall Study|Progressive disease|0|||
170724755|NCT04052204|616996714|FG000|Overall Study|Other|1|||
170724756|NCT04052204|616996715|FG001|Overall Study|Other|0|||
170724757|NCT04052204|616996716|FG002|Overall Study|Other|0|||
170724758|NCT03945188|616996717|FG000|Overall Study|Protocol Violation|1|||
170724759|NCT03945188|616996718|FG001|Overall Study|Protocol Violation|0|||
170724760|NCT03945188|616996717|FG000|Overall Study|Disease worsening|79|||
170724761|NCT03945188|616996718|FG001|Overall Study|Disease worsening|73|||
170724762|NCT03945188|616996717|FG000|Overall Study|Physician Decision|2|||
170724763|NCT03945188|616996718|FG001|Overall Study|Physician Decision|2|||
170724764|NCT03945188|616996717|FG000|Overall Study|Lack of Efficacy|7|||
170724765|NCT03945188|616996718|FG001|Overall Study|Lack of Efficacy|4|||
170724766|NCT03945188|616996717|FG000|Overall Study|Pregnancy|2|||
170724767|NCT03945188|616996718|FG001|Overall Study|Pregnancy|0|||
170724768|NCT03945188|616996717|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
170724769|NCT03945188|616996718|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
170724770|NCT03945188|616996717|FG000|Overall Study|Adverse Event|10|||
170724771|NCT03945188|616996718|FG001|Overall Study|Adverse Event|5|||
170724772|NCT03945188|616996717|FG000|Overall Study|Other|2|||
170724773|NCT03945188|616996718|FG001|Overall Study|Other|2|||
170724774|NCT03945188|616996717|FG000|Overall Study|Lost to Follow-up|1|||
170724775|NCT03945188|616996718|FG001|Overall Study|Lost to Follow-up|2|||
170724776|NCT01433354|616996720|FG000|Overall Study|Adverse Event|6|||
170724777|NCT01433354|616996720|FG000|Overall Study|Lost to Follow-up|1|||
170724778|NCT01433354|616996720|FG000|Overall Study|Administrative problems|90|||
170833785|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
170833786|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
170833787|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
170833788|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Missing|2|||
170833789|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Missing|1|||
170833790|NCT00443209|617399880|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
170833791|NCT00443209|617399881|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
170833792|NCT00443209|617399880|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
170833793|NCT00443209|617399881|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
170833794|NCT00443209|617399880|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
170833795|NCT00443209|617399881|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
170724779|NCT01433354|616996720|FG000|Overall Study|Protocol Violation|2|||
170724780|NCT01433354|616996720|FG000|Overall Study|Lack of Efficacy|17|||
170724781|NCT01433354|616996720|FG000|Overall Study|Subject Withdrew Consent|3|||
170724782|NCT04794803|616996729|FG000|Overall Study|Death|1|||
170724783|NCT04794803|616996730|FG001|Overall Study|Death|3|||
170724784|NCT04794803|616996729|FG000|Overall Study|Lost to Follow-up|2|||
170724785|NCT04794803|616996730|FG001|Overall Study|Lost to Follow-up|2|||
170724786|NCT04794803|616996729|FG000|Overall Study|Withdrawal by Subject|1|||
170724787|NCT04794803|616996730|FG001|Overall Study|Withdrawal by Subject|0|||
170724788|NCT04794803|616996729|FG000|Overall Study|Physician Decision|1|||
170724789|NCT04794803|616996730|FG001|Overall Study|Physician Decision|1|||
170724790|NCT04794803|616996729|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
170724791|NCT04794803|616996730|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
170724792|NCT04794803|616996729|FG000|Overall Study|Refused to continue the treatment|1|||
170724793|NCT04794803|616996730|FG001|Overall Study|Refused to continue the treatment|0|||
170724794|NCT04794803|616996729|FG000|Overall Study|Patient admitted to ICU|0|||
170724795|NCT04794803|616996730|FG001|Overall Study|Patient admitted to ICU|1|||
170724796|NCT04124926|616996735|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
170724797|NCT04124926|616996736|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
170724798|NCT04124926|616996737|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
170724799|NCT04124926|616996738|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
170724800|NCT04124926|616996739|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
170724801|NCT04124926|616996735|FG000|Healing Phase|Protocol Violation|0|||
170724802|NCT04124926|616996736|FG001|Healing Phase|Protocol Violation|1|||
170724803|NCT04124926|616996737|FG002|Healing Phase|Protocol Violation|0|||
170724804|NCT04124926|616996738|FG003|Healing Phase|Protocol Violation|0|||
170724805|NCT04124926|616996739|FG004|Healing Phase|Protocol Violation|0|||
170724806|NCT04124926|616996735|FG000|Healing Phase|Lost to Follow-up|5|||
170724807|NCT04124926|616996736|FG001|Healing Phase|Lost to Follow-up|4|||
170724808|NCT04124926|616996737|FG002|Healing Phase|Lost to Follow-up|0|||
170724809|NCT04124926|616996738|FG003|Healing Phase|Lost to Follow-up|0|||
170724810|NCT04124926|616996739|FG004|Healing Phase|Lost to Follow-up|0|||
170724811|NCT04124926|616996735|FG000|Healing Phase|Voluntary Withdrawal|10|||
170724812|NCT04124926|616996736|FG001|Healing Phase|Voluntary Withdrawal|7|||
170724813|NCT04124926|616996737|FG002|Healing Phase|Voluntary Withdrawal|0|||
170724814|NCT04124926|616996738|FG003|Healing Phase|Voluntary Withdrawal|0|||
170724815|NCT04124926|616996739|FG004|Healing Phase|Voluntary Withdrawal|0|||
170724816|NCT04124926|616996735|FG000|Healing Phase|Withdrawal of Consent|5|||
170724817|NCT04124926|616996736|FG001|Healing Phase|Withdrawal of Consent|3|||
170724818|NCT04124926|616996737|FG002|Healing Phase|Withdrawal of Consent|0|||
170724819|NCT04124926|616996738|FG003|Healing Phase|Withdrawal of Consent|0|||
170724820|NCT04124926|616996739|FG004|Healing Phase|Withdrawal of Consent|0|||
170724821|NCT04124926|616996735|FG000|Healing Phase|Miscellaneous|8|||
170724822|NCT04124926|616996736|FG001|Healing Phase|Miscellaneous|7|||
170724823|NCT04124926|616996737|FG002|Healing Phase|Miscellaneous|0|||
170724824|NCT04124926|616996738|FG003|Healing Phase|Miscellaneous|0|||
170724825|NCT04124926|616996739|FG004|Healing Phase|Miscellaneous|0|||
170724826|NCT04124926|616996735|FG000|Healing Phase|Randomized but not Treated|0|||
170724827|NCT04124926|616996736|FG001|Healing Phase|Randomized but not Treated|3|||
170724828|NCT04124926|616996737|FG002|Healing Phase|Randomized but not Treated|0|||
170724829|NCT04124926|616996738|FG003|Healing Phase|Randomized but not Treated|0|||
170724830|NCT04124926|616996739|FG004|Healing Phase|Randomized but not Treated|0|||
170724831|NCT04124926|616996735|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
170724832|NCT04124926|616996736|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
170724833|NCT04124926|616996737|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
170724834|NCT04124926|616996738|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
170724835|NCT04124926|616996739|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
170724836|NCT04124926|616996735|FG000|Maintenance Phase|Protocol Violation|0|||
170724837|NCT04124926|616996736|FG001|Maintenance Phase|Protocol Violation|0|||
170724838|NCT04124926|616996737|FG002|Maintenance Phase|Protocol Violation|3|||
170724839|NCT04124926|616996738|FG003|Maintenance Phase|Protocol Violation|0|||
170724840|NCT04124926|616996739|FG004|Maintenance Phase|Protocol Violation|0|||
170724841|NCT04124926|616996735|FG000|Maintenance Phase|Lost to Follow-up|0|||
170724842|NCT04124926|616996736|FG001|Maintenance Phase|Lost to Follow-up|0|||
170724843|NCT04124926|616996737|FG002|Maintenance Phase|Lost to Follow-up|7|||
170724844|NCT04124926|616996738|FG003|Maintenance Phase|Lost to Follow-up|8|||
170724845|NCT04124926|616996739|FG004|Maintenance Phase|Lost to Follow-up|9|||
170724846|NCT04124926|616996735|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
170724847|NCT04124926|616996736|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
170724848|NCT04124926|616996737|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
170724849|NCT04124926|616996738|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
170724850|NCT04124926|616996739|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
170724851|NCT04124926|616996735|FG000|Maintenance Phase|Pregnancy|0|||
170724852|NCT04124926|616996736|FG001|Maintenance Phase|Pregnancy|0|||
170724853|NCT04124926|616996737|FG002|Maintenance Phase|Pregnancy|0|||
170724854|NCT04124926|616996738|FG003|Maintenance Phase|Pregnancy|1|||
170724855|NCT04124926|616996739|FG004|Maintenance Phase|Pregnancy|0|||
170724856|NCT04124926|616996735|FG000|Maintenance Phase|Lack of Efficacy|0|||
170724857|NCT04124926|616996736|FG001|Maintenance Phase|Lack of Efficacy|0|||
170724858|NCT04124926|616996737|FG002|Maintenance Phase|Lack of Efficacy|0|||
170724859|NCT04124926|616996738|FG003|Maintenance Phase|Lack of Efficacy|0|||
170724860|NCT04124926|616996739|FG004|Maintenance Phase|Lack of Efficacy|1|||
170724861|NCT04124926|616996735|FG000|Maintenance Phase|Withdrawal of Consent|0|||
170724862|NCT04124926|616996736|FG001|Maintenance Phase|Withdrawal of Consent|0|||
170724863|NCT04124926|616996737|FG002|Maintenance Phase|Withdrawal of Consent|5|||
170724864|NCT04124926|616996738|FG003|Maintenance Phase|Withdrawal of Consent|5|||
170724865|NCT04124926|616996739|FG004|Maintenance Phase|Withdrawal of Consent|5|||
170724866|NCT04124926|616996735|FG000|Maintenance Phase|Miscellaneous|0|||
170833796|NCT00443209|617399880|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
170833797|NCT00443209|617399881|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
170833798|NCT00443209|617399880|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
170833799|NCT00443209|617399881|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
170833800|NCT00443209|617399880|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
170833801|NCT00443209|617399881|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
170833802|NCT00443209|617399880|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
170833803|NCT00443209|617399881|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
170833804|NCT00952848|617399884|FG000|Overall Study|Withdrawal by Subject|4|||
170833805|NCT02250534|617399885|FG000|Overall Study|Lost to Follow-up|18|||
170833806|NCT02250534|617399886|FG001|Overall Study|Lost to Follow-up|28|||
170833807|NCT02250534|617399887|FG002|Overall Study|Lost to Follow-up|33|||
170833808|NCT02250534|617399885|FG000|Overall Study|Personal reasons|7|||
170833809|NCT02250534|617399886|FG001|Overall Study|Personal reasons|8|||
170833810|NCT02250534|617399887|FG002|Overall Study|Personal reasons|14|||
170833811|NCT02250534|617399885|FG000|Overall Study|Adverse Event|6|||
170833812|NCT02250534|617399886|FG001|Overall Study|Adverse Event|3|||
170833813|NCT02250534|617399887|FG002|Overall Study|Adverse Event|8|||
170833814|NCT02250534|617399885|FG000|Overall Study|incarcerated|2|||
170833815|NCT02250534|617399886|FG001|Overall Study|incarcerated|1|||
170833816|NCT02250534|617399887|FG002|Overall Study|incarcerated|2|||
170833817|NCT02250534|617399885|FG000|Overall Study|Withdrawal by Subject|0|||
170833818|NCT02250534|617399886|FG001|Overall Study|Withdrawal by Subject|1|||
170833819|NCT02250534|617399887|FG002|Overall Study|Withdrawal by Subject|2|||
170833820|NCT02250534|617399885|FG000|Overall Study|Death|0|||
170833821|NCT02250534|617399886|FG001|Overall Study|Death|1|||
170833822|NCT02250534|617399887|FG002|Overall Study|Death|1|||
170833823|NCT02250534|617399885|FG000|Overall Study|Physician Decision|1|||
170833824|NCT02250534|617399886|FG001|Overall Study|Physician Decision|3|||
170833825|NCT02250534|617399887|FG002|Overall Study|Physician Decision|1|||
170833826|NCT02250534|617399885|FG000|Overall Study|Protocol Violation|1|||
170833827|NCT02250534|617399886|FG001|Overall Study|Protocol Violation|0|||
170833828|NCT02250534|617399887|FG002|Overall Study|Protocol Violation|1|||
170833829|NCT02250534|617399885|FG000|Overall Study|Reason unknown|1|||
170833830|NCT02250534|617399886|FG001|Overall Study|Reason unknown|0|||
170833831|NCT02250534|617399887|FG002|Overall Study|Reason unknown|0|||
170833832|NCT01628692|617399890|FG000|Overall Study|Lack of Efficacy|4|||
170833833|NCT01628692|617399891|FG001|Overall Study|Lack of Efficacy|4|||
170833834|NCT01628692|617399892|FG002|Overall Study|Lack of Efficacy|5|||
170833835|NCT01628692|617399893|FG003|Overall Study|Lack of Efficacy|1|||
170833836|NCT01628692|617399894|FG004|Overall Study|Lack of Efficacy|4|||
170833837|NCT01628692|617399895|FG005|Overall Study|Lack of Efficacy|7|||
170833838|NCT01628692|617399890|FG000|Overall Study|Adverse Event|2|||
170833839|NCT01628692|617399891|FG001|Overall Study|Adverse Event|0|||
170833840|NCT01628692|617399892|FG002|Overall Study|Adverse Event|2|||
170833841|NCT01628692|617399893|FG003|Overall Study|Adverse Event|0|||
170833842|NCT01628692|617399894|FG004|Overall Study|Adverse Event|0|||
170833843|NCT01628692|617399895|FG005|Overall Study|Adverse Event|0|||
170833844|NCT01628692|617399890|FG000|Overall Study|Withdrawal by Subject|0|||
170833845|NCT01628692|617399891|FG001|Overall Study|Withdrawal by Subject|1|||
170833846|NCT01628692|617399892|FG002|Overall Study|Withdrawal by Subject|1|||
170833847|NCT01628692|617399893|FG003|Overall Study|Withdrawal by Subject|0|||
170833848|NCT01628692|617399894|FG004|Overall Study|Withdrawal by Subject|0|||
170833849|NCT01628692|617399895|FG005|Overall Study|Withdrawal by Subject|0|||
170833850|NCT01628692|617399890|FG000|Overall Study|Death|0|||
170833851|NCT01628692|617399891|FG001|Overall Study|Death|1|||
170833852|NCT01628692|617399892|FG002|Overall Study|Death|0|||
170833853|NCT01628692|617399893|FG003|Overall Study|Death|0|||
170833854|NCT01628692|617399894|FG004|Overall Study|Death|0|||
170833855|NCT01628692|617399895|FG005|Overall Study|Death|0|||
170833856|NCT01628692|617399890|FG000|Overall Study|Poor compliance/noncompliance|1|||
170833857|NCT01628692|617399891|FG001|Overall Study|Poor compliance/noncompliance|0|||
170833858|NCT01628692|617399892|FG002|Overall Study|Poor compliance/noncompliance|0|||
170833859|NCT01628692|617399893|FG003|Overall Study|Poor compliance/noncompliance|0|||
170833860|NCT01628692|617399894|FG004|Overall Study|Poor compliance/noncompliance|0|||
170833861|NCT01628692|617399895|FG005|Overall Study|Poor compliance/noncompliance|0|||
170833862|NCT01628692|617399890|FG000|Overall Study|Administrative reason by sponsor|0|||
170833863|NCT01628692|617399891|FG001|Overall Study|Administrative reason by sponsor|0|||
170833864|NCT01628692|617399892|FG002|Overall Study|Administrative reason by sponsor|0|||
170833865|NCT01628692|617399893|FG003|Overall Study|Administrative reason by sponsor|0|||
170833866|NCT01628692|617399894|FG004|Overall Study|Administrative reason by sponsor|0|||
170833867|NCT01628692|617399895|FG005|Overall Study|Administrative reason by sponsor|1|||
170833868|NCT01628692|617399890|FG000|Overall Study|Completed 12 Week only|0|||
170833869|NCT01628692|617399891|FG001|Overall Study|Completed 12 Week only|0|||
170833870|NCT01628692|617399892|FG002|Overall Study|Completed 12 Week only|0|||
170833871|NCT01628692|617399893|FG003|Overall Study|Completed 12 Week only|0|||
170833872|NCT01628692|617399894|FG004|Overall Study|Completed 12 Week only|0|||
170833873|NCT01628692|617399895|FG005|Overall Study|Completed 12 Week only|1|||
170833874|NCT01253447|617399896|FG000|Overall Study|Adverse Event|2|||
170833875|NCT01560871|617399897|FG000|Overall Study|transportation issues|2|||
170833876|NCT01560871|617399898|FG001|Overall Study|transportation issues|1|||
170833877|NCT01560871|617399897|FG000|Overall Study|relocation|1|||
170833878|NCT01560871|617399898|FG001|Overall Study|relocation|0|||
170833879|NCT01560871|617399897|FG000|Overall Study|readmission to a hospital|2|||
170833880|NCT01560871|617399898|FG001|Overall Study|readmission to a hospital|1|||
170833881|NCT01560871|617399897|FG000|Overall Study|Lost to Follow-up|1|||
170833882|NCT01560871|617399898|FG001|Overall Study|Lost to Follow-up|0|||
170833883|NCT00857233|617399899|FG000|Overall Study|Adverse Event|24|||
170833884|NCT00857233|617399899|FG000|Overall Study|Lack of Efficacy|1|||
170833885|NCT00857233|617399899|FG000|Overall Study|Non-compliance|1|||
170833886|NCT00857233|617399899|FG000|Overall Study|Withdrawal of Consent|9|||
170833887|NCT00857233|617399899|FG000|Overall Study|Lost to Follow-up|4|||
170833888|NCT00857233|617399899|FG000|Overall Study|Nursing Home Placement|14|||
170833889|NCT00857233|617399899|FG000|Overall Study|Other Reasons|2|||
170833890|NCT01575873|617399904|FG000|Overall Study|Withdrawal by Subject|15|||
170833891|NCT01575873|617399905|FG001|Overall Study|Withdrawal by Subject|20|||
170833892|NCT01575873|617399906|FG002|Overall Study|Withdrawal by Subject|34|||
170833893|NCT01575873|617399907|FG003|Overall Study|Withdrawal by Subject|34|||
170833894|NCT01575873|617399904|FG000|Overall Study|Adverse Event|7|||
170833895|NCT01575873|617399905|FG001|Overall Study|Adverse Event|7|||
170833896|NCT01575873|617399906|FG002|Overall Study|Adverse Event|9|||
170833897|NCT01575873|617399907|FG003|Overall Study|Adverse Event|12|||
170833898|NCT01575873|617399904|FG000|Overall Study|Lost to Follow-up|1|||
170833899|NCT01575873|617399905|FG001|Overall Study|Lost to Follow-up|3|||
170833900|NCT01575873|617399906|FG002|Overall Study|Lost to Follow-up|13|||
170833901|NCT01575873|617399907|FG003|Overall Study|Lost to Follow-up|5|||
170833902|NCT01575873|617399904|FG000|Overall Study|Death|3|||
170833903|NCT01575873|617399905|FG001|Overall Study|Death|2|||
170833904|NCT01575873|617399906|FG002|Overall Study|Death|8|||
170833905|NCT01575873|617399907|FG003|Overall Study|Death|9|||
170833906|NCT01575873|617399904|FG000|Overall Study|Noncompliance|1|||
170833907|NCT01575873|617399905|FG001|Overall Study|Noncompliance|2|||
170833908|NCT01575873|617399906|FG002|Overall Study|Noncompliance|4|||
170833909|NCT01575873|617399907|FG003|Overall Study|Noncompliance|3|||
170833910|NCT01575873|617399904|FG000|Overall Study|Administrative decision|1|||
170833911|NCT01575873|617399905|FG001|Overall Study|Administrative decision|1|||
170833912|NCT01575873|617399906|FG002|Overall Study|Administrative decision|1|||
170833913|NCT01575873|617399907|FG003|Overall Study|Administrative decision|0|||
170833914|NCT01575873|617399904|FG000|Overall Study|Protocol deviation|0|||
170833915|NCT01575873|617399905|FG001|Overall Study|Protocol deviation|1|||
170833916|NCT01575873|617399906|FG002|Overall Study|Protocol deviation|0|||
170833917|NCT01575873|617399907|FG003|Overall Study|Protocol deviation|1|||
170833918|NCT01575873|617399904|FG000|Overall Study|Requirement for Alternative Therapy|0|||
170833919|NCT01575873|617399905|FG001|Overall Study|Requirement for Alternative Therapy|0|||
170833920|NCT01575873|617399906|FG002|Overall Study|Requirement for Alternative Therapy|1|||
170833921|NCT01575873|617399907|FG003|Overall Study|Requirement for Alternative Therapy|1|||
170833922|NCT01575873|617399904|FG000|Overall Study|Other|0|||
170833923|NCT01575873|617399905|FG001|Overall Study|Other|0|||
170833924|NCT01575873|617399906|FG002|Overall Study|Other|4|||
170833925|NCT01575873|617399907|FG003|Overall Study|Other|2|||
170833926|NCT02658175|617399908|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
170833927|NCT02658175|617399909|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
170833928|NCT02658175|617399910|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
170833929|NCT02658175|617399908|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
170833930|NCT02658175|617399909|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
170724867|NCT04124926|616996736|FG001|Maintenance Phase|Miscellaneous|0|||
170724868|NCT04124926|616996737|FG002|Maintenance Phase|Miscellaneous|1|||
170724869|NCT04124926|616996738|FG003|Maintenance Phase|Miscellaneous|2|||
170724870|NCT04124926|616996739|FG004|Maintenance Phase|Miscellaneous|4|||
170724871|NCT04124926|616996735|FG000|Maintenance Phase|Randomized but not Treated|0|||
170724872|NCT04124926|616996736|FG001|Maintenance Phase|Randomized but not Treated|0|||
170724873|NCT04124926|616996737|FG002|Maintenance Phase|Randomized but not Treated|2|||
170724874|NCT04124926|616996738|FG003|Maintenance Phase|Randomized but not Treated|2|||
170724875|NCT04124926|616996739|FG004|Maintenance Phase|Randomized but not Treated|0|||
170724876|NCT03321396|616996744|FG000|Overall Study|Physician Decision|1|||
170724877|NCT00937924|616996747|FG000|Overall Study|Lost to Follow-up|44|||
170724878|NCT00937924|616996748|FG001|Overall Study|Lost to Follow-up|44|||
170724879|NCT00937924|616996749|FG002|Overall Study|Lost to Follow-up|41|||
170724880|NCT03280121|616996750|FG000|Overall Study|Physician Decision|1|||
170724881|NCT03280121|616996750|FG000|Overall Study|Lost to Follow-up|1|||
170724882|NCT03280121|616996750|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
170724883|NCT00224874|616996751|FG000|Overall Study|Withdrawal by Subject|0|||
170724884|NCT00224874|616996752|FG001|Overall Study|Withdrawal by Subject|0|||
170724885|NCT00224874|616996753|FG002|Overall Study|Withdrawal by Subject|1|||
170724886|NCT00224874|616996754|FG003|Overall Study|Withdrawal by Subject|0|||
170724887|NCT05585307|616996764|FG000|Overall Study|Lost to Follow-up|0|||
170724888|NCT05585307|616996765|FG001|Overall Study|Lost to Follow-up|0|||
170724889|NCT05585307|616996766|FG002|Overall Study|Lost to Follow-up|0|||
170724890|NCT05585307|616996767|FG003|Overall Study|Lost to Follow-up|0|||
170724891|NCT05585307|616996768|FG004|Overall Study|Lost to Follow-up|0|||
170724892|NCT05585307|616996769|FG005|Overall Study|Lost to Follow-up|0|||
170724893|NCT05585307|616996770|FG006|Overall Study|Lost to Follow-up|1|||
170724894|NCT05585307|616996771|FG007|Overall Study|Lost to Follow-up|0|||
170724895|NCT01972841|616996772|FG000|Overall Study|Randomized but Never Received Treatment|2|||
170724896|NCT01972841|616996773|FG001|Overall Study|Randomized but Never Received Treatment|5|||
170724897|NCT01972841|616996774|FG002|Overall Study|Randomized but Never Received Treatment|4|||
170724898|NCT01972841|616996775|FG003|Overall Study|Randomized but Never Received Treatment|2|||
170724899|NCT01972841|616996776|FG004|Overall Study|Randomized but Never Received Treatment|6|||
170724900|NCT01972841|616996777|FG005|Overall Study|Randomized but Never Received Treatment|13|||
170724901|NCT01972841|616996772|FG000|Overall Study|Adverse Event|13|||
170724902|NCT01972841|616996773|FG001|Overall Study|Adverse Event|8|||
170724903|NCT01972841|616996774|FG002|Overall Study|Adverse Event|12|||
170724904|NCT01972841|616996775|FG003|Overall Study|Adverse Event|9|||
170724905|NCT01972841|616996776|FG004|Overall Study|Adverse Event|21|||
170724906|NCT01972841|616996777|FG005|Overall Study|Adverse Event|26|||
170724907|NCT01972841|616996772|FG000|Overall Study|Lack of Efficacy|1|||
170724908|NCT01972841|616996773|FG001|Overall Study|Lack of Efficacy|0|||
170724909|NCT01972841|616996774|FG002|Overall Study|Lack of Efficacy|0|||
170724910|NCT01972841|616996775|FG003|Overall Study|Lack of Efficacy|2|||
170724911|NCT01972841|616996776|FG004|Overall Study|Lack of Efficacy|4|||
170724912|NCT01972841|616996777|FG005|Overall Study|Lack of Efficacy|1|||
170724913|NCT01972841|616996772|FG000|Overall Study|Lost to Follow-up|4|||
170724914|NCT01972841|616996773|FG001|Overall Study|Lost to Follow-up|2|||
170724915|NCT01972841|616996774|FG002|Overall Study|Lost to Follow-up|4|||
170724916|NCT01972841|616996775|FG003|Overall Study|Lost to Follow-up|2|||
170724917|NCT01972841|616996776|FG004|Overall Study|Lost to Follow-up|9|||
170724918|NCT01972841|616996777|FG005|Overall Study|Lost to Follow-up|3|||
170724919|NCT01972841|616996772|FG000|Overall Study|Protocol Violation|2|||
170724920|NCT01972841|616996773|FG001|Overall Study|Protocol Violation|2|||
170724921|NCT01972841|616996774|FG002|Overall Study|Protocol Violation|3|||
170724922|NCT01972841|616996775|FG003|Overall Study|Protocol Violation|5|||
170724923|NCT01972841|616996776|FG004|Overall Study|Protocol Violation|9|||
170724924|NCT01972841|616996777|FG005|Overall Study|Protocol Violation|4|||
170724925|NCT01972841|616996772|FG000|Overall Study|Withdrawal by participants|21|||
170724926|NCT01972841|616996773|FG001|Overall Study|Withdrawal by participants|27|||
170724927|NCT01972841|616996774|FG002|Overall Study|Withdrawal by participants|23|||
170724928|NCT01972841|616996775|FG003|Overall Study|Withdrawal by participants|16|||
170724929|NCT01972841|616996776|FG004|Overall Study|Withdrawal by participants|33|||
170724930|NCT01972841|616996777|FG005|Overall Study|Withdrawal by participants|34|||
170724931|NCT01972841|616996772|FG000|Overall Study|Miscellaneous|0|||
170724932|NCT01972841|616996773|FG001|Overall Study|Miscellaneous|0|||
170724933|NCT01972841|616996774|FG002|Overall Study|Miscellaneous|4|||
170724934|NCT01972841|616996775|FG003|Overall Study|Miscellaneous|1|||
170724935|NCT01972841|616996776|FG004|Overall Study|Miscellaneous|0|||
170724936|NCT01972841|616996777|FG005|Overall Study|Miscellaneous|4|||
170724937|NCT01972841|616996772|FG000|Overall Study|Did not have end of treatment page|0|||
170724938|NCT01972841|616996773|FG001|Overall Study|Did not have end of treatment page|0|||
170724939|NCT01972841|616996774|FG002|Overall Study|Did not have end of treatment page|0|||
170724940|NCT01972841|616996775|FG003|Overall Study|Did not have end of treatment page|0|||
170724941|NCT01972841|616996776|FG004|Overall Study|Did not have end of treatment page|1|||
170724942|NCT01972841|616996777|FG005|Overall Study|Did not have end of treatment page|0|||
170724943|NCT02734212|616996778|FG000|Overall Study|Lost to Follow-up|5|||
170724944|NCT02734212|616996779|FG001|Overall Study|Lost to Follow-up|10|||
170724945|NCT04084314|616996785|FG000|Overall Study|Subject/guardian decision|91|||
170724946|NCT04084314|616996785|FG000|Overall Study|Adverse Event|24|||
170724947|NCT04084314|616996785|FG000|Overall Study|Lost to Follow-up|19|||
170724948|NCT04084314|616996785|FG000|Overall Study|New therapy for study indication|9|||
170724949|NCT04084314|616996785|FG000|Overall Study|Pregnancy|9|||
170724950|NCT04084314|616996785|FG000|Overall Study|Withdrawal of informed consent|8|||
170724951|NCT04084314|616996785|FG000|Overall Study|Physician Decision|4|||
170724952|NCT04084314|616996785|FG000|Overall Study|Protocol Deviation|3|||
170724953|NCT03346759|616996786|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
170724954|NCT03346759|616996787|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
170724955|NCT03346759|616996786|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
170724956|NCT03346759|616996787|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
170724957|NCT03346759|616996786|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
170724958|NCT03346759|616996787|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
170724959|NCT03943095|616996788|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
170724960|NCT03943095|616996789|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
170724961|NCT03943095|616996788|FG000|Overall Study|Withdrawal by Subject|1|||
170724962|NCT03943095|616996789|FG001|Overall Study|Withdrawal by Subject|0|||
170724963|NCT00679939|616996793|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
170724964|NCT00679939|616996794|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
170724965|NCT00679939|616996793|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
170724966|NCT00679939|616996794|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
170724967|NCT00679939|616996793|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
170724968|NCT00679939|616996794|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
170724969|NCT00679939|616996793|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
170724970|NCT00679939|616996794|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
170724971|NCT00679939|616996793|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
170724972|NCT00679939|616996794|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
170724973|NCT00679939|616996793|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
170724974|NCT00679939|616996794|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
170724975|NCT00679939|616996793|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
170724976|NCT00679939|616996794|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
170724977|NCT00679939|616996793|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
170724978|NCT00679939|616996794|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
170724979|NCT00679939|616996793|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
170724980|NCT00679939|616996794|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
170724981|NCT00679939|616996793|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
170724982|NCT00679939|616996794|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
170724983|NCT00710424|616996795|FG000|Overall Study|Adverse Event|30|||
170724984|NCT00710424|616996796|FG001|Overall Study|Adverse Event|12|||
170724985|NCT00710424|616996795|FG000|Overall Study|Lack of Efficacy|4|||
170724986|NCT00710424|616996796|FG001|Overall Study|Lack of Efficacy|5|||
170724987|NCT00710424|616996795|FG000|Overall Study|Withdrawal by Subject|5|||
170724988|NCT00710424|616996796|FG001|Overall Study|Withdrawal by Subject|3|||
170724989|NCT00710424|616996795|FG000|Overall Study|Lost to Follow-up|0|||
170724990|NCT00710424|616996796|FG001|Overall Study|Lost to Follow-up|1|||
170724991|NCT00710424|616996795|FG000|Overall Study|Refused medication, no side effects|1|||
170724992|NCT00710424|616996796|FG001|Overall Study|Refused medication, no side effects|0|||
170724993|NCT00710424|616996795|FG000|Overall Study|Non-compliance with stable analgesia|1|||
170724994|NCT00710424|616996796|FG001|Overall Study|Non-compliance with stable analgesia|0|||
170724995|NCT00710424|616996795|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
170724996|NCT00710424|616996796|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
170724997|NCT00710424|616996795|FG000|Overall Study|Subject thought medication changed|1|||
170724998|NCT00710424|616996796|FG001|Overall Study|Subject thought medication changed|0|||
170724999|NCT00710424|616996795|FG000|Overall Study|Ceased treatment due to travel|1|||
170725000|NCT00710424|616996796|FG001|Overall Study|Ceased treatment due to travel|0|||
170725001|NCT00710424|616996795|FG000|Overall Study|Subject preferred paracetamol|0|||
170725002|NCT00710424|616996796|FG001|Overall Study|Subject preferred paracetamol|1|||
170725003|NCT00710424|616996795|FG000|Overall Study|Felt good so stopped treatment|0|||
170725004|NCT00710424|616996796|FG001|Overall Study|Felt good so stopped treatment|1|||
170725005|NCT06273774|616996797|FG000|Overall Study|Participant was out of state.|0|||
170725006|NCT06273774|616996798|FG001|Overall Study|Participant was out of state.|0|||
170725007|NCT06273774|616996799|FG002|Overall Study|Participant was out of state.|0|||
170725008|NCT06273774|616996800|FG003|Overall Study|Participant was out of state.|0|||
170725009|NCT06273774|616996801|FG004|Overall Study|Participant was out of state.|0|||
170725010|NCT06273774|616996802|FG005|Overall Study|Participant was out of state.|1|||
170725011|NCT06273774|616996797|FG000|Overall Study|Lost to Follow-up|0|||
170725012|NCT06273774|616996798|FG001|Overall Study|Lost to Follow-up|0|||
170725013|NCT06273774|616996799|FG002|Overall Study|Lost to Follow-up|0|||
170833931|NCT02658175|617399910|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
170833932|NCT02658175|617399908|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
170833933|NCT02658175|617399909|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
170833934|NCT02658175|617399910|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
170833935|NCT02658175|617399908|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
170833936|NCT02658175|617399909|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
170833937|NCT02658175|617399910|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
170833938|NCT02658175|617399908|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
170833939|NCT02658175|617399909|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
170833940|NCT02658175|617399910|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
170833941|NCT02658175|617399908|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
170833942|NCT02658175|617399909|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
170833943|NCT02658175|617399910|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
170833944|NCT02658175|617399908|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
170833945|NCT02658175|617399909|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
170833946|NCT02658175|617399910|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
170833947|NCT02658175|617399908|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
170833948|NCT02658175|617399909|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
170833949|NCT02658175|617399910|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
170833950|NCT02658175|617399908|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
170833951|NCT02658175|617399909|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
170833952|NCT02658175|617399910|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
170833953|NCT02658175|617399908|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
170833954|NCT02658175|617399909|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
170833955|NCT02658175|617399910|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
170833956|NCT04665245|617399914|FG000|Overall Study|Lost to Follow-up|18|||
170833957|NCT03461289|617399915|FG000|Overall Study|Death|1|||
170833958|NCT02900976|617399916|FG000|Overall Study|Adverse Event|0|||
170833959|NCT02900976|617399917|FG001|Overall Study|Adverse Event|1|||
170833960|NCT02900976|617399916|FG000|Overall Study|Physician Decision|0|||
170833961|NCT02900976|617399917|FG001|Overall Study|Physician Decision|2|||
170833962|NCT02900976|617399916|FG000|Overall Study|Progressive disease|0|||
170833963|NCT02900976|617399917|FG001|Overall Study|Progressive disease|6|||
170833964|NCT06319170|617399919|FG000|1-Day Treatment Period|Enrolled But Not Treated|8|||
170833965|NCT06319170|617399920|FG001|1-Day Treatment Period|Enrolled But Not Treated|0|||
170833966|NCT06319170|617399921|FG002|1-Day Treatment Period|Enrolled But Not Treated|0|||
170833967|NCT06319170|617399922|FG003|1-Day Treatment Period|Enrolled But Not Treated|0|||
170833968|NCT06319170|617399919|FG000|1-Day Treatment Period|Withdrawal by Subject|3|||
170833969|NCT06319170|617399920|FG001|1-Day Treatment Period|Withdrawal by Subject|0|||
170833970|NCT06319170|617399921|FG002|1-Day Treatment Period|Withdrawal by Subject|0|||
170833971|NCT06319170|617399922|FG003|1-Day Treatment Period|Withdrawal by Subject|0|||
170833972|NCT06319170|617399919|FG000|1-Day Treatment Period|Lost to Follow-up|2|||
170833973|NCT06319170|617399920|FG001|1-Day Treatment Period|Lost to Follow-up|0|||
170833974|NCT06319170|617399921|FG002|1-Day Treatment Period|Lost to Follow-up|0|||
170833975|NCT06319170|617399922|FG003|1-Day Treatment Period|Lost to Follow-up|0|||
170833976|NCT06319170|617399919|FG000|1-Day Treatment Period|Other Than Specified|2|||
170833977|NCT06319170|617399920|FG001|1-Day Treatment Period|Other Than Specified|0|||
170833978|NCT06319170|617399921|FG002|1-Day Treatment Period|Other Than Specified|0|||
170833979|NCT06319170|617399922|FG003|1-Day Treatment Period|Other Than Specified|0|||
170833980|NCT06319170|617399919|FG000|28-Day Treatment Period|Withdrawal by Subject|0|||
170833981|NCT06319170|617399920|FG001|28-Day Treatment Period|Withdrawal by Subject|0|||
170833982|NCT06319170|617399921|FG002|28-Day Treatment Period|Withdrawal by Subject|2|||
170833983|NCT06319170|617399922|FG003|28-Day Treatment Period|Withdrawal by Subject|0|||
170833984|NCT06319170|617399919|FG000|28-Day Treatment Period|Other Than Specified|0|||
170833985|NCT06319170|617399920|FG001|28-Day Treatment Period|Other Than Specified|1|||
170833986|NCT06319170|617399921|FG002|28-Day Treatment Period|Other Than Specified|0|||
170833987|NCT06319170|617399922|FG003|28-Day Treatment Period|Other Than Specified|0|||
170833988|NCT06319170|617399919|FG000|8-Week Follow-up Period|Lost to Follow-up|0|||
170833989|NCT06319170|617399920|FG001|8-Week Follow-up Period|Lost to Follow-up|1|||
170833990|NCT06319170|617399921|FG002|8-Week Follow-up Period|Lost to Follow-up|1|||
170833991|NCT06319170|617399922|FG003|8-Week Follow-up Period|Lost to Follow-up|0|||
170833992|NCT06319170|617399919|FG000|8-Week Follow-up Period|Withdrawal by Subject|0|||
170833993|NCT06319170|617399920|FG001|8-Week Follow-up Period|Withdrawal by Subject|0|||
170833994|NCT06319170|617399921|FG002|8-Week Follow-up Period|Withdrawal by Subject|1|||
170833995|NCT06319170|617399922|FG003|8-Week Follow-up Period|Withdrawal by Subject|0|||
170833996|NCT06319170|617399919|FG000|8-Week Follow-up Period|Other Than Specified|0|||
170833997|NCT06319170|617399920|FG001|8-Week Follow-up Period|Other Than Specified|0|||
170833998|NCT06319170|617399921|FG002|8-Week Follow-up Period|Other Than Specified|0|||
170833999|NCT06319170|617399922|FG003|8-Week Follow-up Period|Other Than Specified|1|||
170834000|NCT02520544|617399923|FG000|Overall Study|Death|18|||
170834001|NCT02520544|617399924|FG001|Overall Study|Death|8|||
170834002|NCT02520544|617399923|FG000|Overall Study|Lost to Follow-up|8|||
170834003|NCT02520544|617399924|FG001|Overall Study|Lost to Follow-up|8|||
170834004|NCT02520544|617399923|FG000|Overall Study|Withdrawal by Subject|23|||
170834005|NCT02520544|617399924|FG001|Overall Study|Withdrawal by Subject|11|||
170834006|NCT02520544|617399923|FG000|Overall Study|Revision/Removal of Study Device|11|||
170834007|NCT02520544|617399924|FG001|Overall Study|Revision/Removal of Study Device|5|||
170834008|NCT02035696|617401106|FG000|Overall Study|Lost to Follow-up|0|||
170834009|NCT02035696|617401107|FG001|Overall Study|Lost to Follow-up|3|||
170834010|NCT02035696|617401108|FG002|Overall Study|Lost to Follow-up|1|||
170834011|NCT02035696|617401109|FG003|Overall Study|Lost to Follow-up|2|||
170834012|NCT02035696|617401106|FG000|Overall Study|Withdrawal by Subject|3|||
170834013|NCT02035696|617401107|FG001|Overall Study|Withdrawal by Subject|0|||
170834014|NCT02035696|617401108|FG002|Overall Study|Withdrawal by Subject|2|||
170834015|NCT02035696|617401109|FG003|Overall Study|Withdrawal by Subject|1|||
170834016|NCT00379769|617401110|FG000|Main Study|Death|57|||
170834017|NCT00379769|617401111|FG001|Main Study|Death|67|||
170834018|NCT00379769|617401112|FG002|Main Study|Death|54|||
170834019|NCT00379769|617401113|FG003|Main Study|Death|72|||
170834020|NCT00379769|617401114|FG004|Main Study|Death|0|||
170834021|NCT00379769|617401115|FG005|Main Study|Death|0|||
170834022|NCT00379769|617401110|FG000|Main Study|Adverse Event|5|||
170834023|NCT00379769|617401111|FG001|Main Study|Adverse Event|8|||
170834024|NCT00379769|617401112|FG002|Main Study|Adverse Event|10|||
170834025|NCT00379769|617401113|FG003|Main Study|Adverse Event|11|||
170834026|NCT00379769|617401114|FG004|Main Study|Adverse Event|0|||
170834027|NCT00379769|617401115|FG005|Main Study|Adverse Event|0|||
170834028|NCT00379769|617401110|FG000|Main Study|Lost to Follow-up|29|||
170834029|NCT00379769|617401111|FG001|Main Study|Lost to Follow-up|29|||
170834030|NCT00379769|617401112|FG002|Main Study|Lost to Follow-up|25|||
170725014|NCT06273774|616996800|FG003|Overall Study|Lost to Follow-up|0|||
170725015|NCT06273774|616996801|FG004|Overall Study|Lost to Follow-up|1|||
170725016|NCT06273774|616996802|FG005|Overall Study|Lost to Follow-up|0|||
170725017|NCT02097108|616996805|FG000|Overall Study|Adverse Event|1|||
170725018|NCT02097108|616996805|FG000|Overall Study|patient was abroad for 6 months|1|||
170725019|NCT04918784|616999121|FG000|Overall Study|Amputation - no longer eligible|1|||
170725020|NCT04918784|616999122|FG001|Overall Study|Amputation - no longer eligible|2|||
170725021|NCT04918784|616999121|FG000|Overall Study|Death|1|||
170725022|NCT04918784|616999122|FG001|Overall Study|Death|0|||
170725023|NCT04918784|616999121|FG000|Overall Study|patient non-compliance|3|||
170725024|NCT04918784|616999122|FG001|Overall Study|patient non-compliance|1|||
170725025|NCT04918784|616999121|FG000|Overall Study|Adverse Event|1|||
170725026|NCT04918784|616999122|FG001|Overall Study|Adverse Event|0|||
170725027|NCT01111123|616999124|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
170725028|NCT01111123|616999125|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
170725029|NCT01111123|616999124|FG000|Maintenance Phase|Lost to Follow-up|0|||
170725030|NCT01111123|616999125|FG001|Maintenance Phase|Lost to Follow-up|2|||
170725031|NCT01986881|616999126|FG000|Overall Study|Death|228|||
170725032|NCT01986881|616999127|FG001|Overall Study|Death|233|||
170725033|NCT01986881|616999128|FG002|Overall Study|Death|247|||
170725034|NCT01986881|616999126|FG000|Overall Study|Lost to Follow-up|51|||
170725035|NCT01986881|616999127|FG001|Overall Study|Lost to Follow-up|44|||
170725036|NCT01986881|616999128|FG002|Overall Study|Lost to Follow-up|55|||
170725037|NCT01986881|616999126|FG000|Overall Study|Physician Decision|7|||
170725038|NCT01986881|616999127|FG001|Overall Study|Physician Decision|4|||
170725039|NCT01986881|616999128|FG002|Overall Study|Physician Decision|6|||
170725040|NCT01986881|616999126|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
170725041|NCT01986881|616999127|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
170725042|NCT01986881|616999128|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
170725043|NCT01986881|616999126|FG000|Overall Study|Withdrawal by Subject|41|||
170725044|NCT01986881|616999127|FG001|Overall Study|Withdrawal by Subject|60|||
170725045|NCT01986881|616999128|FG002|Overall Study|Withdrawal by Subject|45|||
170725046|NCT01986881|616999126|FG000|Overall Study|Subject Moved|0|||
170725047|NCT01986881|616999127|FG001|Overall Study|Subject Moved|1|||
170725048|NCT01986881|616999128|FG002|Overall Study|Subject Moved|0|||
170725049|NCT01986881|616999126|FG000|Overall Study|Other|1|||
170725050|NCT01986881|616999127|FG001|Overall Study|Other|2|||
170725051|NCT01986881|616999128|FG002|Overall Study|Other|2|||
170725052|NCT02057874|616999129|FG000|Overall Study|participant did not return for scan|1|||
170725053|NCT02979639|616999130|FG000|Overall Study|Withdrawal based on medical judgement|1|||
170725054|NCT02979639|616999130|FG000|Overall Study|Lost to Follow-up|8|||
170725055|NCT02979639|616999130|FG000|Overall Study|Withdrawal by Subject|3|||
170725056|NCT02979639|616999130|FG000|Overall Study|Adverse Event|2|||
170725057|NCT02621931|616999136|FG000|Overall Study|Death|0|||
170725058|NCT02621931|616999137|FG001|Overall Study|Death|1|||
170725059|NCT02621931|616999138|FG002|Overall Study|Death|0|||
170725060|NCT02621931|616999136|FG000|Overall Study|Adverse Event|8|||
170725061|NCT02621931|616999137|FG001|Overall Study|Adverse Event|5|||
170725062|NCT02621931|616999138|FG002|Overall Study|Adverse Event|7|||
170725063|NCT02621931|616999136|FG000|Overall Study|Withdrawal by Subject|12|||
170725064|NCT02621931|616999137|FG001|Overall Study|Withdrawal by Subject|10|||
170725065|NCT02621931|616999138|FG002|Overall Study|Withdrawal by Subject|11|||
170725066|NCT02621931|616999136|FG000|Overall Study|Protocol Violation|2|||
170725067|NCT02621931|616999137|FG001|Overall Study|Protocol Violation|2|||
170725068|NCT02621931|616999138|FG002|Overall Study|Protocol Violation|2|||
170725069|NCT02621931|616999136|FG000|Overall Study|Pregnancy|2|||
170725070|NCT02621931|616999137|FG001|Overall Study|Pregnancy|0|||
170725071|NCT02621931|616999138|FG002|Overall Study|Pregnancy|0|||
170725072|NCT02621931|616999136|FG000|Overall Study|Noncompliance to study procedures|0|||
170725073|NCT02621931|616999137|FG001|Overall Study|Noncompliance to study procedures|1|||
170725074|NCT02621931|616999138|FG002|Overall Study|Noncompliance to study procedures|2|||
170725075|NCT02621931|616999136|FG000|Overall Study|Lost to Follow-up|8|||
170725076|NCT02621931|616999137|FG001|Overall Study|Lost to Follow-up|7|||
170725077|NCT02621931|616999138|FG002|Overall Study|Lost to Follow-up|10|||
170725078|NCT02621931|616999136|FG000|Overall Study|Lack of Efficacy|0|||
170725079|NCT02621931|616999137|FG001|Overall Study|Lack of Efficacy|0|||
170725080|NCT02621931|616999138|FG002|Overall Study|Lack of Efficacy|1|||
170725081|NCT02621931|616999136|FG000|Overall Study|Other|1|||
170725082|NCT02621931|616999137|FG001|Overall Study|Other|1|||
170725083|NCT02621931|616999138|FG002|Overall Study|Other|3|||
170725084|NCT02481310|616999140|FG000|Follow up|Still in follow up|0|||
170834031|NCT00379769|617401113|FG003|Main Study|Lost to Follow-up|26|||
170834032|NCT00379769|617401114|FG004|Main Study|Lost to Follow-up|0|||
170834033|NCT00379769|617401115|FG005|Main Study|Lost to Follow-up|0|||
170834034|NCT00379769|617401110|FG000|Main Study|Withdrawal by Subject|46|||
170834035|NCT00379769|617401111|FG001|Main Study|Withdrawal by Subject|56|||
170834036|NCT00379769|617401112|FG002|Main Study|Withdrawal by Subject|72|||
170834037|NCT00379769|617401113|FG003|Main Study|Withdrawal by Subject|70|||
170834038|NCT00379769|617401114|FG004|Main Study|Withdrawal by Subject|0|||
170834039|NCT00379769|617401115|FG005|Main Study|Withdrawal by Subject|0|||
170834040|NCT00379769|617401110|FG000|Main Study|Moved to survival status follow-up only|27|||
170834041|NCT00379769|617401111|FG001|Main Study|Moved to survival status follow-up only|25|||
170834042|NCT00379769|617401112|FG002|Main Study|Moved to survival status follow-up only|32|||
170834043|NCT00379769|617401113|FG003|Main Study|Moved to survival status follow-up only|36|||
170834044|NCT00379769|617401114|FG004|Main Study|Moved to survival status follow-up only|0|||
170834045|NCT00379769|617401115|FG005|Main Study|Moved to survival status follow-up only|0|||
170834046|NCT00379769|617401110|FG000|Main Study|Participant moved|3|||
170834047|NCT00379769|617401111|FG001|Main Study|Participant moved|2|||
170834048|NCT00379769|617401112|FG002|Main Study|Participant moved|3|||
170834049|NCT00379769|617401113|FG003|Main Study|Participant moved|3|||
170834050|NCT00379769|617401114|FG004|Main Study|Participant moved|0|||
170834051|NCT00379769|617401115|FG005|Main Study|Participant moved|0|||
170834052|NCT00379769|617401110|FG000|Main Study|Poor compliance|3|||
170834053|NCT00379769|617401111|FG001|Main Study|Poor compliance|2|||
170834054|NCT00379769|617401112|FG002|Main Study|Poor compliance|2|||
170834055|NCT00379769|617401113|FG003|Main Study|Poor compliance|1|||
170834056|NCT00379769|617401114|FG004|Main Study|Poor compliance|0|||
170834057|NCT00379769|617401115|FG005|Main Study|Poor compliance|0|||
170834058|NCT00379769|617401110|FG000|Main Study|Prohibited glucose lowering medication|0|||
170834059|NCT00379769|617401111|FG001|Main Study|Prohibited glucose lowering medication|3|||
170834060|NCT00379769|617401112|FG002|Main Study|Prohibited glucose lowering medication|0|||
170834061|NCT00379769|617401113|FG003|Main Study|Prohibited glucose lowering medication|1|||
170834062|NCT00379769|617401114|FG004|Main Study|Prohibited glucose lowering medication|0|||
170834063|NCT00379769|617401115|FG005|Main Study|Prohibited glucose lowering medication|0|||
170834064|NCT00379769|617401110|FG000|Main Study|Site closed|4|||
170834065|NCT00379769|617401111|FG001|Main Study|Site closed|4|||
170834066|NCT00379769|617401112|FG002|Main Study|Site closed|4|||
170834067|NCT00379769|617401113|FG003|Main Study|Site closed|8|||
170834068|NCT00379769|617401114|FG004|Main Study|Site closed|0|||
170834069|NCT00379769|617401115|FG005|Main Study|Site closed|0|||
170834070|NCT00379769|617401110|FG000|Main Study|Entry criteria violation|0|||
170834071|NCT00379769|617401111|FG001|Main Study|Entry criteria violation|0|||
170834072|NCT00379769|617401112|FG002|Main Study|Entry criteria violation|1|||
170834073|NCT00379769|617401113|FG003|Main Study|Entry criteria violation|1|||
170834074|NCT00379769|617401114|FG004|Main Study|Entry criteria violation|0|||
170834075|NCT00379769|617401115|FG005|Main Study|Entry criteria violation|0|||
170834076|NCT00379769|617401110|FG000|Main Study|Participant did not take study drug|0|||
170834077|NCT00379769|617401111|FG001|Main Study|Participant did not take study drug|0|||
170834078|NCT00379769|617401112|FG002|Main Study|Participant did not take study drug|1|||
170834079|NCT00379769|617401113|FG003|Main Study|Participant did not take study drug|0|||
170834080|NCT00379769|617401114|FG004|Main Study|Participant did not take study drug|0|||
170834081|NCT00379769|617401115|FG005|Main Study|Participant did not take study drug|0|||
170834082|NCT00379769|617401110|FG000|Main Study|Physician Decision|2|||
170834083|NCT00379769|617401111|FG001|Main Study|Physician Decision|2|||
170834084|NCT00379769|617401112|FG002|Main Study|Physician Decision|1|||
170725085|NCT02481310|616999141|FG001|Follow up|Still in follow up|3|||
170725086|NCT02481310|616999142|FG002|Follow up|Still in follow up|0|||
170725087|NCT02606279|616999144|FG000|Overall Study|Lost to Follow-up|0|||
170725088|NCT02606279|616999145|FG001|Overall Study|Lost to Follow-up|1|||
170725089|NCT03252587|616999148|FG000|Overall Study|Adverse Event|3|||
170725090|NCT03252587|616999149|FG001|Overall Study|Adverse Event|8|||
170725091|NCT03252587|616999150|FG002|Overall Study|Adverse Event|6|||
170725092|NCT03252587|616999151|FG003|Overall Study|Adverse Event|12|||
170725093|NCT03252587|616999148|FG000|Overall Study|Lack of Efficacy|7|||
170725094|NCT03252587|616999149|FG001|Overall Study|Lack of Efficacy|2|||
170725095|NCT03252587|616999150|FG002|Overall Study|Lack of Efficacy|2|||
170725096|NCT03252587|616999151|FG003|Overall Study|Lack of Efficacy|4|||
170725097|NCT03252587|616999148|FG000|Overall Study|Lost to Follow-up|2|||
170725098|NCT03252587|616999149|FG001|Overall Study|Lost to Follow-up|0|||
170725099|NCT03252587|616999150|FG002|Overall Study|Lost to Follow-up|0|||
170725100|NCT03252587|616999151|FG003|Overall Study|Lost to Follow-up|2|||
170725101|NCT03252587|616999148|FG000|Overall Study|Pregnancy|2|||
170725102|NCT03252587|616999149|FG001|Overall Study|Pregnancy|1|||
170725103|NCT03252587|616999150|FG002|Overall Study|Pregnancy|0|||
170725104|NCT03252587|616999151|FG003|Overall Study|Pregnancy|1|||
170725105|NCT03252587|616999148|FG000|Overall Study|Withdrawal by Subject|8|||
170725106|NCT03252587|616999149|FG001|Overall Study|Withdrawal by Subject|4|||
170725107|NCT03252587|616999150|FG002|Overall Study|Withdrawal by Subject|4|||
170725108|NCT03252587|616999151|FG003|Overall Study|Withdrawal by Subject|4|||
170725109|NCT03252587|616999148|FG000|Overall Study|Other Reasons|2|||
170725110|NCT03252587|616999149|FG001|Overall Study|Other Reasons|5|||
170725111|NCT03252587|616999150|FG002|Overall Study|Other Reasons|5|||
170725112|NCT03252587|616999151|FG003|Overall Study|Other Reasons|4|||
170725113|NCT03647501|616999152|FG000|Overall Study|Lost to Follow-up|1|||
170725114|NCT03647501|616999153|FG001|Overall Study|Lost to Follow-up|1|||
170725115|NCT03647501|616999152|FG000|Overall Study|Withdrawal by Subject|0|||
170725116|NCT03647501|616999153|FG001|Overall Study|Withdrawal by Subject|1|||
170725117|NCT01654549|616999169|FG000|Overall Study|H.pylori eradication not successful|0|||
170725118|NCT01654549|616999170|FG001|Overall Study|H.pylori eradication not successful|1|||
170725119|NCT04969198|616999171|FG000|Overall Study|Withdrawal by Subject|20|||
170725120|NCT04969198|616999171|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
170725121|NCT04969198|616999171|FG000|Overall Study|Lost to Follow-up|20|||
170725122|NCT02192502|616999172|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
170725123|NCT02192502|616999173|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
170725124|NCT02192502|616999172|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
170725125|NCT02192502|616999173|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
170725126|NCT02192502|616999172|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
170725127|NCT02192502|616999173|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
170725128|NCT00295750|616999176|FG000|Overall Study|Adverse Event|19|||
170725129|NCT00295750|616999177|FG001|Overall Study|Adverse Event|15|||
170725130|NCT00295750|616999178|FG002|Overall Study|Adverse Event|12|||
170725131|NCT00295750|616999176|FG000|Overall Study|Lack of Efficacy|1|||
170725132|NCT00295750|616999177|FG001|Overall Study|Lack of Efficacy|1|||
170725133|NCT00295750|616999178|FG002|Overall Study|Lack of Efficacy|0|||
170725134|NCT00295750|616999176|FG000|Overall Study|Lost to Follow-up|1|||
170725135|NCT00295750|616999177|FG001|Overall Study|Lost to Follow-up|4|||
170725136|NCT00295750|616999178|FG002|Overall Study|Lost to Follow-up|1|||
170725137|NCT00295750|616999176|FG000|Overall Study|Taking prohibited therapy|2|||
170725138|NCT00295750|616999177|FG001|Overall Study|Taking prohibited therapy|3|||
170725139|NCT00295750|616999178|FG002|Overall Study|Taking prohibited therapy|2|||
170725140|NCT00295750|616999176|FG000|Overall Study|Administrative errors|2|||
170725141|NCT00295750|616999177|FG001|Overall Study|Administrative errors|4|||
170725142|NCT00295750|616999178|FG002|Overall Study|Administrative errors|5|||
170725143|NCT00295750|616999176|FG000|Overall Study|Trial drug errors|1|||
170725144|NCT00295750|616999177|FG001|Overall Study|Trial drug errors|1|||
170725145|NCT00295750|616999178|FG002|Overall Study|Trial drug errors|0|||
170725146|NCT00295750|616999176|FG000|Overall Study|Disease progression|2|||
170725147|NCT00295750|616999177|FG001|Overall Study|Disease progression|1|||
170725148|NCT00295750|616999178|FG002|Overall Study|Disease progression|0|||
170725149|NCT00295750|616999176|FG000|Overall Study|Personal reasons|0|||
170725150|NCT00295750|616999177|FG001|Overall Study|Personal reasons|1|||
170725151|NCT00295750|616999178|FG002|Overall Study|Personal reasons|0|||
170725152|NCT00295750|616999176|FG000|Overall Study|Randomized but never received trial drug|4|||
170725153|NCT00295750|616999177|FG001|Overall Study|Randomized but never received trial drug|3|||
170725154|NCT00295750|616999178|FG002|Overall Study|Randomized but never received trial drug|3|||
170725155|NCT00295750|616999176|FG000|Overall Study|Withdrawal by Subject|9|||
170725156|NCT00295750|616999177|FG001|Overall Study|Withdrawal by Subject|4|||
170725157|NCT00295750|616999178|FG002|Overall Study|Withdrawal by Subject|7|||
170725158|NCT00295750|616999176|FG000|Overall Study|Protocol Violation|2|||
170725159|NCT00295750|616999177|FG001|Overall Study|Protocol Violation|4|||
170834085|NCT00379769|617401113|FG003|Main Study|Physician Decision|1|||
170834086|NCT00379769|617401114|FG004|Main Study|Physician Decision|0|||
170834087|NCT00379769|617401115|FG005|Main Study|Physician Decision|0|||
170834088|NCT00379769|617401110|FG000|Main Study|Participant completed study at visit 27|1|||
170834089|NCT00379769|617401111|FG001|Main Study|Participant completed study at visit 27|0|||
170834090|NCT00379769|617401112|FG002|Main Study|Participant completed study at visit 27|0|||
170834091|NCT00379769|617401113|FG003|Main Study|Participant completed study at visit 27|0|||
170834092|NCT00379769|617401114|FG004|Main Study|Participant completed study at visit 27|0|||
170834093|NCT00379769|617401115|FG005|Main Study|Participant completed study at visit 27|0|||
170834094|NCT00379769|617401110|FG000|Main Study|Personal reasons|1|||
170834095|NCT00379769|617401111|FG001|Main Study|Personal reasons|0|||
170834096|NCT00379769|617401112|FG002|Main Study|Personal reasons|0|||
170834097|NCT00379769|617401113|FG003|Main Study|Personal reasons|0|||
170834098|NCT00379769|617401114|FG004|Main Study|Personal reasons|0|||
170834099|NCT00379769|617401115|FG005|Main Study|Personal reasons|0|||
170834100|NCT00379769|617401110|FG000|Main Study|Risk of heart failure|0|||
170834101|NCT00379769|617401111|FG001|Main Study|Risk of heart failure|1|||
170834102|NCT00379769|617401112|FG002|Main Study|Risk of heart failure|0|||
170834103|NCT00379769|617401113|FG003|Main Study|Risk of heart failure|0|||
170834104|NCT00379769|617401114|FG004|Main Study|Risk of heart failure|0|||
170834105|NCT00379769|617401115|FG005|Main Study|Risk of heart failure|0|||
170834106|NCT00379769|617401110|FG000|Main Study|Investigator refused to log temperature|0|||
170834107|NCT00379769|617401111|FG001|Main Study|Investigator refused to log temperature|0|||
170834108|NCT00379769|617401112|FG002|Main Study|Investigator refused to log temperature|1|||
170834109|NCT00379769|617401113|FG003|Main Study|Investigator refused to log temperature|0|||
170834110|NCT00379769|617401114|FG004|Main Study|Investigator refused to log temperature|0|||
170834111|NCT00379769|617401115|FG005|Main Study|Investigator refused to log temperature|0|||
170834112|NCT00379769|617401110|FG000|Main Study|Reason unspecified|0|||
170834113|NCT00379769|617401111|FG001|Main Study|Reason unspecified|0|||
170834114|NCT00379769|617401112|FG002|Main Study|Reason unspecified|1|||
170834115|NCT00379769|617401113|FG003|Main Study|Reason unspecified|0|||
170725160|NCT00295750|616999178|FG002|Overall Study|Protocol Violation|2|||
170725161|NCT01650259|616999179|FG000|Overall Study|Improvement|105|||
170725162|NCT01650259|616999180|FG001|Overall Study|Improvement|0|||
170725163|NCT01650259|616999179|FG000|Overall Study|Adverse Event|127|||
170725164|NCT01650259|616999180|FG001|Overall Study|Adverse Event|0|||
170725165|NCT01650259|616999179|FG000|Overall Study|Lack of Efficacy|143|||
170725166|NCT01650259|616999180|FG001|Overall Study|Lack of Efficacy|0|||
170725167|NCT01650259|616999179|FG000|Overall Study|Lost to Follow-up|435|||
170725168|NCT01650259|616999180|FG001|Overall Study|Lost to Follow-up|0|||
170725169|NCT01650259|616999179|FG000|Overall Study|Patients had no visit after entry|70|||
170725170|NCT01650259|616999180|FG001|Overall Study|Patients had no visit after entry|0|||
170725171|NCT01650259|616999179|FG000|Overall Study|CRF not collected|98|||
170725172|NCT01650259|616999180|FG001|Overall Study|CRF not collected|82|||
170725173|NCT01650259|616999179|FG000|Overall Study|Not treated|1|||
170725174|NCT01650259|616999180|FG001|Overall Study|Not treated|7|||
170725175|NCT01650259|616999179|FG000|Overall Study|Other than listed|64|||
170725176|NCT01650259|616999180|FG001|Overall Study|Other than listed|146|||
170725177|NCT01988779|616999190|FG000|Overall Study|Withdrawal by Subject|2|||
170725178|NCT01988779|616999191|FG001|Overall Study|Withdrawal by Subject|2|||
170725179|NCT01988779|616999190|FG000|Overall Study|Protocol Violation|1|||
170725180|NCT01988779|616999191|FG001|Overall Study|Protocol Violation|0|||
170725181|NCT04072159|616999192|FG000|Overall Study|Lost to Follow-up|6|||
170725182|NCT04072159|616999193|FG001|Overall Study|Lost to Follow-up|6|||
170725183|NCT04072159|616999192|FG000|Overall Study|Withdrawal by Subject|2|||
170725184|NCT04072159|616999193|FG001|Overall Study|Withdrawal by Subject|0|||
170725185|NCT02275065|616999198|FG000|Overall Study|Randomized but not treated|1|||
170725186|NCT02275065|616999199|FG001|Overall Study|Randomized but not treated|0|||
170725187|NCT02275065|616999200|FG002|Overall Study|Randomized but not treated|1|||
170725188|NCT02275065|616999201|FG003|Overall Study|Randomized but not treated|1|||
170725189|NCT02275065|616999202|FG004|Overall Study|Randomized but not treated|0|||
170725190|NCT00377403|616999203|FG000|Overall Study|Unable to contact for telephone intervie|4|||
170725191|NCT00377403|616999204|FG001|Overall Study|Unable to contact for telephone intervie|7|||
170725192|NCT00989287|616999205|FG000|Overall Study|Adverse Event|1|||
170725193|NCT00989287|616999206|FG001|Overall Study|Adverse Event|0|||
170725194|NCT00989287|616999205|FG000|Overall Study|Lost to Follow-up|0|||
170725195|NCT00989287|616999206|FG001|Overall Study|Lost to Follow-up|1|||
170725196|NCT00729833|616999207|FG000|Overall Study|Death|5|||
170725197|NCT00729833|616999208|FG001|Overall Study|Death|1|||
170725198|NCT00729833|616999209|FG002|Overall Study|Death|3|||
170725199|NCT00729833|616999210|FG003|Overall Study|Death|5|||
170725200|NCT00729833|616999207|FG000|Overall Study|Study Terminated by Sponsor|0|||
170725201|NCT00729833|616999208|FG001|Overall Study|Study Terminated by Sponsor|0|||
170834116|NCT00379769|617401114|FG004|Main Study|Reason unspecified|0|||
170834117|NCT00379769|617401115|FG005|Main Study|Reason unspecified|0|||
170834118|NCT00379769|617401110|FG000|Observational Follow-up|Death|0|||
170834119|NCT00379769|617401111|FG001|Observational Follow-up|Death|0|||
170834120|NCT00379769|617401112|FG002|Observational Follow-up|Death|0|||
170834121|NCT00379769|617401113|FG003|Observational Follow-up|Death|0|||
170834122|NCT00379769|617401114|FG004|Observational Follow-up|Death|78|||
170834123|NCT00379769|617401115|FG005|Observational Follow-up|Death|70|||
170834124|NCT00379769|617401110|FG000|Observational Follow-up|Adverse Event|0|||
170834125|NCT00379769|617401111|FG001|Observational Follow-up|Adverse Event|0|||
170834126|NCT00379769|617401112|FG002|Observational Follow-up|Adverse Event|0|||
170834127|NCT00379769|617401113|FG003|Observational Follow-up|Adverse Event|0|||
170834128|NCT00379769|617401114|FG004|Observational Follow-up|Adverse Event|1|||
170834129|NCT00379769|617401115|FG005|Observational Follow-up|Adverse Event|0|||
170834130|NCT00379769|617401110|FG000|Observational Follow-up|Lost to Follow-up|0|||
170834131|NCT00379769|617401111|FG001|Observational Follow-up|Lost to Follow-up|0|||
170834132|NCT00379769|617401112|FG002|Observational Follow-up|Lost to Follow-up|0|||
170834133|NCT00379769|617401113|FG003|Observational Follow-up|Lost to Follow-up|0|||
170834134|NCT00379769|617401114|FG004|Observational Follow-up|Lost to Follow-up|25|||
170834135|NCT00379769|617401115|FG005|Observational Follow-up|Lost to Follow-up|27|||
170834136|NCT00379769|617401110|FG000|Observational Follow-up|Withdrawal by Subject|0|||
170834137|NCT00379769|617401111|FG001|Observational Follow-up|Withdrawal by Subject|0|||
170834138|NCT00379769|617401112|FG002|Observational Follow-up|Withdrawal by Subject|0|||
170834139|NCT00379769|617401113|FG003|Observational Follow-up|Withdrawal by Subject|0|||
170834140|NCT00379769|617401114|FG004|Observational Follow-up|Withdrawal by Subject|12|||
170834141|NCT00379769|617401115|FG005|Observational Follow-up|Withdrawal by Subject|12|||
170834142|NCT00379769|617401110|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
170834143|NCT00379769|617401111|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
170834144|NCT00379769|617401112|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
170834145|NCT00379769|617401113|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
170834146|NCT00379769|617401114|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
170834147|NCT00379769|617401115|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
170834148|NCT00379769|617401110|FG000|Observational Follow-up|Physician Decision|0|||
170834149|NCT00379769|617401111|FG001|Observational Follow-up|Physician Decision|0|||
170834150|NCT00379769|617401112|FG002|Observational Follow-up|Physician Decision|0|||
170834151|NCT00379769|617401113|FG003|Observational Follow-up|Physician Decision|0|||
170834152|NCT00379769|617401114|FG004|Observational Follow-up|Physician Decision|8|||
170834153|NCT00379769|617401115|FG005|Observational Follow-up|Physician Decision|8|||
170834154|NCT00379769|617401110|FG000|Observational Follow-up|Site Closed Early|0|||
170834155|NCT00379769|617401111|FG001|Observational Follow-up|Site Closed Early|0|||
170834156|NCT00379769|617401112|FG002|Observational Follow-up|Site Closed Early|0|||
170834157|NCT00379769|617401113|FG003|Observational Follow-up|Site Closed Early|0|||
170834158|NCT00379769|617401114|FG004|Observational Follow-up|Site Closed Early|6|||
170834159|NCT00379769|617401115|FG005|Observational Follow-up|Site Closed Early|7|||
170834160|NCT00379769|617401110|FG000|Observational Follow-up|Participant Moved|0|||
170834161|NCT00379769|617401111|FG001|Observational Follow-up|Participant Moved|0|||
170834162|NCT00379769|617401112|FG002|Observational Follow-up|Participant Moved|0|||
170834163|NCT00379769|617401113|FG003|Observational Follow-up|Participant Moved|0|||
170834164|NCT00379769|617401114|FG004|Observational Follow-up|Participant Moved|0|||
170834165|NCT00379769|617401115|FG005|Observational Follow-up|Participant Moved|1|||
170834166|NCT00379769|617401110|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
170834167|NCT00379769|617401111|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
170834168|NCT00379769|617401112|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
170834169|NCT00379769|617401113|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
170834170|NCT00379769|617401114|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
170834171|NCT00379769|617401115|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
170834172|NCT02104505|617401120|FG000|First Intervention (14 Days)|Adverse Event|2|||
170834173|NCT02104505|617401121|FG001|First Intervention (14 Days)|Adverse Event|0|||
170834174|NCT02104505|617401120|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
170834175|NCT02104505|617401121|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
170834176|NCT02104505|617401120|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
170834177|NCT02104505|617401121|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
170834178|NCT02104505|617401120|FG000|First Intervention (14 Days)|exclusionary condition|0|||
170834179|NCT02104505|617401121|FG001|First Intervention (14 Days)|exclusionary condition|1|||
170834180|NCT02104505|617401120|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
170834181|NCT02104505|617401121|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
170834182|NCT02104505|617401120|FG000|Second Intervention (14 Days)|Adverse Event|2|||
170834183|NCT02104505|617401121|FG001|Second Intervention (14 Days)|Adverse Event|0|||
170834184|NCT01381575|617401122|FG000|Overall Study|Serious Adverse Event|1|||
170834185|NCT01381575|617401123|FG001|Overall Study|Serious Adverse Event|0|||
170834186|NCT01381575|617401124|FG002|Overall Study|Serious Adverse Event|0|||
170834187|NCT01381575|617401122|FG000|Overall Study|Non-Serious Adverse Event|0|||
170834188|NCT01381575|617401123|FG001|Overall Study|Non-Serious Adverse Event|0|||
170834189|NCT01381575|617401124|FG002|Overall Study|Non-Serious Adverse Event|1|||
170834190|NCT01381575|617401122|FG000|Overall Study|Protocol Violation|0|||
170834191|NCT01381575|617401123|FG001|Overall Study|Protocol Violation|1|||
170834192|NCT01381575|617401124|FG002|Overall Study|Protocol Violation|1|||
170834193|NCT01381575|617401122|FG000|Overall Study|Withdrawal by Subject|15|||
170834194|NCT01381575|617401123|FG001|Overall Study|Withdrawal by Subject|9|||
170834195|NCT01381575|617401124|FG002|Overall Study|Withdrawal by Subject|7|||
170834196|NCT01381575|617401122|FG000|Overall Study|Migrated/moved from study area|2|||
170834197|NCT01381575|617401123|FG001|Overall Study|Migrated/moved from study area|12|||
170834198|NCT01381575|617401124|FG002|Overall Study|Migrated/moved from study area|2|||
170834199|NCT01381575|617401122|FG000|Overall Study|Lost to Follow-up|8|||
170834200|NCT01381575|617401123|FG001|Overall Study|Lost to Follow-up|17|||
170834201|NCT01381575|617401124|FG002|Overall Study|Lost to Follow-up|9|||
170834202|NCT01377389|617401127|FG000|Overall Study|Withdrawal by Subject|1|||
170834203|NCT01377389|617401127|FG000|Overall Study|Screen failure|2|||
170834204|NCT03020069|617401128|FG000|Overall Study|Lost to Follow-up|0|||
170834205|NCT03020069|617401129|FG001|Overall Study|Lost to Follow-up|1|||
170834206|NCT02684123|617401130|FG000|Phase 1|Lack of Efficacy|5|||
170834207|NCT02684123|617401131|FG001|Phase 1|Lack of Efficacy|0|||
170834208|NCT02684123|617401130|FG000|Phase 1|Adverse Event|3|||
170834209|NCT02684123|617401131|FG001|Phase 1|Adverse Event|0|||
170834210|NCT02684123|617401130|FG000|Phase 1|Lost to Follow-up|0|||
170834211|NCT02684123|617401131|FG001|Phase 1|Lost to Follow-up|1|||
170834212|NCT02684123|617401130|FG000|Phase 2|Lack of Efficacy|1|||
170834213|NCT02684123|617401131|FG001|Phase 2|Lack of Efficacy|8|||
170834214|NCT04916002|617401135|FG000|Overall Study|Adverse Event|0|||
170834215|NCT04916002|617401136|FG001|Overall Study|Adverse Event|1|||
170834216|NCT04916002|617401137|FG002|Overall Study|Adverse Event|0|||
170834217|NCT04916002|617401138|FG003|Overall Study|Adverse Event|1|||
170834218|NCT04916002|617401139|FG004|Overall Study|Adverse Event|0|||
170834219|NCT04916002|617401135|FG000|Overall Study|Withdrawal by Subject|3|||
170834220|NCT04916002|617401136|FG001|Overall Study|Withdrawal by Subject|1|||
170834221|NCT04916002|617401137|FG002|Overall Study|Withdrawal by Subject|0|||
170834222|NCT04916002|617401138|FG003|Overall Study|Withdrawal by Subject|1|||
170834223|NCT04916002|617401139|FG004|Overall Study|Withdrawal by Subject|0|||
170834224|NCT04916002|617401135|FG000|Overall Study|Death|8|||
170834225|NCT04916002|617401136|FG001|Overall Study|Death|7|||
170834226|NCT04916002|617401137|FG002|Overall Study|Death|4|||
170834227|NCT04916002|617401138|FG003|Overall Study|Death|9|||
170834228|NCT04916002|617401139|FG004|Overall Study|Death|0|||
170834229|NCT04916002|617401135|FG000|Overall Study|Study Terminated by Sponsor|11|||
170834230|NCT04916002|617401136|FG001|Overall Study|Study Terminated by Sponsor|10|||
170834231|NCT04916002|617401137|FG002|Overall Study|Study Terminated by Sponsor|8|||
170834232|NCT04916002|617401138|FG003|Overall Study|Study Terminated by Sponsor|5|||
170834233|NCT04916002|617401139|FG004|Overall Study|Study Terminated by Sponsor|4|||
170834234|NCT04916002|617401135|FG000|Overall Study|End of trial|1|||
170834235|NCT04916002|617401136|FG001|Overall Study|End of trial|0|||
170834236|NCT04916002|617401137|FG002|Overall Study|End of trial|0|||
170834237|NCT04916002|617401138|FG003|Overall Study|End of trial|0|||
170834238|NCT04916002|617401139|FG004|Overall Study|End of trial|0|||
170834239|NCT04916002|617401135|FG000|Overall Study|Progressive disease|0|||
170834240|NCT04916002|617401136|FG001|Overall Study|Progressive disease|0|||
170834241|NCT04916002|617401137|FG002|Overall Study|Progressive disease|1|||
170834242|NCT04916002|617401138|FG003|Overall Study|Progressive disease|0|||
170834243|NCT04916002|617401139|FG004|Overall Study|Progressive disease|0|||
170834244|NCT04916002|617401135|FG000|Overall Study|Participant non-compliance|2|||
170834245|NCT04916002|617401136|FG001|Overall Study|Participant non-compliance|0|||
170834246|NCT04916002|617401137|FG002|Overall Study|Participant non-compliance|0|||
170834247|NCT04916002|617401138|FG003|Overall Study|Participant non-compliance|0|||
170834248|NCT04916002|617401139|FG004|Overall Study|Participant non-compliance|0|||
170834249|NCT01952847|617401140|FG000|Overall Study|Ineligible|1|||
170834250|NCT01952847|617401141|FG001|Overall Study|Ineligible|0|||
170834251|NCT01952847|617401142|FG002|Overall Study|Ineligible|0|||
170834252|NCT01952847|617401143|FG003|Overall Study|Ineligible|0|||
170834253|NCT01952847|617401140|FG000|Overall Study|Lack of Insurance Coverage|0|||
170834254|NCT01952847|617401141|FG001|Overall Study|Lack of Insurance Coverage|1|||
170834255|NCT01952847|617401142|FG002|Overall Study|Lack of Insurance Coverage|0|||
170834256|NCT01952847|617401143|FG003|Overall Study|Lack of Insurance Coverage|0|||
170834257|NCT01952847|617401140|FG000|Overall Study|Withdrawal by Subject|1|||
170834258|NCT01952847|617401141|FG001|Overall Study|Withdrawal by Subject|1|||
170834259|NCT01952847|617401142|FG002|Overall Study|Withdrawal by Subject|0|||
170834260|NCT01952847|617401143|FG003|Overall Study|Withdrawal by Subject|1|||
170834261|NCT05382039|617401144|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
170834262|NCT05382039|617401145|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
170834263|NCT05382039|617401146|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
170834264|NCT05382039|617401144|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
170834265|NCT05382039|617401145|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
170834266|NCT05382039|617401146|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
170834267|NCT05382039|617401144|FG000|Overall Study|waiting for confirmation|0|||
170834268|NCT05382039|617401145|FG001|Overall Study|waiting for confirmation|0|||
170834269|NCT05382039|617401146|FG002|Overall Study|waiting for confirmation|1|||
170834270|NCT04464421|617401147|FG000|Overall Study|Lost to Follow-up|2|||
170834271|NCT04464421|617401148|FG001|Overall Study|Lost to Follow-up|2|||
170834272|NCT04351269|617401149|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
170834273|NCT04351269|617401150|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
170834274|NCT04351269|617401151|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
170834275|NCT04351269|617401149|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
170834276|NCT04351269|617401150|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
170834277|NCT04351269|617401151|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
170834278|NCT04351269|617401149|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
170834279|NCT04351269|617401150|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
170834280|NCT04351269|617401151|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
170834281|NCT04351269|617401149|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
170834282|NCT04351269|617401150|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
170834283|NCT04351269|617401151|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
170834284|NCT04351269|617401149|FG000|Overall Study|Lost to Follow-up|1|||
170834285|NCT04351269|617401150|FG001|Overall Study|Lost to Follow-up|3|||
170834286|NCT04351269|617401151|FG002|Overall Study|Lost to Follow-up|0|||
170834287|NCT01271504|617401156|FG000|Overall Study|Death|7|||
170834288|NCT01271504|617401157|FG001|Overall Study|Death|6|||
170834289|NCT01271504|617401158|FG002|Overall Study|Death|32|||
170834290|NCT01271504|617401159|FG003|Overall Study|Death|32|||
170834291|NCT01271504|617401156|FG000|Overall Study|Lost to Follow-up|0|||
170834292|NCT01271504|617401157|FG001|Overall Study|Lost to Follow-up|1|||
170834293|NCT01271504|617401158|FG002|Overall Study|Lost to Follow-up|3|||
170834294|NCT01271504|617401159|FG003|Overall Study|Lost to Follow-up|1|||
170834295|NCT01271504|617401156|FG000|Overall Study|Protocol Violation|0|||
170834296|NCT01271504|617401157|FG001|Overall Study|Protocol Violation|0|||
170834297|NCT01271504|617401158|FG002|Overall Study|Protocol Violation|0|||
170834298|NCT01271504|617401159|FG003|Overall Study|Protocol Violation|2|||
170834299|NCT01271504|617401156|FG000|Overall Study|Administrative Reasons|0|||
170834300|NCT01271504|617401157|FG001|Overall Study|Administrative Reasons|0|||
170834301|NCT01271504|617401158|FG002|Overall Study|Administrative Reasons|6|||
170834302|NCT01271504|617401159|FG003|Overall Study|Administrative Reasons|5|||
170834303|NCT01271504|617401156|FG000|Overall Study|Withdrawal by Subject|0|||
170834304|NCT01271504|617401157|FG001|Overall Study|Withdrawal by Subject|0|||
170834305|NCT01271504|617401158|FG002|Overall Study|Withdrawal by Subject|1|||
170834306|NCT01271504|617401159|FG003|Overall Study|Withdrawal by Subject|3|||
170834307|NCT01271504|617401156|FG000|Overall Study|Other|0|||
170834308|NCT01271504|617401157|FG001|Overall Study|Other|1|||
170834309|NCT01271504|617401158|FG002|Overall Study|Other|2|||
170834310|NCT01271504|617401159|FG003|Overall Study|Other|0|||
170834311|NCT02552147|617401160|FG000|First Intervention (7 Days)|Protocol Violation|1|||
170834312|NCT02552147|617401161|FG001|First Intervention (7 Days)|Protocol Violation|0|||
170834313|NCT02552147|617401160|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
170834314|NCT02552147|617401161|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
170834315|NCT00940875|617401162|FG000|Treatment Phase|Adverse Event|9|||
170834316|NCT00940875|617401163|FG001|Treatment Phase|Adverse Event|3|||
170834317|NCT00940875|617401162|FG000|Treatment Phase|Death|3|||
170834318|NCT00940875|617401163|FG001|Treatment Phase|Death|5|||
170834319|NCT00940875|617401162|FG000|Treatment Phase|Lack of Efficacy|1|||
170834320|NCT00940875|617401163|FG001|Treatment Phase|Lack of Efficacy|0|||
170834321|NCT00940875|617401162|FG000|Treatment Phase|Withdrawal by Subject|3|||
170834322|NCT00940875|617401163|FG001|Treatment Phase|Withdrawal by Subject|0|||
170834323|NCT00940875|617401162|FG000|Treatment Phase|Disease progression|9|||
170834324|NCT00940875|617401163|FG001|Treatment Phase|Disease progression|11|||
170834325|NCT00940875|617401162|FG000|Treatment Phase|Physician Decision|1|||
170834326|NCT00940875|617401163|FG001|Treatment Phase|Physician Decision|0|||
170725202|NCT00729833|616999209|FG002|Overall Study|Study Terminated by Sponsor|1|||
170725203|NCT00729833|616999210|FG003|Overall Study|Study Terminated by Sponsor|0|||
170725204|NCT00729833|616999207|FG000|Overall Study|Lost to Follow-up|1|||
170725205|NCT00729833|616999208|FG001|Overall Study|Lost to Follow-up|0|||
170725206|NCT00729833|616999209|FG002|Overall Study|Lost to Follow-up|0|||
170725207|NCT00729833|616999210|FG003|Overall Study|Lost to Follow-up|0|||
170725208|NCT00729833|616999207|FG000|Overall Study|Withdrawal by Subject|3|||
170725209|NCT00729833|616999208|FG001|Overall Study|Withdrawal by Subject|1|||
170725210|NCT00729833|616999209|FG002|Overall Study|Withdrawal by Subject|3|||
170725211|NCT00729833|616999210|FG003|Overall Study|Withdrawal by Subject|0|||
170725212|NCT00729833|616999207|FG000|Overall Study|Unspecified Reasons|11|||
170725213|NCT00729833|616999208|FG001|Overall Study|Unspecified Reasons|5|||
170725214|NCT00729833|616999209|FG002|Overall Study|Unspecified Reasons|5|||
170725215|NCT00729833|616999210|FG003|Overall Study|Unspecified Reasons|1|||
170725216|NCT01041638|616999211|FG000|Overall Study|Adverse Event|4|||
170725217|NCT01041638|616999211|FG000|Overall Study|Death|1|||
170725218|NCT01041638|616999211|FG000|Overall Study|Lack of Efficacy|7|||
170725219|NCT01041638|616999211|FG000|Overall Study|Physician Decision|4|||
170725220|NCT01041638|616999211|FG000|Overall Study|Withdrawal by Subject|11|||
170725221|NCT00092131|616999213|FG000|Treatment Period I|Adverse Event|1|||
170725222|NCT00092131|616999214|FG001|Treatment Period I|Adverse Event|0|||
170725223|NCT00092131|616999213|FG000|Treatment Period II|Adverse Event|0|||
170725224|NCT00092131|616999214|FG001|Treatment Period II|Adverse Event|1|||
170725225|NCT00417079|616999215|FG000|Overall Study|Disease progression|267|||
170725226|NCT00417079|616999216|FG001|Overall Study|Disease progression|180|||
170725227|NCT00417079|616999215|FG000|Overall Study|Adverse Event|32|||
170725228|NCT00417079|616999216|FG001|Overall Study|Adverse Event|67|||
170725229|NCT00417079|616999215|FG000|Overall Study|Non-compliance to protocol|0|||
170725230|NCT00417079|616999216|FG001|Overall Study|Non-compliance to protocol|1|||
170725231|NCT00417079|616999215|FG000|Overall Study|Lost to Follow-up|2|||
170725232|NCT00417079|616999216|FG001|Overall Study|Lost to Follow-up|0|||
170725233|NCT00417079|616999215|FG000|Overall Study|Withdrawal by Subject|17|||
170725234|NCT00417079|616999216|FG001|Overall Study|Withdrawal by Subject|8|||
170725235|NCT00417079|616999215|FG000|Overall Study|Not treated|6|||
170725236|NCT00417079|616999216|FG001|Overall Study|Not treated|7|||
170725237|NCT00417079|616999215|FG000|Overall Study|Screened failure|2|||
170725238|NCT00417079|616999216|FG001|Overall Study|Screened failure|1|||
170725239|NCT00417079|616999215|FG000|Overall Study|Investigator's decision|1|||
170725240|NCT00417079|616999216|FG001|Overall Study|Investigator's decision|4|||
170725241|NCT00417079|616999215|FG000|Overall Study|Non-confirmed Disease progression|1|||
170725242|NCT00417079|616999216|FG001|Overall Study|Non-confirmed Disease progression|1|||
170725243|NCT00417079|616999215|FG000|Overall Study|Clinical deterioration|1|||
170725244|NCT00417079|616999216|FG001|Overall Study|Clinical deterioration|0|||
170725245|NCT00417079|616999215|FG000|Overall Study|Screening error|2|||
170725246|NCT00417079|616999216|FG001|Overall Study|Screening error|1|||
170725247|NCT00417079|616999215|FG000|Overall Study|Withdrawal by subject's family|0|||
170725248|NCT00417079|616999216|FG001|Overall Study|Withdrawal by subject's family|1|||
170725249|NCT00417079|616999215|FG000|Overall Study|Patient unable to come to the clinic|0|||
170725250|NCT00417079|616999216|FG001|Overall Study|Patient unable to come to the clinic|1|||
170725251|NCT00417079|616999215|FG000|Overall Study|abnormal liver function tests|0|||
170725252|NCT00417079|616999216|FG001|Overall Study|abnormal liver function tests|1|||
170725253|NCT03152552|616999217|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
170725254|NCT03152552|616999218|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
170725255|NCT03152552|616999219|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
170725256|NCT03152552|616999220|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
170725257|NCT03152552|616999221|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
170725258|NCT03152552|616999217|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
170725259|NCT03152552|616999218|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
170725260|NCT03152552|616999219|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
170725261|NCT03152552|616999220|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
170725262|NCT03152552|616999221|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
170725263|NCT03152552|616999217|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
170725264|NCT03152552|616999218|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
170725265|NCT03152552|616999219|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
170725266|NCT03152552|616999220|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
170725267|NCT03152552|616999221|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
170725268|NCT03152552|616999217|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170725269|NCT03152552|616999218|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170725270|NCT03152552|616999219|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
170725271|NCT03152552|616999220|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170725272|NCT03152552|616999221|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170725273|NCT03152552|616999217|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
170725274|NCT03152552|616999218|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
170725275|NCT03152552|616999219|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
170725276|NCT03152552|616999220|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
170725277|NCT03152552|616999221|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
170725278|NCT03152552|616999217|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
170725279|NCT03152552|616999218|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
170725280|NCT03152552|616999219|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
170725281|NCT03152552|616999220|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
170725282|NCT03152552|616999221|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
170725283|NCT03152552|616999217|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
170725284|NCT03152552|616999218|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
170725285|NCT03152552|616999219|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
170725286|NCT03152552|616999220|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
170725287|NCT03152552|616999221|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
170725288|NCT02194621|616999230|FG000|Overall Study|6 withdrew prior to randomization|2|||
170725289|NCT02194621|616999231|FG001|Overall Study|6 withdrew prior to randomization|2|||
170725290|NCT02194621|616999232|FG002|Overall Study|6 withdrew prior to randomization|2|||
170725291|NCT02194621|616999230|FG000|Overall Study|Withdrawal by Subject|4|||
170725292|NCT02194621|616999231|FG001|Overall Study|Withdrawal by Subject|4|||
170725293|NCT02194621|616999232|FG002|Overall Study|Withdrawal by Subject|7|||
170725294|NCT04988308|616999240|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
170725295|NCT04988308|616999241|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
170725296|NCT04988308|616999242|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
170725297|NCT04988308|616999243|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
170725298|NCT04988308|616999244|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
170725299|NCT04988308|616999245|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
170725300|NCT04988308|616999240|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
170725301|NCT04988308|616999241|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
170725302|NCT04988308|616999242|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
170725303|NCT04988308|616999243|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
170725304|NCT04988308|616999244|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
170725305|NCT04988308|616999245|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
170725306|NCT04988308|616999240|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
170725307|NCT04988308|616999241|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
170725308|NCT04988308|616999242|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
170725309|NCT04988308|616999243|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
170725310|NCT04988308|616999244|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
170725311|NCT04988308|616999245|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
170725312|NCT04988308|616999240|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
170725313|NCT04988308|616999241|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
170725314|NCT04988308|616999242|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
170725315|NCT04988308|616999243|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
170725316|NCT04988308|616999244|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
170725317|NCT04988308|616999245|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
170725318|NCT04988308|616999240|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
170725319|NCT04988308|616999241|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
170725320|NCT04988308|616999242|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
170725321|NCT04988308|616999243|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
170725322|NCT04988308|616999244|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
170725323|NCT04988308|616999245|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
170725324|NCT04988308|616999240|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
170725325|NCT04988308|616999241|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
170725326|NCT04988308|616999242|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
170725327|NCT04988308|616999243|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
170725328|NCT04988308|616999244|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
170725329|NCT04988308|616999245|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
170725330|NCT04988308|616999240|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
170725331|NCT04988308|616999241|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
170725332|NCT04988308|616999242|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
170725333|NCT04988308|616999243|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
170725334|NCT04988308|616999244|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
170725335|NCT04988308|616999245|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
170725336|NCT04988308|616999240|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
170725337|NCT04988308|616999241|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
170725338|NCT04988308|616999242|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
170725339|NCT04988308|616999243|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
170725340|NCT04988308|616999244|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
170725341|NCT04988308|616999245|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
170725342|NCT04988308|616999240|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
170725343|NCT04988308|616999241|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
170725344|NCT04988308|616999242|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
170725345|NCT04988308|616999243|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
170725346|NCT04988308|616999244|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
170725347|NCT04988308|616999245|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
170725348|NCT00809757|616999254|FG000|Overall Study|Adverse Event|2|||
170725349|NCT00809757|616999255|FG001|Overall Study|Adverse Event|3|||
170725350|NCT00809757|616999256|FG002|Overall Study|Adverse Event|3|||
170725351|NCT00809757|616999254|FG000|Overall Study|Lost to Follow-up|0|||
170725352|NCT00809757|616999255|FG001|Overall Study|Lost to Follow-up|0|||
170725353|NCT00809757|616999256|FG002|Overall Study|Lost to Follow-up|1|||
170725354|NCT00809757|616999254|FG000|Overall Study|Protocol Violation|1|||
170725355|NCT00809757|616999255|FG001|Overall Study|Protocol Violation|1|||
170725356|NCT00809757|616999256|FG002|Overall Study|Protocol Violation|1|||
170725357|NCT00809757|616999254|FG000|Overall Study|Withdrawal by Subject|2|||
170725358|NCT00809757|616999255|FG001|Overall Study|Withdrawal by Subject|1|||
170725359|NCT00809757|616999256|FG002|Overall Study|Withdrawal by Subject|3|||
170725360|NCT00809757|616999254|FG000|Overall Study|Subject Uncooperative|1|||
170725361|NCT00809757|616999255|FG001|Overall Study|Subject Uncooperative|0|||
170725362|NCT00809757|616999256|FG002|Overall Study|Subject Uncooperative|2|||
170725363|NCT00809757|616999254|FG000|Overall Study|Noncompliance with Medication|0|||
170725364|NCT00809757|616999255|FG001|Overall Study|Noncompliance with Medication|0|||
170725365|NCT00809757|616999256|FG002|Overall Study|Noncompliance with Medication|1|||
170725366|NCT00253864|616999257|FG000|Overall Study|Lost to Follow-up|5|||
170725367|NCT00253864|616999258|FG001|Overall Study|Lost to Follow-up|8|||
170725368|NCT00659334|616999259|FG000|Overall Study|Screen Failure|8|||
170725369|NCT00659334|616999260|FG001|Overall Study|Screen Failure|5|||
170725370|NCT00659334|616999261|FG002|Overall Study|Screen Failure|0|||
170725371|NCT00659334|616999262|FG003|Overall Study|Screen Failure|0|||
170725372|NCT00659334|616999263|FG004|Overall Study|Screen Failure|0|||
170725373|NCT00659334|616999264|FG005|Overall Study|Screen Failure|0|||
170725374|NCT00659334|616999265|FG006|Overall Study|Screen Failure|1|||
170725375|NCT04177758|616999266|FG000|Overall Study|Lost to Follow-up|19|||
170725376|NCT04177758|616999267|FG001|Overall Study|Lost to Follow-up|11|||
170725377|NCT00833638|616999268|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
170725378|NCT00833638|616999269|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
170725379|NCT00833638|616999270|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
170725380|NCT00833638|616999268|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
170725381|NCT00833638|616999269|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
170725382|NCT00833638|616999270|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
170725383|NCT00833638|616999268|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
170725384|NCT00833638|616999269|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
170725385|NCT00833638|616999270|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
170834327|NCT00940875|617401162|FG000|Post-Study Treatment|Death|0|||
170834328|NCT00940875|617401163|FG001|Post-Study Treatment|Death|1|||
170725386|NCT00833638|616999268|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
170725387|NCT00833638|616999269|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
170725388|NCT00833638|616999270|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
170725389|NCT00833638|616999268|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
170725390|NCT00833638|616999269|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
170725391|NCT00833638|616999270|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
170725392|NCT00833638|616999268|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
170725393|NCT00833638|616999269|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
170725394|NCT00833638|616999270|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
170725395|NCT00833638|616999268|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
170725396|NCT00833638|616999269|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
170725397|NCT00833638|616999270|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
170725398|NCT00833638|616999268|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
170725399|NCT00833638|616999269|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
170725400|NCT00833638|616999270|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
170725401|NCT00833638|616999268|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
170725402|NCT00833638|616999269|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
170725403|NCT00833638|616999270|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
170725404|NCT01178086|616999271|FG000|Overall Study|Participant refusal|7|||
170725405|NCT01178086|616999271|FG000|Overall Study|Physician Decision|44|||
170725406|NCT01178086|616999271|FG000|Overall Study|Switch to other CLL therapy|113|||
170725407|NCT01178086|616999271|FG000|Overall Study|Death|59|||
170725408|NCT01178086|616999271|FG000|Overall Study|Other unspecified|89|||
170725409|NCT01178086|616999271|FG000|Overall Study|Excluded from EAS|20|||
170725410|NCT02653482|616999274|FG000|Overall Study|Death|1|||
170725411|NCT02653482|616999275|FG001|Overall Study|Death|1|||
170725412|NCT01669122|616999276|FG000|Period I|Lost to Follow-up|1|||
170725413|NCT01669122|616999276|FG000|Washout Period II|Protocol Violation|2|||
170725414|NCT05132699|616999280|FG000|Overall Study|Withdrawal by Subject|3|||
170725415|NCT05132699|616999281|FG001|Overall Study|Withdrawal by Subject|0|||
170725416|NCT04370054|616999282|FG000|Treatment Phase|Lost to Follow-up|1|||
170725417|NCT04370054|616999282|FG000|Treatment Phase|Withdrawal by Subject|1|||
170725418|NCT04370054|616999282|FG000|Follow-Up Phase|Ongoing|75|||
170725419|NCT02096900|616999283|FG000|Overall Study|Did not receive medication|3|||
170725420|NCT02096900|616999284|FG001|Overall Study|Did not receive medication|1|||
170725421|NCT02096900|616999283|FG000|Overall Study|Surgery cancelled- medication received|1|||
170725422|NCT02096900|616999284|FG001|Overall Study|Surgery cancelled- medication received|1|||
170725423|NCT03003468|616999285|FG000|Overall Study|Withdrawal by Subject|0|||
170725424|NCT03003468|616999286|FG001|Overall Study|Withdrawal by Subject|0|||
170725425|NCT03003468|616999287|FG002|Overall Study|Withdrawal by Subject|1|||
170725426|NCT03003468|616999285|FG000|Overall Study|No measurable lesions|0|||
170725427|NCT03003468|616999286|FG001|Overall Study|No measurable lesions|0|||
170725428|NCT03003468|616999287|FG002|Overall Study|No measurable lesions|1|||
170725429|NCT01712009|617000880|FG000|Overall Study|Withdrawal by Subject|24|||
170725430|NCT01712009|617000881|FG001|Overall Study|Withdrawal by Subject|15|||
170725431|NCT01712009|617000882|FG002|Overall Study|Withdrawal by Subject|8|||
170725432|NCT01712009|617000880|FG000|Overall Study|Lost to Follow-up|2|||
170725433|NCT01712009|617000881|FG001|Overall Study|Lost to Follow-up|0|||
170725434|NCT01712009|617000882|FG002|Overall Study|Lost to Follow-up|1|||
170725435|NCT01712009|617000880|FG000|Overall Study|Decision by Sponsor|12|||
170725436|NCT01712009|617000881|FG001|Overall Study|Decision by Sponsor|14|||
170725437|NCT01712009|617000882|FG002|Overall Study|Decision by Sponsor|12|||
170725438|NCT03576768|617000883|FG000|Overall Study|Lost to Follow-up|3|||
170725439|NCT03576768|617000884|FG001|Overall Study|Lost to Follow-up|3|||
170725440|NCT03576768|617000885|FG002|Overall Study|Lost to Follow-up|0|||
170725441|NCT03576768|617000886|FG003|Overall Study|Lost to Follow-up|0|||
170725442|NCT00590902|617000887|FG000|Overall Study|Death|1|||
170725443|NCT04050865|617000888|FG000|Overall Study|Adverse Event|1|||
170725444|NCT04050865|617000889|FG001|Overall Study|Adverse Event|0|||
170725445|NCT04050865|617000888|FG000|Overall Study|no insert|1|||
170725446|NCT04050865|617000889|FG001|Overall Study|no insert|0|||
170725447|NCT04050865|617000888|FG000|Overall Study|Only 1 insert|2|||
170725448|NCT04050865|617000889|FG001|Overall Study|Only 1 insert|3|||
170834329|NCT00940875|617401162|FG000|Post-Study Treatment|Disease Progression|0|||
170725449|NCT04050865|617000888|FG000|Overall Study|Physician Decision|0|||
170725450|NCT04050865|617000889|FG001|Overall Study|Physician Decision|1|||
170725451|NCT04050865|617000888|FG000|Overall Study|Withdrawal by Subject|0|||
170725452|NCT04050865|617000889|FG001|Overall Study|Withdrawal by Subject|1|||
170725453|NCT01258608|617000891|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
170834330|NCT00940875|617401163|FG001|Post-Study Treatment|Disease Progression|2|||
170725454|NCT01258608|617000892|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
170725455|NCT01258608|617000891|FG000|Overall Study|Clinical progression|1|||
170834331|NCT04071301|617401165|FG000|Overall Study|Withdrawal by Subject|6|||
170725456|NCT01258608|617000892|FG001|Overall Study|Clinical progression|0|||
170725457|NCT01258608|617000891|FG000|Overall Study|Sponsor decision|0|||
170725458|NCT01258608|617000892|FG001|Overall Study|Sponsor decision|1|||
170725459|NCT01258608|617000891|FG000|Overall Study|Physician Decision|6|||
170725460|NCT01258608|617000892|FG001|Overall Study|Physician Decision|1|||
170725461|NCT01258608|617000891|FG000|Overall Study|Lost to Follow-up|0|||
170725462|NCT01258608|617000892|FG001|Overall Study|Lost to Follow-up|1|||
170725463|NCT01258608|617000891|FG000|Overall Study|Lack of compliance|1|||
170725464|NCT01258608|617000892|FG001|Overall Study|Lack of compliance|0|||
170725465|NCT01258608|617000891|FG000|Overall Study|Lack of Efficacy|0|||
170725466|NCT01258608|617000892|FG001|Overall Study|Lack of Efficacy|1|||
170725467|NCT01258608|617000891|FG000|Overall Study|Adverse Event|6|||
170725468|NCT01258608|617000892|FG001|Overall Study|Adverse Event|10|||
170725469|NCT01258608|617000891|FG000|Overall Study|Withdrawal by Subject|6|||
170725470|NCT01258608|617000892|FG001|Overall Study|Withdrawal by Subject|5|||
170725471|NCT00440531|617000897|FG000|Overall Study|Adverse Event|1|||
170725472|NCT00440531|617000898|FG001|Overall Study|Adverse Event|0|||
170725473|NCT00440531|617000899|FG002|Overall Study|Adverse Event|2|||
170725474|NCT00440531|617000897|FG000|Overall Study|Withdrawal by Subject|2|||
170725475|NCT00440531|617000898|FG001|Overall Study|Withdrawal by Subject|0|||
170725476|NCT00440531|617000899|FG002|Overall Study|Withdrawal by Subject|0|||
170725477|NCT00440531|617000897|FG000|Overall Study|Protocol Violation|1|||
170725478|NCT00440531|617000898|FG001|Overall Study|Protocol Violation|2|||
170725479|NCT00440531|617000899|FG002|Overall Study|Protocol Violation|0|||
170725480|NCT00440531|617000897|FG000|Overall Study|Lost to Follow-up|4|||
170725481|NCT00440531|617000898|FG001|Overall Study|Lost to Follow-up|3|||
170725482|NCT00440531|617000899|FG002|Overall Study|Lost to Follow-up|5|||
170725483|NCT00440531|617000897|FG000|Overall Study|see pre-assignment details|2|||
170725484|NCT00440531|617000898|FG001|Overall Study|see pre-assignment details|0|||
170725485|NCT00440531|617000899|FG002|Overall Study|see pre-assignment details|0|||
170725486|NCT00447057|617000900|FG000|Overall Study|Adverse Event|4|||
170725487|NCT00447057|617000901|FG001|Overall Study|Adverse Event|10|||
170725488|NCT00447057|617000902|FG002|Overall Study|Adverse Event|0|||
170725489|NCT00447057|617000903|FG003|Overall Study|Adverse Event|3|||
170725490|NCT00447057|617000900|FG000|Overall Study|Death due to study disease|6|||
170725491|NCT00447057|617000901|FG001|Overall Study|Death due to study disease|4|||
170725492|NCT00447057|617000902|FG002|Overall Study|Death due to study disease|1|||
170725493|NCT00447057|617000903|FG003|Overall Study|Death due to study disease|1|||
170725494|NCT00447057|617000900|FG000|Overall Study|Lost to Follow-up|0|||
170725495|NCT00447057|617000901|FG001|Overall Study|Lost to Follow-up|1|||
170725496|NCT00447057|617000902|FG002|Overall Study|Lost to Follow-up|0|||
170725497|NCT00447057|617000903|FG003|Overall Study|Lost to Follow-up|0|||
170725498|NCT00447057|617000900|FG000|Overall Study|Entry criteria not met|1|||
170725499|NCT00447057|617000901|FG001|Overall Study|Entry criteria not met|1|||
170725500|NCT00447057|617000902|FG002|Overall Study|Entry criteria not met|0|||
170725501|NCT00447057|617000903|FG003|Overall Study|Entry criteria not met|0|||
170725502|NCT00447057|617000900|FG000|Overall Study|Protocol Violation|0|||
170725503|NCT00447057|617000901|FG001|Overall Study|Protocol Violation|1|||
170725504|NCT00447057|617000902|FG002|Overall Study|Protocol Violation|0|||
170725505|NCT00447057|617000903|FG003|Overall Study|Protocol Violation|0|||
170725506|NCT00447057|617000900|FG000|Overall Study|Withdrawal by Subject|4|||
170725507|NCT00447057|617000901|FG001|Overall Study|Withdrawal by Subject|5|||
170725508|NCT00447057|617000902|FG002|Overall Study|Withdrawal by Subject|1|||
170725509|NCT00447057|617000903|FG003|Overall Study|Withdrawal by Subject|1|||
170725510|NCT00447057|617000900|FG000|Overall Study|Physician Decision|9|||
170725511|NCT00447057|617000901|FG001|Overall Study|Physician Decision|6|||
170725512|NCT00447057|617000902|FG002|Overall Study|Physician Decision|3|||
170834332|NCT04071301|617401165|FG000|Overall Study|Death|1|||
170834333|NCT02879383|617401166|FG000|First 24 Weeks|Physician Decision|0|||
170834334|NCT02879383|617401167|FG001|First 24 Weeks|Physician Decision|1|||
170725513|NCT00447057|617000903|FG003|Overall Study|Physician Decision|1|||
170725514|NCT00447057|617000900|FG000|Overall Study|Sponsor decision|1|||
170725515|NCT00447057|617000901|FG001|Overall Study|Sponsor decision|1|||
170725516|NCT00447057|617000902|FG002|Overall Study|Sponsor decision|0|||
170725517|NCT00447057|617000903|FG003|Overall Study|Sponsor decision|0|||
170725518|NCT00447057|617000900|FG000|Overall Study|Progressive disease|58|||
170725519|NCT00447057|617000901|FG001|Overall Study|Progressive disease|43|||
170725520|NCT00447057|617000902|FG002|Overall Study|Progressive disease|13|||
170725521|NCT00447057|617000903|FG003|Overall Study|Progressive disease|18|||
170725522|NCT00447057|617000900|FG000|Overall Study|Death due to adverse event|0|||
170725523|NCT00447057|617000901|FG001|Overall Study|Death due to adverse event|0|||
170725524|NCT00447057|617000902|FG002|Overall Study|Death due to adverse event|1|||
170834335|NCT02879383|617401168|FG002|First 24 Weeks|Physician Decision|0|||
170834336|NCT02879383|617401169|FG003|First 24 Weeks|Physician Decision|0|||
170834337|NCT05186311|617401170|FG000|Part A: Serum|Withdrawal by Subject|1|||
170725525|NCT00447057|617000903|FG003|Overall Study|Death due to adverse event|2|||
170725526|NCT00447057|617000900|FG000|Overall Study|Death, study drug related|0|||
170834338|NCT01850589|617401171|FG000|Overall Study|Withdrawal by Subject|8|||
170725527|NCT00447057|617000901|FG001|Overall Study|Death, study drug related|1|||
170834339|NCT01850589|617401172|FG001|Overall Study|Withdrawal by Subject|0|||
170834340|NCT03912662|617401173|FG000|Overall Study|Adverse Event|3|||
170834341|NCT03912662|617401173|FG000|Overall Study|Adverse Event and Death|1|||
170834342|NCT03912662|617401173|FG000|Overall Study|Death|1|||
170834343|NCT03912662|617401173|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
170834344|NCT03912662|617401173|FG000|Overall Study|Mesh Removal|1|||
170834345|NCT03912662|617401173|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
170834346|NCT03912662|617401173|FG000|Overall Study|Early study termination|20|||
170834347|NCT03845140|617401174|FG000|Overall Study|Participant travelled outside study area|0|||
170834348|NCT03845140|617401175|FG001|Overall Study|Participant travelled outside study area|1|||
170834349|NCT03845140|617401176|FG002|Overall Study|Participant travelled outside study area|0|||
170834350|NCT03845140|617401177|FG003|Overall Study|Participant travelled outside study area|0|||
170834351|NCT03845140|617401178|FG004|Overall Study|Participant travelled outside study area|0|||
170834352|NCT03845140|617401179|FG005|Overall Study|Participant travelled outside study area|0|||
170834353|NCT00632021|617401180|FG000|Overall Study|Withdrawal/death|4|||
170834354|NCT00632021|617401181|FG001|Overall Study|Withdrawal/death|7|||
170834355|NCT01850030|617401182|FG000|Overall Study|Adverse Event|64|||
170834356|NCT01850030|617401183|FG001|Overall Study|Adverse Event|82|||
170834357|NCT01850030|617401182|FG000|Overall Study|Lack of Efficacy|3|||
170834358|NCT01850030|617401183|FG001|Overall Study|Lack of Efficacy|1|||
170834359|NCT01850030|617401182|FG000|Overall Study|Lost to Follow-up|5|||
170834360|NCT01850030|617401183|FG001|Overall Study|Lost to Follow-up|5|||
170834361|NCT01850030|617401182|FG000|Overall Study|Withdrawal by Subject|3|||
170834362|NCT01850030|617401183|FG001|Overall Study|Withdrawal by Subject|4|||
170834363|NCT01850030|617401182|FG000|Overall Study|Protocol Violation|24|||
170834364|NCT01850030|617401183|FG001|Overall Study|Protocol Violation|28|||
170834365|NCT01850030|617401182|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
170834366|NCT01850030|617401183|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
170834367|NCT01658020|617401187|FG000|Overall Study|Adverse Event|3|||
170834368|NCT01658020|617401188|FG001|Overall Study|Adverse Event|3|||
170834369|NCT01658020|617401187|FG000|Overall Study|Lost to Follow-up|1|||
170834370|NCT01658020|617401188|FG001|Overall Study|Lost to Follow-up|0|||
170834371|NCT01658020|617401187|FG000|Overall Study|Withdrawal by Subject|4|||
170834372|NCT01658020|617401188|FG001|Overall Study|Withdrawal by Subject|5|||
170834373|NCT01658020|617401187|FG000|Overall Study|Protocol Violation|0|||
170834374|NCT01658020|617401188|FG001|Overall Study|Protocol Violation|1|||
170834375|NCT05523219|617401198|FG000|Overall Study|Wrong inclusion|1|||
170834376|NCT05523219|617401198|FG000|Overall Study|Lost to Follow-up|7|||
170834377|NCT03845023|617401203|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
170834378|NCT03845023|617401204|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
170834379|NCT03845023|617401205|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
170834380|NCT03845023|617401206|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
170834381|NCT03845023|617401203|FG000|Follow-Up (14 Days)|Adverse Event|0|||
170834382|NCT03845023|617401204|FG001|Follow-Up (14 Days)|Adverse Event|0|||
170834383|NCT03845023|617401205|FG002|Follow-Up (14 Days)|Adverse Event|1|||
170834384|NCT03845023|617401206|FG003|Follow-Up (14 Days)|Adverse Event|1|||
170834385|NCT03738397|617401207|FG000|Overall Study|Adverse Event|3|||
170834386|NCT03738397|617401208|FG001|Overall Study|Adverse Event|7|||
170834387|NCT03738397|617401207|FG000|Overall Study|Withdrawal by Subject|8|||
170834388|NCT03738397|617401208|FG001|Overall Study|Withdrawal by Subject|11|||
170834389|NCT03738397|617401207|FG000|Overall Study|Lost to Follow-up|7|||
170834390|NCT03738397|617401208|FG001|Overall Study|Lost to Follow-up|5|||
170834391|NCT03738397|617401207|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
170834392|NCT03738397|617401208|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
170834393|NCT03738397|617401207|FG000|Overall Study|Other|4|||
170834394|NCT03738397|617401208|FG001|Overall Study|Other|6|||
170834395|NCT03783689|617401216|FG000|Overall Study|Adverse Event|2|||
170834396|NCT03783689|617401217|FG001|Overall Study|Adverse Event|0|||
170834397|NCT03783689|617401216|FG000|Overall Study|Lost to Follow-up|2|||
170834398|NCT03783689|617401217|FG001|Overall Study|Lost to Follow-up|1|||
170834399|NCT03783689|617401216|FG000|Overall Study|Physician Decision|2|||
170834400|NCT03783689|617401217|FG001|Overall Study|Physician Decision|1|||
170834401|NCT03783689|617401216|FG000|Overall Study|Withdrawal by Subject|3|||
170834402|NCT03783689|617401217|FG001|Overall Study|Withdrawal by Subject|3|||
170834403|NCT05972486|617401223|FG000|Overall Study|Withdrawal by Subject|17|||
170834404|NCT04564547|617401224|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
170834405|NCT04564547|617401225|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
170834406|NCT04564547|617401226|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
170834407|NCT04564547|617401227|FG003|Double-blind Treatment Period|Lost to Follow-up|1|||
170834408|NCT04564547|617401224|FG000|Double-blind Treatment Period|Physician Decision|0|||
170834409|NCT04564547|617401225|FG001|Double-blind Treatment Period|Physician Decision|1|||
170834410|NCT04564547|617401226|FG002|Double-blind Treatment Period|Physician Decision|1|||
170834411|NCT04564547|617401227|FG003|Double-blind Treatment Period|Physician Decision|0|||
170834412|NCT04564547|617401224|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
170834413|NCT04564547|617401225|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
170834414|NCT04564547|617401226|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170834415|NCT04564547|617401227|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
170834416|NCT04564547|617401224|FG000|Unblinded Safety Monitoring Period|Lost to Follow-up|0|||
170834417|NCT04564547|617401225|FG001|Unblinded Safety Monitoring Period|Lost to Follow-up|1|||
170834418|NCT04564547|617401226|FG002|Unblinded Safety Monitoring Period|Lost to Follow-up|1|||
170834419|NCT04564547|617401227|FG003|Unblinded Safety Monitoring Period|Lost to Follow-up|0|||
170834420|NCT04564547|617401224|FG000|Unblinded Safety Monitoring Period|Physician Decision|1|||
170834421|NCT04564547|617401225|FG001|Unblinded Safety Monitoring Period|Physician Decision|0|||
170834422|NCT04564547|617401226|FG002|Unblinded Safety Monitoring Period|Physician Decision|1|||
170834423|NCT04564547|617401227|FG003|Unblinded Safety Monitoring Period|Physician Decision|0|||
170834424|NCT04564547|617401224|FG000|Unblinded Safety Monitoring Period|Sponsor Decision|5|||
170834425|NCT04564547|617401225|FG001|Unblinded Safety Monitoring Period|Sponsor Decision|6|||
170834426|NCT04564547|617401226|FG002|Unblinded Safety Monitoring Period|Sponsor Decision|4|||
170834427|NCT04564547|617401227|FG003|Unblinded Safety Monitoring Period|Sponsor Decision|0|||
170834428|NCT04564547|617401224|FG000|Unblinded Safety Monitoring Period|Withdrawal by Subject|6|||
170834429|NCT04564547|617401225|FG001|Unblinded Safety Monitoring Period|Withdrawal by Subject|7|||
170834430|NCT04564547|617401226|FG002|Unblinded Safety Monitoring Period|Withdrawal by Subject|7|||
170834431|NCT04564547|617401227|FG003|Unblinded Safety Monitoring Period|Withdrawal by Subject|0|||
170834432|NCT03023722|617402787|FG000|Overall Study|No follow-up assessment|4|||
170834433|NCT02737826|617402788|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
170834434|NCT02737826|617402789|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
170834435|NCT02737826|617402790|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
170834436|NCT04596995|617402791|FG000|Overall Study|Lack of Efficacy|8|||
170834437|NCT04596995|617402791|FG000|Overall Study|Lost to Follow-up|3|||
170834438|NCT04596995|617402791|FG000|Overall Study|Withdrawal by Subject|12|||
170834439|NCT04596995|617402791|FG000|Overall Study|Sponsor decision|3|||
170834440|NCT04596995|617402791|FG000|Overall Study|Enrolled in managed access program|3|||
170834441|NCT01385748|617402792|FG000|Overall Study|Withdrawal by Subject|7|||
170834442|NCT01385748|617402793|FG001|Overall Study|Withdrawal by Subject|4|||
170834443|NCT01385748|617402794|FG002|Overall Study|Withdrawal by Subject|5|||
170834444|NCT01385748|617402792|FG000|Overall Study|Noncompliance|3|||
170834445|NCT01385748|617402793|FG001|Overall Study|Noncompliance|1|||
170834446|NCT01385748|617402794|FG002|Overall Study|Noncompliance|6|||
170834447|NCT01385748|617402792|FG000|Overall Study|Other|1|||
170834448|NCT01385748|617402793|FG001|Overall Study|Other|7|||
170834449|NCT01385748|617402794|FG002|Overall Study|Other|1|||
170834450|NCT01385748|617402792|FG000|Overall Study|Adverse Event|4|||
170834451|NCT01385748|617402793|FG001|Overall Study|Adverse Event|2|||
170834452|NCT01385748|617402794|FG002|Overall Study|Adverse Event|1|||
170834453|NCT02354651|617402795|FG000|Overall Study|Withdrawal by Subject|2|||
170834454|NCT02354651|617402795|FG000|Overall Study|Physician Decision|1|||
170834455|NCT01317875|617402797|FG000|Overall Study|Other|0|||
170834456|NCT01317875|617402798|FG001|Overall Study|Other|0|||
170834457|NCT01317875|617402799|FG002|Overall Study|Other|1|||
170834458|NCT01317875|617402800|FG003|Overall Study|Other|0|||
170834459|NCT01317875|617402801|FG004|Overall Study|Other|0|||
170834460|NCT01317875|617402802|FG005|Overall Study|Other|0|||
170834461|NCT01317875|617402803|FG006|Overall Study|Other|0|||
170834462|NCT01317875|617402804|FG007|Overall Study|Other|0|||
170834463|NCT01317875|617402805|FG008|Overall Study|Other|0|||
170834464|NCT01317875|617402806|FG009|Overall Study|Other|0|||
170834465|NCT01317875|617402797|FG000|Overall Study|Noncompliance with study drug|0|||
170834466|NCT01317875|617402798|FG001|Overall Study|Noncompliance with study drug|0|||
170834467|NCT01317875|617402799|FG002|Overall Study|Noncompliance with study drug|1|||
170834468|NCT01317875|617402800|FG003|Overall Study|Noncompliance with study drug|0|||
170834469|NCT01317875|617402801|FG004|Overall Study|Noncompliance with study drug|0|||
170834470|NCT01317875|617402802|FG005|Overall Study|Noncompliance with study drug|0|||
170834471|NCT01317875|617402803|FG006|Overall Study|Noncompliance with study drug|0|||
170834472|NCT01317875|617402804|FG007|Overall Study|Noncompliance with study drug|0|||
170834473|NCT01317875|617402805|FG008|Overall Study|Noncompliance with study drug|0|||
170834474|NCT01317875|617402806|FG009|Overall Study|Noncompliance with study drug|0|||
170834475|NCT01317875|617402797|FG000|Overall Study|Progressive Disease|1|||
170834476|NCT01317875|617402798|FG001|Overall Study|Progressive Disease|0|||
170834477|NCT01317875|617402799|FG002|Overall Study|Progressive Disease|2|||
170834478|NCT01317875|617402800|FG003|Overall Study|Progressive Disease|0|||
170834479|NCT01317875|617402801|FG004|Overall Study|Progressive Disease|1|||
170834480|NCT01317875|617402802|FG005|Overall Study|Progressive Disease|0|||
170834481|NCT01317875|617402803|FG006|Overall Study|Progressive Disease|0|||
170834482|NCT01317875|617402804|FG007|Overall Study|Progressive Disease|1|||
170834483|NCT01317875|617402805|FG008|Overall Study|Progressive Disease|0|||
170834484|NCT01317875|617402806|FG009|Overall Study|Progressive Disease|0|||
170834485|NCT01317875|617402797|FG000|Overall Study|Withdrawal by Subject|0|||
170834486|NCT01317875|617402798|FG001|Overall Study|Withdrawal by Subject|0|||
170834487|NCT01317875|617402799|FG002|Overall Study|Withdrawal by Subject|0|||
170834488|NCT01317875|617402800|FG003|Overall Study|Withdrawal by Subject|0|||
170834489|NCT01317875|617402801|FG004|Overall Study|Withdrawal by Subject|1|||
170834490|NCT01317875|617402802|FG005|Overall Study|Withdrawal by Subject|0|||
170834491|NCT01317875|617402803|FG006|Overall Study|Withdrawal by Subject|0|||
170834492|NCT01317875|617402804|FG007|Overall Study|Withdrawal by Subject|3|||
170834493|NCT01317875|617402805|FG008|Overall Study|Withdrawal by Subject|0|||
170834494|NCT01317875|617402806|FG009|Overall Study|Withdrawal by Subject|0|||
170834495|NCT01317875|617402797|FG000|Overall Study|Physician Decision|0|||
170834496|NCT01317875|617402798|FG001|Overall Study|Physician Decision|1|||
170834497|NCT01317875|617402799|FG002|Overall Study|Physician Decision|1|||
170834498|NCT01317875|617402800|FG003|Overall Study|Physician Decision|0|||
170834499|NCT01317875|617402801|FG004|Overall Study|Physician Decision|2|||
170834500|NCT01317875|617402802|FG005|Overall Study|Physician Decision|0|||
170834501|NCT01317875|617402803|FG006|Overall Study|Physician Decision|0|||
170834502|NCT01317875|617402804|FG007|Overall Study|Physician Decision|2|||
170834503|NCT01317875|617402805|FG008|Overall Study|Physician Decision|0|||
170834504|NCT01317875|617402806|FG009|Overall Study|Physician Decision|0|||
170834505|NCT01317875|617402797|FG000|Overall Study|Death|0|||
170834506|NCT01317875|617402798|FG001|Overall Study|Death|0|||
170834507|NCT01317875|617402799|FG002|Overall Study|Death|2|||
170834508|NCT01317875|617402800|FG003|Overall Study|Death|1|||
170834509|NCT01317875|617402801|FG004|Overall Study|Death|0|||
170834510|NCT01317875|617402802|FG005|Overall Study|Death|1|||
170834511|NCT01317875|617402803|FG006|Overall Study|Death|0|||
170834512|NCT01317875|617402804|FG007|Overall Study|Death|4|||
170834513|NCT01317875|617402805|FG008|Overall Study|Death|0|||
170834514|NCT01317875|617402806|FG009|Overall Study|Death|0|||
170834515|NCT01317875|617402797|FG000|Overall Study|Adverse Event|2|||
170834516|NCT01317875|617402798|FG001|Overall Study|Adverse Event|1|||
170834517|NCT01317875|617402799|FG002|Overall Study|Adverse Event|2|||
170834518|NCT01317875|617402800|FG003|Overall Study|Adverse Event|1|||
170834519|NCT01317875|617402801|FG004|Overall Study|Adverse Event|5|||
170834520|NCT01317875|617402802|FG005|Overall Study|Adverse Event|1|||
170834521|NCT01317875|617402803|FG006|Overall Study|Adverse Event|2|||
170834522|NCT01317875|617402804|FG007|Overall Study|Adverse Event|5|||
170834523|NCT01317875|617402805|FG008|Overall Study|Adverse Event|0|||
170834524|NCT01317875|617402806|FG009|Overall Study|Adverse Event|0|||
170834525|NCT00581893|617402807|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
170834526|NCT00581893|617402808|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
170834527|NCT01200342|617402815|FG000|Overall Study|Disease Progression|1|||
170834528|NCT04546217|617402816|FG000|Overall Study|Withdrawal by Subject|2|||
170834529|NCT04546217|617402817|FG001|Overall Study|Withdrawal by Subject|0|||
170834530|NCT04546217|617402816|FG000|Overall Study|Uncontrolled hypertension|1|||
170834531|NCT04546217|617402817|FG001|Overall Study|Uncontrolled hypertension|0|||
170834532|NCT00420784|617402829|FG000|Overall Study|Adverse Event|11|||
170834533|NCT00420784|617402830|FG001|Overall Study|Adverse Event|29|||
170834534|NCT00420784|617402831|FG002|Overall Study|Adverse Event|10|||
170834535|NCT00420784|617402832|FG003|Overall Study|Adverse Event|5|||
170834536|NCT00420784|617402829|FG000|Overall Study|Withdrawal by Subject|0|||
170834537|NCT00420784|617402830|FG001|Overall Study|Withdrawal by Subject|1|||
170834538|NCT00420784|617402831|FG002|Overall Study|Withdrawal by Subject|0|||
170834539|NCT00420784|617402832|FG003|Overall Study|Withdrawal by Subject|0|||
170834540|NCT00420784|617402829|FG000|Overall Study|Lost to Follow-up|0|||
170834541|NCT00420784|617402830|FG001|Overall Study|Lost to Follow-up|0|||
170834542|NCT00420784|617402831|FG002|Overall Study|Lost to Follow-up|2|||
170834543|NCT00420784|617402832|FG003|Overall Study|Lost to Follow-up|1|||
170834544|NCT00420784|617402829|FG000|Overall Study|Virologic Stopping Rule|17|||
170834545|NCT00420784|617402830|FG001|Overall Study|Virologic Stopping Rule|26|||
170834546|NCT00420784|617402831|FG002|Overall Study|Virologic Stopping Rule|41|||
170834547|NCT00420784|617402832|FG003|Overall Study|Virologic Stopping Rule|67|||
170834548|NCT00420784|617402829|FG000|Overall Study|Other|1|||
170834549|NCT00420784|617402830|FG001|Overall Study|Other|2|||
170834550|NCT00420784|617402831|FG002|Overall Study|Other|0|||
170834551|NCT00420784|617402832|FG003|Overall Study|Other|5|||
170834552|NCT05147350|617402835|FG000|Overall Study|Death|2|||
170834553|NCT05147350|617402836|FG001|Overall Study|Death|3|||
170834554|NCT05147350|617402837|FG002|Overall Study|Death|3|||
170834555|NCT05147350|617402838|FG003|Overall Study|Death|2|||
170834556|NCT05147350|617402839|FG004|Overall Study|Death|2|||
170834557|NCT05147350|617402840|FG005|Overall Study|Death|1|||
170834558|NCT05147350|617402841|FG006|Overall Study|Death|1|||
170834559|NCT05147350|617402842|FG007|Overall Study|Death|3|||
170834560|NCT05147350|617402835|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
170834561|NCT05147350|617402836|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
170834562|NCT05147350|617402837|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
170834563|NCT05147350|617402838|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
170834564|NCT05147350|617402839|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
170834565|NCT05147350|617402840|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
170834566|NCT05147350|617402841|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
170834567|NCT05147350|617402842|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
170834568|NCT05147350|617402835|FG000|Overall Study|Withdrawal by Subject|0|||
170834569|NCT05147350|617402836|FG001|Overall Study|Withdrawal by Subject|0|||
170834570|NCT05147350|617402837|FG002|Overall Study|Withdrawal by Subject|3|||
170834571|NCT05147350|617402838|FG003|Overall Study|Withdrawal by Subject|1|||
170834572|NCT05147350|617402839|FG004|Overall Study|Withdrawal by Subject|1|||
170834573|NCT05147350|617402840|FG005|Overall Study|Withdrawal by Subject|0|||
170834574|NCT05147350|617402841|FG006|Overall Study|Withdrawal by Subject|1|||
170834575|NCT05147350|617402842|FG007|Overall Study|Withdrawal by Subject|0|||
170834576|NCT05147350|617402835|FG000|Overall Study|Other Reasons|0|||
170834577|NCT05147350|617402836|FG001|Overall Study|Other Reasons|0|||
170834578|NCT05147350|617402837|FG002|Overall Study|Other Reasons|2|||
170834579|NCT05147350|617402838|FG003|Overall Study|Other Reasons|0|||
170834580|NCT05147350|617402839|FG004|Overall Study|Other Reasons|0|||
170834581|NCT05147350|617402840|FG005|Overall Study|Other Reasons|2|||
170834582|NCT05147350|617402841|FG006|Overall Study|Other Reasons|1|||
170834583|NCT05147350|617402842|FG007|Overall Study|Other Reasons|1|||
170834584|NCT03016598|617402845|FG000|Overall Study|Lost to Follow-up|0|||
170834585|NCT03016598|617402846|FG001|Overall Study|Lost to Follow-up|2|||
170834586|NCT02402322|617402850|FG000|Pretreatment|Withdrawal by Subject|3|||
170834587|NCT02402322|617402851|FG001|Pretreatment|Withdrawal by Subject|1|||
170834588|NCT02402322|617402852|FG002|Pretreatment|Withdrawal by Subject|1|||
170834589|NCT02402322|617402850|FG000|Follow-up|Withdrawal by Subject|6|||
170834590|NCT02402322|617402851|FG001|Follow-up|Withdrawal by Subject|3|||
170834591|NCT02402322|617402852|FG002|Follow-up|Withdrawal by Subject|24|||
170834592|NCT02818998|617402853|FG000|Overall Study|Adverse Event|3|||
170834593|NCT02818998|617402854|FG001|Overall Study|Adverse Event|2|||
170834594|NCT02818998|617402855|FG002|Overall Study|Adverse Event|1|||
170834595|NCT02818998|617402853|FG000|Overall Study|Lost to Follow-up|4|||
170834596|NCT02818998|617402854|FG001|Overall Study|Lost to Follow-up|1|||
170834597|NCT02818998|617402855|FG002|Overall Study|Lost to Follow-up|2|||
170834598|NCT02818998|617402853|FG000|Overall Study|Withdrawal by sponsor|0|||
170834599|NCT02818998|617402854|FG001|Overall Study|Withdrawal by sponsor|1|||
170834600|NCT02818998|617402855|FG002|Overall Study|Withdrawal by sponsor|1|||
170834601|NCT02818998|617402853|FG000|Overall Study|Death|3|||
170834602|NCT02818998|617402854|FG001|Overall Study|Death|6|||
170834603|NCT02818998|617402855|FG002|Overall Study|Death|8|||
170834604|NCT02818998|617402853|FG000|Overall Study|Withdrawal by Subject|7|||
170834605|NCT02818998|617402854|FG001|Overall Study|Withdrawal by Subject|6|||
170834606|NCT02818998|617402855|FG002|Overall Study|Withdrawal by Subject|6|||
170834607|NCT02818998|617402853|FG000|Overall Study|Physician Decision|1|||
170834608|NCT02818998|617402854|FG001|Overall Study|Physician Decision|0|||
170834609|NCT02818998|617402855|FG002|Overall Study|Physician Decision|0|||
170834610|NCT02472145|617402856|FG000|Overall Study|Death|10|||
170834611|NCT02472145|617402857|FG001|Overall Study|Death|101|||
170834612|NCT02472145|617402858|FG002|Overall Study|Death|99|||
170834613|NCT02472145|617402856|FG000|Overall Study|Lost to Follow-up|0|||
170834614|NCT02472145|617402857|FG001|Overall Study|Lost to Follow-up|1|||
170834615|NCT02472145|617402858|FG002|Overall Study|Lost to Follow-up|0|||
170834616|NCT02472145|617402856|FG000|Overall Study|Withdrawal by Subject|0|||
170834617|NCT02472145|617402857|FG001|Overall Study|Withdrawal by Subject|9|||
170834618|NCT02472145|617402858|FG002|Overall Study|Withdrawal by Subject|13|||
170834619|NCT02472145|617402856|FG000|Overall Study|Sponsor decision|0|||
170834620|NCT02472145|617402857|FG001|Overall Study|Sponsor decision|3|||
170834621|NCT02472145|617402858|FG002|Overall Study|Sponsor decision|2|||
170834622|NCT02472145|617402856|FG000|Overall Study|Other|0|||
170834623|NCT02472145|617402857|FG001|Overall Study|Other|45|||
170834624|NCT02472145|617402858|FG002|Overall Study|Other|43|||
170834625|NCT01318876|617402859|FG000|Day 8 Survey|email address invalid|96|||
170834626|NCT01318876|617402859|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
170834627|NCT01318876|617402859|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
170834628|NCT02437071|617402860|FG000|Overall Study|Withdrawal by Subject|1|||
170834629|NCT02437071|617402861|FG001|Overall Study|Withdrawal by Subject|0|||
170834630|NCT01587118|617402864|FG000|Overall Study|Adverse Event|3|||
170834631|NCT01587118|617402864|FG000|Overall Study|Lost to Follow-up|2|||
170834632|NCT01587118|617402864|FG000|Overall Study|Relocation|1|||
170834633|NCT01587118|617402864|FG000|Overall Study|nonresponse|1|||
170834634|NCT00537329|617402865|FG000|Overall Study|Death|10|||
170834635|NCT00537329|617402865|FG000|Overall Study|Adverse Event|3|||
170834636|NCT00537329|617402865|FG000|Overall Study|Lack of Efficacy|2|||
170834637|NCT00537329|617402865|FG000|Overall Study|Lost to Follow-up|6|||
170834638|NCT00537329|617402865|FG000|Overall Study|Withdrawal by Subject|4|||
170834639|NCT00537329|617402865|FG000|Overall Study|Other|1|||
170834640|NCT00224029|617402868|FG000|Overall Study|Lost to Follow-up|1|||
170834641|NCT00224029|617402868|FG000|Overall Study|Withdrawal by Subject|4|||
170834642|NCT00224029|617402868|FG000|Overall Study|Other|1|||
170834643|NCT00243022|617402869|FG000|Overall Study|Withdrawal by Subject|1|||
170725528|NCT00447057|617000902|FG002|Overall Study|Death, study drug related|0|||
170725529|NCT00447057|617000903|FG003|Overall Study|Death, study drug related|0|||
170725530|NCT00512148|617000904|FG000|Primay Study Period|Withdrawal by Subject|1|||
170725531|NCT00677833|617000905|FG000|Overall Study|Withdrawal by Subject|4|||
170725532|NCT00677833|617000906|FG001|Overall Study|Withdrawal by Subject|0|||
170725533|NCT00677833|617000907|FG002|Overall Study|Withdrawal by Subject|1|||
170725534|NCT00677833|617000908|FG003|Overall Study|Withdrawal by Subject|3|||
170725535|NCT00677833|617000905|FG000|Overall Study|Lost to Follow-up|0|||
170725536|NCT00677833|617000906|FG001|Overall Study|Lost to Follow-up|0|||
170725537|NCT00677833|617000907|FG002|Overall Study|Lost to Follow-up|1|||
170725538|NCT00677833|617000908|FG003|Overall Study|Lost to Follow-up|0|||
170725539|NCT04493216|617000909|FG000|Overall Study|Study terminated by sponsor|30|||
170725540|NCT04493216|617000910|FG001|Overall Study|Study terminated by sponsor|33|||
170725541|NCT04493216|617000911|FG002|Overall Study|Study terminated by sponsor|28|||
170725542|NCT04493216|617000912|FG003|Overall Study|Study terminated by sponsor|27|||
170725543|NCT04493216|617000909|FG000|Overall Study|Withdrawal by Subject|2|||
170725544|NCT04493216|617000910|FG001|Overall Study|Withdrawal by Subject|1|||
170725545|NCT04493216|617000911|FG002|Overall Study|Withdrawal by Subject|1|||
170725546|NCT04493216|617000912|FG003|Overall Study|Withdrawal by Subject|2|||
170725547|NCT04493216|617000909|FG000|Overall Study|Protocol Violation|1|||
170725548|NCT04493216|617000910|FG001|Overall Study|Protocol Violation|2|||
170725549|NCT04493216|617000911|FG002|Overall Study|Protocol Violation|0|||
170725550|NCT04493216|617000912|FG003|Overall Study|Protocol Violation|2|||
170725551|NCT04493216|617000909|FG000|Overall Study|Physician Decision|0|||
170725552|NCT04493216|617000910|FG001|Overall Study|Physician Decision|0|||
170725553|NCT04493216|617000911|FG002|Overall Study|Physician Decision|1|||
170725554|NCT04493216|617000912|FG003|Overall Study|Physician Decision|0|||
170725555|NCT04493216|617000909|FG000|Overall Study|Lost to Follow-up|2|||
170725556|NCT04493216|617000910|FG001|Overall Study|Lost to Follow-up|1|||
170725557|NCT04493216|617000911|FG002|Overall Study|Lost to Follow-up|0|||
170725558|NCT04493216|617000912|FG003|Overall Study|Lost to Follow-up|1|||
170725559|NCT04493216|617000909|FG000|Overall Study|Adverse Event|1|||
170725560|NCT04493216|617000910|FG001|Overall Study|Adverse Event|4|||
170725561|NCT04493216|617000911|FG002|Overall Study|Adverse Event|5|||
170725562|NCT04493216|617000912|FG003|Overall Study|Adverse Event|2|||
170725563|NCT04493216|617000909|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
170725564|NCT04493216|617000910|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
170725565|NCT04493216|617000911|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
170725566|NCT04493216|617000912|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
170725567|NCT01514448|617000915|FG000|Overall Study|Death|7|||
170725568|NCT01514448|617000916|FG001|Overall Study|Death|8|||
170725569|NCT01514448|617000915|FG000|Overall Study|Withdrawal by Subject|2|||
170725570|NCT01514448|617000916|FG001|Overall Study|Withdrawal by Subject|0|||
170725571|NCT01514448|617000915|FG000|Overall Study|Lost to Follow-up|2|||
170725572|NCT01514448|617000916|FG001|Overall Study|Lost to Follow-up|0|||
170725573|NCT01514448|617000915|FG000|Overall Study|New Cancer Therapy|1|||
170725574|NCT01514448|617000916|FG001|Overall Study|New Cancer Therapy|0|||
170725575|NCT03563716|617000920|FG000|Overall Study|Death|20|||
170725576|NCT03563716|617000921|FG001|Overall Study|Death|14|||
170725577|NCT03563716|617000920|FG000|Overall Study|Withdrawal by Subject|3|||
170725578|NCT03563716|617000921|FG001|Overall Study|Withdrawal by Subject|3|||
170725579|NCT03563716|617000920|FG000|Overall Study|Still on Study|45|||
170725580|NCT03563716|617000921|FG001|Overall Study|Still on Study|50|||
170725581|NCT02583425|617000922|FG000|Screening|Did not meet entry criteria|12|||
170725582|NCT02583425|617000922|FG000|Baseline|Did not meet continued criteria|5|||
170725583|NCT02583425|617000922|FG000|Treatment Period|Adverse Event|1|||
170725584|NCT01690130|617000923|FG000|Overall Study|Subject have cancelled visit.|1|||
170725585|NCT01690130|617000924|FG001|Overall Study|Subject have cancelled visit.|0|||
170725586|NCT01644734|617000925|FG000|Overall Study|Adverse Event|4|||
170725587|NCT01644734|617000925|FG000|Overall Study|Lost to Follow-up|17|||
170725588|NCT01644734|617000925|FG000|Overall Study|Reasons other than stated above|7|||
170725589|NCT01644734|617000925|FG000|Overall Study|Missing documentation|238|||
170725590|NCT02216123|617000926|FG000|Overall Study|Lost to Follow-up|4|||
170725591|NCT02216123|617000927|FG001|Overall Study|Lost to Follow-up|2|||
170725592|NCT02216123|617000926|FG000|Overall Study|Withdrawal by Subject|2|||
170725593|NCT02216123|617000927|FG001|Overall Study|Withdrawal by Subject|0|||
170725594|NCT05159622|617000932|FG000|Overall Study|Lost to Follow-up|4|||
170725595|NCT05159622|617000933|FG001|Overall Study|Lost to Follow-up|5|||
170725596|NCT03318523|617000934|FG000|PC Period: Up to Year 1|Adverse Event|1|||
170725597|NCT03318523|617000935|FG001|PC Period: Up to Year 1|Adverse Event|0|||
170725598|NCT03318523|617000936|FG002|PC Period: Up to Year 1|Adverse Event|2|||
170834644|NCT00243022|617402870|FG001|Overall Study|Withdrawal by Subject|0|||
170834645|NCT00243022|617402869|FG000|Overall Study|Death|1|||
170834646|NCT00243022|617402870|FG001|Overall Study|Death|0|||
170834647|NCT00243022|617402869|FG000|Overall Study|Difficult Travel Distance|0|||
170834648|NCT00243022|617402870|FG001|Overall Study|Difficult Travel Distance|1|||
170725599|NCT03318523|617000937|FG003|PC Period: Up to Year 1|Adverse Event|0|||
170725600|NCT03318523|617000938|FG004|PC Period: Up to Year 1|Adverse Event|0|||
170834649|NCT01099579|617402871|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
170834650|NCT01099579|617402872|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
170834651|NCT01099579|617402873|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
170834652|NCT01099579|617402871|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
170834653|NCT01099579|617402872|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
170834654|NCT01099579|617402873|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
170834655|NCT01099579|617402871|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
170834656|NCT01099579|617402872|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
170834657|NCT01099579|617402873|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
170834658|NCT01099579|617402871|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
170834659|NCT01099579|617402872|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
170834660|NCT01099579|617402873|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
170834661|NCT01099579|617402871|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
170834662|NCT01099579|617402872|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
170834663|NCT01099579|617402873|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
170834664|NCT01099579|617402871|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
170834665|NCT01099579|617402872|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
170834666|NCT01099579|617402873|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
170834667|NCT01099579|617402871|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
170834668|NCT01099579|617402872|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
170834669|NCT01099579|617402873|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
170834670|NCT01099579|617402871|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
170834671|NCT01099579|617402872|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
170834672|NCT01099579|617402873|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
170725601|NCT03318523|617000939|FG005|PC Period: Up to Year 1|Adverse Event|0|||
170725602|NCT03318523|617000940|FG006|PC Period: Up to Year 1|Adverse Event|0|||
170725603|NCT03318523|617000941|FG007|PC Period: Up to Year 1|Adverse Event|0|||
170725604|NCT03318523|617000942|FG008|PC Period: Up to Year 1|Adverse Event|0|||
170725605|NCT03318523|617000943|FG009|PC Period: Up to Year 1|Adverse Event|0|||
170725606|NCT03318523|617000934|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
170725607|NCT03318523|617000935|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
170725608|NCT03318523|617000936|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
170725609|NCT03318523|617000937|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
170725610|NCT03318523|617000938|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
170725611|NCT03318523|617000939|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
170725612|NCT03318523|617000940|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
170725613|NCT03318523|617000941|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
170725614|NCT03318523|617000942|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
170725615|NCT03318523|617000943|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
170725616|NCT03318523|617000934|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
170725617|NCT03318523|617000935|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
170725618|NCT03318523|617000936|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
170725619|NCT03318523|617000937|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
170725620|NCT03318523|617000938|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
170725621|NCT03318523|617000939|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
170725622|NCT03318523|617000940|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
170725623|NCT03318523|617000941|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
170725624|NCT03318523|617000942|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
170725625|NCT03318523|617000943|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
170725626|NCT03318523|617000934|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
170725627|NCT03318523|617000935|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
170725628|NCT03318523|617000936|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
170725629|NCT03318523|617000937|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
170725630|NCT03318523|617000938|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
170725631|NCT03318523|617000939|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
170725632|NCT03318523|617000940|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
170725633|NCT03318523|617000941|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
170725634|NCT03318523|617000942|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
170725635|NCT03318523|617000943|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
170725636|NCT03318523|617000934|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170725637|NCT03318523|617000935|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170725638|NCT03318523|617000936|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170834673|NCT01099579|617402871|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
170834674|NCT01099579|617402872|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
170834675|NCT01099579|617402873|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
170725639|NCT03318523|617000937|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170834676|NCT01099579|617402871|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
170834677|NCT01099579|617402872|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
170834678|NCT01099579|617402873|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
170834679|NCT02569957|617402874|FG000|Overall Study|Withdrawal by Subject|0|||
170834680|NCT02569957|617402875|FG001|Overall Study|Withdrawal by Subject|1|||
170834681|NCT03513068|617402876|FG000|Overall Study|Death|1|||
170834682|NCT03513068|617402877|FG001|Overall Study|Death|0|||
170834683|NCT03513068|617402876|FG000|Overall Study|Withdrawal by Subject|4|||
170834684|NCT03513068|617402877|FG001|Overall Study|Withdrawal by Subject|6|||
170834685|NCT03636373|617402879|FG000|Overall Study|Study closure due to Covid-19|1|||
170834686|NCT03636373|617402880|FG001|Overall Study|Study closure due to Covid-19|0|||
170834687|NCT00246090|617402890|FG000|Overall Study|Adverse Event|25|||
170834688|NCT00246090|617402890|FG000|Overall Study|Withdrawal by Subject|7|||
170834689|NCT00246090|617402890|FG000|Overall Study|Progressive Disease|212|||
170834690|NCT00246090|617402890|FG000|Overall Study|Clinical Progression|30|||
170834691|NCT00246090|617402890|FG000|Overall Study|Physician Decision|11|||
170834692|NCT00246090|617402890|FG000|Overall Study|Not Otherwise Specified|10|||
170834693|NCT03332784|617402893|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834694|NCT03332784|617402894|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
170834695|NCT03332784|617402895|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834696|NCT03332784|617402896|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834697|NCT03332784|617402897|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834698|NCT03332784|617402898|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834699|NCT03332784|617402899|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834700|NCT03332784|617402900|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834701|NCT03332784|617402901|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834702|NCT03332784|617402902|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834703|NCT03332784|617402903|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834704|NCT03332784|617402904|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834705|NCT03332784|617402905|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834706|NCT03332784|617402906|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834707|NCT03332784|617402907|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
170834708|NCT03332784|617402908|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834709|NCT03332784|617402909|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834710|NCT03332784|617402910|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834711|NCT03332784|617402911|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834712|NCT03332784|617402912|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
170834713|NCT04206085|617402913|FG000|Overall Study|Lost to Follow-up|0|||
170725640|NCT03318523|617000938|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170725641|NCT03318523|617000939|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
170725642|NCT03318523|617000940|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170725643|NCT03318523|617000941|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170725644|NCT03318523|617000942|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170725645|NCT03318523|617000943|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
170725646|NCT03318523|617000934|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725647|NCT03318523|617000935|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725648|NCT03318523|617000936|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725649|NCT03318523|617000937|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725650|NCT03318523|617000938|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725651|NCT03318523|617000939|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725652|NCT03318523|617000940|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725653|NCT03318523|617000941|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725654|NCT03318523|617000942|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
170725655|NCT03318523|617000943|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
170725656|NCT03318523|617000934|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
170725657|NCT03318523|617000935|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
170725658|NCT03318523|617000936|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
170725659|NCT03318523|617000937|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
170725660|NCT03318523|617000938|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
170725661|NCT03318523|617000939|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
170725662|NCT03318523|617000940|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
170725663|NCT03318523|617000941|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
170725664|NCT03318523|617000942|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
170725665|NCT03318523|617000943|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
170834714|NCT04206085|617402914|FG001|Overall Study|Lost to Follow-up|1|||
170834715|NCT04206085|617402915|FG002|Overall Study|Lost to Follow-up|0|||
170834716|NCT04206085|617402913|FG000|Overall Study|Lost to Follow-up|0|||
170834717|NCT04206085|617402914|FG001|Overall Study|Lost to Follow-up|0|||
170834718|NCT04206085|617402915|FG002|Overall Study|Lost to Follow-up|1|||
170834719|NCT01827046|617402916|FG000|Overall Study|Lost to Follow-up|1|||
170725666|NCT03318523|617000934|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
170725667|NCT03318523|617000935|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
170725668|NCT03318523|617000936|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
170725669|NCT03318523|617000937|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
170725670|NCT03318523|617000938|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
170725671|NCT03318523|617000939|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
170725672|NCT03318523|617000940|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
170725673|NCT03318523|617000941|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
170725674|NCT03318523|617000942|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
170725675|NCT03318523|617000943|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
170725676|NCT03232983|617000944|FG000|Period 1|Physician Decision|0|||
170725677|NCT03232983|617000945|FG001|Period 1|Physician Decision|0|||
170725678|NCT03232983|617000946|FG002|Period 1|Physician Decision|1|||
170725679|NCT03232983|617000947|FG003|Period 1|Physician Decision|0|||
170725680|NCT03232983|617000944|FG000|Washout Period 2|Physician Decision|0|||
170725681|NCT03232983|617000945|FG001|Washout Period 2|Physician Decision|0|||
170725682|NCT03232983|617000946|FG002|Washout Period 2|Physician Decision|1|||
170725683|NCT03232983|617000947|FG003|Washout Period 2|Physician Decision|0|||
170725684|NCT03232983|617000944|FG000|Washout Period 2|Withdrawal by Subject|0|||
170725685|NCT03232983|617000945|FG001|Washout Period 2|Withdrawal by Subject|0|||
170725686|NCT03232983|617000946|FG002|Washout Period 2|Withdrawal by Subject|0|||
170725687|NCT03232983|617000947|FG003|Washout Period 2|Withdrawal by Subject|1|||
170725688|NCT03232983|617000944|FG000|Period 4|Withdrawal by Subject|1|||
170725689|NCT03232983|617000945|FG001|Period 4|Withdrawal by Subject|0|||
170725690|NCT03232983|617000946|FG002|Period 4|Withdrawal by Subject|0|||
170725691|NCT03232983|617000947|FG003|Period 4|Withdrawal by Subject|0|||
170725692|NCT02633800|617000948|FG000|Overall Study|Death|3|||
170725693|NCT02633800|617000949|FG001|Overall Study|Death|3|||
170725694|NCT02633800|617000948|FG000|Overall Study|Reason not provided|1|||
170725695|NCT02633800|617000949|FG001|Overall Study|Reason not provided|0|||
170725696|NCT02633800|617000948|FG000|Overall Study|Radiologic(al) progression|23|||
170725697|NCT02633800|617000949|FG001|Overall Study|Radiologic(al) progression|23|||
170725698|NCT02633800|617000948|FG000|Overall Study|Clinical progression|3|||
170725699|NCT02633800|617000949|FG001|Overall Study|Clinical progression|6|||
170725700|NCT02633800|617000948|FG000|Overall Study|Study terminated by sponsor|6|||
170725701|NCT02633800|617000949|FG001|Overall Study|Study terminated by sponsor|5|||
170725702|NCT02633800|617000948|FG000|Overall Study|Adverse event, non-fatal|7|||
170725703|NCT02633800|617000949|FG001|Overall Study|Adverse event, non-fatal|2|||
170725704|NCT02633800|617000948|FG000|Overall Study|Withdrawal by Subject|0|||
170725705|NCT02633800|617000949|FG001|Overall Study|Withdrawal by Subject|3|||
170725706|NCT02633800|617000948|FG000|Overall Study|Patient Request|1|||
170725707|NCT02633800|617000949|FG001|Overall Study|Patient Request|1|||
170725708|NCT01640808|617000954|FG000|Overall Study|Unable to continue dynamic CT|14|||
170725709|NCT01640808|617000955|FG001|Overall Study|Unable to continue dynamic CT|4|||
170725710|NCT01640808|617000954|FG000|Overall Study|Withdrawal by Subject|12|||
170725711|NCT01640808|617000955|FG001|Overall Study|Withdrawal by Subject|4|||
170834720|NCT01827046|617402917|FG001|Overall Study|Lost to Follow-up|5|||
170834721|NCT01827046|617402916|FG000|Overall Study|Withdrawal by Subject|0|||
170834722|NCT01827046|617402917|FG001|Overall Study|Withdrawal by Subject|4|||
170834723|NCT00087555|617402924|FG000|Overall Study|Adverse Event|3|||
170834724|NCT00087555|617402925|FG001|Overall Study|Adverse Event|6|||
170834725|NCT00087555|617402926|FG002|Overall Study|Adverse Event|14|||
170834726|NCT00087555|617402924|FG000|Overall Study|Lost to Follow-up|0|||
170834727|NCT00087555|617402925|FG001|Overall Study|Lost to Follow-up|1|||
170834728|NCT00087555|617402926|FG002|Overall Study|Lost to Follow-up|1|||
170834729|NCT00087555|617402924|FG000|Overall Study|Non - Compliance|1|||
170834730|NCT00087555|617402925|FG001|Overall Study|Non - Compliance|0|||
170834731|NCT00087555|617402926|FG002|Overall Study|Non - Compliance|0|||
170834732|NCT00087555|617402924|FG000|Overall Study|Protocol Violation|0|||
170834733|NCT00087555|617402925|FG001|Overall Study|Protocol Violation|0|||
170834734|NCT00087555|617402926|FG002|Overall Study|Protocol Violation|2|||
170834735|NCT00087555|617402924|FG000|Overall Study|Screen Failure|1|||
170834736|NCT00087555|617402925|FG001|Overall Study|Screen Failure|1|||
170834737|NCT00087555|617402926|FG002|Overall Study|Screen Failure|0|||
170834738|NCT00087555|617402924|FG000|Overall Study|Pregnancy|0|||
170834739|NCT00087555|617402925|FG001|Overall Study|Pregnancy|1|||
170834740|NCT00087555|617402926|FG002|Overall Study|Pregnancy|1|||
170834741|NCT00087555|617402924|FG000|Overall Study|Withdrawal by Subject|3|||
170834742|NCT00087555|617402925|FG001|Overall Study|Withdrawal by Subject|2|||
170834743|NCT00087555|617402926|FG002|Overall Study|Withdrawal by Subject|1|||
170834744|NCT00087555|617402924|FG000|Overall Study|Lack of Efficacy|2|||
170834745|NCT00087555|617402925|FG001|Overall Study|Lack of Efficacy|0|||
170834746|NCT00087555|617402926|FG002|Overall Study|Lack of Efficacy|1|||
170834747|NCT00087555|617402924|FG000|Overall Study|Non Compliance|0|||
170834748|NCT00087555|617402925|FG001|Overall Study|Non Compliance|0|||
170834749|NCT00087555|617402926|FG002|Overall Study|Non Compliance|1|||
170834750|NCT00087555|617402924|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
170834751|NCT00087555|617402925|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
170834752|NCT00087555|617402926|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
170834753|NCT00087555|617402924|FG000|Overall Study|Patient wanted to go back on Med|1|||
170834754|NCT00087555|617402925|FG001|Overall Study|Patient wanted to go back on Med|0|||
170834755|NCT00087555|617402926|FG002|Overall Study|Patient wanted to go back on Med|0|||
170834756|NCT01530087|617402927|FG000|Overall Study|Physician Decision|2|||
170834757|NCT02760485|617402932|FG000|Phase 1|Death|3|||
170834758|NCT02760485|617402933|FG001|Phase 1|Death|6|||
170834759|NCT02760485|617402934|FG002|Phase 1|Death|0|||
170834760|NCT02760485|617402932|FG000|Phase 1|Withdrawal by Subject|2|||
170834761|NCT02760485|617402933|FG001|Phase 1|Withdrawal by Subject|0|||
170834762|NCT02760485|617402934|FG002|Phase 1|Withdrawal by Subject|0|||
170834763|NCT02760485|617402932|FG000|Phase 1|Progressive Disease|1|||
170834764|NCT02760485|617402933|FG001|Phase 1|Progressive Disease|0|||
170834765|NCT02760485|617402934|FG002|Phase 1|Progressive Disease|0|||
170834766|NCT02760485|617402932|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
170834767|NCT02760485|617402933|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
170834768|NCT02760485|617402934|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
170834769|NCT02760485|617402932|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
170834770|NCT02760485|617402933|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
170834771|NCT02760485|617402934|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
170834772|NCT02760485|617402932|FG000|Phase 2|Death|0|||
170834773|NCT02760485|617402933|FG001|Phase 2|Death|0|||
170834774|NCT02760485|617402934|FG002|Phase 2|Death|12|||
170834775|NCT02760485|617402932|FG000|Phase 2|Withdrawal by Subject|0|||
170834776|NCT02760485|617402933|FG001|Phase 2|Withdrawal by Subject|0|||
170834777|NCT02760485|617402934|FG002|Phase 2|Withdrawal by Subject|3|||
170834778|NCT02760485|617402932|FG000|Phase 2|Progressive Disease|0|||
170834779|NCT02760485|617402933|FG001|Phase 2|Progressive Disease|0|||
170834780|NCT02760485|617402934|FG002|Phase 2|Progressive Disease|1|||
170834781|NCT02760485|617402932|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
170834782|NCT02760485|617402933|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
170834783|NCT02760485|617402934|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
170834784|NCT00115336|617402935|FG000|Overall Study|Hospital discharge before study drug|0|||
170834785|NCT00115336|617402936|FG001|Overall Study|Hospital discharge before study drug|1|||
170834786|NCT01018732|617402940|FG000|Overall Study|Lost to Follow-up|0|||
170834787|NCT01018732|617402941|FG001|Overall Study|Lost to Follow-up|0|||
170834788|NCT01018732|617402942|FG002|Overall Study|Lost to Follow-up|3|||
170834789|NCT01018732|617402940|FG000|Overall Study|Protocol Violation|1|||
170834790|NCT01018732|617402941|FG001|Overall Study|Protocol Violation|1|||
170834791|NCT01018732|617402942|FG002|Overall Study|Protocol Violation|0|||
170834792|NCT01018732|617402940|FG000|Overall Study|Inappropriate Enrollment|0|||
170834793|NCT01018732|617402941|FG001|Overall Study|Inappropriate Enrollment|1|||
170834794|NCT01018732|617402942|FG002|Overall Study|Inappropriate Enrollment|0|||
170834795|NCT01018732|617402940|FG000|Overall Study|Unable to Classify|0|||
170834796|NCT01018732|617402941|FG001|Overall Study|Unable to Classify|0|||
170834797|NCT01018732|617402942|FG002|Overall Study|Unable to Classify|1|||
170834798|NCT02165826|617402943|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
170834799|NCT02165826|617402944|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
170834800|NCT02165826|617402945|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
170834801|NCT02165826|617402943|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
170834802|NCT02165826|617402944|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
170834803|NCT02165826|617402945|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
170834804|NCT02165826|617402943|FG000|Main Treatment Period|Lost to Follow-up|4|||
170834805|NCT02165826|617402944|FG001|Main Treatment Period|Lost to Follow-up|2|||
170834806|NCT02165826|617402945|FG002|Main Treatment Period|Lost to Follow-up|1|||
170834807|NCT02165826|617402943|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
170834808|NCT02165826|617402944|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
170834809|NCT02165826|617402945|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
170834810|NCT02165826|617402943|FG000|Main Treatment Period|Lack of Efficacy|2|||
170834811|NCT02165826|617402944|FG001|Main Treatment Period|Lack of Efficacy|0|||
170834812|NCT02165826|617402945|FG002|Main Treatment Period|Lack of Efficacy|0|||
170834813|NCT02165826|617402943|FG000|Main Treatment Period|Reason Not Specified|8|||
170834814|NCT02165826|617402944|FG001|Main Treatment Period|Reason Not Specified|5|||
170834815|NCT02165826|617402945|FG002|Main Treatment Period|Reason Not Specified|16|||
170834816|NCT02165826|617402943|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
170834817|NCT02165826|617402944|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
170834818|NCT02165826|617402945|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
170834819|NCT02165826|617402943|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
170834820|NCT02165826|617402944|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
170834821|NCT02165826|617402945|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
170834822|NCT02165826|617402943|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
170834823|NCT02165826|617402944|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
170834824|NCT02165826|617402945|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
170834825|NCT02165826|617402943|FG000|Down-Titration Period|Reason Not Specified|1|||
170834826|NCT02165826|617402944|FG001|Down-Titration Period|Reason Not Specified|0|||
170834827|NCT02165826|617402945|FG002|Down-Titration Period|Reason Not Specified|2|||
170834828|NCT02581059|617402946|FG000|Study Treatment|Disease Progression|1|||
170834829|NCT02581059|617402947|FG001|Study Treatment|Disease Progression|1|||
170834830|NCT02581059|617402946|FG000|Study Treatment|Adverse Event|2|||
170834831|NCT02581059|617402947|FG001|Study Treatment|Adverse Event|1|||
170834832|NCT02581059|617402946|FG000|Study Treatment|Death|1|||
170834833|NCT02581059|617402947|FG001|Study Treatment|Death|1|||
170834834|NCT02581059|617402946|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
170834835|NCT02581059|617402947|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
170834836|NCT02581059|617402946|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
170834837|NCT02581059|617402947|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
170834838|NCT02581059|617402946|FG000|Follow up|Death|1|||
170834839|NCT02581059|617402947|FG001|Follow up|Death|3|||
170834840|NCT02581059|617402946|FG000|Follow up|study terminated|1|||
170834841|NCT02581059|617402947|FG001|Follow up|study terminated|1|||
170834842|NCT02581059|617402946|FG000|Follow up|screen failure|0|||
170834843|NCT02581059|617402947|FG001|Follow up|screen failure|1|||
170834844|NCT02581059|617402946|FG000|Follow up|Patient started new clinical trial|1|||
170834845|NCT02581059|617402947|FG001|Follow up|Patient started new clinical trial|0|||
170834846|NCT02392104|617402948|FG000|Overall Study|discontinuation of warfarin|3|||
170834847|NCT02392104|617402948|FG000|Overall Study|bleeding event|1|||
170834848|NCT02392104|617402948|FG000|Overall Study|transferred care to another doctor|2|||
170834849|NCT02392104|617402948|FG000|Overall Study|INR goal range changed|1|||
170834850|NCT02392104|617402948|FG000|Overall Study|admitted to skilled nursing facility|3|||
170834851|NCT02392104|617402948|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
170834852|NCT04887506|617402949|FG000|Overall Study|Death|1|||
170834853|NCT04887506|617402950|FG001|Overall Study|Death|1|||
170834854|NCT04887506|617402949|FG000|Overall Study|Withdrawal by Subject|0|||
170834855|NCT04887506|617402950|FG001|Overall Study|Withdrawal by Subject|3|||
170834856|NCT04887506|617402949|FG000|Overall Study|Adverse Event|4|||
170834857|NCT04887506|617402950|FG001|Overall Study|Adverse Event|3|||
170834858|NCT04887506|617402949|FG000|Overall Study|Other - Not Reported|1|||
170834859|NCT04887506|617402950|FG001|Overall Study|Other - Not Reported|1|||
170834860|NCT02636608|617402954|FG000|Overall Study|Failure to Return|4|||
170834861|NCT02636608|617402954|FG000|Overall Study|Insufficient Virological Response|1|||
170834862|NCT02636608|617402954|FG000|Overall Study|Death|3|||
170834863|NCT02636608|617402954|FG000|Overall Study|Other|2|||
170834864|NCT02636608|617402954|FG000|Overall Study|Did Not Receive Treatment|1|||
170834865|NCT04590404|617402956|FG000|Overall Study|Death|16|||
170834866|NCT04590404|617402957|FG001|Overall Study|Death|17|||
170834867|NCT04590404|617402956|FG000|Overall Study|Withdrawal by Subject|7|||
170834868|NCT04590404|617402957|FG001|Overall Study|Withdrawal by Subject|2|||
170834869|NCT03698019|617402958|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
170834870|NCT03698019|617402959|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
170834871|NCT03698019|617402958|FG000|Step 1: Registration|Withdrawal by Subject|7|||
170834872|NCT03698019|617402959|FG001|Step 1: Registration|Withdrawal by Subject|2|||
170834873|NCT03698019|617402958|FG000|Step 1: Registration|Toxicity|0|||
170834874|NCT03698019|617402959|FG001|Step 1: Registration|Toxicity|1|||
170834875|NCT03698019|617402958|FG000|Step 1: Registration|Disease Progression|0|||
170834876|NCT03698019|617402959|FG001|Step 1: Registration|Disease Progression|12|||
170834877|NCT03698019|617402958|FG000|Step 1: Registration|Co-morbidities|0|||
170834878|NCT03698019|617402959|FG001|Step 1: Registration|Co-morbidities|1|||
170834879|NCT03698019|617402958|FG000|Step 1: Registration|Scheduling Issues|1|||
170834880|NCT03698019|617402959|FG001|Step 1: Registration|Scheduling Issues|0|||
170834881|NCT03698019|617402958|FG000|Step 1: Registration|Participant Refusal|0|||
170834882|NCT03698019|617402959|FG001|Step 1: Registration|Participant Refusal|1|||
170834883|NCT03698019|617402958|FG000|Step 2: Surgery|Participant Refusal|2|||
170834884|NCT03698019|617402959|FG001|Step 2: Surgery|Participant Refusal|1|||
170834885|NCT03698019|617402958|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
170834886|NCT03698019|617402959|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
170834887|NCT03698019|617402958|FG000|Step 2: Surgery|Metastatic Disease|16|||
170834888|NCT03698019|617402959|FG001|Step 2: Surgery|Metastatic Disease|9|||
170834889|NCT03698019|617402958|FG000|Step 2: Surgery|Residual Disease|2|||
170834890|NCT03698019|617402959|FG001|Step 2: Surgery|Residual Disease|1|||
170834891|NCT03698019|617402958|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
170834892|NCT03698019|617402959|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
170834893|NCT03698019|617402958|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
170834894|NCT03698019|617402959|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
170834895|NCT03698019|617402958|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
170834896|NCT03698019|617402959|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
170834897|NCT03698019|617402958|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
170834898|NCT03698019|617402959|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
170834899|NCT03698019|617402958|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
170834900|NCT03698019|617402959|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
170834901|NCT03698019|617402958|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
170834902|NCT03698019|617402959|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
170834903|NCT03698019|617402958|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
170834904|NCT03698019|617402959|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
170834905|NCT03698019|617402958|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
170834906|NCT03698019|617402959|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
170834907|NCT04913948|617402960|FG000|Overall Study|Withdrawal by Subject|2|||
170834908|NCT04913948|617402960|FG000|Overall Study|Sample processing issues|1|||
170834909|NCT04913948|617402960|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
170834910|NCT03783871|617402961|FG000|Overall Study|Withdrawal by Subject|15|||
170834911|NCT03783871|617402961|FG000|Overall Study|Death|13|||
170834912|NCT03783871|617402961|FG000|Overall Study|Lost to Follow-up|2|||
170834913|NCT03149029|617402962|FG000|Overall Study|Adverse Event|2|||
170834914|NCT03149029|617402963|FG001|Overall Study|Adverse Event|0|||
170834915|NCT05739994|617402964|FG000|Overall Study|Withdrawal by Subject|2|||
170834916|NCT05739994|617402965|FG001|Overall Study|Withdrawal by Subject|2|||
170834917|NCT05739994|617402966|FG002|Overall Study|Withdrawal by Subject|4|||
170834918|NCT05990387|617402967|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
170834919|NCT05990387|617402968|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
170834920|NCT04750577|617402969|FG000|Overall Study|Adverse Event|2|||
170834921|NCT04750577|617402970|FG001|Overall Study|Adverse Event|10|||
170834922|NCT04750577|617402971|FG002|Overall Study|Adverse Event|8|||
170834923|NCT04750577|617402972|FG003|Overall Study|Adverse Event|1|||
170834924|NCT04750577|617402969|FG000|Overall Study|Change of residence|0|||
170834925|NCT04750577|617402970|FG001|Overall Study|Change of residence|0|||
170834926|NCT04750577|617402971|FG002|Overall Study|Change of residence|1|||
170834927|NCT04750577|617402972|FG003|Overall Study|Change of residence|0|||
170834928|NCT04750577|617402969|FG000|Overall Study|Burden of study procedures|0|||
170834929|NCT04750577|617402970|FG001|Overall Study|Burden of study procedures|2|||
170834930|NCT04750577|617402971|FG002|Overall Study|Burden of study procedures|2|||
170834931|NCT04750577|617402972|FG003|Overall Study|Burden of study procedures|0|||
170834932|NCT04750577|617402969|FG000|Overall Study|Prematurely discontinued|0|||
170834933|NCT04750577|617402970|FG001|Overall Study|Prematurely discontinued|0|||
170834934|NCT04750577|617402971|FG002|Overall Study|Prematurely discontinued|0|||
170834935|NCT04750577|617402972|FG003|Overall Study|Prematurely discontinued|2|||
170834936|NCT04750577|617402969|FG000|Overall Study|Protocol deviation|1|||
170834937|NCT04750577|617402970|FG001|Overall Study|Protocol deviation|1|||
170834938|NCT04750577|617402971|FG002|Overall Study|Protocol deviation|1|||
170834939|NCT04750577|617402972|FG003|Overall Study|Protocol deviation|1|||
170834940|NCT04750577|617402969|FG000|Overall Study|Other than listed|3|||
170834941|NCT04750577|617402970|FG001|Overall Study|Other than listed|2|||
170834942|NCT04750577|617402971|FG002|Overall Study|Other than listed|2|||
170834943|NCT04750577|617402972|FG003|Overall Study|Other than listed|1|||
170725712|NCT01640808|617000954|FG000|Overall Study|Lost to Follow-up|4|||
170725713|NCT01640808|617000955|FG001|Overall Study|Lost to Follow-up|0|||
170725714|NCT01640808|617000954|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
170725715|NCT01640808|617000955|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
170725716|NCT01640808|617000954|FG000|Overall Study|Administration of anticancer drugs|2|||
170725717|NCT01640808|617000955|FG001|Overall Study|Administration of anticancer drugs|1|||
170725718|NCT01640808|617000954|FG000|Overall Study|Physician Decision|19|||
170725719|NCT01640808|617000955|FG001|Overall Study|Physician Decision|5|||
170725720|NCT01640808|617000954|FG000|Overall Study|Randomized but not treated|4|||
170725721|NCT01640808|617000955|FG001|Overall Study|Randomized but not treated|2|||
170725722|NCT02477111|617000956|FG000|Overall Study|Death|28|||
170725723|NCT02477111|617000956|FG000|Overall Study|Withdrawal by Subject|19|||
170725724|NCT02477111|617000956|FG000|Overall Study|Lost to Follow-up|4|||
170725725|NCT02189798|617000959|FG000|Extended Use Phase|Withdrawal by Subject|0|||
170725726|NCT02189798|617000960|FG001|Extended Use Phase|Withdrawal by Subject|4|||
170725727|NCT02189798|617000959|FG000|Extended Use Phase|Physician Decision|1|||
170725728|NCT02189798|617000960|FG001|Extended Use Phase|Physician Decision|0|||
170834944|NCT04750577|617402969|FG000|Overall Study|Not treated|0|||
170834945|NCT04750577|617402970|FG001|Overall Study|Not treated|0|||
170834946|NCT04750577|617402971|FG002|Overall Study|Not treated|0|||
170834947|NCT04750577|617402972|FG003|Overall Study|Not treated|2|||
170834948|NCT02647645|617402973|FG000|Overall Study|Lost to Follow-up|2|||
170834949|NCT02647645|617402974|FG001|Overall Study|Lost to Follow-up|1|||
170834950|NCT04650698|617404851|FG000|Overall Study|Protocol Violation|2|||
170834951|NCT04650698|617404852|FG001|Overall Study|Protocol Violation|1|||
170834952|NCT04650698|617404851|FG000|Overall Study|Withdrawal by Subject|0|||
170834953|NCT04650698|617404852|FG001|Overall Study|Withdrawal by Subject|1|||
170834954|NCT02358668|617404856|FG000|Overall Study|Adverse Event|2|||
170834955|NCT02358668|617404857|FG001|Overall Study|Adverse Event|0|||
170834956|NCT02358668|617404858|FG002|Overall Study|Adverse Event|0|||
170834957|NCT02358668|617404856|FG000|Overall Study|Withdrawal by Subject|0|||
170834958|NCT02358668|617404857|FG001|Overall Study|Withdrawal by Subject|1|||
170834959|NCT02358668|617404858|FG002|Overall Study|Withdrawal by Subject|0|||
170834960|NCT01689363|617404859|FG000|Overall Study|Protocol Violation|0|||
170834961|NCT01689363|617404860|FG001|Overall Study|Protocol Violation|1|||
170834962|NCT01689363|617404861|FG002|Overall Study|Protocol Violation|0|||
170834963|NCT01689363|617404862|FG003|Overall Study|Protocol Violation|0|||
170834964|NCT01689363|617404863|FG004|Overall Study|Protocol Violation|0|||
170834965|NCT01689363|617404864|FG005|Overall Study|Protocol Violation|0|||
170834966|NCT01689363|617404865|FG006|Overall Study|Protocol Violation|0|||
170834967|NCT01689363|617404866|FG007|Overall Study|Protocol Violation|0|||
170834968|NCT01845805|617404867|FG000|Overall Study|Withdrawal by Subject|1|||
170834969|NCT01845805|617404868|FG001|Overall Study|Withdrawal by Subject|2|||
170834970|NCT01845805|617404867|FG000|Overall Study|Disease Progression|13|||
170834971|NCT01845805|617404868|FG001|Overall Study|Disease Progression|14|||
170834972|NCT01845805|617404867|FG000|Overall Study|Drug-related Toxicity|4|||
170834973|NCT01845805|617404868|FG001|Overall Study|Drug-related Toxicity|0|||
170725729|NCT02189798|617000959|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
170725730|NCT02189798|617000960|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
170725731|NCT02189798|617000959|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
170725732|NCT02189798|617000960|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
170725733|NCT02189798|617000959|FG000|Extended Use Phase|Travel Issues|2|||
170725734|NCT02189798|617000960|FG001|Extended Use Phase|Travel Issues|1|||
170725735|NCT02189798|617000959|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
170725736|NCT02189798|617000960|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
170725737|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
170834974|NCT02859064|617404869|FG000|Overall Study|Progressive Disease|3|||
170834975|NCT02859064|617404869|FG000|Overall Study|Physician Decision|1|||
170834976|NCT02859064|617404869|FG000|Overall Study|Withdrawal by Subject|1|||
170834977|NCT02859064|617404869|FG000|Overall Study|Death|1|||
170834978|NCT00321685|617404870|FG000|Overall Study|Adverse Event|18|||
170834979|NCT00321685|617404870|FG000|Overall Study|Death|2|||
170834980|NCT00321685|617404870|FG000|Overall Study|Withdrawal by Subject|8|||
170834981|NCT00321685|617404870|FG000|Overall Study|Alternative therapy|1|||
170834982|NCT00321685|617404870|FG000|Overall Study|Complicating disese|1|||
170834983|NCT00321685|617404870|FG000|Overall Study|Other|5|||
170834984|NCT00321685|617404870|FG000|Overall Study|Not start protocol therapy|2|||
170834985|NCT00321685|617404870|FG000|Overall Study|Ineligible|2|||
170834986|NCT01240551|617404874|FG000|Overall Study|Refused further treatment|3|||
170834987|NCT01240551|617404875|FG001|Overall Study|Refused further treatment|2|||
170834988|NCT01240551|617404874|FG000|Overall Study|Lost to Follow-up|1|||
170834989|NCT01240551|617404875|FG001|Overall Study|Lost to Follow-up|1|||
170834990|NCT05064488|617404876|FG000|Overall Study|Withdrawal by Subject|2|||
170834991|NCT05064488|617404877|FG001|Overall Study|Withdrawal by Subject|0|||
170834992|NCT01730950|617404883|FG000|Overall Study|Protocol Violation|6|||
170834993|NCT01730950|617404884|FG001|Overall Study|Protocol Violation|6|||
170834994|NCT00667459|617404885|FG000|Overall Study|Death|0|||
170834995|NCT00667459|617404886|FG001|Overall Study|Death|2|||
170834996|NCT00667459|617404885|FG000|Overall Study|Lost to Follow-up|8|||
170834997|NCT00667459|617404886|FG001|Overall Study|Lost to Follow-up|43|||
170834998|NCT02568397|617404887|FG000|Period 2|Withdrawal by Subject|0|||
170834999|NCT02568397|617404888|FG001|Period 2|Withdrawal by Subject|1|||
170835000|NCT02568397|617404887|FG000|Period 2|Physician Decision|0|||
170835001|NCT02568397|617404888|FG001|Period 2|Physician Decision|1|||
170835002|NCT00078377|617404889|FG000|Overall Study|Adverse Event|2|||
170835003|NCT00078377|617404890|FG001|Overall Study|Adverse Event|5|||
170835004|NCT00078377|617404891|FG002|Overall Study|Adverse Event|1|||
170835005|NCT00078377|617404889|FG000|Overall Study|Lack of Efficacy|2|||
170835006|NCT00078377|617404890|FG001|Overall Study|Lack of Efficacy|0|||
170835007|NCT00078377|617404891|FG002|Overall Study|Lack of Efficacy|2|||
170835008|NCT00078377|617404889|FG000|Overall Study|Lost to Follow-up|0|||
170835009|NCT00078377|617404890|FG001|Overall Study|Lost to Follow-up|1|||
170835010|NCT00078377|617404891|FG002|Overall Study|Lost to Follow-up|1|||
170835011|NCT00078377|617404889|FG000|Overall Study|Physician Decision|2|||
170835012|NCT00078377|617404890|FG001|Overall Study|Physician Decision|0|||
170835013|NCT00078377|617404891|FG002|Overall Study|Physician Decision|0|||
170835014|NCT00078377|617404889|FG000|Overall Study|Withdrawal by Subject|3|||
170835015|NCT00078377|617404890|FG001|Overall Study|Withdrawal by Subject|4|||
170835016|NCT00078377|617404891|FG002|Overall Study|Withdrawal by Subject|4|||
170835017|NCT00078377|617404889|FG000|Overall Study|Miscellaneous|2|||
170725738|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
170725739|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
170725740|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
170725741|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
170725742|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
170725743|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
170725744|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
170725745|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
170725746|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
170725747|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
170725748|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
170725749|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
170725750|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
170725751|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
170725752|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
170725753|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
170725754|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
170725755|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
170835018|NCT00078377|617404890|FG001|Overall Study|Miscellaneous|6|||
170835019|NCT00078377|617404891|FG002|Overall Study|Miscellaneous|1|||
170835020|NCT04836559|617404892|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
170835021|NCT04836559|617404893|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
170835022|NCT04836559|617404894|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
170835023|NCT04836559|617404895|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
170835024|NCT04836559|617404896|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
170835025|NCT04836559|617404897|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
170835026|NCT04836559|617404898|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
170835027|NCT04836559|617404899|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
170835028|NCT04836559|617404892|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
170835029|NCT04836559|617404893|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
170835030|NCT04836559|617404894|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
170835031|NCT04836559|617404895|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
170835032|NCT04836559|617404896|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
170835033|NCT04836559|617404897|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
170835034|NCT04836559|617404898|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
170835035|NCT04836559|617404899|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
170835036|NCT04836559|617404892|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
170835037|NCT04836559|617404893|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
170835038|NCT04836559|617404894|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
170835039|NCT04836559|617404895|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
170835040|NCT04836559|617404896|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
170835041|NCT04836559|617404897|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
170835042|NCT04836559|617404898|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
170835043|NCT04836559|617404899|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
170835044|NCT04836559|617404892|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
170835045|NCT04836559|617404893|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
170835046|NCT04836559|617404894|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
170835047|NCT04836559|617404895|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
170835048|NCT04836559|617404896|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
170835049|NCT04836559|617404897|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
170835050|NCT04836559|617404898|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
170835051|NCT04836559|617404899|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
170835052|NCT04836559|617404892|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
170835053|NCT04836559|617404893|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
170835054|NCT04836559|617404894|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
170835055|NCT04836559|617404895|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
170835056|NCT04836559|617404896|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
170835057|NCT04836559|617404897|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
170835058|NCT04836559|617404898|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
170835059|NCT04836559|617404899|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
170835060|NCT04836559|617404892|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
170835061|NCT04836559|617404893|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
170835062|NCT04836559|617404894|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
170835063|NCT04836559|617404895|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
170835064|NCT04836559|617404896|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
170835065|NCT04836559|617404897|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
170835066|NCT04836559|617404898|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
170835067|NCT04836559|617404899|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
170835068|NCT04836559|617404892|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
170835069|NCT04836559|617404893|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
170835070|NCT04836559|617404894|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
170835071|NCT04836559|617404895|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
170835072|NCT04836559|617404896|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
170835073|NCT04836559|617404897|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
170835074|NCT04836559|617404898|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
170835075|NCT04836559|617404899|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
170835076|NCT04836559|617404892|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
170835077|NCT04836559|617404893|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
170835078|NCT04836559|617404894|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
170835079|NCT04836559|617404895|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
170835080|NCT04836559|617404896|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
170835081|NCT04836559|617404897|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
170835082|NCT04836559|617404898|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
170835083|NCT04836559|617404899|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
170835084|NCT04836559|617404892|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
170835085|NCT04836559|617404893|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
170835086|NCT04836559|617404894|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
170835087|NCT04836559|617404895|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
170835088|NCT04836559|617404896|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
170835089|NCT04836559|617404897|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
170835090|NCT04836559|617404898|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
170835091|NCT04836559|617404899|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
170835092|NCT04832971|617404900|FG000|Double-Blind (DB) Treatment Period|Death|1|||
170835093|NCT04832971|617404901|FG001|Double-Blind (DB) Treatment Period|Death|0|||
170835094|NCT04832971|617404902|FG002|Double-Blind (DB) Treatment Period|Death|0|||
170835095|NCT04832971|617404903|FG003|Double-Blind (DB) Treatment Period|Death|0|||
170835096|NCT04832971|617404904|FG004|Double-Blind (DB) Treatment Period|Death|0|||
170835097|NCT04832971|617404905|FG005|Double-Blind (DB) Treatment Period|Death|0|||
170835098|NCT04832971|617404906|FG006|Double-Blind (DB) Treatment Period|Death|0|||
170835099|NCT04832971|617404907|FG007|Double-Blind (DB) Treatment Period|Death|0|||
170835100|NCT04832971|617404908|FG008|Double-Blind (DB) Treatment Period|Death|0|||
170835101|NCT04832971|617404909|FG009|Double-Blind (DB) Treatment Period|Death|0|||
170835102|NCT04832971|617404900|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
170835103|NCT04832971|617404901|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
170835104|NCT04832971|617404902|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
170835105|NCT04832971|617404903|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170835106|NCT04832971|617404904|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170835107|NCT04832971|617404905|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170835108|NCT04832971|617404906|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170835109|NCT04832971|617404907|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170835110|NCT04832971|617404908|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170835111|NCT04832971|617404909|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
170835112|NCT04832971|617404900|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
170835113|NCT04832971|617404901|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
170835114|NCT04832971|617404902|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
170835115|NCT04832971|617404903|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
170835116|NCT04832971|617404904|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170835117|NCT04832971|617404905|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170835118|NCT04832971|617404906|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170835119|NCT04832971|617404907|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170835120|NCT04832971|617404908|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170835121|NCT04832971|617404909|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
170835122|NCT04832971|617404900|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835123|NCT04832971|617404901|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
170835124|NCT04832971|617404902|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835125|NCT04832971|617404903|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835126|NCT04832971|617404904|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835127|NCT04832971|617404905|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835128|NCT04832971|617404906|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835129|NCT04832971|617404907|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835130|NCT04832971|617404908|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835131|NCT04832971|617404909|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
170835132|NCT04832971|617404900|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
170835133|NCT04832971|617404901|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
170835134|NCT04832971|617404902|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
170835135|NCT04832971|617404903|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
170835136|NCT04832971|617404904|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
170835137|NCT04832971|617404905|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
170835138|NCT04832971|617404906|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
170835139|NCT04832971|617404907|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
170835140|NCT04832971|617404908|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
170835141|NCT04832971|617404909|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
170835142|NCT04832971|617404900|FG000|Open-Label Extension (OLE) Period|Death|0|||
170835143|NCT04832971|617404901|FG001|Open-Label Extension (OLE) Period|Death|0|||
170835144|NCT04832971|617404902|FG002|Open-Label Extension (OLE) Period|Death|0|||
170835145|NCT04832971|617404903|FG003|Open-Label Extension (OLE) Period|Death|0|||
170835146|NCT04832971|617404904|FG004|Open-Label Extension (OLE) Period|Death|0|||
170835147|NCT04832971|617404905|FG005|Open-Label Extension (OLE) Period|Death|0|||
170835148|NCT04832971|617404906|FG006|Open-Label Extension (OLE) Period|Death|0|||
170835149|NCT04832971|617404907|FG007|Open-Label Extension (OLE) Period|Death|1|||
170835150|NCT04832971|617404908|FG008|Open-Label Extension (OLE) Period|Death|0|||
170835151|NCT04832971|617404909|FG009|Open-Label Extension (OLE) Period|Death|0|||
170835152|NCT04832971|617404900|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170835153|NCT04832971|617404901|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170835154|NCT04832971|617404902|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170835155|NCT04832971|617404903|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170835156|NCT04832971|617404904|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170835157|NCT04832971|617404905|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170835158|NCT04832971|617404906|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
170835159|NCT04832971|617404907|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
170835160|NCT04832971|617404908|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170835161|NCT04832971|617404909|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
170835162|NCT04832971|617404900|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
170835163|NCT04832971|617404901|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
170835164|NCT04832971|617404902|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
170835165|NCT04832971|617404903|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
170835166|NCT04832971|617404904|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
170835167|NCT04832971|617404905|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
170835168|NCT04832971|617404906|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
170835169|NCT04832971|617404907|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
170835170|NCT04832971|617404908|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
170835171|NCT04832971|617404909|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
170835172|NCT04832971|617404900|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170835173|NCT04832971|617404901|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170835174|NCT04832971|617404902|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170835175|NCT04832971|617404903|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170835176|NCT04832971|617404904|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
170835177|NCT04832971|617404905|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
170835178|NCT04832971|617404906|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170835179|NCT04832971|617404907|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
170835180|NCT04832971|617404908|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
170835181|NCT04832971|617404909|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
170835182|NCT04832971|617404900|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
170835183|NCT04832971|617404901|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
170835184|NCT04832971|617404902|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
170835185|NCT04832971|617404903|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
170835186|NCT04832971|617404904|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
170835187|NCT04832971|617404905|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
170835188|NCT04832971|617404906|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
170725756|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
170725757|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
170725758|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
170725759|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
170725760|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
170725761|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
170725762|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
170725763|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
170725764|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
170725765|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
170725766|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
170725767|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
170725768|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
170725769|NCT04818346|617000961|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
170725770|NCT04818346|617000962|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
170725771|NCT04818346|617000963|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
170725772|NCT04818346|617000964|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
170725773|NCT04818346|617000961|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
170725774|NCT04818346|617000962|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
170725775|NCT04818346|617000963|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
170725776|NCT04818346|617000964|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
170725777|NCT04818346|617000961|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
170725778|NCT04818346|617000962|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
170725779|NCT04818346|617000963|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
170725780|NCT04818346|617000964|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
170725781|NCT04818346|617000961|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
170725782|NCT04818346|617000962|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
170725783|NCT04818346|617000963|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
170725784|NCT04818346|617000964|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
170725785|NCT04818346|617000961|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
170725786|NCT04818346|617000962|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
170725787|NCT04818346|617000963|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
170725788|NCT04818346|617000964|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
170725789|NCT04818346|617000961|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
170725790|NCT04818346|617000962|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
170725791|NCT04818346|617000963|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
170725792|NCT04818346|617000964|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
170725793|NCT04818346|617000961|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
170725794|NCT04818346|617000962|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
170725795|NCT04818346|617000963|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
170725796|NCT04818346|617000964|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
170725797|NCT05553808|617000965|FG000|Overall Study|Death|25|||
170725798|NCT05553808|617000966|FG001|Overall Study|Death|62|||
170725799|NCT05553808|617000965|FG000|Overall Study|Site Closed|6|||
170725800|NCT05553808|617000966|FG001|Overall Study|Site Closed|6|||
170725801|NCT05553808|617000965|FG000|Overall Study|Lost to Follow-up|1|||
170725802|NCT05553808|617000966|FG001|Overall Study|Lost to Follow-up|0|||
170725803|NCT05553808|617000965|FG000|Overall Study|Withdrawal by Subject|3|||
170725804|NCT05553808|617000966|FG001|Overall Study|Withdrawal by Subject|2|||
170725805|NCT02273141|617000967|FG000|Overall Study|Adverse Event|0|||
170725806|NCT02273141|617000968|FG001|Overall Study|Adverse Event|1|||
170725807|NCT02273141|617000967|FG000|Overall Study|Lost to Follow-up|1|||
170725808|NCT02273141|617000968|FG001|Overall Study|Lost to Follow-up|3|||
170725809|NCT02273141|617000967|FG000|Overall Study|Withdrawal by Subject|10|||
170725810|NCT02273141|617000968|FG001|Overall Study|Withdrawal by Subject|15|||
170835189|NCT04832971|617404907|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
170835190|NCT04832971|617404908|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
170835191|NCT04832971|617404909|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
170835192|NCT04082429|617404910|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
170835193|NCT04082429|617404911|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
170835194|NCT04082429|617404912|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
170835195|NCT04082429|617404913|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
170835196|NCT04082429|617404914|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
170835197|NCT04082429|617404915|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
170835198|NCT04082429|617404916|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
170835199|NCT04082429|617404917|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
170835200|NCT04082429|617404918|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
170835201|NCT04082429|617404910|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
170835202|NCT04082429|617404911|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
170835203|NCT04082429|617404912|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
170835204|NCT04082429|617404913|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
170835205|NCT04082429|617404914|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
170835206|NCT04082429|617404915|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
170835207|NCT04082429|617404916|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
170835208|NCT04082429|617404917|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
170835209|NCT04082429|617404918|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
170835210|NCT04082429|617404910|FG000|Main Part (After the Treatment Pause)|Death|0|||
170835211|NCT04082429|617404911|FG001|Main Part (After the Treatment Pause)|Death|0|||
170835212|NCT04082429|617404912|FG002|Main Part (After the Treatment Pause)|Death|0|||
170835213|NCT04082429|617404913|FG003|Main Part (After the Treatment Pause)|Death|0|||
170835214|NCT04082429|617404914|FG004|Main Part (After the Treatment Pause)|Death|1|||
170835215|NCT04082429|617404915|FG005|Main Part (After the Treatment Pause)|Death|0|||
170835216|NCT04082429|617404916|FG006|Main Part (After the Treatment Pause)|Death|0|||
170835217|NCT04082429|617404917|FG007|Main Part (After the Treatment Pause)|Death|0|||
170835218|NCT04082429|617404918|FG008|Main Part (After the Treatment Pause)|Death|0|||
170835219|NCT04082429|617404910|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
170835220|NCT04082429|617404911|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
170835221|NCT04082429|617404912|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
170835222|NCT04082429|617404913|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
170835223|NCT04082429|617404914|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
170835224|NCT04082429|617404915|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
170835225|NCT04082429|617404916|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
170835226|NCT04082429|617404917|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
170835227|NCT04082429|617404918|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
170835228|NCT04082429|617404910|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
170835229|NCT04082429|617404911|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
170835230|NCT04082429|617404912|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
170835231|NCT04082429|617404913|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
170835232|NCT04082429|617404914|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
170835233|NCT04082429|617404915|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
170835234|NCT04082429|617404916|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
170835235|NCT04082429|617404917|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
170835236|NCT04082429|617404918|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
170835237|NCT04082429|617404910|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
170835238|NCT04082429|617404911|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
170835239|NCT04082429|617404912|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
170835240|NCT04082429|617404913|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
170835241|NCT04082429|617404914|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
170835242|NCT04082429|617404915|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
170835243|NCT04082429|617404916|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
170835244|NCT04082429|617404917|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
170835245|NCT04082429|617404918|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
170835246|NCT04082429|617404910|FG000|Extension Part|Ongoing|0|||
170835247|NCT04082429|617404911|FG001|Extension Part|Ongoing|7|||
170835248|NCT04082429|617404912|FG002|Extension Part|Ongoing|17|||
170835249|NCT04082429|617404913|FG003|Extension Part|Ongoing|6|||
170835250|NCT04082429|617404914|FG004|Extension Part|Ongoing|45|||
170835251|NCT04082429|617404915|FG005|Extension Part|Ongoing|0|||
170835252|NCT04082429|617404916|FG006|Extension Part|Ongoing|10|||
170835253|NCT04082429|617404917|FG007|Extension Part|Ongoing|23|||
170835254|NCT04082429|617404918|FG008|Extension Part|Ongoing|25|||
170835255|NCT01107899|617404919|FG000|Overall Study|Physician Decision|5|||
170835256|NCT01107899|617404920|FG001|Overall Study|Physician Decision|0|||
170725811|NCT02273141|617000967|FG000|Overall Study|Various|6|||
170725812|NCT02273141|617000968|FG001|Overall Study|Various|6|||
170725813|NCT00529399|617000971|FG000|Overall Study|Lost to Follow-up|1|||
170725814|NCT00529399|617000972|FG001|Overall Study|Lost to Follow-up|0|||
170725815|NCT00529399|617000973|FG002|Overall Study|Lost to Follow-up|1|||
170725816|NCT00529399|617000971|FG000|Overall Study|Withdrawal by Subject|1|||
170725817|NCT00529399|617000972|FG001|Overall Study|Withdrawal by Subject|0|||
170725818|NCT00529399|617000973|FG002|Overall Study|Withdrawal by Subject|1|||
170725819|NCT00529399|617000971|FG000|Overall Study|Non-compliant|0|||
170725820|NCT00529399|617000972|FG001|Overall Study|Non-compliant|1|||
170725821|NCT00529399|617000973|FG002|Overall Study|Non-compliant|0|||
170725822|NCT03695172|617000974|FG000|Overall Study|Withdrawal by Subject|1|||
170725823|NCT03695172|617000975|FG001|Overall Study|Withdrawal by Subject|1|||
170725824|NCT03695172|617000976|FG002|Overall Study|Withdrawal by Subject|0|||
170725825|NCT01506193|617000977|FG000|Overall Study|Protocol Violation|1|||
170725826|NCT01506193|617000978|FG001|Overall Study|Protocol Violation|0|||
170725827|NCT01506193|617000979|FG002|Overall Study|Protocol Violation|1|||
170725828|NCT01506193|617000977|FG000|Overall Study|Migrated/moved from study area|0|||
170725829|NCT01506193|617000978|FG001|Overall Study|Migrated/moved from study area|0|||
170725830|NCT01506193|617000979|FG002|Overall Study|Migrated/moved from study area|1|||
170725831|NCT01506193|617000977|FG000|Overall Study|Adverse event, non-fatal|0|||
170725832|NCT01506193|617000978|FG001|Overall Study|Adverse event, non-fatal|0|||
170725833|NCT01506193|617000979|FG002|Overall Study|Adverse event, non-fatal|1|||
170725834|NCT01506193|617000977|FG000|Overall Study|Withdrawal by Subject|5|||
170725835|NCT01506193|617000978|FG001|Overall Study|Withdrawal by Subject|1|||
170725836|NCT01506193|617000979|FG002|Overall Study|Withdrawal by Subject|8|||
170725837|NCT01506193|617000977|FG000|Overall Study|Lost to Follow-up|8|||
170725838|NCT01506193|617000978|FG001|Overall Study|Lost to Follow-up|3|||
170725839|NCT01506193|617000979|FG002|Overall Study|Lost to Follow-up|3|||
170725840|NCT04575467|617000994|FG000|Overall Study|Adverse Event|0|||
170725841|NCT04575467|617000995|FG001|Overall Study|Adverse Event|1|||
170725842|NCT04575467|617000996|FG002|Overall Study|Adverse Event|0|||
170725843|NCT04575467|617000997|FG003|Overall Study|Adverse Event|0|||
170725844|NCT01328574|617000998|FG000|Overall Study|Refused further treatment|1|||
170725845|NCT01152580|617001006|FG000|Overall Study|Withdrawal by Subject|0|||
170725846|NCT01152580|617001007|FG001|Overall Study|Withdrawal by Subject|1|||
170725847|NCT03150056|617001008|FG000|Overall Study|Withdrawal by Subject|0|||
170725848|NCT03150056|617001009|FG001|Overall Study|Withdrawal by Subject|0|||
170725849|NCT03150056|617001010|FG002|Overall Study|Withdrawal by Subject|0|||
170725850|NCT03150056|617001011|FG003|Overall Study|Withdrawal by Subject|0|||
170725851|NCT03150056|617001012|FG004|Overall Study|Withdrawal by Subject|0|||
170725852|NCT03150056|617001013|FG005|Overall Study|Withdrawal by Subject|2|||
170725853|NCT03150056|617001008|FG000|Overall Study|Study terminated by Sponsor|1|||
170725854|NCT03150056|617001009|FG001|Overall Study|Study terminated by Sponsor|3|||
170725855|NCT03150056|617001010|FG002|Overall Study|Study terminated by Sponsor|1|||
170725856|NCT03150056|617001011|FG003|Overall Study|Study terminated by Sponsor|1|||
170725857|NCT03150056|617001012|FG004|Overall Study|Study terminated by Sponsor|5|||
170725858|NCT03150056|617001013|FG005|Overall Study|Study terminated by Sponsor|6|||
170725859|NCT03150056|617001008|FG000|Overall Study|Death|9|||
170725860|NCT03150056|617001009|FG001|Overall Study|Death|2|||
170725861|NCT03150056|617001010|FG002|Overall Study|Death|2|||
170725862|NCT03150056|617001011|FG003|Overall Study|Death|7|||
170725863|NCT03150056|617001012|FG004|Overall Study|Death|8|||
170725864|NCT03150056|617001013|FG005|Overall Study|Death|10|||
170725865|NCT00449176|617001014|FG000|Overall Study|Withdrawal by Subject|39|||
170725866|NCT00449176|617001015|FG001|Overall Study|Withdrawal by Subject|43|||
170725867|NCT00449176|617001016|FG002|Overall Study|Withdrawal by Subject|59|||
170725868|NCT00449176|617001014|FG000|Overall Study|Lost to Follow-up|13|||
170725869|NCT00449176|617001015|FG001|Overall Study|Lost to Follow-up|8|||
170725870|NCT00449176|617001016|FG002|Overall Study|Lost to Follow-up|12|||
170725871|NCT00449176|617001014|FG000|Overall Study|Adverse Event|51|||
170725872|NCT00449176|617001015|FG001|Overall Study|Adverse Event|107|||
170725873|NCT00449176|617001016|FG002|Overall Study|Adverse Event|15|||
170725874|NCT00449176|617001014|FG000|Overall Study|Lack of Efficacy|13|||
170725875|NCT00449176|617001015|FG001|Overall Study|Lack of Efficacy|7|||
170725876|NCT00449176|617001016|FG002|Overall Study|Lack of Efficacy|50|||
170725877|NCT00449176|617001014|FG000|Overall Study|Study drug non-compliant|14|||
170725878|NCT00449176|617001015|FG001|Overall Study|Study drug non-compliant|11|||
170725879|NCT00449176|617001016|FG002|Overall Study|Study drug non-compliant|11|||
170725880|NCT00449176|617001014|FG000|Overall Study|all other|22|||
170725881|NCT00449176|617001015|FG001|Overall Study|all other|19|||
170725882|NCT00449176|617001016|FG002|Overall Study|all other|20|||
170725883|NCT02472964|617001017|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
170725884|NCT02472964|617001018|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
170725885|NCT02472964|617001017|FG000|Part 1 (up to Week 24)|disease progression|58|||
170725886|NCT02472964|617001018|FG001|Part 1 (up to Week 24)|disease progression|47|||
170725887|NCT02472964|617001017|FG000|Part 1 (up to Week 24)|Death|3|||
170725888|NCT02472964|617001018|FG001|Part 1 (up to Week 24)|Death|6|||
170725889|NCT02472964|617001017|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
170725890|NCT02472964|617001018|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
170725891|NCT02472964|617001017|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
170725892|NCT02472964|617001018|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
170725893|NCT02472964|617001017|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
170725894|NCT02472964|617001018|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
170725895|NCT02472964|617001017|FG000|Part 1 (up to Week 24)|Other|2|||
170725896|NCT02472964|617001018|FG001|Part 1 (up to Week 24)|Other|1|||
170725897|NCT02472964|617001017|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
170725898|NCT02472964|617001018|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
170725899|NCT02472964|617001017|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
170725900|NCT02472964|617001018|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
170725901|NCT02472964|617001017|FG000|Part 2 (Week 24-week 48)|Death|0|||
170725902|NCT02472964|617001018|FG001|Part 2 (Week 24-week 48)|Death|1|||
170725903|NCT02472964|617001017|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
170725904|NCT02472964|617001018|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
170725905|NCT02472964|617001017|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
170725906|NCT02472964|617001018|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
170725907|NCT02472964|617001017|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
170725908|NCT02472964|617001018|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
170725909|NCT02472964|617001017|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
170725910|NCT02472964|617001018|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
170725911|NCT02491671|617001019|FG000|Overall Study|Adverse Event|6|||
170725912|NCT02491671|617001020|FG001|Overall Study|Adverse Event|8|||
170725913|NCT02491671|617001019|FG000|Overall Study|Death|0|||
170725914|NCT02491671|617001020|FG001|Overall Study|Death|2|||
170725915|NCT02491671|617001019|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
170725916|NCT02491671|617001020|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
170725917|NCT04330638|617001021|FG000|Overall Study|Adverse Event|9|||
170725918|NCT04330638|617001022|FG001|Overall Study|Adverse Event|10|||
170725919|NCT04330638|617001023|FG002|Overall Study|Adverse Event|15|||
170725920|NCT04330638|617001024|FG003|Overall Study|Adverse Event|6|||
170725921|NCT04330638|617001025|FG004|Overall Study|Adverse Event|10|||
170725922|NCT04330638|617001026|FG005|Overall Study|Adverse Event|5|||
170725923|NCT04330638|617001021|FG000|Overall Study|Other|2|||
170725924|NCT04330638|617001022|FG001|Overall Study|Other|2|||
170725925|NCT04330638|617001023|FG002|Overall Study|Other|5|||
170725926|NCT04330638|617001024|FG003|Overall Study|Other|1|||
170725927|NCT04330638|617001025|FG004|Overall Study|Other|3|||
170725928|NCT04330638|617001026|FG005|Overall Study|Other|2|||
170725929|NCT04330638|617001021|FG000|Overall Study|Withdrawal by Subject|4|||
170725930|NCT04330638|617001022|FG001|Overall Study|Withdrawal by Subject|0|||
170725931|NCT04330638|617001023|FG002|Overall Study|Withdrawal by Subject|0|||
170725932|NCT04330638|617001024|FG003|Overall Study|Withdrawal by Subject|0|||
170725933|NCT04330638|617001025|FG004|Overall Study|Withdrawal by Subject|0|||
170725934|NCT04330638|617001026|FG005|Overall Study|Withdrawal by Subject|0|||
170725935|NCT04330638|617001021|FG000|Overall Study|Lost to Follow-up|3|||
170725936|NCT04330638|617001022|FG001|Overall Study|Lost to Follow-up|2|||
170725937|NCT04330638|617001023|FG002|Overall Study|Lost to Follow-up|3|||
170725938|NCT04330638|617001024|FG003|Overall Study|Lost to Follow-up|2|||
170725939|NCT04330638|617001025|FG004|Overall Study|Lost to Follow-up|3|||
170725940|NCT04330638|617001026|FG005|Overall Study|Lost to Follow-up|0|||
170725941|NCT02293538|617001027|FG000|Overall Study|Adverse Event|0|||
170725942|NCT02293538|617001028|FG001|Overall Study|Adverse Event|1|||
170725943|NCT02293538|617001027|FG000|Overall Study|Lost to Follow-up|1|||
170725944|NCT02293538|617001028|FG001|Overall Study|Lost to Follow-up|0|||
170725945|NCT02293538|617001027|FG000|Overall Study|Withdrawal by Subject|0|||
170725946|NCT02293538|617001028|FG001|Overall Study|Withdrawal by Subject|1|||
170725947|NCT01967732|617001030|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
170725948|NCT01967732|617001031|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
170725949|NCT01967732|617001032|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
170725950|NCT01967732|617001033|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
170725951|NCT01967732|617001030|FG000|First Intervention (Day 1)|Poor venous access|0|||
170725952|NCT01967732|617001031|FG001|First Intervention (Day 1)|Poor venous access|1|||
170725953|NCT01967732|617001032|FG002|First Intervention (Day 1)|Poor venous access|0|||
170725954|NCT01967732|617001033|FG003|First Intervention (Day 1)|Poor venous access|0|||
170725955|NCT00936858|617001034|FG000|Overall Study|Death|3|||
170725956|NCT00936858|617001034|FG000|Overall Study|Progression|29|||
170725957|NCT00936858|617001034|FG000|Overall Study|Withdrawal by Subject|5|||
170725958|NCT00936858|617001034|FG000|Overall Study|Adverse Event|1|||
170725959|NCT00936858|617001034|FG000|Overall Study|Physician Decision|7|||
170725960|NCT00936858|617001034|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
170725961|NCT00936858|617001034|FG000|Overall Study|Lost to Follow-up|1|||
170725962|NCT01687257|617001035|FG000|Overall Study|Efficacy Failure|6|||
170725963|NCT01687257|617001036|FG001|Overall Study|Efficacy Failure|0|||
170725964|NCT01687257|617001037|FG002|Overall Study|Efficacy Failure|5|||
170725965|NCT01687257|617001035|FG000|Overall Study|Subject Withdrew Consent|1|||
170725966|NCT01687257|617001036|FG001|Overall Study|Subject Withdrew Consent|1|||
170725967|NCT01687257|617001037|FG002|Overall Study|Subject Withdrew Consent|1|||
170725968|NCT01687257|617001035|FG000|Overall Study|Adverse Event|1|||
170725969|NCT01687257|617001036|FG001|Overall Study|Adverse Event|0|||
170725970|NCT01687257|617001037|FG002|Overall Study|Adverse Event|0|||
170725971|NCT01687257|617001035|FG000|Overall Study|Investigator's Discretion|0|||
170725972|NCT01687257|617001036|FG001|Overall Study|Investigator's Discretion|3|||
170725973|NCT01687257|617001037|FG002|Overall Study|Investigator's Discretion|0|||
170725974|NCT04899349|617001038|FG000|Overall Study|Study terminated by Sponsor|2|||
170725975|NCT04899349|617001039|FG001|Overall Study|Study terminated by Sponsor|0|||
170725976|NCT03336619|617001041|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
170725977|NCT03336619|617001042|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
170725978|NCT03336619|617001041|FG000|Overall Study|Withdrawal by Subject|17|||
170725979|NCT03336619|617001042|FG001|Overall Study|Withdrawal by Subject|16|||
170725980|NCT03336619|617001041|FG000|Overall Study|Adverse Event|2|||
170725981|NCT03336619|617001042|FG001|Overall Study|Adverse Event|5|||
170725982|NCT03336619|617001041|FG000|Overall Study|Physician Decision|3|||
170725983|NCT03336619|617001042|FG001|Overall Study|Physician Decision|0|||
170725984|NCT01300546|617001043|FG000|Overall Study|Withdrawal by Subject|1|||
170725985|NCT01300546|617001044|FG001|Overall Study|Withdrawal by Subject|0|||
170725986|NCT01300546|617001043|FG000|Overall Study|Lost to Follow-up|0|||
170725987|NCT01300546|617001044|FG001|Overall Study|Lost to Follow-up|2|||
170725988|NCT01300546|617001043|FG000|Overall Study|Lack of Efficacy|0|||
170725989|NCT01300546|617001044|FG001|Overall Study|Lack of Efficacy|3|||
170725990|NCT01300546|617001043|FG000|Overall Study|Adverse Event|0|||
170725991|NCT01300546|617001044|FG001|Overall Study|Adverse Event|1|||
170725992|NCT02820623|617001045|FG000|Overall Study|Withdrawal by Subject|1|||
170725993|NCT02820623|617001046|FG001|Overall Study|Withdrawal by Subject|3|||
170725994|NCT02820623|617001047|FG002|Overall Study|Withdrawal by Subject|3|||
170725995|NCT02820623|617001045|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
170725996|NCT02820623|617001046|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
170725997|NCT02820623|617001047|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
170725998|NCT02820623|617001045|FG000|Overall Study|Therapist unable to enroll clients|1|||
170725999|NCT02820623|617001046|FG001|Overall Study|Therapist unable to enroll clients|1|||
170726000|NCT02820623|617001047|FG002|Overall Study|Therapist unable to enroll clients|3|||
170726001|NCT02820623|617001045|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
170726002|NCT02820623|617001046|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
170726003|NCT02820623|617001047|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
170726004|NCT05207813|617001048|FG000|Overall Study|Lost to Follow-up|2|||
170726005|NCT01261338|617001052|FG000|Overall Study|Withdrawal by Subject|3|||
170726006|NCT01261338|617001053|FG001|Overall Study|Withdrawal by Subject|2|||
170726007|NCT05557942|617001054|FG000|Overall Study|Death|0|||
170726008|NCT05557942|617001055|FG001|Overall Study|Death|0|||
170726009|NCT05557942|617001056|FG002|Overall Study|Death|0|||
170726010|NCT05557942|617001057|FG003|Overall Study|Death|2|||
170726011|NCT05557942|617001058|FG004|Overall Study|Death|1|||
170726012|NCT05557942|617001059|FG005|Overall Study|Death|1|||
170726013|NCT05557942|617001054|FG000|Overall Study|Physician Decision|1|||
170726014|NCT05557942|617001055|FG001|Overall Study|Physician Decision|1|||
170726015|NCT05557942|617001056|FG002|Overall Study|Physician Decision|2|||
170726016|NCT05557942|617001057|FG003|Overall Study|Physician Decision|3|||
170726017|NCT05557942|617001058|FG004|Overall Study|Physician Decision|0|||
170726018|NCT05557942|617001059|FG005|Overall Study|Physician Decision|2|||
170726019|NCT05557942|617001054|FG000|Overall Study|Study terminated by sponsor|17|||
170726020|NCT05557942|617001055|FG001|Overall Study|Study terminated by sponsor|17|||
170726021|NCT05557942|617001056|FG002|Overall Study|Study terminated by sponsor|14|||
170726022|NCT05557942|617001057|FG003|Overall Study|Study terminated by sponsor|40|||
170726023|NCT05557942|617001058|FG004|Overall Study|Study terminated by sponsor|45|||
170726024|NCT05557942|617001059|FG005|Overall Study|Study terminated by sponsor|37|||
170726025|NCT05557942|617001054|FG000|Overall Study|Protocol Violation|0|||
170726026|NCT05557942|617001055|FG001|Overall Study|Protocol Violation|0|||
170726027|NCT05557942|617001056|FG002|Overall Study|Protocol Violation|0|||
170726028|NCT05557942|617001057|FG003|Overall Study|Protocol Violation|0|||
170726029|NCT05557942|617001058|FG004|Overall Study|Protocol Violation|0|||
170726030|NCT05557942|617001059|FG005|Overall Study|Protocol Violation|1|||
170726031|NCT05557942|617001054|FG000|Overall Study|Withdrawal by Subject|0|||
170726032|NCT05557942|617001055|FG001|Overall Study|Withdrawal by Subject|0|||
170726033|NCT05557942|617001056|FG002|Overall Study|Withdrawal by Subject|0|||
170726034|NCT05557942|617001057|FG003|Overall Study|Withdrawal by Subject|0|||
170726035|NCT05557942|617001058|FG004|Overall Study|Withdrawal by Subject|2|||
170726036|NCT05557942|617001059|FG005|Overall Study|Withdrawal by Subject|0|||
170726037|NCT00127608|617001062|FG000|Overall Study|VZV DNA negative|1|||
170726038|NCT04605978|617002184|FG000|Overall Study|Adverse Event|2|||
170726039|NCT04605978|617002185|FG001|Overall Study|Adverse Event|1|||
170726040|NCT04605978|617002184|FG000|Overall Study|Withdrawal nonmedical reason|1|||
170726041|NCT04605978|617002185|FG001|Overall Study|Withdrawal nonmedical reason|1|||
170726042|NCT01358968|617002189|FG000|Period 2|Adverse Event|0|||
170726043|NCT01358968|617002190|FG001|Period 2|Adverse Event|1|||
170726044|NCT01358968|617002191|FG002|Period 2|Adverse Event|0|||
170726045|NCT01358968|617002192|FG003|Period 2|Adverse Event|0|||
170726046|NCT01358968|617002189|FG000|Continued Access Phase|Progression of Disease|0|||
170726047|NCT01358968|617002190|FG001|Continued Access Phase|Progression of Disease|0|||
170726048|NCT01358968|617002191|FG002|Continued Access Phase|Progression of Disease|8|||
170726049|NCT01358968|617002192|FG003|Continued Access Phase|Progression of Disease|4|||
170726050|NCT01358968|617002189|FG000|Continued Access Phase|Protocol Violation|0|||
170726051|NCT01358968|617002190|FG001|Continued Access Phase|Protocol Violation|0|||
170726052|NCT01358968|617002191|FG002|Continued Access Phase|Protocol Violation|0|||
170726053|NCT01358968|617002192|FG003|Continued Access Phase|Protocol Violation|2|||
170726054|NCT01358968|617002189|FG000|Continued Access Phase|Withdrawal by Subject|0|||
170726055|NCT01358968|617002190|FG001|Continued Access Phase|Withdrawal by Subject|0|||
170726056|NCT01358968|617002191|FG002|Continued Access Phase|Withdrawal by Subject|3|||
170726057|NCT01358968|617002192|FG003|Continued Access Phase|Withdrawal by Subject|0|||
170726058|NCT01358968|617002189|FG000|Continued Access Phase|Death|0|||
170726059|NCT01358968|617002190|FG001|Continued Access Phase|Death|0|||
170726060|NCT01358968|617002191|FG002|Continued Access Phase|Death|1|||
170726061|NCT01358968|617002192|FG003|Continued Access Phase|Death|1|||
170726062|NCT01597050|617002193|FG000|Overall Study|Withdrawal by Subject|1|||
170726063|NCT01597050|617002194|FG001|Overall Study|Withdrawal by Subject|0|||
170726064|NCT00483184|617002195|FG000|Overall Study|Withdrawal by Subject|2|||
170726065|NCT00483184|617002196|FG001|Overall Study|Withdrawal by Subject|2|||
170726066|NCT00483184|617002197|FG002|Overall Study|Withdrawal by Subject|0|||
170726067|NCT00483184|617002195|FG000|Overall Study|Lost to Follow-up|1|||
170726068|NCT00483184|617002196|FG001|Overall Study|Lost to Follow-up|0|||
170726069|NCT00483184|617002197|FG002|Overall Study|Lost to Follow-up|0|||
170726070|NCT00483184|617002195|FG000|Overall Study|Adverse Event|1|||
170726071|NCT00483184|617002196|FG001|Overall Study|Adverse Event|2|||
170726072|NCT00483184|617002197|FG002|Overall Study|Adverse Event|2|||
170726073|NCT00483184|617002195|FG000|Overall Study|Protocol Violation|1|||
170726074|NCT00483184|617002196|FG001|Overall Study|Protocol Violation|0|||
170726075|NCT00483184|617002197|FG002|Overall Study|Protocol Violation|1|||
170726076|NCT00487162|617002201|FG000|Overall Study|Adverse Event|0|||
170726077|NCT00487162|617002202|FG001|Overall Study|Adverse Event|1|||
170726078|NCT00487162|617002201|FG000|Overall Study|Physician Decision|0|||
170726079|NCT00487162|617002202|FG001|Overall Study|Physician Decision|1|||
170726080|NCT00487162|617002201|FG000|Overall Study|Withdrawal by Subject|2|||
170726081|NCT00487162|617002202|FG001|Overall Study|Withdrawal by Subject|3|||
170726082|NCT00530855|617002203|FG000|Overall Study|Lack of Efficacy|20|||
170726083|NCT00530855|617002203|FG000|Overall Study|Withdrawal by Subject|30|||
170726084|NCT00530855|617002203|FG000|Overall Study|Fatal Serious AE|3|||
170726085|NCT00530855|617002203|FG000|Overall Study|Non Fatal Serious AE|7|||
170726086|NCT00530855|617002203|FG000|Overall Study|Non Fatal Non Serious AE|12|||
170726087|NCT00530855|617002203|FG000|Overall Study|Protocol Violation|3|||
170726088|NCT00530855|617002203|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
170726089|NCT00530855|617002203|FG000|Overall Study|Lost to Follow-up|9|||
170726090|NCT00530855|617002203|FG000|Overall Study|Other reason for premature termination|17|||
170726091|NCT01613248|617002205|FG000|Overall Study|Adverse Event|0|||
170726092|NCT01613248|617002206|FG001|Overall Study|Adverse Event|0|||
170726093|NCT01613248|617002207|FG002|Overall Study|Adverse Event|0|||
170726094|NCT01613248|617002208|FG003|Overall Study|Adverse Event|1|||
170726095|NCT01613248|617002209|FG004|Overall Study|Adverse Event|0|||
170726096|NCT01613248|617002210|FG005|Overall Study|Adverse Event|0|||
170726097|NCT01613248|617002205|FG000|Overall Study|Withdrawal by Subject|3|||
170726098|NCT01613248|617002206|FG001|Overall Study|Withdrawal by Subject|2|||
170726099|NCT01613248|617002207|FG002|Overall Study|Withdrawal by Subject|2|||
170726100|NCT01613248|617002208|FG003|Overall Study|Withdrawal by Subject|5|||
170726101|NCT01613248|617002209|FG004|Overall Study|Withdrawal by Subject|0|||
170726102|NCT01613248|617002210|FG005|Overall Study|Withdrawal by Subject|1|||
170726103|NCT01613248|617002205|FG000|Overall Study|Lost to Follow-up|5|||
170726104|NCT01613248|617002206|FG001|Overall Study|Lost to Follow-up|7|||
170726105|NCT01613248|617002207|FG002|Overall Study|Lost to Follow-up|4|||
170726106|NCT01613248|617002208|FG003|Overall Study|Lost to Follow-up|8|||
170726107|NCT01613248|617002209|FG004|Overall Study|Lost to Follow-up|4|||
170726108|NCT01613248|617002210|FG005|Overall Study|Lost to Follow-up|2|||
170726109|NCT01613248|617002205|FG000|Overall Study|Study Terminated by Sponsor|4|||
170726110|NCT01613248|617002206|FG001|Overall Study|Study Terminated by Sponsor|6|||
170726111|NCT01613248|617002207|FG002|Overall Study|Study Terminated by Sponsor|8|||
170726112|NCT01613248|617002208|FG003|Overall Study|Study Terminated by Sponsor|8|||
170726113|NCT01613248|617002209|FG004|Overall Study|Study Terminated by Sponsor|9|||
170726114|NCT01613248|617002210|FG005|Overall Study|Study Terminated by Sponsor|11|||
170726115|NCT01613248|617002205|FG000|Overall Study|Physician Decision|8|||
170726116|NCT01613248|617002206|FG001|Overall Study|Physician Decision|8|||
170726117|NCT01613248|617002207|FG002|Overall Study|Physician Decision|9|||
170726118|NCT01613248|617002208|FG003|Overall Study|Physician Decision|4|||
170726119|NCT01613248|617002209|FG004|Overall Study|Physician Decision|7|||
170726120|NCT01613248|617002210|FG005|Overall Study|Physician Decision|6|||
170726121|NCT01613248|617002205|FG000|Overall Study|Lack of Qualifying Event|9|||
170726122|NCT01613248|617002206|FG001|Overall Study|Lack of Qualifying Event|11|||
170726123|NCT01613248|617002207|FG002|Overall Study|Lack of Qualifying Event|10|||
170726124|NCT01613248|617002208|FG003|Overall Study|Lack of Qualifying Event|11|||
170726125|NCT01613248|617002209|FG004|Overall Study|Lack of Qualifying Event|15|||
170726126|NCT01613248|617002210|FG005|Overall Study|Lack of Qualifying Event|18|||
170726127|NCT01613248|617002205|FG000|Overall Study|Pregnancy|0|||
170726128|NCT01613248|617002206|FG001|Overall Study|Pregnancy|0|||
170726129|NCT01613248|617002207|FG002|Overall Study|Pregnancy|0|||
170726130|NCT01613248|617002208|FG003|Overall Study|Pregnancy|1|||
170726131|NCT01613248|617002209|FG004|Overall Study|Pregnancy|0|||
170726132|NCT01613248|617002210|FG005|Overall Study|Pregnancy|0|||
170726133|NCT01618162|617002214|FG000|Overall Study|Protocol Violation|13|||
170726134|NCT01618162|617002215|FG001|Overall Study|Protocol Violation|10|||
170726135|NCT01618162|617002214|FG000|Overall Study|Adverse Event|9|||
170726136|NCT01618162|617002215|FG001|Overall Study|Adverse Event|2|||
170726137|NCT01618162|617002214|FG000|Overall Study|Withdrawal Criteria|2|||
170726138|NCT01618162|617002215|FG001|Overall Study|Withdrawal Criteria|10|||
170726139|NCT01618162|617002214|FG000|Overall Study|Unclassified|14|||
170726140|NCT01618162|617002215|FG001|Overall Study|Unclassified|13|||
170726141|NCT00338884|617002216|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
170726142|NCT00338884|617002216|FG000|Overall Study|Adverse Event|14|||
170726143|NCT00338884|617002216|FG000|Overall Study|Death|8|||
170726144|NCT00338884|617002216|FG000|Overall Study|Other|4|||
170726145|NCT00338884|617002216|FG000|Overall Study|Global Deterioration of Health Status|3|||
170726146|NCT00338884|617002216|FG000|Overall Study|Withdrawal by Subject|3|||
170726147|NCT00338884|617002216|FG000|Overall Study|Lost to Follow-up|1|||
170726148|NCT00338884|617002216|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
170726149|NCT02013622|617002217|FG000|Overall Study|Lost to Follow-up|10|||
170726150|NCT02013622|617002217|FG000|Overall Study|Adverse Event|3|||
170726151|NCT02013622|617002217|FG000|Overall Study|Met Withdrawal Criteria|3|||
170726152|NCT02013622|617002217|FG000|Overall Study|Withdrawal by Subject|6|||
170726153|NCT02013622|617002217|FG000|Overall Study|Protocol Deviation|1|||
170726154|NCT02013622|617002217|FG000|Overall Study|Lack of Efficacy|1|||
170726155|NCT03152526|617002224|FG000|Overall Study|Withdrawal by Subject|0|||
170726156|NCT03152526|617002225|FG001|Overall Study|Withdrawal by Subject|1|||
170726157|NCT04867369|617002226|FG000|Overall Study|Withdrawal by Subject|1|||
170726158|NCT04867369|617002227|FG001|Overall Study|Withdrawal by Subject|0|||
170726159|NCT01324271|617002230|FG000|Overall Study|Lost to Follow-up|3|||
170726160|NCT01324271|617002231|FG001|Overall Study|Lost to Follow-up|0|||
170726161|NCT01324271|617002230|FG000|Overall Study|Physician Decision|1|||
170726162|NCT01324271|617002231|FG001|Overall Study|Physician Decision|0|||
170726163|NCT05130970|617002232|FG000|Overall Study|Adverse Event|1|||
170726164|NCT05130970|617002233|FG001|Overall Study|Adverse Event|1|||
170726165|NCT05130970|617002232|FG000|Overall Study|Death|0|||
170726166|NCT05130970|617002233|FG001|Overall Study|Death|1|||
170726167|NCT05130970|617002232|FG000|Overall Study|Lost to Follow-up|0|||
170726168|NCT05130970|617002233|FG001|Overall Study|Lost to Follow-up|1|||
170726169|NCT05130970|617002232|FG000|Overall Study|Physician Decision|0|||
170726170|NCT05130970|617002233|FG001|Overall Study|Physician Decision|1|||
170726171|NCT05130970|617002232|FG000|Overall Study|Withdrawal by Subject|1|||
170726172|NCT05130970|617002233|FG001|Overall Study|Withdrawal by Subject|1|||
170726173|NCT00430989|617002234|FG000|Overall Study|Lost to Follow-up|2|||
170726174|NCT00430989|617002235|FG001|Overall Study|Lost to Follow-up|3|||
170726175|NCT00430989|617002234|FG000|Overall Study|Withdrawal by Subject|15|||
170726176|NCT00430989|617002235|FG001|Overall Study|Withdrawal by Subject|14|||
170726177|NCT00430989|617002234|FG000|Overall Study|Protocol Violation|30|||
170726178|NCT00430989|617002235|FG001|Overall Study|Protocol Violation|37|||
170726179|NCT00430989|617002234|FG000|Overall Study|Not eligible|13|||
170726180|NCT00430989|617002235|FG001|Overall Study|Not eligible|6|||
170726181|NCT05297786|617002236|FG000|Overall Study|Withdrawal by Subject|3|||
170726182|NCT05297786|617002237|FG001|Overall Study|Withdrawal by Subject|0|||
170726183|NCT05297786|617002236|FG000|Overall Study|Renal transplantation|1|||
170726184|NCT05297786|617002237|FG001|Overall Study|Renal transplantation|0|||
170726185|NCT05297786|617002236|FG000|Overall Study|Physician Decision|1|||
170726186|NCT05297786|617002237|FG001|Overall Study|Physician Decision|0|||
170726187|NCT05297786|617002236|FG000|Overall Study|Adverse Event|0|||
170726188|NCT05297786|617002237|FG001|Overall Study|Adverse Event|1|||
170726189|NCT05297786|617002236|FG000|Overall Study|Withdrawal by Subject|0|||
170726190|NCT05297786|617002237|FG001|Overall Study|Withdrawal by Subject|1|||
170726191|NCT05402137|617002238|FG000|Overall Study|Lost to Follow-up|42|||
170726192|NCT05402137|617002239|FG001|Overall Study|Lost to Follow-up|40|||
170726193|NCT06269484|617002240|FG000|Overall Study|Withdrawal by Subject|3|||
170726194|NCT06269484|617002241|FG001|Overall Study|Withdrawal by Subject|0|||
170835257|NCT01107899|617404921|FG002|Overall Study|Physician Decision|3|||
170835258|NCT01107899|617404919|FG000|Overall Study|Withdrawal by Subject|0|||
170835259|NCT01107899|617404920|FG001|Overall Study|Withdrawal by Subject|0|||
170835260|NCT01107899|617404921|FG002|Overall Study|Withdrawal by Subject|1|||
170835261|NCT03584152|617404922|FG000|Overall Study|Discontinued intervention|7|||
170835262|NCT03584152|617404923|FG001|Overall Study|Discontinued intervention|4|||
170835263|NCT04292470|617404930|FG000|Overall Study|Withdrawal by Subject|0|||
170835264|NCT04292470|617404931|FG001|Overall Study|Withdrawal by Subject|1|||
170835265|NCT01454739|617404932|FG000|Overall Study|Protocol Violation|2|||
170835266|NCT01454739|617404933|FG001|Overall Study|Protocol Violation|3|||
170835267|NCT01454739|617404932|FG000|Overall Study|Withdrawal by Subject|2|||
170835268|NCT01454739|617404933|FG001|Overall Study|Withdrawal by Subject|6|||
170835269|NCT01454739|617404932|FG000|Overall Study|Other|3|||
170835270|NCT01454739|617404933|FG001|Overall Study|Other|5|||
170835271|NCT01454739|617404932|FG000|Overall Study|Physician Decision|0|||
170835272|NCT01454739|617404933|FG001|Overall Study|Physician Decision|5|||
170835273|NCT01454739|617404932|FG000|Overall Study|Lost to Follow-up|0|||
170835274|NCT01454739|617404933|FG001|Overall Study|Lost to Follow-up|1|||
170835275|NCT01454739|617404932|FG000|Overall Study|Adverse Event|0|||
170835276|NCT01454739|617404933|FG001|Overall Study|Adverse Event|1|||
170835277|NCT05765435|617404938|FG000|Overall Study|Lost to Follow-up|0|||
170835278|NCT05765435|617404939|FG001|Overall Study|Lost to Follow-up|1|||
170835279|NCT05765435|617404940|FG002|Overall Study|Lost to Follow-up|0|||
170835280|NCT05765435|617404938|FG000|Overall Study|Withdrawal by Subject|0|||
170835281|NCT05765435|617404939|FG001|Overall Study|Withdrawal by Subject|0|||
170835282|NCT05765435|617404940|FG002|Overall Study|Withdrawal by Subject|1|||
170835283|NCT02906020|617404941|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
170835284|NCT02906020|617404942|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
170835285|NCT02906020|617404943|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
170835286|NCT02906020|617404944|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
170835287|NCT02906020|617404945|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
170835288|NCT02906020|617404946|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
170835289|NCT02906020|617404947|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
170835290|NCT02906020|617404948|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
170835291|NCT02906020|617404949|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
170835292|NCT02906020|617404950|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
170835293|NCT02906020|617404951|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
170835294|NCT02906020|617404952|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
170835295|NCT02906020|617404953|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
170835296|NCT02906020|617404954|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
170835297|NCT02906020|617404955|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
170835298|NCT02906020|617404956|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
170835299|NCT02906020|617404941|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835300|NCT02906020|617404942|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835301|NCT02906020|617404943|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835302|NCT02906020|617404944|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835303|NCT02906020|617404945|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835304|NCT02906020|617404946|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835305|NCT02906020|617404947|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835306|NCT02906020|617404948|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835307|NCT02906020|617404949|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
170835308|NCT02906020|617404950|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
170835309|NCT02906020|617404951|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835310|NCT02906020|617404952|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170726195|NCT06269484|617002242|FG002|Overall Study|Withdrawal by Subject|2|||
170726196|NCT06269484|617002240|FG000|Overall Study|All other reasons apart from specified|1|||
170726197|NCT06269484|617002241|FG001|Overall Study|All other reasons apart from specified|0|||
170726198|NCT06269484|617002242|FG002|Overall Study|All other reasons apart from specified|0|||
170726199|NCT06269484|617002240|FG000|Overall Study|Randomised but not started treatment|0|||
170726200|NCT06269484|617002241|FG001|Overall Study|Randomised but not started treatment|1|||
170726201|NCT06269484|617002242|FG002|Overall Study|Randomised but not started treatment|0|||
170726202|NCT02701985|617002243|FG000|Overall Study|Withdrawal by Subject|1|||
170726203|NCT02701985|617002244|FG001|Overall Study|Withdrawal by Subject|1|||
170726204|NCT02701985|617002243|FG000|Overall Study|Lost to Follow-up|1|||
170726205|NCT02701985|617002244|FG001|Overall Study|Lost to Follow-up|0|||
170726206|NCT02701985|617002243|FG000|Overall Study|Death|1|||
170726207|NCT02701985|617002244|FG001|Overall Study|Death|0|||
170726208|NCT02701985|617002243|FG000|Overall Study|Adverse Event|0|||
170726209|NCT02701985|617002244|FG001|Overall Study|Adverse Event|5|||
170726210|NCT01954017|617002252|FG000|Overall Study|Adverse Event|0|||
170726211|NCT01954017|617002253|FG001|Overall Study|Adverse Event|0|||
170726212|NCT01954017|617002254|FG002|Overall Study|Adverse Event|1|||
170726213|NCT01954017|617002252|FG000|Overall Study|Death|2|||
170726214|NCT01954017|617002253|FG001|Overall Study|Death|1|||
170726215|NCT01954017|617002254|FG002|Overall Study|Death|1|||
170726216|NCT01954017|617002252|FG000|Overall Study|Withdrawal by Subject|0|||
170726217|NCT01954017|617002253|FG001|Overall Study|Withdrawal by Subject|1|||
170726218|NCT01954017|617002254|FG002|Overall Study|Withdrawal by Subject|0|||
170726219|NCT01954017|617002252|FG000|Overall Study|Protocol Violation|0|||
170726220|NCT01954017|617002253|FG001|Overall Study|Protocol Violation|3|||
170726221|NCT01954017|617002254|FG002|Overall Study|Protocol Violation|2|||
170835311|NCT02906020|617404953|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835312|NCT02906020|617404954|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835313|NCT02906020|617404955|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835314|NCT02906020|617404956|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
170835315|NCT02906020|617404941|FG000|Part 2: Double-blind Treatment Period|Other|0|||
170835316|NCT02906020|617404942|FG001|Part 2: Double-blind Treatment Period|Other|0|||
170835317|NCT02906020|617404943|FG002|Part 2: Double-blind Treatment Period|Other|0|||
170835318|NCT02906020|617404944|FG003|Part 2: Double-blind Treatment Period|Other|0|||
170835319|NCT02906020|617404945|FG004|Part 2: Double-blind Treatment Period|Other|0|||
170835320|NCT02906020|617404946|FG005|Part 2: Double-blind Treatment Period|Other|0|||
170835321|NCT02906020|617404947|FG006|Part 2: Double-blind Treatment Period|Other|0|||
170835322|NCT02906020|617404948|FG007|Part 2: Double-blind Treatment Period|Other|0|||
170835323|NCT02906020|617404949|FG008|Part 2: Double-blind Treatment Period|Other|6|||
170835324|NCT02906020|617404950|FG009|Part 2: Double-blind Treatment Period|Other|10|||
170835325|NCT02906020|617404951|FG010|Part 2: Double-blind Treatment Period|Other|0|||
170835326|NCT02906020|617404952|FG011|Part 2: Double-blind Treatment Period|Other|0|||
170835327|NCT02906020|617404953|FG012|Part 2: Double-blind Treatment Period|Other|0|||
170835328|NCT02906020|617404954|FG013|Part 2: Double-blind Treatment Period|Other|0|||
170835329|NCT02906020|617404955|FG014|Part 2: Double-blind Treatment Period|Other|0|||
170835330|NCT02906020|617404956|FG015|Part 2: Double-blind Treatment Period|Other|0|||
170835331|NCT02906020|617404941|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835332|NCT02906020|617404942|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835333|NCT02906020|617404943|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835334|NCT02906020|617404944|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835335|NCT02906020|617404945|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835336|NCT02906020|617404946|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835337|NCT02906020|617404947|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835338|NCT02906020|617404948|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835339|NCT02906020|617404949|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835340|NCT02906020|617404950|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835341|NCT02906020|617404951|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835342|NCT02906020|617404952|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835343|NCT02906020|617404953|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
170835344|NCT02906020|617404954|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
170835345|NCT02906020|617404955|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835346|NCT02906020|617404956|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
170835347|NCT02906020|617404941|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835348|NCT02906020|617404942|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835349|NCT02906020|617404943|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835350|NCT02906020|617404944|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835351|NCT02906020|617404945|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835352|NCT02906020|617404946|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835353|NCT02906020|617404947|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835354|NCT02906020|617404948|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835355|NCT02906020|617404949|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835356|NCT02906020|617404950|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835357|NCT02906020|617404951|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835358|NCT02906020|617404952|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835359|NCT02906020|617404953|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
170835360|NCT02906020|617404954|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
170835361|NCT02906020|617404955|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
170835362|NCT02906020|617404956|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
170835363|NCT02906020|617404941|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835364|NCT02906020|617404942|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835365|NCT02906020|617404943|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835366|NCT02906020|617404944|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835367|NCT02906020|617404945|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835368|NCT02906020|617404946|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835369|NCT02906020|617404947|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835370|NCT02906020|617404948|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835371|NCT02906020|617404949|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835372|NCT02906020|617404950|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835373|NCT02906020|617404951|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835374|NCT02906020|617404952|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835375|NCT02906020|617404953|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
170835376|NCT02906020|617404954|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
170835377|NCT02906020|617404955|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170726222|NCT01954017|617002252|FG000|Overall Study|Necrotizing enterocolitis|1|||
170726223|NCT01954017|617002253|FG001|Overall Study|Necrotizing enterocolitis|0|||
170726224|NCT01954017|617002254|FG002|Overall Study|Necrotizing enterocolitis|1|||
170726225|NCT01954017|617002252|FG000|Overall Study|Enteral intake stopped >7 days|0|||
170726226|NCT01954017|617002253|FG001|Overall Study|Enteral intake stopped >7 days|1|||
170726227|NCT01954017|617002254|FG002|Overall Study|Enteral intake stopped >7 days|1|||
170726228|NCT01954017|617002252|FG000|Overall Study|All other reasons|2|||
170726229|NCT01954017|617002253|FG001|Overall Study|All other reasons|2|||
170726230|NCT01954017|617002254|FG002|Overall Study|All other reasons|7|||
170726231|NCT01400503|617002257|FG000|Overall Study|Withdrawal by Subject|1|||
170726232|NCT01400503|617002257|FG000|Overall Study|Study Terminated by Sponsor|58|||
170726233|NCT01400503|617002257|FG000|Overall Study|Other|1|||
170726234|NCT03222609|617002261|FG000|Overall Study|Withdrew consent|3|||
170726235|NCT03222609|617002262|FG001|Overall Study|Withdrew consent|9|||
170726236|NCT03222609|617002263|FG002|Overall Study|Withdrew consent|4|||
170726237|NCT03222609|617002264|FG003|Overall Study|Withdrew consent|2|||
170726238|NCT03222609|617002261|FG000|Overall Study|Lost to Follow-up|2|||
170726239|NCT03222609|617002262|FG001|Overall Study|Lost to Follow-up|2|||
170726240|NCT03222609|617002263|FG002|Overall Study|Lost to Follow-up|1|||
170726241|NCT03222609|617002264|FG003|Overall Study|Lost to Follow-up|0|||
170726242|NCT03222609|617002261|FG000|Overall Study|Death|20|||
170726243|NCT03222609|617002262|FG001|Overall Study|Death|38|||
170726244|NCT03222609|617002263|FG002|Overall Study|Death|18|||
170726245|NCT03222609|617002264|FG003|Overall Study|Death|10|||
170726246|NCT03222609|617002261|FG000|Overall Study|Other, not specified|9|||
170726247|NCT03222609|617002262|FG001|Overall Study|Other, not specified|42|||
170726248|NCT03222609|617002263|FG002|Overall Study|Other, not specified|11|||
170726249|NCT03222609|617002264|FG003|Overall Study|Other, not specified|20|||
170726250|NCT00756509|617002265|FG000|Core Phase|Adverse Event|2|||
170726251|NCT00756509|617002265|FG000|Core Phase|Lack of Efficacy|2|||
170726252|NCT00756509|617002265|FG000|Core Phase|Disease progression|6|||
170726253|NCT00756509|617002265|FG000|Follow-Up Phase|Missing values|2|||
170726254|NCT00756509|617002265|FG000|Follow-Up Phase|Disease progression|9|||
170726255|NCT00756509|617002265|FG000|Follow-Up Phase|Administrative problems|3|||
170726256|NCT00756509|617002265|FG000|Follow-Up Phase|Lost to Follow-up|1|||
170726257|NCT00756509|617002265|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
170726258|NCT00756509|617002265|FG000|Follow-Up Phase|Subject's condition no longer requires study drug|1|||
170726259|NCT00756509|617002265|FG000|Follow-Up Phase|Adverse Event|7|||
170726260|NCT02163733|617003128|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
170726261|NCT02163733|617003129|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
170726262|NCT02163733|617003130|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
170726263|NCT02163733|617003128|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
170726264|NCT02163733|617003129|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
170726265|NCT02163733|617003130|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
170726266|NCT01615328|617003133|FG000|Overall Study|Lost to Follow-up|3|||
170726267|NCT01615328|617003134|FG001|Overall Study|Lost to Follow-up|5|||
170726268|NCT02157779|617003135|FG000|Overall Study|Logistical|9|||
170726269|NCT02157779|617003136|FG001|Overall Study|Logistical|3|||
170726270|NCT02157779|617003135|FG000|Overall Study|Stopped attending, reason unknown|11|||
170726271|NCT02157779|617003136|FG001|Overall Study|Stopped attending, reason unknown|7|||
170726272|NCT02157779|617003135|FG000|Overall Study|No response to outreach after Baseline|1|||
170726273|NCT02157779|617003136|FG001|Overall Study|No response to outreach after Baseline|1|||
170726274|NCT02157779|617003135|FG000|Overall Study|Moved|1|||
170726275|NCT02157779|617003136|FG001|Overall Study|Moved|0|||
170726276|NCT02157779|617003135|FG000|Overall Study|Medical|1|||
170726277|NCT02157779|617003136|FG001|Overall Study|Medical|0|||
170726278|NCT02157779|617003135|FG000|Overall Study|Legal issue|1|||
170726279|NCT02157779|617003136|FG001|Overall Study|Legal issue|0|||
170726280|NCT01132326|617003144|FG000|Overall Study|Lack of Efficacy|25|||
170726281|NCT01132326|617003144|FG000|Overall Study|Adverse Event|37|||
170726282|NCT01132326|617003144|FG000|Overall Study|Protocol Violation|1|||
170726283|NCT01132326|617003144|FG000|Overall Study|Lost to Follow-up|16|||
170726284|NCT01132326|617003144|FG000|Overall Study|Withdrawal by Subject|40|||
170726285|NCT01132326|617003144|FG000|Overall Study|Physician Decision|10|||
170726286|NCT01132326|617003144|FG000|Overall Study|Study Termination|80|||
170726287|NCT01132326|617003144|FG000|Overall Study|Declining Health|1|||
170726288|NCT01132326|617003144|FG000|Overall Study|Pregnancy|1|||
170726289|NCT01132326|617003144|FG000|Overall Study|Caregiver Withdrew Consent|1|||
170726290|NCT01132326|617003144|FG000|Overall Study|Death|5|||
170726291|NCT01132326|617003144|FG000|Overall Study|Subject Unable to Come To Visits|1|||
170726292|NCT04535947|617003145|FG000|Overall Study|Adverse Event|1|||
170726293|NCT04535947|617003146|FG001|Overall Study|Adverse Event|4|||
170726294|NCT04535947|617003145|FG000|Overall Study|Other reasons not specified|2|||
170726295|NCT04535947|617003146|FG001|Overall Study|Other reasons not specified|0|||
170726296|NCT04535947|617003145|FG000|Overall Study|Withdrawal by Subject|1|||
170726297|NCT04535947|617003146|FG001|Overall Study|Withdrawal by Subject|1|||
170726298|NCT00911534|617003148|FG000|Overall Study|Adverse Event|4|||
170726299|NCT00911534|617003149|FG001|Overall Study|Adverse Event|4|||
170726300|NCT00911534|617003148|FG000|Overall Study|Lost to Follow-up|2|||
170726301|NCT00911534|617003149|FG001|Overall Study|Lost to Follow-up|4|||
170726302|NCT00911534|617003148|FG000|Overall Study|Withdrawal by Subject|2|||
170726303|NCT00911534|617003149|FG001|Overall Study|Withdrawal by Subject|1|||
170726304|NCT00911534|617003148|FG000|Overall Study|Lack of Efficacy|4|||
170726305|NCT00911534|617003149|FG001|Overall Study|Lack of Efficacy|1|||
170726306|NCT00911534|617003148|FG000|Overall Study|Withdrawal of consent|1|||
170726307|NCT00911534|617003149|FG001|Overall Study|Withdrawal of consent|4|||
170726308|NCT00911534|617003148|FG000|Overall Study|Other|2|||
170726309|NCT00911534|617003149|FG001|Overall Study|Other|2|||
170726310|NCT00364286|617003151|FG000|Overall Study|Withdrawal by Subject|1|||
170726311|NCT00364286|617003151|FG000|Overall Study|Adverse Event|2|||
170726312|NCT01381692|617003154|FG000|Overall Study|Adverse Event|1|||
170726313|NCT01381692|617003155|FG001|Overall Study|Adverse Event|0|||
170726314|NCT01381692|617003156|FG002|Overall Study|Adverse Event|0|||
170726315|NCT01381692|617003157|FG003|Overall Study|Adverse Event|0|||
170726316|NCT01381692|617003158|FG004|Overall Study|Adverse Event|0|||
170726317|NCT01381692|617003159|FG005|Overall Study|Adverse Event|0|||
170726318|NCT03994601|617003162|FG000|Overall Study|Adverse Event|0|||
170726319|NCT03994601|617003163|FG001|Overall Study|Adverse Event|0|||
170726320|NCT03994601|617003164|FG002|Overall Study|Adverse Event|0|||
170726321|NCT03994601|617003165|FG003|Overall Study|Adverse Event|0|||
170726322|NCT03994601|617003166|FG004|Overall Study|Adverse Event|0|||
170726323|NCT03994601|617003167|FG005|Overall Study|Adverse Event|0|||
170726324|NCT03994601|617003168|FG006|Overall Study|Adverse Event|0|||
170726325|NCT03994601|617003169|FG007|Overall Study|Adverse Event|2|||
170726326|NCT03994601|617003170|FG008|Overall Study|Adverse Event|2|||
170726327|NCT03994601|617003171|FG009|Overall Study|Adverse Event|7|||
170726328|NCT03994601|617003172|FG010|Overall Study|Adverse Event|4|||
170726329|NCT03994601|617003173|FG011|Overall Study|Adverse Event|1|||
170726330|NCT03994601|617003174|FG012|Overall Study|Adverse Event|0|||
170726331|NCT03994601|617003162|FG000|Overall Study|Withdrew Consent|0|||
170726332|NCT03994601|617003163|FG001|Overall Study|Withdrew Consent|0|||
170726333|NCT03994601|617003164|FG002|Overall Study|Withdrew Consent|0|||
170726334|NCT03994601|617003165|FG003|Overall Study|Withdrew Consent|0|||
170726335|NCT03994601|617003166|FG004|Overall Study|Withdrew Consent|0|||
170726336|NCT03994601|617003167|FG005|Overall Study|Withdrew Consent|0|||
170726337|NCT03994601|617003168|FG006|Overall Study|Withdrew Consent|1|||
170726338|NCT03994601|617003169|FG007|Overall Study|Withdrew Consent|2|||
170726339|NCT03994601|617003170|FG008|Overall Study|Withdrew Consent|0|||
170726340|NCT03994601|617003171|FG009|Overall Study|Withdrew Consent|3|||
170726341|NCT03994601|617003172|FG010|Overall Study|Withdrew Consent|0|||
170726342|NCT03994601|617003173|FG011|Overall Study|Withdrew Consent|0|||
170726343|NCT03994601|617003174|FG012|Overall Study|Withdrew Consent|0|||
170726344|NCT03994601|617003162|FG000|Overall Study|Death|1|||
170726345|NCT03994601|617003163|FG001|Overall Study|Death|0|||
170726346|NCT03994601|617003164|FG002|Overall Study|Death|0|||
170726347|NCT03994601|617003165|FG003|Overall Study|Death|0|||
170726348|NCT03994601|617003166|FG004|Overall Study|Death|0|||
170726349|NCT03994601|617003167|FG005|Overall Study|Death|0|||
170726350|NCT03994601|617003168|FG006|Overall Study|Death|1|||
170726351|NCT03994601|617003169|FG007|Overall Study|Death|2|||
170726352|NCT03994601|617003170|FG008|Overall Study|Death|0|||
170726353|NCT03994601|617003171|FG009|Overall Study|Death|5|||
170726354|NCT03994601|617003172|FG010|Overall Study|Death|4|||
170726355|NCT03994601|617003173|FG011|Overall Study|Death|1|||
170726356|NCT03994601|617003174|FG012|Overall Study|Death|3|||
170726357|NCT03994601|617003162|FG000|Overall Study|Other Reasons|0|||
170726358|NCT03994601|617003163|FG001|Overall Study|Other Reasons|1|||
170726359|NCT03994601|617003164|FG002|Overall Study|Other Reasons|0|||
170726360|NCT03994601|617003165|FG003|Overall Study|Other Reasons|0|||
170835378|NCT02906020|617404956|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
170835379|NCT02906020|617404941|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835380|NCT02906020|617404942|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835381|NCT02906020|617404943|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835382|NCT02906020|617404944|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835383|NCT02906020|617404945|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835384|NCT02906020|617404946|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835385|NCT02906020|617404947|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835386|NCT02906020|617404948|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835387|NCT02906020|617404949|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835388|NCT02906020|617404950|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835389|NCT02906020|617404951|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835390|NCT02906020|617404952|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835391|NCT02906020|617404953|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
170835392|NCT02906020|617404954|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
170835393|NCT02906020|617404955|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835394|NCT02906020|617404956|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
170835395|NCT02906020|617404941|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835396|NCT02906020|617404942|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835397|NCT02906020|617404943|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835398|NCT02906020|617404944|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835399|NCT02906020|617404945|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835400|NCT02906020|617404946|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835401|NCT02906020|617404947|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835402|NCT02906020|617404948|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835403|NCT02906020|617404949|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835404|NCT02906020|617404950|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835405|NCT02906020|617404951|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835406|NCT02906020|617404952|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
170835407|NCT02906020|617404953|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
170835408|NCT02906020|617404954|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
170835409|NCT02906020|617404955|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
170835410|NCT02906020|617404956|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
170835411|NCT02906020|617404941|FG000|Part 2: Long-term Follow-up Period|Other|0|||
170835412|NCT02906020|617404942|FG001|Part 2: Long-term Follow-up Period|Other|0|||
170835413|NCT02906020|617404943|FG002|Part 2: Long-term Follow-up Period|Other|0|||
170835414|NCT02906020|617404944|FG003|Part 2: Long-term Follow-up Period|Other|0|||
170835415|NCT02906020|617404945|FG004|Part 2: Long-term Follow-up Period|Other|0|||
170835416|NCT02906020|617404946|FG005|Part 2: Long-term Follow-up Period|Other|0|||
170835417|NCT02906020|617404947|FG006|Part 2: Long-term Follow-up Period|Other|0|||
170835418|NCT02906020|617404948|FG007|Part 2: Long-term Follow-up Period|Other|0|||
170835419|NCT02906020|617404949|FG008|Part 2: Long-term Follow-up Period|Other|0|||
170835420|NCT02906020|617404950|FG009|Part 2: Long-term Follow-up Period|Other|0|||
170835421|NCT02906020|617404951|FG010|Part 2: Long-term Follow-up Period|Other|0|||
170726361|NCT03994601|617003166|FG004|Overall Study|Other Reasons|1|||
170726362|NCT03994601|617003167|FG005|Overall Study|Other Reasons|0|||
170726363|NCT03994601|617003168|FG006|Overall Study|Other Reasons|0|||
170726364|NCT03994601|617003169|FG007|Overall Study|Other Reasons|4|||
170726365|NCT03994601|617003170|FG008|Overall Study|Other Reasons|0|||
170726366|NCT03994601|617003171|FG009|Overall Study|Other Reasons|4|||
170726367|NCT03994601|617003172|FG010|Overall Study|Other Reasons|3|||
170726368|NCT03994601|617003173|FG011|Overall Study|Other Reasons|4|||
170726369|NCT03994601|617003174|FG012|Overall Study|Other Reasons|2|||
170726370|NCT03994601|617003162|FG000|Overall Study|Disease Progression|3|||
170726371|NCT03994601|617003163|FG001|Overall Study|Disease Progression|3|||
170726372|NCT03994601|617003164|FG002|Overall Study|Disease Progression|4|||
170726373|NCT03994601|617003165|FG003|Overall Study|Disease Progression|6|||
170726374|NCT03994601|617003166|FG004|Overall Study|Disease Progression|3|||
170726375|NCT03994601|617003167|FG005|Overall Study|Disease Progression|5|||
170726376|NCT03994601|617003168|FG006|Overall Study|Disease Progression|7|||
170726377|NCT03994601|617003169|FG007|Overall Study|Disease Progression|25|||
170726378|NCT03994601|617003170|FG008|Overall Study|Disease Progression|1|||
170726379|NCT03994601|617003171|FG009|Overall Study|Disease Progression|24|||
170726380|NCT03994601|617003172|FG010|Overall Study|Disease Progression|20|||
170726381|NCT03994601|617003173|FG011|Overall Study|Disease Progression|24|||
170726382|NCT03994601|617003174|FG012|Overall Study|Disease Progression|7|||
170726383|NCT03994601|617003162|FG000|Overall Study|Study Drug Toxicity|0|||
170726384|NCT03994601|617003163|FG001|Overall Study|Study Drug Toxicity|0|||
170726385|NCT03994601|617003164|FG002|Overall Study|Study Drug Toxicity|0|||
170726386|NCT03994601|617003165|FG003|Overall Study|Study Drug Toxicity|0|||
170726387|NCT03994601|617003166|FG004|Overall Study|Study Drug Toxicity|1|||
170726388|NCT03994601|617003167|FG005|Overall Study|Study Drug Toxicity|0|||
170726389|NCT03994601|617003168|FG006|Overall Study|Study Drug Toxicity|0|||
170726390|NCT03994601|617003169|FG007|Overall Study|Study Drug Toxicity|3|||
170835422|NCT02906020|617404952|FG011|Part 2: Long-term Follow-up Period|Other|0|||
170835423|NCT02906020|617404953|FG012|Part 2: Long-term Follow-up Period|Other|13|||
170835424|NCT02906020|617404954|FG013|Part 2: Long-term Follow-up Period|Other|8|||
170726391|NCT03994601|617003170|FG008|Overall Study|Study Drug Toxicity|0|||
170726392|NCT03994601|617003171|FG009|Overall Study|Study Drug Toxicity|0|||
170726393|NCT03994601|617003172|FG010|Overall Study|Study Drug Toxicity|3|||
170726394|NCT03994601|617003173|FG011|Overall Study|Study Drug Toxicity|3|||
170726395|NCT03994601|617003174|FG012|Overall Study|Study Drug Toxicity|0|||
170726396|NCT03994601|617003162|FG000|Overall Study|AE Unrelated to Study Drug|0|||
170726397|NCT03994601|617003163|FG001|Overall Study|AE Unrelated to Study Drug|0|||
170726398|NCT03994601|617003164|FG002|Overall Study|AE Unrelated to Study Drug|1|||
170726399|NCT03994601|617003165|FG003|Overall Study|AE Unrelated to Study Drug|0|||
170726400|NCT03994601|617003166|FG004|Overall Study|AE Unrelated to Study Drug|0|||
170726401|NCT03994601|617003167|FG005|Overall Study|AE Unrelated to Study Drug|0|||
170726402|NCT03994601|617003168|FG006|Overall Study|AE Unrelated to Study Drug|0|||
170726403|NCT03994601|617003169|FG007|Overall Study|AE Unrelated to Study Drug|1|||
170726404|NCT03994601|617003170|FG008|Overall Study|AE Unrelated to Study Drug|0|||
170726405|NCT03994601|617003171|FG009|Overall Study|AE Unrelated to Study Drug|4|||
170726406|NCT03994601|617003172|FG010|Overall Study|AE Unrelated to Study Drug|5|||
170726407|NCT03994601|617003173|FG011|Overall Study|AE Unrelated to Study Drug|0|||
170726408|NCT03994601|617003174|FG012|Overall Study|AE Unrelated to Study Drug|0|||
170726409|NCT03994601|617003162|FG000|Overall Study|Request to Discontinue|0|||
170726410|NCT03994601|617003163|FG001|Overall Study|Request to Discontinue|0|||
170726411|NCT03994601|617003164|FG002|Overall Study|Request to Discontinue|0|||
170726412|NCT03994601|617003165|FG003|Overall Study|Request to Discontinue|0|||
170726413|NCT03994601|617003166|FG004|Overall Study|Request to Discontinue|0|||
170726414|NCT03994601|617003167|FG005|Overall Study|Request to Discontinue|0|||
170726415|NCT03994601|617003168|FG006|Overall Study|Request to Discontinue|0|||
170726416|NCT03994601|617003169|FG007|Overall Study|Request to Discontinue|1|||
170726417|NCT03994601|617003170|FG008|Overall Study|Request to Discontinue|0|||
170726418|NCT03994601|617003171|FG009|Overall Study|Request to Discontinue|0|||
170726419|NCT03994601|617003172|FG010|Overall Study|Request to Discontinue|0|||
170726420|NCT03994601|617003173|FG011|Overall Study|Request to Discontinue|0|||
170726421|NCT03994601|617003174|FG012|Overall Study|Request to Discontinue|0|||
170726422|NCT01362140|617003175|FG000|Overall Study|Noncompliance|1|||
170726423|NCT01362140|617003176|FG001|Overall Study|Noncompliance|0|||
170726424|NCT01362140|617003175|FG000|Overall Study|Adverse Event|2|||
170726425|NCT01362140|617003176|FG001|Overall Study|Adverse Event|2|||
170726426|NCT01362140|617003175|FG000|Overall Study|Withdrawal by Subject|3|||
170726427|NCT01362140|617003176|FG001|Overall Study|Withdrawal by Subject|3|||
170726428|NCT01362140|617003175|FG000|Overall Study|Administrative Decision|0|||
170726429|NCT01362140|617003176|FG001|Overall Study|Administrative Decision|1|||
170726430|NCT01362140|617003175|FG000|Overall Study|Death|2|||
170726431|NCT01362140|617003176|FG001|Overall Study|Death|1|||
170726432|NCT01362140|617003175|FG000|Overall Study|Other|1|||
170726433|NCT01362140|617003176|FG001|Overall Study|Other|1|||
170726434|NCT01362140|617003175|FG000|Overall Study|Protocol-specified Criteria|1|||
170726435|NCT01362140|617003176|FG001|Overall Study|Protocol-specified Criteria|2|||
170726436|NCT01362140|617003175|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
170726437|NCT01362140|617003176|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
170726438|NCT01556438|617003177|FG000|Overall Study|Adverse Event|4|||
170726439|NCT01556438|617003178|FG001|Overall Study|Adverse Event|2|||
170726440|NCT01556438|617003177|FG000|Overall Study|Sponsor Decision|0|||
170835425|NCT02906020|617404955|FG014|Part 2: Long-term Follow-up Period|Other|3|||
170835426|NCT02906020|617404956|FG015|Part 2: Long-term Follow-up Period|Other|2|||
170835427|NCT04328623|617404959|FG000|Overall Study|Protocol Violation|0|||
170835428|NCT04328623|617404960|FG001|Overall Study|Protocol Violation|1|||
170835429|NCT04340947|617404961|FG000|7-day Washout Period|Lost to Follow-up|5|||
170835430|NCT04340947|617404962|FG001|7-day Washout Period|Lost to Follow-up|4|||
170835431|NCT00979953|617404963|FG000|Overall Study|Adverse Event|5|||
170726441|NCT01556438|617003178|FG001|Overall Study|Sponsor Decision|2|||
170726442|NCT01556438|617003177|FG000|Overall Study|Progressive Disease|0|||
170726443|NCT01556438|617003178|FG001|Overall Study|Progressive Disease|6|||
170726444|NCT01556438|617003177|FG000|Overall Study|Death|0|||
170726445|NCT01556438|617003178|FG001|Overall Study|Death|1|||
170726446|NCT03998618|617003181|FG000|Overall Study|Death|7|||
170726447|NCT03998618|617003182|FG001|Overall Study|Death|11|||
170726448|NCT03998618|617003181|FG000|Overall Study|hospice enrollment|3|||
170726449|NCT03998618|617003182|FG001|Overall Study|hospice enrollment|3|||
170726450|NCT03998618|617003181|FG000|Overall Study|Not feeling well/health problems|3|||
170835432|NCT00979953|617404964|FG001|Overall Study|Adverse Event|2|||
170726451|NCT03998618|617003182|FG001|Overall Study|Not feeling well/health problems|5|||
170726452|NCT03998618|617003181|FG000|Overall Study|Lost to Follow-up|6|||
170835433|NCT00979953|617404965|FG002|Overall Study|Adverse Event|17|||
170835434|NCT00979953|617404966|FG003|Overall Study|Adverse Event|4|||
170835435|NCT00979953|617404963|FG000|Overall Study|Lack of Efficacy|1|||
170835436|NCT00979953|617404964|FG001|Overall Study|Lack of Efficacy|2|||
170835437|NCT00979953|617404965|FG002|Overall Study|Lack of Efficacy|0|||
170835438|NCT00979953|617404966|FG003|Overall Study|Lack of Efficacy|0|||
170835439|NCT00979953|617404963|FG000|Overall Study|Lost to Follow-up|1|||
170835440|NCT00979953|617404964|FG001|Overall Study|Lost to Follow-up|1|||
170835441|NCT00979953|617404965|FG002|Overall Study|Lost to Follow-up|1|||
170835442|NCT00979953|617404966|FG003|Overall Study|Lost to Follow-up|0|||
170835443|NCT00979953|617404963|FG000|Overall Study|Withdrawal by Subject|0|||
170835444|NCT00979953|617404964|FG001|Overall Study|Withdrawal by Subject|0|||
170835445|NCT00979953|617404965|FG002|Overall Study|Withdrawal by Subject|2|||
170835446|NCT00979953|617404966|FG003|Overall Study|Withdrawal by Subject|1|||
170835447|NCT00979953|617404963|FG000|Overall Study|Protocol Violation|1|||
170835448|NCT00979953|617404964|FG001|Overall Study|Protocol Violation|0|||
170835449|NCT00979953|617404965|FG002|Overall Study|Protocol Violation|2|||
170835450|NCT00979953|617404966|FG003|Overall Study|Protocol Violation|2|||
170835451|NCT01437423|617404971|FG000|Overall Study|Lost to Follow-up|12|||
170835452|NCT01437423|617404971|FG000|Overall Study|Off label usage|3|||
170835453|NCT01375751|617404972|FG000|Overall Study|Other|0|||
170835454|NCT01375751|617404973|FG001|Overall Study|Other|1|||
170835455|NCT01375751|617404974|FG002|Overall Study|Other|0|||
170835456|NCT00633945|617404975|FG000|Overall Study|Physician Decision|2|||
170835457|NCT00882115|617404976|FG000|Overall Study|Withdrawal by Subject|3|||
170835458|NCT00882115|617404976|FG000|Overall Study|did not respond to DEP challe|6|||
170835459|NCT00943787|617404977|FG000|Overall Study|Physician Decision|4|||
170835460|NCT00943787|617404977|FG000|Overall Study|Withdrawal by Subject|3|||
170835461|NCT01547598|617404978|FG000|Overall Study|Withdrew consent|1|||
170835462|NCT01547598|617404979|FG001|Overall Study|Withdrew consent|1|||
170835463|NCT01547598|617404978|FG000|Overall Study|Lost to Follow-up|1|||
170835464|NCT01547598|617404979|FG001|Overall Study|Lost to Follow-up|1|||
170835465|NCT01547598|617404978|FG000|Overall Study|Adverse Event|1|||
170835466|NCT01547598|617404979|FG001|Overall Study|Adverse Event|1|||
170835467|NCT01547598|617404978|FG000|Overall Study|Protocol Violation|1|||
170835468|NCT01547598|617404979|FG001|Overall Study|Protocol Violation|1|||
170835469|NCT01547598|617404978|FG000|Overall Study|Other Miscellaneous Reasons|2|||
170835470|NCT01547598|617404979|FG001|Overall Study|Other Miscellaneous Reasons|1|||
170835471|NCT00872001|617404980|FG000|Overall Study|Adverse Event|34|||
170835472|NCT00872001|617404981|FG001|Overall Study|Adverse Event|23|||
170835473|NCT00872001|617404980|FG000|Overall Study|Protocol Defined Clinical Event|5|||
170835474|NCT00872001|617404981|FG001|Overall Study|Protocol Defined Clinical Event|7|||
170835475|NCT00872001|617404980|FG000|Overall Study|Lost to Follow-up|13|||
170835476|NCT00872001|617404981|FG001|Overall Study|Lost to Follow-up|12|||
170835477|NCT00872001|617404980|FG000|Overall Study|Withdrawal by Subject|18|||
170835478|NCT00872001|617404981|FG001|Overall Study|Withdrawal by Subject|30|||
170835479|NCT00872001|617404980|FG000|Overall Study|Protocol Violation|5|||
170835480|NCT00872001|617404981|FG001|Overall Study|Protocol Violation|8|||
170835481|NCT00872001|617404980|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
170835482|NCT00872001|617404981|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
170835483|NCT00872001|617404980|FG000|Overall Study|Administrative|23|||
170835484|NCT00872001|617404981|FG001|Overall Study|Administrative|15|||
170835485|NCT02125279|617404982|FG000|Overall Study|Lack of Efficacy|2|||
170835486|NCT02125279|617404982|FG000|Overall Study|Withdrawal by Subject|6|||
170835487|NCT02125279|617404982|FG000|Overall Study|Protocol Violation|1|||
170835488|NCT02125279|617404982|FG000|Overall Study|Lost to Follow-up|4|||
170835489|NCT01607879|617404987|FG000|Overall Study|Death|1|||
170835490|NCT01607879|617404988|FG001|Overall Study|Death|0|||
170835491|NCT01790295|617404991|FG000|Overall Study|Adverse Event|1|||
170835492|NCT01790295|617404991|FG000|Overall Study|Death|4|||
170835493|NCT01790295|617404991|FG000|Overall Study|Lack of Efficacy|2|||
170835494|NCT01790295|617404991|FG000|Overall Study|Study closure|4|||
170835495|NCT03721705|617404992|FG000|Overall Study|Adverse Event|2|||
170835496|NCT03721705|617404993|FG001|Overall Study|Adverse Event|0|||
170835497|NCT03721705|617404992|FG000|Overall Study|Withdrawal by Subject|4|||
170835498|NCT03721705|617404993|FG001|Overall Study|Withdrawal by Subject|10|||
170835499|NCT03721705|617404992|FG000|Overall Study|No Suitable Study Partner|1|||
170835500|NCT03721705|617404993|FG001|Overall Study|No Suitable Study Partner|0|||
170835501|NCT03721705|617404992|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
170835502|NCT03721705|617404993|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
170835503|NCT03721705|617404992|FG000|Overall Study|Death|0|||
170835504|NCT03721705|617404993|FG001|Overall Study|Death|1|||
170835505|NCT01843777|617404994|FG000|Overall Study|Withdrawal by Subject|1|||
170835506|NCT01843777|617404995|FG001|Overall Study|Withdrawal by Subject|0|||
170835507|NCT03721172|617405000|FG000|Placebo-controlled Phase|Adverse Event|7|||
170835508|NCT03721172|617405001|FG001|Placebo-controlled Phase|Adverse Event|7|||
170835509|NCT03721172|617405002|FG002|Placebo-controlled Phase|Adverse Event|0|||
170835510|NCT03721172|617405000|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
170726453|NCT03998618|617003182|FG001|Overall Study|Lost to Follow-up|6|||
170726454|NCT03998618|617003181|FG000|Overall Study|Withdrawal by Subject|0|||
170726455|NCT03998618|617003182|FG001|Overall Study|Withdrawal by Subject|4|||
170726456|NCT01994954|617003185|FG000|Overall Study|Death|1|||
170726457|NCT01994954|617003186|FG001|Overall Study|Death|0|||
170726458|NCT01994954|617003185|FG000|Overall Study|Withdrawal by Subject|9|||
170726459|NCT01994954|617003186|FG001|Overall Study|Withdrawal by Subject|14|||
170726460|NCT01994954|617003185|FG000|Overall Study|Physician Decision|2|||
170726461|NCT01994954|617003186|FG001|Overall Study|Physician Decision|2|||
170726462|NCT01994954|617003185|FG000|Overall Study|Lost to Follow-up|8|||
170726463|NCT01994954|617003186|FG001|Overall Study|Lost to Follow-up|10|||
170726464|NCT01994954|617003185|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
170726465|NCT01994954|617003186|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
170726466|NCT03792126|617003190|FG000|Overall Study|Adverse Event|1|||
170726467|NCT03792126|617003191|FG001|Overall Study|Adverse Event|2|||
170726468|NCT03792126|617003190|FG000|Overall Study|Death|0|||
170726469|NCT03792126|617003191|FG001|Overall Study|Death|1|||
170726470|NCT03792126|617003190|FG000|Overall Study|Lost to Follow-up|1|||
170726471|NCT03792126|617003191|FG001|Overall Study|Lost to Follow-up|0|||
170726472|NCT03792126|617003190|FG000|Overall Study|Withdrawal by Subject|0|||
170726473|NCT03792126|617003191|FG001|Overall Study|Withdrawal by Subject|1|||
170726474|NCT03792126|617003190|FG000|Overall Study|COVID-19 Restrictions|1|||
170726475|NCT03792126|617003191|FG001|Overall Study|COVID-19 Restrictions|3|||
170726476|NCT03792126|617003190|FG000|Overall Study|Symptoms resolved|0|||
170726477|NCT03792126|617003191|FG001|Overall Study|Symptoms resolved|3|||
170726478|NCT03575793|617003192|FG000|Overall Study|Withdrawal by Subject|0|||
170726479|NCT03575793|617003193|FG001|Overall Study|Withdrawal by Subject|1|||
170726480|NCT03575793|617003192|FG000|Overall Study|Never Treated|0|||
170726481|NCT03575793|617003193|FG001|Overall Study|Never Treated|2|||
170726482|NCT04302350|617003194|FG000|Overall Study|Physician Decision|1|||
170726483|NCT04302350|617003195|FG001|Overall Study|Physician Decision|1|||
170726484|NCT04302350|617003196|FG002|Overall Study|Physician Decision|2|||
170726485|NCT04302350|617003194|FG000|Overall Study|Lack of Efficacy|1|||
170726486|NCT04302350|617003195|FG001|Overall Study|Lack of Efficacy|1|||
170726487|NCT04302350|617003196|FG002|Overall Study|Lack of Efficacy|4|||
170726488|NCT04302350|617003194|FG000|Overall Study|Adverse Event|0|||
170726489|NCT04302350|617003195|FG001|Overall Study|Adverse Event|1|||
170726490|NCT04302350|617003196|FG002|Overall Study|Adverse Event|2|||
170726491|NCT02962908|617003199|FG000|Overall Study|Lost to Follow-up|0|||
170726492|NCT02962908|617003200|FG001|Overall Study|Lost to Follow-up|3|||
170726493|NCT02962908|617003201|FG002|Overall Study|Lost to Follow-up|0|||
170726494|NCT02962908|617003202|FG003|Overall Study|Lost to Follow-up|1|||
170726495|NCT02962908|617003199|FG000|Overall Study|Withdrawal by Subject|0|||
170726496|NCT02962908|617003200|FG001|Overall Study|Withdrawal by Subject|3|||
170726497|NCT02962908|617003201|FG002|Overall Study|Withdrawal by Subject|0|||
170726498|NCT02962908|617003202|FG003|Overall Study|Withdrawal by Subject|2|||
170726499|NCT02962908|617003199|FG000|Overall Study|Protocol Violation|0|||
170726500|NCT02962908|617003200|FG001|Overall Study|Protocol Violation|1|||
170726501|NCT02962908|617003201|FG002|Overall Study|Protocol Violation|0|||
170726502|NCT02962908|617003202|FG003|Overall Study|Protocol Violation|0|||
170726503|NCT02962908|617003199|FG000|Overall Study|Physician Decision|0|||
170726504|NCT02962908|617003200|FG001|Overall Study|Physician Decision|1|||
170726505|NCT02962908|617003201|FG002|Overall Study|Physician Decision|0|||
170726506|NCT02962908|617003202|FG003|Overall Study|Physician Decision|0|||
170726507|NCT06286332|617003203|FG000|Overall Study|Death|1|||
170726508|NCT06286332|617003204|FG001|Overall Study|Death|2|||
170726509|NCT06286332|617003203|FG000|Overall Study|Transfer to ICU|2|||
170726510|NCT06286332|617003204|FG001|Overall Study|Transfer to ICU|0|||
170726511|NCT06070987|617003205|FG000|first treatment|Withdrawal by Subject|1|||
170726512|NCT06070987|617003206|FG001|first treatment|Withdrawal by Subject|0|||
170726513|NCT06070987|617003205|FG000|first treatment|Lost to Follow-up|1|||
170726514|NCT06070987|617003206|FG001|first treatment|Lost to Follow-up|1|||
170726515|NCT06070987|617003205|FG000|first treatment|Protocol Violation|1|||
170726516|NCT06070987|617003206|FG001|first treatment|Protocol Violation|1|||
170726517|NCT06070987|617003205|FG000|wash out|did not participate in second treatment|2|||
170726518|NCT06070987|617003206|FG001|wash out|did not participate in second treatment|2|||
170726519|NCT06070987|617003205|FG000|second treatment|Withdrawal by Subject|1|||
170726520|NCT06070987|617003206|FG001|second treatment|Withdrawal by Subject|0|||
170726521|NCT06070987|617003205|FG000|second treatment|Lost to Follow-up|1|||
170726522|NCT06070987|617003206|FG001|second treatment|Lost to Follow-up|1|||
170726523|NCT00826540|617003214|FG000|Overall Study|ineligible|3|||
170726524|NCT00826540|617003214|FG000|Overall Study|Withdrawal by Subject|1|||
170726525|NCT01323530|617004762|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
170726526|NCT01323530|617004763|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170726527|NCT01323530|617004764|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170726528|NCT01323530|617004765|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170726529|NCT01323530|617004766|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170726530|NCT01323530|617004767|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
170726531|NCT01323530|617004768|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
170726532|NCT01323530|617004762|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
170726533|NCT01323530|617004763|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
170726534|NCT01323530|617004764|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
170726535|NCT01323530|617004765|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
170726536|NCT01323530|617004766|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
170726537|NCT01323530|617004767|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
170726538|NCT01323530|617004768|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
170726539|NCT01323530|617004762|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
170726540|NCT01323530|617004763|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
170726541|NCT01323530|617004764|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
170726542|NCT01323530|617004765|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
170726543|NCT01323530|617004766|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
170726544|NCT01323530|617004767|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
170726545|NCT01323530|617004768|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
170726546|NCT01323530|617004762|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
170726547|NCT01323530|617004763|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
170726548|NCT01323530|617004764|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
170726549|NCT01323530|617004765|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
170726550|NCT01323530|617004766|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
170726551|NCT01323530|617004767|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
170726552|NCT01323530|617004768|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
170726553|NCT01323530|617004762|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
170726554|NCT01323530|617004763|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
170726555|NCT01323530|617004764|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
170726556|NCT01323530|617004765|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
170726557|NCT01323530|617004766|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
170726558|NCT01323530|617004767|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
170726559|NCT01323530|617004768|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
170726560|NCT01323530|617004762|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
170726561|NCT01323530|617004763|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
170726562|NCT01323530|617004764|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
170726563|NCT01323530|617004765|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
170726564|NCT01323530|617004766|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
170726565|NCT01323530|617004767|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
170726566|NCT01323530|617004768|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
170726567|NCT01323530|617004762|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
170726568|NCT01323530|617004763|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
170726569|NCT01323530|617004764|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
170726570|NCT01323530|617004765|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
170726571|NCT01323530|617004766|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
170726572|NCT01323530|617004767|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
170726573|NCT01323530|617004768|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
170726574|NCT01323530|617004762|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
170726575|NCT01323530|617004763|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
170726576|NCT01323530|617004764|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
170726577|NCT01323530|617004765|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
170726578|NCT01323530|617004766|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
170726579|NCT01323530|617004767|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
170726580|NCT01323530|617004768|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
170726581|NCT01194570|617004771|FG000|Overall Study|Adverse Event|22|||
170726582|NCT01194570|617004772|FG001|Overall Study|Adverse Event|40|||
170726583|NCT01194570|617004771|FG000|Overall Study|Death|6|||
170726584|NCT01194570|617004772|FG001|Overall Study|Death|20|||
170726585|NCT01194570|617004771|FG000|Overall Study|Lack of Efficacy|32|||
170726586|NCT01194570|617004772|FG001|Overall Study|Lack of Efficacy|33|||
170726587|NCT01194570|617004771|FG000|Overall Study|Lost to Follow-up|4|||
170726588|NCT01194570|617004772|FG001|Overall Study|Lost to Follow-up|15|||
170726589|NCT01194570|617004771|FG000|Overall Study|Non-Compliance|2|||
170726590|NCT01194570|617004772|FG001|Overall Study|Non-Compliance|2|||
170726591|NCT01194570|617004771|FG000|Overall Study|Non-Compliance With Study Drug|2|||
170726592|NCT01194570|617004772|FG001|Overall Study|Non-Compliance With Study Drug|2|||
170726593|NCT01194570|617004771|FG000|Overall Study|Other|18|||
170726594|NCT01194570|617004772|FG001|Overall Study|Other|47|||
170726595|NCT01194570|617004771|FG000|Overall Study|Physician Decision|10|||
170726596|NCT01194570|617004772|FG001|Overall Study|Physician Decision|25|||
170726597|NCT01194570|617004771|FG000|Overall Study|Protocol Violation|1|||
170726598|NCT01194570|617004772|FG001|Overall Study|Protocol Violation|2|||
170726599|NCT01194570|617004771|FG000|Overall Study|Study Terminated By Sponsor|0|||
170726600|NCT01194570|617004772|FG001|Overall Study|Study Terminated By Sponsor|1|||
170726601|NCT01194570|617004771|FG000|Overall Study|Withdrawal by Subject|57|||
170726602|NCT01194570|617004772|FG001|Overall Study|Withdrawal by Subject|82|||
170726603|NCT01194570|617004771|FG000|Overall Study|Pregnancy|1|||
170726604|NCT01194570|617004772|FG001|Overall Study|Pregnancy|1|||
170726605|NCT01377480|617004779|FG000|Overall Study|Protocol Violation|0|||
170726606|NCT01377480|617004780|FG001|Overall Study|Protocol Violation|0|||
170726607|NCT01377480|617004781|FG002|Overall Study|Protocol Violation|0|||
170726608|NCT01377480|617004782|FG003|Overall Study|Protocol Violation|4|||
170726609|NCT01377480|617004779|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
170726610|NCT01377480|617004780|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
170726611|NCT01377480|617004781|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
170726612|NCT01377480|617004782|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
170726613|NCT01377480|617004779|FG000|Overall Study|Withdrawal by Subject|0|||
170726614|NCT01377480|617004780|FG001|Overall Study|Withdrawal by Subject|0|||
170726615|NCT01377480|617004781|FG002|Overall Study|Withdrawal by Subject|1|||
170726616|NCT01377480|617004782|FG003|Overall Study|Withdrawal by Subject|0|||
170726617|NCT01377480|617004779|FG000|Overall Study|Serious adverse event|0|||
170726618|NCT01377480|617004780|FG001|Overall Study|Serious adverse event|0|||
170726619|NCT01377480|617004781|FG002|Overall Study|Serious adverse event|1|||
170726620|NCT01377480|617004782|FG003|Overall Study|Serious adverse event|1|||
170726621|NCT01377480|617004779|FG000|Overall Study|Other|0|||
170726622|NCT01377480|617004780|FG001|Overall Study|Other|0|||
170726623|NCT01377480|617004781|FG002|Overall Study|Other|7|||
170726624|NCT01377480|617004782|FG003|Overall Study|Other|6|||
170726625|NCT02543658|617004783|FG000|Overall Study|Lack of Efficacy|0|||
170726626|NCT02543658|617004784|FG001|Overall Study|Lack of Efficacy|4|||
170726627|NCT01203930|617004796|FG000|Overall Study|Disease Progression|0|||
170726628|NCT01203930|617004797|FG001|Overall Study|Disease Progression|4|||
170726629|NCT01203930|617004796|FG000|Overall Study|Death|3|||
170726630|NCT01203930|617004797|FG001|Overall Study|Death|1|||
170726631|NCT01203930|617004796|FG000|Overall Study|Withdrew Consent|1|||
170726632|NCT01203930|617004797|FG001|Overall Study|Withdrew Consent|10|||
170726633|NCT01203930|617004796|FG000|Overall Study|Investigator Request|0|||
170726634|NCT01203930|617004797|FG001|Overall Study|Investigator Request|8|||
170726635|NCT01203930|617004796|FG000|Overall Study|Study Terminated by Sponsor|0|||
170726636|NCT01203930|617004797|FG001|Overall Study|Study Terminated by Sponsor|12|||
170726637|NCT01203930|617004796|FG000|Overall Study|Poor tolerance of study drug|0|||
170726638|NCT01203930|617004797|FG001|Overall Study|Poor tolerance of study drug|1|||
170726639|NCT01203930|617004796|FG000|Overall Study|Adverse Event|17|||
170726640|NCT01203930|617004797|FG001|Overall Study|Adverse Event|5|||
170726641|NCT02178059|617004798|FG000|Washout|Physician Decision|1|||
170726642|NCT02178059|617004799|FG001|Washout|Physician Decision|0|||
170726643|NCT01266850|617004802|FG000|Overall Study|Lost to Follow-up|19|||
170726644|NCT01266850|617004803|FG001|Overall Study|Lost to Follow-up|19|||
170726645|NCT01266850|617004804|FG002|Overall Study|Lost to Follow-up|13|||
170726646|NCT01266850|617004805|FG003|Overall Study|Lost to Follow-up|13|||
170726647|NCT01266850|617004806|FG004|Overall Study|Lost to Follow-up|12|||
170726648|NCT01266850|617004802|FG000|Overall Study|Withdrawal by Subject|8|||
170726649|NCT01266850|617004803|FG001|Overall Study|Withdrawal by Subject|9|||
170726650|NCT01266850|617004804|FG002|Overall Study|Withdrawal by Subject|6|||
170726651|NCT01266850|617004805|FG003|Overall Study|Withdrawal by Subject|9|||
170726652|NCT01266850|617004806|FG004|Overall Study|Withdrawal by Subject|12|||
170726653|NCT01266850|617004802|FG000|Overall Study|Physician Decision|3|||
170726654|NCT01266850|617004803|FG001|Overall Study|Physician Decision|6|||
170726655|NCT01266850|617004804|FG002|Overall Study|Physician Decision|4|||
170726656|NCT01266850|617004805|FG003|Overall Study|Physician Decision|4|||
170726657|NCT01266850|617004806|FG004|Overall Study|Physician Decision|3|||
170726658|NCT01266850|617004802|FG000|Overall Study|Protocol Violation|0|||
170726659|NCT01266850|617004803|FG001|Overall Study|Protocol Violation|1|||
170726660|NCT01266850|617004804|FG002|Overall Study|Protocol Violation|0|||
170726661|NCT01266850|617004805|FG003|Overall Study|Protocol Violation|1|||
170726662|NCT01266850|617004806|FG004|Overall Study|Protocol Violation|2|||
170726663|NCT01266850|617004802|FG000|Overall Study|Adverse Event|0|||
170726664|NCT01266850|617004803|FG001|Overall Study|Adverse Event|0|||
170726665|NCT01266850|617004804|FG002|Overall Study|Adverse Event|0|||
170726666|NCT01266850|617004805|FG003|Overall Study|Adverse Event|0|||
170726667|NCT01266850|617004806|FG004|Overall Study|Adverse Event|1|||
170726668|NCT01266850|617004802|FG000|Overall Study|Site Closure|0|||
170726669|NCT01266850|617004803|FG001|Overall Study|Site Closure|1|||
170726670|NCT01266850|617004804|FG002|Overall Study|Site Closure|1|||
170726671|NCT01266850|617004805|FG003|Overall Study|Site Closure|1|||
170726672|NCT01266850|617004806|FG004|Overall Study|Site Closure|0|||
170726673|NCT00499031|617004810|FG000|Overall Study|Improper pre-protocol treatment|1|||
170726674|NCT00499031|617004810|FG000|Overall Study|Required test not done|1|||
170726675|NCT00499031|617004810|FG000|Overall Study|Never treated|1|||
170726676|NCT02690974|617004813|FG000|Overall Study|Adverse Event|16|||
170726677|NCT02690974|617004813|FG000|Overall Study|Death|9|||
170726678|NCT02690974|617004813|FG000|Overall Study|Subject/guardian decision|4|||
170726679|NCT02690974|617004813|FG000|Overall Study|Lost to Follow-up|3|||
170726680|NCT02690974|617004813|FG000|Overall Study|Withdrawal of Informed Consent|3|||
170726681|NCT02690974|617004813|FG000|Overall Study|Physician Decision|2|||
170726682|NCT02690974|617004813|FG000|Overall Study|Non-compliance with study treatment|1|||
170726683|NCT02690974|617004813|FG000|Overall Study|Protocol-defined stopping criteria|1|||
170726684|NCT02690974|617004813|FG000|Overall Study|Protocol Deviation|1|||
170726685|NCT01666951|617004814|FG000|Overall Study|Not dosed|1|||
170726686|NCT01666951|617004815|FG001|Overall Study|Not dosed|1|||
170726687|NCT00234052|617004823|FG000|Treatment|Withdrawal by Subject|3|||
170726688|NCT00234052|617004823|FG000|Treatment|Adverse Event|5|||
170726689|NCT00234052|617004823|FG000|Treatment|Death|2|||
170726690|NCT00234052|617004823|FG000|Treatment|Progressive Disease|11|||
170726691|NCT00234052|617004823|FG000|Follow-up for 5 Years|Death|41|||
170726692|NCT00234052|617004823|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
170726693|NCT00234052|617004823|FG000|Follow-up for 5 Years|Other|7|||
170726694|NCT01410474|617004824|FG000|Overall Study|Withdrawal by Subject|0|||
170726695|NCT01410474|617004825|FG001|Overall Study|Withdrawal by Subject|1|||
170726696|NCT04493931|617004827|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
170726697|NCT04493931|617004828|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
170726698|NCT04493931|617004829|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
170726699|NCT04493931|617004830|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
170726700|NCT04493931|617004831|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
170726701|NCT04493931|617004832|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
170726702|NCT04493931|617004833|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
170726703|NCT04493931|617004827|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
170726704|NCT04493931|617004828|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
170726705|NCT04493931|617004829|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
170726706|NCT04493931|617004830|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
170726707|NCT04493931|617004831|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
170726708|NCT04493931|617004832|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
170726709|NCT04493931|617004833|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
170726710|NCT04493931|617004827|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
170726711|NCT04493931|617004828|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
170726712|NCT04493931|617004829|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
170726713|NCT04493931|617004830|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
170726714|NCT04493931|617004831|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
170726715|NCT04493931|617004832|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
170726716|NCT04493931|617004833|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
170726717|NCT04493931|617004827|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
170726718|NCT04493931|617004828|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
170726719|NCT04493931|617004829|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
170726720|NCT04493931|617004830|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
170726721|NCT04493931|617004831|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
170726722|NCT04493931|617004832|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
170726723|NCT04493931|617004833|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
170726724|NCT03338894|617004834|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
170726725|NCT02548455|617004835|FG000|Overall Study|Withdrawal by Subject|27|||
170726726|NCT02548455|617004835|FG000|Overall Study|Death|26|||
170726727|NCT02548455|617004835|FG000|Overall Study|Lost to Follow-up|14|||
170726728|NCT02548455|617004835|FG000|Overall Study|Visit not completed|173|||
170726729|NCT00420199|617004836|FG000|Overall Study|Participant no longer met study criteria|1|||
170726730|NCT00420199|617004837|FG001|Overall Study|Participant no longer met study criteria|0|||
170726731|NCT01292876|617004840|FG000|Overall Study|Physician Decision|4|||
170726732|NCT00917579|617004841|FG000|Washout >= 2 Weeks|Adverse Event|1|||
170726733|NCT00917579|617004842|FG001|Washout >= 2 Weeks|Adverse Event|0|||
170726734|NCT00917579|617004841|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
170726735|NCT00917579|617004842|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
170726736|NCT01137474|617004843|FG000|Overall Study|Adverse Event|3|||
170726737|NCT01137474|617004844|FG001|Overall Study|Adverse Event|5|||
170726738|NCT01137474|617004845|FG002|Overall Study|Adverse Event|1|||
170726739|NCT01137474|617004846|FG003|Overall Study|Adverse Event|3|||
170726740|NCT01137474|617004843|FG000|Overall Study|Withdrawal by Subject|7|||
170726741|NCT01137474|617004844|FG001|Overall Study|Withdrawal by Subject|2|||
170726742|NCT01137474|617004845|FG002|Overall Study|Withdrawal by Subject|6|||
170726743|NCT01137474|617004846|FG003|Overall Study|Withdrawal by Subject|9|||
170726744|NCT01137474|617004843|FG000|Overall Study|No longer met study criteria|6|||
170726745|NCT01137474|617004844|FG001|Overall Study|No longer met study criteria|1|||
170726746|NCT01137474|617004845|FG002|Overall Study|No longer met study criteria|0|||
170726747|NCT01137474|617004846|FG003|Overall Study|No longer met study criteria|5|||
170726748|NCT01137474|617004843|FG000|Overall Study|Lost to Follow-up|5|||
170726749|NCT01137474|617004844|FG001|Overall Study|Lost to Follow-up|1|||
170726750|NCT01137474|617004845|FG002|Overall Study|Lost to Follow-up|0|||
170726751|NCT01137474|617004846|FG003|Overall Study|Lost to Follow-up|2|||
170726752|NCT01137474|617004843|FG000|Overall Study|Lack of Efficacy|0|||
170726753|NCT01137474|617004844|FG001|Overall Study|Lack of Efficacy|0|||
170726754|NCT01137474|617004845|FG002|Overall Study|Lack of Efficacy|0|||
170726755|NCT01137474|617004846|FG003|Overall Study|Lack of Efficacy|2|||
170726756|NCT01137474|617004843|FG000|Overall Study|Other|3|||
170726757|NCT01137474|617004844|FG001|Overall Study|Other|1|||
170726758|NCT01137474|617004845|FG002|Overall Study|Other|0|||
170726759|NCT01137474|617004846|FG003|Overall Study|Other|0|||
170726760|NCT01137474|617004843|FG000|Overall Study|Pregnancy|0|||
170726761|NCT01137474|617004844|FG001|Overall Study|Pregnancy|1|||
170726762|NCT01137474|617004845|FG002|Overall Study|Pregnancy|0|||
170726763|NCT01137474|617004846|FG003|Overall Study|Pregnancy|0|||
170726764|NCT01137474|617004843|FG000|Overall Study|Administrative reason by sponsor|0|||
170726765|NCT01137474|617004844|FG001|Overall Study|Administrative reason by sponsor|1|||
170726766|NCT01137474|617004845|FG002|Overall Study|Administrative reason by sponsor|0|||
170726767|NCT01137474|617004846|FG003|Overall Study|Administrative reason by sponsor|0|||
170726768|NCT02794285|617004847|FG000|Overall Study|Adverse Event|11|||
170726769|NCT02794285|617004848|FG001|Overall Study|Adverse Event|4|||
170726770|NCT02794285|617004849|FG002|Overall Study|Adverse Event|5|||
170726771|NCT02794285|617004850|FG003|Overall Study|Adverse Event|8|||
170726772|NCT02794285|617004847|FG000|Overall Study|Condition Under Investigation Improved|1|||
170726773|NCT02794285|617004848|FG001|Overall Study|Condition Under Investigation Improved|0|||
170726774|NCT02794285|617004849|FG002|Overall Study|Condition Under Investigation Improved|0|||
170726775|NCT02794285|617004850|FG003|Overall Study|Condition Under Investigation Improved|0|||
170726776|NCT02794285|617004847|FG000|Overall Study|Condition Under Investigation Worsened|0|||
170726777|NCT02794285|617004848|FG001|Overall Study|Condition Under Investigation Worsened|2|||
170726778|NCT02794285|617004849|FG002|Overall Study|Condition Under Investigation Worsened|1|||
170726779|NCT02794285|617004850|FG003|Overall Study|Condition Under Investigation Worsened|0|||
170726780|NCT02794285|617004847|FG000|Overall Study|Death|2|||
170726781|NCT02794285|617004848|FG001|Overall Study|Death|1|||
170726782|NCT02794285|617004849|FG002|Overall Study|Death|2|||
170726783|NCT02794285|617004850|FG003|Overall Study|Death|0|||
170726784|NCT02794285|617004847|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
170726785|NCT02794285|617004848|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
170726786|NCT02794285|617004849|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
170726787|NCT02794285|617004850|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
170726788|NCT02794285|617004847|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
170726789|NCT02794285|617004848|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
170835511|NCT03721172|617405001|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
170835512|NCT03721172|617405002|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
170835513|NCT03721172|617405000|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
170835514|NCT03721172|617405001|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
170835515|NCT03721172|617405002|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
170835516|NCT03721172|617405000|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
170835517|NCT03721172|617405001|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
170835518|NCT03721172|617405002|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
170835519|NCT03721172|617405000|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
170835520|NCT03721172|617405001|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
170835521|NCT03721172|617405002|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
170835522|NCT03721172|617405000|FG000|Placebo-controlled Phase|Other|3|||
170835523|NCT03721172|617405001|FG001|Placebo-controlled Phase|Other|0|||
170835524|NCT03721172|617405002|FG002|Placebo-controlled Phase|Other|0|||
170835525|NCT03721172|617405000|FG000|Apremilast Extension Phase|Adverse Event|0|||
170835526|NCT03721172|617405001|FG001|Apremilast Extension Phase|Adverse Event|0|||
170835527|NCT03721172|617405002|FG002|Apremilast Extension Phase|Adverse Event|10|||
170835528|NCT03721172|617405000|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
170835529|NCT03721172|617405001|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
170835530|NCT03721172|617405002|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
170835531|NCT03721172|617405000|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
170835532|NCT03721172|617405001|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
170835533|NCT03721172|617405002|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
170835534|NCT03721172|617405000|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
170835535|NCT03721172|617405001|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
170835536|NCT03721172|617405002|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
170835537|NCT03721172|617405000|FG000|Apremilast Extension Phase|Protocol Violation|0|||
170835538|NCT03721172|617405001|FG001|Apremilast Extension Phase|Protocol Violation|0|||
170835539|NCT03721172|617405002|FG002|Apremilast Extension Phase|Protocol Violation|1|||
170835540|NCT03721172|617405000|FG000|Apremilast Extension Phase|Physician Decision|0|||
170835541|NCT03721172|617405001|FG001|Apremilast Extension Phase|Physician Decision|0|||
170835542|NCT03721172|617405002|FG002|Apremilast Extension Phase|Physician Decision|1|||
170835543|NCT03721172|617405000|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
170835544|NCT03721172|617405001|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
170835545|NCT03721172|617405002|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
170835546|NCT03721172|617405000|FG000|Apremilast Extension Phase|Other|0|||
170835547|NCT03721172|617405001|FG001|Apremilast Extension Phase|Other|0|||
170835548|NCT03721172|617405002|FG002|Apremilast Extension Phase|Other|3|||
170835549|NCT03721172|617405000|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
170835550|NCT03721172|617405001|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
170835551|NCT03721172|617405002|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
170835552|NCT01068210|617405003|FG000|Overall Study|Lost to Follow-up|1|||
170835553|NCT01068210|617405004|FG001|Overall Study|Lost to Follow-up|2|||
170835554|NCT01068210|617405005|FG002|Overall Study|Lost to Follow-up|2|||
170835555|NCT01068210|617405006|FG003|Overall Study|Lost to Follow-up|1|||
170835556|NCT01068210|617405003|FG000|Overall Study|Second cancer|0|||
170835557|NCT01068210|617405004|FG001|Overall Study|Second cancer|1|||
170835558|NCT01068210|617405005|FG002|Overall Study|Second cancer|0|||
170835559|NCT01068210|617405006|FG003|Overall Study|Second cancer|0|||
170835560|NCT01068210|617405003|FG000|Overall Study|Disease progression|0|||
170835561|NCT01068210|617405004|FG001|Overall Study|Disease progression|0|||
170835562|NCT01068210|617405005|FG002|Overall Study|Disease progression|0|||
170835563|NCT01068210|617405006|FG003|Overall Study|Disease progression|2|||
170835564|NCT03735121|617405010|FG000|Overall Study|Death|3|||
170835565|NCT03735121|617405011|FG001|Overall Study|Death|6|||
170835566|NCT03735121|617405012|FG002|Overall Study|Death|19|||
170835567|NCT03735121|617405013|FG003|Overall Study|Death|97|||
170835568|NCT03735121|617405014|FG004|Overall Study|Death|205|||
170835569|NCT03735121|617405010|FG000|Overall Study|Lost to Follow-up|0|||
170835570|NCT03735121|617405011|FG001|Overall Study|Lost to Follow-up|0|||
170835571|NCT03735121|617405012|FG002|Overall Study|Lost to Follow-up|0|||
170835572|NCT03735121|617405013|FG003|Overall Study|Lost to Follow-up|2|||
170835573|NCT03735121|617405014|FG004|Overall Study|Lost to Follow-up|3|||
170835574|NCT03735121|617405010|FG000|Overall Study|New Therapy|0|||
170835575|NCT03735121|617405011|FG001|Overall Study|New Therapy|1|||
170835576|NCT03735121|617405012|FG002|Overall Study|New Therapy|0|||
170835577|NCT03735121|617405013|FG003|Overall Study|New Therapy|0|||
170835578|NCT03735121|617405014|FG004|Overall Study|New Therapy|0|||
170835579|NCT03735121|617405010|FG000|Overall Study|Study Ended by Sponsor|1|||
170835580|NCT03735121|617405011|FG001|Overall Study|Study Ended by Sponsor|0|||
170726790|NCT02794285|617004849|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
170726791|NCT02794285|617004850|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
170726792|NCT02794285|617004847|FG000|Overall Study|Lack of Efficacy|10|||
170726793|NCT02794285|617004848|FG001|Overall Study|Lack of Efficacy|6|||
170726794|NCT02794285|617004849|FG002|Overall Study|Lack of Efficacy|3|||
170726795|NCT02794285|617004850|FG003|Overall Study|Lack of Efficacy|3|||
170726796|NCT02794285|617004847|FG000|Overall Study|Lost to Follow-up|5|||
170726797|NCT02794285|617004848|FG001|Overall Study|Lost to Follow-up|6|||
170726798|NCT02794285|617004849|FG002|Overall Study|Lost to Follow-up|3|||
170726799|NCT02794285|617004850|FG003|Overall Study|Lost to Follow-up|1|||
170726800|NCT02794285|617004847|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
170726801|NCT02794285|617004848|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
170726802|NCT02794285|617004849|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
170726803|NCT02794285|617004850|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
170726804|NCT02794285|617004847|FG000|Overall Study|Withdrawal by Subject|38|||
170726805|NCT02794285|617004848|FG001|Overall Study|Withdrawal by Subject|29|||
170726806|NCT02794285|617004849|FG002|Overall Study|Withdrawal by Subject|20|||
170726807|NCT02794285|617004850|FG003|Overall Study|Withdrawal by Subject|12|||
170726808|NCT02794285|617004847|FG000|Overall Study|Missing|1|||
170726809|NCT02794285|617004848|FG001|Overall Study|Missing|0|||
170726810|NCT02794285|617004849|FG002|Overall Study|Missing|0|||
170726811|NCT02794285|617004850|FG003|Overall Study|Missing|0|||
170726812|NCT02794285|617004847|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
170726813|NCT02794285|617004848|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
170726814|NCT02794285|617004849|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
170726815|NCT02794285|617004850|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
170726816|NCT02794285|617004847|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
170726817|NCT02794285|617004848|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
170726818|NCT02794285|617004849|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
170726819|NCT02794285|617004850|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
170726820|NCT00423176|617004851|FG000|Overall Study|Adverse Event|4|||
170726821|NCT00423176|617004852|FG001|Overall Study|Adverse Event|6|||
170726822|NCT00423176|617004851|FG000|Overall Study|Treatment Failure|1|||
170726823|NCT00423176|617004852|FG001|Overall Study|Treatment Failure|6|||
170726824|NCT00423176|617004851|FG000|Overall Study|Lost to Follow-up|4|||
170726825|NCT00423176|617004852|FG001|Overall Study|Lost to Follow-up|7|||
170726826|NCT00423176|617004851|FG000|Overall Study|Withdrawal by Subject|4|||
170726827|NCT00423176|617004852|FG001|Overall Study|Withdrawal by Subject|3|||
170835581|NCT03735121|617405012|FG002|Overall Study|Study Ended by Sponsor|1|||
170835582|NCT03735121|617405013|FG003|Overall Study|Study Ended by Sponsor|17|||
170835583|NCT03735121|617405014|FG004|Overall Study|Study Ended by Sponsor|28|||
170835584|NCT03735121|617405010|FG000|Overall Study|Withdrawal by Subject|1|||
170835585|NCT03735121|617405011|FG001|Overall Study|Withdrawal by Subject|1|||
170835586|NCT03735121|617405012|FG002|Overall Study|Withdrawal by Subject|6|||
170835587|NCT03735121|617405013|FG003|Overall Study|Withdrawal by Subject|8|||
170835588|NCT03735121|617405014|FG004|Overall Study|Withdrawal by Subject|11|||
170835589|NCT00815919|617405015|FG000|Overall Study|Unrelated Fungal Infection|1|||
170835590|NCT00815919|617405015|FG000|Overall Study|AML Relapse|1|||
170835591|NCT00815919|617405015|FG000|Overall Study|Lack of Efficacy|2|||
170835592|NCT02176863|617405016|FG000|Overall Study|Physician Decision|1|||
170835593|NCT02176863|617405017|FG001|Overall Study|Physician Decision|0|||
170835594|NCT02176863|617405018|FG002|Overall Study|Physician Decision|0|||
170835595|NCT02176863|617405019|FG003|Overall Study|Physician Decision|0|||
170835596|NCT02176863|617405020|FG004|Overall Study|Physician Decision|0|||
170835597|NCT02176863|617405016|FG000|Overall Study|Adverse Event|10|||
170835598|NCT02176863|617405017|FG001|Overall Study|Adverse Event|4|||
170835599|NCT02176863|617405018|FG002|Overall Study|Adverse Event|4|||
170835600|NCT02176863|617405019|FG003|Overall Study|Adverse Event|1|||
170726828|NCT00423176|617004851|FG000|Overall Study|Protocol Violation|1|||
170835601|NCT02176863|617405020|FG004|Overall Study|Adverse Event|1|||
170835602|NCT02176863|617405016|FG000|Overall Study|Protocol Violation|2|||
170835603|NCT02176863|617405017|FG001|Overall Study|Protocol Violation|0|||
170835604|NCT02176863|617405018|FG002|Overall Study|Protocol Violation|1|||
170726829|NCT00423176|617004852|FG001|Overall Study|Protocol Violation|3|||
170726830|NCT00423176|617004851|FG000|Overall Study|Did not meet protocol eligibility|2|||
170726831|NCT00423176|617004852|FG001|Overall Study|Did not meet protocol eligibility|4|||
170835605|NCT02176863|617405019|FG003|Overall Study|Protocol Violation|1|||
170835606|NCT02176863|617405020|FG004|Overall Study|Protocol Violation|0|||
170835607|NCT02176863|617405016|FG000|Overall Study|Withdrawal by Subject|4|||
170835608|NCT02176863|617405017|FG001|Overall Study|Withdrawal by Subject|2|||
170835609|NCT02176863|617405018|FG002|Overall Study|Withdrawal by Subject|2|||
170835610|NCT02176863|617405019|FG003|Overall Study|Withdrawal by Subject|3|||
170835611|NCT02176863|617405020|FG004|Overall Study|Withdrawal by Subject|4|||
170835612|NCT02176863|617405016|FG000|Overall Study|Reason not specified|0|||
170835613|NCT02176863|617405017|FG001|Overall Study|Reason not specified|1|||
170835614|NCT02176863|617405018|FG002|Overall Study|Reason not specified|1|||
170835615|NCT02176863|617405019|FG003|Overall Study|Reason not specified|2|||
170835616|NCT02176863|617405020|FG004|Overall Study|Reason not specified|1|||
170835617|NCT02176863|617405016|FG000|Overall Study|Lost to Follow-up|0|||
170835618|NCT02176863|617405017|FG001|Overall Study|Lost to Follow-up|1|||
170835619|NCT02176863|617405018|FG002|Overall Study|Lost to Follow-up|1|||
170835620|NCT02176863|617405019|FG003|Overall Study|Lost to Follow-up|0|||
170835621|NCT02176863|617405020|FG004|Overall Study|Lost to Follow-up|0|||
170835622|NCT04599907|617405021|FG000|Overall Study|Withdrawal by Subject|1|||
170726832|NCT05072080|617004854|FG000|Overall Study|Death|0|||
170726833|NCT05072080|617004855|FG001|Overall Study|Death|0|||
170726834|NCT05072080|617004856|FG002|Overall Study|Death|1|||
170726835|NCT05072080|617004857|FG003|Overall Study|Death|0|||
170726836|NCT05072080|617004854|FG000|Overall Study|Lost to Follow-up|65|||
170726837|NCT05072080|617004855|FG001|Overall Study|Lost to Follow-up|70|||
170726838|NCT05072080|617004856|FG002|Overall Study|Lost to Follow-up|58|||
170726839|NCT05072080|617004857|FG003|Overall Study|Lost to Follow-up|23|||
170726840|NCT05072080|617004854|FG000|Overall Study|Physician Decision|2|||
170726841|NCT05072080|617004855|FG001|Overall Study|Physician Decision|1|||
170726842|NCT05072080|617004856|FG002|Overall Study|Physician Decision|1|||
170726843|NCT05072080|617004857|FG003|Overall Study|Physician Decision|0|||
170726844|NCT05072080|617004854|FG000|Overall Study|Withdrawal by Subject|45|||
170726845|NCT05072080|617004855|FG001|Overall Study|Withdrawal by Subject|30|||
170726846|NCT05072080|617004856|FG002|Overall Study|Withdrawal by Subject|27|||
170726847|NCT05072080|617004857|FG003|Overall Study|Withdrawal by Subject|7|||
170726848|NCT05072080|617004854|FG000|Overall Study|Sponsor Decision|0|||
170726849|NCT05072080|617004855|FG001|Overall Study|Sponsor Decision|1|||
170726850|NCT05072080|617004856|FG002|Overall Study|Sponsor Decision|0|||
170726851|NCT05072080|617004857|FG003|Overall Study|Sponsor Decision|0|||
170726852|NCT05072080|617004854|FG000|Overall Study|Subject moved|1|||
170726853|NCT05072080|617004855|FG001|Overall Study|Subject moved|3|||
170726854|NCT05072080|617004856|FG002|Overall Study|Subject moved|5|||
170726855|NCT05072080|617004857|FG003|Overall Study|Subject moved|2|||
170726856|NCT05072080|617004854|FG000|Overall Study|Withdrawal by parent|0|||
170726857|NCT05072080|617004855|FG001|Overall Study|Withdrawal by parent|0|||
170726858|NCT05072080|617004856|FG002|Overall Study|Withdrawal by parent|1|||
170726859|NCT05072080|617004857|FG003|Overall Study|Withdrawal by parent|0|||
170726860|NCT05072080|617004854|FG000|Overall Study|Subject was deployed|0|||
170726861|NCT05072080|617004855|FG001|Overall Study|Subject was deployed|1|||
170726862|NCT05072080|617004856|FG002|Overall Study|Subject was deployed|0|||
170726863|NCT05072080|617004857|FG003|Overall Study|Subject was deployed|0|||
170726864|NCT05072080|617004854|FG000|Overall Study|Subject left site without receiving dose|0|||
170726865|NCT05072080|617004855|FG001|Overall Study|Subject left site without receiving dose|1|||
170726866|NCT05072080|617004856|FG002|Overall Study|Subject left site without receiving dose|0|||
170726867|NCT05072080|617004857|FG003|Overall Study|Subject left site without receiving dose|0|||
170726868|NCT05072080|617004854|FG000|Overall Study|Subject incarcerated|0|||
170726869|NCT05072080|617004855|FG001|Overall Study|Subject incarcerated|1|||
170726870|NCT05072080|617004856|FG002|Overall Study|Subject incarcerated|0|||
170726871|NCT05072080|617004857|FG003|Overall Study|Subject incarcerated|1|||
170726872|NCT05072080|617004854|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
170726873|NCT05072080|617004855|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
170726874|NCT05072080|617004856|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
170726875|NCT05072080|617004857|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
170835623|NCT04599907|617405022|FG001|Overall Study|Withdrawal by Subject|7|||
170835624|NCT04599907|617405023|FG002|Overall Study|Withdrawal by Subject|6|||
170835625|NCT04599907|617405021|FG000|Overall Study|Lost to Follow-up|0|||
170835626|NCT04599907|617405022|FG001|Overall Study|Lost to Follow-up|1|||
170835627|NCT04599907|617405023|FG002|Overall Study|Lost to Follow-up|0|||
170835628|NCT03007732|617405024|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
170726876|NCT05072080|617004854|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
170726877|NCT05072080|617004855|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
170726878|NCT05072080|617004856|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
170726879|NCT05072080|617004857|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
170726880|NCT06379893|617004873|FG000|Overall Study|Withdrawal by Subject|1|||
170726881|NCT06379893|617004873|FG000|Overall Study|Sponsors' decision|1|||
170726882|NCT03896035|617004875|FG000|Overall Study|Lost to Follow-up|2|||
170726883|NCT03896035|617004876|FG001|Overall Study|Lost to Follow-up|6|||
170726884|NCT03896035|617004875|FG000|Overall Study|Withdrawal by Subject|0|||
170726885|NCT03896035|617004876|FG001|Overall Study|Withdrawal by Subject|1|||
170726886|NCT03896035|617004875|FG000|Overall Study|Health/family health issues during COVID|0|||
170726887|NCT03896035|617004876|FG001|Overall Study|Health/family health issues during COVID|4|||
170726888|NCT01388816|617004880|FG000|Overall Study|Adverse Event|0|||
170726889|NCT01388816|617004881|FG001|Overall Study|Adverse Event|2|||
170726890|NCT01388816|617004882|FG002|Overall Study|Adverse Event|0|||
170726891|NCT01388816|617004883|FG003|Overall Study|Adverse Event|0|||
170726892|NCT01388816|617004880|FG000|Overall Study|Lost to Follow-up|0|||
170726893|NCT01388816|617004881|FG001|Overall Study|Lost to Follow-up|1|||
170726894|NCT01388816|617004882|FG002|Overall Study|Lost to Follow-up|0|||
170726895|NCT01388816|617004883|FG003|Overall Study|Lost to Follow-up|0|||
170726896|NCT01388816|617004880|FG000|Overall Study|Withdrawal by Subject|2|||
170726897|NCT01388816|617004881|FG001|Overall Study|Withdrawal by Subject|1|||
170726898|NCT01388816|617004882|FG002|Overall Study|Withdrawal by Subject|1|||
170726899|NCT01388816|617004883|FG003|Overall Study|Withdrawal by Subject|0|||
170726900|NCT01388816|617004880|FG000|Overall Study|Protocol Violation|0|||
170726901|NCT01388816|617004881|FG001|Overall Study|Protocol Violation|0|||
170726902|NCT01388816|617004882|FG002|Overall Study|Protocol Violation|2|||
170726903|NCT01388816|617004883|FG003|Overall Study|Protocol Violation|0|||
170726904|NCT00743366|617004884|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
170726905|NCT00743366|617004885|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
170726906|NCT00675766|617004890|FG000|Overall Study|Lost to Follow-up|6|||
170726907|NCT00675766|617004891|FG001|Overall Study|Lost to Follow-up|5|||
170726908|NCT00675766|617004892|FG002|Overall Study|Lost to Follow-up|21|||
170726909|NCT00675766|617004893|FG003|Overall Study|Lost to Follow-up|26|||
170726910|NCT02677116|617004896|FG000|Overall Study|Adverse Event|0|||
170726911|NCT02677116|617004897|FG001|Overall Study|Adverse Event|1|||
170726912|NCT02677116|617004898|FG002|Overall Study|Adverse Event|0|||
170726913|NCT02677116|617004899|FG003|Overall Study|Adverse Event|0|||
170726914|NCT02677116|617004900|FG004|Overall Study|Adverse Event|0|||
170726915|NCT02677116|617004901|FG005|Overall Study|Adverse Event|1|||
170726916|NCT02677116|617004902|FG006|Overall Study|Adverse Event|1|||
170726917|NCT02677116|617004903|FG007|Overall Study|Adverse Event|0|||
170726918|NCT02677116|617004904|FG008|Overall Study|Adverse Event|0|||
170726919|NCT02677116|617004896|FG000|Overall Study|Physician Decision|0|||
170726920|NCT02677116|617004897|FG001|Overall Study|Physician Decision|2|||
170726921|NCT02677116|617004898|FG002|Overall Study|Physician Decision|3|||
170726922|NCT02677116|617004899|FG003|Overall Study|Physician Decision|2|||
170726923|NCT02677116|617004900|FG004|Overall Study|Physician Decision|1|||
170726924|NCT02677116|617004901|FG005|Overall Study|Physician Decision|3|||
170726925|NCT02677116|617004902|FG006|Overall Study|Physician Decision|1|||
170726926|NCT02677116|617004903|FG007|Overall Study|Physician Decision|1|||
170726927|NCT02677116|617004904|FG008|Overall Study|Physician Decision|2|||
170726928|NCT02677116|617004896|FG000|Overall Study|Withdrawal by parent or guardian|2|||
170726929|NCT02677116|617004897|FG001|Overall Study|Withdrawal by parent or guardian|1|||
170726930|NCT02677116|617004898|FG002|Overall Study|Withdrawal by parent or guardian|0|||
170726931|NCT02677116|617004899|FG003|Overall Study|Withdrawal by parent or guardian|1|||
170726932|NCT02677116|617004900|FG004|Overall Study|Withdrawal by parent or guardian|0|||
170726933|NCT02677116|617004901|FG005|Overall Study|Withdrawal by parent or guardian|0|||
170726934|NCT02677116|617004902|FG006|Overall Study|Withdrawal by parent or guardian|2|||
170726935|NCT02677116|617004903|FG007|Overall Study|Withdrawal by parent or guardian|1|||
170726936|NCT02677116|617004904|FG008|Overall Study|Withdrawal by parent or guardian|0|||
170726937|NCT02677116|617004896|FG000|Overall Study|Withdrawal by Subject|1|||
170726938|NCT02677116|617004897|FG001|Overall Study|Withdrawal by Subject|0|||
170726939|NCT02677116|617004898|FG002|Overall Study|Withdrawal by Subject|0|||
170726940|NCT02677116|617004899|FG003|Overall Study|Withdrawal by Subject|0|||
170726941|NCT02677116|617004900|FG004|Overall Study|Withdrawal by Subject|0|||
170726942|NCT02677116|617004901|FG005|Overall Study|Withdrawal by Subject|0|||
170726943|NCT02677116|617004902|FG006|Overall Study|Withdrawal by Subject|0|||
170726944|NCT02677116|617004903|FG007|Overall Study|Withdrawal by Subject|0|||
170726945|NCT02677116|617004904|FG008|Overall Study|Withdrawal by Subject|0|||
170726946|NCT03213158|617004907|FG000|Overall Study|Withdrawal by Subject|1|||
170726947|NCT03213158|617004907|FG000|Overall Study|Physician Decision|2|||
170726948|NCT01569438|617004908|FG000|Overall Study|Lack of Efficacy|1|||
170726949|NCT01569438|617004909|FG001|Overall Study|Lack of Efficacy|2|||
170726950|NCT01569438|617004908|FG000|Overall Study|Withdrawal by Subject|0|||
170835629|NCT03007732|617405025|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
170835630|NCT03007732|617405026|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
170835631|NCT03007732|617405027|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
170835632|NCT04124471|617405028|FG000|Overall Study|screen failure|1|||
170835633|NCT03668223|617405029|FG000|Overall Study|Death|10|||
170835634|NCT03668223|617405030|FG001|Overall Study|Death|5|||
170835635|NCT03668223|617405029|FG000|Overall Study|Lost to Follow-up|12|||
170835636|NCT03668223|617405030|FG001|Overall Study|Lost to Follow-up|12|||
170835637|NCT03668223|617405029|FG000|Overall Study|Withdrawal by Subject|8|||
170835638|NCT03668223|617405030|FG001|Overall Study|Withdrawal by Subject|3|||
170835639|NCT05502783|617405031|FG000|Overall Study|Lack of Efficacy|1|||
170835640|NCT01190449|617405032|FG000|Overall Study|Ineligible|0|||
170835641|NCT01190449|617405033|FG001|Overall Study|Ineligible|4|||
170835642|NCT02419417|617407210|FG000|Overall Study|Disease progression|5|||
170835643|NCT02419417|617407211|FG001|Overall Study|Disease progression|4|||
170835644|NCT02419417|617407212|FG002|Overall Study|Disease progression|13|||
170835645|NCT02419417|617407213|FG003|Overall Study|Disease progression|10|||
170835646|NCT02419417|617407214|FG004|Overall Study|Disease progression|10|||
170835647|NCT02419417|617407215|FG005|Overall Study|Disease progression|3|||
170835648|NCT02419417|617407216|FG006|Overall Study|Disease progression|4|||
170835649|NCT02419417|617407217|FG007|Overall Study|Disease progression|5|||
170835650|NCT02419417|617407218|FG008|Overall Study|Disease progression|13|||
170835651|NCT02419417|617407219|FG009|Overall Study|Disease progression|9|||
170835652|NCT02419417|617407220|FG010|Overall Study|Disease progression|0|||
170835653|NCT02419417|617407210|FG000|Overall Study|Study drug toxicity|0|||
170835654|NCT02419417|617407211|FG001|Overall Study|Study drug toxicity|0|||
170835655|NCT02419417|617407212|FG002|Overall Study|Study drug toxicity|0|||
170835656|NCT02419417|617407213|FG003|Overall Study|Study drug toxicity|0|||
170835657|NCT02419417|617407214|FG004|Overall Study|Study drug toxicity|1|||
170835658|NCT02419417|617407215|FG005|Overall Study|Study drug toxicity|0|||
170835659|NCT02419417|617407216|FG006|Overall Study|Study drug toxicity|0|||
170835660|NCT02419417|617407217|FG007|Overall Study|Study drug toxicity|0|||
170835661|NCT02419417|617407218|FG008|Overall Study|Study drug toxicity|0|||
170835662|NCT02419417|617407219|FG009|Overall Study|Study drug toxicity|0|||
170835663|NCT02419417|617407220|FG010|Overall Study|Study drug toxicity|0|||
170835664|NCT02419417|617407210|FG000|Overall Study|Adverse event unrelated to study drug|0|||
170835665|NCT02419417|617407211|FG001|Overall Study|Adverse event unrelated to study drug|0|||
170835666|NCT02419417|617407212|FG002|Overall Study|Adverse event unrelated to study drug|0|||
170835667|NCT02419417|617407213|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170835668|NCT02419417|617407214|FG004|Overall Study|Adverse event unrelated to study drug|2|||
170835669|NCT02419417|617407215|FG005|Overall Study|Adverse event unrelated to study drug|1|||
170835670|NCT02419417|617407216|FG006|Overall Study|Adverse event unrelated to study drug|0|||
170835671|NCT02419417|617407217|FG007|Overall Study|Adverse event unrelated to study drug|1|||
170835672|NCT02419417|617407218|FG008|Overall Study|Adverse event unrelated to study drug|0|||
170835673|NCT02419417|617407219|FG009|Overall Study|Adverse event unrelated to study drug|0|||
170835674|NCT02419417|617407220|FG010|Overall Study|Adverse event unrelated to study drug|0|||
170835675|NCT02419417|617407210|FG000|Overall Study|Participant request to discontinue|0|||
170835676|NCT02419417|617407211|FG001|Overall Study|Participant request to discontinue|0|||
170835677|NCT02419417|617407212|FG002|Overall Study|Participant request to discontinue|0|||
170835678|NCT02419417|617407213|FG003|Overall Study|Participant request to discontinue|0|||
170835679|NCT02419417|617407214|FG004|Overall Study|Participant request to discontinue|0|||
170835680|NCT02419417|617407215|FG005|Overall Study|Participant request to discontinue|0|||
170835681|NCT02419417|617407216|FG006|Overall Study|Participant request to discontinue|0|||
170835682|NCT02419417|617407217|FG007|Overall Study|Participant request to discontinue|0|||
170835683|NCT02419417|617407218|FG008|Overall Study|Participant request to discontinue|0|||
170835684|NCT02419417|617407219|FG009|Overall Study|Participant request to discontinue|1|||
170835685|NCT02419417|617407220|FG010|Overall Study|Participant request to discontinue|0|||
170835686|NCT02419417|617407210|FG000|Overall Study|Withdrawal by Subject|0|||
170835687|NCT02419417|617407211|FG001|Overall Study|Withdrawal by Subject|0|||
170835688|NCT02419417|617407212|FG002|Overall Study|Withdrawal by Subject|0|||
170835689|NCT02419417|617407213|FG003|Overall Study|Withdrawal by Subject|0|||
170835690|NCT02419417|617407214|FG004|Overall Study|Withdrawal by Subject|0|||
170835691|NCT02419417|617407215|FG005|Overall Study|Withdrawal by Subject|0|||
170835692|NCT02419417|617407216|FG006|Overall Study|Withdrawal by Subject|0|||
170835693|NCT02419417|617407217|FG007|Overall Study|Withdrawal by Subject|0|||
170835694|NCT02419417|617407218|FG008|Overall Study|Withdrawal by Subject|0|||
170835695|NCT02419417|617407219|FG009|Overall Study|Withdrawal by Subject|0|||
170835696|NCT02419417|617407220|FG010|Overall Study|Withdrawal by Subject|1|||
170726951|NCT01569438|617004909|FG001|Overall Study|Withdrawal by Subject|3|||
170726952|NCT01569438|617004908|FG000|Overall Study|Adverse Event|2|||
170726953|NCT01569438|617004909|FG001|Overall Study|Adverse Event|15|||
170726954|NCT01569438|617004908|FG000|Overall Study|Protocol Violation|2|||
170726955|NCT01569438|617004909|FG001|Overall Study|Protocol Violation|0|||
170726956|NCT01569438|617004908|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
170726957|NCT01569438|617004909|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
170726958|NCT01569438|617004908|FG000|Overall Study|Sponsor/Physician decision|1|||
170726959|NCT01569438|617004909|FG001|Overall Study|Sponsor/Physician decision|1|||
170726960|NCT01569438|617004908|FG000|Overall Study|Unable to adhere to study schedule|0|||
170726961|NCT01569438|617004909|FG001|Overall Study|Unable to adhere to study schedule|1|||
170726962|NCT01207102|617004910|FG000|Overall Study|Withdrawal by Subject|5|||
170726963|NCT01207102|617004910|FG000|Overall Study|Adverse Event|2|||
170726964|NCT01207102|617004910|FG000|Overall Study|progression|2|||
170726965|NCT01207102|617004910|FG000|Overall Study|Withdrawal by Treating Physician|1|||
170726966|NCT01018394|617004911|FG000|Overall Study|Withdrawal by Subject|5|||
170726967|NCT01018394|617004912|FG001|Overall Study|Withdrawal by Subject|5|||
170726968|NCT01018394|617004911|FG000|Overall Study|Lost to Follow-up|4|||
170726969|NCT01018394|617004912|FG001|Overall Study|Lost to Follow-up|3|||
170726970|NCT00983073|617004913|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
170726971|NCT00983073|617004913|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
170726972|NCT00983073|617004913|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
170726973|NCT00983073|617004913|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
170726974|NCT00983073|617004913|FG000|Titration and Optimal Dose Period|Other reason|4|||
170726975|NCT00983073|617004913|FG000|Maintenance Period|Adverse Event|5|||
170726976|NCT00983073|617004913|FG000|Maintenance Period|Withdrawal by Subject|2|||
170726977|NCT00983073|617004913|FG000|Maintenance Period|Lack of Efficacy|2|||
170726978|NCT00983073|617004913|FG000|Maintenance Period|Other Reason|7|||
170726979|NCT02077166|617004914|FG000|Overall Study|Death|6|||
170726980|NCT02077166|617004915|FG001|Overall Study|Death|7|||
170726981|NCT02077166|617004916|FG002|Overall Study|Death|5|||
170726982|NCT02077166|617004917|FG003|Overall Study|Death|6|||
170726983|NCT02077166|617004918|FG004|Overall Study|Death|4|||
170726984|NCT02077166|617004919|FG005|Overall Study|Death|32|||
170726985|NCT02077166|617004920|FG006|Overall Study|Death|22|||
170726986|NCT02077166|617004914|FG000|Overall Study|Study Closure by Sponsor|3|||
170726987|NCT02077166|617004915|FG001|Overall Study|Study Closure by Sponsor|0|||
170726988|NCT02077166|617004916|FG002|Overall Study|Study Closure by Sponsor|2|||
170726989|NCT02077166|617004917|FG003|Overall Study|Study Closure by Sponsor|2|||
170726990|NCT02077166|617004918|FG004|Overall Study|Study Closure by Sponsor|2|||
170726991|NCT02077166|617004919|FG005|Overall Study|Study Closure by Sponsor|12|||
170726992|NCT02077166|617004920|FG006|Overall Study|Study Closure by Sponsor|4|||
170726993|NCT02077166|617004914|FG000|Overall Study|Lost to Follow-up|0|||
170726994|NCT02077166|617004915|FG001|Overall Study|Lost to Follow-up|0|||
170726995|NCT02077166|617004916|FG002|Overall Study|Lost to Follow-up|0|||
170726996|NCT02077166|617004917|FG003|Overall Study|Lost to Follow-up|0|||
170726997|NCT02077166|617004918|FG004|Overall Study|Lost to Follow-up|0|||
170726998|NCT02077166|617004919|FG005|Overall Study|Lost to Follow-up|1|||
170726999|NCT02077166|617004920|FG006|Overall Study|Lost to Follow-up|0|||
170727000|NCT02077166|617004914|FG000|Overall Study|Withdrawal by Subject|3|||
170727001|NCT02077166|617004915|FG001|Overall Study|Withdrawal by Subject|0|||
170727002|NCT02077166|617004916|FG002|Overall Study|Withdrawal by Subject|1|||
170727003|NCT02077166|617004917|FG003|Overall Study|Withdrawal by Subject|1|||
170727004|NCT02077166|617004918|FG004|Overall Study|Withdrawal by Subject|1|||
170727005|NCT02077166|617004919|FG005|Overall Study|Withdrawal by Subject|3|||
170727006|NCT02077166|617004920|FG006|Overall Study|Withdrawal by Subject|0|||
170727007|NCT02077166|617004914|FG000|Overall Study|Other, Not Specified|0|||
170727008|NCT02077166|617004915|FG001|Overall Study|Other, Not Specified|0|||
170727009|NCT02077166|617004916|FG002|Overall Study|Other, Not Specified|1|||
170727010|NCT02077166|617004917|FG003|Overall Study|Other, Not Specified|0|||
170727011|NCT02077166|617004918|FG004|Overall Study|Other, Not Specified|1|||
170727012|NCT02077166|617004919|FG005|Overall Study|Other, Not Specified|7|||
170727013|NCT02077166|617004920|FG006|Overall Study|Other, Not Specified|8|||
170727014|NCT01951625|617004922|FG000|Treatment Period|Protocol Violation|2|||
170727015|NCT01951625|617004923|FG001|Treatment Period|Protocol Violation|0|||
170727016|NCT01951625|617004924|FG002|Treatment Period|Protocol Violation|1|||
170727017|NCT01951625|617004925|FG003|Treatment Period|Protocol Violation|3|||
170727018|NCT01951625|617004926|FG004|Treatment Period|Protocol Violation|2|||
170727019|NCT01951625|617004922|FG000|Treatment Period|Physician Decision|0|||
170727020|NCT01951625|617004923|FG001|Treatment Period|Physician Decision|0|||
170727021|NCT01951625|617004924|FG002|Treatment Period|Physician Decision|0|||
170727022|NCT01951625|617004925|FG003|Treatment Period|Physician Decision|0|||
170727023|NCT01951625|617004926|FG004|Treatment Period|Physician Decision|1|||
170727024|NCT01951625|617004922|FG000|Treatment Period|Protocol driven decision point|0|||
170727025|NCT01951625|617004923|FG001|Treatment Period|Protocol driven decision point|5|||
170727026|NCT01951625|617004924|FG002|Treatment Period|Protocol driven decision point|0|||
170727027|NCT01951625|617004925|FG003|Treatment Period|Protocol driven decision point|2|||
170727028|NCT01951625|617004926|FG004|Treatment Period|Protocol driven decision point|1|||
170727029|NCT01951625|617004922|FG000|Treatment Period|Non compliance with study drug|1|||
170727030|NCT01951625|617004923|FG001|Treatment Period|Non compliance with study drug|2|||
170727031|NCT01951625|617004924|FG002|Treatment Period|Non compliance with study drug|2|||
170727032|NCT01951625|617004925|FG003|Treatment Period|Non compliance with study drug|0|||
170727033|NCT01951625|617004926|FG004|Treatment Period|Non compliance with study drug|0|||
170727034|NCT01951625|617004922|FG000|Treatment Period|Death|3|||
170727035|NCT01951625|617004923|FG001|Treatment Period|Death|2|||
170727036|NCT01951625|617004924|FG002|Treatment Period|Death|2|||
170727037|NCT01951625|617004925|FG003|Treatment Period|Death|1|||
170727038|NCT01951625|617004926|FG004|Treatment Period|Death|2|||
170727039|NCT01951625|617004922|FG000|Treatment Period|Adverse Event|7|||
170727040|NCT01951625|617004923|FG001|Treatment Period|Adverse Event|10|||
170727041|NCT01951625|617004924|FG002|Treatment Period|Adverse Event|9|||
170727042|NCT01951625|617004925|FG003|Treatment Period|Adverse Event|8|||
170727043|NCT01951625|617004926|FG004|Treatment Period|Adverse Event|8|||
170727044|NCT01951625|617004922|FG000|Treatment Period|Withdrawal by Subject|5|||
170727045|NCT01951625|617004923|FG001|Treatment Period|Withdrawal by Subject|2|||
170727046|NCT01951625|617004924|FG002|Treatment Period|Withdrawal by Subject|1|||
170727047|NCT01951625|617004925|FG003|Treatment Period|Withdrawal by Subject|7|||
170727048|NCT01951625|617004926|FG004|Treatment Period|Withdrawal by Subject|3|||
170727049|NCT01951625|617004922|FG000|Treatment Period|Lost to Follow-up|1|||
170727050|NCT01951625|617004923|FG001|Treatment Period|Lost to Follow-up|0|||
170727051|NCT01951625|617004924|FG002|Treatment Period|Lost to Follow-up|0|||
170727052|NCT01951625|617004925|FG003|Treatment Period|Lost to Follow-up|1|||
170727053|NCT01951625|617004926|FG004|Treatment Period|Lost to Follow-up|0|||
170727054|NCT01951625|617004922|FG000|Follow Up Period|Non-compliance with study drug|1|||
170727055|NCT01951625|617004923|FG001|Follow Up Period|Non-compliance with study drug|0|||
170727056|NCT01951625|617004924|FG002|Follow Up Period|Non-compliance with study drug|0|||
170727057|NCT01951625|617004925|FG003|Follow Up Period|Non-compliance with study drug|0|||
170727058|NCT01951625|617004926|FG004|Follow Up Period|Non-compliance with study drug|0|||
170727059|NCT01951625|617004922|FG000|Follow Up Period|Death|1|||
170727060|NCT01951625|617004923|FG001|Follow Up Period|Death|3|||
170727061|NCT01951625|617004924|FG002|Follow Up Period|Death|2|||
170727062|NCT01951625|617004925|FG003|Follow Up Period|Death|2|||
170727063|NCT01951625|617004926|FG004|Follow Up Period|Death|1|||
170727064|NCT01951625|617004922|FG000|Follow Up Period|Logistical difficulties|1|||
170727065|NCT01951625|617004923|FG001|Follow Up Period|Logistical difficulties|2|||
170727066|NCT01951625|617004924|FG002|Follow Up Period|Logistical difficulties|0|||
170727067|NCT01951625|617004925|FG003|Follow Up Period|Logistical difficulties|0|||
170727068|NCT01951625|617004926|FG004|Follow Up Period|Logistical difficulties|0|||
170727069|NCT01951625|617004922|FG000|Follow Up Period|Adverse Event|0|||
170727070|NCT01951625|617004923|FG001|Follow Up Period|Adverse Event|3|||
170727071|NCT01951625|617004924|FG002|Follow Up Period|Adverse Event|2|||
170727072|NCT01951625|617004925|FG003|Follow Up Period|Adverse Event|3|||
170727073|NCT01951625|617004926|FG004|Follow Up Period|Adverse Event|5|||
170727074|NCT01951625|617004922|FG000|Follow Up Period|Withdrawal by Subject|4|||
170727075|NCT01951625|617004923|FG001|Follow Up Period|Withdrawal by Subject|1|||
170727076|NCT01951625|617004924|FG002|Follow Up Period|Withdrawal by Subject|0|||
170727077|NCT01951625|617004925|FG003|Follow Up Period|Withdrawal by Subject|5|||
170727078|NCT01951625|617004926|FG004|Follow Up Period|Withdrawal by Subject|3|||
170727079|NCT01951625|617004922|FG000|Follow Up Period|Lost to Follow-up|1|||
170727080|NCT01951625|617004923|FG001|Follow Up Period|Lost to Follow-up|0|||
170727081|NCT01951625|617004924|FG002|Follow Up Period|Lost to Follow-up|0|||
170727082|NCT01951625|617004925|FG003|Follow Up Period|Lost to Follow-up|1|||
170727083|NCT01951625|617004926|FG004|Follow Up Period|Lost to Follow-up|1|||
170727084|NCT00857207|617006164|FG000|Overall Study|Withdrawal by Subject|13|||
170727085|NCT00857207|617006165|FG001|Overall Study|Withdrawal by Subject|0|||
170727086|NCT00857207|617006164|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
170727087|NCT00857207|617006165|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
170727088|NCT00857207|617006164|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
170727089|NCT00857207|617006165|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
170727090|NCT02030015|617006166|FG000|Overall Study|Withdrawal by Subject|3|||
170727091|NCT02030015|617006166|FG000|Overall Study|Death|13|||
170727092|NCT04098406|617006167|FG000|Overall Study|Adverse Event|2|||
170727093|NCT04098406|617006168|FG001|Overall Study|Adverse Event|1|||
170727094|NCT04098406|617006167|FG000|Overall Study|Withdrawal by Subject|1|||
170727095|NCT04098406|617006168|FG001|Overall Study|Withdrawal by Subject|0|||
170727096|NCT03014674|617006169|FG000|Overall Study|Withdrawal by Subject|1|||
170727097|NCT03014674|617006170|FG001|Overall Study|Withdrawal by Subject|0|||
170727098|NCT03014674|617006171|FG002|Overall Study|Withdrawal by Subject|0|||
170727099|NCT01332227|617006172|FG000|Overall Study|Adverse Event|4|||
170727100|NCT01332227|617006173|FG001|Overall Study|Adverse Event|1|||
170727101|NCT01332227|617006172|FG000|Overall Study|Withdrawal by Subject|5|||
170727102|NCT01332227|617006173|FG001|Overall Study|Withdrawal by Subject|1|||
170727103|NCT01332227|617006172|FG000|Overall Study|Lost to Follow-up|2|||
170727104|NCT01332227|617006173|FG001|Overall Study|Lost to Follow-up|0|||
170727105|NCT01332227|617006172|FG000|Overall Study|Lack of Efficacy|3|||
170727106|NCT01332227|617006173|FG001|Overall Study|Lack of Efficacy|1|||
170727107|NCT01332227|617006172|FG000|Overall Study|Poor compliance/noncompliance|1|||
170835697|NCT01443403|617407221|FG000|Overall Study|Adverse Event|1|||
170835698|NCT01443403|617407222|FG001|Overall Study|Adverse Event|1|||
170835699|NCT01443403|617407223|FG002|Overall Study|Adverse Event|4|||
170835700|NCT01443403|617407224|FG003|Overall Study|Adverse Event|5|||
170835701|NCT01443403|617407221|FG000|Overall Study|Withdrawal by Subject|0|||
170835702|NCT01443403|617407222|FG001|Overall Study|Withdrawal by Subject|1|||
170835703|NCT01443403|617407223|FG002|Overall Study|Withdrawal by Subject|2|||
170835704|NCT01443403|617407224|FG003|Overall Study|Withdrawal by Subject|1|||
170835705|NCT01443403|617407221|FG000|Overall Study|Lost to Follow-up|0|||
170835706|NCT01443403|617407222|FG001|Overall Study|Lost to Follow-up|0|||
170835707|NCT01443403|617407223|FG002|Overall Study|Lost to Follow-up|0|||
170835708|NCT01443403|617407224|FG003|Overall Study|Lost to Follow-up|1|||
170835709|NCT01443403|617407221|FG000|Overall Study|Protocol Violation|2|||
170835710|NCT01443403|617407222|FG001|Overall Study|Protocol Violation|1|||
170835711|NCT01443403|617407223|FG002|Overall Study|Protocol Violation|1|||
170835712|NCT01443403|617407224|FG003|Overall Study|Protocol Violation|1|||
170835713|NCT01443403|617407221|FG000|Overall Study|Use of Prohibited Treatment|2|||
170835714|NCT01443403|617407222|FG001|Overall Study|Use of Prohibited Treatment|3|||
170835715|NCT01443403|617407223|FG002|Overall Study|Use of Prohibited Treatment|0|||
170835716|NCT01443403|617407224|FG003|Overall Study|Use of Prohibited Treatment|0|||
170835717|NCT01443403|617407221|FG000|Overall Study|Other - Miscellaneous|1|||
170835718|NCT01443403|617407222|FG001|Overall Study|Other - Miscellaneous|0|||
170835719|NCT01443403|617407223|FG002|Overall Study|Other - Miscellaneous|0|||
170835720|NCT01443403|617407224|FG003|Overall Study|Other - Miscellaneous|1|||
170835721|NCT00725712|617407227|FG000|Overall Study|Withdrawal by Subject|2|||
170835722|NCT00725712|617407228|FG001|Overall Study|Withdrawal by Subject|1|||
170835723|NCT00725712|617407227|FG000|Overall Study|Protocol Violation|1|||
170835724|NCT00725712|617407228|FG001|Overall Study|Protocol Violation|0|||
170835725|NCT00725712|617407227|FG000|Overall Study|Progressive disease|37|||
170835726|NCT00725712|617407228|FG001|Overall Study|Progressive disease|16|||
170835727|NCT00725712|617407227|FG000|Overall Study|Clinical progression not based on RECIST|0|||
170835728|NCT00725712|617407228|FG001|Overall Study|Clinical progression not based on RECIST|3|||
170835729|NCT00725712|617407227|FG000|Overall Study|Adverse Event|5|||
170835730|NCT00725712|617407228|FG001|Overall Study|Adverse Event|5|||
170835731|NCT00725712|617407227|FG000|Overall Study|Death|2|||
170835732|NCT00725712|617407228|FG001|Overall Study|Death|0|||
170835733|NCT00725712|617407227|FG000|Overall Study|Other: Death|1|||
170835734|NCT00725712|617407228|FG001|Overall Study|Other: Death|0|||
170835735|NCT00725712|617407227|FG000|Overall Study|Hospitalized, unable to continue|0|||
170835736|NCT00725712|617407228|FG001|Overall Study|Hospitalized, unable to continue|1|||
170835737|NCT03607422|617407232|FG000|Overall Study|Adverse Event|7|||
170835738|NCT03607422|617407233|FG001|Overall Study|Adverse Event|3|||
170835739|NCT03607422|617407234|FG002|Overall Study|Adverse Event|2|||
170835740|NCT03607422|617407235|FG003|Overall Study|Adverse Event|0|||
170835741|NCT03607422|617407236|FG004|Overall Study|Adverse Event|2|||
170835742|NCT03607422|617407237|FG005|Overall Study|Adverse Event|0|||
170835743|NCT03607422|617407232|FG000|Overall Study|Withdrawal by Subject|11|||
170835744|NCT03607422|617407233|FG001|Overall Study|Withdrawal by Subject|3|||
170835745|NCT03607422|617407234|FG002|Overall Study|Withdrawal by Subject|6|||
170835746|NCT03607422|617407235|FG003|Overall Study|Withdrawal by Subject|2|||
170835747|NCT03607422|617407236|FG004|Overall Study|Withdrawal by Subject|0|||
170835748|NCT03607422|617407237|FG005|Overall Study|Withdrawal by Subject|0|||
170835749|NCT03607422|617407232|FG000|Overall Study|Lost to Follow-up|0|||
170835750|NCT03607422|617407233|FG001|Overall Study|Lost to Follow-up|0|||
170835751|NCT03607422|617407234|FG002|Overall Study|Lost to Follow-up|1|||
170835752|NCT03607422|617407235|FG003|Overall Study|Lost to Follow-up|0|||
170835753|NCT03607422|617407236|FG004|Overall Study|Lost to Follow-up|0|||
170835754|NCT03607422|617407237|FG005|Overall Study|Lost to Follow-up|0|||
170835755|NCT03607422|617407232|FG000|Overall Study|Other|12|||
170835756|NCT03607422|617407233|FG001|Overall Study|Other|4|||
170835757|NCT03607422|617407234|FG002|Overall Study|Other|1|||
170835758|NCT03607422|617407235|FG003|Overall Study|Other|2|||
170835759|NCT03607422|617407236|FG004|Overall Study|Other|0|||
170835760|NCT03607422|617407237|FG005|Overall Study|Other|2|||
170835761|NCT03607422|617407232|FG000|Overall Study|Ongoing at Time of Analysis|8|||
170835762|NCT03607422|617407233|FG001|Overall Study|Ongoing at Time of Analysis|0|||
170835763|NCT03607422|617407234|FG002|Overall Study|Ongoing at Time of Analysis|2|||
170835764|NCT03607422|617407235|FG003|Overall Study|Ongoing at Time of Analysis|1|||
170835765|NCT03607422|617407236|FG004|Overall Study|Ongoing at Time of Analysis|1|||
170835766|NCT03607422|617407237|FG005|Overall Study|Ongoing at Time of Analysis|1|||
170835767|NCT01920932|617407240|FG000|Overall Study|Death|1|||
170835768|NCT01920932|617407240|FG000|Overall Study|Withdrawal of consent|1|||
170835769|NCT00983749|617407241|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
170835770|NCT00983749|617407242|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
170835771|NCT02375347|617407243|FG000|Overall Study|Protocol Violation|1|||
170835772|NCT00425607|617407244|FG000|Overall Study|Death|1|||
170835773|NCT00425607|617407244|FG000|Overall Study|Withdrawal by Subject|1|||
170835774|NCT00193479|617407245|FG000|Induction Chemotherapy|Adverse Event|2|||
170835775|NCT00193479|617407245|FG000|Induction Chemotherapy|Disease Progression|1|||
170835776|NCT00193479|617407245|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
170835777|NCT00193479|617407245|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
170835778|NCT00079339|617407246|FG000|Overall Study|Adverse Event|1|||
170835779|NCT00079339|617407247|FG001|Overall Study|Adverse Event|7|||
170835780|NCT00079339|617407248|FG002|Overall Study|Adverse Event|2|||
170835781|NCT00079339|617407246|FG000|Overall Study|Death|1|||
170835782|NCT00079339|617407247|FG001|Overall Study|Death|0|||
170835783|NCT00079339|617407248|FG002|Overall Study|Death|0|||
170835784|NCT00079339|617407246|FG000|Overall Study|Non-compliance|0|||
170835785|NCT00079339|617407247|FG001|Overall Study|Non-compliance|0|||
170835786|NCT00079339|617407248|FG002|Overall Study|Non-compliance|1|||
170835787|NCT00079339|617407246|FG000|Overall Study|Withdrawal by Subject|0|||
170835788|NCT00079339|617407247|FG001|Overall Study|Withdrawal by Subject|4|||
170835789|NCT00079339|617407248|FG002|Overall Study|Withdrawal by Subject|1|||
170835790|NCT00079339|617407246|FG000|Overall Study|Disease progression|3|||
170835791|NCT00079339|617407247|FG001|Overall Study|Disease progression|28|||
170835792|NCT00079339|617407248|FG002|Overall Study|Disease progression|2|||
170835793|NCT02563548|617407250|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
170835794|NCT02563548|617407251|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
170835795|NCT02563548|617407252|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
170835796|NCT02563548|617407253|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
170835797|NCT02563548|617407254|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
170835798|NCT02563548|617407255|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
170835799|NCT02563548|617407250|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
170835800|NCT02563548|617407251|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
170835801|NCT02563548|617407252|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
170835802|NCT02563548|617407253|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
170835803|NCT02563548|617407254|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
170835804|NCT02563548|617407255|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
170835805|NCT02563548|617407250|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
170835806|NCT02563548|617407251|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
170835807|NCT02563548|617407252|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
170835808|NCT02563548|617407253|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
170835809|NCT02563548|617407254|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
170835810|NCT02563548|617407255|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
170835811|NCT02563548|617407250|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
170835812|NCT02563548|617407251|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
170835813|NCT02563548|617407252|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
170835814|NCT02563548|617407253|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
170835815|NCT02563548|617407254|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
170835816|NCT02563548|617407255|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
170835817|NCT02563548|617407250|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
170835818|NCT02563548|617407251|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
170835819|NCT02563548|617407252|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
170835820|NCT02563548|617407253|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
170835821|NCT02563548|617407254|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
170835822|NCT02563548|617407255|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
170835823|NCT02563548|617407250|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
170835824|NCT02563548|617407251|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
170835825|NCT02563548|617407252|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
170835826|NCT02563548|617407253|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
170835827|NCT02563548|617407254|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
170835828|NCT02563548|617407255|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
170835829|NCT02563548|617407250|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
170727108|NCT01332227|617006173|FG001|Overall Study|Poor compliance/noncompliance|1|||
170727109|NCT01332227|617006172|FG000|Overall Study|Patient moved from area|1|||
170727110|NCT01332227|617006173|FG001|Overall Study|Patient moved from area|0|||
170727111|NCT01332227|617006172|FG000|Overall Study|Patient began prohibited medication|0|||
170727112|NCT01332227|617006173|FG001|Overall Study|Patient began prohibited medication|1|||
170727113|NCT00833560|617006179|FG000|Overall Study|Toxicity|13|||
170727114|NCT00833560|617006179|FG000|Overall Study|Adverse Event|11|||
170727115|NCT00833560|617006179|FG000|Overall Study|Protocol Violation|6|||
170727116|NCT00833560|617006179|FG000|Overall Study|Lack of Efficacy|4|||
170727117|NCT00833560|617006179|FG000|Overall Study|Death|2|||
170727118|NCT00833560|617006179|FG000|Overall Study|Pregression of other disease|1|||
170727119|NCT00833560|617006179|FG000|Overall Study|Other|5|||
170727120|NCT03382782|617006184|FG000|Cohort 1|Withdrawal by Subject|11|||
170727121|NCT03382782|617006185|FG001|Cohort 1|Withdrawal by Subject|5|||
170727122|NCT03382782|617006186|FG002|Cohort 1|Withdrawal by Subject|0|||
170727123|NCT03382782|617006184|FG000|Cohort 2|Withdrawal by Subject|1|||
170727124|NCT03382782|617006185|FG001|Cohort 2|Withdrawal by Subject|1|||
170727125|NCT03382782|617006186|FG002|Cohort 2|Withdrawal by Subject|0|||
170727126|NCT03382782|617006184|FG000|Cohort 3|Withdrawal by Subject|1|||
170727127|NCT03382782|617006185|FG001|Cohort 3|Withdrawal by Subject|2|||
170727128|NCT03382782|617006186|FG002|Cohort 3|Withdrawal by Subject|0|||
170727129|NCT00428090|617006191|FG000|Overall Study|Adverse Event|10|||
170835830|NCT02563548|617407251|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
170835831|NCT02563548|617407252|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
170835832|NCT02563548|617407253|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
170727130|NCT00428090|617006192|FG001|Overall Study|Adverse Event|8|||
170835833|NCT02563548|617407254|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
170835834|NCT02563548|617407255|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
170835835|NCT02563548|617407250|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
170835836|NCT02563548|617407251|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
170835837|NCT02563548|617407252|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
170835838|NCT02563548|617407253|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
170835839|NCT02563548|617407254|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
170835840|NCT02563548|617407255|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
170835841|NCT02563548|617407250|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
170835842|NCT02563548|617407251|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
170835843|NCT02563548|617407252|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
170835844|NCT02563548|617407253|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
170835845|NCT02563548|617407254|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
170835846|NCT02563548|617407255|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
170835847|NCT02563548|617407250|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
170835848|NCT02563548|617407251|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
170835849|NCT02563548|617407252|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
170835850|NCT02563548|617407253|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
170835851|NCT02563548|617407254|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
170835852|NCT02563548|617407255|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
170835853|NCT02563548|617407250|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
170835854|NCT02563548|617407251|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
170835855|NCT02563548|617407252|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
170835856|NCT02563548|617407253|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
170835857|NCT02563548|617407254|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
170835858|NCT02563548|617407255|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
170835859|NCT02563548|617407250|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
170835860|NCT02563548|617407251|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
170835861|NCT02563548|617407252|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
170835862|NCT02563548|617407253|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
170835863|NCT02563548|617407254|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
170835864|NCT02563548|617407255|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
170835865|NCT02417441|617407261|FG000|Overall Study|Inconclusive due to missing data|52|||
170835866|NCT02417441|617407262|FG001|Overall Study|Inconclusive due to missing data|19|||
170835867|NCT05555615|617407267|FG000|Overall Study|Adverse Event|7|||
170835868|NCT05555615|617407267|FG000|Overall Study|Lack of Efficacy|12|||
170835869|NCT05555615|617407267|FG000|Overall Study|Lost to Follow-up|10|||
170835870|NCT05555615|617407267|FG000|Overall Study|Noncompliance with study drug|5|||
170835871|NCT05555615|617407267|FG000|Overall Study|Physician Decision|2|||
170835872|NCT05555615|617407267|FG000|Overall Study|Study terminated by sponsor|80|||
170835873|NCT05555615|617407267|FG000|Overall Study|Prohibited medication use|2|||
170835874|NCT05555615|617407267|FG000|Overall Study|Withdrawal by Subject|20|||
170835875|NCT05555615|617407267|FG000|Overall Study|Not further specified|4|||
170835876|NCT01101061|617407271|FG000|Overall Study|Adverse Event|0|||
170835877|NCT01101061|617407272|FG001|Overall Study|Adverse Event|0|||
170835878|NCT01101061|617407273|FG002|Overall Study|Adverse Event|1|||
170835879|NCT01101061|617407274|FG003|Overall Study|Adverse Event|0|||
170835880|NCT01101061|617407275|FG004|Overall Study|Adverse Event|0|||
170835881|NCT01101061|617407276|FG005|Overall Study|Adverse Event|0|||
170835882|NCT03635086|617407281|FG000|Overall Study|Withdrawal of consent|0|||
170835883|NCT03635086|617407282|FG001|Overall Study|Withdrawal of consent|0|||
170835884|NCT03635086|617407283|FG002|Overall Study|Withdrawal of consent|1|||
170835885|NCT03635086|617407284|FG003|Overall Study|Withdrawal of consent|0|||
170835886|NCT03635086|617407285|FG004|Overall Study|Withdrawal of consent|0|||
170835887|NCT03635086|617407281|FG000|Overall Study|Adverse Event|0|||
170835888|NCT03635086|617407282|FG001|Overall Study|Adverse Event|1|||
170835889|NCT03635086|617407283|FG002|Overall Study|Adverse Event|0|||
170835890|NCT03635086|617407284|FG003|Overall Study|Adverse Event|0|||
170835891|NCT03635086|617407285|FG004|Overall Study|Adverse Event|0|||
170835892|NCT03635086|617407281|FG000|Overall Study|Lost to Follow-up|1|||
170835893|NCT03635086|617407282|FG001|Overall Study|Lost to Follow-up|0|||
170835894|NCT03635086|617407283|FG002|Overall Study|Lost to Follow-up|0|||
170835895|NCT03635086|617407284|FG003|Overall Study|Lost to Follow-up|0|||
170835896|NCT03635086|617407285|FG004|Overall Study|Lost to Follow-up|0|||
170835897|NCT01728623|617407286|FG000|Overall Study|Disease progression|26|||
170835898|NCT01728623|617407286|FG000|Overall Study|Adverse Event|1|||
170835899|NCT01728623|617407286|FG000|Overall Study|Withdrawal by Subject|1|||
170835900|NCT03000348|617407287|FG000|Overall Study|Adverse Event|1|||
170835901|NCT03000348|617407288|FG001|Overall Study|Adverse Event|1|||
170727131|NCT00428090|617006193|FG002|Overall Study|Adverse Event|10|||
170727132|NCT00428090|617006194|FG003|Overall Study|Adverse Event|11|||
170727133|NCT00428090|617006191|FG000|Overall Study|Lost to Follow-up|3|||
170727134|NCT00428090|617006192|FG001|Overall Study|Lost to Follow-up|6|||
170727135|NCT00428090|617006193|FG002|Overall Study|Lost to Follow-up|1|||
170727136|NCT00428090|617006194|FG003|Overall Study|Lost to Follow-up|4|||
170727137|NCT00428090|617006191|FG000|Overall Study|Protocol Violation|3|||
170727138|NCT00428090|617006192|FG001|Overall Study|Protocol Violation|1|||
170727139|NCT00428090|617006193|FG002|Overall Study|Protocol Violation|3|||
170727140|NCT00428090|617006194|FG003|Overall Study|Protocol Violation|3|||
170727141|NCT00428090|617006191|FG000|Overall Study|Withdrawal by Subject|10|||
170727142|NCT00428090|617006192|FG001|Overall Study|Withdrawal by Subject|12|||
170727143|NCT00428090|617006193|FG002|Overall Study|Withdrawal by Subject|15|||
170727144|NCT00428090|617006194|FG003|Overall Study|Withdrawal by Subject|5|||
170727145|NCT00428090|617006191|FG000|Overall Study|Sponsor terminated study|0|||
170727146|NCT00428090|617006192|FG001|Overall Study|Sponsor terminated study|1|||
170727147|NCT00428090|617006193|FG002|Overall Study|Sponsor terminated study|0|||
170727148|NCT00428090|617006194|FG003|Overall Study|Sponsor terminated study|0|||
170727149|NCT00428090|617006191|FG000|Overall Study|Non-compliance|4|||
170727150|NCT00428090|617006192|FG001|Overall Study|Non-compliance|0|||
170727151|NCT00428090|617006193|FG002|Overall Study|Non-compliance|1|||
170727152|NCT00428090|617006194|FG003|Overall Study|Non-compliance|3|||
170727153|NCT00428090|617006191|FG000|Overall Study|Par. did not returned to visit|1|||
170835902|NCT03000348|617407289|FG002|Overall Study|Adverse Event|1|||
170835903|NCT03000348|617407290|FG003|Overall Study|Adverse Event|1|||
170835904|NCT03000348|617407291|FG004|Overall Study|Adverse Event|1|||
170835905|NCT03000348|617407292|FG005|Overall Study|Adverse Event|1|||
170835906|NCT03000348|617407287|FG000|Overall Study|Lost to Follow-up|0|||
170835907|NCT03000348|617407288|FG001|Overall Study|Lost to Follow-up|0|||
170835908|NCT03000348|617407289|FG002|Overall Study|Lost to Follow-up|1|||
170835909|NCT03000348|617407290|FG003|Overall Study|Lost to Follow-up|0|||
170835910|NCT03000348|617407291|FG004|Overall Study|Lost to Follow-up|0|||
170835911|NCT03000348|617407292|FG005|Overall Study|Lost to Follow-up|0|||
170835912|NCT03000348|617407287|FG000|Overall Study|Withdrawal by Subject|0|||
170835913|NCT03000348|617407288|FG001|Overall Study|Withdrawal by Subject|1|||
170835914|NCT03000348|617407289|FG002|Overall Study|Withdrawal by Subject|0|||
170835915|NCT03000348|617407290|FG003|Overall Study|Withdrawal by Subject|0|||
170835916|NCT03000348|617407291|FG004|Overall Study|Withdrawal by Subject|0|||
170835917|NCT03000348|617407292|FG005|Overall Study|Withdrawal by Subject|0|||
170835918|NCT03000348|617407287|FG000|Overall Study|Consent|0|||
170835919|NCT03000348|617407288|FG001|Overall Study|Consent|0|||
170835920|NCT03000348|617407289|FG002|Overall Study|Consent|0|||
170835921|NCT03000348|617407290|FG003|Overall Study|Consent|0|||
170835922|NCT03000348|617407291|FG004|Overall Study|Consent|1|||
170835923|NCT03000348|617407292|FG005|Overall Study|Consent|0|||
170835924|NCT03000348|617407287|FG000|Overall Study|Failure to expectorate sputum|1|||
170835925|NCT03000348|617407288|FG001|Overall Study|Failure to expectorate sputum|0|||
170835926|NCT03000348|617407289|FG002|Overall Study|Failure to expectorate sputum|1|||
170835927|NCT03000348|617407290|FG003|Overall Study|Failure to expectorate sputum|0|||
170835928|NCT03000348|617407291|FG004|Overall Study|Failure to expectorate sputum|1|||
170835929|NCT03000348|617407292|FG005|Overall Study|Failure to expectorate sputum|0|||
170835930|NCT03000348|617407287|FG000|Overall Study|No gram negative|1|||
170835931|NCT03000348|617407288|FG001|Overall Study|No gram negative|2|||
170835932|NCT03000348|617407289|FG002|Overall Study|No gram negative|1|||
170835933|NCT03000348|617407290|FG003|Overall Study|No gram negative|1|||
170835934|NCT03000348|617407291|FG004|Overall Study|No gram negative|1|||
170835935|NCT03000348|617407292|FG005|Overall Study|No gram negative|1|||
170835936|NCT03000348|617407287|FG000|Overall Study|Patient had no transport|0|||
170835937|NCT03000348|617407288|FG001|Overall Study|Patient had no transport|0|||
170835938|NCT03000348|617407289|FG002|Overall Study|Patient had no transport|0|||
170835939|NCT03000348|617407290|FG003|Overall Study|Patient had no transport|1|||
170835940|NCT03000348|617407291|FG004|Overall Study|Patient had no transport|0|||
170835941|NCT03000348|617407292|FG005|Overall Study|Patient had no transport|0|||
170835942|NCT03000348|617407287|FG000|Overall Study|Dosing|0|||
170835943|NCT03000348|617407288|FG001|Overall Study|Dosing|0|||
170835944|NCT03000348|617407289|FG002|Overall Study|Dosing|0|||
170835945|NCT03000348|617407290|FG003|Overall Study|Dosing|0|||
170835946|NCT03000348|617407291|FG004|Overall Study|Dosing|1|||
170835947|NCT03000348|617407292|FG005|Overall Study|Dosing|0|||
170835948|NCT00723125|617407293|FG000|Overall Study|Met Dx|1|||
170835949|NCT00723125|617407294|FG001|Overall Study|Met Dx|0|||
170835950|NCT00723125|617407293|FG000|Overall Study|Withdrawal by Subject|15|||
170835951|NCT00723125|617407294|FG001|Overall Study|Withdrawal by Subject|6|||
170835952|NCT00723125|617407293|FG000|Overall Study|Adverse Event|2|||
170835953|NCT00723125|617407294|FG001|Overall Study|Adverse Event|0|||
170835954|NCT01667549|617407297|FG000|Overall Study|Withdrawal by Subject|3|||
170835955|NCT01667549|617407298|FG001|Overall Study|Withdrawal by Subject|5|||
170727154|NCT00428090|617006192|FG001|Overall Study|Par. did not returned to visit|0|||
170727155|NCT00428090|617006193|FG002|Overall Study|Par. did not returned to visit|0|||
170727156|NCT00428090|617006194|FG003|Overall Study|Par. did not returned to visit|1|||
170727157|NCT00428090|617006191|FG000|Overall Study|Follow-Up visit not possible|1|||
170727158|NCT00428090|617006192|FG001|Overall Study|Follow-Up visit not possible|0|||
170727159|NCT00428090|617006193|FG002|Overall Study|Follow-Up visit not possible|0|||
170727160|NCT00428090|617006194|FG003|Overall Study|Follow-Up visit not possible|0|||
170727161|NCT00428090|617006191|FG000|Overall Study|Prohibited medication used for SAE|1|||
170727162|NCT00428090|617006192|FG001|Overall Study|Prohibited medication used for SAE|0|||
170727163|NCT00428090|617006193|FG002|Overall Study|Prohibited medication used for SAE|0|||
170727164|NCT00428090|617006194|FG003|Overall Study|Prohibited medication used for SAE|0|||
170727165|NCT00428090|617006191|FG000|Overall Study|Death of par.|1|||
170727166|NCT00428090|617006192|FG001|Overall Study|Death of par.|0|||
170727167|NCT00428090|617006193|FG002|Overall Study|Death of par.|1|||
170727168|NCT00428090|617006194|FG003|Overall Study|Death of par.|0|||
170727169|NCT00428090|617006191|FG000|Overall Study|Visit 7 exceed the visit window|0|||
170727170|NCT00428090|617006192|FG001|Overall Study|Visit 7 exceed the visit window|1|||
170727171|NCT00428090|617006193|FG002|Overall Study|Visit 7 exceed the visit window|0|||
170727172|NCT00428090|617006194|FG003|Overall Study|Visit 7 exceed the visit window|0|||
170727173|NCT00428090|617006191|FG000|Overall Study|Medical monitor terminated par.|0|||
170727174|NCT00428090|617006192|FG001|Overall Study|Medical monitor terminated par.|1|||
170727175|NCT00428090|617006193|FG002|Overall Study|Medical monitor terminated par.|0|||
170727176|NCT00428090|617006194|FG003|Overall Study|Medical monitor terminated par.|0|||
170727177|NCT00428090|617006191|FG000|Overall Study|Mental status of par. was|0|||
170727178|NCT00428090|617006192|FG001|Overall Study|Mental status of par. was|1|||
170727179|NCT00428090|617006193|FG002|Overall Study|Mental status of par. was|0|||
170727180|NCT00428090|617006194|FG003|Overall Study|Mental status of par. was|0|||
170727181|NCT00428090|617006191|FG000|Overall Study|Worsening of AD|0|||
170727182|NCT00428090|617006192|FG001|Overall Study|Worsening of AD|0|||
170727183|NCT00428090|617006193|FG002|Overall Study|Worsening of AD|1|||
170727184|NCT00428090|617006194|FG003|Overall Study|Worsening of AD|0|||
170727185|NCT00428090|617006191|FG000|Overall Study|Excluded for concerning QTc value|0|||
170727186|NCT00428090|617006192|FG001|Overall Study|Excluded for concerning QTc value|0|||
170727187|NCT00428090|617006193|FG002|Overall Study|Excluded for concerning QTc value|1|||
170727188|NCT00428090|617006194|FG003|Overall Study|Excluded for concerning QTc value|0|||
170727189|NCT00428090|617006191|FG000|Overall Study|Insufficient AD documentation|0|||
170727190|NCT00428090|617006192|FG001|Overall Study|Insufficient AD documentation|0|||
170727191|NCT00428090|617006193|FG002|Overall Study|Insufficient AD documentation|1|||
170727192|NCT00428090|617006194|FG003|Overall Study|Insufficient AD documentation|0|||
170727193|NCT00428090|617006191|FG000|Overall Study|High MMSE scores|0|||
170727194|NCT00428090|617006192|FG001|Overall Study|High MMSE scores|0|||
170727195|NCT00428090|617006193|FG002|Overall Study|High MMSE scores|1|||
170727196|NCT00428090|617006194|FG003|Overall Study|High MMSE scores|0|||
170727197|NCT00428090|617006191|FG000|Overall Study|Deterioration of cognitive status|0|||
170727198|NCT00428090|617006192|FG001|Overall Study|Deterioration of cognitive status|0|||
170727199|NCT00428090|617006193|FG002|Overall Study|Deterioration of cognitive status|1|||
170727200|NCT00428090|617006194|FG003|Overall Study|Deterioration of cognitive status|0|||
170727201|NCT00428090|617006191|FG000|Overall Study|Serious adverse event|0|||
170727202|NCT00428090|617006192|FG001|Overall Study|Serious adverse event|0|||
170727203|NCT00428090|617006193|FG002|Overall Study|Serious adverse event|1|||
170727204|NCT00428090|617006194|FG003|Overall Study|Serious adverse event|0|||
170727205|NCT00428090|617006191|FG000|Overall Study|Excluded for heart insufficiency|0|||
170727206|NCT00428090|617006192|FG001|Overall Study|Excluded for heart insufficiency|0|||
170727207|NCT00428090|617006193|FG002|Overall Study|Excluded for heart insufficiency|1|||
170727208|NCT00428090|617006194|FG003|Overall Study|Excluded for heart insufficiency|0|||
170727209|NCT00428090|617006191|FG000|Overall Study|Raised Creatinine Value|0|||
170727210|NCT00428090|617006192|FG001|Overall Study|Raised Creatinine Value|0|||
170727211|NCT00428090|617006193|FG002|Overall Study|Raised Creatinine Value|0|||
170727212|NCT00428090|617006194|FG003|Overall Study|Raised Creatinine Value|1|||
170727213|NCT03409666|617006195|FG000|Overall Study|Physician Decision|0|||
170727214|NCT03409666|617006196|FG001|Overall Study|Physician Decision|1|||
170727215|NCT03409666|617006195|FG000|Overall Study|Protocol Violation|0|||
170727216|NCT03409666|617006196|FG001|Overall Study|Protocol Violation|3|||
170727217|NCT01791725|617006200|FG000|Overall Study|Withdrawal by Subject|0|||
170727218|NCT01791725|617006201|FG001|Overall Study|Withdrawal by Subject|1|||
170727219|NCT01791725|617006202|FG002|Overall Study|Withdrawal by Subject|0|||
170727220|NCT00522301|617006210|FG000|Overall Study|Withdrawal by Subject|1|||
170727221|NCT00522301|617006210|FG000|Overall Study|Adverse Event|5|||
170727222|NCT02366910|617006211|FG000|Overall Study|Withdrawal by Subject|2|||
170727223|NCT02366910|617006211|FG000|Overall Study|Screen Failure|3|||
170727224|NCT02623322|617006212|FG000|Overall Study|Lost to Follow-up|2|||
170727225|NCT02623322|617006213|FG001|Overall Study|Lost to Follow-up|1|||
170727226|NCT02623322|617006214|FG002|Overall Study|Lost to Follow-up|0|||
170727227|NCT02462876|617006215|FG000|Overall Study|Death|3|||
170727228|NCT02462876|617006215|FG000|Overall Study|Lost to Follow-up|7|||
170727229|NCT02462876|617006215|FG000|Overall Study|Surgical Bypass|9|||
170727230|NCT02462876|617006215|FG000|Overall Study|Amputation Above the Metatarsals|1|||
170727231|NCT02462876|617006215|FG000|Overall Study|36 months follow-up visit missed|1|||
170727232|NCT02462876|617006215|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
170727233|NCT02462876|617006215|FG000|Overall Study|Patient did not come back to the vascular department|1|||
170727234|NCT02462876|617006215|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
170727235|NCT02462876|617006215|FG000|Overall Study|Patient refused to come back|1|||
170727236|NCT02462876|617006215|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
170727237|NCT02462876|617006215|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
170727238|NCT01786512|617006216|FG000|Overall Study|Lost to Follow-up|0|||
170727239|NCT01786512|617006217|FG001|Overall Study|Lost to Follow-up|0|||
170727240|NCT01786512|617006218|FG002|Overall Study|Lost to Follow-up|0|||
170727241|NCT01786512|617006219|FG003|Overall Study|Lost to Follow-up|0|||
170727242|NCT01786512|617006220|FG004|Overall Study|Lost to Follow-up|0|||
170727243|NCT01786512|617006221|FG005|Overall Study|Lost to Follow-up|0|||
170727244|NCT01786512|617006222|FG006|Overall Study|Lost to Follow-up|0|||
170727245|NCT01786512|617006223|FG007|Overall Study|Lost to Follow-up|0|||
170727246|NCT01786512|617006224|FG008|Overall Study|Lost to Follow-up|0|||
170727247|NCT01786512|617006225|FG009|Overall Study|Lost to Follow-up|1|||
170727248|NCT01786512|617006226|FG010|Overall Study|Lost to Follow-up|0|||
170727249|NCT01786512|617006216|FG000|Overall Study|Decision by sponsor|0|||
170727250|NCT01786512|617006217|FG001|Overall Study|Decision by sponsor|0|||
170727251|NCT01786512|617006218|FG002|Overall Study|Decision by sponsor|0|||
170727252|NCT01786512|617006219|FG003|Overall Study|Decision by sponsor|0|||
170727253|NCT01786512|617006220|FG004|Overall Study|Decision by sponsor|0|||
170727254|NCT01786512|617006221|FG005|Overall Study|Decision by sponsor|0|||
170727255|NCT01786512|617006222|FG006|Overall Study|Decision by sponsor|0|||
170727256|NCT01786512|617006223|FG007|Overall Study|Decision by sponsor|0|||
170727257|NCT01786512|617006224|FG008|Overall Study|Decision by sponsor|0|||
170727258|NCT01786512|617006225|FG009|Overall Study|Decision by sponsor|0|||
170727259|NCT01786512|617006226|FG010|Overall Study|Decision by sponsor|2|||
170727260|NCT01786512|617006216|FG000|Overall Study|Withdrawal by Subject|0|||
170727261|NCT01786512|617006217|FG001|Overall Study|Withdrawal by Subject|1|||
170727262|NCT01786512|617006218|FG002|Overall Study|Withdrawal by Subject|0|||
170727263|NCT01786512|617006219|FG003|Overall Study|Withdrawal by Subject|0|||
170727264|NCT01786512|617006220|FG004|Overall Study|Withdrawal by Subject|0|||
170727265|NCT01786512|617006221|FG005|Overall Study|Withdrawal by Subject|0|||
170727266|NCT01786512|617006222|FG006|Overall Study|Withdrawal by Subject|1|||
170727267|NCT01786512|617006223|FG007|Overall Study|Withdrawal by Subject|0|||
170727268|NCT01786512|617006224|FG008|Overall Study|Withdrawal by Subject|0|||
170727269|NCT01786512|617006225|FG009|Overall Study|Withdrawal by Subject|3|||
170727270|NCT01786512|617006226|FG010|Overall Study|Withdrawal by Subject|7|||
170727271|NCT01786512|617006216|FG000|Overall Study|Death|0|||
170727272|NCT01786512|617006217|FG001|Overall Study|Death|0|||
170727273|NCT01786512|617006218|FG002|Overall Study|Death|0|||
170727274|NCT01786512|617006219|FG003|Overall Study|Death|0|||
170727275|NCT01786512|617006220|FG004|Overall Study|Death|0|||
170727276|NCT01786512|617006221|FG005|Overall Study|Death|0|||
170727277|NCT01786512|617006222|FG006|Overall Study|Death|0|||
170727278|NCT01786512|617006223|FG007|Overall Study|Death|0|||
170727279|NCT01786512|617006224|FG008|Overall Study|Death|4|||
170727280|NCT01786512|617006225|FG009|Overall Study|Death|1|||
170727281|NCT01786512|617006226|FG010|Overall Study|Death|3|||
170727282|NCT02450331|617006227|FG000|Overall Study|Death|162|||
170727283|NCT02450331|617006228|FG001|Overall Study|Death|171|||
170727284|NCT02450331|617006227|FG000|Overall Study|Lost to Follow-up|14|||
170727285|NCT02450331|617006228|FG001|Overall Study|Lost to Follow-up|12|||
170727286|NCT02450331|617006227|FG000|Overall Study|Withdrawal by Subject|55|||
170727287|NCT02450331|617006228|FG001|Overall Study|Withdrawal by Subject|44|||
170727288|NCT02450331|617006227|FG000|Overall Study|Non-specified other|1|||
170727289|NCT02450331|617006228|FG001|Overall Study|Non-specified other|1|||
170727290|NCT02080871|617006229|FG000|Overall Study|Death|1|||
170835956|NCT01667549|617407299|FG002|Overall Study|Withdrawal by Subject|7|||
170835957|NCT01667549|617407300|FG003|Overall Study|Withdrawal by Subject|6|||
170727291|NCT02080871|617006229|FG000|Overall Study|Lost to Follow-up|1|||
170727292|NCT02428296|617006230|FG000|Overall Study|Adverse Event|7|||
170835958|NCT01667549|617407301|FG004|Overall Study|Withdrawal by Subject|1|||
170727293|NCT02428296|617006230|FG000|Overall Study|Withdrawal by Subject|2|||
170727294|NCT02525874|617006240|FG000|Overall Study|Other|1|||
170727295|NCT02525874|617006240|FG000|Overall Study|Investigator Decision|1|||
170727296|NCT02525874|617006240|FG000|Overall Study|Consent withdrawn|22|||
170727297|NCT02525874|617006240|FG000|Overall Study|Non-compliance with study drug|3|||
170727298|NCT02525874|617006240|FG000|Overall Study|Adverse Event|17|||
170727299|NCT02525874|617006240|FG000|Overall Study|Lost to Follow-up|7|||
170727300|NCT02525874|617006240|FG000|Overall Study|Disease progression, defined by protocol|2|||
170835959|NCT00150618|617407302|FG000|Overall Study|Adverse Event|2|||
170835960|NCT00150618|617407303|FG001|Overall Study|Adverse Event|2|||
170727301|NCT02525874|617006240|FG000|Overall Study|Disease relapse|4|||
170727302|NCT02525874|617006240|FG000|Overall Study|Alternative Treatment for MS|2|||
170727303|NCT02525874|617006240|FG000|Overall Study|New lesions in Brain|1|||
170727304|NCT03205371|617006247|FG000|Overall Study|Withdrawal by Subject|4|||
170727305|NCT03205371|617006248|FG001|Overall Study|Withdrawal by Subject|1|||
170727306|NCT03205371|617006249|FG002|Overall Study|Withdrawal by Subject|0|||
170727307|NCT03205371|617006250|FG003|Overall Study|Withdrawal by Subject|0|||
170727308|NCT03205371|617006251|FG004|Overall Study|Withdrawal by Subject|0|||
170727309|NCT03205371|617006252|FG005|Overall Study|Withdrawal by Subject|0|||
170727310|NCT03205371|617006253|FG006|Overall Study|Withdrawal by Subject|4|||
170727311|NCT03205371|617006254|FG007|Overall Study|Withdrawal by Subject|0|||
170727312|NCT03205371|617006255|FG008|Overall Study|Withdrawal by Subject|2|||
170727313|NCT03205371|617006256|FG009|Overall Study|Withdrawal by Subject|0|||
170727314|NCT03205371|617006257|FG010|Overall Study|Withdrawal by Subject|0|||
170727315|NCT03205371|617006258|FG011|Overall Study|Withdrawal by Subject|1|||
170727316|NCT03205371|617006247|FG000|Overall Study|Lost to Follow-up|0|||
170727317|NCT03205371|617006248|FG001|Overall Study|Lost to Follow-up|0|||
170727318|NCT03205371|617006249|FG002|Overall Study|Lost to Follow-up|0|||
170727319|NCT03205371|617006250|FG003|Overall Study|Lost to Follow-up|0|||
170727320|NCT03205371|617006251|FG004|Overall Study|Lost to Follow-up|0|||
170727321|NCT03205371|617006252|FG005|Overall Study|Lost to Follow-up|0|||
170727322|NCT03205371|617006253|FG006|Overall Study|Lost to Follow-up|5|||
170727323|NCT03205371|617006254|FG007|Overall Study|Lost to Follow-up|2|||
170727324|NCT03205371|617006255|FG008|Overall Study|Lost to Follow-up|3|||
170727325|NCT03205371|617006256|FG009|Overall Study|Lost to Follow-up|0|||
170727326|NCT03205371|617006257|FG010|Overall Study|Lost to Follow-up|0|||
170727327|NCT03205371|617006258|FG011|Overall Study|Lost to Follow-up|0|||
170727328|NCT03205371|617006247|FG000|Overall Study|Protocol Violation|0|||
170727329|NCT03205371|617006248|FG001|Overall Study|Protocol Violation|0|||
170727330|NCT03205371|617006249|FG002|Overall Study|Protocol Violation|0|||
170727331|NCT03205371|617006250|FG003|Overall Study|Protocol Violation|0|||
170727332|NCT03205371|617006251|FG004|Overall Study|Protocol Violation|0|||
170727333|NCT03205371|617006252|FG005|Overall Study|Protocol Violation|0|||
170727334|NCT03205371|617006253|FG006|Overall Study|Protocol Violation|1|||
170727335|NCT03205371|617006254|FG007|Overall Study|Protocol Violation|0|||
170727336|NCT03205371|617006255|FG008|Overall Study|Protocol Violation|0|||
170727337|NCT03205371|617006256|FG009|Overall Study|Protocol Violation|0|||
170727338|NCT03205371|617006257|FG010|Overall Study|Protocol Violation|0|||
170727339|NCT03205371|617006258|FG011|Overall Study|Protocol Violation|0|||
170727340|NCT03205371|617006247|FG000|Overall Study|Adverse Event|0|||
170727341|NCT03205371|617006248|FG001|Overall Study|Adverse Event|0|||
170727342|NCT03205371|617006249|FG002|Overall Study|Adverse Event|0|||
170727343|NCT03205371|617006250|FG003|Overall Study|Adverse Event|0|||
170727344|NCT03205371|617006251|FG004|Overall Study|Adverse Event|0|||
170727345|NCT03205371|617006252|FG005|Overall Study|Adverse Event|0|||
170727346|NCT03205371|617006253|FG006|Overall Study|Adverse Event|0|||
170727347|NCT03205371|617006254|FG007|Overall Study|Adverse Event|1|||
170727348|NCT03205371|617006255|FG008|Overall Study|Adverse Event|0|||
170727349|NCT03205371|617006256|FG009|Overall Study|Adverse Event|0|||
170727350|NCT03205371|617006257|FG010|Overall Study|Adverse Event|0|||
170727351|NCT03205371|617006258|FG011|Overall Study|Adverse Event|0|||
170727352|NCT02835339|617006259|FG000|Overall Study|Did not receive allocated intervention|13|||
170727353|NCT02835339|617006260|FG001|Overall Study|Did not receive allocated intervention|16|||
170727354|NCT02308748|617006262|FG000|Period 1|Withdrawal by Subject|0|||
170727355|NCT02308748|617006263|FG001|Period 1|Withdrawal by Subject|0|||
170727356|NCT02308748|617006264|FG002|Period 1|Withdrawal by Subject|1|||
170727357|NCT02308748|617006265|FG003|Period 1|Withdrawal by Subject|0|||
170727358|NCT02308748|617006266|FG004|Period 1|Withdrawal by Subject|0|||
170727359|NCT02308748|617006267|FG005|Period 1|Withdrawal by Subject|0|||
170727360|NCT02308748|617006268|FG006|Period 1|Withdrawal by Subject|0|||
170727361|NCT02308748|617006269|FG007|Period 1|Withdrawal by Subject|0|||
170727362|NCT02308748|617006270|FG008|Period 1|Withdrawal by Subject|0|||
170727363|NCT02308748|617006271|FG009|Period 1|Withdrawal by Subject|0|||
170835961|NCT00150618|617407304|FG002|Overall Study|Adverse Event|6|||
170835962|NCT00150618|617407305|FG003|Overall Study|Adverse Event|9|||
170835963|NCT00150618|617407306|FG004|Overall Study|Adverse Event|5|||
170835964|NCT00150618|617407302|FG000|Overall Study|Withdrawal by Subject|6|||
170835965|NCT00150618|617407303|FG001|Overall Study|Withdrawal by Subject|8|||
170835966|NCT00150618|617407304|FG002|Overall Study|Withdrawal by Subject|8|||
170835967|NCT00150618|617407305|FG003|Overall Study|Withdrawal by Subject|4|||
170835968|NCT00150618|617407306|FG004|Overall Study|Withdrawal by Subject|5|||
170835969|NCT00150618|617407302|FG000|Overall Study|Lost to Follow-up|4|||
170727364|NCT02308748|617006262|FG000|Period 2|Adverse Event|0|||
170727365|NCT02308748|617006263|FG001|Period 2|Adverse Event|0|||
170727366|NCT02308748|617006264|FG002|Period 2|Adverse Event|0|||
170835970|NCT00150618|617407303|FG001|Overall Study|Lost to Follow-up|1|||
170835971|NCT00150618|617407304|FG002|Overall Study|Lost to Follow-up|5|||
170835972|NCT00150618|617407305|FG003|Overall Study|Lost to Follow-up|8|||
170727367|NCT02308748|617006265|FG003|Period 2|Adverse Event|0|||
170727368|NCT02308748|617006266|FG004|Period 2|Adverse Event|0|||
170727369|NCT02308748|617006267|FG005|Period 2|Adverse Event|0|||
170727370|NCT02308748|617006268|FG006|Period 2|Adverse Event|0|||
170727371|NCT02308748|617006269|FG007|Period 2|Adverse Event|1|||
170727372|NCT02308748|617006270|FG008|Period 2|Adverse Event|0|||
170727373|NCT02308748|617006271|FG009|Period 2|Adverse Event|0|||
170727374|NCT02308748|617006262|FG000|Period 3|Protocol Violation|0|||
170727375|NCT02308748|617006263|FG001|Period 3|Protocol Violation|0|||
170727376|NCT02308748|617006264|FG002|Period 3|Protocol Violation|0|||
170727377|NCT02308748|617006265|FG003|Period 3|Protocol Violation|0|||
170727378|NCT02308748|617006266|FG004|Period 3|Protocol Violation|0|||
170727379|NCT02308748|617006267|FG005|Period 3|Protocol Violation|0|||
170727380|NCT02308748|617006268|FG006|Period 3|Protocol Violation|0|||
170727381|NCT02308748|617006269|FG007|Period 3|Protocol Violation|0|||
170727382|NCT02308748|617006270|FG008|Period 3|Protocol Violation|0|||
170727383|NCT02308748|617006271|FG009|Period 3|Protocol Violation|1|||
170727384|NCT02308748|617006262|FG000|Period 5|Adverse Event|1|||
170727385|NCT02308748|617006263|FG001|Period 5|Adverse Event|0|||
170727386|NCT02308748|617006264|FG002|Period 5|Adverse Event|0|||
170727387|NCT02308748|617006265|FG003|Period 5|Adverse Event|0|||
170727388|NCT02308748|617006266|FG004|Period 5|Adverse Event|0|||
170727389|NCT02308748|617006267|FG005|Period 5|Adverse Event|0|||
170727390|NCT02308748|617006268|FG006|Period 5|Adverse Event|0|||
170727391|NCT02308748|617006269|FG007|Period 5|Adverse Event|0|||
170727392|NCT02308748|617006270|FG008|Period 5|Adverse Event|1|||
170727393|NCT02308748|617006271|FG009|Period 5|Adverse Event|0|||
170727394|NCT00736645|617006272|FG000|Overall Study|Adverse Event|0|||
170727395|NCT00736645|617006273|FG001|Overall Study|Adverse Event|2|||
170727396|NCT00736645|617006274|FG002|Overall Study|Adverse Event|0|||
170727397|NCT00736645|617006275|FG003|Overall Study|Adverse Event|0|||
170727398|NCT00490646|617006276|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
170727399|NCT00490646|617006277|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
170727400|NCT00490646|617006276|FG000|Overall Study|Never Treated (had an adverse event)|1|||
170727401|NCT00490646|617006277|FG001|Overall Study|Never Treated (had an adverse event)|0|||
170727402|NCT00490646|617006276|FG000|Overall Study|Never Treated (withdrew consent)|0|||
170727403|NCT00490646|617006277|FG001|Overall Study|Never Treated (withdrew consent)|1|||
170727404|NCT03543254|617006279|FG000|Overall Study|Lost to Follow-up|1|||
170727405|NCT02747238|617006280|FG000|Overall Study|Lack of Efficacy|0|||
170727406|NCT02747238|617006281|FG001|Overall Study|Lack of Efficacy|1|||
170727407|NCT02747238|617006280|FG000|Overall Study|Data lost|3|||
170727408|NCT02747238|617006281|FG001|Overall Study|Data lost|5|||
170727409|NCT05245864|617006288|FG000|Overall Study|Withdrawal by Subject|1|||
170727410|NCT05245864|617006289|FG001|Overall Study|Withdrawal by Subject|1|||
170727411|NCT01475136|617006290|FG000|Overall Study|Sponsor Decision|0|||
170727412|NCT01475136|617006291|FG001|Overall Study|Sponsor Decision|1|||
170727413|NCT01475136|617006292|FG002|Overall Study|Sponsor Decision|0|||
170727414|NCT01475136|617006293|FG003|Overall Study|Sponsor Decision|0|||
170727415|NCT01475136|617006290|FG000|Overall Study|Entry Criteria Not Met|0|||
170727416|NCT01475136|617006291|FG001|Overall Study|Entry Criteria Not Met|2|||
170727417|NCT01475136|617006292|FG002|Overall Study|Entry Criteria Not Met|3|||
170727418|NCT01475136|617006293|FG003|Overall Study|Entry Criteria Not Met|1|||
170727419|NCT01475136|617006290|FG000|Overall Study|Withdrawal by Subject|0|||
170727420|NCT01475136|617006291|FG001|Overall Study|Withdrawal by Subject|0|||
170727421|NCT01475136|617006292|FG002|Overall Study|Withdrawal by Subject|0|||
170727422|NCT01475136|617006293|FG003|Overall Study|Withdrawal by Subject|2|||
170727423|NCT01475136|617006290|FG000|Overall Study|Adverse Event|1|||
170727424|NCT01475136|617006291|FG001|Overall Study|Adverse Event|0|||
170727425|NCT01475136|617006292|FG002|Overall Study|Adverse Event|0|||
170727426|NCT01475136|617006293|FG003|Overall Study|Adverse Event|1|||
170727427|NCT01475136|617006290|FG000|Overall Study|Death|0|||
170727428|NCT01475136|617006291|FG001|Overall Study|Death|0|||
170727429|NCT01475136|617006292|FG002|Overall Study|Death|0|||
170727430|NCT01475136|617006293|FG003|Overall Study|Death|1|||
170727431|NCT01735201|617007747|FG000|Overall Study|Adverse Event|1|||
170727432|NCT01735201|617007748|FG001|Overall Study|Adverse Event|1|||
170727433|NCT01735201|617007749|FG002|Overall Study|Adverse Event|0|||
170727434|NCT01735201|617007750|FG003|Overall Study|Adverse Event|1|||
170727435|NCT01735201|617007751|FG004|Overall Study|Adverse Event|1|||
170727436|NCT01735201|617007752|FG005|Overall Study|Adverse Event|3|||
170727437|NCT01735201|617007753|FG006|Overall Study|Adverse Event|2|||
170727438|NCT01735201|617007754|FG007|Overall Study|Adverse Event|1|||
170727439|NCT01735201|617007747|FG000|Overall Study|Personal Reasons|1|||
170727440|NCT01735201|617007748|FG001|Overall Study|Personal Reasons|0|||
170727441|NCT01735201|617007749|FG002|Overall Study|Personal Reasons|0|||
170727442|NCT01735201|617007750|FG003|Overall Study|Personal Reasons|0|||
170727443|NCT01735201|617007751|FG004|Overall Study|Personal Reasons|0|||
170727444|NCT01735201|617007752|FG005|Overall Study|Personal Reasons|0|||
170727445|NCT01735201|617007753|FG006|Overall Study|Personal Reasons|0|||
170727446|NCT01735201|617007754|FG007|Overall Study|Personal Reasons|0|||
170727447|NCT01735201|617007747|FG000|Overall Study|Protocol Violation|1|||
170727448|NCT01735201|617007748|FG001|Overall Study|Protocol Violation|0|||
170727449|NCT01735201|617007749|FG002|Overall Study|Protocol Violation|0|||
170727450|NCT01735201|617007750|FG003|Overall Study|Protocol Violation|0|||
170727451|NCT01735201|617007751|FG004|Overall Study|Protocol Violation|0|||
170727452|NCT01735201|617007752|FG005|Overall Study|Protocol Violation|0|||
170727453|NCT01735201|617007753|FG006|Overall Study|Protocol Violation|0|||
170727454|NCT01735201|617007754|FG007|Overall Study|Protocol Violation|0|||
170727455|NCT01735201|617007747|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170727456|NCT01735201|617007748|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170727457|NCT01735201|617007749|FG002|Overall Study|Other Miscellaneous Reasons|0|||
170727458|NCT01735201|617007750|FG003|Overall Study|Other Miscellaneous Reasons|1|||
170727459|NCT01735201|617007751|FG004|Overall Study|Other Miscellaneous Reasons|0|||
170727460|NCT01735201|617007752|FG005|Overall Study|Other Miscellaneous Reasons|2|||
170727461|NCT01735201|617007753|FG006|Overall Study|Other Miscellaneous Reasons|1|||
170727462|NCT01735201|617007754|FG007|Overall Study|Other Miscellaneous Reasons|1|||
170727463|NCT04128293|617007758|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
170727464|NCT04128293|617007759|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
170727465|NCT04128293|617007760|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
170727466|NCT04128293|617007761|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
170727467|NCT02822222|617007762|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
170727468|NCT02822222|617007763|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
170727469|NCT03255824|617007765|FG000|Overall Study|Under-sedation|2|||
170727470|NCT03255824|617007766|FG001|Overall Study|Under-sedation|1|||
170727471|NCT03432364|617007774|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
170727472|NCT03040713|617007775|FG000|Overall Study|Positive amyloid scan|3|||
170727473|NCT00254982|617007778|FG000|Overall Study|Other|2|||
170727474|NCT00254982|617007779|FG001|Overall Study|Other|1|||
170727475|NCT00254982|617007778|FG000|Overall Study|Lack of Efficacy|5|||
170727476|NCT00254982|617007779|FG001|Overall Study|Lack of Efficacy|3|||
170727477|NCT00254982|617007778|FG000|Overall Study|Lost to Follow-up|5|||
170727478|NCT00254982|617007779|FG001|Overall Study|Lost to Follow-up|3|||
170727479|NCT00254982|617007778|FG000|Overall Study|Adverse Event|18|||
170727480|NCT00254982|617007779|FG001|Overall Study|Adverse Event|16|||
170727481|NCT00254982|617007778|FG000|Overall Study|Withdrawal by Subject|1|||
170727482|NCT00254982|617007779|FG001|Overall Study|Withdrawal by Subject|1|||
170727483|NCT00254982|617007778|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
170727484|NCT00254982|617007779|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
170727485|NCT00254982|617007778|FG000|Overall Study|Protocol deviation|1|||
170727486|NCT00254982|617007779|FG001|Overall Study|Protocol deviation|1|||
170727487|NCT00254982|617007778|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
170727488|NCT00254982|617007779|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
170727489|NCT00254982|617007778|FG000|Overall Study|Malignancy|0|||
170727490|NCT00254982|617007779|FG001|Overall Study|Malignancy|2|||
170727491|NCT00254982|617007778|FG000|Overall Study|Opportunistic infection|1|||
170727492|NCT00254982|617007779|FG001|Overall Study|Opportunistic infection|0|||
170727493|NCT00254982|617007778|FG000|Overall Study|Abnormal liver function tests|2|||
170727494|NCT00254982|617007779|FG001|Overall Study|Abnormal liver function tests|1|||
170727495|NCT02261493|617007780|FG000|Overall Study|Noncompliance|0|||
170727496|NCT02261493|617007781|FG001|Overall Study|Noncompliance|0|||
170727497|NCT02261493|617007782|FG002|Overall Study|Noncompliance|2|||
170727498|NCT02261493|617007780|FG000|Overall Study|Physician Decision|0|||
170727499|NCT02261493|617007781|FG001|Overall Study|Physician Decision|1|||
170727500|NCT02261493|617007782|FG002|Overall Study|Physician Decision|0|||
170727501|NCT02261493|617007780|FG000|Overall Study|Undisclosed alcohol abuse|0|||
170727502|NCT02261493|617007781|FG001|Overall Study|Undisclosed alcohol abuse|1|||
170727503|NCT02261493|617007782|FG002|Overall Study|Undisclosed alcohol abuse|0|||
170727504|NCT02261493|617007780|FG000|Overall Study|Protocol Violation|1|||
170727505|NCT02261493|617007781|FG001|Overall Study|Protocol Violation|0|||
170727506|NCT02261493|617007782|FG002|Overall Study|Protocol Violation|0|||
170727507|NCT02261493|617007780|FG000|Overall Study|Personal Reasons|14|||
170727508|NCT02261493|617007781|FG001|Overall Study|Personal Reasons|14|||
170727509|NCT02261493|617007782|FG002|Overall Study|Personal Reasons|16|||
170727510|NCT02261493|617007780|FG000|Overall Study|Lost to Follow-up|14|||
170727511|NCT02261493|617007781|FG001|Overall Study|Lost to Follow-up|27|||
170727512|NCT02261493|617007782|FG002|Overall Study|Lost to Follow-up|8|||
170727513|NCT02261493|617007780|FG000|Overall Study|Pregnancy|1|||
170727514|NCT02261493|617007781|FG001|Overall Study|Pregnancy|2|||
170727515|NCT02261493|617007782|FG002|Overall Study|Pregnancy|0|||
170727516|NCT02261493|617007780|FG000|Overall Study|Lack of Efficacy|0|||
170727517|NCT02261493|617007781|FG001|Overall Study|Lack of Efficacy|1|||
170727518|NCT02261493|617007782|FG002|Overall Study|Lack of Efficacy|0|||
170727519|NCT02261493|617007780|FG000|Overall Study|Adverse Event|0|||
170727520|NCT02261493|617007781|FG001|Overall Study|Adverse Event|1|||
170727521|NCT02261493|617007782|FG002|Overall Study|Adverse Event|0|||
170727522|NCT00558428|617007783|FG000|Overall Study|Adverse Event|6|||
170727523|NCT00558428|617007784|FG001|Overall Study|Adverse Event|22|||
170727524|NCT00558428|617007785|FG002|Overall Study|Adverse Event|3|||
170835973|NCT00150618|617407306|FG004|Overall Study|Lost to Follow-up|4|||
170835974|NCT00150618|617407302|FG000|Overall Study|Protocol Violation|1|||
170835975|NCT00150618|617407303|FG001|Overall Study|Protocol Violation|0|||
170835976|NCT00150618|617407304|FG002|Overall Study|Protocol Violation|0|||
170835977|NCT00150618|617407305|FG003|Overall Study|Protocol Violation|0|||
170835978|NCT00150618|617407306|FG004|Overall Study|Protocol Violation|1|||
170835979|NCT00150618|617407302|FG000|Overall Study|Lack of Efficacy|1|||
170835980|NCT00150618|617407303|FG001|Overall Study|Lack of Efficacy|4|||
170835981|NCT00150618|617407304|FG002|Overall Study|Lack of Efficacy|7|||
170835982|NCT00150618|617407305|FG003|Overall Study|Lack of Efficacy|4|||
170835983|NCT00150618|617407306|FG004|Overall Study|Lack of Efficacy|6|||
170835984|NCT00150618|617407302|FG000|Overall Study|No study meds|0|||
170835985|NCT00150618|617407303|FG001|Overall Study|No study meds|0|||
170835986|NCT00150618|617407304|FG002|Overall Study|No study meds|0|||
170835987|NCT00150618|617407305|FG003|Overall Study|No study meds|0|||
170835988|NCT00150618|617407306|FG004|Overall Study|No study meds|2|||
170835989|NCT00150618|617407302|FG000|Overall Study|Physician Decision|0|||
170835990|NCT00150618|617407303|FG001|Overall Study|Physician Decision|2|||
170835991|NCT00150618|617407304|FG002|Overall Study|Physician Decision|0|||
170835992|NCT00150618|617407305|FG003|Overall Study|Physician Decision|0|||
170835993|NCT00150618|617407306|FG004|Overall Study|Physician Decision|1|||
170835994|NCT00150618|617407302|FG000|Overall Study|Lack of compliance|2|||
170835995|NCT00150618|617407303|FG001|Overall Study|Lack of compliance|1|||
170835996|NCT00150618|617407304|FG002|Overall Study|Lack of compliance|1|||
170835997|NCT00150618|617407305|FG003|Overall Study|Lack of compliance|0|||
170835998|NCT00150618|617407306|FG004|Overall Study|Lack of compliance|1|||
170835999|NCT00150618|617407302|FG000|Overall Study|Abnormal ECG|1|||
170836000|NCT00150618|617407303|FG001|Overall Study|Abnormal ECG|0|||
170836001|NCT00150618|617407304|FG002|Overall Study|Abnormal ECG|0|||
170836002|NCT00150618|617407305|FG003|Overall Study|Abnormal ECG|0|||
170836003|NCT00150618|617407306|FG004|Overall Study|Abnormal ECG|0|||
170836004|NCT00150618|617407302|FG000|Overall Study|Sponsor's decision|0|||
170836005|NCT00150618|617407303|FG001|Overall Study|Sponsor's decision|0|||
170836006|NCT00150618|617407304|FG002|Overall Study|Sponsor's decision|0|||
170836007|NCT00150618|617407305|FG003|Overall Study|Sponsor's decision|1|||
170836008|NCT00150618|617407306|FG004|Overall Study|Sponsor's decision|0|||
170836009|NCT00478205|617407307|FG000|Overall Study|Adverse Event|182|||
170836010|NCT00478205|617407308|FG001|Overall Study|Adverse Event|39|||
170836011|NCT00478205|617407307|FG000|Overall Study|Medication Non-compliance|9|||
170836012|NCT00478205|617407308|FG001|Overall Study|Medication Non-compliance|4|||
170836013|NCT00478205|617407307|FG000|Overall Study|Protocol Violation|15|||
170836014|NCT00478205|617407308|FG001|Overall Study|Protocol Violation|5|||
170836015|NCT00478205|617407307|FG000|Overall Study|Request of Investigator or Sponsor|4|||
170836016|NCT00478205|617407308|FG001|Overall Study|Request of Investigator or Sponsor|5|||
170836017|NCT00478205|617407307|FG000|Overall Study|Withdrawal by Subject|61|||
170836018|NCT00478205|617407308|FG001|Overall Study|Withdrawal by Subject|22|||
170836019|NCT00478205|617407307|FG000|Overall Study|Lack of Efficacy|1|||
170836020|NCT00478205|617407308|FG001|Overall Study|Lack of Efficacy|0|||
170836021|NCT00478205|617407307|FG000|Overall Study|Other|24|||
170836022|NCT00478205|617407308|FG001|Overall Study|Other|12|||
170836023|NCT00763451|617407309|FG000|Overall Study|Adverse Event|4|||
170836024|NCT00763451|617407310|FG001|Overall Study|Adverse Event|6|||
170836025|NCT00763451|617407311|FG002|Overall Study|Adverse Event|19|||
170836026|NCT00763451|617407312|FG003|Overall Study|Adverse Event|14|||
170836027|NCT00763451|617407309|FG000|Overall Study|Lack of Efficacy|1|||
170836028|NCT00763451|617407310|FG001|Overall Study|Lack of Efficacy|4|||
170836029|NCT00763451|617407311|FG002|Overall Study|Lack of Efficacy|3|||
170836030|NCT00763451|617407312|FG003|Overall Study|Lack of Efficacy|2|||
170836031|NCT00763451|617407309|FG000|Overall Study|Withdrawal by Subject|1|||
170836032|NCT00763451|617407310|FG001|Overall Study|Withdrawal by Subject|6|||
170836033|NCT00763451|617407311|FG002|Overall Study|Withdrawal by Subject|9|||
170836034|NCT00763451|617407312|FG003|Overall Study|Withdrawal by Subject|7|||
170836035|NCT00763451|617407309|FG000|Overall Study|Protocol Violation|0|||
170836036|NCT00763451|617407310|FG001|Overall Study|Protocol Violation|0|||
170836037|NCT00763451|617407311|FG002|Overall Study|Protocol Violation|1|||
170836038|NCT00763451|617407312|FG003|Overall Study|Protocol Violation|0|||
170836039|NCT00763451|617407309|FG000|Overall Study|Poor Compliance to Protocol|1|||
170836040|NCT00763451|617407310|FG001|Overall Study|Poor Compliance to Protocol|1|||
170836041|NCT00763451|617407311|FG002|Overall Study|Poor Compliance to Protocol|2|||
170836042|NCT00763451|617407312|FG003|Overall Study|Poor Compliance to Protocol|2|||
170836043|NCT00763451|617407309|FG000|Overall Study|Familial and Personal Reasons|5|||
170836044|NCT00763451|617407310|FG001|Overall Study|Familial and Personal Reasons|3|||
170836045|NCT00763451|617407311|FG002|Overall Study|Familial and Personal Reasons|5|||
170836046|NCT00763451|617407312|FG003|Overall Study|Familial and Personal Reasons|4|||
170836047|NCT00763451|617407309|FG000|Overall Study|Randomized but not Treated|1|||
170836048|NCT00763451|617407310|FG001|Overall Study|Randomized but not Treated|1|||
170836049|NCT00763451|617407311|FG002|Overall Study|Randomized but not Treated|0|||
170836050|NCT00763451|617407312|FG003|Overall Study|Randomized but not Treated|0|||
170836051|NCT00763451|617407309|FG000|Overall Study|Study Site Reason|0|||
170836052|NCT00763451|617407310|FG001|Overall Study|Study Site Reason|1|||
170836053|NCT00763451|617407311|FG002|Overall Study|Study Site Reason|1|||
170836054|NCT00763451|617407312|FG003|Overall Study|Study Site Reason|1|||
170836055|NCT01255761|617407313|FG000|Overall Study|Adverse Event|29|||
170836056|NCT01255761|617407314|FG001|Overall Study|Adverse Event|43|||
170836057|NCT01255761|617407313|FG000|Overall Study|Lack of Efficacy|86|||
170836058|NCT01255761|617407314|FG001|Overall Study|Lack of Efficacy|74|||
170836059|NCT01255761|617407313|FG000|Overall Study|Protocol Violation|9|||
170836060|NCT01255761|617407314|FG001|Overall Study|Protocol Violation|5|||
170836061|NCT01255761|617407313|FG000|Overall Study|Lost to Follow-up|10|||
170836062|NCT01255761|617407314|FG001|Overall Study|Lost to Follow-up|8|||
170836063|NCT01255761|617407313|FG000|Overall Study|Withdrawal by Subject|11|||
170836064|NCT01255761|617407314|FG001|Overall Study|Withdrawal by Subject|27|||
170836065|NCT01255761|617407313|FG000|Overall Study|Other Reasons|37|||
170836066|NCT01255761|617407314|FG001|Overall Study|Other Reasons|18|||
170836067|NCT00658606|617407315|FG000|Overall Study|Adverse Event|2|||
170836068|NCT00658606|617407316|FG001|Overall Study|Adverse Event|1|||
170836069|NCT00658606|617407315|FG000|Overall Study|Lack of Efficacy|6|||
170836070|NCT00658606|617407316|FG001|Overall Study|Lack of Efficacy|3|||
170836071|NCT00658606|617407315|FG000|Overall Study|Lost to Follow-up|1|||
170836072|NCT00658606|617407316|FG001|Overall Study|Lost to Follow-up|0|||
170836073|NCT00658606|617407315|FG000|Overall Study|Withdrawal by Subject|7|||
170836074|NCT00658606|617407316|FG001|Overall Study|Withdrawal by Subject|16|||
170836075|NCT00658606|617407315|FG000|Overall Study|Lack of Compliance|0|||
170836076|NCT00658606|617407316|FG001|Overall Study|Lack of Compliance|3|||
170836077|NCT01191008|617407317|FG000|Overall Study|Protocol Violation|7|||
170836078|NCT01191008|617407317|FG000|Overall Study|Lost to Follow-up|8|||
170836079|NCT05903183|617407320|FG000|Main Trial Part (365 Days)|Death|1|||
170836080|NCT05903183|617407321|FG001|Main Trial Part (365 Days)|Death|0|||
170836081|NCT05903183|617407322|FG002|Main Trial Part (365 Days)|Death|0|||
170836082|NCT05903183|617407323|FG003|Main Trial Part (365 Days)|Death|0|||
170836083|NCT05903183|617407324|FG004|Main Trial Part (365 Days)|Death|0|||
170836084|NCT05903183|617407320|FG000|Main Trial Part (365 Days)|Other|1|||
170836085|NCT05903183|617407321|FG001|Main Trial Part (365 Days)|Other|2|||
170836086|NCT05903183|617407322|FG002|Main Trial Part (365 Days)|Other|1|||
170836087|NCT05903183|617407323|FG003|Main Trial Part (365 Days)|Other|0|||
170836088|NCT05903183|617407324|FG004|Main Trial Part (365 Days)|Other|0|||
170836089|NCT05903183|617407320|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
170836090|NCT05903183|617407321|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
170836091|NCT05903183|617407322|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
170836092|NCT05903183|617407323|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
170836093|NCT05903183|617407324|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
170836094|NCT05903183|617407320|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
170836095|NCT05903183|617407321|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
170836096|NCT05903183|617407322|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
170836097|NCT05903183|617407323|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
170836098|NCT05903183|617407324|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
170836099|NCT05903183|617407320|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
170836100|NCT05903183|617407321|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
170836101|NCT05903183|617407322|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
170836102|NCT05903183|617407323|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
170836103|NCT05903183|617407324|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
170836104|NCT00569127|617407325|FG000|Overall Study|Adverse Event|57|||
170836105|NCT00569127|617407326|FG001|Overall Study|Adverse Event|47|||
170836106|NCT00569127|617407325|FG000|Overall Study|Withdrawal by Subject|13|||
170836107|NCT00569127|617407326|FG001|Overall Study|Withdrawal by Subject|27|||
170836108|NCT00569127|617407325|FG000|Overall Study|Progression|99|||
170836109|NCT00569127|617407326|FG001|Overall Study|Progression|100|||
170836110|NCT00569127|617407325|FG000|Overall Study|Death|4|||
170836111|NCT00569127|617407326|FG001|Overall Study|Death|3|||
170836112|NCT00569127|617407325|FG000|Overall Study|Other|20|||
170836113|NCT00569127|617407326|FG001|Overall Study|Other|19|||
170836114|NCT00569127|617407325|FG000|Overall Study|Lost to Follow-up|0|||
170836115|NCT00569127|617407326|FG001|Overall Study|Lost to Follow-up|3|||
170836116|NCT00569127|617407325|FG000|Overall Study|Not Eligible|14|||
170836117|NCT00569127|617407326|FG001|Overall Study|Not Eligible|11|||
170836118|NCT00569127|617407325|FG000|Overall Study|Still on Treatment|7|||
170836119|NCT00569127|617407326|FG001|Overall Study|Still on Treatment|3|||
170836120|NCT02037256|617407341|FG000|Overall Study|Protocol Violation|0|||
170836121|NCT02037256|617407342|FG001|Overall Study|Protocol Violation|1|||
170836122|NCT02037256|617407341|FG000|Overall Study|Withdrawn prior to Velcade|0|||
170836123|NCT02037256|617407342|FG001|Overall Study|Withdrawn prior to Velcade|2|||
170836124|NCT03371823|617407345|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
170836125|NCT03371823|617407346|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
170836126|NCT01466790|617407348|FG000|Overall Study|Adverse Event|1|||
170836127|NCT01466790|617407349|FG001|Overall Study|Adverse Event|0|||
170836128|NCT01466790|617407350|FG002|Overall Study|Adverse Event|0|||
170836129|NCT01466790|617407351|FG003|Overall Study|Adverse Event|0|||
170836130|NCT01466790|617407352|FG004|Overall Study|Adverse Event|2|||
170836131|NCT01466790|617407353|FG005|Overall Study|Adverse Event|0|||
170836132|NCT01466790|617407354|FG006|Overall Study|Adverse Event|0|||
170836133|NCT01466790|617407355|FG007|Overall Study|Adverse Event|0|||
170727525|NCT00558428|617007786|FG003|Overall Study|Adverse Event|4|||
170727526|NCT00558428|617007783|FG000|Overall Study|Lost to Follow-up|0|||
170727527|NCT00558428|617007784|FG001|Overall Study|Lost to Follow-up|1|||
170727528|NCT00558428|617007785|FG002|Overall Study|Lost to Follow-up|0|||
170727529|NCT00558428|617007786|FG003|Overall Study|Lost to Follow-up|0|||
170727530|NCT00558428|617007783|FG000|Overall Study|Lack of Efficacy|0|||
170727531|NCT00558428|617007784|FG001|Overall Study|Lack of Efficacy|0|||
170727532|NCT00558428|617007785|FG002|Overall Study|Lack of Efficacy|1|||
170727533|NCT00558428|617007786|FG003|Overall Study|Lack of Efficacy|2|||
170727534|NCT00558428|617007783|FG000|Overall Study|Non compliant with protocol|1|||
170727535|NCT00558428|617007784|FG001|Overall Study|Non compliant with protocol|0|||
170727536|NCT00558428|617007785|FG002|Overall Study|Non compliant with protocol|0|||
170727537|NCT00558428|617007786|FG003|Overall Study|Non compliant with protocol|3|||
170727538|NCT00558428|617007783|FG000|Overall Study|Consent withdrawn|2|||
170727539|NCT00558428|617007784|FG001|Overall Study|Consent withdrawn|1|||
170727540|NCT00558428|617007785|FG002|Overall Study|Consent withdrawn|0|||
170727541|NCT00558428|617007786|FG003|Overall Study|Consent withdrawn|1|||
170727542|NCT00558428|617007783|FG000|Overall Study|Other|3|||
170727543|NCT00558428|617007784|FG001|Overall Study|Other|0|||
170727544|NCT00558428|617007785|FG002|Overall Study|Other|0|||
170727545|NCT00558428|617007786|FG003|Overall Study|Other|1|||
170727546|NCT00626028|617007787|FG000|Overall Study|Adverse Event|1|||
170727547|NCT00626028|617007788|FG001|Overall Study|Adverse Event|1|||
170727548|NCT00626028|617007787|FG000|Overall Study|Device Failure|0|||
170727549|NCT00626028|617007788|FG001|Overall Study|Device Failure|1|||
170727550|NCT00626028|617007787|FG000|Overall Study|Physician Decision|2|||
170727551|NCT00626028|617007788|FG001|Overall Study|Physician Decision|1|||
170727552|NCT00626028|617007787|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
170727553|NCT00626028|617007788|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
170727554|NCT05224050|617007789|FG000|Overall Study|Withdrawal by Subject|9|||
170727555|NCT05224050|617007789|FG000|Overall Study|Lost to Follow-up|3|||
170727556|NCT01627327|617007791|FG000|Overall Study|Adverse Event|6|||
170727557|NCT01627327|617007792|FG001|Overall Study|Adverse Event|12|||
170727558|NCT01627327|617007791|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
170727559|NCT01627327|617007792|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
170727560|NCT01627327|617007791|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
170727561|NCT01627327|617007792|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
170727562|NCT01627327|617007791|FG000|Overall Study|Protocol Violation|4|||
170727563|NCT01627327|617007792|FG001|Overall Study|Protocol Violation|10|||
170727564|NCT01627327|617007791|FG000|Overall Study|Lost to Follow-up|1|||
170727565|NCT01627327|617007792|FG001|Overall Study|Lost to Follow-up|3|||
170727566|NCT01627327|617007791|FG000|Overall Study|Physician Decision|1|||
170727567|NCT01627327|617007792|FG001|Overall Study|Physician Decision|0|||
170727568|NCT01627327|617007791|FG000|Overall Study|Withdrawal by Subject|3|||
170727569|NCT01627327|617007792|FG001|Overall Study|Withdrawal by Subject|3|||
170727570|NCT00754338|617007793|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
170727571|NCT00754338|617007794|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
170727572|NCT00754338|617007795|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
170727573|NCT00754338|617007796|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
170727574|NCT00754338|617007793|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
170727575|NCT00754338|617007794|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
170727576|NCT00754338|617007795|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
170727577|NCT00754338|617007796|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
170727578|NCT00831779|617007802|FG000|Overall Study|Lost to Follow-up|1|||
170727579|NCT00831779|617007803|FG001|Overall Study|Lost to Follow-up|0|||
170727580|NCT00831779|617007802|FG000|Overall Study|No longer met criteria|0|||
170727581|NCT00831779|617007803|FG001|Overall Study|No longer met criteria|1|||
170727582|NCT04528069|617007804|FG000|Overall Study|Adverse Event|1|||
170836134|NCT01466790|617407348|FG000|Overall Study|Lost to Follow-up|2|||
170836135|NCT01466790|617407349|FG001|Overall Study|Lost to Follow-up|0|||
170836136|NCT01466790|617407350|FG002|Overall Study|Lost to Follow-up|0|||
170836137|NCT01466790|617407351|FG003|Overall Study|Lost to Follow-up|0|||
170836138|NCT01466790|617407352|FG004|Overall Study|Lost to Follow-up|0|||
170836139|NCT01466790|617407353|FG005|Overall Study|Lost to Follow-up|0|||
170836140|NCT01466790|617407354|FG006|Overall Study|Lost to Follow-up|0|||
170836141|NCT01466790|617407355|FG007|Overall Study|Lost to Follow-up|0|||
170836142|NCT01466790|617407348|FG000|Overall Study|Withdrawal by Subject|1|||
170836143|NCT01466790|617407349|FG001|Overall Study|Withdrawal by Subject|1|||
170836144|NCT01466790|617407350|FG002|Overall Study|Withdrawal by Subject|0|||
170836145|NCT01466790|617407351|FG003|Overall Study|Withdrawal by Subject|0|||
170836146|NCT01466790|617407352|FG004|Overall Study|Withdrawal by Subject|1|||
170836147|NCT01466790|617407353|FG005|Overall Study|Withdrawal by Subject|0|||
170836148|NCT01466790|617407354|FG006|Overall Study|Withdrawal by Subject|1|||
170836149|NCT01466790|617407355|FG007|Overall Study|Withdrawal by Subject|1|||
170836150|NCT01310699|617407357|FG000|Overall Study|Patients did not complete tandem.|4|||
170836151|NCT01310699|617407358|FG001|Overall Study|Patients did not complete tandem.|6|||
170836152|NCT00936598|617407359|FG000|Overall Study|Withdrawal by Subject|1|||
170836153|NCT00936598|617407360|FG001|Overall Study|Withdrawal by Subject|0|||
170836154|NCT00936598|617407359|FG000|Overall Study|Ineligible after consent|1|||
170836155|NCT00936598|617407360|FG001|Overall Study|Ineligible after consent|0|||
170836156|NCT02386839|617407361|FG000|Overall Study|Death|1|||
170836157|NCT02386839|617407362|FG001|Overall Study|Death|0|||
170836158|NCT02386839|617407361|FG000|Overall Study|Withdrawal by Subject|9|||
170836159|NCT02386839|617407362|FG001|Overall Study|Withdrawal by Subject|10|||
170836160|NCT02386839|617407361|FG000|Overall Study|Lost to Follow-up|4|||
170836161|NCT02386839|617407362|FG001|Overall Study|Lost to Follow-up|4|||
170836162|NCT02386839|617407361|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
170836163|NCT02386839|617407362|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
170836164|NCT02386839|617407361|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
170836165|NCT02386839|617407362|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
170836166|NCT02386839|617407361|FG000|Overall Study|Other (unspecified)|1|||
170836167|NCT02386839|617407362|FG001|Overall Study|Other (unspecified)|0|||
170836168|NCT00490698|617407365|FG000|Overall Study|Withdrawal by Subject|1|||
170836169|NCT00490698|617407365|FG000|Overall Study|Disease Progression|7|||
170836170|NCT00490698|617407365|FG000|Overall Study|Physician Decision|2|||
170836171|NCT01431950|617407366|FG000|Overall Study|Study Site Closed/Terminated|7|||
170836172|NCT01431950|617407367|FG001|Overall Study|Study Site Closed/Terminated|3|||
170836173|NCT01431950|617407366|FG000|Overall Study|Withdrawal by Subject|4|||
170836174|NCT01431950|617407367|FG001|Overall Study|Withdrawal by Subject|3|||
170836175|NCT01431950|617407366|FG000|Overall Study|Protocol Violation|2|||
170836176|NCT01431950|617407367|FG001|Overall Study|Protocol Violation|3|||
170836177|NCT01431950|617407366|FG000|Overall Study|Adverse Event|2|||
170836178|NCT01431950|617407367|FG001|Overall Study|Adverse Event|2|||
170836179|NCT01431950|617407366|FG000|Overall Study|Physician Decision|2|||
170836180|NCT01431950|617407367|FG001|Overall Study|Physician Decision|1|||
170836181|NCT01431950|617407366|FG000|Overall Study|Lack of Efficacy|2|||
170836182|NCT01431950|617407367|FG001|Overall Study|Lack of Efficacy|1|||
170836183|NCT01431950|617407366|FG000|Overall Study|Lost to Follow-up|0|||
170836184|NCT01431950|617407367|FG001|Overall Study|Lost to Follow-up|1|||
170836185|NCT01431950|617407366|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
170836186|NCT01431950|617407367|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
170836187|NCT02101983|617407372|FG000|Overall Study|Physician Decision|1|||
170836188|NCT02101983|617407373|FG001|Overall Study|Physician Decision|0|||
170836189|NCT03494985|617407374|FG000|Overall Study|Adverse Event|3|||
170836190|NCT03494985|617407375|FG001|Overall Study|Adverse Event|2|||
170836191|NCT03494985|617407376|FG002|Overall Study|Adverse Event|3|||
170836192|NCT03494985|617407377|FG003|Overall Study|Adverse Event|0|||
170836193|NCT03494985|617407374|FG000|Overall Study|Other (Withdrawal of consent)|2|||
170836194|NCT03494985|617407375|FG001|Overall Study|Other (Withdrawal of consent)|3|||
170836195|NCT03494985|617407376|FG002|Overall Study|Other (Withdrawal of consent)|2|||
170836196|NCT03494985|617407377|FG003|Overall Study|Other (Withdrawal of consent)|5|||
170836197|NCT03494985|617407374|FG000|Overall Study|Other (Not specified)|0|||
170836198|NCT03494985|617407375|FG001|Overall Study|Other (Not specified)|1|||
170836199|NCT03494985|617407376|FG002|Overall Study|Other (Not specified)|1|||
170836200|NCT03494985|617407377|FG003|Overall Study|Other (Not specified)|0|||
170836201|NCT04870957|617407378|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
170836202|NCT04870957|617407379|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
170836203|NCT04870957|617407380|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
170836204|NCT04870957|617407381|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
170836205|NCT04870957|617407382|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
170836206|NCT04870957|617407383|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
170836207|NCT04870957|617407378|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
170836208|NCT04870957|617407379|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
170727583|NCT04528069|617007804|FG000|Overall Study|Lost to Follow-up|1|||
170727584|NCT04528069|617007804|FG000|Overall Study|Patient Unable to Come|1|||
170727585|NCT04528069|617007804|FG000|Overall Study|Patient Unable to Attend|1|||
170727586|NCT01814371|617007807|FG000|Overall Study|Lost to Follow-up|30|||
170836209|NCT04870957|617407380|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
170836210|NCT04870957|617407381|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
170836211|NCT04870957|617407382|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
170836212|NCT04870957|617407383|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
170836213|NCT04870957|617407378|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
170836214|NCT04870957|617407379|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
170836215|NCT04870957|617407380|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
170836216|NCT04870957|617407381|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
170836217|NCT04870957|617407382|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
170836218|NCT04870957|617407383|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
170836219|NCT04870957|617407378|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
170836220|NCT04870957|617407379|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
170836221|NCT04870957|617407380|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
170836222|NCT04870957|617407381|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
170836223|NCT04870957|617407382|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
170836224|NCT04870957|617407383|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
170836225|NCT04870957|617407378|FG000|T2 (Randomization) - T3|Adverse Event|1|||
170836226|NCT04870957|617407379|FG001|T2 (Randomization) - T3|Adverse Event|1|||
170836227|NCT04870957|617407380|FG002|T2 (Randomization) - T3|Adverse Event|0|||
170836228|NCT04870957|617407381|FG003|T2 (Randomization) - T3|Adverse Event|0|||
170836229|NCT04870957|617407382|FG004|T2 (Randomization) - T3|Adverse Event|0|||
170836230|NCT04870957|617407383|FG005|T2 (Randomization) - T3|Adverse Event|0|||
170836231|NCT04870957|617407378|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
170836232|NCT04870957|617407379|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
170836233|NCT04870957|617407380|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
170836234|NCT04870957|617407381|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
170836235|NCT04870957|617407382|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
170836236|NCT04870957|617407383|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
170836237|NCT04870957|617407378|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
170836238|NCT04870957|617407379|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
170836239|NCT04870957|617407380|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
170836240|NCT04870957|617407381|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
170836241|NCT04870957|617407382|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
170836242|NCT04870957|617407383|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
170836243|NCT04870957|617407378|FG000|T2 (Randomization) - T3|Physician Decision|0|||
170836244|NCT04870957|617407379|FG001|T2 (Randomization) - T3|Physician Decision|0|||
170836245|NCT04870957|617407380|FG002|T2 (Randomization) - T3|Physician Decision|2|||
170836246|NCT04870957|617407381|FG003|T2 (Randomization) - T3|Physician Decision|1|||
170836247|NCT04870957|617407382|FG004|T2 (Randomization) - T3|Physician Decision|0|||
170836248|NCT04870957|617407383|FG005|T2 (Randomization) - T3|Physician Decision|0|||
170836249|NCT04870957|617407378|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
170836250|NCT04870957|617407379|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
170836251|NCT04870957|617407380|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
170836252|NCT04870957|617407381|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
170836253|NCT04870957|617407382|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
170836254|NCT04870957|617407383|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
170836255|NCT04870957|617407378|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
170836256|NCT04870957|617407379|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
170836257|NCT04870957|617407380|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
170836258|NCT04870957|617407381|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
170836259|NCT04870957|617407382|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
170836260|NCT04870957|617407383|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
170836261|NCT04870957|617407378|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
170836262|NCT04870957|617407379|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
170836263|NCT04870957|617407380|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
170836264|NCT04870957|617407381|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
170836265|NCT04870957|617407382|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
170836266|NCT04870957|617407383|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
170836267|NCT04870957|617407378|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
170836268|NCT04870957|617407379|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
170836269|NCT04870957|617407380|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
170836270|NCT04870957|617407381|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
170836271|NCT04870957|617407382|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
170836272|NCT04870957|617407383|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
170836273|NCT04870957|617407378|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
170836274|NCT04870957|617407379|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
170836275|NCT04870957|617407380|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
170836276|NCT04870957|617407381|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
170836277|NCT04870957|617407382|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
170836278|NCT04870957|617407383|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
170836279|NCT04870957|617407378|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
170836280|NCT04870957|617407379|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
170836281|NCT04870957|617407380|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
170836282|NCT04870957|617407381|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
170836283|NCT04870957|617407382|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
170836284|NCT04870957|617407383|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
170836285|NCT04870957|617407378|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
170836286|NCT04870957|617407379|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
170836287|NCT04870957|617407380|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
170836288|NCT04870957|617407381|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
170836289|NCT04870957|617407382|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
170836290|NCT04870957|617407383|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
170836291|NCT04870957|617407378|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
170836292|NCT04870957|617407379|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
170836293|NCT04870957|617407380|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
170836294|NCT04870957|617407381|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
170836295|NCT04870957|617407382|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
170836296|NCT04870957|617407383|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
170836297|NCT04870957|617407378|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
170836298|NCT04870957|617407379|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
170836299|NCT04870957|617407380|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
170836300|NCT04870957|617407381|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
170836301|NCT04870957|617407382|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
170727587|NCT01814371|617007808|FG001|Overall Study|Lost to Follow-up|27|||
170727588|NCT04683926|617007809|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
170727589|NCT04683926|617007810|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
170727590|NCT04683926|617007811|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
170727591|NCT04683926|617007812|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
170727592|NCT01692782|617007813|FG000|Overall Study|Adverse Event|12|||
170727593|NCT01692782|617007814|FG001|Overall Study|Adverse Event|32|||
170727594|NCT01692782|617007815|FG002|Overall Study|Adverse Event|2|||
170727595|NCT01692782|617007813|FG000|Overall Study|Lack of Efficacy|1|||
170727596|NCT01692782|617007814|FG001|Overall Study|Lack of Efficacy|2|||
170727597|NCT01692782|617007815|FG002|Overall Study|Lack of Efficacy|0|||
170727598|NCT01692782|617007813|FG000|Overall Study|Lost to Follow-up|2|||
170727599|NCT01692782|617007814|FG001|Overall Study|Lost to Follow-up|7|||
170727600|NCT01692782|617007815|FG002|Overall Study|Lost to Follow-up|1|||
170727601|NCT01692782|617007813|FG000|Overall Study|Pregnancy|1|||
170727602|NCT01692782|617007814|FG001|Overall Study|Pregnancy|0|||
170727603|NCT01692782|617007815|FG002|Overall Study|Pregnancy|0|||
170727604|NCT01692782|617007813|FG000|Overall Study|Protocol Violation|1|||
170727605|NCT01692782|617007814|FG001|Overall Study|Protocol Violation|0|||
170727606|NCT01692782|617007815|FG002|Overall Study|Protocol Violation|2|||
170727607|NCT01692782|617007813|FG000|Overall Study|Non-complance with study drug|0|||
170727608|NCT01692782|617007814|FG001|Overall Study|Non-complance with study drug|4|||
170727609|NCT01692782|617007815|FG002|Overall Study|Non-complance with study drug|1|||
170727610|NCT01692782|617007813|FG000|Overall Study|Non-compliant with study visits|0|||
170727611|NCT01692782|617007814|FG001|Overall Study|Non-compliant with study visits|0|||
170727612|NCT01692782|617007815|FG002|Overall Study|Non-compliant with study visits|1|||
170727613|NCT01692782|617007813|FG000|Overall Study|SAE not related to study drug|0|||
170727614|NCT01692782|617007814|FG001|Overall Study|SAE not related to study drug|1|||
170727615|NCT01692782|617007815|FG002|Overall Study|SAE not related to study drug|0|||
170727616|NCT01692782|617007813|FG000|Overall Study|Withdrawal by Subject|3|||
170836302|NCT04870957|617407383|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
170836303|NCT05970640|617407384|FG000|Overall Study|Adverse Event|1|||
170727617|NCT01692782|617007814|FG001|Overall Study|Withdrawal by Subject|10|||
170727618|NCT01692782|617007815|FG002|Overall Study|Withdrawal by Subject|3|||
170727619|NCT00868439|617007828|FG000|Overall Study|Adverse Event|4|||
170727620|NCT00868439|617007829|FG001|Overall Study|Adverse Event|3|||
170836304|NCT05970640|617407385|FG001|Overall Study|Adverse Event|3|||
170836305|NCT05970640|617407386|FG002|Overall Study|Adverse Event|1|||
170727621|NCT00868439|617007828|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
170727622|NCT00868439|617007829|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
170727623|NCT00868439|617007828|FG000|Overall Study|Death|0|||
170727624|NCT00868439|617007829|FG001|Overall Study|Death|1|||
170727625|NCT00868439|617007828|FG000|Overall Study|Protocol Violation|1|||
170727626|NCT00868439|617007829|FG001|Overall Study|Protocol Violation|1|||
170727627|NCT00868439|617007828|FG000|Overall Study|Physician Decision|1|||
170727628|NCT00868439|617007829|FG001|Overall Study|Physician Decision|0|||
170727629|NCT00868439|617007828|FG000|Overall Study|Withdrawal by Subject|0|||
170727630|NCT00868439|617007829|FG001|Overall Study|Withdrawal by Subject|1|||
170727631|NCT00952367|617007830|FG000|Overall Study|Withdrawal by Subject|2|||
170727632|NCT00952367|617007830|FG000|Overall Study|Noncoordination|1|||
170727633|NCT00952367|617007830|FG000|Overall Study|Protocol Violation|3|||
170727634|NCT01777854|617007833|FG000|Overall Study|Physician Decision|3|||
170727635|NCT01777854|617007834|FG001|Overall Study|Physician Decision|3|||
170727636|NCT01693068|617007838|FG000|Randomization Period|On-study|2|||
170727637|NCT01693068|617007839|FG001|Randomization Period|On-study|5|||
170727638|NCT01693068|617007840|FG002|Randomization Period|On-study|0|||
170727639|NCT01693068|617007838|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
170727640|NCT01693068|617007839|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
170727641|NCT01693068|617007840|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
170727642|NCT00734630|617007842|FG000|Overall Study|Lack of Efficacy|4|||
170727643|NCT00734630|617007843|FG001|Overall Study|Lack of Efficacy|4|||
170727644|NCT00734630|617007842|FG000|Overall Study|Withdrawal by Subject|7|||
170727645|NCT00734630|617007843|FG001|Overall Study|Withdrawal by Subject|9|||
170727646|NCT00734630|617007842|FG000|Overall Study|Lost to Follow-up|13|||
170727647|NCT00734630|617007843|FG001|Overall Study|Lost to Follow-up|7|||
170727648|NCT00734630|617007842|FG000|Overall Study|Protocol Violation|0|||
170727649|NCT00734630|617007843|FG001|Overall Study|Protocol Violation|3|||
170727650|NCT00734630|617007842|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
170727651|NCT00734630|617007843|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
170727652|NCT00734630|617007842|FG000|Overall Study|Adverse Event|3|||
170727653|NCT00734630|617007843|FG001|Overall Study|Adverse Event|6|||
170727654|NCT00734630|617007842|FG000|Overall Study|Randomized in Error|0|||
170727655|NCT00734630|617007843|FG001|Overall Study|Randomized in Error|1|||
170727656|NCT00734630|617007842|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
170727657|NCT00734630|617007843|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
170727658|NCT00734630|617007842|FG000|Overall Study|Poor Compliance|1|||
170727659|NCT00734630|617007843|FG001|Overall Study|Poor Compliance|1|||
170727660|NCT01239030|617007844|FG000|Double Blind|Adverse Event|0|||
170727661|NCT01239030|617007845|FG001|Double Blind|Adverse Event|1|||
170727662|NCT01239030|617007846|FG002|Double Blind|Adverse Event|0|||
170727663|NCT01239030|617007847|FG003|Double Blind|Adverse Event|2|||
170727664|NCT01239030|617007848|FG004|Double Blind|Adverse Event|0|||
170727665|NCT01239030|617007844|FG000|Double Blind|Withdrawal by Subject|0|||
170727666|NCT01239030|617007845|FG001|Double Blind|Withdrawal by Subject|1|||
170727667|NCT01239030|617007846|FG002|Double Blind|Withdrawal by Subject|1|||
170727668|NCT01239030|617007847|FG003|Double Blind|Withdrawal by Subject|0|||
170727669|NCT01239030|617007848|FG004|Double Blind|Withdrawal by Subject|1|||
170727670|NCT01239030|617007844|FG000|Double Blind|Lost to Follow-up|1|||
170727671|NCT01239030|617007845|FG001|Double Blind|Lost to Follow-up|1|||
170727672|NCT01239030|617007846|FG002|Double Blind|Lost to Follow-up|0|||
170727673|NCT01239030|617007847|FG003|Double Blind|Lost to Follow-up|0|||
170727674|NCT01239030|617007848|FG004|Double Blind|Lost to Follow-up|0|||
170727675|NCT01239030|617007844|FG000|Double Blind|Physician Decision|0|||
170727676|NCT01239030|617007845|FG001|Double Blind|Physician Decision|1|||
170836306|NCT05970640|617407387|FG003|Overall Study|Adverse Event|0|||
170836307|NCT05970640|617407384|FG000|Overall Study|Withdrawal by Subject|0|||
170836308|NCT05970640|617407385|FG001|Overall Study|Withdrawal by Subject|0|||
170836309|NCT05970640|617407386|FG002|Overall Study|Withdrawal by Subject|1|||
170727677|NCT01239030|617007846|FG002|Double Blind|Physician Decision|0|||
170727678|NCT01239030|617007847|FG003|Double Blind|Physician Decision|0|||
170727679|NCT01239030|617007848|FG004|Double Blind|Physician Decision|0|||
170727680|NCT01239030|617007844|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
170727681|NCT01239030|617007845|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
170836310|NCT05970640|617407387|FG003|Overall Study|Withdrawal by Subject|1|||
170836311|NCT05970640|617407384|FG000|Overall Study|Sponsor decision|0|||
170836312|NCT05970640|617407385|FG001|Overall Study|Sponsor decision|0|||
170836313|NCT05970640|617407386|FG002|Overall Study|Sponsor decision|1|||
170836314|NCT05970640|617407387|FG003|Overall Study|Sponsor decision|1|||
170836315|NCT02394925|617407388|FG000|Overall Study|Adverse Event|1|||
170836316|NCT02394925|617407388|FG000|Overall Study|Lens Discomfort|3|||
170727682|NCT01239030|617007846|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
170727683|NCT01239030|617007847|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
170727684|NCT01239030|617007848|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
170727685|NCT01239030|617007844|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
170836317|NCT02394925|617407388|FG000|Overall Study|Lens handling difficulities|5|||
170727686|NCT01239030|617007845|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
170727687|NCT01239030|617007846|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
170727688|NCT01239030|617007847|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
170727689|NCT01239030|617007848|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
170727690|NCT01239030|617007844|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
170727691|NCT01239030|617007845|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
170727692|NCT01239030|617007846|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
170727693|NCT01239030|617007847|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
170727694|NCT01239030|617007848|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
170727695|NCT01239030|617007844|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
170727696|NCT01239030|617007845|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
170727697|NCT01239030|617007846|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
170727698|NCT01239030|617007847|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
170727699|NCT01239030|617007848|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
170727700|NCT04403698|617007849|FG000|Overall Study|Adverse Event|1|||
170727701|NCT04403698|617007850|FG001|Overall Study|Adverse Event|1|||
170727702|NCT04403698|617007849|FG000|Overall Study|Lost to Follow-up|1|||
170727703|NCT04403698|617007850|FG001|Overall Study|Lost to Follow-up|0|||
170727704|NCT04403698|617007849|FG000|Overall Study|Protocol Violation|0|||
170727705|NCT04403698|617007850|FG001|Overall Study|Protocol Violation|1|||
170727706|NCT00977665|617007851|FG000|Overall Study|Withdrawal by Subject|1|||
170727707|NCT00977665|617007852|FG001|Overall Study|Withdrawal by Subject|3|||
170727708|NCT00977665|617007851|FG000|Overall Study|Physician Decision|2|||
170836318|NCT02394925|617407388|FG000|Overall Study|Lost to Follow-up|9|||
170836319|NCT02394925|617407388|FG000|Overall Study|Protocol Violation|5|||
170836320|NCT02394925|617407388|FG000|Overall Study|No longer meet eligibility criteria|1|||
170836321|NCT02394925|617407388|FG000|Overall Study|Unsatisfactory Visual Response|5|||
170836322|NCT04340843|617407392|FG000|Overall Study|Adverse Event|0|||
170836323|NCT04340843|617407393|FG001|Overall Study|Adverse Event|2|||
170836324|NCT04340843|617407392|FG000|Overall Study|Withdrawal by Subject|0|||
170836325|NCT04340843|617407393|FG001|Overall Study|Withdrawal by Subject|2|||
170836326|NCT03733899|617407396|FG000|Period 1|Protocol Violation|0|||
170836327|NCT03733899|617407397|FG001|Period 1|Protocol Violation|0|||
170836328|NCT03733899|617407398|FG002|Period 1|Protocol Violation|0|||
170836329|NCT03733899|617407399|FG003|Period 1|Protocol Violation|0|||
170836330|NCT03733899|617407400|FG004|Period 1|Protocol Violation|0|||
170836331|NCT03733899|617407401|FG005|Period 1|Protocol Violation|1|||
170836332|NCT03733899|617407396|FG000|Period 2|Unscuccessful Treatment|0|||
170836333|NCT03733899|617407397|FG001|Period 2|Unscuccessful Treatment|1|||
170836334|NCT03733899|617407398|FG002|Period 2|Unscuccessful Treatment|0|||
170836335|NCT03733899|617407399|FG003|Period 2|Unscuccessful Treatment|0|||
170836336|NCT03733899|617407400|FG004|Period 2|Unscuccessful Treatment|0|||
170836337|NCT03733899|617407401|FG005|Period 2|Unscuccessful Treatment|0|||
170836338|NCT03733899|617407396|FG000|Period 3|Withdrawal by Subject|1|||
170836339|NCT03733899|617407397|FG001|Period 3|Withdrawal by Subject|0|||
170836340|NCT03733899|617407398|FG002|Period 3|Withdrawal by Subject|0|||
170836341|NCT03733899|617407399|FG003|Period 3|Withdrawal by Subject|0|||
170836342|NCT03733899|617407400|FG004|Period 3|Withdrawal by Subject|0|||
170836343|NCT03733899|617407401|FG005|Period 3|Withdrawal by Subject|0|||
170836344|NCT02763215|617409244|FG000|Overall Study|Participants withdrew from study|3|||
170836345|NCT02763215|617409244|FG000|Overall Study|Missed visit|1|||
170836346|NCT02763215|617409244|FG000|Overall Study|Visit outside visit-window|1|||
170836347|NCT02763215|617409244|FG000|Overall Study|Death|1|||
170836348|NCT02763215|617409244|FG000|Overall Study|Lost to Follow-up|1|||
170836349|NCT02367352|617409245|FG000|Overall Study|Progressive disease|7|||
170836350|NCT02367352|617409246|FG001|Overall Study|Progressive disease|0|||
170836351|NCT02367352|617409247|FG002|Overall Study|Progressive disease|0|||
170836352|NCT02367352|617409245|FG000|Overall Study|Participant Received Alternative Therapy|1|||
170836353|NCT02367352|617409246|FG001|Overall Study|Participant Received Alternative Therapy|0|||
170836354|NCT02367352|617409247|FG002|Overall Study|Participant Received Alternative Therapy|0|||
170836355|NCT02367352|617409245|FG000|Overall Study|Adverse Event|1|||
170836356|NCT02367352|617409246|FG001|Overall Study|Adverse Event|0|||
170836357|NCT02367352|617409247|FG002|Overall Study|Adverse Event|0|||
170836358|NCT05628285|617409257|FG000|Overall Study|Lost to Follow-up|1|||
170836359|NCT00983853|617409258|FG000|Overall Study|Lost to Follow-up|1|||
170836360|NCT00983853|617409259|FG001|Overall Study|Lost to Follow-up|1|||
170836361|NCT00983853|617409260|FG002|Overall Study|Lost to Follow-up|2|||
170836362|NCT00983853|617409261|FG003|Overall Study|Lost to Follow-up|2|||
170836363|NCT00983853|617409262|FG004|Overall Study|Lost to Follow-up|2|||
170836364|NCT00983853|617409263|FG005|Overall Study|Lost to Follow-up|1|||
170836365|NCT00983853|617409258|FG000|Overall Study|Withdrawal by Subject|0|||
170836366|NCT00983853|617409259|FG001|Overall Study|Withdrawal by Subject|0|||
170836367|NCT00983853|617409260|FG002|Overall Study|Withdrawal by Subject|1|||
170836368|NCT00983853|617409261|FG003|Overall Study|Withdrawal by Subject|0|||
170727709|NCT00977665|617007852|FG001|Overall Study|Physician Decision|1|||
170727710|NCT00977665|617007851|FG000|Overall Study|Sponsor requested withdrawal|0|||
170727711|NCT00977665|617007852|FG001|Overall Study|Sponsor requested withdrawal|1|||
170727712|NCT00977665|617007851|FG000|Overall Study|Lost to Follow-up|1|||
170727713|NCT00977665|617007852|FG001|Overall Study|Lost to Follow-up|0|||
170727714|NCT00977665|617007851|FG000|Overall Study|Death|3|||
170727715|NCT00977665|617007852|FG001|Overall Study|Death|2|||
170727716|NCT00977665|617007851|FG000|Overall Study|Adverse Event|14|||
170727717|NCT00977665|617007852|FG001|Overall Study|Adverse Event|7|||
170727718|NCT00977665|617007851|FG000|Overall Study|Treatment failure|0|||
170727719|NCT00977665|617007852|FG001|Overall Study|Treatment failure|1|||
170727720|NCT01330433|617007853|FG000|Overall Study|Death|1|||
170727721|NCT01330433|617007854|FG001|Overall Study|Death|3|||
170727722|NCT01330433|617007853|FG000|Overall Study|Lost to Follow-up|1|||
170727723|NCT01330433|617007854|FG001|Overall Study|Lost to Follow-up|0|||
170727724|NCT02300220|617007860|FG000|Overall Study|Lost to Follow-up|1|||
170727725|NCT02300220|617007861|FG001|Overall Study|Lost to Follow-up|2|||
170727726|NCT02300220|617007860|FG000|Overall Study|Death|1|||
170727727|NCT02300220|617007861|FG001|Overall Study|Death|1|||
170727728|NCT02300220|617007860|FG000|Overall Study|Adverse Event|1|||
170727729|NCT02300220|617007861|FG001|Overall Study|Adverse Event|1|||
170727730|NCT02300220|617007860|FG000|Overall Study|Protocol Violation|1|||
170836369|NCT00983853|617409262|FG004|Overall Study|Withdrawal by Subject|1|||
170836370|NCT00983853|617409263|FG005|Overall Study|Withdrawal by Subject|0|||
170836371|NCT00983853|617409258|FG000|Overall Study|Unable to come to study follow-up visits|0|||
170836372|NCT00983853|617409259|FG001|Overall Study|Unable to come to study follow-up visits|1|||
170836373|NCT00983853|617409260|FG002|Overall Study|Unable to come to study follow-up visits|0|||
170727731|NCT02300220|617007861|FG001|Overall Study|Protocol Violation|0|||
170727732|NCT02300220|617007860|FG000|Overall Study|Withdrawal by Subject|0|||
170727733|NCT02300220|617007861|FG001|Overall Study|Withdrawal by Subject|2|||
170727734|NCT02300220|617007860|FG000|Overall Study|Did not tolerate IMP|0|||
170727735|NCT02300220|617007861|FG001|Overall Study|Did not tolerate IMP|1|||
170727736|NCT04322682|617007862|FG000|Overall Study|Withdrawal by Subject|33|||
170727737|NCT04322682|617007863|FG001|Overall Study|Withdrawal by Subject|47|||
170727738|NCT04322682|617007862|FG000|Overall Study|Death|5|||
170727739|NCT04322682|617007863|FG001|Overall Study|Death|9|||
170727740|NCT04322682|617007862|FG000|Overall Study|Lost to Follow-up|4|||
170727741|NCT04322682|617007863|FG001|Overall Study|Lost to Follow-up|8|||
170727742|NCT04322682|617007862|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
170727743|NCT04322682|617007863|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
170727744|NCT02238379|617007864|FG000|Overall Study|Lost to Follow-up|1|||
170727745|NCT02238379|617007865|FG001|Overall Study|Lost to Follow-up|0|||
170727746|NCT00441090|617007866|FG000|Overall Study|Adverse Event|0|||
170727747|NCT00441090|617007867|FG001|Overall Study|Adverse Event|1|||
170727748|NCT00441090|617007868|FG002|Overall Study|Adverse Event|1|||
170727749|NCT00441090|617007869|FG003|Overall Study|Adverse Event|0|||
170727750|NCT00441090|617007870|FG004|Overall Study|Adverse Event|0|||
170727751|NCT00441090|617007866|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
170727752|NCT00441090|617007867|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
170727753|NCT00441090|617007868|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
170727754|NCT00441090|617007869|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
170727755|NCT00441090|617007870|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
170727756|NCT00441090|617007866|FG000|Overall Study|Withdrawal by Subject|1|||
170727757|NCT00441090|617007867|FG001|Overall Study|Withdrawal by Subject|0|||
170727758|NCT00441090|617007868|FG002|Overall Study|Withdrawal by Subject|1|||
170727759|NCT00441090|617007869|FG003|Overall Study|Withdrawal by Subject|0|||
170727760|NCT00441090|617007870|FG004|Overall Study|Withdrawal by Subject|0|||
170727761|NCT00441090|617007866|FG000|Overall Study|Lack of Efficacy|1|||
170727762|NCT00441090|617007867|FG001|Overall Study|Lack of Efficacy|0|||
170727763|NCT00441090|617007868|FG002|Overall Study|Lack of Efficacy|0|||
170727764|NCT00441090|617007869|FG003|Overall Study|Lack of Efficacy|0|||
170727765|NCT00441090|617007870|FG004|Overall Study|Lack of Efficacy|0|||
170727766|NCT01441102|617007871|FG000|Overall Study|Adverse Event|1|||
170727767|NCT01441102|617007871|FG000|Overall Study|Withdrawal by Subject|2|||
170727768|NCT03085485|617007872|FG000|Overall Study|Death|1|||
170727769|NCT03085485|617007873|FG001|Overall Study|Death|0|||
170727770|NCT03085485|617007872|FG000|Overall Study|Lost to Follow-up|1|||
170727771|NCT03085485|617007873|FG001|Overall Study|Lost to Follow-up|0|||
170727772|NCT04891419|617007874|FG000|Overall Study|Withdrawal by Subject|4|||
170727773|NCT04891419|617007875|FG001|Overall Study|Withdrawal by Subject|0|||
170727774|NCT04891419|617007874|FG000|Overall Study|Lost to Follow-up|1|||
170727775|NCT04891419|617007875|FG001|Overall Study|Lost to Follow-up|3|||
170727776|NCT00802074|617007879|FG000|Overall Study|Adverse Event|1|||
170727777|NCT00802074|617007880|FG001|Overall Study|Adverse Event|1|||
170727778|NCT00802074|617007881|FG002|Overall Study|Adverse Event|1|||
170727779|NCT00802074|617007882|FG003|Overall Study|Adverse Event|0|||
170727780|NCT00802074|617007883|FG004|Overall Study|Adverse Event|0|||
170727781|NCT00802074|617007884|FG005|Overall Study|Adverse Event|0|||
170727782|NCT00802074|617007879|FG000|Overall Study|Withdrawal by Subject|1|||
170727783|NCT00802074|617007880|FG001|Overall Study|Withdrawal by Subject|0|||
170727784|NCT00802074|617007881|FG002|Overall Study|Withdrawal by Subject|0|||
170727785|NCT00802074|617007882|FG003|Overall Study|Withdrawal by Subject|0|||
170727786|NCT00802074|617007883|FG004|Overall Study|Withdrawal by Subject|0|||
170727787|NCT00802074|617007884|FG005|Overall Study|Withdrawal by Subject|0|||
170727788|NCT03743038|617007887|FG000|Overall Study|Physician Decision|1|||
170727789|NCT01962493|617007889|FG000|Overall Study|Adverse Event|1|||
170727790|NCT01962493|617007890|FG001|Overall Study|Adverse Event|2|||
170727791|NCT01962493|617007889|FG000|Overall Study|Protocol Violation|0|||
170727792|NCT01962493|617007890|FG001|Overall Study|Protocol Violation|1|||
170727793|NCT01962493|617007889|FG000|Overall Study|Withdrawal by Subject|4|||
170727794|NCT01962493|617007890|FG001|Overall Study|Withdrawal by Subject|2|||
170727795|NCT03754803|617007895|FG000|Overall Study|Withdrawal by Subject|2|||
170727796|NCT04348604|617007896|FG000|Week 8|Withdrawal by Subject|1|||
170727797|NCT04348604|617007897|FG001|Week 8|Withdrawal by Subject|1|||
170727798|NCT04348604|617007896|FG000|Week 8|Lost to Follow-up|1|||
170727799|NCT04348604|617007897|FG001|Week 8|Lost to Follow-up|2|||
170727800|NCT04348604|617007896|FG000|Week 8|Suspended|0|||
170727801|NCT04348604|617007897|FG001|Week 8|Suspended|1|||
170727802|NCT04348604|617007896|FG000|Week 12|Lost to Follow-up|1|||
170727803|NCT04348604|617007897|FG001|Week 12|Lost to Follow-up|2|||
170727804|NCT04348604|617007896|FG000|Week 12|Withdrawal by Subject|1|||
170727805|NCT04348604|617007897|FG001|Week 12|Withdrawal by Subject|0|||
170727806|NCT04348604|617007896|FG000|Week 24|Lost to Follow-up|2|||
170727807|NCT04348604|617007897|FG001|Week 24|Lost to Follow-up|1|||
170727808|NCT04814654|617007898|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
170727809|NCT04814654|617007899|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
170727810|NCT04814654|617007900|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
170727811|NCT00789815|617010174|FG000|Overall Study|Protocol Violation|6|||
170727812|NCT00789815|617010175|FG001|Overall Study|Protocol Violation|1|||
170727813|NCT00789815|617010174|FG000|Overall Study|Intubation due to massive bleeding|1|||
170727814|NCT00789815|617010175|FG001|Overall Study|Intubation due to massive bleeding|0|||
170727815|NCT00514943|617010183|FG000|Stage 1|Progressive disease|4|||
170727816|NCT00514943|617010184|FG001|Stage 1|Progressive disease|8|||
170727817|NCT00514943|617010183|FG000|Stage 1|Other Adverse Event|16|||
170727818|NCT00514943|617010184|FG001|Stage 1|Other Adverse Event|6|||
170727819|NCT00514943|617010183|FG000|Stage 1|Not treated|1|||
170727820|NCT00514943|617010184|FG001|Stage 1|Not treated|2|||
170727821|NCT00514943|617010183|FG000|Stage 1|Patient refused to continue study meds|8|||
170727822|NCT00514943|617010184|FG001|Stage 1|Patient refused to continue study meds|3|||
170727823|NCT00514943|617010183|FG000|Stage 1|Other than stated above|1|||
170727824|NCT00514943|617010184|FG001|Stage 1|Other than stated above|7|||
170727825|NCT00514943|617010183|FG000|Stage 2|Progressive disease|27|||
170727826|NCT00514943|617010184|FG001|Stage 2|Progressive disease|24|||
170727827|NCT00514943|617010183|FG000|Stage 2|Other Adverse Event|3|||
170727828|NCT00514943|617010184|FG001|Stage 2|Other Adverse Event|10|||
170727829|NCT00514943|617010183|FG000|Stage 2|Patient refused to continue study meds|2|||
170727830|NCT00514943|617010184|FG001|Stage 2|Patient refused to continue study meds|0|||
170727831|NCT00514943|617010183|FG000|Stage 2|Other than stated above|0|||
170727832|NCT00514943|617010184|FG001|Stage 2|Other than stated above|2|||
170727833|NCT02001194|617010185|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
170727834|NCT02001194|617010186|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
170727835|NCT02001194|617010187|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
170727836|NCT02001194|617010188|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
170727837|NCT02001194|617010185|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
170727838|NCT02001194|617010186|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
170727839|NCT02001194|617010187|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
170727840|NCT02001194|617010188|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
170727841|NCT04539821|617010191|FG000|Overall Study|Withdrawal by Subject|2|||
170727842|NCT04539821|617010191|FG000|Overall Study|continued care with their physician|20|||
170727843|NCT04539821|617010191|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
170727844|NCT03813238|617010192|FG000|Overall Study|Adverse Event|0|||
170727845|NCT03813238|617010193|FG001|Overall Study|Adverse Event|6|||
170727846|NCT03813238|617010192|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170727847|NCT03813238|617010193|FG001|Overall Study|Withdrawal by parent/guardian|2|||
170727848|NCT03813238|617010192|FG000|Overall Study|Lost to Follow-up|0|||
170727849|NCT03813238|617010193|FG001|Overall Study|Lost to Follow-up|1|||
170727850|NCT03813238|617010192|FG000|Overall Study|Other than specified|1|||
170727851|NCT03813238|617010193|FG001|Overall Study|Other than specified|2|||
170727852|NCT02570126|617010194|FG000|Overall Study|Lost to Follow-up|2|||
170727853|NCT02570126|617010195|FG001|Overall Study|Lost to Follow-up|0|||
170727854|NCT02570126|617010194|FG000|Overall Study|Unable To Arrange Visit 3|1|||
170727855|NCT02570126|617010195|FG001|Overall Study|Unable To Arrange Visit 3|0|||
170727856|NCT02570126|617010194|FG000|Overall Study|Violation Of Procedures GSK|0|||
170727857|NCT02570126|617010195|FG001|Overall Study|Violation Of Procedures GSK|1|||
170727858|NCT02570126|617010194|FG000|Overall Study|Protocol Violation|0|||
170727859|NCT02570126|617010195|FG001|Overall Study|Protocol Violation|1|||
170727860|NCT02570126|617010194|FG000|Overall Study|Withdrawal by Subject|3|||
170727861|NCT02570126|617010195|FG001|Overall Study|Withdrawal by Subject|7|||
170727862|NCT04020341|617010196|FG000|Overall Study|Adverse Event|8|||
170727863|NCT04020341|617010197|FG001|Overall Study|Adverse Event|6|||
170727864|NCT04020341|617010196|FG000|Overall Study|Lost to Follow-up|8|||
170727865|NCT04020341|617010197|FG001|Overall Study|Lost to Follow-up|2|||
170727866|NCT04020341|617010196|FG000|Overall Study|Withdrawal by Subject|16|||
170727867|NCT04020341|617010197|FG001|Overall Study|Withdrawal by Subject|16|||
170727868|NCT04020341|617010196|FG000|Overall Study|Participant not able to swallow the tablet|1|||
170727869|NCT04020341|617010197|FG001|Overall Study|Participant not able to swallow the tablet|0|||
170727870|NCT04020341|617010196|FG000|Overall Study|Physician Decision|0|||
170727871|NCT04020341|617010197|FG001|Overall Study|Physician Decision|2|||
170727872|NCT04020341|617010196|FG000|Overall Study|Protocol Deviation|0|||
170727873|NCT04020341|617010197|FG001|Overall Study|Protocol Deviation|2|||
170727874|NCT01984684|617010202|FG000|Overall Study|Lost to Follow-up|25|||
170727875|NCT01984684|617010203|FG001|Overall Study|Lost to Follow-up|24|||
170727876|NCT01984684|617010202|FG000|Overall Study|Adverse Event|8|||
170727877|NCT01984684|617010203|FG001|Overall Study|Adverse Event|12|||
170727878|NCT01984684|617010202|FG000|Overall Study|Withdrawal by Subject|9|||
170727879|NCT01984684|617010203|FG001|Overall Study|Withdrawal by Subject|9|||
170727880|NCT01984684|617010202|FG000|Overall Study|Lack of Efficacy|3|||
170727881|NCT01984684|617010203|FG001|Overall Study|Lack of Efficacy|6|||
170727882|NCT01984684|617010202|FG000|Overall Study|Physician Decision|4|||
170727883|NCT01984684|617010203|FG001|Overall Study|Physician Decision|2|||
170727884|NCT01984684|617010202|FG000|Overall Study|Protocol Violation|4|||
170727885|NCT01984684|617010203|FG001|Overall Study|Protocol Violation|2|||
170727886|NCT01984684|617010202|FG000|Overall Study|Death|0|||
170727887|NCT01984684|617010203|FG001|Overall Study|Death|1|||
170727888|NCT01984684|617010202|FG000|Overall Study|Noncompliance with study drug|2|||
170727889|NCT01984684|617010203|FG001|Overall Study|Noncompliance with study drug|1|||
170727890|NCT01984684|617010202|FG000|Overall Study|Subject incarcerated|1|||
170727891|NCT01984684|617010203|FG001|Overall Study|Subject incarcerated|0|||
170727892|NCT01984684|617010202|FG000|Overall Study|Study drug not available at site|1|||
170727893|NCT01984684|617010203|FG001|Overall Study|Study drug not available at site|1|||
170727894|NCT01984684|617010202|FG000|Overall Study|Subject had inadequate IV access|0|||
170727895|NCT01984684|617010203|FG001|Overall Study|Subject had inadequate IV access|1|||
170727896|NCT01077544|617010208|FG000|Overall Study|New Cancer Therapy|3|||
170727897|NCT01077544|617010209|FG001|Overall Study|New Cancer Therapy|3|||
170727898|NCT01077544|617010208|FG000|Overall Study|Adverse Event|0|||
170727899|NCT01077544|617010209|FG001|Overall Study|Adverse Event|1|||
170727900|NCT01077544|617010208|FG000|Overall Study|Disease Progression|0|||
170727901|NCT01077544|617010209|FG001|Overall Study|Disease Progression|1|||
170727902|NCT04212091|617010210|FG000|Overall Study|Lost to Follow-up|0|||
170727903|NCT04212091|617010211|FG001|Overall Study|Lost to Follow-up|0|||
170727904|NCT04212091|617010212|FG002|Overall Study|Lost to Follow-up|0|||
170727905|NCT04212091|617010213|FG003|Overall Study|Lost to Follow-up|0|||
170727906|NCT04212091|617010214|FG004|Overall Study|Lost to Follow-up|1|||
170727907|NCT04212091|617010215|FG005|Overall Study|Lost to Follow-up|1|||
170727908|NCT04212091|617010210|FG000|Overall Study|Participant unable to adhere to visit|0|||
170727909|NCT04212091|617010211|FG001|Overall Study|Participant unable to adhere to visit|0|||
170727910|NCT04212091|617010212|FG002|Overall Study|Participant unable to adhere to visit|0|||
170727911|NCT04212091|617010213|FG003|Overall Study|Participant unable to adhere to visit|0|||
170727912|NCT04212091|617010214|FG004|Overall Study|Participant unable to adhere to visit|1|||
170727913|NCT04212091|617010215|FG005|Overall Study|Participant unable to adhere to visit|0|||
170727914|NCT03492281|617010216|FG000|Overall Study|Withdrawal by Subject|21|||
170727915|NCT03492281|617010217|FG001|Overall Study|Withdrawal by Subject|14|||
170727916|NCT03492281|617010218|FG002|Overall Study|Withdrawal by Subject|13|||
170727917|NCT03492281|617010216|FG000|Overall Study|Lost to Follow-up|14|||
170727918|NCT03492281|617010217|FG001|Overall Study|Lost to Follow-up|15|||
170727919|NCT03492281|617010218|FG002|Overall Study|Lost to Follow-up|10|||
170727920|NCT03492281|617010216|FG000|Overall Study|Adverse Event|6|||
170727921|NCT03492281|617010217|FG001|Overall Study|Adverse Event|8|||
170727922|NCT03492281|617010218|FG002|Overall Study|Adverse Event|13|||
170727923|NCT03492281|617010216|FG000|Overall Study|Lack of Efficacy|3|||
170727924|NCT03492281|617010217|FG001|Overall Study|Lack of Efficacy|0|||
170727925|NCT03492281|617010218|FG002|Overall Study|Lack of Efficacy|1|||
170727926|NCT03492281|617010216|FG000|Overall Study|Physician Decision|1|||
170727927|NCT03492281|617010217|FG001|Overall Study|Physician Decision|0|||
170727928|NCT03492281|617010218|FG002|Overall Study|Physician Decision|3|||
170727929|NCT03492281|617010216|FG000|Overall Study|Protocol Violation|0|||
170727930|NCT03492281|617010217|FG001|Overall Study|Protocol Violation|2|||
170727931|NCT03492281|617010218|FG002|Overall Study|Protocol Violation|1|||
170727932|NCT03492281|617010216|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
170727933|NCT03492281|617010217|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
170727934|NCT03492281|617010218|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
170727935|NCT03492281|617010216|FG000|Overall Study|Death|0|||
170727936|NCT03492281|617010217|FG001|Overall Study|Death|0|||
170727937|NCT03492281|617010218|FG002|Overall Study|Death|1|||
170727938|NCT03492281|617010216|FG000|Overall Study|Captured as Other in Database|8|||
170727939|NCT03492281|617010217|FG001|Overall Study|Captured as Other in Database|6|||
170727940|NCT03492281|617010218|FG002|Overall Study|Captured as Other in Database|3|||
170727941|NCT03565887|617010219|FG000|Overall Study|Adverse Event|1|||
170727942|NCT03565887|617010220|FG001|Overall Study|Adverse Event|0|||
170727943|NCT03565887|617010219|FG000|Overall Study|Withdrawal by Subject|0|||
170727944|NCT03565887|617010220|FG001|Overall Study|Withdrawal by Subject|2|||
170727945|NCT00689221|617010221|FG000|Overall Study|Ongoing at cut-off date|39|||
170727946|NCT00689221|617010222|FG001|Overall Study|Ongoing at cut-off date|36|||
170727947|NCT01749982|617010223|FG000|Overall Study|Physician Decision|0|||
170727948|NCT01749982|617010224|FG001|Overall Study|Physician Decision|0|||
170727949|NCT01749982|617010225|FG002|Overall Study|Physician Decision|0|||
170727950|NCT01749982|617010226|FG003|Overall Study|Physician Decision|1|||
170727951|NCT01749982|617010223|FG000|Overall Study|Lost to Follow-up|0|||
170727952|NCT01749982|617010224|FG001|Overall Study|Lost to Follow-up|0|||
170727953|NCT01749982|617010225|FG002|Overall Study|Lost to Follow-up|0|||
170727954|NCT01749982|617010226|FG003|Overall Study|Lost to Follow-up|1|||
170727955|NCT01749982|617010223|FG000|Overall Study|Withdrawal by Subject|0|||
170727956|NCT01749982|617010224|FG001|Overall Study|Withdrawal by Subject|0|||
170727957|NCT01749982|617010225|FG002|Overall Study|Withdrawal by Subject|0|||
170727958|NCT01749982|617010226|FG003|Overall Study|Withdrawal by Subject|1|||
170727959|NCT03182868|617010227|FG000|Overall Study|Protocol Violation|3|||
170727960|NCT03182868|617010228|FG001|Overall Study|Protocol Violation|0|||
170727961|NCT03182868|617010229|FG002|Overall Study|Protocol Violation|4|||
170727962|NCT03182868|617010230|FG003|Overall Study|Protocol Violation|1|||
170727963|NCT03182868|617010231|FG004|Overall Study|Protocol Violation|8|||
170727964|NCT03342638|617010232|FG000|Overall Study|Withdrawal by Subject|1|||
170727965|NCT03342638|617010233|FG001|Overall Study|Withdrawal by Subject|0|||
170727966|NCT03342638|617010232|FG000|Overall Study|Physician Decision|0|||
170727967|NCT03342638|617010233|FG001|Overall Study|Physician Decision|1|||
170727968|NCT01292239|617010249|FG000|Overall Study|Other|1|||
170727969|NCT01292239|617010250|FG001|Overall Study|Other|1|||
170727970|NCT01292239|617010249|FG000|Overall Study|Withdrawal by Subject|3|||
170727971|NCT01292239|617010250|FG001|Overall Study|Withdrawal by Subject|6|||
170727972|NCT00113568|617010251|FG000|Overall Study|Adverse Event|97|||
170727973|NCT00113568|617010251|FG000|Overall Study|Death|1|||
170727974|NCT00113568|617010251|FG000|Overall Study|Lack of Efficacy|30|||
170727975|NCT00113568|617010251|FG000|Overall Study|Lost to Follow-up|156|||
170727976|NCT00113568|617010251|FG000|Overall Study|Protocol Violation|32|||
170727977|NCT00113568|617010251|FG000|Overall Study|Withdrawal by Subject|117|||
170727978|NCT00113568|617010251|FG000|Overall Study|Other|112|||
170727979|NCT00262821|617010252|FG000|Overall Study|Ineligible - wrong stage|0|||
170727980|NCT00262821|617010253|FG001|Overall Study|Ineligible - wrong stage|3|||
170727981|NCT00262821|617010252|FG000|Overall Study|Ineligible - wrong cell type|2|||
170727982|NCT00262821|617010253|FG001|Overall Study|Ineligible - wrong cell type|2|||
170727983|NCT00262821|617010252|FG000|Overall Study|Ineligible - wrong primary|0|||
170836374|NCT00983853|617409261|FG003|Overall Study|Unable to come to study follow-up visits|0|||
170836375|NCT00983853|617409262|FG004|Overall Study|Unable to come to study follow-up visits|0|||
170836376|NCT00983853|617409263|FG005|Overall Study|Unable to come to study follow-up visits|0|||
170836377|NCT02339506|617409264|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
170727984|NCT00262821|617010253|FG001|Overall Study|Ineligible - wrong primary|1|||
170727985|NCT00262821|617010252|FG000|Overall Study|Ineligible - inadequate pathology|1|||
170727986|NCT00262821|617010253|FG001|Overall Study|Ineligible - inadequate pathology|3|||
170727987|NCT00262821|617010252|FG000|Overall Study|Ineligible - elevated creatinine|0|||
170727988|NCT00262821|617010253|FG001|Overall Study|Ineligible - elevated creatinine|2|||
170727989|NCT00262821|617010252|FG000|Overall Study|Ineligible - required test not done|1|||
170727990|NCT00262821|617010253|FG001|Overall Study|Ineligible - required test not done|4|||
170727991|NCT00262821|617010252|FG000|Overall Study|Inevaluable - inadequate data|0|||
170727992|NCT00262821|617010253|FG001|Overall Study|Inevaluable - inadequate data|4|||
170727993|NCT03923933|617010255|FG000|Overall Study|Lost to Follow-up|1|||
170727994|NCT03923933|617010256|FG001|Overall Study|Lost to Follow-up|0|||
170727995|NCT03923933|617010255|FG000|Overall Study|Withdrawal by Subject|0|||
170727996|NCT03923933|617010256|FG001|Overall Study|Withdrawal by Subject|1|||
170727997|NCT02191267|617010257|FG000|Overall Study|Withdrawal by Subject|1|||
170727998|NCT02191267|617010258|FG001|Overall Study|Withdrawal by Subject|0|||
170727999|NCT02191267|617010259|FG002|Overall Study|Withdrawal by Subject|0|||
170728000|NCT01995461|617010264|FG000|Overall Study|Death|1|||
170728001|NCT01995461|617010264|FG000|Overall Study|Lost to Follow-up|2|||
170836378|NCT02339506|617409265|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
170728002|NCT01995461|617010264|FG000|Overall Study|Withdrawal by Subject|2|||
170728003|NCT00587964|617010266|FG000|Overall Study|Withdrawal by Subject|1|||
170728004|NCT00587964|617010266|FG000|Overall Study|Lost to Follow-up|1|||
170728005|NCT00587964|617010266|FG000|Overall Study|Patient found to be ineligible|1|||
170728006|NCT00587964|617010266|FG000|Overall Study|Patient did not receive intervention|5|||
170728007|NCT00587964|617010266|FG000|Overall Study|Progression of Disease|4|||
170728008|NCT00518115|617010267|FG000|Overall Study|Adverse Event|6|||
170728009|NCT00518115|617010268|FG001|Overall Study|Adverse Event|1|||
170728010|NCT00518115|617010269|FG002|Overall Study|Adverse Event|5|||
170728011|NCT00518115|617010270|FG003|Overall Study|Adverse Event|6|||
170728012|NCT00518115|617010271|FG004|Overall Study|Adverse Event|5|||
170728013|NCT00518115|617010272|FG005|Overall Study|Adverse Event|5|||
170728014|NCT00518115|617010273|FG006|Overall Study|Adverse Event|5|||
170728015|NCT00518115|617010274|FG007|Overall Study|Adverse Event|10|||
170728016|NCT00518115|617010275|FG008|Overall Study|Adverse Event|2|||
170728017|NCT00518115|617010276|FG009|Overall Study|Adverse Event|9|||
170728018|NCT00518115|617010267|FG000|Overall Study|Lost to Follow-up|0|||
170728019|NCT00518115|617010268|FG001|Overall Study|Lost to Follow-up|0|||
170728020|NCT00518115|617010269|FG002|Overall Study|Lost to Follow-up|2|||
170728021|NCT00518115|617010270|FG003|Overall Study|Lost to Follow-up|3|||
170728022|NCT00518115|617010271|FG004|Overall Study|Lost to Follow-up|1|||
170728023|NCT00518115|617010272|FG005|Overall Study|Lost to Follow-up|3|||
170728024|NCT00518115|617010273|FG006|Overall Study|Lost to Follow-up|0|||
170728025|NCT00518115|617010274|FG007|Overall Study|Lost to Follow-up|1|||
170728026|NCT00518115|617010275|FG008|Overall Study|Lost to Follow-up|1|||
170728027|NCT00518115|617010276|FG009|Overall Study|Lost to Follow-up|1|||
170728028|NCT00518115|617010267|FG000|Overall Study|Protocol Violation|1|||
170728029|NCT00518115|617010268|FG001|Overall Study|Protocol Violation|3|||
170728030|NCT00518115|617010269|FG002|Overall Study|Protocol Violation|1|||
170728031|NCT00518115|617010270|FG003|Overall Study|Protocol Violation|0|||
170728032|NCT00518115|617010271|FG004|Overall Study|Protocol Violation|0|||
170728033|NCT00518115|617010272|FG005|Overall Study|Protocol Violation|0|||
170728034|NCT00518115|617010273|FG006|Overall Study|Protocol Violation|0|||
170728035|NCT00518115|617010274|FG007|Overall Study|Protocol Violation|0|||
170728036|NCT00518115|617010275|FG008|Overall Study|Protocol Violation|0|||
170728037|NCT00518115|617010276|FG009|Overall Study|Protocol Violation|0|||
170728038|NCT00518115|617010267|FG000|Overall Study|Withdrawal by Subject|1|||
170728039|NCT00518115|617010268|FG001|Overall Study|Withdrawal by Subject|1|||
170728040|NCT00518115|617010269|FG002|Overall Study|Withdrawal by Subject|5|||
170728041|NCT00518115|617010270|FG003|Overall Study|Withdrawal by Subject|0|||
170728042|NCT00518115|617010271|FG004|Overall Study|Withdrawal by Subject|2|||
170728043|NCT00518115|617010272|FG005|Overall Study|Withdrawal by Subject|1|||
170728044|NCT00518115|617010273|FG006|Overall Study|Withdrawal by Subject|0|||
170728045|NCT00518115|617010274|FG007|Overall Study|Withdrawal by Subject|2|||
170728046|NCT00518115|617010275|FG008|Overall Study|Withdrawal by Subject|1|||
170728047|NCT00518115|617010276|FG009|Overall Study|Withdrawal by Subject|3|||
170728048|NCT00518115|617010267|FG000|Overall Study|Lack of Efficacy|1|||
170728049|NCT00518115|617010268|FG001|Overall Study|Lack of Efficacy|0|||
170728050|NCT00518115|617010269|FG002|Overall Study|Lack of Efficacy|1|||
170728051|NCT00518115|617010270|FG003|Overall Study|Lack of Efficacy|1|||
170728052|NCT00518115|617010271|FG004|Overall Study|Lack of Efficacy|0|||
170728053|NCT00518115|617010272|FG005|Overall Study|Lack of Efficacy|0|||
170728054|NCT00518115|617010273|FG006|Overall Study|Lack of Efficacy|0|||
170728055|NCT00518115|617010274|FG007|Overall Study|Lack of Efficacy|1|||
170728056|NCT00518115|617010275|FG008|Overall Study|Lack of Efficacy|0|||
170728057|NCT00518115|617010276|FG009|Overall Study|Lack of Efficacy|0|||
170728058|NCT00518115|617010267|FG000|Overall Study|Non-Compliance|1|||
170728059|NCT00518115|617010268|FG001|Overall Study|Non-Compliance|0|||
170728060|NCT00518115|617010269|FG002|Overall Study|Non-Compliance|1|||
170728061|NCT00518115|617010270|FG003|Overall Study|Non-Compliance|0|||
170728062|NCT00518115|617010271|FG004|Overall Study|Non-Compliance|1|||
170728063|NCT00518115|617010272|FG005|Overall Study|Non-Compliance|1|||
170728064|NCT00518115|617010273|FG006|Overall Study|Non-Compliance|1|||
170728065|NCT00518115|617010274|FG007|Overall Study|Non-Compliance|1|||
170728066|NCT00518115|617010275|FG008|Overall Study|Non-Compliance|0|||
170728067|NCT00518115|617010276|FG009|Overall Study|Non-Compliance|1|||
170728068|NCT00518115|617010267|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
170728069|NCT00518115|617010268|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
170836379|NCT02339506|617409264|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
170836380|NCT02339506|617409265|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
170836381|NCT02869867|617409269|FG000|Overall Study|Protocol Violation|1|||
170836382|NCT02869867|617409270|FG001|Overall Study|Protocol Violation|0|||
170836383|NCT02869867|617409269|FG000|Overall Study|Lost to Follow-up|5|||
170836384|NCT02869867|617409270|FG001|Overall Study|Lost to Follow-up|5|||
170836385|NCT02049515|617409271|FG000|Overall Study|Adverse Event|46|||
170836386|NCT02049515|617409272|FG001|Overall Study|Adverse Event|2|||
170836387|NCT02049515|617409271|FG000|Overall Study|Protocol-specified Disease Progression|23|||
170836388|NCT02049515|617409272|FG001|Overall Study|Protocol-specified Disease Progression|2|||
170836389|NCT02049515|617409271|FG000|Overall Study|Death|6|||
170836390|NCT02049515|617409272|FG001|Overall Study|Death|0|||
170836391|NCT02049515|617409271|FG000|Overall Study|Physician Decision|5|||
170836392|NCT02049515|617409272|FG001|Overall Study|Physician Decision|1|||
170836393|NCT02049515|617409271|FG000|Overall Study|Withdrawal by Subject|3|||
170836394|NCT02049515|617409272|FG001|Overall Study|Withdrawal by Subject|0|||
170836395|NCT02049515|617409271|FG000|Overall Study|Termination of the Study by Sponsor|2|||
170836396|NCT02049515|617409272|FG001|Overall Study|Termination of the Study by Sponsor|0|||
170836397|NCT02049515|617409271|FG000|Overall Study|Protocol Violation|1|||
170836398|NCT02049515|617409272|FG001|Overall Study|Protocol Violation|1|||
170836399|NCT02049515|617409271|FG000|Overall Study|Clinical Deterioration|1|||
170836400|NCT02049515|617409272|FG001|Overall Study|Clinical Deterioration|0|||
170836401|NCT02049515|617409271|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
170836402|NCT02049515|617409272|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
170836403|NCT02049515|617409271|FG000|Overall Study|Treatment Interruption >42 Days|1|||
170836404|NCT02049515|617409272|FG001|Overall Study|Treatment Interruption >42 Days|0|||
170836405|NCT02049515|617409271|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
170836406|NCT02049515|617409272|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
170836407|NCT02872012|617409273|FG000|Overall Study|Withdrawal by Subject|1|||
170836408|NCT02872012|617409274|FG001|Overall Study|Withdrawal by Subject|0|||
170836409|NCT02872012|617409275|FG002|Overall Study|Withdrawal by Subject|0|||
170836410|NCT02872012|617409276|FG003|Overall Study|Withdrawal by Subject|0|||
170836411|NCT02872012|617409277|FG004|Overall Study|Withdrawal by Subject|0|||
170836412|NCT01407276|617409280|FG000|Overall Study|Withdrawal by Subject|0|||
170836413|NCT01407276|617409281|FG001|Overall Study|Withdrawal by Subject|0|||
170836414|NCT01407276|617409282|FG002|Overall Study|Withdrawal by Subject|0|||
170836415|NCT01407276|617409283|FG003|Overall Study|Withdrawal by Subject|0|||
170836416|NCT01407276|617409284|FG004|Overall Study|Withdrawal by Subject|0|||
170836417|NCT01407276|617409285|FG005|Overall Study|Withdrawal by Subject|0|||
170836418|NCT01407276|617409286|FG006|Overall Study|Withdrawal by Subject|0|||
170836419|NCT01407276|617409287|FG007|Overall Study|Withdrawal by Subject|1|||
170836420|NCT03482752|617409291|FG000|Overall Study|Withdrawal by Subject|2|||
170836421|NCT03482752|617409291|FG000|Overall Study|Lost to Follow-up|1|||
170836422|NCT03482752|617409291|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
170836423|NCT01807182|617409292|FG000|Overall Study|Death|1|||
170836424|NCT01807182|617409292|FG000|Overall Study|New therapy|1|||
170836425|NCT01807182|617409292|FG000|Overall Study|Moved to hospice care|1|||
170836426|NCT02844777|617409294|FG000|Overall Study|Withdrawal by Subject|2|||
170836427|NCT02844777|617409295|FG001|Overall Study|Withdrawal by Subject|0|||
170836428|NCT02844777|617409296|FG002|Overall Study|Withdrawal by Subject|0|||
170836429|NCT01776008|617409297|FG000|Overall Study|ineligible|2|||
170836430|NCT04092452|617409299|FG000|Overall Study|Adverse Event|1|||
170836431|NCT04092452|617409300|FG001|Overall Study|Adverse Event|3|||
170836432|NCT04092452|617409301|FG002|Overall Study|Adverse Event|3|||
170836433|NCT04092452|617409302|FG003|Overall Study|Adverse Event|7|||
170836434|NCT04092452|617409299|FG000|Overall Study|Lack of Efficacy|1|||
170836435|NCT04092452|617409300|FG001|Overall Study|Lack of Efficacy|1|||
170836436|NCT04092452|617409301|FG002|Overall Study|Lack of Efficacy|1|||
170836437|NCT04092452|617409302|FG003|Overall Study|Lack of Efficacy|0|||
170836438|NCT04092452|617409299|FG000|Overall Study|Lost to Follow-up|4|||
170836439|NCT04092452|617409300|FG001|Overall Study|Lost to Follow-up|3|||
170836440|NCT04092452|617409301|FG002|Overall Study|Lost to Follow-up|5|||
170836441|NCT04092452|617409302|FG003|Overall Study|Lost to Follow-up|1|||
170836442|NCT04092452|617409299|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170836443|NCT04092452|617409300|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170836444|NCT04092452|617409301|FG002|Overall Study|Non-Compliance With Study Drug|1|||
170836445|NCT04092452|617409302|FG003|Overall Study|Non-Compliance With Study Drug|1|||
170836446|NCT04092452|617409299|FG000|Overall Study|Physician Decision|1|||
170836447|NCT04092452|617409300|FG001|Overall Study|Physician Decision|0|||
170836448|NCT04092452|617409301|FG002|Overall Study|Physician Decision|1|||
170836449|NCT04092452|617409302|FG003|Overall Study|Physician Decision|0|||
170836450|NCT04092452|617409299|FG000|Overall Study|Pregnancy|2|||
170836451|NCT04092452|617409300|FG001|Overall Study|Pregnancy|0|||
170836452|NCT04092452|617409301|FG002|Overall Study|Pregnancy|0|||
170836453|NCT04092452|617409302|FG003|Overall Study|Pregnancy|0|||
170728070|NCT00518115|617010269|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
170728071|NCT00518115|617010270|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
170728072|NCT00518115|617010271|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
170728073|NCT00518115|617010272|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
170728074|NCT00518115|617010273|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
170728075|NCT00518115|617010274|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
170728076|NCT00518115|617010275|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
170728077|NCT00518115|617010276|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
170728078|NCT00518115|617010267|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
170728079|NCT00518115|617010268|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728080|NCT00518115|617010269|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728081|NCT00518115|617010270|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728082|NCT00518115|617010271|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728083|NCT00518115|617010272|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728084|NCT00518115|617010273|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728085|NCT00518115|617010274|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728086|NCT00518115|617010275|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728087|NCT00518115|617010276|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
170728088|NCT00518115|617010267|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
170728089|NCT00518115|617010268|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
170728090|NCT00518115|617010269|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
170728091|NCT00518115|617010270|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
170728092|NCT00518115|617010271|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
170728093|NCT00518115|617010272|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
170728094|NCT00518115|617010273|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
170728095|NCT00518115|617010274|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
170728096|NCT00518115|617010275|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
170728097|NCT00518115|617010276|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
170728098|NCT00518115|617010267|FG000|Overall Study|Wrong Monotherapy Administered|0|||
170728099|NCT00518115|617010268|FG001|Overall Study|Wrong Monotherapy Administered|0|||
170728100|NCT00518115|617010269|FG002|Overall Study|Wrong Monotherapy Administered|1|||
170728101|NCT00518115|617010270|FG003|Overall Study|Wrong Monotherapy Administered|0|||
170728102|NCT00518115|617010271|FG004|Overall Study|Wrong Monotherapy Administered|0|||
170728103|NCT00518115|617010272|FG005|Overall Study|Wrong Monotherapy Administered|0|||
170728104|NCT00518115|617010273|FG006|Overall Study|Wrong Monotherapy Administered|1|||
170728105|NCT00518115|617010274|FG007|Overall Study|Wrong Monotherapy Administered|0|||
170728106|NCT00518115|617010275|FG008|Overall Study|Wrong Monotherapy Administered|0|||
170728107|NCT00518115|617010276|FG009|Overall Study|Wrong Monotherapy Administered|0|||
170728108|NCT00518115|617010267|FG000|Overall Study|Violation of Exclusion Criteria|0|||
170728109|NCT00518115|617010268|FG001|Overall Study|Violation of Exclusion Criteria|0|||
170728110|NCT00518115|617010269|FG002|Overall Study|Violation of Exclusion Criteria|0|||
170728111|NCT00518115|617010270|FG003|Overall Study|Violation of Exclusion Criteria|1|||
170728112|NCT00518115|617010271|FG004|Overall Study|Violation of Exclusion Criteria|0|||
170728113|NCT00518115|617010272|FG005|Overall Study|Violation of Exclusion Criteria|0|||
170728114|NCT00518115|617010273|FG006|Overall Study|Violation of Exclusion Criteria|1|||
170728115|NCT00518115|617010274|FG007|Overall Study|Violation of Exclusion Criteria|0|||
170728116|NCT00518115|617010275|FG008|Overall Study|Violation of Exclusion Criteria|0|||
170728117|NCT00518115|617010276|FG009|Overall Study|Violation of Exclusion Criteria|0|||
170728118|NCT00518115|617010267|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
170728119|NCT00518115|617010268|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
170728120|NCT00518115|617010269|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
170728121|NCT00518115|617010270|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
170728122|NCT00518115|617010271|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
170728123|NCT00518115|617010272|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
170728124|NCT00518115|617010273|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
170728125|NCT00518115|617010274|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
170728126|NCT00518115|617010275|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
170728127|NCT00518115|617010276|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
170728128|NCT00518115|617010267|FG000|Overall Study|Withdrew Consent|0|||
170728129|NCT00518115|617010268|FG001|Overall Study|Withdrew Consent|0|||
170728130|NCT00518115|617010269|FG002|Overall Study|Withdrew Consent|0|||
170728131|NCT00518115|617010270|FG003|Overall Study|Withdrew Consent|0|||
170728132|NCT00518115|617010271|FG004|Overall Study|Withdrew Consent|0|||
170728133|NCT00518115|617010272|FG005|Overall Study|Withdrew Consent|1|||
170728134|NCT00518115|617010273|FG006|Overall Study|Withdrew Consent|0|||
170728135|NCT00518115|617010274|FG007|Overall Study|Withdrew Consent|0|||
170728136|NCT00518115|617010275|FG008|Overall Study|Withdrew Consent|0|||
170728137|NCT00518115|617010276|FG009|Overall Study|Withdrew Consent|0|||
170728138|NCT00518115|617010267|FG000|Overall Study|Moved Out of State|0|||
170728139|NCT00518115|617010268|FG001|Overall Study|Moved Out of State|0|||
170836454|NCT04092452|617409299|FG000|Overall Study|Protocol Deviation|1|||
170836455|NCT04092452|617409300|FG001|Overall Study|Protocol Deviation|0|||
170836456|NCT04092452|617409301|FG002|Overall Study|Protocol Deviation|0|||
170836457|NCT04092452|617409302|FG003|Overall Study|Protocol Deviation|0|||
170728140|NCT00518115|617010269|FG002|Overall Study|Moved Out of State|0|||
170728141|NCT00518115|617010270|FG003|Overall Study|Moved Out of State|0|||
170728142|NCT00518115|617010271|FG004|Overall Study|Moved Out of State|0|||
170728143|NCT00518115|617010272|FG005|Overall Study|Moved Out of State|0|||
170728144|NCT00518115|617010273|FG006|Overall Study|Moved Out of State|0|||
170728145|NCT00518115|617010274|FG007|Overall Study|Moved Out of State|0|||
170728146|NCT00518115|617010275|FG008|Overall Study|Moved Out of State|0|||
170728147|NCT00518115|617010276|FG009|Overall Study|Moved Out of State|1|||
170728148|NCT01662310|617010280|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
170728149|NCT01662310|617010281|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
170728150|NCT01662310|617010282|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
170728151|NCT01662310|617010283|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
170728152|NCT01662310|617010284|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
170728153|NCT01662310|617010280|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
170728154|NCT01662310|617010281|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
170728155|NCT01662310|617010282|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
170728156|NCT01662310|617010283|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
170728157|NCT01662310|617010284|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
170728158|NCT01662310|617010280|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
170728159|NCT01662310|617010281|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
170728160|NCT01662310|617010282|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
170728161|NCT01662310|617010283|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
170728162|NCT01662310|617010284|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
170728163|NCT01662310|617010280|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
170728164|NCT01662310|617010281|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
170728165|NCT01662310|617010282|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
170728166|NCT01662310|617010283|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
170728167|NCT01662310|617010284|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
170728168|NCT01662310|617010280|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
170728169|NCT01662310|617010281|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
170728170|NCT01662310|617010282|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
170728171|NCT01662310|617010283|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
170728172|NCT01662310|617010284|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
170728173|NCT01662310|617010280|FG000|Run-In or Stabilization Phase|Other|1|||
170728174|NCT01662310|617010281|FG001|Run-In or Stabilization Phase|Other|0|||
170728175|NCT01662310|617010282|FG002|Run-In or Stabilization Phase|Other|0|||
170728176|NCT01662310|617010283|FG003|Run-In or Stabilization Phase|Other|0|||
170728177|NCT01662310|617010284|FG004|Run-In or Stabilization Phase|Other|0|||
170728178|NCT01662310|617010280|FG000|Double-Blind Phase|Adverse Event|0|||
170728179|NCT01662310|617010281|FG001|Double-Blind Phase|Adverse Event|0|||
170728180|NCT01662310|617010282|FG002|Double-Blind Phase|Adverse Event|1|||
170728181|NCT01662310|617010283|FG003|Double-Blind Phase|Adverse Event|0|||
170728182|NCT01662310|617010284|FG004|Double-Blind Phase|Adverse Event|0|||
170728183|NCT01662310|617010280|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170728184|NCT01662310|617010281|FG001|Double-Blind Phase|Lost to Follow-up|3|||
170728185|NCT01662310|617010282|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170728186|NCT01662310|617010283|FG003|Double-Blind Phase|Lost to Follow-up|0|||
170728187|NCT01662310|617010284|FG004|Double-Blind Phase|Lost to Follow-up|0|||
170728188|NCT01662310|617010280|FG000|Double-Blind Phase|Pregnancy|0|||
170728189|NCT01662310|617010281|FG001|Double-Blind Phase|Pregnancy|2|||
170728190|NCT01662310|617010282|FG002|Double-Blind Phase|Pregnancy|0|||
170728191|NCT01662310|617010283|FG003|Double-Blind Phase|Pregnancy|0|||
170728192|NCT01662310|617010284|FG004|Double-Blind Phase|Pregnancy|0|||
170728193|NCT01662310|617010280|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
170728194|NCT01662310|617010281|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
170728195|NCT01662310|617010282|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
170728196|NCT01662310|617010283|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
170728197|NCT01662310|617010284|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
170728198|NCT01662310|617010280|FG000|Double-Blind Phase|Other|0|||
170728199|NCT01662310|617010281|FG001|Double-Blind Phase|Other|0|||
170728200|NCT01662310|617010282|FG002|Double-Blind Phase|Other|1|||
170728201|NCT01662310|617010283|FG003|Double-Blind Phase|Other|0|||
170728202|NCT01662310|617010284|FG004|Double-Blind Phase|Other|0|||
170728203|NCT01662310|617010280|FG000|Double-Blind Phase|Randomized but not treated|0|||
170728204|NCT01662310|617010281|FG001|Double-Blind Phase|Randomized but not treated|1|||
170728205|NCT01662310|617010282|FG002|Double-Blind Phase|Randomized but not treated|0|||
170728206|NCT01662310|617010283|FG003|Double-Blind Phase|Randomized but not treated|0|||
170728207|NCT01662310|617010284|FG004|Double-Blind Phase|Randomized but not treated|0|||
170728208|NCT01662310|617010280|FG000|Open-Label Extension Phase|Adverse Event|0|||
170728209|NCT01662310|617010281|FG001|Open-Label Extension Phase|Adverse Event|0|||
170836458|NCT04092452|617409299|FG000|Overall Study|Withdrawal by Subject|3|||
170836459|NCT04092452|617409300|FG001|Overall Study|Withdrawal by Subject|10|||
170836460|NCT04092452|617409301|FG002|Overall Study|Withdrawal by Subject|3|||
170836461|NCT04092452|617409302|FG003|Overall Study|Withdrawal by Subject|5|||
170836462|NCT04092452|617409299|FG000|Overall Study|Other|0|||
170836463|NCT04092452|617409300|FG001|Overall Study|Other|0|||
170836464|NCT04092452|617409301|FG002|Overall Study|Other|1|||
170836465|NCT04092452|617409302|FG003|Overall Study|Other|2|||
170836466|NCT01012947|617409311|FG000|Overall Study|Lost to Follow-up|131|||
170836467|NCT01012947|617409312|FG001|Overall Study|Lost to Follow-up|135|||
170836468|NCT01012947|617409313|FG002|Overall Study|Lost to Follow-up|130|||
170836469|NCT01012947|617409314|FG003|Overall Study|Lost to Follow-up|118|||
170836470|NCT01012947|617409315|FG004|Overall Study|Lost to Follow-up|142|||
170836471|NCT02127125|617409316|FG000|Overall Study|Lost to Follow-up|0|||
170836472|NCT02127125|617409317|FG001|Overall Study|Lost to Follow-up|0|||
170836473|NCT02127125|617409318|FG002|Overall Study|Lost to Follow-up|0|||
170836474|NCT02127125|617409319|FG003|Overall Study|Lost to Follow-up|0|||
170836475|NCT02127125|617409320|FG004|Overall Study|Lost to Follow-up|2|||
170836476|NCT02127125|617409321|FG005|Overall Study|Lost to Follow-up|1|||
170836477|NCT02127125|617409322|FG006|Overall Study|Lost to Follow-up|0|||
170836478|NCT02127125|617409323|FG007|Overall Study|Lost to Follow-up|0|||
170836479|NCT02127125|617409324|FG008|Overall Study|Lost to Follow-up|0|||
170836480|NCT02127125|617409316|FG000|Overall Study|Withdrawal by Subject|0|||
170836481|NCT02127125|617409317|FG001|Overall Study|Withdrawal by Subject|0|||
170836482|NCT02127125|617409318|FG002|Overall Study|Withdrawal by Subject|0|||
170836483|NCT02127125|617409319|FG003|Overall Study|Withdrawal by Subject|1|||
170836484|NCT02127125|617409320|FG004|Overall Study|Withdrawal by Subject|0|||
170836485|NCT02127125|617409321|FG005|Overall Study|Withdrawal by Subject|0|||
170836486|NCT02127125|617409322|FG006|Overall Study|Withdrawal by Subject|0|||
170836487|NCT02127125|617409323|FG007|Overall Study|Withdrawal by Subject|0|||
170728210|NCT01662310|617010282|FG002|Open-Label Extension Phase|Adverse Event|0|||
170728211|NCT01662310|617010283|FG003|Open-Label Extension Phase|Adverse Event|3|||
170728212|NCT01662310|617010284|FG004|Open-Label Extension Phase|Adverse Event|0|||
170728213|NCT01662310|617010280|FG000|Open-Label Extension Phase|Death|0|||
170728214|NCT01662310|617010281|FG001|Open-Label Extension Phase|Death|0|||
170728215|NCT01662310|617010282|FG002|Open-Label Extension Phase|Death|0|||
170728216|NCT01662310|617010283|FG003|Open-Label Extension Phase|Death|1|||
170728217|NCT01662310|617010284|FG004|Open-Label Extension Phase|Death|0|||
170728218|NCT01662310|617010280|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
170728219|NCT01662310|617010281|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
170728220|NCT01662310|617010282|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
170728221|NCT01662310|617010283|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
170728222|NCT01662310|617010284|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
170728223|NCT01662310|617010280|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
170728224|NCT01662310|617010281|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
170728225|NCT01662310|617010282|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
170728226|NCT01662310|617010283|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
170728227|NCT01662310|617010284|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
170728228|NCT01662310|617010280|FG000|Open-Label Extension Phase|Pregnancy|0|||
170728229|NCT01662310|617010281|FG001|Open-Label Extension Phase|Pregnancy|0|||
170728230|NCT01662310|617010282|FG002|Open-Label Extension Phase|Pregnancy|0|||
170728231|NCT01662310|617010283|FG003|Open-Label Extension Phase|Pregnancy|1|||
170728232|NCT01662310|617010284|FG004|Open-Label Extension Phase|Pregnancy|0|||
170728233|NCT01662310|617010280|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
170728234|NCT01662310|617010281|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
170728235|NCT01662310|617010282|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
170728236|NCT01662310|617010283|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
170728237|NCT01662310|617010284|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
170728238|NCT01302847|617010287|FG000|Overall Study|Death|0|||
170728239|NCT01302847|617010288|FG001|Overall Study|Death|1|||
170728240|NCT01302847|617010289|FG002|Overall Study|Death|0|||
170728241|NCT01302847|617010290|FG003|Overall Study|Death|0|||
170728242|NCT01302847|617010291|FG004|Overall Study|Death|0|||
170728243|NCT01302847|617010292|FG005|Overall Study|Death|1|||
170836488|NCT02127125|617409324|FG008|Overall Study|Withdrawal by Subject|0|||
170836489|NCT02127125|617409316|FG000|Overall Study|Physician Decision|0|||
170836490|NCT02127125|617409317|FG001|Overall Study|Physician Decision|0|||
170836491|NCT02127125|617409318|FG002|Overall Study|Physician Decision|1|||
170836492|NCT02127125|617409319|FG003|Overall Study|Physician Decision|0|||
170836493|NCT02127125|617409320|FG004|Overall Study|Physician Decision|1|||
170728244|NCT01302847|617010293|FG006|Overall Study|Death|1|||
170728245|NCT01302847|617010294|FG007|Overall Study|Death|0|||
170728246|NCT01302847|617010287|FG000|Overall Study|Pregnancy|2|||
170728247|NCT01302847|617010288|FG001|Overall Study|Pregnancy|0|||
170728248|NCT01302847|617010289|FG002|Overall Study|Pregnancy|0|||
170728249|NCT01302847|617010290|FG003|Overall Study|Pregnancy|0|||
170728250|NCT01302847|617010291|FG004|Overall Study|Pregnancy|0|||
170728251|NCT01302847|617010292|FG005|Overall Study|Pregnancy|0|||
170728252|NCT01302847|617010293|FG006|Overall Study|Pregnancy|0|||
170728253|NCT01302847|617010294|FG007|Overall Study|Pregnancy|0|||
170728254|NCT01302847|617010287|FG000|Overall Study|Virologic failure|0|||
170728255|NCT01302847|617010288|FG001|Overall Study|Virologic failure|2|||
170728256|NCT01302847|617010289|FG002|Overall Study|Virologic failure|0|||
170728257|NCT01302847|617010290|FG003|Overall Study|Virologic failure|2|||
170728258|NCT01302847|617010291|FG004|Overall Study|Virologic failure|1|||
170728259|NCT01302847|617010292|FG005|Overall Study|Virologic failure|3|||
170728260|NCT01302847|617010293|FG006|Overall Study|Virologic failure|1|||
170728261|NCT01302847|617010294|FG007|Overall Study|Virologic failure|2|||
170728262|NCT01302847|617010287|FG000|Overall Study|Severe debilitation, unable to continue|0|||
170728263|NCT01302847|617010288|FG001|Overall Study|Severe debilitation, unable to continue|0|||
170728264|NCT01302847|617010289|FG002|Overall Study|Severe debilitation, unable to continue|0|||
170728265|NCT01302847|617010290|FG003|Overall Study|Severe debilitation, unable to continue|0|||
170728266|NCT01302847|617010291|FG004|Overall Study|Severe debilitation, unable to continue|0|||
170728267|NCT01302847|617010292|FG005|Overall Study|Severe debilitation, unable to continue|1|||
170728268|NCT01302847|617010293|FG006|Overall Study|Severe debilitation, unable to continue|1|||
170836494|NCT02127125|617409321|FG005|Overall Study|Physician Decision|2|||
170836495|NCT02127125|617409322|FG006|Overall Study|Physician Decision|0|||
170836496|NCT02127125|617409323|FG007|Overall Study|Physician Decision|0|||
170836497|NCT02127125|617409324|FG008|Overall Study|Physician Decision|0|||
170836498|NCT01791413|617409325|FG000|Overall Study|Lost to Follow-up|5|||
170836499|NCT01791413|617409326|FG001|Overall Study|Lost to Follow-up|1|||
170836500|NCT04016272|617409336|FG000|Overall Study|Withdrawal by Subject|1|||
170836501|NCT04016272|617409337|FG001|Overall Study|Withdrawal by Subject|2|||
170836502|NCT00825305|617409339|FG000|Overall Study|Adverse Event|1|||
170836503|NCT00825305|617409340|FG001|Overall Study|Adverse Event|1|||
170836504|NCT00825305|617409339|FG000|Overall Study|Withdrawal by Subject|6|||
170728269|NCT01302847|617010294|FG007|Overall Study|Severe debilitation, unable to continue|0|||
170728270|NCT01302847|617010287|FG000|Overall Study|Not able to get to clinic|1|||
170728271|NCT01302847|617010288|FG001|Overall Study|Not able to get to clinic|1|||
170728272|NCT01302847|617010289|FG002|Overall Study|Not able to get to clinic|0|||
170728273|NCT01302847|617010290|FG003|Overall Study|Not able to get to clinic|0|||
170728274|NCT01302847|617010291|FG004|Overall Study|Not able to get to clinic|0|||
170836505|NCT00825305|617409340|FG001|Overall Study|Withdrawal by Subject|12|||
170836506|NCT00825305|617409339|FG000|Overall Study|Inappropriate inclusion|1|||
170836507|NCT00825305|617409340|FG001|Overall Study|Inappropriate inclusion|0|||
170836508|NCT00825305|617409339|FG000|Overall Study|Protocol Violation|9|||
170836509|NCT00825305|617409340|FG001|Overall Study|Protocol Violation|9|||
170836510|NCT00825305|617409339|FG000|Overall Study|Can not be classified|0|||
170836511|NCT00825305|617409340|FG001|Overall Study|Can not be classified|1|||
170836512|NCT01236352|617409343|FG000|Overall Study|Death|0|||
170836513|NCT01236352|617409344|FG001|Overall Study|Death|0|||
170836514|NCT01236352|617409345|FG002|Overall Study|Death|0|||
170836515|NCT01236352|617409346|FG003|Overall Study|Death|0|||
170836516|NCT01236352|617409347|FG004|Overall Study|Death|0|||
170836517|NCT01236352|617409348|FG005|Overall Study|Death|0|||
170836518|NCT01236352|617409349|FG006|Overall Study|Death|0|||
170836519|NCT01236352|617409350|FG007|Overall Study|Death|1|||
170836520|NCT01236352|617409351|FG008|Overall Study|Death|0|||
170836521|NCT01236352|617409352|FG009|Overall Study|Death|0|||
170728275|NCT01302847|617010292|FG005|Overall Study|Not able to get to clinic|0|||
170728276|NCT01302847|617010293|FG006|Overall Study|Not able to get to clinic|0|||
170836522|NCT01236352|617409353|FG010|Overall Study|Death|0|||
170836523|NCT01236352|617409343|FG000|Overall Study|Withdrawal by Subject|0|||
170728277|NCT01302847|617010294|FG007|Overall Study|Not able to get to clinic|0|||
170728278|NCT01302847|617010287|FG000|Overall Study|Site closing|2|||
170728279|NCT01302847|617010288|FG001|Overall Study|Site closing|2|||
170728280|NCT01302847|617010289|FG002|Overall Study|Site closing|0|||
170728281|NCT01302847|617010290|FG003|Overall Study|Site closing|0|||
170836524|NCT01236352|617409344|FG001|Overall Study|Withdrawal by Subject|0|||
170836525|NCT01236352|617409345|FG002|Overall Study|Withdrawal by Subject|0|||
170836526|NCT01236352|617409346|FG003|Overall Study|Withdrawal by Subject|0|||
170836527|NCT01236352|617409347|FG004|Overall Study|Withdrawal by Subject|0|||
170836528|NCT01236352|617409348|FG005|Overall Study|Withdrawal by Subject|0|||
170836529|NCT01236352|617409349|FG006|Overall Study|Withdrawal by Subject|0|||
170836530|NCT01236352|617409350|FG007|Overall Study|Withdrawal by Subject|0|||
170836531|NCT01236352|617409351|FG008|Overall Study|Withdrawal by Subject|0|||
170836532|NCT01236352|617409352|FG009|Overall Study|Withdrawal by Subject|2|||
170836533|NCT01236352|617409353|FG010|Overall Study|Withdrawal by Subject|1|||
170836534|NCT01236352|617409343|FG000|Overall Study|Adverse Event|0|||
170836535|NCT01236352|617409344|FG001|Overall Study|Adverse Event|0|||
170836536|NCT01236352|617409345|FG002|Overall Study|Adverse Event|0|||
170836537|NCT01236352|617409346|FG003|Overall Study|Adverse Event|0|||
170836538|NCT01236352|617409347|FG004|Overall Study|Adverse Event|0|||
170836539|NCT01236352|617409348|FG005|Overall Study|Adverse Event|0|||
170836540|NCT01236352|617409349|FG006|Overall Study|Adverse Event|2|||
170836541|NCT01236352|617409350|FG007|Overall Study|Adverse Event|0|||
170836542|NCT01236352|617409351|FG008|Overall Study|Adverse Event|0|||
170836543|NCT01236352|617409352|FG009|Overall Study|Adverse Event|4|||
170836544|NCT01236352|617409353|FG010|Overall Study|Adverse Event|1|||
170836545|NCT01236352|617409343|FG000|Overall Study|Study drug toxicity|0|||
170836546|NCT01236352|617409344|FG001|Overall Study|Study drug toxicity|0|||
170836547|NCT01236352|617409345|FG002|Overall Study|Study drug toxicity|0|||
170836548|NCT01236352|617409346|FG003|Overall Study|Study drug toxicity|0|||
170836549|NCT01236352|617409347|FG004|Overall Study|Study drug toxicity|0|||
170836550|NCT01236352|617409348|FG005|Overall Study|Study drug toxicity|1|||
170836551|NCT01236352|617409349|FG006|Overall Study|Study drug toxicity|1|||
170836552|NCT01236352|617409350|FG007|Overall Study|Study drug toxicity|0|||
170836553|NCT01236352|617409351|FG008|Overall Study|Study drug toxicity|0|||
170836554|NCT01236352|617409352|FG009|Overall Study|Study drug toxicity|2|||
170836555|NCT01236352|617409353|FG010|Overall Study|Study drug toxicity|2|||
170836556|NCT01236352|617409343|FG000|Overall Study|Disease progression|1|||
170836557|NCT01236352|617409344|FG001|Overall Study|Disease progression|2|||
170836558|NCT01236352|617409345|FG002|Overall Study|Disease progression|1|||
170836559|NCT01236352|617409346|FG003|Overall Study|Disease progression|2|||
170836560|NCT01236352|617409347|FG004|Overall Study|Disease progression|2|||
170836561|NCT01236352|617409348|FG005|Overall Study|Disease progression|2|||
170836562|NCT01236352|617409349|FG006|Overall Study|Disease progression|1|||
170836563|NCT01236352|617409350|FG007|Overall Study|Disease progression|3|||
170836564|NCT01236352|617409351|FG008|Overall Study|Disease progression|2|||
170836565|NCT01236352|617409352|FG009|Overall Study|Disease progression|2|||
170836566|NCT01236352|617409353|FG010|Overall Study|Disease progression|2|||
170836567|NCT01236352|617409343|FG000|Overall Study|Poor/Non-compliance|1|||
170836568|NCT01236352|617409344|FG001|Overall Study|Poor/Non-compliance|0|||
170836569|NCT01236352|617409345|FG002|Overall Study|Poor/Non-compliance|0|||
170836570|NCT01236352|617409346|FG003|Overall Study|Poor/Non-compliance|0|||
170836571|NCT01236352|617409347|FG004|Overall Study|Poor/Non-compliance|0|||
170836572|NCT01236352|617409348|FG005|Overall Study|Poor/Non-compliance|0|||
170836573|NCT01236352|617409349|FG006|Overall Study|Poor/Non-compliance|0|||
170836574|NCT01236352|617409350|FG007|Overall Study|Poor/Non-compliance|0|||
170728282|NCT01302847|617010291|FG004|Overall Study|Site closing|0|||
170728283|NCT01302847|617010292|FG005|Overall Study|Site closing|0|||
170728284|NCT01302847|617010293|FG006|Overall Study|Site closing|0|||
170728285|NCT01302847|617010294|FG007|Overall Study|Site closing|0|||
170728286|NCT01302847|617010287|FG000|Overall Study|Withdrawal by Subject|1|||
170728287|NCT01302847|617010288|FG001|Overall Study|Withdrawal by Subject|0|||
170728288|NCT01302847|617010289|FG002|Overall Study|Withdrawal by Subject|0|||
170728289|NCT01302847|617010290|FG003|Overall Study|Withdrawal by Subject|0|||
170728290|NCT01302847|617010291|FG004|Overall Study|Withdrawal by Subject|1|||
170728291|NCT01302847|617010292|FG005|Overall Study|Withdrawal by Subject|0|||
170728292|NCT01302847|617010293|FG006|Overall Study|Withdrawal by Subject|0|||
170728293|NCT01302847|617010294|FG007|Overall Study|Withdrawal by Subject|1|||
170728294|NCT01302847|617010287|FG000|Overall Study|Not willing to adhere to requirements|5|||
170728295|NCT01302847|617010288|FG001|Overall Study|Not willing to adhere to requirements|0|||
170728296|NCT01302847|617010289|FG002|Overall Study|Not willing to adhere to requirements|1|||
170728297|NCT01302847|617010290|FG003|Overall Study|Not willing to adhere to requirements|0|||
170728298|NCT01302847|617010291|FG004|Overall Study|Not willing to adhere to requirements|0|||
170728299|NCT01302847|617010292|FG005|Overall Study|Not willing to adhere to requirements|0|||
170728300|NCT01302847|617010293|FG006|Overall Study|Not willing to adhere to requirements|0|||
170728301|NCT01302847|617010294|FG007|Overall Study|Not willing to adhere to requirements|2|||
170836575|NCT01236352|617409351|FG008|Overall Study|Poor/Non-compliance|0|||
170836576|NCT01236352|617409352|FG009|Overall Study|Poor/Non-compliance|0|||
170836577|NCT01236352|617409353|FG010|Overall Study|Poor/Non-compliance|0|||
170836578|NCT01236352|617409343|FG000|Overall Study|Maximum clinical benefit|1|||
170836579|NCT01236352|617409344|FG001|Overall Study|Maximum clinical benefit|1|||
170836580|NCT01236352|617409345|FG002|Overall Study|Maximum clinical benefit|1|||
170836581|NCT01236352|617409346|FG003|Overall Study|Maximum clinical benefit|0|||
170836582|NCT01236352|617409347|FG004|Overall Study|Maximum clinical benefit|2|||
170836583|NCT01236352|617409348|FG005|Overall Study|Maximum clinical benefit|0|||
170836584|NCT01236352|617409349|FG006|Overall Study|Maximum clinical benefit|3|||
170836585|NCT01236352|617409350|FG007|Overall Study|Maximum clinical benefit|1|||
170836586|NCT01236352|617409351|FG008|Overall Study|Maximum clinical benefit|1|||
170836587|NCT01236352|617409352|FG009|Overall Study|Maximum clinical benefit|4|||
170836588|NCT01236352|617409353|FG010|Overall Study|Maximum clinical benefit|2|||
170836589|NCT01236352|617409343|FG000|Overall Study|Subject request to discontinue treatment|0|||
170836590|NCT01236352|617409344|FG001|Overall Study|Subject request to discontinue treatment|0|||
170728302|NCT01302847|617010287|FG000|Overall Study|Site unable to contact participant|2|||
170728303|NCT01302847|617010288|FG001|Overall Study|Site unable to contact participant|1|||
170728304|NCT01302847|617010289|FG002|Overall Study|Site unable to contact participant|0|||
170728305|NCT01302847|617010290|FG003|Overall Study|Site unable to contact participant|0|||
170728306|NCT01302847|617010291|FG004|Overall Study|Site unable to contact participant|0|||
170728307|NCT01302847|617010292|FG005|Overall Study|Site unable to contact participant|0|||
170728308|NCT01302847|617010293|FG006|Overall Study|Site unable to contact participant|2|||
170728309|NCT01302847|617010294|FG007|Overall Study|Site unable to contact participant|0|||
170728310|NCT01565707|617010296|FG000|Overall Study|Adverse Event|1|||
170728311|NCT01565707|617010297|FG001|Overall Study|Adverse Event|6|||
170728312|NCT01565707|617010298|FG002|Overall Study|Adverse Event|2|||
170728313|NCT01565707|617010299|FG003|Overall Study|Adverse Event|1|||
170728314|NCT01565707|617010296|FG000|Overall Study|Lost to Follow-up|1|||
170728315|NCT01565707|617010297|FG001|Overall Study|Lost to Follow-up|0|||
170728316|NCT01565707|617010298|FG002|Overall Study|Lost to Follow-up|0|||
170728317|NCT01565707|617010299|FG003|Overall Study|Lost to Follow-up|0|||
170728318|NCT01565707|617010296|FG000|Overall Study|Protocol Violation|1|||
170728319|NCT01565707|617010297|FG001|Overall Study|Protocol Violation|0|||
170728320|NCT01565707|617010298|FG002|Overall Study|Protocol Violation|0|||
170728321|NCT01565707|617010299|FG003|Overall Study|Protocol Violation|1|||
170728322|NCT01565707|617010296|FG000|Overall Study|Withdrawal by Subject|3|||
170728323|NCT01565707|617010297|FG001|Overall Study|Withdrawal by Subject|1|||
170728324|NCT01565707|617010298|FG002|Overall Study|Withdrawal by Subject|1|||
170728325|NCT01565707|617010299|FG003|Overall Study|Withdrawal by Subject|1|||
170728326|NCT01565707|617010296|FG000|Overall Study|Randomized but not evaluable|2|||
170728327|NCT01565707|617010297|FG001|Overall Study|Randomized but not evaluable|0|||
170728328|NCT01565707|617010298|FG002|Overall Study|Randomized but not evaluable|0|||
170728329|NCT01565707|617010299|FG003|Overall Study|Randomized but not evaluable|0|||
170728330|NCT01565707|617010296|FG000|Overall Study|Miscellaneous|1|||
170728331|NCT01565707|617010297|FG001|Overall Study|Miscellaneous|1|||
170728332|NCT01565707|617010298|FG002|Overall Study|Miscellaneous|0|||
170728333|NCT01565707|617010299|FG003|Overall Study|Miscellaneous|2|||
170728334|NCT00617344|617010302|FG000|Overall Study|Serious adverse event|1|||
170728335|NCT00617344|617010303|FG001|Overall Study|Serious adverse event|0|||
170728336|NCT00617344|617010304|FG002|Overall Study|Serious adverse event|0|||
170728337|NCT00617344|617010302|FG000|Overall Study|Other Adverse Event|1|||
170728338|NCT00617344|617010303|FG001|Overall Study|Other Adverse Event|1|||
170728339|NCT00617344|617010304|FG002|Overall Study|Other Adverse Event|0|||
170728340|NCT00617344|617010302|FG000|Overall Study|Protocol Violation|10|||
170728341|NCT00617344|617010303|FG001|Overall Study|Protocol Violation|8|||
170728342|NCT00617344|617010304|FG002|Overall Study|Protocol Violation|5|||
170728343|NCT00617344|617010302|FG000|Overall Study|Lost to Follow-up|5|||
170728344|NCT00617344|617010303|FG001|Overall Study|Lost to Follow-up|4|||
170728345|NCT00617344|617010304|FG002|Overall Study|Lost to Follow-up|1|||
170728346|NCT00617344|617010302|FG000|Overall Study|Withdrawal by Subject|8|||
170728347|NCT00617344|617010303|FG001|Overall Study|Withdrawal by Subject|9|||
170728348|NCT00617344|617010304|FG002|Overall Study|Withdrawal by Subject|2|||
170728349|NCT00450411|617010306|FG000|Overall Study|Protocol Violation|6|||
170728350|NCT00450411|617010306|FG000|Overall Study|No protocol treatment|2|||
170728351|NCT02137369|617010307|FG000|Overall Study|Withdrawal by Subject|3|||
170728352|NCT02137369|617010308|FG001|Overall Study|Withdrawal by Subject|2|||
170728353|NCT02137369|617010307|FG000|Overall Study|Adverse Event|2|||
170728354|NCT02137369|617010308|FG001|Overall Study|Adverse Event|0|||
170728355|NCT02137369|617010307|FG000|Overall Study|Lost to Follow-up|1|||
170728356|NCT02137369|617010308|FG001|Overall Study|Lost to Follow-up|0|||
170728357|NCT02137369|617010307|FG000|Overall Study|Moved away|2|||
170728358|NCT02137369|617010308|FG001|Overall Study|Moved away|0|||
170728359|NCT01212770|617010309|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
170728360|NCT01212770|617010310|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
170728361|NCT01212770|617010311|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
170728362|NCT01212770|617010312|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170728363|NCT01212770|617010313|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170728364|NCT01212770|617010314|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170728365|NCT01212770|617010315|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170728366|NCT01212770|617010316|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170728367|NCT01212770|617010317|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
170728368|NCT01212770|617010309|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
170728369|NCT01212770|617010310|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
170728370|NCT01212770|617010311|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
170836591|NCT01236352|617409345|FG002|Overall Study|Subject request to discontinue treatment|1|||
170728371|NCT01212770|617010312|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170728372|NCT01212770|617010313|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170728373|NCT01212770|617010314|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170728374|NCT01212770|617010315|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170728375|NCT01212770|617010316|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170728376|NCT01212770|617010317|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
170728377|NCT01212770|617010309|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
170728378|NCT01212770|617010310|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
170728379|NCT01212770|617010311|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
170728380|NCT01212770|617010312|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170728381|NCT01212770|617010313|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170728382|NCT01212770|617010314|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170728383|NCT01212770|617010315|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170728384|NCT01212770|617010316|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170728385|NCT01212770|617010317|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
170728386|NCT01212770|617010309|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
170728387|NCT01212770|617010310|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170728388|NCT01212770|617010311|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
170728389|NCT01212770|617010312|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170728390|NCT01212770|617010313|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170728391|NCT01212770|617010314|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170728392|NCT01212770|617010315|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170728393|NCT01212770|617010316|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170728394|NCT01212770|617010317|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
170728395|NCT01212770|617010309|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170728396|NCT01212770|617010310|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170728397|NCT01212770|617010311|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
170728398|NCT01212770|617010312|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170728399|NCT01212770|617010313|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170728400|NCT01212770|617010314|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170728401|NCT01212770|617010315|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170728402|NCT01212770|617010316|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170728403|NCT01212770|617010317|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
170728404|NCT01212770|617010309|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
170728405|NCT01212770|617010310|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
170728406|NCT01212770|617010311|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
170728407|NCT01212770|617010312|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
170728408|NCT01212770|617010313|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
170728409|NCT01212770|617010314|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
170728410|NCT01212770|617010315|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
170728411|NCT01212770|617010316|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
170728412|NCT01212770|617010317|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
170728413|NCT01212770|617010309|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
170728414|NCT01212770|617010310|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
170728415|NCT01212770|617010311|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
170728416|NCT01212770|617010312|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
170728417|NCT01212770|617010313|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
170728418|NCT01212770|617010314|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
170728419|NCT01212770|617010315|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
170728420|NCT01212770|617010316|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
170728421|NCT01212770|617010317|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
170728422|NCT01212770|617010309|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
170728423|NCT01212770|617010310|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
170728424|NCT01212770|617010311|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
170728425|NCT01212770|617010312|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
170728426|NCT01212770|617010313|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
170728427|NCT01212770|617010314|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
170728428|NCT01212770|617010315|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
170728429|NCT01212770|617010316|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
170836592|NCT01236352|617409346|FG003|Overall Study|Subject request to discontinue treatment|1|||
170836593|NCT01236352|617409347|FG004|Overall Study|Subject request to discontinue treatment|0|||
170836594|NCT01236352|617409348|FG005|Overall Study|Subject request to discontinue treatment|1|||
170836595|NCT01236352|617409349|FG006|Overall Study|Subject request to discontinue treatment|0|||
170728430|NCT01212770|617010317|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
170728431|NCT01212770|617010309|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
170728432|NCT01212770|617010310|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
170728433|NCT01212770|617010311|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
170728434|NCT01212770|617010312|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
170728435|NCT01212770|617010313|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
170728436|NCT01212770|617010314|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
170728437|NCT01212770|617010315|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
170728438|NCT01212770|617010316|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
170728439|NCT01212770|617010317|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
170728440|NCT01212770|617010309|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
170728441|NCT01212770|617010310|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
170728442|NCT01212770|617010311|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
170728443|NCT01212770|617010312|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
170728444|NCT01212770|617010313|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
170728445|NCT01212770|617010314|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
170728446|NCT01212770|617010315|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
170728447|NCT01212770|617010316|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
170728448|NCT01212770|617010317|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
170728449|NCT01212770|617010309|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
170728450|NCT01212770|617010310|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
170728451|NCT01212770|617010311|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
170728452|NCT01212770|617010312|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
170728453|NCT01212770|617010313|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
170728454|NCT01212770|617010314|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
170728455|NCT01212770|617010315|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
170728456|NCT01212770|617010316|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
170728457|NCT01212770|617010317|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
170728458|NCT01212770|617010309|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
170728459|NCT01212770|617010310|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
170728460|NCT01212770|617010311|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
170728461|NCT01212770|617010312|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
170728462|NCT01212770|617010313|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
170728463|NCT01212770|617010314|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
170728464|NCT01212770|617010315|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
170728465|NCT01212770|617010316|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
170728466|NCT01212770|617010317|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
170728467|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170728468|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
170728469|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
170728470|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170728471|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170728472|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170728473|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170728474|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
170728475|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
170728476|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170728477|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
170836596|NCT01236352|617409350|FG007|Overall Study|Subject request to discontinue treatment|0|||
170836597|NCT01236352|617409351|FG008|Overall Study|Subject request to discontinue treatment|0|||
170836598|NCT01236352|617409352|FG009|Overall Study|Subject request to discontinue treatment|1|||
170836599|NCT01236352|617409353|FG010|Overall Study|Subject request to discontinue treatment|4|||
170836600|NCT01236352|617409343|FG000|Overall Study|Subject to receive drug via EAP|1|||
170836601|NCT01236352|617409344|FG001|Overall Study|Subject to receive drug via EAP|1|||
170836602|NCT01236352|617409345|FG002|Overall Study|Subject to receive drug via EAP|1|||
170836603|NCT01236352|617409346|FG003|Overall Study|Subject to receive drug via EAP|0|||
170836604|NCT01236352|617409347|FG004|Overall Study|Subject to receive drug via EAP|0|||
170836605|NCT01236352|617409348|FG005|Overall Study|Subject to receive drug via EAP|0|||
170836606|NCT01236352|617409349|FG006|Overall Study|Subject to receive drug via EAP|0|||
170836607|NCT01236352|617409350|FG007|Overall Study|Subject to receive drug via EAP|2|||
170836608|NCT01236352|617409351|FG008|Overall Study|Subject to receive drug via EAP|0|||
170836609|NCT01236352|617409352|FG009|Overall Study|Subject to receive drug via EAP|4|||
170836610|NCT01236352|617409353|FG010|Overall Study|Subject to receive drug via EAP|0|||
170836611|NCT01236352|617409343|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
170836612|NCT01236352|617409344|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
170836613|NCT01236352|617409345|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
170836614|NCT01236352|617409346|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
170728478|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
170728479|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170728480|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170728481|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170728482|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
170728483|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
170728484|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
170728485|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
170728486|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
170728487|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
170728488|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
170728489|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
170728490|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
170728491|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
170728492|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
170728493|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
170728494|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170728495|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
170728496|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
170728497|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170728498|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170728499|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170728500|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
170728501|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
170728502|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
170728503|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
170728504|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
170728505|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
170728506|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
170728507|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
170728508|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
170728509|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
170728510|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
170728511|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
170728512|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170728513|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
170728514|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
170728515|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170728516|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170728517|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170728518|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170728519|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
170728520|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
170728521|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170728522|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
170728523|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
170728524|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170728525|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170728526|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170728527|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
170728528|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
170728529|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
170728530|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170728531|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
170728532|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
170728533|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170728534|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170728535|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170728536|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
170728537|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
170728538|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
170728539|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170728540|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
170728541|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
170728542|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170728543|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170728544|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170728545|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
170836615|NCT01236352|617409347|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
170836616|NCT01236352|617409348|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
170836617|NCT01236352|617409349|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
170836618|NCT01236352|617409350|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
170836619|NCT01236352|617409351|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
170728546|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
170728547|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
170728548|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170728549|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
170728550|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170728551|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170728552|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170728553|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170836620|NCT01236352|617409352|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
170836621|NCT01236352|617409353|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
170836622|NCT01236352|617409343|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836623|NCT01236352|617409344|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836624|NCT01236352|617409345|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836625|NCT01236352|617409346|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836626|NCT01236352|617409347|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836627|NCT01236352|617409348|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836628|NCT01236352|617409349|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836629|NCT01236352|617409350|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836630|NCT01236352|617409351|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836631|NCT01236352|617409352|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
170836632|NCT01236352|617409353|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
170836633|NCT01236352|617409343|FG000|Overall Study|Lack of response to drug|0|||
170836634|NCT01236352|617409344|FG001|Overall Study|Lack of response to drug|0|||
170836635|NCT01236352|617409345|FG002|Overall Study|Lack of response to drug|0|||
170836636|NCT01236352|617409346|FG003|Overall Study|Lack of response to drug|0|||
170836637|NCT01236352|617409347|FG004|Overall Study|Lack of response to drug|0|||
170836638|NCT01236352|617409348|FG005|Overall Study|Lack of response to drug|0|||
170836639|NCT01236352|617409349|FG006|Overall Study|Lack of response to drug|0|||
170836640|NCT01236352|617409350|FG007|Overall Study|Lack of response to drug|0|||
170836641|NCT01236352|617409351|FG008|Overall Study|Lack of response to drug|0|||
170836642|NCT01236352|617409352|FG009|Overall Study|Lack of response to drug|1|||
170836643|NCT01236352|617409353|FG010|Overall Study|Lack of response to drug|1|||
170836644|NCT01236352|617409343|FG000|Overall Study|Patient transferred to IST|0|||
170836645|NCT01236352|617409344|FG001|Overall Study|Patient transferred to IST|0|||
170836646|NCT01236352|617409345|FG002|Overall Study|Patient transferred to IST|0|||
170836647|NCT01236352|617409346|FG003|Overall Study|Patient transferred to IST|0|||
170836648|NCT01236352|617409347|FG004|Overall Study|Patient transferred to IST|0|||
170836649|NCT01236352|617409348|FG005|Overall Study|Patient transferred to IST|0|||
170836650|NCT01236352|617409349|FG006|Overall Study|Patient transferred to IST|0|||
170836651|NCT01236352|617409350|FG007|Overall Study|Patient transferred to IST|0|||
170836652|NCT01236352|617409351|FG008|Overall Study|Patient transferred to IST|0|||
170836653|NCT01236352|617409352|FG009|Overall Study|Patient transferred to IST|2|||
170836654|NCT01236352|617409353|FG010|Overall Study|Patient transferred to IST|6|||
170836655|NCT05594589|617409360|FG000|Overall Study|Other|0|||
170836656|NCT05594589|617409361|FG001|Overall Study|Other|1|||
170836657|NCT05594589|617409362|FG002|Overall Study|Other|0|||
170836658|NCT02282917|617409363|FG000|Overall Study|Withdrawal by Subject|1|||
170836659|NCT02282917|617409363|FG000|Overall Study|Screen Failure/Not Eligible|1|||
170836660|NCT00715117|617409370|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
170836661|NCT00715117|617409371|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
170836662|NCT02498236|617409375|FG000|Overall Study|Did not show for testing|1|||
170836663|NCT02498236|617409376|FG001|Overall Study|Did not show for testing|0|||
170836664|NCT02498236|617409377|FG002|Overall Study|Did not show for testing|0|||
170836665|NCT02498236|617409378|FG003|Overall Study|Did not show for testing|0|||
170836666|NCT02498236|617409379|FG004|Overall Study|Did not show for testing|0|||
170836667|NCT02498236|617409380|FG005|Overall Study|Did not show for testing|0|||
170836668|NCT02498236|617409381|FG006|Overall Study|Did not show for testing|0|||
170836669|NCT02498236|617409382|FG007|Overall Study|Did not show for testing|1|||
170836670|NCT02498236|617409375|FG000|Overall Study|Equipment failure|0|||
170836671|NCT02498236|617409376|FG001|Overall Study|Equipment failure|0|||
170836672|NCT02498236|617409377|FG002|Overall Study|Equipment failure|0|||
170836673|NCT02498236|617409378|FG003|Overall Study|Equipment failure|0|||
170836674|NCT02498236|617409379|FG004|Overall Study|Equipment failure|0|||
170836675|NCT02498236|617409380|FG005|Overall Study|Equipment failure|0|||
170836676|NCT02498236|617409381|FG006|Overall Study|Equipment failure|1|||
170836677|NCT02498236|617409382|FG007|Overall Study|Equipment failure|0|||
170836678|NCT02498236|617409375|FG000|Overall Study|Withdrawal by Subject|0|||
170728554|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170728555|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170728556|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
170728557|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
170728558|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
170728559|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
170728560|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
170728561|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
170728562|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
170728563|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
170728564|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
170728565|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
170728566|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170728567|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
170728568|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
170728569|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170728570|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170728571|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170728572|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
170728573|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
170728574|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
170728575|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170728576|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
170728577|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
170728578|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170728579|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170728580|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170728581|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170728582|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
170728583|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
170728584|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170728585|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
170728586|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
170728587|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170836679|NCT02498236|617409376|FG001|Overall Study|Withdrawal by Subject|0|||
170836680|NCT02498236|617409377|FG002|Overall Study|Withdrawal by Subject|0|||
170836681|NCT02498236|617409378|FG003|Overall Study|Withdrawal by Subject|0|||
170836682|NCT02498236|617409379|FG004|Overall Study|Withdrawal by Subject|1|||
170836683|NCT02498236|617409380|FG005|Overall Study|Withdrawal by Subject|0|||
170728588|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170728589|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170728590|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170728591|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
170728592|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
170728593|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
170728594|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
170728595|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
170728596|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
170728597|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
170728598|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
170728599|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
170728600|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
170728601|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
170728602|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170836684|NCT02498236|617409381|FG006|Overall Study|Withdrawal by Subject|0|||
170836685|NCT02498236|617409382|FG007|Overall Study|Withdrawal by Subject|0|||
170836686|NCT01536171|617409383|FG000|Overall Study|Withdrawal by Subject|1|||
170836687|NCT03566979|617409385|FG000|Overall Study|Withdrawal by Subject|2|||
170728603|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
170728604|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
170728605|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170728606|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170728607|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170728608|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170728609|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170728610|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
170728611|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170728612|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170728613|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
170728614|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170728615|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170728616|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170728617|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170728618|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170728619|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
170728620|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170728621|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
170728622|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170728623|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170728624|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170728625|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170728626|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170728627|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
170728628|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
170728629|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
170728630|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
170728631|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
170728632|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
170728633|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
170728634|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
170728635|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
170728636|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
170728637|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
170728638|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170728639|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170728640|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
170728641|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170728642|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170728643|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170728644|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170728645|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170728646|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
170728647|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170728648|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170728649|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
170728650|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170728651|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170728652|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170728653|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170728654|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
170728655|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
170728656|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170728657|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170728658|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
170728659|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170728660|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170728661|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170728662|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170728663|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170728664|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
170728665|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170728666|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
170728667|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
170728668|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170728669|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170728670|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170728671|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170728672|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
170728673|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
170728674|NCT01212770|617010309|FG000|Long-term Safety Phase (Year 5)|Death|0|||
170728675|NCT01212770|617010310|FG001|Long-term Safety Phase (Year 5)|Death|0|||
170728676|NCT01212770|617010311|FG002|Long-term Safety Phase (Year 5)|Death|0|||
170728677|NCT01212770|617010312|FG003|Long-term Safety Phase (Year 5)|Death|0|||
170728678|NCT01212770|617010313|FG004|Long-term Safety Phase (Year 5)|Death|0|||
170728679|NCT01212770|617010314|FG005|Long-term Safety Phase (Year 5)|Death|0|||
170728680|NCT01212770|617010315|FG006|Long-term Safety Phase (Year 5)|Death|0|||
170728681|NCT01212770|617010316|FG007|Long-term Safety Phase (Year 5)|Death|1|||
170728682|NCT01212770|617010317|FG008|Long-term Safety Phase (Year 5)|Death|0|||
170728683|NCT00829387|617010324|FG000|Overall Study|Withdrawal by Subject|2|||
170728684|NCT00829387|617010325|FG001|Overall Study|Withdrawal by Subject|3|||
170728685|NCT00829387|617010324|FG000|Overall Study|Disqualified by PI|1|||
170728686|NCT00829387|617010325|FG001|Overall Study|Disqualified by PI|0|||
170728687|NCT00707031|617010333|FG000|Overall Study|Adverse Event|45|||
170728688|NCT00707031|617010334|FG001|Overall Study|Adverse Event|45|||
170728689|NCT00707031|617010333|FG000|Overall Study|Lack of Efficacy|19|||
170728690|NCT00707031|617010334|FG001|Overall Study|Lack of Efficacy|6|||
170728691|NCT00707031|617010333|FG000|Overall Study|Lost to Follow-up|2|||
170728692|NCT00707031|617010334|FG001|Overall Study|Lost to Follow-up|1|||
170728693|NCT00707031|617010333|FG000|Overall Study|Protocol Violation|1|||
170728694|NCT00707031|617010334|FG001|Overall Study|Protocol Violation|0|||
170728695|NCT00707031|617010333|FG000|Overall Study|Withdrawal by Subject|7|||
170728696|NCT00707031|617010334|FG001|Overall Study|Withdrawal by Subject|8|||
170728697|NCT00707031|617010333|FG000|Overall Study|Poor Compliance to Protocol|7|||
170728698|NCT00707031|617010334|FG001|Overall Study|Poor Compliance to Protocol|13|||
170728699|NCT00707031|617010333|FG000|Overall Study|Familial or Personal Reasons|12|||
170728700|NCT00707031|617010334|FG001|Overall Study|Familial or Personal Reasons|15|||
170728701|NCT00707031|617010333|FG000|Overall Study|Serious Noncompliance|2|||
170728702|NCT00707031|617010334|FG001|Overall Study|Serious Noncompliance|3|||
170728703|NCT00707031|617010333|FG000|Overall Study|Sponsor Decision|9|||
170728704|NCT00707031|617010334|FG001|Overall Study|Sponsor Decision|8|||
170728705|NCT00951275|617010337|FG000|Overall Study|Administrative Reason|1|||
170728706|NCT00951275|617010337|FG000|Overall Study|Adverse Event|7|||
170728707|NCT00951275|617010337|FG000|Overall Study|Withdrawal by Subject|4|||
170728708|NCT00951275|617010337|FG000|Overall Study|Protocol Violation|1|||
170728709|NCT02925676|617010339|FG000|Overall Study|Withdrawal by Subject|1|||
170728710|NCT00541450|617010340|FG000|Phase A|Adverse Event|3|||
170728711|NCT00541450|617010341|FG001|Phase A|Adverse Event|0|||
170728712|NCT00541450|617010340|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
170728713|NCT00541450|617010341|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
170728714|NCT00541450|617010340|FG000|Phase A|Hyperglycemia|0|||
170728715|NCT00541450|617010341|FG001|Phase A|Hyperglycemia|1|||
170728716|NCT00541450|617010340|FG000|Phase A|Lost to Follow-up|6|||
170728717|NCT00541450|617010341|FG001|Phase A|Lost to Follow-up|4|||
170728718|NCT00541450|617010340|FG000|Phase A|Physician Decision|2|||
170728719|NCT00541450|617010341|FG001|Phase A|Physician Decision|0|||
170728720|NCT00541450|617010340|FG000|Phase A|Protocol Violation|2|||
170728721|NCT00541450|617010341|FG001|Phase A|Protocol Violation|3|||
170728722|NCT00541450|617010340|FG000|Phase A|Withdrawal by Subject|7|||
170728723|NCT00541450|617010341|FG001|Phase A|Withdrawal by Subject|7|||
170728724|NCT00541450|617010340|FG000|Phase B|Adverse Event|6|||
170728725|NCT00541450|617010341|FG001|Phase B|Adverse Event|6|||
170728726|NCT00541450|617010340|FG000|Phase B|Hyperglycemia|10|||
170728727|NCT00541450|617010341|FG001|Phase B|Hyperglycemia|9|||
170836688|NCT03566979|617409386|FG001|Overall Study|Withdrawal by Subject|0|||
170728728|NCT00541450|617010340|FG000|Phase B|Lost to Follow-up|6|||
170728729|NCT00541450|617010341|FG001|Phase B|Lost to Follow-up|4|||
170728730|NCT00541450|617010340|FG000|Phase B|Physician Decision|4|||
170728731|NCT00541450|617010341|FG001|Phase B|Physician Decision|2|||
170728732|NCT00541450|617010340|FG000|Phase B|Pregnancy|0|||
170728733|NCT00541450|617010341|FG001|Phase B|Pregnancy|1|||
170728734|NCT00541450|617010340|FG000|Phase B|Protocol Violation|3|||
170728735|NCT00541450|617010341|FG001|Phase B|Protocol Violation|3|||
170728736|NCT00541450|617010340|FG000|Phase B|Withdrawal by Subject|8|||
170836689|NCT03566979|617409387|FG002|Overall Study|Withdrawal by Subject|1|||
170728737|NCT00541450|617010341|FG001|Phase B|Withdrawal by Subject|6|||
170836690|NCT03566979|617409388|FG003|Overall Study|Withdrawal by Subject|1|||
170728738|NCT02048072|617010342|FG000|Overall Study|Adverse Event|3|||
170728739|NCT02048072|617010342|FG000|Overall Study|Lost to Follow-up|1|||
170728740|NCT03645759|617010343|FG000|Overall Study|Lost to Follow-up|3|||
170728741|NCT03645759|617010344|FG001|Overall Study|Lost to Follow-up|2|||
170728742|NCT02899728|617010345|FG000|Overall Study|Withdrawal by Subject|1|||
170728743|NCT02899728|617010346|FG001|Overall Study|Withdrawal by Subject|1|||
170728744|NCT00902694|617010349|FG000|Overall Study|Death|1|||
170728745|NCT00902694|617010350|FG001|Overall Study|Death|3|||
170728746|NCT00902694|617010349|FG000|Overall Study|Lost to Follow-up|1|||
170728747|NCT00902694|617010350|FG001|Overall Study|Lost to Follow-up|0|||
170728748|NCT00902694|617010349|FG000|Overall Study|Censored per protocol|3|||
170728749|NCT00902694|617010350|FG001|Overall Study|Censored per protocol|1|||
170728750|NCT00902694|617010349|FG000|Overall Study|Pregnancy|1|||
170728751|NCT00902694|617010350|FG001|Overall Study|Pregnancy|1|||
170728752|NCT00902694|617010349|FG000|Overall Study|Incarceration|1|||
170728753|NCT00902694|617010350|FG001|Overall Study|Incarceration|0|||
170728754|NCT02693743|617010352|FG000|Overall Study|Physician Decision|1|||
170728755|NCT02693743|617010353|FG001|Overall Study|Physician Decision|0|||
170728756|NCT02626780|617010354|FG000|Overall Study|Withdrawal by Subject|3|||
170728757|NCT04304833|617010355|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
170728758|NCT04304833|617010356|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
170728759|NCT03776136|617010357|FG000|Overall Study|Death|85|||
170728760|NCT03776136|617010357|FG000|Overall Study|Withdrawal by Subject|3|||
170728761|NCT03776136|617010357|FG000|Overall Study|Sponsor Decision|15|||
170728762|NCT05540522|617010358|FG000|Overall Study|Adverse Event|1|||
170728763|NCT05540522|617010359|FG001|Overall Study|Adverse Event|0|||
170728764|NCT05540522|617010360|FG002|Overall Study|Adverse Event|2|||
170728765|NCT05540522|617010361|FG003|Overall Study|Adverse Event|5|||
170728766|NCT05540522|617010358|FG000|Overall Study|Lost to Follow-up|487|||
170728767|NCT05540522|617010359|FG001|Overall Study|Lost to Follow-up|427|||
170728768|NCT05540522|617010360|FG002|Overall Study|Lost to Follow-up|146|||
170728769|NCT05540522|617010361|FG003|Overall Study|Lost to Follow-up|166|||
170728770|NCT05540522|617010358|FG000|Overall Study|Physician Decision|11|||
170728771|NCT05540522|617010359|FG001|Overall Study|Physician Decision|19|||
170728772|NCT05540522|617010360|FG002|Overall Study|Physician Decision|8|||
170728773|NCT05540522|617010361|FG003|Overall Study|Physician Decision|13|||
170728774|NCT05540522|617010358|FG000|Overall Study|Pregnancy|1|||
170728775|NCT05540522|617010359|FG001|Overall Study|Pregnancy|0|||
170728776|NCT05540522|617010360|FG002|Overall Study|Pregnancy|0|||
170728777|NCT05540522|617010361|FG003|Overall Study|Pregnancy|0|||
170728778|NCT05540522|617010358|FG000|Overall Study|Protocol Violation|3|||
170728779|NCT05540522|617010359|FG001|Overall Study|Protocol Violation|1|||
170728780|NCT05540522|617010360|FG002|Overall Study|Protocol Violation|9|||
170728781|NCT05540522|617010361|FG003|Overall Study|Protocol Violation|7|||
170728782|NCT05540522|617010358|FG000|Overall Study|Withdrawal by Subject|168|||
170728783|NCT05540522|617010359|FG001|Overall Study|Withdrawal by Subject|134|||
170728784|NCT05540522|617010360|FG002|Overall Study|Withdrawal by Subject|331|||
170728785|NCT05540522|617010361|FG003|Overall Study|Withdrawal by Subject|322|||
170728786|NCT05540522|617010358|FG000|Overall Study|Death|7|||
170728787|NCT05540522|617010359|FG001|Overall Study|Death|9|||
170728788|NCT05540522|617010360|FG002|Overall Study|Death|49|||
170728789|NCT05540522|617010361|FG003|Overall Study|Death|46|||
170728790|NCT05540522|617010358|FG000|Overall Study|Not vaccinated|34|||
170728791|NCT05540522|617010359|FG001|Overall Study|Not vaccinated|53|||
170728792|NCT05540522|617010360|FG002|Overall Study|Not vaccinated|57|||
170728793|NCT05540522|617010361|FG003|Overall Study|Not vaccinated|50|||
170728794|NCT05540522|617010358|FG000|Overall Study|No longer meets eligibility criteria|0|||
170728795|NCT05540522|617010359|FG001|Overall Study|No longer meets eligibility criteria|0|||
170728796|NCT05540522|617010360|FG002|Overall Study|No longer meets eligibility criteria|3|||
170728797|NCT05540522|617010361|FG003|Overall Study|No longer meets eligibility criteria|2|||
170728798|NCT05540522|617010358|FG000|Overall Study|Other (Unspecified)|8|||
170728799|NCT05540522|617010359|FG001|Overall Study|Other (Unspecified)|10|||
170728800|NCT05540522|617010360|FG002|Overall Study|Other (Unspecified)|4|||
170728801|NCT05540522|617010361|FG003|Overall Study|Other (Unspecified)|2|||
170728802|NCT05338333|617010362|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
170728803|NCT05338333|617010363|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
170728804|NCT01329029|617010366|FG000|Overall Study|Withdrawal by Subject|117|||
170728805|NCT01329029|617010367|FG001|Overall Study|Withdrawal by Subject|87|||
170728806|NCT01329029|617010366|FG000|Overall Study|Adverse Event|82|||
170728807|NCT01329029|617010367|FG001|Overall Study|Adverse Event|29|||
170728808|NCT01329029|617010366|FG000|Overall Study|Death|16|||
170728809|NCT01329029|617010367|FG001|Overall Study|Death|19|||
170728810|NCT01329029|617010366|FG000|Overall Study|Other|14|||
170728811|NCT01329029|617010367|FG001|Overall Study|Other|20|||
170728812|NCT01329029|617010366|FG000|Overall Study|COPD Exacerbation|11|||
170728813|NCT01329029|617010367|FG001|Overall Study|COPD Exacerbation|18|||
170728814|NCT01329029|617010366|FG000|Overall Study|Physician Decision|16|||
170728815|NCT01329029|617010367|FG001|Overall Study|Physician Decision|13|||
170728816|NCT01329029|617010366|FG000|Overall Study|Lost to Follow-up|8|||
170728817|NCT01329029|617010367|FG001|Overall Study|Lost to Follow-up|5|||
170728818|NCT01329029|617010366|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
170728819|NCT01329029|617010367|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
170728820|NCT01106430|617012614|FG000|Overall Study|Adverse Event|8|||
170728821|NCT01106430|617012615|FG001|Overall Study|Adverse Event|10|||
170728822|NCT01106430|617012614|FG000|Overall Study|Lack of Efficacy|2|||
170728823|NCT01106430|617012615|FG001|Overall Study|Lack of Efficacy|13|||
170728824|NCT01106430|617012614|FG000|Overall Study|Lost to Follow-up|5|||
170728825|NCT01106430|617012615|FG001|Overall Study|Lost to Follow-up|1|||
170728826|NCT01106430|617012614|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
170728827|NCT01106430|617012615|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
170728828|NCT01106430|617012614|FG000|Overall Study|Moved Out Of State|0|||
170728829|NCT01106430|617012615|FG001|Overall Study|Moved Out Of State|1|||
170728830|NCT01106430|617012614|FG000|Overall Study|Refused To Take Medication|0|||
170728831|NCT01106430|617012615|FG001|Overall Study|Refused To Take Medication|1|||
170728832|NCT01106430|617012614|FG000|Overall Study|Noncompliance|0|||
170728833|NCT01106430|617012615|FG001|Overall Study|Noncompliance|1|||
170728834|NCT01106430|617012614|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
170728835|NCT01106430|617012615|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
170728836|NCT01106430|617012614|FG000|Overall Study|Previous Use Of Marijuana|1|||
170728837|NCT01106430|617012615|FG001|Overall Study|Previous Use Of Marijuana|0|||
170728838|NCT01106430|617012614|FG000|Overall Study|Protocol Violation|7|||
170728839|NCT01106430|617012615|FG001|Overall Study|Protocol Violation|2|||
170728840|NCT01106430|617012614|FG000|Overall Study|Withdrawal by Subject|8|||
170728841|NCT01106430|617012615|FG001|Overall Study|Withdrawal by Subject|4|||
170728842|NCT02066402|617012616|FG000|Overall Study|Adverse Event|1|||
170728843|NCT02066402|617012617|FG001|Overall Study|Adverse Event|2|||
170728844|NCT02066402|617012616|FG000|Overall Study|Lost to Follow-up|11|||
170728845|NCT02066402|617012617|FG001|Overall Study|Lost to Follow-up|8|||
170728846|NCT02066402|617012616|FG000|Overall Study|Withdrawal by Subject|14|||
170728847|NCT02066402|617012617|FG001|Overall Study|Withdrawal by Subject|11|||
170728848|NCT02066402|617012616|FG000|Overall Study|Progressive disease-clinical progression|0|||
170728849|NCT02066402|617012617|FG001|Overall Study|Progressive disease-clinical progression|1|||
170728850|NCT02066402|617012616|FG000|Overall Study|Protocol driven decision point|0|||
170728851|NCT02066402|617012617|FG001|Overall Study|Protocol driven decision point|1|||
170728852|NCT03104699|617012618|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
170728853|NCT03104699|617012619|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
170728854|NCT03104699|617012620|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
170728855|NCT03104699|617012621|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
170728856|NCT03104699|617012622|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
170728857|NCT03104699|617012623|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
170728858|NCT03104699|617012618|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
170728859|NCT03104699|617012619|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
170728860|NCT03104699|617012620|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
170728861|NCT03104699|617012621|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
170728862|NCT03104699|617012622|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
170728863|NCT03104699|617012623|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
170728864|NCT03104699|617012618|FG000|Phase 1: Dose Escalation|Death|6|||
170728865|NCT03104699|617012619|FG001|Phase 1: Dose Escalation|Death|3|||
170728866|NCT03104699|617012620|FG002|Phase 1: Dose Escalation|Death|0|||
170728867|NCT03104699|617012621|FG003|Phase 1: Dose Escalation|Death|1|||
170728868|NCT03104699|617012622|FG004|Phase 1: Dose Escalation|Death|1|||
170728869|NCT03104699|617012623|FG005|Phase 1: Dose Escalation|Death|0|||
170728870|NCT03104699|617012618|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
170728871|NCT03104699|617012619|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
170728872|NCT03104699|617012620|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
170728873|NCT03104699|617012621|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
170728874|NCT03104699|617012622|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
170728875|NCT03104699|617012623|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
170728876|NCT03104699|617012618|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
170728877|NCT03104699|617012619|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
170728878|NCT03104699|617012620|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
170728879|NCT03104699|617012621|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
170728880|NCT03104699|617012622|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
170728881|NCT03104699|617012623|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
170728882|NCT03104699|617012618|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
170728883|NCT03104699|617012619|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
170728884|NCT03104699|617012620|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
170728885|NCT03104699|617012621|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
170728886|NCT03104699|617012622|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
170728887|NCT03104699|617012623|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
170728888|NCT03104699|617012618|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
170728889|NCT03104699|617012619|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
170728890|NCT03104699|617012620|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
170728891|NCT03104699|617012621|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
170728892|NCT03104699|617012622|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
170728893|NCT03104699|617012623|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
170728894|NCT03104699|617012618|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
170728895|NCT03104699|617012619|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
170728896|NCT03104699|617012620|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
170728897|NCT03104699|617012621|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
170728898|NCT03104699|617012622|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
170728899|NCT03104699|617012623|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
170728900|NCT03104699|617012618|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170728901|NCT03104699|617012619|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170728902|NCT03104699|617012620|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170728903|NCT03104699|617012621|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170728904|NCT03104699|617012622|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
170728905|NCT03104699|617012623|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
170728906|NCT03104699|617012618|FG000|Phase 2: Dose Expansion|Death|0|||
170728907|NCT03104699|617012619|FG001|Phase 2: Dose Expansion|Death|0|||
170728908|NCT03104699|617012620|FG002|Phase 2: Dose Expansion|Death|0|||
170728909|NCT03104699|617012621|FG003|Phase 2: Dose Expansion|Death|0|||
170728910|NCT03104699|617012622|FG004|Phase 2: Dose Expansion|Death|0|||
170728911|NCT03104699|617012623|FG005|Phase 2: Dose Expansion|Death|107|||
170728912|NCT03104699|617012618|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
170728913|NCT03104699|617012619|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
170728914|NCT03104699|617012620|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
170728915|NCT03104699|617012621|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
170728916|NCT03104699|617012622|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
170728917|NCT03104699|617012623|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
170728918|NCT03104699|617012618|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
170728919|NCT03104699|617012619|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
170728920|NCT03104699|617012620|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
170728921|NCT03104699|617012621|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
170728922|NCT03104699|617012622|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
170728923|NCT03104699|617012623|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
170728924|NCT03104699|617012618|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170728925|NCT03104699|617012619|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170728926|NCT03104699|617012620|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170728927|NCT03104699|617012621|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170728928|NCT03104699|617012622|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
170728929|NCT03104699|617012623|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
170728930|NCT03104699|617012618|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
170728931|NCT03104699|617012619|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
170728932|NCT03104699|617012620|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
170728933|NCT03104699|617012621|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
170728934|NCT03104699|617012622|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
170728935|NCT03104699|617012623|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
170728936|NCT00152464|617012624|FG000|Overall Study|Adverse Event|3|||
170728937|NCT00152464|617012625|FG001|Overall Study|Adverse Event|6|||
170728938|NCT00152464|617012624|FG000|Overall Study|Lost to Follow-up|8|||
170728939|NCT00152464|617012625|FG001|Overall Study|Lost to Follow-up|4|||
170728940|NCT00152464|617012624|FG000|Overall Study|Protocol Violation|3|||
170728941|NCT00152464|617012625|FG001|Overall Study|Protocol Violation|1|||
170728942|NCT00152464|617012624|FG000|Overall Study|Withdrawal by Subject|21|||
170728943|NCT00152464|617012625|FG001|Overall Study|Withdrawal by Subject|22|||
170728944|NCT00152464|617012624|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
170728945|NCT00152464|617012625|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
170728946|NCT00152464|617012624|FG000|Overall Study|Eczema deterioration|0|||
170728947|NCT00152464|617012625|FG001|Overall Study|Eczema deterioration|1|||
170728948|NCT00152464|617012624|FG000|Overall Study|Parent decision|1|||
170728949|NCT00152464|617012625|FG001|Overall Study|Parent decision|1|||
170728950|NCT00152464|617012624|FG000|Overall Study|Investigator decision|1|||
170728951|NCT00152464|617012625|FG001|Overall Study|Investigator decision|0|||
170728952|NCT00152464|617012624|FG000|Overall Study|Lack of Efficacy|1|||
170728953|NCT00152464|617012625|FG001|Overall Study|Lack of Efficacy|0|||
170728954|NCT00152464|617012624|FG000|Overall Study|Eczema poorly controlled|1|||
170728955|NCT00152464|617012625|FG001|Overall Study|Eczema poorly controlled|0|||
170728956|NCT00152464|617012624|FG000|Overall Study|Patient relocated|1|||
170728957|NCT00152464|617012625|FG001|Overall Study|Patient relocated|0|||
170728958|NCT00605293|617012626|FG000|Overall Study|Death|2|||
170728959|NCT00605293|617012627|FG001|Overall Study|Death|1|||
170728960|NCT00605293|617012626|FG000|Overall Study|Insufficient Therapeutic Response|2|||
170728961|NCT00605293|617012627|FG001|Overall Study|Insufficient Therapeutic Response|0|||
170728962|NCT00605293|617012626|FG000|Overall Study|Adverse Event|1|||
170728963|NCT00605293|617012627|FG001|Overall Study|Adverse Event|0|||
170728964|NCT00605293|617012626|FG000|Overall Study|Holidays Dialysis Out|1|||
170728965|NCT00605293|617012627|FG001|Overall Study|Holidays Dialysis Out|0|||
170728966|NCT00605293|617012626|FG000|Overall Study|Blood Transfusion|7|||
170728967|NCT00605293|617012627|FG001|Overall Study|Blood Transfusion|1|||
170728968|NCT00605293|617012626|FG000|Overall Study|Renal Transplantation|3|||
170728969|NCT00605293|617012627|FG001|Overall Study|Renal Transplantation|1|||
170728970|NCT00605293|617012626|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
170728971|NCT00605293|617012627|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
170728972|NCT00605293|617012626|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
170728973|NCT00605293|617012627|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
170728974|NCT00605293|617012626|FG000|Overall Study|Principal Investigator Decision|0|||
170728975|NCT00605293|617012627|FG001|Overall Study|Principal Investigator Decision|1|||
170728976|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
170728977|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
170728978|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
170728979|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
170728980|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
170728981|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
170728982|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
170728983|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
170728984|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Other|18|||
170728985|NCT02565914|617012628|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
170728986|NCT02565914|617012628|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
170728987|NCT02565914|617012628|FG000|Part B (Up to 96 Weeks)|Other|1|||
170728988|NCT02565914|617012628|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
170728989|NCT02565914|617012628|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
170728990|NCT02565914|617012628|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
170728991|NCT02565914|617012628|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
170728992|NCT02565914|617012628|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
170728993|NCT02565914|617012628|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
170728994|NCT02565914|617012628|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
170728995|NCT02565914|617012628|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
170728996|NCT02565914|617012628|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
170728997|NCT02565914|617012628|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
170728998|NCT02565914|617012628|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
170728999|NCT02565914|617012628|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
170729000|NCT03581981|617012629|FG000|Overall Study|Withdrawal by Subject|12|||
170729001|NCT03581981|617012630|FG001|Overall Study|Withdrawal by Subject|13|||
170729002|NCT03581981|617012629|FG000|Overall Study|Physician Decision|1|||
170729003|NCT03581981|617012630|FG001|Overall Study|Physician Decision|2|||
170729004|NCT03581981|617012629|FG000|Overall Study|Lost to Follow-up|0|||
170729005|NCT03581981|617012630|FG001|Overall Study|Lost to Follow-up|4|||
170729006|NCT00828984|617012631|FG000|Overall Study|Adverse Event|2|||
170729007|NCT00828984|617012632|FG001|Overall Study|Adverse Event|3|||
170729008|NCT00828984|617012633|FG002|Overall Study|Adverse Event|0|||
170729009|NCT00828984|617012631|FG000|Overall Study|Lost to Follow-up|5|||
170729010|NCT00828984|617012632|FG001|Overall Study|Lost to Follow-up|3|||
170729011|NCT00828984|617012633|FG002|Overall Study|Lost to Follow-up|1|||
170729012|NCT00828984|617012631|FG000|Overall Study|Withdrawal by Subject|4|||
170729013|NCT00828984|617012632|FG001|Overall Study|Withdrawal by Subject|4|||
170729014|NCT00828984|617012633|FG002|Overall Study|Withdrawal by Subject|4|||
170729015|NCT00828984|617012631|FG000|Overall Study|Ineligable|1|||
170729016|NCT00828984|617012632|FG001|Overall Study|Ineligable|2|||
170729017|NCT00828984|617012633|FG002|Overall Study|Ineligable|0|||
170729018|NCT00828984|617012631|FG000|Overall Study|Medical Contraindication|0|||
170729019|NCT00828984|617012632|FG001|Overall Study|Medical Contraindication|1|||
170729020|NCT00828984|617012633|FG002|Overall Study|Medical Contraindication|0|||
170729021|NCT00828984|617012631|FG000|Overall Study|Noncompliant|1|||
170729022|NCT00828984|617012632|FG001|Overall Study|Noncompliant|2|||
170729023|NCT00828984|617012633|FG002|Overall Study|Noncompliant|3|||
170729024|NCT00828984|617012631|FG000|Overall Study|ConMed|1|||
170729025|NCT00828984|617012632|FG001|Overall Study|ConMed|1|||
170729026|NCT00828984|617012633|FG002|Overall Study|ConMed|1|||
170729027|NCT00002558|617012640|FG000|Overall Study|Withdrawal by Subject|0|||
170729028|NCT00002558|617012641|FG001|Overall Study|Withdrawal by Subject|1|||
170729029|NCT01260350|617012643|FG000|Overall Study|Lack of Efficacy|0|||
170729030|NCT01260350|617012644|FG001|Overall Study|Lack of Efficacy|0|||
170729031|NCT01260350|617012645|FG002|Overall Study|Lack of Efficacy|0|||
170729032|NCT01260350|617012646|FG003|Overall Study|Lack of Efficacy|0|||
170729033|NCT01260350|617012647|FG004|Overall Study|Lack of Efficacy|0|||
170729034|NCT01260350|617012648|FG005|Overall Study|Lack of Efficacy|0|||
170729035|NCT01260350|617012649|FG006|Overall Study|Lack of Efficacy|0|||
170729036|NCT01260350|617012650|FG007|Overall Study|Lack of Efficacy|0|||
170729037|NCT01260350|617012651|FG008|Overall Study|Lack of Efficacy|0|||
170729038|NCT01260350|617012652|FG009|Overall Study|Lack of Efficacy|0|||
170729039|NCT01260350|617012653|FG010|Overall Study|Lack of Efficacy|0|||
170729040|NCT01260350|617012654|FG011|Overall Study|Lack of Efficacy|0|||
170729041|NCT01260350|617012655|FG012|Overall Study|Lack of Efficacy|0|||
170729042|NCT01260350|617012656|FG013|Overall Study|Lack of Efficacy|0|||
170729043|NCT01260350|617012657|FG014|Overall Study|Lack of Efficacy|0|||
170836691|NCT03566979|617409385|FG000|Overall Study|Lost to Follow-up|2|||
170836692|NCT03566979|617409386|FG001|Overall Study|Lost to Follow-up|7|||
170836693|NCT03566979|617409387|FG002|Overall Study|Lost to Follow-up|9|||
170836694|NCT03566979|617409388|FG003|Overall Study|Lost to Follow-up|5|||
170836695|NCT03566979|617409385|FG000|Overall Study|Adverse Event|1|||
170836696|NCT03566979|617409386|FG001|Overall Study|Adverse Event|0|||
170836697|NCT03566979|617409387|FG002|Overall Study|Adverse Event|0|||
170836698|NCT03566979|617409388|FG003|Overall Study|Adverse Event|0|||
170836699|NCT01262092|617409395|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
170836700|NCT01262092|617409396|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
170836701|NCT01262092|617409395|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
170836702|NCT01262092|617409396|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
170836703|NCT01262092|617409395|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
170836704|NCT01262092|617409396|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
170836705|NCT01262092|617409395|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
170836706|NCT01262092|617409396|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
170836707|NCT03784820|617409397|FG000|Overall Study|Lost to Follow-up|5|||
170836708|NCT03784820|617409398|FG001|Overall Study|Lost to Follow-up|5|||
170836709|NCT03784820|617409399|FG002|Overall Study|Lost to Follow-up|3|||
170836710|NCT03784820|617409400|FG003|Overall Study|Lost to Follow-up|3|||
170836711|NCT02336425|617409401|FG000|Overall Study|Study terminated.|2|||
170836712|NCT02336425|617409402|FG001|Overall Study|Study terminated.|2|||
170836713|NCT02336425|617409403|FG002|Overall Study|Study terminated.|3|||
170836714|NCT02336425|617409404|FG003|Overall Study|Study terminated.|3|||
170836715|NCT02394665|617409407|FG000|Overall Study|Physician Decision|1|||
170836716|NCT02394665|617409408|FG001|Overall Study|Physician Decision|0|||
170836717|NCT02394665|617409409|FG002|Overall Study|Physician Decision|0|||
170836718|NCT01056263|617409410|FG000|Overall Study|Adverse Event|12|||
170836719|NCT01056263|617409410|FG000|Overall Study|Death|1|||
170836720|NCT01056263|617409410|FG000|Overall Study|Withdrawal by Subject|1|||
170836721|NCT01056263|617409410|FG000|Overall Study|Lack of Efficacy|29|||
170836722|NCT01056263|617409410|FG000|Overall Study|Progressive disease|2|||
170836723|NCT01056263|617409410|FG000|Overall Study|Neoplasm progression|1|||
170836724|NCT01056263|617409410|FG000|Overall Study|Objective progression or relapse|1|||
170836725|NCT01056263|617409410|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
170836726|NCT03348631|617409411|FG000|Overall Study|Not Eligible, No treatment|0|||
170836727|NCT03348631|617409412|FG001|Overall Study|Not Eligible, No treatment|1|||
170836728|NCT03348631|617409411|FG000|Overall Study|Not Eligible, Treated|2|||
170836729|NCT03348631|617409412|FG001|Overall Study|Not Eligible, Treated|0|||
170836730|NCT03348631|617409411|FG000|Overall Study|Eligible, No Treatment|1|||
170836731|NCT03348631|617409412|FG001|Overall Study|Eligible, No Treatment|0|||
170836732|NCT03299959|617409415|FG000|Overall Study|Lost to Follow-up|7|||
170836733|NCT03299959|617409416|FG001|Overall Study|Lost to Follow-up|9|||
170836734|NCT03299959|617409415|FG000|Overall Study|Death|1|||
170836735|NCT03299959|617409416|FG001|Overall Study|Death|0|||
170836736|NCT03299959|617409415|FG000|Overall Study|Withdrawal by Subject|13|||
170836737|NCT03299959|617409416|FG001|Overall Study|Withdrawal by Subject|9|||
170836738|NCT03299959|617409415|FG000|Overall Study|Changes in study team and government regulations|1|||
170836739|NCT03299959|617409416|FG001|Overall Study|Changes in study team and government regulations|1|||
170836740|NCT03299959|617409415|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
170836741|NCT03299959|617409416|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
170836742|NCT03842436|617409419|FG000|Overall Study|Lost to Follow-up|1|||
170836743|NCT00356811|617409420|FG000|Overall Study|Death|35|||
170729044|NCT01260350|617012658|FG015|Overall Study|Lack of Efficacy|0|||
170729045|NCT01260350|617012659|FG016|Overall Study|Lack of Efficacy|0|||
170729046|NCT01260350|617012660|FG017|Overall Study|Lack of Efficacy|1|||
170729047|NCT01260350|617012661|FG018|Overall Study|Lack of Efficacy|0|||
170836744|NCT00356811|617409420|FG000|Overall Study|Lost to Follow-up|2|||
170729048|NCT01260350|617012662|FG019|Overall Study|Lack of Efficacy|0|||
170729049|NCT01260350|617012663|FG020|Overall Study|Lack of Efficacy|3|||
170729050|NCT01260350|617012664|FG021|Overall Study|Lack of Efficacy|0|||
170729051|NCT01260350|617012643|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729052|NCT01260350|617012644|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729053|NCT01260350|617012645|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729054|NCT01260350|617012646|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729055|NCT01260350|617012647|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729056|NCT01260350|617012648|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729057|NCT01260350|617012649|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729058|NCT01260350|617012650|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729059|NCT01260350|617012651|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
170729060|NCT01260350|617012652|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729061|NCT01260350|617012653|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729062|NCT01260350|617012654|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729063|NCT01260350|617012655|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729064|NCT01260350|617012656|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729065|NCT01260350|617012657|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729066|NCT01260350|617012658|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729067|NCT01260350|617012659|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729068|NCT01260350|617012660|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729069|NCT01260350|617012661|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729070|NCT01260350|617012662|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729071|NCT01260350|617012663|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729072|NCT01260350|617012664|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
170729073|NCT05763628|617012667|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
170729074|NCT05763628|617012668|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
170729075|NCT05763628|617012667|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
170729076|NCT05763628|617012668|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
170729077|NCT05763628|617012667|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
170729078|NCT05763628|617012668|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
170729079|NCT00781391|617012679|FG000|Overall Study|never received study drug|24|||
170729080|NCT00781391|617012680|FG001|Overall Study|never received study drug|23|||
170729081|NCT00781391|617012681|FG002|Overall Study|never received study drug|32|||
170729082|NCT00781391|617012679|FG000|Overall Study|Protocol Violation|19|||
170729083|NCT00781391|617012680|FG001|Overall Study|Protocol Violation|17|||
170729084|NCT00781391|617012681|FG002|Overall Study|Protocol Violation|20|||
170729085|NCT00781391|617012679|FG000|Overall Study|Death|789|||
170729086|NCT00781391|617012680|FG001|Overall Study|Death|730|||
170729087|NCT00781391|617012681|FG002|Overall Study|Death|706|||
170729088|NCT00781391|617012679|FG000|Overall Study|Withdrawal by Subject|47|||
170729089|NCT00781391|617012680|FG001|Overall Study|Withdrawal by Subject|37|||
170729090|NCT00781391|617012681|FG002|Overall Study|Withdrawal by Subject|25|||
170729091|NCT00781391|617012679|FG000|Overall Study|Lost to Follow-up|0|||
170729092|NCT00781391|617012680|FG001|Overall Study|Lost to Follow-up|0|||
170729093|NCT00781391|617012681|FG002|Overall Study|Lost to Follow-up|1|||
170729094|NCT03923959|617012682|FG000|Overall Study|Death|16|||
170729095|NCT03923959|617012683|FG001|Overall Study|Death|12|||
170729096|NCT03923959|617012682|FG000|Overall Study|Lost to Follow-up|56|||
170729097|NCT03923959|617012683|FG001|Overall Study|Lost to Follow-up|56|||
170729098|NCT03923959|617012682|FG000|Overall Study|Withdrawal by Subject|1|||
170729099|NCT03923959|617012683|FG001|Overall Study|Withdrawal by Subject|1|||
170729100|NCT03923959|617012682|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
170729101|NCT03923959|617012683|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
170729102|NCT04575051|617012684|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
170729103|NCT04575051|617012685|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
170729104|NCT04575051|617012686|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
170729105|NCT04575051|617012687|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
170729106|NCT04575051|617012688|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
170729107|NCT04575051|617012684|FG000|Time Period 1|Missing follow up|1|||
170729108|NCT04575051|617012685|FG001|Time Period 1|Missing follow up|3|||
170729109|NCT04575051|617012686|FG002|Time Period 1|Missing follow up|1|||
170729110|NCT04575051|617012687|FG003|Time Period 1|Missing follow up|3|||
170729111|NCT04575051|617012688|FG004|Time Period 1|Missing follow up|2|||
170729112|NCT04575051|617012684|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
170729113|NCT04575051|617012685|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
170729114|NCT04575051|617012686|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
170729115|NCT04575051|617012687|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
170729116|NCT04575051|617012688|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
170729117|NCT04575051|617012684|FG000|Time Period 2|Missing follow up|1|||
170729118|NCT04575051|617012685|FG001|Time Period 2|Missing follow up|8|||
170729119|NCT04575051|617012686|FG002|Time Period 2|Missing follow up|7|||
170729120|NCT04575051|617012687|FG003|Time Period 2|Missing follow up|0|||
170729121|NCT04575051|617012688|FG004|Time Period 2|Missing follow up|1|||
170729122|NCT04575051|617012684|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
170729123|NCT04575051|617012685|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
170729124|NCT04575051|617012686|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
170729125|NCT04575051|617012687|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
170729126|NCT04575051|617012688|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
170729127|NCT04575051|617012684|FG000|Time Period 3|Missing follow up|8|||
170729128|NCT04575051|617012685|FG001|Time Period 3|Missing follow up|6|||
170729129|NCT04575051|617012686|FG002|Time Period 3|Missing follow up|4|||
170729130|NCT04575051|617012687|FG003|Time Period 3|Missing follow up|3|||
170729131|NCT04575051|617012688|FG004|Time Period 3|Missing follow up|0|||
170729132|NCT04575051|617012684|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
170729133|NCT04575051|617012685|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
170729134|NCT04575051|617012686|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
170729135|NCT04575051|617012687|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
170729136|NCT04575051|617012688|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
170729137|NCT04575051|617012684|FG000|Time Period 4|Missing follow up|17|||
170729138|NCT04575051|617012685|FG001|Time Period 4|Missing follow up|3|||
170729139|NCT04575051|617012686|FG002|Time Period 4|Missing follow up|4|||
170729140|NCT04575051|617012687|FG003|Time Period 4|Missing follow up|2|||
170729141|NCT04575051|617012688|FG004|Time Period 4|Missing follow up|1|||
170729142|NCT04575051|617012684|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
170729143|NCT04575051|617012685|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
170729144|NCT04575051|617012686|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
170729145|NCT04575051|617012687|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
170729146|NCT04575051|617012688|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
170729147|NCT04575051|617012684|FG000|Time Period 5|Missing follow up|11|||
170729148|NCT04575051|617012685|FG001|Time Period 5|Missing follow up|8|||
170729149|NCT04575051|617012686|FG002|Time Period 5|Missing follow up|12|||
170729150|NCT04575051|617012687|FG003|Time Period 5|Missing follow up|3|||
170729151|NCT04575051|617012688|FG004|Time Period 5|Missing follow up|11|||
170729152|NCT00765388|617012689|FG000|Period 1|Lack of Efficacy|1|||
170729153|NCT00765388|617012690|FG001|Period 1|Lack of Efficacy|2|||
170729154|NCT00765388|617012689|FG000|Period 1|Lost to Follow-up|0|||
170729155|NCT00765388|617012690|FG001|Period 1|Lost to Follow-up|1|||
170729156|NCT00765388|617012689|FG000|Period 1|Herpes Zoster|0|||
170729157|NCT00765388|617012690|FG001|Period 1|Herpes Zoster|1|||
170729158|NCT00765388|617012689|FG000|Period 1|Hip operation|0|||
170729159|NCT00765388|617012690|FG001|Period 1|Hip operation|1|||
170729160|NCT03649230|617012698|FG000|Overall Study|Adverse Event|12|||
170729161|NCT03649230|617012698|FG000|Overall Study|Death|8|||
170729162|NCT03649230|617012698|FG000|Overall Study|Withdrawal by Subject|6|||
170729163|NCT03649230|617012698|FG000|Overall Study|Physician Decision|5|||
170729164|NCT03649230|617012698|FG000|Overall Study|Disease progression|5|||
170729165|NCT03649230|617012698|FG000|Overall Study|Switched to non-HEC|5|||
170729166|NCT03649230|617012698|FG000|Overall Study|Chemotherapy discontinued|4|||
170729167|NCT03649230|617012698|FG000|Overall Study|Received only 3 HEC cycles|4|||
170729168|NCT03649230|617012698|FG000|Overall Study|Screen Failure|3|||
170729169|NCT03649230|617012698|FG000|Overall Study|Patient stopped treatment|2|||
170729170|NCT03649230|617012698|FG000|Overall Study|Protocol Violation|1|||
170729171|NCT03649230|617012698|FG000|Overall Study|Non-compliance|1|||
170729172|NCT03649230|617012698|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
170729173|NCT03311373|617012704|FG000|Overall Study|Adverse Event|1|||
170729174|NCT03311373|617012704|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
170729175|NCT03311373|617012704|FG000|Overall Study|Lost to Follow-up|1|||
170729176|NCT03311373|617012704|FG000|Overall Study|Physician Decision|1|||
170729177|NCT03311373|617012704|FG000|Overall Study|Withdrawal by Subject|3|||
170729178|NCT01939548|617012705|FG000|Overall Study|Non compliance|0|||
170729179|NCT01939548|617012706|FG001|Overall Study|Non compliance|2|||
170729180|NCT01939548|617012707|FG002|Overall Study|Non compliance|0|||
170729181|NCT01939548|617012705|FG000|Overall Study|Study Terminated by Sponsor|17|||
170729182|NCT01939548|617012706|FG001|Overall Study|Study Terminated by Sponsor|19|||
170729183|NCT01939548|617012707|FG002|Overall Study|Study Terminated by Sponsor|12|||
170729184|NCT01939548|617012705|FG000|Overall Study|Insufficient Clinical Response|1|||
170729185|NCT01939548|617012706|FG001|Overall Study|Insufficient Clinical Response|0|||
170729186|NCT01939548|617012707|FG002|Overall Study|Insufficient Clinical Response|0|||
170729187|NCT01939548|617012705|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
170729188|NCT01939548|617012706|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
170729189|NCT01939548|617012707|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
170729190|NCT01939548|617012705|FG000|Overall Study|Withdrawal by Subject|4|||
170729191|NCT01939548|617012706|FG001|Overall Study|Withdrawal by Subject|4|||
170729192|NCT01939548|617012707|FG002|Overall Study|Withdrawal by Subject|1|||
170729193|NCT01939548|617012705|FG000|Overall Study|Protocol Violation|7|||
170729194|NCT01939548|617012706|FG001|Overall Study|Protocol Violation|6|||
170729195|NCT01939548|617012707|FG002|Overall Study|Protocol Violation|5|||
170729196|NCT01939548|617012705|FG000|Overall Study|Lost to Follow-up|5|||
170729197|NCT01939548|617012706|FG001|Overall Study|Lost to Follow-up|5|||
170729198|NCT01939548|617012707|FG002|Overall Study|Lost to Follow-up|3|||
170729199|NCT01939548|617012705|FG000|Overall Study|Adverse Event|2|||
170729200|NCT01939548|617012706|FG001|Overall Study|Adverse Event|9|||
170729201|NCT01939548|617012707|FG002|Overall Study|Adverse Event|7|||
170729202|NCT01939548|617012705|FG000|Overall Study|Death|0|||
170729203|NCT01939548|617012706|FG001|Overall Study|Death|0|||
170729204|NCT01939548|617012707|FG002|Overall Study|Death|1|||
170729205|NCT01939548|617012705|FG000|Overall Study|Participant dropped|0|||
170729206|NCT01939548|617012706|FG001|Overall Study|Participant dropped|0|||
170729207|NCT01939548|617012707|FG002|Overall Study|Participant dropped|1|||
170729208|NCT01939548|617012705|FG000|Overall Study|Participant unwilling to continue|0|||
170729209|NCT01939548|617012706|FG001|Overall Study|Participant unwilling to continue|1|||
170729210|NCT01939548|617012707|FG002|Overall Study|Participant unwilling to continue|0|||
170729211|NCT01939548|617012705|FG000|Overall Study|Participant withdrew consent|0|||
170729212|NCT01939548|617012706|FG001|Overall Study|Participant withdrew consent|2|||
170729213|NCT01939548|617012707|FG002|Overall Study|Participant withdrew consent|0|||
170729214|NCT01939548|617012705|FG000|Overall Study|Did not complete follow-up|0|||
170729215|NCT01939548|617012706|FG001|Overall Study|Did not complete follow-up|1|||
170729216|NCT01939548|617012707|FG002|Overall Study|Did not complete follow-up|0|||
170729217|NCT00295022|617012708|FG000|Overall Study|Adverse Event|1|||
170729218|NCT00295022|617012709|FG001|Overall Study|Adverse Event|1|||
170729219|NCT00295022|617012710|FG002|Overall Study|Adverse Event|2|||
170729220|NCT00295022|617012708|FG000|Overall Study|Lost to Follow-up|0|||
170729221|NCT00295022|617012709|FG001|Overall Study|Lost to Follow-up|0|||
170729222|NCT00295022|617012710|FG002|Overall Study|Lost to Follow-up|1|||
170729223|NCT00295022|617012708|FG000|Overall Study|Withdrawal by Subject|0|||
170729224|NCT00295022|617012709|FG001|Overall Study|Withdrawal by Subject|0|||
170729225|NCT00295022|617012710|FG002|Overall Study|Withdrawal by Subject|2|||
170729226|NCT04123067|617012714|FG000|Overall Study|Lost to Follow-up|0|||
170729227|NCT04123067|617012715|FG001|Overall Study|Lost to Follow-up|1|||
170729228|NCT01022762|617012716|FG000|Overall Study|Adverse Event|3|||
170729229|NCT01022762|617012717|FG001|Overall Study|Adverse Event|1|||
170729230|NCT01022762|617012716|FG000|Overall Study|Lack of Efficacy|0|||
170729231|NCT01022762|617012717|FG001|Overall Study|Lack of Efficacy|1|||
170729232|NCT01022762|617012716|FG000|Overall Study|Protocol Violation|7|||
170729233|NCT01022762|617012717|FG001|Overall Study|Protocol Violation|6|||
170729234|NCT01022762|617012716|FG000|Overall Study|Unclassified|12|||
170729235|NCT01022762|617012717|FG001|Overall Study|Unclassified|20|||
170729236|NCT00605280|617012718|FG000|Year 1|Protocol Violation|0|||
170729237|NCT00605280|617012719|FG001|Year 1|Protocol Violation|0|||
170729238|NCT00605280|617012720|FG002|Year 1|Protocol Violation|0|||
170729239|NCT00605280|617012721|FG003|Year 1|Protocol Violation|1|||
170729240|NCT00605280|617012718|FG000|Year 1|Adverse Event|3|||
170729241|NCT00605280|617012719|FG001|Year 1|Adverse Event|1|||
170729242|NCT00605280|617012720|FG002|Year 1|Adverse Event|1|||
170729243|NCT00605280|617012721|FG003|Year 1|Adverse Event|5|||
170729244|NCT00605280|617012718|FG000|Year 1|Physician Decision|7|||
170729245|NCT00605280|617012719|FG001|Year 1|Physician Decision|4|||
170729246|NCT00605280|617012720|FG002|Year 1|Physician Decision|0|||
170729247|NCT00605280|617012721|FG003|Year 1|Physician Decision|6|||
170729248|NCT00605280|617012718|FG000|Year 1|Withdrawal by Subject|2|||
170729249|NCT00605280|617012719|FG001|Year 1|Withdrawal by Subject|4|||
170729250|NCT00605280|617012720|FG002|Year 1|Withdrawal by Subject|0|||
170729251|NCT00605280|617012721|FG003|Year 1|Withdrawal by Subject|4|||
170729252|NCT00605280|617012718|FG000|Year 1|Other|2|||
170729253|NCT00605280|617012719|FG001|Year 1|Other|1|||
170729254|NCT00605280|617012720|FG002|Year 1|Other|0|||
170729255|NCT00605280|617012721|FG003|Year 1|Other|1|||
170729256|NCT00605280|617012718|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
170729257|NCT00605280|617012719|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
170729258|NCT00605280|617012720|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
170729259|NCT00605280|617012721|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
170729260|NCT00605280|617012718|FG000|Year 2|Adverse Event|4|||
170729261|NCT00605280|617012719|FG001|Year 2|Adverse Event|0|||
170729262|NCT00605280|617012720|FG002|Year 2|Adverse Event|2|||
170729263|NCT00605280|617012721|FG003|Year 2|Adverse Event|4|||
170729264|NCT00605280|617012718|FG000|Year 2|Physician Decision|11|||
170729265|NCT00605280|617012719|FG001|Year 2|Physician Decision|6|||
170729266|NCT00605280|617012720|FG002|Year 2|Physician Decision|4|||
170729267|NCT00605280|617012721|FG003|Year 2|Physician Decision|11|||
170729268|NCT00605280|617012718|FG000|Year 2|Withdrawal by Subject|4|||
170729269|NCT00605280|617012719|FG001|Year 2|Withdrawal by Subject|0|||
170729270|NCT00605280|617012720|FG002|Year 2|Withdrawal by Subject|0|||
170729271|NCT00605280|617012721|FG003|Year 2|Withdrawal by Subject|4|||
170729272|NCT00605280|617012718|FG000|Year 2|Other|1|||
170729273|NCT00605280|617012719|FG001|Year 2|Other|0|||
170729274|NCT00605280|617012720|FG002|Year 2|Other|0|||
170729275|NCT00605280|617012721|FG003|Year 2|Other|1|||
170729276|NCT00605280|617012718|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
170729277|NCT00605280|617012719|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
170729278|NCT00605280|617012720|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
170729279|NCT00605280|617012721|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
170729280|NCT00605280|617012718|FG000|Year 3 Extension|Adverse Event|2|||
170729281|NCT00605280|617012719|FG001|Year 3 Extension|Adverse Event|0|||
170729282|NCT00605280|617012720|FG002|Year 3 Extension|Adverse Event|0|||
170729283|NCT00605280|617012721|FG003|Year 3 Extension|Adverse Event|2|||
170729284|NCT00605280|617012718|FG000|Year 3 Extension|Physician Decision|0|||
170729285|NCT00605280|617012719|FG001|Year 3 Extension|Physician Decision|0|||
170729286|NCT00605280|617012720|FG002|Year 3 Extension|Physician Decision|0|||
170729287|NCT00605280|617012721|FG003|Year 3 Extension|Physician Decision|2|||
170729288|NCT00605280|617012718|FG000|Year 3 Extension|Withdrawal by Subject|2|||
170729289|NCT00605280|617012719|FG001|Year 3 Extension|Withdrawal by Subject|0|||
170729290|NCT00605280|617012720|FG002|Year 3 Extension|Withdrawal by Subject|0|||
170729291|NCT00605280|617012721|FG003|Year 3 Extension|Withdrawal by Subject|5|||
170729292|NCT00605280|617012718|FG000|Year 3 Extension|Other|2|||
170729293|NCT00605280|617012719|FG001|Year 3 Extension|Other|0|||
170729294|NCT00605280|617012720|FG002|Year 3 Extension|Other|0|||
170729295|NCT00605280|617012721|FG003|Year 3 Extension|Other|0|||
170729296|NCT00605280|617012718|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
170729297|NCT00605280|617012719|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
170729298|NCT00605280|617012720|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
170729299|NCT00605280|617012721|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
170729300|NCT01302119|617012722|FG000|Overall Study|Withdrawal by Subject|30|||
170729301|NCT01302119|617012723|FG001|Overall Study|Withdrawal by Subject|20|||
170729302|NCT01302119|617012722|FG000|Overall Study|Lost to Follow-up|10|||
170729303|NCT01302119|617012723|FG001|Overall Study|Lost to Follow-up|4|||
170729304|NCT01302119|617012722|FG000|Overall Study|Adverse Event|2|||
170729305|NCT01302119|617012723|FG001|Overall Study|Adverse Event|1|||
170729306|NCT01302119|617012722|FG000|Overall Study|Non-compliance|4|||
170729307|NCT01302119|617012723|FG001|Overall Study|Non-compliance|2|||
170836745|NCT00356811|617409420|FG000|Overall Study|Withdrawal by Subject|6|||
170836746|NCT00356811|617409420|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
170729308|NCT01302119|617012722|FG000|Overall Study|Non-specific|4|||
170729309|NCT01302119|617012723|FG001|Overall Study|Non-specific|1|||
170729310|NCT01775904|617012724|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
170729311|NCT01775904|617012724|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
170729312|NCT00827918|617012725|FG000|Overall Study|Adverse Event|4|||
170729313|NCT00827918|617012726|FG001|Overall Study|Adverse Event|0|||
170729314|NCT00827918|617012727|FG002|Overall Study|Adverse Event|0|||
170729315|NCT00827918|617012725|FG000|Overall Study|Lack of Efficacy|16|||
170836747|NCT00356811|617409420|FG000|Overall Study|Study Is Terminating|3|||
170836748|NCT00356811|617409420|FG000|Overall Study|Site Closed during Follow-up|2|||
170836749|NCT00926575|617409422|FG000|Overall Study|Adverse Event|1|||
170729316|NCT00827918|617012726|FG001|Overall Study|Lack of Efficacy|4|||
170729317|NCT00827918|617012727|FG002|Overall Study|Lack of Efficacy|15|||
170729318|NCT00827918|617012725|FG000|Overall Study|Physician Decision|1|||
170729319|NCT00827918|617012726|FG001|Overall Study|Physician Decision|0|||
170729320|NCT00827918|617012727|FG002|Overall Study|Physician Decision|0|||
170729321|NCT00827918|617012725|FG000|Overall Study|Pregnancy|0|||
170729322|NCT00827918|617012726|FG001|Overall Study|Pregnancy|1|||
170729323|NCT00827918|617012727|FG002|Overall Study|Pregnancy|0|||
170729324|NCT00827918|617012725|FG000|Overall Study|Progressive Disease|1|||
170729325|NCT00827918|617012726|FG001|Overall Study|Progressive Disease|1|||
170729326|NCT00827918|617012727|FG002|Overall Study|Progressive Disease|0|||
170729327|NCT00827918|617012725|FG000|Overall Study|Protocol Violation|0|||
170729328|NCT00827918|617012726|FG001|Overall Study|Protocol Violation|1|||
170729329|NCT00827918|617012727|FG002|Overall Study|Protocol Violation|0|||
170729330|NCT00827918|617012725|FG000|Overall Study|Withdrawal by Subject|6|||
170729331|NCT00827918|617012726|FG001|Overall Study|Withdrawal by Subject|2|||
170729332|NCT00827918|617012727|FG002|Overall Study|Withdrawal by Subject|6|||
170729333|NCT00127101|617012728|FG000|Base Protocol|Adverse Event|0|||
170729334|NCT00127101|617012729|FG001|Base Protocol|Adverse Event|2|||
170729335|NCT00127101|617012730|FG002|Base Protocol|Adverse Event|1|||
170729336|NCT00127101|617012731|FG003|Base Protocol|Adverse Event|0|||
170729337|NCT00127101|617012732|FG004|Base Protocol|Adverse Event|0|||
170729338|NCT00127101|617012733|FG005|Base Protocol|Adverse Event|0|||
170729339|NCT00127101|617012728|FG000|Base Protocol|Lack of Efficacy|1|||
170729340|NCT00127101|617012729|FG001|Base Protocol|Lack of Efficacy|0|||
170729341|NCT00127101|617012730|FG002|Base Protocol|Lack of Efficacy|0|||
170729342|NCT00127101|617012731|FG003|Base Protocol|Lack of Efficacy|0|||
170729343|NCT00127101|617012732|FG004|Base Protocol|Lack of Efficacy|2|||
170729344|NCT00127101|617012733|FG005|Base Protocol|Lack of Efficacy|0|||
170729345|NCT00127101|617012728|FG000|Base Protocol|Withdrawal by Subject|1|||
170729346|NCT00127101|617012729|FG001|Base Protocol|Withdrawal by Subject|2|||
170729347|NCT00127101|617012730|FG002|Base Protocol|Withdrawal by Subject|1|||
170729348|NCT00127101|617012731|FG003|Base Protocol|Withdrawal by Subject|0|||
170729349|NCT00127101|617012732|FG004|Base Protocol|Withdrawal by Subject|0|||
170729350|NCT00127101|617012733|FG005|Base Protocol|Withdrawal by Subject|1|||
170729351|NCT00127101|617012728|FG000|Continuation Phase|Adverse Event|0|||
170729352|NCT00127101|617012729|FG001|Continuation Phase|Adverse Event|0|||
170729353|NCT00127101|617012730|FG002|Continuation Phase|Adverse Event|0|||
170729354|NCT00127101|617012731|FG003|Continuation Phase|Adverse Event|0|||
170729355|NCT00127101|617012732|FG004|Continuation Phase|Adverse Event|1|||
170729356|NCT00127101|617012733|FG005|Continuation Phase|Adverse Event|1|||
170729357|NCT00127101|617012728|FG000|Continuation Phase|Lack of Efficacy|0|||
170729358|NCT00127101|617012729|FG001|Continuation Phase|Lack of Efficacy|0|||
170729359|NCT00127101|617012730|FG002|Continuation Phase|Lack of Efficacy|0|||
170729360|NCT00127101|617012731|FG003|Continuation Phase|Lack of Efficacy|0|||
170729361|NCT00127101|617012732|FG004|Continuation Phase|Lack of Efficacy|0|||
170729362|NCT00127101|617012733|FG005|Continuation Phase|Lack of Efficacy|1|||
170729363|NCT00127101|617012728|FG000|Continuation Phase|Withdrawal by Subject|0|||
170836750|NCT00926575|617409423|FG001|Overall Study|Adverse Event|1|||
170836751|NCT00926575|617409422|FG000|Overall Study|Death|4|||
170836752|NCT00926575|617409423|FG001|Overall Study|Death|4|||
170836753|NCT00926575|617409422|FG000|Overall Study|Lost to Follow-up|1|||
170836754|NCT00926575|617409423|FG001|Overall Study|Lost to Follow-up|1|||
170729364|NCT00127101|617012729|FG001|Continuation Phase|Withdrawal by Subject|0|||
170729365|NCT00127101|617012730|FG002|Continuation Phase|Withdrawal by Subject|1|||
170729366|NCT00127101|617012731|FG003|Continuation Phase|Withdrawal by Subject|0|||
170729367|NCT00127101|617012732|FG004|Continuation Phase|Withdrawal by Subject|2|||
170729368|NCT00127101|617012733|FG005|Continuation Phase|Withdrawal by Subject|1|||
170729369|NCT02291614|617012734|FG000|Overall Study|Lost to Follow-up|0|||
170729370|NCT02291614|617012735|FG001|Overall Study|Lost to Follow-up|0|||
170729371|NCT02291614|617012736|FG002|Overall Study|Lost to Follow-up|0|||
170729372|NCT02291614|617012737|FG003|Overall Study|Lost to Follow-up|0|||
170729373|NCT02291614|617012738|FG004|Overall Study|Lost to Follow-up|0|||
170729374|NCT02291614|617012739|FG005|Overall Study|Lost to Follow-up|0|||
170729375|NCT02291614|617012740|FG006|Overall Study|Lost to Follow-up|0|||
170729376|NCT02291614|617012741|FG007|Overall Study|Lost to Follow-up|1|||
170729377|NCT02291614|617012742|FG008|Overall Study|Lost to Follow-up|0|||
170729378|NCT02291614|617012743|FG009|Overall Study|Lost to Follow-up|0|||
170729379|NCT02291614|617012744|FG010|Overall Study|Lost to Follow-up|0|||
170729380|NCT02291614|617012734|FG000|Overall Study|Withdrawal by Subject|0|||
170729381|NCT02291614|617012735|FG001|Overall Study|Withdrawal by Subject|1|||
170729382|NCT02291614|617012736|FG002|Overall Study|Withdrawal by Subject|0|||
170729383|NCT02291614|617012737|FG003|Overall Study|Withdrawal by Subject|0|||
170729384|NCT02291614|617012738|FG004|Overall Study|Withdrawal by Subject|0|||
170729385|NCT02291614|617012739|FG005|Overall Study|Withdrawal by Subject|0|||
170729386|NCT02291614|617012740|FG006|Overall Study|Withdrawal by Subject|0|||
170836755|NCT00926575|617409422|FG000|Overall Study|Physician Decision|1|||
170836756|NCT00926575|617409423|FG001|Overall Study|Physician Decision|2|||
170836757|NCT00926575|617409422|FG000|Overall Study|Protocol Violation|1|||
170836758|NCT00926575|617409423|FG001|Overall Study|Protocol Violation|0|||
170836759|NCT00926575|617409422|FG000|Overall Study|Withdrawal by Subject|8|||
170836760|NCT00926575|617409423|FG001|Overall Study|Withdrawal by Subject|9|||
170836761|NCT02201901|617409424|FG000|Overall Study|Randomized but never treated|0|||
170836762|NCT02201901|617409425|FG001|Overall Study|Randomized but never treated|1|||
170836763|NCT02201901|617409426|FG002|Overall Study|Randomized but never treated|0|||
170836764|NCT02201901|617409424|FG000|Overall Study|Lack of Efficacy|7|||
170836765|NCT02201901|617409425|FG001|Overall Study|Lack of Efficacy|1|||
170836766|NCT02201901|617409426|FG002|Overall Study|Lack of Efficacy|6|||
170836767|NCT02201901|617409424|FG000|Overall Study|Death|3|||
170836768|NCT02201901|617409425|FG001|Overall Study|Death|3|||
170836769|NCT02201901|617409426|FG002|Overall Study|Death|3|||
170836770|NCT02201901|617409424|FG000|Overall Study|Lost to Follow-up|2|||
170836771|NCT02201901|617409425|FG001|Overall Study|Lost to Follow-up|3|||
170836772|NCT02201901|617409426|FG002|Overall Study|Lost to Follow-up|2|||
170836773|NCT02201901|617409424|FG000|Overall Study|Withdrew Consent|2|||
170836774|NCT02201901|617409425|FG001|Overall Study|Withdrew Consent|0|||
170836775|NCT02201901|617409426|FG002|Overall Study|Withdrew Consent|2|||
170836776|NCT02201901|617409424|FG000|Overall Study|Adverse Event|1|||
170836777|NCT02201901|617409425|FG001|Overall Study|Adverse Event|1|||
170836778|NCT02201901|617409426|FG002|Overall Study|Adverse Event|0|||
170836779|NCT00738283|617409429|FG000|Overall Study|Death|1|||
170836780|NCT00738283|617409429|FG000|Overall Study|Transfer to another facility|2|||
170836781|NCT00738283|617409429|FG000|Overall Study|Discharge home prior to end of study|1|||
170836782|NCT00486252|617409430|FG000|Overall Study|Adverse Event|7|||
170836783|NCT00486252|617409430|FG000|Overall Study|Lack of Efficacy|9|||
170836784|NCT00486252|617409430|FG000|Overall Study|Lost to Follow-up|24|||
170836785|NCT00486252|617409430|FG000|Overall Study|Other|18|||
170836786|NCT02559310|617409431|FG000|Overall Study|Death|4|||
170836787|NCT02559310|617409432|FG001|Overall Study|Death|3|||
170729387|NCT02291614|617012741|FG007|Overall Study|Withdrawal by Subject|0|||
170729388|NCT02291614|617012742|FG008|Overall Study|Withdrawal by Subject|0|||
170729389|NCT02291614|617012743|FG009|Overall Study|Withdrawal by Subject|2|||
170729390|NCT02291614|617012744|FG010|Overall Study|Withdrawal by Subject|2|||
170729391|NCT02291614|617012734|FG000|Overall Study|Decision by sponsor|0|||
170729392|NCT02291614|617012735|FG001|Overall Study|Decision by sponsor|0|||
170729393|NCT02291614|617012736|FG002|Overall Study|Decision by sponsor|0|||
170836788|NCT02559310|617409431|FG000|Overall Study|Lost to Follow-up|5|||
170729394|NCT02291614|617012737|FG003|Overall Study|Decision by sponsor|1|||
170729395|NCT02291614|617012738|FG004|Overall Study|Decision by sponsor|0|||
170729396|NCT02291614|617012739|FG005|Overall Study|Decision by sponsor|0|||
170729397|NCT02291614|617012740|FG006|Overall Study|Decision by sponsor|0|||
170729398|NCT02291614|617012741|FG007|Overall Study|Decision by sponsor|0|||
170729399|NCT02291614|617012742|FG008|Overall Study|Decision by sponsor|0|||
170729400|NCT02291614|617012743|FG009|Overall Study|Decision by sponsor|0|||
170729401|NCT02291614|617012744|FG010|Overall Study|Decision by sponsor|0|||
170729402|NCT02291614|617012734|FG000|Overall Study|Death|0|||
170729403|NCT02291614|617012735|FG001|Overall Study|Death|0|||
170729404|NCT02291614|617012736|FG002|Overall Study|Death|1|||
170729405|NCT02291614|617012737|FG003|Overall Study|Death|0|||
170729406|NCT02291614|617012738|FG004|Overall Study|Death|1|||
170729407|NCT02291614|617012739|FG005|Overall Study|Death|1|||
170836789|NCT02559310|617409432|FG001|Overall Study|Lost to Follow-up|3|||
170836790|NCT02559310|617409431|FG000|Overall Study|Physician Decision|2|||
170836791|NCT02559310|617409432|FG001|Overall Study|Physician Decision|1|||
170836792|NCT02559310|617409431|FG000|Overall Study|Withdrawal by Subject|13|||
170836793|NCT02559310|617409432|FG001|Overall Study|Withdrawal by Subject|9|||
170836794|NCT02559310|617409431|FG000|Overall Study|Sponsor Decision|0|||
170836795|NCT02559310|617409432|FG001|Overall Study|Sponsor Decision|1|||
170836796|NCT02559310|617409431|FG000|Overall Study|Randomized but not treated|3|||
170836797|NCT02559310|617409432|FG001|Overall Study|Randomized but not treated|2|||
170836798|NCT04596540|617409433|FG000|Overall Study|Withdrawal by Subject|9|||
170729408|NCT02291614|617012740|FG006|Overall Study|Death|1|||
170729409|NCT02291614|617012741|FG007|Overall Study|Death|0|||
170729410|NCT02291614|617012742|FG008|Overall Study|Death|0|||
170729411|NCT02291614|617012743|FG009|Overall Study|Death|0|||
170729412|NCT02291614|617012744|FG010|Overall Study|Death|0|||
170729413|NCT00843167|617012745|FG000|Treatment Period|Adverse Event|1|||
170729414|NCT00843167|617012746|FG001|Treatment Period|Adverse Event|5|||
170729415|NCT00843167|617012745|FG000|Treatment Period|Withdrawal by Subject|2|||
170729416|NCT00843167|617012746|FG001|Treatment Period|Withdrawal by Subject|3|||
170729417|NCT01830127|617012747|FG000|Overall Study|Adverse Event|1|||
170729418|NCT01830127|617012748|FG001|Overall Study|Adverse Event|6|||
170729419|NCT01830127|617012747|FG000|Overall Study|Lack of Efficacy|3|||
170729420|NCT01830127|617012748|FG001|Overall Study|Lack of Efficacy|0|||
170729421|NCT01830127|617012747|FG000|Overall Study|Withdrawal by Subject|1|||
170729422|NCT01830127|617012748|FG001|Overall Study|Withdrawal by Subject|1|||
170836799|NCT04596540|617409434|FG001|Overall Study|Withdrawal by Subject|8|||
170836800|NCT04596540|617409435|FG002|Overall Study|Withdrawal by Subject|5|||
170836801|NCT04596540|617409433|FG000|Overall Study|Lost to Follow-up|1|||
170836802|NCT04596540|617409434|FG001|Overall Study|Lost to Follow-up|2|||
170836803|NCT04596540|617409435|FG002|Overall Study|Lost to Follow-up|1|||
170836804|NCT04596540|617409433|FG000|Overall Study|Sponsor Decision|2|||
170836805|NCT04596540|617409434|FG001|Overall Study|Sponsor Decision|0|||
170836806|NCT04596540|617409435|FG002|Overall Study|Sponsor Decision|0|||
170836807|NCT04596540|617409433|FG000|Overall Study|Physician Decision|0|||
170836808|NCT04596540|617409434|FG001|Overall Study|Physician Decision|1|||
170836809|NCT04596540|617409435|FG002|Overall Study|Physician Decision|1|||
170836810|NCT04596540|617409433|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
170836811|NCT04596540|617409434|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
170836812|NCT04596540|617409435|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
170836813|NCT04596540|617409433|FG000|Overall Study|Other Than Specified|5|||
170836814|NCT04596540|617409434|FG001|Overall Study|Other Than Specified|5|||
170836815|NCT04596540|617409435|FG002|Overall Study|Other Than Specified|2|||
170836816|NCT02282059|617409438|FG000|Overall Study|Other|15|||
170836817|NCT02282059|617409439|FG001|Overall Study|Other|3|||
170836818|NCT02282059|617409438|FG000|Overall Study|Participant refused further follow-up|8|||
170836819|NCT02282059|617409439|FG001|Overall Study|Participant refused further follow-up|4|||
170729423|NCT01830127|617012747|FG000|Overall Study|Other reason not defined above|0|||
170729424|NCT01830127|617012748|FG001|Overall Study|Other reason not defined above|2|||
170729425|NCT02432105|617012752|FG000|Overall Study|Lost to Follow-up|1|||
170729426|NCT02432105|617012753|FG001|Overall Study|Lost to Follow-up|1|||
170729427|NCT02432105|617012754|FG002|Overall Study|Lost to Follow-up|0|||
170729428|NCT02432105|617012752|FG000|Overall Study|Withdrawal by Subject|1|||
170729429|NCT02432105|617012753|FG001|Overall Study|Withdrawal by Subject|0|||
170729430|NCT02432105|617012754|FG002|Overall Study|Withdrawal by Subject|1|||
170836820|NCT02282059|617409438|FG000|Overall Study|Lost to Follow-up|19|||
170836821|NCT02282059|617409439|FG001|Overall Study|Lost to Follow-up|3|||
170836822|NCT02282059|617409438|FG000|Overall Study|Death|40|||
170836823|NCT02282059|617409439|FG001|Overall Study|Death|8|||
170836824|NCT01090011|617411163|FG000|Overall Study|Progressive disease|128|||
170836825|NCT01090011|617411163|FG000|Overall Study|Adverse Event|32|||
170836826|NCT01090011|617411163|FG000|Overall Study|Protocol Violation|1|||
170836827|NCT01090011|617411163|FG000|Overall Study|Refusal to start/continue medication|5|||
170836828|NCT01090011|617411163|FG000|Overall Study|Other reason not defined above|5|||
170836829|NCT04949802|617411165|FG000|Overall Study|Lost to Follow-up|3|||
170836830|NCT00127842|617411166|FG000|Overall Study|Adverse Event|15|||
170729431|NCT02432105|617012752|FG000|Overall Study|Culture positive for yeast|0|||
170729432|NCT02432105|617012753|FG001|Overall Study|Culture positive for yeast|1|||
170836831|NCT00127842|617411166|FG000|Overall Study|Withdrawal by Subject|3|||
170836832|NCT00127842|617411166|FG000|Overall Study|Lost to Follow-up|1|||
170836833|NCT00127842|617411166|FG000|Overall Study|Lack of Efficacy|12|||
170836834|NCT00127842|617411166|FG000|Overall Study|Noncompliance|2|||
170836835|NCT00127842|617411166|FG000|Overall Study|Protocol Violation|1|||
170836836|NCT00127842|617411166|FG000|Overall Study|Other|5|||
170836837|NCT03595124|617411167|FG000|Overall Study|Physician Decision|1|||
170836838|NCT03595124|617411168|FG001|Overall Study|Physician Decision|1|||
170836839|NCT03595124|617411169|FG002|Overall Study|Physician Decision|1|||
170729433|NCT02432105|617012754|FG002|Overall Study|Culture positive for yeast|0|||
170729434|NCT02432105|617012752|FG000|Overall Study|Randomized in error|0|||
170729435|NCT02432105|617012753|FG001|Overall Study|Randomized in error|0|||
170729436|NCT02432105|617012754|FG002|Overall Study|Randomized in error|2|||
170729437|NCT01371851|617012757|FG000|Overall Study|Lost to Follow-up|5|||
170729438|NCT01371851|617012758|FG001|Overall Study|Lost to Follow-up|8|||
170729439|NCT01371851|617012757|FG000|Overall Study|was arrested and put in jail|0|||
170729440|NCT01371851|617012758|FG001|Overall Study|was arrested and put in jail|1|||
170729441|NCT01371851|617012757|FG000|Overall Study|non study related adverse event|1|||
170729442|NCT01371851|617012758|FG001|Overall Study|non study related adverse event|0|||
170729443|NCT01371851|617012757|FG000|Overall Study|Blood Pressure outside study parameters|2|||
170729444|NCT01371851|617012758|FG001|Overall Study|Blood Pressure outside study parameters|0|||
170729445|NCT03969719|617012772|FG000|Overall Study|Other reasons not specified|1|||
170729446|NCT03969719|617012773|FG001|Overall Study|Other reasons not specified|1|||
170729447|NCT03969719|617012774|FG002|Overall Study|Other reasons not specified|3|||
170729448|NCT03969719|617012772|FG000|Overall Study|Withdrawal by Subject|2|||
170729449|NCT03969719|617012773|FG001|Overall Study|Withdrawal by Subject|3|||
170729450|NCT03969719|617012774|FG002|Overall Study|Withdrawal by Subject|2|||
170729451|NCT03969719|617012772|FG000|Overall Study|Protocol Violation|1|||
170729452|NCT03969719|617012773|FG001|Overall Study|Protocol Violation|2|||
170729453|NCT03969719|617012774|FG002|Overall Study|Protocol Violation|0|||
170729454|NCT03969719|617012772|FG000|Overall Study|Adverse Event|0|||
170729455|NCT03969719|617012773|FG001|Overall Study|Adverse Event|2|||
170729456|NCT03969719|617012774|FG002|Overall Study|Adverse Event|0|||
170729457|NCT03969719|617012772|FG000|Overall Study|Lost to Follow-up|0|||
170729458|NCT03969719|617012773|FG001|Overall Study|Lost to Follow-up|1|||
170836840|NCT03595124|617411167|FG000|Overall Study|Ineligible|1|||
170836841|NCT03595124|617411168|FG001|Overall Study|Ineligible|1|||
170836842|NCT03595124|617411169|FG002|Overall Study|Ineligible|0|||
170836843|NCT03595124|617411167|FG000|Overall Study|Disease Progression|4|||
170836844|NCT03595124|617411168|FG001|Overall Study|Disease Progression|1|||
170836845|NCT03595124|617411169|FG002|Overall Study|Disease Progression|4|||
170836846|NCT02514239|617411170|FG000|Overall Study|Refused to continue trial medication|0|||
170836847|NCT02514239|617411171|FG001|Overall Study|Refused to continue trial medication|0|||
170836848|NCT02514239|617411172|FG002|Overall Study|Refused to continue trial medication|0|||
170836849|NCT02514239|617411173|FG003|Overall Study|Refused to continue trial medication|0|||
170836850|NCT02514239|617411174|FG004|Overall Study|Refused to continue trial medication|0|||
170836851|NCT02514239|617411175|FG005|Overall Study|Refused to continue trial medication|0|||
170836852|NCT02514239|617411176|FG006|Overall Study|Refused to continue trial medication|0|||
170836853|NCT02514239|617411177|FG007|Overall Study|Refused to continue trial medication|0|||
170836854|NCT02514239|617411178|FG008|Overall Study|Refused to continue trial medication|0|||
170836855|NCT02514239|617411179|FG009|Overall Study|Refused to continue trial medication|1|||
170729459|NCT03969719|617012774|FG002|Overall Study|Lost to Follow-up|0|||
170729460|NCT05608629|617012775|FG000|Overall Study|Lost to Follow-up|2|||
170729461|NCT02130193|617012776|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
170729462|NCT02130193|617012777|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
170729463|NCT02130193|617012778|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
170729464|NCT02130193|617012776|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
170729465|NCT02130193|617012777|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
170729466|NCT02130193|617012778|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
170729467|NCT02130193|617012776|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
170729468|NCT02130193|617012777|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
170729469|NCT02130193|617012778|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
170729470|NCT02130193|617012776|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
170729471|NCT02130193|617012777|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
170729472|NCT02130193|617012778|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
170729473|NCT01297959|617012779|FG000|Overall Study|Adverse Event|0|||
170729474|NCT01297959|617012780|FG001|Overall Study|Adverse Event|1|||
170729475|NCT01297959|617012779|FG000|Overall Study|Protocol Violation|2|||
170729476|NCT01297959|617012780|FG001|Overall Study|Protocol Violation|1|||
170729477|NCT01297959|617012779|FG000|Overall Study|Withdrawal by Subject|5|||
170729478|NCT01297959|617012780|FG001|Overall Study|Withdrawal by Subject|4|||
170836856|NCT02514239|617411170|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
170729479|NCT01297959|617012779|FG000|Overall Study|Physician Decision|0|||
170729480|NCT01297959|617012780|FG001|Overall Study|Physician Decision|1|||
170729481|NCT01297959|617012779|FG000|Overall Study|Unrelated medical illness / complication|0|||
170729482|NCT01297959|617012780|FG001|Overall Study|Unrelated medical illness / complication|2|||
170836857|NCT02514239|617411171|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
170729483|NCT01297959|617012779|FG000|Overall Study|Other|13|||
170729484|NCT01297959|617012780|FG001|Overall Study|Other|7|||
170729485|NCT03519854|617012781|FG000|Overall Study|Technical Error|0|||
170729486|NCT03519854|617012782|FG001|Overall Study|Technical Error|0|||
170729487|NCT03519854|617012783|FG002|Overall Study|Technical Error|1|||
170729488|NCT03519854|617012784|FG003|Overall Study|Technical Error|0|||
170729489|NCT03519854|617012785|FG004|Overall Study|Technical Error|0|||
170729490|NCT03519854|617012786|FG005|Overall Study|Technical Error|0|||
170729491|NCT03519854|617012787|FG006|Overall Study|Technical Error|0|||
170729492|NCT03519854|617012788|FG007|Overall Study|Technical Error|0|||
170729493|NCT03519854|617012789|FG008|Overall Study|Technical Error|0|||
170729494|NCT03519854|617012790|FG009|Overall Study|Technical Error|0|||
170729495|NCT03519854|617012791|FG010|Overall Study|Technical Error|0|||
170729496|NCT03519854|617012792|FG011|Overall Study|Technical Error|0|||
170729497|NCT03519854|617012793|FG012|Overall Study|Technical Error|0|||
170729498|NCT03519854|617012794|FG013|Overall Study|Technical Error|0|||
170729499|NCT03519854|617012795|FG014|Overall Study|Technical Error|0|||
170729500|NCT03519854|617012796|FG015|Overall Study|Technical Error|0|||
170729501|NCT03519854|617012797|FG016|Overall Study|Technical Error|0|||
170729502|NCT03519854|617012798|FG017|Overall Study|Technical Error|0|||
170729503|NCT00553696|617012801|FG000|Overall Study|Adverse Event|2|||
170729504|NCT00553696|617012802|FG001|Overall Study|Adverse Event|4|||
170729505|NCT00553696|617012803|FG002|Overall Study|Adverse Event|0|||
170729506|NCT00553696|617012804|FG003|Overall Study|Adverse Event|1|||
170729507|NCT00553696|617012801|FG000|Overall Study|Global deterioration of health status|0|||
170729508|NCT00553696|617012802|FG001|Overall Study|Global deterioration of health status|2|||
170729509|NCT00553696|617012803|FG002|Overall Study|Global deterioration of health status|0|||
170729510|NCT00553696|617012804|FG003|Overall Study|Global deterioration of health status|0|||
170729511|NCT00553696|617012801|FG000|Overall Study|Objective progression or relapse|2|||
170729512|NCT00553696|617012802|FG001|Overall Study|Objective progression or relapse|9|||
170729513|NCT00553696|617012803|FG002|Overall Study|Objective progression or relapse|6|||
170729514|NCT00553696|617012804|FG003|Overall Study|Objective progression or relapse|0|||
170729515|NCT00553696|617012801|FG000|Overall Study|Withdrawal by Subject|0|||
170729516|NCT00553696|617012802|FG001|Overall Study|Withdrawal by Subject|1|||
170729517|NCT00553696|617012803|FG002|Overall Study|Withdrawal by Subject|0|||
170729518|NCT00553696|617012804|FG003|Overall Study|Withdrawal by Subject|0|||
170729519|NCT00941330|617012807|FG000|Overall Study|Other|1|||
170729520|NCT00941330|617012808|FG001|Overall Study|Other|0|||
170729521|NCT00941330|617012807|FG000|Overall Study|Physician Decision|0|||
170729522|NCT00941330|617012808|FG001|Overall Study|Physician Decision|2|||
170729523|NCT02085252|617012809|FG000|Overall Study|Withdrawal of Consent|1|||
170729524|NCT02085252|617012810|FG001|Overall Study|Withdrawal of Consent|0|||
170729525|NCT02085252|617012809|FG000|Overall Study|Adverse Event|0|||
170729526|NCT02085252|617012810|FG001|Overall Study|Adverse Event|1|||
170729527|NCT02085252|617012809|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
170729528|NCT02085252|617012810|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
170729529|NCT02085252|617012809|FG000|Overall Study|Reason Not Specified|0|||
170729530|NCT02085252|617012810|FG001|Overall Study|Reason Not Specified|1|||
170729531|NCT02085252|617012809|FG000|Overall Study|Reason Unknown|0|||
170729532|NCT02085252|617012810|FG001|Overall Study|Reason Unknown|1|||
170729533|NCT03260868|617012814|FG000|Overall Study|Poor Compliance to Protocol|0|||
170729534|NCT03260868|617012815|FG001|Overall Study|Poor Compliance to Protocol|2|||
170729535|NCT03260868|617012814|FG000|Overall Study|Study Terminated By Sponsor|2|||
170729536|NCT03260868|617012815|FG001|Overall Study|Study Terminated By Sponsor|1|||
170729537|NCT03260868|617012814|FG000|Overall Study|Other than specified above|1|||
170729538|NCT03260868|617012815|FG001|Overall Study|Other than specified above|0|||
170836858|NCT02514239|617411172|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
170836859|NCT02514239|617411173|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
170836860|NCT02514239|617411174|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
170836861|NCT02514239|617411175|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
170836862|NCT02514239|617411176|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
170836863|NCT02514239|617411177|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
170836864|NCT02514239|617411178|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
170836865|NCT02514239|617411179|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
170836866|NCT02514239|617411170|FG000|Overall Study|Not treated|0|||
170836867|NCT02514239|617411171|FG001|Overall Study|Not treated|1|||
170836868|NCT02514239|617411172|FG002|Overall Study|Not treated|0|||
170836869|NCT02514239|617411173|FG003|Overall Study|Not treated|0|||
170836870|NCT02514239|617411174|FG004|Overall Study|Not treated|0|||
170729539|NCT00981084|617012816|FG000|Post Intervention (Data Analysis)|poor effort|1|||
170729540|NCT00981084|617012817|FG001|Post Intervention (Data Analysis)|poor effort|1|||
170729541|NCT00981084|617012816|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
170729542|NCT00981084|617012817|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
170836871|NCT02514239|617411175|FG005|Overall Study|Not treated|0|||
170836872|NCT02514239|617411176|FG006|Overall Study|Not treated|0|||
170729543|NCT01112579|617012818|FG000|Overall Study|Missed Visit|1|||
170729544|NCT01112579|617012819|FG001|Overall Study|Missed Visit|1|||
170729545|NCT01112579|617012818|FG000|Overall Study|Death|0|||
170729546|NCT01112579|617012819|FG001|Overall Study|Death|2|||
170729547|NCT01648270|617012823|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
170729548|NCT00818753|617012824|FG000|Overall Study|Protocol Violation|1|||
170729549|NCT00818753|617012825|FG001|Overall Study|Protocol Violation|0|||
170729550|NCT00818753|617012826|FG002|Overall Study|Protocol Violation|0|||
170729551|NCT00818753|617012824|FG000|Overall Study|Other reason (not specified)|0|||
170729552|NCT00818753|617012825|FG001|Overall Study|Other reason (not specified)|0|||
170729553|NCT00818753|617012826|FG002|Overall Study|Other reason (not specified)|1|||
170836873|NCT02514239|617411177|FG007|Overall Study|Not treated|0|||
170836874|NCT02514239|617411178|FG008|Overall Study|Not treated|0|||
170836875|NCT02514239|617411179|FG009|Overall Study|Not treated|0|||
170836876|NCT02514239|617411170|FG000|Overall Study|Other Adverse Events|2|||
170836877|NCT02514239|617411171|FG001|Overall Study|Other Adverse Events|0|||
170836878|NCT02514239|617411172|FG002|Overall Study|Other Adverse Events|0|||
170836879|NCT02514239|617411173|FG003|Overall Study|Other Adverse Events|1|||
170836880|NCT02514239|617411174|FG004|Overall Study|Other Adverse Events|0|||
170836881|NCT02514239|617411175|FG005|Overall Study|Other Adverse Events|1|||
170836882|NCT02514239|617411176|FG006|Overall Study|Other Adverse Events|0|||
170836883|NCT02514239|617411177|FG007|Overall Study|Other Adverse Events|1|||
170836884|NCT02514239|617411178|FG008|Overall Study|Other Adverse Events|2|||
170836885|NCT02514239|617411179|FG009|Overall Study|Other Adverse Events|0|||
170836886|NCT02514239|617411170|FG000|Overall Study|Progressive disease|3|||
170836887|NCT02514239|617411171|FG001|Overall Study|Progressive disease|3|||
170836888|NCT02514239|617411172|FG002|Overall Study|Progressive disease|2|||
170836889|NCT02514239|617411173|FG003|Overall Study|Progressive disease|2|||
170836890|NCT02514239|617411174|FG004|Overall Study|Progressive disease|3|||
170836891|NCT02514239|617411175|FG005|Overall Study|Progressive disease|3|||
170836892|NCT02514239|617411176|FG006|Overall Study|Progressive disease|4|||
170836893|NCT02514239|617411177|FG007|Overall Study|Progressive disease|2|||
170836894|NCT02514239|617411178|FG008|Overall Study|Progressive disease|5|||
170836895|NCT02514239|617411179|FG009|Overall Study|Progressive disease|0|||
170836896|NCT01901419|617411180|FG000|Overall Study|Protocol Violation|2|||
170836897|NCT01901419|617411181|FG001|Overall Study|Protocol Violation|6|||
170836898|NCT01901419|617411180|FG000|Overall Study|unavailable researchers|6|||
170836899|NCT01901419|617411181|FG001|Overall Study|unavailable researchers|3|||
170836900|NCT01439867|617411184|FG000|Overall Study|Non-compliance|0|||
170836901|NCT01439867|617411185|FG001|Overall Study|Non-compliance|1|||
170836902|NCT01439867|617411184|FG000|Overall Study|Withdrawal by Subject|1|||
170836903|NCT01439867|617411185|FG001|Overall Study|Withdrawal by Subject|2|||
170836904|NCT01439867|617411184|FG000|Overall Study|Administrative Decision|4|||
170836905|NCT01439867|617411185|FG001|Overall Study|Administrative Decision|5|||
170836906|NCT01439867|617411184|FG000|Overall Study|Protocol-specified Criteria|1|||
170836907|NCT01439867|617411185|FG001|Overall Study|Protocol-specified Criteria|0|||
170836908|NCT01888874|617411186|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
170836909|NCT01888874|617411187|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
170836910|NCT01888874|617411188|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
170836911|NCT01888874|617411189|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
170836912|NCT01888874|617411190|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
170836913|NCT01888874|617411191|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
170836914|NCT01888874|617411192|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
170836915|NCT01888874|617411186|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
170836916|NCT01888874|617411187|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
170836917|NCT01888874|617411188|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
170836918|NCT01888874|617411189|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
170836919|NCT01888874|617411190|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
170836920|NCT01888874|617411191|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
170729554|NCT00818753|617012824|FG000|Overall Study|Randomised and not treated|2|||
170729555|NCT00818753|617012825|FG001|Overall Study|Randomised and not treated|0|||
170729556|NCT00818753|617012826|FG002|Overall Study|Randomised and not treated|0|||
170729557|NCT00725296|617012827|FG000|Overall Study|Adverse Event|11|||
170729558|NCT00725296|617012827|FG000|Overall Study|Lack of Efficacy|7|||
170729559|NCT00725296|617012827|FG000|Overall Study|Withdrawal by Subject|3|||
170836921|NCT01888874|617411192|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
170836922|NCT01888874|617411186|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
170836923|NCT01888874|617411187|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
170836924|NCT01888874|617411188|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
170729560|NCT00725296|617012827|FG000|Overall Study|Non-Compliance|2|||
170729561|NCT00725296|617012827|FG000|Overall Study|Lost to Follow-up|1|||
170729562|NCT00725296|617012827|FG000|Overall Study|Other|38|||
170836925|NCT01888874|617411189|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
170836926|NCT01888874|617411190|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
170836927|NCT01888874|617411191|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
170836928|NCT01888874|617411192|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
170836929|NCT01888874|617411186|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
170836930|NCT01888874|617411187|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
170836931|NCT01888874|617411188|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
170836932|NCT01888874|617411189|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
170836933|NCT01888874|617411190|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
170836934|NCT01888874|617411191|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
170836935|NCT01888874|617411192|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
170836936|NCT01888874|617411186|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170836937|NCT01888874|617411187|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170836938|NCT01888874|617411188|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170836939|NCT01888874|617411189|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170836940|NCT01888874|617411190|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
170836941|NCT01888874|617411191|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170836942|NCT01888874|617411192|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
170836943|NCT01888874|617411186|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
170836944|NCT01888874|617411187|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
170836945|NCT01888874|617411188|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
170836946|NCT01888874|617411189|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
170836947|NCT01888874|617411190|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
170836948|NCT01888874|617411191|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
170836949|NCT01888874|617411192|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
170836950|NCT01888874|617411186|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
170836951|NCT01888874|617411187|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
170836952|NCT01888874|617411188|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
170836953|NCT01888874|617411189|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
170836954|NCT01888874|617411190|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
170836955|NCT01888874|617411191|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
170836956|NCT01888874|617411192|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
170836957|NCT01888874|617411186|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
170836958|NCT01888874|617411187|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
170836959|NCT01888874|617411188|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
170836960|NCT01888874|617411189|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
170836961|NCT01888874|617411190|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
170836962|NCT01888874|617411191|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
170836963|NCT01888874|617411192|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
170836964|NCT01888874|617411186|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
170836965|NCT01888874|617411187|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
170836966|NCT01888874|617411188|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
170836967|NCT01888874|617411189|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
170836968|NCT01888874|617411190|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
170836969|NCT01888874|617411191|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
170836970|NCT01888874|617411192|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
170836971|NCT01888874|617411186|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
170836972|NCT01888874|617411187|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
170836973|NCT01888874|617411188|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
170836974|NCT01888874|617411189|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
170836975|NCT01888874|617411190|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
170836976|NCT01888874|617411191|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
170836977|NCT01888874|617411192|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
170836978|NCT01888874|617411186|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
170836979|NCT01888874|617411187|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
170836980|NCT01888874|617411188|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
170836981|NCT01888874|617411189|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
170836982|NCT01888874|617411190|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
170836983|NCT01888874|617411191|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
170836984|NCT01888874|617411192|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
170836985|NCT01888874|617411186|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
170836986|NCT01888874|617411187|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
170836987|NCT01888874|617411188|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
170836988|NCT01888874|617411189|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
170836989|NCT01888874|617411190|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
170836990|NCT01888874|617411191|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
170836991|NCT01888874|617411192|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
170836992|NCT01888874|617411186|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
170836993|NCT01888874|617411187|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
170836994|NCT01888874|617411188|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
170729563|NCT03456700|617012828|FG000|Overall Study|Withdrawal by Subject|1|||
170729564|NCT04154787|617012829|FG000|Overall Study|Adverse Event|0|||
170729565|NCT04154787|617012830|FG001|Overall Study|Adverse Event|1|||
170729566|NCT04154787|617012831|FG002|Overall Study|Adverse Event|0|||
170729567|NCT04154787|617012829|FG000|Overall Study|Patient Requires Other Treatment|0|||
170729568|NCT04154787|617012830|FG001|Overall Study|Patient Requires Other Treatment|1|||
170729569|NCT04154787|617012831|FG002|Overall Study|Patient Requires Other Treatment|0|||
170836995|NCT01888874|617411189|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
170836996|NCT01888874|617411190|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
170836997|NCT01888874|617411191|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
170836998|NCT01888874|617411192|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
170836999|NCT01667926|617411193|FG000|Overall Study|Withdrawal by Subject|1|||
170837000|NCT01667926|617411194|FG001|Overall Study|Withdrawal by Subject|2|||
170837001|NCT01667926|617411195|FG002|Overall Study|Withdrawal by Subject|2|||
170837002|NCT01667926|617411193|FG000|Overall Study|Physician Decision|0|||
170837003|NCT01667926|617411194|FG001|Overall Study|Physician Decision|0|||
170837004|NCT01667926|617411195|FG002|Overall Study|Physician Decision|1|||
170837005|NCT01667926|617411193|FG000|Overall Study|Time committment|0|||
170837006|NCT01667926|617411194|FG001|Overall Study|Time committment|0|||
170837007|NCT01667926|617411195|FG002|Overall Study|Time committment|2|||
170837008|NCT01667926|617411193|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
170837009|NCT01667926|617411194|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
170837010|NCT01667926|617411195|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
170837011|NCT01667926|617411193|FG000|Overall Study|Lost to Follow-up|1|||
170837012|NCT01667926|617411194|FG001|Overall Study|Lost to Follow-up|2|||
170837013|NCT01667926|617411195|FG002|Overall Study|Lost to Follow-up|1|||
170837014|NCT01667926|617411193|FG000|Overall Study|Side effects|3|||
170837015|NCT01667926|617411194|FG001|Overall Study|Side effects|0|||
170837016|NCT01667926|617411195|FG002|Overall Study|Side effects|0|||
170837017|NCT00863512|617411200|FG000|Overall Study|Adverse Event|2|||
170837018|NCT00863512|617411201|FG001|Overall Study|Adverse Event|0|||
170837019|NCT00863512|617411200|FG000|Overall Study|Withdrawal by Subject|11|||
170837020|NCT00863512|617411201|FG001|Overall Study|Withdrawal by Subject|0|||
170837021|NCT00863512|617411200|FG000|Overall Study|Physician Decision|1|||
170837022|NCT00863512|617411201|FG001|Overall Study|Physician Decision|0|||
170837023|NCT03258723|617411202|FG000|Overall Study|COVID Interruption of study|54|||
170837024|NCT03258723|617411202|FG000|Overall Study|Lost to Follow-up|8|||
170837025|NCT04024462|617411203|FG000|Overall Study|Withdrawal by Subject|6|||
170837026|NCT04024462|617411204|FG001|Overall Study|Withdrawal by Subject|7|||
170837027|NCT04024462|617411203|FG000|Overall Study|Progressive Disease|0|||
170837028|NCT04024462|617411204|FG001|Overall Study|Progressive Disease|1|||
170837029|NCT04024462|617411203|FG000|Overall Study|Adverse Event|0|||
170837030|NCT04024462|617411204|FG001|Overall Study|Adverse Event|1|||
170837031|NCT04024462|617411203|FG000|Overall Study|Death|0|||
170837032|NCT04024462|617411204|FG001|Overall Study|Death|1|||
170837033|NCT04024462|617411203|FG000|Overall Study|Lost to Follow-up|1|||
170837034|NCT04024462|617411204|FG001|Overall Study|Lost to Follow-up|0|||
170837035|NCT04024462|617411203|FG000|Overall Study|Ongoing in the Study|94|||
170837036|NCT04024462|617411204|FG001|Overall Study|Ongoing in the Study|89|||
170837037|NCT00433511|617411209|FG000|Step 1|Adverse Event|50|||
170837038|NCT00433511|617411210|FG001|Step 1|Adverse Event|157|||
170837039|NCT00433511|617411211|FG002|Step 1|Adverse Event|153|||
170837040|NCT00433511|617411209|FG000|Step 1|Withdrawal by Subject|45|||
170729570|NCT04154787|617012829|FG000|Overall Study|Study Terminated By Sponsor|0|||
170837041|NCT00433511|617411210|FG001|Step 1|Withdrawal by Subject|143|||
170837042|NCT00433511|617411211|FG002|Step 1|Withdrawal by Subject|154|||
170837043|NCT00433511|617411209|FG000|Step 1|Death|3|||
170837044|NCT00433511|617411210|FG001|Step 1|Death|1|||
170837045|NCT00433511|617411211|FG002|Step 1|Death|1|||
170837046|NCT00433511|617411209|FG000|Step 1|Physician Decision|1|||
170837047|NCT00433511|617411210|FG001|Step 1|Physician Decision|4|||
170837048|NCT00433511|617411211|FG002|Step 1|Physician Decision|3|||
170837049|NCT00433511|617411209|FG000|Step 1|Never started protocol therapy|28|||
170837050|NCT00433511|617411210|FG001|Step 1|Never started protocol therapy|64|||
170837051|NCT00433511|617411211|FG002|Step 1|Never started protocol therapy|66|||
170837052|NCT00433511|617411209|FG000|Step 1|Alternative therapy|2|||
170837053|NCT00433511|617411210|FG001|Step 1|Alternative therapy|1|||
170837054|NCT00433511|617411211|FG002|Step 1|Alternative therapy|3|||
170837055|NCT00433511|617411209|FG000|Step 1|Disease progression, relapse|5|||
170837056|NCT00433511|617411210|FG001|Step 1|Disease progression, relapse|3|||
170837057|NCT00433511|617411211|FG002|Step 1|Disease progression, relapse|3|||
170837058|NCT00433511|617411209|FG000|Step 1|Other complicating disease|2|||
170837059|NCT00433511|617411210|FG001|Step 1|Other complicating disease|6|||
170729571|NCT04154787|617012830|FG001|Overall Study|Study Terminated By Sponsor|6|||
170729572|NCT04154787|617012831|FG002|Overall Study|Study Terminated By Sponsor|1|||
170729573|NCT04154787|617012829|FG000|Overall Study|Subject Decision|0|||
170729574|NCT04154787|617012830|FG001|Overall Study|Subject Decision|1|||
170729575|NCT04154787|617012831|FG002|Overall Study|Subject Decision|0|||
170729576|NCT04154787|617012829|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
170729577|NCT04154787|617012830|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
170729578|NCT04154787|617012831|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
170729579|NCT00613951|617012834|FG000|Overall Study|Adverse Event|1|||
170729580|NCT00613951|617012835|FG001|Overall Study|Adverse Event|0|||
170729581|NCT00613951|617012836|FG002|Overall Study|Adverse Event|1|||
170729582|NCT00613951|617012834|FG000|Overall Study|Lack of Efficacy|0|||
170729583|NCT00613951|617012835|FG001|Overall Study|Lack of Efficacy|1|||
170729584|NCT00613951|617012836|FG002|Overall Study|Lack of Efficacy|1|||
170729585|NCT00613951|617012834|FG000|Overall Study|Protocol Violation|1|||
170729586|NCT00613951|617012835|FG001|Overall Study|Protocol Violation|1|||
170729587|NCT00613951|617012836|FG002|Overall Study|Protocol Violation|1|||
170729588|NCT00613951|617012834|FG000|Overall Study|Unclassified|5|||
170729589|NCT00613951|617012835|FG001|Overall Study|Unclassified|3|||
170729590|NCT00613951|617012836|FG002|Overall Study|Unclassified|2|||
170729591|NCT00655980|617012837|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
170729592|NCT00655980|617012838|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
170729593|NCT00655980|617012839|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
170729594|NCT02532179|617014607|FG000|Overall Study|Lost to Follow-up|1|||
170729595|NCT02532179|617014607|FG000|Overall Study|Pregnancy|1|||
170729596|NCT02532179|617014607|FG000|Overall Study|Subject received depot steroid injection|1|||
170729597|NCT01337674|617014608|FG000|Treatment Period 1|Adverse Event|0|||
170729598|NCT01337674|617014609|FG001|Treatment Period 1|Adverse Event|1|||
170729599|NCT01337674|617014610|FG002|Treatment Period 1|Adverse Event|0|||
170729600|NCT01337674|617014611|FG003|Treatment Period 1|Adverse Event|0|||
170729601|NCT01337674|617014608|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
170729602|NCT01337674|617014609|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
170729603|NCT01337674|617014610|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
170729604|NCT01337674|617014611|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
170729605|NCT01337674|617014608|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170729606|NCT01337674|617014609|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170729607|NCT01337674|617014610|FG002|Treatment Period 2|Withdrawal by Subject|1|||
170729608|NCT01337674|617014611|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170729609|NCT01553318|617014614|FG000|Overall Study|Protocol Violation|3|||
170729610|NCT01553318|617014615|FG001|Overall Study|Protocol Violation|2|||
170729611|NCT00695786|617014616|FG000|Overall Study|Adverse Event|0|||
170729612|NCT00695786|617014617|FG001|Overall Study|Adverse Event|3|||
170729613|NCT00695786|617014618|FG002|Overall Study|Adverse Event|4|||
170729614|NCT00695786|617014619|FG003|Overall Study|Adverse Event|2|||
170729615|NCT00695786|617014616|FG000|Overall Study|Lost to Follow-up|0|||
170729616|NCT00695786|617014617|FG001|Overall Study|Lost to Follow-up|5|||
170729617|NCT00695786|617014618|FG002|Overall Study|Lost to Follow-up|1|||
170729618|NCT00695786|617014619|FG003|Overall Study|Lost to Follow-up|1|||
170729619|NCT00695786|617014616|FG000|Overall Study|Withdrawal by Subject|0|||
170729620|NCT00695786|617014617|FG001|Overall Study|Withdrawal by Subject|4|||
170729621|NCT00695786|617014618|FG002|Overall Study|Withdrawal by Subject|3|||
170729622|NCT00695786|617014619|FG003|Overall Study|Withdrawal by Subject|1|||
170729623|NCT00695786|617014616|FG000|Overall Study|Deemed Ineligible|1|||
170729624|NCT00695786|617014617|FG001|Overall Study|Deemed Ineligible|0|||
170729625|NCT00695786|617014618|FG002|Overall Study|Deemed Ineligible|0|||
170729626|NCT00695786|617014619|FG003|Overall Study|Deemed Ineligible|0|||
170837060|NCT00433511|617411211|FG002|Step 1|Other complicating disease|3|||
170837061|NCT00433511|617411209|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
170729627|NCT00695786|617014616|FG000|Overall Study|Lack of Efficacy|0|||
170729628|NCT00695786|617014617|FG001|Overall Study|Lack of Efficacy|0|||
170729629|NCT00695786|617014618|FG002|Overall Study|Lack of Efficacy|0|||
170729630|NCT00695786|617014619|FG003|Overall Study|Lack of Efficacy|4|||
170729631|NCT04244396|617014623|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
170729632|NCT04244396|617014623|FG000|Overall Study|Withdrawal by Subject|2|||
170837062|NCT00433511|617411210|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
170837063|NCT00433511|617411211|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
170729633|NCT04244396|617014623|FG000|Overall Study|Study termination|37|||
170729634|NCT01787097|617014624|FG000|Overall Study|Withdrawal by Subject|1|||
170729635|NCT01787097|617014625|FG001|Overall Study|Withdrawal by Subject|0|||
170729636|NCT01787097|617014626|FG002|Overall Study|Withdrawal by Subject|0|||
170729637|NCT01787097|617014627|FG003|Overall Study|Withdrawal by Subject|0|||
170729638|NCT00245102|617014628|FG000|Overall Study|Not Treated|1|||
170729639|NCT00245102|617014629|FG001|Overall Study|Not Treated|0|||
170729640|NCT00245102|617014630|FG002|Overall Study|Not Treated|1|||
170729641|NCT00245102|617014631|FG003|Overall Study|Not Treated|0|||
170729642|NCT00245102|617014632|FG004|Overall Study|Not Treated|0|||
170729643|NCT00245102|617014633|FG005|Overall Study|Not Treated|0|||
170729644|NCT00245102|617014628|FG000|Overall Study|Protocol Violation|1|||
170729645|NCT00245102|617014629|FG001|Overall Study|Protocol Violation|0|||
170729646|NCT00245102|617014630|FG002|Overall Study|Protocol Violation|0|||
170729647|NCT00245102|617014631|FG003|Overall Study|Protocol Violation|0|||
170729648|NCT00245102|617014632|FG004|Overall Study|Protocol Violation|0|||
170729649|NCT00245102|617014633|FG005|Overall Study|Protocol Violation|0|||
170729650|NCT00245102|617014628|FG000|Overall Study|Death|0|||
170729651|NCT00245102|617014629|FG001|Overall Study|Death|0|||
170729652|NCT00245102|617014630|FG002|Overall Study|Death|0|||
170729653|NCT00245102|617014631|FG003|Overall Study|Death|1|||
170729654|NCT00245102|617014632|FG004|Overall Study|Death|0|||
170729655|NCT00245102|617014633|FG005|Overall Study|Death|0|||
170729656|NCT00245102|617014628|FG000|Overall Study|Adverse Event|4|||
170729657|NCT00245102|617014629|FG001|Overall Study|Adverse Event|2|||
170729658|NCT00245102|617014630|FG002|Overall Study|Adverse Event|5|||
170729659|NCT00245102|617014631|FG003|Overall Study|Adverse Event|1|||
170729660|NCT00245102|617014632|FG004|Overall Study|Adverse Event|0|||
170729661|NCT00245102|617014633|FG005|Overall Study|Adverse Event|2|||
170729662|NCT00245102|617014628|FG000|Overall Study|Decline in performance|0|||
170729663|NCT00245102|617014629|FG001|Overall Study|Decline in performance|2|||
170729664|NCT00245102|617014630|FG002|Overall Study|Decline in performance|0|||
170729665|NCT00245102|617014631|FG003|Overall Study|Decline in performance|1|||
170729666|NCT00245102|617014632|FG004|Overall Study|Decline in performance|0|||
170729667|NCT00245102|617014633|FG005|Overall Study|Decline in performance|2|||
170729668|NCT00245102|617014628|FG000|Overall Study|Participant needed surgery|0|||
170729669|NCT00245102|617014629|FG001|Overall Study|Participant needed surgery|0|||
170729670|NCT00245102|617014630|FG002|Overall Study|Participant needed surgery|1|||
170729671|NCT00245102|617014631|FG003|Overall Study|Participant needed surgery|0|||
170729672|NCT00245102|617014632|FG004|Overall Study|Participant needed surgery|0|||
170729673|NCT00245102|617014633|FG005|Overall Study|Participant needed surgery|0|||
170729674|NCT00245102|617014628|FG000|Overall Study|Clinical progression|1|||
170729675|NCT00245102|617014629|FG001|Overall Study|Clinical progression|0|||
170729676|NCT00245102|617014630|FG002|Overall Study|Clinical progression|0|||
170729677|NCT00245102|617014631|FG003|Overall Study|Clinical progression|0|||
170729678|NCT00245102|617014632|FG004|Overall Study|Clinical progression|0|||
170729679|NCT00245102|617014633|FG005|Overall Study|Clinical progression|0|||
170729680|NCT00289887|617014634|FG000|Overall Study|Adverse Event|3|||
170729681|NCT00289887|617014635|FG001|Overall Study|Adverse Event|3|||
170729682|NCT00289887|617014634|FG000|Overall Study|Lack of Efficacy|3|||
170729683|NCT00289887|617014635|FG001|Overall Study|Lack of Efficacy|11|||
170729684|NCT00289887|617014634|FG000|Overall Study|Lost to Follow-up|3|||
170729685|NCT00289887|617014635|FG001|Overall Study|Lost to Follow-up|3|||
170837064|NCT00433511|617411209|FG000|Step 1|Suspected recurrence|0|||
170837065|NCT00433511|617411210|FG001|Step 1|Suspected recurrence|1|||
170837066|NCT00433511|617411211|FG002|Step 1|Suspected recurrence|0|||
170837067|NCT00433511|617411209|FG000|Step 1|Insurance/drug distribution issues|0|||
170837068|NCT00433511|617411210|FG001|Step 1|Insurance/drug distribution issues|1|||
170837069|NCT00433511|617411211|FG002|Step 1|Insurance/drug distribution issues|2|||
170837070|NCT00433511|617411209|FG000|Step 1|Patient moved|0|||
170837071|NCT00433511|617411210|FG001|Step 1|Patient moved|0|||
170837072|NCT00433511|617411211|FG002|Step 1|Patient moved|1|||
170837073|NCT00433511|617411209|FG000|Step 2 (Arm D)|Adverse Event|0|||
170837074|NCT00433511|617411210|FG001|Step 2 (Arm D)|Adverse Event|0|||
170837075|NCT00433511|617411211|FG002|Step 2 (Arm D)|Adverse Event|135|||
170837076|NCT00433511|617411209|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
170729686|NCT00289887|617014634|FG000|Overall Study|Protocol Violation|3|||
170729687|NCT00289887|617014635|FG001|Overall Study|Protocol Violation|1|||
170729688|NCT00289887|617014634|FG000|Overall Study|Withdrawal by Subject|3|||
170729689|NCT00289887|617014635|FG001|Overall Study|Withdrawal by Subject|8|||
170729690|NCT00289887|617014634|FG000|Overall Study|Other|7|||
170729691|NCT00289887|617014635|FG001|Overall Study|Other|3|||
170729692|NCT02293395|617014638|FG000|Overall Study|Lost to Follow-up|1|||
170729693|NCT02293395|617014639|FG001|Overall Study|Lost to Follow-up|0|||
170729694|NCT02293395|617014638|FG000|Overall Study|Withdrawal by Subject|8|||
170837077|NCT00433511|617411210|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
170729695|NCT02293395|617014639|FG001|Overall Study|Withdrawal by Subject|7|||
170729696|NCT01464021|617014640|FG000|Overall Study|Withdrawal by Subject|13|||
170729697|NCT01464021|617014640|FG000|Overall Study|Lost to Follow-up|1|||
170837078|NCT00433511|617411211|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
170729698|NCT01464021|617014640|FG000|Overall Study|Lack of Efficacy|1|||
170729699|NCT01464021|617014640|FG000|Overall Study|various|11|||
170729700|NCT00224770|617014646|FG000|Overall Study|Lost to Follow-up|4|||
170729701|NCT00224770|617014647|FG001|Overall Study|Lost to Follow-up|2|||
170729702|NCT00224770|617014648|FG002|Overall Study|Lost to Follow-up|0|||
170729703|NCT00437645|617014649|FG000|Overall Study|Adverse Event|15|||
170729704|NCT00437645|617014650|FG001|Overall Study|Adverse Event|84|||
170729705|NCT00437645|617014649|FG000|Overall Study|Withdrawal by Subject|10|||
170729706|NCT00437645|617014650|FG001|Overall Study|Withdrawal by Subject|22|||
170729707|NCT00437645|617014649|FG000|Overall Study|Protocol Violation|3|||
170729708|NCT00437645|617014650|FG001|Overall Study|Protocol Violation|3|||
170729709|NCT00437645|617014649|FG000|Overall Study|Lost to Follow-up|2|||
170729710|NCT00437645|617014650|FG001|Overall Study|Lost to Follow-up|3|||
170729711|NCT00437645|617014649|FG000|Overall Study|Administrative problems|2|||
170729712|NCT00437645|617014650|FG001|Overall Study|Administrative problems|1|||
170729713|NCT00437645|617014649|FG000|Overall Study|Lack of Efficacy|2|||
170729714|NCT00437645|617014650|FG001|Overall Study|Lack of Efficacy|1|||
170729715|NCT00437645|617014649|FG000|Overall Study|Condition no longer requires study drug|1|||
170729716|NCT00437645|617014650|FG001|Overall Study|Condition no longer requires study drug|1|||
170729717|NCT02586025|617014653|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
170729718|NCT02586025|617014654|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
170729719|NCT02586025|617014653|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
170729720|NCT02586025|617014654|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
170729721|NCT02586025|617014653|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
170729722|NCT02586025|617014654|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
170729723|NCT02586025|617014653|FG000|Neoadjuvant Treatment|Death|1|||
170729724|NCT02586025|617014654|FG001|Neoadjuvant Treatment|Death|0|||
170729725|NCT02586025|617014653|FG000|Neoadjuvant Treatment|Adverse Event|1|||
170729726|NCT02586025|617014654|FG001|Neoadjuvant Treatment|Adverse Event|0|||
170729727|NCT02586025|617014653|FG000|Neoadjuvant Treatment|Physician Decision|2|||
170729728|NCT02586025|617014654|FG001|Neoadjuvant Treatment|Physician Decision|1|||
170729729|NCT02586025|617014653|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
170729730|NCT02586025|617014654|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
170729731|NCT02586025|617014653|FG000|Adjuvant Treatment|Recurrent Disease|4|||
170729732|NCT02586025|617014654|FG001|Adjuvant Treatment|Recurrent Disease|5|||
170729733|NCT02586025|617014653|FG000|Adjuvant Treatment|Physician Decision|0|||
170729734|NCT02586025|617014654|FG001|Adjuvant Treatment|Physician Decision|1|||
170729735|NCT02586025|617014653|FG000|Adjuvant Treatment|Pregnancy|1|||
170729736|NCT02586025|617014654|FG001|Adjuvant Treatment|Pregnancy|0|||
170729737|NCT02586025|617014653|FG000|Treatment-Free Follow-Up|Death|11|||
170729738|NCT02586025|617014654|FG001|Treatment-Free Follow-Up|Death|11|||
170729739|NCT02586025|617014653|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
170729740|NCT02586025|617014654|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
170729741|NCT02586025|617014653|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
170729742|NCT02586025|617014654|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
170729743|NCT02586025|617014653|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
170729744|NCT02586025|617014654|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
170729745|NCT02586025|617014653|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
170729746|NCT02586025|617014654|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
170729747|NCT00175825|617014655|FG000|Overall Study|Adverse Event|3|||
170729748|NCT00175825|617014656|FG001|Overall Study|Adverse Event|2|||
170729749|NCT00175825|617014657|FG002|Overall Study|Adverse Event|1|||
170729750|NCT00175825|617014658|FG003|Overall Study|Adverse Event|1|||
170729751|NCT00175825|617014655|FG000|Overall Study|Lost to Follow-up|1|||
170729752|NCT00175825|617014656|FG001|Overall Study|Lost to Follow-up|2|||
170729753|NCT00175825|617014657|FG002|Overall Study|Lost to Follow-up|0|||
170729754|NCT00175825|617014658|FG003|Overall Study|Lost to Follow-up|0|||
170729755|NCT00175825|617014655|FG000|Overall Study|Withdrawal by Subject|1|||
170729756|NCT00175825|617014656|FG001|Overall Study|Withdrawal by Subject|0|||
170729757|NCT00175825|617014657|FG002|Overall Study|Withdrawal by Subject|0|||
170729758|NCT00175825|617014658|FG003|Overall Study|Withdrawal by Subject|0|||
170729759|NCT03704584|617014659|FG000|Overall Study|Withdrawal by Subject|1|||
170729760|NCT03704584|617014660|FG001|Overall Study|Withdrawal by Subject|0|||
170729761|NCT03548207|617014663|FG000|Overall Study|Death|10|||
170729762|NCT03548207|617014664|FG001|Overall Study|Death|23|||
170729763|NCT03548207|617014665|FG002|Overall Study|Death|3|||
170729764|NCT03548207|617014663|FG000|Overall Study|Lost to Follow-up|0|||
170729765|NCT03548207|617014664|FG001|Overall Study|Lost to Follow-up|2|||
170729766|NCT03548207|617014665|FG002|Overall Study|Lost to Follow-up|0|||
170729767|NCT03548207|617014663|FG000|Overall Study|Withdrawal by Subject|0|||
170729768|NCT03548207|617014664|FG001|Overall Study|Withdrawal by Subject|3|||
170729769|NCT03548207|617014665|FG002|Overall Study|Withdrawal by Subject|0|||
170729770|NCT03548207|617014663|FG000|Overall Study|Sponsor decision|19|||
170729771|NCT03548207|617014664|FG001|Overall Study|Sponsor decision|40|||
170729772|NCT03548207|617014665|FG002|Overall Study|Sponsor decision|6|||
170729773|NCT03548207|617014663|FG000|Overall Study|Randomized but not treated|6|||
170729774|NCT03548207|617014664|FG001|Overall Study|Randomized but not treated|10|||
170729775|NCT03548207|617014665|FG002|Overall Study|Randomized but not treated|4|||
170729776|NCT03822117|617014666|FG000|Overall Study|Death|18|||
170729777|NCT03822117|617014667|FG001|Overall Study|Death|17|||
170729778|NCT03822117|617014668|FG002|Overall Study|Death|12|||
170729779|NCT03822117|617014669|FG003|Overall Study|Death|4|||
170729780|NCT03822117|617014666|FG000|Overall Study|Lost to Follow-up|1|||
170729781|NCT03822117|617014667|FG001|Overall Study|Lost to Follow-up|2|||
170837079|NCT00433511|617411209|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
170837080|NCT00433511|617411210|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
170837081|NCT00433511|617411211|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
170837082|NCT00433511|617411209|FG000|Step 2 (Arm D)|Physician Decision|0|||
170729782|NCT03822117|617014668|FG002|Overall Study|Lost to Follow-up|3|||
170729783|NCT03822117|617014669|FG003|Overall Study|Lost to Follow-up|0|||
170729784|NCT03822117|617014666|FG000|Overall Study|Study Terminated by Sponsor|25|||
170729785|NCT03822117|617014667|FG001|Overall Study|Study Terminated by Sponsor|11|||
170729786|NCT03822117|617014668|FG002|Overall Study|Study Terminated by Sponsor|6|||
170729787|NCT03822117|617014669|FG003|Overall Study|Study Terminated by Sponsor|0|||
170729788|NCT03822117|617014666|FG000|Overall Study|Withdrawal by Subject|4|||
170729789|NCT03822117|617014667|FG001|Overall Study|Withdrawal by Subject|0|||
170729790|NCT03822117|617014668|FG002|Overall Study|Withdrawal by Subject|3|||
170729791|NCT03822117|617014669|FG003|Overall Study|Withdrawal by Subject|0|||
170729792|NCT03822117|617014666|FG000|Overall Study|Disease Progression|1|||
170729793|NCT03822117|617014667|FG001|Overall Study|Disease Progression|2|||
170729794|NCT03822117|617014668|FG002|Overall Study|Disease Progression|1|||
170729795|NCT03822117|617014669|FG003|Overall Study|Disease Progression|0|||
170729796|NCT03822117|617014666|FG000|Overall Study|Never Returned to Hospital|0|||
170729797|NCT03822117|617014667|FG001|Overall Study|Never Returned to Hospital|0|||
170729798|NCT03822117|617014668|FG002|Overall Study|Never Returned to Hospital|1|||
170729799|NCT03822117|617014669|FG003|Overall Study|Never Returned to Hospital|0|||
170729800|NCT01357616|617014673|FG000|Overall Study|Adverse Event|1|||
170729801|NCT01357616|617014674|FG001|Overall Study|Adverse Event|1|||
170729802|NCT01357616|617014673|FG000|Overall Study|Lost to Follow-up|4|||
170729803|NCT01357616|617014674|FG001|Overall Study|Lost to Follow-up|3|||
170729804|NCT01357616|617014673|FG000|Overall Study|Protocol Violation|0|||
170729805|NCT01357616|617014674|FG001|Overall Study|Protocol Violation|2|||
170729806|NCT01357616|617014673|FG000|Overall Study|Inadequate Control of IOP|1|||
170729807|NCT01357616|617014674|FG001|Overall Study|Inadequate Control of IOP|2|||
170729808|NCT01357616|617014673|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
170729809|NCT01357616|617014674|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
170729810|NCT01357616|617014673|FG000|Overall Study|Withdrawal by Subject|1|||
170837083|NCT00433511|617411210|FG001|Step 2 (Arm D)|Physician Decision|0|||
170837084|NCT00433511|617411211|FG002|Step 2 (Arm D)|Physician Decision|9|||
170837085|NCT00433511|617411209|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
170837086|NCT00433511|617411210|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
170729811|NCT01357616|617014674|FG001|Overall Study|Withdrawal by Subject|0|||
170729812|NCT01699022|617014678|FG000|Overall Study|Early discontinuation from the study|3|||
170729813|NCT03284788|617014679|FG000|Overall Study|Withdrawal by Subject|2|||
170729814|NCT04465357|617014686|FG000|Overall Study|Adverse Event|2|||
170729815|NCT04465357|617014686|FG000|Overall Study|Lack of Efficacy|1|||
170729816|NCT04465357|617014686|FG000|Overall Study|Lost to Follow-up|2|||
170729817|NCT04465357|617014686|FG000|Overall Study|Withdrawal by Subject|6|||
170837087|NCT00433511|617411211|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
170729818|NCT04465357|617014686|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
170729819|NCT00863655|617014687|FG000|Overall Study|Protocol Violation|4|||
170729820|NCT00863655|617014688|FG001|Overall Study|Protocol Violation|0|||
170729821|NCT00863655|617014687|FG000|Overall Study|Adverse Event|52|||
170729822|NCT00863655|617014688|FG001|Overall Study|Adverse Event|8|||
170729823|NCT00863655|617014687|FG000|Overall Study|Withdrawal by Subject|47|||
170729824|NCT00863655|617014688|FG001|Overall Study|Withdrawal by Subject|7|||
170729825|NCT00863655|617014687|FG000|Overall Study|Administrative problems|1|||
170729826|NCT00863655|617014688|FG001|Overall Study|Administrative problems|0|||
170837088|NCT00433511|617411209|FG000|Step 2 (Arm D)|Other complicating disease|0|||
170729827|NCT00863655|617014687|FG000|Overall Study|Death|7|||
170729828|NCT00863655|617014688|FG001|Overall Study|Death|1|||
170729829|NCT00863655|617014687|FG000|Overall Study|New cancer therapy|5|||
170729830|NCT00863655|617014688|FG001|Overall Study|New cancer therapy|1|||
170729831|NCT00863655|617014687|FG000|Overall Study|Disease progression|364|||
170729832|NCT00863655|617014688|FG001|Overall Study|Disease progression|221|||
170729833|NCT00863655|617014687|FG000|Overall Study|Treatment completed as per protocol|5|||
170729834|NCT00863655|617014688|FG001|Overall Study|Treatment completed as per protocol|1|||
170729835|NCT00430248|617014695|FG000|Overall Study|Adverse Event|49|||
170729836|NCT00430248|617014696|FG001|Overall Study|Adverse Event|61|||
170729837|NCT00430248|617014697|FG002|Overall Study|Adverse Event|64|||
170729838|NCT00430248|617014695|FG000|Overall Study|Protocol Violation|10|||
170729839|NCT00430248|617014696|FG001|Overall Study|Protocol Violation|2|||
170729840|NCT00430248|617014697|FG002|Overall Study|Protocol Violation|4|||
170729841|NCT00430248|617014695|FG000|Overall Study|Personal Reasons|12|||
170729842|NCT00430248|617014696|FG001|Overall Study|Personal Reasons|24|||
170729843|NCT00430248|617014697|FG002|Overall Study|Personal Reasons|9|||
170729844|NCT00430248|617014695|FG000|Overall Study|Lost to Follow-up|28|||
170729845|NCT00430248|617014696|FG001|Overall Study|Lost to Follow-up|33|||
170729846|NCT00430248|617014697|FG002|Overall Study|Lost to Follow-up|28|||
170729847|NCT00430248|617014695|FG000|Overall Study|Therapeutic Failure|1|||
170729848|NCT00430248|617014696|FG001|Overall Study|Therapeutic Failure|1|||
170729849|NCT00430248|617014697|FG002|Overall Study|Therapeutic Failure|1|||
170729850|NCT00430248|617014695|FG000|Overall Study|Withdrawal by Subject|14|||
170729851|NCT00430248|617014696|FG001|Overall Study|Withdrawal by Subject|20|||
170729852|NCT00430248|617014697|FG002|Overall Study|Withdrawal by Subject|16|||
170729853|NCT00430248|617014695|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170729854|NCT00430248|617014696|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
170729855|NCT00430248|617014697|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
170729856|NCT00430248|617014695|FG000|Overall Study|Gout Flare|3|||
170729857|NCT00430248|617014696|FG001|Overall Study|Gout Flare|7|||
170729858|NCT00430248|617014697|FG002|Overall Study|Gout Flare|2|||
170729859|NCT00430248|617014695|FG000|Overall Study|Reason Not Specified|8|||
170729860|NCT00430248|617014696|FG001|Overall Study|Reason Not Specified|8|||
170729861|NCT00430248|617014697|FG002|Overall Study|Reason Not Specified|11|||
170729862|NCT04721925|617014699|FG000|2-Month Assessment|Lost to Follow-up|5|||
170729863|NCT04721925|617014700|FG001|2-Month Assessment|Lost to Follow-up|3|||
170729864|NCT04721925|617014699|FG000|4-Month Assessment|Lost to Follow-up|3|||
170729865|NCT04721925|617014700|FG001|4-Month Assessment|Lost to Follow-up|6|||
170729866|NCT02054806|617014701|FG000|Overall Study|Sponsor Decision|31|||
170729867|NCT02054806|617014701|FG000|Overall Study|Withdrawal by Subject|43|||
170729868|NCT02054806|617014701|FG000|Overall Study|Protocol Violation|2|||
170729869|NCT02054806|617014701|FG000|Overall Study|Lost to Follow-up|10|||
170729870|NCT02054806|617014701|FG000|Overall Study|Death|391|||
170729871|NCT00677235|617014702|FG000|Overall Study|Withdrawal by Subject|1|||
170729872|NCT00677235|617014703|FG001|Overall Study|Withdrawal by Subject|1|||
170729873|NCT00677235|617014702|FG000|Overall Study|Lost to Follow-up|2|||
170729874|NCT00677235|617014703|FG001|Overall Study|Lost to Follow-up|1|||
170729875|NCT00677235|617014702|FG000|Overall Study|Death|37|||
170729876|NCT00677235|617014703|FG001|Overall Study|Death|36|||
170729877|NCT00677235|617014702|FG000|Overall Study|Adverse Experience|1|||
170729878|NCT00677235|617014703|FG001|Overall Study|Adverse Experience|0|||
170729879|NCT00952822|617014710|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
170729880|NCT00952822|617014711|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
170729881|NCT00952822|617014712|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
170729882|NCT00952822|617014713|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
170729883|NCT00952822|617014710|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
170729884|NCT00952822|617014711|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
170729885|NCT00952822|617014712|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
170729886|NCT00952822|617014713|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
170729887|NCT00691938|617014715|FG000|Overall Study|QTc prolongation|1|||
170729888|NCT00691938|617014716|FG001|Overall Study|QTc prolongation|0|||
170729889|NCT00691938|617014717|FG002|Overall Study|QTc prolongation|0|||
170729890|NCT00691938|617014718|FG003|Overall Study|QTc prolongation|0|||
170729891|NCT00691938|617014719|FG004|Overall Study|QTc prolongation|0|||
170729892|NCT00691938|617014720|FG005|Overall Study|QTc prolongation|0|||
170729893|NCT00691938|617014721|FG006|Overall Study|QTc prolongation|0|||
170729894|NCT00594854|617014723|FG000|Overall Study|Study terminated|7|||
170729895|NCT00594854|617014724|FG001|Overall Study|Study terminated|10|||
170729896|NCT03292146|617014733|FG000|Baseline to 12 months|Relocation|1|||
170729897|NCT03292146|617014734|FG001|Baseline to 12 months|Relocation|0|||
170729898|NCT03292146|617014733|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
170729899|NCT03292146|617014734|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
170729900|NCT03292146|617014733|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
170729901|NCT03292146|617014734|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
170729902|NCT03292146|617014733|FG000|12 months to 24 months|Planning pregnancy|2|||
170729903|NCT03292146|617014734|FG001|12 months to 24 months|Planning pregnancy|2|||
170729904|NCT03292146|617014733|FG000|12 months to 24 months|Personal reasons|1|||
170729905|NCT03292146|617014734|FG001|12 months to 24 months|Personal reasons|0|||
170729906|NCT03292146|617014733|FG000|12 months to 24 months|Lost to Follow-up|0|||
170729907|NCT03292146|617014734|FG001|12 months to 24 months|Lost to Follow-up|1|||
170729908|NCT03440372|617014736|FG000|Treatment|Adverse Event|16|||
170729909|NCT03440372|617014737|FG001|Treatment|Adverse Event|8|||
170729910|NCT03440372|617014736|FG000|Treatment|Lack of Efficacy|4|||
170729911|NCT03440372|617014737|FG001|Treatment|Lack of Efficacy|2|||
170729912|NCT03440372|617014736|FG000|Treatment|Withdrawal by Subject|12|||
170729913|NCT03440372|617014737|FG001|Treatment|Withdrawal by Subject|8|||
170729914|NCT03440372|617014736|FG000|Treatment|Lost to Follow-up|1|||
170729915|NCT03440372|617014737|FG001|Treatment|Lost to Follow-up|0|||
170729916|NCT03440372|617014736|FG000|Treatment|Pregnancy|1|||
170729917|NCT03440372|617014737|FG001|Treatment|Pregnancy|0|||
170729918|NCT03440372|617014736|FG000|Treatment|Study Terminated by Sponsor|2|||
170729919|NCT03440372|617014737|FG001|Treatment|Study Terminated by Sponsor|1|||
170729920|NCT03440372|617014736|FG000|Treatment|Other Reason|2|||
170729921|NCT03440372|617014737|FG001|Treatment|Other Reason|3|||
170729922|NCT05711641|617014738|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
170729923|NCT05711641|617014739|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
170729924|NCT05711641|617014738|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
170729925|NCT05711641|617014739|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
170729926|NCT04040751|617014740|FG000|Overall Study|Withdrawal by Subject|2|||
170729927|NCT04040751|617014741|FG001|Overall Study|Withdrawal by Subject|0|||
170729928|NCT04040751|617014742|FG002|Overall Study|Withdrawal by Subject|2|||
170729929|NCT04040751|617014743|FG003|Overall Study|Withdrawal by Subject|0|||
170729930|NCT00951483|617014744|FG000|Overall Study|Physician Decision|4|||
170729931|NCT00951483|617014745|FG001|Overall Study|Physician Decision|0|||
170729932|NCT00951483|617014744|FG000|Overall Study|Withdrawal by Subject|15|||
170729933|NCT00951483|617014745|FG001|Overall Study|Withdrawal by Subject|0|||
170729934|NCT02342886|617014746|FG000|Overall Study|Treatment non-compliance|1|||
170729935|NCT02342886|617014747|FG001|Overall Study|Treatment non-compliance|0|||
170729936|NCT02342886|617014748|FG002|Overall Study|Treatment non-compliance|0|||
170729937|NCT02342886|617014749|FG003|Overall Study|Treatment non-compliance|1|||
170729938|NCT02342886|617014750|FG004|Overall Study|Treatment non-compliance|0|||
170729939|NCT02342886|617014746|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
170729940|NCT02342886|617014747|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
170729941|NCT02342886|617014748|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
170729942|NCT02342886|617014749|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
170729943|NCT02342886|617014750|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
170729944|NCT02342886|617014746|FG000|Overall Study|Adverse event/specific toxicity|4|||
170729945|NCT02342886|617014747|FG001|Overall Study|Adverse event/specific toxicity|3|||
170729946|NCT02342886|617014748|FG002|Overall Study|Adverse event/specific toxicity|11|||
170729947|NCT02342886|617014749|FG003|Overall Study|Adverse event/specific toxicity|2|||
170729948|NCT02342886|617014750|FG004|Overall Study|Adverse event/specific toxicity|1|||
170729949|NCT02342886|617014746|FG000|Overall Study|Lost to Follow-up|1|||
170729950|NCT02342886|617014747|FG001|Overall Study|Lost to Follow-up|0|||
170729951|NCT02342886|617014748|FG002|Overall Study|Lost to Follow-up|0|||
170729952|NCT02342886|617014749|FG003|Overall Study|Lost to Follow-up|0|||
170729953|NCT02342886|617014750|FG004|Overall Study|Lost to Follow-up|0|||
170729954|NCT02342886|617014746|FG000|Overall Study|Death|1|||
170729955|NCT02342886|617014747|FG001|Overall Study|Death|2|||
170729956|NCT02342886|617014748|FG002|Overall Study|Death|1|||
170729957|NCT02342886|617014749|FG003|Overall Study|Death|0|||
170729958|NCT02342886|617014750|FG004|Overall Study|Death|1|||
170729959|NCT02342886|617014746|FG000|Overall Study|Withdrawal by Subject|0|||
170729960|NCT02342886|617014747|FG001|Overall Study|Withdrawal by Subject|1|||
170729961|NCT02342886|617014748|FG002|Overall Study|Withdrawal by Subject|0|||
170729962|NCT02342886|617014749|FG003|Overall Study|Withdrawal by Subject|1|||
170729963|NCT02342886|617014750|FG004|Overall Study|Withdrawal by Subject|0|||
170729964|NCT02342886|617014746|FG000|Overall Study|Investigator/sponsor decision|0|||
170729965|NCT02342886|617014747|FG001|Overall Study|Investigator/sponsor decision|2|||
170729966|NCT02342886|617014748|FG002|Overall Study|Investigator/sponsor decision|0|||
170729967|NCT02342886|617014749|FG003|Overall Study|Investigator/sponsor decision|3|||
170729968|NCT02342886|617014750|FG004|Overall Study|Investigator/sponsor decision|1|||
170729969|NCT02342886|617014746|FG000|Overall Study|Pregnancy|0|||
170729970|NCT02342886|617014747|FG001|Overall Study|Pregnancy|0|||
170729971|NCT02342886|617014748|FG002|Overall Study|Pregnancy|2|||
170729972|NCT02342886|617014749|FG003|Overall Study|Pregnancy|0|||
170729973|NCT02342886|617014750|FG004|Overall Study|Pregnancy|0|||
170729974|NCT02342886|617014746|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
170729975|NCT02342886|617014747|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
170729976|NCT02342886|617014748|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
170729977|NCT02342886|617014749|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
170729978|NCT02342886|617014750|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
170729979|NCT02342886|617014746|FG000|Overall Study|Protocol Violation|0|||
170729980|NCT02342886|617014747|FG001|Overall Study|Protocol Violation|0|||
170729981|NCT02342886|617014748|FG002|Overall Study|Protocol Violation|0|||
170729982|NCT02342886|617014749|FG003|Overall Study|Protocol Violation|2|||
170729983|NCT02342886|617014750|FG004|Overall Study|Protocol Violation|0|||
170729984|NCT01813474|617014751|FG000|Overall Study|Withdrawal by Subject|0|||
170729985|NCT01813474|617014752|FG001|Overall Study|Withdrawal by Subject|0|||
170729986|NCT01813474|617014753|FG002|Overall Study|Withdrawal by Subject|1|||
170729987|NCT01813474|617014751|FG000|Overall Study|Adverse Event|1|||
170729988|NCT01813474|617014752|FG001|Overall Study|Adverse Event|1|||
170729989|NCT01813474|617014753|FG002|Overall Study|Adverse Event|0|||
170729990|NCT01813474|617014751|FG000|Overall Study|Lack of Efficacy|2|||
170729991|NCT01813474|617014752|FG001|Overall Study|Lack of Efficacy|6|||
170729992|NCT01813474|617014753|FG002|Overall Study|Lack of Efficacy|9|||
170729993|NCT01813474|617014751|FG000|Overall Study|Death|0|||
170729994|NCT01813474|617014752|FG001|Overall Study|Death|0|||
170729995|NCT01813474|617014753|FG002|Overall Study|Death|1|||
170729996|NCT03053050|617014757|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
170729997|NCT03053050|617014758|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
170729998|NCT03053050|617014759|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
170729999|NCT03053050|617014760|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
170730000|NCT03053050|617014757|FG000|Randomized Phase|Withdrew Consent|16|||
170730001|NCT03053050|617014758|FG001|Randomized Phase|Withdrew Consent|8|||
170730002|NCT03053050|617014759|FG002|Randomized Phase|Withdrew Consent|9|||
170730003|NCT03053050|617014760|FG003|Randomized Phase|Withdrew Consent|0|||
170730004|NCT03053050|617014757|FG000|Randomized Phase|Investigator's Discretion|6|||
170730005|NCT03053050|617014758|FG001|Randomized Phase|Investigator's Discretion|6|||
170730006|NCT03053050|617014759|FG002|Randomized Phase|Investigator's Discretion|3|||
170730007|NCT03053050|617014760|FG003|Randomized Phase|Investigator's Discretion|0|||
170730008|NCT03053050|617014757|FG000|Randomized Phase|Lost to Follow-up|5|||
170730009|NCT03053050|617014758|FG001|Randomized Phase|Lost to Follow-up|1|||
170730010|NCT03053050|617014759|FG002|Randomized Phase|Lost to Follow-up|1|||
170730011|NCT03053050|617014760|FG003|Randomized Phase|Lost to Follow-up|0|||
170730012|NCT03053050|617014757|FG000|Randomized Phase|Adverse Event|0|||
170730013|NCT03053050|617014758|FG001|Randomized Phase|Adverse Event|1|||
170730014|NCT03053050|617014759|FG002|Randomized Phase|Adverse Event|0|||
170730015|NCT03053050|617014760|FG003|Randomized Phase|Adverse Event|0|||
170730016|NCT03053050|617014757|FG000|Randomized Phase|Randomized but Never Treated|2|||
170730017|NCT03053050|617014758|FG001|Randomized Phase|Randomized but Never Treated|2|||
170730018|NCT03053050|617014759|FG002|Randomized Phase|Randomized but Never Treated|2|||
170730019|NCT03053050|617014760|FG003|Randomized Phase|Randomized but Never Treated|0|||
170730020|NCT03053050|617014757|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
170730021|NCT03053050|617014758|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
170730022|NCT03053050|617014759|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
170730023|NCT03053050|617014760|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
170730024|NCT03053050|617014757|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
170730025|NCT03053050|617014758|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
170730026|NCT03053050|617014759|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
170730027|NCT03053050|617014760|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
170730028|NCT03053050|617014757|FG000|Open-label Phase|Withdrew Consent|0|||
170730029|NCT03053050|617014758|FG001|Open-label Phase|Withdrew Consent|0|||
170730030|NCT03053050|617014759|FG002|Open-label Phase|Withdrew Consent|0|||
170730031|NCT03053050|617014760|FG003|Open-label Phase|Withdrew Consent|6|||
170730032|NCT03053050|617014757|FG000|Open-label Phase|Investigator's Discretion|0|||
170730033|NCT03053050|617014758|FG001|Open-label Phase|Investigator's Discretion|0|||
170730034|NCT03053050|617014759|FG002|Open-label Phase|Investigator's Discretion|0|||
170730035|NCT03053050|617014760|FG003|Open-label Phase|Investigator's Discretion|4|||
170730036|NCT02858895|617014761|FG000|Overall Study|Disease progression|31|||
170730037|NCT02858895|617014761|FG000|Overall Study|Death|2|||
170730038|NCT02858895|617014761|FG000|Overall Study|Adverse Event|1|||
170730039|NCT02858895|617014761|FG000|Overall Study|Withdrawal by Subject|3|||
170730040|NCT02858895|617014761|FG000|Overall Study|hospice,|1|||
170730041|NCT02858895|617014761|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
170730042|NCT00680407|617014770|FG000|Overall Study|Lost to Follow-up|3|||
170730043|NCT00680407|617014771|FG001|Overall Study|Lost to Follow-up|3|||
170730044|NCT00680407|617014772|FG002|Overall Study|Lost to Follow-up|1|||
170730045|NCT00680407|617014770|FG000|Overall Study|Withdrawal by Subject|5|||
170730046|NCT00680407|617014771|FG001|Overall Study|Withdrawal by Subject|2|||
170730047|NCT00680407|617014772|FG002|Overall Study|Withdrawal by Subject|2|||
170730048|NCT04233372|617016284|FG000|Overall Study|Lost to Follow-up|104|||
170730049|NCT04233372|617016284|FG000|Overall Study|Adverse Event|8|||
170730050|NCT04233372|617016284|FG000|Overall Study|Withdrawal by Subject|2|||
170730051|NCT04958785|617016285|FG000|Overall Study|Study Terminated by Sponsor|4|||
170730052|NCT04958785|617016286|FG001|Overall Study|Study Terminated by Sponsor|10|||
170730053|NCT04958785|617016287|FG002|Overall Study|Study Terminated by Sponsor|7|||
170730054|NCT04958785|617016288|FG003|Overall Study|Study Terminated by Sponsor|6|||
170730055|NCT04958785|617016289|FG004|Overall Study|Study Terminated by Sponsor|34|||
170730056|NCT04958785|617016285|FG000|Overall Study|Death|2|||
170730057|NCT04958785|617016286|FG001|Overall Study|Death|3|||
170730058|NCT04958785|617016287|FG002|Overall Study|Death|4|||
170730059|NCT04958785|617016288|FG003|Overall Study|Death|5|||
170730060|NCT04958785|617016289|FG004|Overall Study|Death|5|||
170730061|NCT04958785|617016285|FG000|Overall Study|Withdrew consent|2|||
170730062|NCT04958785|617016286|FG001|Overall Study|Withdrew consent|0|||
170730063|NCT04958785|617016287|FG002|Overall Study|Withdrew consent|3|||
170730064|NCT04958785|617016288|FG003|Overall Study|Withdrew consent|1|||
170730065|NCT04958785|617016289|FG004|Overall Study|Withdrew consent|0|||
170730066|NCT04958785|617016285|FG000|Overall Study|Investigator's discretion|0|||
170730067|NCT04958785|617016286|FG001|Overall Study|Investigator's discretion|1|||
170730068|NCT04958785|617016287|FG002|Overall Study|Investigator's discretion|0|||
170730069|NCT04958785|617016288|FG003|Overall Study|Investigator's discretion|1|||
170730070|NCT04958785|617016289|FG004|Overall Study|Investigator's discretion|2|||
170730071|NCT04958785|617016285|FG000|Overall Study|Adverse Event|0|||
170730072|NCT04958785|617016286|FG001|Overall Study|Adverse Event|0|||
170730073|NCT04958785|617016287|FG002|Overall Study|Adverse Event|0|||
170730074|NCT04958785|617016288|FG003|Overall Study|Adverse Event|0|||
170730075|NCT04958785|617016289|FG004|Overall Study|Adverse Event|1|||
170730076|NCT04958785|617016285|FG000|Overall Study|Lost to Follow-up|0|||
170730077|NCT04958785|617016286|FG001|Overall Study|Lost to Follow-up|0|||
170730078|NCT04958785|617016287|FG002|Overall Study|Lost to Follow-up|0|||
170730079|NCT04958785|617016288|FG003|Overall Study|Lost to Follow-up|0|||
170730080|NCT04958785|617016289|FG004|Overall Study|Lost to Follow-up|1|||
170730081|NCT00553501|617016290|FG000|Overall Study|Adverse Event|2|||
170730082|NCT00553501|617016290|FG000|Overall Study|Death|1|||
170730083|NCT00553501|617016290|FG000|Overall Study|Progression|1|||
170730084|NCT03412812|617016291|FG000|Level 1|Death|3|||
170730085|NCT03412812|617016292|FG001|Level 1|Death|0|||
170730086|NCT03412812|617016291|FG000|Level 1|Adverse Event|0|||
170730087|NCT03412812|617016292|FG001|Level 1|Adverse Event|1|||
170730088|NCT02127372|617016293|FG000|Overall Study|Withdrawal by Subject|1|||
170730089|NCT02127372|617016294|FG001|Overall Study|Withdrawal by Subject|0|||
170730090|NCT03597568|617016295|FG000|Overall Study|Withdrawal by Subject|1|||
170730091|NCT03597568|617016296|FG001|Overall Study|Withdrawal by Subject|1|||
170730092|NCT03597568|617016295|FG000|Overall Study|Unable to analyze vascular data|1|||
170730093|NCT03597568|617016296|FG001|Overall Study|Unable to analyze vascular data|1|||
170730094|NCT01756352|617016299|FG000|Overall Study|moved away and lost to followup|1|||
170730095|NCT00415610|617016300|FG000|Overall Study|Death|3|||
170730096|NCT00415610|617016301|FG001|Overall Study|Death|2|||
170730097|NCT00415610|617016302|FG002|Overall Study|Death|5|||
170730098|NCT00999466|617016303|FG000|Main Part|Withdrawal by Subject|0|||
170730099|NCT00999466|617016304|FG001|Main Part|Withdrawal by Subject|0|||
170730100|NCT00999466|617016305|FG002|Main Part|Withdrawal by Subject|2|||
170730101|NCT00999466|617016303|FG000|Main Part|Adverse Event|0|||
170730102|NCT00999466|617016304|FG001|Main Part|Adverse Event|4|||
170730103|NCT00999466|617016305|FG002|Main Part|Adverse Event|2|||
170730104|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
170730105|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
170730106|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
170730107|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
170730108|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
170730109|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
170730110|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
170730111|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
170730112|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
170730113|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
170730114|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
170730115|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
170730116|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
170730117|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
170730118|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
170730119|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
170730120|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
170730121|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
170730122|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
170730123|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
170730124|NCT00549757|617016308|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
170730125|NCT00549757|617016309|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
170730126|NCT00549757|617016308|FG000|Extension Period (in Average 9 Months)|Death|143|||
170730127|NCT00549757|617016309|FG001|Extension Period (in Average 9 Months)|Death|136|||
170730128|NCT00549757|617016308|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
170730129|NCT00549757|617016309|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
170730130|NCT00549757|617016308|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
170730131|NCT00549757|617016309|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
170730132|NCT00549757|617016308|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
170730133|NCT00549757|617016309|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
170730134|NCT02641392|617016310|FG000|Overall Study|Lost to Follow-up|0|||
170730135|NCT02641392|617016311|FG001|Overall Study|Lost to Follow-up|0|||
170730136|NCT02641392|617016312|FG002|Overall Study|Lost to Follow-up|2|||
170837089|NCT00433511|617411210|FG001|Step 2 (Arm D)|Other complicating disease|0|||
170837090|NCT00433511|617411211|FG002|Step 2 (Arm D)|Other complicating disease|3|||
170837091|NCT00433511|617411209|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
170837092|NCT00433511|617411210|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
170837093|NCT00433511|617411211|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
170837094|NCT00433511|617411209|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
170837095|NCT00433511|617411210|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
170837096|NCT00433511|617411211|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
170837097|NCT00433511|617411209|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
170837098|NCT00433511|617411210|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
170837099|NCT00433511|617411211|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
170837100|NCT00433511|617411209|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
170837101|NCT00433511|617411210|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
170837102|NCT00433511|617411211|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
170837103|NCT02963090|617411228|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
170837104|NCT02963090|617411229|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
170837105|NCT01375673|617411230|FG000|Overall Study|Withdrawal by Subject|0|||
170837106|NCT01375673|617411231|FG001|Overall Study|Withdrawal by Subject|1|||
170837107|NCT05878873|617411242|FG000|Overall Study|Lost to Follow-up|2|||
170837108|NCT05878873|617411243|FG001|Overall Study|Lost to Follow-up|0|||
170837109|NCT00559377|617411250|FG000|Overall Study|Withdrawal by Subject|9|||
170837110|NCT00203047|617411254|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
170837111|NCT00203047|617411255|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
170837112|NCT00203047|617411254|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
170837113|NCT00203047|617411255|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
170837114|NCT00203047|617411254|FG000|Overall Study|Withdrawal by Subject|13|||
170837115|NCT00203047|617411255|FG001|Overall Study|Withdrawal by Subject|47|||
170837116|NCT00203047|617411254|FG000|Overall Study|Teva requested participant withdrawal|1|||
170837117|NCT00203047|617411255|FG001|Overall Study|Teva requested participant withdrawal|1|||
170837118|NCT00203047|617411254|FG000|Overall Study|Physician Decision|8|||
170837119|NCT00203047|617411255|FG001|Overall Study|Physician Decision|7|||
170837120|NCT00203047|617411254|FG000|Overall Study|Non-compliance|4|||
170837121|NCT00203047|617411255|FG001|Overall Study|Non-compliance|8|||
170837122|NCT00203047|617411254|FG000|Overall Study|Protocol Violation|1|||
170837123|NCT00203047|617411255|FG001|Overall Study|Protocol Violation|0|||
170837124|NCT00203047|617411254|FG000|Overall Study|Lost to Follow-up|11|||
170730137|NCT02641392|617016310|FG000|Overall Study|Withdrawal by Subject|0|||
170730138|NCT02641392|617016311|FG001|Overall Study|Withdrawal by Subject|0|||
170730139|NCT02641392|617016312|FG002|Overall Study|Withdrawal by Subject|17|||
170730140|NCT02641392|617016310|FG000|Overall Study|Adverse Event|0|||
170730141|NCT02641392|617016311|FG001|Overall Study|Adverse Event|1|||
170730142|NCT02641392|617016312|FG002|Overall Study|Adverse Event|25|||
170730143|NCT02641392|617016310|FG000|Overall Study|Study Terminated by Sponsor|4|||
170730144|NCT02641392|617016311|FG001|Overall Study|Study Terminated by Sponsor|12|||
170730145|NCT02641392|617016312|FG002|Overall Study|Study Terminated by Sponsor|144|||
170730146|NCT02641392|617016310|FG000|Overall Study|Lack of Efficacy|0|||
170730147|NCT02641392|617016311|FG001|Overall Study|Lack of Efficacy|0|||
170730148|NCT02641392|617016312|FG002|Overall Study|Lack of Efficacy|101|||
170730149|NCT02641392|617016310|FG000|Overall Study|Miscellaneous|0|||
170730150|NCT02641392|617016311|FG001|Overall Study|Miscellaneous|0|||
170730151|NCT02641392|617016312|FG002|Overall Study|Miscellaneous|3|||
170730152|NCT02641392|617016310|FG000|Overall Study|Death|0|||
170730153|NCT02641392|617016311|FG001|Overall Study|Death|0|||
170730154|NCT02641392|617016312|FG002|Overall Study|Death|1|||
170730155|NCT01197508|617016317|FG000|Overall Study|Withdrawal by Subject|8|||
170730156|NCT01197508|617016318|FG001|Overall Study|Withdrawal by Subject|7|||
170730157|NCT01197508|617016319|FG002|Overall Study|Withdrawal by Subject|15|||
170730158|NCT01197508|617016320|FG003|Overall Study|Withdrawal by Subject|4|||
170730159|NCT01197508|617016317|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
170730160|NCT01197508|617016318|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
170730161|NCT01197508|617016319|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
170730162|NCT01197508|617016320|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
170730163|NCT01197508|617016317|FG000|Overall Study|Adverse Event|10|||
170730164|NCT01197508|617016318|FG001|Overall Study|Adverse Event|13|||
170730165|NCT01197508|617016319|FG002|Overall Study|Adverse Event|23|||
170730166|NCT01197508|617016320|FG003|Overall Study|Adverse Event|3|||
170730167|NCT01197508|617016317|FG000|Overall Study|Severe non-compliance to protocol|0|||
170730168|NCT01197508|617016318|FG001|Overall Study|Severe non-compliance to protocol|3|||
170730169|NCT01197508|617016319|FG002|Overall Study|Severe non-compliance to protocol|1|||
170730170|NCT01197508|617016320|FG003|Overall Study|Severe non-compliance to protocol|3|||
170730171|NCT01197508|617016317|FG000|Overall Study|Condition under investigation worsened|1|||
170730172|NCT01197508|617016318|FG001|Overall Study|Condition under investigation worsened|1|||
170730173|NCT01197508|617016319|FG002|Overall Study|Condition under investigation worsened|1|||
170730174|NCT01197508|617016320|FG003|Overall Study|Condition under investigation worsened|1|||
170730175|NCT01197508|617016317|FG000|Overall Study|Lack of Efficacy|1|||
170730176|NCT01197508|617016318|FG001|Overall Study|Lack of Efficacy|2|||
170730177|NCT01197508|617016319|FG002|Overall Study|Lack of Efficacy|2|||
170730178|NCT01197508|617016320|FG003|Overall Study|Lack of Efficacy|1|||
170730179|NCT01197508|617016317|FG000|Overall Study|Study-specific withdrawal criteria|0|||
170730180|NCT01197508|617016318|FG001|Overall Study|Study-specific withdrawal criteria|0|||
170730181|NCT01197508|617016319|FG002|Overall Study|Study-specific withdrawal criteria|1|||
170730182|NCT01197508|617016320|FG003|Overall Study|Study-specific withdrawal criteria|2|||
170730183|NCT01197508|617016317|FG000|Overall Study|Lost to Follow-up|1|||
170730184|NCT01197508|617016318|FG001|Overall Study|Lost to Follow-up|1|||
170730185|NCT01197508|617016319|FG002|Overall Study|Lost to Follow-up|2|||
170730186|NCT01197508|617016320|FG003|Overall Study|Lost to Follow-up|0|||
170730187|NCT01197508|617016317|FG000|Overall Study|Other|2|||
170730188|NCT01197508|617016318|FG001|Overall Study|Other|3|||
170730189|NCT01197508|617016319|FG002|Overall Study|Other|2|||
170730190|NCT01197508|617016320|FG003|Overall Study|Other|2|||
170730191|NCT00266825|617016321|FG000|Completed Follow-Up|Lost to Follow-up|14|||
170730192|NCT00266825|617016322|FG001|Completed Follow-Up|Lost to Follow-up|19|||
170730193|NCT00266825|617016321|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
170730194|NCT00266825|617016322|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
170730195|NCT03466086|617016323|FG000|Period 1|Sponsor decision due to study timeline|1|||
170730196|NCT03466086|617016324|FG001|Period 1|Sponsor decision due to study timeline|0|||
170730197|NCT03466086|617016323|FG000|Period 1|Withdrawal by Subject|1|||
170730198|NCT03466086|617016324|FG001|Period 1|Withdrawal by Subject|0|||
170730199|NCT04385368|617016327|FG000|Overall Study|Death|5|||
170730200|NCT04385368|617016328|FG001|Overall Study|Death|5|||
170730201|NCT04385368|617016327|FG000|Overall Study|Physician Decision|3|||
170730202|NCT04385368|617016328|FG001|Overall Study|Physician Decision|0|||
170730203|NCT04385368|617016327|FG000|Overall Study|Withdrawal by Subject|4|||
170730204|NCT04385368|617016328|FG001|Overall Study|Withdrawal by Subject|3|||
170730205|NCT01256411|617016329|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
170730206|NCT01256411|617016330|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
170730207|NCT01256411|617016331|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
170730208|NCT01256411|617016332|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
170730209|NCT01256411|617016333|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
170730210|NCT01256411|617016334|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
170730211|NCT01256411|617016329|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
170730212|NCT01256411|617016330|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
170730213|NCT01256411|617016331|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
170730214|NCT01256411|617016332|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
170730215|NCT01256411|617016333|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
170730216|NCT01256411|617016334|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
170730217|NCT01256411|617016329|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
170730218|NCT01256411|617016330|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
170730219|NCT01256411|617016331|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
170730220|NCT01256411|617016332|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
170730221|NCT01256411|617016333|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
170730222|NCT01256411|617016334|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
170730223|NCT01256411|617016329|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
170730224|NCT01256411|617016330|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
170730225|NCT01256411|617016331|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
170730226|NCT01256411|617016332|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
170730227|NCT01256411|617016333|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
170730228|NCT01256411|617016334|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
170730229|NCT01256411|617016329|FG000|Extension by Maximum Treatment|Adverse Event|4|||
170730230|NCT01256411|617016330|FG001|Extension by Maximum Treatment|Adverse Event|2|||
170730231|NCT01256411|617016331|FG002|Extension by Maximum Treatment|Adverse Event|1|||
170730232|NCT01256411|617016332|FG003|Extension by Maximum Treatment|Adverse Event|0|||
170730233|NCT01256411|617016333|FG004|Extension by Maximum Treatment|Adverse Event|0|||
170730234|NCT01256411|617016334|FG005|Extension by Maximum Treatment|Adverse Event|0|||
170730235|NCT01256411|617016329|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
170730236|NCT01256411|617016330|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
170730237|NCT01256411|617016331|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
170730238|NCT01256411|617016332|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
170730239|NCT01256411|617016333|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
170730240|NCT01256411|617016334|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
170730241|NCT01256411|617016329|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
170730242|NCT01256411|617016330|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
170730243|NCT01256411|617016331|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
170730244|NCT01256411|617016332|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
170730245|NCT01256411|617016333|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
170730246|NCT01256411|617016334|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
170730247|NCT01256411|617016329|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
170730248|NCT01256411|617016330|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
170730249|NCT01256411|617016331|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
170730250|NCT01256411|617016332|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
170730251|NCT01256411|617016333|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
170730252|NCT01256411|617016334|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
170730253|NCT01256411|617016329|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
170730254|NCT01256411|617016330|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
170730255|NCT01256411|617016331|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
170730256|NCT01256411|617016332|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
170730257|NCT01256411|617016333|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
170730258|NCT01256411|617016334|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
170730259|NCT01256411|617016329|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
170730260|NCT01256411|617016330|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
170730261|NCT01256411|617016331|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
170730262|NCT01256411|617016332|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
170730263|NCT01256411|617016333|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
170730264|NCT01256411|617016334|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
170730265|NCT02123108|617016335|FG000|Overall Study|Death|2|||
170730266|NCT02123108|617016336|FG001|Overall Study|Death|3|||
170730267|NCT00716092|617016340|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
170730268|NCT00716092|617016341|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
170730269|NCT00716092|617016342|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
170730270|NCT02219048|617016343|FG000|Overall Study|Adverse Event|2|||
170730271|NCT02219048|617016344|FG001|Overall Study|Adverse Event|5|||
170730272|NCT02219048|617016343|FG000|Overall Study|No longer meets eligibility criteria|1|||
170730273|NCT02219048|617016344|FG001|Overall Study|No longer meets eligibility criteria|0|||
170730274|NCT02219048|617016343|FG000|Overall Study|Study terminated by sponsor|16|||
170730275|NCT02219048|617016344|FG001|Overall Study|Study terminated by sponsor|15|||
170730276|NCT02219048|617016343|FG000|Overall Study|Withdrawal by Subject|2|||
170730277|NCT02219048|617016344|FG001|Overall Study|Withdrawal by Subject|0|||
170730278|NCT02219048|617016343|FG000|Overall Study|Other|0|||
170730279|NCT02219048|617016344|FG001|Overall Study|Other|1|||
170730280|NCT02436330|617016347|FG000|Cohort 1|Lost to Follow-up|5|||
170730281|NCT02436330|617016348|FG001|Cohort 1|Lost to Follow-up|2|||
170730282|NCT02436330|617016347|FG000|Cohort 1|Withdrawal by Subject|0|||
170730283|NCT02436330|617016348|FG001|Cohort 1|Withdrawal by Subject|1|||
170730284|NCT02436330|617016347|FG000|Cohort 2|Lost to Follow-up|2|||
170730285|NCT02436330|617016348|FG001|Cohort 2|Lost to Follow-up|0|||
170730286|NCT02436330|617016347|FG000|Cohort 2|Withdrawal by Subject|2|||
170730287|NCT02436330|617016348|FG001|Cohort 2|Withdrawal by Subject|3|||
170730288|NCT02436330|617016347|FG000|Cohort 3|Lost to Follow-up|1|||
170730289|NCT02436330|617016348|FG001|Cohort 3|Lost to Follow-up|0|||
170730290|NCT02436330|617016347|FG000|Cohort 3|Withdrawal by Subject|4|||
170730291|NCT02436330|617016348|FG001|Cohort 3|Withdrawal by Subject|0|||
170730292|NCT02436330|617016347|FG000|Cohort 4|Lost to Follow-up|1|||
170730293|NCT02436330|617016348|FG001|Cohort 4|Lost to Follow-up|0|||
170730294|NCT02436330|617016347|FG000|Cohort 4|Withdrawal by Subject|1|||
170730295|NCT02436330|617016348|FG001|Cohort 4|Withdrawal by Subject|0|||
170730296|NCT02436330|617016347|FG000|Cohort 5|Lost to Follow-up|3|||
170730297|NCT02436330|617016348|FG001|Cohort 5|Lost to Follow-up|2|||
170730298|NCT02436330|617016347|FG000|Cohort 5|Withdrawal by Subject|3|||
170730299|NCT02436330|617016348|FG001|Cohort 5|Withdrawal by Subject|2|||
170730300|NCT02436330|617016347|FG000|Cohort 6|Lost to Follow-up|2|||
170730301|NCT02436330|617016348|FG001|Cohort 6|Lost to Follow-up|0|||
170730302|NCT02436330|617016347|FG000|Cohort 6|Withdrawal by Subject|1|||
170730303|NCT02436330|617016348|FG001|Cohort 6|Withdrawal by Subject|1|||
170730304|NCT02403180|617016349|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
170730305|NCT02403180|617016350|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
170730306|NCT02403180|617016349|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
170730307|NCT02403180|617016350|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
170730308|NCT01040260|617016351|FG000|Overall Study|Withdrawal by Subject|12|||
170730309|NCT01040260|617016352|FG001|Overall Study|Withdrawal by Subject|6|||
170730310|NCT01040260|617016351|FG000|Overall Study|Lost to Follow-up|3|||
170730311|NCT01040260|617016352|FG001|Overall Study|Lost to Follow-up|5|||
170730312|NCT01113502|617016354|FG000|Overall Study|Withdrawal by Subject|1|||
170730313|NCT01113502|617016355|FG001|Overall Study|Withdrawal by Subject|0|||
170730314|NCT01113502|617016356|FG002|Overall Study|Withdrawal by Subject|1|||
170730315|NCT01113502|617016357|FG003|Overall Study|Withdrawal by Subject|1|||
170730316|NCT01113502|617016358|FG004|Overall Study|Withdrawal by Subject|0|||
170730317|NCT01113502|617016354|FG000|Overall Study|Adverse Event|0|||
170730318|NCT01113502|617016355|FG001|Overall Study|Adverse Event|0|||
170730319|NCT01113502|617016356|FG002|Overall Study|Adverse Event|3|||
170730320|NCT01113502|617016357|FG003|Overall Study|Adverse Event|2|||
170730321|NCT01113502|617016358|FG004|Overall Study|Adverse Event|0|||
170730322|NCT03002610|617016367|FG000|Overall Study|Withdrawal by Subject|6|||
170730323|NCT03002610|617016368|FG001|Overall Study|Withdrawal by Subject|25|||
170730324|NCT03002610|617016369|FG002|Overall Study|Withdrawal by Subject|13|||
170730325|NCT00929162|617016370|FG000|Overall Study|Adverse Event|8|||
170730326|NCT00929162|617016371|FG001|Overall Study|Adverse Event|5|||
170730327|NCT00929162|617016370|FG000|Overall Study|Withdrawal by Subject|3|||
170730328|NCT00929162|617016371|FG001|Overall Study|Withdrawal by Subject|1|||
170730329|NCT00929162|617016370|FG000|Overall Study|Protocol Violation|32|||
170730330|NCT00929162|617016371|FG001|Overall Study|Protocol Violation|30|||
170730331|NCT00929162|617016370|FG000|Overall Study|Other termination reason|5|||
170730332|NCT00929162|617016371|FG001|Overall Study|Other termination reason|6|||
170730333|NCT03802123|617016372|FG000|Overall Study|Withdrawal by Subject|3|||
170730334|NCT03802123|617016372|FG000|Overall Study|Physician Decision|1|||
170730335|NCT03802123|617016372|FG000|Overall Study|Subject moved to hospice care|1|||
170730336|NCT03802123|617016372|FG000|Overall Study|technician error|1|||
170730337|NCT03802123|617016372|FG000|Overall Study|Death|3|||
170730338|NCT01822587|617016373|FG000|Overall Study|Lost to Follow-up|7|||
170730339|NCT01822587|617016374|FG001|Overall Study|Lost to Follow-up|9|||
170730340|NCT01822587|617016375|FG002|Overall Study|Lost to Follow-up|12|||
170730341|NCT01822587|617016373|FG000|Overall Study|Physician Decision|9|||
170730342|NCT01822587|617016374|FG001|Overall Study|Physician Decision|6|||
170730343|NCT01822587|617016375|FG002|Overall Study|Physician Decision|6|||
170730344|NCT01274182|617016376|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
170730345|NCT01274182|617016377|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170730346|NCT01274182|617016378|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
170730347|NCT01274182|617016376|FG000|Overall Study|Adverse Event|4|||
170730348|NCT01274182|617016377|FG001|Overall Study|Adverse Event|5|||
170730349|NCT01274182|617016378|FG002|Overall Study|Adverse Event|3|||
170730350|NCT01274182|617016376|FG000|Overall Study|Withdrawal by Subject|5|||
170730351|NCT01274182|617016377|FG001|Overall Study|Withdrawal by Subject|5|||
170730352|NCT01274182|617016378|FG002|Overall Study|Withdrawal by Subject|3|||
170730353|NCT01274182|617016376|FG000|Overall Study|Lost to Follow-up|2|||
170730354|NCT01274182|617016377|FG001|Overall Study|Lost to Follow-up|3|||
170730355|NCT01274182|617016378|FG002|Overall Study|Lost to Follow-up|1|||
170730356|NCT01274182|617016376|FG000|Overall Study|Protocol Violation|3|||
170730357|NCT01274182|617016377|FG001|Overall Study|Protocol Violation|2|||
170730358|NCT01274182|617016378|FG002|Overall Study|Protocol Violation|0|||
170730359|NCT01274182|617016376|FG000|Overall Study|Death|1|||
170730360|NCT01274182|617016377|FG001|Overall Study|Death|0|||
170730361|NCT01274182|617016378|FG002|Overall Study|Death|1|||
170730362|NCT01970982|617016379|FG000|Overall Study|Withdrawal by Subject|0|||
170730363|NCT01970982|617016380|FG001|Overall Study|Withdrawal by Subject|0|||
170730364|NCT01970982|617016381|FG002|Overall Study|Withdrawal by Subject|2|||
170730365|NCT00708916|617016385|FG000|Overall Study|Subject Noncompliance|2|||
170730366|NCT00708916|617016385|FG000|Overall Study|Adverse Event|2|||
170730367|NCT02454101|617016388|FG000|Overall Study|Adverse Event|2|||
170730368|NCT02454101|617016389|FG001|Overall Study|Adverse Event|3|||
170730369|NCT02454101|617016388|FG000|Overall Study|Lost to Follow-up|3|||
170730370|NCT02454101|617016389|FG001|Overall Study|Lost to Follow-up|4|||
170730371|NCT00419263|617016390|FG000|Overall Study|Lost to Follow-up|2|||
170730372|NCT00419263|617016391|FG001|Overall Study|Lost to Follow-up|1|||
170730373|NCT00419263|617016392|FG002|Overall Study|Lost to Follow-up|1|||
170730374|NCT00419263|617016390|FG000|Overall Study|Randomized in Error, Not Treated|1|||
170730375|NCT00419263|617016391|FG001|Overall Study|Randomized in Error, Not Treated|1|||
170730376|NCT00419263|617016392|FG002|Overall Study|Randomized in Error, Not Treated|0|||
170730377|NCT00419263|617016390|FG000|Overall Study|Adverse Event|0|||
170730378|NCT00419263|617016391|FG001|Overall Study|Adverse Event|0|||
170730379|NCT00419263|617016392|FG002|Overall Study|Adverse Event|1|||
170730380|NCT00419263|617016390|FG000|Overall Study|Withdrawal by Subject|0|||
170730381|NCT00419263|617016391|FG001|Overall Study|Withdrawal by Subject|0|||
170730382|NCT00419263|617016392|FG002|Overall Study|Withdrawal by Subject|1|||
170730383|NCT00862134|617016396|FG000|Overall Study|Death|1|||
170730384|NCT00862134|617016397|FG001|Overall Study|Death|0|||
170730385|NCT00862134|617016396|FG000|Overall Study|Physician Decision|0|||
170730386|NCT00862134|617016397|FG001|Overall Study|Physician Decision|1|||
170730387|NCT00862134|617016396|FG000|Overall Study|Withdrawal by Subject|1|||
170730388|NCT00862134|617016397|FG001|Overall Study|Withdrawal by Subject|2|||
170730389|NCT00862134|617016396|FG000|Overall Study|Sponsor terminated study|5|||
170730390|NCT00862134|617016397|FG001|Overall Study|Sponsor terminated study|7|||
170730391|NCT00862134|617016396|FG000|Overall Study|Adverse Event|2|||
170730392|NCT00862134|617016397|FG001|Overall Study|Adverse Event|2|||
170730393|NCT00862134|617016396|FG000|Overall Study|Withdrew prior to dosing|2|||
170730394|NCT00862134|617016397|FG001|Overall Study|Withdrew prior to dosing|0|||
170730395|NCT00765674|617016398|FG000|Overall Study|Adverse Event|7|||
170730396|NCT00765674|617016399|FG001|Overall Study|Adverse Event|2|||
170730397|NCT00765674|617016400|FG002|Overall Study|Adverse Event|8|||
170730398|NCT00765674|617016401|FG003|Overall Study|Adverse Event|11|||
170730399|NCT00765674|617016398|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
170730400|NCT00765674|617016399|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
170730401|NCT00765674|617016400|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
170730402|NCT00765674|617016401|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
170730403|NCT00765674|617016398|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
170730404|NCT00765674|617016399|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
170837125|NCT00203047|617411255|FG001|Overall Study|Lost to Follow-up|5|||
170837126|NCT00203047|617411254|FG000|Overall Study|Adverse Event|8|||
170837127|NCT00203047|617411255|FG001|Overall Study|Adverse Event|18|||
170837128|NCT00203047|617411254|FG000|Overall Study|Death|1|||
170837129|NCT00203047|617411255|FG001|Overall Study|Death|2|||
170837130|NCT00203047|617411254|FG000|Overall Study|Pregnancy|3|||
170837131|NCT00203047|617411255|FG001|Overall Study|Pregnancy|0|||
170837132|NCT00203047|617411254|FG000|Overall Study|Other|5|||
170837133|NCT00203047|617411255|FG001|Overall Study|Other|5|||
170837134|NCT02229227|617411256|FG000|Overall Study|Adverse Event|14|||
170837135|NCT02229227|617411257|FG001|Overall Study|Adverse Event|9|||
170837136|NCT02229227|617411256|FG000|Overall Study|Lack of Efficacy|3|||
170837137|NCT02229227|617411257|FG001|Overall Study|Lack of Efficacy|3|||
170837138|NCT02229227|617411256|FG000|Overall Study|Protocol Violation|6|||
170837139|NCT02229227|617411257|FG001|Overall Study|Protocol Violation|8|||
170837140|NCT02229227|617411256|FG000|Overall Study|Protocol defined stopping criteria|1|||
170837141|NCT02229227|617411257|FG001|Overall Study|Protocol defined stopping criteria|3|||
170837142|NCT02229227|617411256|FG000|Overall Study|Lost to Follow-up|3|||
170837143|NCT02229227|617411257|FG001|Overall Study|Lost to Follow-up|3|||
170837144|NCT02229227|617411256|FG000|Overall Study|Study terminated by sponsor|11|||
170837145|NCT02229227|617411257|FG001|Overall Study|Study terminated by sponsor|11|||
170837146|NCT02229227|617411256|FG000|Overall Study|Withdrawal by Subject|8|||
170837147|NCT02229227|617411257|FG001|Overall Study|Withdrawal by Subject|12|||
170837148|NCT02229227|617411256|FG000|Overall Study|Other|0|||
170837149|NCT02229227|617411257|FG001|Overall Study|Other|1|||
170837150|NCT02229227|617411256|FG000|Overall Study|Physician Decision|5|||
170837151|NCT02229227|617411257|FG001|Overall Study|Physician Decision|12|||
170837152|NCT00340704|617411258|FG000|PK Study|Adverse Event|0|||
170837153|NCT00340704|617411259|FG001|PK Study|Adverse Event|1|||
170837154|NCT00340704|617411260|FG002|PK Study|Adverse Event|0|||
170837155|NCT00340704|617411261|FG003|PK Study|Adverse Event|0|||
170837156|NCT00340704|617411262|FG004|PK Study|Adverse Event|0|||
170837157|NCT00340704|617411263|FG005|PK Study|Adverse Event|0|||
170837158|NCT00340704|617411264|FG006|PK Study|Adverse Event|0|||
170837159|NCT00340704|617411265|FG007|PK Study|Adverse Event|0|||
170837160|NCT00340704|617411266|FG008|PK Study|Adverse Event|0|||
170837161|NCT00340704|617411258|FG000|PK Study|Not treated|0|||
170837162|NCT00340704|617411259|FG001|PK Study|Not treated|0|||
170837163|NCT00340704|617411260|FG002|PK Study|Not treated|1|||
170837164|NCT00340704|617411261|FG003|PK Study|Not treated|0|||
170837165|NCT00340704|617411262|FG004|PK Study|Not treated|0|||
170837166|NCT00340704|617411263|FG005|PK Study|Not treated|0|||
170837167|NCT00340704|617411264|FG006|PK Study|Not treated|0|||
170837168|NCT00340704|617411265|FG007|PK Study|Not treated|0|||
170837169|NCT00340704|617411266|FG008|PK Study|Not treated|0|||
170837170|NCT00340704|617411258|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
170837171|NCT00340704|617411259|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
170837172|NCT00340704|617411260|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
170837173|NCT00340704|617411261|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
170837174|NCT00340704|617411262|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
170837175|NCT00340704|617411263|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
170837176|NCT00340704|617411264|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
170837177|NCT00340704|617411265|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
170837178|NCT00340704|617411266|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
170837179|NCT00340704|617411258|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
170837180|NCT00340704|617411259|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
170837181|NCT00340704|617411260|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
170837182|NCT00340704|617411261|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
170837183|NCT00340704|617411262|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
170837184|NCT00340704|617411263|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
170837185|NCT00340704|617411264|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
170837186|NCT00340704|617411265|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
170837187|NCT00340704|617411266|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
170837188|NCT00340704|617411258|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
170837189|NCT00340704|617411259|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
170837190|NCT00340704|617411260|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
170837191|NCT00340704|617411261|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
170837192|NCT00340704|617411262|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
170837193|NCT00340704|617411263|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
170837194|NCT00340704|617411264|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
170837195|NCT00340704|617411265|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
170837196|NCT00340704|617411266|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
170837197|NCT00340704|617411258|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
170837198|NCT00340704|617411259|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
170837199|NCT00340704|617411260|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
170837200|NCT00340704|617411261|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
170837201|NCT00340704|617411262|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
170837202|NCT00340704|617411263|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
170837203|NCT00340704|617411264|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
170837204|NCT00340704|617411265|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
170837205|NCT00340704|617411266|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
170837206|NCT01732549|617411267|FG000|Overall Study|Adverse Event|13|||
170837207|NCT01732549|617411268|FG001|Overall Study|Adverse Event|3|||
170837208|NCT01732549|617411267|FG000|Overall Study|Consent withdrawn|13|||
170837209|NCT01732549|617411268|FG001|Overall Study|Consent withdrawn|6|||
170837210|NCT01732549|617411267|FG000|Overall Study|Disease progression|37|||
170837211|NCT01732549|617411268|FG001|Overall Study|Disease progression|50|||
170837212|NCT01732549|617411267|FG000|Overall Study|Other|8|||
170837213|NCT01732549|617411268|FG001|Overall Study|Other|14|||
170837214|NCT00121667|617411269|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
170837215|NCT00121667|617411270|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
170837216|NCT00121667|617411271|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
170837217|NCT00121667|617411272|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
170837218|NCT00121667|617411269|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
170837219|NCT00121667|617411270|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
170837220|NCT00121667|617411271|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
170837221|NCT00121667|617411272|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
170837222|NCT00121667|617411269|FG000|Short Term (ST) Period|Adverse Event|5|||
170837223|NCT00121667|617411270|FG001|Short Term (ST) Period|Adverse Event|6|||
170837224|NCT00121667|617411271|FG002|Short Term (ST) Period|Adverse Event|5|||
170837225|NCT00121667|617411272|FG003|Short Term (ST) Period|Adverse Event|3|||
170837226|NCT00121667|617411269|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
170837227|NCT00121667|617411270|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
170837228|NCT00121667|617411271|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
170837229|NCT00121667|617411272|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
170837230|NCT00121667|617411269|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
170837231|NCT00121667|617411270|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
170837232|NCT00121667|617411271|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
170837233|NCT00121667|617411272|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
170837234|NCT00121667|617411269|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
170837235|NCT00121667|617411270|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
170837236|NCT00121667|617411271|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
170837237|NCT00121667|617411272|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
170837238|NCT00121667|617411269|FG000|Short Term (ST) Period|Other Reason|3|||
170837239|NCT00121667|617411270|FG001|Short Term (ST) Period|Other Reason|0|||
170837240|NCT00121667|617411271|FG002|Short Term (ST) Period|Other Reason|0|||
170837241|NCT00121667|617411272|FG003|Short Term (ST) Period|Other Reason|0|||
170837242|NCT00121667|617411269|FG000|Short Term (ST) Period|Death|0|||
170837243|NCT00121667|617411270|FG001|Short Term (ST) Period|Death|0|||
170837244|NCT00121667|617411271|FG002|Short Term (ST) Period|Death|0|||
170837245|NCT00121667|617411272|FG003|Short Term (ST) Period|Death|1|||
170837246|NCT00121667|617411269|FG000|Short Term (ST) Period|Pregnancy|0|||
170837247|NCT00121667|617411270|FG001|Short Term (ST) Period|Pregnancy|0|||
170837248|NCT00121667|617411271|FG002|Short Term (ST) Period|Pregnancy|0|||
170837249|NCT00121667|617411272|FG003|Short Term (ST) Period|Pregnancy|1|||
170837250|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
170837251|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
170837252|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
170837253|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
170837254|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
170837255|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
170837256|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
170837257|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
170837258|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
170837259|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
170837260|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
170837261|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
170837262|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
170837263|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
170837264|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
170837265|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
170837266|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
170837267|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
170837268|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
170837269|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
170837270|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
170837271|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
170837272|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
170837273|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
170837274|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
170837275|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
170837276|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
170837277|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
170837278|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
170837279|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
170837280|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
170837281|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
170837282|NCT00121667|617411269|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
170837283|NCT00121667|617411270|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
170837284|NCT00121667|617411271|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
170837285|NCT00121667|617411272|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
170837286|NCT01453023|617411273|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
170837287|NCT01453023|617411274|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
170837288|NCT01453023|617411273|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
170837289|NCT01453023|617411274|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
170837290|NCT01453023|617411273|FG000|Treatment Period 2|Protocol Violation|0|||
170837291|NCT01453023|617411274|FG001|Treatment Period 2|Protocol Violation|1|||
170837292|NCT04468230|617411276|FG000|Overall Study|Adverse Event|2|||
170837293|NCT03994731|617411277|FG000|Pegloticase + IMM Period|Death|2|||
170837294|NCT03994731|617411278|FG001|Pegloticase + IMM Period|Death|0|||
170837295|NCT03994731|617411277|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
170837296|NCT03994731|617411278|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
170837297|NCT03994731|617411277|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
170837298|NCT03994731|617411278|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
170837299|NCT03934099|617411281|FG000|Overall Study|Adverse Event|0|||
170837300|NCT03934099|617411282|FG001|Overall Study|Adverse Event|3|||
170837301|NCT03934099|617411283|FG002|Overall Study|Adverse Event|1|||
170837302|NCT03934099|617411284|FG003|Overall Study|Adverse Event|0|||
170837303|NCT03934099|617411281|FG000|Overall Study|Lost to Follow-up|1|||
170837304|NCT03934099|617411282|FG001|Overall Study|Lost to Follow-up|2|||
170837305|NCT03934099|617411283|FG002|Overall Study|Lost to Follow-up|1|||
170837306|NCT03934099|617411284|FG003|Overall Study|Lost to Follow-up|1|||
170837307|NCT03934099|617411281|FG000|Overall Study|Protocol Violation|1|||
170837308|NCT03934099|617411282|FG001|Overall Study|Protocol Violation|0|||
170837309|NCT03934099|617411283|FG002|Overall Study|Protocol Violation|0|||
170837310|NCT03934099|617411284|FG003|Overall Study|Protocol Violation|0|||
170837311|NCT03934099|617411281|FG000|Overall Study|Withdrawal by Subject|2|||
170837312|NCT03934099|617411282|FG001|Overall Study|Withdrawal by Subject|0|||
170837313|NCT03934099|617411283|FG002|Overall Study|Withdrawal by Subject|1|||
170837314|NCT03934099|617411284|FG003|Overall Study|Withdrawal by Subject|1|||
170837315|NCT03934099|617411281|FG000|Overall Study|Other reasons|0|||
170837316|NCT03934099|617411282|FG001|Overall Study|Other reasons|1|||
170837317|NCT03934099|617411283|FG002|Overall Study|Other reasons|0|||
170837318|NCT03934099|617411284|FG003|Overall Study|Other reasons|0|||
170837319|NCT03569891|617411289|FG000|Lead-in|Ineligible during lead-in|8|||
170837320|NCT03569891|617411289|FG000|Lead-in|Withdrawal by Subject|3|||
170837321|NCT03569891|617411289|FG000|Lead-in|Risks related to COVID-19|2|||
170837322|NCT03569891|617411289|FG000|AMT-061|Adverse Event|1|||
170837323|NCT03170518|617411290|FG000|Overall Study|Lost to Follow-up|4|||
170837324|NCT03170518|617411291|FG001|Overall Study|Lost to Follow-up|1|||
170837325|NCT03170518|617411292|FG002|Overall Study|Lost to Follow-up|0|||
170837326|NCT03170518|617411290|FG000|Overall Study|Physician Decision|1|||
170837327|NCT03170518|617411291|FG001|Overall Study|Physician Decision|0|||
170837328|NCT03170518|617411292|FG002|Overall Study|Physician Decision|0|||
170837329|NCT03170518|617411290|FG000|Overall Study|Withdrawal by Subject|4|||
170837330|NCT03170518|617411291|FG001|Overall Study|Withdrawal by Subject|5|||
170837331|NCT03170518|617411292|FG002|Overall Study|Withdrawal by Subject|2|||
170837332|NCT03170518|617411290|FG000|Overall Study|Site terminated by sponsor|0|||
170837333|NCT03170518|617411291|FG001|Overall Study|Site terminated by sponsor|1|||
170837334|NCT03170518|617411292|FG002|Overall Study|Site terminated by sponsor|0|||
170837335|NCT03170518|617411290|FG000|Overall Study|Non-compliance with study drug|1|||
170837336|NCT03170518|617411291|FG001|Overall Study|Non-compliance with study drug|0|||
170837337|NCT03170518|617411292|FG002|Overall Study|Non-compliance with study drug|1|||
170837338|NCT03170518|617411290|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170837339|NCT03170518|617411291|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170837340|NCT03170518|617411292|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170837341|NCT01948076|617411293|FG000|Overall Study|Withdrawal by Subject|0|||
170837342|NCT01948076|617411294|FG001|Overall Study|Withdrawal by Subject|1|||
170837343|NCT03725605|617411295|FG000|Overall Study|Unsuccessful TIL expansion|2|||
170837344|NCT01503086|617411296|FG000|Overall Study|Lost to Follow-up|0|||
170837345|NCT01503086|617411297|FG001|Overall Study|Lost to Follow-up|1|||
170837346|NCT01503086|617411298|FG002|Overall Study|Lost to Follow-up|0|||
170837347|NCT01503086|617411296|FG000|Overall Study|Did Not Start Treatment|4|||
170837348|NCT01503086|617411297|FG001|Overall Study|Did Not Start Treatment|3|||
170837349|NCT01503086|617411298|FG002|Overall Study|Did Not Start Treatment|3|||
170837350|NCT01503086|617411296|FG000|Overall Study|Progressive disease|3|||
170837351|NCT01503086|617411297|FG001|Overall Study|Progressive disease|1|||
170837352|NCT01503086|617411298|FG002|Overall Study|Progressive disease|0|||
170837353|NCT01503086|617411296|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
170837354|NCT01503086|617411297|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
170837355|NCT01503086|617411298|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
170837356|NCT01503086|617411296|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
170837357|NCT01503086|617411297|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
170837358|NCT01503086|617411298|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
170837359|NCT04886518|617411305|FG000|Overall Study|Noncompliance with study drug|1|||
170837360|NCT04886518|617411306|FG001|Overall Study|Noncompliance with study drug|0|||
170837361|NCT04886518|617411307|FG002|Overall Study|Noncompliance with study drug|0|||
170837362|NCT04886518|617411305|FG000|Overall Study|Adverse Event|0|||
170837363|NCT04886518|617411306|FG001|Overall Study|Adverse Event|1|||
170837364|NCT04886518|617411307|FG002|Overall Study|Adverse Event|0|||
170837365|NCT04886518|617411305|FG000|Overall Study|Withdrawal by Subject|1|||
170837366|NCT04886518|617411306|FG001|Overall Study|Withdrawal by Subject|0|||
170837367|NCT04886518|617411307|FG002|Overall Study|Withdrawal by Subject|0|||
170837368|NCT03778294|617412612|FG000|Overall Study|Death|1|||
170837369|NCT03778294|617412612|FG000|Overall Study|Issues with insurance|1|||
170837370|NCT03778294|617412612|FG000|Overall Study|disease progression before treatment|2|||
170837371|NCT02113124|617412615|FG000|Overall Study|Unable to retrieve blood sample|1|||
170837372|NCT02113124|617412616|FG001|Overall Study|Unable to retrieve blood sample|1|||
170837373|NCT02980042|617412617|FG000|Overall Study|Lost to Follow-up|5|||
170837374|NCT02980042|617412618|FG001|Overall Study|Lost to Follow-up|0|||
170837375|NCT02980042|617412617|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
170837376|NCT02980042|617412618|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
170837377|NCT01784523|617412621|FG000|Overall Study|Study closed early|7|||
170837378|NCT01784523|617412622|FG001|Overall Study|Study closed early|4|||
170837379|NCT02179177|617412623|FG000|Overall Study|Lost to Follow-up|1|||
170837380|NCT02179177|617412624|FG001|Overall Study|Lost to Follow-up|1|||
170837381|NCT02179177|617412623|FG000|Overall Study|Withdrawal by Subject|1|||
170837382|NCT02179177|617412624|FG001|Overall Study|Withdrawal by Subject|1|||
170837383|NCT04698915|617412629|FG000|Overall Study|Adverse Event|2|||
170837384|NCT04698915|617412630|FG001|Overall Study|Adverse Event|0|||
170837385|NCT04698915|617412629|FG000|Overall Study|Death|23|||
170837386|NCT04698915|617412630|FG001|Overall Study|Death|20|||
170837387|NCT04698915|617412629|FG000|Overall Study|Physician Decision|1|||
170837388|NCT04698915|617412630|FG001|Overall Study|Physician Decision|1|||
170837389|NCT04698915|617412629|FG000|Overall Study|Lost to Follow-up|1|||
170837390|NCT04698915|617412630|FG001|Overall Study|Lost to Follow-up|0|||
170837391|NCT04698915|617412629|FG000|Overall Study|Study Terminated by Sponsor|55|||
170837392|NCT04698915|617412630|FG001|Overall Study|Study Terminated by Sponsor|60|||
170837393|NCT04698915|617412629|FG000|Overall Study|Withdrawal by Subject|2|||
170837394|NCT04698915|617412630|FG001|Overall Study|Withdrawal by Subject|3|||
170837395|NCT01907906|617412633|FG000|Overall Study|Withdrawal by Subject|1|||
170837396|NCT01907906|617412634|FG001|Overall Study|Withdrawal by Subject|0|||
170837397|NCT01907906|617412633|FG000|Overall Study|Physician Decision|3|||
170837398|NCT01907906|617412634|FG001|Overall Study|Physician Decision|1|||
170837399|NCT01124097|617412637|FG000|Overall Study|Withdrawal by Subject|4|||
170837400|NCT01124097|617412638|FG001|Overall Study|Withdrawal by Subject|3|||
170837401|NCT01124097|617412639|FG002|Overall Study|Withdrawal by Subject|2|||
170837402|NCT01124097|617412640|FG003|Overall Study|Withdrawal by Subject|3|||
170837403|NCT01124097|617412637|FG000|Overall Study|Lack of Efficacy|2|||
170837404|NCT01124097|617412638|FG001|Overall Study|Lack of Efficacy|3|||
170837405|NCT01124097|617412639|FG002|Overall Study|Lack of Efficacy|1|||
170837406|NCT01124097|617412640|FG003|Overall Study|Lack of Efficacy|3|||
170730405|NCT00765674|617016400|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
170730406|NCT00765674|617016401|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
170730407|NCT00765674|617016398|FG000|Overall Study|Lack of Efficacy|2|||
170730408|NCT00765674|617016399|FG001|Overall Study|Lack of Efficacy|3|||
170730409|NCT00765674|617016400|FG002|Overall Study|Lack of Efficacy|1|||
170730410|NCT00765674|617016401|FG003|Overall Study|Lack of Efficacy|2|||
170730411|NCT00765674|617016398|FG000|Overall Study|Protocol Violation|2|||
170730412|NCT00765674|617016399|FG001|Overall Study|Protocol Violation|0|||
170730413|NCT00765674|617016400|FG002|Overall Study|Protocol Violation|1|||
170730414|NCT00765674|617016401|FG003|Overall Study|Protocol Violation|0|||
170730415|NCT00765674|617016398|FG000|Overall Study|Withdrawal by Subject|5|||
170730416|NCT00765674|617016399|FG001|Overall Study|Withdrawal by Subject|7|||
170730417|NCT00765674|617016400|FG002|Overall Study|Withdrawal by Subject|3|||
170730418|NCT00765674|617016401|FG003|Overall Study|Withdrawal by Subject|8|||
170730419|NCT00765674|617016398|FG000|Overall Study|Lost to Follow-up|4|||
170730420|NCT00765674|617016399|FG001|Overall Study|Lost to Follow-up|6|||
170730421|NCT00765674|617016400|FG002|Overall Study|Lost to Follow-up|2|||
170730422|NCT00765674|617016401|FG003|Overall Study|Lost to Follow-up|1|||
170730423|NCT00765674|617016398|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
170730424|NCT00765674|617016399|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
170730425|NCT00765674|617016400|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
170730426|NCT00765674|617016401|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
170730427|NCT03015402|617016402|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
170730428|NCT03015402|617016403|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
170730429|NCT03015402|617016402|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
170730430|NCT03015402|617016403|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
170730431|NCT00316082|617016409|FG000|Overall Study|Lack of Efficacy|2|||
170730432|NCT00316082|617016410|FG001|Overall Study|Lack of Efficacy|3|||
170730433|NCT00316082|617016411|FG002|Overall Study|Lack of Efficacy|3|||
170730434|NCT00316082|617016412|FG003|Overall Study|Lack of Efficacy|4|||
170730435|NCT00316082|617016413|FG004|Overall Study|Lack of Efficacy|6|||
170730436|NCT00316082|617016409|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
170730437|NCT00316082|617016410|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
170730438|NCT00316082|617016411|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
170730439|NCT00316082|617016412|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
170730440|NCT00316082|617016413|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
170730441|NCT00316082|617016409|FG000|Overall Study|Lost to Follow-up|7|||
170730442|NCT00316082|617016410|FG001|Overall Study|Lost to Follow-up|6|||
170730443|NCT00316082|617016411|FG002|Overall Study|Lost to Follow-up|7|||
170730444|NCT00316082|617016412|FG003|Overall Study|Lost to Follow-up|8|||
170730445|NCT00316082|617016413|FG004|Overall Study|Lost to Follow-up|6|||
170730446|NCT00316082|617016409|FG000|Overall Study|Poor/noncompliance|6|||
170730447|NCT00316082|617016410|FG001|Overall Study|Poor/noncompliance|1|||
170730448|NCT00316082|617016411|FG002|Overall Study|Poor/noncompliance|4|||
170730449|NCT00316082|617016412|FG003|Overall Study|Poor/noncompliance|1|||
170730450|NCT00316082|617016413|FG004|Overall Study|Poor/noncompliance|4|||
170730451|NCT00316082|617016409|FG000|Overall Study|Adverse Event|4|||
170730452|NCT00316082|617016410|FG001|Overall Study|Adverse Event|2|||
170730453|NCT00316082|617016411|FG002|Overall Study|Adverse Event|5|||
170730454|NCT00316082|617016412|FG003|Overall Study|Adverse Event|1|||
170730455|NCT00316082|617016413|FG004|Overall Study|Adverse Event|3|||
170730456|NCT00316082|617016409|FG000|Overall Study|Subject no longer meets study criteria|3|||
170730457|NCT00316082|617016410|FG001|Overall Study|Subject no longer meets study criteria|1|||
170730458|NCT00316082|617016411|FG002|Overall Study|Subject no longer meets study criteria|2|||
170730459|NCT00316082|617016412|FG003|Overall Study|Subject no longer meets study criteria|2|||
170730460|NCT00316082|617016413|FG004|Overall Study|Subject no longer meets study criteria|1|||
170730461|NCT00316082|617016409|FG000|Overall Study|Physician Decision|1|||
170730462|NCT00316082|617016410|FG001|Overall Study|Physician Decision|1|||
170730463|NCT00316082|617016411|FG002|Overall Study|Physician Decision|2|||
170730464|NCT00316082|617016412|FG003|Overall Study|Physician Decision|1|||
170730465|NCT00316082|617016413|FG004|Overall Study|Physician Decision|1|||
170730466|NCT00316082|617016409|FG000|Overall Study|Death|0|||
170730467|NCT00316082|617016410|FG001|Overall Study|Death|0|||
170730468|NCT00316082|617016411|FG002|Overall Study|Death|1|||
170730469|NCT00316082|617016412|FG003|Overall Study|Death|0|||
170730470|NCT00316082|617016413|FG004|Overall Study|Death|0|||
170730471|NCT00316082|617016409|FG000|Overall Study|Administrative reason by sponsor|0|||
170730472|NCT00316082|617016410|FG001|Overall Study|Administrative reason by sponsor|0|||
170730473|NCT00316082|617016411|FG002|Overall Study|Administrative reason by sponsor|1|||
170837407|NCT01124097|617412637|FG000|Overall Study|Adverse Event|24|||
170730474|NCT00316082|617016412|FG003|Overall Study|Administrative reason by sponsor|0|||
170730475|NCT00316082|617016413|FG004|Overall Study|Administrative reason by sponsor|0|||
170730476|NCT00528775|617016416|FG000|Overall Study|Other not specified|1|||
170837408|NCT01124097|617412638|FG001|Overall Study|Adverse Event|15|||
170837409|NCT01124097|617412639|FG002|Overall Study|Adverse Event|15|||
170837410|NCT01124097|617412640|FG003|Overall Study|Adverse Event|7|||
170837411|NCT01124097|617412637|FG000|Overall Study|Protocol Violation|2|||
170837412|NCT01124097|617412638|FG001|Overall Study|Protocol Violation|0|||
170837413|NCT01124097|617412639|FG002|Overall Study|Protocol Violation|2|||
170837414|NCT01124097|617412640|FG003|Overall Study|Protocol Violation|1|||
170837415|NCT01124097|617412637|FG000|Overall Study|Physician Decision|2|||
170837416|NCT01124097|617412638|FG001|Overall Study|Physician Decision|1|||
170837417|NCT01124097|617412639|FG002|Overall Study|Physician Decision|0|||
170837418|NCT01124097|617412640|FG003|Overall Study|Physician Decision|0|||
170837419|NCT05687032|617412641|FG000|Treatment Phase|Adverse Event|13|||
170837420|NCT05687032|617412641|FG000|Treatment Phase|Death|1|||
170837421|NCT05687032|617412641|FG000|Treatment Phase|Physician Decision|3|||
170837422|NCT05687032|617412641|FG000|Treatment Phase|Progressive disease|9|||
170837423|NCT05687032|617412641|FG000|Treatment Phase|Withdrawal by Subject|5|||
170837424|NCT05687032|617412641|FG000|Follow-Up Phase|Death|16|||
170837425|NCT05687032|617412641|FG000|Follow-Up Phase|Ongoing|26|||
170837426|NCT04334278|617412642|FG000|Overall Study|Lost to Follow-up|0|||
170837427|NCT04334278|617412643|FG001|Overall Study|Lost to Follow-up|3|||
170837428|NCT04334278|617412642|FG000|Overall Study|Withdrawal by Subject|4|||
170837429|NCT04334278|617412643|FG001|Overall Study|Withdrawal by Subject|2|||
170837430|NCT04829747|617412644|FG000|Overall Study|Protocol Violation|1|||
170837431|NCT01516749|617412649|FG000|Active Therapy|Lost to Follow-up|1|||
170837432|NCT01516749|617412649|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
170837433|NCT00447590|617412660|FG000|Overall Study|Withdrawal by Subject|26|||
170837434|NCT00447590|617412660|FG000|Overall Study|Lost to Follow-up|24|||
170837435|NCT00447590|617412660|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
170837436|NCT03377361|617412663|FG000|Pre-Treatment|Subject withdrew consent|0|||
170837437|NCT03377361|617412664|FG001|Pre-Treatment|Subject withdrew consent|0|||
170837438|NCT03377361|617412665|FG002|Pre-Treatment|Subject withdrew consent|0|||
170837439|NCT03377361|617412666|FG003|Pre-Treatment|Subject withdrew consent|0|||
170837440|NCT03377361|617412667|FG004|Pre-Treatment|Subject withdrew consent|0|||
170837441|NCT03377361|617412668|FG005|Pre-Treatment|Subject withdrew consent|0|||
170837442|NCT03377361|617412669|FG006|Pre-Treatment|Subject withdrew consent|0|||
170837443|NCT03377361|617412670|FG007|Pre-Treatment|Subject withdrew consent|3|||
170837444|NCT03377361|617412671|FG008|Pre-Treatment|Subject withdrew consent|1|||
170837445|NCT03377361|617412672|FG009|Pre-Treatment|Subject withdrew consent|0|||
170837446|NCT03377361|617412663|FG000|Pre-Treatment|Not Reported|0|||
170837447|NCT03377361|617412664|FG001|Pre-Treatment|Not Reported|0|||
170837448|NCT03377361|617412665|FG002|Pre-Treatment|Not Reported|0|||
170837449|NCT03377361|617412666|FG003|Pre-Treatment|Not Reported|0|||
170837450|NCT03377361|617412667|FG004|Pre-Treatment|Not Reported|0|||
170837451|NCT03377361|617412668|FG005|Pre-Treatment|Not Reported|0|||
170837452|NCT03377361|617412669|FG006|Pre-Treatment|Not Reported|0|||
170837453|NCT03377361|617412670|FG007|Pre-Treatment|Not Reported|0|||
170837454|NCT03377361|617412671|FG008|Pre-Treatment|Not Reported|3|||
170837455|NCT03377361|617412672|FG009|Pre-Treatment|Not Reported|0|||
170837456|NCT03377361|617412663|FG000|Treatment Period|Disease Progression|3|||
170837457|NCT03377361|617412664|FG001|Treatment Period|Disease Progression|2|||
170837458|NCT03377361|617412665|FG002|Treatment Period|Disease Progression|5|||
170837459|NCT03377361|617412666|FG003|Treatment Period|Disease Progression|3|||
170837460|NCT03377361|617412667|FG004|Treatment Period|Disease Progression|3|||
170837461|NCT03377361|617412668|FG005|Treatment Period|Disease Progression|3|||
170837462|NCT03377361|617412669|FG006|Treatment Period|Disease Progression|6|||
170837463|NCT03377361|617412670|FG007|Treatment Period|Disease Progression|106|||
170837464|NCT03377361|617412671|FG008|Treatment Period|Disease Progression|48|||
170837465|NCT03377361|617412672|FG009|Treatment Period|Disease Progression|59|||
170837466|NCT03377361|617412663|FG000|Treatment Period|Study Drug Toxicity|0|||
170837467|NCT03377361|617412664|FG001|Treatment Period|Study Drug Toxicity|0|||
170837468|NCT03377361|617412665|FG002|Treatment Period|Study Drug Toxicity|0|||
170837469|NCT03377361|617412666|FG003|Treatment Period|Study Drug Toxicity|1|||
170837470|NCT03377361|617412667|FG004|Treatment Period|Study Drug Toxicity|0|||
170837471|NCT03377361|617412668|FG005|Treatment Period|Study Drug Toxicity|0|||
170837472|NCT03377361|617412669|FG006|Treatment Period|Study Drug Toxicity|0|||
170837473|NCT03377361|617412670|FG007|Treatment Period|Study Drug Toxicity|7|||
170837474|NCT03377361|617412671|FG008|Treatment Period|Study Drug Toxicity|2|||
170837475|NCT03377361|617412672|FG009|Treatment Period|Study Drug Toxicity|16|||
170837476|NCT03377361|617412663|FG000|Treatment Period|Death|0|||
170837477|NCT03377361|617412664|FG001|Treatment Period|Death|0|||
170837478|NCT03377361|617412665|FG002|Treatment Period|Death|1|||
170730477|NCT02216773|617016417|FG000|Overall Study|Disease progression|4|||
170730478|NCT02216773|617016418|FG001|Overall Study|Disease progression|2|||
170730479|NCT02216773|617016417|FG000|Overall Study|Insufficient FLRV|4|||
170730480|NCT02216773|617016418|FG001|Overall Study|Insufficient FLRV|0|||
170730481|NCT02216773|617016417|FG000|Overall Study|Abandoned|4|||
170730482|NCT02216773|617016418|FG001|Overall Study|Abandoned|3|||
170730483|NCT02124265|617016421|FG000|Overall Study|Adverse Event|1|||
170730484|NCT02012491|617016423|FG000|Overall Study|Lost to Follow-up|1|||
170730485|NCT02012491|617016424|FG001|Overall Study|Lost to Follow-up|0|||
170730486|NCT02012491|617016423|FG000|Overall Study|Protocol Violation|0|||
170730487|NCT02012491|617016424|FG001|Overall Study|Protocol Violation|1|||
170730488|NCT02012491|617016423|FG000|Overall Study|Withdrawal by Subject|1|||
170730489|NCT02012491|617016424|FG001|Overall Study|Withdrawal by Subject|0|||
170730490|NCT00344461|617016427|FG000|Overall Study|Adverse Event|6|||
170730491|NCT00344461|617016427|FG000|Overall Study|Death|1|||
170730492|NCT00344461|617016427|FG000|Overall Study|Lack of Efficacy|2|||
170730493|NCT00344461|617016427|FG000|Overall Study|Lost to Follow-up|2|||
170730494|NCT00344461|617016427|FG000|Overall Study|Physician Decision|2|||
170730495|NCT00344461|617016427|FG000|Overall Study|Protocol Violation|6|||
170730496|NCT00344461|617016427|FG000|Overall Study|Withdrawal by Subject|2|||
170730497|NCT02816138|617016430|FG000|Overall Study|Adverse Event|1|||
170730498|NCT04969263|617016431|FG000|Overall Study|Death|1|||
170730499|NCT04969263|617016431|FG000|Overall Study|Lost to Follow-up|2|||
170730500|NCT04969263|617016431|FG000|Overall Study|Withdrawal by Subject|5|||
170730501|NCT04969263|617016431|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
170730502|NCT01389973|617016432|FG000|Overall Study|Lost to Follow-up|1|||
170730503|NCT01389973|617016432|FG000|Overall Study|Trial Stopped by Sponsor|9|||
170730504|NCT01389973|617016432|FG000|Overall Study|Other|10|||
170730505|NCT03360942|617016435|FG000|Overall Study|Device explanted|2|||
170730506|NCT03360942|617016435|FG000|Overall Study|Study closure|1|||
170730507|NCT03360942|617016435|FG000|Overall Study|Withdrawal by Subject|2|||
170730508|NCT01345630|617017743|FG000|Overall Study|Adverse Event|22|||
170730509|NCT01345630|617017744|FG001|Overall Study|Adverse Event|23|||
170730510|NCT01345630|617017743|FG000|Overall Study|Lost to Follow-up|17|||
170730511|NCT01345630|617017744|FG001|Overall Study|Lost to Follow-up|16|||
170730512|NCT01345630|617017743|FG000|Overall Study|Protocol Violation|4|||
170730513|NCT01345630|617017744|FG001|Overall Study|Protocol Violation|1|||
170730514|NCT01345630|617017743|FG000|Overall Study|Medication error without associated AE|0|||
170730515|NCT01345630|617017744|FG001|Overall Study|Medication error without associated AE|1|||
170730516|NCT01345630|617017743|FG000|Overall Study|Study terminated by sponsor|254|||
170730517|NCT01345630|617017744|FG001|Overall Study|Study terminated by sponsor|285|||
170730518|NCT01345630|617017743|FG000|Overall Study|Other reasons|6|||
170730519|NCT01345630|617017744|FG001|Overall Study|Other reasons|8|||
170730520|NCT01345630|617017743|FG000|Overall Study|Withdrawn due to pregnancy|1|||
170730521|NCT01345630|617017744|FG001|Overall Study|Withdrawn due to pregnancy|2|||
170730522|NCT01345630|617017743|FG000|Overall Study|No longer willing to participate|9|||
170730523|NCT01345630|617017744|FG001|Overall Study|No longer willing to participate|12|||
170730524|NCT01345630|617017743|FG000|Overall Study|Insufficient clinical response|48|||
170730525|NCT01345630|617017744|FG001|Overall Study|Insufficient clinical response|11|||
170730526|NCT00119405|617017745|FG000|Overall Study|Withdrawal by Subject|1|||
170730527|NCT01090310|617017746|FG000|Core Study|Adverse Event|2|||
170730528|NCT01090310|617017747|FG001|Core Study|Adverse Event|2|||
170730529|NCT01090310|617017748|FG002|Core Study|Adverse Event|1|||
170730530|NCT01090310|617017749|FG003|Core Study|Adverse Event|1|||
170730531|NCT01090310|617017746|FG000|Core Study|Subject withdrew consent|0|||
170730532|NCT01090310|617017747|FG001|Core Study|Subject withdrew consent|3|||
170730533|NCT01090310|617017748|FG002|Core Study|Subject withdrew consent|1|||
170730534|NCT01090310|617017749|FG003|Core Study|Subject withdrew consent|1|||
170730535|NCT01090310|617017746|FG000|Core Study|Abnormal test procedure result|0|||
170730536|NCT01090310|617017747|FG001|Core Study|Abnormal test procedure result|0|||
170730537|NCT01090310|617017748|FG002|Core Study|Abnormal test procedure result|1|||
170730538|NCT01090310|617017749|FG003|Core Study|Abnormal test procedure result|0|||
170730539|NCT01090310|617017746|FG000|Core Study|Administrative reasons|5|||
170837479|NCT03377361|617412666|FG003|Treatment Period|Death|0|||
170837480|NCT03377361|617412667|FG004|Treatment Period|Death|0|||
170837481|NCT03377361|617412668|FG005|Treatment Period|Death|0|||
170837482|NCT03377361|617412669|FG006|Treatment Period|Death|0|||
170837483|NCT03377361|617412670|FG007|Treatment Period|Death|2|||
170837484|NCT03377361|617412671|FG008|Treatment Period|Death|1|||
170837485|NCT03377361|617412672|FG009|Treatment Period|Death|3|||
170730540|NCT01090310|617017747|FG001|Core Study|Administrative reasons|6|||
170730541|NCT01090310|617017748|FG002|Core Study|Administrative reasons|4|||
170730542|NCT01090310|617017749|FG003|Core Study|Administrative reasons|4|||
170730543|NCT01090310|617017746|FG000|Core Study|Protocol deviation|1|||
170837486|NCT03377361|617412663|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
170837487|NCT03377361|617412664|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
170730544|NCT01090310|617017747|FG001|Core Study|Protocol deviation|0|||
170730545|NCT01090310|617017748|FG002|Core Study|Protocol deviation|0|||
170730546|NCT01090310|617017749|FG003|Core Study|Protocol deviation|1|||
170837488|NCT03377361|617412665|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
170837489|NCT03377361|617412666|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
170837490|NCT03377361|617412667|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
170837491|NCT03377361|617412668|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
170837492|NCT03377361|617412669|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
170837493|NCT03377361|617412670|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
170837494|NCT03377361|617412671|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
170837495|NCT03377361|617412672|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
170837496|NCT03377361|617412663|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
170837497|NCT03377361|617412664|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
170837498|NCT03377361|617412665|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
170837499|NCT03377361|617412666|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
170837500|NCT03377361|617412667|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
170837501|NCT03377361|617412668|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
170837502|NCT03377361|617412669|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
170837503|NCT03377361|617412670|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
170837504|NCT03377361|617412671|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
170837505|NCT03377361|617412672|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
170837506|NCT03377361|617412663|FG000|Treatment Period|Subject Withdrew Consent|0|||
170837507|NCT03377361|617412664|FG001|Treatment Period|Subject Withdrew Consent|0|||
170837508|NCT03377361|617412665|FG002|Treatment Period|Subject Withdrew Consent|0|||
170837509|NCT03377361|617412666|FG003|Treatment Period|Subject Withdrew Consent|0|||
170837510|NCT03377361|617412667|FG004|Treatment Period|Subject Withdrew Consent|0|||
170837511|NCT03377361|617412668|FG005|Treatment Period|Subject Withdrew Consent|0|||
170837512|NCT03377361|617412669|FG006|Treatment Period|Subject Withdrew Consent|0|||
170837513|NCT03377361|617412670|FG007|Treatment Period|Subject Withdrew Consent|0|||
170837514|NCT03377361|617412671|FG008|Treatment Period|Subject Withdrew Consent|2|||
170837515|NCT03377361|617412672|FG009|Treatment Period|Subject Withdrew Consent|1|||
170837516|NCT03377361|617412663|FG000|Treatment Period|No longer meets study criteria|0|||
170837517|NCT03377361|617412664|FG001|Treatment Period|No longer meets study criteria|1|||
170837518|NCT03377361|617412665|FG002|Treatment Period|No longer meets study criteria|0|||
170837519|NCT03377361|617412666|FG003|Treatment Period|No longer meets study criteria|0|||
170837520|NCT03377361|617412667|FG004|Treatment Period|No longer meets study criteria|0|||
170837521|NCT03377361|617412668|FG005|Treatment Period|No longer meets study criteria|0|||
170837522|NCT03377361|617412669|FG006|Treatment Period|No longer meets study criteria|0|||
170837523|NCT03377361|617412670|FG007|Treatment Period|No longer meets study criteria|1|||
170837524|NCT03377361|617412671|FG008|Treatment Period|No longer meets study criteria|0|||
170837525|NCT03377361|617412672|FG009|Treatment Period|No longer meets study criteria|0|||
170837526|NCT03377361|617412663|FG000|Treatment Period|Other Reasons|0|||
170837527|NCT03377361|617412664|FG001|Treatment Period|Other Reasons|0|||
170837528|NCT03377361|617412665|FG002|Treatment Period|Other Reasons|0|||
170837529|NCT03377361|617412666|FG003|Treatment Period|Other Reasons|3|||
170837530|NCT03377361|617412667|FG004|Treatment Period|Other Reasons|0|||
170837531|NCT03377361|617412668|FG005|Treatment Period|Other Reasons|0|||
170837532|NCT03377361|617412669|FG006|Treatment Period|Other Reasons|0|||
170837533|NCT03377361|617412670|FG007|Treatment Period|Other Reasons|2|||
170837534|NCT03377361|617412671|FG008|Treatment Period|Other Reasons|0|||
170837535|NCT03377361|617412672|FG009|Treatment Period|Other Reasons|1|||
170837536|NCT00742326|617412673|FG000|Overall Study|Physician Decision|0|||
170837537|NCT00742326|617412674|FG001|Overall Study|Physician Decision|1|||
170837538|NCT03698994|617412685|FG000|Overall Study|Adverse Event|2|||
170837539|NCT03698994|617412685|FG000|Overall Study|Death|1|||
170837540|NCT03698994|617412685|FG000|Overall Study|Physician Decision|1|||
170837541|NCT03698994|617412685|FG000|Overall Study|Withdrawal by Subject|3|||
170837542|NCT03698994|617412685|FG000|Overall Study|Progressive Disease|12|||
170837543|NCT02196077|617412688|FG000|Overall Study|Adverse Event|4|||
170837544|NCT02196077|617412688|FG000|Overall Study|Lack of Efficacy|1|||
170837545|NCT02196077|617412688|FG000|Overall Study|Withdrawal by Subject|14|||
170837546|NCT02196077|617412688|FG000|Overall Study|Physician Decision|1|||
170837547|NCT02196077|617412688|FG000|Overall Study|Lost to Follow-up|3|||
170837548|NCT02196077|617412688|FG000|Overall Study|Protocol Violation|24|||
170837549|NCT01162486|617412691|FG000|Overall Study|low ANC|1|||
170837550|NCT01162486|617412692|FG001|Overall Study|low ANC|0|||
170837551|NCT01162486|617412693|FG002|Overall Study|low ANC|0|||
170837552|NCT01162486|617412694|FG003|Overall Study|low ANC|0|||
170837553|NCT01162486|617412695|FG004|Overall Study|low ANC|0|||
170837554|NCT01162486|617412691|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
170837555|NCT01162486|617412692|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
170837556|NCT01162486|617412693|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
170837557|NCT01162486|617412694|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
170837558|NCT01162486|617412695|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
170837559|NCT01162486|617412691|FG000|Overall Study|elevated LFTs|0|||
170837560|NCT01162486|617412692|FG001|Overall Study|elevated LFTs|0|||
170837561|NCT01162486|617412693|FG002|Overall Study|elevated LFTs|1|||
170837562|NCT01162486|617412694|FG003|Overall Study|elevated LFTs|0|||
170837563|NCT01162486|617412695|FG004|Overall Study|elevated LFTs|0|||
170837564|NCT01162486|617412691|FG000|Overall Study|Pregnancy|0|||
170837565|NCT01162486|617412692|FG001|Overall Study|Pregnancy|0|||
170837566|NCT01162486|617412693|FG002|Overall Study|Pregnancy|0|||
170837567|NCT01162486|617412694|FG003|Overall Study|Pregnancy|1|||
170837568|NCT01162486|617412695|FG004|Overall Study|Pregnancy|0|||
170837569|NCT00794924|617412696|FG000|Overall Study|Lost to Follow-up|6|||
170837570|NCT00794924|617412697|FG001|Overall Study|Lost to Follow-up|8|||
170837571|NCT00794924|617412696|FG000|Overall Study|Withdrawal by Subject|48|||
170837572|NCT00794924|617412697|FG001|Overall Study|Withdrawal by Subject|60|||
170837573|NCT00794924|617412696|FG000|Overall Study|Adverse Event|6|||
170837574|NCT00794924|617412697|FG001|Overall Study|Adverse Event|2|||
170837575|NCT00953615|617412698|FG000|Overall Study|Adverse Event|1|||
170837576|NCT03274895|617412699|FG000|Overall Study|Lack of Efficacy|1|||
170837577|NCT03274895|617412700|FG001|Overall Study|Lack of Efficacy|0|||
170837578|NCT03274895|617412699|FG000|Overall Study|Adverse Event|8|||
170837579|NCT03274895|617412700|FG001|Overall Study|Adverse Event|7|||
170837580|NCT03274895|617412699|FG000|Overall Study|Lost to Follow-up|1|||
170837581|NCT03274895|617412700|FG001|Overall Study|Lost to Follow-up|0|||
170837582|NCT03274895|617412699|FG000|Overall Study|Diagnosis not confirmed|3|||
170837583|NCT03274895|617412700|FG001|Overall Study|Diagnosis not confirmed|4|||
170837584|NCT01305239|617412701|FG000|Overall Study|Adverse Event|22|||
170837585|NCT01305239|617412701|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
170837586|NCT02389764|617412702|FG000|Overall Study|Lack of Efficacy|9|||
170837587|NCT02296892|617412709|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
170837588|NCT02296892|617412710|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
170837589|NCT02296892|617412711|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
170837590|NCT02296892|617412709|FG000|Overall Study|Lost to Follow-up|5|||
170837591|NCT02296892|617412710|FG001|Overall Study|Lost to Follow-up|0|||
170837592|NCT02296892|617412711|FG002|Overall Study|Lost to Follow-up|1|||
170837593|NCT00978562|617412716|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
170837594|NCT03375320|617412724|FG000|Overall Study|Adverse Event|34|||
170837595|NCT03375320|617412725|FG001|Overall Study|Adverse Event|9|||
170837596|NCT03375320|617412726|FG002|Overall Study|Adverse Event|10|||
170837597|NCT03375320|617412727|FG003|Overall Study|Adverse Event|0|||
170837598|NCT03375320|617412724|FG000|Overall Study|Death|6|||
170837599|NCT03375320|617412725|FG001|Overall Study|Death|3|||
170837600|NCT03375320|617412726|FG002|Overall Study|Death|0|||
170837601|NCT03375320|617412727|FG003|Overall Study|Death|0|||
170837602|NCT03375320|617412724|FG000|Overall Study|Withdrawal by Subject|7|||
170837603|NCT03375320|617412725|FG001|Overall Study|Withdrawal by Subject|4|||
170837604|NCT03375320|617412726|FG002|Overall Study|Withdrawal by Subject|5|||
170837605|NCT03375320|617412727|FG003|Overall Study|Withdrawal by Subject|4|||
170837606|NCT03375320|617412724|FG000|Overall Study|Progressive disease|55|||
170837607|NCT03375320|617412725|FG001|Overall Study|Progressive disease|41|||
170837608|NCT03375320|617412726|FG002|Overall Study|Progressive disease|29|||
170837609|NCT03375320|617412727|FG003|Overall Study|Progressive disease|24|||
170837610|NCT03375320|617412724|FG000|Overall Study|Alternative treatment|6|||
170837611|NCT03375320|617412725|FG001|Overall Study|Alternative treatment|1|||
170837612|NCT03375320|617412726|FG002|Overall Study|Alternative treatment|1|||
170837613|NCT03375320|617412727|FG003|Overall Study|Alternative treatment|0|||
170837614|NCT03375320|617412724|FG000|Overall Study|Other disease|1|||
170837615|NCT03375320|617412725|FG001|Overall Study|Other disease|1|||
170837616|NCT03375320|617412726|FG002|Overall Study|Other disease|3|||
170837617|NCT03375320|617412727|FG003|Overall Study|Other disease|0|||
170837618|NCT03375320|617412724|FG000|Overall Study|Withdrawal prior to initiation|2|||
170837619|NCT03375320|617412725|FG001|Overall Study|Withdrawal prior to initiation|2|||
170837620|NCT03375320|617412726|FG002|Overall Study|Withdrawal prior to initiation|1|||
170837621|NCT03375320|617412727|FG003|Overall Study|Withdrawal prior to initiation|0|||
170837622|NCT03375320|617412724|FG000|Overall Study|Physician Decision|1|||
170837623|NCT03375320|617412725|FG001|Overall Study|Physician Decision|1|||
170837624|NCT03375320|617412726|FG002|Overall Study|Physician Decision|1|||
170837625|NCT03375320|617412727|FG003|Overall Study|Physician Decision|1|||
170837626|NCT03375320|617412724|FG000|Overall Study|Non-compliance|1|||
170837627|NCT03375320|617412725|FG001|Overall Study|Non-compliance|0|||
170837628|NCT03375320|617412726|FG002|Overall Study|Non-compliance|0|||
170837629|NCT03375320|617412727|FG003|Overall Study|Non-compliance|0|||
170837630|NCT00233480|617414361|FG000|Overall Study|Underwent status II heart transplant|0|||
170837631|NCT00233480|617414362|FG001|Overall Study|Underwent status II heart transplant|1|||
170837632|NCT04042077|617414363|FG000|Overall Study|Adverse Event|0|||
170837633|NCT04042077|617414364|FG001|Overall Study|Adverse Event|1|||
170837634|NCT04042077|617414363|FG000|Overall Study|Death|2|||
170837635|NCT04042077|617414364|FG001|Overall Study|Death|1|||
170837636|NCT04042077|617414363|FG000|Overall Study|Physician Decision|2|||
170837637|NCT04042077|617414364|FG001|Overall Study|Physician Decision|0|||
170837638|NCT04042077|617414363|FG000|Overall Study|Withdrawal by Subject|3|||
170837639|NCT04042077|617414364|FG001|Overall Study|Withdrawal by Subject|2|||
170837640|NCT04042077|617414363|FG000|Overall Study|Lack of Efficacy|0|||
170837641|NCT04042077|617414364|FG001|Overall Study|Lack of Efficacy|1|||
170730547|NCT01090310|617017746|FG000|Extension Study|Aministrative problems|13|||
170730548|NCT01090310|617017747|FG001|Extension Study|Aministrative problems|15|||
170730549|NCT01090310|617017748|FG002|Extension Study|Aministrative problems|14|||
170730550|NCT01090310|617017749|FG003|Extension Study|Aministrative problems|18|||
170730551|NCT01090310|617017746|FG000|Extension Study|Adverse Event|0|||
170730552|NCT01090310|617017747|FG001|Extension Study|Adverse Event|0|||
170730553|NCT01090310|617017748|FG002|Extension Study|Adverse Event|0|||
170730554|NCT01090310|617017749|FG003|Extension Study|Adverse Event|1|||
170730555|NCT01090310|617017746|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
170730556|NCT01090310|617017747|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
170730557|NCT01090310|617017748|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
170730558|NCT01090310|617017749|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
170730559|NCT01090310|617017746|FG000|Extension Study|Subject withdrew consent|0|||
170730560|NCT01090310|617017747|FG001|Extension Study|Subject withdrew consent|1|||
170730561|NCT01090310|617017748|FG002|Extension Study|Subject withdrew consent|0|||
170730562|NCT01090310|617017749|FG003|Extension Study|Subject withdrew consent|0|||
170730563|NCT00662857|617017753|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
170730564|NCT00662857|617017754|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
170730565|NCT00662857|617017753|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
170730566|NCT00662857|617017754|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
170730567|NCT00662857|617017753|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
170730568|NCT00662857|617017754|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
170730569|NCT03966053|617017757|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
170730570|NCT00526630|617017765|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
170730571|NCT00526630|617017766|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
170730572|NCT00526630|617017765|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
170730573|NCT00526630|617017766|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
170730574|NCT00337272|617017767|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
170730575|NCT00337272|617017768|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
170730576|NCT00337272|617017767|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
170730577|NCT00337272|617017768|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
170730578|NCT00337272|617017767|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
170730579|NCT00337272|617017768|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
170730580|NCT00337272|617017767|FG000|Treatment Period|Non-compliance|1|||
170730581|NCT00337272|617017768|FG001|Treatment Period|Non-compliance|1|||
170730582|NCT00337272|617017767|FG000|Treatment Period|Withdrawal by Subject|0|||
170730583|NCT00337272|617017768|FG001|Treatment Period|Withdrawal by Subject|1|||
170730584|NCT00337272|617017767|FG000|Withdrawal Period|Non-compliance|0|||
170730585|NCT00337272|617017768|FG001|Withdrawal Period|Non-compliance|1|||
170730586|NCT05674890|617017772|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
170730587|NCT05674890|617017773|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
170730588|NCT05674890|617017772|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
170730589|NCT05674890|617017773|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
170730590|NCT05674890|617017772|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
170730591|NCT05674890|617017773|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
170730592|NCT05453110|617017776|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
170730593|NCT05453110|617017777|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
170730594|NCT05453110|617017778|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
170730595|NCT02274857|617017782|FG000|Overall Study|Adverse Event|1|||
170730596|NCT02274857|617017783|FG001|Overall Study|Adverse Event|0|||
170730597|NCT02274857|617017782|FG000|Overall Study|Death|1|||
170730598|NCT02274857|617017783|FG001|Overall Study|Death|2|||
170730599|NCT02274857|617017782|FG000|Overall Study|Lost to Follow-up|3|||
170730600|NCT02274857|617017783|FG001|Overall Study|Lost to Follow-up|0|||
170730601|NCT02274857|617017782|FG000|Overall Study|Physician Decision|2|||
170730602|NCT02274857|617017783|FG001|Overall Study|Physician Decision|0|||
170730603|NCT02274857|617017782|FG000|Overall Study|Trial screen failure|0|||
170730604|NCT02274857|617017783|FG001|Overall Study|Trial screen failure|2|||
170730605|NCT02274857|617017782|FG000|Overall Study|Withdrawal by Subject|11|||
170730606|NCT02274857|617017783|FG001|Overall Study|Withdrawal by Subject|2|||
170730607|NCT02274857|617017782|FG000|Overall Study|Other|2|||
170730608|NCT02274857|617017783|FG001|Overall Study|Other|0|||
170837642|NCT01163474|617414368|FG000|Overall Study|Withdrawal by Subject|1|||
170837643|NCT01163474|617414368|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
170837644|NCT01163474|617414368|FG000|Overall Study|Lost to Follow-up|3|||
170837645|NCT00965497|617414369|FG000|Overall Study|Physician Decision|1|||
170837646|NCT02838134|617414370|FG000|Overall Study|Lost to Follow-up|1|||
170837647|NCT02838134|617414371|FG001|Overall Study|Lost to Follow-up|2|||
170837648|NCT02838134|617414370|FG000|Overall Study|logistic problems|1|||
170837649|NCT02838134|617414371|FG001|Overall Study|logistic problems|1|||
170837650|NCT01969851|617414379|FG000|Overall Study|Adverse Event|0|||
170837651|NCT01969851|617414380|FG001|Overall Study|Adverse Event|0|||
170837652|NCT01969851|617414381|FG002|Overall Study|Adverse Event|3|||
170837653|NCT01969851|617414379|FG000|Overall Study|Lack of Efficacy|0|||
170837654|NCT01969851|617414380|FG001|Overall Study|Lack of Efficacy|3|||
170837655|NCT01969851|617414381|FG002|Overall Study|Lack of Efficacy|1|||
170837656|NCT01969851|617414379|FG000|Overall Study|Withdrawal by Subject|1|||
170837657|NCT01969851|617414380|FG001|Overall Study|Withdrawal by Subject|0|||
170837658|NCT01969851|617414381|FG002|Overall Study|Withdrawal by Subject|1|||
170837659|NCT01969851|617414379|FG000|Overall Study|No effective dose in Titration period|0|||
170837660|NCT01969851|617414380|FG001|Overall Study|No effective dose in Titration period|0|||
170837661|NCT01969851|617414381|FG002|Overall Study|No effective dose in Titration period|1|||
170837662|NCT01969851|617414379|FG000|Overall Study|Sponsor decision|0|||
170837663|NCT01969851|617414380|FG001|Overall Study|Sponsor decision|0|||
170837664|NCT01969851|617414381|FG002|Overall Study|Sponsor decision|1|||
170837665|NCT01281839|617414383|FG000|Overall Study|Lost to Follow-up|6|||
170837666|NCT01281839|617414384|FG001|Overall Study|Lost to Follow-up|3|||
170837667|NCT01281839|617414383|FG000|Overall Study|Withdrawal by Subject|4|||
170837668|NCT01281839|617414384|FG001|Overall Study|Withdrawal by Subject|10|||
170837669|NCT01281839|617414383|FG000|Overall Study|Reason not specified|0|||
170837670|NCT01281839|617414384|FG001|Overall Study|Reason not specified|1|||
170837671|NCT01294436|617414385|FG000|Overall Study|Adverse Event|10|||
170837672|NCT01294436|617414386|FG001|Overall Study|Adverse Event|17|||
170837673|NCT01294436|617414385|FG000|Overall Study|Withdrawal by Subject|11|||
170837674|NCT01294436|617414386|FG001|Overall Study|Withdrawal by Subject|28|||
170837675|NCT01294436|617414385|FG000|Overall Study|subject no longer meets study criteria|5|||
170837676|NCT01294436|617414386|FG001|Overall Study|subject no longer meets study criteria|20|||
170837677|NCT01294436|617414385|FG000|Overall Study|poor/non-compliance|2|||
170837678|NCT01294436|617414386|FG001|Overall Study|poor/non-compliance|5|||
170837679|NCT01754753|617414387|FG000|Overall Study|Study close|43|||
170837680|NCT01754753|617414388|FG001|Overall Study|Study close|44|||
170837681|NCT01754753|617414387|FG000|Overall Study|Lost to Follow-up|9|||
170837682|NCT01754753|617414388|FG001|Overall Study|Lost to Follow-up|5|||
170837683|NCT03229486|617414389|FG000|Overall Study|Protocol Violation|0|||
170837684|NCT03229486|617414390|FG001|Overall Study|Protocol Violation|1|||
170837685|NCT00856245|617414391|FG000|Overall Study|Was not transplanted|5|||
170837686|NCT00585078|617414392|FG000|Overall Study|Withdrawal by Subject|4|||
170837687|NCT00585078|617414392|FG000|Overall Study|Poor performance status|1|||
170837688|NCT00585078|617414392|FG000|Overall Study|Disease Progression|24|||
170837689|NCT00585078|617414392|FG000|Overall Study|Adverse Event|10|||
170837690|NCT00585078|617414392|FG000|Overall Study|Death|1|||
170837691|NCT01814072|617414393|FG000|Overall Study|Lost to Follow-up|2|||
170837692|NCT01814072|617414394|FG001|Overall Study|Lost to Follow-up|2|||
170837693|NCT01814072|617414395|FG002|Overall Study|Lost to Follow-up|2|||
170837694|NCT01814072|617414396|FG003|Overall Study|Lost to Follow-up|0|||
170837695|NCT01814072|617414397|FG004|Overall Study|Lost to Follow-up|2|||
170837696|NCT01814072|617414398|FG005|Overall Study|Lost to Follow-up|3|||
170837697|NCT01814072|617414399|FG006|Overall Study|Lost to Follow-up|3|||
170837698|NCT01814072|617414400|FG007|Overall Study|Lost to Follow-up|1|||
170837699|NCT01814072|617414401|FG008|Overall Study|Lost to Follow-up|2|||
170837700|NCT01814072|617414402|FG009|Overall Study|Lost to Follow-up|3|||
170837701|NCT01814072|617414403|FG010|Overall Study|Lost to Follow-up|1|||
170837702|NCT01814072|617414404|FG011|Overall Study|Lost to Follow-up|2|||
170837703|NCT01814072|617414405|FG012|Overall Study|Lost to Follow-up|2|||
170837704|NCT01814072|617414406|FG013|Overall Study|Lost to Follow-up|1|||
170837705|NCT01814072|617414407|FG014|Overall Study|Lost to Follow-up|2|||
170837706|NCT01814072|617414408|FG015|Overall Study|Lost to Follow-up|1|||
170837707|NCT01814072|617414409|FG016|Overall Study|Lost to Follow-up|3|||
170837708|NCT01814072|617414410|FG017|Overall Study|Lost to Follow-up|1|||
170837709|NCT01814072|617414411|FG018|Overall Study|Lost to Follow-up|3|||
170837710|NCT01814072|617414412|FG019|Overall Study|Lost to Follow-up|3|||
170837711|NCT01814072|617414413|FG020|Overall Study|Lost to Follow-up|2|||
170837712|NCT01814072|617414414|FG021|Overall Study|Lost to Follow-up|1|||
170837713|NCT01814072|617414415|FG022|Overall Study|Lost to Follow-up|3|||
170837714|NCT01814072|617414416|FG023|Overall Study|Lost to Follow-up|1|||
170837715|NCT01814072|617414417|FG024|Overall Study|Lost to Follow-up|4|||
170837716|NCT01814072|617414418|FG025|Overall Study|Lost to Follow-up|1|||
170837717|NCT01814072|617414419|FG026|Overall Study|Lost to Follow-up|1|||
170837718|NCT01814072|617414420|FG027|Overall Study|Lost to Follow-up|2|||
170837719|NCT01814072|617414421|FG028|Overall Study|Lost to Follow-up|3|||
170837720|NCT01814072|617414422|FG029|Overall Study|Lost to Follow-up|3|||
170837721|NCT01814072|617414423|FG030|Overall Study|Lost to Follow-up|2|||
170837722|NCT01814072|617414424|FG031|Overall Study|Lost to Follow-up|0|||
170837723|NCT01814072|617414393|FG000|Overall Study|Withdrawal by Subject|2|||
170837724|NCT01814072|617414394|FG001|Overall Study|Withdrawal by Subject|0|||
170730609|NCT00117676|617017784|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
170730610|NCT00117676|617017785|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
170730611|NCT00117676|617017784|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
170730612|NCT00117676|617017785|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
170730613|NCT00117676|617017784|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
170730614|NCT00117676|617017785|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
170730615|NCT00117676|617017784|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
170730616|NCT00117676|617017785|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
170730617|NCT00117676|617017784|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
170730618|NCT00117676|617017785|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
170730619|NCT00117676|617017784|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
170730620|NCT00117676|617017785|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
170730621|NCT00117676|617017784|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
170730622|NCT00117676|617017785|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
170730623|NCT00117676|617017784|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
170730624|NCT00117676|617017785|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
170730625|NCT00117676|617017784|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
170730626|NCT00117676|617017785|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
170730627|NCT00117676|617017784|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
170730628|NCT00117676|617017785|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
170730629|NCT00117676|617017784|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
170730630|NCT00117676|617017785|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
170730631|NCT00117676|617017784|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
170730632|NCT00117676|617017785|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
170730633|NCT00117676|617017784|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
170730634|NCT00117676|617017785|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
170730635|NCT00117676|617017784|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
170730636|NCT00117676|617017785|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
170730637|NCT00117676|617017784|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
170730638|NCT00117676|617017785|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
170730639|NCT00117676|617017784|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
170730640|NCT00117676|617017785|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
170730641|NCT00117676|617017784|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
170730642|NCT00117676|617017785|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
170730643|NCT00117676|617017784|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
170730644|NCT00117676|617017785|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
170730645|NCT00117676|617017784|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
170730646|NCT00117676|617017785|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
170730647|NCT00117676|617017784|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
170730648|NCT00117676|617017785|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
170730649|NCT00117676|617017784|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
170730650|NCT00117676|617017785|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
170730651|NCT00117676|617017784|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
170730652|NCT00117676|617017785|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
170730653|NCT00117676|617017784|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
170730654|NCT00117676|617017785|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
170730655|NCT00117676|617017784|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
170730656|NCT00117676|617017785|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
170837725|NCT01814072|617414395|FG002|Overall Study|Withdrawal by Subject|1|||
170837726|NCT01814072|617414396|FG003|Overall Study|Withdrawal by Subject|0|||
170837727|NCT01814072|617414397|FG004|Overall Study|Withdrawal by Subject|2|||
170837728|NCT01814072|617414398|FG005|Overall Study|Withdrawal by Subject|3|||
170837729|NCT01814072|617414399|FG006|Overall Study|Withdrawal by Subject|1|||
170837730|NCT01814072|617414400|FG007|Overall Study|Withdrawal by Subject|0|||
170837731|NCT01814072|617414401|FG008|Overall Study|Withdrawal by Subject|1|||
170837732|NCT01814072|617414402|FG009|Overall Study|Withdrawal by Subject|2|||
170837733|NCT01814072|617414403|FG010|Overall Study|Withdrawal by Subject|0|||
170837734|NCT01814072|617414404|FG011|Overall Study|Withdrawal by Subject|0|||
170837735|NCT01814072|617414405|FG012|Overall Study|Withdrawal by Subject|1|||
170837736|NCT01814072|617414406|FG013|Overall Study|Withdrawal by Subject|1|||
170837737|NCT01814072|617414407|FG014|Overall Study|Withdrawal by Subject|1|||
170837738|NCT01814072|617414408|FG015|Overall Study|Withdrawal by Subject|1|||
170837739|NCT01814072|617414409|FG016|Overall Study|Withdrawal by Subject|0|||
170837740|NCT01814072|617414410|FG017|Overall Study|Withdrawal by Subject|0|||
170837741|NCT01814072|617414411|FG018|Overall Study|Withdrawal by Subject|0|||
170837742|NCT01814072|617414412|FG019|Overall Study|Withdrawal by Subject|2|||
170837743|NCT01814072|617414413|FG020|Overall Study|Withdrawal by Subject|0|||
170837744|NCT01814072|617414414|FG021|Overall Study|Withdrawal by Subject|0|||
170837745|NCT01814072|617414415|FG022|Overall Study|Withdrawal by Subject|1|||
170837746|NCT01814072|617414416|FG023|Overall Study|Withdrawal by Subject|0|||
170837747|NCT01814072|617414417|FG024|Overall Study|Withdrawal by Subject|2|||
170837748|NCT01814072|617414418|FG025|Overall Study|Withdrawal by Subject|1|||
170837749|NCT01814072|617414419|FG026|Overall Study|Withdrawal by Subject|1|||
170837750|NCT01814072|617414420|FG027|Overall Study|Withdrawal by Subject|2|||
170837751|NCT01814072|617414421|FG028|Overall Study|Withdrawal by Subject|1|||
170837752|NCT01814072|617414422|FG029|Overall Study|Withdrawal by Subject|0|||
170837753|NCT01814072|617414423|FG030|Overall Study|Withdrawal by Subject|0|||
170837754|NCT01814072|617414424|FG031|Overall Study|Withdrawal by Subject|0|||
170837755|NCT00383123|617414425|FG000|Overall Study|Adverse Event|1|||
170837756|NCT00383123|617414426|FG001|Overall Study|Adverse Event|0|||
170837757|NCT00383123|617414425|FG000|Overall Study|Lost to Follow-up|68|||
170837758|NCT00383123|617414426|FG001|Overall Study|Lost to Follow-up|61|||
170837759|NCT00383123|617414425|FG000|Overall Study|Protocol Violation|5|||
170837760|NCT00383123|617414426|FG001|Overall Study|Protocol Violation|1|||
170837761|NCT00383123|617414425|FG000|Overall Study|Withdrawal by Subject|27|||
170837762|NCT00383123|617414426|FG001|Overall Study|Withdrawal by Subject|18|||
170837763|NCT00383123|617414425|FG000|Overall Study|Other reason|10|||
170837764|NCT00383123|617414426|FG001|Overall Study|Other reason|6|||
170837765|NCT02781311|617414427|FG000|Overall Study|Adverse Event|2|||
170837766|NCT02781311|617414428|FG001|Overall Study|Adverse Event|6|||
170837767|NCT02781311|617414429|FG002|Overall Study|Adverse Event|1|||
170837768|NCT02781311|617414427|FG000|Overall Study|Withdrawal of Consent|11|||
170837769|NCT02781311|617414428|FG001|Overall Study|Withdrawal of Consent|12|||
170837770|NCT02781311|617414429|FG002|Overall Study|Withdrawal of Consent|2|||
170837771|NCT02781311|617414427|FG000|Overall Study|Lost to Follow-up|11|||
170837772|NCT02781311|617414428|FG001|Overall Study|Lost to Follow-up|8|||
170837773|NCT02781311|617414429|FG002|Overall Study|Lost to Follow-up|1|||
170837774|NCT02781311|617414427|FG000|Overall Study|Non-Compliance with Study Drug|2|||
170837775|NCT02781311|617414428|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170837776|NCT02781311|617414429|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170837777|NCT00250432|617414434|FG000|Overall Study|Adverse Event|25|||
170837778|NCT00250432|617414435|FG001|Overall Study|Adverse Event|29|||
170837779|NCT00250432|617414434|FG000|Overall Study|Lack of Efficacy|2|||
170837780|NCT00250432|617414435|FG001|Overall Study|Lack of Efficacy|1|||
170837781|NCT00250432|617414434|FG000|Overall Study|Lost to Follow-up|6|||
170837782|NCT00250432|617414435|FG001|Overall Study|Lost to Follow-up|5|||
170837783|NCT00250432|617414434|FG000|Overall Study|Patient Moved|0|||
170837784|NCT00250432|617414435|FG001|Overall Study|Patient Moved|1|||
170837785|NCT00250432|617414434|FG000|Overall Study|Protocol Violation|0|||
170837786|NCT00250432|617414435|FG001|Overall Study|Protocol Violation|3|||
170837787|NCT00250432|617414434|FG000|Overall Study|Withdrawal by Subject|6|||
170837788|NCT00250432|617414435|FG001|Overall Study|Withdrawal by Subject|2|||
170837789|NCT00250432|617414434|FG000|Overall Study|Pt died out of posttherapy report period|6|||
170837790|NCT00250432|617414435|FG001|Overall Study|Pt died out of posttherapy report period|5|||
170837791|NCT00250432|617414434|FG000|Overall Study|Pt was considered untreatable|0|||
170837792|NCT00250432|617414435|FG001|Overall Study|Pt was considered untreatable|1|||
170837793|NCT01011868|617414436|FG000|After Week 18 Follow-up|Adverse Event|8|||
170837794|NCT01011868|617414437|FG001|After Week 18 Follow-up|Adverse Event|6|||
170837795|NCT01011868|617414438|FG002|After Week 18 Follow-up|Adverse Event|13|||
170837796|NCT01011868|617414436|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
170837797|NCT01011868|617414437|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
170837798|NCT01011868|617414438|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
170837799|NCT01011868|617414436|FG000|After Week 18 Follow-up|Protocol Violation|1|||
170837800|NCT01011868|617414437|FG001|After Week 18 Follow-up|Protocol Violation|1|||
170730657|NCT00117676|617017784|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
170730658|NCT00117676|617017785|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
170730659|NCT00117676|617017784|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
170730660|NCT00117676|617017785|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
170730661|NCT00117676|617017784|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
170730662|NCT00117676|617017785|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
170730663|NCT00117676|617017784|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
170730664|NCT00117676|617017785|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
170730665|NCT00117676|617017784|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
170730666|NCT00117676|617017785|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
170730667|NCT00117676|617017784|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
170730668|NCT00117676|617017785|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
170730669|NCT00117676|617017784|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
170730670|NCT00117676|617017785|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
170730671|NCT00117676|617017784|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
170730672|NCT00117676|617017785|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
170730673|NCT00117676|617017784|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
170730674|NCT00117676|617017785|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
170730675|NCT00117676|617017784|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
170730676|NCT00117676|617017785|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
170730677|NCT00117676|617017784|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
170730678|NCT00117676|617017785|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
170730679|NCT00658567|617017787|FG000|Overall Study|Adverse Event|5|||
170730680|NCT00658567|617017788|FG001|Overall Study|Adverse Event|2|||
170730681|NCT00658567|617017789|FG002|Overall Study|Adverse Event|3|||
170730682|NCT00658567|617017787|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
170730683|NCT00658567|617017788|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
170730684|NCT00658567|617017789|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
170730685|NCT00658567|617017787|FG000|Overall Study|Physician Decision|0|||
170730686|NCT00658567|617017788|FG001|Overall Study|Physician Decision|1|||
170730687|NCT00658567|617017789|FG002|Overall Study|Physician Decision|0|||
170730688|NCT00658567|617017787|FG000|Overall Study|At Discretion of Sponsor|1|||
170730689|NCT00658567|617017788|FG001|Overall Study|At Discretion of Sponsor|1|||
170730690|NCT00658567|617017789|FG002|Overall Study|At Discretion of Sponsor|1|||
170730691|NCT04555096|617017790|FG000|Overall Study|Death|4|||
170730692|NCT04555096|617017791|FG001|Overall Study|Death|4|||
170730693|NCT04555096|617017790|FG000|Overall Study|Withdrawal by Subject|1|||
170730694|NCT04555096|617017791|FG001|Overall Study|Withdrawal by Subject|0|||
170730695|NCT04555096|617017790|FG000|Overall Study|Other|0|||
170730696|NCT04555096|617017791|FG001|Overall Study|Other|1|||
170730697|NCT03575325|617017794|FG000|Overall Study|Death|1|||
170730698|NCT02862457|617017795|FG000|Overall Study|Death|1|||
170730699|NCT02862457|617017796|FG001|Overall Study|Death|3|||
170730700|NCT02862457|617017797|FG002|Overall Study|Death|2|||
170730701|NCT02862457|617017798|FG003|Overall Study|Death|3|||
170730702|NCT02862457|617017799|FG004|Overall Study|Death|0|||
170730703|NCT02862457|617017800|FG005|Overall Study|Death|2|||
170730704|NCT02862457|617017801|FG006|Overall Study|Death|1|||
170730705|NCT02862457|617017795|FG000|Overall Study|Lost to Follow-up|1|||
170730706|NCT02862457|617017796|FG001|Overall Study|Lost to Follow-up|0|||
170730707|NCT02862457|617017797|FG002|Overall Study|Lost to Follow-up|0|||
170730708|NCT02862457|617017798|FG003|Overall Study|Lost to Follow-up|1|||
170730709|NCT02862457|617017799|FG004|Overall Study|Lost to Follow-up|0|||
170730710|NCT02862457|617017800|FG005|Overall Study|Lost to Follow-up|0|||
170730711|NCT02862457|617017801|FG006|Overall Study|Lost to Follow-up|0|||
170730712|NCT02862457|617017795|FG000|Overall Study|Withdrawal by Subject|0|||
170730713|NCT02862457|617017796|FG001|Overall Study|Withdrawal by Subject|0|||
170730714|NCT02862457|617017797|FG002|Overall Study|Withdrawal by Subject|1|||
170730715|NCT02862457|617017798|FG003|Overall Study|Withdrawal by Subject|0|||
170730716|NCT02862457|617017799|FG004|Overall Study|Withdrawal by Subject|0|||
170837801|NCT01011868|617414438|FG002|After Week 18 Follow-up|Protocol Violation|1|||
170837802|NCT01011868|617414436|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
170837803|NCT01011868|617414437|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
170837804|NCT01011868|617414438|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
170837805|NCT01011868|617414436|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
170837806|NCT01011868|617414437|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
170837807|NCT01011868|617414438|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
170837808|NCT01011868|617414436|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
170837809|NCT01011868|617414437|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
170730717|NCT02862457|617017800|FG005|Overall Study|Withdrawal by Subject|1|||
170730718|NCT02862457|617017801|FG006|Overall Study|Withdrawal by Subject|0|||
170730719|NCT03364751|617017804|FG000|Overall Study|Withdrawal by Subject|1|||
170730720|NCT03364751|617017805|FG001|Overall Study|Withdrawal by Subject|0|||
170730721|NCT03364751|617017806|FG002|Overall Study|Withdrawal by Subject|0|||
170730722|NCT03364751|617017807|FG003|Overall Study|Withdrawal by Subject|0|||
170730723|NCT03364751|617017804|FG000|Overall Study|Lost to Follow-up|0|||
170730724|NCT03364751|617017805|FG001|Overall Study|Lost to Follow-up|1|||
170730725|NCT03364751|617017806|FG002|Overall Study|Lost to Follow-up|0|||
170730726|NCT03364751|617017807|FG003|Overall Study|Lost to Follow-up|0|||
170730727|NCT03178266|617017809|FG000|Overall Study|Death|0|||
170730728|NCT03178266|617017810|FG001|Overall Study|Death|1|||
170730729|NCT03178266|617017809|FG000|Overall Study|Disont. Early|0|||
170730730|NCT03178266|617017810|FG001|Overall Study|Disont. Early|1|||
170730731|NCT03178266|617017809|FG000|Overall Study|Withdrawal by Subject|0|||
170730732|NCT03178266|617017810|FG001|Overall Study|Withdrawal by Subject|2|||
170730733|NCT01812655|617017814|FG000|Overall Study|Protocol Violation|1|||
170837810|NCT01011868|617414438|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
170837811|NCT01011868|617414436|FG000|After Week 78 Follow-up|Adverse Event|14|||
170837812|NCT01011868|617414437|FG001|After Week 78 Follow-up|Adverse Event|18|||
170837813|NCT01011868|617414438|FG002|After Week 78 Follow-up|Adverse Event|21|||
170837814|NCT01011868|617414436|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
170837815|NCT01011868|617414437|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
170837816|NCT01011868|617414438|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
170837817|NCT01011868|617414436|FG000|After Week 78 Follow-up|Protocol Violation|9|||
170837818|NCT01011868|617414437|FG001|After Week 78 Follow-up|Protocol Violation|1|||
170837819|NCT01011868|617414438|FG002|After Week 78 Follow-up|Protocol Violation|2|||
170837820|NCT01011868|617414436|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
170837821|NCT01011868|617414437|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
170837822|NCT01011868|617414438|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
170837823|NCT01011868|617414436|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
170837824|NCT01011868|617414437|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
170837825|NCT01011868|617414438|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
170837826|NCT01011868|617414436|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
170837827|NCT01011868|617414437|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
170837828|NCT01011868|617414438|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
170837829|NCT04147858|617414439|FG000|Overall Study|Adverse Event|6|||
170837830|NCT04147858|617414440|FG001|Overall Study|Adverse Event|6|||
170837831|NCT04147858|617414441|FG002|Overall Study|Adverse Event|6|||
170837832|NCT04147858|617414439|FG000|Overall Study|Lack of Efficacy|3|||
170837833|NCT04147858|617414440|FG001|Overall Study|Lack of Efficacy|3|||
170837834|NCT04147858|617414441|FG002|Overall Study|Lack of Efficacy|1|||
170837835|NCT04147858|617414439|FG000|Overall Study|Lost to Follow-up|1|||
170730734|NCT01812655|617017815|FG001|Overall Study|Protocol Violation|1|||
170730735|NCT01812655|617017816|FG002|Overall Study|Protocol Violation|0|||
170730736|NCT01596582|617017818|FG000|Overall Study|Deemed ineligible after study visit|3|||
170730737|NCT01596582|617017819|FG001|Overall Study|Deemed ineligible after study visit|6|||
170730738|NCT01596582|617017818|FG000|Overall Study|Missing all outcome data|1|||
170730739|NCT01596582|617017819|FG001|Overall Study|Missing all outcome data|1|||
170730740|NCT01428076|617017820|FG000|Overall Study|Adverse Event|0|||
170730741|NCT01428076|617017821|FG001|Overall Study|Adverse Event|1|||
170730742|NCT04435665|617017822|FG000|Overall Study|Lost to Follow-up|0|||
170730743|NCT04435665|617017823|FG001|Overall Study|Lost to Follow-up|0|||
170730744|NCT04435665|617017824|FG002|Overall Study|Lost to Follow-up|0|||
170730745|NCT04435665|617017825|FG003|Overall Study|Lost to Follow-up|1|||
170730746|NCT00540124|617017829|FG000|Overall Study|Adverse Event|0|||
170837836|NCT04147858|617414440|FG001|Overall Study|Lost to Follow-up|6|||
170837837|NCT04147858|617414441|FG002|Overall Study|Lost to Follow-up|2|||
170837838|NCT04147858|617414439|FG000|Overall Study|Withdrawal by Subject|3|||
170837839|NCT04147858|617414440|FG001|Overall Study|Withdrawal by Subject|4|||
170837840|NCT04147858|617414441|FG002|Overall Study|Withdrawal by Subject|10|||
170837841|NCT04147858|617414439|FG000|Overall Study|Subject Noncompliance, Other|4|||
170837842|NCT04147858|617414440|FG001|Overall Study|Subject Noncompliance, Other|3|||
170837843|NCT04147858|617414441|FG002|Overall Study|Subject Noncompliance, Other|1|||
170837844|NCT02615938|617414442|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
170837845|NCT02615938|617414443|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
170837846|NCT02615938|617414444|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
170837847|NCT02615938|617414445|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
170837848|NCT02615938|617414442|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
170837849|NCT02615938|617414443|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
170730747|NCT00540124|617017830|FG001|Overall Study|Adverse Event|2|||
170730748|NCT00540124|617017831|FG002|Overall Study|Adverse Event|1|||
170730749|NCT00540124|617017829|FG000|Overall Study|Entry Criteria Not Met|2|||
170730750|NCT00540124|617017830|FG001|Overall Study|Entry Criteria Not Met|0|||
170730751|NCT00540124|617017831|FG002|Overall Study|Entry Criteria Not Met|0|||
170730752|NCT00540124|617017829|FG000|Overall Study|Lack of Efficacy|1|||
170730753|NCT00540124|617017830|FG001|Overall Study|Lack of Efficacy|0|||
170730754|NCT00540124|617017831|FG002|Overall Study|Lack of Efficacy|0|||
170730755|NCT00540124|617017829|FG000|Overall Study|Withdrawal by Subject|1|||
170730756|NCT00540124|617017830|FG001|Overall Study|Withdrawal by Subject|1|||
170730757|NCT00540124|617017831|FG002|Overall Study|Withdrawal by Subject|0|||
170730758|NCT00490282|617017833|FG000|Overall Study|Withdrawal by Subject|3|||
170730759|NCT00058123|617017836|FG000|Overall Study|Wrong histology|9|||
170730760|NCT00058123|617017836|FG000|Overall Study|Received >3 prior treatments|1|||
170730761|NCT01667432|617017837|FG000|Overall Study|Premature Study Termination|26|||
170730762|NCT01667432|617017837|FG000|Overall Study|Failure to Return|10|||
170730763|NCT01667432|617017837|FG000|Overall Study|Moved to Another Center|3|||
170730764|NCT01667432|617017837|FG000|Overall Study|Lost to Follow-up|3|||
170730765|NCT01667432|617017837|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
170730766|NCT01667432|617017837|FG000|Overall Study|Insufficient Therapeutic Response|4|||
170730767|NCT01667432|617017837|FG000|Overall Study|Adverse Event|1|||
170730768|NCT01667432|617017837|FG000|Overall Study|Protocol Deviation|2|||
170730769|NCT01667432|617017837|FG000|Overall Study|Principal Investigator Decision|1|||
170730770|NCT01667432|617017837|FG000|Overall Study|Reason Not Specified|2|||
170730771|NCT01667432|617017837|FG000|Overall Study|Missing Information|4|||
170730772|NCT00686881|617017838|FG000|Overall Study|Withdrawal by Subject|11|||
170730773|NCT00686881|617017839|FG001|Overall Study|Withdrawal by Subject|18|||
170730774|NCT00686881|617017838|FG000|Overall Study|Lost to Follow-up|0|||
170730775|NCT00686881|617017839|FG001|Overall Study|Lost to Follow-up|1|||
170730776|NCT00686881|617017838|FG000|Overall Study|Treatment-related adverse event|10|||
170730777|NCT00686881|617017839|FG001|Overall Study|Treatment-related adverse event|9|||
170730778|NCT00686881|617017838|FG000|Overall Study|Met discontinuation criteria|5|||
170730779|NCT00686881|617017839|FG001|Overall Study|Met discontinuation criteria|0|||
170730780|NCT00686881|617017838|FG000|Overall Study|Onset of malignant tumor|11|||
170730781|NCT00686881|617017839|FG001|Overall Study|Onset of malignant tumor|11|||
170730782|NCT00686881|617017838|FG000|Overall Study|Lack of Efficacy|4|||
170730783|NCT00686881|617017839|FG001|Overall Study|Lack of Efficacy|3|||
170730784|NCT00686881|617017838|FG000|Overall Study|Physician Decision|1|||
170730785|NCT00686881|617017839|FG001|Overall Study|Physician Decision|0|||
170730786|NCT00686881|617017838|FG000|Overall Study|Circumstances of site|1|||
170730787|NCT00686881|617017839|FG001|Overall Study|Circumstances of site|1|||
170730788|NCT00686881|617017838|FG000|Overall Study|Did not meet protocol eligibility|1|||
170730789|NCT00686881|617017839|FG001|Overall Study|Did not meet protocol eligibility|0|||
170730790|NCT00686881|617017838|FG000|Overall Study|Irregular visits|1|||
170730791|NCT00686881|617017839|FG001|Overall Study|Irregular visits|0|||
170730792|NCT00686881|617017838|FG000|Overall Study|Study discontinuation|35|||
170730793|NCT00686881|617017839|FG001|Overall Study|Study discontinuation|32|||
170730794|NCT00686881|617017838|FG000|Overall Study|Never received study drug|2|||
170730795|NCT00686881|617017839|FG001|Overall Study|Never received study drug|6|||
170730796|NCT00671931|617017842|FG000|Overall Study|Physician Decision|1|||
170730797|NCT00671931|617017843|FG001|Overall Study|Physician Decision|0|||
170730798|NCT00671931|617017844|FG002|Overall Study|Physician Decision|0|||
170730799|NCT00671931|617017845|FG003|Overall Study|Physician Decision|2|||
170730800|NCT00671931|617017846|FG004|Overall Study|Physician Decision|1|||
170730801|NCT01298999|617017847|FG000|Overall Study|Physician Decision|0|||
170730802|NCT01298999|617017848|FG001|Overall Study|Physician Decision|1|||
170730803|NCT01298999|617017847|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
170730804|NCT01298999|617017848|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
170730805|NCT02151266|617017849|FG000|Overall Study|Lost to Follow-up|1|||
170730806|NCT02151266|617017850|FG001|Overall Study|Lost to Follow-up|4|||
170730807|NCT02151266|617017851|FG002|Overall Study|Lost to Follow-up|1|||
170730808|NCT02151266|617017849|FG000|Overall Study|Did NOT receive intervention|3|||
170730809|NCT02151266|617017850|FG001|Overall Study|Did NOT receive intervention|6|||
170730810|NCT02151266|617017851|FG002|Overall Study|Did NOT receive intervention|2|||
170730811|NCT02151266|617017849|FG000|Overall Study|Not able to exercise|4|||
170730812|NCT02151266|617017850|FG001|Overall Study|Not able to exercise|5|||
170730813|NCT02151266|617017851|FG002|Overall Study|Not able to exercise|4|||
170730814|NCT02355028|617017854|FG000|Overall Study|Adverse Event|2|||
170730815|NCT02355028|617017855|FG001|Overall Study|Adverse Event|0|||
170730816|NCT02355028|617017854|FG000|Overall Study|Withdrawal by Subject|1|||
170837850|NCT02615938|617414444|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
170837851|NCT02615938|617414445|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
170837852|NCT02615938|617414442|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
170837853|NCT02615938|617414443|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
170837854|NCT02615938|617414444|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
170837855|NCT02615938|617414445|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
170837856|NCT04905849|617414447|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
170730817|NCT02355028|617017855|FG001|Overall Study|Withdrawal by Subject|1|||
170730818|NCT02355028|617017854|FG000|Overall Study|Deemed ineligible after randomization|8|||
170730819|NCT02355028|617017855|FG001|Overall Study|Deemed ineligible after randomization|4|||
170730820|NCT05899686|617017856|FG000|Overall Study|Protocol Violation|1|||
170730821|NCT02170025|617017857|FG000|Overall Study|Adverse Event|2|||
170730822|NCT02170025|617017858|FG001|Overall Study|Adverse Event|0|||
170730823|NCT01525602|617017859|FG000|Overall Study|Adverse Event|1|||
170730824|NCT01525602|617017860|FG001|Overall Study|Adverse Event|0|||
170730825|NCT01525602|617017861|FG002|Overall Study|Adverse Event|1|||
170730826|NCT01525602|617017862|FG003|Overall Study|Adverse Event|1|||
170730827|NCT01525602|617017863|FG004|Overall Study|Adverse Event|3|||
170730828|NCT01525602|617017864|FG005|Overall Study|Adverse Event|3|||
170730829|NCT01525602|617017865|FG006|Overall Study|Adverse Event|0|||
170730830|NCT01525602|617017866|FG007|Overall Study|Adverse Event|1|||
170730831|NCT01525602|617017859|FG000|Overall Study|Disease progression|6|||
170730832|NCT01525602|617017860|FG001|Overall Study|Disease progression|3|||
170730833|NCT01525602|617017861|FG002|Overall Study|Disease progression|2|||
170730834|NCT01525602|617017862|FG003|Overall Study|Disease progression|5|||
170730835|NCT01525602|617017863|FG004|Overall Study|Disease progression|22|||
170730836|NCT01525602|617017864|FG005|Overall Study|Disease progression|2|||
170730837|NCT01525602|617017865|FG006|Overall Study|Disease progression|3|||
170730838|NCT01525602|617017866|FG007|Overall Study|Disease progression|3|||
170730839|NCT01525602|617017859|FG000|Overall Study|Clinical progression|2|||
170730840|NCT01525602|617017860|FG001|Overall Study|Clinical progression|0|||
170730841|NCT01525602|617017861|FG002|Overall Study|Clinical progression|0|||
170730842|NCT01525602|617017862|FG003|Overall Study|Clinical progression|0|||
170730843|NCT01525602|617017863|FG004|Overall Study|Clinical progression|0|||
170730844|NCT01525602|617017864|FG005|Overall Study|Clinical progression|0|||
170730845|NCT01525602|617017865|FG006|Overall Study|Clinical progression|1|||
170730846|NCT01525602|617017866|FG007|Overall Study|Clinical progression|1|||
170730847|NCT01525602|617017859|FG000|Overall Study|Non-compliance|0|||
170730848|NCT01525602|617017860|FG001|Overall Study|Non-compliance|0|||
170730849|NCT01525602|617017861|FG002|Overall Study|Non-compliance|0|||
170730850|NCT01525602|617017862|FG003|Overall Study|Non-compliance|0|||
170730851|NCT01525602|617017863|FG004|Overall Study|Non-compliance|1|||
170730852|NCT01525602|617017864|FG005|Overall Study|Non-compliance|0|||
170730853|NCT01525602|617017865|FG006|Overall Study|Non-compliance|0|||
170730854|NCT01525602|617017866|FG007|Overall Study|Non-compliance|0|||
170730855|NCT01525602|617017859|FG000|Overall Study|Withdrawal by Subject|0|||
170730856|NCT01525602|617017860|FG001|Overall Study|Withdrawal by Subject|0|||
170730857|NCT01525602|617017861|FG002|Overall Study|Withdrawal by Subject|0|||
170730858|NCT01525602|617017862|FG003|Overall Study|Withdrawal by Subject|0|||
170730859|NCT01525602|617017863|FG004|Overall Study|Withdrawal by Subject|3|||
170730860|NCT01525602|617017864|FG005|Overall Study|Withdrawal by Subject|1|||
170730861|NCT01525602|617017865|FG006|Overall Study|Withdrawal by Subject|0|||
170730862|NCT01525602|617017866|FG007|Overall Study|Withdrawal by Subject|1|||
170730863|NCT01525602|617017859|FG000|Overall Study|Physician Decision|0|||
170730864|NCT01525602|617017860|FG001|Overall Study|Physician Decision|0|||
170730865|NCT01525602|617017861|FG002|Overall Study|Physician Decision|0|||
170730866|NCT01525602|617017862|FG003|Overall Study|Physician Decision|0|||
170730867|NCT01525602|617017863|FG004|Overall Study|Physician Decision|3|||
170730868|NCT01525602|617017864|FG005|Overall Study|Physician Decision|0|||
170730869|NCT01525602|617017865|FG006|Overall Study|Physician Decision|1|||
170730870|NCT01525602|617017866|FG007|Overall Study|Physician Decision|0|||
170730871|NCT01525602|617017859|FG000|Overall Study|Death|0|||
170730872|NCT01525602|617017860|FG001|Overall Study|Death|0|||
170730873|NCT01525602|617017861|FG002|Overall Study|Death|0|||
170730874|NCT01525602|617017862|FG003|Overall Study|Death|0|||
170730875|NCT01525602|617017863|FG004|Overall Study|Death|1|||
170730876|NCT01525602|617017864|FG005|Overall Study|Death|1|||
170730877|NCT01525602|617017865|FG006|Overall Study|Death|0|||
170730878|NCT01525602|617017866|FG007|Overall Study|Death|0|||
170730879|NCT01525602|617017859|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
170730880|NCT01525602|617017860|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
170730881|NCT01525602|617017861|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
170730882|NCT01525602|617017862|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
170730883|NCT01525602|617017863|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
170730884|NCT01525602|617017864|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
170730885|NCT01525602|617017865|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
170730886|NCT01525602|617017866|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
170730887|NCT02459574|617017869|FG000|Overall Study|Withdrawal by Subject|6|||
170730888|NCT02459574|617017870|FG001|Overall Study|Withdrawal by Subject|6|||
170730889|NCT02459574|617017871|FG002|Overall Study|Withdrawal by Subject|2|||
170730890|NCT02459574|617017869|FG000|Overall Study|Lost to Follow-up|1|||
170730891|NCT02459574|617017870|FG001|Overall Study|Lost to Follow-up|1|||
170730892|NCT02459574|617017871|FG002|Overall Study|Lost to Follow-up|0|||
170730893|NCT02459574|617017869|FG000|Overall Study|Death|0|||
170730894|NCT02459574|617017870|FG001|Overall Study|Death|1|||
170730895|NCT02459574|617017871|FG002|Overall Study|Death|0|||
170837857|NCT04905849|617414448|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
170837858|NCT01637077|617414455|FG000|Overall Study|Cancel|1|||
170837859|NCT01637077|617414456|FG001|Overall Study|Cancel|1|||
170837860|NCT01637077|617414455|FG000|Overall Study|Withdrawal by Subject|1|||
170837861|NCT01637077|617414456|FG001|Overall Study|Withdrawal by Subject|0|||
170837862|NCT01637077|617414455|FG000|Overall Study|No cycle 1 questionnaire data|2|||
170837863|NCT01637077|617414456|FG001|Overall Study|No cycle 1 questionnaire data|0|||
170837864|NCT02638103|617414457|FG000|Overall Study|Adverse Event|13|||
170837865|NCT02638103|617414458|FG001|Overall Study|Adverse Event|12|||
170837866|NCT02638103|617414459|FG002|Overall Study|Adverse Event|19|||
170837867|NCT02638103|617414460|FG003|Overall Study|Adverse Event|12|||
170837868|NCT02638103|617414457|FG000|Overall Study|Withdrawal by Subject|43|||
170837869|NCT02638103|617414458|FG001|Overall Study|Withdrawal by Subject|53|||
170837870|NCT02638103|617414459|FG002|Overall Study|Withdrawal by Subject|30|||
170837871|NCT02638103|617414460|FG003|Overall Study|Withdrawal by Subject|61|||
170837872|NCT02638103|617414457|FG000|Overall Study|Protocol Violation|1|||
170837873|NCT02638103|617414458|FG001|Overall Study|Protocol Violation|2|||
170837874|NCT02638103|617414459|FG002|Overall Study|Protocol Violation|1|||
170837875|NCT02638103|617414460|FG003|Overall Study|Protocol Violation|4|||
170837876|NCT02638103|617414457|FG000|Overall Study|Pregnancy|2|||
170837877|NCT02638103|617414458|FG001|Overall Study|Pregnancy|3|||
170837878|NCT02638103|617414459|FG002|Overall Study|Pregnancy|0|||
170837879|NCT02638103|617414460|FG003|Overall Study|Pregnancy|1|||
170837880|NCT02638103|617414457|FG000|Overall Study|Non-compliance to Study Procedures|2|||
170837881|NCT02638103|617414458|FG001|Overall Study|Non-compliance to Study Procedures|1|||
170837882|NCT02638103|617414459|FG002|Overall Study|Non-compliance to Study Procedures|1|||
170837883|NCT02638103|617414460|FG003|Overall Study|Non-compliance to Study Procedures|1|||
170837884|NCT02638103|617414457|FG000|Overall Study|Lost to Follow-up|26|||
170837885|NCT02638103|617414458|FG001|Overall Study|Lost to Follow-up|33|||
170837886|NCT02638103|617414459|FG002|Overall Study|Lost to Follow-up|20|||
170837887|NCT02638103|617414460|FG003|Overall Study|Lost to Follow-up|37|||
170837888|NCT02638103|617414457|FG000|Overall Study|Lack of Efficacy|14|||
170837889|NCT02638103|617414458|FG001|Overall Study|Lack of Efficacy|10|||
170837890|NCT02638103|617414459|FG002|Overall Study|Lack of Efficacy|12|||
170837891|NCT02638103|617414460|FG003|Overall Study|Lack of Efficacy|22|||
170837892|NCT02638103|617414457|FG000|Overall Study|Other than specified|5|||
170837893|NCT02638103|617414458|FG001|Overall Study|Other than specified|4|||
170837894|NCT02638103|617414459|FG002|Overall Study|Other than specified|2|||
170837895|NCT02638103|617414460|FG003|Overall Study|Other than specified|4|||
170837896|NCT00838929|617414461|FG000|Overall Study|Protocol Violation|0|||
170837897|NCT00838929|617414462|FG001|Overall Study|Protocol Violation|1|||
170837898|NCT00838929|617414463|FG002|Overall Study|Protocol Violation|0|||
170837899|NCT00838929|617414461|FG000|Overall Study|Disease progression|0|||
170837900|NCT00838929|617414462|FG001|Overall Study|Disease progression|2|||
170837901|NCT00838929|617414463|FG002|Overall Study|Disease progression|1|||
170837902|NCT04199052|617414469|FG000|Overall Study|Lost to Follow-up|11|||
170837903|NCT04199052|617414470|FG001|Overall Study|Lost to Follow-up|18|||
170837904|NCT01358331|617414475|FG000|Overall Study|Lost to Follow-up|0|||
170837905|NCT01358331|617414476|FG001|Overall Study|Lost to Follow-up|0|||
170837906|NCT01358331|617414477|FG002|Overall Study|Lost to Follow-up|0|||
170837907|NCT01358331|617414478|FG003|Overall Study|Lost to Follow-up|1|||
170837908|NCT01358331|617414479|FG004|Overall Study|Lost to Follow-up|0|||
170837909|NCT01358331|617414480|FG005|Overall Study|Lost to Follow-up|0|||
170837910|NCT01358331|617414475|FG000|Overall Study|Withdrawal by Subject|0|||
170837911|NCT01358331|617414476|FG001|Overall Study|Withdrawal by Subject|0|||
170837912|NCT01358331|617414477|FG002|Overall Study|Withdrawal by Subject|0|||
170837913|NCT01358331|617414478|FG003|Overall Study|Withdrawal by Subject|1|||
170837914|NCT01358331|617414479|FG004|Overall Study|Withdrawal by Subject|1|||
170837915|NCT01358331|617414480|FG005|Overall Study|Withdrawal by Subject|1|||
170837916|NCT01358331|617414475|FG000|Overall Study|Adverse Events|1|||
170837917|NCT01358331|617414476|FG001|Overall Study|Adverse Events|1|||
170837918|NCT01358331|617414477|FG002|Overall Study|Adverse Events|1|||
170837919|NCT01358331|617414478|FG003|Overall Study|Adverse Events|0|||
170837920|NCT01358331|617414479|FG004|Overall Study|Adverse Events|1|||
170837921|NCT01358331|617414480|FG005|Overall Study|Adverse Events|5|||
170837922|NCT01358331|617414475|FG000|Overall Study|Symptomatic Deterioration|0|||
170837923|NCT01358331|617414476|FG001|Overall Study|Symptomatic Deterioration|0|||
170837924|NCT01358331|617414477|FG002|Overall Study|Symptomatic Deterioration|0|||
170837925|NCT01358331|617414478|FG003|Overall Study|Symptomatic Deterioration|0|||
170837926|NCT01358331|617414479|FG004|Overall Study|Symptomatic Deterioration|1|||
170837927|NCT01358331|617414480|FG005|Overall Study|Symptomatic Deterioration|0|||
170837928|NCT01358331|617414475|FG000|Overall Study|Participants did not wish to continue|0|||
170837929|NCT01358331|617414476|FG001|Overall Study|Participants did not wish to continue|0|||
170837930|NCT01358331|617414477|FG002|Overall Study|Participants did not wish to continue|0|||
170837931|NCT01358331|617414478|FG003|Overall Study|Participants did not wish to continue|0|||
170837932|NCT01358331|617414479|FG004|Overall Study|Participants did not wish to continue|1|||
170837933|NCT01358331|617414480|FG005|Overall Study|Participants did not wish to continue|0|||
170837934|NCT01358331|617414475|FG000|Overall Study|Progress of disease under investigation|1|||
170837935|NCT01358331|617414476|FG001|Overall Study|Progress of disease under investigation|2|||
170837936|NCT01358331|617414477|FG002|Overall Study|Progress of disease under investigation|3|||
170837937|NCT01358331|617414478|FG003|Overall Study|Progress of disease under investigation|1|||
170837938|NCT01358331|617414479|FG004|Overall Study|Progress of disease under investigation|3|||
170837939|NCT01358331|617414480|FG005|Overall Study|Progress of disease under investigation|0|||
170837940|NCT04907357|617414481|FG000|Overall Study|Death|0|||
170837941|NCT04907357|617414482|FG001|Overall Study|Death|1|||
170837942|NCT04907357|617414481|FG000|Overall Study|Lost to Follow-up|9|||
170837943|NCT04907357|617414482|FG001|Overall Study|Lost to Follow-up|18|||
170837944|NCT04907357|617414481|FG000|Overall Study|Physician Decision|1|||
170837945|NCT04907357|617414482|FG001|Overall Study|Physician Decision|0|||
170837946|NCT04907357|617414481|FG000|Overall Study|Withdrawal by Subject|0|||
170837947|NCT04907357|617414482|FG001|Overall Study|Withdrawal by Subject|1|||
170837948|NCT04907357|617414481|FG000|Overall Study|Unable to attend visits|1|||
170837949|NCT04907357|617414482|FG001|Overall Study|Unable to attend visits|0|||
170837950|NCT04907357|617414481|FG000|Overall Study|Incarcerated|1|||
170837951|NCT04907357|617414482|FG001|Overall Study|Incarcerated|1|||
170837952|NCT03342196|617414483|FG000|Overall Study|Physician Decision|1|||
170837953|NCT00546078|617414484|FG000|Overall Study|Lost to Follow-up|1|||
170837954|NCT00546078|617414485|FG001|Overall Study|Lost to Follow-up|3|||
170837955|NCT00546078|617414484|FG000|Overall Study|Withdrawal by Subject|2|||
170837956|NCT00546078|617414485|FG001|Overall Study|Withdrawal by Subject|3|||
170837957|NCT00546078|617414484|FG000|Overall Study|Other reason|1|||
170837958|NCT00546078|617414485|FG001|Overall Study|Other reason|1|||
170837959|NCT02257918|617414486|FG000|Overall Study|Lost to Follow-up|4|||
170837960|NCT02257918|617414487|FG001|Overall Study|Lost to Follow-up|1|||
170837961|NCT02257918|617414488|FG002|Overall Study|Lost to Follow-up|0|||
170837962|NCT02257918|617414486|FG000|Overall Study|Withdrawal by Subject|0|||
170837963|NCT02257918|617414487|FG001|Overall Study|Withdrawal by Subject|0|||
170837964|NCT02257918|617414488|FG002|Overall Study|Withdrawal by Subject|1|||
170837965|NCT02257918|617414486|FG000|Overall Study|Pregnancy|0|||
170837966|NCT02257918|617414487|FG001|Overall Study|Pregnancy|0|||
170837967|NCT02257918|617414488|FG002|Overall Study|Pregnancy|1|||
170837968|NCT03023423|617414491|FG000|Overall Study|Death|5|||
170837969|NCT03023423|617414492|FG001|Overall Study|Death|12|||
170837970|NCT03023423|617414493|FG002|Overall Study|Death|20|||
170837971|NCT03023423|617414491|FG000|Overall Study|Other|0|||
170837972|NCT03023423|617414492|FG001|Overall Study|Other|2|||
170837973|NCT03023423|617414493|FG002|Overall Study|Other|2|||
170837974|NCT03023423|617414491|FG000|Overall Study|Ongoing|2|||
170837975|NCT03023423|617414492|FG001|Overall Study|Ongoing|32|||
170837976|NCT03023423|617414493|FG002|Overall Study|Ongoing|24|||
170837977|NCT03512197|617414494|FG000|Overall Study|Guardian decision|1|||
170837978|NCT03512197|617414495|FG001|Overall Study|Guardian decision|1|||
170837979|NCT03512197|617414494|FG000|Overall Study|Lack of Efficacy|19|||
170837980|NCT03512197|617414495|FG001|Overall Study|Lack of Efficacy|11|||
170837981|NCT03512197|617414494|FG000|Overall Study|New Therapy for Study Indication|16|||
170837982|NCT03512197|617414495|FG001|Overall Study|New Therapy for Study Indication|16|||
170837983|NCT03512197|617414494|FG000|Overall Study|Physician Decision|60|||
170837984|NCT03512197|617414495|FG001|Overall Study|Physician Decision|60|||
170837985|NCT03512197|617414494|FG000|Overall Study|Protocol Violation|0|||
170837986|NCT03512197|617414495|FG001|Overall Study|Protocol Violation|2|||
170837987|NCT03512197|617414494|FG000|Overall Study|Terminated by Sponsored|46|||
170837988|NCT03512197|617414495|FG001|Overall Study|Terminated by Sponsored|50|||
170837989|NCT03512197|617414494|FG000|Overall Study|Subject Decision|15|||
170837990|NCT03512197|617414495|FG001|Overall Study|Subject Decision|12|||
170837991|NCT03512197|617414494|FG000|Overall Study|Withdrawal of informed consent|20|||
170837992|NCT03512197|617414495|FG001|Overall Study|Withdrawal of informed consent|14|||
170837993|NCT03512197|617414494|FG000|Overall Study|Adverse Event|30|||
170837994|NCT03512197|617414495|FG001|Overall Study|Adverse Event|34|||
170837995|NCT03512197|617414494|FG000|Overall Study|Death|14|||
170837996|NCT03512197|617414495|FG001|Overall Study|Death|9|||
170837997|NCT03512197|617414494|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
170837998|NCT03512197|617414495|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
170837999|NCT03512197|617414494|FG000|Overall Study|Missing|3|||
170838000|NCT03512197|617414495|FG001|Overall Study|Missing|13|||
170838001|NCT01806389|617414496|FG000|Overall Study|Withdrawal by Subject|4|||
170838002|NCT01151423|617414497|FG000|Overall Study|Study terminated by Sponsor|9|||
170838003|NCT01151423|617414498|FG001|Overall Study|Study terminated by Sponsor|10|||
170838004|NCT01151423|617414497|FG000|Overall Study|Protocol Violation|0|||
170838005|NCT01151423|617414498|FG001|Overall Study|Protocol Violation|1|||
170838006|NCT01151423|617414497|FG000|Overall Study|Physician Decision|1|||
170730896|NCT00251745|617017873|FG000|Overall Study|Adverse Event|7|||
170730897|NCT00251745|617017874|FG001|Overall Study|Adverse Event|9|||
170730898|NCT00251745|617017875|FG002|Overall Study|Adverse Event|11|||
170730899|NCT00251745|617017873|FG000|Overall Study|Lost to Follow-up|4|||
170730900|NCT00251745|617017874|FG001|Overall Study|Lost to Follow-up|2|||
170730901|NCT00251745|617017875|FG002|Overall Study|Lost to Follow-up|5|||
170730902|NCT00251745|617017873|FG000|Overall Study|Withdrawal by Subject|13|||
170730903|NCT00251745|617017874|FG001|Overall Study|Withdrawal by Subject|7|||
170730904|NCT00251745|617017875|FG002|Overall Study|Withdrawal by Subject|3|||
170730905|NCT00251745|617017873|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
170730906|NCT00251745|617017874|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
170730907|NCT00251745|617017875|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
170730908|NCT00251745|617017873|FG000|Overall Study|Lack of Efficacy|3|||
170730909|NCT00251745|617017874|FG001|Overall Study|Lack of Efficacy|0|||
170730910|NCT00251745|617017875|FG002|Overall Study|Lack of Efficacy|0|||
170730911|NCT00251745|617017873|FG000|Overall Study|Noncompliant|0|||
170730912|NCT00251745|617017874|FG001|Overall Study|Noncompliant|2|||
170730913|NCT00251745|617017875|FG002|Overall Study|Noncompliant|2|||
170730914|NCT00251745|617017873|FG000|Overall Study|Pregnancy|0|||
170730915|NCT00251745|617017874|FG001|Overall Study|Pregnancy|1|||
170730916|NCT00251745|617017875|FG002|Overall Study|Pregnancy|0|||
170730917|NCT00251745|617017873|FG000|Overall Study|Per Subject Request|0|||
170730918|NCT00251745|617017874|FG001|Overall Study|Per Subject Request|0|||
170730919|NCT00251745|617017875|FG002|Overall Study|Per Subject Request|1|||
170730920|NCT00251745|617017873|FG000|Overall Study|Per Investigator Request|1|||
170730921|NCT00251745|617017874|FG001|Overall Study|Per Investigator Request|0|||
170730922|NCT00251745|617017875|FG002|Overall Study|Per Investigator Request|0|||
170730923|NCT04508699|617017880|FG000|Overall Study|Lack of Efficacy|2|||
170730924|NCT04508699|617017881|FG001|Overall Study|Lack of Efficacy|15|||
170730925|NCT04508699|617017880|FG000|Overall Study|Withdrawal by Subject|0|||
170730926|NCT04508699|617017881|FG001|Overall Study|Withdrawal by Subject|2|||
170730927|NCT04866017|617017882|FG000|Overall Study|Study Terminated by Sponsor|13|||
170730928|NCT04866017|617017883|FG001|Overall Study|Study Terminated by Sponsor|14|||
170730929|NCT04866017|617017884|FG002|Overall Study|Study Terminated by Sponsor|13|||
170730930|NCT04866017|617017882|FG000|Overall Study|Death|8|||
170730931|NCT04866017|617017883|FG001|Overall Study|Death|4|||
170730932|NCT04866017|617017884|FG002|Overall Study|Death|8|||
170730933|NCT04866017|617017882|FG000|Overall Study|Withdrawal by Subject|1|||
170730934|NCT04866017|617017883|FG001|Overall Study|Withdrawal by Subject|0|||
170730935|NCT04866017|617017884|FG002|Overall Study|Withdrawal by Subject|1|||
170730936|NCT04866017|617017882|FG000|Overall Study|Physician Decision|0|||
170730937|NCT04866017|617017883|FG001|Overall Study|Physician Decision|1|||
170730938|NCT04866017|617017884|FG002|Overall Study|Physician Decision|0|||
170730939|NCT02412137|617017885|FG000|Overall Study|Withdrawal by Subject|2|||
170730940|NCT02412137|617017886|FG001|Overall Study|Withdrawal by Subject|0|||
170730941|NCT02412137|617017885|FG000|Overall Study|Lost to Follow-up|21|||
170730942|NCT02412137|617017886|FG001|Overall Study|Lost to Follow-up|14|||
170730943|NCT02412137|617017885|FG000|Overall Study|Physician Decision|28|||
170730944|NCT02412137|617017886|FG001|Overall Study|Physician Decision|9|||
170730945|NCT01266642|617017887|FG000|Overall Study|Protocol Violation|0|||
170730946|NCT01266642|617017888|FG001|Overall Study|Protocol Violation|1|||
170730947|NCT03076970|617019605|FG000|Washout Period 2|Adverse Event|0|||
170730948|NCT03076970|617019606|FG001|Washout Period 2|Adverse Event|0|||
170730949|NCT03076970|617019607|FG002|Washout Period 2|Adverse Event|0|||
170730950|NCT03076970|617019608|FG003|Washout Period 2|Adverse Event|0|||
170730951|NCT03076970|617019609|FG004|Washout Period 2|Adverse Event|1|||
170730952|NCT03076970|617019610|FG005|Washout Period 2|Adverse Event|0|||
170730953|NCT03076970|617019605|FG000|Period 3|Withdrawal by Subject|0|||
170730954|NCT03076970|617019606|FG001|Period 3|Withdrawal by Subject|0|||
170730955|NCT03076970|617019607|FG002|Period 3|Withdrawal by Subject|0|||
170730956|NCT03076970|617019608|FG003|Period 3|Withdrawal by Subject|0|||
170838007|NCT01151423|617414498|FG001|Overall Study|Physician Decision|1|||
170838008|NCT01151423|617414497|FG000|Overall Study|Pregnancy|0|||
170838009|NCT01151423|617414498|FG001|Overall Study|Pregnancy|1|||
170838010|NCT01151423|617414497|FG000|Overall Study|Death|0|||
170838011|NCT01151423|617414498|FG001|Overall Study|Death|1|||
170838012|NCT01151423|617414497|FG000|Overall Study|Adverse Event|3|||
170838013|NCT01151423|617414498|FG001|Overall Study|Adverse Event|0|||
170838014|NCT01151423|617414497|FG000|Overall Study|Withdrawal by Subject|1|||
170838015|NCT01151423|617414498|FG001|Overall Study|Withdrawal by Subject|3|||
170838016|NCT01151423|617414497|FG000|Overall Study|Lost to Follow-up|1|||
170838017|NCT01151423|617414498|FG001|Overall Study|Lost to Follow-up|0|||
170838018|NCT01151423|617414497|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
170838019|NCT01151423|617414498|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
170730957|NCT03076970|617019609|FG004|Period 3|Withdrawal by Subject|0|||
170730958|NCT03076970|617019610|FG005|Period 3|Withdrawal by Subject|1|||
170730959|NCT03076970|617019605|FG000|Period 3|Failure to meet I/E criteria|0|||
170730960|NCT03076970|617019606|FG001|Period 3|Failure to meet I/E criteria|0|||
170730961|NCT03076970|617019607|FG002|Period 3|Failure to meet I/E criteria|0|||
170838020|NCT01151423|617414497|FG000|Overall Study|Participated in other clinical trial|1|||
170838021|NCT01151423|617414498|FG001|Overall Study|Participated in other clinical trial|0|||
170838022|NCT01263054|617414501|FG000|Overall Study|Death|1|||
170838023|NCT01263054|617414502|FG001|Overall Study|Death|0|||
170838024|NCT01263054|617414501|FG000|Overall Study|Lost to Follow-up|2|||
170838025|NCT01263054|617414502|FG001|Overall Study|Lost to Follow-up|2|||
170838026|NCT01263054|617414501|FG000|Overall Study|Withdrawal by Subject|1|||
170838027|NCT01263054|617414502|FG001|Overall Study|Withdrawal by Subject|3|||
170838028|NCT01263054|617414501|FG000|Overall Study|Qualification Violation|1|||
170838029|NCT01263054|617414502|FG001|Overall Study|Qualification Violation|0|||
170838030|NCT01263054|617414501|FG000|Overall Study|Other|0|||
170838031|NCT01263054|617414502|FG001|Overall Study|Other|1|||
170838032|NCT00681668|617414503|FG000|Overall Study|Protocol Violation|1|||
170838033|NCT00681668|617414503|FG000|Overall Study|Withdrawal by Subject|1|||
170838034|NCT03358238|617414507|FG000|Overall Study|Withdrawal by Subject|0|||
170838035|NCT03358238|617414508|FG001|Overall Study|Withdrawal by Subject|1|||
170838036|NCT04277507|617414509|FG000|Overall Study|Lost to Follow-up|17|||
170838037|NCT04277507|617414509|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
170838038|NCT04277507|617414509|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
170838039|NCT04277507|617414509|FG000|Overall Study|Withdrawal by Subject|3|||
170838040|NCT04277507|617414509|FG000|Overall Study|Death due to COVID-19|1|||
170838041|NCT04277507|617414509|FG000|Overall Study|Data missing for full evaluation|5|||
170838042|NCT01210651|617414520|FG000|Overall Study|Lost to Follow-up|1|||
170838043|NCT01210651|617414521|FG001|Overall Study|Lost to Follow-up|1|||
170838044|NCT01210651|617414520|FG000|Overall Study|schedule conflicts|1|||
170838045|NCT01210651|617414521|FG001|Overall Study|schedule conflicts|5|||
170838046|NCT01210651|617414520|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
170838047|NCT01210651|617414521|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
170838048|NCT01210651|617414520|FG000|Overall Study|Withdrawal by Subject|1|||
170838049|NCT01210651|617414521|FG001|Overall Study|Withdrawal by Subject|1|||
170838050|NCT01210651|617414520|FG000|Overall Study|Injury outside study|2|||
170838051|NCT01210651|617414521|FG001|Overall Study|Injury outside study|0|||
170838052|NCT01740154|617414522|FG000|Overall Study|Adverse Event|1|||
170838053|NCT02633397|617414523|FG000|Overall Study|Adverse Event|8|||
170838054|NCT02633397|617414524|FG001|Overall Study|Adverse Event|8|||
170838055|NCT02633397|617414523|FG000|Overall Study|Study Burden|4|||
170838056|NCT02633397|617414524|FG001|Overall Study|Study Burden|1|||
170838057|NCT02633397|617414523|FG000|Overall Study|Treatment interruption|2|||
170838058|NCT02633397|617414524|FG001|Overall Study|Treatment interruption|5|||
170838059|NCT02633397|617414523|FG000|Overall Study|Death|2|||
170838060|NCT02633397|617414524|FG001|Overall Study|Death|2|||
170838061|NCT02633397|617414523|FG000|Overall Study|Physician Decision|0|||
170838062|NCT02633397|617414524|FG001|Overall Study|Physician Decision|1|||
170838063|NCT03595878|617414525|FG000|Overall Study|Death|2|||
170838064|NCT03595878|617414526|FG001|Overall Study|Death|1|||
170838065|NCT03595878|617414527|FG002|Overall Study|Death|0|||
170838066|NCT03595878|617414525|FG000|Overall Study|Disease progression|2|||
170838067|NCT03595878|617414526|FG001|Overall Study|Disease progression|1|||
170838068|NCT03595878|617414527|FG002|Overall Study|Disease progression|2|||
170838069|NCT00469859|617414528|FG000|Overall Study|Inevaluable|0|||
170838070|NCT00469859|617414529|FG001|Overall Study|Inevaluable|2|||
170838071|NCT03358472|617414530|FG000|Overall Study|Death|6|||
170838072|NCT03358472|617414531|FG001|Overall Study|Death|3|||
170838073|NCT03358472|617414532|FG002|Overall Study|Death|10|||
170838074|NCT03358472|617414530|FG000|Overall Study|Physician Decision|0|||
170838075|NCT03358472|617414531|FG001|Overall Study|Physician Decision|1|||
170838076|NCT03358472|617414532|FG002|Overall Study|Physician Decision|0|||
170838077|NCT03358472|617414530|FG000|Overall Study|Withdrawal by Subject|0|||
170838078|NCT03358472|617414531|FG001|Overall Study|Withdrawal by Subject|0|||
170838079|NCT03358472|617414532|FG002|Overall Study|Withdrawal by Subject|1|||
170838080|NCT03358472|617414530|FG000|Overall Study|On-going at clinical cut off date|9|||
170838081|NCT03358472|617414531|FG001|Overall Study|On-going at clinical cut off date|6|||
170838082|NCT03358472|617414532|FG002|Overall Study|On-going at clinical cut off date|5|||
170838083|NCT03036124|617414533|FG000|Overall Study|Lost to Follow-up|0|||
170838084|NCT03036124|617414534|FG001|Overall Study|Lost to Follow-up|2|||
170838085|NCT03036124|617414533|FG000|Overall Study|Withdrawal by Subject|5|||
170838086|NCT03036124|617414534|FG001|Overall Study|Withdrawal by Subject|4|||
170838087|NCT01340014|617414535|FG000|Period 1, First 7 Days|Adverse Event|1|||
170838088|NCT01340014|617414536|FG001|Period 1, First 7 Days|Adverse Event|0|||
170838089|NCT01340014|617414535|FG000|Period 1, First 7 Days|Personal Reasons|1|||
170838090|NCT01340014|617414536|FG001|Period 1, First 7 Days|Personal Reasons|0|||
170838091|NCT01340014|617414535|FG000|Period 2, Second 7 Days|Adverse Event|0|||
170838092|NCT01340014|617414536|FG001|Period 2, Second 7 Days|Adverse Event|1|||
170838093|NCT01124838|617414539|FG000|Overall Study|Miscellaneous|4|||
170838094|NCT01124838|617414540|FG001|Overall Study|Miscellaneous|2|||
170838095|NCT01124838|617414539|FG000|Overall Study|Adverse Event|7|||
170838096|NCT01124838|617414540|FG001|Overall Study|Adverse Event|11|||
170838097|NCT01124838|617414539|FG000|Overall Study|Lack of Efficacy|2|||
170838098|NCT01124838|617414540|FG001|Overall Study|Lack of Efficacy|0|||
170838099|NCT01124838|617414539|FG000|Overall Study|Withdrawal by Subject|3|||
170838100|NCT01124838|617414540|FG001|Overall Study|Withdrawal by Subject|2|||
170838101|NCT01124838|617414539|FG000|Overall Study|Lost to Follow-up|2|||
170838102|NCT01124838|617414540|FG001|Overall Study|Lost to Follow-up|0|||
170838103|NCT03213704|617414542|FG000|Overall Study|Physician Decision|3|||
170838104|NCT03213704|617414542|FG000|Overall Study|Protocol Violation|1|||
170838105|NCT03213704|617414542|FG000|Overall Study|Progressive disease|4|||
170838106|NCT04991753|617416119|FG000|Overall Study|Withdrawal by Subject|0|||
170838107|NCT04991753|617416120|FG001|Overall Study|Withdrawal by Subject|1|||
170838108|NCT01484431|617416125|FG000|Period 1: High Dose|Physician Decision|0|||
170838109|NCT01484431|617416126|FG001|Period 1: High Dose|Physician Decision|1|||
170838110|NCT01484431|617416127|FG002|Period 1: High Dose|Physician Decision|0|||
170838111|NCT01484431|617416125|FG000|Period 2|Death|0|||
170838112|NCT01484431|617416126|FG001|Period 2|Death|1|||
170838113|NCT01484431|617416127|FG002|Period 2|Death|1|||
170838114|NCT01484431|617416125|FG000|Period 2|Physician Decision|0|||
170838115|NCT01484431|617416126|FG001|Period 2|Physician Decision|0|||
170838116|NCT01484431|617416127|FG002|Period 2|Physician Decision|1|||
170838117|NCT01484431|617416125|FG000|Period 2|Non-Compliance with Study Drug|1|||
170838118|NCT01484431|617416126|FG001|Period 2|Non-Compliance with Study Drug|0|||
170838119|NCT01484431|617416127|FG002|Period 2|Non-Compliance with Study Drug|0|||
170838120|NCT01251770|617416129|FG000|Overall Study|Protocol Violation|13|||
170838121|NCT01251770|617416130|FG001|Overall Study|Protocol Violation|7|||
170838122|NCT03299049|617416134|FG000|Overall Study|On-going|486|||
170838123|NCT03299049|617416135|FG001|Overall Study|On-going|481|||
170838124|NCT03299049|617416134|FG000|Overall Study|Withdrawal by Subject|6|||
170838125|NCT03299049|617416135|FG001|Overall Study|Withdrawal by Subject|21|||
170838126|NCT03299049|617416134|FG000|Overall Study|Physician Decision|5|||
170838127|NCT03299049|617416135|FG001|Overall Study|Physician Decision|1|||
170838128|NCT03299049|617416134|FG000|Overall Study|Lost to Follow-up|2|||
170838129|NCT03299049|617416135|FG001|Overall Study|Lost to Follow-up|0|||
170838130|NCT03299049|617416134|FG000|Overall Study|Pregnancy|1|||
170838131|NCT03299049|617416135|FG001|Overall Study|Pregnancy|3|||
170838132|NCT03299049|617416134|FG000|Overall Study|Protocol Violation|1|||
170838133|NCT03299049|617416135|FG001|Overall Study|Protocol Violation|1|||
170838134|NCT03299049|617416134|FG000|Overall Study|Lack of Efficacy|9|||
170838135|NCT03299049|617416135|FG001|Overall Study|Lack of Efficacy|3|||
170838136|NCT03299049|617416134|FG000|Overall Study|Adverse Event|12|||
170838137|NCT03299049|617416135|FG001|Overall Study|Adverse Event|13|||
170838138|NCT00475644|617416136|FG000|Overall Study|Protocol Violation|13|||
170838139|NCT01411241|617416139|FG000|Overall Study|Protocol Violation|0|||
170838140|NCT01411241|617416140|FG001|Overall Study|Protocol Violation|5|||
170838141|NCT01411241|617416139|FG000|Overall Study|Withdrawal by Subject|9|||
170838142|NCT01411241|617416140|FG001|Overall Study|Withdrawal by Subject|10|||
170838143|NCT01411241|617416139|FG000|Overall Study|Serious Adverse Event|0|||
170838144|NCT01411241|617416140|FG001|Overall Study|Serious Adverse Event|3|||
170838145|NCT01411241|617416139|FG000|Overall Study|Lost to Follow-up|2|||
170838146|NCT01411241|617416140|FG001|Overall Study|Lost to Follow-up|4|||
170838147|NCT02493946|617416149|FG000|DB Period|Withdrawal by Subject|8|||
170838148|NCT02493946|617416150|FG001|DB Period|Withdrawal by Subject|5|||
170838149|NCT02493946|617416151|FG002|DB Period|Withdrawal by Subject|0|||
170838150|NCT02493946|617416149|FG000|Open Label Period|Withdrawal by Subject|0|||
170838151|NCT02493946|617416150|FG001|Open Label Period|Withdrawal by Subject|0|||
170838152|NCT02493946|617416151|FG002|Open Label Period|Withdrawal by Subject|74|||
170838153|NCT02493946|617416149|FG000|Open Label Period|Adverse Event|0|||
170838154|NCT02493946|617416150|FG001|Open Label Period|Adverse Event|0|||
170838155|NCT02493946|617416151|FG002|Open Label Period|Adverse Event|4|||
170838156|NCT02493946|617416149|FG000|Open Label Period|Lost to Follow-up|0|||
170838157|NCT02493946|617416150|FG001|Open Label Period|Lost to Follow-up|0|||
170838158|NCT02493946|617416151|FG002|Open Label Period|Lost to Follow-up|1|||
170838159|NCT02493946|617416149|FG000|Open Label Period|Investigator decision, non-compliance|0|||
170838160|NCT02493946|617416150|FG001|Open Label Period|Investigator decision, non-compliance|0|||
170838161|NCT02493946|617416151|FG002|Open Label Period|Investigator decision, non-compliance|2|||
170838162|NCT02493946|617416149|FG000|Open Label Period|Investigator decision, non-availability|0|||
170838163|NCT02493946|617416150|FG001|Open Label Period|Investigator decision, non-availability|0|||
170838164|NCT02493946|617416151|FG002|Open Label Period|Investigator decision, non-availability|1|||
170838165|NCT02493946|617416149|FG000|Open Label Period|Pregnancy|0|||
170838166|NCT02493946|617416150|FG001|Open Label Period|Pregnancy|0|||
170838167|NCT02493946|617416151|FG002|Open Label Period|Pregnancy|3|||
170838168|NCT02493946|617416149|FG000|Open Label Period|Site error|0|||
170838169|NCT02493946|617416150|FG001|Open Label Period|Site error|0|||
170838170|NCT02493946|617416151|FG002|Open Label Period|Site error|1|||
170838171|NCT04148651|617416153|FG000|Overall Study|Lost to Follow-up|2|||
170838172|NCT03392168|617416156|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
170838173|NCT03392168|617416157|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
170838174|NCT03392168|617416158|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
170838175|NCT03392168|617416159|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
170838176|NCT03392168|617416156|FG000|Period 2: Cohort 2|Other|0|||
170838177|NCT03392168|617416157|FG001|Period 2: Cohort 2|Other|1|||
170838178|NCT03392168|617416158|FG002|Period 2: Cohort 2|Other|0|||
170838179|NCT03392168|617416159|FG003|Period 2: Cohort 2|Other|0|||
170838180|NCT03519204|617416160|FG000|Overall Study|Lost to Follow-up|3|||
170838181|NCT03519204|617416161|FG001|Overall Study|Lost to Follow-up|8|||
170838182|NCT03519204|617416160|FG000|Overall Study|Withdrawal by Subject|9|||
170838183|NCT03519204|617416161|FG001|Overall Study|Withdrawal by Subject|7|||
170838184|NCT03519204|617416160|FG000|Overall Study|Other Miscellaneous Reasons|1|||
170838185|NCT03519204|617416161|FG001|Overall Study|Other Miscellaneous Reasons|0|||
170838186|NCT02956837|617416162|FG000|Overall Study|Serious Adverse Events|0|||
170838187|NCT02956837|617416163|FG001|Overall Study|Serious Adverse Events|1|||
170838188|NCT02956837|617416164|FG002|Overall Study|Serious Adverse Events|0|||
170838189|NCT02956837|617416165|FG003|Overall Study|Serious Adverse Events|0|||
170838190|NCT02956837|617416162|FG000|Overall Study|Withdrawal by Subject|0|||
170838191|NCT02956837|617416163|FG001|Overall Study|Withdrawal by Subject|1|||
170838192|NCT02956837|617416164|FG002|Overall Study|Withdrawal by Subject|0|||
170838193|NCT02956837|617416165|FG003|Overall Study|Withdrawal by Subject|3|||
170838194|NCT02956837|617416162|FG000|Overall Study|Lost to Follow-up|0|||
170838195|NCT02956837|617416163|FG001|Overall Study|Lost to Follow-up|1|||
170838196|NCT02956837|617416164|FG002|Overall Study|Lost to Follow-up|2|||
170838197|NCT02956837|617416165|FG003|Overall Study|Lost to Follow-up|0|||
170838198|NCT00762476|617416166|FG000|Overall Study|Adverse Event|7|||
170838199|NCT00762476|617416167|FG001|Overall Study|Adverse Event|1|||
170838200|NCT00762476|617416166|FG000|Overall Study|Lost to Follow-up|2|||
170838201|NCT00762476|617416167|FG001|Overall Study|Lost to Follow-up|0|||
170838202|NCT00762476|617416166|FG000|Overall Study|Protocol Violation|5|||
170838203|NCT00762476|617416167|FG001|Overall Study|Protocol Violation|6|||
170838204|NCT00762476|617416166|FG000|Overall Study|Physician Decision|2|||
170838205|NCT00762476|617416167|FG001|Overall Study|Physician Decision|14|||
170838206|NCT00762476|617416166|FG000|Overall Study|Withdrawal by Subject|6|||
170838207|NCT00762476|617416167|FG001|Overall Study|Withdrawal by Subject|12|||
170838208|NCT00762476|617416166|FG000|Overall Study|antibiotic use|0|||
170838209|NCT00762476|617416167|FG001|Overall Study|antibiotic use|1|||
170838210|NCT00762476|617416166|FG000|Overall Study|non-compliance with study visits|0|||
170838211|NCT00762476|617416167|FG001|Overall Study|non-compliance with study visits|2|||
170838212|NCT00762476|617416166|FG000|Overall Study|Seasonal allergies|1|||
170838213|NCT00762476|617416167|FG001|Overall Study|Seasonal allergies|0|||
170838214|NCT01727505|617416172|FG000|First 24 Hours|Adverse Event|0|||
170838215|NCT01727505|617416173|FG001|First 24 Hours|Adverse Event|1|||
170838216|NCT01727505|617416172|FG000|Second 24 Hours|Missing data|0|||
170838217|NCT01727505|617416173|FG001|Second 24 Hours|Missing data|1|||
170838218|NCT01441635|617416174|FG000|Overall Study|Adverse Event|4|||
170838219|NCT01441635|617416175|FG001|Overall Study|Adverse Event|3|||
170838220|NCT01441635|617416176|FG002|Overall Study|Adverse Event|1|||
170838221|NCT01441635|617416177|FG003|Overall Study|Adverse Event|5|||
170838222|NCT01441635|617416178|FG004|Overall Study|Adverse Event|1|||
170838223|NCT01441635|617416179|FG005|Overall Study|Adverse Event|2|||
170838224|NCT01441635|617416180|FG006|Overall Study|Adverse Event|2|||
170838225|NCT01441635|617416181|FG007|Overall Study|Adverse Event|2|||
170838226|NCT01441635|617416182|FG008|Overall Study|Adverse Event|1|||
170838227|NCT01441635|617416183|FG009|Overall Study|Adverse Event|0|||
170838228|NCT01441635|617416174|FG000|Overall Study|Withdrawal by Subject|1|||
170838229|NCT01441635|617416175|FG001|Overall Study|Withdrawal by Subject|1|||
170838230|NCT01441635|617416176|FG002|Overall Study|Withdrawal by Subject|0|||
170838231|NCT01441635|617416177|FG003|Overall Study|Withdrawal by Subject|1|||
170838232|NCT01441635|617416178|FG004|Overall Study|Withdrawal by Subject|0|||
170838233|NCT01441635|617416179|FG005|Overall Study|Withdrawal by Subject|0|||
170838234|NCT01441635|617416180|FG006|Overall Study|Withdrawal by Subject|2|||
170838235|NCT01441635|617416181|FG007|Overall Study|Withdrawal by Subject|0|||
170838236|NCT01441635|617416182|FG008|Overall Study|Withdrawal by Subject|1|||
170838237|NCT01441635|617416183|FG009|Overall Study|Withdrawal by Subject|1|||
170838238|NCT01441635|617416174|FG000|Overall Study|Lost to Follow-up|0|||
170838239|NCT01441635|617416175|FG001|Overall Study|Lost to Follow-up|1|||
170838240|NCT01441635|617416176|FG002|Overall Study|Lost to Follow-up|1|||
170838241|NCT01441635|617416177|FG003|Overall Study|Lost to Follow-up|1|||
170838242|NCT01441635|617416178|FG004|Overall Study|Lost to Follow-up|1|||
170838243|NCT01441635|617416179|FG005|Overall Study|Lost to Follow-up|3|||
170838244|NCT01441635|617416180|FG006|Overall Study|Lost to Follow-up|1|||
170838245|NCT01441635|617416181|FG007|Overall Study|Lost to Follow-up|1|||
170838246|NCT01441635|617416182|FG008|Overall Study|Lost to Follow-up|0|||
170838247|NCT01441635|617416183|FG009|Overall Study|Lost to Follow-up|1|||
170838248|NCT01441635|617416174|FG000|Overall Study|Noncompliance|0|||
170838249|NCT01441635|617416175|FG001|Overall Study|Noncompliance|1|||
170838250|NCT01441635|617416176|FG002|Overall Study|Noncompliance|0|||
170838251|NCT01441635|617416177|FG003|Overall Study|Noncompliance|0|||
170838252|NCT01441635|617416178|FG004|Overall Study|Noncompliance|0|||
170838253|NCT01441635|617416179|FG005|Overall Study|Noncompliance|0|||
170838254|NCT01441635|617416180|FG006|Overall Study|Noncompliance|1|||
170838255|NCT01441635|617416181|FG007|Overall Study|Noncompliance|0|||
170730962|NCT03076970|617019608|FG003|Period 3|Failure to meet I/E criteria|0|||
170730963|NCT03076970|617019609|FG004|Period 3|Failure to meet I/E criteria|1|||
170730964|NCT03076970|617019610|FG005|Period 3|Failure to meet I/E criteria|0|||
170730965|NCT01984697|617019611|FG000|Overall Study|Adverse Event|0|||
170730966|NCT01984697|617019612|FG001|Overall Study|Adverse Event|0|||
170730967|NCT01984697|617019613|FG002|Overall Study|Adverse Event|2|||
170730968|NCT01984697|617019614|FG003|Overall Study|Adverse Event|0|||
170730969|NCT01984697|617019615|FG004|Overall Study|Adverse Event|0|||
170730970|NCT01984697|617019611|FG000|Overall Study|Lost to Follow-up|14|||
170730971|NCT01984697|617019612|FG001|Overall Study|Lost to Follow-up|5|||
170730972|NCT01984697|617019613|FG002|Overall Study|Lost to Follow-up|10|||
170730973|NCT01984697|617019614|FG003|Overall Study|Lost to Follow-up|6|||
170730974|NCT01984697|617019615|FG004|Overall Study|Lost to Follow-up|21|||
170730975|NCT01984697|617019611|FG000|Overall Study|Physician Decision|3|||
170730976|NCT01984697|617019612|FG001|Overall Study|Physician Decision|0|||
170730977|NCT01984697|617019613|FG002|Overall Study|Physician Decision|0|||
170730978|NCT01984697|617019614|FG003|Overall Study|Physician Decision|1|||
170730979|NCT01984697|617019615|FG004|Overall Study|Physician Decision|0|||
170730980|NCT01984697|617019611|FG000|Overall Study|Protocol Violation|8|||
170730981|NCT01984697|617019612|FG001|Overall Study|Protocol Violation|5|||
170730982|NCT01984697|617019613|FG002|Overall Study|Protocol Violation|3|||
170730983|NCT01984697|617019614|FG003|Overall Study|Protocol Violation|2|||
170730984|NCT01984697|617019615|FG004|Overall Study|Protocol Violation|0|||
170730985|NCT01984697|617019611|FG000|Overall Study|Withdrawal by Subject|15|||
170730986|NCT01984697|617019612|FG001|Overall Study|Withdrawal by Subject|21|||
170730987|NCT01984697|617019613|FG002|Overall Study|Withdrawal by Subject|13|||
170730988|NCT01984697|617019614|FG003|Overall Study|Withdrawal by Subject|11|||
170730989|NCT01984697|617019615|FG004|Overall Study|Withdrawal by Subject|13|||
170730990|NCT01984697|617019611|FG000|Overall Study|Missed last follow-up visit|1|||
170730991|NCT01984697|617019612|FG001|Overall Study|Missed last follow-up visit|0|||
170730992|NCT01984697|617019613|FG002|Overall Study|Missed last follow-up visit|0|||
170730993|NCT01984697|617019614|FG003|Overall Study|Missed last follow-up visit|0|||
170730994|NCT01984697|617019615|FG004|Overall Study|Missed last follow-up visit|0|||
170730995|NCT01984697|617019611|FG000|Overall Study|Death|0|||
170730996|NCT01984697|617019612|FG001|Overall Study|Death|0|||
170730997|NCT01984697|617019613|FG002|Overall Study|Death|0|||
170730998|NCT01984697|617019614|FG003|Overall Study|Death|1|||
170730999|NCT01984697|617019615|FG004|Overall Study|Death|0|||
170731000|NCT01984697|617019611|FG000|Overall Study|Pregnancy|2|||
170731001|NCT01984697|617019612|FG001|Overall Study|Pregnancy|0|||
170731002|NCT01984697|617019613|FG002|Overall Study|Pregnancy|1|||
170731003|NCT01984697|617019614|FG003|Overall Study|Pregnancy|0|||
170731004|NCT01984697|617019615|FG004|Overall Study|Pregnancy|1|||
170731005|NCT02240108|617019616|FG000|Overall Study|Other than specified|8|||
170731006|NCT02240108|617019617|FG001|Overall Study|Other than specified|6|||
170731007|NCT02240108|617019616|FG000|Overall Study|Adverse Event|1|||
170731008|NCT02240108|617019617|FG001|Overall Study|Adverse Event|9|||
170731009|NCT02240108|617019616|FG000|Overall Study|Pregnancy|1|||
170731010|NCT02240108|617019617|FG001|Overall Study|Pregnancy|0|||
170731011|NCT02240108|617019616|FG000|Overall Study|Withdrawal by Subject|4|||
170731012|NCT02240108|617019617|FG001|Overall Study|Withdrawal by Subject|9|||
170731013|NCT02240108|617019616|FG000|Overall Study|StudyTerminated by Sponsor|0|||
170731014|NCT02240108|617019617|FG001|Overall Study|StudyTerminated by Sponsor|1|||
170731015|NCT00939484|617019618|FG000|Overall Study|Progression/Relapse|8|||
170731016|NCT00939484|617019619|FG001|Overall Study|Progression/Relapse|20|||
170731017|NCT00939484|617019620|FG002|Overall Study|Progression/Relapse|3|||
170731018|NCT01364922|617019623|FG000|Open-label (OL) Period|Adverse Event|7|||
170731019|NCT01364922|617019624|FG001|Open-label (OL) Period|Adverse Event|0|||
170731020|NCT01364922|617019625|FG002|Open-label (OL) Period|Adverse Event|0|||
170731021|NCT01364922|617019623|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
170731022|NCT01364922|617019624|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
170731023|NCT01364922|617019625|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
170731024|NCT01364922|617019623|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
170731025|NCT01364922|617019624|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
170731026|NCT01364922|617019625|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
170731027|NCT01364922|617019623|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
170731028|NCT01364922|617019624|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
170731029|NCT01364922|617019625|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
170731030|NCT01364922|617019623|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
170731031|NCT01364922|617019624|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
170838256|NCT01441635|617416182|FG008|Overall Study|Noncompliance|0|||
170838257|NCT01441635|617416183|FG009|Overall Study|Noncompliance|0|||
170838258|NCT01441635|617416174|FG000|Overall Study|Surgery or Invasive Intervention|0|||
170838259|NCT01441635|617416175|FG001|Overall Study|Surgery or Invasive Intervention|0|||
170838260|NCT01441635|617416176|FG002|Overall Study|Surgery or Invasive Intervention|1|||
170838261|NCT01441635|617416177|FG003|Overall Study|Surgery or Invasive Intervention|0|||
170838262|NCT01441635|617416178|FG004|Overall Study|Surgery or Invasive Intervention|0|||
170838263|NCT01441635|617416179|FG005|Overall Study|Surgery or Invasive Intervention|0|||
170838264|NCT01441635|617416180|FG006|Overall Study|Surgery or Invasive Intervention|0|||
170838265|NCT01441635|617416181|FG007|Overall Study|Surgery or Invasive Intervention|0|||
170838266|NCT01441635|617416182|FG008|Overall Study|Surgery or Invasive Intervention|0|||
170838267|NCT01441635|617416183|FG009|Overall Study|Surgery or Invasive Intervention|0|||
170838268|NCT01441635|617416174|FG000|Overall Study|Received Exclusionary Medication|1|||
170838269|NCT01441635|617416175|FG001|Overall Study|Received Exclusionary Medication|0|||
170838270|NCT01441635|617416176|FG002|Overall Study|Received Exclusionary Medication|0|||
170838271|NCT01441635|617416177|FG003|Overall Study|Received Exclusionary Medication|0|||
170838272|NCT01441635|617416178|FG004|Overall Study|Received Exclusionary Medication|0|||
170838273|NCT01441635|617416179|FG005|Overall Study|Received Exclusionary Medication|0|||
170838274|NCT01441635|617416180|FG006|Overall Study|Received Exclusionary Medication|0|||
170838275|NCT01441635|617416181|FG007|Overall Study|Received Exclusionary Medication|0|||
170838276|NCT01441635|617416182|FG008|Overall Study|Received Exclusionary Medication|0|||
170838277|NCT01441635|617416183|FG009|Overall Study|Received Exclusionary Medication|0|||
170838278|NCT01441635|617416174|FG000|Overall Study|Other|0|||
170838279|NCT01441635|617416175|FG001|Overall Study|Other|0|||
170838280|NCT01441635|617416176|FG002|Overall Study|Other|0|||
170838281|NCT01441635|617416177|FG003|Overall Study|Other|0|||
170838282|NCT01441635|617416178|FG004|Overall Study|Other|0|||
170838283|NCT01441635|617416179|FG005|Overall Study|Other|0|||
170838284|NCT01441635|617416180|FG006|Overall Study|Other|0|||
170838285|NCT01441635|617416181|FG007|Overall Study|Other|1|||
170731032|NCT01364922|617019625|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
170731033|NCT01364922|617019623|FG000|Open-label (OL) Period|Other, Unspecified|1|||
170731034|NCT01364922|617019624|FG001|Open-label (OL) Period|Other, Unspecified|0|||
170731035|NCT01364922|617019625|FG002|Open-label (OL) Period|Other, Unspecified|0|||
170731036|NCT01364922|617019623|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
170731037|NCT01364922|617019624|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
170731038|NCT01364922|617019625|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
170731039|NCT01364922|617019623|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
170731040|NCT01364922|617019624|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
170731041|NCT01364922|617019625|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
170731042|NCT01364922|617019623|FG000|Double-Blind (DB) Period|Adverse Event|0|||
170731043|NCT01364922|617019624|FG001|Double-Blind (DB) Period|Adverse Event|0|||
170731044|NCT01364922|617019625|FG002|Double-Blind (DB) Period|Adverse Event|1|||
170731045|NCT01364922|617019623|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
170731046|NCT01364922|617019624|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
170731047|NCT01364922|617019625|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
170731048|NCT01224925|617019626|FG000|Overall Study|Lost to Follow-up|3|||
170731049|NCT01224925|617019627|FG001|Overall Study|Lost to Follow-up|2|||
170838286|NCT01441635|617416182|FG008|Overall Study|Other|0|||
170838287|NCT01441635|617416183|FG009|Overall Study|Other|0|||
170838288|NCT02878603|617416184|FG000|Overall Study|Lost to Follow-up|4|||
170838289|NCT02878603|617416185|FG001|Overall Study|Lost to Follow-up|1|||
170838290|NCT02878603|617416184|FG000|Overall Study|Withdrawal by Subject|1|||
170838291|NCT02878603|617416185|FG001|Overall Study|Withdrawal by Subject|1|||
170838292|NCT02878603|617416184|FG000|Overall Study|Death|1|||
170838293|NCT02878603|617416185|FG001|Overall Study|Death|0|||
170838294|NCT02878603|617416184|FG000|Overall Study|Physician Decision|0|||
170838295|NCT02878603|617416185|FG001|Overall Study|Physician Decision|3|||
170838296|NCT00358644|617416186|FG000|Overall Study|Progressive Disease|21|||
170838297|NCT00358644|617416186|FG000|Overall Study|Adverse Event|7|||
170838298|NCT00358644|617416186|FG000|Overall Study|Death|11|||
170838299|NCT00358644|617416186|FG000|Overall Study|Withdrawal by Subject|4|||
170838300|NCT00358644|617416186|FG000|Overall Study|Physician Decision|6|||
170838301|NCT00358644|617416186|FG000|Overall Study|Patient not eligible for study|1|||
170838302|NCT02269423|617416187|FG000|Overall Study|Discontinued due to change in residence|0|||
170838303|NCT02269423|617416188|FG001|Overall Study|Discontinued due to change in residence|1|||
170838304|NCT02269423|617416189|FG002|Overall Study|Discontinued due to change in residence|0|||
170731050|NCT05178121|617019628|FG000|Overall Study|Other|4|||
170731051|NCT05178121|617019628|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
170731052|NCT00949884|617019629|FG000|Overall Study|Adverse Event|14|||
170731053|NCT00949884|617019630|FG001|Overall Study|Adverse Event|3|||
170731054|NCT00949884|617019631|FG002|Overall Study|Adverse Event|12|||
170731055|NCT00949884|617019629|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
170731056|NCT00949884|617019630|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
170731057|NCT00949884|617019631|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
170731058|NCT00949884|617019629|FG000|Overall Study|Lost to Follow-up|7|||
170731059|NCT00949884|617019630|FG001|Overall Study|Lost to Follow-up|5|||
170731060|NCT00949884|617019631|FG002|Overall Study|Lost to Follow-up|5|||
170731061|NCT00949884|617019629|FG000|Overall Study|Physician Decision|5|||
170731062|NCT00949884|617019630|FG001|Overall Study|Physician Decision|0|||
170731063|NCT00949884|617019631|FG002|Overall Study|Physician Decision|6|||
170731064|NCT00949884|617019629|FG000|Overall Study|Treatment non-compliance|5|||
170731065|NCT00949884|617019630|FG001|Overall Study|Treatment non-compliance|0|||
170731066|NCT00949884|617019631|FG002|Overall Study|Treatment non-compliance|8|||
170731067|NCT00949884|617019629|FG000|Overall Study|Withdrawal by Subject|13|||
170731068|NCT00949884|617019630|FG001|Overall Study|Withdrawal by Subject|4|||
170731069|NCT00949884|617019631|FG002|Overall Study|Withdrawal by Subject|16|||
170731070|NCT00949884|617019629|FG000|Overall Study|Lack of Efficacy|4|||
170731071|NCT00949884|617019630|FG001|Overall Study|Lack of Efficacy|2|||
170731072|NCT00949884|617019631|FG002|Overall Study|Lack of Efficacy|7|||
170731073|NCT00949884|617019629|FG000|Overall Study|Study terminated by sponsor|0|||
170731074|NCT00949884|617019630|FG001|Overall Study|Study terminated by sponsor|0|||
170731075|NCT00949884|617019631|FG002|Overall Study|Study terminated by sponsor|1|||
170731076|NCT02364180|617019645|FG000|Overall Study|Screen Fail|1|||
170731077|NCT03320018|617019648|FG000|Treatment Period|Withdrawal by Subject|1|||
170731078|NCT03320018|617019649|FG001|Treatment Period|Withdrawal by Subject|0|||
170731079|NCT03320018|617019648|FG000|Day 90 Follow up|Death|0|||
170731080|NCT03320018|617019649|FG001|Day 90 Follow up|Death|1|||
170731081|NCT02799784|617019654|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
170731082|NCT02799784|617019655|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
170731083|NCT02799784|617019654|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
170731084|NCT02799784|617019655|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
170731085|NCT02799784|617019654|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
170731086|NCT02799784|617019655|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
170731087|NCT02799784|617019654|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
170731088|NCT02799784|617019655|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
170731089|NCT02799784|617019654|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
170731090|NCT02799784|617019655|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
170731091|NCT02799784|617019654|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
170731092|NCT02799784|617019655|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
170731093|NCT01127646|617019656|FG000|Overall Study|Entry Criteria Not Met|1|||
170731094|NCT01127646|617019657|FG001|Overall Study|Entry Criteria Not Met|0|||
170731095|NCT01127646|617019656|FG000|Overall Study|Protocol Violation|0|||
170731096|NCT01127646|617019657|FG001|Overall Study|Protocol Violation|1|||
170731097|NCT00293267|617019658|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
170731098|NCT00293267|617019659|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
170731099|NCT00293267|617019658|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
170731100|NCT00293267|617019659|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
170731101|NCT00293267|617019658|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
170731102|NCT00293267|617019659|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
170731103|NCT00293267|617019658|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
170731104|NCT00293267|617019659|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
170731105|NCT00293267|617019658|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
170731106|NCT00293267|617019659|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
170731107|NCT00293267|617019658|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
170731108|NCT00293267|617019659|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
170838305|NCT02269423|617416190|FG003|Overall Study|Discontinued due to change in residence|1|||
170838306|NCT00699842|617416194|FG000|Overall Study|Death|0|||
170838307|NCT00699842|617416195|FG001|Overall Study|Death|1|||
170838308|NCT00699842|617416196|FG002|Overall Study|Death|0|||
170838309|NCT04946942|617416197|FG000|Overall Study|Lost to Follow-up|6|||
170838310|NCT04946942|617416198|FG001|Overall Study|Lost to Follow-up|2|||
170838311|NCT04946942|617416199|FG002|Overall Study|Lost to Follow-up|0|||
170838312|NCT00365547|617416200|FG000|Overall Study|Insurance did not cover Avastin|1|||
170838313|NCT00365547|617416200|FG000|Overall Study|Screen failure|1|||
170838314|NCT00365547|617416200|FG000|Overall Study|Withdrawal by Subject|1|||
170838315|NCT02520310|617416208|FG000|At 6 Months Clinical Follow-up|Death|1|||
170838316|NCT02520310|617416208|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
170838317|NCT02520310|617416208|FG000|AT 3 Year Clinical Follow-up|Death|2|||
170838318|NCT02520310|617416208|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
170838319|NCT02520310|617416208|FG000|AT 4 Year Clinical Follow-up|Death|1|||
170838320|NCT02520310|617416208|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
170838321|NCT05101993|617416213|FG000|Overall Study|Withdrawal by Subject|1|||
170838322|NCT04577573|617416214|FG000|Overall Study|Technical - invalid protocol|0|||
170838323|NCT04577573|617416215|FG001|Overall Study|Technical - invalid protocol|2|||
170838324|NCT04577573|617416216|FG002|Overall Study|Technical - invalid protocol|0|||
170838325|NCT02065882|617416220|FG000|Part I: PK/PD|Screening failure|5|||
170838326|NCT02065882|617416220|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
170838327|NCT02065882|617416220|FG000|Part I: PK/PD|Adverse Event|1|||
170838328|NCT02065882|617416220|FG000|Part II: Clinical Efficacy|Screening failure|7|||
170838329|NCT02065882|617416220|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
170838330|NCT02065882|617416220|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
170838331|NCT02065882|617416220|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
170838332|NCT02065882|617416220|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
170838333|NCT02065882|617416220|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
170838334|NCT06719986|617416221|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
170838335|NCT06719986|617416222|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
170838336|NCT06719986|617416223|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
170838337|NCT06719986|617416221|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
170838338|NCT06719986|617416222|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
170838339|NCT06719986|617416223|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
170838340|NCT01020877|617417654|FG000|Second Intervention|Withdrawal by Subject|1|||
170838341|NCT01020877|617417655|FG001|Second Intervention|Withdrawal by Subject|0|||
170838342|NCT00790400|617417656|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
170838343|NCT00790400|617417657|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
170838344|NCT00790400|617417656|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
170838345|NCT00790400|617417657|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
170838346|NCT00790400|617417656|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
170838347|NCT00790400|617417657|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
170838348|NCT00790400|617417656|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
170838349|NCT00790400|617417657|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
170838350|NCT00790400|617417656|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
170838351|NCT00790400|617417657|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
170838352|NCT00790400|617417656|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
170838353|NCT00790400|617417657|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
170838354|NCT00790400|617417656|FG000|Double-blind Period (Core Phase)|Death|1|||
170838355|NCT00790400|617417657|FG001|Double-blind Period (Core Phase)|Death|0|||
170838356|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
170838357|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
170838358|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
170838359|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
170838360|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
170838361|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
170838362|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
170838363|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
170838364|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
170838365|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
170838366|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|Death|1|||
170838367|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|Death|0|||
170838368|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
170838369|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
170731109|NCT00293267|617019658|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
170731110|NCT00293267|617019659|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
170731111|NCT00293267|617019658|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
170731112|NCT00293267|617019659|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
170731113|NCT00293267|617019658|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
170731114|NCT00293267|617019659|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
170731115|NCT00293267|617019658|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
170731116|NCT00293267|617019659|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
170731117|NCT00293267|617019658|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
170731118|NCT00293267|617019659|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
170731119|NCT00293267|617019658|FG000|Extension - Double-Blind Week 49-156|Death|3|||
170731120|NCT00293267|617019659|FG001|Extension - Double-Blind Week 49-156|Death|0|||
170731121|NCT00293267|617019658|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
170731122|NCT00293267|617019659|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
170731123|NCT00293267|617019658|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
170731124|NCT00293267|617019659|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
170731125|NCT00293267|617019658|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
170731126|NCT00293267|617019659|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
170731127|NCT00293267|617019658|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
170731128|NCT00293267|617019659|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
170731129|NCT00293267|617019658|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
170731130|NCT00293267|617019659|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
170731131|NCT00293267|617019658|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
170731132|NCT00293267|617019659|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
170731133|NCT00293267|617019658|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
170731134|NCT00293267|617019659|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
170731135|NCT00293267|617019658|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
170731136|NCT00293267|617019659|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
170731137|NCT00293267|617019658|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
170731138|NCT00293267|617019659|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
170731139|NCT00293267|617019658|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
170731140|NCT00293267|617019659|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
170731141|NCT00293267|617019658|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
170731142|NCT00293267|617019659|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
170731143|NCT00293267|617019658|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
170731144|NCT00293267|617019659|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
170731145|NCT00293267|617019658|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
170731146|NCT00293267|617019659|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
170731147|NCT00293267|617019658|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
170731148|NCT00293267|617019659|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
170731149|NCT00293267|617019658|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
170731150|NCT00293267|617019659|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
170731151|NCT00293267|617019658|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
170731152|NCT00293267|617019659|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
170731153|NCT01445652|617019660|FG000|Overall Study|Not comfortable in lenses|5|||
170731154|NCT01445652|617019661|FG001|Overall Study|Not comfortable in lenses|0|||
170731155|NCT01445652|617019660|FG000|Overall Study|Failed to attend scheduled visit|2|||
170731156|NCT01445652|617019661|FG001|Overall Study|Failed to attend scheduled visit|3|||
170731157|NCT01445652|617019660|FG000|Overall Study|Failed teach session|2|||
170731158|NCT01445652|617019661|FG001|Overall Study|Failed teach session|0|||
170731159|NCT01445652|617019660|FG000|Overall Study|Adverse Event|1|||
170731160|NCT01445652|617019661|FG001|Overall Study|Adverse Event|0|||
170731161|NCT04570436|617019662|FG000|Overall Study|Adverse Event|0|||
170731162|NCT04570436|617019663|FG001|Overall Study|Adverse Event|0|||
170731163|NCT04570436|617019664|FG002|Overall Study|Adverse Event|1|||
170731164|NCT04570436|617019665|FG003|Overall Study|Adverse Event|0|||
170731165|NCT04570436|617019666|FG004|Overall Study|Adverse Event|0|||
170731166|NCT04570436|617019667|FG005|Overall Study|Adverse Event|0|||
170731167|NCT04570436|617019668|FG006|Overall Study|Adverse Event|0|||
170731168|NCT04570436|617019669|FG007|Overall Study|Adverse Event|0|||
170731169|NCT04570436|617019670|FG008|Overall Study|Adverse Event|0|||
170731170|NCT04570436|617019671|FG009|Overall Study|Adverse Event|0|||
170731171|NCT04570436|617019662|FG000|Overall Study|Physician Decision|1|||
170731172|NCT04570436|617019663|FG001|Overall Study|Physician Decision|0|||
170731173|NCT04570436|617019664|FG002|Overall Study|Physician Decision|0|||
170731174|NCT04570436|617019665|FG003|Overall Study|Physician Decision|0|||
170838370|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
170838371|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
170731175|NCT04570436|617019666|FG004|Overall Study|Physician Decision|0|||
170731176|NCT04570436|617019667|FG005|Overall Study|Physician Decision|0|||
170731177|NCT04570436|617019668|FG006|Overall Study|Physician Decision|0|||
170731178|NCT04570436|617019669|FG007|Overall Study|Physician Decision|0|||
170731179|NCT04570436|617019670|FG008|Overall Study|Physician Decision|0|||
170731180|NCT04570436|617019671|FG009|Overall Study|Physician Decision|0|||
170731181|NCT03574597|617019677|FG000|Overall Study|Withdrawal by Subject|67|||
170731182|NCT03574597|617019678|FG001|Overall Study|Withdrawal by Subject|96|||
170731183|NCT03574597|617019677|FG000|Overall Study|Lost to Follow-up|192|||
170731184|NCT03574597|617019678|FG001|Overall Study|Lost to Follow-up|188|||
170731185|NCT00162370|617019679|FG000|Efficacy Population|Lost to Follow-up|51|||
170731186|NCT02355743|617019680|FG000|Overall Study|Withdrawal by Subject|1|||
170731187|NCT02355743|617019680|FG000|Overall Study|Lost to Follow-up|1|||
170731188|NCT02712905|617019683|FG000|Monotherapy|Death|2|||
170731189|NCT02712905|617019684|FG001|Monotherapy|Death|5|||
170731190|NCT02712905|617019685|FG002|Monotherapy|Death|0|||
170731191|NCT02712905|617019686|FG003|Monotherapy|Death|3|||
170731192|NCT02712905|617019687|FG004|Monotherapy|Death|15|||
170731193|NCT02712905|617019688|FG005|Monotherapy|Death|1|||
170731194|NCT02712905|617019689|FG006|Monotherapy|Death|3|||
170731195|NCT02712905|617019690|FG007|Monotherapy|Death|3|||
170731196|NCT02712905|617019691|FG008|Monotherapy|Death|0|||
170731197|NCT02712905|617019692|FG009|Monotherapy|Death|27|||
170731198|NCT02712905|617019693|FG010|Monotherapy|Death|2|||
170731199|NCT02712905|617019694|FG011|Monotherapy|Death|5|||
170731200|NCT02712905|617019695|FG012|Monotherapy|Death|0|||
170731201|NCT02712905|617019696|FG013|Monotherapy|Death|0|||
170731202|NCT02712905|617019697|FG014|Monotherapy|Death|0|||
170731203|NCT02712905|617019698|FG015|Monotherapy|Death|0|||
170731204|NCT02712905|617019699|FG016|Monotherapy|Death|0|||
170731205|NCT02712905|617019700|FG017|Monotherapy|Death|0|||
170731206|NCT02712905|617019683|FG000|Monotherapy|Lost to Follow-up|0|||
170731207|NCT02712905|617019684|FG001|Monotherapy|Lost to Follow-up|1|||
170731208|NCT02712905|617019685|FG002|Monotherapy|Lost to Follow-up|0|||
170731209|NCT02712905|617019686|FG003|Monotherapy|Lost to Follow-up|1|||
170731210|NCT02712905|617019687|FG004|Monotherapy|Lost to Follow-up|0|||
170731211|NCT02712905|617019688|FG005|Monotherapy|Lost to Follow-up|0|||
170731212|NCT02712905|617019689|FG006|Monotherapy|Lost to Follow-up|0|||
170731213|NCT02712905|617019690|FG007|Monotherapy|Lost to Follow-up|0|||
170731214|NCT02712905|617019691|FG008|Monotherapy|Lost to Follow-up|0|||
170731215|NCT02712905|617019692|FG009|Monotherapy|Lost to Follow-up|2|||
170731216|NCT02712905|617019693|FG010|Monotherapy|Lost to Follow-up|0|||
170731217|NCT02712905|617019694|FG011|Monotherapy|Lost to Follow-up|0|||
170731218|NCT02712905|617019695|FG012|Monotherapy|Lost to Follow-up|0|||
170731219|NCT02712905|617019696|FG013|Monotherapy|Lost to Follow-up|0|||
170731220|NCT02712905|617019697|FG014|Monotherapy|Lost to Follow-up|0|||
170731221|NCT02712905|617019698|FG015|Monotherapy|Lost to Follow-up|0|||
170731222|NCT02712905|617019699|FG016|Monotherapy|Lost to Follow-up|0|||
170731223|NCT02712905|617019700|FG017|Monotherapy|Lost to Follow-up|0|||
170731224|NCT02712905|617019683|FG000|Monotherapy|Physician Decision|1|||
170731225|NCT02712905|617019684|FG001|Monotherapy|Physician Decision|0|||
170731226|NCT02712905|617019685|FG002|Monotherapy|Physician Decision|0|||
170731227|NCT02712905|617019686|FG003|Monotherapy|Physician Decision|1|||
170731228|NCT02712905|617019687|FG004|Monotherapy|Physician Decision|0|||
170731229|NCT02712905|617019688|FG005|Monotherapy|Physician Decision|0|||
170731230|NCT02712905|617019689|FG006|Monotherapy|Physician Decision|0|||
170731231|NCT02712905|617019690|FG007|Monotherapy|Physician Decision|0|||
170731232|NCT02712905|617019691|FG008|Monotherapy|Physician Decision|0|||
170731233|NCT02712905|617019692|FG009|Monotherapy|Physician Decision|1|||
170731234|NCT02712905|617019693|FG010|Monotherapy|Physician Decision|0|||
170731235|NCT02712905|617019694|FG011|Monotherapy|Physician Decision|0|||
170731236|NCT02712905|617019695|FG012|Monotherapy|Physician Decision|0|||
170731237|NCT02712905|617019696|FG013|Monotherapy|Physician Decision|0|||
170731238|NCT02712905|617019697|FG014|Monotherapy|Physician Decision|0|||
170731239|NCT02712905|617019698|FG015|Monotherapy|Physician Decision|0|||
170731240|NCT02712905|617019699|FG016|Monotherapy|Physician Decision|0|||
170731241|NCT02712905|617019700|FG017|Monotherapy|Physician Decision|0|||
170731242|NCT02712905|617019683|FG000|Monotherapy|Study Terminated by Sponsor|0|||
170731243|NCT02712905|617019684|FG001|Monotherapy|Study Terminated by Sponsor|0|||
170731244|NCT02712905|617019685|FG002|Monotherapy|Study Terminated by Sponsor|0|||
170731245|NCT02712905|617019686|FG003|Monotherapy|Study Terminated by Sponsor|0|||
170731246|NCT02712905|617019687|FG004|Monotherapy|Study Terminated by Sponsor|1|||
170838372|NCT00790400|617417656|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
170731247|NCT02712905|617019688|FG005|Monotherapy|Study Terminated by Sponsor|0|||
170838373|NCT00790400|617417657|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
170731248|NCT02712905|617019689|FG006|Monotherapy|Study Terminated by Sponsor|0|||
170731249|NCT02712905|617019690|FG007|Monotherapy|Study Terminated by Sponsor|0|||
170731250|NCT02712905|617019691|FG008|Monotherapy|Study Terminated by Sponsor|0|||
170731251|NCT02712905|617019692|FG009|Monotherapy|Study Terminated by Sponsor|2|||
170731252|NCT02712905|617019693|FG010|Monotherapy|Study Terminated by Sponsor|0|||
170731253|NCT02712905|617019694|FG011|Monotherapy|Study Terminated by Sponsor|0|||
170731254|NCT02712905|617019695|FG012|Monotherapy|Study Terminated by Sponsor|0|||
170731255|NCT02712905|617019696|FG013|Monotherapy|Study Terminated by Sponsor|0|||
170731256|NCT02712905|617019697|FG014|Monotherapy|Study Terminated by Sponsor|0|||
170731257|NCT02712905|617019698|FG015|Monotherapy|Study Terminated by Sponsor|0|||
170731258|NCT02712905|617019699|FG016|Monotherapy|Study Terminated by Sponsor|0|||
170731259|NCT02712905|617019700|FG017|Monotherapy|Study Terminated by Sponsor|0|||
170731260|NCT02712905|617019683|FG000|Monotherapy|Withdrawal by Subject|0|||
170731261|NCT02712905|617019684|FG001|Monotherapy|Withdrawal by Subject|0|||
170731262|NCT02712905|617019685|FG002|Monotherapy|Withdrawal by Subject|1|||
170731263|NCT02712905|617019686|FG003|Monotherapy|Withdrawal by Subject|0|||
170731264|NCT02712905|617019687|FG004|Monotherapy|Withdrawal by Subject|2|||
170731265|NCT02712905|617019688|FG005|Monotherapy|Withdrawal by Subject|0|||
170731266|NCT02712905|617019689|FG006|Monotherapy|Withdrawal by Subject|0|||
170731267|NCT02712905|617019690|FG007|Monotherapy|Withdrawal by Subject|0|||
170731268|NCT02712905|617019691|FG008|Monotherapy|Withdrawal by Subject|0|||
170731269|NCT02712905|617019692|FG009|Monotherapy|Withdrawal by Subject|4|||
170731270|NCT02712905|617019693|FG010|Monotherapy|Withdrawal by Subject|1|||
170731271|NCT02712905|617019694|FG011|Monotherapy|Withdrawal by Subject|2|||
170731272|NCT02712905|617019695|FG012|Monotherapy|Withdrawal by Subject|0|||
170731273|NCT02712905|617019696|FG013|Monotherapy|Withdrawal by Subject|0|||
170731274|NCT02712905|617019697|FG014|Monotherapy|Withdrawal by Subject|0|||
170731275|NCT02712905|617019698|FG015|Monotherapy|Withdrawal by Subject|0|||
170731276|NCT02712905|617019699|FG016|Monotherapy|Withdrawal by Subject|0|||
170731277|NCT02712905|617019700|FG017|Monotherapy|Withdrawal by Subject|0|||
170731278|NCT02712905|617019683|FG000|Monotherapy|Started New Cancer Drug|0|||
170731279|NCT02712905|617019684|FG001|Monotherapy|Started New Cancer Drug|0|||
170731280|NCT02712905|617019685|FG002|Monotherapy|Started New Cancer Drug|0|||
170731281|NCT02712905|617019686|FG003|Monotherapy|Started New Cancer Drug|0|||
170731282|NCT02712905|617019687|FG004|Monotherapy|Started New Cancer Drug|0|||
170731283|NCT02712905|617019688|FG005|Monotherapy|Started New Cancer Drug|1|||
170731284|NCT02712905|617019689|FG006|Monotherapy|Started New Cancer Drug|0|||
170731285|NCT02712905|617019690|FG007|Monotherapy|Started New Cancer Drug|0|||
170731286|NCT02712905|617019691|FG008|Monotherapy|Started New Cancer Drug|0|||
170731287|NCT02712905|617019692|FG009|Monotherapy|Started New Cancer Drug|0|||
170731288|NCT02712905|617019693|FG010|Monotherapy|Started New Cancer Drug|0|||
170731289|NCT02712905|617019694|FG011|Monotherapy|Started New Cancer Drug|0|||
170731290|NCT02712905|617019695|FG012|Monotherapy|Started New Cancer Drug|0|||
170731291|NCT02712905|617019696|FG013|Monotherapy|Started New Cancer Drug|0|||
170731292|NCT02712905|617019697|FG014|Monotherapy|Started New Cancer Drug|0|||
170731293|NCT02712905|617019698|FG015|Monotherapy|Started New Cancer Drug|0|||
170731294|NCT02712905|617019699|FG016|Monotherapy|Started New Cancer Drug|0|||
170731295|NCT02712905|617019700|FG017|Monotherapy|Started New Cancer Drug|0|||
170731296|NCT02712905|617019683|FG000|Monotherapy|Adverse Event|0|||
170731297|NCT02712905|617019684|FG001|Monotherapy|Adverse Event|0|||
170731298|NCT02712905|617019685|FG002|Monotherapy|Adverse Event|0|||
170731299|NCT02712905|617019686|FG003|Monotherapy|Adverse Event|0|||
170731300|NCT02712905|617019687|FG004|Monotherapy|Adverse Event|0|||
170731301|NCT02712905|617019688|FG005|Monotherapy|Adverse Event|0|||
170731302|NCT02712905|617019689|FG006|Monotherapy|Adverse Event|0|||
170731303|NCT02712905|617019690|FG007|Monotherapy|Adverse Event|0|||
170731304|NCT02712905|617019691|FG008|Monotherapy|Adverse Event|1|||
170731305|NCT02712905|617019692|FG009|Monotherapy|Adverse Event|0|||
170731306|NCT02712905|617019693|FG010|Monotherapy|Adverse Event|0|||
170731307|NCT02712905|617019694|FG011|Monotherapy|Adverse Event|0|||
170731308|NCT02712905|617019695|FG012|Monotherapy|Adverse Event|0|||
170731309|NCT02712905|617019696|FG013|Monotherapy|Adverse Event|0|||
170731310|NCT02712905|617019697|FG014|Monotherapy|Adverse Event|0|||
170731311|NCT02712905|617019698|FG015|Monotherapy|Adverse Event|0|||
170731312|NCT02712905|617019699|FG016|Monotherapy|Adverse Event|0|||
170731313|NCT02712905|617019700|FG017|Monotherapy|Adverse Event|0|||
170731314|NCT02712905|617019683|FG000|Combination Therapy|Death|0|||
170731315|NCT02712905|617019684|FG001|Combination Therapy|Death|0|||
170731316|NCT02712905|617019685|FG002|Combination Therapy|Death|0|||
170731317|NCT02712905|617019686|FG003|Combination Therapy|Death|0|||
170731318|NCT02712905|617019687|FG004|Combination Therapy|Death|0|||
170731319|NCT02712905|617019688|FG005|Combination Therapy|Death|0|||
170731320|NCT02712905|617019689|FG006|Combination Therapy|Death|0|||
170731321|NCT02712905|617019690|FG007|Combination Therapy|Death|0|||
170838374|NCT00699153|617417658|FG000|Overall Study|Lost to Follow-up|1|||
170731322|NCT02712905|617019691|FG008|Combination Therapy|Death|0|||
170731323|NCT02712905|617019692|FG009|Combination Therapy|Death|0|||
170731324|NCT02712905|617019693|FG010|Combination Therapy|Death|0|||
170731325|NCT02712905|617019694|FG011|Combination Therapy|Death|0|||
170731326|NCT02712905|617019695|FG012|Combination Therapy|Death|5|||
170731327|NCT02712905|617019696|FG013|Combination Therapy|Death|6|||
170731328|NCT02712905|617019697|FG014|Combination Therapy|Death|1|||
170731329|NCT02712905|617019698|FG015|Combination Therapy|Death|3|||
170731330|NCT02712905|617019699|FG016|Combination Therapy|Death|1|||
170731331|NCT02712905|617019700|FG017|Combination Therapy|Death|3|||
170731332|NCT02712905|617019683|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
170731333|NCT02712905|617019684|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
170731334|NCT02712905|617019685|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
170731335|NCT02712905|617019686|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
170838375|NCT00699153|617417659|FG001|Overall Study|Lost to Follow-up|0|||
170838376|NCT00699153|617417658|FG000|Overall Study|Adverse Event|0|||
170838377|NCT00699153|617417659|FG001|Overall Study|Adverse Event|2|||
170838378|NCT00699153|617417658|FG000|Overall Study|Protocol Violation|1|||
170838379|NCT00699153|617417659|FG001|Overall Study|Protocol Violation|0|||
170838380|NCT00699153|617417658|FG000|Overall Study|Travel Problem|1|||
170838381|NCT00699153|617417659|FG001|Overall Study|Travel Problem|0|||
170838382|NCT00078338|617417663|FG000|Overall Study|Adverse Event|31|||
170838383|NCT00078338|617417664|FG001|Overall Study|Adverse Event|24|||
170838384|NCT00078338|617417663|FG000|Overall Study|Lost to Follow-up|17|||
170838385|NCT00078338|617417664|FG001|Overall Study|Lost to Follow-up|2|||
170838386|NCT00078338|617417663|FG000|Overall Study|Protocol Violation|2|||
170838387|NCT00078338|617417664|FG001|Overall Study|Protocol Violation|2|||
170838388|NCT00078338|617417663|FG000|Overall Study|Disease Progression|4|||
170838389|NCT00078338|617417664|FG001|Overall Study|Disease Progression|7|||
170838390|NCT00078338|617417663|FG000|Overall Study|Other|28|||
170838391|NCT00078338|617417664|FG001|Overall Study|Other|16|||
170838392|NCT00078338|617417663|FG000|Overall Study|Subjects randomized, but not treated|3|||
170838393|NCT00078338|617417664|FG001|Overall Study|Subjects randomized, but not treated|3|||
170838394|NCT01483144|617417669|FG000|Overall Study|Adverse Event|9|||
170838395|NCT01483144|617417670|FG001|Overall Study|Adverse Event|4|||
170838396|NCT01483144|617417671|FG002|Overall Study|Adverse Event|6|||
170838397|NCT01483144|617417669|FG000|Overall Study|Withdrawal by Subject|0|||
170838398|NCT01483144|617417670|FG001|Overall Study|Withdrawal by Subject|2|||
170838399|NCT01483144|617417671|FG002|Overall Study|Withdrawal by Subject|5|||
170838400|NCT01483144|617417669|FG000|Overall Study|Physician Decision|1|||
170838401|NCT01483144|617417670|FG001|Overall Study|Physician Decision|0|||
170838402|NCT01483144|617417671|FG002|Overall Study|Physician Decision|0|||
170838403|NCT01483144|617417669|FG000|Overall Study|Lost to Follow-up|2|||
170838404|NCT01483144|617417670|FG001|Overall Study|Lost to Follow-up|4|||
170838405|NCT01483144|617417671|FG002|Overall Study|Lost to Follow-up|1|||
170838406|NCT01483144|617417669|FG000|Overall Study|Protocol Violation|3|||
170838407|NCT01483144|617417670|FG001|Overall Study|Protocol Violation|3|||
170838408|NCT01483144|617417671|FG002|Overall Study|Protocol Violation|3|||
170838409|NCT04043143|617417672|FG000|Overall Study|Lost to Follow-up|5|||
170838410|NCT04043143|617417673|FG001|Overall Study|Lost to Follow-up|5|||
170838411|NCT04043143|617417672|FG000|Overall Study|screen failure|1|||
170838412|NCT04043143|617417673|FG001|Overall Study|screen failure|0|||
170838413|NCT02521363|617417677|FG000|Overall Study|Withdrawal by Subject|1|||
170838414|NCT02521363|617417678|FG001|Overall Study|Withdrawal by Subject|2|||
170838415|NCT00953771|617417679|FG000|Overall Study|Death|1|||
170838416|NCT00953771|617417680|FG001|Overall Study|Death|0|||
170838417|NCT00592293|617417683|FG000|Overall Study|Withdrawal by Subject|1|||
170838418|NCT01606319|617417684|FG000|Overall Study|Lost to Follow-up|17|||
170838419|NCT01606319|617417685|FG001|Overall Study|Lost to Follow-up|14|||
170838420|NCT01606319|617417684|FG000|Overall Study|Withdrawal by Subject|9|||
170838421|NCT01606319|617417685|FG001|Overall Study|Withdrawal by Subject|12|||
170838422|NCT01606319|617417684|FG000|Overall Study|Physician Decision|1|||
170838423|NCT01606319|617417685|FG001|Overall Study|Physician Decision|2|||
170838424|NCT01606319|617417684|FG000|Overall Study|Lack of Efficacy|6|||
170838425|NCT01606319|617417685|FG001|Overall Study|Lack of Efficacy|8|||
170838426|NCT01606319|617417684|FG000|Overall Study|Adverse Event|1|||
170838427|NCT01606319|617417685|FG001|Overall Study|Adverse Event|4|||
170838428|NCT01270828|617417686|FG000|Pregabalin CR SB|Reason Unspecified|0|||
170838429|NCT01270828|617417687|FG001|Pregabalin CR SB|Reason Unspecified|0|||
170838430|NCT01270828|617417688|FG002|Pregabalin CR SB|Reason Unspecified|8|||
170838431|NCT01270828|617417686|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
170838432|NCT01270828|617417687|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
170838433|NCT01270828|617417688|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
170838434|NCT01270828|617417686|FG000|Pregabalin CR SB|Related adverse event|0|||
170838435|NCT01270828|617417687|FG001|Pregabalin CR SB|Related adverse event|0|||
170838436|NCT01270828|617417688|FG002|Pregabalin CR SB|Related adverse event|46|||
170838437|NCT01270828|617417686|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
170838438|NCT01270828|617417687|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
170838439|NCT01270828|617417688|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
170838440|NCT01270828|617417686|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
170838441|NCT01270828|617417687|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
170838442|NCT01270828|617417688|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
170838443|NCT01270828|617417686|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
170838444|NCT01270828|617417687|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
170838445|NCT01270828|617417688|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
170838446|NCT01270828|617417686|FG000|Pregabalin CR SB|Unrelated AE|0|||
170838447|NCT01270828|617417687|FG001|Pregabalin CR SB|Unrelated AE|0|||
170838448|NCT01270828|617417688|FG002|Pregabalin CR SB|Unrelated AE|8|||
170838449|NCT01270828|617417686|FG000|Pregabalin CR SB|Protocol Violation|0|||
170838450|NCT01270828|617417687|FG001|Pregabalin CR SB|Protocol Violation|0|||
170838451|NCT01270828|617417688|FG002|Pregabalin CR SB|Protocol Violation|8|||
170838452|NCT01270828|617417686|FG000|Double Blind Phase|Death|0|||
170838453|NCT01270828|617417687|FG001|Double Blind Phase|Death|1|||
170838454|NCT01270828|617417688|FG002|Double Blind Phase|Death|0|||
170838455|NCT01270828|617417686|FG000|Double Blind Phase|Protocol Violation|0|||
170838456|NCT01270828|617417687|FG001|Double Blind Phase|Protocol Violation|1|||
170838457|NCT01270828|617417688|FG002|Double Blind Phase|Protocol Violation|0|||
170838458|NCT01270828|617417686|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
170838459|NCT01270828|617417687|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
170838460|NCT01270828|617417688|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
170838461|NCT01270828|617417686|FG000|Double Blind Phase|Reason Unspecified|7|||
170838462|NCT01270828|617417687|FG001|Double Blind Phase|Reason Unspecified|4|||
170838463|NCT01270828|617417688|FG002|Double Blind Phase|Reason Unspecified|0|||
170838464|NCT01270828|617417686|FG000|Double Blind Phase|Withdrawal by Subject|6|||
170838465|NCT01270828|617417687|FG001|Double Blind Phase|Withdrawal by Subject|15|||
170838466|NCT01270828|617417688|FG002|Double Blind Phase|Withdrawal by Subject|0|||
170838467|NCT01270828|617417686|FG000|Double Blind Phase|Lost to Follow-up|1|||
170838468|NCT01270828|617417687|FG001|Double Blind Phase|Lost to Follow-up|2|||
170838469|NCT01270828|617417688|FG002|Double Blind Phase|Lost to Follow-up|0|||
170838470|NCT01270828|617417686|FG000|Double Blind Phase|Lack of Efficacy|2|||
170838471|NCT01270828|617417687|FG001|Double Blind Phase|Lack of Efficacy|11|||
170838472|NCT01270828|617417688|FG002|Double Blind Phase|Lack of Efficacy|0|||
170838473|NCT01270828|617417686|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
170838474|NCT01270828|617417687|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
170838475|NCT01270828|617417688|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
170838476|NCT01270828|617417686|FG000|Double Blind Phase|Adverse event related to study drug|5|||
170838477|NCT01270828|617417687|FG001|Double Blind Phase|Adverse event related to study drug|7|||
170838478|NCT01270828|617417688|FG002|Double Blind Phase|Adverse event related to study drug|0|||
170838479|NCT00709228|617417692|FG000|Overall Study|Not treated|14|||
170838480|NCT00709228|617417692|FG000|Overall Study|Eligibility criteria not met|281|||
170838481|NCT00709228|617417692|FG000|Overall Study|Adverse events|2|||
170838482|NCT00709228|617417692|FG000|Overall Study|Discontinued treatment|14|||
170838483|NCT00709228|617417692|FG000|Overall Study|Did not enter follow-up|4|||
170838484|NCT00709228|617417692|FG000|Overall Study|Discontinued follow-up|5|||
170838485|NCT00709228|617417692|FG000|Overall Study|Disease progression|1|||
170838486|NCT00709228|617417692|FG000|Overall Study|Lost to Follow-up|6|||
170838487|NCT00709228|617417692|FG000|Overall Study|Non-compliance|5|||
170838488|NCT02870972|617417695|FG000|Overall Study|Adverse Event|1|||
170838489|NCT02870972|617417696|FG001|Overall Study|Adverse Event|0|||
170838490|NCT02870972|617417697|FG002|Overall Study|Adverse Event|0|||
170838491|NCT02870972|617417698|FG003|Overall Study|Adverse Event|0|||
170838492|NCT02870972|617417699|FG004|Overall Study|Adverse Event|0|||
170838493|NCT00022659|617417700|FG000|Overall Study|Ineligible: wrong primary|1|||
170838494|NCT00022659|617417700|FG000|Overall Study|Never treated|1|||
170838495|NCT00884650|617417701|FG000|Overall Study|Did not return complete pain diaries|7|||
170838496|NCT00884650|617417702|FG001|Overall Study|Did not return complete pain diaries|7|||
170838497|NCT00884650|617417701|FG000|Overall Study|Admitted Post-Op|1|||
170838498|NCT00884650|617417702|FG001|Overall Study|Admitted Post-Op|0|||
170838499|NCT00884650|617417701|FG000|Overall Study|Femoral Stress Fracture|1|||
170838500|NCT00884650|617417702|FG001|Overall Study|Femoral Stress Fracture|0|||
170838501|NCT00884650|617417701|FG000|Overall Study|Pain Pump Complication|0|||
170838502|NCT00884650|617417702|FG001|Overall Study|Pain Pump Complication|1|||
170838503|NCT03322540|617417703|FG000|Overall Study|Death|21|||
170838504|NCT03322540|617417704|FG001|Overall Study|Death|28|||
170838505|NCT03322540|617417703|FG000|Overall Study|Lost to Follow-up|0|||
170838506|NCT03322540|617417704|FG001|Overall Study|Lost to Follow-up|1|||
170838507|NCT03322540|617417703|FG000|Overall Study|Physician Decision|7|||
170838508|NCT03322540|617417704|FG001|Overall Study|Physician Decision|6|||
170838509|NCT03322540|617417703|FG000|Overall Study|Withdrawal by Subject|3|||
170838510|NCT03322540|617417704|FG001|Overall Study|Withdrawal by Subject|1|||
170838511|NCT03322540|617417703|FG000|Overall Study|Study terminated by sponsor|0|||
170838512|NCT03322540|617417704|FG001|Overall Study|Study terminated by sponsor|1|||
170838513|NCT04052425|617417709|FG000|24-Week Double-blind Period|Adverse Event|0|||
170838514|NCT04052425|617417710|FG001|24-Week Double-blind Period|Adverse Event|1|||
170838515|NCT04052425|617417711|FG002|24-Week Double-blind Period|Adverse Event|0|||
170838516|NCT04052425|617417712|FG003|24-Week Double-blind Period|Adverse Event|0|||
170838517|NCT04052425|617417709|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
170838518|NCT04052425|617417710|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
170838519|NCT04052425|617417711|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
170838520|NCT04052425|617417712|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
170838521|NCT04052425|617417709|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
170838522|NCT04052425|617417710|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
170731336|NCT02712905|617019687|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
170731337|NCT02712905|617019688|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
170731338|NCT02712905|617019689|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
170731339|NCT02712905|617019690|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
170731340|NCT02712905|617019691|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
170731341|NCT02712905|617019692|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
170731342|NCT02712905|617019693|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
170731343|NCT02712905|617019694|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
170731344|NCT02712905|617019695|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
170731345|NCT02712905|617019696|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
170731346|NCT02712905|617019697|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
170731347|NCT02712905|617019698|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
170731348|NCT02712905|617019699|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
170731349|NCT02712905|617019700|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
170731350|NCT02712905|617019683|FG000|Combination Therapy|Withdrawal by Subject|0|||
170731351|NCT02712905|617019684|FG001|Combination Therapy|Withdrawal by Subject|0|||
170731352|NCT02712905|617019685|FG002|Combination Therapy|Withdrawal by Subject|0|||
170731353|NCT02712905|617019686|FG003|Combination Therapy|Withdrawal by Subject|0|||
170731354|NCT02712905|617019687|FG004|Combination Therapy|Withdrawal by Subject|0|||
170731355|NCT02712905|617019688|FG005|Combination Therapy|Withdrawal by Subject|0|||
170731356|NCT02712905|617019689|FG006|Combination Therapy|Withdrawal by Subject|0|||
170731357|NCT02712905|617019690|FG007|Combination Therapy|Withdrawal by Subject|0|||
170731358|NCT02712905|617019691|FG008|Combination Therapy|Withdrawal by Subject|0|||
170731359|NCT02712905|617019692|FG009|Combination Therapy|Withdrawal by Subject|0|||
170731360|NCT02712905|617019693|FG010|Combination Therapy|Withdrawal by Subject|0|||
170731361|NCT02712905|617019694|FG011|Combination Therapy|Withdrawal by Subject|0|||
170731362|NCT02712905|617019695|FG012|Combination Therapy|Withdrawal by Subject|0|||
170731363|NCT02712905|617019696|FG013|Combination Therapy|Withdrawal by Subject|0|||
170731364|NCT02712905|617019697|FG014|Combination Therapy|Withdrawal by Subject|0|||
170731365|NCT02712905|617019698|FG015|Combination Therapy|Withdrawal by Subject|1|||
170731366|NCT02712905|617019699|FG016|Combination Therapy|Withdrawal by Subject|0|||
170731367|NCT02712905|617019700|FG017|Combination Therapy|Withdrawal by Subject|2|||
170731368|NCT02712905|617019683|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731369|NCT02712905|617019684|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731370|NCT02712905|617019685|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731371|NCT02712905|617019686|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170838523|NCT04052425|617417711|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
170838524|NCT04052425|617417712|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
170838525|NCT04052425|617417709|FG000|24-Week Double-blind Period|Physician Decision|1|||
170838526|NCT04052425|617417710|FG001|24-Week Double-blind Period|Physician Decision|0|||
170838527|NCT04052425|617417711|FG002|24-Week Double-blind Period|Physician Decision|0|||
170838528|NCT04052425|617417712|FG003|24-Week Double-blind Period|Physician Decision|0|||
170838529|NCT04052425|617417709|FG000|24-Week Double-blind Period|Protocol Violation|1|||
170838530|NCT04052425|617417710|FG001|24-Week Double-blind Period|Protocol Violation|0|||
170838531|NCT04052425|617417711|FG002|24-Week Double-blind Period|Protocol Violation|0|||
170838532|NCT04052425|617417712|FG003|24-Week Double-blind Period|Protocol Violation|0|||
170838533|NCT04052425|617417709|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
170838534|NCT04052425|617417710|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
170838535|NCT04052425|617417711|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
170838536|NCT04052425|617417712|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
170838537|NCT04052425|617417709|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
170838538|NCT04052425|617417710|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
170838539|NCT04052425|617417711|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
170838540|NCT04052425|617417712|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
170838541|NCT04052425|617417709|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
170838542|NCT04052425|617417710|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
170838543|NCT04052425|617417711|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
170838544|NCT04052425|617417712|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
170838545|NCT04052425|617417709|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
170838546|NCT04052425|617417710|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
170838547|NCT04052425|617417711|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
170838548|NCT04052425|617417712|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
170838549|NCT04052425|617417709|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
170838550|NCT04052425|617417710|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
170838551|NCT04052425|617417711|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
170838552|NCT04052425|617417712|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
170838553|NCT04052425|617417709|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
170838554|NCT04052425|617417710|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
170838555|NCT04052425|617417711|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
170838556|NCT04052425|617417712|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
170838557|NCT04052425|617417709|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
170838558|NCT04052425|617417710|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
170838559|NCT04052425|617417711|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
170838560|NCT04052425|617417712|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
170838561|NCT04052425|617417709|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
170838562|NCT04052425|617417710|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
170838563|NCT04052425|617417711|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
170838564|NCT04052425|617417712|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
170838565|NCT04052425|617417709|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
170838566|NCT04052425|617417710|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
170838567|NCT04052425|617417711|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
170838568|NCT04052425|617417712|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
170838569|NCT01821937|617417713|FG000|Overall Study|Adverse Event|0|||
170838570|NCT01821937|617417714|FG001|Overall Study|Adverse Event|3|||
170838571|NCT01677299|617417715|FG000|Overall Study|Adverse Event|0|||
170838572|NCT01677299|617417716|FG001|Overall Study|Adverse Event|2|||
170838573|NCT01677299|617417717|FG002|Overall Study|Adverse Event|1|||
170838574|NCT01677299|617417718|FG003|Overall Study|Adverse Event|0|||
170838575|NCT01677299|617417715|FG000|Overall Study|Withdrawal by Subject|0|||
170838576|NCT01677299|617417716|FG001|Overall Study|Withdrawal by Subject|1|||
170838577|NCT01677299|617417717|FG002|Overall Study|Withdrawal by Subject|0|||
170838578|NCT01677299|617417718|FG003|Overall Study|Withdrawal by Subject|1|||
170838579|NCT02615509|617417719|FG000|Overall Study|Lost to Follow-up|134|||
170838580|NCT02615509|617417719|FG000|Overall Study|Death|4|||
170838581|NCT02615509|617417719|FG000|Overall Study|Withdrawal by Subject|8|||
170838582|NCT02153905|617417720|FG000|Overall Study|Death|1|||
170838583|NCT02153905|617417721|FG001|Overall Study|Death|0|||
170838584|NCT03274453|617417722|FG000|Overall Study|Lost to Follow-up|2|||
170838585|NCT03274453|617417723|FG001|Overall Study|Lost to Follow-up|5|||
170838586|NCT03274453|617417724|FG002|Overall Study|Lost to Follow-up|4|||
170838587|NCT03274453|617417725|FG003|Overall Study|Lost to Follow-up|1|||
170838588|NCT03274453|617417722|FG000|Overall Study|Physician Decision|2|||
170838589|NCT03274453|617417723|FG001|Overall Study|Physician Decision|0|||
170838590|NCT03274453|617417724|FG002|Overall Study|Physician Decision|0|||
170838591|NCT03274453|617417725|FG003|Overall Study|Physician Decision|3|||
170838592|NCT03274453|617417722|FG000|Overall Study|Surgery Cancelled|0|||
170838593|NCT03274453|617417723|FG001|Overall Study|Surgery Cancelled|1|||
170838594|NCT03274453|617417724|FG002|Overall Study|Surgery Cancelled|0|||
170838595|NCT03274453|617417725|FG003|Overall Study|Surgery Cancelled|0|||
170838596|NCT01681992|617417730|FG000|Overall Study|Adverse Event|3|||
170838597|NCT01681992|617417731|FG001|Overall Study|Adverse Event|2|||
170838598|NCT01681992|617417732|FG002|Overall Study|Adverse Event|3|||
170838599|NCT01681992|617417730|FG000|Overall Study|Lost to Follow-up|36|||
170838600|NCT01681992|617417731|FG001|Overall Study|Lost to Follow-up|38|||
170838601|NCT01681992|617417732|FG002|Overall Study|Lost to Follow-up|53|||
170838602|NCT01681992|617417730|FG000|Overall Study|As Per Sponsor Decision|0|||
170838603|NCT01681992|617417731|FG001|Overall Study|As Per Sponsor Decision|0|||
170838604|NCT01681992|617417732|FG002|Overall Study|As Per Sponsor Decision|1|||
170838605|NCT01681992|617417730|FG000|Overall Study|Protocol Violation|0|||
170838606|NCT01681992|617417731|FG001|Overall Study|Protocol Violation|0|||
170838607|NCT01681992|617417732|FG002|Overall Study|Protocol Violation|1|||
170838608|NCT01681992|617417730|FG000|Overall Study|Withdrawal by Subject|27|||
170838609|NCT01681992|617417731|FG001|Overall Study|Withdrawal by Subject|30|||
170838610|NCT01681992|617417732|FG002|Overall Study|Withdrawal by Subject|25|||
170838611|NCT03880019|617417733|FG000|Overall Study|Competing disease|1|||
170838612|NCT00504075|617417734|FG000|Overall Study|Adverse Event|1|||
170838613|NCT00504075|617417734|FG000|Overall Study|Lost to Follow-up|5|||
170838614|NCT00504075|617417734|FG000|Overall Study|Withdrawal by Subject|1|||
170838615|NCT00504075|617417734|FG000|Overall Study|Required other therapeutic intervention|1|||
170838616|NCT02406248|617417735|FG000|Overall Study|Death|7|||
170838617|NCT02406248|617417735|FG000|Overall Study|Withdrawal by Subject|2|||
170838618|NCT00755417|617417736|FG000|Overall Study|Adverse Event|28|||
170838619|NCT00755417|617417737|FG001|Overall Study|Adverse Event|20|||
170838620|NCT00755417|617417738|FG002|Overall Study|Adverse Event|7|||
170838621|NCT00755417|617417736|FG000|Overall Study|Lack of Efficacy|8|||
170838622|NCT00755417|617417737|FG001|Overall Study|Lack of Efficacy|4|||
170838623|NCT00755417|617417738|FG002|Overall Study|Lack of Efficacy|9|||
170838624|NCT00755417|617417736|FG000|Overall Study|Protocol Violation|2|||
170838625|NCT00755417|617417737|FG001|Overall Study|Protocol Violation|1|||
170838626|NCT00755417|617417738|FG002|Overall Study|Protocol Violation|1|||
170838627|NCT00755417|617417736|FG000|Overall Study|Lost to Follow-up|3|||
170838628|NCT00755417|617417737|FG001|Overall Study|Lost to Follow-up|0|||
170838629|NCT00755417|617417738|FG002|Overall Study|Lost to Follow-up|1|||
170838630|NCT00755417|617417736|FG000|Overall Study|Withdrawal by Subject|12|||
170838631|NCT00755417|617417737|FG001|Overall Study|Withdrawal by Subject|12|||
170838632|NCT00755417|617417738|FG002|Overall Study|Withdrawal by Subject|12|||
170838633|NCT00755417|617417736|FG000|Overall Study|Not specified or missing data|9|||
170838634|NCT00755417|617417737|FG001|Overall Study|Not specified or missing data|18|||
170838635|NCT00755417|617417738|FG002|Overall Study|Not specified or missing data|12|||
170838636|NCT02362503|617417741|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
170838637|NCT02362503|617417742|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
170838638|NCT02362503|617417743|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
170838639|NCT02362503|617417741|FG000|Double-blind Period-Up to 8 Days|Death|1|||
170838640|NCT02362503|617417742|FG001|Double-blind Period-Up to 8 Days|Death|0|||
170838641|NCT02362503|617417743|FG002|Double-blind Period-Up to 8 Days|Death|0|||
170838642|NCT02362503|617417741|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
170838643|NCT02362503|617417742|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
170838644|NCT02362503|617417743|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
170838645|NCT02362503|617417741|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
170731372|NCT02712905|617019687|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731373|NCT02712905|617019688|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731374|NCT02712905|617019689|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731375|NCT02712905|617019690|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731376|NCT02712905|617019691|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731377|NCT02712905|617019692|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731378|NCT02712905|617019693|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731379|NCT02712905|617019694|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731380|NCT02712905|617019695|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731381|NCT02712905|617019696|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731382|NCT02712905|617019697|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731383|NCT02712905|617019698|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
170731384|NCT02712905|617019699|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731385|NCT02712905|617019700|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
170731386|NCT03624504|617019701|FG000|Overall Study|Unsuccessful Implant|1|||
170731387|NCT02782169|617019702|FG000|Overall Study|Lost to Follow-up|1|||
170731388|NCT02782169|617019703|FG001|Overall Study|Lost to Follow-up|2|||
170731389|NCT02975973|617019704|FG000|Overall Study|Adverse Event|1|||
170731390|NCT02975973|617019705|FG001|Overall Study|Adverse Event|1|||
170731391|NCT02975973|617019706|FG002|Overall Study|Adverse Event|1|||
170731392|NCT02975973|617019707|FG003|Overall Study|Adverse Event|0|||
170731393|NCT03804710|617019708|FG000|Overall Study|Adverse Event|0|||
170731394|NCT03804710|617019709|FG001|Overall Study|Adverse Event|3|||
170731395|NCT03804710|617019708|FG000|Overall Study|Withdrawal by Subject|2|||
170731396|NCT03804710|617019709|FG001|Overall Study|Withdrawal by Subject|1|||
170731397|NCT03804710|617019708|FG000|Overall Study|Other|0|||
170731398|NCT03804710|617019709|FG001|Overall Study|Other|1|||
170731399|NCT04542018|617019710|FG000|Overall Study|Withdrawal by Subject|0|||
170731400|NCT04542018|617019711|FG001|Overall Study|Withdrawal by Subject|0|||
170731401|NCT04542018|617019712|FG002|Overall Study|Withdrawal by Subject|4|||
170731402|NCT04542018|617019710|FG000|Overall Study|Protocol Violation|0|||
170731403|NCT04542018|617019711|FG001|Overall Study|Protocol Violation|0|||
170731404|NCT04542018|617019712|FG002|Overall Study|Protocol Violation|2|||
170731405|NCT03583554|617019713|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
170731406|NCT03583554|617019714|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
170731407|NCT03583554|617019715|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
170731408|NCT05380947|617019725|FG000|Washout Period 1|Not attend visit|1|||
170731409|NCT05380947|617019726|FG001|Washout Period 1|Not attend visit|0|||
170731410|NCT05380947|617019727|FG002|Washout Period 1|Not attend visit|0|||
170731411|NCT05380947|617019728|FG003|Washout Period 1|Not attend visit|0|||
170731412|NCT05380947|617019725|FG000|Washout Period 2|Adverse Event|1|||
170731413|NCT05380947|617019726|FG001|Washout Period 2|Adverse Event|0|||
170731414|NCT05380947|617019727|FG002|Washout Period 2|Adverse Event|0|||
170731415|NCT05380947|617019728|FG003|Washout Period 2|Adverse Event|0|||
170731416|NCT05380947|617019725|FG000|Washout Period 3|Adverse Event|0|||
170731417|NCT05380947|617019726|FG001|Washout Period 3|Adverse Event|1|||
170731418|NCT05380947|617019727|FG002|Washout Period 3|Adverse Event|0|||
170731419|NCT05380947|617019728|FG003|Washout Period 3|Adverse Event|0|||
170731420|NCT05380947|617019725|FG000|Washout Period 3|Not attend visit|0|||
170731421|NCT05380947|617019726|FG001|Washout Period 3|Not attend visit|1|||
170731422|NCT05380947|617019727|FG002|Washout Period 3|Not attend visit|0|||
170731423|NCT05380947|617019728|FG003|Washout Period 3|Not attend visit|1|||
170731424|NCT01563536|617019729|FG000|Overall Study|Withdrawal by Subject|0|||
170731425|NCT01563536|617019730|FG001|Overall Study|Withdrawal by Subject|2|||
170731426|NCT01563536|617019729|FG000|Overall Study|Lost to Follow-up|1|||
170731427|NCT01563536|617019730|FG001|Overall Study|Lost to Follow-up|0|||
170731428|NCT01860703|617019731|FG000|Overall Study|Adverse Event|1|||
170731429|NCT01860703|617019732|FG001|Overall Study|Adverse Event|4|||
170731430|NCT01860703|617019733|FG002|Overall Study|Adverse Event|0|||
170731431|NCT01860703|617019734|FG003|Overall Study|Adverse Event|2|||
170731432|NCT01860703|617019731|FG000|Overall Study|Withdrawal by Subject|0|||
170731433|NCT01860703|617019732|FG001|Overall Study|Withdrawal by Subject|1|||
170731434|NCT01860703|617019733|FG002|Overall Study|Withdrawal by Subject|0|||
170731435|NCT01860703|617019734|FG003|Overall Study|Withdrawal by Subject|0|||
170731436|NCT01860703|617019731|FG000|Overall Study|Personal reason|1|||
170731437|NCT01860703|617019732|FG001|Overall Study|Personal reason|0|||
170731438|NCT01860703|617019733|FG002|Overall Study|Personal reason|1|||
170731439|NCT01860703|617019734|FG003|Overall Study|Personal reason|0|||
170731440|NCT06213701|617019738|FG000|Overall Study|Withdrawal by Subject|2|||
170731441|NCT06213701|617019739|FG001|Overall Study|Withdrawal by Subject|1|||
170731442|NCT06213701|617019740|FG002|Overall Study|Withdrawal by Subject|0|||
170731443|NCT00538590|617019741|FG000|Overall Study|Death|1|||
170731444|NCT00538590|617019742|FG001|Overall Study|Death|0|||
170731445|NCT00636610|617019746|FG000|Overall Study|Adverse Event|4|||
170731446|NCT00636610|617019747|FG001|Overall Study|Adverse Event|4|||
170731447|NCT00636610|617019746|FG000|Overall Study|Death|6|||
170731448|NCT00636610|617019747|FG001|Overall Study|Death|3|||
170731449|NCT00636610|617019746|FG000|Overall Study|Physician decision to withdraw patient|15|||
170731450|NCT00636610|617019747|FG001|Overall Study|Physician decision to withdraw patient|9|||
170731451|NCT00636610|617019746|FG000|Overall Study|Subject decision to withdraw|15|||
170731452|NCT00636610|617019747|FG001|Overall Study|Subject decision to withdraw|11|||
170731453|NCT00636610|617019746|FG000|Overall Study|Disease progression - radiographic|41|||
170731454|NCT00636610|617019747|FG001|Overall Study|Disease progression - radiographic|51|||
170731455|NCT00636610|617019746|FG000|Overall Study|Disease progression - clinical|8|||
170731456|NCT00636610|617019747|FG001|Overall Study|Disease progression - clinical|3|||
170731457|NCT00636610|617019746|FG000|Overall Study|Reason for discontinuation not available|3|||
170731458|NCT00636610|617019747|FG001|Overall Study|Reason for discontinuation not available|2|||
170731459|NCT02495025|617019748|FG000|Overall Study|Lost to Follow-up|21|||
170731460|NCT02495025|617019749|FG001|Overall Study|Lost to Follow-up|14|||
170731461|NCT02495025|617019748|FG000|Overall Study|Withdrawal by Subject|5|||
170731462|NCT02495025|617019749|FG001|Overall Study|Withdrawal by Subject|0|||
170731463|NCT02453685|617019752|FG000|Overall Study|Adverse Event|0|||
170731464|NCT02453685|617019753|FG001|Overall Study|Adverse Event|1|||
170731465|NCT02453685|617019752|FG000|Overall Study|Protocol Violation|7|||
170731466|NCT02453685|617019753|FG001|Overall Study|Protocol Violation|4|||
170731467|NCT02453685|617019752|FG000|Overall Study|Lost to Follow-up|0|||
170731468|NCT02453685|617019753|FG001|Overall Study|Lost to Follow-up|1|||
170731469|NCT02453685|617019752|FG000|Overall Study|Withdrawal by Subject|8|||
170731470|NCT02453685|617019753|FG001|Overall Study|Withdrawal by Subject|4|||
170731471|NCT02453685|617019752|FG000|Overall Study|Unclassified|4|||
170731472|NCT02453685|617019753|FG001|Overall Study|Unclassified|2|||
170731473|NCT04839965|617019758|FG000|Overall Study|Death|6|||
170731474|NCT04839965|617019759|FG001|Overall Study|Death|6|||
170731475|NCT04839965|617019758|FG000|Overall Study|Lost to Follow-up|1|||
170731476|NCT04839965|617019759|FG001|Overall Study|Lost to Follow-up|0|||
170731477|NCT02291679|617019760|FG000|Overall Study|Adverse Event|2|||
170731478|NCT02291679|617019761|FG001|Overall Study|Adverse Event|12|||
170731479|NCT02291679|617019762|FG002|Overall Study|Adverse Event|19|||
170731480|NCT02291679|617019760|FG000|Overall Study|Protocol Violation|5|||
170731481|NCT02291679|617019761|FG001|Overall Study|Protocol Violation|1|||
170731482|NCT02291679|617019762|FG002|Overall Study|Protocol Violation|7|||
170731483|NCT02291679|617019760|FG000|Overall Study|Withdrew Consent|18|||
170731484|NCT02291679|617019761|FG001|Overall Study|Withdrew Consent|10|||
170731485|NCT02291679|617019762|FG002|Overall Study|Withdrew Consent|15|||
170731486|NCT02291679|617019760|FG000|Overall Study|Lost to Follow-up|12|||
170731487|NCT02291679|617019761|FG001|Overall Study|Lost to Follow-up|10|||
170731488|NCT02291679|617019762|FG002|Overall Study|Lost to Follow-up|9|||
170731489|NCT02291679|617019760|FG000|Overall Study|Insufficient Therapeutic Response|5|||
170731490|NCT02291679|617019761|FG001|Overall Study|Insufficient Therapeutic Response|5|||
170731491|NCT02291679|617019762|FG002|Overall Study|Insufficient Therapeutic Response|7|||
170731492|NCT02291679|617019760|FG000|Overall Study|Other|2|||
170731493|NCT02291679|617019761|FG001|Overall Study|Other|4|||
170731494|NCT02291679|617019762|FG002|Overall Study|Other|2|||
170731495|NCT02276222|617019763|FG000|Overall Study|Adverse Event|62|||
170731496|NCT02276222|617019764|FG001|Overall Study|Adverse Event|11|||
170731497|NCT02276222|617019763|FG000|Overall Study|Death|3|||
170731498|NCT02276222|617019764|FG001|Overall Study|Death|4|||
170731499|NCT02276222|617019763|FG000|Overall Study|Lack of Efficacy|13|||
170731500|NCT02276222|617019764|FG001|Overall Study|Lack of Efficacy|3|||
170731501|NCT02276222|617019763|FG000|Overall Study|Protocol Violation|3|||
170731502|NCT02276222|617019764|FG001|Overall Study|Protocol Violation|2|||
170731503|NCT02276222|617019763|FG000|Overall Study|Withdrawal by Subject|79|||
170731504|NCT02276222|617019764|FG001|Overall Study|Withdrawal by Subject|33|||
170731505|NCT02276222|617019763|FG000|Overall Study|non compliance with study medication|6|||
170731506|NCT02276222|617019764|FG001|Overall Study|non compliance with study medication|2|||
170731507|NCT02276222|617019763|FG000|Overall Study|sponsor decision|0|||
170731508|NCT02276222|617019764|FG001|Overall Study|sponsor decision|3|||
170731509|NCT02276222|617019763|FG000|Overall Study|Lost to Follow-up|15|||
170731510|NCT02276222|617019764|FG001|Overall Study|Lost to Follow-up|5|||
170731511|NCT02276222|617019763|FG000|Overall Study|Physician Decision|2|||
170838646|NCT02362503|617417742|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
170838647|NCT02362503|617417743|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
170838648|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
170838649|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
170838650|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
170838651|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
170838652|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
170838653|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
170838654|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
170838655|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
170838656|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
170838657|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
170838658|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
170838659|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
170838660|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
170838661|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
170838662|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
170838663|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
170838664|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
170838665|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
170838666|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
170838667|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
170838668|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
170838669|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
170838670|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
170838671|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
170838672|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
170838673|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
170838674|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
170838675|NCT02362503|617417741|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
170838676|NCT02362503|617417742|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
170838677|NCT02362503|617417743|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
170838678|NCT00732992|617417744|FG000|Overall Study|Adverse Event|1|||
170838679|NCT00732992|617417745|FG001|Overall Study|Adverse Event|1|||
170838680|NCT00732992|617417744|FG000|Overall Study|Objective Progression or Relapse|3|||
170838681|NCT00732992|617417745|FG001|Overall Study|Objective Progression or Relapse|5|||
170838682|NCT00732992|617417744|FG000|Overall Study|Global Deterioration of Health Status|1|||
170838683|NCT00732992|617417745|FG001|Overall Study|Global Deterioration of Health Status|0|||
170838684|NCT00732992|617417744|FG000|Overall Study|Withdrawal by Subject|1|||
170838685|NCT00732992|617417745|FG001|Overall Study|Withdrawal by Subject|0|||
170838686|NCT01080300|617417746|FG000|Overall Study|Adverse Event|49|||
170838687|NCT01080300|617417747|FG001|Overall Study|Adverse Event|35|||
170838688|NCT01080300|617417746|FG000|Overall Study|Lack of Efficacy|12|||
170838689|NCT01080300|617417747|FG001|Overall Study|Lack of Efficacy|15|||
170838690|NCT01080300|617417746|FG000|Overall Study|Protocol Violation|7|||
170838691|NCT01080300|617417747|FG001|Overall Study|Protocol Violation|13|||
170838692|NCT01080300|617417746|FG000|Overall Study|Lost to Follow-up|10|||
170838693|NCT01080300|617417747|FG001|Overall Study|Lost to Follow-up|6|||
170731512|NCT02276222|617019764|FG001|Overall Study|Physician Decision|1|||
170731513|NCT02276222|617019763|FG000|Overall Study|sheduling conflict|1|||
170731514|NCT02276222|617019764|FG001|Overall Study|sheduling conflict|0|||
170731515|NCT02276222|617019763|FG000|Overall Study|subject withdrew after randomization|1|||
170731516|NCT02276222|617019764|FG001|Overall Study|subject withdrew after randomization|0|||
170731517|NCT03703466|617019766|FG000|Overall Study|Death|2|||
170731518|NCT03703466|617019767|FG001|Overall Study|Death|1|||
170731519|NCT03703466|617019768|FG002|Overall Study|Death|0|||
170731520|NCT03703466|617019766|FG000|Overall Study|Withdrawal by Subject|0|||
170731521|NCT03703466|617019767|FG001|Overall Study|Withdrawal by Subject|3|||
170731522|NCT03703466|617019768|FG002|Overall Study|Withdrawal by Subject|0|||
170731523|NCT03703466|617019766|FG000|Overall Study|Completed < 3 Cycles|2|||
170731524|NCT03703466|617019767|FG001|Overall Study|Completed < 3 Cycles|2|||
170731525|NCT03703466|617019768|FG002|Overall Study|Completed < 3 Cycles|2|||
170731526|NCT03770494|617019769|FG000|Overall Study|Lost to Follow-up|0|||
170838694|NCT01080300|617417746|FG000|Overall Study|Death|0|||
170838695|NCT01080300|617417747|FG001|Overall Study|Death|1|||
170838696|NCT01080300|617417746|FG000|Overall Study|Withdrawal by Subject|12|||
170838697|NCT01080300|617417747|FG001|Overall Study|Withdrawal by Subject|28|||
170838698|NCT01080300|617417746|FG000|Overall Study|Reasons not specified|4|||
170838699|NCT01080300|617417747|FG001|Overall Study|Reasons not specified|6|||
170838700|NCT00422734|617417751|FG000|Overall Study|Physician Decision|1|||
170838701|NCT00422734|617417752|FG001|Overall Study|Physician Decision|1|||
170838702|NCT00422734|617417751|FG000|Overall Study|Protocol Violation|1|||
170838703|NCT00422734|617417752|FG001|Overall Study|Protocol Violation|6|||
170838704|NCT00422734|617417751|FG000|Overall Study|Withdrawal by Subject|12|||
170838705|NCT00422734|617417752|FG001|Overall Study|Withdrawal by Subject|8|||
170838706|NCT00422734|617417751|FG000|Overall Study|Adverse Event|0|||
170838707|NCT00422734|617417752|FG001|Overall Study|Adverse Event|3|||
170838708|NCT00422734|617417751|FG000|Overall Study|Partner Decision|0|||
170838709|NCT00422734|617417752|FG001|Overall Study|Partner Decision|3|||
170838710|NCT00848484|617417753|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
170838711|NCT00848484|617417754|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
170838712|NCT00848484|617417753|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
170838713|NCT00848484|617417754|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
170838714|NCT00848484|617417753|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
170838715|NCT00848484|617417754|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
170838716|NCT00848484|617417753|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
170838717|NCT00848484|617417754|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
170838718|NCT00848484|617417753|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
170838719|NCT00848484|617417754|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
170838720|NCT01081886|617417756|FG000|Overall Study|Study termination|11|||
170838721|NCT01081886|617417757|FG001|Overall Study|Study termination|13|||
170838722|NCT02567708|617417758|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
170838723|NCT02567708|617417759|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
170838724|NCT02567708|617417758|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
170838725|NCT02567708|617417759|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
170838726|NCT02567708|617417758|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
170838727|NCT02567708|617417759|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
170838728|NCT02567708|617417758|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
170838729|NCT02567708|617417759|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
170838730|NCT00706654|617417760|FG000|Conversion Phase|Lost to Follow-up|4|||
170838731|NCT00706654|617417761|FG001|Conversion Phase|Lost to Follow-up|0|||
170838732|NCT00706654|617417762|FG002|Conversion Phase|Lost to Follow-up|0|||
170838733|NCT00706654|617417763|FG003|Conversion Phase|Lost to Follow-up|0|||
170838734|NCT00706654|617417760|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
170838735|NCT00706654|617417761|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
170838736|NCT00706654|617417762|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
170838737|NCT00706654|617417763|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
170838738|NCT00706654|617417760|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
170838739|NCT00706654|617417761|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
170838740|NCT00706654|617417762|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
170838741|NCT00706654|617417763|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
170838742|NCT00706654|617417760|FG000|Conversion Phase|Withdrawn by Investigator|14|||
170838743|NCT00706654|617417761|FG001|Conversion Phase|Withdrawn by Investigator|0|||
170838744|NCT00706654|617417762|FG002|Conversion Phase|Withdrawn by Investigator|0|||
170838745|NCT00706654|617417763|FG003|Conversion Phase|Withdrawn by Investigator|0|||
170838746|NCT00706654|617417760|FG000|Conversion Phase|Withdrew Consent|38|||
170838747|NCT00706654|617417761|FG001|Conversion Phase|Withdrew Consent|0|||
170838748|NCT00706654|617417762|FG002|Conversion Phase|Withdrew Consent|0|||
170838749|NCT00706654|617417763|FG003|Conversion Phase|Withdrew Consent|0|||
170838750|NCT00706654|617417760|FG000|Conversion Phase|Adverse Event|18|||
170838751|NCT00706654|617417761|FG001|Conversion Phase|Adverse Event|0|||
170838752|NCT00706654|617417762|FG002|Conversion Phase|Adverse Event|0|||
170838753|NCT00706654|617417763|FG003|Conversion Phase|Adverse Event|0|||
170838754|NCT00706654|617417760|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
170838755|NCT00706654|617417761|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
170838756|NCT00706654|617417762|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
170838757|NCT00706654|617417763|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
170838758|NCT00706654|617417760|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
170838759|NCT00706654|617417761|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
170838760|NCT00706654|617417762|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
170838761|NCT00706654|617417763|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
170838762|NCT00706654|617417760|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
170838763|NCT00706654|617417761|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
170838764|NCT00706654|617417762|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
170838765|NCT00706654|617417763|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
170838766|NCT00706654|617417760|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
170838767|NCT00706654|617417761|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
170838768|NCT00706654|617417762|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
170838769|NCT00706654|617417763|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
170838770|NCT00706654|617417760|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
170838771|NCT00706654|617417761|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
170838772|NCT00706654|617417762|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
170838773|NCT00706654|617417763|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
170838774|NCT00706654|617417760|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
170838775|NCT00706654|617417761|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
170838776|NCT00706654|617417762|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
170838777|NCT00706654|617417763|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
170838778|NCT00706654|617417760|FG000|Oral Stabilization Phase|Withdrew consent|55|||
170838779|NCT00706654|617417761|FG001|Oral Stabilization Phase|Withdrew consent|0|||
170838780|NCT00706654|617417762|FG002|Oral Stabilization Phase|Withdrew consent|0|||
170838781|NCT00706654|617417763|FG003|Oral Stabilization Phase|Withdrew consent|0|||
170838782|NCT00706654|617417760|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
170838783|NCT00706654|617417761|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
170838784|NCT00706654|617417762|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
170838785|NCT00706654|617417763|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
170838786|NCT00706654|617417760|FG000|Oral Stabilization Phase|Adverse Event|21|||
170838787|NCT00706654|617417761|FG001|Oral Stabilization Phase|Adverse Event|0|||
170838788|NCT00706654|617417762|FG002|Oral Stabilization Phase|Adverse Event|0|||
170838789|NCT00706654|617417763|FG003|Oral Stabilization Phase|Adverse Event|0|||
170838790|NCT00706654|617417760|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
170838791|NCT00706654|617417761|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
170838792|NCT00706654|617417762|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
170838793|NCT00706654|617417763|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
170838794|NCT00706654|617417760|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
170838795|NCT00706654|617417761|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
170838796|NCT00706654|617417762|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
170838797|NCT00706654|617417763|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
170838798|NCT00706654|617417760|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
170838799|NCT00706654|617417761|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
170838800|NCT00706654|617417762|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
170838801|NCT00706654|617417763|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
170838802|NCT00706654|617417760|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
170838803|NCT00706654|617417761|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
170838804|NCT00706654|617417762|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
170838805|NCT00706654|617417763|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
170838806|NCT00706654|617417760|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
170838807|NCT00706654|617417761|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
170838808|NCT00706654|617417762|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
170838809|NCT00706654|617417763|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
170838810|NCT00706654|617417760|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
170838811|NCT00706654|617417761|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
170838812|NCT00706654|617417762|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
170838813|NCT00706654|617417763|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
170838814|NCT00706654|617417760|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
170838815|NCT00706654|617417761|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
170838816|NCT00706654|617417762|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
170838817|NCT00706654|617417763|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
170838818|NCT00706654|617417760|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
170838819|NCT00706654|617417761|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
170838820|NCT00706654|617417762|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
170838821|NCT00706654|617417763|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
170838822|NCT00706654|617417760|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
170838823|NCT00706654|617417761|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
170838824|NCT00706654|617417762|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
170838825|NCT00706654|617417763|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
170838826|NCT00706654|617417760|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
170838827|NCT00706654|617417761|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
170838828|NCT00706654|617417762|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
170838829|NCT00706654|617417763|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
170838830|NCT01001390|617417767|FG000|Overall Study|Failure to wear AFO device|2|||
170838831|NCT01001390|617417768|FG001|Overall Study|Failure to wear AFO device|0|||
170838832|NCT03690427|617417769|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
170838833|NCT03690427|617417770|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
170838834|NCT02609672|617417771|FG000|Overall Study|Lost to Follow-up|3|||
170838835|NCT02609672|617417772|FG001|Overall Study|Lost to Follow-up|1|||
170838836|NCT02637323|617417776|FG000|Overall Study|Lost to Follow-up|2|||
170838837|NCT02637323|617417777|FG001|Overall Study|Lost to Follow-up|0|||
170838838|NCT02637323|617417776|FG000|Overall Study|Protocol Violation|0|||
170838839|NCT02637323|617417777|FG001|Overall Study|Protocol Violation|1|||
170838840|NCT02689453|617417778|FG000|Overall Study|Progressive disease|0|||
170838841|NCT02689453|617417779|FG001|Overall Study|Progressive disease|1|||
170838842|NCT02689453|617417780|FG002|Overall Study|Progressive disease|1|||
170838843|NCT01154140|617417781|FG000|Overall Study|Death|71|||
170838844|NCT01154140|617417782|FG001|Overall Study|Death|81|||
170838845|NCT01154140|617417781|FG000|Overall Study|Lost to Follow-up|4|||
170838846|NCT01154140|617417782|FG001|Overall Study|Lost to Follow-up|5|||
170838847|NCT01154140|617417781|FG000|Overall Study|Withdrawal by Subject|12|||
170838848|NCT01154140|617417782|FG001|Overall Study|Withdrawal by Subject|13|||
170838849|NCT01154140|617417781|FG000|Overall Study|Other|3|||
170838850|NCT01154140|617417782|FG001|Overall Study|Other|1|||
170838851|NCT01154140|617417781|FG000|Overall Study|Randomized but not treated|1|||
170838852|NCT01154140|617417782|FG001|Overall Study|Randomized but not treated|2|||
170838853|NCT00368875|617417783|FG000|Overall Study|Adverse Event|0|||
170838854|NCT00368875|617417784|FG001|Overall Study|Adverse Event|12|||
170838855|NCT00368875|617417783|FG000|Overall Study|Progressive disease|3|||
170838856|NCT00368875|617417784|FG001|Overall Study|Progressive disease|27|||
170838857|NCT00368875|617417783|FG000|Overall Study|Withdrawal by Subject|2|||
170838858|NCT00368875|617417784|FG001|Overall Study|Withdrawal by Subject|6|||
170838859|NCT00368875|617417783|FG000|Overall Study|Other Reason|0|||
170838860|NCT00368875|617417784|FG001|Overall Study|Other Reason|2|||
170838861|NCT00368875|617417783|FG000|Overall Study|Alternative Therapy|1|||
170838862|NCT00368875|617417784|FG001|Overall Study|Alternative Therapy|1|||
170838863|NCT01782690|617417785|FG000|Overall Study|Not reported|7|||
170838864|NCT01782690|617417785|FG000|Overall Study|Toxicity of gemcitabine|1|||
170838865|NCT01782690|617417785|FG000|Overall Study|Toxicity of erlotinib|1|||
170838866|NCT01782690|617417785|FG000|Overall Study|Lost to Follow-up|31|||
170838867|NCT01782690|617417785|FG000|Overall Study|Withdrawal of informed consent|2|||
170838868|NCT01782690|617417785|FG000|Overall Study|Absent rash|9|||
170838869|NCT01782690|617417785|FG000|Overall Study|Physician Decision|13|||
170838870|NCT01782690|617417785|FG000|Overall Study|Patient's wish|21|||
170838871|NCT01782690|617417785|FG000|Overall Study|Tumor progression|74|||
170838872|NCT01782690|617417785|FG000|Overall Study|Death|133|||
170838873|NCT01782690|617417785|FG000|Overall Study|Study completion unknown|7|||
170838874|NCT02600897|617417787|FG000|Overall Study|Death|1|||
170838875|NCT02600897|617417788|FG001|Overall Study|Death|2|||
170838876|NCT02600897|617417789|FG002|Overall Study|Death|1|||
170838877|NCT02600897|617417790|FG003|Overall Study|Death|2|||
170838878|NCT02600897|617417791|FG004|Overall Study|Death|3|||
170838879|NCT02600897|617417792|FG005|Overall Study|Death|2|||
170838880|NCT02600897|617417793|FG006|Overall Study|Death|10|||
170838881|NCT02600897|617417794|FG007|Overall Study|Death|7|||
170838882|NCT02600897|617417795|FG008|Overall Study|Death|20|||
170838883|NCT02600897|617417787|FG000|Overall Study|Lost to Follow-up|1|||
170838884|NCT02600897|617417788|FG001|Overall Study|Lost to Follow-up|0|||
170838885|NCT02600897|617417789|FG002|Overall Study|Lost to Follow-up|0|||
170838886|NCT02600897|617417790|FG003|Overall Study|Lost to Follow-up|0|||
170838887|NCT02600897|617417791|FG004|Overall Study|Lost to Follow-up|0|||
170838888|NCT02600897|617417792|FG005|Overall Study|Lost to Follow-up|0|||
170838889|NCT02600897|617417793|FG006|Overall Study|Lost to Follow-up|0|||
170838890|NCT02600897|617417794|FG007|Overall Study|Lost to Follow-up|1|||
170838891|NCT02600897|617417795|FG008|Overall Study|Lost to Follow-up|0|||
170838892|NCT02600897|617417787|FG000|Overall Study|Withdrawal by Subject|0|||
170838893|NCT02600897|617417788|FG001|Overall Study|Withdrawal by Subject|0|||
170838894|NCT02600897|617417789|FG002|Overall Study|Withdrawal by Subject|0|||
170838895|NCT02600897|617417790|FG003|Overall Study|Withdrawal by Subject|0|||
170838896|NCT02600897|617417791|FG004|Overall Study|Withdrawal by Subject|0|||
170838897|NCT02600897|617417792|FG005|Overall Study|Withdrawal by Subject|0|||
170838898|NCT02600897|617417793|FG006|Overall Study|Withdrawal by Subject|0|||
170838899|NCT02600897|617417794|FG007|Overall Study|Withdrawal by Subject|4|||
170838900|NCT02600897|617417795|FG008|Overall Study|Withdrawal by Subject|2|||
170838901|NCT02600897|617417787|FG000|Overall Study|Reason Not Specified|0|||
170838902|NCT02600897|617417788|FG001|Overall Study|Reason Not Specified|0|||
170838903|NCT02600897|617417789|FG002|Overall Study|Reason Not Specified|0|||
170838904|NCT02600897|617417790|FG003|Overall Study|Reason Not Specified|0|||
170838905|NCT02600897|617417791|FG004|Overall Study|Reason Not Specified|0|||
170838906|NCT02600897|617417792|FG005|Overall Study|Reason Not Specified|0|||
170838907|NCT02600897|617417793|FG006|Overall Study|Reason Not Specified|0|||
170838908|NCT02600897|617417794|FG007|Overall Study|Reason Not Specified|0|||
170838909|NCT02600897|617417795|FG008|Overall Study|Reason Not Specified|1|||
170838910|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
170838911|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
170838912|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
170838913|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
170838914|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
170838915|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
170838916|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
170838917|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
170838918|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
170838919|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
170838920|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
170838921|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
170838922|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
170838923|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
170838924|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
170838925|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
170838926|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
170838927|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
170838928|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
170838929|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
170838930|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
170838931|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
170838932|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
170838933|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
170838934|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
170838935|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
170838936|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
170838937|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
170838938|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
170838939|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
170838940|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
170838941|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
170838942|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
170838943|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
170838944|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
170838945|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
170838946|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
170838947|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
170838948|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
170838949|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
170838950|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
170838951|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
170838952|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
170838953|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
170838954|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
170838955|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
170838956|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
170838957|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
170838958|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
170838959|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
170838960|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
170838961|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
170838962|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
170838963|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
170838964|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
170838965|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
170838966|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
170838967|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
170838968|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
170838969|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
170838970|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
170838971|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
170838972|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
170838973|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
170838974|NCT00217737|617417798|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
170838975|NCT00217737|617417799|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
170838976|NCT00217737|617417800|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
170838977|NCT00217737|617417801|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
170838978|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
170838979|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
170838980|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
170838981|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
170838982|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
170838983|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
170838984|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
170838985|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
170838986|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Study suspension|0|||
170838987|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Study suspension|45|||
170838988|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Study suspension|0|||
170838989|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Study suspension|0|||
170838990|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
170838991|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
170838992|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
170838993|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
170838994|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Death|2|||
170838995|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Death|3|||
170838996|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Death|0|||
170838997|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Death|0|||
170838998|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
170838999|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
170839000|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
170839001|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
170731527|NCT03770494|617019770|FG001|Overall Study|Lost to Follow-up|0|||
170731528|NCT03770494|617019771|FG002|Overall Study|Lost to Follow-up|1|||
170731529|NCT03770494|617019772|FG003|Overall Study|Lost to Follow-up|1|||
170731530|NCT03770494|617019773|FG004|Overall Study|Lost to Follow-up|1|||
170731531|NCT03770494|617019774|FG005|Overall Study|Lost to Follow-up|0|||
170731532|NCT03770494|617019775|FG006|Overall Study|Lost to Follow-up|0|||
170731533|NCT03770494|617019776|FG007|Overall Study|Lost to Follow-up|0|||
170731534|NCT03770494|617019777|FG008|Overall Study|Lost to Follow-up|0|||
170731535|NCT03770494|617019778|FG009|Overall Study|Lost to Follow-up|0|||
170731536|NCT03770494|617019779|FG010|Overall Study|Lost to Follow-up|0|||
170731537|NCT03770494|617019780|FG011|Overall Study|Lost to Follow-up|0|||
170731538|NCT03770494|617019781|FG012|Overall Study|Lost to Follow-up|0|||
170731539|NCT03770494|617019782|FG013|Overall Study|Lost to Follow-up|0|||
170731540|NCT03770494|617019769|FG000|Overall Study|Study terminated by sponsor|1|||
170731541|NCT03770494|617019770|FG001|Overall Study|Study terminated by sponsor|2|||
170731542|NCT03770494|617019771|FG002|Overall Study|Study terminated by sponsor|1|||
170731543|NCT03770494|617019772|FG003|Overall Study|Study terminated by sponsor|1|||
170731544|NCT03770494|617019773|FG004|Overall Study|Study terminated by sponsor|1|||
170731545|NCT03770494|617019774|FG005|Overall Study|Study terminated by sponsor|2|||
170731546|NCT03770494|617019775|FG006|Overall Study|Study terminated by sponsor|1|||
170731547|NCT03770494|617019776|FG007|Overall Study|Study terminated by sponsor|2|||
170731548|NCT03770494|617019777|FG008|Overall Study|Study terminated by sponsor|1|||
170731549|NCT03770494|617019778|FG009|Overall Study|Study terminated by sponsor|2|||
170731550|NCT03770494|617019779|FG010|Overall Study|Study terminated by sponsor|1|||
170731551|NCT03770494|617019780|FG011|Overall Study|Study terminated by sponsor|2|||
170731552|NCT03770494|617019781|FG012|Overall Study|Study terminated by sponsor|0|||
170731553|NCT03770494|617019782|FG013|Overall Study|Study terminated by sponsor|0|||
170731554|NCT03770494|617019769|FG000|Overall Study|Withdrawal by Subject|1|||
170731555|NCT03770494|617019770|FG001|Overall Study|Withdrawal by Subject|1|||
170731556|NCT03770494|617019771|FG002|Overall Study|Withdrawal by Subject|0|||
170731557|NCT03770494|617019772|FG003|Overall Study|Withdrawal by Subject|0|||
170731558|NCT03770494|617019773|FG004|Overall Study|Withdrawal by Subject|2|||
170731559|NCT03770494|617019774|FG005|Overall Study|Withdrawal by Subject|2|||
170731560|NCT03770494|617019775|FG006|Overall Study|Withdrawal by Subject|2|||
170731561|NCT03770494|617019776|FG007|Overall Study|Withdrawal by Subject|0|||
170731562|NCT03770494|617019777|FG008|Overall Study|Withdrawal by Subject|2|||
170731563|NCT03770494|617019778|FG009|Overall Study|Withdrawal by Subject|3|||
170731564|NCT03770494|617019779|FG010|Overall Study|Withdrawal by Subject|1|||
170731565|NCT03770494|617019780|FG011|Overall Study|Withdrawal by Subject|0|||
170731566|NCT03770494|617019781|FG012|Overall Study|Withdrawal by Subject|0|||
170731567|NCT03770494|617019782|FG013|Overall Study|Withdrawal by Subject|0|||
170731568|NCT00506493|617019785|FG000|Overall Study|Death|6|||
170731569|NCT00506493|617019785|FG000|Overall Study|Withdrawal by Subject|5|||
170731570|NCT01953003|617021503|FG000|Overall Study|Not treated|0|||
170731571|NCT01953003|617021504|FG001|Overall Study|Not treated|1|||
170731572|NCT01953003|617021503|FG000|Overall Study|Progressive disease|35|||
170731573|NCT01953003|617021504|FG001|Overall Study|Progressive disease|45|||
170731574|NCT01953003|617021503|FG000|Overall Study|Related Adverse events|7|||
170731575|NCT01953003|617021504|FG001|Overall Study|Related Adverse events|2|||
170731576|NCT01953003|617021503|FG000|Overall Study|Non-related adverse events|0|||
170731577|NCT01953003|617021504|FG001|Overall Study|Non-related adverse events|2|||
170731578|NCT01953003|617021503|FG000|Overall Study|Protocol Violation|0|||
170731579|NCT01953003|617021504|FG001|Overall Study|Protocol Violation|1|||
170731580|NCT01953003|617021503|FG000|Overall Study|Withdrawal by Subject|14|||
170731581|NCT01953003|617021504|FG001|Overall Study|Withdrawal by Subject|4|||
170731582|NCT00949715|617021505|FG000|Overall Study|Physician Decision|1|||
170731583|NCT00949715|617021506|FG001|Overall Study|Physician Decision|0|||
170731584|NCT00949715|617021505|FG000|Overall Study|Lost to Follow-up|1|||
170731585|NCT00949715|617021506|FG001|Overall Study|Lost to Follow-up|0|||
170731586|NCT00949715|617021505|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
170731587|NCT00949715|617021506|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
170731588|NCT01582789|617021508|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
170731589|NCT01582789|617021509|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
170731590|NCT03391765|617021510|FG000|Overall Study|Adverse Event|2|||
170731591|NCT03391765|617021511|FG001|Overall Study|Adverse Event|0|||
170731592|NCT03391765|617021512|FG002|Overall Study|Adverse Event|0|||
170731593|NCT03391765|617021513|FG003|Overall Study|Adverse Event|2|||
170731594|NCT03391765|617021510|FG000|Overall Study|Withdrew consent|5|||
170731595|NCT03391765|617021511|FG001|Overall Study|Withdrew consent|7|||
170731596|NCT03391765|617021512|FG002|Overall Study|Withdrew consent|2|||
170731597|NCT03391765|617021513|FG003|Overall Study|Withdrew consent|5|||
170731598|NCT03391765|617021510|FG000|Overall Study|Other, not specified|44|||
170731599|NCT03391765|617021511|FG001|Overall Study|Other, not specified|38|||
170731600|NCT03391765|617021512|FG002|Overall Study|Other, not specified|21|||
170731601|NCT03391765|617021513|FG003|Overall Study|Other, not specified|16|||
170731602|NCT00989092|617021514|FG000|Overall Study|Physician Decision|9|||
170731603|NCT00989092|617021515|FG001|Overall Study|Physician Decision|6|||
170731604|NCT00989092|617021514|FG000|Overall Study|Adverse Event|20|||
170731605|NCT00989092|617021515|FG001|Overall Study|Adverse Event|1|||
170731606|NCT00989092|617021514|FG000|Overall Study|Chemotherapy initiated|12|||
170731607|NCT00989092|617021515|FG001|Overall Study|Chemotherapy initiated|4|||
170731608|NCT00989092|617021514|FG000|Overall Study|Withdrawal by Subject|17|||
170731609|NCT00989092|617021515|FG001|Overall Study|Withdrawal by Subject|9|||
170731610|NCT00989092|617021514|FG000|Overall Study|Death|14|||
170731611|NCT00989092|617021515|FG001|Overall Study|Death|2|||
170731612|NCT00989092|617021514|FG000|Overall Study|Ineligibility determined|3|||
170731613|NCT00989092|617021515|FG001|Overall Study|Ineligibility determined|3|||
170731614|NCT00989092|617021514|FG000|Overall Study|Lost to Follow-up|6|||
170731615|NCT00989092|617021515|FG001|Overall Study|Lost to Follow-up|2|||
170731616|NCT00989092|617021514|FG000|Overall Study|Other|3|||
170731617|NCT00989092|617021515|FG001|Overall Study|Other|1|||
170731618|NCT00989092|617021514|FG000|Overall Study|Protocol deviation|2|||
170731619|NCT00989092|617021515|FG001|Overall Study|Protocol deviation|0|||
170731620|NCT00989092|617021514|FG000|Overall Study|Erythropoietin therapy initiated|2|||
170731621|NCT00989092|617021515|FG001|Overall Study|Erythropoietin therapy initiated|0|||
170731622|NCT00989092|617021514|FG000|Overall Study|Did not receive study drug|2|||
170731623|NCT00989092|617021515|FG001|Overall Study|Did not receive study drug|0|||
170731624|NCT02832622|617021516|FG000|Overall Study|MPP not programmed|1259|||
170731625|NCT02832622|617021516|FG000|Overall Study|Withdrawal by Subject|123|||
170731626|NCT02832622|617021516|FG000|Overall Study|Death|119|||
170731627|NCT02832622|617021516|FG000|Overall Study|Unsuccessful CRT implant|93|||
170731628|NCT02832622|617021516|FG000|Overall Study|Lost to Follow-up|45|||
170731629|NCT02832622|617021516|FG000|Overall Study|Patient non-compliance|42|||
170731630|NCT02832622|617021516|FG000|Overall Study|Withdrawal by other reasons|25|||
170731631|NCT02832622|617021516|FG000|Overall Study|System explant|24|||
170731632|NCT02832622|617021516|FG000|Overall Study|Physician Decision|6|||
170731633|NCT05050578|617021517|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
170731634|NCT05050578|617021518|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
170731635|NCT05050578|617021517|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
170731636|NCT05050578|617021518|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
170731637|NCT05050578|617021517|FG000|Period 2, 30 Days|Protocol Violation|0|||
170731638|NCT05050578|617021518|FG001|Period 2, 30 Days|Protocol Violation|1|||
170731639|NCT02243280|617021519|FG000|Treated|Adverse Event|1|||
170731640|NCT02243280|617021520|FG001|Treated|Adverse Event|0|||
170731641|NCT02243280|617021521|FG002|Treated|Adverse Event|0|||
170731642|NCT02243280|617021522|FG003|Treated|Adverse Event|0|||
170731643|NCT02243280|617021523|FG004|Treated|Adverse Event|0|||
170731644|NCT02243280|617021524|FG005|Treated|Adverse Event|0|||
170731645|NCT02243280|617021525|FG006|Treated|Adverse Event|0|||
170731646|NCT02243280|617021526|FG007|Treated|Adverse Event|0|||
170731647|NCT02243280|617021527|FG008|Treated|Adverse Event|0|||
170731648|NCT02243280|617021528|FG009|Treated|Adverse Event|0|||
170731649|NCT02243280|617021529|FG010|Treated|Adverse Event|1|||
170731650|NCT02243280|617021519|FG000|Treated|Lost to Follow-up|0|||
170731651|NCT02243280|617021520|FG001|Treated|Lost to Follow-up|0|||
170731652|NCT02243280|617021521|FG002|Treated|Lost to Follow-up|0|||
170731653|NCT02243280|617021522|FG003|Treated|Lost to Follow-up|0|||
170731654|NCT02243280|617021523|FG004|Treated|Lost to Follow-up|0|||
170731655|NCT02243280|617021524|FG005|Treated|Lost to Follow-up|0|||
170731656|NCT02243280|617021525|FG006|Treated|Lost to Follow-up|0|||
170731657|NCT02243280|617021526|FG007|Treated|Lost to Follow-up|0|||
170731658|NCT02243280|617021527|FG008|Treated|Lost to Follow-up|1|||
170731659|NCT02243280|617021528|FG009|Treated|Lost to Follow-up|0|||
170731660|NCT02243280|617021529|FG010|Treated|Lost to Follow-up|2|||
170731661|NCT00998400|617021533|FG000|Overall Study|Lack of interest/motivation|1|||
170731662|NCT00998400|617021534|FG001|Overall Study|Lack of interest/motivation|2|||
170731663|NCT00998400|617021533|FG000|Overall Study|Logistical problems|1|||
170731664|NCT00998400|617021534|FG001|Overall Study|Logistical problems|0|||
170731665|NCT03185832|617021535|FG000|Overall Study|Death|9|||
170731666|NCT03185832|617021536|FG001|Overall Study|Death|14|||
170731667|NCT03185832|617021537|FG002|Overall Study|Death|9|||
170839002|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
170839003|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
170839004|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
170839005|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
170839006|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
170839007|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
170839008|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
170839009|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
170839010|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
170839011|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
170839012|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
170839013|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
170839014|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
170839015|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
170839016|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
170839017|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
170839018|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
170839019|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
170839020|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
170839021|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
170839022|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
170839023|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
170839024|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
170839025|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
170839026|NCT00217737|617417798|FG000|Step 2 Randomization/Registration|Other|1|||
170839027|NCT00217737|617417799|FG001|Step 2 Randomization/Registration|Other|2|||
170839028|NCT00217737|617417800|FG002|Step 2 Randomization/Registration|Other|0|||
170839029|NCT00217737|617417801|FG003|Step 2 Randomization/Registration|Other|0|||
170839030|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Adverse Event|2|||
170839031|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Adverse Event|0|||
170839032|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Adverse Event|0|||
170839033|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Adverse Event|0|||
170839034|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
170839035|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
170839036|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
170839037|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
170839038|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
170839039|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
170839040|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
170839041|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
170839042|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Physician Decision|1|||
170839043|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Physician Decision|0|||
170839044|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Physician Decision|0|||
170839045|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Physician Decision|0|||
170839046|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Pregnancy|1|||
170839047|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Pregnancy|0|||
170839048|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Pregnancy|0|||
170839049|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Pregnancy|0|||
170839050|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
170839051|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
170839052|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
170839053|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
170839054|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
170839055|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
170839056|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
170839057|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
170839058|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
170839059|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
170839060|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
170839061|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
170839062|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
170839063|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
170839064|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
170839065|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
170839066|NCT04057573|617419538|FG000|24-Week Double-Blind Period|Not Treated|1|||
170839067|NCT04057573|617419539|FG001|24-Week Double-Blind Period|Not Treated|0|||
170839068|NCT04057573|617419540|FG002|24-Week Double-Blind Period|Not Treated|0|||
170839069|NCT04057573|617419541|FG003|24-Week Double-Blind Period|Not Treated|0|||
170839070|NCT04057573|617419538|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
170839071|NCT04057573|617419539|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
170839072|NCT04057573|617419540|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
170839073|NCT04057573|617419541|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
170839074|NCT04057573|617419538|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
170839075|NCT04057573|617419539|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
170839076|NCT04057573|617419540|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
170839077|NCT04057573|617419541|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
170839078|NCT04057573|617419538|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
170839079|NCT04057573|617419539|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
170839080|NCT04057573|617419540|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
170839081|NCT04057573|617419541|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
170839082|NCT04057573|617419538|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
170839083|NCT04057573|617419539|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
170839084|NCT04057573|617419540|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
170839085|NCT04057573|617419541|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
170839086|NCT04057573|617419538|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
170839087|NCT04057573|617419539|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
170839088|NCT04057573|617419540|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
170839089|NCT04057573|617419541|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
170839090|NCT00603525|617419551|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
170839091|NCT00603525|617419552|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
170839092|NCT00603525|617419553|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
170839093|NCT00603525|617419551|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
170839094|NCT00603525|617419552|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
170839095|NCT00603525|617419553|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
170839096|NCT00603525|617419551|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
170839097|NCT00603525|617419552|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
170839098|NCT00603525|617419553|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
170839099|NCT00603525|617419551|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170839100|NCT00603525|617419552|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
170839101|NCT00603525|617419553|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170839102|NCT00603525|617419551|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
170839103|NCT00603525|617419552|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
170839104|NCT00603525|617419553|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170839105|NCT00603525|617419551|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
170839106|NCT00603525|617419552|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
170839107|NCT00603525|617419553|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
170839108|NCT00603525|617419551|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
170839109|NCT00603525|617419552|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
170839110|NCT00603525|617419553|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
170839111|NCT00603525|617419551|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
170839112|NCT00603525|617419552|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
170839113|NCT00603525|617419553|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
170839114|NCT00603525|617419551|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
170839115|NCT00603525|617419552|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
170839116|NCT00603525|617419553|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
170839117|NCT00603525|617419551|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
170839118|NCT00603525|617419552|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
170839119|NCT00603525|617419553|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
170839120|NCT00603525|617419551|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
170839121|NCT00603525|617419552|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
170839122|NCT00603525|617419553|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
170839123|NCT00603525|617419551|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
170839124|NCT00603525|617419552|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
170839125|NCT00603525|617419553|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
170839126|NCT00603525|617419551|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
170839127|NCT00603525|617419552|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
170839128|NCT00603525|617419553|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
170839129|NCT00603525|617419551|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
170839130|NCT00603525|617419552|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
170839131|NCT00603525|617419553|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
170839132|NCT00603525|617419551|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
170839133|NCT00603525|617419552|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
170839134|NCT00603525|617419553|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
170839135|NCT02460575|617419554|FG000|Overall Study|Lost to Follow-up|1|||
170839136|NCT02460575|617419555|FG001|Overall Study|Lost to Follow-up|0|||
170839137|NCT00770029|617419556|FG000|Overall Study|Lost to Follow-up|2|||
170839138|NCT00770029|617419557|FG001|Overall Study|Lost to Follow-up|0|||
170839139|NCT00770029|617419556|FG000|Overall Study|Withdrawal by Subject|3|||
170839140|NCT00770029|617419557|FG001|Overall Study|Withdrawal by Subject|3|||
170839141|NCT00770029|617419556|FG000|Overall Study|Adverse Event|1|||
170839142|NCT00770029|617419557|FG001|Overall Study|Adverse Event|0|||
170839143|NCT02124811|617419558|FG000|Overall Study|Early termination|2|||
170839144|NCT02124811|617419559|FG001|Overall Study|Early termination|2|||
170839145|NCT02124811|617419558|FG000|Overall Study|Withdrawal by Subject|1|||
170839146|NCT02124811|617419559|FG001|Overall Study|Withdrawal by Subject|0|||
170839147|NCT04307940|617419560|FG000|Overall Study|Adverse Event|1|||
170839148|NCT04307940|617419561|FG001|Overall Study|Adverse Event|0|||
170839149|NCT04307940|617419562|FG002|Overall Study|Adverse Event|0|||
170839150|NCT04307940|617419560|FG000|Overall Study|Withdrawal by Subject|2|||
170839151|NCT04307940|617419561|FG001|Overall Study|Withdrawal by Subject|3|||
170839152|NCT04307940|617419562|FG002|Overall Study|Withdrawal by Subject|1|||
170839153|NCT04307940|617419560|FG000|Overall Study|Lost to Follow-up|2|||
170839154|NCT04307940|617419561|FG001|Overall Study|Lost to Follow-up|0|||
170839155|NCT04307940|617419562|FG002|Overall Study|Lost to Follow-up|1|||
170839156|NCT00974259|617419568|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
170839157|NCT00974259|617419569|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
170839158|NCT04400487|617419570|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
170839159|NCT04400487|617419570|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
170839160|NCT04400487|617419570|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
170839161|NCT03445533|617419571|FG000|Overall Study|Progressive Disease|48|||
170839162|NCT03445533|617419572|FG001|Overall Study|Progressive Disease|81|||
170839163|NCT03445533|617419571|FG000|Overall Study|Adverse Event|60|||
170839164|NCT03445533|617419572|FG001|Overall Study|Adverse Event|64|||
170839165|NCT03445533|617419571|FG000|Overall Study|Death|9|||
170839166|NCT03445533|617419572|FG001|Overall Study|Death|19|||
170839167|NCT03445533|617419571|FG000|Overall Study|Miscellaneous|0|||
170839168|NCT03445533|617419572|FG001|Overall Study|Miscellaneous|16|||
170839169|NCT03445533|617419571|FG000|Overall Study|Withdrawal by Subject|3|||
170839170|NCT03445533|617419572|FG001|Overall Study|Withdrawal by Subject|4|||
170839171|NCT03445533|617419571|FG000|Overall Study|Physician Decision|1|||
170839172|NCT03445533|617419572|FG001|Overall Study|Physician Decision|3|||
170839173|NCT03445533|617419571|FG000|Overall Study|Sponsor Decision|0|||
170839174|NCT03445533|617419572|FG001|Overall Study|Sponsor Decision|1|||
170839175|NCT03445533|617419571|FG000|Overall Study|Lost to Follow-up|0|||
170839176|NCT03445533|617419572|FG001|Overall Study|Lost to Follow-up|1|||
170839177|NCT03445533|617419571|FG000|Overall Study|Never Received any Study Treatment|7|||
170839178|NCT03445533|617419572|FG001|Overall Study|Never Received any Study Treatment|4|||
170839179|NCT03334253|617419573|FG000|Overall Study|Withdrawal by Subject|1|||
170839180|NCT03334253|617419574|FG001|Overall Study|Withdrawal by Subject|0|||
170839181|NCT03334253|617419573|FG000|Overall Study|Lost to Follow-up|4|||
170839182|NCT03334253|617419574|FG001|Overall Study|Lost to Follow-up|3|||
170839183|NCT03334253|617419573|FG000|Overall Study|Moved residence|2|||
170839184|NCT03334253|617419574|FG001|Overall Study|Moved residence|2|||
170839185|NCT00945672|617419575|FG000|Overall Study|Withdrawal by Subject|0|||
170839186|NCT00945672|617419576|FG001|Overall Study|Withdrawal by Subject|0|||
170839187|NCT00945672|617419577|FG002|Overall Study|Withdrawal by Subject|0|||
170839188|NCT00945672|617419578|FG003|Overall Study|Withdrawal by Subject|1|||
170839189|NCT00968526|617419579|FG000|Overall Study|Adverse Event|2|||
170839190|NCT00968526|617419580|FG001|Overall Study|Adverse Event|0|||
170839191|NCT00968526|617419579|FG000|Overall Study|Migrated/moved from study area|1|||
170839192|NCT00968526|617419580|FG001|Overall Study|Migrated/moved from study area|0|||
170839193|NCT02493062|617419582|FG000|Overall Study|Physician Decision|12|||
170839194|NCT02030002|617419583|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
170839195|NCT02030002|617419583|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
170839196|NCT02030002|617419583|FG000|Follow-up|Lost to Follow-up|2|||
170839197|NCT01294397|617419584|FG000|Overall Study|Withdrawal by Subject|1|||
170839198|NCT01294397|617419584|FG000|Overall Study|Administrative Decision|1|||
170839199|NCT01689857|617419586|FG000|Overall Study|Lost to Follow-up|5|||
170839200|NCT01689857|617419587|FG001|Overall Study|Lost to Follow-up|2|||
170839201|NCT00874731|617419589|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
170839202|NCT00874731|617419590|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
170839203|NCT00874731|617419591|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
170839204|NCT00874731|617419589|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
170839205|NCT00874731|617419590|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
170839206|NCT00874731|617419591|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
170839207|NCT00874731|617419589|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
170839208|NCT00874731|617419590|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
170839209|NCT00874731|617419591|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
170839210|NCT05105087|617419592|FG000|Overall Study|Withdrawal by Subject|2|||
170839211|NCT05105087|617419592|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
170839212|NCT01736540|617419593|FG000|Overall Study|Did not complete scan within 45 days|2|||
170839213|NCT01736540|617419593|FG000|Overall Study|Death|1|||
170839214|NCT01736540|617419593|FG000|Overall Study|Abnormal test procedure|1|||
170839215|NCT01736540|617419593|FG000|Overall Study|Withdrawal by Subject|5|||
170839216|NCT01736540|617419593|FG000|Overall Study|Protocol Violation|1|||
170839217|NCT01736540|617419593|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
170839218|NCT01736540|617419593|FG000|Overall Study|No show for MRI appointment|1|||
170839219|NCT01736540|617419593|FG000|Overall Study|Unable to make MRI appointment|3|||
170839220|NCT03812029|617419600|FG000|Overall Study|Protocol Violation|1|||
170839221|NCT03812029|617419601|FG001|Overall Study|Protocol Violation|0|||
170839222|NCT03812029|617419602|FG002|Overall Study|Protocol Violation|0|||
170839223|NCT03812029|617419603|FG003|Overall Study|Protocol Violation|1|||
170839224|NCT03812029|617419604|FG004|Overall Study|Protocol Violation|0|||
170839225|NCT03812029|617419600|FG000|Overall Study|Withdrawal by Subject|1|||
170839226|NCT03812029|617419601|FG001|Overall Study|Withdrawal by Subject|0|||
170839227|NCT03812029|617419602|FG002|Overall Study|Withdrawal by Subject|0|||
170839228|NCT03812029|617419603|FG003|Overall Study|Withdrawal by Subject|2|||
170839229|NCT03812029|617419604|FG004|Overall Study|Withdrawal by Subject|2|||
170839230|NCT03812029|617419600|FG000|Overall Study|Stopping rules|0|||
170839231|NCT03812029|617419601|FG001|Overall Study|Stopping rules|1|||
170839232|NCT03812029|617419602|FG002|Overall Study|Stopping rules|0|||
170839233|NCT03812029|617419603|FG003|Overall Study|Stopping rules|0|||
170839234|NCT03812029|617419604|FG004|Overall Study|Stopping rules|0|||
170839235|NCT03812029|617419600|FG000|Overall Study|Adverse Event|0|||
170839236|NCT03812029|617419601|FG001|Overall Study|Adverse Event|9|||
170839237|NCT03812029|617419602|FG002|Overall Study|Adverse Event|0|||
170839238|NCT03812029|617419603|FG003|Overall Study|Adverse Event|3|||
170839239|NCT03812029|617419604|FG004|Overall Study|Adverse Event|5|||
170839240|NCT03812029|617419600|FG000|Overall Study|Lost to Follow-up|0|||
170839241|NCT03812029|617419601|FG001|Overall Study|Lost to Follow-up|0|||
170839242|NCT03812029|617419602|FG002|Overall Study|Lost to Follow-up|0|||
170839243|NCT03812029|617419603|FG003|Overall Study|Lost to Follow-up|0|||
170839244|NCT03812029|617419604|FG004|Overall Study|Lost to Follow-up|3|||
170839245|NCT00479882|617419605|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
170839246|NCT00479882|617419606|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
170839247|NCT00479882|617419607|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
170839248|NCT00479882|617419608|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
170839249|NCT00479882|617419605|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
170839250|NCT00479882|617419606|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
170839251|NCT00479882|617419607|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
170839252|NCT00479882|617419608|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
170839253|NCT00479882|617419605|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
170839254|NCT00479882|617419606|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
170839255|NCT00479882|617419607|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
170839256|NCT00479882|617419608|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
170839257|NCT00479882|617419605|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
170839258|NCT00479882|617419606|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
170839259|NCT00479882|617419607|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
170839260|NCT00479882|617419608|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
170839261|NCT00479882|617419605|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
170839262|NCT00479882|617419606|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
170839263|NCT00479882|617419607|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
170839264|NCT00479882|617419608|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
170839265|NCT00479882|617419605|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
170839266|NCT00479882|617419606|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
170839267|NCT00479882|617419607|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
170839268|NCT00479882|617419608|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
170839269|NCT00479882|617419605|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
170839270|NCT00479882|617419606|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
170839271|NCT00479882|617419607|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
170839272|NCT00479882|617419608|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
170839273|NCT00479882|617419605|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
170839274|NCT00479882|617419606|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
170839275|NCT00479882|617419607|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
170839276|NCT00479882|617419608|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
170839277|NCT00479882|617419605|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
170839278|NCT00479882|617419606|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
170839279|NCT00479882|617419607|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
170839280|NCT00479882|617419608|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
170839281|NCT00479882|617419605|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
170839282|NCT00479882|617419606|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
170839283|NCT00479882|617419607|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
170839284|NCT00479882|617419608|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
170839285|NCT00479882|617419605|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
170839286|NCT00479882|617419606|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
170839287|NCT00479882|617419607|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
170839288|NCT00479882|617419608|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
170839289|NCT00479882|617419605|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
170839290|NCT00479882|617419606|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
170839291|NCT00479882|617419607|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
170839292|NCT00479882|617419608|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
170839293|NCT00479882|617419605|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
170839294|NCT00479882|617419606|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
170839295|NCT00479882|617419607|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
170839296|NCT00479882|617419608|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
170839297|NCT00479882|617419605|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
170839298|NCT00479882|617419606|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
170839299|NCT00479882|617419607|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
170839300|NCT00479882|617419608|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
170839301|NCT00581477|617419609|FG000|Overall Study|Physician Decision|2|||
170839302|NCT01023958|617419616|FG000|Overall Study|Progressive disease|48|||
170839303|NCT01023958|617419616|FG000|Overall Study|Other adverse event|1|||
170839304|NCT01023958|617419616|FG000|Overall Study|Refused to continue medication|1|||
170839305|NCT00790205|617419617|FG000|Overall Study|Lost to Follow-up|61|||
170839306|NCT00790205|617419618|FG001|Overall Study|Lost to Follow-up|71|||
170839307|NCT00790205|617419617|FG000|Overall Study|Withdrawal by Subject|299|||
170839308|NCT00790205|617419618|FG001|Overall Study|Withdrawal by Subject|363|||
170839309|NCT01031628|617419619|FG000|Overall Study|Study terminated early|0|||
170839310|NCT01031628|617419620|FG001|Overall Study|Study terminated early|1|||
170839311|NCT01031628|617419621|FG002|Overall Study|Study terminated early|3|||
170839312|NCT01031628|617419622|FG003|Overall Study|Study terminated early|0|||
170839313|NCT05143138|617419623|FG000|Overall Study|Death|5|||
170839314|NCT05143138|617419624|FG001|Overall Study|Death|35|||
170839315|NCT05143138|617419625|FG002|Overall Study|Death|1|||
170839316|NCT05143138|617419623|FG000|Overall Study|Lost to Follow-up|2|||
170839317|NCT05143138|617419624|FG001|Overall Study|Lost to Follow-up|4|||
170839318|NCT05143138|617419625|FG002|Overall Study|Lost to Follow-up|0|||
170839319|NCT05143138|617419623|FG000|Overall Study|withdrawal|1|||
170839320|NCT05143138|617419624|FG001|Overall Study|withdrawal|1|||
170839321|NCT05143138|617419625|FG002|Overall Study|withdrawal|0|||
170839322|NCT04245345|617419628|FG000|Overall Study|Death|1|||
170839323|NCT04245345|617419628|FG000|Overall Study|Exited prior to implant|5|||
170839324|NCT04245345|617419628|FG000|Overall Study|Exited prior to 1-month|9|||
170839325|NCT04245345|617419628|FG000|Overall Study|Missed 1-month visit|3|||
170839326|NCT04245345|617419628|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
170839327|NCT04245345|617419628|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
170839328|NCT03443414|617419629|FG000|Overall Study|Adverse Event|6|||
170839329|NCT03443414|617419630|FG001|Overall Study|Adverse Event|0|||
170839330|NCT03443414|617419631|FG002|Overall Study|Adverse Event|4|||
170839331|NCT03443414|617419632|FG003|Overall Study|Adverse Event|2|||
170839332|NCT03443414|617419633|FG004|Overall Study|Adverse Event|3|||
170839333|NCT03443414|617419629|FG000|Overall Study|Withdrawal by Subject|3|||
170839334|NCT03443414|617419630|FG001|Overall Study|Withdrawal by Subject|2|||
170839335|NCT03443414|617419631|FG002|Overall Study|Withdrawal by Subject|2|||
170839336|NCT03443414|617419632|FG003|Overall Study|Withdrawal by Subject|2|||
170839337|NCT03443414|617419633|FG004|Overall Study|Withdrawal by Subject|1|||
170839338|NCT03443414|617419629|FG000|Overall Study|Death|0|||
170839339|NCT03443414|617419630|FG001|Overall Study|Death|1|||
170839340|NCT03443414|617419631|FG002|Overall Study|Death|0|||
170839341|NCT03443414|617419632|FG003|Overall Study|Death|1|||
170839342|NCT03443414|617419633|FG004|Overall Study|Death|0|||
170839343|NCT03443414|617419629|FG000|Overall Study|Reason not specified|2|||
170839344|NCT03443414|617419630|FG001|Overall Study|Reason not specified|0|||
170839345|NCT03443414|617419631|FG002|Overall Study|Reason not specified|0|||
170839346|NCT03443414|617419632|FG003|Overall Study|Reason not specified|0|||
170839347|NCT03443414|617419633|FG004|Overall Study|Reason not specified|1|||
170839348|NCT03933462|617419636|FG000|Overall Study|Adverse Event|2|||
170839349|NCT03933462|617419637|FG001|Overall Study|Adverse Event|0|||
170839350|NCT04805073|617419644|FG000|Overall Study|study personnel not available|2|||
170839351|NCT04805073|617419645|FG001|Overall Study|study personnel not available|0|||
170839352|NCT04805073|617419644|FG000|Overall Study|spinal anesthesia failure|0|||
170839353|NCT04805073|617419645|FG001|Overall Study|spinal anesthesia failure|1|||
170839354|NCT04805073|617419644|FG000|Overall Study|Lost to Follow-up|0|||
170839355|NCT04805073|617419645|FG001|Overall Study|Lost to Follow-up|2|||
170839356|NCT01485120|617419646|FG000|Overall Study|Withdrawal by Subject|2|||
170839357|NCT01912404|617419647|FG000|Overall Study|Due to personal reasons|1|||
170839358|NCT01912404|617419648|FG001|Overall Study|Due to personal reasons|0|||
170839359|NCT01443923|617419649|FG000|Overall Study|Adverse Event|1|||
170839360|NCT01443923|617419650|FG001|Overall Study|Adverse Event|0|||
170839361|NCT04547023|617419653|FG000|Overall Study|Did Not Receive Intervention|3|||
170839362|NCT04547023|617419654|FG001|Overall Study|Did Not Receive Intervention|2|||
170839363|NCT04547023|617419653|FG000|Overall Study|Lost to Follow-up|1|||
170839364|NCT04547023|617419654|FG001|Overall Study|Lost to Follow-up|1|||
170839365|NCT01245374|617419655|FG000|Overall Study|Protocol Violation|1|||
170839366|NCT01245374|617419655|FG000|Overall Study|Withdrawal by Subject|3|||
170839367|NCT04674189|617419657|FG000|Overall Study|Adverse Event|0|||
170839368|NCT04674189|617419658|FG001|Overall Study|Adverse Event|0|||
170839369|NCT04674189|617419659|FG002|Overall Study|Adverse Event|1|||
170839370|NCT04674189|617419657|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
170839371|NCT04674189|617419658|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
170839372|NCT04674189|617419659|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
170839373|NCT04674189|617419657|FG000|Overall Study|Physician Decision|1|||
170839374|NCT04674189|617419658|FG001|Overall Study|Physician Decision|0|||
170839375|NCT04674189|617419659|FG002|Overall Study|Physician Decision|0|||
170839376|NCT04674189|617419657|FG000|Overall Study|Withdrawal by Participant|83|||
170839377|NCT04674189|617419658|FG001|Overall Study|Withdrawal by Participant|71|||
170839378|NCT04674189|617419659|FG002|Overall Study|Withdrawal by Participant|142|||
170839379|NCT04674189|617419657|FG000|Overall Study|Lost to Follow-up|55|||
170839380|NCT04674189|617419658|FG001|Overall Study|Lost to Follow-up|53|||
170839381|NCT04674189|617419659|FG002|Overall Study|Lost to Follow-up|44|||
170839382|NCT04674189|617419657|FG000|Overall Study|Miscellaneous|27|||
170839383|NCT04674189|617419658|FG001|Overall Study|Miscellaneous|23|||
170839384|NCT04674189|617419659|FG002|Overall Study|Miscellaneous|207|||
170839385|NCT04674189|617419657|FG000|Overall Study|Did Not Receive Treatment|3|||
170839386|NCT04674189|617419658|FG001|Overall Study|Did Not Receive Treatment|1|||
170839387|NCT04674189|617419659|FG002|Overall Study|Did Not Receive Treatment|2|||
170839388|NCT00583947|617419661|FG000|Cross-over Period|Adverse Event|2|||
170839389|NCT00583947|617419662|FG001|Cross-over Period|Adverse Event|0|||
170839390|NCT00583947|617419661|FG000|Cross-over Period|Withdrawal by Subject|2|||
170839391|NCT00583947|617419662|FG001|Cross-over Period|Withdrawal by Subject|0|||
170839392|NCT00583947|617419661|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
170839393|NCT00583947|617419662|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
170839394|NCT00583947|617419661|FG000|Cross-over Period|Other|1|||
170839395|NCT00583947|617419662|FG001|Cross-over Period|Other|1|||
170839396|NCT01261247|617419663|FG000|Overall Study|Ineligible|2|||
170839397|NCT05226130|617419664|FG000|Overall Study|Lost to Follow-up|0|||
170839398|NCT05226130|617419665|FG001|Overall Study|Lost to Follow-up|1|||
170839399|NCT05226130|617419664|FG000|Overall Study|Not treatment adherent|0|||
170839400|NCT05226130|617419665|FG001|Overall Study|Not treatment adherent|2|||
170839401|NCT05032066|617419668|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
170839402|NCT05032066|617419669|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
170839403|NCT05032066|617419670|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
170839404|NCT05032066|617419668|FG000|Part 1: Core Phase|Physician Decision|0|||
170839405|NCT05032066|617419669|FG001|Part 1: Core Phase|Physician Decision|1|||
170839406|NCT05032066|617419670|FG002|Part 1: Core Phase|Physician Decision|1|||
170839407|NCT05032066|617419668|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
170839408|NCT05032066|617419669|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
170839409|NCT05032066|617419670|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
170839410|NCT05032066|617419668|FG000|Part 1: Core Phase|Death|3|||
170839411|NCT05032066|617419669|FG001|Part 1: Core Phase|Death|4|||
170839412|NCT05032066|617419670|FG002|Part 1: Core Phase|Death|2|||
170839413|NCT05032066|617419668|FG000|Part 1: Core Phase|Adverse Event|2|||
170839414|NCT05032066|617419669|FG001|Part 1: Core Phase|Adverse Event|3|||
170839415|NCT05032066|617419670|FG002|Part 1: Core Phase|Adverse Event|0|||
170839416|NCT05032066|617419668|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
170839417|NCT05032066|617419669|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
170839418|NCT05032066|617419670|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
170839419|NCT05032066|617419668|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
170839420|NCT05032066|617419669|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
170839421|NCT05032066|617419670|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
170839422|NCT05032066|617419668|FG000|Part 2: Extension Phase|Physician Decision|1|||
170839423|NCT05032066|617419669|FG001|Part 2: Extension Phase|Physician Decision|2|||
170839424|NCT05032066|617419670|FG002|Part 2: Extension Phase|Physician Decision|0|||
170839425|NCT05032066|617419668|FG000|Part 2: Extension Phase|Death|2|||
170839426|NCT05032066|617419669|FG001|Part 2: Extension Phase|Death|4|||
170839427|NCT05032066|617419670|FG002|Part 2: Extension Phase|Death|5|||
170839428|NCT04680533|617419671|FG000|Overall Study|Screen failure|1|||
170839429|NCT02473965|617421445|FG000|Overall Study|Adverse Event|6|||
170839430|NCT02473965|617421446|FG001|Overall Study|Adverse Event|4|||
170839431|NCT02473965|617421445|FG000|Overall Study|MG worsening|4|||
170839432|NCT02473965|617421446|FG001|Overall Study|MG worsening|1|||
170839433|NCT02473965|617421445|FG000|Overall Study|Withdrawal by Subject|2|||
170839434|NCT02473965|617421446|FG001|Overall Study|Withdrawal by Subject|3|||
170839435|NCT02473965|617421445|FG000|Overall Study|Physician Decision|0|||
170839436|NCT02473965|617421446|FG001|Overall Study|Physician Decision|2|||
170839437|NCT01183390|617421447|FG000|First Intervention|Adverse Event|0|||
170839438|NCT01183390|617421448|FG001|First Intervention|Adverse Event|1|||
170839439|NCT03816761|617421449|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
170839440|NCT03816761|617421450|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
170839441|NCT03816761|617421451|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
170839442|NCT03816761|617421452|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
170839443|NCT03816761|617421453|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
170839444|NCT03816761|617421454|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
170839445|NCT03816761|617421449|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
170839446|NCT03816761|617421450|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
170839447|NCT03816761|617421451|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
170839448|NCT03816761|617421452|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
170839449|NCT03816761|617421453|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
170839450|NCT03816761|617421454|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
170839451|NCT00474526|617421461|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
170839452|NCT00474526|617421462|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
170839453|NCT00474526|617421463|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
170839454|NCT00474526|617421464|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
170839455|NCT00474526|617421465|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
170839456|NCT00474526|617421466|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
170839457|NCT00474526|617421467|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
170839458|NCT00474526|617421468|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
170839459|NCT00474526|617421469|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
170839460|NCT00474526|617421470|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
170839461|NCT00474526|617421471|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
170839462|NCT00474526|617421472|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
170839463|NCT00474526|617421473|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
170839464|NCT00474526|617421474|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
170839465|NCT00474526|617421475|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
170839466|NCT00474526|617421476|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
170839467|NCT00474526|617421477|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
170839468|NCT00474526|617421461|FG000|Overall Study|Adverse Event|2|||
170839469|NCT00474526|617421462|FG001|Overall Study|Adverse Event|0|||
170839470|NCT00474526|617421463|FG002|Overall Study|Adverse Event|2|||
170839471|NCT00474526|617421464|FG003|Overall Study|Adverse Event|4|||
170839472|NCT00474526|617421465|FG004|Overall Study|Adverse Event|2|||
170839473|NCT00474526|617421466|FG005|Overall Study|Adverse Event|1|||
170839474|NCT00474526|617421467|FG006|Overall Study|Adverse Event|1|||
170839475|NCT00474526|617421468|FG007|Overall Study|Adverse Event|0|||
170839476|NCT00474526|617421469|FG008|Overall Study|Adverse Event|0|||
170839477|NCT00474526|617421470|FG009|Overall Study|Adverse Event|0|||
170839478|NCT00474526|617421471|FG010|Overall Study|Adverse Event|0|||
170839479|NCT00474526|617421472|FG011|Overall Study|Adverse Event|0|||
170839480|NCT00474526|617421473|FG012|Overall Study|Adverse Event|0|||
170839481|NCT00474526|617421474|FG013|Overall Study|Adverse Event|0|||
170839482|NCT00474526|617421475|FG014|Overall Study|Adverse Event|1|||
170839483|NCT00474526|617421476|FG015|Overall Study|Adverse Event|1|||
170839484|NCT00474526|617421477|FG016|Overall Study|Adverse Event|0|||
170839485|NCT00474526|617421461|FG000|Overall Study|Death|0|||
170839486|NCT00474526|617421462|FG001|Overall Study|Death|0|||
170839487|NCT00474526|617421463|FG002|Overall Study|Death|0|||
170839488|NCT00474526|617421464|FG003|Overall Study|Death|0|||
170839489|NCT00474526|617421465|FG004|Overall Study|Death|0|||
170839490|NCT00474526|617421466|FG005|Overall Study|Death|0|||
170839491|NCT00474526|617421467|FG006|Overall Study|Death|0|||
170839492|NCT00474526|617421468|FG007|Overall Study|Death|0|||
170839493|NCT00474526|617421469|FG008|Overall Study|Death|0|||
170839494|NCT00474526|617421470|FG009|Overall Study|Death|0|||
170839495|NCT00474526|617421471|FG010|Overall Study|Death|0|||
170839496|NCT00474526|617421472|FG011|Overall Study|Death|0|||
170839497|NCT00474526|617421473|FG012|Overall Study|Death|0|||
170839498|NCT00474526|617421474|FG013|Overall Study|Death|3|||
170839499|NCT00474526|617421475|FG014|Overall Study|Death|0|||
170839500|NCT00474526|617421476|FG015|Overall Study|Death|0|||
170839501|NCT00474526|617421477|FG016|Overall Study|Death|0|||
170839502|NCT00474526|617421461|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839503|NCT00474526|617421462|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
170839504|NCT00474526|617421463|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839505|NCT00474526|617421464|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
170839506|NCT00474526|617421465|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
170839507|NCT00474526|617421466|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839508|NCT00474526|617421467|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839509|NCT00474526|617421468|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839510|NCT00474526|617421469|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839511|NCT00474526|617421470|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839512|NCT00474526|617421471|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839513|NCT00474526|617421472|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839514|NCT00474526|617421473|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839515|NCT00474526|617421474|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
170839516|NCT00474526|617421475|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
170839517|NCT00474526|617421476|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839518|NCT00474526|617421477|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
170839519|NCT00474526|617421461|FG000|Overall Study|Lost to Follow-up|8|||
170839520|NCT00474526|617421462|FG001|Overall Study|Lost to Follow-up|6|||
170839521|NCT00474526|617421463|FG002|Overall Study|Lost to Follow-up|13|||
170839522|NCT00474526|617421464|FG003|Overall Study|Lost to Follow-up|29|||
170839523|NCT00474526|617421465|FG004|Overall Study|Lost to Follow-up|11|||
170839524|NCT00474526|617421466|FG005|Overall Study|Lost to Follow-up|5|||
170839525|NCT00474526|617421467|FG006|Overall Study|Lost to Follow-up|8|||
170839526|NCT00474526|617421468|FG007|Overall Study|Lost to Follow-up|1|||
170839527|NCT00474526|617421469|FG008|Overall Study|Lost to Follow-up|0|||
170839528|NCT00474526|617421470|FG009|Overall Study|Lost to Follow-up|6|||
170731668|NCT03185832|617021538|FG003|Overall Study|Death|7|||
170731669|NCT03185832|617021535|FG000|Overall Study|Withdrawn - vital status available|0|||
170731670|NCT03185832|617021536|FG001|Overall Study|Withdrawn - vital status available|1|||
170731671|NCT03185832|617021537|FG002|Overall Study|Withdrawn - vital status available|1|||
170731672|NCT03185832|617021538|FG003|Overall Study|Withdrawn - vital status available|4|||
170731673|NCT03439189|617021541|FG000|Overall Study|Protocol Violation|19|||
170731674|NCT03439189|617021541|FG000|Overall Study|Lack of Efficacy|63|||
170731675|NCT01777321|617021548|FG000|Overall Study|Withdrawal by Subject|0|||
170731676|NCT01777321|617021549|FG001|Overall Study|Withdrawal by Subject|1|||
170731677|NCT03837509|617021554|FG000|Phase 1|Death|5|||
170731678|NCT03837509|617021555|FG001|Phase 1|Death|2|||
170731679|NCT03837509|617021556|FG002|Phase 1|Death|0|||
170839529|NCT00474526|617421471|FG010|Overall Study|Lost to Follow-up|2|||
170839530|NCT00474526|617421472|FG011|Overall Study|Lost to Follow-up|4|||
170839531|NCT00474526|617421473|FG012|Overall Study|Lost to Follow-up|6|||
170839532|NCT00474526|617421474|FG013|Overall Study|Lost to Follow-up|74|||
170839533|NCT00474526|617421475|FG014|Overall Study|Lost to Follow-up|29|||
170731680|NCT03837509|617021557|FG003|Phase 1|Death|0|||
170731681|NCT03837509|617021558|FG004|Phase 1|Death|0|||
170731682|NCT03837509|617021554|FG000|Phase 2|Death|0|||
170731683|NCT03837509|617021555|FG001|Phase 2|Death|0|||
170839534|NCT00474526|617421476|FG015|Overall Study|Lost to Follow-up|4|||
170839535|NCT00474526|617421477|FG016|Overall Study|Lost to Follow-up|5|||
170839536|NCT00474526|617421461|FG000|Overall Study|Protocol Violation|2|||
170839537|NCT00474526|617421462|FG001|Overall Study|Protocol Violation|6|||
170839538|NCT00474526|617421463|FG002|Overall Study|Protocol Violation|4|||
170839539|NCT00474526|617421464|FG003|Overall Study|Protocol Violation|12|||
170839540|NCT00474526|617421465|FG004|Overall Study|Protocol Violation|3|||
170839541|NCT00474526|617421466|FG005|Overall Study|Protocol Violation|1|||
170839542|NCT00474526|617421467|FG006|Overall Study|Protocol Violation|3|||
170839543|NCT00474526|617421468|FG007|Overall Study|Protocol Violation|0|||
170839544|NCT00474526|617421469|FG008|Overall Study|Protocol Violation|0|||
170839545|NCT00474526|617421470|FG009|Overall Study|Protocol Violation|4|||
170731684|NCT03837509|617021556|FG002|Phase 2|Death|0|||
170731685|NCT03837509|617021557|FG003|Phase 2|Death|1|||
170731686|NCT03837509|617021558|FG004|Phase 2|Death|1|||
170731687|NCT05131165|617021559|FG000|Overall Study|Death|1|||
170731688|NCT05131165|617021560|FG001|Overall Study|Death|1|||
170731689|NCT05131165|617021561|FG002|Overall Study|Death|0|||
170731690|NCT05131165|617021559|FG000|Overall Study|Lost to Follow-up|2|||
170731691|NCT05131165|617021560|FG001|Overall Study|Lost to Follow-up|2|||
170839546|NCT00474526|617421471|FG010|Overall Study|Protocol Violation|2|||
170839547|NCT00474526|617421472|FG011|Overall Study|Protocol Violation|2|||
170839548|NCT00474526|617421473|FG012|Overall Study|Protocol Violation|4|||
170839549|NCT00474526|617421474|FG013|Overall Study|Protocol Violation|19|||
170839550|NCT00474526|617421475|FG014|Overall Study|Protocol Violation|9|||
170839551|NCT00474526|617421476|FG015|Overall Study|Protocol Violation|6|||
170839552|NCT00474526|617421477|FG016|Overall Study|Protocol Violation|2|||
170839553|NCT00474526|617421461|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
170839554|NCT00474526|617421462|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
170839555|NCT00474526|617421463|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
170839556|NCT00474526|617421464|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
170839557|NCT00474526|617421465|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
170839558|NCT00474526|617421466|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
170839559|NCT00474526|617421467|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
170839560|NCT00474526|617421468|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
170839561|NCT00474526|617421469|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
170839562|NCT00474526|617421470|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
170839563|NCT00474526|617421471|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
170839564|NCT00474526|617421472|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
170731692|NCT05131165|617021561|FG002|Overall Study|Lost to Follow-up|5|||
170731693|NCT05131165|617021559|FG000|Overall Study|Transferred out of clinic|1|||
170731694|NCT05131165|617021560|FG001|Overall Study|Transferred out of clinic|0|||
170731695|NCT05131165|617021561|FG002|Overall Study|Transferred out of clinic|3|||
170731696|NCT05131165|617021559|FG000|Overall Study|Dropped out|1|||
170731697|NCT05131165|617021560|FG001|Overall Study|Dropped out|2|||
170731698|NCT05131165|617021561|FG002|Overall Study|Dropped out|0|||
170731699|NCT00840801|617021564|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
170731700|NCT00840801|617021565|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
170731701|NCT00840801|617021566|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
170731702|NCT00840801|617021564|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
170731703|NCT00840801|617021565|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
170731704|NCT00840801|617021566|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
170731705|NCT00840801|617021564|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
170731706|NCT00840801|617021565|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
170731707|NCT00840801|617021566|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
170731708|NCT00840801|617021564|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
170731709|NCT00840801|617021565|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
170731710|NCT00840801|617021566|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
170731711|NCT01242748|617021567|FG000|Overall Study|Adverse Event|10|||
170731712|NCT01242748|617021568|FG001|Overall Study|Adverse Event|5|||
170731713|NCT01242748|617021567|FG000|Overall Study|Lost to Follow-up|6|||
170731714|NCT01242748|617021568|FG001|Overall Study|Lost to Follow-up|2|||
170731715|NCT01242748|617021567|FG000|Overall Study|Physician Decision|3|||
170731716|NCT01242748|617021568|FG001|Overall Study|Physician Decision|2|||
170731717|NCT01242748|617021567|FG000|Overall Study|Protocol Violation|1|||
170731718|NCT01242748|617021568|FG001|Overall Study|Protocol Violation|0|||
170731719|NCT01242748|617021567|FG000|Overall Study|Withdrawal by Subject|10|||
170731720|NCT01242748|617021568|FG001|Overall Study|Withdrawal by Subject|2|||
170839565|NCT00474526|617421473|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
170839566|NCT00474526|617421474|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
170839567|NCT00474526|617421475|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
170839568|NCT00474526|617421476|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
170839569|NCT00474526|617421477|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
170731721|NCT01242748|617021567|FG000|Overall Study|Miscellaneous reasons|8|||
170731722|NCT01242748|617021568|FG001|Overall Study|Miscellaneous reasons|3|||
170731723|NCT00335452|617021569|FG000|Overall Study|Death|156|||
170731724|NCT00335452|617021570|FG001|Overall Study|Death|144|||
170731725|NCT00335452|617021571|FG002|Overall Study|Death|158|||
170731726|NCT00335452|617021572|FG003|Overall Study|Death|129|||
170731727|NCT00335452|617021569|FG000|Overall Study|Lost to Follow-up|2|||
170731728|NCT00335452|617021570|FG001|Overall Study|Lost to Follow-up|3|||
170731729|NCT00335452|617021571|FG002|Overall Study|Lost to Follow-up|1|||
170731730|NCT00335452|617021572|FG003|Overall Study|Lost to Follow-up|2|||
170731731|NCT02736825|617021573|FG000|Overall Study|Lost to Follow-up|10|||
170731732|NCT02736825|617021574|FG001|Overall Study|Lost to Follow-up|11|||
170731733|NCT02736825|617021573|FG000|Overall Study|Early Termination|0|||
170731734|NCT02736825|617021574|FG001|Overall Study|Early Termination|1|||
170731735|NCT00790452|617021575|FG000|Overall Study|Drug supply issue|1|||
170731736|NCT00790452|617021576|FG001|Overall Study|Drug supply issue|0|||
170731737|NCT02901626|617021577|FG000|Overall Study|Lost to Follow-up|1|||
170731738|NCT02901626|617021578|FG001|Overall Study|Lost to Follow-up|1|||
170731739|NCT04082884|617021579|FG000|Overall Study|Withdrawal by Subject|1|||
170731740|NCT02052310|617021584|FG000|Overall Study|Death|64|||
170731741|NCT02052310|617021585|FG001|Overall Study|Death|54|||
170731742|NCT02052310|617021584|FG000|Overall Study|Withdrawal by Subject|37|||
170731743|NCT02052310|617021585|FG001|Overall Study|Withdrawal by Subject|49|||
170731744|NCT02052310|617021584|FG000|Overall Study|Other than specified|32|||
170731745|NCT02052310|617021585|FG001|Overall Study|Other than specified|29|||
170731746|NCT02052310|617021584|FG000|Overall Study|Adverse Event|29|||
170731747|NCT02052310|617021585|FG001|Overall Study|Adverse Event|22|||
170731748|NCT02052310|617021584|FG000|Overall Study|Kidney Transplant|23|||
170731749|NCT02052310|617021585|FG001|Overall Study|Kidney Transplant|29|||
170731750|NCT02052310|617021584|FG000|Overall Study|Physician Decision|14|||
170731751|NCT02052310|617021585|FG001|Overall Study|Physician Decision|7|||
170731752|NCT02052310|617021584|FG000|Overall Study|Lack of Efficacy|6|||
170731753|NCT02052310|617021585|FG001|Overall Study|Lack of Efficacy|1|||
170731754|NCT02052310|617021584|FG000|Overall Study|Site Terminated by Sponsor|5|||
170731755|NCT02052310|617021585|FG001|Overall Study|Site Terminated by Sponsor|13|||
170731756|NCT02052310|617021584|FG000|Overall Study|Lost to Follow-up|4|||
170731757|NCT02052310|617021585|FG001|Overall Study|Lost to Follow-up|2|||
170731758|NCT02052310|617021584|FG000|Overall Study|Protocol Violation|1|||
170731759|NCT02052310|617021585|FG001|Overall Study|Protocol Violation|6|||
170731760|NCT02093663|617021592|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
170731761|NCT02093663|617021593|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
170731762|NCT02093663|617021594|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
170731763|NCT02093663|617021595|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
170731764|NCT02093663|617021596|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
170731765|NCT02093663|617021592|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
170731766|NCT02093663|617021593|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
170731767|NCT02093663|617021594|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
170731768|NCT02093663|617021595|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
170731769|NCT02093663|617021596|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
170731770|NCT02093663|617021592|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
170731771|NCT02093663|617021593|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
170731772|NCT02093663|617021594|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
170731773|NCT02093663|617021595|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
170731774|NCT02093663|617021596|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
170731775|NCT02093663|617021592|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
170731776|NCT02093663|617021593|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
170731777|NCT02093663|617021594|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
170731778|NCT02093663|617021595|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
170731779|NCT02093663|617021596|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
170731780|NCT02093663|617021592|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
170731781|NCT02093663|617021593|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
170731782|NCT02093663|617021594|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
170731783|NCT02093663|617021595|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
170731784|NCT02093663|617021596|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
170731785|NCT02093663|617021592|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
170731786|NCT02093663|617021593|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
170731787|NCT02093663|617021594|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
170731788|NCT02093663|617021595|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
170731789|NCT02093663|617021596|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
170731790|NCT02093663|617021592|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
170731791|NCT02093663|617021593|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
170731792|NCT02093663|617021594|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
170731793|NCT02093663|617021595|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
170731794|NCT02093663|617021596|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
170731795|NCT02093663|617021592|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
170731796|NCT02093663|617021593|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
170731797|NCT02093663|617021594|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
170731798|NCT02093663|617021595|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
170731799|NCT02093663|617021596|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
170731800|NCT02093663|617021592|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
170731801|NCT02093663|617021593|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
170731802|NCT02093663|617021594|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
170731803|NCT02093663|617021595|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
170731804|NCT02093663|617021596|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
170731805|NCT00508404|617021601|FG000|Overall Study|Ongoing at Data Cut-off|12|||
170731806|NCT00508404|617021601|FG000|Overall Study|Adverse Event|2|||
170731807|NCT00508404|617021601|FG000|Overall Study|Death|16|||
170731808|NCT00508404|617021601|FG000|Overall Study|Physician Decision|2|||
170731809|NCT00508404|617021601|FG000|Overall Study|Withdrawal by Subject|3|||
170731810|NCT00508404|617021601|FG000|Overall Study|Protocol-specified Criteria|2|||
170731811|NCT00508404|617021601|FG000|Overall Study|Lost to Follow-up|2|||
170731812|NCT00508404|617021601|FG000|Overall Study|Other - Not Specified|3|||
170731813|NCT05906368|617021602|FG000|Overall Study|Withdrawal by Subject|1|||
170731814|NCT05906368|617021603|FG001|Overall Study|Withdrawal by Subject|1|||
170731815|NCT05906368|617021602|FG000|Overall Study|Ineligibility criteria identified|2|||
170731816|NCT05906368|617021603|FG001|Overall Study|Ineligibility criteria identified|0|||
170731817|NCT01050816|617021604|FG000|Overall Study|Lost to Follow-up|2|||
170731818|NCT01050816|617021604|FG000|Overall Study|patient's refusal|2|||
170731819|NCT01804816|617021605|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
170731820|NCT01804816|617021605|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
170731821|NCT01754467|617021606|FG000|Overall Study|Lost to Follow-up|1|||
170731822|NCT01235546|617021607|FG000|Overall Study|Staff error, medication not administered|1|||
170731823|NCT01235546|617021608|FG001|Overall Study|Staff error, medication not administered|0|||
170731824|NCT01235546|617021607|FG000|Overall Study|Protocol Violation|1|||
170731825|NCT01235546|617021608|FG001|Overall Study|Protocol Violation|1|||
170731826|NCT01123382|617021609|FG000|Overall Study|Withdrawal by Subject|1|||
170731827|NCT01123382|617021610|FG001|Overall Study|Withdrawal by Subject|4|||
170731828|NCT01123382|617021609|FG000|Overall Study|Lost to Follow-up|1|||
170731829|NCT01123382|617021610|FG001|Overall Study|Lost to Follow-up|2|||
170731830|NCT00330174|617021613|FG000|Overall Study|Withdrawal by Subject|7|||
170731831|NCT00330174|617021614|FG001|Overall Study|Withdrawal by Subject|7|||
170731832|NCT00330174|617021613|FG000|Overall Study|Lost to Follow-up|4|||
170731833|NCT00330174|617021614|FG001|Overall Study|Lost to Follow-up|1|||
170731834|NCT00330174|617021613|FG000|Overall Study|Clinical deterioration|1|||
170731835|NCT00330174|617021614|FG001|Overall Study|Clinical deterioration|2|||
170731836|NCT00330174|617021613|FG000|Overall Study|Excessive missed visits|3|||
170731837|NCT00330174|617021614|FG001|Overall Study|Excessive missed visits|8|||
170731838|NCT00330174|617021613|FG000|Overall Study|Miscellaneous reasons|7|||
170731839|NCT00330174|617021614|FG001|Overall Study|Miscellaneous reasons|1|||
170731840|NCT02230956|617021617|FG000|Overall Study|Adverse Event|1|||
170731841|NCT02230956|617021618|FG001|Overall Study|Adverse Event|1|||
170731842|NCT02230956|617021619|FG002|Overall Study|Adverse Event|0|||
170731843|NCT02230956|617021617|FG000|Overall Study|Lack of Efficacy|1|||
170731844|NCT02230956|617021618|FG001|Overall Study|Lack of Efficacy|1|||
170731845|NCT02230956|617021619|FG002|Overall Study|Lack of Efficacy|1|||
170731846|NCT02230956|617021617|FG000|Overall Study|Lost to Follow-up|1|||
170731847|NCT02230956|617021618|FG001|Overall Study|Lost to Follow-up|1|||
170731848|NCT02230956|617021619|FG002|Overall Study|Lost to Follow-up|2|||
170731849|NCT02230956|617021617|FG000|Overall Study|Personal Reasons|2|||
170731850|NCT02230956|617021618|FG001|Overall Study|Personal Reasons|1|||
170731851|NCT02230956|617021619|FG002|Overall Study|Personal Reasons|1|||
170731852|NCT02230956|617021617|FG000|Overall Study|Protocol Violation|0|||
170731853|NCT02230956|617021618|FG001|Overall Study|Protocol Violation|1|||
170731854|NCT02230956|617021619|FG002|Overall Study|Protocol Violation|1|||
170731855|NCT02230956|617021617|FG000|Overall Study|Other Miscellaneous Reason|0|||
170731856|NCT02230956|617021618|FG001|Overall Study|Other Miscellaneous Reason|1|||
170731857|NCT02230956|617021619|FG002|Overall Study|Other Miscellaneous Reason|2|||
170731858|NCT00645164|617021620|FG000|Overall Study|Lost to Follow-up|2|||
170731859|NCT00645164|617021620|FG000|Overall Study|Withdrawal by Subject|4|||
170731860|NCT00645164|617021620|FG000|Overall Study|Protocol Violation|1|||
170839570|NCT00474526|617421461|FG000|Overall Study|Withdrawal by Subject|9|||
170839571|NCT00474526|617421462|FG001|Overall Study|Withdrawal by Subject|24|||
170839572|NCT00474526|617421463|FG002|Overall Study|Withdrawal by Subject|21|||
170839573|NCT00474526|617421464|FG003|Overall Study|Withdrawal by Subject|52|||
170839574|NCT00474526|617421465|FG004|Overall Study|Withdrawal by Subject|38|||
170839575|NCT00474526|617421466|FG005|Overall Study|Withdrawal by Subject|6|||
170839576|NCT00474526|617421467|FG006|Overall Study|Withdrawal by Subject|12|||
170839577|NCT00474526|617421468|FG007|Overall Study|Withdrawal by Subject|4|||
170839578|NCT00474526|617421469|FG008|Overall Study|Withdrawal by Subject|4|||
170839579|NCT00474526|617421470|FG009|Overall Study|Withdrawal by Subject|13|||
170839580|NCT00474526|617421471|FG010|Overall Study|Withdrawal by Subject|5|||
170839581|NCT00474526|617421472|FG011|Overall Study|Withdrawal by Subject|4|||
170839582|NCT00474526|617421473|FG012|Overall Study|Withdrawal by Subject|4|||
170839583|NCT00474526|617421474|FG013|Overall Study|Withdrawal by Subject|37|||
170839584|NCT00474526|617421475|FG014|Overall Study|Withdrawal by Subject|22|||
170839585|NCT00474526|617421476|FG015|Overall Study|Withdrawal by Subject|1|||
170839586|NCT00474526|617421477|FG016|Overall Study|Withdrawal by Subject|1|||
170839587|NCT00132678|617421478|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
170839588|NCT00132678|617421479|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
170839589|NCT00132678|617421480|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
170839590|NCT00132678|617421478|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
170839591|NCT00132678|617421479|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
170839592|NCT00132678|617421480|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
170839593|NCT00132678|617421478|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
170839594|NCT00132678|617421479|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
170839595|NCT00132678|617421480|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
170839596|NCT00132678|617421478|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
170839597|NCT00132678|617421479|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
170839598|NCT00132678|617421480|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
170839599|NCT00132678|617421478|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
170839600|NCT00132678|617421479|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
170839601|NCT00132678|617421480|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
170839602|NCT00132678|617421478|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
170839603|NCT00132678|617421479|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
170839604|NCT00132678|617421480|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
170839605|NCT00132678|617421478|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
170839606|NCT00132678|617421479|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
170839607|NCT00132678|617421480|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
170839608|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Death|2|||
170839609|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Death|0|||
170839610|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Death|0|||
170839611|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
170839612|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
170839613|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
170839614|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
170839615|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
170839616|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
170839617|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
170839618|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
170839619|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
170839620|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
170839621|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
170839622|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
170839623|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
170839624|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
170839625|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
170839626|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
170839627|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
170839628|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
170839629|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
170839630|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
170839631|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
170839632|NCT00132678|617421478|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
170839633|NCT00132678|617421479|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
170839634|NCT00132678|617421480|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
170839635|NCT00132678|617421478|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
170839636|NCT00132678|617421479|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
170731861|NCT01755702|617021621|FG000|Wash Out Period I|Other Reason|3|||
170731862|NCT01755702|617021621|FG000|Washout Period II|Other Reason|5|||
170731863|NCT02954354|617021623|FG000|Overall Study|Adverse Event|2|||
170731864|NCT02954354|617021624|FG001|Overall Study|Adverse Event|2|||
170731865|NCT02954354|617021625|FG002|Overall Study|Adverse Event|4|||
170731866|NCT02954354|617021623|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
170731867|NCT02954354|617021624|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
170731868|NCT02954354|617021625|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
170731869|NCT02954354|617021623|FG000|Overall Study|Lack of Efficacy|0|||
170731870|NCT02954354|617021624|FG001|Overall Study|Lack of Efficacy|2|||
170731871|NCT02954354|617021625|FG002|Overall Study|Lack of Efficacy|0|||
170731872|NCT02954354|617021623|FG000|Overall Study|Withdrawal by Subject|17|||
170731873|NCT02954354|617021624|FG001|Overall Study|Withdrawal by Subject|9|||
170731874|NCT02954354|617021625|FG002|Overall Study|Withdrawal by Subject|11|||
170731875|NCT02954354|617021623|FG000|Overall Study|Lost to Follow-up|12|||
170731876|NCT02954354|617021624|FG001|Overall Study|Lost to Follow-up|5|||
170731877|NCT02954354|617021625|FG002|Overall Study|Lost to Follow-up|0|||
170731878|NCT02954354|617021623|FG000|Overall Study|Miscellaneous|2|||
170731879|NCT02954354|617021624|FG001|Overall Study|Miscellaneous|2|||
170731880|NCT02954354|617021625|FG002|Overall Study|Miscellaneous|1|||
170731881|NCT06134180|617021628|FG000|Overall Study|Lost to Follow-up|4|||
170731882|NCT03039023|617021633|FG000|Overall Study|Withdrawal by Subject|1|||
170731883|NCT03039023|617021634|FG001|Overall Study|Withdrawal by Subject|0|||
170731884|NCT03039023|617021635|FG002|Overall Study|Withdrawal by Subject|1|||
170731885|NCT03039023|617021636|FG003|Overall Study|Withdrawal by Subject|1|||
170731886|NCT03039023|617021637|FG004|Overall Study|Withdrawal by Subject|0|||
170731887|NCT03039023|617021633|FG000|Overall Study|Physician Decision|0|||
170731888|NCT03039023|617021634|FG001|Overall Study|Physician Decision|0|||
170731889|NCT03039023|617021635|FG002|Overall Study|Physician Decision|0|||
170731890|NCT03039023|617021636|FG003|Overall Study|Physician Decision|1|||
170731891|NCT03039023|617021637|FG004|Overall Study|Physician Decision|0|||
170731892|NCT01362439|617021639|FG000|Overall Study|Adverse Event|1|||
170731893|NCT01362439|617021639|FG000|Overall Study|Lack of Efficacy|3|||
170731894|NCT01362439|617021639|FG000|Overall Study|Lost to Follow-up|2|||
170731895|NCT01362439|617021639|FG000|Overall Study|Study medication non-compliant|1|||
170731896|NCT01362439|617021639|FG000|Overall Study|Participant who withdrew consent|8|||
170731897|NCT03338829|617021640|FG000|Overall Study|Lost to Follow-up|4|||
170731898|NCT03338829|617021641|FG001|Overall Study|Lost to Follow-up|2|||
170731899|NCT03338829|617021642|FG002|Overall Study|Lost to Follow-up|4|||
170731900|NCT03338829|617021640|FG000|Overall Study|Pregnancy loss|1|||
170731901|NCT03338829|617021641|FG001|Overall Study|Pregnancy loss|1|||
170731902|NCT03338829|617021642|FG002|Overall Study|Pregnancy loss|0|||
170731903|NCT03338829|617021640|FG000|Overall Study|Protocol Violation|0|||
170731904|NCT03338829|617021641|FG001|Overall Study|Protocol Violation|1|||
170731905|NCT03338829|617021642|FG002|Overall Study|Protocol Violation|0|||
170731906|NCT03701399|617021643|FG000|Overall Study|Adverse Event|3|||
170731907|NCT03701399|617021644|FG001|Overall Study|Adverse Event|5|||
170731908|NCT03701399|617021643|FG000|Overall Study|Withdrawal by Subject|6|||
170731909|NCT03701399|617021644|FG001|Overall Study|Withdrawal by Subject|3|||
170731910|NCT03701399|617021643|FG000|Overall Study|Investigators decision|1|||
170731911|NCT03701399|617021644|FG001|Overall Study|Investigators decision|2|||
170731912|NCT03701399|617021643|FG000|Overall Study|Lost to Follow-up|1|||
170731913|NCT03701399|617021644|FG001|Overall Study|Lost to Follow-up|2|||
170731914|NCT03701399|617021643|FG000|Overall Study|Death|1|||
170731915|NCT03701399|617021644|FG001|Overall Study|Death|1|||
170731916|NCT03701399|617021643|FG000|Overall Study|Randomized but not treated|1|||
170731917|NCT03701399|617021644|FG001|Overall Study|Randomized but not treated|0|||
170731918|NCT04179032|617021645|FG000|Part B (Up to Week 52)|Adverse Event|1|||
170731919|NCT04179032|617021645|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
170731920|NCT04179032|617021645|FG000|Access Extension Phase|Ongoing|11|||
170731921|NCT00448448|617021646|FG000|Overall Study|Withdrawal by Subject|13|||
170731922|NCT00448448|617021647|FG001|Overall Study|Withdrawal by Subject|2|||
170731923|NCT00448448|617021646|FG000|Overall Study|On protocol when study ended|83|||
170731924|NCT00448448|617021647|FG001|Overall Study|On protocol when study ended|36|||
170731925|NCT00448448|617021646|FG000|Overall Study|Lost to Follow-up|2|||
170731926|NCT00448448|617021647|FG001|Overall Study|Lost to Follow-up|1|||
170731927|NCT00448448|617021646|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
170731928|NCT00448448|617021647|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
170839637|NCT00132678|617421480|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
170839638|NCT00132678|617421478|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
170839639|NCT00132678|617421479|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
170839640|NCT00132678|617421480|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
170839641|NCT00132678|617421478|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
170839642|NCT00132678|617421479|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
170839643|NCT00132678|617421480|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
170839644|NCT00132678|617421478|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
170839645|NCT00132678|617421479|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
170839646|NCT00132678|617421480|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
170839647|NCT00132678|617421478|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
170839648|NCT00132678|617421479|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
170839649|NCT00132678|617421480|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
170839650|NCT00132678|617421478|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
170839651|NCT00132678|617421479|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
170839652|NCT00132678|617421480|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
170839653|NCT00132678|617421478|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
170839654|NCT00132678|617421479|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
170839655|NCT00132678|617421480|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
170839656|NCT00953147|617421481|FG000|Overall Study|Adverse Event|8|||
170839657|NCT00953147|617421482|FG001|Overall Study|Adverse Event|16|||
170839658|NCT00953147|617421483|FG002|Overall Study|Adverse Event|6|||
170839659|NCT00953147|617421481|FG000|Overall Study|Protocol Violation|2|||
170839660|NCT00953147|617421482|FG001|Overall Study|Protocol Violation|8|||
170839661|NCT00953147|617421483|FG002|Overall Study|Protocol Violation|4|||
170839662|NCT00953147|617421481|FG000|Overall Study|Withdrawal by Subject|13|||
170839663|NCT00953147|617421482|FG001|Overall Study|Withdrawal by Subject|15|||
170839664|NCT00953147|617421483|FG002|Overall Study|Withdrawal by Subject|12|||
170839665|NCT00953147|617421481|FG000|Overall Study|Lost to Follow-up|8|||
170839666|NCT00953147|617421482|FG001|Overall Study|Lost to Follow-up|9|||
170839667|NCT00953147|617421483|FG002|Overall Study|Lost to Follow-up|4|||
170839668|NCT00953147|617421481|FG000|Overall Study|Physician Decision|2|||
170839669|NCT00953147|617421482|FG001|Overall Study|Physician Decision|7|||
170839670|NCT00953147|617421483|FG002|Overall Study|Physician Decision|3|||
170839671|NCT00953147|617421481|FG000|Overall Study|Other|4|||
170839672|NCT00953147|617421482|FG001|Overall Study|Other|11|||
170839673|NCT00953147|617421483|FG002|Overall Study|Other|13|||
170839674|NCT03838731|617421488|FG000|Overall Study|Pregnancy|0|||
170839675|NCT03838731|617421489|FG001|Overall Study|Pregnancy|1|||
170839676|NCT03838731|617421488|FG000|Overall Study|Withdrawal of consent|1|||
170839677|NCT03838731|617421489|FG001|Overall Study|Withdrawal of consent|0|||
170839678|NCT02412735|617421490|FG000|Overall Study|Adverse Event|0|||
170839679|NCT02412735|617421491|FG001|Overall Study|Adverse Event|1|||
170839680|NCT02412735|617421492|FG002|Overall Study|Adverse Event|2|||
170839681|NCT02412735|617421490|FG000|Overall Study|Withdrawal by Subject|23|||
170839682|NCT02412735|617421491|FG001|Overall Study|Withdrawal by Subject|27|||
170839683|NCT02412735|617421492|FG002|Overall Study|Withdrawal by Subject|22|||
170839684|NCT02412735|617421490|FG000|Overall Study|Investigator Decision|3|||
170839685|NCT02412735|617421491|FG001|Overall Study|Investigator Decision|3|||
170839686|NCT02412735|617421492|FG002|Overall Study|Investigator Decision|2|||
170839687|NCT02412735|617421490|FG000|Overall Study|Lost to Follow-up|17|||
170839688|NCT02412735|617421491|FG001|Overall Study|Lost to Follow-up|11|||
170839689|NCT02412735|617421492|FG002|Overall Study|Lost to Follow-up|18|||
170839690|NCT02412735|617421490|FG000|Overall Study|Reason not Specified|3|||
170839691|NCT02412735|617421491|FG001|Overall Study|Reason not Specified|2|||
170839692|NCT02412735|617421492|FG002|Overall Study|Reason not Specified|2|||
170839693|NCT01006980|617421493|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
170839694|NCT01006980|617421494|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
170839695|NCT01006980|617421493|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
170839696|NCT01006980|617421494|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
170839697|NCT01006980|617421493|FG000|Vemurafenib and Dacarbazine|Death|13|||
170839698|NCT01006980|617421494|FG001|Vemurafenib and Dacarbazine|Death|12|||
170839699|NCT01006980|617421493|FG000|Vemurafenib and Dacarbazine|Progression|257|||
170839700|NCT01006980|617421494|FG001|Vemurafenib and Dacarbazine|Progression|218|||
170839701|NCT01006980|617421493|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
170839702|NCT01006980|617421494|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
170839703|NCT01006980|617421493|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
170839704|NCT01006980|617421494|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
170731929|NCT00448448|617021646|FG000|Overall Study|Signed consent lost|0|||
170731930|NCT00448448|617021647|FG001|Overall Study|Signed consent lost|1|||
170731931|NCT02340026|617021648|FG000|Treatment Phase|Withdrawal by Subject|2|||
170731932|NCT02340026|617021649|FG001|Treatment Phase|Withdrawal by Subject|2|||
170731933|NCT02340026|617021648|FG000|Follow-up Phase|Lost to Follow-up|1|||
170731934|NCT02340026|617021649|FG001|Follow-up Phase|Lost to Follow-up|0|||
170731935|NCT03641313|617021650|FG000|Overall Study|Death|1|||
170731936|NCT03641313|617021650|FG000|Overall Study|Withdrawal by Subject|2|||
170731937|NCT03641313|617021650|FG000|Overall Study|Declining health|1|||
170731938|NCT03641313|617021650|FG000|Overall Study|Adverse Event|1|||
170731939|NCT04642898|617021651|FG000|Overall Study|Withdrawal by Subject|2|||
170731940|NCT04642898|617021652|FG001|Overall Study|Withdrawal by Subject|4|||
170731941|NCT04642898|617021653|FG002|Overall Study|Withdrawal by Subject|4|||
170731942|NCT04642898|617021654|FG003|Overall Study|Withdrawal by Subject|6|||
170731943|NCT04642898|617021655|FG004|Overall Study|Withdrawal by Subject|2|||
170731944|NCT04642898|617021656|FG005|Overall Study|Withdrawal by Subject|6|||
170731945|NCT04642898|617021651|FG000|Overall Study|Lost to Follow-up|0|||
170731946|NCT04642898|617021652|FG001|Overall Study|Lost to Follow-up|0|||
170731947|NCT04642898|617021653|FG002|Overall Study|Lost to Follow-up|0|||
170731948|NCT04642898|617021654|FG003|Overall Study|Lost to Follow-up|2|||
170731949|NCT04642898|617021655|FG004|Overall Study|Lost to Follow-up|0|||
170731950|NCT04642898|617021656|FG005|Overall Study|Lost to Follow-up|1|||
170731951|NCT04642898|617021651|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
170731952|NCT04642898|617021652|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
170731953|NCT04642898|617021653|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
170731954|NCT04642898|617021654|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
170731955|NCT04642898|617021655|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
170731956|NCT04642898|617021656|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
170731957|NCT04642898|617021651|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
170731958|NCT04642898|617021652|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
170731959|NCT04642898|617021653|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
170731960|NCT04642898|617021654|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
170731961|NCT04642898|617021655|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
170731962|NCT04642898|617021656|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
170731963|NCT04280562|617021657|FG000|Study|Adverse Event|2|||
170731964|NCT04280562|617021658|FG001|Study|Adverse Event|0|||
170731965|NCT04280562|617021657|FG000|Study|Lost to Follow-up|3|||
170731966|NCT04280562|617021658|FG001|Study|Lost to Follow-up|3|||
170731967|NCT00946296|617021659|FG000|Overall Study|Physician Decision|3|||
170731968|NCT00946296|617021660|FG001|Overall Study|Physician Decision|0|||
170731969|NCT03434678|617021661|FG000|Overall Study|Withdrawal by Subject|13|||
170731970|NCT03434678|617021662|FG001|Overall Study|Withdrawal by Subject|13|||
170731971|NCT03434678|617021661|FG000|Overall Study|Found to be ineligible post randomization|2|||
170731972|NCT03434678|617021662|FG001|Overall Study|Found to be ineligible post randomization|1|||
170731973|NCT02618967|617021663|FG000|Overall Study|Lost to Follow-up|0|||
170731974|NCT02618967|617021664|FG001|Overall Study|Lost to Follow-up|0|||
170731975|NCT02618967|617021665|FG002|Overall Study|Lost to Follow-up|1|||
170731976|NCT02618967|617021666|FG003|Overall Study|Lost to Follow-up|0|||
170731977|NCT02618967|617021667|FG004|Overall Study|Lost to Follow-up|2|||
170731978|NCT02618967|617021668|FG005|Overall Study|Lost to Follow-up|0|||
170731979|NCT02618967|617021669|FG006|Overall Study|Lost to Follow-up|0|||
170731980|NCT02618967|617021670|FG007|Overall Study|Lost to Follow-up|0|||
170731981|NCT02618967|617021663|FG000|Overall Study|Withdrawal by Subject|1|||
170731982|NCT02618967|617021664|FG001|Overall Study|Withdrawal by Subject|0|||
170731983|NCT02618967|617021665|FG002|Overall Study|Withdrawal by Subject|0|||
170731984|NCT02618967|617021666|FG003|Overall Study|Withdrawal by Subject|0|||
170731985|NCT02618967|617021667|FG004|Overall Study|Withdrawal by Subject|0|||
170731986|NCT02618967|617021668|FG005|Overall Study|Withdrawal by Subject|0|||
170731987|NCT02618967|617021669|FG006|Overall Study|Withdrawal by Subject|0|||
170839705|NCT01006980|617421493|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
170839706|NCT01006980|617421494|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
170839707|NCT01006980|617421493|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
170839708|NCT01006980|617421494|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
170839709|NCT01006980|617421493|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
170839710|NCT01006980|617421494|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
170839711|NCT01006980|617421493|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
170839712|NCT01006980|617421494|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
170839713|NCT01006980|617421493|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
170839714|NCT01006980|617421494|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
170839715|NCT01006980|617421493|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
170839716|NCT01006980|617421494|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
170839717|NCT01006980|617421493|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
170839718|NCT01006980|617421494|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
170839719|NCT02706405|617421499|FG000|Overall Study|Death|3|||
170839720|NCT02706405|617421500|FG001|Overall Study|Death|2|||
170839721|NCT02706405|617421501|FG002|Overall Study|Death|0|||
170839722|NCT02706405|617421502|FG003|Overall Study|Death|1|||
170839723|NCT02706405|617421503|FG004|Overall Study|Death|0|||
170839724|NCT02706405|617421504|FG005|Overall Study|Death|0|||
170839725|NCT02706405|617421505|FG006|Overall Study|Death|3|||
170839726|NCT02706405|617421506|FG007|Overall Study|Death|4|||
170839727|NCT02706405|617421499|FG000|Overall Study|Disease progression|0|||
170839728|NCT02706405|617421500|FG001|Overall Study|Disease progression|0|||
170839729|NCT02706405|617421501|FG002|Overall Study|Disease progression|0|||
170839730|NCT02706405|617421502|FG003|Overall Study|Disease progression|0|||
170839731|NCT02706405|617421503|FG004|Overall Study|Disease progression|0|||
170839732|NCT02706405|617421504|FG005|Overall Study|Disease progression|0|||
170839733|NCT02706405|617421505|FG006|Overall Study|Disease progression|0|||
170839734|NCT02706405|617421506|FG007|Overall Study|Disease progression|1|||
170839735|NCT02706405|617421499|FG000|Overall Study|Pt moved to new therapy|0|||
170839736|NCT02706405|617421500|FG001|Overall Study|Pt moved to new therapy|0|||
170839737|NCT02706405|617421501|FG002|Overall Study|Pt moved to new therapy|0|||
170839738|NCT02706405|617421502|FG003|Overall Study|Pt moved to new therapy|0|||
170839739|NCT02706405|617421503|FG004|Overall Study|Pt moved to new therapy|0|||
170839740|NCT02706405|617421504|FG005|Overall Study|Pt moved to new therapy|1|||
170839741|NCT02706405|617421505|FG006|Overall Study|Pt moved to new therapy|0|||
170839742|NCT02706405|617421506|FG007|Overall Study|Pt moved to new therapy|1|||
170839743|NCT02706405|617421499|FG000|Overall Study|Physician Decision|1|||
170839744|NCT02706405|617421500|FG001|Overall Study|Physician Decision|0|||
170839745|NCT02706405|617421501|FG002|Overall Study|Physician Decision|0|||
170839746|NCT02706405|617421502|FG003|Overall Study|Physician Decision|0|||
170839747|NCT02706405|617421503|FG004|Overall Study|Physician Decision|0|||
170839748|NCT02706405|617421504|FG005|Overall Study|Physician Decision|0|||
170839749|NCT02706405|617421505|FG006|Overall Study|Physician Decision|0|||
170839750|NCT02706405|617421506|FG007|Overall Study|Physician Decision|0|||
170839751|NCT05620108|617421507|FG000|Overall Study|Physician Decision|1|||
170839752|NCT05620108|617421508|FG001|Overall Study|Physician Decision|2|||
170839753|NCT03104075|617421510|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
170839754|NCT03104075|617421511|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
170839755|NCT05602727|617421512|FG000|Overall Study|Physician Decision|0|||
170839756|NCT05602727|617421513|FG001|Overall Study|Physician Decision|1|||
170839757|NCT05602727|617421514|FG002|Overall Study|Physician Decision|0|||
170839758|NCT05602727|617421512|FG000|Overall Study|Randomized by mistake without study medication|1|||
170839759|NCT05602727|617421513|FG001|Overall Study|Randomized by mistake without study medication|0|||
170839760|NCT05602727|617421514|FG002|Overall Study|Randomized by mistake without study medication|0|||
170839761|NCT05602727|617421512|FG000|Overall Study|Study termination by Sponsor|18|||
170839762|NCT05602727|617421513|FG001|Overall Study|Study termination by Sponsor|15|||
170839763|NCT05602727|617421514|FG002|Overall Study|Study termination by Sponsor|19|||
170839764|NCT05602727|617421512|FG000|Overall Study|Withdrawal by Subject|2|||
170839765|NCT05602727|617421513|FG001|Overall Study|Withdrawal by Subject|1|||
170839766|NCT05602727|617421514|FG002|Overall Study|Withdrawal by Subject|1|||
170839767|NCT05602727|617421512|FG000|Overall Study|Various reasons|1|||
170839768|NCT05602727|617421513|FG001|Overall Study|Various reasons|6|||
170839769|NCT05602727|617421514|FG002|Overall Study|Various reasons|1|||
170839770|NCT04896008|617421515|FG000|Overall Study|Ongoing|70|||
170839771|NCT04896008|617421516|FG001|Overall Study|Ongoing|38|||
170839772|NCT04896008|617421515|FG000|Overall Study|Adverse Event|0|||
170839773|NCT04896008|617421516|FG001|Overall Study|Adverse Event|2|||
170731988|NCT02618967|617021670|FG007|Overall Study|Withdrawal by Subject|0|||
170731989|NCT06060457|617021671|FG000|Overall Study|Adverse Event|1|||
170731990|NCT06060457|617021672|FG001|Overall Study|Adverse Event|1|||
170731991|NCT06060457|617021671|FG000|Overall Study|Death|2|||
170731992|NCT06060457|617021672|FG001|Overall Study|Death|2|||
170731993|NCT06060457|617021671|FG000|Overall Study|Lost to Follow-up|17|||
170731994|NCT06060457|617021672|FG001|Overall Study|Lost to Follow-up|19|||
170731995|NCT06060457|617021671|FG000|Overall Study|Physician Decision|0|||
170731996|NCT06060457|617021672|FG001|Overall Study|Physician Decision|1|||
170731997|NCT06060457|617021671|FG000|Overall Study|Protocol Violation|1|||
170731998|NCT06060457|617021672|FG001|Overall Study|Protocol Violation|1|||
170731999|NCT06060457|617021671|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
170732000|NCT06060457|617021672|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
170732001|NCT06060457|617021671|FG000|Overall Study|Withdrawal by Subject|12|||
170732002|NCT06060457|617021672|FG001|Overall Study|Withdrawal by Subject|15|||
170732003|NCT06060457|617021671|FG000|Overall Study|Other Than Specified|2|||
170732004|NCT06060457|617021672|FG001|Overall Study|Other Than Specified|1|||
170732005|NCT01255592|617023625|FG000|Overall Study|Adverse Event|5|||
170732006|NCT01255592|617023626|FG001|Overall Study|Adverse Event|0|||
170732007|NCT01255592|617023625|FG000|Overall Study|Withdrawal by Subject|1|||
170732008|NCT01255592|617023626|FG001|Overall Study|Withdrawal by Subject|0|||
170732009|NCT01255592|617023625|FG000|Overall Study|Other|0|||
170732010|NCT01255592|617023626|FG001|Overall Study|Other|1|||
170732011|NCT02472652|617023628|FG000|Overall Study|Lost to Follow-up|1|||
170732012|NCT04586569|617023633|FG000|Overall Study|Withdrawal by Subject|0|||
170732013|NCT04586569|617023634|FG001|Overall Study|Withdrawal by Subject|2|||
170732014|NCT04586569|617023633|FG000|Overall Study|No longer eligible|2|||
170732015|NCT04586569|617023634|FG001|Overall Study|No longer eligible|3|||
170732016|NCT04586569|617023633|FG000|Overall Study|Physician Decision|1|||
170732017|NCT04586569|617023634|FG001|Overall Study|Physician Decision|0|||
170732018|NCT01083641|617023635|FG000|Overall Study|Withdrawal by Subject|2|||
170732019|NCT04525547|617023641|FG000|Overall Study|Not treated with Ofev|2|||
170732020|NCT04525547|617023641|FG000|Overall Study|Off-label use|2|||
170732021|NCT04525547|617023641|FG000|Overall Study|Lost to Follow-up|1|||
170732022|NCT03122119|617023642|FG000|Overall Study|Did not meet eligibility critria|1|||
170732023|NCT00800202|617023643|FG000|Overall Study|Adverse Event|7|||
170732024|NCT00800202|617023644|FG001|Overall Study|Adverse Event|6|||
170732025|NCT00800202|617023643|FG000|Overall Study|Death|1|||
170732026|NCT00800202|617023644|FG001|Overall Study|Death|0|||
170732027|NCT00800202|617023643|FG000|Overall Study|Other|5|||
170732028|NCT00800202|617023644|FG001|Overall Study|Other|0|||
170732029|NCT00800202|617023643|FG000|Overall Study|Disease Progression|54|||
170732030|NCT00800202|617023644|FG001|Overall Study|Disease Progression|18|||
170732031|NCT02173548|617023648|FG000|Overall Study|Lost to Follow-up|0|||
170732032|NCT02173548|617023649|FG001|Overall Study|Lost to Follow-up|2|||
170732033|NCT02173548|617023648|FG000|Overall Study|Withdrawal by Subject|1|||
170839774|NCT04896008|617421515|FG000|Overall Study|Death|5|||
170839775|NCT04896008|617421516|FG001|Overall Study|Death|10|||
170839776|NCT04896008|617421515|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
170839777|NCT04896008|617421516|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
170839778|NCT04896008|617421515|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
170839779|NCT04896008|617421516|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
170839780|NCT04896008|617421515|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
170839781|NCT04896008|617421516|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
170839782|NCT04896008|617421515|FG000|Overall Study|Withdrawal by Subject|1|||
170839783|NCT04896008|617421516|FG001|Overall Study|Withdrawal by Subject|4|||
170839784|NCT04896008|617421515|FG000|Overall Study|Investigator Decision|2|||
170839785|NCT04896008|617421516|FG001|Overall Study|Investigator Decision|0|||
170839786|NCT04896008|617421515|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
170839787|NCT04896008|617421516|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
170839788|NCT04201288|617421519|FG000|Overall Study|Death|1|||
170839789|NCT04201288|617421520|FG001|Overall Study|Death|1|||
170839790|NCT04201288|617421519|FG000|Overall Study|Lost to Follow-up|5|||
170839791|NCT04201288|617421520|FG001|Overall Study|Lost to Follow-up|3|||
170732034|NCT02173548|617023649|FG001|Overall Study|Withdrawal by Subject|0|||
170732035|NCT01783418|617023650|FG000|Overall Study|Withdrawal by Subject|1|||
170732036|NCT01783418|617023651|FG001|Overall Study|Withdrawal by Subject|0|||
170732037|NCT02563002|617023652|FG000|Overall Study|Death|72|||
170732038|NCT02563002|617023653|FG001|Overall Study|Death|87|||
170732039|NCT02563002|617023652|FG000|Overall Study|Lost to Follow-up|5|||
170732040|NCT02563002|617023653|FG001|Overall Study|Lost to Follow-up|0|||
170839792|NCT04201288|617421519|FG000|Overall Study|Withdrawal by Subject|1|||
170732041|NCT02563002|617023652|FG000|Overall Study|Physician Decision|0|||
170732042|NCT02563002|617023653|FG001|Overall Study|Physician Decision|2|||
170732043|NCT02563002|617023652|FG000|Overall Study|Withdrawal by Subject|2|||
170839793|NCT04201288|617421520|FG001|Overall Study|Withdrawal by Subject|0|||
170839794|NCT02038842|617421524|FG000|Overall Study|Withdrawal by Subject|2|||
170839795|NCT02038842|617421525|FG001|Overall Study|Withdrawal by Subject|2|||
170839796|NCT02038842|617421526|FG002|Overall Study|Withdrawal by Subject|0|||
170839797|NCT02038842|617421527|FG003|Overall Study|Withdrawal by Subject|0|||
170839798|NCT02038842|617421524|FG000|Overall Study|Participant decision|0|||
170839799|NCT02038842|617421525|FG001|Overall Study|Participant decision|0|||
170839800|NCT02038842|617421526|FG002|Overall Study|Participant decision|2|||
170839801|NCT02038842|617421527|FG003|Overall Study|Participant decision|1|||
170839802|NCT02038842|617421524|FG000|Overall Study|Adverse Event|0|||
170839803|NCT02038842|617421525|FG001|Overall Study|Adverse Event|0|||
170839804|NCT02038842|617421526|FG002|Overall Study|Adverse Event|3|||
170839805|NCT02038842|617421527|FG003|Overall Study|Adverse Event|1|||
170839806|NCT02038842|617421524|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
170839807|NCT02038842|617421525|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
170839808|NCT02038842|617421526|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
170839809|NCT02038842|617421527|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
170839810|NCT00944229|617421530|FG000|Overall Study|Withdrawal by Subject|11|||
170839811|NCT00944229|617421530|FG000|Overall Study|Physician Decision|14|||
170839812|NCT04497389|617421531|FG000|Overall Study|Withdrawal by Subject|1|||
170839813|NCT04497389|617421532|FG001|Overall Study|Withdrawal by Subject|0|||
170839814|NCT01594827|617421533|FG000|Overall Study|Adverse Event|1|||
170839815|NCT01594827|617421534|FG001|Overall Study|Adverse Event|0|||
170839816|NCT01594827|617421533|FG000|Overall Study|Physician Decision|3|||
170839817|NCT01594827|617421534|FG001|Overall Study|Physician Decision|0|||
170839818|NCT01661205|617421540|FG000|Overall Study|Physician Decision|2|||
170839819|NCT00426127|617421541|FG000|Overall Study|Adverse Event|1|||
170839820|NCT00426127|617421541|FG000|Overall Study|Removed due to disease progression|1|||
170839821|NCT00609947|617421542|FG000|Overall Study|Death|1|||
170839822|NCT05569421|617421544|FG000|Overall Study|Withdrawal by Subject|1|||
170839823|NCT05569421|617421545|FG001|Overall Study|Withdrawal by Subject|0|||
170839824|NCT05569421|617421546|FG002|Overall Study|Withdrawal by Subject|0|||
170839825|NCT03111095|617421547|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
170839826|NCT03111095|617421548|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
170839827|NCT03111095|617421547|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
170839828|NCT03111095|617421548|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
170839829|NCT03106753|617421549|FG000|Overall Study|Withdrawal by Subject|0|||
170839830|NCT03106753|617421550|FG001|Overall Study|Withdrawal by Subject|1|||
170839831|NCT00667394|617421551|FG000|Overall Study|Adverse Event|3|||
170839832|NCT00667394|617421552|FG001|Overall Study|Adverse Event|0|||
170839833|NCT00667394|617421551|FG000|Overall Study|Progressive disease|1|||
170839834|NCT00667394|617421552|FG001|Overall Study|Progressive disease|0|||
170839835|NCT03149042|617421563|FG000|Overall Study|Invasive FFR not performed|21|||
170839836|NCT03149042|617421563|FG000|Overall Study|Poor CT Image Quality|1|||
170839837|NCT03149042|617421563|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
170839838|NCT01643044|617421564|FG000|Overall Study|Lost to Follow-up|1|||
170839839|NCT01643044|617421565|FG001|Overall Study|Lost to Follow-up|1|||
170839840|NCT01643044|617421564|FG000|Overall Study|Miscarried baby|2|||
170839841|NCT01643044|617421565|FG001|Overall Study|Miscarried baby|2|||
170839842|NCT01643044|617421564|FG000|Overall Study|Delivered outside of hospital|1|||
170839843|NCT01643044|617421565|FG001|Overall Study|Delivered outside of hospital|2|||
170839844|NCT02522728|617421566|FG000|Overall Study|Withdrawal by Subject|6|||
170839845|NCT02522728|617421567|FG001|Overall Study|Withdrawal by Subject|6|||
170839846|NCT02522728|617421566|FG000|Overall Study|Death|4|||
170839847|NCT02522728|617421567|FG001|Overall Study|Death|3|||
170839848|NCT02522728|617421566|FG000|Overall Study|Adverse Event|2|||
170839849|NCT02522728|617421567|FG001|Overall Study|Adverse Event|1|||
170732044|NCT02563002|617023653|FG001|Overall Study|Withdrawal by Subject|10|||
170732045|NCT02563002|617023652|FG000|Overall Study|Sponsor decision|74|||
170732046|NCT02563002|617023653|FG001|Overall Study|Sponsor decision|55|||
170732047|NCT01505387|617023655|FG000|Overall Study|Protocol Violation|1|||
170732048|NCT01505387|617023656|FG001|Overall Study|Protocol Violation|0|||
170732049|NCT01505387|617023655|FG000|Overall Study|Withdrawal by Subject|1|||
170732050|NCT01505387|617023656|FG001|Overall Study|Withdrawal by Subject|1|||
170732051|NCT01078155|617023657|FG000|Overall Study|Adverse Event|7|||
170732052|NCT01078155|617023657|FG000|Overall Study|Lack of Efficacy|16|||
170732053|NCT01078155|617023657|FG000|Overall Study|Participant's Decision|6|||
170732054|NCT01078155|617023657|FG000|Overall Study|Lost to Follow-up|15|||
170732055|NCT01621880|617023658|FG000|Overall Study|Adverse Event|5|||
170732056|NCT01621880|617023659|FG001|Overall Study|Adverse Event|1|||
170732057|NCT01621880|617023658|FG000|Overall Study|Withdrawal by Subject|5|||
170732058|NCT01621880|617023659|FG001|Overall Study|Withdrawal by Subject|4|||
170732059|NCT00595504|617023663|FG000|Overall Study|Withdrawal by Subject|1|||
170732060|NCT00595504|617023664|FG001|Overall Study|Withdrawal by Subject|3|||
170732061|NCT00595504|617023663|FG000|Overall Study|Physician Decision|1|||
170732062|NCT00595504|617023664|FG001|Overall Study|Physician Decision|0|||
170732063|NCT01662063|617023665|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
170732064|NCT01662063|617023666|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
170732065|NCT01662063|617023667|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
170732066|NCT01662063|617023665|FG000|Overall Study|Lack of Efficacy|1|||
170732067|NCT01662063|617023666|FG001|Overall Study|Lack of Efficacy|6|||
170732068|NCT01662063|617023667|FG002|Overall Study|Lack of Efficacy|0|||
170732069|NCT01662063|617023665|FG000|Overall Study|Lost to Follow-up|0|||
170732070|NCT01662063|617023666|FG001|Overall Study|Lost to Follow-up|4|||
170732071|NCT01662063|617023667|FG002|Overall Study|Lost to Follow-up|0|||
170732072|NCT01662063|617023665|FG000|Overall Study|Protocol Violation|1|||
170732073|NCT01662063|617023666|FG001|Overall Study|Protocol Violation|0|||
170732074|NCT01662063|617023667|FG002|Overall Study|Protocol Violation|0|||
170732075|NCT01662063|617023665|FG000|Overall Study|Withdrawal by Subject|2|||
170732076|NCT01662063|617023666|FG001|Overall Study|Withdrawal by Subject|4|||
170732077|NCT01662063|617023667|FG002|Overall Study|Withdrawal by Subject|1|||
170732078|NCT01662063|617023665|FG000|Overall Study|Physician Decision|0|||
170732079|NCT01662063|617023666|FG001|Overall Study|Physician Decision|2|||
170732080|NCT01662063|617023667|FG002|Overall Study|Physician Decision|0|||
170732081|NCT01662063|617023665|FG000|Overall Study|Other|0|||
170732082|NCT01662063|617023666|FG001|Overall Study|Other|1|||
170732083|NCT01662063|617023667|FG002|Overall Study|Other|0|||
170732084|NCT01949870|617023668|FG000|Overall Study|Lack of Efficacy|2|||
170732085|NCT01949870|617023668|FG000|Overall Study|Adverse Event|1|||
170732086|NCT01949870|617023668|FG000|Overall Study|Study termination|1|||
170732087|NCT01949870|617023668|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
170732088|NCT01477853|617023669|FG000|Phase A|Adverse Event|1|||
170732089|NCT01477853|617023670|FG001|Phase A|Adverse Event|2|||
170732090|NCT01477853|617023671|FG002|Phase A|Adverse Event|2|||
170732091|NCT01477853|617023669|FG000|Phase A|Lost to Follow-up|4|||
170732092|NCT01477853|617023670|FG001|Phase A|Lost to Follow-up|3|||
170732093|NCT01477853|617023671|FG002|Phase A|Lost to Follow-up|2|||
170732094|NCT01477853|617023669|FG000|Phase A|Physician Decision|1|||
170732095|NCT01477853|617023670|FG001|Phase A|Physician Decision|0|||
170732096|NCT01477853|617023671|FG002|Phase A|Physician Decision|1|||
170732097|NCT01477853|617023669|FG000|Phase A|Study terminated by sponsor|37|||
170732098|NCT01477853|617023670|FG001|Phase A|Study terminated by sponsor|40|||
170732099|NCT01477853|617023671|FG002|Phase A|Study terminated by sponsor|39|||
170732100|NCT01477853|617023669|FG000|Phase B|Lost to Follow-up|0|||
170732101|NCT01477853|617023670|FG001|Phase B|Lost to Follow-up|1|||
170732102|NCT01477853|617023671|FG002|Phase B|Lost to Follow-up|0|||
170732103|NCT01477853|617023669|FG000|Phase B|Study terminated by sponsor|12|||
170732104|NCT01477853|617023670|FG001|Phase B|Study terminated by sponsor|10|||
170732105|NCT01477853|617023671|FG002|Phase B|Study terminated by sponsor|11|||
170732106|NCT03086330|617023672|FG000|Overall Study|Withdrawal by Subject|3|||
170732107|NCT03086330|617023673|FG001|Overall Study|Withdrawal by Subject|2|||
170732108|NCT03086330|617023672|FG000|Overall Study|Lost to Follow-up|1|||
170732109|NCT03086330|617023673|FG001|Overall Study|Lost to Follow-up|2|||
170732110|NCT01970462|617023674|FG000|Overall Study|Lost to Follow-up|0|||
170732111|NCT01970462|617023675|FG001|Overall Study|Lost to Follow-up|2|||
170732112|NCT02316769|617023687|FG000|Overall Study|Physician Decision|1|||
170732113|NCT02316769|617023688|FG001|Overall Study|Physician Decision|0|||
170732114|NCT02316769|617023687|FG000|Overall Study|Withdrawal by Subject|1|||
170732115|NCT02316769|617023688|FG001|Overall Study|Withdrawal by Subject|0|||
170732116|NCT01281644|617023689|FG000|Overall Study|Lost to Follow-up|3|||
170732117|NCT01281644|617023689|FG000|Overall Study|Withdrawal by Subject|2|||
170732118|NCT04860518|617023690|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
170732119|NCT04860518|617023691|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
170732120|NCT03945292|617023695|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
170732121|NCT03945292|617023696|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
170732122|NCT03945292|617023697|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
170732123|NCT03945292|617023698|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
170732124|NCT03945292|617023699|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
170732125|NCT03945292|617023700|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
170732126|NCT03945292|617023701|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
170732127|NCT03945292|617023702|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
170732128|NCT03945292|617023695|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
170732129|NCT03945292|617023696|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
170732130|NCT03945292|617023697|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
170732131|NCT03945292|617023698|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
170732132|NCT03945292|617023699|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
170732133|NCT03945292|617023700|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
170732134|NCT03945292|617023701|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
170732135|NCT03945292|617023702|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
170732136|NCT03945292|617023695|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
170732137|NCT03945292|617023696|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
170732138|NCT03945292|617023697|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
170732139|NCT03945292|617023698|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
170732140|NCT03945292|617023699|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
170732141|NCT03945292|617023700|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
170732142|NCT03945292|617023701|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
170732143|NCT03945292|617023702|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
170732144|NCT02684006|617023703|FG000|Overall Study|Other|18|||
170732145|NCT02684006|617023704|FG001|Overall Study|Other|6|||
170732146|NCT02684006|617023703|FG000|Overall Study|Protocol Violation|2|||
170732147|NCT02684006|617023704|FG001|Overall Study|Protocol Violation|1|||
170732148|NCT02684006|617023703|FG000|Overall Study|Non-compliance with study drug|1|||
170732149|NCT02684006|617023704|FG001|Overall Study|Non-compliance with study drug|1|||
170732150|NCT02684006|617023703|FG000|Overall Study|No longer met eligibility criteria|6|||
170732151|NCT02684006|617023704|FG001|Overall Study|No longer met eligibility criteria|2|||
170732152|NCT02684006|617023703|FG000|Overall Study|Lost to Follow-up|0|||
170732153|NCT02684006|617023704|FG001|Overall Study|Lost to Follow-up|1|||
170732154|NCT02684006|617023703|FG000|Overall Study|Death|25|||
170732155|NCT02684006|617023704|FG001|Overall Study|Death|22|||
170732156|NCT02684006|617023703|FG000|Overall Study|Global deterioration of health status|18|||
170732157|NCT02684006|617023704|FG001|Overall Study|Global deterioration of health status|20|||
170732158|NCT02684006|617023703|FG000|Overall Study|Physician Decision|15|||
170732159|NCT02684006|617023704|FG001|Overall Study|Physician Decision|8|||
170732160|NCT02684006|617023703|FG000|Overall Study|Adverse Event|86|||
170732161|NCT02684006|617023704|FG001|Overall Study|Adverse Event|65|||
170732162|NCT02684006|617023703|FG000|Overall Study|Withdrawal by Subject|29|||
170732163|NCT02684006|617023704|FG001|Overall Study|Withdrawal by Subject|43|||
170732164|NCT02684006|617023703|FG000|Overall Study|Progressive disease|236|||
170839850|NCT02522728|617421566|FG000|Overall Study|Did not receive randomized study device|0|||
170839851|NCT02522728|617421567|FG001|Overall Study|Did not receive randomized study device|1|||
170839852|NCT01266161|617421568|FG000|Overall Study|Ineligible|1|||
170839853|NCT01266161|617421569|FG001|Overall Study|Ineligible|0|||
170839854|NCT01266161|617421568|FG000|Overall Study|Lack of Efficacy|0|||
170839855|NCT01266161|617421569|FG001|Overall Study|Lack of Efficacy|1|||
170839856|NCT01266161|617421568|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
170839857|NCT01266161|617421569|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
170839858|NCT01436305|617421571|FG000|Overall Study|Death|1|||
170839859|NCT01436305|617421572|FG001|Overall Study|Death|0|||
170839860|NCT01436305|617421573|FG002|Overall Study|Death|0|||
170839861|NCT01436305|617421571|FG000|Overall Study|Lost to Follow-up|0|||
170839862|NCT01436305|617421572|FG001|Overall Study|Lost to Follow-up|1|||
170839863|NCT01436305|617421573|FG002|Overall Study|Lost to Follow-up|0|||
170839864|NCT01436305|617421571|FG000|Overall Study|Withdrawal by Subject|1|||
170839865|NCT01436305|617421572|FG001|Overall Study|Withdrawal by Subject|3|||
170839866|NCT01436305|617421573|FG002|Overall Study|Withdrawal by Subject|0|||
170839867|NCT02344342|617421574|FG000|Overall Study|Industry partner dropped out|11|||
170839868|NCT02344342|617421575|FG001|Overall Study|Industry partner dropped out|9|||
170839869|NCT02344342|617421576|FG002|Overall Study|Industry partner dropped out|14|||
170839870|NCT02344342|617421577|FG003|Overall Study|Industry partner dropped out|10|||
170839871|NCT03017742|617421579|FG000|Overall Study|Protocol Violation|36|||
170839872|NCT03017742|617421579|FG000|Overall Study|Withdrawal by Subject|37|||
170839873|NCT02975102|617421580|FG000|Overall Study|Adverse Event|2|||
170839874|NCT02975102|617421581|FG001|Overall Study|Adverse Event|1|||
170839875|NCT05262751|617421582|FG000|Washout Period 2|Adverse Event|1|||
170839876|NCT05262751|617421583|FG001|Washout Period 2|Adverse Event|0|||
170839877|NCT05262751|617421584|FG002|Washout Period 2|Adverse Event|0|||
170839878|NCT05262751|617421585|FG003|Washout Period 2|Adverse Event|0|||
170839879|NCT05262751|617421586|FG004|Washout Period 2|Adverse Event|0|||
170839880|NCT05262751|617421587|FG005|Washout Period 2|Adverse Event|0|||
170839881|NCT05262751|617421582|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
170839882|NCT05262751|617421583|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
170839883|NCT05262751|617421584|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
170839884|NCT05262751|617421585|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
170839885|NCT05262751|617421586|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
170839886|NCT05262751|617421587|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
170839887|NCT01151215|617421591|FG000|Overall Study|Worsening of condition under study|1|||
170839888|NCT01151215|617421592|FG001|Overall Study|Worsening of condition under study|1|||
170839889|NCT01151215|617421593|FG002|Overall Study|Worsening of condition under study|1|||
170839890|NCT01151215|617421591|FG000|Overall Study|Death|16|||
170839891|NCT01151215|617421592|FG001|Overall Study|Death|20|||
170839892|NCT01151215|617421593|FG002|Overall Study|Death|11|||
170839893|NCT01151215|617421591|FG000|Overall Study|Lost to Follow-up|0|||
170839894|NCT01151215|617421592|FG001|Overall Study|Lost to Follow-up|0|||
170839895|NCT01151215|617421593|FG002|Overall Study|Lost to Follow-up|3|||
170839896|NCT01151215|617421591|FG000|Overall Study|Withdrawal by Subject|3|||
170839897|NCT01151215|617421592|FG001|Overall Study|Withdrawal by Subject|1|||
170839898|NCT01151215|617421593|FG002|Overall Study|Withdrawal by Subject|2|||
170839899|NCT01151215|617421591|FG000|Overall Study|Disease progression|0|||
170839900|NCT01151215|617421592|FG001|Overall Study|Disease progression|1|||
170839901|NCT01151215|617421593|FG002|Overall Study|Disease progression|1|||
170839902|NCT01151215|617421591|FG000|Overall Study|Safety as judged by the investigator|0|||
170839903|NCT01151215|617421592|FG001|Overall Study|Safety as judged by the investigator|0|||
170839904|NCT01151215|617421593|FG002|Overall Study|Safety as judged by the investigator|1|||
170839905|NCT02597712|617421594|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
170839906|NCT02597712|617421595|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
170839907|NCT02597712|617421594|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
170839908|NCT02597712|617421595|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
170839909|NCT02597712|617421594|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
170839910|NCT02597712|617421595|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
170839911|NCT00513708|617421599|FG000|Overall Study|Lost to Follow-up|4|||
170839912|NCT00513708|617421600|FG001|Overall Study|Lost to Follow-up|4|||
170839913|NCT00513708|617421601|FG002|Overall Study|Lost to Follow-up|4|||
170839914|NCT03327831|617421602|FG000|Overall Study|Lost to Follow-up|2|||
170839915|NCT01564277|617421603|FG000|Overall Study|Protocol Violation|0|||
170839916|NCT01564277|617421604|FG001|Overall Study|Protocol Violation|1|||
170839917|NCT01564277|617421603|FG000|Overall Study|Physician Decision|1|||
170839918|NCT01564277|617421604|FG001|Overall Study|Physician Decision|0|||
170839919|NCT02595372|617421605|FG000|Overall Study|Adverse Event|6|||
170839920|NCT02595372|617421605|FG000|Overall Study|Physician Decision|2|||
170839921|NCT02595372|617421605|FG000|Overall Study|Disease Progression|1|||
170839922|NCT01594970|617421608|FG000|Overall Study|Non-Adverse Event Related|4|||
170839923|NCT01594970|617421609|FG001|Overall Study|Non-Adverse Event Related|5|||
170839924|NCT01594970|617421610|FG002|Overall Study|Non-Adverse Event Related|6|||
170839925|NCT01594970|617421608|FG000|Overall Study|Adverse Event|17|||
170839926|NCT01594970|617421609|FG001|Overall Study|Adverse Event|23|||
170839927|NCT01594970|617421610|FG002|Overall Study|Adverse Event|23|||
170839928|NCT01594970|617421608|FG000|Overall Study|Lost to Follow-up|54|||
170839929|NCT01594970|617421609|FG001|Overall Study|Lost to Follow-up|54|||
170839930|NCT01594970|617421610|FG002|Overall Study|Lost to Follow-up|37|||
170839931|NCT00401258|617421611|FG000|Overall Study|Adverse Event|7|||
170839932|NCT00617929|617421614|FG000|Overall Study|Physician Decision|1|||
170839933|NCT00760747|617421617|FG000|Study Period II|Adverse Event|3|||
170839934|NCT00760747|617421618|FG001|Study Period II|Adverse Event|4|||
170839935|NCT00760747|617421617|FG000|Study Period II|Lack of Efficacy|0|||
170839936|NCT00760747|617421618|FG001|Study Period II|Lack of Efficacy|6|||
170839937|NCT00760747|617421617|FG000|Study Period II|Parent/Caregiver Decision|3|||
170839938|NCT00760747|617421618|FG001|Study Period II|Parent/Caregiver Decision|0|||
170839939|NCT00760747|617421617|FG000|Study Period II|Protocol Violation|6|||
170839940|NCT00760747|617421618|FG001|Study Period II|Protocol Violation|3|||
170839941|NCT00760747|617421617|FG000|Study Period II|Withdrawal by Subject|1|||
170839942|NCT00760747|617421618|FG001|Study Period II|Withdrawal by Subject|0|||
170839943|NCT00760747|617421617|FG000|Study Period II|No drug administered|0|||
170839944|NCT00760747|617421618|FG001|Study Period II|No drug administered|1|||
170839945|NCT00760747|617421617|FG000|Study Period III|Adverse Event|1|||
170839946|NCT00760747|617421618|FG001|Study Period III|Adverse Event|0|||
170839947|NCT00760747|617421617|FG000|Study Period III|Lack of Efficacy|1|||
170839948|NCT00760747|617421618|FG001|Study Period III|Lack of Efficacy|0|||
170839949|NCT00760747|617421617|FG000|Study Period III|Parent/Caregiver Decision|0|||
170839950|NCT00760747|617421618|FG001|Study Period III|Parent/Caregiver Decision|1|||
170839951|NCT00760747|617421617|FG000|Study Period III|Protocol Violation|1|||
170839952|NCT00760747|617421618|FG001|Study Period III|Protocol Violation|1|||
170839953|NCT00760747|617421617|FG000|Study Period III|Physician Decision|0|||
170839954|NCT00760747|617421618|FG001|Study Period III|Physician Decision|1|||
170839955|NCT04160988|617421619|FG000|Overall Study|poor image quality|28|||
170839956|NCT00243074|617421623|FG000|Overall Study|Ineligible|6|||
170839957|NCT00243074|617421623|FG000|Overall Study|Adverse Event|6|||
170839958|NCT00243074|617421623|FG000|Overall Study|Withdrawal by Subject|2|||
170839959|NCT00243074|617421623|FG000|Overall Study|Lack of Efficacy|36|||
170839960|NCT00243074|617421623|FG000|Overall Study|Death|2|||
170839961|NCT00243074|617421623|FG000|Overall Study|not protocol specified|1|||
170839962|NCT00243074|617421623|FG000|Overall Study|Did not receive any treatment|1|||
170839963|NCT00402051|617421628|FG000|Overall Study|Progressive Disease|13|||
170839964|NCT00402051|617421629|FG001|Overall Study|Progressive Disease|20|||
170839965|NCT00402051|617421628|FG000|Overall Study|Adverse Event|11|||
170839966|NCT00402051|617421629|FG001|Overall Study|Adverse Event|4|||
170839967|NCT00402051|617421628|FG000|Overall Study|Physician Decision|7|||
170839968|NCT00402051|617421629|FG001|Overall Study|Physician Decision|3|||
170839969|NCT00402051|617421628|FG000|Overall Study|Withdrawal by Subject|3|||
170839970|NCT00402051|617421629|FG001|Overall Study|Withdrawal by Subject|3|||
170839971|NCT00402051|617421628|FG000|Overall Study|Death - Related to Study Drug|1|||
170839972|NCT00402051|617421629|FG001|Overall Study|Death - Related to Study Drug|2|||
170839973|NCT00402051|617421628|FG000|Overall Study|Death Due to Study Disease|2|||
170839974|NCT00402051|617421629|FG001|Overall Study|Death Due to Study Disease|1|||
170839975|NCT00402051|617421628|FG000|Overall Study|Death Due to Adverse Event|0|||
170839976|NCT00402051|617421629|FG001|Overall Study|Death Due to Adverse Event|2|||
170839977|NCT00402051|617421628|FG000|Overall Study|Lost to Follow-up|1|||
170839978|NCT00402051|617421629|FG001|Overall Study|Lost to Follow-up|0|||
170839979|NCT00570908|617421630|FG000|Overall Study|Adverse Event|5|||
170839980|NCT00570908|617421630|FG000|Overall Study|Withdrawal by Subject|2|||
170839981|NCT00277095|617421631|FG000|Overall Study|Death|2|||
170839982|NCT00277095|617421631|FG000|Overall Study|Explanted|7|||
170839983|NCT00277095|617421631|FG000|Overall Study|Lost to Follow-up|2|||
170839984|NCT00277095|617421631|FG000|Overall Study|Missed Follow-up|9|||
170839985|NCT00277095|617421631|FG000|Overall Study|Physician Decision|1|||
170839986|NCT01213524|617421632|FG000|Baseline|Withdrawal by Subject|5|||
170839987|NCT01213524|617421632|FG000|Baseline|high breath alcohol levels|1|||
170839988|NCT01213524|617421632|FG000|Baseline|Physician Decision|1|||
170839989|NCT01213524|617421632|FG000|Session 2|Withdrawal by Subject|5|||
170839990|NCT01213524|617421632|FG000|Session 3|Withdrawal by Subject|4|||
170839991|NCT01213524|617421632|FG000|Session 4|Physician Decision|1|||
170839992|NCT01213524|617421632|FG000|Session 4|Withdrawal by Subject|2|||
170839993|NCT05415748|617421636|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
170839994|NCT05415748|617421637|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
170839995|NCT05415748|617421638|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
170839996|NCT05415748|617421639|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
170839997|NCT05415748|617421636|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
170839998|NCT05415748|617421637|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
170839999|NCT05415748|617421638|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
170840000|NCT05415748|617421639|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
170840001|NCT01123070|617423580|FG000|Part B Double Blind Period|Protocol Violation|0|||
170840002|NCT01123070|617423581|FG001|Part B Double Blind Period|Protocol Violation|0|||
170840003|NCT01123070|617423582|FG002|Part B Double Blind Period|Protocol Violation|0|||
170840004|NCT01123070|617423583|FG003|Part B Double Blind Period|Protocol Violation|1|||
170840005|NCT01123070|617423580|FG000|Part B Double Blind Period|Adverse Event|0|||
170840006|NCT01123070|617423581|FG001|Part B Double Blind Period|Adverse Event|0|||
170840007|NCT01123070|617423582|FG002|Part B Double Blind Period|Adverse Event|2|||
170840008|NCT01123070|617423583|FG003|Part B Double Blind Period|Adverse Event|0|||
170840009|NCT01123070|617423580|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
170840010|NCT01123070|617423581|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
170840011|NCT01123070|617423582|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
170840012|NCT01123070|617423583|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
170840013|NCT03554629|617423584|FG000|Overall Study|Inadequate data|6|||
170840014|NCT02271984|617423587|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840015|NCT02271984|617423588|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840016|NCT02271984|617423589|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840017|NCT02271984|617423590|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840018|NCT02271984|617423591|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840019|NCT02271984|617423592|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
170840020|NCT02271984|617423593|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840021|NCT02271984|617423594|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
170840022|NCT02271984|617423595|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840023|NCT02271984|617423596|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840024|NCT02271984|617423597|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840025|NCT02271984|617423598|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
170840026|NCT01088984|617423599|FG000|Phase 1|Death|2|||
170840027|NCT01088984|617423600|FG001|Phase 1|Death|1|||
170840028|NCT01088984|617423599|FG000|Phase 1|Disease Progression|2|||
170840029|NCT01088984|617423600|FG001|Phase 1|Disease Progression|4|||
170840030|NCT01088984|617423599|FG000|Phase 1|Other|1|||
170840031|NCT01088984|617423600|FG001|Phase 1|Other|1|||
170840032|NCT01088984|617423599|FG000|Phase 2|Death|0|||
170840033|NCT01088984|617423600|FG001|Phase 2|Death|5|||
170840034|NCT01088984|617423599|FG000|Phase 2|Withdrawal by Subject|0|||
170840035|NCT01088984|617423600|FG001|Phase 2|Withdrawal by Subject|1|||
170840036|NCT01088984|617423599|FG000|Phase 2|DIsease Progression|0|||
170840037|NCT01088984|617423600|FG001|Phase 2|DIsease Progression|25|||
170840038|NCT01088984|617423599|FG000|Phase 2|Other|0|||
170840039|NCT01088984|617423600|FG001|Phase 2|Other|1|||
170840040|NCT03339245|617423601|FG000|Overall Study|Adverse Event|1|||
170840041|NCT03339245|617423602|FG001|Overall Study|Adverse Event|1|||
170840042|NCT03339245|617423601|FG000|Overall Study|Withdrawal by Subject|1|||
170840043|NCT03339245|617423602|FG001|Overall Study|Withdrawal by Subject|0|||
170840044|NCT01182441|617423603|FG000|Overall Study|Patient Still in Follow-up|152|||
170840045|NCT01182441|617423604|FG001|Overall Study|Patient Still in Follow-up|72|||
170840046|NCT01182441|617423603|FG000|Overall Study|Death|37|||
170840047|NCT01182441|617423604|FG001|Overall Study|Death|25|||
170840048|NCT01182441|617423603|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
170840049|NCT01182441|617423604|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
170840050|NCT01182441|617423603|FG000|Overall Study|Lost to Follow-up|5|||
170840051|NCT01182441|617423604|FG001|Overall Study|Lost to Follow-up|8|||
170732165|NCT02684006|617023704|FG001|Overall Study|Progressive disease|266|||
170732166|NCT02684006|617023703|FG000|Overall Study|Participation terminated by sponsor|6|||
170732167|NCT02684006|617023704|FG001|Overall Study|Participation terminated by sponsor|9|||
170732168|NCT04495179|617023705|FG000|Overall Study|Lost to Follow-up|0|||
170732169|NCT04495179|617023706|FG001|Overall Study|Lost to Follow-up|1|||
170732170|NCT04495179|617023705|FG000|Overall Study|Withdrawal by Subject|2|||
170732171|NCT04495179|617023706|FG001|Overall Study|Withdrawal by Subject|4|||
170732172|NCT04495179|617023705|FG000|Overall Study|Study terminated by sponsor|0|||
170732173|NCT04495179|617023706|FG001|Overall Study|Study terminated by sponsor|18|||
170732174|NCT04495179|617023705|FG000|Overall Study|Death|0|||
170732175|NCT04495179|617023706|FG001|Overall Study|Death|4|||
170732176|NCT04495179|617023705|FG000|Overall Study|Adverse Event|0|||
170732177|NCT04495179|617023706|FG001|Overall Study|Adverse Event|1|||
170732178|NCT03033225|617023707|FG000|Overall Study|Withdrawal by Subject|5|||
170732179|NCT02061202|617023713|FG000|Overall Study|Lost to Follow-up|1|||
170732180|NCT02061202|617023714|FG001|Overall Study|Lost to Follow-up|1|||
170732181|NCT04559568|617023715|FG000|Overall Study|Physician Decision|0|||
170732182|NCT04559568|617023716|FG001|Overall Study|Physician Decision|0|||
170732183|NCT04559568|617023717|FG002|Overall Study|Physician Decision|0|||
170732184|NCT04559568|617023718|FG003|Overall Study|Physician Decision|0|||
170732185|NCT04559568|617023719|FG004|Overall Study|Physician Decision|0|||
170732186|NCT04559568|617023720|FG005|Overall Study|Physician Decision|0|||
170732187|NCT04559568|617023721|FG006|Overall Study|Physician Decision|0|||
170732188|NCT04559568|617023722|FG007|Overall Study|Physician Decision|0|||
170732189|NCT04559568|617023723|FG008|Overall Study|Physician Decision|0|||
170732190|NCT04559568|617023724|FG009|Overall Study|Physician Decision|1|||
170732191|NCT04559568|617023725|FG010|Overall Study|Physician Decision|0|||
170732192|NCT04559568|617023715|FG000|Overall Study|Withdrawal by Subject|0|||
170732193|NCT04559568|617023716|FG001|Overall Study|Withdrawal by Subject|0|||
170732194|NCT04559568|617023717|FG002|Overall Study|Withdrawal by Subject|0|||
170732195|NCT04559568|617023718|FG003|Overall Study|Withdrawal by Subject|0|||
170732196|NCT04559568|617023719|FG004|Overall Study|Withdrawal by Subject|0|||
170732197|NCT04559568|617023720|FG005|Overall Study|Withdrawal by Subject|0|||
170732198|NCT04559568|617023721|FG006|Overall Study|Withdrawal by Subject|0|||
170732199|NCT04559568|617023722|FG007|Overall Study|Withdrawal by Subject|0|||
170732200|NCT04559568|617023723|FG008|Overall Study|Withdrawal by Subject|0|||
170732201|NCT04559568|617023724|FG009|Overall Study|Withdrawal by Subject|0|||
170732202|NCT04559568|617023725|FG010|Overall Study|Withdrawal by Subject|1|||
170732203|NCT03721965|617023730|FG000|Overall Study|Death|1|||
170732204|NCT03721965|617023730|FG000|Overall Study|Study Terminated by Sponsor|1|||
170732205|NCT05103384|617023731|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
170732206|NCT02612311|617023732|FG000|Overall Study|Adverse Event|16|||
170732207|NCT02612311|617023733|FG001|Overall Study|Adverse Event|12|||
170732208|NCT02612311|617023734|FG002|Overall Study|Adverse Event|7|||
170732209|NCT02612311|617023735|FG003|Overall Study|Adverse Event|13|||
170732210|NCT02612311|617023732|FG000|Overall Study|Death|29|||
170732211|NCT02612311|617023733|FG001|Overall Study|Death|10|||
170732212|NCT02612311|617023734|FG002|Overall Study|Death|11|||
170732213|NCT02612311|617023735|FG003|Overall Study|Death|11|||
170732214|NCT02612311|617023732|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
170732215|NCT02612311|617023733|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
170732216|NCT02612311|617023734|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
170732217|NCT02612311|617023735|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
170732218|NCT02612311|617023732|FG000|Overall Study|Investigator's Decision|11|||
170732219|NCT02612311|617023733|FG001|Overall Study|Investigator's Decision|15|||
170732220|NCT02612311|617023734|FG002|Overall Study|Investigator's Decision|6|||
170732221|NCT02612311|617023735|FG003|Overall Study|Investigator's Decision|6|||
170732222|NCT02612311|617023732|FG000|Overall Study|Lack of Efficacy|0|||
170732223|NCT02612311|617023733|FG001|Overall Study|Lack of Efficacy|0|||
170732224|NCT02612311|617023734|FG002|Overall Study|Lack of Efficacy|1|||
170732225|NCT02612311|617023735|FG003|Overall Study|Lack of Efficacy|1|||
170732226|NCT02612311|617023732|FG000|Overall Study|Lost to Follow-up|2|||
170732227|NCT02612311|617023733|FG001|Overall Study|Lost to Follow-up|2|||
170732228|NCT02612311|617023734|FG002|Overall Study|Lost to Follow-up|1|||
170732229|NCT02612311|617023735|FG003|Overall Study|Lost to Follow-up|2|||
170732230|NCT02612311|617023732|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
170732231|NCT02612311|617023733|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
170732232|NCT02612311|617023734|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
170732233|NCT02612311|617023735|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
170732234|NCT02612311|617023732|FG000|Overall Study|Site Terminated by Sponsor|29|||
170732235|NCT02612311|617023733|FG001|Overall Study|Site Terminated by Sponsor|12|||
170732236|NCT02612311|617023734|FG002|Overall Study|Site Terminated by Sponsor|13|||
170732237|NCT02612311|617023735|FG003|Overall Study|Site Terminated by Sponsor|5|||
170732238|NCT02612311|617023732|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
170732239|NCT02612311|617023733|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
170840052|NCT01182441|617423603|FG000|Overall Study|Withdrawal by Subject|6|||
170840053|NCT01182441|617423604|FG001|Overall Study|Withdrawal by Subject|13|||
170840054|NCT01182441|617423603|FG000|Overall Study|Implant Not Attempted|4|||
170840055|NCT01182441|617423604|FG001|Overall Study|Implant Not Attempted|0|||
170840056|NCT01182441|617423603|FG000|Overall Study|Adverse Event|2|||
170840057|NCT01182441|617423604|FG001|Overall Study|Adverse Event|0|||
170840058|NCT01182441|617423603|FG000|Overall Study|Physician Decision|1|||
170840059|NCT01182441|617423604|FG001|Overall Study|Physician Decision|1|||
170840060|NCT02304705|617423605|FG000|Overall Study|Withdrawal by Subject|2|||
170840061|NCT02304705|617423606|FG001|Overall Study|Withdrawal by Subject|0|||
170840062|NCT02304705|617423605|FG000|Overall Study|Physician Decision|2|||
170840063|NCT02304705|617423606|FG001|Overall Study|Physician Decision|4|||
170840064|NCT02304705|617423605|FG000|Overall Study|Death|0|||
170840065|NCT02304705|617423606|FG001|Overall Study|Death|1|||
170840066|NCT02304705|617423605|FG000|Overall Study|Lost to Follow-up|0|||
170840067|NCT02304705|617423606|FG001|Overall Study|Lost to Follow-up|2|||
170840068|NCT03140280|617423607|FG000|Overall Study|Physician Decision|5|||
170840069|NCT04996004|617423618|FG000|Phase I|Death|1|||
170840070|NCT04996004|617423619|FG001|Phase I|Death|2|||
170840071|NCT04996004|617423620|FG002|Phase I|Death|1|||
170840072|NCT04996004|617423621|FG003|Phase I|Death|0|||
170840073|NCT04996004|617423622|FG004|Phase I|Death|0|||
170840074|NCT04996004|617423623|FG005|Phase I|Death|0|||
170840075|NCT04996004|617423618|FG000|Phase I|Study terminated by sponsor|2|||
170840076|NCT04996004|617423619|FG001|Phase I|Study terminated by sponsor|1|||
170840077|NCT04996004|617423620|FG002|Phase I|Study terminated by sponsor|2|||
170840078|NCT04996004|617423621|FG003|Phase I|Study terminated by sponsor|0|||
170840079|NCT04996004|617423622|FG004|Phase I|Study terminated by sponsor|0|||
170840080|NCT04996004|617423623|FG005|Phase I|Study terminated by sponsor|0|||
170840081|NCT04996004|617423618|FG000|Phase II|Study terminated by sponsor|0|||
170840082|NCT04996004|617423619|FG001|Phase II|Study terminated by sponsor|0|||
170840083|NCT04996004|617423620|FG002|Phase II|Study terminated by sponsor|0|||
170840084|NCT04996004|617423621|FG003|Phase II|Study terminated by sponsor|20|||
170840085|NCT04996004|617423622|FG004|Phase II|Study terminated by sponsor|10|||
170840086|NCT04996004|617423623|FG005|Phase II|Study terminated by sponsor|10|||
170840087|NCT04996004|617423618|FG000|Phase II|Withdrawal by Subject|0|||
170840088|NCT04996004|617423619|FG001|Phase II|Withdrawal by Subject|0|||
170840089|NCT04996004|617423620|FG002|Phase II|Withdrawal by Subject|0|||
170840090|NCT04996004|617423621|FG003|Phase II|Withdrawal by Subject|0|||
170840091|NCT04996004|617423622|FG004|Phase II|Withdrawal by Subject|1|||
170840092|NCT04996004|617423623|FG005|Phase II|Withdrawal by Subject|2|||
170840093|NCT04996004|617423618|FG000|Phase II|Death|0|||
170840094|NCT04996004|617423619|FG001|Phase II|Death|0|||
170840095|NCT04996004|617423620|FG002|Phase II|Death|0|||
170840096|NCT04996004|617423621|FG003|Phase II|Death|12|||
170840097|NCT04996004|617423622|FG004|Phase II|Death|2|||
170840098|NCT04996004|617423623|FG005|Phase II|Death|9|||
170840099|NCT04996004|617423618|FG000|Phase II|Other|0|||
170840100|NCT04996004|617423619|FG001|Phase II|Other|0|||
170840101|NCT04996004|617423620|FG002|Phase II|Other|0|||
170840102|NCT04996004|617423621|FG003|Phase II|Other|0|||
170840103|NCT04996004|617423622|FG004|Phase II|Other|0|||
170840104|NCT04996004|617423623|FG005|Phase II|Other|1|||
170840105|NCT03374488|617423624|FG000|Overall Study|Death|13|||
170840106|NCT03374488|617423625|FG001|Overall Study|Death|13|||
170840107|NCT03374488|617423624|FG000|Overall Study|Withdrawal by Subject|3|||
170840108|NCT03374488|617423625|FG001|Overall Study|Withdrawal by Subject|1|||
170840109|NCT03374488|617423624|FG000|Overall Study|Physician Decision|3|||
170840110|NCT03374488|617423625|FG001|Overall Study|Physician Decision|0|||
170840111|NCT03412773|617423626|FG000|Overall Study|Lost to Follow-up|0|||
170840112|NCT03412773|617423627|FG001|Overall Study|Lost to Follow-up|7|||
170840113|NCT03412773|617423628|FG002|Overall Study|Lost to Follow-up|6|||
170840114|NCT03412773|617423626|FG000|Overall Study|Withdrawal by Subject|0|||
170840115|NCT03412773|617423627|FG001|Overall Study|Withdrawal by Subject|15|||
170840116|NCT03412773|617423628|FG002|Overall Study|Withdrawal by Subject|19|||
170840117|NCT03412773|617423626|FG000|Overall Study|Study Closed By Sponsor|3|||
170840118|NCT03412773|617423627|FG001|Overall Study|Study Closed By Sponsor|46|||
170840119|NCT03412773|617423628|FG002|Overall Study|Study Closed By Sponsor|33|||
170840120|NCT03412773|617423626|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
170840121|NCT03412773|617423627|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
170840122|NCT03412773|617423628|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
170840123|NCT03412773|617423626|FG000|Overall Study|Death|7|||
170840124|NCT03412773|617423627|FG001|Overall Study|Death|259|||
170840125|NCT03412773|617423628|FG002|Overall Study|Death|273|||
170840126|NCT03412773|617423626|FG000|Overall Study|Physician Decision|0|||
170840127|NCT03412773|617423627|FG001|Overall Study|Physician Decision|0|||
170840128|NCT03412773|617423628|FG002|Overall Study|Physician Decision|1|||
170840129|NCT01810939|617423631|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
170840130|NCT01810939|617423632|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
170840131|NCT01810939|617423633|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
170732240|NCT02612311|617023734|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
170732241|NCT02612311|617023735|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
170732242|NCT02612311|617023732|FG000|Overall Study|Reason Not Specified|3|||
170732243|NCT02612311|617023733|FG001|Overall Study|Reason Not Specified|7|||
170732244|NCT02612311|617023734|FG002|Overall Study|Reason Not Specified|4|||
170732245|NCT02612311|617023735|FG003|Overall Study|Reason Not Specified|5|||
170732246|NCT02612311|617023732|FG000|Overall Study|Unknown/Missing|10|||
170732247|NCT02612311|617023733|FG001|Overall Study|Unknown/Missing|13|||
170732248|NCT02612311|617023734|FG002|Overall Study|Unknown/Missing|4|||
170732249|NCT02612311|617023735|FG003|Overall Study|Unknown/Missing|0|||
170732250|NCT02612311|617023732|FG000|Overall Study|Non-Compliance with Study|1|||
170732251|NCT02612311|617023733|FG001|Overall Study|Non-Compliance with Study|0|||
170732252|NCT02612311|617023734|FG002|Overall Study|Non-Compliance with Study|0|||
170732253|NCT02612311|617023735|FG003|Overall Study|Non-Compliance with Study|0|||
170732254|NCT04085328|617023737|FG000|Overall Study|Witihdrew Consent|16|||
170732255|NCT04085328|617023738|FG001|Overall Study|Witihdrew Consent|16|||
170732256|NCT04085328|617023737|FG000|Overall Study|Adverse Event|8|||
170732257|NCT04085328|617023738|FG001|Overall Study|Adverse Event|7|||
170732258|NCT04085328|617023737|FG000|Overall Study|Lost to Follow-up|7|||
170732259|NCT04085328|617023738|FG001|Overall Study|Lost to Follow-up|2|||
170732260|NCT04085328|617023737|FG000|Overall Study|Physician Decision|0|||
170732261|NCT04085328|617023738|FG001|Overall Study|Physician Decision|1|||
170732262|NCT04085328|617023737|FG000|Overall Study|Pregnancy|0|||
170732263|NCT04085328|617023738|FG001|Overall Study|Pregnancy|1|||
170732264|NCT04085328|617023737|FG000|Overall Study|Reasons Related to COVID-19|5|||
170732265|NCT04085328|617023738|FG001|Overall Study|Reasons Related to COVID-19|8|||
170732266|NCT04085328|617023737|FG000|Overall Study|Did not meet inclusion criteria|1|||
170732267|NCT04085328|617023738|FG001|Overall Study|Did not meet inclusion criteria|1|||
170732268|NCT04085328|617023737|FG000|Overall Study|Early termination|1|||
170732269|NCT04085328|617023738|FG001|Overall Study|Early termination|0|||
170732270|NCT00514735|617023739|FG000|Overall Study|Withdrawal by Subject|13|||
170732271|NCT00514735|617023740|FG001|Overall Study|Withdrawal by Subject|5|||
170732272|NCT00514735|617023739|FG000|Overall Study|Death|1|||
170732273|NCT00514735|617023740|FG001|Overall Study|Death|0|||
170732274|NCT00514735|617023739|FG000|Overall Study|Lost to Follow-up|0|||
170732275|NCT00514735|617023740|FG001|Overall Study|Lost to Follow-up|1|||
170732276|NCT04003610|617023741|FG000|Overall Study|Lost to Follow-up|0|||
170732277|NCT04003610|617023742|FG001|Overall Study|Lost to Follow-up|1|||
170732278|NCT04003610|617023743|FG002|Overall Study|Lost to Follow-up|0|||
170732279|NCT04003610|617023741|FG000|Overall Study|Death|0|||
170732280|NCT04003610|617023742|FG001|Overall Study|Death|0|||
170732281|NCT04003610|617023743|FG002|Overall Study|Death|3|||
170732282|NCT04003610|617023741|FG000|Overall Study|Study Terminated by Sponsor|0|||
170732283|NCT04003610|617023742|FG001|Overall Study|Study Terminated by Sponsor|0|||
170732284|NCT04003610|617023743|FG002|Overall Study|Study Terminated by Sponsor|3|||
170732285|NCT04751942|617023744|FG000|Overall Study|Lost to Follow-up|9|||
170732286|NCT04751942|617023745|FG001|Overall Study|Lost to Follow-up|6|||
170732287|NCT01494584|617023751|FG000|Overall Study|Study Closed/Terminated|1|||
170732288|NCT01218126|617023754|FG000|Overall Study|Adverse Event|8|||
170732289|NCT01218126|617023755|FG001|Overall Study|Adverse Event|10|||
170732290|NCT01218126|617023756|FG002|Overall Study|Adverse Event|12|||
170732291|NCT01218126|617023757|FG003|Overall Study|Adverse Event|16|||
170732292|NCT01218126|617023754|FG000|Overall Study|Lack of Efficacy|7|||
170732293|NCT01218126|617023755|FG001|Overall Study|Lack of Efficacy|2|||
170732294|NCT01218126|617023756|FG002|Overall Study|Lack of Efficacy|2|||
170732295|NCT01218126|617023757|FG003|Overall Study|Lack of Efficacy|6|||
170732296|NCT01218126|617023754|FG000|Overall Study|Protocol Violation|5|||
170732297|NCT01218126|617023755|FG001|Overall Study|Protocol Violation|2|||
170732298|NCT01218126|617023756|FG002|Overall Study|Protocol Violation|2|||
170732299|NCT01218126|617023757|FG003|Overall Study|Protocol Violation|3|||
170732300|NCT01218126|617023754|FG000|Overall Study|Protocol-defined stopping criteria|1|||
170732301|NCT01218126|617023755|FG001|Overall Study|Protocol-defined stopping criteria|1|||
170732302|NCT01218126|617023756|FG002|Overall Study|Protocol-defined stopping criteria|0|||
170732303|NCT01218126|617023757|FG003|Overall Study|Protocol-defined stopping criteria|0|||
170732304|NCT01218126|617023754|FG000|Overall Study|Lost to Follow-up|0|||
170732305|NCT01218126|617023755|FG001|Overall Study|Lost to Follow-up|0|||
170732306|NCT01218126|617023756|FG002|Overall Study|Lost to Follow-up|0|||
170732307|NCT01218126|617023757|FG003|Overall Study|Lost to Follow-up|2|||
170732308|NCT01218126|617023754|FG000|Overall Study|Physician Decision|1|||
170732309|NCT01218126|617023755|FG001|Overall Study|Physician Decision|2|||
170732310|NCT01218126|617023756|FG002|Overall Study|Physician Decision|4|||
170732311|NCT01218126|617023757|FG003|Overall Study|Physician Decision|2|||
170732312|NCT01218126|617023754|FG000|Overall Study|Withdrawal by Subject|2|||
170732313|NCT01218126|617023755|FG001|Overall Study|Withdrawal by Subject|5|||
170732314|NCT01218126|617023756|FG002|Overall Study|Withdrawal by Subject|4|||
170732315|NCT01218126|617023757|FG003|Overall Study|Withdrawal by Subject|6|||
170732316|NCT01256567|617023764|FG000|Overall Study|Withdrawal by Subject|1|||
170732317|NCT00567190|617023770|FG000|Overall Study|Death|235|||
170840132|NCT01810939|617423631|FG000|Part A Treatment Period|Protocol Violation|2|||
170840133|NCT01810939|617423632|FG001|Part A Treatment Period|Protocol Violation|0|||
170840134|NCT01810939|617423633|FG002|Part A Treatment Period|Protocol Violation|0|||
170840135|NCT01810939|617423631|FG000|Part A Treatment Period|Adverse Event|10|||
170840136|NCT01810939|617423632|FG001|Part A Treatment Period|Adverse Event|0|||
170840137|NCT01810939|617423633|FG002|Part A Treatment Period|Adverse Event|0|||
170840138|NCT01810939|617423631|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
170732318|NCT00567190|617023771|FG001|Overall Study|Death|280|||
170732319|NCT00567190|617023770|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
170732320|NCT00567190|617023771|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
170732321|NCT00374322|617023779|FG000|Overall Study|Lost to Follow-up|92|||
170732322|NCT00374322|617023780|FG001|Overall Study|Lost to Follow-up|90|||
170732323|NCT00374322|617023779|FG000|Overall Study|Protocol Violation|8|||
170732324|NCT00374322|617023780|FG001|Overall Study|Protocol Violation|3|||
170732325|NCT00374322|617023779|FG000|Overall Study|Withdrawal by Subject|235|||
170732326|NCT00374322|617023780|FG001|Overall Study|Withdrawal by Subject|167|||
170732327|NCT00374322|617023779|FG000|Overall Study|Sponsor Terminated Study|866|||
170732328|NCT00374322|617023780|FG001|Overall Study|Sponsor Terminated Study|990|||
170732329|NCT00374322|617023779|FG000|Overall Study|Physician Decision|36|||
170732330|NCT00374322|617023780|FG001|Overall Study|Physician Decision|32|||
170732331|NCT00374322|617023779|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
170732332|NCT00374322|617023780|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
170732333|NCT00374322|617023779|FG000|Overall Study|Sponsor Decision|2|||
170732334|NCT00374322|617023780|FG001|Overall Study|Sponsor Decision|3|||
170732335|NCT00374322|617023779|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
170732336|NCT00374322|617023780|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
170732337|NCT00374322|617023779|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
170732338|NCT00374322|617023780|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
170732339|NCT00374322|617023779|FG000|Overall Study|Severe Toxicity|1|||
170732340|NCT00374322|617023780|FG001|Overall Study|Severe Toxicity|0|||
170732341|NCT00374322|617023779|FG000|Overall Study|Site Closed|2|||
170732342|NCT00374322|617023780|FG001|Overall Study|Site Closed|2|||
170732343|NCT00374322|617023779|FG000|Overall Study|Participant Changed Physician|1|||
170732344|NCT00374322|617023780|FG001|Overall Study|Participant Changed Physician|0|||
170732345|NCT00374322|617023779|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
170732346|NCT00374322|617023780|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
170732347|NCT00374322|617023779|FG000|Overall Study|Noncompliance with Study Requirements|0|||
170732348|NCT00374322|617023780|FG001|Overall Study|Noncompliance with Study Requirements|1|||
170732349|NCT00374322|617023779|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
170732350|NCT00374322|617023780|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
170732351|NCT00374322|617023779|FG000|Overall Study|Did Not Receive Study Medication|8|||
170732352|NCT00374322|617023780|FG001|Overall Study|Did Not Receive Study Medication|6|||
170732353|NCT00522626|617023787|FG000|Overall Study|Lost to Follow-up|7|||
170732354|NCT01169675|617023788|FG000|Overall Study|Progressive disease|13|||
170732355|NCT01169675|617023789|FG001|Overall Study|Progressive disease|2|||
170732356|NCT01169675|617023790|FG002|Overall Study|Progressive disease|5|||
170732357|NCT01169675|617023791|FG003|Overall Study|Progressive disease|15|||
170732358|NCT01169675|617023792|FG004|Overall Study|Progressive disease|1|||
170840139|NCT01810939|617423632|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
170840140|NCT01810939|617423633|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
170840141|NCT01810939|617423631|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
170840142|NCT01810939|617423632|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
170840143|NCT01810939|617423633|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
170840144|NCT01810939|617423631|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
170840145|NCT01810939|617423632|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
170840146|NCT01810939|617423633|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
170840147|NCT01810939|617423631|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
170840148|NCT01810939|617423632|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
170840149|NCT01810939|617423633|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
170840150|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
170840151|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
170840152|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
170840153|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
170840154|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
170840155|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
170840156|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
170840157|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
170840158|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
170840159|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
170732359|NCT01169675|617023788|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
170732360|NCT01169675|617023789|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170840160|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
170840161|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
170840162|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
170840163|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
170840164|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
170840165|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
170840166|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
170840167|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
170840168|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
170840169|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
170840170|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
170840171|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
170840172|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
170840173|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
170840174|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
170840175|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
170840176|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
170840177|NCT01810939|617423631|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
170840178|NCT01810939|617423632|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
170840179|NCT01810939|617423633|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
170840180|NCT00789360|617423638|FG000|Overall Study|Protocol Violation|3|||
170840181|NCT00789360|617423639|FG001|Overall Study|Protocol Violation|1|||
170840182|NCT03559062|617423640|FG000|Overall Study|Other|0|||
170840183|NCT03559062|617423641|FG001|Overall Study|Other|1|||
170840184|NCT03559062|617423642|FG002|Overall Study|Other|0|||
170840185|NCT00520845|617423645|FG000|Overall Study|Death|3|||
170840186|NCT00520845|617423645|FG000|Overall Study|Adverse Event|4|||
170840187|NCT00520845|617423645|FG000|Overall Study|Disease Progression, relapse|13|||
170840188|NCT00520845|617423645|FG000|Overall Study|Withdrawal by Subject|1|||
170840189|NCT00520845|617423645|FG000|Overall Study|Alternative Therapy|1|||
170840190|NCT01250925|617423646|FG000|Overall Study|Lost to Follow-up|1|||
170840191|NCT01250925|617423647|FG001|Overall Study|Lost to Follow-up|1|||
170840192|NCT01250925|617423648|FG002|Overall Study|Lost to Follow-up|0|||
170840193|NCT01250925|617423646|FG000|Overall Study|Withdrawal by Subject|2|||
170840194|NCT01250925|617423647|FG001|Overall Study|Withdrawal by Subject|0|||
170840195|NCT01250925|617423648|FG002|Overall Study|Withdrawal by Subject|0|||
170840196|NCT01250925|617423646|FG000|Overall Study|Protocol Violation|2|||
170840197|NCT01250925|617423647|FG001|Overall Study|Protocol Violation|0|||
170840198|NCT01250925|617423648|FG002|Overall Study|Protocol Violation|0|||
170840199|NCT01250925|617423646|FG000|Overall Study|Physician Decision|0|||
170840200|NCT01250925|617423647|FG001|Overall Study|Physician Decision|2|||
170840201|NCT01250925|617423648|FG002|Overall Study|Physician Decision|1|||
170840202|NCT01250925|617423646|FG000|Overall Study|Adverse Event|0|||
170840203|NCT01250925|617423647|FG001|Overall Study|Adverse Event|0|||
170840204|NCT01250925|617423648|FG002|Overall Study|Adverse Event|1|||
170840205|NCT00955708|617423649|FG000|Overall Study|Death|269|||
170840206|NCT00955708|617423649|FG000|Overall Study|Lost to Follow-up|72|||
170840207|NCT00955708|617423649|FG000|Overall Study|Physician Decision|36|||
170840208|NCT00955708|617423649|FG000|Overall Study|Protocol Violation|134|||
170840209|NCT00955708|617423649|FG000|Overall Study|Registry Conclusion|186|||
170840210|NCT00955708|617423649|FG000|Overall Study|Product removed from service|94|||
170840211|NCT00955708|617423649|FG000|Overall Study|Patient Refused to participate further|116|||
170840212|NCT00955708|617423649|FG000|Overall Study|Closure of study location|60|||
170840213|NCT00955708|617423649|FG000|Overall Study|Patient changed care provider/moved|91|||
170840214|NCT03738475|617423652|FG000|Overall Study|Participant Non-Compliance|1|||
170840215|NCT03738475|617423653|FG001|Overall Study|Participant Non-Compliance|0|||
170840216|NCT00677534|617423656|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
170840217|NCT00677534|617423656|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
170840218|NCT00677534|617423656|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
170840219|NCT01370655|617423657|FG000|Period 1|Adverse Event|2|||
170840220|NCT01370655|617423658|FG001|Period 1|Adverse Event|0|||
170840221|NCT01370655|617423659|FG002|Period 1|Adverse Event|0|||
170840222|NCT01370655|617423660|FG003|Period 1|Adverse Event|0|||
170840223|NCT01370655|617423661|FG004|Period 1|Adverse Event|0|||
170840224|NCT01370655|617423662|FG005|Period 1|Adverse Event|0|||
170840225|NCT01370655|617423663|FG006|Period 1|Adverse Event|1|||
170840226|NCT01370655|617423664|FG007|Period 1|Adverse Event|0|||
170840227|NCT01370655|617423665|FG008|Period 1|Adverse Event|0|||
170840228|NCT01370655|617423666|FG009|Period 1|Adverse Event|0|||
170840229|NCT01370655|617423667|FG010|Period 1|Adverse Event|0|||
170840230|NCT01370655|617423668|FG011|Period 1|Adverse Event|0|||
170840231|NCT01370655|617423657|FG000|Period 2|Adverse Event|0|||
170732361|NCT01169675|617023790|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170732362|NCT01169675|617023791|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
170732363|NCT01169675|617023792|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
170732364|NCT01169675|617023788|FG000|Overall Study|Adverse Event|5|||
170732365|NCT01169675|617023789|FG001|Overall Study|Adverse Event|1|||
170732366|NCT01169675|617023790|FG002|Overall Study|Adverse Event|2|||
170732367|NCT01169675|617023791|FG003|Overall Study|Adverse Event|0|||
170732368|NCT01169675|617023792|FG004|Overall Study|Adverse Event|0|||
170732369|NCT01169675|617023788|FG000|Overall Study|Withdrawal by Subject|1|||
170732370|NCT01169675|617023789|FG001|Overall Study|Withdrawal by Subject|0|||
170732371|NCT01169675|617023790|FG002|Overall Study|Withdrawal by Subject|0|||
170732372|NCT01169675|617023791|FG003|Overall Study|Withdrawal by Subject|1|||
170732373|NCT01169675|617023792|FG004|Overall Study|Withdrawal by Subject|2|||
170732374|NCT01169675|617023788|FG000|Overall Study|Other Reason Not Defined Above|0|||
170732375|NCT01169675|617023789|FG001|Overall Study|Other Reason Not Defined Above|0|||
170732376|NCT01169675|617023790|FG002|Overall Study|Other Reason Not Defined Above|0|||
170732377|NCT01169675|617023791|FG003|Overall Study|Other Reason Not Defined Above|1|||
170732378|NCT01169675|617023792|FG004|Overall Study|Other Reason Not Defined Above|1|||
170732379|NCT02365519|617023793|FG000|Randomized and Treated|Adverse Event|0|||
170840232|NCT01370655|617423658|FG001|Period 2|Adverse Event|0|||
170840233|NCT01370655|617423659|FG002|Period 2|Adverse Event|1|||
170840234|NCT01370655|617423660|FG003|Period 2|Adverse Event|0|||
170840235|NCT01370655|617423661|FG004|Period 2|Adverse Event|1|||
170840236|NCT01370655|617423662|FG005|Period 2|Adverse Event|0|||
170840237|NCT01370655|617423663|FG006|Period 2|Adverse Event|0|||
170840238|NCT01370655|617423664|FG007|Period 2|Adverse Event|1|||
170840239|NCT01370655|617423665|FG008|Period 2|Adverse Event|0|||
170840240|NCT01370655|617423666|FG009|Period 2|Adverse Event|0|||
170840241|NCT01370655|617423667|FG010|Period 2|Adverse Event|0|||
170840242|NCT01370655|617423668|FG011|Period 2|Adverse Event|0|||
170840243|NCT01370655|617423657|FG000|Period 2|met protocol specified stopping criteria|0|||
170840244|NCT01370655|617423658|FG001|Period 2|met protocol specified stopping criteria|0|||
170840245|NCT01370655|617423659|FG002|Period 2|met protocol specified stopping criteria|1|||
170840246|NCT01370655|617423660|FG003|Period 2|met protocol specified stopping criteria|0|||
170840247|NCT01370655|617423661|FG004|Period 2|met protocol specified stopping criteria|0|||
170840248|NCT01370655|617423662|FG005|Period 2|met protocol specified stopping criteria|0|||
170840249|NCT01370655|617423663|FG006|Period 2|met protocol specified stopping criteria|1|||
170840250|NCT01370655|617423664|FG007|Period 2|met protocol specified stopping criteria|0|||
170840251|NCT01370655|617423665|FG008|Period 2|met protocol specified stopping criteria|1|||
170840252|NCT01370655|617423666|FG009|Period 2|met protocol specified stopping criteria|0|||
170840253|NCT01370655|617423667|FG010|Period 2|met protocol specified stopping criteria|1|||
170840254|NCT01370655|617423668|FG011|Period 2|met protocol specified stopping criteria|0|||
170840255|NCT01370655|617423657|FG000|Period 2|Withdrawal by Subject|0|||
170840256|NCT01370655|617423658|FG001|Period 2|Withdrawal by Subject|0|||
170840257|NCT01370655|617423659|FG002|Period 2|Withdrawal by Subject|0|||
170840258|NCT01370655|617423660|FG003|Period 2|Withdrawal by Subject|0|||
170840259|NCT01370655|617423661|FG004|Period 2|Withdrawal by Subject|0|||
170840260|NCT01370655|617423662|FG005|Period 2|Withdrawal by Subject|0|||
170840261|NCT01370655|617423663|FG006|Period 2|Withdrawal by Subject|0|||
170840262|NCT01370655|617423664|FG007|Period 2|Withdrawal by Subject|0|||
170840263|NCT01370655|617423665|FG008|Period 2|Withdrawal by Subject|1|||
170840264|NCT01370655|617423666|FG009|Period 2|Withdrawal by Subject|0|||
170840265|NCT01370655|617423667|FG010|Period 2|Withdrawal by Subject|0|||
170840266|NCT01370655|617423668|FG011|Period 2|Withdrawal by Subject|0|||
170840267|NCT02922023|617423669|FG000|Overall Study|Lost to Follow-up|2|||
170840268|NCT02922023|617423670|FG001|Overall Study|Lost to Follow-up|0|||
170840269|NCT01735175|617423671|FG000|Overall Study|Withdrawal by Subject|9|||
170840270|NCT01735175|617423672|FG001|Overall Study|Withdrawal by Subject|2|||
170840271|NCT01735175|617423671|FG000|Overall Study|Lost to Follow-up|4|||
170840272|NCT01735175|617423672|FG001|Overall Study|Lost to Follow-up|2|||
170840273|NCT01735175|617423671|FG000|Overall Study|Death|3|||
170840274|NCT01735175|617423672|FG001|Overall Study|Death|2|||
170840275|NCT01735175|617423671|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
170840276|NCT01735175|617423672|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
170840277|NCT02643628|617423676|FG000|Overall Study|Lost to Follow-up|1|||
170840278|NCT02643628|617423677|FG001|Overall Study|Lost to Follow-up|4|||
170840279|NCT02643628|617423676|FG000|Overall Study|Withdrawal by Subject|0|||
170840280|NCT02643628|617423677|FG001|Overall Study|Withdrawal by Subject|1|||
170840281|NCT02643628|617423676|FG000|Overall Study|Relocated out of state|0|||
170840282|NCT02643628|617423677|FG001|Overall Study|Relocated out of state|1|||
170840283|NCT02803593|617423678|FG000|Overall Study|Lost to Follow-up|17|||
170840284|NCT02803593|617423679|FG001|Overall Study|Lost to Follow-up|35|||
170840285|NCT01430468|617423691|FG000|Overall Study|Physician Decision|2|||
170840286|NCT01430468|617423692|FG001|Overall Study|Physician Decision|1|||
170840287|NCT01430468|617423691|FG000|Overall Study|Withdrawal by Subject|5|||
170840288|NCT01430468|617423692|FG001|Overall Study|Withdrawal by Subject|5|||
170840289|NCT00604708|617423693|FG000|Overall Study|Withdrawal by Subject|9|||
170840290|NCT00604708|617423694|FG001|Overall Study|Withdrawal by Subject|10|||
170840291|NCT00604708|617423693|FG000|Overall Study|Protocol Violation|2|||
170840292|NCT00604708|617423694|FG001|Overall Study|Protocol Violation|8|||
170840293|NCT00604708|617423693|FG000|Overall Study|Lost to Follow-up|5|||
170840294|NCT00604708|617423694|FG001|Overall Study|Lost to Follow-up|5|||
170840295|NCT00604708|617423693|FG000|Overall Study|administrative reasons|9|||
170840296|NCT00604708|617423694|FG001|Overall Study|administrative reasons|11|||
170840297|NCT00604708|617423693|FG000|Overall Study|Adverse Event|6|||
170840298|NCT00604708|617423694|FG001|Overall Study|Adverse Event|6|||
170840299|NCT00415051|617423697|FG000|Overall Study|Protocol Violation|1|||
170840300|NCT04916730|617423698|FG000|Overall Study|Withdrawal by Subject|4|||
170840301|NCT04916730|617423699|FG001|Overall Study|Withdrawal by Subject|2|||
170840302|NCT04916730|617423698|FG000|Overall Study|Lost to Follow-up|0|||
170840303|NCT04916730|617423699|FG001|Overall Study|Lost to Follow-up|2|||
170840304|NCT04916730|617423698|FG000|Overall Study|Physician Decision|1|||
170840305|NCT04916730|617423699|FG001|Overall Study|Physician Decision|0|||
170840306|NCT00844597|617423707|FG000|Overall Study|Adverse Event|0|||
170840307|NCT00844597|617423708|FG001|Overall Study|Adverse Event|0|||
170840308|NCT00844597|617423709|FG002|Overall Study|Adverse Event|0|||
170840309|NCT00844597|617423710|FG003|Overall Study|Adverse Event|1|||
170840310|NCT00844597|617423711|FG004|Overall Study|Adverse Event|0|||
170840311|NCT00844597|617423712|FG005|Overall Study|Adverse Event|0|||
170840312|NCT01250509|617423713|FG000|Overall Study|Lost to Follow-up|5|||
170840313|NCT01250509|617423714|FG001|Overall Study|Lost to Follow-up|2|||
170840314|NCT01371708|617423715|FG000|Overall Study|Insufficient clinical response|3|||
170840315|NCT01371708|617423716|FG001|Overall Study|Insufficient clinical response|2|||
170840316|NCT01371708|617423717|FG002|Overall Study|Insufficient clinical response|0|||
170840317|NCT01371708|617423715|FG000|Overall Study|Lost to Follow-up|5|||
170840318|NCT01371708|617423716|FG001|Overall Study|Lost to Follow-up|9|||
170840319|NCT01371708|617423717|FG002|Overall Study|Lost to Follow-up|7|||
170840320|NCT01371708|617423715|FG000|Overall Study|Protocol Violation|2|||
170840321|NCT01371708|617423716|FG001|Overall Study|Protocol Violation|1|||
170840322|NCT01371708|617423717|FG002|Overall Study|Protocol Violation|2|||
170840323|NCT01371708|617423715|FG000|Overall Study|No longer willing to participate|7|||
170840324|NCT01371708|617423716|FG001|Overall Study|No longer willing to participate|7|||
170840325|NCT01371708|617423717|FG002|Overall Study|No longer willing to participate|13|||
170840326|NCT01371708|617423715|FG000|Overall Study|Medication error/not related to AE|0|||
170840327|NCT01371708|617423716|FG001|Overall Study|Medication error/not related to AE|1|||
170840328|NCT01371708|617423717|FG002|Overall Study|Medication error/not related to AE|0|||
170840329|NCT01371708|617423715|FG000|Overall Study|Other|3|||
170840330|NCT01371708|617423716|FG001|Overall Study|Other|2|||
170840331|NCT01371708|617423717|FG002|Overall Study|Other|4|||
170840332|NCT01371708|617423715|FG000|Overall Study|Adverse Event|5|||
170840333|NCT01371708|617423716|FG001|Overall Study|Adverse Event|8|||
170840334|NCT01371708|617423717|FG002|Overall Study|Adverse Event|12|||
170840335|NCT01371708|617423715|FG000|Overall Study|Started but did not receive treatment|1|||
170840336|NCT01371708|617423716|FG001|Overall Study|Started but did not receive treatment|0|||
170840337|NCT01371708|617423717|FG002|Overall Study|Started but did not receive treatment|1|||
170840338|NCT04463680|617423718|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
170840339|NCT04463680|617423718|FG000|Overall Study|Not eligible due to implant duration of use|1|||
170840340|NCT04463680|617423718|FG000|Overall Study|Withdrawal by Subject|3|||
170840341|NCT05239598|617423721|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
170840342|NCT05239598|617423722|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
170840343|NCT05239598|617423721|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
170840344|NCT05239598|617423722|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
170840345|NCT02592707|617423723|FG000|Overall Study|Consent Withdrawn|0|||
170840346|NCT02592707|617423724|FG001|Overall Study|Consent Withdrawn|1|||
170840347|NCT02592707|617423725|FG002|Overall Study|Consent Withdrawn|2|||
170840348|NCT02592707|617423726|FG003|Overall Study|Consent Withdrawn|0|||
170840349|NCT02592707|617423723|FG000|Overall Study|Death|1|||
170840350|NCT02592707|617423724|FG001|Overall Study|Death|0|||
170840351|NCT02592707|617423725|FG002|Overall Study|Death|0|||
170840352|NCT02592707|617423726|FG003|Overall Study|Death|0|||
170840353|NCT02592707|617423723|FG000|Overall Study|Progressive Disease|4|||
170840354|NCT02592707|617423724|FG001|Overall Study|Progressive Disease|4|||
170840355|NCT02592707|617423725|FG002|Overall Study|Progressive Disease|3|||
170840356|NCT02592707|617423726|FG003|Overall Study|Progressive Disease|3|||
170840357|NCT02592707|617423723|FG000|Overall Study|Other|0|||
170840358|NCT02592707|617423724|FG001|Overall Study|Other|0|||
170840359|NCT02592707|617423725|FG002|Overall Study|Other|1|||
170840360|NCT02592707|617423726|FG003|Overall Study|Other|2|||
170840361|NCT02592707|617423723|FG000|Overall Study|Never entered LTFU period|1|||
170840362|NCT02592707|617423724|FG001|Overall Study|Never entered LTFU period|0|||
170840363|NCT02592707|617423725|FG002|Overall Study|Never entered LTFU period|0|||
170732380|NCT02365519|617023794|FG001|Randomized and Treated|Adverse Event|1|||
170732381|NCT02365519|617023795|FG002|Randomized and Treated|Adverse Event|0|||
170732382|NCT02365519|617023793|FG000|Randomized and Treated|Withdrawal by Subject|0|||
170732383|NCT02365519|617023794|FG001|Randomized and Treated|Withdrawal by Subject|1|||
170732384|NCT02365519|617023795|FG002|Randomized and Treated|Withdrawal by Subject|1|||
170732385|NCT00572195|617023796|FG000|Overall Study|Withdrawal by Subject|50|||
170732386|NCT00572195|617023796|FG000|Overall Study|Death|9|||
170732387|NCT00572195|617023796|FG000|Overall Study|Adverse Event|4|||
170732388|NCT00572195|617023796|FG000|Overall Study|Lost to Follow-up|5|||
170732389|NCT04120233|617023797|FG000|Overall Study|Adverse Event|0|||
170732390|NCT04120233|617023798|FG001|Overall Study|Adverse Event|0|||
170732391|NCT04120233|617023799|FG002|Overall Study|Adverse Event|0|||
170732392|NCT04120233|617023800|FG003|Overall Study|Adverse Event|0|||
170732393|NCT04120233|617023801|FG004|Overall Study|Adverse Event|1|||
170732394|NCT04120233|617023802|FG005|Overall Study|Adverse Event|0|||
170732395|NCT05809596|617023805|FG000|Overall Study|Death|16|||
170732396|NCT05809596|617023805|FG000|Overall Study|Withdrawal by Subject|4|||
170732397|NCT05809596|617023805|FG000|Overall Study|Physician Decision|1|||
170732398|NCT05809596|617023805|FG000|Overall Study|Missed Visit|2|||
170732399|NCT05809596|617023805|FG000|Overall Study|Other|3|||
170732400|NCT01679301|617025438|FG000|Screening Period|screen failure|3|||
170732401|NCT01679301|617025439|FG001|Screening Period|screen failure|0|||
170732402|NCT01679301|617025440|FG002|Screening Period|screen failure|0|||
170732403|NCT00861614|617025441|FG000|Overall Study|Disease Progression|182|||
170732404|NCT00861614|617025442|FG001|Overall Study|Disease Progression|263|||
170732405|NCT00861614|617025441|FG000|Overall Study|Study Drug Toxicity|79|||
170732406|NCT00861614|617025442|FG001|Overall Study|Study Drug Toxicity|6|||
170732407|NCT00861614|617025441|FG000|Overall Study|Death|32|||
170732408|NCT00861614|617025442|FG001|Overall Study|Death|19|||
170732409|NCT00861614|617025441|FG000|Overall Study|Adverse Event|27|||
170732410|NCT00861614|617025442|FG001|Overall Study|Adverse Event|23|||
170732411|NCT00861614|617025441|FG000|Overall Study|Withdrawal by Subject|34|||
170732412|NCT00861614|617025442|FG001|Overall Study|Withdrawal by Subject|35|||
170732413|NCT00861614|617025441|FG000|Overall Study|Other|17|||
170732414|NCT00861614|617025442|FG001|Overall Study|Other|22|||
170732415|NCT01289418|617025443|FG000|Day 8 Survey|email address invalid|283|||
170732416|NCT01289418|617025443|FG000|Day 8 Survey|participants did not complete the survey|1935|||
170732417|NCT01289418|617025443|FG000|Day 29 Survey|email address invalid|283|||
170732418|NCT01289418|617025443|FG000|Day 29 Survey|participants did not complete the survey|2185|||
170732419|NCT00838682|617025445|FG000|Overall Study|Lost to Follow-up|21|||
170732420|NCT00838682|617025446|FG001|Overall Study|Lost to Follow-up|14|||
170732421|NCT00838682|617025445|FG000|Overall Study|detection of exclusion criteria|4|||
170732422|NCT00838682|617025446|FG001|Overall Study|detection of exclusion criteria|3|||
170732423|NCT00838682|617025445|FG000|Overall Study|Protocol Violation|0|||
170732424|NCT00838682|617025446|FG001|Overall Study|Protocol Violation|1|||
170732425|NCT00838682|617025445|FG000|Overall Study|Withdrawal by Subject|0|||
170732426|NCT00838682|617025446|FG001|Overall Study|Withdrawal by Subject|1|||
170732427|NCT02305381|617025447|FG000|Overall Study|Unclassified|5|||
170732428|NCT02305381|617025448|FG001|Overall Study|Unclassified|5|||
170732429|NCT02305381|617025449|FG002|Overall Study|Unclassified|7|||
170732430|NCT02276066|617025450|FG000|Overall Study|Lost to Follow-up|21|||
170732431|NCT02276066|617025451|FG001|Overall Study|Lost to Follow-up|11|||
170732432|NCT02882282|617025452|FG000|Overall Study|Adverse Event|1|||
170732433|NCT02882282|617025453|FG001|Overall Study|Adverse Event|0|||
170732434|NCT03386032|617025454|FG000|Overall Study|Lack of Efficacy|6|||
170732435|NCT03386032|617025455|FG001|Overall Study|Lack of Efficacy|2|||
170732436|NCT03386032|617025456|FG002|Overall Study|Lack of Efficacy|0|||
170732437|NCT03386032|617025454|FG000|Overall Study|Adverse Event|2|||
170732438|NCT03386032|617025455|FG001|Overall Study|Adverse Event|2|||
170732439|NCT03386032|617025456|FG002|Overall Study|Adverse Event|0|||
170732440|NCT03386032|617025454|FG000|Overall Study|Withdrawal by Subject|1|||
170732441|NCT03386032|617025455|FG001|Overall Study|Withdrawal by Subject|0|||
170732442|NCT03386032|617025456|FG002|Overall Study|Withdrawal by Subject|0|||
170732443|NCT03386032|617025454|FG000|Overall Study|Lost to Follow-up|9|||
170732444|NCT03386032|617025455|FG001|Overall Study|Lost to Follow-up|3|||
170732445|NCT03386032|617025456|FG002|Overall Study|Lost to Follow-up|0|||
170732446|NCT01807156|617025457|FG000|Overall Study|Physician Decision|1|||
170732447|NCT01493687|617025468|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
170732448|NCT01493687|617025469|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
170732449|NCT01493687|617025468|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
170732450|NCT01493687|617025469|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
170732451|NCT01493687|617025468|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
170732452|NCT01493687|617025469|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
170732453|NCT01493687|617025468|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
170732454|NCT01493687|617025469|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
170732455|NCT01493687|617025468|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
170840364|NCT02592707|617423726|FG003|Overall Study|Never entered LTFU period|2|||
170840365|NCT02998476|617423731|FG000|Overall Study|Lost to Follow-up|1|||
170840366|NCT02998476|617423732|FG001|Overall Study|Lost to Follow-up|0|||
170840367|NCT02998476|617423731|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
170840368|NCT02998476|617423732|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
170840369|NCT02998476|617423731|FG000|Overall Study|Withdrawal by Subject|1|||
170840370|NCT02998476|617423732|FG001|Overall Study|Withdrawal by Subject|2|||
170840371|NCT02998476|617423731|FG000|Overall Study|Death|45|||
170840372|NCT02998476|617423732|FG001|Overall Study|Death|2|||
170840373|NCT02998476|617423731|FG000|Overall Study|Other|6|||
170840374|NCT02998476|617423732|FG001|Overall Study|Other|1|||
170840375|NCT04855734|617423733|FG000|Overall Study|Lost to Follow-up|2|||
170840376|NCT04855734|617423734|FG001|Overall Study|Lost to Follow-up|2|||
170840377|NCT03832595|617423735|FG000|Overall Study|Death|142|||
170840378|NCT03832595|617423736|FG001|Overall Study|Death|130|||
170840379|NCT03832595|617423735|FG000|Overall Study|Medical management without dialysis|37|||
170840380|NCT03832595|617423736|FG001|Overall Study|Medical management without dialysis|1|||
170840381|NCT03277352|617423737|FG000|Overall Study|Study Terminated By Sponsor|2|||
170840382|NCT03277352|617423737|FG000|Overall Study|Withdrawal by Subject|4|||
170840383|NCT03277352|617423737|FG000|Overall Study|Death|4|||
170840384|NCT05131477|617423742|FG000|PART 1|Withdrawal by Subject|2|||
170840385|NCT05131477|617423743|FG001|PART 1|Withdrawal by Subject|9|||
170840386|NCT05131477|617423744|FG002|PART 1|Withdrawal by Subject|6|||
170840387|NCT05131477|617423745|FG003|PART 1|Withdrawal by Subject|2|||
170840388|NCT05131477|617423746|FG004|PART 1|Withdrawal by Subject|8|||
170840389|NCT05131477|617423747|FG005|PART 1|Withdrawal by Subject|0|||
170840390|NCT05131477|617423748|FG006|PART 1|Withdrawal by Subject|0|||
170840391|NCT05131477|617423749|FG007|PART 1|Withdrawal by Subject|0|||
170840392|NCT05131477|617423750|FG008|PART 1|Withdrawal by Subject|0|||
170840393|NCT05131477|617423751|FG009|PART 1|Withdrawal by Subject|0|||
170840394|NCT05131477|617423752|FG010|PART 1|Withdrawal by Subject|0|||
170840395|NCT05131477|617423753|FG011|PART 1|Withdrawal by Subject|0|||
170732456|NCT01493687|617025469|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
170732457|NCT01493687|617025468|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
170732458|NCT01493687|617025469|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
170732459|NCT01493687|617025468|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
170732460|NCT01493687|617025469|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
170732461|NCT01493687|617025468|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
170732462|NCT01493687|617025469|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
170732463|NCT01493687|617025468|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
170732464|NCT01493687|617025469|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
170732465|NCT01493687|617025468|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
170732466|NCT01493687|617025469|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
170732467|NCT01493687|617025468|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
170732468|NCT01493687|617025469|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
170732469|NCT01493687|617025468|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
170732470|NCT01493687|617025469|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
170732471|NCT01493687|617025468|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
170732472|NCT01493687|617025469|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
170732473|NCT01493687|617025468|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
170732474|NCT01493687|617025469|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
170732475|NCT01493687|617025468|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
170732476|NCT01493687|617025469|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
170732477|NCT02323646|617025470|FG000|Treatment Course 1|Adverse Event|1|||
170732478|NCT02323646|617025471|FG001|Treatment Course 1|Adverse Event|0|||
170732479|NCT02323646|617025472|FG002|Treatment Course 1|Adverse Event|1|||
170732480|NCT02323646|617025470|FG000|Treatment Course 1|Heavy Bleeding|1|||
170732481|NCT02323646|617025471|FG001|Treatment Course 1|Heavy Bleeding|1|||
170732482|NCT02323646|617025472|FG002|Treatment Course 1|Heavy Bleeding|0|||
170732483|NCT02323646|617025470|FG000|Treatment Course 1|Lost to Follow-up|1|||
170732484|NCT02323646|617025471|FG001|Treatment Course 1|Lost to Follow-up|0|||
170732485|NCT02323646|617025472|FG002|Treatment Course 1|Lost to Follow-up|2|||
170732486|NCT02323646|617025470|FG000|Treatment Course 1|Withdrawal by Subject|0|||
170732487|NCT02323646|617025471|FG001|Treatment Course 1|Withdrawal by Subject|2|||
170732488|NCT02323646|617025472|FG002|Treatment Course 1|Withdrawal by Subject|0|||
170732489|NCT02323646|617025470|FG000|Treatment Course 2|Adverse Event|1|||
170732490|NCT02323646|617025471|FG001|Treatment Course 2|Adverse Event|0|||
170732491|NCT02323646|617025472|FG002|Treatment Course 2|Adverse Event|1|||
170732492|NCT02323646|617025470|FG000|Treatment Course 2|Lost to Follow-up|0|||
170732493|NCT02323646|617025471|FG001|Treatment Course 2|Lost to Follow-up|0|||
170732494|NCT02323646|617025472|FG002|Treatment Course 2|Lost to Follow-up|1|||
170732495|NCT02323646|617025470|FG000|Treatment Course 2|Non-compliance|0|||
170732496|NCT02323646|617025471|FG001|Treatment Course 2|Non-compliance|1|||
170732497|NCT02323646|617025472|FG002|Treatment Course 2|Non-compliance|1|||
170732498|NCT00521144|617025473|FG000|Overall Study|Not Treated|0|||
170732499|NCT00521144|617025474|FG001|Overall Study|Not Treated|0|||
170732500|NCT00521144|617025475|FG002|Overall Study|Not Treated|0|||
170732501|NCT00521144|617025476|FG003|Overall Study|Not Treated|1|||
170732502|NCT00521144|617025477|FG004|Overall Study|Not Treated|0|||
170732503|NCT00521144|617025473|FG000|Overall Study|Adverse Event|0|||
170732504|NCT00521144|617025474|FG001|Overall Study|Adverse Event|1|||
170732505|NCT00521144|617025475|FG002|Overall Study|Adverse Event|0|||
170732506|NCT00521144|617025476|FG003|Overall Study|Adverse Event|0|||
170732507|NCT00521144|617025477|FG004|Overall Study|Adverse Event|1|||
170732508|NCT00521144|617025473|FG000|Overall Study|Progressive Disease|4|||
170732509|NCT00521144|617025474|FG001|Overall Study|Progressive Disease|2|||
170732510|NCT00521144|617025475|FG002|Overall Study|Progressive Disease|2|||
170732511|NCT00521144|617025476|FG003|Overall Study|Progressive Disease|0|||
170732512|NCT00521144|617025477|FG004|Overall Study|Progressive Disease|6|||
170732513|NCT01370525|617025478|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
170732514|NCT01370525|617025479|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
170732515|NCT01370525|617025478|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
170732516|NCT01370525|617025479|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170732517|NCT01370525|617025478|FG000|Overall Study|Adverse Event|0|||
170732518|NCT01370525|617025479|FG001|Overall Study|Adverse Event|1|||
170732519|NCT01370525|617025478|FG000|Overall Study|Protocol Violation|2|||
170732520|NCT01370525|617025479|FG001|Overall Study|Protocol Violation|1|||
170732521|NCT01370525|617025478|FG000|Overall Study|Lost to follow up|2|||
170732522|NCT01370525|617025479|FG001|Overall Study|Lost to follow up|6|||
170840396|NCT05131477|617423754|FG012|PART 1|Withdrawal by Subject|0|||
170840397|NCT05131477|617423755|FG013|PART 1|Withdrawal by Subject|0|||
170840398|NCT05131477|617423742|FG000|PART 1|Physician Decision|1|||
170840399|NCT05131477|617423743|FG001|PART 1|Physician Decision|0|||
170840400|NCT05131477|617423744|FG002|PART 1|Physician Decision|0|||
170840401|NCT05131477|617423745|FG003|PART 1|Physician Decision|0|||
170840402|NCT05131477|617423746|FG004|PART 1|Physician Decision|0|||
170840403|NCT05131477|617423747|FG005|PART 1|Physician Decision|0|||
170840404|NCT05131477|617423748|FG006|PART 1|Physician Decision|0|||
170840405|NCT05131477|617423749|FG007|PART 1|Physician Decision|0|||
170840406|NCT05131477|617423750|FG008|PART 1|Physician Decision|0|||
170840407|NCT05131477|617423751|FG009|PART 1|Physician Decision|0|||
170840408|NCT05131477|617423752|FG010|PART 1|Physician Decision|0|||
170840409|NCT05131477|617423753|FG011|PART 1|Physician Decision|0|||
170840410|NCT05131477|617423754|FG012|PART 1|Physician Decision|0|||
170840411|NCT05131477|617423755|FG013|PART 1|Physician Decision|0|||
170840412|NCT05131477|617423742|FG000|PART 1|Adverse Event|3|||
170840413|NCT05131477|617423743|FG001|PART 1|Adverse Event|5|||
170840414|NCT05131477|617423744|FG002|PART 1|Adverse Event|1|||
170840415|NCT05131477|617423745|FG003|PART 1|Adverse Event|6|||
170840416|NCT05131477|617423746|FG004|PART 1|Adverse Event|4|||
170840417|NCT05131477|617423747|FG005|PART 1|Adverse Event|0|||
170840418|NCT05131477|617423748|FG006|PART 1|Adverse Event|0|||
170840419|NCT05131477|617423749|FG007|PART 1|Adverse Event|0|||
170840420|NCT05131477|617423750|FG008|PART 1|Adverse Event|0|||
170840421|NCT05131477|617423751|FG009|PART 1|Adverse Event|0|||
170840422|NCT05131477|617423752|FG010|PART 1|Adverse Event|0|||
170840423|NCT05131477|617423753|FG011|PART 1|Adverse Event|0|||
170840424|NCT05131477|617423754|FG012|PART 1|Adverse Event|0|||
170840425|NCT05131477|617423755|FG013|PART 1|Adverse Event|0|||
170840426|NCT05131477|617423742|FG000|PART 1|unclassified|1|||
170840427|NCT05131477|617423743|FG001|PART 1|unclassified|1|||
170840428|NCT05131477|617423744|FG002|PART 1|unclassified|0|||
170840429|NCT05131477|617423745|FG003|PART 1|unclassified|0|||
170840430|NCT05131477|617423746|FG004|PART 1|unclassified|4|||
170840431|NCT05131477|617423747|FG005|PART 1|unclassified|0|||
170840432|NCT05131477|617423748|FG006|PART 1|unclassified|0|||
170840433|NCT05131477|617423749|FG007|PART 1|unclassified|0|||
170840434|NCT05131477|617423750|FG008|PART 1|unclassified|0|||
170840435|NCT05131477|617423751|FG009|PART 1|unclassified|0|||
170840436|NCT05131477|617423752|FG010|PART 1|unclassified|0|||
170840437|NCT05131477|617423753|FG011|PART 1|unclassified|0|||
170840438|NCT05131477|617423754|FG012|PART 1|unclassified|0|||
170840439|NCT05131477|617423755|FG013|PART 1|unclassified|0|||
170840440|NCT05131477|617423742|FG000|PART 1|Randomized and not treated|0|||
170840441|NCT05131477|617423743|FG001|PART 1|Randomized and not treated|0|||
170840442|NCT05131477|617423744|FG002|PART 1|Randomized and not treated|0|||
170840443|NCT05131477|617423745|FG003|PART 1|Randomized and not treated|1|||
170840444|NCT05131477|617423746|FG004|PART 1|Randomized and not treated|1|||
170840445|NCT05131477|617423747|FG005|PART 1|Randomized and not treated|0|||
170840446|NCT05131477|617423748|FG006|PART 1|Randomized and not treated|0|||
170840447|NCT05131477|617423749|FG007|PART 1|Randomized and not treated|0|||
170840448|NCT05131477|617423750|FG008|PART 1|Randomized and not treated|0|||
170840449|NCT05131477|617423751|FG009|PART 1|Randomized and not treated|0|||
170840450|NCT05131477|617423752|FG010|PART 1|Randomized and not treated|0|||
170840451|NCT05131477|617423753|FG011|PART 1|Randomized and not treated|0|||
170840452|NCT05131477|617423754|FG012|PART 1|Randomized and not treated|0|||
170840453|NCT05131477|617423755|FG013|PART 1|Randomized and not treated|0|||
170840454|NCT05131477|617423742|FG000|PART 1|Protocol Violation|2|||
170840455|NCT05131477|617423743|FG001|PART 1|Protocol Violation|0|||
170840456|NCT05131477|617423744|FG002|PART 1|Protocol Violation|0|||
170840457|NCT05131477|617423745|FG003|PART 1|Protocol Violation|1|||
170840458|NCT05131477|617423746|FG004|PART 1|Protocol Violation|0|||
170840459|NCT05131477|617423747|FG005|PART 1|Protocol Violation|0|||
170840460|NCT05131477|617423748|FG006|PART 1|Protocol Violation|0|||
170840461|NCT05131477|617423749|FG007|PART 1|Protocol Violation|0|||
170840462|NCT05131477|617423750|FG008|PART 1|Protocol Violation|0|||
170840463|NCT05131477|617423751|FG009|PART 1|Protocol Violation|0|||
170840464|NCT05131477|617423752|FG010|PART 1|Protocol Violation|0|||
170840465|NCT05131477|617423753|FG011|PART 1|Protocol Violation|0|||
170840466|NCT05131477|617423754|FG012|PART 1|Protocol Violation|0|||
170840467|NCT05131477|617423755|FG013|PART 1|Protocol Violation|0|||
170840468|NCT05131477|617423742|FG000|PART 1|Lack of Efficacy|0|||
170840469|NCT05131477|617423743|FG001|PART 1|Lack of Efficacy|1|||
170840470|NCT05131477|617423744|FG002|PART 1|Lack of Efficacy|1|||
170840471|NCT05131477|617423745|FG003|PART 1|Lack of Efficacy|2|||
170840472|NCT05131477|617423746|FG004|PART 1|Lack of Efficacy|5|||
170840473|NCT05131477|617423747|FG005|PART 1|Lack of Efficacy|0|||
170840474|NCT05131477|617423748|FG006|PART 1|Lack of Efficacy|0|||
170840475|NCT05131477|617423749|FG007|PART 1|Lack of Efficacy|0|||
170840476|NCT05131477|617423750|FG008|PART 1|Lack of Efficacy|0|||
170840477|NCT05131477|617423751|FG009|PART 1|Lack of Efficacy|0|||
170840478|NCT05131477|617423752|FG010|PART 1|Lack of Efficacy|0|||
170732523|NCT00089141|617025481|FG000|Overall Study|Termination of trial|18|||
170732524|NCT00089141|617025482|FG001|Overall Study|Termination of trial|24|||
170732525|NCT00508261|617025485|FG000|Overall Study|Other|0|||
170732526|NCT00508261|617025486|FG001|Overall Study|Other|1|||
170732527|NCT00508261|617025487|FG002|Overall Study|Other|1|||
170732528|NCT00508261|617025488|FG003|Overall Study|Other|0|||
170732529|NCT00508261|617025485|FG000|Overall Study|Serious Adverse Event|0|||
170732530|NCT00508261|617025486|FG001|Overall Study|Serious Adverse Event|1|||
170732531|NCT00508261|617025487|FG002|Overall Study|Serious Adverse Event|0|||
170732532|NCT00508261|617025488|FG003|Overall Study|Serious Adverse Event|0|||
170732533|NCT00508261|617025485|FG000|Overall Study|Withdrawal by Subject|3|||
170732534|NCT00508261|617025486|FG001|Overall Study|Withdrawal by Subject|4|||
170732535|NCT00508261|617025487|FG002|Overall Study|Withdrawal by Subject|4|||
170732536|NCT00508261|617025488|FG003|Overall Study|Withdrawal by Subject|0|||
170732537|NCT00508261|617025485|FG000|Overall Study|Migrated/ moved from study area|0|||
170732538|NCT00508261|617025486|FG001|Overall Study|Migrated/ moved from study area|1|||
170732539|NCT00508261|617025487|FG002|Overall Study|Migrated/ moved from study area|0|||
170732540|NCT00508261|617025488|FG003|Overall Study|Migrated/ moved from study area|0|||
170732541|NCT00508261|617025485|FG000|Overall Study|Lost to Follow-up|0|||
170732542|NCT00508261|617025486|FG001|Overall Study|Lost to Follow-up|1|||
170732543|NCT00508261|617025487|FG002|Overall Study|Lost to Follow-up|1|||
170732544|NCT00508261|617025488|FG003|Overall Study|Lost to Follow-up|1|||
170732545|NCT00180479|617025489|FG000|Overall Study|Death|4|||
170732546|NCT00180479|617025490|FG001|Overall Study|Death|2|||
170732547|NCT00180479|617025489|FG000|Overall Study|Lost to Follow-up|9|||
170732548|NCT00180479|617025490|FG001|Overall Study|Lost to Follow-up|7|||
170732549|NCT00180479|617025489|FG000|Overall Study|Withdrawal by Subject|3|||
170732550|NCT00180479|617025490|FG001|Overall Study|Withdrawal by Subject|3|||
170732551|NCT00180479|617025489|FG000|Overall Study|Informed consent not signed|0|||
170732552|NCT00180479|617025490|FG001|Overall Study|Informed consent not signed|1|||
170732553|NCT03315143|617025491|FG000|Overall Study|Death|240|||
170732554|NCT03315143|617025492|FG001|Overall Study|Death|246|||
170732555|NCT03315143|617025491|FG000|Overall Study|Withdrawal by Subject|57|||
170732556|NCT03315143|617025492|FG001|Overall Study|Withdrawal by Subject|68|||
170732557|NCT03315143|617025491|FG000|Overall Study|Site Terminated by Sponsor|256|||
170732558|NCT03315143|617025492|FG001|Overall Study|Site Terminated by Sponsor|282|||
170732559|NCT03315143|617025491|FG000|Overall Study|Study Terminated by Sponsor|4723|||
170732560|NCT03315143|617025492|FG001|Overall Study|Study Terminated by Sponsor|4664|||
170732561|NCT03315143|617025491|FG000|Overall Study|Reason not Specified|16|||
170732562|NCT03315143|617025492|FG001|Overall Study|Reason not Specified|32|||
170732563|NCT02459262|617025497|FG000|Overall Study|Withdrawal by Subject|0|||
170732564|NCT02459262|617025498|FG001|Overall Study|Withdrawal by Subject|0|||
170732565|NCT02459262|617025499|FG002|Overall Study|Withdrawal by Subject|0|||
170732566|NCT02459262|617025500|FG003|Overall Study|Withdrawal by Subject|0|||
170732567|NCT02459262|617025501|FG004|Overall Study|Withdrawal by Subject|0|||
170732568|NCT02459262|617025502|FG005|Overall Study|Withdrawal by Subject|0|||
170732569|NCT02459262|617025503|FG006|Overall Study|Withdrawal by Subject|0|||
170732570|NCT02459262|617025504|FG007|Overall Study|Withdrawal by Subject|0|||
170732571|NCT02459262|617025505|FG008|Overall Study|Withdrawal by Subject|0|||
170732572|NCT02459262|617025506|FG009|Overall Study|Withdrawal by Subject|1|||
170732573|NCT02459262|617025507|FG010|Overall Study|Withdrawal by Subject|0|||
170732574|NCT01649232|617025509|FG000|Overall Study|Physician Decision|2|||
170732575|NCT01649232|617025510|FG001|Overall Study|Physician Decision|0|||
170732576|NCT02691182|617025511|FG000|Overall Study|Withdrawal by Subject|4|||
170732577|NCT02691182|617025512|FG001|Overall Study|Withdrawal by Subject|7|||
170732578|NCT02691182|617025513|FG002|Overall Study|Withdrawal by Subject|6|||
170732579|NCT02691182|617025514|FG003|Overall Study|Withdrawal by Subject|8|||
170732580|NCT02691182|617025511|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
170732581|NCT02691182|617025512|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
170732582|NCT02691182|617025513|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
170732583|NCT02691182|617025514|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
170732584|NCT02691182|617025511|FG000|Overall Study|Lost to Follow-up|8|||
170732585|NCT02691182|617025512|FG001|Overall Study|Lost to Follow-up|33|||
170732586|NCT02691182|617025513|FG002|Overall Study|Lost to Follow-up|19|||
170732587|NCT02691182|617025514|FG003|Overall Study|Lost to Follow-up|22|||
170732588|NCT02691182|617025511|FG000|Overall Study|Adverse Event|3|||
170732589|NCT02691182|617025512|FG001|Overall Study|Adverse Event|10|||
170732590|NCT02691182|617025513|FG002|Overall Study|Adverse Event|10|||
170732591|NCT02691182|617025514|FG003|Overall Study|Adverse Event|11|||
170732592|NCT02691182|617025511|FG000|Overall Study|Physician Decision|3|||
170732593|NCT02691182|617025512|FG001|Overall Study|Physician Decision|7|||
170732594|NCT02691182|617025513|FG002|Overall Study|Physician Decision|14|||
170732595|NCT02691182|617025514|FG003|Overall Study|Physician Decision|8|||
170732596|NCT02691182|617025511|FG000|Overall Study|Lack of Efficacy|0|||
170732597|NCT02691182|617025512|FG001|Overall Study|Lack of Efficacy|0|||
170732598|NCT02691182|617025513|FG002|Overall Study|Lack of Efficacy|0|||
170732599|NCT02691182|617025514|FG003|Overall Study|Lack of Efficacy|4|||
170732600|NCT02691182|617025511|FG000|Overall Study|Protocol Violation|2|||
170840479|NCT05131477|617423753|FG011|PART 1|Lack of Efficacy|0|||
170840480|NCT05131477|617423754|FG012|PART 1|Lack of Efficacy|0|||
170840481|NCT05131477|617423755|FG013|PART 1|Lack of Efficacy|0|||
170840482|NCT05131477|617423742|FG000|PART 2|Withdrawal by Subject|0|||
170840483|NCT05131477|617423743|FG001|PART 2|Withdrawal by Subject|0|||
170840484|NCT05131477|617423744|FG002|PART 2|Withdrawal by Subject|0|||
170840485|NCT05131477|617423745|FG003|PART 2|Withdrawal by Subject|0|||
170840486|NCT05131477|617423746|FG004|PART 2|Withdrawal by Subject|0|||
170840487|NCT05131477|617423747|FG005|PART 2|Withdrawal by Subject|0|||
170840488|NCT05131477|617423748|FG006|PART 2|Withdrawal by Subject|2|||
170840489|NCT05131477|617423749|FG007|PART 2|Withdrawal by Subject|0|||
170840490|NCT05131477|617423750|FG008|PART 2|Withdrawal by Subject|0|||
170840491|NCT05131477|617423751|FG009|PART 2|Withdrawal by Subject|0|||
170840492|NCT05131477|617423752|FG010|PART 2|Withdrawal by Subject|2|||
170840493|NCT05131477|617423753|FG011|PART 2|Withdrawal by Subject|0|||
170840494|NCT05131477|617423754|FG012|PART 2|Withdrawal by Subject|2|||
170840495|NCT05131477|617423755|FG013|PART 2|Withdrawal by Subject|2|||
170840496|NCT05131477|617423742|FG000|PART 2|Other|0|||
170840497|NCT05131477|617423743|FG001|PART 2|Other|0|||
170840498|NCT05131477|617423744|FG002|PART 2|Other|0|||
170840499|NCT05131477|617423745|FG003|PART 2|Other|0|||
170840500|NCT05131477|617423746|FG004|PART 2|Other|0|||
170840501|NCT05131477|617423747|FG005|PART 2|Other|0|||
170840502|NCT05131477|617423748|FG006|PART 2|Other|0|||
170840503|NCT05131477|617423749|FG007|PART 2|Other|0|||
170840504|NCT05131477|617423750|FG008|PART 2|Other|1|||
170840505|NCT05131477|617423751|FG009|PART 2|Other|1|||
170840506|NCT05131477|617423752|FG010|PART 2|Other|0|||
170840507|NCT05131477|617423753|FG011|PART 2|Other|0|||
170840508|NCT05131477|617423754|FG012|PART 2|Other|1|||
170840509|NCT05131477|617423755|FG013|PART 2|Other|0|||
170840510|NCT05131477|617423742|FG000|PART 2|Lack of Efficacy|0|||
170840511|NCT05131477|617423743|FG001|PART 2|Lack of Efficacy|0|||
170840512|NCT05131477|617423744|FG002|PART 2|Lack of Efficacy|0|||
170840513|NCT05131477|617423745|FG003|PART 2|Lack of Efficacy|0|||
170840514|NCT05131477|617423746|FG004|PART 2|Lack of Efficacy|0|||
170840515|NCT05131477|617423747|FG005|PART 2|Lack of Efficacy|1|||
170840516|NCT05131477|617423748|FG006|PART 2|Lack of Efficacy|1|||
170840517|NCT05131477|617423749|FG007|PART 2|Lack of Efficacy|0|||
170840518|NCT05131477|617423750|FG008|PART 2|Lack of Efficacy|3|||
170840519|NCT05131477|617423751|FG009|PART 2|Lack of Efficacy|0|||
170840520|NCT05131477|617423752|FG010|PART 2|Lack of Efficacy|1|||
170840521|NCT05131477|617423753|FG011|PART 2|Lack of Efficacy|0|||
170840522|NCT05131477|617423754|FG012|PART 2|Lack of Efficacy|2|||
170840523|NCT05131477|617423755|FG013|PART 2|Lack of Efficacy|0|||
170840524|NCT05131477|617423742|FG000|PART 2|Unclassified|0|||
170840525|NCT05131477|617423743|FG001|PART 2|Unclassified|0|||
170840526|NCT05131477|617423744|FG002|PART 2|Unclassified|0|||
170840527|NCT05131477|617423745|FG003|PART 2|Unclassified|0|||
170840528|NCT05131477|617423746|FG004|PART 2|Unclassified|0|||
170840529|NCT05131477|617423747|FG005|PART 2|Unclassified|0|||
170840530|NCT05131477|617423748|FG006|PART 2|Unclassified|0|||
170840531|NCT05131477|617423749|FG007|PART 2|Unclassified|0|||
170840532|NCT05131477|617423750|FG008|PART 2|Unclassified|0|||
170840533|NCT05131477|617423751|FG009|PART 2|Unclassified|0|||
170840534|NCT05131477|617423752|FG010|PART 2|Unclassified|1|||
170840535|NCT05131477|617423753|FG011|PART 2|Unclassified|0|||
170840536|NCT05131477|617423754|FG012|PART 2|Unclassified|0|||
170840537|NCT05131477|617423755|FG013|PART 2|Unclassified|0|||
170840538|NCT05131477|617423742|FG000|PART 2|Re-randomized and not treated|0|||
170840539|NCT05131477|617423743|FG001|PART 2|Re-randomized and not treated|0|||
170840540|NCT05131477|617423744|FG002|PART 2|Re-randomized and not treated|0|||
170840541|NCT05131477|617423745|FG003|PART 2|Re-randomized and not treated|0|||
170840542|NCT05131477|617423746|FG004|PART 2|Re-randomized and not treated|0|||
170840543|NCT05131477|617423747|FG005|PART 2|Re-randomized and not treated|0|||
170840544|NCT05131477|617423748|FG006|PART 2|Re-randomized and not treated|0|||
170840545|NCT05131477|617423749|FG007|PART 2|Re-randomized and not treated|1|||
170840546|NCT05131477|617423750|FG008|PART 2|Re-randomized and not treated|0|||
170840547|NCT05131477|617423751|FG009|PART 2|Re-randomized and not treated|0|||
170840548|NCT05131477|617423752|FG010|PART 2|Re-randomized and not treated|1|||
170840549|NCT05131477|617423753|FG011|PART 2|Re-randomized and not treated|0|||
170840550|NCT05131477|617423754|FG012|PART 2|Re-randomized and not treated|1|||
170840551|NCT05131477|617423755|FG013|PART 2|Re-randomized and not treated|1|||
170840552|NCT02194829|617423756|FG000|Overall Study|Adverse Event|2|||
170840553|NCT02194829|617423757|FG001|Overall Study|Adverse Event|2|||
170840554|NCT02194829|617423756|FG000|Overall Study|Death|0|||
170840555|NCT02194829|617423757|FG001|Overall Study|Death|1|||
170840556|NCT02194829|617423756|FG000|Overall Study|Disease progression|0|||
170840557|NCT02194829|617423757|FG001|Overall Study|Disease progression|1|||
170840558|NCT02194829|617423756|FG000|Overall Study|Withdrawal by Subject|0|||
170840559|NCT02194829|617423757|FG001|Overall Study|Withdrawal by Subject|1|||
170840560|NCT02194829|617423756|FG000|Overall Study|Never started protocol therapy|0|||
170840561|NCT02194829|617423757|FG001|Overall Study|Never started protocol therapy|1|||
170840562|NCT04297618|617423758|FG000|Overall Study|Adverse Event|1|||
170840563|NCT04297618|617423758|FG000|Overall Study|Withdrawal by Subject|1|||
170840564|NCT04704219|617423759|FG000|Overall Study|Screen Failure|1|||
170840565|NCT04704219|617423759|FG000|Overall Study|Withdrawal by Subject|1|||
170840566|NCT04704219|617423759|FG000|Overall Study|Death|78|||
170840567|NCT04704219|617423759|FG000|Overall Study|Participants Ongoing|80|||
170840568|NCT02614183|617423760|FG000|Double Blind Treatment Phase|Adverse Event|10|||
170840569|NCT02614183|617423761|FG001|Double Blind Treatment Phase|Adverse Event|9|||
170840570|NCT02614183|617423762|FG002|Double Blind Treatment Phase|Adverse Event|7|||
170840571|NCT02614183|617423760|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
170840572|NCT02614183|617423761|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
170840573|NCT02614183|617423762|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
170840574|NCT02614183|617423760|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
170732601|NCT02691182|617025512|FG001|Overall Study|Protocol Violation|6|||
170732602|NCT02691182|617025513|FG002|Overall Study|Protocol Violation|6|||
170732603|NCT02691182|617025514|FG003|Overall Study|Protocol Violation|8|||
170732604|NCT02691182|617025511|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
170732605|NCT02691182|617025512|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
170732606|NCT02691182|617025513|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
170732607|NCT02691182|617025514|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
170732608|NCT02691182|617025511|FG000|Overall Study|Missing|0|||
170732609|NCT02691182|617025512|FG001|Overall Study|Missing|5|||
170732610|NCT02691182|617025513|FG002|Overall Study|Missing|1|||
170732611|NCT02691182|617025514|FG003|Overall Study|Missing|5|||
170732612|NCT00105235|617025515|FG000|Overall Study|Death|4|||
170732613|NCT00105235|617025515|FG000|Overall Study|Physician Decision|1|||
170732614|NCT00105235|617025515|FG000|Overall Study|Withdrawal by Subject|2|||
170732615|NCT01964326|617025516|FG000|Overall Study|Adverse Event|48|||
170732616|NCT01964326|617025516|FG000|Overall Study|Death|2|||
170732617|NCT01964326|617025516|FG000|Overall Study|Protocol Violation|4|||
170732618|NCT01964326|617025516|FG000|Overall Study|Lost to Follow-up|88|||
170732619|NCT01964326|617025516|FG000|Overall Study|Withdrawal by Subject|87|||
170732620|NCT01964326|617025516|FG000|Overall Study|Pregnancy|1|||
170732621|NCT01964326|617025516|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
170732622|NCT01964326|617025516|FG000|Overall Study|Physician Decision|55|||
170732623|NCT01964326|617025516|FG000|Overall Study|Investigator Discretion|1|||
170732624|NCT01964326|617025516|FG000|Overall Study|Other|9|||
170732625|NCT01964326|617025516|FG000|Overall Study|Did not meet eligibility criteria|1|||
170732626|NCT04998604|617025517|FG000|Overall Study|Adverse Event|3|||
170732627|NCT04998604|617025518|FG001|Overall Study|Adverse Event|2|||
170732628|NCT04998604|617025517|FG000|Overall Study|Withdrawal by Subject|2|||
170732629|NCT04998604|617025518|FG001|Overall Study|Withdrawal by Subject|4|||
170732630|NCT04998604|617025517|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
170732631|NCT04998604|617025518|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
170732632|NCT03518125|617025521|FG000|Overall Study|Lost to Follow-up|0|||
170732633|NCT03518125|617025522|FG001|Overall Study|Lost to Follow-up|2|||
170732634|NCT03518125|617025523|FG002|Overall Study|Lost to Follow-up|0|||
170732635|NCT03518125|617025524|FG003|Overall Study|Lost to Follow-up|0|||
170732636|NCT03518125|617025525|FG004|Overall Study|Lost to Follow-up|3|||
170732637|NCT03518125|617025526|FG005|Overall Study|Lost to Follow-up|5|||
170732638|NCT03518125|617025521|FG000|Overall Study|Physician Decision|0|||
170732639|NCT03518125|617025522|FG001|Overall Study|Physician Decision|1|||
170732640|NCT03518125|617025523|FG002|Overall Study|Physician Decision|0|||
170732641|NCT03518125|617025524|FG003|Overall Study|Physician Decision|0|||
170732642|NCT03518125|617025525|FG004|Overall Study|Physician Decision|0|||
170732643|NCT03518125|617025526|FG005|Overall Study|Physician Decision|0|||
170732644|NCT03518125|617025521|FG000|Overall Study|Withdrawal by Subject|1|||
170732645|NCT03518125|617025522|FG001|Overall Study|Withdrawal by Subject|1|||
170732646|NCT03518125|617025523|FG002|Overall Study|Withdrawal by Subject|0|||
170732647|NCT03518125|617025524|FG003|Overall Study|Withdrawal by Subject|1|||
170732648|NCT03518125|617025525|FG004|Overall Study|Withdrawal by Subject|1|||
170732649|NCT03518125|617025526|FG005|Overall Study|Withdrawal by Subject|3|||
170732650|NCT03518125|617025521|FG000|Overall Study|Missed Day 394 Visit|1|||
170732651|NCT03518125|617025522|FG001|Overall Study|Missed Day 394 Visit|0|||
170732652|NCT03518125|617025523|FG002|Overall Study|Missed Day 394 Visit|0|||
170732653|NCT03518125|617025524|FG003|Overall Study|Missed Day 394 Visit|0|||
170732654|NCT03518125|617025525|FG004|Overall Study|Missed Day 394 Visit|0|||
170732655|NCT03518125|617025526|FG005|Overall Study|Missed Day 394 Visit|0|||
170732656|NCT03286751|617025527|FG000|Washout Period 1|Withdrawal by Subject|0|||
170732657|NCT03286751|617025528|FG001|Washout Period 1|Withdrawal by Subject|0|||
170732658|NCT03286751|617025529|FG002|Washout Period 1|Withdrawal by Subject|0|||
170732659|NCT03286751|617025530|FG003|Washout Period 1|Withdrawal by Subject|0|||
170732660|NCT03286751|617025531|FG004|Washout Period 1|Withdrawal by Subject|1|||
170732661|NCT03286751|617025532|FG005|Washout Period 1|Withdrawal by Subject|0|||
170732662|NCT03286751|617025527|FG000|Washout Period 2|Personal Reasons|0|||
170732663|NCT03286751|617025528|FG001|Washout Period 2|Personal Reasons|1|||
170732664|NCT03286751|617025529|FG002|Washout Period 2|Personal Reasons|0|||
170732665|NCT03286751|617025530|FG003|Washout Period 2|Personal Reasons|0|||
170732666|NCT03286751|617025531|FG004|Washout Period 2|Personal Reasons|0|||
170732667|NCT03286751|617025532|FG005|Washout Period 2|Personal Reasons|0|||
170732668|NCT03286751|617025527|FG000|Washout Period 5|Adverse Event|0|||
170732669|NCT03286751|617025528|FG001|Washout Period 5|Adverse Event|0|||
170732670|NCT03286751|617025529|FG002|Washout Period 5|Adverse Event|0|||
170732671|NCT03286751|617025530|FG003|Washout Period 5|Adverse Event|0|||
170732672|NCT03286751|617025531|FG004|Washout Period 5|Adverse Event|1|||
170732673|NCT03286751|617025532|FG005|Washout Period 5|Adverse Event|0|||
170732674|NCT01301391|617025533|FG000|Overall Study|Death|13|||
170732675|NCT01301391|617025533|FG000|Overall Study|Lost to Follow-up|3|||
170732676|NCT01301391|617025533|FG000|Overall Study|Physician Decision|2|||
170732677|NCT01301391|617025533|FG000|Overall Study|Sponsor's decision|8|||
170732678|NCT01059643|617025534|FG000|Overall Study|Adverse Event|3|||
170732679|NCT01059643|617025534|FG000|Overall Study|Withdrawal by Subject|2|||
170732680|NCT01059643|617025534|FG000|Overall Study|Physician Decision|1|||
170732681|NCT00454571|617025546|FG000|Overall Study|Adverse Event|2|||
170732682|NCT00454571|617025547|FG001|Overall Study|Adverse Event|0|||
170732683|NCT00454571|617025546|FG000|Overall Study|Physician Decision|0|||
170732684|NCT00454571|617025547|FG001|Overall Study|Physician Decision|1|||
170732685|NCT00454571|617025546|FG000|Overall Study|Protocol Violation|1|||
170732686|NCT00454571|617025547|FG001|Overall Study|Protocol Violation|0|||
170732687|NCT00454571|617025546|FG000|Overall Study|Withdrawal by Subject|10|||
170732688|NCT00454571|617025547|FG001|Overall Study|Withdrawal by Subject|5|||
170732689|NCT04209725|617025548|FG000|Overall Study|Adverse Event|1|||
170732690|NCT03172702|617025553|FG000|Overall Study|Adverse Event|9|||
170732691|NCT03172702|617025553|FG000|Overall Study|Death|2|||
170732692|NCT03172702|617025553|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
170732693|NCT03172702|617025553|FG000|Overall Study|Withdrawal by Subject|5|||
170732694|NCT03172702|617025553|FG000|Overall Study|Other|2|||
170732695|NCT05608499|617025571|FG000|Overall Study|Lack of Efficacy|1|||
170732696|NCT05608499|617025572|FG001|Overall Study|Lack of Efficacy|0|||
170732697|NCT05608499|617025571|FG000|Overall Study|Lost to Follow-up|0|||
170840575|NCT02614183|617423761|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
170840576|NCT02614183|617423762|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
170840577|NCT02614183|617423760|FG000|Double Blind Treatment Phase|Physician Decision|7|||
170840578|NCT02614183|617423761|FG001|Double Blind Treatment Phase|Physician Decision|3|||
170840579|NCT02614183|617423762|FG002|Double Blind Treatment Phase|Physician Decision|2|||
170840580|NCT02614183|617423760|FG000|Double Blind Treatment Phase|Pregnancy|2|||
170840581|NCT02614183|617423761|FG001|Double Blind Treatment Phase|Pregnancy|1|||
170840582|NCT02614183|617423762|FG002|Double Blind Treatment Phase|Pregnancy|3|||
170840583|NCT02614183|617423760|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
170840584|NCT02614183|617423761|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
170840585|NCT02614183|617423762|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
170840586|NCT02614183|617423760|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
170840587|NCT02614183|617423761|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
170840588|NCT02614183|617423762|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
170840589|NCT02614183|617423760|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
170840590|NCT02614183|617423761|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
170840591|NCT02614183|617423762|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
170840592|NCT02614183|617423760|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
170840593|NCT02614183|617423761|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
170840594|NCT02614183|617423762|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
170840595|NCT02614183|617423760|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
170840596|NCT02614183|617423761|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
170840597|NCT02614183|617423762|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
170840598|NCT02614183|617423760|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
170840599|NCT02614183|617423761|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
170840600|NCT02614183|617423762|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
170840601|NCT02614183|617423760|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
170732698|NCT05608499|617025572|FG001|Overall Study|Lost to Follow-up|1|||
170732699|NCT04393441|617025578|FG000|Overall Study|Adverse Event|0|||
170732700|NCT04393441|617025579|FG001|Overall Study|Adverse Event|3|||
170732701|NCT04393441|617025578|FG000|Overall Study|Withdrawal by Subject|5|||
170732702|NCT04393441|617025579|FG001|Overall Study|Withdrawal by Subject|7|||
170732703|NCT04393441|617025578|FG000|Overall Study|Lost to Follow-up|0|||
170732704|NCT04393441|617025579|FG001|Overall Study|Lost to Follow-up|2|||
170732705|NCT04393441|617025578|FG000|Overall Study|Protocol Deviation|2|||
170732706|NCT04393441|617025579|FG001|Overall Study|Protocol Deviation|1|||
170732707|NCT04393441|617025578|FG000|Overall Study|Reason not Specified|1|||
170732708|NCT04393441|617025579|FG001|Overall Study|Reason not Specified|1|||
170732709|NCT02660827|617025584|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
170840602|NCT02614183|617423761|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
170840603|NCT02614183|617423762|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
170840604|NCT03939689|617425819|FG000|Overall Study|Radiographic progression|14|||
170840605|NCT03939689|617425820|FG001|Overall Study|Radiographic progression|17|||
170840606|NCT03939689|617425819|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
170732710|NCT02660827|617025584|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
170732711|NCT02660827|617025584|FG000|From Study to End of Continued Access|Adverse Event|3|||
170732712|NCT02660827|617025584|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
170732713|NCT02660827|617025584|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
170732714|NCT02660827|617025584|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
170732715|NCT02660827|617025584|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
170732716|NCT02660827|617025584|FG000|Period 2: Continued Access Period|Adverse Event|3|||
170732717|NCT01422408|617025585|FG000|Overall Study|Adverse Event|1|||
170732718|NCT01422408|617025585|FG000|Overall Study|Withdrawal by Subject|3|||
170732719|NCT02953938|617025586|FG000|Overall Study|Adverse Event|0|||
170732720|NCT02953938|617025587|FG001|Overall Study|Adverse Event|1|||
170732721|NCT02953938|617025586|FG000|Overall Study|Withdrawal by Subject|1|||
170732722|NCT02953938|617025587|FG001|Overall Study|Withdrawal by Subject|1|||
170732723|NCT00724152|617025588|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
170732724|NCT00724152|617025589|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
170732725|NCT00724152|617025590|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
170732726|NCT00724152|617025588|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
170732727|NCT00724152|617025589|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
170732728|NCT00724152|617025590|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
170732729|NCT01328080|617025594|FG000|Overall Study|Lost to Follow-up|5|||
170732730|NCT01936857|617025595|FG000|Overall Study|Sent to prison or 06 center|11|||
170732731|NCT01936857|617025596|FG001|Overall Study|Sent to prison or 06 center|12|||
170732732|NCT01936857|617025595|FG000|Overall Study|Lost to Follow-up|10|||
170732733|NCT01936857|617025596|FG001|Overall Study|Lost to Follow-up|7|||
170732734|NCT01936857|617025595|FG000|Overall Study|Death|7|||
170732735|NCT01936857|617025596|FG001|Overall Study|Death|3|||
170732736|NCT01936857|617025595|FG000|Overall Study|Moved|2|||
170732737|NCT01936857|617025596|FG001|Overall Study|Moved|1|||
170732738|NCT01936857|617025595|FG000|Overall Study|Withdrawal by Subject|1|||
170732739|NCT01936857|617025596|FG001|Overall Study|Withdrawal by Subject|0|||
170732740|NCT01936857|617025595|FG000|Overall Study|Side effect of medication|1|||
170732741|NCT01936857|617025596|FG001|Overall Study|Side effect of medication|0|||
170732742|NCT01936857|617025595|FG000|Overall Study|Other|2|||
170732743|NCT01936857|617025596|FG001|Overall Study|Other|2|||
170732744|NCT02279043|617025597|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
170732745|NCT02279043|617025598|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
170732746|NCT02279043|617025599|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
170732747|NCT02279043|617025597|FG000|Overall Study|Lost to Follow-up|46|||
170732748|NCT02279043|617025598|FG001|Overall Study|Lost to Follow-up|88|||
170732749|NCT02279043|617025599|FG002|Overall Study|Lost to Follow-up|0|||
170732750|NCT00168038|617025600|FG000|Overall Study|Adverse Event|1|||
170732751|NCT00168038|617025600|FG000|Overall Study|Therapy failure|1|||
170732752|NCT00810264|617025606|FG000|Overall Study|Lost to Follow-up|191|||
170732753|NCT00810264|617025606|FG000|Overall Study|Withdrawal by subject or physician|721|||
170732754|NCT00810264|617025606|FG000|Overall Study|Death|641|||
170732755|NCT00313820|617025617|FG000|Assigned to Treatment|Other|1|||
170732756|NCT00313820|617025618|FG001|Assigned to Treatment|Other|0|||
170732757|NCT00313820|617025617|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
170732758|NCT00313820|617025618|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
170732759|NCT00313820|617025617|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
170732760|NCT00313820|617025618|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
170732761|NCT00313820|617025617|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
170732762|NCT00313820|617025618|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
170732763|NCT00313820|617025617|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
170732764|NCT00313820|617025618|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
170732765|NCT00313820|617025617|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
170732766|NCT00313820|617025618|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
170732767|NCT02778100|617025621|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
170732768|NCT02778100|617025622|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
170732769|NCT04102579|617025625|FG000|Overall Study|Withdrawal by Subject|3|||
170732770|NCT04102579|617025626|FG001|Overall Study|Withdrawal by Subject|4|||
170732771|NCT04102579|617025625|FG000|Overall Study|Lost to Follow-up|0|||
170732772|NCT04102579|617025626|FG001|Overall Study|Lost to Follow-up|1|||
170732773|NCT04102579|617025625|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
170732774|NCT04102579|617025626|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
170732775|NCT04102579|617025625|FG000|Overall Study|Other than Specified|1|||
170732776|NCT04102579|617025626|FG001|Overall Study|Other than Specified|0|||
170732777|NCT04102579|617025625|FG000|Overall Study|Not Dosed with Study Drug|0|||
170732778|NCT04102579|617025626|FG001|Overall Study|Not Dosed with Study Drug|1|||
170840607|NCT03939689|617425820|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
170840608|NCT03939689|617425819|FG000|Overall Study|Adverse Event|1|||
170840609|NCT03939689|617425820|FG001|Overall Study|Adverse Event|8|||
170732779|NCT03559218|617027452|FG000|Overall Study|Withdrawal by Subject|1|||
170732780|NCT03559218|617027453|FG001|Overall Study|Withdrawal by Subject|0|||
170840610|NCT03939689|617425819|FG000|Overall Study|Unequivocal clinical progression|2|||
170840611|NCT03939689|617425820|FG001|Overall Study|Unequivocal clinical progression|5|||
170840612|NCT03939689|617425819|FG000|Overall Study|Other|1|||
170840613|NCT03939689|617425820|FG001|Overall Study|Other|4|||
170840614|NCT03939689|617425819|FG000|Overall Study|Death|0|||
170732781|NCT03328143|617027455|FG000|Overall Study|Declined|3|||
170732782|NCT03328143|617027455|FG000|Overall Study|Required increased sedation|4|||
170732783|NCT03328143|617027455|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
170732784|NCT03328143|617027455|FG000|Overall Study|Surgery cancelled|1|||
170732785|NCT05168579|617027459|FG000|Overall Study|Lack of Consent|1|||
170732786|NCT05168579|617027460|FG001|Overall Study|Lack of Consent|0|||
170732787|NCT05168579|617027459|FG000|Overall Study|Conflicts with time|2|||
170732788|NCT05168579|617027460|FG001|Overall Study|Conflicts with time|0|||
170732789|NCT05168579|617027459|FG000|Overall Study|Time slots were full|3|||
170732790|NCT05168579|617027460|FG001|Overall Study|Time slots were full|0|||
170732791|NCT05168579|617027459|FG000|Overall Study|Lost to Follow-up|0|||
170732792|NCT05168579|617027460|FG001|Overall Study|Lost to Follow-up|15|||
170732793|NCT01564368|617027461|FG000|Overall Study|Ineligible|18|||
170732794|NCT01564368|617027461|FG000|Overall Study|Not Randomized in Parent study|116|||
170732795|NCT01564368|617027461|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
170732796|NCT01564368|617027461|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
170732797|NCT00387894|617027462|FG000|Overall Study|Withdrawal by Subject|1|||
170732798|NCT00659490|617027465|FG000|Overall Study|Lost to Follow-up|2|||
170732799|NCT00659490|617027466|FG001|Overall Study|Lost to Follow-up|0|||
170732800|NCT00659490|617027467|FG002|Overall Study|Lost to Follow-up|1|||
170732801|NCT00827541|617027468|FG000|Overall Study|Exitus|1|||
170732802|NCT00827541|617027469|FG001|Overall Study|Exitus|8|||
170732803|NCT00827541|617027468|FG000|Overall Study|Other|1|||
170732804|NCT00827541|617027469|FG001|Overall Study|Other|3|||
170732805|NCT00827541|617027468|FG000|Overall Study|Pathogen not susceptible|1|||
170732806|NCT00827541|617027469|FG001|Overall Study|Pathogen not susceptible|0|||
170732807|NCT00827541|617027468|FG000|Overall Study|Lack of effectiveness|1|||
170732808|NCT00827541|617027469|FG001|Overall Study|Lack of effectiveness|0|||
170732809|NCT01750879|617027470|FG000|Overall Study|Adverse Event|8|||
170732810|NCT01750879|617027471|FG001|Overall Study|Adverse Event|0|||
170732811|NCT01750879|617027470|FG000|Overall Study|Lack of Efficacy|1|||
170732812|NCT01750879|617027471|FG001|Overall Study|Lack of Efficacy|0|||
170732813|NCT01750879|617027470|FG000|Overall Study|Withdrawal by Subject|1|||
170732814|NCT01750879|617027471|FG001|Overall Study|Withdrawal by Subject|0|||
170732815|NCT01750879|617027470|FG000|Overall Study|Did not complete per protocol|0|||
170732816|NCT01750879|617027471|FG001|Overall Study|Did not complete per protocol|3|||
170732817|NCT02421666|617027472|FG000|6-month Follow-up|Lost to Follow-up|8|||
170732818|NCT02421666|617027473|FG001|6-month Follow-up|Lost to Follow-up|7|||
170732819|NCT02421666|617027472|FG000|6-month Follow-up|Withdrawal by Subject|5|||
170732820|NCT02421666|617027473|FG001|6-month Follow-up|Withdrawal by Subject|6|||
170732821|NCT02421666|617027472|FG000|12-month Follow-up|Lost to Follow-up|5|||
170732822|NCT02421666|617027473|FG001|12-month Follow-up|Lost to Follow-up|5|||
170732823|NCT02421666|617027472|FG000|12-month Follow-up|Withdrawal by Subject|6|||
170732824|NCT02421666|617027473|FG001|12-month Follow-up|Withdrawal by Subject|11|||
170732825|NCT01181726|617027474|FG000|First Intervention|Adverse Event|1|||
170732826|NCT01181726|617027475|FG001|First Intervention|Adverse Event|0|||
170732827|NCT01264380|617027476|FG000|Period C|Disease Progression|0|||
170732828|NCT01264380|617027477|FG001|Period C|Disease Progression|0|||
170732829|NCT01264380|617027478|FG002|Period C|Disease Progression|4|||
170732830|NCT01264380|617027476|FG000|Period C|Death|0|||
170732831|NCT01264380|617027477|FG001|Period C|Death|0|||
170732832|NCT01264380|617027478|FG002|Period C|Death|2|||
170732833|NCT01264380|617027476|FG000|Period C|Follow-up for survival status|0|||
170732834|NCT01264380|617027477|FG001|Period C|Follow-up for survival status|0|||
170732835|NCT01264380|617027478|FG002|Period C|Follow-up for survival status|6|||
170732836|NCT01264380|617027476|FG000|Period C|Withdrawal by Subject|0|||
170732837|NCT01264380|617027477|FG001|Period C|Withdrawal by Subject|0|||
170732838|NCT01264380|617027478|FG002|Period C|Withdrawal by Subject|1|||
170840615|NCT03939689|617425820|FG001|Overall Study|Death|3|||
170732839|NCT01264380|617027476|FG000|Period C|Adverse Event|0|||
170840616|NCT03939689|617425819|FG000|Overall Study|Participant decision|0|||
170732840|NCT01264380|617027477|FG001|Period C|Adverse Event|0|||
170732841|NCT01264380|617027478|FG002|Period C|Adverse Event|1|||
170732842|NCT01119768|617027484|FG000|Treatment Period|Lack of Efficacy|18|||
170732843|NCT01119768|617027485|FG001|Treatment Period|Lack of Efficacy|25|||
170732844|NCT00677352|617027497|FG000|Treatment Phase|Adverse Event|14|||
170732845|NCT00677352|617027498|FG001|Treatment Phase|Adverse Event|22|||
170732846|NCT00677352|617027497|FG000|Treatment Phase|Lack of Efficacy|2|||
170732847|NCT00677352|617027498|FG001|Treatment Phase|Lack of Efficacy|3|||
170732848|NCT00677352|617027497|FG000|Treatment Phase|Lost to Follow-up|0|||
170732849|NCT00677352|617027498|FG001|Treatment Phase|Lost to Follow-up|1|||
170732850|NCT00677352|617027497|FG000|Treatment Phase|Withdrawal by Subject|7|||
170732851|NCT00677352|617027498|FG001|Treatment Phase|Withdrawal by Subject|7|||
170732852|NCT00677352|617027497|FG000|Treatment Phase|Physician Decision|1|||
170732853|NCT00677352|617027498|FG001|Treatment Phase|Physician Decision|0|||
170732854|NCT00677352|617027497|FG000|Treatment Phase|Pregnancy|0|||
170732855|NCT00677352|617027498|FG001|Treatment Phase|Pregnancy|1|||
170732856|NCT00677352|617027497|FG000|Treatment Phase|Protocol Violation|1|||
170732857|NCT00677352|617027498|FG001|Treatment Phase|Protocol Violation|1|||
170732858|NCT00677352|617027497|FG000|Treatment Phase|Transference or work related matter|0|||
170732859|NCT00677352|617027498|FG001|Treatment Phase|Transference or work related matter|5|||
170732860|NCT00677352|617027497|FG000|Treatment Phase|Not treated|0|||
170732861|NCT00677352|617027498|FG001|Treatment Phase|Not treated|2|||
170732862|NCT00677352|617027497|FG000|Tapering Phase|Adverse Event|1|||
170732863|NCT00677352|617027498|FG001|Tapering Phase|Adverse Event|5|||
170732864|NCT00677352|617027497|FG000|Tapering Phase|Withdrawal by Subject|5|||
170732865|NCT00677352|617027498|FG001|Tapering Phase|Withdrawal by Subject|3|||
170732866|NCT00677352|617027497|FG000|Tapering Phase|Pregnancy|0|||
170732867|NCT00677352|617027498|FG001|Tapering Phase|Pregnancy|1|||
170732868|NCT00677352|617027497|FG000|Tapering Phase|Job transfer|0|||
170732869|NCT00677352|617027498|FG001|Tapering Phase|Job transfer|1|||
170732870|NCT02182973|617027501|FG000|Overall Study|Withdrawal by Subject|3|||
170732871|NCT02182973|617027502|FG001|Overall Study|Withdrawal by Subject|0|||
170732872|NCT00238433|617027503|FG000|Overall Study|Screen failure|1|||
170732873|NCT00238433|617027503|FG000|Overall Study|Lost to Follow-up|1|||
170732874|NCT00238433|617027503|FG000|Overall Study|Death|1|||
170732875|NCT02740049|617027504|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
170732876|NCT01814748|617027507|FG000|Overall Study|Lost to Follow-up|1|||
170732877|NCT01814748|617027508|FG001|Overall Study|Lost to Follow-up|2|||
170732878|NCT01814748|617027507|FG000|Overall Study|Study site terminated by sponsor|1|||
170732879|NCT01814748|617027508|FG001|Overall Study|Study site terminated by sponsor|1|||
170732880|NCT01814748|617027507|FG000|Overall Study|Withdrawal by Subject|6|||
170732881|NCT01814748|617027508|FG001|Overall Study|Withdrawal by Subject|4|||
170732882|NCT04044456|617027509|FG000|Overall Study|Lost to Follow-up|4|||
170732883|NCT04044456|617027510|FG001|Overall Study|Lost to Follow-up|1|||
170732884|NCT04044456|617027509|FG000|Overall Study|Withdrawal by Subject|1|||
170732885|NCT04044456|617027510|FG001|Overall Study|Withdrawal by Subject|0|||
170732886|NCT00409682|617027516|FG000|Open-label Induction Period|Adverse Event|1|||
170732887|NCT00409682|617027517|FG001|Open-label Induction Period|Adverse Event|0|||
170732888|NCT00409682|617027518|FG002|Open-label Induction Period|Adverse Event|0|||
170732889|NCT00409682|617027516|FG000|Open-label Induction Period|Lack of Efficacy|1|||
170732890|NCT00409682|617027517|FG001|Open-label Induction Period|Lack of Efficacy|0|||
170732891|NCT00409682|617027518|FG002|Open-label Induction Period|Lack of Efficacy|0|||
170732892|NCT00409682|617027516|FG000|Open-label Induction Period|Protocol Violation|1|||
170732893|NCT00409682|617027517|FG001|Open-label Induction Period|Protocol Violation|0|||
170732894|NCT00409682|617027518|FG002|Open-label Induction Period|Protocol Violation|0|||
170732895|NCT00409682|617027516|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
170732896|NCT00409682|617027517|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
170732897|NCT00409682|617027518|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
170732898|NCT00409682|617027516|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
170732899|NCT00409682|617027517|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
170732900|NCT00409682|617027518|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
170732901|NCT00409682|617027516|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
170732902|NCT00409682|617027517|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
170732903|NCT00409682|617027518|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
170732904|NCT00409682|617027516|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
170732905|NCT00409682|617027517|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
170840617|NCT03939689|617425820|FG001|Overall Study|Participant decision|3|||
170840618|NCT03939689|617425819|FG000|Overall Study|Withdrawal of consent|2|||
170840619|NCT03939689|617425820|FG001|Overall Study|Withdrawal of consent|1|||
170840620|NCT03939689|617425819|FG000|Overall Study|Investigator decision|1|||
170732906|NCT00409682|617027518|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
170732907|NCT00409682|617027516|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
170732908|NCT00409682|617027517|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
170732909|NCT00409682|617027518|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
170840621|NCT03939689|617425820|FG001|Overall Study|Investigator decision|0|||
170840622|NCT04427280|617425821|FG000|Overall Study|Withdrawal by Subject|0|||
170732910|NCT00409682|617027516|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
170732911|NCT00409682|617027517|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
170732912|NCT00409682|617027518|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
170732913|NCT00409682|617027516|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
170732914|NCT00409682|617027517|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
170732915|NCT00409682|617027518|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
170732916|NCT01896869|617027519|FG000|Overall Study|Withdrawal by Subject|0|||
170732917|NCT01896869|617027520|FG001|Overall Study|Withdrawal by Subject|6|||
170732918|NCT01896869|617027519|FG000|Overall Study|Lost to Follow-up|1|||
170732919|NCT01896869|617027520|FG001|Overall Study|Lost to Follow-up|0|||
170732920|NCT02831257|617027522|FG000|Overall Study|Lack of Efficacy|3|||
170732921|NCT02831257|617027522|FG000|Overall Study|Adverse Event|2|||
170732922|NCT02831257|617027522|FG000|Overall Study|Physician Decision|1|||
170732923|NCT02831257|617027522|FG000|Overall Study|Withdrawal by Subject|6|||
170732924|NCT02597036|617027523|FG000|Overall Study|Progressive Disease|0|||
170732925|NCT02597036|617027524|FG001|Overall Study|Progressive Disease|0|||
170732926|NCT02597036|617027525|FG002|Overall Study|Progressive Disease|0|||
170732927|NCT02597036|617027526|FG003|Overall Study|Progressive Disease|0|||
170732928|NCT02597036|617027527|FG004|Overall Study|Progressive Disease|1|||
170732929|NCT02597036|617027528|FG005|Overall Study|Progressive Disease|1|||
170732930|NCT02597036|617027529|FG006|Overall Study|Progressive Disease|1|||
170732931|NCT02597036|617027530|FG007|Overall Study|Progressive Disease|0|||
170732932|NCT02597036|617027531|FG008|Overall Study|Progressive Disease|0|||
170732933|NCT02597036|617027532|FG009|Overall Study|Progressive Disease|0|||
170732934|NCT02597036|617027533|FG010|Overall Study|Progressive Disease|0|||
170732935|NCT02597036|617027534|FG011|Overall Study|Progressive Disease|0|||
170732936|NCT02597036|617027523|FG000|Overall Study|Adverse Event|0|||
170732937|NCT02597036|617027524|FG001|Overall Study|Adverse Event|0|||
170732938|NCT02597036|617027525|FG002|Overall Study|Adverse Event|0|||
170732939|NCT02597036|617027526|FG003|Overall Study|Adverse Event|0|||
170732940|NCT02597036|617027527|FG004|Overall Study|Adverse Event|0|||
170732941|NCT02597036|617027528|FG005|Overall Study|Adverse Event|0|||
170732942|NCT02597036|617027529|FG006|Overall Study|Adverse Event|0|||
170732943|NCT02597036|617027530|FG007|Overall Study|Adverse Event|1|||
170732944|NCT02597036|617027531|FG008|Overall Study|Adverse Event|0|||
170732945|NCT02597036|617027532|FG009|Overall Study|Adverse Event|0|||
170732946|NCT02597036|617027533|FG010|Overall Study|Adverse Event|0|||
170732947|NCT02597036|617027534|FG011|Overall Study|Adverse Event|1|||
170732948|NCT02597036|617027523|FG000|Overall Study|Death|0|||
170732949|NCT02597036|617027524|FG001|Overall Study|Death|0|||
170732950|NCT02597036|617027525|FG002|Overall Study|Death|0|||
170732951|NCT02597036|617027526|FG003|Overall Study|Death|0|||
170840623|NCT04427280|617425822|FG001|Overall Study|Withdrawal by Subject|2|||
170840624|NCT02964013|617425826|FG000|Overall Study|Death|58|||
170840625|NCT02964013|617425827|FG001|Overall Study|Death|239|||
170840626|NCT02964013|617425828|FG002|Overall Study|Death|38|||
170840627|NCT02964013|617425829|FG003|Overall Study|Death|10|||
170840628|NCT02964013|617425830|FG004|Overall Study|Death|33|||
170840629|NCT02964013|617425826|FG000|Overall Study|Lost to Follow-up|1|||
170840630|NCT02964013|617425827|FG001|Overall Study|Lost to Follow-up|4|||
170840631|NCT02964013|617425828|FG002|Overall Study|Lost to Follow-up|2|||
170840632|NCT02964013|617425829|FG003|Overall Study|Lost to Follow-up|0|||
170840633|NCT02964013|617425830|FG004|Overall Study|Lost to Follow-up|0|||
170840634|NCT02964013|617425826|FG000|Overall Study|Physician Decision|0|||
170840635|NCT02964013|617425827|FG001|Overall Study|Physician Decision|1|||
170840636|NCT02964013|617425828|FG002|Overall Study|Physician Decision|0|||
170840637|NCT02964013|617425829|FG003|Overall Study|Physician Decision|0|||
170840638|NCT02964013|617425830|FG004|Overall Study|Physician Decision|0|||
170840639|NCT02964013|617425826|FG000|Overall Study|Sponsor Decision|3|||
170840640|NCT02964013|617425827|FG001|Overall Study|Sponsor Decision|22|||
170840641|NCT02964013|617425828|FG002|Overall Study|Sponsor Decision|11|||
170840642|NCT02964013|617425829|FG003|Overall Study|Sponsor Decision|0|||
170840643|NCT02964013|617425830|FG004|Overall Study|Sponsor Decision|7|||
170840644|NCT02964013|617425826|FG000|Overall Study|Withdrawal by Subject|6|||
170840645|NCT02964013|617425827|FG001|Overall Study|Withdrawal by Subject|27|||
170840646|NCT02964013|617425828|FG002|Overall Study|Withdrawal by Subject|9|||
170840647|NCT02964013|617425829|FG003|Overall Study|Withdrawal by Subject|0|||
170840648|NCT02964013|617425830|FG004|Overall Study|Withdrawal by Subject|0|||
170840649|NCT02964013|617425826|FG000|Overall Study|Not Treated|0|||
170732952|NCT02597036|617027527|FG004|Overall Study|Death|0|||
170732953|NCT02597036|617027528|FG005|Overall Study|Death|0|||
170732954|NCT02597036|617027529|FG006|Overall Study|Death|0|||
170732955|NCT02597036|617027530|FG007|Overall Study|Death|0|||
170732956|NCT02597036|617027531|FG008|Overall Study|Death|0|||
170732957|NCT02597036|617027532|FG009|Overall Study|Death|1|||
170840650|NCT02964013|617425827|FG001|Overall Study|Not Treated|2|||
170840651|NCT02964013|617425828|FG002|Overall Study|Not Treated|0|||
170840652|NCT02964013|617425829|FG003|Overall Study|Not Treated|1|||
170840653|NCT02964013|617425830|FG004|Overall Study|Not Treated|0|||
170840654|NCT01920477|617425831|FG000|Overall Study|Adverse Event|0|||
170840655|NCT01920477|617425832|FG001|Overall Study|Adverse Event|1|||
170732958|NCT02597036|617027533|FG010|Overall Study|Death|1|||
170732959|NCT02597036|617027534|FG011|Overall Study|Death|0|||
170732960|NCT02597036|617027523|FG000|Overall Study|Lost to Follow-up|0|||
170732961|NCT02597036|617027524|FG001|Overall Study|Lost to Follow-up|0|||
170732962|NCT02597036|617027525|FG002|Overall Study|Lost to Follow-up|0|||
170732963|NCT02597036|617027526|FG003|Overall Study|Lost to Follow-up|0|||
170732964|NCT02597036|617027527|FG004|Overall Study|Lost to Follow-up|0|||
170732965|NCT02597036|617027528|FG005|Overall Study|Lost to Follow-up|0|||
170732966|NCT02597036|617027529|FG006|Overall Study|Lost to Follow-up|0|||
170732967|NCT02597036|617027530|FG007|Overall Study|Lost to Follow-up|0|||
170732968|NCT02597036|617027531|FG008|Overall Study|Lost to Follow-up|0|||
170732969|NCT02597036|617027532|FG009|Overall Study|Lost to Follow-up|0|||
170732970|NCT02597036|617027533|FG010|Overall Study|Lost to Follow-up|1|||
170732971|NCT02597036|617027534|FG011|Overall Study|Lost to Follow-up|0|||
170732972|NCT02597036|617027523|FG000|Overall Study|Withdrawal by Subject|0|||
170732973|NCT02597036|617027524|FG001|Overall Study|Withdrawal by Subject|0|||
170732974|NCT02597036|617027525|FG002|Overall Study|Withdrawal by Subject|0|||
170732975|NCT02597036|617027526|FG003|Overall Study|Withdrawal by Subject|0|||
170732976|NCT02597036|617027527|FG004|Overall Study|Withdrawal by Subject|0|||
170732977|NCT02597036|617027528|FG005|Overall Study|Withdrawal by Subject|0|||
170732978|NCT02597036|617027529|FG006|Overall Study|Withdrawal by Subject|0|||
170732979|NCT02597036|617027530|FG007|Overall Study|Withdrawal by Subject|0|||
170732980|NCT02597036|617027531|FG008|Overall Study|Withdrawal by Subject|0|||
170732981|NCT02597036|617027532|FG009|Overall Study|Withdrawal by Subject|0|||
170732982|NCT02597036|617027533|FG010|Overall Study|Withdrawal by Subject|0|||
170732983|NCT02597036|617027534|FG011|Overall Study|Withdrawal by Subject|1|||
170732984|NCT00569582|617027535|FG000|Overall Study|Withdrawal by Subject|5|||
170732985|NCT00569582|617027535|FG000|Overall Study|Death|2|||
170732986|NCT00569582|617027535|FG000|Overall Study|Adverse Event|7|||
170732987|NCT00569582|617027535|FG000|Overall Study|Subject was too ill to travel.|1|||
170732988|NCT00569582|617027535|FG000|Overall Study|Subject was non-compliant.|1|||
170732989|NCT05614089|617027539|FG000|Overall Study|Pregnancy|5|||
170732990|NCT05614089|617027540|FG001|Overall Study|Pregnancy|2|||
170732991|NCT05614089|617027539|FG000|Overall Study|Lost to Follow-up|5|||
170732992|NCT05614089|617027540|FG001|Overall Study|Lost to Follow-up|1|||
170732993|NCT05614089|617027539|FG000|Overall Study|Death|0|||
170732994|NCT05614089|617027540|FG001|Overall Study|Death|1|||
170732995|NCT05614089|617027539|FG000|Overall Study|Adverse Event|1|||
170732996|NCT05614089|617027540|FG001|Overall Study|Adverse Event|0|||
170732997|NCT05163522|617027541|FG000|Overall Study|Withdrawal by Subject|0|||
170732998|NCT05163522|617027542|FG001|Overall Study|Withdrawal by Subject|0|||
170732999|NCT05163522|617027543|FG002|Overall Study|Withdrawal by Subject|1|||
170733000|NCT05163522|617027544|FG003|Overall Study|Withdrawal by Subject|0|||
170733001|NCT05163522|617027545|FG004|Overall Study|Withdrawal by Subject|0|||
170733002|NCT05163522|617027546|FG005|Overall Study|Withdrawal by Subject|0|||
170733003|NCT05163522|617027547|FG006|Overall Study|Withdrawal by Subject|0|||
170733004|NCT05163522|617027548|FG007|Overall Study|Withdrawal by Subject|0|||
170733005|NCT05163522|617027549|FG008|Overall Study|Withdrawal by Subject|0|||
170733006|NCT05163522|617027550|FG009|Overall Study|Withdrawal by Subject|0|||
170733007|NCT05163522|617027551|FG010|Overall Study|Withdrawal by Subject|0|||
170733008|NCT02521285|617027553|FG000|Overall Study|Lost to Follow-up|1|||
170733009|NCT02521285|617027554|FG001|Overall Study|Lost to Follow-up|1|||
170733010|NCT02521285|617027553|FG000|Overall Study|Withdrawal by Subject|1|||
170733011|NCT02521285|617027554|FG001|Overall Study|Withdrawal by Subject|1|||
170733012|NCT02521285|617027553|FG000|Overall Study|Adverse Event|0|||
170733013|NCT02521285|617027554|FG001|Overall Study|Adverse Event|1|||
170733014|NCT05701995|617027556|FG000|Pre-Treatment|Randomization Error|1|||
170733015|NCT05701995|617027557|FG001|Pre-Treatment|Randomization Error|1|||
170733016|NCT05701995|617027556|FG000|Treatment|Withdrawal by Subject|8|||
170733017|NCT05701995|617027557|FG001|Treatment|Withdrawal by Subject|4|||
170733018|NCT05701995|617027556|FG000|Treatment|Lost to Follow-up|2|||
170733019|NCT05701995|617027557|FG001|Treatment|Lost to Follow-up|3|||
170733020|NCT05701995|617027556|FG000|Treatment|Adverse Event|3|||
170733021|NCT05701995|617027557|FG001|Treatment|Adverse Event|1|||
170733022|NCT05701995|617027556|FG000|Treatment|Other Reason|1|||
170733023|NCT05701995|617027557|FG001|Treatment|Other Reason|1|||
170733024|NCT05701995|617027556|FG000|Treatment|Death|1|||
170733025|NCT05701995|617027557|FG001|Treatment|Death|0|||
170733026|NCT05701995|617027556|FG000|Treatment|Physician Decision|0|||
170733027|NCT05701995|617027557|FG001|Treatment|Physician Decision|1|||
170733028|NCT03937219|617027561|FG000|Overall Study|Death|223|||
170733029|NCT03937219|617027562|FG001|Overall Study|Death|211|||
170733030|NCT03937219|617027561|FG000|Overall Study|Withdrawal by Subject|17|||
170733031|NCT03937219|617027562|FG001|Overall Study|Withdrawal by Subject|25|||
170733032|NCT03937219|617027561|FG000|Overall Study|Lost to Follow-up|3|||
170733033|NCT03937219|617027562|FG001|Overall Study|Lost to Follow-up|4|||
170733034|NCT00771810|617027563|FG000|Overall Study|Adverse Event|3|||
170733035|NCT00771810|617027564|FG001|Overall Study|Adverse Event|0|||
170733036|NCT00771810|617027565|FG002|Overall Study|Adverse Event|2|||
170733037|NCT00771810|617027563|FG000|Overall Study|Lost to Follow-up|0|||
170733038|NCT00771810|617027564|FG001|Overall Study|Lost to Follow-up|0|||
170733039|NCT00771810|617027565|FG002|Overall Study|Lost to Follow-up|1|||
170733040|NCT00771810|617027563|FG000|Overall Study|Physician Decision|1|||
170733041|NCT00771810|617027564|FG001|Overall Study|Physician Decision|2|||
170733042|NCT00771810|617027565|FG002|Overall Study|Physician Decision|2|||
170733043|NCT00771810|617027563|FG000|Overall Study|Protocol Violation|0|||
170733044|NCT00771810|617027564|FG001|Overall Study|Protocol Violation|1|||
170840656|NCT01920477|617425831|FG000|Overall Study|Lack of Efficacy|1|||
170733045|NCT00771810|617027565|FG002|Overall Study|Protocol Violation|1|||
170733046|NCT00771810|617027563|FG000|Overall Study|Withdrawal by Subject|1|||
170733047|NCT00771810|617027564|FG001|Overall Study|Withdrawal by Subject|2|||
170733048|NCT00771810|617027565|FG002|Overall Study|Withdrawal by Subject|0|||
170733049|NCT00771810|617027563|FG000|Overall Study|Other|0|||
170733050|NCT00771810|617027564|FG001|Overall Study|Other|0|||
170733051|NCT00771810|617027565|FG002|Overall Study|Other|1|||
170733052|NCT00386022|617027578|FG000|Plus Estrogen|Lost to Follow-up|2|||
170733053|NCT00386022|617027579|FG001|Plus Estrogen|Lost to Follow-up|0|||
170840657|NCT01920477|617425832|FG001|Overall Study|Lack of Efficacy|0|||
170840658|NCT01920477|617425831|FG000|Overall Study|Study closed/terminated|14|||
170733054|NCT00386022|617027578|FG000|Plus Estrogen|Adverse Event|0|||
170733055|NCT00386022|617027579|FG001|Plus Estrogen|Adverse Event|1|||
170733056|NCT00045305|617027580|FG000|Overall Study|Lack of Efficacy|6|||
170733057|NCT00045305|617027580|FG000|Overall Study|Adverse Event|3|||
170733058|NCT00045305|617027580|FG000|Overall Study|Death|3|||
170733059|NCT00045305|617027580|FG000|Overall Study|site error|2|||
170733060|NCT03266770|617027581|FG000|Overall Study|Physician Decision|3|||
170733061|NCT03266770|617027581|FG000|Overall Study|Insufficient study supplies|1|||
170840659|NCT01920477|617425832|FG001|Overall Study|Study closed/terminated|15|||
170733062|NCT03266770|617027581|FG000|Overall Study|Adverse Event|1|||
170733063|NCT04198805|617027584|FG000|Overall Study|Death|0|||
170733064|NCT04198805|617027585|FG001|Overall Study|Death|0|||
170733065|NCT04198805|617027586|FG002|Overall Study|Death|0|||
170733066|NCT04198805|617027587|FG003|Overall Study|Death|1|||
170733067|NCT04198805|617027584|FG000|Overall Study|Early Termination|8|||
170840660|NCT01920477|617425831|FG000|Overall Study|Withdrawal by Subject|0|||
170840661|NCT01920477|617425832|FG001|Overall Study|Withdrawal by Subject|1|||
170840662|NCT01681277|617425833|FG000|Overall Study|Adverse Event|1|||
170840663|NCT01681277|617425834|FG001|Overall Study|Adverse Event|0|||
170840664|NCT01681277|617425835|FG002|Overall Study|Adverse Event|0|||
170840665|NCT01681277|617425836|FG003|Overall Study|Adverse Event|0|||
170840666|NCT01681277|617425837|FG004|Overall Study|Adverse Event|0|||
170840667|NCT01228318|617425838|FG000|Overall Study|Clinic no show to receive intervention|1|||
170840668|NCT01228318|617425839|FG001|Overall Study|Clinic no show to receive intervention|0|||
170840669|NCT01228318|617425838|FG000|Overall Study|Unable to contact|2|||
170840670|NCT01228318|617425839|FG001|Overall Study|Unable to contact|5|||
170840671|NCT01228318|617425838|FG000|Overall Study|Moved|0|||
170840672|NCT01228318|617425839|FG001|Overall Study|Moved|2|||
170840673|NCT01228318|617425838|FG000|Overall Study|Incarcerated|1|||
170840674|NCT01228318|617425839|FG001|Overall Study|Incarcerated|0|||
170840675|NCT05577715|617425848|FG000|Overall Study|Withdrawal by Subject|1|||
170840676|NCT05577715|617425848|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
170840677|NCT05577715|617425848|FG000|Overall Study|Lost to Follow-up|1|||
170733068|NCT04198805|617027585|FG001|Overall Study|Early Termination|4|||
170733069|NCT04198805|617027586|FG002|Overall Study|Early Termination|6|||
170733070|NCT04198805|617027587|FG003|Overall Study|Early Termination|9|||
170733071|NCT00453986|617027588|FG000|Overall Study|Lost to Follow-up|6|||
170840678|NCT05577715|617425848|FG000|Overall Study|Death|6|||
170840679|NCT02643303|617425855|FG000|Overall Study|Progressive Disease|4|||
170840680|NCT02643303|617425856|FG001|Overall Study|Progressive Disease|4|||
170733072|NCT00453986|617027589|FG001|Overall Study|Lost to Follow-up|5|||
170733073|NCT00453986|617027590|FG002|Overall Study|Lost to Follow-up|6|||
170733074|NCT00453986|617027591|FG003|Overall Study|Lost to Follow-up|2|||
170733075|NCT00453986|617027592|FG004|Overall Study|Lost to Follow-up|0|||
170733076|NCT01515748|617027593|FG000|Overall Study|Withdrawal by Subject|32|||
170733077|NCT01515748|617027594|FG001|Overall Study|Withdrawal by Subject|41|||
170840681|NCT02643303|617425857|FG002|Overall Study|Progressive Disease|1|||
170733078|NCT01515748|617027593|FG000|Overall Study|Lost to Follow-up|2|||
170733079|NCT01515748|617027594|FG001|Overall Study|Lost to Follow-up|4|||
170733080|NCT01515748|617027593|FG000|Overall Study|Other than specified above|5|||
170733081|NCT01515748|617027594|FG001|Overall Study|Other than specified above|10|||
170733082|NCT00803452|617027595|FG000|Overall Study|Adverse Event|0|||
170733083|NCT00803452|617027596|FG001|Overall Study|Adverse Event|2|||
170733084|NCT00803452|617027595|FG000|Overall Study|Lost to Follow-up|0|||
170733085|NCT00803452|617027596|FG001|Overall Study|Lost to Follow-up|3|||
170733086|NCT01971723|617027598|FG000|Overall Study|Withdrawal by Subject|1|||
170733087|NCT01971723|617027599|FG001|Overall Study|Withdrawal by Subject|1|||
170733088|NCT01971723|617027598|FG000|Overall Study|Protocol Violation|1|||
170733089|NCT01971723|617027599|FG001|Overall Study|Protocol Violation|2|||
170733090|NCT03419364|617027600|FG000|Overall Study|Delivery due to maternal condition|2|||
170733091|NCT03419364|617027601|FG001|Overall Study|Delivery due to maternal condition|0|||
170840682|NCT02643303|617425858|FG003|Overall Study|Progressive Disease|12|||
170840683|NCT02643303|617425859|FG004|Overall Study|Progressive Disease|6|||
170840684|NCT02643303|617425860|FG005|Overall Study|Progressive Disease|4|||
170733092|NCT03419364|617027602|FG002|Overall Study|Delivery due to maternal condition|0|||
170733093|NCT03017079|617027606|FG000|Overall Study|Physician Decision|1|||
170733094|NCT03017079|617027607|FG001|Overall Study|Physician Decision|1|||
170733095|NCT03017079|617027606|FG000|Overall Study|Death|3|||
170733096|NCT03017079|617027607|FG001|Overall Study|Death|2|||
170733097|NCT03017079|617027606|FG000|Overall Study|Lack of Efficacy|2|||
170733098|NCT03017079|617027607|FG001|Overall Study|Lack of Efficacy|2|||
170733099|NCT03017079|617027606|FG000|Overall Study|Protocol Violation|0|||
170733100|NCT03017079|617027607|FG001|Overall Study|Protocol Violation|1|||
170733101|NCT06223373|617027611|FG000|Overall Study|Lost to Follow-up|1|||
170733102|NCT06223373|617027612|FG001|Overall Study|Lost to Follow-up|2|||
170733103|NCT03355326|617027622|FG000|Overall Study|Protocol Violation|3|||
170733104|NCT03355326|617027623|FG001|Overall Study|Protocol Violation|3|||
170733105|NCT00608582|617027633|FG000|Overall Study|Lost to Follow-up|2|||
170733106|NCT00608582|617027634|FG001|Overall Study|Lost to Follow-up|0|||
170733107|NCT00608582|617027633|FG000|Overall Study|No Best Response in Phase 1 located|1|||
170733108|NCT00608582|617027634|FG001|Overall Study|No Best Response in Phase 1 located|1|||
170733109|NCT00608582|617027633|FG000|Overall Study|Illicit Drug Use|1|||
170733110|NCT00608582|617027634|FG001|Overall Study|Illicit Drug Use|0|||
170733111|NCT00608582|617027633|FG000|Overall Study|Early stage Design Change|0|||
170733112|NCT00608582|617027634|FG001|Overall Study|Early stage Design Change|3|||
170733113|NCT03308825|617029652|FG000|Overall Study|Lost to Follow-up|2|||
170733114|NCT03308825|617029653|FG001|Overall Study|Lost to Follow-up|2|||
170733115|NCT03308825|617029654|FG002|Overall Study|Lost to Follow-up|1|||
170733116|NCT03308825|617029655|FG003|Overall Study|Lost to Follow-up|0|||
170733117|NCT03308825|617029652|FG000|Overall Study|Protocol Violation|0|||
170733118|NCT03308825|617029653|FG001|Overall Study|Protocol Violation|2|||
170733119|NCT03308825|617029654|FG002|Overall Study|Protocol Violation|0|||
170733120|NCT03308825|617029655|FG003|Overall Study|Protocol Violation|0|||
170733121|NCT00045708|617029656|FG000|Phase 1|early progressive disease|0|||
170733122|NCT00045708|617029657|FG001|Phase 1|early progressive disease|1|||
170733123|NCT00045708|617029658|FG002|Phase 1|early progressive disease|0|||
170733124|NCT00685945|617029659|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
170733125|NCT00847405|617029661|FG000|First Intervention|Adverse Event|0|||
170733126|NCT00847405|617029662|FG001|First Intervention|Adverse Event|1|||
170733127|NCT00847405|617029661|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
170733128|NCT00847405|617029662|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
170733129|NCT01728792|617029663|FG000|Overall Study|Withdrawal of Consent|1|||
170733130|NCT01728792|617029664|FG001|Overall Study|Withdrawal of Consent|1|||
170733131|NCT01728792|617029665|FG002|Overall Study|Withdrawal of Consent|0|||
170733132|NCT01728792|617029666|FG003|Overall Study|Withdrawal of Consent|1|||
170733133|NCT01728792|617029667|FG004|Overall Study|Withdrawal of Consent|0|||
170733134|NCT01728792|617029663|FG000|Overall Study|Lost to Follow-up|2|||
170733135|NCT01728792|617029664|FG001|Overall Study|Lost to Follow-up|1|||
170733136|NCT01728792|617029665|FG002|Overall Study|Lost to Follow-up|4|||
170733137|NCT01728792|617029666|FG003|Overall Study|Lost to Follow-up|2|||
170733138|NCT01728792|617029667|FG004|Overall Study|Lost to Follow-up|0|||
170733139|NCT04277455|617029668|FG000|Overall Study|Lost to Follow-up|1|||
170733140|NCT01782742|617029675|FG000|Double-blind Treatment Phase|Adverse Event|1|||
170733141|NCT01782742|617029676|FG001|Double-blind Treatment Phase|Adverse Event|0|||
170733142|NCT04737109|617029683|FG000|Study Treatment|Disease Progression|5|||
170733143|NCT04737109|617029684|FG001|Study Treatment|Disease Progression|0|||
170733144|NCT04737109|617029685|FG002|Study Treatment|Disease Progression|0|||
170733145|NCT04737109|617029686|FG003|Study Treatment|Disease Progression|0|||
170733146|NCT04737109|617029683|FG000|Study Treatment|Death on study|1|||
170733147|NCT04737109|617029684|FG001|Study Treatment|Death on study|0|||
170733148|NCT04737109|617029685|FG002|Study Treatment|Death on study|0|||
170733149|NCT04737109|617029686|FG003|Study Treatment|Death on study|0|||
170733150|NCT03092375|617029687|FG000|Overall Study|Lack of Efficacy|0|||
170733151|NCT03092375|617029688|FG001|Overall Study|Lack of Efficacy|1|||
170733152|NCT03092375|617029689|FG002|Overall Study|Lack of Efficacy|1|||
170733153|NCT03092375|617029690|FG003|Overall Study|Lack of Efficacy|0|||
170733154|NCT02790073|617029693|FG000|Overall Study|Death|1|||
170733155|NCT02790073|617029693|FG000|Overall Study|Withdrawal from HD|1|||
170733156|NCT02790073|617029693|FG000|Overall Study|Withdrawal by Subject|1|||
170733157|NCT00944658|617029694|FG000|Treatment 12 Weeks|Adverse Event|0|||
170733158|NCT00944658|617029695|FG001|Treatment 12 Weeks|Adverse Event|2|||
170840685|NCT02643303|617425861|FG006|Overall Study|Progressive Disease|8|||
170733159|NCT02259517|617029696|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
170733160|NCT02259517|617029697|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
170733161|NCT02259517|617029698|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
170733162|NCT02259517|617029696|FG000|Overall Study|Withdrawal by Subject|0|||
170733163|NCT02259517|617029697|FG001|Overall Study|Withdrawal by Subject|0|||
170733164|NCT02259517|617029698|FG002|Overall Study|Withdrawal by Subject|3|||
170733165|NCT01352585|617029702|FG000|Overall Study|Adverse Event|2|||
170840686|NCT02643303|617425862|FG007|Overall Study|Progressive Disease|2|||
170733166|NCT01352585|617029703|FG001|Overall Study|Adverse Event|1|||
170733167|NCT01352585|617029702|FG000|Overall Study|Lost to Follow-up|1|||
170733168|NCT01352585|617029703|FG001|Overall Study|Lost to Follow-up|0|||
170733169|NCT01352585|617029702|FG000|Overall Study|Other|5|||
170733170|NCT01352585|617029703|FG001|Overall Study|Other|2|||
170733171|NCT03928028|617029704|FG000|Overall Study|Physician Decision|9|||
170733172|NCT03928028|617029705|FG001|Overall Study|Physician Decision|6|||
170733173|NCT03928028|617029706|FG002|Overall Study|Physician Decision|3|||
170733174|NCT03928028|617029704|FG000|Overall Study|Withdrawal by Subject|12|||
170733175|NCT03928028|617029705|FG001|Overall Study|Withdrawal by Subject|3|||
170733176|NCT03928028|617029706|FG002|Overall Study|Withdrawal by Subject|3|||
170733177|NCT00514683|617029712|FG000|Overall Study|Not treated|2|||
170733178|NCT00514683|617029713|FG001|Overall Study|Not treated|1|||
170733179|NCT00514683|617029714|FG002|Overall Study|Not treated|0|||
170733180|NCT00514683|617029715|FG003|Overall Study|Not treated|0|||
170733181|NCT00514683|617029716|FG004|Overall Study|Not treated|1|||
170733182|NCT00514683|617029712|FG000|Overall Study|Adverse Event|21|||
170733183|NCT00514683|617029713|FG001|Overall Study|Adverse Event|20|||
170733184|NCT00514683|617029714|FG002|Overall Study|Adverse Event|15|||
170733185|NCT00514683|617029715|FG003|Overall Study|Adverse Event|13|||
170733186|NCT00514683|617029716|FG004|Overall Study|Adverse Event|27|||
170733187|NCT00514683|617029712|FG000|Overall Study|Protocol Violation|1|||
170733188|NCT00514683|617029713|FG001|Overall Study|Protocol Violation|1|||
170733189|NCT00514683|617029714|FG002|Overall Study|Protocol Violation|0|||
170733190|NCT00514683|617029715|FG003|Overall Study|Protocol Violation|1|||
170733191|NCT00514683|617029716|FG004|Overall Study|Protocol Violation|0|||
170733192|NCT00514683|617029712|FG000|Overall Study|Withdrawal by Subject|2|||
170733193|NCT00514683|617029713|FG001|Overall Study|Withdrawal by Subject|2|||
170733194|NCT00514683|617029714|FG002|Overall Study|Withdrawal by Subject|1|||
170733195|NCT00514683|617029715|FG003|Overall Study|Withdrawal by Subject|0|||
170733196|NCT00514683|617029716|FG004|Overall Study|Withdrawal by Subject|4|||
170733197|NCT00514683|617029712|FG000|Overall Study|Reason other than listed above|0|||
170733198|NCT00514683|617029713|FG001|Overall Study|Reason other than listed above|1|||
170733199|NCT00514683|617029714|FG002|Overall Study|Reason other than listed above|2|||
170733200|NCT00514683|617029715|FG003|Overall Study|Reason other than listed above|0|||
170733201|NCT00514683|617029716|FG004|Overall Study|Reason other than listed above|1|||
170733202|NCT01802437|617029717|FG000|Overall Study|Lost to Follow-up|1|||
170733203|NCT01802437|617029718|FG001|Overall Study|Lost to Follow-up|0|||
170733204|NCT01802437|617029717|FG000|Overall Study|Withdrawal by Subject|3|||
170733205|NCT01802437|617029718|FG001|Overall Study|Withdrawal by Subject|4|||
170733206|NCT04810221|617029719|FG000|Overall Study|Physician Decision|3|||
170733207|NCT03642938|617029720|FG000|Overall Study|Withdrawal by Subject|0|||
170733208|NCT03642938|617029721|FG001|Overall Study|Withdrawal by Subject|0|||
170733209|NCT03642938|617029722|FG002|Overall Study|Withdrawal by Subject|0|||
170733210|NCT03642938|617029723|FG003|Overall Study|Withdrawal by Subject|1|||
170840687|NCT02643303|617425863|FG008|Overall Study|Progressive Disease|6|||
170840688|NCT02643303|617425855|FG000|Overall Study|Adverse Event|0|||
170840689|NCT02643303|617425856|FG001|Overall Study|Adverse Event|1|||
170840690|NCT02643303|617425857|FG002|Overall Study|Adverse Event|0|||
170840691|NCT02643303|617425858|FG003|Overall Study|Adverse Event|0|||
170840692|NCT02643303|617425859|FG004|Overall Study|Adverse Event|1|||
170840693|NCT02643303|617425860|FG005|Overall Study|Adverse Event|0|||
170733211|NCT02347657|617029724|FG000|Overall Study|Physician Decision|0|||
170733212|NCT02347657|617029725|FG001|Overall Study|Physician Decision|1|||
170733213|NCT02347657|617029724|FG000|Overall Study|Adverse Event|8|||
170733214|NCT02347657|617029725|FG001|Overall Study|Adverse Event|4|||
170733215|NCT02347657|617029724|FG000|Overall Study|Withdrawal by Subject|6|||
170733216|NCT02347657|617029725|FG001|Overall Study|Withdrawal by Subject|7|||
170733217|NCT02347657|617029724|FG000|Overall Study|Randomized but not treated|1|||
170733218|NCT02347657|617029725|FG001|Overall Study|Randomized but not treated|0|||
170733219|NCT02347657|617029724|FG000|Overall Study|Other|3|||
170733220|NCT02347657|617029725|FG001|Overall Study|Other|3|||
170733221|NCT03953898|617029726|FG000|Overall Study|Lack of Efficacy|8|||
170733222|NCT03953898|617029726|FG000|Overall Study|Death|3|||
170733223|NCT03953898|617029726|FG000|Overall Study|Withdrawal by Subject|2|||
170733224|NCT03953898|617029726|FG000|Overall Study|Adverse Event|1|||
170733225|NCT00792103|617029730|FG000|Overall Study|Enrolled, not treated|15|||
170733226|NCT00792103|617029730|FG000|Overall Study|Lost to Follow-up|17|||
170733227|NCT00792103|617029730|FG000|Overall Study|Adverse Event|25|||
170733228|NCT00792103|617029730|FG000|Overall Study|Withdrawal by Subject|52|||
170733229|NCT00792103|617029730|FG000|Overall Study|Protocol Violation|10|||
170733230|NCT00792103|617029730|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
170733231|NCT01844284|617029731|FG000|Overall Study|Lost to Follow-up|12|||
170733232|NCT01844284|617029732|FG001|Overall Study|Lost to Follow-up|7|||
170733233|NCT04274894|617029749|FG000|Overall Study|Adverse Event|7|||
170733234|NCT04274894|617029749|FG000|Overall Study|Withdrew consent|5|||
170733235|NCT04274894|617029749|FG000|Overall Study|Lost to Follow-up|9|||
170733236|NCT04274894|617029749|FG000|Overall Study|COVID-19 infection|1|||
170733237|NCT04274894|617029749|FG000|Overall Study|Other, not specified|20|||
170733238|NCT03848403|617029756|FG000|Period 2 (Day 8)|Adverse Event|1|||
170733239|NCT03848403|617029757|FG001|Period 2 (Day 8)|Adverse Event|2|||
170733240|NCT03848403|617029758|FG002|Period 2 (Day 8)|Adverse Event|2|||
170733241|NCT03848403|617029756|FG000|Period 2 (Day 8)|Physician Decision|0|||
170733242|NCT03848403|617029757|FG001|Period 2 (Day 8)|Physician Decision|1|||
170733243|NCT03848403|617029758|FG002|Period 2 (Day 8)|Physician Decision|0|||
170733244|NCT03848403|617029756|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
170840694|NCT02643303|617425861|FG006|Overall Study|Adverse Event|0|||
170840695|NCT02643303|617425862|FG007|Overall Study|Adverse Event|0|||
170840696|NCT02643303|617425863|FG008|Overall Study|Adverse Event|0|||
170840697|NCT02643303|617425855|FG000|Overall Study|Withdrawal by Subject|0|||
170840698|NCT02643303|617425856|FG001|Overall Study|Withdrawal by Subject|0|||
170840699|NCT02643303|617425857|FG002|Overall Study|Withdrawal by Subject|0|||
170840700|NCT02643303|617425858|FG003|Overall Study|Withdrawal by Subject|1|||
170840701|NCT02643303|617425859|FG004|Overall Study|Withdrawal by Subject|0|||
170840702|NCT02643303|617425860|FG005|Overall Study|Withdrawal by Subject|0|||
170840703|NCT02643303|617425861|FG006|Overall Study|Withdrawal by Subject|1|||
170840704|NCT02643303|617425862|FG007|Overall Study|Withdrawal by Subject|1|||
170840705|NCT02643303|617425863|FG008|Overall Study|Withdrawal by Subject|1|||
170840706|NCT01757197|617425870|FG000|Overall Study|Death|2|||
170840707|NCT03057847|617425878|FG000|Overall Study|Lost to Follow-up|16|||
170840708|NCT00351377|617425880|FG000|Overall Study|Adverse Event|5|||
170840709|NCT00351377|617425880|FG000|Overall Study|Death|1|||
170840710|NCT00351377|617425880|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170840711|NCT03926195|617425882|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
170840712|NCT03926195|617425883|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
170840713|NCT03926195|617425882|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
170840714|NCT03926195|617425883|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
170840715|NCT03926195|617425882|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
170840716|NCT03926195|617425883|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
170733245|NCT03848403|617029757|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
170733246|NCT03848403|617029758|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
170733247|NCT04510675|617029761|FG000|Overall Study|Withdrawal by Subject|5|||
170733248|NCT02657031|617029762|FG000|Overall Study|Adverse Event|1|||
170733249|NCT02657031|617029763|FG001|Overall Study|Adverse Event|2|||
170733250|NCT03078816|617029766|FG000|Overall Study|Withdrawal by Subject|1|||
170733251|NCT02114151|617029767|FG000|Overall Study|Death|1|||
170733252|NCT02114151|617029767|FG000|Overall Study|Lost to Follow-up|1|||
170733253|NCT02114151|617029767|FG000|Overall Study|Withdrawal by Subject|5|||
170733254|NCT01666808|617029768|FG000|Overall Study|Lost to Follow-up|9|||
170733255|NCT01666808|617029769|FG001|Overall Study|Lost to Follow-up|15|||
170840717|NCT03926195|617425882|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
170733256|NCT01666808|617029768|FG000|Overall Study|Withdrawal by Subject|3|||
170733257|NCT01666808|617029769|FG001|Overall Study|Withdrawal by Subject|1|||
170733258|NCT01666808|617029768|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
170733259|NCT01666808|617029769|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
170733260|NCT05007392|617029773|FG000|Overall Study|Randomized but not treated|1|||
170733261|NCT05007392|617029774|FG001|Overall Study|Randomized but not treated|2|||
170733262|NCT05007392|617029773|FG000|Overall Study|Other|5|||
170733263|NCT05007392|617029774|FG001|Overall Study|Other|4|||
170733264|NCT05007392|617029773|FG000|Overall Study|Lost to Follow-up|1|||
170733265|NCT05007392|617029774|FG001|Overall Study|Lost to Follow-up|2|||
170733266|NCT05007392|617029773|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
170733267|NCT05007392|617029774|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
170733268|NCT05007392|617029773|FG000|Overall Study|Use of prohibited concomitant drug|1|||
170733269|NCT05007392|617029774|FG001|Overall Study|Use of prohibited concomitant drug|1|||
170733270|NCT05007392|617029773|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
170733271|NCT05007392|617029774|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
170733272|NCT05007392|617029773|FG000|Overall Study|Adverse Event|10|||
170733273|NCT05007392|617029774|FG001|Overall Study|Adverse Event|6|||
170733274|NCT05007392|617029773|FG000|Overall Study|Participant choice|5|||
170733275|NCT05007392|617029774|FG001|Overall Study|Participant choice|10|||
170733276|NCT05007392|617029773|FG000|Overall Study|Withdrawal of consent|5|||
170733277|NCT05007392|617029774|FG001|Overall Study|Withdrawal of consent|4|||
170733278|NCT00500903|617029775|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
170733279|NCT00500903|617029776|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
170733280|NCT00500903|617029777|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
170733281|NCT00500903|617029775|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
170733282|NCT00500903|617029776|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
170733283|NCT00500903|617029777|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
170733284|NCT00500903|617029775|FG000|Overall Study|Progressive Disease|41|||
170733285|NCT00500903|617029776|FG001|Overall Study|Progressive Disease|2|||
170733286|NCT00500903|617029777|FG002|Overall Study|Progressive Disease|15|||
170733287|NCT00500903|617029775|FG000|Overall Study|Patient Declined Further Treatment|0|||
170733288|NCT00500903|617029776|FG001|Overall Study|Patient Declined Further Treatment|0|||
170733289|NCT00500903|617029777|FG002|Overall Study|Patient Declined Further Treatment|3|||
170733290|NCT00500903|617029775|FG000|Overall Study|Symptomatic Deterioration|2|||
170733291|NCT00500903|617029776|FG001|Overall Study|Symptomatic Deterioration|0|||
170733292|NCT00500903|617029777|FG002|Overall Study|Symptomatic Deterioration|0|||
170733293|NCT00500903|617029775|FG000|Overall Study|Reason Not Specified|10|||
170733294|NCT00500903|617029776|FG001|Overall Study|Reason Not Specified|0|||
170733295|NCT00500903|617029777|FG002|Overall Study|Reason Not Specified|2|||
170733296|NCT00696410|617029780|FG000|Overall Study|Lost to Follow-up|2|||
170733297|NCT00696410|617029781|FG001|Overall Study|Lost to Follow-up|0|||
170733298|NCT00696410|617029780|FG000|Overall Study|Withdrawal by Subject|8|||
170733299|NCT00696410|617029781|FG001|Overall Study|Withdrawal by Subject|0|||
170733300|NCT00696410|617029780|FG000|Overall Study|Physician Decision|3|||
170733301|NCT00696410|617029781|FG001|Overall Study|Physician Decision|0|||
170733302|NCT03184792|617029782|FG000|Overall Study|Pandemic|2|||
170733303|NCT03184792|617029783|FG001|Overall Study|Pandemic|2|||
170733304|NCT02134587|617029787|FG000|Overall Study|Did not completed all meetings|30|||
170733305|NCT00265889|617029788|FG000|Overall Study|Physician Decision|1|||
170733306|NCT00265889|617029788|FG000|Overall Study|Protocol Violation|1|||
170733307|NCT00265889|617029788|FG000|Overall Study|Insurance denied the request|3|||
170733308|NCT03221387|617029794|FG000|Overall Study|Lost to Follow-up|1|||
170733309|NCT03221387|617029794|FG000|Overall Study|Lung transplant|1|||
170733310|NCT02390531|617029795|FG000|Overall Study|Death|0|||
170733311|NCT02390531|617029796|FG001|Overall Study|Death|2|||
170733312|NCT02390531|617029797|FG002|Overall Study|Death|0|||
170733313|NCT02390531|617029798|FG003|Overall Study|Death|1|||
170733314|NCT02390531|617029799|FG004|Overall Study|Death|0|||
170733315|NCT02390531|617029800|FG005|Overall Study|Death|0|||
170733316|NCT02390531|617029801|FG006|Overall Study|Death|0|||
170733317|NCT02390531|617029802|FG007|Overall Study|Death|1|||
170733318|NCT02390531|617029795|FG000|Overall Study|Protocol Violation|0|||
170733319|NCT02390531|617029796|FG001|Overall Study|Protocol Violation|0|||
170733320|NCT02390531|617029797|FG002|Overall Study|Protocol Violation|0|||
170733321|NCT02390531|617029798|FG003|Overall Study|Protocol Violation|0|||
170733322|NCT02390531|617029799|FG004|Overall Study|Protocol Violation|1|||
170733323|NCT02390531|617029800|FG005|Overall Study|Protocol Violation|0|||
170733324|NCT02390531|617029801|FG006|Overall Study|Protocol Violation|2|||
170733325|NCT02390531|617029802|FG007|Overall Study|Protocol Violation|0|||
170733326|NCT03764072|617029804|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
170733327|NCT03764072|617029805|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
170733328|NCT03764072|617029806|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
170733329|NCT03764072|617029807|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
170733330|NCT03764072|617029808|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
170733331|NCT03764072|617029809|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
170733332|NCT03764072|617029804|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
170840718|NCT03926195|617425883|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
170840719|NCT03926195|617425882|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
170733333|NCT03764072|617029805|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
170733334|NCT03764072|617029806|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
170733335|NCT03764072|617029807|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
170733336|NCT03764072|617029808|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
170733337|NCT03764072|617029809|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
170733338|NCT03764072|617029804|FG000|Overall Study|Lost to Follow-up|0|||
170733339|NCT03764072|617029805|FG001|Overall Study|Lost to Follow-up|0|||
170733340|NCT03764072|617029806|FG002|Overall Study|Lost to Follow-up|0|||
170733341|NCT03764072|617029807|FG003|Overall Study|Lost to Follow-up|0|||
170733342|NCT03764072|617029808|FG004|Overall Study|Lost to Follow-up|1|||
170733343|NCT03764072|617029809|FG005|Overall Study|Lost to Follow-up|0|||
170733344|NCT00657618|617029814|FG000|Overall Study|Adverse Event|32|||
170733345|NCT00657618|617029814|FG000|Overall Study|Withdrawal by Subject|8|||
170733346|NCT00657618|617029814|FG000|Overall Study|negative for leishmaniasis|2|||
170733347|NCT00657618|617029814|FG000|Overall Study|didn't start due to schedule conflicts|1|||
170733348|NCT01659151|617029817|FG000|Overall Study|Inadequate TIL growth|1|||
170733349|NCT05774197|617029818|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
170733350|NCT05073133|617029820|FG000|Overall Study|Death|2|||
170733351|NCT04981678|617029821|FG000|Overall Study|Lost to Follow-up|0|||
170733352|NCT04981678|617029822|FG001|Overall Study|Lost to Follow-up|1|||
170733353|NCT03764774|617029823|FG000|Overall Study|Withdrawal by Subject|0|||
170733354|NCT03764774|617029824|FG001|Overall Study|Withdrawal by Subject|0|||
170733355|NCT03764774|617029825|FG002|Overall Study|Withdrawal by Subject|0|||
170733356|NCT03764774|617029826|FG003|Overall Study|Withdrawal by Subject|0|||
170733357|NCT03764774|617029827|FG004|Overall Study|Withdrawal by Subject|0|||
170733358|NCT03764774|617029828|FG005|Overall Study|Withdrawal by Subject|0|||
170733359|NCT03764774|617029829|FG006|Overall Study|Withdrawal by Subject|0|||
170733360|NCT03764774|617029830|FG007|Overall Study|Withdrawal by Subject|0|||
170733361|NCT03764774|617029831|FG008|Overall Study|Withdrawal by Subject|0|||
170733362|NCT03764774|617029832|FG009|Overall Study|Withdrawal by Subject|0|||
170733363|NCT03764774|617029833|FG010|Overall Study|Withdrawal by Subject|1|||
170733364|NCT03764774|617029834|FG011|Overall Study|Withdrawal by Subject|0|||
170733365|NCT03764774|617029835|FG012|Overall Study|Withdrawal by Subject|0|||
170733366|NCT03764774|617029836|FG013|Overall Study|Withdrawal by Subject|0|||
170733367|NCT03764774|617029823|FG000|Overall Study|Adverse Event|0|||
170733368|NCT03764774|617029824|FG001|Overall Study|Adverse Event|0|||
170733369|NCT03764774|617029825|FG002|Overall Study|Adverse Event|0|||
170733370|NCT03764774|617029826|FG003|Overall Study|Adverse Event|0|||
170733371|NCT03764774|617029827|FG004|Overall Study|Adverse Event|0|||
170733372|NCT03764774|617029828|FG005|Overall Study|Adverse Event|0|||
170733373|NCT03764774|617029829|FG006|Overall Study|Adverse Event|0|||
170733374|NCT03764774|617029830|FG007|Overall Study|Adverse Event|0|||
170733375|NCT03764774|617029831|FG008|Overall Study|Adverse Event|0|||
170733376|NCT03764774|617029832|FG009|Overall Study|Adverse Event|0|||
170733377|NCT03764774|617029833|FG010|Overall Study|Adverse Event|0|||
170733378|NCT03764774|617029834|FG011|Overall Study|Adverse Event|0|||
170733379|NCT03764774|617029835|FG012|Overall Study|Adverse Event|2|||
170733380|NCT03764774|617029836|FG013|Overall Study|Adverse Event|0|||
170733381|NCT03764774|617029823|FG000|Overall Study|Lost to Follow-up|0|||
170733382|NCT03764774|617029824|FG001|Overall Study|Lost to Follow-up|0|||
170840720|NCT03926195|617425883|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
170840721|NCT03926195|617425882|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
170840722|NCT03926195|617425883|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
170840723|NCT03054337|617425884|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
170840724|NCT03054337|617425885|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
170733383|NCT03764774|617029825|FG002|Overall Study|Lost to Follow-up|0|||
170733384|NCT03764774|617029826|FG003|Overall Study|Lost to Follow-up|0|||
170733385|NCT03764774|617029827|FG004|Overall Study|Lost to Follow-up|0|||
170733386|NCT03764774|617029828|FG005|Overall Study|Lost to Follow-up|0|||
170733387|NCT03764774|617029829|FG006|Overall Study|Lost to Follow-up|0|||
170733388|NCT03764774|617029830|FG007|Overall Study|Lost to Follow-up|0|||
170733389|NCT03764774|617029831|FG008|Overall Study|Lost to Follow-up|0|||
170733390|NCT03764774|617029832|FG009|Overall Study|Lost to Follow-up|0|||
170733391|NCT03764774|617029833|FG010|Overall Study|Lost to Follow-up|0|||
170733392|NCT03764774|617029834|FG011|Overall Study|Lost to Follow-up|0|||
170733393|NCT03764774|617029835|FG012|Overall Study|Lost to Follow-up|0|||
170733394|NCT03764774|617029836|FG013|Overall Study|Lost to Follow-up|1|||
170733395|NCT03764774|617029823|FG000|Overall Study|Physician Decision|0|||
170733396|NCT03764774|617029824|FG001|Overall Study|Physician Decision|0|||
170733397|NCT03764774|617029825|FG002|Overall Study|Physician Decision|0|||
170733398|NCT03764774|617029826|FG003|Overall Study|Physician Decision|0|||
170733399|NCT03764774|617029827|FG004|Overall Study|Physician Decision|0|||
170733400|NCT03764774|617029828|FG005|Overall Study|Physician Decision|0|||
170733401|NCT03764774|617029829|FG006|Overall Study|Physician Decision|0|||
170733402|NCT03764774|617029830|FG007|Overall Study|Physician Decision|0|||
170733403|NCT03764774|617029831|FG008|Overall Study|Physician Decision|0|||
170733404|NCT03764774|617029832|FG009|Overall Study|Physician Decision|4|||
170733405|NCT03764774|617029833|FG010|Overall Study|Physician Decision|1|||
170733406|NCT03764774|617029834|FG011|Overall Study|Physician Decision|4|||
170733407|NCT03764774|617029835|FG012|Overall Study|Physician Decision|9|||
170733408|NCT03764774|617029836|FG013|Overall Study|Physician Decision|0|||
170733409|NCT03764774|617029823|FG000|Overall Study|Study Termination|0|||
170733410|NCT03764774|617029824|FG001|Overall Study|Study Termination|0|||
170733411|NCT03764774|617029825|FG002|Overall Study|Study Termination|0|||
170733412|NCT03764774|617029826|FG003|Overall Study|Study Termination|0|||
170733413|NCT03764774|617029827|FG004|Overall Study|Study Termination|0|||
170733414|NCT03764774|617029828|FG005|Overall Study|Study Termination|0|||
170733415|NCT03764774|617029829|FG006|Overall Study|Study Termination|0|||
170733416|NCT03764774|617029830|FG007|Overall Study|Study Termination|0|||
170733417|NCT03764774|617029831|FG008|Overall Study|Study Termination|0|||
170733418|NCT03764774|617029832|FG009|Overall Study|Study Termination|1|||
170733419|NCT03764774|617029833|FG010|Overall Study|Study Termination|0|||
170733420|NCT03764774|617029834|FG011|Overall Study|Study Termination|0|||
170733421|NCT03764774|617029835|FG012|Overall Study|Study Termination|0|||
170733422|NCT03764774|617029836|FG013|Overall Study|Study Termination|2|||
170733423|NCT01493960|617031403|FG000|Overall Study|Adverse Event|0|||
170733424|NCT01493960|617031404|FG001|Overall Study|Adverse Event|1|||
170733425|NCT01493960|617031403|FG000|Overall Study|Lack of Efficacy|15|||
170733426|NCT01493960|617031404|FG001|Overall Study|Lack of Efficacy|9|||
170733427|NCT01493960|617031403|FG000|Overall Study|Protocol Violation|3|||
170733428|NCT01493960|617031404|FG001|Overall Study|Protocol Violation|0|||
170733429|NCT01493960|617031403|FG000|Overall Study|Withdrawal by Subject|10|||
170733430|NCT01493960|617031404|FG001|Overall Study|Withdrawal by Subject|4|||
170733431|NCT01493960|617031403|FG000|Overall Study|Non-specified|4|||
170733432|NCT01493960|617031404|FG001|Overall Study|Non-specified|4|||
170733433|NCT01679236|617031409|FG000|Overall Study|Lost to Follow-up|15|||
170733434|NCT01679236|617031410|FG001|Overall Study|Lost to Follow-up|15|||
170733435|NCT00284141|617031411|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
170733436|NCT00284141|617031411|FG000|Overall Study|Adverse Event|19|||
170733437|NCT00284141|617031411|FG000|Overall Study|Participant's request|9|||
170733438|NCT00284141|617031411|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
170733439|NCT00284141|617031411|FG000|Overall Study|Clinical deterioration / death|2|||
170733440|NCT00284141|617031411|FG000|Overall Study|General decline|1|||
170733441|NCT00284141|617031411|FG000|Overall Study|Pneumonia|1|||
170733442|NCT00284141|617031411|FG000|Overall Study|Did not take study medication|2|||
170733443|NCT00284141|617031411|FG000|Overall Study|Ongoing treatment|2|||
170733444|NCT03935217|617031414|FG000|Overall Study|Adverse Event|1|||
170733445|NCT03935217|617031415|FG001|Overall Study|Adverse Event|0|||
170733446|NCT03935217|617031414|FG000|Overall Study|Lost to Follow-up|0|||
170733447|NCT03935217|617031415|FG001|Overall Study|Lost to Follow-up|1|||
170733448|NCT03935217|617031414|FG000|Overall Study|Withdrawal by Subject|0|||
170733449|NCT03935217|617031415|FG001|Overall Study|Withdrawal by Subject|2|||
170733450|NCT00803101|617031418|FG000|Overall Study|Death / Serious Adverse Event|4|||
170733451|NCT00803101|617031419|FG001|Overall Study|Death / Serious Adverse Event|6|||
170733452|NCT00803101|617031418|FG000|Overall Study|Withdrawal by Subject|6|||
170733453|NCT00803101|617031419|FG001|Overall Study|Withdrawal by Subject|4|||
170733454|NCT00803101|617031418|FG000|Overall Study|Lost to Follow-up|2|||
170733455|NCT00803101|617031419|FG001|Overall Study|Lost to Follow-up|2|||
170733456|NCT00803101|617031418|FG000|Overall Study|Protocol Violation|1|||
170733457|NCT00803101|617031419|FG001|Overall Study|Protocol Violation|7|||
170733458|NCT00803101|617031418|FG000|Overall Study|Surgery finished outside protocol window|1|||
170733459|NCT00803101|617031419|FG001|Overall Study|Surgery finished outside protocol window|1|||
170733460|NCT00803101|617031418|FG000|Overall Study|Patient died outside SAE report period|1|||
170733461|NCT00803101|617031419|FG001|Overall Study|Patient died outside SAE report period|0|||
170733462|NCT00803101|617031418|FG000|Overall Study|Patient did not attend scheduled visit|2|||
170733463|NCT00803101|617031419|FG001|Overall Study|Patient did not attend scheduled visit|1|||
170733464|NCT00803101|617031418|FG000|Overall Study|Patient did not have surgery|1|||
170733465|NCT00803101|617031419|FG001|Overall Study|Patient did not have surgery|1|||
170733466|NCT02026232|617031420|FG000|Overall Study|incomplete visit/missing data|3|||
170733467|NCT02026232|617031421|FG001|Overall Study|incomplete visit/missing data|2|||
170733468|NCT01382602|617031422|FG000|Overall Study|Protocol Violation|0|||
170733469|NCT01382602|617031423|FG001|Overall Study|Protocol Violation|3|||
170733470|NCT01382602|617031422|FG000|Overall Study|Withdrawal by Subject|0|||
170733471|NCT01382602|617031423|FG001|Overall Study|Withdrawal by Subject|1|||
170733472|NCT02710292|617031425|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
170733473|NCT02710292|617031426|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
170733474|NCT02710292|617031425|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
170733475|NCT02710292|617031426|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
170733476|NCT00676130|617031428|FG000|Overall Study|Lost to Follow-up|0|||
170733477|NCT00676130|617031429|FG001|Overall Study|Lost to Follow-up|1|||
170733478|NCT00676130|617031428|FG000|Overall Study|Found ineligible|3|||
170733479|NCT00676130|617031429|FG001|Overall Study|Found ineligible|2|||
170733480|NCT00676130|617031428|FG000|Overall Study|Withdrawal by Subject|0|||
170733481|NCT00676130|617031429|FG001|Overall Study|Withdrawal by Subject|1|||
170733482|NCT01424930|617031430|FG000|Overall Study|Adverse Event|0|||
170733483|NCT01424930|617031431|FG001|Overall Study|Adverse Event|1|||
170733484|NCT01424930|617031430|FG000|Overall Study|Death|1|||
170733485|NCT01424930|617031431|FG001|Overall Study|Death|0|||
170733486|NCT01424930|617031430|FG000|Overall Study|Progressive Disease|3|||
170733487|NCT01424930|617031431|FG001|Overall Study|Progressive Disease|6|||
170733488|NCT01424930|617031430|FG000|Overall Study|Screen Failure|0|||
170733489|NCT01424930|617031431|FG001|Overall Study|Screen Failure|1|||
170733490|NCT01424930|617031430|FG000|Overall Study|Reason not specified|0|||
170733491|NCT01424930|617031431|FG001|Overall Study|Reason not specified|6|||
170733492|NCT00106184|617031433|FG000|Overall Study|Withdrawal by Subject|3|||
170733493|NCT00106184|617031434|FG001|Overall Study|Withdrawal by Subject|2|||
170733494|NCT05292534|617031436|FG000|Overall Study|Protocol Violation|3|||
170733495|NCT05292534|617031437|FG001|Overall Study|Protocol Violation|4|||
170733496|NCT05292534|617031436|FG000|Overall Study|Withdrawal by Subject|0|||
170733497|NCT05292534|617031437|FG001|Overall Study|Withdrawal by Subject|1|||
170733498|NCT01892345|617031438|FG000|Overall Study|Adverse Event|0|||
170733499|NCT01892345|617031439|FG001|Overall Study|Adverse Event|2|||
170733500|NCT01892345|617031438|FG000|Overall Study|Death|1|||
170733501|NCT01892345|617031439|FG001|Overall Study|Death|0|||
170733502|NCT01892345|617031438|FG000|Overall Study|Lost to Follow-up|3|||
170733503|NCT01892345|617031439|FG001|Overall Study|Lost to Follow-up|0|||
170733504|NCT01892345|617031438|FG000|Overall Study|Withdrawal by Subject|12|||
170733505|NCT01892345|617031439|FG001|Overall Study|Withdrawal by Subject|1|||
170733506|NCT02133872|617031440|FG000|Overall Study|Withdrawal by Subject|5|||
170733507|NCT02133872|617031441|FG001|Overall Study|Withdrawal by Subject|3|||
170733508|NCT02133872|617031442|FG002|Overall Study|Withdrawal by Subject|0|||
170733509|NCT02487810|617031447|FG000|Overall Study|Withdrawal by Subject|1|||
170733510|NCT02487810|617031448|FG001|Overall Study|Withdrawal by Subject|0|||
170733511|NCT01889186|617031449|FG000|Overall Study|Adverse event- not related to progression|18|||
170733512|NCT01889186|617031450|FG001|Overall Study|Adverse event- not related to progression|5|||
170733513|NCT01889186|617031449|FG000|Overall Study|Adverse event- related to progression|7|||
170733514|NCT01889186|617031450|FG001|Overall Study|Adverse event- related to progression|2|||
170733515|NCT01889186|617031449|FG000|Overall Study|COVID-19 logistical restrictions|1|||
170733516|NCT01889186|617031450|FG001|Overall Study|COVID-19 logistical restrictions|0|||
170733517|NCT01889186|617031449|FG000|Overall Study|Investigator request|1|||
170840725|NCT03054337|617425886|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
170840726|NCT03054337|617425887|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
170840727|NCT03054337|617425888|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
170840728|NCT03054337|617425889|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
170840729|NCT02088957|617425890|FG000|Overall Study|Lack of Efficacy|1|||
170840730|NCT02088957|617425891|FG001|Overall Study|Lack of Efficacy|0|||
170840731|NCT01327612|617425892|FG000|Overall Study|Withdrawal by Subject|0|||
170840732|NCT01327612|617425893|FG001|Overall Study|Withdrawal by Subject|0|||
170840733|NCT01327612|617425894|FG002|Overall Study|Withdrawal by Subject|0|||
170840734|NCT01327612|617425895|FG003|Overall Study|Withdrawal by Subject|0|||
170840735|NCT01327612|617425896|FG004|Overall Study|Withdrawal by Subject|0|||
170840736|NCT01327612|617425897|FG005|Overall Study|Withdrawal by Subject|1|||
170840737|NCT01327612|617425898|FG006|Overall Study|Withdrawal by Subject|0|||
170733518|NCT01889186|617031450|FG001|Overall Study|Investigator request|1|||
170733519|NCT01889186|617031449|FG000|Overall Study|Progressive disease- Richter's|12|||
170840738|NCT01327612|617425892|FG000|Overall Study|Disease Progression|1|||
170840739|NCT01327612|617425893|FG001|Overall Study|Disease Progression|1|||
170733520|NCT01889186|617031450|FG001|Overall Study|Progressive disease- Richter's|7|||
170733521|NCT01889186|617031449|FG000|Overall Study|Progressive disease per protocol|46|||
170733522|NCT01889186|617031450|FG001|Overall Study|Progressive disease per protocol|17|||
170733523|NCT01889186|617031449|FG000|Overall Study|Stem cell transplant|2|||
170733524|NCT01889186|617031450|FG001|Overall Study|Stem cell transplant|1|||
170733525|NCT01889186|617031449|FG000|Overall Study|Withdrew consent|2|||
170733526|NCT01889186|617031450|FG001|Overall Study|Withdrew consent|3|||
170733527|NCT01889186|617031449|FG000|Overall Study|Other, not specified|18|||
170733528|NCT01889186|617031450|FG001|Overall Study|Other, not specified|15|||
170733529|NCT04710927|617031451|FG000|Overall Study|Lost to Follow-up|7|||
170733530|NCT04710927|617031452|FG001|Overall Study|Lost to Follow-up|6|||
170733531|NCT04710927|617031453|FG002|Overall Study|Lost to Follow-up|5|||
170733532|NCT01201811|617031454|FG000|Overall Study|Adverse Event|6|||
170733533|NCT01201811|617031454|FG000|Overall Study|Disease progression|3|||
170733534|NCT01201811|617031454|FG000|Overall Study|Withdrawal by Subject|3|||
170733535|NCT01201811|617031454|FG000|Overall Study|Death|4|||
170733536|NCT01201811|617031454|FG000|Overall Study|Treatment Failure|2|||
170733537|NCT01201811|617031454|FG000|Overall Study|Physician Decision|1|||
170733538|NCT01058304|617031457|FG000|Overall Study|Withdrawal by Subject|8|||
170733539|NCT01058304|617031458|FG001|Overall Study|Withdrawal by Subject|5|||
170733540|NCT01058304|617031457|FG000|Overall Study|Lost to Follow-up|13|||
170733541|NCT01058304|617031458|FG001|Overall Study|Lost to Follow-up|16|||
170733542|NCT01058304|617031457|FG000|Overall Study|Developed exclusion criterion|6|||
170733543|NCT01058304|617031458|FG001|Overall Study|Developed exclusion criterion|12|||
170733544|NCT02496767|617031459|FG000|Open-label Lead-in Phase|Adverse Event|176|||
170733545|NCT02496767|617031460|FG001|Open-label Lead-in Phase|Adverse Event|0|||
170733546|NCT02496767|617031461|FG002|Open-label Lead-in Phase|Adverse Event|0|||
170733547|NCT02496767|617031462|FG003|Open-label Lead-in Phase|Adverse Event|0|||
170733548|NCT02496767|617031463|FG004|Open-label Lead-in Phase|Adverse Event|0|||
170733549|NCT02496767|617031464|FG005|Open-label Lead-in Phase|Adverse Event|0|||
170733550|NCT02496767|617031465|FG006|Open-label Lead-in Phase|Adverse Event|0|||
170733551|NCT02496767|617031466|FG007|Open-label Lead-in Phase|Adverse Event|0|||
170733552|NCT02496767|617031459|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
170733553|NCT02496767|617031460|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
170733554|NCT02496767|617031461|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
170733555|NCT02496767|617031462|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
170733556|NCT02496767|617031463|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
170733557|NCT02496767|617031464|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
170733558|NCT02496767|617031465|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
170733559|NCT02496767|617031466|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
170733560|NCT02496767|617031459|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
170733561|NCT02496767|617031460|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
170733562|NCT02496767|617031461|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
170733563|NCT02496767|617031462|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
170733564|NCT02496767|617031463|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
170733565|NCT02496767|617031464|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
170733566|NCT02496767|617031465|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
170733567|NCT02496767|617031466|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
170733568|NCT02496767|617031459|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
170733569|NCT02496767|617031460|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
170733570|NCT02496767|617031461|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
170733571|NCT02496767|617031462|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
170733572|NCT02496767|617031463|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
170733573|NCT02496767|617031464|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
170733574|NCT02496767|617031465|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
170733575|NCT02496767|617031466|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
170733576|NCT02496767|617031459|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
170733577|NCT02496767|617031460|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
170733578|NCT02496767|617031461|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
170733579|NCT02496767|617031462|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
170733580|NCT02496767|617031463|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
170733581|NCT02496767|617031464|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
170733582|NCT02496767|617031465|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
170733583|NCT02496767|617031466|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
170733584|NCT02496767|617031459|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
170733585|NCT02496767|617031460|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
170733586|NCT02496767|617031461|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
170733587|NCT02496767|617031462|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
170733588|NCT02496767|617031463|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
170733589|NCT02496767|617031464|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
170733590|NCT02496767|617031465|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
170733591|NCT02496767|617031466|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
170840740|NCT01327612|617425894|FG002|Overall Study|Disease Progression|1|||
170840741|NCT01327612|617425895|FG003|Overall Study|Disease Progression|0|||
170733592|NCT02496767|617031459|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
170733593|NCT02496767|617031460|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
170733594|NCT02496767|617031461|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
170733595|NCT02496767|617031462|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
170733596|NCT02496767|617031463|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
170733597|NCT02496767|617031464|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
170733598|NCT02496767|617031465|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
170733599|NCT02496767|617031466|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
170733600|NCT02496767|617031459|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
170733601|NCT02496767|617031460|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
170733602|NCT02496767|617031461|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
170733603|NCT02496767|617031462|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
170733604|NCT02496767|617031463|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
170733605|NCT02496767|617031464|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
170733606|NCT02496767|617031465|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
170733607|NCT02496767|617031466|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
170733608|NCT02496767|617031459|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
170733609|NCT02496767|617031460|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
170733610|NCT02496767|617031461|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
170733611|NCT02496767|617031462|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
170733612|NCT02496767|617031463|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
170733613|NCT02496767|617031464|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
170733614|NCT02496767|617031465|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
170733615|NCT02496767|617031466|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
170733616|NCT02496767|617031459|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170733617|NCT02496767|617031460|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
170733618|NCT02496767|617031461|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170733619|NCT02496767|617031462|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
170733620|NCT02496767|617031463|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
170733621|NCT02496767|617031464|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170733622|NCT02496767|617031465|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170733623|NCT02496767|617031466|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
170733624|NCT02496767|617031459|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
170733625|NCT02496767|617031460|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
170733626|NCT02496767|617031461|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
170733627|NCT02496767|617031462|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
170733628|NCT02496767|617031463|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
170733629|NCT02496767|617031464|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
170733630|NCT02496767|617031465|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
170733631|NCT02496767|617031466|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
170733632|NCT02496767|617031459|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
170733633|NCT02496767|617031460|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
170733634|NCT02496767|617031461|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
170733635|NCT02496767|617031462|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
170733636|NCT02496767|617031463|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
170733637|NCT02496767|617031464|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
170733638|NCT02496767|617031465|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
170733639|NCT02496767|617031466|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
170733640|NCT02496767|617031459|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
170733641|NCT02496767|617031460|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
170733642|NCT02496767|617031461|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
170733643|NCT02496767|617031462|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
170733644|NCT02496767|617031463|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
170733645|NCT02496767|617031464|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
170733646|NCT02496767|617031465|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
170733647|NCT02496767|617031466|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
170733648|NCT02496767|617031459|FG000|Double-blind, Withdrawal Phase|Death|0|||
170733649|NCT02496767|617031460|FG001|Double-blind, Withdrawal Phase|Death|0|||
170733650|NCT02496767|617031461|FG002|Double-blind, Withdrawal Phase|Death|0|||
170733651|NCT02496767|617031462|FG003|Double-blind, Withdrawal Phase|Death|0|||
170733652|NCT02496767|617031463|FG004|Double-blind, Withdrawal Phase|Death|0|||
170733653|NCT02496767|617031464|FG005|Double-blind, Withdrawal Phase|Death|0|||
170733654|NCT02496767|617031465|FG006|Double-blind, Withdrawal Phase|Death|1|||
170733655|NCT02496767|617031466|FG007|Double-blind, Withdrawal Phase|Death|2|||
170733656|NCT02496767|617031459|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
170733657|NCT02496767|617031460|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
170733658|NCT02496767|617031461|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
170733659|NCT02496767|617031462|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
170733660|NCT02496767|617031463|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
170733661|NCT02496767|617031464|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
170733662|NCT02496767|617031465|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
170733663|NCT02496767|617031466|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
170733664|NCT04035200|617031472|FG000|Overall Study|Lost to Follow-up|0|||
170733665|NCT04035200|617031473|FG001|Overall Study|Lost to Follow-up|1|||
170733666|NCT04035200|617031474|FG002|Overall Study|Lost to Follow-up|0|||
170733667|NCT04035200|617031472|FG000|Overall Study|Withdrawal by Subject|1|||
170733668|NCT04035200|617031473|FG001|Overall Study|Withdrawal by Subject|4|||
170733669|NCT04035200|617031474|FG002|Overall Study|Withdrawal by Subject|4|||
170733670|NCT04035200|617031472|FG000|Overall Study|COVID-19|1|||
170733671|NCT04035200|617031473|FG001|Overall Study|COVID-19|0|||
170733672|NCT04035200|617031474|FG002|Overall Study|COVID-19|0|||
170733673|NCT04035200|617031472|FG000|Overall Study|Early Termination|0|||
170733674|NCT04035200|617031473|FG001|Overall Study|Early Termination|1|||
170733675|NCT04035200|617031474|FG002|Overall Study|Early Termination|0|||
170733676|NCT04035200|617031472|FG000|Overall Study|Non-compliance|0|||
170733677|NCT04035200|617031473|FG001|Overall Study|Non-compliance|1|||
170733678|NCT04035200|617031474|FG002|Overall Study|Non-compliance|0|||
170733679|NCT02277990|617031475|FG000|Overall Study|Death|170|||
170733680|NCT02277990|617031476|FG001|Overall Study|Death|188|||
170733681|NCT02277990|617031475|FG000|Overall Study|Withdrawal by Subject|64|||
170733682|NCT02277990|617031476|FG001|Overall Study|Withdrawal by Subject|53|||
170733683|NCT02277990|617031475|FG000|Overall Study|Physician Decision|40|||
170733684|NCT02277990|617031476|FG001|Overall Study|Physician Decision|34|||
170733685|NCT02277990|617031475|FG000|Overall Study|Lost to Follow-up|66|||
170733686|NCT02277990|617031476|FG001|Overall Study|Lost to Follow-up|69|||
170733687|NCT02277990|617031475|FG000|Overall Study|Had other reason|26|||
170733688|NCT02277990|617031476|FG001|Overall Study|Had other reason|32|||
170733689|NCT01368965|617031477|FG000|Overall Study|Lost to Follow-up|12|||
170733690|NCT01533493|617031478|FG000|Overall Study|Adverse Event|2|||
170733691|NCT01533493|617031479|FG001|Overall Study|Adverse Event|1|||
170733692|NCT01533493|617031478|FG000|Overall Study|Withdrawal by Subject|1|||
170733693|NCT01533493|617031479|FG001|Overall Study|Withdrawal by Subject|2|||
170733694|NCT01533493|617031478|FG000|Overall Study|Lost to Follow-up|2|||
170733695|NCT01533493|617031479|FG001|Overall Study|Lost to Follow-up|0|||
170733696|NCT06351371|617031480|FG000|Overall Study|Mutation Status Not Confirmed|9|||
170733697|NCT06351371|617031480|FG000|Overall Study|Ineligible|1|||
170733698|NCT06351371|617031480|FG000|Overall Study|Adverse Event|4|||
170733699|NCT06351371|617031480|FG000|Overall Study|Death|1|||
170733700|NCT06351371|617031480|FG000|Overall Study|Disease progression|14|||
170733701|NCT06351371|617031480|FG000|Overall Study|Withdrawal by Subject|3|||
170733702|NCT06351371|617031480|FG000|Overall Study|Physician Decision|3|||
170733703|NCT03759834|617031481|FG000|Overall Study|Withdrawal by Subject|1|||
170733704|NCT00715429|617031484|FG000|Overall Study|Did not complete the study diary|0|||
170733705|NCT00715429|617031485|FG001|Overall Study|Did not complete the study diary|1|||
170733706|NCT04672941|617031493|FG000|Overall Study|Investigator decision|1|||
170733707|NCT04672941|617031493|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
170733708|NCT04672941|617031493|FG000|Overall Study|COVID-19 related but no adverse event|1|||
170733709|NCT04672941|617031493|FG000|Overall Study|Adverse Event|2|||
170840742|NCT01327612|617425896|FG004|Overall Study|Disease Progression|1|||
170840743|NCT01327612|617425897|FG005|Overall Study|Disease Progression|2|||
170840744|NCT01327612|617425898|FG006|Overall Study|Disease Progression|2|||
170840745|NCT01327612|617425892|FG000|Overall Study|Administrative Decision|0|||
170840746|NCT01327612|617425893|FG001|Overall Study|Administrative Decision|0|||
170840747|NCT01327612|617425894|FG002|Overall Study|Administrative Decision|0|||
170840748|NCT01327612|617425895|FG003|Overall Study|Administrative Decision|1|||
170840749|NCT01327612|617425896|FG004|Overall Study|Administrative Decision|0|||
170840750|NCT01327612|617425897|FG005|Overall Study|Administrative Decision|0|||
170840751|NCT01327612|617425898|FG006|Overall Study|Administrative Decision|0|||
170733710|NCT04672941|617031493|FG000|Overall Study|Lost to Follow-up|2|||
170733711|NCT00504426|617031500|FG000|Overall Study|Adverse Event|0|||
170840752|NCT01327612|617425892|FG000|Overall Study|Death|0|||
170733712|NCT00504426|617031501|FG001|Overall Study|Adverse Event|0|||
170733713|NCT00504426|617031502|FG002|Overall Study|Adverse Event|2|||
170733714|NCT00504426|617031503|FG003|Overall Study|Adverse Event|0|||
170733715|NCT00504426|617031500|FG000|Overall Study|Protocol Violation|1|||
170733716|NCT00504426|617031501|FG001|Overall Study|Protocol Violation|1|||
170733717|NCT00504426|617031502|FG002|Overall Study|Protocol Violation|2|||
170733718|NCT00504426|617031503|FG003|Overall Study|Protocol Violation|0|||
170733719|NCT00504426|617031500|FG000|Overall Study|Withdrawal by Subject|2|||
170733720|NCT00504426|617031501|FG001|Overall Study|Withdrawal by Subject|0|||
170733721|NCT00504426|617031502|FG002|Overall Study|Withdrawal by Subject|0|||
170733722|NCT00504426|617031503|FG003|Overall Study|Withdrawal by Subject|0|||
170733723|NCT03685591|617031504|FG000|Overall Study|Global Deterioration of Health Status|0|||
170733724|NCT03685591|617031505|FG001|Overall Study|Global Deterioration of Health Status|0|||
170733725|NCT03685591|617031506|FG002|Overall Study|Global Deterioration of Health Status|0|||
170733726|NCT03685591|617031507|FG003|Overall Study|Global Deterioration of Health Status|1|||
170733727|NCT03685591|617031508|FG004|Overall Study|Global Deterioration of Health Status|2|||
170733728|NCT03685591|617031509|FG005|Overall Study|Global Deterioration of Health Status|4|||
170733729|NCT03685591|617031510|FG006|Overall Study|Global Deterioration of Health Status|1|||
170733730|NCT03685591|617031511|FG007|Overall Study|Global Deterioration of Health Status|1|||
170733731|NCT03685591|617031512|FG008|Overall Study|Global Deterioration of Health Status|0|||
170733732|NCT03685591|617031504|FG000|Overall Study|Progressive Disease|1|||
170733733|NCT03685591|617031505|FG001|Overall Study|Progressive Disease|1|||
170733734|NCT03685591|617031506|FG002|Overall Study|Progressive Disease|0|||
170733735|NCT03685591|617031507|FG003|Overall Study|Progressive Disease|3|||
170733736|NCT03685591|617031508|FG004|Overall Study|Progressive Disease|5|||
170733737|NCT03685591|617031509|FG005|Overall Study|Progressive Disease|4|||
170733738|NCT03685591|617031510|FG006|Overall Study|Progressive Disease|3|||
170733739|NCT03685591|617031511|FG007|Overall Study|Progressive Disease|2|||
170733740|NCT03685591|617031512|FG008|Overall Study|Progressive Disease|1|||
170733741|NCT03685591|617031504|FG000|Overall Study|Other|0|||
170733742|NCT03685591|617031505|FG001|Overall Study|Other|0|||
170733743|NCT03685591|617031506|FG002|Overall Study|Other|1|||
170733744|NCT03685591|617031507|FG003|Overall Study|Other|0|||
170733745|NCT03685591|617031508|FG004|Overall Study|Other|2|||
170733746|NCT03685591|617031509|FG005|Overall Study|Other|3|||
170733747|NCT03685591|617031510|FG006|Overall Study|Other|0|||
170733748|NCT03685591|617031511|FG007|Overall Study|Other|0|||
170733749|NCT03685591|617031512|FG008|Overall Study|Other|0|||
170733750|NCT03685591|617031504|FG000|Overall Study|Withdrawal by Subject|0|||
170733751|NCT03685591|617031505|FG001|Overall Study|Withdrawal by Subject|0|||
170733752|NCT03685591|617031506|FG002|Overall Study|Withdrawal by Subject|0|||
170733753|NCT03685591|617031507|FG003|Overall Study|Withdrawal by Subject|0|||
170733754|NCT03685591|617031508|FG004|Overall Study|Withdrawal by Subject|3|||
170733755|NCT03685591|617031509|FG005|Overall Study|Withdrawal by Subject|2|||
170733756|NCT03685591|617031510|FG006|Overall Study|Withdrawal by Subject|0|||
170733757|NCT03685591|617031511|FG007|Overall Study|Withdrawal by Subject|0|||
170733758|NCT03685591|617031512|FG008|Overall Study|Withdrawal by Subject|1|||
170840753|NCT01327612|617425893|FG001|Overall Study|Death|0|||
170840754|NCT01327612|617425894|FG002|Overall Study|Death|0|||
170840755|NCT01327612|617425895|FG003|Overall Study|Death|0|||
170840756|NCT01327612|617425896|FG004|Overall Study|Death|1|||
170840757|NCT01327612|617425897|FG005|Overall Study|Death|0|||
170840758|NCT01327612|617425898|FG006|Overall Study|Death|0|||
170840759|NCT01967069|617425900|FG000|Overall Study|Adverse Event|2|||
170840760|NCT01967069|617425901|FG001|Overall Study|Adverse Event|2|||
170840761|NCT01967069|617425900|FG000|Overall Study|Lost to Follow-up|5|||
170840762|NCT01967069|617425901|FG001|Overall Study|Lost to Follow-up|2|||
170840763|NCT01967069|617425900|FG000|Overall Study|Withdrawal by Subject|1|||
170840764|NCT01967069|617425901|FG001|Overall Study|Withdrawal by Subject|3|||
170840765|NCT01967069|617425900|FG000|Overall Study|Lack of Efficacy|0|||
170840766|NCT01967069|617425901|FG001|Overall Study|Lack of Efficacy|1|||
170840767|NCT02766777|617425906|FG000|Overall Study|Adverse Event|12|||
170840768|NCT02766777|617425906|FG000|Overall Study|Lost to Follow-up|16|||
170840769|NCT02766777|617425906|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170840770|NCT02766777|617425906|FG000|Overall Study|Protocol Violation|1|||
170840771|NCT02766777|617425906|FG000|Overall Study|Withdrawal by Subject|4|||
170840772|NCT01886287|617425907|FG000|Overall Study|Radiographic disease progression|1|||
170840773|NCT01886287|617425907|FG000|Overall Study|Clinical progression due to disease|1|||
170840774|NCT03842228|617425908|FG000|Overall Study|Adverse Event|1|||
170840775|NCT03842228|617425909|FG001|Overall Study|Adverse Event|1|||
170840776|NCT03842228|617425910|FG002|Overall Study|Adverse Event|1|||
170733759|NCT03685591|617031504|FG000|Overall Study|Adverse Event|0|||
170733760|NCT03685591|617031505|FG001|Overall Study|Adverse Event|0|||
170733761|NCT03685591|617031506|FG002|Overall Study|Adverse Event|0|||
170733762|NCT03685591|617031507|FG003|Overall Study|Adverse Event|1|||
170840777|NCT03842228|617425911|FG003|Overall Study|Adverse Event|0|||
170840778|NCT03842228|617425912|FG004|Overall Study|Adverse Event|0|||
170840779|NCT03842228|617425913|FG005|Overall Study|Adverse Event|0|||
170840780|NCT03842228|617425914|FG006|Overall Study|Adverse Event|0|||
170733763|NCT03685591|617031508|FG004|Overall Study|Adverse Event|1|||
170733764|NCT03685591|617031509|FG005|Overall Study|Adverse Event|4|||
170733765|NCT03685591|617031510|FG006|Overall Study|Adverse Event|0|||
170733766|NCT03685591|617031511|FG007|Overall Study|Adverse Event|1|||
170840781|NCT03842228|617425908|FG000|Overall Study|Death|0|||
170733767|NCT03685591|617031512|FG008|Overall Study|Adverse Event|1|||
170733768|NCT01685138|617031513|FG000|Overall Study|Lost to Follow-up|1|||
170733769|NCT01685138|617031513|FG000|Overall Study|Protocol Violation|1|||
170733770|NCT01685138|617031513|FG000|Overall Study|No longer requires treatment|1|||
170733771|NCT01685138|617031513|FG000|Overall Study|Subject/guardian decision|2|||
170733772|NCT01685138|617031513|FG000|Overall Study|Physician Decision|6|||
170733773|NCT01685138|617031513|FG000|Overall Study|Death|10|||
170733774|NCT01685138|617031513|FG000|Overall Study|Adverse Event|18|||
170733775|NCT01685138|617031513|FG000|Overall Study|Progressive disease|53|||
170840782|NCT03842228|617425909|FG001|Overall Study|Death|1|||
170840783|NCT03842228|617425910|FG002|Overall Study|Death|0|||
170840784|NCT03842228|617425911|FG003|Overall Study|Death|0|||
170840785|NCT03842228|617425912|FG004|Overall Study|Death|0|||
170840786|NCT03842228|617425913|FG005|Overall Study|Death|0|||
170840787|NCT03842228|617425914|FG006|Overall Study|Death|0|||
170840788|NCT03842228|617425908|FG000|Overall Study|Withdrawal by Subject|0|||
170840789|NCT03842228|617425909|FG001|Overall Study|Withdrawal by Subject|0|||
170840790|NCT03842228|617425910|FG002|Overall Study|Withdrawal by Subject|2|||
170840791|NCT03842228|617425911|FG003|Overall Study|Withdrawal by Subject|1|||
170840792|NCT03842228|617425912|FG004|Overall Study|Withdrawal by Subject|0|||
170840793|NCT03842228|617425913|FG005|Overall Study|Withdrawal by Subject|0|||
170840794|NCT03842228|617425914|FG006|Overall Study|Withdrawal by Subject|2|||
170840795|NCT03842228|617425908|FG000|Overall Study|Progression|8|||
170840796|NCT03842228|617425909|FG001|Overall Study|Progression|1|||
170840797|NCT03842228|617425910|FG002|Overall Study|Progression|7|||
170840798|NCT03842228|617425911|FG003|Overall Study|Progression|5|||
170840799|NCT03842228|617425912|FG004|Overall Study|Progression|4|||
170840800|NCT03842228|617425913|FG005|Overall Study|Progression|2|||
170840801|NCT03842228|617425914|FG006|Overall Study|Progression|3|||
170840802|NCT01304498|617425915|FG000|Overall Study|Adverse Event|1|||
170840803|NCT01304498|617425916|FG001|Overall Study|Adverse Event|1|||
170840804|NCT01304498|617425915|FG000|Overall Study|Withdrawal by Subject|2|||
170840805|NCT01304498|617425916|FG001|Overall Study|Withdrawal by Subject|3|||
170840806|NCT01304498|617425915|FG000|Overall Study|Protocol Violation|1|||
170840807|NCT01304498|617425916|FG001|Overall Study|Protocol Violation|0|||
170840808|NCT01304498|617425915|FG000|Overall Study|Lost to Follow-up|2|||
170840809|NCT01304498|617425916|FG001|Overall Study|Lost to Follow-up|1|||
170840810|NCT02195479|617425925|FG000|Overall Study|Lost to Follow-up|18|||
170840811|NCT02195479|617425926|FG001|Overall Study|Lost to Follow-up|15|||
170840812|NCT02195479|617425925|FG000|Overall Study|Death|217|||
170840813|NCT02195479|617425926|FG001|Overall Study|Death|171|||
170840814|NCT02195479|617425925|FG000|Overall Study|Physician Decision|1|||
170840815|NCT02195479|617425926|FG001|Overall Study|Physician Decision|0|||
170733776|NCT00689026|617031516|FG000|Overall Study|Withdrawal by Subject|13|||
170733777|NCT00689026|617031517|FG001|Overall Study|Withdrawal by Subject|6|||
170733778|NCT03217747|617031520|FG000|Overall Study|Adverse Event|0|||
170733779|NCT03217747|617031521|FG001|Overall Study|Adverse Event|1|||
170733780|NCT03217747|617031522|FG002|Overall Study|Adverse Event|0|||
170733781|NCT03217747|617031523|FG003|Overall Study|Adverse Event|0|||
170733782|NCT03217747|617031524|FG004|Overall Study|Adverse Event|0|||
170733783|NCT03217747|617031525|FG005|Overall Study|Adverse Event|0|||
170733784|NCT03217747|617031526|FG006|Overall Study|Adverse Event|0|||
170733785|NCT03217747|617031527|FG007|Overall Study|Adverse Event|0|||
170733786|NCT03217747|617031528|FG008|Overall Study|Adverse Event|0|||
170733787|NCT03217747|617031529|FG009|Overall Study|Adverse Event|0|||
170733788|NCT03217747|617031530|FG010|Overall Study|Adverse Event|0|||
170733789|NCT03217747|617031531|FG011|Overall Study|Adverse Event|0|||
170733790|NCT03217747|617031532|FG012|Overall Study|Adverse Event|1|||
170733791|NCT03217747|617031533|FG013|Overall Study|Adverse Event|1|||
170733792|NCT03217747|617031520|FG000|Overall Study|Death|0|||
170733793|NCT03217747|617031521|FG001|Overall Study|Death|0|||
170733794|NCT03217747|617031522|FG002|Overall Study|Death|0|||
170733795|NCT03217747|617031523|FG003|Overall Study|Death|0|||
170733796|NCT03217747|617031524|FG004|Overall Study|Death|0|||
170733797|NCT03217747|617031525|FG005|Overall Study|Death|0|||
170733798|NCT03217747|617031526|FG006|Overall Study|Death|0|||
170733799|NCT03217747|617031527|FG007|Overall Study|Death|0|||
170840816|NCT02195479|617425925|FG000|Overall Study|Withdrawal by Subject|30|||
170840817|NCT02195479|617425926|FG001|Overall Study|Withdrawal by Subject|30|||
170840818|NCT02195479|617425925|FG000|Overall Study|Other|3|||
170840819|NCT02195479|617425926|FG001|Overall Study|Other|4|||
170840820|NCT02195479|617425925|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
170733800|NCT03217747|617031528|FG008|Overall Study|Death|1|||
170733801|NCT03217747|617031529|FG009|Overall Study|Death|0|||
170733802|NCT03217747|617031530|FG010|Overall Study|Death|0|||
170733803|NCT03217747|617031531|FG011|Overall Study|Death|0|||
170733804|NCT03217747|617031532|FG012|Overall Study|Death|0|||
170840821|NCT02195479|617425926|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
170733805|NCT03217747|617031533|FG013|Overall Study|Death|0|||
170733806|NCT03217747|617031520|FG000|Overall Study|Lack of Efficacy|12|||
170840822|NCT03325777|617425927|FG000|Overall Study|Lost to Follow-up|9|||
170733807|NCT03217747|617031521|FG001|Overall Study|Lack of Efficacy|6|||
170733808|NCT03217747|617031522|FG002|Overall Study|Lack of Efficacy|15|||
170733809|NCT03217747|617031523|FG003|Overall Study|Lack of Efficacy|11|||
170733810|NCT03217747|617031524|FG004|Overall Study|Lack of Efficacy|3|||
170733811|NCT03217747|617031525|FG005|Overall Study|Lack of Efficacy|14|||
170733812|NCT03217747|617031526|FG006|Overall Study|Lack of Efficacy|10|||
170733813|NCT03217747|617031527|FG007|Overall Study|Lack of Efficacy|4|||
170733814|NCT03217747|617031528|FG008|Overall Study|Lack of Efficacy|2|||
170733815|NCT03217747|617031529|FG009|Overall Study|Lack of Efficacy|7|||
170733816|NCT03217747|617031530|FG010|Overall Study|Lack of Efficacy|3|||
170733817|NCT03217747|617031531|FG011|Overall Study|Lack of Efficacy|1|||
170733818|NCT03217747|617031532|FG012|Overall Study|Lack of Efficacy|3|||
170733819|NCT03217747|617031533|FG013|Overall Study|Lack of Efficacy|1|||
170733820|NCT03217747|617031520|FG000|Overall Study|Withdrawal by Subject|2|||
170733821|NCT03217747|617031521|FG001|Overall Study|Withdrawal by Subject|1|||
170733822|NCT03217747|617031522|FG002|Overall Study|Withdrawal by Subject|1|||
170733823|NCT03217747|617031523|FG003|Overall Study|Withdrawal by Subject|1|||
170733824|NCT03217747|617031524|FG004|Overall Study|Withdrawal by Subject|1|||
170733825|NCT03217747|617031525|FG005|Overall Study|Withdrawal by Subject|2|||
170733826|NCT03217747|617031526|FG006|Overall Study|Withdrawal by Subject|1|||
170733827|NCT03217747|617031527|FG007|Overall Study|Withdrawal by Subject|0|||
170733828|NCT03217747|617031528|FG008|Overall Study|Withdrawal by Subject|0|||
170733829|NCT03217747|617031529|FG009|Overall Study|Withdrawal by Subject|0|||
170733830|NCT03217747|617031530|FG010|Overall Study|Withdrawal by Subject|0|||
170733831|NCT03217747|617031531|FG011|Overall Study|Withdrawal by Subject|1|||
170733832|NCT03217747|617031532|FG012|Overall Study|Withdrawal by Subject|0|||
170733833|NCT03217747|617031533|FG013|Overall Study|Withdrawal by Subject|1|||
170733834|NCT03217747|617031520|FG000|Overall Study|Toxicity and progression|1|||
170733835|NCT03217747|617031521|FG001|Overall Study|Toxicity and progression|0|||
170733836|NCT03217747|617031522|FG002|Overall Study|Toxicity and progression|0|||
170733837|NCT03217747|617031523|FG003|Overall Study|Toxicity and progression|0|||
170733838|NCT03217747|617031524|FG004|Overall Study|Toxicity and progression|0|||
170733839|NCT03217747|617031525|FG005|Overall Study|Toxicity and progression|0|||
170733840|NCT03217747|617031526|FG006|Overall Study|Toxicity and progression|0|||
170733841|NCT03217747|617031527|FG007|Overall Study|Toxicity and progression|0|||
170733842|NCT03217747|617031528|FG008|Overall Study|Toxicity and progression|0|||
170733843|NCT03217747|617031529|FG009|Overall Study|Toxicity and progression|0|||
170733844|NCT03217747|617031530|FG010|Overall Study|Toxicity and progression|0|||
170733845|NCT03217747|617031531|FG011|Overall Study|Toxicity and progression|0|||
170733846|NCT03217747|617031532|FG012|Overall Study|Toxicity and progression|0|||
170733847|NCT03217747|617031533|FG013|Overall Study|Toxicity and progression|0|||
170733848|NCT03217747|617031520|FG000|Overall Study|Removal of sole target lesion|1|||
170733849|NCT03217747|617031521|FG001|Overall Study|Removal of sole target lesion|0|||
170733850|NCT03217747|617031522|FG002|Overall Study|Removal of sole target lesion|0|||
170733851|NCT03217747|617031523|FG003|Overall Study|Removal of sole target lesion|0|||
170733852|NCT03217747|617031524|FG004|Overall Study|Removal of sole target lesion|0|||
170733853|NCT03217747|617031525|FG005|Overall Study|Removal of sole target lesion|0|||
170733854|NCT03217747|617031526|FG006|Overall Study|Removal of sole target lesion|0|||
170733855|NCT03217747|617031527|FG007|Overall Study|Removal of sole target lesion|0|||
170733856|NCT03217747|617031528|FG008|Overall Study|Removal of sole target lesion|0|||
170733857|NCT03217747|617031529|FG009|Overall Study|Removal of sole target lesion|0|||
170733858|NCT03217747|617031530|FG010|Overall Study|Removal of sole target lesion|0|||
170733859|NCT03217747|617031531|FG011|Overall Study|Removal of sole target lesion|0|||
170733860|NCT03217747|617031532|FG012|Overall Study|Removal of sole target lesion|0|||
170733861|NCT03217747|617031533|FG013|Overall Study|Removal of sole target lesion|0|||
170733862|NCT03217747|617031520|FG000|Overall Study|Stroke|0|||
170733863|NCT03217747|617031521|FG001|Overall Study|Stroke|0|||
170733864|NCT03217747|617031522|FG002|Overall Study|Stroke|0|||
170733865|NCT03217747|617031523|FG003|Overall Study|Stroke|0|||
170733866|NCT03217747|617031524|FG004|Overall Study|Stroke|0|||
170733867|NCT03217747|617031525|FG005|Overall Study|Stroke|1|||
170733868|NCT03217747|617031526|FG006|Overall Study|Stroke|0|||
170733869|NCT03217747|617031527|FG007|Overall Study|Stroke|0|||
170733870|NCT03217747|617031528|FG008|Overall Study|Stroke|0|||
170733871|NCT03217747|617031529|FG009|Overall Study|Stroke|0|||
170733872|NCT03217747|617031530|FG010|Overall Study|Stroke|0|||
170733873|NCT03217747|617031531|FG011|Overall Study|Stroke|1|||
170840823|NCT03325777|617425928|FG001|Overall Study|Lost to Follow-up|12|||
170733874|NCT03217747|617031532|FG012|Overall Study|Stroke|0|||
170733875|NCT03217747|617031533|FG013|Overall Study|Stroke|0|||
170733876|NCT03996291|617031534|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
170733877|NCT03996291|617031535|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
170733878|NCT03996291|617031536|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
170733879|NCT03996291|617031537|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
170733880|NCT03996291|617031538|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
170733881|NCT03996291|617031539|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
170733882|NCT03996291|617031540|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
170733883|NCT03996291|617031541|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
170733884|NCT03996291|617031534|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
170733885|NCT03996291|617031535|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
170733886|NCT03996291|617031536|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
170733887|NCT03996291|617031537|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
170733888|NCT03996291|617031538|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
170733889|NCT03996291|617031539|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
170733890|NCT03996291|617031540|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
170733891|NCT03996291|617031541|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
170733892|NCT03996291|617031534|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
170733893|NCT03996291|617031535|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
170733894|NCT03996291|617031536|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
170733895|NCT03996291|617031537|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
170733896|NCT03996291|617031538|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
170733897|NCT03996291|617031539|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
170733898|NCT03996291|617031540|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
170733899|NCT03996291|617031541|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
170733900|NCT03996291|617031534|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
170733901|NCT03996291|617031535|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
170733902|NCT03996291|617031536|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
170733903|NCT03996291|617031537|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
170733904|NCT03996291|617031538|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
170733905|NCT03996291|617031539|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
170733906|NCT03996291|617031540|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
170733907|NCT03996291|617031541|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
170733908|NCT03996291|617031534|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
170733909|NCT03996291|617031535|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
170733910|NCT03996291|617031536|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
170733911|NCT03996291|617031537|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
170733912|NCT03996291|617031538|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
170733913|NCT03996291|617031539|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
170733914|NCT03996291|617031540|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
170733915|NCT03996291|617031541|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
170733916|NCT03933826|617031542|FG000|Overall Study|Withdrawal by Subject|8|||
170733917|NCT03933826|617031543|FG001|Overall Study|Withdrawal by Subject|1|||
170733918|NCT03933826|617031542|FG000|Overall Study|Death|19|||
170733919|NCT03933826|617031543|FG001|Overall Study|Death|11|||
170733920|NCT03933826|617031542|FG000|Overall Study|Lost to Follow-up|41|||
170733921|NCT03933826|617031543|FG001|Overall Study|Lost to Follow-up|13|||
170733922|NCT03599349|617031544|FG000|Overall Study|Lost to Follow-up|1|||
170733923|NCT02638948|617031545|FG000|Overall Study|Withdrawal by Subject|4|||
170733924|NCT02638948|617031546|FG001|Overall Study|Withdrawal by Subject|5|||
170733925|NCT02638948|617031547|FG002|Overall Study|Withdrawal by Subject|3|||
170733926|NCT02638948|617031548|FG003|Overall Study|Withdrawal by Subject|1|||
170733927|NCT02638948|617031545|FG000|Overall Study|Administrative Reason by Sponsor|0|||
170733928|NCT02638948|617031546|FG001|Overall Study|Administrative Reason by Sponsor|1|||
170733929|NCT02638948|617031547|FG002|Overall Study|Administrative Reason by Sponsor|0|||
170733930|NCT02638948|617031548|FG003|Overall Study|Administrative Reason by Sponsor|4|||
170733931|NCT02638948|617031545|FG000|Overall Study|Adverse Event|0|||
170733932|NCT02638948|617031546|FG001|Overall Study|Adverse Event|0|||
170733933|NCT02638948|617031547|FG002|Overall Study|Adverse Event|1|||
170733934|NCT02638948|617031548|FG003|Overall Study|Adverse Event|1|||
170733935|NCT02638948|617031545|FG000|Overall Study|Lack of Efficacy|1|||
170733936|NCT02638948|617031546|FG001|Overall Study|Lack of Efficacy|1|||
170733937|NCT02638948|617031547|FG002|Overall Study|Lack of Efficacy|0|||
170733938|NCT02638948|617031548|FG003|Overall Study|Lack of Efficacy|0|||
170733939|NCT02638948|617031545|FG000|Overall Study|Lost to Follow-up|0|||
170733940|NCT02638948|617031546|FG001|Overall Study|Lost to Follow-up|0|||
170733941|NCT02638948|617031547|FG002|Overall Study|Lost to Follow-up|1|||
170733942|NCT02638948|617031548|FG003|Overall Study|Lost to Follow-up|1|||
170733943|NCT02638948|617031545|FG000|Overall Study|Poor/Non-Compliance|0|||
170733944|NCT02638948|617031546|FG001|Overall Study|Poor/Non-Compliance|2|||
170733945|NCT02638948|617031547|FG002|Overall Study|Poor/Non-Compliance|1|||
170733946|NCT02638948|617031548|FG003|Overall Study|Poor/Non-Compliance|0|||
170733947|NCT02638948|617031545|FG000|Overall Study|Participant no longer met study criteria|0|||
170733948|NCT02638948|617031546|FG001|Overall Study|Participant no longer met study criteria|1|||
170733949|NCT02638948|617031547|FG002|Overall Study|Participant no longer met study criteria|0|||
170733950|NCT02638948|617031548|FG003|Overall Study|Participant no longer met study criteria|0|||
170733951|NCT02638948|617031545|FG000|Overall Study|Other than specified above|4|||
170733952|NCT02638948|617031546|FG001|Overall Study|Other than specified above|1|||
170733953|NCT02638948|617031547|FG002|Overall Study|Other than specified above|1|||
170733954|NCT02638948|617031548|FG003|Overall Study|Other than specified above|1|||
170733955|NCT03248375|617031549|FG000|Overall Study|Lost to Follow-up|5|||
170733956|NCT04992546|617031550|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
170733957|NCT04992546|617031550|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
170733958|NCT04992546|617031550|FG000|Open-Label Treatment Period|Adverse Event|3|||
170733959|NCT04992546|617031550|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
170733960|NCT00394355|617031552|FG000|Overall Study|Adverse Event|10|||
170733961|NCT00394355|617031553|FG001|Overall Study|Adverse Event|6|||
170733962|NCT00394355|617031554|FG002|Overall Study|Adverse Event|7|||
170733963|NCT00394355|617031555|FG003|Overall Study|Adverse Event|8|||
170840824|NCT03004404|617425930|FG000|Period 2|Adverse Event|0|||
170840825|NCT03004404|617425931|FG001|Period 2|Adverse Event|0|||
170840826|NCT03004404|617425932|FG002|Period 2|Adverse Event|0|||
170840827|NCT03004404|617425933|FG003|Period 2|Adverse Event|0|||
170840828|NCT03004404|617425934|FG004|Period 2|Adverse Event|0|||
170840829|NCT03004404|617425935|FG005|Period 2|Adverse Event|0|||
170840830|NCT03004404|617425936|FG006|Period 2|Adverse Event|0|||
170840831|NCT03004404|617425937|FG007|Period 2|Adverse Event|0|||
170840832|NCT03004404|617425938|FG008|Period 2|Adverse Event|1|||
170840833|NCT03004404|617425939|FG009|Period 2|Adverse Event|0|||
170840834|NCT03004404|617425940|FG010|Period 2|Adverse Event|0|||
170840835|NCT03004404|617425941|FG011|Period 2|Adverse Event|0|||
170840836|NCT03004404|617425942|FG012|Period 2|Adverse Event|0|||
170840837|NCT03004404|617425943|FG013|Period 2|Adverse Event|0|||
170840838|NCT03004404|617425944|FG014|Period 2|Adverse Event|0|||
170840839|NCT03004404|617425945|FG015|Period 2|Adverse Event|1|||
170840840|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
170840841|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
170840842|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
170840843|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
170840844|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
170840845|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
170840846|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
170840847|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
170840848|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
170840849|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
170840850|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
170840851|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
170840852|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
170840853|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
170840854|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
170840855|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
170840856|NCT04210843|617425950|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
170840857|NCT04210843|617425951|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
170840858|NCT04210843|617425950|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
170840859|NCT04210843|617425951|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
170840860|NCT04210843|617425950|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
170840861|NCT04210843|617425951|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
170840862|NCT04210843|617425950|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
170840863|NCT04210843|617425951|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
170840864|NCT04210843|617425950|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
170840865|NCT04210843|617425951|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
170840866|NCT04210843|617425950|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
170840867|NCT04210843|617425951|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
170840868|NCT04210843|617425950|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
170840869|NCT04210843|617425951|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
170840870|NCT04210843|617425950|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
170840871|NCT04210843|617425951|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
170840872|NCT04210843|617425950|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
170840873|NCT04210843|617425951|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
170840874|NCT04210843|617425950|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
170840875|NCT04210843|617425951|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
170733964|NCT00394355|617031552|FG000|Overall Study|Did not meet protocol eligibility|1|||
170733965|NCT00394355|617031553|FG001|Overall Study|Did not meet protocol eligibility|5|||
170840876|NCT04210843|617425950|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
170840877|NCT04210843|617425951|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
170840878|NCT04210843|617425950|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
170840879|NCT04210843|617425951|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
170840880|NCT04210843|617425950|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
170840881|NCT04210843|617425951|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
170840882|NCT04210843|617425950|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
170840883|NCT04210843|617425951|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
170840884|NCT04210843|617425950|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
170840885|NCT04210843|617425951|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
170840886|NCT04210843|617425950|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
170840887|NCT04210843|617425951|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
170840888|NCT01099917|617425952|FG000|Overall Study|Adverse Event|3|||
170840889|NCT01099917|617425952|FG000|Overall Study|Not Treated|24|||
170840890|NCT02990468|617425953|FG000|Phase 2: MTD|Change in treatment|0|||
170840891|NCT02990468|617425954|FG001|Phase 2: MTD|Change in treatment|0|||
170840892|NCT02990468|617425955|FG002|Phase 2: MTD|Change in treatment|1|||
170840893|NCT01721954|617425966|FG000|Overall Study|Death|58|||
170840894|NCT01721954|617425967|FG001|Overall Study|Death|64|||
170840895|NCT01721954|617425966|FG000|Overall Study|Withdrawal by Subject|8|||
170840896|NCT01721954|617425967|FG001|Overall Study|Withdrawal by Subject|4|||
170840897|NCT01721954|617425966|FG000|Overall Study|Adverse Event|2|||
170840898|NCT01721954|617425967|FG001|Overall Study|Adverse Event|0|||
170840899|NCT01721954|617425966|FG000|Overall Study|Lost to Follow-up|2|||
170840900|NCT01721954|617425967|FG001|Overall Study|Lost to Follow-up|1|||
170840901|NCT01825577|617425968|FG000|Overall Study|Physician Decision|2|||
170840902|NCT01825577|617425968|FG000|Overall Study|Withdrawal by Subject|1|||
170840903|NCT01825577|617425968|FG000|Overall Study|Withdrawn by family members|2|||
170840904|NCT01825577|617425968|FG000|Overall Study|Lack of Efficacy|3|||
170840905|NCT01228175|617425969|FG000|Overall Study|Lost to Follow-up|64|||
170840906|NCT01228175|617425970|FG001|Overall Study|Lost to Follow-up|50|||
170840907|NCT01228175|617425969|FG000|Overall Study|Withdrawal by Subject|1|||
170840908|NCT01228175|617425970|FG001|Overall Study|Withdrawal by Subject|2|||
170840909|NCT01228175|617425969|FG000|Overall Study|Physician Decision|1|||
170733966|NCT00394355|617031554|FG002|Overall Study|Did not meet protocol eligibility|4|||
170733967|NCT00394355|617031555|FG003|Overall Study|Did not meet protocol eligibility|2|||
170733968|NCT00394355|617031552|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
170733969|NCT00394355|617031553|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
170733970|NCT00394355|617031554|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
170733971|NCT00394355|617031555|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
170733972|NCT00394355|617031552|FG000|Overall Study|Subject withdrawal - related to drug|1|||
170733973|NCT00394355|617031553|FG001|Overall Study|Subject withdrawal - related to drug|0|||
170733974|NCT00394355|617031554|FG002|Overall Study|Subject withdrawal - related to drug|0|||
170733975|NCT00394355|617031555|FG003|Overall Study|Subject withdrawal - related to drug|0|||
170733976|NCT00394355|617031552|FG000|Overall Study|Lost to Follow-up|7|||
170733977|NCT00394355|617031553|FG001|Overall Study|Lost to Follow-up|5|||
170733978|NCT00394355|617031554|FG002|Overall Study|Lost to Follow-up|4|||
170733979|NCT00394355|617031555|FG003|Overall Study|Lost to Follow-up|3|||
170733980|NCT00394355|617031552|FG000|Overall Study|Noncompliance with protocol|4|||
170733981|NCT00394355|617031553|FG001|Overall Study|Noncompliance with protocol|3|||
170733982|NCT00394355|617031554|FG002|Overall Study|Noncompliance with protocol|10|||
170733983|NCT00394355|617031555|FG003|Overall Study|Noncompliance with protocol|8|||
170733984|NCT00394355|617031552|FG000|Overall Study|Administrative|0|||
170840910|NCT01228175|617425970|FG001|Overall Study|Physician Decision|1|||
170840911|NCT02227992|617425971|FG000|Overall Study|Lost to Follow-up|1|||
170840912|NCT02227992|617425972|FG001|Overall Study|Lost to Follow-up|1|||
170840913|NCT00632502|617425975|FG000|Overall Study|Adverse Event|0|||
170840914|NCT00632502|617425976|FG001|Overall Study|Adverse Event|1|||
170733985|NCT00394355|617031553|FG001|Overall Study|Administrative|1|||
170733986|NCT00394355|617031554|FG002|Overall Study|Administrative|1|||
170733987|NCT00394355|617031555|FG003|Overall Study|Administrative|1|||
170733988|NCT00394355|617031552|FG000|Overall Study|Lack of Efficacy|0|||
170840915|NCT00632502|617425975|FG000|Overall Study|Randomized not treated|3|||
170840916|NCT00632502|617425976|FG001|Overall Study|Randomized not treated|0|||
170840917|NCT01447576|617425980|FG000|Overall Study|Lost to Follow-up|52|||
170840918|NCT01447576|617425980|FG000|Overall Study|Adverse Event|127|||
170733989|NCT00394355|617031553|FG001|Overall Study|Lack of Efficacy|0|||
170840919|NCT01447576|617425980|FG000|Overall Study|Participant met withdrawal criteria|40|||
170840920|NCT01447576|617425980|FG000|Overall Study|Withdrawal by Subject|100|||
170840921|NCT01447576|617425980|FG000|Overall Study|Protocol deviation|83|||
170840922|NCT01447576|617425980|FG000|Overall Study|Lack of Efficacy|68|||
170840923|NCT01447576|617425980|FG000|Overall Study|Physician Decision|6|||
170840924|NCT00975676|617425981|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
170840925|NCT00975676|617425982|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
170840926|NCT02209181|617425983|FG000|Overall Study|Adverse Event|1|||
170840927|NCT02209181|617425984|FG001|Overall Study|Adverse Event|0|||
170840928|NCT02209181|617425985|FG002|Overall Study|Adverse Event|1|||
170840929|NCT02209181|617425986|FG003|Overall Study|Adverse Event|0|||
170840930|NCT02209181|617425983|FG000|Overall Study|Withdrawal by Subject|0|||
170840931|NCT02209181|617425984|FG001|Overall Study|Withdrawal by Subject|1|||
170733990|NCT00394355|617031554|FG002|Overall Study|Lack of Efficacy|2|||
170733991|NCT00394355|617031555|FG003|Overall Study|Lack of Efficacy|3|||
170733992|NCT01648348|617031556|FG000|Overall Study|Cancel|1|||
170733993|NCT01648348|617031557|FG001|Overall Study|Cancel|0|||
170733994|NCT01648348|617031558|FG002|Overall Study|Cancel|0|||
170733995|NCT01648348|617031559|FG003|Overall Study|Cancel|0|||
170733996|NCT01648348|617031560|FG004|Overall Study|Cancel|3|||
170733997|NCT01648348|617031561|FG005|Overall Study|Cancel|6|||
170733998|NCT01648348|617031556|FG000|Overall Study|Replaced for MTD analysis|1|||
170733999|NCT01648348|617031557|FG001|Overall Study|Replaced for MTD analysis|0|||
170734000|NCT01648348|617031558|FG002|Overall Study|Replaced for MTD analysis|1|||
170734001|NCT01648348|617031559|FG003|Overall Study|Replaced for MTD analysis|0|||
170734002|NCT01648348|617031560|FG004|Overall Study|Replaced for MTD analysis|0|||
170734003|NCT01648348|617031561|FG005|Overall Study|Replaced for MTD analysis|0|||
170734004|NCT00552084|617031564|FG000|Overall Study|Adverse Event|2|||
170734005|NCT00552084|617031565|FG001|Overall Study|Adverse Event|3|||
170734006|NCT00552084|617031564|FG000|Overall Study|Withdrawal by Subject|4|||
170734007|NCT00552084|617031565|FG001|Overall Study|Withdrawal by Subject|5|||
170734008|NCT00552084|617031564|FG000|Overall Study|Protocol Violation|1|||
170734009|NCT00552084|617031565|FG001|Overall Study|Protocol Violation|0|||
170734010|NCT00552084|617031564|FG000|Overall Study|change in anti-arrythmic drug|1|||
170734011|NCT00552084|617031565|FG001|Overall Study|change in anti-arrythmic drug|1|||
170734012|NCT03657277|617031566|FG000|Overall Study|Physician Decision|2|||
170734013|NCT03657277|617031566|FG000|Overall Study|Lost to Follow-up|1|||
170734014|NCT03657277|617031566|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
170734015|NCT01024608|617031569|FG000|Overall Study|Adverse Event|1|||
170734016|NCT01024608|617031570|FG001|Overall Study|Adverse Event|0|||
170734017|NCT01024608|617031569|FG000|Overall Study|Withdrawal by Subject|1|||
170734018|NCT01024608|617031570|FG001|Overall Study|Withdrawal by Subject|0|||
170734019|NCT01024608|617031569|FG000|Overall Study|Lost to Follow-up|0|||
170840932|NCT02209181|617425985|FG002|Overall Study|Withdrawal by Subject|0|||
170840933|NCT02209181|617425986|FG003|Overall Study|Withdrawal by Subject|0|||
170840934|NCT02548078|617425987|FG000|Overall Study|Serious adverse event/Adverse event|1|||
170840935|NCT02548078|617425988|FG001|Overall Study|Serious adverse event/Adverse event|0|||
170840936|NCT02548078|617425987|FG000|Overall Study|Moved from study area|3|||
170840937|NCT02548078|617425988|FG001|Overall Study|Moved from study area|3|||
170840938|NCT02548078|617425987|FG000|Overall Study|Lost to Follow-up|1|||
170840939|NCT02548078|617425988|FG001|Overall Study|Lost to Follow-up|3|||
170840940|NCT02579772|617425989|FG000|Overall Study|Withdrawal by Subject|0|||
170840941|NCT02579772|617425990|FG001|Overall Study|Withdrawal by Subject|1|||
170840942|NCT02579772|617425989|FG000|Overall Study|Usage of additional antioxidants|1|||
170840943|NCT02579772|617425990|FG001|Overall Study|Usage of additional antioxidants|0|||
170840944|NCT02579772|617425989|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
170840945|NCT02579772|617425990|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
170840946|NCT01040169|617425991|FG000|Overall Study|Lost to Follow-up|3|||
170840947|NCT01040169|617425992|FG001|Overall Study|Lost to Follow-up|8|||
170840948|NCT03128671|617425993|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
170840949|NCT03128671|617425994|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
170840950|NCT03128671|617425993|FG000|Allocation|Death|1|||
170840951|NCT03128671|617425994|FG001|Allocation|Death|0|||
170840952|NCT03128671|617425993|FG000|Allocation|Withdrawal by Subject|4|||
170840953|NCT03128671|617425994|FG001|Allocation|Withdrawal by Subject|0|||
170840954|NCT03128671|617425993|FG000|Intervention|Withdrawal by Subject|11|||
170840955|NCT03128671|617425994|FG001|Intervention|Withdrawal by Subject|10|||
170840956|NCT03128671|617425993|FG000|Intervention|Palliative/hospice care initiated|9|||
170840957|NCT03128671|617425994|FG001|Intervention|Palliative/hospice care initiated|10|||
170840958|NCT03128671|617425993|FG000|Intervention|Death|13|||
170840959|NCT03128671|617425994|FG001|Intervention|Death|11|||
170840960|NCT03128671|617425993|FG000|Intervention|Interrupted by hurricane|1|||
170840961|NCT03128671|617425994|FG001|Intervention|Interrupted by hurricane|0|||
170840962|NCT03128671|617425993|FG000|Intervention|Physician Decision|2|||
170840963|NCT03128671|617425994|FG001|Intervention|Physician Decision|3|||
170840964|NCT04641962|617425996|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
170840965|NCT04641962|617425997|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
170840966|NCT04641962|617425998|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
170840967|NCT04641962|617425999|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
170734020|NCT01024608|617031570|FG001|Overall Study|Lost to Follow-up|1|||
170734021|NCT01024608|617031569|FG000|Overall Study|Protocol Violation|0|||
170734022|NCT01024608|617031570|FG001|Overall Study|Protocol Violation|3|||
170734023|NCT01024608|617031569|FG000|Overall Study|Never received study treatment|2|||
170734024|NCT01024608|617031570|FG001|Overall Study|Never received study treatment|0|||
170840968|NCT04641962|617426000|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
170840969|NCT04641962|617425996|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
170840970|NCT04641962|617425997|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
170840971|NCT04641962|617425998|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
170840972|NCT04641962|617425999|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
170734025|NCT04922554|617031572|FG000|Overall Study|Adverse Event|4|||
170734026|NCT04922554|617031573|FG001|Overall Study|Adverse Event|0|||
170734027|NCT04922554|617031572|FG000|Overall Study|Withdrawal by Subject|1|||
170734028|NCT04922554|617031573|FG001|Overall Study|Withdrawal by Subject|0|||
170734029|NCT01529008|617033165|FG000|Bone Marrow Harvesting|Physician Decision|1|||
170734030|NCT01529008|617033166|FG001|Bone Marrow Harvesting|Physician Decision|1|||
170734031|NCT01529008|617033165|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
170734032|NCT01529008|617033166|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
170734033|NCT01529008|617033165|FG000|Treatment|Adverse Event|6|||
170734034|NCT01529008|617033166|FG001|Treatment|Adverse Event|0|||
170734035|NCT01529008|617033165|FG000|Treatment|Other|3|||
170734036|NCT01529008|617033166|FG001|Treatment|Other|1|||
170734037|NCT01529008|617033165|FG000|Efficacy Analysis|Protocol Violation|2|||
170734038|NCT01529008|617033166|FG001|Efficacy Analysis|Protocol Violation|0|||
170734039|NCT01529008|617033165|FG000|Efficacy Analysis|Physician Decision|0|||
170734040|NCT01529008|617033166|FG001|Efficacy Analysis|Physician Decision|1|||
170734041|NCT01529008|617033165|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
170734042|NCT01529008|617033166|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
170734043|NCT04170686|617033171|FG000|Screening|Physician Decision|12|||
170734044|NCT04170686|617033172|FG001|Screening|Physician Decision|13|||
170734045|NCT04170686|617033171|FG000|Randomization and Treatment|Lost to Follow-up|26|||
170734046|NCT04170686|617033172|FG001|Randomization and Treatment|Lost to Follow-up|15|||
170734047|NCT04669600|617033177|FG000|Overall Study|Withdrawal by Subject|1|||
170734048|NCT04669600|617033177|FG000|Overall Study|Other|6|||
170840973|NCT04641962|617426000|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
170840974|NCT04641962|617425996|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
170840975|NCT04641962|617425997|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
170840976|NCT04641962|617425998|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
170840977|NCT04641962|617425999|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
170840978|NCT04641962|617426000|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
170840979|NCT04641962|617425996|FG000|DBT Period: Up to 52 Weeks|Death|1|||
170840980|NCT04641962|617425997|FG001|DBT Period: Up to 52 Weeks|Death|0|||
170840981|NCT04641962|617425998|FG002|DBT Period: Up to 52 Weeks|Death|0|||
170840982|NCT04641962|617425999|FG003|DBT Period: Up to 52 Weeks|Death|0|||
170840983|NCT04641962|617426000|FG004|DBT Period: Up to 52 Weeks|Death|0|||
170840984|NCT04641962|617425996|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
170840985|NCT04641962|617425997|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
170840986|NCT04641962|617425998|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
170840987|NCT04641962|617425999|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
170840988|NCT04641962|617426000|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
170734049|NCT04857034|617033184|FG000|Placebo-Controlled Period|Request to discontinue|2|||
170734050|NCT04857034|617033185|FG001|Placebo-Controlled Period|Request to discontinue|2|||
170734051|NCT04857034|617033186|FG002|Placebo-Controlled Period|Request to discontinue|0|||
170734052|NCT04857034|617033187|FG003|Placebo-Controlled Period|Request to discontinue|0|||
170734053|NCT04857034|617033188|FG004|Placebo-Controlled Period|Request to discontinue|0|||
170734054|NCT04857034|617033184|FG000|Placebo-Controlled Period|withdrew consent|1|||
170734055|NCT04857034|617033185|FG001|Placebo-Controlled Period|withdrew consent|1|||
170734056|NCT04857034|617033186|FG002|Placebo-Controlled Period|withdrew consent|2|||
170734057|NCT04857034|617033187|FG003|Placebo-Controlled Period|withdrew consent|0|||
170734058|NCT04857034|617033188|FG004|Placebo-Controlled Period|withdrew consent|0|||
170734059|NCT04857034|617033184|FG000|Placebo-Controlled Period|Pregnancy|1|||
170734060|NCT04857034|617033185|FG001|Placebo-Controlled Period|Pregnancy|1|||
170734061|NCT04857034|617033186|FG002|Placebo-Controlled Period|Pregnancy|0|||
170734062|NCT04857034|617033187|FG003|Placebo-Controlled Period|Pregnancy|0|||
170734063|NCT04857034|617033188|FG004|Placebo-Controlled Period|Pregnancy|0|||
170734064|NCT04857034|617033184|FG000|Placebo-Controlled Period|Ongoing study period|0|||
170734065|NCT04857034|617033185|FG001|Placebo-Controlled Period|Ongoing study period|1|||
170734066|NCT04857034|617033186|FG002|Placebo-Controlled Period|Ongoing study period|0|||
170734067|NCT04857034|617033187|FG003|Placebo-Controlled Period|Ongoing study period|0|||
170734068|NCT04857034|617033188|FG004|Placebo-Controlled Period|Ongoing study period|0|||
170734069|NCT04857034|617033184|FG000|Active Treatment Period|Lack of Efficacy|1|||
170734070|NCT04857034|617033185|FG001|Active Treatment Period|Lack of Efficacy|0|||
170734071|NCT04857034|617033186|FG002|Active Treatment Period|Lack of Efficacy|0|||
170734072|NCT04857034|617033187|FG003|Active Treatment Period|Lack of Efficacy|0|||
170734073|NCT04857034|617033188|FG004|Active Treatment Period|Lack of Efficacy|0|||
170734074|NCT04857034|617033184|FG000|Active Treatment Period|request to discontinue|0|||
170734075|NCT04857034|617033185|FG001|Active Treatment Period|request to discontinue|1|||
170734076|NCT04857034|617033186|FG002|Active Treatment Period|request to discontinue|0|||
170734077|NCT04857034|617033187|FG003|Active Treatment Period|request to discontinue|1|||
170734078|NCT04857034|617033188|FG004|Active Treatment Period|request to discontinue|0|||
170734079|NCT04857034|617033184|FG000|Active Treatment Period|administrative reason by sponsor|1|||
170734080|NCT04857034|617033185|FG001|Active Treatment Period|administrative reason by sponsor|5|||
170734081|NCT04857034|617033186|FG002|Active Treatment Period|administrative reason by sponsor|0|||
170734082|NCT04857034|617033187|FG003|Active Treatment Period|administrative reason by sponsor|2|||
170734083|NCT04857034|617033188|FG004|Active Treatment Period|administrative reason by sponsor|2|||
170734084|NCT04857034|617033184|FG000|Active Treatment Period|other reasons|1|||
170734085|NCT04857034|617033185|FG001|Active Treatment Period|other reasons|1|||
170734086|NCT04857034|617033186|FG002|Active Treatment Period|other reasons|0|||
170734087|NCT04857034|617033187|FG003|Active Treatment Period|other reasons|0|||
170734088|NCT04857034|617033188|FG004|Active Treatment Period|other reasons|1|||
170734089|NCT04857034|617033184|FG000|Active Treatment Period|Ongoing Study Period|2|||
170734090|NCT04857034|617033185|FG001|Active Treatment Period|Ongoing Study Period|4|||
170734091|NCT04857034|617033186|FG002|Active Treatment Period|Ongoing Study Period|0|||
170734092|NCT04857034|617033187|FG003|Active Treatment Period|Ongoing Study Period|1|||
170734093|NCT04857034|617033188|FG004|Active Treatment Period|Ongoing Study Period|0|||
170734094|NCT02940574|617033189|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
170734095|NCT02940574|617033190|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
170734096|NCT02940574|617033189|FG000|1-year Follow-up|Lost to Follow-up|3|||
170734097|NCT02940574|617033190|FG001|1-year Follow-up|Lost to Follow-up|4|||
170734098|NCT04538144|617033191|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
170734099|NCT04538144|617033192|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
170734100|NCT04538144|617033193|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
170734101|NCT04538144|617033194|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
170734102|NCT00261495|617033199|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
170734103|NCT00261495|617033200|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
170734104|NCT00261495|617033199|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
170734105|NCT00261495|617033200|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
170734106|NCT00261495|617033199|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
170734107|NCT00261495|617033200|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
170734108|NCT00261495|617033199|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
170734109|NCT00261495|617033200|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
170734110|NCT00261495|617033199|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
170734111|NCT00261495|617033200|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
170734112|NCT00261495|617033199|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
170734113|NCT00261495|617033200|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
170734114|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
170734115|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
170840989|NCT04641962|617425996|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
170734116|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
170734117|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
170734118|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
170734119|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
170734120|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
170734121|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
170734122|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
170734123|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
170734124|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
170734125|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
170734126|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
170734127|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
170734128|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
170734129|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
170734130|NCT00261495|617033199|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
170734131|NCT00261495|617033200|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
170734132|NCT00261495|617033199|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
170734133|NCT00261495|617033200|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
170840990|NCT04641962|617425997|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
170840991|NCT04641962|617425998|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
170840992|NCT04641962|617425999|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
170840993|NCT04641962|617426000|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
170840994|NCT04641962|617425996|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
170840995|NCT04641962|617425997|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
170840996|NCT04641962|617425998|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
170840997|NCT04641962|617425999|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
170840998|NCT04641962|617426000|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
170840999|NCT00862836|617426001|FG000|Overall Study|Withdrawal by Subject|1|||
170841000|NCT04013971|617426002|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
170841001|NCT04013971|617426003|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
170841002|NCT04013971|617426002|FG000|Overall Study|Missing biomechanical data|0|||
170841003|NCT04013971|617426003|FG001|Overall Study|Missing biomechanical data|1|||
170841004|NCT04535544|617426004|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
170841005|NCT04535544|617426005|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
170841006|NCT04535544|617426006|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
170841007|NCT04535544|617426007|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
170841008|NCT04535544|617426004|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
170841009|NCT04535544|617426005|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
170734134|NCT00261495|617033199|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
170734135|NCT00261495|617033200|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
170734136|NCT00261495|617033199|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
170734137|NCT00261495|617033200|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
170734138|NCT00261495|617033199|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
170734139|NCT00261495|617033200|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
170734140|NCT00261495|617033199|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
170734141|NCT00261495|617033200|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
170734142|NCT00261495|617033199|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
170734143|NCT00261495|617033200|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
170734144|NCT03243422|617033203|FG000|Overall Study|Death|20|||
170734145|NCT03243422|617033204|FG001|Overall Study|Death|21|||
170734146|NCT03243422|617033203|FG000|Overall Study|Lost to Follow-up|9|||
170734147|NCT03243422|617033204|FG001|Overall Study|Lost to Follow-up|21|||
170734148|NCT03243422|617033203|FG000|Overall Study|Withdrawal by Subject|22|||
170734149|NCT03243422|617033204|FG001|Overall Study|Withdrawal by Subject|8|||
170734150|NCT01722162|617033207|FG000|Overall Study|Withdrawal by Subject|1|||
170734151|NCT01722162|617033208|FG001|Overall Study|Withdrawal by Subject|1|||
170734152|NCT01722162|617033207|FG000|Overall Study|Found ineligible|1|||
170734153|NCT01722162|617033208|FG001|Overall Study|Found ineligible|0|||
170734154|NCT01722162|617033207|FG000|Overall Study|Unrelated to study adverse event|2|||
170734155|NCT01722162|617033208|FG001|Overall Study|Unrelated to study adverse event|2|||
170841010|NCT04535544|617426006|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
170734156|NCT01722162|617033207|FG000|Overall Study|Adverse Event|1|||
170734157|NCT01722162|617033208|FG001|Overall Study|Adverse Event|1|||
170734158|NCT01722162|617033207|FG000|Overall Study|Insurance denial post enrollment|0|||
170734159|NCT01722162|617033208|FG001|Overall Study|Insurance denial post enrollment|1|||
170734160|NCT01722162|617033207|FG000|Overall Study|Noncompliance|0|||
170734161|NCT01722162|617033208|FG001|Overall Study|Noncompliance|1|||
170734162|NCT00643123|617033209|FG000|Overall Study|Lost to Follow-up|4|||
170734163|NCT00643123|617033210|FG001|Overall Study|Lost to Follow-up|0|||
170734164|NCT00643123|617033209|FG000|Overall Study|Withdrawal by Subject|1|||
170734165|NCT00643123|617033210|FG001|Overall Study|Withdrawal by Subject|1|||
170734166|NCT01538472|617033211|FG000|Overall Study|Disease Progression|3|||
170734167|NCT01538472|617033211|FG000|Overall Study|Death|1|||
170734168|NCT04074590|617033212|FG000|Overall Study|Adverse Event|1|||
170734169|NCT04074590|617033213|FG001|Overall Study|Adverse Event|0|||
170734170|NCT04074590|617033212|FG000|Overall Study|Physician Decision|1|||
170734171|NCT04074590|617033213|FG001|Overall Study|Physician Decision|0|||
170734172|NCT04074590|617033212|FG000|Overall Study|Withdrawal by Subject|2|||
170734173|NCT04074590|617033213|FG001|Overall Study|Withdrawal by Subject|0|||
170734174|NCT00509236|617033216|FG000|Overall Study|Adverse Event|7|||
170734175|NCT00509236|617033217|FG001|Overall Study|Adverse Event|9|||
170734176|NCT00509236|617033216|FG000|Overall Study|Withdrawal by Subject|5|||
170734177|NCT00509236|617033217|FG001|Overall Study|Withdrawal by Subject|10|||
170734178|NCT00509236|617033216|FG000|Overall Study|Protocol Violation|3|||
170734179|NCT00509236|617033217|FG001|Overall Study|Protocol Violation|0|||
170734180|NCT00509236|617033216|FG000|Overall Study|Excluded Medication|1|||
170734181|NCT00509236|617033217|FG001|Overall Study|Excluded Medication|1|||
170734182|NCT00509236|617033216|FG000|Overall Study|Scheduled Kidney Transplant|1|||
170734183|NCT00509236|617033217|FG001|Overall Study|Scheduled Kidney Transplant|0|||
170734184|NCT02227875|617033221|FG000|Overall Study|Protocol Violation|10|||
170734185|NCT02227875|617033222|FG001|Overall Study|Protocol Violation|7|||
170734186|NCT02227875|617033221|FG000|Overall Study|Other|1|||
170734187|NCT02227875|617033222|FG001|Overall Study|Other|3|||
170734188|NCT02227875|617033221|FG000|Overall Study|Physician Decision|1|||
170734189|NCT02227875|617033222|FG001|Overall Study|Physician Decision|0|||
170734190|NCT02227875|617033221|FG000|Overall Study|Adverse Event|3|||
170734191|NCT02227875|617033222|FG001|Overall Study|Adverse Event|0|||
170841011|NCT04535544|617426007|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
170841012|NCT04535544|617426004|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
170841013|NCT04535544|617426005|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
170841014|NCT04535544|617426006|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
170841015|NCT04535544|617426007|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
170841016|NCT04535544|617426004|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
170841017|NCT04535544|617426005|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
170841018|NCT04535544|617426006|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
170841019|NCT04535544|617426007|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
170734192|NCT02227875|617033221|FG000|Overall Study|Withdrawal by Subject|12|||
170734193|NCT02227875|617033222|FG001|Overall Study|Withdrawal by Subject|13|||
170734194|NCT02227875|617033221|FG000|Overall Study|Lost to Follow-up|10|||
170734195|NCT02227875|617033222|FG001|Overall Study|Lost to Follow-up|10|||
170734196|NCT02709005|617033223|FG000|Overall Study|Lost to Follow-up|1|||
170734197|NCT02709005|617033224|FG001|Overall Study|Lost to Follow-up|1|||
170734198|NCT02709005|617033223|FG000|Overall Study|Withdrawal by Subject|3|||
170734199|NCT02709005|617033224|FG001|Overall Study|Withdrawal by Subject|0|||
170734200|NCT03494166|617033225|FG000|Overall Study|Death|0|||
170734201|NCT03494166|617033226|FG001|Overall Study|Death|0|||
170734202|NCT03494166|617033227|FG002|Overall Study|Death|0|||
170734203|NCT03494166|617033228|FG003|Overall Study|Death|1|||
170734204|NCT03494166|617033229|FG004|Overall Study|Death|3|||
170734205|NCT03494166|617033230|FG005|Overall Study|Death|0|||
170734206|NCT03494166|617033225|FG000|Overall Study|Lost to Follow-up|2|||
170734207|NCT03494166|617033226|FG001|Overall Study|Lost to Follow-up|2|||
170734208|NCT03494166|617033227|FG002|Overall Study|Lost to Follow-up|2|||
170734209|NCT03494166|617033228|FG003|Overall Study|Lost to Follow-up|2|||
170841020|NCT04535544|617426004|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
170841021|NCT04535544|617426005|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
170841022|NCT04535544|617426006|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
170841023|NCT04535544|617426007|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
170841024|NCT04535544|617426004|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
170841025|NCT04535544|617426005|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
170841026|NCT04535544|617426006|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
170841027|NCT04535544|617426007|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
170841028|NCT04535544|617426004|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
170841029|NCT04535544|617426005|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
170734210|NCT03494166|617033229|FG004|Overall Study|Lost to Follow-up|14|||
170734211|NCT03494166|617033230|FG005|Overall Study|Lost to Follow-up|0|||
170734212|NCT03494166|617033225|FG000|Overall Study|Withdrawal by Subject|10|||
170734213|NCT03494166|617033226|FG001|Overall Study|Withdrawal by Subject|7|||
170734214|NCT03494166|617033227|FG002|Overall Study|Withdrawal by Subject|0|||
170734215|NCT03494166|617033228|FG003|Overall Study|Withdrawal by Subject|5|||
170734216|NCT03494166|617033229|FG004|Overall Study|Withdrawal by Subject|3|||
170734217|NCT03494166|617033230|FG005|Overall Study|Withdrawal by Subject|17|||
170734218|NCT03494166|617033225|FG000|Overall Study|Screen failure|1|||
170734219|NCT03494166|617033226|FG001|Overall Study|Screen failure|0|||
170734220|NCT03494166|617033227|FG002|Overall Study|Screen failure|0|||
170734221|NCT03494166|617033228|FG003|Overall Study|Screen failure|0|||
170734222|NCT03494166|617033229|FG004|Overall Study|Screen failure|1|||
170734223|NCT03494166|617033230|FG005|Overall Study|Screen failure|0|||
170734224|NCT02857426|617033235|FG000|Overall Study|Disease progression|34|||
170734225|NCT02857426|617033236|FG001|Overall Study|Disease progression|13|||
170734226|NCT02857426|617033235|FG000|Overall Study|Study drug toxicity|4|||
170734227|NCT02857426|617033236|FG001|Overall Study|Study drug toxicity|1|||
170734228|NCT02857426|617033235|FG000|Overall Study|Death|1|||
170734229|NCT02857426|617033236|FG001|Overall Study|Death|0|||
170734230|NCT02857426|617033235|FG000|Overall Study|Adverse event unrelated to study drug|6|||
170734231|NCT02857426|617033236|FG001|Overall Study|Adverse event unrelated to study drug|2|||
170734232|NCT02857426|617033235|FG000|Overall Study|Participant withdrew consent|1|||
170734233|NCT02857426|617033236|FG001|Overall Study|Participant withdrew consent|1|||
170734234|NCT02857426|617033235|FG000|Overall Study|Maximum clinical benefit|1|||
170734235|NCT02857426|617033236|FG001|Overall Study|Maximum clinical benefit|0|||
170734236|NCT02857426|617033235|FG000|Overall Study|Completed treatment|0|||
170734237|NCT02857426|617033236|FG001|Overall Study|Completed treatment|2|||
170734238|NCT01960725|617033237|FG000|Overall Study|Lost to Follow-up|4|||
170734239|NCT01960725|617033238|FG001|Overall Study|Lost to Follow-up|3|||
170734240|NCT01960725|617033237|FG000|Overall Study|Withdrawal by Subject|1|||
170734241|NCT01960725|617033238|FG001|Overall Study|Withdrawal by Subject|0|||
170734242|NCT01960725|617033237|FG000|Overall Study|unable to obtain blood sample|1|||
170734243|NCT01960725|617033238|FG001|Overall Study|unable to obtain blood sample|2|||
170734244|NCT02110901|617033243|FG000|Overall Study|Death|6|||
170734245|NCT02110901|617033244|FG001|Overall Study|Death|3|||
170734246|NCT02110901|617033243|FG000|Overall Study|Lost to Follow-up|12|||
170734247|NCT02110901|617033244|FG001|Overall Study|Lost to Follow-up|8|||
170734248|NCT02110901|617033243|FG000|Overall Study|Withdrawal by Subject|7|||
170734249|NCT02110901|617033244|FG001|Overall Study|Withdrawal by Subject|3|||
170734250|NCT02110901|617033243|FG000|Overall Study|received a kidney transplant|5|||
170734251|NCT02110901|617033244|FG001|Overall Study|received a kidney transplant|0|||
170734252|NCT02634788|617033245|FG000|Overall Study|Adverse Event|0|||
170734253|NCT02634788|617033246|FG001|Overall Study|Adverse Event|8|||
170734254|NCT02634788|617033247|FG002|Overall Study|Adverse Event|3|||
170734255|NCT02634788|617033248|FG003|Overall Study|Adverse Event|1|||
170734256|NCT02634788|617033245|FG000|Overall Study|Lack of Efficacy|4|||
170734257|NCT02634788|617033246|FG001|Overall Study|Lack of Efficacy|0|||
170734258|NCT02634788|617033247|FG002|Overall Study|Lack of Efficacy|1|||
170734259|NCT02634788|617033248|FG003|Overall Study|Lack of Efficacy|4|||
170734260|NCT02634788|617033245|FG000|Overall Study|Lost to Follow-up|0|||
170734261|NCT02634788|617033246|FG001|Overall Study|Lost to Follow-up|1|||
170734262|NCT02634788|617033247|FG002|Overall Study|Lost to Follow-up|0|||
170734263|NCT02634788|617033248|FG003|Overall Study|Lost to Follow-up|0|||
170734264|NCT02634788|617033245|FG000|Overall Study|Withdrawal by Subject|0|||
170734265|NCT02634788|617033246|FG001|Overall Study|Withdrawal by Subject|1|||
170734266|NCT02634788|617033247|FG002|Overall Study|Withdrawal by Subject|1|||
170734267|NCT02634788|617033248|FG003|Overall Study|Withdrawal by Subject|0|||
170734268|NCT00855595|617033252|FG000|Overall Study|Withdrawal by Subject|1|||
170734269|NCT00855595|617033253|FG001|Overall Study|Withdrawal by Subject|2|||
170841030|NCT04535544|617426006|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
170841031|NCT04535544|617426007|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
170841032|NCT04535544|617426004|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
170841033|NCT04535544|617426005|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
170841034|NCT04535544|617426006|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
170841035|NCT04535544|617426007|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
170841036|NCT00344032|617426008|FG000|Overall Study|Adverse Event|0|||
170841037|NCT00344032|617426009|FG001|Overall Study|Adverse Event|1|||
170841038|NCT00344032|617426008|FG000|Overall Study|Withdrawal by Subject|6|||
170841039|NCT00344032|617426009|FG001|Overall Study|Withdrawal by Subject|2|||
170841040|NCT00344032|617426008|FG000|Overall Study|Lost to Follow-up|4|||
170841041|NCT00344032|617426009|FG001|Overall Study|Lost to Follow-up|6|||
170841042|NCT00344032|617426008|FG000|Overall Study|Physician Decision|4|||
170734270|NCT00855595|617033252|FG000|Overall Study|Lost to Follow-up|3|||
170734271|NCT00855595|617033253|FG001|Overall Study|Lost to Follow-up|3|||
170734272|NCT00855595|617033252|FG000|Overall Study|Adverse Event|1|||
170734273|NCT00855595|617033253|FG001|Overall Study|Adverse Event|1|||
170734274|NCT00855595|617033252|FG000|Overall Study|patient moved out of state|1|||
170734275|NCT00855595|617033253|FG001|Overall Study|patient moved out of state|0|||
170734276|NCT00855595|617033252|FG000|Overall Study|patient left country|0|||
170734277|NCT00855595|617033253|FG001|Overall Study|patient left country|1|||
170734278|NCT00611858|617033254|FG000|Overall Study|Adverse Event|2|||
170734279|NCT00611858|617033254|FG000|Overall Study|Withdrawal by Subject|2|||
170734280|NCT01820559|617033255|FG000|Overall Study|Adverse Event|4|||
170734281|NCT01820559|617033256|FG001|Overall Study|Adverse Event|6|||
170734282|NCT01820559|617033257|FG002|Overall Study|Adverse Event|13|||
170734283|NCT01820559|617033255|FG000|Overall Study|Withdrawal by Subject|1|||
170734284|NCT01820559|617033256|FG001|Overall Study|Withdrawal by Subject|2|||
170841043|NCT00344032|617426009|FG001|Overall Study|Physician Decision|1|||
170841044|NCT04707664|617427822|FG000|Overall Study|Adverse Event|2|||
170841045|NCT04707664|617427823|FG001|Overall Study|Adverse Event|0|||
170841046|NCT04707664|617427822|FG000|Overall Study|Death|1|||
170841047|NCT04707664|617427823|FG001|Overall Study|Death|2|||
170841048|NCT04707664|617427822|FG000|Overall Study|Withdrawal by Subject|13|||
170841049|NCT04707664|617427823|FG001|Overall Study|Withdrawal by Subject|21|||
170841050|NCT04707664|617427822|FG000|Overall Study|Lost to Follow-up|11|||
170841051|NCT04707664|617427823|FG001|Overall Study|Lost to Follow-up|13|||
170841052|NCT04707664|617427822|FG000|Overall Study|Not treated|2|||
170841053|NCT04707664|617427823|FG001|Overall Study|Not treated|0|||
170841054|NCT00288639|617427832|FG000|Overall Study|Adverse Event|5|||
170841055|NCT00288639|617427832|FG000|Overall Study|Lack of Efficacy|4|||
170841056|NCT00288639|617427832|FG000|Overall Study|Withdrawal by Subject|2|||
170841057|NCT00288639|617427832|FG000|Overall Study|Other|1|||
170841058|NCT03480932|617427833|FG000|Overall Study|Death|1|||
170841059|NCT03480932|617427834|FG001|Overall Study|Death|1|||
170841060|NCT03480932|617427835|FG002|Overall Study|Death|0|||
170841061|NCT03480932|617427833|FG000|Overall Study|Lost to Follow-up|0|||
170841062|NCT03480932|617427834|FG001|Overall Study|Lost to Follow-up|2|||
170841063|NCT03480932|617427835|FG002|Overall Study|Lost to Follow-up|3|||
170841064|NCT03480932|617427833|FG000|Overall Study|Incarcerated|2|||
170841065|NCT03480932|617427834|FG001|Overall Study|Incarcerated|2|||
170841066|NCT03480932|617427835|FG002|Overall Study|Incarcerated|2|||
170841067|NCT04020185|617427838|FG000|Overall Study|Death|0|||
170841068|NCT04020185|617427839|FG001|Overall Study|Death|0|||
170841069|NCT04020185|617427840|FG002|Overall Study|Death|1|||
170841070|NCT04020185|617427841|FG003|Overall Study|Death|2|||
170841071|NCT04020185|617427842|FG004|Overall Study|Death|1|||
170841072|NCT04020185|617427843|FG005|Overall Study|Death|0|||
170841073|NCT04020185|617427844|FG006|Overall Study|Death|1|||
170841074|NCT04020185|617427845|FG007|Overall Study|Death|0|||
170841075|NCT04020185|617427838|FG000|Overall Study|Consent withdrawn|1|||
170841076|NCT04020185|617427839|FG001|Overall Study|Consent withdrawn|0|||
170841077|NCT04020185|617427840|FG002|Overall Study|Consent withdrawn|0|||
170841078|NCT04020185|617427841|FG003|Overall Study|Consent withdrawn|0|||
170841079|NCT04020185|617427842|FG004|Overall Study|Consent withdrawn|2|||
170841080|NCT04020185|617427843|FG005|Overall Study|Consent withdrawn|0|||
170841081|NCT04020185|617427844|FG006|Overall Study|Consent withdrawn|1|||
170841082|NCT04020185|617427845|FG007|Overall Study|Consent withdrawn|1|||
170841083|NCT04020185|617427838|FG000|Overall Study|Patient in hospice|0|||
170841084|NCT04020185|617427839|FG001|Overall Study|Patient in hospice|1|||
170841085|NCT04020185|617427840|FG002|Overall Study|Patient in hospice|0|||
170841086|NCT04020185|617427841|FG003|Overall Study|Patient in hospice|0|||
170841087|NCT04020185|617427842|FG004|Overall Study|Patient in hospice|0|||
170841088|NCT04020185|617427843|FG005|Overall Study|Patient in hospice|0|||
170841089|NCT04020185|617427844|FG006|Overall Study|Patient in hospice|0|||
170841090|NCT04020185|617427845|FG007|Overall Study|Patient in hospice|0|||
170841091|NCT04020185|617427838|FG000|Overall Study|Continuing on expanded access|0|||
170841092|NCT04020185|617427839|FG001|Overall Study|Continuing on expanded access|0|||
170841093|NCT04020185|617427840|FG002|Overall Study|Continuing on expanded access|0|||
170841094|NCT04020185|617427841|FG003|Overall Study|Continuing on expanded access|0|||
170841095|NCT04020185|617427842|FG004|Overall Study|Continuing on expanded access|0|||
170841096|NCT04020185|617427843|FG005|Overall Study|Continuing on expanded access|0|||
170841097|NCT04020185|617427844|FG006|Overall Study|Continuing on expanded access|1|||
170841098|NCT04020185|617427845|FG007|Overall Study|Continuing on expanded access|1|||
170841099|NCT05332912|617427848|FG000|Overall Study|Withdrawal by Subject|0|||
170841100|NCT05332912|617427849|FG001|Overall Study|Withdrawal by Subject|1|||
170841101|NCT05332912|617427850|FG002|Overall Study|Withdrawal by Subject|2|||
170841102|NCT05332912|617427851|FG003|Overall Study|Withdrawal by Subject|0|||
170841103|NCT05332912|617427848|FG000|Overall Study|Lost to Follow-up|0|||
170841104|NCT05332912|617427849|FG001|Overall Study|Lost to Follow-up|0|||
170841105|NCT05332912|617427850|FG002|Overall Study|Lost to Follow-up|1|||
170841106|NCT05332912|617427851|FG003|Overall Study|Lost to Follow-up|0|||
170841107|NCT04335591|617427852|FG000|Overall Study|Adverse Event|5|||
170841108|NCT04335591|617427853|FG001|Overall Study|Adverse Event|2|||
170841109|NCT04335591|617427854|FG002|Overall Study|Adverse Event|3|||
170841110|NCT04335591|617427855|FG003|Overall Study|Adverse Event|2|||
170841111|NCT04335591|617427852|FG000|Overall Study|Protocol Violation|1|||
170841112|NCT04335591|617427853|FG001|Overall Study|Protocol Violation|0|||
170841113|NCT04335591|617427854|FG002|Overall Study|Protocol Violation|0|||
170841114|NCT04335591|617427855|FG003|Overall Study|Protocol Violation|0|||
170841115|NCT04335591|617427852|FG000|Overall Study|Withdrawal by Subject|8|||
170841116|NCT04335591|617427853|FG001|Overall Study|Withdrawal by Subject|4|||
170841117|NCT04335591|617427854|FG002|Overall Study|Withdrawal by Subject|4|||
170841118|NCT04335591|617427855|FG003|Overall Study|Withdrawal by Subject|5|||
170841119|NCT04335591|617427852|FG000|Overall Study|Subject planning pregnancy|0|||
170841120|NCT04335591|617427853|FG001|Overall Study|Subject planning pregnancy|1|||
170841121|NCT04335591|617427854|FG002|Overall Study|Subject planning pregnancy|0|||
170841122|NCT04335591|617427855|FG003|Overall Study|Subject planning pregnancy|0|||
170841123|NCT04335591|617427852|FG000|Overall Study|Ukrainian Russian war conflict|4|||
170841124|NCT04335591|617427853|FG001|Overall Study|Ukrainian Russian war conflict|5|||
170841125|NCT04335591|617427854|FG002|Overall Study|Ukrainian Russian war conflict|2|||
170841126|NCT04335591|617427855|FG003|Overall Study|Ukrainian Russian war conflict|0|||
170841127|NCT05282121|617427856|FG000|Overall Study|Adverse Event|1|||
170841128|NCT05282121|617427857|FG001|Overall Study|Adverse Event|1|||
170841129|NCT05282121|617427858|FG002|Overall Study|Adverse Event|4|||
170841130|NCT05282121|617427859|FG003|Overall Study|Adverse Event|1|||
170841131|NCT05282121|617427856|FG000|Overall Study|Study Terminated by Sponsor|1|||
170841132|NCT05282121|617427857|FG001|Overall Study|Study Terminated by Sponsor|2|||
170841133|NCT05282121|617427858|FG002|Overall Study|Study Terminated by Sponsor|2|||
170841134|NCT05282121|617427859|FG003|Overall Study|Study Terminated by Sponsor|2|||
170841135|NCT05282121|617427856|FG000|Overall Study|Other than listed|0|||
170841136|NCT05282121|617427857|FG001|Overall Study|Other than listed|0|||
170841137|NCT05282121|617427858|FG002|Overall Study|Other than listed|1|||
170841138|NCT05282121|617427859|FG003|Overall Study|Other than listed|0|||
170841139|NCT05282121|617427856|FG000|Overall Study|No reason available|0|||
170841140|NCT05282121|617427857|FG001|Overall Study|No reason available|0|||
170841141|NCT05282121|617427858|FG002|Overall Study|No reason available|1|||
170841142|NCT05282121|617427859|FG003|Overall Study|No reason available|0|||
170841143|NCT03301155|617427863|FG000|Overall Study|Сompliance with exclusion criteria|8|||
170841144|NCT03301155|617427864|FG001|Overall Study|Сompliance with exclusion criteria|7|||
170841145|NCT01706705|617427867|FG000|Overall Study|Death|1|||
170841146|NCT01706705|617427867|FG000|Overall Study|Lack of Efficacy|13|||
170841147|NCT01706705|617427867|FG000|Overall Study|Non-clinical|6|||
170841148|NCT00384189|617427868|FG000|Overall Study|Reason Not Specified|50|||
170841149|NCT00384189|617427869|FG001|Overall Study|Reason Not Specified|57|||
170841150|NCT00384189|617427870|FG002|Overall Study|Reason Not Specified|58|||
170841151|NCT00384189|617427871|FG003|Overall Study|Reason Not Specified|40|||
170841152|NCT02942004|617427872|FG000|Overall Study|Withdrawal by Subject|0|||
170841153|NCT02942004|617427873|FG001|Overall Study|Withdrawal by Subject|2|||
170841154|NCT02942004|617427874|FG002|Overall Study|Withdrawal by Subject|3|||
170841155|NCT02942004|617427872|FG000|Overall Study|Lost to Follow-up|1|||
170841156|NCT02942004|617427873|FG001|Overall Study|Lost to Follow-up|1|||
170841157|NCT02942004|617427874|FG002|Overall Study|Lost to Follow-up|2|||
170841158|NCT02942004|617427872|FG000|Overall Study|Randomized but not dosed|3|||
170841159|NCT02942004|617427873|FG001|Overall Study|Randomized but not dosed|9|||
170841160|NCT02942004|617427874|FG002|Overall Study|Randomized but not dosed|4|||
170841161|NCT05627258|617427875|FG000|Overall Study|Lost to Follow-up|1|||
170841162|NCT05627258|617427876|FG001|Overall Study|Lost to Follow-up|0|||
170841163|NCT05627258|617427877|FG002|Overall Study|Lost to Follow-up|0|||
170841164|NCT05627258|617427878|FG003|Overall Study|Lost to Follow-up|0|||
170841165|NCT05627258|617427879|FG004|Overall Study|Lost to Follow-up|0|||
170841166|NCT05627258|617427880|FG005|Overall Study|Lost to Follow-up|0|||
170841167|NCT05627258|617427875|FG000|Overall Study|Withdrawal by Subject|0|||
170841168|NCT05627258|617427876|FG001|Overall Study|Withdrawal by Subject|0|||
170841169|NCT05627258|617427877|FG002|Overall Study|Withdrawal by Subject|0|||
170841170|NCT05627258|617427878|FG003|Overall Study|Withdrawal by Subject|0|||
170841171|NCT05627258|617427879|FG004|Overall Study|Withdrawal by Subject|2|||
170841172|NCT05627258|617427880|FG005|Overall Study|Withdrawal by Subject|0|||
170841173|NCT05627258|617427875|FG000|Overall Study|Enrolled, but product not administered|1|||
170841174|NCT05627258|617427876|FG001|Overall Study|Enrolled, but product not administered|0|||
170841175|NCT05627258|617427877|FG002|Overall Study|Enrolled, but product not administered|0|||
170841176|NCT05627258|617427878|FG003|Overall Study|Enrolled, but product not administered|0|||
170841177|NCT05627258|617427879|FG004|Overall Study|Enrolled, but product not administered|0|||
170841178|NCT05627258|617427880|FG005|Overall Study|Enrolled, but product not administered|0|||
170841179|NCT05627258|617427875|FG000|Overall Study|Other subject illness/injury|1|||
170841180|NCT05627258|617427876|FG001|Overall Study|Other subject illness/injury|0|||
170841181|NCT05627258|617427877|FG002|Overall Study|Other subject illness/injury|0|||
170841182|NCT05627258|617427878|FG003|Overall Study|Other subject illness/injury|0|||
170841183|NCT05627258|617427879|FG004|Overall Study|Other subject illness/injury|0|||
170841184|NCT05627258|617427880|FG005|Overall Study|Other subject illness/injury|0|||
170841185|NCT05627258|617427875|FG000|Overall Study|Subject moved from area|0|||
170841186|NCT05627258|617427876|FG001|Overall Study|Subject moved from area|0|||
170841187|NCT05627258|617427877|FG002|Overall Study|Subject moved from area|1|||
170841188|NCT05627258|617427878|FG003|Overall Study|Subject moved from area|0|||
170841189|NCT05627258|617427879|FG004|Overall Study|Subject moved from area|0|||
170841190|NCT05627258|617427880|FG005|Overall Study|Subject moved from area|0|||
170841191|NCT04517669|617427881|FG000|Overall Study|Lost to Follow-up|2|||
170841192|NCT04517669|617427881|FG000|Overall Study|Withdrawal by Subject|3|||
170841193|NCT04517669|617427881|FG000|Overall Study|Drug withdrawn|44|||
170841194|NCT04517669|617427881|FG000|Overall Study|Other|1|||
170841195|NCT04517669|617427881|FG000|Overall Study|Eligibility criteria not met|4|||
170841196|NCT04517669|617427881|FG000|Overall Study|Did not receive treatment|3|||
170841197|NCT02138786|617427882|FG000|Overall Study|Adverse Event|0|||
170841198|NCT02138786|617427883|FG001|Overall Study|Adverse Event|2|||
170841199|NCT02138786|617427884|FG002|Overall Study|Adverse Event|1|||
170841200|NCT02138786|617427882|FG000|Overall Study|Death|1|||
170841201|NCT02138786|617427883|FG001|Overall Study|Death|7|||
170841202|NCT02138786|617427884|FG002|Overall Study|Death|2|||
170841203|NCT02138786|617427882|FG000|Overall Study|Disease Progression|1|||
170841204|NCT02138786|617427883|FG001|Overall Study|Disease Progression|1|||
170841205|NCT02138786|617427884|FG002|Overall Study|Disease Progression|3|||
170841206|NCT02138786|617427882|FG000|Overall Study|Withdrawal by Subject|1|||
170841207|NCT02138786|617427883|FG001|Overall Study|Withdrawal by Subject|2|||
170841208|NCT02138786|617427884|FG002|Overall Study|Withdrawal by Subject|0|||
170841209|NCT02138786|617427882|FG000|Overall Study|Patient's Wish|0|||
170841210|NCT02138786|617427883|FG001|Overall Study|Patient's Wish|2|||
170841211|NCT02138786|617427884|FG002|Overall Study|Patient's Wish|0|||
170841212|NCT02138786|617427882|FG000|Overall Study|Sponsor Terminated Study|0|||
170841213|NCT02138786|617427883|FG001|Overall Study|Sponsor Terminated Study|1|||
170841214|NCT02138786|617427884|FG002|Overall Study|Sponsor Terminated Study|1|||
170841215|NCT02138786|617427882|FG000|Overall Study|Non-Compliance|0|||
170841216|NCT02138786|617427883|FG001|Overall Study|Non-Compliance|0|||
170841217|NCT02138786|617427884|FG002|Overall Study|Non-Compliance|1|||
170841218|NCT01199068|617427885|FG000|Overall Study|Unacceptable toxicity|0|||
170841219|NCT01199068|617427886|FG001|Overall Study|Unacceptable toxicity|0|||
170841220|NCT01199068|617427887|FG002|Overall Study|Unacceptable toxicity|2|||
170841221|NCT01199068|617427885|FG000|Overall Study|Progressive disease|3|||
170841222|NCT01199068|617427886|FG001|Overall Study|Progressive disease|3|||
170841223|NCT01199068|617427887|FG002|Overall Study|Progressive disease|6|||
170841224|NCT01199068|617427885|FG000|Overall Study|Withdrawal by Subject|0|||
170841225|NCT01199068|617427886|FG001|Overall Study|Withdrawal by Subject|0|||
170841226|NCT01199068|617427887|FG002|Overall Study|Withdrawal by Subject|1|||
170841227|NCT00678301|617427888|FG000|Overall Study|Non-compliance with study procedures|0|||
170841228|NCT00678301|617427889|FG001|Overall Study|Non-compliance with study procedures|1|||
170841229|NCT00678301|617427888|FG000|Overall Study|Adverse Event|1|||
170841230|NCT00678301|617427889|FG001|Overall Study|Adverse Event|0|||
170841231|NCT00678301|617427888|FG000|Overall Study|Withdrawal by Subject|4|||
170841232|NCT00678301|617427889|FG001|Overall Study|Withdrawal by Subject|0|||
170841233|NCT00678301|617427888|FG000|Overall Study|Lost to Follow-up|3|||
170841234|NCT00678301|617427889|FG001|Overall Study|Lost to Follow-up|1|||
170841235|NCT02476175|617427892|FG000|Overall Study|Adverse Event|2|||
170841236|NCT01016262|617427895|FG000|Double-blind Phase|Adverse Event|0|||
170841237|NCT01016262|617427896|FG001|Double-blind Phase|Adverse Event|0|||
170841238|NCT01016262|617427897|FG002|Double-blind Phase|Adverse Event|1|||
170841239|NCT01016262|617427898|FG003|Double-blind Phase|Adverse Event|0|||
170841240|NCT01016262|617427899|FG004|Double-blind Phase|Adverse Event|0|||
170841241|NCT01016262|617427900|FG005|Double-blind Phase|Adverse Event|0|||
170841242|NCT01016262|617427895|FG000|Double-blind Phase|Lack of Efficacy|1|||
170841243|NCT01016262|617427896|FG001|Double-blind Phase|Lack of Efficacy|0|||
170841244|NCT01016262|617427897|FG002|Double-blind Phase|Lack of Efficacy|5|||
170841245|NCT01016262|617427898|FG003|Double-blind Phase|Lack of Efficacy|0|||
170841246|NCT01016262|617427899|FG004|Double-blind Phase|Lack of Efficacy|0|||
170841247|NCT01016262|617427900|FG005|Double-blind Phase|Lack of Efficacy|0|||
170841248|NCT01016262|617427895|FG000|Double-blind Phase|Disease Progression|0|||
170841249|NCT01016262|617427896|FG001|Double-blind Phase|Disease Progression|1|||
170841250|NCT01016262|617427897|FG002|Double-blind Phase|Disease Progression|2|||
170841251|NCT01016262|617427898|FG003|Double-blind Phase|Disease Progression|0|||
170841252|NCT01016262|617427899|FG004|Double-blind Phase|Disease Progression|0|||
170841253|NCT01016262|617427900|FG005|Double-blind Phase|Disease Progression|0|||
170841254|NCT01016262|617427895|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
170841255|NCT01016262|617427896|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
170841256|NCT01016262|617427897|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
170841257|NCT01016262|617427898|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
170841258|NCT01016262|617427899|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
170841259|NCT01016262|617427900|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
170841260|NCT01016262|617427895|FG000|Open-Label Phase|Adverse Event|0|||
170841261|NCT01016262|617427896|FG001|Open-Label Phase|Adverse Event|0|||
170841262|NCT01016262|617427897|FG002|Open-Label Phase|Adverse Event|0|||
170841263|NCT01016262|617427898|FG003|Open-Label Phase|Adverse Event|1|||
170841264|NCT01016262|617427899|FG004|Open-Label Phase|Adverse Event|0|||
170841265|NCT01016262|617427900|FG005|Open-Label Phase|Adverse Event|0|||
170841266|NCT01016262|617427895|FG000|Open-Label Phase|Lost to Follow-up|0|||
170841267|NCT01016262|617427896|FG001|Open-Label Phase|Lost to Follow-up|0|||
170841268|NCT01016262|617427897|FG002|Open-Label Phase|Lost to Follow-up|0|||
170841269|NCT01016262|617427898|FG003|Open-Label Phase|Lost to Follow-up|0|||
170841270|NCT01016262|617427899|FG004|Open-Label Phase|Lost to Follow-up|1|||
170841271|NCT01016262|617427900|FG005|Open-Label Phase|Lost to Follow-up|0|||
170841272|NCT01016262|617427895|FG000|Open-Label Phase|Lack of Efficacy|0|||
170841273|NCT01016262|617427896|FG001|Open-Label Phase|Lack of Efficacy|0|||
170841274|NCT01016262|617427897|FG002|Open-Label Phase|Lack of Efficacy|0|||
170734285|NCT01820559|617033257|FG002|Overall Study|Withdrawal by Subject|5|||
170734286|NCT01820559|617033255|FG000|Overall Study|Protocol Violation|2|||
170734287|NCT01820559|617033256|FG001|Overall Study|Protocol Violation|1|||
170734288|NCT01820559|617033257|FG002|Overall Study|Protocol Violation|3|||
170734289|NCT01820559|617033255|FG000|Overall Study|Subject's non-compliance|1|||
170734290|NCT01820559|617033256|FG001|Overall Study|Subject's non-compliance|0|||
170734291|NCT01820559|617033257|FG002|Overall Study|Subject's non-compliance|2|||
170734292|NCT01820559|617033255|FG000|Overall Study|Lost to Follow-up|3|||
170734293|NCT01820559|617033256|FG001|Overall Study|Lost to Follow-up|2|||
170734294|NCT01820559|617033257|FG002|Overall Study|Lost to Follow-up|2|||
170734295|NCT01820559|617033255|FG000|Overall Study|At sponsor request|0|||
170734296|NCT01820559|617033256|FG001|Overall Study|At sponsor request|0|||
170734297|NCT01820559|617033257|FG002|Overall Study|At sponsor request|1|||
170734298|NCT01820559|617033255|FG000|Overall Study|Lack of Efficacy|3|||
170734299|NCT01820559|617033256|FG001|Overall Study|Lack of Efficacy|2|||
170734300|NCT01820559|617033257|FG002|Overall Study|Lack of Efficacy|3|||
170734301|NCT02755597|617033258|FG000|Overall Study|Withdrew consent|27|||
170734302|NCT02755597|617033259|FG001|Overall Study|Withdrew consent|11|||
170734303|NCT02755597|617033258|FG000|Overall Study|Lost to Follow-up|1|||
170734304|NCT02755597|617033259|FG001|Overall Study|Lost to Follow-up|0|||
170734305|NCT02755597|617033258|FG000|Overall Study|Death|78|||
170734306|NCT02755597|617033259|FG001|Overall Study|Death|36|||
170734307|NCT02755597|617033258|FG000|Overall Study|Study terminated by Sponsor|67|||
170734308|NCT02755597|617033259|FG001|Overall Study|Study terminated by Sponsor|47|||
170734309|NCT02755597|617033258|FG000|Overall Study|Other, not specified|20|||
170734310|NCT02755597|617033259|FG001|Overall Study|Other, not specified|3|||
170734311|NCT02755597|617033258|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
170734312|NCT02755597|617033259|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
170734313|NCT00166296|617033261|FG000|Overall Study|Withdrawal by Subject|1|||
170734314|NCT00166296|617033262|FG001|Overall Study|Withdrawal by Subject|3|||
170734315|NCT00166296|617033261|FG000|Overall Study|Adverse Event|2|||
170734316|NCT00166296|617033262|FG001|Overall Study|Adverse Event|4|||
170734317|NCT00166296|617033261|FG000|Overall Study|Lost to Follow-up|4|||
170734318|NCT00166296|617033262|FG001|Overall Study|Lost to Follow-up|2|||
170734319|NCT04581200|617033263|FG000|Overall Study|Lost to Follow-up|6|||
170734320|NCT04581200|617033264|FG001|Overall Study|Lost to Follow-up|5|||
170734321|NCT04711603|617033265|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
170734322|NCT04711603|617033266|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
170734323|NCT04711603|617033267|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
170734324|NCT04711603|617033268|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
170734325|NCT04711603|617033265|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
170734326|NCT04711603|617033266|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
170734327|NCT04711603|617033267|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
170734328|NCT04711603|617033268|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
170734329|NCT04711603|617033265|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
170734330|NCT04711603|617033266|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
170734331|NCT04711603|617033267|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
170734332|NCT04711603|617033268|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
170734333|NCT04711603|617033265|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
170734334|NCT04711603|617033266|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
170734335|NCT04711603|617033267|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
170734336|NCT04711603|617033268|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
170734337|NCT04711603|617033265|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
170734338|NCT04711603|617033266|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
170734339|NCT04711603|617033267|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
170841275|NCT01016262|617427898|FG003|Open-Label Phase|Lack of Efficacy|1|||
170841276|NCT01016262|617427899|FG004|Open-Label Phase|Lack of Efficacy|0|||
170841277|NCT01016262|617427900|FG005|Open-Label Phase|Lack of Efficacy|0|||
170841278|NCT01016262|617427895|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
170841279|NCT01016262|617427896|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
170841280|NCT01016262|617427897|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
170841281|NCT01016262|617427898|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
170841282|NCT01016262|617427899|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
170734340|NCT04711603|617033268|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
170734341|NCT04711603|617033265|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
170734342|NCT04711603|617033266|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
170734343|NCT04711603|617033267|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
170734344|NCT04711603|617033268|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
170734345|NCT04711603|617033265|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
170734346|NCT04711603|617033266|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
170734347|NCT04711603|617033267|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
170734348|NCT04711603|617033268|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
170734349|NCT04711603|617033265|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
170734350|NCT04711603|617033266|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
170734351|NCT04711603|617033267|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
170734352|NCT04711603|617033268|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
170734353|NCT04711603|617033265|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
170734354|NCT04711603|617033266|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
170734355|NCT04711603|617033267|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
170734356|NCT04711603|617033268|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
170734357|NCT04711603|617033265|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
170734358|NCT04711603|617033266|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
170734359|NCT04711603|617033267|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
170734360|NCT04711603|617033268|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
170734361|NCT04711603|617033265|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
170734362|NCT04711603|617033266|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
170734363|NCT04711603|617033267|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
170734364|NCT04711603|617033268|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
170734365|NCT04711603|617033265|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
170734366|NCT04711603|617033266|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
170734367|NCT04711603|617033267|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
170734368|NCT04711603|617033268|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
170734369|NCT03351738|617033269|FG000|Overall Study|Withdrawal by Subject|0|||
170734370|NCT03351738|617033270|FG001|Overall Study|Withdrawal by Subject|1|||
170734371|NCT03351738|617033271|FG002|Overall Study|Withdrawal by Subject|0|||
170734372|NCT03351738|617033272|FG003|Overall Study|Withdrawal by Subject|1|||
170734373|NCT03351738|617033273|FG004|Overall Study|Withdrawal by Subject|0|||
170734374|NCT03351738|617033274|FG005|Overall Study|Withdrawal by Subject|0|||
170734375|NCT03138733|617033279|FG000|Overall Study|Death|17|||
170734376|NCT03138733|617033280|FG001|Overall Study|Death|18|||
170734377|NCT03138733|617033279|FG000|Overall Study|Withdrawal by Subject|11|||
170734378|NCT03138733|617033280|FG001|Overall Study|Withdrawal by Subject|6|||
170734379|NCT03138733|617033279|FG000|Overall Study|Lost to Follow-up|3|||
170734380|NCT03138733|617033280|FG001|Overall Study|Lost to Follow-up|2|||
170734381|NCT03138733|617033279|FG000|Overall Study|Adverse Event|1|||
170734382|NCT03138733|617033280|FG001|Overall Study|Adverse Event|0|||
170734383|NCT03138733|617033279|FG000|Overall Study|Protocol Violation|1|||
170734384|NCT03138733|617033280|FG001|Overall Study|Protocol Violation|3|||
170734385|NCT03138733|617033279|FG000|Overall Study|Administrative or logistical reason|1|||
170734386|NCT03138733|617033280|FG001|Overall Study|Administrative or logistical reason|0|||
170734387|NCT03138733|617033279|FG000|Overall Study|The patient was transferred to another hospital|1|||
170734388|NCT03138733|617033280|FG001|Overall Study|The patient was transferred to another hospital|0|||
170734389|NCT01089374|617033281|FG000|Overall Study|Lost to Follow-up|3|||
170734390|NCT01089374|617033282|FG001|Overall Study|Lost to Follow-up|0|||
170734391|NCT01089374|617033281|FG000|Overall Study|Withdrawal by Subject|1|||
170734392|NCT01089374|617033282|FG001|Overall Study|Withdrawal by Subject|0|||
170734393|NCT01089374|617033281|FG000|Overall Study|Study closed early - low accrual|6|||
170734394|NCT01089374|617033282|FG001|Overall Study|Study closed early - low accrual|0|||
170734395|NCT04252742|617033283|FG000|Overall Study|Decision by sponsor|0|||
170734396|NCT04252742|617033284|FG001|Overall Study|Decision by sponsor|2|||
170734397|NCT04252742|617033283|FG000|Overall Study|Withdrawal by Subject|15|||
170734398|NCT04252742|617033284|FG001|Overall Study|Withdrawal by Subject|9|||
170734399|NCT04252742|617033283|FG000|Overall Study|Lost to Follow-up|0|||
170734400|NCT04252742|617033284|FG001|Overall Study|Lost to Follow-up|1|||
170734401|NCT01784068|617033292|FG000|NTCS Phase|Adverse Event|5|||
170734402|NCT01784068|617033293|FG001|NTCS Phase|Adverse Event|0|||
170734403|NCT01784068|617033292|FG000|NTCS Phase|Physician Decision|2|||
170734404|NCT01784068|617033293|FG001|NTCS Phase|Physician Decision|0|||
170734405|NCT01784068|617033292|FG000|NTCS Phase|Patient/guardian decision|3|||
170734406|NCT01784068|617033293|FG001|NTCS Phase|Patient/guardian decision|0|||
170734407|NCT01784068|617033292|FG000|NTCS Phase|Death|2|||
170734408|NCT01784068|617033293|FG001|NTCS Phase|Death|0|||
170841283|NCT01016262|617427900|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
170841284|NCT04546425|617427901|FG000|Overall Study|Protocol Violation|1|||
170841285|NCT04546425|617427902|FG001|Overall Study|Protocol Violation|1|||
170841286|NCT04546425|617427903|FG002|Overall Study|Protocol Violation|0|||
170841287|NCT04546425|617427904|FG003|Overall Study|Protocol Violation|0|||
170841288|NCT04546425|617427901|FG000|Overall Study|Adverse Event|3|||
170841289|NCT04546425|617427902|FG001|Overall Study|Adverse Event|0|||
170841290|NCT04546425|617427903|FG002|Overall Study|Adverse Event|0|||
170841291|NCT04546425|617427904|FG003|Overall Study|Adverse Event|0|||
170841292|NCT04546425|617427901|FG000|Overall Study|Lost to Follow-up|5|||
170841293|NCT04546425|617427902|FG001|Overall Study|Lost to Follow-up|4|||
170734409|NCT01784068|617033292|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
170734410|NCT01784068|617033293|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
170734411|NCT01784068|617033292|FG000|TFR Phase|Physician Decision|0|||
170734412|NCT01784068|617033293|FG001|TFR Phase|Physician Decision|1|||
170734413|NCT01784068|617033292|FG000|TFR Phase|Patient/guardian decision|0|||
170734414|NCT01784068|617033293|FG001|TFR Phase|Patient/guardian decision|3|||
170734415|NCT01784068|617033292|FG000|TFR Phase|Death|0|||
170734416|NCT01784068|617033293|FG001|TFR Phase|Death|1|||
170734417|NCT01784068|617033292|FG000|TFR Phase|Lack of Efficacy|0|||
170734418|NCT01784068|617033293|FG001|TFR Phase|Lack of Efficacy|88|||
170734419|NCT04899245|617033294|FG000|Overall Study|Withdrawal by Subject|3|||
170734420|NCT04899245|617033295|FG001|Overall Study|Withdrawal by Subject|5|||
170734421|NCT04899245|617033296|FG002|Overall Study|Withdrawal by Subject|2|||
170734422|NCT04899245|617033294|FG000|Overall Study|No longer eligible - Left staff position|0|||
170734423|NCT04899245|617033295|FG001|Overall Study|No longer eligible - Left staff position|0|||
170734424|NCT04899245|617033296|FG002|Overall Study|No longer eligible - Left staff position|1|||
170734425|NCT04899245|617033294|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
170734426|NCT04899245|617033295|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
170734427|NCT04899245|617033296|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
170734428|NCT04899245|617033294|FG000|Overall Study|No longer eligible - Moved away from area|2|||
170734429|NCT04899245|617033295|FG001|Overall Study|No longer eligible - Moved away from area|2|||
170734430|NCT04899245|617033296|FG002|Overall Study|No longer eligible - Moved away from area|0|||
170734431|NCT02063828|617033297|FG000|Overall Study|Withdrawal by Subject|4|||
170734432|NCT02063828|617033298|FG001|Overall Study|Withdrawal by Subject|6|||
170734433|NCT02063828|617033299|FG002|Overall Study|Withdrawal by Subject|3|||
170734434|NCT02063828|617033297|FG000|Overall Study|Death|0|||
170734435|NCT02063828|617033298|FG001|Overall Study|Death|0|||
170734436|NCT02063828|617033299|FG002|Overall Study|Death|1|||
170734437|NCT00031486|617033300|FG000|Overall Study|Adverse Event|1|||
170734438|NCT00031486|617033301|FG001|Overall Study|Adverse Event|0|||
170734439|NCT00031486|617033300|FG000|Overall Study|Lost to Follow-up|0|||
170734440|NCT00031486|617033301|FG001|Overall Study|Lost to Follow-up|1|||
170734441|NCT00031486|617033300|FG000|Overall Study|Withdrawal by Subject|3|||
170734442|NCT00031486|617033301|FG001|Overall Study|Withdrawal by Subject|2|||
170734443|NCT00031486|617033300|FG000|Overall Study|Death|0|||
170734444|NCT00031486|617033301|FG001|Overall Study|Death|3|||
170734445|NCT00031486|617033300|FG000|Overall Study|Non-compliant|0|||
170734446|NCT00031486|617033301|FG001|Overall Study|Non-compliant|4|||
170734447|NCT00031486|617033300|FG000|Overall Study|Did not meet eligibility requirement|2|||
170734448|NCT00031486|617033301|FG001|Overall Study|Did not meet eligibility requirement|1|||
170734449|NCT00031486|617033300|FG000|Overall Study|Other|1|||
170734450|NCT00031486|617033301|FG001|Overall Study|Other|1|||
170734451|NCT03988166|617033304|FG000|Overall Study|Lost to Follow-up|2|||
170734452|NCT03988166|617033304|FG000|Overall Study|Death|1|||
170734453|NCT02220894|617033305|FG000|Overall Study|Adverse Event|127|||
170734454|NCT02220894|617033306|FG001|Overall Study|Adverse Event|74|||
170734455|NCT02220894|617033305|FG000|Overall Study|Death|418|||
170734456|NCT02220894|617033306|FG001|Overall Study|Death|508|||
170734457|NCT02220894|617033305|FG000|Overall Study|Lost to Follow-up|0|||
170734458|NCT02220894|617033306|FG001|Overall Study|Lost to Follow-up|4|||
170734459|NCT02220894|617033305|FG000|Overall Study|Site Terminated by Sponsor|2|||
170734460|NCT02220894|617033306|FG001|Overall Study|Site Terminated by Sponsor|0|||
170734461|NCT02220894|617033305|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
170734462|NCT02220894|617033306|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
170734463|NCT02220894|617033305|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170734464|NCT02220894|617033306|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170734465|NCT02220894|617033305|FG000|Overall Study|Withdrawal by Subject|10|||
170734466|NCT02220894|617033306|FG001|Overall Study|Withdrawal by Subject|9|||
170734467|NCT01499082|617033307|FG000|Overall Study|Randomized but not Treated|0|||
170734468|NCT01499082|617033308|FG001|Overall Study|Randomized but not Treated|1|||
170734469|NCT01499082|617033307|FG000|Overall Study|Adverse Event|12|||
170734470|NCT01499082|617033308|FG001|Overall Study|Adverse Event|16|||
170734471|NCT01499082|617033307|FG000|Overall Study|Lack of Efficacy|1|||
170734472|NCT01499082|617033308|FG001|Overall Study|Lack of Efficacy|1|||
170734473|NCT01499082|617033307|FG000|Overall Study|Protocol Violation|6|||
170734474|NCT01499082|617033308|FG001|Overall Study|Protocol Violation|8|||
170734475|NCT01499082|617033307|FG000|Overall Study|Diverse Reasons|18|||
170734476|NCT01499082|617033308|FG001|Overall Study|Diverse Reasons|14|||
170734477|NCT01499082|617033307|FG000|Overall Study|Site Closure for Noncompliance|5|||
170734478|NCT01499082|617033308|FG001|Overall Study|Site Closure for Noncompliance|2|||
170734479|NCT01499082|617033307|FG000|Overall Study|Hypoglycemia|2|||
170734480|NCT01499082|617033308|FG001|Overall Study|Hypoglycemia|3|||
170734481|NCT01499082|617033307|FG000|Overall Study|Lost to Follow-up|1|||
170734482|NCT01499082|617033308|FG001|Overall Study|Lost to Follow-up|3|||
170734483|NCT02703922|617033309|FG000|Overall Study|Death|5|||
170734484|NCT02703922|617033310|FG001|Overall Study|Death|8|||
170734485|NCT02703922|617033309|FG000|Overall Study|Lost to Follow-up|10|||
170734486|NCT02703922|617033310|FG001|Overall Study|Lost to Follow-up|10|||
170734487|NCT05805657|617033315|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
170734488|NCT05805657|617033316|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
170734489|NCT04058353|617033317|FG000|Overall Study|Adverse Event|2|||
170734490|NCT04058353|617033318|FG001|Overall Study|Adverse Event|1|||
170734491|NCT04058353|617033317|FG000|Overall Study|Physician Decision|1|||
170734492|NCT04058353|617033318|FG001|Overall Study|Physician Decision|0|||
170734493|NCT04058353|617033317|FG000|Overall Study|Other|1|||
170734494|NCT04058353|617033318|FG001|Overall Study|Other|0|||
170734495|NCT02618616|617033323|FG000|Overall Study|Lack of Efficacy|4|||
170734496|NCT02618616|617033324|FG001|Overall Study|Lack of Efficacy|0|||
170734497|NCT02618616|617033323|FG000|Overall Study|Pregnancy|0|||
170734498|NCT02618616|617033324|FG001|Overall Study|Pregnancy|1|||
170734499|NCT02618616|617033323|FG000|Overall Study|Adverse Event|8|||
170734500|NCT02618616|617033324|FG001|Overall Study|Adverse Event|0|||
170734501|NCT02618616|617033323|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
170734502|NCT02618616|617033324|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
170734503|NCT02618616|617033323|FG000|Overall Study|Consent withdrawn by subject|8|||
170734504|NCT02618616|617033324|FG001|Overall Study|Consent withdrawn by subject|5|||
170734505|NCT02618616|617033323|FG000|Overall Study|Lost to Follow-up|0|||
170734506|NCT02618616|617033324|FG001|Overall Study|Lost to Follow-up|1|||
170734507|NCT04349280|617033325|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
170734508|NCT04349280|617033326|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
170734509|NCT04349280|617033325|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
170734510|NCT04349280|617033326|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
170734511|NCT04349280|617033325|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
170734512|NCT04349280|617033326|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
170734513|NCT02044848|617035313|FG000|Overall Study|Administrative Problems|2|||
170734514|NCT02044848|617035314|FG001|Overall Study|Administrative Problems|3|||
170734515|NCT04425902|617035315|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
170734516|NCT01191840|617035316|FG000|Overall Study|withdrew consent|2|||
170734517|NCT01191840|617035317|FG001|Overall Study|withdrew consent|1|||
170734518|NCT01191840|617035316|FG000|Overall Study|Subject discontinued treatment|1|||
170734519|NCT01191840|617035317|FG001|Overall Study|Subject discontinued treatment|2|||
170734520|NCT01191840|617035316|FG000|Overall Study|Lost to Follow-up|4|||
170734521|NCT01191840|617035317|FG001|Overall Study|Lost to Follow-up|6|||
170734522|NCT01191840|617035316|FG000|Overall Study|Non Staph Infection|4|||
170734523|NCT01191840|617035317|FG001|Overall Study|Non Staph Infection|3|||
170734524|NCT01191840|617035316|FG000|Overall Study|ineligible at enrollment|1|||
170734525|NCT01191840|617035317|FG001|Overall Study|ineligible at enrollment|0|||
170734526|NCT01191840|617035316|FG000|Overall Study|IRB approval lapse|0|||
170734527|NCT01191840|617035317|FG001|Overall Study|IRB approval lapse|2|||
170734528|NCT01191840|617035316|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
170734529|NCT01191840|617035317|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
170734530|NCT01191840|617035316|FG000|Overall Study|Withdrawal by Subject|2|||
170734531|NCT01191840|617035317|FG001|Overall Study|Withdrawal by Subject|0|||
170734532|NCT01392300|617035318|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
170734533|NCT01392300|617035319|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
170734534|NCT01392300|617035320|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
170734535|NCT01392300|617035318|FG000|Main Period (MP)|Withdrawal by Subject|5|||
170734536|NCT01392300|617035319|FG001|Main Period (MP)|Withdrawal by Subject|1|||
170734537|NCT01392300|617035320|FG002|Main Period (MP)|Withdrawal by Subject|0|||
170734538|NCT01392300|617035318|FG000|Main Period (MP)|Lost to Follow-up|3|||
170734539|NCT01392300|617035319|FG001|Main Period (MP)|Lost to Follow-up|3|||
170734540|NCT01392300|617035320|FG002|Main Period (MP)|Lost to Follow-up|0|||
170734541|NCT01392300|617035318|FG000|Main Period (MP)|Non-compliance|1|||
170734542|NCT01392300|617035319|FG001|Main Period (MP)|Non-compliance|0|||
170734543|NCT01392300|617035320|FG002|Main Period (MP)|Non-compliance|0|||
170734544|NCT01392300|617035318|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
170734545|NCT01392300|617035319|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
170734546|NCT01392300|617035320|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
170734547|NCT01392300|617035318|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
170734548|NCT01392300|617035319|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
170734549|NCT01392300|617035320|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
170734550|NCT01392300|617035318|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
170734551|NCT01392300|617035319|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
170734552|NCT01392300|617035320|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
170841294|NCT04546425|617427903|FG002|Overall Study|Lost to Follow-up|0|||
170734553|NCT01392300|617035318|FG000|Open Label Extension (OLEX) Period|Death|0|||
170734554|NCT01392300|617035319|FG001|Open Label Extension (OLEX) Period|Death|0|||
170734555|NCT01392300|617035320|FG002|Open Label Extension (OLEX) Period|Death|4|||
170734556|NCT01392300|617035318|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
170734557|NCT01392300|617035319|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
170734558|NCT01392300|617035320|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
170734559|NCT01392300|617035318|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
170734560|NCT01392300|617035319|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
170734561|NCT01392300|617035320|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
170841295|NCT04546425|617427904|FG003|Overall Study|Lost to Follow-up|0|||
170841296|NCT04546425|617427901|FG000|Overall Study|No Longer met eligibility criteria|3|||
170734562|NCT01392300|617035318|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
170734563|NCT01392300|617035319|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
170734564|NCT01392300|617035320|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
170734565|NCT04791761|617035321|FG000|Overall Study|Lost to Follow-up|8|||
170734566|NCT04791761|617035322|FG001|Overall Study|Lost to Follow-up|6|||
170734567|NCT04791761|617035323|FG002|Overall Study|Lost to Follow-up|10|||
170734568|NCT04791761|617035321|FG000|Overall Study|Withdrawal by Subject|0|||
170734569|NCT04791761|617035322|FG001|Overall Study|Withdrawal by Subject|1|||
170734570|NCT04791761|617035323|FG002|Overall Study|Withdrawal by Subject|1|||
170734571|NCT04791761|617035321|FG000|Overall Study|Protocol Violation|0|||
170734572|NCT04791761|617035322|FG001|Overall Study|Protocol Violation|1|||
170734573|NCT04791761|617035323|FG002|Overall Study|Protocol Violation|1|||
170734574|NCT02487498|617035326|FG000|Period: Period 1|Adverse Event|2|||
170734575|NCT02487498|617035327|FG001|Period: Period 1|Adverse Event|4|||
170734576|NCT02487498|617035326|FG000|Period: Period 1|Subject/guardian decision|2|||
170734577|NCT02487498|617035327|FG001|Period: Period 1|Subject/guardian decision|4|||
170734578|NCT02487498|617035326|FG000|Period: Period 1|Lost to Follow-up|0|||
170734579|NCT02487498|617035327|FG001|Period: Period 1|Lost to Follow-up|2|||
170734580|NCT02487498|617035326|FG000|Period: Period 1|Lack of Efficacy|1|||
170734581|NCT02487498|617035327|FG001|Period: Period 1|Lack of Efficacy|0|||
170734582|NCT02487498|617035326|FG000|Period: Period 1|Physician Decision|0|||
170734583|NCT02487498|617035327|FG001|Period: Period 1|Physician Decision|1|||
170734584|NCT02487498|617035326|FG000|Period: Period 1|Protocol deviation|1|||
170734585|NCT02487498|617035327|FG001|Period: Period 1|Protocol deviation|0|||
170734586|NCT02487498|617035326|FG000|Period: Washout|Subject/guardian decision|0|||
170734587|NCT02487498|617035327|FG001|Period: Washout|Subject/guardian decision|5|||
170734588|NCT02487498|617035326|FG000|Period: Washout|Lack of Efficacy|1|||
170734589|NCT02487498|617035327|FG001|Period: Washout|Lack of Efficacy|1|||
170734590|NCT02487498|617035326|FG000|Period: Washout|Physician Decision|1|||
170734591|NCT02487498|617035327|FG001|Period: Washout|Physician Decision|0|||
170734592|NCT02487498|617035326|FG000|Period: Washout|Non-compliance with study treatment|0|||
170734593|NCT02487498|617035327|FG001|Period: Washout|Non-compliance with study treatment|1|||
170734594|NCT02487498|617035326|FG000|Period: Period 2|Adverse Event|2|||
170734595|NCT02487498|617035327|FG001|Period: Period 2|Adverse Event|2|||
170734596|NCT02487498|617035326|FG000|Period: Period 2|Subject/guardian decision|2|||
170734597|NCT02487498|617035327|FG001|Period: Period 2|Subject/guardian decision|1|||
170734598|NCT02487498|617035326|FG000|Period: Period 2|Lost to Follow-up|1|||
170734599|NCT02487498|617035327|FG001|Period: Period 2|Lost to Follow-up|1|||
170734600|NCT02487498|617035326|FG000|Period: Period 2|Death|0|||
170734601|NCT02487498|617035327|FG001|Period: Period 2|Death|1|||
170734602|NCT02487498|617035326|FG000|Period: Period 2|Physician Decision|1|||
170734603|NCT02487498|617035327|FG001|Period: Period 2|Physician Decision|0|||
170734604|NCT00755222|617035337|FG000|Overall Study|Withdrawal by Subject|4|||
170734605|NCT00755222|617035338|FG001|Overall Study|Withdrawal by Subject|2|||
170734606|NCT00755222|617035337|FG000|Overall Study|Adverse Event|2|||
170734607|NCT00755222|617035338|FG001|Overall Study|Adverse Event|0|||
170734608|NCT00755222|617035337|FG000|Overall Study|Protocol Violation|2|||
170734609|NCT00755222|617035338|FG001|Overall Study|Protocol Violation|0|||
170734610|NCT00331344|617035343|FG000|Phase I|Adverse Event|0|||
170734611|NCT00331344|617035344|FG001|Phase I|Adverse Event|0|||
170734612|NCT00331344|617035345|FG002|Phase I|Adverse Event|0|||
170734613|NCT00331344|617035346|FG003|Phase I|Adverse Event|1|||
170734614|NCT00331344|617035347|FG004|Phase I|Adverse Event|2|||
170734615|NCT00331344|617035348|FG005|Phase I|Adverse Event|2|||
170734616|NCT00331344|617035349|FG006|Phase I|Adverse Event|0|||
170734617|NCT00331344|617035350|FG007|Phase I|Adverse Event|1|||
170734618|NCT00331344|617035351|FG008|Phase I|Adverse Event|0|||
170734619|NCT00331344|617035343|FG000|Phase II|Death|0|||
170734620|NCT00331344|617035344|FG001|Phase II|Death|0|||
170734621|NCT00331344|617035345|FG002|Phase II|Death|0|||
170734622|NCT00331344|617035346|FG003|Phase II|Death|0|||
170734623|NCT00331344|617035347|FG004|Phase II|Death|0|||
170734624|NCT00331344|617035348|FG005|Phase II|Death|0|||
170734625|NCT00331344|617035349|FG006|Phase II|Death|0|||
170734626|NCT00331344|617035350|FG007|Phase II|Death|0|||
170734627|NCT00331344|617035351|FG008|Phase II|Death|4|||
170734628|NCT02228967|617035352|FG000|Overall Study|Lost to Follow-up|146|||
170734629|NCT02228967|617035353|FG001|Overall Study|Lost to Follow-up|142|||
170734630|NCT02228967|617035352|FG000|Overall Study|Withdrawal by Subject|13|||
170734631|NCT02228967|617035353|FG001|Overall Study|Withdrawal by Subject|18|||
170734632|NCT00520975|617035354|FG000|Overall Study|Disease progression|31|||
170734633|NCT00520975|617035355|FG001|Overall Study|Disease progression|23|||
170734634|NCT00520975|617035354|FG000|Overall Study|Adverse Event|7|||
170734635|NCT00520975|617035355|FG001|Overall Study|Adverse Event|10|||
170734636|NCT00520975|617035354|FG000|Overall Study|Death|0|||
170734637|NCT00520975|617035355|FG001|Overall Study|Death|2|||
170734638|NCT00520975|617035354|FG000|Overall Study|Withdrawal by Subject|3|||
170734639|NCT00520975|617035355|FG001|Overall Study|Withdrawal by Subject|5|||
170734640|NCT00520975|617035354|FG000|Overall Study|Other therapy|2|||
170734641|NCT00520975|617035355|FG001|Overall Study|Other therapy|4|||
170734642|NCT00520975|617035354|FG000|Overall Study|Other reasons|4|||
170734643|NCT00520975|617035355|FG001|Overall Study|Other reasons|2|||
170734644|NCT00520975|617035354|FG000|Overall Study|Not start protocol therapy|1|||
170734645|NCT00520975|617035355|FG001|Overall Study|Not start protocol therapy|2|||
170734646|NCT01682213|617035358|FG000|Overall Study|Withdrawal by Subject|2|||
170734647|NCT01995539|617035359|FG000|Overall Study|Screening Failure|1|||
170734648|NCT01995539|617035359|FG000|Overall Study|Withdrawal by Investigator|15|||
170734649|NCT01995539|617035359|FG000|Overall Study|Withdrawal by Subject|11|||
170734650|NCT01995539|617035359|FG000|Overall Study|Lost to Follow-up|5|||
170734651|NCT01995539|617035359|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
170734652|NCT04382924|617035360|FG000|Overall Study|Death|2|||
170734653|NCT04382924|617035361|FG001|Overall Study|Death|5|||
170734654|NCT04382924|617035362|FG002|Overall Study|Death|4|||
170734655|NCT04382924|617035360|FG000|Overall Study|Protocol Violation|0|||
170734656|NCT04382924|617035361|FG001|Overall Study|Protocol Violation|1|||
170734657|NCT04382924|617035362|FG002|Overall Study|Protocol Violation|1|||
170734658|NCT04382924|617035360|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
170734659|NCT04382924|617035361|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
170734660|NCT04382924|617035362|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
170734661|NCT04382924|617035360|FG000|Overall Study|Withdrawal by Subject|6|||
170734662|NCT04382924|617035361|FG001|Overall Study|Withdrawal by Subject|3|||
170734663|NCT04382924|617035362|FG002|Overall Study|Withdrawal by Subject|6|||
170734664|NCT00642902|617035365|FG000|Overall Study|Adverse Event|0|||
170734665|NCT00642902|617035366|FG001|Overall Study|Adverse Event|1|||
170734666|NCT00642902|617035367|FG002|Overall Study|Adverse Event|3|||
170734667|NCT00642902|617035368|FG003|Overall Study|Adverse Event|1|||
170734668|NCT00642902|617035365|FG000|Overall Study|Lost to Follow-up|1|||
170734669|NCT00642902|617035366|FG001|Overall Study|Lost to Follow-up|1|||
170734670|NCT00642902|617035367|FG002|Overall Study|Lost to Follow-up|0|||
170734671|NCT00642902|617035368|FG003|Overall Study|Lost to Follow-up|0|||
170734672|NCT00642902|617035365|FG000|Overall Study|Lack of Efficacy|0|||
170734673|NCT00642902|617035366|FG001|Overall Study|Lack of Efficacy|3|||
170734674|NCT00642902|617035367|FG002|Overall Study|Lack of Efficacy|3|||
170734675|NCT00642902|617035368|FG003|Overall Study|Lack of Efficacy|0|||
170734676|NCT00642902|617035365|FG000|Overall Study|Death|1|||
170734677|NCT00642902|617035366|FG001|Overall Study|Death|0|||
170734678|NCT00642902|617035367|FG002|Overall Study|Death|0|||
170734679|NCT00642902|617035368|FG003|Overall Study|Death|0|||
170734680|NCT00642902|617035365|FG000|Overall Study|Premature termination of clinical trial|37|||
170734681|NCT00642902|617035366|FG001|Overall Study|Premature termination of clinical trial|32|||
170734682|NCT00642902|617035367|FG002|Overall Study|Premature termination of clinical trial|35|||
170734683|NCT00642902|617035368|FG003|Overall Study|Premature termination of clinical trial|35|||
170734684|NCT00642902|617035365|FG000|Overall Study|Randomized, but not treated|0|||
170734685|NCT00642902|617035366|FG001|Overall Study|Randomized, but not treated|0|||
170734686|NCT00642902|617035367|FG002|Overall Study|Randomized, but not treated|1|||
170734687|NCT00642902|617035368|FG003|Overall Study|Randomized, but not treated|0|||
170734688|NCT00642902|617035365|FG000|Overall Study|Other|1|||
170734689|NCT00642902|617035366|FG001|Overall Study|Other|5|||
170734690|NCT00642902|617035367|FG002|Overall Study|Other|1|||
170734691|NCT00642902|617035368|FG003|Overall Study|Other|4|||
170734692|NCT00429663|617035369|FG000|Overall Study|Lost to Follow-up|24|||
170734693|NCT00429663|617035370|FG001|Overall Study|Lost to Follow-up|31|||
170734694|NCT00429663|617035369|FG000|Overall Study|Physician Decision|6|||
170734695|NCT00429663|617035370|FG001|Overall Study|Physician Decision|3|||
170734696|NCT00429663|617035369|FG000|Overall Study|Withdrawal by Subject|2|||
170734697|NCT00429663|617035370|FG001|Overall Study|Withdrawal by Subject|5|||
170734698|NCT00429663|617035369|FG000|Overall Study|Death|4|||
170734699|NCT00429663|617035370|FG001|Overall Study|Death|0|||
170734700|NCT04207840|617035371|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
170734701|NCT04207840|617035372|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
170734702|NCT04207840|617035373|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
170734703|NCT04207840|617035371|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
170841297|NCT04546425|617427902|FG001|Overall Study|No Longer met eligibility criteria|3|||
170841298|NCT04546425|617427903|FG002|Overall Study|No Longer met eligibility criteria|1|||
170841299|NCT04546425|617427904|FG003|Overall Study|No Longer met eligibility criteria|1|||
170841300|NCT04546425|617427901|FG000|Overall Study|Withdrawal by parent/guardian|6|||
170841301|NCT04546425|617427902|FG001|Overall Study|Withdrawal by parent/guardian|5|||
170841302|NCT04546425|617427903|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170734704|NCT04207840|617035372|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
170734705|NCT04207840|617035373|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
170734706|NCT03261271|617035374|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
170734707|NCT03261271|617035375|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
170734708|NCT01330316|617035376|FG000|Overall Study|Adverse Event|2|||
170734709|NCT01330316|617035377|FG001|Overall Study|Adverse Event|2|||
170734710|NCT01330316|617035376|FG000|Overall Study|Lack of Efficacy|0|||
170734711|NCT01330316|617035377|FG001|Overall Study|Lack of Efficacy|10|||
170734712|NCT01330316|617035376|FG000|Overall Study|Lost to Follow-up|0|||
170734713|NCT01330316|617035377|FG001|Overall Study|Lost to Follow-up|1|||
170734714|NCT01330316|617035376|FG000|Overall Study|Withdrawal by Subject|0|||
170734715|NCT01330316|617035377|FG001|Overall Study|Withdrawal by Subject|1|||
170734716|NCT01330316|617035376|FG000|Overall Study|other than above|0|||
170734717|NCT01330316|617035377|FG001|Overall Study|other than above|1|||
170734718|NCT03430063|617035378|FG000|Overall Study|Adverse Event|0|||
170734719|NCT03430063|617035379|FG001|Overall Study|Adverse Event|1|||
170734720|NCT03430063|617035380|FG002|Overall Study|Adverse Event|0|||
170734721|NCT03430063|617035378|FG000|Overall Study|Death|3|||
170734722|NCT03430063|617035379|FG001|Overall Study|Death|2|||
170734723|NCT03430063|617035380|FG002|Overall Study|Death|3|||
170734724|NCT03430063|617035378|FG000|Overall Study|Lost to Follow-up|0|||
170734725|NCT03430063|617035379|FG001|Overall Study|Lost to Follow-up|1|||
170734726|NCT03430063|617035380|FG002|Overall Study|Lost to Follow-up|0|||
170734727|NCT03430063|617035378|FG000|Overall Study|Withdrawal by Subject|0|||
170734728|NCT03430063|617035379|FG001|Overall Study|Withdrawal by Subject|0|||
170734729|NCT03430063|617035380|FG002|Overall Study|Withdrawal by Subject|1|||
170734730|NCT03430063|617035378|FG000|Overall Study|Withdrawal of consent|3|||
170734731|NCT03430063|617035379|FG001|Overall Study|Withdrawal of consent|1|||
170734732|NCT03430063|617035380|FG002|Overall Study|Withdrawal of consent|2|||
170734733|NCT03430063|617035378|FG000|Overall Study|Progressive disease|1|||
170734734|NCT03430063|617035379|FG001|Overall Study|Progressive disease|2|||
170734735|NCT03430063|617035380|FG002|Overall Study|Progressive disease|1|||
170734736|NCT03430063|617035378|FG000|Overall Study|Other un-specified|1|||
170734737|NCT03430063|617035379|FG001|Overall Study|Other un-specified|1|||
170734738|NCT03430063|617035380|FG002|Overall Study|Other un-specified|0|||
170734739|NCT03430063|617035378|FG000|Overall Study|Randomized, but never treated|0|||
170734740|NCT03430063|617035379|FG001|Overall Study|Randomized, but never treated|0|||
170734741|NCT03430063|617035380|FG002|Overall Study|Randomized, but never treated|1|||
170734742|NCT03124199|617035381|FG000|Overall Study|Lost to Follow-up|4|||
170734743|NCT02798211|617035382|FG000|Period 1|Adverse Event|1|||
170734744|NCT02798211|617035383|FG001|Period 1|Adverse Event|1|||
170734745|NCT02798211|617035384|FG002|Period 1|Adverse Event|0|||
170734746|NCT02798211|617035385|FG003|Period 1|Adverse Event|0|||
170734747|NCT02798211|617035386|FG004|Period 1|Adverse Event|0|||
170734748|NCT02798211|617035387|FG005|Period 1|Adverse Event|0|||
170734749|NCT02798211|617035382|FG000|Period 1|Lost to Follow-up|2|||
170734750|NCT02798211|617035383|FG001|Period 1|Lost to Follow-up|1|||
170734751|NCT02798211|617035384|FG002|Period 1|Lost to Follow-up|0|||
170734752|NCT02798211|617035385|FG003|Period 1|Lost to Follow-up|0|||
170734753|NCT02798211|617035386|FG004|Period 1|Lost to Follow-up|0|||
170734754|NCT02798211|617035387|FG005|Period 1|Lost to Follow-up|0|||
170734755|NCT02798211|617035382|FG000|Period 1|Protocol Violation|0|||
170734756|NCT02798211|617035383|FG001|Period 1|Protocol Violation|0|||
170734757|NCT02798211|617035384|FG002|Period 1|Protocol Violation|2|||
170734758|NCT02798211|617035385|FG003|Period 1|Protocol Violation|0|||
170734759|NCT02798211|617035386|FG004|Period 1|Protocol Violation|0|||
170734760|NCT02798211|617035387|FG005|Period 1|Protocol Violation|0|||
170734761|NCT02798211|617035382|FG000|Period 1|Withdrawal by Subject|1|||
170734762|NCT02798211|617035383|FG001|Period 1|Withdrawal by Subject|1|||
170734763|NCT02798211|617035384|FG002|Period 1|Withdrawal by Subject|0|||
170734764|NCT02798211|617035385|FG003|Period 1|Withdrawal by Subject|0|||
170734765|NCT02798211|617035386|FG004|Period 1|Withdrawal by Subject|0|||
170734766|NCT02798211|617035387|FG005|Period 1|Withdrawal by Subject|0|||
170734767|NCT02798211|617035382|FG000|Period 1|Death|0|||
170734768|NCT02798211|617035383|FG001|Period 1|Death|0|||
170734769|NCT02798211|617035384|FG002|Period 1|Death|1|||
170734770|NCT02798211|617035385|FG003|Period 1|Death|0|||
170734771|NCT02798211|617035386|FG004|Period 1|Death|0|||
170841303|NCT04546425|617427904|FG003|Overall Study|Withdrawal by parent/guardian|1|||
170841304|NCT04638660|617427905|FG000|Overall Study|Withdrawal by Subject|2|||
170841305|NCT04638660|617427906|FG001|Overall Study|Withdrawal by Subject|0|||
170734772|NCT02798211|617035387|FG005|Period 1|Death|0|||
170734773|NCT02798211|617035382|FG000|Period 1|Withdrawal of Informed Consent|2|||
170841306|NCT04638660|617427905|FG000|Overall Study|Lost to Follow-up|1|||
170841307|NCT04638660|617427906|FG001|Overall Study|Lost to Follow-up|0|||
170841308|NCT04076943|617427907|FG000|Overall Study|Withdrawal by Subject|12|||
170841309|NCT04076943|617427907|FG000|Overall Study|Adverse Event|1|||
170841310|NCT04076943|617427907|FG000|Overall Study|Progressive Disease|2|||
170841311|NCT04076943|617427907|FG000|Overall Study|Death|13|||
170734774|NCT02798211|617035383|FG001|Period 1|Withdrawal of Informed Consent|7|||
170734775|NCT02798211|617035384|FG002|Period 1|Withdrawal of Informed Consent|3|||
170734776|NCT02798211|617035385|FG003|Period 1|Withdrawal of Informed Consent|0|||
170734777|NCT02798211|617035386|FG004|Period 1|Withdrawal of Informed Consent|0|||
170734778|NCT02798211|617035387|FG005|Period 1|Withdrawal of Informed Consent|0|||
170734779|NCT02798211|617035382|FG000|Period 2|Withdrawal by Subject|2|||
170734780|NCT02798211|617035383|FG001|Period 2|Withdrawal by Subject|0|||
170734781|NCT02798211|617035384|FG002|Period 2|Withdrawal by Subject|0|||
170734782|NCT02798211|617035385|FG003|Period 2|Withdrawal by Subject|0|||
170734783|NCT02798211|617035386|FG004|Period 2|Withdrawal by Subject|2|||
170734784|NCT02798211|617035387|FG005|Period 2|Withdrawal by Subject|2|||
170734785|NCT02798211|617035382|FG000|Period 2|Adverse Event|5|||
170734786|NCT02798211|617035383|FG001|Period 2|Adverse Event|0|||
170734787|NCT02798211|617035384|FG002|Period 2|Adverse Event|0|||
170734788|NCT02798211|617035385|FG003|Period 2|Adverse Event|0|||
170734789|NCT02798211|617035386|FG004|Period 2|Adverse Event|1|||
170734790|NCT02798211|617035387|FG005|Period 2|Adverse Event|0|||
170734791|NCT02798211|617035382|FG000|Period 2|Lack of Efficacy|1|||
170734792|NCT02798211|617035383|FG001|Period 2|Lack of Efficacy|0|||
170734793|NCT02798211|617035384|FG002|Period 2|Lack of Efficacy|0|||
170734794|NCT02798211|617035385|FG003|Period 2|Lack of Efficacy|1|||
170734795|NCT02798211|617035386|FG004|Period 2|Lack of Efficacy|0|||
170734796|NCT02798211|617035387|FG005|Period 2|Lack of Efficacy|1|||
170734797|NCT02798211|617035382|FG000|Period 2|Lost to Follow-up|3|||
170734798|NCT02798211|617035383|FG001|Period 2|Lost to Follow-up|0|||
170734799|NCT02798211|617035384|FG002|Period 2|Lost to Follow-up|0|||
170734800|NCT02798211|617035385|FG003|Period 2|Lost to Follow-up|0|||
170734801|NCT02798211|617035386|FG004|Period 2|Lost to Follow-up|2|||
170734802|NCT02798211|617035387|FG005|Period 2|Lost to Follow-up|0|||
170734803|NCT02798211|617035382|FG000|Period 2|Physician Decision|1|||
170734804|NCT02798211|617035383|FG001|Period 2|Physician Decision|0|||
170734805|NCT02798211|617035384|FG002|Period 2|Physician Decision|0|||
170734806|NCT02798211|617035385|FG003|Period 2|Physician Decision|1|||
170734807|NCT02798211|617035386|FG004|Period 2|Physician Decision|1|||
170734808|NCT02798211|617035387|FG005|Period 2|Physician Decision|0|||
170734809|NCT02798211|617035382|FG000|Period 2|Pregnancy|0|||
170734810|NCT02798211|617035383|FG001|Period 2|Pregnancy|0|||
170734811|NCT02798211|617035384|FG002|Period 2|Pregnancy|0|||
170734812|NCT02798211|617035385|FG003|Period 2|Pregnancy|2|||
170734813|NCT02798211|617035386|FG004|Period 2|Pregnancy|0|||
170734814|NCT02798211|617035387|FG005|Period 2|Pregnancy|0|||
170734815|NCT02798211|617035382|FG000|Period 2|Technical problems|1|||
170734816|NCT02798211|617035383|FG001|Period 2|Technical problems|0|||
170734817|NCT02798211|617035384|FG002|Period 2|Technical problems|0|||
170734818|NCT02798211|617035385|FG003|Period 2|Technical problems|1|||
170734819|NCT02798211|617035386|FG004|Period 2|Technical problems|0|||
170734820|NCT02798211|617035387|FG005|Period 2|Technical problems|0|||
170734821|NCT02798211|617035382|FG000|Period 2|Withdrawal of Informed Consent|1|||
170734822|NCT02798211|617035383|FG001|Period 2|Withdrawal of Informed Consent|0|||
170734823|NCT02798211|617035384|FG002|Period 2|Withdrawal of Informed Consent|0|||
170734824|NCT02798211|617035385|FG003|Period 2|Withdrawal of Informed Consent|2|||
170734825|NCT02798211|617035386|FG004|Period 2|Withdrawal of Informed Consent|2|||
170734826|NCT02798211|617035387|FG005|Period 2|Withdrawal of Informed Consent|3|||
170734827|NCT03086018|617035388|FG000|Final Testing for End of Trial|Adverse Event|1|||
170734828|NCT03086018|617035388|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
170734829|NCT01782872|617035389|FG000|Overall Study|Protocol Violation|0|||
170734830|NCT01782872|617035390|FG001|Overall Study|Protocol Violation|0|||
170734831|NCT01782872|617035391|FG002|Overall Study|Protocol Violation|0|||
170734832|NCT01782872|617035392|FG003|Overall Study|Protocol Violation|1|||
170734833|NCT01782872|617035389|FG000|Overall Study|Withdrawal by Subject|0|||
170734834|NCT01782872|617035390|FG001|Overall Study|Withdrawal by Subject|1|||
170734835|NCT01782872|617035391|FG002|Overall Study|Withdrawal by Subject|0|||
170734836|NCT01782872|617035392|FG003|Overall Study|Withdrawal by Subject|0|||
170734837|NCT02309112|617035393|FG000|Overall Study|Withdrawal by Subject|1|||
170734838|NCT02309112|617035394|FG001|Overall Study|Withdrawal by Subject|0|||
170734839|NCT02309112|617035395|FG002|Overall Study|Withdrawal by Subject|1|||
170734840|NCT02309112|617035393|FG000|Overall Study|Lost to Follow-up|0|||
170734841|NCT02309112|617035394|FG001|Overall Study|Lost to Follow-up|1|||
170734842|NCT02309112|617035395|FG002|Overall Study|Lost to Follow-up|0|||
170734843|NCT00659984|617035397|FG000|Overall Study|Adverse Event|1|||
170734844|NCT00948974|617035398|FG000|Overall Study|Lost to Follow-up|23|||
170734845|NCT00948974|617035399|FG001|Overall Study|Lost to Follow-up|20|||
170734846|NCT01972529|617035400|FG000|Overall Study|Adverse Event|0|||
170734847|NCT01972529|617035401|FG001|Overall Study|Adverse Event|1|||
170734848|NCT01972529|617035402|FG002|Overall Study|Adverse Event|0|||
170734849|NCT01972529|617035403|FG003|Overall Study|Adverse Event|0|||
170734850|NCT01972529|617035400|FG000|Overall Study|Lost to Follow-up|1|||
170734851|NCT01972529|617035401|FG001|Overall Study|Lost to Follow-up|0|||
170734852|NCT01972529|617035402|FG002|Overall Study|Lost to Follow-up|0|||
170734853|NCT01972529|617035403|FG003|Overall Study|Lost to Follow-up|0|||
170734854|NCT01972529|617035400|FG000|Overall Study|Participant Choice|0|||
170734855|NCT01972529|617035401|FG001|Overall Study|Participant Choice|1|||
170734856|NCT01972529|617035402|FG002|Overall Study|Participant Choice|0|||
170734857|NCT01972529|617035403|FG003|Overall Study|Participant Choice|0|||
170734858|NCT01972529|617035400|FG000|Overall Study|Withdrawl of Consent|1|||
170734859|NCT01972529|617035401|FG001|Overall Study|Withdrawl of Consent|2|||
170734860|NCT01972529|617035402|FG002|Overall Study|Withdrawl of Consent|0|||
170734861|NCT01972529|617035403|FG003|Overall Study|Withdrawl of Consent|1|||
170734862|NCT01972529|617035400|FG000|Overall Study|Other|0|||
170734863|NCT01972529|617035401|FG001|Overall Study|Other|0|||
170734864|NCT01972529|617035402|FG002|Overall Study|Other|0|||
170734865|NCT01972529|617035403|FG003|Overall Study|Other|2|||
170734866|NCT01972529|617035400|FG000|Overall Study|Not treated|0|||
170734867|NCT01972529|617035401|FG001|Overall Study|Not treated|1|||
170734868|NCT01972529|617035402|FG002|Overall Study|Not treated|2|||
170734869|NCT01972529|617035403|FG003|Overall Study|Not treated|1|||
170734870|NCT00118716|617035411|FG000|Overall Study|Adverse Event|2|||
170734871|NCT00118716|617035412|FG001|Overall Study|Adverse Event|7|||
170734872|NCT00118716|617035411|FG000|Overall Study|Protocol Violation|5|||
170734873|NCT00118716|617035412|FG001|Overall Study|Protocol Violation|4|||
170734874|NCT00118716|617035411|FG000|Overall Study|Withdrawal by Subject|0|||
170734875|NCT00118716|617035412|FG001|Overall Study|Withdrawal by Subject|1|||
170734876|NCT00118716|617035411|FG000|Overall Study|Exacerbation|2|||
170734877|NCT00118716|617035412|FG001|Overall Study|Exacerbation|2|||
170734878|NCT00118716|617035411|FG000|Overall Study|Discontinued by sponsor|1|||
170734879|NCT00118716|617035412|FG001|Overall Study|Discontinued by sponsor|1|||
170734880|NCT00118716|617035411|FG000|Overall Study|Non-compliance|1|||
170734881|NCT00118716|617035412|FG001|Overall Study|Non-compliance|3|||
170734882|NCT00118716|617035411|FG000|Overall Study|misrandomized|1|||
170734883|NCT00118716|617035412|FG001|Overall Study|misrandomized|1|||
170734884|NCT00118716|617035411|FG000|Overall Study|Expired drug use|1|||
170734885|NCT00118716|617035412|FG001|Overall Study|Expired drug use|2|||
170734886|NCT00118716|617035411|FG000|Overall Study|Investigator discretion|0|||
170734887|NCT00118716|617035412|FG001|Overall Study|Investigator discretion|1|||
170734888|NCT00855062|617035414|FG000|Step1|Early Study Closure|5|||
170734889|NCT00855062|617035415|FG001|Step1|Early Study Closure|7|||
170734890|NCT00855062|617035414|FG000|Step1|Adverse Event|1|||
170734891|NCT00855062|617035415|FG001|Step1|Adverse Event|1|||
170734892|NCT00855062|617035414|FG000|Step1|Protocol Violation|1|||
170734893|NCT00855062|617035415|FG001|Step1|Protocol Violation|0|||
170734894|NCT00855062|617035414|FG000|Step1|Pregnancy|1|||
170734895|NCT00855062|617035415|FG001|Step1|Pregnancy|0|||
170734896|NCT00855062|617035414|FG000|Step1|Withdrawal by Subject|2|||
170734897|NCT00855062|617035415|FG001|Step1|Withdrawal by Subject|3|||
170734898|NCT00855062|617035414|FG000|Step2|Early Study Closure|6|||
170734899|NCT00855062|617035415|FG001|Step2|Early Study Closure|2|||
170734900|NCT00855062|617035414|FG000|Step2|Adverse Event|0|||
170734901|NCT00855062|617035415|FG001|Step2|Adverse Event|3|||
170734902|NCT00855062|617035414|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
170734903|NCT00855062|617035415|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
170734904|NCT01287611|617035416|FG000|Overall Study|Lost to Follow-up|29|||
170734905|NCT01287611|617035417|FG001|Overall Study|Lost to Follow-up|16|||
170734906|NCT01287611|617035416|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
170734907|NCT01287611|617035417|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
170734908|NCT02255357|617035418|FG000|Overall Study|Physician Decision|10|||
170734909|NCT02255357|617035419|FG001|Overall Study|Physician Decision|24|||
170734910|NCT02192970|617035420|FG000|Overall Study|Lost to Follow-up|6|||
170734911|NCT02192970|617035421|FG001|Overall Study|Lost to Follow-up|0|||
170734912|NCT01376323|617035424|FG000|Overall Study|Adverse Event|1|||
170734913|NCT01376323|617035425|FG001|Overall Study|Adverse Event|0|||
170734914|NCT01376323|617035426|FG002|Overall Study|Adverse Event|0|||
170734915|NCT01376323|617035427|FG003|Overall Study|Adverse Event|2|||
170734916|NCT01376323|617035428|FG004|Overall Study|Adverse Event|0|||
170841312|NCT04076943|617427907|FG000|Overall Study|Other than specified|6|||
170841313|NCT01125046|617427908|FG000|First 6 Months of Treatment|Death|1|||
170841314|NCT01125046|617427908|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
170841315|NCT01125046|617427908|FG000|First 6 Months of Treatment|Non-compliance|1|||
170841316|NCT01125046|617427908|FG000|First 6 Months of Treatment|Surgery|1|||
170841317|NCT01125046|617427908|FG000|First 6 Months of Treatment|Progressive Disease|7|||
170734917|NCT01376323|617035424|FG000|Overall Study|Lost to Follow-up|0|||
170734918|NCT01376323|617035425|FG001|Overall Study|Lost to Follow-up|0|||
170734919|NCT01376323|617035426|FG002|Overall Study|Lost to Follow-up|0|||
170734920|NCT01376323|617035427|FG003|Overall Study|Lost to Follow-up|2|||
170734921|NCT01376323|617035428|FG004|Overall Study|Lost to Follow-up|0|||
170734922|NCT01376323|617035424|FG000|Overall Study|Physician Decision|1|||
170734923|NCT01376323|617035425|FG001|Overall Study|Physician Decision|0|||
170734924|NCT01376323|617035426|FG002|Overall Study|Physician Decision|2|||
170734925|NCT01376323|617035427|FG003|Overall Study|Physician Decision|1|||
170734926|NCT01376323|617035428|FG004|Overall Study|Physician Decision|1|||
170734927|NCT01376323|617035424|FG000|Overall Study|Withdrawal by Subject|0|||
170734928|NCT01376323|617035425|FG001|Overall Study|Withdrawal by Subject|1|||
170734929|NCT01376323|617035426|FG002|Overall Study|Withdrawal by Subject|1|||
170734930|NCT01376323|617035427|FG003|Overall Study|Withdrawal by Subject|0|||
170734931|NCT01376323|617035428|FG004|Overall Study|Withdrawal by Subject|0|||
170734932|NCT04681729|617035439|FG000|Overall Study|Lack of Efficacy|2|||
170734933|NCT04681729|617035440|FG001|Overall Study|Lack of Efficacy|2|||
170734934|NCT04681729|617035439|FG000|Overall Study|Withdrawal by Subject|8|||
170734935|NCT04681729|617035440|FG001|Overall Study|Withdrawal by Subject|9|||
170734936|NCT02436811|617035441|FG000|Overall Study|Lost to Follow-up|2|||
170734937|NCT02436811|617035442|FG001|Overall Study|Lost to Follow-up|9|||
170734938|NCT02436811|617035443|FG002|Overall Study|Lost to Follow-up|7|||
170734939|NCT03745222|617035445|FG000|Overall Study|Withdrawal by Subject|0|||
170734940|NCT03745222|617035446|FG001|Overall Study|Withdrawal by Subject|1|||
170734941|NCT03745222|617035447|FG002|Overall Study|Withdrawal by Subject|0|||
170734942|NCT03595332|617035448|FG000|Overall Study|Lost to Follow-up|16|||
170734943|NCT03595332|617035449|FG001|Overall Study|Lost to Follow-up|22|||
170734944|NCT03595332|617035448|FG000|Overall Study|Unable to retrieve ID from school|0|||
170734945|NCT03595332|617035449|FG001|Overall Study|Unable to retrieve ID from school|2|||
170734946|NCT02856113|617035450|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
170734947|NCT02856113|617035451|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
170734948|NCT02856113|617035450|FG000|Overall Study|Significant Protocol Deviation|1|||
170734949|NCT02856113|617035451|FG001|Overall Study|Significant Protocol Deviation|0|||
170734950|NCT02856113|617035450|FG000|Overall Study|Lost to Follow-up|3|||
170734951|NCT02856113|617035451|FG001|Overall Study|Lost to Follow-up|5|||
170734952|NCT02856113|617035450|FG000|Overall Study|Voluntary Withdrawal|3|||
170734953|NCT02856113|617035451|FG001|Overall Study|Voluntary Withdrawal|5|||
170734954|NCT02856113|617035450|FG000|Overall Study|Pregnancy|0|||
170734955|NCT02856113|617035451|FG001|Overall Study|Pregnancy|1|||
170734956|NCT02856113|617035450|FG000|Overall Study|Principal Investigator Discretion|2|||
170734957|NCT02856113|617035451|FG001|Overall Study|Principal Investigator Discretion|1|||
170734958|NCT02856113|617035450|FG000|Overall Study|Randomized but not Treated|1|||
170734959|NCT02856113|617035451|FG001|Overall Study|Randomized but not Treated|0|||
170734960|NCT02856113|617035450|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
170734961|NCT02856113|617035451|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
170734962|NCT01446796|617035452|FG000|Overall Study|Withdrawal by Subject|1|||
170734963|NCT01446796|617035453|FG001|Overall Study|Withdrawal by Subject|0|||
170734964|NCT01862796|617035456|FG000|Overall Study|Prohibited medications|0|||
170734965|NCT01862796|617035457|FG001|Overall Study|Prohibited medications|0|||
170734966|NCT01862796|617035458|FG002|Overall Study|Prohibited medications|1|||
170734967|NCT01462162|617035459|FG000|Overall Study|Adverse Event|5|||
170734968|NCT01462162|617035459|FG000|Overall Study|Lack of Efficacy|4|||
170734969|NCT01462162|617035459|FG000|Overall Study|Abnormal laboratory parameters|1|||
170734970|NCT01462162|617035459|FG000|Overall Study|Other|2|||
170734971|NCT03485911|617035460|FG000|Part 1|Perceived lack of efficacy|1|||
170734972|NCT03485911|617035461|FG001|Part 1|Perceived lack of efficacy|1|||
170734973|NCT03485911|617035462|FG002|Part 1|Perceived lack of efficacy|2|||
170734974|NCT03485911|617035463|FG003|Part 1|Perceived lack of efficacy|0|||
170734975|NCT03485911|617035460|FG000|Part 1|Subject withdrew consent|0|||
170734976|NCT03485911|617035461|FG001|Part 1|Subject withdrew consent|1|||
170734977|NCT03485911|617035462|FG002|Part 1|Subject withdrew consent|0|||
170734978|NCT03485911|617035463|FG003|Part 1|Subject withdrew consent|1|||
170734979|NCT03485911|617035460|FG000|Part 1|Lab abnormalities/AEs|3|||
170734980|NCT03485911|617035461|FG001|Part 1|Lab abnormalities/AEs|1|||
170734981|NCT03485911|617035462|FG002|Part 1|Lab abnormalities/AEs|1|||
170734982|NCT03485911|617035463|FG003|Part 1|Lab abnormalities/AEs|0|||
170734983|NCT03485911|617035460|FG000|Part 1|Withdrew Consent prior to dosing|0|||
170734984|NCT03485911|617035461|FG001|Part 1|Withdrew Consent prior to dosing|0|||
170734985|NCT03485911|617035462|FG002|Part 1|Withdrew Consent prior to dosing|0|||
170734986|NCT03485911|617035463|FG003|Part 1|Withdrew Consent prior to dosing|1|||
170734987|NCT03485911|617035460|FG000|Part 1|Other NOS|0|||
170734988|NCT03485911|617035461|FG001|Part 1|Other NOS|0|||
170734989|NCT03485911|617035462|FG002|Part 1|Other NOS|0|||
170734990|NCT03485911|617035463|FG003|Part 1|Other NOS|1|||
170734991|NCT03485911|617035460|FG000|Part 2|Perceived lack of efficacy|5|||
170734992|NCT03485911|617035461|FG001|Part 2|Perceived lack of efficacy|3|||
170734993|NCT03485911|617035462|FG002|Part 2|Perceived lack of efficacy|0|||
170841318|NCT01125046|617427908|FG000|First 6 Months of Treatment|Adverse Event|2|||
170734994|NCT03485911|617035463|FG003|Part 2|Perceived lack of efficacy|2|||
170734995|NCT03485911|617035460|FG000|Part 2|Subject withdrew consent|1|||
170734996|NCT03485911|617035461|FG001|Part 2|Subject withdrew consent|0|||
170734997|NCT03485911|617035462|FG002|Part 2|Subject withdrew consent|2|||
170734998|NCT03485911|617035463|FG003|Part 2|Subject withdrew consent|1|||
170734999|NCT03485911|617035460|FG000|Part 2|Lab abnormalities/AEs|1|||
170735000|NCT03485911|617035461|FG001|Part 2|Lab abnormalities/AEs|2|||
170735001|NCT03485911|617035462|FG002|Part 2|Lab abnormalities/AEs|0|||
170735002|NCT03485911|617035463|FG003|Part 2|Lab abnormalities/AEs|0|||
170735003|NCT03485911|617035460|FG000|Part 2|Other NOS|0|||
170735004|NCT03485911|617035461|FG001|Part 2|Other NOS|1|||
170735005|NCT03485911|617035462|FG002|Part 2|Other NOS|0|||
170735006|NCT03485911|617035463|FG003|Part 2|Other NOS|0|||
170735007|NCT03485911|617035460|FG000|Part 2|Intercurrent illness/new medical condition|1|||
170735008|NCT03485911|617035461|FG001|Part 2|Intercurrent illness/new medical condition|0|||
170735009|NCT03485911|617035462|FG002|Part 2|Intercurrent illness/new medical condition|0|||
170735010|NCT03485911|617035463|FG003|Part 2|Intercurrent illness/new medical condition|0|||
170735011|NCT03485911|617035460|FG000|Part 2|Investigator judgement|1|||
170735012|NCT03485911|617035461|FG001|Part 2|Investigator judgement|0|||
170735013|NCT03485911|617035462|FG002|Part 2|Investigator judgement|0|||
170735014|NCT03485911|617035463|FG003|Part 2|Investigator judgement|0|||
170735015|NCT03485911|617035460|FG000|Part 3|Perceived lack of efficacy|2|||
170735016|NCT03485911|617035461|FG001|Part 3|Perceived lack of efficacy|2|||
170735017|NCT03485911|617035462|FG002|Part 3|Perceived lack of efficacy|2|||
170735018|NCT03485911|617035463|FG003|Part 3|Perceived lack of efficacy|0|||
170735019|NCT03485911|617035460|FG000|Part 3|Subject withdrew consent|1|||
170735020|NCT03485911|617035461|FG001|Part 3|Subject withdrew consent|4|||
170735021|NCT03485911|617035462|FG002|Part 3|Subject withdrew consent|0|||
170735022|NCT03485911|617035463|FG003|Part 3|Subject withdrew consent|1|||
170735023|NCT03485911|617035460|FG000|Part 3|Lab abnormalities/AEs|1|||
170735024|NCT03485911|617035461|FG001|Part 3|Lab abnormalities/AEs|1|||
170735025|NCT03485911|617035462|FG002|Part 3|Lab abnormalities/AEs|0|||
170735026|NCT03485911|617035463|FG003|Part 3|Lab abnormalities/AEs|2|||
170735027|NCT03485911|617035460|FG000|Part 3|Other NOS|1|||
170735028|NCT03485911|617035461|FG001|Part 3|Other NOS|1|||
170735029|NCT03485911|617035462|FG002|Part 3|Other NOS|0|||
170735030|NCT03485911|617035463|FG003|Part 3|Other NOS|0|||
170735031|NCT03485911|617035460|FG000|Part 3|Intercurrent illness/new medical condition|0|||
170735032|NCT03485911|617035461|FG001|Part 3|Intercurrent illness/new medical condition|1|||
170735033|NCT03485911|617035462|FG002|Part 3|Intercurrent illness/new medical condition|1|||
170735034|NCT03485911|617035463|FG003|Part 3|Intercurrent illness/new medical condition|0|||
170735035|NCT03485911|617035460|FG000|Part 3|Sponsor discontinuation|1|||
170735036|NCT03485911|617035461|FG001|Part 3|Sponsor discontinuation|0|||
170735037|NCT03485911|617035462|FG002|Part 3|Sponsor discontinuation|0|||
170735038|NCT03485911|617035463|FG003|Part 3|Sponsor discontinuation|0|||
170735039|NCT03485911|617035460|FG000|Part 3|Berotralstat provided by alternative means|13|||
170735040|NCT03485911|617035461|FG001|Part 3|Berotralstat provided by alternative means|13|||
170735041|NCT03485911|617035462|FG002|Part 3|Berotralstat provided by alternative means|7|||
170735042|NCT03485911|617035463|FG003|Part 3|Berotralstat provided by alternative means|7|||
170735043|NCT01215357|617035464|FG000|Overall Study|Withdrawal by Subject|3|||
170735044|NCT01215357|617035464|FG000|Overall Study|Protocol Violation|9|||
170735045|NCT03333928|617035465|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
170735046|NCT03333928|617035466|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
170735047|NCT03333928|617035467|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
170735048|NCT03333928|617035465|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
170735049|NCT03333928|617035466|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
170735050|NCT03333928|617035467|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
170735051|NCT03333928|617035465|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
170735052|NCT03333928|617035466|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
170735053|NCT03333928|617035467|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
170735054|NCT03333928|617035465|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
170735055|NCT03333928|617035466|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
170735056|NCT03333928|617035467|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
170735057|NCT03333928|617035465|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
170735058|NCT03333928|617035466|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
170735059|NCT03333928|617035467|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
170735060|NCT03333928|617035465|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
170735061|NCT03333928|617035466|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
170735062|NCT03333928|617035467|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
170735063|NCT03333928|617035465|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
170735064|NCT03333928|617035466|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
170735065|NCT03333928|617035467|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
170735066|NCT03333928|617035465|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
170735067|NCT03333928|617035466|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
170735068|NCT03333928|617035467|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
170735069|NCT01375205|617035472|FG000|Overall Study|Lost to Follow-up|15|||
170735070|NCT01375205|617035473|FG001|Overall Study|Lost to Follow-up|12|||
170735071|NCT01375205|617035472|FG000|Overall Study|Withdrawal by Subject|6|||
170735072|NCT01375205|617035473|FG001|Overall Study|Withdrawal by Subject|1|||
170735073|NCT01859793|617035474|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
170735074|NCT01859793|617035475|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
170735075|NCT01859793|617035474|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
170735076|NCT01859793|617035475|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
170735077|NCT01859793|617035474|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
170735078|NCT01859793|617035475|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
170735079|NCT01859793|617035474|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
170735080|NCT01859793|617035475|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
170735081|NCT05479604|617035476|FG000|Overall Study|Lost to Follow-up|1|||
170735082|NCT05479604|617035477|FG001|Overall Study|Lost to Follow-up|5|||
170735083|NCT02515279|617035481|FG000|Overall Study|Adverse Event|7|||
170735084|NCT02515279|617035481|FG000|Overall Study|Lack of Efficacy|31|||
170735085|NCT02515279|617035481|FG000|Overall Study|Lost to Follow-up|9|||
170735086|NCT02515279|617035481|FG000|Overall Study|Withdrawal by Subject|18|||
170735087|NCT02515279|617035481|FG000|Overall Study|End-of-treatment visit not attended|17|||
170735088|NCT02515279|617035481|FG000|Overall Study|Other|22|||
170735089|NCT03185481|617035482|FG000|Overall Study|Adverse Event|1|||
170735090|NCT03185481|617035482|FG000|Overall Study|Study Terminated by Sponsor|4|||
170735091|NCT00511875|617035488|FG000|Overall Study|Lost to Follow-up|4|||
170735092|NCT00511875|617035489|FG001|Overall Study|Lost to Follow-up|0|||
170735093|NCT00511875|617035488|FG000|Overall Study|Missing variables|1|||
170735094|NCT00511875|617035489|FG001|Overall Study|Missing variables|0|||
170735095|NCT01951638|617035490|FG000|Treatment Period|Protocol Violation|0|||
170735096|NCT01951638|617035491|FG001|Treatment Period|Protocol Violation|0|||
170735097|NCT01951638|617035492|FG002|Treatment Period|Protocol Violation|0|||
170735098|NCT01951638|617035493|FG003|Treatment Period|Protocol Violation|2|||
170735099|NCT01951638|617035494|FG004|Treatment Period|Protocol Violation|0|||
170735100|NCT01951638|617035490|FG000|Treatment Period|Protocol-driven decision point|1|||
170735101|NCT01951638|617035491|FG001|Treatment Period|Protocol-driven decision point|3|||
170735102|NCT01951638|617035492|FG002|Treatment Period|Protocol-driven decision point|0|||
170735103|NCT01951638|617035493|FG003|Treatment Period|Protocol-driven decision point|0|||
170735104|NCT01951638|617035494|FG004|Treatment Period|Protocol-driven decision point|0|||
170735105|NCT01951638|617035490|FG000|Treatment Period|Logistical difficulties|0|||
170735106|NCT01951638|617035491|FG001|Treatment Period|Logistical difficulties|1|||
170735107|NCT01951638|617035492|FG002|Treatment Period|Logistical difficulties|1|||
170735108|NCT01951638|617035493|FG003|Treatment Period|Logistical difficulties|0|||
170735109|NCT01951638|617035494|FG004|Treatment Period|Logistical difficulties|0|||
170735110|NCT01951638|617035490|FG000|Treatment Period|Withdrawal by Subject|9|||
170735111|NCT01951638|617035491|FG001|Treatment Period|Withdrawal by Subject|6|||
170735112|NCT01951638|617035492|FG002|Treatment Period|Withdrawal by Subject|4|||
170735113|NCT01951638|617035493|FG003|Treatment Period|Withdrawal by Subject|5|||
170735114|NCT01951638|617035494|FG004|Treatment Period|Withdrawal by Subject|4|||
170735115|NCT01951638|617035490|FG000|Treatment Period|Death|0|||
170735116|NCT01951638|617035491|FG001|Treatment Period|Death|0|||
170735117|NCT01951638|617035492|FG002|Treatment Period|Death|0|||
170735118|NCT01951638|617035493|FG003|Treatment Period|Death|3|||
170735119|NCT01951638|617035494|FG004|Treatment Period|Death|1|||
170735120|NCT01951638|617035490|FG000|Treatment Period|Adverse Event|3|||
170841319|NCT01125046|617427908|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
170841320|NCT01125046|617427908|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
170841321|NCT01125046|617427908|FG000|Follow-up/Data Cut Off Point|Death|29|||
170841322|NCT01125046|617427908|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
170841323|NCT01853475|617427919|FG000|Overall Study|Withdrawal by Subject|0|||
170735121|NCT01951638|617035491|FG001|Treatment Period|Adverse Event|4|||
170735122|NCT01951638|617035492|FG002|Treatment Period|Adverse Event|8|||
170735123|NCT01951638|617035493|FG003|Treatment Period|Adverse Event|6|||
170735124|NCT01951638|617035494|FG004|Treatment Period|Adverse Event|5|||
170735125|NCT01951638|617035490|FG000|Follow-up Period|Protocol Violation|0|||
170735126|NCT01951638|617035491|FG001|Follow-up Period|Protocol Violation|0|||
170735127|NCT01951638|617035492|FG002|Follow-up Period|Protocol Violation|0|||
170735128|NCT01951638|617035493|FG003|Follow-up Period|Protocol Violation|1|||
170735129|NCT01951638|617035494|FG004|Follow-up Period|Protocol Violation|0|||
170735130|NCT01951638|617035490|FG000|Follow-up Period|Logistical difficulties|0|||
170735131|NCT01951638|617035491|FG001|Follow-up Period|Logistical difficulties|2|||
170735132|NCT01951638|617035492|FG002|Follow-up Period|Logistical difficulties|0|||
170735133|NCT01951638|617035493|FG003|Follow-up Period|Logistical difficulties|0|||
170735134|NCT01951638|617035494|FG004|Follow-up Period|Logistical difficulties|1|||
170735135|NCT01951638|617035490|FG000|Follow-up Period|Withdrawal by Subject|1|||
170735136|NCT01951638|617035491|FG001|Follow-up Period|Withdrawal by Subject|5|||
170735137|NCT01951638|617035492|FG002|Follow-up Period|Withdrawal by Subject|2|||
170735138|NCT01951638|617035493|FG003|Follow-up Period|Withdrawal by Subject|1|||
170735139|NCT01951638|617035494|FG004|Follow-up Period|Withdrawal by Subject|2|||
170735140|NCT01951638|617035490|FG000|Follow-up Period|Lost to Follow-up|0|||
170735141|NCT01951638|617035491|FG001|Follow-up Period|Lost to Follow-up|1|||
170735142|NCT01951638|617035492|FG002|Follow-up Period|Lost to Follow-up|0|||
170735143|NCT01951638|617035493|FG003|Follow-up Period|Lost to Follow-up|1|||
170735144|NCT01951638|617035494|FG004|Follow-up Period|Lost to Follow-up|0|||
170735145|NCT01951638|617035490|FG000|Follow-up Period|Death|1|||
170735146|NCT01951638|617035491|FG001|Follow-up Period|Death|0|||
170735147|NCT01951638|617035492|FG002|Follow-up Period|Death|1|||
170735148|NCT01951638|617035493|FG003|Follow-up Period|Death|4|||
170735149|NCT01951638|617035494|FG004|Follow-up Period|Death|1|||
170735150|NCT01951638|617035490|FG000|Follow-up Period|Adverse Event|0|||
170841324|NCT01853475|617427920|FG001|Overall Study|Withdrawal by Subject|1|||
170841325|NCT01853475|617427921|FG002|Overall Study|Withdrawal by Subject|0|||
170841326|NCT00659880|617427922|FG000|Overall Study|Lost to Follow-up|5|||
170841327|NCT02159040|617427923|FG000|Overall Study|Death|1|||
170841328|NCT01427725|617427932|FG000|Overall Study|Lost to Follow-up|17|||
170841329|NCT01427725|617427932|FG000|Overall Study|Protocol Violation|1|||
170841330|NCT01427725|617427932|FG000|Overall Study|Drug not administered|1|||
170841331|NCT01427725|617427932|FG000|Overall Study|Failure to visit|7|||
170841332|NCT01427725|617427932|FG000|Overall Study|Adverse Event|46|||
170841333|NCT01427725|617427932|FG000|Overall Study|Failure to visit after administration|40|||
170841334|NCT01427725|617427932|FG000|Overall Study|Patient's rejection|27|||
170841335|NCT01427725|617427932|FG000|Overall Study|Transfer to a different hospital|17|||
170841336|NCT01427725|617427932|FG000|Overall Study|Lack of Efficacy|8|||
170841337|NCT01427725|617427932|FG000|Overall Study|Death|7|||
170841338|NCT01427725|617427932|FG000|Overall Study|Symptom improvement|6|||
170841339|NCT01427725|617427932|FG000|Overall Study|AE and Patient's rejection|5|||
170841340|NCT01427725|617427932|FG000|Overall Study|Physician Decision|5|||
170841341|NCT01427725|617427932|FG000|Overall Study|Exacerbation of underlying disease|5|||
170841342|NCT01427725|617427932|FG000|Overall Study|Oral feeding difficulty|5|||
170841343|NCT01427725|617427932|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
170841344|NCT01427725|617427932|FG000|Overall Study|Forgetting prescription|1|||
170841345|NCT01427725|617427932|FG000|Overall Study|Other|2|||
170841346|NCT04276051|617427933|FG000|Overall Study|Lost to Follow-up|0|||
170841347|NCT04276051|617427934|FG001|Overall Study|Lost to Follow-up|1|||
170841348|NCT04276051|617427933|FG000|Overall Study|Physician Decision|0|||
170841349|NCT04276051|617427934|FG001|Overall Study|Physician Decision|1|||
170841350|NCT04276051|617427933|FG000|Overall Study|Withdrawal by Subject|1|||
170841351|NCT04276051|617427934|FG001|Overall Study|Withdrawal by Subject|1|||
170841352|NCT01299480|617427935|FG000|Overall Study|No longer willing to participate|19|||
170841353|NCT01299480|617427936|FG001|Overall Study|No longer willing to participate|17|||
170841354|NCT01299480|617427937|FG002|Overall Study|No longer willing to participate|14|||
170841355|NCT01299480|617427938|FG003|Overall Study|No longer willing to participate|13|||
170841356|NCT01299480|617427939|FG004|Overall Study|No longer willing to participate|10|||
170841357|NCT01299480|617427935|FG000|Overall Study|Protocol Violation|7|||
170841358|NCT01299480|617427936|FG001|Overall Study|Protocol Violation|5|||
170841359|NCT01299480|617427937|FG002|Overall Study|Protocol Violation|8|||
170841360|NCT01299480|617427938|FG003|Overall Study|Protocol Violation|1|||
170841361|NCT01299480|617427939|FG004|Overall Study|Protocol Violation|1|||
170841362|NCT01299480|617427935|FG000|Overall Study|Withdrawal by Subject|3|||
170841363|NCT01299480|617427936|FG001|Overall Study|Withdrawal by Subject|4|||
170841364|NCT01299480|617427937|FG002|Overall Study|Withdrawal by Subject|7|||
170735151|NCT01951638|617035491|FG001|Follow-up Period|Adverse Event|1|||
170841365|NCT01299480|617427938|FG003|Overall Study|Withdrawal by Subject|3|||
170841366|NCT01299480|617427939|FG004|Overall Study|Withdrawal by Subject|4|||
170841367|NCT01299480|617427935|FG000|Overall Study|Adverse Event|6|||
170841368|NCT01299480|617427936|FG001|Overall Study|Adverse Event|4|||
170841369|NCT01299480|617427937|FG002|Overall Study|Adverse Event|5|||
170735152|NCT01951638|617035492|FG002|Follow-up Period|Adverse Event|2|||
170735153|NCT01951638|617035493|FG003|Follow-up Period|Adverse Event|1|||
170841370|NCT01299480|617427938|FG003|Overall Study|Adverse Event|4|||
170841371|NCT01299480|617427939|FG004|Overall Study|Adverse Event|0|||
170841372|NCT01299480|617427935|FG000|Overall Study|Withdrawal due to pregnancy|0|||
170735154|NCT01951638|617035494|FG004|Follow-up Period|Adverse Event|1|||
170841373|NCT01299480|617427936|FG001|Overall Study|Withdrawal due to pregnancy|1|||
170841374|NCT01299480|617427937|FG002|Overall Study|Withdrawal due to pregnancy|1|||
170841375|NCT01299480|617427938|FG003|Overall Study|Withdrawal due to pregnancy|0|||
170841376|NCT01299480|617427939|FG004|Overall Study|Withdrawal due to pregnancy|0|||
170841377|NCT01299480|617427935|FG000|Overall Study|Physician Decision|1|||
170841378|NCT01299480|617427936|FG001|Overall Study|Physician Decision|1|||
170735155|NCT00459342|617035495|FG000|Overall Study|Not eligible|1|||
170735156|NCT02027402|617035496|FG000|Overall Study|Withdrawal by Subject|4|||
170735157|NCT02027402|617035497|FG001|Overall Study|Withdrawal by Subject|1|||
170735158|NCT01338025|617035502|FG000|Overall Study|Unexpected closure of study|10|||
170735159|NCT01338025|617035503|FG001|Overall Study|Unexpected closure of study|9|||
170735160|NCT01338025|617035502|FG000|Overall Study|Withdrawal by Subject|0|||
170735161|NCT01338025|617035503|FG001|Overall Study|Withdrawal by Subject|2|||
170735162|NCT01338025|617035502|FG000|Overall Study|Found ineligible after starting|1|||
170735163|NCT01338025|617035503|FG001|Overall Study|Found ineligible after starting|0|||
170735164|NCT03904043|617035504|FG000|Overall Study|Adverse Event|1|||
170735165|NCT03904043|617035505|FG001|Overall Study|Adverse Event|1|||
170735166|NCT03904043|617035504|FG000|Overall Study|Withdrawal by Subject|1|||
170735167|NCT03904043|617035505|FG001|Overall Study|Withdrawal by Subject|0|||
170735168|NCT03904043|617035504|FG000|Overall Study|Non-compliance|1|||
170735169|NCT03904043|617035505|FG001|Overall Study|Non-compliance|0|||
170735170|NCT03904043|617035504|FG000|Overall Study|Did not start treatment|1|||
170735171|NCT03904043|617035505|FG001|Overall Study|Did not start treatment|0|||
170735172|NCT03750006|617035506|FG000|Overall Study|Withdrawal by Subject|8|||
170735173|NCT03750006|617035506|FG000|Overall Study|COVID PANDEMIC|11|||
170735174|NCT03538951|617035507|FG000|Overall Study|Withdrawal by Subject|1|||
170735175|NCT03538951|617035508|FG001|Overall Study|Withdrawal by Subject|2|||
170735176|NCT03779906|617035513|FG000|Overall Study|Lost to Follow-up|7|||
170735177|NCT03779906|617035513|FG000|Overall Study|COVID pandemic|1|||
170735178|NCT06027619|617035514|FG000|Overall Study|Adverse Event|0|||
170735179|NCT06027619|617035515|FG001|Overall Study|Adverse Event|0|||
170735180|NCT06027619|617035516|FG002|Overall Study|Adverse Event|1|||
170735181|NCT00766675|617036911|FG000|Overall Study|Adverse Event|16|||
170735182|NCT00766675|617036911|FG000|Overall Study|Lost to Follow-up|2|||
170735183|NCT00766675|617036911|FG000|Overall Study|Withdrawal by Subject|11|||
170735184|NCT00766675|617036911|FG000|Overall Study|Protocol Violation|8|||
170735185|NCT00766675|617036911|FG000|Overall Study|Participant took prohibited medication|1|||
170735186|NCT00766675|617036911|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
170735187|NCT00766675|617036911|FG000|Overall Study|Insufficient therapy|1|||
170735188|NCT03183388|617036912|FG000|Overall Study|Lost to Follow-up|3|||
170735189|NCT03183388|617036913|FG001|Overall Study|Lost to Follow-up|5|||
170735190|NCT03183388|617036912|FG000|Overall Study|Physician Decision|1|||
170735191|NCT03183388|617036913|FG001|Overall Study|Physician Decision|4|||
170735192|NCT03183388|617036912|FG000|Overall Study|Withdrawal by Subject|4|||
170735193|NCT03183388|617036913|FG001|Overall Study|Withdrawal by Subject|1|||
170735194|NCT03183388|617036912|FG000|Overall Study|Moved|1|||
170735195|NCT03183388|617036913|FG001|Overall Study|Moved|0|||
170735196|NCT03183388|617036912|FG000|Overall Study|Met Exclusion Criteria|2|||
170735197|NCT03183388|617036913|FG001|Overall Study|Met Exclusion Criteria|2|||
170735198|NCT03183388|617036912|FG000|Overall Study|COVID Pandemic Related|2|||
170735199|NCT03183388|617036913|FG001|Overall Study|COVID Pandemic Related|4|||
170735200|NCT01160484|617036917|FG000|Overall Study|Lack of Efficacy|9|||
170735201|NCT01160484|617036917|FG000|Overall Study|Adverse Event|6|||
170735202|NCT01160484|617036917|FG000|Overall Study|Withdrawal by Subject|2|||
170735203|NCT01160484|617036917|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
170735204|NCT02173054|617036923|FG000|Overall Study|lack of compliance|1|||
170735205|NCT02173054|617036924|FG001|Overall Study|lack of compliance|0|||
170735206|NCT02173054|617036925|FG002|Overall Study|lack of compliance|0|||
170735207|NCT02173054|617036923|FG000|Overall Study|Withdrawal by Subject|0|||
170735208|NCT02173054|617036924|FG001|Overall Study|Withdrawal by Subject|0|||
170735209|NCT02173054|617036925|FG002|Overall Study|Withdrawal by Subject|1|||
170735210|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
170735211|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
170735212|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
170735213|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
170735214|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
170735215|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
170841379|NCT01299480|617427937|FG002|Overall Study|Physician Decision|0|||
170841380|NCT01299480|617427938|FG003|Overall Study|Physician Decision|2|||
170735216|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
170735217|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
170735218|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
170735219|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
170841381|NCT01299480|617427939|FG004|Overall Study|Physician Decision|0|||
170735220|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
170735221|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
170841382|NCT01299480|617427935|FG000|Overall Study|Lost to Follow-up|3|||
170841383|NCT01299480|617427936|FG001|Overall Study|Lost to Follow-up|1|||
170841384|NCT01299480|617427937|FG002|Overall Study|Lost to Follow-up|2|||
170841385|NCT01299480|617427938|FG003|Overall Study|Lost to Follow-up|1|||
170841386|NCT01299480|617427939|FG004|Overall Study|Lost to Follow-up|2|||
170841387|NCT01299480|617427935|FG000|Overall Study|Other|3|||
170841388|NCT01299480|617427936|FG001|Overall Study|Other|2|||
170841389|NCT01299480|617427937|FG002|Overall Study|Other|3|||
170841390|NCT01299480|617427938|FG003|Overall Study|Other|0|||
170841391|NCT01299480|617427939|FG004|Overall Study|Other|3|||
170841392|NCT01299480|617427935|FG000|Overall Study|Started, but not vaccinated|0|||
170841393|NCT01299480|617427936|FG001|Overall Study|Started, but not vaccinated|0|||
170841394|NCT01299480|617427937|FG002|Overall Study|Started, but not vaccinated|1|||
170841395|NCT01299480|617427938|FG003|Overall Study|Started, but not vaccinated|1|||
170841396|NCT01299480|617427939|FG004|Overall Study|Started, but not vaccinated|0|||
170841397|NCT01374568|617427940|FG000|Overall Study|Lab unable to analyze BTM|0|||
170841398|NCT01374568|617427941|FG001|Overall Study|Lab unable to analyze BTM|2|||
170841399|NCT04230122|617427942|FG000|Overall Study|Lost to Follow-up|1|||
170841400|NCT04230122|617427943|FG001|Overall Study|Lost to Follow-up|0|||
170841401|NCT01361594|617427945|FG000|Overall Study|Withdrawal by Subject|1|||
170841402|NCT01361594|617427946|FG001|Overall Study|Withdrawal by Subject|2|||
170841403|NCT01277887|617427947|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
170841404|NCT01277887|617427948|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
170841405|NCT01277887|617427947|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
170841406|NCT01277887|617427948|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
170841407|NCT01277887|617427947|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
170841408|NCT01277887|617427948|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
170841409|NCT05479734|617427958|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
170841410|NCT05479734|617427959|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
170841411|NCT05479734|617427958|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
170841412|NCT05479734|617427959|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
170841413|NCT05479734|617427958|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
170841414|NCT05479734|617427959|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
170841415|NCT05479734|617427958|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
170841416|NCT05479734|617427959|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
170841417|NCT02670122|617427960|FG000|Overall Study|Lost to Follow-up|4|||
170841418|NCT00203268|617427961|FG000|Early Treatment|only treated one headache|2|||
170841419|NCT00203268|617427961|FG000|Early Treatment|Lost to Follow-up|1|||
170841420|NCT00203268|617427961|FG000|Early Treatment|Withdrawal by Subject|1|||
170841421|NCT00600613|617427962|FG000|Overall Study|Protocol Deviation|1|||
170841422|NCT01509547|617427965|FG000|Overall Study|Lost to Follow-up|24|||
170841423|NCT01509547|617427966|FG001|Overall Study|Lost to Follow-up|14|||
170841424|NCT01509547|617427965|FG000|Overall Study|Withdrawal by Subject|11|||
170841425|NCT01509547|617427966|FG001|Overall Study|Withdrawal by Subject|24|||
170841426|NCT01509547|617427965|FG000|Overall Study|Physician Decision|0|||
170841427|NCT01509547|617427966|FG001|Overall Study|Physician Decision|1|||
170841428|NCT02514551|617427969|FG000|Overall Study|Lost to Follow-up|0|||
170841429|NCT02514551|617427970|FG001|Overall Study|Lost to Follow-up|1|||
170841430|NCT02514551|617427969|FG000|Overall Study|Participant Never Treated|0|||
170841431|NCT02514551|617427970|FG001|Overall Study|Participant Never Treated|2|||
170841432|NCT03197766|617427971|FG000|Overall Study|Withdrawal by Subject|2|||
170841433|NCT03197766|617427972|FG001|Overall Study|Withdrawal by Subject|0|||
170841434|NCT02519348|617427975|FG000|Overall Study|Death|31|||
170841435|NCT02519348|617427976|FG001|Overall Study|Death|74|||
170841436|NCT02519348|617427977|FG002|Overall Study|Death|47|||
170841437|NCT02519348|617427978|FG003|Overall Study|Death|54|||
170841438|NCT02519348|617427979|FG004|Overall Study|Death|63|||
170841439|NCT02519348|617427980|FG005|Overall Study|Death|18|||
170841440|NCT02519348|617427981|FG006|Overall Study|Death|2|||
170841441|NCT02519348|617427982|FG007|Overall Study|Death|5|||
170841442|NCT02519348|617427983|FG008|Overall Study|Death|5|||
170841443|NCT02519348|617427975|FG000|Overall Study|Withdrawal by Subject|4|||
170841444|NCT02519348|617427976|FG001|Overall Study|Withdrawal by Subject|7|||
170841445|NCT02519348|617427977|FG002|Overall Study|Withdrawal by Subject|4|||
170841446|NCT02519348|617427978|FG003|Overall Study|Withdrawal by Subject|3|||
170841447|NCT02519348|617427979|FG004|Overall Study|Withdrawal by Subject|3|||
170841448|NCT02519348|617427980|FG005|Overall Study|Withdrawal by Subject|2|||
170841449|NCT02519348|617427981|FG006|Overall Study|Withdrawal by Subject|0|||
170841450|NCT02519348|617427982|FG007|Overall Study|Withdrawal by Subject|0|||
170841451|NCT02519348|617427983|FG008|Overall Study|Withdrawal by Subject|1|||
170841452|NCT02519348|617427975|FG000|Overall Study|Lost to Follow-up|0|||
170841453|NCT02519348|617427976|FG001|Overall Study|Lost to Follow-up|0|||
170841454|NCT02519348|617427977|FG002|Overall Study|Lost to Follow-up|1|||
170841455|NCT02519348|617427978|FG003|Overall Study|Lost to Follow-up|0|||
170735222|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
170735223|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
170735224|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
170735225|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
170735226|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
170735227|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
170735228|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
170735229|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
170735230|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Death|2|||
170735231|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Death|2|||
170735232|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Death|0|||
170735233|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Death|0|||
170735234|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Death|0|||
170735235|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
170735236|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
170735237|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
170735238|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
170735239|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
170735240|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
170735241|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
170735242|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
170735243|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
170735244|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
170735245|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
170735246|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
170735247|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
170735248|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
170735249|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
170735250|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
170735251|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
170735252|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
170735253|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
170735254|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
170735255|NCT03420781|617036926|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
170735256|NCT03420781|617036927|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
170735257|NCT03420781|617036928|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
170735258|NCT03420781|617036929|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
170735259|NCT03420781|617036930|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
170735260|NCT03420781|617036926|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
170735261|NCT03420781|617036927|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
170735262|NCT03420781|617036928|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
170735263|NCT03420781|617036929|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
170735264|NCT03420781|617036930|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
170735265|NCT03420781|617036926|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
170735266|NCT03420781|617036927|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
170735267|NCT03420781|617036928|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
170735268|NCT03420781|617036929|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
170735269|NCT03420781|617036930|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
170735270|NCT03420781|617036926|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
170735271|NCT03420781|617036927|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
170735272|NCT03420781|617036928|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
170735273|NCT03420781|617036929|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
170735274|NCT03420781|617036930|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
170735275|NCT01226511|617036940|FG000|Acute Treatment Period|Adverse Event|7|||
170735276|NCT01226511|617036941|FG001|Acute Treatment Period|Adverse Event|6|||
170735277|NCT01226511|617036940|FG000|Acute Treatment Period|Lack of Efficacy|2|||
170735278|NCT01226511|617036941|FG001|Acute Treatment Period|Lack of Efficacy|1|||
170735279|NCT01226511|617036940|FG000|Acute Treatment Period|Lost to Follow-up|3|||
170735280|NCT01226511|617036941|FG001|Acute Treatment Period|Lost to Follow-up|6|||
170735281|NCT01226511|617036940|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
170735282|NCT01226511|617036941|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
170735283|NCT01226511|617036940|FG000|Acute Treatment Period|Protocol Violation|5|||
170735284|NCT01226511|617036941|FG001|Acute Treatment Period|Protocol Violation|5|||
170735285|NCT01226511|617036940|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
170735286|NCT01226511|617036941|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
170841456|NCT02519348|617427979|FG004|Overall Study|Lost to Follow-up|2|||
170841457|NCT02519348|617427980|FG005|Overall Study|Lost to Follow-up|1|||
170841458|NCT02519348|617427981|FG006|Overall Study|Lost to Follow-up|1|||
170841459|NCT02519348|617427982|FG007|Overall Study|Lost to Follow-up|0|||
170841460|NCT02519348|617427983|FG008|Overall Study|Lost to Follow-up|0|||
170841461|NCT02519348|617427975|FG000|Overall Study|Other|0|||
170735287|NCT01226511|617036940|FG000|Extension Treatment Period|Adverse Event|8|||
170735288|NCT01226511|617036941|FG001|Extension Treatment Period|Adverse Event|8|||
170735289|NCT01226511|617036940|FG000|Extension Treatment Period|Lack of Efficacy|3|||
170735290|NCT01226511|617036941|FG001|Extension Treatment Period|Lack of Efficacy|2|||
170735291|NCT01226511|617036940|FG000|Extension Treatment Period|Lost to Follow-up|4|||
170735292|NCT01226511|617036941|FG001|Extension Treatment Period|Lost to Follow-up|3|||
170735293|NCT01226511|617036940|FG000|Extension Treatment Period|Protocol Violation|2|||
170735294|NCT01226511|617036941|FG001|Extension Treatment Period|Protocol Violation|2|||
170735295|NCT01226511|617036940|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
170735296|NCT01226511|617036941|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
170735297|NCT01226511|617036940|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
170735298|NCT01226511|617036941|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
170735299|NCT01226511|617036940|FG000|Extension Treatment Period|Sponsor Decision|1|||
170735300|NCT01226511|617036941|FG001|Extension Treatment Period|Sponsor Decision|1|||
170735301|NCT01226511|617036940|FG000|Taper Period|Adverse Event|1|||
170735302|NCT01226511|617036941|FG001|Taper Period|Adverse Event|0|||
170735303|NCT01226511|617036940|FG000|Taper Period|Lost to Follow-up|2|||
170735304|NCT01226511|617036941|FG001|Taper Period|Lost to Follow-up|2|||
170735305|NCT01226511|617036940|FG000|Taper Period|Protocol Violation|1|||
170735306|NCT01226511|617036941|FG001|Taper Period|Protocol Violation|0|||
170735307|NCT01226511|617036940|FG000|Taper Period|Parent/Caregiver Decision|1|||
170735308|NCT01226511|617036941|FG001|Taper Period|Parent/Caregiver Decision|1|||
170735309|NCT01966003|617036943|FG000|Overall Study|Death|43|||
170735310|NCT01966003|617036944|FG001|Overall Study|Death|36|||
170735311|NCT01966003|617036943|FG000|Overall Study|Protocol Violation|6|||
170735312|NCT01966003|617036944|FG001|Overall Study|Protocol Violation|4|||
170735313|NCT01966003|617036943|FG000|Overall Study|Lost to Follow-up|4|||
170735314|NCT01966003|617036944|FG001|Overall Study|Lost to Follow-up|3|||
170735315|NCT01966003|617036943|FG000|Overall Study|Physician Decision|12|||
170735316|NCT01966003|617036944|FG001|Overall Study|Physician Decision|13|||
170735317|NCT01966003|617036943|FG000|Overall Study|Withdrawal by Subject|29|||
170735318|NCT01966003|617036944|FG001|Overall Study|Withdrawal by Subject|19|||
170735319|NCT01966003|617036943|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
170735320|NCT01966003|617036944|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
170735321|NCT01966003|617036943|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
170735322|NCT01966003|617036944|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
170735323|NCT01966003|617036943|FG000|Overall Study|Other|1|||
170735324|NCT01966003|617036944|FG001|Overall Study|Other|1|||
170735325|NCT02696564|617036945|FG000|Overall Study|Death|1|||
170735326|NCT02696564|617036946|FG001|Overall Study|Death|2|||
170735327|NCT02696564|617036945|FG000|Overall Study|Withdrawal by Subject|3|||
170735328|NCT02696564|617036946|FG001|Overall Study|Withdrawal by Subject|2|||
170735329|NCT02696564|617036945|FG000|Overall Study|Lost to Follow-up|3|||
170735330|NCT02696564|617036946|FG001|Overall Study|Lost to Follow-up|3|||
170735331|NCT02696564|617036945|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
170735332|NCT02696564|617036946|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
170735333|NCT02696564|617036945|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
170735334|NCT02696564|617036946|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
170735335|NCT02696564|617036945|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
170735336|NCT02696564|617036946|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
170735337|NCT02696564|617036945|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
170735338|NCT02696564|617036946|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
170735339|NCT02696564|617036945|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
170735340|NCT02696564|617036946|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
170735341|NCT05267600|617036947|FG000|Overall Study|Adverse Event|1|||
170735342|NCT05267600|617036948|FG001|Overall Study|Adverse Event|4|||
170735343|NCT05267600|617036947|FG000|Overall Study|Death|1|||
170735344|NCT05267600|617036948|FG001|Overall Study|Death|2|||
170735345|NCT05267600|617036947|FG000|Overall Study|Lack of Efficacy|1|||
170735346|NCT05267600|617036948|FG001|Overall Study|Lack of Efficacy|2|||
170735347|NCT05267600|617036947|FG000|Overall Study|Lost to Follow-up|3|||
170735348|NCT05267600|617036948|FG001|Overall Study|Lost to Follow-up|0|||
170735349|NCT05267600|617036947|FG000|Overall Study|Physician Decision|4|||
170735350|NCT05267600|617036948|FG001|Overall Study|Physician Decision|0|||
170735351|NCT05267600|617036947|FG000|Overall Study|Treatment Unblinded|0|||
170735352|NCT05267600|617036948|FG001|Overall Study|Treatment Unblinded|1|||
170841462|NCT02519348|617427976|FG001|Overall Study|Other|3|||
170735353|NCT05267600|617036947|FG000|Overall Study|Withdrawal by Subject|5|||
170735354|NCT05267600|617036948|FG001|Overall Study|Withdrawal by Subject|4|||
170735355|NCT04067401|617036950|FG000|Overall Study|Withdrawal by Subject|7|||
170735356|NCT04067401|617036951|FG001|Overall Study|Withdrawal by Subject|0|||
170735357|NCT04067401|617036950|FG000|Overall Study|no data provided|1|||
170735358|NCT04067401|617036951|FG001|Overall Study|no data provided|0|||
170735359|NCT03633929|617036952|FG000|Overall Study|Lost to Follow-up|1|||
170735360|NCT03633929|617036952|FG000|Overall Study|Did not login to software. Did not participate|3|||
170735361|NCT01520402|617036955|FG000|Overall Study|Withdrawal by Subject|2|||
170735362|NCT01520402|617036955|FG000|Overall Study|Physician Decision|3|||
170735363|NCT02287584|617036956|FG000|the Double-blind Phase|Adverse Event|17|||
170735364|NCT02287584|617036957|FG001|the Double-blind Phase|Adverse Event|17|||
170735365|NCT02287584|617036958|FG002|the Double-blind Phase|Adverse Event|12|||
170735366|NCT02287584|617036959|FG003|the Double-blind Phase|Adverse Event|0|||
170735367|NCT02287584|617036960|FG004|the Double-blind Phase|Adverse Event|0|||
170735368|NCT02287584|617036961|FG005|the Double-blind Phase|Adverse Event|0|||
170735369|NCT02287584|617036956|FG000|the Double-blind Phase|Lack of Efficacy|18|||
170735370|NCT02287584|617036957|FG001|the Double-blind Phase|Lack of Efficacy|8|||
170735371|NCT02287584|617036958|FG002|the Double-blind Phase|Lack of Efficacy|8|||
170735372|NCT02287584|617036959|FG003|the Double-blind Phase|Lack of Efficacy|0|||
170735373|NCT02287584|617036960|FG004|the Double-blind Phase|Lack of Efficacy|0|||
170735374|NCT02287584|617036961|FG005|the Double-blind Phase|Lack of Efficacy|0|||
170735375|NCT02287584|617036956|FG000|the Double-blind Phase|Lost to Follow-up|0|||
170735376|NCT02287584|617036957|FG001|the Double-blind Phase|Lost to Follow-up|1|||
170735377|NCT02287584|617036958|FG002|the Double-blind Phase|Lost to Follow-up|1|||
170735378|NCT02287584|617036959|FG003|the Double-blind Phase|Lost to Follow-up|0|||
170735379|NCT02287584|617036960|FG004|the Double-blind Phase|Lost to Follow-up|0|||
170735380|NCT02287584|617036961|FG005|the Double-blind Phase|Lost to Follow-up|0|||
170735381|NCT02287584|617036956|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
170735382|NCT02287584|617036957|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
170735383|NCT02287584|617036958|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
170735384|NCT02287584|617036959|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
170735385|NCT02287584|617036960|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
170735386|NCT02287584|617036961|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
170735387|NCT02287584|617036956|FG000|the Double-blind Phase|Pregnancy|0|||
170735388|NCT02287584|617036957|FG001|the Double-blind Phase|Pregnancy|1|||
170735389|NCT02287584|617036958|FG002|the Double-blind Phase|Pregnancy|0|||
170735390|NCT02287584|617036959|FG003|the Double-blind Phase|Pregnancy|0|||
170735391|NCT02287584|617036960|FG004|the Double-blind Phase|Pregnancy|0|||
170735392|NCT02287584|617036961|FG005|the Double-blind Phase|Pregnancy|0|||
170735393|NCT02287584|617036956|FG000|the Double-blind Phase|Protocol Violation|0|||
170735394|NCT02287584|617036957|FG001|the Double-blind Phase|Protocol Violation|3|||
170735395|NCT02287584|617036958|FG002|the Double-blind Phase|Protocol Violation|0|||
170735396|NCT02287584|617036959|FG003|the Double-blind Phase|Protocol Violation|0|||
170735397|NCT02287584|617036960|FG004|the Double-blind Phase|Protocol Violation|0|||
170735398|NCT02287584|617036961|FG005|the Double-blind Phase|Protocol Violation|0|||
170735399|NCT02287584|617036956|FG000|the Double-blind Phase|other reasons|0|||
170735400|NCT02287584|617036957|FG001|the Double-blind Phase|other reasons|0|||
170735401|NCT02287584|617036958|FG002|the Double-blind Phase|other reasons|1|||
170735402|NCT02287584|617036959|FG003|the Double-blind Phase|other reasons|0|||
170735403|NCT02287584|617036960|FG004|the Double-blind Phase|other reasons|0|||
170735404|NCT02287584|617036961|FG005|the Double-blind Phase|other reasons|0|||
170735405|NCT02287584|617036956|FG000|the Open-label Phase|Did not receive drug|0|||
170735406|NCT02287584|617036957|FG001|the Open-label Phase|Did not receive drug|0|||
170735407|NCT02287584|617036958|FG002|the Open-label Phase|Did not receive drug|0|||
170735408|NCT02287584|617036959|FG003|the Open-label Phase|Did not receive drug|7|||
170735409|NCT02287584|617036960|FG004|the Open-label Phase|Did not receive drug|6|||
170735410|NCT02287584|617036961|FG005|the Open-label Phase|Did not receive drug|4|||
170735411|NCT02287584|617036956|FG000|the Open-label Phase|Adverse Event|0|||
170735412|NCT02287584|617036957|FG001|the Open-label Phase|Adverse Event|0|||
170735413|NCT02287584|617036958|FG002|the Open-label Phase|Adverse Event|0|||
170735414|NCT02287584|617036959|FG003|the Open-label Phase|Adverse Event|15|||
170735415|NCT02287584|617036960|FG004|the Open-label Phase|Adverse Event|12|||
170735416|NCT02287584|617036961|FG005|the Open-label Phase|Adverse Event|16|||
170735417|NCT02287584|617036956|FG000|the Open-label Phase|Lack of Efficacy|0|||
170735418|NCT02287584|617036957|FG001|the Open-label Phase|Lack of Efficacy|0|||
170735419|NCT02287584|617036958|FG002|the Open-label Phase|Lack of Efficacy|0|||
170735420|NCT02287584|617036959|FG003|the Open-label Phase|Lack of Efficacy|8|||
170735421|NCT02287584|617036960|FG004|the Open-label Phase|Lack of Efficacy|3|||
170735422|NCT02287584|617036961|FG005|the Open-label Phase|Lack of Efficacy|7|||
170735423|NCT02287584|617036956|FG000|the Open-label Phase|Lost to Follow-up|0|||
170735424|NCT02287584|617036957|FG001|the Open-label Phase|Lost to Follow-up|0|||
170841463|NCT02519348|617427977|FG002|Overall Study|Other|0|||
170841464|NCT02519348|617427978|FG003|Overall Study|Other|0|||
170841465|NCT02519348|617427979|FG004|Overall Study|Other|1|||
170841466|NCT02519348|617427980|FG005|Overall Study|Other|0|||
170735425|NCT02287584|617036958|FG002|the Open-label Phase|Lost to Follow-up|0|||
170735426|NCT02287584|617036959|FG003|the Open-label Phase|Lost to Follow-up|4|||
170735427|NCT02287584|617036960|FG004|the Open-label Phase|Lost to Follow-up|1|||
170735428|NCT02287584|617036961|FG005|the Open-label Phase|Lost to Follow-up|2|||
170735429|NCT02287584|617036956|FG000|the Open-label Phase|Withdrawal by Subject|0|||
170735430|NCT02287584|617036957|FG001|the Open-label Phase|Withdrawal by Subject|0|||
170735431|NCT02287584|617036958|FG002|the Open-label Phase|Withdrawal by Subject|0|||
170735432|NCT02287584|617036959|FG003|the Open-label Phase|Withdrawal by Subject|18|||
170735433|NCT02287584|617036960|FG004|the Open-label Phase|Withdrawal by Subject|29|||
170735434|NCT02287584|617036961|FG005|the Open-label Phase|Withdrawal by Subject|21|||
170735435|NCT02287584|617036956|FG000|the Open-label Phase|non-compliance|0|||
170735436|NCT02287584|617036957|FG001|the Open-label Phase|non-compliance|0|||
170735437|NCT02287584|617036958|FG002|the Open-label Phase|non-compliance|0|||
170735438|NCT02287584|617036959|FG003|the Open-label Phase|non-compliance|2|||
170841467|NCT02519348|617427981|FG006|Overall Study|Other|0|||
170841468|NCT02519348|617427982|FG007|Overall Study|Other|0|||
170841469|NCT02519348|617427983|FG008|Overall Study|Other|0|||
170841470|NCT02519348|617427975|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
170841471|NCT02519348|617427976|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
170841472|NCT02519348|617427977|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
170841473|NCT02519348|617427978|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
170841474|NCT02519348|617427979|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
170841475|NCT02519348|617427980|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
170841476|NCT02519348|617427981|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
170841477|NCT02519348|617427982|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
170735439|NCT02287584|617036960|FG004|the Open-label Phase|non-compliance|5|||
170735440|NCT02287584|617036961|FG005|the Open-label Phase|non-compliance|1|||
170735441|NCT02287584|617036956|FG000|the Open-label Phase|other reasons|0|||
170735442|NCT02287584|617036957|FG001|the Open-label Phase|other reasons|0|||
170735443|NCT02287584|617036958|FG002|the Open-label Phase|other reasons|0|||
170735444|NCT02287584|617036959|FG003|the Open-label Phase|other reasons|3|||
170735445|NCT02287584|617036960|FG004|the Open-label Phase|other reasons|6|||
170735446|NCT02287584|617036961|FG005|the Open-label Phase|other reasons|6|||
170735447|NCT02313909|617036967|FG000|Overall Study|Consent withdrawn by participant|33|||
170735448|NCT02313909|617036968|FG001|Overall Study|Consent withdrawn by participant|33|||
170735449|NCT02313909|617036967|FG000|Overall Study|Lost to Follow-up|24|||
170735450|NCT02313909|617036968|FG001|Overall Study|Lost to Follow-up|17|||
170735451|NCT00871403|617036973|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
170735452|NCT00871403|617036974|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
170735453|NCT00871403|617036975|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
170735454|NCT00871403|617036973|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
170735455|NCT00871403|617036974|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
170735456|NCT00871403|617036975|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
170735457|NCT00871403|617036973|FG000|Combination Treatment Phase|Adverse Event|0|||
170735458|NCT00871403|617036974|FG001|Combination Treatment Phase|Adverse Event|17|||
170735459|NCT00871403|617036975|FG002|Combination Treatment Phase|Adverse Event|2|||
170735460|NCT00871403|617036973|FG000|Combination Treatment Phase|Disease Progression|0|||
170735461|NCT00871403|617036974|FG001|Combination Treatment Phase|Disease Progression|8|||
170735462|NCT00871403|617036975|FG002|Combination Treatment Phase|Disease Progression|5|||
170735463|NCT00871403|617036973|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
170735464|NCT00871403|617036974|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
170735465|NCT00871403|617036975|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
170735466|NCT00871403|617036973|FG000|Combination Treatment Phase|Physician Decision|0|||
170735467|NCT00871403|617036974|FG001|Combination Treatment Phase|Physician Decision|1|||
170735468|NCT00871403|617036975|FG002|Combination Treatment Phase|Physician Decision|3|||
170735469|NCT00871403|617036973|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
170735470|NCT00871403|617036974|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
170735471|NCT00871403|617036975|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
170735472|NCT00871403|617036973|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
170735473|NCT00871403|617036974|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
170735474|NCT00871403|617036975|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
170735475|NCT03505476|617036977|FG000|Overall Study|Physician Decision|18|||
170735476|NCT03505476|617036977|FG000|Overall Study|Device Malfunctioned|101|||
170735477|NCT03505476|617036977|FG000|Overall Study|Data Corrupt|6|||
170735478|NCT03505476|617036977|FG000|Overall Study|Device application insufficiant|3|||
170735479|NCT02923739|617036978|FG000|Overall Study|Withdrawal by Subject|2|||
170735480|NCT02923739|617036979|FG001|Overall Study|Withdrawal by Subject|0|||
170735481|NCT02923739|617036980|FG002|Overall Study|Withdrawal by Subject|0|||
170735482|NCT02923739|617036981|FG003|Overall Study|Withdrawal by Subject|0|||
170735483|NCT02923739|617036978|FG000|Overall Study|Failed Screening|3|||
170841478|NCT02519348|617427983|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
170841479|NCT03635099|617427984|FG000|Period 1|Adverse Event|1|||
170841480|NCT03635099|617427985|FG001|Period 1|Adverse Event|0|||
170841481|NCT03635099|617427986|FG002|Period 1|Adverse Event|0|||
170841482|NCT03635099|617427987|FG003|Period 1|Adverse Event|1|||
170841483|NCT03635099|617427988|FG004|Period 1|Adverse Event|0|||
170841484|NCT03635099|617427989|FG005|Period 1|Adverse Event|0|||
170841485|NCT03635099|617427990|FG006|Period 1|Adverse Event|0|||
170841486|NCT03635099|617427991|FG007|Period 1|Adverse Event|0|||
170841487|NCT03635099|617427984|FG000|Period 1|Protocol Violation|0|||
170841488|NCT03635099|617427985|FG001|Period 1|Protocol Violation|0|||
170841489|NCT03635099|617427986|FG002|Period 1|Protocol Violation|1|||
170841490|NCT03635099|617427987|FG003|Period 1|Protocol Violation|0|||
170841491|NCT03635099|617427988|FG004|Period 1|Protocol Violation|0|||
170841492|NCT03635099|617427989|FG005|Period 1|Protocol Violation|0|||
170841493|NCT03635099|617427990|FG006|Period 1|Protocol Violation|0|||
170841494|NCT03635099|617427991|FG007|Period 1|Protocol Violation|0|||
170841495|NCT03635099|617427984|FG000|Period 1|Lost to Follow-up|0|||
170841496|NCT03635099|617427985|FG001|Period 1|Lost to Follow-up|0|||
170841497|NCT03635099|617427986|FG002|Period 1|Lost to Follow-up|1|||
170841498|NCT03635099|617427987|FG003|Period 1|Lost to Follow-up|2|||
170841499|NCT03635099|617427988|FG004|Period 1|Lost to Follow-up|1|||
170841500|NCT03635099|617427989|FG005|Period 1|Lost to Follow-up|0|||
170841501|NCT03635099|617427990|FG006|Period 1|Lost to Follow-up|1|||
170841502|NCT03635099|617427991|FG007|Period 1|Lost to Follow-up|2|||
170841503|NCT03635099|617427984|FG000|Period 1|Withdrawal by Subject|3|||
170841504|NCT03635099|617427985|FG001|Period 1|Withdrawal by Subject|3|||
170841505|NCT03635099|617427986|FG002|Period 1|Withdrawal by Subject|5|||
170841506|NCT03635099|617427987|FG003|Period 1|Withdrawal by Subject|2|||
170841507|NCT03635099|617427988|FG004|Period 1|Withdrawal by Subject|2|||
170841508|NCT03635099|617427989|FG005|Period 1|Withdrawal by Subject|0|||
170841509|NCT03635099|617427990|FG006|Period 1|Withdrawal by Subject|3|||
170841510|NCT03635099|617427991|FG007|Period 1|Withdrawal by Subject|0|||
170841511|NCT03635099|617427984|FG000|Period 1|History of suicidal ideation|0|||
170841512|NCT03635099|617427985|FG001|Period 1|History of suicidal ideation|0|||
170841513|NCT03635099|617427986|FG002|Period 1|History of suicidal ideation|1|||
170841514|NCT03635099|617427987|FG003|Period 1|History of suicidal ideation|0|||
170841515|NCT03635099|617427988|FG004|Period 1|History of suicidal ideation|0|||
170841516|NCT03635099|617427989|FG005|Period 1|History of suicidal ideation|0|||
170841517|NCT03635099|617427990|FG006|Period 1|History of suicidal ideation|0|||
170841518|NCT03635099|617427991|FG007|Period 1|History of suicidal ideation|0|||
170841519|NCT03635099|617427984|FG000|Period 1|pursue other treatment options|0|||
170841520|NCT03635099|617427985|FG001|Period 1|pursue other treatment options|0|||
170841521|NCT03635099|617427986|FG002|Period 1|pursue other treatment options|0|||
170841522|NCT03635099|617427987|FG003|Period 1|pursue other treatment options|0|||
170841523|NCT03635099|617427988|FG004|Period 1|pursue other treatment options|0|||
170841524|NCT03635099|617427989|FG005|Period 1|pursue other treatment options|1|||
170841525|NCT03635099|617427990|FG006|Period 1|pursue other treatment options|0|||
170841526|NCT03635099|617427991|FG007|Period 1|pursue other treatment options|0|||
170841527|NCT03635099|617427984|FG000|Not Eligible for Period 2|Pregnancy|0|||
170841528|NCT03635099|617427985|FG001|Not Eligible for Period 2|Pregnancy|0|||
170841529|NCT03635099|617427986|FG002|Not Eligible for Period 2|Pregnancy|0|||
170841530|NCT03635099|617427987|FG003|Not Eligible for Period 2|Pregnancy|1|||
170841531|NCT03635099|617427988|FG004|Not Eligible for Period 2|Pregnancy|0|||
170841532|NCT03635099|617427989|FG005|Not Eligible for Period 2|Pregnancy|0|||
170841533|NCT03635099|617427990|FG006|Not Eligible for Period 2|Pregnancy|0|||
170841534|NCT03635099|617427991|FG007|Not Eligible for Period 2|Pregnancy|0|||
170841535|NCT03635099|617427984|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
170841536|NCT03635099|617427985|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
170841537|NCT03635099|617427986|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
170841538|NCT03635099|617427987|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
170841539|NCT03635099|617427988|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
170841540|NCT03635099|617427989|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
170841541|NCT03635099|617427990|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
170841542|NCT03635099|617427991|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
170841543|NCT03635099|617427984|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
170841544|NCT03635099|617427985|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
170841545|NCT03635099|617427986|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
170841546|NCT03635099|617427987|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
170841547|NCT03635099|617427988|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
170841548|NCT03635099|617427989|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
170841549|NCT03635099|617427990|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
170841550|NCT03635099|617427991|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
170841551|NCT03635099|617427984|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
170841552|NCT03635099|617427985|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
170841553|NCT03635099|617427986|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
170841554|NCT03635099|617427987|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
170841555|NCT03635099|617427988|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
170841556|NCT03635099|617427989|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
170841557|NCT03635099|617427990|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
170841558|NCT03635099|617427991|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
170841559|NCT03635099|617427984|FG000|Period 2|Adverse Event|0|||
170841560|NCT03635099|617427985|FG001|Period 2|Adverse Event|0|||
170841561|NCT03635099|617427986|FG002|Period 2|Adverse Event|1|||
170841562|NCT03635099|617427987|FG003|Period 2|Adverse Event|0|||
170841563|NCT03635099|617427988|FG004|Period 2|Adverse Event|1|||
170841564|NCT03635099|617427989|FG005|Period 2|Adverse Event|0|||
170841565|NCT03635099|617427990|FG006|Period 2|Adverse Event|0|||
170841566|NCT03635099|617427991|FG007|Period 2|Adverse Event|0|||
170841567|NCT03635099|617427984|FG000|Period 2|Lost to Follow-up|0|||
170841568|NCT03635099|617427985|FG001|Period 2|Lost to Follow-up|0|||
170841569|NCT03635099|617427986|FG002|Period 2|Lost to Follow-up|1|||
170841570|NCT03635099|617427987|FG003|Period 2|Lost to Follow-up|0|||
170841571|NCT03635099|617427988|FG004|Period 2|Lost to Follow-up|4|||
170841572|NCT03635099|617427989|FG005|Period 2|Lost to Follow-up|0|||
170841573|NCT03635099|617427990|FG006|Period 2|Lost to Follow-up|0|||
170841574|NCT03635099|617427991|FG007|Period 2|Lost to Follow-up|0|||
170841575|NCT03635099|617427984|FG000|Period 2|Withdrawal by Subject|0|||
170841576|NCT03635099|617427985|FG001|Period 2|Withdrawal by Subject|0|||
170841577|NCT03635099|617427986|FG002|Period 2|Withdrawal by Subject|7|||
170841578|NCT03635099|617427987|FG003|Period 2|Withdrawal by Subject|4|||
170841579|NCT03635099|617427988|FG004|Period 2|Withdrawal by Subject|7|||
170841580|NCT03635099|617427989|FG005|Period 2|Withdrawal by Subject|0|||
170841581|NCT03635099|617427990|FG006|Period 2|Withdrawal by Subject|0|||
170841582|NCT03635099|617427991|FG007|Period 2|Withdrawal by Subject|0|||
170841583|NCT00350727|617427993|FG000|Phase I: Dose Escalation|Adverse Event|4|||
170841584|NCT00350727|617427994|FG001|Phase I: Dose Escalation|Adverse Event|0|||
170841585|NCT00350727|617427995|FG002|Phase I: Dose Escalation|Adverse Event|0|||
170841586|NCT00350727|617427993|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
170841587|NCT00350727|617427994|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
170841588|NCT00350727|617427995|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
170841589|NCT00350727|617427993|FG000|Phase I: Dose Escalation|Death|1|||
170841590|NCT00350727|617427994|FG001|Phase I: Dose Escalation|Death|0|||
170841591|NCT00350727|617427995|FG002|Phase I: Dose Escalation|Death|0|||
170841592|NCT00350727|617427993|FG000|Phase I: Dose Escalation|Physician Decision|1|||
170841593|NCT00350727|617427994|FG001|Phase I: Dose Escalation|Physician Decision|0|||
170841594|NCT00350727|617427995|FG002|Phase I: Dose Escalation|Physician Decision|0|||
170841595|NCT00350727|617427993|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
170841596|NCT00350727|617427994|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
170841597|NCT00350727|617427995|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
170841598|NCT00350727|617427993|FG000|Phase II|Disease Progression|0|||
170841599|NCT00350727|617427994|FG001|Phase II|Disease Progression|15|||
170841600|NCT00350727|617427995|FG002|Phase II|Disease Progression|16|||
170841601|NCT00350727|617427993|FG000|Phase II|Clinical Deterioration|0|||
170841602|NCT00350727|617427994|FG001|Phase II|Clinical Deterioration|1|||
170841603|NCT00350727|617427995|FG002|Phase II|Clinical Deterioration|0|||
170841604|NCT00350727|617427993|FG000|Phase II|Withdrawal by Subject|0|||
170841605|NCT00350727|617427994|FG001|Phase II|Withdrawal by Subject|2|||
170841606|NCT00350727|617427995|FG002|Phase II|Withdrawal by Subject|1|||
170841607|NCT00350727|617427993|FG000|Phase II|Adverse Event|0|||
170841608|NCT00350727|617427994|FG001|Phase II|Adverse Event|1|||
170841609|NCT00350727|617427995|FG002|Phase II|Adverse Event|1|||
170841610|NCT00350727|617427993|FG000|Phase II|Death|0|||
170841611|NCT00350727|617427994|FG001|Phase II|Death|0|||
170841612|NCT00350727|617427995|FG002|Phase II|Death|2|||
170841613|NCT00350727|617427993|FG000|Phase II|Sponsor Terminated Study|0|||
170841614|NCT00350727|617427994|FG001|Phase II|Sponsor Terminated Study|0|||
170841615|NCT00350727|617427995|FG002|Phase II|Sponsor Terminated Study|1|||
170841616|NCT00350727|617427993|FG000|Phase II|Enrolled in Rollover Study|0|||
170841617|NCT00350727|617427994|FG001|Phase II|Enrolled in Rollover Study|0|||
170841618|NCT00350727|617427995|FG002|Phase II|Enrolled in Rollover Study|1|||
170841619|NCT01876082|617430797|FG000|Overall Study|Withdrawal by Subject|0|||
170841620|NCT01876082|617430798|FG001|Overall Study|Withdrawal by Subject|2|||
170841621|NCT01876082|617430797|FG000|Overall Study|Protocol Violation|1|||
170841622|NCT01876082|617430798|FG001|Overall Study|Protocol Violation|0|||
170841623|NCT01876082|617430797|FG000|Overall Study|Adverse Event|1|||
170841624|NCT01876082|617430798|FG001|Overall Study|Adverse Event|1|||
170841625|NCT01876082|617430797|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
170841626|NCT01876082|617430798|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
170841627|NCT05718466|617430800|FG000|Overall Study|Withdrawal by Subject|1|||
170841628|NCT05718466|617430801|FG001|Overall Study|Withdrawal by Subject|2|||
170841629|NCT05718466|617430800|FG000|Overall Study|Death|0|||
170841630|NCT05718466|617430801|FG001|Overall Study|Death|1|||
170841631|NCT03829501|617430811|FG000|Overall Study|Withdrawal of Consent|2|||
170841632|NCT03829501|617430812|FG001|Overall Study|Withdrawal of Consent|0|||
170841633|NCT03829501|617430813|FG002|Overall Study|Withdrawal of Consent|3|||
170841634|NCT03829501|617430814|FG003|Overall Study|Withdrawal of Consent|0|||
170841635|NCT03829501|617430815|FG004|Overall Study|Withdrawal of Consent|1|||
170841636|NCT03829501|617430816|FG005|Overall Study|Withdrawal of Consent|1|||
170841637|NCT03829501|617430817|FG006|Overall Study|Withdrawal of Consent|0|||
170841638|NCT03829501|617430818|FG007|Overall Study|Withdrawal of Consent|10|||
170841639|NCT03829501|617430819|FG008|Overall Study|Withdrawal of Consent|10|||
170841640|NCT03829501|617430820|FG009|Overall Study|Withdrawal of Consent|3|||
170841641|NCT03829501|617430821|FG010|Overall Study|Withdrawal of Consent|4|||
170841642|NCT03829501|617430822|FG011|Overall Study|Withdrawal of Consent|4|||
170841643|NCT03829501|617430823|FG012|Overall Study|Withdrawal of Consent|4|||
170841644|NCT03829501|617430824|FG013|Overall Study|Withdrawal of Consent|0|||
170841645|NCT03829501|617430825|FG014|Overall Study|Withdrawal of Consent|3|||
170841646|NCT03829501|617430826|FG015|Overall Study|Withdrawal of Consent|0|||
170841647|NCT03829501|617430827|FG016|Overall Study|Withdrawal of Consent|1|||
170841648|NCT03829501|617430828|FG017|Overall Study|Withdrawal of Consent|1|||
170841649|NCT03829501|617430829|FG018|Overall Study|Withdrawal of Consent|0|||
170841650|NCT03829501|617430830|FG019|Overall Study|Withdrawal of Consent|0|||
170841651|NCT03829501|617430831|FG020|Overall Study|Withdrawal of Consent|3|||
170841652|NCT03829501|617430832|FG021|Overall Study|Withdrawal of Consent|0|||
170841653|NCT03829501|617430833|FG022|Overall Study|Withdrawal of Consent|1|||
170841654|NCT03829501|617430811|FG000|Overall Study|PD|0|||
170841655|NCT03829501|617430812|FG001|Overall Study|PD|0|||
170841656|NCT03829501|617430813|FG002|Overall Study|PD|0|||
170841657|NCT03829501|617430814|FG003|Overall Study|PD|2|||
170841658|NCT03829501|617430815|FG004|Overall Study|PD|0|||
170841659|NCT03829501|617430816|FG005|Overall Study|PD|0|||
170841660|NCT03829501|617430817|FG006|Overall Study|PD|0|||
170841661|NCT03829501|617430818|FG007|Overall Study|PD|0|||
170841662|NCT03829501|617430819|FG008|Overall Study|PD|0|||
170841663|NCT03829501|617430820|FG009|Overall Study|PD|0|||
170841664|NCT03829501|617430821|FG010|Overall Study|PD|0|||
170841665|NCT03829501|617430822|FG011|Overall Study|PD|0|||
170841666|NCT03829501|617430823|FG012|Overall Study|PD|0|||
170841667|NCT03829501|617430824|FG013|Overall Study|PD|0|||
170841668|NCT03829501|617430825|FG014|Overall Study|PD|0|||
170841669|NCT03829501|617430826|FG015|Overall Study|PD|1|||
170841670|NCT03829501|617430827|FG016|Overall Study|PD|0|||
170841671|NCT03829501|617430828|FG017|Overall Study|PD|0|||
170841672|NCT03829501|617430829|FG018|Overall Study|PD|0|||
170841673|NCT03829501|617430830|FG019|Overall Study|PD|0|||
170841674|NCT03829501|617430831|FG020|Overall Study|PD|1|||
170841675|NCT03829501|617430832|FG021|Overall Study|PD|0|||
170841676|NCT03829501|617430833|FG022|Overall Study|PD|0|||
170841677|NCT03829501|617430811|FG000|Overall Study|Study Terminated by Sponsor|0|||
170841678|NCT03829501|617430812|FG001|Overall Study|Study Terminated by Sponsor|0|||
170841679|NCT03829501|617430813|FG002|Overall Study|Study Terminated by Sponsor|0|||
170841680|NCT03829501|617430814|FG003|Overall Study|Study Terminated by Sponsor|0|||
170841681|NCT03829501|617430815|FG004|Overall Study|Study Terminated by Sponsor|0|||
170841682|NCT03829501|617430816|FG005|Overall Study|Study Terminated by Sponsor|0|||
170841683|NCT03829501|617430817|FG006|Overall Study|Study Terminated by Sponsor|0|||
170841684|NCT03829501|617430818|FG007|Overall Study|Study Terminated by Sponsor|3|||
170841685|NCT03829501|617430819|FG008|Overall Study|Study Terminated by Sponsor|1|||
170841686|NCT03829501|617430820|FG009|Overall Study|Study Terminated by Sponsor|0|||
170841687|NCT03829501|617430821|FG010|Overall Study|Study Terminated by Sponsor|0|||
170841688|NCT03829501|617430822|FG011|Overall Study|Study Terminated by Sponsor|0|||
170841689|NCT03829501|617430823|FG012|Overall Study|Study Terminated by Sponsor|0|||
170841690|NCT03829501|617430824|FG013|Overall Study|Study Terminated by Sponsor|0|||
170841691|NCT03829501|617430825|FG014|Overall Study|Study Terminated by Sponsor|3|||
170841692|NCT03829501|617430826|FG015|Overall Study|Study Terminated by Sponsor|2|||
170841693|NCT03829501|617430827|FG016|Overall Study|Study Terminated by Sponsor|2|||
170841694|NCT03829501|617430828|FG017|Overall Study|Study Terminated by Sponsor|0|||
170841695|NCT03829501|617430829|FG018|Overall Study|Study Terminated by Sponsor|0|||
170841696|NCT03829501|617430830|FG019|Overall Study|Study Terminated by Sponsor|0|||
170841697|NCT03829501|617430831|FG020|Overall Study|Study Terminated by Sponsor|1|||
170841698|NCT03829501|617430832|FG021|Overall Study|Study Terminated by Sponsor|0|||
170841699|NCT03829501|617430833|FG022|Overall Study|Study Terminated by Sponsor|3|||
170841700|NCT03829501|617430811|FG000|Overall Study|Lost to Follow Up|0|||
170841701|NCT03829501|617430812|FG001|Overall Study|Lost to Follow Up|0|||
170735484|NCT02923739|617036979|FG001|Overall Study|Failed Screening|0|||
170735485|NCT02923739|617036980|FG002|Overall Study|Failed Screening|0|||
170735486|NCT02923739|617036981|FG003|Overall Study|Failed Screening|0|||
170735487|NCT00441701|617036982|FG000|Overall Study|Adverse Event|3|||
170735488|NCT00441701|617036983|FG001|Overall Study|Adverse Event|2|||
170735489|NCT00441701|617036984|FG002|Overall Study|Adverse Event|1|||
170735490|NCT00441701|617036985|FG003|Overall Study|Adverse Event|0|||
170735491|NCT00441701|617036986|FG004|Overall Study|Adverse Event|2|||
170735492|NCT00441701|617036987|FG005|Overall Study|Adverse Event|2|||
170735493|NCT00441701|617036988|FG006|Overall Study|Adverse Event|0|||
170735494|NCT00441701|617036989|FG007|Overall Study|Adverse Event|0|||
170735495|NCT00441701|617036990|FG008|Overall Study|Adverse Event|0|||
170735496|NCT00441701|617036991|FG009|Overall Study|Adverse Event|0|||
170735497|NCT00441701|617036982|FG000|Overall Study|Lack of Efficacy|2|||
170735498|NCT00441701|617036983|FG001|Overall Study|Lack of Efficacy|0|||
170735499|NCT00441701|617036984|FG002|Overall Study|Lack of Efficacy|2|||
170735500|NCT00441701|617036985|FG003|Overall Study|Lack of Efficacy|2|||
170735501|NCT00441701|617036986|FG004|Overall Study|Lack of Efficacy|0|||
170735502|NCT00441701|617036987|FG005|Overall Study|Lack of Efficacy|1|||
170735503|NCT00441701|617036988|FG006|Overall Study|Lack of Efficacy|0|||
170735504|NCT00441701|617036989|FG007|Overall Study|Lack of Efficacy|0|||
170735505|NCT00441701|617036990|FG008|Overall Study|Lack of Efficacy|0|||
170735506|NCT00441701|617036991|FG009|Overall Study|Lack of Efficacy|0|||
170735507|NCT00441701|617036982|FG000|Overall Study|Withdrawal by Subject|0|||
170735508|NCT00441701|617036983|FG001|Overall Study|Withdrawal by Subject|2|||
170735509|NCT00441701|617036984|FG002|Overall Study|Withdrawal by Subject|1|||
170735510|NCT00441701|617036985|FG003|Overall Study|Withdrawal by Subject|1|||
170735511|NCT00441701|617036986|FG004|Overall Study|Withdrawal by Subject|0|||
170735512|NCT00441701|617036987|FG005|Overall Study|Withdrawal by Subject|0|||
170735513|NCT00441701|617036988|FG006|Overall Study|Withdrawal by Subject|0|||
170735514|NCT00441701|617036989|FG007|Overall Study|Withdrawal by Subject|0|||
170735515|NCT00441701|617036990|FG008|Overall Study|Withdrawal by Subject|0|||
170735516|NCT00441701|617036991|FG009|Overall Study|Withdrawal by Subject|0|||
170735517|NCT00621543|617036992|FG000|Overall Study|Lost to Follow-up|23|||
170735518|NCT02657317|617036995|FG000|Overall Study|Withdrawal by Subject|2|||
170735519|NCT02657317|617036996|FG001|Overall Study|Withdrawal by Subject|0|||
170735520|NCT02657317|617036995|FG000|Overall Study|Lost to Follow-up|3|||
170735521|NCT02657317|617036996|FG001|Overall Study|Lost to Follow-up|3|||
170735522|NCT02535364|617036997|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
170735523|NCT02535364|617036997|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
170735524|NCT02535364|617036997|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
170735525|NCT02535364|617036997|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
170735526|NCT02535364|617036997|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
170735527|NCT02535364|617036997|FG000|Part B Screening|Death|2|||
170735528|NCT02535364|617036997|FG000|Part B Screening|Physician Decision|1|||
170735529|NCT02535364|617036997|FG000|Part B Screening|Withdrawal by Subject|1|||
170735530|NCT02535364|617036997|FG000|Part B Screening|Adverse Event|1|||
170735531|NCT02535364|617036997|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
170735532|NCT02535364|617036997|FG000|Study Treatment|Death|1|||
170735533|NCT02535364|617036997|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
170735534|NCT02535364|617036997|FG000|12-Month Follow-up Period|Disease progression|22|||
170735535|NCT02535364|617036997|FG000|12-Month Follow-up Period|Death|5|||
170735536|NCT02535364|617036997|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
170735537|NCT02535364|617036997|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
170735538|NCT02535364|617036997|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
170735539|NCT00499863|617036998|FG000|Overall Study|Lack of Efficacy|21|||
170735540|NCT00499863|617036999|FG001|Overall Study|Lack of Efficacy|27|||
170735541|NCT00499863|617036998|FG000|Overall Study|Protocol Violation|12|||
170735542|NCT00499863|617036999|FG001|Overall Study|Protocol Violation|7|||
170735543|NCT00499863|617036998|FG000|Overall Study|Withdrawal by Subject|6|||
170735544|NCT00499863|617036999|FG001|Overall Study|Withdrawal by Subject|4|||
170735545|NCT00499863|617036998|FG000|Overall Study|Adverse Event|8|||
170735546|NCT00499863|617036999|FG001|Overall Study|Adverse Event|2|||
170735547|NCT00499863|617036998|FG000|Overall Study|Sponsor decision|2|||
170735548|NCT00499863|617036999|FG001|Overall Study|Sponsor decision|2|||
170735549|NCT00499863|617036998|FG000|Overall Study|Lost to Follow-up|1|||
170735550|NCT00499863|617036999|FG001|Overall Study|Lost to Follow-up|1|||
170735551|NCT00571701|617037000|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
170735552|NCT00571701|617037001|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
170735553|NCT00571701|617037000|FG000|First Intervention 12 Months|Death|1|||
170735554|NCT00571701|617037001|FG001|First Intervention 12 Months|Death|0|||
170735555|NCT00571701|617037000|FG000|Second Intervention 12 Months|Adverse Event|0|||
170735556|NCT00571701|617037001|FG001|Second Intervention 12 Months|Adverse Event|1|||
170735557|NCT00571701|617037000|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
170735558|NCT00571701|617037001|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
170735559|NCT00758459|617037002|FG000|Overall Study|Adverse Event|3|||
170841702|NCT03829501|617430813|FG002|Overall Study|Lost to Follow Up|0|||
170841703|NCT03829501|617430814|FG003|Overall Study|Lost to Follow Up|0|||
170841704|NCT03829501|617430815|FG004|Overall Study|Lost to Follow Up|1|||
170841705|NCT03829501|617430816|FG005|Overall Study|Lost to Follow Up|0|||
170841706|NCT03829501|617430817|FG006|Overall Study|Lost to Follow Up|0|||
170841707|NCT03829501|617430818|FG007|Overall Study|Lost to Follow Up|2|||
170841708|NCT03829501|617430819|FG008|Overall Study|Lost to Follow Up|2|||
170841709|NCT03829501|617430820|FG009|Overall Study|Lost to Follow Up|0|||
170841710|NCT03829501|617430821|FG010|Overall Study|Lost to Follow Up|2|||
170841711|NCT03829501|617430822|FG011|Overall Study|Lost to Follow Up|1|||
170841712|NCT03829501|617430823|FG012|Overall Study|Lost to Follow Up|0|||
170841713|NCT03829501|617430824|FG013|Overall Study|Lost to Follow Up|1|||
170841714|NCT03829501|617430825|FG014|Overall Study|Lost to Follow Up|1|||
170841715|NCT03829501|617430826|FG015|Overall Study|Lost to Follow Up|0|||
170841716|NCT03829501|617430827|FG016|Overall Study|Lost to Follow Up|0|||
170841717|NCT03829501|617430828|FG017|Overall Study|Lost to Follow Up|0|||
170841718|NCT03829501|617430829|FG018|Overall Study|Lost to Follow Up|0|||
170841719|NCT03829501|617430830|FG019|Overall Study|Lost to Follow Up|0|||
170841720|NCT03829501|617430831|FG020|Overall Study|Lost to Follow Up|0|||
170841721|NCT03829501|617430832|FG021|Overall Study|Lost to Follow Up|0|||
170841722|NCT03829501|617430833|FG022|Overall Study|Lost to Follow Up|1|||
170841723|NCT03829501|617430811|FG000|Overall Study|Death|2|||
170841724|NCT03829501|617430812|FG001|Overall Study|Death|4|||
170841725|NCT03829501|617430813|FG002|Overall Study|Death|5|||
170841726|NCT03829501|617430814|FG003|Overall Study|Death|6|||
170841727|NCT03829501|617430815|FG004|Overall Study|Death|5|||
170841728|NCT03829501|617430816|FG005|Overall Study|Death|4|||
170735560|NCT00758459|617037003|FG001|Overall Study|Adverse Event|2|||
170735561|NCT00758459|617037002|FG000|Overall Study|Protocol Violation|0|||
170735562|NCT00758459|617037003|FG001|Overall Study|Protocol Violation|1|||
170735563|NCT00758459|617037002|FG000|Overall Study|Withdrawal by Subject|0|||
170735564|NCT00758459|617037003|FG001|Overall Study|Withdrawal by Subject|1|||
170735565|NCT00691132|617037004|FG000|Overall Study|Adverse Event|2|||
170735566|NCT00691132|617037005|FG001|Overall Study|Adverse Event|3|||
170735567|NCT00691132|617037004|FG000|Overall Study|Withdrawal by Subject|10|||
170735568|NCT00691132|617037005|FG001|Overall Study|Withdrawal by Subject|10|||
170735569|NCT01591382|617037006|FG000|Overall Study|Discharged Prior to Study Completion|2|||
170735570|NCT01591382|617037007|FG001|Overall Study|Discharged Prior to Study Completion|1|||
170735571|NCT01591382|617037006|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
170735572|NCT01591382|617037007|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
170735573|NCT00728962|617037010|FG000|Implant Placement Surgery|Adverse Event|8|||
170735574|NCT00728962|617037010|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
170735575|NCT00728962|617037010|FG000|Implant Placement Surgery|Protocol Violation|1|||
170735576|NCT00728962|617037010|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
170735577|NCT00728962|617037010|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
170735578|NCT04954586|617037013|FG000|Overall Study|Withdrawal by Subject|5|||
170735579|NCT04359784|617037015|FG000|Overall Study|Death|2|||
170735580|NCT02753595|617037019|FG000|Overall Study|Sponsor termination|2|||
170735581|NCT02753595|617037020|FG001|Overall Study|Sponsor termination|2|||
170735582|NCT01800968|617037023|FG000|Overall Study|Death|23|||
170735583|NCT01800968|617037024|FG001|Overall Study|Death|16|||
170735584|NCT01800968|617037023|FG000|Overall Study|Lost to Follow-up|5|||
170735585|NCT01800968|617037024|FG001|Overall Study|Lost to Follow-up|7|||
170735586|NCT01800968|617037023|FG000|Overall Study|Withdrawal by Subject|7|||
170735587|NCT01800968|617037024|FG001|Overall Study|Withdrawal by Subject|9|||
170735588|NCT01800968|617037023|FG000|Overall Study|Physician Decision|1|||
170735589|NCT01800968|617037024|FG001|Overall Study|Physician Decision|0|||
170841729|NCT03829501|617430817|FG006|Overall Study|Death|5|||
170841730|NCT03829501|617430818|FG007|Overall Study|Death|24|||
170841731|NCT03829501|617430819|FG008|Overall Study|Death|22|||
170841732|NCT03829501|617430820|FG009|Overall Study|Death|6|||
170841733|NCT03829501|617430821|FG010|Overall Study|Death|3|||
170841734|NCT03829501|617430822|FG011|Overall Study|Death|10|||
170841735|NCT03829501|617430823|FG012|Overall Study|Death|10|||
170841736|NCT03829501|617430824|FG013|Overall Study|Death|5|||
170735590|NCT04987762|617037025|FG000|Overall Study|Study was Terminated by Sponsor|103|||
170735591|NCT02068495|617037028|FG000|Overall Study|Case Report Forms Uncollected|60|||
170841737|NCT03829501|617430825|FG014|Overall Study|Death|7|||
170735592|NCT02068495|617037028|FG000|Overall Study|Protocol Deviation|49|||
170735593|NCT00316173|617037032|FG000|Run-in Phase|Adverse Event|1|||
170735594|NCT00316173|617037033|FG001|Run-in Phase|Adverse Event|0|||
170841738|NCT03829501|617430826|FG015|Overall Study|Death|2|||
170841739|NCT03829501|617430827|FG016|Overall Study|Death|2|||
170841740|NCT03829501|617430828|FG017|Overall Study|Death|1|||
170841741|NCT03829501|617430829|FG018|Overall Study|Death|1|||
170841742|NCT03829501|617430830|FG019|Overall Study|Death|1|||
170841743|NCT03829501|617430831|FG020|Overall Study|Death|1|||
170841744|NCT03829501|617430832|FG021|Overall Study|Death|2|||
170841745|NCT03829501|617430833|FG022|Overall Study|Death|3|||
170841746|NCT03829501|617430811|FG000|Overall Study|Miscellaneous|0|||
170735595|NCT00316173|617037032|FG000|Run-in Phase|Protocol Violation|1|||
170735596|NCT00316173|617037033|FG001|Run-in Phase|Protocol Violation|0|||
170735597|NCT00316173|617037032|FG000|Run-in Phase|Study Follow-up Stopped|5|||
170735598|NCT00316173|617037033|FG001|Run-in Phase|Study Follow-up Stopped|0|||
170735599|NCT00316173|617037032|FG000|Treatment Phase|Adverse Event|0|||
170735600|NCT00316173|617037033|FG001|Treatment Phase|Adverse Event|1|||
170735601|NCT00316173|617037032|FG000|Treatment Phase|Lack of Efficacy|0|||
170735602|NCT00316173|617037033|FG001|Treatment Phase|Lack of Efficacy|3|||
170735603|NCT00316173|617037032|FG000|Treatment Phase|Lost to Follow-up|0|||
170735604|NCT00316173|617037033|FG001|Treatment Phase|Lost to Follow-up|3|||
170735605|NCT00316173|617037032|FG000|Treatment Phase|Withdrawal by Subject|0|||
170735606|NCT00316173|617037033|FG001|Treatment Phase|Withdrawal by Subject|1|||
170735607|NCT00316173|617037032|FG000|Treatment Phase|Study Follow-up Stopped|0|||
170735608|NCT00316173|617037033|FG001|Treatment Phase|Study Follow-up Stopped|34|||
170735609|NCT02686034|617037038|FG000|Run-In Period 1|Eligibility|12|||
170735610|NCT02686034|617037039|FG001|Run-In Period 1|Eligibility|10|||
170735611|NCT02686034|617037038|FG000|Run-In Period 1|Withdrawal by Subject|4|||
170735612|NCT02686034|617037039|FG001|Run-In Period 1|Withdrawal by Subject|3|||
170735613|NCT02686034|617037038|FG000|Run-In Period 1|Lost to Follow-up|4|||
170735614|NCT02686034|617037039|FG001|Run-In Period 1|Lost to Follow-up|4|||
170735615|NCT02686034|617037038|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
170735616|NCT02686034|617037039|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
170735617|NCT02686034|617037038|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
170735618|NCT02686034|617037039|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
170735619|NCT02686034|617037038|FG000|Randomized Controlled Period 2|Adverse Event|0|||
170735620|NCT02686034|617037039|FG001|Randomized Controlled Period 2|Adverse Event|2|||
170735621|NCT02686034|617037038|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
170735622|NCT02686034|617037039|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
170735623|NCT02686034|617037038|FG000|Open Label Period 3|Lost to Follow-up|0|||
170735624|NCT02686034|617037039|FG001|Open Label Period 3|Lost to Follow-up|1|||
170735625|NCT00542880|617037040|FG000|Period 1|Eligibility criteria not fulfilled|2|||
170735626|NCT00542880|617037041|FG001|Period 1|Eligibility criteria not fulfilled|6|||
170735627|NCT00542880|617037040|FG000|Period 1|Adverse Event|2|||
170735628|NCT00542880|617037041|FG001|Period 1|Adverse Event|2|||
170735629|NCT00542880|617037040|FG000|Period 1|Development of study-specific criteria|1|||
170735630|NCT00542880|617037041|FG001|Period 1|Development of study-specific criteria|2|||
170735631|NCT00542880|617037040|FG000|Period 1|Withdrawal by Subject|1|||
170735632|NCT00542880|617037041|FG001|Period 1|Withdrawal by Subject|1|||
170735633|NCT00542880|617037040|FG000|Period 1|Protocol Violation|0|||
170735634|NCT00542880|617037041|FG001|Period 1|Protocol Violation|1|||
170735635|NCT00542880|617037040|FG000|Period 2|Adverse Event|5|||
170735636|NCT00542880|617037041|FG001|Period 2|Adverse Event|7|||
170735637|NCT00542880|617037040|FG000|Period 2|Eligibility not fulfilled|0|||
170735638|NCT00542880|617037041|FG001|Period 2|Eligibility not fulfilled|1|||
170735639|NCT00542880|617037040|FG000|Period 2|Discontinuation criteria|2|||
170735640|NCT00542880|617037041|FG001|Period 2|Discontinuation criteria|0|||
170735641|NCT00542880|617037040|FG000|Period 2|Severe non-compliance|0|||
170735642|NCT00542880|617037041|FG001|Period 2|Severe non-compliance|1|||
170735643|NCT00542880|617037040|FG000|Period 2|Other|0|||
170735644|NCT00542880|617037041|FG001|Period 2|Other|1|||
170735645|NCT00542880|617037040|FG000|Period 3|Adverse Event|0|||
170735646|NCT00542880|617037041|FG001|Period 3|Adverse Event|2|||
170735647|NCT00558064|617037042|FG000|Overall Study|Adverse Event|3|||
170735648|NCT00558064|617037043|FG001|Overall Study|Adverse Event|2|||
170735649|NCT00558064|617037042|FG000|Overall Study|Lack of Efficacy|0|||
170735650|NCT00558064|617037043|FG001|Overall Study|Lack of Efficacy|1|||
170735651|NCT00558064|617037042|FG000|Overall Study|Protocol Violation|1|||
170735652|NCT00558064|617037043|FG001|Overall Study|Protocol Violation|0|||
170735653|NCT00558064|617037042|FG000|Overall Study|Lost to Follow-up|0|||
170735654|NCT00558064|617037043|FG001|Overall Study|Lost to Follow-up|1|||
170735655|NCT00558064|617037042|FG000|Overall Study|Withdrawal by Subject|0|||
170735656|NCT00558064|617037043|FG001|Overall Study|Withdrawal by Subject|1|||
170735657|NCT00558064|617037042|FG000|Overall Study|No visit within allowance period|1|||
170735658|NCT00558064|617037043|FG001|Overall Study|No visit within allowance period|0|||
170735659|NCT00982930|617037044|FG000|Overall Study|Adverse Event|1|||
170735660|NCT00982930|617037044|FG000|Overall Study|Withdrawal by Subject|1|||
170735661|NCT00982930|617037044|FG000|Overall Study|Administrative Problems|2|||
170735662|NCT00404495|617037045|FG000|Overall Study|Death|37|||
170735663|NCT00404495|617037046|FG001|Overall Study|Death|11|||
170735664|NCT00404495|617037045|FG000|Overall Study|Lost to Follow-up|5|||
170735665|NCT00404495|617037046|FG001|Overall Study|Lost to Follow-up|0|||
170735666|NCT00404495|617037045|FG000|Overall Study|Other|1|||
170735667|NCT00404495|617037046|FG001|Overall Study|Other|0|||
170735668|NCT00404495|617037045|FG000|Overall Study|Withdrawal by Subject|1|||
170841747|NCT03829501|617430812|FG001|Overall Study|Miscellaneous|0|||
170841748|NCT03829501|617430813|FG002|Overall Study|Miscellaneous|1|||
170841749|NCT03829501|617430814|FG003|Overall Study|Miscellaneous|0|||
170841750|NCT03829501|617430815|FG004|Overall Study|Miscellaneous|0|||
170841751|NCT03829501|617430816|FG005|Overall Study|Miscellaneous|0|||
170841752|NCT03829501|617430817|FG006|Overall Study|Miscellaneous|0|||
170841753|NCT03829501|617430818|FG007|Overall Study|Miscellaneous|1|||
170841754|NCT03829501|617430819|FG008|Overall Study|Miscellaneous|0|||
170841755|NCT03829501|617430820|FG009|Overall Study|Miscellaneous|0|||
170841756|NCT03829501|617430821|FG010|Overall Study|Miscellaneous|0|||
170841757|NCT03829501|617430822|FG011|Overall Study|Miscellaneous|0|||
170841758|NCT03829501|617430823|FG012|Overall Study|Miscellaneous|0|||
170841759|NCT03829501|617430824|FG013|Overall Study|Miscellaneous|0|||
170841760|NCT03829501|617430825|FG014|Overall Study|Miscellaneous|0|||
170841761|NCT03829501|617430826|FG015|Overall Study|Miscellaneous|0|||
170841762|NCT03829501|617430827|FG016|Overall Study|Miscellaneous|0|||
170841763|NCT03829501|617430828|FG017|Overall Study|Miscellaneous|0|||
170841764|NCT03829501|617430829|FG018|Overall Study|Miscellaneous|0|||
170841765|NCT03829501|617430830|FG019|Overall Study|Miscellaneous|0|||
170841766|NCT03829501|617430831|FG020|Overall Study|Miscellaneous|0|||
170841767|NCT03829501|617430832|FG021|Overall Study|Miscellaneous|0|||
170841768|NCT03829501|617430833|FG022|Overall Study|Miscellaneous|1|||
170841769|NCT04942366|617430834|FG000|Overall Study|Withdrawal by Subject|5|||
170841770|NCT04942366|617430835|FG001|Overall Study|Withdrawal by Subject|5|||
170841771|NCT00747227|617430840|FG000|Overall Study|Death|3|||
170841772|NCT00747227|617430841|FG001|Overall Study|Death|1|||
170841773|NCT00747227|617430840|FG000|Overall Study|Withdrawal by Subject|1|||
170841774|NCT00747227|617430841|FG001|Overall Study|Withdrawal by Subject|0|||
170841775|NCT00747227|617430840|FG000|Overall Study|Lost to Follow-up|1|||
170841776|NCT00747227|617430841|FG001|Overall Study|Lost to Follow-up|2|||
170841777|NCT00747227|617430840|FG000|Overall Study|Illness|1|||
170841778|NCT00747227|617430841|FG001|Overall Study|Illness|1|||
170841779|NCT03284229|617430842|FG000|Overall Study|Lost to Follow-up|3|||
170841780|NCT00918879|617430844|FG000|Overall Study|Withdrawal by Subject|4|||
170841781|NCT00918879|617430845|FG001|Overall Study|Withdrawal by Subject|4|||
170841782|NCT00918879|617430844|FG000|Overall Study|Lost to Follow-up|1|||
170841783|NCT00918879|617430845|FG001|Overall Study|Lost to Follow-up|1|||
170841784|NCT00918879|617430844|FG000|Overall Study|Severe non-compliance to protocol|1|||
170841785|NCT00918879|617430845|FG001|Overall Study|Severe non-compliance to protocol|1|||
170841786|NCT00357110|617430848|FG000|Overall Study|Early study termination|5|||
170841787|NCT00357110|617430849|FG001|Overall Study|Early study termination|5|||
170841788|NCT01195948|617430859|FG000|Overall Study|Lost to Follow-up|0|||
170841789|NCT01195948|617430860|FG001|Overall Study|Lost to Follow-up|1|||
170841790|NCT01195948|617430861|FG002|Overall Study|Lost to Follow-up|2|||
170841791|NCT00818168|617430862|FG000|Overall Study|Lack of Efficacy|18|||
170841792|NCT00818168|617430862|FG000|Overall Study|Pregnancy|2|||
170841793|NCT00818168|617430862|FG000|Overall Study|Withdrawal by Subject|16|||
170841794|NCT00818168|617430862|FG000|Overall Study|Lost to Follow-up|7|||
170841795|NCT00818168|617430862|FG000|Overall Study|Adverse Event|19|||
170841796|NCT00818168|617430862|FG000|Overall Study|Reason for Non-completion Not reported|6|||
170841797|NCT00818168|617430862|FG000|Overall Study|Participant Moved|2|||
170841798|NCT00737477|617430866|FG000|Overall Study|Adverse Event|9|||
170841799|NCT00737477|617430866|FG000|Overall Study|Death|9|||
170841800|NCT00737477|617430866|FG000|Overall Study|Treatment Refusal|1|||
170841801|NCT00737477|617430866|FG000|Overall Study|Withdrawal by Subject|1|||
170841802|NCT00737477|617430866|FG000|Overall Study|Renal Transplantation|10|||
170841803|NCT00737477|617430866|FG000|Overall Study|Other|4|||
170841804|NCT01730378|617430867|FG000|Overall Study|Lost to Follow-up|1|||
170841805|NCT01730378|617430868|FG001|Overall Study|Lost to Follow-up|0|||
170841806|NCT05000216|617430873|FG000|Stage 1|Lost to Follow-up|0|||
170841807|NCT05000216|617430874|FG001|Stage 1|Lost to Follow-up|0|||
170841808|NCT05000216|617430875|FG002|Stage 1|Lost to Follow-up|0|||
170841809|NCT05000216|617430876|FG003|Stage 1|Lost to Follow-up|0|||
170841810|NCT05000216|617430877|FG004|Stage 1|Lost to Follow-up|0|||
170841811|NCT05000216|617430878|FG005|Stage 1|Lost to Follow-up|0|||
170841812|NCT05000216|617430879|FG006|Stage 1|Lost to Follow-up|1|||
170841813|NCT05000216|617430880|FG007|Stage 1|Lost to Follow-up|1|||
170841814|NCT05000216|617430881|FG008|Stage 1|Lost to Follow-up|0|||
170841815|NCT05000216|617430882|FG009|Stage 1|Lost to Follow-up|2|||
170841816|NCT05000216|617430883|FG010|Stage 1|Lost to Follow-up|3|||
170841817|NCT05000216|617430884|FG011|Stage 1|Lost to Follow-up|0|||
170841818|NCT05000216|617430885|FG012|Stage 1|Lost to Follow-up|0|||
170841819|NCT05000216|617430886|FG013|Stage 1|Lost to Follow-up|0|||
170841820|NCT05000216|617430887|FG014|Stage 1|Lost to Follow-up|0|||
170841821|NCT05000216|617430888|FG015|Stage 1|Lost to Follow-up|0|||
170841822|NCT05000216|617430889|FG016|Stage 1|Lost to Follow-up|0|||
170841823|NCT05000216|617430890|FG017|Stage 1|Lost to Follow-up|0|||
170841824|NCT05000216|617430891|FG018|Stage 1|Lost to Follow-up|0|||
170841825|NCT05000216|617430892|FG019|Stage 1|Lost to Follow-up|0|||
170841826|NCT05000216|617430893|FG020|Stage 1|Lost to Follow-up|0|||
170841827|NCT05000216|617430894|FG021|Stage 1|Lost to Follow-up|0|||
170841828|NCT05000216|617430873|FG000|Stage 1|Physician Decision|0|||
170841829|NCT05000216|617430874|FG001|Stage 1|Physician Decision|0|||
170841830|NCT05000216|617430875|FG002|Stage 1|Physician Decision|0|||
170841831|NCT05000216|617430876|FG003|Stage 1|Physician Decision|0|||
170841832|NCT05000216|617430877|FG004|Stage 1|Physician Decision|0|||
170841833|NCT05000216|617430878|FG005|Stage 1|Physician Decision|0|||
170841834|NCT05000216|617430879|FG006|Stage 1|Physician Decision|0|||
170841835|NCT05000216|617430880|FG007|Stage 1|Physician Decision|1|||
170841836|NCT05000216|617430881|FG008|Stage 1|Physician Decision|1|||
170841837|NCT05000216|617430882|FG009|Stage 1|Physician Decision|0|||
170841838|NCT05000216|617430883|FG010|Stage 1|Physician Decision|0|||
170841839|NCT05000216|617430884|FG011|Stage 1|Physician Decision|0|||
170841840|NCT05000216|617430885|FG012|Stage 1|Physician Decision|0|||
170841841|NCT05000216|617430886|FG013|Stage 1|Physician Decision|0|||
170841842|NCT05000216|617430887|FG014|Stage 1|Physician Decision|0|||
170841843|NCT05000216|617430888|FG015|Stage 1|Physician Decision|0|||
170841844|NCT05000216|617430889|FG016|Stage 1|Physician Decision|0|||
170841845|NCT05000216|617430890|FG017|Stage 1|Physician Decision|0|||
170841846|NCT05000216|617430891|FG018|Stage 1|Physician Decision|0|||
170841847|NCT05000216|617430892|FG019|Stage 1|Physician Decision|0|||
170841848|NCT05000216|617430893|FG020|Stage 1|Physician Decision|0|||
170841849|NCT05000216|617430894|FG021|Stage 1|Physician Decision|0|||
170841850|NCT05000216|617430873|FG000|Stage 1|Withdrawal by Subject|0|||
170841851|NCT05000216|617430874|FG001|Stage 1|Withdrawal by Subject|1|||
170841852|NCT05000216|617430875|FG002|Stage 1|Withdrawal by Subject|0|||
170841853|NCT05000216|617430876|FG003|Stage 1|Withdrawal by Subject|0|||
170841854|NCT05000216|617430877|FG004|Stage 1|Withdrawal by Subject|0|||
170841855|NCT05000216|617430878|FG005|Stage 1|Withdrawal by Subject|0|||
170841856|NCT05000216|617430879|FG006|Stage 1|Withdrawal by Subject|0|||
170841857|NCT05000216|617430880|FG007|Stage 1|Withdrawal by Subject|0|||
170841858|NCT05000216|617430881|FG008|Stage 1|Withdrawal by Subject|0|||
170841859|NCT05000216|617430882|FG009|Stage 1|Withdrawal by Subject|3|||
170841860|NCT05000216|617430883|FG010|Stage 1|Withdrawal by Subject|10|||
170841861|NCT05000216|617430884|FG011|Stage 1|Withdrawal by Subject|0|||
170841862|NCT05000216|617430885|FG012|Stage 1|Withdrawal by Subject|0|||
170841863|NCT05000216|617430886|FG013|Stage 1|Withdrawal by Subject|0|||
170841864|NCT05000216|617430887|FG014|Stage 1|Withdrawal by Subject|0|||
170841865|NCT05000216|617430888|FG015|Stage 1|Withdrawal by Subject|0|||
170841866|NCT05000216|617430889|FG016|Stage 1|Withdrawal by Subject|0|||
170841867|NCT05000216|617430890|FG017|Stage 1|Withdrawal by Subject|0|||
170841868|NCT05000216|617430891|FG018|Stage 1|Withdrawal by Subject|0|||
170841869|NCT05000216|617430892|FG019|Stage 1|Withdrawal by Subject|0|||
170841870|NCT05000216|617430893|FG020|Stage 1|Withdrawal by Subject|0|||
170841871|NCT05000216|617430894|FG021|Stage 1|Withdrawal by Subject|0|||
170841872|NCT05000216|617430873|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
170841873|NCT05000216|617430874|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
170841874|NCT05000216|617430875|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
170841875|NCT05000216|617430876|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
170841876|NCT05000216|617430877|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
170841877|NCT05000216|617430878|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
170841878|NCT05000216|617430879|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
170841879|NCT05000216|617430880|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
170841880|NCT05000216|617430881|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
170841881|NCT05000216|617430882|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
170841882|NCT05000216|617430883|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
170841883|NCT05000216|617430884|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
170841884|NCT05000216|617430885|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
170841885|NCT05000216|617430886|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
170841886|NCT05000216|617430887|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
170841887|NCT05000216|617430888|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
170841888|NCT05000216|617430889|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
170841889|NCT05000216|617430890|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
170841890|NCT05000216|617430891|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
170841891|NCT05000216|617430892|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
170841892|NCT05000216|617430893|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
170841893|NCT05000216|617430894|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
170841894|NCT05000216|617430873|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841895|NCT05000216|617430874|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841896|NCT05000216|617430875|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841897|NCT05000216|617430876|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841898|NCT05000216|617430877|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841899|NCT05000216|617430878|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841900|NCT05000216|617430879|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841901|NCT05000216|617430880|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841902|NCT05000216|617430881|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
170841903|NCT05000216|617430882|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841904|NCT05000216|617430883|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841905|NCT05000216|617430884|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841906|NCT05000216|617430885|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841907|NCT05000216|617430886|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841908|NCT05000216|617430887|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841909|NCT05000216|617430888|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841910|NCT05000216|617430889|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841911|NCT05000216|617430890|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841912|NCT05000216|617430891|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841913|NCT05000216|617430892|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841914|NCT05000216|617430893|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841915|NCT05000216|617430894|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
170841916|NCT05000216|617430873|FG000|Stage 1|Other|0|||
170841917|NCT05000216|617430874|FG001|Stage 1|Other|0|||
170841918|NCT05000216|617430875|FG002|Stage 1|Other|0|||
170841919|NCT05000216|617430876|FG003|Stage 1|Other|0|||
170841920|NCT05000216|617430877|FG004|Stage 1|Other|1|||
170841921|NCT05000216|617430878|FG005|Stage 1|Other|0|||
170841922|NCT05000216|617430879|FG006|Stage 1|Other|0|||
170841923|NCT05000216|617430880|FG007|Stage 1|Other|2|||
170841924|NCT05000216|617430881|FG008|Stage 1|Other|0|||
170841925|NCT05000216|617430882|FG009|Stage 1|Other|0|||
170841926|NCT05000216|617430883|FG010|Stage 1|Other|1|||
170841927|NCT05000216|617430884|FG011|Stage 1|Other|1|||
170841928|NCT05000216|617430885|FG012|Stage 1|Other|0|||
170841929|NCT05000216|617430886|FG013|Stage 1|Other|0|||
170841930|NCT05000216|617430887|FG014|Stage 1|Other|0|||
170841931|NCT05000216|617430888|FG015|Stage 1|Other|0|||
170841932|NCT05000216|617430889|FG016|Stage 1|Other|0|||
170841933|NCT05000216|617430890|FG017|Stage 1|Other|0|||
170841934|NCT05000216|617430891|FG018|Stage 1|Other|0|||
170841935|NCT05000216|617430892|FG019|Stage 1|Other|0|||
170841936|NCT05000216|617430893|FG020|Stage 1|Other|0|||
170841937|NCT05000216|617430894|FG021|Stage 1|Other|0|||
170841938|NCT05000216|617430873|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
170841939|NCT05000216|617430874|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
170841940|NCT05000216|617430875|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
170841941|NCT05000216|617430876|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
170841942|NCT05000216|617430877|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
170841943|NCT05000216|617430878|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
170841944|NCT05000216|617430879|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
170841945|NCT05000216|617430880|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
170841946|NCT05000216|617430881|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
170841947|NCT05000216|617430882|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
170841948|NCT05000216|617430883|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
170841949|NCT05000216|617430884|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
170841950|NCT05000216|617430885|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
170841951|NCT05000216|617430886|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
170841952|NCT05000216|617430887|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
170841953|NCT05000216|617430888|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
170841954|NCT05000216|617430889|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
170841955|NCT05000216|617430890|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
170841956|NCT05000216|617430891|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
170841957|NCT05000216|617430892|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
170841958|NCT05000216|617430893|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
170841959|NCT05000216|617430894|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
170841960|NCT05000216|617430873|FG000|Stage 2|Lost to Follow-up|0|||
170841961|NCT05000216|617430874|FG001|Stage 2|Lost to Follow-up|0|||
170841962|NCT05000216|617430875|FG002|Stage 2|Lost to Follow-up|0|||
170841963|NCT05000216|617430876|FG003|Stage 2|Lost to Follow-up|0|||
170841964|NCT05000216|617430877|FG004|Stage 2|Lost to Follow-up|0|||
170841965|NCT05000216|617430878|FG005|Stage 2|Lost to Follow-up|0|||
170841966|NCT05000216|617430879|FG006|Stage 2|Lost to Follow-up|0|||
170841967|NCT05000216|617430880|FG007|Stage 2|Lost to Follow-up|0|||
170841968|NCT05000216|617430881|FG008|Stage 2|Lost to Follow-up|0|||
170841969|NCT05000216|617430882|FG009|Stage 2|Lost to Follow-up|0|||
170841970|NCT05000216|617430883|FG010|Stage 2|Lost to Follow-up|0|||
170841971|NCT05000216|617430884|FG011|Stage 2|Lost to Follow-up|0|||
170841972|NCT05000216|617430885|FG012|Stage 2|Lost to Follow-up|0|||
170841973|NCT05000216|617430886|FG013|Stage 2|Lost to Follow-up|0|||
170841974|NCT05000216|617430887|FG014|Stage 2|Lost to Follow-up|0|||
170841975|NCT05000216|617430888|FG015|Stage 2|Lost to Follow-up|0|||
170841976|NCT05000216|617430889|FG016|Stage 2|Lost to Follow-up|4|||
170841977|NCT05000216|617430890|FG017|Stage 2|Lost to Follow-up|0|||
170841978|NCT05000216|617430891|FG018|Stage 2|Lost to Follow-up|0|||
170841979|NCT05000216|617430892|FG019|Stage 2|Lost to Follow-up|0|||
170841980|NCT05000216|617430893|FG020|Stage 2|Lost to Follow-up|0|||
170841981|NCT05000216|617430894|FG021|Stage 2|Lost to Follow-up|0|||
170841982|NCT05000216|617430873|FG000|Stage 2|Physician Decision|0|||
170841983|NCT05000216|617430874|FG001|Stage 2|Physician Decision|0|||
170841984|NCT05000216|617430875|FG002|Stage 2|Physician Decision|0|||
170841985|NCT05000216|617430876|FG003|Stage 2|Physician Decision|0|||
170841986|NCT05000216|617430877|FG004|Stage 2|Physician Decision|0|||
170841987|NCT05000216|617430878|FG005|Stage 2|Physician Decision|0|||
170841988|NCT05000216|617430879|FG006|Stage 2|Physician Decision|0|||
170841989|NCT05000216|617430880|FG007|Stage 2|Physician Decision|0|||
170841990|NCT05000216|617430881|FG008|Stage 2|Physician Decision|0|||
170841991|NCT05000216|617430882|FG009|Stage 2|Physician Decision|0|||
170841992|NCT05000216|617430883|FG010|Stage 2|Physician Decision|0|||
170841993|NCT05000216|617430884|FG011|Stage 2|Physician Decision|0|||
170841994|NCT05000216|617430885|FG012|Stage 2|Physician Decision|1|||
170841995|NCT05000216|617430886|FG013|Stage 2|Physician Decision|0|||
170841996|NCT05000216|617430887|FG014|Stage 2|Physician Decision|0|||
170841997|NCT05000216|617430888|FG015|Stage 2|Physician Decision|0|||
170841998|NCT05000216|617430889|FG016|Stage 2|Physician Decision|0|||
170841999|NCT05000216|617430890|FG017|Stage 2|Physician Decision|0|||
170842000|NCT05000216|617430891|FG018|Stage 2|Physician Decision|0|||
170842001|NCT05000216|617430892|FG019|Stage 2|Physician Decision|0|||
170842002|NCT05000216|617430893|FG020|Stage 2|Physician Decision|0|||
170842003|NCT05000216|617430894|FG021|Stage 2|Physician Decision|0|||
170842004|NCT05000216|617430873|FG000|Stage 2|Withdrawal by Subject|0|||
170842005|NCT05000216|617430874|FG001|Stage 2|Withdrawal by Subject|0|||
170842006|NCT05000216|617430875|FG002|Stage 2|Withdrawal by Subject|0|||
170842007|NCT05000216|617430876|FG003|Stage 2|Withdrawal by Subject|0|||
170842008|NCT05000216|617430877|FG004|Stage 2|Withdrawal by Subject|0|||
170842009|NCT05000216|617430878|FG005|Stage 2|Withdrawal by Subject|0|||
170842010|NCT05000216|617430879|FG006|Stage 2|Withdrawal by Subject|0|||
170842011|NCT05000216|617430880|FG007|Stage 2|Withdrawal by Subject|0|||
170842012|NCT05000216|617430881|FG008|Stage 2|Withdrawal by Subject|0|||
170842013|NCT05000216|617430882|FG009|Stage 2|Withdrawal by Subject|0|||
170842014|NCT05000216|617430883|FG010|Stage 2|Withdrawal by Subject|0|||
170842015|NCT05000216|617430884|FG011|Stage 2|Withdrawal by Subject|0|||
170842016|NCT05000216|617430885|FG012|Stage 2|Withdrawal by Subject|0|||
170842017|NCT05000216|617430886|FG013|Stage 2|Withdrawal by Subject|0|||
170842018|NCT05000216|617430887|FG014|Stage 2|Withdrawal by Subject|2|||
170842019|NCT05000216|617430888|FG015|Stage 2|Withdrawal by Subject|0|||
170842020|NCT05000216|617430889|FG016|Stage 2|Withdrawal by Subject|9|||
170842021|NCT05000216|617430890|FG017|Stage 2|Withdrawal by Subject|0|||
170842022|NCT05000216|617430891|FG018|Stage 2|Withdrawal by Subject|0|||
170842023|NCT05000216|617430892|FG019|Stage 2|Withdrawal by Subject|0|||
170842024|NCT05000216|617430893|FG020|Stage 2|Withdrawal by Subject|0|||
170842025|NCT05000216|617430894|FG021|Stage 2|Withdrawal by Subject|0|||
170842026|NCT05000216|617430873|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
170842027|NCT05000216|617430874|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
170842028|NCT05000216|617430875|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
170842029|NCT05000216|617430876|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
170842030|NCT05000216|617430877|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
170842031|NCT05000216|617430878|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
170842032|NCT05000216|617430879|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
170842033|NCT05000216|617430880|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
170842034|NCT05000216|617430881|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
170842035|NCT05000216|617430882|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
170842036|NCT05000216|617430883|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
170842037|NCT05000216|617430884|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
170842038|NCT05000216|617430885|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
170842039|NCT05000216|617430886|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
170842040|NCT05000216|617430887|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
170842041|NCT05000216|617430888|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
170842042|NCT05000216|617430889|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
170842043|NCT05000216|617430890|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
170842044|NCT05000216|617430891|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
170842045|NCT05000216|617430892|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
170842046|NCT05000216|617430893|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
170842047|NCT05000216|617430894|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
170842048|NCT05000216|617430873|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842049|NCT05000216|617430874|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842050|NCT05000216|617430875|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842051|NCT05000216|617430876|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842052|NCT05000216|617430877|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842053|NCT05000216|617430878|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842054|NCT05000216|617430879|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842055|NCT05000216|617430880|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842056|NCT05000216|617430881|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842057|NCT05000216|617430882|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842058|NCT05000216|617430883|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842059|NCT05000216|617430884|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842060|NCT05000216|617430885|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842061|NCT05000216|617430886|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842062|NCT05000216|617430887|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
170842063|NCT05000216|617430888|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842064|NCT05000216|617430889|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
170842065|NCT05000216|617430890|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842066|NCT05000216|617430891|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842067|NCT05000216|617430892|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842068|NCT05000216|617430893|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842069|NCT05000216|617430894|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
170842070|NCT05000216|617430873|FG000|Stage 2|Other reason|0|||
170842071|NCT05000216|617430874|FG001|Stage 2|Other reason|0|||
170842072|NCT05000216|617430875|FG002|Stage 2|Other reason|0|||
170842073|NCT05000216|617430876|FG003|Stage 2|Other reason|0|||
170842074|NCT05000216|617430877|FG004|Stage 2|Other reason|0|||
170842075|NCT05000216|617430878|FG005|Stage 2|Other reason|0|||
170842076|NCT05000216|617430879|FG006|Stage 2|Other reason|0|||
170842077|NCT05000216|617430880|FG007|Stage 2|Other reason|0|||
170842078|NCT05000216|617430881|FG008|Stage 2|Other reason|0|||
170842079|NCT05000216|617430882|FG009|Stage 2|Other reason|0|||
170842080|NCT05000216|617430883|FG010|Stage 2|Other reason|0|||
170842081|NCT05000216|617430884|FG011|Stage 2|Other reason|0|||
170842082|NCT05000216|617430885|FG012|Stage 2|Other reason|0|||
170842083|NCT05000216|617430886|FG013|Stage 2|Other reason|0|||
170842084|NCT05000216|617430887|FG014|Stage 2|Other reason|0|||
170842085|NCT05000216|617430888|FG015|Stage 2|Other reason|0|||
170842086|NCT05000216|617430889|FG016|Stage 2|Other reason|1|||
170842087|NCT05000216|617430890|FG017|Stage 2|Other reason|0|||
170842088|NCT05000216|617430891|FG018|Stage 2|Other reason|0|||
170842089|NCT05000216|617430892|FG019|Stage 2|Other reason|0|||
170842090|NCT05000216|617430893|FG020|Stage 2|Other reason|0|||
170842091|NCT05000216|617430894|FG021|Stage 2|Other reason|0|||
170842092|NCT05000216|617430873|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
170842093|NCT05000216|617430874|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
170842094|NCT05000216|617430875|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
170842095|NCT05000216|617430876|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
170842096|NCT05000216|617430877|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
170842097|NCT05000216|617430878|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
170842098|NCT05000216|617430879|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
170842099|NCT05000216|617430880|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
170842100|NCT05000216|617430881|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
170842101|NCT05000216|617430882|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
170842102|NCT05000216|617430883|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
170842103|NCT05000216|617430884|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
170842104|NCT05000216|617430885|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
170842105|NCT05000216|617430886|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
170842106|NCT05000216|617430887|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
170842107|NCT05000216|617430888|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
170842108|NCT05000216|617430889|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
170842109|NCT05000216|617430890|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
170842110|NCT05000216|617430891|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
170842111|NCT05000216|617430892|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
170842112|NCT05000216|617430893|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
170842113|NCT05000216|617430894|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
170842114|NCT05000216|617430873|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842115|NCT05000216|617430874|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842116|NCT05000216|617430875|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842117|NCT05000216|617430876|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842118|NCT05000216|617430877|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842119|NCT05000216|617430878|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842120|NCT05000216|617430879|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842121|NCT05000216|617430880|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842122|NCT05000216|617430881|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842123|NCT05000216|617430882|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842124|NCT05000216|617430883|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842125|NCT05000216|617430884|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842126|NCT05000216|617430885|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842127|NCT05000216|617430886|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842128|NCT05000216|617430887|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842129|NCT05000216|617430888|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
170842130|NCT05000216|617430889|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842131|NCT05000216|617430890|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842132|NCT05000216|617430891|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842133|NCT05000216|617430892|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842134|NCT05000216|617430893|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842135|NCT05000216|617430894|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
170842136|NCT05000216|617430873|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842137|NCT05000216|617430874|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842138|NCT05000216|617430875|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842139|NCT05000216|617430876|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842140|NCT05000216|617430877|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842141|NCT05000216|617430878|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842142|NCT05000216|617430879|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842143|NCT05000216|617430880|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842144|NCT05000216|617430881|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842145|NCT05000216|617430882|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842146|NCT05000216|617430883|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842147|NCT05000216|617430884|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842148|NCT05000216|617430885|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842149|NCT05000216|617430886|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
170842150|NCT05000216|617430887|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842151|NCT05000216|617430888|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
170842152|NCT05000216|617430889|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842153|NCT05000216|617430890|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842154|NCT05000216|617430891|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
170842155|NCT05000216|617430892|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842156|NCT05000216|617430893|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842157|NCT05000216|617430894|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
170842158|NCT04481373|617430895|FG000|Overall Study|Protocol Violation|1|||
170842159|NCT04481373|617430896|FG001|Overall Study|Protocol Violation|0|||
170842160|NCT04481373|617430895|FG000|Overall Study|Viral load in hospital not over 1000|2|||
170842161|NCT04481373|617430896|FG001|Overall Study|Viral load in hospital not over 1000|1|||
170842162|NCT04481373|617430895|FG000|Overall Study|Death before hospital discharge|1|||
170842163|NCT04481373|617430896|FG001|Overall Study|Death before hospital discharge|0|||
170842164|NCT02242097|617430903|FG000|Ibrutinib Treatment|Adverse Event|16|||
170842165|NCT02242097|617430903|FG000|Ibrutinib Treatment|Physician Decision|1|||
170842166|NCT02242097|617430903|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
170842167|NCT02242097|617430903|FG000|Ibrutinib Treatment|Death|1|||
170842168|NCT02242097|617430903|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
170842169|NCT02242097|617430903|FG000|Post Therapy Follow Up|Death|3|||
170842170|NCT02242097|617430903|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
170842171|NCT02224703|617430904|FG000|Overall Study|Adverse Event|0|||
170842172|NCT02224703|617430905|FG001|Overall Study|Adverse Event|5|||
170842173|NCT02224703|617430906|FG002|Overall Study|Adverse Event|0|||
170842174|NCT02224703|617430904|FG000|Overall Study|Withdrawn by investigator|1|||
170842175|NCT02224703|617430905|FG001|Overall Study|Withdrawn by investigator|0|||
170842176|NCT02224703|617430906|FG002|Overall Study|Withdrawn by investigator|0|||
170842177|NCT02224703|617430904|FG000|Overall Study|Advised by medical monitor|1|||
170842178|NCT02224703|617430905|FG001|Overall Study|Advised by medical monitor|0|||
170842179|NCT02224703|617430906|FG002|Overall Study|Advised by medical monitor|0|||
170842180|NCT02224703|617430904|FG000|Overall Study|Withdrawn by parent/guardian|0|||
170842181|NCT02224703|617430905|FG001|Overall Study|Withdrawn by parent/guardian|1|||
170842182|NCT02224703|617430906|FG002|Overall Study|Withdrawn by parent/guardian|0|||
170842183|NCT02224703|617430904|FG000|Overall Study|Lack of Efficacy|1|||
170842184|NCT02224703|617430905|FG001|Overall Study|Lack of Efficacy|0|||
170842185|NCT02224703|617430906|FG002|Overall Study|Lack of Efficacy|0|||
170842186|NCT02057575|617430907|FG000|Overall Study|Adverse Event|0|||
170842187|NCT02057575|617430908|FG001|Overall Study|Adverse Event|2|||
170842188|NCT02057575|617430909|FG002|Overall Study|Adverse Event|0|||
170842189|NCT02057575|617430910|FG003|Overall Study|Adverse Event|1|||
170842190|NCT02057575|617430907|FG000|Overall Study|Withdrawal by Subject|1|||
170842191|NCT02057575|617430908|FG001|Overall Study|Withdrawal by Subject|0|||
170842192|NCT02057575|617430909|FG002|Overall Study|Withdrawal by Subject|0|||
170842193|NCT02057575|617430910|FG003|Overall Study|Withdrawal by Subject|0|||
170842194|NCT02057575|617430907|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
170842195|NCT02057575|617430908|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
170842196|NCT02057575|617430909|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
170842197|NCT02057575|617430910|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
170842198|NCT02057575|617430907|FG000|Overall Study|Protocol Violation|0|||
170842199|NCT02057575|617430908|FG001|Overall Study|Protocol Violation|1|||
170842200|NCT02057575|617430909|FG002|Overall Study|Protocol Violation|0|||
170842201|NCT02057575|617430910|FG003|Overall Study|Protocol Violation|0|||
170842202|NCT00332462|617430911|FG000|Overall Study|Adverse Event|5|||
170842203|NCT00332462|617430911|FG000|Overall Study|Abnormal Lab Value|1|||
170842204|NCT00332462|617430911|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170842205|NCT00332462|617430911|FG000|Overall Study|no longer requires study drug|1|||
170842206|NCT00332462|617430911|FG000|Overall Study|Death|3|||
170842207|NCT00332462|617430911|FG000|Overall Study|Graft Loss|2|||
170842208|NCT00863681|617430916|FG000|Overall Study|Other|2|||
170842209|NCT00863681|617430917|FG001|Overall Study|Other|0|||
170842210|NCT00863681|617430918|FG002|Overall Study|Other|0|||
170842211|NCT00863681|617430916|FG000|Overall Study|Missing|1|||
170842212|NCT00863681|617430917|FG001|Overall Study|Missing|0|||
170842213|NCT00863681|617430918|FG002|Overall Study|Missing|0|||
170842214|NCT00863681|617430916|FG000|Overall Study|Death|40|||
170842215|NCT00863681|617430917|FG001|Overall Study|Death|23|||
170842216|NCT00863681|617430918|FG002|Overall Study|Death|6|||
170842217|NCT00863681|617430916|FG000|Overall Study|Withdrawal by Subject|12|||
170842218|NCT00863681|617430917|FG001|Overall Study|Withdrawal by Subject|5|||
170842219|NCT00863681|617430918|FG002|Overall Study|Withdrawal by Subject|2|||
170842220|NCT00863681|617430916|FG000|Overall Study|Protocol Violation|2|||
170842221|NCT00863681|617430917|FG001|Overall Study|Protocol Violation|0|||
170842222|NCT00863681|617430918|FG002|Overall Study|Protocol Violation|0|||
170842223|NCT00863681|617430916|FG000|Overall Study|Lost to Follow-up|3|||
170842224|NCT00863681|617430917|FG001|Overall Study|Lost to Follow-up|0|||
170842225|NCT00863681|617430918|FG002|Overall Study|Lost to Follow-up|3|||
170842226|NCT00863681|617430916|FG000|Overall Study|Adverse Event|28|||
170842227|NCT00863681|617430917|FG001|Overall Study|Adverse Event|10|||
170842228|NCT00863681|617430918|FG002|Overall Study|Adverse Event|6|||
170842229|NCT00863681|617430916|FG000|Overall Study|Lack of Efficacy|2|||
170842230|NCT00863681|617430917|FG001|Overall Study|Lack of Efficacy|2|||
170842231|NCT00863681|617430918|FG002|Overall Study|Lack of Efficacy|1|||
170842232|NCT00863681|617430916|FG000|Overall Study|Non-compliance with study drug|1|||
170842233|NCT00863681|617430917|FG001|Overall Study|Non-compliance with study drug|3|||
170842234|NCT00863681|617430918|FG002|Overall Study|Non-compliance with study drug|0|||
170842235|NCT02979249|617430920|FG000|Overall Study|Lost to Follow-up|2|||
170842236|NCT02979249|617430920|FG000|Overall Study|Withdrawal by Subject|4|||
170842237|NCT01685229|617430921|FG000|Overall Study|Subjects missing Study Exit form|3|||
170842238|NCT01685229|617430922|FG001|Overall Study|Subjects missing Study Exit form|1|||
170842239|NCT01685229|617430921|FG000|Overall Study|Lost to Follow-up|16|||
170842240|NCT01685229|617430922|FG001|Overall Study|Lost to Follow-up|10|||
170735669|NCT00404495|617037046|FG001|Overall Study|Withdrawal by Subject|0|||
170735670|NCT04108000|617037047|FG000|Overall Study|Death of patient|1|||
170735671|NCT04108000|617037048|FG001|Overall Study|Death of patient|0|||
170735672|NCT04108000|617037049|FG002|Overall Study|Death of patient|1|||
170735673|NCT04108000|617037050|FG003|Overall Study|Death of patient|0|||
170735674|NCT04108000|617037047|FG000|Overall Study|Withdrawal by Subject|2|||
170735675|NCT04108000|617037048|FG001|Overall Study|Withdrawal by Subject|2|||
170735676|NCT04108000|617037049|FG002|Overall Study|Withdrawal by Subject|0|||
170735677|NCT04108000|617037050|FG003|Overall Study|Withdrawal by Subject|0|||
170735678|NCT04108000|617037047|FG000|Overall Study|Death of surrogate partner|0|||
170735679|NCT04108000|617037048|FG001|Overall Study|Death of surrogate partner|1|||
170735680|NCT04108000|617037049|FG002|Overall Study|Death of surrogate partner|0|||
170735681|NCT04108000|617037050|FG003|Overall Study|Death of surrogate partner|1|||
170735682|NCT03188055|617037051|FG000|Overall Study|Unavailable for training|0|||
170735683|NCT03188055|617037052|FG001|Overall Study|Unavailable for training|0|||
170735684|NCT03188055|617037053|FG002|Overall Study|Unavailable for training|19|||
170735685|NCT03188055|617037054|FG003|Overall Study|Unavailable for training|0|||
170735686|NCT03188055|617037055|FG004|Overall Study|Unavailable for training|0|||
170735687|NCT03188055|617037056|FG005|Overall Study|Unavailable for training|0|||
170735688|NCT03188055|617037051|FG000|Overall Study|Lost to Follow-up|0|||
170735689|NCT03188055|617037052|FG001|Overall Study|Lost to Follow-up|18|||
170735690|NCT03188055|617037053|FG002|Overall Study|Lost to Follow-up|0|||
170735691|NCT03188055|617037054|FG003|Overall Study|Lost to Follow-up|11|||
170735692|NCT03188055|617037055|FG004|Overall Study|Lost to Follow-up|0|||
170735693|NCT03188055|617037056|FG005|Overall Study|Lost to Follow-up|0|||
170735694|NCT03188055|617037051|FG000|Overall Study|Withdrawal by Subject|0|||
170735695|NCT03188055|617037052|FG001|Overall Study|Withdrawal by Subject|1|||
170735696|NCT03188055|617037053|FG002|Overall Study|Withdrawal by Subject|0|||
170735697|NCT03188055|617037054|FG003|Overall Study|Withdrawal by Subject|1|||
170735698|NCT03188055|617037055|FG004|Overall Study|Withdrawal by Subject|0|||
170735699|NCT03188055|617037056|FG005|Overall Study|Withdrawal by Subject|0|||
170735700|NCT05002218|617037062|FG000|Overall Study|Lost to Follow-up|5|||
170735701|NCT05002218|617037063|FG001|Overall Study|Lost to Follow-up|6|||
170735702|NCT00215540|617038517|FG000|Overall Study|Withdrew from study medication|1|||
170735703|NCT00215540|617038518|FG001|Overall Study|Withdrew from study medication|0|||
170735704|NCT00215540|617038519|FG002|Overall Study|Withdrew from study medication|0|||
170735705|NCT00246337|617038522|FG000|Overall Study|Lost to Follow-up|3|||
170735706|NCT00246337|617038523|FG001|Overall Study|Lost to Follow-up|0|||
170735707|NCT00246337|617038524|FG002|Overall Study|Lost to Follow-up|0|||
170735708|NCT00246337|617038525|FG003|Overall Study|Lost to Follow-up|0|||
170735709|NCT00246337|617038526|FG004|Overall Study|Lost to Follow-up|2|||
170735710|NCT00246337|617038527|FG005|Overall Study|Lost to Follow-up|2|||
170735711|NCT00246337|617038528|FG006|Overall Study|Lost to Follow-up|1|||
170735712|NCT00246337|617038529|FG007|Overall Study|Lost to Follow-up|2|||
170735713|NCT00246337|617038530|FG008|Overall Study|Lost to Follow-up|0|||
170735714|NCT00246337|617038522|FG000|Overall Study|Protocol Violation|1|||
170735715|NCT00246337|617038523|FG001|Overall Study|Protocol Violation|0|||
170735716|NCT00246337|617038524|FG002|Overall Study|Protocol Violation|0|||
170735717|NCT00246337|617038525|FG003|Overall Study|Protocol Violation|0|||
170735718|NCT00246337|617038526|FG004|Overall Study|Protocol Violation|1|||
170735719|NCT00246337|617038527|FG005|Overall Study|Protocol Violation|0|||
170735720|NCT00246337|617038528|FG006|Overall Study|Protocol Violation|1|||
170735721|NCT00246337|617038529|FG007|Overall Study|Protocol Violation|1|||
170735722|NCT00246337|617038530|FG008|Overall Study|Protocol Violation|0|||
170735723|NCT00246337|617038522|FG000|Overall Study|Withdrawal by Subject|2|||
170735724|NCT00246337|617038523|FG001|Overall Study|Withdrawal by Subject|0|||
170735725|NCT00246337|617038524|FG002|Overall Study|Withdrawal by Subject|0|||
170735726|NCT00246337|617038525|FG003|Overall Study|Withdrawal by Subject|0|||
170735727|NCT00246337|617038526|FG004|Overall Study|Withdrawal by Subject|0|||
170735728|NCT00246337|617038527|FG005|Overall Study|Withdrawal by Subject|0|||
170735729|NCT00246337|617038528|FG006|Overall Study|Withdrawal by Subject|1|||
170735730|NCT00246337|617038529|FG007|Overall Study|Withdrawal by Subject|1|||
170735731|NCT00246337|617038530|FG008|Overall Study|Withdrawal by Subject|0|||
170735732|NCT00246337|617038522|FG000|Overall Study|Lack of Qualifying Event|8|||
170735733|NCT00246337|617038523|FG001|Overall Study|Lack of Qualifying Event|2|||
170735734|NCT00246337|617038524|FG002|Overall Study|Lack of Qualifying Event|1|||
170735735|NCT00246337|617038525|FG003|Overall Study|Lack of Qualifying Event|1|||
170735736|NCT00246337|617038526|FG004|Overall Study|Lack of Qualifying Event|1|||
170735737|NCT00246337|617038527|FG005|Overall Study|Lack of Qualifying Event|3|||
170735738|NCT00246337|617038528|FG006|Overall Study|Lack of Qualifying Event|3|||
170735739|NCT00246337|617038529|FG007|Overall Study|Lack of Qualifying Event|2|||
170842241|NCT01685229|617430921|FG000|Overall Study|Withdrawal by Subject|6|||
170842242|NCT01685229|617430922|FG001|Overall Study|Withdrawal by Subject|5|||
170735740|NCT00246337|617038530|FG008|Overall Study|Lack of Qualifying Event|5|||
170735741|NCT00246337|617038522|FG000|Overall Study|Site Terminated|10|||
170735742|NCT00246337|617038523|FG001|Overall Study|Site Terminated|0|||
170735743|NCT00246337|617038524|FG002|Overall Study|Site Terminated|0|||
170735744|NCT00246337|617038525|FG003|Overall Study|Site Terminated|0|||
170735745|NCT00246337|617038526|FG004|Overall Study|Site Terminated|0|||
170735746|NCT00246337|617038527|FG005|Overall Study|Site Terminated|7|||
170735747|NCT00246337|617038528|FG006|Overall Study|Site Terminated|1|||
170735748|NCT00246337|617038529|FG007|Overall Study|Site Terminated|6|||
170735749|NCT00246337|617038530|FG008|Overall Study|Site Terminated|2|||
170735750|NCT00246337|617038522|FG000|Overall Study|Abnormal baseline lab values|7|||
170735751|NCT00246337|617038523|FG001|Overall Study|Abnormal baseline lab values|0|||
170735752|NCT00246337|617038524|FG002|Overall Study|Abnormal baseline lab values|2|||
170735753|NCT00246337|617038525|FG003|Overall Study|Abnormal baseline lab values|0|||
170735754|NCT00246337|617038526|FG004|Overall Study|Abnormal baseline lab values|0|||
170735755|NCT00246337|617038527|FG005|Overall Study|Abnormal baseline lab values|2|||
170735756|NCT00246337|617038528|FG006|Overall Study|Abnormal baseline lab values|2|||
170735757|NCT00246337|617038529|FG007|Overall Study|Abnormal baseline lab values|0|||
170735758|NCT00246337|617038530|FG008|Overall Study|Abnormal baseline lab values|4|||
170735759|NCT00246337|617038522|FG000|Overall Study|Overwhelmed|0|||
170735760|NCT00246337|617038523|FG001|Overall Study|Overwhelmed|0|||
170735761|NCT00246337|617038524|FG002|Overall Study|Overwhelmed|0|||
170735762|NCT00246337|617038525|FG003|Overall Study|Overwhelmed|0|||
170735763|NCT00246337|617038526|FG004|Overall Study|Overwhelmed|0|||
170735764|NCT00246337|617038527|FG005|Overall Study|Overwhelmed|1|||
170735765|NCT00246337|617038528|FG006|Overall Study|Overwhelmed|0|||
170735766|NCT00246337|617038529|FG007|Overall Study|Overwhelmed|0|||
170735767|NCT00246337|617038530|FG008|Overall Study|Overwhelmed|0|||
170735768|NCT00246337|617038522|FG000|Overall Study|Protocol Violator|1|||
170735769|NCT00246337|617038523|FG001|Overall Study|Protocol Violator|0|||
170735770|NCT00246337|617038524|FG002|Overall Study|Protocol Violator|0|||
170735771|NCT00246337|617038525|FG003|Overall Study|Protocol Violator|0|||
170735772|NCT00246337|617038526|FG004|Overall Study|Protocol Violator|0|||
170735773|NCT00246337|617038527|FG005|Overall Study|Protocol Violator|0|||
170735774|NCT00246337|617038528|FG006|Overall Study|Protocol Violator|0|||
170735775|NCT00246337|617038529|FG007|Overall Study|Protocol Violator|0|||
170735776|NCT00246337|617038530|FG008|Overall Study|Protocol Violator|0|||
170735777|NCT00246337|617038522|FG000|Overall Study|Reported as completing trial in error|0|||
170735778|NCT00246337|617038523|FG001|Overall Study|Reported as completing trial in error|0|||
170735779|NCT00246337|617038524|FG002|Overall Study|Reported as completing trial in error|0|||
170735780|NCT00246337|617038525|FG003|Overall Study|Reported as completing trial in error|0|||
170735781|NCT00246337|617038526|FG004|Overall Study|Reported as completing trial in error|0|||
170735782|NCT00246337|617038527|FG005|Overall Study|Reported as completing trial in error|0|||
170735783|NCT00246337|617038528|FG006|Overall Study|Reported as completing trial in error|0|||
170735784|NCT00246337|617038529|FG007|Overall Study|Reported as completing trial in error|1|||
170735785|NCT00246337|617038530|FG008|Overall Study|Reported as completing trial in error|0|||
170735786|NCT00674570|617038531|FG000|Overall Study|Withdrawal by Subject|0|||
170735787|NCT00674570|617038532|FG001|Overall Study|Withdrawal by Subject|2|||
170735788|NCT00674570|617038533|FG002|Overall Study|Withdrawal by Subject|0|||
170735789|NCT01337986|617038534|FG000|Overall Study|Adverse Event|2|||
170735790|NCT01337986|617038535|FG001|Overall Study|Adverse Event|2|||
170735791|NCT01337986|617038534|FG000|Overall Study|Lost to Follow-up|1|||
170735792|NCT01337986|617038535|FG001|Overall Study|Lost to Follow-up|0|||
170735793|NCT01337986|617038534|FG000|Overall Study|Protocol Violation|0|||
170735794|NCT01337986|617038535|FG001|Overall Study|Protocol Violation|3|||
170735795|NCT00185640|617038538|FG000|Overall Study|Not Eligible|4|||
170735796|NCT00185640|617038538|FG000|Overall Study|Withdrawal by Subject|3|||
170735797|NCT00185640|617038538|FG000|Overall Study|Death|138|||
170735798|NCT00058422|617038539|FG000|Overall Study|Not treated|2|||
170735799|NCT04026165|617038541|FG000|Run-in Placebo Period|Enrollment Error|13|||
170842243|NCT01685229|617430921|FG000|Overall Study|Death|1|||
170842244|NCT01685229|617430922|FG001|Overall Study|Death|0|||
170842245|NCT03596762|617430928|FG000|Overall Study|Protocol Violation|0|||
170842246|NCT03596762|617430929|FG001|Overall Study|Protocol Violation|0|||
170842247|NCT03596762|617430930|FG002|Overall Study|Protocol Violation|0|||
170735800|NCT04026165|617038542|FG001|Run-in Placebo Period|Enrollment Error|0|||
170735801|NCT04026165|617038543|FG002|Run-in Placebo Period|Enrollment Error|0|||
170735802|NCT04026165|617038544|FG003|Run-in Placebo Period|Enrollment Error|0|||
170735803|NCT04026165|617038541|FG000|Run-in Placebo Period|Run-in Failure|4|||
170735804|NCT04026165|617038542|FG001|Run-in Placebo Period|Run-in Failure|0|||
170735805|NCT04026165|617038543|FG002|Run-in Placebo Period|Run-in Failure|0|||
170735806|NCT04026165|617038544|FG003|Run-in Placebo Period|Run-in Failure|0|||
170735807|NCT04026165|617038541|FG000|Run-in Placebo Period|Protocol Violation|2|||
170735808|NCT04026165|617038542|FG001|Run-in Placebo Period|Protocol Violation|0|||
170842248|NCT03596762|617430931|FG003|Overall Study|Protocol Violation|0|||
170842249|NCT03596762|617430932|FG004|Overall Study|Protocol Violation|1|||
170842250|NCT03596762|617430928|FG000|Overall Study|Adverse Event|2|||
170842251|NCT03596762|617430929|FG001|Overall Study|Adverse Event|0|||
170842252|NCT03596762|617430930|FG002|Overall Study|Adverse Event|1|||
170842253|NCT03596762|617430931|FG003|Overall Study|Adverse Event|0|||
170842254|NCT03596762|617430932|FG004|Overall Study|Adverse Event|5|||
170842255|NCT03596762|617430928|FG000|Overall Study|Withdrawal by Subject|2|||
170842256|NCT03596762|617430929|FG001|Overall Study|Withdrawal by Subject|1|||
170842257|NCT03596762|617430930|FG002|Overall Study|Withdrawal by Subject|0|||
170842258|NCT03596762|617430931|FG003|Overall Study|Withdrawal by Subject|1|||
170842259|NCT03596762|617430932|FG004|Overall Study|Withdrawal by Subject|1|||
170842260|NCT03080493|617430933|FG000|Overall Study|Did not provide NRS pain results|1|||
170842261|NCT03080493|617430934|FG001|Overall Study|Did not provide NRS pain results|0|||
170842262|NCT03080493|617430933|FG000|Overall Study|Adverse Event|0|||
170842263|NCT03080493|617430934|FG001|Overall Study|Adverse Event|1|||
170842264|NCT03080493|617430933|FG000|Overall Study|Randomization error (parity group)|0|||
170842265|NCT03080493|617430934|FG001|Overall Study|Randomization error (parity group)|1|||
170842266|NCT01834586|617430939|FG000|Overall Study|Adverse Event|1|||
170842267|NCT02593123|617430940|FG000|Overall Study|Physician Decision|2|||
170842268|NCT02593123|617430941|FG001|Overall Study|Physician Decision|1|||
170842269|NCT02593123|617430940|FG000|Overall Study|Relapse|1|||
170842270|NCT02593123|617430941|FG001|Overall Study|Relapse|1|||
170842271|NCT03355209|617430942|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
170842272|NCT03355209|617430943|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
170842273|NCT03355209|617430944|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
170842274|NCT03355209|617430945|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
170842275|NCT03355209|617430946|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
170842276|NCT03355209|617430947|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
170842277|NCT03355209|617430942|FG000|Part 1: Double-Blind Period|Death|0|||
170842278|NCT03355209|617430943|FG001|Part 1: Double-Blind Period|Death|0|||
170842279|NCT03355209|617430944|FG002|Part 1: Double-Blind Period|Death|1|||
170842280|NCT03355209|617430945|FG003|Part 1: Double-Blind Period|Death|0|||
170842281|NCT03355209|617430946|FG004|Part 1: Double-Blind Period|Death|0|||
170842282|NCT03355209|617430947|FG005|Part 1: Double-Blind Period|Death|0|||
170842283|NCT03355209|617430942|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
170842284|NCT03355209|617430943|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
170842285|NCT03355209|617430944|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
170842286|NCT03355209|617430945|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
170842287|NCT03355209|617430946|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
170842288|NCT03355209|617430947|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
170842289|NCT03355209|617430942|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
170842290|NCT03355209|617430943|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
170842291|NCT03355209|617430944|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
170842292|NCT03355209|617430945|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
170842293|NCT03355209|617430946|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
170842294|NCT03355209|617430947|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
170842295|NCT03355209|617430942|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
170842296|NCT03355209|617430943|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
170842297|NCT03355209|617430944|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
170842298|NCT03355209|617430945|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
170842299|NCT03355209|617430946|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
170842300|NCT03355209|617430947|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
170842301|NCT03355209|617430942|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
170842302|NCT03355209|617430943|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
170842303|NCT03355209|617430944|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
170842304|NCT03355209|617430945|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
170842305|NCT03355209|617430946|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
170842306|NCT03355209|617430947|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
170842307|NCT03355209|617430942|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
170842308|NCT03355209|617430943|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
170842309|NCT03355209|617430944|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
170842310|NCT03355209|617430945|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
170842311|NCT03355209|617430946|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
170842312|NCT03355209|617430947|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
170842313|NCT03355209|617430942|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
170842314|NCT03355209|617430943|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
170842315|NCT03355209|617430944|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
170842316|NCT03355209|617430945|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
170842317|NCT03355209|617430946|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
170735809|NCT04026165|617038543|FG002|Run-in Placebo Period|Protocol Violation|0|||
170735810|NCT04026165|617038544|FG003|Run-in Placebo Period|Protocol Violation|0|||
170735811|NCT04026165|617038541|FG000|Run-in Placebo Period|Withdrew Consent|2|||
170735812|NCT04026165|617038542|FG001|Run-in Placebo Period|Withdrew Consent|0|||
170735813|NCT04026165|617038543|FG002|Run-in Placebo Period|Withdrew Consent|0|||
170735814|NCT04026165|617038544|FG003|Run-in Placebo Period|Withdrew Consent|0|||
170735815|NCT04026165|617038541|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
170735816|NCT04026165|617038542|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
170735817|NCT04026165|617038543|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
170735818|NCT04026165|617038544|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
170735819|NCT04026165|617038541|FG000|Run-in SEL Period|Run-in Failure|0|||
170735820|NCT04026165|617038542|FG001|Run-in SEL Period|Run-in Failure|26|||
170735821|NCT04026165|617038543|FG002|Run-in SEL Period|Run-in Failure|0|||
170735822|NCT04026165|617038544|FG003|Run-in SEL Period|Run-in Failure|0|||
170735823|NCT04026165|617038541|FG000|Run-in SEL Period|Withdrew Consent|0|||
170735824|NCT04026165|617038542|FG001|Run-in SEL Period|Withdrew Consent|10|||
170735825|NCT04026165|617038543|FG002|Run-in SEL Period|Withdrew Consent|0|||
170735826|NCT04026165|617038544|FG003|Run-in SEL Period|Withdrew Consent|0|||
170735827|NCT04026165|617038541|FG000|Run-in SEL Period|Enrollment Error|0|||
170735828|NCT04026165|617038542|FG001|Run-in SEL Period|Enrollment Error|4|||
170735829|NCT04026165|617038543|FG002|Run-in SEL Period|Enrollment Error|0|||
170735830|NCT04026165|617038544|FG003|Run-in SEL Period|Enrollment Error|0|||
170735831|NCT04026165|617038541|FG000|Run-in SEL Period|Protocol Violation|0|||
170735832|NCT04026165|617038542|FG001|Run-in SEL Period|Protocol Violation|3|||
170735833|NCT04026165|617038543|FG002|Run-in SEL Period|Protocol Violation|0|||
170735834|NCT04026165|617038544|FG003|Run-in SEL Period|Protocol Violation|0|||
170735835|NCT04026165|617038541|FG000|Run-in SEL Period|Investigator's Discretion|0|||
170735836|NCT04026165|617038542|FG001|Run-in SEL Period|Investigator's Discretion|2|||
170735837|NCT04026165|617038543|FG002|Run-in SEL Period|Investigator's Discretion|0|||
170735838|NCT04026165|617038544|FG003|Run-in SEL Period|Investigator's Discretion|0|||
170735839|NCT04026165|617038541|FG000|Run-in SEL Period|Death|0|||
170735840|NCT04026165|617038542|FG001|Run-in SEL Period|Death|1|||
170735841|NCT04026165|617038543|FG002|Run-in SEL Period|Death|0|||
170735842|NCT04026165|617038544|FG003|Run-in SEL Period|Death|0|||
170735843|NCT04026165|617038541|FG000|Randomized Period|Withdrew Consent|0|||
170735844|NCT04026165|617038542|FG001|Randomized Period|Withdrew Consent|0|||
170735845|NCT04026165|617038543|FG002|Randomized Period|Withdrew Consent|5|||
170735846|NCT04026165|617038544|FG003|Randomized Period|Withdrew Consent|8|||
170735847|NCT04026165|617038541|FG000|Randomized Period|Death|0|||
170735848|NCT04026165|617038542|FG001|Randomized Period|Death|0|||
170735849|NCT04026165|617038543|FG002|Randomized Period|Death|5|||
170735850|NCT04026165|617038544|FG003|Randomized Period|Death|7|||
170735851|NCT04026165|617038541|FG000|Randomized Period|Investigator's Discretion|0|||
170735852|NCT04026165|617038542|FG001|Randomized Period|Investigator's Discretion|0|||
170735853|NCT04026165|617038543|FG002|Randomized Period|Investigator's Discretion|2|||
170735854|NCT04026165|617038544|FG003|Randomized Period|Investigator's Discretion|2|||
170735855|NCT04026165|617038541|FG000|Randomized Period|Lost to Follow-up|0|||
170735856|NCT04026165|617038542|FG001|Randomized Period|Lost to Follow-up|0|||
170735857|NCT04026165|617038543|FG002|Randomized Period|Lost to Follow-up|2|||
170735858|NCT04026165|617038544|FG003|Randomized Period|Lost to Follow-up|2|||
170735859|NCT01059630|617038545|FG000|Overall Study|Death|100|||
170735860|NCT01059630|617038546|FG001|Overall Study|Death|84|||
170735861|NCT01059630|617038545|FG000|Overall Study|Lost to Follow-up|4|||
170735862|NCT01059630|617038546|FG001|Overall Study|Lost to Follow-up|1|||
170735863|NCT01059630|617038545|FG000|Overall Study|Physician Decision|2|||
170735864|NCT01059630|617038546|FG001|Overall Study|Physician Decision|4|||
170735865|NCT01059630|617038545|FG000|Overall Study|Withdrawal by Subject|21|||
170735866|NCT01059630|617038546|FG001|Overall Study|Withdrawal by Subject|14|||
170735867|NCT02569437|617038547|FG000|Overall Study|Lost to Follow-up|12|||
170735868|NCT02569437|617038548|FG001|Overall Study|Lost to Follow-up|14|||
170735869|NCT00077064|617038549|FG000|Overall Study|Adverse Event|0|||
170735870|NCT00077064|617038550|FG001|Overall Study|Adverse Event|4|||
170735871|NCT00077064|617038549|FG000|Overall Study|Patient refusal|0|||
170735872|NCT00077064|617038550|FG001|Overall Study|Patient refusal|2|||
170735873|NCT02007434|617038552|FG000|Overall Study|Lost to Follow-up|0|||
170735874|NCT02007434|617038553|FG001|Overall Study|Lost to Follow-up|1|||
170735875|NCT02007434|617038554|FG002|Overall Study|Lost to Follow-up|0|||
170735876|NCT02007434|617038555|FG003|Overall Study|Lost to Follow-up|0|||
170735877|NCT02007434|617038556|FG004|Overall Study|Lost to Follow-up|0|||
170735878|NCT02007434|617038557|FG005|Overall Study|Lost to Follow-up|0|||
170842318|NCT03355209|617430947|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
170735879|NCT02007434|617038558|FG006|Overall Study|Lost to Follow-up|0|||
170735880|NCT02007434|617038559|FG007|Overall Study|Lost to Follow-up|0|||
170735881|NCT02007434|617038552|FG000|Overall Study|Non-compliance|1|||
170735882|NCT02007434|617038553|FG001|Overall Study|Non-compliance|0|||
170735883|NCT02007434|617038554|FG002|Overall Study|Non-compliance|1|||
170735884|NCT02007434|617038555|FG003|Overall Study|Non-compliance|0|||
170735885|NCT02007434|617038556|FG004|Overall Study|Non-compliance|0|||
170735886|NCT02007434|617038557|FG005|Overall Study|Non-compliance|0|||
170735887|NCT02007434|617038558|FG006|Overall Study|Non-compliance|0|||
170735888|NCT02007434|617038559|FG007|Overall Study|Non-compliance|0|||
170735889|NCT00927355|617038562|FG000|Overall Study|Adverse Event|1|||
170735890|NCT00927355|617038563|FG001|Overall Study|Adverse Event|1|||
170735891|NCT03299686|617038564|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
170735892|NCT03299686|617038565|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
170735893|NCT03299686|617038564|FG000|Treatment Epoch|Physician Decision|1|||
170735894|NCT03299686|617038565|FG001|Treatment Epoch|Physician Decision|0|||
170735895|NCT03299686|617038564|FG000|Treatment Epoch|Adverse Event|8|||
170735896|NCT03299686|617038565|FG001|Treatment Epoch|Adverse Event|4|||
170735897|NCT03299686|617038564|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
170735898|NCT03299686|617038565|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
170735899|NCT01572389|617038567|FG000|Overall Study|Death|1|||
170735900|NCT01572389|617038568|FG001|Overall Study|Death|3|||
170735901|NCT01572389|617038567|FG000|Overall Study|Withdrawal by Subject|14|||
170735902|NCT01572389|617038568|FG001|Overall Study|Withdrawal by Subject|2|||
170735903|NCT01572389|617038567|FG000|Overall Study|Lost to Follow-up|25|||
170735904|NCT01572389|617038568|FG001|Overall Study|Lost to Follow-up|14|||
170735905|NCT01572389|617038567|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
170735906|NCT01572389|617038568|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
170735907|NCT01959347|617038579|FG000|Overall Study|Protocol Violation|9|||
170735908|NCT01959347|617038580|FG001|Overall Study|Protocol Violation|7|||
170735909|NCT01282801|617038581|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
170735910|NCT01282801|617038582|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
170735911|NCT01281202|617038583|FG000|Overall Study|Adverse Event|2|||
170735912|NCT01281202|617038584|FG001|Overall Study|Adverse Event|0|||
170735913|NCT01281202|617038583|FG000|Overall Study|Withdrawal by Subject|2|||
170735914|NCT01281202|617038584|FG001|Overall Study|Withdrawal by Subject|2|||
170735915|NCT01281202|617038583|FG000|Overall Study|Protocol Violation|11|||
170735916|NCT01281202|617038584|FG001|Overall Study|Protocol Violation|10|||
170735917|NCT01281202|617038583|FG000|Overall Study|Administrative|2|||
170735918|NCT01281202|617038584|FG001|Overall Study|Administrative|8|||
170735919|NCT01281202|617038583|FG000|Overall Study|Lost to Follow-up|11|||
170735920|NCT01281202|617038584|FG001|Overall Study|Lost to Follow-up|13|||
170735921|NCT01281202|617038583|FG000|Overall Study|Incarceration|0|||
170735922|NCT01281202|617038584|FG001|Overall Study|Incarceration|3|||
170735923|NCT02889133|617038590|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
170735924|NCT02889133|617038591|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
170735925|NCT02889133|617038590|FG000|Completed Primary Outcome|Manufacturing error|3|||
170735926|NCT02889133|617038591|FG001|Completed Primary Outcome|Manufacturing error|8|||
170735927|NCT02889133|617038590|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
170735928|NCT02889133|617038591|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
170735929|NCT02889133|617038590|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
170735930|NCT02889133|617038591|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
170735931|NCT02889133|617038590|FG000|Completed Primary Outcome|Protocol Violation|1|||
170735932|NCT02889133|617038591|FG001|Completed Primary Outcome|Protocol Violation|0|||
170735933|NCT02889133|617038590|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
170735934|NCT02889133|617038591|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
170735935|NCT02889133|617038590|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
170735936|NCT02889133|617038591|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
170735937|NCT02889133|617038590|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
170735938|NCT02889133|617038591|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
170735939|NCT02889133|617038590|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
170735940|NCT02889133|617038591|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
170735941|NCT02889133|617038590|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
170735942|NCT02889133|617038591|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
170735943|NCT01060553|617038592|FG000|Overall Study|Lost to Follow-up|3|||
170735944|NCT01060553|617038593|FG001|Overall Study|Lost to Follow-up|5|||
170735945|NCT01060553|617038592|FG000|Overall Study|Withdrawal by Subject|5|||
170735946|NCT01060553|617038593|FG001|Overall Study|Withdrawal by Subject|5|||
170735947|NCT01060553|617038592|FG000|Overall Study|Lack of Efficacy|1|||
170735948|NCT01060553|617038593|FG001|Overall Study|Lack of Efficacy|0|||
170735949|NCT00701038|617038597|FG000|Overall Study|study amended pilot group of patients|4|||
170735950|NCT00701038|617038598|FG001|Overall Study|study amended pilot group of patients|4|||
170735951|NCT03371940|617038599|FG000|Overall Study|Withdrawal by Subject|8|||
170735952|NCT03371940|617038600|FG001|Overall Study|Withdrawal by Subject|1|||
170842319|NCT03355209|617430942|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
170842320|NCT03355209|617430943|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
170842321|NCT03355209|617430944|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
170842322|NCT03355209|617430945|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170842323|NCT03355209|617430946|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
170842324|NCT03355209|617430947|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170842325|NCT03355209|617430942|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
170842326|NCT03355209|617430943|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
170842327|NCT03355209|617430944|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
170842328|NCT03355209|617430945|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
170842329|NCT03355209|617430946|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
170842330|NCT03355209|617430947|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
170842331|NCT03355209|617430942|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
170842332|NCT03355209|617430943|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
170842333|NCT03355209|617430944|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
170842334|NCT03355209|617430945|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
170842335|NCT03355209|617430946|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
170842336|NCT03355209|617430947|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
170842337|NCT01371825|617430949|FG000|Overall Study|Death|4|||
170842338|NCT01602510|617430950|FG000|Open Label Phase|Adverse Event|46|||
170842339|NCT01602510|617430951|FG001|Open Label Phase|Adverse Event|0|||
170842340|NCT01602510|617430952|FG002|Open Label Phase|Adverse Event|0|||
170842341|NCT01602510|617430950|FG000|Open Label Phase|Lack of Efficacy|22|||
170842342|NCT01602510|617430951|FG001|Open Label Phase|Lack of Efficacy|0|||
170842343|NCT01602510|617430952|FG002|Open Label Phase|Lack of Efficacy|0|||
170842344|NCT01602510|617430950|FG000|Open Label Phase|Protocol Violation|15|||
170842345|NCT01602510|617430951|FG001|Open Label Phase|Protocol Violation|0|||
170842346|NCT01602510|617430952|FG002|Open Label Phase|Protocol Violation|0|||
170842347|NCT01602510|617430950|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
170842348|NCT01602510|617430951|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
170842349|NCT01602510|617430952|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
170842350|NCT01602510|617430950|FG000|Open Label Phase|Lost to Follow-up|22|||
170842351|NCT01602510|617430951|FG001|Open Label Phase|Lost to Follow-up|0|||
170842352|NCT01602510|617430952|FG002|Open Label Phase|Lost to Follow-up|0|||
170842353|NCT01602510|617430950|FG000|Open Label Phase|Physician Decision|19|||
170842354|NCT01602510|617430951|FG001|Open Label Phase|Physician Decision|0|||
170842355|NCT01602510|617430952|FG002|Open Label Phase|Physician Decision|0|||
170842356|NCT01602510|617430950|FG000|Open Label Phase|Withdrawal by Subject|57|||
170842357|NCT01602510|617430951|FG001|Open Label Phase|Withdrawal by Subject|0|||
170842358|NCT01602510|617430952|FG002|Open Label Phase|Withdrawal by Subject|0|||
170842359|NCT01602510|617430950|FG000|Randomized Phase|Adverse Event|0|||
170842360|NCT01602510|617430951|FG001|Randomized Phase|Adverse Event|2|||
170842361|NCT01602510|617430952|FG002|Randomized Phase|Adverse Event|6|||
170842362|NCT01602510|617430950|FG000|Randomized Phase|Lack of Efficacy|0|||
170842363|NCT01602510|617430951|FG001|Randomized Phase|Lack of Efficacy|4|||
170842364|NCT01602510|617430952|FG002|Randomized Phase|Lack of Efficacy|4|||
170842365|NCT01602510|617430950|FG000|Randomized Phase|Protocol Violation|0|||
170842366|NCT01602510|617430951|FG001|Randomized Phase|Protocol Violation|3|||
170842367|NCT01602510|617430952|FG002|Randomized Phase|Protocol Violation|3|||
170842368|NCT01602510|617430950|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
170842369|NCT01602510|617430951|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
170842370|NCT01602510|617430952|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
170842371|NCT01602510|617430950|FG000|Randomized Phase|Lost to Follow-up|0|||
170842372|NCT01602510|617430951|FG001|Randomized Phase|Lost to Follow-up|1|||
170842373|NCT01602510|617430952|FG002|Randomized Phase|Lost to Follow-up|3|||
170842374|NCT01602510|617430950|FG000|Randomized Phase|Physician Decision|0|||
170842375|NCT01602510|617430951|FG001|Randomized Phase|Physician Decision|0|||
170842376|NCT01602510|617430952|FG002|Randomized Phase|Physician Decision|2|||
170842377|NCT01602510|617430950|FG000|Randomized Phase|Withdrawal by Subject|0|||
170842378|NCT01602510|617430951|FG001|Randomized Phase|Withdrawal by Subject|6|||
170842379|NCT01602510|617430952|FG002|Randomized Phase|Withdrawal by Subject|7|||
170842380|NCT00895895|617430953|FG000|Period 1|Adverse Event|7|||
170842381|NCT00895895|617430954|FG001|Period 1|Adverse Event|6|||
170842382|NCT00895895|617430955|FG002|Period 1|Adverse Event|4|||
170842383|NCT00895895|617430956|FG003|Period 1|Adverse Event|6|||
170842384|NCT00895895|617430957|FG004|Period 1|Adverse Event|7|||
170842385|NCT00895895|617430953|FG000|Period 1|Death|0|||
170842386|NCT00895895|617430954|FG001|Period 1|Death|0|||
170842387|NCT00895895|617430955|FG002|Period 1|Death|0|||
170842388|NCT00895895|617430956|FG003|Period 1|Death|0|||
170842389|NCT00895895|617430957|FG004|Period 1|Death|1|||
170842390|NCT00895895|617430953|FG000|Period 1|discontinued by sponsor|2|||
170842391|NCT00895895|617430954|FG001|Period 1|discontinued by sponsor|1|||
170842392|NCT00895895|617430955|FG002|Period 1|discontinued by sponsor|2|||
170842393|NCT00895895|617430956|FG003|Period 1|discontinued by sponsor|1|||
170842394|NCT00895895|617430957|FG004|Period 1|discontinued by sponsor|1|||
170842395|NCT00895895|617430953|FG000|Period 1|failed to return|0|||
170842396|NCT00895895|617430954|FG001|Period 1|failed to return|0|||
170842397|NCT00895895|617430955|FG002|Period 1|failed to return|1|||
170842398|NCT00895895|617430956|FG003|Period 1|failed to return|0|||
170842399|NCT00895895|617430957|FG004|Period 1|failed to return|1|||
170842400|NCT00895895|617430953|FG000|Period 1|investigator request|0|||
170842401|NCT00895895|617430954|FG001|Period 1|investigator request|1|||
170842402|NCT00895895|617430955|FG002|Period 1|investigator request|0|||
170842403|NCT00895895|617430956|FG003|Period 1|investigator request|0|||
170842404|NCT00895895|617430957|FG004|Period 1|investigator request|0|||
170842405|NCT00895895|617430953|FG000|Period 1|Lost to Follow-up|2|||
170842406|NCT00895895|617430954|FG001|Period 1|Lost to Follow-up|1|||
170842407|NCT00895895|617430955|FG002|Period 1|Lost to Follow-up|3|||
170842408|NCT00895895|617430956|FG003|Period 1|Lost to Follow-up|2|||
170842409|NCT00895895|617430957|FG004|Period 1|Lost to Follow-up|3|||
170842410|NCT00895895|617430953|FG000|Period 1|Other|1|||
170842411|NCT00895895|617430954|FG001|Period 1|Other|2|||
170842412|NCT00895895|617430955|FG002|Period 1|Other|1|||
170842413|NCT00895895|617430956|FG003|Period 1|Other|1|||
170842414|NCT00895895|617430957|FG004|Period 1|Other|1|||
170842415|NCT00895895|617430953|FG000|Period 1|Protocol Violation|0|||
170842416|NCT00895895|617430954|FG001|Period 1|Protocol Violation|1|||
170842417|NCT00895895|617430955|FG002|Period 1|Protocol Violation|0|||
170842418|NCT00895895|617430956|FG003|Period 1|Protocol Violation|0|||
170842419|NCT00895895|617430957|FG004|Period 1|Protocol Violation|0|||
170842420|NCT00895895|617430953|FG000|Period 1|Withdrawal by Subject|6|||
170842421|NCT00895895|617430954|FG001|Period 1|Withdrawal by Subject|6|||
170842422|NCT00895895|617430955|FG002|Period 1|Withdrawal by Subject|8|||
170842423|NCT00895895|617430956|FG003|Period 1|Withdrawal by Subject|2|||
170842424|NCT00895895|617430957|FG004|Period 1|Withdrawal by Subject|4|||
170842425|NCT00895895|617430953|FG000|Period 1|unsatisfactory response-efficacy|2|||
170842426|NCT00895895|617430954|FG001|Period 1|unsatisfactory response-efficacy|0|||
170842427|NCT00895895|617430955|FG002|Period 1|unsatisfactory response-efficacy|0|||
170842428|NCT00895895|617430956|FG003|Period 1|unsatisfactory response-efficacy|0|||
170842429|NCT00895895|617430957|FG004|Period 1|unsatisfactory response-efficacy|0|||
170842430|NCT00895895|617430953|FG000|Period 1|randomized and not treated|1|||
170842431|NCT00895895|617430954|FG001|Period 1|randomized and not treated|3|||
170842432|NCT00895895|617430955|FG002|Period 1|randomized and not treated|1|||
170842433|NCT00895895|617430956|FG003|Period 1|randomized and not treated|1|||
170842434|NCT00895895|617430957|FG004|Period 1|randomized and not treated|2|||
170842435|NCT00895895|617430953|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
170842436|NCT00895895|617430954|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
170842437|NCT00895895|617430955|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
170842438|NCT00895895|617430956|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
170842439|NCT00895895|617430957|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
170842440|NCT00895895|617430953|FG000|After Period 1, Prior to Period 2|Other|0|||
170842441|NCT00895895|617430954|FG001|After Period 1, Prior to Period 2|Other|0|||
170842442|NCT00895895|617430955|FG002|After Period 1, Prior to Period 2|Other|1|||
170842443|NCT00895895|617430956|FG003|After Period 1, Prior to Period 2|Other|0|||
170842444|NCT00895895|617430957|FG004|After Period 1, Prior to Period 2|Other|0|||
170842445|NCT00895895|617430953|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
170842446|NCT00895895|617430954|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
170842447|NCT00895895|617430955|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
170842448|NCT00895895|617430956|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
170842449|NCT00895895|617430957|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
170842450|NCT00895895|617430953|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
170842451|NCT00895895|617430954|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
170842452|NCT00895895|617430955|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
170842453|NCT00895895|617430956|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
170842454|NCT00895895|617430957|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
170842455|NCT00895895|617430953|FG000|Period 2|Adverse Event|3|||
170842456|NCT00895895|617430954|FG001|Period 2|Adverse Event|3|||
170842457|NCT00895895|617430955|FG002|Period 2|Adverse Event|5|||
170842458|NCT00895895|617430956|FG003|Period 2|Adverse Event|2|||
170842459|NCT00895895|617430957|FG004|Period 2|Adverse Event|5|||
170842460|NCT00895895|617430953|FG000|Period 2|Death|0|||
170842461|NCT00895895|617430954|FG001|Period 2|Death|0|||
170842462|NCT00895895|617430955|FG002|Period 2|Death|1|||
170842463|NCT00895895|617430956|FG003|Period 2|Death|0|||
170842464|NCT00895895|617430957|FG004|Period 2|Death|0|||
170842465|NCT00895895|617430953|FG000|Period 2|discontinued by sponsor|44|||
170842466|NCT00895895|617430954|FG001|Period 2|discontinued by sponsor|44|||
170842467|NCT00895895|617430955|FG002|Period 2|discontinued by sponsor|38|||
170842468|NCT00895895|617430956|FG003|Period 2|discontinued by sponsor|46|||
170842469|NCT00895895|617430957|FG004|Period 2|discontinued by sponsor|37|||
170842470|NCT00895895|617430953|FG000|Period 2|failed to return|2|||
170842471|NCT00895895|617430954|FG001|Period 2|failed to return|0|||
170842472|NCT00895895|617430955|FG002|Period 2|failed to return|0|||
170842473|NCT00895895|617430956|FG003|Period 2|failed to return|0|||
170842474|NCT00895895|617430957|FG004|Period 2|failed to return|0|||
170842475|NCT00895895|617430953|FG000|Period 2|investigator request|2|||
170842476|NCT00895895|617430954|FG001|Period 2|investigator request|0|||
170842477|NCT00895895|617430955|FG002|Period 2|investigator request|0|||
170842478|NCT00895895|617430956|FG003|Period 2|investigator request|0|||
170842479|NCT00895895|617430957|FG004|Period 2|investigator request|0|||
170842480|NCT00895895|617430953|FG000|Period 2|Lost to Follow-up|1|||
170842481|NCT00895895|617430954|FG001|Period 2|Lost to Follow-up|2|||
170842482|NCT00895895|617430955|FG002|Period 2|Lost to Follow-up|1|||
170842483|NCT00895895|617430956|FG003|Period 2|Lost to Follow-up|1|||
170842484|NCT00895895|617430957|FG004|Period 2|Lost to Follow-up|0|||
170842485|NCT00895895|617430953|FG000|Period 2|Other|1|||
170842486|NCT00895895|617430954|FG001|Period 2|Other|1|||
170842487|NCT00895895|617430955|FG002|Period 2|Other|3|||
170842488|NCT00895895|617430956|FG003|Period 2|Other|1|||
170842489|NCT00895895|617430957|FG004|Period 2|Other|1|||
170842490|NCT00895895|617430953|FG000|Period 2|Protocol Violation|1|||
170842491|NCT00895895|617430954|FG001|Period 2|Protocol Violation|0|||
170842492|NCT00895895|617430955|FG002|Period 2|Protocol Violation|1|||
170842493|NCT00895895|617430956|FG003|Period 2|Protocol Violation|1|||
170842494|NCT00895895|617430957|FG004|Period 2|Protocol Violation|1|||
170842495|NCT00895895|617430953|FG000|Period 2|Withdrawal by Subject|0|||
170842496|NCT00895895|617430954|FG001|Period 2|Withdrawal by Subject|2|||
170842497|NCT00895895|617430955|FG002|Period 2|Withdrawal by Subject|0|||
170842498|NCT00895895|617430956|FG003|Period 2|Withdrawal by Subject|3|||
170842499|NCT00895895|617430957|FG004|Period 2|Withdrawal by Subject|5|||
170842500|NCT00895895|617430953|FG000|Period 2|unsatisfactory response-efficacy|2|||
170842501|NCT00895895|617430954|FG001|Period 2|unsatisfactory response-efficacy|1|||
170842502|NCT00895895|617430955|FG002|Period 2|unsatisfactory response-efficacy|0|||
170842503|NCT00895895|617430956|FG003|Period 2|unsatisfactory response-efficacy|0|||
170842504|NCT00895895|617430957|FG004|Period 2|unsatisfactory response-efficacy|0|||
170842505|NCT01261000|617430958|FG000|Overall Study|Screen failure|1|||
170842506|NCT03019640|617430959|FG000|Overall Study|Screen Failures|4|||
170842507|NCT03019640|617430959|FG000|Overall Study|Adverse Event|3|||
170842508|NCT03019640|617430959|FG000|Overall Study|Participant Relapsed|1|||
170842509|NCT01195623|617430960|FG000|Overall Study|Lost to Follow-up|35|||
170842510|NCT01195623|617430961|FG001|Overall Study|Lost to Follow-up|37|||
170842511|NCT00534495|617430962|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
170842512|NCT00534495|617430963|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
170842513|NCT00534495|617430964|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
170842514|NCT00534495|617430962|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
170842515|NCT00534495|617430963|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
170842516|NCT00534495|617430964|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
170842517|NCT00534495|617430962|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
170842518|NCT00534495|617430963|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
170842519|NCT00534495|617430964|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
170842520|NCT00534495|617430962|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
170842521|NCT00534495|617430963|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
170842522|NCT00534495|617430964|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
170842523|NCT00534495|617430962|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
170842524|NCT00534495|617430963|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
170842525|NCT00534495|617430964|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
170842526|NCT00534495|617430962|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
170842527|NCT00534495|617430963|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
170842528|NCT00534495|617430964|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
170842529|NCT00534495|617430962|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
170842530|NCT00534495|617430963|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
170842531|NCT00534495|617430964|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
170842532|NCT00534495|617430962|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
170842533|NCT00534495|617430963|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
170842534|NCT00534495|617430964|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
170842535|NCT00534495|617430962|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
170842536|NCT00534495|617430963|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
170842537|NCT00534495|617430964|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
170842538|NCT01818531|617430965|FG000|Overall Study|Withdrawn for case delay after block|1|||
170842539|NCT01818531|617430966|FG001|Overall Study|Withdrawn for case delay after block|0|||
170842540|NCT01818531|617430965|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
170842541|NCT01818531|617430966|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
170842542|NCT01818531|617430965|FG000|Overall Study|Withdrawn for failure to place block|0|||
170842543|NCT01818531|617430966|FG001|Overall Study|Withdrawn for failure to place block|1|||
170842544|NCT01646177|617430969|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
170842545|NCT01646177|617430970|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
170842546|NCT01646177|617430971|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
170842547|NCT01646177|617430972|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
170842548|NCT01646177|617430973|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
170842549|NCT01646177|617430974|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
170842550|NCT01646177|617430975|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
170842551|NCT01646177|617430976|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
170842552|NCT01646177|617430977|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
170842553|NCT01646177|617430978|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
170842554|NCT01646177|617430979|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
170842555|NCT01646177|617430980|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
170842556|NCT01646177|617430969|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
170842557|NCT01646177|617430970|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
170842558|NCT01646177|617430971|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
170842559|NCT01646177|617430972|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
170842560|NCT01646177|617430973|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
170842561|NCT01646177|617430974|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
170842562|NCT01646177|617430975|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
170842563|NCT01646177|617430976|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
170842564|NCT01646177|617430977|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
170842565|NCT01646177|617430978|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
170842566|NCT01646177|617430979|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
170842567|NCT01646177|617430980|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
170842568|NCT01646177|617430969|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
170842569|NCT01646177|617430970|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
170842570|NCT01646177|617430971|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
170842571|NCT01646177|617430972|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
170842572|NCT01646177|617430973|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
170842573|NCT01646177|617430974|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
170842574|NCT01646177|617430975|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
170842575|NCT01646177|617430976|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
170842576|NCT01646177|617430977|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
170842577|NCT01646177|617430978|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
170842578|NCT01646177|617430979|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
170842579|NCT01646177|617430980|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
170842580|NCT01646177|617430969|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
170842581|NCT01646177|617430970|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
170842582|NCT01646177|617430971|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
170842583|NCT01646177|617430972|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
170842584|NCT01646177|617430973|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
170842585|NCT01646177|617430974|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
170842586|NCT01646177|617430975|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
170842587|NCT01646177|617430976|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
170842588|NCT01646177|617430977|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
170842589|NCT01646177|617430978|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
170842590|NCT01646177|617430979|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
170842591|NCT01646177|617430980|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
170842592|NCT01646177|617430969|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842593|NCT01646177|617430970|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842594|NCT01646177|617430971|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
170842595|NCT01646177|617430972|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
170842596|NCT01646177|617430973|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842597|NCT01646177|617430974|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842598|NCT01646177|617430975|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842599|NCT01646177|617430976|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842600|NCT01646177|617430977|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842601|NCT01646177|617430978|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842602|NCT01646177|617430979|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842603|NCT01646177|617430980|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
170842604|NCT01646177|617430969|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
170842605|NCT01646177|617430970|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
170842606|NCT01646177|617430971|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
170842607|NCT01646177|617430972|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842608|NCT01646177|617430973|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842609|NCT01646177|617430974|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842610|NCT01646177|617430975|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842611|NCT01646177|617430976|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842612|NCT01646177|617430977|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842613|NCT01646177|617430978|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842614|NCT01646177|617430979|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842615|NCT01646177|617430980|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
170842616|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
170842617|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
170842618|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
170842619|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
170842620|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
170842621|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
170842622|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
170842623|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
170842624|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
170842625|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
170842626|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
170842627|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
170842628|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
170842629|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
170842630|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
170842631|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
170842632|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
170842633|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
170842634|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
170842635|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
170842636|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
170842637|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
170842638|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
170842639|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
170842640|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
170842641|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
170842642|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
170842643|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
170842644|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
170842645|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
170842646|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
170842647|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
170842648|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
170842649|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
170842650|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
170842651|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
170842652|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
170842653|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
170842654|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
170735953|NCT03371940|617038601|FG002|Overall Study|Withdrawal by Subject|3|||
170735954|NCT03371940|617038602|FG003|Overall Study|Withdrawal by Subject|4|||
170735955|NCT05099926|617038603|FG000|Overall Study|Lost to Follow-up|1|||
170735956|NCT01064297|617038604|FG000|Overall Study|Lost to Follow-up|791|||
170735957|NCT01064297|617038605|FG001|Overall Study|Lost to Follow-up|48|||
170735958|NCT01064297|617038606|FG002|Overall Study|Lost to Follow-up|133|||
170735959|NCT01987817|617038609|FG000|Overall Study|Adverse Event|4|||
170735960|NCT01987817|617038610|FG001|Overall Study|Adverse Event|0|||
170735961|NCT01987817|617038609|FG000|Overall Study|Withdrawal by Subject|1|||
170735962|NCT01987817|617038610|FG001|Overall Study|Withdrawal by Subject|1|||
170735963|NCT01987817|617038609|FG000|Overall Study|Physician Decision|1|||
170735964|NCT01987817|617038610|FG001|Overall Study|Physician Decision|0|||
170735965|NCT04098250|617038611|FG000|Overall Study|Withdrawal by Subject|1|||
170735966|NCT04098250|617038612|FG001|Overall Study|Withdrawal by Subject|0|||
170735967|NCT04098250|617038611|FG000|Overall Study|Lost to Follow-up|0|||
170735968|NCT04098250|617038612|FG001|Overall Study|Lost to Follow-up|1|||
170735969|NCT02332590|617038620|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
170735970|NCT02332590|617038621|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
170735971|NCT02332590|617038620|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
170735972|NCT02332590|617038621|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
170735973|NCT02332590|617038620|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
170735974|NCT02332590|617038621|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
170735975|NCT02332590|617038620|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
170735976|NCT02332590|617038621|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
170735977|NCT02332590|617038620|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
170735978|NCT02332590|617038621|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
170735979|NCT02332590|617038620|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
170735980|NCT02332590|617038621|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
170735981|NCT02332590|617038620|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
170735982|NCT02332590|617038621|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
170735983|NCT02332590|617038620|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
170735984|NCT02332590|617038621|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
170735985|NCT02332590|617038620|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
170735986|NCT02332590|617038621|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
170735987|NCT01678131|617038628|FG000|Overall Study|Adverse Event|0|||
170735988|NCT01678131|617038629|FG001|Overall Study|Adverse Event|1|||
170735989|NCT01678131|617038630|FG002|Overall Study|Adverse Event|0|||
170735990|NCT01678131|617038628|FG000|Overall Study|Withdrawal by Subject|0|||
170735991|NCT01678131|617038629|FG001|Overall Study|Withdrawal by Subject|0|||
170735992|NCT01678131|617038630|FG002|Overall Study|Withdrawal by Subject|2|||
170735993|NCT00941798|617038637|FG000|Overall Study|Withdrawal by Subject|72|||
170735994|NCT00941798|617038638|FG001|Overall Study|Withdrawal by Subject|74|||
170735995|NCT00941798|617038637|FG000|Overall Study|Adverse Event|43|||
170735996|NCT00941798|617038638|FG001|Overall Study|Adverse Event|23|||
170735997|NCT00941798|617038637|FG000|Overall Study|Lost to Follow-up|29|||
170735998|NCT00941798|617038638|FG001|Overall Study|Lost to Follow-up|23|||
170735999|NCT00941798|617038637|FG000|Overall Study|Protocol Violation|17|||
170736000|NCT00941798|617038638|FG001|Overall Study|Protocol Violation|20|||
170736001|NCT00941798|617038637|FG000|Overall Study|Administrative problems|13|||
170736002|NCT00941798|617038638|FG001|Overall Study|Administrative problems|23|||
170736003|NCT00941798|617038637|FG000|Overall Study|Lack of Efficacy|10|||
170736004|NCT00941798|617038638|FG001|Overall Study|Lack of Efficacy|17|||
170736005|NCT00941798|617038637|FG000|Overall Study|Patient's inability to use device|6|||
170736006|NCT00941798|617038638|FG001|Overall Study|Patient's inability to use device|1|||
170736007|NCT00941798|617038637|FG000|Overall Study|Abnormal test procedure results|3|||
170736008|NCT00941798|617038638|FG001|Overall Study|Abnormal test procedure results|1|||
170736009|NCT00941798|617038637|FG000|Overall Study|Abnormal laboratory values|1|||
170736010|NCT00941798|617038638|FG001|Overall Study|Abnormal laboratory values|2|||
170736011|NCT00941798|617038637|FG000|Overall Study|Death|0|||
170736012|NCT00941798|617038638|FG001|Overall Study|Death|1|||
170736013|NCT01489189|617038639|FG000|Overall Study|Withdrawal by Subject|20|||
170736014|NCT01489189|617038640|FG001|Overall Study|Withdrawal by Subject|23|||
170736015|NCT01489189|617038639|FG000|Overall Study|Death|10|||
170736016|NCT01489189|617038640|FG001|Overall Study|Death|8|||
170736017|NCT01489189|617038639|FG000|Overall Study|Missed Visit|1|||
170736018|NCT01489189|617038640|FG001|Overall Study|Missed Visit|4|||
170736019|NCT00112580|617038641|FG000|Overall Study|Adverse Event|1|||
170736020|NCT00112580|617038642|FG001|Overall Study|Adverse Event|2|||
170736021|NCT00112580|617038641|FG000|Overall Study|Disease progression|5|||
170736022|NCT00112580|617038642|FG001|Overall Study|Disease progression|16|||
170736023|NCT00112580|617038641|FG000|Overall Study|Participant withdrew consent|2|||
170736024|NCT00112580|617038642|FG001|Overall Study|Participant withdrew consent|1|||
170736025|NCT05597722|617038643|FG000|Overall Study|Study was terminated|6|||
170736026|NCT05597722|617038644|FG001|Overall Study|Study was terminated|1|||
170736027|NCT03421808|617038646|FG000|Overall Study|COVID related problems|2|||
170842655|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
170842656|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
170842657|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
170842658|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
170842659|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
170842660|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
170842661|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
170842662|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
170736028|NCT03421808|617038647|FG001|Overall Study|COVID related problems|0|||
170736029|NCT03421808|617038646|FG000|Overall Study|Withdrawal by Subject|1|||
170736030|NCT03421808|617038647|FG001|Overall Study|Withdrawal by Subject|0|||
170736031|NCT03421808|617038646|FG000|Overall Study|Protocol Violation|0|||
170736032|NCT03421808|617038647|FG001|Overall Study|Protocol Violation|1|||
170736033|NCT03444376|617038648|FG000|Part A|Disease relapse or Progression|1|||
170736034|NCT03444376|617038648|FG000|Part A|Withdrawal by Subject|2|||
170736035|NCT03444376|617038648|FG000|Part A|Adverse Event|1|||
170736036|NCT03444376|617038648|FG000|Part B|Disease relapse or Progression|18|||
170736037|NCT03444376|617038648|FG000|Part B|Withdrawal by Subject|2|||
170736038|NCT03444376|617038648|FG000|Part B|Adverse Event|2|||
170736039|NCT03444376|617038648|FG000|Part B|Physician Decision|1|||
170736040|NCT03444376|617038648|FG000|Part C|Disease relapse or Progression|43|||
170736041|NCT03444376|617038648|FG000|Part C|Withdrawal by Subject|5|||
170736042|NCT03444376|617038648|FG000|Part C|Adverse Event|2|||
170736043|NCT03444376|617038648|FG000|Part C|Physician Decision|2|||
170736044|NCT03444376|617038648|FG000|Part C|Death|1|||
170736045|NCT03881696|617038654|FG000|Overall Study|Adverse Event|2|||
170736046|NCT03881696|617038655|FG001|Overall Study|Adverse Event|0|||
170736047|NCT03881696|617038654|FG000|Overall Study|Withdrawal by Subject|2|||
170736048|NCT03881696|617038655|FG001|Overall Study|Withdrawal by Subject|0|||
170736049|NCT03881696|617038654|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
170736050|NCT03881696|617038655|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
170736051|NCT03881696|617038654|FG000|Overall Study|Failure to meet continuation criteria|1|||
170736052|NCT03881696|617038655|FG001|Overall Study|Failure to meet continuation criteria|0|||
170736053|NCT00856167|617038659|FG000|Period 1|Withdrawal by Subject|1|||
170736054|NCT00856167|617038660|FG001|Period 1|Withdrawal by Subject|4|||
170736055|NCT00856167|617038661|FG002|Period 1|Withdrawal by Subject|0|||
170736056|NCT00856167|617038662|FG003|Period 1|Withdrawal by Subject|0|||
170736057|NCT00856167|617038659|FG000|Period 1|Lost to Follow-up|2|||
170736058|NCT00856167|617038660|FG001|Period 1|Lost to Follow-up|1|||
170736059|NCT00856167|617038661|FG002|Period 1|Lost to Follow-up|0|||
170736060|NCT00856167|617038662|FG003|Period 1|Lost to Follow-up|0|||
170736061|NCT00856167|617038659|FG000|Period 2|Lost to Follow-up|0|||
170736062|NCT00856167|617038660|FG001|Period 2|Lost to Follow-up|0|||
170736063|NCT00856167|617038661|FG002|Period 2|Lost to Follow-up|3|||
170736064|NCT00856167|617038662|FG003|Period 2|Lost to Follow-up|1|||
170736065|NCT00856167|617038659|FG000|Period 2|Withdrawal by Subject|0|||
170736066|NCT00856167|617038660|FG001|Period 2|Withdrawal by Subject|0|||
170736067|NCT00856167|617038661|FG002|Period 2|Withdrawal by Subject|2|||
170736068|NCT00856167|617038662|FG003|Period 2|Withdrawal by Subject|4|||
170736069|NCT01061333|617038663|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
170736070|NCT01061333|617038664|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
170736071|NCT01816763|617040339|FG000|Overall Study|The main reason for an incomplete survey|4|||
170736072|NCT01816763|617040340|FG001|Overall Study|The main reason for an incomplete survey|15|||
170736073|NCT01816763|617040341|FG002|Overall Study|The main reason for an incomplete survey|11|||
170736074|NCT04022889|617040343|FG000|Stage 1: Period 1|Adverse Event|1|||
170736075|NCT04022889|617040344|FG001|Stage 1: Period 1|Adverse Event|0|||
170736076|NCT04022889|617040345|FG002|Stage 1: Period 1|Adverse Event|0|||
170736077|NCT04022889|617040343|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
170736078|NCT04022889|617040344|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
170736079|NCT04022889|617040345|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
170736080|NCT04022889|617040343|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
170736081|NCT04022889|617040344|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
170736082|NCT04022889|617040345|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
170736083|NCT04022889|617040343|FG000|Stage 2|Screen Failure|0|||
170736084|NCT04022889|617040344|FG001|Stage 2|Screen Failure|0|||
170736085|NCT04022889|617040345|FG002|Stage 2|Screen Failure|3|||
170736086|NCT04022889|617040343|FG000|Stage 2|Ineligible for apheresis donation|0|||
170736087|NCT04022889|617040344|FG001|Stage 2|Ineligible for apheresis donation|0|||
170842663|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
170736088|NCT04022889|617040345|FG002|Stage 2|Ineligible for apheresis donation|2|||
170842664|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
170736089|NCT04022889|617040343|FG000|Stage 2|Adverse Event|0|||
170736090|NCT04022889|617040344|FG001|Stage 2|Adverse Event|0|||
170736091|NCT04022889|617040345|FG002|Stage 2|Adverse Event|2|||
170736092|NCT04022889|617040343|FG000|Stage 2|Protocol Violation|0|||
170842665|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
170842666|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
170842667|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
170842668|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
170842669|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
170842670|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
170842671|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
170842672|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
170842673|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
170842674|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
170842675|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
170842676|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842677|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842678|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842679|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842680|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
170842681|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
170842682|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842683|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
170842684|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842685|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842686|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842687|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
170842688|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
170842689|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
170842690|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
170842691|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
170842692|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
170842693|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
170842694|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
170842695|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
170842696|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
170842697|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
170842698|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
170842699|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
170736093|NCT04022889|617040344|FG001|Stage 2|Protocol Violation|0|||
170736094|NCT04022889|617040345|FG002|Stage 2|Protocol Violation|1|||
170736095|NCT04022889|617040343|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
170736096|NCT04022889|617040344|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
170736097|NCT04022889|617040345|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
170736098|NCT02202434|617040350|FG000|Overall Study|Death|70|||
170736099|NCT02202434|617040351|FG001|Overall Study|Death|39|||
170736100|NCT02202434|617040352|FG002|Overall Study|Death|13|||
170736101|NCT02202434|617040353|FG003|Overall Study|Death|27|||
170736102|NCT02202434|617040350|FG000|Overall Study|Lost to Follow-up|1|||
170736103|NCT02202434|617040351|FG001|Overall Study|Lost to Follow-up|1|||
170736104|NCT02202434|617040352|FG002|Overall Study|Lost to Follow-up|1|||
170736105|NCT02202434|617040353|FG003|Overall Study|Lost to Follow-up|0|||
170736106|NCT02202434|617040350|FG000|Overall Study|Physician Decision|2|||
170736107|NCT02202434|617040351|FG001|Overall Study|Physician Decision|3|||
170736108|NCT02202434|617040352|FG002|Overall Study|Physician Decision|0|||
170736109|NCT02202434|617040353|FG003|Overall Study|Physician Decision|0|||
170736110|NCT02202434|617040350|FG000|Overall Study|Withdrawal by Subject|13|||
170736111|NCT02202434|617040351|FG001|Overall Study|Withdrawal by Subject|14|||
170736112|NCT02202434|617040352|FG002|Overall Study|Withdrawal by Subject|1|||
170736113|NCT02202434|617040353|FG003|Overall Study|Withdrawal by Subject|4|||
170736114|NCT02202434|617040350|FG000|Overall Study|Completed Study|1|||
170736115|NCT02202434|617040351|FG001|Overall Study|Completed Study|0|||
170736116|NCT02202434|617040352|FG002|Overall Study|Completed Study|0|||
170736117|NCT02202434|617040353|FG003|Overall Study|Completed Study|0|||
170736118|NCT02202434|617040350|FG000|Overall Study|Visit Missed|21|||
170736119|NCT02202434|617040351|FG001|Overall Study|Visit Missed|12|||
170736120|NCT02202434|617040352|FG002|Overall Study|Visit Missed|0|||
170736121|NCT02202434|617040353|FG003|Overall Study|Visit Missed|5|||
170736122|NCT02202434|617040350|FG000|Overall Study|Other|1|||
170736123|NCT02202434|617040351|FG001|Overall Study|Other|0|||
170736124|NCT02202434|617040352|FG002|Overall Study|Other|0|||
170736125|NCT02202434|617040353|FG003|Overall Study|Other|1|||
170736126|NCT03237858|617040354|FG000|Overall Study|Death|19|||
170842700|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
170842701|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
170842702|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
170842703|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
170842704|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
170842705|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
170842706|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
170842707|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
170842708|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
170842709|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
170842710|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
170842711|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
170842712|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
170842713|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
170842714|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
170842715|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
170842716|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
170842717|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
170842718|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
170842719|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
170842720|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
170842721|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
170842722|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
170842723|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
170842724|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842725|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842726|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842727|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842728|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842729|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842730|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842731|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
170842732|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842733|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842734|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842735|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
170842736|NCT01646177|617430969|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842737|NCT01646177|617430970|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842738|NCT01646177|617430971|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842739|NCT01646177|617430972|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842740|NCT01646177|617430973|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842741|NCT01646177|617430974|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
170842742|NCT01646177|617430975|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
170842743|NCT01646177|617430976|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
170842744|NCT01646177|617430977|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842745|NCT01646177|617430978|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842746|NCT01646177|617430979|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842747|NCT01646177|617430980|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
170842748|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
170842749|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
170842750|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
170842751|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
170842752|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
170842753|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
170842754|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
170842755|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
170842756|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
170842757|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
170842758|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
170842759|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
170842760|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
170842761|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
170842762|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
170842763|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
170842764|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
170842765|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
170842766|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
170842767|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
170842768|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
170842769|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
170842770|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
170842771|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
170842772|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
170842773|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
170842774|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
170842775|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
170842776|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
170842777|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
170842778|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
170842779|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
170842780|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
170842781|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
170842782|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
170842783|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
170842784|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
170842785|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
170842786|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
170842787|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
170842788|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
170842789|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
170842790|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
170842791|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
170842792|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
170842793|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
170842794|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
170842795|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
170842796|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
170842797|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
170842798|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
170842799|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
170842800|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
170842801|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
170736127|NCT03237858|617040354|FG000|Overall Study|Withdrawal by Subject|37|||
170736128|NCT04858802|617040355|FG000|Overall Study|Lost to Follow-up|1|||
170736129|NCT04858802|617040356|FG001|Overall Study|Lost to Follow-up|1|||
170736130|NCT04858802|617040355|FG000|Overall Study|Withdrawal by Subject|1|||
170736131|NCT04858802|617040356|FG001|Overall Study|Withdrawal by Subject|1|||
170736132|NCT03610737|617040357|FG000|Overall Study|Withdrawal by Subject|1|||
170736133|NCT03610737|617040358|FG001|Overall Study|Withdrawal by Subject|5|||
170736134|NCT03610737|617040357|FG000|Overall Study|Death|1|||
170736135|NCT03610737|617040358|FG001|Overall Study|Death|0|||
170736136|NCT03610737|617040357|FG000|Overall Study|Not treated|5|||
170736137|NCT03610737|617040358|FG001|Overall Study|Not treated|2|||
170736138|NCT03610737|617040357|FG000|Overall Study|Missed Visit|1|||
170736139|NCT03610737|617040358|FG001|Overall Study|Missed Visit|2|||
170736140|NCT03145766|617040372|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
170736141|NCT03145766|617040373|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
170736142|NCT03145766|617040374|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
170842802|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
170842803|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
170842804|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
170842805|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
170842806|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
170842807|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
170842808|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
170842809|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
170842810|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
170842811|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
170842812|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
170842813|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
170842814|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
170842815|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
170842816|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
170842817|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
170842818|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
170842819|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
170842820|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842821|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842822|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842823|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842824|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842825|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842826|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842827|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842828|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
170842829|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
170842830|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
170842831|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
170842832|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842833|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842834|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842835|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842836|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842837|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842838|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842839|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842840|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
170842841|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
170842842|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
170842843|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
170842844|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842845|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842846|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842847|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842848|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842849|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842850|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842851|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842852|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
170842853|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
170842854|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
170842855|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
170842856|NCT01646177|617430969|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842857|NCT01646177|617430970|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842858|NCT01646177|617430971|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842859|NCT01646177|617430972|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842860|NCT01646177|617430973|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842861|NCT01646177|617430974|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842862|NCT01646177|617430975|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842863|NCT01646177|617430976|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842864|NCT01646177|617430977|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842865|NCT01646177|617430978|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
170842866|NCT01646177|617430979|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
170842867|NCT01646177|617430980|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
170842868|NCT02920970|617430981|FG000|First Intervention|Protocol Violation|0|||
170842869|NCT02920970|617430982|FG001|First Intervention|Protocol Violation|1|||
170842870|NCT02920970|617430981|FG000|First Intervention|Adverse Event|0|||
170842871|NCT02920970|617430982|FG001|First Intervention|Adverse Event|1|||
170842872|NCT02920970|617430981|FG000|Second Intervention|Poor Lens Fit|1|||
170842873|NCT02920970|617430982|FG001|Second Intervention|Poor Lens Fit|0|||
170842874|NCT01711853|617430984|FG000|Overall Study|Not treated|3|||
170842875|NCT02762903|617430985|FG000|Overall Study|Lost to Follow-up|0|||
170842876|NCT02762903|617430986|FG001|Overall Study|Lost to Follow-up|1|||
170842877|NCT00108745|617430987|FG000|Overall Study|Withdrawal by Subject|19|||
170842878|NCT00108745|617430988|FG001|Overall Study|Withdrawal by Subject|12|||
170842879|NCT00108745|617430989|FG002|Overall Study|Withdrawal by Subject|12|||
170842880|NCT00108745|617430987|FG000|Overall Study|Never Treated|8|||
170842881|NCT00108745|617430988|FG001|Overall Study|Never Treated|10|||
170842882|NCT00108745|617430989|FG002|Overall Study|Never Treated|12|||
170842883|NCT00108745|617430987|FG000|Overall Study|Ineligible|7|||
170842884|NCT00108745|617430988|FG001|Overall Study|Ineligible|13|||
170736143|NCT03145766|617040375|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
170736144|NCT03145766|617040376|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
170736145|NCT03145766|617040372|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
170736146|NCT03145766|617040373|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
170736147|NCT03145766|617040374|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
170736148|NCT03145766|617040375|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
170736149|NCT03145766|617040376|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
170736150|NCT03145766|617040372|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
170736151|NCT03145766|617040373|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
170736152|NCT03145766|617040374|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
170736153|NCT03145766|617040375|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
170736154|NCT03145766|617040376|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
170736155|NCT03145766|617040372|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
170736156|NCT03145766|617040373|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
170736157|NCT03145766|617040374|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
170736158|NCT03145766|617040375|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
170736159|NCT03145766|617040376|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
170736160|NCT03145766|617040372|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
170736161|NCT03145766|617040373|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
170736162|NCT03145766|617040374|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
170736163|NCT03145766|617040375|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
170736164|NCT03145766|617040376|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
170736165|NCT03145766|617040372|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
170736166|NCT03145766|617040373|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
170736167|NCT03145766|617040374|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
170736168|NCT03145766|617040375|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
170736169|NCT03145766|617040376|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
170736170|NCT03145766|617040372|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
170736171|NCT03145766|617040373|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
170842885|NCT00108745|617430989|FG002|Overall Study|Ineligible|13|||
170842886|NCT01426347|617430990|FG000|Overall Study|Lost to Follow-up|0|||
170842887|NCT01426347|617430991|FG001|Overall Study|Lost to Follow-up|3|||
170842888|NCT01426347|617430990|FG000|Overall Study|Protocol Violation|2|||
170842889|NCT01426347|617430991|FG001|Overall Study|Protocol Violation|0|||
170842890|NCT01426347|617430990|FG000|Overall Study|Withdrawal by Subject|5|||
170842891|NCT01426347|617430991|FG001|Overall Study|Withdrawal by Subject|0|||
170842892|NCT00996606|617430994|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
170842893|NCT00996606|617430994|FG000|Overall Study|Insufficient Therapeutic Response|2|||
170842894|NCT00996606|617430994|FG000|Overall Study|Protocol Violation|1|||
170842895|NCT00996606|617430994|FG000|Overall Study|Withdrawal by Subject|3|||
170842896|NCT03686423|617430997|FG000|Overall Study|Withdrawal by Subject|9|||
170842897|NCT03686423|617430997|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
170842898|NCT02367040|617430998|FG000|Overall Study|Lost to Follow-up|1|||
170842899|NCT02367040|617430999|FG001|Overall Study|Lost to Follow-up|1|||
170842900|NCT02367040|617430998|FG000|Overall Study|Lack of Efficacy|1|||
170842901|NCT02367040|617430999|FG001|Overall Study|Lack of Efficacy|0|||
170842902|NCT02367040|617430998|FG000|Overall Study|Additional primary malignancy|1|||
170842903|NCT02367040|617430999|FG001|Overall Study|Additional primary malignancy|1|||
170842904|NCT02367040|617430998|FG000|Overall Study|AE not associated with clinical disease progression|117|||
170842905|NCT02367040|617430999|FG001|Overall Study|AE not associated with clinical disease progression|12|||
170842906|NCT02367040|617430998|FG000|Overall Study|AE associated with clinical disease progression|1|||
170842907|NCT02367040|617430999|FG001|Overall Study|AE associated with clinical disease progression|4|||
170842908|NCT02367040|617430998|FG000|Overall Study|Physician Decision|2|||
170842909|NCT02367040|617430999|FG001|Overall Study|Physician Decision|8|||
170842910|NCT02367040|617430998|FG000|Overall Study|Non-compliance to study drug|1|||
170842911|NCT02367040|617430999|FG001|Overall Study|Non-compliance to study drug|0|||
170842912|NCT02367040|617430998|FG000|Overall Study|Failure to meet continuation criteria|1|||
170842913|NCT02367040|617430999|FG001|Overall Study|Failure to meet continuation criteria|0|||
170842914|NCT02367040|617430998|FG000|Overall Study|Switching to other therapy|2|||
170842915|NCT02367040|617430999|FG001|Overall Study|Switching to other therapy|0|||
170842916|NCT02367040|617430998|FG000|Overall Study|Withdrawal by Subject|51|||
170842917|NCT02367040|617430999|FG001|Overall Study|Withdrawal by Subject|16|||
170842918|NCT02367040|617430998|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
170842919|NCT02367040|617430999|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
170842920|NCT02367040|617430998|FG000|Overall Study|Patient decision|40|||
170842921|NCT02367040|617430999|FG001|Overall Study|Patient decision|14|||
170842922|NCT02367040|617430998|FG000|Overall Study|Required procedure failed|1|||
170842923|NCT02367040|617430999|FG001|Overall Study|Required procedure failed|0|||
170842924|NCT02367040|617430998|FG000|Overall Study|Randomized by mistake with study treatment|1|||
170842925|NCT02367040|617430999|FG001|Overall Study|Randomized by mistake with study treatment|0|||
170842926|NCT02367040|617430998|FG000|Overall Study|Protocol Violation|1|||
170842927|NCT02367040|617430999|FG001|Overall Study|Protocol Violation|0|||
170842928|NCT02367040|617430998|FG000|Overall Study|Progressive disease - radiological progression|54|||
170842929|NCT02367040|617430999|FG001|Overall Study|Progressive disease - radiological progression|80|||
170842930|NCT02367040|617430998|FG000|Overall Study|Progressive disease - clinical progression|6|||
170842931|NCT02367040|617430999|FG001|Overall Study|Progressive disease - clinical progression|6|||
170842932|NCT02367040|617430998|FG000|Overall Study|Drug not administered|3|||
170842933|NCT02367040|617430999|FG001|Overall Study|Drug not administered|2|||
170842934|NCT02367040|617430998|FG000|Overall Study|Progressive disease|0|||
170842935|NCT02367040|617430999|FG001|Overall Study|Progressive disease|1|||
170842936|NCT02367040|617430998|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
170842937|NCT02367040|617430999|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
170842938|NCT02367040|617430998|FG000|Overall Study|Death|2|||
170842939|NCT02367040|617430999|FG001|Overall Study|Death|0|||
170842940|NCT02367040|617430998|FG000|Overall Study|Study terminated by sponsor|19|||
170842941|NCT02367040|617430999|FG001|Overall Study|Study terminated by sponsor|2|||
170842942|NCT06840769|617431003|FG000|Overall Study|Withdrawal by Subject|1|||
170842943|NCT06840769|617431004|FG001|Overall Study|Withdrawal by Subject|0|||
170842944|NCT06840769|617431005|FG002|Overall Study|Withdrawal by Subject|0|||
170842945|NCT06840769|617431006|FG003|Overall Study|Withdrawal by Subject|0|||
170842946|NCT06840769|617431007|FG004|Overall Study|Withdrawal by Subject|0|||
170842947|NCT00663702|617433204|FG000|Overall Study|Adverse Event|8|||
170842948|NCT00663702|617433205|FG001|Overall Study|Adverse Event|4|||
170842949|NCT00663702|617433204|FG000|Overall Study|Withdrawal by Subject|3|||
170842950|NCT00663702|617433205|FG001|Overall Study|Withdrawal by Subject|1|||
170842951|NCT00663702|617433204|FG000|Overall Study|Pregnancy|0|||
170842952|NCT00663702|617433205|FG001|Overall Study|Pregnancy|1|||
170842953|NCT00663702|617433204|FG000|Overall Study|Lost to Follow-up|3|||
170842954|NCT00663702|617433205|FG001|Overall Study|Lost to Follow-up|0|||
170842955|NCT00663702|617433204|FG000|Overall Study|Death|1|||
170842956|NCT00663702|617433205|FG001|Overall Study|Death|1|||
170842957|NCT00663702|617433204|FG000|Overall Study|Lack of Efficacy|3|||
170842958|NCT00663702|617433205|FG001|Overall Study|Lack of Efficacy|3|||
170842959|NCT03056300|617433210|FG000|Overall Study|Surgical reason per study protocol|3|||
170842960|NCT05262517|617433211|FG000|Overall Study|Randomized but not treated|5|||
170842961|NCT05262517|617433212|FG001|Overall Study|Randomized but not treated|11|||
170842962|NCT00527787|617433215|FG000|Overall Study|Adverse Event|14|||
170842963|NCT00527787|617433216|FG001|Overall Study|Adverse Event|24|||
170842964|NCT00527787|617433215|FG000|Overall Study|Withdrawal by Subject|13|||
170842965|NCT00527787|617433216|FG001|Overall Study|Withdrawal by Subject|25|||
170842966|NCT00527787|617433215|FG000|Overall Study|Lost to Follow-up|5|||
170842967|NCT00527787|617433216|FG001|Overall Study|Lost to Follow-up|2|||
170842968|NCT00527787|617433215|FG000|Overall Study|Duodenal Ulcer|1|||
170842969|NCT00527787|617433216|FG001|Overall Study|Duodenal Ulcer|10|||
170842970|NCT00527787|617433215|FG000|Overall Study|misc|5|||
170842971|NCT00527787|617433216|FG001|Overall Study|misc|2|||
170842972|NCT01077128|617433222|FG000|Overall Study|Adverse Event|8|||
170842973|NCT01077128|617433222|FG000|Overall Study|Lack of Efficacy|1|||
170842974|NCT01077128|617433222|FG000|Overall Study|Disease exacerbation|1|||
170842975|NCT01077128|617433222|FG000|Overall Study|Adverse event and consent withdrawal|1|||
170842976|NCT01077128|617433222|FG000|Overall Study|Adverse event and disease exacerbation|1|||
170842977|NCT01077128|617433222|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
170842978|NCT01077128|617433222|FG000|Overall Study|Other|54|||
170842979|NCT00847626|617433223|FG000|Overall Study|Adverse Event|10|||
170842980|NCT00847626|617433224|FG001|Overall Study|Adverse Event|10|||
170736172|NCT03145766|617040374|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
170736173|NCT03145766|617040375|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
170736174|NCT03145766|617040376|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
170736175|NCT00462670|617040379|FG000|Overall Study|Adverse Event|3|||
170736176|NCT00462670|617040380|FG001|Overall Study|Adverse Event|5|||
170736177|NCT00462670|617040379|FG000|Overall Study|Lack of Efficacy|1|||
170736178|NCT00462670|617040380|FG001|Overall Study|Lack of Efficacy|0|||
170736179|NCT00462670|617040379|FG000|Overall Study|Protocol Violation|1|||
170736180|NCT00462670|617040380|FG001|Overall Study|Protocol Violation|0|||
170736181|NCT00462670|617040379|FG000|Overall Study|Resolution of signs and symptoms|0|||
170736182|NCT00462670|617040380|FG001|Overall Study|Resolution of signs and symptoms|2|||
170736183|NCT00482274|617040381|FG000|Overall Study|Adverse Event|1|||
170736184|NCT04836858|617040382|FG000|Overall Study|Adverse Event|0|||
170736185|NCT04836858|617040383|FG001|Overall Study|Adverse Event|0|||
170736186|NCT04836858|617040384|FG002|Overall Study|Adverse Event|0|||
170736187|NCT04836858|617040385|FG003|Overall Study|Adverse Event|1|||
170736188|NCT04836858|617040382|FG000|Overall Study|Lost to Follow-up|1|||
170736189|NCT04836858|617040383|FG001|Overall Study|Lost to Follow-up|0|||
170736190|NCT04836858|617040384|FG002|Overall Study|Lost to Follow-up|0|||
170736191|NCT04836858|617040385|FG003|Overall Study|Lost to Follow-up|0|||
170736192|NCT04836858|617040382|FG000|Overall Study|Subject/Guardian decision|3|||
170736193|NCT04836858|617040383|FG001|Overall Study|Subject/Guardian decision|0|||
170736194|NCT04836858|617040384|FG002|Overall Study|Subject/Guardian decision|0|||
170736195|NCT04836858|617040385|FG003|Overall Study|Subject/Guardian decision|1|||
170736196|NCT04836858|617040382|FG000|Overall Study|Randomized but not treated|4|||
170736197|NCT04836858|617040383|FG001|Overall Study|Randomized but not treated|0|||
170736198|NCT04836858|617040384|FG002|Overall Study|Randomized but not treated|0|||
170736199|NCT04836858|617040385|FG003|Overall Study|Randomized but not treated|0|||
170736200|NCT02748694|617040386|FG000|Overall Study|Voluntary Withdrawal|0|||
170736201|NCT02748694|617040387|FG001|Overall Study|Voluntary Withdrawal|0|||
170736202|NCT02748694|617040388|FG002|Overall Study|Voluntary Withdrawal|0|||
170736203|NCT02748694|617040389|FG003|Overall Study|Voluntary Withdrawal|0|||
170842981|NCT00847626|617433225|FG002|Overall Study|Adverse Event|6|||
170842982|NCT00847626|617433226|FG003|Overall Study|Adverse Event|19|||
170842983|NCT00847626|617433227|FG004|Overall Study|Adverse Event|11|||
170842984|NCT00847626|617433228|FG005|Overall Study|Adverse Event|22|||
170736204|NCT02748694|617040390|FG004|Overall Study|Voluntary Withdrawal|0|||
170842985|NCT00847626|617433229|FG006|Overall Study|Adverse Event|4|||
170842986|NCT00847626|617433230|FG007|Overall Study|Adverse Event|6|||
170736205|NCT02748694|617040391|FG005|Overall Study|Voluntary Withdrawal|0|||
170842987|NCT00847626|617433231|FG008|Overall Study|Adverse Event|3|||
170842988|NCT00847626|617433232|FG009|Overall Study|Adverse Event|6|||
170842989|NCT00847626|617433233|FG010|Overall Study|Adverse Event|6|||
170842990|NCT00847626|617433223|FG000|Overall Study|Protocol Violation|2|||
170842991|NCT00847626|617433224|FG001|Overall Study|Protocol Violation|1|||
170842992|NCT00847626|617433225|FG002|Overall Study|Protocol Violation|2|||
170842993|NCT00847626|617433226|FG003|Overall Study|Protocol Violation|1|||
170842994|NCT00847626|617433227|FG004|Overall Study|Protocol Violation|1|||
170842995|NCT00847626|617433228|FG005|Overall Study|Protocol Violation|1|||
170842996|NCT00847626|617433229|FG006|Overall Study|Protocol Violation|1|||
170842997|NCT00847626|617433230|FG007|Overall Study|Protocol Violation|1|||
170842998|NCT00847626|617433231|FG008|Overall Study|Protocol Violation|0|||
170842999|NCT00847626|617433232|FG009|Overall Study|Protocol Violation|1|||
170843000|NCT00847626|617433233|FG010|Overall Study|Protocol Violation|1|||
170843001|NCT00847626|617433223|FG000|Overall Study|Lost to Follow-up|0|||
170843002|NCT00847626|617433224|FG001|Overall Study|Lost to Follow-up|1|||
170843003|NCT00847626|617433225|FG002|Overall Study|Lost to Follow-up|1|||
170843004|NCT00847626|617433226|FG003|Overall Study|Lost to Follow-up|1|||
170843005|NCT00847626|617433227|FG004|Overall Study|Lost to Follow-up|0|||
170843006|NCT00847626|617433228|FG005|Overall Study|Lost to Follow-up|3|||
170843007|NCT00847626|617433229|FG006|Overall Study|Lost to Follow-up|1|||
170843008|NCT00847626|617433230|FG007|Overall Study|Lost to Follow-up|3|||
170843009|NCT00847626|617433231|FG008|Overall Study|Lost to Follow-up|1|||
170843010|NCT00847626|617433232|FG009|Overall Study|Lost to Follow-up|0|||
170843011|NCT00847626|617433233|FG010|Overall Study|Lost to Follow-up|1|||
170843012|NCT00847626|617433223|FG000|Overall Study|Withdrawal by Subject|5|||
170843013|NCT00847626|617433224|FG001|Overall Study|Withdrawal by Subject|5|||
170843014|NCT00847626|617433225|FG002|Overall Study|Withdrawal by Subject|3|||
170843015|NCT00847626|617433226|FG003|Overall Study|Withdrawal by Subject|8|||
170843016|NCT00847626|617433227|FG004|Overall Study|Withdrawal by Subject|12|||
170843017|NCT00847626|617433228|FG005|Overall Study|Withdrawal by Subject|9|||
170843018|NCT00847626|617433229|FG006|Overall Study|Withdrawal by Subject|8|||
170843019|NCT00847626|617433230|FG007|Overall Study|Withdrawal by Subject|4|||
170843020|NCT00847626|617433231|FG008|Overall Study|Withdrawal by Subject|4|||
170843021|NCT00847626|617433232|FG009|Overall Study|Withdrawal by Subject|5|||
170843022|NCT00847626|617433233|FG010|Overall Study|Withdrawal by Subject|2|||
170843023|NCT00847626|617433223|FG000|Overall Study|Lack of Efficacy|3|||
170843024|NCT00847626|617433224|FG001|Overall Study|Lack of Efficacy|1|||
170843025|NCT00847626|617433225|FG002|Overall Study|Lack of Efficacy|0|||
170843026|NCT00847626|617433226|FG003|Overall Study|Lack of Efficacy|1|||
170843027|NCT00847626|617433227|FG004|Overall Study|Lack of Efficacy|2|||
170843028|NCT00847626|617433228|FG005|Overall Study|Lack of Efficacy|0|||
170843029|NCT00847626|617433229|FG006|Overall Study|Lack of Efficacy|6|||
170843030|NCT00847626|617433230|FG007|Overall Study|Lack of Efficacy|2|||
170843031|NCT00847626|617433231|FG008|Overall Study|Lack of Efficacy|5|||
170843032|NCT00847626|617433232|FG009|Overall Study|Lack of Efficacy|1|||
170843033|NCT00847626|617433233|FG010|Overall Study|Lack of Efficacy|7|||
170843034|NCT00847626|617433223|FG000|Overall Study|Other|1|||
170843035|NCT00847626|617433224|FG001|Overall Study|Other|5|||
170843036|NCT00847626|617433225|FG002|Overall Study|Other|4|||
170843037|NCT00847626|617433226|FG003|Overall Study|Other|1|||
170843038|NCT00847626|617433227|FG004|Overall Study|Other|2|||
170843039|NCT00847626|617433228|FG005|Overall Study|Other|2|||
170843040|NCT00847626|617433229|FG006|Overall Study|Other|2|||
170843041|NCT00847626|617433230|FG007|Overall Study|Other|3|||
170843042|NCT00847626|617433231|FG008|Overall Study|Other|1|||
170843043|NCT00847626|617433232|FG009|Overall Study|Other|1|||
170843044|NCT00847626|617433233|FG010|Overall Study|Other|3|||
170843045|NCT04958642|617433237|FG000|Overall Study|Transferred to OLEX program|3|||
170843046|NCT04958642|617433238|FG001|Overall Study|Transferred to OLEX program|0|||
170843047|NCT04958642|617433239|FG002|Overall Study|Transferred to OLEX program|5|||
170843048|NCT04958642|617433237|FG000|Overall Study|Death|0|||
170843049|NCT04958642|617433238|FG001|Overall Study|Death|0|||
170843050|NCT04958642|617433239|FG002|Overall Study|Death|1|||
170843051|NCT04958642|617433237|FG000|Overall Study|Withdrawal by Subject|4|||
170843052|NCT04958642|617433238|FG001|Overall Study|Withdrawal by Subject|9|||
170843053|NCT04958642|617433239|FG002|Overall Study|Withdrawal by Subject|13|||
170843054|NCT04958642|617433237|FG000|Overall Study|Investigator's Decision|0|||
170843055|NCT04958642|617433238|FG001|Overall Study|Investigator's Decision|0|||
170843056|NCT04958642|617433239|FG002|Overall Study|Investigator's Decision|1|||
170843057|NCT04958642|617433237|FG000|Overall Study|Adverse Event|1|||
170843058|NCT04958642|617433238|FG001|Overall Study|Adverse Event|0|||
170843059|NCT04958642|617433239|FG002|Overall Study|Adverse Event|1|||
170843060|NCT04958642|617433237|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
170843061|NCT04958642|617433238|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
170843062|NCT04958642|617433239|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
170843063|NCT04958642|617433237|FG000|Overall Study|Lost to Follow-up|1|||
170843064|NCT04958642|617433238|FG001|Overall Study|Lost to Follow-up|0|||
170843065|NCT04958642|617433239|FG002|Overall Study|Lost to Follow-up|0|||
170736206|NCT02748694|617040392|FG006|Overall Study|Voluntary Withdrawal|0|||
170736207|NCT02748694|617040393|FG007|Overall Study|Voluntary Withdrawal|0|||
170736208|NCT02748694|617040394|FG008|Overall Study|Voluntary Withdrawal|0|||
170736209|NCT02748694|617040395|FG009|Overall Study|Voluntary Withdrawal|0|||
170736210|NCT02748694|617040396|FG010|Overall Study|Voluntary Withdrawal|0|||
170736211|NCT02748694|617040397|FG011|Overall Study|Voluntary Withdrawal|0|||
170736212|NCT02748694|617040398|FG012|Overall Study|Voluntary Withdrawal|0|||
170736213|NCT02748694|617040399|FG013|Overall Study|Voluntary Withdrawal|0|||
170736214|NCT02748694|617040400|FG014|Overall Study|Voluntary Withdrawal|2|||
170736215|NCT00763958|617040405|FG000|Overall Study|did not meet final criteria|4|||
170736216|NCT00763958|617040406|FG001|Overall Study|did not meet final criteria|4|||
170736217|NCT00763958|617040405|FG000|Overall Study|Lost to Follow-up|10|||
170736218|NCT00763958|617040406|FG001|Overall Study|Lost to Follow-up|2|||
170736219|NCT00763958|617040405|FG000|Overall Study|Believed they were receiving placebo|0|||
170736220|NCT00763958|617040406|FG001|Overall Study|Believed they were receiving placebo|5|||
170736221|NCT01780935|617040407|FG000|Overall Study|Admin problems due to early termination|321|||
170736222|NCT01780935|617040408|FG001|Overall Study|Admin problems due to early termination|309|||
170736223|NCT01780935|617040407|FG000|Overall Study|Adverse Event|2|||
170736224|NCT01780935|617040408|FG001|Overall Study|Adverse Event|4|||
170736225|NCT01780935|617040407|FG000|Overall Study|Death|1|||
170736226|NCT01780935|617040408|FG001|Overall Study|Death|6|||
170736227|NCT01780935|617040407|FG000|Overall Study|Lost to Follow-up|2|||
170736228|NCT01780935|617040408|FG001|Overall Study|Lost to Follow-up|6|||
170736229|NCT01780935|617040407|FG000|Overall Study|Physician Decision|1|||
170736230|NCT01780935|617040408|FG001|Overall Study|Physician Decision|1|||
170736231|NCT01780935|617040407|FG000|Overall Study|Protocol deviation|0|||
170736232|NCT01780935|617040408|FG001|Overall Study|Protocol deviation|1|||
170736233|NCT01780935|617040407|FG000|Overall Study|Patient withdrew consent|8|||
170736234|NCT01780935|617040408|FG001|Overall Study|Patient withdrew consent|9|||
170736235|NCT01691521|617040409|FG000|Overall Study|Adverse Event|4|||
170736236|NCT01691521|617040410|FG001|Overall Study|Adverse Event|0|||
170736237|NCT01691521|617040411|FG002|Overall Study|Adverse Event|1|||
170736238|NCT01691521|617040409|FG000|Overall Study|Lack of Efficacy|1|||
170736239|NCT01691521|617040410|FG001|Overall Study|Lack of Efficacy|1|||
170736240|NCT01691521|617040411|FG002|Overall Study|Lack of Efficacy|2|||
170736241|NCT01691521|617040409|FG000|Overall Study|Protocol Violation|0|||
170736242|NCT01691521|617040410|FG001|Overall Study|Protocol Violation|3|||
170736243|NCT01691521|617040411|FG002|Overall Study|Protocol Violation|0|||
170736244|NCT01691521|617040409|FG000|Overall Study|Lost to Follow-up|0|||
170736245|NCT01691521|617040410|FG001|Overall Study|Lost to Follow-up|2|||
170736246|NCT01691521|617040411|FG002|Overall Study|Lost to Follow-up|2|||
170736247|NCT01691521|617040409|FG000|Overall Study|Physician Decision|2|||
170736248|NCT01691521|617040410|FG001|Overall Study|Physician Decision|1|||
170736249|NCT01691521|617040411|FG002|Overall Study|Physician Decision|0|||
170736250|NCT01691521|617040409|FG000|Overall Study|Withdrawal by Subject|5|||
170736251|NCT01691521|617040410|FG001|Overall Study|Withdrawal by Subject|9|||
170736252|NCT01691521|617040411|FG002|Overall Study|Withdrawal by Subject|4|||
170736253|NCT00954733|617040417|FG000|Overall Study|blood gas machine did not work|1|||
170736254|NCT03131960|617040418|FG000|Overall Study|Adverse Event|0|||
170736255|NCT03131960|617040419|FG001|Overall Study|Adverse Event|1|||
170736256|NCT04707196|617040420|FG000|Overall Study|Withdrawal by Subject|9|||
170736257|NCT04707196|617040421|FG001|Overall Study|Withdrawal by Subject|6|||
170736258|NCT04707196|617040420|FG000|Overall Study|Lost to Follow-up|1|||
170736259|NCT04707196|617040421|FG001|Overall Study|Lost to Follow-up|0|||
170736260|NCT04707196|617040420|FG000|Overall Study|Protocol Violation|4|||
170736261|NCT04707196|617040421|FG001|Overall Study|Protocol Violation|1|||
170736262|NCT04707196|617040420|FG000|Overall Study|Adverse Event|2|||
170736263|NCT04707196|617040421|FG001|Overall Study|Adverse Event|2|||
170736264|NCT04707196|617040420|FG000|Overall Study|Death|3|||
170736265|NCT04707196|617040421|FG001|Overall Study|Death|1|||
170736266|NCT04707196|617040420|FG000|Overall Study|Non-compliance with study drug|1|||
170736267|NCT04707196|617040421|FG001|Overall Study|Non-compliance with study drug|0|||
170736268|NCT04707196|617040420|FG000|Overall Study|Progressive disease|9|||
170736269|NCT04707196|617040421|FG001|Overall Study|Progressive disease|10|||
170736270|NCT01725386|617040425|FG000|Overall Study|Death|84|||
170736271|NCT01725386|617040426|FG001|Overall Study|Death|40|||
170736272|NCT01725386|617040425|FG000|Overall Study|Lost to Follow-up|81|||
170736273|NCT01725386|617040426|FG001|Overall Study|Lost to Follow-up|6|||
170736274|NCT01725386|617040425|FG000|Overall Study|Withdrawal by Subject|10|||
170736275|NCT01725386|617040426|FG001|Overall Study|Withdrawal by Subject|0|||
170736276|NCT00879996|617040430|FG000|Overall Study|Lost to Follow-up|7|||
170736277|NCT00879996|617040431|FG001|Overall Study|Lost to Follow-up|6|||
170736278|NCT00879996|617040430|FG000|Overall Study|non-compliance|6|||
170736279|NCT00879996|617040431|FG001|Overall Study|non-compliance|4|||
170736280|NCT00879996|617040430|FG000|Overall Study|Physician Decision|1|||
170736281|NCT00879996|617040431|FG001|Overall Study|Physician Decision|2|||
170736282|NCT00879996|617040430|FG000|Overall Study|psychiatric problem|0|||
170736283|NCT00879996|617040431|FG001|Overall Study|psychiatric problem|1|||
170736284|NCT00879996|617040430|FG000|Overall Study|put on parole|1|||
170736285|NCT00879996|617040431|FG001|Overall Study|put on parole|0|||
170736286|NCT01216163|617040436|FG000|Overall Study|Withdrawal by Subject|1|||
170736287|NCT01216163|617040437|FG001|Overall Study|Withdrawal by Subject|1|||
170736288|NCT01216163|617040438|FG002|Overall Study|Withdrawal by Subject|0|||
170736289|NCT02914314|617040439|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
170736290|NCT02914314|617040440|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
170736291|NCT02914314|617040441|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
170736292|NCT02914314|617040442|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
170736293|NCT02914314|617040439|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
170736294|NCT02914314|617040440|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
170736295|NCT02914314|617040441|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
170736296|NCT02914314|617040442|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
170736297|NCT02914314|617040439|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
170736298|NCT02914314|617040440|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
170736299|NCT02914314|617040441|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
170736300|NCT02914314|617040442|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
170736301|NCT02914314|617040439|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
170736302|NCT02914314|617040440|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
170736303|NCT02914314|617040441|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
170736304|NCT02914314|617040442|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
170736305|NCT02914314|617040439|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
170736306|NCT02914314|617040440|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
170736307|NCT02914314|617040441|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
170736308|NCT02914314|617040442|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
170736309|NCT01148862|617040447|FG000|Second Intervention|Withdrawal by Subject|0|||
170736310|NCT01148862|617040448|FG001|Second Intervention|Withdrawal by Subject|2|||
170736311|NCT03056534|617040449|FG000|Overall Study|Participant withdrew consent|8|||
170736312|NCT03056534|617040449|FG000|Overall Study|Participant not able to return|6|||
170736313|NCT03056534|617040449|FG000|Overall Study|Lost to Follow-up|37|||
170736314|NCT03056534|617040449|FG000|Overall Study|Investigator judgment|1|||
170736315|NCT03056534|617040449|FG000|Overall Study|Death|4|||
170736316|NCT03056534|617040449|FG000|Overall Study|Adverse Event|1|||
170736317|NCT03056534|617040449|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
170736318|NCT04270747|617040451|FG000|Through Week 16|Adverse Event|1|||
170736319|NCT04270747|617040452|FG001|Through Week 16|Adverse Event|2|||
170736320|NCT04270747|617040453|FG002|Through Week 16|Adverse Event|0|||
170736321|NCT04270747|617040451|FG000|Through Week 16|Death|0|||
170736322|NCT04270747|617040452|FG001|Through Week 16|Death|2|||
170736323|NCT04270747|617040453|FG002|Through Week 16|Death|0|||
170736324|NCT04270747|617040451|FG000|Through Week 16|Consent Withdrawn|3|||
170736325|NCT04270747|617040452|FG001|Through Week 16|Consent Withdrawn|3|||
170736326|NCT04270747|617040453|FG002|Through Week 16|Consent Withdrawn|0|||
170736327|NCT04270747|617040451|FG000|Through Week 16|Physician Decision|1|||
170736328|NCT04270747|617040452|FG001|Through Week 16|Physician Decision|1|||
170736329|NCT04270747|617040453|FG002|Through Week 16|Physician Decision|0|||
170736330|NCT04270747|617040451|FG000|Through Week 16|Lost to Follow-up|2|||
170736331|NCT04270747|617040452|FG001|Through Week 16|Lost to Follow-up|0|||
170736332|NCT04270747|617040453|FG002|Through Week 16|Lost to Follow-up|0|||
170736333|NCT04270747|617040451|FG000|Through Week 16|Protocol Violation|1|||
170736334|NCT04270747|617040452|FG001|Through Week 16|Protocol Violation|2|||
170736335|NCT04270747|617040453|FG002|Through Week 16|Protocol Violation|0|||
170736336|NCT04270747|617040451|FG000|Through Week 16|Protocol Specified Criteria|6|||
170736337|NCT04270747|617040452|FG001|Through Week 16|Protocol Specified Criteria|7|||
170736338|NCT04270747|617040453|FG002|Through Week 16|Protocol Specified Criteria|0|||
170736339|NCT04270747|617040451|FG000|Through Week 16|Miscellaneous|1|||
170843066|NCT04958642|617433237|FG000|Overall Study|Transferred to EAP following study termination|0|||
170736340|NCT04270747|617040452|FG001|Through Week 16|Miscellaneous|1|||
170736341|NCT04270747|617040453|FG002|Through Week 16|Miscellaneous|0|||
170736342|NCT04270747|617040451|FG000|Post Week 16|Adverse Event|7|||
170736343|NCT04270747|617040452|FG001|Post Week 16|Adverse Event|5|||
170736344|NCT04270747|617040453|FG002|Post Week 16|Adverse Event|1|||
170736345|NCT04270747|617040451|FG000|Post Week 16|Death|2|||
170736346|NCT04270747|617040452|FG001|Post Week 16|Death|0|||
170736347|NCT04270747|617040453|FG002|Post Week 16|Death|2|||
170736348|NCT04270747|617040451|FG000|Post Week 16|Consent Withdrawn|4|||
170843067|NCT04958642|617433238|FG001|Overall Study|Transferred to EAP following study termination|0|||
170843068|NCT04958642|617433239|FG002|Overall Study|Transferred to EAP following study termination|1|||
170843069|NCT04958642|617433237|FG000|Overall Study|Transferred to Expanded Access Program|1|||
170843070|NCT04958642|617433238|FG001|Overall Study|Transferred to Expanded Access Program|0|||
170843071|NCT04958642|617433239|FG002|Overall Study|Transferred to Expanded Access Program|0|||
170843072|NCT01923662|617433245|FG000|Overall Study|Withdrawal by Subject|1|||
170843073|NCT01939353|617433246|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
170843074|NCT01939353|617433246|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
170843075|NCT01939353|617433246|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
170843076|NCT01939353|617433246|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
170843077|NCT01939353|617433246|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
170843078|NCT04421950|617433255|FG000|Overall Study|Dropped or lost to follow up|4|||
170843079|NCT04421950|617433256|FG001|Overall Study|Dropped or lost to follow up|2|||
170843080|NCT01132820|617433258|FG000|Overall Study|Ineligible: wrong cell type|1|||
170843081|NCT01132820|617433258|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
170843082|NCT01132820|617433258|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
170843083|NCT01132820|617433258|FG000|Overall Study|Never treated|1|||
170843084|NCT01132820|617433258|FG000|Overall Study|Inadequate data|1|||
170843085|NCT02687035|617433259|FG000|Overall Study|Withdrawal by Subject|1|||
170843086|NCT02687035|617433259|FG000|Overall Study|Death|87|||
170843087|NCT02687035|617433259|FG000|Overall Study|Lost to Follow-up|1|||
170843088|NCT02687035|617433259|FG000|Overall Study|Missed Visit|87|||
170843089|NCT02687035|617433259|FG000|Overall Study|Did not receive Study Device|8|||
170843090|NCT03435692|617433260|FG000|Overall Study|Lack of Efficacy|2|||
170843091|NCT03435692|617433261|FG001|Overall Study|Lack of Efficacy|2|||
170843092|NCT03435692|617433262|FG002|Overall Study|Lack of Efficacy|0|||
170843093|NCT02964325|617433263|FG000|Overall Study|Lost to Follow-up|3|||
170843094|NCT02964325|617433264|FG001|Overall Study|Lost to Follow-up|3|||
170843095|NCT02964325|617433263|FG000|Overall Study|Physician Decision|5|||
170843096|NCT02964325|617433264|FG001|Overall Study|Physician Decision|4|||
170843097|NCT02964325|617433263|FG000|Overall Study|Death|1|||
170843098|NCT02964325|617433264|FG001|Overall Study|Death|3|||
170843099|NCT02964325|617433263|FG000|Overall Study|Withdrawal by Subject|2|||
170843100|NCT02964325|617433264|FG001|Overall Study|Withdrawal by Subject|1|||
170843101|NCT02964325|617433263|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
170843102|NCT02964325|617433264|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
170843103|NCT02510040|617433265|FG000|Overall Study|Deemed no longer eligible|18|||
170843104|NCT02510040|617433266|FG001|Overall Study|Deemed no longer eligible|3|||
170843105|NCT02510040|617433267|FG002|Overall Study|Deemed no longer eligible|1|||
170843106|NCT01712061|617433269|FG000|Overall Study|Adverse Event|4|||
170843107|NCT01712061|617433270|FG001|Overall Study|Adverse Event|9|||
170843108|NCT01712061|617433271|FG002|Overall Study|Adverse Event|5|||
170843109|NCT01712061|617433269|FG000|Overall Study|Death|0|||
170843110|NCT01712061|617433270|FG001|Overall Study|Death|0|||
170843111|NCT01712061|617433271|FG002|Overall Study|Death|1|||
170843112|NCT01712061|617433269|FG000|Overall Study|Lost to Follow-up|1|||
170843113|NCT01712061|617433270|FG001|Overall Study|Lost to Follow-up|0|||
170843114|NCT01712061|617433271|FG002|Overall Study|Lost to Follow-up|1|||
170843115|NCT01712061|617433269|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
170843116|NCT01712061|617433270|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
170843117|NCT01712061|617433271|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
170843118|NCT01712061|617433269|FG000|Overall Study|Medication Error Without Associated AE|0|||
170843119|NCT01712061|617433270|FG001|Overall Study|Medication Error Without Associated AE|1|||
170843120|NCT01712061|617433271|FG002|Overall Study|Medication Error Without Associated AE|0|||
170843121|NCT01712061|617433269|FG000|Overall Study|Withdrawal by Subject|1|||
170843122|NCT01712061|617433270|FG001|Overall Study|Withdrawal by Subject|7|||
170843123|NCT01712061|617433271|FG002|Overall Study|Withdrawal by Subject|1|||
170843124|NCT01712061|617433269|FG000|Overall Study|Other|0|||
170843125|NCT01712061|617433270|FG001|Overall Study|Other|3|||
170843126|NCT01712061|617433271|FG002|Overall Study|Other|0|||
170843127|NCT01263509|617433274|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
170843128|NCT01263509|617433275|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
170843129|NCT01263509|617433276|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
170843130|NCT01263509|617433277|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
170843131|NCT01263509|617433274|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
170843132|NCT01263509|617433275|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
170843133|NCT01263509|617433276|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
170843134|NCT01263509|617433277|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
170843135|NCT01263509|617433274|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
170843136|NCT01263509|617433275|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
170843137|NCT01263509|617433276|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
170843138|NCT01263509|617433277|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
170736349|NCT04270747|617040452|FG001|Post Week 16|Consent Withdrawn|3|||
170736350|NCT04270747|617040453|FG002|Post Week 16|Consent Withdrawn|6|||
170736351|NCT04270747|617040451|FG000|Post Week 16|Physician Decision|3|||
170736352|NCT04270747|617040452|FG001|Post Week 16|Physician Decision|1|||
170736353|NCT04270747|617040453|FG002|Post Week 16|Physician Decision|1|||
170736354|NCT04270747|617040451|FG000|Post Week 16|Lost to Follow-up|2|||
170736355|NCT04270747|617040452|FG001|Post Week 16|Lost to Follow-up|1|||
170736356|NCT04270747|617040453|FG002|Post Week 16|Lost to Follow-up|0|||
170736357|NCT04270747|617040451|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
170736358|NCT04270747|617040452|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
170736359|NCT04270747|617040453|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
170736360|NCT04270747|617040451|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
170736361|NCT04270747|617040452|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
170736362|NCT04270747|617040453|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
170736363|NCT04270747|617040451|FG000|Post Week 16|Miscellaneous|1|||
170736364|NCT04270747|617040452|FG001|Post Week 16|Miscellaneous|0|||
170736365|NCT04270747|617040453|FG002|Post Week 16|Miscellaneous|1|||
170736366|NCT05004688|617040454|FG000|Overall Study|Protocol Violation|7|||
170736367|NCT05004688|617040454|FG000|Overall Study|Physician Decision|2|||
170736368|NCT05004688|617040454|FG000|Overall Study|Withdrawal by Subject|2|||
170736369|NCT00532155|617040457|FG000|Overall Study|Adverse Event|66|||
170736370|NCT00532155|617040458|FG001|Overall Study|Adverse Event|123|||
170736371|NCT00532155|617040457|FG000|Overall Study|Lack of Efficacy|332|||
170736372|NCT00532155|617040458|FG001|Overall Study|Lack of Efficacy|255|||
170736373|NCT00532155|617040457|FG000|Overall Study|Protocol Violation|1|||
170736374|NCT00532155|617040458|FG001|Overall Study|Protocol Violation|3|||
170736375|NCT00532155|617040457|FG000|Overall Study|Lost to Follow-up|2|||
170736376|NCT00532155|617040458|FG001|Overall Study|Lost to Follow-up|0|||
170736377|NCT00532155|617040457|FG000|Overall Study|Physician Decision|16|||
170736378|NCT00532155|617040458|FG001|Overall Study|Physician Decision|15|||
170736379|NCT00532155|617040457|FG000|Overall Study|Withdrawal by Subject|23|||
170736380|NCT00532155|617040458|FG001|Overall Study|Withdrawal by Subject|44|||
170736381|NCT00532155|617040457|FG000|Overall Study|Consent withdrawn|5|||
170736382|NCT00532155|617040458|FG001|Overall Study|Consent withdrawn|7|||
170736383|NCT00532155|617040457|FG000|Overall Study|Moved|1|||
170736384|NCT00532155|617040458|FG001|Overall Study|Moved|0|||
170736385|NCT00532155|617040457|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
170736386|NCT00532155|617040458|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
170736387|NCT00532155|617040457|FG000|Overall Study|Occurence of a second cancer|0|||
170736388|NCT00532155|617040458|FG001|Overall Study|Occurence of a second cancer|1|||
170736389|NCT00532155|617040457|FG000|Overall Study|Occurence of a secondary cancer|0|||
170736390|NCT00532155|617040458|FG001|Overall Study|Occurence of a secondary cancer|1|||
170736391|NCT00532155|617040457|FG000|Overall Study|Promotor ended study|1|||
170736392|NCT00532155|617040458|FG001|Overall Study|Promotor ended study|0|||
170736393|NCT00532155|617040457|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
170736394|NCT00532155|617040458|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
170736395|NCT00532155|617040457|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
170736396|NCT00532155|617040458|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
170736397|NCT00532155|617040457|FG000|Overall Study|Study stopped|1|||
170736398|NCT00532155|617040458|FG001|Overall Study|Study stopped|0|||
170736399|NCT00532155|617040457|FG000|Overall Study|Study terminated by sponsor|1|||
170736400|NCT00532155|617040458|FG001|Overall Study|Study terminated by sponsor|0|||
170736401|NCT00532155|617040457|FG000|Overall Study|Study termination stop further treatment|4|||
170736402|NCT00532155|617040458|FG001|Overall Study|Study termination stop further treatment|0|||
170736403|NCT00532155|617040457|FG000|Overall Study|Did not receive study medication|2|||
170736404|NCT00532155|617040458|FG001|Overall Study|Did not receive study medication|6|||
170736405|NCT03635489|617040459|FG000|Overall Study|Death|19|||
170736406|NCT03635489|617040460|FG001|Overall Study|Death|13|||
170736407|NCT03635489|617040459|FG000|Overall Study|Lost to Follow-up|1|||
170736408|NCT03635489|617040460|FG001|Overall Study|Lost to Follow-up|2|||
170736409|NCT03635489|617040459|FG000|Overall Study|Withdrawal by Subject|1|||
170736410|NCT03635489|617040460|FG001|Overall Study|Withdrawal by Subject|2|||
170736411|NCT03635489|617040459|FG000|Overall Study|Study Ended by Sponsor|28|||
170736412|NCT03635489|617040460|FG001|Overall Study|Study Ended by Sponsor|34|||
170736413|NCT00654901|617040474|FG000|Overall Study|Lost to Follow-up|1|||
170736414|NCT00654901|617040475|FG001|Overall Study|Lost to Follow-up|0|||
170736415|NCT00654901|617040476|FG002|Overall Study|Lost to Follow-up|1|||
170736416|NCT00654901|617040477|FG003|Overall Study|Lost to Follow-up|0|||
170736417|NCT00654901|617040474|FG000|Overall Study|Withdrawal by Subject|3|||
170736418|NCT00654901|617040475|FG001|Overall Study|Withdrawal by Subject|0|||
170736419|NCT00654901|617040476|FG002|Overall Study|Withdrawal by Subject|1|||
170736420|NCT00654901|617040477|FG003|Overall Study|Withdrawal by Subject|0|||
170843139|NCT01263509|617433274|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
170843140|NCT01263509|617433275|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
170843141|NCT01263509|617433276|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170843142|NCT01263509|617433277|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
170843143|NCT01263509|617433274|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
170843144|NCT01263509|617433275|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
170843145|NCT01263509|617433276|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
170843146|NCT01263509|617433277|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
170843147|NCT05071053|617433278|FG000|Overall Study|Progressive disease|30|||
170843148|NCT05071053|617433278|FG000|Overall Study|Adverse Event|5|||
170843149|NCT01572740|617433281|FG000|Overall Study|Adverse Event|1|||
170843150|NCT01572740|617433282|FG001|Overall Study|Adverse Event|1|||
170843151|NCT01572740|617433281|FG000|Overall Study|Withdrawal by Subject|1|||
170843152|NCT01572740|617433282|FG001|Overall Study|Withdrawal by Subject|1|||
170843153|NCT01572740|617433281|FG000|Overall Study|unclassified|4|||
170843154|NCT01572740|617433282|FG001|Overall Study|unclassified|3|||
170843155|NCT00214019|617433286|FG000|Overall Study|Lost to Follow-up|11|||
170843156|NCT00214019|617433286|FG000|Overall Study|Withdrawal by Subject|2|||
170843157|NCT00214019|617433286|FG000|Overall Study|Screen Failed prior to randomization|17|||
170843158|NCT00477490|617433287|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
170843159|NCT00477490|617433288|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
170843160|NCT00477490|617433289|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
170843161|NCT00477490|617433290|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
170843162|NCT00477490|617433291|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
170843163|NCT00477490|617433292|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
170843164|NCT00477490|617433293|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
170843165|NCT00477490|617433294|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
170843166|NCT00477490|617433295|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
170843167|NCT00477490|617433287|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
170843168|NCT00477490|617433288|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
170843169|NCT00477490|617433289|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
170843170|NCT00477490|617433290|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
170843171|NCT00477490|617433291|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
170843172|NCT00477490|617433292|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
170843173|NCT00477490|617433293|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
170843174|NCT00477490|617433294|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
170843175|NCT00477490|617433295|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
170843176|NCT00477490|617433287|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
170843177|NCT00477490|617433288|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
170843178|NCT00477490|617433289|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
170843179|NCT00477490|617433290|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
170843180|NCT00477490|617433291|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
170843181|NCT00477490|617433292|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
170843182|NCT00477490|617433293|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
170843183|NCT00477490|617433294|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
170843184|NCT00477490|617433295|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
170843185|NCT00477490|617433287|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
170843186|NCT00477490|617433288|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
170843187|NCT00477490|617433289|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
170843188|NCT00477490|617433290|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
170843189|NCT00477490|617433291|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
170843190|NCT00477490|617433292|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
170843191|NCT00477490|617433293|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
170843192|NCT00477490|617433294|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
170843193|NCT00477490|617433295|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
170843194|NCT00477490|617433287|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
170843195|NCT00477490|617433288|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
170843196|NCT00477490|617433289|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
170843197|NCT00477490|617433290|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
170843198|NCT00477490|617433291|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
170843199|NCT00477490|617433292|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
170843200|NCT00477490|617433293|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
170843201|NCT00477490|617433294|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
170843202|NCT00477490|617433295|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
170843203|NCT00477490|617433287|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
170843204|NCT00477490|617433288|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
170843205|NCT00477490|617433289|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
170843206|NCT00477490|617433290|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
170843207|NCT00477490|617433291|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
170843208|NCT00477490|617433292|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
170843209|NCT00477490|617433293|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
170843210|NCT00477490|617433294|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
170843211|NCT00477490|617433295|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
170843212|NCT00477490|617433287|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
170843213|NCT00477490|617433288|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
170843214|NCT00477490|617433289|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
170843215|NCT00477490|617433290|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
170843216|NCT00477490|617433291|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
170843217|NCT00477490|617433292|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
170843218|NCT00477490|617433293|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
170843219|NCT00477490|617433294|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
170843220|NCT00477490|617433295|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
170843221|NCT00477490|617433287|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
170843222|NCT00477490|617433288|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
170843223|NCT00477490|617433289|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
170843224|NCT00477490|617433290|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
170843225|NCT00477490|617433291|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
170843226|NCT00477490|617433292|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
170843227|NCT00477490|617433293|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
170843228|NCT00477490|617433294|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
170843229|NCT00477490|617433295|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
170843230|NCT00477490|617433287|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
170843231|NCT00477490|617433288|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
170843232|NCT00477490|617433289|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
170843233|NCT00477490|617433290|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
170843234|NCT00477490|617433291|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
170843235|NCT00477490|617433292|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
170843236|NCT00477490|617433293|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
170843237|NCT00477490|617433294|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
170843238|NCT00477490|617433295|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
170843239|NCT00477490|617433287|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
170843240|NCT00477490|617433288|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
170843241|NCT00477490|617433289|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
170843242|NCT00477490|617433290|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
170843243|NCT00477490|617433291|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
170843244|NCT00477490|617433292|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
170843245|NCT00477490|617433293|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
170843246|NCT00477490|617433294|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
170843247|NCT00477490|617433295|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
170843248|NCT00477490|617433287|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
170843249|NCT00477490|617433288|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
170843250|NCT00477490|617433289|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
170843251|NCT00477490|617433290|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
170843252|NCT00477490|617433291|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
170843253|NCT00477490|617433292|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
170843254|NCT00477490|617433293|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
170843255|NCT00477490|617433294|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
170843256|NCT00477490|617433295|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
170843257|NCT00477490|617433287|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
170843258|NCT00477490|617433288|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
170843259|NCT00477490|617433289|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
170843260|NCT00477490|617433290|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
170843261|NCT00477490|617433291|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
170843262|NCT00477490|617433292|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
170843263|NCT00477490|617433293|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
170843264|NCT00477490|617433294|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
170843265|NCT00477490|617433295|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
170843266|NCT00477490|617433287|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
170843267|NCT00477490|617433288|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
170843268|NCT00477490|617433289|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
170843269|NCT00477490|617433290|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
170843270|NCT00477490|617433291|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
170843271|NCT00477490|617433292|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
170843272|NCT00477490|617433293|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
170843273|NCT00477490|617433294|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
170843274|NCT00477490|617433295|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
170736421|NCT04179721|617040479|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
170736422|NCT04179721|617040480|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
170736423|NCT04179721|617040479|FG000|Overall Study|Lost to Follow-up|0|||
170736424|NCT04179721|617040480|FG001|Overall Study|Lost to Follow-up|1|||
170736425|NCT00975221|617042292|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
170736426|NCT00975221|617042293|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
170736427|NCT00975221|617042292|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
170736428|NCT00975221|617042293|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
170736429|NCT00975221|617042292|FG000|Titration Phase (Weeks 1-12)|Other|0|||
170736430|NCT00975221|617042293|FG001|Titration Phase (Weeks 1-12)|Other|1|||
170736431|NCT00975221|617042292|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
170736432|NCT00975221|617042293|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
170736433|NCT00975221|617042292|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
170736434|NCT00975221|617042293|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
170736435|NCT00975221|617042292|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
170736436|NCT00975221|617042293|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
170736437|NCT00710606|617042300|FG000|Overall Study|Adverse Event|0|||
170736438|NCT00710606|617042301|FG001|Overall Study|Adverse Event|2|||
170736439|NCT05056870|617042306|FG000|Period 1|Site COVID-19 Related|3|||
170736440|NCT05056870|617042307|FG001|Period 1|Site COVID-19 Related|3|||
170736441|NCT05056870|617042306|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
170736442|NCT05056870|617042307|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
170736443|NCT05056870|617042306|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
170736444|NCT05056870|617042307|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
170736445|NCT05056870|617042306|FG000|Period 2|COVID-19 Related|1|||
170736446|NCT05056870|617042307|FG001|Period 2|COVID-19 Related|0|||
170736447|NCT05056870|617042306|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
170736448|NCT05056870|617042307|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
170736449|NCT02670538|617042310|FG000|Overall Study|Withdrawal of Consent|8|||
170736450|NCT02670538|617042311|FG001|Overall Study|Withdrawal of Consent|6|||
170736451|NCT02670538|617042312|FG002|Overall Study|Withdrawal of Consent|5|||
170736452|NCT02670538|617042310|FG000|Overall Study|Lost to Follow-up|8|||
170736453|NCT02670538|617042311|FG001|Overall Study|Lost to Follow-up|12|||
170736454|NCT02670538|617042312|FG002|Overall Study|Lost to Follow-up|7|||
170736455|NCT02670538|617042310|FG000|Overall Study|Adverse Event|5|||
170736456|NCT02670538|617042311|FG001|Overall Study|Adverse Event|5|||
170736457|NCT02670538|617042312|FG002|Overall Study|Adverse Event|11|||
170736458|NCT02670538|617042310|FG000|Overall Study|Lack of Efficacy|7|||
170736459|NCT02670538|617042311|FG001|Overall Study|Lack of Efficacy|1|||
170736460|NCT02670538|617042312|FG002|Overall Study|Lack of Efficacy|2|||
170736461|NCT02670538|617042310|FG000|Overall Study|Protocol Violation|3|||
170736462|NCT02670538|617042311|FG001|Overall Study|Protocol Violation|4|||
170736463|NCT02670538|617042312|FG002|Overall Study|Protocol Violation|1|||
170736464|NCT02670538|617042310|FG000|Overall Study|Noncompliance with Study Drug|1|||
170736465|NCT02670538|617042311|FG001|Overall Study|Noncompliance with Study Drug|3|||
170736466|NCT02670538|617042312|FG002|Overall Study|Noncompliance with Study Drug|2|||
170736467|NCT02670538|617042310|FG000|Overall Study|Other Miscellaneous Reasons|0|||
170736468|NCT02670538|617042311|FG001|Overall Study|Other Miscellaneous Reasons|1|||
170736469|NCT02670538|617042312|FG002|Overall Study|Other Miscellaneous Reasons|2|||
170736470|NCT02243202|617042314|FG000|Overall Study|Adverse Event|5|||
170736471|NCT02243202|617042315|FG001|Overall Study|Adverse Event|6|||
170736472|NCT02243202|617042316|FG002|Overall Study|Adverse Event|10|||
170736473|NCT02243202|617042317|FG003|Overall Study|Adverse Event|4|||
170736474|NCT02243202|617042314|FG000|Overall Study|Lost to Follow-up|9|||
170736475|NCT02243202|617042315|FG001|Overall Study|Lost to Follow-up|9|||
170736476|NCT02243202|617042316|FG002|Overall Study|Lost to Follow-up|14|||
170736477|NCT02243202|617042317|FG003|Overall Study|Lost to Follow-up|11|||
170736478|NCT02243202|617042314|FG000|Overall Study|Protocol Violation|3|||
170736479|NCT02243202|617042315|FG001|Overall Study|Protocol Violation|1|||
170736480|NCT02243202|617042316|FG002|Overall Study|Protocol Violation|2|||
170736481|NCT02243202|617042317|FG003|Overall Study|Protocol Violation|1|||
170736482|NCT02243202|617042314|FG000|Overall Study|Withdrawal by Subject|7|||
170736483|NCT02243202|617042315|FG001|Overall Study|Withdrawal by Subject|6|||
170736484|NCT02243202|617042316|FG002|Overall Study|Withdrawal by Subject|4|||
170736485|NCT02243202|617042317|FG003|Overall Study|Withdrawal by Subject|4|||
170736486|NCT02243202|617042314|FG000|Overall Study|Other|1|||
170736487|NCT02243202|617042315|FG001|Overall Study|Other|3|||
170736488|NCT02243202|617042316|FG002|Overall Study|Other|1|||
170736489|NCT02243202|617042317|FG003|Overall Study|Other|2|||
170736490|NCT02243202|617042314|FG000|Overall Study|Randomized but not received treatment|0|||
170736491|NCT02243202|617042315|FG001|Overall Study|Randomized but not received treatment|0|||
170736492|NCT02243202|617042316|FG002|Overall Study|Randomized but not received treatment|0|||
170736493|NCT02243202|617042317|FG003|Overall Study|Randomized but not received treatment|1|||
170736494|NCT01147822|617042318|FG000|Overall Study|Lost to Follow-up|14|||
170843275|NCT00477490|617433287|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
170843276|NCT00477490|617433288|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
170843277|NCT00477490|617433289|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
170843278|NCT00477490|617433290|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
170843279|NCT00477490|617433291|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
170843280|NCT00477490|617433292|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
170843281|NCT00477490|617433293|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
170843282|NCT00477490|617433294|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
170843283|NCT00477490|617433295|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
170843284|NCT01465763|617433296|FG000|Overall Study|Withdrawal by Subject|4|||
170843285|NCT01465763|617433297|FG001|Overall Study|Withdrawal by Subject|0|||
170843286|NCT01465763|617433298|FG002|Overall Study|Withdrawal by Subject|1|||
170843287|NCT01465763|617433296|FG000|Overall Study|Insufficient Clinical Response|11|||
170843288|NCT01465763|617433297|FG001|Overall Study|Insufficient Clinical Response|0|||
170843289|NCT01465763|617433298|FG002|Overall Study|Insufficient Clinical Response|1|||
170843290|NCT01465763|617433296|FG000|Overall Study|Adverse Event|9|||
170843291|NCT01465763|617433297|FG001|Overall Study|Adverse Event|0|||
170843292|NCT01465763|617433298|FG002|Overall Study|Adverse Event|1|||
170843293|NCT01465763|617433296|FG000|Overall Study|Other|2|||
170736495|NCT01147822|617042319|FG001|Overall Study|Lost to Follow-up|6|||
170736496|NCT01147822|617042318|FG000|Overall Study|Withdrawal by Subject|10|||
170736497|NCT01147822|617042319|FG001|Overall Study|Withdrawal by Subject|16|||
170736498|NCT01147822|617042318|FG000|Overall Study|Physician Decision|9|||
170736499|NCT01147822|617042319|FG001|Overall Study|Physician Decision|8|||
170736500|NCT01147822|617042318|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
170736501|NCT01147822|617042319|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
170736502|NCT01147822|617042318|FG000|Overall Study|Protocol Violation|1|||
170736503|NCT01147822|617042319|FG001|Overall Study|Protocol Violation|1|||
170736504|NCT02013388|617042322|FG000|Overall Study|work emergency|1|||
170736505|NCT02013388|617042323|FG001|Overall Study|work emergency|0|||
170736506|NCT02013388|617042324|FG002|Overall Study|work emergency|0|||
170736507|NCT02013388|617042325|FG003|Overall Study|work emergency|0|||
170736508|NCT02013388|617042326|FG004|Overall Study|work emergency|1|||
170736509|NCT02013388|617042327|FG005|Overall Study|work emergency|0|||
170736510|NCT02013388|617042328|FG006|Overall Study|work emergency|0|||
170736511|NCT02013388|617042329|FG007|Overall Study|work emergency|0|||
170736512|NCT01559454|617042332|FG000|Overall Study|Lost to Follow-up|3|||
170736513|NCT01559454|617042333|FG001|Overall Study|Lost to Follow-up|2|||
170736514|NCT01559454|617042332|FG000|Overall Study|Withdrawal by Subject|0|||
170736515|NCT01559454|617042333|FG001|Overall Study|Withdrawal by Subject|1|||
170736516|NCT01559454|617042332|FG000|Overall Study|Physician Decision|0|||
170736517|NCT01559454|617042333|FG001|Overall Study|Physician Decision|1|||
170736518|NCT01559454|617042332|FG000|Overall Study|Protocol Violation|0|||
170736519|NCT01559454|617042333|FG001|Overall Study|Protocol Violation|1|||
170736520|NCT01559454|617042332|FG000|Overall Study|Lack of Efficacy|0|||
170736521|NCT01559454|617042333|FG001|Overall Study|Lack of Efficacy|1|||
170736522|NCT01114204|617042334|FG000|Overall Study|Adverse Event|3|||
170736523|NCT01114204|617042335|FG001|Overall Study|Adverse Event|2|||
170736524|NCT01114204|617042334|FG000|Overall Study|Lost to Follow-up|1|||
170736525|NCT01114204|617042335|FG001|Overall Study|Lost to Follow-up|0|||
170736526|NCT01114204|617042334|FG000|Overall Study|Withdrawal by Subject|10|||
170843294|NCT01465763|617433297|FG001|Overall Study|Other|0|||
170843295|NCT01465763|617433298|FG002|Overall Study|Other|0|||
170843296|NCT01465763|617433296|FG000|Overall Study|Protocol Violation|4|||
170843297|NCT01465763|617433297|FG001|Overall Study|Protocol Violation|1|||
170736527|NCT01114204|617042335|FG001|Overall Study|Withdrawal by Subject|6|||
170736528|NCT01114204|617042334|FG000|Overall Study|Death|1|||
170736529|NCT01114204|617042335|FG001|Overall Study|Death|0|||
170736530|NCT01114204|617042334|FG000|Overall Study|Other-Personal reasons|2|||
170736531|NCT01114204|617042335|FG001|Overall Study|Other-Personal reasons|0|||
170736532|NCT01114204|617042334|FG000|Overall Study|Other-Medical monitor request|1|||
170843298|NCT01465763|617433298|FG002|Overall Study|Protocol Violation|1|||
170843299|NCT01465763|617433296|FG000|Overall Study|Death|1|||
170843300|NCT01465763|617433297|FG001|Overall Study|Death|0|||
170843301|NCT01465763|617433298|FG002|Overall Study|Death|0|||
170843302|NCT00588692|617433299|FG000|Overall Study|Withdrawal by Subject|4|||
170843303|NCT00588692|617433300|FG001|Overall Study|Withdrawal by Subject|2|||
170843304|NCT00588692|617433299|FG000|Overall Study|Hip Surgery|0|||
170843305|NCT00588692|617433300|FG001|Overall Study|Hip Surgery|1|||
170843306|NCT00588692|617433299|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
170843307|NCT00588692|617433300|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
170843308|NCT00588692|617433299|FG000|Overall Study|Cancer|1|||
170843309|NCT00588692|617433300|FG001|Overall Study|Cancer|0|||
170843310|NCT00588692|617433299|FG000|Overall Study|Death|1|||
170843311|NCT00588692|617433300|FG001|Overall Study|Death|0|||
170843312|NCT00820170|617433302|FG000|Overall Study|Adverse Event|0|||
170843313|NCT00820170|617433303|FG001|Overall Study|Adverse Event|0|||
170843314|NCT00820170|617433304|FG002|Overall Study|Adverse Event|0|||
170843315|NCT00820170|617433305|FG003|Overall Study|Adverse Event|0|||
170843316|NCT00820170|617433306|FG004|Overall Study|Adverse Event|2|||
170843317|NCT00820170|617433302|FG000|Overall Study|Progressive Disease|0|||
170843318|NCT00820170|617433303|FG001|Overall Study|Progressive Disease|0|||
170843319|NCT00820170|617433304|FG002|Overall Study|Progressive Disease|0|||
170843320|NCT00820170|617433305|FG003|Overall Study|Progressive Disease|0|||
170843321|NCT00820170|617433306|FG004|Overall Study|Progressive Disease|2|||
170843322|NCT03538938|617433307|FG000|Overall Study|Death|0|||
170843323|NCT03538938|617433308|FG001|Overall Study|Death|0|||
170843324|NCT03538938|617433309|FG002|Overall Study|Death|2|||
170843325|NCT03538938|617433310|FG003|Overall Study|Death|0|||
170843326|NCT03538938|617433311|FG004|Overall Study|Death|0|||
170843327|NCT03538938|617433312|FG005|Overall Study|Death|1|||
170843328|NCT03538938|617433313|FG006|Overall Study|Death|0|||
170843329|NCT03538938|617433314|FG007|Overall Study|Death|1|||
170843330|NCT03538938|617433315|FG008|Overall Study|Death|1|||
170843331|NCT03538938|617433316|FG009|Overall Study|Death|1|||
170843332|NCT03538938|617433317|FG010|Overall Study|Death|0|||
170843333|NCT03538938|617433318|FG011|Overall Study|Death|0|||
170843334|NCT03538938|617433319|FG012|Overall Study|Death|1|||
170843335|NCT03538938|617433320|FG013|Overall Study|Death|1|||
170843336|NCT03538938|617433321|FG014|Overall Study|Death|0|||
170843337|NCT03538938|617433322|FG015|Overall Study|Death|1|||
170843338|NCT03538938|617433307|FG000|Overall Study|Withdrawal by Subject|4|||
170843339|NCT03538938|617433308|FG001|Overall Study|Withdrawal by Subject|6|||
170843340|NCT03538938|617433309|FG002|Overall Study|Withdrawal by Subject|5|||
170843341|NCT03538938|617433310|FG003|Overall Study|Withdrawal by Subject|3|||
170736533|NCT01114204|617042335|FG001|Overall Study|Other-Medical monitor request|0|||
170736534|NCT01114204|617042334|FG000|Overall Study|Other-Participant request|2|||
170736535|NCT01114204|617042335|FG001|Overall Study|Other-Participant request|0|||
170736536|NCT01114204|617042334|FG000|Overall Study|Other-Protocol Violation|1|||
170736537|NCT01114204|617042335|FG001|Overall Study|Other-Protocol Violation|0|||
170736538|NCT00991341|617042339|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
170736539|NCT00991341|617042340|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
170736540|NCT00991341|617042339|FG000|Overall Study|Death|3|||
170736541|NCT00991341|617042340|FG001|Overall Study|Death|0|||
170736542|NCT00991341|617042339|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
170736543|NCT00991341|617042340|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
170736544|NCT00991341|617042339|FG000|Overall Study|Physician Decision|1|||
170736545|NCT00991341|617042340|FG001|Overall Study|Physician Decision|2|||
170736546|NCT00991341|617042339|FG000|Overall Study|Withdrawal by Subject|3|||
170736547|NCT00991341|617042340|FG001|Overall Study|Withdrawal by Subject|4|||
170736548|NCT03010462|617042342|FG000|Overall Study|Withdrawal by Subject|3|||
170736549|NCT03010462|617042343|FG001|Overall Study|Withdrawal by Subject|1|||
170736550|NCT02207725|617042344|FG000|Overall Study|Did Not Receive Treatment|0|||
170736551|NCT02207725|617042345|FG001|Overall Study|Did Not Receive Treatment|1|||
170736552|NCT02207725|617042346|FG002|Overall Study|Did Not Receive Treatment|1|||
170736553|NCT02207725|617042347|FG003|Overall Study|Did Not Receive Treatment|1|||
170736554|NCT03170375|617042349|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
170736555|NCT03170375|617042350|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
170736556|NCT03170375|617042351|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
170736557|NCT03170375|617042349|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
170843342|NCT03538938|617433311|FG004|Overall Study|Withdrawal by Subject|0|||
170843343|NCT03538938|617433312|FG005|Overall Study|Withdrawal by Subject|0|||
170843344|NCT03538938|617433313|FG006|Overall Study|Withdrawal by Subject|3|||
170843345|NCT03538938|617433314|FG007|Overall Study|Withdrawal by Subject|1|||
170843346|NCT03538938|617433315|FG008|Overall Study|Withdrawal by Subject|5|||
170843347|NCT03538938|617433316|FG009|Overall Study|Withdrawal by Subject|1|||
170843348|NCT03538938|617433317|FG010|Overall Study|Withdrawal by Subject|2|||
170843349|NCT03538938|617433318|FG011|Overall Study|Withdrawal by Subject|1|||
170843350|NCT03538938|617433319|FG012|Overall Study|Withdrawal by Subject|3|||
170843351|NCT03538938|617433320|FG013|Overall Study|Withdrawal by Subject|0|||
170843352|NCT03538938|617433321|FG014|Overall Study|Withdrawal by Subject|2|||
170843353|NCT03538938|617433322|FG015|Overall Study|Withdrawal by Subject|4|||
170843354|NCT03538938|617433307|FG000|Overall Study|Incarcerated|0|||
170843355|NCT03538938|617433308|FG001|Overall Study|Incarcerated|0|||
170843356|NCT03538938|617433309|FG002|Overall Study|Incarcerated|0|||
170843357|NCT03538938|617433310|FG003|Overall Study|Incarcerated|0|||
170843358|NCT03538938|617433311|FG004|Overall Study|Incarcerated|0|||
170843359|NCT03538938|617433312|FG005|Overall Study|Incarcerated|0|||
170843360|NCT03538938|617433313|FG006|Overall Study|Incarcerated|0|||
170843361|NCT03538938|617433314|FG007|Overall Study|Incarcerated|0|||
170843362|NCT03538938|617433315|FG008|Overall Study|Incarcerated|0|||
170843363|NCT03538938|617433316|FG009|Overall Study|Incarcerated|0|||
170843364|NCT03538938|617433317|FG010|Overall Study|Incarcerated|0|||
170843365|NCT03538938|617433318|FG011|Overall Study|Incarcerated|1|||
170843366|NCT03538938|617433319|FG012|Overall Study|Incarcerated|0|||
170843367|NCT03538938|617433320|FG013|Overall Study|Incarcerated|0|||
170843368|NCT03538938|617433321|FG014|Overall Study|Incarcerated|0|||
170843369|NCT03538938|617433322|FG015|Overall Study|Incarcerated|0|||
170843370|NCT00755105|617433323|FG000|Overall Study|Withdrawal by Subject|9|||
170843371|NCT00755105|617433324|FG001|Overall Study|Withdrawal by Subject|11|||
170843372|NCT00755105|617433325|FG002|Overall Study|Withdrawal by Subject|4|||
170843373|NCT03995316|617433326|FG000|Overall Study|Lost to Follow-up|10|||
170843374|NCT03995316|617433327|FG001|Overall Study|Lost to Follow-up|3|||
170843375|NCT01137578|617433328|FG000|Overall Study|Participant requested to Discontinue|3|||
170843376|NCT01137578|617433329|FG001|Overall Study|Participant requested to Discontinue|0|||
170843377|NCT01137578|617433330|FG002|Overall Study|Participant requested to Discontinue|0|||
170843378|NCT01137578|617433328|FG000|Overall Study|Withdrawal by Subject|1|||
170843379|NCT01137578|617433329|FG001|Overall Study|Withdrawal by Subject|0|||
170843380|NCT01137578|617433330|FG002|Overall Study|Withdrawal by Subject|0|||
170843381|NCT01137578|617433328|FG000|Overall Study|Other|12|||
170843382|NCT01137578|617433329|FG001|Overall Study|Other|2|||
170843383|NCT01137578|617433330|FG002|Overall Study|Other|6|||
170843384|NCT00780559|617433333|FG000|Overall Study|Lost to Follow-up|2|||
170843385|NCT00780559|617433334|FG001|Overall Study|Lost to Follow-up|7|||
170843386|NCT00780559|617433333|FG000|Overall Study|Death|1|||
170843387|NCT00780559|617433334|FG001|Overall Study|Death|0|||
170843388|NCT03945825|617433339|FG000|Overall Study|Enrolled but treatment not administered|0|||
170843389|NCT03945825|617433340|FG001|Overall Study|Enrolled but treatment not administered|0|||
170843390|NCT03945825|617433341|FG002|Overall Study|Enrolled but treatment not administered|0|||
170736558|NCT03170375|617042350|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
170736559|NCT03170375|617042351|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
170736560|NCT04543188|617042353|FG000|Phase 1a|Adverse Event|0|||
170736561|NCT04543188|617042354|FG001|Phase 1a|Adverse Event|0|||
170736562|NCT04543188|617042355|FG002|Phase 1a|Adverse Event|0|||
170736563|NCT04543188|617042356|FG003|Phase 1a|Adverse Event|1|||
170736564|NCT04543188|617042357|FG004|Phase 1a|Adverse Event|0|||
170736565|NCT04543188|617042358|FG005|Phase 1a|Adverse Event|0|||
170736566|NCT04543188|617042359|FG006|Phase 1a|Adverse Event|1|||
170736567|NCT04543188|617042360|FG007|Phase 1a|Adverse Event|0|||
170736568|NCT04543188|617042361|FG008|Phase 1a|Adverse Event|0|||
170736569|NCT04543188|617042362|FG009|Phase 1a|Adverse Event|0|||
170736570|NCT04543188|617042363|FG010|Phase 1a|Adverse Event|0|||
170736571|NCT04543188|617042364|FG011|Phase 1a|Adverse Event|0|||
170736572|NCT04543188|617042365|FG012|Phase 1a|Adverse Event|0|||
170736573|NCT04543188|617042366|FG013|Phase 1a|Adverse Event|0|||
170736574|NCT04543188|617042367|FG014|Phase 1a|Adverse Event|0|||
170736575|NCT04543188|617042353|FG000|Phase 1a|Other (Death)|0|||
170736576|NCT04543188|617042354|FG001|Phase 1a|Other (Death)|1|||
170736577|NCT04543188|617042355|FG002|Phase 1a|Other (Death)|0|||
170736578|NCT04543188|617042356|FG003|Phase 1a|Other (Death)|0|||
170736579|NCT04543188|617042357|FG004|Phase 1a|Other (Death)|1|||
170736580|NCT04543188|617042358|FG005|Phase 1a|Other (Death)|0|||
170736581|NCT04543188|617042359|FG006|Phase 1a|Other (Death)|0|||
170736582|NCT04543188|617042360|FG007|Phase 1a|Other (Death)|0|||
170736583|NCT04543188|617042361|FG008|Phase 1a|Other (Death)|0|||
170736584|NCT04543188|617042362|FG009|Phase 1a|Other (Death)|1|||
170736585|NCT04543188|617042363|FG010|Phase 1a|Other (Death)|0|||
170736586|NCT04543188|617042364|FG011|Phase 1a|Other (Death)|0|||
170736587|NCT04543188|617042365|FG012|Phase 1a|Other (Death)|0|||
170736588|NCT04543188|617042366|FG013|Phase 1a|Other (Death)|0|||
170736589|NCT04543188|617042367|FG014|Phase 1a|Other (Death)|0|||
170736590|NCT04543188|617042353|FG000|Phase 1a|Lost to Follow-up|0|||
170736591|NCT04543188|617042354|FG001|Phase 1a|Lost to Follow-up|0|||
170736592|NCT04543188|617042355|FG002|Phase 1a|Lost to Follow-up|0|||
170736593|NCT04543188|617042356|FG003|Phase 1a|Lost to Follow-up|0|||
170736594|NCT04543188|617042357|FG004|Phase 1a|Lost to Follow-up|0|||
170736595|NCT04543188|617042358|FG005|Phase 1a|Lost to Follow-up|0|||
170736596|NCT04543188|617042359|FG006|Phase 1a|Lost to Follow-up|0|||
170736597|NCT04543188|617042360|FG007|Phase 1a|Lost to Follow-up|0|||
170736598|NCT04543188|617042361|FG008|Phase 1a|Lost to Follow-up|0|||
170736599|NCT04543188|617042362|FG009|Phase 1a|Lost to Follow-up|0|||
170736600|NCT04543188|617042363|FG010|Phase 1a|Lost to Follow-up|1|||
170736601|NCT04543188|617042364|FG011|Phase 1a|Lost to Follow-up|0|||
170736602|NCT04543188|617042365|FG012|Phase 1a|Lost to Follow-up|0|||
170736603|NCT04543188|617042366|FG013|Phase 1a|Lost to Follow-up|0|||
170736604|NCT04543188|617042367|FG014|Phase 1a|Lost to Follow-up|0|||
170736605|NCT04543188|617042353|FG000|Phase 1a|Progressive Disease|2|||
170736606|NCT04543188|617042354|FG001|Phase 1a|Progressive Disease|2|||
170736607|NCT04543188|617042355|FG002|Phase 1a|Progressive Disease|3|||
170736608|NCT04543188|617042356|FG003|Phase 1a|Progressive Disease|1|||
170736609|NCT04543188|617042357|FG004|Phase 1a|Progressive Disease|4|||
170736610|NCT04543188|617042358|FG005|Phase 1a|Progressive Disease|2|||
170736611|NCT04543188|617042359|FG006|Phase 1a|Progressive Disease|3|||
170736612|NCT04543188|617042360|FG007|Phase 1a|Progressive Disease|4|||
170736613|NCT04543188|617042361|FG008|Phase 1a|Progressive Disease|1|||
170736614|NCT04543188|617042362|FG009|Phase 1a|Progressive Disease|0|||
170736615|NCT04543188|617042363|FG010|Phase 1a|Progressive Disease|4|||
170736616|NCT04543188|617042364|FG011|Phase 1a|Progressive Disease|0|||
170736617|NCT04543188|617042365|FG012|Phase 1a|Progressive Disease|0|||
170736618|NCT04543188|617042366|FG013|Phase 1a|Progressive Disease|0|||
170736619|NCT04543188|617042367|FG014|Phase 1a|Progressive Disease|0|||
170736620|NCT04543188|617042353|FG000|Phase 1a|Study terminated by sponsor|0|||
170736621|NCT04543188|617042354|FG001|Phase 1a|Study terminated by sponsor|0|||
170736622|NCT04543188|617042355|FG002|Phase 1a|Study terminated by sponsor|0|||
170843391|NCT03945825|617433342|FG003|Overall Study|Enrolled but treatment not administered|0|||
170843392|NCT03945825|617433343|FG004|Overall Study|Enrolled but treatment not administered|1|||
170843393|NCT03945825|617433344|FG005|Overall Study|Enrolled but treatment not administered|0|||
170843394|NCT03945825|617433339|FG000|Overall Study|Lost to Follow-up|1|||
170843395|NCT03945825|617433340|FG001|Overall Study|Lost to Follow-up|5|||
170843396|NCT03945825|617433341|FG002|Overall Study|Lost to Follow-up|0|||
170843397|NCT03945825|617433342|FG003|Overall Study|Lost to Follow-up|1|||
170843398|NCT03945825|617433343|FG004|Overall Study|Lost to Follow-up|2|||
170843399|NCT03945825|617433344|FG005|Overall Study|Lost to Follow-up|2|||
170843400|NCT03945825|617433339|FG000|Overall Study|Withdrawal by Subject|1|||
170843401|NCT03945825|617433340|FG001|Overall Study|Withdrawal by Subject|0|||
170843402|NCT03945825|617433341|FG002|Overall Study|Withdrawal by Subject|1|||
170843403|NCT03945825|617433342|FG003|Overall Study|Withdrawal by Subject|1|||
170843404|NCT03945825|617433343|FG004|Overall Study|Withdrawal by Subject|0|||
170843405|NCT03945825|617433344|FG005|Overall Study|Withdrawal by Subject|1|||
170843406|NCT01889069|617433351|FG000|Overall Study|Death|18|||
170843407|NCT01889069|617433351|FG000|Overall Study|Progression of Disease|14|||
170843408|NCT01889069|617433351|FG000|Overall Study|Lost to Follow-up|6|||
170843409|NCT01889069|617433351|FG000|Overall Study|Other|4|||
170843410|NCT01889069|617433351|FG000|Overall Study|Consent Withdrawal|3|||
170843411|NCT00664534|617433356|FG000|Overall Study|Adverse Event|2|||
170843412|NCT00664534|617433357|FG001|Overall Study|Adverse Event|3|||
170843413|NCT00664534|617433356|FG000|Overall Study|Lost to Follow-up|6|||
170843414|NCT00664534|617433357|FG001|Overall Study|Lost to Follow-up|10|||
170843415|NCT00664534|617433356|FG000|Overall Study|Protocol Violation|10|||
170843416|NCT00664534|617433357|FG001|Overall Study|Protocol Violation|8|||
170843417|NCT00664534|617433356|FG000|Overall Study|Withdrawal by Subject|7|||
170843418|NCT00664534|617433357|FG001|Overall Study|Withdrawal by Subject|6|||
170843419|NCT00664534|617433356|FG000|Overall Study|Physician Decision|8|||
170843420|NCT00664534|617433357|FG001|Overall Study|Physician Decision|0|||
170843421|NCT00664534|617433356|FG000|Overall Study|Sponsor decision|8|||
170843422|NCT00664534|617433357|FG001|Overall Study|Sponsor decision|6|||
170843423|NCT04978090|617433358|FG000|Overall Study|unable to adequately fit device|2|||
170843424|NCT00935532|617433359|FG000|Overall Study|Adverse Event|11|||
170736623|NCT04543188|617042356|FG003|Phase 1a|Study terminated by sponsor|0|||
170736624|NCT04543188|617042357|FG004|Phase 1a|Study terminated by sponsor|1|||
170736625|NCT04543188|617042358|FG005|Phase 1a|Study terminated by sponsor|0|||
170736626|NCT04543188|617042359|FG006|Phase 1a|Study terminated by sponsor|0|||
170843425|NCT00935532|617433360|FG001|Overall Study|Adverse Event|6|||
170843426|NCT00935532|617433359|FG000|Overall Study|Death|1|||
170843427|NCT00935532|617433360|FG001|Overall Study|Death|0|||
170843428|NCT00935532|617433359|FG000|Overall Study|Lost to Follow-up|1|||
170843429|NCT00935532|617433360|FG001|Overall Study|Lost to Follow-up|0|||
170843430|NCT00935532|617433359|FG000|Overall Study|Physician Decision|1|||
170843431|NCT00935532|617433360|FG001|Overall Study|Physician Decision|2|||
170843432|NCT00935532|617433359|FG000|Overall Study|Protocol Violation|2|||
170843433|NCT00935532|617433360|FG001|Overall Study|Protocol Violation|1|||
170843434|NCT00935532|617433359|FG000|Overall Study|Subject Decision|2|||
170843435|NCT00935532|617433360|FG001|Overall Study|Subject Decision|1|||
170843436|NCT00935532|617433359|FG000|Overall Study|Sponsor Decision|0|||
170843437|NCT00935532|617433360|FG001|Overall Study|Sponsor Decision|1|||
170843438|NCT00935532|617433359|FG000|Overall Study|Loss Glucose Control|4|||
170843439|NCT00935532|617433360|FG001|Overall Study|Loss Glucose Control|0|||
170843440|NCT01399918|617433374|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
170843441|NCT03083665|617433381|FG000|Double-Blind Period|Adverse Event|5|||
170843442|NCT03083665|617433382|FG001|Double-Blind Period|Adverse Event|4|||
170843443|NCT03083665|617433383|FG002|Double-Blind Period|Adverse Event|5|||
170843444|NCT03083665|617433384|FG003|Double-Blind Period|Adverse Event|0|||
170843445|NCT03083665|617433385|FG004|Double-Blind Period|Adverse Event|0|||
170843446|NCT03083665|617433386|FG005|Double-Blind Period|Adverse Event|0|||
170843447|NCT03083665|617433381|FG000|Double-Blind Period|Lack of Efficacy|0|||
170843448|NCT03083665|617433382|FG001|Double-Blind Period|Lack of Efficacy|0|||
170843449|NCT03083665|617433383|FG002|Double-Blind Period|Lack of Efficacy|1|||
170843450|NCT03083665|617433384|FG003|Double-Blind Period|Lack of Efficacy|0|||
170843451|NCT03083665|617433385|FG004|Double-Blind Period|Lack of Efficacy|0|||
170843452|NCT03083665|617433386|FG005|Double-Blind Period|Lack of Efficacy|0|||
170843453|NCT03083665|617433381|FG000|Double-Blind Period|Protocol Violation|1|||
170843454|NCT03083665|617433382|FG001|Double-Blind Period|Protocol Violation|0|||
170843455|NCT03083665|617433383|FG002|Double-Blind Period|Protocol Violation|1|||
170843456|NCT03083665|617433384|FG003|Double-Blind Period|Protocol Violation|0|||
170843457|NCT03083665|617433385|FG004|Double-Blind Period|Protocol Violation|0|||
170843458|NCT03083665|617433386|FG005|Double-Blind Period|Protocol Violation|0|||
170843459|NCT03083665|617433381|FG000|Double-Blind Period|Lost to Follow-up|1|||
170843460|NCT03083665|617433382|FG001|Double-Blind Period|Lost to Follow-up|0|||
170843461|NCT03083665|617433383|FG002|Double-Blind Period|Lost to Follow-up|1|||
170843462|NCT03083665|617433384|FG003|Double-Blind Period|Lost to Follow-up|0|||
170843463|NCT03083665|617433385|FG004|Double-Blind Period|Lost to Follow-up|0|||
170843464|NCT03083665|617433386|FG005|Double-Blind Period|Lost to Follow-up|0|||
170843465|NCT03083665|617433381|FG000|Double-Blind Period|Withdrawal by Subject|3|||
170843466|NCT03083665|617433382|FG001|Double-Blind Period|Withdrawal by Subject|0|||
170843467|NCT03083665|617433383|FG002|Double-Blind Period|Withdrawal by Subject|0|||
170843468|NCT03083665|617433384|FG003|Double-Blind Period|Withdrawal by Subject|0|||
170843469|NCT03083665|617433385|FG004|Double-Blind Period|Withdrawal by Subject|0|||
170843470|NCT03083665|617433386|FG005|Double-Blind Period|Withdrawal by Subject|0|||
170843471|NCT03083665|617433381|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
170843472|NCT03083665|617433382|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
170843473|NCT03083665|617433383|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
170843474|NCT03083665|617433384|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
170843475|NCT03083665|617433385|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
170843476|NCT03083665|617433386|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
170843477|NCT03083665|617433381|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
170843478|NCT03083665|617433382|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
170843479|NCT03083665|617433383|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
170843480|NCT03083665|617433384|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
170843481|NCT03083665|617433385|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
170843482|NCT03083665|617433386|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
170843483|NCT03083665|617433381|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
170843484|NCT03083665|617433382|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
170843485|NCT03083665|617433383|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
170843486|NCT03083665|617433384|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
170843487|NCT03083665|617433385|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
170843488|NCT03083665|617433386|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
170843489|NCT03083665|617433381|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
170843490|NCT03083665|617433382|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
170843491|NCT03083665|617433383|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
170843492|NCT03083665|617433384|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
170843493|NCT03083665|617433385|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
170843494|NCT03083665|617433386|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
170843495|NCT03083665|617433381|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
170843496|NCT03083665|617433382|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
170843497|NCT03083665|617433383|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
170736627|NCT04543188|617042360|FG007|Phase 1a|Study terminated by sponsor|0|||
170736628|NCT04543188|617042361|FG008|Phase 1a|Study terminated by sponsor|0|||
170736629|NCT04543188|617042362|FG009|Phase 1a|Study terminated by sponsor|0|||
170736630|NCT04543188|617042363|FG010|Phase 1a|Study terminated by sponsor|1|||
170736631|NCT04543188|617042364|FG011|Phase 1a|Study terminated by sponsor|0|||
170736632|NCT04543188|617042365|FG012|Phase 1a|Study terminated by sponsor|0|||
170736633|NCT04543188|617042366|FG013|Phase 1a|Study terminated by sponsor|0|||
170736634|NCT04543188|617042367|FG014|Phase 1a|Study terminated by sponsor|0|||
170736635|NCT04543188|617042353|FG000|Phase 1a|Withdrawal by Subject|0|||
170736636|NCT04543188|617042354|FG001|Phase 1a|Withdrawal by Subject|0|||
170736637|NCT04543188|617042355|FG002|Phase 1a|Withdrawal by Subject|0|||
170736638|NCT04543188|617042356|FG003|Phase 1a|Withdrawal by Subject|0|||
170736639|NCT04543188|617042357|FG004|Phase 1a|Withdrawal by Subject|3|||
170736640|NCT04543188|617042358|FG005|Phase 1a|Withdrawal by Subject|0|||
170736641|NCT04543188|617042359|FG006|Phase 1a|Withdrawal by Subject|0|||
170736642|NCT04543188|617042360|FG007|Phase 1a|Withdrawal by Subject|0|||
170736643|NCT04543188|617042361|FG008|Phase 1a|Withdrawal by Subject|1|||
170736644|NCT04543188|617042362|FG009|Phase 1a|Withdrawal by Subject|1|||
170736645|NCT04543188|617042363|FG010|Phase 1a|Withdrawal by Subject|2|||
170736646|NCT04543188|617042364|FG011|Phase 1a|Withdrawal by Subject|0|||
170736647|NCT04543188|617042365|FG012|Phase 1a|Withdrawal by Subject|0|||
170736648|NCT04543188|617042366|FG013|Phase 1a|Withdrawal by Subject|0|||
170736649|NCT04543188|617042367|FG014|Phase 1a|Withdrawal by Subject|0|||
170736650|NCT04543188|617042353|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
170736651|NCT04543188|617042354|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
170736652|NCT04543188|617042355|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
170736653|NCT04543188|617042356|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
170736654|NCT04543188|617042357|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
170736655|NCT04543188|617042358|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
170736656|NCT04543188|617042359|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
170736657|NCT04543188|617042360|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
170736658|NCT04543188|617042361|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
170736659|NCT04543188|617042362|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
170736660|NCT04543188|617042363|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
170736661|NCT04543188|617042364|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
170736662|NCT04543188|617042365|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
170736663|NCT04543188|617042366|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
170736664|NCT04543188|617042367|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
170736665|NCT04543188|617042353|FG000|Phase 1a|Other|0|||
170736666|NCT04543188|617042354|FG001|Phase 1a|Other|0|||
170736667|NCT04543188|617042355|FG002|Phase 1a|Other|0|||
170736668|NCT04543188|617042356|FG003|Phase 1a|Other|0|||
170736669|NCT04543188|617042357|FG004|Phase 1a|Other|0|||
170736670|NCT04543188|617042358|FG005|Phase 1a|Other|0|||
170736671|NCT04543188|617042359|FG006|Phase 1a|Other|0|||
170736672|NCT04543188|617042360|FG007|Phase 1a|Other|0|||
170736673|NCT04543188|617042361|FG008|Phase 1a|Other|0|||
170736674|NCT04543188|617042362|FG009|Phase 1a|Other|1|||
170736675|NCT04543188|617042363|FG010|Phase 1a|Other|0|||
170736676|NCT04543188|617042364|FG011|Phase 1a|Other|0|||
170736677|NCT04543188|617042365|FG012|Phase 1a|Other|0|||
170736678|NCT04543188|617042366|FG013|Phase 1a|Other|0|||
170736679|NCT04543188|617042367|FG014|Phase 1a|Other|0|||
170736680|NCT04543188|617042353|FG000|Phase 1b|Adverse Event|0|||
170736681|NCT04543188|617042354|FG001|Phase 1b|Adverse Event|0|||
170736682|NCT04543188|617042355|FG002|Phase 1b|Adverse Event|0|||
170736683|NCT04543188|617042356|FG003|Phase 1b|Adverse Event|0|||
170736684|NCT04543188|617042357|FG004|Phase 1b|Adverse Event|0|||
170736685|NCT04543188|617042358|FG005|Phase 1b|Adverse Event|0|||
170736686|NCT04543188|617042359|FG006|Phase 1b|Adverse Event|0|||
170736687|NCT04543188|617042360|FG007|Phase 1b|Adverse Event|0|||
170736688|NCT04543188|617042361|FG008|Phase 1b|Adverse Event|0|||
170736689|NCT04543188|617042362|FG009|Phase 1b|Adverse Event|0|||
170736690|NCT04543188|617042363|FG010|Phase 1b|Adverse Event|0|||
170736691|NCT04543188|617042364|FG011|Phase 1b|Adverse Event|0|||
170736692|NCT04543188|617042365|FG012|Phase 1b|Adverse Event|0|||
170736693|NCT04543188|617042366|FG013|Phase 1b|Adverse Event|0|||
170736694|NCT04543188|617042367|FG014|Phase 1b|Adverse Event|2|||
170843498|NCT03083665|617433384|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
170736695|NCT04543188|617042353|FG000|Phase 1b|Other (Death)|0|||
170736696|NCT04543188|617042354|FG001|Phase 1b|Other (Death)|0|||
170736697|NCT04543188|617042355|FG002|Phase 1b|Other (Death)|0|||
170736698|NCT04543188|617042356|FG003|Phase 1b|Other (Death)|0|||
170736699|NCT04543188|617042357|FG004|Phase 1b|Other (Death)|0|||
170736700|NCT04543188|617042358|FG005|Phase 1b|Other (Death)|0|||
170736701|NCT04543188|617042359|FG006|Phase 1b|Other (Death)|0|||
170736702|NCT04543188|617042360|FG007|Phase 1b|Other (Death)|0|||
170736703|NCT04543188|617042361|FG008|Phase 1b|Other (Death)|0|||
170736704|NCT04543188|617042362|FG009|Phase 1b|Other (Death)|0|||
170736705|NCT04543188|617042363|FG010|Phase 1b|Other (Death)|0|||
170843499|NCT03083665|617433385|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
170843500|NCT03083665|617433386|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
170843501|NCT03083665|617433381|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
170843502|NCT03083665|617433382|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
170843503|NCT03083665|617433383|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
170843504|NCT03083665|617433384|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
170843505|NCT03083665|617433385|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
170843506|NCT03083665|617433386|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
170843507|NCT03083665|617433381|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
170843508|NCT03083665|617433382|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
170843509|NCT03083665|617433383|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
170843510|NCT03083665|617433384|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
170843511|NCT03083665|617433385|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
170843512|NCT03083665|617433386|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
170843513|NCT03083665|617433381|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
170843514|NCT03083665|617433382|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
170843515|NCT03083665|617433383|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
170843516|NCT03083665|617433384|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
170843517|NCT03083665|617433385|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
170843518|NCT03083665|617433386|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
170843519|NCT03083665|617433381|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
170843520|NCT03083665|617433382|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
170843521|NCT03083665|617433383|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
170843522|NCT03083665|617433384|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
170843523|NCT03083665|617433385|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
170843524|NCT03083665|617433386|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
170843525|NCT01289210|617433387|FG000|Overall Study|Adverse Event|1|||
170843526|NCT00281320|617433388|FG000|Overall Study|Adverse Event|12|||
170843527|NCT00281320|617433389|FG001|Overall Study|Adverse Event|9|||
170843528|NCT00281320|617433388|FG000|Overall Study|Lack of Efficacy|4|||
170843529|NCT00281320|617433389|FG001|Overall Study|Lack of Efficacy|3|||
170843530|NCT00281320|617433388|FG000|Overall Study|Withdrawal by Subject|5|||
170843531|NCT00281320|617433389|FG001|Overall Study|Withdrawal by Subject|6|||
170843532|NCT00281320|617433388|FG000|Overall Study|Lost to Follow-up|1|||
170843533|NCT00281320|617433389|FG001|Overall Study|Lost to Follow-up|2|||
170843534|NCT00281320|617433388|FG000|Overall Study|Other|3|||
170843535|NCT00281320|617433389|FG001|Overall Study|Other|1|||
170843536|NCT03008005|617433390|FG000|Overall Study|Physician Decision|1|||
170843537|NCT03008005|617433391|FG001|Overall Study|Physician Decision|0|||
170843538|NCT03008005|617433392|FG002|Overall Study|Physician Decision|0|||
170736706|NCT04543188|617042364|FG011|Phase 1b|Other (Death)|0|||
170736707|NCT04543188|617042365|FG012|Phase 1b|Other (Death)|1|||
170736708|NCT04543188|617042366|FG013|Phase 1b|Other (Death)|0|||
170736709|NCT04543188|617042367|FG014|Phase 1b|Other (Death)|1|||
170736710|NCT04543188|617042353|FG000|Phase 1b|Progressive Disease|0|||
170736711|NCT04543188|617042354|FG001|Phase 1b|Progressive Disease|0|||
170736712|NCT04543188|617042355|FG002|Phase 1b|Progressive Disease|0|||
170736713|NCT04543188|617042356|FG003|Phase 1b|Progressive Disease|0|||
170736714|NCT04543188|617042357|FG004|Phase 1b|Progressive Disease|0|||
170736715|NCT04543188|617042358|FG005|Phase 1b|Progressive Disease|0|||
170736716|NCT04543188|617042359|FG006|Phase 1b|Progressive Disease|0|||
170736717|NCT04543188|617042360|FG007|Phase 1b|Progressive Disease|0|||
170736718|NCT04543188|617042361|FG008|Phase 1b|Progressive Disease|0|||
170736719|NCT04543188|617042362|FG009|Phase 1b|Progressive Disease|0|||
170736720|NCT04543188|617042363|FG010|Phase 1b|Progressive Disease|0|||
170736721|NCT04543188|617042364|FG011|Phase 1b|Progressive Disease|0|||
170736722|NCT04543188|617042365|FG012|Phase 1b|Progressive Disease|2|||
170736723|NCT04543188|617042366|FG013|Phase 1b|Progressive Disease|1|||
170736724|NCT04543188|617042367|FG014|Phase 1b|Progressive Disease|5|||
170736725|NCT04543188|617042353|FG000|Phase 1b|Study Terminated By Sponsor|0|||
170736726|NCT04543188|617042354|FG001|Phase 1b|Study Terminated By Sponsor|0|||
170736727|NCT04543188|617042355|FG002|Phase 1b|Study Terminated By Sponsor|0|||
170736728|NCT04543188|617042356|FG003|Phase 1b|Study Terminated By Sponsor|0|||
170736729|NCT04543188|617042357|FG004|Phase 1b|Study Terminated By Sponsor|0|||
170736730|NCT04543188|617042358|FG005|Phase 1b|Study Terminated By Sponsor|0|||
170736731|NCT04543188|617042359|FG006|Phase 1b|Study Terminated By Sponsor|0|||
170736732|NCT04543188|617042360|FG007|Phase 1b|Study Terminated By Sponsor|0|||
170736733|NCT04543188|617042361|FG008|Phase 1b|Study Terminated By Sponsor|0|||
170736734|NCT04543188|617042362|FG009|Phase 1b|Study Terminated By Sponsor|0|||
170736735|NCT04543188|617042363|FG010|Phase 1b|Study Terminated By Sponsor|0|||
170736736|NCT04543188|617042364|FG011|Phase 1b|Study Terminated By Sponsor|1|||
170736737|NCT04543188|617042365|FG012|Phase 1b|Study Terminated By Sponsor|1|||
170736738|NCT04543188|617042366|FG013|Phase 1b|Study Terminated By Sponsor|0|||
170736739|NCT04543188|617042367|FG014|Phase 1b|Study Terminated By Sponsor|1|||
170736740|NCT04543188|617042353|FG000|Phase 1b|Withdrawal by Subject|0|||
170736741|NCT04543188|617042354|FG001|Phase 1b|Withdrawal by Subject|0|||
170736742|NCT04543188|617042355|FG002|Phase 1b|Withdrawal by Subject|0|||
170736743|NCT04543188|617042356|FG003|Phase 1b|Withdrawal by Subject|0|||
170736744|NCT04543188|617042357|FG004|Phase 1b|Withdrawal by Subject|0|||
170736745|NCT04543188|617042358|FG005|Phase 1b|Withdrawal by Subject|0|||
170736746|NCT04543188|617042359|FG006|Phase 1b|Withdrawal by Subject|0|||
170736747|NCT04543188|617042360|FG007|Phase 1b|Withdrawal by Subject|0|||
170736748|NCT04543188|617042361|FG008|Phase 1b|Withdrawal by Subject|0|||
170736749|NCT04543188|617042362|FG009|Phase 1b|Withdrawal by Subject|0|||
170736750|NCT04543188|617042363|FG010|Phase 1b|Withdrawal by Subject|0|||
170736751|NCT04543188|617042364|FG011|Phase 1b|Withdrawal by Subject|0|||
170736752|NCT04543188|617042365|FG012|Phase 1b|Withdrawal by Subject|0|||
170736753|NCT04543188|617042366|FG013|Phase 1b|Withdrawal by Subject|0|||
170736754|NCT04543188|617042367|FG014|Phase 1b|Withdrawal by Subject|2|||
170736755|NCT03815019|617042368|FG000|Overall Study|Withdrawal by Subject|6|||
170736756|NCT03815019|617042369|FG001|Overall Study|Withdrawal by Subject|8|||
170736757|NCT05398796|617042370|FG000|Overall Study|Participant moved from the area|0|||
170843539|NCT03008005|617433390|FG000|Overall Study|Withdrawal by Subject|1|||
170843540|NCT03008005|617433391|FG001|Overall Study|Withdrawal by Subject|0|||
170843541|NCT03008005|617433392|FG002|Overall Study|Withdrawal by Subject|0|||
170843542|NCT03008005|617433390|FG000|Overall Study|Ineligible|0|||
170843543|NCT03008005|617433391|FG001|Overall Study|Ineligible|1|||
170843544|NCT03008005|617433392|FG002|Overall Study|Ineligible|0|||
170843545|NCT05292586|617433393|FG000|Overall Study|Withdrawal by Subject|3|||
170843546|NCT05292586|617433394|FG001|Overall Study|Withdrawal by Subject|10|||
170843547|NCT05292586|617433393|FG000|Overall Study|Randomization error|3|||
170843548|NCT05292586|617433394|FG001|Overall Study|Randomization error|7|||
170843549|NCT05292586|617433393|FG000|Overall Study|Adverse Event|3|||
170843550|NCT05292586|617433394|FG001|Overall Study|Adverse Event|0|||
170843551|NCT05292586|617433393|FG000|Overall Study|Lost to Follow-up|0|||
170843552|NCT05292586|617433394|FG001|Overall Study|Lost to Follow-up|1|||
170843553|NCT05292586|617433393|FG000|Overall Study|Patient refused treatment|1|||
170843554|NCT05292586|617433394|FG001|Overall Study|Patient refused treatment|0|||
170843555|NCT05292586|617433393|FG000|Overall Study|Patient could not travel to the study site|1|||
170843556|NCT05292586|617433394|FG001|Overall Study|Patient could not travel to the study site|0|||
170843557|NCT05292586|617433393|FG000|Overall Study|Technical issues with the masterscope|0|||
170843558|NCT05292586|617433394|FG001|Overall Study|Technical issues with the masterscope|3|||
170843559|NCT05292586|617433393|FG000|Overall Study|Patient moved to a different state|0|||
170843560|NCT05292586|617433394|FG001|Overall Study|Patient moved to a different state|1|||
170843561|NCT02446821|617433397|FG000|Overall Study|Adverse Event|28|||
170843562|NCT02446821|617433397|FG000|Overall Study|Withdrawal by Subject|6|||
170843563|NCT02446821|617433397|FG000|Overall Study|Lost to Follow-up|22|||
170843564|NCT02446821|617433397|FG000|Overall Study|other|9|||
170843565|NCT02446821|617433397|FG000|Overall Study|insertion failure|3|||
170843566|NCT02726945|617433398|FG000|Overall Study|Withdrawal by Subject|0|||
170843567|NCT02726945|617433399|FG001|Overall Study|Withdrawal by Subject|0|||
170843568|NCT02726945|617433400|FG002|Overall Study|Withdrawal by Subject|1|||
170843569|NCT02726945|617433398|FG000|Overall Study|Elected to have total knee replacement|0|||
170843570|NCT02726945|617433399|FG001|Overall Study|Elected to have total knee replacement|1|||
170843571|NCT02726945|617433400|FG002|Overall Study|Elected to have total knee replacement|0|||
170843572|NCT03843554|617435140|FG000|Overall Study|Physician Decision|0|||
170843573|NCT03843554|617435141|FG001|Overall Study|Physician Decision|2|||
170843574|NCT00264303|617435147|FG000|Overall Study|Adverse Event|4|||
170843575|NCT00264303|617435148|FG001|Overall Study|Adverse Event|3|||
170843576|NCT00264303|617435147|FG000|Overall Study|Lack of Efficacy|10|||
170843577|NCT00264303|617435148|FG001|Overall Study|Lack of Efficacy|13|||
170843578|NCT00264303|617435147|FG000|Overall Study|Lost to Follow-up|3|||
170843579|NCT00264303|617435148|FG001|Overall Study|Lost to Follow-up|3|||
170843580|NCT00264303|617435147|FG000|Overall Study|Withdrawal by Subject|2|||
170843581|NCT00264303|617435148|FG001|Overall Study|Withdrawal by Subject|3|||
170843582|NCT00264303|617435147|FG000|Overall Study|Various reasons listed in study report|6|||
170843583|NCT00264303|617435148|FG001|Overall Study|Various reasons listed in study report|7|||
170843584|NCT02389452|617435149|FG000|Overall Study|Lost to Follow-up|13|||
170843585|NCT02389452|617435149|FG000|Overall Study|Adverse Event|1|||
170843586|NCT02389452|617435149|FG000|Overall Study|Withdrawal by Subject|5|||
170843587|NCT02389452|617435149|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
170843588|NCT01076153|617435157|FG000|Overall Study|Symptoms improved/resolved|10|||
170843589|NCT01076153|617435157|FG000|Overall Study|Adverse Event|1|||
170843590|NCT01977677|617435158|FG000|Overall Study|Unrelated Adverse Event|0|||
170843591|NCT01977677|617435159|FG001|Overall Study|Unrelated Adverse Event|0|||
170843592|NCT01977677|617435160|FG002|Overall Study|Unrelated Adverse Event|1|||
170843593|NCT01498887|617435161|FG000|Overall Study|Administrative problems|1|||
170843594|NCT01498887|617435162|FG001|Overall Study|Administrative problems|0|||
170843595|NCT01498887|617435161|FG000|Overall Study|Lost to Follow-up|1|||
170843596|NCT01498887|617435162|FG001|Overall Study|Lost to Follow-up|1|||
170843597|NCT01498887|617435161|FG000|Overall Study|Withdrawal by Subject|1|||
170843598|NCT01498887|617435162|FG001|Overall Study|Withdrawal by Subject|0|||
170843599|NCT01498887|617435161|FG000|Overall Study|Protocol Violation|1|||
170843600|NCT01498887|617435162|FG001|Overall Study|Protocol Violation|3|||
170843601|NCT01498887|617435161|FG000|Overall Study|Lack of Efficacy|5|||
170843602|NCT01498887|617435162|FG001|Overall Study|Lack of Efficacy|3|||
170843603|NCT01498887|617435161|FG000|Overall Study|Abnormal result from test procedure|1|||
170843604|NCT01498887|617435162|FG001|Overall Study|Abnormal result from test procedure|1|||
170843605|NCT01498887|617435161|FG000|Overall Study|Abnormal laboratory value|2|||
170843606|NCT01498887|617435162|FG001|Overall Study|Abnormal laboratory value|2|||
170843607|NCT01498887|617435161|FG000|Overall Study|Adverse Event|4|||
170843608|NCT01498887|617435162|FG001|Overall Study|Adverse Event|1|||
170843609|NCT00667225|617435165|FG000|Overall Study|Subject had no more lesions to treat.|1|||
170843610|NCT00667225|617435166|FG001|Overall Study|Subject had no more lesions to treat.|0|||
170843611|NCT00667225|617435165|FG000|Overall Study|Lost to Follow-up|0|||
170843612|NCT00667225|617435166|FG001|Overall Study|Lost to Follow-up|1|||
170843613|NCT02993406|617435167|FG000|Overall Study|Withdrawal by Subject|170|||
170843614|NCT02993406|617435168|FG001|Overall Study|Withdrawal by Subject|196|||
170843615|NCT02993406|617435167|FG000|Overall Study|Physician Decision|3|||
170843616|NCT02993406|617435168|FG001|Overall Study|Physician Decision|5|||
170843617|NCT02993406|617435167|FG000|Overall Study|Lost to Follow-up|12|||
170843618|NCT02993406|617435168|FG001|Overall Study|Lost to Follow-up|13|||
170843619|NCT02993406|617435167|FG000|Overall Study|Unclassifiable Response|105|||
170843620|NCT02993406|617435168|FG001|Overall Study|Unclassifiable Response|139|||
170843621|NCT02993406|617435167|FG000|Overall Study|Administrative decision|1|||
170843622|NCT02993406|617435168|FG001|Overall Study|Administrative decision|0|||
170843623|NCT02993406|617435167|FG000|Overall Study|Sponsor decision|4|||
170843624|NCT02993406|617435168|FG001|Overall Study|Sponsor decision|5|||
170843625|NCT03563157|617435169|FG000|Overall Study|Progressive Disease|2|||
170843626|NCT02942277|617435172|FG000|Year 1|Withdrawal by Subject|0|||
170843627|NCT02942277|617435173|FG001|Year 1|Withdrawal by Subject|0|||
170843628|NCT02942277|617435174|FG002|Year 1|Withdrawal by Subject|0|||
170843629|NCT02942277|617435175|FG003|Year 1|Withdrawal by Subject|0|||
170843630|NCT02942277|617435176|FG004|Year 1|Withdrawal by Subject|1|||
170843631|NCT02942277|617435177|FG005|Year 1|Withdrawal by Subject|3|||
170843632|NCT02942277|617435178|FG006|Year 1|Withdrawal by Subject|0|||
170843633|NCT02942277|617435179|FG007|Year 1|Withdrawal by Subject|1|||
170843634|NCT02942277|617435180|FG008|Year 1|Withdrawal by Subject|0|||
170843635|NCT02942277|617435181|FG009|Year 1|Withdrawal by Subject|0|||
170843636|NCT02942277|617435182|FG010|Year 1|Withdrawal by Subject|3|||
170843637|NCT02942277|617435172|FG000|Year 1|Travel|0|||
170843638|NCT02942277|617435173|FG001|Year 1|Travel|1|||
170843639|NCT02942277|617435174|FG002|Year 1|Travel|0|||
170843640|NCT02942277|617435175|FG003|Year 1|Travel|0|||
170843641|NCT02942277|617435176|FG004|Year 1|Travel|4|||
170843642|NCT02942277|617435177|FG005|Year 1|Travel|5|||
170843643|NCT02942277|617435178|FG006|Year 1|Travel|0|||
170843644|NCT02942277|617435179|FG007|Year 1|Travel|0|||
170843645|NCT02942277|617435180|FG008|Year 1|Travel|0|||
170843646|NCT02942277|617435181|FG009|Year 1|Travel|0|||
170843647|NCT02942277|617435182|FG010|Year 1|Travel|8|||
170843648|NCT02942277|617435172|FG000|Year 1|Joined Army|0|||
170843649|NCT02942277|617435173|FG001|Year 1|Joined Army|1|||
170843650|NCT02942277|617435174|FG002|Year 1|Joined Army|0|||
170843651|NCT02942277|617435175|FG003|Year 1|Joined Army|0|||
170843652|NCT02942277|617435176|FG004|Year 1|Joined Army|0|||
170843653|NCT02942277|617435177|FG005|Year 1|Joined Army|0|||
170843654|NCT02942277|617435178|FG006|Year 1|Joined Army|0|||
170843655|NCT02942277|617435179|FG007|Year 1|Joined Army|0|||
170843656|NCT02942277|617435180|FG008|Year 1|Joined Army|0|||
170843657|NCT02942277|617435181|FG009|Year 1|Joined Army|0|||
170843658|NCT02942277|617435182|FG010|Year 1|Joined Army|0|||
170843659|NCT02942277|617435172|FG000|Year 1|Subject met withdrawal criteria|0|||
170843660|NCT02942277|617435173|FG001|Year 1|Subject met withdrawal criteria|0|||
170843661|NCT02942277|617435174|FG002|Year 1|Subject met withdrawal criteria|0|||
170843662|NCT02942277|617435175|FG003|Year 1|Subject met withdrawal criteria|1|||
170843663|NCT02942277|617435176|FG004|Year 1|Subject met withdrawal criteria|0|||
170843664|NCT02942277|617435177|FG005|Year 1|Subject met withdrawal criteria|0|||
170843665|NCT02942277|617435178|FG006|Year 1|Subject met withdrawal criteria|0|||
170843666|NCT02942277|617435179|FG007|Year 1|Subject met withdrawal criteria|0|||
170843667|NCT02942277|617435180|FG008|Year 1|Subject met withdrawal criteria|0|||
170843668|NCT02942277|617435181|FG009|Year 1|Subject met withdrawal criteria|0|||
170843669|NCT02942277|617435182|FG010|Year 1|Subject met withdrawal criteria|0|||
170843670|NCT02942277|617435172|FG000|Year 1|Lost to Follow-up|0|||
170843671|NCT02942277|617435173|FG001|Year 1|Lost to Follow-up|0|||
170843672|NCT02942277|617435174|FG002|Year 1|Lost to Follow-up|0|||
170843673|NCT02942277|617435175|FG003|Year 1|Lost to Follow-up|0|||
170843674|NCT02942277|617435176|FG004|Year 1|Lost to Follow-up|1|||
170843675|NCT02942277|617435177|FG005|Year 1|Lost to Follow-up|0|||
170843676|NCT02942277|617435178|FG006|Year 1|Lost to Follow-up|0|||
170843677|NCT02942277|617435179|FG007|Year 1|Lost to Follow-up|0|||
170843678|NCT02942277|617435180|FG008|Year 1|Lost to Follow-up|0|||
170843679|NCT02942277|617435181|FG009|Year 1|Lost to Follow-up|0|||
170843680|NCT02942277|617435182|FG010|Year 1|Lost to Follow-up|2|||
170843681|NCT02942277|617435172|FG000|Year 1|Protocol Violation|0|||
170843682|NCT02942277|617435173|FG001|Year 1|Protocol Violation|0|||
170736758|NCT05398796|617042371|FG001|Overall Study|Participant moved from the area|1|||
170736759|NCT05398796|617042372|FG002|Overall Study|Participant moved from the area|0|||
170736760|NCT05398796|617042373|FG003|Overall Study|Participant moved from the area|0|||
170736761|NCT05960097|617042374|FG000|Overall Study|Lost to Follow-up|3|||
170736762|NCT05960097|617042375|FG001|Overall Study|Lost to Follow-up|1|||
170736763|NCT05960097|617042376|FG002|Overall Study|Lost to Follow-up|1|||
170736764|NCT05960097|617042377|FG003|Overall Study|Lost to Follow-up|2|||
170736765|NCT05960097|617042378|FG004|Overall Study|Lost to Follow-up|1|||
170736766|NCT05960097|617042379|FG005|Overall Study|Lost to Follow-up|1|||
170736767|NCT05960097|617042380|FG006|Overall Study|Lost to Follow-up|2|||
170736768|NCT05960097|617042381|FG007|Overall Study|Lost to Follow-up|3|||
170736769|NCT05960097|617042374|FG000|Overall Study|Physician Decision|0|||
170736770|NCT05960097|617042375|FG001|Overall Study|Physician Decision|0|||
170736771|NCT05960097|617042376|FG002|Overall Study|Physician Decision|0|||
170736772|NCT05960097|617042377|FG003|Overall Study|Physician Decision|0|||
170736773|NCT05960097|617042378|FG004|Overall Study|Physician Decision|0|||
170736774|NCT05960097|617042379|FG005|Overall Study|Physician Decision|0|||
170736775|NCT05960097|617042380|FG006|Overall Study|Physician Decision|1|||
170736776|NCT05960097|617042381|FG007|Overall Study|Physician Decision|0|||
170736777|NCT05960097|617042374|FG000|Overall Study|Withdrawal by Subject|1|||
170736778|NCT05960097|617042375|FG001|Overall Study|Withdrawal by Subject|0|||
170736779|NCT05960097|617042376|FG002|Overall Study|Withdrawal by Subject|0|||
170736780|NCT05960097|617042377|FG003|Overall Study|Withdrawal by Subject|1|||
170736781|NCT05960097|617042378|FG004|Overall Study|Withdrawal by Subject|1|||
170736782|NCT05960097|617042379|FG005|Overall Study|Withdrawal by Subject|0|||
170736783|NCT05960097|617042380|FG006|Overall Study|Withdrawal by Subject|0|||
170736784|NCT05960097|617042381|FG007|Overall Study|Withdrawal by Subject|0|||
170736785|NCT05960097|617042374|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
170736786|NCT05960097|617042375|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
170736787|NCT05960097|617042376|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
170843683|NCT02942277|617435174|FG002|Year 1|Protocol Violation|0|||
170843684|NCT02942277|617435175|FG003|Year 1|Protocol Violation|0|||
170843685|NCT02942277|617435176|FG004|Year 1|Protocol Violation|1|||
170843686|NCT02942277|617435177|FG005|Year 1|Protocol Violation|1|||
170843687|NCT02942277|617435178|FG006|Year 1|Protocol Violation|0|||
170843688|NCT02942277|617435179|FG007|Year 1|Protocol Violation|0|||
170843689|NCT02942277|617435180|FG008|Year 1|Protocol Violation|0|||
170843690|NCT02942277|617435181|FG009|Year 1|Protocol Violation|0|||
170843691|NCT02942277|617435182|FG010|Year 1|Protocol Violation|2|||
170843692|NCT02942277|617435172|FG000|Year 1|Pregnancy|0|||
170843693|NCT02942277|617435173|FG001|Year 1|Pregnancy|0|||
170843694|NCT02942277|617435174|FG002|Year 1|Pregnancy|0|||
170843695|NCT02942277|617435175|FG003|Year 1|Pregnancy|0|||
170843696|NCT02942277|617435176|FG004|Year 1|Pregnancy|0|||
170843697|NCT02942277|617435177|FG005|Year 1|Pregnancy|1|||
170843698|NCT02942277|617435178|FG006|Year 1|Pregnancy|0|||
170843699|NCT02942277|617435179|FG007|Year 1|Pregnancy|0|||
170843700|NCT02942277|617435180|FG008|Year 1|Pregnancy|0|||
170843701|NCT02942277|617435181|FG009|Year 1|Pregnancy|0|||
170843702|NCT02942277|617435182|FG010|Year 1|Pregnancy|0|||
170843703|NCT02942277|617435172|FG000|Year 2|Lost to Follow-up|0|||
170843704|NCT02942277|617435173|FG001|Year 2|Lost to Follow-up|0|||
170843705|NCT02942277|617435174|FG002|Year 2|Lost to Follow-up|0|||
170843706|NCT02942277|617435175|FG003|Year 2|Lost to Follow-up|0|||
170843707|NCT02942277|617435176|FG004|Year 2|Lost to Follow-up|2|||
170843708|NCT02942277|617435177|FG005|Year 2|Lost to Follow-up|1|||
170843709|NCT02942277|617435178|FG006|Year 2|Lost to Follow-up|0|||
170843710|NCT02942277|617435179|FG007|Year 2|Lost to Follow-up|0|||
170843711|NCT02942277|617435180|FG008|Year 2|Lost to Follow-up|0|||
170843712|NCT02942277|617435181|FG009|Year 2|Lost to Follow-up|0|||
170843713|NCT02942277|617435182|FG010|Year 2|Lost to Follow-up|0|||
170843714|NCT02942277|617435172|FG000|Year 2|Did not rescreen|0|||
170843715|NCT02942277|617435173|FG001|Year 2|Did not rescreen|0|||
170843716|NCT02942277|617435174|FG002|Year 2|Did not rescreen|1|||
170843717|NCT02942277|617435175|FG003|Year 2|Did not rescreen|1|||
170843718|NCT02942277|617435176|FG004|Year 2|Did not rescreen|9|||
170843719|NCT02942277|617435177|FG005|Year 2|Did not rescreen|6|||
170843720|NCT02942277|617435178|FG006|Year 2|Did not rescreen|0|||
170843721|NCT02942277|617435179|FG007|Year 2|Did not rescreen|1|||
170843722|NCT02942277|617435180|FG008|Year 2|Did not rescreen|0|||
170843723|NCT02942277|617435181|FG009|Year 2|Did not rescreen|0|||
170843724|NCT02942277|617435182|FG010|Year 2|Did not rescreen|21|||
170843725|NCT02942277|617435172|FG000|Year 2|Met withdrawal criteria|0|||
170843726|NCT02942277|617435173|FG001|Year 2|Met withdrawal criteria|0|||
170843727|NCT02942277|617435174|FG002|Year 2|Met withdrawal criteria|0|||
170843728|NCT02942277|617435175|FG003|Year 2|Met withdrawal criteria|0|||
170843729|NCT02942277|617435176|FG004|Year 2|Met withdrawal criteria|1|||
170843730|NCT02942277|617435177|FG005|Year 2|Met withdrawal criteria|2|||
170843731|NCT02942277|617435178|FG006|Year 2|Met withdrawal criteria|0|||
170843732|NCT02942277|617435179|FG007|Year 2|Met withdrawal criteria|0|||
170843733|NCT02942277|617435180|FG008|Year 2|Met withdrawal criteria|0|||
170843734|NCT02942277|617435181|FG009|Year 2|Met withdrawal criteria|0|||
170843735|NCT02942277|617435182|FG010|Year 2|Met withdrawal criteria|1|||
170843736|NCT02942277|617435172|FG000|Year 2|Travel|0|||
170843737|NCT02942277|617435173|FG001|Year 2|Travel|1|||
170843738|NCT02942277|617435174|FG002|Year 2|Travel|0|||
170843739|NCT02942277|617435175|FG003|Year 2|Travel|0|||
170843740|NCT02942277|617435176|FG004|Year 2|Travel|0|||
170843741|NCT02942277|617435177|FG005|Year 2|Travel|1|||
170843742|NCT02942277|617435178|FG006|Year 2|Travel|0|||
170843743|NCT02942277|617435179|FG007|Year 2|Travel|0|||
170843744|NCT02942277|617435180|FG008|Year 2|Travel|0|||
170843745|NCT02942277|617435181|FG009|Year 2|Travel|1|||
170843746|NCT02942277|617435182|FG010|Year 2|Travel|3|||
170843747|NCT02942277|617435172|FG000|Year 2|Non-compliant|0|||
170843748|NCT02942277|617435173|FG001|Year 2|Non-compliant|0|||
170843749|NCT02942277|617435174|FG002|Year 2|Non-compliant|0|||
170843750|NCT02942277|617435175|FG003|Year 2|Non-compliant|0|||
170843751|NCT02942277|617435176|FG004|Year 2|Non-compliant|1|||
170843752|NCT02942277|617435177|FG005|Year 2|Non-compliant|1|||
170843753|NCT02942277|617435178|FG006|Year 2|Non-compliant|0|||
170843754|NCT02942277|617435179|FG007|Year 2|Non-compliant|0|||
170843755|NCT02942277|617435180|FG008|Year 2|Non-compliant|0|||
170843756|NCT02942277|617435181|FG009|Year 2|Non-compliant|0|||
170843757|NCT02942277|617435182|FG010|Year 2|Non-compliant|0|||
170843758|NCT02942277|617435172|FG000|Year 2|Withdrawal by Subject|0|||
170843759|NCT02942277|617435173|FG001|Year 2|Withdrawal by Subject|0|||
170843760|NCT02942277|617435174|FG002|Year 2|Withdrawal by Subject|0|||
170843761|NCT02942277|617435175|FG003|Year 2|Withdrawal by Subject|0|||
170843762|NCT02942277|617435176|FG004|Year 2|Withdrawal by Subject|0|||
170843763|NCT02942277|617435177|FG005|Year 2|Withdrawal by Subject|0|||
170843764|NCT02942277|617435178|FG006|Year 2|Withdrawal by Subject|1|||
170843765|NCT02942277|617435179|FG007|Year 2|Withdrawal by Subject|0|||
170843766|NCT02942277|617435180|FG008|Year 2|Withdrawal by Subject|0|||
170843767|NCT02942277|617435181|FG009|Year 2|Withdrawal by Subject|0|||
170843768|NCT02942277|617435182|FG010|Year 2|Withdrawal by Subject|0|||
170843769|NCT02187159|617435183|FG000|Overall Study|Protocol Violation|4|||
170843770|NCT02187159|617435184|FG001|Overall Study|Protocol Violation|6|||
170736788|NCT05960097|617042377|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
170736789|NCT05960097|617042378|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
170736790|NCT05960097|617042379|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
170736791|NCT05960097|617042380|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
170736792|NCT05960097|617042381|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
170736793|NCT03483038|617042382|FG000|Overall Study|Subjects still in follow-up|18|||
170736794|NCT02134925|617042383|FG000|Overall Study|Withdrawal by Subject|1|||
170736795|NCT02134925|617042384|FG001|Overall Study|Withdrawal by Subject|0|||
170736796|NCT02134925|617042383|FG000|Overall Study|Cancel|1|||
170736797|NCT02134925|617042384|FG001|Overall Study|Cancel|6|||
170736798|NCT02158884|617042385|FG000|Baseline Assessment|Missed performance assessment|3|||
170736799|NCT02158884|617042385|FG000|Baseline Assessment|Missed SMFA|1|||
170736800|NCT02158884|617042385|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
170736801|NCT02158884|617042385|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
170736802|NCT02158884|617042385|FG000|6 Month Assessment|Missed SMFA|20|||
170736803|NCT02158884|617042385|FG000|12 Month Assessment|Missed SMFA|17|||
170736804|NCT05158296|617042388|FG000|Overall Study|Sponsor Decision|2|||
170736805|NCT05158296|617042389|FG001|Overall Study|Sponsor Decision|3|||
170736806|NCT05158296|617042390|FG002|Overall Study|Sponsor Decision|2|||
170736807|NCT02010632|617042391|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
170736808|NCT02010632|617042392|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
170736809|NCT02404389|617042393|FG000|Overall Study|Adverse Event|1|||
170736810|NCT02404389|617042394|FG001|Overall Study|Adverse Event|0|||
170736811|NCT02404389|617042395|FG002|Overall Study|Adverse Event|1|||
170736812|NCT02404389|617042396|FG003|Overall Study|Adverse Event|0|||
170736813|NCT02404389|617042397|FG004|Overall Study|Adverse Event|2|||
170736814|NCT02404389|617042393|FG000|Overall Study|Subject/guardian decision|1|||
170736815|NCT02404389|617042394|FG001|Overall Study|Subject/guardian decision|0|||
170736816|NCT02404389|617042395|FG002|Overall Study|Subject/guardian decision|0|||
170736817|NCT02404389|617042396|FG003|Overall Study|Subject/guardian decision|1|||
170736818|NCT02404389|617042397|FG004|Overall Study|Subject/guardian decision|1|||
170736819|NCT01576718|617042400|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
170736820|NCT01576718|617042401|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170736821|NCT01576718|617042402|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170736822|NCT01576718|617042403|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170736823|NCT01576718|617042404|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170736824|NCT01576718|617042405|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170736825|NCT01576718|617042406|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
170736826|NCT01576718|617042400|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
170736827|NCT01576718|617042401|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170736828|NCT01576718|617042402|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170736829|NCT01576718|617042403|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170736830|NCT01576718|617042404|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170736831|NCT01576718|617042405|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170736832|NCT01576718|617042406|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
170736833|NCT01576718|617042400|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
170736834|NCT01576718|617042401|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170736835|NCT01576718|617042402|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170736836|NCT01576718|617042403|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170736837|NCT01576718|617042404|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170736838|NCT01576718|617042405|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170736839|NCT01576718|617042406|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
170736840|NCT01576718|617042400|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
170736841|NCT01576718|617042401|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170736842|NCT01576718|617042402|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170736843|NCT01576718|617042403|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170736844|NCT01576718|617042404|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170736845|NCT01576718|617042405|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170736846|NCT01576718|617042406|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
170736847|NCT01576718|617042400|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
170736848|NCT01576718|617042401|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170843771|NCT02187159|617435185|FG002|Overall Study|Protocol Violation|3|||
170843772|NCT02187159|617435186|FG003|Overall Study|Protocol Violation|4|||
170843773|NCT02187159|617435183|FG000|Overall Study|Lack of Efficacy|10|||
170843774|NCT02187159|617435184|FG001|Overall Study|Lack of Efficacy|5|||
170843775|NCT02187159|617435185|FG002|Overall Study|Lack of Efficacy|4|||
170843776|NCT02187159|617435186|FG003|Overall Study|Lack of Efficacy|7|||
170843777|NCT02187159|617435183|FG000|Overall Study|Adverse Event|28|||
170843778|NCT02187159|617435184|FG001|Overall Study|Adverse Event|33|||
170843779|NCT02187159|617435185|FG002|Overall Study|Adverse Event|42|||
170843780|NCT02187159|617435186|FG003|Overall Study|Adverse Event|50|||
170843781|NCT02187159|617435183|FG000|Overall Study|Withdrawal by Subject|24|||
170843782|NCT02187159|617435184|FG001|Overall Study|Withdrawal by Subject|28|||
170843783|NCT02187159|617435185|FG002|Overall Study|Withdrawal by Subject|25|||
170843784|NCT02187159|617435186|FG003|Overall Study|Withdrawal by Subject|26|||
170843785|NCT02187159|617435183|FG000|Overall Study|Other|3|||
170843786|NCT02187159|617435184|FG001|Overall Study|Other|7|||
170843787|NCT02187159|617435185|FG002|Overall Study|Other|3|||
170843788|NCT02187159|617435186|FG003|Overall Study|Other|9|||
170843789|NCT00626197|617435187|FG000|Overall Study|Did not cooperate|2|||
170843790|NCT00626197|617435188|FG001|Overall Study|Did not cooperate|6|||
170843791|NCT00626197|617435189|FG002|Overall Study|Did not cooperate|1|||
170843792|NCT00626197|617435187|FG000|Overall Study|Failure to return|6|||
170843793|NCT00626197|617435188|FG001|Overall Study|Failure to return|5|||
170843794|NCT00626197|617435189|FG002|Overall Study|Failure to return|6|||
170843795|NCT00626197|617435187|FG000|Overall Study|Adverse event, serious fatal|3|||
170843796|NCT00626197|617435188|FG001|Overall Study|Adverse event, serious fatal|6|||
170843797|NCT00626197|617435189|FG002|Overall Study|Adverse event, serious fatal|6|||
170843798|NCT00626197|617435187|FG000|Overall Study|Adverse Event|1|||
170843799|NCT00626197|617435188|FG001|Overall Study|Adverse Event|1|||
170843800|NCT00626197|617435189|FG002|Overall Study|Adverse Event|2|||
170843801|NCT00626197|617435187|FG000|Overall Study|Withdrawal by Subject|17|||
170843802|NCT00626197|617435188|FG001|Overall Study|Withdrawal by Subject|17|||
170843803|NCT00626197|617435189|FG002|Overall Study|Withdrawal by Subject|7|||
170843804|NCT00626197|617435187|FG000|Overall Study|Administrative reasons|15|||
170843805|NCT00626197|617435188|FG001|Overall Study|Administrative reasons|19|||
170843806|NCT00626197|617435189|FG002|Overall Study|Administrative reasons|55|||
170843807|NCT01174446|617435193|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
170843808|NCT01174446|617435194|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
170843809|NCT01174446|617435195|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
170843810|NCT01174446|617435196|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
170843811|NCT01174446|617435193|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
170843812|NCT01174446|617435194|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
170843813|NCT01174446|617435195|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
170843814|NCT01174446|617435196|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
170843815|NCT01174446|617435193|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
170843816|NCT01174446|617435194|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
170843817|NCT01174446|617435195|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
170843818|NCT01174446|617435196|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
170843819|NCT01174446|617435193|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
170843820|NCT01174446|617435194|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
170843821|NCT01174446|617435195|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
170843822|NCT01174446|617435196|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
170843823|NCT03510455|617435199|FG000|Overall Study|Physician Decision|1|||
170843824|NCT05048238|617435203|FG000|Overall Study|Withdrawal by Subject|1|||
170843825|NCT00335140|617435207|FG000|Overall Study|Ineligible|1|||
170843826|NCT00967005|617435211|FG000|Overall Study|Lost to Follow-up|7|||
170843827|NCT00967005|617435212|FG001|Overall Study|Lost to Follow-up|10|||
170843828|NCT00504777|617435216|FG000|Overall Study|Adverse Event|1|||
170843829|NCT01068665|617435217|FG000|Overall Study|Adverse Event|5|||
170843830|NCT01068665|617435218|FG001|Overall Study|Adverse Event|4|||
170843831|NCT01068665|617435217|FG000|Overall Study|Lack of Efficacy|0|||
170843832|NCT01068665|617435218|FG001|Overall Study|Lack of Efficacy|2|||
170843833|NCT01068665|617435217|FG000|Overall Study|Protocol Violation|5|||
170843834|NCT01068665|617435218|FG001|Overall Study|Protocol Violation|2|||
170843835|NCT01068665|617435217|FG000|Overall Study|Withdrawal Criteria|3|||
170843836|NCT01068665|617435218|FG001|Overall Study|Withdrawal Criteria|9|||
170843837|NCT01068665|617435217|FG000|Overall Study|Other|17|||
170843838|NCT01068665|617435218|FG001|Overall Study|Other|12|||
170843839|NCT04191616|617435221|FG000|Pre-assignment Period|Did not receive study treatment|2|||
170843840|NCT04191616|617435221|FG000|Treatment Period|Death|37|||
170843841|NCT04191616|617435221|FG000|Treatment Period|Sponsor decision|11|||
170843842|NCT04191616|617435221|FG000|Treatment Period|Withdrawal by Subject|4|||
170843843|NCT01038427|617435222|FG000|Overall Study|Lost to follow up|1|||
170843844|NCT01038427|617435223|FG001|Overall Study|Lost to follow up|1|||
170843845|NCT01038427|617435224|FG002|Overall Study|Lost to follow up|0|||
170843846|NCT01038427|617435222|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
170843847|NCT01038427|617435223|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
170843848|NCT01038427|617435224|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
170843849|NCT01038427|617435222|FG000|Overall Study|Withdrew consent|0|||
170843850|NCT01038427|617435223|FG001|Overall Study|Withdrew consent|0|||
170843851|NCT01038427|617435224|FG002|Overall Study|Withdrew consent|1|||
170843852|NCT01038427|617435222|FG000|Overall Study|Adverse Event|2|||
170843853|NCT01038427|617435223|FG001|Overall Study|Adverse Event|2|||
170843854|NCT01038427|617435224|FG002|Overall Study|Adverse Event|1|||
170843855|NCT01038427|617435222|FG000|Overall Study|Enrolled in error|0|||
170843856|NCT01038427|617435223|FG001|Overall Study|Enrolled in error|1|||
170843857|NCT01038427|617435224|FG002|Overall Study|Enrolled in error|1|||
170843858|NCT01038427|617435222|FG000|Overall Study|Other|0|||
170843859|NCT01038427|617435223|FG001|Overall Study|Other|2|||
170843860|NCT01038427|617435224|FG002|Overall Study|Other|0|||
170843861|NCT02992691|617435225|FG000|Overall Study|Adverse Event|2|||
170843862|NCT02992691|617435225|FG000|Overall Study|Withdrawal by Subject|1|||
170843863|NCT03651700|617435226|FG000|Overall Study|Withdrawal by Subject|1|||
170843864|NCT03651700|617435227|FG001|Overall Study|Withdrawal by Subject|0|||
170843865|NCT01461005|617435228|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
170843866|NCT00455741|617435229|FG000|Overall Study|Physician Decision|0|||
170843867|NCT00455741|617435230|FG001|Overall Study|Physician Decision|1|||
170843868|NCT01840410|617435231|FG000|Overall Study|Physician Decision|1|||
170843869|NCT01840410|617435232|FG001|Overall Study|Physician Decision|2|||
170843870|NCT01840410|617435231|FG000|Overall Study|Pregnancy|1|||
170843871|NCT01840410|617435232|FG001|Overall Study|Pregnancy|0|||
170843872|NCT01840410|617435231|FG000|Overall Study|Protocol deviation|1|||
170843873|NCT01840410|617435232|FG001|Overall Study|Protocol deviation|0|||
170843874|NCT01840410|617435231|FG000|Overall Study|Lost to Follow-up|1|||
170843875|NCT01840410|617435232|FG001|Overall Study|Lost to Follow-up|0|||
170843876|NCT01840410|617435231|FG000|Overall Study|Withdrawal by Subject|2|||
170843877|NCT01840410|617435232|FG001|Overall Study|Withdrawal by Subject|1|||
170843878|NCT01840410|617435231|FG000|Overall Study|Adverse Event|1|||
170843879|NCT01840410|617435232|FG001|Overall Study|Adverse Event|1|||
170843880|NCT03041792|617435233|FG000|Overall Study|Adverse Event|4|||
170843881|NCT03041792|617435234|FG001|Overall Study|Adverse Event|0|||
170843882|NCT03041792|617435233|FG000|Overall Study|Death in the family|0|||
170843883|NCT03041792|617435234|FG001|Overall Study|Death in the family|2|||
170843884|NCT03041792|617435233|FG000|Overall Study|Randomized but not treated|0|||
170843885|NCT03041792|617435234|FG001|Overall Study|Randomized but not treated|1|||
170843886|NCT00594880|617435235|FG000|Overall Study|Withdrawal by Subject|1|||
170843887|NCT00594880|617435236|FG001|Overall Study|Withdrawal by Subject|1|||
170843888|NCT00594880|617435235|FG000|Overall Study|Lost to Follow-up|1|||
170843889|NCT00594880|617435236|FG001|Overall Study|Lost to Follow-up|0|||
170843890|NCT02206061|617435237|FG000|Overall Study|Withdrawal by Subject|4|||
170843891|NCT02206061|617435238|FG001|Overall Study|Withdrawal by Subject|7|||
170843892|NCT02206061|617435239|FG002|Overall Study|Withdrawal by Subject|1|||
170843893|NCT02206061|617435237|FG000|Overall Study|Lost to Follow-up|14|||
170843894|NCT02206061|617435238|FG001|Overall Study|Lost to Follow-up|7|||
170843895|NCT02206061|617435239|FG002|Overall Study|Lost to Follow-up|20|||
170843896|NCT00694109|617435240|FG000|Overall Study|Physician Decision|3|||
170843897|NCT00694109|617435240|FG000|Overall Study|Adverse Event|74|||
170843898|NCT00694109|617435240|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
170843899|NCT00694109|617435240|FG000|Overall Study|Lack of Efficacy|2|||
170843900|NCT00694109|617435240|FG000|Overall Study|Withdrawal by Subject|13|||
170843901|NCT00694109|617435240|FG000|Overall Study|Pregnancy|1|||
170843902|NCT00694109|617435240|FG000|Overall Study|Enrolled but not treated|1|||
170843903|NCT00694109|617435240|FG000|Overall Study|Other|2|||
170843904|NCT00694109|617435240|FG000|Overall Study|Consented but no additional treatment|3|||
170843905|NCT01110408|617435245|FG000|Overall Study|Protocol Violation|1|||
170843906|NCT01110408|617435246|FG001|Overall Study|Protocol Violation|0|||
170843907|NCT06285240|617435247|FG000|Overall Study|Withdrawal by Subject|2|||
170843908|NCT06285240|617435248|FG001|Overall Study|Withdrawal by Subject|0|||
170843909|NCT06285240|617435249|FG002|Overall Study|Withdrawal by Subject|0|||
170843910|NCT06285240|617435250|FG003|Overall Study|Withdrawal by Subject|0|||
170843911|NCT06285240|617435247|FG000|Overall Study|Serious Adverse Event|0|||
170843912|NCT06285240|617435248|FG001|Overall Study|Serious Adverse Event|0|||
170843913|NCT06285240|617435249|FG002|Overall Study|Serious Adverse Event|1|||
170843914|NCT06285240|617435250|FG003|Overall Study|Serious Adverse Event|0|||
170843915|NCT04844879|617435253|FG000|Overall Study|Death|1|||
170843916|NCT04844879|617435253|FG000|Overall Study|Withdrawal by Subject|1|||
170843917|NCT04844879|617435253|FG000|Overall Study|Adverse Event|1|||
170843918|NCT05140915|617435254|FG000|Overall Study|Lost to Follow-up|2|||
170843919|NCT05140915|617435255|FG001|Overall Study|Lost to Follow-up|1|||
170843920|NCT04879849|617435256|FG000|Overall Study|Lost to Follow-up|0|||
170736849|NCT01576718|617042402|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170736850|NCT01576718|617042403|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170736851|NCT01576718|617042404|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170736852|NCT01576718|617042405|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170736853|NCT01576718|617042406|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
170736854|NCT01576718|617042400|FG000|Treatment Period|Adverse Event|0|||
170736855|NCT01576718|617042401|FG001|Treatment Period|Adverse Event|1|||
170736856|NCT01576718|617042402|FG002|Treatment Period|Adverse Event|1|||
170736857|NCT01576718|617042403|FG003|Treatment Period|Adverse Event|1|||
170736858|NCT01576718|617042404|FG004|Treatment Period|Adverse Event|1|||
170736859|NCT01576718|617042405|FG005|Treatment Period|Adverse Event|1|||
170736860|NCT01576718|617042406|FG006|Treatment Period|Adverse Event|0|||
170736861|NCT01576718|617042400|FG000|Treatment Period|Withdrawal by Subject|0|||
170736862|NCT01576718|617042401|FG001|Treatment Period|Withdrawal by Subject|1|||
170736863|NCT01576718|617042402|FG002|Treatment Period|Withdrawal by Subject|1|||
170736864|NCT01576718|617042403|FG003|Treatment Period|Withdrawal by Subject|0|||
170736865|NCT01576718|617042404|FG004|Treatment Period|Withdrawal by Subject|2|||
170736866|NCT01576718|617042405|FG005|Treatment Period|Withdrawal by Subject|4|||
170736867|NCT01576718|617042406|FG006|Treatment Period|Withdrawal by Subject|2|||
170736868|NCT01576718|617042400|FG000|Treatment Period|Physician Decision|0|||
170736869|NCT01576718|617042401|FG001|Treatment Period|Physician Decision|1|||
170736870|NCT01576718|617042402|FG002|Treatment Period|Physician Decision|1|||
170736871|NCT01576718|617042403|FG003|Treatment Period|Physician Decision|1|||
170736872|NCT01576718|617042404|FG004|Treatment Period|Physician Decision|1|||
170736873|NCT01576718|617042405|FG005|Treatment Period|Physician Decision|0|||
170736874|NCT01576718|617042406|FG006|Treatment Period|Physician Decision|0|||
170736875|NCT01576718|617042400|FG000|Treatment Period|Protocol Violation|0|||
170736876|NCT01576718|617042401|FG001|Treatment Period|Protocol Violation|5|||
170736877|NCT01576718|617042402|FG002|Treatment Period|Protocol Violation|4|||
170736878|NCT01576718|617042403|FG003|Treatment Period|Protocol Violation|10|||
170736879|NCT01576718|617042404|FG004|Treatment Period|Protocol Violation|6|||
170736880|NCT01576718|617042405|FG005|Treatment Period|Protocol Violation|8|||
170736881|NCT01576718|617042406|FG006|Treatment Period|Protocol Violation|12|||
170736882|NCT01576718|617042400|FG000|Treatment Period|Sponsor request|0|||
170736883|NCT01576718|617042401|FG001|Treatment Period|Sponsor request|1|||
170736884|NCT01576718|617042402|FG002|Treatment Period|Sponsor request|0|||
170736885|NCT01576718|617042403|FG003|Treatment Period|Sponsor request|0|||
170736886|NCT01576718|617042404|FG004|Treatment Period|Sponsor request|0|||
170736887|NCT01576718|617042405|FG005|Treatment Period|Sponsor request|1|||
170736888|NCT01576718|617042406|FG006|Treatment Period|Sponsor request|0|||
170736889|NCT01576718|617042400|FG000|Treatment Period|Met stopping criteria|0|||
170736890|NCT01576718|617042401|FG001|Treatment Period|Met stopping criteria|16|||
170736891|NCT01576718|617042402|FG002|Treatment Period|Met stopping criteria|13|||
170736892|NCT01576718|617042403|FG003|Treatment Period|Met stopping criteria|19|||
170736893|NCT01576718|617042404|FG004|Treatment Period|Met stopping criteria|16|||
170736894|NCT01576718|617042405|FG005|Treatment Period|Met stopping criteria|33|||
170736895|NCT01576718|617042406|FG006|Treatment Period|Met stopping criteria|15|||
170736896|NCT01576718|617042400|FG000|Treatment Period|Lost to Follow-up|0|||
170736897|NCT01576718|617042401|FG001|Treatment Period|Lost to Follow-up|0|||
170736898|NCT01576718|617042402|FG002|Treatment Period|Lost to Follow-up|0|||
170736899|NCT01576718|617042403|FG003|Treatment Period|Lost to Follow-up|0|||
170736900|NCT01576718|617042404|FG004|Treatment Period|Lost to Follow-up|1|||
170736901|NCT01576718|617042405|FG005|Treatment Period|Lost to Follow-up|0|||
170736902|NCT01576718|617042406|FG006|Treatment Period|Lost to Follow-up|0|||
170736903|NCT01576718|617042400|FG000|Treatment Period|Noncompliance to study medication|0|||
170736904|NCT01576718|617042401|FG001|Treatment Period|Noncompliance to study medication|0|||
170736905|NCT01576718|617042402|FG002|Treatment Period|Noncompliance to study medication|0|||
170736906|NCT01576718|617042403|FG003|Treatment Period|Noncompliance to study medication|0|||
170736907|NCT01576718|617042404|FG004|Treatment Period|Noncompliance to study medication|0|||
170736908|NCT01576718|617042405|FG005|Treatment Period|Noncompliance to study medication|1|||
170736909|NCT01576718|617042406|FG006|Treatment Period|Noncompliance to study medication|1|||
170736910|NCT04631705|617042407|FG000|Overall Study|Withdrawal by Subject|0|||
170736911|NCT04631705|617042408|FG001|Overall Study|Withdrawal by Subject|0|||
170736912|NCT04631705|617042409|FG002|Overall Study|Withdrawal by Subject|0|||
170736913|NCT04631705|617042410|FG003|Overall Study|Withdrawal by Subject|0|||
170736914|NCT04631705|617042411|FG004|Overall Study|Withdrawal by Subject|0|||
170736915|NCT04631705|617042412|FG005|Overall Study|Withdrawal by Subject|0|||
170736916|NCT04631705|617042413|FG006|Overall Study|Withdrawal by Subject|1|||
170736917|NCT04631705|617042414|FG007|Overall Study|Withdrawal by Subject|0|||
170736918|NCT04631705|617042415|FG008|Overall Study|Withdrawal by Subject|0|||
170736919|NCT02070484|617042417|FG000|Overall Study|Withdrawal by Subject|1|||
170736920|NCT02070484|617042418|FG001|Overall Study|Withdrawal by Subject|0|||
170736921|NCT02612064|617042423|FG000|Overall Study|Withdrawal by Subject|1|||
170736922|NCT02612064|617042424|FG001|Overall Study|Withdrawal by Subject|1|||
170736923|NCT02612064|617042423|FG000|Overall Study|Other|0|||
170736924|NCT02612064|617042424|FG001|Overall Study|Other|2|||
170736925|NCT05918978|617042427|FG000|Overall Study|Study Terminated by Sponsor|17|||
170736926|NCT05918978|617042428|FG001|Overall Study|Study Terminated by Sponsor|11|||
170736927|NCT05918978|617042427|FG000|Overall Study|Withdrawal by Subject|1|||
170736928|NCT05918978|617042428|FG001|Overall Study|Withdrawal by Subject|1|||
170736929|NCT05918978|617042427|FG000|Overall Study|Adverse Event|1|||
170736930|NCT05918978|617042428|FG001|Overall Study|Adverse Event|0|||
170736931|NCT05918978|617042427|FG000|Overall Study|Other|0|||
170736932|NCT05918978|617042428|FG001|Overall Study|Other|1|||
170736933|NCT00622180|617042429|FG000|Overall Study|Lost to Follow-up|1|||
170736934|NCT00622180|617042430|FG001|Overall Study|Lost to Follow-up|2|||
170736935|NCT06387472|617042433|FG000|Overall Study|Withdrawal by Subject|1|||
170736936|NCT06387472|617042433|FG000|Overall Study|Lost to Follow-up|2|||
170736937|NCT06387472|617042433|FG000|Overall Study|Physician Decision|1|||
170736938|NCT04182880|617042434|FG000|Overall Study|Pregnancy|1|||
170736939|NCT04182880|617042435|FG001|Overall Study|Pregnancy|0|||
170736940|NCT02036645|617042436|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736941|NCT02036645|617042437|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736942|NCT02036645|617042438|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736943|NCT02036645|617042439|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736944|NCT02036645|617042440|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736945|NCT02036645|617042441|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736946|NCT02036645|617042442|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
170736947|NCT02036645|617042443|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736948|NCT02036645|617042444|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736949|NCT02036645|617042445|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736950|NCT02036645|617042446|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736951|NCT02036645|617042447|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
170736952|NCT02036645|617042436|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736953|NCT02036645|617042437|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736954|NCT02036645|617042438|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736955|NCT02036645|617042439|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
170736956|NCT02036645|617042440|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736957|NCT02036645|617042441|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736958|NCT02036645|617042442|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736959|NCT02036645|617042443|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736960|NCT02036645|617042444|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736961|NCT02036645|617042445|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736962|NCT02036645|617042446|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736963|NCT02036645|617042447|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
170736964|NCT00717860|617042448|FG000|Overall Study|Clinical adverse experience|5|||
170736965|NCT00717860|617042449|FG001|Overall Study|Clinical adverse experience|9|||
170736966|NCT00717860|617042448|FG000|Overall Study|Laboratory adverse experience|2|||
170736967|NCT00717860|617042449|FG001|Overall Study|Laboratory adverse experience|2|||
170736968|NCT00717860|617042448|FG000|Overall Study|Lack of Efficacy|7|||
170736969|NCT00717860|617042449|FG001|Overall Study|Lack of Efficacy|13|||
170736970|NCT00717860|617042448|FG000|Overall Study|Discontinued for other reason|6|||
170736971|NCT00717860|617042449|FG001|Overall Study|Discontinued for other reason|1|||
170736972|NCT00717860|617042448|FG000|Overall Study|Withdrew consent|7|||
170736973|NCT00717860|617042449|FG001|Overall Study|Withdrew consent|3|||
170736974|NCT00698646|617042450|FG000|Overall Study|Adverse Event|8|||
170736975|NCT00698646|617042451|FG001|Overall Study|Adverse Event|7|||
170736976|NCT00698646|617042452|FG002|Overall Study|Adverse Event|8|||
170843921|NCT04879849|617435257|FG001|Overall Study|Lost to Follow-up|0|||
170843922|NCT04879849|617435258|FG002|Overall Study|Lost to Follow-up|0|||
170843923|NCT04879849|617435259|FG003|Overall Study|Lost to Follow-up|1|||
170843924|NCT04879849|617435260|FG004|Overall Study|Lost to Follow-up|0|||
170843925|NCT04879849|617435261|FG005|Overall Study|Lost to Follow-up|0|||
170843926|NCT04879849|617435262|FG006|Overall Study|Lost to Follow-up|0|||
170843927|NCT04879849|617435263|FG007|Overall Study|Lost to Follow-up|0|||
170843928|NCT04879849|617435256|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
170843929|NCT04879849|617435257|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
170843930|NCT04879849|617435258|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
170843931|NCT04879849|617435259|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
170843932|NCT04879849|617435260|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
170843933|NCT04879849|617435261|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
170843934|NCT04879849|617435262|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
170843935|NCT04879849|617435263|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
170843936|NCT04879849|617435256|FG000|Overall Study|Withdrawal by Subject|0|||
170843937|NCT04879849|617435257|FG001|Overall Study|Withdrawal by Subject|0|||
170843938|NCT04879849|617435258|FG002|Overall Study|Withdrawal by Subject|0|||
170843939|NCT04879849|617435259|FG003|Overall Study|Withdrawal by Subject|0|||
170843940|NCT04879849|617435260|FG004|Overall Study|Withdrawal by Subject|2|||
170843941|NCT04879849|617435261|FG005|Overall Study|Withdrawal by Subject|0|||
170843942|NCT04879849|617435262|FG006|Overall Study|Withdrawal by Subject|1|||
170843943|NCT04879849|617435263|FG007|Overall Study|Withdrawal by Subject|0|||
170843944|NCT04879849|617435256|FG000|Overall Study|Progressive Disease|0|||
170843945|NCT04879849|617435257|FG001|Overall Study|Progressive Disease|0|||
170843946|NCT04879849|617435258|FG002|Overall Study|Progressive Disease|1|||
170843947|NCT04879849|617435259|FG003|Overall Study|Progressive Disease|0|||
170843948|NCT04879849|617435260|FG004|Overall Study|Progressive Disease|0|||
170843949|NCT04879849|617435261|FG005|Overall Study|Progressive Disease|0|||
170843950|NCT04879849|617435262|FG006|Overall Study|Progressive Disease|0|||
170843951|NCT04879849|617435263|FG007|Overall Study|Progressive Disease|0|||
170843952|NCT04879849|617435256|FG000|Overall Study|Death|0|||
170843953|NCT04879849|617435257|FG001|Overall Study|Death|0|||
170843954|NCT04879849|617435258|FG002|Overall Study|Death|1|||
170843955|NCT04879849|617435259|FG003|Overall Study|Death|1|||
170843956|NCT04879849|617435260|FG004|Overall Study|Death|1|||
170843957|NCT04879849|617435261|FG005|Overall Study|Death|2|||
170843958|NCT04879849|617435262|FG006|Overall Study|Death|1|||
170843959|NCT04879849|617435263|FG007|Overall Study|Death|2|||
170843960|NCT04879849|617435256|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
170843961|NCT04879849|617435257|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
170843962|NCT04879849|617435258|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
170843963|NCT04879849|617435259|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
170843964|NCT04879849|617435260|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
170843965|NCT04879849|617435261|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
170843966|NCT04879849|617435262|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
170843967|NCT04879849|617435263|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
170843968|NCT04879849|617435256|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
170843969|NCT04879849|617435257|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
170843970|NCT04879849|617435258|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
170843971|NCT04879849|617435259|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
170843972|NCT04879849|617435260|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
170843973|NCT04879849|617435261|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
170843974|NCT04879849|617435262|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
170843975|NCT04879849|617435263|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
170843976|NCT04879849|617435256|FG000|Overall Study|Reason Not Specified|1|||
170843977|NCT04879849|617435257|FG001|Overall Study|Reason Not Specified|0|||
170843978|NCT04879849|617435258|FG002|Overall Study|Reason Not Specified|0|||
170843979|NCT04879849|617435259|FG003|Overall Study|Reason Not Specified|0|||
170843980|NCT04879849|617435260|FG004|Overall Study|Reason Not Specified|0|||
170843981|NCT04879849|617435261|FG005|Overall Study|Reason Not Specified|0|||
170843982|NCT04879849|617435262|FG006|Overall Study|Reason Not Specified|0|||
170843983|NCT04879849|617435263|FG007|Overall Study|Reason Not Specified|0|||
170843984|NCT04103892|617435267|FG000|Overall Study|Adverse Event|0|||
170843985|NCT04103892|617435268|FG001|Overall Study|Adverse Event|0|||
170843986|NCT04103892|617435269|FG002|Overall Study|Adverse Event|0|||
170843987|NCT04103892|617435270|FG003|Overall Study|Adverse Event|3|||
170843988|NCT04103892|617435267|FG000|Overall Study|Lost to Follow-up|0|||
170843989|NCT04103892|617435268|FG001|Overall Study|Lost to Follow-up|0|||
170843990|NCT04103892|617435269|FG002|Overall Study|Lost to Follow-up|2|||
170843991|NCT04103892|617435270|FG003|Overall Study|Lost to Follow-up|0|||
170843992|NCT04103892|617435267|FG000|Overall Study|Protocol Violation|0|||
170843993|NCT04103892|617435268|FG001|Overall Study|Protocol Violation|0|||
170843994|NCT04103892|617435269|FG002|Overall Study|Protocol Violation|1|||
170843995|NCT04103892|617435270|FG003|Overall Study|Protocol Violation|1|||
170843996|NCT04103892|617435267|FG000|Overall Study|Withdrawal by Subject|1|||
170843997|NCT04103892|617435268|FG001|Overall Study|Withdrawal by Subject|0|||
170843998|NCT04103892|617435269|FG002|Overall Study|Withdrawal by Subject|2|||
170843999|NCT04103892|617435270|FG003|Overall Study|Withdrawal by Subject|5|||
170844000|NCT04103892|617435267|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
170844001|NCT04103892|617435268|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
170844002|NCT04103892|617435269|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
170844003|NCT04103892|617435270|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
170736977|NCT00698646|617042450|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
170736978|NCT00698646|617042451|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
170844004|NCT05576662|617435271|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
170844005|NCT05576662|617435272|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
170844006|NCT05576662|617435271|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
170844007|NCT05576662|617435272|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
170844008|NCT05576662|617435271|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
170844009|NCT05576662|617435272|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
170844010|NCT05576662|617435271|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
170844011|NCT05576662|617435272|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
170844012|NCT03633799|617435283|FG000|Overall Study|Adverse Event|349|||
170844013|NCT03633799|617435283|FG000|Overall Study|Withdrawal by Subject|288|||
170844014|NCT03633799|617435283|FG000|Overall Study|Lost to Follow-up|97|||
170844015|NCT03633799|617435283|FG000|Overall Study|Physician Decision|9|||
170844016|NCT03633799|617435283|FG000|Overall Study|Protocol Violation|4|||
170844017|NCT03633799|617435283|FG000|Overall Study|Pregnancy|20|||
170844018|NCT03633799|617435283|FG000|Overall Study|other|39|||
170844019|NCT03633799|617435283|FG000|Overall Study|ongoing within third year of study|106|||
170844020|NCT03633799|617435283|FG000|Overall Study|unsuccessful study drug placement|19|||
170844021|NCT03548220|617435285|FG000|Overall Study|Lost to Follow-up|1|||
170844022|NCT03548220|617435286|FG001|Overall Study|Lost to Follow-up|0|||
170844023|NCT03548220|617435287|FG002|Overall Study|Lost to Follow-up|0|||
170844024|NCT03548220|617435288|FG003|Overall Study|Lost to Follow-up|0|||
170844025|NCT02477618|617435289|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
170844026|NCT02477618|617435290|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
170844027|NCT02477618|617435289|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
170844028|NCT02477618|617435290|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
170844029|NCT02477618|617435289|FG000|Overall Study|Adverse Event|1|||
170844030|NCT02477618|617435290|FG001|Overall Study|Adverse Event|1|||
170844031|NCT02477618|617435289|FG000|Overall Study|Transferred Away from Study Site|1|||
170844032|NCT02477618|617435290|FG001|Overall Study|Transferred Away from Study Site|0|||
170844033|NCT02477618|617435289|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
170844034|NCT02477618|617435290|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
170844035|NCT05855967|617435291|FG000|Overall Study|Withdrawal by Subject|7|||
170844036|NCT05855967|617435292|FG001|Overall Study|Withdrawal by Subject|5|||
170844037|NCT05855967|617435291|FG000|Overall Study|Lost to Follow-up|2|||
170844038|NCT05855967|617435292|FG001|Overall Study|Lost to Follow-up|1|||
170844039|NCT02397447|617435295|FG000|Overall Study|Lost to Follow-up|2|||
170844040|NCT02397447|617435296|FG001|Overall Study|Lost to Follow-up|2|||
170844041|NCT02994069|617435299|FG000|Overall Study|Death|7|||
170844042|NCT02994069|617435300|FG001|Overall Study|Death|13|||
170844043|NCT02994069|617435299|FG000|Overall Study|Adverse Event|1|||
170844044|NCT02994069|617435300|FG001|Overall Study|Adverse Event|0|||
170844045|NCT02994069|617435299|FG000|Overall Study|Other|2|||
170844046|NCT02994069|617435300|FG001|Overall Study|Other|0|||
170844047|NCT02994069|617435299|FG000|Overall Study|still on follow up/treatment|5|||
170844048|NCT02994069|617435300|FG001|Overall Study|still on follow up/treatment|6|||
170844049|NCT05992922|617435303|FG000|Overall Study|Adverse Event|6|||
170844050|NCT05992922|617435304|FG001|Overall Study|Adverse Event|0|||
170844051|NCT05992922|617435303|FG000|Overall Study|Sponsor Termination of Study|14|||
170844052|NCT05992922|617435304|FG001|Overall Study|Sponsor Termination of Study|20|||
170844053|NCT01967147|617437270|FG000|Overall Study|Adverse Event|5|||
170844054|NCT01967147|617437271|FG001|Overall Study|Adverse Event|2|||
170844055|NCT01967147|617437270|FG000|Overall Study|Lack of Efficacy|1|||
170844056|NCT01967147|617437271|FG001|Overall Study|Lack of Efficacy|4|||
170844057|NCT01967147|617437270|FG000|Overall Study|Lost to Follow-up|1|||
170844058|NCT01967147|617437271|FG001|Overall Study|Lost to Follow-up|2|||
170844059|NCT01967147|617437270|FG000|Overall Study|Withdrawal by Subject|2|||
170844060|NCT01967147|617437271|FG001|Overall Study|Withdrawal by Subject|4|||
170844061|NCT01967147|617437270|FG000|Overall Study|Non-compliance with Study Drug|0|||
170844062|NCT01967147|617437271|FG001|Overall Study|Non-compliance with Study Drug|3|||
170844063|NCT01967147|617437270|FG000|Overall Study|Other|4|||
170844064|NCT01967147|617437271|FG001|Overall Study|Other|5|||
170844065|NCT02218606|617437273|FG000|Overall Study|Adverse Event|1|||
170844066|NCT02218606|617437274|FG001|Overall Study|Adverse Event|1|||
170844067|NCT02218606|617437273|FG000|Overall Study|Death|15|||
170844068|NCT02218606|617437274|FG001|Overall Study|Death|28|||
170844069|NCT02218606|617437273|FG000|Overall Study|Physician Decision|0|||
170844070|NCT02218606|617437274|FG001|Overall Study|Physician Decision|1|||
170844071|NCT02218606|617437273|FG000|Overall Study|Withdrawal by Subject|4|||
170844072|NCT02218606|617437274|FG001|Overall Study|Withdrawal by Subject|0|||
170844073|NCT02218606|617437273|FG000|Overall Study|Noncompliance|1|||
170844074|NCT02218606|617437274|FG001|Overall Study|Noncompliance|0|||
170844075|NCT02218606|617437273|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
170844076|NCT02218606|617437274|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
170844077|NCT02218606|617437273|FG000|Overall Study|Other|2|||
170844078|NCT02218606|617437274|FG001|Overall Study|Other|1|||
170736979|NCT00698646|617042452|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
170736980|NCT00698646|617042450|FG000|Overall Study|Protocol Deviation|6|||
170736981|NCT00698646|617042451|FG001|Overall Study|Protocol Deviation|2|||
170736982|NCT00698646|617042452|FG002|Overall Study|Protocol Deviation|3|||
170736983|NCT00698646|617042450|FG000|Overall Study|Withdrawal by Subject|10|||
170736984|NCT00698646|617042451|FG001|Overall Study|Withdrawal by Subject|11|||
170736985|NCT00698646|617042452|FG002|Overall Study|Withdrawal by Subject|8|||
170736986|NCT00698646|617042450|FG000|Overall Study|Lost to Follow-up|0|||
170736987|NCT00698646|617042451|FG001|Overall Study|Lost to Follow-up|0|||
170736988|NCT00698646|617042452|FG002|Overall Study|Lost to Follow-up|2|||
170736989|NCT00698646|617042450|FG000|Overall Study|Administrative problems|1|||
170736990|NCT00698646|617042451|FG001|Overall Study|Administrative problems|0|||
170736991|NCT00698646|617042452|FG002|Overall Study|Administrative problems|1|||
170736992|NCT00279201|617042455|FG000|Initiation|Death|1|||
170736993|NCT00279201|617042456|FG001|Initiation|Death|5|||
170736994|NCT00279201|617042457|FG002|Initiation|Death|0|||
170736995|NCT00279201|617042458|FG003|Initiation|Death|0|||
170736996|NCT00279201|617042459|FG004|Initiation|Death|0|||
170736997|NCT00279201|617042460|FG005|Initiation|Death|0|||
170736998|NCT00279201|617042455|FG000|Initiation|Adverse Event|6|||
170736999|NCT00279201|617042456|FG001|Initiation|Adverse Event|15|||
170737000|NCT00279201|617042457|FG002|Initiation|Adverse Event|0|||
170737001|NCT00279201|617042458|FG003|Initiation|Adverse Event|0|||
170737002|NCT00279201|617042459|FG004|Initiation|Adverse Event|0|||
170737003|NCT00279201|617042460|FG005|Initiation|Adverse Event|0|||
170737004|NCT00279201|617042455|FG000|Initiation|Lost to Follow-up|42|||
170737005|NCT00279201|617042456|FG001|Initiation|Lost to Follow-up|41|||
170737006|NCT00279201|617042457|FG002|Initiation|Lost to Follow-up|0|||
170737007|NCT00279201|617042458|FG003|Initiation|Lost to Follow-up|0|||
170737008|NCT00279201|617042459|FG004|Initiation|Lost to Follow-up|0|||
170737009|NCT00279201|617042460|FG005|Initiation|Lost to Follow-up|0|||
170737010|NCT00279201|617042455|FG000|Initiation|Entry Criteria Exclusion|7|||
170737011|NCT00279201|617042456|FG001|Initiation|Entry Criteria Exclusion|9|||
170737012|NCT00279201|617042457|FG002|Initiation|Entry Criteria Exclusion|0|||
170737013|NCT00279201|617042458|FG003|Initiation|Entry Criteria Exclusion|0|||
170737014|NCT00279201|617042459|FG004|Initiation|Entry Criteria Exclusion|0|||
170737015|NCT00279201|617042460|FG005|Initiation|Entry Criteria Exclusion|0|||
170737016|NCT00279201|617042455|FG000|Initiation|Protocol Violation|9|||
170737017|NCT00279201|617042456|FG001|Initiation|Protocol Violation|10|||
170737018|NCT00279201|617042457|FG002|Initiation|Protocol Violation|0|||
170737019|NCT00279201|617042458|FG003|Initiation|Protocol Violation|0|||
170737020|NCT00279201|617042459|FG004|Initiation|Protocol Violation|0|||
170737021|NCT00279201|617042460|FG005|Initiation|Protocol Violation|0|||
170737022|NCT00279201|617042455|FG000|Initiation|Withdrawal by Subject|35|||
170737023|NCT00279201|617042456|FG001|Initiation|Withdrawal by Subject|41|||
170737024|NCT00279201|617042457|FG002|Initiation|Withdrawal by Subject|0|||
170737025|NCT00279201|617042458|FG003|Initiation|Withdrawal by Subject|0|||
170737026|NCT00279201|617042459|FG004|Initiation|Withdrawal by Subject|0|||
170737027|NCT00279201|617042460|FG005|Initiation|Withdrawal by Subject|0|||
170737028|NCT00279201|617042455|FG000|Initiation|Physician Decision|15|||
170737029|NCT00279201|617042456|FG001|Initiation|Physician Decision|18|||
170737030|NCT00279201|617042457|FG002|Initiation|Physician Decision|0|||
170737031|NCT00279201|617042458|FG003|Initiation|Physician Decision|0|||
170737032|NCT00279201|617042459|FG004|Initiation|Physician Decision|0|||
170737033|NCT00279201|617042460|FG005|Initiation|Physician Decision|0|||
170737034|NCT00279201|617042455|FG000|Initiation|Sponsor Decision|13|||
170737035|NCT00279201|617042456|FG001|Initiation|Sponsor Decision|5|||
170737036|NCT00279201|617042457|FG002|Initiation|Sponsor Decision|0|||
170737037|NCT00279201|617042458|FG003|Initiation|Sponsor Decision|0|||
170737038|NCT00279201|617042459|FG004|Initiation|Sponsor Decision|0|||
170737039|NCT00279201|617042460|FG005|Initiation|Sponsor Decision|0|||
170737040|NCT00279201|617042455|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
170737041|NCT00279201|617042456|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
170737042|NCT00279201|617042457|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
170737043|NCT00279201|617042458|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
170737044|NCT00279201|617042459|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
170737045|NCT00279201|617042460|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
170737046|NCT00279201|617042455|FG000|Maintenance|Lack of Efficacy|32|||
170737047|NCT00279201|617042456|FG001|Maintenance|Lack of Efficacy|30|||
170737048|NCT00279201|617042457|FG002|Maintenance|Lack of Efficacy|0|||
170737049|NCT00279201|617042458|FG003|Maintenance|Lack of Efficacy|0|||
170737050|NCT00279201|617042459|FG004|Maintenance|Lack of Efficacy|0|||
170737051|NCT00279201|617042460|FG005|Maintenance|Lack of Efficacy|0|||
170737052|NCT00279201|617042455|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
170737053|NCT00279201|617042456|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
170737054|NCT00279201|617042457|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
170737055|NCT00279201|617042458|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
170737056|NCT00279201|617042459|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
170737057|NCT00279201|617042460|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
170844079|NCT02218606|617437273|FG000|Overall Study|Never started treatment|0|||
170844080|NCT02218606|617437274|FG001|Overall Study|Never started treatment|1|||
170844081|NCT00890695|617437277|FG000|Overall Study|Protocol Violation|1|||
170844082|NCT00890695|617437278|FG001|Overall Study|Protocol Violation|0|||
170844083|NCT01253135|617437279|FG000|Original Protocol|Protocol Amendment|15|||
170844084|NCT01253135|617437279|FG000|Amended Protocol|Non-compliance|1|||
170844085|NCT00215137|617437282|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
170844086|NCT00215137|617437283|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
170844087|NCT00215137|617437284|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
170844088|NCT00215137|617437282|FG000|Randomization Period|Lost to Follow-up|0|||
170844089|NCT00215137|617437283|FG001|Randomization Period|Lost to Follow-up|1|||
170844090|NCT00215137|617437284|FG002|Randomization Period|Lost to Follow-up|0|||
170844091|NCT00215137|617437282|FG000|Randomization Period|Withdrawal by Subject|0|||
170844092|NCT00215137|617437283|FG001|Randomization Period|Withdrawal by Subject|1|||
170844093|NCT00215137|617437284|FG002|Randomization Period|Withdrawal by Subject|0|||
170844094|NCT03333876|617437285|FG000|Screening Period|Screen Failure|4|||
170844095|NCT03333876|617437285|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
170844096|NCT03333876|617437285|FG000|Mandibular Advancement|Adverse Event|2|||
170844097|NCT03333876|617437285|FG000|Mandibular Advancement|Product Damage|2|||
170844098|NCT00095498|617437289|FG000|Overall Study|Physician Decision|9|||
170844099|NCT00095498|617437290|FG001|Overall Study|Physician Decision|10|||
170844100|NCT00095498|617437291|FG002|Overall Study|Physician Decision|8|||
170844101|NCT00095498|617437289|FG000|Overall Study|Adverse Event|1|||
170844102|NCT00095498|617437290|FG001|Overall Study|Adverse Event|0|||
170844103|NCT00095498|617437291|FG002|Overall Study|Adverse Event|1|||
170844104|NCT00095498|617437289|FG000|Overall Study|Withdrawal by Subject|15|||
170844105|NCT00095498|617437290|FG001|Overall Study|Withdrawal by Subject|16|||
170844106|NCT00095498|617437291|FG002|Overall Study|Withdrawal by Subject|15|||
170844107|NCT00095498|617437289|FG000|Overall Study|Disease progression|0|||
170844108|NCT00095498|617437290|FG001|Overall Study|Disease progression|1|||
170844109|NCT00095498|617437291|FG002|Overall Study|Disease progression|1|||
170844110|NCT00095498|617437289|FG000|Overall Study|Ineligibility determined|3|||
170844111|NCT00095498|617437290|FG001|Overall Study|Ineligibility determined|0|||
170844112|NCT00095498|617437291|FG002|Overall Study|Ineligibility determined|2|||
170844113|NCT00095498|617437289|FG000|Overall Study|Lost to Follow-up|1|||
170844114|NCT00095498|617437290|FG001|Overall Study|Lost to Follow-up|1|||
170844115|NCT00095498|617437291|FG002|Overall Study|Lost to Follow-up|2|||
170844116|NCT00095498|617437289|FG000|Overall Study|Noncompliance|1|||
170844117|NCT00095498|617437290|FG001|Overall Study|Noncompliance|0|||
170844118|NCT00095498|617437291|FG002|Overall Study|Noncompliance|1|||
170844119|NCT00095498|617437289|FG000|Overall Study|Other|6|||
170844120|NCT00095498|617437290|FG001|Overall Study|Other|7|||
170844121|NCT00095498|617437291|FG002|Overall Study|Other|6|||
170844122|NCT00095498|617437289|FG000|Overall Study|Protocol Violation|0|||
170844123|NCT00095498|617437290|FG001|Overall Study|Protocol Violation|0|||
170844124|NCT00095498|617437291|FG002|Overall Study|Protocol Violation|1|||
170844125|NCT00095498|617437289|FG000|Overall Study|Requirement for alternative therapy|1|||
170844126|NCT00095498|617437290|FG001|Overall Study|Requirement for alternative therapy|0|||
170844127|NCT00095498|617437291|FG002|Overall Study|Requirement for alternative therapy|2|||
170844128|NCT04396366|617437292|FG000|Overall Study|Adverse Event|1|||
170844129|NCT04396366|617437293|FG001|Overall Study|Adverse Event|0|||
170844130|NCT05020327|617437295|FG000|Overall Study|Physician Decision|3|||
170844131|NCT05020327|617437296|FG001|Overall Study|Physician Decision|0|||
170844132|NCT05020327|617437297|FG002|Overall Study|Physician Decision|0|||
170844133|NCT05020327|617437295|FG000|Overall Study|Withdrawal by Subject|1|||
170844134|NCT05020327|617437296|FG001|Overall Study|Withdrawal by Subject|1|||
170844135|NCT05020327|617437297|FG002|Overall Study|Withdrawal by Subject|0|||
170844136|NCT05020327|617437295|FG000|Overall Study|personal/cultural, ineligible|12|||
170844137|NCT05020327|617437296|FG001|Overall Study|personal/cultural, ineligible|0|||
170844138|NCT05020327|617437297|FG002|Overall Study|personal/cultural, ineligible|0|||
170844139|NCT03002220|617437299|FG000|Overall Study|Lack of Efficacy|2|||
170844140|NCT03002220|617437299|FG000|Overall Study|Withdrawal by Subject|3|||
170844141|NCT03002220|617437299|FG000|Overall Study|Adverse Event|2|||
170844142|NCT03002220|617437299|FG000|Overall Study|Disease progression|13|||
170844143|NCT03002220|617437299|FG000|Overall Study|Physician Decision|1|||
170844144|NCT00833261|617437300|FG000|Overall Study|Withdrawal by Subject|4|||
170844145|NCT00128102|617437303|FG000|Overall Study|Site Discontinued|3|||
170844146|NCT00128102|617437304|FG001|Overall Study|Site Discontinued|6|||
170844147|NCT00128102|617437303|FG000|Overall Study|Other|0|||
170844148|NCT00128102|617437304|FG001|Overall Study|Other|1|||
170844149|NCT00128102|617437303|FG000|Overall Study|Progressive Disease|255|||
170844150|NCT00128102|617437304|FG001|Overall Study|Progressive Disease|285|||
170844151|NCT00128102|617437303|FG000|Overall Study|Adverse Event|34|||
170844152|NCT00128102|617437304|FG001|Overall Study|Adverse Event|11|||
170844153|NCT00128102|617437303|FG000|Overall Study|Death|12|||
170844154|NCT00128102|617437304|FG001|Overall Study|Death|13|||
170844155|NCT00128102|617437303|FG000|Overall Study|Physician Decision|3|||
170844156|NCT00128102|617437304|FG001|Overall Study|Physician Decision|3|||
170844157|NCT00128102|617437303|FG000|Overall Study|Withdrawal by Subject|19|||
170844158|NCT00128102|617437304|FG001|Overall Study|Withdrawal by Subject|11|||
170844159|NCT00128102|617437303|FG000|Overall Study|Protocol Violation|2|||
170844160|NCT00128102|617437304|FG001|Overall Study|Protocol Violation|2|||
170844161|NCT01255631|617437305|FG000|Overall Study|poor enrollment, no data analyzed|9|||
170844162|NCT01255631|617437306|FG001|Overall Study|poor enrollment, no data analyzed|6|||
170844163|NCT00515671|617437307|FG000|Overall Study|Lost to Follow-up|13|||
170844164|NCT00515671|617437308|FG001|Overall Study|Lost to Follow-up|10|||
170844165|NCT00515671|617437307|FG000|Overall Study|Withdrawal by Subject|3|||
170844166|NCT00515671|617437308|FG001|Overall Study|Withdrawal by Subject|5|||
170844167|NCT00515671|617437307|FG000|Overall Study|incarcerated|1|||
170844168|NCT00515671|617437308|FG001|Overall Study|incarcerated|2|||
170844169|NCT02815579|617437311|FG000|Overall Study|Non-payment of loan down-payment|16|||
170844170|NCT02815579|617437312|FG001|Overall Study|Non-payment of loan down-payment|0|||
170844171|NCT02815579|617437311|FG000|Overall Study|Withdrawal by Subject|7|||
170844172|NCT02815579|617437312|FG001|Overall Study|Withdrawal by Subject|1|||
170844173|NCT02815579|617437311|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
170844174|NCT02815579|617437312|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
170844175|NCT02815579|617437311|FG000|Overall Study|Lost to Follow-up|7|||
170844176|NCT02815579|617437312|FG001|Overall Study|Lost to Follow-up|4|||
170844177|NCT02815579|617437311|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
170844178|NCT02815579|617437312|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
170844179|NCT02815579|617437311|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
170844180|NCT02815579|617437312|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
170844181|NCT02815579|617437311|FG000|Overall Study|Death|5|||
170844182|NCT02815579|617437312|FG001|Overall Study|Death|4|||
170844183|NCT02815579|617437311|FG000|Overall Study|Imprisoned|0|||
170844184|NCT02815579|617437312|FG001|Overall Study|Imprisoned|2|||
170844185|NCT02815579|617437311|FG000|Overall Study|Did not meet enrollment criteria|0|||
170844186|NCT02815579|617437312|FG001|Overall Study|Did not meet enrollment criteria|1|||
170844187|NCT02311673|617437313|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
170844188|NCT02311673|617437314|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
170844189|NCT02311673|617437315|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
170844190|NCT02311673|617437316|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
170844191|NCT01014208|617437320|FG000|Overall Study|Lost to Follow-up|2|||
170844192|NCT01014208|617437321|FG001|Overall Study|Lost to Follow-up|5|||
170844193|NCT01014208|617437320|FG000|Overall Study|Participant Withdrew Consent|12|||
170844194|NCT01014208|617437321|FG001|Overall Study|Participant Withdrew Consent|12|||
170844195|NCT01014208|617437320|FG000|Overall Study|Did Not Receive Study Drug|2|||
170844196|NCT01014208|617437321|FG001|Overall Study|Did Not Receive Study Drug|0|||
170844197|NCT01014208|617437320|FG000|Overall Study|Study Closed/terminated|78|||
170844198|NCT01014208|617437321|FG001|Overall Study|Study Closed/terminated|83|||
170844199|NCT00414908|617437324|FG000|Overall Study|Protocol Violation|1|||
170844200|NCT00414908|617437325|FG001|Overall Study|Protocol Violation|1|||
170844201|NCT04165031|617437326|FG000|Overall Study|Adverse Event|1|||
170844202|NCT04165031|617437327|FG001|Overall Study|Adverse Event|1|||
170844203|NCT04165031|617437328|FG002|Overall Study|Adverse Event|0|||
170844204|NCT04165031|617437329|FG003|Overall Study|Adverse Event|0|||
170844205|NCT04165031|617437330|FG004|Overall Study|Adverse Event|0|||
170844206|NCT04165031|617437331|FG005|Overall Study|Adverse Event|0|||
170844207|NCT04165031|617437326|FG000|Overall Study|Withdrawal by Subject|0|||
170844208|NCT04165031|617437327|FG001|Overall Study|Withdrawal by Subject|0|||
170844209|NCT04165031|617437328|FG002|Overall Study|Withdrawal by Subject|1|||
170844210|NCT04165031|617437329|FG003|Overall Study|Withdrawal by Subject|0|||
170844211|NCT04165031|617437330|FG004|Overall Study|Withdrawal by Subject|0|||
170844212|NCT04165031|617437331|FG005|Overall Study|Withdrawal by Subject|0|||
170844213|NCT01008410|617437336|FG000|Overall Study|Adverse Event|13|||
170844214|NCT01008410|617437337|FG001|Overall Study|Adverse Event|7|||
170844215|NCT01008410|617437336|FG000|Overall Study|Withdrawal by Subject|6|||
170844216|NCT01008410|617437337|FG001|Overall Study|Withdrawal by Subject|2|||
170844217|NCT01008410|617437336|FG000|Overall Study|Lost to Follow-up|1|||
170844218|NCT01008410|617437337|FG001|Overall Study|Lost to Follow-up|0|||
170844219|NCT01008410|617437336|FG000|Overall Study|Noncompliance|1|||
170844220|NCT01008410|617437337|FG001|Overall Study|Noncompliance|0|||
170844221|NCT01008410|617437336|FG000|Overall Study|Low Cortisol|2|||
170844222|NCT01008410|617437337|FG001|Overall Study|Low Cortisol|0|||
170844223|NCT01008410|617437336|FG000|Overall Study|Lack of Efficacy|2|||
170844224|NCT01008410|617437337|FG001|Overall Study|Lack of Efficacy|6|||
170844225|NCT01008410|617437336|FG000|Overall Study|Met Exclusion Criterion|0|||
170844226|NCT01008410|617437337|FG001|Overall Study|Met Exclusion Criterion|1|||
170844227|NCT00297427|617437338|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
170844228|NCT00297427|617437339|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
170844229|NCT00297427|617437338|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
170844230|NCT00297427|617437339|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
170844231|NCT00297427|617437338|FG000|Phase 1: Initial Intervention|Death|0|||
170844232|NCT00297427|617437339|FG001|Phase 1: Initial Intervention|Death|1|||
170844233|NCT00297427|617437338|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
170844234|NCT00297427|617437339|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
170844235|NCT00297427|617437338|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
170844236|NCT00297427|617437339|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
170844237|NCT00297427|617437338|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
170844238|NCT00297427|617437339|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
170844239|NCT00297427|617437338|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
170844240|NCT00297427|617437339|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
170844241|NCT00297427|617437338|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
170844242|NCT00297427|617437339|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
170844243|NCT01127893|617437342|FG000|Overall Study|Study Termination by the Sponsor|1|||
170844244|NCT04079868|617437343|FG000|Overall Study|Lost to Follow-up|100|||
170844245|NCT04079868|617437344|FG001|Overall Study|Lost to Follow-up|200|||
170844246|NCT04079868|617437343|FG000|Overall Study|Physician Decision|100|||
170844247|NCT04079868|617437344|FG001|Overall Study|Physician Decision|0|||
170844248|NCT03338296|617437345|FG000|Overall Study|Adverse Event|0|||
170844249|NCT03338296|617437346|FG001|Overall Study|Adverse Event|1|||
170844250|NCT03338296|617437345|FG000|Overall Study|Withdrawal by Subject|14|||
170844251|NCT03338296|617437346|FG001|Overall Study|Withdrawal by Subject|13|||
170844252|NCT03338296|617437345|FG000|Overall Study|Lost to Follow-up|10|||
170844253|NCT03338296|617437346|FG001|Overall Study|Lost to Follow-up|10|||
170844254|NCT03338296|617437345|FG000|Overall Study|Study Terminated by Sponsor|77|||
170844255|NCT03338296|617437346|FG001|Overall Study|Study Terminated by Sponsor|76|||
170844256|NCT03338296|617437345|FG000|Overall Study|Other|2|||
170844257|NCT03338296|617437346|FG001|Overall Study|Other|7|||
170844258|NCT03338296|617437345|FG000|Overall Study|Missing|0|||
170844259|NCT03338296|617437346|FG001|Overall Study|Missing|1|||
170844260|NCT00702962|617437347|FG000|Overall Study|Progressive disease|0|||
170844261|NCT00702962|617437348|FG001|Overall Study|Progressive disease|1|||
170844262|NCT00702962|617437347|FG000|Overall Study|Hospitalized for other health disorder|1|||
170844263|NCT00702962|617437348|FG001|Overall Study|Hospitalized for other health disorder|0|||
170844264|NCT01867333|617437351|FG000|Overall Study|Withdrawal by Subject|1|||
170844265|NCT01867333|617437352|FG001|Overall Study|Withdrawal by Subject|0|||
170844266|NCT01867333|617437351|FG000|Overall Study|Adverse Event|1|||
170844267|NCT01867333|617437352|FG001|Overall Study|Adverse Event|0|||
170844268|NCT01867333|617437351|FG000|Overall Study|Participant choice|1|||
170844269|NCT01867333|617437352|FG001|Overall Study|Participant choice|2|||
170844270|NCT01867333|617437351|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
170844271|NCT01867333|617437352|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
170844272|NCT01867333|617437351|FG000|Overall Study|Death|0|||
170844273|NCT01867333|617437352|FG001|Overall Study|Death|1|||
170844274|NCT01867333|617437351|FG000|Overall Study|Physician Decision|3|||
170844275|NCT01867333|617437352|FG001|Overall Study|Physician Decision|2|||
170844276|NCT01867333|617437351|FG000|Overall Study|Switched to alternative treatment|1|||
170844277|NCT01867333|617437352|FG001|Overall Study|Switched to alternative treatment|0|||
170844278|NCT04868539|617437358|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
170844279|NCT04868539|617437359|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
170844280|NCT02202785|617437360|FG000|Overall Study|Study Terminated by Sponsor|1|||
170844281|NCT02202785|617437361|FG001|Overall Study|Study Terminated by Sponsor|6|||
170844282|NCT02202785|617437362|FG002|Overall Study|Study Terminated by Sponsor|4|||
170844283|NCT02202785|617437360|FG000|Overall Study|Withdrawal by Subject|0|||
170844284|NCT02202785|617437361|FG001|Overall Study|Withdrawal by Subject|1|||
170844285|NCT02202785|617437362|FG002|Overall Study|Withdrawal by Subject|0|||
170844286|NCT02202785|617437360|FG000|Overall Study|Lost to Follow-up|0|||
170737058|NCT00279201|617042455|FG000|Maintenance|Adverse Event|4|||
170737059|NCT00279201|617042456|FG001|Maintenance|Adverse Event|4|||
170737060|NCT00279201|617042457|FG002|Maintenance|Adverse Event|0|||
170737061|NCT00279201|617042458|FG003|Maintenance|Adverse Event|0|||
170737062|NCT00279201|617042459|FG004|Maintenance|Adverse Event|0|||
170737063|NCT00279201|617042460|FG005|Maintenance|Adverse Event|0|||
170737064|NCT00279201|617042455|FG000|Maintenance|Death|4|||
170737065|NCT00279201|617042456|FG001|Maintenance|Death|4|||
170737066|NCT00279201|617042457|FG002|Maintenance|Death|0|||
170737067|NCT00279201|617042458|FG003|Maintenance|Death|0|||
170737068|NCT00279201|617042459|FG004|Maintenance|Death|0|||
170737069|NCT00279201|617042460|FG005|Maintenance|Death|0|||
170737070|NCT00279201|617042455|FG000|Maintenance|Lost to Follow-up|17|||
170737071|NCT00279201|617042456|FG001|Maintenance|Lost to Follow-up|13|||
170737072|NCT00279201|617042457|FG002|Maintenance|Lost to Follow-up|0|||
170737073|NCT00279201|617042458|FG003|Maintenance|Lost to Follow-up|0|||
170737074|NCT00279201|617042459|FG004|Maintenance|Lost to Follow-up|0|||
170737075|NCT00279201|617042460|FG005|Maintenance|Lost to Follow-up|0|||
170737076|NCT00279201|617042455|FG000|Maintenance|Entry Criteria Exclusion|1|||
170737077|NCT00279201|617042456|FG001|Maintenance|Entry Criteria Exclusion|4|||
170737078|NCT00279201|617042457|FG002|Maintenance|Entry Criteria Exclusion|0|||
170737079|NCT00279201|617042458|FG003|Maintenance|Entry Criteria Exclusion|0|||
170737080|NCT00279201|617042459|FG004|Maintenance|Entry Criteria Exclusion|0|||
170737081|NCT00279201|617042460|FG005|Maintenance|Entry Criteria Exclusion|0|||
170737082|NCT00279201|617042455|FG000|Maintenance|Protocol Violation|16|||
170737083|NCT00279201|617042456|FG001|Maintenance|Protocol Violation|24|||
170737084|NCT00279201|617042457|FG002|Maintenance|Protocol Violation|0|||
170737085|NCT00279201|617042458|FG003|Maintenance|Protocol Violation|0|||
170737086|NCT00279201|617042459|FG004|Maintenance|Protocol Violation|0|||
170737087|NCT00279201|617042460|FG005|Maintenance|Protocol Violation|0|||
170737088|NCT00279201|617042455|FG000|Maintenance|Withdrawal by Subject|18|||
170737089|NCT00279201|617042456|FG001|Maintenance|Withdrawal by Subject|18|||
170737090|NCT00279201|617042457|FG002|Maintenance|Withdrawal by Subject|0|||
170737091|NCT00279201|617042458|FG003|Maintenance|Withdrawal by Subject|0|||
170737092|NCT00279201|617042459|FG004|Maintenance|Withdrawal by Subject|0|||
170737093|NCT00279201|617042460|FG005|Maintenance|Withdrawal by Subject|0|||
170737094|NCT00279201|617042455|FG000|Maintenance|Physician Decision|9|||
170737095|NCT00279201|617042456|FG001|Maintenance|Physician Decision|9|||
170737096|NCT00279201|617042457|FG002|Maintenance|Physician Decision|0|||
170737097|NCT00279201|617042458|FG003|Maintenance|Physician Decision|0|||
170737098|NCT00279201|617042459|FG004|Maintenance|Physician Decision|0|||
170737099|NCT00279201|617042460|FG005|Maintenance|Physician Decision|0|||
170737100|NCT00279201|617042455|FG000|Maintenance|Sponsor Decision|4|||
170737101|NCT00279201|617042456|FG001|Maintenance|Sponsor Decision|0|||
170737102|NCT00279201|617042457|FG002|Maintenance|Sponsor Decision|0|||
170737103|NCT00279201|617042458|FG003|Maintenance|Sponsor Decision|0|||
170737104|NCT00279201|617042459|FG004|Maintenance|Sponsor Decision|0|||
170737105|NCT00279201|617042460|FG005|Maintenance|Sponsor Decision|0|||
170737106|NCT00279201|617042455|FG000|Maintenance|HbA1c>7.5%|123|||
170737107|NCT00279201|617042456|FG001|Maintenance|HbA1c>7.5%|126|||
170737108|NCT00279201|617042457|FG002|Maintenance|HbA1c>7.5%|0|||
170737109|NCT00279201|617042458|FG003|Maintenance|HbA1c>7.5%|0|||
170737110|NCT00279201|617042459|FG004|Maintenance|HbA1c>7.5%|0|||
170737111|NCT00279201|617042460|FG005|Maintenance|HbA1c>7.5%|0|||
170737112|NCT00279201|617042455|FG000|Intensification Addendum|Withdrawal by Subject|0|||
170737113|NCT00279201|617042456|FG001|Intensification Addendum|Withdrawal by Subject|0|||
170737114|NCT00279201|617042457|FG002|Intensification Addendum|Withdrawal by Subject|12|||
170737115|NCT00279201|617042458|FG003|Intensification Addendum|Withdrawal by Subject|14|||
170737116|NCT00279201|617042459|FG004|Intensification Addendum|Withdrawal by Subject|9|||
170737117|NCT00279201|617042460|FG005|Intensification Addendum|Withdrawal by Subject|18|||
170737118|NCT00279201|617042455|FG000|Intensification Addendum|Lost to Follow-up|0|||
170737119|NCT00279201|617042456|FG001|Intensification Addendum|Lost to Follow-up|0|||
170737120|NCT00279201|617042457|FG002|Intensification Addendum|Lost to Follow-up|4|||
170737121|NCT00279201|617042458|FG003|Intensification Addendum|Lost to Follow-up|6|||
170737122|NCT00279201|617042459|FG004|Intensification Addendum|Lost to Follow-up|7|||
170737123|NCT00279201|617042460|FG005|Intensification Addendum|Lost to Follow-up|7|||
170737124|NCT00279201|617042455|FG000|Intensification Addendum|Protocol Violation|0|||
170737125|NCT00279201|617042456|FG001|Intensification Addendum|Protocol Violation|0|||
170737126|NCT00279201|617042457|FG002|Intensification Addendum|Protocol Violation|2|||
170844287|NCT02202785|617437361|FG001|Overall Study|Lost to Follow-up|1|||
170844288|NCT02202785|617437362|FG002|Overall Study|Lost to Follow-up|0|||
170844289|NCT02202785|617437360|FG000|Overall Study|Reason not Specified|10|||
170844290|NCT02202785|617437361|FG001|Overall Study|Reason not Specified|7|||
170844291|NCT02202785|617437362|FG002|Overall Study|Reason not Specified|13|||
170737127|NCT00279201|617042458|FG003|Intensification Addendum|Protocol Violation|2|||
170737128|NCT00279201|617042459|FG004|Intensification Addendum|Protocol Violation|6|||
170737129|NCT00279201|617042460|FG005|Intensification Addendum|Protocol Violation|6|||
170737130|NCT00279201|617042455|FG000|Intensification Addendum|Adverse Event|0|||
170737131|NCT00279201|617042456|FG001|Intensification Addendum|Adverse Event|0|||
170737132|NCT00279201|617042457|FG002|Intensification Addendum|Adverse Event|0|||
170737133|NCT00279201|617042458|FG003|Intensification Addendum|Adverse Event|4|||
170737134|NCT00279201|617042459|FG004|Intensification Addendum|Adverse Event|1|||
170737135|NCT00279201|617042460|FG005|Intensification Addendum|Adverse Event|3|||
170737136|NCT00279201|617042455|FG000|Intensification Addendum|Physician Decision|0|||
170737137|NCT00279201|617042456|FG001|Intensification Addendum|Physician Decision|0|||
170737138|NCT00279201|617042457|FG002|Intensification Addendum|Physician Decision|4|||
170844292|NCT00208325|617437363|FG000|Overall Study|Death|18|||
170737139|NCT00279201|617042458|FG003|Intensification Addendum|Physician Decision|1|||
170737140|NCT00279201|617042459|FG004|Intensification Addendum|Physician Decision|3|||
170737141|NCT00279201|617042460|FG005|Intensification Addendum|Physician Decision|2|||
170737142|NCT00279201|617042455|FG000|Intensification Addendum|Sponsor Decision|0|||
170737143|NCT00279201|617042456|FG001|Intensification Addendum|Sponsor Decision|0|||
170737144|NCT00279201|617042457|FG002|Intensification Addendum|Sponsor Decision|0|||
170737145|NCT00279201|617042458|FG003|Intensification Addendum|Sponsor Decision|0|||
170737146|NCT00279201|617042459|FG004|Intensification Addendum|Sponsor Decision|1|||
170737147|NCT00279201|617042460|FG005|Intensification Addendum|Sponsor Decision|1|||
170737148|NCT00279201|617042455|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
170737149|NCT00279201|617042456|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
170737150|NCT00279201|617042457|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
170737151|NCT00279201|617042458|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
170737152|NCT00279201|617042459|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
170737153|NCT00279201|617042460|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
170737154|NCT00279201|617042455|FG000|Intensification Addendum|Lack of Efficacy|0|||
170737155|NCT00279201|617042456|FG001|Intensification Addendum|Lack of Efficacy|0|||
170737156|NCT00279201|617042457|FG002|Intensification Addendum|Lack of Efficacy|0|||
170737157|NCT00279201|617042458|FG003|Intensification Addendum|Lack of Efficacy|1|||
170737158|NCT00279201|617042459|FG004|Intensification Addendum|Lack of Efficacy|1|||
170737159|NCT00279201|617042460|FG005|Intensification Addendum|Lack of Efficacy|0|||
170737160|NCT00279201|617042455|FG000|Intensification Addendum|Death|0|||
170737161|NCT00279201|617042456|FG001|Intensification Addendum|Death|0|||
170737162|NCT00279201|617042457|FG002|Intensification Addendum|Death|0|||
170737163|NCT00279201|617042458|FG003|Intensification Addendum|Death|0|||
170737164|NCT00279201|617042459|FG004|Intensification Addendum|Death|1|||
170737165|NCT00279201|617042460|FG005|Intensification Addendum|Death|0|||
170737166|NCT00696384|617042464|FG000|Open Label Phase|Adverse Event|27|||
170737167|NCT00696384|617042465|FG001|Open Label Phase|Adverse Event|0|||
170737168|NCT00696384|617042466|FG002|Open Label Phase|Adverse Event|0|||
170737169|NCT00696384|617042464|FG000|Open Label Phase|Protocol Violation|18|||
170737170|NCT00696384|617042465|FG001|Open Label Phase|Protocol Violation|0|||
170737171|NCT00696384|617042466|FG002|Open Label Phase|Protocol Violation|0|||
170737172|NCT00696384|617042464|FG000|Open Label Phase|Lost to Follow-up|24|||
170737173|NCT00696384|617042465|FG001|Open Label Phase|Lost to Follow-up|0|||
170737174|NCT00696384|617042466|FG002|Open Label Phase|Lost to Follow-up|0|||
170737175|NCT00696384|617042464|FG000|Open Label Phase|Withdrawal by Subject|37|||
170737176|NCT00696384|617042465|FG001|Open Label Phase|Withdrawal by Subject|0|||
170737177|NCT00696384|617042466|FG002|Open Label Phase|Withdrawal by Subject|0|||
170737178|NCT00696384|617042464|FG000|Open Label Phase|Other|6|||
170737179|NCT00696384|617042465|FG001|Open Label Phase|Other|0|||
170737180|NCT00696384|617042466|FG002|Open Label Phase|Other|0|||
170737181|NCT00696384|617042464|FG000|Open Label Phase|Lack of Efficacy|3|||
170737182|NCT00696384|617042465|FG001|Open Label Phase|Lack of Efficacy|0|||
170737183|NCT00696384|617042466|FG002|Open Label Phase|Lack of Efficacy|0|||
170737184|NCT00696384|617042464|FG000|Open Label Phase|Physician Decision|4|||
170737185|NCT00696384|617042465|FG001|Open Label Phase|Physician Decision|0|||
170737186|NCT00696384|617042466|FG002|Open Label Phase|Physician Decision|0|||
170737187|NCT00696384|617042464|FG000|Double Blind Phase|Adverse Event|0|||
170737188|NCT00696384|617042465|FG001|Double Blind Phase|Adverse Event|2|||
170737189|NCT00696384|617042466|FG002|Double Blind Phase|Adverse Event|2|||
170737190|NCT00696384|617042464|FG000|Double Blind Phase|Lost to Follow-up|0|||
170737191|NCT00696384|617042465|FG001|Double Blind Phase|Lost to Follow-up|2|||
170737192|NCT00696384|617042466|FG002|Double Blind Phase|Lost to Follow-up|1|||
170737193|NCT00696384|617042464|FG000|Double Blind Phase|Withdrawal by Subject|0|||
170737194|NCT00696384|617042465|FG001|Double Blind Phase|Withdrawal by Subject|4|||
170737195|NCT00696384|617042466|FG002|Double Blind Phase|Withdrawal by Subject|3|||
170737196|NCT00696384|617042464|FG000|Double Blind Phase|Lack of Efficacy|0|||
170737197|NCT00696384|617042465|FG001|Double Blind Phase|Lack of Efficacy|1|||
170737198|NCT00696384|617042466|FG002|Double Blind Phase|Lack of Efficacy|0|||
170737199|NCT00696384|617042464|FG000|Double Blind Phase|Physician Decision|0|||
170737200|NCT00696384|617042465|FG001|Double Blind Phase|Physician Decision|2|||
170737201|NCT00696384|617042466|FG002|Double Blind Phase|Physician Decision|0|||
170737202|NCT05559866|617042469|FG000|Overall Study|Withdrawal by Subject|1|||
170737203|NCT05559866|617042470|FG001|Overall Study|Withdrawal by Subject|0|||
170737204|NCT02764775|617043984|FG000|Overall Study|Death|1|||
170737205|NCT02764775|617043984|FG000|Overall Study|Lost to Follow-up|2|||
170737206|NCT02764775|617043984|FG000|Overall Study|Withdrawal by Subject|3|||
170737207|NCT00332332|617043989|FG000|Overall Study|Adverse Event|13|||
170737208|NCT00332332|617043989|FG000|Overall Study|Death|1|||
170737209|NCT00332332|617043989|FG000|Overall Study|Withdrawal by Subject|8|||
170737210|NCT00332332|617043989|FG000|Overall Study|Physician Decision|1|||
170737211|NCT00332332|617043989|FG000|Overall Study|Lost to Follow-up|3|||
170737212|NCT00332332|617043989|FG000|Overall Study|Protocol deviation|4|||
170737213|NCT00332332|617043989|FG000|Overall Study|Noncompliance|2|||
170737214|NCT00332332|617043989|FG000|Overall Study|Disease progression|2|||
170737215|NCT00332332|617043989|FG000|Overall Study|Other|18|||
170737216|NCT00332332|617043989|FG000|Overall Study|Did not receive study treatment|16|||
170737217|NCT03075501|617043990|FG000|Overall Study|Scheduling difficulties|15|||
170737218|NCT03075501|617043991|FG001|Overall Study|Scheduling difficulties|9|||
170737219|NCT02714868|617043992|FG000|Overall Study|Withdrawal by Subject|3|||
170737220|NCT02714868|617043993|FG001|Overall Study|Withdrawal by Subject|0|||
170737221|NCT02714868|617043992|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
170737222|NCT02714868|617043993|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
170737223|NCT02714868|617043992|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
170737224|NCT02714868|617043993|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
170737225|NCT01373931|617044006|FG000|Lead-in Period|Adverse Event|2|||
170737226|NCT01373931|617044007|FG001|Lead-in Period|Adverse Event|0|||
170737227|NCT01373931|617044006|FG000|Period 1|Adverse Event|2|||
170737228|NCT01373931|617044007|FG001|Period 1|Adverse Event|0|||
170737229|NCT01373931|617044006|FG000|Period 1|Withdrawal by Subject|0|||
170737230|NCT01373931|617044007|FG001|Period 1|Withdrawal by Subject|2|||
170737231|NCT00674323|617044008|FG000|Overall Study|Adverse Event|0|||
170737232|NCT00674323|617044009|FG001|Overall Study|Adverse Event|1|||
170737233|NCT00674323|617044010|FG002|Overall Study|Adverse Event|0|||
170737234|NCT00674323|617044008|FG000|Overall Study|Protocol Violation|1|||
170737235|NCT00674323|617044009|FG001|Overall Study|Protocol Violation|0|||
170737236|NCT00674323|617044010|FG002|Overall Study|Protocol Violation|0|||
170737237|NCT00742079|617044011|FG000|Overall Study|Lost to Follow-up|0|||
170737238|NCT00742079|617044012|FG001|Overall Study|Lost to Follow-up|1|||
170737239|NCT02799472|617044019|FG000|Overall Study|Withdrawal by Subject|2|||
170737240|NCT02799472|617044020|FG001|Overall Study|Withdrawal by Subject|4|||
170737241|NCT02799472|617044019|FG000|Overall Study|Lack of Efficacy|2|||
170737242|NCT02799472|617044020|FG001|Overall Study|Lack of Efficacy|0|||
170737243|NCT02799472|617044019|FG000|Overall Study|Lost to Follow-up|0|||
170737244|NCT02799472|617044020|FG001|Overall Study|Lost to Follow-up|1|||
170737245|NCT02801669|617044021|FG000|Overall Study|Death|66|||
170737246|NCT02801669|617044022|FG001|Overall Study|Death|69|||
170737247|NCT02801669|617044021|FG000|Overall Study|Withdrawal by Subject|81|||
170737248|NCT02801669|617044022|FG001|Overall Study|Withdrawal by Subject|77|||
170737249|NCT02801669|617044021|FG000|Overall Study|Other|4|||
170737250|NCT02801669|617044022|FG001|Overall Study|Other|6|||
170737251|NCT04461795|617044023|FG000|Overall Study|Lost to Follow-up|2|||
170737252|NCT04461795|617044023|FG000|Overall Study|Withdrawal by Subject|2|||
170737253|NCT04461795|617044023|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
170737254|NCT00633932|617044025|FG000|Overall Study|Adverse Event|1|||
170737255|NCT00633932|617044026|FG001|Overall Study|Adverse Event|3|||
170737256|NCT00633932|617044027|FG002|Overall Study|Adverse Event|4|||
170737257|NCT00633932|617044025|FG000|Overall Study|Withdrawal by Subject|3|||
170737258|NCT00633932|617044026|FG001|Overall Study|Withdrawal by Subject|9|||
170737259|NCT00633932|617044027|FG002|Overall Study|Withdrawal by Subject|1|||
170737260|NCT00633932|617044025|FG000|Overall Study|Lost to Follow-up|1|||
170737261|NCT00633932|617044026|FG001|Overall Study|Lost to Follow-up|0|||
170737262|NCT00633932|617044027|FG002|Overall Study|Lost to Follow-up|2|||
170737263|NCT00633932|617044025|FG000|Overall Study|Protocol Violation|5|||
170737264|NCT00633932|617044026|FG001|Overall Study|Protocol Violation|2|||
170737265|NCT00633932|617044027|FG002|Overall Study|Protocol Violation|3|||
170737266|NCT00633932|617044025|FG000|Overall Study|Physician Decision|0|||
170737267|NCT00633932|617044026|FG001|Overall Study|Physician Decision|0|||
170737268|NCT00633932|617044027|FG002|Overall Study|Physician Decision|1|||
170737269|NCT00633932|617044025|FG000|Overall Study|Doctor's judgement|1|||
170737270|NCT00633932|617044026|FG001|Overall Study|Doctor's judgement|0|||
170737271|NCT00633932|617044027|FG002|Overall Study|Doctor's judgement|0|||
170737272|NCT00633932|617044025|FG000|Overall Study|Moved Away|1|||
170737273|NCT00633932|617044026|FG001|Overall Study|Moved Away|0|||
170737274|NCT00633932|617044027|FG002|Overall Study|Moved Away|0|||
170737275|NCT02396537|617044029|FG000|Overall Study|Protocol Violation|0|||
170737276|NCT02396537|617044030|FG001|Overall Study|Protocol Violation|1|||
170737277|NCT00597714|617044038|FG000|Overall Study|Death|56|||
170737278|NCT00597714|617044039|FG001|Overall Study|Death|46|||
170737279|NCT00597714|617044040|FG002|Overall Study|Death|0|||
170737280|NCT00597714|617044038|FG000|Overall Study|Recipient death|0|||
170737281|NCT00597714|617044039|FG001|Overall Study|Recipient death|0|||
170737282|NCT00597714|617044040|FG002|Overall Study|Recipient death|10|||
170737283|NCT00985985|617044043|FG000|Overall Study|Adverse Event|4|||
170737284|NCT00985985|617044044|FG001|Overall Study|Adverse Event|2|||
170737285|NCT00985985|617044045|FG002|Overall Study|Adverse Event|2|||
170737286|NCT00985985|617044046|FG003|Overall Study|Adverse Event|2|||
170737287|NCT00985985|617044043|FG000|Overall Study|Lost to Follow-up|4|||
170737288|NCT00985985|617044044|FG001|Overall Study|Lost to Follow-up|11|||
170737289|NCT00985985|617044045|FG002|Overall Study|Lost to Follow-up|2|||
170737290|NCT00985985|617044046|FG003|Overall Study|Lost to Follow-up|3|||
170737291|NCT00985985|617044043|FG000|Overall Study|Protocol Violation|1|||
170737292|NCT00985985|617044044|FG001|Overall Study|Protocol Violation|2|||
170737293|NCT00985985|617044045|FG002|Overall Study|Protocol Violation|0|||
170737294|NCT00985985|617044046|FG003|Overall Study|Protocol Violation|1|||
170737295|NCT00985985|617044043|FG000|Overall Study|Lack of Efficacy|5|||
170737296|NCT00985985|617044044|FG001|Overall Study|Lack of Efficacy|6|||
170737297|NCT00985985|617044045|FG002|Overall Study|Lack of Efficacy|1|||
170737298|NCT00985985|617044046|FG003|Overall Study|Lack of Efficacy|3|||
170737299|NCT00985985|617044043|FG000|Overall Study|Withdrawal by Subject|4|||
170737300|NCT00985985|617044044|FG001|Overall Study|Withdrawal by Subject|2|||
170737301|NCT00985985|617044045|FG002|Overall Study|Withdrawal by Subject|2|||
170737302|NCT00985985|617044046|FG003|Overall Study|Withdrawal by Subject|2|||
170737303|NCT00985985|617044043|FG000|Overall Study|Other Reason|6|||
170737304|NCT00985985|617044044|FG001|Overall Study|Other Reason|1|||
170737305|NCT00985985|617044045|FG002|Overall Study|Other Reason|4|||
170737306|NCT00985985|617044046|FG003|Overall Study|Other Reason|2|||
170737307|NCT02343003|617044047|FG000|Overall Study|Withdrawal by Subject|9|||
170737308|NCT02343003|617044048|FG001|Overall Study|Withdrawal by Subject|4|||
170737309|NCT02343003|617044047|FG000|Overall Study|Lost to Follow-up|5|||
170737310|NCT02343003|617044048|FG001|Overall Study|Lost to Follow-up|1|||
170844293|NCT00208325|617437364|FG001|Overall Study|Death|19|||
170844294|NCT00208325|617437365|FG002|Overall Study|Death|7|||
170844295|NCT00208325|617437366|FG003|Overall Study|Death|5|||
170844296|NCT00208325|617437363|FG000|Overall Study|Withdrawal by Subject|0|||
170844297|NCT00208325|617437364|FG001|Overall Study|Withdrawal by Subject|1|||
170844298|NCT00208325|617437365|FG002|Overall Study|Withdrawal by Subject|0|||
170844299|NCT00208325|617437366|FG003|Overall Study|Withdrawal by Subject|0|||
170844300|NCT00208325|617437363|FG000|Overall Study|Revision|4|||
170844301|NCT00208325|617437364|FG001|Overall Study|Revision|1|||
170844302|NCT00208325|617437365|FG002|Overall Study|Revision|0|||
170844303|NCT00208325|617437366|FG003|Overall Study|Revision|4|||
170844304|NCT00208325|617437363|FG000|Overall Study|Lost to Follow-up|1|||
170844305|NCT00208325|617437364|FG001|Overall Study|Lost to Follow-up|0|||
170844306|NCT00208325|617437365|FG002|Overall Study|Lost to Follow-up|2|||
170844307|NCT00208325|617437366|FG003|Overall Study|Lost to Follow-up|0|||
170844308|NCT00208325|617437363|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
170844309|NCT00208325|617437364|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
170844310|NCT00208325|617437365|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
170844311|NCT00208325|617437366|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
170844312|NCT00208325|617437363|FG000|Overall Study|Does not wish to Continue in Study|5|||
170844313|NCT00208325|617437364|FG001|Overall Study|Does not wish to Continue in Study|8|||
170844314|NCT00208325|617437365|FG002|Overall Study|Does not wish to Continue in Study|3|||
170844315|NCT00208325|617437366|FG003|Overall Study|Does not wish to Continue in Study|2|||
170844316|NCT00208325|617437363|FG000|Overall Study|Other|2|||
170844317|NCT00208325|617437364|FG001|Overall Study|Other|1|||
170844318|NCT00208325|617437365|FG002|Overall Study|Other|1|||
170844319|NCT00208325|617437366|FG003|Overall Study|Other|0|||
170844320|NCT00208325|617437363|FG000|Overall Study|Mis-Randomized|17|||
170844321|NCT00208325|617437364|FG001|Overall Study|Mis-Randomized|20|||
170844322|NCT00208325|617437365|FG002|Overall Study|Mis-Randomized|0|||
170844323|NCT00208325|617437366|FG003|Overall Study|Mis-Randomized|0|||
170844324|NCT00245960|617437367|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
170844325|NCT00245960|617437368|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
170844326|NCT00245960|617437367|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
170844327|NCT00245960|617437368|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
170737311|NCT02343003|617044047|FG000|Overall Study|Protocol Violation|1|||
170737312|NCT02343003|617044048|FG001|Overall Study|Protocol Violation|0|||
170737313|NCT02343003|617044047|FG000|Overall Study|Death|0|||
170737314|NCT02343003|617044048|FG001|Overall Study|Death|1|||
170737315|NCT02343003|617044047|FG000|Overall Study|exclusion criteria met|1|||
170737316|NCT02343003|617044048|FG001|Overall Study|exclusion criteria met|1|||
170737317|NCT02343003|617044047|FG000|Overall Study|terminated by sponsor|2|||
170737318|NCT02343003|617044048|FG001|Overall Study|terminated by sponsor|0|||
170737319|NCT01153269|617044049|FG000|Overall Study|Withdrawal by Subject|1|||
170737320|NCT01153269|617044049|FG000|Overall Study|Antiretroviral therapy break|1|||
170844328|NCT00245960|617437367|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
170844329|NCT00245960|617437368|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
170844330|NCT00245960|617437367|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
170844331|NCT00245960|617437368|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
170844332|NCT00245960|617437367|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
170844333|NCT00245960|617437368|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
170844334|NCT00245960|617437367|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
170737321|NCT03541044|617044050|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
170737322|NCT03541044|617044051|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
170737323|NCT03541044|617044050|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
170737324|NCT03541044|617044051|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
170737325|NCT02635724|617044052|FG000|Overall Study|Withdrawal by Subject|0|||
170737326|NCT02635724|617044053|FG001|Overall Study|Withdrawal by Subject|1|||
170737327|NCT02635724|617044054|FG002|Overall Study|Withdrawal by Subject|0|||
170737328|NCT00860067|617044055|FG000|Overall Study|Lost to Follow-up|46|||
170737329|NCT00860067|617044056|FG001|Overall Study|Lost to Follow-up|9|||
170737330|NCT00860067|617044057|FG002|Overall Study|Lost to Follow-up|9|||
170737331|NCT00860067|617044055|FG000|Overall Study|Withdrawal by Subject|4|||
170737332|NCT00860067|617044056|FG001|Overall Study|Withdrawal by Subject|0|||
170737333|NCT00860067|617044057|FG002|Overall Study|Withdrawal by Subject|0|||
170737334|NCT00860067|617044055|FG000|Overall Study|Pregnancy|1|||
170737335|NCT00860067|617044056|FG001|Overall Study|Pregnancy|0|||
170737336|NCT00860067|617044057|FG002|Overall Study|Pregnancy|0|||
170737337|NCT01498822|617044065|FG000|Overall Study|Protocol Violation|8|||
170737338|NCT01498822|617044066|FG001|Overall Study|Protocol Violation|4|||
170737339|NCT01498822|617044065|FG000|Overall Study|Other Reason|5|||
170737340|NCT01498822|617044066|FG001|Overall Study|Other Reason|2|||
170737341|NCT01498822|617044065|FG000|Overall Study|Lack of Efficacy|7|||
170737342|NCT01498822|617044066|FG001|Overall Study|Lack of Efficacy|2|||
170737343|NCT01498822|617044065|FG000|Overall Study|AE, non-serious non-fatal|8|||
170737344|NCT01498822|617044066|FG001|Overall Study|AE, non-serious non-fatal|17|||
170737345|NCT01498822|617044065|FG000|Overall Study|SAE, non-fatal|2|||
170737346|NCT01498822|617044066|FG001|Overall Study|SAE, non-fatal|2|||
170737347|NCT01498822|617044065|FG000|Overall Study|Adverse Event, serious fatal|1|||
170844335|NCT00245960|617437368|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
170844336|NCT00245960|617437367|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
170844337|NCT00245960|617437368|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
170844338|NCT00245960|617437367|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
170844339|NCT00245960|617437368|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
170844340|NCT00245960|617437367|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
170844341|NCT00245960|617437368|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
170844342|NCT00245960|617437367|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
170844343|NCT00245960|617437368|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
170844344|NCT00245960|617437367|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
170844345|NCT00245960|617437368|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
170844346|NCT00245960|617437367|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
170844347|NCT00245960|617437368|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
170844348|NCT00737698|617437369|FG000|Overall Study|Withdrawal by Subject|6|||
170844349|NCT00737698|617437370|FG001|Overall Study|Withdrawal by Subject|5|||
170844350|NCT00737698|617437371|FG002|Overall Study|Withdrawal by Subject|3|||
170844351|NCT00737698|617437369|FG000|Overall Study|Death|0|||
170844352|NCT00737698|617437370|FG001|Overall Study|Death|0|||
170844353|NCT00737698|617437371|FG002|Overall Study|Death|1|||
170844354|NCT02817906|617437372|FG000|Overall Study|Adverse Event|3|||
170844355|NCT02817906|617437373|FG001|Overall Study|Adverse Event|0|||
170844356|NCT02817906|617437372|FG000|Overall Study|Lack of Efficacy|1|||
170844357|NCT02817906|617437373|FG001|Overall Study|Lack of Efficacy|0|||
170844358|NCT02817906|617437372|FG000|Overall Study|Protocol Violation|1|||
170844359|NCT02817906|617437373|FG001|Overall Study|Protocol Violation|1|||
170844360|NCT02817906|617437372|FG000|Overall Study|Study Terminated by Sponsor|2|||
170844361|NCT02817906|617437373|FG001|Overall Study|Study Terminated by Sponsor|2|||
170844362|NCT02817906|617437372|FG000|Overall Study|Withdrawal by Subject|7|||
170844363|NCT02817906|617437373|FG001|Overall Study|Withdrawal by Subject|0|||
170844364|NCT02817906|617437372|FG000|Overall Study|Other|2|||
170844365|NCT02817906|617437373|FG001|Overall Study|Other|2|||
170844366|NCT04954326|617437378|FG000|Overall Study|Protocol Violation|0|||
170844367|NCT04954326|617437379|FG001|Overall Study|Protocol Violation|1|||
170844368|NCT04954326|617437378|FG000|Overall Study|Death|0|||
170844369|NCT04954326|617437379|FG001|Overall Study|Death|2|||
170844370|NCT04954326|617437378|FG000|Overall Study|Physician Decision|0|||
170844371|NCT04954326|617437379|FG001|Overall Study|Physician Decision|1|||
170844372|NCT01436253|617437382|FG000|Overall Study|Lost to Follow-up|182|||
170844373|NCT01436253|617437382|FG000|Overall Study|Not meeting all eligibility criteria|117|||
170737348|NCT01498822|617044066|FG001|Overall Study|Adverse Event, serious fatal|1|||
170737349|NCT01498822|617044065|FG000|Overall Study|Withdrawal by Subject|15|||
170737350|NCT01498822|617044066|FG001|Overall Study|Withdrawal by Subject|25|||
170737351|NCT01498822|617044065|FG000|Overall Study|Lost to Follow-up|8|||
170844374|NCT00669877|617437383|FG000|Overall Study|Disease Progression/Death|4|||
170844375|NCT04520659|617437384|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
170844376|NCT04520659|617437385|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
170844377|NCT04520659|617437386|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
170737352|NCT01498822|617044066|FG001|Overall Study|Lost to Follow-up|3|||
170737353|NCT03592277|617044067|FG000|Overall Study|Withdrawal by Subject|6|||
170737354|NCT03592277|617044068|FG001|Overall Study|Withdrawal by Subject|8|||
170737355|NCT03579290|617044071|FG000|Overall Study|Lost to Follow-up|9|||
170737356|NCT01781390|617044072|FG000|Overall Study|Withdrawal of Consent|0|||
170737357|NCT01781390|617044073|FG001|Overall Study|Withdrawal of Consent|3|||
170737358|NCT01781390|617044074|FG002|Overall Study|Withdrawal of Consent|1|||
170737359|NCT01781390|617044072|FG000|Overall Study|Lost to Follow-up|1|||
170737360|NCT01781390|617044073|FG001|Overall Study|Lost to Follow-up|1|||
170737361|NCT01781390|617044074|FG002|Overall Study|Lost to Follow-up|1|||
170737362|NCT01781390|617044072|FG000|Overall Study|Adverse Event|1|||
170737363|NCT01781390|617044073|FG001|Overall Study|Adverse Event|2|||
170737364|NCT01781390|617044074|FG002|Overall Study|Adverse Event|1|||
170737365|NCT01781390|617044072|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
170737366|NCT01781390|617044073|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
170737367|NCT01781390|617044074|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
170737368|NCT00622713|617044075|FG000|Overall Study|Adverse Event|35|||
170737369|NCT00622713|617044075|FG000|Overall Study|Administrative problems|4|||
170737370|NCT00622713|617044075|FG000|Overall Study|Withdrawal by Subject|11|||
170737371|NCT00622713|617044075|FG000|Overall Study|Lost to Follow-up|5|||
170737372|NCT00622713|617044075|FG000|Overall Study|Death|2|||
170737373|NCT00622713|617044075|FG000|Overall Study|Subject no longer required study drug|1|||
170737374|NCT00622713|617044075|FG000|Overall Study|Did not meet eligibility criteria|1|||
170737375|NCT04404478|617044076|FG000|Overall Study|Withdrawal by Subject|1|||
170737376|NCT04404478|617044077|FG001|Overall Study|Withdrawal by Subject|3|||
170737377|NCT02917265|617044078|FG000|Overall Study|Physician Decision|1|||
170737378|NCT02917265|617044079|FG001|Overall Study|Physician Decision|0|||
170737379|NCT02917265|617044078|FG000|Overall Study|Withdrawal by Subject|1|||
170737380|NCT02917265|617044079|FG001|Overall Study|Withdrawal by Subject|0|||
170737381|NCT01674621|617044089|FG000|Overall Study|Adverse Event|3|||
170737382|NCT01674621|617044090|FG001|Overall Study|Adverse Event|2|||
170737383|NCT01674621|617044091|FG002|Overall Study|Adverse Event|5|||
170737384|NCT01674621|617044092|FG003|Overall Study|Adverse Event|5|||
170737385|NCT01674621|617044093|FG004|Overall Study|Adverse Event|1|||
170737386|NCT01674621|617044089|FG000|Overall Study|Inability to Complete Study Procedures|0|||
170737387|NCT01674621|617044090|FG001|Overall Study|Inability to Complete Study Procedures|0|||
170737388|NCT01674621|617044091|FG002|Overall Study|Inability to Complete Study Procedures|0|||
170737389|NCT01674621|617044092|FG003|Overall Study|Inability to Complete Study Procedures|0|||
170737390|NCT01674621|617044093|FG004|Overall Study|Inability to Complete Study Procedures|2|||
170737391|NCT01674621|617044089|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
170737392|NCT01674621|617044090|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
170737393|NCT01674621|617044091|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
170737394|NCT01674621|617044092|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
170737395|NCT01674621|617044093|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
170737396|NCT01674621|617044089|FG000|Overall Study|Withdrawal by Subject|2|||
170737397|NCT01674621|617044090|FG001|Overall Study|Withdrawal by Subject|5|||
170737398|NCT01674621|617044091|FG002|Overall Study|Withdrawal by Subject|2|||
170737399|NCT01674621|617044092|FG003|Overall Study|Withdrawal by Subject|0|||
170737400|NCT01674621|617044093|FG004|Overall Study|Withdrawal by Subject|1|||
170737401|NCT01674621|617044089|FG000|Overall Study|Other than specified|0|||
170737402|NCT01674621|617044090|FG001|Overall Study|Other than specified|1|||
170737403|NCT01674621|617044091|FG002|Overall Study|Other than specified|0|||
170737404|NCT01674621|617044092|FG003|Overall Study|Other than specified|0|||
170737405|NCT01674621|617044093|FG004|Overall Study|Other than specified|2|||
170737406|NCT01368900|617044094|FG000|Overall Study|Lost to Follow-up|7|||
170737407|NCT04027348|617044099|FG000|Overall Study|Adverse Event|2|||
170737408|NCT02487472|617044100|FG000|Overall Study|Did not complete telephonic interviews|9|||
170737409|NCT02487472|617044100|FG000|Overall Study|Other|2|||
170737410|NCT01313286|617044101|FG000|Period 1|Withdrawal by Subject|2|||
170737411|NCT01313286|617044102|FG001|Period 1|Withdrawal by Subject|0|||
170737412|NCT02552238|617044103|FG000|Overall Study|Withdrawal by Subject|2|||
170737413|NCT02552238|617044103|FG000|Overall Study|Adverse Event|2|||
170737414|NCT01521884|617044104|FG000|Overall Study|Non Responders|10|||
170737415|NCT01521884|617044104|FG000|Overall Study|Adverse Event|5|||
170737416|NCT01521884|617044104|FG000|Overall Study|Pregnancy|1|||
170844378|NCT04520659|617437387|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
170844379|NCT04485611|617437390|FG000|Prehabilitation|Physician Decision|1|||
170844380|NCT00475228|617437391|FG000|Overall Study|Lost to Follow-up|17|||
170844381|NCT00475228|617437392|FG001|Overall Study|Lost to Follow-up|17|||
170844382|NCT03682185|617437406|FG000|Overall Study|Lost to Follow-up|4|||
170844383|NCT03682185|617437407|FG001|Overall Study|Lost to Follow-up|7|||
170844384|NCT03682185|617437408|FG002|Overall Study|Lost to Follow-up|4|||
170844385|NCT03682185|617437409|FG003|Overall Study|Lost to Follow-up|7|||
170844386|NCT03682185|617437410|FG004|Overall Study|Lost to Follow-up|1|||
170844387|NCT03682185|617437406|FG000|Overall Study|Withdrawal by Subject|7|||
170844388|NCT03682185|617437407|FG001|Overall Study|Withdrawal by Subject|3|||
170844389|NCT03682185|617437408|FG002|Overall Study|Withdrawal by Subject|7|||
170844390|NCT03682185|617437409|FG003|Overall Study|Withdrawal by Subject|3|||
170844391|NCT03682185|617437410|FG004|Overall Study|Withdrawal by Subject|0|||
170844392|NCT03551691|617437411|FG000|Overall Study|Withdrawal by Subject|3|||
170844393|NCT03551691|617437412|FG001|Overall Study|Withdrawal by Subject|3|||
170844394|NCT01435772|617437414|FG000|Overall Study|Adverse Event|1|||
170844395|NCT01435772|617437415|FG001|Overall Study|Adverse Event|0|||
170844396|NCT01435772|617437416|FG002|Overall Study|Adverse Event|2|||
170844397|NCT01435772|617437414|FG000|Overall Study|Withdrawal by Subject|0|||
170844398|NCT01435772|617437415|FG001|Overall Study|Withdrawal by Subject|1|||
170844399|NCT01435772|617437416|FG002|Overall Study|Withdrawal by Subject|3|||
170844400|NCT01435772|617437414|FG000|Overall Study|Other - study termination|2|||
170844401|NCT01435772|617437415|FG001|Overall Study|Other - study termination|2|||
170844402|NCT01435772|617437416|FG002|Overall Study|Other - study termination|10|||
170844403|NCT01424813|617437417|FG000|Overall Study|Withdrawal by Subject|3|||
170844404|NCT01424813|617437418|FG001|Overall Study|Withdrawal by Subject|0|||
170844405|NCT01424813|617437417|FG000|Overall Study|Protocol Violation|1|||
170844406|NCT01424813|617437418|FG001|Overall Study|Protocol Violation|0|||
170844407|NCT01424813|617437417|FG000|Overall Study|Other|1|||
170844408|NCT01424813|617437418|FG001|Overall Study|Other|2|||
170844409|NCT01015560|617438962|FG000|Overall Study|Adverse Event|1|||
170844410|NCT01015560|617438962|FG000|Overall Study|Not protocol specified|1|||
170844411|NCT01015560|617438962|FG000|Overall Study|Withdrawal by Subject|1|||
170844412|NCT01008553|617438963|FG000|Period 1 (Titration Period)|Physician Decision|2|||
170844413|NCT01008553|617438964|FG001|Period 1 (Titration Period)|Physician Decision|0|||
170844414|NCT01008553|617438965|FG002|Period 1 (Titration Period)|Physician Decision|0|||
170844415|NCT01008553|617438963|FG000|Period 1 (Titration Period)|Adverse Event|33|||
170844416|NCT01008553|617438964|FG001|Period 1 (Titration Period)|Adverse Event|0|||
170844417|NCT01008553|617438965|FG002|Period 1 (Titration Period)|Adverse Event|0|||
170844418|NCT01008553|617438963|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
170844419|NCT01008553|617438964|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
170844420|NCT01008553|617438965|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
170844421|NCT01008553|617438963|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
170844422|NCT01008553|617438964|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
170844423|NCT01008553|617438965|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
170844424|NCT01008553|617438963|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
170844425|NCT01008553|617438964|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
170844426|NCT01008553|617438965|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
170844427|NCT01008553|617438963|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
170844428|NCT01008553|617438964|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
170844429|NCT01008553|617438965|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
170844430|NCT01008553|617438963|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
170844431|NCT01008553|617438964|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
170844432|NCT01008553|617438965|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
170844433|NCT01008553|617438963|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
170844434|NCT01008553|617438964|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
170844435|NCT01008553|617438965|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
170844436|NCT01008553|617438963|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
170844437|NCT01008553|617438964|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
170844438|NCT01008553|617438965|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
170844439|NCT01008553|617438963|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
170844440|NCT01008553|617438964|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
170844441|NCT01008553|617438965|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
170844442|NCT01008553|617438963|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
170844443|NCT01008553|617438964|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
170844444|NCT01008553|617438965|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
170844445|NCT01008553|617438963|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
170844446|NCT01008553|617438964|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
170844447|NCT01008553|617438965|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
170844448|NCT01008553|617438963|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
170844449|NCT01008553|617438964|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
170844450|NCT01008553|617438965|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
170844451|NCT01008553|617438963|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
170844452|NCT01008553|617438964|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
170844453|NCT01008553|617438965|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
170844454|NCT01262677|617438966|FG000|Overall Study|Does not meet entrance criteria|0|||
170844455|NCT01262677|617438967|FG001|Overall Study|Does not meet entrance criteria|2|||
170844456|NCT01262677|617438968|FG002|Overall Study|Does not meet entrance criteria|0|||
170844457|NCT01262677|617438966|FG000|Overall Study|Insufficient clinical response|0|||
170844458|NCT01262677|617438967|FG001|Overall Study|Insufficient clinical response|0|||
170844459|NCT01262677|617438968|FG002|Overall Study|Insufficient clinical response|1|||
170844460|NCT01262677|617438966|FG000|Overall Study|Lost to Follow-up|1|||
170844461|NCT01262677|617438967|FG001|Overall Study|Lost to Follow-up|0|||
170844462|NCT01262677|617438968|FG002|Overall Study|Lost to Follow-up|2|||
170844463|NCT01262677|617438966|FG000|Overall Study|No longer willing to participate|3|||
170844464|NCT01262677|617438967|FG001|Overall Study|No longer willing to participate|3|||
170844465|NCT01262677|617438968|FG002|Overall Study|No longer willing to participate|2|||
170844466|NCT01262677|617438966|FG000|Overall Study|Reason not provided|2|||
170844467|NCT01262677|617438967|FG001|Overall Study|Reason not provided|1|||
170844468|NCT01262677|617438968|FG002|Overall Study|Reason not provided|3|||
170844469|NCT01262677|617438966|FG000|Overall Study|Protocol Violation|0|||
170844470|NCT01262677|617438967|FG001|Overall Study|Protocol Violation|1|||
170844471|NCT01262677|617438968|FG002|Overall Study|Protocol Violation|1|||
170844472|NCT01262677|617438966|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
170844473|NCT01262677|617438967|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
170844474|NCT01262677|617438968|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
170844475|NCT00574873|617438969|FG000|Overall Study|Withdrawal by Subject|18|||
170844476|NCT00574873|617438970|FG001|Overall Study|Withdrawal by Subject|19|||
170844477|NCT00574873|617438969|FG000|Overall Study|Investigator request|18|||
170844478|NCT00574873|617438970|FG001|Overall Study|Investigator request|8|||
170844479|NCT00574873|617438969|FG000|Overall Study|Death|15|||
170844480|NCT00574873|617438970|FG001|Overall Study|Death|14|||
170844481|NCT00574873|617438969|FG000|Overall Study|Lost to Follow-up|14|||
170844482|NCT00574873|617438970|FG001|Overall Study|Lost to Follow-up|5|||
170844483|NCT00574873|617438969|FG000|Overall Study|Other|40|||
170844484|NCT00574873|617438970|FG001|Overall Study|Other|4|||
170844485|NCT00574873|617438969|FG000|Overall Study|Discontinuation of study by sponsor|5|||
170844486|NCT00574873|617438970|FG001|Overall Study|Discontinuation of study by sponsor|199|||
170844487|NCT00574873|617438969|FG000|Overall Study|Blank, site closed per local regulations|2|||
170844488|NCT00574873|617438970|FG001|Overall Study|Blank, site closed per local regulations|2|||
170844489|NCT00574873|617438969|FG000|Overall Study|Extension Study|126|||
170844490|NCT00574873|617438970|FG001|Overall Study|Extension Study|0|||
170844491|NCT00581555|617438977|FG000|Overall Study|Adverse Event|4|||
170844492|NCT00581555|617438978|FG001|Overall Study|Adverse Event|3|||
170844493|NCT00581555|617438977|FG000|Overall Study|Physician Decision|3|||
170844494|NCT00581555|617438978|FG001|Overall Study|Physician Decision|2|||
170844495|NCT00581555|617438977|FG000|Overall Study|Withdrawal by Subject|18|||
170844496|NCT00581555|617438978|FG001|Overall Study|Withdrawal by Subject|9|||
170844497|NCT00581555|617438977|FG000|Overall Study|Lost to Follow-up|2|||
170844498|NCT00581555|617438978|FG001|Overall Study|Lost to Follow-up|2|||
170844499|NCT00581555|617438977|FG000|Overall Study|Other reasons|16|||
170844500|NCT00581555|617438978|FG001|Overall Study|Other reasons|4|||
170844501|NCT02248818|617438979|FG000|Screening|Protocol Violation|0|||
170844502|NCT02248818|617438980|FG001|Screening|Protocol Violation|0|||
170844503|NCT02248818|617438981|FG002|Screening|Protocol Violation|0|||
170844504|NCT02248818|617438982|FG003|Screening|Protocol Violation|0|||
170844505|NCT02248818|617438983|FG004|Screening|Protocol Violation|0|||
170844506|NCT02248818|617438984|FG005|Screening|Protocol Violation|0|||
170844507|NCT02248818|617438985|FG006|Screening|Protocol Violation|0|||
170844508|NCT02248818|617438986|FG007|Screening|Protocol Violation|0|||
170844509|NCT02248818|617438987|FG008|Screening|Protocol Violation|7|||
170844510|NCT02248818|617438979|FG000|Screening|Study fully enrolled|0|||
170844511|NCT02248818|617438980|FG001|Screening|Study fully enrolled|0|||
170844512|NCT02248818|617438981|FG002|Screening|Study fully enrolled|0|||
170844513|NCT02248818|617438982|FG003|Screening|Study fully enrolled|0|||
170844514|NCT02248818|617438983|FG004|Screening|Study fully enrolled|0|||
170844515|NCT02248818|617438984|FG005|Screening|Study fully enrolled|0|||
170844516|NCT02248818|617438985|FG006|Screening|Study fully enrolled|0|||
170844517|NCT02248818|617438986|FG007|Screening|Study fully enrolled|0|||
170844518|NCT02248818|617438987|FG008|Screening|Study fully enrolled|14|||
170844519|NCT02248818|617438979|FG000|Screening|Physician Decision|0|||
170844520|NCT02248818|617438980|FG001|Screening|Physician Decision|0|||
170844521|NCT02248818|617438981|FG002|Screening|Physician Decision|0|||
170844522|NCT02248818|617438982|FG003|Screening|Physician Decision|0|||
170844523|NCT02248818|617438983|FG004|Screening|Physician Decision|0|||
170844524|NCT02248818|617438984|FG005|Screening|Physician Decision|0|||
170844525|NCT02248818|617438985|FG006|Screening|Physician Decision|0|||
170844526|NCT02248818|617438986|FG007|Screening|Physician Decision|0|||
170844527|NCT02248818|617438987|FG008|Screening|Physician Decision|73|||
170844528|NCT02248818|617438979|FG000|Screening|Withdrawal by Subject|0|||
170844529|NCT02248818|617438980|FG001|Screening|Withdrawal by Subject|0|||
170844530|NCT02248818|617438981|FG002|Screening|Withdrawal by Subject|0|||
170844531|NCT02248818|617438982|FG003|Screening|Withdrawal by Subject|0|||
170844532|NCT02248818|617438983|FG004|Screening|Withdrawal by Subject|0|||
170844533|NCT02248818|617438984|FG005|Screening|Withdrawal by Subject|0|||
170844534|NCT02248818|617438985|FG006|Screening|Withdrawal by Subject|0|||
170844535|NCT02248818|617438986|FG007|Screening|Withdrawal by Subject|0|||
170844536|NCT02248818|617438987|FG008|Screening|Withdrawal by Subject|6|||
170844537|NCT02248818|617438979|FG000|Screening|Lost to Follow-up|0|||
170844538|NCT02248818|617438980|FG001|Screening|Lost to Follow-up|0|||
170844539|NCT02248818|617438981|FG002|Screening|Lost to Follow-up|0|||
170844540|NCT02248818|617438982|FG003|Screening|Lost to Follow-up|0|||
170844541|NCT02248818|617438983|FG004|Screening|Lost to Follow-up|0|||
170844542|NCT02248818|617438984|FG005|Screening|Lost to Follow-up|0|||
170844543|NCT02248818|617438985|FG006|Screening|Lost to Follow-up|0|||
170844544|NCT02248818|617438986|FG007|Screening|Lost to Follow-up|0|||
170844545|NCT02248818|617438987|FG008|Screening|Lost to Follow-up|7|||
170844546|NCT02248818|617438979|FG000|Randomised Study|Administrative - randomization error|0|||
170844547|NCT02248818|617438980|FG001|Randomised Study|Administrative - randomization error|0|||
170844548|NCT02248818|617438981|FG002|Randomised Study|Administrative - randomization error|0|||
170844549|NCT02248818|617438982|FG003|Randomised Study|Administrative - randomization error|0|||
170844550|NCT02248818|617438983|FG004|Randomised Study|Administrative - randomization error|0|||
170844551|NCT02248818|617438984|FG005|Randomised Study|Administrative - randomization error|8|||
170844552|NCT02248818|617438985|FG006|Randomised Study|Administrative - randomization error|0|||
170844553|NCT02248818|617438986|FG007|Randomised Study|Administrative - randomization error|0|||
170844554|NCT02248818|617438987|FG008|Randomised Study|Administrative - randomization error|0|||
170844555|NCT04325282|617438988|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
170844556|NCT04325282|617438989|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
170844557|NCT04325282|617438988|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
170844558|NCT04325282|617438989|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
170844559|NCT01283152|617438992|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
170844560|NCT01283152|617438993|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
170844561|NCT01283152|617438992|FG000|Overall Study|Refused HESA|1|||
170844562|NCT01283152|617438993|FG001|Overall Study|Refused HESA|0|||
170844563|NCT00567567|617438995|FG000|Overall Study|Adverse Event|0|||
170844564|NCT00567567|617438996|FG001|Overall Study|Adverse Event|2|||
170844565|NCT00567567|617438997|FG002|Overall Study|Adverse Event|5|||
170844566|NCT00567567|617438995|FG000|Overall Study|Death|8|||
170844567|NCT00567567|617438996|FG001|Overall Study|Death|1|||
170844568|NCT00567567|617438997|FG002|Overall Study|Death|5|||
170844569|NCT00567567|617438995|FG000|Overall Study|Lack of Efficacy|16|||
170844570|NCT00567567|617438996|FG001|Overall Study|Lack of Efficacy|17|||
170844571|NCT00567567|617438997|FG002|Overall Study|Lack of Efficacy|48|||
170844572|NCT00567567|617438995|FG000|Overall Study|Lost to Follow-up|0|||
170844573|NCT00567567|617438996|FG001|Overall Study|Lost to Follow-up|0|||
170844574|NCT00567567|617438997|FG002|Overall Study|Lost to Follow-up|1|||
170844575|NCT00567567|617438995|FG000|Overall Study|Physician Decision|16|||
170844576|NCT00567567|617438996|FG001|Overall Study|Physician Decision|18|||
170844577|NCT00567567|617438997|FG002|Overall Study|Physician Decision|84|||
170844578|NCT00567567|617438995|FG000|Overall Study|Withdrawal by Subject|0|||
170844579|NCT00567567|617438996|FG001|Overall Study|Withdrawal by Subject|0|||
170844580|NCT00567567|617438997|FG002|Overall Study|Withdrawal by Subject|2|||
170844581|NCT00567567|617438995|FG000|Overall Study|Ineligible|4|||
170844582|NCT00567567|617438996|FG001|Overall Study|Ineligible|0|||
170844583|NCT00567567|617438997|FG002|Overall Study|Ineligible|9|||
170844584|NCT00567567|617438995|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
170844585|NCT00567567|617438996|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
170844586|NCT00567567|617438997|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
170844587|NCT00567567|617438995|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
170844588|NCT00567567|617438996|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
170844589|NCT00567567|617438997|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
170844590|NCT00567567|617438995|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
170844591|NCT00567567|617438996|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
170844592|NCT00567567|617438997|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
170844593|NCT03433677|617438998|FG000|Period 1|Protocol Violation|1|||
170844594|NCT03433677|617438999|FG001|Period 1|Protocol Violation|0|||
170844595|NCT03433677|617438998|FG000|Period 2|Withdrawal by Subject|1|||
170844596|NCT03433677|617438999|FG001|Period 2|Withdrawal by Subject|1|||
170844597|NCT03330405|617439000|FG000|Overall Study|Other|1|||
170844598|NCT03330405|617439001|FG001|Overall Study|Other|3|||
170844599|NCT03330405|617439002|FG002|Overall Study|Other|1|||
170844600|NCT03330405|617439003|FG003|Overall Study|Other|0|||
170844601|NCT03330405|617439004|FG004|Overall Study|Other|2|||
170844602|NCT03330405|617439005|FG005|Overall Study|Other|0|||
170844603|NCT03330405|617439006|FG006|Overall Study|Other|1|||
170844604|NCT03330405|617439007|FG007|Overall Study|Other|0|||
170844605|NCT03330405|617439008|FG008|Overall Study|Other|0|||
170844606|NCT03330405|617439009|FG009|Overall Study|Other|0|||
170844607|NCT03330405|617439010|FG010|Overall Study|Other|0|||
170844608|NCT03330405|617439000|FG000|Overall Study|Progressive disease|8|||
170844609|NCT03330405|617439001|FG001|Overall Study|Progressive disease|27|||
170844610|NCT03330405|617439002|FG002|Overall Study|Progressive disease|4|||
170844611|NCT03330405|617439003|FG003|Overall Study|Progressive disease|18|||
170844612|NCT03330405|617439004|FG004|Overall Study|Progressive disease|16|||
170844613|NCT03330405|617439005|FG005|Overall Study|Progressive disease|14|||
170844614|NCT03330405|617439006|FG006|Overall Study|Progressive disease|7|||
170844615|NCT03330405|617439007|FG007|Overall Study|Progressive disease|29|||
170844616|NCT03330405|617439008|FG008|Overall Study|Progressive disease|9|||
170844617|NCT03330405|617439009|FG009|Overall Study|Progressive disease|11|||
170844618|NCT03330405|617439010|FG010|Overall Study|Progressive disease|5|||
170844619|NCT03330405|617439000|FG000|Overall Study|Withdrawal by Subject|1|||
170844620|NCT03330405|617439001|FG001|Overall Study|Withdrawal by Subject|4|||
170844621|NCT03330405|617439002|FG002|Overall Study|Withdrawal by Subject|0|||
170844622|NCT03330405|617439003|FG003|Overall Study|Withdrawal by Subject|1|||
170844623|NCT03330405|617439004|FG004|Overall Study|Withdrawal by Subject|1|||
170844624|NCT03330405|617439005|FG005|Overall Study|Withdrawal by Subject|1|||
170844625|NCT03330405|617439006|FG006|Overall Study|Withdrawal by Subject|0|||
170844626|NCT03330405|617439007|FG007|Overall Study|Withdrawal by Subject|2|||
170844627|NCT03330405|617439008|FG008|Overall Study|Withdrawal by Subject|2|||
170844628|NCT03330405|617439009|FG009|Overall Study|Withdrawal by Subject|1|||
170844629|NCT03330405|617439010|FG010|Overall Study|Withdrawal by Subject|1|||
170844630|NCT03330405|617439000|FG000|Overall Study|Global deterioration of health status|2|||
170844631|NCT03330405|617439001|FG001|Overall Study|Global deterioration of health status|3|||
170844632|NCT03330405|617439002|FG002|Overall Study|Global deterioration of health status|0|||
170844633|NCT03330405|617439003|FG003|Overall Study|Global deterioration of health status|2|||
170844634|NCT03330405|617439004|FG004|Overall Study|Global deterioration of health status|3|||
170844635|NCT03330405|617439005|FG005|Overall Study|Global deterioration of health status|3|||
170844636|NCT03330405|617439006|FG006|Overall Study|Global deterioration of health status|0|||
170844637|NCT03330405|617439007|FG007|Overall Study|Global deterioration of health status|2|||
170844638|NCT03330405|617439008|FG008|Overall Study|Global deterioration of health status|8|||
170844639|NCT03330405|617439009|FG009|Overall Study|Global deterioration of health status|4|||
170844640|NCT03330405|617439010|FG010|Overall Study|Global deterioration of health status|1|||
170844641|NCT03330405|617439000|FG000|Overall Study|Adverse Event|0|||
170844642|NCT03330405|617439001|FG001|Overall Study|Adverse Event|1|||
170844643|NCT03330405|617439002|FG002|Overall Study|Adverse Event|0|||
170844644|NCT03330405|617439003|FG003|Overall Study|Adverse Event|1|||
170844645|NCT03330405|617439004|FG004|Overall Study|Adverse Event|1|||
170844646|NCT03330405|617439005|FG005|Overall Study|Adverse Event|1|||
170844647|NCT03330405|617439006|FG006|Overall Study|Adverse Event|3|||
170844648|NCT03330405|617439007|FG007|Overall Study|Adverse Event|4|||
170844649|NCT03330405|617439008|FG008|Overall Study|Adverse Event|2|||
170844650|NCT03330405|617439009|FG009|Overall Study|Adverse Event|2|||
170844651|NCT03330405|617439010|FG010|Overall Study|Adverse Event|2|||
170844652|NCT03330405|617439000|FG000|Overall Study|Death|0|||
170844653|NCT03330405|617439001|FG001|Overall Study|Death|4|||
170844654|NCT03330405|617439002|FG002|Overall Study|Death|0|||
170844655|NCT03330405|617439003|FG003|Overall Study|Death|0|||
170844656|NCT03330405|617439004|FG004|Overall Study|Death|0|||
170844657|NCT03330405|617439005|FG005|Overall Study|Death|1|||
170844658|NCT03330405|617439006|FG006|Overall Study|Death|0|||
170844659|NCT03330405|617439007|FG007|Overall Study|Death|2|||
170844660|NCT03330405|617439008|FG008|Overall Study|Death|0|||
170844661|NCT03330405|617439009|FG009|Overall Study|Death|0|||
170844662|NCT03330405|617439010|FG010|Overall Study|Death|0|||
170844663|NCT03330405|617439000|FG000|Overall Study|Physician Decision|0|||
170844664|NCT03330405|617439001|FG001|Overall Study|Physician Decision|0|||
170844665|NCT03330405|617439002|FG002|Overall Study|Physician Decision|0|||
170844666|NCT03330405|617439003|FG003|Overall Study|Physician Decision|0|||
170844667|NCT03330405|617439004|FG004|Overall Study|Physician Decision|0|||
170844668|NCT03330405|617439005|FG005|Overall Study|Physician Decision|0|||
170844669|NCT03330405|617439006|FG006|Overall Study|Physician Decision|0|||
170844670|NCT03330405|617439007|FG007|Overall Study|Physician Decision|1|||
170844671|NCT03330405|617439008|FG008|Overall Study|Physician Decision|0|||
170844672|NCT03330405|617439009|FG009|Overall Study|Physician Decision|0|||
170844673|NCT03330405|617439010|FG010|Overall Study|Physician Decision|0|||
170844674|NCT03889704|617439012|FG000|Overall Study|Study terminated due to pandemic|1|||
170844675|NCT03482466|617439013|FG000|Overall Study|Protocol Violation|2|||
170844676|NCT04833127|617439014|FG000|Overall Study|Lost to Follow-up|1|||
170844677|NCT04833127|617439015|FG001|Overall Study|Lost to Follow-up|1|||
170844678|NCT00608868|617439018|FG000|Overall Study|Withdrawal by Subject|7|||
170844679|NCT00608868|617439018|FG000|Overall Study|Protocol Violation|3|||
170844680|NCT00608868|617439018|FG000|Overall Study|Lost to Follow-up|2|||
170844681|NCT00608868|617439018|FG000|Overall Study|Adverse Event|1|||
170844682|NCT00608868|617439018|FG000|Overall Study|Physician Decision|2|||
170844683|NCT01252355|617439021|FG000|Overall Study|Adverse Event|9|||
170844684|NCT01252355|617439022|FG001|Overall Study|Adverse Event|17|||
170737417|NCT01521884|617044104|FG000|Overall Study|Withdrawal by Subject|1|||
170737418|NCT01521884|617044104|FG000|Overall Study|Physician Decision|2|||
170737419|NCT01521884|617044104|FG000|Overall Study|Protocol Violation|3|||
170737420|NCT01521884|617044104|FG000|Overall Study|Participant non-eligible|1|||
170737421|NCT01521884|617044104|FG000|Overall Study|Lost to Follow-up|4|||
170737422|NCT02821819|617044105|FG000|Overall Study|Protocol Violation|1|||
170737423|NCT04241094|617044110|FG000|Overall Study|Dropped out of treatment|4|||
170737424|NCT04241094|617044110|FG000|Overall Study|Ineligible after clinical assessment|2|||
170737425|NCT04241094|617044110|FG000|Overall Study|Lost to Follow-up|2|||
170737426|NCT03995784|617044118|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
170737427|NCT02243631|617045694|FG000|Overall Study|no synovial fluid on second aspirate|0|||
170737428|NCT02243631|617045695|FG001|Overall Study|no synovial fluid on second aspirate|1|||
170737429|NCT01590771|617045700|FG000|Overall Study|Other Protocol Specified Criteria|5|||
170737430|NCT01590771|617045701|FG001|Overall Study|Other Protocol Specified Criteria|14|||
170737431|NCT01590771|617045700|FG000|Overall Study|Withdrawal by Subject|8|||
170737432|NCT01590771|617045701|FG001|Overall Study|Withdrawal by Subject|15|||
170737433|NCT01590771|617045700|FG000|Overall Study|Protocol Violation|1|||
170737434|NCT01590771|617045701|FG001|Overall Study|Protocol Violation|2|||
170737435|NCT01590771|617045700|FG000|Overall Study|Lost to Follow-up|1|||
170737436|NCT01590771|617045701|FG001|Overall Study|Lost to Follow-up|1|||
170737437|NCT01590771|617045700|FG000|Overall Study|Lack of Efficacy|1|||
170737438|NCT01590771|617045701|FG001|Overall Study|Lack of Efficacy|0|||
170737439|NCT01590771|617045700|FG000|Overall Study|Adverse Event|3|||
170737440|NCT01590771|617045701|FG001|Overall Study|Adverse Event|7|||
170737441|NCT01785628|617045702|FG000|Overall Study|Lost to Follow-up|2|||
170737442|NCT01785628|617045703|FG001|Overall Study|Lost to Follow-up|3|||
170737443|NCT01186328|617045704|FG000|Overall Study|Death|1|||
170737444|NCT01186328|617045705|FG001|Overall Study|Death|0|||
170737445|NCT01186328|617045706|FG002|Overall Study|Death|0|||
170737446|NCT03015116|617045707|FG000|Overall Study|Lost to Follow-up|3|||
170737447|NCT03015116|617045708|FG001|Overall Study|Lost to Follow-up|0|||
170737448|NCT03015116|617045709|FG002|Overall Study|Lost to Follow-up|2|||
170737449|NCT03015116|617045707|FG000|Overall Study|Withdrawal by Subject|3|||
170737450|NCT03015116|617045708|FG001|Overall Study|Withdrawal by Subject|1|||
170737451|NCT03015116|617045709|FG002|Overall Study|Withdrawal by Subject|0|||
170737452|NCT03015116|617045707|FG000|Overall Study|Subject has New Medical Status|1|||
170737453|NCT03015116|617045708|FG001|Overall Study|Subject has New Medical Status|0|||
170737454|NCT03015116|617045709|FG002|Overall Study|Subject has New Medical Status|0|||
170737455|NCT03015116|617045707|FG000|Overall Study|Physician Decision|0|||
170737456|NCT03015116|617045708|FG001|Overall Study|Physician Decision|1|||
170737457|NCT03015116|617045709|FG002|Overall Study|Physician Decision|0|||
170737458|NCT01862991|617045710|FG000|Overall Study|Lost to Follow-up|2|||
170737459|NCT01862991|617045711|FG001|Overall Study|Lost to Follow-up|1|||
170737460|NCT01862991|617045712|FG002|Overall Study|Lost to Follow-up|1|||
170844685|NCT01252355|617439023|FG002|Overall Study|Adverse Event|22|||
170844686|NCT01252355|617439021|FG000|Overall Study|Lack of Efficacy|6|||
170844687|NCT01252355|617439022|FG001|Overall Study|Lack of Efficacy|4|||
170844688|NCT01252355|617439023|FG002|Overall Study|Lack of Efficacy|2|||
170844689|NCT01252355|617439021|FG000|Overall Study|Lost to Follow-up|0|||
170844690|NCT01252355|617439022|FG001|Overall Study|Lost to Follow-up|0|||
170844691|NCT01252355|617439023|FG002|Overall Study|Lost to Follow-up|1|||
170844692|NCT01252355|617439021|FG000|Overall Study|Poor Compliance to Protocol|1|||
170844693|NCT01252355|617439022|FG001|Overall Study|Poor Compliance to Protocol|1|||
170844694|NCT01252355|617439023|FG002|Overall Study|Poor Compliance to Protocol|1|||
170844695|NCT01252355|617439021|FG000|Overall Study|Progressive Disease|2|||
170844696|NCT01252355|617439022|FG001|Overall Study|Progressive Disease|0|||
170844697|NCT01252355|617439023|FG002|Overall Study|Progressive Disease|0|||
170844698|NCT01252355|617439021|FG000|Overall Study|Sponsor Early Termination of Study|149|||
170844699|NCT01252355|617439022|FG001|Overall Study|Sponsor Early Termination of Study|149|||
170737461|NCT01862991|617045710|FG000|Overall Study|Protocol Violation|1|||
170737462|NCT01862991|617045711|FG001|Overall Study|Protocol Violation|0|||
170737463|NCT01862991|617045712|FG002|Overall Study|Protocol Violation|0|||
170737464|NCT01108458|617045713|FG000|Overall Study|Withdrawal by Subject|1|||
170737465|NCT02200939|617045715|FG000|Overall Study|Participant withdrew consent|0|||
170737466|NCT02200939|617045716|FG001|Overall Study|Participant withdrew consent|1|||
170737467|NCT02200939|617045715|FG000|Overall Study|Lost to Follow-up|2|||
170737468|NCT02200939|617045716|FG001|Overall Study|Lost to Follow-up|9|||
170737469|NCT02200939|617045715|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
170737470|NCT02200939|617045716|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
170737471|NCT00857805|617045719|FG000|Overall Study|Withdrawal by Subject|1|||
170737472|NCT00857805|617045720|FG001|Overall Study|Withdrawal by Subject|1|||
170737473|NCT01289041|617045721|FG000|Overall Study|Adverse Event|24|||
170737474|NCT01289041|617045721|FG000|Overall Study|Physician Decision|1|||
170737475|NCT01289041|617045721|FG000|Overall Study|Progressive Disease|41|||
170737476|NCT01289041|617045721|FG000|Overall Study|Withdrawal by Subject|3|||
170737477|NCT01289041|617045721|FG000|Overall Study|Death|1|||
170737478|NCT02392611|617045725|FG000|Overall Study|Adverse Event|0|||
170737479|NCT02392611|617045726|FG001|Overall Study|Adverse Event|0|||
170737480|NCT02392611|617045727|FG002|Overall Study|Adverse Event|0|||
170737481|NCT02392611|617045728|FG003|Overall Study|Adverse Event|1|||
170737482|NCT02392611|617045729|FG004|Overall Study|Adverse Event|0|||
170737483|NCT02392611|617045730|FG005|Overall Study|Adverse Event|0|||
170737484|NCT02392611|617045731|FG006|Overall Study|Adverse Event|0|||
170737485|NCT02392611|617045732|FG007|Overall Study|Adverse Event|0|||
170737486|NCT02392611|617045733|FG008|Overall Study|Adverse Event|0|||
170737487|NCT02392611|617045725|FG000|Overall Study|Progressive disease|0|||
170737488|NCT02392611|617045726|FG001|Overall Study|Progressive disease|0|||
170737489|NCT02392611|617045727|FG002|Overall Study|Progressive disease|0|||
170737490|NCT02392611|617045728|FG003|Overall Study|Progressive disease|2|||
170737491|NCT02392611|617045729|FG004|Overall Study|Progressive disease|1|||
170737492|NCT02392611|617045730|FG005|Overall Study|Progressive disease|0|||
170737493|NCT02392611|617045731|FG006|Overall Study|Progressive disease|0|||
170737494|NCT02392611|617045732|FG007|Overall Study|Progressive disease|0|||
170737495|NCT02392611|617045733|FG008|Overall Study|Progressive disease|0|||
170737496|NCT02392611|617045725|FG000|Overall Study|Death|1|||
170737497|NCT02392611|617045726|FG001|Overall Study|Death|0|||
170737498|NCT02392611|617045727|FG002|Overall Study|Death|0|||
170737499|NCT02392611|617045728|FG003|Overall Study|Death|0|||
170737500|NCT02392611|617045729|FG004|Overall Study|Death|0|||
170737501|NCT02392611|617045730|FG005|Overall Study|Death|1|||
170737502|NCT02392611|617045731|FG006|Overall Study|Death|0|||
170737503|NCT02392611|617045732|FG007|Overall Study|Death|0|||
170737504|NCT02392611|617045733|FG008|Overall Study|Death|0|||
170737505|NCT02392611|617045725|FG000|Overall Study|Withdrawal by Subject|0|||
170737506|NCT02392611|617045726|FG001|Overall Study|Withdrawal by Subject|0|||
170737507|NCT02392611|617045727|FG002|Overall Study|Withdrawal by Subject|0|||
170737508|NCT02392611|617045728|FG003|Overall Study|Withdrawal by Subject|1|||
170737509|NCT02392611|617045729|FG004|Overall Study|Withdrawal by Subject|0|||
170737510|NCT02392611|617045730|FG005|Overall Study|Withdrawal by Subject|0|||
170737511|NCT02392611|617045731|FG006|Overall Study|Withdrawal by Subject|0|||
170737512|NCT02392611|617045732|FG007|Overall Study|Withdrawal by Subject|0|||
170737513|NCT02392611|617045733|FG008|Overall Study|Withdrawal by Subject|0|||
170737514|NCT02392611|617045725|FG000|Overall Study|Lost to Follow-up|0|||
170737515|NCT02392611|617045726|FG001|Overall Study|Lost to Follow-up|0|||
170737516|NCT02392611|617045727|FG002|Overall Study|Lost to Follow-up|0|||
170737517|NCT02392611|617045728|FG003|Overall Study|Lost to Follow-up|0|||
170737518|NCT02392611|617045729|FG004|Overall Study|Lost to Follow-up|0|||
170737519|NCT02392611|617045730|FG005|Overall Study|Lost to Follow-up|0|||
170737520|NCT02392611|617045731|FG006|Overall Study|Lost to Follow-up|1|||
170737521|NCT02392611|617045732|FG007|Overall Study|Lost to Follow-up|0|||
170737522|NCT02392611|617045733|FG008|Overall Study|Lost to Follow-up|0|||
170737523|NCT02392611|617045725|FG000|Overall Study|Enrolled, not treated|0|||
170737524|NCT02392611|617045726|FG001|Overall Study|Enrolled, not treated|0|||
170737525|NCT02392611|617045727|FG002|Overall Study|Enrolled, not treated|0|||
170737526|NCT02392611|617045728|FG003|Overall Study|Enrolled, not treated|2|||
170737527|NCT02392611|617045729|FG004|Overall Study|Enrolled, not treated|0|||
170737528|NCT02392611|617045730|FG005|Overall Study|Enrolled, not treated|0|||
170737529|NCT02392611|617045731|FG006|Overall Study|Enrolled, not treated|0|||
170737530|NCT02392611|617045732|FG007|Overall Study|Enrolled, not treated|0|||
170737531|NCT02392611|617045733|FG008|Overall Study|Enrolled, not treated|0|||
170737532|NCT00553202|617045738|FG000|Overall Study|Death|16|||
170737533|NCT00553202|617045738|FG000|Overall Study|Lost to Follow-up|1|||
170737534|NCT00553202|617045738|FG000|Overall Study|Physician Decision|28|||
170737535|NCT00553202|617045738|FG000|Overall Study|Withdrawal by Subject|1|||
170737536|NCT00553202|617045738|FG000|Overall Study|No donor identified|16|||
170737537|NCT00553202|617045738|FG000|Overall Study|Fails to meet organ function|6|||
170737538|NCT00369681|617045739|FG000|Overall Study|Death|1|||
170737539|NCT03239873|617045740|FG000|Overall Study|Lost to Follow-up|15|||
170737540|NCT03239873|617045741|FG001|Overall Study|Lost to Follow-up|16|||
170737541|NCT03239873|617045740|FG000|Overall Study|Physician Decision|1|||
170737542|NCT03239873|617045741|FG001|Overall Study|Physician Decision|0|||
170737543|NCT03239873|617045740|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
170737544|NCT03239873|617045741|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
170737545|NCT03239873|617045740|FG000|Overall Study|Withdrawal by Subject|2|||
170737546|NCT03239873|617045741|FG001|Overall Study|Withdrawal by Subject|0|||
170737547|NCT03239873|617045740|FG000|Overall Study|Contraindication to study medication|1|||
170737548|NCT03239873|617045741|FG001|Overall Study|Contraindication to study medication|0|||
170737549|NCT03239873|617045740|FG000|Overall Study|Protocol Violation|1|||
170737550|NCT03239873|617045741|FG001|Overall Study|Protocol Violation|0|||
170737551|NCT00605319|617045747|FG000|Overall Study|Adverse Event|6|||
170737552|NCT03075904|617045755|FG000|Overall Study|Physician Decision|3|||
170737553|NCT03075904|617045755|FG000|Overall Study|Need for Medication not Permitted|1|||
170737554|NCT02228395|617045756|FG000|First Intervention Period|No longer willing to participate|1|||
170737555|NCT02228395|617045757|FG001|First Intervention Period|No longer willing to participate|0|||
170737556|NCT02228395|617045758|FG002|First Intervention Period|No longer willing to participate|0|||
170737557|NCT02228395|617045756|FG000|First Intervention Period|Unable to comply with study dates|0|||
170737558|NCT02228395|617045757|FG001|First Intervention Period|Unable to comply with study dates|1|||
170737559|NCT02228395|617045758|FG002|First Intervention Period|Unable to comply with study dates|1|||
170737560|NCT04766086|617045760|FG000|Overall Study|Lost to Follow-up|3|||
170737561|NCT04766086|617045761|FG001|Overall Study|Lost to Follow-up|5|||
170737562|NCT04766086|617045762|FG002|Overall Study|Lost to Follow-up|3|||
170737563|NCT04766086|617045760|FG000|Overall Study|Withdrawal by Subject|1|||
170737564|NCT04766086|617045761|FG001|Overall Study|Withdrawal by Subject|1|||
170737565|NCT04766086|617045762|FG002|Overall Study|Withdrawal by Subject|2|||
170737566|NCT04766086|617045760|FG000|Overall Study|Other|0|||
170737567|NCT04766086|617045761|FG001|Overall Study|Other|0|||
170737568|NCT04766086|617045762|FG002|Overall Study|Other|1|||
170737569|NCT02281760|617045777|FG000|Overall Study|Withdrawal by Subject|1|||
170737570|NCT00100932|617045778|FG000|Overall Study|Adverse Event|11|||
170737571|NCT00100932|617045779|FG001|Overall Study|Adverse Event|2|||
170737572|NCT00100932|617045778|FG000|Overall Study|Withdrawal by Subject|6|||
170737573|NCT00100932|617045779|FG001|Overall Study|Withdrawal by Subject|0|||
170737574|NCT00100932|617045778|FG000|Overall Study|Progressive Disease|44|||
170737575|NCT00100932|617045779|FG001|Overall Study|Progressive Disease|18|||
170737576|NCT00100932|617045778|FG000|Overall Study|Physician Decision|7|||
170737577|NCT00100932|617045779|FG001|Overall Study|Physician Decision|5|||
170737578|NCT00100932|617045778|FG000|Overall Study|Other|5|||
170737579|NCT00100932|617045779|FG001|Overall Study|Other|2|||
170737580|NCT02387996|617045782|FG000|Overall Study|Disease Progression|167|||
170737581|NCT02387996|617045782|FG000|Overall Study|Study Drug Toxicity|31|||
170737582|NCT02387996|617045782|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
170737583|NCT02387996|617045782|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
170737584|NCT02387996|617045782|FG000|Overall Study|Subject Withdrew Consent|5|||
170737585|NCT02387996|617045782|FG000|Overall Study|Lost to Follow-up|1|||
170737586|NCT02387996|617045782|FG000|Overall Study|Poor/Non-Compliance|1|||
170737587|NCT02387996|617045782|FG000|Overall Study|Other Reasons|5|||
170737588|NCT02387996|617045782|FG000|Overall Study|Death|1|||
170737589|NCT00312702|617045783|FG000|Immunization Phase|Lost to Follow-up|0|||
170737590|NCT00312702|617045784|FG001|Immunization Phase|Lost to Follow-up|1|||
170737591|NCT00312702|617045785|FG002|Immunization Phase|Lost to Follow-up|0|||
170737592|NCT00770432|617045786|FG000|Overall Study|Other|4|||
170737593|NCT00770432|617045787|FG001|Overall Study|Other|6|||
170737594|NCT00770432|617045786|FG000|Overall Study|Non-compliance|0|||
170737595|NCT00770432|617045787|FG001|Overall Study|Non-compliance|1|||
170737596|NCT01453348|617045788|FG000|Overall Study|Death|0|||
170737597|NCT01453348|617045789|FG001|Overall Study|Death|0|||
170737598|NCT01453348|617045790|FG002|Overall Study|Death|1|||
170737599|NCT01453348|617045788|FG000|Overall Study|Withdrawal by Subject|0|||
170737600|NCT01453348|617045789|FG001|Overall Study|Withdrawal by Subject|1|||
170737601|NCT01453348|617045790|FG002|Overall Study|Withdrawal by Subject|0|||
170737602|NCT01453348|617045788|FG000|Overall Study|Protocol Violation|1|||
170844700|NCT01252355|617439023|FG002|Overall Study|Sponsor Early Termination of Study|146|||
170844701|NCT01252355|617439021|FG000|Overall Study|Randomized but not Treated|2|||
170737603|NCT01453348|617045789|FG001|Overall Study|Protocol Violation|0|||
170737604|NCT01453348|617045790|FG002|Overall Study|Protocol Violation|0|||
170737605|NCT02756832|617045791|FG000|Overall Study|Lost for Observation after Baseline|6|||
170737606|NCT02756832|617045791|FG000|Overall Study|Lost for Observation|13|||
170737607|NCT02756832|617045791|FG000|Overall Study|Patient's Unwillingness|12|||
170737608|NCT02756832|617045791|FG000|Overall Study|Insufficient Efficacy|2|||
170737609|NCT02756832|617045791|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
170737610|NCT02756832|617045791|FG000|Overall Study|Reason not Specified|9|||
170737611|NCT02756832|617045791|FG000|Overall Study|Protocol Deviation|10|||
170737612|NCT01719237|617045797|FG000|Overall Study|Physician Decision|0|||
170737613|NCT01719237|617045798|FG001|Overall Study|Physician Decision|1|||
170737614|NCT02002182|617045802|FG000|Overall Study|Withdraw from study|3|||
170844702|NCT01252355|617439022|FG001|Overall Study|Randomized but not Treated|0|||
170844703|NCT01252355|617439023|FG002|Overall Study|Randomized but not Treated|0|||
170844704|NCT01252355|617439021|FG000|Overall Study|Other Than Above|8|||
170844705|NCT01252355|617439022|FG001|Overall Study|Other Than Above|7|||
170844706|NCT01252355|617439023|FG002|Overall Study|Other Than Above|7|||
170844707|NCT02175641|617439024|FG000|Overall Study|Death|3|||
170844708|NCT02175641|617439025|FG001|Overall Study|Death|4|||
170844709|NCT02175641|617439024|FG000|Overall Study|Lost to Follow-up|4|||
170844710|NCT02175641|617439025|FG001|Overall Study|Lost to Follow-up|4|||
170844711|NCT02175641|617439024|FG000|Overall Study|Withdrawal by Subject|7|||
170844712|NCT02175641|617439025|FG001|Overall Study|Withdrawal by Subject|4|||
170844713|NCT02175641|617439024|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
170844714|NCT02175641|617439025|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
170844715|NCT02175641|617439024|FG000|Overall Study|Developed Contraindicated Condition|8|||
170844716|NCT02175641|617439025|FG001|Overall Study|Developed Contraindicated Condition|0|||
170844717|NCT01876901|617439028|FG000|Overall Study|Protocol Violation|10|||
170844718|NCT01876901|617439029|FG001|Overall Study|Protocol Violation|2|||
170844719|NCT01876901|617439028|FG000|Overall Study|No or other surgical intervention|7|||
170844720|NCT01876901|617439029|FG001|Overall Study|No or other surgical intervention|5|||
170844721|NCT03868787|617439032|FG000|Overall Study|Withdrawal by Subject|2|||
170844722|NCT03868787|617439033|FG001|Overall Study|Withdrawal by Subject|1|||
170844723|NCT01399697|617439036|FG000|Overall Study|Adverse Event|13|||
170844724|NCT01399697|617439037|FG001|Overall Study|Adverse Event|3|||
170844725|NCT01399697|617439038|FG002|Overall Study|Adverse Event|1|||
170844726|NCT01399697|617439036|FG000|Overall Study|Lost to Follow-up|2|||
170844727|NCT01399697|617439037|FG001|Overall Study|Lost to Follow-up|0|||
170844728|NCT01399697|617439038|FG002|Overall Study|Lost to Follow-up|0|||
170844729|NCT01399697|617439036|FG000|Overall Study|Withdrawal by Subject|8|||
170844730|NCT01399697|617439037|FG001|Overall Study|Withdrawal by Subject|0|||
170844731|NCT01399697|617439038|FG002|Overall Study|Withdrawal by Subject|0|||
170844732|NCT01399697|617439036|FG000|Overall Study|Investigator Decisión|1|||
170844733|NCT01399697|617439037|FG001|Overall Study|Investigator Decisión|0|||
170844734|NCT01399697|617439038|FG002|Overall Study|Investigator Decisión|2|||
170844735|NCT01399697|617439036|FG000|Overall Study|Lack of Efficacy|9|||
170844736|NCT01399697|617439037|FG001|Overall Study|Lack of Efficacy|0|||
170844737|NCT01399697|617439038|FG002|Overall Study|Lack of Efficacy|1|||
170844738|NCT01399697|617439036|FG000|Overall Study|Protocol Violation|2|||
170844739|NCT01399697|617439037|FG001|Overall Study|Protocol Violation|0|||
170844740|NCT01399697|617439038|FG002|Overall Study|Protocol Violation|0|||
170844741|NCT01399697|617439036|FG000|Overall Study|Non-Compliant|1|||
170844742|NCT01399697|617439037|FG001|Overall Study|Non-Compliant|0|||
170844743|NCT01399697|617439038|FG002|Overall Study|Non-Compliant|0|||
170844744|NCT01399697|617439036|FG000|Overall Study|Inclusion Error|2|||
170844745|NCT01399697|617439037|FG001|Overall Study|Inclusion Error|0|||
170844746|NCT01399697|617439038|FG002|Overall Study|Inclusion Error|0|||
170844747|NCT01399697|617439036|FG000|Overall Study|Positive result for hepatitis B|1|||
170844748|NCT01399697|617439037|FG001|Overall Study|Positive result for hepatitis B|0|||
170844749|NCT01399697|617439038|FG002|Overall Study|Positive result for hepatitis B|0|||
170844750|NCT01399697|617439036|FG000|Overall Study|Clinical RA remission|1|||
170844751|NCT01399697|617439037|FG001|Overall Study|Clinical RA remission|0|||
170844752|NCT01399697|617439038|FG002|Overall Study|Clinical RA remission|0|||
170844753|NCT01399697|617439036|FG000|Overall Study|Sponsor Decision|1|||
170844754|NCT01399697|617439037|FG001|Overall Study|Sponsor Decision|0|||
170844755|NCT01399697|617439038|FG002|Overall Study|Sponsor Decision|0|||
170844756|NCT04313608|617439039|FG000|Overall Study|Death|12|||
170844757|NCT04313608|617439040|FG001|Overall Study|Death|3|||
170844758|NCT01145898|617439041|FG000|3-year Treatment|medication change by treating physician|3|||
170844759|NCT01145898|617439042|FG001|3-year Treatment|medication change by treating physician|16|||
170844760|NCT00879775|617439043|FG000|Overall Study|Lost to Follow-up|2|||
170844761|NCT00879775|617439044|FG001|Overall Study|Lost to Follow-up|1|||
170844762|NCT01401153|617439045|FG000|First Test Day|Learning disabilities; illness|1|||
170844763|NCT01401153|617439046|FG001|First Test Day|Learning disabilities; illness|10|||
170844764|NCT01401153|617439045|FG000|Second Test Day|illness|0|||
170844765|NCT01401153|617439046|FG001|Second Test Day|illness|5|||
170844766|NCT03101462|617439047|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
170844767|NCT03101462|617439048|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
170844768|NCT02807272|617439049|FG000|Overall Study|Death|9|||
170844769|NCT02807272|617439050|FG001|Overall Study|Death|5|||
170844770|NCT02807272|617439051|FG002|Overall Study|Death|2|||
170844771|NCT02807272|617439052|FG003|Overall Study|Death|0|||
170844772|NCT02807272|617439053|FG004|Overall Study|Death|1|||
170844773|NCT02807272|617439049|FG000|Overall Study|Lost to Follow-up|1|||
170844774|NCT02807272|617439050|FG001|Overall Study|Lost to Follow-up|0|||
170844775|NCT02807272|617439051|FG002|Overall Study|Lost to Follow-up|0|||
170844776|NCT02807272|617439052|FG003|Overall Study|Lost to Follow-up|0|||
170844777|NCT02807272|617439053|FG004|Overall Study|Lost to Follow-up|0|||
170844778|NCT02807272|617439049|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
170844779|NCT02807272|617439050|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
170844780|NCT02807272|617439051|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
170844781|NCT02807272|617439052|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
170844782|NCT02807272|617439053|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
170844783|NCT02807272|617439049|FG000|Overall Study|Protocol-defined Disease Progression|0|||
170844784|NCT02807272|617439050|FG001|Overall Study|Protocol-defined Disease Progression|1|||
170844785|NCT02807272|617439051|FG002|Overall Study|Protocol-defined Disease Progression|0|||
170844786|NCT02807272|617439052|FG003|Overall Study|Protocol-defined Disease Progression|0|||
170844787|NCT02807272|617439053|FG004|Overall Study|Protocol-defined Disease Progression|1|||
170844788|NCT02807272|617439049|FG000|Overall Study|Study Terminated by Sponsor|1|||
170844789|NCT02807272|617439050|FG001|Overall Study|Study Terminated by Sponsor|0|||
170844790|NCT02807272|617439051|FG002|Overall Study|Study Terminated by Sponsor|0|||
170844791|NCT02807272|617439052|FG003|Overall Study|Study Terminated by Sponsor|1|||
170844792|NCT02807272|617439053|FG004|Overall Study|Study Terminated by Sponsor|0|||
170844793|NCT02807272|617439049|FG000|Overall Study|Other|1|||
170844794|NCT02807272|617439050|FG001|Overall Study|Other|0|||
170844795|NCT02807272|617439051|FG002|Overall Study|Other|0|||
170844796|NCT02807272|617439052|FG003|Overall Study|Other|0|||
170844797|NCT02807272|617439053|FG004|Overall Study|Other|1|||
170844798|NCT02180243|617439054|FG000|Overall Study|Withdrawal by Subject|12|||
170844799|NCT02180243|617439055|FG001|Overall Study|Withdrawal by Subject|12|||
170844800|NCT02180243|617439054|FG000|Overall Study|Lost to Follow-up|12|||
170844801|NCT02180243|617439055|FG001|Overall Study|Lost to Follow-up|2|||
170844802|NCT04145700|617439056|FG000|Overall Study|Withdrawal by Subject|8|||
170844803|NCT04145700|617439057|FG001|Overall Study|Withdrawal by Subject|3|||
170844804|NCT01327846|617439058|FG000|Core Phase|Subject decision (vital status: missing)|1|||
170844805|NCT01327846|617439059|FG001|Core Phase|Subject decision (vital status: missing)|2|||
170844806|NCT01327846|617439060|FG002|Core Phase|Subject decision (vital status: missing)|2|||
170844807|NCT01327846|617439061|FG003|Core Phase|Subject decision (vital status: missing)|1|||
170844808|NCT01327846|617439058|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
170844809|NCT01327846|617439059|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
170844810|NCT01327846|617439060|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
170844811|NCT01327846|617439061|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
170844812|NCT01327846|617439058|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
170844813|NCT01327846|617439059|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
170844814|NCT01327846|617439060|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
170844815|NCT01327846|617439061|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
170844816|NCT01327846|617439058|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
170844817|NCT01327846|617439059|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
170844818|NCT01327846|617439060|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
170844819|NCT01327846|617439061|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
170844820|NCT01327846|617439058|FG000|Core Phase|Lost to Follow-up|3|||
170844821|NCT01327846|617439059|FG001|Core Phase|Lost to Follow-up|3|||
170844822|NCT01327846|617439060|FG002|Core Phase|Lost to Follow-up|4|||
170844823|NCT01327846|617439061|FG003|Core Phase|Lost to Follow-up|5|||
170844824|NCT01327846|617439058|FG000|Extension Phase|Study terminated by sponsor|1073|||
170844825|NCT01327846|617439059|FG001|Extension Phase|Study terminated by sponsor|1124|||
170844826|NCT01327846|617439060|FG002|Extension Phase|Study terminated by sponsor|1067|||
170844827|NCT01327846|617439061|FG003|Extension Phase|Study terminated by sponsor|1660|||
170844828|NCT01327846|617439058|FG000|Extension Phase|Withdrawal by Subject|20|||
170844829|NCT01327846|617439059|FG001|Extension Phase|Withdrawal by Subject|13|||
170844830|NCT01327846|617439060|FG002|Extension Phase|Withdrawal by Subject|19|||
170844831|NCT01327846|617439061|FG003|Extension Phase|Withdrawal by Subject|37|||
170844832|NCT01327846|617439058|FG000|Extension Phase|Lost to Follow-up|4|||
170844833|NCT01327846|617439059|FG001|Extension Phase|Lost to Follow-up|3|||
170844834|NCT01327846|617439060|FG002|Extension Phase|Lost to Follow-up|4|||
170844835|NCT01327846|617439061|FG003|Extension Phase|Lost to Follow-up|7|||
170844836|NCT01327846|617439058|FG000|Extension Phase|Technical Problems|2|||
170844837|NCT01327846|617439059|FG001|Extension Phase|Technical Problems|4|||
170844838|NCT01327846|617439060|FG002|Extension Phase|Technical Problems|2|||
170844839|NCT01327846|617439061|FG003|Extension Phase|Technical Problems|2|||
170844840|NCT04662931|617439062|FG000|Overall Study|Withdrawal by Subject|17|||
170844841|NCT04662931|617439062|FG000|Overall Study|Death|3|||
170844842|NCT04662931|617439062|FG000|Overall Study|Lost to Follow-up|3|||
170844843|NCT04662931|617439062|FG000|Overall Study|Guardian Decision|1|||
170844844|NCT00839956|617439063|FG000|Overall Study|Adverse Event|2|||
170844845|NCT00839956|617439063|FG000|Overall Study|Lack of Efficacy|6|||
170844846|NCT00839956|617439063|FG000|Overall Study|Physician Decision|1|||
170844847|NCT00839956|617439063|FG000|Overall Study|Withdrawal by Subject|3|||
170844848|NCT02807883|617439064|FG000|Overall Study|Withdrawal by Subject|2|||
170844849|NCT00846807|617439065|FG000|Overall Study|Adverse Event|270|||
170844850|NCT00846807|617439065|FG000|Overall Study|Lost to Follow-up|94|||
170844851|NCT00846807|617439065|FG000|Overall Study|Withdrawal by Subject|56|||
170844852|NCT00846807|617439065|FG000|Overall Study|Non compliant with European label|7|||
170844853|NCT00846807|617439065|FG000|Overall Study|Switch to other anticoagulants|89|||
170844854|NCT00846807|617439065|FG000|Overall Study|No prescription after hospital discharge|56|||
170844855|NCT00846807|617439065|FG000|Overall Study|Other|60|||
170844856|NCT04958200|617439066|FG000|Overall Study|Withdrawal by Subject|0|||
170844857|NCT04958200|617439067|FG001|Overall Study|Withdrawal by Subject|2|||
170844858|NCT04958200|617439066|FG000|Overall Study|Lost to Follow-up|3|||
170844859|NCT04958200|617439067|FG001|Overall Study|Lost to Follow-up|2|||
170844860|NCT01495598|617439070|FG000|Overall Study|Death during follow up period|2|||
170844861|NCT01495598|617439070|FG000|Overall Study|Death on study|1|||
170844862|NCT01495598|617439070|FG000|Overall Study|Lost to Follow-up|3|||
170844863|NCT01495598|617439070|FG000|Overall Study|Physician Decision|8|||
170844864|NCT03238963|617439079|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
170844865|NCT03238963|617439080|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
170844866|NCT03238963|617439079|FG000|Overall Study|Withdrawal by Subject|1|||
170844867|NCT03238963|617439080|FG001|Overall Study|Withdrawal by Subject|1|||
170844868|NCT03238963|617439079|FG000|Overall Study|Lost to Follow-up|1|||
170844869|NCT03238963|617439080|FG001|Overall Study|Lost to Follow-up|0|||
170844870|NCT03238963|617439079|FG000|Overall Study|Protocol Violation|1|||
170844871|NCT03238963|617439080|FG001|Overall Study|Protocol Violation|1|||
170844872|NCT03238963|617439079|FG000|Overall Study|Adverse Event|1|||
170844873|NCT03238963|617439080|FG001|Overall Study|Adverse Event|0|||
170844874|NCT06926673|617439081|FG000|Overall Study|Lost to Follow-up|0|||
170844875|NCT06926673|617439082|FG001|Overall Study|Lost to Follow-up|0|||
170844876|NCT06926673|617439083|FG002|Overall Study|Lost to Follow-up|0|||
170844877|NCT06926673|617439084|FG003|Overall Study|Lost to Follow-up|1|||
170844878|NCT06926673|617439085|FG004|Overall Study|Lost to Follow-up|0|||
170844879|NCT06926673|617439086|FG005|Overall Study|Lost to Follow-up|0|||
170844880|NCT06926673|617439087|FG006|Overall Study|Lost to Follow-up|0|||
170844881|NCT06926673|617439081|FG000|Overall Study|Physician Decision|0|||
170844882|NCT06926673|617439082|FG001|Overall Study|Physician Decision|0|||
170844883|NCT06926673|617439083|FG002|Overall Study|Physician Decision|0|||
170844884|NCT06926673|617439084|FG003|Overall Study|Physician Decision|0|||
170844885|NCT06926673|617439085|FG004|Overall Study|Physician Decision|0|||
170844886|NCT06926673|617439086|FG005|Overall Study|Physician Decision|0|||
170844887|NCT06926673|617439087|FG006|Overall Study|Physician Decision|1|||
170844888|NCT06926673|617439081|FG000|Overall Study|Withdrawal by Subject|0|||
170844889|NCT06926673|617439082|FG001|Overall Study|Withdrawal by Subject|3|||
170844890|NCT06926673|617439083|FG002|Overall Study|Withdrawal by Subject|2|||
170844891|NCT06926673|617439084|FG003|Overall Study|Withdrawal by Subject|1|||
170844892|NCT06926673|617439085|FG004|Overall Study|Withdrawal by Subject|0|||
170844893|NCT06926673|617439086|FG005|Overall Study|Withdrawal by Subject|2|||
170844894|NCT06926673|617439087|FG006|Overall Study|Withdrawal by Subject|0|||
170844895|NCT05823012|617439088|FG000|Titration Period|Adverse Event|1|||
170844896|NCT05823012|617439088|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
170844897|NCT05823012|617439088|FG000|Maintenance Period|Adverse Event|1|||
170844898|NCT05823012|617439088|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
170844899|NCT05823012|617439088|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
170844900|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
170844901|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
170844902|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
170844903|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
170844904|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
170844905|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
170844906|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
170844907|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
170844908|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
170844909|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
170844910|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
170844911|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
170844912|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Death|1|||
170844913|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Death|2|||
170844914|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Death|2|||
170844915|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Death|0|||
170844916|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Death|0|||
170844917|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Death|0|||
170844918|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
170844919|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
170844920|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
170844921|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
170844922|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
170844923|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
170844924|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
170844925|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
170844926|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
170844927|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
170844928|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
170844929|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
170844930|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
170844931|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
170844932|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
170844933|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
170844934|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
170844935|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
170844936|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
170844937|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
170844938|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
170844939|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
170844940|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
170844941|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
170844942|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
170844943|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
170844944|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
170844945|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
170844946|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
170844947|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
170737615|NCT02002182|617045803|FG001|Overall Study|Withdraw from study|1|||
170844948|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
170844949|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
170844950|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
170844951|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
170844952|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
170844953|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
170844954|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
170844955|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
170844956|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
170844957|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
170844958|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
170844959|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
170844960|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Site closure|0|||
170844961|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Site closure|0|||
170844962|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Site closure|1|||
170844963|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Site closure|0|||
170844964|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Site closure|0|||
170844965|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Site closure|0|||
170844966|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
170844967|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
170844968|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
170844969|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
170844970|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
170844971|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
170844972|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
170844973|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
170844974|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
170844975|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
170844976|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
170844977|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
170844978|NCT03439254|617440944|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
170844979|NCT03439254|617440945|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
170844980|NCT03439254|617440946|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
170844981|NCT03439254|617440947|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
170844982|NCT03439254|617440948|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
170844983|NCT03439254|617440949|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
170844984|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
170844985|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
170844986|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
170844987|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
170844988|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
170844989|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
170844990|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
170844991|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
170844992|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
170844993|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
170844994|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
170844995|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
170844996|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
170844997|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
170844998|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
170844999|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
170845000|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
170845001|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
170845002|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
170845003|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
170845004|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
170845005|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
170845006|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
170845007|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
170845008|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
170845009|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
170845010|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
170845011|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
170845012|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
170845013|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
170845014|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
170845015|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
170845016|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
170845017|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
170845018|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
170845019|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
170845020|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
170845021|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
170845022|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
170737616|NCT02002182|617045802|FG000|Overall Study|Health Reasons|1|||
170737617|NCT02002182|617045803|FG001|Overall Study|Health Reasons|0|||
170737618|NCT02002182|617045802|FG000|Overall Study|Death|1|||
170737619|NCT02002182|617045803|FG001|Overall Study|Death|0|||
170737620|NCT00572624|617045804|FG000|Overall Study|Lost to Follow-up|10|||
170737621|NCT00572624|617045805|FG001|Overall Study|Lost to Follow-up|4|||
170737622|NCT00572624|617045804|FG000|Overall Study|Wanted to do a different diet program|1|||
170737623|NCT00572624|617045805|FG001|Overall Study|Wanted to do a different diet program|0|||
170737624|NCT00572624|617045804|FG000|Overall Study|Medication change|1|||
170737625|NCT00572624|617045805|FG001|Overall Study|Medication change|0|||
170737626|NCT00572624|617045804|FG000|Overall Study|Started a new job-- no time for study|1|||
170737627|NCT00572624|617045805|FG001|Overall Study|Started a new job-- no time for study|0|||
170737628|NCT00572624|617045804|FG000|Overall Study|Admitted to being a smoker|1|||
170737629|NCT00572624|617045805|FG001|Overall Study|Admitted to being a smoker|0|||
170737630|NCT00572624|617045804|FG000|Overall Study|Refused to do the stress test|1|||
170737631|NCT00572624|617045805|FG001|Overall Study|Refused to do the stress test|0|||
170737632|NCT00572624|617045804|FG000|Overall Study|Problem with vascular access|1|||
170737633|NCT00572624|617045805|FG001|Overall Study|Problem with vascular access|0|||
170737634|NCT00572624|617045804|FG000|Overall Study|Health issues unrelated to the study|1|||
170737635|NCT00572624|617045805|FG001|Overall Study|Health issues unrelated to the study|0|||
170737636|NCT04146896|617045809|FG000|Overall Study|Adverse Event|5|||
170737637|NCT04146896|617045810|FG001|Overall Study|Adverse Event|8|||
170737638|NCT04146896|617045809|FG000|Overall Study|Lack of Efficacy|3|||
170737639|NCT04146896|617045810|FG001|Overall Study|Lack of Efficacy|2|||
170737640|NCT04146896|617045809|FG000|Overall Study|Lost to Follow-up|0|||
170737641|NCT04146896|617045810|FG001|Overall Study|Lost to Follow-up|1|||
170737642|NCT04146896|617045809|FG000|Overall Study|Non-compliance|5|||
170737643|NCT04146896|617045810|FG001|Overall Study|Non-compliance|4|||
170737644|NCT04146896|617045809|FG000|Overall Study|Withdrawal by Subject|3|||
170737645|NCT04146896|617045810|FG001|Overall Study|Withdrawal by Subject|5|||
170737646|NCT04146896|617045809|FG000|Overall Study|Randomized in error|1|||
170737647|NCT04146896|617045810|FG001|Overall Study|Randomized in error|2|||
170737648|NCT01597505|617045811|FG000|Overall Study|Physician Decision|5|||
170737649|NCT01597505|617045812|FG001|Overall Study|Physician Decision|0|||
170737650|NCT01597505|617045811|FG000|Overall Study|Adverse Event|19|||
170737651|NCT01597505|617045812|FG001|Overall Study|Adverse Event|7|||
170737652|NCT01597505|617045811|FG000|Overall Study|Lost to Follow-up|4|||
170737653|NCT01597505|617045812|FG001|Overall Study|Lost to Follow-up|2|||
170737654|NCT01597505|617045811|FG000|Overall Study|Withdrawal by Subject|10|||
170737655|NCT01597505|617045812|FG001|Overall Study|Withdrawal by Subject|18|||
170737656|NCT01597505|617045811|FG000|Overall Study|Other|5|||
170737657|NCT01597505|617045812|FG001|Overall Study|Other|6|||
170737658|NCT01597505|617045811|FG000|Overall Study|Missing|1|||
170737659|NCT01597505|617045812|FG001|Overall Study|Missing|0|||
170737660|NCT02675465|617045816|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
170737661|NCT02675465|617045817|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
170737662|NCT02675465|617045818|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
170737663|NCT02675465|617045819|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
170737664|NCT02675465|617045820|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
170737665|NCT02675465|617045821|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
170737666|NCT02675465|617045816|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
170737667|NCT02675465|617045817|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
170737668|NCT02675465|617045818|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
170737669|NCT02675465|617045819|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
170737670|NCT02675465|617045820|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
170737671|NCT02675465|617045821|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
170737672|NCT02675465|617045816|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
170737673|NCT02675465|617045817|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
170737674|NCT02675465|617045818|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
170737675|NCT02675465|617045819|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
170737676|NCT02675465|617045820|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
170737677|NCT02675465|617045821|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
170737678|NCT02675465|617045816|FG000|Stage 4: Long Term Extension|Death|0|||
170737679|NCT02675465|617045817|FG001|Stage 4: Long Term Extension|Death|0|||
170737680|NCT02675465|617045818|FG002|Stage 4: Long Term Extension|Death|0|||
170737681|NCT02675465|617045819|FG003|Stage 4: Long Term Extension|Death|1|||
170845023|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
170845024|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
170737682|NCT02675465|617045820|FG004|Stage 4: Long Term Extension|Death|0|||
170737683|NCT02675465|617045821|FG005|Stage 4: Long Term Extension|Death|0|||
170737684|NCT05031078|617045822|FG000|Overall Study|Withdrawal by Subject|0|||
170737685|NCT05031078|617045823|FG001|Overall Study|Withdrawal by Subject|1|||
170737686|NCT05031078|617045824|FG002|Overall Study|Withdrawal by Subject|0|||
170737687|NCT01919970|617045834|FG000|Overall Study|Withdrawal by Subject|3|||
170737688|NCT01919970|617045835|FG001|Overall Study|Withdrawal by Subject|0|||
170737689|NCT03565068|617045836|FG000|Overall Study|Protocol Violation|0|||
170737690|NCT03565068|617045837|FG001|Overall Study|Protocol Violation|0|||
170737691|NCT03565068|617045838|FG002|Overall Study|Protocol Violation|0|||
170737692|NCT03565068|617045839|FG003|Overall Study|Protocol Violation|0|||
170737693|NCT03565068|617045840|FG004|Overall Study|Protocol Violation|1|||
170737694|NCT03565068|617045841|FG005|Overall Study|Protocol Violation|0|||
170737695|NCT03565068|617045842|FG006|Overall Study|Protocol Violation|0|||
170737696|NCT03565068|617045843|FG007|Overall Study|Protocol Violation|1|||
170737697|NCT03565068|617045844|FG008|Overall Study|Protocol Violation|0|||
170737698|NCT03565068|617045836|FG000|Overall Study|Sponsor decision|0|||
170737699|NCT03565068|617045837|FG001|Overall Study|Sponsor decision|0|||
170737700|NCT03565068|617045838|FG002|Overall Study|Sponsor decision|0|||
170737701|NCT03565068|617045839|FG003|Overall Study|Sponsor decision|0|||
170737702|NCT03565068|617045840|FG004|Overall Study|Sponsor decision|1|||
170737703|NCT03565068|617045841|FG005|Overall Study|Sponsor decision|1|||
170737704|NCT03565068|617045842|FG006|Overall Study|Sponsor decision|0|||
170737705|NCT03565068|617045843|FG007|Overall Study|Sponsor decision|0|||
170737706|NCT03565068|617045844|FG008|Overall Study|Sponsor decision|0|||
170737707|NCT03565068|617045836|FG000|Overall Study|Withdrawal by Subject|0|||
170737708|NCT03565068|617045837|FG001|Overall Study|Withdrawal by Subject|0|||
170737709|NCT03565068|617045838|FG002|Overall Study|Withdrawal by Subject|1|||
170737710|NCT03565068|617045839|FG003|Overall Study|Withdrawal by Subject|0|||
170737711|NCT03565068|617045840|FG004|Overall Study|Withdrawal by Subject|2|||
170737712|NCT03565068|617045841|FG005|Overall Study|Withdrawal by Subject|0|||
170737713|NCT03565068|617045842|FG006|Overall Study|Withdrawal by Subject|1|||
170737714|NCT03565068|617045843|FG007|Overall Study|Withdrawal by Subject|5|||
170737715|NCT03565068|617045844|FG008|Overall Study|Withdrawal by Subject|1|||
170737716|NCT03565068|617045836|FG000|Overall Study|Physician Decision|0|||
170737717|NCT03565068|617045837|FG001|Overall Study|Physician Decision|0|||
170737718|NCT03565068|617045838|FG002|Overall Study|Physician Decision|0|||
170737719|NCT03565068|617045839|FG003|Overall Study|Physician Decision|0|||
170737720|NCT03565068|617045840|FG004|Overall Study|Physician Decision|0|||
170737721|NCT03565068|617045841|FG005|Overall Study|Physician Decision|0|||
170737722|NCT03565068|617045842|FG006|Overall Study|Physician Decision|0|||
170737723|NCT03565068|617045843|FG007|Overall Study|Physician Decision|1|||
170737724|NCT03565068|617045844|FG008|Overall Study|Physician Decision|0|||
170737725|NCT03565068|617045836|FG000|Overall Study|Lost to Follow-up|0|||
170737726|NCT03565068|617045837|FG001|Overall Study|Lost to Follow-up|0|||
170737727|NCT03565068|617045838|FG002|Overall Study|Lost to Follow-up|0|||
170737728|NCT03565068|617045839|FG003|Overall Study|Lost to Follow-up|0|||
170737729|NCT03565068|617045840|FG004|Overall Study|Lost to Follow-up|0|||
170737730|NCT03565068|617045841|FG005|Overall Study|Lost to Follow-up|0|||
170737731|NCT03565068|617045842|FG006|Overall Study|Lost to Follow-up|0|||
170737732|NCT03565068|617045843|FG007|Overall Study|Lost to Follow-up|1|||
170737733|NCT03565068|617045844|FG008|Overall Study|Lost to Follow-up|0|||
170737734|NCT00633464|617045845|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
170737735|NCT00633464|617045846|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
170737736|NCT00633464|617045845|FG000|Overall Study|Never Treated (Randomized in error)|0|||
170737737|NCT00633464|617045846|FG001|Overall Study|Never Treated (Randomized in error)|1|||
170737738|NCT04225988|617045847|FG000|Overall Study|Withdrawal by Subject|2|||
170737739|NCT04225988|617045848|FG001|Overall Study|Withdrawal by Subject|0|||
170845025|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
170845026|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
170845027|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
170845028|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
170845029|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
170845030|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
170845031|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
170845032|NCT03439254|617440944|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
170845033|NCT03439254|617440945|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
170737740|NCT01167179|617047190|FG000|Overall Study|disease recurrence|4|||
170737741|NCT01167179|617047191|FG001|Overall Study|disease recurrence|4|||
170737742|NCT01167179|617047190|FG000|Overall Study|Death|4|||
170737743|NCT01167179|617047191|FG001|Overall Study|Death|10|||
170737744|NCT01167179|617047190|FG000|Overall Study|Withdrawal by Subject|1|||
170737745|NCT01167179|617047191|FG001|Overall Study|Withdrawal by Subject|2|||
170737746|NCT01167179|617047190|FG000|Overall Study|diverse|6|||
170737747|NCT01167179|617047191|FG001|Overall Study|diverse|5|||
170737748|NCT00311155|617047192|FG000|Overall Study|Adverse Event|21|||
170737749|NCT00311155|617047192|FG000|Overall Study|Withdrawal by Subject|17|||
170737750|NCT00311155|617047192|FG000|Overall Study|Did not meet entry criteria|55|||
170737751|NCT03017235|617047193|FG000|Overall Study|Withdrawal by Subject|4|||
170737752|NCT03017235|617047194|FG001|Overall Study|Withdrawal by Subject|3|||
170737753|NCT03017235|617047193|FG000|Overall Study|Lost to Follow-up|2|||
170737754|NCT03017235|617047194|FG001|Overall Study|Lost to Follow-up|7|||
170737755|NCT03017235|617047193|FG000|Overall Study|Adverse Event|0|||
170737756|NCT03017235|617047194|FG001|Overall Study|Adverse Event|1|||
170737757|NCT03017235|617047193|FG000|Overall Study|Protocol Violation|2|||
170737758|NCT03017235|617047194|FG001|Overall Study|Protocol Violation|1|||
170737759|NCT03017235|617047193|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
170737760|NCT03017235|617047194|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
170737761|NCT00429494|617047195|FG000|Overall Study|Withdrawal by Subject|9|||
170737762|NCT00429494|617047195|FG000|Overall Study|Death|6|||
170737763|NCT00976703|617047196|FG000|Overall Study|Physician Decision|1|||
170737764|NCT00976703|617047197|FG001|Overall Study|Physician Decision|1|||
170737765|NCT00976703|617047196|FG000|Overall Study|ineligible for study|2|||
170737766|NCT00976703|617047197|FG001|Overall Study|ineligible for study|2|||
170737767|NCT00767104|617047198|FG000|Overall Study|Lost to Follow-up|1|||
170737768|NCT00767104|617047199|FG001|Overall Study|Lost to Follow-up|2|||
170737769|NCT04567693|617047202|FG000|Overall Study|Death|0|||
170737770|NCT04567693|617047203|FG001|Overall Study|Death|0|||
170737771|NCT04567693|617047204|FG002|Overall Study|Death|2|||
170737772|NCT04567693|617047202|FG000|Overall Study|Lost to Follow-up|1|||
170737773|NCT04567693|617047203|FG001|Overall Study|Lost to Follow-up|0|||
170737774|NCT04567693|617047204|FG002|Overall Study|Lost to Follow-up|2|||
170737775|NCT04567693|617047202|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
170737776|NCT04567693|617047203|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
170737777|NCT04567693|617047204|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
170737778|NCT00957931|617047206|FG000|Overall Study|Death|4|||
170737779|NCT02959671|617047207|FG000|Overall Study|Adverse Event|2|||
170737780|NCT02959671|617047207|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
170737781|NCT02991482|617047208|FG000|Overall Study|Disease progression|56|||
170737782|NCT02991482|617047209|FG001|Overall Study|Disease progression|47|||
170737783|NCT02991482|617047208|FG000|Overall Study|Death|4|||
170737784|NCT02991482|617047209|FG001|Overall Study|Death|4|||
170737785|NCT02991482|617047208|FG000|Overall Study|Adverse Event|1|||
170737786|NCT02991482|617047209|FG001|Overall Study|Adverse Event|6|||
170737787|NCT02991482|617047208|FG000|Overall Study|Patient decision|1|||
170737788|NCT02991482|617047209|FG001|Overall Study|Patient decision|1|||
170737789|NCT02991482|617047208|FG000|Overall Study|Physician Decision|0|||
170737790|NCT02991482|617047209|FG001|Overall Study|Physician Decision|6|||
170737791|NCT02991482|617047208|FG000|Overall Study|Clinical deterioration|1|||
170737792|NCT02991482|617047209|FG001|Overall Study|Clinical deterioration|0|||
170737793|NCT02991482|617047208|FG000|Overall Study|Patient feeling too unwell|1|||
170737794|NCT02991482|617047209|FG001|Overall Study|Patient feeling too unwell|0|||
170737795|NCT02991482|617047208|FG000|Overall Study|Worsening of performance status|0|||
170737796|NCT02991482|617047209|FG001|Overall Study|Worsening of performance status|1|||
170737797|NCT02991482|617047208|FG000|Overall Study|Death prior to study drug initiation|1|||
170737798|NCT02991482|617047209|FG001|Overall Study|Death prior to study drug initiation|0|||
170737799|NCT02991482|617047208|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
170737800|NCT02991482|617047209|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
170737801|NCT05044325|617047210|FG000|Part A:Treatment Period 1|Adverse Event|0|||
170737802|NCT05044325|617047211|FG001|Part A:Treatment Period 1|Adverse Event|0|||
170737803|NCT05044325|617047212|FG002|Part A:Treatment Period 1|Adverse Event|0|||
170737804|NCT05044325|617047213|FG003|Part A:Treatment Period 1|Adverse Event|0|||
170737805|NCT05044325|617047214|FG004|Part A:Treatment Period 1|Adverse Event|0|||
170737806|NCT05044325|617047215|FG005|Part A:Treatment Period 1|Adverse Event|1|||
170737807|NCT05044325|617047216|FG006|Part A:Treatment Period 1|Adverse Event|0|||
170737808|NCT05044325|617047217|FG007|Part A:Treatment Period 1|Adverse Event|1|||
170737809|NCT05044325|617047218|FG008|Part A:Treatment Period 1|Adverse Event|0|||
170737810|NCT05044325|617047219|FG009|Part A:Treatment Period 1|Adverse Event|0|||
170737811|NCT05044325|617047210|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
170737812|NCT05044325|617047211|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
170737813|NCT05044325|617047212|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
170737814|NCT05044325|617047213|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
170845034|NCT03439254|617440946|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
170845035|NCT03439254|617440947|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
170845036|NCT03439254|617440948|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
170845037|NCT03439254|617440949|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
170737815|NCT05044325|617047214|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
170737816|NCT05044325|617047215|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
170737817|NCT05044325|617047216|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
170737818|NCT05044325|617047217|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
170737819|NCT05044325|617047218|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
170737820|NCT05044325|617047219|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
170737821|NCT05044325|617047210|FG000|Part A:Treatment Period 1|Physician Decision|0|||
170737822|NCT05044325|617047211|FG001|Part A:Treatment Period 1|Physician Decision|0|||
170737823|NCT05044325|617047212|FG002|Part A:Treatment Period 1|Physician Decision|0|||
170737824|NCT05044325|617047213|FG003|Part A:Treatment Period 1|Physician Decision|0|||
170737825|NCT05044325|617047214|FG004|Part A:Treatment Period 1|Physician Decision|0|||
170737826|NCT05044325|617047215|FG005|Part A:Treatment Period 1|Physician Decision|0|||
170737827|NCT05044325|617047216|FG006|Part A:Treatment Period 1|Physician Decision|1|||
170737828|NCT05044325|617047217|FG007|Part A:Treatment Period 1|Physician Decision|0|||
170737829|NCT05044325|617047218|FG008|Part A:Treatment Period 1|Physician Decision|0|||
170737830|NCT05044325|617047219|FG009|Part A:Treatment Period 1|Physician Decision|0|||
170737831|NCT05044325|617047210|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737832|NCT05044325|617047211|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737833|NCT05044325|617047212|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
170737834|NCT05044325|617047213|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737835|NCT05044325|617047214|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737836|NCT05044325|617047215|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737837|NCT05044325|617047216|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737838|NCT05044325|617047217|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737839|NCT05044325|617047218|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737840|NCT05044325|617047219|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
170737841|NCT05044325|617047210|FG000|Part A:Treatment Period 2|Adverse Event|0|||
170737842|NCT05044325|617047211|FG001|Part A:Treatment Period 2|Adverse Event|1|||
170737843|NCT05044325|617047212|FG002|Part A:Treatment Period 2|Adverse Event|0|||
170737844|NCT05044325|617047213|FG003|Part A:Treatment Period 2|Adverse Event|0|||
170737845|NCT05044325|617047214|FG004|Part A:Treatment Period 2|Adverse Event|1|||
170737846|NCT05044325|617047215|FG005|Part A:Treatment Period 2|Adverse Event|1|||
170737847|NCT05044325|617047216|FG006|Part A:Treatment Period 2|Adverse Event|0|||
170737848|NCT05044325|617047217|FG007|Part A:Treatment Period 2|Adverse Event|0|||
170737849|NCT05044325|617047218|FG008|Part A:Treatment Period 2|Adverse Event|0|||
170737850|NCT05044325|617047219|FG009|Part A:Treatment Period 2|Adverse Event|0|||
170737851|NCT05044325|617047210|FG000|Part A:Treatment Period 2|Physician Decision|0|||
170737852|NCT05044325|617047211|FG001|Part A:Treatment Period 2|Physician Decision|0|||
170845038|NCT04552899|617440950|FG000|Overall Study|Adverse Event|4|||
170845039|NCT04552899|617440951|FG001|Overall Study|Adverse Event|3|||
170845040|NCT04552899|617440950|FG000|Overall Study|Death|4|||
170845041|NCT04552899|617440951|FG001|Overall Study|Death|4|||
170845042|NCT04552899|617440950|FG000|Overall Study|Lost to Follow-up|8|||
170845043|NCT04552899|617440951|FG001|Overall Study|Lost to Follow-up|13|||
170845044|NCT04552899|617440950|FG000|Overall Study|Lung Transplant|4|||
170845045|NCT04552899|617440951|FG001|Overall Study|Lung Transplant|3|||
170845046|NCT04552899|617440950|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
170845047|NCT04552899|617440951|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
170845048|NCT04552899|617440950|FG000|Overall Study|Physician Decision|3|||
170845049|NCT04552899|617440951|FG001|Overall Study|Physician Decision|4|||
170845050|NCT04552899|617440950|FG000|Overall Study|Study Terminated By Sponsor|237|||
170845051|NCT04552899|617440951|FG001|Overall Study|Study Terminated By Sponsor|239|||
170845052|NCT04552899|617440950|FG000|Overall Study|Withdrawal by Subject|15|||
170845053|NCT04552899|617440951|FG001|Overall Study|Withdrawal by Subject|17|||
170845054|NCT01736189|617440952|FG000|Overall Study|Violation of registration criteria|41|||
170845055|NCT01736189|617440952|FG000|Overall Study|Protocol Violation|4|||
170845056|NCT01736189|617440952|FG000|Overall Study|Criteria and protocol violations|1|||
170845057|NCT01499303|617440953|FG000|Overall Study|Ongoing|2|||
170737853|NCT05044325|617047212|FG002|Part A:Treatment Period 2|Physician Decision|0|||
170845058|NCT01499303|617440954|FG001|Overall Study|Ongoing|1|||
170845059|NCT01499303|617440953|FG000|Overall Study|Withdrawal by Subject|0|||
170845060|NCT01499303|617440954|FG001|Overall Study|Withdrawal by Subject|1|||
170845061|NCT01499303|617440953|FG000|Overall Study|Adverse Event|1|||
170845062|NCT01499303|617440954|FG001|Overall Study|Adverse Event|4|||
170845063|NCT01499303|617440953|FG000|Overall Study|Other|0|||
170845064|NCT01499303|617440954|FG001|Overall Study|Other|1|||
170845065|NCT00461981|617440955|FG000|Overall Study|Lost to Follow-up|9|||
170845066|NCT00461981|617440956|FG001|Overall Study|Lost to Follow-up|6|||
170845067|NCT00461981|617440955|FG000|Overall Study|Withdrawal by Subject|2|||
170845068|NCT00461981|617440956|FG001|Overall Study|Withdrawal by Subject|3|||
170845069|NCT01896557|617440959|FG000|Clopidogrel Alone|Adverse Event|1|||
170845070|NCT01896557|617440960|FG001|Clopidogrel Alone|Adverse Event|0|||
170845071|NCT01896557|617440959|FG000|Clopidogrel + GI Protector|low adherence|1|||
170845072|NCT01896557|617440960|FG001|Clopidogrel + GI Protector|low adherence|1|||
170845073|NCT01896557|617440959|FG000|Clopidogrel + GI Protector|Reading error|1|||
170845074|NCT01896557|617440960|FG001|Clopidogrel + GI Protector|Reading error|3|||
170845075|NCT02383940|617440961|FG000|Overall Study|Adverse Event|1|||
170845076|NCT02383940|617440962|FG001|Overall Study|Adverse Event|0|||
170845077|NCT02383940|617440961|FG000|Overall Study|Lost to Follow-up|2|||
170845078|NCT02383940|617440962|FG001|Overall Study|Lost to Follow-up|2|||
170845079|NCT02383940|617440961|FG000|Overall Study|Physician Decision|2|||
170845080|NCT02383940|617440962|FG001|Overall Study|Physician Decision|0|||
170845081|NCT02383940|617440961|FG000|Overall Study|Withdrawal by Subject|1|||
170845082|NCT02383940|617440962|FG001|Overall Study|Withdrawal by Subject|1|||
170845083|NCT02383940|617440961|FG000|Overall Study|Randomized but not treated|2|||
170845084|NCT02383940|617440962|FG001|Overall Study|Randomized but not treated|0|||
170845085|NCT02383940|617440961|FG000|Overall Study|Other than specified above|1|||
170845086|NCT02383940|617440962|FG001|Overall Study|Other than specified above|0|||
170845087|NCT01517295|617440963|FG000|Overall Study|Physician Decision|1|||
170845088|NCT01517295|617440964|FG001|Overall Study|Physician Decision|0|||
170845089|NCT01353859|617440965|FG000|Overall Study|Adverse Event|3|||
170845090|NCT01353859|617440965|FG000|Overall Study|Lack of Efficacy|1|||
170845091|NCT02672852|617440966|FG000|Part A1|Disease Worsening|1|||
170845092|NCT02672852|617440967|FG001|Part A1|Disease Worsening|0|||
170845093|NCT02672852|617440968|FG002|Part A1|Disease Worsening|0|||
170845094|NCT02672852|617440969|FG003|Part A1|Disease Worsening|0|||
170845095|NCT02672852|617440970|FG004|Part A1|Disease Worsening|0|||
170845096|NCT02672852|617440971|FG005|Part A1|Disease Worsening|0|||
170845097|NCT02672852|617440972|FG006|Part A1|Disease Worsening|0|||
170845098|NCT02672852|617440966|FG000|Part A1|Adverse Event|0|||
170845099|NCT02672852|617440967|FG001|Part A1|Adverse Event|1|||
170845100|NCT02672852|617440968|FG002|Part A1|Adverse Event|0|||
170845101|NCT02672852|617440969|FG003|Part A1|Adverse Event|0|||
170845102|NCT02672852|617440970|FG004|Part A1|Adverse Event|0|||
170845103|NCT02672852|617440971|FG005|Part A1|Adverse Event|0|||
170845104|NCT02672852|617440972|FG006|Part A1|Adverse Event|0|||
170845105|NCT02672852|617440966|FG000|Part A1|Lost to Follow-up|1|||
170845106|NCT02672852|617440967|FG001|Part A1|Lost to Follow-up|2|||
170845107|NCT02672852|617440968|FG002|Part A1|Lost to Follow-up|0|||
170845108|NCT02672852|617440969|FG003|Part A1|Lost to Follow-up|0|||
170845109|NCT02672852|617440970|FG004|Part A1|Lost to Follow-up|0|||
170845110|NCT02672852|617440971|FG005|Part A1|Lost to Follow-up|0|||
170845111|NCT02672852|617440972|FG006|Part A1|Lost to Follow-up|0|||
170845112|NCT02672852|617440966|FG000|Part A1|Withdrawal by Subject|1|||
170845113|NCT02672852|617440967|FG001|Part A1|Withdrawal by Subject|1|||
170845114|NCT02672852|617440968|FG002|Part A1|Withdrawal by Subject|0|||
170845115|NCT02672852|617440969|FG003|Part A1|Withdrawal by Subject|0|||
170845116|NCT02672852|617440970|FG004|Part A1|Withdrawal by Subject|0|||
170845117|NCT02672852|617440971|FG005|Part A1|Withdrawal by Subject|0|||
170845118|NCT02672852|617440972|FG006|Part A1|Withdrawal by Subject|0|||
170845119|NCT02672852|617440966|FG000|Part A2|Disease worsening|0|||
170845120|NCT02672852|617440967|FG001|Part A2|Disease worsening|0|||
170845121|NCT02672852|617440968|FG002|Part A2|Disease worsening|1|||
170845122|NCT02672852|617440969|FG003|Part A2|Disease worsening|0|||
170845123|NCT02672852|617440970|FG004|Part A2|Disease worsening|0|||
170845124|NCT02672852|617440971|FG005|Part A2|Disease worsening|0|||
170845125|NCT02672852|617440972|FG006|Part A2|Disease worsening|0|||
170845126|NCT02672852|617440966|FG000|Part A2|Adverse Event|0|||
170845127|NCT02672852|617440967|FG001|Part A2|Adverse Event|0|||
170845128|NCT02672852|617440968|FG002|Part A2|Adverse Event|3|||
170845129|NCT02672852|617440969|FG003|Part A2|Adverse Event|0|||
170845130|NCT02672852|617440970|FG004|Part A2|Adverse Event|0|||
170845131|NCT02672852|617440971|FG005|Part A2|Adverse Event|0|||
170845132|NCT02672852|617440972|FG006|Part A2|Adverse Event|0|||
170845133|NCT02672852|617440966|FG000|Part A2|Lost to Follow-up|0|||
170845134|NCT02672852|617440967|FG001|Part A2|Lost to Follow-up|0|||
170845135|NCT02672852|617440968|FG002|Part A2|Lost to Follow-up|2|||
170845136|NCT02672852|617440969|FG003|Part A2|Lost to Follow-up|0|||
170845137|NCT02672852|617440970|FG004|Part A2|Lost to Follow-up|0|||
170845138|NCT02672852|617440971|FG005|Part A2|Lost to Follow-up|0|||
170845139|NCT02672852|617440972|FG006|Part A2|Lost to Follow-up|0|||
170845140|NCT02672852|617440966|FG000|Part A2|Withdrawal by Subject|0|||
170845141|NCT02672852|617440967|FG001|Part A2|Withdrawal by Subject|0|||
170845142|NCT02672852|617440968|FG002|Part A2|Withdrawal by Subject|1|||
170845143|NCT02672852|617440969|FG003|Part A2|Withdrawal by Subject|0|||
170737854|NCT05044325|617047213|FG003|Part A:Treatment Period 2|Physician Decision|0|||
170737855|NCT05044325|617047214|FG004|Part A:Treatment Period 2|Physician Decision|0|||
170737856|NCT05044325|617047215|FG005|Part A:Treatment Period 2|Physician Decision|1|||
170737857|NCT05044325|617047216|FG006|Part A:Treatment Period 2|Physician Decision|0|||
170737858|NCT05044325|617047217|FG007|Part A:Treatment Period 2|Physician Decision|0|||
170737859|NCT05044325|617047218|FG008|Part A:Treatment Period 2|Physician Decision|0|||
170737860|NCT05044325|617047219|FG009|Part A:Treatment Period 2|Physician Decision|0|||
170737861|NCT05044325|617047210|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
170737862|NCT05044325|617047211|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
170737863|NCT05044325|617047212|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
170737864|NCT05044325|617047213|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
170737865|NCT05044325|617047214|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
170737866|NCT05044325|617047215|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
170737867|NCT05044325|617047216|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
170737868|NCT05044325|617047217|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
170737869|NCT05044325|617047218|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
170737870|NCT05044325|617047219|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
170737871|NCT01250119|617047222|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
170737872|NCT01250119|617047223|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
170737873|NCT01250119|617047222|FG000|Diagnostic Phase|Participants Not Tested|44|||
170737874|NCT01250119|617047223|FG001|Diagnostic Phase|Participants Not Tested|0|||
170737875|NCT01250119|617047222|FG000|Treatment Phase|Progressive Disease|0|||
170737876|NCT01250119|617047223|FG001|Treatment Phase|Progressive Disease|32|||
170737877|NCT01250119|617047222|FG000|Treatment Phase|Death|0|||
170737878|NCT01250119|617047223|FG001|Treatment Phase|Death|2|||
170737879|NCT01250119|617047222|FG000|Treatment Phase|Withdrawal by Subject|0|||
170845144|NCT02672852|617440970|FG004|Part A2|Withdrawal by Subject|0|||
170845145|NCT02672852|617440971|FG005|Part A2|Withdrawal by Subject|0|||
170845146|NCT02672852|617440972|FG006|Part A2|Withdrawal by Subject|0|||
170845147|NCT02672852|617440966|FG000|Part A2|Other|0|||
170845148|NCT02672852|617440967|FG001|Part A2|Other|0|||
170845149|NCT02672852|617440968|FG002|Part A2|Other|3|||
170845150|NCT02672852|617440969|FG003|Part A2|Other|0|||
170845151|NCT02672852|617440970|FG004|Part A2|Other|0|||
170845152|NCT02672852|617440971|FG005|Part A2|Other|0|||
170845153|NCT02672852|617440972|FG006|Part A2|Other|0|||
170845154|NCT02672852|617440966|FG000|Part A2|Not entered in Part B|0|||
170845155|NCT02672852|617440967|FG001|Part A2|Not entered in Part B|0|||
170845156|NCT02672852|617440968|FG002|Part A2|Not entered in Part B|0|||
170845157|NCT02672852|617440969|FG003|Part A2|Not entered in Part B|4|||
170845158|NCT02672852|617440970|FG004|Part A2|Not entered in Part B|0|||
170845159|NCT02672852|617440971|FG005|Part A2|Not entered in Part B|0|||
170845160|NCT02672852|617440972|FG006|Part A2|Not entered in Part B|0|||
170845161|NCT02672852|617440966|FG000|Part B|Disease worsening|0|||
170845162|NCT02672852|617440967|FG001|Part B|Disease worsening|0|||
170845163|NCT02672852|617440968|FG002|Part B|Disease worsening|0|||
170845164|NCT02672852|617440969|FG003|Part B|Disease worsening|0|||
170845165|NCT02672852|617440970|FG004|Part B|Disease worsening|1|||
170845166|NCT02672852|617440971|FG005|Part B|Disease worsening|0|||
170845167|NCT02672852|617440972|FG006|Part B|Disease worsening|1|||
170845168|NCT02672852|617440966|FG000|Part B|Worsening pre-existing condition|0|||
170845169|NCT02672852|617440967|FG001|Part B|Worsening pre-existing condition|0|||
170845170|NCT02672852|617440968|FG002|Part B|Worsening pre-existing condition|0|||
170845171|NCT02672852|617440969|FG003|Part B|Worsening pre-existing condition|0|||
170845172|NCT02672852|617440970|FG004|Part B|Worsening pre-existing condition|0|||
170845173|NCT02672852|617440971|FG005|Part B|Worsening pre-existing condition|1|||
170845174|NCT02672852|617440972|FG006|Part B|Worsening pre-existing condition|0|||
170845175|NCT02672852|617440966|FG000|Part B|Other adverse event|0|||
170845176|NCT02672852|617440967|FG001|Part B|Other adverse event|0|||
170845177|NCT02672852|617440968|FG002|Part B|Other adverse event|0|||
170845178|NCT02672852|617440969|FG003|Part B|Other adverse event|0|||
170845179|NCT02672852|617440970|FG004|Part B|Other adverse event|3|||
170845180|NCT02672852|617440971|FG005|Part B|Other adverse event|5|||
170845181|NCT02672852|617440972|FG006|Part B|Other adverse event|1|||
170845182|NCT02672852|617440966|FG000|Part B|Lost to Follow-up|0|||
170845183|NCT02672852|617440967|FG001|Part B|Lost to Follow-up|0|||
170845184|NCT02672852|617440968|FG002|Part B|Lost to Follow-up|0|||
170845185|NCT02672852|617440969|FG003|Part B|Lost to Follow-up|0|||
170845186|NCT02672852|617440970|FG004|Part B|Lost to Follow-up|3|||
170845187|NCT02672852|617440971|FG005|Part B|Lost to Follow-up|4|||
170845188|NCT02672852|617440972|FG006|Part B|Lost to Follow-up|1|||
170845189|NCT02672852|617440966|FG000|Part B|Withdrawal by Subject|0|||
170845190|NCT02672852|617440967|FG001|Part B|Withdrawal by Subject|0|||
170845191|NCT02672852|617440968|FG002|Part B|Withdrawal by Subject|0|||
170845192|NCT02672852|617440969|FG003|Part B|Withdrawal by Subject|0|||
170845193|NCT02672852|617440970|FG004|Part B|Withdrawal by Subject|5|||
170845194|NCT02672852|617440971|FG005|Part B|Withdrawal by Subject|0|||
170845195|NCT02672852|617440972|FG006|Part B|Withdrawal by Subject|7|||
170845196|NCT02672852|617440966|FG000|Part B|Other|0|||
170845197|NCT02672852|617440967|FG001|Part B|Other|0|||
170845198|NCT02672852|617440968|FG002|Part B|Other|0|||
170845199|NCT02672852|617440969|FG003|Part B|Other|0|||
170845200|NCT02672852|617440970|FG004|Part B|Other|4|||
170845201|NCT02672852|617440971|FG005|Part B|Other|1|||
170845202|NCT02672852|617440972|FG006|Part B|Other|2|||
170845203|NCT00565773|617440975|FG000|Overall Study|Withdrawal by Subject|1|||
170845204|NCT00565773|617440975|FG000|Overall Study|Physician Decision|1|||
170845205|NCT03853551|617440976|FG000|Overall Study|Death|2|||
170845206|NCT03853551|617440976|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
170845207|NCT01725126|617440977|FG000|Overall Study|Protocol Violation|0|||
170845208|NCT01725126|617440978|FG001|Overall Study|Protocol Violation|1|||
170845209|NCT01725126|617440979|FG002|Overall Study|Protocol Violation|0|||
170845210|NCT01725126|617440980|FG003|Overall Study|Protocol Violation|0|||
170845211|NCT01725126|617440981|FG004|Overall Study|Protocol Violation|0|||
170845212|NCT01725126|617440982|FG005|Overall Study|Protocol Violation|0|||
170845213|NCT01725126|617440977|FG000|Overall Study|Withdrawal by Subject|0|||
170845214|NCT01725126|617440978|FG001|Overall Study|Withdrawal by Subject|0|||
170845215|NCT01725126|617440979|FG002|Overall Study|Withdrawal by Subject|0|||
170845216|NCT01725126|617440980|FG003|Overall Study|Withdrawal by Subject|1|||
170845217|NCT01725126|617440981|FG004|Overall Study|Withdrawal by Subject|0|||
170845218|NCT01725126|617440982|FG005|Overall Study|Withdrawal by Subject|0|||
170845219|NCT03031496|617440985|FG000|Period 1|Adverse Event|2|||
170845220|NCT03031496|617440986|FG001|Period 1|Adverse Event|0|||
170845221|NCT03031496|617440985|FG000|Period 1|Withdrawal by Subject|0|||
170845222|NCT03031496|617440986|FG001|Period 1|Withdrawal by Subject|2|||
170845223|NCT01240915|617440987|FG000|Overall Study|Adverse Event|0|||
170845224|NCT01240915|617440988|FG001|Overall Study|Adverse Event|0|||
170845225|NCT01240915|617440989|FG002|Overall Study|Adverse Event|0|||
170845226|NCT01240915|617440990|FG003|Overall Study|Adverse Event|1|||
170845227|NCT01240915|617440991|FG004|Overall Study|Adverse Event|0|||
170845228|NCT01240915|617440992|FG005|Overall Study|Adverse Event|2|||
170845229|NCT01240915|617440993|FG006|Overall Study|Adverse Event|0|||
170845230|NCT01240915|617440994|FG007|Overall Study|Adverse Event|0|||
170845231|NCT01240915|617440995|FG008|Overall Study|Adverse Event|1|||
170845232|NCT01240915|617440987|FG000|Overall Study|Lost to Follow-up|0|||
170845233|NCT01240915|617440988|FG001|Overall Study|Lost to Follow-up|0|||
170845234|NCT01240915|617440989|FG002|Overall Study|Lost to Follow-up|0|||
170845235|NCT01240915|617440990|FG003|Overall Study|Lost to Follow-up|0|||
170845236|NCT01240915|617440991|FG004|Overall Study|Lost to Follow-up|1|||
170845237|NCT01240915|617440992|FG005|Overall Study|Lost to Follow-up|1|||
170845238|NCT01240915|617440993|FG006|Overall Study|Lost to Follow-up|0|||
170845239|NCT01240915|617440994|FG007|Overall Study|Lost to Follow-up|1|||
170845240|NCT01240915|617440995|FG008|Overall Study|Lost to Follow-up|1|||
170845241|NCT01240915|617440987|FG000|Overall Study|Withdrawal by Subject|2|||
170845242|NCT01240915|617440988|FG001|Overall Study|Withdrawal by Subject|1|||
170845243|NCT01240915|617440989|FG002|Overall Study|Withdrawal by Subject|0|||
170845244|NCT01240915|617440990|FG003|Overall Study|Withdrawal by Subject|2|||
170845245|NCT01240915|617440991|FG004|Overall Study|Withdrawal by Subject|0|||
170845246|NCT01240915|617440992|FG005|Overall Study|Withdrawal by Subject|4|||
170845247|NCT01240915|617440993|FG006|Overall Study|Withdrawal by Subject|2|||
170845248|NCT01240915|617440994|FG007|Overall Study|Withdrawal by Subject|3|||
170845249|NCT01240915|617440995|FG008|Overall Study|Withdrawal by Subject|3|||
170845250|NCT01240915|617440987|FG000|Overall Study|Other|0|||
170845251|NCT01240915|617440988|FG001|Overall Study|Other|0|||
170845252|NCT01240915|617440989|FG002|Overall Study|Other|0|||
170845253|NCT01240915|617440990|FG003|Overall Study|Other|0|||
170845254|NCT01240915|617440991|FG004|Overall Study|Other|2|||
170845255|NCT01240915|617440992|FG005|Overall Study|Other|0|||
170845256|NCT01240915|617440993|FG006|Overall Study|Other|0|||
170845257|NCT01240915|617440994|FG007|Overall Study|Other|0|||
170845258|NCT01240915|617440995|FG008|Overall Study|Other|0|||
170845259|NCT01240915|617440987|FG000|Overall Study|Insufficient Clinical Response|0|||
170845260|NCT01240915|617440988|FG001|Overall Study|Insufficient Clinical Response|0|||
170845261|NCT01240915|617440989|FG002|Overall Study|Insufficient Clinical Response|0|||
170845262|NCT01240915|617440990|FG003|Overall Study|Insufficient Clinical Response|0|||
170845263|NCT01240915|617440991|FG004|Overall Study|Insufficient Clinical Response|1|||
170845264|NCT01240915|617440992|FG005|Overall Study|Insufficient Clinical Response|3|||
170845265|NCT01240915|617440993|FG006|Overall Study|Insufficient Clinical Response|6|||
170845266|NCT01240915|617440994|FG007|Overall Study|Insufficient Clinical Response|0|||
170845267|NCT01240915|617440995|FG008|Overall Study|Insufficient Clinical Response|3|||
170845268|NCT02440425|617440997|FG000|Overall Study|Death likely due to disease progression|1|||
170845269|NCT02440425|617440997|FG000|Overall Study|Withdrawal by Subject|2|||
170845270|NCT02440425|617440997|FG000|Overall Study|Adverse Event|1|||
170845271|NCT02440425|617440997|FG000|Overall Study|Adverse Event/Ineligible|1|||
170845272|NCT01677767|617440999|FG000|Overall Study|Adverse Event|1|||
170845273|NCT01677767|617440999|FG000|Overall Study|Death|4|||
170845274|NCT01677767|617440999|FG000|Overall Study|Protocol Violation|4|||
170845275|NCT01677767|617440999|FG000|Overall Study|Withdrawal by Subject|10|||
170845276|NCT01677767|617440999|FG000|Overall Study|Non-compliance by the participants|3|||
170845277|NCT00842244|617441000|FG000|Overall Study|Death|3|||
170737880|NCT01250119|617047223|FG001|Treatment Phase|Withdrawal by Subject|1|||
170737881|NCT01250119|617047222|FG000|Treatment Phase|Adverse Event|0|||
170737882|NCT01250119|617047223|FG001|Treatment Phase|Adverse Event|2|||
170737883|NCT01250119|617047222|FG000|Treatment Phase|Unknown reason|0|||
170845278|NCT00842244|617441000|FG000|Overall Study|Withdrawal by Subject|1|||
170845279|NCT00842244|617441000|FG000|Overall Study|Other|17|||
170737884|NCT01250119|617047223|FG001|Treatment Phase|Unknown reason|4|||
170737885|NCT02887989|617047230|FG000|Overall Study|Withdrawal by Subject|8|||
170737886|NCT02887989|617047231|FG001|Overall Study|Withdrawal by Subject|11|||
170737887|NCT02887989|617047230|FG000|Overall Study|Death|1|||
170737888|NCT02887989|617047231|FG001|Overall Study|Death|0|||
170737889|NCT00768430|617047233|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
170737890|NCT00768430|617047234|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
170737891|NCT00432835|617047237|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
170737892|NCT00432835|617047238|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
170737893|NCT02045433|617047244|FG000|Overall Study|Withdrawal by Subject|1|||
170737894|NCT00041756|617047245|FG000|Overall Study|Adverse Event|4|||
170845280|NCT02636725|617441009|FG000|Overall Study|Adverse Event|1|||
170845281|NCT01162863|617441010|FG000|Overall Study|Lack of Efficacy|1|||
170845282|NCT01162863|617441011|FG001|Overall Study|Lack of Efficacy|0|||
170845283|NCT01162863|617441012|FG002|Overall Study|Lack of Efficacy|0|||
170845284|NCT01162863|617441010|FG000|Overall Study|Adverse Event|0|||
170845285|NCT01162863|617441011|FG001|Overall Study|Adverse Event|1|||
170845286|NCT01162863|617441012|FG002|Overall Study|Adverse Event|0|||
170845287|NCT00392925|617441013|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
170845288|NCT00392925|617441014|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
170845289|NCT00392925|617441015|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
170845290|NCT00392925|617441016|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
170845291|NCT00392925|617441013|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
170845292|NCT00392925|617441014|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
170845293|NCT00392925|617441015|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
170845294|NCT00392925|617441016|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
170845295|NCT00392925|617441013|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
170845296|NCT00392925|617441014|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
170845297|NCT00392925|617441015|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
170845298|NCT00392925|617441016|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
170845299|NCT00392925|617441013|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
170845300|NCT00392925|617441014|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
170845301|NCT00392925|617441015|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
170845302|NCT00392925|617441016|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
170845303|NCT00392925|617441013|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
170845304|NCT00392925|617441014|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
170845305|NCT00392925|617441015|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
170845306|NCT00392925|617441016|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
170845307|NCT00392925|617441013|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
170845308|NCT00392925|617441014|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
170845309|NCT00392925|617441015|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
170845310|NCT00392925|617441016|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
170845311|NCT00392925|617441013|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
170845312|NCT00392925|617441014|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
170845313|NCT00392925|617441015|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
170845314|NCT00392925|617441016|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
170845315|NCT00392925|617441013|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
170845316|NCT00392925|617441014|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
170845317|NCT00392925|617441015|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
170845318|NCT00392925|617441016|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
170845319|NCT00392925|617441013|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
170845320|NCT00392925|617441014|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
170845321|NCT00392925|617441015|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
170845322|NCT00392925|617441016|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
170845323|NCT03552523|617441017|FG000|Overall Study|Withdrawal by Subject|1|||
170845324|NCT03552523|617441018|FG001|Overall Study|Withdrawal by Subject|1|||
170845325|NCT03525392|617441021|FG000|Overall Study|Adverse Event|1|||
170845326|NCT03525392|617441022|FG001|Overall Study|Adverse Event|0|||
170845327|NCT03525392|617441023|FG002|Overall Study|Adverse Event|2|||
170845328|NCT03525392|617441024|FG003|Overall Study|Adverse Event|0|||
170737895|NCT00041756|617047246|FG001|Overall Study|Adverse Event|10|||
170737896|NCT00041756|617047247|FG002|Overall Study|Adverse Event|6|||
170737897|NCT00041756|617047248|FG003|Overall Study|Adverse Event|11|||
170737898|NCT00041756|617047249|FG004|Overall Study|Adverse Event|34|||
170737899|NCT00041756|617047245|FG000|Overall Study|Protocol Violation|1|||
170737900|NCT00041756|617047246|FG001|Overall Study|Protocol Violation|1|||
170737901|NCT00041756|617047247|FG002|Overall Study|Protocol Violation|2|||
170737902|NCT00041756|617047248|FG003|Overall Study|Protocol Violation|2|||
170737903|NCT00041756|617047249|FG004|Overall Study|Protocol Violation|1|||
170737904|NCT00041756|617047245|FG000|Overall Study|Withdrawal by Subject|3|||
170737905|NCT00041756|617047246|FG001|Overall Study|Withdrawal by Subject|3|||
170737906|NCT00041756|617047247|FG002|Overall Study|Withdrawal by Subject|4|||
170737907|NCT00041756|617047248|FG003|Overall Study|Withdrawal by Subject|2|||
170737908|NCT00041756|617047249|FG004|Overall Study|Withdrawal by Subject|3|||
170737909|NCT00041756|617047245|FG000|Overall Study|Lost to Follow-up|0|||
170737910|NCT00041756|617047246|FG001|Overall Study|Lost to Follow-up|1|||
170737911|NCT00041756|617047247|FG002|Overall Study|Lost to Follow-up|0|||
170737912|NCT00041756|617047248|FG003|Overall Study|Lost to Follow-up|1|||
170845329|NCT03525392|617441025|FG004|Overall Study|Adverse Event|0|||
170845330|NCT03525392|617441021|FG000|Overall Study|Progressive disease|0|||
170845331|NCT03525392|617441022|FG001|Overall Study|Progressive disease|1|||
170845332|NCT03525392|617441023|FG002|Overall Study|Progressive disease|1|||
170845333|NCT03525392|617441024|FG003|Overall Study|Progressive disease|3|||
170845334|NCT03525392|617441025|FG004|Overall Study|Progressive disease|1|||
170845335|NCT01669577|617441031|FG000|Overall Study|Death|22|||
170845336|NCT01669577|617441031|FG000|Overall Study|Lost to Follow-up|78|||
170845337|NCT01669577|617441031|FG000|Overall Study|Physician Decision|34|||
170845338|NCT04462289|617441034|FG000|Overall Study|Lost to Follow-up|4|||
170845339|NCT04462289|617441035|FG001|Overall Study|Lost to Follow-up|5|||
170845340|NCT04462289|617441034|FG000|Overall Study|Death|0|||
170845341|NCT04462289|617441035|FG001|Overall Study|Death|3|||
170845342|NCT04462289|617441034|FG000|Overall Study|Withdrawal by Subject|1|||
170845343|NCT04462289|617441035|FG001|Overall Study|Withdrawal by Subject|3|||
170845344|NCT00818779|617441036|FG000|Overall Study|Protocol Violation|1|||
170845345|NCT00818779|617441037|FG001|Overall Study|Protocol Violation|0|||
170845346|NCT00818779|617441036|FG000|Overall Study|Lost to Follow-up|1|||
170845347|NCT00818779|617441037|FG001|Overall Study|Lost to Follow-up|0|||
170845348|NCT00818779|617441036|FG000|Overall Study|Adverse Event|4|||
170845349|NCT00818779|617441037|FG001|Overall Study|Adverse Event|1|||
170845350|NCT01518153|617441038|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
170845351|NCT01518153|617441039|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
170845352|NCT01518153|617441040|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
170845353|NCT01518153|617441038|FG000|Stem Cell Transplant|Death|2|||
170845354|NCT01518153|617441039|FG001|Stem Cell Transplant|Death|0|||
170845355|NCT01518153|617441040|FG002|Stem Cell Transplant|Death|0|||
170845356|NCT01518153|617441038|FG000|Stem Cell Transplant|Secondary graft failure|1|||
170845357|NCT01518153|617441039|FG001|Stem Cell Transplant|Secondary graft failure|0|||
170845358|NCT01518153|617441040|FG002|Stem Cell Transplant|Secondary graft failure|0|||
170845359|NCT01518153|617441038|FG000|Stem Cell Transplant|Adverse Event|1|||
170845360|NCT01518153|617441039|FG001|Stem Cell Transplant|Adverse Event|0|||
170845361|NCT01518153|617441040|FG002|Stem Cell Transplant|Adverse Event|0|||
170845362|NCT01518153|617441038|FG000|Donor Lymphocyte Infusion|Death|0|||
170845363|NCT01518153|617441039|FG001|Donor Lymphocyte Infusion|Death|2|||
170845364|NCT01518153|617441040|FG002|Donor Lymphocyte Infusion|Death|1|||
170845365|NCT00132873|617441041|FG000|Overall Study|Adverse Event|3|||
170845366|NCT00132873|617441041|FG000|Overall Study|Lost to Follow-up|1|||
170845367|NCT00132873|617441041|FG000|Overall Study|Lack of Efficacy|1|||
170845368|NCT00132873|617441041|FG000|Overall Study|Withdrawal by Subject|3|||
170845369|NCT00132873|617441041|FG000|Overall Study|Planned Pregnancy|1|||
170845370|NCT00316017|617441048|FG000|Overall Study|Protocol Violation|11|||
170845371|NCT00316017|617441049|FG001|Overall Study|Protocol Violation|13|||
170845372|NCT00316017|617441050|FG002|Overall Study|Protocol Violation|19|||
170845373|NCT04157400|617441051|FG000|Overall Study|Withdrawal by Subject|1|||
170845374|NCT04157400|617441051|FG000|Overall Study|Lost to Follow-up|3|||
170845375|NCT03361865|617441054|FG000|Overall Study|Death|17|||
170845376|NCT03361865|617441055|FG001|Overall Study|Death|18|||
170845377|NCT03361865|617441054|FG000|Overall Study|Physician Decision|1|||
170845378|NCT03361865|617441055|FG001|Overall Study|Physician Decision|9|||
170845379|NCT03361865|617441054|FG000|Overall Study|Withdrawal by Subject|1|||
170845380|NCT03361865|617441055|FG001|Overall Study|Withdrawal by Subject|0|||
170845381|NCT03852719|617441056|FG000|Overall Study|Withdrawal of consent|8|||
170845382|NCT03852719|617441057|FG001|Overall Study|Withdrawal of consent|8|||
170845383|NCT03852719|617441058|FG002|Overall Study|Withdrawal of consent|9|||
170737913|NCT00041756|617047249|FG004|Overall Study|Lost to Follow-up|0|||
170737914|NCT00041756|617047245|FG000|Overall Study|Unable to meet protocol criteria|0|||
170737915|NCT00041756|617047246|FG001|Overall Study|Unable to meet protocol criteria|0|||
170737916|NCT00041756|617047247|FG002|Overall Study|Unable to meet protocol criteria|1|||
170845384|NCT03852719|617441056|FG000|Overall Study|Physician Decision|5|||
170845385|NCT03852719|617441057|FG001|Overall Study|Physician Decision|4|||
170845386|NCT03852719|617441058|FG002|Overall Study|Physician Decision|1|||
170845387|NCT03852719|617441056|FG000|Overall Study|Pregnancy|2|||
170845388|NCT03852719|617441057|FG001|Overall Study|Pregnancy|1|||
170845389|NCT03852719|617441058|FG002|Overall Study|Pregnancy|0|||
170845390|NCT03852719|617441056|FG000|Overall Study|Death|1|||
170845391|NCT03852719|617441057|FG001|Overall Study|Death|0|||
170845392|NCT03852719|617441058|FG002|Overall Study|Death|0|||
170845393|NCT03852719|617441056|FG000|Overall Study|Reason not Specified|3|||
170845394|NCT03852719|617441057|FG001|Overall Study|Reason not Specified|3|||
170845395|NCT03852719|617441058|FG002|Overall Study|Reason not Specified|5|||
170845396|NCT03852719|617441056|FG000|Overall Study|Adverse Event|2|||
170845397|NCT03852719|617441057|FG001|Overall Study|Adverse Event|1|||
170845398|NCT03852719|617441058|FG002|Overall Study|Adverse Event|4|||
170845399|NCT03852719|617441056|FG000|Overall Study|Progressive disease|1|||
170845400|NCT03852719|617441057|FG001|Overall Study|Progressive disease|4|||
170845401|NCT03852719|617441058|FG002|Overall Study|Progressive disease|1|||
170845402|NCT03852719|617441056|FG000|Overall Study|Lost to Follow-up|1|||
170845403|NCT03852719|617441057|FG001|Overall Study|Lost to Follow-up|0|||
170845404|NCT03852719|617441058|FG002|Overall Study|Lost to Follow-up|0|||
170845405|NCT04201262|617441061|FG000|Primary Treatment Period|Adverse Event|1|||
170845406|NCT04201262|617441062|FG001|Primary Treatment Period|Adverse Event|2|||
170845407|NCT04201262|617441061|FG000|Primary Treatment Period|Physician Decision|1|||
170845408|NCT04201262|617441062|FG001|Primary Treatment Period|Physician Decision|1|||
170845409|NCT04201262|617441061|FG000|Long-term Extension Period|Death|1|||
170845410|NCT04201262|617441062|FG001|Long-term Extension Period|Death|0|||
170845411|NCT02819024|617441064|FG000|Overall Study|Withdrawal by Subject|1|||
170845412|NCT03007420|617441068|FG000|Overall Study|Withdrawal by Subject|0|||
170845413|NCT03007420|617441069|FG001|Overall Study|Withdrawal by Subject|2|||
170845414|NCT03007420|617441068|FG000|Overall Study|Physician Decision|0|||
170845415|NCT03007420|617441069|FG001|Overall Study|Physician Decision|1|||
170845416|NCT02284009|617441070|FG000|Overall Study|Adverse Event|3|||
170845417|NCT02284009|617441071|FG001|Overall Study|Adverse Event|0|||
170845418|NCT02284009|617441070|FG000|Overall Study|Lost to Follow-up|1|||
170845419|NCT02284009|617441071|FG001|Overall Study|Lost to Follow-up|3|||
170845420|NCT02284009|617441070|FG000|Overall Study|Physician Decision|0|||
170845421|NCT02284009|617441071|FG001|Overall Study|Physician Decision|2|||
170845422|NCT02284009|617441070|FG000|Overall Study|Withdrawal by Subject|2|||
170845423|NCT02284009|617441071|FG001|Overall Study|Withdrawal by Subject|5|||
170845424|NCT04147195|617441075|FG000|Overall Study|Adverse Event|0|||
170845425|NCT04147195|617441076|FG001|Overall Study|Adverse Event|3|||
170845426|NCT04147195|617441075|FG000|Overall Study|Study Terminated by Sponsor|4|||
170845427|NCT04147195|617441076|FG001|Overall Study|Study Terminated by Sponsor|2|||
170845428|NCT04147195|617441075|FG000|Overall Study|Withdrawal by Subject|0|||
170845429|NCT04147195|617441076|FG001|Overall Study|Withdrawal by Subject|1|||
170845430|NCT03841526|617441077|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
170845431|NCT03841526|617441078|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
170845432|NCT03841526|617441079|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
170845433|NCT03841526|617441080|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
170845434|NCT03841526|617441081|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
170845435|NCT03841526|617441082|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
170845436|NCT03841526|617441077|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
170845437|NCT03841526|617441078|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
170845438|NCT03841526|617441079|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
170845439|NCT03841526|617441080|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
170845440|NCT03841526|617441081|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
170845441|NCT03841526|617441082|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
170845442|NCT03841526|617441077|FG000|Outpatient Phase Treatment|Physician Decision|0|||
170845443|NCT03841526|617441078|FG001|Outpatient Phase Treatment|Physician Decision|1|||
170845444|NCT03841526|617441079|FG002|Outpatient Phase Treatment|Physician Decision|0|||
170845445|NCT03841526|617441080|FG003|Outpatient Phase Treatment|Physician Decision|0|||
170845446|NCT03841526|617441081|FG004|Outpatient Phase Treatment|Physician Decision|0|||
170845447|NCT03841526|617441082|FG005|Outpatient Phase Treatment|Physician Decision|0|||
170845448|NCT03841526|617441077|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
170845449|NCT03841526|617441078|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
170845450|NCT03841526|617441079|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
170845451|NCT03841526|617441080|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
170845452|NCT03841526|617441081|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
170845453|NCT03841526|617441082|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
170845454|NCT07149155|617441085|FG000|Overall Study|Lost to Follow-up|10|||
170845455|NCT03345576|617441086|FG000|Overall Study|Withdrawal by Subject|2|||
170845456|NCT03345576|617441087|FG001|Overall Study|Withdrawal by Subject|2|||
170845457|NCT03345576|617441086|FG000|Overall Study|Adverse Event|1|||
170845458|NCT03345576|617441087|FG001|Overall Study|Adverse Event|0|||
170845459|NCT01099215|617442623|FG000|Overall Study|Withdrawal by Subject|1|||
170845460|NCT01099215|617442624|FG001|Overall Study|Withdrawal by Subject|0|||
170845461|NCT01099215|617442623|FG000|Overall Study|Adverse Event|0|||
170845462|NCT01099215|617442624|FG001|Overall Study|Adverse Event|1|||
170845463|NCT00387426|617442625|FG000|Overall Study|Lack of Response|7|||
170845464|NCT00387426|617442625|FG000|Overall Study|Toxicities|4|||
170845465|NCT00387426|617442625|FG000|Overall Study|Disease Progression|3|||
170845466|NCT02314780|617442626|FG000|Overall Study|organizational reasons|0|||
170845467|NCT02314780|617442627|FG001|Overall Study|organizational reasons|2|||
170845468|NCT02314780|617442628|FG002|Overall Study|organizational reasons|0|||
170845469|NCT02314780|617442626|FG000|Overall Study|Adverse Event|0|||
170845470|NCT02314780|617442627|FG001|Overall Study|Adverse Event|1|||
170845471|NCT02314780|617442628|FG002|Overall Study|Adverse Event|0|||
170845472|NCT04684394|617442631|FG000|Overall Study|Death|1|||
170845473|NCT04684394|617442632|FG001|Overall Study|Death|2|||
170845474|NCT04684394|617442631|FG000|Overall Study|Lost to Follow-up|1|||
170845475|NCT04684394|617442632|FG001|Overall Study|Lost to Follow-up|0|||
170845476|NCT04684394|617442631|FG000|Overall Study|Withdrawal by Subject|2|||
170845477|NCT04684394|617442632|FG001|Overall Study|Withdrawal by Subject|0|||
170845478|NCT04684394|617442631|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
170845479|NCT04684394|617442632|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
170845480|NCT03986944|617442633|FG000|Overall Study|Adverse Event|1|||
170845481|NCT03986944|617442634|FG001|Overall Study|Adverse Event|2|||
170845482|NCT03986944|617442635|FG002|Overall Study|Adverse Event|3|||
170845483|NCT03986944|617442633|FG000|Overall Study|Protocol Violation|0|||
170845484|NCT03986944|617442634|FG001|Overall Study|Protocol Violation|1|||
170845485|NCT03986944|617442635|FG002|Overall Study|Protocol Violation|1|||
170845486|NCT03986944|617442633|FG000|Overall Study|Withdrawal by Subject|3|||
170845487|NCT03986944|617442634|FG001|Overall Study|Withdrawal by Subject|5|||
170845488|NCT03986944|617442635|FG002|Overall Study|Withdrawal by Subject|5|||
170845489|NCT03986944|617442633|FG000|Overall Study|Study termination|10|||
170845490|NCT03986944|617442634|FG001|Overall Study|Study termination|10|||
170845491|NCT03986944|617442635|FG002|Overall Study|Study termination|10|||
170845492|NCT03986944|617442633|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
170845493|NCT03986944|617442634|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
170845494|NCT03986944|617442635|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
170845495|NCT03986944|617442633|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
170845496|NCT03986944|617442634|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
170845497|NCT03986944|617442635|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
170845498|NCT00568178|617442638|FG000|Double Blind Base Study|Adverse Event|0|||
170845499|NCT00568178|617442639|FG001|Double Blind Base Study|Adverse Event|2|||
170845500|NCT00568178|617442640|FG002|Double Blind Base Study|Adverse Event|1|||
170845501|NCT00568178|617442641|FG003|Double Blind Base Study|Adverse Event|2|||
170845502|NCT00568178|617442642|FG004|Double Blind Base Study|Adverse Event|0|||
170845503|NCT00568178|617442643|FG005|Double Blind Base Study|Adverse Event|0|||
170845504|NCT00568178|617442638|FG000|Double Blind Base Study|Lost to Follow-up|1|||
170845505|NCT00568178|617442639|FG001|Double Blind Base Study|Lost to Follow-up|0|||
170845506|NCT00568178|617442640|FG002|Double Blind Base Study|Lost to Follow-up|0|||
170737917|NCT00041756|617047248|FG003|Overall Study|Unable to meet protocol criteria|0|||
170737918|NCT00041756|617047249|FG004|Overall Study|Unable to meet protocol criteria|1|||
170737919|NCT00041756|617047245|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
170737920|NCT00041756|617047246|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
170737921|NCT00041756|617047247|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
170737922|NCT00041756|617047248|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
170737923|NCT00041756|617047249|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
170737924|NCT00615264|617047250|FG000|Overall Study|Withdrawal by Subject|17|||
170737925|NCT00615264|617047251|FG001|Overall Study|Withdrawal by Subject|19|||
170737926|NCT00615264|617047250|FG000|Overall Study|Lost to Follow-up|6|||
170737927|NCT00615264|617047251|FG001|Overall Study|Lost to Follow-up|13|||
170737928|NCT00615264|617047250|FG000|Overall Study|Adverse Event|8|||
170737929|NCT00615264|617047251|FG001|Overall Study|Adverse Event|5|||
170737930|NCT00615264|617047250|FG000|Overall Study|Death|1|||
170737931|NCT00615264|617047251|FG001|Overall Study|Death|1|||
170737932|NCT00615264|617047250|FG000|Overall Study|Protocol Violation|11|||
170737933|NCT00615264|617047251|FG001|Overall Study|Protocol Violation|7|||
170737934|NCT00615264|617047250|FG000|Overall Study|Not defined|7|||
170737935|NCT00615264|617047251|FG001|Overall Study|Not defined|4|||
170737936|NCT00615264|617047250|FG000|Overall Study|Dermal Hypersensitivity|0|||
170737937|NCT00615264|617047251|FG001|Overall Study|Dermal Hypersensitivity|3|||
170737938|NCT01982435|617047256|FG000|Overall Study|Adverse Event|1|||
170737939|NCT01982435|617047257|FG001|Overall Study|Adverse Event|0|||
170737940|NCT00409786|617047258|FG000|Overall Study|Withdrawal by Subject|3|||
170737941|NCT02508532|617047261|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
170737942|NCT02508532|617047262|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
170737943|NCT02508532|617047263|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
170737944|NCT02508532|617047264|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
170737945|NCT02508532|617047265|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
170737946|NCT02508532|617047266|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
170737947|NCT02508532|617047267|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
170737948|NCT02508532|617047268|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
170737949|NCT02508532|617047269|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
170737950|NCT02508532|617047261|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
170737951|NCT02508532|617047262|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
170737952|NCT02508532|617047263|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
170737953|NCT02508532|617047264|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
170737954|NCT02508532|617047265|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
170737955|NCT02508532|617047266|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
170737956|NCT02508532|617047267|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
170737957|NCT02508532|617047268|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
170737958|NCT02508532|617047269|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
170737959|NCT02508532|617047261|FG000|Part 2 - Treatment|Disease Progression|0|||
170737960|NCT02508532|617047262|FG001|Part 2 - Treatment|Disease Progression|0|||
170737961|NCT02508532|617047263|FG002|Part 2 - Treatment|Disease Progression|0|||
170737962|NCT02508532|617047264|FG003|Part 2 - Treatment|Disease Progression|0|||
170737963|NCT02508532|617047265|FG004|Part 2 - Treatment|Disease Progression|0|||
170737964|NCT02508532|617047266|FG005|Part 2 - Treatment|Disease Progression|0|||
170737965|NCT02508532|617047267|FG006|Part 2 - Treatment|Disease Progression|0|||
170737966|NCT02508532|617047268|FG007|Part 2 - Treatment|Disease Progression|0|||
170737967|NCT02508532|617047269|FG008|Part 2 - Treatment|Disease Progression|118|||
170737968|NCT02508532|617047261|FG000|Part 2 - Treatment|Adverse Event|0|||
170737969|NCT02508532|617047262|FG001|Part 2 - Treatment|Adverse Event|0|||
170737970|NCT02508532|617047263|FG002|Part 2 - Treatment|Adverse Event|0|||
170737971|NCT02508532|617047264|FG003|Part 2 - Treatment|Adverse Event|0|||
170737972|NCT02508532|617047265|FG004|Part 2 - Treatment|Adverse Event|0|||
170737973|NCT02508532|617047266|FG005|Part 2 - Treatment|Adverse Event|0|||
170737974|NCT02508532|617047267|FG006|Part 2 - Treatment|Adverse Event|0|||
170737975|NCT02508532|617047268|FG007|Part 2 - Treatment|Adverse Event|0|||
170737976|NCT02508532|617047269|FG008|Part 2 - Treatment|Adverse Event|49|||
170737977|NCT02508532|617047261|FG000|Part 2 - Treatment|Physician Decision|0|||
170737978|NCT02508532|617047262|FG001|Part 2 - Treatment|Physician Decision|0|||
170737979|NCT02508532|617047263|FG002|Part 2 - Treatment|Physician Decision|0|||
170737980|NCT02508532|617047264|FG003|Part 2 - Treatment|Physician Decision|0|||
170737981|NCT02508532|617047265|FG004|Part 2 - Treatment|Physician Decision|0|||
170737982|NCT02508532|617047266|FG005|Part 2 - Treatment|Physician Decision|0|||
170737983|NCT02508532|617047267|FG006|Part 2 - Treatment|Physician Decision|0|||
170737984|NCT02508532|617047268|FG007|Part 2 - Treatment|Physician Decision|0|||
170737985|NCT02508532|617047269|FG008|Part 2 - Treatment|Physician Decision|12|||
170737986|NCT02508532|617047261|FG000|Part 2 - Treatment|Administrative|0|||
170737987|NCT02508532|617047262|FG001|Part 2 - Treatment|Administrative|0|||
170737988|NCT02508532|617047263|FG002|Part 2 - Treatment|Administrative|0|||
170845507|NCT00568178|617442641|FG003|Double Blind Base Study|Lost to Follow-up|1|||
170845508|NCT00568178|617442642|FG004|Double Blind Base Study|Lost to Follow-up|0|||
170845509|NCT00568178|617442643|FG005|Double Blind Base Study|Lost to Follow-up|0|||
170845510|NCT00568178|617442638|FG000|Double Blind Base Study|Physician Decision|1|||
170845511|NCT00568178|617442639|FG001|Double Blind Base Study|Physician Decision|1|||
170845512|NCT00568178|617442640|FG002|Double Blind Base Study|Physician Decision|0|||
170845513|NCT00568178|617442641|FG003|Double Blind Base Study|Physician Decision|1|||
170845514|NCT00568178|617442642|FG004|Double Blind Base Study|Physician Decision|0|||
170845515|NCT00568178|617442643|FG005|Double Blind Base Study|Physician Decision|0|||
170845516|NCT00568178|617442638|FG000|Double Blind Base Study|Protocol Violation|3|||
170845517|NCT00568178|617442639|FG001|Double Blind Base Study|Protocol Violation|2|||
170845518|NCT00568178|617442640|FG002|Double Blind Base Study|Protocol Violation|0|||
170845519|NCT00568178|617442641|FG003|Double Blind Base Study|Protocol Violation|0|||
170845520|NCT00568178|617442642|FG004|Double Blind Base Study|Protocol Violation|0|||
170845521|NCT00568178|617442643|FG005|Double Blind Base Study|Protocol Violation|0|||
170845522|NCT00568178|617442638|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
170845523|NCT00568178|617442639|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
170845524|NCT00568178|617442640|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
170845525|NCT00568178|617442641|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
170845526|NCT00568178|617442642|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
170845527|NCT00568178|617442643|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
170845528|NCT00568178|617442638|FG000|Double Blind Base Study|Progressive Disease|0|||
170845529|NCT00568178|617442639|FG001|Double Blind Base Study|Progressive Disease|0|||
170845530|NCT00568178|617442640|FG002|Double Blind Base Study|Progressive Disease|0|||
170845531|NCT00568178|617442641|FG003|Double Blind Base Study|Progressive Disease|1|||
170845532|NCT00568178|617442642|FG004|Double Blind Base Study|Progressive Disease|0|||
170845533|NCT00568178|617442643|FG005|Double Blind Base Study|Progressive Disease|0|||
170845534|NCT00568178|617442638|FG000|Open Label Extension|Adverse Event|0|||
170845535|NCT00568178|617442639|FG001|Open Label Extension|Adverse Event|0|||
170845536|NCT00568178|617442640|FG002|Open Label Extension|Adverse Event|0|||
170845537|NCT00568178|617442641|FG003|Open Label Extension|Adverse Event|0|||
170845538|NCT00568178|617442642|FG004|Open Label Extension|Adverse Event|11|||
170845539|NCT00568178|617442643|FG005|Open Label Extension|Adverse Event|8|||
170845540|NCT00568178|617442638|FG000|Open Label Extension|Protocol Violation|0|||
170845541|NCT00568178|617442639|FG001|Open Label Extension|Protocol Violation|0|||
170845542|NCT00568178|617442640|FG002|Open Label Extension|Protocol Violation|0|||
170845543|NCT00568178|617442641|FG003|Open Label Extension|Protocol Violation|0|||
170845544|NCT00568178|617442642|FG004|Open Label Extension|Protocol Violation|1|||
170845545|NCT00568178|617442643|FG005|Open Label Extension|Protocol Violation|0|||
170845546|NCT00568178|617442638|FG000|Open Label Extension|Lost to Follow-up|0|||
170845547|NCT00568178|617442639|FG001|Open Label Extension|Lost to Follow-up|0|||
170845548|NCT00568178|617442640|FG002|Open Label Extension|Lost to Follow-up|0|||
170845549|NCT00568178|617442641|FG003|Open Label Extension|Lost to Follow-up|0|||
170845550|NCT00568178|617442642|FG004|Open Label Extension|Lost to Follow-up|6|||
170845551|NCT00568178|617442643|FG005|Open Label Extension|Lost to Follow-up|11|||
170845552|NCT00568178|617442638|FG000|Open Label Extension|Physician Decision|0|||
170845553|NCT00568178|617442639|FG001|Open Label Extension|Physician Decision|0|||
170845554|NCT00568178|617442640|FG002|Open Label Extension|Physician Decision|0|||
170845555|NCT00568178|617442641|FG003|Open Label Extension|Physician Decision|0|||
170845556|NCT00568178|617442642|FG004|Open Label Extension|Physician Decision|9|||
170845557|NCT00568178|617442643|FG005|Open Label Extension|Physician Decision|8|||
170845558|NCT00568178|617442638|FG000|Open Label Extension|Pregnancy|0|||
170845559|NCT00568178|617442639|FG001|Open Label Extension|Pregnancy|0|||
170845560|NCT00568178|617442640|FG002|Open Label Extension|Pregnancy|0|||
170845561|NCT00568178|617442641|FG003|Open Label Extension|Pregnancy|0|||
170845562|NCT00568178|617442642|FG004|Open Label Extension|Pregnancy|0|||
170845563|NCT00568178|617442643|FG005|Open Label Extension|Pregnancy|1|||
170845564|NCT00568178|617442638|FG000|Open Label Extension|Progressive Disease|0|||
170845565|NCT00568178|617442639|FG001|Open Label Extension|Progressive Disease|0|||
170845566|NCT00568178|617442640|FG002|Open Label Extension|Progressive Disease|0|||
170845567|NCT00568178|617442641|FG003|Open Label Extension|Progressive Disease|0|||
170845568|NCT00568178|617442642|FG004|Open Label Extension|Progressive Disease|3|||
170845569|NCT00568178|617442643|FG005|Open Label Extension|Progressive Disease|1|||
170845570|NCT00568178|617442638|FG000|Open Label Extension|Termination of Trial|0|||
170845571|NCT00568178|617442639|FG001|Open Label Extension|Termination of Trial|0|||
170845572|NCT00568178|617442640|FG002|Open Label Extension|Termination of Trial|0|||
170845573|NCT00568178|617442641|FG003|Open Label Extension|Termination of Trial|0|||
170845574|NCT00568178|617442642|FG004|Open Label Extension|Termination of Trial|45|||
170845575|NCT00568178|617442643|FG005|Open Label Extension|Termination of Trial|47|||
170845576|NCT00568178|617442638|FG000|Open Label Extension|Withdrawal by Subject|0|||
170845577|NCT00568178|617442639|FG001|Open Label Extension|Withdrawal by Subject|0|||
170845578|NCT00568178|617442640|FG002|Open Label Extension|Withdrawal by Subject|0|||
170845579|NCT00568178|617442641|FG003|Open Label Extension|Withdrawal by Subject|0|||
170845580|NCT00568178|617442642|FG004|Open Label Extension|Withdrawal by Subject|4|||
170845581|NCT00568178|617442643|FG005|Open Label Extension|Withdrawal by Subject|4|||
170845582|NCT00095056|617442644|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
170845583|NCT00095056|617442645|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
170845584|NCT00095056|617442644|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
170845585|NCT00095056|617442645|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
170845586|NCT00095056|617442644|FG000|Phase A (Weeks 0-12)|Death|1|||
170845587|NCT00095056|617442645|FG001|Phase A (Weeks 0-12)|Death|0|||
170845588|NCT00095056|617442644|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
170845589|NCT00095056|617442645|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
170845590|NCT00095056|617442644|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
170845591|NCT00095056|617442645|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
170845592|NCT00095056|617442644|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
170845593|NCT00095056|617442645|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
170845594|NCT00095056|617442644|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
170845595|NCT00095056|617442645|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
170845596|NCT00095056|617442644|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
170845597|NCT00095056|617442645|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
170845598|NCT00095056|617442644|FG000|Phase B (Weeks 12-54)|Death|3|||
170845599|NCT00095056|617442645|FG001|Phase B (Weeks 12-54)|Death|1|||
170845600|NCT00095056|617442644|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
170845601|NCT00095056|617442645|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
170845602|NCT00095056|617442644|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
170845603|NCT00095056|617442645|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
170845604|NCT04476251|617442648|FG000|Overall Study|Not treated|1|||
170845605|NCT01638429|617442654|FG000|Overall Study|Withdrawal by Subject|1|||
170845606|NCT02040584|617442656|FG000|Overall Study|Adverse Event|13|||
170845607|NCT02040584|617442657|FG001|Overall Study|Adverse Event|6|||
170845608|NCT02040584|617442656|FG000|Overall Study|Protocol Violation|9|||
170845609|NCT02040584|617442657|FG001|Overall Study|Protocol Violation|11|||
170845610|NCT02040584|617442656|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170845611|NCT02040584|617442657|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170845612|NCT02040584|617442656|FG000|Overall Study|Death|6|||
170845613|NCT02040584|617442657|FG001|Overall Study|Death|3|||
170845614|NCT02040584|617442656|FG000|Overall Study|Transplant rejection/retransplant|0|||
170845615|NCT02040584|617442657|FG001|Overall Study|Transplant rejection/retransplant|1|||
170845616|NCT02040584|617442656|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
170845617|NCT02040584|617442657|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
170845618|NCT04939701|617442658|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
170845619|NCT04939701|617442659|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
170845620|NCT04939701|617442660|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
170845621|NCT04939701|617442658|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
170845622|NCT04939701|617442659|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
170845623|NCT04939701|617442660|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
170845624|NCT04939701|617442658|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
170845625|NCT04939701|617442659|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
170845626|NCT04939701|617442660|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
170845627|NCT04939701|617442658|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
170845628|NCT04939701|617442659|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
170845629|NCT04939701|617442660|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
170845630|NCT04939701|617442658|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
170845631|NCT04939701|617442659|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
170845632|NCT04939701|617442660|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
170845633|NCT04939701|617442658|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
170845634|NCT04939701|617442659|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
170845635|NCT04939701|617442660|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
170845636|NCT04939701|617442658|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
170845637|NCT04939701|617442659|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
170845638|NCT04939701|617442660|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
170845639|NCT00772330|617442661|FG000|Overall Study|Lost to Follow-up|3|||
170845640|NCT01923467|617442662|FG000|Overall Study|Lost to Follow-up|62|||
170845641|NCT01923467|617442662|FG000|Overall Study|Subject non-interest|479|||
170845642|NCT01075958|617442663|FG000|Overall Study|Blood sample could not be obtained|44|||
170845643|NCT02574845|617442667|FG000|Overall Study|Consent withdrawn further participation|0|||
170845644|NCT02574845|617442668|FG001|Overall Study|Consent withdrawn further participation|0|||
170845645|NCT02574845|617442669|FG002|Overall Study|Consent withdrawn further participation|0|||
170845646|NCT02574845|617442670|FG003|Overall Study|Consent withdrawn further participation|0|||
170845647|NCT02574845|617442671|FG004|Overall Study|Consent withdrawn further participation|1|||
170845648|NCT02574845|617442672|FG005|Overall Study|Consent withdrawn further participation|0|||
170845649|NCT02574845|617442667|FG000|Overall Study|Adverse Event|0|||
170845650|NCT02574845|617442668|FG001|Overall Study|Adverse Event|1|||
170845651|NCT02574845|617442669|FG002|Overall Study|Adverse Event|0|||
170845652|NCT02574845|617442670|FG003|Overall Study|Adverse Event|0|||
170845653|NCT02574845|617442671|FG004|Overall Study|Adverse Event|0|||
170845654|NCT02574845|617442672|FG005|Overall Study|Adverse Event|1|||
170845655|NCT01696045|617442678|FG000|Overall Study|Study drug toxicity|1|||
170845656|NCT01696045|617442679|FG001|Overall Study|Study drug toxicity|5|||
170845657|NCT01696045|617442678|FG000|Overall Study|Disease progression|2|||
170845658|NCT01696045|617442679|FG001|Overall Study|Disease progression|2|||
170845659|NCT01559129|617442680|FG000|Treatment Phase|Adverse Event|0|||
170845660|NCT01559129|617442681|FG001|Treatment Phase|Adverse Event|2|||
170845661|NCT01559129|617442680|FG000|Treatment Phase|Progressive Disease|1|||
170845662|NCT01559129|617442681|FG001|Treatment Phase|Progressive Disease|1|||
170845663|NCT01559129|617442680|FG000|Treatment Phase|Lack of Efficacy|0|||
170845664|NCT01559129|617442681|FG001|Treatment Phase|Lack of Efficacy|1|||
170845665|NCT01559129|617442680|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
170845666|NCT01559129|617442681|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
170845667|NCT01559129|617442680|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
170845668|NCT01559129|617442681|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
170845669|NCT01559129|617442680|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
170845670|NCT01559129|617442681|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
170845671|NCT01559129|617442680|FG000|Open-label Extension Period|Adverse Event|1|||
170845672|NCT01559129|617442681|FG001|Open-label Extension Period|Adverse Event|0|||
170845673|NCT01559129|617442680|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
170845674|NCT01559129|617442681|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
170845675|NCT00831129|617442683|FG000|Overall Study|Adverse Event|0|||
170845676|NCT00831129|617442684|FG001|Overall Study|Adverse Event|1|||
170845677|NCT00831129|617442683|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
170845678|NCT00831129|617442684|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
170845679|NCT04276415|617442688|FG000|Overall Study|Adverse Event|0|||
170845680|NCT04276415|617442689|FG001|Overall Study|Adverse Event|0|||
170845681|NCT04276415|617442690|FG002|Overall Study|Adverse Event|0|||
170845682|NCT04276415|617442691|FG003|Overall Study|Adverse Event|3|||
170845683|NCT04276415|617442692|FG004|Overall Study|Adverse Event|0|||
170845684|NCT04276415|617442693|FG005|Overall Study|Adverse Event|0|||
170845685|NCT04276415|617442688|FG000|Overall Study|Clinical progression|1|||
170845686|NCT04276415|617442689|FG001|Overall Study|Clinical progression|1|||
170845687|NCT04276415|617442690|FG002|Overall Study|Clinical progression|0|||
170845688|NCT04276415|617442691|FG003|Overall Study|Clinical progression|0|||
170845689|NCT04276415|617442692|FG004|Overall Study|Clinical progression|1|||
170845690|NCT04276415|617442693|FG005|Overall Study|Clinical progression|0|||
170845691|NCT04276415|617442688|FG000|Overall Study|Other|0|||
170845692|NCT04276415|617442689|FG001|Overall Study|Other|0|||
170845693|NCT04276415|617442690|FG002|Overall Study|Other|0|||
170845694|NCT04276415|617442691|FG003|Overall Study|Other|1|||
170845695|NCT04276415|617442692|FG004|Overall Study|Other|0|||
170845696|NCT04276415|617442693|FG005|Overall Study|Other|0|||
170845697|NCT04276415|617442688|FG000|Overall Study|Physician Decision|0|||
170845698|NCT04276415|617442689|FG001|Overall Study|Physician Decision|0|||
170845699|NCT04276415|617442690|FG002|Overall Study|Physician Decision|1|||
170845700|NCT04276415|617442691|FG003|Overall Study|Physician Decision|3|||
170845701|NCT04276415|617442692|FG004|Overall Study|Physician Decision|2|||
170845702|NCT04276415|617442693|FG005|Overall Study|Physician Decision|0|||
170845703|NCT04276415|617442688|FG000|Overall Study|Progressive disease|3|||
170845704|NCT04276415|617442689|FG001|Overall Study|Progressive disease|3|||
170845705|NCT04276415|617442690|FG002|Overall Study|Progressive disease|4|||
170845706|NCT04276415|617442691|FG003|Overall Study|Progressive disease|5|||
170845707|NCT04276415|617442692|FG004|Overall Study|Progressive disease|1|||
170845708|NCT04276415|617442693|FG005|Overall Study|Progressive disease|2|||
170845709|NCT04276415|617442688|FG000|Overall Study|Withdrawal by patient|0|||
170845710|NCT04276415|617442689|FG001|Overall Study|Withdrawal by patient|0|||
170845711|NCT04276415|617442690|FG002|Overall Study|Withdrawal by patient|0|||
170845712|NCT04276415|617442691|FG003|Overall Study|Withdrawal by patient|1|||
170845713|NCT04276415|617442692|FG004|Overall Study|Withdrawal by patient|2|||
170845714|NCT04276415|617442693|FG005|Overall Study|Withdrawal by patient|0|||
170845715|NCT03309813|617442694|FG000|Main Randomized Study|Withdrawal by Subject|1|||
170845716|NCT03309813|617442695|FG001|Main Randomized Study|Withdrawal by Subject|0|||
170845717|NCT01896726|617442696|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
170845718|NCT01896726|617442696|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
170845719|NCT04343976|617442700|FG000|Overall Study|Withdrawal by Subject|0|||
170845720|NCT04343976|617442701|FG001|Overall Study|Withdrawal by Subject|1|||
170845721|NCT01254747|617442702|FG000|Overall Study|Unacceptable subjective vision|0|||
170845722|NCT01254747|617442703|FG001|Overall Study|Unacceptable subjective vision|0|||
170845723|NCT01254747|617442704|FG002|Overall Study|Unacceptable subjective vision|0|||
170845724|NCT01254747|617442705|FG003|Overall Study|Unacceptable subjective vision|2|||
170845725|NCT01254747|617442702|FG000|Overall Study|Difficult removal handling|0|||
170845726|NCT01254747|617442703|FG001|Overall Study|Difficult removal handling|0|||
170845727|NCT01254747|617442704|FG002|Overall Study|Difficult removal handling|1|||
170845728|NCT01254747|617442705|FG003|Overall Study|Difficult removal handling|0|||
170845729|NCT01254747|617442702|FG000|Overall Study|Symptoms and problems|0|||
170845730|NCT01254747|617442703|FG001|Overall Study|Symptoms and problems|2|||
170845731|NCT01254747|617442704|FG002|Overall Study|Symptoms and problems|1|||
170845732|NCT01254747|617442705|FG003|Overall Study|Symptoms and problems|0|||
170845733|NCT01254747|617442702|FG000|Overall Study|Lost to Follow-up|0|||
170845734|NCT01254747|617442703|FG001|Overall Study|Lost to Follow-up|0|||
170845735|NCT01254747|617442704|FG002|Overall Study|Lost to Follow-up|1|||
170845736|NCT01254747|617442705|FG003|Overall Study|Lost to Follow-up|0|||
170845737|NCT01254747|617442702|FG000|Overall Study|Biomicroscopy|0|||
170845738|NCT01254747|617442703|FG001|Overall Study|Biomicroscopy|0|||
170845739|NCT01254747|617442704|FG002|Overall Study|Biomicroscopy|1|||
170845740|NCT01254747|617442705|FG003|Overall Study|Biomicroscopy|0|||
170845741|NCT01254747|617442702|FG000|Overall Study|Discomfort|0|||
170845742|NCT01254747|617442703|FG001|Overall Study|Discomfort|4|||
170845743|NCT01254747|617442704|FG002|Overall Study|Discomfort|0|||
170845744|NCT01254747|617442705|FG003|Overall Study|Discomfort|0|||
170845745|NCT01067846|617442706|FG000|Overall Study|Lost to Follow-up|17|||
170845746|NCT01067846|617442707|FG001|Overall Study|Lost to Follow-up|19|||
170845747|NCT01067846|617442706|FG000|Overall Study|Withdrawal by Subject|1|||
170845748|NCT01067846|617442707|FG001|Overall Study|Withdrawal by Subject|0|||
170845749|NCT01067846|617442706|FG000|Overall Study|participation in other tx study|1|||
170845750|NCT01067846|617442707|FG001|Overall Study|participation in other tx study|0|||
170845751|NCT02406677|617442708|FG000|Overall Study|Death|16|||
170845752|NCT02406677|617442709|FG001|Overall Study|Death|8|||
170845753|NCT02406677|617442708|FG000|Overall Study|Discharged without P2Y12|1|||
170845754|NCT02406677|617442709|FG001|Overall Study|Discharged without P2Y12|3|||
170845755|NCT02406677|617442708|FG000|Overall Study|Discharged on prasugrel|283|||
170845756|NCT02406677|617442709|FG001|Overall Study|Discharged on prasugrel|587|||
170845757|NCT02406677|617442708|FG000|Overall Study|Withdrawal by Subject|1|||
170845758|NCT02406677|617442709|FG001|Overall Study|Withdrawal by Subject|0|||
170845759|NCT02833077|617442712|FG000|Overall Study|Adverse Event|1|||
170845760|NCT02833077|617442713|FG001|Overall Study|Adverse Event|2|||
170845761|NCT02833077|617442712|FG000|Overall Study|Lost to Follow-up|10|||
170845762|NCT02833077|617442713|FG001|Overall Study|Lost to Follow-up|1|||
170845763|NCT02833077|617442712|FG000|Overall Study|Personal Reasons|6|||
170845764|NCT02833077|617442713|FG001|Overall Study|Personal Reasons|4|||
170845765|NCT02833077|617442712|FG000|Overall Study|Protocol Deviation|0|||
170845766|NCT02833077|617442713|FG001|Overall Study|Protocol Deviation|1|||
170845767|NCT04608773|617442714|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
170845768|NCT04608773|617442715|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
170845769|NCT04608773|617442714|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
170845770|NCT04608773|617442715|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
170845771|NCT04608773|617442714|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
170845772|NCT04608773|617442715|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
170845773|NCT04608773|617442714|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
170845774|NCT04608773|617442715|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
170845775|NCT04608773|617442714|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
170845776|NCT04608773|617442715|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
170845777|NCT01077518|617442716|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
170845778|NCT01077518|617442717|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
170845779|NCT01077518|617442718|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
170845780|NCT01077518|617442716|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
170845781|NCT01077518|617442717|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
170845782|NCT01077518|617442718|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
170845783|NCT01077518|617442716|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
170845784|NCT01077518|617442717|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
170845785|NCT01077518|617442718|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
170845786|NCT01077518|617442716|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
170845787|NCT01077518|617442717|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
170845788|NCT01077518|617442718|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
170845789|NCT01077518|617442716|FG000|Optional Ofa Phase|Physician Decision|0|||
170845790|NCT01077518|617442717|FG001|Optional Ofa Phase|Physician Decision|0|||
170845791|NCT01077518|617442718|FG002|Optional Ofa Phase|Physician Decision|1|||
170845792|NCT01077518|617442716|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
170845793|NCT01077518|617442717|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
170845794|NCT01077518|617442718|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
170845795|NCT01077518|617442716|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
170845796|NCT01077518|617442717|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
170845797|NCT01077518|617442718|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
170845798|NCT00972322|617442719|FG000|Overall Study|Adverse Event|2|||
170845799|NCT00972322|617442720|FG001|Overall Study|Adverse Event|1|||
170845800|NCT00972322|617442719|FG000|Overall Study|Positive drug screen|0|||
170845801|NCT00972322|617442720|FG001|Overall Study|Positive drug screen|1|||
170845802|NCT00972322|617442719|FG000|Overall Study|Lost to Follow-up|0|||
170845803|NCT00972322|617442720|FG001|Overall Study|Lost to Follow-up|1|||
170845804|NCT00972322|617442719|FG000|Overall Study|Consistently high glucose values|1|||
170845805|NCT00972322|617442720|FG001|Overall Study|Consistently high glucose values|0|||
170845806|NCT04531098|617442723|FG000|Stage I|Adverse Event|0|||
170845807|NCT04531098|617442724|FG001|Stage I|Adverse Event|0|||
170845808|NCT04531098|617442725|FG002|Stage I|Adverse Event|3|||
170845809|NCT04531098|617442723|FG000|Stage I|Protocol Violation|0|||
170845810|NCT04531098|617442724|FG001|Stage I|Protocol Violation|0|||
170845811|NCT04531098|617442725|FG002|Stage I|Protocol Violation|5|||
170845812|NCT04531098|617442723|FG000|Stage I|Withdrawal by Subject|0|||
170845813|NCT04531098|617442724|FG001|Stage I|Withdrawal by Subject|5|||
170737989|NCT02508532|617047264|FG003|Part 2 - Treatment|Administrative|0|||
170737990|NCT02508532|617047265|FG004|Part 2 - Treatment|Administrative|0|||
170737991|NCT02508532|617047266|FG005|Part 2 - Treatment|Administrative|0|||
170737992|NCT02508532|617047267|FG006|Part 2 - Treatment|Administrative|0|||
170737993|NCT02508532|617047268|FG007|Part 2 - Treatment|Administrative|0|||
170737994|NCT02508532|617047269|FG008|Part 2 - Treatment|Administrative|3|||
170737995|NCT02508532|617047261|FG000|Part 2 - Treatment|Sponsor Decision|0|||
170737996|NCT02508532|617047262|FG001|Part 2 - Treatment|Sponsor Decision|0|||
170737997|NCT02508532|617047263|FG002|Part 2 - Treatment|Sponsor Decision|0|||
170737998|NCT02508532|617047264|FG003|Part 2 - Treatment|Sponsor Decision|0|||
170737999|NCT02508532|617047265|FG004|Part 2 - Treatment|Sponsor Decision|0|||
170738000|NCT02508532|617047266|FG005|Part 2 - Treatment|Sponsor Decision|0|||
170738001|NCT02508532|617047267|FG006|Part 2 - Treatment|Sponsor Decision|0|||
170738002|NCT02508532|617047268|FG007|Part 2 - Treatment|Sponsor Decision|0|||
170738003|NCT02508532|617047269|FG008|Part 2 - Treatment|Sponsor Decision|28|||
170738004|NCT02508532|617047261|FG000|Part 2 - Treatment|Death|0|||
170738005|NCT02508532|617047262|FG001|Part 2 - Treatment|Death|0|||
170738006|NCT02508532|617047263|FG002|Part 2 - Treatment|Death|0|||
170738007|NCT02508532|617047264|FG003|Part 2 - Treatment|Death|0|||
170738008|NCT02508532|617047265|FG004|Part 2 - Treatment|Death|0|||
170738009|NCT02508532|617047266|FG005|Part 2 - Treatment|Death|0|||
170845814|NCT04531098|617442725|FG002|Stage I|Withdrawal by Subject|10|||
170845815|NCT04531098|617442723|FG000|Stage II|Adverse Event|1|||
170845816|NCT04531098|617442724|FG001|Stage II|Adverse Event|2|||
170845817|NCT04531098|617442725|FG002|Stage II|Adverse Event|0|||
170845818|NCT04531098|617442723|FG000|Stage II|Protocol Violation|1|||
170845819|NCT04531098|617442724|FG001|Stage II|Protocol Violation|2|||
170845820|NCT04531098|617442725|FG002|Stage II|Protocol Violation|0|||
170845821|NCT04531098|617442723|FG000|Stage II|Withdrawal by Subject|3|||
170845822|NCT04531098|617442724|FG001|Stage II|Withdrawal by Subject|1|||
170845823|NCT04531098|617442725|FG002|Stage II|Withdrawal by Subject|0|||
170845824|NCT04531098|617442723|FG000|Stage II|Moved from study area|8|||
170845825|NCT04531098|617442724|FG001|Stage II|Moved from study area|5|||
170845826|NCT04531098|617442725|FG002|Stage II|Moved from study area|0|||
170845827|NCT02628028|617442726|FG000|Dosing Period|Withdrawal by Subject|0|||
170845828|NCT02628028|617442727|FG001|Dosing Period|Withdrawal by Subject|0|||
170845829|NCT02628028|617442728|FG002|Dosing Period|Withdrawal by Subject|1|||
170845830|NCT02628028|617442729|FG003|Dosing Period|Withdrawal by Subject|0|||
170845831|NCT02628028|617442730|FG004|Dosing Period|Withdrawal by Subject|2|||
170845832|NCT02628028|617442731|FG005|Dosing Period|Withdrawal by Subject|4|||
170845833|NCT02628028|617442732|FG006|Dosing Period|Withdrawal by Subject|1|||
170845834|NCT02628028|617442733|FG007|Dosing Period|Withdrawal by Subject|1|||
170845835|NCT02628028|617442726|FG000|Dosing Period|Adverse Event|0|||
170845836|NCT02628028|617442727|FG001|Dosing Period|Adverse Event|0|||
170845837|NCT02628028|617442728|FG002|Dosing Period|Adverse Event|0|||
170845838|NCT02628028|617442729|FG003|Dosing Period|Adverse Event|0|||
170845839|NCT02628028|617442730|FG004|Dosing Period|Adverse Event|2|||
170845840|NCT02628028|617442731|FG005|Dosing Period|Adverse Event|1|||
170845841|NCT02628028|617442732|FG006|Dosing Period|Adverse Event|3|||
170845842|NCT02628028|617442733|FG007|Dosing Period|Adverse Event|2|||
170845843|NCT02628028|617442726|FG000|Dosing Period|Death|0|||
170845844|NCT02628028|617442727|FG001|Dosing Period|Death|0|||
170845845|NCT02628028|617442728|FG002|Dosing Period|Death|0|||
170845846|NCT02628028|617442729|FG003|Dosing Period|Death|0|||
170845847|NCT02628028|617442730|FG004|Dosing Period|Death|0|||
170845848|NCT02628028|617442731|FG005|Dosing Period|Death|0|||
170845849|NCT02628028|617442732|FG006|Dosing Period|Death|0|||
170845850|NCT02628028|617442733|FG007|Dosing Period|Death|1|||
170845851|NCT02628028|617442726|FG000|Dosing Period|Lack of Efficacy|0|||
170845852|NCT02628028|617442727|FG001|Dosing Period|Lack of Efficacy|0|||
170845853|NCT02628028|617442728|FG002|Dosing Period|Lack of Efficacy|0|||
170845854|NCT02628028|617442729|FG003|Dosing Period|Lack of Efficacy|0|||
170845855|NCT02628028|617442730|FG004|Dosing Period|Lack of Efficacy|3|||
170845856|NCT02628028|617442731|FG005|Dosing Period|Lack of Efficacy|0|||
170845857|NCT02628028|617442732|FG006|Dosing Period|Lack of Efficacy|1|||
170845858|NCT02628028|617442733|FG007|Dosing Period|Lack of Efficacy|0|||
170845859|NCT02628028|617442726|FG000|Dosing Period|Study Terminated by Sponsor|0|||
170845860|NCT02628028|617442727|FG001|Dosing Period|Study Terminated by Sponsor|0|||
170845861|NCT02628028|617442728|FG002|Dosing Period|Study Terminated by Sponsor|0|||
170845862|NCT02628028|617442729|FG003|Dosing Period|Study Terminated by Sponsor|0|||
170845863|NCT02628028|617442730|FG004|Dosing Period|Study Terminated by Sponsor|7|||
170845864|NCT02628028|617442731|FG005|Dosing Period|Study Terminated by Sponsor|6|||
170845865|NCT02628028|617442732|FG006|Dosing Period|Study Terminated by Sponsor|7|||
170845866|NCT02628028|617442733|FG007|Dosing Period|Study Terminated by Sponsor|7|||
170845867|NCT02628028|617442726|FG000|Dosing Period|Physician Decision|0|||
170845868|NCT02628028|617442727|FG001|Dosing Period|Physician Decision|0|||
170845869|NCT02628028|617442728|FG002|Dosing Period|Physician Decision|0|||
170845870|NCT02628028|617442729|FG003|Dosing Period|Physician Decision|0|||
170845871|NCT02628028|617442730|FG004|Dosing Period|Physician Decision|0|||
170845872|NCT02628028|617442731|FG005|Dosing Period|Physician Decision|1|||
170845873|NCT02628028|617442732|FG006|Dosing Period|Physician Decision|0|||
170845874|NCT02628028|617442733|FG007|Dosing Period|Physician Decision|0|||
170845875|NCT02628028|617442726|FG000|Dosing Period|Site Terminated by Sponsor|0|||
170845876|NCT02628028|617442727|FG001|Dosing Period|Site Terminated by Sponsor|0|||
170845877|NCT02628028|617442728|FG002|Dosing Period|Site Terminated by Sponsor|0|||
170845878|NCT02628028|617442729|FG003|Dosing Period|Site Terminated by Sponsor|0|||
170845879|NCT02628028|617442730|FG004|Dosing Period|Site Terminated by Sponsor|0|||
170845880|NCT02628028|617442731|FG005|Dosing Period|Site Terminated by Sponsor|1|||
170845881|NCT02628028|617442732|FG006|Dosing Period|Site Terminated by Sponsor|1|||
170845882|NCT02628028|617442733|FG007|Dosing Period|Site Terminated by Sponsor|0|||
170845883|NCT02628028|617442726|FG000|Dosing Period|Lost to Follow-up|0|||
170845884|NCT02628028|617442727|FG001|Dosing Period|Lost to Follow-up|0|||
170845885|NCT02628028|617442728|FG002|Dosing Period|Lost to Follow-up|0|||
170845886|NCT02628028|617442729|FG003|Dosing Period|Lost to Follow-up|0|||
170845887|NCT02628028|617442730|FG004|Dosing Period|Lost to Follow-up|0|||
170845888|NCT02628028|617442731|FG005|Dosing Period|Lost to Follow-up|0|||
170845889|NCT02628028|617442732|FG006|Dosing Period|Lost to Follow-up|1|||
170845890|NCT02628028|617442733|FG007|Dosing Period|Lost to Follow-up|0|||
170845891|NCT02628028|617442726|FG000|Dosing Period|Other|0|||
170845892|NCT02628028|617442727|FG001|Dosing Period|Other|0|||
170845893|NCT02628028|617442728|FG002|Dosing Period|Other|0|||
170845894|NCT02628028|617442729|FG003|Dosing Period|Other|0|||
170845895|NCT02628028|617442730|FG004|Dosing Period|Other|2|||
170845896|NCT02628028|617442731|FG005|Dosing Period|Other|1|||
170845897|NCT02628028|617442732|FG006|Dosing Period|Other|2|||
170845898|NCT02628028|617442733|FG007|Dosing Period|Other|4|||
170845899|NCT02628028|617442726|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
170845900|NCT02628028|617442727|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
170845901|NCT02628028|617442728|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
170845902|NCT02628028|617442729|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
170845903|NCT02628028|617442730|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
170845904|NCT02628028|617442731|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
170845905|NCT02628028|617442732|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
170845906|NCT02628028|617442733|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
170845907|NCT02628028|617442726|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
170845908|NCT02628028|617442727|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
170845909|NCT02628028|617442728|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
170845910|NCT02628028|617442729|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
170845911|NCT02628028|617442730|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
170845912|NCT02628028|617442731|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
170845913|NCT02628028|617442732|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
170845914|NCT02628028|617442733|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
170845915|NCT02628028|617442726|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
170845916|NCT02628028|617442727|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
170845917|NCT02628028|617442728|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
170845918|NCT02628028|617442729|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
170845919|NCT02628028|617442730|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
170845920|NCT02628028|617442731|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
170845921|NCT02628028|617442732|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
170845922|NCT02628028|617442733|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
170845923|NCT02628028|617442726|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
170845924|NCT02628028|617442727|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
170845925|NCT02628028|617442728|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
170845926|NCT02628028|617442729|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
170845927|NCT02628028|617442730|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
170845928|NCT02628028|617442731|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
170845929|NCT02628028|617442732|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
170845930|NCT02628028|617442733|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
170845931|NCT02628028|617442726|FG000|Long-term Extension (LTE) Period|Other|0|||
170845932|NCT02628028|617442727|FG001|Long-term Extension (LTE) Period|Other|0|||
170845933|NCT02628028|617442728|FG002|Long-term Extension (LTE) Period|Other|0|||
170845934|NCT02628028|617442729|FG003|Long-term Extension (LTE) Period|Other|0|||
170845935|NCT02628028|617442730|FG004|Long-term Extension (LTE) Period|Other|0|||
170845936|NCT02628028|617442731|FG005|Long-term Extension (LTE) Period|Other|3|||
170845937|NCT02628028|617442732|FG006|Long-term Extension (LTE) Period|Other|4|||
170845938|NCT02628028|617442733|FG007|Long-term Extension (LTE) Period|Other|3|||
170845939|NCT02145468|617442734|FG000|Overall Study|Withdrawal by Subject|5|||
170845940|NCT02145468|617442735|FG001|Overall Study|Withdrawal by Subject|8|||
170845941|NCT00586612|617442736|FG000|Primary Phase|Protocol Violation|1|||
170845942|NCT00586612|617442737|FG001|Primary Phase|Protocol Violation|0|||
170845943|NCT00586612|617442736|FG000|Primary Phase|Lost to Follow-up|0|||
170845944|NCT00586612|617442737|FG001|Primary Phase|Lost to Follow-up|1|||
170845945|NCT00586612|617442736|FG000|Primary Phase|Withdrawal by Subject|0|||
170845946|NCT00586612|617442737|FG001|Primary Phase|Withdrawal by Subject|2|||
170845947|NCT00586612|617442736|FG000|Booster Phase|Lost to Follow-up|3|||
170845948|NCT00586612|617442737|FG001|Booster Phase|Lost to Follow-up|1|||
170845949|NCT00623805|617442739|FG000|Overall Study|Adverse Event|9|||
170845950|NCT00623805|617442740|FG001|Overall Study|Adverse Event|6|||
170845951|NCT00623805|617442739|FG000|Overall Study|Death|2|||
170845952|NCT00623805|617442740|FG001|Overall Study|Death|0|||
170845953|NCT00623805|617442739|FG000|Overall Study|Lack of Efficacy|3|||
170845954|NCT00623805|617442740|FG001|Overall Study|Lack of Efficacy|7|||
170845955|NCT00623805|617442739|FG000|Overall Study|Lost to Follow-up|2|||
170845956|NCT00623805|617442740|FG001|Overall Study|Lost to Follow-up|2|||
170845957|NCT00623805|617442739|FG000|Overall Study|Protocol Violation|1|||
170845958|NCT00623805|617442740|FG001|Overall Study|Protocol Violation|1|||
170845959|NCT00623805|617442739|FG000|Overall Study|Reason not Specified|3|||
170845960|NCT00623805|617442740|FG001|Overall Study|Reason not Specified|6|||
170845961|NCT01803282|617442741|FG000|Overall Study|Progressive Disease|4|||
170845962|NCT01803282|617442742|FG001|Overall Study|Progressive Disease|3|||
170845963|NCT01803282|617442743|FG002|Overall Study|Progressive Disease|6|||
170845964|NCT01803282|617442744|FG003|Overall Study|Progressive Disease|22|||
170845965|NCT01803282|617442745|FG004|Overall Study|Progressive Disease|5|||
170845966|NCT01803282|617442746|FG005|Overall Study|Progressive Disease|8|||
170845967|NCT01803282|617442747|FG006|Overall Study|Progressive Disease|23|||
170738010|NCT02508532|617047267|FG006|Part 2 - Treatment|Death|0|||
170738011|NCT02508532|617047268|FG007|Part 2 - Treatment|Death|0|||
170738012|NCT02508532|617047269|FG008|Part 2 - Treatment|Death|1|||
170738013|NCT02508532|617047261|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
170738014|NCT02508532|617047262|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
170738015|NCT02508532|617047263|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
170738016|NCT02508532|617047264|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
170738017|NCT02508532|617047265|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
170738018|NCT02508532|617047266|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
170738019|NCT02508532|617047267|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
170738020|NCT02508532|617047268|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
170738021|NCT02508532|617047269|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
170738022|NCT02508532|617047261|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
170738023|NCT02508532|617047262|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
170738024|NCT02508532|617047263|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
170738025|NCT02508532|617047264|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
170738026|NCT02508532|617047265|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
170738027|NCT02508532|617047266|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
170738028|NCT02508532|617047267|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
170738029|NCT02508532|617047268|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
170738030|NCT02508532|617047269|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
170738031|NCT02508532|617047261|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
170738032|NCT02508532|617047262|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
170738033|NCT02508532|617047263|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
170738034|NCT02508532|617047264|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
170738035|NCT02508532|617047265|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
170738036|NCT02508532|617047266|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
170738037|NCT02508532|617047267|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
170738038|NCT02508532|617047268|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
170738039|NCT02508532|617047269|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
170738040|NCT02508532|617047261|FG000|Part 1 and Part 2 End of Study|Death|0|||
170738041|NCT02508532|617047262|FG001|Part 1 and Part 2 End of Study|Death|4|||
170738042|NCT02508532|617047263|FG002|Part 1 and Part 2 End of Study|Death|2|||
170738043|NCT02508532|617047264|FG003|Part 1 and Part 2 End of Study|Death|4|||
170738044|NCT02508532|617047265|FG004|Part 1 and Part 2 End of Study|Death|3|||
170738045|NCT02508532|617047266|FG005|Part 1 and Part 2 End of Study|Death|0|||
170738046|NCT02508532|617047267|FG006|Part 1 and Part 2 End of Study|Death|0|||
170738047|NCT02508532|617047268|FG007|Part 1 and Part 2 End of Study|Death|1|||
170738048|NCT02508532|617047269|FG008|Part 1 and Part 2 End of Study|Death|111|||
170738049|NCT02508532|617047261|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
170738050|NCT02508532|617047262|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
170738051|NCT02508532|617047263|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
170738052|NCT02508532|617047264|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
170738053|NCT02508532|617047265|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
170738054|NCT02508532|617047266|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
170738055|NCT02508532|617047267|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
170738056|NCT02508532|617047268|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
170738057|NCT02508532|617047269|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
170738058|NCT02508532|617047261|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
170738059|NCT02508532|617047262|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
170738060|NCT02508532|617047263|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
170738061|NCT02508532|617047264|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
170738062|NCT02508532|617047265|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
170738063|NCT02508532|617047266|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
170738064|NCT02508532|617047267|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
170738065|NCT02508532|617047268|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
170738066|NCT02508532|617047269|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
170738067|NCT02508532|617047261|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
170738068|NCT02508532|617047262|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
170738069|NCT02508532|617047263|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
170738070|NCT02508532|617047264|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
170738071|NCT02508532|617047265|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
170738072|NCT02508532|617047266|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
170738073|NCT02508532|617047267|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
170738074|NCT02508532|617047268|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
170738075|NCT02508532|617047269|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
170738076|NCT02508532|617047261|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
170738077|NCT02508532|617047262|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
170845968|NCT01803282|617442748|FG007|Overall Study|Progressive Disease|24|||
170738078|NCT02508532|617047263|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
170738079|NCT02508532|617047264|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
170738080|NCT02508532|617047265|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
170738081|NCT02508532|617047266|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
170738082|NCT02508532|617047267|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
170738083|NCT02508532|617047268|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
170738084|NCT02508532|617047269|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
170738085|NCT02508532|617047261|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
170738086|NCT02508532|617047262|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
170738087|NCT02508532|617047263|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
170738088|NCT02508532|617047264|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
170738089|NCT02508532|617047265|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
170738090|NCT02508532|617047266|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
170738091|NCT02508532|617047267|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
170738092|NCT02508532|617047268|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
170738093|NCT02508532|617047269|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
170738094|NCT01800201|617047272|FG000|Overall Study|Withdrawal by Subject|2|||
170738095|NCT01800201|617047273|FG001|Overall Study|Withdrawal by Subject|0|||
170738096|NCT01800201|617047272|FG000|Overall Study|patient privacy concerns|1|||
170738097|NCT01800201|617047273|FG001|Overall Study|patient privacy concerns|1|||
170738098|NCT01800201|617047272|FG000|Overall Study|did not want to use device|0|||
170738099|NCT01800201|617047273|FG001|Overall Study|did not want to use device|1|||
170738100|NCT01800201|617047272|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
170738101|NCT01800201|617047273|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
170845969|NCT01803282|617442749|FG008|Overall Study|Progressive Disease|3|||
170845970|NCT01803282|617442750|FG009|Overall Study|Progressive Disease|29|||
170845971|NCT01803282|617442751|FG010|Overall Study|Progressive Disease|6|||
170845972|NCT01803282|617442752|FG011|Overall Study|Progressive Disease|11|||
170845973|NCT01803282|617442741|FG000|Overall Study|Death|0|||
170845974|NCT01803282|617442742|FG001|Overall Study|Death|0|||
170845975|NCT01803282|617442743|FG002|Overall Study|Death|0|||
170845976|NCT01803282|617442744|FG003|Overall Study|Death|0|||
170845977|NCT01803282|617442745|FG004|Overall Study|Death|2|||
170845978|NCT01803282|617442746|FG005|Overall Study|Death|1|||
170845979|NCT01803282|617442747|FG006|Overall Study|Death|1|||
170845980|NCT01803282|617442748|FG007|Overall Study|Death|5|||
170845981|NCT01803282|617442749|FG008|Overall Study|Death|1|||
170845982|NCT01803282|617442750|FG009|Overall Study|Death|1|||
170845983|NCT01803282|617442751|FG010|Overall Study|Death|0|||
170845984|NCT01803282|617442752|FG011|Overall Study|Death|0|||
170845985|NCT01803282|617442741|FG000|Overall Study|Withdrew Consent|0|||
170845986|NCT01803282|617442742|FG001|Overall Study|Withdrew Consent|0|||
170845987|NCT01803282|617442743|FG002|Overall Study|Withdrew Consent|0|||
170845988|NCT01803282|617442744|FG003|Overall Study|Withdrew Consent|6|||
170845989|NCT01803282|617442745|FG004|Overall Study|Withdrew Consent|1|||
170845990|NCT01803282|617442746|FG005|Overall Study|Withdrew Consent|0|||
170845991|NCT01803282|617442747|FG006|Overall Study|Withdrew Consent|8|||
170845992|NCT01803282|617442748|FG007|Overall Study|Withdrew Consent|3|||
170845993|NCT01803282|617442749|FG008|Overall Study|Withdrew Consent|1|||
170845994|NCT01803282|617442750|FG009|Overall Study|Withdrew Consent|5|||
170845995|NCT01803282|617442751|FG010|Overall Study|Withdrew Consent|0|||
170845996|NCT01803282|617442752|FG011|Overall Study|Withdrew Consent|1|||
170845997|NCT01803282|617442741|FG000|Overall Study|Investigator's Discretion|0|||
170845998|NCT01803282|617442742|FG001|Overall Study|Investigator's Discretion|0|||
170845999|NCT01803282|617442743|FG002|Overall Study|Investigator's Discretion|0|||
170846000|NCT01803282|617442744|FG003|Overall Study|Investigator's Discretion|7|||
170846001|NCT01803282|617442745|FG004|Overall Study|Investigator's Discretion|2|||
170846002|NCT01803282|617442746|FG005|Overall Study|Investigator's Discretion|1|||
170846003|NCT01803282|617442747|FG006|Overall Study|Investigator's Discretion|7|||
170846004|NCT01803282|617442748|FG007|Overall Study|Investigator's Discretion|10|||
170846005|NCT01803282|617442749|FG008|Overall Study|Investigator's Discretion|6|||
170846006|NCT01803282|617442750|FG009|Overall Study|Investigator's Discretion|7|||
170846007|NCT01803282|617442751|FG010|Overall Study|Investigator's Discretion|1|||
170846008|NCT01803282|617442752|FG011|Overall Study|Investigator's Discretion|0|||
170846009|NCT01803282|617442741|FG000|Overall Study|Adverse Event|0|||
170846010|NCT01803282|617442742|FG001|Overall Study|Adverse Event|0|||
170846011|NCT01803282|617442743|FG002|Overall Study|Adverse Event|0|||
170846012|NCT01803282|617442744|FG003|Overall Study|Adverse Event|0|||
170846013|NCT01803282|617442745|FG004|Overall Study|Adverse Event|0|||
170846014|NCT01803282|617442746|FG005|Overall Study|Adverse Event|0|||
170846015|NCT01803282|617442747|FG006|Overall Study|Adverse Event|1|||
170846016|NCT01803282|617442748|FG007|Overall Study|Adverse Event|2|||
170846017|NCT01803282|617442749|FG008|Overall Study|Adverse Event|0|||
170846018|NCT01803282|617442750|FG009|Overall Study|Adverse Event|1|||
170846019|NCT01803282|617442751|FG010|Overall Study|Adverse Event|0|||
170846020|NCT01803282|617442752|FG011|Overall Study|Adverse Event|3|||
170846021|NCT01803282|617442741|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170846022|NCT01803282|617442742|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170846023|NCT01803282|617442743|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170846024|NCT01803282|617442744|FG003|Overall Study|Non-Compliance with Study Drug|1|||
170846025|NCT01803282|617442745|FG004|Overall Study|Non-Compliance with Study Drug|0|||
170846026|NCT01803282|617442746|FG005|Overall Study|Non-Compliance with Study Drug|0|||
170846027|NCT01803282|617442747|FG006|Overall Study|Non-Compliance with Study Drug|0|||
170846028|NCT01803282|617442748|FG007|Overall Study|Non-Compliance with Study Drug|0|||
170846029|NCT01803282|617442749|FG008|Overall Study|Non-Compliance with Study Drug|0|||
170846030|NCT01803282|617442750|FG009|Overall Study|Non-Compliance with Study Drug|0|||
170846031|NCT01803282|617442751|FG010|Overall Study|Non-Compliance with Study Drug|0|||
170846032|NCT01803282|617442752|FG011|Overall Study|Non-Compliance with Study Drug|0|||
170846033|NCT01803282|617442741|FG000|Overall Study|Unknown Reason|0|||
170846034|NCT01803282|617442742|FG001|Overall Study|Unknown Reason|0|||
170846035|NCT01803282|617442743|FG002|Overall Study|Unknown Reason|0|||
170846036|NCT01803282|617442744|FG003|Overall Study|Unknown Reason|0|||
170846037|NCT01803282|617442745|FG004|Overall Study|Unknown Reason|0|||
170846038|NCT01803282|617442746|FG005|Overall Study|Unknown Reason|0|||
170846039|NCT01803282|617442747|FG006|Overall Study|Unknown Reason|0|||
170846040|NCT01803282|617442748|FG007|Overall Study|Unknown Reason|1|||
170846041|NCT01803282|617442749|FG008|Overall Study|Unknown Reason|0|||
170846042|NCT01803282|617442750|FG009|Overall Study|Unknown Reason|0|||
170846043|NCT01803282|617442751|FG010|Overall Study|Unknown Reason|0|||
170846044|NCT01803282|617442752|FG011|Overall Study|Unknown Reason|0|||
170846045|NCT01803282|617442741|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
170846046|NCT01803282|617442742|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
170846047|NCT01803282|617442743|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
170846048|NCT01803282|617442744|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
170846049|NCT01803282|617442745|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
170846050|NCT01803282|617442746|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
170846051|NCT01803282|617442747|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
170846052|NCT01803282|617442748|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
170846053|NCT01803282|617442749|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
170846054|NCT01803282|617442750|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
170846055|NCT01803282|617442751|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
170738102|NCT00708435|617047274|FG000|Overall Study|Death / Serious Adverse Event|10|||
170738103|NCT00708435|617047275|FG001|Overall Study|Death / Serious Adverse Event|5|||
170738104|NCT00708435|617047274|FG000|Overall Study|Lost to Follow-up|9|||
170846056|NCT01803282|617442752|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
170846057|NCT01803282|617442741|FG000|Overall Study|Enrolled but Never Treated|0|||
170846058|NCT01803282|617442742|FG001|Overall Study|Enrolled but Never Treated|0|||
170846059|NCT01803282|617442743|FG002|Overall Study|Enrolled but Never Treated|0|||
170846060|NCT01803282|617442744|FG003|Overall Study|Enrolled but Never Treated|0|||
170846061|NCT01803282|617442745|FG004|Overall Study|Enrolled but Never Treated|1|||
170846062|NCT01803282|617442746|FG005|Overall Study|Enrolled but Never Treated|0|||
170846063|NCT01803282|617442747|FG006|Overall Study|Enrolled but Never Treated|1|||
170846064|NCT01803282|617442748|FG007|Overall Study|Enrolled but Never Treated|1|||
170846065|NCT01803282|617442749|FG008|Overall Study|Enrolled but Never Treated|0|||
170846066|NCT01803282|617442750|FG009|Overall Study|Enrolled but Never Treated|1|||
170846067|NCT01803282|617442751|FG010|Overall Study|Enrolled but Never Treated|0|||
170846068|NCT01803282|617442752|FG011|Overall Study|Enrolled but Never Treated|0|||
170846069|NCT02235311|617442753|FG000|Overall Study|Lost to Follow-up|0|||
170846070|NCT02235311|617442754|FG001|Overall Study|Lost to Follow-up|1|||
170846071|NCT02235311|617442753|FG000|Overall Study|Protocol Violation|0|||
170846072|NCT02235311|617442754|FG001|Overall Study|Protocol Violation|1|||
170846073|NCT05217641|617442755|FG000|Overall Study|Lost to Follow-up|1|||
170846074|NCT05217641|617442756|FG001|Overall Study|Lost to Follow-up|1|||
170846075|NCT05217641|617442757|FG002|Overall Study|Lost to Follow-up|0|||
170846076|NCT05217641|617442758|FG003|Overall Study|Lost to Follow-up|1|||
170846077|NCT05217641|617442759|FG004|Overall Study|Lost to Follow-up|1|||
170846078|NCT05217641|617442760|FG005|Overall Study|Lost to Follow-up|0|||
170846079|NCT05217641|617442755|FG000|Overall Study|Withdrawal by Subject|0|||
170846080|NCT05217641|617442756|FG001|Overall Study|Withdrawal by Subject|0|||
170846081|NCT05217641|617442757|FG002|Overall Study|Withdrawal by Subject|0|||
170846082|NCT05217641|617442758|FG003|Overall Study|Withdrawal by Subject|3|||
170846083|NCT05217641|617442759|FG004|Overall Study|Withdrawal by Subject|1|||
170846084|NCT05217641|617442760|FG005|Overall Study|Withdrawal by Subject|0|||
170846085|NCT05217641|617442755|FG000|Overall Study|Other: participant did not specify reason|0|||
170846086|NCT05217641|617442756|FG001|Overall Study|Other: participant did not specify reason|0|||
170846087|NCT05217641|617442757|FG002|Overall Study|Other: participant did not specify reason|0|||
170846088|NCT05217641|617442758|FG003|Overall Study|Other: participant did not specify reason|0|||
170846089|NCT05217641|617442759|FG004|Overall Study|Other: participant did not specify reason|1|||
170846090|NCT05217641|617442760|FG005|Overall Study|Other: participant did not specify reason|0|||
170846091|NCT05217641|617442755|FG000|Overall Study|Extended Follow up|1|||
170846092|NCT05217641|617442756|FG001|Overall Study|Extended Follow up|1|||
170846093|NCT05217641|617442757|FG002|Overall Study|Extended Follow up|0|||
170846094|NCT05217641|617442758|FG003|Overall Study|Extended Follow up|0|||
170846095|NCT05217641|617442759|FG004|Overall Study|Extended Follow up|1|||
170846096|NCT05217641|617442760|FG005|Overall Study|Extended Follow up|0|||
170846097|NCT01217437|617442761|FG000|Overall Study|Adverse Event|0|||
170846098|NCT01217437|617442762|FG001|Overall Study|Adverse Event|8|||
170846099|NCT01217437|617442761|FG000|Overall Study|Death|5|||
170846100|NCT01217437|617442762|FG001|Overall Study|Death|0|||
170846101|NCT01217437|617442761|FG000|Overall Study|Lack of Efficacy|29|||
170738105|NCT00708435|617047275|FG001|Overall Study|Lost to Follow-up|4|||
170738106|NCT00708435|617047274|FG000|Overall Study|Withdrawal by Subject|3|||
170738107|NCT00708435|617047275|FG001|Overall Study|Withdrawal by Subject|7|||
170738108|NCT00708435|617047274|FG000|Overall Study|Adverse Event|1|||
170738109|NCT00708435|617047275|FG001|Overall Study|Adverse Event|0|||
170738110|NCT00708435|617047274|FG000|Overall Study|Protocol Violation|0|||
170738111|NCT00708435|617047275|FG001|Overall Study|Protocol Violation|1|||
170738112|NCT00708435|617047274|FG000|Overall Study|Intervention by primary care physician|1|||
170846102|NCT01217437|617442762|FG001|Overall Study|Lack of Efficacy|25|||
170846103|NCT01217437|617442761|FG000|Overall Study|Physician Decision|8|||
170846104|NCT01217437|617442762|FG001|Overall Study|Physician Decision|5|||
170846105|NCT01217437|617442761|FG000|Overall Study|Withdrawal by Subject|0|||
170846106|NCT01217437|617442762|FG001|Overall Study|Withdrawal by Subject|2|||
170846107|NCT01217437|617442761|FG000|Overall Study|Ineligible|1|||
170846108|NCT01217437|617442762|FG001|Overall Study|Ineligible|1|||
170846109|NCT01732822|617444967|FG000|Overall Study|Withdrawal by Subject|123|||
170846110|NCT01732822|617444968|FG001|Overall Study|Withdrawal by Subject|113|||
170846111|NCT01077271|617444969|FG000|Overall Study|Parental desire|8|||
170846112|NCT01077271|617444969|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
170846113|NCT01077271|617444969|FG000|Overall Study|Noncompliance|2|||
170846114|NCT01077271|617444969|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
170846115|NCT01077271|617444969|FG000|Overall Study|Changed doctors|2|||
170846116|NCT01077271|617444969|FG000|Overall Study|Parents thought too many injections|2|||
170846117|NCT01077271|617444969|FG000|Overall Study|End of RSV season nearly reached|1|||
170846118|NCT01077271|617444969|FG000|Overall Study|Mother unconvinced of the necessity|1|||
170846119|NCT01302080|617444970|FG000|Overall Study|Withdrew Consent|92|||
170738113|NCT00708435|617047275|FG001|Overall Study|Intervention by primary care physician|0|||
170738114|NCT00708435|617047274|FG000|Overall Study|Refused hospitalization|1|||
170738115|NCT00708435|617047275|FG001|Overall Study|Refused hospitalization|0|||
170738116|NCT03954743|617047276|FG000|Overall Study|Adverse Event|1|||
170738117|NCT03954743|617047277|FG001|Overall Study|Adverse Event|0|||
170738118|NCT03954743|617047276|FG000|Overall Study|Lost to Follow-up|6|||
170738119|NCT03954743|617047277|FG001|Overall Study|Lost to Follow-up|4|||
170738120|NCT03954743|617047276|FG000|Overall Study|Protocol Violation|1|||
170738121|NCT03954743|617047277|FG001|Overall Study|Protocol Violation|0|||
170738122|NCT03954743|617047276|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
170738123|NCT03954743|617047277|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
170738124|NCT03954743|617047276|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
170738125|NCT03954743|617047277|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170738126|NCT00988221|617047280|FG000|Part I|Adverse Event|0|||
170738127|NCT00988221|617047281|FG001|Part I|Adverse Event|1|||
170738128|NCT00988221|617047282|FG002|Part I|Adverse Event|2|||
170738129|NCT00988221|617047283|FG003|Part I|Adverse Event|0|||
170738130|NCT00988221|617047280|FG000|Part I|Insufficient Therapeutic Response|4|||
170738131|NCT00988221|617047281|FG001|Part I|Insufficient Therapeutic Response|6|||
170738132|NCT00988221|617047282|FG002|Part I|Insufficient Therapeutic Response|5|||
170738133|NCT00988221|617047283|FG003|Part I|Insufficient Therapeutic Response|0|||
170738134|NCT00988221|617047280|FG000|Part I|Refused Treatment|0|||
170738135|NCT00988221|617047281|FG001|Part I|Refused Treatment|2|||
170738136|NCT00988221|617047282|FG002|Part I|Refused Treatment|1|||
170738137|NCT00988221|617047283|FG003|Part I|Refused Treatment|0|||
170738138|NCT00988221|617047280|FG000|Part I|Lost to Follow-up|0|||
170738139|NCT00988221|617047281|FG001|Part I|Lost to Follow-up|1|||
170738140|NCT00988221|617047282|FG002|Part I|Lost to Follow-up|0|||
170738141|NCT00988221|617047283|FG003|Part I|Lost to Follow-up|0|||
170738142|NCT00988221|617047280|FG000|Part II|Adverse Event|1|||
170738143|NCT00988221|617047281|FG001|Part II|Adverse Event|0|||
170738144|NCT00988221|617047282|FG002|Part II|Adverse Event|0|||
170738145|NCT00988221|617047283|FG003|Part II|Adverse Event|1|||
170738146|NCT00988221|617047280|FG000|Part II|Withdrawal by Subject|0|||
170738147|NCT00988221|617047281|FG001|Part II|Withdrawal by Subject|0|||
170738148|NCT00988221|617047282|FG002|Part II|Withdrawal by Subject|2|||
170738149|NCT00988221|617047283|FG003|Part II|Withdrawal by Subject|2|||
170738150|NCT00988221|617047280|FG000|Part II|Reason not Specified|0|||
170738151|NCT00988221|617047281|FG001|Part II|Reason not Specified|0|||
170738152|NCT00988221|617047282|FG002|Part II|Reason not Specified|1|||
170738153|NCT00988221|617047283|FG003|Part II|Reason not Specified|0|||
170738154|NCT00988221|617047280|FG000|Part III|Adverse Event|1|||
170738155|NCT00988221|617047281|FG001|Part III|Adverse Event|0|||
170738156|NCT00988221|617047282|FG002|Part III|Adverse Event|1|||
170738157|NCT00988221|617047283|FG003|Part III|Adverse Event|0|||
170738158|NCT00988221|617047280|FG000|Part III|Insufficient Therapeutic Response|0|||
170738159|NCT00988221|617047281|FG001|Part III|Insufficient Therapeutic Response|1|||
170738160|NCT00988221|617047282|FG002|Part III|Insufficient Therapeutic Response|1|||
170738161|NCT00988221|617047283|FG003|Part III|Insufficient Therapeutic Response|0|||
170738162|NCT00988221|617047280|FG000|Part III|Refused Treatment|0|||
170738163|NCT00988221|617047281|FG001|Part III|Refused Treatment|0|||
170738164|NCT00988221|617047282|FG002|Part III|Refused Treatment|1|||
170738165|NCT00988221|617047283|FG003|Part III|Refused Treatment|0|||
170738166|NCT03812536|617047296|FG000|Overall Study|Protocol Violation|2|||
170738167|NCT03812536|617047297|FG001|Overall Study|Protocol Violation|0|||
170738168|NCT03812536|617047296|FG000|Overall Study|Withdrawal by Subject|1|||
170738169|NCT03812536|617047297|FG001|Overall Study|Withdrawal by Subject|1|||
170738170|NCT00152009|617047298|FG000|Overall Study|Adverse Event|9|||
170738171|NCT00152009|617047299|FG001|Overall Study|Adverse Event|13|||
170738172|NCT00152009|617047300|FG002|Overall Study|Adverse Event|20|||
170738173|NCT00152009|617047301|FG003|Overall Study|Adverse Event|1|||
170738174|NCT00152009|617047298|FG000|Overall Study|Protocol Violation|3|||
170738175|NCT00152009|617047299|FG001|Overall Study|Protocol Violation|0|||
170738176|NCT00152009|617047300|FG002|Overall Study|Protocol Violation|0|||
170738177|NCT00152009|617047301|FG003|Overall Study|Protocol Violation|1|||
170738178|NCT00152009|617047298|FG000|Overall Study|Withdrawal by Subject|2|||
170738179|NCT00152009|617047299|FG001|Overall Study|Withdrawal by Subject|3|||
170738180|NCT00152009|617047300|FG002|Overall Study|Withdrawal by Subject|4|||
170738181|NCT00152009|617047301|FG003|Overall Study|Withdrawal by Subject|9|||
170846120|NCT01302080|617444971|FG001|Overall Study|Withdrew Consent|39|||
170846121|NCT01302080|617444970|FG000|Overall Study|Patient/Family Moved|28|||
170846122|NCT01302080|617444971|FG001|Overall Study|Patient/Family Moved|3|||
170846123|NCT01302080|617444970|FG000|Overall Study|Lost to Follow-up|192|||
170846124|NCT01302080|617444971|FG001|Overall Study|Lost to Follow-up|93|||
170846125|NCT01302080|617444970|FG000|Overall Study|Death|1|||
170846126|NCT01302080|617444971|FG001|Overall Study|Death|0|||
170846127|NCT01302080|617444970|FG000|Overall Study|Other|52|||
170846128|NCT01302080|617444971|FG001|Overall Study|Other|8|||
170846129|NCT01302080|617444970|FG000|Overall Study|Reason Missing For Discontinuation|1|||
170846130|NCT01302080|617444971|FG001|Overall Study|Reason Missing For Discontinuation|0|||
170846131|NCT05816330|617444976|FG000|Overall Study|Withdrawal by Subject|4|||
170846132|NCT05816330|617444977|FG001|Overall Study|Withdrawal by Subject|1|||
170846133|NCT00201643|617444978|FG000|Overall Study|Withdrawal by Subject|5|||
170846134|NCT00201643|617444979|FG001|Overall Study|Withdrawal by Subject|4|||
170846135|NCT02898077|617444986|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
170846136|NCT02898077|617444987|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
170846137|NCT02898077|617444986|FG000|Overall Study|Lost to Follow-up|4|||
170846138|NCT02898077|617444987|FG001|Overall Study|Lost to Follow-up|3|||
170846139|NCT02898077|617444986|FG000|Overall Study|Physician Decision|0|||
170846140|NCT02898077|617444987|FG001|Overall Study|Physician Decision|2|||
170846141|NCT02898077|617444986|FG000|Overall Study|Sponsor Decision|32|||
170846142|NCT02898077|617444987|FG001|Overall Study|Sponsor Decision|13|||
170846143|NCT02898077|617444986|FG000|Overall Study|Withdrawal by Subject|6|||
170846144|NCT02898077|617444987|FG001|Overall Study|Withdrawal by Subject|3|||
170846145|NCT02898077|617444986|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
170846146|NCT02898077|617444987|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
170846147|NCT02898077|617444986|FG000|Overall Study|Ended extension period|3|||
170846148|NCT02898077|617444987|FG001|Overall Study|Ended extension period|0|||
170846149|NCT02060370|617444988|FG000|Overall Study|Physician Decision|1|||
170846150|NCT00731133|617444989|FG000|Overall Study|Withdrawal by Subject|10|||
170846151|NCT00943852|617444990|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846152|NCT00943852|617444991|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846153|NCT00943852|617444992|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846154|NCT00943852|617444993|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
170846155|NCT00943852|617444994|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846156|NCT00943852|617444995|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846157|NCT00943852|617444996|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846158|NCT00943852|617444997|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846159|NCT00943852|617444998|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846160|NCT00943852|617444999|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
170846161|NCT00943852|617444990|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846162|NCT00943852|617444991|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846163|NCT00943852|617444992|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846164|NCT00943852|617444993|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846165|NCT00943852|617444994|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846166|NCT00943852|617444995|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
170846167|NCT00943852|617444996|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846168|NCT00943852|617444997|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846169|NCT00943852|617444998|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846170|NCT00943852|617444999|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
170846171|NCT00943852|617444990|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170846172|NCT00943852|617444991|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170846173|NCT00943852|617444992|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170846174|NCT00943852|617444993|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170846175|NCT00943852|617444994|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170846176|NCT00943852|617444995|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170738182|NCT00152009|617047298|FG000|Overall Study|Lost to Follow-up|2|||
170738183|NCT00152009|617047299|FG001|Overall Study|Lost to Follow-up|4|||
170846177|NCT00943852|617444996|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
170846178|NCT00943852|617444997|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170846179|NCT00943852|617444998|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170846180|NCT00943852|617444999|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
170846181|NCT00943852|617444990|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846182|NCT00943852|617444991|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846183|NCT00943852|617444992|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846184|NCT00943852|617444993|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846185|NCT00943852|617444994|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846186|NCT00943852|617444995|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846187|NCT00943852|617444996|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846188|NCT00943852|617444997|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
170846189|NCT00943852|617444998|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846190|NCT00943852|617444999|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
170846191|NCT00943852|617444990|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
170846192|NCT00943852|617444991|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
170846193|NCT00943852|617444992|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
170846194|NCT00943852|617444993|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
170846195|NCT00943852|617444994|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
170846196|NCT00943852|617444995|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
170846197|NCT00943852|617444996|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
170846198|NCT00943852|617444997|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
170846199|NCT00943852|617444998|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
170846200|NCT00943852|617444999|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
170846201|NCT00734591|617445004|FG000|Screening for Prospective Period|Site did not participate|1604|||
170846202|NCT00734591|617445005|FG001|Screening for Prospective Period|Site did not participate|1488|||
170846203|NCT00734591|617445004|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
170846204|NCT00734591|617445005|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
170846205|NCT00734591|617445004|FG000|Prospective Period|Withdrawal by Subject|11|||
170846206|NCT00734591|617445005|FG001|Prospective Period|Withdrawal by Subject|9|||
170846207|NCT00734591|617445004|FG000|Prospective Period|Lost to Follow-up|37|||
170846208|NCT00734591|617445005|FG001|Prospective Period|Lost to Follow-up|33|||
170846209|NCT00734591|617445004|FG000|Prospective Period|Study Terminated|1|||
170846210|NCT00734591|617445005|FG001|Prospective Period|Study Terminated|0|||
170846211|NCT00734591|617445004|FG000|Prospective Period|Other|2|||
170846212|NCT00734591|617445005|FG001|Prospective Period|Other|2|||
170846213|NCT03248882|617445009|FG000|Overall Study|Adverse Event|3|||
170846214|NCT03248882|617445010|FG001|Overall Study|Adverse Event|3|||
170846215|NCT03248882|617445011|FG002|Overall Study|Adverse Event|2|||
170846216|NCT03248882|617445012|FG003|Overall Study|Adverse Event|6|||
170846217|NCT03248882|617445013|FG004|Overall Study|Adverse Event|9|||
170846218|NCT03248882|617445009|FG000|Overall Study|Lost to Follow-up|0|||
170846219|NCT03248882|617445010|FG001|Overall Study|Lost to Follow-up|0|||
170846220|NCT03248882|617445011|FG002|Overall Study|Lost to Follow-up|0|||
170846221|NCT03248882|617445012|FG003|Overall Study|Lost to Follow-up|0|||
170846222|NCT03248882|617445013|FG004|Overall Study|Lost to Follow-up|1|||
170846223|NCT03248882|617445009|FG000|Overall Study|Protocol Violation|2|||
170846224|NCT03248882|617445010|FG001|Overall Study|Protocol Violation|0|||
170846225|NCT03248882|617445011|FG002|Overall Study|Protocol Violation|2|||
170846226|NCT03248882|617445012|FG003|Overall Study|Protocol Violation|0|||
170846227|NCT03248882|617445013|FG004|Overall Study|Protocol Violation|1|||
170846228|NCT03248882|617445009|FG000|Overall Study|Withdrawal by Subject|2|||
170846229|NCT03248882|617445010|FG001|Overall Study|Withdrawal by Subject|2|||
170846230|NCT03248882|617445011|FG002|Overall Study|Withdrawal by Subject|3|||
170846231|NCT03248882|617445012|FG003|Overall Study|Withdrawal by Subject|4|||
170846232|NCT03248882|617445013|FG004|Overall Study|Withdrawal by Subject|2|||
170846233|NCT02236988|617445014|FG000|Overall Study|Lost to Follow-up|0|||
170846234|NCT02236988|617445015|FG001|Overall Study|Lost to Follow-up|0|||
170846235|NCT02236988|617445016|FG002|Overall Study|Lost to Follow-up|0|||
170846236|NCT02236988|617445017|FG003|Overall Study|Lost to Follow-up|1|||
170846237|NCT02236988|617445014|FG000|Overall Study|Unable to Comply with Study Visits|0|||
170846238|NCT02236988|617445015|FG001|Overall Study|Unable to Comply with Study Visits|0|||
170846239|NCT02236988|617445016|FG002|Overall Study|Unable to Comply with Study Visits|0|||
170846240|NCT02236988|617445017|FG003|Overall Study|Unable to Comply with Study Visits|2|||
170846241|NCT04308590|617445018|FG000|Overall Study|Adverse Event|12|||
170846242|NCT04308590|617445019|FG001|Overall Study|Adverse Event|2|||
170846243|NCT04308590|617445018|FG000|Overall Study|Withdrawal by Subject|10|||
170846244|NCT04308590|617445019|FG001|Overall Study|Withdrawal by Subject|4|||
170846245|NCT04308590|617445018|FG000|Overall Study|Death|1|||
170846246|NCT04308590|617445019|FG001|Overall Study|Death|0|||
170846247|NCT04308590|617445018|FG000|Overall Study|Lost to Follow-up|1|||
170846248|NCT04308590|617445019|FG001|Overall Study|Lost to Follow-up|1|||
170846249|NCT04308590|617445018|FG000|Overall Study|Physician Decision|1|||
170846250|NCT04308590|617445019|FG001|Overall Study|Physician Decision|0|||
170846251|NCT04308590|617445018|FG000|Overall Study|Subject does not want to continue with Pi|0|||
170846252|NCT04308590|617445019|FG001|Overall Study|Subject does not want to continue with Pi|1|||
170846253|NCT00939822|617445020|FG000|Overall Study|Lost to Follow-up|1|||
170846254|NCT00939822|617445021|FG001|Overall Study|Lost to Follow-up|0|||
170846255|NCT00939822|617445020|FG000|Overall Study|withdrew from study due to busy schedule|1|||
170846256|NCT00939822|617445021|FG001|Overall Study|withdrew from study due to busy schedule|1|||
170846257|NCT00939822|617445020|FG000|Overall Study|Mental health issues|0|||
170846258|NCT00939822|617445021|FG001|Overall Study|Mental health issues|2|||
170846259|NCT01072630|617445026|FG000|Overall Study|Adverse Event|11|||
170846260|NCT01072630|617445027|FG001|Overall Study|Adverse Event|19|||
170846261|NCT01072630|617445028|FG002|Overall Study|Adverse Event|2|||
170846262|NCT01072630|617445026|FG000|Overall Study|Lack of Efficacy|10|||
170846263|NCT01072630|617445027|FG001|Overall Study|Lack of Efficacy|10|||
170846264|NCT01072630|617445028|FG002|Overall Study|Lack of Efficacy|1|||
170846265|NCT01072630|617445026|FG000|Overall Study|Withdrawal by Subject|8|||
170846266|NCT01072630|617445027|FG001|Overall Study|Withdrawal by Subject|7|||
170846267|NCT01072630|617445028|FG002|Overall Study|Withdrawal by Subject|2|||
170846268|NCT01072630|617445026|FG000|Overall Study|Protocol Violation|10|||
170846269|NCT01072630|617445027|FG001|Overall Study|Protocol Violation|8|||
170846270|NCT01072630|617445028|FG002|Overall Study|Protocol Violation|4|||
170738184|NCT00152009|617047300|FG002|Overall Study|Lost to Follow-up|3|||
170738185|NCT00152009|617047301|FG003|Overall Study|Lost to Follow-up|3|||
170738186|NCT00152009|617047298|FG000|Overall Study|Lack of Efficacy|8|||
170738187|NCT00152009|617047299|FG001|Overall Study|Lack of Efficacy|6|||
170738188|NCT00152009|617047300|FG002|Overall Study|Lack of Efficacy|7|||
170738189|NCT00152009|617047301|FG003|Overall Study|Lack of Efficacy|15|||
170738190|NCT00152009|617047298|FG000|Overall Study|ECG abnormalities|2|||
170738191|NCT00152009|617047299|FG001|Overall Study|ECG abnormalities|2|||
170738192|NCT00152009|617047300|FG002|Overall Study|ECG abnormalities|2|||
170738193|NCT00152009|617047301|FG003|Overall Study|ECG abnormalities|1|||
170738194|NCT00152009|617047298|FG000|Overall Study|Sponsor's decision|3|||
170738195|NCT00152009|617047299|FG001|Overall Study|Sponsor's decision|3|||
170738196|NCT00152009|617047300|FG002|Overall Study|Sponsor's decision|1|||
170738197|NCT00152009|617047301|FG003|Overall Study|Sponsor's decision|3|||
170738198|NCT01306201|617047304|FG000|Overall Study|Arrhythmia|4|||
170738199|NCT01306201|617047304|FG000|Overall Study|Files could not be processed|3|||
170738200|NCT01306201|617047304|FG000|Overall Study|Files unreadable|3|||
170738201|NCT03107377|617047309|FG000|Overall Study|Adverse Event|3|||
170738202|NCT03107377|617047310|FG001|Overall Study|Adverse Event|3|||
170738203|NCT03107377|617047309|FG000|Overall Study|Protocol Violation|9|||
170738204|NCT03107377|617047310|FG001|Overall Study|Protocol Violation|12|||
170738205|NCT03107377|617047309|FG000|Overall Study|Physician Decision|3|||
170738206|NCT03107377|617047310|FG001|Overall Study|Physician Decision|6|||
170738207|NCT03107377|617047309|FG000|Overall Study|Pregnancy|7|||
170738208|NCT03107377|617047310|FG001|Overall Study|Pregnancy|7|||
170738209|NCT03107377|617047309|FG000|Overall Study|Withdrawal by Subject|16|||
170738210|NCT03107377|617047310|FG001|Overall Study|Withdrawal by Subject|22|||
170738211|NCT03107377|617047309|FG000|Overall Study|Lost to Follow-up|37|||
170738212|NCT03107377|617047310|FG001|Overall Study|Lost to Follow-up|34|||
170738213|NCT03107377|617047309|FG000|Overall Study|Other reason not specified|16|||
170738214|NCT03107377|617047310|FG001|Overall Study|Other reason not specified|15|||
170738215|NCT01320943|617047314|FG000|Overall Study|Lost to Follow-up|1|||
170738216|NCT01320943|617047315|FG001|Overall Study|Lost to Follow-up|0|||
170738217|NCT01320943|617047314|FG000|Overall Study|Physician Decision|0|||
170738218|NCT01320943|617047315|FG001|Overall Study|Physician Decision|1|||
170738219|NCT01320943|617047314|FG000|Overall Study|Randomized but not Treated|0|||
170738220|NCT01320943|617047315|FG001|Overall Study|Randomized but not Treated|1|||
170738221|NCT00117156|617047316|FG000|Overall Study|Adverse Event|9|||
170738222|NCT00117156|617047316|FG000|Overall Study|Physician Decision|1|||
170738223|NCT00117156|617047316|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
170738224|NCT00990340|617047317|FG000|First 14-day Treatment|Not Compliant|2|||
170738225|NCT00990340|617047318|FG001|First 14-day Treatment|Not Compliant|1|||
170738226|NCT00990340|617047317|FG000|First 14-day Treatment|Lost to Follow-up|2|||
170738227|NCT00990340|617047318|FG001|First 14-day Treatment|Lost to Follow-up|1|||
170738228|NCT00990340|617047317|FG000|First 14-day Treatment|Protocol Violation|2|||
170738229|NCT00990340|617047318|FG001|First 14-day Treatment|Protocol Violation|2|||
170738230|NCT01126060|617047319|FG000|Overall Study|Protocol Violation|0|||
170738231|NCT01126060|617047320|FG001|Overall Study|Protocol Violation|2|||
170846271|NCT01072630|617445026|FG000|Overall Study|Lost to Follow-up|11|||
170846272|NCT01072630|617445027|FG001|Overall Study|Lost to Follow-up|11|||
170846273|NCT01072630|617445028|FG002|Overall Study|Lost to Follow-up|1|||
170846274|NCT01072630|617445026|FG000|Overall Study|Noncompliance with study medication|1|||
170846275|NCT01072630|617445027|FG001|Overall Study|Noncompliance with study medication|1|||
170846276|NCT01072630|617445028|FG002|Overall Study|Noncompliance with study medication|1|||
170846277|NCT01072630|617445026|FG000|Overall Study|Noncompliance with study procedures|1|||
170846278|NCT01072630|617445027|FG001|Overall Study|Noncompliance with study procedures|2|||
170846279|NCT01072630|617445028|FG002|Overall Study|Noncompliance with study procedures|1|||
170846280|NCT01072630|617445026|FG000|Overall Study|Other|3|||
170846281|NCT01072630|617445027|FG001|Overall Study|Other|2|||
170846282|NCT01072630|617445028|FG002|Overall Study|Other|1|||
170846283|NCT00338962|617445029|FG000|Overall Study|Lost to Follow-up|3|||
170846284|NCT00338962|617445030|FG001|Overall Study|Lost to Follow-up|3|||
170846285|NCT00338962|617445031|FG002|Overall Study|Lost to Follow-up|2|||
170846286|NCT00338962|617445032|FG003|Overall Study|Lost to Follow-up|3|||
170846287|NCT00338962|617445029|FG000|Overall Study|Withdrawal by Subject|1|||
170846288|NCT00338962|617445030|FG001|Overall Study|Withdrawal by Subject|0|||
170846289|NCT00338962|617445031|FG002|Overall Study|Withdrawal by Subject|0|||
170846290|NCT00338962|617445032|FG003|Overall Study|Withdrawal by Subject|0|||
170846291|NCT00338962|617445029|FG000|Overall Study|No Transportation|2|||
170846292|NCT00338962|617445030|FG001|Overall Study|No Transportation|0|||
170846293|NCT00338962|617445031|FG002|Overall Study|No Transportation|0|||
170846294|NCT00338962|617445032|FG003|Overall Study|No Transportation|0|||
170846295|NCT00338962|617445029|FG000|Overall Study|Time Constraint|2|||
170846296|NCT00338962|617445030|FG001|Overall Study|Time Constraint|0|||
170846297|NCT00338962|617445031|FG002|Overall Study|Time Constraint|0|||
170846298|NCT00338962|617445032|FG003|Overall Study|Time Constraint|0|||
170846299|NCT00338962|617445029|FG000|Overall Study|Moved|0|||
170846300|NCT00338962|617445030|FG001|Overall Study|Moved|1|||
170846301|NCT00338962|617445031|FG002|Overall Study|Moved|0|||
170846302|NCT00338962|617445032|FG003|Overall Study|Moved|0|||
170846303|NCT00338962|617445029|FG000|Overall Study|Adverse Event|0|||
170846304|NCT00338962|617445030|FG001|Overall Study|Adverse Event|0|||
170846305|NCT00338962|617445031|FG002|Overall Study|Adverse Event|2|||
170846306|NCT00338962|617445032|FG003|Overall Study|Adverse Event|0|||
170846307|NCT00338962|617445029|FG000|Overall Study|Poor Compliance|0|||
170846308|NCT00338962|617445030|FG001|Overall Study|Poor Compliance|0|||
170846309|NCT00338962|617445031|FG002|Overall Study|Poor Compliance|2|||
170846310|NCT00338962|617445032|FG003|Overall Study|Poor Compliance|0|||
170846311|NCT02683785|617445033|FG000|Overall Study|Withdrawal by Subject|1|||
170846312|NCT02683785|617445034|FG001|Overall Study|Withdrawal by Subject|1|||
170846313|NCT02683785|617445033|FG000|Overall Study|Lost to Follow-up|0|||
170846314|NCT02683785|617445034|FG001|Overall Study|Lost to Follow-up|1|||
170846315|NCT02683785|617445033|FG000|Overall Study|Adverse Event|0|||
170846316|NCT02683785|617445034|FG001|Overall Study|Adverse Event|2|||
170846317|NCT00416195|617445035|FG000|Overall Study|Adverse Event|1|||
170846318|NCT00416195|617445036|FG001|Overall Study|Adverse Event|2|||
170846319|NCT00416195|617445035|FG000|Overall Study|Protocol Violation|1|||
170846320|NCT00416195|617445036|FG001|Overall Study|Protocol Violation|1|||
170846321|NCT00416195|617445035|FG000|Overall Study|Other|0|||
170846322|NCT00416195|617445036|FG001|Overall Study|Other|1|||
170846323|NCT01305408|617445037|FG000|Overall Study|Adverse Event|10|||
170846324|NCT01305408|617445038|FG001|Overall Study|Adverse Event|7|||
170846325|NCT01305408|617445037|FG000|Overall Study|Lack of Efficacy|3|||
170846326|NCT01305408|617445038|FG001|Overall Study|Lack of Efficacy|4|||
170846327|NCT01305408|617445037|FG000|Overall Study|Withdrawal by Subject|9|||
170846328|NCT01305408|617445038|FG001|Overall Study|Withdrawal by Subject|9|||
170846329|NCT01305408|617445037|FG000|Overall Study|Protocol Violation|4|||
170846330|NCT01305408|617445038|FG001|Overall Study|Protocol Violation|6|||
170846331|NCT01305408|617445037|FG000|Overall Study|Lost to Follow-up|5|||
170846332|NCT01305408|617445038|FG001|Overall Study|Lost to Follow-up|3|||
170846333|NCT01305408|617445037|FG000|Overall Study|Noncompliance with study medication|0|||
170846334|NCT01305408|617445038|FG001|Overall Study|Noncompliance with study medication|1|||
170846335|NCT01305408|617445037|FG000|Overall Study|Noncompliance with study procedures|0|||
170846336|NCT01305408|617445038|FG001|Overall Study|Noncompliance with study procedures|1|||
170846337|NCT01305408|617445037|FG000|Overall Study|Other|1|||
170846338|NCT01305408|617445038|FG001|Overall Study|Other|0|||
170846339|NCT02530970|617445039|FG000|Overall Study|Adverse Event|8|||
170846340|NCT02530970|617445039|FG000|Overall Study|Lost to Follow-up|88|||
170846341|NCT02530970|617445039|FG000|Overall Study|Physician Decision|5|||
170846342|NCT02530970|617445039|FG000|Overall Study|Withdrawal by Subject|14|||
170846343|NCT02530970|617445039|FG000|Overall Study|Death|6|||
170846344|NCT02530970|617445039|FG000|Overall Study|Hospitalization|1|||
170846345|NCT02530970|617445039|FG000|Overall Study|Insurance|2|||
170846346|NCT02530970|617445039|FG000|Overall Study|Explant|2|||
170846347|NCT02530970|617445039|FG000|Overall Study|Change in Provider|5|||
170846348|NCT02530970|617445039|FG000|Overall Study|Relocation|3|||
170846349|NCT01877239|617445041|FG000|Overall Study|Adverse Event|4|||
170846350|NCT01877239|617445041|FG000|Overall Study|Disease Remission|1|||
170846351|NCT01877239|617445041|FG000|Overall Study|Withdrawal by Subject|4|||
170846352|NCT01877239|617445041|FG000|Overall Study|Other|2|||
170846353|NCT01877239|617445041|FG000|Overall Study|Lack of Efficacy|4|||
170846354|NCT01877239|617445041|FG000|Overall Study|Data not available|35|||
170846355|NCT00444275|617445045|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
170846356|NCT00444275|617445046|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
170846357|NCT00444275|617445047|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
170846358|NCT00444275|617445048|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
170846359|NCT00444275|617445049|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
170846360|NCT00444275|617445045|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
170846361|NCT00444275|617445046|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
170846362|NCT00444275|617445047|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
170846363|NCT00444275|617445048|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
170846364|NCT00444275|617445049|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
170846365|NCT00444275|617445045|FG000|Maintenance Treatment Phase|Adverse Event|0|||
170846366|NCT00444275|617445046|FG001|Maintenance Treatment Phase|Adverse Event|0|||
170846367|NCT00444275|617445047|FG002|Maintenance Treatment Phase|Adverse Event|3|||
170846368|NCT00444275|617445048|FG003|Maintenance Treatment Phase|Adverse Event|2|||
170846369|NCT00444275|617445049|FG004|Maintenance Treatment Phase|Adverse Event|13|||
170846370|NCT00444275|617445045|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
170846371|NCT00444275|617445046|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
170846372|NCT00444275|617445047|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
170846373|NCT00444275|617445048|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
170846374|NCT00444275|617445049|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
170846375|NCT00444275|617445045|FG000|Maintenance Treatment Phase|Patient's wish|0|||
170846376|NCT00444275|617445046|FG001|Maintenance Treatment Phase|Patient's wish|0|||
170846377|NCT00444275|617445047|FG002|Maintenance Treatment Phase|Patient's wish|19|||
170846378|NCT00444275|617445048|FG003|Maintenance Treatment Phase|Patient's wish|9|||
170846379|NCT00444275|617445049|FG004|Maintenance Treatment Phase|Patient's wish|20|||
170846380|NCT00444275|617445045|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
170846381|NCT00444275|617445046|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
170846382|NCT00444275|617445047|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
170846383|NCT00444275|617445048|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
170846384|NCT00444275|617445049|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
170846385|NCT00444275|617445045|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
170846386|NCT00444275|617445046|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
170846387|NCT00444275|617445047|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
170846388|NCT00444275|617445048|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
170846389|NCT00444275|617445049|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
170846390|NCT03291288|617445050|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
170846391|NCT03291288|617445051|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
170738232|NCT01874145|617047321|FG000|Core Period|Non-compliance|1|||
170738233|NCT01874145|617047322|FG001|Core Period|Non-compliance|0|||
170738234|NCT01874145|617047321|FG000|Core Period|Protocol Violation|1|||
170738235|NCT01874145|617047322|FG001|Core Period|Protocol Violation|1|||
170738236|NCT01874145|617047321|FG000|Core Period|Physician Decision|1|||
170738237|NCT01874145|617047322|FG001|Core Period|Physician Decision|1|||
170738238|NCT01874145|617047321|FG000|Core Period|Adverse Event|0|||
170738239|NCT01874145|617047322|FG001|Core Period|Adverse Event|1|||
170738240|NCT01874145|617047321|FG000|Core Period|Withdrawal by Subject|0|||
170738241|NCT01874145|617047322|FG001|Core Period|Withdrawal by Subject|4|||
170738242|NCT01874145|617047321|FG000|Extension Period|Adverse Event|3|||
170738243|NCT01874145|617047322|FG001|Extension Period|Adverse Event|2|||
170738244|NCT01874145|617047321|FG000|Extension Period|Withdrawal by Subject|2|||
170738245|NCT01874145|617047322|FG001|Extension Period|Withdrawal by Subject|1|||
170738246|NCT01874145|617047321|FG000|Extension Period|Lost to Follow-up|1|||
170738247|NCT01874145|617047322|FG001|Extension Period|Lost to Follow-up|1|||
170738248|NCT00402337|617047323|FG000|Overall Study|Adverse Event|0|||
170738249|NCT00402337|617047324|FG001|Overall Study|Adverse Event|2|||
170738250|NCT00402337|617047325|FG002|Overall Study|Adverse Event|2|||
170738251|NCT00402337|617047326|FG003|Overall Study|Adverse Event|3|||
170738252|NCT00402337|617047327|FG004|Overall Study|Adverse Event|2|||
170738253|NCT00402337|617047323|FG000|Overall Study|Noncompliance|0|||
170738254|NCT00402337|617047324|FG001|Overall Study|Noncompliance|0|||
170738255|NCT00402337|617047325|FG002|Overall Study|Noncompliance|0|||
170738256|NCT00402337|617047326|FG003|Overall Study|Noncompliance|0|||
170738257|NCT00402337|617047327|FG004|Overall Study|Noncompliance|2|||
170738258|NCT00402337|617047323|FG000|Overall Study|Withdrawal by Subject|5|||
170738259|NCT00402337|617047324|FG001|Overall Study|Withdrawal by Subject|3|||
170738260|NCT00402337|617047325|FG002|Overall Study|Withdrawal by Subject|1|||
170738261|NCT00402337|617047326|FG003|Overall Study|Withdrawal by Subject|6|||
170738262|NCT00402337|617047327|FG004|Overall Study|Withdrawal by Subject|4|||
170738263|NCT00402337|617047323|FG000|Overall Study|Lost to Follow-up|0|||
170738264|NCT00402337|617047324|FG001|Overall Study|Lost to Follow-up|0|||
170738265|NCT00402337|617047325|FG002|Overall Study|Lost to Follow-up|1|||
170738266|NCT00402337|617047326|FG003|Overall Study|Lost to Follow-up|2|||
170738267|NCT00402337|617047327|FG004|Overall Study|Lost to Follow-up|0|||
170738268|NCT00402337|617047323|FG000|Overall Study|Physician Decision|0|||
170738269|NCT00402337|617047324|FG001|Overall Study|Physician Decision|0|||
170738270|NCT00402337|617047325|FG002|Overall Study|Physician Decision|0|||
170738271|NCT00402337|617047326|FG003|Overall Study|Physician Decision|1|||
170738272|NCT00402337|617047327|FG004|Overall Study|Physician Decision|0|||
170738273|NCT00402337|617047323|FG000|Overall Study|Other Reason|0|||
170738274|NCT00402337|617047324|FG001|Overall Study|Other Reason|1|||
170738275|NCT00402337|617047325|FG002|Overall Study|Other Reason|0|||
170738276|NCT00402337|617047326|FG003|Overall Study|Other Reason|0|||
170738277|NCT00402337|617047327|FG004|Overall Study|Other Reason|0|||
170738278|NCT01992549|617049686|FG000|Overall Study|Lost to Follow-up|2|||
170738279|NCT01992549|617049686|FG000|Overall Study|Serious Adverse Event|1|||
170738280|NCT01992549|617049686|FG000|Overall Study|Product Switch to Extend Half Life|1|||
170738281|NCT00840996|617049689|FG000|Overall Study|Withdrawal by Subject|1|||
170738282|NCT00840996|617049690|FG001|Overall Study|Withdrawal by Subject|0|||
170738283|NCT03518658|617049694|FG000|Overall Study|Other|51|||
170738284|NCT03518658|617049695|FG001|Overall Study|Other|0|||
170738285|NCT00649389|617049696|FG000|Overall Study|Adverse Event|22|||
170738286|NCT00649389|617049697|FG001|Overall Study|Adverse Event|46|||
170738287|NCT00649389|617049698|FG002|Overall Study|Adverse Event|38|||
170738288|NCT00649389|617049699|FG003|Overall Study|Adverse Event|48|||
170738289|NCT00649389|617049696|FG000|Overall Study|Lost to Follow-up|15|||
170738290|NCT00649389|617049697|FG001|Overall Study|Lost to Follow-up|17|||
170738291|NCT00649389|617049698|FG002|Overall Study|Lost to Follow-up|21|||
170738292|NCT00649389|617049699|FG003|Overall Study|Lost to Follow-up|26|||
170738293|NCT00649389|617049696|FG000|Overall Study|Protocol Violation|11|||
170738294|NCT00649389|617049697|FG001|Overall Study|Protocol Violation|13|||
170738295|NCT00649389|617049698|FG002|Overall Study|Protocol Violation|9|||
170738296|NCT00649389|617049699|FG003|Overall Study|Protocol Violation|8|||
170738297|NCT00649389|617049696|FG000|Overall Study|Withdrawal by Subject|20|||
170738298|NCT00649389|617049697|FG001|Overall Study|Withdrawal by Subject|21|||
170738299|NCT00649389|617049698|FG002|Overall Study|Withdrawal by Subject|19|||
170738300|NCT00649389|617049699|FG003|Overall Study|Withdrawal by Subject|23|||
170738301|NCT00649389|617049696|FG000|Overall Study|Other|3|||
170738302|NCT00649389|617049697|FG001|Overall Study|Other|9|||
170738303|NCT00649389|617049698|FG002|Overall Study|Other|1|||
170738304|NCT00649389|617049699|FG003|Overall Study|Other|6|||
170738305|NCT02746575|617049702|FG000|Overall Study|Surgery cancelled or time chaned|13|||
170738306|NCT02746575|617049702|FG000|Overall Study|Received epidural|10|||
170738307|NCT02746575|617049702|FG000|Overall Study|Withdrawal by Subject|3|||
170738308|NCT02746575|617049702|FG000|Overall Study|Bradycardia/hypotension|9|||
170738309|NCT02746575|617049702|FG000|Overall Study|Study paused|8|||
170738310|NCT02746575|617049702|FG000|Overall Study|put on beta-blocker|3|||
170738311|NCT02746575|617049702|FG000|Overall Study|type of surgery|1|||
170738312|NCT02746575|617049702|FG000|Overall Study|typ of surgery|1|||
170738313|NCT02746575|617049702|FG000|Overall Study|PI unavailable|1|||
170738314|NCT02746575|617049702|FG000|Overall Study|Unknown history of CVA|1|||
170738315|NCT02762981|617049703|FG000|Overall Study|Adverse Event|2|||
170738316|NCT02762981|617049704|FG001|Overall Study|Adverse Event|3|||
170738317|NCT02762981|617049705|FG002|Overall Study|Adverse Event|1|||
170738318|NCT02762981|617049706|FG003|Overall Study|Adverse Event|1|||
170846392|NCT03291288|617445050|FG000|Drug-drug Interaction Phase|Disease progression|1|||
170846393|NCT03291288|617445051|FG001|Drug-drug Interaction Phase|Disease progression|0|||
170846394|NCT03291288|617445050|FG000|Drug-drug Interaction Phase|Other|3|||
170846395|NCT03291288|617445051|FG001|Drug-drug Interaction Phase|Other|0|||
170846396|NCT03291288|617445050|FG000|Pexidartinib Only|Ongoing|0|||
170846397|NCT03291288|617445051|FG001|Pexidartinib Only|Ongoing|2|||
170846398|NCT04978493|617445052|FG000|Overall Study|No reason available|0|||
170846399|NCT04978493|617445053|FG001|Overall Study|No reason available|1|||
170846400|NCT04978493|617445052|FG000|Overall Study|Adverse Event|1|||
170846401|NCT04978493|617445053|FG001|Overall Study|Adverse Event|0|||
170846402|NCT01128114|617445054|FG000|Overall Study|Treatment Withdrawn|6|||
170846403|NCT01128114|617445054|FG000|Overall Study|Screening Failed|2|||
170846404|NCT02387970|617445057|FG000|Overall Study|Did not complete 1-year follow up|1|||
170846405|NCT02387970|617445058|FG001|Overall Study|Did not complete 1-year follow up|2|||
170846406|NCT01743989|617445067|FG000|Treatment Phase|Unstable MR4.0|0|||
170846407|NCT01743989|617445068|FG001|Treatment Phase|Unstable MR4.0|6|||
170846408|NCT01743989|617445069|FG002|Treatment Phase|Unstable MR4.0|263|||
170846409|NCT01743989|617445067|FG000|Treatment Phase|Adverse Event|0|||
170846410|NCT01743989|617445068|FG001|Treatment Phase|Adverse Event|4|||
170846411|NCT01743989|617445069|FG002|Treatment Phase|Adverse Event|67|||
170846412|NCT01743989|617445067|FG000|Treatment Phase|Withdrawal by Subject|1|||
170846413|NCT01743989|617445068|FG001|Treatment Phase|Withdrawal by Subject|3|||
170846414|NCT01743989|617445069|FG002|Treatment Phase|Withdrawal by Subject|28|||
170846415|NCT01743989|617445067|FG000|Treatment Phase|Death|0|||
170846416|NCT01743989|617445068|FG001|Treatment Phase|Death|1|||
170846417|NCT01743989|617445069|FG002|Treatment Phase|Death|3|||
170846418|NCT01743989|617445067|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
170846419|NCT01743989|617445068|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
170846420|NCT01743989|617445069|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
170846421|NCT01743989|617445067|FG000|Treatment Phase|Protocol deviation|0|||
170846422|NCT01743989|617445068|FG001|Treatment Phase|Protocol deviation|0|||
170846423|NCT01743989|617445069|FG002|Treatment Phase|Protocol deviation|3|||
170846424|NCT01743989|617445067|FG000|Treatment Phase|Pregnancy|0|||
170846425|NCT01743989|617445068|FG001|Treatment Phase|Pregnancy|0|||
170846426|NCT01743989|617445069|FG002|Treatment Phase|Pregnancy|2|||
170846427|NCT01743989|617445067|FG000|Treatment Phase|Lost to Follow-up|0|||
170846428|NCT01743989|617445068|FG001|Treatment Phase|Lost to Follow-up|0|||
170846429|NCT01743989|617445069|FG002|Treatment Phase|Lost to Follow-up|2|||
170846430|NCT01743989|617445067|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
170846431|NCT01743989|617445068|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
170846432|NCT01743989|617445069|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
170846433|NCT01743989|617445067|FG000|Treatment Phase|Administrative problems|0|||
170846434|NCT01743989|617445068|FG001|Treatment Phase|Administrative problems|0|||
170846435|NCT01743989|617445069|FG002|Treatment Phase|Administrative problems|1|||
170846436|NCT01743989|617445067|FG000|Treatment Phase|New cancer (CML) therapy|0|||
170846437|NCT01743989|617445068|FG001|Treatment Phase|New cancer (CML) therapy|1|||
170846438|NCT01743989|617445069|FG002|Treatment Phase|New cancer (CML) therapy|0|||
170846439|NCT01743989|617445067|FG000|Treatment Phase|Physician Decision|0|||
170846440|NCT01743989|617445068|FG001|Treatment Phase|Physician Decision|0|||
170846441|NCT01743989|617445069|FG002|Treatment Phase|Physician Decision|3|||
170846442|NCT01743989|617445067|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
170846443|NCT01743989|617445068|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
170846444|NCT01743989|617445069|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
170846445|NCT01743989|617445067|FG000|Treatment Phase|Not randomized by mistake|0|||
170846446|NCT01743989|617445068|FG001|Treatment Phase|Not randomized by mistake|0|||
170846447|NCT01743989|617445069|FG002|Treatment Phase|Not randomized by mistake|1|||
170846448|NCT01743989|617445067|FG000|Treatment Phase|Included by mistake|0|||
170846449|NCT01743989|617445068|FG001|Treatment Phase|Included by mistake|0|||
170846450|NCT01743989|617445069|FG002|Treatment Phase|Included by mistake|1|||
170846451|NCT01743989|617445067|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
170846452|NCT01743989|617445068|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
170846453|NCT01743989|617445069|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
170846454|NCT01743989|617445067|FG000|TFR Phase|Adverse Event|0|||
170846455|NCT01743989|617445068|FG001|TFR Phase|Adverse Event|1|||
170846456|NCT01743989|617445069|FG002|TFR Phase|Adverse Event|0|||
170846457|NCT01743989|617445067|FG000|TFR Phase|Lost to Follow-up|0|||
170846458|NCT01743989|617445068|FG001|TFR Phase|Lost to Follow-up|2|||
170846459|NCT01743989|617445069|FG002|TFR Phase|Lost to Follow-up|0|||
170846460|NCT01743989|617445067|FG000|TFR Phase|Physician Decision|0|||
170846461|NCT01743989|617445068|FG001|TFR Phase|Physician Decision|1|||
170846462|NCT01743989|617445069|FG002|TFR Phase|Physician Decision|0|||
170846463|NCT01743989|617445067|FG000|TFR Phase|Logistical problems|0|||
170846464|NCT01743989|617445068|FG001|TFR Phase|Logistical problems|2|||
170738319|NCT02762981|617049707|FG004|Overall Study|Adverse Event|3|||
170738320|NCT02762981|617049703|FG000|Overall Study|Physician Decision|0|||
170738321|NCT02762981|617049704|FG001|Overall Study|Physician Decision|1|||
170738322|NCT02762981|617049705|FG002|Overall Study|Physician Decision|0|||
170738323|NCT02762981|617049706|FG003|Overall Study|Physician Decision|0|||
170738324|NCT02762981|617049707|FG004|Overall Study|Physician Decision|1|||
170738325|NCT02762981|617049703|FG000|Overall Study|Disease progression|11|||
170738326|NCT02762981|617049704|FG001|Overall Study|Disease progression|23|||
170738327|NCT02762981|617049705|FG002|Overall Study|Disease progression|4|||
170738328|NCT02762981|617049706|FG003|Overall Study|Disease progression|10|||
170738329|NCT02762981|617049707|FG004|Overall Study|Disease progression|1|||
170738330|NCT02762981|617049703|FG000|Overall Study|Enrolled not treated|1|||
170738331|NCT02762981|617049704|FG001|Overall Study|Enrolled not treated|5|||
170738332|NCT02762981|617049705|FG002|Overall Study|Enrolled not treated|0|||
170738333|NCT02762981|617049706|FG003|Overall Study|Enrolled not treated|2|||
170738334|NCT02762981|617049707|FG004|Overall Study|Enrolled not treated|0|||
170738335|NCT02762981|617049703|FG000|Overall Study|Other|2|||
170738336|NCT02762981|617049704|FG001|Overall Study|Other|3|||
170738337|NCT02762981|617049705|FG002|Overall Study|Other|1|||
170738338|NCT02762981|617049706|FG003|Overall Study|Other|0|||
170738339|NCT02762981|617049707|FG004|Overall Study|Other|0|||
170738340|NCT02762981|617049703|FG000|Overall Study|Missing|1|||
170738341|NCT02762981|617049704|FG001|Overall Study|Missing|0|||
170738342|NCT02762981|617049705|FG002|Overall Study|Missing|0|||
170738343|NCT02762981|617049706|FG003|Overall Study|Missing|0|||
170738344|NCT02762981|617049707|FG004|Overall Study|Missing|0|||
170738345|NCT02762981|617049703|FG000|Overall Study|Withdrawal by Subject|0|||
170738346|NCT02762981|617049704|FG001|Overall Study|Withdrawal by Subject|5|||
170738347|NCT02762981|617049705|FG002|Overall Study|Withdrawal by Subject|1|||
170738348|NCT02762981|617049706|FG003|Overall Study|Withdrawal by Subject|3|||
170738349|NCT02762981|617049707|FG004|Overall Study|Withdrawal by Subject|0|||
170738350|NCT00976482|617049708|FG000|Overall Study|Death|208|||
170738351|NCT00976482|617049708|FG000|Overall Study|Withdrawal by Subject|45|||
170738352|NCT00976482|617049708|FG000|Overall Study|Center terminated|1|||
170738353|NCT00976482|617049708|FG000|Overall Study|Protocol Violation|5|||
170738354|NCT03722264|617049709|FG000|Overall Study|Physician Decision|3|||
170738355|NCT04867785|617049710|FG000|Overall Study|Adverse Event|1|||
170738356|NCT04867785|617049711|FG001|Overall Study|Adverse Event|0|||
170738357|NCT04867785|617049712|FG002|Overall Study|Adverse Event|1|||
170738358|NCT04867785|617049713|FG003|Overall Study|Adverse Event|0|||
170738359|NCT04867785|617049714|FG004|Overall Study|Adverse Event|0|||
170738360|NCT04867785|617049715|FG005|Overall Study|Adverse Event|0|||
170738361|NCT04867785|617049716|FG006|Overall Study|Adverse Event|0|||
170738362|NCT04867785|617049717|FG007|Overall Study|Adverse Event|2|||
170738363|NCT04867785|617049710|FG000|Overall Study|Lost to Follow-up|4|||
170738364|NCT04867785|617049711|FG001|Overall Study|Lost to Follow-up|4|||
170738365|NCT04867785|617049712|FG002|Overall Study|Lost to Follow-up|3|||
170738366|NCT04867785|617049713|FG003|Overall Study|Lost to Follow-up|2|||
170738367|NCT04867785|617049714|FG004|Overall Study|Lost to Follow-up|0|||
170738368|NCT04867785|617049715|FG005|Overall Study|Lost to Follow-up|1|||
170738369|NCT04867785|617049716|FG006|Overall Study|Lost to Follow-up|0|||
170738370|NCT04867785|617049717|FG007|Overall Study|Lost to Follow-up|1|||
170738371|NCT04867785|617049710|FG000|Overall Study|Withdrawal by Subject|6|||
170738372|NCT04867785|617049711|FG001|Overall Study|Withdrawal by Subject|2|||
170738373|NCT04867785|617049712|FG002|Overall Study|Withdrawal by Subject|2|||
170738374|NCT04867785|617049713|FG003|Overall Study|Withdrawal by Subject|1|||
170738375|NCT04867785|617049714|FG004|Overall Study|Withdrawal by Subject|2|||
170738376|NCT04867785|617049715|FG005|Overall Study|Withdrawal by Subject|0|||
170738377|NCT04867785|617049716|FG006|Overall Study|Withdrawal by Subject|2|||
170738378|NCT04867785|617049717|FG007|Overall Study|Withdrawal by Subject|5|||
170738379|NCT04867785|617049710|FG000|Overall Study|Physician Decision|0|||
170738380|NCT04867785|617049711|FG001|Overall Study|Physician Decision|0|||
170738381|NCT04867785|617049712|FG002|Overall Study|Physician Decision|0|||
170738382|NCT04867785|617049713|FG003|Overall Study|Physician Decision|0|||
170738383|NCT04867785|617049714|FG004|Overall Study|Physician Decision|0|||
170738384|NCT04867785|617049715|FG005|Overall Study|Physician Decision|0|||
170738385|NCT04867785|617049716|FG006|Overall Study|Physician Decision|0|||
170738386|NCT04867785|617049717|FG007|Overall Study|Physician Decision|1|||
170738387|NCT04867785|617049710|FG000|Overall Study|Inadvertent Enrollment|0|||
170738388|NCT04867785|617049711|FG001|Overall Study|Inadvertent Enrollment|0|||
170738389|NCT04867785|617049712|FG002|Overall Study|Inadvertent Enrollment|0|||
170738390|NCT04867785|617049713|FG003|Overall Study|Inadvertent Enrollment|1|||
170738391|NCT04867785|617049714|FG004|Overall Study|Inadvertent Enrollment|1|||
170738392|NCT04867785|617049715|FG005|Overall Study|Inadvertent Enrollment|0|||
170738393|NCT04867785|617049716|FG006|Overall Study|Inadvertent Enrollment|0|||
170738394|NCT04867785|617049717|FG007|Overall Study|Inadvertent Enrollment|1|||
170738395|NCT04867785|617049710|FG000|Overall Study|Eligibility Criteria Not Met|0|||
170738396|NCT04867785|617049711|FG001|Overall Study|Eligibility Criteria Not Met|0|||
170846465|NCT01743989|617445069|FG002|TFR Phase|Logistical problems|0|||
170738397|NCT04867785|617049712|FG002|Overall Study|Eligibility Criteria Not Met|0|||
170738398|NCT04867785|617049713|FG003|Overall Study|Eligibility Criteria Not Met|0|||
170738399|NCT04867785|617049714|FG004|Overall Study|Eligibility Criteria Not Met|0|||
170738400|NCT04867785|617049715|FG005|Overall Study|Eligibility Criteria Not Met|0|||
170738401|NCT04867785|617049716|FG006|Overall Study|Eligibility Criteria Not Met|0|||
170738402|NCT04867785|617049717|FG007|Overall Study|Eligibility Criteria Not Met|1|||
170738403|NCT01486758|617049718|FG000|Overall Study|Lost to Follow-up|0|||
170738404|NCT01486758|617049719|FG001|Overall Study|Lost to Follow-up|1|||
170738405|NCT01062763|617049722|FG000|Overall Study|Adverse Event|3|||
170738406|NCT01062763|617049723|FG001|Overall Study|Adverse Event|4|||
170738407|NCT02494921|617049724|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
170738408|NCT02494921|617049725|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
170738409|NCT02494921|617049726|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
170738410|NCT02494921|617049727|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
170738411|NCT02494921|617049728|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
170738412|NCT02494921|617049724|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
170738413|NCT02494921|617049725|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
170738414|NCT02494921|617049726|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
170738415|NCT02494921|617049727|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
170738416|NCT02494921|617049728|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
170738417|NCT02494921|617049724|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
170738418|NCT02494921|617049725|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
170738419|NCT02494921|617049726|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
170738420|NCT02494921|617049727|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
170738421|NCT02494921|617049728|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
170738422|NCT05648357|617049742|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
170738423|NCT03585296|617049748|FG000|Overall Study|Adverse Event|1|||
170738424|NCT03585296|617049748|FG000|Overall Study|Lost to Follow-up|2|||
170738425|NCT03585296|617049748|FG000|Overall Study|Withdrawal by Subject|2|||
170738426|NCT00787319|617049749|FG000|Overall Study|Lost to Follow-up|2|||
170738427|NCT00787319|617049749|FG000|Overall Study|Withdrawal by Subject|15|||
170738428|NCT00787319|617049749|FG000|Overall Study|Adverse Event|3|||
170738429|NCT00787319|617049749|FG000|Overall Study|Objective progression or relapse|30|||
170738430|NCT00787319|617049749|FG000|Overall Study|Lack of Efficacy|1|||
170738431|NCT00787319|617049749|FG000|Overall Study|Budget exhausted/exceeded|1|||
170738432|NCT00787319|617049749|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
170738433|NCT00787319|617049749|FG000|Overall Study|No health insurance reimbursement|2|||
170738434|NCT00787319|617049749|FG000|Overall Study|Stabilized disease findings|3|||
170738435|NCT00787319|617049749|FG000|Overall Study|Inactive disease|5|||
170738436|NCT02948959|617049750|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
170738437|NCT02948959|617049751|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
170738438|NCT02948959|617049750|FG000|52 Weeks Treatment Period|Adverse Event|2|||
170738439|NCT02948959|617049751|FG001|52 Weeks Treatment Period|Adverse Event|5|||
170738440|NCT02948959|617049750|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
170738441|NCT02948959|617049751|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
170738442|NCT02948959|617049750|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
170738443|NCT02948959|617049751|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
170738444|NCT02948959|617049750|FG000|52 Weeks Treatment Period|Randomized by error|0|||
170738445|NCT02948959|617049751|FG001|52 Weeks Treatment Period|Randomized by error|5|||
170738446|NCT02948959|617049750|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
170738447|NCT02948959|617049751|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
170738448|NCT02948959|617049750|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
170738449|NCT02948959|617049751|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
170738450|NCT02948959|617049750|FG000|52 Weeks Treatment Period|Change of residence location|0|||
170738451|NCT02948959|617049751|FG001|52 Weeks Treatment Period|Change of residence location|1|||
170738452|NCT02948959|617049750|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
170738453|NCT02948959|617049751|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
170738454|NCT02948959|617049750|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
170738455|NCT02948959|617049751|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
170738456|NCT02948959|617049750|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
170738457|NCT02948959|617049751|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
170738458|NCT02948959|617049750|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
170738459|NCT02948959|617049751|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
170738460|NCT02948959|617049750|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
170738461|NCT02948959|617049751|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
170738462|NCT02948959|617049750|FG000|12 Weeks Follow-up Period|Study site closure|1|||
170738463|NCT02948959|617049751|FG001|12 Weeks Follow-up Period|Study site closure|0|||
170738464|NCT02312856|617049752|FG000|Overall Study|Death|1|||
170738465|NCT02312856|617049752|FG000|Overall Study|Lost to Follow-up|3|||
170738466|NCT01932294|617049753|FG000|Overall Study|Death|43|||
170738467|NCT01932294|617049753|FG000|Overall Study|Lost to Follow-up|8|||
170738468|NCT01932294|617049753|FG000|Overall Study|VAD Implantation|20|||
170738469|NCT01932294|617049753|FG000|Overall Study|Heart Transplantation|16|||
170738470|NCT01932294|617049753|FG000|Overall Study|Transferred to other hospitals|12|||
170738471|NCT01641926|617049754|FG000|Overall Study|Adverse Event|5|||
170738472|NCT01641926|617049755|FG001|Overall Study|Adverse Event|2|||
170738473|NCT01641926|617049756|FG002|Overall Study|Adverse Event|3|||
170738474|NCT01641926|617049757|FG003|Overall Study|Adverse Event|1|||
170738475|NCT01641926|617049754|FG000|Overall Study|Lost to Follow-up|2|||
170738476|NCT01641926|617049755|FG001|Overall Study|Lost to Follow-up|2|||
170738477|NCT01641926|617049756|FG002|Overall Study|Lost to Follow-up|1|||
170738478|NCT01641926|617049757|FG003|Overall Study|Lost to Follow-up|0|||
170738479|NCT01641926|617049754|FG000|Overall Study|Physician Decision|6|||
170738480|NCT01641926|617049755|FG001|Overall Study|Physician Decision|5|||
170738481|NCT01641926|617049756|FG002|Overall Study|Physician Decision|0|||
170738482|NCT01641926|617049757|FG003|Overall Study|Physician Decision|1|||
170738483|NCT01641926|617049754|FG000|Overall Study|Protocol Violation|1|||
170738484|NCT01641926|617049755|FG001|Overall Study|Protocol Violation|0|||
170738485|NCT01641926|617049756|FG002|Overall Study|Protocol Violation|0|||
170738486|NCT01641926|617049757|FG003|Overall Study|Protocol Violation|1|||
170738487|NCT01641926|617049754|FG000|Overall Study|Withdrawal by Subject|13|||
170738488|NCT01641926|617049755|FG001|Overall Study|Withdrawal by Subject|5|||
170738489|NCT01641926|617049756|FG002|Overall Study|Withdrawal by Subject|6|||
170738490|NCT01641926|617049757|FG003|Overall Study|Withdrawal by Subject|1|||
170738491|NCT01641926|617049754|FG000|Overall Study|Not Treated|1|||
170738492|NCT01641926|617049755|FG001|Overall Study|Not Treated|1|||
170738493|NCT01641926|617049756|FG002|Overall Study|Not Treated|1|||
170738494|NCT01641926|617049757|FG003|Overall Study|Not Treated|0|||
170738495|NCT01111838|617049758|FG000|Overall Study|Patient Ineligible|2|||
170738496|NCT01111838|617049758|FG000|Overall Study|Not Treated|3|||
170738497|NCT01111838|617049758|FG000|Overall Study|Clinical deterioration|1|||
170738498|NCT01111838|617049758|FG000|Overall Study|Other Complicating Disease|1|||
170738499|NCT02567825|617049759|FG000|Overall Study|No follow-up post-randomization|5|||
170738500|NCT02567825|617049760|FG001|Overall Study|No follow-up post-randomization|1|||
170738501|NCT02567825|617049759|FG000|Overall Study|Follow-up less than 23 months|16|||
170738502|NCT02567825|617049760|FG001|Overall Study|Follow-up less than 23 months|20|||
170738503|NCT01480596|617049767|FG000|Overall Study|Adverse Event|3|||
170738504|NCT01480596|617049768|FG001|Overall Study|Adverse Event|0|||
170738505|NCT01480596|617049767|FG000|Overall Study|MG exacerbation or change in medication|2|||
170738506|NCT01480596|617049768|FG001|Overall Study|MG exacerbation or change in medication|2|||
170738507|NCT02424591|617049770|FG000|Overall Study|Protocol Violation|2|||
170738508|NCT02424591|617049771|FG001|Overall Study|Protocol Violation|3|||
170738509|NCT04399356|617049773|FG000|Overall Study|Lost to Follow-up|1|||
170738510|NCT04399356|617049774|FG001|Overall Study|Lost to Follow-up|1|||
170738511|NCT04399356|617049773|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
170738512|NCT04399356|617049774|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
170738513|NCT04399356|617049773|FG000|Overall Study|Withdrawal by Subject|1|||
170738514|NCT04399356|617049774|FG001|Overall Study|Withdrawal by Subject|0|||
170738515|NCT04041440|617049777|FG000|Overall Study|Withdrawal by Subject|0|||
170738516|NCT04041440|617049778|FG001|Overall Study|Withdrawal by Subject|1|||
170738517|NCT04041440|617049777|FG000|Overall Study|Lost to Follow-up|0|||
170738518|NCT04041440|617049778|FG001|Overall Study|Lost to Follow-up|1|||
170738519|NCT03002038|617049785|FG000|Overall Study|Adverse Event|3|||
170738520|NCT03002038|617049786|FG001|Overall Study|Adverse Event|1|||
170738521|NCT03002038|617049785|FG000|Overall Study|Withdrawal by Subject|8|||
170738522|NCT03002038|617049786|FG001|Overall Study|Withdrawal by Subject|4|||
170738523|NCT03002038|617049785|FG000|Overall Study|Immigration to another region|0|||
170738524|NCT03002038|617049786|FG001|Overall Study|Immigration to another region|2|||
170738525|NCT00979602|617049790|FG000|Overall Study|Serious Adverse Event|5|||
170738526|NCT00979602|617049791|FG001|Overall Study|Serious Adverse Event|3|||
170738527|NCT00979602|617049790|FG000|Overall Study|Protocol Violation|3|||
170738528|NCT00979602|617049791|FG001|Overall Study|Protocol Violation|0|||
170738529|NCT00979602|617049790|FG000|Overall Study|Withdrawal by Subject|31|||
170738530|NCT00979602|617049791|FG001|Overall Study|Withdrawal by Subject|25|||
170738531|NCT00979602|617049790|FG000|Overall Study|Lost to Follow-up|100|||
170738532|NCT00979602|617049791|FG001|Overall Study|Lost to Follow-up|96|||
170738533|NCT00979602|617049790|FG000|Overall Study|Migrated/moved from study area|3|||
170738534|NCT00979602|617049791|FG001|Overall Study|Migrated/moved from study area|6|||
170738535|NCT00979602|617049790|FG000|Overall Study|Others|3|||
170738536|NCT00979602|617049791|FG001|Overall Study|Others|3|||
170738537|NCT02904902|617049792|FG000|Overall Study|Withdrawal by Subject|1|||
170738538|NCT02712398|617049796|FG000|Overall Study|Withdrawal by Subject|6|||
170738539|NCT02712398|617049796|FG000|Overall Study|Lost to Follow-up|6|||
170738540|NCT02712398|617049796|FG000|Overall Study|Sponsor Decision|1|||
170738541|NCT02712398|617049796|FG000|Overall Study|Physician Decision|1|||
170738542|NCT02712398|617049796|FG000|Overall Study|Death|2|||
170738543|NCT02712398|617049796|FG000|Overall Study|Re-operation|21|||
170738544|NCT00980005|617049799|FG000|Overall Study|Withdrawal by Subject|6|||
170738545|NCT00980005|617049800|FG001|Overall Study|Withdrawal by Subject|17|||
170738546|NCT00980005|617049799|FG000|Overall Study|Lost to Follow-up|37|||
170738547|NCT00980005|617049800|FG001|Overall Study|Lost to Follow-up|43|||
170738548|NCT00980005|617049799|FG000|Overall Study|Other|4|||
170738549|NCT00980005|617049800|FG001|Overall Study|Other|3|||
170738550|NCT01003639|617049803|FG000|Overall Study|Lost to Follow-up|6|||
170738551|NCT01003639|617049804|FG001|Overall Study|Lost to Follow-up|9|||
170738552|NCT01003639|617049803|FG000|Overall Study|Withdrawal by Subject|9|||
170738553|NCT01003639|617049804|FG001|Overall Study|Withdrawal by Subject|5|||
170738554|NCT01003639|617049803|FG000|Overall Study|Lack of Efficacy|1|||
170738555|NCT01003639|617049804|FG001|Overall Study|Lack of Efficacy|6|||
170738556|NCT01003639|617049803|FG000|Overall Study|Adverse Event|0|||
170738557|NCT01003639|617049804|FG001|Overall Study|Adverse Event|1|||
170738558|NCT01003639|617049803|FG000|Overall Study|Protocol Violation|0|||
170738559|NCT01003639|617049804|FG001|Overall Study|Protocol Violation|1|||
170738560|NCT01003639|617049803|FG000|Overall Study|Physician Decision|1|||
170738561|NCT01003639|617049804|FG001|Overall Study|Physician Decision|0|||
170738562|NCT03787680|617049813|FG000|Overall Study|Physician Decision|2|||
170738563|NCT03787680|617049814|FG001|Overall Study|Physician Decision|3|||
170738564|NCT03787680|617049813|FG000|Overall Study|Adverse Event|7|||
170738565|NCT03787680|617049814|FG001|Overall Study|Adverse Event|3|||
170738566|NCT03787680|617049813|FG000|Overall Study|Withdrawal by Subject|2|||
170738567|NCT03787680|617049814|FG001|Overall Study|Withdrawal by Subject|1|||
170738568|NCT05400746|617049815|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
170738569|NCT05400746|617049816|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
170738570|NCT05400746|617049817|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
170738571|NCT05375955|617049820|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
170738572|NCT05375955|617049821|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
170738573|NCT05375955|617049822|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
170738574|NCT05375955|617049823|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
170738575|NCT05375955|617049824|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
170738576|NCT05375955|617049825|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
170738577|NCT05375955|617049826|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
170738578|NCT05375955|617049820|FG000|Treatment (12 Weeks)|Physician Decision|4|||
170738579|NCT05375955|617049821|FG001|Treatment (12 Weeks)|Physician Decision|1|||
170738580|NCT05375955|617049822|FG002|Treatment (12 Weeks)|Physician Decision|3|||
170738581|NCT05375955|617049823|FG003|Treatment (12 Weeks)|Physician Decision|0|||
170738582|NCT05375955|617049824|FG004|Treatment (12 Weeks)|Physician Decision|0|||
170738583|NCT05375955|617049825|FG005|Treatment (12 Weeks)|Physician Decision|1|||
170738584|NCT05375955|617049826|FG006|Treatment (12 Weeks)|Physician Decision|0|||
170738585|NCT05375955|617049820|FG000|Treatment (12 Weeks)|Other|0|||
170738586|NCT05375955|617049821|FG001|Treatment (12 Weeks)|Other|1|||
170738587|NCT05375955|617049822|FG002|Treatment (12 Weeks)|Other|0|||
170738588|NCT05375955|617049823|FG003|Treatment (12 Weeks)|Other|0|||
170738589|NCT05375955|617049824|FG004|Treatment (12 Weeks)|Other|0|||
170738590|NCT05375955|617049825|FG005|Treatment (12 Weeks)|Other|0|||
170738591|NCT05375955|617049826|FG006|Treatment (12 Weeks)|Other|0|||
170738592|NCT05375955|617049820|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
170738593|NCT05375955|617049821|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
170738594|NCT05375955|617049822|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
170738595|NCT05375955|617049823|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
170738596|NCT05375955|617049824|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
170738597|NCT05375955|617049825|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
170738598|NCT05375955|617049826|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
170738599|NCT05375955|617049820|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
170738600|NCT05375955|617049821|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
170738601|NCT05375955|617049822|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
170738602|NCT05375955|617049823|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
170738603|NCT05375955|617049824|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
170738604|NCT05375955|617049825|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
170738605|NCT05375955|617049826|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
170738606|NCT05375955|617049820|FG000|Treatment (12 Weeks)|Pregnancy|0|||
170738607|NCT05375955|617049821|FG001|Treatment (12 Weeks)|Pregnancy|0|||
170738608|NCT05375955|617049822|FG002|Treatment (12 Weeks)|Pregnancy|1|||
170738609|NCT05375955|617049823|FG003|Treatment (12 Weeks)|Pregnancy|0|||
170738610|NCT05375955|617049824|FG004|Treatment (12 Weeks)|Pregnancy|0|||
170738611|NCT05375955|617049825|FG005|Treatment (12 Weeks)|Pregnancy|0|||
170738612|NCT05375955|617049826|FG006|Treatment (12 Weeks)|Pregnancy|0|||
170738613|NCT05375955|617049820|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
170738614|NCT05375955|617049821|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
170738615|NCT05375955|617049822|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
170738616|NCT05375955|617049823|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
170738617|NCT05375955|617049824|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
170738618|NCT05375955|617049825|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
170738619|NCT05375955|617049826|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
170738620|NCT05375955|617049820|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
170738621|NCT05375955|617049821|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
170738622|NCT05375955|617049822|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
170738623|NCT05375955|617049823|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
170738624|NCT05375955|617049824|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
170738625|NCT05375955|617049825|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
170738626|NCT05375955|617049826|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
170738627|NCT05375955|617049820|FG000|Follow-up (up to 5 Weeks)|Other|0|||
170738628|NCT05375955|617049821|FG001|Follow-up (up to 5 Weeks)|Other|1|||
170738629|NCT05375955|617049822|FG002|Follow-up (up to 5 Weeks)|Other|0|||
170738630|NCT05375955|617049823|FG003|Follow-up (up to 5 Weeks)|Other|0|||
170738631|NCT05375955|617049824|FG004|Follow-up (up to 5 Weeks)|Other|0|||
170738632|NCT05375955|617049825|FG005|Follow-up (up to 5 Weeks)|Other|0|||
170738633|NCT05375955|617049826|FG006|Follow-up (up to 5 Weeks)|Other|0|||
170738634|NCT05375955|617049820|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
170738635|NCT05375955|617049821|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
170738636|NCT05375955|617049822|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
170738637|NCT05375955|617049823|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
170738638|NCT05375955|617049824|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
170738639|NCT05375955|617049825|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
170846466|NCT01743989|617445067|FG000|TFR Phase|Protocol deviation|0|||
170846467|NCT01743989|617445068|FG001|TFR Phase|Protocol deviation|1|||
170846468|NCT01743989|617445069|FG002|TFR Phase|Protocol deviation|0|||
170846469|NCT01743989|617445067|FG000|TFR Phase|Withdrawal by Subject|0|||
170846470|NCT01743989|617445068|FG001|TFR Phase|Withdrawal by Subject|2|||
170846471|NCT01743989|617445069|FG002|TFR Phase|Withdrawal by Subject|0|||
170846472|NCT01743989|617445067|FG000|Re-treatment Phase|Adverse Event|8|||
170846473|NCT01743989|617445068|FG001|Re-treatment Phase|Adverse Event|4|||
170846474|NCT01743989|617445069|FG002|Re-treatment Phase|Adverse Event|0|||
170846475|NCT01743989|617445067|FG000|Re-treatment Phase|Death|1|||
170846476|NCT01743989|617445068|FG001|Re-treatment Phase|Death|1|||
170846477|NCT01743989|617445069|FG002|Re-treatment Phase|Death|0|||
170846478|NCT01743989|617445067|FG000|Re-treatment Phase|Administrative problems|1|||
170846479|NCT01743989|617445068|FG001|Re-treatment Phase|Administrative problems|1|||
170846480|NCT01743989|617445069|FG002|Re-treatment Phase|Administrative problems|0|||
170846481|NCT01743989|617445067|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
170846482|NCT01743989|617445068|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
170846483|NCT01743989|617445069|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
170846484|NCT01743989|617445067|FG000|Re-treatment Phase|Unstable MR|1|||
170846485|NCT01743989|617445068|FG001|Re-treatment Phase|Unstable MR|0|||
170846486|NCT01743989|617445069|FG002|Re-treatment Phase|Unstable MR|0|||
170846487|NCT01743989|617445067|FG000|Re-treatment Phase|Physician Decision|0|||
170846488|NCT01743989|617445068|FG001|Re-treatment Phase|Physician Decision|1|||
170846489|NCT01743989|617445069|FG002|Re-treatment Phase|Physician Decision|0|||
170846490|NCT01743989|617445067|FG000|Re-treatment Phase|Lost to Follow-up|0|||
170846491|NCT01743989|617445068|FG001|Re-treatment Phase|Lost to Follow-up|1|||
170846492|NCT01743989|617445069|FG002|Re-treatment Phase|Lost to Follow-up|0|||
170846493|NCT02671500|617445072|FG000|Overall Study|Lack of Efficacy|12|||
170846494|NCT02671500|617445072|FG000|Overall Study|Lost to Follow-up|2|||
170846495|NCT00653523|617445078|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
170846496|NCT00653523|617445078|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
170846497|NCT00653523|617445078|FG000|Overall Study|Adverse Event|7|||
170846498|NCT00653523|617445078|FG000|Overall Study|Withdrawal by Subject|6|||
170846499|NCT00653523|617445078|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
170846500|NCT00653523|617445078|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
170846501|NCT05235269|617445083|FG000|Overall Study|Adverse Event|1|||
170846502|NCT05235269|617445083|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
170846503|NCT05235269|617445083|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
170846504|NCT00186888|617445084|FG000|Overall Study|Toxicity|0|||
170846505|NCT00186888|617445085|FG001|Overall Study|Toxicity|1|||
170846506|NCT00186888|617445086|FG002|Overall Study|Toxicity|0|||
170846507|NCT00186888|617445084|FG000|Overall Study|Relapse or progression of disease|4|||
170846508|NCT00186888|617445085|FG001|Overall Study|Relapse or progression of disease|2|||
170846509|NCT00186888|617445086|FG002|Overall Study|Relapse or progression of disease|0|||
170846510|NCT05511038|617445087|FG000|Overall|Withdrawal by Subject|5|||
170846511|NCT05511038|617445088|FG001|Overall|Withdrawal by Subject|3|||
170846512|NCT05511038|617445087|FG000|Overall|Screen Failure|20|||
170846513|NCT05511038|617445088|FG001|Overall|Screen Failure|1|||
170846514|NCT05511038|617445087|FG000|Overall|Physician Decision|3|||
170846515|NCT05511038|617445088|FG001|Overall|Physician Decision|0|||
170846516|NCT05511038|617445087|FG000|Overall|Lost to Follow-up|3|||
170846517|NCT05511038|617445088|FG001|Overall|Lost to Follow-up|0|||
170846518|NCT05511038|617445087|FG000|Overall|Death|1|||
170846519|NCT05511038|617445088|FG001|Overall|Death|0|||
170846520|NCT05511038|617445087|FG000|Screening|Withdrawal by Subject|1|||
170846521|NCT05511038|617445088|FG001|Screening|Withdrawal by Subject|0|||
170846522|NCT05511038|617445087|FG000|Screening|Lost to Follow Up (1 participant)|1|||
170846523|NCT05511038|617445088|FG001|Screening|Lost to Follow Up (1 participant)|0|||
170846524|NCT05511038|617445087|FG000|Screening|Screen Failure|3|||
170846525|NCT05511038|617445088|FG001|Screening|Screen Failure|0|||
170846526|NCT05511038|617445087|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
170846527|NCT05511038|617445088|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
170846528|NCT05511038|617445087|FG000|Treatment|Withdrawal by Subject|5|||
170846529|NCT05511038|617445088|FG001|Treatment|Withdrawal by Subject|3|||
170846530|NCT05511038|617445087|FG000|Treatment|Physician Decision|4|||
170846531|NCT05511038|617445088|FG001|Treatment|Physician Decision|0|||
170846532|NCT05511038|617445087|FG000|Treatment|Lost to Follow-up|2|||
170846533|NCT05511038|617445088|FG001|Treatment|Lost to Follow-up|0|||
170846534|NCT05511038|617445087|FG000|Treatment|Death|1|||
170846535|NCT05511038|617445088|FG001|Treatment|Death|0|||
170846536|NCT05511038|617445087|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
170846537|NCT05511038|617445088|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
170846538|NCT05511038|617445087|FG000|Treatment|Refuse by subject|1|||
170846539|NCT05511038|617445088|FG001|Treatment|Refuse by subject|0|||
170846540|NCT05511038|617445087|FG000|Treatment|Subject did not go to the site for visit|1|||
170738640|NCT05375955|617049826|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
170738641|NCT05375955|617049820|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
170738642|NCT05375955|617049821|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
170738643|NCT05375955|617049822|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
170738644|NCT05375955|617049823|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
170738645|NCT05375955|617049824|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
170738646|NCT05375955|617049825|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
170738647|NCT05375955|617049826|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
170738648|NCT05454410|617049827|FG000|Overall Study|Withdrawal by Subject|0|||
170738649|NCT05454410|617049828|FG001|Overall Study|Withdrawal by Subject|0|||
170738650|NCT05454410|617049829|FG002|Overall Study|Withdrawal by Subject|1|||
170738651|NCT05454410|617049830|FG003|Overall Study|Withdrawal by Subject|1|||
170738652|NCT00895622|617049831|FG000|Overall Study|Protocol Violation|5|||
170738653|NCT00895622|617049832|FG001|Overall Study|Protocol Violation|4|||
170738654|NCT00895622|617049833|FG002|Overall Study|Protocol Violation|4|||
170738655|NCT03724396|617049834|FG000|Overall Study|Lost to Follow-up|1|||
170738656|NCT03724396|617049835|FG001|Overall Study|Lost to Follow-up|1|||
170738657|NCT03724396|617049834|FG000|Overall Study|Withdrawal by Subject|1|||
170738658|NCT03724396|617049835|FG001|Overall Study|Withdrawal by Subject|0|||
170738659|NCT03879408|617049836|FG000|Overall Study|Lost to Follow-up|0|||
170738660|NCT03879408|617049837|FG001|Overall Study|Lost to Follow-up|3|||
170738661|NCT03879408|617049838|FG002|Overall Study|Lost to Follow-up|2|||
170738662|NCT03879408|617049839|FG003|Overall Study|Lost to Follow-up|1|||
170738663|NCT03879408|617049840|FG004|Overall Study|Lost to Follow-up|0|||
170738664|NCT03879408|617049836|FG000|Overall Study|Withdrawal by Subject|2|||
170738665|NCT03879408|617049837|FG001|Overall Study|Withdrawal by Subject|1|||
170738666|NCT03879408|617049838|FG002|Overall Study|Withdrawal by Subject|1|||
170738667|NCT03879408|617049839|FG003|Overall Study|Withdrawal by Subject|0|||
170738668|NCT03879408|617049840|FG004|Overall Study|Withdrawal by Subject|1|||
170738669|NCT01490125|617049841|FG000|Period I|Adverse Event|4|||
170738670|NCT01490125|617049842|FG001|Period I|Adverse Event|1|||
170738671|NCT01490125|617049843|FG002|Period I|Adverse Event|1|||
170738672|NCT01490125|617049844|FG003|Period I|Adverse Event|3|||
170738673|NCT01490125|617049845|FG004|Period I|Adverse Event|2|||
170738674|NCT01490125|617049846|FG005|Period I|Adverse Event|4|||
170738675|NCT01490125|617049841|FG000|Period I|Protocol Violation|1|||
170738676|NCT01490125|617049842|FG001|Period I|Protocol Violation|1|||
170738677|NCT01490125|617049843|FG002|Period I|Protocol Violation|1|||
170738678|NCT01490125|617049844|FG003|Period I|Protocol Violation|1|||
170738679|NCT01490125|617049845|FG004|Period I|Protocol Violation|0|||
170738680|NCT01490125|617049846|FG005|Period I|Protocol Violation|0|||
170738681|NCT01490125|617049841|FG000|Period I|Withdrawal by Subject|1|||
170738682|NCT01490125|617049842|FG001|Period I|Withdrawal by Subject|3|||
170738683|NCT01490125|617049843|FG002|Period I|Withdrawal by Subject|2|||
170738684|NCT01490125|617049844|FG003|Period I|Withdrawal by Subject|1|||
170738685|NCT01490125|617049845|FG004|Period I|Withdrawal by Subject|2|||
170738686|NCT01490125|617049846|FG005|Period I|Withdrawal by Subject|1|||
170738687|NCT01490125|617049841|FG000|Period II|Adverse Event|2|||
170738688|NCT01490125|617049842|FG001|Period II|Adverse Event|3|||
170738689|NCT01490125|617049843|FG002|Period II|Adverse Event|2|||
170738690|NCT01490125|617049844|FG003|Period II|Adverse Event|2|||
170738691|NCT01490125|617049845|FG004|Period II|Adverse Event|4|||
170738692|NCT01490125|617049846|FG005|Period II|Adverse Event|2|||
170738693|NCT01490125|617049841|FG000|Period II|Protocol Violation|0|||
170738694|NCT01490125|617049842|FG001|Period II|Protocol Violation|0|||
170738695|NCT01490125|617049843|FG002|Period II|Protocol Violation|1|||
170738696|NCT01490125|617049844|FG003|Period II|Protocol Violation|1|||
170738697|NCT01490125|617049845|FG004|Period II|Protocol Violation|0|||
170738698|NCT01490125|617049846|FG005|Period II|Protocol Violation|0|||
170738699|NCT01490125|617049841|FG000|Period II|Lost to Follow-up|0|||
170738700|NCT01490125|617049842|FG001|Period II|Lost to Follow-up|1|||
170738701|NCT01490125|617049843|FG002|Period II|Lost to Follow-up|0|||
170738702|NCT01490125|617049844|FG003|Period II|Lost to Follow-up|0|||
170738703|NCT01490125|617049845|FG004|Period II|Lost to Follow-up|0|||
170738704|NCT01490125|617049846|FG005|Period II|Lost to Follow-up|0|||
170738705|NCT01490125|617049841|FG000|Period II|Withdrawal by Subject|1|||
170738706|NCT01490125|617049842|FG001|Period II|Withdrawal by Subject|0|||
170738707|NCT01490125|617049843|FG002|Period II|Withdrawal by Subject|0|||
170738708|NCT01490125|617049844|FG003|Period II|Withdrawal by Subject|0|||
170738709|NCT01490125|617049845|FG004|Period II|Withdrawal by Subject|0|||
170846541|NCT05511038|617445088|FG001|Treatment|Subject did not go to the site for visit|0|||
170846542|NCT02108964|617445089|FG000|Overall Study|Progressive disease|15|||
170738710|NCT01490125|617049846|FG005|Period II|Withdrawal by Subject|0|||
170738711|NCT01490125|617049841|FG000|Period III|Adverse Event|3|||
170738712|NCT01490125|617049842|FG001|Period III|Adverse Event|1|||
170738713|NCT01490125|617049843|FG002|Period III|Adverse Event|0|||
170846543|NCT02108964|617445090|FG001|Overall Study|Progressive disease|31|||
170846544|NCT02108964|617445091|FG002|Overall Study|Progressive disease|54|||
170846545|NCT02108964|617445092|FG003|Overall Study|Progressive disease|7|||
170846546|NCT02108964|617445093|FG004|Overall Study|Progressive disease|20|||
170846547|NCT02108964|617445094|FG005|Overall Study|Progressive disease|4|||
170846548|NCT02108964|617445095|FG006|Overall Study|Progressive disease|6|||
170846549|NCT02108964|617445096|FG007|Overall Study|Progressive disease|33|||
170846550|NCT02108964|617445089|FG000|Overall Study|Physician Decision|1|||
170846551|NCT02108964|617445090|FG001|Overall Study|Physician Decision|5|||
170846552|NCT02108964|617445091|FG002|Overall Study|Physician Decision|7|||
170846553|NCT02108964|617445092|FG003|Overall Study|Physician Decision|1|||
170846554|NCT02108964|617445093|FG004|Overall Study|Physician Decision|2|||
170846555|NCT02108964|617445094|FG005|Overall Study|Physician Decision|1|||
170846556|NCT02108964|617445095|FG006|Overall Study|Physician Decision|1|||
170846557|NCT02108964|617445096|FG007|Overall Study|Physician Decision|3|||
170846558|NCT02108964|617445089|FG000|Overall Study|Adverse Event|0|||
170846559|NCT02108964|617445090|FG001|Overall Study|Adverse Event|0|||
170846560|NCT02108964|617445091|FG002|Overall Study|Adverse Event|4|||
170846561|NCT02108964|617445092|FG003|Overall Study|Adverse Event|0|||
170846562|NCT02108964|617445093|FG004|Overall Study|Adverse Event|1|||
170846563|NCT02108964|617445094|FG005|Overall Study|Adverse Event|0|||
170846564|NCT02108964|617445095|FG006|Overall Study|Adverse Event|3|||
170846565|NCT02108964|617445096|FG007|Overall Study|Adverse Event|2|||
170846566|NCT02108964|617445089|FG000|Overall Study|Death|1|||
170846567|NCT02108964|617445090|FG001|Overall Study|Death|1|||
170846568|NCT02108964|617445091|FG002|Overall Study|Death|4|||
170846569|NCT02108964|617445092|FG003|Overall Study|Death|0|||
170846570|NCT02108964|617445093|FG004|Overall Study|Death|3|||
170846571|NCT02108964|617445094|FG005|Overall Study|Death|0|||
170846572|NCT02108964|617445095|FG006|Overall Study|Death|0|||
170846573|NCT02108964|617445096|FG007|Overall Study|Death|2|||
170846574|NCT02108964|617445089|FG000|Overall Study|Subject/Guardian decision|0|||
170846575|NCT02108964|617445090|FG001|Overall Study|Subject/Guardian decision|1|||
170846576|NCT02108964|617445091|FG002|Overall Study|Subject/Guardian decision|4|||
170846577|NCT02108964|617445092|FG003|Overall Study|Subject/Guardian decision|0|||
170846578|NCT02108964|617445093|FG004|Overall Study|Subject/Guardian decision|2|||
170846579|NCT02108964|617445094|FG005|Overall Study|Subject/Guardian decision|0|||
170846580|NCT02108964|617445095|FG006|Overall Study|Subject/Guardian decision|1|||
170846581|NCT02108964|617445096|FG007|Overall Study|Subject/Guardian decision|2|||
170846582|NCT02108964|617445089|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
170846583|NCT02108964|617445090|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
170846584|NCT02108964|617445091|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
170846585|NCT02108964|617445092|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
170846586|NCT02108964|617445093|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
170846587|NCT02108964|617445094|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
170846588|NCT02108964|617445095|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
170846589|NCT02108964|617445096|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
170846590|NCT03006848|617445097|FG000|Overall Study|Adverse Event|1|||
170846591|NCT03006848|617445097|FG000|Overall Study|Physician Decision|1|||
170846592|NCT03006848|617445097|FG000|Overall Study|Lack of Efficacy|16|||
170846593|NCT03810235|617445099|FG000|Overall Study|Withdrawal by Subject|2|||
170846594|NCT03810235|617445100|FG001|Overall Study|Withdrawal by Subject|0|||
170846595|NCT01647542|617445101|FG000|Overall Study|Major Protocol Deviation|1|||
170846596|NCT01647542|617445102|FG001|Overall Study|Major Protocol Deviation|0|||
170846597|NCT01647542|617445103|FG002|Overall Study|Major Protocol Deviation|0|||
170846598|NCT01647542|617445101|FG000|Overall Study|Adverse Event|4|||
170846599|NCT01647542|617445102|FG001|Overall Study|Adverse Event|5|||
170846600|NCT01647542|617445103|FG002|Overall Study|Adverse Event|4|||
170846601|NCT01647542|617445101|FG000|Overall Study|Lost to Follow-up|0|||
170846602|NCT01647542|617445102|FG001|Overall Study|Lost to Follow-up|2|||
170846603|NCT01647542|617445103|FG002|Overall Study|Lost to Follow-up|2|||
170846604|NCT01647542|617445101|FG000|Overall Study|Withdrawal by Subject|6|||
170846605|NCT01647542|617445102|FG001|Overall Study|Withdrawal by Subject|4|||
170846606|NCT01647542|617445103|FG002|Overall Study|Withdrawal by Subject|0|||
170846607|NCT01647542|617445101|FG000|Overall Study|Study Termination|64|||
170846608|NCT01647542|617445102|FG001|Overall Study|Study Termination|61|||
170846609|NCT01647542|617445103|FG002|Overall Study|Study Termination|65|||
170846610|NCT01647542|617445101|FG000|Overall Study|Lack of Efficacy|1|||
170846611|NCT01647542|617445102|FG001|Overall Study|Lack of Efficacy|1|||
170846612|NCT01647542|617445103|FG002|Overall Study|Lack of Efficacy|0|||
170846613|NCT01647542|617445101|FG000|Overall Study|Death|0|||
170846614|NCT01647542|617445102|FG001|Overall Study|Death|0|||
170846615|NCT01647542|617445103|FG002|Overall Study|Death|1|||
170846616|NCT03086655|617445104|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
170846617|NCT03086655|617445105|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
170846618|NCT03086655|617445104|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
170846619|NCT03086655|617445105|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
170846620|NCT03086655|617445104|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
170846621|NCT03086655|617445105|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
170846622|NCT03086655|617445104|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
170846623|NCT03086655|617445105|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
170846624|NCT03086655|617445104|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
170846625|NCT03086655|617445105|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
170846626|NCT03086655|617445104|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
170846627|NCT03086655|617445105|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
170846628|NCT03086655|617445104|FG000|12 Month Follow-up = Final Assessment|Death|0|||
170846629|NCT03086655|617445105|FG001|12 Month Follow-up = Final Assessment|Death|1|||
170846630|NCT00798434|617445106|FG000|Double-Blind|Adverse Event|22|||
170846631|NCT00798434|617445107|FG001|Double-Blind|Adverse Event|46|||
170846632|NCT00798434|617445106|FG000|Double-Blind|Death|0|||
170846633|NCT00798434|617445107|FG001|Double-Blind|Death|1|||
170846634|NCT00798434|617445106|FG000|Double-Blind|Lost to Follow-up|1|||
170846635|NCT00798434|617445107|FG001|Double-Blind|Lost to Follow-up|0|||
170846636|NCT00798434|617445106|FG000|Double-Blind|Lack of Efficacy|8|||
170846637|NCT00798434|617445107|FG001|Double-Blind|Lack of Efficacy|12|||
170846638|NCT00798434|617445106|FG000|Double-Blind|Withdrawal by Subject|17|||
170846639|NCT00798434|617445107|FG001|Double-Blind|Withdrawal by Subject|14|||
170846640|NCT00798434|617445106|FG000|Double-Blind|Protocol Violation|1|||
170846641|NCT00798434|617445107|FG001|Double-Blind|Protocol Violation|4|||
170846642|NCT00798434|617445106|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
170846643|NCT00798434|617445107|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
170846644|NCT00798434|617445106|FG000|Double-Blind|Other|1|||
170846645|NCT00798434|617445107|FG001|Double-Blind|Other|0|||
170846646|NCT00798434|617445106|FG000|Double-Blind|Not Treated|3|||
170846647|NCT00798434|617445107|FG001|Double-Blind|Not Treated|6|||
170846648|NCT00798434|617445106|FG000|Open-Label|Adverse Event|33|||
170846649|NCT00798434|617445107|FG001|Open-Label|Adverse Event|11|||
170738714|NCT01490125|617049844|FG003|Period III|Adverse Event|1|||
170738715|NCT01490125|617049845|FG004|Period III|Adverse Event|0|||
170738716|NCT01490125|617049846|FG005|Period III|Adverse Event|0|||
170738717|NCT01490125|617049841|FG000|Period III|Death|0|||
170738718|NCT01490125|617049842|FG001|Period III|Death|0|||
170738719|NCT01490125|617049843|FG002|Period III|Death|0|||
170738720|NCT01490125|617049844|FG003|Period III|Death|1|||
170738721|NCT01490125|617049845|FG004|Period III|Death|0|||
170738722|NCT01490125|617049846|FG005|Period III|Death|0|||
170738723|NCT01490125|617049841|FG000|Period III|Lack of Efficacy|0|||
170738724|NCT01490125|617049842|FG001|Period III|Lack of Efficacy|0|||
170738725|NCT01490125|617049843|FG002|Period III|Lack of Efficacy|0|||
170738726|NCT01490125|617049844|FG003|Period III|Lack of Efficacy|0|||
170738727|NCT01490125|617049845|FG004|Period III|Lack of Efficacy|1|||
170738728|NCT01490125|617049846|FG005|Period III|Lack of Efficacy|0|||
170738729|NCT02237508|617049847|FG000|Overall Study|Withdrawal by Subject|0|||
170738730|NCT02237508|617049848|FG001|Overall Study|Withdrawal by Subject|2|||
170738731|NCT02237508|617049849|FG002|Overall Study|Withdrawal by Subject|0|||
170738732|NCT02237508|617049850|FG003|Overall Study|Withdrawal by Subject|1|||
170738733|NCT02237508|617049851|FG004|Overall Study|Withdrawal by Subject|0|||
170738734|NCT02237508|617049852|FG005|Overall Study|Withdrawal by Subject|1|||
170738735|NCT02237508|617049853|FG006|Overall Study|Withdrawal by Subject|1|||
170738736|NCT02237508|617049854|FG007|Overall Study|Withdrawal by Subject|0|||
170738737|NCT02237508|617049855|FG008|Overall Study|Withdrawal by Subject|1|||
170738738|NCT02237508|617049856|FG009|Overall Study|Withdrawal by Subject|0|||
170738739|NCT02237508|617049847|FG000|Overall Study|Physician Decision|0|||
170738740|NCT02237508|617049848|FG001|Overall Study|Physician Decision|1|||
170738741|NCT02237508|617049849|FG002|Overall Study|Physician Decision|0|||
170738742|NCT02237508|617049850|FG003|Overall Study|Physician Decision|0|||
170738743|NCT02237508|617049851|FG004|Overall Study|Physician Decision|0|||
170738744|NCT02237508|617049852|FG005|Overall Study|Physician Decision|0|||
170738745|NCT02237508|617049853|FG006|Overall Study|Physician Decision|0|||
170846650|NCT00798434|617445106|FG000|Open-Label|Lack of Efficacy|5|||
170846651|NCT00798434|617445107|FG001|Open-Label|Lack of Efficacy|11|||
170846652|NCT00798434|617445106|FG000|Open-Label|Withdrawal by Subject|2|||
170846653|NCT00798434|617445107|FG001|Open-Label|Withdrawal by Subject|7|||
170846654|NCT00798434|617445106|FG000|Open-Label|Protocol Violation|1|||
170846655|NCT00798434|617445107|FG001|Open-Label|Protocol Violation|0|||
170846656|NCT00798434|617445106|FG000|Open-Label|Other|1|||
170846657|NCT00798434|617445107|FG001|Open-Label|Other|2|||
170846658|NCT00798434|617445106|FG000|Open-Label|Not Treated|0|||
170738746|NCT02237508|617049854|FG007|Overall Study|Physician Decision|0|||
170738747|NCT02237508|617049855|FG008|Overall Study|Physician Decision|0|||
170738748|NCT02237508|617049856|FG009|Overall Study|Physician Decision|0|||
170738749|NCT02237508|617049847|FG000|Overall Study|Protocol Violation|0|||
170846659|NCT00798434|617445107|FG001|Open-Label|Not Treated|1|||
170846660|NCT04908631|617445111|FG000|Overall Study|Lost to Follow-up|1|||
170846661|NCT04908631|617445111|FG000|Overall Study|Physician Decision|1|||
170846662|NCT04908631|617445111|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
170846663|NCT02336451|617445115|FG000|Overall Study|Adverse Event|1|||
170846664|NCT02336451|617445116|FG001|Overall Study|Adverse Event|2|||
170846665|NCT02336451|617445117|FG002|Overall Study|Adverse Event|0|||
170846666|NCT02336451|617445118|FG003|Overall Study|Adverse Event|6|||
170846667|NCT02336451|617445119|FG004|Overall Study|Adverse Event|4|||
170846668|NCT02336451|617445115|FG000|Overall Study|Death|6|||
170846669|NCT02336451|617445116|FG001|Overall Study|Death|2|||
170846670|NCT02336451|617445117|FG002|Overall Study|Death|3|||
170846671|NCT02336451|617445118|FG003|Overall Study|Death|6|||
170846672|NCT02336451|617445119|FG004|Overall Study|Death|6|||
170846673|NCT02336451|617445115|FG000|Overall Study|Physician Decision|9|||
170846674|NCT02336451|617445116|FG001|Overall Study|Physician Decision|6|||
170846675|NCT02336451|617445117|FG002|Overall Study|Physician Decision|7|||
170846676|NCT02336451|617445118|FG003|Overall Study|Physician Decision|16|||
170846677|NCT02336451|617445119|FG004|Overall Study|Physician Decision|3|||
170846678|NCT02336451|617445115|FG000|Overall Study|Progressive disease|23|||
170846679|NCT02336451|617445116|FG001|Overall Study|Progressive disease|26|||
170846680|NCT02336451|617445117|FG002|Overall Study|Progressive disease|2|||
170846681|NCT02336451|617445118|FG003|Overall Study|Progressive disease|14|||
170846682|NCT02336451|617445119|FG004|Overall Study|Progressive disease|4|||
170846683|NCT02336451|617445115|FG000|Overall Study|Protocol Violation|1|||
170846684|NCT02336451|617445116|FG001|Overall Study|Protocol Violation|0|||
170846685|NCT02336451|617445117|FG002|Overall Study|Protocol Violation|0|||
170846686|NCT02336451|617445118|FG003|Overall Study|Protocol Violation|0|||
170846687|NCT02336451|617445119|FG004|Overall Study|Protocol Violation|0|||
170846688|NCT02336451|617445115|FG000|Overall Study|Patient/guardian decision|2|||
170846689|NCT02336451|617445116|FG001|Overall Study|Patient/guardian decision|4|||
170846690|NCT02336451|617445117|FG002|Overall Study|Patient/guardian decision|0|||
170846691|NCT02336451|617445118|FG003|Overall Study|Patient/guardian decision|2|||
170846692|NCT02336451|617445119|FG004|Overall Study|Patient/guardian decision|1|||
170846693|NCT04696653|617445120|FG000|Overall Study|left organization|18|||
170846694|NCT04696653|617445120|FG000|Overall Study|Lost to Follow-up|3|||
170846695|NCT04531982|617445121|FG000|Overall Study|Withdrawal by Subject|10|||
170846696|NCT04531982|617445122|FG001|Overall Study|Withdrawal by Subject|11|||
170846697|NCT04531982|617445121|FG000|Overall Study|Adverse Event|6|||
170846698|NCT04531982|617445122|FG001|Overall Study|Adverse Event|14|||
170846699|NCT04531982|617445121|FG000|Overall Study|Protocol Violation|6|||
170846700|NCT04531982|617445122|FG001|Overall Study|Protocol Violation|9|||
170846701|NCT04531982|617445121|FG000|Overall Study|Non-compliance with study drug|3|||
170846702|NCT04531982|617445122|FG001|Overall Study|Non-compliance with study drug|2|||
170846703|NCT04531982|617445121|FG000|Overall Study|Use of prohibited medication|2|||
170846704|NCT04531982|617445122|FG001|Overall Study|Use of prohibited medication|0|||
170846705|NCT04531982|617445121|FG000|Overall Study|Lost to Follow-up|0|||
170846706|NCT04531982|617445122|FG001|Overall Study|Lost to Follow-up|1|||
170846707|NCT04531982|617445121|FG000|Overall Study|Geopolitical conflict|2|||
170846708|NCT04531982|617445122|FG001|Overall Study|Geopolitical conflict|0|||
170846709|NCT04531982|617445121|FG000|Overall Study|Lack of Efficacy|3|||
170846710|NCT04531982|617445122|FG001|Overall Study|Lack of Efficacy|1|||
170846711|NCT06748729|617445124|FG000|Overall Study|Withdrawal by Subject|1|||
170846712|NCT01531673|617446264|FG000|Overall Study|Non-Compliance|0|||
170846713|NCT01531673|617446265|FG001|Overall Study|Non-Compliance|0|||
170846714|NCT01531673|617446266|FG002|Overall Study|Non-Compliance|0|||
170846715|NCT01531673|617446267|FG003|Overall Study|Non-Compliance|0|||
170846716|NCT01531673|617446268|FG004|Overall Study|Non-Compliance|0|||
170846717|NCT01531673|617446269|FG005|Overall Study|Non-Compliance|1|||
170846718|NCT01531673|617446270|FG006|Overall Study|Non-Compliance|0|||
170846719|NCT01531673|617446271|FG007|Overall Study|Non-Compliance|0|||
170846720|NCT01531673|617446272|FG008|Overall Study|Non-Compliance|0|||
170846721|NCT01531673|617446273|FG009|Overall Study|Non-Compliance|0|||
170846722|NCT01531673|617446274|FG010|Overall Study|Non-Compliance|0|||
170846723|NCT01531673|617446275|FG011|Overall Study|Non-Compliance|0|||
170846724|NCT01531673|617446276|FG012|Overall Study|Non-Compliance|0|||
170846725|NCT01531673|617446264|FG000|Overall Study|Adverse Event|0|||
170846726|NCT01531673|617446265|FG001|Overall Study|Adverse Event|1|||
170846727|NCT01531673|617446266|FG002|Overall Study|Adverse Event|0|||
170846728|NCT01531673|617446267|FG003|Overall Study|Adverse Event|0|||
170846729|NCT01531673|617446268|FG004|Overall Study|Adverse Event|0|||
170846730|NCT01531673|617446269|FG005|Overall Study|Adverse Event|0|||
170846731|NCT01531673|617446270|FG006|Overall Study|Adverse Event|0|||
170846732|NCT01531673|617446271|FG007|Overall Study|Adverse Event|0|||
170846733|NCT01531673|617446272|FG008|Overall Study|Adverse Event|0|||
170846734|NCT01531673|617446273|FG009|Overall Study|Adverse Event|0|||
170846735|NCT01531673|617446274|FG010|Overall Study|Adverse Event|0|||
170846736|NCT01531673|617446275|FG011|Overall Study|Adverse Event|0|||
170846737|NCT01531673|617446276|FG012|Overall Study|Adverse Event|0|||
170738750|NCT02237508|617049848|FG001|Overall Study|Protocol Violation|0|||
170738751|NCT02237508|617049849|FG002|Overall Study|Protocol Violation|1|||
170738752|NCT02237508|617049850|FG003|Overall Study|Protocol Violation|0|||
170738753|NCT02237508|617049851|FG004|Overall Study|Protocol Violation|0|||
170738754|NCT02237508|617049852|FG005|Overall Study|Protocol Violation|0|||
170738755|NCT02237508|617049853|FG006|Overall Study|Protocol Violation|0|||
170738756|NCT02237508|617049854|FG007|Overall Study|Protocol Violation|0|||
170738757|NCT02237508|617049855|FG008|Overall Study|Protocol Violation|0|||
170738758|NCT02237508|617049856|FG009|Overall Study|Protocol Violation|0|||
170738759|NCT05458024|617049857|FG000|Overall Study|Withdrawal by Subject|1|||
170738760|NCT05458024|617049858|FG001|Overall Study|Withdrawal by Subject|1|||
170738761|NCT04522180|617049860|FG000|Overall Study|Investigator judgement|3|||
170738762|NCT04522180|617049861|FG001|Overall Study|Investigator judgement|4|||
170738763|NCT04522180|617049860|FG000|Overall Study|Voluntary withdrawal|1|||
170738764|NCT04522180|617049861|FG001|Overall Study|Voluntary withdrawal|0|||
170738765|NCT04522180|617049860|FG000|Overall Study|Pregnancy|0|||
170738766|NCT04522180|617049861|FG001|Overall Study|Pregnancy|1|||
170738767|NCT04522180|617049860|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
170738768|NCT04522180|617049861|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
170738769|NCT04522180|617049860|FG000|Overall Study|Reason not specified|8|||
170738770|NCT04522180|617049861|FG001|Overall Study|Reason not specified|5|||
170738771|NCT02055157|617049864|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
170738772|NCT02055157|617049865|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
170738773|NCT02055157|617049866|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
170738774|NCT02055157|617049867|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
170738775|NCT02055157|617049864|FG000|Initial 6 Months|Adverse Event|0|||
170738776|NCT02055157|617049865|FG001|Initial 6 Months|Adverse Event|0|||
170738777|NCT02055157|617049866|FG002|Initial 6 Months|Adverse Event|0|||
170738778|NCT02055157|617049867|FG003|Initial 6 Months|Adverse Event|1|||
170738779|NCT02055157|617049864|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
170738780|NCT02055157|617049865|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
170738781|NCT02055157|617049866|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
170738782|NCT02055157|617049867|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
170738783|NCT02055157|617049864|FG000|18-month Extension|Investigator decision|0|||
170738784|NCT02055157|617049865|FG001|18-month Extension|Investigator decision|1|||
170738785|NCT02055157|617049866|FG002|18-month Extension|Investigator decision|0|||
170738786|NCT02055157|617049867|FG003|18-month Extension|Investigator decision|0|||
170738787|NCT02055157|617049864|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
170738788|NCT02055157|617049865|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
170738789|NCT02055157|617049866|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
170738790|NCT02055157|617049867|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
170738791|NCT04843930|617049872|FG000|Randomization|Withdrawal by Subject|6|||
170738792|NCT04843930|617049873|FG001|Randomization|Withdrawal by Subject|6|||
170738793|NCT04843930|617049874|FG002|Randomization|Withdrawal by Subject|0|||
170738794|NCT04843930|617049875|FG003|Randomization|Withdrawal by Subject|0|||
170738795|NCT04843930|617049872|FG000|Week 6 Assessment|Adverse Event|3|||
170738796|NCT04843930|617049873|FG001|Week 6 Assessment|Adverse Event|0|||
170738797|NCT04843930|617049874|FG002|Week 6 Assessment|Adverse Event|0|||
170738798|NCT04843930|617049875|FG003|Week 6 Assessment|Adverse Event|0|||
170738799|NCT04843930|617049872|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
170738800|NCT04843930|617049873|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
170738801|NCT04843930|617049874|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
170738802|NCT04843930|617049875|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
170738803|NCT04843930|617049872|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
170738804|NCT04843930|617049873|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
170738805|NCT04843930|617049874|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
170738806|NCT04843930|617049875|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
170738807|NCT01412801|617049882|FG000|Overall Study|Death|0|||
170738808|NCT01412801|617049883|FG001|Overall Study|Death|1|||
170738809|NCT01412801|617049884|FG002|Overall Study|Death|0|||
170738810|NCT01412801|617049885|FG003|Overall Study|Death|4|||
170738811|NCT01412801|617049886|FG004|Overall Study|Death|2|||
170738812|NCT01412801|617049887|FG005|Overall Study|Death|2|||
170738813|NCT01412801|617049882|FG000|Overall Study|Lost to Follow-up|1|||
170846738|NCT01531673|617446264|FG000|Overall Study|Lost to Follow-up|0|||
170846739|NCT01531673|617446265|FG001|Overall Study|Lost to Follow-up|0|||
170738814|NCT01412801|617049883|FG001|Overall Study|Lost to Follow-up|2|||
170738815|NCT01412801|617049884|FG002|Overall Study|Lost to Follow-up|4|||
170738816|NCT01412801|617049885|FG003|Overall Study|Lost to Follow-up|0|||
170738817|NCT01412801|617049886|FG004|Overall Study|Lost to Follow-up|1|||
170738818|NCT01412801|617049887|FG005|Overall Study|Lost to Follow-up|1|||
170738819|NCT01412801|617049882|FG000|Overall Study|Withdrawal by Subject|3|||
170738820|NCT01412801|617049883|FG001|Overall Study|Withdrawal by Subject|2|||
170738821|NCT01412801|617049884|FG002|Overall Study|Withdrawal by Subject|1|||
170738822|NCT01412801|617049885|FG003|Overall Study|Withdrawal by Subject|0|||
170738823|NCT01412801|617049886|FG004|Overall Study|Withdrawal by Subject|0|||
170846740|NCT01531673|617446266|FG002|Overall Study|Lost to Follow-up|0|||
170846741|NCT01531673|617446267|FG003|Overall Study|Lost to Follow-up|0|||
170846742|NCT01531673|617446268|FG004|Overall Study|Lost to Follow-up|1|||
170846743|NCT01531673|617446269|FG005|Overall Study|Lost to Follow-up|0|||
170846744|NCT01531673|617446270|FG006|Overall Study|Lost to Follow-up|0|||
170846745|NCT01531673|617446271|FG007|Overall Study|Lost to Follow-up|0|||
170846746|NCT01531673|617446272|FG008|Overall Study|Lost to Follow-up|0|||
170846747|NCT01531673|617446273|FG009|Overall Study|Lost to Follow-up|0|||
170846748|NCT01531673|617446274|FG010|Overall Study|Lost to Follow-up|0|||
170846749|NCT01531673|617446275|FG011|Overall Study|Lost to Follow-up|0|||
170846750|NCT01531673|617446276|FG012|Overall Study|Lost to Follow-up|0|||
170846751|NCT01531673|617446264|FG000|Overall Study|Other|0|||
170846752|NCT01531673|617446265|FG001|Overall Study|Other|0|||
170846753|NCT01531673|617446266|FG002|Overall Study|Other|0|||
170846754|NCT01531673|617446267|FG003|Overall Study|Other|1|||
170846755|NCT01531673|617446268|FG004|Overall Study|Other|0|||
170846756|NCT01531673|617446269|FG005|Overall Study|Other|0|||
170846757|NCT01531673|617446270|FG006|Overall Study|Other|0|||
170846758|NCT01531673|617446271|FG007|Overall Study|Other|0|||
170846759|NCT01531673|617446272|FG008|Overall Study|Other|0|||
170846760|NCT01531673|617446273|FG009|Overall Study|Other|1|||
170846761|NCT01531673|617446274|FG010|Overall Study|Other|0|||
170846762|NCT01531673|617446275|FG011|Overall Study|Other|0|||
170846763|NCT01531673|617446276|FG012|Overall Study|Other|0|||
170846764|NCT00306670|617446279|FG000|Overall Study|patients recruited; Genentech, the st|0|||
170846765|NCT00306670|617446280|FG001|Overall Study|patients recruited; Genentech, the st|2|||
170846766|NCT00503139|617446281|FG000|Overall Study|Case Report Forms were not collected|4|||
170846767|NCT00503139|617446281|FG000|Overall Study|Protocol Violation|4|||
170846768|NCT00091169|617446285|FG000|Overall Study|Disease progression|3|||
170846769|NCT00091169|617446286|FG001|Overall Study|Disease progression|1|||
170846770|NCT00091169|617446285|FG000|Overall Study|Adverse Event|11|||
170846771|NCT00091169|617446286|FG001|Overall Study|Adverse Event|17|||
170846772|NCT00091169|617446285|FG000|Overall Study|Death|4|||
170846773|NCT00091169|617446286|FG001|Overall Study|Death|1|||
170846774|NCT00091169|617446285|FG000|Overall Study|Withdrawal by Subject|10|||
170846775|NCT00091169|617446286|FG001|Overall Study|Withdrawal by Subject|13|||
170846776|NCT00091169|617446285|FG000|Overall Study|Other|3|||
170846777|NCT00091169|617446286|FG001|Overall Study|Other|4|||
170846778|NCT00091169|617446285|FG000|Overall Study|Not start protocol therapy|26|||
170738824|NCT01412801|617049887|FG005|Overall Study|Withdrawal by Subject|0|||
170738825|NCT01412801|617049882|FG000|Overall Study|Relocated to another area|0|||
170738826|NCT01412801|617049883|FG001|Overall Study|Relocated to another area|0|||
170738827|NCT01412801|617049884|FG002|Overall Study|Relocated to another area|2|||
170738828|NCT01412801|617049885|FG003|Overall Study|Relocated to another area|0|||
170738829|NCT01412801|617049886|FG004|Overall Study|Relocated to another area|0|||
170738830|NCT01412801|617049887|FG005|Overall Study|Relocated to another area|0|||
170738831|NCT01547299|617049890|FG000|Overall Study|Withdrawal by Subject|2|||
170738832|NCT01547299|617049891|FG001|Overall Study|Withdrawal by Subject|2|||
170738833|NCT03682705|617049892|FG000|Overall Study|Adverse Event|1|||
170738834|NCT03682705|617049893|FG001|Overall Study|Adverse Event|1|||
170738835|NCT03682705|617049894|FG002|Overall Study|Adverse Event|1|||
170738836|NCT03682705|617049895|FG003|Overall Study|Adverse Event|0|||
170738837|NCT03682705|617049896|FG004|Overall Study|Adverse Event|1|||
170738838|NCT03682705|617049897|FG005|Overall Study|Adverse Event|1|||
170738839|NCT03682705|617049892|FG000|Overall Study|Withdrawal by Subject|1|||
170738840|NCT03682705|617049893|FG001|Overall Study|Withdrawal by Subject|3|||
170738841|NCT03682705|617049894|FG002|Overall Study|Withdrawal by Subject|2|||
170738842|NCT03682705|617049895|FG003|Overall Study|Withdrawal by Subject|4|||
170738843|NCT03682705|617049896|FG004|Overall Study|Withdrawal by Subject|0|||
170738844|NCT03682705|617049897|FG005|Overall Study|Withdrawal by Subject|1|||
170738845|NCT03682705|617049892|FG000|Overall Study|Other, not specified|0|||
170738846|NCT03682705|617049893|FG001|Overall Study|Other, not specified|0|||
170738847|NCT03682705|617049894|FG002|Overall Study|Other, not specified|0|||
170738848|NCT03682705|617049895|FG003|Overall Study|Other, not specified|1|||
170738849|NCT03682705|617049896|FG004|Overall Study|Other, not specified|2|||
170738850|NCT03682705|617049897|FG005|Overall Study|Other, not specified|0|||
170738851|NCT03682705|617049892|FG000|Overall Study|Lost to Follow-up|0|||
170738852|NCT03682705|617049893|FG001|Overall Study|Lost to Follow-up|0|||
170738853|NCT03682705|617049894|FG002|Overall Study|Lost to Follow-up|0|||
170738854|NCT03682705|617049895|FG003|Overall Study|Lost to Follow-up|0|||
170738855|NCT03682705|617049896|FG004|Overall Study|Lost to Follow-up|3|||
170738856|NCT03682705|617049897|FG005|Overall Study|Lost to Follow-up|0|||
170738857|NCT04615182|617049898|FG000|Overall Study|Re-transplanted|2|||
170738858|NCT04615182|617049898|FG000|Overall Study|Protocol Violation|6|||
170738859|NCT04615182|617049898|FG000|Overall Study|Death|6|||
170738860|NCT04615182|617049898|FG000|Overall Study|Death and protocol violation|1|||
170738861|NCT01669798|617049899|FG000|Overall Study|Physician Decision|5|||
170738862|NCT02636270|617049907|FG000|Overall Study|Adverse Event|1|||
170738863|NCT02636270|617049908|FG001|Overall Study|Adverse Event|0|||
170738864|NCT02636270|617049909|FG002|Overall Study|Adverse Event|0|||
170738865|NCT02636270|617049907|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
170738866|NCT02636270|617049908|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
170738867|NCT02636270|617049909|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
170738868|NCT05619003|617049914|FG000|Overall Study|Adverse Event|1|||
170738869|NCT02272725|617049915|FG000|Overall Study|equipment malfunction|2|||
170738870|NCT02272725|617049916|FG001|Overall Study|equipment malfunction|0|||
170738871|NCT07018999|617049917|FG000|Overall Study|Protocol Violation|0|||
170738872|NCT07018999|617049918|FG001|Overall Study|Protocol Violation|1|||
170738873|NCT07018999|617049917|FG000|Overall Study|Incomplete data entry|4|||
170738874|NCT07018999|617049918|FG001|Overall Study|Incomplete data entry|7|||
170738875|NCT02769065|617052293|FG000|Overall Study|Voluntary Withdrawal|1|||
170738876|NCT02769065|617052294|FG001|Overall Study|Voluntary Withdrawal|0|||
170738877|NCT02769065|617052295|FG002|Overall Study|Voluntary Withdrawal|0|||
170738878|NCT02769065|617052296|FG003|Overall Study|Voluntary Withdrawal|0|||
170738879|NCT02769065|617052297|FG004|Overall Study|Voluntary Withdrawal|0|||
170738880|NCT02769065|617052298|FG005|Overall Study|Voluntary Withdrawal|0|||
170738881|NCT02769065|617052299|FG006|Overall Study|Voluntary Withdrawal|0|||
170738882|NCT02769065|617052300|FG007|Overall Study|Voluntary Withdrawal|0|||
170738883|NCT02769065|617052301|FG008|Overall Study|Voluntary Withdrawal|0|||
170738884|NCT02769065|617052302|FG009|Overall Study|Voluntary Withdrawal|0|||
170738885|NCT02769065|617052303|FG010|Overall Study|Voluntary Withdrawal|0|||
170738886|NCT02769065|617052304|FG011|Overall Study|Voluntary Withdrawal|0|||
170738887|NCT02769065|617052305|FG012|Overall Study|Voluntary Withdrawal|0|||
170738888|NCT02769065|617052306|FG013|Overall Study|Voluntary Withdrawal|0|||
170738889|NCT02769065|617052307|FG014|Overall Study|Voluntary Withdrawal|0|||
170738890|NCT02769065|617052308|FG015|Overall Study|Voluntary Withdrawal|0|||
170738891|NCT02769065|617052309|FG016|Overall Study|Voluntary Withdrawal|0|||
170738892|NCT02769065|617052310|FG017|Overall Study|Voluntary Withdrawal|0|||
170738893|NCT02769065|617052311|FG018|Overall Study|Voluntary Withdrawal|0|||
170738894|NCT02769065|617052312|FG019|Overall Study|Voluntary Withdrawal|0|||
170738895|NCT02769065|617052313|FG020|Overall Study|Voluntary Withdrawal|0|||
170738896|NCT02769065|617052314|FG021|Overall Study|Voluntary Withdrawal|0|||
170738897|NCT02769065|617052315|FG022|Overall Study|Voluntary Withdrawal|0|||
170846779|NCT00091169|617446286|FG001|Overall Study|Not start protocol therapy|17|||
170846780|NCT02735577|617446287|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
170846781|NCT02735577|617446287|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
170846782|NCT01332630|617446288|FG000|Overall Study|Withdrawal by Subject|3|||
170846783|NCT02040259|617446289|FG000|Overall Study|Death|280|||
170846784|NCT02040259|617446289|FG000|Overall Study|Lost to Follow-up|76|||
170846785|NCT02040259|617446289|FG000|Overall Study|Assessment not completed|3|||
170846786|NCT02040259|617446289|FG000|Overall Study|Withdrawal by Subject|4|||
170846787|NCT00316602|617446292|FG000|Overall Study|Withdrawal by Subject|3|||
170846788|NCT00316602|617446293|FG001|Overall Study|Withdrawal by Subject|2|||
170846789|NCT00316602|617446292|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
170846790|NCT00316602|617446293|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
170846791|NCT00316602|617446292|FG000|Overall Study|Adverse Event|1|||
170846792|NCT00316602|617446293|FG001|Overall Study|Adverse Event|0|||
170846793|NCT00316602|617446292|FG000|Overall Study|Other|3|||
170846794|NCT00316602|617446293|FG001|Overall Study|Other|6|||
170846795|NCT00626990|617446294|FG000|Overall Study|Lack of Efficacy|6|||
170846796|NCT00626990|617446295|FG001|Overall Study|Lack of Efficacy|7|||
170846797|NCT00626990|617446296|FG002|Overall Study|Lack of Efficacy|49|||
170846798|NCT00626990|617446297|FG003|Overall Study|Lack of Efficacy|40|||
170846799|NCT00626990|617446294|FG000|Overall Study|Adverse Event|1|||
170846800|NCT00626990|617446295|FG001|Overall Study|Adverse Event|7|||
170846801|NCT00626990|617446296|FG002|Overall Study|Adverse Event|14|||
170846802|NCT00626990|617446297|FG003|Overall Study|Adverse Event|28|||
170846803|NCT00626990|617446294|FG000|Overall Study|Death|0|||
170846804|NCT00626990|617446295|FG001|Overall Study|Death|1|||
170846805|NCT00626990|617446296|FG002|Overall Study|Death|0|||
170846806|NCT00626990|617446297|FG003|Overall Study|Death|0|||
170846807|NCT00626990|617446294|FG000|Overall Study|Withdrawal by Subject|3|||
170846808|NCT00626990|617446295|FG001|Overall Study|Withdrawal by Subject|1|||
170846809|NCT00626990|617446296|FG002|Overall Study|Withdrawal by Subject|5|||
170846810|NCT00626990|617446297|FG003|Overall Study|Withdrawal by Subject|11|||
170846811|NCT00626990|617446294|FG000|Overall Study|Protocol Violation|0|||
170846812|NCT00626990|617446295|FG001|Overall Study|Protocol Violation|1|||
170846813|NCT00626990|617446296|FG002|Overall Study|Protocol Violation|1|||
170846814|NCT00626990|617446297|FG003|Overall Study|Protocol Violation|0|||
170846815|NCT00626990|617446294|FG000|Overall Study|Various different reasons/missing|4|||
170846816|NCT00626990|617446295|FG001|Overall Study|Various different reasons/missing|8|||
170846817|NCT00626990|617446296|FG002|Overall Study|Various different reasons/missing|8|||
170846818|NCT00626990|617446297|FG003|Overall Study|Various different reasons/missing|16|||
170846819|NCT01940939|617446302|FG000|Overall Study|Withdrawal by Subject|2|||
170846820|NCT01940939|617446303|FG001|Overall Study|Withdrawal by Subject|8|||
170846821|NCT01895101|617446304|FG000|Overall Study|OPCAB procedure|1|||
170846822|NCT01895101|617446305|FG001|Overall Study|OPCAB procedure|1|||
170846823|NCT01895101|617446306|FG002|Overall Study|OPCAB procedure|3|||
170846824|NCT01895101|617446304|FG000|Overall Study|Withdrawal by Subject|0|||
170846825|NCT01895101|617446305|FG001|Overall Study|Withdrawal by Subject|1|||
170846826|NCT01895101|617446306|FG002|Overall Study|Withdrawal by Subject|2|||
170846827|NCT01895101|617446304|FG000|Overall Study|another study, enrolled in other study|0|||
170846828|NCT01895101|617446305|FG001|Overall Study|another study, enrolled in other study|1|||
170846829|NCT01895101|617446306|FG002|Overall Study|another study, enrolled in other study|0|||
170846830|NCT01895101|617446304|FG000|Overall Study|Death|0|||
170846831|NCT01895101|617446305|FG001|Overall Study|Death|1|||
170846832|NCT01895101|617446306|FG002|Overall Study|Death|0|||
170846833|NCT01895101|617446304|FG000|Overall Study|coagulation disorder|0|||
170846834|NCT01895101|617446305|FG001|Overall Study|coagulation disorder|1|||
170846835|NCT01895101|617446306|FG002|Overall Study|coagulation disorder|0|||
170846836|NCT02591953|617446310|FG000|Overall Study|Lost to Follow-up|6|||
170846837|NCT02591953|617446311|FG001|Overall Study|Lost to Follow-up|6|||
170846838|NCT02182947|617446312|FG000|Overall Study|Withdrawal by Subject|7|||
170846839|NCT02182947|617446312|FG000|Overall Study|Lost to Follow-up|3|||
170846840|NCT02182947|617446312|FG000|Overall Study|Failed screening activities|8|||
170846841|NCT03921723|617446315|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
170846842|NCT03921723|617446315|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
170846843|NCT01461811|617446316|FG000|Overall Study|Adverse Event|2|||
170846844|NCT01461811|617446317|FG001|Overall Study|Adverse Event|1|||
170846845|NCT01461811|617446316|FG000|Overall Study|Subject decision unrelated to an AE|1|||
170846846|NCT01461811|617446317|FG001|Overall Study|Subject decision unrelated to an AE|1|||
170846847|NCT01461811|617446316|FG000|Overall Study|Noncompliance|1|||
170846848|NCT01461811|617446317|FG001|Overall Study|Noncompliance|1|||
170846849|NCT05032872|617446318|FG000|Overall Study|Adverse Event|1|||
170846850|NCT05032872|617446319|FG001|Overall Study|Adverse Event|0|||
170846851|NCT05032872|617446318|FG000|Overall Study|Lost to Follow-up|2|||
170846852|NCT05032872|617446319|FG001|Overall Study|Lost to Follow-up|4|||
170846853|NCT05032872|617446318|FG000|Overall Study|Withdrawal by Subject|4|||
170846854|NCT05032872|617446319|FG001|Overall Study|Withdrawal by Subject|3|||
170846855|NCT03046121|617446320|FG000|Overall Study|Death|32|||
170846856|NCT03046121|617446321|FG001|Overall Study|Death|60|||
170846857|NCT03046121|617446320|FG000|Overall Study|Withdrawal by Subject|14|||
170846858|NCT03046121|617446321|FG001|Overall Study|Withdrawal by Subject|12|||
170846859|NCT04514510|617446323|FG000|Overall Study|Lost to Follow-up|0|||
170846860|NCT04514510|617446324|FG001|Overall Study|Lost to Follow-up|1|||
170846861|NCT04514510|617446323|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
170846862|NCT04514510|617446324|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
170846863|NCT00406692|617446325|FG000|Overall Study|Withdrawal by Subject|4|||
170846864|NCT00406692|617446325|FG000|Overall Study|Physician Decision|1|||
170846865|NCT00406692|617446325|FG000|Overall Study|Adverse Event|1|||
170846866|NCT00406692|617446325|FG000|Overall Study|Lack of Efficacy|1|||
170846867|NCT00573859|617446326|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
170846868|NCT00573859|617446326|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
170846869|NCT02416453|617446327|FG000|Overall Study|Adverse Event|0|||
170846870|NCT02416453|617446328|FG001|Overall Study|Adverse Event|0|||
170846871|NCT02416453|617446329|FG002|Overall Study|Adverse Event|0|||
170846872|NCT02416453|617446330|FG003|Overall Study|Adverse Event|2|||
170846873|NCT02416453|617446331|FG004|Overall Study|Adverse Event|0|||
170846874|NCT02416453|617446332|FG005|Overall Study|Adverse Event|1|||
170846875|NCT02416453|617446333|FG006|Overall Study|Adverse Event|0|||
170846876|NCT02416453|617446334|FG007|Overall Study|Adverse Event|0|||
170846877|NCT02416453|617446335|FG008|Overall Study|Adverse Event|0|||
170846878|NCT02416453|617446336|FG009|Overall Study|Adverse Event|0|||
170846879|NCT02416453|617446337|FG010|Overall Study|Adverse Event|0|||
170846880|NCT02416453|617446327|FG000|Overall Study|Lost to Follow-up|1|||
170846881|NCT02416453|617446328|FG001|Overall Study|Lost to Follow-up|3|||
170846882|NCT02416453|617446329|FG002|Overall Study|Lost to Follow-up|0|||
170846883|NCT02416453|617446330|FG003|Overall Study|Lost to Follow-up|8|||
170846884|NCT02416453|617446331|FG004|Overall Study|Lost to Follow-up|0|||
170846885|NCT02416453|617446332|FG005|Overall Study|Lost to Follow-up|5|||
170846886|NCT02416453|617446333|FG006|Overall Study|Lost to Follow-up|1|||
170846887|NCT02416453|617446334|FG007|Overall Study|Lost to Follow-up|3|||
170846888|NCT02416453|617446335|FG008|Overall Study|Lost to Follow-up|1|||
170846889|NCT02416453|617446336|FG009|Overall Study|Lost to Follow-up|0|||
170846890|NCT02416453|617446337|FG010|Overall Study|Lost to Follow-up|0|||
170846891|NCT02416453|617446327|FG000|Overall Study|Physician Decision|0|||
170846892|NCT02416453|617446328|FG001|Overall Study|Physician Decision|0|||
170846893|NCT02416453|617446329|FG002|Overall Study|Physician Decision|0|||
170846894|NCT02416453|617446330|FG003|Overall Study|Physician Decision|0|||
170846895|NCT02416453|617446331|FG004|Overall Study|Physician Decision|0|||
170846896|NCT02416453|617446332|FG005|Overall Study|Physician Decision|1|||
170846897|NCT02416453|617446333|FG006|Overall Study|Physician Decision|1|||
170846898|NCT02416453|617446334|FG007|Overall Study|Physician Decision|1|||
170846899|NCT02416453|617446335|FG008|Overall Study|Physician Decision|0|||
170846900|NCT02416453|617446336|FG009|Overall Study|Physician Decision|0|||
170846901|NCT02416453|617446337|FG010|Overall Study|Physician Decision|0|||
170846902|NCT02416453|617446327|FG000|Overall Study|Withdrawal by Subject|2|||
170846903|NCT02416453|617446328|FG001|Overall Study|Withdrawal by Subject|0|||
170846904|NCT02416453|617446329|FG002|Overall Study|Withdrawal by Subject|0|||
170846905|NCT02416453|617446330|FG003|Overall Study|Withdrawal by Subject|5|||
170846906|NCT02416453|617446331|FG004|Overall Study|Withdrawal by Subject|1|||
170846907|NCT02416453|617446332|FG005|Overall Study|Withdrawal by Subject|8|||
170846908|NCT02416453|617446333|FG006|Overall Study|Withdrawal by Subject|0|||
170846909|NCT02416453|617446334|FG007|Overall Study|Withdrawal by Subject|8|||
170846910|NCT02416453|617446335|FG008|Overall Study|Withdrawal by Subject|4|||
170846911|NCT02416453|617446336|FG009|Overall Study|Withdrawal by Subject|0|||
170846912|NCT02416453|617446337|FG010|Overall Study|Withdrawal by Subject|0|||
170846913|NCT02416453|617446327|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846914|NCT02416453|617446328|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846915|NCT02416453|617446329|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
170846916|NCT02416453|617446330|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846917|NCT02416453|617446331|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846918|NCT02416453|617446332|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846919|NCT02416453|617446333|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846920|NCT02416453|617446334|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846921|NCT02416453|617446335|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846922|NCT02416453|617446336|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846923|NCT02416453|617446337|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
170846924|NCT02416453|617446327|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846925|NCT02416453|617446328|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846926|NCT02416453|617446329|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846927|NCT02416453|617446330|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846928|NCT02416453|617446331|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846929|NCT02416453|617446332|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
170846930|NCT02416453|617446333|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846931|NCT02416453|617446334|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846932|NCT02416453|617446335|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846933|NCT02416453|617446336|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846934|NCT02416453|617446337|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
170846935|NCT00368927|617446338|FG000|Overall Study|Lost to Follow-up|2|||
170846936|NCT00368927|617446339|FG001|Overall Study|Lost to Follow-up|0|||
170846937|NCT00368927|617446338|FG000|Overall Study|Adverse Event|1|||
170846938|NCT00368927|617446339|FG001|Overall Study|Adverse Event|1|||
170846939|NCT00368927|617446338|FG000|Overall Study|Withdrawal by Subject|1|||
170846940|NCT00368927|617446339|FG001|Overall Study|Withdrawal by Subject|2|||
170846941|NCT00368927|617446338|FG000|Overall Study|Physician Decision|1|||
170846942|NCT00368927|617446339|FG001|Overall Study|Physician Decision|0|||
170846943|NCT01989169|617446340|FG000|Period 2|Adverse Event|0|||
170846944|NCT01989169|617446341|FG001|Period 2|Adverse Event|1|||
170846945|NCT04187326|617446342|FG000|Overall Study|Lost to Follow-up|2|||
170846946|NCT04187326|617446343|FG001|Overall Study|Lost to Follow-up|1|||
170846947|NCT04187326|617446342|FG000|Overall Study|Computer error- task was only partially completed.|0|||
170846948|NCT04187326|617446343|FG001|Overall Study|Computer error- task was only partially completed.|1|||
170846949|NCT01114880|617446344|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
170846950|NCT01114880|617446345|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
170846951|NCT01114880|617446344|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
170846952|NCT01114880|617446345|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
170846953|NCT01114880|617446344|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
170846954|NCT01114880|617446345|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
170846955|NCT01114880|617446344|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
170846956|NCT01114880|617446345|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
170846957|NCT01114880|617446344|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
170846958|NCT01114880|617446345|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
170846959|NCT01114880|617446344|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
170846960|NCT01114880|617446345|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
170846961|NCT02906007|617446347|FG000|Overall Study|Physician Decision|0|||
170846962|NCT02906007|617446348|FG001|Overall Study|Physician Decision|0|||
170846963|NCT02906007|617446349|FG002|Overall Study|Physician Decision|1|||
170846964|NCT02906007|617446347|FG000|Overall Study|Died|1|||
170846965|NCT02906007|617446348|FG001|Overall Study|Died|0|||
170846966|NCT02906007|617446349|FG002|Overall Study|Died|0|||
170846967|NCT06655558|617446350|FG000|Overall Study|Protocol Violation|1|||
170846968|NCT04998812|617446356|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
170846969|NCT04998812|617446357|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
170846970|NCT04998812|617446356|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
170846971|NCT04998812|617446357|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
170846972|NCT04998812|617446356|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
170846973|NCT04998812|617446357|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
170846974|NCT04998812|617446356|FG000|Vaccination Period|Ongoing in study|23|||
170846975|NCT04998812|617446357|FG001|Vaccination Period|Ongoing in study|23|||
170846976|NCT03524092|617446363|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
170846977|NCT03524092|617446364|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
170846978|NCT03524092|617446365|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
170846979|NCT03524092|617446366|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
170846980|NCT03524092|617446367|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
170846981|NCT03524092|617446368|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
170846982|NCT03524092|617446363|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
170846983|NCT03524092|617446364|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
170846984|NCT03524092|617446365|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
170846985|NCT03524092|617446366|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
170846986|NCT03524092|617446367|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
170846987|NCT03524092|617446368|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
170846988|NCT03524092|617446363|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
170738898|NCT02769065|617052316|FG023|Overall Study|Voluntary Withdrawal|0|||
170738899|NCT02769065|617052317|FG024|Overall Study|Voluntary Withdrawal|0|||
170738900|NCT02769065|617052318|FG025|Overall Study|Voluntary Withdrawal|0|||
170738901|NCT02769065|617052319|FG026|Overall Study|Voluntary Withdrawal|0|||
170738902|NCT02769065|617052320|FG027|Overall Study|Voluntary Withdrawal|0|||
170738903|NCT02769065|617052321|FG028|Overall Study|Voluntary Withdrawal|0|||
170846989|NCT03524092|617446364|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
170846990|NCT03524092|617446365|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
170846991|NCT03524092|617446366|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
170846992|NCT03524092|617446367|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
170846993|NCT03524092|617446368|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
170846994|NCT03524092|617446363|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
170738904|NCT02769065|617052322|FG029|Overall Study|Voluntary Withdrawal|0|||
170738905|NCT02769065|617052293|FG000|Overall Study|Reason Not Specified|0|||
170846995|NCT03524092|617446364|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
170846996|NCT03524092|617446365|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
170846997|NCT03524092|617446366|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
170846998|NCT03524092|617446367|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
170846999|NCT03524092|617446368|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
170847000|NCT03524092|617446363|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
170847001|NCT03524092|617446364|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
170847002|NCT03524092|617446365|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
170847003|NCT03524092|617446366|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
170847004|NCT03524092|617446367|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
170847005|NCT03524092|617446368|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
170847006|NCT03524092|617446363|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
170847007|NCT03524092|617446364|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
170847008|NCT03524092|617446365|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
170847009|NCT03524092|617446366|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
170847010|NCT03524092|617446367|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
170847011|NCT03524092|617446368|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
170847012|NCT03524092|617446363|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
170847013|NCT03524092|617446364|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
170847014|NCT03524092|617446365|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
170847015|NCT03524092|617446366|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
170847016|NCT03524092|617446367|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
170847017|NCT03524092|617446368|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
170847018|NCT03524092|617446363|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
170847019|NCT03524092|617446364|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
170847020|NCT03524092|617446365|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
170847021|NCT03524092|617446366|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
170847022|NCT03524092|617446367|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
170847023|NCT03524092|617446368|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
170847024|NCT03524092|617446363|FG000|Loss of Response Rescue Period|Adverse Event|0|||
170847025|NCT03524092|617446364|FG001|Loss of Response Rescue Period|Adverse Event|0|||
170847026|NCT03524092|617446365|FG002|Loss of Response Rescue Period|Adverse Event|0|||
170847027|NCT03524092|617446366|FG003|Loss of Response Rescue Period|Adverse Event|2|||
170847028|NCT03524092|617446367|FG004|Loss of Response Rescue Period|Adverse Event|0|||
170847029|NCT03524092|617446368|FG005|Loss of Response Rescue Period|Adverse Event|0|||
170847030|NCT03524092|617446363|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
170847031|NCT03524092|617446364|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
170847032|NCT03524092|617446365|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
170847033|NCT03524092|617446366|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
170847034|NCT03524092|617446367|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
170847035|NCT03524092|617446368|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
170847036|NCT03524092|617446363|FG000|Loss of Response Rescue Period|Pregnancy|0|||
170847037|NCT03524092|617446364|FG001|Loss of Response Rescue Period|Pregnancy|0|||
170847038|NCT03524092|617446365|FG002|Loss of Response Rescue Period|Pregnancy|0|||
170847039|NCT03524092|617446366|FG003|Loss of Response Rescue Period|Pregnancy|1|||
170847040|NCT03524092|617446367|FG004|Loss of Response Rescue Period|Pregnancy|0|||
170847041|NCT03524092|617446368|FG005|Loss of Response Rescue Period|Pregnancy|0|||
170847042|NCT03524092|617446363|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
170847043|NCT03524092|617446364|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
170847044|NCT03524092|617446365|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
170847045|NCT03524092|617446366|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
170847046|NCT03524092|617446367|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
170847047|NCT03524092|617446368|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
170847048|NCT03524092|617446363|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
170847049|NCT03524092|617446364|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
170847050|NCT03524092|617446365|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
170847051|NCT03524092|617446366|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
170847052|NCT03524092|617446367|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
170847053|NCT03524092|617446368|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
170847054|NCT03524092|617446363|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
170847055|NCT03524092|617446364|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
170847056|NCT03524092|617446365|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
170847057|NCT03524092|617446366|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
170847058|NCT03524092|617446367|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
170847059|NCT03524092|617446368|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
170847060|NCT03524092|617446363|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
170847061|NCT03524092|617446364|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
170847062|NCT03524092|617446365|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
170847063|NCT03524092|617446366|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
170847064|NCT03524092|617446367|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
170847065|NCT03524092|617446368|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
170847066|NCT03524092|617446363|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
170847067|NCT03524092|617446364|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
170847068|NCT03524092|617446365|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
170847069|NCT03524092|617446366|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
170847070|NCT03524092|617446367|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
170847071|NCT03524092|617446368|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
170847072|NCT03524092|617446363|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
170847073|NCT03524092|617446364|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
170847074|NCT03524092|617446365|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
170847075|NCT03524092|617446366|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
170847076|NCT03524092|617446367|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
170847077|NCT03524092|617446368|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
170847078|NCT03524092|617446363|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
170847079|NCT03524092|617446364|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
170847080|NCT03524092|617446365|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
170847081|NCT03524092|617446366|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
170847082|NCT03524092|617446367|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
170847083|NCT03524092|617446368|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
170847084|NCT03524092|617446363|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
170847085|NCT03524092|617446364|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
170847086|NCT03524092|617446365|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
170847087|NCT03524092|617446366|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
170847088|NCT03524092|617446367|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
170847089|NCT03524092|617446368|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
170847090|NCT03524092|617446363|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
170847091|NCT03524092|617446364|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
170847092|NCT03524092|617446365|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
170847093|NCT03524092|617446366|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
170847094|NCT03524092|617446367|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
170847095|NCT03524092|617446368|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
170847096|NCT03524092|617446363|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
170847097|NCT03524092|617446364|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
170847098|NCT03524092|617446365|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
170847099|NCT03524092|617446366|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
170847100|NCT03524092|617446367|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
170847101|NCT03524092|617446368|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
170847102|NCT03524092|617446363|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
170847103|NCT03524092|617446364|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
170847104|NCT03524092|617446365|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
170847105|NCT03524092|617446366|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
170847106|NCT03524092|617446367|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
170847107|NCT03524092|617446368|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
170847108|NCT03524092|617446363|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
170847109|NCT03524092|617446364|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
170847110|NCT03524092|617446365|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
170847111|NCT03524092|617446366|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
170847112|NCT03524092|617446367|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
170847113|NCT03524092|617446368|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
170847114|NCT04303780|617446369|FG000|Overall Study|Death|104|||
170847115|NCT04303780|617446370|FG001|Overall Study|Death|85|||
170847116|NCT04303780|617446369|FG000|Overall Study|Lost to Follow-up|5|||
170847117|NCT04303780|617446370|FG001|Overall Study|Lost to Follow-up|2|||
170738906|NCT02769065|617052294|FG001|Overall Study|Reason Not Specified|0|||
170738907|NCT02769065|617052295|FG002|Overall Study|Reason Not Specified|0|||
170738908|NCT02769065|617052296|FG003|Overall Study|Reason Not Specified|0|||
170738909|NCT02769065|617052297|FG004|Overall Study|Reason Not Specified|0|||
170738910|NCT02769065|617052298|FG005|Overall Study|Reason Not Specified|0|||
170738911|NCT02769065|617052299|FG006|Overall Study|Reason Not Specified|1|||
170738912|NCT02769065|617052300|FG007|Overall Study|Reason Not Specified|0|||
170738913|NCT02769065|617052301|FG008|Overall Study|Reason Not Specified|0|||
170738914|NCT02769065|617052302|FG009|Overall Study|Reason Not Specified|0|||
170738915|NCT02769065|617052303|FG010|Overall Study|Reason Not Specified|0|||
170738916|NCT02769065|617052304|FG011|Overall Study|Reason Not Specified|0|||
170738917|NCT02769065|617052305|FG012|Overall Study|Reason Not Specified|0|||
170738918|NCT02769065|617052306|FG013|Overall Study|Reason Not Specified|0|||
170738919|NCT02769065|617052307|FG014|Overall Study|Reason Not Specified|0|||
170738920|NCT02769065|617052308|FG015|Overall Study|Reason Not Specified|0|||
170738921|NCT02769065|617052309|FG016|Overall Study|Reason Not Specified|0|||
170738922|NCT02769065|617052310|FG017|Overall Study|Reason Not Specified|0|||
170738923|NCT02769065|617052311|FG018|Overall Study|Reason Not Specified|0|||
170738924|NCT02769065|617052312|FG019|Overall Study|Reason Not Specified|0|||
170738925|NCT02769065|617052313|FG020|Overall Study|Reason Not Specified|0|||
170738926|NCT02769065|617052314|FG021|Overall Study|Reason Not Specified|0|||
170738927|NCT02769065|617052315|FG022|Overall Study|Reason Not Specified|0|||
170738928|NCT02769065|617052316|FG023|Overall Study|Reason Not Specified|0|||
170738929|NCT02769065|617052317|FG024|Overall Study|Reason Not Specified|0|||
170738930|NCT02769065|617052318|FG025|Overall Study|Reason Not Specified|0|||
170738931|NCT02769065|617052319|FG026|Overall Study|Reason Not Specified|0|||
170738932|NCT02769065|617052320|FG027|Overall Study|Reason Not Specified|0|||
170738933|NCT02769065|617052321|FG028|Overall Study|Reason Not Specified|0|||
170738934|NCT02769065|617052322|FG029|Overall Study|Reason Not Specified|0|||
170738935|NCT02769065|617052293|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738936|NCT02769065|617052294|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738937|NCT02769065|617052295|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738938|NCT02769065|617052296|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738939|NCT02769065|617052297|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738940|NCT02769065|617052298|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738941|NCT02769065|617052299|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738942|NCT02769065|617052300|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738943|NCT02769065|617052301|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738944|NCT02769065|617052302|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738945|NCT02769065|617052303|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
170738946|NCT02769065|617052304|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738947|NCT02769065|617052305|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738948|NCT02769065|617052306|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738949|NCT02769065|617052307|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738950|NCT02769065|617052308|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738951|NCT02769065|617052309|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738952|NCT02769065|617052310|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738953|NCT02769065|617052311|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738954|NCT02769065|617052312|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738955|NCT02769065|617052313|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738956|NCT02769065|617052314|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738957|NCT02769065|617052315|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738958|NCT02769065|617052316|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738959|NCT02769065|617052317|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738960|NCT02769065|617052318|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738961|NCT02769065|617052319|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738962|NCT02769065|617052320|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738963|NCT02769065|617052321|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738964|NCT02769065|617052322|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
170738965|NCT03285295|617052328|FG000|Alinity s HBsAg|Protocol Violation|11|||
170738966|NCT03285295|617052329|FG001|Alinity s HBsAg|Protocol Violation|0|||
170738967|NCT03285295|617052330|FG002|Alinity s HBsAg|Protocol Violation|0|||
170738968|NCT03285295|617052331|FG003|Alinity s HBsAg|Protocol Violation|0|||
170738969|NCT03285295|617052332|FG004|Alinity s HBsAg|Protocol Violation|0|||
170738970|NCT03285295|617052328|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
170738971|NCT03285295|617052329|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
170738972|NCT03285295|617052330|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
170738973|NCT03285295|617052331|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
170738974|NCT03285295|617052332|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
170738975|NCT03285295|617052328|FG000|Alinity s HBsAg|No Results Generated|74|||
170738976|NCT03285295|617052329|FG001|Alinity s HBsAg|No Results Generated|6|||
170847118|NCT04303780|617446369|FG000|Overall Study|Withdrawal by Subject|12|||
170847119|NCT04303780|617446370|FG001|Overall Study|Withdrawal by Subject|39|||
170847120|NCT04303780|617446369|FG000|Overall Study|Ongoing in study|50|||
170847121|NCT04303780|617446370|FG001|Overall Study|Ongoing in study|45|||
170847122|NCT03826030|617446371|FG000|Overall Study|Withdrawal by Subject|2|||
170847123|NCT03826030|617446372|FG001|Overall Study|Withdrawal by Subject|0|||
170847124|NCT03826030|617446373|FG002|Overall Study|Withdrawal by Subject|1|||
170847125|NCT03826030|617446371|FG000|Overall Study|Lost to Follow-up|1|||
170847126|NCT03826030|617446372|FG001|Overall Study|Lost to Follow-up|1|||
170847127|NCT03826030|617446373|FG002|Overall Study|Lost to Follow-up|1|||
170847128|NCT03826030|617446371|FG000|Overall Study|Too busy to return for visits|1|||
170847129|NCT03826030|617446372|FG001|Overall Study|Too busy to return for visits|0|||
170847130|NCT03826030|617446373|FG002|Overall Study|Too busy to return for visits|0|||
170847131|NCT04893460|617446374|FG000|Overall Study|Lost to Follow-up|18|||
170847132|NCT03578887|617446376|FG000|Overall Study|Withdrawal by Subject|7|||
170847133|NCT03578887|617446377|FG001|Overall Study|Withdrawal by Subject|2|||
170847134|NCT03578887|617446378|FG002|Overall Study|Withdrawal by Subject|1|||
170847135|NCT03578887|617446376|FG000|Overall Study|Lost to Follow-up|13|||
170847136|NCT03578887|617446377|FG001|Overall Study|Lost to Follow-up|1|||
170847137|NCT03578887|617446378|FG002|Overall Study|Lost to Follow-up|4|||
170847138|NCT03578887|617446376|FG000|Overall Study|Physician Decision|0|||
170847139|NCT03578887|617446377|FG001|Overall Study|Physician Decision|1|||
170847140|NCT03578887|617446378|FG002|Overall Study|Physician Decision|1|||
170847141|NCT01901432|617448668|FG000|Overall Study|Adverse Event|0|||
170847142|NCT01901432|617448669|FG001|Overall Study|Adverse Event|1|||
170847143|NCT01901432|617448670|FG002|Overall Study|Adverse Event|1|||
170847144|NCT01901432|617448671|FG003|Overall Study|Adverse Event|0|||
170847145|NCT01901432|617448672|FG004|Overall Study|Adverse Event|1|||
170847146|NCT01901432|617448668|FG000|Overall Study|Withdrawal by Subject|0|||
170847147|NCT01901432|617448669|FG001|Overall Study|Withdrawal by Subject|0|||
170847148|NCT01901432|617448670|FG002|Overall Study|Withdrawal by Subject|1|||
170847149|NCT01901432|617448671|FG003|Overall Study|Withdrawal by Subject|0|||
170847150|NCT01901432|617448672|FG004|Overall Study|Withdrawal by Subject|5|||
170847151|NCT01901432|617448668|FG000|Overall Study|Physician Decision|0|||
170847152|NCT01901432|617448669|FG001|Overall Study|Physician Decision|0|||
170847153|NCT01901432|617448670|FG002|Overall Study|Physician Decision|0|||
170847154|NCT01901432|617448671|FG003|Overall Study|Physician Decision|0|||
170847155|NCT01901432|617448672|FG004|Overall Study|Physician Decision|2|||
170847156|NCT01901432|617448668|FG000|Overall Study|Patient decision to stop study drug|0|||
170847157|NCT01901432|617448669|FG001|Overall Study|Patient decision to stop study drug|0|||
170847158|NCT01901432|617448670|FG002|Overall Study|Patient decision to stop study drug|0|||
170847159|NCT01901432|617448671|FG003|Overall Study|Patient decision to stop study drug|0|||
170847160|NCT01901432|617448672|FG004|Overall Study|Patient decision to stop study drug|1|||
170847161|NCT00379288|617448676|FG000|Overall Study|Adverse Event|5|||
170847162|NCT00379288|617448677|FG001|Overall Study|Adverse Event|6|||
170847163|NCT00379288|617448678|FG002|Overall Study|Adverse Event|2|||
170847164|NCT00379288|617448679|FG003|Overall Study|Adverse Event|0|||
170847165|NCT00379288|617448676|FG000|Overall Study|Treatment Failure|0|||
170847166|NCT00379288|617448677|FG001|Overall Study|Treatment Failure|1|||
170847167|NCT00379288|617448678|FG002|Overall Study|Treatment Failure|0|||
170847168|NCT00379288|617448679|FG003|Overall Study|Treatment Failure|1|||
170847169|NCT00379288|617448676|FG000|Overall Study|Lost to Follow-up|3|||
170847170|NCT00379288|617448677|FG001|Overall Study|Lost to Follow-up|3|||
170847171|NCT00379288|617448678|FG002|Overall Study|Lost to Follow-up|2|||
170847172|NCT00379288|617448679|FG003|Overall Study|Lost to Follow-up|0|||
170847173|NCT00379288|617448676|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
170847174|NCT00379288|617448677|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
170847175|NCT00379288|617448678|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
170847176|NCT00379288|617448679|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
170847177|NCT00379288|617448676|FG000|Overall Study|Subject withdrew-related to study drug|1|||
170847178|NCT00379288|617448677|FG001|Overall Study|Subject withdrew-related to study drug|0|||
170847179|NCT00379288|617448678|FG002|Overall Study|Subject withdrew-related to study drug|0|||
170847180|NCT00379288|617448679|FG003|Overall Study|Subject withdrew-related to study drug|1|||
170847181|NCT00379288|617448676|FG000|Overall Study|Noncompliance with protocol|8|||
170847182|NCT00379288|617448677|FG001|Overall Study|Noncompliance with protocol|6|||
170847183|NCT00379288|617448678|FG002|Overall Study|Noncompliance with protocol|2|||
170847184|NCT00379288|617448679|FG003|Overall Study|Noncompliance with protocol|1|||
170847185|NCT00379288|617448676|FG000|Overall Study|Did not meet protocol eligibility|0|||
170847186|NCT00379288|617448677|FG001|Overall Study|Did not meet protocol eligibility|1|||
170847187|NCT00379288|617448678|FG002|Overall Study|Did not meet protocol eligibility|0|||
170847188|NCT00379288|617448679|FG003|Overall Study|Did not meet protocol eligibility|2|||
170847189|NCT00379288|617448676|FG000|Overall Study|Administrative|2|||
170847190|NCT00379288|617448677|FG001|Overall Study|Administrative|2|||
170847191|NCT00379288|617448678|FG002|Overall Study|Administrative|0|||
170847192|NCT00379288|617448679|FG003|Overall Study|Administrative|1|||
170847193|NCT00166712|617448680|FG000|Overall Study|Death|0|||
170847194|NCT00166712|617448681|FG001|Overall Study|Death|1|||
170847195|NCT00166712|617448680|FG000|Overall Study|Adverse Event|1|||
170847196|NCT00166712|617448681|FG001|Overall Study|Adverse Event|0|||
170847197|NCT00166712|617448680|FG000|Overall Study|Withdrawal by Subject|1|||
170847198|NCT00166712|617448681|FG001|Overall Study|Withdrawal by Subject|2|||
170847199|NCT00166712|617448680|FG000|Overall Study|Physician Decision|0|||
170847200|NCT00166712|617448681|FG001|Overall Study|Physician Decision|2|||
170847201|NCT02980731|617448682|FG000|Overall Study|Death|63|||
170847202|NCT02980731|617448682|FG000|Overall Study|Withdrawal by Subject|6|||
170847203|NCT02980731|617448682|FG000|Overall Study|Lost to Follow-up|5|||
170847204|NCT02980731|617448682|FG000|Overall Study|Study terminated by Sponsor|4|||
170847205|NCT02980731|617448682|FG000|Overall Study|Completed survival follow-up period|65|||
170847206|NCT02980731|617448682|FG000|Overall Study|COVID-19 infection|1|||
170847207|NCT02980731|617448682|FG000|Overall Study|Other, not specified|66|||
170847208|NCT00591370|617448684|FG000|Overall Study|Not Treated|2|||
170847209|NCT01202903|617448685|FG000|Overall Study|Administrative Probelms|1|||
170847210|NCT01202903|617448686|FG001|Overall Study|Administrative Probelms|4|||
170847211|NCT01202903|617448685|FG000|Overall Study|Protocol Violation|0|||
170847212|NCT01202903|617448686|FG001|Overall Study|Protocol Violation|1|||
170847213|NCT01202903|617448685|FG000|Overall Study|Death|1|||
170847214|NCT01202903|617448686|FG001|Overall Study|Death|0|||
170847215|NCT01202903|617448685|FG000|Overall Study|Lost to Follow-up|1|||
170847216|NCT01202903|617448686|FG001|Overall Study|Lost to Follow-up|1|||
170847217|NCT01202903|617448685|FG000|Overall Study|Lack of Efficacy|1|||
170847218|NCT01202903|617448686|FG001|Overall Study|Lack of Efficacy|3|||
170847219|NCT01202903|617448685|FG000|Overall Study|Adverse Event|3|||
170847220|NCT01202903|617448686|FG001|Overall Study|Adverse Event|3|||
170847221|NCT01202903|617448685|FG000|Overall Study|Withdrawal by Subject|4|||
170847222|NCT01202903|617448686|FG001|Overall Study|Withdrawal by Subject|4|||
170847223|NCT03446781|617448688|FG000|Overall Study|Lost to Follow-up|11|||
170847224|NCT03446781|617448689|FG001|Overall Study|Lost to Follow-up|5|||
170847225|NCT03446781|617448688|FG000|Overall Study|Withdrawal by Subject|9|||
170847226|NCT03446781|617448689|FG001|Overall Study|Withdrawal by Subject|7|||
170847227|NCT03446781|617448688|FG000|Overall Study|Adverse Event|8|||
170847228|NCT03446781|617448689|FG001|Overall Study|Adverse Event|2|||
170847229|NCT03446781|617448688|FG000|Overall Study|Protocol Violation|0|||
170847230|NCT03446781|617448689|FG001|Overall Study|Protocol Violation|3|||
170847231|NCT02787044|617448690|FG000|Overall Study|Lost to Follow-up|15|||
170847232|NCT02787044|617448691|FG001|Overall Study|Lost to Follow-up|19|||
170847233|NCT04410523|617448692|FG000|Overall Study|Study terminated by sponsor|1|||
170847234|NCT04410523|617448693|FG001|Overall Study|Study terminated by sponsor|3|||
170847235|NCT04410523|617448694|FG002|Overall Study|Study terminated by sponsor|2|||
170847236|NCT04410523|617448695|FG003|Overall Study|Study terminated by sponsor|6|||
170847237|NCT04410523|617448696|FG004|Overall Study|Study terminated by sponsor|3|||
170847238|NCT04410523|617448697|FG005|Overall Study|Study terminated by sponsor|4|||
170847239|NCT04410523|617448692|FG000|Overall Study|Adverse Event|1|||
170847240|NCT04410523|617448693|FG001|Overall Study|Adverse Event|0|||
170847241|NCT04410523|617448694|FG002|Overall Study|Adverse Event|0|||
170847242|NCT04410523|617448695|FG003|Overall Study|Adverse Event|0|||
170847243|NCT04410523|617448696|FG004|Overall Study|Adverse Event|0|||
170847244|NCT04410523|617448697|FG005|Overall Study|Adverse Event|2|||
170847245|NCT04410523|617448692|FG000|Overall Study|Lost to Follow-up|0|||
170847246|NCT04410523|617448693|FG001|Overall Study|Lost to Follow-up|1|||
170847247|NCT04410523|617448694|FG002|Overall Study|Lost to Follow-up|0|||
170847248|NCT04410523|617448695|FG003|Overall Study|Lost to Follow-up|0|||
170847249|NCT04410523|617448696|FG004|Overall Study|Lost to Follow-up|0|||
170847250|NCT04410523|617448697|FG005|Overall Study|Lost to Follow-up|0|||
170847251|NCT04410523|617448692|FG000|Overall Study|Physician Decision|0|||
170847252|NCT04410523|617448693|FG001|Overall Study|Physician Decision|1|||
170847253|NCT04410523|617448694|FG002|Overall Study|Physician Decision|0|||
170847254|NCT04410523|617448695|FG003|Overall Study|Physician Decision|0|||
170847255|NCT04410523|617448696|FG004|Overall Study|Physician Decision|0|||
170847256|NCT04410523|617448697|FG005|Overall Study|Physician Decision|0|||
170847257|NCT04410523|617448692|FG000|Overall Study|Pregnancy|0|||
170847258|NCT04410523|617448693|FG001|Overall Study|Pregnancy|0|||
170847259|NCT04410523|617448694|FG002|Overall Study|Pregnancy|0|||
170847260|NCT04410523|617448695|FG003|Overall Study|Pregnancy|0|||
170847261|NCT04410523|617448696|FG004|Overall Study|Pregnancy|0|||
170847262|NCT04410523|617448697|FG005|Overall Study|Pregnancy|1|||
170847263|NCT04410523|617448692|FG000|Overall Study|Protocol deviation|0|||
170847264|NCT04410523|617448693|FG001|Overall Study|Protocol deviation|0|||
170847265|NCT04410523|617448694|FG002|Overall Study|Protocol deviation|0|||
170847266|NCT04410523|617448695|FG003|Overall Study|Protocol deviation|0|||
170847267|NCT04410523|617448696|FG004|Overall Study|Protocol deviation|0|||
170847268|NCT04410523|617448697|FG005|Overall Study|Protocol deviation|2|||
170847269|NCT04410523|617448692|FG000|Overall Study|Subject decision|2|||
170847270|NCT04410523|617448693|FG001|Overall Study|Subject decision|0|||
170847271|NCT04410523|617448694|FG002|Overall Study|Subject decision|0|||
170847272|NCT04410523|617448695|FG003|Overall Study|Subject decision|1|||
170847273|NCT04410523|617448696|FG004|Overall Study|Subject decision|0|||
170847274|NCT04410523|617448697|FG005|Overall Study|Subject decision|1|||
170847275|NCT00490490|617448698|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
170847276|NCT00490490|617448698|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
170847277|NCT01598662|617448699|FG000|Overall Study|Lost to Follow-up|10|||
170847278|NCT01598662|617448700|FG001|Overall Study|Lost to Follow-up|17|||
170847279|NCT01598662|617448699|FG000|Overall Study|Physician Decision|1|||
170847280|NCT01598662|617448700|FG001|Overall Study|Physician Decision|2|||
170847281|NCT01598662|617448699|FG000|Overall Study|IUD expelled before month 6|0|||
170847282|NCT01598662|617448700|FG001|Overall Study|IUD expelled before month 6|2|||
170847283|NCT04155047|617448704|FG000|Overall Study|Adverse Event|1|||
170847284|NCT04155047|617448705|FG001|Overall Study|Adverse Event|0|||
170847285|NCT04155047|617448704|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
170847286|NCT04155047|617448705|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
170847287|NCT00821587|617448709|FG000|Overall Study|Physician Decision|0|||
170847288|NCT00821587|617448710|FG001|Overall Study|Physician Decision|1|||
170847289|NCT04488770|617448713|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847290|NCT04488770|617448714|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847291|NCT04488770|617448715|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847292|NCT04488770|617448716|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
170847293|NCT04488770|617448717|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847294|NCT04488770|617448718|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847295|NCT04488770|617448719|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847296|NCT04488770|617448720|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847297|NCT04488770|617448721|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847298|NCT04488770|617448722|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847299|NCT04488770|617448723|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847300|NCT04488770|617448724|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847301|NCT04488770|617448725|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
170847302|NCT04488770|617448713|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
170847303|NCT04488770|617448714|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847304|NCT04488770|617448715|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847305|NCT04488770|617448716|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847306|NCT04488770|617448717|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847307|NCT04488770|617448718|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847308|NCT04488770|617448719|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847309|NCT04488770|617448720|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847310|NCT04488770|617448721|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847311|NCT04488770|617448722|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847312|NCT04488770|617448723|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847313|NCT04488770|617448724|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847314|NCT04488770|617448725|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
170847315|NCT04488770|617448713|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847316|NCT04488770|617448714|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847317|NCT04488770|617448715|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847318|NCT04488770|617448716|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847319|NCT04488770|617448717|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847320|NCT04488770|617448718|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
170847321|NCT04488770|617448719|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
170847322|NCT04488770|617448720|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847323|NCT04488770|617448721|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847324|NCT04488770|617448722|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847325|NCT04488770|617448723|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847326|NCT04488770|617448724|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847327|NCT04488770|617448725|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
170847328|NCT04488770|617448713|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847329|NCT04488770|617448714|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847330|NCT04488770|617448715|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847331|NCT04488770|617448716|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847332|NCT04488770|617448717|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
170847333|NCT04488770|617448718|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847334|NCT04488770|617448719|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847335|NCT04488770|617448720|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847336|NCT04488770|617448721|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847337|NCT04488770|617448722|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847338|NCT04488770|617448723|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847339|NCT04488770|617448724|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847340|NCT04488770|617448725|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
170847341|NCT00643617|617448726|FG000|Overall Study|Death|6|||
170847342|NCT00643617|617448727|FG001|Overall Study|Death|9|||
170847343|NCT00643617|617448726|FG000|Overall Study|Lost to Follow-up|42|||
170847344|NCT00643617|617448727|FG001|Overall Study|Lost to Follow-up|51|||
170847345|NCT02075073|617448728|FG000|Overall Study|Withdrawal by Subject|0|||
170847346|NCT02075073|617448729|FG001|Overall Study|Withdrawal by Subject|1|||
170847347|NCT02075073|617448730|FG002|Overall Study|Withdrawal by Subject|0|||
170847348|NCT01744392|617448746|FG000|Overall Study|Physician Decision|1|||
170847349|NCT00299494|617448749|FG000|Overall Study|Withdrawal by Subject|0|||
170847350|NCT00299494|617448750|FG001|Overall Study|Withdrawal by Subject|0|||
170847351|NCT00299494|617448751|FG002|Overall Study|Withdrawal by Subject|0|||
170847352|NCT00299494|617448752|FG003|Overall Study|Withdrawal by Subject|3|||
170847353|NCT00299494|617448753|FG004|Overall Study|Withdrawal by Subject|1|||
170847354|NCT00299494|617448754|FG005|Overall Study|Withdrawal by Subject|4|||
170847355|NCT00299494|617448749|FG000|Overall Study|Physician Decision|0|||
170847356|NCT00299494|617448750|FG001|Overall Study|Physician Decision|0|||
170847357|NCT00299494|617448751|FG002|Overall Study|Physician Decision|0|||
170847358|NCT00299494|617448752|FG003|Overall Study|Physician Decision|0|||
170847359|NCT00299494|617448753|FG004|Overall Study|Physician Decision|1|||
170847360|NCT00299494|617448754|FG005|Overall Study|Physician Decision|0|||
170847361|NCT00299494|617448749|FG000|Overall Study|Death|3|||
170847362|NCT00299494|617448750|FG001|Overall Study|Death|1|||
170847363|NCT00299494|617448751|FG002|Overall Study|Death|4|||
170847364|NCT00299494|617448752|FG003|Overall Study|Death|6|||
170847365|NCT00299494|617448753|FG004|Overall Study|Death|18|||
170847366|NCT00299494|617448754|FG005|Overall Study|Death|19|||
170847367|NCT00299494|617448749|FG000|Overall Study|Lost to Follow-up|0|||
170847368|NCT00299494|617448750|FG001|Overall Study|Lost to Follow-up|0|||
170847369|NCT00299494|617448751|FG002|Overall Study|Lost to Follow-up|0|||
170847370|NCT00299494|617448752|FG003|Overall Study|Lost to Follow-up|0|||
170847371|NCT00299494|617448753|FG004|Overall Study|Lost to Follow-up|3|||
170847372|NCT00299494|617448754|FG005|Overall Study|Lost to Follow-up|1|||
170847373|NCT00299494|617448749|FG000|Overall Study|Other - Unspecified|0|||
170847374|NCT00299494|617448750|FG001|Overall Study|Other - Unspecified|0|||
170847375|NCT00299494|617448751|FG002|Overall Study|Other - Unspecified|0|||
170847376|NCT00299494|617448752|FG003|Overall Study|Other - Unspecified|0|||
170847377|NCT00299494|617448753|FG004|Overall Study|Other - Unspecified|3|||
170847378|NCT00299494|617448754|FG005|Overall Study|Other - Unspecified|1|||
170847379|NCT00299494|617448749|FG000|Overall Study|Other - site closure|0|||
170847380|NCT00299494|617448750|FG001|Overall Study|Other - site closure|0|||
170847381|NCT00299494|617448751|FG002|Overall Study|Other - site closure|0|||
170847382|NCT00299494|617448752|FG003|Overall Study|Other - site closure|1|||
170847383|NCT00299494|617448753|FG004|Overall Study|Other - site closure|1|||
170847384|NCT00299494|617448754|FG005|Overall Study|Other - site closure|1|||
170847385|NCT02770612|617448759|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
170847386|NCT02233803|617448760|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
170847387|NCT02233803|617448761|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
170847388|NCT02233803|617448760|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
170847389|NCT02233803|617448761|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
170847390|NCT02233803|617448760|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
170847391|NCT02233803|617448761|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
170847392|NCT02233803|617448760|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
170847393|NCT02233803|617448761|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
170847394|NCT02233803|617448760|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
170847395|NCT02233803|617448761|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
170847396|NCT02233803|617448760|FG000|Washout Period (4-Wks)|Physician Decision|1|||
170847397|NCT02233803|617448761|FG001|Washout Period (4-Wks)|Physician Decision|0|||
170847398|NCT02233803|617448760|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
170847399|NCT02233803|617448761|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
170847400|NCT02233803|617448760|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
170847401|NCT02233803|617448761|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
170847402|NCT02233803|617448760|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
170847403|NCT02233803|617448761|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
170847404|NCT01365481|617448762|FG000|Overall Study|Adverse Event|6|||
170847405|NCT01365481|617448763|FG001|Overall Study|Adverse Event|9|||
170847406|NCT01365481|617448764|FG002|Overall Study|Adverse Event|0|||
170847407|NCT01365481|617448765|FG003|Overall Study|Adverse Event|2|||
170847408|NCT01365481|617448762|FG000|Overall Study|Withdrawal by Subject|0|||
170847409|NCT01365481|617448763|FG001|Overall Study|Withdrawal by Subject|2|||
170847410|NCT01365481|617448764|FG002|Overall Study|Withdrawal by Subject|1|||
170847411|NCT01365481|617448765|FG003|Overall Study|Withdrawal by Subject|1|||
170847412|NCT01365481|617448762|FG000|Overall Study|Lost to Follow-up|1|||
170847413|NCT01365481|617448763|FG001|Overall Study|Lost to Follow-up|1|||
170847414|NCT01365481|617448764|FG002|Overall Study|Lost to Follow-up|2|||
170847415|NCT01365481|617448765|FG003|Overall Study|Lost to Follow-up|3|||
170847416|NCT01365481|617448762|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170847417|NCT01365481|617448763|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170847418|NCT01365481|617448764|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170847419|NCT01365481|617448765|FG003|Overall Study|Abnormal laboratory value(s)|0|||
170847420|NCT01365481|617448762|FG000|Overall Study|Administrative problems|0|||
170847421|NCT01365481|617448763|FG001|Overall Study|Administrative problems|1|||
170847422|NCT01365481|617448764|FG002|Overall Study|Administrative problems|0|||
170847423|NCT01365481|617448765|FG003|Overall Study|Administrative problems|0|||
170847424|NCT01365481|617448762|FG000|Overall Study|Protocol deviation|0|||
170847425|NCT01365481|617448763|FG001|Overall Study|Protocol deviation|1|||
170847426|NCT01365481|617448764|FG002|Overall Study|Protocol deviation|0|||
170847427|NCT01365481|617448765|FG003|Overall Study|Protocol deviation|1|||
170847428|NCT01365481|617448762|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170847429|NCT01365481|617448763|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170847430|NCT01365481|617448764|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
170847431|NCT01365481|617448765|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
170847432|NCT03846453|617448766|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
170847433|NCT03846453|617448767|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
170847434|NCT03846453|617448768|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
170847435|NCT03846453|617448766|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
170847436|NCT03846453|617448767|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
170847437|NCT03846453|617448768|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
170847438|NCT03846453|617448766|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
170847439|NCT03846453|617448767|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
170847440|NCT03846453|617448768|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
170847441|NCT03846453|617448766|FG000|Placebo Run-in (14 Days)|Other|2|||
170847442|NCT03846453|617448767|FG001|Placebo Run-in (14 Days)|Other|0|||
170847443|NCT03846453|617448768|FG002|Placebo Run-in (14 Days)|Other|0|||
170847444|NCT03846453|617448766|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
170847445|NCT03846453|617448767|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
170847446|NCT03846453|617448768|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
170847447|NCT03846453|617448766|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
170847448|NCT03846453|617448767|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
170847449|NCT03846453|617448768|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
170847450|NCT03846453|617448766|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
170847451|NCT03846453|617448767|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
170847452|NCT03846453|617448768|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
170847453|NCT03846453|617448766|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
170847454|NCT03846453|617448767|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
170847455|NCT03846453|617448768|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
170847456|NCT03846453|617448766|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
170847457|NCT03846453|617448767|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
170847458|NCT03846453|617448768|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
170847459|NCT00757627|617448769|FG000|Overall Study|Adverse Event|15|||
170847460|NCT00757627|617448769|FG000|Overall Study|Lack of Efficacy|10|||
170847461|NCT00757627|617448769|FG000|Overall Study|Lost to Follow-up|28|||
170847462|NCT00757627|617448769|FG000|Overall Study|Withdrawal by Subject|27|||
170847463|NCT00757627|617448769|FG000|Overall Study|Other|1|||
170847464|NCT00635661|617448774|FG000|Overall Study|Withdrawal by Subject|4|||
170847465|NCT01606670|617448777|FG000|Overall Study|Adverse Event|6|||
170847466|NCT01606670|617448777|FG000|Overall Study|Lack of Efficacy|2|||
170847467|NCT01606670|617448777|FG000|Overall Study|Lost to Follow-up|3|||
170847468|NCT01606670|617448777|FG000|Overall Study|Withdrawal by Subject|3|||
170847469|NCT01606670|617448777|FG000|Overall Study|Other Reason|2|||
170847470|NCT01696955|617448785|FG000|Main Study|Protocol Violation|1|||
170847471|NCT01696955|617448786|FG001|Main Study|Protocol Violation|0|||
170847472|NCT01696955|617448785|FG000|Main Study|Withdrawal by Subject|1|||
170847473|NCT01696955|617448786|FG001|Main Study|Withdrawal by Subject|1|||
170847474|NCT03980808|617448787|FG000|Overall Study|Lost to Follow-up|2|||
170847475|NCT03980808|617448788|FG001|Overall Study|Lost to Follow-up|2|||
170847476|NCT00798590|617448789|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
170847477|NCT00798590|617448790|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
170847478|NCT05330676|617448791|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
170847479|NCT05330676|617448792|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
170847480|NCT03653208|617448793|FG000|Overall Study|Withdrawal by Subject|0|||
170847481|NCT03653208|617448794|FG001|Overall Study|Withdrawal by Subject|0|||
170847482|NCT03653208|617448795|FG002|Overall Study|Withdrawal by Subject|0|||
170847483|NCT03653208|617448796|FG003|Overall Study|Withdrawal by Subject|0|||
170847484|NCT03653208|617448797|FG004|Overall Study|Withdrawal by Subject|1|||
170847485|NCT03653208|617448798|FG005|Overall Study|Withdrawal by Subject|0|||
170847486|NCT03653208|617448799|FG006|Overall Study|Withdrawal by Subject|0|||
170847487|NCT03653208|617448800|FG007|Overall Study|Withdrawal by Subject|1|||
170847488|NCT03653208|617448801|FG008|Overall Study|Withdrawal by Subject|1|||
170847489|NCT00436605|617448802|FG000|Overall Study|Protocol Violation|3|||
170847490|NCT02229851|617448807|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
170847491|NCT02229851|617448808|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
170847492|NCT02229851|617448809|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
170847493|NCT02229851|617448810|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
170847494|NCT02229851|617448811|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
170847495|NCT02229851|617448812|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
170847496|NCT02229851|617448813|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
170847497|NCT02229851|617448807|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
170847498|NCT02229851|617448808|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
170847499|NCT02229851|617448809|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
170847500|NCT02229851|617448810|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
170847501|NCT02229851|617448811|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
170847502|NCT02229851|617448812|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
170847503|NCT02229851|617448813|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
170847504|NCT02229851|617448807|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
170847505|NCT02229851|617448808|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
170847506|NCT02229851|617448809|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
170847507|NCT02229851|617448810|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
170847508|NCT02229851|617448811|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
170847509|NCT02229851|617448812|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
170847510|NCT02229851|617448813|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
170847511|NCT02229851|617448807|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
170847512|NCT02229851|617448808|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
170847513|NCT02229851|617448809|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
170847514|NCT02229851|617448810|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
170847515|NCT02229851|617448811|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
170847516|NCT02229851|617448812|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
170847517|NCT02229851|617448813|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
170847518|NCT02229851|617448807|FG000|Main Phase (Double-blind Phase)|Death|1|||
170847519|NCT02229851|617448808|FG001|Main Phase (Double-blind Phase)|Death|1|||
170847520|NCT02229851|617448809|FG002|Main Phase (Double-blind Phase)|Death|0|||
170847521|NCT02229851|617448810|FG003|Main Phase (Double-blind Phase)|Death|0|||
170847522|NCT02229851|617448811|FG004|Main Phase (Double-blind Phase)|Death|0|||
170847523|NCT02229851|617448812|FG005|Main Phase (Double-blind Phase)|Death|0|||
170847524|NCT02229851|617448813|FG006|Main Phase (Double-blind Phase)|Death|0|||
170847525|NCT02229851|617448807|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
170847526|NCT02229851|617448808|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
170847527|NCT02229851|617448809|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
170847528|NCT02229851|617448810|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
170847529|NCT02229851|617448811|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
170847530|NCT02229851|617448812|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
170847531|NCT02229851|617448813|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
170847532|NCT02229851|617448807|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
170847533|NCT02229851|617448808|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
170847534|NCT02229851|617448809|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
170847535|NCT02229851|617448810|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
170847536|NCT02229851|617448811|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
170847537|NCT02229851|617448812|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
170847538|NCT02229851|617448813|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
170847539|NCT02229851|617448807|FG000|Extension Phase (Open-label Phase)|Death|0|||
170847540|NCT02229851|617448808|FG001|Extension Phase (Open-label Phase)|Death|0|||
170847541|NCT02229851|617448809|FG002|Extension Phase (Open-label Phase)|Death|0|||
170847542|NCT02229851|617448810|FG003|Extension Phase (Open-label Phase)|Death|1|||
170847543|NCT02229851|617448811|FG004|Extension Phase (Open-label Phase)|Death|0|||
170847544|NCT02229851|617448812|FG005|Extension Phase (Open-label Phase)|Death|1|||
170847545|NCT02229851|617448813|FG006|Extension Phase (Open-label Phase)|Death|1|||
170847546|NCT01283516|617448816|FG000|Overall Study|Adverse Event|0|||
170847547|NCT01283516|617448817|FG001|Overall Study|Adverse Event|0|||
170847548|NCT01283516|617448818|FG002|Overall Study|Adverse Event|0|||
170847549|NCT01283516|617448819|FG003|Overall Study|Adverse Event|0|||
170847550|NCT01283516|617448820|FG004|Overall Study|Adverse Event|0|||
170847551|NCT01283516|617448821|FG005|Overall Study|Adverse Event|0|||
170847552|NCT01283516|617448822|FG006|Overall Study|Adverse Event|2|||
170847553|NCT01283516|617448823|FG007|Overall Study|Adverse Event|0|||
170847554|NCT01283516|617448824|FG008|Overall Study|Adverse Event|28|||
170847555|NCT01283516|617448816|FG000|Overall Study|Death|0|||
170847556|NCT01283516|617448817|FG001|Overall Study|Death|0|||
170847557|NCT01283516|617448818|FG002|Overall Study|Death|0|||
170847558|NCT01283516|617448819|FG003|Overall Study|Death|0|||
170847559|NCT01283516|617448820|FG004|Overall Study|Death|0|||
170847560|NCT01283516|617448821|FG005|Overall Study|Death|1|||
170847561|NCT01283516|617448822|FG006|Overall Study|Death|0|||
170847562|NCT01283516|617448823|FG007|Overall Study|Death|1|||
170847563|NCT01283516|617448824|FG008|Overall Study|Death|12|||
170847564|NCT01283516|617448816|FG000|Overall Study|Disease Progression|2|||
170847565|NCT01283516|617448817|FG001|Overall Study|Disease Progression|2|||
170847566|NCT01283516|617448818|FG002|Overall Study|Disease Progression|3|||
170847567|NCT01283516|617448819|FG003|Overall Study|Disease Progression|3|||
170847568|NCT01283516|617448820|FG004|Overall Study|Disease Progression|13|||
170847569|NCT01283516|617448821|FG005|Overall Study|Disease Progression|8|||
170847570|NCT01283516|617448822|FG006|Overall Study|Disease Progression|6|||
170847571|NCT01283516|617448823|FG007|Overall Study|Disease Progression|3|||
170847572|NCT01283516|617448824|FG008|Overall Study|Disease Progression|139|||
170847573|NCT01283516|617448816|FG000|Overall Study|Withdrawal by Subject|0|||
170847574|NCT01283516|617448817|FG001|Overall Study|Withdrawal by Subject|0|||
170847575|NCT01283516|617448818|FG002|Overall Study|Withdrawal by Subject|0|||
170847576|NCT01283516|617448819|FG003|Overall Study|Withdrawal by Subject|0|||
170847577|NCT01283516|617448820|FG004|Overall Study|Withdrawal by Subject|1|||
170847578|NCT01283516|617448821|FG005|Overall Study|Withdrawal by Subject|0|||
170847579|NCT01283516|617448822|FG006|Overall Study|Withdrawal by Subject|1|||
170847580|NCT01283516|617448823|FG007|Overall Study|Withdrawal by Subject|0|||
170847581|NCT01283516|617448824|FG008|Overall Study|Withdrawal by Subject|36|||
170847582|NCT01283516|617448816|FG000|Overall Study|Administrative problems|0|||
170847583|NCT01283516|617448817|FG001|Overall Study|Administrative problems|0|||
170847584|NCT01283516|617448818|FG002|Overall Study|Administrative problems|0|||
170847585|NCT01283516|617448819|FG003|Overall Study|Administrative problems|0|||
170847586|NCT01283516|617448820|FG004|Overall Study|Administrative problems|0|||
170847587|NCT01283516|617448821|FG005|Overall Study|Administrative problems|1|||
170847588|NCT01283516|617448822|FG006|Overall Study|Administrative problems|1|||
170847589|NCT01283516|617448823|FG007|Overall Study|Administrative problems|1|||
170847590|NCT01283516|617448824|FG008|Overall Study|Administrative problems|39|||
170847591|NCT01283516|617448816|FG000|Overall Study|Lost to Follow-up|0|||
170847592|NCT01283516|617448817|FG001|Overall Study|Lost to Follow-up|0|||
170847593|NCT01283516|617448818|FG002|Overall Study|Lost to Follow-up|0|||
170847594|NCT01283516|617448819|FG003|Overall Study|Lost to Follow-up|0|||
170847595|NCT01283516|617448820|FG004|Overall Study|Lost to Follow-up|0|||
170847596|NCT01283516|617448821|FG005|Overall Study|Lost to Follow-up|0|||
170847597|NCT01283516|617448822|FG006|Overall Study|Lost to Follow-up|0|||
170847598|NCT01283516|617448823|FG007|Overall Study|Lost to Follow-up|0|||
170847599|NCT01283516|617448824|FG008|Overall Study|Lost to Follow-up|1|||
170847600|NCT01204710|617448827|FG000|Randomization Treatment|Lost to Follow-up|1|||
170847601|NCT01204710|617448828|FG001|Randomization Treatment|Lost to Follow-up|0|||
170847602|NCT01204710|617448827|FG000|Randomization Treatment|Withdrawal by Subject|6|||
170847603|NCT01204710|617448828|FG001|Randomization Treatment|Withdrawal by Subject|5|||
170847604|NCT01204710|617448827|FG000|Randomization Treatment|Physician Decision|3|||
170847605|NCT01204710|617448828|FG001|Randomization Treatment|Physician Decision|2|||
170847606|NCT01204710|617448827|FG000|Randomization Treatment|Entry criteria not met|0|||
170847607|NCT01204710|617448828|FG001|Randomization Treatment|Entry criteria not met|1|||
170847608|NCT01204710|617448827|FG000|Randomization Treatment|Adverse Event|4|||
170847609|NCT01204710|617448828|FG001|Randomization Treatment|Adverse Event|2|||
170847610|NCT01204710|617448827|FG000|Randomization Treatment|Sponsor Decision|0|||
170847611|NCT01204710|617448828|FG001|Randomization Treatment|Sponsor Decision|1|||
170847612|NCT01204710|617448827|FG000|Randomization Treatment|Worsening of General condition|0|||
170847613|NCT01204710|617448828|FG001|Randomization Treatment|Worsening of General condition|1|||
170847614|NCT01204710|617448827|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
170847615|NCT01204710|617448828|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
170847616|NCT01204710|617448827|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
170847617|NCT01204710|617448828|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
170847618|NCT01204710|617448827|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
170847619|NCT01204710|617448828|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
170847620|NCT01204710|617448827|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
170847621|NCT01204710|617448828|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
170847622|NCT00743431|617448829|FG000|Overall Study|Toxicity|6|||
170847623|NCT00743431|617448829|FG000|Overall Study|Tumor progression|56|||
170847624|NCT00743431|617448829|FG000|Overall Study|Withdrawal by Subject|13|||
170847625|NCT00743431|617448829|FG000|Overall Study|Death|9|||
170847626|NCT00743431|617448829|FG000|Overall Study|Reason for discontinuation not specified|29|||
170847627|NCT00743431|617448829|FG000|Overall Study|No documentation available|13|||
170847628|NCT04531904|617448830|FG000|Overall Study|Lost to Follow-up|1|||
170847629|NCT04531904|617448830|FG000|Overall Study|Death|14|||
170847630|NCT00283244|617448831|FG000|Overall Study|Adverse Event|0|||
170847631|NCT00283244|617448832|FG001|Overall Study|Adverse Event|8|||
170847632|NCT00283244|617448833|FG002|Overall Study|Adverse Event|11|||
170847633|NCT00283244|617448831|FG000|Overall Study|Death|4|||
170847634|NCT00283244|617448832|FG001|Overall Study|Death|3|||
170847635|NCT00283244|617448833|FG002|Overall Study|Death|2|||
170847636|NCT00283244|617448831|FG000|Overall Study|Lack of Efficacy|8|||
170847637|NCT00283244|617448832|FG001|Overall Study|Lack of Efficacy|32|||
170847638|NCT00283244|617448833|FG002|Overall Study|Lack of Efficacy|26|||
170847639|NCT00283244|617448831|FG000|Overall Study|Withdrawal by Subject|1|||
170847640|NCT00283244|617448832|FG001|Overall Study|Withdrawal by Subject|2|||
170847641|NCT00283244|617448833|FG002|Overall Study|Withdrawal by Subject|2|||
170847642|NCT00283244|617448831|FG000|Overall Study|Physician Decision|0|||
170847643|NCT00283244|617448832|FG001|Overall Study|Physician Decision|0|||
170847644|NCT00283244|617448833|FG002|Overall Study|Physician Decision|1|||
170847645|NCT00283244|617448831|FG000|Overall Study|Medical illness (other complicating dz)|4|||
170847646|NCT00283244|617448832|FG001|Overall Study|Medical illness (other complicating dz)|3|||
170847647|NCT00283244|617448833|FG002|Overall Study|Medical illness (other complicating dz)|6|||
170847648|NCT00283244|617448831|FG000|Overall Study|Clinical deterioration|1|||
170847649|NCT00283244|617448832|FG001|Overall Study|Clinical deterioration|3|||
170847650|NCT00283244|617448833|FG002|Overall Study|Clinical deterioration|3|||
170847651|NCT04655027|617448836|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
170847652|NCT04655027|617448837|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
170847653|NCT00658788|617448838|FG000|Overall Study|Adverse Event|11|||
170847654|NCT00658788|617448838|FG000|Overall Study|Withdrawal by Subject|13|||
170847655|NCT00658788|617448838|FG000|Overall Study|Lost to Follow-up|18|||
170847656|NCT00658788|617448838|FG000|Overall Study|Treatment Discontinuation|32|||
170847657|NCT03361605|617448839|FG000|Overall Study|Analyzable data not available|3|||
170847658|NCT04777864|617448842|FG000|Overall Study|Lost to Follow-up|8|||
170847659|NCT04777864|617448843|FG001|Overall Study|Lost to Follow-up|19|||
170847660|NCT00384397|617448846|FG000|Overall Study|Adverse Event|0|||
170847661|NCT00384397|617448847|FG001|Overall Study|Adverse Event|1|||
170847662|NCT00384397|617448848|FG002|Overall Study|Adverse Event|2|||
170847663|NCT00384397|617448846|FG000|Overall Study|Protocol Violation|7|||
170847664|NCT00384397|617448847|FG001|Overall Study|Protocol Violation|15|||
170847665|NCT00384397|617448848|FG002|Overall Study|Protocol Violation|13|||
170847666|NCT00384397|617448846|FG000|Overall Study|Lost to Follow-up|11|||
170847667|NCT00384397|617448847|FG001|Overall Study|Lost to Follow-up|13|||
170847668|NCT00384397|617448848|FG002|Overall Study|Lost to Follow-up|3|||
170847669|NCT00384397|617448846|FG000|Overall Study|Withdrawal by Subject|14|||
170847670|NCT00384397|617448847|FG001|Overall Study|Withdrawal by Subject|17|||
170847671|NCT00384397|617448848|FG002|Overall Study|Withdrawal by Subject|15|||
170847672|NCT03520712|617448849|FG000|Overall Study|Early termination of the study by Sponsor|2|||
170847673|NCT00775463|617450772|FG000|Overall Study|Withdrawal by Subject|0|||
170847674|NCT00775463|617450773|FG001|Overall Study|Withdrawal by Subject|1|||
170847675|NCT00775463|617450772|FG000|Overall Study|Adverse Event|7|||
170847676|NCT00775463|617450773|FG001|Overall Study|Adverse Event|9|||
170847677|NCT00775463|617450772|FG000|Overall Study|Protocol Violation|2|||
170847678|NCT00775463|617450773|FG001|Overall Study|Protocol Violation|2|||
170847679|NCT00775463|617450772|FG000|Overall Study|Lost to Follow-up|1|||
170847680|NCT00775463|617450773|FG001|Overall Study|Lost to Follow-up|0|||
170847681|NCT00775463|617450772|FG000|Overall Study|Lack of Efficacy|1|||
170847682|NCT00775463|617450773|FG001|Overall Study|Lack of Efficacy|1|||
170847683|NCT01183260|617450774|FG000|Overall Study|Intraop screen failure|2|||
170847684|NCT01183260|617450775|FG001|Overall Study|Intraop screen failure|0|||
170847685|NCT01183260|617450774|FG000|Overall Study|Withdrawal by Subject|1|||
170847686|NCT01183260|617450775|FG001|Overall Study|Withdrawal by Subject|1|||
170847687|NCT01183260|617450774|FG000|Overall Study|Revised within 30 days|0|||
170847688|NCT01183260|617450775|FG001|Overall Study|Revised within 30 days|1|||
170847689|NCT01183260|617450774|FG000|Overall Study|Death|1|||
170847690|NCT01183260|617450775|FG001|Overall Study|Death|0|||
170847691|NCT00837694|617450777|FG000|Overall Study|Lost to Follow-up|2|||
170847692|NCT00837694|617450778|FG001|Overall Study|Lost to Follow-up|0|||
170847693|NCT00837694|617450779|FG002|Overall Study|Lost to Follow-up|2|||
170847694|NCT00837694|617450780|FG003|Overall Study|Lost to Follow-up|1|||
170847695|NCT00837694|617450781|FG004|Overall Study|Lost to Follow-up|1|||
170847696|NCT00837694|617450782|FG005|Overall Study|Lost to Follow-up|1|||
170847697|NCT00833833|617450783|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
170847698|NCT00833833|617450784|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
170847699|NCT00833833|617450785|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
170847700|NCT00833833|617450786|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
170847701|NCT00833833|617450787|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
170847702|NCT00833833|617450788|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
170847703|NCT00833833|617450783|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
170847704|NCT00833833|617450784|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
170847705|NCT00833833|617450785|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
170847706|NCT00833833|617450786|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
170847707|NCT00833833|617450787|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
170847708|NCT00833833|617450788|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
170847709|NCT00833833|617450783|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
170847710|NCT00833833|617450784|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
170847711|NCT00833833|617450785|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
170847712|NCT00833833|617450786|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
170847713|NCT00833833|617450787|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
170847714|NCT00833833|617450788|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
170847715|NCT00833833|617450783|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
170847716|NCT00833833|617450784|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
170847717|NCT00833833|617450785|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
170847718|NCT00833833|617450786|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
170847719|NCT00833833|617450787|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
170847720|NCT00833833|617450788|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
170847721|NCT00833833|617450783|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
170847722|NCT00833833|617450784|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
170847723|NCT00833833|617450785|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
170847724|NCT00833833|617450786|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
170847725|NCT00833833|617450787|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
170847726|NCT00833833|617450788|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
170847727|NCT00833833|617450783|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
170847728|NCT00833833|617450784|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
170847729|NCT00833833|617450785|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
170847730|NCT00833833|617450786|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
170847731|NCT00833833|617450787|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
170847732|NCT00833833|617450788|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
170847733|NCT00833833|617450783|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
170847734|NCT00833833|617450784|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
170847735|NCT00833833|617450785|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
170847736|NCT00833833|617450786|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
170847737|NCT00833833|617450787|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
170847738|NCT00833833|617450788|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
170847739|NCT00833833|617450783|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
170847740|NCT00833833|617450784|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
170847741|NCT00833833|617450785|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
170847742|NCT00833833|617450786|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
170847743|NCT00833833|617450787|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
170847744|NCT00833833|617450788|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
170847745|NCT00833833|617450783|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
170847746|NCT00833833|617450784|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
170847747|NCT00833833|617450785|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
170847748|NCT00833833|617450786|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
170847749|NCT00833833|617450787|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
170847750|NCT00833833|617450788|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
170847751|NCT00833833|617450783|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
170847752|NCT00833833|617450784|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
170847753|NCT00833833|617450785|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
170847754|NCT00833833|617450786|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
170847755|NCT00833833|617450787|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
170847756|NCT00833833|617450788|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
170847757|NCT00833833|617450783|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
170847758|NCT00833833|617450784|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
170847759|NCT00833833|617450785|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
170847760|NCT00833833|617450786|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
170847761|NCT00833833|617450787|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
170847762|NCT00833833|617450788|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
170847763|NCT00833833|617450783|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
170847764|NCT00833833|617450784|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
170847765|NCT00833833|617450785|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
170847766|NCT00833833|617450786|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
170847767|NCT00833833|617450787|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
170847768|NCT00833833|617450788|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
170847769|NCT00833833|617450783|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
170847770|NCT00833833|617450784|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
170847771|NCT00833833|617450785|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
170847772|NCT00833833|617450786|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
170847773|NCT00833833|617450787|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
170847774|NCT00833833|617450788|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
170847775|NCT01142232|617450797|FG000|Overall Study|Adverse Event|1|||
170847776|NCT01142232|617450798|FG001|Overall Study|Adverse Event|2|||
170847777|NCT01142232|617450799|FG002|Overall Study|Adverse Event|1|||
170847778|NCT01142232|617450800|FG003|Overall Study|Adverse Event|0|||
170847779|NCT01142232|617450801|FG004|Overall Study|Adverse Event|4|||
170847780|NCT01142232|617450797|FG000|Overall Study|Death|0|||
170847781|NCT01142232|617450798|FG001|Overall Study|Death|0|||
170847782|NCT01142232|617450799|FG002|Overall Study|Death|0|||
170847783|NCT01142232|617450800|FG003|Overall Study|Death|0|||
170847784|NCT01142232|617450801|FG004|Overall Study|Death|1|||
170847785|NCT01142232|617450797|FG000|Overall Study|Disease Progression|2|||
170847786|NCT01142232|617450798|FG001|Overall Study|Disease Progression|0|||
170847787|NCT01142232|617450799|FG002|Overall Study|Disease Progression|1|||
170847788|NCT01142232|617450800|FG003|Overall Study|Disease Progression|2|||
170847789|NCT01142232|617450801|FG004|Overall Study|Disease Progression|12|||
170847790|NCT01142232|617450797|FG000|Overall Study|Withdrawal by Subject|0|||
170847791|NCT01142232|617450798|FG001|Overall Study|Withdrawal by Subject|0|||
170847792|NCT01142232|617450799|FG002|Overall Study|Withdrawal by Subject|0|||
170847793|NCT01142232|617450800|FG003|Overall Study|Withdrawal by Subject|1|||
170847794|NCT01142232|617450801|FG004|Overall Study|Withdrawal by Subject|3|||
170847795|NCT01142232|617450797|FG000|Overall Study|Physician Decision|0|||
170847796|NCT01142232|617450798|FG001|Overall Study|Physician Decision|1|||
170847797|NCT01142232|617450799|FG002|Overall Study|Physician Decision|0|||
170847798|NCT01142232|617450800|FG003|Overall Study|Physician Decision|2|||
170847799|NCT01142232|617450801|FG004|Overall Study|Physician Decision|10|||
170847800|NCT01142232|617450797|FG000|Overall Study|Alternative Therapy|0|||
170847801|NCT01142232|617450798|FG001|Overall Study|Alternative Therapy|1|||
170847802|NCT01142232|617450799|FG002|Overall Study|Alternative Therapy|1|||
170847803|NCT01142232|617450800|FG003|Overall Study|Alternative Therapy|0|||
170847804|NCT01142232|617450801|FG004|Overall Study|Alternative Therapy|1|||
170847805|NCT01142232|617450797|FG000|Overall Study|Off Trt for other complicating disease|0|||
170847806|NCT01142232|617450798|FG001|Overall Study|Off Trt for other complicating disease|0|||
170847807|NCT01142232|617450799|FG002|Overall Study|Off Trt for other complicating disease|0|||
170847808|NCT01142232|617450800|FG003|Overall Study|Off Trt for other complicating disease|0|||
170847809|NCT01142232|617450801|FG004|Overall Study|Off Trt for other complicating disease|1|||
170847810|NCT01142232|617450797|FG000|Overall Study|Noncompliance|0|||
170847811|NCT01142232|617450798|FG001|Overall Study|Noncompliance|0|||
170847812|NCT01142232|617450799|FG002|Overall Study|Noncompliance|0|||
170847813|NCT01142232|617450800|FG003|Overall Study|Noncompliance|0|||
170847814|NCT01142232|617450801|FG004|Overall Study|Noncompliance|2|||
170847815|NCT04138576|617450802|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
170847816|NCT03900416|617450803|FG000|Six Week Follow-up|Lost to Follow-up|1|||
170847817|NCT03900416|617450804|FG001|Six Week Follow-up|Lost to Follow-up|0|||
170847818|NCT03900416|617450803|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
170847819|NCT03900416|617450804|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
170847820|NCT03900416|617450803|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
170847821|NCT03900416|617450804|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
170847822|NCT03900416|617450803|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
170847823|NCT03900416|617450804|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
170847824|NCT03900416|617450803|FG000|Twelve Week Follow-up|Adverse Event|1|||
170847825|NCT03900416|617450804|FG001|Twelve Week Follow-up|Adverse Event|1|||
170847826|NCT03900416|617450803|FG000|Six Month Follow-up|Lost to Follow-up|4|||
170847827|NCT03900416|617450804|FG001|Six Month Follow-up|Lost to Follow-up|3|||
170847828|NCT03900416|617450803|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
170847829|NCT03900416|617450804|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
170847830|NCT00996476|617450805|FG000|Overall Study|Withdrawal by Subject|1|||
170847831|NCT00996476|617450806|FG001|Overall Study|Withdrawal by Subject|2|||
170847832|NCT00996476|617450807|FG002|Overall Study|Withdrawal by Subject|1|||
170847833|NCT00996476|617450808|FG003|Overall Study|Withdrawal by Subject|0|||
170847834|NCT00996476|617450809|FG004|Overall Study|Withdrawal by Subject|1|||
170847835|NCT00996476|617450805|FG000|Overall Study|Adverse Event|0|||
170847836|NCT00996476|617450806|FG001|Overall Study|Adverse Event|1|||
170847837|NCT00996476|617450807|FG002|Overall Study|Adverse Event|0|||
170847838|NCT00996476|617450808|FG003|Overall Study|Adverse Event|0|||
170847839|NCT00996476|617450809|FG004|Overall Study|Adverse Event|1|||
170847840|NCT01802567|617450810|FG000|Overall Study|Withdrawal by Subject|2|||
170847841|NCT01802567|617450810|FG000|Overall Study|Physician Decision|1|||
170847842|NCT01802567|617450810|FG000|Overall Study|Lack of Efficacy|7|||
170847843|NCT01802567|617450810|FG000|Overall Study|Consented but did not start therapy|7|||
170847844|NCT01802567|617450810|FG000|Overall Study|Protocol Violation|1|||
170847845|NCT01470001|617450811|FG000|Overall Study|Lost to Follow-up|1|||
170847846|NCT01470001|617450812|FG001|Overall Study|Lost to Follow-up|1|||
170847847|NCT01470001|617450811|FG000|Overall Study|Physician Decision|2|||
170847848|NCT01470001|617450812|FG001|Overall Study|Physician Decision|0|||
170847849|NCT01470001|617450811|FG000|Overall Study|Withdrawal by Subject|2|||
170847850|NCT01470001|617450812|FG001|Overall Study|Withdrawal by Subject|1|||
170847851|NCT03268603|617450813|FG000|Overall Study|Withdrawal by Subject|6|||
170847852|NCT03268603|617450813|FG000|Overall Study|Physician Decision|1|||
170847853|NCT03268603|617450813|FG000|Overall Study|Withdrawn due to disease progression|2|||
170847854|NCT00224887|617450816|FG000|Overall Study|Pregnancy|6|||
170847855|NCT00224887|617450817|FG001|Overall Study|Pregnancy|6|||
170847856|NCT01656200|617450818|FG000|Overall Study|Withdrawal by Subject|1|||
170847857|NCT01659853|617450820|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
170847858|NCT01659853|617450821|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
170847859|NCT01659853|617450820|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
170847860|NCT01659853|617450821|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
170847861|NCT01156376|617450822|FG000|Overall Study|Adverse Event|1|||
170847862|NCT01156376|617450823|FG001|Overall Study|Adverse Event|0|||
170847863|NCT01156376|617450824|FG002|Overall Study|Adverse Event|1|||
170847864|NCT01156376|617450822|FG000|Overall Study|Withdrawal by Subject|0|||
170847865|NCT01156376|617450823|FG001|Overall Study|Withdrawal by Subject|0|||
170847866|NCT01156376|617450824|FG002|Overall Study|Withdrawal by Subject|3|||
170847867|NCT01493427|617450825|FG000|Overall Study|Adverse Event|10|||
170847868|NCT01493427|617450825|FG000|Overall Study|Personal Reasons|4|||
170847869|NCT01493427|617450825|FG000|Overall Study|Lost to Follow-up|2|||
170847870|NCT01493427|617450825|FG000|Overall Study|Inability to Follow Instructions|2|||
170847871|NCT01493427|617450825|FG000|Overall Study|Other|2|||
170847872|NCT05775991|617450826|FG000|Overall Study|Withdrawal by Subject|0|||
170847873|NCT05775991|617450827|FG001|Overall Study|Withdrawal by Subject|0|||
170847874|NCT05775991|617450828|FG002|Overall Study|Withdrawal by Subject|2|||
170847875|NCT03015129|617450829|FG000|Overall Study|Death|2|||
170847876|NCT03015129|617450830|FG001|Overall Study|Death|2|||
170847877|NCT03015129|617450829|FG000|Overall Study|Lost to Follow-up|0|||
170847878|NCT03015129|617450830|FG001|Overall Study|Lost to Follow-up|1|||
170847879|NCT03015129|617450829|FG000|Overall Study|Progression of disease|38|||
170847880|NCT03015129|617450830|FG001|Overall Study|Progression of disease|33|||
170847881|NCT03015129|617450829|FG000|Overall Study|Adverse Event|0|||
170847882|NCT03015129|617450830|FG001|Overall Study|Adverse Event|4|||
170847883|NCT03733314|617450832|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
170847884|NCT03733314|617450833|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
170847885|NCT03733314|617450832|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
170847886|NCT03733314|617450833|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
170847887|NCT03733314|617450832|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
170847888|NCT03733314|617450833|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
170847889|NCT03733314|617450832|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
170847890|NCT03733314|617450833|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
170847891|NCT03733314|617450832|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
170847892|NCT03733314|617450833|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
170847893|NCT03733314|617450832|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
170847894|NCT03733314|617450833|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
170847895|NCT03214640|617450834|FG000|Overall Study|Protocol Violation|1|||
170847896|NCT03214640|617450835|FG001|Overall Study|Protocol Violation|2|||
170847897|NCT03214640|617450836|FG002|Overall Study|Protocol Violation|1|||
170847898|NCT03214640|617450837|FG003|Overall Study|Protocol Violation|4|||
170847899|NCT00910039|617450838|FG000|Overall Study|Physician Decision|1|||
170847900|NCT02781090|617450839|FG000|3-Month Follow-Up|Missed Visit|20|||
170847901|NCT02781090|617450840|FG001|3-Month Follow-Up|Missed Visit|20|||
170847902|NCT02781090|617450839|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
170847903|NCT02781090|617450840|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
170847904|NCT02781090|617450839|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
170847905|NCT02781090|617450840|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
170847906|NCT02781090|617450839|FG000|3-Month Follow-Up|Death|1|||
170847907|NCT02781090|617450840|FG001|3-Month Follow-Up|Death|0|||
170847908|NCT02781090|617450839|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
170847909|NCT02781090|617450840|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
170847910|NCT02781090|617450839|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
170847911|NCT02781090|617450840|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
170847912|NCT02781090|617450839|FG000|6-Month Follow-Up|Death|0|||
170847913|NCT02781090|617450840|FG001|6-Month Follow-Up|Death|1|||
170847914|NCT03547739|617450841|FG000|Overall Study|Death|0|||
170847915|NCT03547739|617450842|FG001|Overall Study|Death|1|||
170847916|NCT03547739|617450843|FG002|Overall Study|Death|5|||
170847917|NCT03547739|617450841|FG000|Overall Study|Adverse Event|24|||
170847918|NCT03547739|617450842|FG001|Overall Study|Adverse Event|11|||
170847919|NCT03547739|617450843|FG002|Overall Study|Adverse Event|13|||
170847920|NCT03547739|617450841|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
170847921|NCT03547739|617450842|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
170847922|NCT03547739|617450843|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
170847923|NCT03547739|617450841|FG000|Overall Study|Lost to Follow-up|80|||
170847924|NCT03547739|617450842|FG001|Overall Study|Lost to Follow-up|84|||
170847925|NCT03547739|617450843|FG002|Overall Study|Lost to Follow-up|116|||
170847926|NCT01208103|617450854|FG000|Overall Study|Adverse Event|1|||
170847927|NCT01208103|617450854|FG000|Overall Study|Withdrawal by Subject|1|||
170847928|NCT00468143|617450855|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
170847929|NCT00468143|617450856|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
170847930|NCT00468143|617450855|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
170847931|NCT00468143|617450856|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
170847932|NCT00403767|617450859|FG000|Overall Study|Adverse Event|993|||
170847933|NCT00403767|617450860|FG001|Overall Study|Adverse Event|919|||
170847934|NCT00403767|617450859|FG000|Overall Study|Non-compliant with study medication|134|||
170847935|NCT00403767|617450860|FG001|Overall Study|Non-compliant with study medication|164|||
170847936|NCT00403767|617450859|FG000|Overall Study|Consent withdrawn|671|||
170847937|NCT00403767|617450860|FG001|Overall Study|Consent withdrawn|673|||
170847938|NCT00403767|617450859|FG000|Overall Study|Investigator dec./not protocol-related|191|||
170847939|NCT00403767|617450860|FG001|Overall Study|Investigator dec./not protocol-related|178|||
170847940|NCT00403767|617450859|FG000|Overall Study|Lost to Follow-up|6|||
170847941|NCT00403767|617450860|FG001|Overall Study|Lost to Follow-up|8|||
170847942|NCT00403767|617450859|FG000|Overall Study|Protocol Violation|142|||
170847943|NCT00403767|617450860|FG001|Overall Study|Protocol Violation|124|||
170847944|NCT00403767|617450859|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
170847945|NCT00403767|617450860|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
170847946|NCT00403767|617450859|FG000|Overall Study|Study terminated by sponsor|82|||
170847947|NCT00403767|617450860|FG001|Overall Study|Study terminated by sponsor|69|||
170847948|NCT00403767|617450859|FG000|Overall Study|Missing/incomplete data|1|||
170847949|NCT00403767|617450860|FG001|Overall Study|Missing/incomplete data|1|||
170847950|NCT03192475|617450867|FG000|Overall Study|Death|0|||
170847951|NCT03192475|617450868|FG001|Overall Study|Death|1|||
170847952|NCT03192475|617450867|FG000|Overall Study|Lost to Follow-up|13|||
170847953|NCT03192475|617450868|FG001|Overall Study|Lost to Follow-up|8|||
170847954|NCT01641159|617450869|FG000|Overall Study|Lost to Follow-up|2|||
170847955|NCT01641159|617450870|FG001|Overall Study|Lost to Follow-up|1|||
170847956|NCT01641159|617450869|FG000|Overall Study|Withdrawal by Subject|0|||
170847957|NCT01641159|617450870|FG001|Overall Study|Withdrawal by Subject|1|||
170847958|NCT03014011|617450875|FG000|First Intervention|Withdrawal by Subject|1|||
170847959|NCT03014011|617450876|FG001|First Intervention|Withdrawal by Subject|0|||
170847960|NCT03014011|617450875|FG000|Washout|Withdrawal by Subject|1|||
170847961|NCT03014011|617450876|FG001|Washout|Withdrawal by Subject|0|||
170847962|NCT02755818|617450877|FG000|Overall Study|Withdrawal by Subject|0|||
170847963|NCT02755818|617450878|FG001|Overall Study|Withdrawal by Subject|0|||
170847964|NCT02755818|617450879|FG002|Overall Study|Withdrawal by Subject|0|||
170847965|NCT02755818|617450880|FG003|Overall Study|Withdrawal by Subject|2|||
170847966|NCT02755818|617450877|FG000|Overall Study|withdrawal by PI|0|||
170847967|NCT02755818|617450878|FG001|Overall Study|withdrawal by PI|0|||
170847968|NCT02755818|617450879|FG002|Overall Study|withdrawal by PI|1|||
170847969|NCT02755818|617450880|FG003|Overall Study|withdrawal by PI|1|||
170847970|NCT01152814|617450881|FG000|Overall Study|Lost to Follow-up|2|||
170847971|NCT03223662|617450892|FG000|Overall Study|Physician Decision|1|||
170847972|NCT03223662|617450892|FG000|Overall Study|Study closure|1|||
170847973|NCT01280357|617450893|FG000|Overall Study|Excluded no internal monitoring|14|||
170847974|NCT01280357|617450893|FG000|Overall Study|IInsufficient data/No data supplied|12|||
170847975|NCT00886795|617450894|FG000|Overall Study|Lack of Efficacy|1|||
170847976|NCT05543707|617450895|FG000|Overall Study|Study drug non-compliance/|5|||
170847977|NCT05543707|617450896|FG001|Overall Study|Study drug non-compliance/|0|||
170847978|NCT05543707|617450895|FG000|Overall Study|Withdrawal by Subject|1|||
170847979|NCT05543707|617450896|FG001|Overall Study|Withdrawal by Subject|1|||
170847980|NCT05543707|617450895|FG000|Overall Study|Adverse Event|1|||
170847981|NCT05543707|617450896|FG001|Overall Study|Adverse Event|0|||
170847982|NCT05543707|617450895|FG000|Overall Study|concurrent illness|0|||
170847983|NCT05543707|617450896|FG001|Overall Study|concurrent illness|1|||
170847984|NCT05543707|617450895|FG000|Overall Study|Pregnancy|1|||
170847985|NCT05543707|617450896|FG001|Overall Study|Pregnancy|1|||
170847986|NCT05148962|617450897|FG000|Overall Study|Withdrawal by Subject|1|||
170847987|NCT05148962|617450898|FG001|Overall Study|Withdrawal by Subject|1|||
170847988|NCT05148962|617450899|FG002|Overall Study|Withdrawal by Subject|0|||
170847989|NCT05148962|617450900|FG003|Overall Study|Withdrawal by Subject|1|||
170847990|NCT05148962|617450901|FG004|Overall Study|Withdrawal by Subject|0|||
170847991|NCT05148962|617450897|FG000|Overall Study|Participant was early terminated per protocol|0|||
170847992|NCT05148962|617450898|FG001|Overall Study|Participant was early terminated per protocol|0|||
170847993|NCT05148962|617450899|FG002|Overall Study|Participant was early terminated per protocol|3|||
170847994|NCT05148962|617450900|FG003|Overall Study|Participant was early terminated per protocol|5|||
170847995|NCT05148962|617450901|FG004|Overall Study|Participant was early terminated per protocol|2|||
170847996|NCT05148962|617450897|FG000|Overall Study|Miscellaneous|0|||
170847997|NCT05148962|617450898|FG001|Overall Study|Miscellaneous|0|||
170847998|NCT05148962|617450899|FG002|Overall Study|Miscellaneous|0|||
170847999|NCT05148962|617450900|FG003|Overall Study|Miscellaneous|1|||
170848000|NCT05148962|617450901|FG004|Overall Study|Miscellaneous|0|||
170848001|NCT02344290|617450902|FG000|Overall Study|Withdrawal by Subject|315|||
170848002|NCT02344290|617450903|FG001|Overall Study|Withdrawal by Subject|324|||
170848003|NCT02344290|617450902|FG000|Overall Study|Lost to Follow-up|258|||
170848004|NCT02344290|617450903|FG001|Overall Study|Lost to Follow-up|249|||
170848005|NCT02344290|617450902|FG000|Overall Study|Unable to get to clinic|69|||
170848006|NCT02344290|617450903|FG001|Overall Study|Unable to get to clinic|60|||
170848007|NCT02344290|617450902|FG000|Overall Study|Physician Decision|25|||
170848008|NCT02344290|617450903|FG001|Overall Study|Physician Decision|25|||
170848009|NCT02344290|617450902|FG000|Overall Study|Site Closure|15|||
170848010|NCT02344290|617450903|FG001|Overall Study|Site Closure|19|||
170848011|NCT02344290|617450902|FG000|Overall Study|Other|5|||
170848012|NCT02344290|617450903|FG001|Overall Study|Other|3|||
170848013|NCT04047862|617450908|FG000|Overall Study|Death|0|||
170848014|NCT04047862|617450909|FG001|Overall Study|Death|0|||
170848015|NCT04047862|617450910|FG002|Overall Study|Death|4|||
170848016|NCT04047862|617450911|FG003|Overall Study|Death|7|||
170848017|NCT04047862|617450912|FG004|Overall Study|Death|2|||
170848018|NCT04047862|617450913|FG005|Overall Study|Death|4|||
170848019|NCT04047862|617450914|FG006|Overall Study|Death|3|||
170848020|NCT04047862|617450915|FG007|Overall Study|Death|24|||
170848021|NCT04047862|617450916|FG008|Overall Study|Death|24|||
170848022|NCT04047862|617450917|FG009|Overall Study|Death|22|||
170848023|NCT04047862|617450918|FG010|Overall Study|Death|35|||
170848024|NCT04047862|617450919|FG011|Overall Study|Death|18|||
170848025|NCT04047862|617450920|FG012|Overall Study|Death|14|||
170848026|NCT04047862|617450921|FG013|Overall Study|Death|6|||
170848027|NCT04047862|617450922|FG014|Overall Study|Death|19|||
170848028|NCT04047862|617450923|FG015|Overall Study|Death|42|||
170848029|NCT04047862|617450924|FG016|Overall Study|Death|9|||
170848030|NCT04047862|617450925|FG017|Overall Study|Death|8|||
170848031|NCT04047862|617450926|FG018|Overall Study|Death|10|||
170738977|NCT03285295|617052330|FG002|Alinity s HBsAg|No Results Generated|0|||
170738978|NCT03285295|617052331|FG003|Alinity s HBsAg|No Results Generated|0|||
170738979|NCT03285295|617052332|FG004|Alinity s HBsAg|No Results Generated|0|||
170738980|NCT03285295|617052328|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
170738981|NCT03285295|617052329|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
170738982|NCT03285295|617052330|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
170738983|NCT03285295|617052331|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
170738984|NCT03285295|617052332|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
170738985|NCT03285295|617052328|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
170738986|NCT03285295|617052329|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
170738987|NCT03285295|617052330|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
170738988|NCT03285295|617052331|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
170738989|NCT03285295|617052332|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
170738990|NCT03285295|617052328|FG000|Alinity s HTLV I/II|No Results Generated|70|||
170738991|NCT03285295|617052329|FG001|Alinity s HTLV I/II|No Results Generated|0|||
170738992|NCT03285295|617052330|FG002|Alinity s HTLV I/II|No Results Generated|0|||
170738993|NCT03285295|617052331|FG003|Alinity s HTLV I/II|No Results Generated|0|||
170738994|NCT03285295|617052332|FG004|Alinity s HTLV I/II|No Results Generated|0|||
170738995|NCT03285295|617052328|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
170738996|NCT03285295|617052329|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
170738997|NCT03285295|617052330|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
170738998|NCT03285295|617052331|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
170738999|NCT03285295|617052332|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
170739000|NCT03285295|617052328|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
170739001|NCT03285295|617052329|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
170739002|NCT03285295|617052330|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
170739003|NCT03285295|617052331|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
170739004|NCT03285295|617052332|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
170739005|NCT03285295|617052328|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
170739006|NCT03285295|617052329|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
170739007|NCT03285295|617052330|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
170739008|NCT03285295|617052331|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
170739009|NCT03285295|617052332|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
170739010|NCT03285295|617052328|FG000|Alinity s Anti-HCV|No Results Generated|71|||
170739011|NCT03285295|617052329|FG001|Alinity s Anti-HCV|No Results Generated|0|||
170739012|NCT03285295|617052330|FG002|Alinity s Anti-HCV|No Results Generated|0|||
170739013|NCT03285295|617052331|FG003|Alinity s Anti-HCV|No Results Generated|0|||
170848032|NCT04047862|617450908|FG000|Overall Study|Withdrawal by Subject|0|||
170848033|NCT04047862|617450909|FG001|Overall Study|Withdrawal by Subject|0|||
170848034|NCT04047862|617450910|FG002|Overall Study|Withdrawal by Subject|0|||
170848035|NCT04047862|617450911|FG003|Overall Study|Withdrawal by Subject|5|||
170848036|NCT04047862|617450912|FG004|Overall Study|Withdrawal by Subject|2|||
170848037|NCT04047862|617450913|FG005|Overall Study|Withdrawal by Subject|0|||
170848038|NCT04047862|617450914|FG006|Overall Study|Withdrawal by Subject|1|||
170848039|NCT04047862|617450915|FG007|Overall Study|Withdrawal by Subject|0|||
170848040|NCT04047862|617450916|FG008|Overall Study|Withdrawal by Subject|4|||
170848041|NCT04047862|617450917|FG009|Overall Study|Withdrawal by Subject|4|||
170848042|NCT04047862|617450918|FG010|Overall Study|Withdrawal by Subject|4|||
170848043|NCT04047862|617450919|FG011|Overall Study|Withdrawal by Subject|2|||
170848044|NCT04047862|617450920|FG012|Overall Study|Withdrawal by Subject|3|||
170848045|NCT04047862|617450921|FG013|Overall Study|Withdrawal by Subject|0|||
170848046|NCT04047862|617450922|FG014|Overall Study|Withdrawal by Subject|9|||
170848047|NCT04047862|617450923|FG015|Overall Study|Withdrawal by Subject|5|||
170848048|NCT04047862|617450924|FG016|Overall Study|Withdrawal by Subject|1|||
170848049|NCT04047862|617450925|FG017|Overall Study|Withdrawal by Subject|3|||
170848050|NCT04047862|617450926|FG018|Overall Study|Withdrawal by Subject|1|||
170848051|NCT04047862|617450908|FG000|Overall Study|Lost to Follow-up|0|||
170848052|NCT04047862|617450909|FG001|Overall Study|Lost to Follow-up|0|||
170848053|NCT04047862|617450910|FG002|Overall Study|Lost to Follow-up|1|||
170848054|NCT04047862|617450911|FG003|Overall Study|Lost to Follow-up|0|||
170848055|NCT04047862|617450912|FG004|Overall Study|Lost to Follow-up|0|||
170848056|NCT04047862|617450913|FG005|Overall Study|Lost to Follow-up|0|||
170848057|NCT04047862|617450914|FG006|Overall Study|Lost to Follow-up|0|||
170848058|NCT04047862|617450915|FG007|Overall Study|Lost to Follow-up|1|||
170848059|NCT04047862|617450916|FG008|Overall Study|Lost to Follow-up|0|||
170848060|NCT04047862|617450917|FG009|Overall Study|Lost to Follow-up|1|||
170848061|NCT04047862|617450918|FG010|Overall Study|Lost to Follow-up|0|||
170848062|NCT04047862|617450919|FG011|Overall Study|Lost to Follow-up|3|||
170848063|NCT04047862|617450920|FG012|Overall Study|Lost to Follow-up|0|||
170848064|NCT04047862|617450921|FG013|Overall Study|Lost to Follow-up|0|||
170848065|NCT04047862|617450922|FG014|Overall Study|Lost to Follow-up|2|||
170848066|NCT04047862|617450923|FG015|Overall Study|Lost to Follow-up|2|||
170848067|NCT04047862|617450924|FG016|Overall Study|Lost to Follow-up|1|||
170848068|NCT04047862|617450925|FG017|Overall Study|Lost to Follow-up|0|||
170848069|NCT04047862|617450926|FG018|Overall Study|Lost to Follow-up|0|||
170848070|NCT04047862|617450908|FG000|Overall Study|Physician Decision|0|||
170848071|NCT04047862|617450909|FG001|Overall Study|Physician Decision|0|||
170848072|NCT04047862|617450910|FG002|Overall Study|Physician Decision|0|||
170848073|NCT04047862|617450911|FG003|Overall Study|Physician Decision|1|||
170848074|NCT04047862|617450912|FG004|Overall Study|Physician Decision|0|||
170848075|NCT04047862|617450913|FG005|Overall Study|Physician Decision|0|||
170848076|NCT04047862|617450914|FG006|Overall Study|Physician Decision|0|||
170848077|NCT04047862|617450915|FG007|Overall Study|Physician Decision|0|||
170848078|NCT04047862|617450916|FG008|Overall Study|Physician Decision|0|||
170848079|NCT04047862|617450917|FG009|Overall Study|Physician Decision|0|||
170848080|NCT04047862|617450918|FG010|Overall Study|Physician Decision|0|||
170848081|NCT04047862|617450919|FG011|Overall Study|Physician Decision|0|||
170848082|NCT04047862|617450920|FG012|Overall Study|Physician Decision|0|||
170848083|NCT04047862|617450921|FG013|Overall Study|Physician Decision|0|||
170848084|NCT04047862|617450922|FG014|Overall Study|Physician Decision|1|||
170848085|NCT04047862|617450923|FG015|Overall Study|Physician Decision|0|||
170848086|NCT04047862|617450924|FG016|Overall Study|Physician Decision|1|||
170848087|NCT04047862|617450925|FG017|Overall Study|Physician Decision|0|||
170848088|NCT04047862|617450926|FG018|Overall Study|Physician Decision|0|||
170848089|NCT04047862|617450908|FG000|Overall Study|Completed all Assessments|1|||
170848090|NCT04047862|617450909|FG001|Overall Study|Completed all Assessments|3|||
170848091|NCT04047862|617450910|FG002|Overall Study|Completed all Assessments|1|||
170848092|NCT04047862|617450911|FG003|Overall Study|Completed all Assessments|3|||
170848093|NCT04047862|617450912|FG004|Overall Study|Completed all Assessments|2|||
170848094|NCT04047862|617450913|FG005|Overall Study|Completed all Assessments|5|||
170848095|NCT04047862|617450914|FG006|Overall Study|Completed all Assessments|7|||
170848096|NCT04047862|617450915|FG007|Overall Study|Completed all Assessments|0|||
170848097|NCT04047862|617450916|FG008|Overall Study|Completed all Assessments|0|||
170848098|NCT04047862|617450917|FG009|Overall Study|Completed all Assessments|0|||
170848099|NCT04047862|617450918|FG010|Overall Study|Completed all Assessments|0|||
170848100|NCT04047862|617450919|FG011|Overall Study|Completed all Assessments|0|||
170848101|NCT04047862|617450920|FG012|Overall Study|Completed all Assessments|0|||
170848102|NCT04047862|617450921|FG013|Overall Study|Completed all Assessments|0|||
170848103|NCT04047862|617450922|FG014|Overall Study|Completed all Assessments|0|||
170848104|NCT04047862|617450923|FG015|Overall Study|Completed all Assessments|0|||
170848105|NCT04047862|617450924|FG016|Overall Study|Completed all Assessments|0|||
170848106|NCT04047862|617450925|FG017|Overall Study|Completed all Assessments|0|||
170848107|NCT04047862|617450926|FG018|Overall Study|Completed all Assessments|0|||
170848108|NCT04047862|617450908|FG000|Overall Study|Sponsor Decision|0|||
170848109|NCT04047862|617450909|FG001|Overall Study|Sponsor Decision|0|||
170848110|NCT04047862|617450910|FG002|Overall Study|Sponsor Decision|0|||
170848111|NCT04047862|617450911|FG003|Overall Study|Sponsor Decision|0|||
170848112|NCT04047862|617450912|FG004|Overall Study|Sponsor Decision|0|||
170848113|NCT04047862|617450913|FG005|Overall Study|Sponsor Decision|0|||
170848114|NCT04047862|617450914|FG006|Overall Study|Sponsor Decision|0|||
170848115|NCT04047862|617450915|FG007|Overall Study|Sponsor Decision|13|||
170848116|NCT04047862|617450916|FG008|Overall Study|Sponsor Decision|10|||
170848117|NCT04047862|617450917|FG009|Overall Study|Sponsor Decision|18|||
170848118|NCT04047862|617450918|FG010|Overall Study|Sponsor Decision|3|||
170848119|NCT04047862|617450919|FG011|Overall Study|Sponsor Decision|3|||
170848120|NCT04047862|617450920|FG012|Overall Study|Sponsor Decision|4|||
170848121|NCT04047862|617450921|FG013|Overall Study|Sponsor Decision|0|||
170848122|NCT04047862|617450922|FG014|Overall Study|Sponsor Decision|7|||
170848123|NCT04047862|617450923|FG015|Overall Study|Sponsor Decision|8|||
170848124|NCT04047862|617450924|FG016|Overall Study|Sponsor Decision|9|||
170848125|NCT04047862|617450925|FG017|Overall Study|Sponsor Decision|7|||
170848126|NCT04047862|617450926|FG018|Overall Study|Sponsor Decision|8|||
170848127|NCT04047862|617450908|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848128|NCT04047862|617450909|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848129|NCT04047862|617450910|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848130|NCT04047862|617450911|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848131|NCT04047862|617450912|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848132|NCT04047862|617450913|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848133|NCT04047862|617450914|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848134|NCT04047862|617450915|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
170848135|NCT04047862|617450916|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
170848136|NCT04047862|617450917|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848137|NCT04047862|617450918|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
170848138|NCT04047862|617450919|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848139|NCT04047862|617450920|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848140|NCT04047862|617450921|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
170848141|NCT04047862|617450922|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
170848142|NCT04047862|617450923|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
170848143|NCT04047862|617450924|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
170848144|NCT04047862|617450925|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
170848145|NCT04047862|617450926|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
170848146|NCT04047862|617450908|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848147|NCT04047862|617450909|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848148|NCT04047862|617450910|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848149|NCT04047862|617450911|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848150|NCT04047862|617450912|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848151|NCT04047862|617450913|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848152|NCT04047862|617450914|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848153|NCT04047862|617450915|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848154|NCT04047862|617450916|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848155|NCT04047862|617450917|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848156|NCT04047862|617450918|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848157|NCT04047862|617450919|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848158|NCT04047862|617450920|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848159|NCT04047862|617450921|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848160|NCT04047862|617450922|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848161|NCT04047862|617450923|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
170848162|NCT04047862|617450924|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848163|NCT04047862|617450925|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
170848164|NCT04047862|617450926|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
170848165|NCT04047862|617450908|FG000|Overall Study|Other|0|||
170848166|NCT04047862|617450909|FG001|Overall Study|Other|0|||
170848167|NCT04047862|617450910|FG002|Overall Study|Other|0|||
170848168|NCT04047862|617450911|FG003|Overall Study|Other|0|||
170848169|NCT04047862|617450912|FG004|Overall Study|Other|0|||
170848170|NCT04047862|617450913|FG005|Overall Study|Other|0|||
170848171|NCT04047862|617450914|FG006|Overall Study|Other|0|||
170848172|NCT04047862|617450915|FG007|Overall Study|Other|0|||
170848173|NCT04047862|617450916|FG008|Overall Study|Other|0|||
170848174|NCT04047862|617450917|FG009|Overall Study|Other|0|||
170848175|NCT04047862|617450918|FG010|Overall Study|Other|0|||
170848176|NCT04047862|617450919|FG011|Overall Study|Other|0|||
170848177|NCT04047862|617450920|FG012|Overall Study|Other|0|||
170848178|NCT04047862|617450921|FG013|Overall Study|Other|0|||
170848179|NCT04047862|617450922|FG014|Overall Study|Other|2|||
170848180|NCT04047862|617450923|FG015|Overall Study|Other|1|||
170848181|NCT04047862|617450924|FG016|Overall Study|Other|1|||
170848182|NCT04047862|617450925|FG017|Overall Study|Other|1|||
170848183|NCT04047862|617450926|FG018|Overall Study|Other|0|||
170848184|NCT00969709|617452171|FG000|Overall Study|Adverse Event|3|||
170848185|NCT00969709|617452172|FG001|Overall Study|Adverse Event|13|||
170848186|NCT00969709|617452173|FG002|Overall Study|Adverse Event|26|||
170848187|NCT00969709|617452174|FG003|Overall Study|Adverse Event|12|||
170848188|NCT00969709|617452171|FG000|Overall Study|Lack of Efficacy|7|||
170848189|NCT00969709|617452172|FG001|Overall Study|Lack of Efficacy|4|||
170848190|NCT00969709|617452173|FG002|Overall Study|Lack of Efficacy|1|||
170848191|NCT00969709|617452174|FG003|Overall Study|Lack of Efficacy|3|||
170848192|NCT00969709|617452171|FG000|Overall Study|Protocol Violation|9|||
170848193|NCT00969709|617452172|FG001|Overall Study|Protocol Violation|5|||
170848194|NCT00969709|617452173|FG002|Overall Study|Protocol Violation|9|||
170848195|NCT00969709|617452174|FG003|Overall Study|Protocol Violation|10|||
170848196|NCT00969709|617452171|FG000|Overall Study|Withdrawal by Subject|9|||
170848197|NCT00969709|617452172|FG001|Overall Study|Withdrawal by Subject|12|||
170848198|NCT00969709|617452173|FG002|Overall Study|Withdrawal by Subject|11|||
170848199|NCT00969709|617452174|FG003|Overall Study|Withdrawal by Subject|23|||
170848200|NCT00969709|617452171|FG000|Overall Study|Lost to Follow-up|10|||
170848201|NCT00969709|617452172|FG001|Overall Study|Lost to Follow-up|14|||
170848202|NCT00969709|617452173|FG002|Overall Study|Lost to Follow-up|8|||
170848203|NCT00969709|617452174|FG003|Overall Study|Lost to Follow-up|15|||
170848204|NCT00969709|617452171|FG000|Overall Study|Other reasons|0|||
170848205|NCT00969709|617452172|FG001|Overall Study|Other reasons|0|||
170848206|NCT00969709|617452173|FG002|Overall Study|Other reasons|3|||
170848207|NCT00969709|617452174|FG003|Overall Study|Other reasons|0|||
170848208|NCT00640133|617452175|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
170848209|NCT00640133|617452176|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
170848210|NCT00640133|617452175|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
170848211|NCT00640133|617452176|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
170848212|NCT00640133|617452175|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
170848213|NCT00640133|617452176|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
170848214|NCT00055601|617452177|FG000|Overall Study|Protocol Violation|1|||
170848215|NCT00055601|617452178|FG001|Overall Study|Protocol Violation|1|||
170848216|NCT00055601|617452177|FG000|Overall Study|No protocol treatment received|1|||
170848217|NCT00055601|617452178|FG001|Overall Study|No protocol treatment received|1|||
170848218|NCT03037931|617452179|FG000|Overall Study|Death|354|||
170848219|NCT03037931|617452180|FG001|Overall Study|Death|367|||
170848220|NCT03037931|617452179|FG000|Overall Study|Lost to Follow-up|7|||
170848221|NCT03037931|617452180|FG001|Overall Study|Lost to Follow-up|4|||
170848222|NCT03037931|617452179|FG000|Overall Study|Withdrawal by Subject|48|||
170848223|NCT03037931|617452180|FG001|Overall Study|Withdrawal by Subject|41|||
170848224|NCT02075476|617452181|FG000|Overall Study|Death|2|||
170848225|NCT02075476|617452182|FG001|Overall Study|Death|2|||
170848226|NCT02075476|617452181|FG000|Overall Study|Lost to Follow-up|1|||
170739014|NCT03285295|617052332|FG004|Alinity s Anti-HCV|No Results Generated|0|||
170739015|NCT03285295|617052328|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
170739016|NCT03285295|617052329|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
170739017|NCT03285295|617052330|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
170739018|NCT03285295|617052331|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
170739019|NCT03285295|617052332|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
170739020|NCT03285295|617052328|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
170739021|NCT03285295|617052329|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
170739022|NCT03285295|617052330|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
170739023|NCT03285295|617052331|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
170739024|NCT03285295|617052332|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
170739025|NCT03285295|617052328|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
170739026|NCT03285295|617052329|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
170739027|NCT03285295|617052330|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
170739028|NCT03285295|617052331|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
170739029|NCT03285295|617052332|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
170739030|NCT03285295|617052328|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
170739031|NCT03285295|617052329|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
170739032|NCT03285295|617052330|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
170739033|NCT03285295|617052331|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
170739034|NCT03285295|617052332|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
170739035|NCT03285295|617052328|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
170739036|NCT03285295|617052329|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
170739037|NCT03285295|617052330|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
170739038|NCT03285295|617052331|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
170739039|NCT03285295|617052332|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
170739040|NCT03285295|617052328|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
170739041|NCT03285295|617052329|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
170739042|NCT03285295|617052330|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
170739043|NCT03285295|617052331|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
170739044|NCT03285295|617052332|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
170739045|NCT03285295|617052328|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
170739046|NCT03285295|617052329|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
170739047|NCT03285295|617052330|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
170739048|NCT03285295|617052331|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
170739049|NCT03285295|617052332|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
170739050|NCT03285295|617052328|FG000|Alinity s Anti-HBc|No Results Generated|70|||
170739051|NCT03285295|617052329|FG001|Alinity s Anti-HBc|No Results Generated|0|||
170739052|NCT03285295|617052330|FG002|Alinity s Anti-HBc|No Results Generated|0|||
170739053|NCT03285295|617052331|FG003|Alinity s Anti-HBc|No Results Generated|0|||
170739054|NCT03285295|617052332|FG004|Alinity s Anti-HBc|No Results Generated|0|||
170739055|NCT03285295|617052328|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
170739056|NCT03285295|617052329|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
170739057|NCT03285295|617052330|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
170739058|NCT03285295|617052331|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
170739059|NCT03285295|617052332|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
170739060|NCT03285295|617052328|FG000|Alinity s Chagas|Protocol Violation|76|||
170739061|NCT03285295|617052329|FG001|Alinity s Chagas|Protocol Violation|0|||
170739062|NCT03285295|617052330|FG002|Alinity s Chagas|Protocol Violation|0|||
170739063|NCT03285295|617052331|FG003|Alinity s Chagas|Protocol Violation|0|||
170739064|NCT03285295|617052332|FG004|Alinity s Chagas|Protocol Violation|0|||
170739065|NCT03285295|617052328|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
170739066|NCT03285295|617052329|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
170739067|NCT03285295|617052330|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
170739068|NCT03285295|617052331|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
170739069|NCT03285295|617052332|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
170739070|NCT03285295|617052328|FG000|Alinity s Chagas|No Results Generated|105|||
170739071|NCT03285295|617052329|FG001|Alinity s Chagas|No Results Generated|0|||
170739072|NCT03285295|617052330|FG002|Alinity s Chagas|No Results Generated|0|||
170739073|NCT03285295|617052331|FG003|Alinity s Chagas|No Results Generated|0|||
170739074|NCT03285295|617052332|FG004|Alinity s Chagas|No Results Generated|0|||
170739075|NCT03285295|617052328|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
170739076|NCT03285295|617052329|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
170739077|NCT03285295|617052330|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
170739078|NCT03285295|617052331|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
170739079|NCT03285295|617052332|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
170739080|NCT01287520|617052346|FG000|Overall Study|Adverse Event|2|||
170739081|NCT01287520|617052347|FG001|Overall Study|Adverse Event|2|||
170739082|NCT01287520|617052348|FG002|Overall Study|Adverse Event|2|||
170848227|NCT02075476|617452182|FG001|Overall Study|Lost to Follow-up|3|||
170848228|NCT01789567|617452187|FG000|Overall Study|Death|6|||
170848229|NCT02731690|617452188|FG000|Overall Study|Adverse Event|1|||
170848230|NCT02731690|617452188|FG000|Overall Study|Withdrawal by Subject|3|||
170848231|NCT02731690|617452188|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
170848232|NCT02407990|617452189|FG000|Overall Study|Death|2|||
170848233|NCT02407990|617452190|FG001|Overall Study|Death|22|||
170848234|NCT02407990|617452191|FG002|Overall Study|Death|23|||
170848235|NCT02407990|617452192|FG003|Overall Study|Death|7|||
170848236|NCT02407990|617452193|FG004|Overall Study|Death|17|||
170848237|NCT02407990|617452194|FG005|Overall Study|Death|16|||
170848238|NCT02407990|617452195|FG006|Overall Study|Death|10|||
170848239|NCT02407990|617452196|FG007|Overall Study|Death|248|||
170848240|NCT02407990|617452189|FG000|Overall Study|Lost to Follow-up|0|||
170848241|NCT02407990|617452190|FG001|Overall Study|Lost to Follow-up|1|||
170848242|NCT02407990|617452191|FG002|Overall Study|Lost to Follow-up|0|||
170848243|NCT02407990|617452192|FG003|Overall Study|Lost to Follow-up|0|||
170848244|NCT02407990|617452193|FG004|Overall Study|Lost to Follow-up|0|||
170848245|NCT02407990|617452194|FG005|Overall Study|Lost to Follow-up|0|||
170848246|NCT02407990|617452195|FG006|Overall Study|Lost to Follow-up|0|||
170848247|NCT02407990|617452196|FG007|Overall Study|Lost to Follow-up|17|||
170848248|NCT02407990|617452189|FG000|Overall Study|Progressive Disease|0|||
170848249|NCT02407990|617452190|FG001|Overall Study|Progressive Disease|0|||
170848250|NCT02407990|617452191|FG002|Overall Study|Progressive Disease|0|||
170848251|NCT02407990|617452192|FG003|Overall Study|Progressive Disease|0|||
170848252|NCT02407990|617452193|FG004|Overall Study|Progressive Disease|0|||
170848253|NCT02407990|617452194|FG005|Overall Study|Progressive Disease|0|||
170848254|NCT02407990|617452195|FG006|Overall Study|Progressive Disease|0|||
170848255|NCT02407990|617452196|FG007|Overall Study|Progressive Disease|1|||
170848256|NCT02407990|617452189|FG000|Overall Study|Withdrawal by Subject|0|||
170848257|NCT02407990|617452190|FG001|Overall Study|Withdrawal by Subject|0|||
170848258|NCT02407990|617452191|FG002|Overall Study|Withdrawal by Subject|0|||
170848259|NCT02407990|617452192|FG003|Overall Study|Withdrawal by Subject|0|||
170848260|NCT02407990|617452193|FG004|Overall Study|Withdrawal by Subject|1|||
170848261|NCT02407990|617452194|FG005|Overall Study|Withdrawal by Subject|0|||
170848262|NCT02407990|617452195|FG006|Overall Study|Withdrawal by Subject|0|||
170848263|NCT02407990|617452196|FG007|Overall Study|Withdrawal by Subject|30|||
170848264|NCT02407990|617452189|FG000|Overall Study|Study Terminated by Sponsor|1|||
170848265|NCT02407990|617452190|FG001|Overall Study|Study Terminated by Sponsor|3|||
170848266|NCT02407990|617452191|FG002|Overall Study|Study Terminated by Sponsor|3|||
170848267|NCT02407990|617452192|FG003|Overall Study|Study Terminated by Sponsor|0|||
170848268|NCT02407990|617452193|FG004|Overall Study|Study Terminated by Sponsor|3|||
170848269|NCT02407990|617452194|FG005|Overall Study|Study Terminated by Sponsor|4|||
170848270|NCT02407990|617452195|FG006|Overall Study|Study Terminated by Sponsor|3|||
170848271|NCT02407990|617452196|FG007|Overall Study|Study Terminated by Sponsor|37|||
170848272|NCT02407990|617452189|FG000|Overall Study|Logistics|0|||
170848273|NCT02407990|617452190|FG001|Overall Study|Logistics|0|||
170848274|NCT02407990|617452191|FG002|Overall Study|Logistics|0|||
170848275|NCT02407990|617452192|FG003|Overall Study|Logistics|0|||
170848276|NCT02407990|617452193|FG004|Overall Study|Logistics|0|||
170848277|NCT02407990|617452194|FG005|Overall Study|Logistics|0|||
170848278|NCT02407990|617452195|FG006|Overall Study|Logistics|0|||
170848279|NCT02407990|617452196|FG007|Overall Study|Logistics|1|||
170848280|NCT02407990|617452189|FG000|Overall Study|Rolled into long-term extension study|0|||
170848281|NCT02407990|617452190|FG001|Overall Study|Rolled into long-term extension study|0|||
170848282|NCT02407990|617452191|FG002|Overall Study|Rolled into long-term extension study|0|||
170848283|NCT02407990|617452192|FG003|Overall Study|Rolled into long-term extension study|0|||
170848284|NCT02407990|617452193|FG004|Overall Study|Rolled into long-term extension study|0|||
170848285|NCT02407990|617452194|FG005|Overall Study|Rolled into long-term extension study|0|||
170848286|NCT02407990|617452195|FG006|Overall Study|Rolled into long-term extension study|0|||
170848287|NCT02407990|617452196|FG007|Overall Study|Rolled into long-term extension study|1|||
170848288|NCT01238900|617452197|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
170848289|NCT01238900|617452197|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
170848290|NCT01994837|617452198|FG000|Overall Study|Progressive disease per protocol|23|||
170848291|NCT01994837|617452198|FG000|Overall Study|Adv event related to progressive disease|3|||
170848292|NCT01994837|617452198|FG000|Overall Study|Fatal progressive disease|2|||
170848293|NCT01994837|617452198|FG000|Overall Study|Adverse event not related to progression|1|||
170848294|NCT01994837|617452198|FG000|Overall Study|Chose palliative care|1|||
170848295|NCT01994837|617452198|FG000|Overall Study|Proceeded to transplant|1|||
170848296|NCT01994837|617452198|FG000|Overall Study|Removed from study due to no response|1|||
170848297|NCT05087979|617452200|FG000|Overall Study|Converted to general anesthesia|1|||
170848298|NCT05087979|617452201|FG001|Overall Study|Converted to general anesthesia|0|||
170848299|NCT03241927|617452202|FG000|Overall Study|study terminated|1|||
170848300|NCT03241927|617452203|FG001|Overall Study|study terminated|0|||
170848301|NCT03573583|617452204|FG000|Overall Study|Lost to Follow-up|1|||
170848302|NCT03573583|617452205|FG001|Overall Study|Lost to Follow-up|0|||
170848303|NCT03573583|617452204|FG000|Overall Study|Withdrawal by Subject|1|||
170848304|NCT03573583|617452205|FG001|Overall Study|Withdrawal by Subject|1|||
170848305|NCT01198756|617452206|FG000|Overall Study|Adverse Event|0|||
170848306|NCT01198756|617452207|FG001|Overall Study|Adverse Event|0|||
170848307|NCT01198756|617452208|FG002|Overall Study|Adverse Event|0|||
170848308|NCT01198756|617452209|FG003|Overall Study|Adverse Event|1|||
170848309|NCT01198756|617452206|FG000|Overall Study|Protocol Violation|0|||
170848310|NCT01198756|617452207|FG001|Overall Study|Protocol Violation|0|||
170848311|NCT01198756|617452208|FG002|Overall Study|Protocol Violation|0|||
170848312|NCT01198756|617452209|FG003|Overall Study|Protocol Violation|2|||
170848313|NCT01198756|617452206|FG000|Overall Study|Withdrawal by Subject|9|||
170848314|NCT01198756|617452207|FG001|Overall Study|Withdrawal by Subject|4|||
170848315|NCT01198756|617452208|FG002|Overall Study|Withdrawal by Subject|7|||
170848316|NCT01198756|617452209|FG003|Overall Study|Withdrawal by Subject|5|||
170848317|NCT01198756|617452206|FG000|Overall Study|Lost to Follow-up|29|||
170848318|NCT01198756|617452207|FG001|Overall Study|Lost to Follow-up|36|||
170848319|NCT01198756|617452208|FG002|Overall Study|Lost to Follow-up|23|||
170848320|NCT01198756|617452209|FG003|Overall Study|Lost to Follow-up|18|||
170848321|NCT02915302|617452212|FG000|Overall Study|Adverse Event|3|||
170848322|NCT02915302|617452213|FG001|Overall Study|Adverse Event|0|||
170848323|NCT02915302|617452212|FG000|Overall Study|Protocol Violation|20|||
170848324|NCT02915302|617452213|FG001|Overall Study|Protocol Violation|27|||
170848325|NCT02915302|617452212|FG000|Overall Study|Lost to Follow-up|19|||
170848326|NCT02915302|617452213|FG001|Overall Study|Lost to Follow-up|22|||
170848327|NCT02915302|617452212|FG000|Overall Study|Withdrawal by Subject|22|||
170848328|NCT02915302|617452213|FG001|Overall Study|Withdrawal by Subject|29|||
170848329|NCT02915302|617452212|FG000|Overall Study|Other|1|||
170848330|NCT02915302|617452213|FG001|Overall Study|Other|0|||
170848331|NCT04343872|617452216|FG000|Overall Study|Lost to Follow-up|6|||
170848332|NCT04343872|617452217|FG001|Overall Study|Lost to Follow-up|3|||
170848333|NCT01850446|617452218|FG000|Overall Study|Lack of Efficacy|1|||
170848334|NCT01850446|617452219|FG001|Overall Study|Lack of Efficacy|0|||
170848335|NCT01850446|617452218|FG000|Overall Study|Withdrawal by Subject|4|||
170848336|NCT01850446|617452219|FG001|Overall Study|Withdrawal by Subject|0|||
170848337|NCT01850446|617452218|FG000|Overall Study|Protocol Violation|0|||
170848338|NCT01850446|617452219|FG001|Overall Study|Protocol Violation|2|||
170848339|NCT00591721|617452220|FG000|Overall Study|Withdrawal by Subject|10|||
170848340|NCT00591721|617452221|FG001|Overall Study|Withdrawal by Subject|10|||
170848341|NCT00591721|617452220|FG000|Overall Study|Lost to Follow-up|1|||
170848342|NCT00591721|617452221|FG001|Overall Study|Lost to Follow-up|4|||
170848343|NCT00591721|617452220|FG000|Overall Study|Intervention not received|10|||
170848344|NCT00591721|617452221|FG001|Overall Study|Intervention not received|8|||
170848345|NCT01879722|617452222|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
170848346|NCT01879722|617452223|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
170848347|NCT01879722|617452224|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
170848348|NCT01879722|617452225|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
170848349|NCT01879722|617452226|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
170848350|NCT01879722|617452227|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
170848351|NCT01879722|617452228|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
170848352|NCT01879722|617452229|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
170848353|NCT01879722|617452230|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
170848354|NCT01879722|617452231|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
170848355|NCT01879722|617452222|FG000|Overall Study|Voluntary Withdrawal|0|||
170848356|NCT01879722|617452223|FG001|Overall Study|Voluntary Withdrawal|0|||
170848357|NCT01879722|617452224|FG002|Overall Study|Voluntary Withdrawal|0|||
170848358|NCT01879722|617452225|FG003|Overall Study|Voluntary Withdrawal|0|||
170848359|NCT01879722|617452226|FG004|Overall Study|Voluntary Withdrawal|0|||
170848360|NCT01879722|617452227|FG005|Overall Study|Voluntary Withdrawal|0|||
170848361|NCT01879722|617452228|FG006|Overall Study|Voluntary Withdrawal|0|||
170848362|NCT01879722|617452229|FG007|Overall Study|Voluntary Withdrawal|0|||
170848363|NCT01879722|617452230|FG008|Overall Study|Voluntary Withdrawal|1|||
170848364|NCT01879722|617452231|FG009|Overall Study|Voluntary Withdrawal|0|||
170848365|NCT00037830|617452234|FG000|Overall Study|Adverse Event|2|||
170848366|NCT00037830|617452235|FG001|Overall Study|Adverse Event|0|||
170848367|NCT00037830|617452236|FG002|Overall Study|Adverse Event|0|||
170848368|NCT00037830|617452234|FG000|Overall Study|Withdrawal by Subject|4|||
170848369|NCT00037830|617452235|FG001|Overall Study|Withdrawal by Subject|5|||
170848370|NCT00037830|617452236|FG002|Overall Study|Withdrawal by Subject|1|||
170848371|NCT00037830|617452234|FG000|Overall Study|Protocol Violation|2|||
170848372|NCT00037830|617452235|FG001|Overall Study|Protocol Violation|2|||
170848373|NCT00037830|617452236|FG002|Overall Study|Protocol Violation|0|||
170848374|NCT00037830|617452234|FG000|Overall Study|Unrelated Medical Problem|2|||
170848375|NCT00037830|617452235|FG001|Overall Study|Unrelated Medical Problem|0|||
170848376|NCT00037830|617452236|FG002|Overall Study|Unrelated Medical Problem|0|||
170848377|NCT03651622|617452237|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
170848378|NCT03651622|617452238|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
170848379|NCT03651622|617452239|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
170739083|NCT01287520|617052349|FG003|Overall Study|Adverse Event|1|||
170739084|NCT01287520|617052350|FG004|Overall Study|Adverse Event|1|||
170739085|NCT01287520|617052351|FG005|Overall Study|Adverse Event|2|||
170739086|NCT01287520|617052352|FG006|Overall Study|Adverse Event|0|||
170739087|NCT01287520|617052353|FG007|Overall Study|Adverse Event|2|||
170739088|NCT01287520|617052354|FG008|Overall Study|Adverse Event|0|||
170739089|NCT01287520|617052346|FG000|Overall Study|Physician Decision|1|||
170739090|NCT01287520|617052347|FG001|Overall Study|Physician Decision|1|||
170739091|NCT01287520|617052348|FG002|Overall Study|Physician Decision|2|||
170739092|NCT01287520|617052349|FG003|Overall Study|Physician Decision|0|||
170739093|NCT01287520|617052350|FG004|Overall Study|Physician Decision|1|||
170739094|NCT01287520|617052351|FG005|Overall Study|Physician Decision|1|||
170739095|NCT01287520|617052352|FG006|Overall Study|Physician Decision|0|||
170739096|NCT01287520|617052353|FG007|Overall Study|Physician Decision|1|||
170739097|NCT01287520|617052354|FG008|Overall Study|Physician Decision|0|||
170739098|NCT01287520|617052346|FG000|Overall Study|Progressive disease|0|||
170739099|NCT01287520|617052347|FG001|Overall Study|Progressive disease|4|||
170739100|NCT01287520|617052348|FG002|Overall Study|Progressive disease|1|||
170739101|NCT01287520|617052349|FG003|Overall Study|Progressive disease|6|||
170739102|NCT01287520|617052350|FG004|Overall Study|Progressive disease|1|||
170739103|NCT01287520|617052351|FG005|Overall Study|Progressive disease|0|||
170739104|NCT01287520|617052352|FG006|Overall Study|Progressive disease|2|||
170739105|NCT01287520|617052353|FG007|Overall Study|Progressive disease|2|||
170739106|NCT01287520|617052354|FG008|Overall Study|Progressive disease|4|||
170739107|NCT01287520|617052346|FG000|Overall Study|Withdrawal by Subject|0|||
170739108|NCT01287520|617052347|FG001|Overall Study|Withdrawal by Subject|0|||
170739109|NCT01287520|617052348|FG002|Overall Study|Withdrawal by Subject|0|||
170739110|NCT01287520|617052349|FG003|Overall Study|Withdrawal by Subject|0|||
170739111|NCT01287520|617052350|FG004|Overall Study|Withdrawal by Subject|0|||
170739112|NCT01287520|617052351|FG005|Overall Study|Withdrawal by Subject|1|||
170739113|NCT01287520|617052352|FG006|Overall Study|Withdrawal by Subject|0|||
170739114|NCT01287520|617052353|FG007|Overall Study|Withdrawal by Subject|0|||
170848380|NCT03651622|617452237|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
170739115|NCT01287520|617052354|FG008|Overall Study|Withdrawal by Subject|1|||
170739116|NCT03673462|617052355|FG000|Overall Study|Adverse Event|11|||
170739117|NCT03673462|617052356|FG001|Overall Study|Adverse Event|1|||
170739118|NCT03673462|617052355|FG000|Overall Study|Protocol Violation|25|||
170739119|NCT03673462|617052356|FG001|Overall Study|Protocol Violation|11|||
170739120|NCT03673462|617052355|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
170739121|NCT03673462|617052356|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
170739122|NCT03673462|617052355|FG000|Overall Study|Lost to Follow-up|102|||
170739123|NCT03673462|617052356|FG001|Overall Study|Lost to Follow-up|19|||
170739124|NCT05061537|617052361|FG000|Treatment Phase|Progressive disease|0|||
170739125|NCT05061537|617052362|FG001|Treatment Phase|Progressive disease|1|||
170739126|NCT05061537|617052363|FG002|Treatment Phase|Progressive disease|2|||
170739127|NCT05061537|617052364|FG003|Treatment Phase|Progressive disease|0|||
170739128|NCT05061537|617052365|FG004|Treatment Phase|Progressive disease|0|||
170739129|NCT05061537|617052361|FG000|Treatment Phase|Adverse Event|0|||
170739130|NCT05061537|617052362|FG001|Treatment Phase|Adverse Event|0|||
170739131|NCT05061537|617052363|FG002|Treatment Phase|Adverse Event|2|||
170739132|NCT05061537|617052364|FG003|Treatment Phase|Adverse Event|0|||
170739133|NCT05061537|617052365|FG004|Treatment Phase|Adverse Event|0|||
170739134|NCT05061537|617052361|FG000|Treatment Phase|Global deterioration of health status|0|||
170739135|NCT05061537|617052362|FG001|Treatment Phase|Global deterioration of health status|1|||
170739136|NCT05061537|617052363|FG002|Treatment Phase|Global deterioration of health status|0|||
170739137|NCT05061537|617052364|FG003|Treatment Phase|Global deterioration of health status|0|||
170739138|NCT05061537|617052365|FG004|Treatment Phase|Global deterioration of health status|0|||
170739139|NCT05061537|617052361|FG000|Follow up|Other|2|||
170739140|NCT05061537|617052362|FG001|Follow up|Other|0|||
170739141|NCT05061537|617052363|FG002|Follow up|Other|2|||
170739142|NCT05061537|617052364|FG003|Follow up|Other|0|||
170739143|NCT05061537|617052365|FG004|Follow up|Other|0|||
170739144|NCT05061537|617052361|FG000|Follow up|Study terminated by sponsor|0|||
170739145|NCT05061537|617052362|FG001|Follow up|Study terminated by sponsor|0|||
170739146|NCT05061537|617052363|FG002|Follow up|Study terminated by sponsor|2|||
170739147|NCT05061537|617052364|FG003|Follow up|Study terminated by sponsor|0|||
170739148|NCT05061537|617052365|FG004|Follow up|Study terminated by sponsor|0|||
170739149|NCT05061537|617052361|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
170739150|NCT05061537|617052362|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
170739151|NCT05061537|617052363|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
170739152|NCT05061537|617052364|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
170739153|NCT05061537|617052365|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
170739154|NCT05061537|617052361|FG000|Long-term Follow-up|Death|0|||
170739155|NCT05061537|617052362|FG001|Long-term Follow-up|Death|1|||
170739156|NCT05061537|617052363|FG002|Long-term Follow-up|Death|0|||
170739157|NCT05061537|617052364|FG003|Long-term Follow-up|Death|0|||
170739158|NCT05061537|617052365|FG004|Long-term Follow-up|Death|0|||
170739159|NCT01616771|617052367|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
170739160|NCT04772053|617052377|FG000|Overall Study|Physician Decision|2|||
170739161|NCT04772053|617052377|FG000|Overall Study|Withdrawal by Subject|3|||
170739162|NCT04772053|617052377|FG000|Overall Study|Study Terminated by Sponsor|1|||
170739163|NCT00525265|617052378|FG000|Overall Study|Protocol Violation|1|||
170739164|NCT00525265|617052379|FG001|Overall Study|Protocol Violation|0|||
170739165|NCT00098254|617052382|FG000|Overall Study|Adverse Event|2|||
170739166|NCT00098254|617052382|FG000|Overall Study|Death|1|||
170739167|NCT02118337|617052383|FG000|Overall Study|Other|1|||
170739168|NCT02118337|617052384|FG001|Overall Study|Other|0|||
170739169|NCT02118337|617052385|FG002|Overall Study|Other|0|||
170739170|NCT02118337|617052386|FG003|Overall Study|Other|0|||
170739171|NCT02118337|617052387|FG004|Overall Study|Other|2|||
170739172|NCT02118337|617052388|FG005|Overall Study|Other|3|||
170739173|NCT02118337|617052389|FG006|Overall Study|Other|1|||
170739174|NCT02118337|617052390|FG007|Overall Study|Other|28|||
170739175|NCT02118337|617052391|FG008|Overall Study|Other|15|||
170739176|NCT02118337|617052383|FG000|Overall Study|Lost to Follow-up|0|||
170739177|NCT02118337|617052384|FG001|Overall Study|Lost to Follow-up|0|||
170739178|NCT02118337|617052385|FG002|Overall Study|Lost to Follow-up|0|||
170739179|NCT02118337|617052386|FG003|Overall Study|Lost to Follow-up|0|||
170739180|NCT02118337|617052387|FG004|Overall Study|Lost to Follow-up|0|||
170739181|NCT02118337|617052388|FG005|Overall Study|Lost to Follow-up|0|||
170739182|NCT02118337|617052389|FG006|Overall Study|Lost to Follow-up|0|||
170739183|NCT02118337|617052390|FG007|Overall Study|Lost to Follow-up|1|||
170739184|NCT02118337|617052391|FG008|Overall Study|Lost to Follow-up|0|||
170739185|NCT02118337|617052383|FG000|Overall Study|Withdrawal by Subject|1|||
170739186|NCT02118337|617052384|FG001|Overall Study|Withdrawal by Subject|3|||
170739187|NCT02118337|617052385|FG002|Overall Study|Withdrawal by Subject|2|||
170739188|NCT02118337|617052386|FG003|Overall Study|Withdrawal by Subject|1|||
170739189|NCT02118337|617052387|FG004|Overall Study|Withdrawal by Subject|2|||
170739190|NCT02118337|617052388|FG005|Overall Study|Withdrawal by Subject|2|||
170739191|NCT02118337|617052389|FG006|Overall Study|Withdrawal by Subject|1|||
170739192|NCT02118337|617052390|FG007|Overall Study|Withdrawal by Subject|4|||
170739193|NCT02118337|617052391|FG008|Overall Study|Withdrawal by Subject|2|||
170739194|NCT02118337|617052383|FG000|Overall Study|Death|2|||
170739195|NCT02118337|617052384|FG001|Overall Study|Death|2|||
170739196|NCT02118337|617052385|FG002|Overall Study|Death|1|||
170739197|NCT02118337|617052386|FG003|Overall Study|Death|2|||
170739198|NCT02118337|617052387|FG004|Overall Study|Death|5|||
170739199|NCT02118337|617052388|FG005|Overall Study|Death|1|||
170739200|NCT02118337|617052389|FG006|Overall Study|Death|2|||
170739201|NCT02118337|617052390|FG007|Overall Study|Death|9|||
170739202|NCT02118337|617052391|FG008|Overall Study|Death|4|||
170739203|NCT00130793|617052393|FG000|Overall Study|Lost to Follow-up|1|||
170739204|NCT00130793|617052394|FG001|Overall Study|Lost to Follow-up|4|||
170739205|NCT00130793|617052393|FG000|Overall Study|Withdrew consent|2|||
170739206|NCT00130793|617052394|FG001|Overall Study|Withdrew consent|0|||
170739207|NCT00211237|617052395|FG000|Baseline|Withdrew|1|||
170739208|NCT00211237|617052396|FG001|Baseline|Withdrew|3|||
170739209|NCT00211237|617052397|FG002|Baseline|Withdrew|0|||
170739210|NCT00211237|617052395|FG000|Baseline|Refused random assignment|1|||
170739211|NCT00211237|617052396|FG001|Baseline|Refused random assignment|0|||
170739212|NCT00211237|617052397|FG002|Baseline|Refused random assignment|0|||
170739213|NCT00211237|617052395|FG000|1 Month|Death|2|||
170739214|NCT00211237|617052396|FG001|1 Month|Death|1|||
170739215|NCT00211237|617052397|FG002|1 Month|Death|0|||
170739216|NCT00211237|617052395|FG000|1 Month|Lost to Follow-up|0|||
170739217|NCT00211237|617052396|FG001|1 Month|Lost to Follow-up|2|||
170739218|NCT00211237|617052397|FG002|1 Month|Lost to Follow-up|0|||
170739219|NCT00211237|617052395|FG000|1 Month|Withdrew|0|||
170739220|NCT00211237|617052396|FG001|1 Month|Withdrew|4|||
170739221|NCT00211237|617052397|FG002|1 Month|Withdrew|0|||
170739222|NCT00211237|617052395|FG000|1 Month|Additional surgery needed|1|||
170739223|NCT00211237|617052396|FG001|1 Month|Additional surgery needed|0|||
170739224|NCT00211237|617052397|FG002|1 Month|Additional surgery needed|0|||
170739225|NCT00211237|617052395|FG000|1 Month|Non-medical problem|0|||
170739226|NCT00211237|617052396|FG001|1 Month|Non-medical problem|2|||
170739227|NCT00211237|617052397|FG002|1 Month|Non-medical problem|0|||
170739228|NCT00211237|617052395|FG000|3 Months|Death|7|||
170739229|NCT00211237|617052396|FG001|3 Months|Death|3|||
170739230|NCT00211237|617052397|FG002|3 Months|Death|0|||
170739231|NCT00211237|617052395|FG000|3 Months|Could not comply with protocol|1|||
170739232|NCT00211237|617052396|FG001|3 Months|Could not comply with protocol|0|||
170739233|NCT00211237|617052397|FG002|3 Months|Could not comply with protocol|0|||
170739234|NCT00211237|617052395|FG000|3 Months|Withdrew|0|||
170739235|NCT00211237|617052396|FG001|3 Months|Withdrew|1|||
170739236|NCT00211237|617052397|FG002|3 Months|Withdrew|0|||
170739237|NCT00211237|617052395|FG000|3 Months|Non-medical problem|0|||
170739238|NCT00211237|617052396|FG001|3 Months|Non-medical problem|0|||
170739239|NCT00211237|617052397|FG002|3 Months|Non-medical problem|1|||
170739240|NCT00211237|617052395|FG000|6 Months|Death|6|||
170739241|NCT00211237|617052396|FG001|6 Months|Death|0|||
170739242|NCT00211237|617052397|FG002|6 Months|Death|3|||
170739243|NCT00211237|617052395|FG000|6 Months|Lost to Follow-up|2|||
170739244|NCT00211237|617052396|FG001|6 Months|Lost to Follow-up|0|||
170739245|NCT00211237|617052397|FG002|6 Months|Lost to Follow-up|0|||
170739246|NCT00211237|617052395|FG000|6 Months|Could not comply with protocol|0|||
170739247|NCT00211237|617052396|FG001|6 Months|Could not comply with protocol|2|||
170739248|NCT00211237|617052397|FG002|6 Months|Could not comply with protocol|0|||
170739249|NCT00211237|617052395|FG000|12 Months|Death|8|||
170739250|NCT00211237|617052396|FG001|12 Months|Death|2|||
170739251|NCT00211237|617052397|FG002|12 Months|Death|3|||
170739252|NCT00211237|617052395|FG000|12 Months|Lost to Follow-up|1|||
170739253|NCT00211237|617052396|FG001|12 Months|Lost to Follow-up|0|||
170739254|NCT00211237|617052397|FG002|12 Months|Lost to Follow-up|1|||
170739255|NCT00211237|617052395|FG000|12 Months|Withdrew|0|||
170739256|NCT00211237|617052396|FG001|12 Months|Withdrew|0|||
170739257|NCT00211237|617052397|FG002|12 Months|Withdrew|1|||
170739258|NCT00211237|617052395|FG000|12 Months|unrelated medical problem|0|||
170739259|NCT00211237|617052396|FG001|12 Months|unrelated medical problem|0|||
170739260|NCT00211237|617052397|FG002|12 Months|unrelated medical problem|1|||
170739261|NCT00453102|617052398|FG000|Overall Study|Withdrawal by Subject|2|||
170739262|NCT03728972|617052399|FG000|Overall Study|Death|1|||
170739263|NCT03728972|617052400|FG001|Overall Study|Death|0|||
170739264|NCT03728972|617052399|FG000|Overall Study|Lack of Efficacy|1|||
170739265|NCT03728972|617052400|FG001|Overall Study|Lack of Efficacy|0|||
170739266|NCT03728972|617052399|FG000|Overall Study|Physician Decision|3|||
170739267|NCT03728972|617052400|FG001|Overall Study|Physician Decision|0|||
170739268|NCT03728972|617052399|FG000|Overall Study|Disease progression|4|||
170739269|NCT03728972|617052400|FG001|Overall Study|Disease progression|3|||
170848381|NCT03651622|617452238|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
170848382|NCT03651622|617452239|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
170848383|NCT03651622|617452237|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
170848384|NCT03651622|617452238|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
170848385|NCT03651622|617452239|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
170848386|NCT03651622|617452237|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
170848387|NCT03651622|617452238|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
170848388|NCT03651622|617452239|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
170848389|NCT03651622|617452237|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
170848390|NCT03651622|617452238|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
170848391|NCT03651622|617452239|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
170848392|NCT01417104|617452246|FG000|Overall Study|Withdrawal by Subject|5|||
170848393|NCT01417104|617452247|FG001|Overall Study|Withdrawal by Subject|1|||
170848394|NCT01417104|617452246|FG000|Overall Study|Failure to make contact|0|||
170848395|NCT01417104|617452247|FG001|Overall Study|Failure to make contact|1|||
170848396|NCT01417104|617452246|FG000|Overall Study|Adverse Event|1|||
170848397|NCT01417104|617452247|FG001|Overall Study|Adverse Event|0|||
170848398|NCT00528931|617452248|FG000|Overall Study|Lost to Follow-up|1|||
170848399|NCT03122223|617452249|FG000|Overall Study|Withdrawal by Subject|2|||
170848400|NCT03122223|617452250|FG001|Overall Study|Withdrawal by Subject|2|||
170848401|NCT03122223|617452251|FG002|Overall Study|Withdrawal by Subject|1|||
170848402|NCT03122223|617452252|FG003|Overall Study|Withdrawal by Subject|0|||
170848403|NCT03122223|617452249|FG000|Overall Study|Lost to Follow-up|0|||
170848404|NCT03122223|617452250|FG001|Overall Study|Lost to Follow-up|2|||
170848405|NCT03122223|617452251|FG002|Overall Study|Lost to Follow-up|2|||
170848406|NCT03122223|617452252|FG003|Overall Study|Lost to Follow-up|0|||
170848407|NCT03122223|617452249|FG000|Overall Study|Participant unable to adhere|1|||
170848408|NCT03122223|617452250|FG001|Overall Study|Participant unable to adhere|1|||
170848409|NCT03122223|617452251|FG002|Overall Study|Participant unable to adhere|1|||
170848410|NCT03122223|617452252|FG003|Overall Study|Participant unable to adhere|0|||
170848411|NCT01489891|617452254|FG000|Overall Study|Endoscopy failure|1|||
170848412|NCT01489891|617452255|FG001|Overall Study|Endoscopy failure|0|||
170848413|NCT00532493|617452256|FG000|Overall Study|Death|1|||
170848414|NCT00532493|617452257|FG001|Overall Study|Death|1|||
170848415|NCT00532493|617452256|FG000|Overall Study|Lost to Follow-up|10|||
170848416|NCT00532493|617452257|FG001|Overall Study|Lost to Follow-up|7|||
170848417|NCT00532493|617452256|FG000|Overall Study|Withdrawal by Subject|7|||
170848418|NCT00532493|617452257|FG001|Overall Study|Withdrawal by Subject|9|||
170848419|NCT00532493|617452256|FG000|Overall Study|Physician Decision|1|||
170848420|NCT00532493|617452257|FG001|Overall Study|Physician Decision|6|||
170848421|NCT00532493|617452256|FG000|Overall Study|Adverse Event|6|||
170848422|NCT00532493|617452257|FG001|Overall Study|Adverse Event|5|||
170848423|NCT00532493|617452256|FG000|Overall Study|Protocol Deviation|1|||
170848424|NCT00532493|617452257|FG001|Overall Study|Protocol Deviation|0|||
170848425|NCT00532493|617452256|FG000|Overall Study|Subject Moved Away|3|||
170848426|NCT00532493|617452257|FG001|Overall Study|Subject Moved Away|1|||
170848427|NCT00532493|617452256|FG000|Overall Study|Contraindicative Medication|1|||
170848428|NCT00532493|617452257|FG001|Overall Study|Contraindicative Medication|0|||
170848429|NCT02045875|617452258|FG000|Overall Study|Lost to Follow-up|3|||
170848430|NCT02045875|617452259|FG001|Overall Study|Lost to Follow-up|0|||
170848431|NCT02045875|617452258|FG000|Overall Study|Withdrawal by Subject|4|||
170848432|NCT02045875|617452259|FG001|Overall Study|Withdrawal by Subject|3|||
170848433|NCT00948766|617452260|FG000|Core Study|Adverse Event|73|||
170848434|NCT00948766|617452261|FG001|Core Study|Adverse Event|51|||
170848435|NCT00948766|617452260|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
170848436|NCT00948766|617452261|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
170848437|NCT00948766|617452260|FG000|Core Study|Patient Withdrew Consent|27|||
170848438|NCT00948766|617452261|FG001|Core Study|Patient Withdrew Consent|46|||
170848439|NCT00948766|617452260|FG000|Core Study|Lost to Follow-up|3|||
170848440|NCT00948766|617452261|FG001|Core Study|Lost to Follow-up|2|||
170848441|NCT00948766|617452260|FG000|Core Study|Administrative Problems|2|||
170848442|NCT00948766|617452261|FG001|Core Study|Administrative Problems|2|||
170848443|NCT00948766|617452260|FG000|Core Study|Death|1|||
170848444|NCT00948766|617452261|FG001|Core Study|Death|1|||
170848445|NCT00948766|617452260|FG000|Core Study|Protocol Deviation|8|||
170848446|NCT00948766|617452261|FG001|Core Study|Protocol Deviation|10|||
170848447|NCT00948766|617452260|FG000|Extension Study|Adverse Event|43|||
170848448|NCT00948766|617452261|FG001|Extension Study|Adverse Event|0|||
170848449|NCT00948766|617452260|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
170848450|NCT00948766|617452261|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
170848451|NCT00948766|617452260|FG000|Extension Study|Study Drug No Longer Required|1|||
170848452|NCT00948766|617452261|FG001|Extension Study|Study Drug No Longer Required|0|||
170848453|NCT00948766|617452260|FG000|Extension Study|Patient Withdrew Consent|32|||
170848454|NCT00948766|617452261|FG001|Extension Study|Patient Withdrew Consent|0|||
170848455|NCT00948766|617452260|FG000|Extension Study|Lost to Follow-up|8|||
170848456|NCT00948766|617452261|FG001|Extension Study|Lost to Follow-up|0|||
170848457|NCT00948766|617452260|FG000|Extension Study|Administrative Problems|1|||
170848458|NCT00948766|617452261|FG001|Extension Study|Administrative Problems|0|||
170848459|NCT00948766|617452260|FG000|Extension Study|Death|4|||
170848460|NCT00948766|617452261|FG001|Extension Study|Death|0|||
170848461|NCT02153073|617452264|FG000|Overall Study|Case Report Forms Uncollected|230|||
170848462|NCT02153073|617452264|FG000|Overall Study|Protocol Deviation|68|||
170848463|NCT03702231|617452265|FG000|Overall Study|Withdrawal by Subject|1|||
170848464|NCT03702231|617452266|FG001|Overall Study|Withdrawal by Subject|0|||
170848465|NCT03702231|617452267|FG002|Overall Study|Withdrawal by Subject|0|||
170848466|NCT03702231|617452265|FG000|Overall Study|Protocol Violation|0|||
170848467|NCT03702231|617452266|FG001|Overall Study|Protocol Violation|0|||
170848468|NCT03702231|617452267|FG002|Overall Study|Protocol Violation|1|||
170848469|NCT03702231|617452265|FG000|Overall Study|Change in CLL Treatment|0|||
170848470|NCT03702231|617452266|FG001|Overall Study|Change in CLL Treatment|0|||
170848471|NCT03702231|617452267|FG002|Overall Study|Change in CLL Treatment|1|||
170848472|NCT03702231|617452265|FG000|Overall Study|COVID Pandemic|1|||
170848473|NCT03702231|617452266|FG001|Overall Study|COVID Pandemic|4|||
170848474|NCT03702231|617452267|FG002|Overall Study|COVID Pandemic|1|||
170848475|NCT03702231|617452265|FG000|Overall Study|Non-compliance|0|||
170848476|NCT03702231|617452266|FG001|Overall Study|Non-compliance|0|||
170848477|NCT03702231|617452267|FG002|Overall Study|Non-compliance|1|||
170848478|NCT02729831|617452268|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
170848479|NCT02729831|617452269|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
170848480|NCT02729831|617452270|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
170848481|NCT02729831|617452271|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
170848482|NCT02729831|617452268|FG000|1 Week Post-visit|Lost to Follow-up|43|||
170848483|NCT02729831|617452269|FG001|1 Week Post-visit|Lost to Follow-up|40|||
170848484|NCT02729831|617452270|FG002|1 Week Post-visit|Lost to Follow-up|38|||
170848485|NCT02729831|617452271|FG003|1 Week Post-visit|Lost to Follow-up|36|||
170848486|NCT02729831|617452268|FG000|6 Month Follow-up|Lost to Follow-up|54|||
170848487|NCT02729831|617452269|FG001|6 Month Follow-up|Lost to Follow-up|51|||
170848488|NCT02729831|617452270|FG002|6 Month Follow-up|Lost to Follow-up|48|||
170848489|NCT02729831|617452271|FG003|6 Month Follow-up|Lost to Follow-up|42|||
170848490|NCT02729831|617452268|FG000|6 Month Follow-up|Death|1|||
170848491|NCT02729831|617452269|FG001|6 Month Follow-up|Death|3|||
170848492|NCT02729831|617452270|FG002|6 Month Follow-up|Death|0|||
170848493|NCT02729831|617452271|FG003|6 Month Follow-up|Death|1|||
170848494|NCT00864253|617452272|FG000|Overall Study|Adverse Event|56|||
170848495|NCT00864253|617452273|FG001|Overall Study|Adverse Event|11|||
170848496|NCT00864253|617452272|FG000|Overall Study|Unrelated Adverse Event|3|||
170848497|NCT00864253|617452273|FG001|Overall Study|Unrelated Adverse Event|1|||
170848498|NCT00864253|617452272|FG000|Overall Study|Physician Decision|11|||
170848499|NCT00864253|617452273|FG001|Overall Study|Physician Decision|15|||
170848500|NCT00864253|617452272|FG000|Overall Study|Protocol Violation|0|||
170848501|NCT00864253|617452273|FG001|Overall Study|Protocol Violation|2|||
170848502|NCT00864253|617452272|FG000|Overall Study|Lost to Follow-up|1|||
170848503|NCT00864253|617452273|FG001|Overall Study|Lost to Follow-up|1|||
170848504|NCT00864253|617452272|FG000|Overall Study|Withdrawal by Subject|18|||
170848505|NCT00864253|617452273|FG001|Overall Study|Withdrawal by Subject|18|||
170848506|NCT00864253|617452272|FG000|Overall Study|Death|1|||
170848507|NCT00864253|617452273|FG001|Overall Study|Death|0|||
170848508|NCT00864253|617452272|FG000|Overall Study|Ongoing|2|||
170848509|NCT00864253|617452273|FG001|Overall Study|Ongoing|3|||
170848510|NCT00864253|617452272|FG000|Overall Study|Untreated|7|||
170848511|NCT00864253|617452273|FG001|Overall Study|Untreated|7|||
170848512|NCT01747551|617452275|FG000|Overall Study|Progressive Disease|24|||
170848513|NCT01747551|617452276|FG001|Overall Study|Progressive Disease|17|||
170848514|NCT01747551|617452275|FG000|Overall Study|Death|3|||
170848515|NCT01747551|617452276|FG001|Overall Study|Death|1|||
170848516|NCT01747551|617452275|FG000|Overall Study|Adverse Event|7|||
170848517|NCT01747551|617452276|FG001|Overall Study|Adverse Event|1|||
170848518|NCT01747551|617452275|FG000|Overall Study|Prolonged Treatment Delay|2|||
170848519|NCT01747551|617452276|FG001|Overall Study|Prolonged Treatment Delay|0|||
170848520|NCT01747551|617452275|FG000|Overall Study|Withdrawal by Subject|3|||
170848521|NCT01747551|617452276|FG001|Overall Study|Withdrawal by Subject|1|||
170848522|NCT01747551|617452275|FG000|Overall Study|Physician Decision|2|||
170848523|NCT01747551|617452276|FG001|Overall Study|Physician Decision|1|||
170848524|NCT01747551|617452275|FG000|Overall Study|Other|2|||
170848525|NCT01747551|617452276|FG001|Overall Study|Other|0|||
170848526|NCT02091206|617452277|FG000|Treatment Period|Adverse Event|0|||
170739270|NCT01650519|617052410|FG000|Overall Study|Withdrawal by Subject|1|||
170739271|NCT01650519|617052411|FG001|Overall Study|Withdrawal by Subject|0|||
170739272|NCT04000594|617052412|FG000|Overall Study|Withdrawal by Subject|1|||
170739273|NCT04000594|617052413|FG001|Overall Study|Withdrawal by Subject|0|||
170739274|NCT04000594|617052414|FG002|Overall Study|Withdrawal by Subject|0|||
170739275|NCT05807919|617052415|FG000|Overall Study|Received antibiotics - excluded|0|||
170739276|NCT05807919|617052416|FG001|Overall Study|Received antibiotics - excluded|1|||
170739277|NCT05807919|617052415|FG000|Overall Study|Withdrawal by Subject|0|||
170739278|NCT05807919|617052416|FG001|Overall Study|Withdrawal by Subject|3|||
170739279|NCT05807919|617052415|FG000|Overall Study|Adverse Event|1|||
170739280|NCT05807919|617052416|FG001|Overall Study|Adverse Event|1|||
170739281|NCT00747123|617052417|FG000|Overall Study|Investigator's request|0|||
170739282|NCT00747123|617052418|FG001|Overall Study|Investigator's request|0|||
170739283|NCT00747123|617052419|FG002|Overall Study|Investigator's request|1|||
170739284|NCT00747123|617052420|FG003|Overall Study|Investigator's request|0|||
170739285|NCT00747123|617052417|FG000|Overall Study|Withdrew consent|0|||
170739286|NCT00747123|617052418|FG001|Overall Study|Withdrew consent|1|||
170739287|NCT00747123|617052419|FG002|Overall Study|Withdrew consent|0|||
170739288|NCT00747123|617052420|FG003|Overall Study|Withdrew consent|0|||
170739289|NCT00747123|617052417|FG000|Overall Study|Adverse Event|0|||
170739290|NCT00747123|617052418|FG001|Overall Study|Adverse Event|1|||
170739291|NCT00747123|617052419|FG002|Overall Study|Adverse Event|0|||
170739292|NCT00747123|617052420|FG003|Overall Study|Adverse Event|1|||
170739293|NCT03489057|617052425|FG000|Overall Study|Lost to Follow-up|16|||
170739294|NCT03489057|617052426|FG001|Overall Study|Lost to Follow-up|16|||
170739295|NCT03489057|617052427|FG002|Overall Study|Lost to Follow-up|14|||
170739296|NCT03489057|617052428|FG003|Overall Study|Lost to Follow-up|14|||
170739297|NCT03489057|617052425|FG000|Overall Study|Withdrawal by Subject|12|||
170739298|NCT03489057|617052426|FG001|Overall Study|Withdrawal by Subject|12|||
170739299|NCT03489057|617052427|FG002|Overall Study|Withdrawal by Subject|8|||
170739300|NCT03489057|617052428|FG003|Overall Study|Withdrawal by Subject|8|||
170739301|NCT03489057|617052425|FG000|Overall Study|Protocol Violation|7|||
170739302|NCT03489057|617052426|FG001|Overall Study|Protocol Violation|7|||
170739303|NCT03489057|617052427|FG002|Overall Study|Protocol Violation|2|||
170739304|NCT03489057|617052428|FG003|Overall Study|Protocol Violation|2|||
170739305|NCT02277743|617052431|FG000|Overall Study|Protocol Violation|1|||
170739306|NCT02277743|617052432|FG001|Overall Study|Protocol Violation|1|||
170739307|NCT02277743|617052433|FG002|Overall Study|Protocol Violation|1|||
170739308|NCT02277743|617052431|FG000|Overall Study|Adverse Event|10|||
170739309|NCT02277743|617052432|FG001|Overall Study|Adverse Event|6|||
170739310|NCT02277743|617052433|FG002|Overall Study|Adverse Event|6|||
170739311|NCT02277743|617052431|FG000|Overall Study|Lack of Efficacy|11|||
170848527|NCT02091206|617452278|FG001|Treatment Period|Adverse Event|1|||
170848528|NCT02091206|617452279|FG002|Treatment Period|Adverse Event|0|||
170848529|NCT02091206|617452280|FG003|Treatment Period|Adverse Event|0|||
170848530|NCT02091206|617452277|FG000|Treatment Period|Met withdrawal criteria|0|||
170848531|NCT02091206|617452278|FG001|Treatment Period|Met withdrawal criteria|0|||
170848532|NCT02091206|617452279|FG002|Treatment Period|Met withdrawal criteria|1|||
170848533|NCT02091206|617452280|FG003|Treatment Period|Met withdrawal criteria|0|||
170848534|NCT02091206|617452277|FG000|Taper Period|Participant refused study drug|1|||
170848535|NCT02091206|617452278|FG001|Taper Period|Participant refused study drug|0|||
170848536|NCT02091206|617452279|FG002|Taper Period|Participant refused study drug|0|||
170848537|NCT02091206|617452280|FG003|Taper Period|Participant refused study drug|1|||
170848538|NCT02091206|617452277|FG000|Taper Period|Lost to Follow-up|0|||
170848539|NCT02091206|617452278|FG001|Taper Period|Lost to Follow-up|0|||
170848540|NCT02091206|617452279|FG002|Taper Period|Lost to Follow-up|0|||
170848541|NCT02091206|617452280|FG003|Taper Period|Lost to Follow-up|1|||
170848542|NCT02738853|617452284|FG000|Enrollment|Inclusion/Exclusion not met|21|||
170848543|NCT02738853|617452284|FG000|Enrollment|Withdrawal by Subject|3|||
170848544|NCT02738853|617452284|FG000|Enrollment|Subject treated with commercially available device|6|||
170848545|NCT02738853|617452284|FG000|Enrollment|Study Enrollment Closed|3|||
170848546|NCT02738853|617452284|FG000|Procedure|Death|1|||
170848547|NCT02738853|617452284|FG000|1 Month|Death|2|||
170848548|NCT02738853|617452284|FG000|6 Month|Death|4|||
170848549|NCT02738853|617452284|FG000|6 Month|Withdrawal by Subject|2|||
170848550|NCT02738853|617452284|FG000|1 Year|Death|6|||
170848551|NCT02738853|617452284|FG000|1 Year|Withdrawal by Subject|1|||
170848552|NCT02738853|617452284|FG000|2 Year|Death|2|||
170848553|NCT02738853|617452284|FG000|2 Year|Lost to Follow-up|1|||
170848554|NCT02738853|617452284|FG000|3 Year|Death|2|||
170848555|NCT02738853|617452284|FG000|3 Year|Withdrawal by Subject|1|||
170848556|NCT02738853|617452284|FG000|4 Year|Death|9|||
170848557|NCT02738853|617452284|FG000|5 Year|Lost to Follow-up|4|||
170739312|NCT02277743|617052432|FG001|Overall Study|Lack of Efficacy|4|||
170739313|NCT02277743|617052433|FG002|Overall Study|Lack of Efficacy|3|||
170739314|NCT02277743|617052431|FG000|Overall Study|Other than specified above|18|||
170739315|NCT02277743|617052432|FG001|Overall Study|Other than specified above|5|||
170739316|NCT02277743|617052433|FG002|Overall Study|Other than specified above|16|||
170739317|NCT01224158|617052434|FG000|Overall Study|Withdrawal by Subject|1|||
170739318|NCT01224158|617052435|FG001|Overall Study|Withdrawal by Subject|0|||
170739319|NCT03976466|617052436|FG000|Overall Study|Lost to Follow-up|1|||
170739320|NCT03976466|617052437|FG001|Overall Study|Lost to Follow-up|3|||
170739321|NCT02034708|617052438|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
170739322|NCT02034708|617052439|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
170739323|NCT02034708|617052438|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
170739324|NCT02034708|617052439|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
170739325|NCT02034708|617052438|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
170739326|NCT02034708|617052439|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
170739327|NCT02034708|617052438|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
170739328|NCT02034708|617052439|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
170739329|NCT00733499|617052440|FG000|Pre-operative|Protocol Violation|0|||
170739330|NCT00733499|617052441|FG001|Pre-operative|Protocol Violation|1|||
170739331|NCT00733499|617052440|FG000|3 Months Follow-up|Death|1|||
170739332|NCT00733499|617052441|FG001|3 Months Follow-up|Death|2|||
170739333|NCT00733499|617052440|FG000|6 Months Follow-up|Death|0|||
170739334|NCT00733499|617052441|FG001|6 Months Follow-up|Death|2|||
170739335|NCT00733499|617052440|FG000|6 Months Follow-up|Adverse Event|0|||
170739336|NCT00733499|617052441|FG001|6 Months Follow-up|Adverse Event|1|||
170739337|NCT00733499|617052440|FG000|12 Months Follow-up|Death|2|||
170739338|NCT00733499|617052441|FG001|12 Months Follow-up|Death|1|||
170739339|NCT00733499|617052440|FG000|24 Months Follow-up|Death|0|||
170739340|NCT00733499|617052441|FG001|24 Months Follow-up|Death|1|||
170739341|NCT00733499|617052440|FG000|5 Year Followup|Adverse Event|2|||
170739342|NCT00733499|617052441|FG001|5 Year Followup|Adverse Event|2|||
170739343|NCT00733499|617052440|FG000|5 Year Followup|Non device related AE|0|||
170739344|NCT00733499|617052441|FG001|5 Year Followup|Non device related AE|1|||
170739345|NCT00733499|617052440|FG000|5 Year Followup|Revision of Study Implant|0|||
170739346|NCT00733499|617052441|FG001|5 Year Followup|Revision of Study Implant|1|||
170739347|NCT00733499|617052440|FG000|5 Year Followup|Lost to Follow-up|2|||
170739348|NCT00733499|617052441|FG001|5 Year Followup|Lost to Follow-up|0|||
170739349|NCT00733499|617052440|FG000|5 Year Followup|Death|13|||
170739350|NCT00733499|617052441|FG001|5 Year Followup|Death|19|||
170739351|NCT00733499|617052440|FG000|5 Year Followup|missing, unable to locate|0|||
170739352|NCT00733499|617052441|FG001|5 Year Followup|missing, unable to locate|1|||
170739353|NCT00733499|617052440|FG000|5 Year Followup|Withdrawal by Subject|4|||
170739354|NCT00733499|617052441|FG001|5 Year Followup|Withdrawal by Subject|1|||
170739355|NCT00733499|617052440|FG000|10 Year Followup|Death|9|||
170739356|NCT00733499|617052441|FG001|10 Year Followup|Death|7|||
170739357|NCT00733499|617052440|FG000|10 Year Followup|Adverse Event|3|||
170739358|NCT00733499|617052441|FG001|10 Year Followup|Adverse Event|3|||
170739359|NCT00733499|617052440|FG000|10 Year Followup|Lost to Follow-up|3|||
170739360|NCT00733499|617052441|FG001|10 Year Followup|Lost to Follow-up|2|||
170739361|NCT00733499|617052440|FG000|10 Year Followup|Withdrawal by Subject|5|||
170739362|NCT00733499|617052441|FG001|10 Year Followup|Withdrawal by Subject|5|||
170739363|NCT00733499|617052440|FG000|10 Year Followup|missing, unable to locate|0|||
170739364|NCT00733499|617052441|FG001|10 Year Followup|missing, unable to locate|2|||
170739365|NCT00943306|617052442|FG000|Overall Study|Physician Decision|1|||
170739366|NCT00943306|617052442|FG000|Overall Study|Death|1|||
170739367|NCT00943306|617052442|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
170848558|NCT00680992|617452285|FG000|Overall Study|Complete Resection (as per protocol)|25|||
170848559|NCT00680992|617452286|FG001|Overall Study|Complete Resection (as per protocol)|121|||
170848560|NCT00680992|617452287|FG002|Overall Study|Complete Resection (as per protocol)|0|||
170848561|NCT00680992|617452285|FG000|Overall Study|Administrative Decision|83|||
170848562|NCT00680992|617452286|FG001|Overall Study|Administrative Decision|42|||
170848563|NCT00680992|617452287|FG002|Overall Study|Administrative Decision|5|||
170848564|NCT00680992|617452285|FG000|Overall Study|End of Trial|32|||
170848565|NCT00680992|617452286|FG001|Overall Study|End of Trial|12|||
170848566|NCT00680992|617452287|FG002|Overall Study|End of Trial|3|||
170848567|NCT00680992|617452285|FG000|Overall Study|Withdrawal by Subject|33|||
170848568|NCT00680992|617452286|FG001|Overall Study|Withdrawal by Subject|11|||
170739368|NCT00733980|617052443|FG000|Overall Study|Adverse Event|5|||
170739369|NCT00733980|617052444|FG001|Overall Study|Adverse Event|2|||
170739370|NCT00733980|617052443|FG000|Overall Study|Lack of Efficacy|0|||
170848569|NCT00680992|617452287|FG002|Overall Study|Withdrawal by Subject|1|||
170848570|NCT00680992|617452285|FG000|Overall Study|Adverse Event|21|||
170848571|NCT00680992|617452286|FG001|Overall Study|Adverse Event|19|||
170848572|NCT00680992|617452287|FG002|Overall Study|Adverse Event|1|||
170848573|NCT00680992|617452285|FG000|Overall Study|Other|19|||
170848574|NCT00680992|617452286|FG001|Overall Study|Other|14|||
170848575|NCT00680992|617452287|FG002|Overall Study|Other|1|||
170848576|NCT00680992|617452285|FG000|Overall Study|Disease Progression|21|||
170848577|NCT00680992|617452286|FG001|Overall Study|Disease Progression|9|||
170848578|NCT00680992|617452287|FG002|Overall Study|Disease Progression|0|||
170848579|NCT00680992|617452285|FG000|Overall Study|Lost to Follow-up|12|||
170848580|NCT00680992|617452286|FG001|Overall Study|Lost to Follow-up|14|||
170848581|NCT00680992|617452287|FG002|Overall Study|Lost to Follow-up|0|||
170848582|NCT00680992|617452285|FG000|Overall Study|Noncompliance|4|||
170848583|NCT00680992|617452286|FG001|Overall Study|Noncompliance|6|||
170848584|NCT00680992|617452287|FG002|Overall Study|Noncompliance|0|||
170848585|NCT00680992|617452285|FG000|Overall Study|Requirement for Alternative Therapy|8|||
170848586|NCT00680992|617452286|FG001|Overall Study|Requirement for Alternative Therapy|2|||
170848587|NCT00680992|617452287|FG002|Overall Study|Requirement for Alternative Therapy|0|||
170848588|NCT00680992|617452285|FG000|Overall Study|Pregnancy|5|||
170848589|NCT00680992|617452286|FG001|Overall Study|Pregnancy|0|||
170848590|NCT00680992|617452287|FG002|Overall Study|Pregnancy|1|||
170848591|NCT00680992|617452285|FG000|Overall Study|Death|5|||
170848592|NCT00680992|617452286|FG001|Overall Study|Death|1|||
170848593|NCT00680992|617452287|FG002|Overall Study|Death|0|||
170848594|NCT00680992|617452285|FG000|Overall Study|Ineligibility Determined|0|||
170848595|NCT00680992|617452286|FG001|Overall Study|Ineligibility Determined|1|||
170848596|NCT00680992|617452287|FG002|Overall Study|Ineligibility Determined|0|||
170848597|NCT00607724|617452292|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
170848598|NCT00607724|617452293|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
170848599|NCT00607724|617452294|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
170848600|NCT00607724|617452295|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
170848601|NCT00607724|617452296|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
170848602|NCT00607724|617452297|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
170848603|NCT00607724|617452298|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
170848604|NCT00607724|617452292|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
170848605|NCT00607724|617452293|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
170848606|NCT00607724|617452294|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
170848607|NCT00607724|617452295|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
170848608|NCT00607724|617452296|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
170848609|NCT00607724|617452297|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
170848610|NCT00607724|617452298|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
170848611|NCT00607724|617452292|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
170848612|NCT00607724|617452293|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
170848613|NCT00607724|617452294|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
170848614|NCT00607724|617452295|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
170848615|NCT00607724|617452296|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
170848616|NCT00607724|617452297|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
170848617|NCT00607724|617452298|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
170848618|NCT00607724|617452292|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
170848619|NCT00607724|617452293|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
170848620|NCT00607724|617452294|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
170848621|NCT00607724|617452295|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
170848622|NCT00607724|617452296|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
170848623|NCT00607724|617452297|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
170848624|NCT00607724|617452298|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
170848625|NCT00607724|617452292|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
170848626|NCT00607724|617452293|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
170848627|NCT00607724|617452294|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
170848628|NCT00607724|617452295|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
170848629|NCT00607724|617452296|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
170848630|NCT00607724|617452297|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
170848631|NCT00607724|617452298|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
170848632|NCT02914275|617453445|FG000|Overall Study|Lost to Follow-up|84|||
170848633|NCT02914275|617453446|FG001|Overall Study|Lost to Follow-up|29|||
170848634|NCT02914275|617453445|FG000|Overall Study|Withdrawal by Subject|26|||
170848635|NCT02914275|617453446|FG001|Overall Study|Withdrawal by Subject|10|||
170848636|NCT02914275|617453445|FG000|Overall Study|Protocol Violation|1|||
170848637|NCT02914275|617453446|FG001|Overall Study|Protocol Violation|1|||
170848638|NCT02914275|617453445|FG000|Overall Study|Physician Decision|3|||
170848639|NCT02914275|617453446|FG001|Overall Study|Physician Decision|1|||
170848640|NCT02914275|617453445|FG000|Overall Study|Other|4|||
170848641|NCT02914275|617453446|FG001|Overall Study|Other|1|||
170848642|NCT02914275|617453445|FG000|Overall Study|Excluded due to invalid informed consent|3|||
170848643|NCT02914275|617453446|FG001|Overall Study|Excluded due to invalid informed consent|0|||
170848644|NCT02134977|617453447|FG000|Overall Study|Protocol Deviation|102|||
170848645|NCT01639495|617453448|FG000|Overall Study|Lost to Follow-up|6|||
170848646|NCT01639495|617453448|FG000|Overall Study|Consented but didn't have study catheter|4|||
170848647|NCT01639495|617453448|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
170848648|NCT01639495|617453448|FG000|Overall Study|No radiofrequency energy applied|2|||
170848649|NCT01119105|617453449|FG000|Overall Study|Withdrawal by Subject|1|||
170848650|NCT01119105|617453450|FG001|Overall Study|Withdrawal by Subject|1|||
170848651|NCT01119105|617453451|FG002|Overall Study|Withdrawal by Subject|1|||
170848652|NCT01119105|617453449|FG000|Overall Study|Lost to Follow-up|0|||
170848653|NCT01119105|617453450|FG001|Overall Study|Lost to Follow-up|2|||
170848654|NCT01119105|617453451|FG002|Overall Study|Lost to Follow-up|5|||
170848655|NCT01119105|617453449|FG000|Overall Study|Adverse Event|1|||
170848656|NCT01119105|617453450|FG001|Overall Study|Adverse Event|0|||
170848657|NCT01119105|617453451|FG002|Overall Study|Adverse Event|1|||
170848658|NCT01119105|617453449|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
170848659|NCT01119105|617453450|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
170848660|NCT01119105|617453451|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
170848661|NCT01119105|617453449|FG000|Overall Study|Other|1|||
170848662|NCT01119105|617453450|FG001|Overall Study|Other|1|||
170848663|NCT01119105|617453451|FG002|Overall Study|Other|0|||
170848664|NCT03828747|617453452|FG000|Double-Blind Treatment Period|Adverse Event|6|||
170848665|NCT03828747|617453453|FG001|Double-Blind Treatment Period|Adverse Event|6|||
170848666|NCT03828747|617453452|FG000|Double-Blind Treatment Period|Death|1|||
170848667|NCT03828747|617453453|FG001|Double-Blind Treatment Period|Death|1|||
170848668|NCT03828747|617453452|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170848669|NCT03828747|617453453|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
170848670|NCT03828747|617453452|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
170848671|NCT03828747|617453453|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
170848672|NCT03828747|617453452|FG000|Double-Blind Treatment Period|Physician Decision|1|||
170848673|NCT03828747|617453453|FG001|Double-Blind Treatment Period|Physician Decision|4|||
170848674|NCT03828747|617453452|FG000|Double-Blind Treatment Period|Various reasons|5|||
170848675|NCT03828747|617453453|FG001|Double-Blind Treatment Period|Various reasons|3|||
170739371|NCT00733980|617052444|FG001|Overall Study|Lack of Efficacy|1|||
170739372|NCT00733980|617052443|FG000|Overall Study|Protocol Violation|2|||
170739373|NCT00733980|617052444|FG001|Overall Study|Protocol Violation|1|||
170739374|NCT00733980|617052443|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
170739375|NCT00733980|617052444|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
170739376|NCT00733980|617052443|FG000|Overall Study|Lost to Follow-up|6|||
170739377|NCT00733980|617052444|FG001|Overall Study|Lost to Follow-up|11|||
170739378|NCT00733980|617052443|FG000|Overall Study|Physician Decision|2|||
170739379|NCT00733980|617052444|FG001|Overall Study|Physician Decision|3|||
170739380|NCT00733980|617052443|FG000|Overall Study|Withdrawal by Subject|6|||
170739381|NCT00733980|617052444|FG001|Overall Study|Withdrawal by Subject|2|||
170739382|NCT01552954|617052445|FG000|Overall Study|Adverse Event|1|||
170739383|NCT01552954|617052446|FG001|Overall Study|Adverse Event|2|||
170739384|NCT01552954|617052445|FG000|Overall Study|Lost to Follow-up|1|||
170739385|NCT01552954|617052446|FG001|Overall Study|Lost to Follow-up|1|||
170739386|NCT01552954|617052445|FG000|Overall Study|Withdrawal by Subject|1|||
170739387|NCT01552954|617052446|FG001|Overall Study|Withdrawal by Subject|1|||
170739388|NCT01552954|617052445|FG000|Overall Study|Protocol Violation|1|||
170739389|NCT01552954|617052446|FG001|Overall Study|Protocol Violation|2|||
170739390|NCT01552954|617052445|FG000|Overall Study|diagnosed DM|1|||
170739391|NCT01552954|617052446|FG001|Overall Study|diagnosed DM|0|||
170739392|NCT00779779|617052447|FG000|Overall Study|Adverse Event|1|||
170739393|NCT00779779|617052447|FG000|Overall Study|Protocol Violation|14|||
170739394|NCT00779779|617052447|FG000|Overall Study|Withdrawal by Subject|4|||
170739395|NCT00779779|617052447|FG000|Overall Study|Lost to Follow-up|5|||
170739396|NCT01395823|617052448|FG000|Overall Study|Death|4|||
170739397|NCT01395823|617052449|FG001|Overall Study|Death|4|||
170739398|NCT01395823|617052448|FG000|Overall Study|Physician Decision|3|||
170739399|NCT01395823|617052449|FG001|Overall Study|Physician Decision|1|||
170739400|NCT01395823|617052448|FG000|Overall Study|Lost to Follow-up|1|||
170739401|NCT01395823|617052449|FG001|Overall Study|Lost to Follow-up|0|||
170739402|NCT01395823|617052448|FG000|Overall Study|Transplant|1|||
170739403|NCT01395823|617052449|FG001|Overall Study|Transplant|0|||
170739404|NCT01395823|617052448|FG000|Overall Study|GI symptoms|1|||
170848676|NCT03828747|617453452|FG000|Open-Label Extension|Adverse Event|9|||
170739405|NCT01395823|617052449|FG001|Overall Study|GI symptoms|0|||
170739406|NCT01395823|617052448|FG000|Overall Study|Withdrawal by Subject|5|||
170739407|NCT01395823|617052449|FG001|Overall Study|Withdrawal by Subject|4|||
170739408|NCT02719990|617052453|FG000|Overall Study|Physician Decision|2|||
170739409|NCT02719990|617052453|FG000|Overall Study|Withdrawal by Subject|2|||
170739410|NCT02719990|617052453|FG000|Overall Study|Study Terminated By Sponsor|32|||
170739411|NCT01778556|617052454|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
170739412|NCT01778556|617052455|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
170739413|NCT01778556|617052454|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
170739414|NCT01778556|617052455|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
170739415|NCT01778556|617052454|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
170739416|NCT01778556|617052455|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
170739417|NCT01778556|617052454|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
170739418|NCT01778556|617052455|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
170739419|NCT03324880|617052456|FG000|Overall Study|Adverse Event|0|||
170739420|NCT03324880|617052457|FG001|Overall Study|Adverse Event|2|||
170739421|NCT03324880|617052456|FG000|Overall Study|Withdrawal by Subject|2|||
170739422|NCT03324880|617052457|FG001|Overall Study|Withdrawal by Subject|2|||
170739423|NCT03324880|617052456|FG000|Overall Study|Lost to Follow-up|0|||
170739424|NCT03324880|617052457|FG001|Overall Study|Lost to Follow-up|1|||
170739425|NCT03324880|617052456|FG000|Overall Study|Product Recall|0|||
170739426|NCT03324880|617052457|FG001|Overall Study|Product Recall|1|||
170739427|NCT00652938|617052458|FG000|Overall Study|Adverse Event|1|||
170739428|NCT00652938|617052459|FG001|Overall Study|Adverse Event|0|||
170739429|NCT00652938|617052460|FG002|Overall Study|Adverse Event|2|||
170739430|NCT00652938|617052458|FG000|Overall Study|Withdrawal by Subject|0|||
170739431|NCT00652938|617052459|FG001|Overall Study|Withdrawal by Subject|6|||
170739432|NCT00652938|617052460|FG002|Overall Study|Withdrawal by Subject|1|||
170739433|NCT00652938|617052458|FG000|Overall Study|Lost to Follow-up|0|||
170739434|NCT00652938|617052459|FG001|Overall Study|Lost to Follow-up|0|||
170739435|NCT00652938|617052460|FG002|Overall Study|Lost to Follow-up|2|||
170739436|NCT00652938|617052458|FG000|Overall Study|fear of blood sampling|0|||
170739437|NCT00652938|617052459|FG001|Overall Study|fear of blood sampling|1|||
170739438|NCT00652938|617052460|FG002|Overall Study|fear of blood sampling|0|||
170739439|NCT00116272|617052461|FG000|Overall Study|Lost to Follow-up|11|||
170739440|NCT00116272|617052462|FG001|Overall Study|Lost to Follow-up|6|||
170739441|NCT01235403|617052464|FG000|Overall Study|Adverse Event|14|||
170739442|NCT01235403|617052464|FG000|Overall Study|Lost to Follow-up|2|||
170739443|NCT01235403|617052464|FG000|Overall Study|Withdrawal by Subject|4|||
170739444|NCT01235403|617052464|FG000|Overall Study|Lack of Efficacy|2|||
170739445|NCT01235403|617052464|FG000|Overall Study|Other reasons for premature termination|4|||
170739446|NCT00782496|617052466|FG000|Overall Study|Lost to Follow-up|14|||
170739447|NCT00782496|617052467|FG001|Overall Study|Lost to Follow-up|15|||
170739448|NCT02087501|617052468|FG000|Overall Study|Death|7|||
170739449|NCT02087501|617052468|FG000|Overall Study|Open repair of aneurysm|1|||
170739450|NCT02087501|617052468|FG000|Overall Study|Lost to Follow-up|2|||
170739451|NCT00094328|617052471|FG000|Overall Study|Lost to Follow-up|1|||
170739452|NCT02213328|617052472|FG000|Overall Study|Withdrawal by Subject|10|||
170739453|NCT02213328|617052472|FG000|Overall Study|Physician Decision|2|||
170739454|NCT02213328|617052472|FG000|Overall Study|Lost to Follow-up|16|||
170739455|NCT01686581|617052477|FG000|Overall Study|Side-effects or Health Problems|15|||
170739456|NCT01686581|617052477|FG000|Overall Study|Lack of Efficacy|90|||
170739457|NCT01686581|617052477|FG000|Overall Study|Participant Concerned about Risks|6|||
170739458|NCT01686581|617052477|FG000|Overall Study|Thinks Injections Too Painful|8|||
170739459|NCT01686581|617052477|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
170739460|NCT01686581|617052477|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
170739461|NCT01686581|617052477|FG000|Overall Study|Thinks it is Inconvenient|17|||
170739462|NCT01686581|617052477|FG000|Overall Study|Other Miscellaneous Reasons|36|||
170739463|NCT01686581|617052477|FG000|Overall Study|Reason Missing|1|||
170739464|NCT02613221|617052480|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
170739465|NCT02613221|617052480|FG000|Overall Study|Adverse Event|2|||
170739466|NCT02613221|617052480|FG000|Overall Study|Voluntary Discontinuation|1|||
170739467|NCT02613221|617052480|FG000|Overall Study|Delayed Treatment|1|||
170739468|NCT02613221|617052480|FG000|Overall Study|Enrolled but Not Treated|1|||
170739469|NCT00399763|617052481|FG000|Overall Study|Lost to Follow-up|2|||
170739470|NCT00399763|617052482|FG001|Overall Study|Lost to Follow-up|3|||
170739471|NCT03389477|617052483|FG000|Step 1|Withdrawal by Subject|1|||
170739472|NCT03389477|617052484|FG001|Step 1|Withdrawal by Subject|0|||
170739473|NCT03389477|617052483|FG000|Step 2|Withdrawal by Subject|1|||
170739474|NCT03389477|617052484|FG001|Step 2|Withdrawal by Subject|2|||
170739475|NCT03389477|617052483|FG000|Step 2|Disease progression|1|||
170739476|NCT03389477|617052484|FG001|Step 2|Disease progression|0|||
170739477|NCT03389477|617052483|FG000|Step 2|Death|0|||
170739478|NCT03389477|617052484|FG001|Step 2|Death|1|||
170739479|NCT03389477|617052483|FG000|Step 2|Poor performance status and nutrition|0|||
170739480|NCT03389477|617052484|FG001|Step 2|Poor performance status and nutrition|1|||
170739481|NCT03389477|617052483|FG000|Step 3|Withdrawal after 3 cycles|0|||
170739482|NCT03389477|617052484|FG001|Step 3|Withdrawal after 3 cycles|1|||
170739483|NCT03389477|617052483|FG000|Step 3|Still receiving active treatment|4|||
170739484|NCT03389477|617052484|FG001|Step 3|Still receiving active treatment|0|||
170739485|NCT03389477|617052483|FG000|Step 3|Progressive disease after 2 cycles|1|||
170739486|NCT03389477|617052484|FG001|Step 3|Progressive disease after 2 cycles|0|||
170739487|NCT00386308|617054066|FG000|Overall Study|Adverse Event|3|||
170848677|NCT03828747|617453453|FG001|Open-Label Extension|Adverse Event|7|||
170848678|NCT03828747|617453452|FG000|Open-Label Extension|Death|0|||
170848679|NCT03828747|617453453|FG001|Open-Label Extension|Death|2|||
170848680|NCT03828747|617453452|FG000|Open-Label Extension|Lost to Follow-up|4|||
170848681|NCT03828747|617453453|FG001|Open-Label Extension|Lost to Follow-up|0|||
170848682|NCT03828747|617453452|FG000|Open-Label Extension|Withdrawal by Subject|31|||
170848683|NCT03828747|617453453|FG001|Open-Label Extension|Withdrawal by Subject|30|||
170848684|NCT03828747|617453452|FG000|Open-Label Extension|Various reasons|4|||
170848685|NCT03828747|617453453|FG001|Open-Label Extension|Various reasons|4|||
170848686|NCT03828747|617453452|FG000|Open-Label Extension|Physician Decision|6|||
170848687|NCT03828747|617453453|FG001|Open-Label Extension|Physician Decision|2|||
170848688|NCT04187989|617453454|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
170848689|NCT04187989|617453455|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
170848690|NCT04187989|617453454|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
170848691|NCT04187989|617453455|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
170848692|NCT03646656|617453456|FG000|Overall Study|Lost to Follow-up|1|||
170848693|NCT03646656|617453457|FG001|Overall Study|Lost to Follow-up|0|||
170848694|NCT03646656|617453456|FG000|Overall Study|Withdrawal by Subject|2|||
170848695|NCT03646656|617453457|FG001|Overall Study|Withdrawal by Subject|0|||
170848696|NCT02366468|617453461|FG000|Overall Study|Adverse Event|2|||
170848697|NCT02366468|617453462|FG001|Overall Study|Adverse Event|0|||
170848698|NCT02366468|617453461|FG000|Overall Study|Withdrawal by Subject|1|||
170848699|NCT02366468|617453462|FG001|Overall Study|Withdrawal by Subject|5|||
170848700|NCT02366468|617453461|FG000|Overall Study|Lost to Follow-up|2|||
170848701|NCT02366468|617453462|FG001|Overall Study|Lost to Follow-up|0|||
170848702|NCT02366468|617453461|FG000|Overall Study|Death|1|||
170848703|NCT02366468|617453462|FG001|Overall Study|Death|2|||
170848704|NCT02366468|617453461|FG000|Overall Study|Other|0|||
170848705|NCT02366468|617453462|FG001|Overall Study|Other|2|||
170848706|NCT03207451|617453465|FG000|Overall Study|scheduling conflict|1|||
170848707|NCT03207451|617453466|FG001|Overall Study|scheduling conflict|0|||
170848708|NCT03207451|617453467|FG002|Overall Study|scheduling conflict|2|||
170848709|NCT03207451|617453468|FG003|Overall Study|scheduling conflict|2|||
170848710|NCT03207451|617453465|FG000|Overall Study|Adverse Event|0|||
170848711|NCT03207451|617453466|FG001|Overall Study|Adverse Event|0|||
170848712|NCT03207451|617453467|FG002|Overall Study|Adverse Event|0|||
170848713|NCT03207451|617453468|FG003|Overall Study|Adverse Event|1|||
170848714|NCT03896152|617453469|FG000|Overall Study|Patient/guardian decision|1|||
170848715|NCT03896152|617453470|FG001|Overall Study|Patient/guardian decision|1|||
170848716|NCT03896152|617453469|FG000|Overall Study|Adverse Event|0|||
170848717|NCT03896152|617453470|FG001|Overall Study|Adverse Event|1|||
170848718|NCT03896152|617453469|FG000|Overall Study|Physician Decision|1|||
170848719|NCT03896152|617453470|FG001|Overall Study|Physician Decision|0|||
170848720|NCT03896152|617453469|FG000|Overall Study|Technical problems|1|||
170848721|NCT03896152|617453470|FG001|Overall Study|Technical problems|0|||
170848722|NCT00307684|617453471|FG000|Open Label Phase|Lack of Efficacy|0|||
170848723|NCT00307684|617453472|FG001|Open Label Phase|Lack of Efficacy|0|||
170848724|NCT00307684|617453473|FG002|Open Label Phase|Lack of Efficacy|3|||
170848725|NCT00307684|617453471|FG000|Open Label Phase|Adverse Event|0|||
170848726|NCT00307684|617453472|FG001|Open Label Phase|Adverse Event|0|||
170739488|NCT00386308|617054067|FG001|Overall Study|Adverse Event|3|||
170739489|NCT00386308|617054066|FG000|Overall Study|Protocol Violation|2|||
170739490|NCT00386308|617054067|FG001|Overall Study|Protocol Violation|5|||
170739491|NCT00386308|617054066|FG000|Overall Study|Lack of Efficacy|0|||
170739492|NCT00386308|617054067|FG001|Overall Study|Lack of Efficacy|2|||
170739493|NCT00386308|617054066|FG000|Overall Study|Lost to Follow-up|10|||
170739494|NCT00386308|617054067|FG001|Overall Study|Lost to Follow-up|6|||
170739495|NCT00386308|617054066|FG000|Overall Study|Withdrawal by Subject|6|||
170739496|NCT00386308|617054067|FG001|Overall Study|Withdrawal by Subject|2|||
170739497|NCT00386308|617054066|FG000|Overall Study|Other Event|8|||
170739498|NCT00386308|617054067|FG001|Overall Study|Other Event|1|||
170739499|NCT02105636|617054069|FG000|Pre-Treatment|Disease Progression|1|||
170739500|NCT02105636|617054070|FG001|Pre-Treatment|Disease Progression|0|||
170739501|NCT02105636|617054069|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
170739502|NCT02105636|617054070|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
170739503|NCT02105636|617054069|FG000|Pre-Treatment|Participant withdrew consent|0|||
170739504|NCT02105636|617054070|FG001|Pre-Treatment|Participant withdrew consent|6|||
170739505|NCT02105636|617054069|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
170739506|NCT02105636|617054070|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
170739507|NCT02105636|617054069|FG000|Treatment|Study Drug Toxicity|14|||
170739508|NCT02105636|617054070|FG001|Treatment|Study Drug Toxicity|10|||
170739509|NCT02105636|617054069|FG000|Treatment|Adverse event unrelated to study drug|19|||
170739510|NCT02105636|617054070|FG001|Treatment|Adverse event unrelated to study drug|3|||
170739511|NCT02105636|617054069|FG000|Treatment|Participant request to discontinue study treatment|8|||
170739512|NCT02105636|617054070|FG001|Treatment|Participant request to discontinue study treatment|6|||
170739513|NCT02105636|617054069|FG000|Treatment|Participant withdrew consent|5|||
170739514|NCT02105636|617054070|FG001|Treatment|Participant withdrew consent|1|||
170739515|NCT02105636|617054069|FG000|Treatment|Lost to Follow-up|1|||
170739516|NCT02105636|617054070|FG001|Treatment|Lost to Follow-up|0|||
170739517|NCT02105636|617054069|FG000|Treatment|Maximum Clinical Benefit|1|||
170739518|NCT02105636|617054070|FG001|Treatment|Maximum Clinical Benefit|3|||
170739519|NCT02105636|617054069|FG000|Treatment|Poor/Non-compliance|0|||
170739520|NCT02105636|617054070|FG001|Treatment|Poor/Non-compliance|1|||
170739521|NCT02105636|617054069|FG000|Treatment|Participant no longer meets study criteria|1|||
170739522|NCT02105636|617054070|FG001|Treatment|Participant no longer meets study criteria|0|||
170739523|NCT02105636|617054069|FG000|Treatment|Other reasons|1|||
170739524|NCT02105636|617054070|FG001|Treatment|Other reasons|0|||
170739525|NCT02105636|617054069|FG000|Treatment|Disease Progression|185|||
170739526|NCT02105636|617054070|FG001|Treatment|Disease Progression|87|||
170739527|NCT02002884|617054077|FG000|Main Period (MP)|Other|0|||
170739528|NCT02002884|617054078|FG001|Main Period (MP)|Other|3|||
170739529|NCT02002884|617054079|FG002|Main Period (MP)|Other|3|||
170739530|NCT02002884|617054080|FG003|Main Period (MP)|Other|0|||
170739531|NCT02002884|617054077|FG000|Main Period (MP)|Adverse Event|0|||
170739532|NCT02002884|617054078|FG001|Main Period (MP)|Adverse Event|1|||
170739533|NCT02002884|617054079|FG002|Main Period (MP)|Adverse Event|1|||
170739534|NCT02002884|617054080|FG003|Main Period (MP)|Adverse Event|0|||
170739535|NCT02002884|617054077|FG000|Main Period (MP)|Withdrawal by Subject|6|||
170739536|NCT02002884|617054078|FG001|Main Period (MP)|Withdrawal by Subject|2|||
170739537|NCT02002884|617054079|FG002|Main Period (MP)|Withdrawal by Subject|2|||
170739538|NCT02002884|617054080|FG003|Main Period (MP)|Withdrawal by Subject|0|||
170739539|NCT02002884|617054077|FG000|Main Period (MP)|Lost to Follow-up|0|||
170739540|NCT02002884|617054078|FG001|Main Period (MP)|Lost to Follow-up|0|||
170739541|NCT02002884|617054079|FG002|Main Period (MP)|Lost to Follow-up|2|||
170739542|NCT02002884|617054080|FG003|Main Period (MP)|Lost to Follow-up|0|||
170848727|NCT00307684|617453473|FG002|Open Label Phase|Adverse Event|16|||
170848728|NCT00307684|617453471|FG000|Open Label Phase|Withdrawal by Subject|0|||
170739543|NCT02002884|617054077|FG000|Open-Label Extension Period (OLEX)|Other|0|||
170739544|NCT02002884|617054078|FG001|Open-Label Extension Period (OLEX)|Other|0|||
170739545|NCT02002884|617054079|FG002|Open-Label Extension Period (OLEX)|Other|0|||
170739546|NCT02002884|617054080|FG003|Open-Label Extension Period (OLEX)|Other|24|||
170739547|NCT02002884|617054077|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
170739548|NCT02002884|617054078|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
170739549|NCT02002884|617054079|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
170739550|NCT02002884|617054080|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
170739551|NCT02002884|617054077|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
170739552|NCT02002884|617054078|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
170739553|NCT02002884|617054079|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
170739554|NCT02002884|617054080|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
170739555|NCT02002884|617054077|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
170739556|NCT02002884|617054078|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
170739557|NCT02002884|617054079|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
170739558|NCT02002884|617054080|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
170848729|NCT00307684|617453472|FG001|Open Label Phase|Withdrawal by Subject|0|||
170848730|NCT00307684|617453473|FG002|Open Label Phase|Withdrawal by Subject|15|||
170848731|NCT00307684|617453471|FG000|Open Label Phase|Lost to Follow-up|0|||
170848732|NCT00307684|617453472|FG001|Open Label Phase|Lost to Follow-up|0|||
170848733|NCT00307684|617453473|FG002|Open Label Phase|Lost to Follow-up|11|||
170848734|NCT00307684|617453471|FG000|Open Label Phase|non compliance|0|||
170848735|NCT00307684|617453472|FG001|Open Label Phase|non compliance|0|||
170848736|NCT00307684|617453473|FG002|Open Label Phase|non compliance|5|||
170848737|NCT00307684|617453471|FG000|Open Label Phase|other|0|||
170848738|NCT00307684|617453472|FG001|Open Label Phase|other|0|||
170848739|NCT00307684|617453473|FG002|Open Label Phase|other|6|||
170848740|NCT00307684|617453471|FG000|Double Blind Phase|Lack of Efficacy|2|||
170848741|NCT00307684|617453472|FG001|Double Blind Phase|Lack of Efficacy|5|||
170848742|NCT00307684|617453473|FG002|Double Blind Phase|Lack of Efficacy|0|||
170848743|NCT03377699|617453474|FG000|Overall Study|Withdrawal by Subject|2|||
170848744|NCT03377699|617453475|FG001|Overall Study|Withdrawal by Subject|9|||
170848745|NCT03377699|617453474|FG000|Overall Study|Lost to Follow-up|1|||
170848746|NCT03377699|617453475|FG001|Overall Study|Lost to Follow-up|1|||
170848747|NCT03377699|617453474|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
170848748|NCT03377699|617453475|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
170848749|NCT03377699|617453474|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
170848750|NCT03377699|617453475|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
170848751|NCT03377699|617453474|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
170848752|NCT03377699|617453475|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
170848753|NCT03377699|617453474|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
170848754|NCT03377699|617453475|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
170848755|NCT03582943|617453476|FG000|Allocated to Groups|Withdrawal by Subject|1|||
170848756|NCT03582943|617453477|FG001|Allocated to Groups|Withdrawal by Subject|1|||
170848757|NCT03582943|617453476|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
170848758|NCT03582943|617453477|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
170848759|NCT03582943|617453476|FG000|Analyzed|Protocol Violation|4|||
170848760|NCT03582943|617453477|FG001|Analyzed|Protocol Violation|1|||
170848761|NCT03527550|617453478|FG000|Overall Study|Lost to Follow-up|4|||
170848762|NCT03527550|617453479|FG001|Overall Study|Lost to Follow-up|2|||
170848763|NCT03527550|617453478|FG000|Overall Study|Withdrawal by Subject|4|||
170848764|NCT03527550|617453479|FG001|Overall Study|Withdrawal by Subject|1|||
170848765|NCT03527550|617453478|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
170848766|NCT03527550|617453479|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
170848767|NCT05487586|617453483|FG000|Overall Study|Death|22|||
170848768|NCT05487586|617453483|FG000|Overall Study|Physician Decision|1|||
170848769|NCT05487586|617453483|FG000|Overall Study|Transfer to another hospital|4|||
170848770|NCT05487586|617453483|FG000|Overall Study|Other|1|||
170848771|NCT01232738|617453484|FG000|Overall Study|Death|3|||
170848772|NCT01232738|617453484|FG000|Overall Study|Physician Decision|2|||
170848773|NCT01232738|617453484|FG000|Overall Study|Lost to Follow-up|1|||
170848774|NCT01232738|617453484|FG000|Overall Study|Withdrawal by Subject|2|||
170848775|NCT01232738|617453484|FG000|Overall Study|Adverse Event|5|||
170848776|NCT00252577|617453490|FG000|Overall Study|Lost to Follow-up|20|||
170848777|NCT03284203|617453501|FG000|Overall Study|Lost to Follow-up|3|||
170848778|NCT00992225|617453504|FG000|Overall Study|Entry Criteria Not Met|8|||
170848779|NCT00992225|617453504|FG000|Overall Study|Adverse Event|2|||
170848780|NCT01253018|617453505|FG000|Overall Study|Lost to Follow-up|1|||
170848781|NCT01253018|617453506|FG001|Overall Study|Lost to Follow-up|1|||
170848782|NCT01253018|617453505|FG000|Overall Study|Robot Repair Issues|2|||
170848783|NCT01253018|617453506|FG001|Overall Study|Robot Repair Issues|0|||
170848784|NCT01253018|617453505|FG000|Overall Study|Withdrawal by Subject|1|||
170848785|NCT01253018|617453506|FG001|Overall Study|Withdrawal by Subject|1|||
170848786|NCT03466073|617453507|FG000|Overall Study|Death|1|||
170848787|NCT03466073|617453508|FG001|Overall Study|Death|0|||
170848788|NCT03466073|617453509|FG002|Overall Study|Death|0|||
170848789|NCT03466073|617453510|FG003|Overall Study|Death|0|||
170848790|NCT03466073|617453511|FG004|Overall Study|Death|0|||
170848791|NCT03466073|617453512|FG005|Overall Study|Death|1|||
170848792|NCT03682302|617453513|FG000|Overall Study|Lost to Follow-up|1|||
170848793|NCT03682302|617453514|FG001|Overall Study|Lost to Follow-up|2|||
170848794|NCT03682302|617453515|FG002|Overall Study|Lost to Follow-up|0|||
170848795|NCT03682302|617453516|FG003|Overall Study|Lost to Follow-up|1|||
170848796|NCT03682302|617453513|FG000|Overall Study|Study drug was not administered|0|||
170848797|NCT03682302|617453514|FG001|Overall Study|Study drug was not administered|0|||
170848798|NCT03682302|617453515|FG002|Overall Study|Study drug was not administered|1|||
170848799|NCT03682302|617453516|FG003|Overall Study|Study drug was not administered|1|||
170848800|NCT02285153|617453517|FG000|Overall Study|Adverse Event|1|||
170848801|NCT02285153|617453518|FG001|Overall Study|Adverse Event|0|||
170848802|NCT01712659|617453519|FG000|Dose Escalation|Physician Decision|0|||
170848803|NCT01712659|617453520|FG001|Dose Escalation|Physician Decision|1|||
170848804|NCT01712659|617453521|FG002|Dose Escalation|Physician Decision|0|||
170848805|NCT01712659|617453522|FG003|Dose Escalation|Physician Decision|0|||
170848806|NCT01712659|617453523|FG004|Dose Escalation|Physician Decision|0|||
170848807|NCT01712659|617453519|FG000|Dose Escalation|Unable to take study drug|0|||
170848808|NCT01712659|617453520|FG001|Dose Escalation|Unable to take study drug|1|||
170848809|NCT01712659|617453521|FG002|Dose Escalation|Unable to take study drug|0|||
170848810|NCT01712659|617453522|FG003|Dose Escalation|Unable to take study drug|0|||
170848811|NCT01712659|617453523|FG004|Dose Escalation|Unable to take study drug|0|||
170848812|NCT01712659|617453519|FG000|Dose Expansion|Early disease progression|1|||
170848813|NCT01712659|617453520|FG001|Dose Expansion|Early disease progression|0|||
170848814|NCT01712659|617453521|FG002|Dose Expansion|Early disease progression|0|||
170848815|NCT01712659|617453522|FG003|Dose Expansion|Early disease progression|0|||
170848816|NCT01712659|617453523|FG004|Dose Expansion|Early disease progression|0|||
170848817|NCT01712659|617453519|FG000|Dose Expansion|Physician Decision|1|||
170848818|NCT01712659|617453520|FG001|Dose Expansion|Physician Decision|0|||
170848819|NCT01712659|617453521|FG002|Dose Expansion|Physician Decision|0|||
170848820|NCT01712659|617453522|FG003|Dose Expansion|Physician Decision|0|||
170848821|NCT01712659|617453523|FG004|Dose Expansion|Physician Decision|0|||
170848822|NCT03459443|617453528|FG000|Overall Study|Lack of Efficacy|3|||
170848823|NCT03459443|617453528|FG000|Overall Study|Adverse Event|1|||
170848824|NCT03459443|617453528|FG000|Overall Study|Sponsor's decision to close the study|18|||
170848825|NCT03189745|617453529|FG000|Overall Study|Conflict in work schedule of participant|1|||
170848826|NCT03189745|617453530|FG001|Overall Study|Conflict in work schedule of participant|1|||
170848827|NCT01276379|617453531|FG000|Overall Study|Screening failure|40|||
170848828|NCT03842358|617453534|FG000|Overall Study|Poor DOT probe contact with breast|2|||
170848829|NCT03842358|617453534|FG000|Overall Study|DOT system problem|1|||
170848830|NCT03842358|617453534|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
170848831|NCT03842358|617453534|FG000|Overall Study|No biopsy after physician review|4|||
170848832|NCT03842358|617453534|FG000|Overall Study|Patient withdrew|2|||
170848833|NCT05384938|617453535|FG000|Overall Study|Withdrawal by Subject|8|||
170848834|NCT05384938|617453535|FG000|Overall Study|Lost to Follow-up|6|||
170848835|NCT05384938|617453535|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
170848836|NCT03898167|617453536|FG000|Overall Study|Terminated phone call early|7|||
170848837|NCT03898167|617453537|FG001|Overall Study|Terminated phone call early|0|||
170848838|NCT03898167|617453538|FG002|Overall Study|Terminated phone call early|0|||
170848839|NCT03898167|617453536|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
170848840|NCT03898167|617453537|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
170848841|NCT03898167|617453538|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
170848842|NCT01200290|617453539|FG000|Treatment Period|Adverse Event|1|||
170848843|NCT01200290|617453539|FG000|Post-Treatment Follow-Up Period|Death|2|||
170848844|NCT01525238|617453540|FG000|Overall Study|Withdrawal by Subject|1|||
170848845|NCT01525238|617453541|FG001|Overall Study|Withdrawal by Subject|0|||
170848846|NCT01525238|617453542|FG002|Overall Study|Withdrawal by Subject|0|||
170848847|NCT04349631|617453550|FG000|Overall Study|Lost to Follow-up|3|||
170848848|NCT04349631|617453550|FG000|Overall Study|Withdrawal by Subject|7|||
170848849|NCT00432666|617455063|FG000|Main Period|Adverse Event|1|||
170848850|NCT00432666|617455064|FG001|Main Period|Adverse Event|1|||
170848851|NCT00432666|617455063|FG000|Main Period|Consent Withdrawn|1|||
170848852|NCT00432666|617455064|FG001|Main Period|Consent Withdrawn|0|||
170848853|NCT00432666|617455063|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
170848854|NCT00432666|617455064|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
170848855|NCT00432666|617455063|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
170848856|NCT00432666|617455064|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
170848857|NCT00432666|617455063|FG000|Open-Label Extension Period|Adverse Event|5|||
170848858|NCT00432666|617455064|FG001|Open-Label Extension Period|Adverse Event|0|||
170848859|NCT00432666|617455063|FG000|Open-Label Extension Period|Consent withdrawn|10|||
170848860|NCT00432666|617455064|FG001|Open-Label Extension Period|Consent withdrawn|0|||
170848861|NCT00432666|617455063|FG000|Open-Label Extension Period|Physician Decision|3|||
170848862|NCT00432666|617455064|FG001|Open-Label Extension Period|Physician Decision|0|||
170848863|NCT00978627|617455065|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
170848864|NCT00978627|617455066|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
170848865|NCT00978627|617455065|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
170848866|NCT00978627|617455066|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
170848867|NCT00978627|617455065|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
170848868|NCT00978627|617455066|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
170848869|NCT00978627|617455065|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
170848870|NCT00978627|617455066|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
170848871|NCT00978627|617455065|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
170848872|NCT00978627|617455066|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
170848873|NCT00978627|617455065|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
170848874|NCT00978627|617455066|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
170848875|NCT00978627|617455065|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
170848876|NCT00978627|617455066|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
170848877|NCT00978627|617455065|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
170848878|NCT00978627|617455066|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
170848879|NCT00978627|617455065|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
170848880|NCT00978627|617455066|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
170848881|NCT01506453|617455067|FG000|Overall Study|Withdrawal prior to treatment|0|||
170848882|NCT01506453|617455068|FG001|Overall Study|Withdrawal prior to treatment|2|||
170848883|NCT00923260|617455071|FG000|Overall Study|Lost to Follow-up|1|||
170848884|NCT00923260|617455072|FG001|Overall Study|Lost to Follow-up|1|||
170848885|NCT00603304|617455075|FG000|Overall Study|Lost to Follow-up|5|||
170848886|NCT00603304|617455076|FG001|Overall Study|Lost to Follow-up|7|||
170848887|NCT00603304|617455075|FG000|Overall Study|Withdrawal by Subject|8|||
170848888|NCT00603304|617455076|FG001|Overall Study|Withdrawal by Subject|5|||
170848889|NCT00603304|617455075|FG000|Overall Study|Protocol Violation|1|||
170848890|NCT00603304|617455076|FG001|Overall Study|Protocol Violation|0|||
170848891|NCT00603304|617455075|FG000|Overall Study|Adverse Event|4|||
170848892|NCT00603304|617455076|FG001|Overall Study|Adverse Event|2|||
170848893|NCT00603304|617455075|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
170848894|NCT00603304|617455076|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
170848895|NCT00603304|617455075|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
170848896|NCT00603304|617455076|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
170848897|NCT00603304|617455075|FG000|Overall Study|Exclusionary Medication|2|||
170848898|NCT00603304|617455076|FG001|Overall Study|Exclusionary Medication|3|||
170848899|NCT00603304|617455075|FG000|Overall Study|Non-Compliant|0|||
170848900|NCT00603304|617455076|FG001|Overall Study|Non-Compliant|1|||
170848901|NCT00603304|617455075|FG000|Overall Study|Moved Away|0|||
170848902|NCT00603304|617455076|FG001|Overall Study|Moved Away|2|||
170848903|NCT00603304|617455075|FG000|Overall Study|Other|2|||
170848904|NCT00603304|617455076|FG001|Overall Study|Other|0|||
170848905|NCT00603304|617455075|FG000|Overall Study|Patient Decision|2|||
170848906|NCT00603304|617455076|FG001|Overall Study|Patient Decision|0|||
170848907|NCT01076192|617455077|FG000|Overall Study|Other|197|||
170848908|NCT02738203|617455079|FG000|Overall Study|Failed IUD Insertion|2|||
170848909|NCT02738203|617455080|FG001|Overall Study|Failed IUD Insertion|2|||
170848910|NCT02738203|617455079|FG000|Overall Study|Protocol Violation|0|||
170848911|NCT02738203|617455080|FG001|Overall Study|Protocol Violation|1|||
170848912|NCT00446043|617455083|FG000|Overall Study|Adverse Event|9|||
170848913|NCT00446043|617455083|FG000|Overall Study|Withdrawal by Subject|70|||
170848914|NCT00446043|617455083|FG000|Overall Study|Protocol Violation|2|||
170848915|NCT00446043|617455083|FG000|Overall Study|Lost to Follow-up|42|||
170848916|NCT00446043|617455083|FG000|Overall Study|Pregnancy|2|||
170848917|NCT01239043|617455084|FG000|Overall Study|Protocol Violation|2|||
170848918|NCT01239043|617455085|FG001|Overall Study|Protocol Violation|1|||
170848919|NCT02929329|617455088|FG000|Overall Study|Withdrawal by Subject|24|||
170848920|NCT02929329|617455089|FG001|Overall Study|Withdrawal by Subject|21|||
170848921|NCT02929329|617455088|FG000|Overall Study|Lost to Follow-up|26|||
170848922|NCT02929329|617455089|FG001|Overall Study|Lost to Follow-up|20|||
170848923|NCT02929329|617455088|FG000|Overall Study|Death|1054|||
170848924|NCT02929329|617455089|FG001|Overall Study|Death|1051|||
170848925|NCT00436852|617455092|FG000|Overall Study|Death|23|||
170848926|NCT00436852|617455093|FG001|Overall Study|Death|34|||
170848927|NCT00436852|617455092|FG000|Overall Study|Lack of Efficacy|9|||
170848928|NCT00436852|617455093|FG001|Overall Study|Lack of Efficacy|7|||
170848929|NCT00436852|617455092|FG000|Overall Study|Withdrawal by Subject|2|||
170848930|NCT00436852|617455093|FG001|Overall Study|Withdrawal by Subject|4|||
170848931|NCT00436852|617455092|FG000|Overall Study|Ineligible|1|||
170848932|NCT00436852|617455093|FG001|Overall Study|Ineligible|0|||
170848933|NCT00370682|617455094|FG000|Overall Study|Moved from area|0|||
170848934|NCT00370682|617455095|FG001|Overall Study|Moved from area|2|||
170848935|NCT00370682|617455096|FG002|Overall Study|Moved from area|0|||
170848936|NCT00370682|617455094|FG000|Overall Study|Lost to Follow-up|0|||
170848937|NCT00370682|617455095|FG001|Overall Study|Lost to Follow-up|1|||
170848938|NCT00370682|617455096|FG002|Overall Study|Lost to Follow-up|1|||
170848939|NCT03167359|617455097|FG000|Overall Study|Physician Decision|1|||
170848940|NCT03167359|617455097|FG000|Overall Study|Lost to Follow-up|1|||
170848941|NCT03339583|617455098|FG000|First Intervention (14 Days)|Adverse Event|1|||
170848942|NCT03339583|617455099|FG001|First Intervention (14 Days)|Adverse Event|0|||
170848943|NCT03339583|617455098|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
170848944|NCT03339583|617455099|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
170848945|NCT03339583|617455098|FG000|Second Intervention (14 Days)|Adverse Event|0|||
170848946|NCT03339583|617455099|FG001|Second Intervention (14 Days)|Adverse Event|1|||
170848947|NCT03339583|617455098|FG000|Follow-up (14 Days)|Physician Decision|6|||
170848948|NCT03339583|617455099|FG001|Follow-up (14 Days)|Physician Decision|3|||
170848949|NCT03836716|617455100|FG000|Overall Study|Adverse Event|3|||
170848950|NCT03836716|617455100|FG000|Overall Study|Death|22|||
170848951|NCT03836716|617455100|FG000|Overall Study|Withdrawal by Subject|8|||
170848952|NCT03836716|617455100|FG000|Overall Study|Study terminated by sponsor|87|||
170848953|NCT01983254|617455101|FG000|Overall Study|Death|6|||
170848954|NCT01983254|617455102|FG001|Overall Study|Death|6|||
170848955|NCT01983254|617455101|FG000|Overall Study|Lost to Follow-up|17|||
170848956|NCT01983254|617455102|FG001|Overall Study|Lost to Follow-up|16|||
170848957|NCT01983254|617455101|FG000|Overall Study|too ill|11|||
170848958|NCT01983254|617455102|FG001|Overall Study|too ill|8|||
170848959|NCT02141620|617455103|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
170848960|NCT02141620|617455104|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
170848961|NCT00127205|617455105|FG000|Overall Study|Adverse Event|228|||
170848962|NCT00127205|617455106|FG001|Overall Study|Adverse Event|387|||
170848963|NCT00127205|617455107|FG002|Overall Study|Adverse Event|273|||
170848964|NCT00127205|617455105|FG000|Overall Study|Death|8|||
170848965|NCT00127205|617455106|FG001|Overall Study|Death|6|||
170848966|NCT00127205|617455107|FG002|Overall Study|Death|5|||
170848967|NCT00127205|617455105|FG000|Overall Study|Withdrawal by Subject|318|||
170848968|NCT00127205|617455106|FG001|Overall Study|Withdrawal by Subject|310|||
170848969|NCT00127205|617455107|FG002|Overall Study|Withdrawal by Subject|172|||
170848970|NCT00127205|617455105|FG000|Overall Study|Other-non protocol specified|142|||
170848971|NCT00127205|617455106|FG001|Overall Study|Other-non protocol specified|129|||
170848972|NCT00127205|617455107|FG002|Overall Study|Other-non protocol specified|77|||
170848973|NCT00127205|617455105|FG000|Overall Study|Data not reported|6|||
170848974|NCT00127205|617455106|FG001|Overall Study|Data not reported|10|||
170848975|NCT00127205|617455107|FG002|Overall Study|Data not reported|1|||
170848976|NCT00127205|617455105|FG000|Overall Study|Progression|127|||
170848977|NCT00127205|617455106|FG001|Overall Study|Progression|131|||
170848978|NCT00127205|617455107|FG002|Overall Study|Progression|84|||
170848979|NCT00356408|617455117|FG000|Overall Study|Adverse Event|9|||
170848980|NCT00356408|617455117|FG000|Overall Study|Lack of Efficacy|36|||
170848981|NCT00356408|617455117|FG000|Overall Study|Lost to Follow-up|2|||
170848982|NCT00356408|617455117|FG000|Overall Study|Withdrawal by Subject|6|||
170848983|NCT00356408|617455117|FG000|Overall Study|Other: Principal investigator discretion|3|||
170848984|NCT00356408|617455117|FG000|Overall Study|Other: Sponsor request|1|||
170848985|NCT00356408|617455117|FG000|Overall Study|Other: Azathioprine stopped|1|||
170848986|NCT00356408|617455117|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
170848987|NCT00356408|617455117|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
170848988|NCT04032613|617455121|FG000|Overall Study|Did not complete post-program assessment|5|||
170848989|NCT04032613|617455122|FG001|Overall Study|Did not complete post-program assessment|2|||
170848990|NCT03231800|617455125|FG000|Overall Study|Lost to Follow-up|0|||
170848991|NCT03231800|617455126|FG001|Overall Study|Lost to Follow-up|2|||
170848992|NCT03231800|617455125|FG000|Overall Study|Protocol Violation|1|||
170848993|NCT03231800|617455126|FG001|Overall Study|Protocol Violation|1|||
170848994|NCT03231800|617455125|FG000|Overall Study|reason not provided|2|||
170848995|NCT03231800|617455126|FG001|Overall Study|reason not provided|0|||
170848996|NCT00560066|617455129|FG000|Overall Study|Death|2|||
170848997|NCT00560066|617455130|FG001|Overall Study|Death|1|||
170848998|NCT00560066|617455129|FG000|Overall Study|Withdrawal by Subject|0|||
170848999|NCT00560066|617455130|FG001|Overall Study|Withdrawal by Subject|3|||
170849000|NCT00560066|617455129|FG000|Overall Study|Lost to Follow-up|4|||
170849001|NCT00560066|617455130|FG001|Overall Study|Lost to Follow-up|10|||
170849002|NCT00560066|617455129|FG000|Overall Study|Protocol Violation|0|||
170849003|NCT00560066|617455130|FG001|Overall Study|Protocol Violation|1|||
170849004|NCT00560066|617455129|FG000|Overall Study|Administrative reason|0|||
170849005|NCT00560066|617455130|FG001|Overall Study|Administrative reason|5|||
170849006|NCT00560066|617455129|FG000|Overall Study|Missing primary reason|0|||
170849007|NCT00560066|617455130|FG001|Overall Study|Missing primary reason|2|||
170849008|NCT01163292|617455131|FG000|Overall Study|Lack of Efficacy|9|||
170849009|NCT01163292|617455132|FG001|Overall Study|Lack of Efficacy|0|||
170849010|NCT01163292|617455131|FG000|Overall Study|Adverse Event|6|||
170849011|NCT01163292|617455132|FG001|Overall Study|Adverse Event|0|||
170849012|NCT01163292|617455131|FG000|Overall Study|Initiation of biological therapy|0|||
170849013|NCT01163292|617455132|FG001|Overall Study|Initiation of biological therapy|15|||
170849014|NCT01163292|617455131|FG000|Overall Study|Sufficient response to adalimumab|8|||
170849015|NCT01163292|617455132|FG001|Overall Study|Sufficient response to adalimumab|0|||
170849016|NCT01163292|617455131|FG000|Overall Study|Refusal to receive adalimumab|7|||
170849017|NCT01163292|617455132|FG001|Overall Study|Refusal to receive adalimumab|0|||
170849018|NCT01163292|617455131|FG000|Overall Study|Economic reasons|6|||
170849019|NCT01163292|617455132|FG001|Overall Study|Economic reasons|0|||
170849020|NCT01163292|617455131|FG000|Overall Study|No further visits|5|||
170849021|NCT01163292|617455132|FG001|Overall Study|No further visits|7|||
170849022|NCT01259089|617455133|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
170849023|NCT01259089|617455134|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
170849024|NCT01259089|617455135|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
170849025|NCT01259089|617455136|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
170849026|NCT01259089|617455137|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
170849027|NCT01259089|617455138|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
170849028|NCT01259089|617455133|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
170849029|NCT01259089|617455134|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
170849030|NCT01259089|617455135|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
170849031|NCT01259089|617455136|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
170849032|NCT01259089|617455137|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
170849033|NCT01259089|617455138|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
170849034|NCT01259089|617455133|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
170849035|NCT01259089|617455134|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
170849036|NCT01259089|617455135|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
170849037|NCT01259089|617455136|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
170849038|NCT01259089|617455137|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
170849039|NCT01259089|617455138|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
170849040|NCT01259089|617455133|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
170849041|NCT01259089|617455134|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
170849042|NCT01259089|617455135|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
170849043|NCT01259089|617455136|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
170849044|NCT01259089|617455137|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
170849045|NCT01259089|617455138|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
170849046|NCT01259089|617455133|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
170849047|NCT01259089|617455134|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
170849048|NCT01259089|617455135|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
170849049|NCT01259089|617455136|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
170849050|NCT01259089|617455137|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
170849051|NCT01259089|617455138|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
170849052|NCT01259089|617455133|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
170849053|NCT01259089|617455134|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
170849054|NCT01259089|617455135|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
170849055|NCT01259089|617455136|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
170849056|NCT01259089|617455137|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
170849057|NCT01259089|617455138|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
170849058|NCT01259089|617455133|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
170849059|NCT01259089|617455134|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
170849060|NCT01259089|617455135|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
170849061|NCT01259089|617455136|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
170849062|NCT01259089|617455137|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
170849063|NCT01259089|617455138|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
170849064|NCT01259089|617455133|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
170849065|NCT01259089|617455134|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
170849066|NCT01259089|617455135|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
170849067|NCT01259089|617455136|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
170849068|NCT01259089|617455137|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
170849069|NCT01259089|617455138|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
170849070|NCT01259089|617455133|FG000|Survival Follow up for Two Years|Death|3|||
170849071|NCT01259089|617455134|FG001|Survival Follow up for Two Years|Death|2|||
170849072|NCT01259089|617455135|FG002|Survival Follow up for Two Years|Death|2|||
170849073|NCT01259089|617455136|FG003|Survival Follow up for Two Years|Death|3|||
170849074|NCT01259089|617455137|FG004|Survival Follow up for Two Years|Death|6|||
170849075|NCT01259089|617455138|FG005|Survival Follow up for Two Years|Death|13|||
170849076|NCT01259089|617455133|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
170849077|NCT01259089|617455134|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
170849078|NCT01259089|617455135|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
170849079|NCT01259089|617455136|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
170849080|NCT01259089|617455137|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
170849081|NCT01259089|617455138|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
170849082|NCT01259089|617455133|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
170849083|NCT01259089|617455134|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
170849084|NCT01259089|617455135|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
170849085|NCT01259089|617455136|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
170849086|NCT01259089|617455137|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
170849087|NCT01259089|617455138|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
170849088|NCT02643472|617455139|FG000|Overall Study|Death|2|||
170849089|NCT02643472|617455140|FG001|Overall Study|Death|5|||
170849090|NCT02643472|617455139|FG000|Overall Study|Withdrawal by Subject|3|||
170849091|NCT02643472|617455140|FG001|Overall Study|Withdrawal by Subject|2|||
170849092|NCT02643472|617455139|FG000|Overall Study|Protocol Violation|0|||
170849093|NCT02643472|617455140|FG001|Overall Study|Protocol Violation|1|||
170849094|NCT02643472|617455139|FG000|Overall Study|Lost to Follow-up|22|||
170849095|NCT02643472|617455140|FG001|Overall Study|Lost to Follow-up|26|||
170849096|NCT00688870|617455144|FG000|Infant Series|Parent or legal guardian request|4|||
170849097|NCT00688870|617455145|FG001|Infant Series|Parent or legal guardian request|0|||
170849098|NCT01151410|617455148|FG000|Overall Study|Withdrawal by Subject|3|||
170849099|NCT01151410|617455149|FG001|Overall Study|Withdrawal by Subject|5|||
170849100|NCT01151410|617455148|FG000|Overall Study|Lost to Follow-up|3|||
170849101|NCT01151410|617455149|FG001|Overall Study|Lost to Follow-up|4|||
170849102|NCT01151410|617455148|FG000|Overall Study|Adverse Event|1|||
170849103|NCT01151410|617455149|FG001|Overall Study|Adverse Event|2|||
170849104|NCT01151410|617455148|FG000|Overall Study|Protocol deviation|2|||
170849105|NCT01151410|617455149|FG001|Overall Study|Protocol deviation|1|||
170849106|NCT01151410|617455148|FG000|Overall Study|Administrative problems|1|||
170849107|NCT01151410|617455149|FG001|Overall Study|Administrative problems|1|||
170849108|NCT01151410|617455148|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170849109|NCT01151410|617455149|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
170849110|NCT01151410|617455148|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170849111|NCT01151410|617455149|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170849112|NCT01820585|617455150|FG000|Overall Study|Adverse Event|9|||
170849113|NCT01820585|617455151|FG001|Overall Study|Adverse Event|13|||
170849114|NCT01820585|617455152|FG002|Overall Study|Adverse Event|23|||
170849115|NCT01820585|617455153|FG003|Overall Study|Adverse Event|34|||
170849116|NCT01820585|617455150|FG000|Overall Study|Lack of Efficacy|9|||
170849117|NCT01820585|617455151|FG001|Overall Study|Lack of Efficacy|7|||
170849118|NCT01820585|617455152|FG002|Overall Study|Lack of Efficacy|5|||
170849119|NCT01820585|617455153|FG003|Overall Study|Lack of Efficacy|1|||
170849120|NCT01820585|617455150|FG000|Overall Study|Withdrawal by Subject|3|||
170849121|NCT01820585|617455151|FG001|Overall Study|Withdrawal by Subject|7|||
170849122|NCT01820585|617455152|FG002|Overall Study|Withdrawal by Subject|3|||
170849123|NCT01820585|617455153|FG003|Overall Study|Withdrawal by Subject|8|||
170849124|NCT01820585|617455150|FG000|Overall Study|Lost to Follow-up|3|||
170849125|NCT01820585|617455151|FG001|Overall Study|Lost to Follow-up|3|||
170849126|NCT01820585|617455152|FG002|Overall Study|Lost to Follow-up|0|||
170849127|NCT01820585|617455153|FG003|Overall Study|Lost to Follow-up|3|||
170849128|NCT01820585|617455150|FG000|Overall Study|Protocol Violation|3|||
170849129|NCT01820585|617455151|FG001|Overall Study|Protocol Violation|1|||
170849130|NCT01820585|617455152|FG002|Overall Study|Protocol Violation|1|||
170849131|NCT01820585|617455153|FG003|Overall Study|Protocol Violation|1|||
170849132|NCT01820585|617455150|FG000|Overall Study|Subject non-compliance|0|||
170849133|NCT01820585|617455151|FG001|Overall Study|Subject non-compliance|0|||
170849134|NCT01820585|617455152|FG002|Overall Study|Subject non-compliance|1|||
170849135|NCT01820585|617455153|FG003|Overall Study|Subject non-compliance|2|||
170849136|NCT01820585|617455150|FG000|Overall Study|at sponsor request|0|||
170849137|NCT01820585|617455151|FG001|Overall Study|at sponsor request|0|||
170849138|NCT01820585|617455152|FG002|Overall Study|at sponsor request|1|||
170849139|NCT01820585|617455153|FG003|Overall Study|at sponsor request|0|||
170849140|NCT01820585|617455150|FG000|Overall Study|Pregnancy|0|||
170849141|NCT01820585|617455151|FG001|Overall Study|Pregnancy|1|||
170849142|NCT01820585|617455152|FG002|Overall Study|Pregnancy|0|||
170849143|NCT01820585|617455153|FG003|Overall Study|Pregnancy|0|||
170849144|NCT00548262|617455154|FG000|Overall Study|Death|21|||
170849145|NCT00548262|617455154|FG000|Overall Study|Adverse Event|2|||
170849146|NCT00548262|617455154|FG000|Overall Study|Lack of Efficacy|4|||
170849147|NCT00548262|617455154|FG000|Overall Study|Lost to Follow-up|1|||
170849148|NCT00548262|617455154|FG000|Overall Study|Other|3|||
170849149|NCT00548262|617455154|FG000|Overall Study|Withdrawal by Subject|1|||
170849150|NCT01278173|617455158|FG000|Overall Study|Lack of Efficacy|13|||
170849151|NCT01278173|617455158|FG000|Overall Study|Adverse Event|8|||
170849152|NCT01278173|617455158|FG000|Overall Study|Administrative or other reason|4|||
170849153|NCT01278173|617455158|FG000|Overall Study|Protocol Violation|1|||
170849154|NCT01278173|617455158|FG000|Overall Study|Withdrawal by Subject|1|||
170849155|NCT02270515|617455159|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
170849156|NCT02270515|617455159|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
170849157|NCT02270515|617455159|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
170849158|NCT02270515|617455159|FG000|Intervention Period 1: 0-6 Months|Death|7|||
170849159|NCT02270515|617455159|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
170849160|NCT02270515|617455159|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
170849161|NCT02270515|617455159|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
170849162|NCT02270515|617455159|FG000|Intervention Period 2: 6-12 Months|Death|5|||
170849163|NCT02270515|617455159|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
170849164|NCT02270515|617455159|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
170849165|NCT02270515|617455159|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
170849166|NCT02270515|617455159|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
170849167|NCT02270515|617455159|FG000|Intervention Period 3: 12-18 Months|Death|3|||
170849168|NCT02270515|617455159|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
170849169|NCT01111240|617455163|FG000|Overall Study|Adverse Event|190|||
170849170|NCT01111240|617455163|FG000|Overall Study|Lack of Efficacy|545|||
170849171|NCT01111240|617455163|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
170849172|NCT01111240|617455163|FG000|Overall Study|Other|312|||
170849173|NCT01607476|617455164|FG000|Overall Study|Withdrawal by Subject|1|||
170849174|NCT01607476|617455165|FG001|Overall Study|Withdrawal by Subject|0|||
170849175|NCT01607476|617455166|FG002|Overall Study|Withdrawal by Subject|1|||
170849176|NCT01607476|617455164|FG000|Overall Study|Lost to Follow-up|0|||
170849177|NCT01607476|617455165|FG001|Overall Study|Lost to Follow-up|0|||
170849178|NCT01607476|617455166|FG002|Overall Study|Lost to Follow-up|2|||
170849179|NCT04445987|617455167|FG000|Overall Study|Adverse Event|0|||
170849180|NCT04445987|617455168|FG001|Overall Study|Adverse Event|0|||
170849181|NCT04445987|617455169|FG002|Overall Study|Adverse Event|1|||
170849182|NCT04445987|617455170|FG003|Overall Study|Adverse Event|0|||
170849183|NCT04445987|617455171|FG004|Overall Study|Adverse Event|4|||
170849184|NCT04445987|617455172|FG005|Overall Study|Adverse Event|0|||
170849185|NCT04445987|617455167|FG000|Overall Study|Lost to Follow-up|4|||
170849186|NCT04445987|617455168|FG001|Overall Study|Lost to Follow-up|3|||
170849187|NCT04445987|617455169|FG002|Overall Study|Lost to Follow-up|1|||
170849188|NCT04445987|617455170|FG003|Overall Study|Lost to Follow-up|1|||
170849189|NCT04445987|617455171|FG004|Overall Study|Lost to Follow-up|29|||
170849190|NCT04445987|617455172|FG005|Overall Study|Lost to Follow-up|0|||
170849191|NCT04445987|617455167|FG000|Overall Study|Physician Decision|0|||
170849192|NCT04445987|617455168|FG001|Overall Study|Physician Decision|0|||
170849193|NCT04445987|617455169|FG002|Overall Study|Physician Decision|0|||
170849194|NCT04445987|617455170|FG003|Overall Study|Physician Decision|0|||
170849195|NCT04445987|617455171|FG004|Overall Study|Physician Decision|1|||
170849196|NCT04445987|617455172|FG005|Overall Study|Physician Decision|0|||
170849197|NCT04445987|617455167|FG000|Overall Study|Protocol Violation|1|||
170849198|NCT04445987|617455168|FG001|Overall Study|Protocol Violation|0|||
170849199|NCT04445987|617455169|FG002|Overall Study|Protocol Violation|0|||
170849200|NCT04445987|617455170|FG003|Overall Study|Protocol Violation|0|||
170849201|NCT04445987|617455171|FG004|Overall Study|Protocol Violation|2|||
170739559|NCT02002884|617054077|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
170739560|NCT02002884|617054078|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
170739561|NCT02002884|617054079|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
170739562|NCT02002884|617054080|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
170739563|NCT02110732|617054081|FG000|Overall Study|Physician Decision|5|||
170739564|NCT02110732|617054082|FG001|Overall Study|Physician Decision|2|||
170849202|NCT04445987|617455172|FG005|Overall Study|Protocol Violation|0|||
170849203|NCT04445987|617455167|FG000|Overall Study|Withdrawal by Subject|4|||
170849204|NCT04445987|617455168|FG001|Overall Study|Withdrawal by Subject|0|||
170849205|NCT04445987|617455169|FG002|Overall Study|Withdrawal by Subject|1|||
170849206|NCT04445987|617455170|FG003|Overall Study|Withdrawal by Subject|0|||
170849207|NCT04445987|617455171|FG004|Overall Study|Withdrawal by Subject|18|||
170849208|NCT04445987|617455172|FG005|Overall Study|Withdrawal by Subject|1|||
170849209|NCT04445987|617455167|FG000|Overall Study|Other reason|0|||
170849210|NCT04445987|617455168|FG001|Overall Study|Other reason|0|||
170849211|NCT04445987|617455169|FG002|Overall Study|Other reason|1|||
170739565|NCT02110732|617054081|FG000|Overall Study|Lost to Follow-up|1|||
170739566|NCT02110732|617054082|FG001|Overall Study|Lost to Follow-up|1|||
170739567|NCT04887948|617054087|FG000|Overall Study|Death|1|||
170739568|NCT04887948|617054088|FG001|Overall Study|Death|0|||
170849212|NCT04445987|617455170|FG003|Overall Study|Other reason|0|||
170849213|NCT04445987|617455171|FG004|Overall Study|Other reason|2|||
170849214|NCT04445987|617455172|FG005|Overall Study|Other reason|0|||
170849215|NCT01609062|617455173|FG000|Extension Phase|Terminated by Sponsor|14|||
170849216|NCT01609062|617455174|FG001|Extension Phase|Terminated by Sponsor|9|||
170849217|NCT01609062|617455173|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
170849218|NCT01609062|617455174|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
170849219|NCT01609062|617455173|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
170849220|NCT01609062|617455174|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
170849221|NCT01133418|617455175|FG000|Overall Study|Lost to Follow-up|5|||
170739569|NCT04887948|617054089|FG002|Overall Study|Death|0|||
170739570|NCT04887948|617054087|FG000|Overall Study|Lost to Follow-up|1|||
170739571|NCT04887948|617054088|FG001|Overall Study|Lost to Follow-up|0|||
170739572|NCT04887948|617054089|FG002|Overall Study|Lost to Follow-up|3|||
170739573|NCT04887948|617054087|FG000|Overall Study|Physician Decision|0|||
170739574|NCT04887948|617054088|FG001|Overall Study|Physician Decision|4|||
170739575|NCT04887948|617054089|FG002|Overall Study|Physician Decision|1|||
170739576|NCT04887948|617054087|FG000|Overall Study|Protocol Violation|1|||
170739577|NCT04887948|617054088|FG001|Overall Study|Protocol Violation|1|||
170739578|NCT04887948|617054089|FG002|Overall Study|Protocol Violation|0|||
170739579|NCT04887948|617054087|FG000|Overall Study|Withdrawal by Subject|0|||
170739580|NCT04887948|617054088|FG001|Overall Study|Withdrawal by Subject|6|||
170739581|NCT04887948|617054089|FG002|Overall Study|Withdrawal by Subject|1|||
170739582|NCT04887948|617054087|FG000|Overall Study|No longer met eligibility criteria|1|||
170739583|NCT04887948|617054088|FG001|Overall Study|No longer met eligibility criteria|2|||
170739584|NCT04887948|617054089|FG002|Overall Study|No longer met eligibility criteria|1|||
170739585|NCT04887948|617054087|FG000|Overall Study|Other|2|||
170739586|NCT04887948|617054088|FG001|Overall Study|Other|1|||
170739587|NCT04887948|617054089|FG002|Overall Study|Other|1|||
170739588|NCT02291432|617054090|FG000|Overall Study|Withdrawal by Subject|2|||
170739589|NCT01588990|617054091|FG000|Phase A|Withdrawal by Subject|5|||
170739590|NCT01588990|617054091|FG000|Phase A|Physician Decision|11|||
170739591|NCT01588990|617054091|FG000|Phase A|Other|14|||
170739592|NCT01588990|617054091|FG000|Phase A|Lost to Follow-up|1|||
170739593|NCT01588990|617054091|FG000|Phase A|Death|5|||
170739594|NCT01588990|617054091|FG000|Phase A|Adverse Event|28|||
170739595|NCT01588990|617054091|FG000|Phase A|Still on therapy at end of study|6|||
170739596|NCT01588990|617054091|FG000|Phase B|Adverse Event|2|||
170739597|NCT01588990|617054091|FG000|Phase B|Still on therapy at end of study|5|||
170739598|NCT01588990|617054091|FG000|Phase B|Withdrawal by Subject|3|||
170739599|NCT01588990|617054091|FG000|Phase B|Physician Decision|4|||
170739600|NCT01588990|617054091|FG000|Phase B|Other|2|||
170739601|NCT02367716|617054092|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
170739602|NCT00584805|617054093|FG000|Overall Study|No longer at risk of exposure|39|||
170739603|NCT00584805|617054093|FG000|Overall Study|Relocation|36|||
170739604|NCT00584805|617054093|FG000|Overall Study|Withdrawal by Subject|18|||
170739605|NCT00584805|617054093|FG000|Overall Study|Non-compliance|1|||
170739606|NCT00584805|617054093|FG000|Overall Study|Lost to follow up|3|||
170739607|NCT00584805|617054093|FG000|Overall Study|Screen failures|2|||
170739608|NCT01077362|617054097|FG000|Overall Study|Lack of Efficacy|13|||
170739609|NCT01077362|617054098|FG001|Overall Study|Lack of Efficacy|8|||
170739610|NCT01077362|617054099|FG002|Overall Study|Lack of Efficacy|10|||
170739611|NCT01077362|617054097|FG000|Overall Study|Lost to Follow-up|1|||
170739612|NCT01077362|617054098|FG001|Overall Study|Lost to Follow-up|0|||
170739613|NCT01077362|617054099|FG002|Overall Study|Lost to Follow-up|3|||
170739614|NCT01077362|617054097|FG000|Overall Study|Adverse Event|12|||
170739615|NCT01077362|617054098|FG001|Overall Study|Adverse Event|7|||
170739616|NCT01077362|617054099|FG002|Overall Study|Adverse Event|4|||
170739617|NCT01077362|617054097|FG000|Overall Study|Withdrawal by Subject|5|||
170739618|NCT01077362|617054098|FG001|Overall Study|Withdrawal by Subject|3|||
170739619|NCT01077362|617054099|FG002|Overall Study|Withdrawal by Subject|5|||
170739620|NCT01077362|617054097|FG000|Overall Study|Other|0|||
170739621|NCT01077362|617054098|FG001|Overall Study|Other|1|||
170739622|NCT01077362|617054099|FG002|Overall Study|Other|2|||
170739623|NCT00301080|617054102|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
170849222|NCT01133418|617455176|FG001|Overall Study|Lost to Follow-up|6|||
170849223|NCT04150068|617455179|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
170849224|NCT04150068|617455180|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
170739624|NCT00301080|617054103|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
170739625|NCT00301080|617054104|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
170739626|NCT00301080|617054105|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
170739627|NCT00301080|617054106|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
170739628|NCT04359771|617054107|FG000|Overall Study|Lack of Efficacy|2|||
170739629|NCT04359771|617054108|FG001|Overall Study|Lack of Efficacy|2|||
170739630|NCT03469349|617054109|FG000|Overall Study|Withdrawal by Subject|1|||
170739631|NCT03469349|617054110|FG001|Overall Study|Withdrawal by Subject|3|||
170739632|NCT03469349|617054109|FG000|Overall Study|Progressive Disease|0|||
170739633|NCT03469349|617054110|FG001|Overall Study|Progressive Disease|1|||
170739634|NCT03469349|617054109|FG000|Overall Study|Lost to Follow-up|2|||
170739635|NCT03469349|617054110|FG001|Overall Study|Lost to Follow-up|2|||
170739636|NCT03469349|617054109|FG000|Overall Study|Adverse Event|2|||
170739637|NCT03469349|617054110|FG001|Overall Study|Adverse Event|4|||
170739638|NCT02306265|617054111|FG000|Overall Study|Withdrawal by Subject|1|||
170739639|NCT01346514|617054112|FG000|Overall Study|Lost to Follow-up|19|||
170739640|NCT01346514|617054113|FG001|Overall Study|Lost to Follow-up|30|||
170849225|NCT04150068|617455181|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
170739641|NCT01346514|617054112|FG000|Overall Study|Withdrawal by Subject|7|||
170739642|NCT01346514|617054113|FG001|Overall Study|Withdrawal by Subject|3|||
170739643|NCT01346514|617054112|FG000|Overall Study|Death|3|||
170849226|NCT04150068|617455179|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
170849227|NCT04150068|617455180|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
170849228|NCT04150068|617455181|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
170849229|NCT05316701|617455182|FG000|Overall Study|Adverse Event|0|||
170849230|NCT05316701|617455183|FG001|Overall Study|Adverse Event|1|||
170849231|NCT05316701|617455182|FG000|Overall Study|Death|3|||
170849232|NCT05316701|617455183|FG001|Overall Study|Death|9|||
170849233|NCT05316701|617455182|FG000|Overall Study|Lost to Follow-up|1|||
170849234|NCT05316701|617455183|FG001|Overall Study|Lost to Follow-up|0|||
170849235|NCT05316701|617455182|FG000|Overall Study|Physician Decision|1|||
170849236|NCT05316701|617455183|FG001|Overall Study|Physician Decision|4|||
170849237|NCT05316701|617455182|FG000|Overall Study|Withdrawal by Subject|3|||
170849238|NCT05316701|617455183|FG001|Overall Study|Withdrawal by Subject|5|||
170849239|NCT05316701|617455182|FG000|Overall Study|Progression/Relapse|14|||
170849240|NCT05316701|617455183|FG001|Overall Study|Progression/Relapse|9|||
170849241|NCT05316701|617455182|FG000|Overall Study|Received Standard of Care|1|||
170849242|NCT05316701|617455183|FG001|Overall Study|Received Standard of Care|0|||
170849243|NCT05316701|617455182|FG000|Overall Study|Ongoing|70|||
170849244|NCT05316701|617455183|FG001|Overall Study|Ongoing|64|||
170849245|NCT01946529|617455184|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
170849246|NCT01946529|617455185|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
170849247|NCT01946529|617455186|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
170849248|NCT01946529|617455184|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
170849249|NCT01946529|617455185|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
170849250|NCT01946529|617455186|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
170849251|NCT04362189|617455196|FG000|Overall Study|Lost to Follow-up|0|||
170849252|NCT04362189|617455197|FG001|Overall Study|Lost to Follow-up|1|||
170849253|NCT04362189|617455196|FG000|Overall Study|Withdrawal by Subject|1|||
170849254|NCT04362189|617455197|FG001|Overall Study|Withdrawal by Subject|0|||
170849255|NCT04362189|617455196|FG000|Overall Study|FDA Clinical Hold|7|||
170849256|NCT04362189|617455197|FG001|Overall Study|FDA Clinical Hold|2|||
170849257|NCT04362189|617455196|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
170849258|NCT04362189|617455197|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
170849259|NCT04362189|617455196|FG000|Overall Study|Adverse Event|0|||
170849260|NCT04362189|617455197|FG001|Overall Study|Adverse Event|2|||
170849261|NCT04362189|617455196|FG000|Overall Study|Death|4|||
170849262|NCT04362189|617455197|FG001|Overall Study|Death|1|||
170849263|NCT03981861|617455198|FG000|Overall Study|Withdrawal by Subject|3|||
170849264|NCT04372121|617455199|FG000|Overall Study|Lost to Follow-up|0|||
170849265|NCT04372121|617455200|FG001|Overall Study|Lost to Follow-up|0|||
170849266|NCT04372121|617455201|FG002|Overall Study|Lost to Follow-up|0|||
170849267|NCT04372121|617455202|FG003|Overall Study|Lost to Follow-up|1|||
170849268|NCT04372121|617455199|FG000|Overall Study|Protocol Violation|0|||
170849269|NCT04372121|617455200|FG001|Overall Study|Protocol Violation|0|||
170849270|NCT04372121|617455201|FG002|Overall Study|Protocol Violation|1|||
170849271|NCT04372121|617455202|FG003|Overall Study|Protocol Violation|0|||
170849272|NCT04372121|617455199|FG000|Overall Study|Withdrawal by Subject|3|||
170849273|NCT04372121|617455200|FG001|Overall Study|Withdrawal by Subject|1|||
170849274|NCT04372121|617455201|FG002|Overall Study|Withdrawal by Subject|0|||
170849275|NCT04372121|617455202|FG003|Overall Study|Withdrawal by Subject|0|||
170849276|NCT04372121|617455199|FG000|Overall Study|Study termination|6|||
170849277|NCT04372121|617455200|FG001|Overall Study|Study termination|5|||
170849278|NCT04372121|617455201|FG002|Overall Study|Study termination|1|||
170849279|NCT04372121|617455202|FG003|Overall Study|Study termination|1|||
170849280|NCT04372121|617455199|FG000|Overall Study|Hysterectomy planned|1|||
170849281|NCT04372121|617455200|FG001|Overall Study|Hysterectomy planned|0|||
170849282|NCT04372121|617455201|FG002|Overall Study|Hysterectomy planned|0|||
170849283|NCT04372121|617455202|FG003|Overall Study|Hysterectomy planned|0|||
170849284|NCT00872989|617457190|FG000|Overall Study|Adverse Event|7|||
170849285|NCT00872989|617457191|FG001|Overall Study|Adverse Event|15|||
170849286|NCT00872989|617457190|FG000|Overall Study|Withdrawal by Subject|8|||
170849287|NCT00872989|617457191|FG001|Overall Study|Withdrawal by Subject|5|||
170849288|NCT00872989|617457190|FG000|Overall Study|Progression/relapse|47|||
170849289|NCT00872989|617457191|FG001|Overall Study|Progression/relapse|35|||
170849290|NCT00872989|617457190|FG000|Overall Study|Not protocol specified|3|||
170849291|NCT00872989|617457191|FG001|Overall Study|Not protocol specified|8|||
170849292|NCT01290315|617457196|FG000|Overall Study|Adverse Event|0|||
170849293|NCT01290315|617457197|FG001|Overall Study|Adverse Event|0|||
170849294|NCT01290315|617457198|FG002|Overall Study|Adverse Event|0|||
170849295|NCT01290315|617457199|FG003|Overall Study|Adverse Event|3|||
170849296|NCT01290315|617457196|FG000|Overall Study|Selection criteria/compliance|2|||
170849297|NCT01290315|617457197|FG001|Overall Study|Selection criteria/compliance|1|||
170849298|NCT01290315|617457198|FG002|Overall Study|Selection criteria/compliance|0|||
170849299|NCT01290315|617457199|FG003|Overall Study|Selection criteria/compliance|2|||
170849300|NCT01290315|617457196|FG000|Overall Study|Lost to Follow-up|0|||
170849301|NCT01290315|617457197|FG001|Overall Study|Lost to Follow-up|1|||
170849302|NCT01290315|617457198|FG002|Overall Study|Lost to Follow-up|0|||
170849303|NCT01290315|617457199|FG003|Overall Study|Lost to Follow-up|0|||
170849304|NCT01290315|617457196|FG000|Overall Study|Withdrawal by Subject|1|||
170849305|NCT01290315|617457197|FG001|Overall Study|Withdrawal by Subject|1|||
170849306|NCT01290315|617457198|FG002|Overall Study|Withdrawal by Subject|0|||
170849307|NCT01290315|617457199|FG003|Overall Study|Withdrawal by Subject|0|||
170849308|NCT01658150|617457205|FG000|Overall Study|Withdrawal by Subject|1|||
170849309|NCT05540717|617457206|FG000|Overall Study|Lost to Follow-up|2|||
170849310|NCT05540717|617457207|FG001|Overall Study|Lost to Follow-up|5|||
170849311|NCT05540717|617457206|FG000|Overall Study|Withdrawal by Subject|6|||
170849312|NCT05540717|617457207|FG001|Overall Study|Withdrawal by Subject|6|||
170849313|NCT05540717|617457206|FG000|Overall Study|Sponsor request|1|||
170849314|NCT05540717|617457207|FG001|Overall Study|Sponsor request|0|||
170849315|NCT05540717|617457206|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
170849316|NCT05540717|617457207|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
170849317|NCT05540717|617457206|FG000|Overall Study|Other|0|||
170849318|NCT05540717|617457207|FG001|Overall Study|Other|1|||
170849319|NCT01144052|617457211|FG000|Overall Study|Withdrawal by Subject|1|||
170849320|NCT01144052|617457212|FG001|Overall Study|Withdrawal by Subject|1|||
170849321|NCT01519089|617457216|FG000|Overall Study|Adverse Event|4|||
170849322|NCT01519089|617457217|FG001|Overall Study|Adverse Event|4|||
170849323|NCT01519089|617457216|FG000|Overall Study|Lack of Efficacy|0|||
170849324|NCT01519089|617457217|FG001|Overall Study|Lack of Efficacy|2|||
170849325|NCT01519089|617457216|FG000|Overall Study|Lost to Follow-up|1|||
170849326|NCT01519089|617457217|FG001|Overall Study|Lost to Follow-up|0|||
170849327|NCT01519089|617457216|FG000|Overall Study|Withdrawal by Subject|0|||
170849328|NCT01519089|617457217|FG001|Overall Study|Withdrawal by Subject|2|||
170849329|NCT01519089|617457216|FG000|Overall Study|Other|2|||
170849330|NCT01519089|617457217|FG001|Overall Study|Other|6|||
170849331|NCT01519089|617457216|FG000|Overall Study|Not received study drug|0|||
170849332|NCT01519089|617457217|FG001|Overall Study|Not received study drug|1|||
170849333|NCT01327495|617457218|FG000|Overall Study|Adverse Event|2|||
170849334|NCT01327495|617457219|FG001|Overall Study|Adverse Event|1|||
170849335|NCT01327495|617457220|FG002|Overall Study|Adverse Event|1|||
170849336|NCT01327495|617457221|FG003|Overall Study|Adverse Event|0|||
170849337|NCT01327495|617457222|FG004|Overall Study|Adverse Event|0|||
170849338|NCT01327495|617457223|FG005|Overall Study|Adverse Event|2|||
170849339|NCT01327495|617457218|FG000|Overall Study|Withdrawal by Subject|0|||
170849340|NCT01327495|617457219|FG001|Overall Study|Withdrawal by Subject|1|||
170849341|NCT01327495|617457220|FG002|Overall Study|Withdrawal by Subject|1|||
170849342|NCT01327495|617457221|FG003|Overall Study|Withdrawal by Subject|0|||
170849343|NCT01327495|617457222|FG004|Overall Study|Withdrawal by Subject|1|||
170849344|NCT01327495|617457223|FG005|Overall Study|Withdrawal by Subject|0|||
170849345|NCT01327495|617457218|FG000|Overall Study|Physician Decision|0|||
170849346|NCT01327495|617457219|FG001|Overall Study|Physician Decision|0|||
170849347|NCT01327495|617457220|FG002|Overall Study|Physician Decision|0|||
170849348|NCT01327495|617457221|FG003|Overall Study|Physician Decision|0|||
170849349|NCT01327495|617457222|FG004|Overall Study|Physician Decision|2|||
170849350|NCT01327495|617457223|FG005|Overall Study|Physician Decision|0|||
170849351|NCT02580305|617457224|FG000|Overall Study|Adverse Event|15|||
170849352|NCT02580305|617457225|FG001|Overall Study|Adverse Event|19|||
170849353|NCT02580305|617457226|FG002|Overall Study|Adverse Event|10|||
170849354|NCT02580305|617457224|FG000|Overall Study|Lack of Efficacy|5|||
170849355|NCT02580305|617457225|FG001|Overall Study|Lack of Efficacy|0|||
170849356|NCT02580305|617457226|FG002|Overall Study|Lack of Efficacy|2|||
170849357|NCT02580305|617457224|FG000|Overall Study|Protocol Violation|4|||
170849358|NCT02580305|617457225|FG001|Overall Study|Protocol Violation|9|||
170849359|NCT02580305|617457226|FG002|Overall Study|Protocol Violation|6|||
170849360|NCT02580305|617457224|FG000|Overall Study|Lost to Follow-up|4|||
170849361|NCT02580305|617457225|FG001|Overall Study|Lost to Follow-up|4|||
170849362|NCT02580305|617457226|FG002|Overall Study|Lost to Follow-up|2|||
170849363|NCT02580305|617457224|FG000|Overall Study|Withdrawal by Subject|11|||
170849364|NCT02580305|617457225|FG001|Overall Study|Withdrawal by Subject|9|||
170849365|NCT02580305|617457226|FG002|Overall Study|Withdrawal by Subject|7|||
170849366|NCT02580305|617457224|FG000|Overall Study|Randomized in error and never treated|4|||
170849367|NCT02580305|617457225|FG001|Overall Study|Randomized in error and never treated|8|||
170849368|NCT02580305|617457226|FG002|Overall Study|Randomized in error and never treated|5|||
170849369|NCT01699503|617457227|FG000|Overall Study|Death|31|||
170849370|NCT01699503|617457228|FG001|Overall Study|Death|40|||
170849371|NCT01699503|617457227|FG000|Overall Study|Withdrawal by Subject|65|||
170849372|NCT01699503|617457228|FG001|Overall Study|Withdrawal by Subject|57|||
170849373|NCT01699503|617457227|FG000|Overall Study|Lost to Follow-up|121|||
170849374|NCT01699503|617457228|FG001|Overall Study|Lost to Follow-up|117|||
170849375|NCT01699503|617457227|FG000|Overall Study|Excluded due to quality|783|||
170849376|NCT01699503|617457228|FG001|Overall Study|Excluded due to quality|791|||
170849377|NCT01639560|617457231|FG000|Overall Study|Withdrawal by Subject|9|||
170849378|NCT01639560|617457232|FG001|Overall Study|Withdrawal by Subject|14|||
170849379|NCT01639560|617457231|FG000|Overall Study|Lack of Efficacy|1|||
170849380|NCT01639560|617457232|FG001|Overall Study|Lack of Efficacy|2|||
170849381|NCT01639560|617457231|FG000|Overall Study|Lost to Follow-up|9|||
170849382|NCT01639560|617457232|FG001|Overall Study|Lost to Follow-up|11|||
170849383|NCT01639560|617457231|FG000|Overall Study|Adverse Event|0|||
170849384|NCT01639560|617457232|FG001|Overall Study|Adverse Event|2|||
170849385|NCT01631227|617457233|FG000|Overall Study|withdrawn consent|27|||
170849386|NCT01631227|617457234|FG001|Overall Study|withdrawn consent|21|||
170849387|NCT01631227|617457233|FG000|Overall Study|Adverse Event|1|||
170849388|NCT01631227|617457234|FG001|Overall Study|Adverse Event|0|||
170849389|NCT01631227|617457233|FG000|Overall Study|administrative|2|||
170849390|NCT01631227|617457234|FG001|Overall Study|administrative|1|||
170849391|NCT00730275|617457235|FG000|Overall Study|Withdrawal by Subject|0|||
170849392|NCT00730275|617457236|FG001|Overall Study|Withdrawal by Subject|0|||
170849393|NCT00730275|617457237|FG002|Overall Study|Withdrawal by Subject|0|||
170849394|NCT00730275|617457238|FG003|Overall Study|Withdrawal by Subject|1|||
170849395|NCT01153321|617457239|FG000|Overall Study|Development of study withdrawal criteria|0|||
170849396|NCT01153321|617457240|FG001|Overall Study|Development of study withdrawal criteria|1|||
170849397|NCT01153321|617457239|FG000|Overall Study|Withdrawal by Subject|0|||
170849398|NCT01153321|617457240|FG001|Overall Study|Withdrawal by Subject|1|||
170849399|NCT01153321|617457239|FG000|Overall Study|Adverse Event|1|||
170849400|NCT01153321|617457240|FG001|Overall Study|Adverse Event|1|||
170849401|NCT01177800|617457241|FG000|Overall Study|Adverse Event|9|||
170849402|NCT01177800|617457242|FG001|Overall Study|Adverse Event|3|||
170849403|NCT01177800|617457241|FG000|Overall Study|Protocol Violation|0|||
170849404|NCT01177800|617457242|FG001|Overall Study|Protocol Violation|1|||
170849405|NCT01177800|617457241|FG000|Overall Study|Physician Decision|1|||
170849406|NCT01177800|617457242|FG001|Overall Study|Physician Decision|0|||
170849407|NCT01177800|617457241|FG000|Overall Study|Withdrawal of informed consent|0|||
170849408|NCT01177800|617457242|FG001|Overall Study|Withdrawal of informed consent|1|||
170849409|NCT01871805|617457243|FG000|Phase I|Death|7|||
170849410|NCT01871805|617457244|FG001|Phase I|Death|4|||
170849411|NCT01871805|617457245|FG002|Phase I|Death|6|||
170849412|NCT01871805|617457246|FG003|Phase I|Death|2|||
170849413|NCT01871805|617457247|FG004|Phase I|Death|9|||
170849414|NCT01871805|617457248|FG005|Phase I|Death|0|||
170849415|NCT01871805|617457243|FG000|Phase I|Alive in Survival Follow-up|0|||
170849416|NCT01871805|617457244|FG001|Phase I|Alive in Survival Follow-up|2|||
170849417|NCT01871805|617457245|FG002|Phase I|Alive in Survival Follow-up|4|||
170849418|NCT01871805|617457246|FG003|Phase I|Alive in Survival Follow-up|5|||
170849419|NCT01871805|617457247|FG004|Phase I|Alive in Survival Follow-up|4|||
170849420|NCT01871805|617457248|FG005|Phase I|Alive in Survival Follow-up|0|||
170849421|NCT01871805|617457243|FG000|Phase I|Lost to Follow-up|0|||
170849422|NCT01871805|617457244|FG001|Phase I|Lost to Follow-up|1|||
170849423|NCT01871805|617457245|FG002|Phase I|Lost to Follow-up|3|||
170849424|NCT01871805|617457246|FG003|Phase I|Lost to Follow-up|0|||
170849425|NCT01871805|617457247|FG004|Phase I|Lost to Follow-up|0|||
170849426|NCT01871805|617457248|FG005|Phase I|Lost to Follow-up|0|||
170849427|NCT01871805|617457243|FG000|Phase II|Death|0|||
170849428|NCT01871805|617457244|FG001|Phase II|Death|0|||
170849429|NCT01871805|617457245|FG002|Phase II|Death|0|||
170849430|NCT01871805|617457246|FG003|Phase II|Death|0|||
170849431|NCT01871805|617457247|FG004|Phase II|Death|0|||
170849432|NCT01871805|617457248|FG005|Phase II|Death|45|||
170849433|NCT01871805|617457243|FG000|Phase II|Alive in Survival Follow-up|0|||
170849434|NCT01871805|617457244|FG001|Phase II|Alive in Survival Follow-up|0|||
170849435|NCT01871805|617457245|FG002|Phase II|Alive in Survival Follow-up|0|||
170849436|NCT01871805|617457246|FG003|Phase II|Alive in Survival Follow-up|0|||
170849437|NCT01871805|617457247|FG004|Phase II|Alive in Survival Follow-up|0|||
170849438|NCT01871805|617457248|FG005|Phase II|Alive in Survival Follow-up|29|||
170849439|NCT01871805|617457243|FG000|Phase II|Lost to Follow-up|0|||
170849440|NCT01871805|617457244|FG001|Phase II|Lost to Follow-up|0|||
170849441|NCT01871805|617457245|FG002|Phase II|Lost to Follow-up|0|||
170849442|NCT01871805|617457246|FG003|Phase II|Lost to Follow-up|0|||
170849443|NCT01871805|617457247|FG004|Phase II|Lost to Follow-up|0|||
170849444|NCT01871805|617457248|FG005|Phase II|Lost to Follow-up|13|||
170849445|NCT00488475|617457249|FG000|Overall Study|Other|1754|||
170849446|NCT00941070|617457266|FG000|Overall Study|Patient non-compliant|1|||
170849447|NCT00400725|617457267|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
170739644|NCT01346514|617054113|FG001|Overall Study|Death|4|||
170739645|NCT00909480|617054114|FG000|Overall Study|Adverse Event|5|||
170739646|NCT00909480|617054115|FG001|Overall Study|Adverse Event|3|||
170739647|NCT00909480|617054114|FG000|Overall Study|Protocol Violation|6|||
170739648|NCT00909480|617054115|FG001|Overall Study|Protocol Violation|8|||
170739649|NCT00909480|617054114|FG000|Overall Study|Withdrawal criteria|9|||
170739650|NCT00909480|617054115|FG001|Overall Study|Withdrawal criteria|11|||
170739651|NCT00909480|617054114|FG000|Overall Study|Unclassified|18|||
170739652|NCT00909480|617054115|FG001|Overall Study|Unclassified|19|||
170739653|NCT03528174|617054117|FG000|Overall Study|Adverse Event|1|||
170739654|NCT03528174|617054117|FG000|Overall Study|sensors dislodged|1|||
170739655|NCT04251065|617054118|FG000|Overall Study|Death|2|||
170739656|NCT04251065|617054118|FG000|Overall Study|Lack of Efficacy|3|||
170739657|NCT04251065|617054118|FG000|Overall Study|Death|1|||
170739658|NCT01054573|617054119|FG000|Overall Study|Adverse Event|1|||
170739659|NCT01054573|617054120|FG001|Overall Study|Adverse Event|0|||
170739660|NCT01054573|617054121|FG002|Overall Study|Adverse Event|1|||
170739661|NCT01054573|617054122|FG003|Overall Study|Adverse Event|1|||
170739662|NCT01054573|617054119|FG000|Overall Study|Lost to Follow-up|0|||
170739663|NCT01054573|617054120|FG001|Overall Study|Lost to Follow-up|2|||
170739664|NCT01054573|617054121|FG002|Overall Study|Lost to Follow-up|0|||
170739665|NCT01054573|617054122|FG003|Overall Study|Lost to Follow-up|0|||
170739666|NCT01054573|617054119|FG000|Overall Study|Withdrawal by Subject|0|||
170739667|NCT01054573|617054120|FG001|Overall Study|Withdrawal by Subject|2|||
170739668|NCT01054573|617054121|FG002|Overall Study|Withdrawal by Subject|2|||
170739669|NCT01054573|617054122|FG003|Overall Study|Withdrawal by Subject|1|||
170739670|NCT00393523|617054123|FG000|Overall Study|Lost to Follow-up|0|||
170739671|NCT00393523|617054124|FG001|Overall Study|Lost to Follow-up|0|||
170739672|NCT00393523|617054125|FG002|Overall Study|Lost to Follow-up|0|||
170739673|NCT00393523|617054126|FG003|Overall Study|Lost to Follow-up|2|||
170739674|NCT00393523|617054127|FG004|Overall Study|Lost to Follow-up|1|||
170739675|NCT00393523|617054123|FG000|Overall Study|Protocol Violation|6|||
170739676|NCT00393523|617054124|FG001|Overall Study|Protocol Violation|2|||
170849448|NCT00400725|617457268|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
170849449|NCT00400725|617457269|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
170849450|NCT00400725|617457267|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
170849451|NCT00400725|617457268|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
170849452|NCT00400725|617457269|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
170849453|NCT00400725|617457267|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
170849454|NCT00400725|617457268|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
170849455|NCT00400725|617457269|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
170849456|NCT00400725|617457267|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
170849457|NCT00400725|617457268|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
170849458|NCT00400725|617457269|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
170849459|NCT00400725|617457267|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
170849460|NCT00400725|617457268|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
170849461|NCT00400725|617457269|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
170849462|NCT00400725|617457267|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
170849463|NCT00400725|617457268|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
170849464|NCT00400725|617457269|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
170849465|NCT00400725|617457267|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
170849466|NCT00400725|617457268|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
170849467|NCT00400725|617457269|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
170849468|NCT00400725|617457267|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
170849469|NCT00400725|617457268|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
170849470|NCT00400725|617457269|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
170849471|NCT00400725|617457267|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
170849472|NCT00400725|617457268|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
170849473|NCT00400725|617457269|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
170849474|NCT03174431|617457270|FG000|Overall Study|Withdrawal by Subject|14|||
170849475|NCT03174431|617457271|FG001|Overall Study|Withdrawal by Subject|11|||
170849476|NCT03174431|617457270|FG000|Overall Study|alternative treatment|2|||
170849477|NCT03174431|617457271|FG001|Overall Study|alternative treatment|0|||
170849478|NCT03174431|617457270|FG000|Overall Study|Lost to Follow-up|1|||
170849479|NCT03174431|617457271|FG001|Overall Study|Lost to Follow-up|5|||
170849480|NCT03500159|617457272|FG000|Overall Study|Study Terminated|2|||
170849481|NCT03500159|617457273|FG001|Overall Study|Study Terminated|1|||
170849482|NCT01263665|617457274|FG000|Overall Study|Withdrew Consent|1|||
170849483|NCT01263665|617457274|FG000|Overall Study|Lost to Follow-up|3|||
170849484|NCT01263665|617457274|FG000|Overall Study|Death|2|||
170849485|NCT01263665|617457274|FG000|Overall Study|Amputation above the ankle|1|||
170849486|NCT01263665|617457274|FG000|Overall Study|Surgical Bypass|2|||
170849487|NCT00951015|617457276|FG000|Randomization Phase 96 Week|Adverse Event|1|||
170849488|NCT00951015|617457277|FG001|Randomization Phase 96 Week|Adverse Event|1|||
170849489|NCT00951015|617457278|FG002|Randomization Phase 96 Week|Adverse Event|2|||
170849490|NCT00951015|617457279|FG003|Randomization Phase 96 Week|Adverse Event|5|||
170849491|NCT00951015|617457280|FG004|Randomization Phase 96 Week|Adverse Event|0|||
170849492|NCT00951015|617457276|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
170849493|NCT00951015|617457277|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
170849494|NCT00951015|617457278|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
170849495|NCT00951015|617457279|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
170849496|NCT00951015|617457280|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
170849497|NCT00951015|617457276|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
170849498|NCT00951015|617457277|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
170849499|NCT00951015|617457278|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
170849500|NCT00951015|617457279|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
170849501|NCT00951015|617457280|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
170849502|NCT00951015|617457276|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
170849503|NCT00951015|617457277|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
170849504|NCT00951015|617457278|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
170849505|NCT00951015|617457279|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
170849506|NCT00951015|617457280|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
170849507|NCT00951015|617457276|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
170849508|NCT00951015|617457277|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
170849509|NCT00951015|617457278|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
170849510|NCT00951015|617457279|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
170849511|NCT00951015|617457280|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
170849512|NCT00951015|617457276|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
170849513|NCT00951015|617457277|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
170849514|NCT00951015|617457278|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
170849515|NCT00951015|617457279|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
170849516|NCT00951015|617457280|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
170739677|NCT00393523|617054125|FG002|Overall Study|Protocol Violation|0|||
170739678|NCT00393523|617054126|FG003|Overall Study|Protocol Violation|1|||
170739679|NCT00393523|617054127|FG004|Overall Study|Protocol Violation|0|||
170739680|NCT00393523|617054123|FG000|Overall Study|Withdrawal by Subject|6|||
170739681|NCT00393523|617054124|FG001|Overall Study|Withdrawal by Subject|7|||
170739682|NCT00393523|617054125|FG002|Overall Study|Withdrawal by Subject|2|||
170739683|NCT00393523|617054126|FG003|Overall Study|Withdrawal by Subject|3|||
170739684|NCT00393523|617054127|FG004|Overall Study|Withdrawal by Subject|0|||
170739685|NCT00393523|617054123|FG000|Overall Study|Difficulties in specimen collection|0|||
170739686|NCT00393523|617054124|FG001|Overall Study|Difficulties in specimen collection|0|||
170739687|NCT00393523|617054125|FG002|Overall Study|Difficulties in specimen collection|1|||
170739688|NCT00393523|617054126|FG003|Overall Study|Difficulties in specimen collection|0|||
170739689|NCT00393523|617054127|FG004|Overall Study|Difficulties in specimen collection|0|||
170739690|NCT00393523|617054123|FG000|Overall Study|Vaccine supply issue|0|||
170739691|NCT00393523|617054124|FG001|Overall Study|Vaccine supply issue|0|||
170739692|NCT00393523|617054125|FG002|Overall Study|Vaccine supply issue|1|||
170739693|NCT00393523|617054126|FG003|Overall Study|Vaccine supply issue|0|||
170739694|NCT00393523|617054127|FG004|Overall Study|Vaccine supply issue|0|||
170739695|NCT01735396|617054131|FG000|Overall Study|not evaluable|1|||
170739696|NCT02739347|617054138|FG000|Overall Study|Adverse Event|3|||
170739697|NCT02739347|617054139|FG001|Overall Study|Adverse Event|0|||
170739698|NCT02739347|617054138|FG000|Overall Study|Protocol Violation|0|||
170739699|NCT02739347|617054139|FG001|Overall Study|Protocol Violation|1|||
170739700|NCT02739347|617054138|FG000|Overall Study|Lost to Follow-up|0|||
170739701|NCT02739347|617054139|FG001|Overall Study|Lost to Follow-up|2|||
170739702|NCT01931735|617054140|FG000|Randomized Phase|Lost to Follow-up|2|||
170739703|NCT01931735|617054141|FG001|Randomized Phase|Lost to Follow-up|2|||
170739704|NCT01931735|617054142|FG002|Randomized Phase|Lost to Follow-up|5|||
170739705|NCT01931735|617054143|FG003|Randomized Phase|Lost to Follow-up|0|||
170739706|NCT01931735|617054140|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
170739707|NCT01931735|617054141|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
170739708|NCT01931735|617054142|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
170739709|NCT01931735|617054143|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
170739710|NCT01931735|617054140|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
170739711|NCT01931735|617054141|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
170739712|NCT01931735|617054142|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
170739713|NCT01931735|617054143|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
170739714|NCT03300570|617054145|FG000|Overall Study|Adverse Event|0|||
170739715|NCT03300570|617054146|FG001|Overall Study|Adverse Event|1|||
170739716|NCT03300570|617054145|FG000|Overall Study|Withdrawal by Subject|1|||
170739717|NCT03300570|617054146|FG001|Overall Study|Withdrawal by Subject|0|||
170739718|NCT03300570|617054145|FG000|Overall Study|Inadequate bowel prep|1|||
170739719|NCT03300570|617054146|FG001|Overall Study|Inadequate bowel prep|0|||
170739720|NCT02296190|617054147|FG000|Overall Study|Lost to Follow-up|0|||
170739721|NCT02296190|617054148|FG001|Overall Study|Lost to Follow-up|0|||
170739722|NCT02296190|617054149|FG002|Overall Study|Lost to Follow-up|0|||
170739723|NCT02296190|617054150|FG003|Overall Study|Lost to Follow-up|0|||
170739724|NCT02296190|617054151|FG004|Overall Study|Lost to Follow-up|1|||
170739725|NCT02296190|617054152|FG005|Overall Study|Lost to Follow-up|0|||
170739726|NCT02296190|617054147|FG000|Overall Study|Failure to induce PSVT|6|||
170739727|NCT02296190|617054148|FG001|Overall Study|Failure to induce PSVT|10|||
170739728|NCT02296190|617054149|FG002|Overall Study|Failure to induce PSVT|5|||
170739729|NCT02296190|617054150|FG003|Overall Study|Failure to induce PSVT|13|||
170739730|NCT02296190|617054151|FG004|Overall Study|Failure to induce PSVT|8|||
170739731|NCT02296190|617054152|FG005|Overall Study|Failure to induce PSVT|0|||
170849517|NCT00951015|617457276|FG000|Open-label Phase|Adverse Event|0|||
170849518|NCT00951015|617457277|FG001|Open-label Phase|Adverse Event|0|||
170849519|NCT00951015|617457278|FG002|Open-label Phase|Adverse Event|0|||
170849520|NCT00951015|617457279|FG003|Open-label Phase|Adverse Event|0|||
170849521|NCT00951015|617457280|FG004|Open-label Phase|Adverse Event|3|||
170849522|NCT00951015|617457276|FG000|Open-label Phase|Lack of Efficacy|0|||
170849523|NCT00951015|617457277|FG001|Open-label Phase|Lack of Efficacy|0|||
170849524|NCT00951015|617457278|FG002|Open-label Phase|Lack of Efficacy|0|||
170849525|NCT00951015|617457279|FG003|Open-label Phase|Lack of Efficacy|0|||
170849526|NCT00951015|617457280|FG004|Open-label Phase|Lack of Efficacy|1|||
170849527|NCT00951015|617457276|FG000|Open-label Phase|Protocol Violation|0|||
170849528|NCT00951015|617457277|FG001|Open-label Phase|Protocol Violation|0|||
170849529|NCT00951015|617457278|FG002|Open-label Phase|Protocol Violation|0|||
170849530|NCT00951015|617457279|FG003|Open-label Phase|Protocol Violation|0|||
170849531|NCT00951015|617457280|FG004|Open-label Phase|Protocol Violation|12|||
170849532|NCT00951015|617457276|FG000|Open-label Phase|Lost to Follow-up|0|||
170849533|NCT00951015|617457277|FG001|Open-label Phase|Lost to Follow-up|0|||
170849534|NCT00951015|617457278|FG002|Open-label Phase|Lost to Follow-up|0|||
170849535|NCT00951015|617457279|FG003|Open-label Phase|Lost to Follow-up|0|||
170849536|NCT00951015|617457280|FG004|Open-label Phase|Lost to Follow-up|12|||
170849537|NCT00951015|617457276|FG000|Open-label Phase|Withdrawal by Subject|0|||
170849538|NCT00951015|617457277|FG001|Open-label Phase|Withdrawal by Subject|0|||
170849539|NCT00951015|617457278|FG002|Open-label Phase|Withdrawal by Subject|0|||
170849540|NCT00951015|617457279|FG003|Open-label Phase|Withdrawal by Subject|0|||
170849541|NCT00951015|617457280|FG004|Open-label Phase|Withdrawal by Subject|14|||
170849542|NCT00951015|617457276|FG000|Open-label Phase|Physician Decision|0|||
170849543|NCT00951015|617457277|FG001|Open-label Phase|Physician Decision|0|||
170849544|NCT00951015|617457278|FG002|Open-label Phase|Physician Decision|0|||
170849545|NCT00951015|617457279|FG003|Open-label Phase|Physician Decision|0|||
170739732|NCT02296190|617054147|FG000|Overall Study|Physician Decision|1|||
170739733|NCT02296190|617054148|FG001|Overall Study|Physician Decision|1|||
170739734|NCT02296190|617054149|FG002|Overall Study|Physician Decision|0|||
170739735|NCT02296190|617054150|FG003|Overall Study|Physician Decision|1|||
170739736|NCT02296190|617054151|FG004|Overall Study|Physician Decision|2|||
170739737|NCT02296190|617054152|FG005|Overall Study|Physician Decision|0|||
170739738|NCT02296190|617054147|FG000|Overall Study|Withdrawal by Subject|0|||
170739739|NCT02296190|617054148|FG001|Overall Study|Withdrawal by Subject|1|||
170739740|NCT02296190|617054149|FG002|Overall Study|Withdrawal by Subject|0|||
170739741|NCT02296190|617054150|FG003|Overall Study|Withdrawal by Subject|0|||
170739742|NCT02296190|617054151|FG004|Overall Study|Withdrawal by Subject|0|||
170739743|NCT02296190|617054152|FG005|Overall Study|Withdrawal by Subject|0|||
170739744|NCT02296190|617054147|FG000|Overall Study|PSVT < 5 minutes|5|||
170739745|NCT02296190|617054148|FG001|Overall Study|PSVT < 5 minutes|6|||
170739746|NCT02296190|617054149|FG002|Overall Study|PSVT < 5 minutes|6|||
170739747|NCT02296190|617054150|FG003|Overall Study|PSVT < 5 minutes|6|||
170739748|NCT02296190|617054151|FG004|Overall Study|PSVT < 5 minutes|5|||
170739749|NCT02296190|617054152|FG005|Overall Study|PSVT < 5 minutes|0|||
170739750|NCT02296190|617054147|FG000|Overall Study|Patient was given Propofol|0|||
170739751|NCT02296190|617054148|FG001|Overall Study|Patient was given Propofol|1|||
170739752|NCT02296190|617054149|FG002|Overall Study|Patient was given Propofol|0|||
170739753|NCT02296190|617054150|FG003|Overall Study|Patient was given Propofol|1|||
170849546|NCT00951015|617457280|FG004|Open-label Phase|Physician Decision|8|||
170849547|NCT01416389|617457281|FG000|Overall Study|Lost to Follow-up|1|||
170849548|NCT01416389|617457282|FG001|Overall Study|Lost to Follow-up|0|||
170849549|NCT01416389|617457281|FG000|Overall Study|Started New Therapy|2|||
170849550|NCT01416389|617457282|FG001|Overall Study|Started New Therapy|0|||
170849551|NCT00958841|617457283|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170849552|NCT00958841|617457283|FG000|Overall Study|Abnormal test procedure result(s)|3|||
170849553|NCT00958841|617457283|FG000|Overall Study|Administrative problems|1|||
170849554|NCT00958841|617457283|FG000|Overall Study|Adverse Event|8|||
170849555|NCT00958841|617457283|FG000|Overall Study|New cancer therapy|5|||
170849556|NCT00958841|617457283|FG000|Overall Study|Withdrawal by Subject|1|||
170849557|NCT00958841|617457283|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
170849558|NCT00958841|617457283|FG000|Overall Study|Completed M6/did not enter extension|27|||
170849559|NCT00958841|617457283|FG000|Overall Study|Discontinued prior to M*|28|||
170849560|NCT01125514|617457290|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
170849561|NCT01125514|617457290|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
170849562|NCT01125514|617457290|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
170849563|NCT01125514|617457290|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
170849564|NCT01125514|617457290|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
170849565|NCT01125514|617457290|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
170849566|NCT00858364|617457291|FG000|Overall Study|Administrative Decision|3|||
170849567|NCT00858364|617457292|FG001|Overall Study|Administrative Decision|2|||
170849568|NCT00858364|617457291|FG000|Overall Study|Adverse Event|5|||
170849569|NCT00858364|617457292|FG001|Overall Study|Adverse Event|2|||
170849570|NCT00858364|617457291|FG000|Overall Study|Withdrawal by Subject|44|||
170849571|NCT00858364|617457292|FG001|Overall Study|Withdrawal by Subject|118|||
170849572|NCT00858364|617457291|FG000|Overall Study|Ineligibility Determined|1|||
170849573|NCT00858364|617457292|FG001|Overall Study|Ineligibility Determined|10|||
170849574|NCT00858364|617457291|FG000|Overall Study|Lost to Follow-up|24|||
170849575|NCT00858364|617457292|FG001|Overall Study|Lost to Follow-up|54|||
170849576|NCT00858364|617457291|FG000|Overall Study|Noncompliance|3|||
170849577|NCT00858364|617457292|FG001|Overall Study|Noncompliance|4|||
170849578|NCT00858364|617457291|FG000|Overall Study|Protocol Deviation|0|||
170849579|NCT00858364|617457292|FG001|Overall Study|Protocol Deviation|2|||
170849580|NCT00858364|617457291|FG000|Overall Study|Other|9|||
170849581|NCT00858364|617457292|FG001|Overall Study|Other|17|||
170849582|NCT00858364|617457291|FG000|Overall Study|Missing|1|||
170849583|NCT00858364|617457292|FG001|Overall Study|Missing|1|||
170849584|NCT00858364|617457291|FG000|Overall Study|Still on-study|114|||
170849585|NCT00858364|617457292|FG001|Overall Study|Still on-study|247|||
170849586|NCT01655693|617457293|FG000|Overall Study|Progression of Disease|92|||
170849587|NCT01655693|617457294|FG001|Overall Study|Progression of Disease|76|||
170849588|NCT01655693|617457295|FG002|Overall Study|Progression of Disease|58|||
170849589|NCT01655693|617457293|FG000|Overall Study|Death|8|||
170849590|NCT01655693|617457294|FG001|Overall Study|Death|9|||
170849591|NCT01655693|617457295|FG002|Overall Study|Death|12|||
170849592|NCT01655693|617457293|FG000|Overall Study|Serious Adverse Event|3|||
170849593|NCT01655693|617457294|FG001|Overall Study|Serious Adverse Event|15|||
170849594|NCT01655693|617457295|FG002|Overall Study|Serious Adverse Event|11|||
170849595|NCT01655693|617457293|FG000|Overall Study|Withdrawal by Subject|3|||
170739754|NCT02296190|617054151|FG004|Overall Study|Patient was given Propofol|0|||
170739755|NCT02296190|617054152|FG005|Overall Study|Patient was given Propofol|0|||
170739756|NCT02296190|617054147|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
170739757|NCT02296190|617054148|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
170739758|NCT02296190|617054149|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
170739759|NCT02296190|617054150|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
170739760|NCT02296190|617054151|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
170739761|NCT02296190|617054152|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
170739762|NCT02296190|617054147|FG000|Overall Study|Blood pressure <100 after sedation|0|||
170739763|NCT02296190|617054148|FG001|Overall Study|Blood pressure <100 after sedation|0|||
170739764|NCT02296190|617054149|FG002|Overall Study|Blood pressure <100 after sedation|0|||
170739765|NCT02296190|617054150|FG003|Overall Study|Blood pressure <100 after sedation|1|||
170739766|NCT02296190|617054151|FG004|Overall Study|Blood pressure <100 after sedation|0|||
170739767|NCT02296190|617054152|FG005|Overall Study|Blood pressure <100 after sedation|0|||
170739768|NCT02296190|617054147|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
170739769|NCT02296190|617054148|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
170739770|NCT02296190|617054149|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
170739771|NCT02296190|617054150|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
170739772|NCT02296190|617054151|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
170739773|NCT02296190|617054152|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
170739774|NCT02296190|617054147|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
170739775|NCT02296190|617054148|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
170739776|NCT02296190|617054149|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
170739777|NCT02296190|617054150|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
170739778|NCT02296190|617054151|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
170739779|NCT02296190|617054152|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
170739780|NCT02296190|617054147|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
170739781|NCT02296190|617054148|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
170739782|NCT02296190|617054149|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
170739783|NCT02296190|617054150|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
170739784|NCT02296190|617054151|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
170739785|NCT02296190|617054152|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
170739786|NCT02296190|617054147|FG000|Overall Study|Lab result not available in time|1|||
170739787|NCT02296190|617054148|FG001|Overall Study|Lab result not available in time|0|||
170739788|NCT02296190|617054149|FG002|Overall Study|Lab result not available in time|0|||
170739789|NCT02296190|617054150|FG003|Overall Study|Lab result not available in time|0|||
170739790|NCT02296190|617054151|FG004|Overall Study|Lab result not available in time|0|||
170739791|NCT02296190|617054152|FG005|Overall Study|Lab result not available in time|0|||
170739792|NCT05076149|617054153|FG000|Overall Study|Adverse Event|3|||
170739793|NCT05076149|617054154|FG001|Overall Study|Adverse Event|9|||
170739794|NCT05076149|617054153|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
170739795|NCT05076149|617054154|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
170739796|NCT05076149|617054153|FG000|Overall Study|Lost to Follow-up|0|||
170739797|NCT05076149|617054154|FG001|Overall Study|Lost to Follow-up|1|||
170739798|NCT05076149|617054153|FG000|Overall Study|Commercial drug is available for participant|0|||
170739799|NCT05076149|617054154|FG001|Overall Study|Commercial drug is available for participant|1|||
170739800|NCT05076149|617054153|FG000|Overall Study|Other non compliance|1|||
170739801|NCT05076149|617054154|FG001|Overall Study|Other non compliance|1|||
170739802|NCT05076149|617054153|FG000|Overall Study|Physician Decision|0|||
170739803|NCT05076149|617054154|FG001|Overall Study|Physician Decision|1|||
170739804|NCT05076149|617054153|FG000|Overall Study|Other|5|||
170739805|NCT05076149|617054154|FG001|Overall Study|Other|4|||
170739806|NCT00717314|617054155|FG000|Overall Study|Adverse Event|3|||
170739807|NCT00717314|617054156|FG001|Overall Study|Adverse Event|2|||
170849596|NCT01655693|617457294|FG001|Overall Study|Withdrawal by Subject|2|||
170849597|NCT01655693|617457295|FG002|Overall Study|Withdrawal by Subject|20|||
170849598|NCT01655693|617457293|FG000|Overall Study|Adverse Event|3|||
170849599|NCT01655693|617457294|FG001|Overall Study|Adverse Event|11|||
170849600|NCT01655693|617457295|FG002|Overall Study|Adverse Event|3|||
170849601|NCT01655693|617457293|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
170849602|NCT01655693|617457294|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
170849603|NCT01655693|617457295|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
170849604|NCT01655693|617457293|FG000|Overall Study|Non-Compliance|0|||
170849605|NCT01655693|617457294|FG001|Overall Study|Non-Compliance|0|||
170849606|NCT01655693|617457295|FG002|Overall Study|Non-Compliance|7|||
170849607|NCT01655693|617457293|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
170849608|NCT01655693|617457294|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
170849609|NCT01655693|617457295|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
170849610|NCT01655693|617457293|FG000|Overall Study|Protocol Violation|1|||
170849611|NCT01655693|617457294|FG001|Overall Study|Protocol Violation|0|||
170849612|NCT01655693|617457295|FG002|Overall Study|Protocol Violation|3|||
170849613|NCT01655693|617457293|FG000|Overall Study|Lost to Follow-up|1|||
170849614|NCT01655693|617457294|FG001|Overall Study|Lost to Follow-up|0|||
170849615|NCT01655693|617457295|FG002|Overall Study|Lost to Follow-up|1|||
170849616|NCT01655693|617457293|FG000|Overall Study|Screening Failure|1|||
170849617|NCT01655693|617457294|FG001|Overall Study|Screening Failure|0|||
170849618|NCT01655693|617457295|FG002|Overall Study|Screening Failure|0|||
170849619|NCT01655693|617457293|FG000|Overall Study|Other|8|||
170849620|NCT01655693|617457294|FG001|Overall Study|Other|6|||
170849621|NCT01655693|617457295|FG002|Overall Study|Other|15|||
170849622|NCT00929110|617457300|FG000|Overall Study|Adverse Event|40|||
170849623|NCT00929110|617457301|FG001|Overall Study|Adverse Event|29|||
170849624|NCT00929110|617457302|FG002|Overall Study|Adverse Event|18|||
170849625|NCT00929110|617457300|FG000|Overall Study|Subject withdrew consent|40|||
170849626|NCT00929110|617457301|FG001|Overall Study|Subject withdrew consent|23|||
170849627|NCT00929110|617457302|FG002|Overall Study|Subject withdrew consent|26|||
170849628|NCT00929110|617457300|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
170849629|NCT00929110|617457301|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
170849630|NCT00929110|617457302|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
170849631|NCT00929110|617457300|FG000|Overall Study|Lost to Follow-up|7|||
170849632|NCT00929110|617457301|FG001|Overall Study|Lost to Follow-up|7|||
170849633|NCT00929110|617457302|FG002|Overall Study|Lost to Follow-up|3|||
170849634|NCT00929110|617457300|FG000|Overall Study|Protocol deviation|5|||
170849635|NCT00929110|617457301|FG001|Overall Study|Protocol deviation|2|||
170849636|NCT00929110|617457302|FG002|Overall Study|Protocol deviation|4|||
170849637|NCT00929110|617457300|FG000|Overall Study|Administrative problems|4|||
170849638|NCT00929110|617457301|FG001|Overall Study|Administrative problems|1|||
170849639|NCT00929110|617457302|FG002|Overall Study|Administrative problems|2|||
170849640|NCT00929110|617457300|FG000|Overall Study|Death|2|||
170849641|NCT00929110|617457301|FG001|Overall Study|Death|2|||
170849642|NCT00929110|617457302|FG002|Overall Study|Death|2|||
170849643|NCT00929110|617457300|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170849644|NCT00929110|617457301|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170849645|NCT00929110|617457302|FG002|Overall Study|Abnormal laboratory value(s)|0|||
170849646|NCT00929110|617457300|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170849647|NCT00929110|617457301|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170849648|NCT00929110|617457302|FG002|Overall Study|Abnormal test procedure result(s)|1|||
170849649|NCT00929110|617457300|FG000|Overall Study|Patient inability to use the device|0|||
170849650|NCT00929110|617457301|FG001|Overall Study|Patient inability to use the device|1|||
170849651|NCT00929110|617457302|FG002|Overall Study|Patient inability to use the device|0|||
170849652|NCT02535091|617457304|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
170849653|NCT02535091|617457305|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
170849654|NCT02535091|617457306|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
170849655|NCT02535091|617457304|FG000|Overall Study|Withdrawal by Subject|14|||
170849656|NCT02535091|617457305|FG001|Overall Study|Withdrawal by Subject|5|||
170849657|NCT02535091|617457306|FG002|Overall Study|Withdrawal by Subject|121|||
170849658|NCT02535091|617457304|FG000|Overall Study|Adverse Event|9|||
170849659|NCT02535091|617457305|FG001|Overall Study|Adverse Event|4|||
170849660|NCT02535091|617457306|FG002|Overall Study|Adverse Event|170|||
170849661|NCT02535091|617457304|FG000|Overall Study|Other|4|||
170849662|NCT02535091|617457305|FG001|Overall Study|Other|3|||
170849663|NCT02535091|617457306|FG002|Overall Study|Other|81|||
170849664|NCT02535091|617457304|FG000|Overall Study|Lost to Follow-up|0|||
170849665|NCT02535091|617457305|FG001|Overall Study|Lost to Follow-up|1|||
170849666|NCT02535091|617457306|FG002|Overall Study|Lost to Follow-up|19|||
170849667|NCT02535091|617457304|FG000|Overall Study|Protocol Violation|0|||
170849668|NCT02535091|617457305|FG001|Overall Study|Protocol Violation|1|||
170849669|NCT02535091|617457306|FG002|Overall Study|Protocol Violation|11|||
170849670|NCT02535091|617457304|FG000|Overall Study|Pregnancy|0|||
170849671|NCT02535091|617457305|FG001|Overall Study|Pregnancy|0|||
170849672|NCT02535091|617457306|FG002|Overall Study|Pregnancy|7|||
170849673|NCT00744757|617457307|FG000|Overall Study|Objective disease progression|7|||
170849674|NCT00744757|617457307|FG000|Overall Study|Physician Decision|5|||
170849675|NCT00744757|617457307|FG000|Overall Study|Withdrawal by Subject|1|||
170849676|NCT00744757|617457307|FG000|Overall Study|Death|6|||
170849677|NCT00744757|617457307|FG000|Overall Study|Adverse Event|2|||
170849678|NCT01769326|617457310|FG000|Overall Study|Lost to Follow-up|1|||
170849679|NCT01769326|617457311|FG001|Overall Study|Lost to Follow-up|2|||
170849680|NCT01769326|617457312|FG002|Overall Study|Lost to Follow-up|0|||
170849681|NCT01769326|617457313|FG003|Overall Study|Lost to Follow-up|0|||
170849682|NCT01769326|617457310|FG000|Overall Study|unrelated injry|1|||
170849683|NCT01769326|617457311|FG001|Overall Study|unrelated injry|1|||
170849684|NCT01769326|617457312|FG002|Overall Study|unrelated injry|0|||
170849685|NCT01769326|617457313|FG003|Overall Study|unrelated injry|0|||
170849686|NCT01769326|617457310|FG000|Overall Study|got a job|0|||
170849687|NCT01769326|617457311|FG001|Overall Study|got a job|1|||
170849688|NCT01769326|617457312|FG002|Overall Study|got a job|0|||
170849689|NCT01769326|617457313|FG003|Overall Study|got a job|0|||
170849690|NCT01769326|617457310|FG000|Overall Study|Got sick and could not complete study|0|||
170849691|NCT01769326|617457311|FG001|Overall Study|Got sick and could not complete study|0|||
170849692|NCT01769326|617457312|FG002|Overall Study|Got sick and could not complete study|1|||
170849693|NCT01769326|617457313|FG003|Overall Study|Got sick and could not complete study|0|||
170849694|NCT03381339|617457316|FG000|Overall Study|Protocol Violation|4|||
170849695|NCT03381339|617457317|FG001|Overall Study|Protocol Violation|3|||
170849696|NCT03381339|617457316|FG000|Overall Study|Lost to Follow-up|0|||
170849697|NCT03381339|617457317|FG001|Overall Study|Lost to Follow-up|1|||
170849698|NCT03772587|617457318|FG000|Overall Study|COVID-19|0|||
170849699|NCT03772587|617457319|FG001|Overall Study|COVID-19|0|||
170849700|NCT03772587|617457320|FG002|Overall Study|COVID-19|1|||
170849701|NCT03772587|617457321|FG003|Overall Study|COVID-19|1|||
170849702|NCT03772587|617457322|FG004|Overall Study|COVID-19|0|||
170739808|NCT00717314|617054155|FG000|Overall Study|Protocol Violation|1|||
170739809|NCT00717314|617054156|FG001|Overall Study|Protocol Violation|0|||
170739810|NCT00717314|617054155|FG000|Overall Study|Lost to Follow-up|1|||
170739811|NCT00717314|617054156|FG001|Overall Study|Lost to Follow-up|5|||
170739812|NCT00717314|617054155|FG000|Overall Study|Withdrawal by Subject|1|||
170739813|NCT00717314|617054156|FG001|Overall Study|Withdrawal by Subject|3|||
170739814|NCT05096208|617054157|FG000|Overall Study|Lost to Follow-up|3|||
170739815|NCT05096208|617054158|FG001|Overall Study|Lost to Follow-up|5|||
170739816|NCT05096208|617054159|FG002|Overall Study|Lost to Follow-up|5|||
170739817|NCT05096208|617054160|FG003|Overall Study|Lost to Follow-up|2|||
170739818|NCT05096208|617054157|FG000|Overall Study|Withdrawal by Subject|0|||
170739819|NCT05096208|617054158|FG001|Overall Study|Withdrawal by Subject|1|||
170739820|NCT05096208|617054159|FG002|Overall Study|Withdrawal by Subject|2|||
170739821|NCT05096208|617054160|FG003|Overall Study|Withdrawal by Subject|3|||
170739822|NCT05096208|617054157|FG000|Overall Study|No longer met eligibility criteria|1|||
170739823|NCT05096208|617054158|FG001|Overall Study|No longer met eligibility criteria|0|||
170739824|NCT05096208|617054159|FG002|Overall Study|No longer met eligibility criteria|0|||
170739825|NCT05096208|617054160|FG003|Overall Study|No longer met eligibility criteria|0|||
170739826|NCT05096208|617054157|FG000|Overall Study|Other|0|||
170739827|NCT05096208|617054158|FG001|Overall Study|Other|0|||
170739828|NCT05096208|617054159|FG002|Overall Study|Other|1|||
170739829|NCT05096208|617054160|FG003|Overall Study|Other|0|||
170849703|NCT03772587|617457318|FG000|Overall Study|Withdrawal by Subject|1|||
170849704|NCT03772587|617457319|FG001|Overall Study|Withdrawal by Subject|0|||
170849705|NCT03772587|617457320|FG002|Overall Study|Withdrawal by Subject|0|||
170849706|NCT03772587|617457321|FG003|Overall Study|Withdrawal by Subject|0|||
170849707|NCT03772587|617457322|FG004|Overall Study|Withdrawal by Subject|0|||
170849708|NCT02626455|617457323|FG000|Overall Study|Other|1|||
170739830|NCT01483937|617054162|FG000|Overall Study|Withdrawal by Subject|4|||
170739831|NCT01483937|617054163|FG001|Overall Study|Withdrawal by Subject|3|||
170739832|NCT04043962|617054164|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
170739833|NCT04043962|617054164|FG000|Post-Treatment|Withdrawal by Subject|5|||
170739834|NCT04043962|617054164|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
170849709|NCT02626455|617457324|FG001|Overall Study|Other|1|||
170849710|NCT02626455|617457325|FG002|Overall Study|Other|0|||
170849711|NCT02626455|617457326|FG003|Overall Study|Other|0|||
170849712|NCT02626455|617457327|FG004|Overall Study|Other|0|||
170849713|NCT02626455|617457328|FG005|Overall Study|Other|17|||
170849714|NCT02626455|617457329|FG006|Overall Study|Other|23|||
170849715|NCT02626455|617457323|FG000|Overall Study|Withdrawal by Subject|1|||
170849716|NCT02626455|617457324|FG001|Overall Study|Withdrawal by Subject|0|||
170849717|NCT02626455|617457325|FG002|Overall Study|Withdrawal by Subject|0|||
170849718|NCT02626455|617457326|FG003|Overall Study|Withdrawal by Subject|0|||
170849719|NCT02626455|617457327|FG004|Overall Study|Withdrawal by Subject|0|||
170849720|NCT02626455|617457328|FG005|Overall Study|Withdrawal by Subject|10|||
170849721|NCT02626455|617457329|FG006|Overall Study|Withdrawal by Subject|6|||
170849722|NCT02626455|617457323|FG000|Overall Study|Physician Decision|0|||
170849723|NCT02626455|617457324|FG001|Overall Study|Physician Decision|2|||
170849724|NCT02626455|617457325|FG002|Overall Study|Physician Decision|2|||
170849725|NCT02626455|617457326|FG003|Overall Study|Physician Decision|2|||
170849726|NCT02626455|617457327|FG004|Overall Study|Physician Decision|1|||
170849727|NCT02626455|617457328|FG005|Overall Study|Physician Decision|10|||
170849728|NCT02626455|617457329|FG006|Overall Study|Physician Decision|3|||
170849729|NCT02626455|617457323|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
170849730|NCT02626455|617457324|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
170849731|NCT02626455|617457325|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
170849732|NCT02626455|617457326|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
170849733|NCT02626455|617457327|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
170849734|NCT02626455|617457328|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
170849735|NCT02626455|617457329|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
170849736|NCT02626455|617457323|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
170849737|NCT02626455|617457324|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
170849738|NCT02626455|617457325|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
170849739|NCT02626455|617457326|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
170849740|NCT02626455|617457327|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
170849741|NCT02626455|617457328|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
170849742|NCT02626455|617457329|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
170849743|NCT02626455|617457323|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
170849744|NCT02626455|617457324|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
170849745|NCT02626455|617457325|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
170849746|NCT02626455|617457326|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
170849747|NCT02626455|617457327|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
170849748|NCT02626455|617457328|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
170849749|NCT02626455|617457329|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
170849750|NCT02626455|617457323|FG000|Overall Study|Patient decision|0|||
170849751|NCT02626455|617457324|FG001|Overall Study|Patient decision|1|||
170849752|NCT02626455|617457325|FG002|Overall Study|Patient decision|0|||
170849753|NCT02626455|617457326|FG003|Overall Study|Patient decision|0|||
170849754|NCT02626455|617457327|FG004|Overall Study|Patient decision|1|||
170849755|NCT02626455|617457328|FG005|Overall Study|Patient decision|36|||
170849756|NCT02626455|617457329|FG006|Overall Study|Patient decision|22|||
170849757|NCT02626455|617457323|FG000|Overall Study|Protocol Violation|0|||
170849758|NCT02626455|617457324|FG001|Overall Study|Protocol Violation|0|||
170849759|NCT02626455|617457325|FG002|Overall Study|Protocol Violation|0|||
170849760|NCT02626455|617457326|FG003|Overall Study|Protocol Violation|0|||
170849761|NCT02626455|617457327|FG004|Overall Study|Protocol Violation|0|||
170849762|NCT02626455|617457328|FG005|Overall Study|Protocol Violation|0|||
170849763|NCT02626455|617457329|FG006|Overall Study|Protocol Violation|1|||
170849764|NCT02626455|617457323|FG000|Overall Study|Progressive disease - radiological progression|0|||
170849765|NCT02626455|617457324|FG001|Overall Study|Progressive disease - radiological progression|0|||
170849766|NCT02626455|617457325|FG002|Overall Study|Progressive disease - radiological progression|0|||
170849767|NCT02626455|617457326|FG003|Overall Study|Progressive disease - radiological progression|0|||
170849768|NCT02626455|617457327|FG004|Overall Study|Progressive disease - radiological progression|0|||
170849769|NCT02626455|617457328|FG005|Overall Study|Progressive disease - radiological progression|11|||
170849770|NCT02626455|617457329|FG006|Overall Study|Progressive disease - radiological progression|22|||
170849771|NCT02626455|617457323|FG000|Overall Study|Progressive disease - clinical progression|0|||
170849772|NCT02626455|617457324|FG001|Overall Study|Progressive disease - clinical progression|0|||
170849773|NCT02626455|617457325|FG002|Overall Study|Progressive disease - clinical progression|0|||
170849774|NCT02626455|617457326|FG003|Overall Study|Progressive disease - clinical progression|0|||
170849775|NCT02626455|617457327|FG004|Overall Study|Progressive disease - clinical progression|0|||
170849776|NCT02626455|617457328|FG005|Overall Study|Progressive disease - clinical progression|1|||
170849777|NCT02626455|617457329|FG006|Overall Study|Progressive disease - clinical progression|2|||
170849778|NCT02626455|617457323|FG000|Overall Study|Lost to Follow-up|0|||
170849779|NCT02626455|617457324|FG001|Overall Study|Lost to Follow-up|0|||
170849780|NCT02626455|617457325|FG002|Overall Study|Lost to Follow-up|0|||
170849781|NCT02626455|617457326|FG003|Overall Study|Lost to Follow-up|0|||
170849782|NCT02626455|617457327|FG004|Overall Study|Lost to Follow-up|0|||
170849783|NCT02626455|617457328|FG005|Overall Study|Lost to Follow-up|1|||
170849784|NCT02626455|617457329|FG006|Overall Study|Lost to Follow-up|0|||
170849785|NCT02626455|617457323|FG000|Overall Study|AE not associated with clinical disease progression|1|||
170849786|NCT02626455|617457324|FG001|Overall Study|AE not associated with clinical disease progression|1|||
170849787|NCT02626455|617457325|FG002|Overall Study|AE not associated with clinical disease progression|0|||
170849788|NCT02626455|617457326|FG003|Overall Study|AE not associated with clinical disease progression|2|||
170849789|NCT02626455|617457327|FG004|Overall Study|AE not associated with clinical disease progression|1|||
170849790|NCT02626455|617457328|FG005|Overall Study|AE not associated with clinical disease progression|65|||
170849791|NCT02626455|617457329|FG006|Overall Study|AE not associated with clinical disease progression|21|||
170849792|NCT02626455|617457323|FG000|Overall Study|AE associated with clinical disease progression|0|||
170849793|NCT02626455|617457324|FG001|Overall Study|AE associated with clinical disease progression|0|||
170849794|NCT02626455|617457325|FG002|Overall Study|AE associated with clinical disease progression|0|||
170849795|NCT02626455|617457326|FG003|Overall Study|AE associated with clinical disease progression|0|||
170849796|NCT02626455|617457327|FG004|Overall Study|AE associated with clinical disease progression|0|||
170849797|NCT02626455|617457328|FG005|Overall Study|AE associated with clinical disease progression|1|||
170849798|NCT02626455|617457329|FG006|Overall Study|AE associated with clinical disease progression|2|||
170849799|NCT02626455|617457323|FG000|Overall Study|Study intervention never administered|0|||
170849800|NCT02626455|617457324|FG001|Overall Study|Study intervention never administered|0|||
170849801|NCT02626455|617457325|FG002|Overall Study|Study intervention never administered|0|||
170849802|NCT02626455|617457326|FG003|Overall Study|Study intervention never administered|0|||
170849803|NCT02626455|617457327|FG004|Overall Study|Study intervention never administered|0|||
170849804|NCT02626455|617457328|FG005|Overall Study|Study intervention never administered|1|||
170849805|NCT02626455|617457329|FG006|Overall Study|Study intervention never administered|3|||
170849806|NCT06665919|617457330|FG000|Overall Study|Withdrawal by Subject|4|||
170849807|NCT06665919|617457331|FG001|Overall Study|Withdrawal by Subject|4|||
170849808|NCT06665919|617457332|FG002|Overall Study|Withdrawal by Subject|4|||
170849809|NCT06665919|617457330|FG000|Overall Study|Non-compliance to Treatment|4|||
170849810|NCT06665919|617457331|FG001|Overall Study|Non-compliance to Treatment|1|||
170849811|NCT06665919|617457332|FG002|Overall Study|Non-compliance to Treatment|6|||
170849812|NCT06665919|617457330|FG000|Overall Study|Lost to Follow-up|3|||
170849813|NCT06665919|617457331|FG001|Overall Study|Lost to Follow-up|0|||
170849814|NCT06665919|617457332|FG002|Overall Study|Lost to Follow-up|2|||
170849815|NCT06665919|617457330|FG000|Overall Study|Physician Decision|4|||
170849816|NCT06665919|617457331|FG001|Overall Study|Physician Decision|0|||
170849817|NCT06665919|617457332|FG002|Overall Study|Physician Decision|1|||
170849818|NCT01241604|617457333|FG000|Screening Period|Screen Failure|3|||
170849819|NCT01241604|617457334|FG001|Screening Period|Screen Failure|0|||
170849820|NCT01241604|617457335|FG002|Screening Period|Screen Failure|0|||
170849821|NCT01214642|617457336|FG000|Overall Study|Progressive Disease|3|||
170849822|NCT01214642|617457337|FG001|Overall Study|Progressive Disease|2|||
170849823|NCT01214642|617457338|FG002|Overall Study|Progressive Disease|3|||
170849824|NCT01214642|617457339|FG003|Overall Study|Progressive Disease|5|||
170849825|NCT01214642|617457340|FG004|Overall Study|Progressive Disease|5|||
170849826|NCT01214642|617457341|FG005|Overall Study|Progressive Disease|3|||
170849827|NCT01214642|617457342|FG006|Overall Study|Progressive Disease|5|||
170849828|NCT01214642|617457343|FG007|Overall Study|Progressive Disease|3|||
170849829|NCT01214642|617457344|FG008|Overall Study|Progressive Disease|10|||
170849830|NCT01214642|617457345|FG009|Overall Study|Progressive Disease|2|||
170849831|NCT01214642|617457346|FG010|Overall Study|Progressive Disease|1|||
170849832|NCT01214642|617457347|FG011|Overall Study|Progressive Disease|4|||
170849833|NCT01214642|617457336|FG000|Overall Study|Adverse Event|0|||
170849834|NCT01214642|617457337|FG001|Overall Study|Adverse Event|1|||
170849835|NCT01214642|617457338|FG002|Overall Study|Adverse Event|0|||
170849836|NCT01214642|617457339|FG003|Overall Study|Adverse Event|0|||
170849837|NCT01214642|617457340|FG004|Overall Study|Adverse Event|0|||
170849838|NCT01214642|617457341|FG005|Overall Study|Adverse Event|0|||
170849839|NCT01214642|617457342|FG006|Overall Study|Adverse Event|1|||
170849840|NCT01214642|617457343|FG007|Overall Study|Adverse Event|0|||
170849841|NCT01214642|617457344|FG008|Overall Study|Adverse Event|0|||
170849842|NCT01214642|617457345|FG009|Overall Study|Adverse Event|1|||
170849843|NCT01214642|617457346|FG010|Overall Study|Adverse Event|1|||
170849844|NCT01214642|617457347|FG011|Overall Study|Adverse Event|0|||
170849845|NCT01214642|617457336|FG000|Overall Study|Death|0|||
170849846|NCT01214642|617457337|FG001|Overall Study|Death|0|||
170849847|NCT01214642|617457338|FG002|Overall Study|Death|1|||
170849848|NCT01214642|617457339|FG003|Overall Study|Death|0|||
170849849|NCT01214642|617457340|FG004|Overall Study|Death|0|||
170849850|NCT01214642|617457341|FG005|Overall Study|Death|0|||
170849851|NCT01214642|617457342|FG006|Overall Study|Death|0|||
170849852|NCT01214642|617457343|FG007|Overall Study|Death|0|||
170849853|NCT01214642|617457344|FG008|Overall Study|Death|0|||
170849854|NCT01214642|617457345|FG009|Overall Study|Death|0|||
170849855|NCT01214642|617457346|FG010|Overall Study|Death|1|||
170849856|NCT01214642|617457347|FG011|Overall Study|Death|0|||
170849857|NCT01214642|617457336|FG000|Overall Study|Withdrawal by Subject|0|||
170849858|NCT01214642|617457337|FG001|Overall Study|Withdrawal by Subject|0|||
170849859|NCT01214642|617457338|FG002|Overall Study|Withdrawal by Subject|1|||
170849860|NCT01214642|617457339|FG003|Overall Study|Withdrawal by Subject|0|||
170849861|NCT01214642|617457340|FG004|Overall Study|Withdrawal by Subject|0|||
170849862|NCT01214642|617457341|FG005|Overall Study|Withdrawal by Subject|0|||
170849863|NCT01214642|617457342|FG006|Overall Study|Withdrawal by Subject|0|||
170849864|NCT01214642|617457343|FG007|Overall Study|Withdrawal by Subject|0|||
170849865|NCT01214642|617457344|FG008|Overall Study|Withdrawal by Subject|3|||
170849866|NCT01214642|617457345|FG009|Overall Study|Withdrawal by Subject|1|||
170849867|NCT01214642|617457346|FG010|Overall Study|Withdrawal by Subject|1|||
170849868|NCT01214642|617457347|FG011|Overall Study|Withdrawal by Subject|0|||
170849869|NCT01214642|617457336|FG000|Overall Study|Physician Decision|0|||
170849870|NCT01214642|617457337|FG001|Overall Study|Physician Decision|0|||
170849871|NCT01214642|617457338|FG002|Overall Study|Physician Decision|1|||
170849872|NCT01214642|617457339|FG003|Overall Study|Physician Decision|1|||
170849873|NCT01214642|617457340|FG004|Overall Study|Physician Decision|1|||
170849874|NCT01214642|617457341|FG005|Overall Study|Physician Decision|0|||
170849875|NCT01214642|617457342|FG006|Overall Study|Physician Decision|0|||
170849876|NCT01214642|617457343|FG007|Overall Study|Physician Decision|0|||
170849877|NCT01214642|617457344|FG008|Overall Study|Physician Decision|0|||
170849878|NCT01214642|617457345|FG009|Overall Study|Physician Decision|0|||
170849879|NCT01214642|617457346|FG010|Overall Study|Physician Decision|0|||
170849880|NCT01214642|617457347|FG011|Overall Study|Physician Decision|2|||
170849881|NCT01593787|617457348|FG000|Overall Study|Adverse Event|1|||
170849882|NCT01593787|617457349|FG001|Overall Study|Adverse Event|0|||
170849883|NCT01593787|617457350|FG002|Overall Study|Adverse Event|0|||
170849884|NCT00151281|617457351|FG000|Overall Study|Not evaluable|3|||
170849885|NCT03695237|617459145|FG000|Overall Study|Withdrawal by Subject|1|||
170849886|NCT03695237|617459146|FG001|Overall Study|Withdrawal by Subject|3|||
170849887|NCT03695237|617459145|FG000|Overall Study|Lost to Follow-up|1|||
170849888|NCT03695237|617459146|FG001|Overall Study|Lost to Follow-up|2|||
170849889|NCT03695237|617459145|FG000|Overall Study|Other, Not Specified|8|||
170849890|NCT03695237|617459146|FG001|Overall Study|Other, Not Specified|2|||
170849891|NCT02516332|617459147|FG000|Overall Study|Withdrawal by Subject|2|||
170849892|NCT02516332|617459148|FG001|Overall Study|Withdrawal by Subject|1|||
170849893|NCT02516332|617459149|FG002|Overall Study|Withdrawal by Subject|2|||
170849894|NCT03725085|617459158|FG000|Overall Study|Lost to Follow-up|2|||
170849895|NCT00705679|617459159|FG000|Overall Study|Adverse Event|1|||
170849896|NCT00705679|617459160|FG001|Overall Study|Adverse Event|1|||
170849897|NCT00705679|617459161|FG002|Overall Study|Adverse Event|0|||
170849898|NCT00705679|617459162|FG003|Overall Study|Adverse Event|0|||
170849899|NCT00705679|617459163|FG004|Overall Study|Adverse Event|0|||
170849900|NCT00705679|617459159|FG000|Overall Study|Death|0|||
170849901|NCT00705679|617459160|FG001|Overall Study|Death|0|||
170849902|NCT00705679|617459161|FG002|Overall Study|Death|3|||
170849903|NCT00705679|617459162|FG003|Overall Study|Death|2|||
170849904|NCT00705679|617459163|FG004|Overall Study|Death|1|||
170849905|NCT00705679|617459159|FG000|Overall Study|Lost to Follow-up|32|||
170849906|NCT00705679|617459160|FG001|Overall Study|Lost to Follow-up|60|||
170849907|NCT00705679|617459161|FG002|Overall Study|Lost to Follow-up|44|||
170849908|NCT00705679|617459162|FG003|Overall Study|Lost to Follow-up|30|||
170849909|NCT00705679|617459163|FG004|Overall Study|Lost to Follow-up|35|||
170849910|NCT00705679|617459159|FG000|Overall Study|Physician Decision|0|||
170849911|NCT00705679|617459160|FG001|Overall Study|Physician Decision|1|||
170849912|NCT00705679|617459161|FG002|Overall Study|Physician Decision|0|||
170849913|NCT00705679|617459162|FG003|Overall Study|Physician Decision|1|||
170849914|NCT00705679|617459163|FG004|Overall Study|Physician Decision|0|||
170849915|NCT00705679|617459159|FG000|Overall Study|Withdrawal by Subject|32|||
170849916|NCT00705679|617459160|FG001|Overall Study|Withdrawal by Subject|77|||
170849917|NCT00705679|617459161|FG002|Overall Study|Withdrawal by Subject|68|||
170849918|NCT00705679|617459162|FG003|Overall Study|Withdrawal by Subject|47|||
170849919|NCT00705679|617459163|FG004|Overall Study|Withdrawal by Subject|33|||
170849920|NCT03527173|617459164|FG000|Overall Study|Lost to Follow-up|4|||
170849921|NCT03527173|617459165|FG001|Overall Study|Lost to Follow-up|2|||
170849922|NCT03527173|617459164|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
170849923|NCT03527173|617459165|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
170849924|NCT03527173|617459164|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
170849925|NCT03527173|617459165|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
170849926|NCT03527173|617459164|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
170849927|NCT03527173|617459165|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
170849928|NCT01248780|617459166|FG000|Overall Study|Lack of Efficacy|2|||
170849929|NCT01248780|617459167|FG001|Overall Study|Lack of Efficacy|0|||
170849930|NCT01248780|617459166|FG000|Overall Study|Lost to Follow-up|0|||
170849931|NCT01248780|617459167|FG001|Overall Study|Lost to Follow-up|1|||
170849932|NCT01248780|617459166|FG000|Overall Study|Death|0|||
170849933|NCT01248780|617459167|FG001|Overall Study|Death|1|||
170849934|NCT01248780|617459166|FG000|Overall Study|Adverse Event|2|||
170849935|NCT01248780|617459167|FG001|Overall Study|Adverse Event|7|||
170849936|NCT01248780|617459166|FG000|Overall Study|Protocol Violation|1|||
170849937|NCT01248780|617459167|FG001|Overall Study|Protocol Violation|1|||
170849938|NCT01248780|617459166|FG000|Overall Study|Withdrawal by Subject|4|||
170849939|NCT01248780|617459167|FG001|Overall Study|Withdrawal by Subject|4|||
170849940|NCT01248780|617459166|FG000|Overall Study|Not treated|0|||
170849941|NCT01248780|617459167|FG001|Overall Study|Not treated|1|||
170849942|NCT01227577|617459170|FG000|Overall Study|Protocol deviation|3|||
170849943|NCT01227577|617459170|FG000|Overall Study|Death|3|||
170849944|NCT01227577|617459170|FG000|Overall Study|Administrative problems|2|||
170849945|NCT01227577|617459170|FG000|Overall Study|Lost to Follow-up|1|||
170849946|NCT01227577|617459170|FG000|Overall Study|Withdrawal by Subject|4|||
170849947|NCT01227577|617459170|FG000|Overall Study|Lack of Efficacy|5|||
170849948|NCT01227577|617459170|FG000|Overall Study|Adverse Event|17|||
170849949|NCT03809429|617459171|FG000|Overall Study|Withdrawal by Subject|7|||
170849950|NCT03809429|617459172|FG001|Overall Study|Withdrawal by Subject|3|||
170849951|NCT03809429|617459171|FG000|Overall Study|Adverse Event|6|||
170849952|NCT03809429|617459172|FG001|Overall Study|Adverse Event|9|||
170849953|NCT03809429|617459171|FG000|Overall Study|COVID-19|3|||
170849954|NCT03809429|617459172|FG001|Overall Study|COVID-19|1|||
170849955|NCT03809429|617459171|FG000|Overall Study|Participant was discontinued by investigator|12|||
170849956|NCT03809429|617459172|FG001|Overall Study|Participant was discontinued by investigator|7|||
170849957|NCT04214600|617459173|FG000|Overall Study|Lost to Follow-up|9|||
170849958|NCT04214600|617459174|FG001|Overall Study|Lost to Follow-up|14|||
170849959|NCT00896051|617459175|FG000|Overall Study|Adverse Event|2|||
170849960|NCT00896051|617459176|FG001|Overall Study|Adverse Event|1|||
170849961|NCT00896051|617459175|FG000|Overall Study|Lost to Follow-up|3|||
170849962|NCT00896051|617459176|FG001|Overall Study|Lost to Follow-up|2|||
170849963|NCT00896051|617459175|FG000|Overall Study|Withdrawal by Subject|3|||
170849964|NCT00896051|617459176|FG001|Overall Study|Withdrawal by Subject|2|||
170849965|NCT00896051|617459175|FG000|Overall Study|Subject noncompliant|1|||
170849966|NCT00896051|617459176|FG001|Overall Study|Subject noncompliant|3|||
170849967|NCT00896051|617459175|FG000|Overall Study|Other|1|||
170849968|NCT00896051|617459176|FG001|Overall Study|Other|1|||
170849969|NCT02935452|617459177|FG000|Overall Study|work and life commintment|3|||
170849970|NCT02935452|617459178|FG001|Overall Study|work and life commintment|1|||
170849971|NCT04433585|617459180|FG000|Overall Study|Withdrawal by Subject|15|||
170849972|NCT04433585|617459181|FG001|Overall Study|Withdrawal by Subject|3|||
170849973|NCT04433585|617459182|FG002|Overall Study|Withdrawal by Subject|15|||
170849974|NCT04433585|617459183|FG003|Overall Study|Withdrawal by Subject|6|||
170849975|NCT04433585|617459180|FG000|Overall Study|Adverse Event|10|||
170849976|NCT04433585|617459181|FG001|Overall Study|Adverse Event|4|||
170849977|NCT04433585|617459182|FG002|Overall Study|Adverse Event|1|||
170849978|NCT04433585|617459183|FG003|Overall Study|Adverse Event|0|||
170849979|NCT04433585|617459180|FG000|Overall Study|Due to the conflict in Ukraine|2|||
170849980|NCT04433585|617459181|FG001|Overall Study|Due to the conflict in Ukraine|1|||
170849981|NCT04433585|617459182|FG002|Overall Study|Due to the conflict in Ukraine|1|||
170849982|NCT04433585|617459183|FG003|Overall Study|Due to the conflict in Ukraine|2|||
170849983|NCT04433585|617459180|FG000|Overall Study|Physician Decision|1|||
170849984|NCT04433585|617459181|FG001|Overall Study|Physician Decision|2|||
170849985|NCT04433585|617459182|FG002|Overall Study|Physician Decision|0|||
170849986|NCT04433585|617459183|FG003|Overall Study|Physician Decision|0|||
170849987|NCT04433585|617459180|FG000|Overall Study|Lost to Follow-up|1|||
170849988|NCT04433585|617459181|FG001|Overall Study|Lost to Follow-up|1|||
170849989|NCT04433585|617459182|FG002|Overall Study|Lost to Follow-up|1|||
170849990|NCT04433585|617459183|FG003|Overall Study|Lost to Follow-up|0|||
170849991|NCT04433585|617459180|FG000|Overall Study|Lack of Efficacy|0|||
170849992|NCT04433585|617459181|FG001|Overall Study|Lack of Efficacy|1|||
170849993|NCT04433585|617459182|FG002|Overall Study|Lack of Efficacy|1|||
170849994|NCT04433585|617459183|FG003|Overall Study|Lack of Efficacy|1|||
170849995|NCT04433585|617459180|FG000|Overall Study|Death|0|||
170849996|NCT04433585|617459181|FG001|Overall Study|Death|1|||
170849997|NCT04433585|617459182|FG002|Overall Study|Death|0|||
170849998|NCT04433585|617459183|FG003|Overall Study|Death|0|||
170849999|NCT02245737|617459186|FG000|Overall Study|Adverse Event|23|||
170850000|NCT02245737|617459187|FG001|Overall Study|Adverse Event|26|||
170850001|NCT02245737|617459188|FG002|Overall Study|Adverse Event|33|||
170850002|NCT02245737|617459186|FG000|Overall Study|Condition Worsened|9|||
170850003|NCT02245737|617459187|FG001|Overall Study|Condition Worsened|10|||
170850004|NCT02245737|617459188|FG002|Overall Study|Condition Worsened|9|||
170850005|NCT02245737|617459186|FG000|Overall Study|Death|2|||
170850006|NCT02245737|617459187|FG001|Overall Study|Death|4|||
170850007|NCT02245737|617459188|FG002|Overall Study|Death|4|||
170850008|NCT02245737|617459186|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
170850009|NCT02245737|617459187|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
170850010|NCT02245737|617459188|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
170850011|NCT02245737|617459186|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
170850012|NCT02245737|617459187|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
170850013|NCT02245737|617459188|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
170850014|NCT02245737|617459186|FG000|Overall Study|Lost to Follow-up|2|||
170850015|NCT02245737|617459187|FG001|Overall Study|Lost to Follow-up|5|||
170850016|NCT02245737|617459188|FG002|Overall Study|Lost to Follow-up|4|||
170850017|NCT02245737|617459186|FG000|Overall Study|Other-determined by Investigator|9|||
170850018|NCT02245737|617459187|FG001|Overall Study|Other-determined by Investigator|10|||
170850019|NCT02245737|617459188|FG002|Overall Study|Other-determined by Investigator|10|||
170739835|NCT02178566|617054170|FG000|Overall Study|patient did not complete due to noncompliance|0|||
170739836|NCT02178566|617054171|FG001|Overall Study|patient did not complete due to noncompliance|1|||
170739837|NCT00682643|617054174|FG000|Overall Study|Adverse Event|12|||
170739838|NCT00682643|617054175|FG001|Overall Study|Adverse Event|23|||
170739839|NCT00682643|617054174|FG000|Overall Study|Lack of Efficacy|2|||
170739840|NCT00682643|617054175|FG001|Overall Study|Lack of Efficacy|0|||
170739841|NCT00682643|617054174|FG000|Overall Study|Protocol Violation|38|||
170739842|NCT00682643|617054175|FG001|Overall Study|Protocol Violation|76|||
170739843|NCT00682643|617054174|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
170739844|NCT00682643|617054175|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
170739845|NCT00682643|617054174|FG000|Overall Study|Lost to Follow-up|1|||
170739846|NCT00682643|617054175|FG001|Overall Study|Lost to Follow-up|6|||
170739847|NCT00682643|617054174|FG000|Overall Study|Physician Decision|2|||
170739848|NCT00682643|617054175|FG001|Overall Study|Physician Decision|6|||
170739849|NCT00682643|617054174|FG000|Overall Study|Withdrawal by Subject|19|||
170739850|NCT00682643|617054175|FG001|Overall Study|Withdrawal by Subject|53|||
170739851|NCT00682643|617054174|FG000|Overall Study|Did Not Receive Study Drug|1|||
170739852|NCT00682643|617054175|FG001|Overall Study|Did Not Receive Study Drug|1|||
170739853|NCT01875185|617054176|FG000|Overall Study|study was terminated|52|||
170739854|NCT01875185|617054177|FG001|Overall Study|study was terminated|48|||
170739855|NCT03238300|617054178|FG000|Baseline (Before Intervention)|Physician Decision|0|||
170739856|NCT03238300|617054179|FG001|Baseline (Before Intervention)|Physician Decision|1|||
170739857|NCT03238300|617054178|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
170739858|NCT03238300|617054179|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
170739859|NCT03238300|617054178|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
170739860|NCT03238300|617054179|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
170739861|NCT03238300|617054178|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
170739862|NCT03238300|617054179|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
170739863|NCT01301274|617054181|FG000|Overall Study|Physician Decision|2|||
170739864|NCT01301274|617054182|FG001|Overall Study|Physician Decision|1|||
170739865|NCT04512066|617054187|FG000|Double-blind Treatment Period|Adverse Event|6|||
170739866|NCT04512066|617054188|FG001|Double-blind Treatment Period|Adverse Event|4|||
170739867|NCT04512066|617054189|FG002|Double-blind Treatment Period|Adverse Event|5|||
170739868|NCT04512066|617054190|FG003|Double-blind Treatment Period|Adverse Event|1|||
170739869|NCT04512066|617054191|FG004|Double-blind Treatment Period|Adverse Event|0|||
170739870|NCT04512066|617054192|FG005|Double-blind Treatment Period|Adverse Event|0|||
170739871|NCT04512066|617054187|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
170739872|NCT04512066|617054188|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
170739873|NCT04512066|617054189|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
170739874|NCT04512066|617054190|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
170739875|NCT04512066|617054191|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
170739876|NCT04512066|617054192|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
170850020|NCT02245737|617459186|FG000|Overall Study|Physician Decision|6|||
170850021|NCT02245737|617459187|FG001|Overall Study|Physician Decision|3|||
170850022|NCT02245737|617459188|FG002|Overall Study|Physician Decision|6|||
170850023|NCT02245737|617459186|FG000|Overall Study|Protocol Violation|3|||
170850024|NCT02245737|617459187|FG001|Overall Study|Protocol Violation|2|||
170850025|NCT02245737|617459188|FG002|Overall Study|Protocol Violation|3|||
170850026|NCT02245737|617459186|FG000|Overall Study|Withdrawal by Subject|40|||
170850027|NCT02245737|617459187|FG001|Overall Study|Withdrawal by Subject|41|||
170850028|NCT02245737|617459188|FG002|Overall Study|Withdrawal by Subject|44|||
170850029|NCT02245737|617459186|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
170850030|NCT02245737|617459187|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
170850031|NCT02245737|617459188|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
170850032|NCT02245737|617459186|FG000|Overall Study|Sponsor Decision|445|||
170850033|NCT02245737|617459187|FG001|Overall Study|Sponsor Decision|430|||
170850034|NCT02245737|617459188|FG002|Overall Study|Sponsor Decision|432|||
170850035|NCT00836745|617459192|FG000|Overall Study|Death|2|||
170850036|NCT00836745|617459192|FG000|Overall Study|Lost to Follow-up|10|||
170850037|NCT00836745|617459192|FG000|Overall Study|Adverse Event|3|||
170850038|NCT00836745|617459192|FG000|Overall Study|Objective progression or relapse|4|||
170850039|NCT00836745|617459192|FG000|Overall Study|Other|2|||
170850040|NCT00774930|617459193|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
170850041|NCT00774930|617459194|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
170850042|NCT00774930|617459193|FG000|DB Phase|Adverse Event|1|||
170850043|NCT00774930|617459194|FG001|DB Phase|Adverse Event|2|||
170850044|NCT00774930|617459193|FG000|DB Phase|Subject Decision|1|||
170850045|NCT00774930|617459194|FG001|DB Phase|Subject Decision|5|||
170850046|NCT00774930|617459193|FG000|DB Phase|Sponsor Decision|0|||
170850047|NCT00774930|617459194|FG001|DB Phase|Sponsor Decision|1|||
170850048|NCT00774930|617459193|FG000|DB Phase|Disease Progression|1|||
170850049|NCT00774930|617459194|FG001|DB Phase|Disease Progression|1|||
170850050|NCT00774930|617459193|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
170850051|NCT00774930|617459194|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
170850052|NCT00774930|617459193|FG000|IOL Phase|Adverse Event|1|||
170850053|NCT00774930|617459194|FG001|IOL Phase|Adverse Event|1|||
170850054|NCT00774930|617459193|FG000|IOL Phase|Subject Decision|4|||
170850055|NCT00774930|617459194|FG001|IOL Phase|Subject Decision|3|||
170850056|NCT00774930|617459193|FG000|IOL Phase|Physician Decision|3|||
170850057|NCT00774930|617459194|FG001|IOL Phase|Physician Decision|2|||
170850058|NCT00774930|617459193|FG000|IOL Phase|Sponsor Decision|1|||
170850059|NCT00774930|617459194|FG001|IOL Phase|Sponsor Decision|0|||
170850060|NCT00774930|617459193|FG000|IOL Phase|Disease Progression|2|||
170850061|NCT00774930|617459194|FG001|IOL Phase|Disease Progression|1|||
170850062|NCT00774930|617459193|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
170850063|NCT00774930|617459194|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
170850064|NCT00774930|617459193|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
170850065|NCT00774930|617459194|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
170850066|NCT00774930|617459193|FG000|IOL Phase|Other|1|||
170850067|NCT00774930|617459194|FG001|IOL Phase|Other|0|||
170850068|NCT00774930|617459193|FG000|IOL Phase|Brain radiation|0|||
170850069|NCT00774930|617459194|FG001|IOL Phase|Brain radiation|1|||
170850070|NCT00774930|617459193|FG000|LTOLE Phase|Adverse Event|7|||
170850071|NCT00774930|617459194|FG001|LTOLE Phase|Adverse Event|3|||
170850072|NCT00774930|617459193|FG000|LTOLE Phase|Subject decision|0|||
170850073|NCT00774930|617459194|FG001|LTOLE Phase|Subject decision|5|||
170850074|NCT00774930|617459193|FG000|LTOLE Phase|Physician Decision|4|||
170850075|NCT00774930|617459194|FG001|LTOLE Phase|Physician Decision|1|||
170850076|NCT00774930|617459193|FG000|LTOLE Phase|Sponsor decision|2|||
170850077|NCT00774930|617459194|FG001|LTOLE Phase|Sponsor decision|1|||
170850078|NCT00774930|617459193|FG000|LTOLE Phase|Disease Progression|2|||
170850079|NCT00774930|617459194|FG001|LTOLE Phase|Disease Progression|5|||
170850080|NCT00774930|617459193|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
170850081|NCT00774930|617459194|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
170850082|NCT00774930|617459193|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
170850083|NCT00774930|617459194|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
170850084|NCT03020576|617459196|FG000|Overall Study|Withdrawal by Subject|1|||
170850085|NCT03020576|617459197|FG001|Overall Study|Withdrawal by Subject|2|||
170850086|NCT03292432|617459198|FG000|Overall Study|Lost to Follow-up|11|||
170850087|NCT03292432|617459199|FG001|Overall Study|Lost to Follow-up|8|||
170850088|NCT03292432|617459198|FG000|Overall Study|Death|2|||
170850089|NCT03292432|617459199|FG001|Overall Study|Death|1|||
170850090|NCT03292432|617459198|FG000|Overall Study|Withdrawal by Subject|1|||
170850091|NCT03292432|617459199|FG001|Overall Study|Withdrawal by Subject|2|||
170850092|NCT03292432|617459198|FG000|Overall Study|Site closed before any data collected|1|||
170850093|NCT03292432|617459199|FG001|Overall Study|Site closed before any data collected|0|||
170850094|NCT01097707|617459201|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
170850095|NCT01097707|617459202|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
170850096|NCT01097707|617459203|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
170850097|NCT01097707|617459204|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
170850098|NCT01097707|617459205|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
170850099|NCT01097707|617459201|FG000|Overall Study|Adverse Event|4|||
170850100|NCT01097707|617459202|FG001|Overall Study|Adverse Event|2|||
170850101|NCT01097707|617459203|FG002|Overall Study|Adverse Event|3|||
170850102|NCT01097707|617459204|FG003|Overall Study|Adverse Event|1|||
170850103|NCT01097707|617459205|FG004|Overall Study|Adverse Event|3|||
170850104|NCT01097707|617459201|FG000|Overall Study|Entry Criteria Not Met|2|||
170850105|NCT01097707|617459202|FG001|Overall Study|Entry Criteria Not Met|1|||
170850106|NCT01097707|617459203|FG002|Overall Study|Entry Criteria Not Met|1|||
170850107|NCT01097707|617459204|FG003|Overall Study|Entry Criteria Not Met|0|||
170850108|NCT01097707|617459205|FG004|Overall Study|Entry Criteria Not Met|1|||
170850109|NCT01097707|617459201|FG000|Overall Study|Lack of Efficacy|1|||
170850110|NCT01097707|617459202|FG001|Overall Study|Lack of Efficacy|0|||
170850111|NCT01097707|617459203|FG002|Overall Study|Lack of Efficacy|0|||
170850112|NCT01097707|617459204|FG003|Overall Study|Lack of Efficacy|1|||
170850113|NCT01097707|617459205|FG004|Overall Study|Lack of Efficacy|0|||
170850114|NCT01097707|617459201|FG000|Overall Study|Lost to Follow-up|1|||
170850115|NCT01097707|617459202|FG001|Overall Study|Lost to Follow-up|1|||
170850116|NCT01097707|617459203|FG002|Overall Study|Lost to Follow-up|2|||
170850117|NCT01097707|617459204|FG003|Overall Study|Lost to Follow-up|0|||
170850118|NCT01097707|617459205|FG004|Overall Study|Lost to Follow-up|3|||
170850119|NCT01097707|617459201|FG000|Overall Study|Protocol Violation|2|||
170850120|NCT01097707|617459202|FG001|Overall Study|Protocol Violation|2|||
170850121|NCT01097707|617459203|FG002|Overall Study|Protocol Violation|3|||
170850122|NCT01097707|617459204|FG003|Overall Study|Protocol Violation|2|||
170850123|NCT01097707|617459205|FG004|Overall Study|Protocol Violation|2|||
170850124|NCT01097707|617459201|FG000|Overall Study|Sponsor Decision|31|||
170850125|NCT01097707|617459202|FG001|Overall Study|Sponsor Decision|31|||
170850126|NCT01097707|617459203|FG002|Overall Study|Sponsor Decision|34|||
170850127|NCT01097707|617459204|FG003|Overall Study|Sponsor Decision|35|||
170850128|NCT01097707|617459205|FG004|Overall Study|Sponsor Decision|36|||
170850129|NCT01097707|617459201|FG000|Overall Study|Withdrawal by Subject|3|||
170850130|NCT01097707|617459202|FG001|Overall Study|Withdrawal by Subject|6|||
170850131|NCT01097707|617459203|FG002|Overall Study|Withdrawal by Subject|1|||
170850132|NCT01097707|617459204|FG003|Overall Study|Withdrawal by Subject|4|||
170850133|NCT01097707|617459205|FG004|Overall Study|Withdrawal by Subject|3|||
170850134|NCT01097707|617459201|FG000|Overall Study|Reason unknown|0|||
170850135|NCT01097707|617459202|FG001|Overall Study|Reason unknown|0|||
170850136|NCT01097707|617459203|FG002|Overall Study|Reason unknown|0|||
170850137|NCT01097707|617459204|FG003|Overall Study|Reason unknown|0|||
170850138|NCT01097707|617459205|FG004|Overall Study|Reason unknown|1|||
170850139|NCT01498679|617459206|FG000|Overall Study|Adverse Event|1|||
170850140|NCT01498679|617459207|FG001|Overall Study|Adverse Event|4|||
170850141|NCT01498679|617459206|FG000|Overall Study|Lack of Efficacy|72|||
170850142|NCT01498679|617459207|FG001|Overall Study|Lack of Efficacy|12|||
170850143|NCT01498679|617459206|FG000|Overall Study|Protocol Violation|4|||
170850144|NCT01498679|617459207|FG001|Overall Study|Protocol Violation|0|||
170850145|NCT01498679|617459206|FG000|Overall Study|Physician Decision|0|||
170850146|NCT01498679|617459207|FG001|Overall Study|Physician Decision|2|||
170850147|NCT01498679|617459206|FG000|Overall Study|Withdrawal by Subject|12|||
170850148|NCT01498679|617459207|FG001|Overall Study|Withdrawal by Subject|4|||
170850149|NCT03053518|617459209|FG000|Overall Study|Withdrawal by Subject|3|||
170850150|NCT03053518|617459209|FG000|Overall Study|Lost to Follow-up|2|||
170850151|NCT03053518|617459209|FG000|Overall Study|Ineligible|5|||
170850152|NCT00424385|617459210|FG000|Cohort 0|Withdrawal by Subject|5|||
170850153|NCT00424385|617459210|FG000|Cohort 0|Physician Decision|1|||
170850154|NCT00424385|617459210|FG000|Cohort 1|Withdrawal by Subject|1|||
170850155|NCT02683876|617459211|FG000|Overall Study|samples damaged during shipping|2|||
170850156|NCT02683876|617459212|FG001|Overall Study|samples damaged during shipping|0|||
170850157|NCT02057523|617459213|FG000|Overall Study|Withdrawal by Subject|1|||
170850158|NCT02057523|617459213|FG000|Overall Study|Lack of Efficacy|1|||
170850159|NCT02071290|617459216|FG000|Overall Study|Death|1|||
170850160|NCT02071290|617459217|FG001|Overall Study|Death|0|||
170850161|NCT02071290|617459216|FG000|Overall Study|Withdrawal by Subject|0|||
170850162|NCT02071290|617459217|FG001|Overall Study|Withdrawal by Subject|1|||
170850163|NCT02071290|617459216|FG000|Overall Study|Protocol Violation|3|||
170850164|NCT02071290|617459217|FG001|Overall Study|Protocol Violation|5|||
170850165|NCT02071290|617459216|FG000|Overall Study|Physician Decision|0|||
170850166|NCT02071290|617459217|FG001|Overall Study|Physician Decision|1|||
170850167|NCT05560243|617459221|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
170850168|NCT05870228|617459223|FG000|Overall Study|Lost to Follow-up|2|||
170850169|NCT05870228|617459224|FG001|Overall Study|Lost to Follow-up|0|||
170850170|NCT05870228|617459223|FG000|Overall Study|Withdrawal by Subject|1|||
170850171|NCT05870228|617459224|FG001|Overall Study|Withdrawal by Subject|0|||
170850172|NCT00859222|617459232|FG000|Overall Study|Adverse Event|2|||
170850173|NCT00859222|617459233|FG001|Overall Study|Adverse Event|3|||
170850174|NCT00859222|617459234|FG002|Overall Study|Adverse Event|6|||
170850175|NCT00859222|617459235|FG003|Overall Study|Adverse Event|24|||
170850176|NCT00859222|617459236|FG004|Overall Study|Adverse Event|15|||
170850177|NCT00859222|617459232|FG000|Overall Study|DLT|1|||
170850178|NCT00859222|617459233|FG001|Overall Study|DLT|0|||
170850179|NCT00859222|617459234|FG002|Overall Study|DLT|0|||
170850180|NCT00859222|617459235|FG003|Overall Study|DLT|0|||
170850181|NCT00859222|617459236|FG004|Overall Study|DLT|0|||
170850182|NCT01941719|617459240|FG000|Overall Study|Lost to Follow-up|20|||
170850183|NCT01941719|617459241|FG001|Overall Study|Lost to Follow-up|19|||
170850184|NCT00381615|617459244|FG000|Overall Study|Withdrawal by Subject|1|||
170850185|NCT00381615|617459245|FG001|Overall Study|Withdrawal by Subject|3|||
170850186|NCT00381615|617459246|FG002|Overall Study|Withdrawal by Subject|0|||
170850187|NCT00381615|617459247|FG003|Overall Study|Withdrawal by Subject|1|||
170850188|NCT00381615|617459244|FG000|Overall Study|Lost to Follow-up|3|||
170850189|NCT00381615|617459245|FG001|Overall Study|Lost to Follow-up|2|||
170850190|NCT00381615|617459246|FG002|Overall Study|Lost to Follow-up|0|||
170850191|NCT00381615|617459247|FG003|Overall Study|Lost to Follow-up|1|||
170850192|NCT00381615|617459244|FG000|Overall Study|Protocol Violation|0|||
170850193|NCT00381615|617459245|FG001|Overall Study|Protocol Violation|0|||
170850194|NCT00381615|617459246|FG002|Overall Study|Protocol Violation|1|||
170850195|NCT00381615|617459247|FG003|Overall Study|Protocol Violation|0|||
170850196|NCT02797080|617459250|FG000|Overall Study|Lost to Follow-up|1|||
170850197|NCT02797080|617459250|FG000|Overall Study|Withdrawal by Subject|1|||
170850198|NCT03819634|617459251|FG000|Overall Study|Physician Decision|2|||
170850199|NCT02217475|617459257|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
170850200|NCT02217475|617459258|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
170850201|NCT02217475|617459259|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
170850202|NCT02217475|617459257|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
170850203|NCT02217475|617459258|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
170850204|NCT02217475|617459259|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
170850205|NCT02217475|617459257|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
170850206|NCT02217475|617459258|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
170850207|NCT02217475|617459259|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
170850208|NCT02217475|617459257|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
170850209|NCT02217475|617459258|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
170850210|NCT02217475|617459259|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
170850211|NCT02217475|617459257|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
170850212|NCT02217475|617459258|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
170850213|NCT02217475|617459259|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
170850214|NCT02217475|617459257|FG000|Discontinued After Period 1|Adverse Event|1|||
170850215|NCT02217475|617459258|FG001|Discontinued After Period 1|Adverse Event|2|||
170850216|NCT02217475|617459259|FG002|Discontinued After Period 1|Adverse Event|0|||
170850217|NCT02217475|617459257|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
170850218|NCT02217475|617459258|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
170850219|NCT02217475|617459259|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
170850220|NCT02217475|617459257|FG000|Discontinued After Period 1|Physician Decision|0|||
170850221|NCT02217475|617459258|FG001|Discontinued After Period 1|Physician Decision|0|||
170850222|NCT02217475|617459259|FG002|Discontinued After Period 1|Physician Decision|1|||
170850223|NCT02217475|617459257|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
170850224|NCT02217475|617459258|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
170850225|NCT02217475|617459259|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
170850226|NCT02217475|617459257|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
170850227|NCT02217475|617459258|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
170850228|NCT02217475|617459259|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
170850229|NCT02217475|617459257|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
170850230|NCT02217475|617459258|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
170850231|NCT02217475|617459259|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
170850232|NCT02217475|617459257|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
170850233|NCT02217475|617459258|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
170850234|NCT02217475|617459259|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
170850235|NCT02217475|617459257|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
170850236|NCT02217475|617459258|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
170850237|NCT02217475|617459259|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
170850238|NCT01258595|617459264|FG000|Overall Study|Lost to Follow-up|1|||
170850239|NCT01258595|617459265|FG001|Overall Study|Lost to Follow-up|0|||
170850240|NCT01258595|617459264|FG000|Overall Study|Withdrawal by Subject|0|||
170850241|NCT01258595|617459265|FG001|Overall Study|Withdrawal by Subject|1|||
170850242|NCT01215188|617459266|FG000|Overall Study|Lost to Follow-up|22|||
170850243|NCT01215188|617459267|FG001|Overall Study|Lost to Follow-up|22|||
170850244|NCT01215188|617459268|FG002|Overall Study|Lost to Follow-up|16|||
170850245|NCT01215188|617459266|FG000|Overall Study|Adverse Event|1|||
170850246|NCT01215188|617459267|FG001|Overall Study|Adverse Event|1|||
170850247|NCT01215188|617459268|FG002|Overall Study|Adverse Event|3|||
170850248|NCT01215188|617459266|FG000|Overall Study|Physician Decision|2|||
170850249|NCT01215188|617459267|FG001|Overall Study|Physician Decision|1|||
170850250|NCT01215188|617459268|FG002|Overall Study|Physician Decision|0|||
170850251|NCT01215188|617459266|FG000|Overall Study|Lack of Efficacy|0|||
170850252|NCT01215188|617459267|FG001|Overall Study|Lack of Efficacy|0|||
170850253|NCT01215188|617459268|FG002|Overall Study|Lack of Efficacy|1|||
170850254|NCT01215188|617459266|FG000|Overall Study|Protocol Violation|1|||
170850255|NCT01215188|617459267|FG001|Overall Study|Protocol Violation|1|||
170850256|NCT01215188|617459268|FG002|Overall Study|Protocol Violation|1|||
170850257|NCT01215188|617459266|FG000|Overall Study|Withdrawal by Subject|32|||
170850258|NCT01215188|617459267|FG001|Overall Study|Withdrawal by Subject|34|||
170850259|NCT01215188|617459268|FG002|Overall Study|Withdrawal by Subject|31|||
170850260|NCT01012414|617459269|FG000|Overall Study|Withdrawal by Subject|2|||
170850261|NCT01012414|617459269|FG000|Overall Study|Lost to Follow-up|1|||
170850262|NCT01012414|617459269|FG000|Overall Study|Trial was stopped before completed|7|||
170850263|NCT02310100|617459270|FG000|Overall Study|Physician Decision|3|||
170850264|NCT02310100|617459270|FG000|Overall Study|Withdrawal by Subject|10|||
170850265|NCT02310100|617459270|FG000|Overall Study|Enrollment closure|1|||
170850266|NCT02310100|617459270|FG000|Overall Study|Unapproved ablation operator|1|||
170850267|NCT02310100|617459270|FG000|Overall Study|Visit compliance|1|||
170850268|NCT02310100|617459270|FG000|Overall Study|Lost to Follow-up|2|||
170850269|NCT02601300|617459271|FG000|Induction Phase|Lack of Efficacy|2|||
170850270|NCT02601300|617459271|FG000|Induction Phase|Protocol Violation|1|||
170850271|NCT02601300|617459271|FG000|Extension Phase|Withdrawal by Subject|3|||
170850272|NCT02601300|617459271|FG000|Extension Phase|Adverse Event|4|||
170850273|NCT02601300|617459271|FG000|Extension Phase|Lack of Efficacy|10|||
170850274|NCT00888927|617459276|FG000|Overall Study|Adverse Event|0|||
170850275|NCT00888927|617459277|FG001|Overall Study|Adverse Event|0|||
170850276|NCT00888927|617459278|FG002|Overall Study|Adverse Event|0|||
170850277|NCT00888927|617459279|FG003|Overall Study|Adverse Event|1|||
170850278|NCT00888927|617459276|FG000|Overall Study|Withdrawal of consent|0|||
170850279|NCT00888927|617459277|FG001|Overall Study|Withdrawal of consent|0|||
170850280|NCT00888927|617459278|FG002|Overall Study|Withdrawal of consent|0|||
170850281|NCT00888927|617459279|FG003|Overall Study|Withdrawal of consent|1|||
170850282|NCT00738894|617459280|FG000|Overall Study|Lost to Follow-up|23|||
170850283|NCT00738894|617459281|FG001|Overall Study|Lost to Follow-up|13|||
170850284|NCT00738894|617459280|FG000|Overall Study|Withdrawal by Subject|10|||
170850285|NCT00738894|617459281|FG001|Overall Study|Withdrawal by Subject|15|||
170850286|NCT00738894|617459280|FG000|Overall Study|Physician Decision|4|||
170850287|NCT00738894|617459281|FG001|Overall Study|Physician Decision|5|||
170850288|NCT00738894|617459280|FG000|Overall Study|Death|2|||
170850289|NCT00738894|617459281|FG001|Overall Study|Death|0|||
170850290|NCT03026075|617459285|FG000|Overall Study|Physician Decision|1|||
170850291|NCT02297139|617459290|FG000|Overall Study|Disease progression|0|||
170850292|NCT02297139|617459291|FG001|Overall Study|Disease progression|1|||
170850293|NCT02297139|617459290|FG000|Overall Study|Study drug toxicity|0|||
170850294|NCT02297139|617459291|FG001|Overall Study|Study drug toxicity|4|||
170850295|NCT02297139|617459290|FG000|Overall Study|Participant request to discontinue study treatment|0|||
170850296|NCT02297139|617459291|FG001|Overall Study|Participant request to discontinue study treatment|1|||
170850297|NCT02297139|617459290|FG000|Overall Study|Maximum clinical benefit|1|||
170850298|NCT02297139|617459291|FG001|Overall Study|Maximum clinical benefit|0|||
170850299|NCT02297139|617459290|FG000|Overall Study|Administrative reason by sponsor|0|||
170850300|NCT02297139|617459291|FG001|Overall Study|Administrative reason by sponsor|2|||
170850301|NCT02297139|617459290|FG000|Overall Study|Other reasons|0|||
170850302|NCT02297139|617459291|FG001|Overall Study|Other reasons|8|||
170850303|NCT05051462|617459298|FG000|Overall Study|Lost to Follow-up|1|||
170850304|NCT05051462|617459299|FG001|Overall Study|Lost to Follow-up|8|||
170850305|NCT05051462|617459298|FG000|Overall Study|Withdrawal by Subject|1|||
170850306|NCT05051462|617459299|FG001|Overall Study|Withdrawal by Subject|0|||
170850307|NCT05051462|617459298|FG000|Overall Study|Protocol Violation|0|||
170850308|NCT05051462|617459299|FG001|Overall Study|Protocol Violation|2|||
170850309|NCT02425904|617459300|FG000|Overall Study|Lost to Follow-up|1|||
170850310|NCT02425904|617459301|FG001|Overall Study|Lost to Follow-up|0|||
170850311|NCT02425904|617459300|FG000|Overall Study|Withdrawal by Subject|2|||
170850312|NCT02425904|617459301|FG001|Overall Study|Withdrawal by Subject|0|||
170850313|NCT02425904|617459300|FG000|Overall Study|Death|0|||
170850314|NCT02425904|617459301|FG001|Overall Study|Death|3|||
170850315|NCT05260021|617459302|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
170850316|NCT05260021|617459303|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
170850317|NCT05260021|617459304|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
170850318|NCT05260021|617459302|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
170850319|NCT05260021|617459303|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
170850320|NCT05260021|617459304|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
170850321|NCT05260021|617459302|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
170850322|NCT05260021|617459303|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
170850323|NCT05260021|617459304|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
170850324|NCT05260021|617459302|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
170850325|NCT05260021|617459303|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
170850326|NCT05260021|617459304|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
170850327|NCT05260021|617459302|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
170850328|NCT05260021|617459303|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
170850329|NCT05260021|617459304|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
170850330|NCT05597787|617459305|FG000|Overall Study|Withdrawal by Subject|0|||
170850331|NCT05597787|617459306|FG001|Overall Study|Withdrawal by Subject|0|||
170850332|NCT05597787|617459307|FG002|Overall Study|Withdrawal by Subject|1|||
170850333|NCT01144377|617459308|FG000|52 Week Treatment Period|Adverse Event|0|||
170850334|NCT01144377|617459309|FG001|52 Week Treatment Period|Adverse Event|0|||
170850335|NCT01144377|617459310|FG002|52 Week Treatment Period|Adverse Event|3|||
170850336|NCT01144377|617459311|FG003|52 Week Treatment Period|Adverse Event|2|||
170850337|NCT01144377|617459312|FG004|52 Week Treatment Period|Adverse Event|1|||
170850338|NCT01144377|617459308|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
170850339|NCT01144377|617459309|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
170850340|NCT01144377|617459310|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
170739877|NCT04512066|617054187|FG000|Double-blind Treatment Period|Physician Decision|1|||
170739878|NCT04512066|617054188|FG001|Double-blind Treatment Period|Physician Decision|0|||
170739879|NCT04512066|617054189|FG002|Double-blind Treatment Period|Physician Decision|1|||
170739880|NCT04512066|617054190|FG003|Double-blind Treatment Period|Physician Decision|0|||
170739881|NCT04512066|617054191|FG004|Double-blind Treatment Period|Physician Decision|0|||
170739882|NCT04512066|617054192|FG005|Double-blind Treatment Period|Physician Decision|0|||
170739883|NCT04512066|617054187|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
170739884|NCT04512066|617054188|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
170739885|NCT04512066|617054189|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
170739886|NCT04512066|617054190|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
170739887|NCT04512066|617054191|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
170739888|NCT04512066|617054192|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
170739889|NCT04512066|617054187|FG000|Extension Period|Adverse Event|0|||
170739890|NCT04512066|617054188|FG001|Extension Period|Adverse Event|1|||
170739891|NCT04512066|617054189|FG002|Extension Period|Adverse Event|4|||
170739892|NCT04512066|617054190|FG003|Extension Period|Adverse Event|3|||
170739893|NCT04512066|617054191|FG004|Extension Period|Adverse Event|1|||
170739894|NCT04512066|617054192|FG005|Extension Period|Adverse Event|3|||
170739895|NCT04512066|617054187|FG000|Extension Period|Death|0|||
170739896|NCT04512066|617054188|FG001|Extension Period|Death|0|||
170739897|NCT04512066|617054189|FG002|Extension Period|Death|0|||
170739898|NCT04512066|617054190|FG003|Extension Period|Death|0|||
170739899|NCT04512066|617054191|FG004|Extension Period|Death|0|||
170739900|NCT04512066|617054192|FG005|Extension Period|Death|1|||
170739901|NCT04512066|617054187|FG000|Extension Period|Lack of Efficacy|0|||
170739902|NCT04512066|617054188|FG001|Extension Period|Lack of Efficacy|4|||
170739903|NCT04512066|617054189|FG002|Extension Period|Lack of Efficacy|4|||
170739904|NCT04512066|617054190|FG003|Extension Period|Lack of Efficacy|1|||
170739905|NCT04512066|617054191|FG004|Extension Period|Lack of Efficacy|3|||
170739906|NCT04512066|617054192|FG005|Extension Period|Lack of Efficacy|3|||
170739907|NCT04512066|617054187|FG000|Extension Period|Lost to Follow-up|0|||
170739908|NCT04512066|617054188|FG001|Extension Period|Lost to Follow-up|1|||
170739909|NCT04512066|617054189|FG002|Extension Period|Lost to Follow-up|5|||
170739910|NCT04512066|617054190|FG003|Extension Period|Lost to Follow-up|2|||
170739911|NCT04512066|617054191|FG004|Extension Period|Lost to Follow-up|3|||
170850341|NCT01144377|617459311|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
170850342|NCT01144377|617459312|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
170850343|NCT01144377|617459308|FG000|52 Week Treatment Period|Protocol Violation|0|||
170739912|NCT04512066|617054192|FG005|Extension Period|Lost to Follow-up|2|||
170850344|NCT01144377|617459309|FG001|52 Week Treatment Period|Protocol Violation|0|||
170850345|NCT01144377|617459310|FG002|52 Week Treatment Period|Protocol Violation|0|||
170850346|NCT01144377|617459311|FG003|52 Week Treatment Period|Protocol Violation|0|||
170850347|NCT01144377|617459312|FG004|52 Week Treatment Period|Protocol Violation|1|||
170850348|NCT01144377|617459308|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
170850349|NCT01144377|617459309|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
170850350|NCT01144377|617459310|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
170850351|NCT01144377|617459311|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
170850352|NCT01144377|617459312|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
170850353|NCT01144377|617459308|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
170850354|NCT01144377|617459309|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
170850355|NCT01144377|617459310|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
170850356|NCT01144377|617459311|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
170850357|NCT01144377|617459312|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
170850358|NCT01144377|617459308|FG000|52 Week Treatment Period|Sponsor Decision|0|||
170850359|NCT01144377|617459309|FG001|52 Week Treatment Period|Sponsor Decision|0|||
170850360|NCT01144377|617459310|FG002|52 Week Treatment Period|Sponsor Decision|0|||
170850361|NCT01144377|617459311|FG003|52 Week Treatment Period|Sponsor Decision|0|||
170850362|NCT01144377|617459312|FG004|52 Week Treatment Period|Sponsor Decision|1|||
170850363|NCT01144377|617459308|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
170850364|NCT01144377|617459309|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
170850365|NCT01144377|617459310|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
170850366|NCT01144377|617459311|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
170739913|NCT04512066|617054187|FG000|Extension Period|Non-compliance with study drug|0|||
170739914|NCT04512066|617054188|FG001|Extension Period|Non-compliance with study drug|1|||
170739915|NCT04512066|617054189|FG002|Extension Period|Non-compliance with study drug|0|||
170739916|NCT04512066|617054190|FG003|Extension Period|Non-compliance with study drug|0|||
170739917|NCT04512066|617054191|FG004|Extension Period|Non-compliance with study drug|0|||
170739918|NCT04512066|617054192|FG005|Extension Period|Non-compliance with study drug|1|||
170739919|NCT04512066|617054187|FG000|Extension Period|Other|0|||
170739920|NCT04512066|617054188|FG001|Extension Period|Other|2|||
170739921|NCT04512066|617054189|FG002|Extension Period|Other|0|||
170739922|NCT04512066|617054190|FG003|Extension Period|Other|0|||
170739923|NCT04512066|617054191|FG004|Extension Period|Other|0|||
170739924|NCT04512066|617054192|FG005|Extension Period|Other|0|||
170739925|NCT04512066|617054187|FG000|Extension Period|Physician Decision|0|||
170739926|NCT04512066|617054188|FG001|Extension Period|Physician Decision|2|||
170739927|NCT04512066|617054189|FG002|Extension Period|Physician Decision|0|||
170739928|NCT04512066|617054190|FG003|Extension Period|Physician Decision|1|||
170739929|NCT04512066|617054191|FG004|Extension Period|Physician Decision|1|||
170739930|NCT04512066|617054192|FG005|Extension Period|Physician Decision|0|||
170739931|NCT04512066|617054187|FG000|Extension Period|Withdrawal by Subject|0|||
170739932|NCT04512066|617054188|FG001|Extension Period|Withdrawal by Subject|3|||
170739933|NCT04512066|617054189|FG002|Extension Period|Withdrawal by Subject|7|||
170739934|NCT04512066|617054190|FG003|Extension Period|Withdrawal by Subject|11|||
170739935|NCT04512066|617054191|FG004|Extension Period|Withdrawal by Subject|8|||
170739936|NCT04512066|617054192|FG005|Extension Period|Withdrawal by Subject|4|||
170739937|NCT03403426|617054193|FG000|Overall Study|Death|1|||
170739938|NCT03403426|617054193|FG000|Overall Study|Lost to Follow-up|2|||
170739939|NCT01657266|617054197|FG000|Overall Study|Lost to Follow-up|2|||
170739940|NCT01657266|617054198|FG001|Overall Study|Lost to Follow-up|2|||
170739941|NCT01657266|617054197|FG000|Overall Study|Adverse Event|2|||
170739942|NCT01657266|617054198|FG001|Overall Study|Adverse Event|3|||
170739943|NCT03520400|617054199|FG000|Overall Study|Physician Decision|15|||
170739944|NCT03520400|617054200|FG001|Overall Study|Physician Decision|7|||
170739945|NCT00445679|617054203|FG000|Overall Study|Adverse Event|22|||
170739946|NCT00445679|617054204|FG001|Overall Study|Adverse Event|12|||
170739947|NCT00445679|617054205|FG002|Overall Study|Adverse Event|30|||
170739948|NCT00445679|617054206|FG003|Overall Study|Adverse Event|19|||
170739949|NCT00445679|617054203|FG000|Overall Study|Failed to return|1|||
170739950|NCT00445679|617054204|FG001|Overall Study|Failed to return|3|||
170739951|NCT00445679|617054205|FG002|Overall Study|Failed to return|2|||
170739952|NCT00445679|617054206|FG003|Overall Study|Failed to return|2|||
170739953|NCT00445679|617054203|FG000|Overall Study|Physician Decision|0|||
170739954|NCT00445679|617054204|FG001|Overall Study|Physician Decision|0|||
170850367|NCT01144377|617459312|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
170850368|NCT01144377|617459308|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
170739955|NCT00445679|617054205|FG002|Overall Study|Physician Decision|1|||
170739956|NCT00445679|617054206|FG003|Overall Study|Physician Decision|0|||
170739957|NCT00445679|617054203|FG000|Overall Study|Lost to Follow-up|10|||
170739958|NCT00445679|617054204|FG001|Overall Study|Lost to Follow-up|6|||
170850369|NCT01144377|617459309|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
170850370|NCT01144377|617459310|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
170850371|NCT01144377|617459311|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
170850372|NCT01144377|617459312|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
170850373|NCT01144377|617459308|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
170850374|NCT01144377|617459309|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
170850375|NCT01144377|617459310|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
170850376|NCT01144377|617459311|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
170850377|NCT01144377|617459312|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
170850378|NCT04679935|617459314|FG000|Overall Study|Death|0|||
170850379|NCT04679935|617459315|FG001|Overall Study|Death|1|||
170850380|NCT02111681|617459317|FG000|Overall Study|Death|5|||
170850381|NCT02111681|617459317|FG000|Overall Study|Lack of Efficacy|2|||
170850382|NCT02111681|617459317|FG000|Overall Study|Progression of disease|4|||
170850383|NCT03541174|617461148|FG000|Part 1 Double-Blind|Adverse Event|6|||
170850384|NCT03541174|617461149|FG001|Part 1 Double-Blind|Adverse Event|5|||
170850385|NCT03541174|617461150|FG002|Part 1 Double-Blind|Adverse Event|2|||
170850386|NCT03541174|617461151|FG003|Part 1 Double-Blind|Adverse Event|0|||
170850387|NCT03541174|617461152|FG004|Part 1 Double-Blind|Adverse Event|0|||
170850388|NCT03541174|617461153|FG005|Part 1 Double-Blind|Adverse Event|0|||
170850389|NCT03541174|617461148|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
170850390|NCT03541174|617461149|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
170850391|NCT03541174|617461150|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
170850392|NCT03541174|617461151|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
170850393|NCT03541174|617461152|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
170850394|NCT03541174|617461153|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
170850395|NCT03541174|617461148|FG000|Part 1 Double-Blind|Other reasons|3|||
170850396|NCT03541174|617461149|FG001|Part 1 Double-Blind|Other reasons|2|||
170850397|NCT03541174|617461150|FG002|Part 1 Double-Blind|Other reasons|3|||
170850398|NCT03541174|617461151|FG003|Part 1 Double-Blind|Other reasons|0|||
170850399|NCT03541174|617461152|FG004|Part 1 Double-Blind|Other reasons|0|||
170850400|NCT03541174|617461153|FG005|Part 1 Double-Blind|Other reasons|0|||
170850401|NCT03541174|617461148|FG000|Part 2 Single-Blind|Adverse Event|0|||
170850402|NCT03541174|617461149|FG001|Part 2 Single-Blind|Adverse Event|0|||
170850403|NCT03541174|617461150|FG002|Part 2 Single-Blind|Adverse Event|0|||
170850404|NCT03541174|617461151|FG003|Part 2 Single-Blind|Adverse Event|25|||
170850405|NCT03541174|617461152|FG004|Part 2 Single-Blind|Adverse Event|0|||
170850406|NCT03541174|617461153|FG005|Part 2 Single-Blind|Adverse Event|0|||
170850407|NCT03541174|617461148|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
170850408|NCT03541174|617461149|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
170850409|NCT03541174|617461150|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
170850410|NCT03541174|617461151|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
170850411|NCT03541174|617461152|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
170850412|NCT03541174|617461153|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
170850413|NCT03541174|617461148|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
170850414|NCT03541174|617461149|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
170850415|NCT03541174|617461150|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
170850416|NCT03541174|617461151|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
170850417|NCT03541174|617461152|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
170850418|NCT03541174|617461153|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
170850419|NCT03541174|617461148|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
170850420|NCT03541174|617461149|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
170850421|NCT03541174|617461150|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
170850422|NCT03541174|617461151|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
170850423|NCT03541174|617461152|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
170850424|NCT03541174|617461153|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
170850425|NCT03541174|617461148|FG000|Part 2 Single-Blind|Death|0|||
170850426|NCT03541174|617461149|FG001|Part 2 Single-Blind|Death|0|||
170850427|NCT03541174|617461150|FG002|Part 2 Single-Blind|Death|0|||
170850428|NCT03541174|617461151|FG003|Part 2 Single-Blind|Death|5|||
170850429|NCT03541174|617461152|FG004|Part 2 Single-Blind|Death|0|||
170850430|NCT03541174|617461153|FG005|Part 2 Single-Blind|Death|0|||
170850431|NCT03541174|617461148|FG000|Part 2 Single-Blind|Pregnancy|0|||
170850432|NCT03541174|617461149|FG001|Part 2 Single-Blind|Pregnancy|0|||
170850433|NCT03541174|617461150|FG002|Part 2 Single-Blind|Pregnancy|0|||
170850434|NCT03541174|617461151|FG003|Part 2 Single-Blind|Pregnancy|1|||
170850435|NCT03541174|617461152|FG004|Part 2 Single-Blind|Pregnancy|0|||
170850436|NCT03541174|617461153|FG005|Part 2 Single-Blind|Pregnancy|0|||
170850437|NCT03541174|617461148|FG000|Part 2 Single-Blind|Other reasons|0|||
170850438|NCT03541174|617461149|FG001|Part 2 Single-Blind|Other reasons|0|||
170850439|NCT03541174|617461150|FG002|Part 2 Single-Blind|Other reasons|0|||
170850440|NCT03541174|617461151|FG003|Part 2 Single-Blind|Other reasons|32|||
170850441|NCT03541174|617461152|FG004|Part 2 Single-Blind|Other reasons|0|||
170850442|NCT03541174|617461153|FG005|Part 2 Single-Blind|Other reasons|0|||
170850443|NCT03541174|617461148|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
170739959|NCT00445679|617054205|FG002|Overall Study|Lost to Follow-up|6|||
170739960|NCT00445679|617054206|FG003|Overall Study|Lost to Follow-up|5|||
170739961|NCT00445679|617054203|FG000|Overall Study|Compliance|3|||
170739962|NCT00445679|617054204|FG001|Overall Study|Compliance|2|||
170739963|NCT00445679|617054205|FG002|Overall Study|Compliance|1|||
170739964|NCT00445679|617054206|FG003|Overall Study|Compliance|2|||
170739965|NCT00445679|617054203|FG000|Overall Study|Withdrawal of Informed Consent|0|||
170739966|NCT00445679|617054204|FG001|Overall Study|Withdrawal of Informed Consent|0|||
170739967|NCT00445679|617054205|FG002|Overall Study|Withdrawal of Informed Consent|1|||
170739968|NCT00445679|617054206|FG003|Overall Study|Withdrawal of Informed Consent|0|||
170739969|NCT00445679|617054203|FG000|Overall Study|Protocol Violation|2|||
170739970|NCT00445679|617054204|FG001|Overall Study|Protocol Violation|3|||
170739971|NCT00445679|617054205|FG002|Overall Study|Protocol Violation|3|||
170739972|NCT00445679|617054206|FG003|Overall Study|Protocol Violation|1|||
170739973|NCT00445679|617054203|FG000|Overall Study|Withdrawal by Subject|8|||
170739974|NCT00445679|617054204|FG001|Overall Study|Withdrawal by Subject|14|||
170739975|NCT00445679|617054205|FG002|Overall Study|Withdrawal by Subject|20|||
170739976|NCT00445679|617054206|FG003|Overall Study|Withdrawal by Subject|18|||
170739977|NCT00445679|617054203|FG000|Overall Study|Lack of Efficacy|2|||
170739978|NCT00445679|617054204|FG001|Overall Study|Lack of Efficacy|6|||
170739979|NCT00445679|617054205|FG002|Overall Study|Lack of Efficacy|2|||
170739980|NCT00445679|617054206|FG003|Overall Study|Lack of Efficacy|0|||
170739981|NCT01353222|617054209|FG000|Overall Study|Death|30|||
170739982|NCT01353222|617054210|FG001|Overall Study|Death|30|||
170739983|NCT01353222|617054209|FG000|Overall Study|Withdrawal by Subject|8|||
170739984|NCT01353222|617054210|FG001|Overall Study|Withdrawal by Subject|5|||
170739985|NCT01353222|617054209|FG000|Overall Study|Study Terminated|31|||
170739986|NCT01353222|617054210|FG001|Overall Study|Study Terminated|37|||
170739987|NCT01353222|617054209|FG000|Overall Study|Site closed research department|1|||
170739988|NCT01353222|617054210|FG001|Overall Study|Site closed research department|0|||
170739989|NCT01654601|617054211|FG000|1st Administration|Withdrawal by Subject|2|||
170739990|NCT01654601|617054212|FG001|1st Administration|Withdrawal by Subject|0|||
170739991|NCT01654601|617054211|FG000|1st Administration|Protocol Violation|0|||
170739992|NCT01654601|617054212|FG001|1st Administration|Protocol Violation|2|||
170739993|NCT01654601|617054211|FG000|2nd Administration|Adverse Event|1|||
170739994|NCT01654601|617054212|FG001|2nd Administration|Adverse Event|0|||
170739995|NCT01654601|617054211|FG000|2nd Administration|Protocol Violation|0|||
170739996|NCT01654601|617054212|FG001|2nd Administration|Protocol Violation|1|||
170739997|NCT01119898|617054213|FG000|Overall Study|Adverse Event|4|||
170739998|NCT01119898|617054214|FG001|Overall Study|Adverse Event|5|||
170739999|NCT01119898|617054213|FG000|Overall Study|Withdrawal by Subject|1|||
170740000|NCT01119898|617054214|FG001|Overall Study|Withdrawal by Subject|4|||
170740001|NCT01119898|617054213|FG000|Overall Study|Lack of Efficacy|0|||
170740002|NCT01119898|617054214|FG001|Overall Study|Lack of Efficacy|2|||
170740003|NCT01119898|617054213|FG000|Overall Study|Protocol Violation|1|||
170740004|NCT01119898|617054214|FG001|Overall Study|Protocol Violation|1|||
170740005|NCT01119898|617054213|FG000|Overall Study|Medical procedure|1|||
170740006|NCT01119898|617054214|FG001|Overall Study|Medical procedure|0|||
170740007|NCT01119898|617054213|FG000|Overall Study|Randomized in error did not participate|1|||
170740008|NCT01119898|617054214|FG001|Overall Study|Randomized in error did not participate|0|||
170740009|NCT01806584|617054215|FG000|Overall Study|Adverse Event|2|||
170740010|NCT01806584|617054216|FG001|Overall Study|Adverse Event|1|||
170740011|NCT01806584|617054215|FG000|Overall Study|Death|1|||
170740012|NCT01806584|617054216|FG001|Overall Study|Death|0|||
170740013|NCT01806584|617054215|FG000|Overall Study|Lost to Follow-up|0|||
170740014|NCT01806584|617054216|FG001|Overall Study|Lost to Follow-up|2|||
170740015|NCT01806584|617054215|FG000|Overall Study|Study terminated by sponsor|9|||
170740016|NCT01806584|617054216|FG001|Overall Study|Study terminated by sponsor|14|||
170740017|NCT01806584|617054215|FG000|Overall Study|Withdrawal by Subject|1|||
170740018|NCT01806584|617054216|FG001|Overall Study|Withdrawal by Subject|1|||
170740019|NCT01806584|617054215|FG000|Overall Study|Other unspecified|1|||
170740020|NCT01806584|617054216|FG001|Overall Study|Other unspecified|0|||
170740021|NCT01833143|617054217|FG000|Overall Study|Not Treated|1|||
170740022|NCT03021668|617054218|FG000|Overall Study|Physician Decision|0|||
170740023|NCT03021668|617054219|FG001|Overall Study|Physician Decision|1|||
170740024|NCT01807650|617054220|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
170740025|NCT01807650|617054220|FG000|Overall Study|Adverse Event|5|||
170740026|NCT01807650|617054220|FG000|Overall Study|Other|2|||
170740027|NCT00909428|617054223|FG000|Overall Study|Lost to Follow-up|13|||
170740028|NCT00909428|617054224|FG001|Overall Study|Lost to Follow-up|10|||
170740029|NCT00909428|617054225|FG002|Overall Study|Lost to Follow-up|9|||
170740030|NCT02217280|617054226|FG000|Overall Study|Withdrawal by Subject|2|||
170740031|NCT02217280|617054226|FG000|Overall Study|Post-consent sceen fail|2|||
170740032|NCT00736489|617054229|FG000|Period 1|Lost to Follow-up|1|||
170740033|NCT00736489|617054230|FG001|Period 1|Lost to Follow-up|0|||
170740034|NCT00736489|617054231|FG002|Period 1|Lost to Follow-up|0|||
170740035|NCT00736489|617054232|FG003|Period 1|Lost to Follow-up|0|||
170740036|NCT00736489|617054233|FG004|Period 1|Lost to Follow-up|0|||
170740037|NCT00736489|617054234|FG005|Period 1|Lost to Follow-up|0|||
170740038|NCT00736489|617054229|FG000|Period 1|Withdrawal by Subject|0|||
170740039|NCT00736489|617054230|FG001|Period 1|Withdrawal by Subject|0|||
170740040|NCT00736489|617054231|FG002|Period 1|Withdrawal by Subject|0|||
170740041|NCT00736489|617054232|FG003|Period 1|Withdrawal by Subject|0|||
170740042|NCT00736489|617054233|FG004|Period 1|Withdrawal by Subject|0|||
170740043|NCT00736489|617054234|FG005|Period 1|Withdrawal by Subject|1|||
170740044|NCT01933880|617054235|FG000|Overall Study|Withdrawal by Subject|5|||
170740045|NCT01933880|617054236|FG001|Overall Study|Withdrawal by Subject|0|||
170740046|NCT01933880|617054235|FG000|Overall Study|Lack of Efficacy|1|||
170740047|NCT01933880|617054236|FG001|Overall Study|Lack of Efficacy|0|||
170740048|NCT01933880|617054235|FG000|Overall Study|Concomitant medication Interference|0|||
170740049|NCT01933880|617054236|FG001|Overall Study|Concomitant medication Interference|1|||
170740050|NCT01933880|617054235|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
170740051|NCT01933880|617054236|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
170740052|NCT01933880|617054235|FG000|Overall Study|Other|4|||
170740053|NCT01933880|617054236|FG001|Overall Study|Other|0|||
170740054|NCT01933880|617054235|FG000|Overall Study|Protocol Violation|1|||
170740055|NCT01933880|617054236|FG001|Overall Study|Protocol Violation|0|||
170740056|NCT02906683|617056237|FG000|Overall Study|Adverse Event|0|||
170740057|NCT02906683|617056238|FG001|Overall Study|Adverse Event|1|||
170740058|NCT02906683|617056239|FG002|Overall Study|Adverse Event|0|||
170740059|NCT02906683|617056237|FG000|Overall Study|Physician Decision|0|||
170740060|NCT02906683|617056238|FG001|Overall Study|Physician Decision|1|||
170740061|NCT02906683|617056239|FG002|Overall Study|Physician Decision|1|||
170740062|NCT02906683|617056237|FG000|Overall Study|Withdrawal by Subject|0|||
170740063|NCT02906683|617056238|FG001|Overall Study|Withdrawal by Subject|2|||
170740064|NCT02906683|617056239|FG002|Overall Study|Withdrawal by Subject|1|||
170740065|NCT02906683|617056237|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
170740066|NCT02906683|617056238|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
170740067|NCT02906683|617056239|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
170740068|NCT02906683|617056237|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
170740069|NCT02906683|617056238|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
170740070|NCT02906683|617056239|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
170740071|NCT03462706|617056242|FG000|Overall Study|Polyp was pedunculated|1|||
170740072|NCT03462706|617056243|FG001|Overall Study|Polyp was pedunculated|0|||
170740073|NCT03462706|617056244|FG002|Overall Study|Polyp was pedunculated|1|||
170740074|NCT03462706|617056245|FG003|Overall Study|Polyp was pedunculated|0|||
170740075|NCT03462706|617056242|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
170740076|NCT03462706|617056243|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
170740077|NCT03462706|617056244|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
170740078|NCT03462706|617056245|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
170740079|NCT04105972|617056246|FG000|Overall Study|Adverse Event|2|||
170740080|NCT04105972|617056247|FG001|Overall Study|Adverse Event|1|||
170740081|NCT02802319|617056250|FG000|Overall Study|Physician Decision|2|||
170740082|NCT02802319|617056251|FG001|Overall Study|Physician Decision|1|||
170740083|NCT02802319|617056250|FG000|Overall Study|Lost to Follow-up|0|||
170740084|NCT02802319|617056251|FG001|Overall Study|Lost to Follow-up|4|||
170740085|NCT02254408|617056252|FG000|Overall Study|Randomized But Not Treated|1|||
170740086|NCT02254408|617056253|FG001|Overall Study|Randomized But Not Treated|3|||
170740087|NCT02254408|617056252|FG000|Overall Study|Adverse Event|1|||
170740088|NCT02254408|617056253|FG001|Overall Study|Adverse Event|0|||
170740089|NCT02254408|617056252|FG000|Overall Study|Death|2|||
170740090|NCT02254408|617056253|FG001|Overall Study|Death|3|||
170740091|NCT02254408|617056252|FG000|Overall Study|Investigator's Discretion|0|||
170740092|NCT02254408|617056253|FG001|Overall Study|Investigator's Discretion|1|||
170740093|NCT02254408|617056252|FG000|Overall Study|Withdrawal by Subject|3|||
170740094|NCT02254408|617056253|FG001|Overall Study|Withdrawal by Subject|3|||
170740095|NCT02254408|617056252|FG000|Overall Study|Lost to Follow-up|1|||
170850444|NCT03541174|617461149|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
170850445|NCT03541174|617461150|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
170850446|NCT03541174|617461151|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
170850447|NCT03541174|617461152|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
170850448|NCT03541174|617461153|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
170850449|NCT03541174|617461148|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
170850450|NCT03541174|617461149|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
170850451|NCT03541174|617461150|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
170850452|NCT03541174|617461151|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
170850453|NCT03541174|617461152|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
170850454|NCT03541174|617461153|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
170850455|NCT03541174|617461148|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
170850456|NCT03541174|617461149|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
170850457|NCT03541174|617461150|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
170850458|NCT03541174|617461151|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
170850459|NCT03541174|617461152|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
170850460|NCT03541174|617461153|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
170850461|NCT03541174|617461148|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
170850462|NCT03541174|617461149|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
170850463|NCT03541174|617461150|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
170850464|NCT03541174|617461151|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
170850465|NCT03541174|617461152|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
170850466|NCT03541174|617461153|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
170850467|NCT03541174|617461148|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
170850468|NCT03541174|617461149|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
170850469|NCT03541174|617461150|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
170850470|NCT03541174|617461151|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
170850471|NCT03541174|617461152|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
170850472|NCT03541174|617461153|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
170850473|NCT00275262|617461154|FG000|Overall Study|Adverse Event|2|||
170850474|NCT00275262|617461155|FG001|Overall Study|Adverse Event|0|||
170850475|NCT00275262|617461154|FG000|Overall Study|Disease progression|2|||
170850476|NCT00275262|617461155|FG001|Overall Study|Disease progression|5|||
170850477|NCT00275262|617461154|FG000|Overall Study|Lost to Follow-up|0|||
170850478|NCT00275262|617461155|FG001|Overall Study|Lost to Follow-up|2|||
170850479|NCT00275262|617461154|FG000|Overall Study|Protocol Violation|0|||
170850480|NCT00275262|617461155|FG001|Overall Study|Protocol Violation|2|||
170850481|NCT00275262|617461154|FG000|Overall Study|Death|1|||
170850482|NCT00275262|617461155|FG001|Overall Study|Death|0|||
170850483|NCT00275262|617461154|FG000|Overall Study|Started Chemotherapy|1|||
170850484|NCT00275262|617461155|FG001|Overall Study|Started Chemotherapy|0|||
170850485|NCT02217332|617461156|FG000|Overall Study|Adverse Event|3|||
170850486|NCT02217332|617461156|FG000|Overall Study|Dose interruption >1 month|1|||
170850487|NCT02217332|617461156|FG000|Overall Study|Protocol Violation (eligibility)|1|||
170850488|NCT02217332|617461156|FG000|Overall Study|Withdrawal by Subject|1|||
170850489|NCT02217332|617461156|FG000|Overall Study|Lost to Follow-up|1|||
170850490|NCT04058366|617461157|FG000|Overall Study|Adverse Event|14|||
170850491|NCT04058366|617461157|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
170850492|NCT04058366|617461157|FG000|Overall Study|Commercial drug is available for participants|6|||
170850493|NCT04058366|617461157|FG000|Overall Study|Death|1|||
170850494|NCT04058366|617461157|FG000|Overall Study|Other non-compliance|2|||
170850495|NCT04058366|617461157|FG000|Overall Study|Other|6|||
170850496|NCT02594163|617461158|FG000|Treatment Period|Progressive disease|2|||
170850497|NCT02594163|617461159|FG001|Treatment Period|Progressive disease|3|||
170850498|NCT02594163|617461158|FG000|Treatment Period|Adverse Event|1|||
170850499|NCT02594163|617461159|FG001|Treatment Period|Adverse Event|5|||
170850500|NCT02594163|617461158|FG000|Treatment Period|Physician Decision|1|||
170850501|NCT02594163|617461159|FG001|Treatment Period|Physician Decision|3|||
170850502|NCT02594163|617461158|FG000|Treatment Period|Study termination by sponsor|2|||
170850503|NCT02594163|617461159|FG001|Treatment Period|Study termination by sponsor|1|||
170850504|NCT02594163|617461158|FG000|Treatment Period|Other, Non-AE|1|||
170850505|NCT02594163|617461159|FG001|Treatment Period|Other, Non-AE|0|||
170850506|NCT02594163|617461158|FG000|Follow-up Period|Withdrawal by Subject|0|||
170850507|NCT02594163|617461159|FG001|Follow-up Period|Withdrawal by Subject|1|||
170850508|NCT02594163|617461158|FG000|Follow-up Period|Study Termination by Sponsor|6|||
170850509|NCT02594163|617461159|FG001|Follow-up Period|Study Termination by Sponsor|4|||
170850510|NCT02594163|617461158|FG000|Follow-up Period|Lost to Follow-up|1|||
170850511|NCT02594163|617461159|FG001|Follow-up Period|Lost to Follow-up|0|||
170850512|NCT02594163|617461158|FG000|Follow-up Period|Death|2|||
170850513|NCT02594163|617461159|FG001|Follow-up Period|Death|5|||
170850514|NCT02594163|617461158|FG000|Follow-up Period|Adverse Event|0|||
170850515|NCT02594163|617461159|FG001|Follow-up Period|Adverse Event|1|||
170850516|NCT02594163|617461158|FG000|Follow-up Period|Progressive Disease|2|||
170850517|NCT02594163|617461159|FG001|Follow-up Period|Progressive Disease|0|||
170850518|NCT02594163|617461158|FG000|Follow-up Period|Physician Decision|0|||
170850519|NCT02594163|617461159|FG001|Follow-up Period|Physician Decision|1|||
170850520|NCT01342341|617461160|FG000|Overall Study|Lost to Follow-up|4|||
170850521|NCT01342341|617461161|FG001|Overall Study|Lost to Follow-up|4|||
170850522|NCT01034176|617461165|FG000|Overall Study|Physician Decision|2|||
170850523|NCT01034176|617461166|FG001|Overall Study|Physician Decision|0|||
170850524|NCT01034176|617461165|FG000|Overall Study|Withdrawal by Subject|0|||
170850525|NCT01034176|617461166|FG001|Overall Study|Withdrawal by Subject|1|||
170850526|NCT01034176|617461165|FG000|Overall Study|Lost to Follow-up|0|||
170850527|NCT01034176|617461166|FG001|Overall Study|Lost to Follow-up|1|||
170850528|NCT00266227|617461167|FG000|Initial Treatment|Adverse Event|0|||
170850529|NCT00266227|617461168|FG001|Initial Treatment|Adverse Event|0|||
170850530|NCT00266227|617461169|FG002|Initial Treatment|Adverse Event|13|||
170850531|NCT00266227|617461167|FG000|Initial Treatment|Lost to Follow-up|0|||
170850532|NCT00266227|617461168|FG001|Initial Treatment|Lost to Follow-up|0|||
170850533|NCT00266227|617461169|FG002|Initial Treatment|Lost to Follow-up|6|||
170850534|NCT00266227|617461167|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
170850535|NCT00266227|617461168|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
170850536|NCT00266227|617461169|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
170850537|NCT00266227|617461167|FG000|Initial Treatment|Physician decision to withdraw|0|||
170850538|NCT00266227|617461168|FG001|Initial Treatment|Physician decision to withdraw|0|||
170850539|NCT00266227|617461169|FG002|Initial Treatment|Physician decision to withdraw|12|||
170850540|NCT00266227|617461167|FG000|Initial Treatment|Pregnancy|0|||
170850541|NCT00266227|617461168|FG001|Initial Treatment|Pregnancy|0|||
170850542|NCT00266227|617461169|FG002|Initial Treatment|Pregnancy|1|||
170850543|NCT00266227|617461167|FG000|Retreatment: Up to Week 48|Death|1|||
170850544|NCT00266227|617461168|FG001|Retreatment: Up to Week 48|Death|0|||
170850545|NCT00266227|617461169|FG002|Retreatment: Up to Week 48|Death|0|||
170850546|NCT00266227|617461167|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
170850547|NCT00266227|617461168|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
170850548|NCT00266227|617461169|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
170850549|NCT00266227|617461167|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
170850550|NCT00266227|617461168|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
170850551|NCT00266227|617461169|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
170850552|NCT00266227|617461167|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
170850553|NCT00266227|617461168|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
170850554|NCT00266227|617461169|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
170850555|NCT00266227|617461167|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
170850556|NCT00266227|617461168|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
170850557|NCT00266227|617461169|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
170850558|NCT00266227|617461167|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
170850559|NCT00266227|617461168|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
170850560|NCT00266227|617461169|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
170850561|NCT00266227|617461167|FG000|Retreatment: Week 48 to Week 72|Death|1|||
170850562|NCT00266227|617461168|FG001|Retreatment: Week 48 to Week 72|Death|1|||
170850563|NCT00266227|617461169|FG002|Retreatment: Week 48 to Week 72|Death|0|||
170850564|NCT00266227|617461167|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
170850565|NCT00266227|617461168|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
170850566|NCT00266227|617461169|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
170850567|NCT00266227|617461167|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
170850568|NCT00266227|617461168|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
170850569|NCT00266227|617461169|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
170850570|NCT00266227|617461167|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
170850571|NCT00266227|617461168|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
170850572|NCT00266227|617461169|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
170850573|NCT00266227|617461167|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
170850574|NCT00266227|617461168|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
170850575|NCT00266227|617461169|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
170850576|NCT01813929|617461171|FG000|Overall Study|Withdrawal by Subject|0|||
170850577|NCT01813929|617461172|FG001|Overall Study|Withdrawal by Subject|1|||
170850578|NCT00007345|617461173|FG000|Overall Study|Refused further treatment|0|||
170850579|NCT00007345|617461174|FG001|Overall Study|Refused further treatment|7|||
170850580|NCT00007345|617461173|FG000|Overall Study|Switched to alternative treatment|0|||
170850581|NCT00007345|617461174|FG001|Overall Study|Switched to alternative treatment|3|||
170850582|NCT00007345|617461173|FG000|Overall Study|Intercurrent illness|1|||
170850583|NCT00007345|617461174|FG001|Overall Study|Intercurrent illness|0|||
170850584|NCT00007345|617461173|FG000|Overall Study|Death on study|1|||
170850585|NCT00007345|617461174|FG001|Overall Study|Death on study|1|||
170850586|NCT02074553|617461175|FG000|Intervention Period 1|Family Emergency|0|||
170850587|NCT02074553|617461176|FG001|Intervention Period 1|Family Emergency|0|||
170850588|NCT02074553|617461177|FG002|Intervention Period 1|Family Emergency|0|||
170850589|NCT02074553|617461178|FG003|Intervention Period 1|Family Emergency|1|||
170850590|NCT02074553|617461179|FG004|Intervention Period 1|Family Emergency|0|||
170850591|NCT02074553|617461180|FG005|Intervention Period 1|Family Emergency|0|||
170850592|NCT02074553|617461181|FG006|Intervention Period 1|Family Emergency|0|||
170850593|NCT02074553|617461182|FG007|Intervention Period 1|Family Emergency|0|||
170850594|NCT02074553|617461175|FG000|Washout Period 1|Adverse Event|1|||
170850595|NCT02074553|617461176|FG001|Washout Period 1|Adverse Event|0|||
170850596|NCT02074553|617461177|FG002|Washout Period 1|Adverse Event|0|||
170850597|NCT02074553|617461178|FG003|Washout Period 1|Adverse Event|0|||
170850598|NCT02074553|617461179|FG004|Washout Period 1|Adverse Event|0|||
170850599|NCT02074553|617461180|FG005|Washout Period 1|Adverse Event|0|||
170850600|NCT02074553|617461181|FG006|Washout Period 1|Adverse Event|0|||
170850601|NCT02074553|617461182|FG007|Washout Period 1|Adverse Event|0|||
170850602|NCT02074553|617461175|FG000|Washout Period 1|Physician Decision|0|||
170850603|NCT02074553|617461176|FG001|Washout Period 1|Physician Decision|0|||
170850604|NCT02074553|617461177|FG002|Washout Period 1|Physician Decision|0|||
170850605|NCT02074553|617461178|FG003|Washout Period 1|Physician Decision|1|||
170850606|NCT02074553|617461179|FG004|Washout Period 1|Physician Decision|0|||
170850607|NCT02074553|617461180|FG005|Washout Period 1|Physician Decision|0|||
170850608|NCT02074553|617461181|FG006|Washout Period 1|Physician Decision|0|||
170850609|NCT02074553|617461182|FG007|Washout Period 1|Physician Decision|0|||
170850610|NCT02074553|617461175|FG000|Washout Period 1|Other|0|||
170850611|NCT02074553|617461176|FG001|Washout Period 1|Other|0|||
170850612|NCT02074553|617461177|FG002|Washout Period 1|Other|0|||
170850613|NCT02074553|617461178|FG003|Washout Period 1|Other|0|||
170850614|NCT02074553|617461179|FG004|Washout Period 1|Other|0|||
170850615|NCT02074553|617461180|FG005|Washout Period 1|Other|1|||
170850616|NCT02074553|617461181|FG006|Washout Period 1|Other|0|||
170850617|NCT02074553|617461182|FG007|Washout Period 1|Other|0|||
170850618|NCT02074553|617461175|FG000|Washout Period 2|Adverse Event|0|||
170850619|NCT02074553|617461176|FG001|Washout Period 2|Adverse Event|0|||
170850620|NCT02074553|617461177|FG002|Washout Period 2|Adverse Event|0|||
170850621|NCT02074553|617461178|FG003|Washout Period 2|Adverse Event|0|||
170850622|NCT02074553|617461179|FG004|Washout Period 2|Adverse Event|0|||
170850623|NCT02074553|617461180|FG005|Washout Period 2|Adverse Event|0|||
170850624|NCT02074553|617461181|FG006|Washout Period 2|Adverse Event|1|||
170850625|NCT02074553|617461182|FG007|Washout Period 2|Adverse Event|0|||
170850626|NCT02074553|617461175|FG000|Washout Period 2|Physician Decision|0|||
170850627|NCT02074553|617461176|FG001|Washout Period 2|Physician Decision|0|||
170850628|NCT02074553|617461177|FG002|Washout Period 2|Physician Decision|0|||
170850629|NCT02074553|617461178|FG003|Washout Period 2|Physician Decision|0|||
170850630|NCT02074553|617461179|FG004|Washout Period 2|Physician Decision|0|||
170850631|NCT02074553|617461180|FG005|Washout Period 2|Physician Decision|1|||
170850632|NCT02074553|617461181|FG006|Washout Period 2|Physician Decision|0|||
170850633|NCT02074553|617461182|FG007|Washout Period 2|Physician Decision|0|||
170850634|NCT02074553|617461175|FG000|Washout Period 2|Lost to Follow-up|0|||
170850635|NCT02074553|617461176|FG001|Washout Period 2|Lost to Follow-up|0|||
170850636|NCT02074553|617461177|FG002|Washout Period 2|Lost to Follow-up|1|||
170850637|NCT02074553|617461178|FG003|Washout Period 2|Lost to Follow-up|0|||
170850638|NCT02074553|617461179|FG004|Washout Period 2|Lost to Follow-up|0|||
170850639|NCT02074553|617461180|FG005|Washout Period 2|Lost to Follow-up|0|||
170850640|NCT02074553|617461181|FG006|Washout Period 2|Lost to Follow-up|0|||
170850641|NCT02074553|617461182|FG007|Washout Period 2|Lost to Follow-up|0|||
170850642|NCT02074553|617461175|FG000|Washout Period 3|Physician Decision|0|||
170850643|NCT02074553|617461176|FG001|Washout Period 3|Physician Decision|0|||
170850644|NCT02074553|617461177|FG002|Washout Period 3|Physician Decision|0|||
170850645|NCT02074553|617461178|FG003|Washout Period 3|Physician Decision|0|||
170850646|NCT02074553|617461179|FG004|Washout Period 3|Physician Decision|0|||
170850647|NCT02074553|617461180|FG005|Washout Period 3|Physician Decision|0|||
170850648|NCT02074553|617461181|FG006|Washout Period 3|Physician Decision|0|||
170850649|NCT02074553|617461182|FG007|Washout Period 3|Physician Decision|1|||
170850650|NCT00194987|617461183|FG000|Overall Study|Withdrawal by Subject|0|||
170850651|NCT00194987|617461184|FG001|Overall Study|Withdrawal by Subject|3|||
170850652|NCT01664598|617461185|FG000|Overall Study|Sponsor Decision|1|||
170850653|NCT01664598|617461185|FG000|Overall Study|Withdrawal of Informed Consent|4|||
170850654|NCT01664598|617461185|FG000|Overall Study|Adverse Event|1|||
170850655|NCT00938470|617461186|FG000|Overall Study|Disease Progression|3|||
170850656|NCT00938470|617461187|FG001|Overall Study|Disease Progression|0|||
170850657|NCT00938470|617461186|FG000|Overall Study|Alternate Treatment|1|||
170850658|NCT00938470|617461187|FG001|Overall Study|Alternate Treatment|0|||
170850659|NCT00938470|617461186|FG000|Overall Study|Death|3|||
170850660|NCT00938470|617461187|FG001|Overall Study|Death|2|||
170850661|NCT00938470|617461186|FG000|Overall Study|Other Reason|0|||
170850662|NCT00938470|617461187|FG001|Overall Study|Other Reason|1|||
170850663|NCT00766363|617461188|FG000|Overall Study|Withdrawal by Subject|1|||
170850664|NCT00766363|617461189|FG001|Overall Study|Withdrawal by Subject|0|||
170850665|NCT00766363|617461190|FG002|Overall Study|Withdrawal by Subject|0|||
170850666|NCT00766363|617461191|FG003|Overall Study|Withdrawal by Subject|0|||
170850667|NCT00766363|617461188|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
170850668|NCT00766363|617461189|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
170850669|NCT00766363|617461190|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
170850670|NCT00766363|617461191|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
170850671|NCT00911937|617461192|FG000|Overall Study|Death|1|||
170850672|NCT00911937|617461193|FG001|Overall Study|Death|0|||
170850673|NCT00911937|617461192|FG000|Overall Study|Lost to Follow-up|8|||
170850674|NCT00911937|617461193|FG001|Overall Study|Lost to Follow-up|5|||
170850675|NCT00911937|617461192|FG000|Overall Study|Withdrawal by Subject|10|||
170850676|NCT00911937|617461193|FG001|Overall Study|Withdrawal by Subject|7|||
170850677|NCT00911937|617461192|FG000|Overall Study|Withdrawn due to pregnancy|1|||
170850678|NCT00911937|617461193|FG001|Overall Study|Withdrawn due to pregnancy|0|||
170850679|NCT00911937|617461192|FG000|Overall Study|Adverse Event|11|||
170850680|NCT00911937|617461193|FG001|Overall Study|Adverse Event|25|||
170850681|NCT00911937|617461192|FG000|Overall Study|Lack of Efficacy|11|||
170850682|NCT00911937|617461193|FG001|Overall Study|Lack of Efficacy|6|||
170850683|NCT00911937|617461192|FG000|Overall Study|Did not meet inclusion criteria|9|||
170850684|NCT00911937|617461193|FG001|Overall Study|Did not meet inclusion criteria|11|||
170850685|NCT00911937|617461192|FG000|Overall Study|Protocol Violation|14|||
170850686|NCT00911937|617461193|FG001|Overall Study|Protocol Violation|23|||
170850687|NCT00911937|617461192|FG000|Overall Study|Randomized but not treated|13|||
170850688|NCT00911937|617461193|FG001|Overall Study|Randomized but not treated|13|||
170850689|NCT00911937|617461192|FG000|Overall Study|Other|9|||
170850690|NCT00911937|617461193|FG001|Overall Study|Other|5|||
170850691|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
170850692|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
170850693|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
170850694|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
170850695|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
170850696|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
170850697|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
170850698|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
170850699|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
170850700|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
170850701|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
170850702|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
170850703|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
170740096|NCT02254408|617056253|FG001|Overall Study|Lost to Follow-up|0|||
170740097|NCT04651114|617056254|FG000|Overall Study|Withdrawal by Subject|8|||
170740098|NCT01993017|617056255|FG000|Overall Study|Death|23|||
170740099|NCT01993017|617056256|FG001|Overall Study|Death|26|||
170740100|NCT01993017|617056257|FG002|Overall Study|Death|18|||
170740101|NCT01993017|617056255|FG000|Overall Study|Could not be contacted|43|||
170740102|NCT01993017|617056256|FG001|Overall Study|Could not be contacted|42|||
170740103|NCT01993017|617056257|FG002|Overall Study|Could not be contacted|38|||
170740104|NCT01993017|617056255|FG000|Overall Study|Dropped out|19|||
170740105|NCT01993017|617056256|FG001|Overall Study|Dropped out|6|||
170740106|NCT01993017|617056257|FG002|Overall Study|Dropped out|11|||
170740107|NCT01993017|617056255|FG000|Overall Study|Other reasons|17|||
170850704|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
170850705|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
170850706|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
170850707|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
170850708|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
170740108|NCT01993017|617056256|FG001|Overall Study|Other reasons|11|||
170850709|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
170850710|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
170740109|NCT01993017|617056257|FG002|Overall Study|Other reasons|7|||
170740110|NCT01993017|617056255|FG000|Overall Study|Ineligible after randomization|4|||
170740111|NCT01993017|617056256|FG001|Overall Study|Ineligible after randomization|5|||
170740112|NCT01993017|617056257|FG002|Overall Study|Ineligible after randomization|5|||
170740113|NCT01478113|617056258|FG000|Overall Study|Withdrawal by Subject|0|||
170740114|NCT01478113|617056259|FG001|Overall Study|Withdrawal by Subject|1|||
170740115|NCT01478113|617056258|FG000|Overall Study|Physician Decision|1|||
170740116|NCT01478113|617056259|FG001|Overall Study|Physician Decision|0|||
170740117|NCT00289770|617056260|FG000|Year 15|Withdrawal by Subject|1|||
170740118|NCT02966002|617056261|FG000|Overall Study|Withdrawal by Subject|2|||
170740119|NCT02966002|617056261|FG000|Overall Study|Adverse Event|1|||
170740120|NCT02966002|617056261|FG000|Overall Study|Lost to Follow-up|1|||
170740121|NCT00067990|617056262|FG000|Overall Study|Death|5|||
170740122|NCT00067990|617056263|FG001|Overall Study|Death|7|||
170740123|NCT00067990|617056262|FG000|Overall Study|ESRD, Non IF/TA|1|||
170740124|NCT00067990|617056263|FG001|Overall Study|ESRD, Non IF/TA|3|||
170740125|NCT00067990|617056262|FG000|Overall Study|Withdrawal by Subject|4|||
170740126|NCT00067990|617056263|FG001|Overall Study|Withdrawal by Subject|12|||
170740127|NCT04415151|617056264|FG000|Overall Study|Death|1|||
170740128|NCT04415151|617056265|FG001|Overall Study|Death|1|||
170740129|NCT04415151|617056264|FG000|Overall Study|Withdrawal by Subject|1|||
170740130|NCT04415151|617056265|FG001|Overall Study|Withdrawal by Subject|0|||
170740131|NCT00638235|617056266|FG000|Overall Study|Lost to Follow-up|31|||
170740132|NCT00638235|617056267|FG001|Overall Study|Lost to Follow-up|3|||
170740133|NCT00638235|617056268|FG002|Overall Study|Lost to Follow-up|18|||
170740134|NCT00638235|617056269|FG003|Overall Study|Lost to Follow-up|10|||
170740135|NCT00638235|617056270|FG004|Overall Study|Lost to Follow-up|13|||
170740136|NCT00638235|617056271|FG005|Overall Study|Lost to Follow-up|26|||
170740137|NCT00638235|617056272|FG006|Overall Study|Lost to Follow-up|0|||
170740138|NCT00638235|617056273|FG007|Overall Study|Lost to Follow-up|1|||
170740139|NCT00638235|617056274|FG008|Overall Study|Lost to Follow-up|18|||
170740140|NCT02145078|617056278|FG000|Overall Study|Death|1|||
170740141|NCT02145078|617056278|FG000|Overall Study|Reason not given|3|||
170740142|NCT01350141|617056279|FG000|Overall Study|Lost to Follow-up|1|||
170740143|NCT01350141|617056280|FG001|Overall Study|Lost to Follow-up|0|||
170740144|NCT01350141|617056281|FG002|Overall Study|Lost to Follow-up|1|||
170740145|NCT01350141|617056279|FG000|Overall Study|Withdrawal by Subject|1|||
170740146|NCT01350141|617056280|FG001|Overall Study|Withdrawal by Subject|0|||
170740147|NCT01350141|617056281|FG002|Overall Study|Withdrawal by Subject|0|||
170740148|NCT01350141|617056279|FG000|Overall Study|Randomized but not treated|1|||
170740149|NCT01350141|617056280|FG001|Overall Study|Randomized but not treated|0|||
170740150|NCT01350141|617056281|FG002|Overall Study|Randomized but not treated|0|||
170740151|NCT00519896|617056282|FG000|Overall Study|Protocol Violation|1|||
170740152|NCT00519896|617056282|FG000|Overall Study|Adverse Event|1|||
170740153|NCT00810082|617056283|FG000|Overall Study|Lost to Follow-up|0|||
170740154|NCT00810082|617056284|FG001|Overall Study|Lost to Follow-up|4|||
170740155|NCT03327402|617056285|FG000|Overall Study|Withdrawal by Subject|1|||
170740156|NCT03327402|617056285|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
170740157|NCT01473381|617056292|FG000|Overall Study|Adverse Event|8|||
170740158|NCT01473381|617056293|FG001|Overall Study|Adverse Event|20|||
170740159|NCT01473381|617056294|FG002|Overall Study|Adverse Event|25|||
170740160|NCT01473381|617056295|FG003|Overall Study|Adverse Event|17|||
170740161|NCT01473381|617056292|FG000|Overall Study|Insufficient Therapeutic Response|10|||
170850711|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
170850712|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
170850713|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
170850714|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
170850715|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
170850716|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
170850717|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
170850718|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
170850719|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
170850720|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
170850721|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
170850722|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
170850723|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
170850724|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
170850725|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
170740162|NCT01473381|617056293|FG001|Overall Study|Insufficient Therapeutic Response|1|||
170740163|NCT01473381|617056294|FG002|Overall Study|Insufficient Therapeutic Response|2|||
170740164|NCT01473381|617056295|FG003|Overall Study|Insufficient Therapeutic Response|3|||
170740165|NCT01473381|617056292|FG000|Overall Study|Protocol Violation|17|||
170740166|NCT01473381|617056293|FG001|Overall Study|Protocol Violation|23|||
170740167|NCT01473381|617056294|FG002|Overall Study|Protocol Violation|19|||
170740168|NCT01473381|617056295|FG003|Overall Study|Protocol Violation|17|||
170740169|NCT01473381|617056292|FG000|Overall Study|Withdrawal of Consent|20|||
170740170|NCT01473381|617056293|FG001|Overall Study|Withdrawal of Consent|21|||
170740171|NCT01473381|617056294|FG002|Overall Study|Withdrawal of Consent|20|||
170740172|NCT01473381|617056295|FG003|Overall Study|Withdrawal of Consent|26|||
170740173|NCT01473381|617056292|FG000|Overall Study|Lost to Follow-up|25|||
170740174|NCT01473381|617056293|FG001|Overall Study|Lost to Follow-up|28|||
170740175|NCT01473381|617056294|FG002|Overall Study|Lost to Follow-up|35|||
170740176|NCT01473381|617056295|FG003|Overall Study|Lost to Follow-up|23|||
170740177|NCT01473381|617056292|FG000|Overall Study|Other Reasons|0|||
170740178|NCT01473381|617056293|FG001|Overall Study|Other Reasons|0|||
170740179|NCT01473381|617056294|FG002|Overall Study|Other Reasons|1|||
170740180|NCT01473381|617056295|FG003|Overall Study|Other Reasons|3|||
170740181|NCT01454830|617056296|FG000|Overall Study|Withdrawal by Subject|4|||
170740182|NCT01454830|617056297|FG001|Overall Study|Withdrawal by Subject|4|||
170740183|NCT01454830|617056296|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
170740184|NCT01454830|617056297|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
170740185|NCT01454830|617056296|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
170740186|NCT01454830|617056297|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
170740187|NCT01454830|617056296|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
170740188|NCT01454830|617056297|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
170740189|NCT01454830|617056296|FG000|Overall Study|Withdrawal - no polysomnography|3|||
170740190|NCT01454830|617056297|FG001|Overall Study|Withdrawal - no polysomnography|2|||
170740191|NCT03810313|617056298|FG000|Overall Study|Study terminated by sponsor|164|||
170740192|NCT03810313|617056299|FG001|Overall Study|Study terminated by sponsor|159|||
170740193|NCT03810313|617056298|FG000|Overall Study|Subject decision|10|||
170740194|NCT03810313|617056299|FG001|Overall Study|Subject decision|11|||
170740195|NCT03810313|617056298|FG000|Overall Study|Lost to Follow-up|3|||
170740196|NCT03810313|617056299|FG001|Overall Study|Lost to Follow-up|3|||
170740197|NCT03810313|617056298|FG000|Overall Study|Adverse Event|2|||
170740198|NCT03810313|617056299|FG001|Overall Study|Adverse Event|1|||
170740199|NCT03810313|617056298|FG000|Overall Study|Death|2|||
170740200|NCT03810313|617056299|FG001|Overall Study|Death|1|||
170740201|NCT03810313|617056298|FG000|Overall Study|Physician Decision|0|||
170740202|NCT03810313|617056299|FG001|Overall Study|Physician Decision|1|||
170740203|NCT00539643|617056302|FG000|Overall Study|Adverse Event|1|||
170740204|NCT00539643|617056303|FG001|Overall Study|Adverse Event|0|||
170740205|NCT00539643|617056302|FG000|Overall Study|Death|2|||
170740206|NCT00539643|617056303|FG001|Overall Study|Death|1|||
170740207|NCT00539643|617056302|FG000|Overall Study|Physician Decision|3|||
170740208|NCT00539643|617056303|FG001|Overall Study|Physician Decision|1|||
170740209|NCT00539643|617056302|FG000|Overall Study|Withdrawal by Subject|0|||
170740210|NCT00539643|617056303|FG001|Overall Study|Withdrawal by Subject|1|||
170740211|NCT02341456|617056306|FG000|Overall Study|Disease progression|2|||
170740212|NCT02341456|617056307|FG001|Overall Study|Disease progression|3|||
170740213|NCT02341456|617056308|FG002|Overall Study|Disease progression|1|||
170740214|NCT02341456|617056306|FG000|Overall Study|Death|1|||
170740215|NCT02341456|617056307|FG001|Overall Study|Death|1|||
170740216|NCT02341456|617056308|FG002|Overall Study|Death|1|||
170740217|NCT02341456|617056306|FG000|Overall Study|Withdrawal by Subject|0|||
170740218|NCT02341456|617056307|FG001|Overall Study|Withdrawal by Subject|1|||
170740219|NCT02341456|617056308|FG002|Overall Study|Withdrawal by Subject|1|||
170740220|NCT02341456|617056306|FG000|Overall Study|Moved to local access programme.|0|||
170740221|NCT02341456|617056307|FG001|Overall Study|Moved to local access programme.|1|||
170740222|NCT02341456|617056308|FG002|Overall Study|Moved to local access programme.|1|||
170740223|NCT02341456|617056306|FG000|Overall Study|Physician Decision|1|||
170740224|NCT02341456|617056307|FG001|Overall Study|Physician Decision|0|||
170740225|NCT02341456|617056308|FG002|Overall Study|Physician Decision|0|||
170740226|NCT03502616|617056312|FG000|Up to Week 16|Withdrawal by Subject|1|||
170740227|NCT03502616|617056313|FG001|Up to Week 16|Withdrawal by Subject|2|||
170740228|NCT03502616|617056312|FG000|Up to Week 16|Lost to Follow-up|0|||
170740229|NCT03502616|617056313|FG001|Up to Week 16|Lost to Follow-up|1|||
170740230|NCT03502616|617056312|FG000|Up to Week 16|Randomized, but not treated|1|||
170740231|NCT03502616|617056313|FG001|Up to Week 16|Randomized, but not treated|0|||
170740232|NCT03502616|617056312|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
170740233|NCT03502616|617056313|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
170740234|NCT03502616|617056312|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
170740235|NCT03502616|617056313|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
170740236|NCT01785563|617056314|FG000|Overall Study|Physician Decision|10|||
170740237|NCT01785563|617056314|FG000|Overall Study|Withdrawal by Subject|1|||
170740238|NCT01785563|617056314|FG000|Overall Study|Protocol Violation|2|||
170740239|NCT02091739|617056323|FG000|MP: 16 Weeks|Adverse Event|1|||
170740240|NCT02091739|617056324|FG001|MP: 16 Weeks|Adverse Event|1|||
170740241|NCT02091739|617056325|FG002|MP: 16 Weeks|Adverse Event|1|||
170740242|NCT02091739|617056326|FG003|MP: 16 Weeks|Adverse Event|0|||
170740243|NCT02091739|617056327|FG004|MP: 16 Weeks|Adverse Event|0|||
170740244|NCT02091739|617056323|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
170740245|NCT02091739|617056324|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
170740246|NCT02091739|617056325|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
170740247|NCT02091739|617056326|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
170850726|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
170850727|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
170850728|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
170850729|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
170850730|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
170850731|NCT00700427|617461194|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
170850732|NCT00700427|617461195|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
170850733|NCT00700427|617461196|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
170850734|NCT00700427|617461197|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
170850735|NCT00700427|617461198|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
170850736|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
170850737|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
170850738|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
170850739|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
170850740|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
170850741|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
170850742|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
170850743|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
170850744|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
170850745|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
170850746|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
170850747|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
170850748|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
170850749|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
170850750|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
170850751|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
170850752|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
170850753|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
170850754|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
170850755|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
170850756|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
170850757|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
170850758|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
170850759|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
170850760|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
170850761|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
170850762|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
170850763|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
170850764|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
170850765|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
170850766|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
170850767|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
170850768|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
170850769|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
170850770|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
170850771|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
170850772|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
170850773|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
170850774|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
170850775|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
170850776|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
170850777|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
170850778|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
170850779|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
170850780|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
170850781|NCT00700427|617461194|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
170850782|NCT00700427|617461195|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
170850783|NCT00700427|617461196|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
170850784|NCT00700427|617461197|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
170850785|NCT00700427|617461198|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
170850786|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
170850787|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
170850788|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
170850789|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
170850790|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
170850791|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
170850792|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
170850793|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
170850794|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
170850795|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
170850796|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
170850797|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
170850798|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
170850799|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
170850800|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
170850801|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
170850802|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
170850803|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
170850804|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
170850805|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
170850806|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
170850807|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
170850808|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
170850809|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
170850810|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
170850811|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
170850812|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
170850813|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
170850814|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
170850815|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
170850816|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
170850817|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
170850818|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
170850819|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
170850820|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
170850821|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
170850822|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
170850823|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
170850824|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
170850825|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
170850826|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
170850827|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
170850828|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
170850829|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
170850830|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
170850831|NCT00700427|617461194|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
170850832|NCT00700427|617461195|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
170850833|NCT00700427|617461196|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
170850834|NCT00700427|617461197|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
170850835|NCT00700427|617461198|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
170850836|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
170850837|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
170850838|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
170850839|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
170850840|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
170850841|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
170850842|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
170850843|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
170850844|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
170850845|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
170850846|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
170850847|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
170850848|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
170850849|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
170850850|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
170850851|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
170850852|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
170850853|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
170850854|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
170850855|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
170850856|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
170850857|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
170850858|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
170850859|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
170850860|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
170850861|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
170850862|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
170850863|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
170850864|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
170850865|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
170850866|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
170850867|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
170850868|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
170850869|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
170850870|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
170850871|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
170850872|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
170850873|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
170850874|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
170850875|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
170850876|NCT00700427|617461194|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
170850877|NCT00700427|617461195|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
170850878|NCT00700427|617461196|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
170850879|NCT00700427|617461197|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
170850880|NCT00700427|617461198|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
170850881|NCT03212989|617461200|FG000|Overall Study|Physician Decision|8|||
170850882|NCT03047395|617461202|FG000|Overall Study|Adverse Event|142|||
170850883|NCT03047395|617461202|FG000|Overall Study|Withdrawal by Subject|155|||
170850884|NCT03047395|617461202|FG000|Overall Study|Lost to Follow-up|144|||
170850885|NCT03047395|617461202|FG000|Overall Study|COVID-19 Infection|2|||
170850886|NCT03047395|617461202|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
170850887|NCT03047395|617461202|FG000|Overall Study|Other, Not Specified|117|||
170850888|NCT03484273|617461207|FG000|Overall Study|Equipment Malfunction|1|||
170850889|NCT03484273|617461207|FG000|Overall Study|Data excluded from analysis|1|||
170850890|NCT04075994|617461208|FG000|Overall Study|Withdrawal by Subject|8|||
170850891|NCT04075994|617461209|FG001|Overall Study|Withdrawal by Subject|9|||
170850892|NCT04075994|617461208|FG000|Overall Study|Adverse Event|2|||
170850893|NCT04075994|617461209|FG001|Overall Study|Adverse Event|2|||
170850894|NCT04075994|617461208|FG000|Overall Study|Investigator withdrew|3|||
170850895|NCT04075994|617461209|FG001|Overall Study|Investigator withdrew|1|||
170850896|NCT00291642|617461217|FG000|Overall Study|Adverse Event|1|||
170850897|NCT00291642|617461218|FG001|Overall Study|Adverse Event|0|||
170850898|NCT00291642|617461219|FG002|Overall Study|Adverse Event|1|||
170850899|NCT00291642|617461220|FG003|Overall Study|Adverse Event|0|||
170850900|NCT00291642|617461221|FG004|Overall Study|Adverse Event|1|||
170850901|NCT00291642|617461217|FG000|Overall Study|Patient missed visit|0|||
170850902|NCT00291642|617461218|FG001|Overall Study|Patient missed visit|0|||
170850903|NCT00291642|617461219|FG002|Overall Study|Patient missed visit|1|||
170850904|NCT00291642|617461220|FG003|Overall Study|Patient missed visit|0|||
170850905|NCT00291642|617461221|FG004|Overall Study|Patient missed visit|0|||
170850906|NCT00291642|617461217|FG000|Overall Study|Intake of prohibited medication|1|||
170850907|NCT00291642|617461218|FG001|Overall Study|Intake of prohibited medication|0|||
170850908|NCT00291642|617461219|FG002|Overall Study|Intake of prohibited medication|0|||
170850909|NCT00291642|617461220|FG003|Overall Study|Intake of prohibited medication|0|||
170850910|NCT00291642|617461221|FG004|Overall Study|Intake of prohibited medication|0|||
170850911|NCT00735475|617461222|FG000|Overall Study|Adverse Event|0|||
170850912|NCT00735475|617461223|FG001|Overall Study|Adverse Event|1|||
170850913|NCT00735475|617461222|FG000|Overall Study|Death|1|||
170850914|NCT00735475|617461223|FG001|Overall Study|Death|1|||
170850915|NCT00735475|617461222|FG000|Overall Study|Lost to Follow-up|3|||
170850916|NCT00735475|617461223|FG001|Overall Study|Lost to Follow-up|3|||
170850917|NCT00735475|617461222|FG000|Overall Study|Physician Decision|0|||
170850918|NCT00735475|617461223|FG001|Overall Study|Physician Decision|1|||
170850919|NCT00735475|617461222|FG000|Overall Study|Withdrawal by Subject|4|||
170850920|NCT00735475|617461223|FG001|Overall Study|Withdrawal by Subject|5|||
170850921|NCT04602221|617461228|FG000|Overall Study|Discontinuation of trial treatment|0|||
170850922|NCT04602221|617461229|FG001|Overall Study|Discontinuation of trial treatment|0|||
170850923|NCT04602221|617461230|FG002|Overall Study|Discontinuation of trial treatment|1|||
170850924|NCT04602221|617461231|FG003|Overall Study|Discontinuation of trial treatment|0|||
170850925|NCT04602221|617461232|FG004|Overall Study|Discontinuation of trial treatment|0|||
170850926|NCT04602221|617461233|FG005|Overall Study|Discontinuation of trial treatment|0|||
170850927|NCT04602221|617461234|FG006|Overall Study|Discontinuation of trial treatment|0|||
170850928|NCT04602221|617461235|FG007|Overall Study|Discontinuation of trial treatment|0|||
170850929|NCT04602221|617461236|FG008|Overall Study|Discontinuation of trial treatment|0|||
170850930|NCT04602221|617461237|FG009|Overall Study|Discontinuation of trial treatment|0|||
170850931|NCT04602221|617461238|FG010|Overall Study|Discontinuation of trial treatment|0|||
170850932|NCT04602221|617461239|FG011|Overall Study|Discontinuation of trial treatment|0|||
170850933|NCT04602221|617461240|FG012|Overall Study|Discontinuation of trial treatment|0|||
170850934|NCT04602221|617461241|FG013|Overall Study|Discontinuation of trial treatment|0|||
170850935|NCT04602221|617461242|FG014|Overall Study|Discontinuation of trial treatment|0|||
170850936|NCT04602221|617461243|FG015|Overall Study|Discontinuation of trial treatment|0|||
170850937|NCT04602221|617461244|FG016|Overall Study|Discontinuation of trial treatment|0|||
170850938|NCT04602221|617461245|FG017|Overall Study|Discontinuation of trial treatment|0|||
170850939|NCT04602221|617461228|FG000|Overall Study|Other than listed|0|||
170850940|NCT04602221|617461229|FG001|Overall Study|Other than listed|0|||
170850941|NCT04602221|617461230|FG002|Overall Study|Other than listed|0|||
170850942|NCT04602221|617461231|FG003|Overall Study|Other than listed|0|||
170850943|NCT04602221|617461232|FG004|Overall Study|Other than listed|0|||
170850944|NCT04602221|617461233|FG005|Overall Study|Other than listed|0|||
170850945|NCT04602221|617461234|FG006|Overall Study|Other than listed|0|||
170850946|NCT04602221|617461235|FG007|Overall Study|Other than listed|0|||
170850947|NCT04602221|617461236|FG008|Overall Study|Other than listed|0|||
170850948|NCT04602221|617461237|FG009|Overall Study|Other than listed|0|||
170850949|NCT04602221|617461238|FG010|Overall Study|Other than listed|0|||
170850950|NCT04602221|617461239|FG011|Overall Study|Other than listed|0|||
170850951|NCT04602221|617461240|FG012|Overall Study|Other than listed|0|||
170850952|NCT04602221|617461241|FG013|Overall Study|Other than listed|0|||
170850953|NCT04602221|617461242|FG014|Overall Study|Other than listed|0|||
170850954|NCT04602221|617461243|FG015|Overall Study|Other than listed|1|||
170850955|NCT04602221|617461244|FG016|Overall Study|Other than listed|0|||
170850956|NCT04602221|617461245|FG017|Overall Study|Other than listed|1|||
170850957|NCT04602221|617461228|FG000|Overall Study|Withdrawal by Subject|0|||
170850958|NCT04602221|617461229|FG001|Overall Study|Withdrawal by Subject|0|||
170850959|NCT04602221|617461230|FG002|Overall Study|Withdrawal by Subject|0|||
170850960|NCT04602221|617461231|FG003|Overall Study|Withdrawal by Subject|0|||
170850961|NCT04602221|617461232|FG004|Overall Study|Withdrawal by Subject|0|||
170850962|NCT04602221|617461233|FG005|Overall Study|Withdrawal by Subject|0|||
170850963|NCT04602221|617461234|FG006|Overall Study|Withdrawal by Subject|0|||
170850964|NCT04602221|617461235|FG007|Overall Study|Withdrawal by Subject|0|||
170850965|NCT04602221|617461236|FG008|Overall Study|Withdrawal by Subject|0|||
170850966|NCT04602221|617461237|FG009|Overall Study|Withdrawal by Subject|0|||
170850967|NCT04602221|617461238|FG010|Overall Study|Withdrawal by Subject|0|||
170850968|NCT04602221|617461239|FG011|Overall Study|Withdrawal by Subject|0|||
170850969|NCT04602221|617461240|FG012|Overall Study|Withdrawal by Subject|1|||
170850970|NCT04602221|617461241|FG013|Overall Study|Withdrawal by Subject|0|||
170850971|NCT04602221|617461242|FG014|Overall Study|Withdrawal by Subject|0|||
170850972|NCT04602221|617461243|FG015|Overall Study|Withdrawal by Subject|0|||
170850973|NCT04602221|617461244|FG016|Overall Study|Withdrawal by Subject|0|||
170850974|NCT04602221|617461245|FG017|Overall Study|Withdrawal by Subject|0|||
170850975|NCT04602221|617461228|FG000|Overall Study|Lost to Follow-up|0|||
170850976|NCT04602221|617461229|FG001|Overall Study|Lost to Follow-up|0|||
170850977|NCT04602221|617461230|FG002|Overall Study|Lost to Follow-up|0|||
170850978|NCT04602221|617461231|FG003|Overall Study|Lost to Follow-up|0|||
170850979|NCT04602221|617461232|FG004|Overall Study|Lost to Follow-up|0|||
170850980|NCT04602221|617461233|FG005|Overall Study|Lost to Follow-up|1|||
170850981|NCT04602221|617461234|FG006|Overall Study|Lost to Follow-up|0|||
170850982|NCT04602221|617461235|FG007|Overall Study|Lost to Follow-up|0|||
170850983|NCT04602221|617461236|FG008|Overall Study|Lost to Follow-up|0|||
170850984|NCT04602221|617461237|FG009|Overall Study|Lost to Follow-up|0|||
170850985|NCT04602221|617461238|FG010|Overall Study|Lost to Follow-up|0|||
170850986|NCT04602221|617461239|FG011|Overall Study|Lost to Follow-up|0|||
170850987|NCT04602221|617461240|FG012|Overall Study|Lost to Follow-up|0|||
170850988|NCT04602221|617461241|FG013|Overall Study|Lost to Follow-up|0|||
170850989|NCT04602221|617461242|FG014|Overall Study|Lost to Follow-up|0|||
170850990|NCT04602221|617461243|FG015|Overall Study|Lost to Follow-up|0|||
170850991|NCT04602221|617461244|FG016|Overall Study|Lost to Follow-up|0|||
170850992|NCT04602221|617461245|FG017|Overall Study|Lost to Follow-up|0|||
170850993|NCT03001076|617461246|FG000|Overall Study|Withdrawal by patient|2|||
170850994|NCT03001076|617461247|FG001|Overall Study|Withdrawal by patient|0|||
170850995|NCT03001076|617461246|FG000|Overall Study|Other|1|||
170850996|NCT03001076|617461247|FG001|Overall Study|Other|0|||
170850997|NCT03001076|617461246|FG000|Overall Study|Adverse Event|3|||
170850998|NCT03001076|617461247|FG001|Overall Study|Adverse Event|3|||
170850999|NCT03001076|617461246|FG000|Overall Study|Sponsor decision|1|||
170851000|NCT03001076|617461247|FG001|Overall Study|Sponsor decision|0|||
170851001|NCT03001076|617461246|FG000|Overall Study|Lost to Follow-up|0|||
170851002|NCT03001076|617461247|FG001|Overall Study|Lost to Follow-up|2|||
170851003|NCT02576587|617461248|FG000|Baseline|Equipment failure|0|||
170851004|NCT02576587|617461249|FG001|Baseline|Equipment failure|1|||
170851005|NCT02576587|617461248|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
170851006|NCT02576587|617461249|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
170851007|NCT02576587|617461248|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
170851008|NCT02576587|617461249|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
170851009|NCT02576587|617461248|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
170851010|NCT02576587|617461249|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
170851011|NCT00844532|617461250|FG000|Overall Study|Death|16|||
170851012|NCT00844532|617461250|FG000|Overall Study|Withdrawal by Subject|16|||
170851013|NCT00844532|617461250|FG000|Overall Study|Lost to Follow-up|7|||
170851014|NCT01036438|617461251|FG000|Overall Study|Adverse Event|7|||
170851015|NCT01036438|617461252|FG001|Overall Study|Adverse Event|8|||
170851016|NCT01036438|617461251|FG000|Overall Study|Death|0|||
170851017|NCT01036438|617461252|FG001|Overall Study|Death|1|||
170851018|NCT01036438|617461251|FG000|Overall Study|No effect of study treatment|3|||
170851019|NCT01036438|617461252|FG001|Overall Study|No effect of study treatment|1|||
170851020|NCT01080716|617461253|FG000|Part 1|Physician Decision|1|||
170851021|NCT01080716|617461254|FG001|Part 1|Physician Decision|0|||
170851022|NCT01080716|617461255|FG002|Part 1|Physician Decision|0|||
170851023|NCT01080716|617461256|FG003|Part 1|Physician Decision|0|||
170851024|NCT01056718|617461257|FG000|Overall Study|Withdrawal by Subject|2|||
170851025|NCT01056718|617461257|FG000|Overall Study|Ischemia on baseline stress test|1|||
170851026|NCT00777088|617461258|FG000|Overall Study|PED Treatment not attempted|1|||
170851027|NCT03592745|617461259|FG000|Overall Study|Adverse Event|0|||
170851028|NCT03592745|617461260|FG001|Overall Study|Adverse Event|2|||
170851029|NCT03592745|617461259|FG000|Overall Study|Lost to Follow-up|2|||
170851030|NCT03592745|617461260|FG001|Overall Study|Lost to Follow-up|0|||
170851031|NCT03592745|617461259|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
170851032|NCT03592745|617461260|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
170851033|NCT03590366|617461261|FG000|Overall Study|Adverse Event|0|||
170851034|NCT03590366|617461262|FG001|Overall Study|Adverse Event|3|||
170851035|NCT03590366|617461261|FG000|Overall Study|Lost to Follow-up|3|||
170851036|NCT03590366|617461262|FG001|Overall Study|Lost to Follow-up|3|||
170851037|NCT03590366|617461261|FG000|Overall Study|Withdrawal by Subject|0|||
170851038|NCT03590366|617461262|FG001|Overall Study|Withdrawal by Subject|2|||
170851039|NCT05017103|617461263|FG000|Overall Study|Death|2|||
170851040|NCT02656329|617461264|FG000|Overall Study|Lost to Follow-up|2|||
170851041|NCT02656329|617461265|FG001|Overall Study|Lost to Follow-up|3|||
170851042|NCT02656329|617461264|FG000|Overall Study|Withdrawal by Subject|7|||
170851043|NCT02656329|617461265|FG001|Overall Study|Withdrawal by Subject|6|||
170851044|NCT02656329|617461264|FG000|Overall Study|Study termination by Sponsor|150|||
170851045|NCT02656329|617461265|FG001|Overall Study|Study termination by Sponsor|142|||
170851046|NCT02656329|617461264|FG000|Overall Study|Other than specified above|5|||
170851047|NCT02656329|617461265|FG001|Overall Study|Other than specified above|6|||
170851048|NCT03117998|617461270|FG000|Overall Study|Adverse Event|1|||
170851049|NCT03117998|617461271|FG001|Overall Study|Adverse Event|0|||
170851050|NCT03117998|617461272|FG002|Overall Study|Adverse Event|0|||
170851051|NCT03117998|617461273|FG003|Overall Study|Adverse Event|0|||
170851052|NCT03117998|617461274|FG004|Overall Study|Adverse Event|0|||
170851053|NCT03117998|617461275|FG005|Overall Study|Adverse Event|0|||
170851054|NCT03117998|617461270|FG000|Overall Study|Withdrawal by Subject|0|||
170851055|NCT03117998|617461271|FG001|Overall Study|Withdrawal by Subject|0|||
170851056|NCT03117998|617461272|FG002|Overall Study|Withdrawal by Subject|2|||
170851057|NCT03117998|617461273|FG003|Overall Study|Withdrawal by Subject|3|||
170851058|NCT03117998|617461274|FG004|Overall Study|Withdrawal by Subject|3|||
170851059|NCT03117998|617461275|FG005|Overall Study|Withdrawal by Subject|0|||
170851060|NCT03117998|617461270|FG000|Overall Study|Physician Decision|0|||
170851061|NCT03117998|617461271|FG001|Overall Study|Physician Decision|1|||
170851062|NCT03117998|617461272|FG002|Overall Study|Physician Decision|1|||
170851063|NCT03117998|617461273|FG003|Overall Study|Physician Decision|0|||
170851064|NCT03117998|617461274|FG004|Overall Study|Physician Decision|0|||
170851065|NCT03117998|617461275|FG005|Overall Study|Physician Decision|0|||
170851066|NCT03117998|617461270|FG000|Overall Study|Lost to Follow-up|0|||
170851067|NCT03117998|617461271|FG001|Overall Study|Lost to Follow-up|0|||
170851068|NCT03117998|617461272|FG002|Overall Study|Lost to Follow-up|0|||
170851069|NCT03117998|617461273|FG003|Overall Study|Lost to Follow-up|1|||
170851070|NCT03117998|617461274|FG004|Overall Study|Lost to Follow-up|4|||
170851071|NCT03117998|617461275|FG005|Overall Study|Lost to Follow-up|0|||
170851072|NCT03117998|617461270|FG000|Overall Study|Subject noncompliance|0|||
170851073|NCT03117998|617461271|FG001|Overall Study|Subject noncompliance|0|||
170851074|NCT03117998|617461272|FG002|Overall Study|Subject noncompliance|1|||
170851075|NCT03117998|617461273|FG003|Overall Study|Subject noncompliance|0|||
170851076|NCT03117998|617461274|FG004|Overall Study|Subject noncompliance|0|||
170851077|NCT03117998|617461275|FG005|Overall Study|Subject noncompliance|2|||
170851078|NCT03117998|617461270|FG000|Overall Study|Protocol Violation|0|||
170851079|NCT03117998|617461271|FG001|Overall Study|Protocol Violation|0|||
170851080|NCT03117998|617461272|FG002|Overall Study|Protocol Violation|0|||
170851081|NCT03117998|617461273|FG003|Overall Study|Protocol Violation|0|||
170851082|NCT03117998|617461274|FG004|Overall Study|Protocol Violation|0|||
170851083|NCT03117998|617461275|FG005|Overall Study|Protocol Violation|1|||
170851084|NCT04927247|617461276|FG000|Overall Study|Other|2|||
170851085|NCT04927247|617461277|FG001|Overall Study|Other|1|||
170851086|NCT04927247|617461276|FG000|Overall Study|Physician Decision|0|||
170851087|NCT04927247|617461277|FG001|Overall Study|Physician Decision|1|||
170851088|NCT04927247|617461276|FG000|Overall Study|Adverse Event|1|||
170851089|NCT04927247|617461277|FG001|Overall Study|Adverse Event|0|||
170851090|NCT00293059|617461278|FG000|Overall Study|Adverse Event|12|||
170851091|NCT00293059|617461279|FG001|Overall Study|Adverse Event|4|||
170851092|NCT00293059|617461278|FG000|Overall Study|Lack of Efficacy|2|||
170851093|NCT00293059|617461279|FG001|Overall Study|Lack of Efficacy|0|||
170851094|NCT00293059|617461278|FG000|Overall Study|Lost to Follow-up|2|||
170851095|NCT00293059|617461279|FG001|Overall Study|Lost to Follow-up|3|||
170851096|NCT00293059|617461278|FG000|Overall Study|Pregnancy|1|||
170851097|NCT00293059|617461279|FG001|Overall Study|Pregnancy|1|||
170851098|NCT00293059|617461278|FG000|Overall Study|Protocol Violation|2|||
170851099|NCT00293059|617461279|FG001|Overall Study|Protocol Violation|0|||
170851100|NCT00293059|617461278|FG000|Overall Study|Withdrawal by Subject|11|||
170851101|NCT00293059|617461279|FG001|Overall Study|Withdrawal by Subject|5|||
170851102|NCT00293059|617461278|FG000|Overall Study|Participant moved out of state|1|||
170851103|NCT00293059|617461279|FG001|Overall Study|Participant moved out of state|0|||
170851104|NCT00293059|617461278|FG000|Overall Study|Participant stopped study drug|1|||
170851105|NCT00293059|617461279|FG001|Overall Study|Participant stopped study drug|0|||
170851106|NCT00293059|617461278|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
170851107|NCT00293059|617461279|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
170851108|NCT00293059|617461278|FG000|Overall Study|missing|3|||
170851109|NCT00293059|617461279|FG001|Overall Study|missing|5|||
170851110|NCT02001064|617461281|FG000|Overall Study|Withdrawal by Subject|2|||
170851111|NCT02001064|617461282|FG001|Overall Study|Withdrawal by Subject|1|||
170851112|NCT01468181|617461287|FG000|Overall Study|Adverse Event|8|||
170851113|NCT01468181|617461288|FG001|Overall Study|Adverse Event|1|||
170851114|NCT01468181|617461289|FG002|Overall Study|Adverse Event|6|||
170851115|NCT01468181|617461290|FG003|Overall Study|Adverse Event|2|||
170851116|NCT01468181|617461291|FG004|Overall Study|Adverse Event|2|||
170851117|NCT01468181|617461287|FG000|Overall Study|Protocol Violation|2|||
170851118|NCT01468181|617461288|FG001|Overall Study|Protocol Violation|0|||
170851119|NCT01468181|617461289|FG002|Overall Study|Protocol Violation|1|||
170851120|NCT01468181|617461290|FG003|Overall Study|Protocol Violation|0|||
170851121|NCT01468181|617461291|FG004|Overall Study|Protocol Violation|1|||
170851122|NCT01468181|617461287|FG000|Overall Study|Physician Decision|0|||
170851123|NCT01468181|617461288|FG001|Overall Study|Physician Decision|0|||
170851124|NCT01468181|617461289|FG002|Overall Study|Physician Decision|0|||
170851125|NCT01468181|617461290|FG003|Overall Study|Physician Decision|1|||
170851126|NCT01468181|617461291|FG004|Overall Study|Physician Decision|1|||
170851127|NCT01468181|617461287|FG000|Overall Study|Lost to Follow-up|0|||
170851128|NCT01468181|617461288|FG001|Overall Study|Lost to Follow-up|0|||
170851129|NCT01468181|617461289|FG002|Overall Study|Lost to Follow-up|1|||
170851130|NCT01468181|617461290|FG003|Overall Study|Lost to Follow-up|0|||
170851131|NCT01468181|617461291|FG004|Overall Study|Lost to Follow-up|1|||
170851132|NCT01468181|617461287|FG000|Overall Study|Withdrawal by Subject|0|||
170851133|NCT01468181|617461288|FG001|Overall Study|Withdrawal by Subject|1|||
170851134|NCT01468181|617461289|FG002|Overall Study|Withdrawal by Subject|0|||
170851135|NCT01468181|617461290|FG003|Overall Study|Withdrawal by Subject|0|||
170851136|NCT01468181|617461291|FG004|Overall Study|Withdrawal by Subject|0|||
170851137|NCT00513305|617461297|FG000|Overall Study|Adverse Event|6|||
170851138|NCT00513305|617461298|FG001|Overall Study|Adverse Event|2|||
170851139|NCT00513305|617461297|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
170851140|NCT00513305|617461298|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
170851141|NCT00513305|617461297|FG000|Overall Study|Lack of Efficacy|8|||
170851142|NCT00513305|617461298|FG001|Overall Study|Lack of Efficacy|13|||
170851143|NCT00513305|617461297|FG000|Overall Study|Withdrawal by Subject|1|||
170851144|NCT00513305|617461298|FG001|Overall Study|Withdrawal by Subject|2|||
170851145|NCT00513305|617461297|FG000|Overall Study|Disease progression|8|||
170851146|NCT00513305|617461298|FG001|Overall Study|Disease progression|5|||
170851147|NCT00513305|617461297|FG000|Overall Study|Eligible for stem cell transplant|1|||
170851148|NCT00513305|617461298|FG001|Overall Study|Eligible for stem cell transplant|0|||
170851149|NCT00513305|617461297|FG000|Overall Study|Hematologic counts did not recover|1|||
170851150|NCT00513305|617461298|FG001|Overall Study|Hematologic counts did not recover|0|||
170851151|NCT00513305|617461297|FG000|Overall Study|Physician Decision|1|||
170851152|NCT00513305|617461298|FG001|Overall Study|Physician Decision|0|||
170851153|NCT00513305|617461297|FG000|Overall Study|Persistent hypocellularity|0|||
170851154|NCT00513305|617461298|FG001|Overall Study|Persistent hypocellularity|1|||
170851155|NCT00513305|617461297|FG000|Overall Study|Sponsor Decision|0|||
170851156|NCT00513305|617461298|FG001|Overall Study|Sponsor Decision|2|||
170851157|NCT01081132|617461303|FG000|Overall Study|Lack of Efficacy|25|||
170851158|NCT01081132|617461304|FG001|Overall Study|Lack of Efficacy|9|||
170851159|NCT01081132|617461303|FG000|Overall Study|Withdrawal by Subject|13|||
170851160|NCT01081132|617461304|FG001|Overall Study|Withdrawal by Subject|16|||
170851161|NCT01081132|617461303|FG000|Overall Study|Lost to Follow-up|4|||
170851162|NCT01081132|617461304|FG001|Overall Study|Lost to Follow-up|11|||
170851163|NCT01081132|617461303|FG000|Overall Study|Adverse Event|3|||
170851164|NCT01081132|617461304|FG001|Overall Study|Adverse Event|9|||
170851165|NCT01081132|617461303|FG000|Overall Study|Non Compliance|4|||
170851166|NCT01081132|617461304|FG001|Overall Study|Non Compliance|2|||
170851167|NCT01081132|617461303|FG000|Overall Study|Lack Of Compliance|0|||
170851168|NCT01081132|617461304|FG001|Overall Study|Lack Of Compliance|1|||
170851169|NCT01081132|617461303|FG000|Overall Study|Missed Visits|1|||
170851170|NCT01081132|617461304|FG001|Overall Study|Missed Visits|1|||
170851171|NCT01081132|617461303|FG000|Overall Study|Stopped Taking Meds|2|||
170851172|NCT01081132|617461304|FG001|Overall Study|Stopped Taking Meds|0|||
170851173|NCT01081132|617461303|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
170851174|NCT01081132|617461304|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
170851175|NCT01081132|617461303|FG000|Overall Study|Declined Taper Phase|0|||
170851176|NCT01081132|617461304|FG001|Overall Study|Declined Taper Phase|1|||
170851177|NCT01081132|617461303|FG000|Overall Study|Protocol Violation|3|||
170851178|NCT01081132|617461304|FG001|Overall Study|Protocol Violation|1|||
170851179|NCT01147536|617461305|FG000|Overall Study|Administrative study close|2|||
170851180|NCT01147536|617461305|FG000|Overall Study|Death|1|||
170851181|NCT02489968|617461306|FG000|Open-label Treatment Period|Adverse Event|14|||
170851182|NCT02489968|617461307|FG001|Open-label Treatment Period|Adverse Event|7|||
170851183|NCT02489968|617461308|FG002|Open-label Treatment Period|Adverse Event|0|||
170851184|NCT02489968|617461309|FG003|Open-label Treatment Period|Adverse Event|0|||
170851185|NCT02489968|617461310|FG004|Open-label Treatment Period|Adverse Event|0|||
170851186|NCT02489968|617461311|FG005|Open-label Treatment Period|Adverse Event|0|||
170851187|NCT02489968|617461306|FG000|Open-label Treatment Period|Protocol Violation|2|||
170851188|NCT02489968|617461307|FG001|Open-label Treatment Period|Protocol Violation|2|||
170851189|NCT02489968|617461308|FG002|Open-label Treatment Period|Protocol Violation|0|||
170851190|NCT02489968|617461309|FG003|Open-label Treatment Period|Protocol Violation|0|||
170851191|NCT02489968|617461310|FG004|Open-label Treatment Period|Protocol Violation|0|||
170851192|NCT02489968|617461311|FG005|Open-label Treatment Period|Protocol Violation|0|||
170851193|NCT02489968|617461306|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
170851194|NCT02489968|617461307|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
170851195|NCT02489968|617461308|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
170851196|NCT02489968|617461309|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
170851197|NCT02489968|617461310|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
170851198|NCT02489968|617461311|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
170851199|NCT02489968|617461306|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
170851200|NCT02489968|617461307|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
170851201|NCT02489968|617461308|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
170851202|NCT02489968|617461309|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
170851203|NCT02489968|617461310|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
170851204|NCT02489968|617461311|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
170851205|NCT02489968|617461306|FG000|Open-label Treatment Period|Other than specified above|204|||
170851206|NCT02489968|617461307|FG001|Open-label Treatment Period|Other than specified above|189|||
170851207|NCT02489968|617461308|FG002|Open-label Treatment Period|Other than specified above|0|||
170851208|NCT02489968|617461309|FG003|Open-label Treatment Period|Other than specified above|0|||
170851209|NCT02489968|617461310|FG004|Open-label Treatment Period|Other than specified above|0|||
170851210|NCT02489968|617461311|FG005|Open-label Treatment Period|Other than specified above|0|||
170851211|NCT02489968|617461306|FG000|Double-blind Treatment Period|Adverse Event|0|||
170851212|NCT02489968|617461307|FG001|Double-blind Treatment Period|Adverse Event|0|||
170851213|NCT02489968|617461308|FG002|Double-blind Treatment Period|Adverse Event|2|||
170851214|NCT02489968|617461309|FG003|Double-blind Treatment Period|Adverse Event|6|||
170851215|NCT02489968|617461310|FG004|Double-blind Treatment Period|Adverse Event|4|||
170851216|NCT02489968|617461311|FG005|Double-blind Treatment Period|Adverse Event|5|||
170851217|NCT02489968|617461306|FG000|Double-blind Treatment Period|Protocol Violation|0|||
170851218|NCT02489968|617461307|FG001|Double-blind Treatment Period|Protocol Violation|0|||
170851219|NCT02489968|617461308|FG002|Double-blind Treatment Period|Protocol Violation|0|||
170851220|NCT02489968|617461309|FG003|Double-blind Treatment Period|Protocol Violation|0|||
170851221|NCT02489968|617461310|FG004|Double-blind Treatment Period|Protocol Violation|1|||
170851222|NCT02489968|617461311|FG005|Double-blind Treatment Period|Protocol Violation|1|||
170851223|NCT02489968|617461306|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
170851224|NCT02489968|617461307|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
170851225|NCT02489968|617461308|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170851226|NCT02489968|617461309|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
170851227|NCT02489968|617461310|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
170851228|NCT02489968|617461311|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
170851229|NCT02489968|617461306|FG000|Double-blind Treatment Period|Other than specified above|0|||
170851230|NCT02489968|617461307|FG001|Double-blind Treatment Period|Other than specified above|0|||
170851231|NCT02489968|617461308|FG002|Double-blind Treatment Period|Other than specified above|0|||
170851232|NCT02489968|617461309|FG003|Double-blind Treatment Period|Other than specified above|0|||
170851233|NCT02489968|617461310|FG004|Double-blind Treatment Period|Other than specified above|1|||
170851234|NCT02489968|617461311|FG005|Double-blind Treatment Period|Other than specified above|0|||
170851235|NCT01982448|617461312|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
170851236|NCT01982448|617461313|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
170851237|NCT01982448|617461312|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
170851238|NCT01982448|617461313|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
170851239|NCT01982448|617461312|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
170851240|NCT01982448|617461313|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
170851241|NCT01982448|617461312|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
170851242|NCT01982448|617461313|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
170851243|NCT00605215|617463270|FG000|Overall Study|Death|0|||
170851244|NCT00605215|617463271|FG001|Overall Study|Death|0|||
170851245|NCT00605215|617463272|FG002|Overall Study|Death|1|||
170851246|NCT00605215|617463270|FG000|Overall Study|Adverse Event|19|||
170851247|NCT00605215|617463271|FG001|Overall Study|Adverse Event|21|||
170851248|NCT00605215|617463272|FG002|Overall Study|Adverse Event|26|||
170851249|NCT00605215|617463270|FG000|Overall Study|Refusal to sign the re-consent form|8|||
170851250|NCT00605215|617463271|FG001|Overall Study|Refusal to sign the re-consent form|3|||
170851251|NCT00605215|617463272|FG002|Overall Study|Refusal to sign the re-consent form|3|||
170851252|NCT00605215|617463270|FG000|Overall Study|Withdrawal by Subject|39|||
170851253|NCT00605215|617463271|FG001|Overall Study|Withdrawal by Subject|37|||
170851254|NCT00605215|617463272|FG002|Overall Study|Withdrawal by Subject|27|||
170851255|NCT00605215|617463270|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
170851256|NCT00605215|617463271|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
170851257|NCT00605215|617463272|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
170851258|NCT00605215|617463270|FG000|Overall Study|Protocol Violation|3|||
170851259|NCT00605215|617463271|FG001|Overall Study|Protocol Violation|4|||
170851260|NCT00605215|617463272|FG002|Overall Study|Protocol Violation|1|||
170851261|NCT00605215|617463270|FG000|Overall Study|Pregnancy|8|||
170851262|NCT00605215|617463271|FG001|Overall Study|Pregnancy|5|||
170851263|NCT00605215|617463272|FG002|Overall Study|Pregnancy|4|||
170851264|NCT00605215|617463270|FG000|Overall Study|Lost to Follow-up|8|||
170851265|NCT00605215|617463271|FG001|Overall Study|Lost to Follow-up|5|||
170851266|NCT00605215|617463272|FG002|Overall Study|Lost to Follow-up|2|||
170851267|NCT00605215|617463270|FG000|Overall Study|Other than specified|0|||
170851268|NCT00605215|617463271|FG001|Overall Study|Other than specified|2|||
170851269|NCT00605215|617463272|FG002|Overall Study|Other than specified|1|||
170851270|NCT01022268|617463273|FG000|Overall Study|Withdrawal by Subject|1|||
170851271|NCT01022268|617463274|FG001|Overall Study|Withdrawal by Subject|0|||
170851272|NCT01022268|617463273|FG000|Overall Study|Withdrawal by Subject|1|||
170851273|NCT01022268|617463274|FG001|Overall Study|Withdrawal by Subject|0|||
170851274|NCT00734097|617463275|FG000|Screening|Protocol Violation|12|||
170851275|NCT00734097|617463275|FG000|Screening|Withdrawal by Subject|5|||
170851276|NCT00734097|617463275|FG000|Screening|Lost to Follow-up|2|||
170851277|NCT00734097|617463275|FG000|Screening|Unconfirmed pregnancy|1|||
170851278|NCT00734097|617463275|FG000|Open Label|Lost to Follow-up|7|||
170851279|NCT00734097|617463275|FG000|Open Label|Withdrawal by Subject|5|||
170851280|NCT00734097|617463275|FG000|Open Label|Protocol Violation|4|||
170851281|NCT01290029|617463276|FG000|Overall Study|Other|2|||
170851282|NCT01302067|617463279|FG000|Overall Study|Death|0|||
170851283|NCT01302067|617463280|FG001|Overall Study|Death|0|||
170851284|NCT01302067|617463281|FG002|Overall Study|Death|1|||
170851285|NCT01302067|617463279|FG000|Overall Study|Physician Decision|9|||
170851286|NCT01302067|617463280|FG001|Overall Study|Physician Decision|5|||
170851287|NCT01302067|617463281|FG002|Overall Study|Physician Decision|14|||
170851288|NCT01302067|617463279|FG000|Overall Study|Lack of Efficacy|8|||
170851289|NCT01302067|617463280|FG001|Overall Study|Lack of Efficacy|4|||
170851290|NCT01302067|617463281|FG002|Overall Study|Lack of Efficacy|2|||
170851291|NCT01302067|617463279|FG000|Overall Study|Lost to Follow-up|9|||
170851292|NCT01302067|617463280|FG001|Overall Study|Lost to Follow-up|4|||
170851293|NCT01302067|617463281|FG002|Overall Study|Lost to Follow-up|15|||
170851294|NCT01302067|617463279|FG000|Overall Study|Withdrawal by Subject|13|||
170851295|NCT01302067|617463280|FG001|Overall Study|Withdrawal by Subject|6|||
170851296|NCT01302067|617463281|FG002|Overall Study|Withdrawal by Subject|10|||
170851297|NCT01302067|617463279|FG000|Overall Study|Other|1|||
170851298|NCT01302067|617463280|FG001|Overall Study|Other|1|||
170851299|NCT01302067|617463281|FG002|Overall Study|Other|3|||
170851300|NCT01302067|617463279|FG000|Overall Study|Protocol Violation|11|||
170851301|NCT01302067|617463280|FG001|Overall Study|Protocol Violation|0|||
170851302|NCT01302067|617463281|FG002|Overall Study|Protocol Violation|8|||
170851303|NCT01302067|617463279|FG000|Overall Study|Adverse Event|27|||
170851304|NCT01302067|617463280|FG001|Overall Study|Adverse Event|14|||
170851305|NCT01302067|617463281|FG002|Overall Study|Adverse Event|45|||
170851306|NCT04875676|617463284|FG000|Overall Study|Lost to Follow-up|1|||
170851307|NCT04875676|617463285|FG001|Overall Study|Lost to Follow-up|0|||
170851308|NCT04875676|617463286|FG002|Overall Study|Lost to Follow-up|0|||
170851309|NCT03602066|617463287|FG000|Overall Study|Withdrawal by Subject|2|||
170851310|NCT03602066|617463288|FG001|Overall Study|Withdrawal by Subject|0|||
170851311|NCT03602066|617463287|FG000|Overall Study|Physician Decision|1|||
170851312|NCT03602066|617463288|FG001|Overall Study|Physician Decision|0|||
170851313|NCT00092495|617463289|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
170851314|NCT00092495|617463290|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
170851315|NCT00092495|617463291|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
170851316|NCT00092495|617463292|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
170851317|NCT00092495|617463293|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
170851318|NCT00092495|617463289|FG000|Base Study Vaccination Period|Extended|0|||
170851319|NCT00092495|617463290|FG001|Base Study Vaccination Period|Extended|0|||
170851320|NCT00092495|617463291|FG002|Base Study Vaccination Period|Extended|0|||
170851321|NCT00092495|617463292|FG003|Base Study Vaccination Period|Extended|1|||
170851322|NCT00092495|617463293|FG004|Base Study Vaccination Period|Extended|0|||
170851323|NCT00092495|617463289|FG000|Base Study Vaccination Period|*Clinical AE|1|||
170851324|NCT00092495|617463290|FG001|Base Study Vaccination Period|*Clinical AE|0|||
170851325|NCT00092495|617463291|FG002|Base Study Vaccination Period|*Clinical AE|1|||
170851326|NCT00092495|617463292|FG003|Base Study Vaccination Period|*Clinical AE|2|||
170851327|NCT00092495|617463293|FG004|Base Study Vaccination Period|*Clinical AE|0|||
170851328|NCT00092495|617463289|FG000|Base Study Vaccination Period|*Other reasons|1|||
170851329|NCT00092495|617463290|FG001|Base Study Vaccination Period|*Other reasons|0|||
170851330|NCT00092495|617463291|FG002|Base Study Vaccination Period|*Other reasons|0|||
170851331|NCT00092495|617463292|FG003|Base Study Vaccination Period|*Other reasons|1|||
170851332|NCT00092495|617463293|FG004|Base Study Vaccination Period|*Other reasons|0|||
170851333|NCT00092495|617463289|FG000|Base Study Vaccination Period|*Pregnancy|0|||
170851334|NCT00092495|617463290|FG001|Base Study Vaccination Period|*Pregnancy|2|||
170851335|NCT00092495|617463291|FG002|Base Study Vaccination Period|*Pregnancy|5|||
170851336|NCT00092495|617463292|FG003|Base Study Vaccination Period|*Pregnancy|7|||
170851337|NCT00092495|617463293|FG004|Base Study Vaccination Period|*Pregnancy|0|||
170851338|NCT00092495|617463289|FG000|Base Study Vaccination Period|Adverse Event|1|||
170851339|NCT00092495|617463290|FG001|Base Study Vaccination Period|Adverse Event|0|||
170851340|NCT00092495|617463291|FG002|Base Study Vaccination Period|Adverse Event|0|||
170851341|NCT00092495|617463292|FG003|Base Study Vaccination Period|Adverse Event|3|||
170851342|NCT00092495|617463293|FG004|Base Study Vaccination Period|Adverse Event|0|||
170851343|NCT00092495|617463289|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
170851344|NCT00092495|617463290|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
170851345|NCT00092495|617463291|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
170851346|NCT00092495|617463292|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
170851347|NCT00092495|617463293|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
170851348|NCT00092495|617463289|FG000|Base Study Vaccination Period|Moved|3|||
170851349|NCT00092495|617463290|FG001|Base Study Vaccination Period|Moved|1|||
170851350|NCT00092495|617463291|FG002|Base Study Vaccination Period|Moved|2|||
170851351|NCT00092495|617463292|FG003|Base Study Vaccination Period|Moved|2|||
170851352|NCT00092495|617463293|FG004|Base Study Vaccination Period|Moved|0|||
170851353|NCT00092495|617463289|FG000|Base Study Vaccination Period|Other|1|||
170851354|NCT00092495|617463290|FG001|Base Study Vaccination Period|Other|1|||
170851355|NCT00092495|617463291|FG002|Base Study Vaccination Period|Other|0|||
170851356|NCT00092495|617463292|FG003|Base Study Vaccination Period|Other|2|||
170851357|NCT00092495|617463293|FG004|Base Study Vaccination Period|Other|0|||
170851358|NCT00092495|617463289|FG000|Base Study Vaccination Period|Pregnancy|2|||
170851359|NCT00092495|617463290|FG001|Base Study Vaccination Period|Pregnancy|0|||
170851360|NCT00092495|617463291|FG002|Base Study Vaccination Period|Pregnancy|0|||
170851361|NCT00092495|617463292|FG003|Base Study Vaccination Period|Pregnancy|0|||
170851362|NCT00092495|617463293|FG004|Base Study Vaccination Period|Pregnancy|0|||
170851363|NCT00092495|617463289|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
170851364|NCT00092495|617463290|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
170851365|NCT00092495|617463291|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
170851366|NCT00092495|617463292|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
170851367|NCT00092495|617463293|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
170851368|NCT00092495|617463289|FG000|Base Study Vaccination Period|Protocol Violation|1|||
170851369|NCT00092495|617463290|FG001|Base Study Vaccination Period|Protocol Violation|0|||
170851370|NCT00092495|617463291|FG002|Base Study Vaccination Period|Protocol Violation|0|||
170851371|NCT00092495|617463292|FG003|Base Study Vaccination Period|Protocol Violation|0|||
170851372|NCT00092495|617463293|FG004|Base Study Vaccination Period|Protocol Violation|0|||
170851373|NCT00092495|617463289|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
170851374|NCT00092495|617463290|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
170851375|NCT00092495|617463291|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
170851376|NCT00092495|617463292|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
170851377|NCT00092495|617463293|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
170851378|NCT00092495|617463289|FG000|Base Study Follow-up Period|Extended|0|||
170851379|NCT00092495|617463290|FG001|Base Study Follow-up Period|Extended|0|||
170851380|NCT00092495|617463291|FG002|Base Study Follow-up Period|Extended|1|||
170851381|NCT00092495|617463292|FG003|Base Study Follow-up Period|Extended|2|||
170851382|NCT00092495|617463293|FG004|Base Study Follow-up Period|Extended|0|||
170851383|NCT00092495|617463289|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
170851384|NCT00092495|617463290|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
170851385|NCT00092495|617463291|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
170851386|NCT00092495|617463292|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
170851387|NCT00092495|617463293|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
170851388|NCT00092495|617463289|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
170851389|NCT00092495|617463290|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
170851390|NCT00092495|617463291|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
170851391|NCT00092495|617463292|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
170851392|NCT00092495|617463293|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
170851393|NCT03103763|617463298|FG000|Overall Study|Death|15|||
170851394|NCT03103763|617463299|FG001|Overall Study|Death|5|||
170851395|NCT03103763|617463300|FG002|Overall Study|Death|5|||
170851396|NCT03103763|617463298|FG000|Overall Study|Withdrawal by Subject|0|||
170851397|NCT03103763|617463299|FG001|Overall Study|Withdrawal by Subject|3|||
170851398|NCT03103763|617463300|FG002|Overall Study|Withdrawal by Subject|2|||
170851399|NCT03245151|617463301|FG000|Overall Study|Withdrawal by Subject|2|||
170851400|NCT03245151|617463302|FG001|Overall Study|Withdrawal by Subject|0|||
170851401|NCT03245151|617463303|FG002|Overall Study|Withdrawal by Subject|0|||
170851402|NCT03245151|617463304|FG003|Overall Study|Withdrawal by Subject|2|||
170851403|NCT03245151|617463305|FG004|Overall Study|Withdrawal by Subject|1|||
170851404|NCT03245151|617463301|FG000|Overall Study|Death|3|||
170851405|NCT03245151|617463302|FG001|Overall Study|Death|14|||
170851406|NCT03245151|617463303|FG002|Overall Study|Death|9|||
170851407|NCT03245151|617463304|FG003|Overall Study|Death|16|||
170851408|NCT03245151|617463305|FG004|Overall Study|Death|7|||
170851409|NCT03245151|617463301|FG000|Overall Study|Sponsor's decision|0|||
170851410|NCT03245151|617463302|FG001|Overall Study|Sponsor's decision|1|||
170851411|NCT03245151|617463303|FG002|Overall Study|Sponsor's decision|0|||
170851412|NCT03245151|617463304|FG003|Overall Study|Sponsor's decision|0|||
170851413|NCT03245151|617463305|FG004|Overall Study|Sponsor's decision|0|||
170851414|NCT01970345|617463306|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
170851415|NCT01970345|617463307|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
170851416|NCT01970345|617463306|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
170851417|NCT01970345|617463307|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
170851418|NCT02663518|617463314|FG000|Part 1: Phase 1a Escalation|Death|0|||
170851419|NCT02663518|617463315|FG001|Part 1: Phase 1a Escalation|Death|0|||
170851420|NCT02663518|617463316|FG002|Part 1: Phase 1a Escalation|Death|1|||
170851421|NCT02663518|617463317|FG003|Part 1: Phase 1a Escalation|Death|0|||
170851422|NCT02663518|617463318|FG004|Part 1: Phase 1a Escalation|Death|0|||
170851423|NCT02663518|617463319|FG005|Part 1: Phase 1a Escalation|Death|0|||
170851424|NCT02663518|617463320|FG006|Part 1: Phase 1a Escalation|Death|0|||
170851425|NCT02663518|617463321|FG007|Part 1: Phase 1a Escalation|Death|0|||
170851426|NCT02663518|617463322|FG008|Part 1: Phase 1a Escalation|Death|0|||
170851427|NCT02663518|617463323|FG009|Part 1: Phase 1a Escalation|Death|0|||
170851428|NCT02663518|617463324|FG010|Part 1: Phase 1a Escalation|Death|0|||
170851429|NCT02663518|617463325|FG011|Part 1: Phase 1a Escalation|Death|0|||
170851430|NCT02663518|617463326|FG012|Part 1: Phase 1a Escalation|Death|0|||
170851431|NCT02663518|617463327|FG013|Part 1: Phase 1a Escalation|Death|0|||
170851432|NCT02663518|617463314|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851433|NCT02663518|617463315|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851434|NCT02663518|617463316|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
170851435|NCT02663518|617463317|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851436|NCT02663518|617463318|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851437|NCT02663518|617463319|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851438|NCT02663518|617463320|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851439|NCT02663518|617463321|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851440|NCT02663518|617463322|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851441|NCT02663518|617463323|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851442|NCT02663518|617463324|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851443|NCT02663518|617463325|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851444|NCT02663518|617463326|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170740248|NCT02091739|617056327|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
170740249|NCT02091739|617056323|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
170740250|NCT02091739|617056324|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
170740251|NCT02091739|617056325|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
170740252|NCT02091739|617056326|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
170740253|NCT02091739|617056327|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
170740254|NCT02091739|617056323|FG000|EP: 48 Weeks|Other|0|||
170740255|NCT02091739|617056324|FG001|EP: 48 Weeks|Other|0|||
170740256|NCT02091739|617056325|FG002|EP: 48 Weeks|Other|0|||
170740257|NCT02091739|617056326|FG003|EP: 48 Weeks|Other|1|||
170740258|NCT02091739|617056327|FG004|EP: 48 Weeks|Other|0|||
170740259|NCT02091739|617056323|FG000|EP: 48 Weeks|Death|0|||
170740260|NCT02091739|617056324|FG001|EP: 48 Weeks|Death|0|||
170740261|NCT02091739|617056325|FG002|EP: 48 Weeks|Death|0|||
170740262|NCT02091739|617056326|FG003|EP: 48 Weeks|Death|3|||
170740263|NCT02091739|617056327|FG004|EP: 48 Weeks|Death|2|||
170740264|NCT02091739|617056323|FG000|EP: 48 Weeks|Adverse Event|0|||
170740265|NCT02091739|617056324|FG001|EP: 48 Weeks|Adverse Event|0|||
170740266|NCT02091739|617056325|FG002|EP: 48 Weeks|Adverse Event|0|||
170740267|NCT02091739|617056326|FG003|EP: 48 Weeks|Adverse Event|2|||
170740268|NCT02091739|617056327|FG004|EP: 48 Weeks|Adverse Event|6|||
170740269|NCT02091739|617056323|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
170740270|NCT02091739|617056324|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
170740271|NCT02091739|617056325|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
170740272|NCT02091739|617056326|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
170740273|NCT02091739|617056327|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
170740274|NCT02247804|617056329|FG000|Treatment Period 1|Adverse Event|9|||
170740275|NCT02247804|617056330|FG001|Treatment Period 1|Adverse Event|2|||
170740276|NCT02247804|617056331|FG002|Treatment Period 1|Adverse Event|0|||
170740277|NCT02247804|617056329|FG000|Treatment Period 1|Lack of Efficacy|0|||
170740278|NCT02247804|617056330|FG001|Treatment Period 1|Lack of Efficacy|0|||
170740279|NCT02247804|617056331|FG002|Treatment Period 1|Lack of Efficacy|2|||
170740280|NCT02247804|617056329|FG000|Treatment Period 1|Lost to Follow-up|1|||
170740281|NCT02247804|617056330|FG001|Treatment Period 1|Lost to Follow-up|0|||
170740282|NCT02247804|617056331|FG002|Treatment Period 1|Lost to Follow-up|2|||
170740283|NCT02247804|617056329|FG000|Treatment Period 1|Personal Reasons|7|||
170740284|NCT02247804|617056330|FG001|Treatment Period 1|Personal Reasons|1|||
170740285|NCT02247804|617056331|FG002|Treatment Period 1|Personal Reasons|2|||
170740286|NCT02247804|617056329|FG000|Treatment Period 1|Protocol Deviation|0|||
170740287|NCT02247804|617056330|FG001|Treatment Period 1|Protocol Deviation|0|||
170740288|NCT02247804|617056331|FG002|Treatment Period 1|Protocol Deviation|1|||
170740289|NCT02247804|617056329|FG000|Treatment Period 1|Randomized but not Treated|5|||
170740290|NCT02247804|617056330|FG001|Treatment Period 1|Randomized but not Treated|1|||
170740291|NCT02247804|617056331|FG002|Treatment Period 1|Randomized but not Treated|1|||
170740292|NCT02247804|617056329|FG000|Treatment Period 2|Adverse Event|6|||
170740293|NCT02247804|617056330|FG001|Treatment Period 2|Adverse Event|3|||
170740294|NCT02247804|617056331|FG002|Treatment Period 2|Adverse Event|3|||
170740295|NCT02247804|617056329|FG000|Treatment Period 2|Lack of Efficacy|0|||
170740296|NCT02247804|617056330|FG001|Treatment Period 2|Lack of Efficacy|0|||
170740297|NCT02247804|617056331|FG002|Treatment Period 2|Lack of Efficacy|1|||
170740298|NCT02247804|617056329|FG000|Treatment Period 2|Lost to Follow-up|0|||
170740299|NCT02247804|617056330|FG001|Treatment Period 2|Lost to Follow-up|1|||
170740300|NCT02247804|617056331|FG002|Treatment Period 2|Lost to Follow-up|1|||
170740301|NCT02247804|617056329|FG000|Treatment Period 2|Personal Reasons|2|||
170740302|NCT02247804|617056330|FG001|Treatment Period 2|Personal Reasons|1|||
170740303|NCT02247804|617056331|FG002|Treatment Period 2|Personal Reasons|1|||
170740304|NCT02247804|617056329|FG000|Treatment Period 2|Reason not Specified|0|||
170740305|NCT02247804|617056330|FG001|Treatment Period 2|Reason not Specified|0|||
170740306|NCT02247804|617056331|FG002|Treatment Period 2|Reason not Specified|2|||
170740307|NCT02247804|617056329|FG000|Treatment Period 3|Adverse Event|4|||
170740308|NCT02247804|617056330|FG001|Treatment Period 3|Adverse Event|3|||
170740309|NCT02247804|617056331|FG002|Treatment Period 3|Adverse Event|3|||
170740310|NCT02247804|617056329|FG000|Treatment Period 3|Lack of Efficacy|0|||
170740311|NCT02247804|617056330|FG001|Treatment Period 3|Lack of Efficacy|1|||
170740312|NCT02247804|617056331|FG002|Treatment Period 3|Lack of Efficacy|0|||
170740313|NCT02247804|617056329|FG000|Treatment Period 3|Lost to Follow-up|1|||
170740314|NCT02247804|617056330|FG001|Treatment Period 3|Lost to Follow-up|2|||
170740315|NCT02247804|617056331|FG002|Treatment Period 3|Lost to Follow-up|2|||
170740316|NCT02247804|617056329|FG000|Treatment Period 3|Personal Reasons|4|||
170740317|NCT02247804|617056330|FG001|Treatment Period 3|Personal Reasons|3|||
170740318|NCT02247804|617056331|FG002|Treatment Period 3|Personal Reasons|2|||
170740319|NCT02247804|617056329|FG000|Treatment Period 3|Reason not Specified|2|||
170851445|NCT02663518|617463327|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
170851446|NCT02663518|617463314|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
170851447|NCT02663518|617463315|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
170851448|NCT02663518|617463316|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
170851449|NCT02663518|617463317|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
170851450|NCT02663518|617463318|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851451|NCT02663518|617463319|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851452|NCT02663518|617463320|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851453|NCT02663518|617463321|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851454|NCT02663518|617463322|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851455|NCT02663518|617463323|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851456|NCT02663518|617463324|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851457|NCT02663518|617463325|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851458|NCT02663518|617463326|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851459|NCT02663518|617463327|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
170851460|NCT02663518|617463314|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
170851461|NCT02663518|617463315|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851462|NCT02663518|617463316|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
170851463|NCT02663518|617463317|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
170851464|NCT02663518|617463318|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851465|NCT02663518|617463319|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851466|NCT02663518|617463320|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851467|NCT02663518|617463321|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851468|NCT02663518|617463322|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851469|NCT02663518|617463323|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851470|NCT02663518|617463324|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851471|NCT02663518|617463325|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851472|NCT02663518|617463326|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851473|NCT02663518|617463327|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
170851474|NCT02663518|617463314|FG000|Part 1: Phase 1a Escalation|Other|0|||
170851475|NCT02663518|617463315|FG001|Part 1: Phase 1a Escalation|Other|0|||
170851476|NCT02663518|617463316|FG002|Part 1: Phase 1a Escalation|Other|2|||
170851477|NCT02663518|617463317|FG003|Part 1: Phase 1a Escalation|Other|0|||
170851478|NCT02663518|617463318|FG004|Part 1: Phase 1a Escalation|Other|0|||
170851479|NCT02663518|617463319|FG005|Part 1: Phase 1a Escalation|Other|0|||
170851480|NCT02663518|617463320|FG006|Part 1: Phase 1a Escalation|Other|0|||
170851481|NCT02663518|617463321|FG007|Part 1: Phase 1a Escalation|Other|0|||
170851482|NCT02663518|617463322|FG008|Part 1: Phase 1a Escalation|Other|0|||
170851483|NCT02663518|617463323|FG009|Part 1: Phase 1a Escalation|Other|0|||
170851484|NCT02663518|617463324|FG010|Part 1: Phase 1a Escalation|Other|0|||
170851485|NCT02663518|617463325|FG011|Part 1: Phase 1a Escalation|Other|0|||
170851486|NCT02663518|617463326|FG012|Part 1: Phase 1a Escalation|Other|0|||
170851487|NCT02663518|617463327|FG013|Part 1: Phase 1a Escalation|Other|0|||
170851488|NCT02663518|617463314|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851489|NCT02663518|617463315|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851490|NCT02663518|617463316|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851491|NCT02663518|617463317|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851492|NCT02663518|617463318|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
170851493|NCT02663518|617463319|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851494|NCT02663518|617463320|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
170851495|NCT02663518|617463321|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
170851496|NCT02663518|617463322|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851497|NCT02663518|617463323|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851498|NCT02663518|617463324|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851499|NCT02663518|617463325|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851500|NCT02663518|617463326|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851501|NCT02663518|617463327|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
170851502|NCT02663518|617463314|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851503|NCT02663518|617463315|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851504|NCT02663518|617463316|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851505|NCT02663518|617463317|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851506|NCT02663518|617463318|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
170851507|NCT02663518|617463319|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851508|NCT02663518|617463320|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
170851509|NCT02663518|617463321|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
170851510|NCT02663518|617463322|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851511|NCT02663518|617463323|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851512|NCT02663518|617463324|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851513|NCT02663518|617463325|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851514|NCT02663518|617463326|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851515|NCT02663518|617463327|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
170851516|NCT02663518|617463314|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851517|NCT02663518|617463315|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851518|NCT02663518|617463316|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851519|NCT02663518|617463317|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851520|NCT02663518|617463318|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
170851521|NCT02663518|617463319|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851522|NCT02663518|617463320|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851523|NCT02663518|617463321|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851524|NCT02663518|617463322|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851525|NCT02663518|617463323|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851526|NCT02663518|617463324|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851527|NCT02663518|617463325|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851528|NCT02663518|617463326|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851529|NCT02663518|617463327|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
170851530|NCT02663518|617463314|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851531|NCT02663518|617463315|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851532|NCT02663518|617463316|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851533|NCT02663518|617463317|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851534|NCT02663518|617463318|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
170851535|NCT02663518|617463319|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
170851536|NCT02663518|617463320|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
170851537|NCT02663518|617463321|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
170851538|NCT02663518|617463322|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851539|NCT02663518|617463323|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851540|NCT02663518|617463324|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851541|NCT02663518|617463325|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851542|NCT02663518|617463326|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851543|NCT02663518|617463327|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
170851544|NCT02663518|617463314|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851545|NCT02663518|617463315|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851546|NCT02663518|617463316|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851547|NCT02663518|617463317|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851548|NCT02663518|617463318|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
170851549|NCT02663518|617463319|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851550|NCT02663518|617463320|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
170851551|NCT02663518|617463321|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851552|NCT02663518|617463322|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851553|NCT02663518|617463323|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851554|NCT02663518|617463324|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851555|NCT02663518|617463325|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851556|NCT02663518|617463326|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851557|NCT02663518|617463327|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
170851558|NCT02663518|617463314|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851559|NCT02663518|617463315|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851560|NCT02663518|617463316|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851561|NCT02663518|617463317|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851562|NCT02663518|617463318|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851563|NCT02663518|617463319|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851564|NCT02663518|617463320|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
170851565|NCT02663518|617463321|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851566|NCT02663518|617463322|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851567|NCT02663518|617463323|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170740320|NCT02247804|617056330|FG001|Treatment Period 3|Reason not Specified|1|||
170740321|NCT02247804|617056331|FG002|Treatment Period 3|Reason not Specified|3|||
170740322|NCT01107743|617056338|FG000|Overall Study|Protocol Violation|46|||
170740323|NCT03929562|617056342|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
170740324|NCT03929562|617056343|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
170740325|NCT03929562|617056342|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
170740326|NCT03929562|617056343|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
170740327|NCT03929562|617056342|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
170740328|NCT03929562|617056343|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
170740329|NCT02978443|617056345|FG000|Overall Study|Withdrawal by Subject|1|||
170740330|NCT02978443|617056345|FG000|Overall Study|Adverse Event|3|||
170740331|NCT02978443|617056345|FG000|Overall Study|Disease Progression on study|6|||
170740332|NCT02978443|617056345|FG000|Overall Study|Death|1|||
170740333|NCT02978443|617056345|FG000|Overall Study|Physician Decision|1|||
170740334|NCT02978443|617056345|FG000|Overall Study|Switch to alternative therapy|1|||
170740335|NCT02978443|617056345|FG000|Overall Study|Refused further treatment|1|||
170740336|NCT02658630|617056349|FG000|Overall Study|Withdrawal by Subject|4|||
170740337|NCT03108157|617056354|FG000|Overall Study|Protocol Violation|15|||
170740338|NCT03108157|617056355|FG001|Overall Study|Protocol Violation|4|||
170740339|NCT01436201|617056356|FG000|Overall Study|Adverse Event|2|||
170740340|NCT01436201|617056356|FG000|Overall Study|Withdrawal by Subject|1|||
170740341|NCT01436201|617056356|FG000|Overall Study|Protocol Violation|1|||
170740342|NCT00110890|617056357|FG000|Overall Study|Adverse Event|30|||
170740343|NCT00110890|617056358|FG001|Overall Study|Adverse Event|7|||
170740344|NCT00110890|617056357|FG000|Overall Study|Death|16|||
170740345|NCT00110890|617056358|FG001|Overall Study|Death|9|||
170740346|NCT00110890|617056357|FG000|Overall Study|Lost to Follow-up|3|||
170740347|NCT00110890|617056358|FG001|Overall Study|Lost to Follow-up|1|||
170740348|NCT00110890|617056357|FG000|Overall Study|Physician Decision|4|||
170740349|NCT00110890|617056358|FG001|Overall Study|Physician Decision|5|||
170740350|NCT00110890|617056357|FG000|Overall Study|Withdrawal by Subject|17|||
170740351|NCT00110890|617056358|FG001|Overall Study|Withdrawal by Subject|5|||
170740352|NCT00110890|617056357|FG000|Overall Study|Protocol Deviation|1|||
170740353|NCT00110890|617056358|FG001|Overall Study|Protocol Deviation|0|||
170740354|NCT00110890|617056357|FG000|Overall Study|Noncompliance|10|||
170740355|NCT00110890|617056358|FG001|Overall Study|Noncompliance|0|||
170740356|NCT00110890|617056357|FG000|Overall Study|Kidney Transplant|16|||
170740357|NCT00110890|617056358|FG001|Overall Study|Kidney Transplant|12|||
170740358|NCT00110890|617056357|FG000|Overall Study|Invest. Product Commercially Available|217|||
170740359|NCT00110890|617056358|FG001|Overall Study|Invest. Product Commercially Available|110|||
170740360|NCT00110890|617056357|FG000|Overall Study|Other|34|||
170740361|NCT00110890|617056358|FG001|Overall Study|Other|23|||
170740362|NCT00110890|617056357|FG000|Overall Study|Ineligibility determined|3|||
170740363|NCT00110890|617056358|FG001|Overall Study|Ineligibility determined|0|||
170740364|NCT00110890|617056357|FG000|Overall Study|Requirement for alternative therapy|0|||
170740365|NCT00110890|617056358|FG001|Overall Study|Requirement for alternative therapy|1|||
170740366|NCT00110890|617056357|FG000|Overall Study|Disease progression|0|||
170740367|NCT00110890|617056358|FG001|Overall Study|Disease progression|1|||
170740368|NCT00110890|617056357|FG000|Overall Study|Parathyroidectomy|0|||
170851568|NCT02663518|617463324|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851569|NCT02663518|617463325|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851570|NCT02663518|617463326|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851571|NCT02663518|617463327|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
170851572|NCT02663518|617463314|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
170851573|NCT02663518|617463315|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
170851574|NCT02663518|617463316|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
170851575|NCT02663518|617463317|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
170851576|NCT02663518|617463318|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
170851577|NCT02663518|617463319|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
170851578|NCT02663518|617463320|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
170851579|NCT02663518|617463321|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
170851580|NCT02663518|617463322|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
170851581|NCT02663518|617463323|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
170851582|NCT02663518|617463324|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
170851583|NCT02663518|617463325|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
170851584|NCT02663518|617463326|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
170851585|NCT02663518|617463327|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
170851586|NCT02663518|617463314|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851587|NCT02663518|617463315|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851588|NCT02663518|617463316|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851589|NCT02663518|617463317|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851590|NCT02663518|617463318|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851591|NCT02663518|617463319|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851592|NCT02663518|617463320|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851593|NCT02663518|617463321|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851594|NCT02663518|617463322|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851595|NCT02663518|617463323|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851596|NCT02663518|617463324|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851597|NCT02663518|617463325|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851598|NCT02663518|617463326|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
170851599|NCT02663518|617463327|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
170851600|NCT02663518|617463314|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851601|NCT02663518|617463315|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851602|NCT02663518|617463316|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851603|NCT02663518|617463317|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851604|NCT02663518|617463318|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851605|NCT02663518|617463319|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851606|NCT02663518|617463320|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851607|NCT02663518|617463321|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851608|NCT02663518|617463322|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851609|NCT02663518|617463323|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851610|NCT02663518|617463324|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851611|NCT02663518|617463325|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
170851612|NCT02663518|617463326|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851613|NCT02663518|617463327|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
170851614|NCT02663518|617463314|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851615|NCT02663518|617463315|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851616|NCT02663518|617463316|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851617|NCT02663518|617463317|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851618|NCT02663518|617463318|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851619|NCT02663518|617463319|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851620|NCT02663518|617463320|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851621|NCT02663518|617463321|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851622|NCT02663518|617463322|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851623|NCT02663518|617463323|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
170851624|NCT02663518|617463324|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
170851625|NCT02663518|617463325|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
170851626|NCT02663518|617463326|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
170851627|NCT02663518|617463327|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
170851628|NCT02663518|617463314|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
170851629|NCT02663518|617463315|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
170851630|NCT02663518|617463316|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
170851631|NCT02663518|617463317|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
170851632|NCT02663518|617463318|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
170851633|NCT02663518|617463319|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
170851634|NCT02663518|617463320|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
170851635|NCT02663518|617463321|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
170851636|NCT02663518|617463322|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
170851637|NCT02663518|617463323|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
170851638|NCT02663518|617463324|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
170851639|NCT02663518|617463325|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
170851640|NCT02663518|617463326|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
170851641|NCT02663518|617463327|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
170851642|NCT02663518|617463314|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851643|NCT02663518|617463315|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851644|NCT02663518|617463316|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851645|NCT02663518|617463317|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851646|NCT02663518|617463318|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851647|NCT02663518|617463319|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851648|NCT02663518|617463320|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851649|NCT02663518|617463321|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851650|NCT02663518|617463322|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851651|NCT02663518|617463323|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851652|NCT02663518|617463324|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851653|NCT02663518|617463325|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851654|NCT02663518|617463326|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
170851655|NCT02663518|617463327|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
170851656|NCT00434213|617463328|FG000|Overall Study|Adverse Event|12|||
170851657|NCT00434213|617463328|FG000|Overall Study|Lack of Efficacy|9|||
170851658|NCT00434213|617463328|FG000|Overall Study|Lost to Follow-up|14|||
170851659|NCT00434213|617463328|FG000|Overall Study|Withdrawal by Subject|7|||
170851660|NCT00434213|617463328|FG000|Overall Study|Protocol Violation|3|||
170851661|NCT00434213|617463328|FG000|Overall Study|Unable to comply with study visit window|2|||
170851662|NCT00434213|617463328|FG000|Overall Study|Application site reaction|1|||
170851663|NCT00434213|617463328|FG000|Overall Study|Non-compliant to study schedule|1|||
170851664|NCT04988867|617463329|FG000|Overall Study|Study terminated by Sponsor|12|||
170851665|NCT04988867|617463329|FG000|Overall Study|Adverse Event|2|||
170851666|NCT04988867|617463329|FG000|Overall Study|Study drug noncompliance|1|||
170851667|NCT04638920|617463344|FG000|Overall Study|Withdrawal by Subject|5|||
170851668|NCT00964886|617463351|FG000|Overall Study|Lost to Follow-up|2|||
170851669|NCT00964886|617463352|FG001|Overall Study|Lost to Follow-up|2|||
170851670|NCT00964886|617463353|FG002|Overall Study|Lost to Follow-up|6|||
170851671|NCT00964886|617463354|FG003|Overall Study|Lost to Follow-up|4|||
170851672|NCT00964886|617463351|FG000|Overall Study|Withdrawal by Subject|6|||
170851673|NCT00964886|617463352|FG001|Overall Study|Withdrawal by Subject|2|||
170851674|NCT00964886|617463353|FG002|Overall Study|Withdrawal by Subject|5|||
170851675|NCT00964886|617463354|FG003|Overall Study|Withdrawal by Subject|3|||
170851676|NCT00964886|617463351|FG000|Overall Study|Adverse Event|3|||
170851677|NCT00964886|617463352|FG001|Overall Study|Adverse Event|1|||
170851678|NCT00964886|617463353|FG002|Overall Study|Adverse Event|5|||
170851679|NCT00964886|617463354|FG003|Overall Study|Adverse Event|2|||
170851680|NCT00964886|617463351|FG000|Overall Study|Protocol Violation|0|||
170851681|NCT00964886|617463352|FG001|Overall Study|Protocol Violation|2|||
170851682|NCT00964886|617463353|FG002|Overall Study|Protocol Violation|0|||
170851683|NCT00964886|617463354|FG003|Overall Study|Protocol Violation|0|||
170851684|NCT03775434|617463355|FG000|Overall Study|Adverse Event|2|||
170851685|NCT03775434|617463355|FG000|Overall Study|Withdrawal by Subject|1|||
170851686|NCT00468104|617463356|FG000|First Intervention|Protocol Violation|2|||
170851687|NCT00468104|617463357|FG001|First Intervention|Protocol Violation|1|||
170851688|NCT00468104|617463356|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
170851689|NCT00468104|617463357|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
170851690|NCT00468104|617463356|FG000|First Intervention|died within 3 weeks|1|||
170851691|NCT00468104|617463357|FG001|First Intervention|died within 3 weeks|0|||
170851692|NCT00468104|617463356|FG000|First Intervention|malposition/blocked chest tube tube|2|||
170851693|NCT00468104|617463357|FG001|First Intervention|malposition/blocked chest tube tube|0|||
170851694|NCT00468104|617463356|FG000|First Intervention|large lung mass with minimal effusion|1|||
170851695|NCT00468104|617463357|FG001|First Intervention|large lung mass with minimal effusion|0|||
170851696|NCT00468104|617463356|FG000|First Intervention|associated prolonged pneumothorax|1|||
170851697|NCT00468104|617463357|FG001|First Intervention|associated prolonged pneumothorax|0|||
170851698|NCT00468104|617463356|FG000|First Intervention|trapped lung|1|||
170851699|NCT00468104|617463357|FG001|First Intervention|trapped lung|0|||
170851700|NCT00468104|617463356|FG000|Second Intervention|Withdrawal by Subject|5|||
170851701|NCT00468104|617463357|FG001|Second Intervention|Withdrawal by Subject|2|||
170851702|NCT00468104|617463356|FG000|Second Intervention|discarded for malposition of chest tube|0|||
170851703|NCT00468104|617463357|FG001|Second Intervention|discarded for malposition of chest tube|2|||
170851704|NCT02706899|617463363|FG000|Overall Study|Withdrawal by Subject|1|||
170851705|NCT02706899|617463364|FG001|Overall Study|Withdrawal by Subject|0|||
170851706|NCT02706899|617463363|FG000|Overall Study|Death|8|||
170740369|NCT00110890|617056358|FG001|Overall Study|Parathyroidectomy|1|||
170740370|NCT00110890|617056357|FG000|Overall Study|Did not enter follow-up phase|10|||
170740371|NCT00110890|617056358|FG001|Overall Study|Did not enter follow-up phase|4|||
170740372|NCT01975220|617056359|FG000|Test Period 1|Not treated|0|||
170740373|NCT01975220|617056360|FG001|Test Period 1|Not treated|1|||
170740374|NCT01975220|617056361|FG002|Test Period 1|Not treated|0|||
170740375|NCT01975220|617056362|FG003|Test Period 1|Not treated|0|||
170740376|NCT01975220|617056363|FG004|Test Period 1|Not treated|0|||
170740377|NCT01975220|617056364|FG005|Test Period 1|Not treated|0|||
170740378|NCT02839343|617056365|FG000|Overall Study|Withdrawal by Subject|3|||
170740379|NCT02839343|617056366|FG001|Overall Study|Withdrawal by Subject|1|||
170740380|NCT02839343|617056365|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
170740381|NCT02839343|617056366|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
170740382|NCT02839343|617056365|FG000|Overall Study|Adverse Event|1|||
170740383|NCT02839343|617056366|FG001|Overall Study|Adverse Event|0|||
170740384|NCT03287414|617056368|FG000|Treatment Epoch|Adverse Event|0|||
170740385|NCT03287414|617056369|FG001|Treatment Epoch|Adverse Event|1|||
170740386|NCT03287414|617056368|FG000|Treatment Epoch|Study terminated by sponsor|2|||
170740387|NCT03287414|617056369|FG001|Treatment Epoch|Study terminated by sponsor|2|||
170740388|NCT03287414|617056368|FG000|Treatment Epoch|Subject/Guardian decision|4|||
170740389|NCT03287414|617056369|FG001|Treatment Epoch|Subject/Guardian decision|0|||
170740390|NCT03287414|617056368|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
170740391|NCT03287414|617056369|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
170740392|NCT03287414|617056368|FG000|Treatment Epoch|Withdrawal by Subject|1|||
170740393|NCT03287414|617056369|FG001|Treatment Epoch|Withdrawal by Subject|0|||
170740394|NCT03287414|617056368|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
170740395|NCT03287414|617056369|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
170740396|NCT03287414|617056368|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
170740397|NCT03287414|617056369|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
170740398|NCT01008475|617056372|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
170740399|NCT01008475|617056373|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
170740400|NCT01008475|617056374|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
170740401|NCT01008475|617056375|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
170740402|NCT01008475|617056376|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
170740403|NCT01008475|617056377|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
170740404|NCT01008475|617056378|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
170740405|NCT00661661|617056379|FG000|Overall Study|Adverse Event|99|||
170740406|NCT00661661|617056380|FG001|Overall Study|Adverse Event|24|||
170740407|NCT00661661|617056379|FG000|Overall Study|Lack of Efficacy|3|||
170740408|NCT00661661|617056380|FG001|Overall Study|Lack of Efficacy|2|||
170740409|NCT00661661|617056379|FG000|Overall Study|Lost to Follow-up|0|||
170740410|NCT00661661|617056380|FG001|Overall Study|Lost to Follow-up|1|||
170740411|NCT00661661|617056379|FG000|Overall Study|Withdrawal by Subject|15|||
170740412|NCT00661661|617056380|FG001|Overall Study|Withdrawal by Subject|5|||
170740413|NCT00661661|617056379|FG000|Overall Study|Other|22|||
170740414|NCT00661661|617056380|FG001|Overall Study|Other|7|||
170740415|NCT00661661|617056379|FG000|Overall Study|Not assigned treatment|1|||
170740416|NCT00661661|617056380|FG001|Overall Study|Not assigned treatment|0|||
170740417|NCT00116844|617056383|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
170740418|NCT00116844|617056384|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
170740419|NCT00116844|617056383|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
170740420|NCT00116844|617056384|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
170740421|NCT00116844|617056383|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
170740422|NCT00116844|617056384|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
170740423|NCT00116844|617056383|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
170740424|NCT00116844|617056384|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
170740425|NCT00116844|617056383|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
170740426|NCT00116844|617056384|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
170740427|NCT00116844|617056383|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
170740428|NCT00116844|617056384|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
170740429|NCT00116844|617056383|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
170740430|NCT00116844|617056384|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
170740431|NCT00116844|617056383|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
170740432|NCT00116844|617056384|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
170851707|NCT02706899|617463364|FG001|Overall Study|Death|0|||
170851708|NCT02706899|617463363|FG000|Overall Study|Study Termination by Sponsor|4|||
170851709|NCT02706899|617463364|FG001|Overall Study|Study Termination by Sponsor|6|||
170740433|NCT00116844|617056383|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
170740434|NCT00116844|617056384|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
170740435|NCT01125722|617056387|FG000|Overall Study|Withdrawal by Subject|2|||
170740436|NCT01125722|617056388|FG001|Overall Study|Withdrawal by Subject|1|||
170740437|NCT01125722|617056387|FG000|Overall Study|Lost to Follow-up|1|||
170740438|NCT01125722|617056388|FG001|Overall Study|Lost to Follow-up|0|||
170740439|NCT03474549|617056391|FG000|Overall Study|Death|31|||
170740440|NCT03474549|617056391|FG000|Overall Study|Lost to Follow-up|4|||
170740441|NCT03474549|617056391|FG000|Overall Study|Withdrawal by Subject|2|||
170740442|NCT00069784|617056392|FG000|Overall Study|Adverse Event|105|||
170740443|NCT00069784|617056393|FG001|Overall Study|Adverse Event|0|||
170740444|NCT00069784|617056392|FG000|Overall Study|Withdrawal by Subject|1090|||
170740445|NCT00069784|617056393|FG001|Overall Study|Withdrawal by Subject|0|||
170740446|NCT00069784|617056392|FG000|Overall Study|Other|17|||
170740447|NCT00069784|617056393|FG001|Overall Study|Other|0|||
170740448|NCT00709059|617056394|FG000|Overall Study|Lost to Follow-up|34|||
170740449|NCT00709059|617056394|FG000|Overall Study|Withdrawal by Subject|19|||
170740450|NCT00709059|617056394|FG000|Overall Study|Physician Decision|7|||
170740451|NCT00709059|617056394|FG000|Overall Study|Disease complication|3|||
170740452|NCT00709059|617056394|FG000|Overall Study|Side effects|20|||
170740453|NCT00709059|617056394|FG000|Overall Study|Serious side effects|11|||
170740454|NCT00663117|617057848|FG000|Overall Study|Lack of Efficacy|1|||
170740455|NCT00663117|617057849|FG001|Overall Study|Lack of Efficacy|0|||
170740456|NCT02781506|617057850|FG000|Overall Study|Adverse Event|5|||
170740457|NCT01158378|617057851|FG000|Overall Study|Death|4|||
170740458|NCT01158378|617057852|FG001|Overall Study|Death|5|||
170740459|NCT01158378|617057851|FG000|Overall Study|Lost to Follow-up|2|||
170740460|NCT01158378|617057852|FG001|Overall Study|Lost to Follow-up|4|||
170740461|NCT01158378|617057851|FG000|Overall Study|Withdrawal by Subject|4|||
170740462|NCT01158378|617057852|FG001|Overall Study|Withdrawal by Subject|0|||
170740463|NCT02593539|617057857|FG000|Overall Study|Adverse Event|1|||
170740464|NCT00437125|617057860|FG000|Overall Study|Adverse Event|12|||
170740465|NCT00437125|617057860|FG000|Overall Study|Death|1|||
170740466|NCT00437125|617057860|FG000|Overall Study|Clinical Relapse|1|||
170740467|NCT00437125|617057860|FG000|Overall Study|Lack of Efficacy|1|||
170740468|NCT00437125|617057860|FG000|Overall Study|Lost to Follow-up|1|||
170740469|NCT00437125|617057860|FG000|Overall Study|Withdrawal by Subject|13|||
170740470|NCT00437125|617057860|FG000|Overall Study|Withdrawal by Caregiver|2|||
170740471|NCT00437125|617057860|FG000|Overall Study|Physician Decision|1|||
170740472|NCT02248961|617057861|FG000|Overall Study|Adverse Event|1|||
170740473|NCT02248961|617057862|FG001|Overall Study|Adverse Event|0|||
170740474|NCT02248961|617057861|FG000|Overall Study|Withdrawal by Subject|1|||
170740475|NCT02248961|617057862|FG001|Overall Study|Withdrawal by Subject|2|||
170740476|NCT02248961|617057861|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
170740477|NCT02248961|617057862|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
170740478|NCT02531295|617057863|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
170740479|NCT02531295|617057864|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
170740480|NCT02531295|617057865|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
170740481|NCT02531295|617057866|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
170740482|NCT02531295|617057867|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
170740483|NCT02531295|617057868|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
170740484|NCT04424290|617057871|FG000|Overall Study|Not treated|0|||
170740485|NCT04424290|617057872|FG001|Overall Study|Not treated|0|||
170740486|NCT04424290|617057873|FG002|Overall Study|Not treated|1|||
170740487|NCT04424290|617057874|FG003|Overall Study|Not treated|0|||
170740488|NCT04424290|617057875|FG004|Overall Study|Not treated|1|||
170740489|NCT04424290|617057871|FG000|Overall Study|Adverse Event|0|||
170740490|NCT04424290|617057872|FG001|Overall Study|Adverse Event|0|||
170740491|NCT04424290|617057873|FG002|Overall Study|Adverse Event|0|||
170740492|NCT04424290|617057874|FG003|Overall Study|Adverse Event|2|||
170740493|NCT04424290|617057875|FG004|Overall Study|Adverse Event|0|||
170740494|NCT04424290|617057871|FG000|Overall Study|Withdrawal by Subject|0|||
170740495|NCT04424290|617057872|FG001|Overall Study|Withdrawal by Subject|0|||
170740496|NCT04424290|617057873|FG002|Overall Study|Withdrawal by Subject|0|||
170740497|NCT04424290|617057874|FG003|Overall Study|Withdrawal by Subject|0|||
170740498|NCT04424290|617057875|FG004|Overall Study|Withdrawal by Subject|1|||
170740499|NCT04424290|617057871|FG000|Overall Study|Other than listed|0|||
170740500|NCT04424290|617057872|FG001|Overall Study|Other than listed|0|||
170740501|NCT04424290|617057873|FG002|Overall Study|Other than listed|0|||
170740502|NCT04424290|617057874|FG003|Overall Study|Other than listed|1|||
170851710|NCT00324675|617463365|FG000|Overall Study|Adverse Event|1|||
170740503|NCT04424290|617057875|FG004|Overall Study|Other than listed|0|||
170740504|NCT00453310|617057876|FG000|Overall Study|Progression of Disease|10|||
170740505|NCT01806740|617057877|FG000|Overall Study|Withdrawal by Subject|4|||
170740506|NCT01806740|617057877|FG000|Overall Study|Physician Decision|1|||
170740507|NCT01806740|617057877|FG000|Overall Study|Patient's refusal of treatment|1|||
170740508|NCT04666922|617057878|FG000|Overall Study|Withdrawal by Subject|1|||
170740509|NCT04666922|617057879|FG001|Overall Study|Withdrawal by Subject|0|||
170740510|NCT04666922|617057880|FG002|Overall Study|Withdrawal by Subject|0|||
170740511|NCT04666922|617057881|FG003|Overall Study|Withdrawal by Subject|0|||
170740512|NCT04666922|617057882|FG004|Overall Study|Withdrawal by Subject|0|||
170740513|NCT04666922|617057883|FG005|Overall Study|Withdrawal by Subject|0|||
170851711|NCT00324675|617463366|FG001|Overall Study|Adverse Event|0|||
170740514|NCT04666922|617057884|FG006|Overall Study|Withdrawal by Subject|0|||
170740515|NCT01382940|617057887|FG000|Overall Study|Adverse Event|19|||
170740516|NCT01382940|617057887|FG000|Overall Study|Lost to Follow-up|4|||
170740517|NCT01382940|617057887|FG000|Overall Study|Physician Decision|7|||
170740518|NCT01382940|617057887|FG000|Overall Study|Withdrawal by Subject|23|||
170740519|NCT01382940|617057887|FG000|Overall Study|Protocol Violation|20|||
170740520|NCT00244374|617057890|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
170740521|NCT00244374|617057891|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
170740522|NCT00244374|617057892|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
170740523|NCT00244374|617057893|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
170740524|NCT00244374|617057894|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
170740525|NCT00244374|617057890|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
170740526|NCT00244374|617057891|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
170740527|NCT00244374|617057892|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
170740528|NCT00244374|617057893|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
170740529|NCT00244374|617057894|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
170740530|NCT00244374|617057890|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
170740531|NCT00244374|617057891|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
170740532|NCT00244374|617057892|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
170740533|NCT00244374|617057893|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
170740534|NCT00244374|617057894|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
170740535|NCT00244374|617057890|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
170740536|NCT00244374|617057891|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
170740537|NCT00244374|617057892|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
170740538|NCT00244374|617057893|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
170740539|NCT00244374|617057894|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
170740540|NCT00244374|617057890|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
170740541|NCT00244374|617057891|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
170740542|NCT00244374|617057892|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
170740543|NCT00244374|617057893|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
170740544|NCT00244374|617057894|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
170740545|NCT00244374|617057890|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
170740546|NCT00244374|617057891|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
170740547|NCT00244374|617057892|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
170740548|NCT00244374|617057893|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
170740549|NCT00244374|617057894|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
170740550|NCT00244374|617057890|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
170740551|NCT00244374|617057891|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
170740552|NCT00244374|617057892|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
170740553|NCT00244374|617057893|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
170740554|NCT00244374|617057894|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
170740555|NCT00244374|617057890|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
170740556|NCT00244374|617057891|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
170740557|NCT00244374|617057892|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
170740558|NCT00244374|617057893|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
170740559|NCT00244374|617057894|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
170740560|NCT00244374|617057890|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
170740561|NCT00244374|617057891|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
170851712|NCT04811131|617463373|FG000|Overall Study|Adverse Event|0|||
170851713|NCT04811131|617463374|FG001|Overall Study|Adverse Event|0|||
170851714|NCT04811131|617463375|FG002|Overall Study|Adverse Event|1|||
170851715|NCT04811131|617463376|FG003|Overall Study|Adverse Event|0|||
170851716|NCT04811131|617463373|FG000|Overall Study|Lack of Efficacy|0|||
170851717|NCT04811131|617463374|FG001|Overall Study|Lack of Efficacy|0|||
170851718|NCT04811131|617463375|FG002|Overall Study|Lack of Efficacy|0|||
170851719|NCT04811131|617463376|FG003|Overall Study|Lack of Efficacy|1|||
170851720|NCT04811131|617463373|FG000|Overall Study|Lost to Follow-up|0|||
170851721|NCT04811131|617463374|FG001|Overall Study|Lost to Follow-up|1|||
170851722|NCT04811131|617463375|FG002|Overall Study|Lost to Follow-up|0|||
170851723|NCT04811131|617463376|FG003|Overall Study|Lost to Follow-up|0|||
170851724|NCT04811131|617463373|FG000|Overall Study|Sponsor request|31|||
170851725|NCT04811131|617463374|FG001|Overall Study|Sponsor request|35|||
170851726|NCT04811131|617463375|FG002|Overall Study|Sponsor request|27|||
170851727|NCT04811131|617463376|FG003|Overall Study|Sponsor request|10|||
170851728|NCT04811131|617463373|FG000|Overall Study|Withdrawal by Subject|3|||
170851729|NCT04811131|617463374|FG001|Overall Study|Withdrawal by Subject|1|||
170851730|NCT04811131|617463375|FG002|Overall Study|Withdrawal by Subject|3|||
170851731|NCT04811131|617463376|FG003|Overall Study|Withdrawal by Subject|1|||
170851732|NCT00620282|617463382|FG000|Overall Study|Adverse Event|0|||
170851733|NCT00620282|617463383|FG001|Overall Study|Adverse Event|1|||
170851734|NCT00620282|617463384|FG002|Overall Study|Adverse Event|0|||
170851735|NCT00620282|617463382|FG000|Overall Study|Arterial line unable to be placed|0|||
170851736|NCT00620282|617463383|FG001|Overall Study|Arterial line unable to be placed|0|||
170851737|NCT00620282|617463384|FG002|Overall Study|Arterial line unable to be placed|1|||
170851738|NCT00620282|617463382|FG000|Overall Study|Withdrawal by Subject|0|||
170851739|NCT00620282|617463383|FG001|Overall Study|Withdrawal by Subject|1|||
170851740|NCT00620282|617463384|FG002|Overall Study|Withdrawal by Subject|0|||
170851741|NCT04738292|617463385|FG000|Overall Study|Death|1|||
170851742|NCT01131182|617463387|FG000|Overall Study|Withdrawal by Subject|1|||
170851743|NCT01131182|617463388|FG001|Overall Study|Withdrawal by Subject|1|||
170851744|NCT01131182|617463387|FG000|Overall Study|Lost to Follow-up|14|||
170851745|NCT01131182|617463388|FG001|Overall Study|Lost to Follow-up|15|||
170851746|NCT01131182|617463387|FG000|Overall Study|Other Reason|1|||
170851747|NCT01131182|617463388|FG001|Overall Study|Other Reason|0|||
170851748|NCT01081665|617463390|FG000|Overall Study|Death|41|||
170851749|NCT01081665|617463390|FG000|Overall Study|Lost to Follow-up|18|||
170851750|NCT01081665|617463390|FG000|Overall Study|Withdrawal by Subject|17|||
170851751|NCT01081665|617463390|FG000|Overall Study|Change of dialysis unit|10|||
170851752|NCT01081665|617463390|FG000|Overall Study|Regulation of iPTH|5|||
170851753|NCT01081665|617463390|FG000|Overall Study|Change in renal replacement therapy|2|||
170851754|NCT01081665|617463390|FG000|Overall Study|Adverse Event|1|||
170851755|NCT01081665|617463390|FG000|Overall Study|Lack of Efficacy|1|||
170851756|NCT00633880|617463399|FG000|Open Label Titration|Lack of Efficacy|1|||
170851757|NCT00633880|617463400|FG001|Open Label Titration|Lack of Efficacy|0|||
170851758|NCT00633880|617463401|FG002|Open Label Titration|Lack of Efficacy|0|||
170851759|NCT00633880|617463399|FG000|Open Label Titration|Adverse Event|13|||
170851760|NCT00633880|617463400|FG001|Open Label Titration|Adverse Event|0|||
170851761|NCT00633880|617463401|FG002|Open Label Titration|Adverse Event|0|||
170851762|NCT00633880|617463399|FG000|Open Label Titration|Treatment Failure|55|||
170851763|NCT00633880|617463400|FG001|Open Label Titration|Treatment Failure|0|||
170851764|NCT00633880|617463401|FG002|Open Label Titration|Treatment Failure|0|||
170851765|NCT00633880|617463399|FG000|Open Label Titration|Protocol Violation|6|||
170851766|NCT00633880|617463400|FG001|Open Label Titration|Protocol Violation|0|||
170851767|NCT00633880|617463401|FG002|Open Label Titration|Protocol Violation|0|||
170851768|NCT00633880|617463399|FG000|Open Label Titration|Physician Decision|1|||
170851769|NCT00633880|617463400|FG001|Open Label Titration|Physician Decision|0|||
170851770|NCT00633880|617463401|FG002|Open Label Titration|Physician Decision|0|||
170851771|NCT00633880|617463399|FG000|Open Label Titration|Withdrawal by Subject|4|||
170851772|NCT00633880|617463400|FG001|Open Label Titration|Withdrawal by Subject|0|||
170851773|NCT00633880|617463401|FG002|Open Label Titration|Withdrawal by Subject|0|||
170851774|NCT01413503|617463402|FG000|Overall Study|Lost to Follow-up|1|||
170851775|NCT02546921|617463403|FG000|Overall Study|Adverse Event|0|||
170851776|NCT02546921|617463404|FG001|Overall Study|Adverse Event|5|||
170851777|NCT02546921|617463405|FG002|Overall Study|Adverse Event|2|||
170851778|NCT02546921|617463406|FG003|Overall Study|Adverse Event|0|||
170851779|NCT02546921|617463407|FG004|Overall Study|Adverse Event|0|||
170851780|NCT02546921|617463408|FG005|Overall Study|Adverse Event|0|||
170851781|NCT02546921|617463409|FG006|Overall Study|Adverse Event|0|||
170851782|NCT02546921|617463403|FG000|Overall Study|Evidence of Disease Progression|1|||
170851783|NCT02546921|617463404|FG001|Overall Study|Evidence of Disease Progression|0|||
170851784|NCT02546921|617463405|FG002|Overall Study|Evidence of Disease Progression|0|||
170851785|NCT02546921|617463406|FG003|Overall Study|Evidence of Disease Progression|0|||
170851786|NCT02546921|617463407|FG004|Overall Study|Evidence of Disease Progression|1|||
170851787|NCT02546921|617463408|FG005|Overall Study|Evidence of Disease Progression|0|||
170851788|NCT02546921|617463409|FG006|Overall Study|Evidence of Disease Progression|0|||
170851789|NCT02546921|617463403|FG000|Overall Study|Patient Choice|0|||
170851790|NCT02546921|617463404|FG001|Overall Study|Patient Choice|1|||
170851791|NCT02546921|617463405|FG002|Overall Study|Patient Choice|0|||
170851792|NCT02546921|617463406|FG003|Overall Study|Patient Choice|0|||
170851793|NCT02546921|617463407|FG004|Overall Study|Patient Choice|0|||
170851794|NCT02546921|617463408|FG005|Overall Study|Patient Choice|1|||
170851795|NCT02546921|617463409|FG006|Overall Study|Patient Choice|0|||
170851796|NCT01373151|617463410|FG000|Period 1|Lack of Efficacy|3|||
170851797|NCT01373151|617463411|FG001|Period 1|Lack of Efficacy|0|||
170851798|NCT01373151|617463412|FG002|Period 1|Lack of Efficacy|0|||
170851799|NCT01373151|617463413|FG003|Period 1|Lack of Efficacy|0|||
170851800|NCT01373151|617463414|FG004|Period 1|Lack of Efficacy|1|||
170851801|NCT01373151|617463415|FG005|Period 1|Lack of Efficacy|0|||
170851802|NCT01373151|617463416|FG006|Period 1|Lack of Efficacy|0|||
170851803|NCT01373151|617463410|FG000|Period 1|Adverse Event|0|||
170851804|NCT01373151|617463411|FG001|Period 1|Adverse Event|0|||
170851805|NCT01373151|617463412|FG002|Period 1|Adverse Event|1|||
170851806|NCT01373151|617463413|FG003|Period 1|Adverse Event|0|||
170851807|NCT01373151|617463414|FG004|Period 1|Adverse Event|4|||
170851808|NCT01373151|617463415|FG005|Period 1|Adverse Event|3|||
170851809|NCT01373151|617463416|FG006|Period 1|Adverse Event|0|||
170851810|NCT01373151|617463410|FG000|Period 1|Withdrawal by Subject|2|||
170851811|NCT01373151|617463411|FG001|Period 1|Withdrawal by Subject|0|||
170851812|NCT01373151|617463412|FG002|Period 1|Withdrawal by Subject|3|||
170851813|NCT01373151|617463413|FG003|Period 1|Withdrawal by Subject|1|||
170851814|NCT01373151|617463414|FG004|Period 1|Withdrawal by Subject|0|||
170851815|NCT01373151|617463415|FG005|Period 1|Withdrawal by Subject|1|||
170851816|NCT01373151|617463416|FG006|Period 1|Withdrawal by Subject|0|||
170851817|NCT01373151|617463410|FG000|Period 2|Lack of Efficacy|9|||
170851818|NCT01373151|617463411|FG001|Period 2|Lack of Efficacy|0|||
170851819|NCT01373151|617463412|FG002|Period 2|Lack of Efficacy|0|||
170851820|NCT01373151|617463413|FG003|Period 2|Lack of Efficacy|1|||
170851821|NCT01373151|617463414|FG004|Period 2|Lack of Efficacy|2|||
170851822|NCT01373151|617463415|FG005|Period 2|Lack of Efficacy|0|||
170851823|NCT01373151|617463416|FG006|Period 2|Lack of Efficacy|3|||
170851824|NCT01373151|617463410|FG000|Period 2|Adverse Event|0|||
170851825|NCT01373151|617463411|FG001|Period 2|Adverse Event|0|||
170851826|NCT01373151|617463412|FG002|Period 2|Adverse Event|3|||
170851827|NCT01373151|617463413|FG003|Period 2|Adverse Event|3|||
170851828|NCT01373151|617463414|FG004|Period 2|Adverse Event|0|||
170851829|NCT01373151|617463415|FG005|Period 2|Adverse Event|0|||
170851830|NCT01373151|617463416|FG006|Period 2|Adverse Event|1|||
170851831|NCT01373151|617463410|FG000|Period 2|subject request to discontinue|0|||
170851832|NCT01373151|617463411|FG001|Period 2|subject request to discontinue|1|||
170851833|NCT01373151|617463412|FG002|Period 2|subject request to discontinue|0|||
170851834|NCT01373151|617463413|FG003|Period 2|subject request to discontinue|0|||
170851835|NCT01373151|617463414|FG004|Period 2|subject request to discontinue|0|||
170851836|NCT01373151|617463415|FG005|Period 2|subject request to discontinue|0|||
170851837|NCT01373151|617463416|FG006|Period 2|subject request to discontinue|0|||
170851838|NCT01373151|617463410|FG000|Period 2|Withdrawal by Subject|0|||
170851839|NCT01373151|617463411|FG001|Period 2|Withdrawal by Subject|0|||
170851840|NCT01373151|617463412|FG002|Period 2|Withdrawal by Subject|0|||
170851841|NCT01373151|617463413|FG003|Period 2|Withdrawal by Subject|1|||
170851842|NCT01373151|617463414|FG004|Period 2|Withdrawal by Subject|0|||
170851843|NCT01373151|617463415|FG005|Period 2|Withdrawal by Subject|0|||
170851844|NCT01373151|617463416|FG006|Period 2|Withdrawal by Subject|0|||
170851845|NCT01373151|617463410|FG000|Period 2|Other|0|||
170851846|NCT01373151|617463411|FG001|Period 2|Other|0|||
170851847|NCT01373151|617463412|FG002|Period 2|Other|1|||
170851848|NCT01373151|617463413|FG003|Period 2|Other|0|||
170851849|NCT01373151|617463414|FG004|Period 2|Other|0|||
170851850|NCT01373151|617463415|FG005|Period 2|Other|0|||
170851851|NCT01373151|617463416|FG006|Period 2|Other|1|||
170851852|NCT00350103|617463417|FG000|Overall Study|Adverse Event|12|||
170851853|NCT00350103|617463418|FG001|Overall Study|Adverse Event|29|||
170851854|NCT00350103|617463419|FG002|Overall Study|Adverse Event|17|||
170851855|NCT00350103|617463417|FG000|Overall Study|Lack of Efficacy|5|||
170851856|NCT00350103|617463418|FG001|Overall Study|Lack of Efficacy|1|||
170851857|NCT00350103|617463419|FG002|Overall Study|Lack of Efficacy|3|||
170851858|NCT00350103|617463417|FG000|Overall Study|Withdrawal by Subject|6|||
170851859|NCT00350103|617463418|FG001|Overall Study|Withdrawal by Subject|6|||
170851860|NCT00350103|617463419|FG002|Overall Study|Withdrawal by Subject|8|||
170851861|NCT00350103|617463417|FG000|Overall Study|Protocol Violation|0|||
170851862|NCT00350103|617463418|FG001|Overall Study|Protocol Violation|0|||
170851863|NCT00350103|617463419|FG002|Overall Study|Protocol Violation|1|||
170851864|NCT00350103|617463417|FG000|Overall Study|Unsatisfactory Compliance|2|||
170851865|NCT00350103|617463418|FG001|Overall Study|Unsatisfactory Compliance|2|||
170851866|NCT00350103|617463419|FG002|Overall Study|Unsatisfactory Compliance|1|||
170851867|NCT00350103|617463417|FG000|Overall Study|Investigator´s decision|1|||
170851868|NCT00350103|617463418|FG001|Overall Study|Investigator´s decision|1|||
170851869|NCT00350103|617463419|FG002|Overall Study|Investigator´s decision|0|||
170851870|NCT00350103|617463417|FG000|Overall Study|Exclusion criteria met|0|||
170851871|NCT00350103|617463418|FG001|Overall Study|Exclusion criteria met|0|||
170851872|NCT00350103|617463419|FG002|Overall Study|Exclusion criteria met|1|||
170851873|NCT00350103|617463417|FG000|Overall Study|Patient relocated|0|||
170851874|NCT00350103|617463418|FG001|Overall Study|Patient relocated|0|||
170851875|NCT00350103|617463419|FG002|Overall Study|Patient relocated|1|||
170851876|NCT00350103|617463417|FG000|Overall Study|Need for prohibited medication|1|||
170851877|NCT00350103|617463418|FG001|Overall Study|Need for prohibited medication|0|||
170851878|NCT00350103|617463419|FG002|Overall Study|Need for prohibited medication|0|||
170851879|NCT00350103|617463417|FG000|Overall Study|Personal reasons|0|||
170851880|NCT00350103|617463418|FG001|Overall Study|Personal reasons|0|||
170851881|NCT00350103|617463419|FG002|Overall Study|Personal reasons|1|||
170851882|NCT00350103|617463417|FG000|Overall Study|Patient stopped feeling pain|1|||
170851883|NCT00350103|617463418|FG001|Overall Study|Patient stopped feeling pain|0|||
170851884|NCT00350103|617463419|FG002|Overall Study|Patient stopped feeling pain|0|||
170851885|NCT00350103|617463417|FG000|Overall Study|PR greater than 250ms|0|||
170851886|NCT00350103|617463418|FG001|Overall Study|PR greater than 250ms|0|||
170851887|NCT00350103|617463419|FG002|Overall Study|PR greater than 250ms|1|||
170851888|NCT00350103|617463417|FG000|Overall Study|Wrong calculation of QT interval|0|||
170851889|NCT00350103|617463418|FG001|Overall Study|Wrong calculation of QT interval|0|||
170851890|NCT00350103|617463419|FG002|Overall Study|Wrong calculation of QT interval|1|||
170851891|NCT00350103|617463417|FG000|Overall Study|Sponsor mistake|1|||
170851892|NCT00350103|617463418|FG001|Overall Study|Sponsor mistake|0|||
170851893|NCT00350103|617463419|FG002|Overall Study|Sponsor mistake|0|||
170851894|NCT00350103|617463417|FG000|Overall Study|Randomization mistake|0|||
170851895|NCT00350103|617463418|FG001|Overall Study|Randomization mistake|1|||
170851896|NCT00350103|617463419|FG002|Overall Study|Randomization mistake|1|||
170851897|NCT00350103|617463417|FG000|Overall Study|Sponsor´s decision|0|||
170851898|NCT00350103|617463418|FG001|Overall Study|Sponsor´s decision|1|||
170851899|NCT00350103|617463419|FG002|Overall Study|Sponsor´s decision|0|||
170851900|NCT00350103|617463417|FG000|Overall Study|Lost, Reason unknown|1|||
170851901|NCT00350103|617463418|FG001|Overall Study|Lost, Reason unknown|1|||
170851902|NCT00350103|617463419|FG002|Overall Study|Lost, Reason unknown|0|||
170851903|NCT01879553|617463420|FG000|Overall Study|Withdrawal by Subject|1|||
170851904|NCT01879553|617463421|FG001|Overall Study|Withdrawal by Subject|0|||
170851905|NCT04828837|617463422|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
170851906|NCT04828837|617463423|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
170851907|NCT04828837|617463422|FG000|Overall Study|Lost to Follow-up|2|||
170851908|NCT04828837|617463423|FG001|Overall Study|Lost to Follow-up|6|||
170851909|NCT04828837|617463422|FG000|Overall Study|Lack of Efficacy|1|||
170851910|NCT04828837|617463423|FG001|Overall Study|Lack of Efficacy|0|||
170851911|NCT04828837|617463422|FG000|Overall Study|Admitted due to pneumothorax.|1|||
170851912|NCT04828837|617463423|FG001|Overall Study|Admitted due to pneumothorax.|0|||
170851913|NCT04828837|617463422|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
170851914|NCT04828837|617463423|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
170851915|NCT00320528|617463424|FG000|Study Period II|Adverse Event|3|||
170851916|NCT00320528|617463425|FG001|Study Period II|Adverse Event|4|||
170740562|NCT00244374|617057892|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
170740563|NCT00244374|617057893|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
170740564|NCT00244374|617057894|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
170740565|NCT04249336|617057895|FG000|Overall Study|Lost to Follow-up|3|||
170740566|NCT04249336|617057896|FG001|Overall Study|Lost to Follow-up|3|||
170740567|NCT04249336|617057897|FG002|Overall Study|Lost to Follow-up|3|||
170740568|NCT04249336|617057898|FG003|Overall Study|Lost to Follow-up|3|||
170740569|NCT00720902|617057900|FG000|Overall Study|Withdrawal by Subject|1|||
170740570|NCT00720902|617057901|FG001|Overall Study|Withdrawal by Subject|0|||
170851917|NCT00320528|617463426|FG002|Study Period II|Adverse Event|8|||
170851918|NCT00320528|617463424|FG000|Study Period II|Parent/Caregiver Decision|8|||
170851919|NCT00320528|617463425|FG001|Study Period II|Parent/Caregiver Decision|3|||
170851920|NCT00320528|617463426|FG002|Study Period II|Parent/Caregiver Decision|11|||
170851921|NCT00320528|617463424|FG000|Study Period II|Withdrawal by Subject|0|||
170851922|NCT00320528|617463425|FG001|Study Period II|Withdrawal by Subject|1|||
170851923|NCT00320528|617463426|FG002|Study Period II|Withdrawal by Subject|1|||
170851924|NCT00320528|617463424|FG000|Study Period II|Entry Criteria Exclusion|0|||
170851925|NCT00320528|617463425|FG001|Study Period II|Entry Criteria Exclusion|2|||
170851926|NCT00320528|617463426|FG002|Study Period II|Entry Criteria Exclusion|2|||
170851927|NCT00320528|617463424|FG000|Study Period III|Adverse Event|1|||
170851928|NCT00320528|617463425|FG001|Study Period III|Adverse Event|0|||
170851929|NCT00320528|617463426|FG002|Study Period III|Adverse Event|0|||
170851930|NCT00320528|617463424|FG000|Study Period III|Lost to Follow-up|1|||
170851931|NCT00320528|617463425|FG001|Study Period III|Lost to Follow-up|0|||
170851932|NCT00320528|617463426|FG002|Study Period III|Lost to Follow-up|0|||
170851933|NCT00320528|617463424|FG000|Study Period III|Withdrawal by Subject|1|||
170851934|NCT00320528|617463425|FG001|Study Period III|Withdrawal by Subject|1|||
170851935|NCT00320528|617463426|FG002|Study Period III|Withdrawal by Subject|2|||
170851936|NCT00320528|617463424|FG000|Study Period III|Lack of Efficacy|2|||
170851937|NCT00320528|617463425|FG001|Study Period III|Lack of Efficacy|0|||
170851938|NCT00320528|617463426|FG002|Study Period III|Lack of Efficacy|0|||
170851939|NCT00320528|617463424|FG000|Study Period III|Parent/Caregiver Decision|14|||
170851940|NCT00320528|617463425|FG001|Study Period III|Parent/Caregiver Decision|3|||
170851941|NCT00320528|617463426|FG002|Study Period III|Parent/Caregiver Decision|11|||
170851942|NCT00320528|617463424|FG000|Study Period III|Protocol Violation|0|||
170851943|NCT00320528|617463425|FG001|Study Period III|Protocol Violation|1|||
170851944|NCT00320528|617463426|FG002|Study Period III|Protocol Violation|0|||
170851945|NCT00320528|617463424|FG000|Study Period III|Physician Decision|0|||
170851946|NCT00320528|617463425|FG001|Study Period III|Physician Decision|1|||
170851947|NCT00320528|617463426|FG002|Study Period III|Physician Decision|2|||
170851948|NCT00320528|617463424|FG000|Study Period III|Sponsor Decision|0|||
170851949|NCT00320528|617463425|FG001|Study Period III|Sponsor Decision|0|||
170851950|NCT00320528|617463426|FG002|Study Period III|Sponsor Decision|1|||
170851951|NCT00320528|617463424|FG000|Study Period III|Atomoxetine Commercially Available|68|||
170851952|NCT00320528|617463425|FG001|Study Period III|Atomoxetine Commercially Available|25|||
170851953|NCT00320528|617463426|FG002|Study Period III|Atomoxetine Commercially Available|90|||
170851954|NCT01934790|617463428|FG000|Treatment|Adverse Event|3|||
170851955|NCT01934790|617463428|FG000|Treatment|Clinical progression|6|||
170851956|NCT01934790|617463428|FG000|Treatment|Radiological progression|4|||
170851957|NCT01934790|617463428|FG000|Treatment|Withdrawal by Subject|2|||
170851958|NCT01934790|617463428|FG000|Treatment|Study drug never administered|1|||
170851959|NCT01934790|617463428|FG000|Active Follow up|Death|20|||
170851960|NCT01934790|617463428|FG000|Active Follow up|Physician Decision|2|||
170851961|NCT01934790|617463428|FG000|Active Follow up|Progressive disease|1|||
170851962|NCT01934790|617463428|FG000|Active Follow up|Other reason|1|||
170851963|NCT00552929|617463429|FG000|Overall Study|Lost to Follow-up|0|||
170851964|NCT00552929|617463430|FG001|Overall Study|Lost to Follow-up|0|||
170851965|NCT00552929|617463431|FG002|Overall Study|Lost to Follow-up|0|||
170851966|NCT00552929|617463432|FG003|Overall Study|Lost to Follow-up|0|||
170851967|NCT00552929|617463433|FG004|Overall Study|Lost to Follow-up|0|||
170851968|NCT00552929|617463434|FG005|Overall Study|Lost to Follow-up|0|||
170851969|NCT00552929|617463435|FG006|Overall Study|Lost to Follow-up|0|||
170851970|NCT00552929|617463436|FG007|Overall Study|Lost to Follow-up|0|||
170851971|NCT00552929|617463437|FG008|Overall Study|Lost to Follow-up|1|||
170851972|NCT00552929|617463438|FG009|Overall Study|Lost to Follow-up|0|||
170851973|NCT00552929|617463429|FG000|Overall Study|Not Eligible|0|||
170851974|NCT00552929|617463430|FG001|Overall Study|Not Eligible|0|||
170851975|NCT00552929|617463431|FG002|Overall Study|Not Eligible|0|||
170851976|NCT00552929|617463432|FG003|Overall Study|Not Eligible|0|||
170851977|NCT00552929|617463433|FG004|Overall Study|Not Eligible|0|||
170851978|NCT00552929|617463434|FG005|Overall Study|Not Eligible|1|||
170851979|NCT00552929|617463435|FG006|Overall Study|Not Eligible|0|||
170851980|NCT00552929|617463436|FG007|Overall Study|Not Eligible|0|||
170851981|NCT00552929|617463437|FG008|Overall Study|Not Eligible|0|||
170851982|NCT00552929|617463438|FG009|Overall Study|Not Eligible|0|||
170851983|NCT03762200|617463444|FG000|Overall Study|Death|2|||
170851984|NCT02592876|617463451|FG000|Overall Study|Withdrawal by Subject|3|||
170851985|NCT02592876|617463452|FG001|Overall Study|Withdrawal by Subject|3|||
170851986|NCT02592876|617463451|FG000|Overall Study|Study Termination by Sponsor|32|||
170851987|NCT02592876|617463452|FG001|Overall Study|Study Termination by Sponsor|27|||
170851988|NCT02592876|617463451|FG000|Overall Study|Lost to Follow-up|0|||
170851989|NCT02592876|617463452|FG001|Overall Study|Lost to Follow-up|1|||
170851990|NCT02592876|617463451|FG000|Overall Study|Death|6|||
170851991|NCT02592876|617463452|FG001|Overall Study|Death|9|||
170851992|NCT01865747|617463453|FG000|Overall Study (ITT)|Adverse Event|32|||
170851993|NCT01865747|617463454|FG001|Overall Study (ITT)|Adverse Event|31|||
170851994|NCT01865747|617463453|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
170851995|NCT01865747|617463454|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
170851996|NCT01865747|617463453|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
170851997|NCT01865747|617463454|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
170851998|NCT01865747|617463453|FG000|Overall Study (ITT)|Protocol Violation|1|||
170851999|NCT01865747|617463454|FG001|Overall Study (ITT)|Protocol Violation|1|||
170852000|NCT01865747|617463453|FG000|Overall Study (ITT)|Physician Decision|5|||
170852001|NCT01865747|617463454|FG001|Overall Study (ITT)|Physician Decision|2|||
170852002|NCT01865747|617463453|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
170852003|NCT01865747|617463454|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
170852004|NCT01865747|617463453|FG000|Overall Study (ITT)|Sponsor Decision|0|||
170852005|NCT01865747|617463454|FG001|Overall Study (ITT)|Sponsor Decision|1|||
170852006|NCT01865747|617463453|FG000|Overall Study (ITT)|Progressive Disease|122|||
170852007|NCT01865747|617463454|FG001|Overall Study (ITT)|Progressive Disease|158|||
170852008|NCT01865747|617463453|FG000|Overall Study (ITT)|Reason Not Provided|0|||
170852009|NCT01865747|617463454|FG001|Overall Study (ITT)|Reason Not Provided|1|||
170852010|NCT01865747|617463453|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
170852011|NCT01865747|617463454|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
170852012|NCT01865747|617463453|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
170852013|NCT01865747|617463454|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
170852014|NCT01865747|617463453|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
170852015|NCT01865747|617463454|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
170852016|NCT01865747|617463453|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
170852017|NCT01865747|617463454|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
170852018|NCT01865747|617463453|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
170852019|NCT01865747|617463454|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
170852020|NCT01865747|617463453|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
170852021|NCT01865747|617463454|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
170852022|NCT01865747|617463453|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
170852023|NCT01865747|617463454|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
170852024|NCT01865747|617463453|FG000|Primary Intent to Treat (PITT)|Other|0|||
170852025|NCT01865747|617463454|FG001|Primary Intent to Treat (PITT)|Other|1|||
170852026|NCT00611975|617463455|FG000|Overall Study|Withdrawal by Subject|3|||
170852027|NCT00611975|617463456|FG001|Overall Study|Withdrawal by Subject|7|||
170852028|NCT00611975|617463455|FG000|Overall Study|Pregnancy|2|||
170852029|NCT00611975|617463456|FG001|Overall Study|Pregnancy|1|||
170852030|NCT05618912|617463457|FG000|Overall Study|Lost to Follow-up|14|||
170852031|NCT05618912|617463458|FG001|Overall Study|Lost to Follow-up|19|||
170852032|NCT02924428|617464775|FG000|Overall Study|Adverse Event|1|||
170852033|NCT02924428|617464776|FG001|Overall Study|Adverse Event|0|||
170852034|NCT02924428|617464775|FG000|Overall Study|Physician Decision|1|||
170852035|NCT02924428|617464776|FG001|Overall Study|Physician Decision|0|||
170852036|NCT02924428|617464775|FG000|Overall Study|Lost to Follow-up|2|||
170852037|NCT02924428|617464776|FG001|Overall Study|Lost to Follow-up|4|||
170852038|NCT02924428|617464775|FG000|Overall Study|Pregnancy|0|||
170852039|NCT02924428|617464776|FG001|Overall Study|Pregnancy|1|||
170852040|NCT02704754|617464777|FG000|Overall Study|Lost to Follow-up|1|||
170852041|NCT02704754|617464778|FG001|Overall Study|Lost to Follow-up|1|||
170852042|NCT02704754|617464777|FG000|Overall Study|Lack of Efficacy|1|||
170852043|NCT02704754|617464778|FG001|Overall Study|Lack of Efficacy|0|||
170852044|NCT02704754|617464777|FG000|Overall Study|Withdrawal by Subject|1|||
170852045|NCT02704754|617464778|FG001|Overall Study|Withdrawal by Subject|0|||
170852046|NCT00423943|617464779|FG000|Overall Study|Withdrawal by Subject|3|||
170852047|NCT00423943|617464780|FG001|Overall Study|Withdrawal by Subject|1|||
170852048|NCT03730480|617464781|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
170852049|NCT04097301|617464782|FG000|Overall Study|Death|1|||
170852050|NCT04097301|617464782|FG000|Overall Study|Withdrawal by Subject|1|||
170852051|NCT04097301|617464782|FG000|Overall Study|Screening Failure|5|||
170852052|NCT01773291|617464786|FG000|Overall Study|Protocol Violation|1|||
170852053|NCT01773291|617464787|FG001|Overall Study|Protocol Violation|0|||
170852054|NCT01773291|617464788|FG002|Overall Study|Protocol Violation|0|||
170852055|NCT01773291|617464786|FG000|Overall Study|Withdrawal by Subject|0|||
170852056|NCT01773291|617464787|FG001|Overall Study|Withdrawal by Subject|0|||
170852057|NCT01773291|617464788|FG002|Overall Study|Withdrawal by Subject|1|||
170852058|NCT01403610|617464789|FG000|Overall Study|Withdrawal by Subject|2|||
170852059|NCT01403610|617464790|FG001|Overall Study|Withdrawal by Subject|0|||
170852060|NCT01403610|617464791|FG002|Overall Study|Withdrawal by Subject|0|||
170852061|NCT01403610|617464792|FG003|Overall Study|Withdrawal by Subject|0|||
170852062|NCT01403610|617464789|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
170852063|NCT01403610|617464790|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
170852064|NCT01403610|617464791|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
170852065|NCT01403610|617464792|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
170852066|NCT00107120|617464793|FG000|Overall Study|Adverse Event|4|||
170852067|NCT00107120|617464794|FG001|Overall Study|Adverse Event|1|||
170852068|NCT00107120|617464793|FG000|Overall Study|Lack of Efficacy|5|||
170852069|NCT00107120|617464794|FG001|Overall Study|Lack of Efficacy|5|||
170852070|NCT00107120|617464793|FG000|Overall Study|Protocol Violation|3|||
170852071|NCT00107120|617464794|FG001|Overall Study|Protocol Violation|0|||
170852072|NCT00107120|617464793|FG000|Overall Study|Withdrawal by Subject|8|||
170852073|NCT00107120|617464794|FG001|Overall Study|Withdrawal by Subject|9|||
170852074|NCT00107120|617464793|FG000|Overall Study|Lost to Follow-up|8|||
170852075|NCT00107120|617464794|FG001|Overall Study|Lost to Follow-up|6|||
170852076|NCT00107120|617464793|FG000|Overall Study|Pregnancy|0|||
170852077|NCT00107120|617464794|FG001|Overall Study|Pregnancy|1|||
170852078|NCT00107120|617464793|FG000|Overall Study|moving away from site|1|||
170852079|NCT00107120|617464794|FG001|Overall Study|moving away from site|1|||
170852080|NCT00107120|617464793|FG000|Overall Study|death of parent|0|||
170852081|NCT00107120|617464794|FG001|Overall Study|death of parent|1|||
170852082|NCT03241225|617464795|FG000|Overall Study|Lost to Follow-up|2|||
170852083|NCT03241225|617464796|FG001|Overall Study|Lost to Follow-up|1|||
170852084|NCT03241225|617464795|FG000|Overall Study|Protocol Violation|4|||
170852085|NCT03241225|617464796|FG001|Overall Study|Protocol Violation|1|||
170852086|NCT03241225|617464795|FG000|Overall Study|Withdrawal by Subject|1|||
170852087|NCT03241225|617464796|FG001|Overall Study|Withdrawal by Subject|0|||
170852088|NCT00686725|617464797|FG000|Overall Study|Adverse Event|1|||
170852089|NCT00686725|617464798|FG001|Overall Study|Adverse Event|1|||
170852090|NCT00686725|617464797|FG000|Overall Study|Progressive Disease|17|||
170852091|NCT00686725|617464798|FG001|Overall Study|Progressive Disease|23|||
170852092|NCT00686725|617464797|FG000|Overall Study|Lost to Follow-up|7|||
170852093|NCT00686725|617464798|FG001|Overall Study|Lost to Follow-up|5|||
170852094|NCT00686725|617464797|FG000|Overall Study|Death|6|||
170852095|NCT00686725|617464798|FG001|Overall Study|Death|3|||
170852096|NCT00686725|617464797|FG000|Overall Study|Withdrawal by Subject|13|||
170852097|NCT00686725|617464798|FG001|Overall Study|Withdrawal by Subject|4|||
170852098|NCT00686725|617464797|FG000|Overall Study|Protocol Violation|1|||
170852099|NCT00686725|617464798|FG001|Overall Study|Protocol Violation|3|||
170852100|NCT00686725|617464797|FG000|Overall Study|Other|1|||
170852101|NCT00686725|617464798|FG001|Overall Study|Other|3|||
170852102|NCT03064035|617464799|FG000|Overall Study|Did not receive allocated intervention|4|||
170852103|NCT03064035|617464800|FG001|Overall Study|Did not receive allocated intervention|2|||
170852104|NCT03064035|617464799|FG000|Overall Study|Lost to Follow-up|1|||
170852105|NCT03064035|617464800|FG001|Overall Study|Lost to Follow-up|1|||
170852106|NCT03507777|617464801|FG000|Overall Study|Lost to Follow-up|5|||
170852107|NCT03507777|617464802|FG001|Overall Study|Lost to Follow-up|7|||
170740571|NCT00720902|617057900|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
170740572|NCT00720902|617057901|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
170740573|NCT01189890|617057904|FG000|Overall Study|Adverse Event|3|||
170740574|NCT01189890|617057905|FG001|Overall Study|Adverse Event|4|||
170740575|NCT01189890|617057904|FG000|Overall Study|Lack of Efficacy|7|||
170740576|NCT01189890|617057905|FG001|Overall Study|Lack of Efficacy|2|||
170740577|NCT01189890|617057904|FG000|Overall Study|Lost to Follow-up|1|||
170740578|NCT01189890|617057905|FG001|Overall Study|Lost to Follow-up|7|||
170740579|NCT01189890|617057904|FG000|Overall Study|Protocol Violation|1|||
170740580|NCT01189890|617057905|FG001|Overall Study|Protocol Violation|5|||
170740581|NCT01189890|617057904|FG000|Overall Study|Withdrawal by Subject|15|||
170740582|NCT01189890|617057905|FG001|Overall Study|Withdrawal by Subject|11|||
170740583|NCT01189890|617057904|FG000|Overall Study|Non Compliance|0|||
170740584|NCT01189890|617057905|FG001|Overall Study|Non Compliance|1|||
170740585|NCT01189890|617057904|FG000|Overall Study|Physician Decision|5|||
170740586|NCT01189890|617057905|FG001|Overall Study|Physician Decision|4|||
170740587|NCT01189890|617057904|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
170740588|NCT01189890|617057905|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
170740589|NCT01161472|617057915|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
170740590|NCT01161472|617057916|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
170740591|NCT01161472|617057917|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
170740592|NCT01161472|617057918|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
170740593|NCT00003511|617057919|FG000|Overall Study|Not evaluable|4|||
170740594|NCT00798174|617057920|FG000|Overall Study|inability to implant azygos coil|3|||
170740595|NCT00798174|617057921|FG001|Overall Study|inability to implant azygos coil|3|||
170740596|NCT00798174|617057920|FG000|Overall Study|Inability to sedate for DFT testing|1|||
170740597|NCT00798174|617057921|FG001|Overall Study|Inability to sedate for DFT testing|0|||
170740598|NCT03638635|617057925|FG000|Initial Hospitalization|Study terminated prematurely|0|||
170740599|NCT03638635|617057926|FG001|Initial Hospitalization|Study terminated prematurely|1|||
170740600|NCT03638635|617057925|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
170740601|NCT03638635|617057926|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
170740602|NCT03638635|617057925|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
170740603|NCT03638635|617057926|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
170740604|NCT00423293|617057927|FG000|Overall Study|Ineligible / No protocol treatment|11|||
170740605|NCT03980184|617057929|FG000|Overall Study|Dropped out before treatment|2|||
170740606|NCT03980184|617057930|FG001|Overall Study|Dropped out before treatment|2|||
170740607|NCT03980184|617057929|FG000|Overall Study|Lost to Follow-up|11|||
170740608|NCT03980184|617057930|FG001|Overall Study|Lost to Follow-up|13|||
170740609|NCT00791921|617057931|FG000|Overall Study|Protocol planed|24|||
170852108|NCT03507777|617464801|FG000|Overall Study|Withdrawal by Subject|6|||
170852109|NCT03507777|617464802|FG001|Overall Study|Withdrawal by Subject|11|||
170852110|NCT03507777|617464801|FG000|Overall Study|Death|30|||
170852111|NCT03507777|617464802|FG001|Overall Study|Death|44|||
170852112|NCT03507777|617464801|FG000|Overall Study|Other Reasons|3|||
170852113|NCT03507777|617464802|FG001|Overall Study|Other Reasons|8|||
170852114|NCT01346475|617464806|FG000|First Intervention|Lost to Follow-up|4|||
170852115|NCT01346475|617464807|FG001|First Intervention|Lost to Follow-up|3|||
170852116|NCT00618618|617464808|FG000|Overall Study|Patient Request|0|||
170852117|NCT00618618|617464809|FG001|Overall Study|Patient Request|0|||
170852118|NCT00618618|617464810|FG002|Overall Study|Patient Request|2|||
170852119|NCT00618618|617464811|FG003|Overall Study|Patient Request|0|||
170852120|NCT00618618|617464808|FG000|Overall Study|Inability to Complete Study Procedures|0|||
170852121|NCT00618618|617464809|FG001|Overall Study|Inability to Complete Study Procedures|1|||
170852122|NCT00618618|617464810|FG002|Overall Study|Inability to Complete Study Procedures|0|||
170852123|NCT00618618|617464811|FG003|Overall Study|Inability to Complete Study Procedures|0|||
170852124|NCT00618618|617464808|FG000|Overall Study|Lost to Follow-up|3|||
170852125|NCT00618618|617464809|FG001|Overall Study|Lost to Follow-up|0|||
170852126|NCT00618618|617464810|FG002|Overall Study|Lost to Follow-up|0|||
170852127|NCT00618618|617464811|FG003|Overall Study|Lost to Follow-up|1|||
170852128|NCT00618618|617464808|FG000|Overall Study|Non-compliance|1|||
170852129|NCT00618618|617464809|FG001|Overall Study|Non-compliance|1|||
170852130|NCT00618618|617464810|FG002|Overall Study|Non-compliance|0|||
170740610|NCT00791921|617057932|FG001|Overall Study|Protocol planed|88|||
170740611|NCT00791921|617057931|FG000|Overall Study|Withdrawal by Subject|1|||
170740612|NCT00791921|617057932|FG001|Overall Study|Withdrawal by Subject|2|||
170740613|NCT00791921|617057931|FG000|Overall Study|Adverse Event|8|||
170852131|NCT00618618|617464811|FG003|Overall Study|Non-compliance|0|||
170852132|NCT00618618|617464808|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
170852133|NCT00618618|617464809|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
170852134|NCT00618618|617464810|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
170852135|NCT00618618|617464811|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
170740614|NCT00791921|617057932|FG001|Overall Study|Adverse Event|2|||
170740615|NCT00791921|617057931|FG000|Overall Study|Lack of Efficacy|0|||
170740616|NCT00791921|617057932|FG001|Overall Study|Lack of Efficacy|2|||
170740617|NCT00791921|617057931|FG000|Overall Study|Lack of study drug administration|1|||
170740618|NCT00791921|617057932|FG001|Overall Study|Lack of study drug administration|1|||
170740619|NCT00791921|617057931|FG000|Overall Study|Reason other than those above|0|||
170740620|NCT00791921|617057932|FG001|Overall Study|Reason other than those above|1|||
170740621|NCT03587142|617057933|FG000|Overall Study|Lost to Follow-up|5|||
170740622|NCT03587142|617057934|FG001|Overall Study|Lost to Follow-up|3|||
170740623|NCT03587142|617057933|FG000|Overall Study|Did not complete the f4 visit|3|||
170740624|NCT03587142|617057934|FG001|Overall Study|Did not complete the f4 visit|7|||
170740625|NCT02768662|617057935|FG000|Overall Study|Adverse Event|1|||
170740626|NCT02768662|617057935|FG000|Overall Study|Lost to Follow-up|4|||
170740627|NCT02768662|617057935|FG000|Overall Study|Withdrawal by Subject|3|||
170740628|NCT02768662|617057935|FG000|Overall Study|Study terminated by Sponsor|78|||
170740629|NCT03097861|617057937|FG000|Overall Study|Adverse Event|3|||
170740630|NCT03097861|617057938|FG001|Overall Study|Adverse Event|8|||
170740631|NCT03097861|617057939|FG002|Overall Study|Adverse Event|4|||
170740632|NCT03097861|617057937|FG000|Overall Study|Investigator Decision|0|||
170740633|NCT03097861|617057938|FG001|Overall Study|Investigator Decision|1|||
170740634|NCT03097861|617057939|FG002|Overall Study|Investigator Decision|0|||
170740635|NCT03097861|617057937|FG000|Overall Study|Lost to Follow-up|0|||
170740636|NCT03097861|617057938|FG001|Overall Study|Lost to Follow-up|7|||
170740637|NCT03097861|617057939|FG002|Overall Study|Lost to Follow-up|1|||
170740638|NCT03097861|617057937|FG000|Overall Study|Withdrawal by Subject|1|||
170740639|NCT03097861|617057938|FG001|Overall Study|Withdrawal by Subject|5|||
170740640|NCT03097861|617057939|FG002|Overall Study|Withdrawal by Subject|3|||
170740641|NCT03097861|617057937|FG000|Overall Study|Reason not provided|3|||
170740642|NCT03097861|617057938|FG001|Overall Study|Reason not provided|1|||
170740643|NCT03097861|617057939|FG002|Overall Study|Reason not provided|1|||
170740644|NCT04503096|617057942|FG000|Overall Study|Withdrawal by Subject|3|||
170740645|NCT01872910|617057944|FG000|Overall Study|Lost to Follow-up|2|||
170740646|NCT01872910|617057945|FG001|Overall Study|Lost to Follow-up|0|||
170740647|NCT01872910|617057946|FG002|Overall Study|Lost to Follow-up|2|||
170740648|NCT01872910|617057947|FG003|Overall Study|Lost to Follow-up|0|||
170740649|NCT01872910|617057948|FG004|Overall Study|Lost to Follow-up|0|||
170740650|NCT01872910|617057949|FG005|Overall Study|Lost to Follow-up|0|||
170740651|NCT00744328|617057950|FG000|Overall Study|Lost to Follow-up|2|||
170740652|NCT00744328|617057951|FG001|Overall Study|Lost to Follow-up|5|||
170852136|NCT00618618|617464808|FG000|Overall Study|Death|0|||
170852137|NCT00618618|617464809|FG001|Overall Study|Death|1|||
170740653|NCT00744328|617057952|FG002|Overall Study|Lost to Follow-up|3|||
170740654|NCT00744328|617057950|FG000|Overall Study|Withdrawal by Subject|5|||
170740655|NCT00744328|617057951|FG001|Overall Study|Withdrawal by Subject|3|||
170852138|NCT00618618|617464810|FG002|Overall Study|Death|0|||
170852139|NCT00618618|617464811|FG003|Overall Study|Death|0|||
170740656|NCT00744328|617057952|FG002|Overall Study|Withdrawal by Subject|4|||
170740657|NCT00744328|617057950|FG000|Overall Study|Found ineligible after randomization|0|||
170740658|NCT00744328|617057951|FG001|Overall Study|Found ineligible after randomization|0|||
170740659|NCT00744328|617057952|FG002|Overall Study|Found ineligible after randomization|1|||
170740660|NCT01576367|617057953|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170740661|NCT01576367|617057953|FG000|Overall Study|Moved to commercial use after 6 months|1|||
170740662|NCT02387216|617057954|FG000|Overall Study|Progressive disease|2|||
170740663|NCT02387216|617057955|FG001|Overall Study|Progressive disease|0|||
170740664|NCT02387216|617057954|FG000|Overall Study|Withdrawal by Subject|3|||
170740665|NCT02387216|617057955|FG001|Overall Study|Withdrawal by Subject|5|||
170740666|NCT02387216|617057954|FG000|Overall Study|Physician Decision|2|||
170740667|NCT02387216|617057955|FG001|Overall Study|Physician Decision|0|||
170740668|NCT02387216|617057954|FG000|Overall Study|Sponsor Decision|28|||
170740669|NCT02387216|617057955|FG001|Overall Study|Sponsor Decision|12|||
170740670|NCT02387216|617057954|FG000|Overall Study|Death|60|||
170740671|NCT02387216|617057955|FG001|Overall Study|Death|23|||
170740672|NCT02387216|617057954|FG000|Overall Study|Other|5|||
170740673|NCT02387216|617057955|FG001|Overall Study|Other|4|||
170740674|NCT02387216|617057954|FG000|Overall Study|Lost to Follow-up|0|||
170740675|NCT02387216|617057955|FG001|Overall Study|Lost to Follow-up|3|||
170740676|NCT03447730|617057956|FG000|Overall Study|Adverse Event|0|||
170740677|NCT03447730|617057957|FG001|Overall Study|Adverse Event|2|||
170740678|NCT03447730|617057958|FG002|Overall Study|Adverse Event|0|||
170740679|NCT01827254|617057959|FG000|Overall Study|Death|10|||
170740680|NCT01827254|617057959|FG000|Overall Study|Case report form not completed|4|||
170740681|NCT01827254|617057959|FG000|Overall Study|Invalidated centre|3|||
170740682|NCT01827254|617057959|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
170740683|NCT01827254|617057959|FG000|Overall Study|Did not complete re-challenge|1|||
170740684|NCT01827254|617057959|FG000|Overall Study|Disease progression|36|||
170740685|NCT01827254|617057959|FG000|Overall Study|Intolerance to treatment|4|||
170740686|NCT04702568|617057960|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
170740687|NCT04702568|617057961|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
170740688|NCT04702568|617057960|FG000|Overall Study|Pregnancy|1|||
170740689|NCT04702568|617057961|FG001|Overall Study|Pregnancy|0|||
170740690|NCT04702568|617057960|FG000|Overall Study|Bone marrow transplant|1|||
170740691|NCT04702568|617057961|FG001|Overall Study|Bone marrow transplant|0|||
170740692|NCT04702568|617057960|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
170740693|NCT04702568|617057961|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
170740694|NCT04702568|617057960|FG000|Overall Study|Withdrawal by Subject|0|||
170740695|NCT04702568|617057961|FG001|Overall Study|Withdrawal by Subject|2|||
170740696|NCT00744263|617057968|FG000|Overall Study|Death|3006|||
170740697|NCT00744263|617057969|FG001|Overall Study|Death|3005|||
170740698|NCT00744263|617057968|FG000|Overall Study|Lost to Follow-up|2038|||
170740699|NCT00744263|617057969|FG001|Overall Study|Lost to Follow-up|2135|||
170740700|NCT00744263|617057968|FG000|Overall Study|Withdrawal by Subject|166|||
170740701|NCT00744263|617057969|FG001|Overall Study|Withdrawal by Subject|150|||
170740702|NCT00744263|617057968|FG000|Overall Study|Physician Decision|20|||
170740703|NCT00744263|617057969|FG001|Overall Study|Physician Decision|23|||
170740704|NCT00744263|617057968|FG000|Overall Study|Protocol Violation|3|||
170740705|NCT00744263|617057969|FG001|Overall Study|Protocol Violation|5|||
170740706|NCT00744263|617057968|FG000|Overall Study|Adverse Event|1|||
170740707|NCT00744263|617057969|FG001|Overall Study|Adverse Event|0|||
170740708|NCT00744263|617057968|FG000|Overall Study|Other|2|||
170740709|NCT00744263|617057969|FG001|Overall Study|Other|2|||
170740710|NCT01913639|617057970|FG000|Overall Study|Not Eligible|3|||
170740711|NCT01225822|617057980|FG000|Overall Study|Adverse Event|13|||
170740712|NCT01225822|617057981|FG001|Overall Study|Adverse Event|31|||
170740713|NCT01225822|617057982|FG002|Overall Study|Adverse Event|18|||
170740714|NCT01225822|617057983|FG003|Overall Study|Adverse Event|23|||
170740715|NCT01225822|617057984|FG004|Overall Study|Adverse Event|14|||
170740716|NCT01225822|617057980|FG000|Overall Study|Protocol Violation|6|||
170740717|NCT01225822|617057981|FG001|Overall Study|Protocol Violation|8|||
170740718|NCT01225822|617057982|FG002|Overall Study|Protocol Violation|6|||
170740719|NCT01225822|617057983|FG003|Overall Study|Protocol Violation|7|||
170740720|NCT01225822|617057984|FG004|Overall Study|Protocol Violation|4|||
170740721|NCT01225822|617057980|FG000|Overall Study|Lost to Follow-up|0|||
170740722|NCT01225822|617057981|FG001|Overall Study|Lost to Follow-up|0|||
170740723|NCT01225822|617057982|FG002|Overall Study|Lost to Follow-up|0|||
170740724|NCT01225822|617057983|FG003|Overall Study|Lost to Follow-up|1|||
170852140|NCT00621777|617464814|FG000|Open Phase|Adverse Event|20|||
170852141|NCT00621777|617464815|FG001|Open Phase|Adverse Event|0|||
170852142|NCT00621777|617464814|FG000|Open Phase|Did not abstain during open phase|56|||
170852143|NCT00621777|617464815|FG001|Open Phase|Did not abstain during open phase|0|||
170852144|NCT00621777|617464814|FG000|Open Phase|Withdrawal by Subject|17|||
170852145|NCT00621777|617464815|FG001|Open Phase|Withdrawal by Subject|0|||
170852146|NCT00621777|617464814|FG000|Open Phase|administrative|13|||
170852147|NCT00621777|617464815|FG001|Open Phase|administrative|0|||
170852148|NCT00621777|617464814|FG000|Open Phase|Lost to Follow-up|10|||
170740725|NCT01225822|617057984|FG004|Overall Study|Lost to Follow-up|0|||
170740726|NCT01225822|617057980|FG000|Overall Study|Withdrawal by Subject|6|||
170740727|NCT01225822|617057981|FG001|Overall Study|Withdrawal by Subject|7|||
170740728|NCT01225822|617057982|FG002|Overall Study|Withdrawal by Subject|7|||
170740729|NCT01225822|617057983|FG003|Overall Study|Withdrawal by Subject|11|||
170740730|NCT01225822|617057984|FG004|Overall Study|Withdrawal by Subject|6|||
170740731|NCT01225822|617057980|FG000|Overall Study|Other|13|||
170740732|NCT01225822|617057981|FG001|Overall Study|Other|10|||
170852149|NCT00621777|617464815|FG001|Open Phase|Lost to Follow-up|0|||
170852150|NCT00621777|617464814|FG000|Randomized Phase|Adverse Event|3|||
170852151|NCT00621777|617464815|FG001|Randomized Phase|Adverse Event|3|||
170852152|NCT00621777|617464814|FG000|Randomized Phase|Lost to Follow-up|3|||
170740733|NCT01225822|617057982|FG002|Overall Study|Other|7|||
170740734|NCT01225822|617057983|FG003|Overall Study|Other|10|||
170740735|NCT01225822|617057984|FG004|Overall Study|Other|7|||
170740736|NCT01290822|617057987|FG000|Overall Study|Withdrawal by Subject|1|||
170740737|NCT01290822|617057987|FG000|Overall Study|Physician Decision|10|||
170740738|NCT00089895|617057988|FG000|Overall Study|Consent Withdrawn|11|||
170740739|NCT00089895|617057989|FG001|Overall Study|Consent Withdrawn|14|||
170740740|NCT00089895|617057988|FG000|Overall Study|Technical reason|7|||
170740741|NCT00089895|617057989|FG001|Overall Study|Technical reason|2|||
170740742|NCT00089895|617057988|FG000|Overall Study|Surgery|0|||
170740743|NCT00089895|617057989|FG001|Overall Study|Surgery|1|||
170740744|NCT00089895|617057988|FG000|Overall Study|Bleeding|0|||
170740745|NCT00089895|617057989|FG001|Overall Study|Bleeding|2|||
170740746|NCT00089895|617057988|FG000|Overall Study|Physician Decision|3|||
170740747|NCT00089895|617057989|FG001|Overall Study|Physician Decision|7|||
170740748|NCT00089895|617057988|FG000|Overall Study|Exclusion criteria met|6|||
170852153|NCT00621777|617464815|FG001|Randomized Phase|Lost to Follow-up|3|||
170852154|NCT00621777|617464814|FG000|Randomized Phase|Withdrawal by Subject|1|||
170852155|NCT00621777|617464815|FG001|Randomized Phase|Withdrawal by Subject|9|||
170852156|NCT00621777|617464814|FG000|Randomized Phase|administrative|0|||
170852157|NCT00621777|617464815|FG001|Randomized Phase|administrative|3|||
170852158|NCT00621777|617464814|FG000|Randomized Phase|Death|0|||
170740749|NCT00089895|617057989|FG001|Overall Study|Exclusion criteria met|6|||
170740750|NCT00089895|617057988|FG000|Overall Study|Not otherwise specified|4|||
170740751|NCT00089895|617057989|FG001|Overall Study|Not otherwise specified|8|||
170852159|NCT00621777|617464815|FG001|Randomized Phase|Death|1|||
170852160|NCT02121301|617464820|FG000|Overall Study|Protocol Violation|1|||
170852161|NCT02121301|617464821|FG001|Overall Study|Protocol Violation|4|||
170852162|NCT02121301|617464822|FG002|Overall Study|Protocol Violation|1|||
170852163|NCT00993668|617464826|FG000|Single-Blind Period|Adverse Event|1|||
170740752|NCT00089895|617057988|FG000|Overall Study|Missing|4|||
170740753|NCT00089895|617057989|FG001|Overall Study|Missing|2|||
170740754|NCT04078035|617057990|FG000|Session 2|Lost to Follow-up|3|||
170852164|NCT00993668|617464827|FG001|Single-Blind Period|Adverse Event|1|||
170740755|NCT04078035|617057991|FG001|Session 2|Lost to Follow-up|1|||
170740756|NCT04078035|617057990|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
170740757|NCT04078035|617057991|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
170740758|NCT04296890|617057994|FG000|Overall Study|Withdrawal by Subject|1|||
170740759|NCT04296890|617057994|FG000|Overall Study|Death|62|||
170740760|NCT04296890|617057994|FG000|Overall Study|Lost to Follow-up|3|||
170740761|NCT04296890|617057994|FG000|Overall Study|Other than specified|2|||
170740762|NCT02100722|617057995|FG000|Overall Study|Withdrawal pre-procedure|4|||
170740763|NCT02100722|617057996|FG001|Overall Study|Withdrawal pre-procedure|9|||
170740764|NCT02100722|617057995|FG000|Overall Study|Withdrawal post-procedure|0|||
170740765|NCT02100722|617057996|FG001|Overall Study|Withdrawal post-procedure|3|||
170740766|NCT02100722|617057995|FG000|Overall Study|Lost to Follow-up|2|||
170740767|NCT02100722|617057996|FG001|Overall Study|Lost to Follow-up|2|||
170740768|NCT02100722|617057995|FG000|Overall Study|Continuing on study|751|||
170740769|NCT02100722|617057996|FG001|Overall Study|Continuing on study|729|||
170740770|NCT05644353|617057997|FG000|Overall Study|Physician Decision|1|||
170740771|NCT05644353|617057998|FG001|Overall Study|Physician Decision|0|||
170740772|NCT05644353|617057999|FG002|Overall Study|Physician Decision|0|||
170740773|NCT05644353|617058000|FG003|Overall Study|Physician Decision|0|||
170740774|NCT05644353|617058001|FG004|Overall Study|Physician Decision|0|||
170740775|NCT05644353|617058002|FG005|Overall Study|Physician Decision|0|||
170740776|NCT05644353|617057997|FG000|Overall Study|Protocol Violation|1|||
170740777|NCT05644353|617057998|FG001|Overall Study|Protocol Violation|0|||
170740778|NCT05644353|617057999|FG002|Overall Study|Protocol Violation|0|||
170740779|NCT05644353|617058000|FG003|Overall Study|Protocol Violation|0|||
170740780|NCT05644353|617058001|FG004|Overall Study|Protocol Violation|0|||
170740781|NCT05644353|617058002|FG005|Overall Study|Protocol Violation|0|||
170740782|NCT05644353|617057997|FG000|Overall Study|Withdrawal by Subject|0|||
170740783|NCT05644353|617057998|FG001|Overall Study|Withdrawal by Subject|2|||
170740784|NCT05644353|617057999|FG002|Overall Study|Withdrawal by Subject|0|||
170740785|NCT05644353|617058000|FG003|Overall Study|Withdrawal by Subject|0|||
170740786|NCT05644353|617058001|FG004|Overall Study|Withdrawal by Subject|1|||
170740787|NCT05644353|617058002|FG005|Overall Study|Withdrawal by Subject|0|||
170740788|NCT05644353|617057997|FG000|Overall Study|Lost to Follow-up|0|||
170740789|NCT05644353|617057998|FG001|Overall Study|Lost to Follow-up|0|||
170740790|NCT05644353|617057999|FG002|Overall Study|Lost to Follow-up|1|||
170740791|NCT05644353|617058000|FG003|Overall Study|Lost to Follow-up|0|||
170740792|NCT05644353|617058001|FG004|Overall Study|Lost to Follow-up|0|||
170740793|NCT05644353|617058002|FG005|Overall Study|Lost to Follow-up|0|||
170740794|NCT04986982|617058003|FG000|Overall Study|Withdrawal by Subject|3|||
170740795|NCT04986982|617058004|FG001|Overall Study|Withdrawal by Subject|1|||
170740796|NCT04986982|617058003|FG000|Overall Study|Lack of Efficacy|0|||
170740797|NCT04986982|617058004|FG001|Overall Study|Lack of Efficacy|2|||
170740798|NCT04986982|617058003|FG000|Overall Study|Ineligibility|3|||
170740799|NCT04986982|617058004|FG001|Overall Study|Ineligibility|0|||
170740800|NCT04986982|617058003|FG000|Overall Study|Adverse Event|4|||
170740801|NCT04986982|617058004|FG001|Overall Study|Adverse Event|4|||
170740802|NCT04986982|617058003|FG000|Overall Study|Lost to Follow-up|0|||
170740803|NCT04986982|617058004|FG001|Overall Study|Lost to Follow-up|1|||
170740804|NCT04986982|617058003|FG000|Overall Study|Sponsor's discretion|1|||
170740805|NCT04986982|617058004|FG001|Overall Study|Sponsor's discretion|0|||
170740806|NCT03500640|617058005|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
170740807|NCT03500640|617058006|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
170740808|NCT03500640|617058007|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
170740809|NCT03500640|617058005|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
170740810|NCT03500640|617058006|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
170740811|NCT03500640|617058007|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
170740812|NCT03500640|617058005|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
170740813|NCT03500640|617058006|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
170740814|NCT03500640|617058007|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
170740815|NCT03500640|617058005|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
170740816|NCT03500640|617058006|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
170740817|NCT03500640|617058007|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
170740818|NCT03500640|617058005|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
170740819|NCT03500640|617058006|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
170740820|NCT03500640|617058007|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
170740821|NCT03500640|617058005|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
170740822|NCT03500640|617058006|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
170740823|NCT03500640|617058007|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
170740824|NCT03500640|617058005|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
170740825|NCT03500640|617058006|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
170740826|NCT03500640|617058007|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
170740827|NCT03500640|617058005|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
170740828|NCT03500640|617058006|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
170740829|NCT03500640|617058007|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
170740830|NCT03500640|617058005|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
170740831|NCT03500640|617058006|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
170740832|NCT03500640|617058007|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
170740833|NCT03500640|617058005|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
170740834|NCT03500640|617058006|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
170740835|NCT03500640|617058007|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
170740836|NCT01122381|617058008|FG000|Overall Study|study terminated early|0|||
170740837|NCT01122381|617058009|FG001|Overall Study|study terminated early|1|||
170740838|NCT00926003|617058015|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
170740839|NCT00926003|617058016|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
170740840|NCT00926003|617058017|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
170740841|NCT00926003|617058015|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
170740842|NCT00926003|617058016|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
170740843|NCT00926003|617058017|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
170740844|NCT01786330|617058019|FG000|Overall Study|Withdrawal by Subject|0|||
170740845|NCT01786330|617058020|FG001|Overall Study|Withdrawal by Subject|1|||
170740846|NCT01786330|617058019|FG000|Overall Study|Lost to Follow-up|0|||
170740847|NCT01786330|617058020|FG001|Overall Study|Lost to Follow-up|1|||
170740848|NCT01786330|617058019|FG000|Overall Study|Excluded intraoperatively|0|||
170740849|NCT01786330|617058020|FG001|Overall Study|Excluded intraoperatively|1|||
170740850|NCT01786330|617058019|FG000|Overall Study|Protocol Violation|1|||
170740851|NCT01786330|617058020|FG001|Overall Study|Protocol Violation|0|||
170740852|NCT03545113|617060280|FG000|Overall Study|Surgery Cancelled|1|||
170740853|NCT03545113|617060281|FG001|Overall Study|Surgery Cancelled|0|||
170740854|NCT03545113|617060280|FG000|Overall Study|Death|1|||
170740855|NCT03545113|617060281|FG001|Overall Study|Death|0|||
170740856|NCT03545113|617060280|FG000|Overall Study|Adverse Event|2|||
170740857|NCT03545113|617060281|FG001|Overall Study|Adverse Event|0|||
170740858|NCT03545113|617060280|FG000|Overall Study|Received different surgery|1|||
170740859|NCT03545113|617060281|FG001|Overall Study|Received different surgery|0|||
170740860|NCT00235443|617060282|FG000|Overall Study|Adverse Event|4|||
170740861|NCT00235443|617060283|FG001|Overall Study|Adverse Event|12|||
170740862|NCT00235443|617060284|FG002|Overall Study|Adverse Event|17|||
170740863|NCT00235443|617060285|FG003|Overall Study|Adverse Event|44|||
170740864|NCT00235443|617060286|FG004|Overall Study|Adverse Event|10|||
170740865|NCT00235443|617060287|FG005|Overall Study|Adverse Event|15|||
170740866|NCT00235443|617060282|FG000|Overall Study|Lack of Efficacy|0|||
170740867|NCT00235443|617060283|FG001|Overall Study|Lack of Efficacy|1|||
170740868|NCT00235443|617060284|FG002|Overall Study|Lack of Efficacy|5|||
170740869|NCT00235443|617060285|FG003|Overall Study|Lack of Efficacy|12|||
170740870|NCT00235443|617060286|FG004|Overall Study|Lack of Efficacy|2|||
170740871|NCT00235443|617060287|FG005|Overall Study|Lack of Efficacy|9|||
170740872|NCT00235443|617060282|FG000|Overall Study|Withdrawal by Subject|3|||
170740873|NCT00235443|617060283|FG001|Overall Study|Withdrawal by Subject|9|||
170740874|NCT00235443|617060284|FG002|Overall Study|Withdrawal by Subject|25|||
170740875|NCT00235443|617060285|FG003|Overall Study|Withdrawal by Subject|24|||
170740876|NCT00235443|617060286|FG004|Overall Study|Withdrawal by Subject|10|||
170740877|NCT00235443|617060287|FG005|Overall Study|Withdrawal by Subject|12|||
170740878|NCT00235443|617060282|FG000|Overall Study|Lost to Follow-up|0|||
170740879|NCT00235443|617060283|FG001|Overall Study|Lost to Follow-up|8|||
170740880|NCT00235443|617060284|FG002|Overall Study|Lost to Follow-up|6|||
170740881|NCT00235443|617060285|FG003|Overall Study|Lost to Follow-up|6|||
170740882|NCT00235443|617060286|FG004|Overall Study|Lost to Follow-up|4|||
170740883|NCT00235443|617060287|FG005|Overall Study|Lost to Follow-up|3|||
170740884|NCT00235443|617060282|FG000|Overall Study|Unsatisfactory compliance|0|||
170740885|NCT00235443|617060283|FG001|Overall Study|Unsatisfactory compliance|2|||
170740886|NCT00235443|617060284|FG002|Overall Study|Unsatisfactory compliance|3|||
170740887|NCT00235443|617060285|FG003|Overall Study|Unsatisfactory compliance|4|||
170740888|NCT00235443|617060286|FG004|Overall Study|Unsatisfactory compliance|1|||
170740889|NCT00235443|617060287|FG005|Overall Study|Unsatisfactory compliance|0|||
170740890|NCT00235443|617060282|FG000|Overall Study|Other reasons for premature termination|1|||
170740891|NCT00235443|617060283|FG001|Overall Study|Other reasons for premature termination|6|||
170740892|NCT00235443|617060284|FG002|Overall Study|Other reasons for premature termination|6|||
170740893|NCT00235443|617060285|FG003|Overall Study|Other reasons for premature termination|7|||
170740894|NCT00235443|617060286|FG004|Overall Study|Other reasons for premature termination|3|||
170740895|NCT00235443|617060287|FG005|Overall Study|Other reasons for premature termination|6|||
170740896|NCT00474929|617060291|FG000|Overall Study|Withdrawal by Subject|0|||
170740897|NCT00474929|617060292|FG001|Overall Study|Withdrawal by Subject|1|||
170740898|NCT00474929|617060293|FG002|Overall Study|Withdrawal by Subject|0|||
170740899|NCT00474929|617060294|FG003|Overall Study|Withdrawal by Subject|0|||
170740900|NCT00474929|617060295|FG004|Overall Study|Withdrawal by Subject|0|||
170740901|NCT00474929|617060291|FG000|Overall Study|Unrelated medical condition|0|||
170740902|NCT00474929|617060292|FG001|Overall Study|Unrelated medical condition|0|||
170740903|NCT00474929|617060293|FG002|Overall Study|Unrelated medical condition|1|||
170740904|NCT00474929|617060294|FG003|Overall Study|Unrelated medical condition|0|||
170740905|NCT00474929|617060295|FG004|Overall Study|Unrelated medical condition|0|||
170740906|NCT00474929|617060291|FG000|Overall Study|Physician Decision|0|||
170740907|NCT00474929|617060292|FG001|Overall Study|Physician Decision|0|||
170740908|NCT00474929|617060293|FG002|Overall Study|Physician Decision|1|||
170740909|NCT00474929|617060294|FG003|Overall Study|Physician Decision|2|||
170740910|NCT00474929|617060295|FG004|Overall Study|Physician Decision|0|||
170740911|NCT03661996|617060298|FG000|Overall Study|Adverse Event|0|||
170740912|NCT03661996|617060299|FG001|Overall Study|Adverse Event|0|||
170740913|NCT03661996|617060300|FG002|Overall Study|Adverse Event|1|||
170740914|NCT03661996|617060301|FG003|Overall Study|Adverse Event|1|||
170740915|NCT03661996|617060302|FG004|Overall Study|Adverse Event|0|||
170740916|NCT03661996|617060298|FG000|Overall Study|Lost to Follow-up|5|||
170740917|NCT03661996|617060299|FG001|Overall Study|Lost to Follow-up|1|||
170740918|NCT03661996|617060300|FG002|Overall Study|Lost to Follow-up|2|||
170740919|NCT03661996|617060301|FG003|Overall Study|Lost to Follow-up|2|||
170740920|NCT03661996|617060302|FG004|Overall Study|Lost to Follow-up|6|||
170740921|NCT03661996|617060298|FG000|Overall Study|Physician Decision|1|||
170740922|NCT03661996|617060299|FG001|Overall Study|Physician Decision|1|||
170740923|NCT03661996|617060300|FG002|Overall Study|Physician Decision|1|||
170740924|NCT03661996|617060301|FG003|Overall Study|Physician Decision|2|||
170740925|NCT03661996|617060302|FG004|Overall Study|Physician Decision|0|||
170740926|NCT03661996|617060298|FG000|Overall Study|Protocol Violation|0|||
170740927|NCT03661996|617060299|FG001|Overall Study|Protocol Violation|0|||
170740928|NCT03661996|617060300|FG002|Overall Study|Protocol Violation|0|||
170740929|NCT03661996|617060301|FG003|Overall Study|Protocol Violation|0|||
170740930|NCT03661996|617060302|FG004|Overall Study|Protocol Violation|1|||
170740931|NCT03661996|617060298|FG000|Overall Study|Withdrawal by Subject|3|||
170740932|NCT03661996|617060299|FG001|Overall Study|Withdrawal by Subject|5|||
170740933|NCT03661996|617060300|FG002|Overall Study|Withdrawal by Subject|1|||
170740934|NCT03661996|617060301|FG003|Overall Study|Withdrawal by Subject|7|||
170740935|NCT03661996|617060302|FG004|Overall Study|Withdrawal by Subject|7|||
170740936|NCT03661996|617060298|FG000|Overall Study|Sponsors Decision|2|||
170740937|NCT03661996|617060299|FG001|Overall Study|Sponsors Decision|0|||
170740938|NCT03661996|617060300|FG002|Overall Study|Sponsors Decision|0|||
170740939|NCT03661996|617060301|FG003|Overall Study|Sponsors Decision|0|||
170740940|NCT03661996|617060302|FG004|Overall Study|Sponsors Decision|0|||
170740941|NCT03661996|617060298|FG000|Overall Study|Other|1|||
170740942|NCT03661996|617060299|FG001|Overall Study|Other|1|||
170740943|NCT03661996|617060300|FG002|Overall Study|Other|1|||
170740944|NCT03661996|617060301|FG003|Overall Study|Other|1|||
170740945|NCT03661996|617060302|FG004|Overall Study|Other|0|||
170740946|NCT03321513|617060303|FG000|Overall Study|Death|11|||
170740947|NCT03321513|617060304|FG001|Overall Study|Death|5|||
170740948|NCT03321513|617060303|FG000|Overall Study|Withdrawal by Subject|5|||
170740949|NCT03321513|617060304|FG001|Overall Study|Withdrawal by Subject|10|||
170740950|NCT03321513|617060303|FG000|Overall Study|Lost to Follow-up|10|||
170740951|NCT03321513|617060304|FG001|Overall Study|Lost to Follow-up|11|||
170740952|NCT03029247|617060305|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
170740953|NCT03029247|617060306|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
170740954|NCT03029247|617060305|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
170740955|NCT03029247|617060306|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
170740956|NCT03029247|617060305|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
170740957|NCT03029247|617060306|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
170740958|NCT03029247|617060305|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
170740959|NCT03029247|617060306|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
170740960|NCT02593305|617060307|FG000|Post 1|Comparison only group. No intervention.|0|||
170740961|NCT02593305|617060308|FG001|Post 1|Comparison only group. No intervention.|0|||
170740962|NCT02593305|617060309|FG002|Post 1|Comparison only group. No intervention.|10|||
170740963|NCT01976364|617060310|FG000|Main Study (36 Months)|Adverse Event|63|||
170740964|NCT01976364|617060311|FG001|Main Study (36 Months)|Adverse Event|0|||
170740965|NCT01976364|617060312|FG002|Main Study (36 Months)|Adverse Event|0|||
170740966|NCT01976364|617060310|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
170740967|NCT01976364|617060311|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
170740968|NCT01976364|617060312|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
170740969|NCT01976364|617060310|FG000|Main Study (36 Months)|Other|13|||
170740970|NCT01976364|617060311|FG001|Main Study (36 Months)|Other|0|||
170740971|NCT01976364|617060312|FG002|Main Study (36 Months)|Other|0|||
170740972|NCT01976364|617060310|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
170740973|NCT01976364|617060311|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
170740974|NCT01976364|617060312|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
170740975|NCT01976364|617060310|FG000|Main Study (36 Months)|Medication error|1|||
170740976|NCT01976364|617060311|FG001|Main Study (36 Months)|Medication error|0|||
170740977|NCT01976364|617060312|FG002|Main Study (36 Months)|Medication error|0|||
170740978|NCT01976364|617060310|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
170740979|NCT01976364|617060311|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
170740980|NCT01976364|617060312|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
170740981|NCT01976364|617060310|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
170740982|NCT01976364|617060311|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
170740983|NCT01976364|617060312|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
170740984|NCT01976364|617060310|FG000|Main Study (36 Months)|Protocol Violation|13|||
170740985|NCT01976364|617060311|FG001|Main Study (36 Months)|Protocol Violation|0|||
170740986|NCT01976364|617060312|FG002|Main Study (36 Months)|Protocol Violation|0|||
170740987|NCT01976364|617060310|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
170740988|NCT01976364|617060311|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
170740989|NCT01976364|617060312|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
170740990|NCT01976364|617060310|FG000|Main Study (36 Months)|Death|5|||
170740991|NCT01976364|617060311|FG001|Main Study (36 Months)|Death|0|||
170740992|NCT01976364|617060312|FG002|Main Study (36 Months)|Death|0|||
170740993|NCT01976364|617060310|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
170740994|NCT01976364|617060311|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
170740995|NCT01976364|617060312|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
170740996|NCT01976364|617060310|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
170740997|NCT01976364|617060311|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
170740998|NCT01976364|617060312|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
170740999|NCT01976364|617060310|FG000|Sub-study (12 Months)|Protocol Violation|0|||
170741000|NCT01976364|617060311|FG001|Sub-study (12 Months)|Protocol Violation|1|||
170741001|NCT01976364|617060312|FG002|Sub-study (12 Months)|Protocol Violation|1|||
170741002|NCT01976364|617060310|FG000|Sub-study (12 Months)|Adverse Event|0|||
170741003|NCT01976364|617060311|FG001|Sub-study (12 Months)|Adverse Event|4|||
170741004|NCT01976364|617060312|FG002|Sub-study (12 Months)|Adverse Event|3|||
170741005|NCT02757521|617060313|FG000|Overall Study|Adverse Event|1|||
170741006|NCT02757521|617060314|FG001|Overall Study|Adverse Event|0|||
170741007|NCT01683994|617060337|FG000|Overall Study|Withdrawal by Subject|1|||
170741008|NCT01683994|617060338|FG001|Overall Study|Withdrawal by Subject|0|||
170741009|NCT01683994|617060339|FG002|Overall Study|Withdrawal by Subject|0|||
170741010|NCT01683994|617060340|FG003|Overall Study|Withdrawal by Subject|1|||
170741011|NCT01683994|617060341|FG004|Overall Study|Withdrawal by Subject|0|||
170741012|NCT01683994|617060337|FG000|Overall Study|Intercurrent illness|0|||
170741013|NCT01683994|617060338|FG001|Overall Study|Intercurrent illness|0|||
170741014|NCT01683994|617060339|FG002|Overall Study|Intercurrent illness|0|||
170741015|NCT01683994|617060340|FG003|Overall Study|Intercurrent illness|2|||
170741016|NCT01683994|617060341|FG004|Overall Study|Intercurrent illness|1|||
170741017|NCT00999661|617060342|FG000|Overall Study|Lost to Follow-up|59|||
170741018|NCT00999661|617060342|FG000|Overall Study|Adverse Event|1|||
170741019|NCT00999661|617060342|FG000|Overall Study|Withdrawal by Subject|1|||
170741020|NCT00999661|617060342|FG000|Overall Study|Not meeting eligibility criteria|9|||
170741021|NCT00917267|617060343|FG000|Overall Study|Adverse Event|15|||
170741022|NCT00917267|617060344|FG001|Overall Study|Adverse Event|36|||
170741023|NCT00917267|617060343|FG000|Overall Study|Physician Decision|2|||
170741024|NCT00917267|617060344|FG001|Overall Study|Physician Decision|4|||
170741025|NCT00917267|617060343|FG000|Overall Study|Protocol Violation|9|||
170741026|NCT00917267|617060344|FG001|Overall Study|Protocol Violation|18|||
170741027|NCT00917267|617060343|FG000|Overall Study|Withdrawal by Subject|5|||
170741028|NCT00917267|617060344|FG001|Overall Study|Withdrawal by Subject|12|||
170741029|NCT00917267|617060343|FG000|Overall Study|Lost to follow up|0|||
170741030|NCT00917267|617060344|FG001|Overall Study|Lost to follow up|2|||
170741031|NCT00917267|617060343|FG000|Overall Study|Entry Criteria Not Met|1|||
170741032|NCT00917267|617060344|FG001|Overall Study|Entry Criteria Not Met|0|||
170741033|NCT00917267|617060343|FG000|Overall Study|Sponsor Decision|5|||
170741034|NCT00917267|617060344|FG001|Overall Study|Sponsor Decision|5|||
170741035|NCT00917267|617060343|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
170741036|NCT00917267|617060344|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
170741037|NCT01863043|617060347|FG000|Overall Study|Death|6|||
170741038|NCT01863043|617060348|FG001|Overall Study|Death|1|||
170741039|NCT01863043|617060347|FG000|Overall Study|Withdrawal by Subject|0|||
170741040|NCT01863043|617060348|FG001|Overall Study|Withdrawal by Subject|2|||
170741041|NCT01863043|617060347|FG000|Overall Study|Adverse Event|7|||
170741042|NCT01863043|617060348|FG001|Overall Study|Adverse Event|8|||
170741043|NCT01863043|617060347|FG000|Overall Study|exclusion criteria found after enrollment|0|||
170741044|NCT01863043|617060348|FG001|Overall Study|exclusion criteria found after enrollment|1|||
170741045|NCT00854295|617060349|FG000|Overall Study|Death|7|||
170741046|NCT00854295|617060350|FG001|Overall Study|Death|0|||
170741047|NCT00854295|617060351|FG002|Overall Study|Death|1|||
170741048|NCT00854295|617060352|FG003|Overall Study|Death|1|||
170741049|NCT00854295|617060349|FG000|Overall Study|Adverse Event|6|||
170741050|NCT00854295|617060350|FG001|Overall Study|Adverse Event|1|||
170741051|NCT00854295|617060351|FG002|Overall Study|Adverse Event|1|||
170741052|NCT00854295|617060352|FG003|Overall Study|Adverse Event|3|||
170741053|NCT00854295|617060349|FG000|Overall Study|Lost to Follow-up|18|||
170741054|NCT00854295|617060350|FG001|Overall Study|Lost to Follow-up|5|||
170741055|NCT00854295|617060351|FG002|Overall Study|Lost to Follow-up|21|||
170741056|NCT00854295|617060352|FG003|Overall Study|Lost to Follow-up|21|||
170741057|NCT00854295|617060349|FG000|Overall Study|Physician Decision|10|||
170741058|NCT00854295|617060350|FG001|Overall Study|Physician Decision|0|||
170741059|NCT00854295|617060351|FG002|Overall Study|Physician Decision|0|||
170741060|NCT00854295|617060352|FG003|Overall Study|Physician Decision|0|||
170741061|NCT00197028|617060354|FG000|Overall Study|Adverse Event|2|||
170741062|NCT00197028|617060355|FG001|Overall Study|Adverse Event|2|||
170741063|NCT00197028|617060354|FG000|Overall Study|Protocol Violation|2|||
170741064|NCT00197028|617060355|FG001|Overall Study|Protocol Violation|1|||
170741065|NCT00197028|617060354|FG000|Overall Study|Withdrawal by Subject|8|||
170741066|NCT00197028|617060355|FG001|Overall Study|Withdrawal by Subject|12|||
170741067|NCT00197028|617060354|FG000|Overall Study|Lost to Follow-up|1|||
170741068|NCT00197028|617060355|FG001|Overall Study|Lost to Follow-up|0|||
170741069|NCT00197028|617060354|FG000|Overall Study|Other|3|||
170741070|NCT00197028|617060355|FG001|Overall Study|Other|6|||
170741071|NCT01248962|617060356|FG000|Overall Study|Withdrawal by Subject|1|||
170741072|NCT01248962|617060357|FG001|Overall Study|Withdrawal by Subject|1|||
170741073|NCT01248962|617060356|FG000|Overall Study|Adverse Event|2|||
170741074|NCT01248962|617060357|FG001|Overall Study|Adverse Event|1|||
170741075|NCT01248962|617060356|FG000|Overall Study|Complete Response after 4 Cycles|1|||
170741076|NCT01248962|617060357|FG001|Overall Study|Complete Response after 4 Cycles|0|||
170741077|NCT01248962|617060356|FG000|Overall Study|Complete Response after 3 Cycles|0|||
170741078|NCT01248962|617060357|FG001|Overall Study|Complete Response after 3 Cycles|1|||
170741079|NCT01248962|617060356|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
170741080|NCT01248962|617060357|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
170741081|NCT02307513|617060358|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
170741082|NCT02307513|617060359|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
170741083|NCT02307513|617060358|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
170741084|NCT02307513|617060359|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
170741085|NCT02307513|617060358|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
170741086|NCT02307513|617060359|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
170741087|NCT02307513|617060358|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
170741088|NCT02307513|617060359|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
170741089|NCT02307513|617060358|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
170741090|NCT02307513|617060359|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
170741091|NCT02307513|617060358|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
170741092|NCT02307513|617060359|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
170741093|NCT02307513|617060358|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
170741094|NCT02307513|617060359|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
170741095|NCT02307513|617060358|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
170741096|NCT02307513|617060359|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
170741097|NCT02307513|617060358|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
170741098|NCT02307513|617060359|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
170741099|NCT02307513|617060358|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
170741100|NCT02307513|617060359|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
170741101|NCT02307513|617060358|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
170741102|NCT02307513|617060359|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
170741103|NCT02307513|617060358|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
170741104|NCT02307513|617060359|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
170741105|NCT02307513|617060358|FG000|Long-term Extension|Physician Decision|1|||
170741106|NCT02307513|617060359|FG001|Long-term Extension|Physician Decision|0|||
170741107|NCT00308737|617060361|FG000|Overall Study|Adverse Event|104|||
170741108|NCT00308737|617060362|FG001|Overall Study|Adverse Event|9|||
170741109|NCT00308737|617060363|FG002|Overall Study|Adverse Event|0|||
170741110|NCT00308737|617060361|FG000|Overall Study|Death|4|||
170741111|NCT00308737|617060362|FG001|Overall Study|Death|3|||
170741112|NCT00308737|617060363|FG002|Overall Study|Death|0|||
170741113|NCT00308737|617060361|FG000|Overall Study|Lost to Follow-up|56|||
170741114|NCT00308737|617060362|FG001|Overall Study|Lost to Follow-up|80|||
170741115|NCT00308737|617060363|FG002|Overall Study|Lost to Follow-up|5|||
170741116|NCT00308737|617060361|FG000|Overall Study|Physician Decision|15|||
170741117|NCT00308737|617060362|FG001|Overall Study|Physician Decision|2|||
170741118|NCT00308737|617060363|FG002|Overall Study|Physician Decision|1|||
170741119|NCT00308737|617060361|FG000|Overall Study|Protocol Violation|34|||
170741120|NCT00308737|617060362|FG001|Overall Study|Protocol Violation|9|||
170741121|NCT00308737|617060363|FG002|Overall Study|Protocol Violation|5|||
170741122|NCT00308737|617060361|FG000|Overall Study|Withdrawal by Subject|218|||
170741123|NCT00308737|617060362|FG001|Overall Study|Withdrawal by Subject|166|||
170741124|NCT00308737|617060363|FG002|Overall Study|Withdrawal by Subject|18|||
170741125|NCT00308737|617060361|FG000|Overall Study|Various|32|||
170741126|NCT00308737|617060362|FG001|Overall Study|Various|20|||
170741127|NCT00308737|617060363|FG002|Overall Study|Various|8|||
170741128|NCT00284089|617060364|FG000|Multiple Dose Phase|Adverse Event|1|||
170741129|NCT00284089|617060365|FG001|Multiple Dose Phase|Adverse Event|0|||
170741130|NCT00284089|617060366|FG002|Multiple Dose Phase|Adverse Event|1|||
170741131|NCT00284089|617060367|FG003|Multiple Dose Phase|Adverse Event|1|||
170741132|NCT00284089|617060364|FG000|Multiple Dose Phase|Protocol Violation|0|||
170741133|NCT00284089|617060365|FG001|Multiple Dose Phase|Protocol Violation|0|||
170741134|NCT00284089|617060366|FG002|Multiple Dose Phase|Protocol Violation|1|||
170741135|NCT00284089|617060367|FG003|Multiple Dose Phase|Protocol Violation|0|||
170741136|NCT00284089|617060364|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
170741137|NCT00284089|617060365|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
170741138|NCT00284089|617060366|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
170741139|NCT00284089|617060367|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
170741140|NCT00284089|617060364|FG000|Multiple Dose Phase|Death|0|||
170741141|NCT00284089|617060365|FG001|Multiple Dose Phase|Death|0|||
170741142|NCT00284089|617060366|FG002|Multiple Dose Phase|Death|1|||
170741143|NCT00284089|617060367|FG003|Multiple Dose Phase|Death|1|||
170741144|NCT00284089|617060364|FG000|Extension Phase|Adverse Event|0|||
170741145|NCT00284089|617060365|FG001|Extension Phase|Adverse Event|0|||
170741146|NCT00284089|617060366|FG002|Extension Phase|Adverse Event|2|||
170741147|NCT00284089|617060367|FG003|Extension Phase|Adverse Event|2|||
170741148|NCT00284089|617060364|FG000|Extension Phase|condition no longer requires study drug|2|||
170741149|NCT00284089|617060365|FG001|Extension Phase|condition no longer requires study drug|0|||
170741150|NCT00284089|617060366|FG002|Extension Phase|condition no longer requires study drug|2|||
170741151|NCT00284089|617060367|FG003|Extension Phase|condition no longer requires study drug|7|||
170741152|NCT00284089|617060364|FG000|Extension Phase|Protocol Violation|0|||
170741153|NCT00284089|617060365|FG001|Extension Phase|Protocol Violation|0|||
170741154|NCT00284089|617060366|FG002|Extension Phase|Protocol Violation|1|||
170741155|NCT00284089|617060367|FG003|Extension Phase|Protocol Violation|0|||
170741156|NCT00284089|617060364|FG000|Extension Phase|Withdrawal by Subject|0|||
170741157|NCT00284089|617060365|FG001|Extension Phase|Withdrawal by Subject|0|||
170741158|NCT00284089|617060366|FG002|Extension Phase|Withdrawal by Subject|1|||
170741159|NCT00284089|617060367|FG003|Extension Phase|Withdrawal by Subject|3|||
170741160|NCT02541383|617060368|FG000|Overall Study|Death|50|||
170741161|NCT02541383|617060369|FG001|Overall Study|Death|37|||
170741162|NCT02541383|617060370|FG002|Overall Study|Death|48|||
170741163|NCT02541383|617060371|FG003|Overall Study|Death|41|||
170741164|NCT02541383|617060372|FG004|Overall Study|Death|21|||
170741165|NCT02541383|617060373|FG005|Overall Study|Death|25|||
170741166|NCT02541383|617060368|FG000|Overall Study|Lost to Follow-up|5|||
170741167|NCT02541383|617060369|FG001|Overall Study|Lost to Follow-up|3|||
170741168|NCT02541383|617060370|FG002|Overall Study|Lost to Follow-up|1|||
170741169|NCT02541383|617060371|FG003|Overall Study|Lost to Follow-up|1|||
170741170|NCT02541383|617060372|FG004|Overall Study|Lost to Follow-up|3|||
170741171|NCT02541383|617060373|FG005|Overall Study|Lost to Follow-up|0|||
170741172|NCT02541383|617060368|FG000|Overall Study|Consent withdrawn|5|||
170741173|NCT02541383|617060369|FG001|Overall Study|Consent withdrawn|6|||
170741174|NCT02541383|617060370|FG002|Overall Study|Consent withdrawn|1|||
170741175|NCT02541383|617060371|FG003|Overall Study|Consent withdrawn|1|||
170741176|NCT02541383|617060372|FG004|Overall Study|Consent withdrawn|0|||
170741177|NCT02541383|617060373|FG005|Overall Study|Consent withdrawn|0|||
170741178|NCT02541383|617060368|FG000|Overall Study|Sponsor's decision|1|||
170741179|NCT02541383|617060369|FG001|Overall Study|Sponsor's decision|1|||
170741180|NCT02541383|617060370|FG002|Overall Study|Sponsor's decision|0|||
170741181|NCT02541383|617060371|FG003|Overall Study|Sponsor's decision|0|||
170741182|NCT02541383|617060372|FG004|Overall Study|Sponsor's decision|0|||
170741183|NCT02541383|617060373|FG005|Overall Study|Sponsor's decision|0|||
170741184|NCT01535274|617060374|FG000|Overall Study|Determined to be ineligible|0|||
170741185|NCT01535274|617060375|FG001|Overall Study|Determined to be ineligible|1|||
170741186|NCT01535274|617060374|FG000|Overall Study|Misallocated to propofol intervention|0|||
170741187|NCT01535274|617060375|FG001|Overall Study|Misallocated to propofol intervention|1|||
170741188|NCT02954458|617060378|FG000|Overall Study|Adverse Event|0|||
170741189|NCT02954458|617060379|FG001|Overall Study|Adverse Event|0|||
170741190|NCT02954458|617060380|FG002|Overall Study|Adverse Event|0|||
170741191|NCT02954458|617060381|FG003|Overall Study|Adverse Event|1|||
170741192|NCT02954458|617060378|FG000|Overall Study|Withdrawal by Subject|0|||
170741193|NCT02954458|617060379|FG001|Overall Study|Withdrawal by Subject|0|||
170741194|NCT02954458|617060380|FG002|Overall Study|Withdrawal by Subject|0|||
170741195|NCT02954458|617060381|FG003|Overall Study|Withdrawal by Subject|1|||
170741196|NCT02954458|617060378|FG000|Overall Study|Physician Decision|0|||
170741197|NCT02954458|617060379|FG001|Overall Study|Physician Decision|0|||
170741198|NCT02954458|617060380|FG002|Overall Study|Physician Decision|1|||
170741199|NCT02954458|617060381|FG003|Overall Study|Physician Decision|1|||
170741200|NCT02954458|617060378|FG000|Overall Study|Lost to Follow-up|1|||
170741201|NCT02954458|617060379|FG001|Overall Study|Lost to Follow-up|0|||
170741202|NCT02954458|617060380|FG002|Overall Study|Lost to Follow-up|0|||
170741203|NCT02954458|617060381|FG003|Overall Study|Lost to Follow-up|1|||
170741204|NCT02954458|617060378|FG000|Overall Study|Death|0|||
170741205|NCT02954458|617060379|FG001|Overall Study|Death|0|||
170741206|NCT02954458|617060380|FG002|Overall Study|Death|0|||
170852165|NCT00993668|617464826|FG000|Single-Blind Period|Lack of Efficacy|0|||
170852166|NCT00993668|617464827|FG001|Single-Blind Period|Lack of Efficacy|1|||
170852167|NCT00993668|617464826|FG000|Single-Blind Period|Lost to Follow-up|3|||
170852168|NCT00993668|617464827|FG001|Single-Blind Period|Lost to Follow-up|1|||
170852169|NCT00993668|617464826|FG000|Open-Label Period|Adverse Event|9|||
170852170|NCT00993668|617464827|FG001|Open-Label Period|Adverse Event|8|||
170852171|NCT00993668|617464826|FG000|Open-Label Period|Lack of Efficacy|4|||
170852172|NCT00993668|617464827|FG001|Open-Label Period|Lack of Efficacy|3|||
170852173|NCT00993668|617464826|FG000|Open-Label Period|Withdrawal by Subject|4|||
170852174|NCT00993668|617464827|FG001|Open-Label Period|Withdrawal by Subject|3|||
170852175|NCT00993668|617464826|FG000|Open-Label Period|Lost to Follow-up|6|||
170741207|NCT02954458|617060381|FG003|Overall Study|Death|1|||
170741208|NCT02954458|617060378|FG000|Overall Study|Other|0|||
170741209|NCT02954458|617060379|FG001|Overall Study|Other|0|||
170741210|NCT02954458|617060380|FG002|Overall Study|Other|0|||
170741211|NCT02954458|617060381|FG003|Overall Study|Other|7|||
170741212|NCT02690077|617060384|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
170741213|NCT02690077|617060385|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
170741214|NCT02690077|617060384|FG000|Overall Study|Withdrawal by Subject|0|||
170852176|NCT00993668|617464827|FG001|Open-Label Period|Lost to Follow-up|1|||
170852177|NCT02207569|617464830|FG000|1-Month|Death|6|||
170852178|NCT02207569|617464830|FG000|1-Month|Withdrawal by Subject|2|||
170741215|NCT02690077|617060385|FG001|Overall Study|Withdrawal by Subject|5|||
170741216|NCT02690077|617060384|FG000|Overall Study|Excluded by IRB|0|||
170741217|NCT02690077|617060385|FG001|Overall Study|Excluded by IRB|2|||
170741218|NCT01845974|617060386|FG000|Overall Study|screen failure|1|||
170741219|NCT01845974|617060387|FG001|Overall Study|screen failure|0|||
170741220|NCT02667886|617060388|FG000|Dose Escalation (Part A)|Adverse Event|1|||
170741221|NCT02667886|617060389|FG001|Dose Escalation (Part A)|Adverse Event|3|||
170741222|NCT02667886|617060390|FG002|Dose Escalation (Part A)|Adverse Event|1|||
170741223|NCT02667886|617060391|FG003|Dose Escalation (Part A)|Adverse Event|0|||
170741224|NCT02667886|617060392|FG004|Dose Escalation (Part A)|Adverse Event|0|||
170741225|NCT02667886|617060388|FG000|Dose Escalation (Part A)|Disease Progression|1|||
170741226|NCT02667886|617060389|FG001|Dose Escalation (Part A)|Disease Progression|4|||
170741227|NCT02667886|617060390|FG002|Dose Escalation (Part A)|Disease Progression|3|||
170741228|NCT02667886|617060391|FG003|Dose Escalation (Part A)|Disease Progression|0|||
170741229|NCT02667886|617060392|FG004|Dose Escalation (Part A)|Disease Progression|0|||
170741230|NCT02667886|617060388|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
170741231|NCT02667886|617060389|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
170741232|NCT02667886|617060390|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
170741233|NCT02667886|617060391|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
170741234|NCT02667886|617060392|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
170741235|NCT02667886|617060388|FG000|Dose Expansion (Part B)|Adverse Event|0|||
170741236|NCT02667886|617060389|FG001|Dose Expansion (Part B)|Adverse Event|0|||
170741237|NCT02667886|617060390|FG002|Dose Expansion (Part B)|Adverse Event|0|||
170741238|NCT02667886|617060391|FG003|Dose Expansion (Part B)|Adverse Event|9|||
170741239|NCT02667886|617060392|FG004|Dose Expansion (Part B)|Adverse Event|0|||
170852179|NCT02207569|617464830|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
170852180|NCT02207569|617464830|FG000|6-Month|Death|8|||
170852181|NCT02207569|617464830|FG000|6-Month|Withdrawal by Subject|2|||
170852182|NCT02207569|617464830|FG000|12-Month|Death|14|||
170852183|NCT02207569|617464830|FG000|12-Month|Withdrawal by Subject|2|||
170852184|NCT02207569|617464830|FG000|24-Month|Death|23|||
170852185|NCT02207569|617464830|FG000|24-Month|Withdrawal by Subject|3|||
170852186|NCT02207569|617464830|FG000|36-Month|Death|23|||
170852187|NCT02207569|617464830|FG000|36-Month|Withdrawal by Subject|4|||
170852188|NCT02207569|617464830|FG000|48-Month|Death|25|||
170852189|NCT02207569|617464830|FG000|48-Month|Withdrawal by Subject|2|||
170852190|NCT02207569|617464830|FG000|48-Month|Lost to Follow-up|4|||
170852191|NCT02207569|617464830|FG000|60-Month|Death|1|||
170852192|NCT02207569|617464830|FG000|60-Month|Lost to Follow-up|1|||
170852193|NCT02207569|617464830|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
170852194|NCT02207569|617464830|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
170852195|NCT01577745|617464833|FG000|Overall Study|Withdrawal by Subject|0|||
170852196|NCT01577745|617464834|FG001|Overall Study|Withdrawal by Subject|1|||
170852197|NCT01577745|617464835|FG002|Overall Study|Withdrawal by Subject|0|||
170852198|NCT01577745|617464836|FG003|Overall Study|Withdrawal by Subject|3|||
170852199|NCT01577745|617464837|FG004|Overall Study|Withdrawal by Subject|2|||
170852200|NCT01577745|617464838|FG005|Overall Study|Withdrawal by Subject|0|||
170852201|NCT01577745|617464833|FG000|Overall Study|Death|3|||
170852202|NCT01577745|617464834|FG001|Overall Study|Death|2|||
170852203|NCT01577745|617464835|FG002|Overall Study|Death|2|||
170852204|NCT01577745|617464836|FG003|Overall Study|Death|1|||
170852205|NCT01577745|617464837|FG004|Overall Study|Death|1|||
170852206|NCT01577745|617464838|FG005|Overall Study|Death|3|||
170852207|NCT01577745|617464833|FG000|Overall Study|Physician Decision|0|||
170852208|NCT01577745|617464834|FG001|Overall Study|Physician Decision|0|||
170852209|NCT01577745|617464835|FG002|Overall Study|Physician Decision|0|||
170852210|NCT01577745|617464836|FG003|Overall Study|Physician Decision|1|||
170852211|NCT01577745|617464837|FG004|Overall Study|Physician Decision|1|||
170741240|NCT02667886|617060388|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
170741241|NCT02667886|617060389|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
170852212|NCT01577745|617464838|FG005|Overall Study|Physician Decision|0|||
170852213|NCT01577745|617464833|FG000|Overall Study|Lost to Follow-up|0|||
170852214|NCT01577745|617464834|FG001|Overall Study|Lost to Follow-up|0|||
170852215|NCT01577745|617464835|FG002|Overall Study|Lost to Follow-up|0|||
170852216|NCT01577745|617464836|FG003|Overall Study|Lost to Follow-up|0|||
170852217|NCT01577745|617464837|FG004|Overall Study|Lost to Follow-up|0|||
170741242|NCT02667886|617060390|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
170741243|NCT02667886|617060391|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
170741244|NCT02667886|617060392|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
170741245|NCT02667886|617060388|FG000|Dose Expansion (Part B)|Disease Progression|0|||
170741246|NCT02667886|617060389|FG001|Dose Expansion (Part B)|Disease Progression|0|||
170741247|NCT02667886|617060390|FG002|Dose Expansion (Part B)|Disease Progression|0|||
170741248|NCT02667886|617060391|FG003|Dose Expansion (Part B)|Disease Progression|38|||
170741249|NCT02667886|617060392|FG004|Dose Expansion (Part B)|Disease Progression|0|||
170741250|NCT02667886|617060388|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
170741251|NCT02667886|617060389|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
170741252|NCT02667886|617060390|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
170741253|NCT02667886|617060391|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
170741254|NCT02667886|617060392|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
170741255|NCT02667886|617060388|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
170741256|NCT02667886|617060389|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
170741257|NCT02667886|617060390|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
170741258|NCT02667886|617060391|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
170741259|NCT02667886|617060392|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
170741260|NCT02667886|617060388|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
170741261|NCT02667886|617060389|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
170741262|NCT02667886|617060390|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
170741263|NCT02667886|617060391|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
170741264|NCT02667886|617060392|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
170741265|NCT01905046|617060393|FG000|Months 13-24|Withdrawal by Subject|10|||
170741266|NCT01905046|617060394|FG001|Months 13-24|Withdrawal by Subject|10|||
170741267|NCT01905046|617060393|FG000|Months 13-24|Adverse Event|3|||
170741268|NCT01905046|617060394|FG001|Months 13-24|Adverse Event|2|||
170741269|NCT01905046|617060393|FG000|Months 13-24|Protocol Violation|3|||
170741270|NCT01905046|617060394|FG001|Months 13-24|Protocol Violation|3|||
170741271|NCT01905046|617060393|FG000|Months 13-24|Physician Decision|1|||
170741272|NCT01905046|617060394|FG001|Months 13-24|Physician Decision|0|||
170741273|NCT05672680|617060395|FG000|Overall Study|Patient Did Not Complete the Form|5|||
170741274|NCT05672680|617060396|FG001|Overall Study|Patient Did Not Complete the Form|4|||
170741275|NCT05672680|617060395|FG000|Overall Study|Procedure Aborted|1|||
170741276|NCT05672680|617060396|FG001|Overall Study|Procedure Aborted|0|||
170741277|NCT02778399|617060405|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
170741278|NCT02778399|617060406|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
170741279|NCT02778399|617060407|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
170741280|NCT02778399|617060408|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
170741281|NCT02778399|617060409|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
170741282|NCT02778399|617060410|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
170741283|NCT02778399|617060405|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
170741284|NCT02778399|617060406|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
170741285|NCT02778399|617060407|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
170741286|NCT02778399|617060408|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
170741287|NCT02778399|617060409|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
170741288|NCT02778399|617060410|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
170741289|NCT02778399|617060405|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
170741290|NCT02778399|617060406|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
170741291|NCT02778399|617060407|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
170741292|NCT02778399|617060408|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
170852218|NCT01577745|617464838|FG005|Overall Study|Lost to Follow-up|1|||
170852219|NCT01577745|617464833|FG000|Overall Study|Alternative Therapy|0|||
170852220|NCT01577745|617464834|FG001|Overall Study|Alternative Therapy|0|||
170852221|NCT01577745|617464835|FG002|Overall Study|Alternative Therapy|0|||
170852222|NCT01577745|617464836|FG003|Overall Study|Alternative Therapy|1|||
170852223|NCT01577745|617464837|FG004|Overall Study|Alternative Therapy|1|||
170852224|NCT01577745|617464838|FG005|Overall Study|Alternative Therapy|0|||
170852225|NCT01127763|617464839|FG000|Overall Study|Adverse Event|2|||
170852226|NCT01127763|617464839|FG000|Overall Study|Withdrawal by Subject|1|||
170852227|NCT01127763|617464839|FG000|Overall Study|Physician Decision|2|||
170852228|NCT00371683|617464844|FG000|DB Treatment Period-Randomized Patients|Death|1|||
170852229|NCT00371683|617464845|FG001|DB Treatment Period-Randomized Patients|Death|1|||
170852230|NCT00371683|617464844|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
170852231|NCT00371683|617464845|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
170852232|NCT00371683|617464844|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
170852233|NCT00371683|617464845|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
170852234|NCT00371683|617464844|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
170852235|NCT00371683|617464845|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
170852236|NCT00371683|617464844|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
170741293|NCT02778399|617060409|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
170741294|NCT02778399|617060410|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
170741295|NCT02778399|617060405|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
170741296|NCT02778399|617060406|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
170741297|NCT02778399|617060407|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
170741298|NCT02778399|617060408|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
170741299|NCT02778399|617060409|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
170741300|NCT02778399|617060410|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
170741301|NCT02778399|617060405|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
170741302|NCT02778399|617060406|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
170741303|NCT02778399|617060407|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
170741304|NCT02778399|617060408|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
170741305|NCT02778399|617060409|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
170741306|NCT02778399|617060410|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
170741307|NCT02778399|617060405|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
170741308|NCT02778399|617060406|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
170741309|NCT02778399|617060407|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
170741310|NCT02778399|617060408|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
170741311|NCT02778399|617060409|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
170741312|NCT02778399|617060410|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
170741313|NCT02778399|617060405|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
170741314|NCT02778399|617060406|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
170741315|NCT02778399|617060407|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
170741316|NCT02778399|617060408|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
170741317|NCT02778399|617060409|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
170741318|NCT02778399|617060410|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
170741319|NCT02778399|617060405|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
170741320|NCT02778399|617060406|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
170741321|NCT02778399|617060407|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
170741322|NCT02778399|617060408|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
170741323|NCT02778399|617060409|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
170741324|NCT02778399|617060410|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
170741325|NCT02778399|617060405|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
170741326|NCT02778399|617060406|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
170741327|NCT02778399|617060407|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
170741328|NCT02778399|617060408|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
170741329|NCT02778399|617060409|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
170741330|NCT02778399|617060410|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
170741331|NCT02778399|617060405|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
170741332|NCT02778399|617060406|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
170741333|NCT02778399|617060407|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
170741334|NCT02778399|617060408|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
170741335|NCT02778399|617060409|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
170741336|NCT02778399|617060410|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
170741337|NCT02778399|617060405|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
170741338|NCT02778399|617060406|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
170741339|NCT02778399|617060407|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
170741340|NCT02778399|617060408|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
170741341|NCT02778399|617060409|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
170741342|NCT02778399|617060410|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
170741343|NCT00576732|617060411|FG000|DOUBLE BLIND|Adverse Event|0|||
170741344|NCT00576732|617060412|FG001|DOUBLE BLIND|Adverse Event|0|||
170741345|NCT00576732|617060413|FG002|DOUBLE BLIND|Adverse Event|1|||
170741346|NCT00576732|617060414|FG003|DOUBLE BLIND|Adverse Event|0|||
170741347|NCT00576732|617060415|FG004|DOUBLE BLIND|Adverse Event|0|||
170741348|NCT00576732|617060416|FG005|DOUBLE BLIND|Adverse Event|0|||
170741349|NCT00576732|617060411|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
170741350|NCT00576732|617060412|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
170741351|NCT00576732|617060413|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
170741352|NCT00576732|617060414|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
170741353|NCT00576732|617060415|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
170741354|NCT00576732|617060416|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
170741355|NCT00576732|617060411|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
170741356|NCT00576732|617060412|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
170741357|NCT00576732|617060413|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
170741358|NCT00576732|617060414|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
170741359|NCT00576732|617060415|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
170741360|NCT00576732|617060416|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
170741361|NCT00576732|617060411|FG000|DOUBLE BLIND|OTHER|0|||
170741362|NCT00576732|617060412|FG001|DOUBLE BLIND|OTHER|2|||
170741363|NCT00576732|617060413|FG002|DOUBLE BLIND|OTHER|1|||
170741364|NCT00576732|617060414|FG003|DOUBLE BLIND|OTHER|0|||
170741365|NCT00576732|617060415|FG004|DOUBLE BLIND|OTHER|0|||
170741366|NCT00576732|617060416|FG005|DOUBLE BLIND|OTHER|0|||
170741367|NCT00576732|617060411|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
170741368|NCT00576732|617060412|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
170741369|NCT00576732|617060413|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
170741370|NCT00576732|617060414|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
170741371|NCT00576732|617060415|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
170741372|NCT00576732|617060416|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
170741373|NCT00576732|617060411|FG000|DOUBLE BLIND|Protocol Violation|1|||
170741374|NCT00576732|617060412|FG001|DOUBLE BLIND|Protocol Violation|0|||
170741375|NCT00576732|617060413|FG002|DOUBLE BLIND|Protocol Violation|0|||
170741376|NCT00576732|617060414|FG003|DOUBLE BLIND|Protocol Violation|0|||
170741377|NCT00576732|617060415|FG004|DOUBLE BLIND|Protocol Violation|0|||
170741378|NCT00576732|617060416|FG005|DOUBLE BLIND|Protocol Violation|0|||
170741379|NCT00576732|617060411|FG000|OPEN LABEL|Adverse Event|0|||
170741380|NCT00576732|617060412|FG001|OPEN LABEL|Adverse Event|0|||
170741381|NCT00576732|617060413|FG002|OPEN LABEL|Adverse Event|0|||
170741382|NCT00576732|617060414|FG003|OPEN LABEL|Adverse Event|4|||
170741383|NCT00576732|617060415|FG004|OPEN LABEL|Adverse Event|0|||
170741384|NCT00576732|617060416|FG005|OPEN LABEL|Adverse Event|1|||
170741385|NCT00576732|617060411|FG000|OPEN LABEL|Lost to Follow-up|0|||
170741386|NCT00576732|617060412|FG001|OPEN LABEL|Lost to Follow-up|0|||
170741387|NCT00576732|617060413|FG002|OPEN LABEL|Lost to Follow-up|0|||
170741388|NCT00576732|617060414|FG003|OPEN LABEL|Lost to Follow-up|2|||
170741389|NCT00576732|617060415|FG004|OPEN LABEL|Lost to Follow-up|1|||
170741390|NCT00576732|617060416|FG005|OPEN LABEL|Lost to Follow-up|1|||
170741391|NCT00576732|617060411|FG000|OPEN LABEL|Withdrawal by Subject|0|||
170741392|NCT00576732|617060412|FG001|OPEN LABEL|Withdrawal by Subject|0|||
170741393|NCT00576732|617060413|FG002|OPEN LABEL|Withdrawal by Subject|0|||
170741394|NCT00576732|617060414|FG003|OPEN LABEL|Withdrawal by Subject|1|||
170741395|NCT00576732|617060415|FG004|OPEN LABEL|Withdrawal by Subject|0|||
170741396|NCT00576732|617060416|FG005|OPEN LABEL|Withdrawal by Subject|1|||
170741397|NCT00576732|617060411|FG000|OPEN LABEL|OTHER|0|||
170741398|NCT00576732|617060412|FG001|OPEN LABEL|OTHER|0|||
170741399|NCT00576732|617060413|FG002|OPEN LABEL|OTHER|0|||
170741400|NCT00576732|617060414|FG003|OPEN LABEL|OTHER|0|||
170741401|NCT00576732|617060415|FG004|OPEN LABEL|OTHER|0|||
170741402|NCT00576732|617060416|FG005|OPEN LABEL|OTHER|2|||
170741403|NCT00576732|617060411|FG000|OPEN LABEL|Lack of Efficacy|0|||
170741404|NCT00576732|617060412|FG001|OPEN LABEL|Lack of Efficacy|0|||
170741405|NCT00576732|617060413|FG002|OPEN LABEL|Lack of Efficacy|0|||
170741406|NCT00576732|617060414|FG003|OPEN LABEL|Lack of Efficacy|2|||
170741407|NCT00576732|617060415|FG004|OPEN LABEL|Lack of Efficacy|2|||
170741408|NCT00576732|617060416|FG005|OPEN LABEL|Lack of Efficacy|3|||
170741409|NCT00576732|617060411|FG000|OPEN LABEL|Protocol Violation|0|||
170741410|NCT00576732|617060412|FG001|OPEN LABEL|Protocol Violation|0|||
170741411|NCT00576732|617060413|FG002|OPEN LABEL|Protocol Violation|0|||
170741412|NCT00576732|617060414|FG003|OPEN LABEL|Protocol Violation|2|||
170741413|NCT00576732|617060415|FG004|OPEN LABEL|Protocol Violation|1|||
170741414|NCT00576732|617060416|FG005|OPEN LABEL|Protocol Violation|0|||
170741415|NCT03188120|617060417|FG000|Overall Study|Adverse Event|4|||
170741416|NCT03188120|617060417|FG000|Overall Study|Insufficient Effectiveness|8|||
170741417|NCT03188120|617060417|FG000|Overall Study|Improved|12|||
170741418|NCT03188120|617060417|FG000|Overall Study|Lost to Follow-up|7|||
170741419|NCT03188120|617060417|FG000|Overall Study|Other than specified|3|||
170741420|NCT03188120|617060417|FG000|Overall Study|No visit after the first visit|13|||
170741421|NCT00405639|617060418|FG000|Overall Study|Withdrawal by Subject|1|||
170741422|NCT00405639|617060419|FG001|Overall Study|Withdrawal by Subject|0|||
170741423|NCT00405639|617060418|FG000|Overall Study|Adverse Event|1|||
170741424|NCT00405639|617060419|FG001|Overall Study|Adverse Event|0|||
170741425|NCT00405639|617060418|FG000|Overall Study|Seizure prior to receiving BNP|1|||
170741426|NCT00405639|617060419|FG001|Overall Study|Seizure prior to receiving BNP|0|||
170741427|NCT00612534|617060421|FG000|Overall Study|Adverse Event|0|||
170741428|NCT00612534|617060422|FG001|Overall Study|Adverse Event|4|||
170741429|NCT00612534|617060423|FG002|Overall Study|Adverse Event|2|||
170741430|NCT00612534|617060424|FG003|Overall Study|Adverse Event|1|||
170741431|NCT00612534|617060421|FG000|Overall Study|Lack of Efficacy|13|||
170741432|NCT00612534|617060422|FG001|Overall Study|Lack of Efficacy|12|||
170741433|NCT00612534|617060423|FG002|Overall Study|Lack of Efficacy|5|||
170741434|NCT00612534|617060424|FG003|Overall Study|Lack of Efficacy|16|||
170741435|NCT00612534|617060421|FG000|Overall Study|Other Reason|0|||
170741436|NCT00612534|617060422|FG001|Overall Study|Other Reason|1|||
170741437|NCT00612534|617060423|FG002|Overall Study|Other Reason|0|||
170741438|NCT00612534|617060424|FG003|Overall Study|Other Reason|0|||
170741439|NCT00265330|617060425|FG000|Overall Study|Adverse Event|41|||
170741440|NCT00265330|617060425|FG000|Overall Study|Lost to Follow-up|8|||
170741441|NCT00265330|617060425|FG000|Overall Study|Withdrawal by Subject|34|||
170741442|NCT00265330|617060425|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
170741443|NCT00265330|617060425|FG000|Overall Study|Lack of Efficacy|4|||
170741444|NCT00265330|617060425|FG000|Overall Study|Family Scheduling Conflicts|1|||
170741445|NCT00265330|617060425|FG000|Overall Study|Began Taking Formulary Geodon|1|||
170741446|NCT00265330|617060425|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
170741447|NCT00265330|617060425|FG000|Overall Study|Site Closed by Sponsor|1|||
170741448|NCT00265330|617060425|FG000|Overall Study|Principal Investigators Request|1|||
170741449|NCT00265330|617060425|FG000|Overall Study|Withdrew Consent|1|||
170741450|NCT00265330|617060425|FG000|Overall Study|Protocol Violation|1|||
170741451|NCT02130284|617060432|FG000|Overall Study|Withdrawal by Subject|3|||
170741452|NCT02130284|617060432|FG000|Overall Study|Subject Withdrew Consent|1|||
170741453|NCT02130284|617060432|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
170741454|NCT02130284|617060432|FG000|Overall Study|Subject was screened as backup for study|3|||
170741455|NCT02130284|617060432|FG000|Overall Study|Screen Failure|1|||
170741456|NCT05778526|617060434|FG000|Overall Study|Lost to Follow-up|0|||
170741457|NCT05778526|617060435|FG001|Overall Study|Lost to Follow-up|1|||
170741458|NCT05778526|617060436|FG002|Overall Study|Lost to Follow-up|3|||
170741459|NCT05778526|617060434|FG000|Overall Study|Protocol Violation|0|||
170741460|NCT05778526|617060435|FG001|Overall Study|Protocol Violation|0|||
170741461|NCT05778526|617060436|FG002|Overall Study|Protocol Violation|8|||
170741462|NCT00085202|617060437|FG000|Overall Study|Still on therapy|2|||
170741463|NCT00085202|617060438|FG001|Overall Study|Still on therapy|0|||
170741464|NCT00085202|617060437|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
170741465|NCT00085202|617060438|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
170741466|NCT00085202|617060437|FG000|Overall Study|Excessive toxicity|6|||
170741467|NCT00085202|617060438|FG001|Overall Study|Excessive toxicity|5|||
170741468|NCT00085202|617060437|FG000|Overall Study|Non-specified|3|||
170741469|NCT00085202|617060438|FG001|Overall Study|Non-specified|5|||
170741470|NCT00085202|617060437|FG000|Overall Study|Withdrawal by Subject|2|||
170741471|NCT00085202|617060438|FG001|Overall Study|Withdrawal by Subject|1|||
170741472|NCT00085202|617060437|FG000|Overall Study|Physician Decision|4|||
170741473|NCT00085202|617060438|FG001|Overall Study|Physician Decision|1|||
170741474|NCT00085202|617060437|FG000|Overall Study|Progressive disease|1|||
170741475|NCT00085202|617060438|FG001|Overall Study|Progressive disease|11|||
170741476|NCT01852058|617060443|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
170741477|NCT01852058|617060444|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741478|NCT01852058|617060445|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741479|NCT01852058|617060446|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741480|NCT01852058|617060447|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741481|NCT01852058|617060448|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741482|NCT01852058|617060449|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741483|NCT01852058|617060450|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741484|NCT01852058|617060451|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741485|NCT01852058|617060452|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741486|NCT01852058|617060453|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741487|NCT01852058|617060454|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
170741488|NCT01852058|617060443|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741489|NCT01852058|617060444|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741490|NCT01852058|617060445|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741491|NCT01852058|617060446|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741492|NCT01852058|617060447|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
170741493|NCT01852058|617060448|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741494|NCT01852058|617060449|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741495|NCT01852058|617060450|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741496|NCT01852058|617060451|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741497|NCT01852058|617060452|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741498|NCT01852058|617060453|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741499|NCT01852058|617060454|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
170741500|NCT01852058|617060443|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741501|NCT01852058|617060444|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741502|NCT01852058|617060445|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741503|NCT01852058|617060446|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741504|NCT01852058|617060447|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
170741505|NCT01852058|617060448|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
170741506|NCT01852058|617060449|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741507|NCT01852058|617060450|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741508|NCT01852058|617060451|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741509|NCT01852058|617060452|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741510|NCT01852058|617060453|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741511|NCT01852058|617060454|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
170741512|NCT01852058|617060443|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741513|NCT01852058|617060444|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741514|NCT01852058|617060445|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741515|NCT01852058|617060446|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741516|NCT01852058|617060447|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
170741517|NCT01852058|617060448|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741518|NCT01852058|617060449|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741519|NCT01852058|617060450|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741520|NCT01852058|617060451|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741521|NCT01852058|617060452|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170852237|NCT00371683|617464845|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
170852238|NCT00371683|617464844|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
170852239|NCT00371683|617464845|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
170852240|NCT00371683|617464844|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
170852241|NCT00371683|617464845|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
170852242|NCT00371683|617464844|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
170852243|NCT00371683|617464845|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
170852244|NCT00371683|617464844|FG000|Follow-Up Period - Randomized Patients|Death|0|||
170852245|NCT00371683|617464845|FG001|Follow-Up Period - Randomized Patients|Death|2|||
170852246|NCT00371683|617464844|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
170852247|NCT00371683|617464845|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
170852248|NCT00371683|617464844|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
170852249|NCT00371683|617464845|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
170852250|NCT03181789|617464846|FG000|Overall Study|Withdrawal by Subject|0|||
170852251|NCT03181789|617464847|FG001|Overall Study|Withdrawal by Subject|1|||
170852252|NCT03181789|617464848|FG002|Overall Study|Withdrawal by Subject|1|||
170852253|NCT03181789|617464849|FG003|Overall Study|Withdrawal by Subject|0|||
170852254|NCT03181789|617464846|FG000|Overall Study|Lost to Follow-up|7|||
170852255|NCT03181789|617464847|FG001|Overall Study|Lost to Follow-up|1|||
170852256|NCT03181789|617464848|FG002|Overall Study|Lost to Follow-up|0|||
170852257|NCT03181789|617464849|FG003|Overall Study|Lost to Follow-up|0|||
170852258|NCT03181789|617464846|FG000|Overall Study|Participant unable to adhere to visit|0|||
170852259|NCT03181789|617464847|FG001|Overall Study|Participant unable to adhere to visit|1|||
170852260|NCT03181789|617464848|FG002|Overall Study|Participant unable to adhere to visit|0|||
170852261|NCT03181789|617464849|FG003|Overall Study|Participant unable to adhere to visit|0|||
170852262|NCT02544451|617464854|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
170852263|NCT02544451|617464855|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
170852264|NCT02544451|617464856|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
170852265|NCT02544451|617464857|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
170852266|NCT02544451|617464854|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
170852267|NCT02544451|617464855|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
170852268|NCT02544451|617464856|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
170852269|NCT02544451|617464857|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
170852270|NCT02544451|617464854|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
170852271|NCT02544451|617464855|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
170852272|NCT02544451|617464856|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
170852273|NCT02544451|617464857|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
170852274|NCT02544451|617464854|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
170852275|NCT02544451|617464855|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
170852276|NCT02544451|617464856|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
170852277|NCT02544451|617464857|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
170852278|NCT02544451|617464854|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
170852279|NCT02544451|617464855|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
170852280|NCT02544451|617464856|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
170852281|NCT02544451|617464857|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
170852282|NCT02544451|617464854|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
170852283|NCT02544451|617464855|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
170852284|NCT02544451|617464856|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
170852285|NCT02544451|617464857|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
170852286|NCT00545753|617464858|FG000|Overall Study|Withdrawal by Subject|0|||
170852287|NCT00545753|617464859|FG001|Overall Study|Withdrawal by Subject|1|||
170852288|NCT00545753|617464860|FG002|Overall Study|Withdrawal by Subject|10|||
170852289|NCT00545753|617464858|FG000|Overall Study|Lost to Follow-up|13|||
170852290|NCT00545753|617464859|FG001|Overall Study|Lost to Follow-up|3|||
170852291|NCT00545753|617464860|FG002|Overall Study|Lost to Follow-up|12|||
170852292|NCT00545753|617464858|FG000|Overall Study|Protocol Violation|3|||
170852293|NCT00545753|617464859|FG001|Overall Study|Protocol Violation|1|||
170852294|NCT00545753|617464860|FG002|Overall Study|Protocol Violation|4|||
170852295|NCT00760474|617464861|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
170852296|NCT00760474|617464862|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
170852297|NCT00760474|617464861|FG000|Placebo Washout Period|Other|0|||
170852298|NCT00760474|617464862|FG001|Placebo Washout Period|Other|1|||
170852299|NCT00760474|617464861|FG000|Period 2 (P2)|Lost to Follow-up|1|||
170852300|NCT00760474|617464862|FG001|Period 2 (P2)|Lost to Follow-up|0|||
170852301|NCT00760474|617464861|FG000|Period 2 (P2)|Adverse Event|0|||
170852302|NCT00760474|617464862|FG001|Period 2 (P2)|Adverse Event|1|||
170852303|NCT04540887|617464863|FG000|Overall Study|Withdrawal by Subject|2|||
170852304|NCT01262027|617464865|FG000|Overall Study|Adverse Event|1|||
170852305|NCT01262027|617464865|FG000|Overall Study|Withdrawal by Subject|3|||
170852306|NCT01262027|617464865|FG000|Overall Study|Protocol Violation|1|||
170852307|NCT01011153|617464869|FG000|Overall Study|Less than 78 cases completed|8|||
170852308|NCT01011153|617464870|FG001|Overall Study|Less than 78 cases completed|11|||
170852309|NCT01011153|617464871|FG002|Overall Study|Less than 78 cases completed|9|||
170852310|NCT03014479|617464872|FG000|Overall Study|Adverse Event|0|||
170852311|NCT03014479|617464873|FG001|Overall Study|Adverse Event|1|||
170852312|NCT03014479|617464872|FG000|Overall Study|Voluntary Withdrawal|0|||
170852313|NCT03014479|617464873|FG001|Overall Study|Voluntary Withdrawal|2|||
170852314|NCT03014479|617464872|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
170852315|NCT03014479|617464873|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
170852316|NCT02019667|617464879|FG000|First Intervention (6 Months)|Adverse Event|0|||
170852317|NCT02019667|617464880|FG001|First Intervention (6 Months)|Adverse Event|1|||
170852318|NCT02019667|617464879|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
170852319|NCT02019667|617464880|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
170852320|NCT02019667|617464879|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
170852321|NCT02019667|617464880|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
170852322|NCT02101385|617464881|FG000|Study Treatment|Disease Progression|9|||
170852323|NCT02101385|617464882|FG001|Study Treatment|Disease Progression|3|||
170852324|NCT02101385|617464881|FG000|Study Treatment|Alternative therapy|0|||
170852325|NCT02101385|617464882|FG001|Study Treatment|Alternative therapy|1|||
170852326|NCT02101385|617464881|FG000|Study Treatment|No treatment, per protocol criteria|0|||
170852327|NCT02101385|617464882|FG001|Study Treatment|No treatment, per protocol criteria|4|||
170852328|NCT02101385|617464881|FG000|Study Treatment|Patient Non compliance|0|||
170852329|NCT02101385|617464882|FG001|Study Treatment|Patient Non compliance|2|||
170852330|NCT02101385|617464881|FG000|Study Treatment|Withdrawal by Subject|5|||
170852331|NCT02101385|617464882|FG001|Study Treatment|Withdrawal by Subject|2|||
170852332|NCT02101385|617464881|FG000|Study Treatment|screen failure|1|||
170852333|NCT02101385|617464882|FG001|Study Treatment|screen failure|0|||
170852334|NCT02101385|617464881|FG000|Study Treatment|AE/Side Effects/Complications|8|||
170852335|NCT02101385|617464882|FG001|Study Treatment|AE/Side Effects/Complications|0|||
170852336|NCT02101385|617464881|FG000|Study Treatment|Lost to Follow-up|1|||
170852337|NCT02101385|617464882|FG001|Study Treatment|Lost to Follow-up|0|||
170852338|NCT02101385|617464881|FG000|Study Treatment|Disease Progression before treatment|1|||
170852339|NCT02101385|617464882|FG001|Study Treatment|Disease Progression before treatment|0|||
170852340|NCT02101385|617464881|FG000|Study Treatment|Death|1|||
170852341|NCT02101385|617464882|FG001|Study Treatment|Death|0|||
170852342|NCT02101385|617464881|FG000|Follow up|Lost to Follow-up|4|||
170852343|NCT02101385|617464882|FG001|Follow up|Lost to Follow-up|9|||
170852344|NCT02101385|617464881|FG000|Follow up|Refused to follow up|5|||
170852345|NCT02101385|617464882|FG001|Follow up|Refused to follow up|4|||
170852346|NCT02101385|617464881|FG000|Follow up|Death|21|||
170852347|NCT02101385|617464882|FG001|Follow up|Death|39|||
170852348|NCT02101385|617464881|FG000|Follow up|study completed|33|||
170852349|NCT02101385|617464882|FG001|Follow up|study completed|52|||
170852350|NCT02101385|617464881|FG000|Follow up|screen failure|2|||
170852351|NCT02101385|617464882|FG001|Follow up|screen failure|0|||
170852352|NCT02101385|617464881|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
170852353|NCT02101385|617464882|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
170852354|NCT02101385|617464881|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
170852355|NCT02101385|617464882|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
170852356|NCT02101385|617464881|FG000|Follow up|Withdrawal by Subject|2|||
170852357|NCT02101385|617464882|FG001|Follow up|Withdrawal by Subject|2|||
170852358|NCT02101385|617464881|FG000|Follow up|PI requested closure of site|0|||
170852359|NCT02101385|617464882|FG001|Follow up|PI requested closure of site|5|||
170852360|NCT02432196|617464883|FG000|Overall Study|Exit - did not receive study device|1|||
170852361|NCT02432196|617464883|FG000|Overall Study|Death|2|||
170852362|NCT02432196|617464883|FG000|Overall Study|Reoperation|3|||
170852363|NCT03738423|617464891|FG000|Overall Study|Withdrawal by Subject|9|||
170852364|NCT03738423|617464892|FG001|Overall Study|Withdrawal by Subject|12|||
170852365|NCT03738423|617464893|FG002|Overall Study|Withdrawal by Subject|9|||
170852366|NCT03738423|617464894|FG003|Overall Study|Withdrawal by Subject|12|||
170852367|NCT03738423|617464895|FG004|Overall Study|Withdrawal by Subject|10|||
170852368|NCT03738423|617464891|FG000|Overall Study|Lack of Efficacy|3|||
170852369|NCT03738423|617464892|FG001|Overall Study|Lack of Efficacy|1|||
170741522|NCT01852058|617060453|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741523|NCT01852058|617060454|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
170741524|NCT01852058|617060443|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741525|NCT01852058|617060444|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741526|NCT01852058|617060445|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741527|NCT01852058|617060446|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741528|NCT01852058|617060447|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
170741529|NCT01852058|617060448|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
170741530|NCT01852058|617060449|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741531|NCT01852058|617060450|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741532|NCT01852058|617060451|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741533|NCT01852058|617060452|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741534|NCT01852058|617060453|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741535|NCT01852058|617060454|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
170741536|NCT01852058|617060443|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741537|NCT01852058|617060444|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741538|NCT01852058|617060445|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741539|NCT01852058|617060446|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
170741540|NCT01852058|617060447|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741541|NCT01852058|617060448|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741542|NCT01852058|617060449|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741543|NCT01852058|617060450|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741544|NCT01852058|617060451|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741545|NCT01852058|617060452|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741546|NCT01852058|617060453|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741547|NCT01852058|617060454|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
170741548|NCT01852058|617060443|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741549|NCT01852058|617060444|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170852370|NCT03738423|617464893|FG002|Overall Study|Lack of Efficacy|1|||
170852371|NCT03738423|617464894|FG003|Overall Study|Lack of Efficacy|1|||
170852372|NCT03738423|617464895|FG004|Overall Study|Lack of Efficacy|2|||
170852373|NCT03738423|617464891|FG000|Overall Study|Lost to Follow-up|1|||
170852374|NCT03738423|617464892|FG001|Overall Study|Lost to Follow-up|0|||
170852375|NCT03738423|617464893|FG002|Overall Study|Lost to Follow-up|1|||
170852376|NCT03738423|617464894|FG003|Overall Study|Lost to Follow-up|1|||
170852377|NCT03738423|617464895|FG004|Overall Study|Lost to Follow-up|0|||
170852378|NCT03738423|617464891|FG000|Overall Study|Protocol Violation|1|||
170852379|NCT03738423|617464892|FG001|Overall Study|Protocol Violation|0|||
170852380|NCT03738423|617464893|FG002|Overall Study|Protocol Violation|0|||
170852381|NCT03738423|617464894|FG003|Overall Study|Protocol Violation|0|||
170852382|NCT03738423|617464895|FG004|Overall Study|Protocol Violation|1|||
170852383|NCT03738423|617464891|FG000|Overall Study|Physician Decision|0|||
170852384|NCT03738423|617464892|FG001|Overall Study|Physician Decision|0|||
170852385|NCT03738423|617464893|FG002|Overall Study|Physician Decision|1|||
170852386|NCT03738423|617464894|FG003|Overall Study|Physician Decision|0|||
170852387|NCT03738423|617464895|FG004|Overall Study|Physician Decision|1|||
170852388|NCT03738423|617464891|FG000|Overall Study|Death|0|||
170852389|NCT03738423|617464892|FG001|Overall Study|Death|0|||
170852390|NCT03738423|617464893|FG002|Overall Study|Death|0|||
170852391|NCT03738423|617464894|FG003|Overall Study|Death|0|||
170852392|NCT03738423|617464895|FG004|Overall Study|Death|1|||
170852393|NCT03738423|617464891|FG000|Overall Study|Randomized but never treated|0|||
170852394|NCT03738423|617464892|FG001|Overall Study|Randomized but never treated|0|||
170852395|NCT03738423|617464893|FG002|Overall Study|Randomized but never treated|1|||
170852396|NCT03738423|617464894|FG003|Overall Study|Randomized but never treated|1|||
170852397|NCT03738423|617464895|FG004|Overall Study|Randomized but never treated|0|||
170852398|NCT04664400|617464900|FG000|Overall Study|Withdrawal by Subject|2|||
170852399|NCT03973931|617464901|FG000|Overall Study|Lost to Follow-up|47|||
170852400|NCT03973931|617464902|FG001|Overall Study|Lost to Follow-up|63|||
170852401|NCT03973931|617464903|FG002|Overall Study|Lost to Follow-up|51|||
170852402|NCT03973931|617464904|FG003|Overall Study|Lost to Follow-up|54|||
170852403|NCT03973931|617464901|FG000|Overall Study|opted out|6|||
170852404|NCT03973931|617464902|FG001|Overall Study|opted out|5|||
170852405|NCT03973931|617464903|FG002|Overall Study|opted out|5|||
170852406|NCT03973931|617464904|FG003|Overall Study|opted out|1|||
170852407|NCT00153062|617466429|FG000|Overall Study|Death|360|||
170852408|NCT00153062|617466430|FG001|Overall Study|Death|352|||
170852409|NCT00153062|617466431|FG002|Overall Study|Death|369|||
170852410|NCT00153062|617466432|FG003|Overall Study|Death|365|||
170852411|NCT00153062|617466429|FG000|Overall Study|Withdrawal by Subject|14|||
170852412|NCT00153062|617466430|FG001|Overall Study|Withdrawal by Subject|30|||
170852413|NCT00153062|617466431|FG002|Overall Study|Withdrawal by Subject|27|||
170741550|NCT01852058|617060445|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741551|NCT01852058|617060446|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741552|NCT01852058|617060447|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
170741553|NCT01852058|617060448|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
170741554|NCT01852058|617060449|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741555|NCT01852058|617060450|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741556|NCT01852058|617060451|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741557|NCT01852058|617060452|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741558|NCT01852058|617060453|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741559|NCT01852058|617060454|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
170741560|NCT01852058|617060443|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741561|NCT01852058|617060444|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741562|NCT01852058|617060445|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741563|NCT01852058|617060446|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741564|NCT01852058|617060447|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741565|NCT01852058|617060448|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741566|NCT01852058|617060449|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741567|NCT01852058|617060450|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
170741568|NCT01852058|617060451|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741569|NCT01852058|617060452|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741570|NCT01852058|617060453|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741571|NCT01852058|617060454|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
170741572|NCT01852058|617060443|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741573|NCT01852058|617060444|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741574|NCT01852058|617060445|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741575|NCT01852058|617060446|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741576|NCT01852058|617060447|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741577|NCT01852058|617060448|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741578|NCT01852058|617060449|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741579|NCT01852058|617060450|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741580|NCT01852058|617060451|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
170741581|NCT01852058|617060452|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741582|NCT01852058|617060453|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741583|NCT01852058|617060454|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
170741584|NCT00263328|617060455|FG000|Overall Study|Death|0|||
170741585|NCT00263328|617060456|FG001|Overall Study|Death|0|||
170741586|NCT00263328|617060457|FG002|Overall Study|Death|1|||
170741587|NCT00263328|617060455|FG000|Overall Study|Lost to Follow-up|1|||
170741588|NCT00263328|617060456|FG001|Overall Study|Lost to Follow-up|1|||
170741589|NCT00263328|617060457|FG002|Overall Study|Lost to Follow-up|0|||
170741590|NCT00263328|617060455|FG000|Overall Study|Withdrawal by Subject|3|||
170741591|NCT00263328|617060456|FG001|Overall Study|Withdrawal by Subject|0|||
170741592|NCT00263328|617060457|FG002|Overall Study|Withdrawal by Subject|1|||
170741593|NCT00263328|617060455|FG000|Overall Study|Other|3|||
170741594|NCT00263328|617060456|FG001|Overall Study|Other|0|||
170741595|NCT00263328|617060457|FG002|Overall Study|Other|1|||
170741596|NCT00263328|617060455|FG000|Overall Study|Adverse Event|1|||
170741597|NCT00263328|617060456|FG001|Overall Study|Adverse Event|1|||
170741598|NCT00263328|617060457|FG002|Overall Study|Adverse Event|4|||
170852414|NCT00153062|617466432|FG003|Overall Study|Withdrawal by Subject|28|||
170852415|NCT00153062|617466429|FG000|Overall Study|Lost to Follow-up|12|||
170852416|NCT00153062|617466430|FG001|Overall Study|Lost to Follow-up|20|||
170852417|NCT00153062|617466431|FG002|Overall Study|Lost to Follow-up|15|||
170852418|NCT00153062|617466432|FG003|Overall Study|Lost to Follow-up|16|||
170852419|NCT00153062|617466429|FG000|Overall Study|Adverse Event|0|||
170852420|NCT00153062|617466430|FG001|Overall Study|Adverse Event|1|||
170852421|NCT00153062|617466431|FG002|Overall Study|Adverse Event|1|||
170852422|NCT00153062|617466432|FG003|Overall Study|Adverse Event|0|||
170852423|NCT00153062|617466429|FG000|Overall Study|Protocol Violation|0|||
170852424|NCT00153062|617466430|FG001|Overall Study|Protocol Violation|2|||
170852425|NCT00153062|617466431|FG002|Overall Study|Protocol Violation|1|||
170852426|NCT00153062|617466432|FG003|Overall Study|Protocol Violation|1|||
170852427|NCT00153062|617466429|FG000|Overall Study|No disposition data available|1|||
170852428|NCT00153062|617466430|FG001|Overall Study|No disposition data available|1|||
170852429|NCT00153062|617466431|FG002|Overall Study|No disposition data available|1|||
170852430|NCT00153062|617466432|FG003|Overall Study|No disposition data available|1|||
170852431|NCT00153062|617466429|FG000|Overall Study|Other|0|||
170852432|NCT00153062|617466430|FG001|Overall Study|Other|0|||
170852433|NCT00153062|617466431|FG002|Overall Study|Other|1|||
170741599|NCT01279343|617060458|FG000|Overall Study|Did not receive treatment|2|||
170741600|NCT01279343|617060459|FG001|Overall Study|Did not receive treatment|6|||
170741601|NCT02223754|617060462|FG000|Period 1|Adverse Event|1|||
170741602|NCT02223754|617060463|FG001|Period 1|Adverse Event|0|||
170741603|NCT02223754|617060462|FG000|Period 1|Lost to Follow-up|0|||
170741604|NCT02223754|617060463|FG001|Period 1|Lost to Follow-up|1|||
170741605|NCT02223754|617060462|FG000|Period 1|Protocol Violation|2|||
170741606|NCT02223754|617060463|FG001|Period 1|Protocol Violation|4|||
170741607|NCT02223754|617060462|FG000|Period 1|Withdrawal by Subject|0|||
170741608|NCT02223754|617060463|FG001|Period 1|Withdrawal by Subject|4|||
170741609|NCT02223754|617060462|FG000|Period 1|Test Article No Longer Available|1|||
170741610|NCT02223754|617060463|FG001|Period 1|Test Article No Longer Available|5|||
170741611|NCT02223754|617060462|FG000|Period 1|Unsatisfactory Visual Response|0|||
170741612|NCT02223754|617060463|FG001|Period 1|Unsatisfactory Visual Response|1|||
170741613|NCT02223754|617060462|FG000|Period 2|Adverse Event|0|||
170741614|NCT02223754|617060463|FG001|Period 2|Adverse Event|1|||
170741615|NCT02223754|617060462|FG000|Period 2|Protocol Violation|1|||
170741616|NCT02223754|617060463|FG001|Period 2|Protocol Violation|0|||
170741617|NCT02223754|617060462|FG000|Period 2|Lens Discomfort|1|||
170741618|NCT02223754|617060463|FG001|Period 2|Lens Discomfort|1|||
170741619|NCT02223754|617060462|FG000|Period 2|Lost to Follow-up|1|||
170741620|NCT02223754|617060463|FG001|Period 2|Lost to Follow-up|0|||
170741621|NCT02223754|617060462|FG000|Period 2|Test Article No Longer Available|0|||
170741622|NCT02223754|617060463|FG001|Period 2|Test Article No Longer Available|1|||
170741623|NCT04395183|617060466|FG000|Overall Study|Withdrawal by Subject|1|||
170741624|NCT04395183|617060467|FG001|Overall Study|Withdrawal by Subject|0|||
170741625|NCT04395183|617060468|FG002|Overall Study|Withdrawal by Subject|2|||
170741626|NCT04395183|617060469|FG003|Overall Study|Withdrawal by Subject|2|||
170741627|NCT02668016|617060470|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
170741628|NCT02668016|617060470|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
170741629|NCT02668016|617060470|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
170741630|NCT02668016|617060470|FG000|Month 4|Withdrawal due to severe symptoms|1|||
170741631|NCT02668016|617060470|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
170741632|NCT02668016|617060470|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
170741633|NCT02668016|617060470|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
170741634|NCT02668016|617060470|FG000|Month 6|Withdrawal due to severe symptoms|2|||
170741635|NCT02668016|617060470|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
170741636|NCT02668016|617060470|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
170741637|NCT02668016|617060470|FG000|Month 8|Withdrawal due to severe symptoms|1|||
170741638|NCT02668016|617060470|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
170741639|NCT02668016|617060470|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
170741640|NCT02668016|617060470|FG000|Month 10|Withdrawal due to severe symptoms|1|||
170741641|NCT02668016|617060470|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
170741642|NCT01893827|617060472|FG000|Overall Study|Lost to Follow-up|19|||
170852434|NCT00153062|617466432|FG003|Overall Study|Other|0|||
170852435|NCT00117845|617466442|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
170852436|NCT00910689|617466443|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
170852437|NCT00910689|617466444|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
170852438|NCT00910689|617466445|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
170852439|NCT00910689|617466446|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
170852440|NCT00910689|617466443|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
170852441|NCT00910689|617466444|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
170852442|NCT00910689|617466445|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
170852443|NCT00910689|617466446|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
170852444|NCT00910689|617466443|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
170852445|NCT00910689|617466444|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
170852446|NCT00910689|617466445|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
170852447|NCT00910689|617466446|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
170852448|NCT00910689|617466443|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
170852449|NCT00910689|617466444|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
170852450|NCT00910689|617466445|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
170852451|NCT00910689|617466446|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
170852452|NCT00910689|617466443|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
170852453|NCT00910689|617466444|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
170852454|NCT00910689|617466445|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
170852455|NCT00910689|617466446|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
170852456|NCT00910689|617466443|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
170852457|NCT00910689|617466444|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
170852458|NCT00910689|617466445|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
170852459|NCT00910689|617466446|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
170852460|NCT00910689|617466443|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
170852461|NCT00910689|617466444|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
170852462|NCT00910689|617466445|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
170852463|NCT00910689|617466446|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
170852464|NCT00910689|617466443|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
170852465|NCT00910689|617466444|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
170852466|NCT00910689|617466445|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
170852467|NCT00910689|617466446|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
170852468|NCT00910689|617466443|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
170852469|NCT00910689|617466444|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
170852470|NCT00910689|617466445|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
170852471|NCT00910689|617466446|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
170852472|NCT00910689|617466443|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
170852473|NCT00910689|617466444|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
170852474|NCT00910689|617466445|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
170852475|NCT00910689|617466446|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
170852476|NCT00910689|617466443|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
170852477|NCT00910689|617466444|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
170852478|NCT00910689|617466445|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
170852479|NCT00910689|617466446|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
170852480|NCT00910689|617466443|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
170852481|NCT00910689|617466444|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
170852482|NCT00910689|617466445|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
170852483|NCT00910689|617466446|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
170852484|NCT00910689|617466443|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
170852485|NCT00910689|617466444|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
170852486|NCT00910689|617466445|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
170852487|NCT00910689|617466446|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
170852488|NCT00910689|617466443|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
170852489|NCT00910689|617466444|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
170852490|NCT00910689|617466445|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
170852491|NCT00910689|617466446|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
170852492|NCT00910689|617466443|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
170852493|NCT00910689|617466444|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
170852494|NCT00910689|617466445|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
170852495|NCT00910689|617466446|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
170852496|NCT00910689|617466443|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
170852497|NCT00910689|617466444|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
170852498|NCT00910689|617466445|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
170852499|NCT00910689|617466446|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
170852500|NCT00910689|617466443|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
170852501|NCT00910689|617466444|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
170741643|NCT01893827|617060473|FG001|Overall Study|Lost to Follow-up|26|||
170741644|NCT02917941|617060474|FG000|Treatment Period|Adverse Event|11|||
170741645|NCT02917941|617060474|FG000|Treatment Period|Progressive Disease|11|||
170741646|NCT02917941|617060474|FG000|Treatment Period|Reason not Specified|2|||
170741647|NCT02917941|617060474|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
170741648|NCT02917941|617060474|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
170741649|NCT03573908|617060475|FG000|Treatment Period|Adverse Event|4|||
170741650|NCT03573908|617060476|FG001|Treatment Period|Adverse Event|9|||
170741651|NCT03573908|617060477|FG002|Treatment Period|Adverse Event|0|||
170741652|NCT03573908|617060478|FG003|Treatment Period|Adverse Event|0|||
170741653|NCT03573908|617060479|FG004|Treatment Period|Adverse Event|0|||
170741654|NCT03573908|617060475|FG000|Treatment Period|Protocol Violation|1|||
170741655|NCT03573908|617060476|FG001|Treatment Period|Protocol Violation|0|||
170741656|NCT03573908|617060477|FG002|Treatment Period|Protocol Violation|0|||
170741657|NCT03573908|617060478|FG003|Treatment Period|Protocol Violation|0|||
170741658|NCT03573908|617060479|FG004|Treatment Period|Protocol Violation|0|||
170741659|NCT03573908|617060475|FG000|Treatment Period|Withdrawal by Subject|7|||
170741660|NCT03573908|617060476|FG001|Treatment Period|Withdrawal by Subject|5|||
170741661|NCT03573908|617060477|FG002|Treatment Period|Withdrawal by Subject|0|||
170741662|NCT03573908|617060478|FG003|Treatment Period|Withdrawal by Subject|0|||
170741663|NCT03573908|617060479|FG004|Treatment Period|Withdrawal by Subject|0|||
170741664|NCT03573908|617060475|FG000|Treatment Period|Lost to Follow-up|7|||
170741665|NCT03573908|617060476|FG001|Treatment Period|Lost to Follow-up|6|||
170741666|NCT03573908|617060477|FG002|Treatment Period|Lost to Follow-up|0|||
170741667|NCT03573908|617060478|FG003|Treatment Period|Lost to Follow-up|0|||
170741668|NCT03573908|617060479|FG004|Treatment Period|Lost to Follow-up|0|||
170741669|NCT03573908|617060475|FG000|Treatment Period|Pregnancy|1|||
170741670|NCT03573908|617060476|FG001|Treatment Period|Pregnancy|0|||
170741671|NCT03573908|617060477|FG002|Treatment Period|Pregnancy|0|||
170741672|NCT03573908|617060478|FG003|Treatment Period|Pregnancy|0|||
170741673|NCT03573908|617060479|FG004|Treatment Period|Pregnancy|0|||
170741674|NCT03573908|617060475|FG000|Treatment Period|Other, Not Specified|4|||
170741675|NCT03573908|617060476|FG001|Treatment Period|Other, Not Specified|6|||
170741676|NCT03573908|617060477|FG002|Treatment Period|Other, Not Specified|0|||
170741677|NCT03573908|617060478|FG003|Treatment Period|Other, Not Specified|0|||
170741678|NCT03573908|617060479|FG004|Treatment Period|Other, Not Specified|0|||
170741679|NCT03573908|617060475|FG000|Randomized Withdrawal Period|Adverse Event|0|||
170741680|NCT03573908|617060476|FG001|Randomized Withdrawal Period|Adverse Event|0|||
170741681|NCT03573908|617060477|FG002|Randomized Withdrawal Period|Adverse Event|3|||
170741682|NCT03573908|617060478|FG003|Randomized Withdrawal Period|Adverse Event|0|||
170741683|NCT03573908|617060479|FG004|Randomized Withdrawal Period|Adverse Event|0|||
170741684|NCT03573908|617060475|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170741685|NCT03573908|617060476|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170741686|NCT03573908|617060477|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170741687|NCT03573908|617060478|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170741688|NCT03573908|617060479|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
170741689|NCT03573908|617060475|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
170741690|NCT03573908|617060476|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
170741691|NCT03573908|617060477|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
170741692|NCT03573908|617060478|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
170741693|NCT03573908|617060479|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
170741694|NCT03573908|617060475|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
170741695|NCT03573908|617060476|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
170741696|NCT03573908|617060477|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
170741697|NCT03573908|617060478|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
170741698|NCT03573908|617060479|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
170741699|NCT04006925|617060480|FG000|Overall Study|Side effects|2|||
170741700|NCT04006925|617060481|FG001|Overall Study|Side effects|0|||
170741701|NCT02669095|617060482|FG000|Overall Study|Adverse Event|1|||
170741702|NCT02669095|617060483|FG001|Overall Study|Adverse Event|0|||
170741703|NCT02669095|617060482|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
170741704|NCT02669095|617060483|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
170741705|NCT02669095|617060482|FG000|Overall Study|Torn Lens|0|||
170741706|NCT02669095|617060483|FG001|Overall Study|Torn Lens|1|||
170741707|NCT02669095|617060482|FG000|Overall Study|Visit 5 assessments not completed|0|||
170741708|NCT02669095|617060483|FG001|Overall Study|Visit 5 assessments not completed|1|||
170741709|NCT00738101|617060488|FG000|Overall Study|Physician Decision|5|||
170741710|NCT00738101|617060488|FG000|Overall Study|Death|1|||
170741711|NCT00738101|617060488|FG000|Overall Study|Repeat enrollment|1|||
170741712|NCT01923896|617062129|FG000|Overall Study|Adverse Event|1|||
170741713|NCT01923896|617062130|FG001|Overall Study|Adverse Event|0|||
170741714|NCT00312858|617062134|FG000|Overall Study|Adverse Event|0|||
170741715|NCT00312858|617062135|FG001|Overall Study|Adverse Event|1|||
170741716|NCT00312858|617062134|FG000|Overall Study|Lost to Follow-up|25|||
170741717|NCT00312858|617062135|FG001|Overall Study|Lost to Follow-up|42|||
170741718|NCT00312858|617062134|FG000|Overall Study|Protocol Violation|3|||
170741719|NCT00312858|617062135|FG001|Overall Study|Protocol Violation|8|||
170741720|NCT00312858|617062134|FG000|Overall Study|Withdraw by Participant|20|||
170741721|NCT00312858|617062135|FG001|Overall Study|Withdraw by Participant|20|||
170741722|NCT00312858|617062134|FG000|Overall Study|Participant Moved|11|||
170741723|NCT00312858|617062135|FG001|Overall Study|Participant Moved|10|||
170741724|NCT00312858|617062134|FG000|Overall Study|Other|9|||
170741725|NCT00312858|617062135|FG001|Overall Study|Other|12|||
170741726|NCT02318719|617062136|FG000|Double-blind Phase|Adverse Event|7|||
170741727|NCT02318719|617062137|FG001|Double-blind Phase|Adverse Event|6|||
170741728|NCT02318719|617062138|FG002|Double-blind Phase|Adverse Event|12|||
170741729|NCT02318719|617062139|FG003|Double-blind Phase|Adverse Event|4|||
170741730|NCT02318719|617062140|FG004|Double-blind Phase|Adverse Event|0|||
170741731|NCT02318719|617062136|FG000|Double-blind Phase|Lack of Efficacy|5|||
170741732|NCT02318719|617062137|FG001|Double-blind Phase|Lack of Efficacy|0|||
170741733|NCT02318719|617062138|FG002|Double-blind Phase|Lack of Efficacy|1|||
170741734|NCT02318719|617062139|FG003|Double-blind Phase|Lack of Efficacy|1|||
170741735|NCT02318719|617062140|FG004|Double-blind Phase|Lack of Efficacy|0|||
170741736|NCT02318719|617062136|FG000|Double-blind Phase|Protocol Violation|0|||
170741737|NCT02318719|617062137|FG001|Double-blind Phase|Protocol Violation|1|||
170741738|NCT02318719|617062138|FG002|Double-blind Phase|Protocol Violation|3|||
170741739|NCT02318719|617062139|FG003|Double-blind Phase|Protocol Violation|0|||
170741740|NCT02318719|617062140|FG004|Double-blind Phase|Protocol Violation|0|||
170741741|NCT02318719|617062136|FG000|Double-blind Phase|Withdrawal by Subject|25|||
170741742|NCT02318719|617062137|FG001|Double-blind Phase|Withdrawal by Subject|7|||
170741743|NCT02318719|617062138|FG002|Double-blind Phase|Withdrawal by Subject|9|||
170741744|NCT02318719|617062139|FG003|Double-blind Phase|Withdrawal by Subject|10|||
170741745|NCT02318719|617062140|FG004|Double-blind Phase|Withdrawal by Subject|0|||
170741746|NCT02318719|617062136|FG000|Double-blind Phase|Other|1|||
170741747|NCT02318719|617062137|FG001|Double-blind Phase|Other|2|||
170741748|NCT02318719|617062138|FG002|Double-blind Phase|Other|0|||
170741749|NCT02318719|617062139|FG003|Double-blind Phase|Other|0|||
170741750|NCT02318719|617062140|FG004|Double-blind Phase|Other|0|||
170741751|NCT02318719|617062136|FG000|Open-label Extension Phase|Adverse Event|0|||
170741752|NCT02318719|617062137|FG001|Open-label Extension Phase|Adverse Event|0|||
170741753|NCT02318719|617062138|FG002|Open-label Extension Phase|Adverse Event|0|||
170741754|NCT02318719|617062139|FG003|Open-label Extension Phase|Adverse Event|0|||
170741755|NCT02318719|617062140|FG004|Open-label Extension Phase|Adverse Event|15|||
170741756|NCT02318719|617062136|FG000|Open-label Extension Phase|Death|0|||
170741757|NCT02318719|617062137|FG001|Open-label Extension Phase|Death|0|||
170741758|NCT02318719|617062138|FG002|Open-label Extension Phase|Death|0|||
170741759|NCT02318719|617062139|FG003|Open-label Extension Phase|Death|0|||
170741760|NCT02318719|617062140|FG004|Open-label Extension Phase|Death|1|||
170741761|NCT02318719|617062136|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
170741762|NCT02318719|617062137|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
170741763|NCT02318719|617062138|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
170741764|NCT02318719|617062139|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
170741765|NCT02318719|617062140|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
170741766|NCT02318719|617062136|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
170741767|NCT02318719|617062137|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
170741768|NCT02318719|617062138|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
170741769|NCT02318719|617062139|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
170741770|NCT02318719|617062140|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
170741771|NCT02318719|617062136|FG000|Open-label Extension Phase|Other|0|||
170741772|NCT02318719|617062137|FG001|Open-label Extension Phase|Other|0|||
170741773|NCT02318719|617062138|FG002|Open-label Extension Phase|Other|0|||
170741774|NCT02318719|617062139|FG003|Open-label Extension Phase|Other|0|||
170741775|NCT02318719|617062140|FG004|Open-label Extension Phase|Other|7|||
170741776|NCT00802659|617062144|FG000|Overall Study|Physician Decision|0|||
170741777|NCT00802659|617062145|FG001|Overall Study|Physician Decision|1|||
170741778|NCT00802659|617062146|FG002|Overall Study|Physician Decision|0|||
170741779|NCT00802659|617062147|FG003|Overall Study|Physician Decision|0|||
170741780|NCT03093428|617062148|FG000|Overall Study|Not eligible for treatment|2|||
170741781|NCT03093428|617062149|FG001|Overall Study|Not eligible for treatment|1|||
170741782|NCT03093428|617062148|FG000|Overall Study|Progression|14|||
170741783|NCT03093428|617062149|FG001|Overall Study|Progression|4|||
170741784|NCT03093428|617062148|FG000|Overall Study|Death|1|||
170741785|NCT03093428|617062149|FG001|Overall Study|Death|0|||
170741786|NCT03093428|617062148|FG000|Overall Study|Adverse Event|1|||
170741787|NCT03093428|617062149|FG001|Overall Study|Adverse Event|0|||
170741788|NCT03093428|617062148|FG000|Overall Study|Withdrawal by Subject|1|||
170741789|NCT03093428|617062149|FG001|Overall Study|Withdrawal by Subject|1|||
170741790|NCT02176421|617062152|FG000|Overall Study|Lost to Follow-up|4|||
170741791|NCT02176421|617062152|FG000|Overall Study|Adverse Event|1|||
170741792|NCT01129336|617062153|FG000|Overall Study|Protocol Violation|1|||
170741793|NCT01129336|617062154|FG001|Overall Study|Protocol Violation|0|||
170741794|NCT01129336|617062153|FG000|Overall Study|Disease Progression|1|||
170852502|NCT00910689|617466445|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
170852503|NCT00910689|617466446|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
170852504|NCT00910689|617466443|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
170852505|NCT00910689|617466444|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
170852506|NCT00910689|617466445|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
170852507|NCT00910689|617466446|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
170852508|NCT00910689|617466443|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
170852509|NCT00910689|617466444|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
170852510|NCT00910689|617466445|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
170852511|NCT00910689|617466446|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
170852512|NCT00910689|617466443|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
170852513|NCT00910689|617466444|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
170852514|NCT00910689|617466445|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
170852515|NCT00910689|617466446|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
170852516|NCT00910689|617466443|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
170852517|NCT00910689|617466444|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
170852518|NCT00910689|617466445|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
170852519|NCT00910689|617466446|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
170852520|NCT00189488|617466447|FG000|Overall Study|Ineligibility determined|1|||
170852521|NCT00189488|617466448|FG001|Overall Study|Ineligibility determined|0|||
170852522|NCT00189488|617466447|FG000|Overall Study|Protocol deviation|2|||
170852523|NCT00189488|617466448|FG001|Overall Study|Protocol deviation|1|||
170852524|NCT00189488|617466447|FG000|Overall Study|Adverse Event|2|||
170852525|NCT00189488|617466448|FG001|Overall Study|Adverse Event|1|||
170852526|NCT00189488|617466447|FG000|Overall Study|Withdrawal by Subject|2|||
170852527|NCT00189488|617466448|FG001|Overall Study|Withdrawal by Subject|6|||
170852528|NCT00189488|617466447|FG000|Overall Study|Disease progression|2|||
170852529|NCT00189488|617466448|FG001|Overall Study|Disease progression|4|||
170852530|NCT00189488|617466447|FG000|Overall Study|Administrative Decision|0|||
170852531|NCT00189488|617466448|FG001|Overall Study|Administrative Decision|2|||
170852532|NCT00189488|617466447|FG000|Overall Study|Death|5|||
170852533|NCT00189488|617466448|FG001|Overall Study|Death|8|||
170852534|NCT00189488|617466447|FG000|Overall Study|Other|1|||
170852535|NCT00189488|617466448|FG001|Overall Study|Other|0|||
170852536|NCT02233543|617466449|FG000|Period 1|Withdrawal by Subject|1|||
170852537|NCT02233543|617466450|FG001|Period 1|Withdrawal by Subject|0|||
170852538|NCT02233543|617466449|FG000|Period 1|Participants required other treatment.|2|||
170852539|NCT02233543|617466450|FG001|Period 1|Participants required other treatment.|3|||
170852540|NCT02233543|617466449|FG000|Period 2|Adverse Event|1|||
170852541|NCT02233543|617466450|FG001|Period 2|Adverse Event|0|||
170852542|NCT02233543|617466449|FG000|Period 2|Participant required other treatment.|0|||
170852543|NCT02233543|617466450|FG001|Period 2|Participant required other treatment.|1|||
170852544|NCT02233543|617466449|FG000|Period 2|COPD exacerbation|1|||
170852545|NCT02233543|617466450|FG001|Period 2|COPD exacerbation|0|||
170852546|NCT02349425|617466451|FG000|Period 1|Adverse Event|1|||
170852547|NCT02349425|617466452|FG001|Period 1|Adverse Event|1|||
170852548|NCT02349425|617466453|FG002|Period 1|Adverse Event|0|||
170852549|NCT02349425|617466454|FG003|Period 1|Adverse Event|0|||
170852550|NCT02349425|617466451|FG000|Period 2|Adverse Event|0|||
170852551|NCT02349425|617466452|FG001|Period 2|Adverse Event|1|||
170852552|NCT02349425|617466453|FG002|Period 2|Adverse Event|1|||
170852553|NCT02349425|617466454|FG003|Period 2|Adverse Event|0|||
170852554|NCT02480153|617466462|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
170852555|NCT02480153|617466463|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
170852556|NCT02480153|617466464|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
170852557|NCT02480153|617466462|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
170852558|NCT02480153|617466463|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
170852559|NCT02480153|617466464|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
170852560|NCT02480153|617466462|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
170852561|NCT02480153|617466463|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
170852562|NCT02480153|617466464|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
170852563|NCT02480153|617466462|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
170852564|NCT02480153|617466463|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
170852565|NCT02480153|617466464|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
170741795|NCT01129336|617062154|FG001|Overall Study|Disease Progression|4|||
170741796|NCT01129336|617062153|FG000|Overall Study|Lost to Follow-up|1|||
170741797|NCT01129336|617062154|FG001|Overall Study|Lost to Follow-up|0|||
170741798|NCT01129336|617062153|FG000|Overall Study|Withdrawal by Subject|7|||
170741799|NCT01129336|617062154|FG001|Overall Study|Withdrawal by Subject|4|||
170741800|NCT01129336|617062153|FG000|Overall Study|Adverse Event|0|||
170741801|NCT01129336|617062154|FG001|Overall Study|Adverse Event|1|||
170741802|NCT01129336|617062153|FG000|Overall Study|Missing Study Completion Status|2|||
170741803|NCT01129336|617062154|FG001|Overall Study|Missing Study Completion Status|3|||
170741804|NCT01129336|617062153|FG000|Overall Study|Death|0|||
170741805|NCT01129336|617062154|FG001|Overall Study|Death|4|||
170741806|NCT03066622|617062161|FG000|Overall Study|Lost to Follow-up|24|||
170741807|NCT03066622|617062162|FG001|Overall Study|Lost to Follow-up|25|||
170741808|NCT03066622|617062161|FG000|Overall Study|Withdrawal by Subject|2|||
170741809|NCT03066622|617062162|FG001|Overall Study|Withdrawal by Subject|1|||
170741810|NCT00641719|617062163|FG000|Overall Study|Lack of Efficacy|1|||
170741811|NCT00641719|617062164|FG001|Overall Study|Lack of Efficacy|2|||
170852566|NCT02480153|617466462|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
170852567|NCT02480153|617466463|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
170852568|NCT02480153|617466464|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
170852569|NCT02480153|617466462|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
170852570|NCT02480153|617466463|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
170852571|NCT02480153|617466464|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
170852572|NCT02480153|617466462|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
170852573|NCT02480153|617466463|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
170852574|NCT02480153|617466464|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
170852575|NCT02480153|617466462|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
170852576|NCT02480153|617466463|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
170852577|NCT02480153|617466464|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
170852578|NCT02480153|617466462|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
170852579|NCT02480153|617466463|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
170852580|NCT02480153|617466464|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
170852581|NCT02480153|617466462|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
170852582|NCT02480153|617466463|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
170852583|NCT02480153|617466464|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
170852584|NCT02480153|617466462|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
170852585|NCT02480153|617466463|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
170852586|NCT02480153|617466464|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
170852587|NCT02480153|617466462|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
170852588|NCT02480153|617466463|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
170852589|NCT02480153|617466464|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
170852590|NCT02480153|617466462|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
170852591|NCT02480153|617466463|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
170852592|NCT02480153|617466464|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
170852593|NCT02480153|617466462|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
170852594|NCT02480153|617466463|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
170852595|NCT02480153|617466464|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
170852596|NCT02480153|617466462|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
170741812|NCT00641719|617062163|FG000|Overall Study|Adverse Event|24|||
170741813|NCT00641719|617062164|FG001|Overall Study|Adverse Event|29|||
170741814|NCT00641719|617062163|FG000|Overall Study|Withdrawal by Subject|4|||
170741815|NCT00641719|617062164|FG001|Overall Study|Withdrawal by Subject|4|||
170741816|NCT00641719|617062163|FG000|Overall Study|Reason Not Specified|1|||
170741817|NCT00641719|617062164|FG001|Overall Study|Reason Not Specified|2|||
170741818|NCT03321006|617062165|FG000|Overall Study|Death|1|||
170741819|NCT03321006|617062166|FG001|Overall Study|Death|0|||
170741820|NCT03321006|617062165|FG000|Overall Study|Lack of Efficacy|1|||
170741821|NCT03321006|617062166|FG001|Overall Study|Lack of Efficacy|0|||
170741822|NCT03303469|617062167|FG000|Overall Study|Lost to Follow-up|2|||
170741823|NCT03893825|617062170|FG000|Overall Study|Death|2|||
170741824|NCT03893825|617062171|FG001|Overall Study|Death|1|||
170741825|NCT03893825|617062170|FG000|Overall Study|Adverse Event|0|||
170741826|NCT03893825|617062171|FG001|Overall Study|Adverse Event|2|||
170741827|NCT03893825|617062170|FG000|Overall Study|Withdrawal by Subject|19|||
170741828|NCT03893825|617062171|FG001|Overall Study|Withdrawal by Subject|21|||
170741829|NCT03893825|617062170|FG000|Overall Study|Protocol deviation|1|||
170741830|NCT03893825|617062171|FG001|Overall Study|Protocol deviation|0|||
170741831|NCT03893825|617062170|FG000|Overall Study|Lost to Follow-up|10|||
170741832|NCT03893825|617062171|FG001|Overall Study|Lost to Follow-up|10|||
170741833|NCT03893825|617062170|FG000|Overall Study|Other than specified|7|||
170741834|NCT03893825|617062171|FG001|Overall Study|Other than specified|6|||
170741835|NCT00154310|617062172|FG000|Overall Study|Adverse Event|19|||
170741836|NCT00154310|617062173|FG001|Overall Study|Adverse Event|9|||
170741837|NCT00154310|617062172|FG000|Overall Study|Lack of Efficacy|5|||
170741838|NCT00154310|617062173|FG001|Overall Study|Lack of Efficacy|4|||
170741839|NCT00154310|617062172|FG000|Overall Study|Protocol Violation|4|||
170741840|NCT00154310|617062173|FG001|Overall Study|Protocol Violation|2|||
170741841|NCT00154310|617062172|FG000|Overall Study|Withdrawal by Subject|9|||
170741842|NCT00154310|617062173|FG001|Overall Study|Withdrawal by Subject|3|||
170741843|NCT00154310|617062172|FG000|Overall Study|Lost to Follow-up|0|||
170741844|NCT00154310|617062173|FG001|Overall Study|Lost to Follow-up|8|||
170741845|NCT00154310|617062172|FG000|Overall Study|Administrative problems|0|||
170741846|NCT00154310|617062173|FG001|Overall Study|Administrative problems|1|||
170741847|NCT00154310|617062172|FG000|Overall Study|Death|0|||
170741848|NCT00154310|617062173|FG001|Overall Study|Death|1|||
170741849|NCT01540565|617062174|FG000|Overall Study|Ineligible|2|||
170741850|NCT04488003|617062177|FG000|Assessed for Eligibility|Screen Failure|24|||
170741851|NCT04488003|617062178|FG001|Assessed for Eligibility|Screen Failure|0|||
170741852|NCT04488003|617062179|FG002|Assessed for Eligibility|Screen Failure|0|||
170852597|NCT02480153|617466463|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
170852598|NCT02480153|617466464|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
170852599|NCT02480153|617466462|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
170852600|NCT02480153|617466463|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
170852601|NCT02480153|617466464|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
170852602|NCT02480153|617466462|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
170852603|NCT02480153|617466463|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
170852604|NCT02480153|617466464|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
170852605|NCT02480153|617466462|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
170852606|NCT02480153|617466463|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
170852607|NCT02480153|617466464|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
170852608|NCT02342743|617466469|FG000|Baseline Period|Withdrawal by Subject|3|||
170741853|NCT04488003|617062177|FG000|Assessed for Eligibility|Adverse Event|1|||
170741854|NCT04488003|617062178|FG001|Assessed for Eligibility|Adverse Event|0|||
170741855|NCT04488003|617062179|FG002|Assessed for Eligibility|Adverse Event|0|||
170741856|NCT04488003|617062177|FG000|Assessed for Eligibility|Death|1|||
170741857|NCT04488003|617062178|FG001|Assessed for Eligibility|Death|0|||
170741858|NCT04488003|617062179|FG002|Assessed for Eligibility|Death|0|||
170741859|NCT04488003|617062177|FG000|Assessed for Eligibility|Physician Decision|1|||
170741860|NCT04488003|617062178|FG001|Assessed for Eligibility|Physician Decision|0|||
170741861|NCT04488003|617062179|FG002|Assessed for Eligibility|Physician Decision|0|||
170741862|NCT04488003|617062177|FG000|Allocated to Treatment|Progressive Disease|51|||
170741863|NCT04488003|617062178|FG001|Allocated to Treatment|Progressive Disease|0|||
170741864|NCT04488003|617062179|FG002|Allocated to Treatment|Progressive Disease|0|||
170741865|NCT04488003|617062177|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
170741866|NCT04488003|617062178|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
170741867|NCT04488003|617062179|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
170741868|NCT04488003|617062177|FG000|Allocated to Treatment|Adverse Event|6|||
170741869|NCT04488003|617062178|FG001|Allocated to Treatment|Adverse Event|0|||
170741870|NCT04488003|617062179|FG002|Allocated to Treatment|Adverse Event|0|||
170741871|NCT04488003|617062177|FG000|Allocated to Treatment|Other|5|||
170741872|NCT04488003|617062178|FG001|Allocated to Treatment|Other|0|||
170741873|NCT04488003|617062179|FG002|Allocated to Treatment|Other|0|||
170741874|NCT04488003|617062177|FG000|Allocated to Treatment|Physician Decision|4|||
170741875|NCT04488003|617062178|FG001|Allocated to Treatment|Physician Decision|0|||
170741876|NCT04488003|617062179|FG002|Allocated to Treatment|Physician Decision|0|||
170741877|NCT04488003|617062177|FG000|Allocated to Treatment|Death|4|||
170741878|NCT04488003|617062178|FG001|Allocated to Treatment|Death|0|||
170741879|NCT04488003|617062179|FG002|Allocated to Treatment|Death|0|||
170741880|NCT02086162|617062181|FG000|Overall Study|Withdrawal by Subject|4|||
170741881|NCT02086162|617062182|FG001|Overall Study|Withdrawal by Subject|4|||
170741882|NCT02086162|617062181|FG000|Overall Study|moved|1|||
170741883|NCT02086162|617062182|FG001|Overall Study|moved|1|||
170741884|NCT02086162|617062181|FG000|Overall Study|Lost to Follow-up|4|||
170741885|NCT02086162|617062182|FG001|Overall Study|Lost to Follow-up|2|||
170741886|NCT02086162|617062181|FG000|Overall Study|Death|1|||
170741887|NCT02086162|617062182|FG001|Overall Study|Death|0|||
170852609|NCT02342743|617466469|FG000|Baseline Period|Lost to Follow-up|2|||
170852610|NCT02342743|617466469|FG000|Baseline Period|Change in prophylactic medication|3|||
170852611|NCT02342743|617466469|FG000|Baseline Period|Screening failure regarding baseline|7|||
170741888|NCT03283696|617062189|FG000|Overall Study|Physician Decision|5|||
170741889|NCT03283696|617062190|FG001|Overall Study|Physician Decision|6|||
170741890|NCT03283696|617062189|FG000|Overall Study|Withdrawal by Subject|2|||
170741891|NCT03283696|617062190|FG001|Overall Study|Withdrawal by Subject|0|||
170741892|NCT00007475|617062191|FG000|Overall Study|Withdrawal by Subject|1|||
170741893|NCT00007475|617062192|FG001|Overall Study|Withdrawal by Subject|0|||
170741894|NCT00007475|617062193|FG002|Overall Study|Withdrawal by Subject|0|||
170741895|NCT00007475|617062194|FG003|Overall Study|Withdrawal by Subject|0|||
170741896|NCT00007475|617062191|FG000|Overall Study|Adverse Event|3|||
170741897|NCT00007475|617062192|FG001|Overall Study|Adverse Event|0|||
170741898|NCT00007475|617062193|FG002|Overall Study|Adverse Event|0|||
170741899|NCT00007475|617062194|FG003|Overall Study|Adverse Event|0|||
170741900|NCT03000673|617062195|FG000|Overall Study|Withdrawal by Subject|1|||
170741901|NCT03000673|617062196|FG001|Overall Study|Withdrawal by Subject|0|||
170741902|NCT03000673|617062197|FG002|Overall Study|Withdrawal by Subject|0|||
170741903|NCT03000673|617062198|FG003|Overall Study|Withdrawal by Subject|0|||
170741904|NCT00423852|617062201|FG000|Overall Study|Removed pior to the high-dose portion|3|||
170741905|NCT00594217|617062206|FG000|Overall Study|Withdrawal by Subject|1|||
170741906|NCT00594217|617062207|FG001|Overall Study|Withdrawal by Subject|3|||
170741907|NCT01065350|617062214|FG000|Overall Study|Received incorrect drug allocation|0|||
170741908|NCT01065350|617062215|FG001|Overall Study|Received incorrect drug allocation|1|||
170741909|NCT00962247|617062221|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
170741910|NCT00962247|617062221|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
170741911|NCT02234063|617062222|FG000|Overall Study|Lost to Follow-up|235|||
170741912|NCT02234063|617062223|FG001|Overall Study|Lost to Follow-up|42|||
170741913|NCT02234063|617062222|FG000|Overall Study|Withdrawal by Subject|20|||
170741914|NCT02234063|617062223|FG001|Overall Study|Withdrawal by Subject|1|||
170741915|NCT02569710|617062224|FG000|Overall Study|Adverse Event|1|||
170741916|NCT02569710|617062225|FG001|Overall Study|Adverse Event|0|||
170741917|NCT02569710|617062226|FG002|Overall Study|Adverse Event|0|||
170741918|NCT02569710|617062227|FG003|Overall Study|Adverse Event|0|||
170741919|NCT02569710|617062228|FG004|Overall Study|Adverse Event|0|||
170741920|NCT02569710|617062229|FG005|Overall Study|Adverse Event|0|||
170741921|NCT02569710|617062230|FG006|Overall Study|Adverse Event|0|||
170741922|NCT02569710|617062231|FG007|Overall Study|Adverse Event|0|||
170741923|NCT02569710|617062232|FG008|Overall Study|Adverse Event|0|||
170741924|NCT02569710|617062233|FG009|Overall Study|Adverse Event|0|||
170741925|NCT02569710|617062224|FG000|Overall Study|Lost to Follow-up|0|||
170741926|NCT02569710|617062225|FG001|Overall Study|Lost to Follow-up|0|||
170741927|NCT02569710|617062226|FG002|Overall Study|Lost to Follow-up|0|||
170741928|NCT02569710|617062227|FG003|Overall Study|Lost to Follow-up|0|||
170741929|NCT02569710|617062228|FG004|Overall Study|Lost to Follow-up|0|||
170741930|NCT02569710|617062229|FG005|Overall Study|Lost to Follow-up|0|||
170741931|NCT02569710|617062230|FG006|Overall Study|Lost to Follow-up|1|||
170741932|NCT02569710|617062231|FG007|Overall Study|Lost to Follow-up|0|||
170741933|NCT02569710|617062232|FG008|Overall Study|Lost to Follow-up|1|||
170741934|NCT02569710|617062233|FG009|Overall Study|Lost to Follow-up|0|||
170852612|NCT02342743|617466469|FG000|Treatment Period|Withdrawal by Subject|2|||
170852613|NCT02342743|617466469|FG000|Treatment Period|Lost to Follow-up|8|||
170852614|NCT02342743|617466469|FG000|Treatment Period|Change in prophylactic medication|1|||
170741935|NCT02569710|617062224|FG000|Overall Study|Virologic failure|0|||
170741936|NCT02569710|617062225|FG001|Overall Study|Virologic failure|0|||
170852615|NCT02336178|617466470|FG000|Overall Study|Lost to Follow-up|1|||
170852616|NCT02336178|617466470|FG000|Overall Study|Protocol Violation|1|||
170852617|NCT02336178|617466470|FG000|Overall Study|Withdrawal by Subject|1|||
170852618|NCT02336178|617466470|FG000|Overall Study|Other|1|||
170852619|NCT00558259|617466472|FG000|Overall Study|Adverse Event|50|||
170852620|NCT00558259|617466473|FG001|Overall Study|Adverse Event|81|||
170852621|NCT00558259|617466472|FG000|Overall Study|Protocol Violation|9|||
170852622|NCT00558259|617466473|FG001|Overall Study|Protocol Violation|5|||
170852623|NCT00558259|617466472|FG000|Overall Study|Withdrawal by Subject|12|||
170852624|NCT00558259|617466473|FG001|Overall Study|Withdrawal by Subject|13|||
170852625|NCT02937454|617466479|FG000|Overall Study|Adverse Event|0|||
170852626|NCT02937454|617466480|FG001|Overall Study|Adverse Event|1|||
170852627|NCT02937454|617466479|FG000|Overall Study|Death|98|||
170852628|NCT02937454|617466480|FG001|Overall Study|Death|95|||
170852629|NCT02937454|617466479|FG000|Overall Study|Lost to Follow-up|1|||
170852630|NCT02937454|617466480|FG001|Overall Study|Lost to Follow-up|1|||
170852631|NCT02937454|617466479|FG000|Overall Study|Physician Decision|0|||
170852632|NCT02937454|617466480|FG001|Overall Study|Physician Decision|1|||
170852633|NCT02937454|617466479|FG000|Overall Study|Protocol Violation|6|||
170852634|NCT02937454|617466480|FG001|Overall Study|Protocol Violation|10|||
170852635|NCT02937454|617466479|FG000|Overall Study|Withdrawal by Subject|27|||
170741937|NCT02569710|617062226|FG002|Overall Study|Virologic failure|0|||
170741938|NCT02569710|617062227|FG003|Overall Study|Virologic failure|0|||
170741939|NCT02569710|617062228|FG004|Overall Study|Virologic failure|1|||
170741940|NCT02569710|617062229|FG005|Overall Study|Virologic failure|0|||
170741941|NCT02569710|617062230|FG006|Overall Study|Virologic failure|1|||
170741942|NCT02569710|617062231|FG007|Overall Study|Virologic failure|0|||
170741943|NCT02569710|617062232|FG008|Overall Study|Virologic failure|0|||
170741944|NCT02569710|617062233|FG009|Overall Study|Virologic failure|0|||
170741945|NCT02569710|617062224|FG000|Overall Study|Withdrawal by Subject|0|||
170741946|NCT02569710|617062225|FG001|Overall Study|Withdrawal by Subject|0|||
170852636|NCT02937454|617466480|FG001|Overall Study|Withdrawal by Subject|15|||
170852637|NCT02937454|617466479|FG000|Overall Study|Other|8|||
170852638|NCT02937454|617466480|FG001|Overall Study|Other|5|||
170852639|NCT01253304|617466481|FG000|Overall Study|Adverse Event|0|||
170852640|NCT01253304|617466482|FG001|Overall Study|Adverse Event|0|||
170852641|NCT01253304|617466483|FG002|Overall Study|Adverse Event|0|||
170852642|NCT01253304|617466484|FG003|Overall Study|Adverse Event|1|||
170852643|NCT01004848|617466487|FG000|Overall Study|Lost to Follow-up|55|||
170852644|NCT01004848|617466488|FG001|Overall Study|Lost to Follow-up|45|||
170852645|NCT01844687|617466496|FG000|Visit 1|Protocol Violation|3|||
170852646|NCT01844687|617466496|FG000|Visit 1|Lost to Follow-up|5|||
170852647|NCT01844687|617466496|FG000|Visit 2|Withdrawal by Subject|1|||
170852648|NCT01844687|617466496|FG000|Visit 2|Protocol Violation|1|||
170852649|NCT01844687|617466496|FG000|Visit 3|Lost to Follow-up|1|||
170852650|NCT01844687|617466496|FG000|Visit 3|Withdrawal by Subject|3|||
170852651|NCT01844687|617466496|FG000|Visit 3|child care problems|1|||
170852652|NCT01844687|617466496|FG000|Visit 4|Pregnancy|1|||
170852653|NCT01844687|617466496|FG000|Visit 4|Lost to Follow-up|1|||
170852654|NCT01844687|617466496|FG000|Visit 4|Withdrawal by Subject|2|||
170852655|NCT02585232|617466497|FG000|Overall Study|Lost to Follow-up|8|||
170852656|NCT02585232|617466498|FG001|Overall Study|Lost to Follow-up|8|||
170852657|NCT02585232|617466497|FG000|Overall Study|Withdrawal by Subject|4|||
170852658|NCT02585232|617466498|FG001|Overall Study|Withdrawal by Subject|8|||
170852659|NCT03215810|617466501|FG000|Overall Study|Still responding to nivolumab|1|||
170852660|NCT03215810|617466501|FG000|Overall Study|Insufficient TIL growth|1|||
170852661|NCT03215810|617466501|FG000|Overall Study|Decline in performance status|1|||
170852662|NCT03215810|617466501|FG000|Overall Study|Withdrawal by Subject|1|||
170852663|NCT01859988|617466505|FG000|Overall Study|Withdrawal by Subject|6|||
170852664|NCT01859988|617466506|FG001|Overall Study|Withdrawal by Subject|3|||
170852665|NCT01859988|617466507|FG002|Overall Study|Withdrawal by Subject|4|||
170852666|NCT01859988|617466508|FG003|Overall Study|Withdrawal by Subject|3|||
170852667|NCT01859988|617466509|FG004|Overall Study|Withdrawal by Subject|2|||
170852668|NCT01859988|617466510|FG005|Overall Study|Withdrawal by Subject|2|||
170852669|NCT01859988|617466505|FG000|Overall Study|Lack of Efficacy|1|||
170852670|NCT01859988|617466506|FG001|Overall Study|Lack of Efficacy|1|||
170852671|NCT01859988|617466507|FG002|Overall Study|Lack of Efficacy|5|||
170852672|NCT01859988|617466508|FG003|Overall Study|Lack of Efficacy|0|||
170852673|NCT01859988|617466509|FG004|Overall Study|Lack of Efficacy|7|||
170852674|NCT01859988|617466510|FG005|Overall Study|Lack of Efficacy|9|||
170852675|NCT01859988|617466505|FG000|Overall Study|Physician Decision|1|||
170852676|NCT01859988|617466506|FG001|Overall Study|Physician Decision|3|||
170852677|NCT01859988|617466507|FG002|Overall Study|Physician Decision|1|||
170852678|NCT01859988|617466508|FG003|Overall Study|Physician Decision|3|||
170852679|NCT01859988|617466509|FG004|Overall Study|Physician Decision|4|||
170852680|NCT01859988|617466510|FG005|Overall Study|Physician Decision|1|||
170852681|NCT01859988|617466505|FG000|Overall Study|Adverse Event|2|||
170852682|NCT01859988|617466506|FG001|Overall Study|Adverse Event|1|||
170852683|NCT01859988|617466507|FG002|Overall Study|Adverse Event|3|||
170852684|NCT01859988|617466508|FG003|Overall Study|Adverse Event|1|||
170852685|NCT01859988|617466509|FG004|Overall Study|Adverse Event|2|||
170852686|NCT01859988|617466510|FG005|Overall Study|Adverse Event|2|||
170852687|NCT01859988|617466505|FG000|Overall Study|Lost to Follow-up|1|||
170852688|NCT01859988|617466506|FG001|Overall Study|Lost to Follow-up|2|||
170852689|NCT01859988|617466507|FG002|Overall Study|Lost to Follow-up|3|||
170852690|NCT01859988|617466508|FG003|Overall Study|Lost to Follow-up|0|||
170852691|NCT01859988|617466509|FG004|Overall Study|Lost to Follow-up|3|||
170852692|NCT01859988|617466510|FG005|Overall Study|Lost to Follow-up|2|||
170852693|NCT01859988|617466505|FG000|Overall Study|Protocol Violation|0|||
170852694|NCT01859988|617466506|FG001|Overall Study|Protocol Violation|0|||
170852695|NCT01859988|617466507|FG002|Overall Study|Protocol Violation|1|||
170852696|NCT01859988|617466508|FG003|Overall Study|Protocol Violation|0|||
170852697|NCT01859988|617466509|FG004|Overall Study|Protocol Violation|0|||
170852698|NCT01859988|617466510|FG005|Overall Study|Protocol Violation|0|||
170852699|NCT01859988|617466505|FG000|Overall Study|Other than specified above|0|||
170852700|NCT01859988|617466506|FG001|Overall Study|Other than specified above|2|||
170852701|NCT01859988|617466507|FG002|Overall Study|Other than specified above|11|||
170852702|NCT01859988|617466508|FG003|Overall Study|Other than specified above|3|||
170852703|NCT01859988|617466509|FG004|Overall Study|Other than specified above|5|||
170852704|NCT01859988|617466510|FG005|Overall Study|Other than specified above|3|||
170852705|NCT01157676|617466514|FG000|Randomization|Death|1|||
170852706|NCT01157676|617466515|FG001|Randomization|Death|1|||
170852707|NCT01157676|617466514|FG000|Randomization|unresectable|2|||
170852708|NCT01157676|617466515|FG001|Randomization|unresectable|3|||
170852709|NCT01157676|617466514|FG000|Randomization|Withdrawal by Subject|17|||
170852710|NCT01157676|617466515|FG001|Randomization|Withdrawal by Subject|13|||
170852711|NCT01157676|617466514|FG000|Randomization|Physician Decision|1|||
170852712|NCT01157676|617466515|FG001|Randomization|Physician Decision|0|||
170852713|NCT01157676|617466514|FG000|Surgery|underwent open cystectomy|0|||
170852714|NCT01157676|617466515|FG001|Surgery|underwent open cystectomy|4|||
170852715|NCT01157676|617466514|FG000|Surgery|converted to open procedure|0|||
170852716|NCT01157676|617466515|FG001|Surgery|converted to open procedure|5|||
170852717|NCT01157676|617466514|FG000|Surgery|underwent robotic cystectomy|1|||
170741947|NCT02569710|617062226|FG002|Overall Study|Withdrawal by Subject|0|||
170741948|NCT02569710|617062227|FG003|Overall Study|Withdrawal by Subject|0|||
170741949|NCT02569710|617062228|FG004|Overall Study|Withdrawal by Subject|0|||
170741950|NCT02569710|617062229|FG005|Overall Study|Withdrawal by Subject|1|||
170741951|NCT02569710|617062230|FG006|Overall Study|Withdrawal by Subject|0|||
170741952|NCT02569710|617062231|FG007|Overall Study|Withdrawal by Subject|0|||
170741953|NCT02569710|617062232|FG008|Overall Study|Withdrawal by Subject|0|||
170741954|NCT02569710|617062233|FG009|Overall Study|Withdrawal by Subject|0|||
170741955|NCT01871558|617062238|FG000|Overall Study|Other reason|0|||
170741956|NCT01871558|617062239|FG001|Overall Study|Other reason|1|||
170741957|NCT01871558|617062238|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
170741958|NCT01871558|617062239|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
170741959|NCT01871558|617062238|FG000|Overall Study|Withdrawal by Subject|2|||
170741960|NCT01871558|617062239|FG001|Overall Study|Withdrawal by Subject|0|||
170741961|NCT03203694|617062240|FG000|Overall Study|Withdrawal by Subject|2|||
170741962|NCT03203694|617062241|FG001|Overall Study|Withdrawal by Subject|0|||
170741963|NCT03203694|617062242|FG002|Overall Study|Withdrawal by Subject|0|||
170741964|NCT03203694|617062243|FG003|Overall Study|Withdrawal by Subject|0|||
170741965|NCT03203694|617062244|FG004|Overall Study|Withdrawal by Subject|0|||
170852718|NCT01157676|617466515|FG001|Surgery|underwent robotic cystectomy|0|||
170852719|NCT05753670|617466516|FG000|Overall Study|Withdrawal by Subject|6|||
170852720|NCT05753670|617466517|FG001|Overall Study|Withdrawal by Subject|8|||
170852721|NCT05753670|617466516|FG000|Overall Study|Protocol Violation|3|||
170852722|NCT05753670|617466517|FG001|Overall Study|Protocol Violation|1|||
170852723|NCT01801735|617466518|FG000|Overall Study|Adverse Event|79|||
170852724|NCT01801735|617466518|FG000|Overall Study|Lack of Efficacy|28|||
170852725|NCT01801735|617466518|FG000|Overall Study|Withdrawal by Subject|27|||
170852726|NCT01801735|617466518|FG000|Overall Study|Protocol Violation|25|||
170852727|NCT01801735|617466518|FG000|Overall Study|Lost to Follow-up|15|||
170852728|NCT01801735|617466518|FG000|Overall Study|Non-compliance with Trial Drug|13|||
170852729|NCT01801735|617466518|FG000|Overall Study|Physician Decision|3|||
170852730|NCT01801735|617466518|FG000|Overall Study|Death|1|||
170852731|NCT01801735|617466518|FG000|Overall Study|Other, including site closure|19|||
170852732|NCT02325557|617466519|FG000|Overall Study|Progressive disease|1|||
170852733|NCT02325557|617466520|FG001|Overall Study|Progressive disease|0|||
170852734|NCT02325557|617466521|FG002|Overall Study|Progressive disease|0|||
170852735|NCT02325557|617466522|FG003|Overall Study|Progressive disease|0|||
170852736|NCT02325557|617466519|FG000|Overall Study|Withdrawal by Subject|4|||
170852737|NCT02325557|617466520|FG001|Overall Study|Withdrawal by Subject|0|||
170852738|NCT02325557|617466521|FG002|Overall Study|Withdrawal by Subject|0|||
170852739|NCT02325557|617466522|FG003|Overall Study|Withdrawal by Subject|15|||
170852740|NCT02325557|617466519|FG000|Overall Study|Death|5|||
170852741|NCT02325557|617466520|FG001|Overall Study|Death|1|||
170852742|NCT02325557|617466521|FG002|Overall Study|Death|1|||
170852743|NCT02325557|617466522|FG003|Overall Study|Death|16|||
170852744|NCT02325557|617466519|FG000|Overall Study|Lost to Follow-up|0|||
170852745|NCT02325557|617466520|FG001|Overall Study|Lost to Follow-up|0|||
170852746|NCT02325557|617466521|FG002|Overall Study|Lost to Follow-up|1|||
170852747|NCT02325557|617466522|FG003|Overall Study|Lost to Follow-up|1|||
170852748|NCT02325557|617466519|FG000|Overall Study|Other|0|||
170852749|NCT02325557|617466520|FG001|Overall Study|Other|0|||
170852750|NCT02325557|617466521|FG002|Overall Study|Other|0|||
170852751|NCT02325557|617466522|FG003|Overall Study|Other|5|||
170852752|NCT05086276|617466523|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
170852753|NCT05086276|617466524|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
170852754|NCT00540046|617466525|FG000|Overall Study|Lost to Follow-up|33|||
170852755|NCT00540046|617466526|FG001|Overall Study|Lost to Follow-up|23|||
170852756|NCT01237587|617466527|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
170852757|NCT01237587|617466528|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
170852758|NCT01237587|617466527|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
170852759|NCT01237587|617466528|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
170852760|NCT01237587|617466527|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
170852761|NCT01237587|617466528|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
170852762|NCT01237587|617466527|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
170852763|NCT01237587|617466528|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
170852764|NCT01237587|617466527|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
170852765|NCT01237587|617466528|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
170852766|NCT01237587|617466527|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
170852767|NCT01237587|617466528|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
170852768|NCT01237587|617466527|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
170852769|NCT01237587|617466528|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
170852770|NCT01237587|617466527|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
170852771|NCT01237587|617466528|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
170852772|NCT01237587|617466527|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
170852773|NCT01237587|617466528|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
170852774|NCT01237587|617466527|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
170852775|NCT01237587|617466528|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
170852776|NCT01237587|617466527|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
170852777|NCT01237587|617466528|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
170852778|NCT01237587|617466527|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
170852779|NCT01237587|617466528|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
170852780|NCT01237587|617466527|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
170852781|NCT01237587|617466528|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
170852782|NCT01237587|617466527|FG000|Taper Phase|Adverse Event|0|||
170852783|NCT01237587|617466528|FG001|Taper Phase|Adverse Event|2|||
170852784|NCT01237587|617466527|FG000|Taper Phase|Protocol Violation|2|||
170852785|NCT01237587|617466528|FG001|Taper Phase|Protocol Violation|0|||
170852786|NCT01237587|617466527|FG000|Taper Phase|Lack of Efficacy|2|||
170852787|NCT01237587|617466528|FG001|Taper Phase|Lack of Efficacy|5|||
170852788|NCT01237587|617466527|FG000|Taper Phase|Parent/Guardian Decision|0|||
170852789|NCT01237587|617466528|FG001|Taper Phase|Parent/Guardian Decision|2|||
170852790|NCT01237587|617466527|FG000|Taper Phase|Sponsor Decision|1|||
170852791|NCT01237587|617466528|FG001|Taper Phase|Sponsor Decision|0|||
170852792|NCT01237587|617466527|FG000|Taper Phase|Withdrawal by Subject|0|||
170852793|NCT01237587|617466528|FG001|Taper Phase|Withdrawal by Subject|1|||
170852794|NCT01103362|617466529|FG000|Overall Study|study terminated|596|||
170852795|NCT01011387|617466530|FG000|Overall Study|Withdrawal by Subject|3|||
170852796|NCT01011387|617466530|FG000|Overall Study|Adverse Event|2|||
170852797|NCT01011387|617466530|FG000|Overall Study|Protocol Violation|1|||
170852798|NCT01139580|617466531|FG000|Overall Study|Adverse Event|5|||
170852799|NCT01139580|617466532|FG001|Overall Study|Adverse Event|4|||
170852800|NCT01139580|617466531|FG000|Overall Study|Lost to Follow-up|9|||
170852801|NCT01139580|617466532|FG001|Overall Study|Lost to Follow-up|1|||
170852802|NCT01139580|617466531|FG000|Overall Study|Lack of Efficacy|0|||
170852803|NCT01139580|617466532|FG001|Overall Study|Lack of Efficacy|2|||
170852804|NCT01139580|617466531|FG000|Overall Study|Withdrawal by Subject|6|||
170852805|NCT01139580|617466532|FG001|Overall Study|Withdrawal by Subject|9|||
170852806|NCT01139580|617466531|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
170852807|NCT01139580|617466532|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
170852808|NCT01139580|617466531|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
170852809|NCT01139580|617466532|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
170852810|NCT01139580|617466531|FG000|Overall Study|Misrandomized|1|||
170852811|NCT01139580|617466532|FG001|Overall Study|Misrandomized|0|||
170852812|NCT01139580|617466531|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
170852813|NCT01139580|617466532|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
170852814|NCT01139580|617466531|FG000|Overall Study|Participant Randomization in Error|0|||
170852815|NCT01139580|617466532|FG001|Overall Study|Participant Randomization in Error|1|||
170852816|NCT00700778|617466533|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
170852817|NCT02559895|617466536|FG000|Overall Study|Adverse Event|3|||
170852818|NCT02559895|617466537|FG001|Overall Study|Adverse Event|3|||
170852819|NCT02559895|617466538|FG002|Overall Study|Adverse Event|2|||
170852820|NCT02559895|617466539|FG003|Overall Study|Adverse Event|1|||
170852821|NCT02559895|617466536|FG000|Overall Study|Lack of Efficacy|2|||
170852822|NCT02559895|617466537|FG001|Overall Study|Lack of Efficacy|3|||
170852823|NCT02559895|617466538|FG002|Overall Study|Lack of Efficacy|2|||
170852824|NCT02559895|617466539|FG003|Overall Study|Lack of Efficacy|8|||
170852825|NCT02559895|617466536|FG000|Overall Study|Lost to Follow-up|22|||
170852826|NCT02559895|617466537|FG001|Overall Study|Lost to Follow-up|16|||
170852827|NCT02559895|617466538|FG002|Overall Study|Lost to Follow-up|12|||
170852828|NCT02559895|617466539|FG003|Overall Study|Lost to Follow-up|17|||
170852829|NCT02559895|617466536|FG000|Overall Study|Physician Decision|1|||
170852830|NCT02559895|617466537|FG001|Overall Study|Physician Decision|1|||
170852831|NCT02559895|617466538|FG002|Overall Study|Physician Decision|3|||
170852832|NCT02559895|617466539|FG003|Overall Study|Physician Decision|0|||
170852833|NCT02559895|617466536|FG000|Overall Study|Withdrawal by Subject|16|||
170852834|NCT02559895|617466537|FG001|Overall Study|Withdrawal by Subject|9|||
170852835|NCT02559895|617466538|FG002|Overall Study|Withdrawal by Subject|20|||
170852836|NCT02559895|617466539|FG003|Overall Study|Withdrawal by Subject|9|||
170852837|NCT02559895|617466536|FG000|Overall Study|Study Burden|10|||
170852838|NCT02559895|617466537|FG001|Overall Study|Study Burden|16|||
170852839|NCT02559895|617466538|FG002|Overall Study|Study Burden|12|||
170852840|NCT02559895|617466539|FG003|Overall Study|Study Burden|22|||
170852841|NCT02559895|617466536|FG000|Overall Study|Other|1|||
170852842|NCT02559895|617466537|FG001|Overall Study|Other|5|||
170852843|NCT02559895|617466538|FG002|Overall Study|Other|3|||
170852844|NCT02559895|617466539|FG003|Overall Study|Other|3|||
170852845|NCT01397422|617466540|FG000|Overall Study|Adverse Event|0|||
170852846|NCT01397422|617466541|FG001|Overall Study|Adverse Event|3|||
170852847|NCT01397422|617466542|FG002|Overall Study|Adverse Event|3|||
170852848|NCT01397422|617466543|FG003|Overall Study|Adverse Event|8|||
170852849|NCT01397422|617466540|FG000|Overall Study|Withdrawal by Subject|1|||
170852850|NCT01397422|617466541|FG001|Overall Study|Withdrawal by Subject|0|||
170852851|NCT01397422|617466542|FG002|Overall Study|Withdrawal by Subject|0|||
170852852|NCT01397422|617466543|FG003|Overall Study|Withdrawal by Subject|0|||
170852853|NCT01397422|617466540|FG000|Overall Study|Increased bradykinesia related to PD|1|||
170852854|NCT01397422|617466541|FG001|Overall Study|Increased bradykinesia related to PD|0|||
170852855|NCT01397422|617466542|FG002|Overall Study|Increased bradykinesia related to PD|0|||
170852856|NCT01397422|617466543|FG003|Overall Study|Increased bradykinesia related to PD|0|||
170852857|NCT01942785|617466545|FG000|Overall Study|Adverse Event|2|||
170852858|NCT01942785|617466545|FG000|Overall Study|Withdrawal by Subject|1|||
170852859|NCT01942785|617466545|FG000|Overall Study|Protocol Violation|1|||
170852860|NCT01905150|617466546|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
170852861|NCT01905150|617466547|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
170852862|NCT05453201|617466548|FG000|Overall Study|Withdrawal by Subject|1|||
170852863|NCT03562975|617466549|FG000|Overall Study|Death|1|||
170852864|NCT03562975|617466549|FG000|Overall Study|Lost to Follow-up|1|||
170852865|NCT03562975|617466549|FG000|Overall Study|Withdrawal by Subject|1|||
170852866|NCT00867308|617466554|FG000|Overall Study|Death|1|||
170852867|NCT00867308|617466555|FG001|Overall Study|Death|0|||
170852868|NCT00867308|617466554|FG000|Overall Study|Adverse Event|1|||
170852869|NCT00867308|617466555|FG001|Overall Study|Adverse Event|4|||
170852870|NCT00867308|617466554|FG000|Overall Study|Lack of Efficacy|6|||
170852871|NCT00867308|617466555|FG001|Overall Study|Lack of Efficacy|12|||
170852872|NCT00867308|617466554|FG000|Overall Study|Withdrawal by Subject|1|||
170852873|NCT00867308|617466555|FG001|Overall Study|Withdrawal by Subject|2|||
170852874|NCT03647488|617468323|FG000|Overall Study|Progressive disease|10|||
170852875|NCT03647488|617468324|FG001|Overall Study|Progressive disease|0|||
170852876|NCT03647488|617468325|FG002|Overall Study|Progressive disease|0|||
170852877|NCT03647488|617468323|FG000|Overall Study|Adverse Event|5|||
170852878|NCT03647488|617468324|FG001|Overall Study|Adverse Event|0|||
170852879|NCT03647488|617468325|FG002|Overall Study|Adverse Event|0|||
170852880|NCT03647488|617468323|FG000|Overall Study|Clinical progression|2|||
170852881|NCT03647488|617468324|FG001|Overall Study|Clinical progression|0|||
170852882|NCT03647488|617468325|FG002|Overall Study|Clinical progression|0|||
170852883|NCT03647488|617468323|FG000|Overall Study|Participant refused to take investigational product|1|||
170852884|NCT03647488|617468324|FG001|Overall Study|Participant refused to take investigational product|0|||
170852885|NCT03647488|617468325|FG002|Overall Study|Participant refused to take investigational product|0|||
170852886|NCT02359877|617468326|FG000|Overall Study|Withdrawal by Subject|1|||
170852887|NCT02359877|617468327|FG001|Overall Study|Withdrawal by Subject|0|||
170852888|NCT02359877|617468328|FG002|Overall Study|Withdrawal by Subject|0|||
170852889|NCT02359877|617468329|FG003|Overall Study|Withdrawal by Subject|2|||
170852890|NCT02359877|617468326|FG000|Overall Study|Adverse Event|0|||
170852891|NCT02359877|617468327|FG001|Overall Study|Adverse Event|0|||
170852892|NCT02359877|617468328|FG002|Overall Study|Adverse Event|0|||
170852893|NCT02359877|617468329|FG003|Overall Study|Adverse Event|1|||
170852894|NCT01589237|617468332|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
170852895|NCT01589237|617468333|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
170852896|NCT01589237|617468334|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
170852897|NCT01589237|617468335|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
170852898|NCT01589237|617468332|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
170852899|NCT01589237|617468333|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
170852900|NCT01589237|617468334|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
170852901|NCT01589237|617468335|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
170852902|NCT01589237|617468332|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
170852903|NCT01589237|617468333|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
170852904|NCT01589237|617468334|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
170852905|NCT01589237|617468335|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
170852906|NCT01589237|617468332|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
170852907|NCT01589237|617468333|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
170852908|NCT01589237|617468334|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
170852909|NCT01589237|617468335|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
170852910|NCT02680002|617468339|FG000|Overall Study|Lost to Follow-up|5|||
170852911|NCT02680002|617468340|FG001|Overall Study|Lost to Follow-up|1|||
170852912|NCT02680002|617468341|FG002|Overall Study|Lost to Follow-up|4|||
170852913|NCT02680002|617468342|FG003|Overall Study|Lost to Follow-up|2|||
170852914|NCT02680002|617468343|FG004|Overall Study|Lost to Follow-up|0|||
170852915|NCT02680002|617468344|FG005|Overall Study|Lost to Follow-up|2|||
170852916|NCT02680002|617468339|FG000|Overall Study|Physician Decision|5|||
170852917|NCT02680002|617468340|FG001|Overall Study|Physician Decision|1|||
170852918|NCT02680002|617468341|FG002|Overall Study|Physician Decision|1|||
170852919|NCT02680002|617468342|FG003|Overall Study|Physician Decision|1|||
170852920|NCT02680002|617468343|FG004|Overall Study|Physician Decision|1|||
170852921|NCT02680002|617468344|FG005|Overall Study|Physician Decision|1|||
170852922|NCT02680002|617468339|FG000|Overall Study|Protocol Violation|1|||
170852923|NCT02680002|617468340|FG001|Overall Study|Protocol Violation|0|||
170852924|NCT02680002|617468341|FG002|Overall Study|Protocol Violation|1|||
170852925|NCT02680002|617468342|FG003|Overall Study|Protocol Violation|0|||
170852926|NCT02680002|617468343|FG004|Overall Study|Protocol Violation|1|||
170852927|NCT02680002|617468344|FG005|Overall Study|Protocol Violation|2|||
170852928|NCT02680002|617468339|FG000|Overall Study|Withdrawal by Subject|0|||
170852929|NCT02680002|617468340|FG001|Overall Study|Withdrawal by Subject|0|||
170852930|NCT02680002|617468341|FG002|Overall Study|Withdrawal by Subject|1|||
170852931|NCT02680002|617468342|FG003|Overall Study|Withdrawal by Subject|0|||
170852932|NCT02680002|617468343|FG004|Overall Study|Withdrawal by Subject|2|||
170852933|NCT02680002|617468344|FG005|Overall Study|Withdrawal by Subject|2|||
170852934|NCT02680002|617468339|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
170852935|NCT02680002|617468340|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
170852936|NCT02680002|617468341|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
170852937|NCT02680002|617468342|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
170852938|NCT02680002|617468343|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
170852939|NCT02680002|617468344|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
170852940|NCT02680002|617468339|FG000|Overall Study|Other|0|||
170852941|NCT02680002|617468340|FG001|Overall Study|Other|1|||
170852942|NCT02680002|617468341|FG002|Overall Study|Other|0|||
170852943|NCT02680002|617468342|FG003|Overall Study|Other|0|||
170852944|NCT02680002|617468343|FG004|Overall Study|Other|1|||
170852945|NCT02680002|617468344|FG005|Overall Study|Other|0|||
170852946|NCT02680002|617468339|FG000|Overall Study|Adverse Event|0|||
170852947|NCT02680002|617468340|FG001|Overall Study|Adverse Event|0|||
170852948|NCT02680002|617468341|FG002|Overall Study|Adverse Event|0|||
170852949|NCT02680002|617468342|FG003|Overall Study|Adverse Event|0|||
170852950|NCT02680002|617468343|FG004|Overall Study|Adverse Event|1|||
170852951|NCT02680002|617468344|FG005|Overall Study|Adverse Event|2|||
170852952|NCT00759915|617468345|FG000|Overall Study|Withdrawal by Subject|1|||
170852953|NCT00759915|617468346|FG001|Overall Study|Withdrawal by Subject|0|||
170852954|NCT00759915|617468345|FG000|Overall Study|Adverse Event|0|||
170852955|NCT00759915|617468346|FG001|Overall Study|Adverse Event|1|||
170852956|NCT00932113|617468349|FG000|Overall Study|Lost to Follow-up|1|||
170852957|NCT00932113|617468350|FG001|Overall Study|Lost to Follow-up|0|||
170852958|NCT00852540|617468353|FG000|Overall Study|Adverse Event|10|||
170852959|NCT00852540|617468354|FG001|Overall Study|Adverse Event|3|||
170852960|NCT00852540|617468353|FG000|Overall Study|Lack of Efficacy|15|||
170852961|NCT00852540|617468354|FG001|Overall Study|Lack of Efficacy|3|||
170852962|NCT00852540|617468353|FG000|Overall Study|Protocol Violation|1|||
170852963|NCT00852540|617468354|FG001|Overall Study|Protocol Violation|2|||
170852964|NCT00852540|617468353|FG000|Overall Study|Lost to Follow-up|2|||
170852965|NCT00852540|617468354|FG001|Overall Study|Lost to Follow-up|3|||
170852966|NCT00852540|617468353|FG000|Overall Study|Investigator Discretion|2|||
170852967|NCT00852540|617468354|FG001|Overall Study|Investigator Discretion|3|||
170852968|NCT00852540|617468353|FG000|Overall Study|Withdrawal by Subject|3|||
170852969|NCT00852540|617468354|FG001|Overall Study|Withdrawal by Subject|1|||
170852970|NCT00852540|617468353|FG000|Overall Study|Did Not Receive Study Drug|3|||
170852971|NCT00852540|617468354|FG001|Overall Study|Did Not Receive Study Drug|3|||
170852972|NCT02383056|617468357|FG000|Overall Study|Adverse Event|1|||
170852973|NCT02383056|617468358|FG001|Overall Study|Adverse Event|0|||
170852974|NCT02383056|617468357|FG000|Overall Study|Lost to Follow-up|0|||
170852975|NCT02383056|617468358|FG001|Overall Study|Lost to Follow-up|2|||
170852976|NCT01775475|617468362|FG000|Overall Study|Death|3|||
170852977|NCT01775475|617468363|FG001|Overall Study|Death|3|||
170852978|NCT01635920|617468369|FG000|Overall Study|Adverse Event|1|||
170852979|NCT01635920|617468370|FG001|Overall Study|Adverse Event|0|||
170852980|NCT01635920|617468369|FG000|Overall Study|Lost to Follow-up|0|||
170852981|NCT01635920|617468370|FG001|Overall Study|Lost to Follow-up|1|||
170852982|NCT01635920|617468369|FG000|Overall Study|Subject decision|2|||
170852983|NCT01635920|617468370|FG001|Overall Study|Subject decision|0|||
170852984|NCT01552603|617468371|FG000|Overall Study|Physician Decision|1|||
170852985|NCT00717067|617468375|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
170852986|NCT00717067|617468376|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
170852987|NCT00717067|617468377|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
170852988|NCT00717067|617468378|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
170852989|NCT00717067|617468379|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
170852990|NCT00006011|617468382|FG000|Overall Study|Disease progression|13|||
170852991|NCT00006011|617468383|FG001|Overall Study|Disease progression|6|||
170852992|NCT00006011|617468384|FG002|Overall Study|Disease progression|26|||
170852993|NCT00006011|617468382|FG000|Overall Study|Refused further treatment|15|||
170852994|NCT00006011|617468383|FG001|Overall Study|Refused further treatment|13|||
170852995|NCT00006011|617468384|FG002|Overall Study|Refused further treatment|26|||
170852996|NCT00006011|617468382|FG000|Overall Study|Adverse Event|15|||
170852997|NCT00006011|617468383|FG001|Overall Study|Adverse Event|39|||
170852998|NCT00006011|617468384|FG002|Overall Study|Adverse Event|5|||
170852999|NCT00006011|617468382|FG000|Overall Study|Death|0|||
170741966|NCT03203694|617062245|FG005|Overall Study|Withdrawal by Subject|0|||
170741967|NCT01396317|617062246|FG000|Overall Study|Adverse Event|1|||
170741968|NCT01396317|617062247|FG001|Overall Study|Adverse Event|0|||
170853000|NCT00006011|617468383|FG001|Overall Study|Death|1|||
170853001|NCT00006011|617468384|FG002|Overall Study|Death|2|||
170853002|NCT00006011|617468382|FG000|Overall Study|Other|4|||
170741969|NCT01709305|617062248|FG000|Phase 1|Clinical Adverse Event|80|||
170741970|NCT01709305|617062249|FG001|Phase 1|Clinical Adverse Event|0|||
170741971|NCT01709305|617062250|FG002|Phase 1|Clinical Adverse Event|0|||
170741972|NCT01709305|617062251|FG003|Phase 1|Clinical Adverse Event|0|||
170741973|NCT01709305|617062252|FG004|Phase 1|Clinical Adverse Event|0|||
170741974|NCT01709305|617062248|FG000|Phase 1|Death|2|||
170741975|NCT01709305|617062249|FG001|Phase 1|Death|0|||
170741976|NCT01709305|617062250|FG002|Phase 1|Death|0|||
170741977|NCT01709305|617062251|FG003|Phase 1|Death|0|||
170741978|NCT01709305|617062252|FG004|Phase 1|Death|0|||
170741979|NCT01709305|617062248|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
170741980|NCT01709305|617062249|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
170741981|NCT01709305|617062250|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
170741982|NCT01709305|617062251|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
170741983|NCT01709305|617062252|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
170741984|NCT01709305|617062248|FG000|Phase 1|Laboratory Adverse Event|16|||
170741985|NCT01709305|617062249|FG001|Phase 1|Laboratory Adverse Event|0|||
170741986|NCT01709305|617062250|FG002|Phase 1|Laboratory Adverse Event|0|||
170741987|NCT01709305|617062251|FG003|Phase 1|Laboratory Adverse Event|0|||
170741988|NCT01709305|617062252|FG004|Phase 1|Laboratory Adverse Event|0|||
170741989|NCT01709305|617062248|FG000|Phase 1|Lost to Follow-up|147|||
170741990|NCT01709305|617062249|FG001|Phase 1|Lost to Follow-up|0|||
170741991|NCT01709305|617062250|FG002|Phase 1|Lost to Follow-up|0|||
170741992|NCT01709305|617062251|FG003|Phase 1|Lost to Follow-up|0|||
170741993|NCT01709305|617062252|FG004|Phase 1|Lost to Follow-up|0|||
170741994|NCT01709305|617062248|FG000|Phase 1|Travel, moving, etc.|30|||
170741995|NCT01709305|617062249|FG001|Phase 1|Travel, moving, etc.|0|||
170741996|NCT01709305|617062250|FG002|Phase 1|Travel, moving, etc.|0|||
170741997|NCT01709305|617062251|FG003|Phase 1|Travel, moving, etc.|0|||
170741998|NCT01709305|617062252|FG004|Phase 1|Travel, moving, etc.|0|||
170741999|NCT01709305|617062248|FG000|Phase 1|Physician Decision|13|||
170742000|NCT01709305|617062249|FG001|Phase 1|Physician Decision|0|||
170742001|NCT01709305|617062250|FG002|Phase 1|Physician Decision|0|||
170742002|NCT01709305|617062251|FG003|Phase 1|Physician Decision|0|||
170742003|NCT01709305|617062252|FG004|Phase 1|Physician Decision|0|||
170742004|NCT01709305|617062248|FG000|Phase 1|Protocol Violation|118|||
170742005|NCT01709305|617062249|FG001|Phase 1|Protocol Violation|0|||
170742006|NCT01709305|617062250|FG002|Phase 1|Protocol Violation|0|||
170742007|NCT01709305|617062251|FG003|Phase 1|Protocol Violation|0|||
170742008|NCT01709305|617062252|FG004|Phase 1|Protocol Violation|0|||
170853003|NCT00006011|617468383|FG001|Overall Study|Other|2|||
170853004|NCT00006011|617468384|FG002|Overall Study|Other|5|||
170853005|NCT00006011|617468382|FG000|Overall Study|Ineligible|18|||
170742009|NCT01709305|617062248|FG000|Phase 1|Withdrawal by Subject|218|||
170853006|NCT00006011|617468383|FG001|Overall Study|Ineligible|16|||
170853007|NCT00006011|617468384|FG002|Overall Study|Ineligible|9|||
170742010|NCT01709305|617062249|FG001|Phase 1|Withdrawal by Subject|0|||
170742011|NCT01709305|617062250|FG002|Phase 1|Withdrawal by Subject|0|||
170742012|NCT01709305|617062251|FG003|Phase 1|Withdrawal by Subject|0|||
170742013|NCT01709305|617062252|FG004|Phase 1|Withdrawal by Subject|0|||
170853008|NCT01474434|617468385|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
170853009|NCT01474434|617468386|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
170853010|NCT01474434|617468387|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
170853011|NCT01474434|617468388|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
170853012|NCT01474434|617468385|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
170853013|NCT01474434|617468386|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
170853014|NCT01474434|617468387|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
170853015|NCT01474434|617468388|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
170853016|NCT01474434|617468385|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
170853017|NCT01474434|617468386|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
170853018|NCT01474434|617468387|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
170853019|NCT01474434|617468388|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
170853020|NCT03618823|617468389|FG000|Overall Study|Lost to Follow-up|63|||
170853021|NCT03618823|617468390|FG001|Overall Study|Lost to Follow-up|61|||
170853022|NCT00141219|617468398|FG000|Overall Study|Protocol violations|5|||
170853023|NCT00141219|617468399|FG001|Overall Study|Protocol violations|4|||
170853024|NCT00141219|617468398|FG000|Overall Study|Adverse Event|8|||
170853025|NCT00141219|617468399|FG001|Overall Study|Adverse Event|6|||
170853026|NCT00141219|617468398|FG000|Overall Study|Lack of Efficacy|5|||
170853027|NCT00141219|617468399|FG001|Overall Study|Lack of Efficacy|4|||
170853028|NCT00141219|617468398|FG000|Overall Study|Withdrawal by Subject|6|||
170853029|NCT00141219|617468399|FG001|Overall Study|Withdrawal by Subject|2|||
170853030|NCT02224690|617468400|FG000|Overall Study|Adverse Event|8|||
170853031|NCT02224690|617468401|FG001|Overall Study|Adverse Event|1|||
170853032|NCT02224690|617468400|FG000|Overall Study|Met Withdrawal Criteria|4|||
170853033|NCT02224690|617468401|FG001|Overall Study|Met Withdrawal Criteria|0|||
170853034|NCT02224690|617468400|FG000|Overall Study|Use of G-tube|1|||
170853035|NCT02224690|617468401|FG001|Overall Study|Use of G-tube|0|||
170853036|NCT02224690|617468400|FG000|Overall Study|Did not meet eligibility criteria|1|||
170853037|NCT02224690|617468401|FG001|Overall Study|Did not meet eligibility criteria|0|||
170853038|NCT01506609|617468402|FG000|Overall Study|Adverse Event Related to Progression|0|||
170853039|NCT01506609|617468403|FG001|Overall Study|Adverse Event Related to Progression|0|||
170853040|NCT01506609|617468404|FG002|Overall Study|Adverse Event Related to Progression|0|||
170853041|NCT01506609|617468405|FG003|Overall Study|Adverse Event Related to Progression|3|||
170853042|NCT01506609|617468406|FG004|Overall Study|Adverse Event Related to Progression|7|||
170853043|NCT01506609|617468407|FG005|Overall Study|Adverse Event Related to Progression|3|||
170853044|NCT01506609|617468402|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
170853045|NCT01506609|617468403|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
170853046|NCT01506609|617468404|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
170853047|NCT01506609|617468405|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
170853048|NCT01506609|617468406|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
170853049|NCT01506609|617468407|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
170853050|NCT01506609|617468402|FG000|Overall Study|Withdrawal by Subject|0|||
170853051|NCT01506609|617468403|FG001|Overall Study|Withdrawal by Subject|0|||
170853052|NCT01506609|617468404|FG002|Overall Study|Withdrawal by Subject|0|||
170853053|NCT01506609|617468405|FG003|Overall Study|Withdrawal by Subject|9|||
170853054|NCT01506609|617468406|FG004|Overall Study|Withdrawal by Subject|7|||
170853055|NCT01506609|617468407|FG005|Overall Study|Withdrawal by Subject|7|||
170853056|NCT01506609|617468402|FG000|Overall Study|Lost to Follow-up|0|||
170853057|NCT01506609|617468403|FG001|Overall Study|Lost to Follow-up|0|||
170853058|NCT01506609|617468404|FG002|Overall Study|Lost to Follow-up|0|||
170853059|NCT01506609|617468405|FG003|Overall Study|Lost to Follow-up|1|||
170853060|NCT01506609|617468406|FG004|Overall Study|Lost to Follow-up|2|||
170853061|NCT01506609|617468407|FG005|Overall Study|Lost to Follow-up|0|||
170853062|NCT01506609|617468402|FG000|Overall Study|Sponsor Discontinued Study|0|||
170853063|NCT01506609|617468403|FG001|Overall Study|Sponsor Discontinued Study|0|||
170853064|NCT01506609|617468404|FG002|Overall Study|Sponsor Discontinued Study|0|||
170853065|NCT01506609|617468405|FG003|Overall Study|Sponsor Discontinued Study|2|||
170853066|NCT01506609|617468406|FG004|Overall Study|Sponsor Discontinued Study|2|||
170853067|NCT01506609|617468407|FG005|Overall Study|Sponsor Discontinued Study|0|||
170853068|NCT01506609|617468402|FG000|Overall Study|Progressive Disease per Protocol|1|||
170853069|NCT01506609|617468403|FG001|Overall Study|Progressive Disease per Protocol|0|||
170853070|NCT01506609|617468404|FG002|Overall Study|Progressive Disease per Protocol|0|||
170853071|NCT01506609|617468405|FG003|Overall Study|Progressive Disease per Protocol|64|||
170853072|NCT01506609|617468406|FG004|Overall Study|Progressive Disease per Protocol|57|||
170853073|NCT01506609|617468407|FG005|Overall Study|Progressive Disease per Protocol|74|||
170853074|NCT01506609|617468402|FG000|Overall Study|Other, Not Specified|0|||
170853075|NCT01506609|617468403|FG001|Overall Study|Other, Not Specified|0|||
170853076|NCT01506609|617468404|FG002|Overall Study|Other, Not Specified|0|||
170853077|NCT01506609|617468405|FG003|Overall Study|Other, Not Specified|10|||
170853078|NCT01506609|617468406|FG004|Overall Study|Other, Not Specified|7|||
170853079|NCT01506609|617468407|FG005|Overall Study|Other, Not Specified|3|||
170853080|NCT01506609|617468402|FG000|Overall Study|Missing / Unknown Reason|1|||
170853081|NCT01506609|617468403|FG001|Overall Study|Missing / Unknown Reason|0|||
170853082|NCT01506609|617468404|FG002|Overall Study|Missing / Unknown Reason|1|||
170853083|NCT01506609|617468405|FG003|Overall Study|Missing / Unknown Reason|4|||
170853084|NCT01506609|617468406|FG004|Overall Study|Missing / Unknown Reason|4|||
170853085|NCT01506609|617468407|FG005|Overall Study|Missing / Unknown Reason|2|||
170853086|NCT01435616|617468410|FG000|Overall Study|Adverse Event|39|||
170853087|NCT01435616|617468411|FG001|Overall Study|Adverse Event|21|||
170853088|NCT01435616|617468410|FG000|Overall Study|Death|7|||
170853089|NCT01435616|617468411|FG001|Overall Study|Death|2|||
170853090|NCT01435616|617468410|FG000|Overall Study|Lost to Follow-up|22|||
170853091|NCT01435616|617468411|FG001|Overall Study|Lost to Follow-up|13|||
170853092|NCT01435616|617468410|FG000|Overall Study|Protocol Violation|16|||
170853093|NCT01435616|617468411|FG001|Overall Study|Protocol Violation|13|||
170853094|NCT01435616|617468410|FG000|Overall Study|Withdrawal by Subject|66|||
170853095|NCT01435616|617468411|FG001|Overall Study|Withdrawal by Subject|24|||
170853096|NCT01435616|617468410|FG000|Overall Study|Physician Decision|20|||
170853097|NCT01435616|617468411|FG001|Overall Study|Physician Decision|7|||
170853098|NCT01435616|617468410|FG000|Overall Study|Sponsor Decision|1|||
170853099|NCT01435616|617468411|FG001|Overall Study|Sponsor Decision|0|||
170853100|NCT00468559|617468415|FG000|Open-label Treatment Phase|Adverse Event|5|||
170853101|NCT00468559|617468416|FG001|Open-label Treatment Phase|Adverse Event|0|||
170853102|NCT00468559|617468417|FG002|Open-label Treatment Phase|Adverse Event|0|||
170853103|NCT00468559|617468415|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
170853104|NCT00468559|617468416|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
170853105|NCT00468559|617468417|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
170853106|NCT00468559|617468415|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
170853107|NCT00468559|617468416|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
170853108|NCT00468559|617468417|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
170853109|NCT00468559|617468415|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
170853110|NCT00468559|617468416|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
170853111|NCT00468559|617468417|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
170853112|NCT00468559|617468415|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
170853113|NCT00468559|617468416|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
170853114|NCT00468559|617468417|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
170853115|NCT01153958|617468418|FG000|Overall Study|Study Terminated|36|||
170853116|NCT01153958|617468419|FG001|Overall Study|Study Terminated|32|||
170853117|NCT02442336|617468420|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
170853118|NCT02442336|617468420|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
170853119|NCT02442336|617468420|FG000|Overall Study|Lost to Follow-up|11|||
170853120|NCT01993927|617468421|FG000|Overall Study|Case Report Forms Uncollected|18|||
170853121|NCT01993927|617468421|FG000|Overall Study|Protocol Violation|11|||
170853122|NCT01605916|617468422|FG000|Overall Study|Adverse Event|1|||
170853123|NCT01605916|617468423|FG001|Overall Study|Adverse Event|0|||
170853124|NCT01605916|617468424|FG002|Overall Study|Adverse Event|0|||
170853125|NCT01605916|617468425|FG003|Overall Study|Adverse Event|1|||
170853126|NCT01605916|617468426|FG004|Overall Study|Adverse Event|0|||
170853127|NCT01605916|617468422|FG000|Overall Study|Lack of Efficacy|2|||
170853128|NCT01605916|617468423|FG001|Overall Study|Lack of Efficacy|3|||
170853129|NCT01605916|617468424|FG002|Overall Study|Lack of Efficacy|3|||
170853130|NCT01605916|617468425|FG003|Overall Study|Lack of Efficacy|5|||
170853131|NCT01605916|617468426|FG004|Overall Study|Lack of Efficacy|4|||
170853132|NCT01605916|617468422|FG000|Overall Study|Withdrawal by Subject|1|||
170853133|NCT01605916|617468423|FG001|Overall Study|Withdrawal by Subject|1|||
170853134|NCT01605916|617468424|FG002|Overall Study|Withdrawal by Subject|0|||
170853135|NCT01605916|617468425|FG003|Overall Study|Withdrawal by Subject|0|||
170853136|NCT01605916|617468426|FG004|Overall Study|Withdrawal by Subject|2|||
170853137|NCT02414932|617468427|FG000|Overall Study|Withdrawal by Subject|2|||
170853138|NCT02414932|617468428|FG001|Overall Study|Withdrawal by Subject|3|||
170853139|NCT02414932|617468427|FG000|Overall Study|Adverse Event|1|||
170853140|NCT02414932|617468428|FG001|Overall Study|Adverse Event|0|||
170853141|NCT00470366|617468429|FG000|Overall Study|Adverse Event|3|||
170853142|NCT00470366|617468429|FG000|Overall Study|Poor compliance|1|||
170853143|NCT01021215|617468432|FG000|Overall Study|Lost to Follow-up|3|||
170853144|NCT01021215|617468433|FG001|Overall Study|Lost to Follow-up|0|||
170853145|NCT01688830|617468434|FG000|Overall Study|Lost to Follow-up|0|||
170853146|NCT01688830|617468435|FG001|Overall Study|Lost to Follow-up|0|||
170853147|NCT01688830|617468436|FG002|Overall Study|Lost to Follow-up|0|||
170853148|NCT01688830|617468437|FG003|Overall Study|Lost to Follow-up|0|||
170853149|NCT01688830|617468438|FG004|Overall Study|Lost to Follow-up|0|||
170853150|NCT01688830|617468439|FG005|Overall Study|Lost to Follow-up|0|||
170853151|NCT01688830|617468440|FG006|Overall Study|Lost to Follow-up|0|||
170853152|NCT01688830|617468441|FG007|Overall Study|Lost to Follow-up|0|||
170853153|NCT01688830|617468442|FG008|Overall Study|Lost to Follow-up|0|||
170853154|NCT01688830|617468443|FG009|Overall Study|Lost to Follow-up|0|||
170853155|NCT01688830|617468444|FG010|Overall Study|Lost to Follow-up|1|||
170853156|NCT01688830|617468445|FG011|Overall Study|Lost to Follow-up|0|||
170853157|NCT01688830|617468446|FG012|Overall Study|Lost to Follow-up|0|||
170853158|NCT01688830|617468447|FG013|Overall Study|Lost to Follow-up|0|||
170853159|NCT01688830|617468448|FG014|Overall Study|Lost to Follow-up|0|||
170853160|NCT01688830|617468449|FG015|Overall Study|Lost to Follow-up|0|||
170853161|NCT01688830|617468450|FG016|Overall Study|Lost to Follow-up|0|||
170853162|NCT01688830|617468451|FG017|Overall Study|Lost to Follow-up|0|||
170853163|NCT01688830|617468452|FG018|Overall Study|Lost to Follow-up|0|||
170853164|NCT01688830|617468453|FG019|Overall Study|Lost to Follow-up|0|||
170853165|NCT01688830|617468454|FG020|Overall Study|Lost to Follow-up|0|||
170853166|NCT01285609|617468455|FG000|Randomized|Progressive Disease|41|||
170853167|NCT01285609|617468456|FG001|Randomized|Progressive Disease|61|||
170853168|NCT01285609|617468455|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
170853169|NCT01285609|617468456|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
170853170|NCT01285609|617468455|FG000|Randomized|Study Drug Toxicity|13|||
170853171|NCT01285609|617468456|FG001|Randomized|Study Drug Toxicity|14|||
170853172|NCT01285609|617468455|FG000|Randomized|Death|5|||
170853173|NCT01285609|617468456|FG001|Randomized|Death|7|||
170853174|NCT01285609|617468455|FG000|Randomized|Withdrawal by Subject|8|||
170853175|NCT01285609|617468456|FG001|Randomized|Withdrawal by Subject|11|||
170853176|NCT01285609|617468455|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
170853177|NCT01285609|617468456|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
170853178|NCT01285609|617468455|FG000|Randomized|Undisclosed Reasons|1|||
170853179|NCT01285609|617468456|FG001|Randomized|Undisclosed Reasons|0|||
170853180|NCT01285609|617468455|FG000|Randomized|Randomized but not Treated|4|||
170853181|NCT01285609|617468456|FG001|Randomized|Randomized but not Treated|4|||
170853182|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
170853183|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
170853184|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
170853185|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
170853186|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
170853187|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
170853188|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
170853189|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
170853190|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Death|11|||
170853191|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Death|3|||
170853192|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
170853193|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
170853194|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Not Reported|0|||
170853195|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Not Reported|2|||
170742014|NCT01709305|617062248|FG000|Phase 2|Clinical Adverse Event|0|||
170742015|NCT01709305|617062249|FG001|Phase 2|Clinical Adverse Event|10|||
170742016|NCT01709305|617062250|FG002|Phase 2|Clinical Adverse Event|10|||
170742017|NCT01709305|617062251|FG003|Phase 2|Clinical Adverse Event|6|||
170742018|NCT01709305|617062252|FG004|Phase 2|Clinical Adverse Event|11|||
170742019|NCT01709305|617062248|FG000|Phase 2|Death|0|||
170742020|NCT01709305|617062249|FG001|Phase 2|Death|0|||
170742021|NCT01709305|617062250|FG002|Phase 2|Death|1|||
170742022|NCT01709305|617062251|FG003|Phase 2|Death|0|||
170742023|NCT01709305|617062252|FG004|Phase 2|Death|0|||
170742024|NCT01709305|617062248|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
170742025|NCT01709305|617062249|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
170742026|NCT01709305|617062250|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
170742027|NCT01709305|617062251|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
170742028|NCT01709305|617062252|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
170742029|NCT01709305|617062248|FG000|Phase 2|Laboratory Adverse Event|0|||
170742030|NCT01709305|617062249|FG001|Phase 2|Laboratory Adverse Event|1|||
170742031|NCT01709305|617062250|FG002|Phase 2|Laboratory Adverse Event|0|||
170742032|NCT01709305|617062251|FG003|Phase 2|Laboratory Adverse Event|1|||
170742033|NCT01709305|617062252|FG004|Phase 2|Laboratory Adverse Event|1|||
170742034|NCT01709305|617062248|FG000|Phase 2|Lost to Follow-up|0|||
170742035|NCT01709305|617062249|FG001|Phase 2|Lost to Follow-up|10|||
170742036|NCT01709305|617062250|FG002|Phase 2|Lost to Follow-up|6|||
170742037|NCT01709305|617062251|FG003|Phase 2|Lost to Follow-up|9|||
170742038|NCT01709305|617062252|FG004|Phase 2|Lost to Follow-up|5|||
170742039|NCT01709305|617062248|FG000|Phase 2|Travel, moving, etc.|0|||
170742040|NCT01709305|617062249|FG001|Phase 2|Travel, moving, etc.|2|||
170742041|NCT01709305|617062250|FG002|Phase 2|Travel, moving, etc.|3|||
170742042|NCT01709305|617062251|FG003|Phase 2|Travel, moving, etc.|3|||
170742043|NCT01709305|617062252|FG004|Phase 2|Travel, moving, etc.|5|||
170742044|NCT01709305|617062248|FG000|Phase 2|Physician Decision|0|||
170853196|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
170742045|NCT01709305|617062249|FG001|Phase 2|Physician Decision|2|||
170742046|NCT01709305|617062250|FG002|Phase 2|Physician Decision|0|||
170742047|NCT01709305|617062251|FG003|Phase 2|Physician Decision|1|||
170742048|NCT01709305|617062252|FG004|Phase 2|Physician Decision|2|||
170742049|NCT01709305|617062248|FG000|Phase 2|Protocol Violation|0|||
170742050|NCT01709305|617062249|FG001|Phase 2|Protocol Violation|19|||
170742051|NCT01709305|617062250|FG002|Phase 2|Protocol Violation|19|||
170742052|NCT01709305|617062251|FG003|Phase 2|Protocol Violation|13|||
170742053|NCT01709305|617062252|FG004|Phase 2|Protocol Violation|9|||
170742054|NCT01709305|617062248|FG000|Phase 2|Withdrawal by Subject|0|||
170742055|NCT01709305|617062249|FG001|Phase 2|Withdrawal by Subject|8|||
170742056|NCT01709305|617062250|FG002|Phase 2|Withdrawal by Subject|6|||
170742057|NCT01709305|617062251|FG003|Phase 2|Withdrawal by Subject|15|||
170742058|NCT01709305|617062252|FG004|Phase 2|Withdrawal by Subject|12|||
170742059|NCT02875834|617062253|FG000|Open-label Phase|Withdrawal by Subject|3|||
170742060|NCT02875834|617062254|FG001|Open-label Phase|Withdrawal by Subject|0|||
170742061|NCT02875834|617062255|FG002|Open-label Phase|Withdrawal by Subject|0|||
170742062|NCT02875834|617062256|FG003|Open-label Phase|Withdrawal by Subject|0|||
170853197|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
170853198|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
170853199|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
170853200|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
170853201|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
170853202|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
170853203|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
170853204|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
170853205|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
170853206|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
170853207|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
170853208|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
170853209|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
170853210|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
170853211|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
170853212|NCT01285609|617468455|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
170853213|NCT01285609|617468456|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
170853214|NCT01285609|617468455|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
170853215|NCT01285609|617468456|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
170853216|NCT01142115|617468457|FG000|First Intervention|Lack of Efficacy|1|||
170853217|NCT01142115|617468458|FG001|First Intervention|Lack of Efficacy|1|||
170742063|NCT02875834|617062253|FG000|Open-label Phase|(Not collected)|4|||
170742064|NCT02875834|617062254|FG001|Open-label Phase|(Not collected)|0|||
170742065|NCT02875834|617062255|FG002|Open-label Phase|(Not collected)|0|||
170742066|NCT02875834|617062256|FG003|Open-label Phase|(Not collected)|0|||
170742067|NCT02875834|617062253|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
170742068|NCT02875834|617062254|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
170742069|NCT02875834|617062255|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
170742070|NCT02875834|617062256|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
170742071|NCT02875834|617062253|FG000|Randomized Treatment Phase|Protocol Violation|0|||
170742072|NCT02875834|617062254|FG001|Randomized Treatment Phase|Protocol Violation|2|||
170742073|NCT02875834|617062255|FG002|Randomized Treatment Phase|Protocol Violation|0|||
170742074|NCT02875834|617062256|FG003|Randomized Treatment Phase|Protocol Violation|0|||
170742075|NCT02875834|617062253|FG000|Randomized Treatment Phase|(Not collected)|0|||
170742076|NCT02875834|617062254|FG001|Randomized Treatment Phase|(Not collected)|9|||
170742077|NCT02875834|617062255|FG002|Randomized Treatment Phase|(Not collected)|10|||
170742078|NCT02875834|617062256|FG003|Randomized Treatment Phase|(Not collected)|9|||
170742079|NCT02969525|617062260|FG000|Double-Blind Period|Adverse Event|0|||
170853218|NCT01142115|617468457|FG000|First Intervention|Adverse Event|1|||
170853219|NCT01142115|617468458|FG001|First Intervention|Adverse Event|0|||
170853220|NCT03208036|617468459|FG000|Baseline Assessment|Withdrawal by Subject|1|||
170853221|NCT03208036|617468460|FG001|Baseline Assessment|Withdrawal by Subject|1|||
170853222|NCT03208036|617468459|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
170853223|NCT03208036|617468460|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
170853224|NCT03208036|617468459|FG000|Intervention|Withdrawal by Subject|3|||
170853225|NCT03208036|617468460|FG001|Intervention|Withdrawal by Subject|2|||
170742080|NCT02969525|617062261|FG001|Double-Blind Period|Adverse Event|0|||
170853226|NCT03208036|617468459|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
170853227|NCT03208036|617468460|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
170742081|NCT02969525|617062262|FG002|Double-Blind Period|Adverse Event|1|||
170742082|NCT02969525|617062263|FG003|Double-Blind Period|Adverse Event|1|||
170742083|NCT02969525|617062264|FG004|Double-Blind Period|Adverse Event|0|||
170742084|NCT02969525|617062265|FG005|Double-Blind Period|Adverse Event|0|||
170742085|NCT02969525|617062266|FG006|Double-Blind Period|Adverse Event|0|||
170742086|NCT02969525|617062267|FG007|Double-Blind Period|Adverse Event|0|||
170742087|NCT02969525|617062268|FG008|Double-Blind Period|Adverse Event|0|||
170742088|NCT02969525|617062269|FG009|Double-Blind Period|Adverse Event|0|||
170742089|NCT02969525|617062270|FG010|Double-Blind Period|Adverse Event|0|||
170742090|NCT02969525|617062271|FG011|Double-Blind Period|Adverse Event|0|||
170742091|NCT02969525|617062260|FG000|Double-Blind Period|LOW EGFR|0|||
170853228|NCT02842151|617468464|FG000|Overall Study|Adverse Event|1|||
170853229|NCT02842151|617468464|FG000|Overall Study|Subject moved too far away|1|||
170853230|NCT00438672|617468465|FG000|Overall Study|Lost to Follow-up|7|||
170853231|NCT00438672|617468466|FG001|Overall Study|Lost to Follow-up|9|||
170853232|NCT01394978|617468473|FG000|Overall Study|Withdrawal by Subject|2|||
170853233|NCT01394978|617468474|FG001|Overall Study|Withdrawal by Subject|4|||
170853234|NCT01394978|617468473|FG000|Overall Study|Lost to Follow-up|13|||
170853235|NCT01394978|617468474|FG001|Overall Study|Lost to Follow-up|20|||
170853236|NCT01394978|617468473|FG000|Overall Study|Death|6|||
170853237|NCT01394978|617468474|FG001|Overall Study|Death|7|||
170853238|NCT02217501|617468475|FG000|Overall Study|Death|3|||
170853239|NCT02217501|617468476|FG001|Overall Study|Death|4|||
170853240|NCT04577001|617468483|FG000|Overall Study|Subject became ineligible|0|||
170853241|NCT04577001|617468484|FG001|Overall Study|Subject became ineligible|1|||
170853242|NCT00604825|617468486|FG000|Overall Study|Adverse Event|2|||
170853243|NCT00604825|617468487|FG001|Overall Study|Adverse Event|6|||
170853244|NCT00604825|617468488|FG002|Overall Study|Adverse Event|7|||
170853245|NCT00604825|617468489|FG003|Overall Study|Adverse Event|4|||
170853246|NCT00604825|617468486|FG000|Overall Study|Lost to Follow-up|0|||
170853247|NCT00604825|617468487|FG001|Overall Study|Lost to Follow-up|3|||
170853248|NCT00604825|617468488|FG002|Overall Study|Lost to Follow-up|1|||
170853249|NCT00604825|617468489|FG003|Overall Study|Lost to Follow-up|0|||
170853250|NCT00604825|617468486|FG000|Overall Study|Protocol Violation|0|||
170853251|NCT00604825|617468487|FG001|Overall Study|Protocol Violation|1|||
170853252|NCT00604825|617468488|FG002|Overall Study|Protocol Violation|0|||
170853253|NCT00604825|617468489|FG003|Overall Study|Protocol Violation|0|||
170853254|NCT00604825|617468486|FG000|Overall Study|Withdrawal by Subject|4|||
170853255|NCT00604825|617468487|FG001|Overall Study|Withdrawal by Subject|3|||
170853256|NCT00604825|617468488|FG002|Overall Study|Withdrawal by Subject|5|||
170853257|NCT00604825|617468489|FG003|Overall Study|Withdrawal by Subject|5|||
170853258|NCT00604825|617468486|FG000|Overall Study|Lack of Efficacy|3|||
170853259|NCT00604825|617468487|FG001|Overall Study|Lack of Efficacy|2|||
170853260|NCT00604825|617468488|FG002|Overall Study|Lack of Efficacy|1|||
170853261|NCT00604825|617468489|FG003|Overall Study|Lack of Efficacy|0|||
170853262|NCT00604825|617468486|FG000|Overall Study|Did not meet eligibility criteria|0|||
170853263|NCT00604825|617468487|FG001|Overall Study|Did not meet eligibility criteria|0|||
170853264|NCT00604825|617468488|FG002|Overall Study|Did not meet eligibility criteria|2|||
170853265|NCT00604825|617468489|FG003|Overall Study|Did not meet eligibility criteria|0|||
170853266|NCT00604825|617468486|FG000|Overall Study|Physician Decision|0|||
170853267|NCT00604825|617468487|FG001|Overall Study|Physician Decision|0|||
170853268|NCT00604825|617468488|FG002|Overall Study|Physician Decision|0|||
170853269|NCT00604825|617468489|FG003|Overall Study|Physician Decision|1|||
170853270|NCT00604825|617468486|FG000|Overall Study|Exclusion criterion met|0|||
170853271|NCT00604825|617468487|FG001|Overall Study|Exclusion criterion met|0|||
170853272|NCT00604825|617468488|FG002|Overall Study|Exclusion criterion met|0|||
170853273|NCT00604825|617468489|FG003|Overall Study|Exclusion criterion met|1|||
170853274|NCT03465904|617468492|FG000|Overall Study|Withdrawal by Subject|9|||
170853275|NCT03465904|617468493|FG001|Overall Study|Withdrawal by Subject|5|||
170853276|NCT03465904|617468492|FG000|Overall Study|Lost to Follow-up|11|||
170853277|NCT03465904|617468493|FG001|Overall Study|Lost to Follow-up|9|||
170853278|NCT03465904|617468492|FG000|Overall Study|Protocol Violation|20|||
170853279|NCT03465904|617468493|FG001|Overall Study|Protocol Violation|15|||
170853280|NCT05593445|617468494|FG000|12-Week DBVC Period|Adverse Event|1|||
170853281|NCT05593445|617468495|FG001|12-Week DBVC Period|Adverse Event|0|||
170853282|NCT05593445|617468496|FG002|12-Week DBVC Period|Adverse Event|0|||
170853283|NCT05593445|617468497|FG003|12-Week DBVC Period|Adverse Event|0|||
170853284|NCT05593445|617468494|FG000|12-Week DBVC Period|Physician Decision|0|||
170853285|NCT05593445|617468495|FG001|12-Week DBVC Period|Physician Decision|1|||
170853286|NCT05593445|617468496|FG002|12-Week DBVC Period|Physician Decision|0|||
170853287|NCT05593445|617468497|FG003|12-Week DBVC Period|Physician Decision|0|||
170853288|NCT05593445|617468494|FG000|12-Week DBVC Period|Protocol Violation|0|||
170853289|NCT05593445|617468495|FG001|12-Week DBVC Period|Protocol Violation|1|||
170853290|NCT05593445|617468496|FG002|12-Week DBVC Period|Protocol Violation|0|||
170853291|NCT05593445|617468497|FG003|12-Week DBVC Period|Protocol Violation|0|||
170853292|NCT05593445|617468494|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
170853293|NCT05593445|617468495|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
170853294|NCT05593445|617468496|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
170853295|NCT05593445|617468497|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
170853296|NCT05593445|617468494|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
170853297|NCT05593445|617468495|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
170853298|NCT05593445|617468496|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
170853299|NCT05593445|617468497|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
170853300|NCT05593445|617468494|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
170853301|NCT05593445|617468495|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
170853302|NCT05593445|617468496|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
170853303|NCT05593445|617468497|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
170853304|NCT05593445|617468494|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
170853305|NCT05593445|617468495|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
170853306|NCT05593445|617468496|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
170853307|NCT05593445|617468497|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
170853308|NCT05593445|617468494|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170853309|NCT05593445|617468495|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170853310|NCT05593445|617468496|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
170853311|NCT05593445|617468497|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
170853312|NCT05559476|617468498|FG000|Overall Study|Adverse Event|2|||
170853313|NCT05559476|617468499|FG001|Overall Study|Adverse Event|0|||
170853314|NCT05559476|617468498|FG000|Overall Study|Lost to Follow-up|13|||
170853315|NCT05559476|617468499|FG001|Overall Study|Lost to Follow-up|12|||
170853316|NCT05559476|617468498|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
170853317|NCT05559476|617468499|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
170853318|NCT05559476|617468498|FG000|Overall Study|Other|0|||
170853319|NCT05559476|617468499|FG001|Overall Study|Other|2|||
170853320|NCT00616902|617469854|FG000|Overall Study|Termination of study|6|||
170853321|NCT00616902|617469855|FG001|Overall Study|Termination of study|6|||
170853322|NCT03207009|617469856|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
170853323|NCT01877837|617469857|FG000|Overall Study|Lost to Follow-up|1|||
170853324|NCT01877837|617469857|FG000|Overall Study|Ineligible|4|||
170853325|NCT00645801|617469858|FG000|Overall Study|unclear if patient took all the medication.|1|||
170853326|NCT00645801|617469859|FG001|Overall Study|unclear if patient took all the medication.|0|||
170853327|NCT00645801|617469858|FG000|Overall Study|Lost to Follow-up|19|||
170853328|NCT00645801|617469859|FG001|Overall Study|Lost to Follow-up|15|||
170853329|NCT00901186|617469860|FG000|Overall Study|Lack of Efficacy|0|||
170853330|NCT00901186|617469861|FG001|Overall Study|Lack of Efficacy|1|||
170853331|NCT00901186|617469860|FG000|Overall Study|Abnormal laboratory values|0|||
170853332|NCT00901186|617469861|FG001|Overall Study|Abnormal laboratory values|1|||
170853333|NCT00901186|617469860|FG000|Overall Study|Lost to Follow-up|2|||
170853334|NCT00901186|617469861|FG001|Overall Study|Lost to Follow-up|0|||
170853335|NCT00901186|617469860|FG000|Overall Study|Adverse Event|2|||
170853336|NCT00901186|617469861|FG001|Overall Study|Adverse Event|4|||
170853337|NCT00901186|617469860|FG000|Overall Study|Administration problems|0|||
170853338|NCT00901186|617469861|FG001|Overall Study|Administration problems|1|||
170853339|NCT00901186|617469860|FG000|Overall Study|Protocol deviations|5|||
170853340|NCT00901186|617469861|FG001|Overall Study|Protocol deviations|4|||
170853341|NCT00953407|617469862|FG000|Overall Study|Failed inclusion criteria|1|||
170853342|NCT00953407|617469863|FG001|Overall Study|Failed inclusion criteria|1|||
170853343|NCT00953407|617469864|FG002|Overall Study|Failed inclusion criteria|1|||
170853344|NCT00953407|617469865|FG003|Overall Study|Failed inclusion criteria|1|||
170853345|NCT00953407|617469866|FG004|Overall Study|Failed inclusion criteria|1|||
170853346|NCT00953407|617469862|FG000|Overall Study|Lost to Follow-up|0|||
170853347|NCT00953407|617469863|FG001|Overall Study|Lost to Follow-up|0|||
170853348|NCT00953407|617469864|FG002|Overall Study|Lost to Follow-up|0|||
170853349|NCT00953407|617469865|FG003|Overall Study|Lost to Follow-up|1|||
170853350|NCT00953407|617469866|FG004|Overall Study|Lost to Follow-up|0|||
170853351|NCT02186223|617469867|FG000|Overall Study|Not eligible for device placement|6|||
170853352|NCT02186223|617469867|FG000|Overall Study|Unable to obtain femoral access|3|||
170853353|NCT02186223|617469867|FG000|Overall Study|Death|3|||
170853354|NCT02186223|617469867|FG000|Overall Study|Device in place less than 48 hours|9|||
170853355|NCT00203476|617469868|FG000|Overall Study|Lost to Follow-up|1|||
170853356|NCT00203476|617469869|FG001|Overall Study|Lost to Follow-up|0|||
170853357|NCT00203476|617469870|FG002|Overall Study|Lost to Follow-up|0|||
170853358|NCT00203476|617469868|FG000|Overall Study|Withdrawal by Subject|0|||
170853359|NCT00203476|617469869|FG001|Overall Study|Withdrawal by Subject|1|||
170853360|NCT00203476|617469870|FG002|Overall Study|Withdrawal by Subject|0|||
170853361|NCT01190514|617469871|FG000|First Intervention (Period 1)|Adverse Event|1|||
170853362|NCT01190514|617469872|FG001|First Intervention (Period 1)|Adverse Event|0|||
170853363|NCT01190514|617469873|FG002|First Intervention (Period 1)|Adverse Event|0|||
170853364|NCT01190514|617469874|FG003|First Intervention (Period 1)|Adverse Event|0|||
170853365|NCT01190514|617469871|FG000|Third Intervention (Period 3)|Adverse Event|1|||
170853366|NCT01190514|617469872|FG001|Third Intervention (Period 3)|Adverse Event|0|||
170853367|NCT01190514|617469873|FG002|Third Intervention (Period 3)|Adverse Event|0|||
170853368|NCT01190514|617469874|FG003|Third Intervention (Period 3)|Adverse Event|0|||
170853369|NCT00252733|617469875|FG000|Overall Study|Withdrawal by Subject|73|||
170853370|NCT00252733|617469876|FG001|Overall Study|Withdrawal by Subject|67|||
170853371|NCT00252733|617469875|FG000|Overall Study|Death|7|||
170853372|NCT00252733|617469876|FG001|Overall Study|Death|5|||
170853373|NCT00252733|617469875|FG000|Overall Study|Lost to Follow-up|12|||
170853374|NCT00252733|617469876|FG001|Overall Study|Lost to Follow-up|6|||
170853375|NCT00252733|617469875|FG000|Overall Study|Multiple Reasons|14|||
170853376|NCT00252733|617469876|FG001|Overall Study|Multiple Reasons|14|||
170853377|NCT00512317|617469877|FG000|Overall Study|Insufficient clinical response|36|||
170853378|NCT00512317|617469877|FG000|Overall Study|Withdrawal by Subject|23|||
170853379|NCT00512317|617469877|FG000|Overall Study|Sponsor closure of study|21|||
170742092|NCT02969525|617062261|FG001|Double-Blind Period|LOW EGFR|0|||
170742093|NCT02969525|617062262|FG002|Double-Blind Period|LOW EGFR|0|||
170742094|NCT02969525|617062263|FG003|Double-Blind Period|LOW EGFR|1|||
170742095|NCT02969525|617062264|FG004|Double-Blind Period|LOW EGFR|0|||
170742096|NCT02969525|617062265|FG005|Double-Blind Period|LOW EGFR|0|||
170742097|NCT02969525|617062266|FG006|Double-Blind Period|LOW EGFR|0|||
170742098|NCT02969525|617062267|FG007|Double-Blind Period|LOW EGFR|0|||
170742099|NCT02969525|617062268|FG008|Double-Blind Period|LOW EGFR|0|||
170742100|NCT02969525|617062269|FG009|Double-Blind Period|LOW EGFR|0|||
170742101|NCT02969525|617062270|FG010|Double-Blind Period|LOW EGFR|0|||
170742102|NCT02969525|617062271|FG011|Double-Blind Period|LOW EGFR|0|||
170742103|NCT02969525|617062260|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
170742104|NCT02969525|617062261|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742105|NCT02969525|617062262|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742106|NCT02969525|617062263|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
170742107|NCT02969525|617062264|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742108|NCT02969525|617062265|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742109|NCT02969525|617062266|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742110|NCT02969525|617062267|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742111|NCT02969525|617062268|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742112|NCT02969525|617062269|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742113|NCT02969525|617062270|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742114|NCT02969525|617062271|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
170742115|NCT02969525|617062260|FG000|Dose-Blind Period|Adverse Event|0|||
170742116|NCT02969525|617062261|FG001|Dose-Blind Period|Adverse Event|0|||
170742117|NCT02969525|617062262|FG002|Dose-Blind Period|Adverse Event|0|||
170742118|NCT02969525|617062263|FG003|Dose-Blind Period|Adverse Event|0|||
170742119|NCT02969525|617062264|FG004|Dose-Blind Period|Adverse Event|0|||
170742120|NCT02969525|617062265|FG005|Dose-Blind Period|Adverse Event|0|||
170742121|NCT02969525|617062266|FG006|Dose-Blind Period|Adverse Event|0|||
170742122|NCT02969525|617062267|FG007|Dose-Blind Period|Adverse Event|0|||
170742123|NCT02969525|617062268|FG008|Dose-Blind Period|Adverse Event|0|||
170742124|NCT02969525|617062269|FG009|Dose-Blind Period|Adverse Event|1|||
170742125|NCT02969525|617062270|FG010|Dose-Blind Period|Adverse Event|1|||
170742126|NCT02969525|617062271|FG011|Dose-Blind Period|Adverse Event|1|||
170742127|NCT02969525|617062260|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
170742128|NCT02969525|617062261|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
170742129|NCT02969525|617062262|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
170742130|NCT02969525|617062263|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
170742131|NCT02969525|617062264|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
170742132|NCT02969525|617062265|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
170742133|NCT02969525|617062266|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
170742134|NCT02969525|617062267|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
170742135|NCT02969525|617062268|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
170742136|NCT02969525|617062269|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
170742137|NCT02969525|617062270|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
170742138|NCT02969525|617062271|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
170742139|NCT02969525|617062260|FG000|Dose-Blind Period|Non-cooperating patient|0|||
170742140|NCT02969525|617062261|FG001|Dose-Blind Period|Non-cooperating patient|0|||
170742141|NCT02969525|617062262|FG002|Dose-Blind Period|Non-cooperating patient|0|||
170742142|NCT02969525|617062263|FG003|Dose-Blind Period|Non-cooperating patient|0|||
170742143|NCT02969525|617062264|FG004|Dose-Blind Period|Non-cooperating patient|0|||
170742144|NCT02969525|617062265|FG005|Dose-Blind Period|Non-cooperating patient|0|||
170742145|NCT02969525|617062266|FG006|Dose-Blind Period|Non-cooperating patient|0|||
170742146|NCT02969525|617062267|FG007|Dose-Blind Period|Non-cooperating patient|0|||
170742147|NCT02969525|617062268|FG008|Dose-Blind Period|Non-cooperating patient|0|||
170742148|NCT02969525|617062269|FG009|Dose-Blind Period|Non-cooperating patient|0|||
170742149|NCT02969525|617062270|FG010|Dose-Blind Period|Non-cooperating patient|0|||
170742150|NCT02969525|617062271|FG011|Dose-Blind Period|Non-cooperating patient|1|||
170742151|NCT02969525|617062260|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742152|NCT02969525|617062261|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742153|NCT02969525|617062262|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742154|NCT02969525|617062263|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742155|NCT02969525|617062264|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742156|NCT02969525|617062265|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742157|NCT02969525|617062266|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742158|NCT02969525|617062267|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742159|NCT02969525|617062268|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742160|NCT02969525|617062269|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742161|NCT02969525|617062270|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
170742162|NCT02969525|617062271|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
170742163|NCT02172625|617062272|FG000|Overall Study|Adverse Event|0|||
170853380|NCT00512317|617469877|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
170853381|NCT00512317|617469877|FG000|Overall Study|Adverse Event|13|||
170853382|NCT00512317|617469877|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
170853383|NCT00512317|617469877|FG000|Overall Study|Lost to Follow-up|2|||
170853384|NCT00512317|617469877|FG000|Overall Study|Other|2|||
170853385|NCT01491672|617469878|FG000|Overall Study|Lost to Follow-up|0|||
170853386|NCT01491672|617469879|FG001|Overall Study|Lost to Follow-up|4|||
170853387|NCT01491672|617469880|FG002|Overall Study|Lost to Follow-up|1|||
170853388|NCT01491672|617469878|FG000|Overall Study|Withdrawal by Subject|6|||
170853389|NCT01491672|617469879|FG001|Overall Study|Withdrawal by Subject|7|||
170853390|NCT01491672|617469880|FG002|Overall Study|Withdrawal by Subject|0|||
170853391|NCT01491672|617469878|FG000|Overall Study|Adverse Event|8|||
170853392|NCT01491672|617469879|FG001|Overall Study|Adverse Event|10|||
170853393|NCT01491672|617469880|FG002|Overall Study|Adverse Event|4|||
170853394|NCT01491672|617469878|FG000|Overall Study|Disease progression|42|||
170853395|NCT01491672|617469879|FG001|Overall Study|Disease progression|34|||
170853396|NCT01491672|617469880|FG002|Overall Study|Disease progression|6|||
170853397|NCT01491672|617469878|FG000|Overall Study|Protocol deviation|0|||
170853398|NCT01491672|617469879|FG001|Overall Study|Protocol deviation|1|||
170853399|NCT01491672|617469880|FG002|Overall Study|Protocol deviation|0|||
170853400|NCT01491672|617469878|FG000|Overall Study|Death|0|||
170853401|NCT01491672|617469879|FG001|Overall Study|Death|4|||
170853402|NCT01491672|617469880|FG002|Overall Study|Death|0|||
170853403|NCT01111474|617469881|FG000|Overall Study|Lost to Follow-up|12|||
170853404|NCT00706433|617469885|FG000|Overall Study|Lost to Follow-up|3|||
170853405|NCT00706433|617469886|FG001|Overall Study|Lost to Follow-up|1|||
170853406|NCT00706433|617469887|FG002|Overall Study|Lost to Follow-up|6|||
170853407|NCT00706433|617469888|FG003|Overall Study|Lost to Follow-up|0|||
170853408|NCT00706433|617469885|FG000|Overall Study|Withdrawal by Subject|1|||
170853409|NCT00706433|617469886|FG001|Overall Study|Withdrawal by Subject|2|||
170853410|NCT00706433|617469887|FG002|Overall Study|Withdrawal by Subject|3|||
170853411|NCT00706433|617469888|FG003|Overall Study|Withdrawal by Subject|1|||
170853412|NCT00706433|617469885|FG000|Overall Study|Adverse Event|0|||
170853413|NCT00706433|617469886|FG001|Overall Study|Adverse Event|0|||
170853414|NCT00706433|617469887|FG002|Overall Study|Adverse Event|1|||
170853415|NCT00706433|617469888|FG003|Overall Study|Adverse Event|0|||
170853416|NCT00706433|617469885|FG000|Overall Study|Protocol Violation|1|||
170853417|NCT00706433|617469886|FG001|Overall Study|Protocol Violation|0|||
170853418|NCT00706433|617469887|FG002|Overall Study|Protocol Violation|0|||
170853419|NCT00706433|617469888|FG003|Overall Study|Protocol Violation|0|||
170853420|NCT00706433|617469885|FG000|Overall Study|new job|0|||
170853421|NCT00706433|617469886|FG001|Overall Study|new job|0|||
170853422|NCT00706433|617469887|FG002|Overall Study|new job|0|||
170853423|NCT00706433|617469888|FG003|Overall Study|new job|1|||
170853424|NCT01236365|617469890|FG000|Overall Study|Lost to Follow-up|0|||
170853425|NCT01236365|617469891|FG001|Overall Study|Lost to Follow-up|2|||
170853426|NCT01236365|617469890|FG000|Overall Study|Moved Out of State|1|||
170853427|NCT01236365|617469891|FG001|Overall Study|Moved Out of State|0|||
170853428|NCT01236365|617469890|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
170853429|NCT01236365|617469891|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
170853430|NCT00156819|617469894|FG000|Overall Study|Lost to Follow-up|1|||
170853431|NCT00156819|617469895|FG001|Overall Study|Lost to Follow-up|1|||
170853432|NCT00156819|617469896|FG002|Overall Study|Lost to Follow-up|3|||
170853433|NCT01183234|617469897|FG000|First Intervention|Adverse Event|1|||
170853434|NCT01183234|617469898|FG001|First Intervention|Adverse Event|0|||
170853435|NCT02966301|617469901|FG000|Overall Study|Death|2|||
170853436|NCT02966301|617469901|FG000|Overall Study|Withdrawal by Subject|1|||
170853437|NCT01689337|617469902|FG000|Overall Study|Study Discontinuation|1|||
170853438|NCT00370331|617469904|FG000|Overall Study|Adverse Event|4|||
170853439|NCT00370331|617469905|FG001|Overall Study|Adverse Event|13|||
170853440|NCT00370331|617469904|FG000|Overall Study|Withdrawal by Subject|2|||
170853441|NCT00370331|617469905|FG001|Overall Study|Withdrawal by Subject|4|||
170853442|NCT00370331|617469904|FG000|Overall Study|Lost to Follow-up|0|||
170853443|NCT00370331|617469905|FG001|Overall Study|Lost to Follow-up|3|||
170853444|NCT00370331|617469904|FG000|Overall Study|Lack of Efficacy|0|||
170853445|NCT00370331|617469905|FG001|Overall Study|Lack of Efficacy|1|||
170853446|NCT00370331|617469904|FG000|Overall Study|Non-compliance|0|||
170853447|NCT00370331|617469905|FG001|Overall Study|Non-compliance|1|||
170853448|NCT00370331|617469904|FG000|Overall Study|Protocol Violation|1|||
170853449|NCT00370331|617469905|FG001|Overall Study|Protocol Violation|1|||
170853450|NCT00309959|617469906|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
170853451|NCT00642772|617469908|FG000|Overall Study|Lost to Follow-up|3|||
170853452|NCT00642772|617469908|FG000|Overall Study|Withdrawal by Subject|7|||
170853453|NCT00545051|617469910|FG000|Overall Study|Adverse Event|7|||
170853454|NCT00545051|617469911|FG001|Overall Study|Adverse Event|3|||
170853455|NCT00545051|617469910|FG000|Overall Study|Death|1|||
170853456|NCT00545051|617469911|FG001|Overall Study|Death|0|||
170853457|NCT00545051|617469910|FG000|Overall Study|Violation of inclusion/exclusion|0|||
170853458|NCT00545051|617469911|FG001|Overall Study|Violation of inclusion/exclusion|2|||
170853459|NCT00545051|617469910|FG000|Overall Study|Protocol Violation|1|||
170853460|NCT00545051|617469911|FG001|Overall Study|Protocol Violation|0|||
170853461|NCT00545051|617469910|FG000|Overall Study|Withdrawal by Subject|0|||
170853462|NCT00545051|617469911|FG001|Overall Study|Withdrawal by Subject|1|||
170853463|NCT00545051|617469910|FG000|Overall Study|Administrative reasons|0|||
170853464|NCT00545051|617469911|FG001|Overall Study|Administrative reasons|1|||
170853465|NCT01888900|617469918|FG000|Overall Study|failed treatment|0|||
170853466|NCT01888900|617469919|FG001|Overall Study|failed treatment|2|||
170853467|NCT01312857|617469920|FG000|Overall Study|Adverse Event|1|||
170853468|NCT01312857|617469921|FG001|Overall Study|Adverse Event|1|||
170853469|NCT01312857|617469920|FG000|Overall Study|Lost to Follow-up|2|||
170853470|NCT01312857|617469921|FG001|Overall Study|Lost to Follow-up|0|||
170853471|NCT01312857|617469920|FG000|Overall Study|Physician Decision|3|||
170853472|NCT01312857|617469921|FG001|Overall Study|Physician Decision|0|||
170853473|NCT01312857|617469920|FG000|Overall Study|Withdrawal by Subject|2|||
170853474|NCT01312857|617469921|FG001|Overall Study|Withdrawal by Subject|0|||
170853475|NCT01156792|617469928|FG000|Overall Study|Adverse Event|1|||
170853476|NCT01156792|617469928|FG000|Overall Study|Lack of Efficacy|36|||
170853477|NCT01156792|617469928|FG000|Overall Study|Protocol Violation|6|||
170853478|NCT01156792|617469928|FG000|Overall Study|Lost to Follow-up|3|||
170853479|NCT01156792|617469928|FG000|Overall Study|Physician Decision|3|||
170853480|NCT01156792|617469928|FG000|Overall Study|Withdrawal by Subject|9|||
170853481|NCT01156792|617469928|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
170853482|NCT00768079|617469929|FG000|Overall Study|Lost to Follow-up|2|||
170853483|NCT00768079|617469930|FG001|Overall Study|Lost to Follow-up|0|||
170853484|NCT00768079|617469931|FG002|Overall Study|Lost to Follow-up|4|||
170853485|NCT00768079|617469929|FG000|Overall Study|Participant incarcerated|0|||
170853486|NCT00768079|617469930|FG001|Overall Study|Participant incarcerated|1|||
170853487|NCT00768079|617469931|FG002|Overall Study|Participant incarcerated|0|||
170853488|NCT01146782|617469938|FG000|Screening Cohort|Screen Failure|187|||
170853489|NCT01146782|617469938|FG000|Screening Cohort|Lost to Follow-up|4|||
170853490|NCT01146782|617469938|FG000|Screening Cohort|Physician Decision|1|||
170853491|NCT01146782|617469938|FG000|Screening Cohort|Withdrawal by Subject|29|||
170853492|NCT01146782|617469938|FG000|Safety Cohort|Screen Failure|61|||
170853493|NCT01146782|617469938|FG000|Safety Cohort|Withdrawal by Subject|4|||
170853494|NCT01146782|617469938|FG000|Safety Cohort|Control AHI <5|4|||
170853495|NCT01146782|617469938|FG000|Safety Cohort|TST <4 hrs|14|||
170853496|NCT01146782|617469938|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
170853497|NCT01146782|617469938|FG000|Primary Endpoint Cohort|Physician Decision|1|||
170853498|NCT01014533|617469939|FG000|Overall Study|Protocol Violation|3|||
170853499|NCT01014533|617469940|FG001|Overall Study|Protocol Violation|2|||
170853500|NCT01014533|617469939|FG000|Overall Study|Withdrawal by Subject|2|||
170853501|NCT01014533|617469940|FG001|Overall Study|Withdrawal by Subject|0|||
170853502|NCT01014533|617469939|FG000|Overall Study|unable to come to appointment|0|||
170853503|NCT01014533|617469940|FG001|Overall Study|unable to come to appointment|3|||
170853504|NCT01226095|617469945|FG000|Overall Study|Poor compliance|1|||
170853505|NCT05038163|617469948|FG000|Stage 1|Did not complete survey|374|||
170853506|NCT05038163|617469949|FG001|Stage 1|Did not complete survey|0|||
170853507|NCT05038163|617469950|FG002|Stage 1|Did not complete survey|0|||
170853508|NCT05038163|617469951|FG003|Stage 1|Did not complete survey|0|||
170853509|NCT05038163|617469952|FG004|Stage 1|Did not complete survey|0|||
170853510|NCT05038163|617469953|FG005|Stage 1|Did not complete survey|0|||
170853511|NCT05038163|617469948|FG000|Stage 2|Did not complete Stage 2 survey|0|||
170853512|NCT05038163|617469949|FG001|Stage 2|Did not complete Stage 2 survey|29|||
170853513|NCT05038163|617469950|FG002|Stage 2|Did not complete Stage 2 survey|30|||
170853514|NCT05038163|617469951|FG003|Stage 2|Did not complete Stage 2 survey|24|||
170853515|NCT05038163|617469952|FG004|Stage 2|Did not complete Stage 2 survey|21|||
170853516|NCT05038163|617469953|FG005|Stage 2|Did not complete Stage 2 survey|100|||
170853517|NCT01758900|617469959|FG000|Overall Study|difficulty for further intubation|7|||
170853518|NCT01758900|617469960|FG001|Overall Study|difficulty for further intubation|8|||
170853519|NCT00935818|617469961|FG000|Overall Study|Withdrawal by Subject|45|||
170853520|NCT00935818|617469962|FG001|Overall Study|Withdrawal by Subject|50|||
170853521|NCT00935818|617469961|FG000|Overall Study|Lost to Follow-up|40|||
170853522|NCT00935818|617469962|FG001|Overall Study|Lost to Follow-up|42|||
170853523|NCT00935818|617469961|FG000|Overall Study|Adverse Event|6|||
170853524|NCT00935818|617469962|FG001|Overall Study|Adverse Event|7|||
170853525|NCT00935818|617469961|FG000|Overall Study|Physician Decision|0|||
170853526|NCT00935818|617469962|FG001|Overall Study|Physician Decision|1|||
170853527|NCT02631577|617469963|FG000|Overall Study|Death|1|||
170853528|NCT02631577|617469964|FG001|Overall Study|Death|7|||
170853529|NCT02631577|617469963|FG000|Overall Study|Withdrawal by Subject|0|||
170853530|NCT02631577|617469964|FG001|Overall Study|Withdrawal by Subject|3|||
170853531|NCT01305200|617469968|FG000|Overall Study|Physician Decision|4|||
170742164|NCT02172625|617062273|FG001|Overall Study|Adverse Event|1|||
170742165|NCT02172625|617062272|FG000|Overall Study|Pregnancy|0|||
170742166|NCT02172625|617062273|FG001|Overall Study|Pregnancy|1|||
170742167|NCT02172625|617062272|FG000|Overall Study|car accident|0|||
170742168|NCT02172625|617062273|FG001|Overall Study|car accident|1|||
170742169|NCT03445065|617062274|FG000|Overall Study|Withdrawal by Subject|3|||
170742170|NCT03445065|617062275|FG001|Overall Study|Withdrawal by Subject|6|||
170742171|NCT03445065|617062276|FG002|Overall Study|Withdrawal by Subject|2|||
170742172|NCT03445065|617062277|FG003|Overall Study|Withdrawal by Subject|2|||
170742173|NCT03445065|617062274|FG000|Overall Study|Other|4|||
170742174|NCT03445065|617062275|FG001|Overall Study|Other|3|||
170742175|NCT03445065|617062276|FG002|Overall Study|Other|3|||
170742176|NCT03445065|617062277|FG003|Overall Study|Other|1|||
170742177|NCT02944656|617062278|FG000|Overall Study|No longer eligible|3|||
170742178|NCT02944656|617062279|FG001|Overall Study|No longer eligible|0|||
170742179|NCT02944656|617062278|FG000|Overall Study|Lost to Follow-up|7|||
170742180|NCT02944656|617062279|FG001|Overall Study|Lost to Follow-up|10|||
170742181|NCT01811563|617064170|FG000|Overall Study|Lost to Follow-up|5|||
170742182|NCT01811563|617064171|FG001|Overall Study|Lost to Follow-up|2|||
170742183|NCT01811563|617064170|FG000|Overall Study|Incorrect Randomization procedure|0|||
170742184|NCT01811563|617064171|FG001|Overall Study|Incorrect Randomization procedure|1|||
170742185|NCT02936037|617064172|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
170742186|NCT02936037|617064173|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
170742187|NCT02936037|617064172|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
170742188|NCT02936037|617064173|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
170742189|NCT02936037|617064172|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
170742190|NCT02936037|617064173|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
170742191|NCT02936037|617064172|FG000|Double-Blind Treatment Period|Death|0|||
170742192|NCT02936037|617064173|FG001|Double-Blind Treatment Period|Death|1|||
170742193|NCT02936037|617064172|FG000|Double-Blind Treatment Period|Adverse Event|11|||
170742194|NCT02936037|617064173|FG001|Double-Blind Treatment Period|Adverse Event|11|||
170742195|NCT02936037|617064172|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
170742196|NCT02936037|617064173|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
170742197|NCT02936037|617064172|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170742198|NCT02936037|617064173|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
170742199|NCT02936037|617064172|FG000|Open Label Extension|Adverse Event|0|||
170742200|NCT02936037|617064173|FG001|Open Label Extension|Adverse Event|3|||
170742201|NCT02936037|617064172|FG000|Open Label Extension|Other|0|||
170742202|NCT02936037|617064173|FG001|Open Label Extension|Other|3|||
170742203|NCT02936037|617064172|FG000|Open Label Extension|Withdrawal by Subject|0|||
170742204|NCT02936037|617064173|FG001|Open Label Extension|Withdrawal by Subject|4|||
170742205|NCT01267825|617064174|FG000|Overall Study|study terminated. no data collected.|1|||
170742206|NCT01267825|617064175|FG001|Overall Study|study terminated. no data collected.|0|||
170742207|NCT00077636|617064179|FG000|Overall Study|Refused Treatment|9|||
170742208|NCT00077636|617064180|FG001|Overall Study|Refused Treatment|31|||
170742209|NCT00077636|617064179|FG000|Overall Study|Admin|3|||
170742210|NCT00077636|617064180|FG001|Overall Study|Admin|3|||
170742211|NCT00077636|617064179|FG000|Overall Study|Withdrawal by Subject|2|||
170742212|NCT00077636|617064180|FG001|Overall Study|Withdrawal by Subject|2|||
170742213|NCT00077636|617064179|FG000|Overall Study|Adverse Event|17|||
170742214|NCT00077636|617064180|FG001|Overall Study|Adverse Event|34|||
170742215|NCT00077636|617064179|FG000|Overall Study|Protocol Violation|0|||
170742216|NCT00077636|617064180|FG001|Overall Study|Protocol Violation|2|||
170742217|NCT00077636|617064179|FG000|Overall Study|Lost to Follow-up|10|||
170742218|NCT00077636|617064180|FG001|Overall Study|Lost to Follow-up|18|||
170742219|NCT00077636|617064179|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
170742220|NCT00077636|617064180|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
170742221|NCT00068380|617064183|FG000|Overall Study|Withdrawal by Subject|3|||
170742222|NCT00068380|617064183|FG000|Overall Study|Adverse Event|2|||
170742223|NCT01190215|617064184|FG000|Up to Month 6|Lost to Follow-up|2|||
170742224|NCT01190215|617064185|FG001|Up to Month 6|Lost to Follow-up|0|||
170742225|NCT02914184|617064187|FG000|Overall Study|Lost to Follow-up|7|||
170853532|NCT01305200|617469969|FG001|Overall Study|Physician Decision|6|||
170853533|NCT01305200|617469970|FG002|Overall Study|Physician Decision|1|||
170853534|NCT01305200|617469968|FG000|Overall Study|Withdrawal by Subject|24|||
170853535|NCT01305200|617469969|FG001|Overall Study|Withdrawal by Subject|21|||
170742226|NCT02914184|617064188|FG001|Overall Study|Lost to Follow-up|10|||
170742227|NCT02914184|617064189|FG002|Overall Study|Lost to Follow-up|8|||
170742228|NCT02914184|617064190|FG003|Overall Study|Lost to Follow-up|7|||
170742229|NCT02914184|617064187|FG000|Overall Study|Withdrawal by Subject|4|||
170742230|NCT02914184|617064188|FG001|Overall Study|Withdrawal by Subject|2|||
170742231|NCT02914184|617064189|FG002|Overall Study|Withdrawal by Subject|7|||
170742232|NCT02914184|617064190|FG003|Overall Study|Withdrawal by Subject|3|||
170742233|NCT02914184|617064187|FG000|Overall Study|Other|1|||
170742234|NCT02914184|617064188|FG001|Overall Study|Other|0|||
170742235|NCT02914184|617064189|FG002|Overall Study|Other|0|||
170742236|NCT02914184|617064190|FG003|Overall Study|Other|0|||
170853536|NCT01305200|617469970|FG002|Overall Study|Withdrawal by Subject|1|||
170853537|NCT01305200|617469968|FG000|Overall Study|Ineligible|1|||
170853538|NCT01305200|617469969|FG001|Overall Study|Ineligible|2|||
170853539|NCT01305200|617469970|FG002|Overall Study|Ineligible|1|||
170853540|NCT01305200|617469968|FG000|Overall Study|Death|0|||
170853541|NCT01305200|617469969|FG001|Overall Study|Death|2|||
170853542|NCT01305200|617469970|FG002|Overall Study|Death|0|||
170853543|NCT05110690|617469971|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
170853544|NCT05110690|617469971|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
170853545|NCT05110690|617469971|FG000|Completion of Intervention|Lost to Follow-up|1|||
170853546|NCT05110690|617469971|FG000|Completion of Intervention|Death|1|||
170853547|NCT05110690|617469971|FG000|Completion of Intervention|Withdrawal by Subject|2|||
170853548|NCT00812331|617471665|FG000|Overall Study|Adverse Event|1|||
170853549|NCT00812331|617471666|FG001|Overall Study|Adverse Event|0|||
170853550|NCT00812331|617471667|FG002|Overall Study|Adverse Event|0|||
170853551|NCT00812331|617471668|FG003|Overall Study|Adverse Event|0|||
170853552|NCT00812331|617471669|FG004|Overall Study|Adverse Event|0|||
170853553|NCT02502799|617471670|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
170853554|NCT02502799|617471671|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
170853555|NCT02502799|617471672|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
170853556|NCT02502799|617471673|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
170742237|NCT02914184|617064187|FG000|Overall Study|Migrated/moved from the study area|2|||
170742238|NCT02914184|617064188|FG001|Overall Study|Migrated/moved from the study area|1|||
170742239|NCT02914184|617064189|FG002|Overall Study|Migrated/moved from the study area|2|||
170742240|NCT02914184|617064190|FG003|Overall Study|Migrated/moved from the study area|1|||
170742241|NCT02960763|617064191|FG000|Step 1|Withdrawal by Subject|10|||
170742242|NCT02960763|617064192|FG001|Step 1|Withdrawal by Subject|8|||
170742243|NCT02960763|617064193|FG002|Step 1|Withdrawal by Subject|13|||
170742244|NCT02960763|617064194|FG003|Step 1|Withdrawal by Subject|0|||
170742245|NCT02960763|617064195|FG004|Step 1|Withdrawal by Subject|0|||
170742246|NCT02960763|617064191|FG000|Step 1|Lost to Follow-up|7|||
170742247|NCT02960763|617064192|FG001|Step 1|Lost to Follow-up|9|||
170742248|NCT02960763|617064193|FG002|Step 1|Lost to Follow-up|12|||
170742249|NCT02960763|617064194|FG003|Step 1|Lost to Follow-up|0|||
170742250|NCT02960763|617064195|FG004|Step 1|Lost to Follow-up|0|||
170742251|NCT02960763|617064191|FG000|Step 1|Death|1|||
170742252|NCT02960763|617064192|FG001|Step 1|Death|1|||
170742253|NCT02960763|617064193|FG002|Step 1|Death|1|||
170742254|NCT02960763|617064194|FG003|Step 1|Death|0|||
170742255|NCT02960763|617064195|FG004|Step 1|Death|0|||
170742256|NCT02960763|617064191|FG000|Step 1|Investigator discretion|1|||
170742257|NCT02960763|617064192|FG001|Step 1|Investigator discretion|0|||
170742258|NCT02960763|617064193|FG002|Step 1|Investigator discretion|1|||
170742259|NCT02960763|617064194|FG003|Step 1|Investigator discretion|0|||
170742260|NCT02960763|617064195|FG004|Step 1|Investigator discretion|0|||
170742261|NCT02960763|617064191|FG000|Step 1|Other|0|||
170742262|NCT02960763|617064192|FG001|Step 1|Other|0|||
170853557|NCT02502799|617471670|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
170853558|NCT02502799|617471671|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
170853559|NCT02502799|617471672|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
170853560|NCT02502799|617471673|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
170853561|NCT02502799|617471670|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
170853562|NCT02502799|617471671|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
170853563|NCT02502799|617471672|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
170853564|NCT02502799|617471673|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
170853565|NCT02502799|617471670|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
170853566|NCT02502799|617471671|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
170853567|NCT02502799|617471672|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
170853568|NCT02502799|617471673|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
170853569|NCT02502799|617471670|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
170853570|NCT02502799|617471671|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
170853571|NCT02502799|617471672|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
170853572|NCT02502799|617471673|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
170853573|NCT01143038|617471674|FG000|Overall Study|Withdrawal by Subject|4|||
170853574|NCT01143038|617471674|FG000|Overall Study|Requirement for alternative therapy|5|||
170853575|NCT01143038|617471674|FG000|Overall Study|Adverse Event|3|||
170853576|NCT01143038|617471674|FG000|Overall Study|Lost to Follow-up|2|||
170853577|NCT01143038|617471674|FG000|Overall Study|Protocol Deviation|1|||
170853578|NCT01143038|617471674|FG000|Overall Study|Death|1|||
170853579|NCT03310268|617471675|FG000|Overall Study|(Not specified)|1|||
170853580|NCT03310268|617471676|FG001|Overall Study|(Not specified)|5|||
170853581|NCT03310268|617471677|FG002|Overall Study|(Not specified)|0|||
170853582|NCT00618982|617471678|FG000|Overall Study|Adverse Event|23|||
170853583|NCT00618982|617471678|FG000|Overall Study|Withdrawal by Subject|1|||
170853584|NCT00618982|617471678|FG000|Overall Study|Protocol Violation|1|||
170853585|NCT00618982|617471678|FG000|Overall Study|ongoing, still treated with study med.|25|||
170853586|NCT04101318|617471681|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
170853587|NCT04101318|617471682|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
170853588|NCT04101318|617471681|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
170853589|NCT04101318|617471682|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
170853590|NCT04101318|617471681|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
170853591|NCT04101318|617471682|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
170853592|NCT04797650|617471683|FG000|Overall Study|Reason Not Specified|5|||
170853593|NCT04797650|617471684|FG001|Overall Study|Reason Not Specified|12|||
170853594|NCT04797650|617471685|FG002|Overall Study|Reason Not Specified|5|||
170853595|NCT04797650|617471683|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
170853596|NCT04797650|617471684|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
170853597|NCT04797650|617471685|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
170853598|NCT04797650|617471683|FG000|Overall Study|Lack of Efficacy|1|||
170853599|NCT04797650|617471684|FG001|Overall Study|Lack of Efficacy|0|||
170853600|NCT04797650|617471685|FG002|Overall Study|Lack of Efficacy|1|||
170853601|NCT04797650|617471683|FG000|Overall Study|Non-compliance with Study Drug|0|||
170853602|NCT04797650|617471684|FG001|Overall Study|Non-compliance with Study Drug|0|||
170853603|NCT04797650|617471685|FG002|Overall Study|Non-compliance with Study Drug|2|||
170853604|NCT04797650|617471683|FG000|Overall Study|Lost to Follow-up|4|||
170853605|NCT04797650|617471684|FG001|Overall Study|Lost to Follow-up|6|||
170853606|NCT04797650|617471685|FG002|Overall Study|Lost to Follow-up|1|||
170853607|NCT02090959|617471686|FG000|Overall Study|Withdrawal by Subject|10|||
170853608|NCT02090959|617471686|FG000|Overall Study|Adverse Event|1|||
170853609|NCT02090959|617471686|FG000|Overall Study|Investigator decision|2|||
170853610|NCT02090959|617471686|FG000|Overall Study|Study termination|6|||
170853611|NCT02090959|617471686|FG000|Overall Study|Enrolled but not treated|1|||
170853612|NCT02090959|617471686|FG000|Overall Study|Transfer for compassionate use medicine|4|||
170853613|NCT02090959|617471686|FG000|Overall Study|Move to medical need program|3|||
170853614|NCT02090959|617471686|FG000|Overall Study|Entered in to other study|34|||
170853615|NCT02090959|617471686|FG000|Overall Study|Switched to commercial supply|88|||
170853616|NCT02090959|617471686|FG000|Overall Study|Other than specified|2|||
170853617|NCT02808143|617471687|FG000|Maintenance Phase|Disease recurrence|1|||
170853618|NCT02808143|617471688|FG001|Maintenance Phase|Disease recurrence|3|||
170853619|NCT02808143|617471687|FG000|Maintenance Phase|Disease progression|1|||
170853620|NCT02808143|617471688|FG001|Maintenance Phase|Disease progression|2|||
170853621|NCT02808143|617471687|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
170853622|NCT02808143|617471688|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
170853623|NCT02808143|617471687|FG000|Survival Follow-Up|Disease recurrence|0|||
170853624|NCT02808143|617471688|FG001|Survival Follow-Up|Disease recurrence|2|||
170853625|NCT02808143|617471687|FG000|Survival Follow-Up|Adverse Event|0|||
170853626|NCT02808143|617471688|FG001|Survival Follow-Up|Adverse Event|1|||
170853627|NCT02808143|617471687|FG000|Survival Follow-Up|Death|1|||
170853628|NCT02808143|617471688|FG001|Survival Follow-Up|Death|0|||
170853629|NCT00522873|617471689|FG000|Overall Study|Adverse Event|41|||
170853630|NCT00522873|617471690|FG001|Overall Study|Adverse Event|26|||
170853631|NCT00522873|617471689|FG000|Overall Study|Withdrawal by Subject|20|||
170853632|NCT00522873|617471690|FG001|Overall Study|Withdrawal by Subject|9|||
170853633|NCT00522873|617471689|FG000|Overall Study|Protocol Violation|14|||
170853634|NCT00522873|617471690|FG001|Overall Study|Protocol Violation|4|||
170853635|NCT00522873|617471689|FG000|Overall Study|Lost to Follow-up|11|||
170853636|NCT00522873|617471690|FG001|Overall Study|Lost to Follow-up|3|||
170853637|NCT00522873|617471689|FG000|Overall Study|Personal Reasons|8|||
170853638|NCT00522873|617471690|FG001|Overall Study|Personal Reasons|1|||
170853639|NCT00522873|617471689|FG000|Overall Study|Medication Errors|1|||
170853640|NCT00522873|617471690|FG001|Overall Study|Medication Errors|1|||
170853641|NCT00522873|617471689|FG000|Overall Study|Never Received Medication|1|||
170853642|NCT00522873|617471690|FG001|Overall Study|Never Received Medication|0|||
170853643|NCT00657020|617471691|FG000|PERIOD 1|Adverse Event|0|||
170853644|NCT00657020|617471692|FG001|PERIOD 1|Adverse Event|1|||
170853645|NCT02029846|617471693|FG000|Overall Study|n=1 each arm|1|||
170853646|NCT02029846|617471694|FG001|Overall Study|n=1 each arm|1|||
170853647|NCT00822172|617471702|FG000|Overall Study|Adverse Event|10|||
170853648|NCT00822172|617471703|FG001|Overall Study|Adverse Event|12|||
170853649|NCT00822172|617471702|FG000|Overall Study|Death|1|||
170853650|NCT00822172|617471703|FG001|Overall Study|Death|0|||
170853651|NCT00822172|617471702|FG000|Overall Study|Lost to Follow-up|3|||
170853652|NCT00822172|617471703|FG001|Overall Study|Lost to Follow-up|1|||
170853653|NCT00822172|617471702|FG000|Overall Study|Withdrawal by Subject|1|||
170853654|NCT00822172|617471703|FG001|Overall Study|Withdrawal by Subject|4|||
170853655|NCT00822172|617471702|FG000|Overall Study|site closed|0|||
170853656|NCT00822172|617471703|FG001|Overall Study|site closed|1|||
170853657|NCT00822172|617471702|FG000|Overall Study|Other|0|||
170853658|NCT00822172|617471703|FG001|Overall Study|Other|1|||
170853659|NCT00473265|617471705|FG000|Overall Study|Unrelated adverse event|5|||
170853660|NCT00473265|617471705|FG000|Overall Study|Off treatment early|15|||
170853661|NCT01160289|617471708|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
170853662|NCT01160289|617471709|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
170853663|NCT01160289|617471710|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
170853664|NCT01160289|617471711|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
170853665|NCT01160289|617471712|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
170853666|NCT01160289|617471713|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
170853667|NCT01160289|617471708|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
170853668|NCT01160289|617471709|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
170853669|NCT01160289|617471710|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
170853670|NCT01160289|617471711|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
170853671|NCT01160289|617471712|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
170853672|NCT01160289|617471713|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
170853673|NCT01160289|617471708|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
170853674|NCT01160289|617471709|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
170853675|NCT01160289|617471710|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
170853676|NCT01160289|617471711|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
170853677|NCT01160289|617471712|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
170853678|NCT01160289|617471713|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
170853679|NCT01160289|617471708|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
170853680|NCT01160289|617471709|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
170853681|NCT01160289|617471710|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
170853682|NCT01160289|617471711|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
170853683|NCT01160289|617471712|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
170853684|NCT01160289|617471713|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
170853685|NCT01160289|617471708|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
170853686|NCT01160289|617471709|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
170853687|NCT01160289|617471710|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
170853688|NCT01160289|617471711|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
170853689|NCT01160289|617471712|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
170853690|NCT01160289|617471713|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
170853691|NCT01160289|617471708|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
170853692|NCT01160289|617471709|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
170853693|NCT01160289|617471710|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
170853694|NCT01160289|617471711|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
170853695|NCT01160289|617471712|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
170853696|NCT01160289|617471713|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
170853697|NCT01160289|617471708|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
170853698|NCT01160289|617471709|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
170853699|NCT01160289|617471710|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
170853700|NCT01160289|617471711|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
170853701|NCT01160289|617471712|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
170853702|NCT01160289|617471713|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
170853703|NCT01160289|617471708|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
170853704|NCT01160289|617471709|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
170853705|NCT01160289|617471710|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
170853706|NCT01160289|617471711|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
170853707|NCT01160289|617471712|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
170853708|NCT01160289|617471713|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
170853709|NCT01160289|617471708|FG000|Post-Randomization Period|Adverse Event|0|||
170853710|NCT01160289|617471709|FG001|Post-Randomization Period|Adverse Event|4|||
170853711|NCT01160289|617471710|FG002|Post-Randomization Period|Adverse Event|4|||
170853712|NCT01160289|617471711|FG003|Post-Randomization Period|Adverse Event|2|||
170853713|NCT01160289|617471712|FG004|Post-Randomization Period|Adverse Event|0|||
170853714|NCT01160289|617471713|FG005|Post-Randomization Period|Adverse Event|0|||
170853715|NCT01160289|617471708|FG000|Post-Randomization Period|Death|0|||
170853716|NCT01160289|617471709|FG001|Post-Randomization Period|Death|0|||
170853717|NCT01160289|617471710|FG002|Post-Randomization Period|Death|0|||
170853718|NCT01160289|617471711|FG003|Post-Randomization Period|Death|1|||
170853719|NCT01160289|617471712|FG004|Post-Randomization Period|Death|0|||
170853720|NCT01160289|617471713|FG005|Post-Randomization Period|Death|0|||
170853721|NCT01160289|617471708|FG000|Post-Randomization Period|Lack of Efficacy|0|||
170853722|NCT01160289|617471709|FG001|Post-Randomization Period|Lack of Efficacy|1|||
170853723|NCT01160289|617471710|FG002|Post-Randomization Period|Lack of Efficacy|0|||
170853724|NCT01160289|617471711|FG003|Post-Randomization Period|Lack of Efficacy|3|||
170853725|NCT01160289|617471712|FG004|Post-Randomization Period|Lack of Efficacy|0|||
170853726|NCT01160289|617471713|FG005|Post-Randomization Period|Lack of Efficacy|0|||
170853727|NCT01160289|617471708|FG000|Post-Randomization Period|Lost to Follow-up|0|||
170853728|NCT01160289|617471709|FG001|Post-Randomization Period|Lost to Follow-up|3|||
170853729|NCT01160289|617471710|FG002|Post-Randomization Period|Lost to Follow-up|2|||
170853730|NCT01160289|617471711|FG003|Post-Randomization Period|Lost to Follow-up|5|||
170853731|NCT01160289|617471712|FG004|Post-Randomization Period|Lost to Follow-up|3|||
170853732|NCT01160289|617471713|FG005|Post-Randomization Period|Lost to Follow-up|4|||
170853733|NCT01160289|617471708|FG000|Post-Randomization Period|Physician Decision|0|||
170853734|NCT01160289|617471709|FG001|Post-Randomization Period|Physician Decision|0|||
170853735|NCT01160289|617471710|FG002|Post-Randomization Period|Physician Decision|1|||
170853736|NCT01160289|617471711|FG003|Post-Randomization Period|Physician Decision|0|||
170853737|NCT01160289|617471712|FG004|Post-Randomization Period|Physician Decision|0|||
170853738|NCT01160289|617471713|FG005|Post-Randomization Period|Physician Decision|0|||
170853739|NCT01160289|617471708|FG000|Post-Randomization Period|Protocol Violation|0|||
170853740|NCT01160289|617471709|FG001|Post-Randomization Period|Protocol Violation|4|||
170853741|NCT01160289|617471710|FG002|Post-Randomization Period|Protocol Violation|2|||
170853742|NCT01160289|617471711|FG003|Post-Randomization Period|Protocol Violation|0|||
170853743|NCT01160289|617471712|FG004|Post-Randomization Period|Protocol Violation|1|||
170853744|NCT01160289|617471713|FG005|Post-Randomization Period|Protocol Violation|3|||
170853745|NCT01160289|617471708|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
170853746|NCT01160289|617471709|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
170853747|NCT01160289|617471710|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
170853748|NCT01160289|617471711|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
170853749|NCT01160289|617471712|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
170853750|NCT01160289|617471713|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
170853751|NCT01160289|617471708|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
170853752|NCT01160289|617471709|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
170853753|NCT01160289|617471710|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
170853754|NCT01160289|617471711|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
170853755|NCT01160289|617471712|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
170853756|NCT01160289|617471713|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
170853757|NCT01160289|617471708|FG000|Post-Randomization Period|Sponsor Decision|0|||
170853758|NCT01160289|617471709|FG001|Post-Randomization Period|Sponsor Decision|1|||
170853759|NCT01160289|617471710|FG002|Post-Randomization Period|Sponsor Decision|0|||
170853760|NCT01160289|617471711|FG003|Post-Randomization Period|Sponsor Decision|0|||
170853761|NCT01160289|617471712|FG004|Post-Randomization Period|Sponsor Decision|0|||
170853762|NCT01160289|617471713|FG005|Post-Randomization Period|Sponsor Decision|0|||
170853763|NCT01248065|617471714|FG000|Overall Study|Lost to Follow-up|3|||
170853764|NCT01248065|617471715|FG001|Overall Study|Lost to Follow-up|5|||
170853765|NCT01248065|617471714|FG000|Overall Study|Withdrawal by Subject|14|||
170853766|NCT01248065|617471715|FG001|Overall Study|Withdrawal by Subject|11|||
170853767|NCT01248065|617471714|FG000|Overall Study|Adverse Event|3|||
170853768|NCT01248065|617471715|FG001|Overall Study|Adverse Event|0|||
170853769|NCT01248065|617471714|FG000|Overall Study|Third treatment failure event|3|||
170853770|NCT01248065|617471715|FG001|Overall Study|Third treatment failure event|1|||
170853771|NCT01248065|617471714|FG000|Overall Study|Other|3|||
170853772|NCT01248065|617471715|FG001|Overall Study|Other|5|||
170853773|NCT04256629|617471716|FG000|Overall Study|Adverse Event|0|||
170853774|NCT04256629|617471717|FG001|Overall Study|Adverse Event|0|||
170853775|NCT04256629|617471718|FG002|Overall Study|Adverse Event|0|||
170853776|NCT04256629|617471719|FG003|Overall Study|Adverse Event|0|||
170853777|NCT04256629|617471720|FG004|Overall Study|Adverse Event|0|||
170853778|NCT04256629|617471721|FG005|Overall Study|Adverse Event|1|||
170853779|NCT04256629|617471716|FG000|Overall Study|Protocol Violation|0|||
170853780|NCT04256629|617471717|FG001|Overall Study|Protocol Violation|1|||
170853781|NCT04256629|617471718|FG002|Overall Study|Protocol Violation|0|||
170853782|NCT04256629|617471719|FG003|Overall Study|Protocol Violation|0|||
170853783|NCT04256629|617471720|FG004|Overall Study|Protocol Violation|0|||
170853784|NCT04256629|617471721|FG005|Overall Study|Protocol Violation|0|||
170853785|NCT00158860|617471722|FG000|Overall Study|Adverse Event|3|||
170853786|NCT00158860|617471723|FG001|Overall Study|Adverse Event|6|||
170853787|NCT00158860|617471722|FG000|Overall Study|Lost to Follow-up|11|||
170853788|NCT00158860|617471723|FG001|Overall Study|Lost to Follow-up|17|||
170853789|NCT00158860|617471722|FG000|Overall Study|Protocol Violation|8|||
170853790|NCT00158860|617471723|FG001|Overall Study|Protocol Violation|23|||
170853791|NCT00158860|617471722|FG000|Overall Study|Withdrawal by Subject|7|||
170853792|NCT00158860|617471723|FG001|Overall Study|Withdrawal by Subject|17|||
170853793|NCT00158860|617471722|FG000|Overall Study|MOVING OUT OF STATE|1|||
170853794|NCT00158860|617471723|FG001|Overall Study|MOVING OUT OF STATE|0|||
170853795|NCT00158860|617471722|FG000|Overall Study|Pregnancy|3|||
170853796|NCT00158860|617471723|FG001|Overall Study|Pregnancy|3|||
170853797|NCT00158860|617471722|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
170853798|NCT00158860|617471723|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
170853799|NCT00158860|617471722|FG000|Overall Study|SPONSOR REQUEST|0|||
170853800|NCT00158860|617471723|FG001|Overall Study|SPONSOR REQUEST|1|||
170853801|NCT00158860|617471722|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
170853802|NCT00158860|617471723|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
170853803|NCT00158860|617471722|FG000|Overall Study|Closed per sponsor|0|||
170853804|NCT00158860|617471723|FG001|Overall Study|Closed per sponsor|1|||
170853805|NCT00093808|617471724|FG000|Overall Study|Cancel participation before receiving tx|1|||
170853806|NCT00093808|617471724|FG000|Overall Study|Protocol Violation|1|||
170853807|NCT05767021|617471725|FG000|Overall Study|Adverse Event|2|||
170853808|NCT05767021|617471725|FG000|Overall Study|Protocol Deviation|1|||
170853809|NCT05767021|617471725|FG000|Overall Study|Withdrawal by Subject|1|||
170853810|NCT05767021|617471725|FG000|Overall Study|Physician Decision|1|||
170853811|NCT05767021|617471725|FG000|Overall Study|Lack of Efficacy|11|||
170853812|NCT05767021|617471725|FG000|Overall Study|Assigned Treatment by Mistake|1|||
170853813|NCT02095951|617471726|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
170853814|NCT02095951|617471727|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
170853815|NCT01621568|617471730|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
170853816|NCT01621568|617471731|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
170853817|NCT01621568|617471730|FG000|Week 5-6 No Treatment|Death|1|||
170853818|NCT01621568|617471731|FG001|Week 5-6 No Treatment|Death|0|||
170853819|NCT02930226|617471732|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
170853820|NCT02930226|617471733|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
170853821|NCT02930226|617471734|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
170853822|NCT02930226|617471735|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
170853823|NCT02930226|617471736|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
170853824|NCT02930226|617471737|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
170853825|NCT00652327|617471738|FG000|Overall Study|Adverse Event|0|||
170853826|NCT00652327|617471739|FG001|Overall Study|Adverse Event|2|||
170853827|NCT00652327|617471738|FG000|Overall Study|Lost to Follow-up|0|||
170853828|NCT00652327|617471739|FG001|Overall Study|Lost to Follow-up|3|||
170853829|NCT00564889|617471742|FG000|Overall Study|Death|7|||
170853830|NCT00564889|617471742|FG000|Overall Study|Adverse Event|12|||
170853831|NCT00564889|617471742|FG000|Overall Study|Alternative treatment|3|||
170853832|NCT00564889|617471742|FG000|Overall Study|Disease progression|3|||
170853833|NCT00564889|617471742|FG000|Overall Study|Other, not specified|4|||
170853834|NCT01065844|617471747|FG000|Overall Study|Adverse Event|5|||
170853835|NCT03545503|617471749|FG000|Overall Study|Protocol Violation|14|||
170853836|NCT03545503|617471750|FG001|Overall Study|Protocol Violation|16|||
170853837|NCT00682890|617471751|FG000|Overall Study|Lost to Follow-up|1|||
170853838|NCT00682890|617471752|FG001|Overall Study|Lost to Follow-up|1|||
170853839|NCT00682890|617471751|FG000|Overall Study|subject moved away|0|||
170853840|NCT00682890|617471752|FG001|Overall Study|subject moved away|1|||
170853841|NCT00682890|617471751|FG000|Overall Study|heavy menstrual bleeding|1|||
170853842|NCT00682890|617471752|FG001|Overall Study|heavy menstrual bleeding|0|||
170853843|NCT04494256|617471753|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
170853844|NCT04494256|617471754|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
170853845|NCT04494256|617471755|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
170853846|NCT04494256|617471756|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
170853847|NCT04494256|617471757|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
170853848|NCT04494256|617471758|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
170853849|NCT04494256|617471759|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
170853850|NCT04494256|617471753|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
170853851|NCT04494256|617471754|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
170853852|NCT04494256|617471755|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
170853853|NCT04494256|617471756|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
170853854|NCT04494256|617471757|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
170853855|NCT04494256|617471758|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
170853856|NCT04494256|617471759|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
170853857|NCT04494256|617471753|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
170853858|NCT04494256|617471754|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
170853859|NCT04494256|617471755|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
170853860|NCT04494256|617471756|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
170853861|NCT04494256|617471757|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
170853862|NCT04494256|617471758|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
170853863|NCT04494256|617471759|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
170853864|NCT04494256|617471753|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853865|NCT04494256|617471754|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853866|NCT04494256|617471755|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853867|NCT04494256|617471756|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
170853868|NCT04494256|617471757|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
170853869|NCT04494256|617471758|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853870|NCT04494256|617471759|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853871|NCT04494256|617471753|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
170853872|NCT04494256|617471754|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
170853873|NCT04494256|617471755|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
170853874|NCT04494256|617471756|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
170853875|NCT04494256|617471757|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
170853876|NCT04494256|617471758|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
170853877|NCT04494256|617471759|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
170853878|NCT04494256|617471753|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
170853879|NCT04494256|617471754|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
170853880|NCT04494256|617471755|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
170853881|NCT04494256|617471756|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
170853882|NCT04494256|617471757|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
170853883|NCT04494256|617471758|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
170742263|NCT02960763|617064193|FG002|Step 1|Other|1|||
170742264|NCT02960763|617064194|FG003|Step 1|Other|0|||
170742265|NCT02960763|617064195|FG004|Step 1|Other|0|||
170742266|NCT02960763|617064191|FG000|Step 2|Withdrawal by Subject|0|||
170742267|NCT02960763|617064192|FG001|Step 2|Withdrawal by Subject|0|||
170742268|NCT02960763|617064193|FG002|Step 2|Withdrawal by Subject|0|||
170742269|NCT02960763|617064194|FG003|Step 2|Withdrawal by Subject|7|||
170742270|NCT02960763|617064195|FG004|Step 2|Withdrawal by Subject|3|||
170742271|NCT02960763|617064191|FG000|Step 2|Lost to Follow-up|0|||
170742272|NCT02960763|617064192|FG001|Step 2|Lost to Follow-up|0|||
170742273|NCT02960763|617064193|FG002|Step 2|Lost to Follow-up|0|||
170742274|NCT02960763|617064194|FG003|Step 2|Lost to Follow-up|4|||
170742275|NCT02960763|617064195|FG004|Step 2|Lost to Follow-up|1|||
170742276|NCT02960763|617064191|FG000|Step 2|Investigator discretion|0|||
170742277|NCT02960763|617064192|FG001|Step 2|Investigator discretion|0|||
170742278|NCT02960763|617064193|FG002|Step 2|Investigator discretion|0|||
170742279|NCT02960763|617064194|FG003|Step 2|Investigator discretion|0|||
170742280|NCT02960763|617064195|FG004|Step 2|Investigator discretion|1|||
170742281|NCT02961881|617064196|FG000|Overall Study|Adverse Event|1|||
170742282|NCT02961881|617064197|FG001|Overall Study|Adverse Event|2|||
170742283|NCT02961881|617064198|FG002|Overall Study|Adverse Event|2|||
170742284|NCT02961881|617064199|FG003|Overall Study|Adverse Event|0|||
170742285|NCT02961881|617064200|FG004|Overall Study|Adverse Event|1|||
170742286|NCT02961881|617064196|FG000|Overall Study|Participant request|0|||
170742287|NCT02961881|617064197|FG001|Overall Study|Participant request|2|||
170742288|NCT02961881|617064198|FG002|Overall Study|Participant request|0|||
170742289|NCT02961881|617064199|FG003|Overall Study|Participant request|0|||
170742290|NCT02961881|617064200|FG004|Overall Study|Participant request|0|||
170742291|NCT02961881|617064196|FG000|Overall Study|Disease progression|1|||
170742292|NCT02961881|617064197|FG001|Overall Study|Disease progression|0|||
170742293|NCT02961881|617064198|FG002|Overall Study|Disease progression|1|||
170742294|NCT02961881|617064199|FG003|Overall Study|Disease progression|0|||
170742295|NCT02961881|617064200|FG004|Overall Study|Disease progression|0|||
170742296|NCT00313911|617064201|FG000|Overall Study|Serious adverse event|6|||
170742297|NCT00313911|617064202|FG001|Overall Study|Serious adverse event|1|||
170742298|NCT00313911|617064201|FG000|Overall Study|Adverse Event|2|||
170742299|NCT00313911|617064202|FG001|Overall Study|Adverse Event|3|||
170742300|NCT00313911|617064201|FG000|Overall Study|Protocol Violation|19|||
170742301|NCT00313911|617064202|FG001|Overall Study|Protocol Violation|10|||
170742302|NCT00313911|617064201|FG000|Overall Study|Lost to Follow-up|27|||
170742303|NCT00313911|617064202|FG001|Overall Study|Lost to Follow-up|14|||
170742304|NCT00313911|617064201|FG000|Overall Study|Withdrawal by Subject|39|||
170742305|NCT00313911|617064202|FG001|Overall Study|Withdrawal by Subject|12|||
170742306|NCT00313911|617064201|FG000|Overall Study|Did not meet age criteria|1|||
170742307|NCT00313911|617064202|FG001|Overall Study|Did not meet age criteria|1|||
170742308|NCT01987596|617064203|FG000|Overall Study|Physician Decision|1|||
170742309|NCT01987596|617064204|FG001|Overall Study|Physician Decision|0|||
170742310|NCT01987596|617064203|FG000|Overall Study|Progressive Disease; missing all period|0|||
170742311|NCT01987596|617064204|FG001|Overall Study|Progressive Disease; missing all period|1|||
170742312|NCT02632786|617064207|FG000|Overall Study|Adverse Event|2|||
170742313|NCT02632786|617064208|FG001|Overall Study|Adverse Event|1|||
170742314|NCT02632786|617064207|FG000|Overall Study|Death|3|||
170742315|NCT02632786|617064208|FG001|Overall Study|Death|2|||
170742316|NCT02632786|617064207|FG000|Overall Study|Physician Decision|5|||
170742317|NCT02632786|617064208|FG001|Overall Study|Physician Decision|4|||
170742318|NCT02632786|617064207|FG000|Overall Study|Withdrawal by Subject|1|||
170742319|NCT02632786|617064208|FG001|Overall Study|Withdrawal by Subject|0|||
170742320|NCT02440594|617064210|FG000|Overall Study|Lost to Follow-up|34|||
170742321|NCT02440594|617064211|FG001|Overall Study|Lost to Follow-up|33|||
170742322|NCT02440594|617064212|FG002|Overall Study|Lost to Follow-up|54|||
170742323|NCT02440594|617064213|FG003|Overall Study|Lost to Follow-up|47|||
170742324|NCT02440594|617064214|FG004|Overall Study|Lost to Follow-up|5|||
170742325|NCT02440594|617064215|FG005|Overall Study|Lost to Follow-up|4|||
170742326|NCT02440594|617064216|FG006|Overall Study|Lost to Follow-up|28|||
170742327|NCT02440594|617064217|FG007|Overall Study|Lost to Follow-up|48|||
170742328|NCT02440594|617064210|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
170742329|NCT02440594|617064211|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
170742330|NCT02440594|617064212|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
170742331|NCT02440594|617064213|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
170742332|NCT02440594|617064214|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
170742333|NCT02440594|617064215|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
170742334|NCT02440594|617064216|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
170742335|NCT02440594|617064217|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
170742336|NCT02440594|617064210|FG000|Overall Study|Withdrawal by Subject|81|||
170742337|NCT02440594|617064211|FG001|Overall Study|Withdrawal by Subject|67|||
170742338|NCT02440594|617064212|FG002|Overall Study|Withdrawal by Subject|59|||
170742339|NCT02440594|617064213|FG003|Overall Study|Withdrawal by Subject|38|||
170742340|NCT02440594|617064214|FG004|Overall Study|Withdrawal by Subject|2|||
170742341|NCT02440594|617064215|FG005|Overall Study|Withdrawal by Subject|2|||
170742342|NCT02440594|617064216|FG006|Overall Study|Withdrawal by Subject|7|||
170742343|NCT02440594|617064217|FG007|Overall Study|Withdrawal by Subject|7|||
170742344|NCT02440594|617064210|FG000|Overall Study|Administratively w/drawn|3|||
170742345|NCT02440594|617064211|FG001|Overall Study|Administratively w/drawn|2|||
170742346|NCT02440594|617064212|FG002|Overall Study|Administratively w/drawn|0|||
170742347|NCT02440594|617064213|FG003|Overall Study|Administratively w/drawn|0|||
170742348|NCT02440594|617064214|FG004|Overall Study|Administratively w/drawn|0|||
170742349|NCT02440594|617064215|FG005|Overall Study|Administratively w/drawn|0|||
170742350|NCT02440594|617064216|FG006|Overall Study|Administratively w/drawn|2|||
170742351|NCT02440594|617064217|FG007|Overall Study|Administratively w/drawn|1|||
170742352|NCT00152763|617064218|FG000|Overall Study|Death|4|||
170742353|NCT00152763|617064219|FG001|Overall Study|Death|1|||
170742354|NCT00152763|617064220|FG002|Overall Study|Death|2|||
170742355|NCT00152763|617064221|FG003|Overall Study|Death|1|||
170742356|NCT00152763|617064218|FG000|Overall Study|Lost to Follow-up|6|||
170742357|NCT00152763|617064219|FG001|Overall Study|Lost to Follow-up|4|||
170742358|NCT00152763|617064220|FG002|Overall Study|Lost to Follow-up|2|||
170742359|NCT00152763|617064221|FG003|Overall Study|Lost to Follow-up|13|||
170742360|NCT01622348|617064222|FG000|Overall Study|Withdrawal by Subject|1|||
170742361|NCT01622348|617064223|FG001|Overall Study|Withdrawal by Subject|0|||
170742362|NCT01622348|617064224|FG002|Overall Study|Withdrawal by Subject|1|||
170742363|NCT01592695|617064227|FG000|Overall Study|Lost to Follow-up|8|||
170742364|NCT01592695|617064228|FG001|Overall Study|Lost to Follow-up|4|||
170742365|NCT00422799|617064229|FG000|Overall Study|Withdrawal by Subject|6|||
170742366|NCT00422799|617064229|FG000|Overall Study|Adverse Event|7|||
170742367|NCT00474175|617064230|FG000|Overall Study|Lack of Efficacy|0|||
170742368|NCT00474175|617064231|FG001|Overall Study|Lack of Efficacy|0|||
170742369|NCT00474175|617064232|FG002|Overall Study|Lack of Efficacy|1|||
170742370|NCT00474175|617064230|FG000|Overall Study|Withdrawal by Subject|0|||
170742371|NCT00474175|617064231|FG001|Overall Study|Withdrawal by Subject|1|||
170742372|NCT00474175|617064232|FG002|Overall Study|Withdrawal by Subject|1|||
170742373|NCT00474175|617064230|FG000|Overall Study|Ineligible|1|||
170742374|NCT00474175|617064231|FG001|Overall Study|Ineligible|3|||
170742375|NCT00474175|617064232|FG002|Overall Study|Ineligible|1|||
170742376|NCT00474175|617064230|FG000|Overall Study|Protocol Violation|0|||
170742377|NCT00474175|617064231|FG001|Overall Study|Protocol Violation|2|||
170742378|NCT00474175|617064232|FG002|Overall Study|Protocol Violation|1|||
170742379|NCT00474175|617064230|FG000|Overall Study|Administrative|0|||
170742380|NCT00474175|617064231|FG001|Overall Study|Administrative|1|||
170742381|NCT00474175|617064232|FG002|Overall Study|Administrative|0|||
170742382|NCT01619787|617064233|FG000|Overall Study|Lost to Follow-up|5|||
170742383|NCT03029780|617064234|FG000|Overall Study|Disease Progression|20|||
170742384|NCT03029780|617064235|FG001|Overall Study|Disease Progression|22|||
170742385|NCT03029780|617064234|FG000|Overall Study|Study Drug Toxicity|15|||
170742386|NCT03029780|617064235|FG001|Overall Study|Study Drug Toxicity|11|||
170742387|NCT03029780|617064234|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
170742388|NCT03029780|617064235|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
170742389|NCT03029780|617064234|FG000|Overall Study|Participant request to discontinue study treatment|4|||
170742390|NCT03029780|617064235|FG001|Overall Study|Participant request to discontinue study treatment|1|||
170742391|NCT03029780|617064234|FG000|Overall Study|Maximum clinical benefit|1|||
170742392|NCT03029780|617064235|FG001|Overall Study|Maximum clinical benefit|0|||
170742393|NCT03029780|617064234|FG000|Overall Study|Participant no longer meets study criteria|0|||
170742394|NCT03029780|617064235|FG001|Overall Study|Participant no longer meets study criteria|1|||
170742395|NCT03029780|617064234|FG000|Overall Study|Other reasons|6|||
170742396|NCT03029780|617064235|FG001|Overall Study|Other reasons|6|||
170742397|NCT03029780|617064234|FG000|Overall Study|Not reported|1|||
170742398|NCT03029780|617064235|FG001|Overall Study|Not reported|1|||
170742399|NCT03029780|617064234|FG000|Overall Study|Death|2|||
170742400|NCT03029780|617064235|FG001|Overall Study|Death|6|||
170742401|NCT01763788|617064236|FG000|Overall Study|Lost to Follow-up|0|||
170742402|NCT01763788|617064237|FG001|Overall Study|Lost to Follow-up|0|||
170742403|NCT01763788|617064238|FG002|Overall Study|Lost to Follow-up|1|||
170742404|NCT01763788|617064239|FG003|Overall Study|Lost to Follow-up|0|||
170742405|NCT03560258|617064240|FG000|Overall Study|Lost to Follow-up|3|||
170742406|NCT03560258|617064241|FG001|Overall Study|Lost to Follow-up|0|||
170742407|NCT03560258|617064242|FG002|Overall Study|Lost to Follow-up|0|||
170742408|NCT03560258|617064240|FG000|Overall Study|Protocol Violation|0|||
170742409|NCT03560258|617064241|FG001|Overall Study|Protocol Violation|1|||
170742410|NCT03560258|617064242|FG002|Overall Study|Protocol Violation|0|||
170742411|NCT03560258|617064240|FG000|Overall Study|Withdrawal by Subject|0|||
170742412|NCT03560258|617064241|FG001|Overall Study|Withdrawal by Subject|0|||
170742413|NCT03560258|617064242|FG002|Overall Study|Withdrawal by Subject|1|||
170742414|NCT03101241|617064243|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
170742415|NCT03101241|617064244|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
170742416|NCT03101241|617064243|FG000|Overall Study|Participant withdrew consent|3|||
170742417|NCT03101241|617064244|FG001|Overall Study|Participant withdrew consent|1|||
170742418|NCT03101241|617064243|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
170742419|NCT03101241|617064244|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
170742420|NCT03101241|617064243|FG000|Overall Study|Lost to Follow-up|2|||
170742421|NCT03101241|617064244|FG001|Overall Study|Lost to Follow-up|0|||
170742422|NCT03101241|617064243|FG000|Overall Study|Lack of Efficacy|0|||
170742423|NCT03101241|617064244|FG001|Overall Study|Lack of Efficacy|1|||
170742424|NCT03101241|617064243|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
170742425|NCT03101241|617064244|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
170742426|NCT04498247|617064245|FG000|Overall Study|Lost to Follow-up|0|||
170742427|NCT04498247|617064246|FG001|Overall Study|Lost to Follow-up|0|||
170742428|NCT04498247|617064247|FG002|Overall Study|Lost to Follow-up|0|||
170742429|NCT04498247|617064248|FG003|Overall Study|Lost to Follow-up|1|||
170742430|NCT04498247|617064249|FG004|Overall Study|Lost to Follow-up|0|||
170742431|NCT04498247|617064250|FG005|Overall Study|Lost to Follow-up|0|||
170742432|NCT04498247|617064251|FG006|Overall Study|Lost to Follow-up|0|||
170742433|NCT04498247|617064252|FG007|Overall Study|Lost to Follow-up|0|||
170742434|NCT04498247|617064245|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
170742435|NCT04498247|617064246|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
170742436|NCT04498247|617064247|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
170742437|NCT04498247|617064248|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
170742438|NCT04498247|617064249|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
170742439|NCT04498247|617064250|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
170742440|NCT04498247|617064251|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
170742441|NCT04498247|617064252|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
170742442|NCT04498247|617064245|FG000|Overall Study|Withdrawal by Subject|0|||
170742443|NCT04498247|617064246|FG001|Overall Study|Withdrawal by Subject|8|||
170853884|NCT04494256|617471759|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
170853885|NCT04494256|617471753|FG000|Part 2: Open Label Period|Death|0|||
170853886|NCT04494256|617471754|FG001|Part 2: Open Label Period|Death|0|||
170853887|NCT04494256|617471755|FG002|Part 2: Open Label Period|Death|0|||
170853888|NCT04494256|617471756|FG003|Part 2: Open Label Period|Death|0|||
170853889|NCT04494256|617471757|FG004|Part 2: Open Label Period|Death|0|||
170853890|NCT04494256|617471758|FG005|Part 2: Open Label Period|Death|4|||
170853891|NCT04494256|617471759|FG006|Part 2: Open Label Period|Death|2|||
170853892|NCT04494256|617471753|FG000|Part 2: Open Label Period|Adverse Event|0|||
170853893|NCT04494256|617471754|FG001|Part 2: Open Label Period|Adverse Event|0|||
170853894|NCT04494256|617471755|FG002|Part 2: Open Label Period|Adverse Event|0|||
170853895|NCT04494256|617471756|FG003|Part 2: Open Label Period|Adverse Event|0|||
170853896|NCT04494256|617471757|FG004|Part 2: Open Label Period|Adverse Event|0|||
170853897|NCT04494256|617471758|FG005|Part 2: Open Label Period|Adverse Event|0|||
170853898|NCT04494256|617471759|FG006|Part 2: Open Label Period|Adverse Event|2|||
170853899|NCT04494256|617471753|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
170853900|NCT04494256|617471754|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
170853901|NCT04494256|617471755|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
170853902|NCT04494256|617471756|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
170853903|NCT04494256|617471757|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
170853904|NCT04494256|617471758|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
170853905|NCT04494256|617471759|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
170853906|NCT04494256|617471753|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
170853907|NCT04494256|617471754|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
170853908|NCT04494256|617471755|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
170853909|NCT04494256|617471756|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
170853910|NCT04494256|617471757|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
170853911|NCT04494256|617471758|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
170853912|NCT04494256|617471759|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
170853913|NCT04494256|617471753|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
170853914|NCT04494256|617471754|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
170853915|NCT04494256|617471755|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
170853916|NCT04494256|617471756|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
170853917|NCT04494256|617471757|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
170853918|NCT04494256|617471758|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
170853919|NCT04494256|617471759|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
170853920|NCT04494256|617471753|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853921|NCT04494256|617471754|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853922|NCT04494256|617471755|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853923|NCT04494256|617471756|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853924|NCT04494256|617471757|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
170853925|NCT04494256|617471758|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
170853926|NCT04494256|617471759|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
170853927|NCT04494256|617471753|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
170853928|NCT04494256|617471754|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
170853929|NCT04494256|617471755|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
170853930|NCT04494256|617471756|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
170853931|NCT04494256|617471757|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
170853932|NCT04494256|617471758|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
170853933|NCT04494256|617471759|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
170853934|NCT00577473|617471762|FG000|Overall Study|Protocol Violation|1|||
170853935|NCT00577473|617471763|FG001|Overall Study|Protocol Violation|4|||
170853936|NCT00577473|617471762|FG000|Overall Study|Adverse Event|8|||
170853937|NCT00577473|617471763|FG001|Overall Study|Adverse Event|5|||
170853938|NCT00577473|617471762|FG000|Overall Study|Withdrawal by Subject|2|||
170853939|NCT00577473|617471763|FG001|Overall Study|Withdrawal by Subject|6|||
170853940|NCT00577473|617471762|FG000|Overall Study|Physician Decision|2|||
170853941|NCT00577473|617471763|FG001|Overall Study|Physician Decision|2|||
170853942|NCT00577473|617471762|FG000|Overall Study|Lack of Efficacy|8|||
170853943|NCT00577473|617471763|FG001|Overall Study|Lack of Efficacy|7|||
170853944|NCT02595073|617471766|FG000|Overall Study|Progressive Disease|0|||
170853945|NCT02595073|617471767|FG001|Overall Study|Progressive Disease|1|||
170853946|NCT02595073|617471766|FG000|Overall Study|Protocol Violation|2|||
170853947|NCT02595073|617471767|FG001|Overall Study|Protocol Violation|0|||
170853948|NCT01990560|617471770|FG000|Overall Study|Withdrawal by Subject|1|||
170853949|NCT02884908|617471776|FG000|Overall Study|Lost to Follow-up|13|||
170853950|NCT02884908|617471777|FG001|Overall Study|Lost to Follow-up|18|||
170853951|NCT01236339|617471778|FG000|Overall Study|Termination of study by sponsor|11|||
170853952|NCT01236339|617471779|FG001|Overall Study|Termination of study by sponsor|13|||
170853953|NCT01324440|617471780|FG000|Overall Study|Subject moved|0|||
170853954|NCT01324440|617471781|FG001|Overall Study|Subject moved|1|||
170853955|NCT02054741|617471782|FG000|Overall Study|Protocol Violation|13|||
170853956|NCT02054741|617471783|FG001|Overall Study|Protocol Violation|2|||
170853957|NCT02054741|617471782|FG000|Overall Study|Withdrawal by Subject|10|||
170853958|NCT02054741|617471783|FG001|Overall Study|Withdrawal by Subject|5|||
170853959|NCT02054741|617471782|FG000|Overall Study|Death|94|||
170853960|NCT02054741|617471783|FG001|Overall Study|Death|90|||
170853961|NCT02054741|617471782|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
170853962|NCT02054741|617471783|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
170853963|NCT01768117|617471788|FG000|Overall Study|Lost to Follow-up|1|||
170853964|NCT01768117|617471788|FG000|Overall Study|Withdrawal by Subject|2|||
170853965|NCT01768117|617471788|FG000|Overall Study|Protocol Violation|3|||
170853966|NCT00138671|617471789|FG000|Overall Study|Death|0|||
170853967|NCT00138671|617471790|FG001|Overall Study|Death|3|||
170853968|NCT00138671|617471789|FG000|Overall Study|Adverse Event|6|||
170853969|NCT00138671|617471790|FG001|Overall Study|Adverse Event|3|||
170853970|NCT00138671|617471789|FG000|Overall Study|Lost to Follow-up|1|||
170853971|NCT00138671|617471790|FG001|Overall Study|Lost to Follow-up|2|||
170853972|NCT00138671|617471789|FG000|Overall Study|Withdrawal by Subject|3|||
170853973|NCT00138671|617471790|FG001|Overall Study|Withdrawal by Subject|5|||
170853974|NCT00138671|617471789|FG000|Overall Study|Other|3|||
170853975|NCT00138671|617471790|FG001|Overall Study|Other|3|||
170853976|NCT01737827|617471791|FG000|Overall Study|Adverse Event|3|||
170853977|NCT01737827|617471792|FG001|Overall Study|Adverse Event|6|||
170853978|NCT01737827|617471793|FG002|Overall Study|Adverse Event|0|||
170853979|NCT01737827|617471791|FG000|Overall Study|Lost to Follow-up|0|||
170853980|NCT01737827|617471792|FG001|Overall Study|Lost to Follow-up|1|||
170853981|NCT01737827|617471793|FG002|Overall Study|Lost to Follow-up|0|||
170853982|NCT01737827|617471791|FG000|Overall Study|Physician Decision|0|||
170853983|NCT01737827|617471792|FG001|Overall Study|Physician Decision|2|||
170853984|NCT01737827|617471793|FG002|Overall Study|Physician Decision|0|||
170853985|NCT01737827|617471791|FG000|Overall Study|Progressive Disease|5|||
170853986|NCT01737827|617471792|FG001|Overall Study|Progressive Disease|16|||
170853987|NCT01737827|617471793|FG002|Overall Study|Progressive Disease|2|||
170853988|NCT01737827|617471791|FG000|Overall Study|Study Terminated by Sponsor|0|||
170853989|NCT01737827|617471792|FG001|Overall Study|Study Terminated by Sponsor|1|||
170853990|NCT01737827|617471793|FG002|Overall Study|Study Terminated by Sponsor|0|||
170853991|NCT01737827|617471791|FG000|Overall Study|Subject/Guardian Decision|0|||
170853992|NCT01737827|617471792|FG001|Overall Study|Subject/Guardian Decision|2|||
170853993|NCT01737827|617471793|FG002|Overall Study|Subject/Guardian Decision|0|||
170853994|NCT02971761|617471795|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
170853995|NCT01642251|617471798|FG000|Overall Study|Progressive disease|0|||
170853996|NCT01642251|617471799|FG001|Overall Study|Progressive disease|0|||
170853997|NCT01642251|617471800|FG002|Overall Study|Progressive disease|3|||
170853998|NCT01642251|617471801|FG003|Overall Study|Progressive disease|3|||
170853999|NCT01642251|617471798|FG000|Overall Study|Adverse Event|0|||
170854000|NCT01642251|617471799|FG001|Overall Study|Adverse Event|0|||
170854001|NCT01642251|617471800|FG002|Overall Study|Adverse Event|5|||
170854002|NCT01642251|617471801|FG003|Overall Study|Adverse Event|4|||
170854003|NCT01642251|617471798|FG000|Overall Study|Death|0|||
170854004|NCT01642251|617471799|FG001|Overall Study|Death|0|||
170854005|NCT01642251|617471800|FG002|Overall Study|Death|1|||
170854006|NCT01642251|617471801|FG003|Overall Study|Death|3|||
170854007|NCT01642251|617471798|FG000|Overall Study|Withdrawal by Subject|0|||
170854008|NCT01642251|617471799|FG001|Overall Study|Withdrawal by Subject|0|||
170854009|NCT01642251|617471800|FG002|Overall Study|Withdrawal by Subject|1|||
170854010|NCT01642251|617471801|FG003|Overall Study|Withdrawal by Subject|3|||
170854011|NCT01642251|617471798|FG000|Overall Study|Alternative therapy|0|||
170854012|NCT01642251|617471799|FG001|Overall Study|Alternative therapy|0|||
170854013|NCT01642251|617471800|FG002|Overall Study|Alternative therapy|0|||
170854014|NCT01642251|617471801|FG003|Overall Study|Alternative therapy|2|||
170854015|NCT01642251|617471798|FG000|Overall Study|Other complicating disease|0|||
170854016|NCT01642251|617471799|FG001|Overall Study|Other complicating disease|0|||
170854017|NCT01642251|617471800|FG002|Overall Study|Other complicating disease|1|||
170854018|NCT01642251|617471801|FG003|Overall Study|Other complicating disease|0|||
170854019|NCT01642251|617471798|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
170854020|NCT01642251|617471799|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
170854021|NCT01642251|617471800|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
170854022|NCT01642251|617471801|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
170854023|NCT00998790|617471802|FG000|Overall Study|Withdrawal by Subject|21|||
170854024|NCT02533531|617471806|FG000|Overall Study|Device did not turn on|1|||
170854025|NCT05249829|617471807|FG000|Overall Study|Participant Relocation|0|||
170854026|NCT05249829|617471808|FG001|Overall Study|Participant Relocation|1|||
170854027|NCT05249829|617471809|FG002|Overall Study|Participant Relocation|2|||
170854028|NCT05249829|617471810|FG003|Overall Study|Participant Relocation|2|||
170854029|NCT05249829|617471807|FG000|Overall Study|Withdrawal by Subject|9|||
170854030|NCT05249829|617471808|FG001|Overall Study|Withdrawal by Subject|17|||
170854031|NCT05249829|617471809|FG002|Overall Study|Withdrawal by Subject|40|||
170854032|NCT05249829|617471810|FG003|Overall Study|Withdrawal by Subject|35|||
170854033|NCT05249829|617471807|FG000|Overall Study|Physician Decision|1|||
170854034|NCT05249829|617471808|FG001|Overall Study|Physician Decision|0|||
170854035|NCT05249829|617471809|FG002|Overall Study|Physician Decision|0|||
170854036|NCT05249829|617471810|FG003|Overall Study|Physician Decision|0|||
170854037|NCT05249829|617471807|FG000|Overall Study|Lost to Follow-up|16|||
170854038|NCT05249829|617471808|FG001|Overall Study|Lost to Follow-up|16|||
170854039|NCT05249829|617471809|FG002|Overall Study|Lost to Follow-up|57|||
170854040|NCT05249829|617471810|FG003|Overall Study|Lost to Follow-up|60|||
170854041|NCT05249829|617471807|FG000|Overall Study|Adverse Event|2|||
170854042|NCT05249829|617471808|FG001|Overall Study|Adverse Event|2|||
170854043|NCT05249829|617471809|FG002|Overall Study|Adverse Event|2|||
170854044|NCT05249829|617471810|FG003|Overall Study|Adverse Event|2|||
170854045|NCT05249829|617471807|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
170854046|NCT05249829|617471808|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
170854047|NCT05249829|617471809|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
170854048|NCT05249829|617471810|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
170854049|NCT05249829|617471807|FG000|Overall Study|Protocol Violation|2|||
170854050|NCT05249829|617471808|FG001|Overall Study|Protocol Violation|0|||
170854051|NCT05249829|617471809|FG002|Overall Study|Protocol Violation|5|||
170854052|NCT05249829|617471810|FG003|Overall Study|Protocol Violation|3|||
170854053|NCT05249829|617471807|FG000|Overall Study|Death|0|||
170854054|NCT05249829|617471808|FG001|Overall Study|Death|1|||
170854055|NCT05249829|617471809|FG002|Overall Study|Death|2|||
170854056|NCT05249829|617471810|FG003|Overall Study|Death|4|||
170854057|NCT03814187|617471811|FG000|Overall Study|Sponsor's Administrative Decision|0|||
170854058|NCT03814187|617471812|FG001|Overall Study|Sponsor's Administrative Decision|0|||
170854059|NCT03814187|617471813|FG002|Overall Study|Sponsor's Administrative Decision|272|||
170854060|NCT03814187|617471811|FG000|Overall Study|Death|80|||
170854061|NCT03814187|617471812|FG001|Overall Study|Death|81|||
170854062|NCT03814187|617471813|FG002|Overall Study|Death|4|||
170854063|NCT03814187|617471811|FG000|Overall Study|Withdrew Consent|77|||
170854064|NCT03814187|617471812|FG001|Overall Study|Withdrew Consent|78|||
170854065|NCT03814187|617471813|FG002|Overall Study|Withdrew Consent|2|||
170854066|NCT03814187|617471811|FG000|Overall Study|Lost to Follow-up|47|||
170854067|NCT03814187|617471812|FG001|Overall Study|Lost to Follow-up|52|||
170854068|NCT03814187|617471813|FG002|Overall Study|Lost to Follow-up|1|||
170854069|NCT03814187|617471811|FG000|Overall Study|Adverse Event|22|||
170854070|NCT03814187|617471812|FG001|Overall Study|Adverse Event|23|||
170854071|NCT03814187|617471813|FG002|Overall Study|Adverse Event|0|||
170854072|NCT03814187|617471811|FG000|Overall Study|Physician Decision|7|||
170854073|NCT03814187|617471812|FG001|Overall Study|Physician Decision|4|||
170854074|NCT03814187|617471813|FG002|Overall Study|Physician Decision|2|||
170854075|NCT03814187|617471811|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
170854076|NCT03814187|617471812|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
170854077|NCT03814187|617471813|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
170854078|NCT03814187|617471811|FG000|Overall Study|Other reasons|34|||
170854079|NCT03814187|617471812|FG001|Overall Study|Other reasons|40|||
170854080|NCT03814187|617471813|FG002|Overall Study|Other reasons|2|||
170854081|NCT02047903|617471814|FG000|Overall Study|Adverse Event|14|||
170854082|NCT02047903|617471814|FG000|Overall Study|Serious adverse event|10|||
170854083|NCT02047903|617471814|FG000|Overall Study|Withdrawal by Subject|16|||
170854084|NCT02047903|617471814|FG000|Overall Study|Lost to Follow-up|4|||
170854085|NCT02047903|617471814|FG000|Overall Study|Reason not listed|6|||
170854086|NCT02047903|617471814|FG000|Overall Study|Not Treated|9|||
170854087|NCT00513604|617471818|FG000|Overall Study|Not treated|2|||
170854088|NCT00513604|617471819|FG001|Overall Study|Not treated|0|||
170854089|NCT00513604|617471820|FG002|Overall Study|Not treated|1|||
170854090|NCT00513604|617471821|FG003|Overall Study|Not treated|0|||
170742444|NCT04498247|617064247|FG002|Overall Study|Withdrawal by Subject|0|||
170742445|NCT04498247|617064248|FG003|Overall Study|Withdrawal by Subject|7|||
170742446|NCT04498247|617064249|FG004|Overall Study|Withdrawal by Subject|0|||
170742447|NCT04498247|617064250|FG005|Overall Study|Withdrawal by Subject|0|||
170742448|NCT04498247|617064251|FG006|Overall Study|Withdrawal by Subject|1|||
170742449|NCT04498247|617064252|FG007|Overall Study|Withdrawal by Subject|0|||
170742450|NCT04498247|617064245|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
170742451|NCT04498247|617064246|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
170742452|NCT04498247|617064247|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
170742453|NCT04498247|617064248|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
170742454|NCT04498247|617064249|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
170742455|NCT04498247|617064250|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
170742456|NCT04498247|617064251|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
170742457|NCT04498247|617064252|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
170742458|NCT00669903|617064253|FG000|Overall Study|Adverse Event|0|||
170742459|NCT00669903|617064254|FG001|Overall Study|Adverse Event|1|||
170742460|NCT00669903|617064255|FG002|Overall Study|Adverse Event|3|||
170742461|NCT00669903|617064256|FG003|Overall Study|Adverse Event|1|||
170742462|NCT00669903|617064253|FG000|Overall Study|Withdrawal by Subject|0|||
170742463|NCT00669903|617064254|FG001|Overall Study|Withdrawal by Subject|2|||
170742464|NCT00669903|617064255|FG002|Overall Study|Withdrawal by Subject|2|||
170742465|NCT00669903|617064256|FG003|Overall Study|Withdrawal by Subject|2|||
170742466|NCT00669903|617064253|FG000|Overall Study|Lost to Follow-up|1|||
170742467|NCT00669903|617064254|FG001|Overall Study|Lost to Follow-up|1|||
170742468|NCT00669903|617064255|FG002|Overall Study|Lost to Follow-up|0|||
170742469|NCT00669903|617064256|FG003|Overall Study|Lost to Follow-up|1|||
170742470|NCT00669903|617064253|FG000|Overall Study|Protocol Violation|0|||
170742471|NCT00669903|617064254|FG001|Overall Study|Protocol Violation|1|||
170742472|NCT00669903|617064255|FG002|Overall Study|Protocol Violation|0|||
170742473|NCT00669903|617064256|FG003|Overall Study|Protocol Violation|0|||
170742474|NCT00251927|617064258|FG000|Overall Study|Adverse Event|3|||
170742475|NCT00251927|617064259|FG001|Overall Study|Adverse Event|15|||
170742476|NCT00251927|617064258|FG000|Overall Study|Lack of Efficacy|22|||
170742477|NCT00251927|617064259|FG001|Overall Study|Lack of Efficacy|16|||
170742478|NCT00251927|617064258|FG000|Overall Study|Lost to Follow-up|22|||
170742479|NCT00251927|617064259|FG001|Overall Study|Lost to Follow-up|8|||
170742480|NCT00251927|617064258|FG000|Overall Study|Protocol Violation|1|||
170742481|NCT00251927|617064259|FG001|Overall Study|Protocol Violation|2|||
170742482|NCT00251927|617064258|FG000|Overall Study|Pregnancy|2|||
170742483|NCT00251927|617064259|FG001|Overall Study|Pregnancy|0|||
170742484|NCT00251927|617064258|FG000|Overall Study|Withdrawal by Subject|40|||
170742485|NCT00251927|617064259|FG001|Overall Study|Withdrawal by Subject|25|||
170742486|NCT00251927|617064258|FG000|Overall Study|Study-specific discont. achieved|13|||
170742487|NCT00251927|617064259|FG001|Overall Study|Study-specific discont. achieved|2|||
170742488|NCT00251927|617064258|FG000|Overall Study|Study procedure non-compliance|5|||
170742489|NCT00251927|617064259|FG001|Overall Study|Study procedure non-compliance|6|||
170742490|NCT01381874|617064260|FG000|Overall Study|Lost to Follow-up|1|||
170742491|NCT01381874|617064261|FG001|Overall Study|Lost to Follow-up|1|||
170742492|NCT01381874|617064262|FG002|Overall Study|Lost to Follow-up|0|||
170742493|NCT01381874|617064260|FG000|Overall Study|Withdrawal by Subject|9|||
170742494|NCT01381874|617064261|FG001|Overall Study|Withdrawal by Subject|10|||
170742495|NCT01381874|617064262|FG002|Overall Study|Withdrawal by Subject|9|||
170742496|NCT01381874|617064260|FG000|Overall Study|Other|67|||
170742497|NCT01381874|617064261|FG001|Overall Study|Other|52|||
170742498|NCT01381874|617064262|FG002|Overall Study|Other|67|||
170742499|NCT01737996|617064263|FG000|Overall Study|Adverse Event|0|||
170742500|NCT01737996|617064264|FG001|Overall Study|Adverse Event|1|||
170742501|NCT01737996|617064265|FG002|Overall Study|Adverse Event|1|||
170742502|NCT01737996|617064263|FG000|Overall Study|Withdrawal by Subject|0|||
170742503|NCT01737996|617064264|FG001|Overall Study|Withdrawal by Subject|0|||
170742504|NCT01737996|617064265|FG002|Overall Study|Withdrawal by Subject|1|||
170742505|NCT01003184|617064266|FG000|Overall Study|Adverse Event|12|||
170742506|NCT01003184|617064267|FG001|Overall Study|Adverse Event|5|||
170742507|NCT01003184|617064266|FG000|Overall Study|Lost to Follow-up|1|||
170742508|NCT01003184|617064267|FG001|Overall Study|Lost to Follow-up|0|||
170742509|NCT01003184|617064266|FG000|Overall Study|Loss of glucose control|1|||
170854091|NCT00513604|617471822|FG004|Overall Study|Not treated|0|||
170742510|NCT01003184|617064267|FG001|Overall Study|Loss of glucose control|1|||
170742511|NCT01003184|617064266|FG000|Overall Study|Protocol Violation|3|||
170742512|NCT01003184|617064267|FG001|Overall Study|Protocol Violation|0|||
170742513|NCT01003184|617064266|FG000|Overall Study|Withdrawal by Subject|1|||
170742514|NCT01003184|617064267|FG001|Overall Study|Withdrawal by Subject|6|||
170742515|NCT01003184|617064266|FG000|Overall Study|Physician Decision|1|||
170742516|NCT01003184|617064267|FG001|Overall Study|Physician Decision|0|||
170742517|NCT01468922|617064268|FG000|Overall Study|Screening failure|0|||
170742518|NCT01468922|617064269|FG001|Overall Study|Screening failure|0|||
170742519|NCT01468922|617064270|FG002|Overall Study|Screening failure|0|||
170854092|NCT00513604|617471818|FG000|Overall Study|Death during treatment|0|||
170854093|NCT00513604|617471819|FG001|Overall Study|Death during treatment|3|||
170854094|NCT00513604|617471820|FG002|Overall Study|Death during treatment|2|||
170854095|NCT00513604|617471821|FG003|Overall Study|Death during treatment|0|||
170854096|NCT00513604|617471822|FG004|Overall Study|Death during treatment|0|||
170854097|NCT00412061|617471823|FG000|Double Blind Phase|Disease Progression|101|||
170854098|NCT00412061|617471824|FG001|Double Blind Phase|Disease Progression|154|||
170854099|NCT00412061|617471823|FG000|Double Blind Phase|Adverse Event|61|||
170854100|NCT00412061|617471824|FG001|Double Blind Phase|Adverse Event|16|||
170854101|NCT00412061|617471823|FG000|Double Blind Phase|Final Primary Analysis|26|||
170854102|NCT00412061|617471824|FG001|Double Blind Phase|Final Primary Analysis|14|||
170854103|NCT00412061|617471823|FG000|Double Blind Phase|Withdrawal by Subject|18|||
170854104|NCT00412061|617471824|FG001|Double Blind Phase|Withdrawal by Subject|20|||
170854105|NCT00412061|617471823|FG000|Double Blind Phase|Death|6|||
170854106|NCT00412061|617471824|FG001|Double Blind Phase|Death|3|||
170854107|NCT00412061|617471823|FG000|Double Blind Phase|Protocol Violation|3|||
170854108|NCT00412061|617471824|FG001|Double Blind Phase|Protocol Violation|4|||
170854109|NCT00412061|617471823|FG000|Double Blind Phase|New Cander Therapy|1|||
170854110|NCT00412061|617471824|FG001|Double Blind Phase|New Cander Therapy|1|||
170854111|NCT00412061|617471823|FG000|Double Blind Phase|Lost to Follow-up|0|||
170854112|NCT00412061|617471824|FG001|Double Blind Phase|Lost to Follow-up|1|||
170854113|NCT00412061|617471823|FG000|Open Label Phase|Disease Progression|0|||
170854114|NCT00412061|617471824|FG001|Open Label Phase|Disease Progression|86|||
170854115|NCT00412061|617471823|FG000|Open Label Phase|Adverse Event|0|||
170854116|NCT00412061|617471824|FG001|Open Label Phase|Adverse Event|46|||
170854117|NCT00412061|617471823|FG000|Open Label Phase|Withdrawal by Subject|0|||
170854118|NCT00412061|617471824|FG001|Open Label Phase|Withdrawal by Subject|15|||
170854119|NCT00412061|617471823|FG000|Open Label Phase|Administrative Problems|0|||
170742520|NCT01468922|617064271|FG003|Overall Study|Screening failure|0|||
170742521|NCT01468922|617064272|FG004|Overall Study|Screening failure|0|||
170742522|NCT01468922|617064273|FG005|Overall Study|Screening failure|0|||
170742523|NCT01468922|617064274|FG006|Overall Study|Screening failure|0|||
170742524|NCT01468922|617064275|FG007|Overall Study|Screening failure|0|||
170742525|NCT01468922|617064276|FG008|Overall Study|Screening failure|1|||
170742526|NCT01468922|617064268|FG000|Overall Study|Per patient choice|1|||
170742527|NCT01468922|617064269|FG001|Overall Study|Per patient choice|0|||
170742528|NCT01468922|617064270|FG002|Overall Study|Per patient choice|0|||
170742529|NCT01468922|617064271|FG003|Overall Study|Per patient choice|0|||
170742530|NCT01468922|617064272|FG004|Overall Study|Per patient choice|0|||
170742531|NCT01468922|617064273|FG005|Overall Study|Per patient choice|0|||
170742532|NCT01468922|617064274|FG006|Overall Study|Per patient choice|0|||
170742533|NCT01468922|617064275|FG007|Overall Study|Per patient choice|0|||
170742534|NCT01468922|617064276|FG008|Overall Study|Per patient choice|0|||
170742535|NCT01468922|617064268|FG000|Overall Study|Switched to alternative treatment|1|||
170742536|NCT01468922|617064269|FG001|Overall Study|Switched to alternative treatment|0|||
170742537|NCT01468922|617064270|FG002|Overall Study|Switched to alternative treatment|0|||
170742538|NCT01468922|617064271|FG003|Overall Study|Switched to alternative treatment|0|||
170742539|NCT01468922|617064272|FG004|Overall Study|Switched to alternative treatment|1|||
170742540|NCT01468922|617064273|FG005|Overall Study|Switched to alternative treatment|0|||
170742541|NCT01468922|617064274|FG006|Overall Study|Switched to alternative treatment|0|||
170742542|NCT01468922|617064275|FG007|Overall Study|Switched to alternative treatment|0|||
170742543|NCT01468922|617064276|FG008|Overall Study|Switched to alternative treatment|0|||
170742544|NCT01468922|617064268|FG000|Overall Study|Enrolled on new protocol|0|||
170742545|NCT01468922|617064269|FG001|Overall Study|Enrolled on new protocol|0|||
170742546|NCT01468922|617064270|FG002|Overall Study|Enrolled on new protocol|0|||
170742547|NCT01468922|617064271|FG003|Overall Study|Enrolled on new protocol|0|||
170742548|NCT01468922|617064272|FG004|Overall Study|Enrolled on new protocol|1|||
170742549|NCT01468922|617064273|FG005|Overall Study|Enrolled on new protocol|0|||
170742550|NCT01468922|617064274|FG006|Overall Study|Enrolled on new protocol|0|||
170742551|NCT01468922|617064275|FG007|Overall Study|Enrolled on new protocol|0|||
170742552|NCT01468922|617064276|FG008|Overall Study|Enrolled on new protocol|0|||
170742553|NCT01468922|617064268|FG000|Overall Study|Adverse Event|0|||
170742554|NCT01468922|617064269|FG001|Overall Study|Adverse Event|0|||
170854120|NCT00412061|617471824|FG001|Open Label Phase|Administrative Problems|13|||
170854121|NCT00412061|617471823|FG000|Open Label Phase|Death|0|||
170854122|NCT00412061|617471824|FG001|Open Label Phase|Death|7|||
170854123|NCT00412061|617471823|FG000|Open Label Phase|Lost to Follow-up|0|||
170854124|NCT00412061|617471824|FG001|Open Label Phase|Lost to Follow-up|2|||
170854125|NCT00412061|617471823|FG000|Open Label Phase|New Cancer Therapy|0|||
170742555|NCT01468922|617064270|FG002|Overall Study|Adverse Event|0|||
170742556|NCT01468922|617064271|FG003|Overall Study|Adverse Event|0|||
170742557|NCT01468922|617064272|FG004|Overall Study|Adverse Event|0|||
170854126|NCT00412061|617471824|FG001|Open Label Phase|New Cancer Therapy|1|||
170742558|NCT01468922|617064273|FG005|Overall Study|Adverse Event|0|||
170742559|NCT01468922|617064274|FG006|Overall Study|Adverse Event|0|||
170742560|NCT01468922|617064275|FG007|Overall Study|Adverse Event|1|||
170854127|NCT02689518|617471825|FG000|Overall Study|Withdrawal by Subject|3|||
170854128|NCT03406078|617471836|FG000|Overall Study|Death|1|||
170854129|NCT03406078|617471837|FG001|Overall Study|Death|0|||
170854130|NCT03406078|617471836|FG000|Overall Study|Lost to Follow-up|0|||
170854131|NCT03406078|617471837|FG001|Overall Study|Lost to Follow-up|1|||
170854132|NCT03406078|617471836|FG000|Overall Study|Withdrawal by Subject|5|||
170854133|NCT03406078|617471837|FG001|Overall Study|Withdrawal by Subject|2|||
170854134|NCT03616977|617471841|FG000|Period 1|Physician Decision|0|||
170854135|NCT03616977|617471842|FG001|Period 1|Physician Decision|1|||
170854136|NCT03616977|617471841|FG000|Period 3|Adverse Event|1|||
170854137|NCT03616977|617471842|FG001|Period 3|Adverse Event|1|||
170854138|NCT00515853|617471843|FG000|Overall Study|Lost to Follow-up|9|||
170854139|NCT00515853|617471844|FG001|Overall Study|Lost to Follow-up|13|||
170854140|NCT00515853|617471843|FG000|Overall Study|Withdrawal by Subject|6|||
170854141|NCT00515853|617471844|FG001|Overall Study|Withdrawal by Subject|4|||
170854142|NCT03965351|617471846|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
170854143|NCT03965351|617471847|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
170854144|NCT03965351|617471846|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
170854145|NCT03965351|617471847|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
170854146|NCT00928018|617471852|FG000|Overall Study|Withdrawal by Subject|1|||
170854147|NCT00928018|617471853|FG001|Overall Study|Withdrawal by Subject|0|||
170854148|NCT03694275|617475412|FG000|Overall Study|Adverse Event|0|||
170854149|NCT03694275|617475413|FG001|Overall Study|Adverse Event|1|||
170854150|NCT03694275|617475412|FG000|Overall Study|Reason not Specified|0|||
170854151|NCT03694275|617475413|FG001|Overall Study|Reason not Specified|1|||
170854152|NCT04289051|617475416|FG000|Overall Study|Lost to Follow-up|0|||
170854153|NCT04289051|617475417|FG001|Overall Study|Lost to Follow-up|0|||
170854154|NCT04289051|617475418|FG002|Overall Study|Lost to Follow-up|2|||
170854155|NCT02874924|617475419|FG000|Overall Study|Adverse Event|2|||
170854156|NCT02874924|617475420|FG001|Overall Study|Adverse Event|0|||
170854157|NCT02874924|617475421|FG002|Overall Study|Adverse Event|0|||
170854158|NCT02874924|617475419|FG000|Overall Study|Withdrawal by Subject|1|||
170854159|NCT02874924|617475420|FG001|Overall Study|Withdrawal by Subject|0|||
170854160|NCT02874924|617475421|FG002|Overall Study|Withdrawal by Subject|0|||
170854161|NCT00700258|617475424|FG000|Overall Study|Premature discontinuation of documentation|136|||
170854162|NCT00700258|617475424|FG000|Overall Study|Type of study end not documented|1|||
170854163|NCT00700258|617475424|FG000|Overall Study|Lost to Follow-up|81|||
170854164|NCT00700258|617475424|FG000|Overall Study|Premature discontinuation of therapy|1013|||
170854165|NCT04772898|617475425|FG000|Overall Study|Withdrawal by Subject|0|||
170854166|NCT04772898|617475426|FG001|Overall Study|Withdrawal by Subject|1|||
170854167|NCT01874431|617475427|FG000|Overall Study|Physician Decision|0|||
170854168|NCT01874431|617475428|FG001|Overall Study|Physician Decision|0|||
170854169|NCT01874431|617475429|FG002|Overall Study|Physician Decision|1|||
170854170|NCT01874431|617475430|FG003|Overall Study|Physician Decision|0|||
170854171|NCT01874431|617475431|FG004|Overall Study|Physician Decision|0|||
170854172|NCT01874431|617475432|FG005|Overall Study|Physician Decision|0|||
170854173|NCT01874431|617475433|FG006|Overall Study|Physician Decision|0|||
170854174|NCT01874431|617475434|FG007|Overall Study|Physician Decision|0|||
170854175|NCT01874431|617475427|FG000|Overall Study|Adverse Event|5|||
170854176|NCT01874431|617475428|FG001|Overall Study|Adverse Event|4|||
170854177|NCT01874431|617475429|FG002|Overall Study|Adverse Event|6|||
170854178|NCT01874431|617475430|FG003|Overall Study|Adverse Event|5|||
170854179|NCT01874431|617475431|FG004|Overall Study|Adverse Event|2|||
170854180|NCT01874431|617475432|FG005|Overall Study|Adverse Event|8|||
170854181|NCT01874431|617475433|FG006|Overall Study|Adverse Event|2|||
170854182|NCT01874431|617475434|FG007|Overall Study|Adverse Event|3|||
170854183|NCT01874431|617475427|FG000|Overall Study|Protocol Violation|1|||
170854184|NCT01874431|617475428|FG001|Overall Study|Protocol Violation|1|||
170854185|NCT01874431|617475429|FG002|Overall Study|Protocol Violation|1|||
170854186|NCT01874431|617475430|FG003|Overall Study|Protocol Violation|0|||
170854187|NCT01874431|617475431|FG004|Overall Study|Protocol Violation|3|||
170854188|NCT01874431|617475432|FG005|Overall Study|Protocol Violation|2|||
170854189|NCT01874431|617475433|FG006|Overall Study|Protocol Violation|1|||
170854190|NCT01874431|617475434|FG007|Overall Study|Protocol Violation|1|||
170854191|NCT01874431|617475427|FG000|Overall Study|Non-compliance|0|||
170854192|NCT01874431|617475428|FG001|Overall Study|Non-compliance|0|||
170854193|NCT01874431|617475429|FG002|Overall Study|Non-compliance|0|||
170854194|NCT01874431|617475430|FG003|Overall Study|Non-compliance|0|||
170854195|NCT01874431|617475431|FG004|Overall Study|Non-compliance|1|||
170854196|NCT01874431|617475432|FG005|Overall Study|Non-compliance|0|||
170854197|NCT01874431|617475433|FG006|Overall Study|Non-compliance|1|||
170854198|NCT01874431|617475434|FG007|Overall Study|Non-compliance|0|||
170854199|NCT01874431|617475427|FG000|Overall Study|Logistical difficulties|0|||
170854200|NCT01874431|617475428|FG001|Overall Study|Logistical difficulties|0|||
170854201|NCT01874431|617475429|FG002|Overall Study|Logistical difficulties|0|||
170854202|NCT01874431|617475430|FG003|Overall Study|Logistical difficulties|0|||
170854203|NCT01874431|617475431|FG004|Overall Study|Logistical difficulties|0|||
170854204|NCT01874431|617475432|FG005|Overall Study|Logistical difficulties|0|||
170854205|NCT01874431|617475433|FG006|Overall Study|Logistical difficulties|1|||
170854206|NCT01874431|617475434|FG007|Overall Study|Logistical difficulties|0|||
170854207|NCT01874431|617475427|FG000|Overall Study|Withdrawal by Subject|0|||
170854208|NCT01874431|617475428|FG001|Overall Study|Withdrawal by Subject|0|||
170854209|NCT01874431|617475429|FG002|Overall Study|Withdrawal by Subject|1|||
170854210|NCT01874431|617475430|FG003|Overall Study|Withdrawal by Subject|2|||
170854211|NCT01874431|617475431|FG004|Overall Study|Withdrawal by Subject|1|||
170854212|NCT01874431|617475432|FG005|Overall Study|Withdrawal by Subject|1|||
170854213|NCT01874431|617475433|FG006|Overall Study|Withdrawal by Subject|3|||
170854214|NCT01874431|617475434|FG007|Overall Study|Withdrawal by Subject|0|||
170854215|NCT01874431|617475427|FG000|Overall Study|Sponsor decision|0|||
170854216|NCT01874431|617475428|FG001|Overall Study|Sponsor decision|0|||
170854217|NCT01874431|617475429|FG002|Overall Study|Sponsor decision|0|||
170854218|NCT01874431|617475430|FG003|Overall Study|Sponsor decision|0|||
170854219|NCT01874431|617475431|FG004|Overall Study|Sponsor decision|1|||
170854220|NCT01874431|617475432|FG005|Overall Study|Sponsor decision|0|||
170854221|NCT01874431|617475433|FG006|Overall Study|Sponsor decision|0|||
170854222|NCT01874431|617475434|FG007|Overall Study|Sponsor decision|0|||
170854223|NCT01874431|617475427|FG000|Overall Study|Lost to Follow-up|0|||
170854224|NCT01874431|617475428|FG001|Overall Study|Lost to Follow-up|0|||
170854225|NCT01874431|617475429|FG002|Overall Study|Lost to Follow-up|1|||
170854226|NCT01874431|617475430|FG003|Overall Study|Lost to Follow-up|0|||
170854227|NCT01874431|617475431|FG004|Overall Study|Lost to Follow-up|0|||
170854228|NCT01874431|617475432|FG005|Overall Study|Lost to Follow-up|0|||
170854229|NCT01874431|617475433|FG006|Overall Study|Lost to Follow-up|0|||
170854230|NCT01874431|617475434|FG007|Overall Study|Lost to Follow-up|0|||
170854231|NCT02947087|617475435|FG000|Overall Study|Withdrawal by Subject|3|||
170854232|NCT02947087|617475436|FG001|Overall Study|Withdrawal by Subject|2|||
170854233|NCT01375114|617475439|FG000|Overall Study|Lost to Follow-up|1|||
170854234|NCT01375114|617475440|FG001|Overall Study|Lost to Follow-up|0|||
170854235|NCT01375114|617475441|FG002|Overall Study|Lost to Follow-up|1|||
170854236|NCT01375114|617475439|FG000|Overall Study|Disease Progression|3|||
170854237|NCT01375114|617475440|FG001|Overall Study|Disease Progression|2|||
170854238|NCT01375114|617475441|FG002|Overall Study|Disease Progression|2|||
170854239|NCT01375114|617475439|FG000|Overall Study|Patient Changed Mind|0|||
170854240|NCT01375114|617475440|FG001|Overall Study|Patient Changed Mind|0|||
170854241|NCT01375114|617475441|FG002|Overall Study|Patient Changed Mind|2|||
170854242|NCT01375114|617475439|FG000|Overall Study|Pruritus|0|||
170854243|NCT01375114|617475440|FG001|Overall Study|Pruritus|0|||
170854244|NCT01375114|617475441|FG002|Overall Study|Pruritus|1|||
170854245|NCT01375114|617475439|FG000|Overall Study|Restlessness|0|||
170854246|NCT01375114|617475440|FG001|Overall Study|Restlessness|0|||
170854247|NCT01375114|617475441|FG002|Overall Study|Restlessness|1|||
170854248|NCT01375114|617475439|FG000|Overall Study|Diarrhea|0|||
170854249|NCT01375114|617475440|FG001|Overall Study|Diarrhea|0|||
170854250|NCT01375114|617475441|FG002|Overall Study|Diarrhea|1|||
170854251|NCT01375114|617475439|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
170854252|NCT01375114|617475440|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
170854253|NCT01375114|617475441|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
170854254|NCT01375114|617475439|FG000|Overall Study|Nausea|0|||
170854255|NCT01375114|617475440|FG001|Overall Study|Nausea|1|||
170854256|NCT01375114|617475441|FG002|Overall Study|Nausea|0|||
170854257|NCT01375114|617475439|FG000|Overall Study|Increased AST/ALT|0|||
170854258|NCT01375114|617475440|FG001|Overall Study|Increased AST/ALT|1|||
170854259|NCT01375114|617475441|FG002|Overall Study|Increased AST/ALT|0|||
170854260|NCT01375114|617475439|FG000|Overall Study|Vaginal Hemorrhage|0|||
170854261|NCT01375114|617475440|FG001|Overall Study|Vaginal Hemorrhage|1|||
170854262|NCT01375114|617475441|FG002|Overall Study|Vaginal Hemorrhage|0|||
170742561|NCT01468922|617064276|FG008|Overall Study|Adverse Event|0|||
170742562|NCT01468922|617064268|FG000|Overall Study|Infection of blood|0|||
170742563|NCT01468922|617064269|FG001|Overall Study|Infection of blood|0|||
170742564|NCT01468922|617064270|FG002|Overall Study|Infection of blood|0|||
170742565|NCT01468922|617064271|FG003|Overall Study|Infection of blood|0|||
170742566|NCT01468922|617064272|FG004|Overall Study|Infection of blood|0|||
170742567|NCT01468922|617064273|FG005|Overall Study|Infection of blood|0|||
170742568|NCT01468922|617064274|FG006|Overall Study|Infection of blood|0|||
170742569|NCT01468922|617064275|FG007|Overall Study|Infection of blood|1|||
170742570|NCT01468922|617064276|FG008|Overall Study|Infection of blood|0|||
170742571|NCT01468922|617064268|FG000|Overall Study|Patient choice - surgery|0|||
170742572|NCT01468922|617064269|FG001|Overall Study|Patient choice - surgery|0|||
170742573|NCT01468922|617064270|FG002|Overall Study|Patient choice - surgery|0|||
170742574|NCT01468922|617064271|FG003|Overall Study|Patient choice - surgery|0|||
170742575|NCT01468922|617064272|FG004|Overall Study|Patient choice - surgery|0|||
170742576|NCT01468922|617064273|FG005|Overall Study|Patient choice - surgery|0|||
170742577|NCT01468922|617064274|FG006|Overall Study|Patient choice - surgery|0|||
170742578|NCT01468922|617064275|FG007|Overall Study|Patient choice - surgery|1|||
170742579|NCT01468922|617064276|FG008|Overall Study|Patient choice - surgery|0|||
170742580|NCT01468922|617064268|FG000|Overall Study|Refused further treatment|0|||
170742581|NCT01468922|617064269|FG001|Overall Study|Refused further treatment|0|||
170742582|NCT01468922|617064270|FG002|Overall Study|Refused further treatment|0|||
170742583|NCT01468922|617064271|FG003|Overall Study|Refused further treatment|0|||
170742584|NCT01468922|617064272|FG004|Overall Study|Refused further treatment|0|||
170742585|NCT01468922|617064273|FG005|Overall Study|Refused further treatment|0|||
170742586|NCT01468922|617064274|FG006|Overall Study|Refused further treatment|0|||
170742587|NCT01468922|617064275|FG007|Overall Study|Refused further treatment|1|||
170742588|NCT01468922|617064276|FG008|Overall Study|Refused further treatment|0|||
170742589|NCT04848662|617064277|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
170742590|NCT04848662|617064278|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
170742591|NCT01350505|617064279|FG000|Overall Study|Lost to Follow-up|4|||
170742592|NCT01719224|617064280|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
170742593|NCT01719224|617064281|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
170742594|NCT00258440|617064282|FG000|Overall Study|Withdrawal by Subject|0|||
170742595|NCT00258440|617064283|FG001|Overall Study|Withdrawal by Subject|0|||
170742596|NCT00258440|617064284|FG002|Overall Study|Withdrawal by Subject|1|||
170742597|NCT01834222|617064285|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
170742598|NCT00152971|617064286|FG000|Overall Study|Adverse Event|12|||
170742599|NCT00152971|617064287|FG001|Overall Study|Adverse Event|10|||
170742600|NCT00152971|617064288|FG002|Overall Study|Adverse Event|9|||
170742601|NCT00152971|617064286|FG000|Overall Study|Protocol Violation|10|||
170742602|NCT00152971|617064287|FG001|Overall Study|Protocol Violation|11|||
170742603|NCT00152971|617064288|FG002|Overall Study|Protocol Violation|8|||
170742604|NCT00152971|617064286|FG000|Overall Study|Lost to Follow-up|17|||
170742605|NCT00152971|617064287|FG001|Overall Study|Lost to Follow-up|14|||
170742606|NCT00152971|617064288|FG002|Overall Study|Lost to Follow-up|13|||
170742607|NCT00152971|617064286|FG000|Overall Study|Withdrawal by Subject|9|||
170742608|NCT00152971|617064287|FG001|Overall Study|Withdrawal by Subject|8|||
170854263|NCT01375114|617475439|FG000|Overall Study|Family problem|0|||
170854264|NCT01375114|617475440|FG001|Overall Study|Family problem|1|||
170854265|NCT01375114|617475441|FG002|Overall Study|Family problem|0|||
170854266|NCT01375114|617475439|FG000|Overall Study|Protocol Violation|2|||
170854267|NCT01375114|617475440|FG001|Overall Study|Protocol Violation|0|||
170854268|NCT01375114|617475441|FG002|Overall Study|Protocol Violation|0|||
170854269|NCT05398237|617475442|FG000|Overall Study|Withdrawal by Subject|1|||
170854270|NCT02781844|617475446|FG000|Treatment Period 1|Adverse Event|0|||
170854271|NCT02781844|617475447|FG001|Treatment Period 1|Adverse Event|0|||
170854272|NCT02781844|617475448|FG002|Treatment Period 1|Adverse Event|0|||
170854273|NCT02781844|617475449|FG003|Treatment Period 1|Adverse Event|0|||
170854274|NCT02781844|617475450|FG004|Treatment Period 1|Adverse Event|0|||
170854275|NCT02781844|617475451|FG005|Treatment Period 1|Adverse Event|1|||
170854276|NCT02781844|617475452|FG006|Treatment Period 1|Adverse Event|0|||
170854277|NCT02781844|617475453|FG007|Treatment Period 1|Adverse Event|0|||
170854278|NCT03271021|617475454|FG000|Overall Study|Adverse Event|3|||
170854279|NCT03271021|617475455|FG001|Overall Study|Adverse Event|2|||
170854280|NCT03271021|617475454|FG000|Overall Study|Withdrawal by Subject|36|||
170854281|NCT03271021|617475455|FG001|Overall Study|Withdrawal by Subject|53|||
170854282|NCT03271021|617475454|FG000|Overall Study|Lost to Follow-up|34|||
170854283|NCT03271021|617475455|FG001|Overall Study|Lost to Follow-up|39|||
170854284|NCT03271021|617475454|FG000|Overall Study|Protocol Violation|6|||
170854285|NCT03271021|617475455|FG001|Overall Study|Protocol Violation|4|||
170854286|NCT03271021|617475454|FG000|Overall Study|Abnormal Lab Results|1|||
170854287|NCT03271021|617475455|FG001|Overall Study|Abnormal Lab Results|0|||
170854288|NCT03271021|617475454|FG000|Overall Study|Miscellaneous|9|||
170854289|NCT03271021|617475455|FG001|Overall Study|Miscellaneous|8|||
170854290|NCT00321373|617475460|FG000|Overall Study|Adverse Event|0|||
170854291|NCT00321373|617475461|FG001|Overall Study|Adverse Event|0|||
170854292|NCT00321373|617475462|FG002|Overall Study|Adverse Event|1|||
170854293|NCT00321373|617475460|FG000|Overall Study|Lost to Follow-up|1|||
170854294|NCT00321373|617475461|FG001|Overall Study|Lost to Follow-up|0|||
170854295|NCT00321373|617475462|FG002|Overall Study|Lost to Follow-up|1|||
170854296|NCT00321373|617475460|FG000|Overall Study|Withdrawal by Subject|1|||
170854297|NCT00321373|617475461|FG001|Overall Study|Withdrawal by Subject|0|||
170854298|NCT00321373|617475462|FG002|Overall Study|Withdrawal by Subject|0|||
170854299|NCT00321373|617475460|FG000|Overall Study|Other|0|||
170854300|NCT00321373|617475461|FG001|Overall Study|Other|0|||
170854301|NCT00321373|617475462|FG002|Overall Study|Other|1|||
170854302|NCT01383499|617475463|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
170854303|NCT01383499|617475464|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
170854304|NCT01383499|617475465|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
170854305|NCT01383499|617475466|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
170854306|NCT00477334|617475467|FG000|Overall Study|Discontinued prior to taking study drug|106|||
170854307|NCT00477334|617475468|FG001|Overall Study|Discontinued prior to taking study drug|53|||
170854308|NCT00477334|617475467|FG000|Overall Study|Adverse Event|1|||
170854309|NCT00477334|617475468|FG001|Overall Study|Adverse Event|2|||
170854310|NCT00477334|617475467|FG000|Overall Study|Withdrawal by Subject|2|||
170854311|NCT00477334|617475468|FG001|Overall Study|Withdrawal by Subject|1|||
170854312|NCT00477334|617475467|FG000|Overall Study|Lost to Follow-up|15|||
170854313|NCT00477334|617475468|FG001|Overall Study|Lost to Follow-up|4|||
170854314|NCT00477334|617475467|FG000|Overall Study|Administrative Problems|39|||
170742609|NCT00152971|617064288|FG002|Overall Study|Withdrawal by Subject|14|||
170742610|NCT00152971|617064286|FG000|Overall Study|Other|3|||
170854315|NCT00477334|617475468|FG001|Overall Study|Administrative Problems|15|||
170854316|NCT00477334|617475467|FG000|Overall Study|Protocol Violation|7|||
170742611|NCT00152971|617064287|FG001|Overall Study|Other|5|||
170742612|NCT00152971|617064288|FG002|Overall Study|Other|5|||
170742613|NCT00152971|617064286|FG000|Treatment|Adverse Event|49|||
170742614|NCT00152971|617064287|FG001|Treatment|Adverse Event|40|||
170742615|NCT00152971|617064288|FG002|Treatment|Adverse Event|54|||
170742616|NCT00152971|617064286|FG000|Treatment|Protocol Violation|8|||
170742617|NCT00152971|617064287|FG001|Treatment|Protocol Violation|6|||
170742618|NCT00152971|617064288|FG002|Treatment|Protocol Violation|10|||
170742619|NCT00152971|617064286|FG000|Treatment|Lost to Follow-up|1|||
170742620|NCT00152971|617064287|FG001|Treatment|Lost to Follow-up|2|||
170742621|NCT00152971|617064288|FG002|Treatment|Lost to Follow-up|1|||
170742622|NCT00152971|617064286|FG000|Treatment|Withdrawal by Subject|4|||
170742623|NCT00152971|617064287|FG001|Treatment|Withdrawal by Subject|4|||
170742624|NCT00152971|617064288|FG002|Treatment|Withdrawal by Subject|5|||
170742625|NCT00152971|617064286|FG000|Treatment|Other|9|||
170742626|NCT00152971|617064287|FG001|Treatment|Other|11|||
170742627|NCT00152971|617064288|FG002|Treatment|Other|10|||
170742628|NCT01372605|617064289|FG000|Overall Study|Death|1|||
170742629|NCT01372605|617064290|FG001|Overall Study|Death|2|||
170742630|NCT01372605|617064289|FG000|Overall Study|Lost to Follow-up|2|||
170742631|NCT01372605|617064290|FG001|Overall Study|Lost to Follow-up|1|||
170742632|NCT01372605|617064289|FG000|Overall Study|Withdrawal by Subject|4|||
170742633|NCT01372605|617064290|FG001|Overall Study|Withdrawal by Subject|7|||
170742634|NCT01372605|617064289|FG000|Overall Study|Moved|3|||
170742635|NCT01372605|617064290|FG001|Overall Study|Moved|0|||
170742636|NCT01372605|617064289|FG000|Overall Study|Changed medical home|2|||
170742637|NCT01372605|617064290|FG001|Overall Study|Changed medical home|0|||
170742638|NCT00734214|617064291|FG000|Overall Study|Withdrawal by Subject|3|||
170742639|NCT00734214|617064292|FG001|Overall Study|Withdrawal by Subject|4|||
170742640|NCT00734214|617064291|FG000|Overall Study|MD withdrawal|1|||
170742641|NCT00734214|617064292|FG001|Overall Study|MD withdrawal|0|||
170742642|NCT00692406|617064293|FG000|Overall Study|PI dropped, bad data|57|||
170742643|NCT02597933|617064294|FG000|Overall Study|Withdrawal by Subject|7|||
170742644|NCT02597933|617064295|FG001|Overall Study|Withdrawal by Subject|5|||
170742645|NCT02597933|617064294|FG000|Overall Study|Protocol Violation|2|||
170742646|NCT02597933|617064295|FG001|Overall Study|Protocol Violation|2|||
170854317|NCT00477334|617475468|FG001|Overall Study|Protocol Violation|1|||
170854318|NCT01236534|617475469|FG000|Overall Study|Adverse Event|3|||
170854319|NCT01236534|617475470|FG001|Overall Study|Adverse Event|0|||
170854320|NCT02572882|617475471|FG000|Overall Study|Withdrawal by Subject|1|||
170854321|NCT02572882|617475471|FG000|Overall Study|Participant received kidney transplant|1|||
170854322|NCT00461032|617475473|FG000|Overall Study|Adverse Event|5|||
170854323|NCT00461032|617475474|FG001|Overall Study|Adverse Event|6|||
170854324|NCT00461032|617475473|FG000|Overall Study|Lack of Efficacy|5|||
170854325|NCT00461032|617475474|FG001|Overall Study|Lack of Efficacy|1|||
170854326|NCT00461032|617475473|FG000|Overall Study|Lost to Follow-up|7|||
170854327|NCT00461032|617475474|FG001|Overall Study|Lost to Follow-up|12|||
170854328|NCT00461032|617475473|FG000|Overall Study|Protocol Violation|4|||
170854329|NCT00461032|617475474|FG001|Overall Study|Protocol Violation|4|||
170854330|NCT00461032|617475473|FG000|Overall Study|Withdrawal by Subject|7|||
170854331|NCT00461032|617475474|FG001|Overall Study|Withdrawal by Subject|15|||
170854332|NCT00461032|617475473|FG000|Overall Study|Patient Moved or Relocated|2|||
170854333|NCT00461032|617475474|FG001|Overall Study|Patient Moved or Relocated|1|||
170854334|NCT00461032|617475473|FG000|Overall Study|Other|7|||
170854335|NCT00461032|617475474|FG001|Overall Study|Other|5|||
170854336|NCT00372229|617475476|FG000|Study Phase|Graft loss|0|||
170854337|NCT00372229|617475477|FG001|Study Phase|Graft loss|3|||
170854338|NCT00372229|617475476|FG000|Study Phase|Protocol Violation|3|||
170854339|NCT00372229|617475477|FG001|Study Phase|Protocol Violation|4|||
170854340|NCT00372229|617475476|FG000|Study Phase|Consent withdrawn|16|||
170854341|NCT00372229|617475477|FG001|Study Phase|Consent withdrawn|14|||
170854342|NCT00372229|617475476|FG000|Study Phase|Refused treatment/did not cooperate|3|||
170854343|NCT00372229|617475477|FG001|Study Phase|Refused treatment/did not cooperate|1|||
170854344|NCT00372229|617475476|FG000|Study Phase|Death|3|||
170854345|NCT00372229|617475477|FG001|Study Phase|Death|2|||
170854346|NCT00372229|617475476|FG000|Study Phase|Reason not specified|3|||
170854347|NCT00372229|617475477|FG001|Study Phase|Reason not specified|2|||
170854348|NCT00372229|617475476|FG000|Study Phase|Lost to Follow-up|3|||
170854349|NCT00372229|617475477|FG001|Study Phase|Lost to Follow-up|3|||
170854350|NCT00372229|617475476|FG000|Follow-Up Phase|Graft loss|8|||
170854351|NCT00372229|617475477|FG001|Follow-Up Phase|Graft loss|7|||
170854352|NCT00372229|617475476|FG000|Follow-Up Phase|Consent withdrawn|13|||
170854353|NCT00372229|617475477|FG001|Follow-Up Phase|Consent withdrawn|19|||
170854354|NCT00372229|617475476|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
170854355|NCT00372229|617475477|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
170854356|NCT00372229|617475476|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
170854357|NCT00372229|617475477|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
170854358|NCT00372229|617475476|FG000|Follow-Up Phase|Death|9|||
170854359|NCT00372229|617475477|FG001|Follow-Up Phase|Death|12|||
170854360|NCT00372229|617475476|FG000|Follow-Up Phase|Administrative|1|||
170854361|NCT00372229|617475477|FG001|Follow-Up Phase|Administrative|0|||
170854362|NCT00372229|617475476|FG000|Follow-Up Phase|Reason not specified|2|||
170854363|NCT00372229|617475477|FG001|Follow-Up Phase|Reason not specified|3|||
170854364|NCT00372229|617475476|FG000|Follow-Up Phase|Lost to Follow-up|12|||
170854365|NCT00372229|617475477|FG001|Follow-Up Phase|Lost to Follow-up|10|||
170854366|NCT02257567|617475478|FG000|Overall Study|Adverse Event|0|||
170854367|NCT02257567|617475479|FG001|Overall Study|Adverse Event|0|||
170854368|NCT02257567|617475480|FG002|Overall Study|Adverse Event|0|||
170854369|NCT02257567|617475481|FG003|Overall Study|Adverse Event|1|||
170854370|NCT02257567|617475482|FG004|Overall Study|Adverse Event|1|||
170854371|NCT02257567|617475483|FG005|Overall Study|Adverse Event|0|||
170854372|NCT02257567|617475484|FG006|Overall Study|Adverse Event|0|||
170854373|NCT02257567|617475485|FG007|Overall Study|Adverse Event|0|||
170854374|NCT02257567|617475486|FG008|Overall Study|Adverse Event|1|||
170854375|NCT02257567|617475487|FG009|Overall Study|Adverse Event|0|||
170854376|NCT02257567|617475488|FG010|Overall Study|Adverse Event|0|||
170854377|NCT02257567|617475478|FG000|Overall Study|Death|2|||
170854378|NCT02257567|617475479|FG001|Overall Study|Death|2|||
170854379|NCT02257567|617475480|FG002|Overall Study|Death|2|||
170854380|NCT02257567|617475481|FG003|Overall Study|Death|4|||
170854381|NCT02257567|617475482|FG004|Overall Study|Death|15|||
170854382|NCT02257567|617475483|FG005|Overall Study|Death|11|||
170854383|NCT02257567|617475484|FG006|Overall Study|Death|26|||
170854384|NCT02257567|617475485|FG007|Overall Study|Death|30|||
170854385|NCT02257567|617475486|FG008|Overall Study|Death|2|||
170854386|NCT02257567|617475487|FG009|Overall Study|Death|18|||
170854387|NCT02257567|617475488|FG010|Overall Study|Death|65|||
170854388|NCT02257567|617475478|FG000|Overall Study|Lost to Follow-up|0|||
170854389|NCT02257567|617475479|FG001|Overall Study|Lost to Follow-up|0|||
170854390|NCT02257567|617475480|FG002|Overall Study|Lost to Follow-up|0|||
170854391|NCT02257567|617475481|FG003|Overall Study|Lost to Follow-up|0|||
170854392|NCT02257567|617475482|FG004|Overall Study|Lost to Follow-up|2|||
170854393|NCT02257567|617475483|FG005|Overall Study|Lost to Follow-up|2|||
170854394|NCT02257567|617475484|FG006|Overall Study|Lost to Follow-up|0|||
170854395|NCT02257567|617475485|FG007|Overall Study|Lost to Follow-up|0|||
170854396|NCT02257567|617475486|FG008|Overall Study|Lost to Follow-up|0|||
170854397|NCT02257567|617475487|FG009|Overall Study|Lost to Follow-up|1|||
170854398|NCT02257567|617475488|FG010|Overall Study|Lost to Follow-up|1|||
170854399|NCT02257567|617475478|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854400|NCT02257567|617475479|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854401|NCT02257567|617475480|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854402|NCT02257567|617475481|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854403|NCT02257567|617475482|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
170854404|NCT02257567|617475483|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854405|NCT02257567|617475484|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
170854406|NCT02257567|617475485|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854407|NCT02257567|617475486|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854408|NCT02257567|617475487|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854409|NCT02257567|617475488|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
170854410|NCT02257567|617475478|FG000|Overall Study|Physician Decision|0|||
170854411|NCT02257567|617475479|FG001|Overall Study|Physician Decision|0|||
170854412|NCT02257567|617475480|FG002|Overall Study|Physician Decision|0|||
170854413|NCT02257567|617475481|FG003|Overall Study|Physician Decision|0|||
170854414|NCT02257567|617475482|FG004|Overall Study|Physician Decision|0|||
170854415|NCT02257567|617475483|FG005|Overall Study|Physician Decision|0|||
170854416|NCT02257567|617475484|FG006|Overall Study|Physician Decision|0|||
170854417|NCT02257567|617475485|FG007|Overall Study|Physician Decision|2|||
170854418|NCT02257567|617475486|FG008|Overall Study|Physician Decision|0|||
170854419|NCT02257567|617475487|FG009|Overall Study|Physician Decision|1|||
170854420|NCT02257567|617475488|FG010|Overall Study|Physician Decision|0|||
170854421|NCT02257567|617475478|FG000|Overall Study|Withdrawal by Subject|0|||
170854422|NCT02257567|617475479|FG001|Overall Study|Withdrawal by Subject|0|||
170854423|NCT02257567|617475480|FG002|Overall Study|Withdrawal by Subject|2|||
170854424|NCT02257567|617475481|FG003|Overall Study|Withdrawal by Subject|0|||
170854425|NCT02257567|617475482|FG004|Overall Study|Withdrawal by Subject|0|||
170854426|NCT02257567|617475483|FG005|Overall Study|Withdrawal by Subject|6|||
170854427|NCT02257567|617475484|FG006|Overall Study|Withdrawal by Subject|6|||
170854428|NCT02257567|617475485|FG007|Overall Study|Withdrawal by Subject|6|||
170854429|NCT02257567|617475486|FG008|Overall Study|Withdrawal by Subject|1|||
170854430|NCT02257567|617475487|FG009|Overall Study|Withdrawal by Subject|1|||
170854431|NCT02257567|617475488|FG010|Overall Study|Withdrawal by Subject|10|||
170854432|NCT05383508|617475493|FG000|Overall Study|Withdrawal by Subject|1|||
170854433|NCT05383508|617475494|FG001|Overall Study|Withdrawal by Subject|0|||
170854434|NCT05383508|617475495|FG002|Overall Study|Withdrawal by Subject|1|||
170854435|NCT05383508|617475496|FG003|Overall Study|Withdrawal by Subject|1|||
170854436|NCT05383508|617475497|FG004|Overall Study|Withdrawal by Subject|2|||
170854437|NCT05383508|617475498|FG005|Overall Study|Withdrawal by Subject|0|||
170854438|NCT02399254|617475500|FG000|Overall Study|Physician Decision|2|||
170854439|NCT02334423|617475501|FG000|Overall Study|Protocol Violation|10|||
170854440|NCT02334423|617475502|FG001|Overall Study|Protocol Violation|3|||
170854441|NCT00635427|617475503|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
170854442|NCT00635427|617475504|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
170854443|NCT00635427|617475505|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
170854444|NCT00635427|617475506|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
170854445|NCT00635427|617475507|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
170854446|NCT00635427|617475503|FG000|Overall Study|Death|0|||
170854447|NCT00635427|617475504|FG001|Overall Study|Death|0|||
170854448|NCT00635427|617475505|FG002|Overall Study|Death|0|||
170854449|NCT00635427|617475506|FG003|Overall Study|Death|1|||
170854450|NCT00635427|617475507|FG004|Overall Study|Death|0|||
170854451|NCT00635427|617475503|FG000|Overall Study|Termination Of Study By Sponsor|12|||
170854452|NCT00635427|617475504|FG001|Overall Study|Termination Of Study By Sponsor|6|||
170854453|NCT00635427|617475505|FG002|Overall Study|Termination Of Study By Sponsor|10|||
170854454|NCT00635427|617475506|FG003|Overall Study|Termination Of Study By Sponsor|6|||
170854455|NCT00635427|617475507|FG004|Overall Study|Termination Of Study By Sponsor|6|||
170854456|NCT00635427|617475503|FG000|Overall Study|Withdrawal Of Consent|0|||
170854457|NCT00635427|617475504|FG001|Overall Study|Withdrawal Of Consent|0|||
170742647|NCT02597933|617064294|FG000|Overall Study|Adverse Event|20|||
170742648|NCT02597933|617064295|FG001|Overall Study|Adverse Event|28|||
170742649|NCT02597933|617064294|FG000|Overall Study|Not treated|2|||
170742650|NCT02597933|617064295|FG001|Overall Study|Not treated|2|||
170742651|NCT02597933|617064294|FG000|Overall Study|Other than stated above|7|||
170742652|NCT02597933|617064295|FG001|Overall Study|Other than stated above|14|||
170742653|NCT04145037|617064296|FG000|Overall Study|Study terminated|2|||
170742654|NCT04145037|617064297|FG001|Overall Study|Study terminated|0|||
170742655|NCT04145037|617064296|FG000|Overall Study|Withdrawal by Subject|1|||
170742656|NCT04145037|617064297|FG001|Overall Study|Withdrawal by Subject|0|||
170742657|NCT04145037|617064296|FG000|Overall Study|Lost to Follow-up|1|||
170742658|NCT04145037|617064297|FG001|Overall Study|Lost to Follow-up|0|||
170742659|NCT01515189|617064298|FG000|Induction|Disease Progression|109|||
170742660|NCT01515189|617064299|FG001|Induction|Disease Progression|155|||
170742661|NCT01515189|617064298|FG000|Induction|Study drug toxicity|86|||
170742662|NCT01515189|617064299|FG001|Induction|Study drug toxicity|36|||
170742663|NCT01515189|617064298|FG000|Induction|Death|24|||
170742664|NCT01515189|617064299|FG001|Induction|Death|17|||
170742665|NCT01515189|617064298|FG000|Induction|Adverse Event|14|||
170742666|NCT01515189|617064299|FG001|Induction|Adverse Event|9|||
170742667|NCT01515189|617064298|FG000|Induction|Withdrawal by Subject|3|||
170854458|NCT00635427|617475505|FG002|Overall Study|Withdrawal Of Consent|0|||
170854459|NCT00635427|617475506|FG003|Overall Study|Withdrawal Of Consent|2|||
170854460|NCT00635427|617475507|FG004|Overall Study|Withdrawal Of Consent|2|||
170854461|NCT02292927|617475508|FG000|Overall Study|Protocol Violation|13|||
170854462|NCT02292927|617475509|FG001|Overall Study|Protocol Violation|7|||
170854463|NCT03625895|617475510|FG000|Overall Study|Protocol Violation|585|||
170854464|NCT03256851|617475511|FG000|Overall Study|Withdrawal by Subject|1|||
170854465|NCT03256851|617475512|FG001|Overall Study|Withdrawal by Subject|0|||
170854466|NCT02081417|617475513|FG000|Overall Study|Lost to Follow-up|26|||
170854467|NCT02081417|617475514|FG001|Overall Study|Lost to Follow-up|23|||
170854468|NCT02081417|617475513|FG000|Overall Study|Moved Away|1|||
170854469|NCT02081417|617475514|FG001|Overall Study|Moved Away|2|||
170854470|NCT02081417|617475513|FG000|Overall Study|Incarcerated|2|||
170854471|NCT02081417|617475514|FG001|Overall Study|Incarcerated|2|||
170854472|NCT02081417|617475513|FG000|Overall Study|Death|4|||
170854473|NCT02081417|617475514|FG001|Overall Study|Death|3|||
170854474|NCT02081417|617475513|FG000|Overall Study|Withdrawal by Subject|4|||
170854475|NCT02081417|617475514|FG001|Overall Study|Withdrawal by Subject|0|||
170854476|NCT02081417|617475513|FG000|Overall Study|Admitted to Residential Treatment|2|||
170854477|NCT02081417|617475514|FG001|Overall Study|Admitted to Residential Treatment|0|||
170854478|NCT02081417|617475513|FG000|Overall Study|Did not start treatment|17|||
170854479|NCT02081417|617475514|FG001|Overall Study|Did not start treatment|21|||
170854480|NCT00122460|617475516|FG000|Overall Study|investigational study phase ongoing|7|||
170854481|NCT00122460|617475517|FG001|Overall Study|investigational study phase ongoing|1|||
170854482|NCT01778023|617475519|FG000|Overall Study|Withdrawal by Subject|0|||
170854483|NCT01778023|617475520|FG001|Overall Study|Withdrawal by Subject|3|||
170854484|NCT00394082|617475521|FG000|Overall Study|Unacceptable toxicity|15|||
170854485|NCT00394082|617475521|FG000|Overall Study|Adverse Event|4|||
170854486|NCT00394082|617475521|FG000|Overall Study|Physician Decision|4|||
170854487|NCT00394082|617475521|FG000|Overall Study|Withdrawal by Subject|2|||
170854488|NCT00394082|617475521|FG000|Overall Study|Other|1|||
170854489|NCT02344004|617475522|FG000|Overall Study|Adverse Event|11|||
170854490|NCT02344004|617475523|FG001|Overall Study|Adverse Event|1|||
170854491|NCT02344004|617475522|FG000|Overall Study|Death|9|||
170854492|NCT02344004|617475523|FG001|Overall Study|Death|7|||
170854493|NCT02344004|617475522|FG000|Overall Study|Physician Decision|4|||
170854494|NCT02344004|617475523|FG001|Overall Study|Physician Decision|1|||
170854495|NCT02344004|617475522|FG000|Overall Study|Withdrawal by Subject|22|||
170854496|NCT02344004|617475523|FG001|Overall Study|Withdrawal by Subject|5|||
170854497|NCT02344004|617475522|FG000|Overall Study|Rescue Medication|2|||
170854498|NCT02344004|617475523|FG001|Overall Study|Rescue Medication|0|||
170854499|NCT02344004|617475522|FG000|Overall Study|Other Not Specified|12|||
170854500|NCT02344004|617475523|FG001|Overall Study|Other Not Specified|0|||
170854501|NCT02344004|617475522|FG000|Overall Study|Protocol Violation|1|||
170854502|NCT02344004|617475523|FG001|Overall Study|Protocol Violation|0|||
170854503|NCT01945060|617475524|FG000|Overall Study|Lost to follow up|1|||
170854504|NCT01945060|617475525|FG001|Overall Study|Lost to follow up|0|||
170854505|NCT01945060|617475524|FG000|Overall Study|Distress related to IV access|0|||
170854506|NCT01945060|617475525|FG001|Overall Study|Distress related to IV access|1|||
170854507|NCT01293487|617475526|FG000|Overall Study|Lost to Follow-up|0|||
170854508|NCT01293487|617475527|FG001|Overall Study|Lost to Follow-up|0|||
170854509|NCT01293487|617475528|FG002|Overall Study|Lost to Follow-up|0|||
170854510|NCT01293487|617475529|FG003|Overall Study|Lost to Follow-up|1|||
170854511|NCT01293487|617475530|FG004|Overall Study|Lost to Follow-up|0|||
170854512|NCT01293487|617475531|FG005|Overall Study|Lost to Follow-up|0|||
170854513|NCT01293487|617475532|FG006|Overall Study|Lost to Follow-up|0|||
170854514|NCT01293487|617475533|FG007|Overall Study|Lost to Follow-up|0|||
170854515|NCT01293487|617475526|FG000|Overall Study|Withdrawal by Subject|0|||
170854516|NCT01293487|617475527|FG001|Overall Study|Withdrawal by Subject|0|||
170854517|NCT01293487|617475528|FG002|Overall Study|Withdrawal by Subject|0|||
170854518|NCT01293487|617475529|FG003|Overall Study|Withdrawal by Subject|0|||
170854519|NCT01293487|617475530|FG004|Overall Study|Withdrawal by Subject|0|||
170854520|NCT01293487|617475531|FG005|Overall Study|Withdrawal by Subject|0|||
170854521|NCT01293487|617475532|FG006|Overall Study|Withdrawal by Subject|0|||
170854522|NCT01293487|617475533|FG007|Overall Study|Withdrawal by Subject|2|||
170854523|NCT00938860|617475537|FG000|Overall Study|Adverse Event|2|||
170854524|NCT00938860|617475538|FG001|Overall Study|Adverse Event|1|||
170854525|NCT00938860|617475537|FG000|Overall Study|Abnormal laboratory values|2|||
170854526|NCT00938860|617475538|FG001|Overall Study|Abnormal laboratory values|2|||
170854527|NCT00938860|617475537|FG000|Overall Study|Withdrawal by Subject|11|||
170854528|NCT00938860|617475538|FG001|Overall Study|Withdrawal by Subject|8|||
170854529|NCT00938860|617475537|FG000|Overall Study|Lost to Follow-up|4|||
170854530|NCT00938860|617475538|FG001|Overall Study|Lost to Follow-up|4|||
170854531|NCT00938860|617475537|FG000|Overall Study|Administration problems|2|||
170854532|NCT00938860|617475538|FG001|Overall Study|Administration problems|0|||
170854533|NCT00938860|617475537|FG000|Overall Study|Death|1|||
170854534|NCT00938860|617475538|FG001|Overall Study|Death|1|||
170854535|NCT00938860|617475537|FG000|Overall Study|Protocol Violation|3|||
170854536|NCT00938860|617475538|FG001|Overall Study|Protocol Violation|1|||
170854537|NCT01605019|617475539|FG000|Overall Study|pt did not meet transplant endpoint|3|||
170854538|NCT01605019|617475540|FG001|Overall Study|pt did not meet transplant endpoint|0|||
170854539|NCT01964924|617475541|FG000|Trametinib Monotherapy|Progression|19|||
170854540|NCT01964924|617475542|FG001|Trametinib Monotherapy|Progression|0|||
170854541|NCT02703259|617475543|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
170854542|NCT02703259|617475544|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
170854543|NCT02703259|617475543|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
170854544|NCT02703259|617475544|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
170854545|NCT02703259|617475543|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
170854546|NCT02703259|617475544|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
170854547|NCT01090427|617475545|FG000|After Controlled Period|Death|0|||
170854548|NCT01090427|617475546|FG001|After Controlled Period|Death|0|||
170854549|NCT01090427|617475547|FG002|After Controlled Period|Death|0|||
170742668|NCT01515189|617064299|FG001|Induction|Withdrawal by Subject|9|||
170742669|NCT01515189|617064298|FG000|Induction|No longer meets study criteria|0|||
170742670|NCT01515189|617064299|FG001|Induction|No longer meets study criteria|2|||
170742671|NCT01515189|617064298|FG000|Induction|Lost to Follow-up|1|||
170742672|NCT01515189|617064299|FG001|Induction|Lost to Follow-up|0|||
170742673|NCT01515189|617064298|FG000|Induction|Other|0|||
170742674|NCT01515189|617064299|FG001|Induction|Other|4|||
170742675|NCT01515189|617064298|FG000|First Re-Induction Phase|Disease progression|6|||
170742676|NCT01515189|617064299|FG001|First Re-Induction Phase|Disease progression|14|||
170742677|NCT01515189|617064298|FG000|First Re-Induction Phase|Study drug toxicity|5|||
170742678|NCT01515189|617064299|FG001|First Re-Induction Phase|Study drug toxicity|0|||
170742679|NCT01515189|617064298|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
170742680|NCT01515189|617064299|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
170742681|NCT01515189|617064298|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
170742682|NCT01515189|617064299|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
170742683|NCT01515189|617064298|FG000|First Re-Induction Phase|Other|1|||
170742684|NCT01515189|617064299|FG001|First Re-Induction Phase|Other|0|||
170742685|NCT05796518|617064302|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
170742686|NCT01407354|617064303|FG000|First Intervention|Withdrawal by Subject|0|||
170742687|NCT01407354|617064304|FG001|First Intervention|Withdrawal by Subject|2|||
170742688|NCT01407354|617064303|FG000|First Intervention|Adverse Event|1|||
170742689|NCT01407354|617064304|FG001|First Intervention|Adverse Event|0|||
170742690|NCT01407354|617064303|FG000|First Intervention|Physician Decision|1|||
170854550|NCT01090427|617475548|FG003|After Controlled Period|Death|0|||
170854551|NCT01090427|617475549|FG004|After Controlled Period|Death|0|||
170854552|NCT01090427|617475550|FG005|After Controlled Period|Death|1|||
170854553|NCT01090427|617475551|FG006|After Controlled Period|Death|0|||
170854554|NCT01090427|617475545|FG000|After Controlled Period|Lack of Efficacy|0|||
170854555|NCT01090427|617475546|FG001|After Controlled Period|Lack of Efficacy|0|||
170854556|NCT01090427|617475547|FG002|After Controlled Period|Lack of Efficacy|0|||
170854557|NCT01090427|617475548|FG003|After Controlled Period|Lack of Efficacy|0|||
170854558|NCT01090427|617475549|FG004|After Controlled Period|Lack of Efficacy|0|||
170854559|NCT01090427|617475550|FG005|After Controlled Period|Lack of Efficacy|3|||
170854560|NCT01090427|617475551|FG006|After Controlled Period|Lack of Efficacy|2|||
170854561|NCT01090427|617475545|FG000|After Controlled Period|Adverse Event|0|||
170854562|NCT01090427|617475546|FG001|After Controlled Period|Adverse Event|0|||
170854563|NCT01090427|617475547|FG002|After Controlled Period|Adverse Event|0|||
170854564|NCT01090427|617475548|FG003|After Controlled Period|Adverse Event|2|||
170854565|NCT01090427|617475549|FG004|After Controlled Period|Adverse Event|0|||
170854566|NCT01090427|617475550|FG005|After Controlled Period|Adverse Event|1|||
170854567|NCT01090427|617475551|FG006|After Controlled Period|Adverse Event|0|||
170854568|NCT00895154|617475552|FG000|Overall Study|Lost to Follow-up|1|||
170854569|NCT00895154|617475553|FG001|Overall Study|Lost to Follow-up|1|||
170854570|NCT00895154|617475552|FG000|Overall Study|Withdrawal by Subject|0|||
170854571|NCT00895154|617475553|FG001|Overall Study|Withdrawal by Subject|1|||
170854572|NCT01465347|617475554|FG000|Overall Study|Withdrawal by Subject|1|||
170854573|NCT01465347|617475555|FG001|Overall Study|Withdrawal by Subject|1|||
170854574|NCT01465347|617475554|FG000|Overall Study|Physician Decision|0|||
170854575|NCT01465347|617475555|FG001|Overall Study|Physician Decision|1|||
170854576|NCT01465347|617475554|FG000|Overall Study|Admitted to hospice|0|||
170854577|NCT01465347|617475555|FG001|Overall Study|Admitted to hospice|1|||
170854578|NCT00906945|617475556|FG000|Overall Study|Found to be not eligible|0|||
170854579|NCT00906945|617475557|FG001|Overall Study|Found to be not eligible|0|||
170854580|NCT00906945|617475558|FG002|Overall Study|Found to be not eligible|0|||
170854581|NCT00906945|617475559|FG003|Overall Study|Found to be not eligible|1|||
170854582|NCT00906945|617475560|FG004|Overall Study|Found to be not eligible|1|||
170854583|NCT00906945|617475561|FG005|Overall Study|Found to be not eligible|1|||
170854584|NCT00906945|617475556|FG000|Overall Study|Physician Decision|0|||
170854585|NCT00906945|617475557|FG001|Overall Study|Physician Decision|0|||
170854586|NCT00906945|617475558|FG002|Overall Study|Physician Decision|0|||
170854587|NCT00906945|617475559|FG003|Overall Study|Physician Decision|0|||
170854588|NCT00906945|617475560|FG004|Overall Study|Physician Decision|0|||
170854589|NCT00906945|617475561|FG005|Overall Study|Physician Decision|1|||
170854590|NCT04493502|617475562|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
170854591|NCT04493502|617475563|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
170854592|NCT04493502|617475562|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
170854593|NCT04493502|617475563|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
170854594|NCT04493502|617475562|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
170854595|NCT04493502|617475563|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
170854596|NCT04493502|617475562|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
170854597|NCT04493502|617475563|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
170854598|NCT04493502|617475562|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
170854599|NCT04493502|617475563|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
170854600|NCT04493502|617475562|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
170854601|NCT04493502|617475563|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
170854602|NCT04493502|617475562|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
170854603|NCT04493502|617475563|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
170854604|NCT04493502|617475562|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
170854605|NCT04493502|617475563|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
170854606|NCT04493502|617475562|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
170854607|NCT04493502|617475563|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
170854608|NCT04493502|617475562|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
170854609|NCT04493502|617475563|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
170854610|NCT04493502|617475562|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
170854611|NCT04493502|617475563|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
170854612|NCT04493502|617475562|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
170854613|NCT04493502|617475563|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
170854614|NCT04493502|617475562|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
170854615|NCT04493502|617475563|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
170854616|NCT01853644|617475564|FG000|Registration and Treatment Start|Did not start treatment|1|||
170854617|NCT01853644|617475564|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
170854618|NCT01853644|617475564|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
170854619|NCT01853644|617475564|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
170854620|NCT01853644|617475564|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
170742691|NCT01407354|617064304|FG001|First Intervention|Physician Decision|0|||
170742692|NCT01036022|617064305|FG000|Overall Study|Adverse Event|1|||
170742693|NCT01036022|617064306|FG001|Overall Study|Adverse Event|3|||
170742694|NCT01036022|617064307|FG002|Overall Study|Adverse Event|2|||
170742695|NCT01036022|617064308|FG003|Overall Study|Adverse Event|1|||
170742696|NCT01036022|617064309|FG004|Overall Study|Adverse Event|0|||
170742697|NCT01036022|617064310|FG005|Overall Study|Adverse Event|2|||
170742698|NCT01036022|617064305|FG000|Overall Study|Lack of Efficacy|1|||
170742699|NCT01036022|617064306|FG001|Overall Study|Lack of Efficacy|1|||
170742700|NCT01036022|617064307|FG002|Overall Study|Lack of Efficacy|1|||
170854621|NCT01853644|617475564|FG000|Continued Treatment After First Response|Adverse Event|2|||
170854622|NCT01853644|617475564|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
170854623|NCT02891408|617475565|FG000|Overall Study|Lost to Follow-up|0|||
170854624|NCT02891408|617475566|FG001|Overall Study|Lost to Follow-up|0|||
170854625|NCT02891408|617475567|FG002|Overall Study|Lost to Follow-up|1|||
170854626|NCT02891408|617475568|FG003|Overall Study|Lost to Follow-up|0|||
170854627|NCT02891408|617475569|FG004|Overall Study|Lost to Follow-up|0|||
170854628|NCT02891408|617475570|FG005|Overall Study|Lost to Follow-up|0|||
170854629|NCT02891408|617475571|FG006|Overall Study|Lost to Follow-up|0|||
170854630|NCT02891837|617475572|FG000|Overall Study|Lost to Follow-up|2|||
170854631|NCT02891837|617475573|FG001|Overall Study|Lost to Follow-up|0|||
170854632|NCT02891837|617475572|FG000|Overall Study|Withdrawal by Subject|1|||
170854633|NCT02891837|617475573|FG001|Overall Study|Withdrawal by Subject|0|||
170854634|NCT00296400|617475580|FG000|Overall Study|Adverse Event|7|||
170854635|NCT00296400|617475581|FG001|Overall Study|Adverse Event|7|||
170854636|NCT00296400|617475582|FG002|Overall Study|Adverse Event|7|||
170854637|NCT00296400|617475580|FG000|Overall Study|Withdrawal by Subject|5|||
170854638|NCT00296400|617475581|FG001|Overall Study|Withdrawal by Subject|6|||
170854639|NCT00296400|617475582|FG002|Overall Study|Withdrawal by Subject|2|||
170854640|NCT00296400|617475580|FG000|Overall Study|Incorrect enrollment|2|||
170854641|NCT00296400|617475581|FG001|Overall Study|Incorrect enrollment|0|||
170854642|NCT00296400|617475582|FG002|Overall Study|Incorrect enrollment|0|||
170854643|NCT00296400|617475580|FG000|Overall Study|Protocol Violation|1|||
170854644|NCT00296400|617475581|FG001|Overall Study|Protocol Violation|1|||
170854645|NCT00296400|617475582|FG002|Overall Study|Protocol Violation|1|||
170854646|NCT00296400|617475580|FG000|Overall Study|Lost to Follow-up|1|||
170854647|NCT00296400|617475581|FG001|Overall Study|Lost to Follow-up|1|||
170854648|NCT00296400|617475582|FG002|Overall Study|Lost to Follow-up|2|||
170854649|NCT00296400|617475580|FG000|Overall Study|Study specific discontinuation criteria|0|||
170854650|NCT00296400|617475581|FG001|Overall Study|Study specific discontinuation criteria|0|||
170854651|NCT00296400|617475582|FG002|Overall Study|Study specific discontinuation criteria|1|||
170854652|NCT00296400|617475580|FG000|Overall Study|Visit 10 was performed earlier|0|||
170854653|NCT00296400|617475581|FG001|Overall Study|Visit 10 was performed earlier|1|||
170854654|NCT00296400|617475582|FG002|Overall Study|Visit 10 was performed earlier|0|||
170854655|NCT00296400|617475580|FG000|Overall Study|Pregnancy|1|||
170854656|NCT00296400|617475581|FG001|Overall Study|Pregnancy|2|||
170854657|NCT00296400|617475582|FG002|Overall Study|Pregnancy|0|||
170854658|NCT02433340|617475583|FG000|Overall Study|Adverse Event|0|||
170854659|NCT02433340|617475584|FG001|Overall Study|Adverse Event|0|||
170854660|NCT02433340|617475585|FG002|Overall Study|Adverse Event|1|||
170854661|NCT02433340|617475586|FG003|Overall Study|Adverse Event|0|||
170854662|NCT02433340|617475583|FG000|Overall Study|Withdrawal by Subject|1|||
170854663|NCT02433340|617475584|FG001|Overall Study|Withdrawal by Subject|0|||
170854664|NCT02433340|617475585|FG002|Overall Study|Withdrawal by Subject|1|||
170854665|NCT02433340|617475586|FG003|Overall Study|Withdrawal by Subject|2|||
170854666|NCT02433340|617475583|FG000|Overall Study|Lost to Follow-up|0|||
170854667|NCT02433340|617475584|FG001|Overall Study|Lost to Follow-up|1|||
170854668|NCT02433340|617475585|FG002|Overall Study|Lost to Follow-up|0|||
170854669|NCT02433340|617475586|FG003|Overall Study|Lost to Follow-up|0|||
170854670|NCT02433340|617475583|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
170854671|NCT02433340|617475584|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
170854672|NCT02433340|617475585|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
170854673|NCT02433340|617475586|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
170854674|NCT02433340|617475583|FG000|Overall Study|Other|0|||
170854675|NCT02433340|617475584|FG001|Overall Study|Other|1|||
170854676|NCT02433340|617475585|FG002|Overall Study|Other|0|||
170854677|NCT02433340|617475586|FG003|Overall Study|Other|0|||
170854678|NCT02859324|617475587|FG000|Overall Study|Death|4|||
170854679|NCT02859324|617475588|FG001|Overall Study|Death|6|||
170854680|NCT02859324|617475589|FG002|Overall Study|Death|5|||
170854681|NCT02859324|617475587|FG000|Overall Study|Other reasons|3|||
170854682|NCT02859324|617475588|FG001|Overall Study|Other reasons|3|||
170854683|NCT02859324|617475589|FG002|Overall Study|Other reasons|0|||
170854684|NCT02665338|617475590|FG000|Overall Study|Withdrawal by Subject|0|||
170854685|NCT02665338|617475591|FG001|Overall Study|Withdrawal by Subject|1|||
170854686|NCT00998335|617475592|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
170854687|NCT00998335|617475593|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
170854688|NCT05326815|617475595|FG000|Overall Study|Withdrawal by Subject|3|||
170854689|NCT05326815|617475595|FG000|Overall Study|Did not complete required labs|6|||
170854690|NCT05326815|617475595|FG000|Overall Study|Screen fail- abnormal labs|5|||
170854691|NCT03798691|617475596|FG000|Overall Study|Lost to Follow-up|2|||
170854692|NCT03798691|617475597|FG001|Overall Study|Lost to Follow-up|2|||
170854693|NCT00925353|617475609|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
170854694|NCT00729378|617477836|FG000|Baseline|Did not complete study measurements|72|||
170854695|NCT00729378|617477837|FG001|Baseline|Did not complete study measurements|33|||
170854696|NCT00729378|617477836|FG000|Baseline|Withdrawal by Subject|66|||
170854697|NCT00729378|617477837|FG001|Baseline|Withdrawal by Subject|59|||
170742701|NCT01036022|617064308|FG003|Overall Study|Lack of Efficacy|0|||
170742702|NCT01036022|617064309|FG004|Overall Study|Lack of Efficacy|1|||
170742703|NCT01036022|617064310|FG005|Overall Study|Lack of Efficacy|1|||
170742704|NCT01036022|617064305|FG000|Overall Study|Physician Decision|0|||
170742705|NCT01036022|617064306|FG001|Overall Study|Physician Decision|0|||
170742706|NCT01036022|617064307|FG002|Overall Study|Physician Decision|1|||
170742707|NCT01036022|617064308|FG003|Overall Study|Physician Decision|0|||
170742708|NCT01036022|617064309|FG004|Overall Study|Physician Decision|0|||
170742709|NCT01036022|617064310|FG005|Overall Study|Physician Decision|0|||
170742710|NCT01036022|617064305|FG000|Overall Study|Withdrawal by Subject|0|||
170742711|NCT01036022|617064306|FG001|Overall Study|Withdrawal by Subject|0|||
170742712|NCT01036022|617064307|FG002|Overall Study|Withdrawal by Subject|0|||
170742713|NCT01036022|617064308|FG003|Overall Study|Withdrawal by Subject|1|||
170742714|NCT01036022|617064309|FG004|Overall Study|Withdrawal by Subject|2|||
170742715|NCT01036022|617064310|FG005|Overall Study|Withdrawal by Subject|0|||
170742716|NCT02487095|617064312|FG000|Dose Expansion|Unable to scan/restage participant|0|||
170742717|NCT02487095|617064313|FG001|Dose Expansion|Unable to scan/restage participant|0|||
170742718|NCT02487095|617064314|FG002|Dose Expansion|Unable to scan/restage participant|0|||
170742719|NCT02487095|617064315|FG003|Dose Expansion|Unable to scan/restage participant|0|||
170742720|NCT02487095|617064316|FG004|Dose Expansion|Unable to scan/restage participant|1|||
170742721|NCT01435655|617064319|FG000|Overall Study|Death|2|||
170742722|NCT01435655|617064319|FG000|Overall Study|Other|1|||
170742723|NCT02395133|617064320|FG000|Overall Study|Adverse Event|4|||
170742724|NCT02395133|617064321|FG001|Overall Study|Adverse Event|1|||
170742725|NCT02395133|617064322|FG002|Overall Study|Adverse Event|3|||
170742726|NCT02395133|617064323|FG003|Overall Study|Adverse Event|0|||
170742727|NCT02395133|617064320|FG000|Overall Study|Lack of Efficacy|1|||
170742728|NCT02395133|617064321|FG001|Overall Study|Lack of Efficacy|0|||
170742729|NCT02395133|617064322|FG002|Overall Study|Lack of Efficacy|1|||
170742730|NCT02395133|617064323|FG003|Overall Study|Lack of Efficacy|1|||
170742731|NCT02395133|617064320|FG000|Overall Study|Protocol Violation|1|||
170742732|NCT02395133|617064321|FG001|Overall Study|Protocol Violation|1|||
170742733|NCT02395133|617064322|FG002|Overall Study|Protocol Violation|0|||
170742734|NCT02395133|617064323|FG003|Overall Study|Protocol Violation|3|||
170742735|NCT02395133|617064320|FG000|Overall Study|Lost to Follow-up|0|||
170742736|NCT02395133|617064321|FG001|Overall Study|Lost to Follow-up|1|||
170742737|NCT02395133|617064322|FG002|Overall Study|Lost to Follow-up|1|||
170742738|NCT02395133|617064323|FG003|Overall Study|Lost to Follow-up|0|||
170742739|NCT02395133|617064320|FG000|Overall Study|Pregnancy|0|||
170742740|NCT02395133|617064321|FG001|Overall Study|Pregnancy|0|||
170742741|NCT02395133|617064322|FG002|Overall Study|Pregnancy|3|||
170742742|NCT02395133|617064323|FG003|Overall Study|Pregnancy|0|||
170742743|NCT02395133|617064320|FG000|Overall Study|Consent withdrawn with no reason given|1|||
170742744|NCT02395133|617064321|FG001|Overall Study|Consent withdrawn with no reason given|3|||
170742745|NCT02395133|617064322|FG002|Overall Study|Consent withdrawn with no reason given|0|||
170742746|NCT02395133|617064323|FG003|Overall Study|Consent withdrawn with no reason given|2|||
170742747|NCT02395133|617064320|FG000|Overall Study|Consent withdrawn with personal reason|0|||
170742748|NCT02395133|617064321|FG001|Overall Study|Consent withdrawn with personal reason|1|||
170742749|NCT02395133|617064322|FG002|Overall Study|Consent withdrawn with personal reason|0|||
170742750|NCT02395133|617064323|FG003|Overall Study|Consent withdrawn with personal reason|3|||
170742751|NCT02395133|617064320|FG000|Overall Study|Sponsor decision|2|||
170742752|NCT02395133|617064321|FG001|Overall Study|Sponsor decision|0|||
170742753|NCT02395133|617064322|FG002|Overall Study|Sponsor decision|0|||
170742754|NCT02395133|617064323|FG003|Overall Study|Sponsor decision|1|||
170742755|NCT02395133|617064320|FG000|Overall Study|Other than specified above|5|||
170742756|NCT02395133|617064321|FG001|Overall Study|Other than specified above|2|||
170742757|NCT02395133|617064322|FG002|Overall Study|Other than specified above|2|||
170742758|NCT02395133|617064323|FG003|Overall Study|Other than specified above|4|||
170742759|NCT00510458|617064326|FG000|Overall Study|5 year not evaluable/missed|21|||
170742760|NCT00510458|617064326|FG000|Overall Study|Death|1|||
170742761|NCT00510458|617064326|FG000|Overall Study|Terminated|14|||
170742762|NCT00510458|617064326|FG000|Overall Study|Lost to Follow-up|6|||
170742763|NCT00510458|617064326|FG000|Overall Study|Withdrawal by Subject|3|||
170742764|NCT00510458|617064326|FG000|Overall Study|Revision|2|||
170742765|NCT02946918|617064327|FG000|Overall Study|Patient unblinded himself|1|||
170742766|NCT02946918|617064328|FG001|Overall Study|Patient unblinded himself|0|||
170742767|NCT02946918|617064327|FG000|Overall Study|Physician Decision|0|||
170742768|NCT02946918|617064328|FG001|Overall Study|Physician Decision|2|||
170742769|NCT02946918|617064327|FG000|Overall Study|Ran out of study medication|0|||
170742770|NCT02946918|617064328|FG001|Overall Study|Ran out of study medication|1|||
170742771|NCT01555164|617064332|FG000|Overall Study|Adverse Event|5|||
170742772|NCT01555164|617064333|FG001|Overall Study|Adverse Event|7|||
170742773|NCT01555164|617064332|FG000|Overall Study|Hyperglycemia|0|||
170742774|NCT01555164|617064333|FG001|Overall Study|Hyperglycemia|1|||
170742775|NCT01555164|617064332|FG000|Overall Study|Investigator's Discretion|2|||
170742776|NCT01555164|617064333|FG001|Overall Study|Investigator's Discretion|2|||
170742777|NCT01555164|617064332|FG000|Overall Study|Lost to Follow-up|4|||
170742778|NCT01555164|617064333|FG001|Overall Study|Lost to Follow-up|3|||
170742779|NCT01555164|617064332|FG000|Overall Study|Protocol Violation|9|||
170742780|NCT01555164|617064333|FG001|Overall Study|Protocol Violation|5|||
170742781|NCT01555164|617064332|FG000|Overall Study|Subject Non-compliance|14|||
170742782|NCT01555164|617064333|FG001|Overall Study|Subject Non-compliance|6|||
170742783|NCT01555164|617064332|FG000|Overall Study|Subject Withdrew Consent|6|||
170742784|NCT01555164|617064333|FG001|Overall Study|Subject Withdrew Consent|11|||
170742785|NCT00886639|617064334|FG000|Overall Study|acute exacerbation|14|||
170742786|NCT00886639|617064334|FG000|Overall Study|non-compliance|2|||
170742787|NCT01302938|617064335|FG000|Overall Study|Withdrawal by Subject|1|||
170854698|NCT00729378|617477836|FG000|12-months|Lost to Follow-up|100|||
170854699|NCT00729378|617477837|FG001|12-months|Lost to Follow-up|65|||
170854700|NCT00729378|617477836|FG000|24-months|Lost to Follow-up|72|||
170854701|NCT00729378|617477837|FG001|24-months|Lost to Follow-up|51|||
170854702|NCT00729378|617477836|FG000|36-months|Lost to Follow-up|15|||
170854703|NCT00729378|617477837|FG001|36-months|Lost to Follow-up|6|||
170854704|NCT01586910|617477838|FG000|Overall Study|Death|4|||
170854705|NCT01586910|617477839|FG001|Overall Study|Death|4|||
170854706|NCT01586910|617477838|FG000|Overall Study|Withdrawal by Subject|6|||
170854707|NCT01586910|617477839|FG001|Overall Study|Withdrawal by Subject|43|||
170854708|NCT01586910|617477838|FG000|Overall Study|Physician withdrew Subject|5|||
170854709|NCT01586910|617477839|FG001|Overall Study|Physician withdrew Subject|24|||
170854710|NCT01328717|617477840|FG000|Overall Study|Adverse Event|1|||
170854711|NCT00346268|617477841|FG000|Overall Study|Adverse Event|1|||
170854712|NCT00346268|617477842|FG001|Overall Study|Adverse Event|0|||
170854713|NCT00346268|617477841|FG000|Overall Study|Protocol Violation|1|||
170854714|NCT00346268|617477842|FG001|Overall Study|Protocol Violation|0|||
170854715|NCT00346268|617477841|FG000|Overall Study|Participant refused|0|||
170854716|NCT00346268|617477842|FG001|Overall Study|Participant refused|3|||
170854717|NCT00192647|617477847|FG000|Overall Study|Death|1|||
170854718|NCT00192647|617477848|FG001|Overall Study|Death|1|||
170854719|NCT00192647|617477847|FG000|Overall Study|Adverse Event|35|||
170854720|NCT00192647|617477848|FG001|Overall Study|Adverse Event|29|||
170854721|NCT00192647|617477847|FG000|Overall Study|Laboratory Test Abnormality|4|||
170854722|NCT00192647|617477848|FG001|Overall Study|Laboratory Test Abnormality|2|||
170854723|NCT00192647|617477847|FG000|Overall Study|Insufficient Therapeutic Response|53|||
170854724|NCT00192647|617477848|FG001|Overall Study|Insufficient Therapeutic Response|83|||
170854725|NCT00192647|617477847|FG000|Overall Study|Entry Criteria Violation|6|||
170854726|NCT00192647|617477848|FG001|Overall Study|Entry Criteria Violation|6|||
170854727|NCT00192647|617477847|FG000|Overall Study|Protocol Violation|3|||
170854728|NCT00192647|617477848|FG001|Overall Study|Protocol Violation|1|||
170854729|NCT00192647|617477847|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
170854730|NCT00192647|617477848|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
170854731|NCT00192647|617477847|FG000|Overall Study|Failure to Return|11|||
170854732|NCT00192647|617477848|FG001|Overall Study|Failure to Return|13|||
170854733|NCT00192647|617477847|FG000|Overall Study|Other/Administrative|5|||
170854734|NCT00192647|617477848|FG001|Overall Study|Other/Administrative|3|||
170854735|NCT05081388|617477849|FG000|Overall Study|Adverse Event|1|||
170854736|NCT05081388|617477850|FG001|Overall Study|Adverse Event|0|||
170854737|NCT05081388|617477851|FG002|Overall Study|Adverse Event|0|||
170854738|NCT05081388|617477852|FG003|Overall Study|Adverse Event|0|||
170854739|NCT05081388|617477853|FG004|Overall Study|Adverse Event|0|||
170854740|NCT05081388|617477849|FG000|Overall Study|Lost to Follow-up|0|||
170854741|NCT05081388|617477850|FG001|Overall Study|Lost to Follow-up|1|||
170854742|NCT05081388|617477851|FG002|Overall Study|Lost to Follow-up|0|||
170854743|NCT05081388|617477852|FG003|Overall Study|Lost to Follow-up|0|||
170854744|NCT05081388|617477853|FG004|Overall Study|Lost to Follow-up|0|||
170854745|NCT05081388|617477849|FG000|Overall Study|Subject decision|0|||
170854746|NCT05081388|617477850|FG001|Overall Study|Subject decision|0|||
170854747|NCT05081388|617477851|FG002|Overall Study|Subject decision|0|||
170854748|NCT05081388|617477852|FG003|Overall Study|Subject decision|1|||
170854749|NCT05081388|617477853|FG004|Overall Study|Subject decision|0|||
170854750|NCT00738582|617477855|FG000|Combination Therapy|Completed Combination Therapy|1|||
170854751|NCT00738582|617477856|FG001|Combination Therapy|Completed Combination Therapy|0|||
170854752|NCT00738582|617477855|FG000|Combination Therapy|Physician Decision|1|||
170854753|NCT00738582|617477856|FG001|Combination Therapy|Physician Decision|0|||
170854754|NCT00738582|617477855|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
170854755|NCT00738582|617477856|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
170854756|NCT00738582|617477855|FG000|Combination Therapy|Other|5|||
170854757|NCT00738582|617477856|FG001|Combination Therapy|Other|0|||
170854758|NCT00738582|617477855|FG000|Combination Therapy|Adverse Event|16|||
170742788|NCT01302938|617064336|FG001|Overall Study|Withdrawal by Subject|0|||
170742789|NCT01302938|617064335|FG000|Overall Study|Adverse Event|1|||
170742790|NCT01302938|617064336|FG001|Overall Study|Adverse Event|0|||
170742791|NCT03443713|617064338|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
170742792|NCT03443713|617064339|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
170854759|NCT00738582|617477856|FG001|Combination Therapy|Adverse Event|0|||
170742793|NCT03443713|617064340|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
170742794|NCT00524030|617064344|FG000|Overall Study|Lack of Efficacy|10|||
170742795|NCT00524030|617064345|FG001|Overall Study|Lack of Efficacy|24|||
170742796|NCT00524030|617064344|FG000|Overall Study|Lost to Follow-up|0|||
170742797|NCT00524030|617064345|FG001|Overall Study|Lost to Follow-up|2|||
170742798|NCT00524030|617064344|FG000|Overall Study|Withdrawal by Subject|3|||
170742799|NCT00524030|617064345|FG001|Overall Study|Withdrawal by Subject|8|||
170742800|NCT00524030|617064344|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
170742801|NCT00524030|617064345|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
170742802|NCT00524030|617064344|FG000|Overall Study|Protocol Violation|0|||
170742803|NCT00524030|617064345|FG001|Overall Study|Protocol Violation|1|||
170742804|NCT00524030|617064344|FG000|Overall Study|Pregnancy|1|||
170742805|NCT00524030|617064345|FG001|Overall Study|Pregnancy|0|||
170742806|NCT00524030|617064344|FG000|Overall Study|Adverse Event|3|||
170742807|NCT00524030|617064345|FG001|Overall Study|Adverse Event|21|||
170742808|NCT00524030|617064344|FG000|Overall Study|Death|0|||
170742809|NCT00524030|617064345|FG001|Overall Study|Death|1|||
170742810|NCT03315130|617064346|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
170742811|NCT03315130|617064347|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
170742812|NCT03315130|617064348|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
170742813|NCT03315130|617064349|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
170742814|NCT03315130|617064346|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
170742815|NCT03315130|617064347|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
170742816|NCT03315130|617064348|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
170742817|NCT03315130|617064349|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
170742818|NCT03315130|617064346|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
170742819|NCT03315130|617064347|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
170742820|NCT03315130|617064348|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
170742821|NCT03315130|617064349|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
170742822|NCT03315130|617064346|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
170742823|NCT03315130|617064347|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
170742824|NCT03315130|617064348|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
170742825|NCT03315130|617064349|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
170742826|NCT03315130|617064346|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
170742827|NCT03315130|617064347|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
170742828|NCT03315130|617064348|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
170742829|NCT03315130|617064349|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
170742830|NCT03315130|617064346|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
170742831|NCT03315130|617064347|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
170742832|NCT03315130|617064348|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
170742833|NCT03315130|617064349|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
170742834|NCT04398537|617064350|FG000|Overall Study|Physician Decision|10|||
170742835|NCT04398537|617064351|FG001|Overall Study|Physician Decision|15|||
170742836|NCT00118898|617064352|FG000|Overall Study|Death|6|||
170742837|NCT00118898|617064353|FG001|Overall Study|Death|11|||
170742838|NCT00118898|617064354|FG002|Overall Study|Death|6|||
170742839|NCT00118898|617064355|FG003|Overall Study|Death|8|||
170742840|NCT00118898|617064352|FG000|Overall Study|Lost to Follow-up|26|||
170742841|NCT00118898|617064353|FG001|Overall Study|Lost to Follow-up|34|||
170742842|NCT00118898|617064354|FG002|Overall Study|Lost to Follow-up|33|||
170742843|NCT00118898|617064355|FG003|Overall Study|Lost to Follow-up|33|||
170742844|NCT00118898|617064352|FG000|Overall Study|Withdrawal by Subject|10|||
170742845|NCT00118898|617064353|FG001|Overall Study|Withdrawal by Subject|5|||
170742846|NCT00118898|617064354|FG002|Overall Study|Withdrawal by Subject|8|||
170854760|NCT00738582|617477855|FG000|Combination Therapy|Progressive Disease|9|||
170854761|NCT00738582|617477856|FG001|Combination Therapy|Progressive Disease|0|||
170854762|NCT00738582|617477855|FG000|Maintenance Therapy|Other|0|||
170854763|NCT00738582|617477856|FG001|Maintenance Therapy|Other|2|||
170854764|NCT00738582|617477855|FG000|Maintenance Therapy|Adverse Event|0|||
170854765|NCT00738582|617477856|FG001|Maintenance Therapy|Adverse Event|6|||
170854766|NCT00738582|617477855|FG000|Maintenance Therapy|Progressive Disease|0|||
170854767|NCT00738582|617477856|FG001|Maintenance Therapy|Progressive Disease|47|||
170854768|NCT00738582|617477855|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
170854769|NCT00738582|617477856|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
170854770|NCT03718533|617477857|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
170854771|NCT03718533|617477857|FG000|Overall Study|Protocol deviation|1|||
170854772|NCT03718533|617477857|FG000|Overall Study|Disease progression|1|||
170742847|NCT00118898|617064355|FG003|Overall Study|Withdrawal by Subject|8|||
170742848|NCT00118898|617064352|FG000|Overall Study|Site Closure|33|||
170742849|NCT00118898|617064353|FG001|Overall Study|Site Closure|31|||
170854773|NCT03718533|617477857|FG000|Overall Study|Relapse|1|||
170854774|NCT03718533|617477857|FG000|Overall Study|Physician Decision|2|||
170854775|NCT03718533|617477857|FG000|Overall Study|Physician Decision and Adverse Event|1|||
170854776|NCT01774487|617477860|FG000|Overall Study|Did not tolerate taste|4|||
170854777|NCT01774487|617477861|FG001|Overall Study|Did not tolerate taste|4|||
170854778|NCT00918580|617477862|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
170854779|NCT00918580|617477862|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
170854780|NCT00918580|617477862|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
170854781|NCT00918580|617477862|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
170854782|NCT00918580|617477862|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
170854783|NCT00918580|617477862|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
170854784|NCT00918580|617477862|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
170854785|NCT04275089|617477867|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
170854786|NCT01079663|617477870|FG000|Overall Study|Adverse Event|0|||
170854787|NCT01079663|617477871|FG001|Overall Study|Adverse Event|2|||
170854788|NCT01079663|617477870|FG000|Overall Study|Protocol Violation|0|||
170854789|NCT01079663|617477871|FG001|Overall Study|Protocol Violation|2|||
170854790|NCT01014143|617477872|FG000|Second Intervention|Lost to Follow-up|2|||
170854791|NCT01014143|617477873|FG001|Second Intervention|Lost to Follow-up|0|||
170854792|NCT01014143|617477874|FG002|Second Intervention|Lost to Follow-up|0|||
170854793|NCT01878214|617477878|FG000|Overall Study|Withdrawal by Subject|18|||
170854794|NCT01878214|617477879|FG001|Overall Study|Withdrawal by Subject|7|||
170854795|NCT01878214|617477878|FG000|Overall Study|Death|0|||
170854796|NCT01878214|617477879|FG001|Overall Study|Death|1|||
170854797|NCT01878214|617477878|FG000|Overall Study|Lost to Follow-up|35|||
170854798|NCT01878214|617477879|FG001|Overall Study|Lost to Follow-up|36|||
170854799|NCT00946101|617477880|FG000|Overall Study|Lost to Follow-up|2|||
170854800|NCT00946101|617477881|FG001|Overall Study|Lost to Follow-up|1|||
170854801|NCT00946101|617477880|FG000|Overall Study|Withdrawal of consent|2|||
170854802|NCT00946101|617477881|FG001|Overall Study|Withdrawal of consent|0|||
170854803|NCT00946101|617477880|FG000|Overall Study|Physician Decision|0|||
170854804|NCT00946101|617477881|FG001|Overall Study|Physician Decision|1|||
170854805|NCT02038543|617477882|FG000|Overall Study|Screen Failure|0|||
170854806|NCT02038543|617477883|FG001|Overall Study|Screen Failure|0|||
170854807|NCT02038543|617477884|FG002|Overall Study|Screen Failure|0|||
170854808|NCT02038543|617477885|FG003|Overall Study|Screen Failure|1|||
170854809|NCT02038543|617477882|FG000|Overall Study|Withdrawal by Subject|0|||
170854810|NCT02038543|617477883|FG001|Overall Study|Withdrawal by Subject|0|||
170854811|NCT02038543|617477884|FG002|Overall Study|Withdrawal by Subject|0|||
170854812|NCT02038543|617477885|FG003|Overall Study|Withdrawal by Subject|1|||
170854813|NCT02647866|617477886|FG000|Overall Study|Adverse Event|0|||
170854814|NCT02647866|617477887|FG001|Overall Study|Adverse Event|0|||
170854815|NCT02647866|617477888|FG002|Overall Study|Adverse Event|2|||
170854816|NCT02647866|617477889|FG003|Overall Study|Adverse Event|2|||
170854817|NCT02647866|617477890|FG004|Overall Study|Adverse Event|1|||
170854818|NCT02647866|617477886|FG000|Overall Study|Disease Worsening|3|||
170854819|NCT02647866|617477887|FG001|Overall Study|Disease Worsening|1|||
170854820|NCT02647866|617477888|FG002|Overall Study|Disease Worsening|0|||
170854821|NCT02647866|617477889|FG003|Overall Study|Disease Worsening|0|||
170854822|NCT02647866|617477890|FG004|Overall Study|Disease Worsening|1|||
170854823|NCT02647866|617477886|FG000|Overall Study|Withdrawal by Subject|1|||
170854824|NCT02647866|617477887|FG001|Overall Study|Withdrawal by Subject|1|||
170854825|NCT02647866|617477888|FG002|Overall Study|Withdrawal by Subject|2|||
170854826|NCT02647866|617477889|FG003|Overall Study|Withdrawal by Subject|4|||
170854827|NCT02647866|617477890|FG004|Overall Study|Withdrawal by Subject|4|||
170854828|NCT02647866|617477886|FG000|Overall Study|Physician Decision|0|||
170854829|NCT02647866|617477887|FG001|Overall Study|Physician Decision|1|||
170854830|NCT02647866|617477888|FG002|Overall Study|Physician Decision|1|||
170854831|NCT02647866|617477889|FG003|Overall Study|Physician Decision|0|||
170854832|NCT02647866|617477890|FG004|Overall Study|Physician Decision|2|||
170854833|NCT02647866|617477886|FG000|Overall Study|Death|0|||
170854834|NCT02647866|617477887|FG001|Overall Study|Death|1|||
170854835|NCT02647866|617477888|FG002|Overall Study|Death|0|||
170854836|NCT02647866|617477889|FG003|Overall Study|Death|0|||
170854837|NCT02647866|617477890|FG004|Overall Study|Death|0|||
170854838|NCT02647866|617477886|FG000|Overall Study|Subject moved to different country|1|||
170854839|NCT02647866|617477887|FG001|Overall Study|Subject moved to different country|0|||
170854840|NCT02647866|617477888|FG002|Overall Study|Subject moved to different country|0|||
170854841|NCT02647866|617477889|FG003|Overall Study|Subject moved to different country|0|||
170854842|NCT02647866|617477890|FG004|Overall Study|Subject moved to different country|0|||
170854843|NCT03406260|617477891|FG000|Period 1|Adverse Event|0|||
170854844|NCT03406260|617477892|FG001|Period 1|Adverse Event|0|||
170854845|NCT03406260|617477893|FG002|Period 1|Adverse Event|0|||
170854846|NCT03406260|617477894|FG003|Period 1|Adverse Event|0|||
170854847|NCT03406260|617477895|FG004|Period 1|Adverse Event|1|||
170854848|NCT03406260|617477896|FG005|Period 1|Adverse Event|0|||
170854849|NCT02313233|617477897|FG000|Overall Study|Withdrawal by Subject|1|||
170742850|NCT00118898|617064354|FG002|Overall Study|Site Closure|28|||
170742851|NCT00118898|617064355|FG003|Overall Study|Site Closure|37|||
170742852|NCT00118898|617064352|FG000|Overall Study|Severe debilitation|1|||
170742853|NCT00118898|617064353|FG001|Overall Study|Severe debilitation|4|||
170742854|NCT00118898|617064354|FG002|Overall Study|Severe debilitation|6|||
170742855|NCT00118898|617064355|FG003|Overall Study|Severe debilitation|4|||
170854850|NCT02313233|617477898|FG001|Overall Study|Withdrawal by Subject|2|||
170854851|NCT02313233|617477897|FG000|Overall Study|Administrative reason|1|||
170854852|NCT02313233|617477898|FG001|Overall Study|Administrative reason|1|||
170854853|NCT06377488|617477899|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
170854854|NCT06377488|617477899|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
170854855|NCT06377488|617477899|FG000|Overall Study|Protocol Violation|1|||
170854856|NCT06377488|617477899|FG000|Overall Study|Lost to Follow-up|1|||
170854857|NCT06377488|617477899|FG000|Overall Study|Incorrect Lens Dispensed|2|||
170854858|NCT04745026|617477902|FG000|Overall Study|Physician Decision|1|||
170854859|NCT04745026|617477903|FG001|Overall Study|Physician Decision|0|||
170854860|NCT04745026|617477902|FG000|Overall Study|Adverse Event|2|||
170854861|NCT04745026|617477903|FG001|Overall Study|Adverse Event|2|||
170854862|NCT04745026|617477902|FG000|Overall Study|Protocol Violation|1|||
170854863|NCT04745026|617477903|FG001|Overall Study|Protocol Violation|3|||
170854864|NCT04745026|617477902|FG000|Overall Study|Lost to Follow-up|4|||
170854865|NCT04745026|617477903|FG001|Overall Study|Lost to Follow-up|3|||
170854866|NCT04745026|617477902|FG000|Overall Study|Withdrawal by Subject|5|||
170854867|NCT04745026|617477903|FG001|Overall Study|Withdrawal by Subject|5|||
170854868|NCT05478499|617477906|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
170854869|NCT05478499|617477907|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
170854870|NCT05478499|617477906|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
170854871|NCT05478499|617477907|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
170854872|NCT05478499|617477906|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
170854873|NCT05478499|617477907|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
170854874|NCT05478499|617477906|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
170854875|NCT05478499|617477907|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
170854876|NCT05478499|617477906|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
170854877|NCT05478499|617477907|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
170854878|NCT05478499|617477906|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
170854879|NCT05478499|617477907|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
170854880|NCT05478499|617477906|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
170854881|NCT05478499|617477907|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
170854882|NCT05478499|617477906|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
170854883|NCT05478499|617477907|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
170854884|NCT05478499|617477906|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
170854885|NCT05478499|617477907|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
170854886|NCT05478499|617477906|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
170854887|NCT05478499|617477907|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
170854888|NCT05478499|617477906|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
170854889|NCT05478499|617477907|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
170854890|NCT01076647|617477908|FG000|Overall Study|Adverse Event|4|||
170854891|NCT01076647|617477909|FG001|Overall Study|Adverse Event|1|||
170854892|NCT01076647|617477908|FG000|Overall Study|Lack of Efficacy|0|||
170854893|NCT01076647|617477909|FG001|Overall Study|Lack of Efficacy|1|||
170854894|NCT01076647|617477908|FG000|Overall Study|Protocol Violation|7|||
170854895|NCT01076647|617477909|FG001|Overall Study|Protocol Violation|9|||
170854896|NCT01076647|617477908|FG000|Overall Study|Withdrawal criteria|2|||
170854897|NCT01076647|617477909|FG001|Overall Study|Withdrawal criteria|2|||
170854898|NCT01076647|617477908|FG000|Overall Study|Unclassified|12|||
170854899|NCT01076647|617477909|FG001|Overall Study|Unclassified|12|||
170854900|NCT04426851|617477913|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
170854901|NCT04426851|617477914|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
170854902|NCT04426851|617477913|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
170854903|NCT04426851|617477914|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
170854904|NCT01656733|617477916|FG000|Overall Study|No permission to collect birth outcomes|0|||
170854905|NCT01656733|617477917|FG001|Overall Study|No permission to collect birth outcomes|1|||
170854906|NCT01656733|617477916|FG000|Overall Study|Delivery at another hospital|0|||
170854907|NCT01656733|617477917|FG001|Overall Study|Delivery at another hospital|2|||
170854908|NCT01656733|617477916|FG000|Overall Study|Spontaneous abortion|0|||
170854909|NCT01656733|617477917|FG001|Overall Study|Spontaneous abortion|1|||
170854910|NCT01415531|617477919|FG000|Overall Study|Adverse Event|7|||
170854911|NCT01415531|617477920|FG001|Overall Study|Adverse Event|10|||
170854912|NCT01415531|617477919|FG000|Overall Study|Lack of Efficacy|3|||
170854913|NCT01415531|617477920|FG001|Overall Study|Lack of Efficacy|2|||
170854914|NCT01415531|617477919|FG000|Overall Study|Protocol Violation|0|||
170854915|NCT01415531|617477920|FG001|Overall Study|Protocol Violation|1|||
170854916|NCT01415531|617477919|FG000|Overall Study|Withdrawal by Subject|5|||
170854917|NCT01415531|617477920|FG001|Overall Study|Withdrawal by Subject|4|||
170854918|NCT01415531|617477919|FG000|Overall Study|Lost to Follow-up|6|||
170854919|NCT01415531|617477920|FG001|Overall Study|Lost to Follow-up|14|||
170854920|NCT01415531|617477919|FG000|Overall Study|Lack of Compliance|1|||
170854921|NCT01415531|617477920|FG001|Overall Study|Lack of Compliance|4|||
170854922|NCT01415531|617477919|FG000|Overall Study|Other Reasons|3|||
170854923|NCT01415531|617477920|FG001|Overall Study|Other Reasons|2|||
170854924|NCT00262951|617477921|FG000|Overall Study|Progressive disease/relapse|3|||
170854925|NCT00262951|617477921|FG000|Overall Study|Adverse Event|7|||
170854926|NCT00262951|617477921|FG000|Overall Study|Death|1|||
170854927|NCT00262951|617477921|FG000|Overall Study|Withdrawal by Subject|1|||
170854928|NCT00262951|617477921|FG000|Overall Study|Alternative treatment|3|||
170854929|NCT00262951|617477921|FG000|Overall Study|Off treatment for other disease|1|||
170854930|NCT02962960|617477924|FG000|Overall Study|Withdrawal by Subject|1|||
170854931|NCT02962960|617477925|FG001|Overall Study|Withdrawal by Subject|1|||
170854932|NCT02962960|617477926|FG002|Overall Study|Withdrawal by Subject|0|||
170854933|NCT02962960|617477924|FG000|Overall Study|Adverse Event|1|||
170854934|NCT02962960|617477925|FG001|Overall Study|Adverse Event|1|||
170854935|NCT02962960|617477926|FG002|Overall Study|Adverse Event|0|||
170854936|NCT02962960|617477924|FG000|Overall Study|Protocol Violation|1|||
170854937|NCT02962960|617477925|FG001|Overall Study|Protocol Violation|0|||
170854938|NCT02962960|617477926|FG002|Overall Study|Protocol Violation|0|||
170854939|NCT01098097|617477927|FG000|Overall Study|Adverse Event|17|||
170854940|NCT01098097|617477927|FG000|Overall Study|Lost to Follow-up|18|||
170854941|NCT01098097|617477927|FG000|Overall Study|Status unknown|16|||
170854942|NCT01098097|617477927|FG000|Overall Study|No reason reported|31|||
170854943|NCT02084056|617477932|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
170854944|NCT02084056|617477933|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
170854945|NCT02084056|617477934|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
170854946|NCT02084056|617477935|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
170854947|NCT02084056|617477932|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
170854948|NCT02084056|617477933|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
170854949|NCT02084056|617477934|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
170854950|NCT02084056|617477935|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
170854951|NCT01488487|617477938|FG000|Overall Study|Adverse Event|6|||
170854952|NCT01488487|617477938|FG000|Overall Study|Death|1|||
170854953|NCT01488487|617477938|FG000|Overall Study|Withdrawal by Subject|2|||
170854954|NCT00395460|617477939|FG000|Overall Study|Withdrawal by Subject|1|||
170854955|NCT00395460|617477940|FG001|Overall Study|Withdrawal by Subject|0|||
170854956|NCT02319525|617477944|FG000|Overall Study|Withdrawal by Subject|2|||
170854957|NCT02319525|617477945|FG001|Overall Study|Withdrawal by Subject|1|||
170854958|NCT04860297|617477948|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
170854959|NCT04860297|617477949|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
170854960|NCT04860297|617477950|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
170854961|NCT04860297|617477951|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
170854962|NCT04860297|617477952|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
170854963|NCT04860297|617477953|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
170854964|NCT04860297|617477954|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
170854965|NCT04860297|617477955|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
170854966|NCT04860297|617477948|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
170854967|NCT04860297|617477949|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
170854968|NCT04860297|617477950|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
170854969|NCT04860297|617477951|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
170854970|NCT04860297|617477952|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
170854971|NCT04860297|617477953|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
170854972|NCT04860297|617477954|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
170854973|NCT04860297|617477955|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
170854974|NCT04860297|617477948|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
170854975|NCT04860297|617477949|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
170854976|NCT04860297|617477950|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
170854977|NCT04860297|617477951|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
170854978|NCT04860297|617477952|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
170854979|NCT04860297|617477953|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
170854980|NCT04860297|617477954|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
170854981|NCT04860297|617477955|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
170854982|NCT04860297|617477948|FG000|Part B (Booster Dose)|Other Than Specified|0|||
170854983|NCT04860297|617477949|FG001|Part B (Booster Dose)|Other Than Specified|0|||
170854984|NCT04860297|617477950|FG002|Part B (Booster Dose)|Other Than Specified|0|||
170854985|NCT04860297|617477951|FG003|Part B (Booster Dose)|Other Than Specified|0|||
170854986|NCT04860297|617477952|FG004|Part B (Booster Dose)|Other Than Specified|0|||
170854987|NCT04860297|617477953|FG005|Part B (Booster Dose)|Other Than Specified|1|||
170854988|NCT04860297|617477954|FG006|Part B (Booster Dose)|Other Than Specified|1|||
170854989|NCT04860297|617477955|FG007|Part B (Booster Dose)|Other Than Specified|0|||
170854990|NCT04860297|617477948|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
170854991|NCT04860297|617477949|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
170854992|NCT04860297|617477950|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
170854993|NCT04860297|617477951|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
170854994|NCT04860297|617477952|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
170854995|NCT04860297|617477953|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
170854996|NCT04860297|617477954|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
170854997|NCT04860297|617477955|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
170854998|NCT04860297|617477948|FG000|Part B (Booster Dose)|Death|0|||
170854999|NCT04860297|617477949|FG001|Part B (Booster Dose)|Death|0|||
170855000|NCT04860297|617477950|FG002|Part B (Booster Dose)|Death|0|||
170855001|NCT04860297|617477951|FG003|Part B (Booster Dose)|Death|0|||
170855002|NCT04860297|617477952|FG004|Part B (Booster Dose)|Death|1|||
170855003|NCT04860297|617477953|FG005|Part B (Booster Dose)|Death|2|||
170855004|NCT04860297|617477954|FG006|Part B (Booster Dose)|Death|1|||
170855005|NCT04860297|617477955|FG007|Part B (Booster Dose)|Death|0|||
170855006|NCT04860297|617477948|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
170855007|NCT04860297|617477949|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
170855008|NCT04860297|617477950|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
170855009|NCT04860297|617477951|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
170855010|NCT04860297|617477952|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
170855011|NCT04860297|617477953|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
170855012|NCT04860297|617477954|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
170855013|NCT04860297|617477955|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
170855014|NCT00324116|617477959|FG000|Overall Study|Adverse Event|5|||
170855015|NCT00324116|617477959|FG000|Overall Study|Lack of Efficacy|17|||
170855016|NCT00324116|617477959|FG000|Overall Study|Withdrawal by Subject|5|||
170855017|NCT00324116|617477959|FG000|Overall Study|Other|5|||
170855018|NCT01451827|617477960|FG000|Overall Study|Adverse Event|2|||
170855019|NCT01451827|617477961|FG001|Overall Study|Adverse Event|0|||
170855020|NCT01451827|617477962|FG002|Overall Study|Adverse Event|1|||
170855021|NCT01451827|617477963|FG003|Overall Study|Adverse Event|1|||
170855022|NCT01451827|617477960|FG000|Overall Study|Protocol deviation|1|||
170855023|NCT01451827|617477961|FG001|Overall Study|Protocol deviation|0|||
170855024|NCT01451827|617477962|FG002|Overall Study|Protocol deviation|0|||
170855025|NCT01451827|617477963|FG003|Overall Study|Protocol deviation|0|||
170855026|NCT01451827|617477960|FG000|Overall Study|Lost to Follow-up|0|||
170855027|NCT01451827|617477961|FG001|Overall Study|Lost to Follow-up|3|||
170855028|NCT01451827|617477962|FG002|Overall Study|Lost to Follow-up|0|||
170855029|NCT01451827|617477963|FG003|Overall Study|Lost to Follow-up|2|||
170855030|NCT01451827|617477960|FG000|Overall Study|Participant met withdrawal criteria|0|||
170855031|NCT01451827|617477961|FG001|Overall Study|Participant met withdrawal criteria|2|||
170855032|NCT01451827|617477962|FG002|Overall Study|Participant met withdrawal criteria|0|||
170855033|NCT01451827|617477963|FG003|Overall Study|Participant met withdrawal criteria|0|||
170855034|NCT01451827|617477960|FG000|Overall Study|Withdrawal by Subject|0|||
170855035|NCT01451827|617477961|FG001|Overall Study|Withdrawal by Subject|0|||
170855036|NCT01451827|617477962|FG002|Overall Study|Withdrawal by Subject|1|||
170855037|NCT01451827|617477963|FG003|Overall Study|Withdrawal by Subject|1|||
170855038|NCT01528345|617477964|FG000|Overall Study|Adverse Event|10|||
170855039|NCT01528345|617477965|FG001|Overall Study|Adverse Event|1|||
170855040|NCT01528345|617477964|FG000|Overall Study|Death|1|||
170855041|NCT01528345|617477965|FG001|Overall Study|Death|1|||
170855042|NCT01528345|617477964|FG000|Overall Study|Non-compliance with study treatment|1|||
170855043|NCT01528345|617477965|FG001|Overall Study|Non-compliance with study treatment|0|||
170855044|NCT01528345|617477964|FG000|Overall Study|Progressive Disease|26|||
170855045|NCT01528345|617477965|FG001|Overall Study|Progressive Disease|40|||
170855046|NCT01528345|617477964|FG000|Overall Study|Study Terminated by Sponsor|4|||
170855047|NCT01528345|617477965|FG001|Overall Study|Study Terminated by Sponsor|8|||
170855048|NCT01528345|617477964|FG000|Overall Study|Subject/Guardian Decision|5|||
170855049|NCT01528345|617477965|FG001|Overall Study|Subject/Guardian Decision|0|||
170855050|NCT02624791|617477966|FG000|Overall Study|Withdrawal by Subject|2|||
170855051|NCT02624791|617477967|FG001|Overall Study|Withdrawal by Subject|0|||
170855052|NCT02624791|617477968|FG002|Overall Study|Withdrawal by Subject|0|||
170855053|NCT02624791|617477969|FG003|Overall Study|Withdrawal by Subject|0|||
170855054|NCT02624791|617477970|FG004|Overall Study|Withdrawal by Subject|0|||
170855055|NCT02624791|617477971|FG005|Overall Study|Withdrawal by Subject|0|||
170855056|NCT01034163|617477972|FG000|Overall Study|Treatment completed as per protocol|8|||
170855057|NCT01034163|617477973|FG001|Overall Study|Treatment completed as per protocol|7|||
170855058|NCT01034163|617477972|FG000|Overall Study|Withdrawal by Subject|8|||
170855059|NCT01034163|617477973|FG001|Overall Study|Withdrawal by Subject|2|||
170855060|NCT01034163|617477972|FG000|Overall Study|Protocol deviation|1|||
170855061|NCT01034163|617477973|FG001|Overall Study|Protocol deviation|0|||
170855062|NCT01034163|617477972|FG000|Overall Study|Disease progression|3|||
170855063|NCT01034163|617477973|FG001|Overall Study|Disease progression|4|||
170855064|NCT01034163|617477972|FG000|Overall Study|Adverse Event|6|||
170855065|NCT01034163|617477973|FG001|Overall Study|Adverse Event|0|||
170855066|NCT01034163|617477972|FG000|Overall Study|Administrative problems|0|||
170855067|NCT01034163|617477973|FG001|Overall Study|Administrative problems|1|||
170855068|NCT01034163|617477972|FG000|Overall Study|Abnormal laboratory value|1|||
170855069|NCT01034163|617477973|FG001|Overall Study|Abnormal laboratory value|0|||
170855070|NCT02424734|617477974|FG000|Overall Study|Treatment stopped to be discharged home|2|||
170855071|NCT02424734|617477975|FG001|Overall Study|Treatment stopped to be discharged home|2|||
170855072|NCT02424734|617477976|FG002|Overall Study|Treatment stopped to be discharged home|0|||
170855073|NCT00752557|617477977|FG000|Overall Study|Withdrawal by Subject|4|||
170855074|NCT00752557|617477978|FG001|Overall Study|Withdrawal by Subject|3|||
170855075|NCT00752557|617477979|FG002|Overall Study|Withdrawal by Subject|3|||
170855076|NCT00752557|617477977|FG000|Overall Study|Unspecified resaons|0|||
170855077|NCT00752557|617477978|FG001|Overall Study|Unspecified resaons|2|||
170855078|NCT00752557|617477979|FG002|Overall Study|Unspecified resaons|2|||
170855079|NCT00752557|617477977|FG000|Overall Study|Lost to Follow-up|1|||
170855080|NCT00752557|617477978|FG001|Overall Study|Lost to Follow-up|0|||
170855081|NCT00752557|617477979|FG002|Overall Study|Lost to Follow-up|1|||
170855082|NCT01154010|617477980|FG000|Overall Study|Lost to Follow-up|0|||
170855083|NCT01154010|617477981|FG001|Overall Study|Lost to Follow-up|1|||
170855084|NCT00287690|617477985|FG000|Overall Study|Protocol Violation|20|||
170855085|NCT00287690|617477986|FG001|Overall Study|Protocol Violation|26|||
170855086|NCT02413333|617477987|FG000|Period 1|Adverse Event|1|||
170855087|NCT02413333|617477988|FG001|Period 1|Adverse Event|0|||
170855088|NCT02413333|617477987|FG000|Period 1|Reason Not Specified|0|||
170855089|NCT02413333|617477988|FG001|Period 1|Reason Not Specified|1|||
170855090|NCT02413333|617477987|FG000|Period 2|Protocol Deviation|1|||
170855091|NCT02413333|617477988|FG001|Period 2|Protocol Deviation|0|||
170855092|NCT00709852|617477991|FG000|Period 1|Adverse Event|2|||
170855093|NCT00709852|617477992|FG001|Period 1|Adverse Event|0|||
170855094|NCT00709852|617477991|FG000|Period 1|Withdrawal by Subject|4|||
170855095|NCT00709852|617477992|FG001|Period 1|Withdrawal by Subject|2|||
170855096|NCT00709852|617477991|FG000|Period 1|Protocol Violation|1|||
170855097|NCT00709852|617477992|FG001|Period 1|Protocol Violation|0|||
170855098|NCT00709852|617477991|FG000|Period 1|Defective scanner|0|||
170855099|NCT00709852|617477992|FG001|Period 1|Defective scanner|1|||
170855100|NCT00709852|617477991|FG000|Period 1|Lost to Follow-up|1|||
170855101|NCT00709852|617477992|FG001|Period 1|Lost to Follow-up|0|||
170855102|NCT00709852|617477991|FG000|Period 2|Protocol Violation|4|||
170855103|NCT00709852|617477992|FG001|Period 2|Protocol Violation|1|||
170855104|NCT00709852|617477991|FG000|Period 2|Adverse Event|1|||
170855105|NCT00709852|617477992|FG001|Period 2|Adverse Event|1|||
170855106|NCT00709852|617477991|FG000|Period 2|Lost to Follow-up|1|||
170855107|NCT00709852|617477992|FG001|Period 2|Lost to Follow-up|0|||
170855108|NCT00709852|617477991|FG000|Period 2|No 72-hour follow-up|3|||
170855109|NCT00709852|617477992|FG001|Period 2|No 72-hour follow-up|0|||
170855110|NCT00185965|617477993|FG000|Overall Study|Adverse Event|0|||
170855111|NCT00185965|617477994|FG001|Overall Study|Adverse Event|1|||
170855112|NCT01048671|617477995|FG000|Overall Study|Protocol Violation|0|||
170855113|NCT01048671|617477996|FG001|Overall Study|Protocol Violation|1|||
170855114|NCT01048671|617477997|FG002|Overall Study|Protocol Violation|1|||
170855115|NCT02009761|617477998|FG000|Overall Study|Adverse Event|4|||
170855116|NCT00825825|617478001|FG000|First Medication Period (14 Days)|Adverse Event|1|||
170855117|NCT00825825|617478002|FG001|First Medication Period (14 Days)|Adverse Event|0|||
170855118|NCT00825825|617478003|FG002|First Medication Period (14 Days)|Adverse Event|0|||
170855119|NCT00825825|617478004|FG003|First Medication Period (14 Days)|Adverse Event|0|||
170855120|NCT00825825|617478005|FG004|First Medication Period (14 Days)|Adverse Event|0|||
170742856|NCT00118898|617064352|FG000|Overall Study|Not compliant with requirements|11|||
170742857|NCT00118898|617064353|FG001|Overall Study|Not compliant with requirements|13|||
170742858|NCT00118898|617064354|FG002|Overall Study|Not compliant with requirements|11|||
170742859|NCT00118898|617064355|FG003|Overall Study|Not compliant with requirements|11|||
170742860|NCT00118898|617064352|FG000|Overall Study|Not able to get to clinic|34|||
170742861|NCT00118898|617064353|FG001|Overall Study|Not able to get to clinic|43|||
170742862|NCT00118898|617064354|FG002|Overall Study|Not able to get to clinic|31|||
170742863|NCT00118898|617064355|FG003|Overall Study|Not able to get to clinic|40|||
170742864|NCT01242176|617065937|FG000|Washout Period of 7 Days|Adverse Event|0|||
170742865|NCT01242176|617065938|FG001|Washout Period of 7 Days|Adverse Event|2|||
170742866|NCT01242176|617065937|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
170742867|NCT01242176|617065938|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
170742868|NCT01017120|617065939|FG000|Overall Study|Adverse Event|9|||
170742869|NCT01017120|617065940|FG001|Overall Study|Adverse Event|0|||
170742870|NCT01017120|617065939|FG000|Overall Study|Lost to Follow-up|13|||
170742871|NCT01017120|617065940|FG001|Overall Study|Lost to Follow-up|11|||
170742872|NCT01017120|617065939|FG000|Overall Study|Lack of Efficacy|1|||
170742873|NCT01017120|617065940|FG001|Overall Study|Lack of Efficacy|0|||
170742874|NCT01017120|617065939|FG000|Overall Study|Withdrawal by Subject|39|||
170742875|NCT01017120|617065940|FG001|Overall Study|Withdrawal by Subject|21|||
170742876|NCT01017120|617065939|FG000|Overall Study|Pregnancy|1|||
170742877|NCT01017120|617065940|FG001|Overall Study|Pregnancy|1|||
170855121|NCT00825825|617478006|FG005|First Medication Period (14 Days)|Adverse Event|1|||
170855122|NCT00825825|617478001|FG000|First Medication Period (14 Days)|Physician Decision|2|||
170742878|NCT01017120|617065939|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
170742879|NCT01017120|617065940|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
170742880|NCT01017120|617065939|FG000|Overall Study|Relocated Out of Town|0|||
170742881|NCT01017120|617065940|FG001|Overall Study|Relocated Out of Town|2|||
170742882|NCT01017120|617065939|FG000|Overall Study|Protocol Violation|1|||
170742883|NCT01017120|617065940|FG001|Overall Study|Protocol Violation|0|||
170742884|NCT01017120|617065939|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
170742885|NCT01017120|617065940|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
170742886|NCT00806624|617065941|FG000|Overall Study|Adverse Event|2|||
170742887|NCT00806624|617065942|FG001|Overall Study|Adverse Event|8|||
170742888|NCT00806624|617065943|FG002|Overall Study|Adverse Event|0|||
170742889|NCT00806624|617065941|FG000|Overall Study|Death|0|||
170742890|NCT00806624|617065942|FG001|Overall Study|Death|1|||
170742891|NCT00806624|617065943|FG002|Overall Study|Death|1|||
170742892|NCT00806624|617065941|FG000|Overall Study|Lost to Follow-up|1|||
170742893|NCT00806624|617065942|FG001|Overall Study|Lost to Follow-up|0|||
170742894|NCT00806624|617065943|FG002|Overall Study|Lost to Follow-up|1|||
170742895|NCT00806624|617065941|FG000|Overall Study|Withdrawal by Subject|6|||
170742896|NCT00806624|617065942|FG001|Overall Study|Withdrawal by Subject|3|||
170742897|NCT00806624|617065943|FG002|Overall Study|Withdrawal by Subject|3|||
170742898|NCT00806624|617065941|FG000|Overall Study|discontinued before start of treatment|0|||
170742899|NCT00806624|617065942|FG001|Overall Study|discontinued before start of treatment|0|||
170742900|NCT00806624|617065943|FG002|Overall Study|discontinued before start of treatment|1|||
170742901|NCT01014975|617065957|FG000|Overall Study|Withdrawal by Subject|1|||
170742902|NCT01014975|617065958|FG001|Overall Study|Withdrawal by Subject|0|||
170742903|NCT01014975|617065959|FG002|Overall Study|Withdrawal by Subject|1|||
170742904|NCT01014975|617065957|FG000|Overall Study|Death|3|||
170742905|NCT01014975|617065958|FG001|Overall Study|Death|3|||
170742906|NCT01014975|617065959|FG002|Overall Study|Death|4|||
170742907|NCT01014975|617065957|FG000|Overall Study|Lost to Follow-up|0|||
170742908|NCT01014975|617065958|FG001|Overall Study|Lost to Follow-up|0|||
170742909|NCT01014975|617065959|FG002|Overall Study|Lost to Follow-up|1|||
170742910|NCT01642602|617065960|FG000|Overall Study|Adverse Event|2|||
170742911|NCT01336634|617065963|FG000|Overall Study|Study closed/terminated|5|||
170742912|NCT01336634|617065964|FG001|Overall Study|Study closed/terminated|6|||
170742913|NCT01336634|617065965|FG002|Overall Study|Study closed/terminated|6|||
170742914|NCT01336634|617065963|FG000|Overall Study|Lost to Follow-up|2|||
170742915|NCT01336634|617065964|FG001|Overall Study|Lost to Follow-up|1|||
170742916|NCT01336634|617065965|FG002|Overall Study|Lost to Follow-up|1|||
170742917|NCT01336634|617065963|FG000|Overall Study|Physician Decision|1|||
170742918|NCT01336634|617065964|FG001|Overall Study|Physician Decision|1|||
170742919|NCT01336634|617065965|FG002|Overall Study|Physician Decision|0|||
170742920|NCT01336634|617065963|FG000|Overall Study|Withdrawal by Subject|6|||
170742921|NCT01336634|617065964|FG001|Overall Study|Withdrawal by Subject|0|||
170742922|NCT01336634|617065965|FG002|Overall Study|Withdrawal by Subject|2|||
170742923|NCT01112514|617065966|FG000|Overall Study|Lost to Follow-up|1|||
170742924|NCT01024959|617065967|FG000|Overall Study|ineligible|12|||
170742925|NCT01024959|617065967|FG000|Overall Study|results not evaluable|12|||
170742926|NCT01024959|617065967|FG000|Overall Study|missing results required for analysis|17|||
170742927|NCT01973491|617065968|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
170742928|NCT01973491|617065968|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
170742929|NCT01973491|617065968|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
170742930|NCT00636792|617065969|FG000|Overall Study|Adverse Event|16|||
170742931|NCT00636792|617065969|FG000|Overall Study|Physician Decision|7|||
170742932|NCT00636792|617065969|FG000|Overall Study|Progressive Disease|4|||
170742933|NCT00636792|617065969|FG000|Overall Study|Withdrawal by Subject|3|||
170742934|NCT00636792|617065969|FG000|Overall Study|Other|3|||
170742935|NCT01928225|617065972|FG000|Overall Study|Pregnancy|1|||
170742936|NCT01928225|617065973|FG001|Overall Study|Pregnancy|0|||
170742937|NCT01928225|617065972|FG000|Overall Study|basaloid cervical cancer|1|||
170742938|NCT01928225|617065973|FG001|Overall Study|basaloid cervical cancer|0|||
170742939|NCT01928225|617065972|FG000|Overall Study|Lost to Follow-up|1|||
170742940|NCT01928225|617065973|FG001|Overall Study|Lost to Follow-up|3|||
170742941|NCT00709592|617065974|FG000|Overall Study|Unable to proceed to transplant|0|||
170742942|NCT00709592|617065975|FG001|Overall Study|Unable to proceed to transplant|1|||
170742943|NCT00451217|617065977|FG000|Overall Study|Lost to Follow-up|0|||
170742944|NCT00451217|617065978|FG001|Overall Study|Lost to Follow-up|1|||
170742945|NCT00451217|617065979|FG002|Overall Study|Lost to Follow-up|1|||
170742946|NCT00451217|617065980|FG003|Overall Study|Lost to Follow-up|1|||
170742947|NCT00451217|617065977|FG000|Overall Study|Withdrawal by Subject|1|||
170742948|NCT00451217|617065978|FG001|Overall Study|Withdrawal by Subject|0|||
170742949|NCT00451217|617065979|FG002|Overall Study|Withdrawal by Subject|0|||
170742950|NCT00451217|617065980|FG003|Overall Study|Withdrawal by Subject|0|||
170855123|NCT00825825|617478002|FG001|First Medication Period (14 Days)|Physician Decision|0|||
170855124|NCT00825825|617478003|FG002|First Medication Period (14 Days)|Physician Decision|1|||
170855125|NCT00825825|617478004|FG003|First Medication Period (14 Days)|Physician Decision|0|||
170855126|NCT00825825|617478005|FG004|First Medication Period (14 Days)|Physician Decision|0|||
170855127|NCT00825825|617478006|FG005|First Medication Period (14 Days)|Physician Decision|1|||
170855128|NCT00825825|617478001|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
170855129|NCT00825825|617478002|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
170855130|NCT00825825|617478003|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
170855131|NCT00825825|617478004|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
170855132|NCT00825825|617478005|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
170855133|NCT00825825|617478006|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
170855134|NCT00825825|617478001|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
170855135|NCT00825825|617478002|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
170855136|NCT00825825|617478003|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
170855137|NCT00825825|617478004|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
170855138|NCT00825825|617478005|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
170855139|NCT00825825|617478006|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
170855140|NCT00825825|617478001|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
170855141|NCT00825825|617478002|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
170855142|NCT00825825|617478003|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
170855143|NCT00825825|617478004|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
170855144|NCT00825825|617478005|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
170855145|NCT00825825|617478006|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
170855146|NCT00825825|617478001|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
170855147|NCT00825825|617478002|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
170855148|NCT00825825|617478003|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
170855149|NCT00825825|617478004|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
170855150|NCT00825825|617478005|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
170855151|NCT00825825|617478006|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
170855152|NCT00825825|617478001|FG000|Third Medication Period (14 Days)|poor data quality|0|||
170855153|NCT00825825|617478002|FG001|Third Medication Period (14 Days)|poor data quality|1|||
170855154|NCT00825825|617478003|FG002|Third Medication Period (14 Days)|poor data quality|0|||
170855155|NCT00825825|617478004|FG003|Third Medication Period (14 Days)|poor data quality|0|||
170855156|NCT00825825|617478005|FG004|Third Medication Period (14 Days)|poor data quality|0|||
170855157|NCT00825825|617478006|FG005|Third Medication Period (14 Days)|poor data quality|0|||
170855158|NCT01942590|617478007|FG000|Overall Study|Withdrawal by Subject|0|||
170855159|NCT01942590|617478008|FG001|Overall Study|Withdrawal by Subject|1|||
170855160|NCT01942590|617478007|FG000|Overall Study|Adverse Event|1|||
170855161|NCT01942590|617478008|FG001|Overall Study|Adverse Event|0|||
170855162|NCT03538301|617478021|FG000|Overall Study|Adverse Event|1|||
170855163|NCT03538301|617478022|FG001|Overall Study|Adverse Event|4|||
170855164|NCT03538301|617478023|FG002|Overall Study|Adverse Event|4|||
170855165|NCT03538301|617478021|FG000|Overall Study|Death|1|||
170855166|NCT03538301|617478022|FG001|Overall Study|Death|1|||
170855167|NCT03538301|617478023|FG002|Overall Study|Death|0|||
170855168|NCT03538301|617478021|FG000|Overall Study|Physician Decision|0|||
170855169|NCT03538301|617478022|FG001|Overall Study|Physician Decision|1|||
170742951|NCT00451217|617065977|FG000|Overall Study|Not Treated|1|||
170742952|NCT00451217|617065978|FG001|Overall Study|Not Treated|1|||
170742953|NCT00451217|617065979|FG002|Overall Study|Not Treated|3|||
170742954|NCT00451217|617065980|FG003|Overall Study|Not Treated|4|||
170742955|NCT04250337|617065981|FG000|Overall Study|Adverse Event|0|||
170742956|NCT04250337|617065982|FG001|Overall Study|Adverse Event|3|||
170742957|NCT04250337|617065981|FG000|Overall Study|Lack of Efficacy|1|||
170742958|NCT04250337|617065982|FG001|Overall Study|Lack of Efficacy|3|||
170742959|NCT04250337|617065981|FG000|Overall Study|Physician Decision|1|||
170742960|NCT04250337|617065982|FG001|Overall Study|Physician Decision|0|||
170742961|NCT04250337|617065981|FG000|Overall Study|Protocol Deviation|2|||
170742962|NCT04250337|617065982|FG001|Overall Study|Protocol Deviation|2|||
170742963|NCT04250337|617065981|FG000|Overall Study|Withdrawal by Subject|4|||
170742964|NCT04250337|617065982|FG001|Overall Study|Withdrawal by Subject|3|||
170855170|NCT03538301|617478023|FG002|Overall Study|Physician Decision|0|||
170855171|NCT03538301|617478021|FG000|Overall Study|Protocol Violation|0|||
170855172|NCT03538301|617478022|FG001|Overall Study|Protocol Violation|0|||
170855173|NCT03538301|617478023|FG002|Overall Study|Protocol Violation|1|||
170742965|NCT04668989|617065984|FG000|First Intervention|Covid-19 related self-isolation|0|||
170742966|NCT04668989|617065985|FG001|First Intervention|Covid-19 related self-isolation|1|||
170742967|NCT04668989|617065984|FG000|Second Intervention|Adverse Event|0|||
170742968|NCT04668989|617065985|FG001|Second Intervention|Adverse Event|1|||
170742969|NCT00569803|617065989|FG000|Overall Study|Lost to Follow-up|1|||
170742970|NCT00569803|617065990|FG001|Overall Study|Lost to Follow-up|0|||
170742971|NCT00569803|617065991|FG002|Overall Study|Lost to Follow-up|0|||
170742972|NCT00569803|617065992|FG003|Overall Study|Lost to Follow-up|0|||
170742973|NCT00569803|617065993|FG004|Overall Study|Lost to Follow-up|0|||
170742974|NCT00569803|617065994|FG005|Overall Study|Lost to Follow-up|0|||
170742975|NCT00569803|617065995|FG006|Overall Study|Lost to Follow-up|0|||
170742976|NCT00569803|617065996|FG007|Overall Study|Lost to Follow-up|0|||
170742977|NCT00569803|617065989|FG000|Overall Study|injection syringe leaked during dosing|0|||
170742978|NCT00569803|617065990|FG001|Overall Study|injection syringe leaked during dosing|0|||
170742979|NCT00569803|617065991|FG002|Overall Study|injection syringe leaked during dosing|0|||
170742980|NCT00569803|617065992|FG003|Overall Study|injection syringe leaked during dosing|1|||
170742981|NCT00569803|617065993|FG004|Overall Study|injection syringe leaked during dosing|0|||
170742982|NCT00569803|617065994|FG005|Overall Study|injection syringe leaked during dosing|0|||
170742983|NCT00569803|617065995|FG006|Overall Study|injection syringe leaked during dosing|0|||
170742984|NCT00569803|617065996|FG007|Overall Study|injection syringe leaked during dosing|0|||
170742985|NCT00569803|617065989|FG000|Overall Study|Withdrawal by Subject|0|||
170742986|NCT00569803|617065990|FG001|Overall Study|Withdrawal by Subject|0|||
170742987|NCT00569803|617065991|FG002|Overall Study|Withdrawal by Subject|0|||
170742988|NCT00569803|617065992|FG003|Overall Study|Withdrawal by Subject|0|||
170742989|NCT00569803|617065993|FG004|Overall Study|Withdrawal by Subject|0|||
170742990|NCT00569803|617065994|FG005|Overall Study|Withdrawal by Subject|0|||
170742991|NCT00569803|617065995|FG006|Overall Study|Withdrawal by Subject|0|||
170742992|NCT00569803|617065996|FG007|Overall Study|Withdrawal by Subject|1|||
170742993|NCT01993823|617065997|FG000|Overall Study|Requested by the patient|6|||
170742994|NCT01993823|617065998|FG001|Overall Study|Requested by the patient|11|||
170742995|NCT01993823|617065997|FG000|Overall Study|Protocol Violation|0|||
170742996|NCT01993823|617065998|FG001|Overall Study|Protocol Violation|1|||
170742997|NCT01993823|617065997|FG000|Overall Study|Lost to Follow-up|1|||
170742998|NCT01993823|617065998|FG001|Overall Study|Lost to Follow-up|4|||
170742999|NCT01235975|617065999|FG000|Overall Study|Serious Adverse Event|0|||
170743000|NCT01235975|617066000|FG001|Overall Study|Serious Adverse Event|1|||
170743001|NCT01235975|617065999|FG000|Overall Study|Withdrawal by Subject|8|||
170743002|NCT01235975|617066000|FG001|Overall Study|Withdrawal by Subject|2|||
170743003|NCT01235975|617065999|FG000|Overall Study|Migrated/moved from study area|2|||
170743004|NCT01235975|617066000|FG001|Overall Study|Migrated/moved from study area|1|||
170743005|NCT01235975|617065999|FG000|Overall Study|Lost to Follow-up|7|||
170743006|NCT01235975|617066000|FG001|Overall Study|Lost to Follow-up|3|||
170743007|NCT01965158|617066006|FG000|Overall Study|Adverse Event|14|||
170743008|NCT01965158|617066007|FG001|Overall Study|Adverse Event|5|||
170743009|NCT01965158|617066006|FG000|Overall Study|Withdrawal by Subject|16|||
170743010|NCT01965158|617066007|FG001|Overall Study|Withdrawal by Subject|24|||
170743011|NCT01965158|617066006|FG000|Overall Study|Lost to Follow-up|7|||
170743012|NCT01965158|617066007|FG001|Overall Study|Lost to Follow-up|5|||
170743013|NCT01965158|617066006|FG000|Overall Study|Protocol Violation|1|||
170743014|NCT01965158|617066007|FG001|Overall Study|Protocol Violation|1|||
170743015|NCT01965158|617066006|FG000|Overall Study|Other - Miscellaneous|3|||
170743016|NCT01965158|617066007|FG001|Overall Study|Other - Miscellaneous|0|||
170743017|NCT00467142|617066008|FG000|Overall Study|Withdrawal by Subject|1|||
170743018|NCT00467142|617066008|FG000|Overall Study|Adverse Event|1|||
170743019|NCT00467142|617066008|FG000|Overall Study|Protocol Violation|1|||
170743020|NCT04537897|617066009|FG000|Overall Study|Other than listed|0|||
170743021|NCT04537897|617066010|FG001|Overall Study|Other than listed|0|||
170743022|NCT04537897|617066011|FG002|Overall Study|Other than listed|0|||
170743023|NCT04537897|617066012|FG003|Overall Study|Other than listed|0|||
170743024|NCT04537897|617066013|FG004|Overall Study|Other than listed|0|||
170743025|NCT04537897|617066014|FG005|Overall Study|Other than listed|0|||
170743026|NCT04537897|617066015|FG006|Overall Study|Other than listed|1|||
170743027|NCT04537897|617066016|FG007|Overall Study|Other than listed|0|||
170743028|NCT04537897|617066017|FG008|Overall Study|Other than listed|0|||
170743029|NCT04537897|617066009|FG000|Overall Study|Adverse Event|0|||
170743030|NCT04537897|617066010|FG001|Overall Study|Adverse Event|0|||
170743031|NCT04537897|617066011|FG002|Overall Study|Adverse Event|0|||
170743032|NCT04537897|617066012|FG003|Overall Study|Adverse Event|1|||
170743033|NCT04537897|617066013|FG004|Overall Study|Adverse Event|0|||
170855174|NCT03538301|617478021|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
170855175|NCT03538301|617478022|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
170855176|NCT03538301|617478023|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
170855177|NCT00591851|617478024|FG000|Overall Study|Withdrawal by Subject|3|||
170855178|NCT00591851|617478024|FG000|Overall Study|Adverse Event|2|||
170855179|NCT00591851|617478024|FG000|Overall Study|Progressive Disease|1|||
170855180|NCT00943111|617478025|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
170855181|NCT00943111|617478026|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
170855182|NCT00943111|617478027|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
170855183|NCT00943111|617478025|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
170855184|NCT00943111|617478026|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
170855185|NCT00943111|617478027|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
170855186|NCT00943111|617478025|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
170855187|NCT00943111|617478026|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
170855188|NCT00943111|617478027|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
170855189|NCT00943111|617478025|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
170855190|NCT00943111|617478026|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
170855191|NCT00943111|617478027|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
170855192|NCT00943111|617478025|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
170855193|NCT00943111|617478026|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
170855194|NCT00943111|617478027|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
170855195|NCT00943111|617478025|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
170855196|NCT00943111|617478026|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
170855197|NCT00943111|617478027|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
170855198|NCT00943111|617478025|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
170855199|NCT00943111|617478026|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
170855200|NCT00943111|617478027|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
170855201|NCT00943111|617478025|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
170855202|NCT00943111|617478026|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
170855203|NCT00943111|617478027|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
170855204|NCT00847808|617478028|FG000|Overall Study|Adverse Event|7|||
170855205|NCT00847808|617478028|FG000|Overall Study|Protocol Violation|1|||
170855206|NCT00847808|617478028|FG000|Overall Study|Lost to Follow-up|1|||
170855207|NCT00847808|617478028|FG000|Overall Study|Withdrawal by Subject|4|||
170855208|NCT00847808|617478028|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
170855209|NCT00847808|617478028|FG000|Overall Study|Participant Took Excluded Medication|1|||
170855210|NCT00979134|617478029|FG000|Overall Study|Disease progression|18|||
170855211|NCT00979134|617478030|FG001|Overall Study|Disease progression|2|||
170855212|NCT00979134|617478031|FG002|Overall Study|Disease progression|5|||
170855213|NCT00979134|617478029|FG000|Overall Study|Adverse Event|0|||
170855214|NCT00979134|617478030|FG001|Overall Study|Adverse Event|0|||
170855215|NCT00979134|617478031|FG002|Overall Study|Adverse Event|2|||
170855216|NCT00979134|617478029|FG000|Overall Study|Withdrawal by Subject|1|||
170855217|NCT00979134|617478030|FG001|Overall Study|Withdrawal by Subject|1|||
170855218|NCT00979134|617478031|FG002|Overall Study|Withdrawal by Subject|2|||
170855219|NCT00979134|617478029|FG000|Overall Study|Lost to Follow-up|2|||
170855220|NCT00979134|617478030|FG001|Overall Study|Lost to Follow-up|2|||
170855221|NCT00979134|617478031|FG002|Overall Study|Lost to Follow-up|0|||
170855222|NCT00979134|617478029|FG000|Overall Study|Death|4|||
170855223|NCT00979134|617478030|FG001|Overall Study|Death|0|||
170855224|NCT00979134|617478031|FG002|Overall Study|Death|26|||
170855225|NCT00979134|617478029|FG000|Overall Study|Other|8|||
170855226|NCT00979134|617478030|FG001|Overall Study|Other|1|||
170855227|NCT00979134|617478031|FG002|Overall Study|Other|5|||
170855228|NCT05172050|617478032|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
170855229|NCT05172050|617478033|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
170855230|NCT05172050|617478034|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
170855231|NCT05172050|617478032|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
170855232|NCT05172050|617478033|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
170855233|NCT05172050|617478034|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
170855234|NCT05172050|617478032|FG000|Overall Study|Other|2|||
170855235|NCT05172050|617478033|FG001|Overall Study|Other|2|||
170855236|NCT05172050|617478034|FG002|Overall Study|Other|1|||
170855237|NCT00409773|617480422|FG000|Overall Study|Adverse Event|3|||
170855238|NCT00409773|617480423|FG001|Overall Study|Adverse Event|4|||
170855239|NCT00409773|617480424|FG002|Overall Study|Adverse Event|4|||
170855240|NCT00409773|617480425|FG003|Overall Study|Adverse Event|2|||
170855241|NCT00409773|617480426|FG004|Overall Study|Adverse Event|6|||
170855242|NCT00409773|617480422|FG000|Overall Study|Lost to Follow-up|6|||
170855243|NCT00409773|617480423|FG001|Overall Study|Lost to Follow-up|1|||
170855244|NCT00409773|617480424|FG002|Overall Study|Lost to Follow-up|2|||
170855245|NCT00409773|617480425|FG003|Overall Study|Lost to Follow-up|3|||
170743034|NCT04537897|617066014|FG005|Overall Study|Adverse Event|0|||
170743035|NCT04537897|617066015|FG006|Overall Study|Adverse Event|0|||
170743036|NCT04537897|617066016|FG007|Overall Study|Adverse Event|0|||
170743037|NCT04537897|617066017|FG008|Overall Study|Adverse Event|0|||
170743038|NCT04537897|617066009|FG000|Overall Study|Withdrawal by Subject|0|||
170743039|NCT04537897|617066010|FG001|Overall Study|Withdrawal by Subject|1|||
170743040|NCT04537897|617066011|FG002|Overall Study|Withdrawal by Subject|0|||
170743041|NCT04537897|617066012|FG003|Overall Study|Withdrawal by Subject|0|||
170743042|NCT04537897|617066013|FG004|Overall Study|Withdrawal by Subject|0|||
170743043|NCT04537897|617066014|FG005|Overall Study|Withdrawal by Subject|0|||
170743044|NCT04537897|617066015|FG006|Overall Study|Withdrawal by Subject|0|||
170743045|NCT04537897|617066016|FG007|Overall Study|Withdrawal by Subject|0|||
170743046|NCT04537897|617066017|FG008|Overall Study|Withdrawal by Subject|0|||
170743047|NCT00178256|617066021|FG000|Overall Study|Adverse Event|2|||
170743048|NCT00178256|617066022|FG001|Overall Study|Adverse Event|0|||
170743049|NCT00178256|617066023|FG002|Overall Study|Adverse Event|0|||
170743050|NCT00178256|617066024|FG003|Overall Study|Adverse Event|0|||
170743051|NCT00178256|617066021|FG000|Overall Study|Death|0|||
170743052|NCT00178256|617066022|FG001|Overall Study|Death|1|||
170743053|NCT00178256|617066023|FG002|Overall Study|Death|0|||
170743054|NCT00178256|617066024|FG003|Overall Study|Death|1|||
170743055|NCT00178256|617066021|FG000|Overall Study|Cancer progression|2|||
170743056|NCT00178256|617066022|FG001|Overall Study|Cancer progression|0|||
170743057|NCT00178256|617066023|FG002|Overall Study|Cancer progression|0|||
170855246|NCT00409773|617480426|FG004|Overall Study|Lost to Follow-up|1|||
170855247|NCT00409773|617480422|FG000|Overall Study|Physician Decision|0|||
170855248|NCT00409773|617480423|FG001|Overall Study|Physician Decision|0|||
170855249|NCT00409773|617480424|FG002|Overall Study|Physician Decision|0|||
170855250|NCT00409773|617480425|FG003|Overall Study|Physician Decision|2|||
170855251|NCT00409773|617480426|FG004|Overall Study|Physician Decision|0|||
170855252|NCT00409773|617480422|FG000|Overall Study|Protocol Violation|0|||
170855253|NCT00409773|617480423|FG001|Overall Study|Protocol Violation|2|||
170855254|NCT00409773|617480424|FG002|Overall Study|Protocol Violation|3|||
170855255|NCT00409773|617480425|FG003|Overall Study|Protocol Violation|3|||
170855256|NCT00409773|617480426|FG004|Overall Study|Protocol Violation|1|||
170855257|NCT00409773|617480422|FG000|Overall Study|Withdrawal by Subject|0|||
170855258|NCT00409773|617480423|FG001|Overall Study|Withdrawal by Subject|0|||
170855259|NCT00409773|617480424|FG002|Overall Study|Withdrawal by Subject|0|||
170855260|NCT00409773|617480425|FG003|Overall Study|Withdrawal by Subject|2|||
170855261|NCT00409773|617480426|FG004|Overall Study|Withdrawal by Subject|1|||
170855262|NCT00409773|617480422|FG000|Overall Study|Lack of Eligibility|0|||
170855263|NCT00409773|617480423|FG001|Overall Study|Lack of Eligibility|0|||
170855264|NCT00409773|617480424|FG002|Overall Study|Lack of Eligibility|0|||
170855265|NCT00409773|617480425|FG003|Overall Study|Lack of Eligibility|0|||
170855266|NCT00409773|617480426|FG004|Overall Study|Lack of Eligibility|1|||
170855267|NCT01201343|617480427|FG000|Overall Study|Adverse Event|6|||
170855268|NCT01201343|617480427|FG000|Overall Study|Withdrawal by Subject|5|||
170855269|NCT01201343|617480427|FG000|Overall Study|Lost to Follow-up|2|||
170855270|NCT01201343|617480427|FG000|Overall Study|Lack of Efficacy|2|||
170855271|NCT01201343|617480427|FG000|Overall Study|Participant wrongly included in trial|1|||
170855272|NCT01201343|617480427|FG000|Overall Study|Randomized, not treated|3|||
170855273|NCT01919814|617480428|FG000|Overall Study|Adverse Event|1|||
170855274|NCT01919814|617480429|FG001|Overall Study|Adverse Event|0|||
170855275|NCT01919814|617480428|FG000|Overall Study|Protocol Violation|1|||
170855276|NCT01919814|617480429|FG001|Overall Study|Protocol Violation|0|||
170855277|NCT01919814|617480428|FG000|Overall Study|Withdrawal by Subject|1|||
170855278|NCT01919814|617480429|FG001|Overall Study|Withdrawal by Subject|0|||
170855279|NCT02164383|617480430|FG000|Overall Study|Lost to Follow-up|1|||
170855280|NCT02164383|617480431|FG001|Overall Study|Lost to Follow-up|0|||
170855281|NCT00171704|617480433|FG000|Overall Study|Adverse Event|24|||
170855282|NCT00171704|617480434|FG001|Overall Study|Adverse Event|33|||
170855283|NCT00171704|617480433|FG000|Overall Study|Disease Progression|14|||
170855284|NCT00171704|617480434|FG001|Overall Study|Disease Progression|9|||
170855285|NCT00171704|617480433|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
170855286|NCT00171704|617480434|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
170855287|NCT00171704|617480433|FG000|Overall Study|Administrative Problems|2|||
170855288|NCT00171704|617480434|FG001|Overall Study|Administrative Problems|1|||
170855289|NCT00171704|617480433|FG000|Overall Study|Death|2|||
170855290|NCT00171704|617480434|FG001|Overall Study|Death|2|||
170855291|NCT00171704|617480433|FG000|Overall Study|Withdrawal by Subject|1|||
170855292|NCT00171704|617480434|FG001|Overall Study|Withdrawal by Subject|3|||
170855293|NCT00171704|617480433|FG000|Overall Study|Protocol Violation|0|||
170855294|NCT00171704|617480434|FG001|Overall Study|Protocol Violation|1|||
170855295|NCT00484289|617480440|FG000|Long Term Phase|Adverse Event|1|||
170855296|NCT00484289|617480441|FG001|Long Term Phase|Adverse Event|17|||
170855297|NCT00484289|617480442|FG002|Long Term Phase|Adverse Event|5|||
170855298|NCT00484289|617480440|FG000|Long Term Phase|Withdrawal by Subject|0|||
170855299|NCT00484289|617480441|FG001|Long Term Phase|Withdrawal by Subject|7|||
170855300|NCT00484289|617480442|FG002|Long Term Phase|Withdrawal by Subject|6|||
170855301|NCT00484289|617480440|FG000|Long Term Phase|Inadequate response|2|||
170855302|NCT00484289|617480441|FG001|Long Term Phase|Inadequate response|7|||
170855303|NCT00484289|617480442|FG002|Long Term Phase|Inadequate response|4|||
170855304|NCT00484289|617480440|FG000|Long Term Phase|Other Reason|0|||
170855305|NCT00484289|617480441|FG001|Long Term Phase|Other Reason|5|||
170855306|NCT00484289|617480442|FG002|Long Term Phase|Other Reason|1|||
170855307|NCT00484289|617480440|FG000|Post Marketing Phase|Adverse Event|0|||
170855308|NCT00484289|617480441|FG001|Post Marketing Phase|Adverse Event|1|||
170855309|NCT00484289|617480442|FG002|Post Marketing Phase|Adverse Event|0|||
170855310|NCT02831387|617480443|FG000|Overall Study|Withdrawal by Subject|1|||
170855311|NCT02831387|617480444|FG001|Overall Study|Withdrawal by Subject|1|||
170855312|NCT02831387|617480443|FG000|Overall Study|Discontinued due to stock recovery|0|||
170855313|NCT02831387|617480444|FG001|Overall Study|Discontinued due to stock recovery|1|||
170855314|NCT01828073|617480445|FG000|Overall Study|Lost to Follow-up|1|||
170855315|NCT01828073|617480446|FG001|Overall Study|Lost to Follow-up|2|||
170855316|NCT00690443|617480451|FG000|Overall Study|Adverse Event|1|||
170855317|NCT00690443|617480452|FG001|Overall Study|Adverse Event|2|||
170855318|NCT02502097|617480453|FG000|Period 1|Adverse Event|0|||
170855319|NCT02502097|617480454|FG001|Period 1|Adverse Event|0|||
170855320|NCT02502097|617480455|FG002|Period 1|Adverse Event|1|||
170855321|NCT02502097|617480456|FG003|Period 1|Adverse Event|0|||
170855322|NCT02502097|617480453|FG000|Wash Out Period|Adverse Event|0|||
170855323|NCT02502097|617480454|FG001|Wash Out Period|Adverse Event|1|||
170855324|NCT02502097|617480455|FG002|Wash Out Period|Adverse Event|1|||
170855325|NCT02502097|617480456|FG003|Wash Out Period|Adverse Event|1|||
170855326|NCT02502097|617480453|FG000|Period 2|Adverse Event|0|||
170855327|NCT02502097|617480454|FG001|Period 2|Adverse Event|0|||
170855328|NCT02502097|617480455|FG002|Period 2|Adverse Event|1|||
170855329|NCT02502097|617480456|FG003|Period 2|Adverse Event|0|||
170855330|NCT01557283|617480463|FG000|Overall Study|Lost to Follow-up|7|||
170855331|NCT01557283|617480463|FG000|Overall Study|Non-responder|19|||
170855332|NCT01557283|617480463|FG000|Overall Study|Adverse Event|7|||
170855333|NCT01557283|617480463|FG000|Overall Study|Lack of Efficacy|1|||
170855334|NCT01557283|617480463|FG000|Overall Study|Non-compliance|1|||
170855335|NCT01557283|617480463|FG000|Overall Study|Withdrawal by Subject|1|||
170855336|NCT01557283|617480463|FG000|Overall Study|Participant's weight too high for dose|1|||
170855337|NCT01557283|617480463|FG000|Overall Study|Worsening of psoriasis|1|||
170855338|NCT01557283|617480463|FG000|Overall Study|Other|6|||
170855339|NCT01765192|617480464|FG000|Treatment Period 1|Adverse Event|0|||
170855340|NCT01765192|617480465|FG001|Treatment Period 1|Adverse Event|1|||
170855341|NCT01765192|617480464|FG000|Washout Period|Voluntary Withdrawal|1|||
170855342|NCT01765192|617480465|FG001|Washout Period|Voluntary Withdrawal|1|||
170855343|NCT01765192|617480464|FG000|Washout Period|Reason not specified|1|||
170855344|NCT01765192|617480465|FG001|Washout Period|Reason not specified|0|||
170855345|NCT01765192|617480464|FG000|Treatment Period 2|Reason not specified|0|||
170855346|NCT01765192|617480465|FG001|Treatment Period 2|Reason not specified|2|||
170855347|NCT01765192|617480464|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
170855348|NCT01765192|617480465|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
170855349|NCT03184870|617480468|FG000|Initial Treatment|Death|6|||
170855350|NCT03184870|617480469|FG001|Initial Treatment|Death|6|||
170855351|NCT03184870|617480470|FG002|Initial Treatment|Death|8|||
170855352|NCT03184870|617480471|FG003|Initial Treatment|Death|8|||
170855353|NCT03184870|617480472|FG004|Initial Treatment|Death|6|||
170855354|NCT03184870|617480473|FG005|Initial Treatment|Death|6|||
170855355|NCT03184870|617480474|FG006|Initial Treatment|Death|6|||
170855356|NCT03184870|617480475|FG007|Initial Treatment|Death|7|||
170855357|NCT03184870|617480476|FG008|Initial Treatment|Death|1|||
170855358|NCT03184870|617480477|FG009|Initial Treatment|Death|2|||
170855359|NCT03184870|617480478|FG010|Initial Treatment|Death|26|||
170855360|NCT03184870|617480479|FG011|Initial Treatment|Death|28|||
170855361|NCT03184870|617480480|FG012|Initial Treatment|Death|10|||
170855362|NCT03184870|617480481|FG013|Initial Treatment|Death|33|||
170855363|NCT03184870|617480482|FG014|Initial Treatment|Death|34|||
170855364|NCT03184870|617480483|FG015|Initial Treatment|Death|26|||
170855365|NCT03184870|617480484|FG016|Initial Treatment|Death|20|||
170855366|NCT03184870|617480485|FG017|Initial Treatment|Death|18|||
170855367|NCT03184870|617480468|FG000|Initial Treatment|Other Reasons|2|||
170855368|NCT03184870|617480469|FG001|Initial Treatment|Other Reasons|2|||
170855369|NCT03184870|617480470|FG002|Initial Treatment|Other Reasons|0|||
170855370|NCT03184870|617480471|FG003|Initial Treatment|Other Reasons|1|||
170855371|NCT03184870|617480472|FG004|Initial Treatment|Other Reasons|0|||
170855372|NCT03184870|617480473|FG005|Initial Treatment|Other Reasons|0|||
170855373|NCT03184870|617480474|FG006|Initial Treatment|Other Reasons|0|||
170743058|NCT00178256|617066024|FG003|Overall Study|Cancer progression|1|||
170743059|NCT01678820|617066025|FG000|Overall Study|Study Terminated by Sponsor|45|||
170743060|NCT01678820|617066026|FG001|Overall Study|Study Terminated by Sponsor|43|||
170743061|NCT01678820|617066027|FG002|Overall Study|Study Terminated by Sponsor|43|||
170743062|NCT01678820|617066025|FG000|Overall Study|Withdrawal by Subject|2|||
170743063|NCT01678820|617066026|FG001|Overall Study|Withdrawal by Subject|5|||
170743064|NCT01678820|617066027|FG002|Overall Study|Withdrawal by Subject|2|||
170743065|NCT01678820|617066025|FG000|Overall Study|Protocol Specified Criteria|2|||
170743066|NCT01678820|617066026|FG001|Overall Study|Protocol Specified Criteria|3|||
170743067|NCT01678820|617066027|FG002|Overall Study|Protocol Specified Criteria|1|||
170743068|NCT01678820|617066025|FG000|Overall Study|Adverse Event|2|||
170743069|NCT01678820|617066026|FG001|Overall Study|Adverse Event|2|||
170743070|NCT01678820|617066027|FG002|Overall Study|Adverse Event|2|||
170743071|NCT01678820|617066025|FG000|Overall Study|Lost to Follow-up|7|||
170743072|NCT01678820|617066026|FG001|Overall Study|Lost to Follow-up|2|||
170743073|NCT01678820|617066027|FG002|Overall Study|Lost to Follow-up|2|||
170743074|NCT01678820|617066025|FG000|Overall Study|Non-compliance with study drug|0|||
170743075|NCT01678820|617066026|FG001|Overall Study|Non-compliance with study drug|1|||
170743076|NCT01678820|617066027|FG002|Overall Study|Non-compliance with study drug|0|||
170743077|NCT01678820|617066025|FG000|Overall Study|Physician Decision|0|||
170743078|NCT01678820|617066026|FG001|Overall Study|Physician Decision|0|||
170743079|NCT01678820|617066027|FG002|Overall Study|Physician Decision|1|||
170743080|NCT01678820|617066025|FG000|Overall Study|Protocol Violation|4|||
170743081|NCT01678820|617066026|FG001|Overall Study|Protocol Violation|5|||
170743082|NCT01678820|617066027|FG002|Overall Study|Protocol Violation|4|||
170743083|NCT01678820|617066025|FG000|Overall Study|Not treated with double-blind study drug|0|||
170743084|NCT01678820|617066026|FG001|Overall Study|Not treated with double-blind study drug|2|||
170743085|NCT01678820|617066027|FG002|Overall Study|Not treated with double-blind study drug|2|||
170743086|NCT00452413|617066034|FG000|Overall Study|Progressive Disease|4|||
170743087|NCT00452413|617066035|FG001|Overall Study|Progressive Disease|11|||
170743088|NCT00452413|617066036|FG002|Overall Study|Progressive Disease|30|||
170743089|NCT00452413|617066034|FG000|Overall Study|Withdrawal by Subject|0|||
170743090|NCT00452413|617066035|FG001|Overall Study|Withdrawal by Subject|1|||
170743091|NCT00452413|617066036|FG002|Overall Study|Withdrawal by Subject|4|||
170743092|NCT00452413|617066034|FG000|Overall Study|Adverse Event|0|||
170743093|NCT00452413|617066035|FG001|Overall Study|Adverse Event|0|||
170743094|NCT00452413|617066036|FG002|Overall Study|Adverse Event|5|||
170743095|NCT00452413|617066034|FG000|Overall Study|Physician Decision|0|||
170743096|NCT00452413|617066035|FG001|Overall Study|Physician Decision|0|||
170743097|NCT00452413|617066036|FG002|Overall Study|Physician Decision|4|||
170743098|NCT00452413|617066034|FG000|Overall Study|Death due to study disease|0|||
170743099|NCT00452413|617066035|FG001|Overall Study|Death due to study disease|0|||
170743100|NCT00452413|617066036|FG002|Overall Study|Death due to study disease|2|||
170743101|NCT00452413|617066034|FG000|Overall Study|Death due to adverse event (AE)|0|||
170743102|NCT00452413|617066035|FG001|Overall Study|Death due to adverse event (AE)|0|||
170743103|NCT00452413|617066036|FG002|Overall Study|Death due to adverse event (AE)|1|||
170743104|NCT00452413|617066034|FG000|Overall Study|On treatment|0|||
170743105|NCT00452413|617066035|FG001|Overall Study|On treatment|0|||
170855374|NCT03184870|617480475|FG007|Initial Treatment|Other Reasons|2|||
170855375|NCT03184870|617480476|FG008|Initial Treatment|Other Reasons|0|||
170743106|NCT00452413|617066036|FG002|Overall Study|On treatment|3|||
170743107|NCT03119610|617066038|FG000|Overall Study|Adverse Event|1|||
170743108|NCT03119610|617066039|FG001|Overall Study|Adverse Event|0|||
170855376|NCT03184870|617480477|FG009|Initial Treatment|Other Reasons|0|||
170855377|NCT03184870|617480478|FG010|Initial Treatment|Other Reasons|4|||
170855378|NCT03184870|617480479|FG011|Initial Treatment|Other Reasons|2|||
170855379|NCT03184870|617480480|FG012|Initial Treatment|Other Reasons|2|||
170743109|NCT03119610|617066038|FG000|Overall Study|Lost to Follow-up|0|||
170743110|NCT03119610|617066039|FG001|Overall Study|Lost to Follow-up|1|||
170743111|NCT01512745|617066044|FG000|Overall Study|Adverse Event|22|||
170743112|NCT01512745|617066045|FG001|Overall Study|Adverse Event|3|||
170743113|NCT01512745|617066044|FG000|Overall Study|Death|9|||
170743114|NCT01512745|617066045|FG001|Overall Study|Death|13|||
170743115|NCT01512745|617066044|FG000|Overall Study|Withdrawal by Subject|2|||
170743116|NCT01512745|617066045|FG001|Overall Study|Withdrawal by Subject|2|||
170743117|NCT01512745|617066044|FG000|Overall Study|Lost to Follow-up|4|||
170743118|NCT01512745|617066045|FG001|Overall Study|Lost to Follow-up|0|||
170743119|NCT01512745|617066044|FG000|Overall Study|Lack of Efficacy|2|||
170743120|NCT01512745|617066045|FG001|Overall Study|Lack of Efficacy|2|||
170743121|NCT01512745|617066044|FG000|Overall Study|Protocol Violation|1|||
170743122|NCT01512745|617066045|FG001|Overall Study|Protocol Violation|0|||
170743123|NCT02357810|617066046|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
170743124|NCT02357810|617066046|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
170743125|NCT02357810|617066046|FG000|Reached 12 Weeks Response|Adverse Event|5|||
170743126|NCT02357810|617066046|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
170743127|NCT02357810|617066046|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
170743128|NCT02357810|617066046|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
170743129|NCT02357810|617066046|FG000|Reached 12 Weeks Response|Death|1|||
170855380|NCT03184870|617480481|FG013|Initial Treatment|Other Reasons|0|||
170855381|NCT03184870|617480482|FG014|Initial Treatment|Other Reasons|0|||
170855382|NCT03184870|617480483|FG015|Initial Treatment|Other Reasons|1|||
170855383|NCT03184870|617480484|FG016|Initial Treatment|Other Reasons|0|||
170855384|NCT03184870|617480485|FG017|Initial Treatment|Other Reasons|2|||
170855385|NCT03184870|617480468|FG000|Initial Treatment|Lost to Follow-up|2|||
170855386|NCT03184870|617480469|FG001|Initial Treatment|Lost to Follow-up|0|||
170855387|NCT03184870|617480470|FG002|Initial Treatment|Lost to Follow-up|0|||
170855388|NCT03184870|617480471|FG003|Initial Treatment|Lost to Follow-up|1|||
170855389|NCT03184870|617480472|FG004|Initial Treatment|Lost to Follow-up|1|||
170855390|NCT03184870|617480473|FG005|Initial Treatment|Lost to Follow-up|1|||
170855391|NCT03184870|617480474|FG006|Initial Treatment|Lost to Follow-up|0|||
170855392|NCT03184870|617480475|FG007|Initial Treatment|Lost to Follow-up|2|||
170855393|NCT03184870|617480476|FG008|Initial Treatment|Lost to Follow-up|0|||
170855394|NCT03184870|617480477|FG009|Initial Treatment|Lost to Follow-up|0|||
170855395|NCT03184870|617480478|FG010|Initial Treatment|Lost to Follow-up|2|||
170855396|NCT03184870|617480479|FG011|Initial Treatment|Lost to Follow-up|0|||
170855397|NCT03184870|617480480|FG012|Initial Treatment|Lost to Follow-up|2|||
170855398|NCT03184870|617480481|FG013|Initial Treatment|Lost to Follow-up|2|||
170855399|NCT03184870|617480482|FG014|Initial Treatment|Lost to Follow-up|0|||
170855400|NCT03184870|617480483|FG015|Initial Treatment|Lost to Follow-up|0|||
170855401|NCT03184870|617480484|FG016|Initial Treatment|Lost to Follow-up|2|||
170855402|NCT03184870|617480485|FG017|Initial Treatment|Lost to Follow-up|2|||
170855403|NCT03184870|617480468|FG000|Initial Treatment|Withdrawal by Subject|0|||
170855404|NCT03184870|617480469|FG001|Initial Treatment|Withdrawal by Subject|0|||
170855405|NCT03184870|617480470|FG002|Initial Treatment|Withdrawal by Subject|2|||
170855406|NCT03184870|617480471|FG003|Initial Treatment|Withdrawal by Subject|1|||
170855407|NCT03184870|617480472|FG004|Initial Treatment|Withdrawal by Subject|1|||
170855408|NCT03184870|617480473|FG005|Initial Treatment|Withdrawal by Subject|0|||
170855409|NCT03184870|617480474|FG006|Initial Treatment|Withdrawal by Subject|1|||
170855410|NCT03184870|617480475|FG007|Initial Treatment|Withdrawal by Subject|0|||
170855411|NCT03184870|617480476|FG008|Initial Treatment|Withdrawal by Subject|0|||
170855412|NCT03184870|617480477|FG009|Initial Treatment|Withdrawal by Subject|0|||
170855413|NCT03184870|617480478|FG010|Initial Treatment|Withdrawal by Subject|0|||
170855414|NCT03184870|617480479|FG011|Initial Treatment|Withdrawal by Subject|2|||
170855415|NCT03184870|617480480|FG012|Initial Treatment|Withdrawal by Subject|3|||
170855416|NCT03184870|617480481|FG013|Initial Treatment|Withdrawal by Subject|0|||
170855417|NCT03184870|617480482|FG014|Initial Treatment|Withdrawal by Subject|1|||
170855418|NCT03184870|617480483|FG015|Initial Treatment|Withdrawal by Subject|5|||
170855419|NCT03184870|617480484|FG016|Initial Treatment|Withdrawal by Subject|2|||
170855420|NCT03184870|617480485|FG017|Initial Treatment|Withdrawal by Subject|2|||
170855421|NCT03184870|617480468|FG000|Initial Treatment|Moved to crossover treatment|0|||
170855422|NCT03184870|617480469|FG001|Initial Treatment|Moved to crossover treatment|0|||
170855423|NCT03184870|617480470|FG002|Initial Treatment|Moved to crossover treatment|0|||
170855424|NCT03184870|617480471|FG003|Initial Treatment|Moved to crossover treatment|0|||
170855425|NCT03184870|617480472|FG004|Initial Treatment|Moved to crossover treatment|0|||
170855426|NCT03184870|617480473|FG005|Initial Treatment|Moved to crossover treatment|0|||
170855427|NCT03184870|617480474|FG006|Initial Treatment|Moved to crossover treatment|0|||
170855428|NCT03184870|617480475|FG007|Initial Treatment|Moved to crossover treatment|0|||
170855429|NCT03184870|617480476|FG008|Initial Treatment|Moved to crossover treatment|0|||
170855430|NCT03184870|617480477|FG009|Initial Treatment|Moved to crossover treatment|0|||
170855431|NCT03184870|617480478|FG010|Initial Treatment|Moved to crossover treatment|0|||
170855432|NCT03184870|617480479|FG011|Initial Treatment|Moved to crossover treatment|0|||
170855433|NCT03184870|617480480|FG012|Initial Treatment|Moved to crossover treatment|9|||
170855434|NCT03184870|617480481|FG013|Initial Treatment|Moved to crossover treatment|0|||
170855435|NCT03184870|617480482|FG014|Initial Treatment|Moved to crossover treatment|0|||
170855436|NCT03184870|617480483|FG015|Initial Treatment|Moved to crossover treatment|0|||
170855437|NCT03184870|617480484|FG016|Initial Treatment|Moved to crossover treatment|0|||
170855438|NCT03184870|617480485|FG017|Initial Treatment|Moved to crossover treatment|0|||
170855439|NCT03184870|617480468|FG000|Crossover Treatment|Other reasons|0|||
170855440|NCT03184870|617480469|FG001|Crossover Treatment|Other reasons|0|||
170855441|NCT03184870|617480470|FG002|Crossover Treatment|Other reasons|0|||
170855442|NCT03184870|617480471|FG003|Crossover Treatment|Other reasons|0|||
170855443|NCT03184870|617480472|FG004|Crossover Treatment|Other reasons|0|||
170855444|NCT03184870|617480473|FG005|Crossover Treatment|Other reasons|0|||
170855445|NCT03184870|617480474|FG006|Crossover Treatment|Other reasons|0|||
170855446|NCT03184870|617480475|FG007|Crossover Treatment|Other reasons|0|||
170855447|NCT03184870|617480476|FG008|Crossover Treatment|Other reasons|0|||
170855448|NCT03184870|617480477|FG009|Crossover Treatment|Other reasons|0|||
170855449|NCT03184870|617480478|FG010|Crossover Treatment|Other reasons|0|||
170855450|NCT03184870|617480479|FG011|Crossover Treatment|Other reasons|0|||
170855451|NCT03184870|617480480|FG012|Crossover Treatment|Other reasons|0|||
170855452|NCT03184870|617480481|FG013|Crossover Treatment|Other reasons|0|||
170855453|NCT03184870|617480482|FG014|Crossover Treatment|Other reasons|0|||
170855454|NCT03184870|617480483|FG015|Crossover Treatment|Other reasons|0|||
170855455|NCT03184870|617480484|FG016|Crossover Treatment|Other reasons|0|||
170855456|NCT03184870|617480485|FG017|Crossover Treatment|Other reasons|2|||
170855457|NCT03184870|617480468|FG000|Crossover Treatment|Death|0|||
170855458|NCT03184870|617480469|FG001|Crossover Treatment|Death|0|||
170855459|NCT03184870|617480470|FG002|Crossover Treatment|Death|0|||
170855460|NCT03184870|617480471|FG003|Crossover Treatment|Death|0|||
170855461|NCT03184870|617480472|FG004|Crossover Treatment|Death|0|||
170855462|NCT03184870|617480473|FG005|Crossover Treatment|Death|0|||
170855463|NCT03184870|617480474|FG006|Crossover Treatment|Death|0|||
170855464|NCT03184870|617480475|FG007|Crossover Treatment|Death|0|||
170855465|NCT03184870|617480476|FG008|Crossover Treatment|Death|0|||
170855466|NCT03184870|617480477|FG009|Crossover Treatment|Death|0|||
170855467|NCT03184870|617480478|FG010|Crossover Treatment|Death|0|||
170855468|NCT03184870|617480479|FG011|Crossover Treatment|Death|0|||
170855469|NCT03184870|617480480|FG012|Crossover Treatment|Death|0|||
170855470|NCT03184870|617480481|FG013|Crossover Treatment|Death|0|||
170855471|NCT03184870|617480482|FG014|Crossover Treatment|Death|0|||
170855472|NCT03184870|617480483|FG015|Crossover Treatment|Death|0|||
170855473|NCT03184870|617480484|FG016|Crossover Treatment|Death|0|||
170855474|NCT03184870|617480485|FG017|Crossover Treatment|Death|7|||
170855475|NCT00666679|617480486|FG000|First Intervention|Lost to Follow-up|1|||
170855476|NCT00666679|617480487|FG001|First Intervention|Lost to Follow-up|0|||
170855477|NCT00666679|617480486|FG000|First Intervention|Protocol Violation|1|||
170855478|NCT00666679|617480487|FG001|First Intervention|Protocol Violation|0|||
170855479|NCT00666679|617480486|FG000|First Intervention|Withdrawal by Subject|1|||
170855480|NCT00666679|617480487|FG001|First Intervention|Withdrawal by Subject|0|||
170855481|NCT00666679|617480486|FG000|First Intervention|Randomized did not start treatment|1|||
170855482|NCT00666679|617480487|FG001|First Intervention|Randomized did not start treatment|1|||
170855483|NCT00666679|617480486|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
170855484|NCT00666679|617480487|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
170855485|NCT00666679|617480486|FG000|Washout Period of 1 Week|Protocol Violation|0|||
170855486|NCT00666679|617480487|FG001|Washout Period of 1 Week|Protocol Violation|1|||
170855487|NCT00666679|617480486|FG000|Second Intervention|Adverse Event|1|||
170855488|NCT00666679|617480487|FG001|Second Intervention|Adverse Event|0|||
170855489|NCT00666679|617480486|FG000|Second Intervention|Death|0|||
170855490|NCT00666679|617480487|FG001|Second Intervention|Death|1|||
170855491|NCT00346632|617480492|FG000|Overall Study|Progressive Disease|2|||
170855492|NCT00346632|617480493|FG001|Overall Study|Progressive Disease|2|||
170855493|NCT00346632|617480494|FG002|Overall Study|Progressive Disease|4|||
170855494|NCT00346632|617480495|FG003|Overall Study|Progressive Disease|3|||
170855495|NCT00346632|617480496|FG004|Overall Study|Progressive Disease|3|||
170855496|NCT00346632|617480497|FG005|Overall Study|Progressive Disease|1|||
170855497|NCT00346632|617480498|FG006|Overall Study|Progressive Disease|2|||
170855498|NCT00346632|617480499|FG007|Overall Study|Progressive Disease|2|||
170855499|NCT00346632|617480500|FG008|Overall Study|Progressive Disease|2|||
170855500|NCT00346632|617480501|FG009|Overall Study|Progressive Disease|2|||
170855501|NCT00346632|617480492|FG000|Overall Study|Adverse Event|0|||
170855502|NCT00346632|617480493|FG001|Overall Study|Adverse Event|0|||
170855503|NCT00346632|617480494|FG002|Overall Study|Adverse Event|0|||
170855504|NCT00346632|617480495|FG003|Overall Study|Adverse Event|0|||
170855505|NCT00346632|617480496|FG004|Overall Study|Adverse Event|1|||
170855506|NCT00346632|617480497|FG005|Overall Study|Adverse Event|1|||
170855507|NCT00346632|617480498|FG006|Overall Study|Adverse Event|1|||
170855508|NCT00346632|617480499|FG007|Overall Study|Adverse Event|0|||
170855509|NCT00346632|617480500|FG008|Overall Study|Adverse Event|0|||
170855510|NCT00346632|617480501|FG009|Overall Study|Adverse Event|0|||
170855511|NCT00346632|617480492|FG000|Overall Study|Death|0|||
170855512|NCT00346632|617480493|FG001|Overall Study|Death|0|||
170855513|NCT00346632|617480494|FG002|Overall Study|Death|1|||
170855514|NCT00346632|617480495|FG003|Overall Study|Death|0|||
170855515|NCT00346632|617480496|FG004|Overall Study|Death|0|||
170855516|NCT00346632|617480497|FG005|Overall Study|Death|0|||
170855517|NCT00346632|617480498|FG006|Overall Study|Death|0|||
170855518|NCT00346632|617480499|FG007|Overall Study|Death|0|||
170855519|NCT00346632|617480500|FG008|Overall Study|Death|0|||
170855520|NCT00346632|617480501|FG009|Overall Study|Death|0|||
170855521|NCT00346632|617480492|FG000|Overall Study|Protocol Violation|0|||
170855522|NCT00346632|617480493|FG001|Overall Study|Protocol Violation|0|||
170855523|NCT00346632|617480494|FG002|Overall Study|Protocol Violation|0|||
170855524|NCT00346632|617480495|FG003|Overall Study|Protocol Violation|0|||
170855525|NCT00346632|617480496|FG004|Overall Study|Protocol Violation|0|||
170855526|NCT00346632|617480497|FG005|Overall Study|Protocol Violation|0|||
170855527|NCT00346632|617480498|FG006|Overall Study|Protocol Violation|1|||
170855528|NCT00346632|617480499|FG007|Overall Study|Protocol Violation|0|||
170855529|NCT00346632|617480500|FG008|Overall Study|Protocol Violation|0|||
170855530|NCT00346632|617480501|FG009|Overall Study|Protocol Violation|0|||
170855531|NCT00346632|617480492|FG000|Overall Study|Withdrawal by Subject|0|||
170855532|NCT00346632|617480493|FG001|Overall Study|Withdrawal by Subject|0|||
170855533|NCT00346632|617480494|FG002|Overall Study|Withdrawal by Subject|0|||
170855534|NCT00346632|617480495|FG003|Overall Study|Withdrawal by Subject|0|||
170855535|NCT00346632|617480496|FG004|Overall Study|Withdrawal by Subject|0|||
170855536|NCT00346632|617480497|FG005|Overall Study|Withdrawal by Subject|0|||
170855537|NCT00346632|617480498|FG006|Overall Study|Withdrawal by Subject|1|||
170855538|NCT00346632|617480499|FG007|Overall Study|Withdrawal by Subject|0|||
170855539|NCT00346632|617480500|FG008|Overall Study|Withdrawal by Subject|0|||
170855540|NCT00346632|617480501|FG009|Overall Study|Withdrawal by Subject|0|||
170855541|NCT00346632|617480492|FG000|Overall Study|Switched to alternative treatment|0|||
170855542|NCT00346632|617480493|FG001|Overall Study|Switched to alternative treatment|0|||
170855543|NCT00346632|617480494|FG002|Overall Study|Switched to alternative treatment|1|||
170855544|NCT00346632|617480495|FG003|Overall Study|Switched to alternative treatment|0|||
170855545|NCT00346632|617480496|FG004|Overall Study|Switched to alternative treatment|0|||
170855546|NCT00346632|617480497|FG005|Overall Study|Switched to alternative treatment|0|||
170855547|NCT00346632|617480498|FG006|Overall Study|Switched to alternative treatment|0|||
170855548|NCT00346632|617480499|FG007|Overall Study|Switched to alternative treatment|0|||
170855549|NCT00346632|617480500|FG008|Overall Study|Switched to alternative treatment|0|||
170855550|NCT00346632|617480501|FG009|Overall Study|Switched to alternative treatment|0|||
170855551|NCT00346632|617480492|FG000|Overall Study|Not Stated|1|||
170855552|NCT00346632|617480493|FG001|Overall Study|Not Stated|1|||
170855553|NCT00346632|617480494|FG002|Overall Study|Not Stated|0|||
170855554|NCT00346632|617480495|FG003|Overall Study|Not Stated|0|||
170855555|NCT00346632|617480496|FG004|Overall Study|Not Stated|0|||
170855556|NCT00346632|617480497|FG005|Overall Study|Not Stated|0|||
170855557|NCT00346632|617480498|FG006|Overall Study|Not Stated|0|||
170855558|NCT00346632|617480499|FG007|Overall Study|Not Stated|2|||
170855559|NCT00346632|617480500|FG008|Overall Study|Not Stated|2|||
170855560|NCT00346632|617480501|FG009|Overall Study|Not Stated|1|||
170855561|NCT04882995|617480502|FG000|Overall Study|Withdrawal by Subject|1|||
170855562|NCT04882995|617480503|FG001|Overall Study|Withdrawal by Subject|2|||
170855563|NCT04882995|617480502|FG000|Overall Study|Protocol Violation|4|||
170855564|NCT04882995|617480503|FG001|Overall Study|Protocol Violation|4|||
170855565|NCT04882995|617480502|FG000|Overall Study|Surgery postponed due to COVID|1|||
170855566|NCT04882995|617480503|FG001|Overall Study|Surgery postponed due to COVID|1|||
170855567|NCT03606668|617480507|FG000|Overall Study|Screen Failure|1|||
170855568|NCT03606668|617480507|FG000|Overall Study|Lost to Follow-up|1|||
170855569|NCT02354508|617480508|FG000|Period 1: Core Phase|Adverse Event|1|||
170855570|NCT02354508|617480509|FG001|Period 1: Core Phase|Adverse Event|1|||
170855571|NCT02354508|617480510|FG002|Period 1: Core Phase|Adverse Event|2|||
170855572|NCT02354508|617480508|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
170855573|NCT02354508|617480509|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
170855574|NCT02354508|617480510|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
170855575|NCT02354508|617480508|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
170855576|NCT02354508|617480509|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
170855577|NCT02354508|617480510|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
170855578|NCT02354508|617480508|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
170855579|NCT02354508|617480509|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
170855580|NCT02354508|617480510|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
170855581|NCT02354508|617480508|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
170855582|NCT02354508|617480509|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
170855583|NCT02354508|617480510|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
170855584|NCT02354508|617480508|FG000|Period 2: Extension Phase|Physician Decision|5|||
170855585|NCT02354508|617480509|FG001|Period 2: Extension Phase|Physician Decision|0|||
170855586|NCT02354508|617480510|FG002|Period 2: Extension Phase|Physician Decision|1|||
170855587|NCT02354508|617480508|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
170855588|NCT02354508|617480509|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
170855589|NCT02354508|617480510|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
170855590|NCT02354508|617480508|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
170855591|NCT02354508|617480509|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
170855592|NCT02354508|617480510|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
170855593|NCT02354508|617480508|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
170855594|NCT02354508|617480509|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
170855595|NCT02354508|617480510|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
170855596|NCT03587974|617480511|FG000|Overall Study|caregiver demented, care recipient died|3|||
170855597|NCT03587974|617480512|FG001|Overall Study|caregiver demented, care recipient died|3|||
170855598|NCT03587974|617480511|FG000|Overall Study|Withdrawal by Subject|2|||
170855599|NCT03587974|617480512|FG001|Overall Study|Withdrawal by Subject|1|||
170855600|NCT04447846|617480513|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
170855601|NCT00297232|617480516|FG000|Overall Study|Lack of Efficacy|7|||
170855602|NCT00297232|617480516|FG000|Overall Study|Lost to Follow-up|10|||
170855603|NCT00297232|617480516|FG000|Overall Study|Adverse Event|63|||
170855604|NCT00297232|617480516|FG000|Overall Study|Voluntary Withdrawal|120|||
170855605|NCT00297232|617480516|FG000|Overall Study|Subject was Noncompliant|9|||
170855606|NCT00297232|617480516|FG000|Overall Study|Death|9|||
170855607|NCT00297232|617480516|FG000|Overall Study|Anti-natalizumab Positive|8|||
170855608|NCT00297232|617480516|FG000|Overall Study|Switched to Commercial Tysabri|22|||
170855609|NCT00297232|617480516|FG000|Overall Study|Disease Progression|8|||
170855610|NCT00297232|617480516|FG000|Overall Study|Fear of PML|10|||
170855611|NCT00297232|617480516|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
170855612|NCT00297232|617480516|FG000|Overall Study|Miscellaneous|5|||
170855613|NCT00297232|617480516|FG000|Overall Study|Sponsor Decision|34|||
170855614|NCT00297232|617480516|FG000|Overall Study|Subject Relocated|7|||
170855615|NCT00297232|617480516|FG000|Overall Study|Subject Withdrew Consent|37|||
170855616|NCT00297232|617480516|FG000|Overall Study|Persistently Positive Antibodies|11|||
170855617|NCT00297232|617480516|FG000|Overall Study|Investigator Withdrew From Program|19|||
170855618|NCT00297232|617480516|FG000|Overall Study|Did Not Enroll to Week 264|34|||
170855619|NCT00297232|617480516|FG000|Overall Study|Did Not Enroll to Week 480|17|||
170855620|NCT00297232|617480516|FG000|Overall Study|No data available after Week 264|161|||
170855621|NCT00297232|617480516|FG000|Overall Study|Other|1|||
170855622|NCT03486457|617480517|FG000|Up to Month 3|Adverse Event|2|||
170855623|NCT03486457|617480518|FG001|Up to Month 3|Adverse Event|5|||
170855624|NCT03486457|617480517|FG000|Up to Month 3|Lack of Efficacy|1|||
170855625|NCT03486457|617480518|FG001|Up to Month 3|Lack of Efficacy|0|||
170855626|NCT03486457|617480517|FG000|Up to Month 3|Withdrawal by Subject|1|||
170855627|NCT03486457|617480518|FG001|Up to Month 3|Withdrawal by Subject|0|||
170855628|NCT03486457|617480517|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
170855629|NCT03486457|617480518|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
170855630|NCT03486457|617480517|FG000|Up to Month 3|Other|1|||
170855631|NCT03486457|617480518|FG001|Up to Month 3|Other|0|||
170855632|NCT03486457|617480517|FG000|Month 3 to Month 6|Adverse Event|2|||
170855633|NCT03486457|617480518|FG001|Month 3 to Month 6|Adverse Event|0|||
170855634|NCT03486457|617480517|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
170855635|NCT03486457|617480518|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
170855636|NCT03486457|617480517|FG000|Month 3 to Month 6|Pregnancy|0|||
170855637|NCT03486457|617480518|FG001|Month 3 to Month 6|Pregnancy|1|||
170855638|NCT03486457|617480517|FG000|Month 3 to Month 6|Other|1|||
170855639|NCT03486457|617480518|FG001|Month 3 to Month 6|Other|0|||
170855640|NCT03536143|617480519|FG000|Overall Study|Early termination, Sponsor decision|1|||
170855641|NCT00495586|617480520|FG000|Overall Study|Withdrawal by Subject|4|||
170855642|NCT00495586|617480521|FG001|Overall Study|Withdrawal by Subject|4|||
170855643|NCT03038438|617480522|FG000|Overall Study|Death|3|||
170855644|NCT03038438|617480522|FG000|Overall Study|Lost to Follow-up|8|||
170855645|NCT03038438|617480522|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
170855646|NCT03038438|617480522|FG000|Overall Study|Withdrawal by Subject|5|||
170855647|NCT03038438|617480522|FG000|Overall Study|No 36-Month Follow-Up|18|||
170855648|NCT01174160|617480523|FG000|Overall Study|Adverse Event|1|||
170855649|NCT01174160|617480524|FG001|Overall Study|Adverse Event|0|||
170855650|NCT01174160|617480523|FG000|Overall Study|Lost to Follow-up|1|||
170855651|NCT01174160|617480524|FG001|Overall Study|Lost to Follow-up|0|||
170855652|NCT01174160|617480523|FG000|Overall Study|Physician Decision|1|||
170855653|NCT01174160|617480524|FG001|Overall Study|Physician Decision|0|||
170855654|NCT01174160|617480523|FG000|Overall Study|Protocol Violation|4|||
170855655|NCT01174160|617480524|FG001|Overall Study|Protocol Violation|6|||
170855656|NCT01174160|617480523|FG000|Overall Study|Withdrawal by Subject|1|||
170855657|NCT01174160|617480524|FG001|Overall Study|Withdrawal by Subject|0|||
170743130|NCT02357810|617066046|FG000|Reached 12 Weeks Response|Physician Decision|1|||
170743131|NCT02357810|617066046|FG000|Reached 12 Weeks Response|Other|1|||
170743132|NCT02357810|617066046|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
170743133|NCT02357810|617066046|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
170743134|NCT02357810|617066046|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
170743135|NCT02357810|617066046|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
170743136|NCT02357810|617066046|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
170743137|NCT02357810|617066046|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
170743138|NCT00562978|617066047|FG000|Overall Study|Patient had imaging dose only|1|||
170743139|NCT00562978|617066048|FG001|Overall Study|Patient had imaging dose only|11|||
170743140|NCT00936221|617066050|FG000|Overall Study|Withdrawal by Subject|1|||
170743141|NCT00936221|617066051|FG001|Overall Study|Withdrawal by Subject|1|||
170743142|NCT03820323|617066052|FG000|Overall Study|Lost to Follow-up|2|||
170743143|NCT03820323|617066053|FG001|Overall Study|Lost to Follow-up|1|||
170743144|NCT03820323|617066052|FG000|Overall Study|Missed 12-month visit|22|||
170743145|NCT03820323|617066053|FG001|Overall Study|Missed 12-month visit|14|||
170743146|NCT03820323|617066052|FG000|Overall Study|Death|2|||
170855658|NCT01590017|617480525|FG000|Overall Study|Adverse Event|1|||
170855659|NCT01590017|617480525|FG000|Overall Study|Withdrawal by Subject|1|||
170855660|NCT01590017|617480525|FG000|Overall Study|Lack of Efficacy|1|||
170855661|NCT01590017|617480525|FG000|Overall Study|Physician Decision|1|||
170855662|NCT01347762|617480526|FG000|Overall Study|Lost to Follow-up|0|||
170855663|NCT01347762|617480527|FG001|Overall Study|Lost to Follow-up|1|||
170855664|NCT01347762|617480528|FG002|Overall Study|Lost to Follow-up|6|||
170855665|NCT01347762|617480529|FG003|Overall Study|Lost to Follow-up|5|||
170855666|NCT01347762|617480526|FG000|Overall Study|Withdrawal by Subject|4|||
170855667|NCT01347762|617480527|FG001|Overall Study|Withdrawal by Subject|1|||
170855668|NCT01347762|617480528|FG002|Overall Study|Withdrawal by Subject|3|||
170855669|NCT01347762|617480529|FG003|Overall Study|Withdrawal by Subject|3|||
170855670|NCT02527343|617480533|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
170855671|NCT02527343|617480534|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
170855672|NCT02527343|617480535|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
170855673|NCT02527343|617480536|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
170855674|NCT02527343|617480537|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
170855675|NCT02527343|617480538|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
170855676|NCT02527343|617480533|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
170855677|NCT02527343|617480534|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
170855678|NCT02527343|617480535|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
170855679|NCT02527343|617480536|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
170855680|NCT02527343|617480537|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
170855681|NCT02527343|617480538|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
170855682|NCT02527343|617480533|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
170855683|NCT02527343|617480534|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
170855684|NCT02527343|617480535|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
170855685|NCT02527343|617480536|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
170855686|NCT02527343|617480537|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
170855687|NCT02527343|617480538|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
170855688|NCT02527343|617480533|FG000|RT Period: Weeks 1 to 52|Other|4|||
170855689|NCT02527343|617480534|FG001|RT Period: Weeks 1 to 52|Other|3|||
170855690|NCT02527343|617480535|FG002|RT Period: Weeks 1 to 52|Other|0|||
170855691|NCT02527343|617480536|FG003|RT Period: Weeks 1 to 52|Other|0|||
170855692|NCT02527343|617480537|FG004|RT Period: Weeks 1 to 52|Other|0|||
170855693|NCT02527343|617480538|FG005|RT Period: Weeks 1 to 52|Other|0|||
170855694|NCT02527343|617480533|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
170855695|NCT02527343|617480534|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
170855696|NCT02527343|617480535|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
170855697|NCT02527343|617480536|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
170855698|NCT02527343|617480537|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
170855699|NCT02527343|617480538|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
170855700|NCT02527343|617480533|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
170855701|NCT02527343|617480534|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
170855702|NCT02527343|617480535|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
170855703|NCT02527343|617480536|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
170855704|NCT02527343|617480537|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
170855705|NCT02527343|617480538|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
170855706|NCT02527343|617480533|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
170855707|NCT02527343|617480534|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
170855708|NCT02527343|617480535|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
170855709|NCT02527343|617480536|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
170855710|NCT02527343|617480537|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
170855711|NCT02527343|617480538|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
170855712|NCT02527343|617480533|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
170855713|NCT02527343|617480534|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
170855714|NCT02527343|617480535|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
170855715|NCT02527343|617480536|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
170855716|NCT02527343|617480537|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
170855717|NCT02527343|617480538|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
170855718|NCT02527343|617480533|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
170855719|NCT02527343|617480534|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
170855720|NCT02527343|617480535|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
170855721|NCT02527343|617480536|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
170855722|NCT02527343|617480537|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
170855723|NCT02527343|617480538|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
170855724|NCT02527343|617480533|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
170855725|NCT02527343|617480534|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
170855726|NCT02527343|617480535|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
170855727|NCT02527343|617480536|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
170855728|NCT02527343|617480537|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
170855729|NCT02527343|617480538|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
170855730|NCT02527343|617480533|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
170743147|NCT03820323|617066053|FG001|Overall Study|Death|1|||
170743148|NCT03820323|617066052|FG000|Overall Study|Transferred out|13|||
170743149|NCT03820323|617066053|FG001|Overall Study|Transferred out|11|||
170743150|NCT03820323|617066052|FG000|Overall Study|Terminated|0|||
170743151|NCT03820323|617066053|FG001|Overall Study|Terminated|3|||
170743152|NCT03820323|617066052|FG000|Overall Study|Withdrawal by Subject|1|||
170743153|NCT03820323|617066053|FG001|Overall Study|Withdrawal by Subject|6|||
170743154|NCT03151395|617066054|FG000|Overall Study|Adverse Event|2|||
170743155|NCT03151395|617066054|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
170743156|NCT03151395|617066054|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
170743157|NCT03151395|617066054|FG000|Overall Study|Unspecified reason|4|||
170743158|NCT00545363|617066055|FG000|Overall Study|Adverse Event|6|||
170743159|NCT00545363|617066056|FG001|Overall Study|Adverse Event|7|||
170743160|NCT00545363|617066055|FG000|Overall Study|Withdrawal by Subject|6|||
170743161|NCT00545363|617066056|FG001|Overall Study|Withdrawal by Subject|5|||
170743162|NCT00545363|617066055|FG000|Overall Study|Non-compliance|3|||
170743163|NCT00545363|617066056|FG001|Overall Study|Non-compliance|1|||
170743164|NCT00545363|617066055|FG000|Overall Study|Did not meet entry criteria|1|||
170743165|NCT00545363|617066056|FG001|Overall Study|Did not meet entry criteria|1|||
170743166|NCT00545363|617066055|FG000|Overall Study|Lost to Follow-up|2|||
170743167|NCT00545363|617066056|FG001|Overall Study|Lost to Follow-up|0|||
170743168|NCT00545363|617066055|FG000|Overall Study|Other|1|||
170743169|NCT00545363|617066056|FG001|Overall Study|Other|1|||
170743170|NCT00366301|617066057|FG000|Overall Study|Lost to Follow-up|4|||
170743171|NCT00366301|617066058|FG001|Overall Study|Lost to Follow-up|4|||
170743172|NCT00366301|617066059|FG002|Overall Study|Lost to Follow-up|3|||
170743173|NCT00366301|617066060|FG003|Overall Study|Lost to Follow-up|7|||
170743174|NCT00366301|617066057|FG000|Overall Study|Withdrawal by Subject|4|||
170743175|NCT00366301|617066058|FG001|Overall Study|Withdrawal by Subject|2|||
170743176|NCT00366301|617066059|FG002|Overall Study|Withdrawal by Subject|1|||
170743177|NCT00366301|617066060|FG003|Overall Study|Withdrawal by Subject|1|||
170743178|NCT02153359|617066061|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
170743179|NCT02153359|617066062|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
170743180|NCT01348776|617066063|FG000|Overall Study|Lost to Follow-up|3|||
170743181|NCT02912468|617066064|FG000|Overall Study|Adverse Event|3|||
170743182|NCT02912468|617066065|FG001|Overall Study|Adverse Event|2|||
170743183|NCT02912468|617066064|FG000|Overall Study|Withdrawal by Subject|6|||
170743184|NCT02912468|617066065|FG001|Overall Study|Withdrawal by Subject|2|||
170743185|NCT02912468|617066064|FG000|Overall Study|Randomized and not treated|0|||
170743186|NCT02912468|617066065|FG001|Overall Study|Randomized and not treated|1|||
170743187|NCT01617005|617066069|FG000|Overall Study|Pregnancy|1|||
170743188|NCT01617005|617066069|FG000|Overall Study|Lack of motivation for treatment|1|||
170743189|NCT04534114|617066070|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
170743190|NCT04534114|617066071|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
170743191|NCT04534114|617066072|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
170743192|NCT04534114|617066073|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
170743193|NCT04534114|617066070|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
170743194|NCT04534114|617066071|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
170743195|NCT04534114|617066072|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
170743196|NCT04534114|617066073|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
170743197|NCT04534114|617066070|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
170743198|NCT04534114|617066071|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
170743199|NCT04534114|617066072|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
170743200|NCT04534114|617066073|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
170743201|NCT04534114|617066070|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
170743202|NCT04534114|617066071|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
170743203|NCT04534114|617066072|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
170743204|NCT04534114|617066073|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
170743205|NCT04534114|617066070|FG000|Main Treatment Period|Physician Decision|0|||
170743206|NCT04534114|617066071|FG001|Main Treatment Period|Physician Decision|0|||
170855731|NCT02527343|617480534|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
170743207|NCT04534114|617066072|FG002|Main Treatment Period|Physician Decision|0|||
170743208|NCT04534114|617066073|FG003|Main Treatment Period|Physician Decision|1|||
170743209|NCT04534114|617066070|FG000|Main Treatment Period|Death|1|||
170743210|NCT04534114|617066071|FG001|Main Treatment Period|Death|0|||
170743211|NCT04534114|617066072|FG002|Main Treatment Period|Death|0|||
170855732|NCT02527343|617480535|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
170855733|NCT02527343|617480536|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
170855734|NCT02527343|617480537|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
170743212|NCT04534114|617066073|FG003|Main Treatment Period|Death|1|||
170743213|NCT04534114|617066070|FG000|Main Treatment Period|Other reason|1|||
170743214|NCT04534114|617066071|FG001|Main Treatment Period|Other reason|1|||
170855735|NCT02527343|617480538|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
170855736|NCT02527343|617480533|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
170855737|NCT02527343|617480534|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
170855738|NCT02527343|617480535|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
170855739|NCT02527343|617480536|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
170855740|NCT02527343|617480537|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
170855741|NCT02527343|617480538|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
170855742|NCT02527343|617480533|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
170855743|NCT02527343|617480534|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
170855744|NCT02527343|617480535|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
170855745|NCT02527343|617480536|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
170855746|NCT02527343|617480537|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
170855747|NCT02527343|617480538|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
170855748|NCT03235284|617480539|FG000|Overall Study|Adverse Event|1|||
170855749|NCT03235284|617480540|FG001|Overall Study|Adverse Event|2|||
170855750|NCT03235284|617480541|FG002|Overall Study|Adverse Event|1|||
170855751|NCT00523640|617480544|FG000|Overall Study|Death|1|||
170855752|NCT04055090|617480545|FG000|Overall Study|screen failure|1|||
170855753|NCT04055090|617480546|FG001|Overall Study|screen failure|0|||
170855754|NCT04055090|617480545|FG000|Overall Study|Withdrawal by Subject|1|||
170855755|NCT04055090|617480546|FG001|Overall Study|Withdrawal by Subject|0|||
170855756|NCT00211185|617480549|FG000|Overall Study|Death|2|||
170855757|NCT00211185|617480549|FG000|Overall Study|Disease progression|7|||
170855758|NCT00211185|617480549|FG000|Overall Study|Withdrawal by Subject|6|||
170855759|NCT00211185|617480549|FG000|Overall Study|Physician Decision|5|||
170855760|NCT00249002|617480550|FG000|Overall Study|Adverse Event|2|||
170855761|NCT00249002|617480550|FG000|Overall Study|Study cancellation|3|||
170855762|NCT00249002|617480550|FG000|Overall Study|Other|2|||
170855763|NCT00825916|617480554|FG000|Overall Study|Lost to Follow-up|4|||
170855764|NCT00825916|617480555|FG001|Overall Study|Lost to Follow-up|2|||
170855765|NCT00825916|617480556|FG002|Overall Study|Lost to Follow-up|1|||
170855766|NCT04223830|617480557|FG000|Overall Study|Lost to Follow-up|9|||
170855767|NCT04223830|617480557|FG000|Overall Study|Adverse Event|1|||
170855768|NCT00862719|617480558|FG000|Overall Study|Disease Progression|5|||
170855769|NCT00862719|617480559|FG001|Overall Study|Disease Progression|0|||
170855770|NCT00862719|617480560|FG002|Overall Study|Disease Progression|1|||
170855771|NCT00862719|617480561|FG003|Overall Study|Disease Progression|0|||
170855772|NCT00862719|617480558|FG000|Overall Study|Death|5|||
170855773|NCT00862719|617480559|FG001|Overall Study|Death|6|||
170855774|NCT00862719|617480560|FG002|Overall Study|Death|1|||
170855775|NCT00862719|617480561|FG003|Overall Study|Death|1|||
170855776|NCT00862719|617480558|FG000|Overall Study|Engraftment failure|0|||
170855777|NCT00862719|617480559|FG001|Overall Study|Engraftment failure|0|||
170855778|NCT00862719|617480560|FG002|Overall Study|Engraftment failure|1|||
170855779|NCT00862719|617480561|FG003|Overall Study|Engraftment failure|0|||
170855780|NCT00862719|617480558|FG000|Overall Study|Veno-Occlusive Disease|0|||
170855781|NCT00862719|617480559|FG001|Overall Study|Veno-Occlusive Disease|0|||
170855782|NCT00862719|617480560|FG002|Overall Study|Veno-Occlusive Disease|1|||
170855783|NCT00862719|617480561|FG003|Overall Study|Veno-Occlusive Disease|0|||
170855784|NCT01806623|617480562|FG000|Overall Study|Withdrawal by Subject|1|||
170855785|NCT01806623|617480562|FG000|Overall Study|Adverse Event|1|||
170855786|NCT01806623|617480562|FG000|Overall Study|Did not meet the inclusion criteria|56|||
170855787|NCT00439231|617480567|FG000|Overall Study|Lack of Efficacy|28|||
170855788|NCT01210664|617480570|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
170855789|NCT01210664|617480571|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
170855790|NCT01210664|617480572|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
170855791|NCT01210664|617480573|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
170855792|NCT01210664|617480570|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
170855793|NCT01210664|617480571|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
170855794|NCT01210664|617480572|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
170855795|NCT01210664|617480573|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
170855796|NCT01210664|617480570|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
170855797|NCT01210664|617480571|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
170855798|NCT01210664|617480572|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
170855799|NCT01210664|617480573|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
170855800|NCT00196976|617480575|FG000|Primary Study|Migrated from study area|0|||
170855801|NCT00196976|617480576|FG001|Primary Study|Migrated from study area|0|||
170855802|NCT00196976|617480577|FG002|Primary Study|Migrated from study area|0|||
170855803|NCT00196976|617480578|FG003|Primary Study|Migrated from study area|0|||
170855804|NCT00196976|617480579|FG004|Primary Study|Migrated from study area|0|||
170855805|NCT00196976|617480580|FG005|Primary Study|Migrated from study area|0|||
170855806|NCT00196976|617480581|FG006|Primary Study|Migrated from study area|0|||
170855807|NCT00196976|617480582|FG007|Primary Study|Migrated from study area|1|||
170855808|NCT00196976|617480583|FG008|Primary Study|Migrated from study area|0|||
170855809|NCT00196976|617480584|FG009|Primary Study|Migrated from study area|0|||
170855810|NCT00196976|617480585|FG010|Primary Study|Migrated from study area|0|||
170855811|NCT00196976|617480586|FG011|Primary Study|Migrated from study area|0|||
170855812|NCT00196976|617480587|FG012|Primary Study|Migrated from study area|0|||
170855813|NCT00196976|617480588|FG013|Primary Study|Migrated from study area|0|||
170855814|NCT00196976|617480575|FG000|Primary Study|Protocol Violation|0|||
170855815|NCT00196976|617480576|FG001|Primary Study|Protocol Violation|1|||
170855816|NCT00196976|617480577|FG002|Primary Study|Protocol Violation|1|||
170855817|NCT00196976|617480578|FG003|Primary Study|Protocol Violation|0|||
170855818|NCT00196976|617480579|FG004|Primary Study|Protocol Violation|0|||
170855819|NCT00196976|617480580|FG005|Primary Study|Protocol Violation|0|||
170855820|NCT00196976|617480581|FG006|Primary Study|Protocol Violation|0|||
170855821|NCT00196976|617480582|FG007|Primary Study|Protocol Violation|0|||
170855822|NCT00196976|617480583|FG008|Primary Study|Protocol Violation|0|||
170855823|NCT00196976|617480584|FG009|Primary Study|Protocol Violation|0|||
170855824|NCT00196976|617480585|FG010|Primary Study|Protocol Violation|0|||
170855825|NCT00196976|617480586|FG011|Primary Study|Protocol Violation|0|||
170855826|NCT00196976|617480587|FG012|Primary Study|Protocol Violation|0|||
170855827|NCT00196976|617480588|FG013|Primary Study|Protocol Violation|0|||
170855828|NCT00196976|617480575|FG000|Primary Study|Withdrawal by Subject|1|||
170855829|NCT00196976|617480576|FG001|Primary Study|Withdrawal by Subject|0|||
170855830|NCT00196976|617480577|FG002|Primary Study|Withdrawal by Subject|1|||
170855831|NCT00196976|617480578|FG003|Primary Study|Withdrawal by Subject|1|||
170855832|NCT00196976|617480579|FG004|Primary Study|Withdrawal by Subject|2|||
170855833|NCT00196976|617480580|FG005|Primary Study|Withdrawal by Subject|1|||
170855834|NCT00196976|617480581|FG006|Primary Study|Withdrawal by Subject|0|||
170855835|NCT00196976|617480582|FG007|Primary Study|Withdrawal by Subject|0|||
170855836|NCT00196976|617480583|FG008|Primary Study|Withdrawal by Subject|0|||
170855837|NCT00196976|617480584|FG009|Primary Study|Withdrawal by Subject|1|||
170855838|NCT00196976|617480585|FG010|Primary Study|Withdrawal by Subject|0|||
170855839|NCT00196976|617480586|FG011|Primary Study|Withdrawal by Subject|0|||
170855840|NCT00196976|617480587|FG012|Primary Study|Withdrawal by Subject|0|||
170855841|NCT00196976|617480588|FG013|Primary Study|Withdrawal by Subject|0|||
170855842|NCT00196976|617480575|FG000|Primary Study|Lost to Follow-up|0|||
170855843|NCT00196976|617480576|FG001|Primary Study|Lost to Follow-up|0|||
170855844|NCT00196976|617480577|FG002|Primary Study|Lost to Follow-up|0|||
170855845|NCT00196976|617480578|FG003|Primary Study|Lost to Follow-up|0|||
170855846|NCT00196976|617480579|FG004|Primary Study|Lost to Follow-up|1|||
170855847|NCT00196976|617480580|FG005|Primary Study|Lost to Follow-up|1|||
170855848|NCT00196976|617480581|FG006|Primary Study|Lost to Follow-up|0|||
170855849|NCT00196976|617480582|FG007|Primary Study|Lost to Follow-up|2|||
170855850|NCT00196976|617480583|FG008|Primary Study|Lost to Follow-up|0|||
170855851|NCT00196976|617480584|FG009|Primary Study|Lost to Follow-up|0|||
170855852|NCT00196976|617480585|FG010|Primary Study|Lost to Follow-up|0|||
170855853|NCT00196976|617480586|FG011|Primary Study|Lost to Follow-up|0|||
170855854|NCT00196976|617480587|FG012|Primary Study|Lost to Follow-up|0|||
170855855|NCT00196976|617480588|FG013|Primary Study|Lost to Follow-up|0|||
170855856|NCT00196976|617480575|FG000|Primary Study|Other|0|||
170855857|NCT00196976|617480576|FG001|Primary Study|Other|0|||
170855858|NCT00196976|617480577|FG002|Primary Study|Other|2|||
170855859|NCT00196976|617480578|FG003|Primary Study|Other|0|||
170855860|NCT00196976|617480579|FG004|Primary Study|Other|0|||
170855861|NCT00196976|617480580|FG005|Primary Study|Other|0|||
170855862|NCT00196976|617480581|FG006|Primary Study|Other|0|||
170855863|NCT00196976|617480582|FG007|Primary Study|Other|0|||
170855864|NCT00196976|617480583|FG008|Primary Study|Other|0|||
170855865|NCT00196976|617480584|FG009|Primary Study|Other|0|||
170855866|NCT00196976|617480585|FG010|Primary Study|Other|0|||
170855867|NCT00196976|617480586|FG011|Primary Study|Other|0|||
170855868|NCT00196976|617480587|FG012|Primary Study|Other|0|||
170855869|NCT00196976|617480588|FG013|Primary Study|Other|0|||
170855870|NCT00196976|617480575|FG000|Booster Study|Withdrawal by Subject|0|||
170855871|NCT00196976|617480576|FG001|Booster Study|Withdrawal by Subject|0|||
170855872|NCT00196976|617480577|FG002|Booster Study|Withdrawal by Subject|0|||
170855873|NCT00196976|617480578|FG003|Booster Study|Withdrawal by Subject|0|||
170855874|NCT00196976|617480579|FG004|Booster Study|Withdrawal by Subject|0|||
170855875|NCT00196976|617480580|FG005|Booster Study|Withdrawal by Subject|0|||
170855876|NCT00196976|617480581|FG006|Booster Study|Withdrawal by Subject|0|||
170855877|NCT00196976|617480582|FG007|Booster Study|Withdrawal by Subject|0|||
170855878|NCT00196976|617480583|FG008|Booster Study|Withdrawal by Subject|0|||
170855879|NCT00196976|617480584|FG009|Booster Study|Withdrawal by Subject|0|||
170855880|NCT00196976|617480585|FG010|Booster Study|Withdrawal by Subject|1|||
170855881|NCT00196976|617480586|FG011|Booster Study|Withdrawal by Subject|0|||
170855882|NCT00196976|617480587|FG012|Booster Study|Withdrawal by Subject|0|||
170855883|NCT00196976|617480588|FG013|Booster Study|Withdrawal by Subject|0|||
170855884|NCT00196976|617480575|FG000|Booster Study|Lost to Follow-up|0|||
170855885|NCT00196976|617480576|FG001|Booster Study|Lost to Follow-up|0|||
170855886|NCT00196976|617480577|FG002|Booster Study|Lost to Follow-up|0|||
170855887|NCT00196976|617480578|FG003|Booster Study|Lost to Follow-up|0|||
170855888|NCT00196976|617480579|FG004|Booster Study|Lost to Follow-up|0|||
170855889|NCT00196976|617480580|FG005|Booster Study|Lost to Follow-up|0|||
170855890|NCT00196976|617480581|FG006|Booster Study|Lost to Follow-up|0|||
170855891|NCT00196976|617480582|FG007|Booster Study|Lost to Follow-up|0|||
170855892|NCT00196976|617480583|FG008|Booster Study|Lost to Follow-up|0|||
170855893|NCT00196976|617480584|FG009|Booster Study|Lost to Follow-up|0|||
170855894|NCT00196976|617480585|FG010|Booster Study|Lost to Follow-up|1|||
170855895|NCT00196976|617480586|FG011|Booster Study|Lost to Follow-up|2|||
170855896|NCT00196976|617480587|FG012|Booster Study|Lost to Follow-up|0|||
170855897|NCT00196976|617480588|FG013|Booster Study|Lost to Follow-up|0|||
170855898|NCT01535560|617480589|FG000|Overall Study|Adverse Event|12|||
170855899|NCT01535560|617480590|FG001|Overall Study|Adverse Event|7|||
170855900|NCT01535560|617480589|FG000|Overall Study|Lost to Follow-up|1|||
170855901|NCT01535560|617480590|FG001|Overall Study|Lost to Follow-up|3|||
170855902|NCT01535560|617480589|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
170855903|NCT01535560|617480590|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
170855904|NCT01535560|617480589|FG000|Overall Study|Treatment Failure|21|||
170855905|NCT01535560|617480590|FG001|Overall Study|Treatment Failure|83|||
170855906|NCT01535560|617480589|FG000|Overall Study|Other|0|||
170855907|NCT01535560|617480590|FG001|Overall Study|Other|1|||
170855908|NCT01535560|617480589|FG000|Overall Study|Randomized in Error|0|||
170855909|NCT01535560|617480590|FG001|Overall Study|Randomized in Error|1|||
170855910|NCT02649946|617480595|FG000|Overall Study|Withdrawal by Subject|1|||
170855911|NCT02649946|617480596|FG001|Overall Study|Withdrawal by Subject|1|||
170855912|NCT02649946|617480595|FG000|Overall Study|Death|7|||
170855913|NCT02649946|617480596|FG001|Overall Study|Death|9|||
170855914|NCT02649946|617480595|FG000|Overall Study|Physician Decision|1|||
170855915|NCT02649946|617480596|FG001|Overall Study|Physician Decision|0|||
170855916|NCT02649946|617480595|FG000|Overall Study|Lost to Follow-up|2|||
170855917|NCT02649946|617480596|FG001|Overall Study|Lost to Follow-up|1|||
170855918|NCT02649946|617480595|FG000|Overall Study|Erroneously enrolled|1|||
170855919|NCT02649946|617480596|FG001|Overall Study|Erroneously enrolled|0|||
170855920|NCT02649946|617480595|FG000|Overall Study|Missed 6-month follow-up visit|0|||
170855921|NCT02649946|617480596|FG001|Overall Study|Missed 6-month follow-up visit|4|||
170855922|NCT01047293|617480597|FG000|Overall Study|DLT criteria not fulfilled|1|||
170855923|NCT01047293|617480598|FG001|Overall Study|DLT criteria not fulfilled|1|||
170855924|NCT01047293|617480599|FG002|Overall Study|DLT criteria not fulfilled|0|||
170855925|NCT01047293|617480600|FG003|Overall Study|DLT criteria not fulfilled|0|||
170855926|NCT00757783|617480601|FG000|Overall Study|Adverse Event|0|||
170855927|NCT00757783|617480602|FG001|Overall Study|Adverse Event|2|||
170855928|NCT00757783|617480601|FG000|Overall Study|Lost to Follow-up|1|||
170855929|NCT00757783|617480602|FG001|Overall Study|Lost to Follow-up|1|||
170855930|NCT00757783|617480601|FG000|Overall Study|Protocol Violation|1|||
170855931|NCT00757783|617480602|FG001|Overall Study|Protocol Violation|0|||
170855932|NCT00757783|617480601|FG000|Overall Study|Withdrawal by Subject|2|||
170855933|NCT00757783|617480602|FG001|Overall Study|Withdrawal by Subject|1|||
170855934|NCT00757783|617480601|FG000|Overall Study|Other|1|||
170855935|NCT00757783|617480602|FG001|Overall Study|Other|2|||
170855936|NCT01178385|617480603|FG000|Overall Study|Withdrawal by Subject|2|||
170855937|NCT01178385|617480604|FG001|Overall Study|Withdrawal by Subject|0|||
170855938|NCT04822597|617480607|FG000|Overall Study|Withdrawal by Subject|0|||
170855939|NCT04822597|617480608|FG001|Overall Study|Withdrawal by Subject|1|||
170855940|NCT04822597|617480609|FG002|Overall Study|Withdrawal by Subject|1|||
170855941|NCT04822597|617480610|FG003|Overall Study|Withdrawal by Subject|0|||
170855942|NCT04822597|617480607|FG000|Overall Study|Physician Decision|0|||
170855943|NCT04822597|617480608|FG001|Overall Study|Physician Decision|0|||
170855944|NCT04822597|617480609|FG002|Overall Study|Physician Decision|1|||
170855945|NCT04822597|617480610|FG003|Overall Study|Physician Decision|1|||
170855946|NCT04822597|617480607|FG000|Overall Study|Subject withdrawn after enrollment|0|||
170855947|NCT04822597|617480608|FG001|Overall Study|Subject withdrawn after enrollment|1|||
170855948|NCT04822597|617480609|FG002|Overall Study|Subject withdrawn after enrollment|0|||
170855949|NCT04822597|617480610|FG003|Overall Study|Subject withdrawn after enrollment|1|||
170855950|NCT04822597|617480607|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
170855951|NCT04822597|617480608|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
170855952|NCT04822597|617480609|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
170855953|NCT04822597|617480610|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
170855954|NCT05924945|617480615|FG000|Overall Study|Withdrawal by Subject|3|||
170855955|NCT05924945|617480616|FG001|Overall Study|Withdrawal by Subject|4|||
170855956|NCT00911768|617480617|FG000|Overall Study|Protocol Violation|5|||
170855957|NCT00911768|617480618|FG001|Overall Study|Protocol Violation|4|||
170855958|NCT00911768|617480617|FG000|Overall Study|Withdrawal by Subject|1|||
170855959|NCT00911768|617480618|FG001|Overall Study|Withdrawal by Subject|0|||
170855960|NCT05026710|617480623|FG000|Overall Study|No longer met eligibility criteria|3|||
170855961|NCT05026710|617480624|FG001|Overall Study|No longer met eligibility criteria|1|||
170855962|NCT00589121|617480625|FG000|Overall Study|Protocol Violation|2|||
170855963|NCT00589121|617480626|FG001|Overall Study|Protocol Violation|6|||
170855964|NCT00589121|617480625|FG000|Overall Study|No protocol treatment received|0|||
170855965|NCT00589121|617480626|FG001|Overall Study|No protocol treatment received|1|||
170855966|NCT02495792|617480627|FG000|Overall Study|Lost to Follow-up|5|||
170855967|NCT02495792|617480628|FG001|Overall Study|Lost to Follow-up|9|||
170855968|NCT02495792|617480627|FG000|Overall Study|Protocol Violation|32|||
170855969|NCT02495792|617480628|FG001|Overall Study|Protocol Violation|31|||
170855970|NCT03519971|617480637|FG000|Overall Study|Death|142|||
170855971|NCT03519971|617480638|FG001|Overall Study|Death|69|||
170855972|NCT03519971|617480637|FG000|Overall Study|Lost to Follow-up|0|||
170855973|NCT03519971|617480638|FG001|Overall Study|Lost to Follow-up|1|||
170855974|NCT03519971|617480637|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
170855975|NCT03519971|617480638|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
170855976|NCT03519971|617480637|FG000|Overall Study|Withdrawal by Subject|3|||
170855977|NCT03519971|617480638|FG001|Overall Study|Withdrawal by Subject|2|||
170855978|NCT03519971|617480637|FG000|Overall Study|Other|1|||
170855979|NCT03519971|617480638|FG001|Overall Study|Other|0|||
170855980|NCT05195489|617482164|FG000|Overall Study|Lost to Follow-up|1|||
170855981|NCT05195489|617482165|FG001|Overall Study|Lost to Follow-up|0|||
170855982|NCT05195489|617482164|FG000|Overall Study|Protocol Violation|0|||
170855983|NCT05195489|617482165|FG001|Overall Study|Protocol Violation|2|||
170855984|NCT05195489|617482164|FG000|Overall Study|Withdrawal by Subject|1|||
170855985|NCT05195489|617482165|FG001|Overall Study|Withdrawal by Subject|1|||
170855986|NCT05195489|617482164|FG000|Overall Study|Removed|0|||
170855987|NCT05195489|617482165|FG001|Overall Study|Removed|1|||
170855988|NCT01036763|617482167|FG000|Overall Study|Adverse Event|25|||
170855989|NCT01036763|617482167|FG000|Overall Study|Lost to Follow-up|28|||
170855990|NCT01036763|617482167|FG000|Overall Study|Other reason (not specified)|40|||
170855991|NCT01672723|617482168|FG000|First Intervention|Adverse Event|3|||
170855992|NCT01672723|617482169|FG001|First Intervention|Adverse Event|0|||
170855993|NCT00743275|617482170|FG000|Overall Study|Protocol Violation|0|||
170855994|NCT00743275|617482171|FG001|Overall Study|Protocol Violation|1|||
170855995|NCT01177722|617482174|FG000|Overall Study|Serious Adverse Event|0|||
170855996|NCT01177722|617482175|FG001|Overall Study|Serious Adverse Event|0|||
170855997|NCT01177722|617482176|FG002|Overall Study|Serious Adverse Event|1|||
170855998|NCT01177722|617482177|FG003|Overall Study|Serious Adverse Event|0|||
170855999|NCT01177722|617482174|FG000|Overall Study|Protocol Violation|0|||
170856000|NCT01177722|617482175|FG001|Overall Study|Protocol Violation|0|||
170856001|NCT01177722|617482176|FG002|Overall Study|Protocol Violation|1|||
170856002|NCT01177722|617482177|FG003|Overall Study|Protocol Violation|0|||
170856003|NCT01177722|617482174|FG000|Overall Study|Lost to Follow-up|3|||
170856004|NCT01177722|617482175|FG001|Overall Study|Lost to Follow-up|4|||
170856005|NCT01177722|617482176|FG002|Overall Study|Lost to Follow-up|3|||
170856006|NCT01177722|617482177|FG003|Overall Study|Lost to Follow-up|1|||
170856007|NCT01177722|617482174|FG000|Overall Study|Withdrawal by Subject|10|||
170856008|NCT01177722|617482175|FG001|Overall Study|Withdrawal by Subject|6|||
170856009|NCT01177722|617482176|FG002|Overall Study|Withdrawal by Subject|4|||
170856010|NCT01177722|617482177|FG003|Overall Study|Withdrawal by Subject|6|||
170856011|NCT02079610|617482181|FG000|Overall Study|Withdrawal by Subject|1|||
170856012|NCT02079610|617482182|FG001|Overall Study|Withdrawal by Subject|1|||
170856013|NCT05220254|617482184|FG000|Overall Study|Withdrawal by Subject|4|||
170856014|NCT05220254|617482184|FG000|Overall Study|Removed due to ineligibility|1|||
170856015|NCT05220254|617482184|FG000|Overall Study|Lost to Follow-up|7|||
170856016|NCT01620255|617482185|FG000|Overall Study|Withdrawal by Subject|4|||
170856017|NCT01620255|617482186|FG001|Overall Study|Withdrawal by Subject|1|||
170856018|NCT01620255|617482187|FG002|Overall Study|Withdrawal by Subject|1|||
170856019|NCT01620255|617482188|FG003|Overall Study|Withdrawal by Subject|2|||
170856020|NCT01620255|617482189|FG004|Overall Study|Withdrawal by Subject|4|||
170856021|NCT01620255|617482185|FG000|Overall Study|Participant underwent fecal transplant|0|||
170856022|NCT01620255|617482186|FG001|Overall Study|Participant underwent fecal transplant|0|||
170856023|NCT01620255|617482187|FG002|Overall Study|Participant underwent fecal transplant|1|||
170856024|NCT01620255|617482188|FG003|Overall Study|Participant underwent fecal transplant|0|||
170856025|NCT01620255|617482189|FG004|Overall Study|Participant underwent fecal transplant|0|||
170856026|NCT01620255|617482185|FG000|Overall Study|Non-compliance|0|||
170856027|NCT01620255|617482186|FG001|Overall Study|Non-compliance|1|||
170856028|NCT01620255|617482187|FG002|Overall Study|Non-compliance|0|||
170856029|NCT01620255|617482188|FG003|Overall Study|Non-compliance|0|||
170856030|NCT01620255|617482189|FG004|Overall Study|Non-compliance|0|||
170856031|NCT01620255|617482185|FG000|Overall Study|Adverse Event|0|||
170856032|NCT01620255|617482186|FG001|Overall Study|Adverse Event|4|||
170856033|NCT01620255|617482187|FG002|Overall Study|Adverse Event|0|||
170856034|NCT01620255|617482188|FG003|Overall Study|Adverse Event|1|||
170856035|NCT01620255|617482189|FG004|Overall Study|Adverse Event|1|||
170856036|NCT01620255|617482185|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
170856037|NCT01620255|617482186|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
170856038|NCT01620255|617482187|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
170856039|NCT01620255|617482188|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
170856040|NCT01620255|617482189|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
170856041|NCT02080221|617482194|FG000|Overall Study|Withdrawal by Subject|1|||
170856042|NCT02080221|617482194|FG000|Overall Study|Clinical Progression of Disease|1|||
170856043|NCT04279392|617482197|FG000|Overall Study|Physician Decision|1|||
170856044|NCT04279392|617482198|FG001|Overall Study|Physician Decision|0|||
170856045|NCT00871780|617482199|FG000|Overall Study|Enrolled But Not Treated|6|||
170856046|NCT00871780|617482199|FG000|Overall Study|Withdrawal by Subject|9|||
170856047|NCT00871780|617482199|FG000|Overall Study|Adverse Event|6|||
170856048|NCT00871780|617482199|FG000|Overall Study|Voluntary Discontinuation|4|||
170856049|NCT00871780|617482199|FG000|Overall Study|Death|1|||
170856050|NCT00871780|617482199|FG000|Overall Study|Physician Decision|1|||
170856051|NCT00552240|617482200|FG000|Overall Study|Adverse Event|9|||
170856052|NCT00552240|617482201|FG001|Overall Study|Adverse Event|9|||
170856053|NCT00552240|617482200|FG000|Overall Study|Protocol Violation|1|||
170856054|NCT00552240|617482201|FG001|Overall Study|Protocol Violation|1|||
170856055|NCT00552240|617482200|FG000|Overall Study|Lost to Follow-up|5|||
170856056|NCT00552240|617482201|FG001|Overall Study|Lost to Follow-up|6|||
170856057|NCT00552240|617482200|FG000|Overall Study|Withdrawal by Subject|2|||
170856058|NCT00552240|617482201|FG001|Overall Study|Withdrawal by Subject|2|||
170856059|NCT00552240|617482200|FG000|Overall Study|Lack of Efficacy|6|||
170856060|NCT00552240|617482201|FG001|Overall Study|Lack of Efficacy|0|||
170856061|NCT00552240|617482200|FG000|Overall Study|Other|1|||
170856062|NCT00552240|617482201|FG001|Overall Study|Other|0|||
170856063|NCT02476279|617482202|FG000|Overall Study|Lost to Follow-up|1|||
170856064|NCT02476279|617482203|FG001|Overall Study|Lost to Follow-up|1|||
170856065|NCT01411215|617482204|FG000|Overall Study|Adverse Event|1|||
170856066|NCT01411215|617482205|FG001|Overall Study|Adverse Event|2|||
170856067|NCT01411215|617482204|FG000|Overall Study|Lack of Efficacy|2|||
170856068|NCT01411215|617482205|FG001|Overall Study|Lack of Efficacy|4|||
170856069|NCT01411215|617482204|FG000|Overall Study|Lost to Follow-up|12|||
170856070|NCT01411215|617482205|FG001|Overall Study|Lost to Follow-up|18|||
170856071|NCT01411215|617482204|FG000|Overall Study|Did not meet entrance criteria|0|||
170856072|NCT01411215|617482205|FG001|Overall Study|Did not meet entrance criteria|1|||
170856073|NCT01411215|617482204|FG000|Overall Study|Study terminated by sponsor|2|||
170856074|NCT01411215|617482205|FG001|Overall Study|Study terminated by sponsor|15|||
170856075|NCT01411215|617482204|FG000|Overall Study|Protocol Violation|3|||
170856076|NCT01411215|617482205|FG001|Overall Study|Protocol Violation|5|||
170856077|NCT01411215|617482204|FG000|Overall Study|Withdrawal by Subject|34|||
170856078|NCT01411215|617482205|FG001|Overall Study|Withdrawal by Subject|21|||
170856079|NCT01411215|617482204|FG000|Overall Study|Other|12|||
170856080|NCT01411215|617482205|FG001|Overall Study|Other|17|||
170856081|NCT01411215|617482204|FG000|Overall Study|Screen failure|0|||
170856082|NCT01411215|617482205|FG001|Overall Study|Screen failure|1|||
170856083|NCT01502631|617482206|FG000|Overall Study|Adverse Event|5|||
170856084|NCT01502631|617482207|FG001|Overall Study|Adverse Event|8|||
170856085|NCT01502631|617482206|FG000|Overall Study|Lost to Follow-up|2|||
170856086|NCT01502631|617482207|FG001|Overall Study|Lost to Follow-up|2|||
170856087|NCT01502631|617482206|FG000|Overall Study|Participant withdrew consent|2|||
170856088|NCT01502631|617482207|FG001|Overall Study|Participant withdrew consent|4|||
170856089|NCT01502631|617482206|FG000|Overall Study|Participant non-compliant|1|||
170856090|NCT01502631|617482207|FG001|Overall Study|Participant non-compliant|0|||
170856091|NCT01502631|617482206|FG000|Overall Study|Investigator's decision|0|||
170856092|NCT01502631|617482207|FG001|Overall Study|Investigator's decision|1|||
170856093|NCT01502631|617482206|FG000|Overall Study|Other|10|||
170856094|NCT01502631|617482207|FG001|Overall Study|Other|5|||
170856095|NCT01000636|617482210|FG000|Overall Study|Withdrawal by Subject|1|||
170856096|NCT01000636|617482210|FG000|Overall Study|Adverse Event|1|||
170856097|NCT03451162|617482211|FG000|Overall Study|Lost to Follow-up|1|||
170856098|NCT03451162|617482212|FG001|Overall Study|Lost to Follow-up|0|||
170856099|NCT03451162|617482213|FG002|Overall Study|Lost to Follow-up|0|||
170856100|NCT03451162|617482214|FG003|Overall Study|Lost to Follow-up|0|||
170856101|NCT03451162|617482215|FG004|Overall Study|Lost to Follow-up|0|||
170856102|NCT03451162|617482211|FG000|Overall Study|Physician Decision|0|||
170856103|NCT03451162|617482212|FG001|Overall Study|Physician Decision|1|||
170856104|NCT03451162|617482213|FG002|Overall Study|Physician Decision|0|||
170856105|NCT03451162|617482214|FG003|Overall Study|Physician Decision|0|||
170856106|NCT03451162|617482215|FG004|Overall Study|Physician Decision|0|||
170856107|NCT03451162|617482211|FG000|Overall Study|Withdrawal by Subject|1|||
170856108|NCT03451162|617482212|FG001|Overall Study|Withdrawal by Subject|1|||
170856109|NCT03451162|617482213|FG002|Overall Study|Withdrawal by Subject|0|||
170856110|NCT03451162|617482214|FG003|Overall Study|Withdrawal by Subject|0|||
170856111|NCT03451162|617482215|FG004|Overall Study|Withdrawal by Subject|0|||
170856112|NCT01952054|617482216|FG000|Overall Study|Physician Decision|1|||
170856113|NCT01136772|617482217|FG000|Overall Study|Adverse Event|15|||
170856114|NCT01136772|617482218|FG001|Overall Study|Adverse Event|14|||
170856115|NCT01136772|617482217|FG000|Overall Study|Lack of Efficacy|42|||
170856116|NCT01136772|617482218|FG001|Overall Study|Lack of Efficacy|39|||
170856117|NCT01136772|617482217|FG000|Overall Study|Administrative|14|||
170856118|NCT01136772|617482218|FG001|Overall Study|Administrative|12|||
170856119|NCT01136772|617482217|FG000|Overall Study|Withdrawal by Subject|33|||
170856120|NCT01136772|617482218|FG001|Overall Study|Withdrawal by Subject|36|||
170856121|NCT01136772|617482217|FG000|Overall Study|Did not receive injection|10|||
170856122|NCT01136772|617482218|FG001|Overall Study|Did not receive injection|7|||
170856123|NCT01136772|617482217|FG000|Overall Study|Did not follow up after first injection|2|||
170856124|NCT01136772|617482218|FG001|Overall Study|Did not follow up after first injection|2|||
170856125|NCT00402597|617482219|FG000|Overall Study|Death|15|||
170856126|NCT00402597|617482220|FG001|Overall Study|Death|7|||
170856127|NCT00402597|617482221|FG002|Overall Study|Death|6|||
170856128|NCT00402597|617482222|FG003|Overall Study|Death|4|||
170856129|NCT00402597|617482223|FG004|Overall Study|Death|6|||
170856130|NCT00402597|617482219|FG000|Overall Study|Adverse Event|81|||
170856131|NCT00402597|617482220|FG001|Overall Study|Adverse Event|18|||
170856132|NCT00402597|617482221|FG002|Overall Study|Adverse Event|106|||
170856133|NCT00402597|617482222|FG003|Overall Study|Adverse Event|39|||
170856134|NCT00402597|617482223|FG004|Overall Study|Adverse Event|71|||
170856135|NCT00402597|617482219|FG000|Overall Study|Lost to Follow-up|8|||
170856136|NCT00402597|617482220|FG001|Overall Study|Lost to Follow-up|1|||
170856137|NCT00402597|617482221|FG002|Overall Study|Lost to Follow-up|8|||
170856138|NCT00402597|617482222|FG003|Overall Study|Lost to Follow-up|2|||
170856139|NCT00402597|617482223|FG004|Overall Study|Lost to Follow-up|3|||
170856140|NCT00402597|617482219|FG000|Overall Study|Withdrawal by Subject|57|||
170856141|NCT00402597|617482220|FG001|Overall Study|Withdrawal by Subject|16|||
170856142|NCT00402597|617482221|FG002|Overall Study|Withdrawal by Subject|65|||
170856143|NCT00402597|617482222|FG003|Overall Study|Withdrawal by Subject|15|||
170856144|NCT00402597|617482223|FG004|Overall Study|Withdrawal by Subject|24|||
170856145|NCT00402597|617482219|FG000|Overall Study|reason not specified|30|||
170856146|NCT00402597|617482220|FG001|Overall Study|reason not specified|4|||
170856147|NCT00402597|617482221|FG002|Overall Study|reason not specified|27|||
170856148|NCT00402597|617482222|FG003|Overall Study|reason not specified|14|||
170856149|NCT00402597|617482223|FG004|Overall Study|reason not specified|20|||
170856150|NCT01127139|617482224|FG000|Overall Study|Adverse Event|40|||
170856151|NCT01127139|617482224|FG000|Overall Study|Incompliance|12|||
170856152|NCT01127139|617482224|FG000|Overall Study|Lack of Efficacy|4|||
170856153|NCT01127139|617482224|FG000|Overall Study|Reason not specified|1|||
170856154|NCT00235326|617482225|FG000|Overall Study|Lost to Follow-up|746|||
170856155|NCT00235326|617482226|FG001|Overall Study|Lost to Follow-up|1400|||
170856156|NCT04964414|617482227|FG000|Overall Study|Lost to Follow-up|10|||
170856157|NCT04964414|617482228|FG001|Overall Study|Lost to Follow-up|8|||
170856158|NCT04964414|617482227|FG000|Overall Study|Withdrawal by Subject|1|||
170856159|NCT04964414|617482228|FG001|Overall Study|Withdrawal by Subject|1|||
170856160|NCT00577577|617482232|FG000|Overall Study|Adverse Event|3|||
170743215|NCT04534114|617066072|FG002|Main Treatment Period|Other reason|0|||
170743216|NCT04534114|617066073|FG003|Main Treatment Period|Other reason|0|||
170743217|NCT04534114|617066070|FG000|Main Treatment Period|Participant decision|1|||
170743218|NCT04534114|617066071|FG001|Main Treatment Period|Participant decision|3|||
170743219|NCT04534114|617066072|FG002|Main Treatment Period|Participant decision|3|||
170743220|NCT04534114|617066073|FG003|Main Treatment Period|Participant decision|1|||
170743221|NCT04534114|617066070|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
170743222|NCT04534114|617066071|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
170743223|NCT04534114|617066072|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
170743224|NCT04534114|617066073|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
170743225|NCT04534114|617066070|FG000|Main Treatment Period|Adverse Event|4|||
170743226|NCT04534114|617066071|FG001|Main Treatment Period|Adverse Event|2|||
170743227|NCT04534114|617066072|FG002|Main Treatment Period|Adverse Event|1|||
170743228|NCT04534114|617066073|FG003|Main Treatment Period|Adverse Event|2|||
170743229|NCT04534114|617066070|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
170743230|NCT04534114|617066071|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
170743231|NCT04534114|617066072|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
170743232|NCT04534114|617066073|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
170743233|NCT04534114|617066070|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
170743234|NCT04534114|617066071|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
170743235|NCT04534114|617066072|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
170743236|NCT04534114|617066073|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
170743237|NCT04534114|617066070|FG000|Extension Treatment Period|Other reason|0|||
170743238|NCT04534114|617066071|FG001|Extension Treatment Period|Other reason|1|||
170743239|NCT04534114|617066072|FG002|Extension Treatment Period|Other reason|0|||
170743240|NCT04534114|617066073|FG003|Extension Treatment Period|Other reason|0|||
170743241|NCT04534114|617066070|FG000|Extension Treatment Period|Death|0|||
170743242|NCT04534114|617066071|FG001|Extension Treatment Period|Death|0|||
170743243|NCT04534114|617066072|FG002|Extension Treatment Period|Death|1|||
170743244|NCT04534114|617066073|FG003|Extension Treatment Period|Death|2|||
170743245|NCT04534114|617066070|FG000|Extension Treatment Period|Adverse Event|0|||
170743246|NCT04534114|617066071|FG001|Extension Treatment Period|Adverse Event|1|||
170743247|NCT04534114|617066072|FG002|Extension Treatment Period|Adverse Event|0|||
170743248|NCT04534114|617066073|FG003|Extension Treatment Period|Adverse Event|1|||
170743249|NCT04534114|617066070|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
170743250|NCT04534114|617066071|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
170743251|NCT04534114|617066072|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
170743252|NCT04534114|617066073|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
170743253|NCT02759185|617066074|FG000|Stage 1|Adverse Event|0|||
170743254|NCT02759185|617066075|FG001|Stage 1|Adverse Event|1|||
170743255|NCT02759185|617066076|FG002|Stage 1|Adverse Event|3|||
170743256|NCT02759185|617066077|FG003|Stage 1|Adverse Event|0|||
170743257|NCT02759185|617066078|FG004|Stage 1|Adverse Event|0|||
170743258|NCT02759185|617066079|FG005|Stage 1|Adverse Event|0|||
170743259|NCT02759185|617066080|FG006|Stage 1|Adverse Event|0|||
170743260|NCT02759185|617066074|FG000|Stage 1|Withdrawal by Subject|1|||
170743261|NCT02759185|617066075|FG001|Stage 1|Withdrawal by Subject|0|||
170856161|NCT00577577|617482233|FG001|Overall Study|Adverse Event|2|||
170856162|NCT00577577|617482232|FG000|Overall Study|Lost to Follow-up|1|||
170856163|NCT00577577|617482233|FG001|Overall Study|Lost to Follow-up|0|||
170856164|NCT00577577|617482232|FG000|Overall Study|Protocol Violation|0|||
170856165|NCT00577577|617482233|FG001|Overall Study|Protocol Violation|3|||
170856166|NCT00577577|617482232|FG000|Overall Study|Transportation|1|||
170856167|NCT00577577|617482233|FG001|Overall Study|Transportation|0|||
170856168|NCT00528645|617482234|FG000|Overall Study|Adverse Event|3|||
170856169|NCT01445301|617482235|FG000|Overall Study|Adverse Event|15|||
170856170|NCT01445301|617482236|FG001|Overall Study|Adverse Event|25|||
170856171|NCT01445301|617482237|FG002|Overall Study|Adverse Event|4|||
170856172|NCT01445301|617482235|FG000|Overall Study|Lack of Efficacy|0|||
170856173|NCT01445301|617482236|FG001|Overall Study|Lack of Efficacy|1|||
170856174|NCT01445301|617482237|FG002|Overall Study|Lack of Efficacy|0|||
170856175|NCT01445301|617482235|FG000|Overall Study|Protocol Violation|1|||
170856176|NCT01445301|617482236|FG001|Overall Study|Protocol Violation|0|||
170856177|NCT01445301|617482237|FG002|Overall Study|Protocol Violation|0|||
170856178|NCT01445301|617482235|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
170856179|NCT01445301|617482236|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
170856180|NCT01445301|617482237|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
170856181|NCT01445301|617482235|FG000|Overall Study|Physician Decision|0|||
170856182|NCT01445301|617482236|FG001|Overall Study|Physician Decision|2|||
170743262|NCT02759185|617066076|FG002|Stage 1|Withdrawal by Subject|0|||
170743263|NCT02759185|617066077|FG003|Stage 1|Withdrawal by Subject|0|||
170856183|NCT01445301|617482237|FG002|Overall Study|Physician Decision|0|||
170856184|NCT01445301|617482235|FG000|Overall Study|Withdrawal by Subject|5|||
170743264|NCT02759185|617066078|FG004|Stage 1|Withdrawal by Subject|0|||
170743265|NCT02759185|617066079|FG005|Stage 1|Withdrawal by Subject|0|||
170743266|NCT02759185|617066080|FG006|Stage 1|Withdrawal by Subject|0|||
170743267|NCT02759185|617066074|FG000|Stage 2|Adverse Event|0|||
170743268|NCT02759185|617066075|FG001|Stage 2|Adverse Event|0|||
170743269|NCT02759185|617066076|FG002|Stage 2|Adverse Event|0|||
170743270|NCT02759185|617066077|FG003|Stage 2|Adverse Event|0|||
170743271|NCT02759185|617066078|FG004|Stage 2|Adverse Event|1|||
170743272|NCT02759185|617066079|FG005|Stage 2|Adverse Event|2|||
170743273|NCT02759185|617066080|FG006|Stage 2|Adverse Event|0|||
170743274|NCT02759185|617066074|FG000|Stage 2|Withdrawal by Subject|0|||
170743275|NCT02759185|617066075|FG001|Stage 2|Withdrawal by Subject|0|||
170743276|NCT02759185|617066076|FG002|Stage 2|Withdrawal by Subject|0|||
170743277|NCT02759185|617066077|FG003|Stage 2|Withdrawal by Subject|0|||
170743278|NCT02759185|617066078|FG004|Stage 2|Withdrawal by Subject|1|||
170743279|NCT02759185|617066079|FG005|Stage 2|Withdrawal by Subject|1|||
170743280|NCT02759185|617066080|FG006|Stage 2|Withdrawal by Subject|1|||
170743281|NCT02716038|617066088|FG000|Overall Study|Not evaluable|1|||
170743282|NCT02716038|617066088|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
170743283|NCT02716038|617066088|FG000|Overall Study|Unresectable|3|||
170743284|NCT01672853|617066091|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
170743285|NCT01672853|617066092|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
170743286|NCT01672853|617066093|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
170743287|NCT01672853|617066091|FG000|Overall Study|Pregnancy|0|||
170743288|NCT01672853|617066092|FG001|Overall Study|Pregnancy|1|||
170743289|NCT01672853|617066093|FG002|Overall Study|Pregnancy|0|||
170743290|NCT01672853|617066091|FG000|Overall Study|Investigator's Discretion|1|||
170743291|NCT01672853|617066092|FG001|Overall Study|Investigator's Discretion|0|||
170743292|NCT01672853|617066093|FG002|Overall Study|Investigator's Discretion|0|||
170743293|NCT01672853|617066091|FG000|Overall Study|Withdrew Consent|5|||
170743294|NCT01672853|617066092|FG001|Overall Study|Withdrew Consent|5|||
170743295|NCT01672853|617066093|FG002|Overall Study|Withdrew Consent|5|||
170743296|NCT01672853|617066091|FG000|Overall Study|Adverse Event|4|||
170743297|NCT01672853|617066092|FG001|Overall Study|Adverse Event|6|||
170743298|NCT01672853|617066093|FG002|Overall Study|Adverse Event|8|||
170743299|NCT01672853|617066091|FG000|Overall Study|Lost to Follow-up|0|||
170743300|NCT01672853|617066092|FG001|Overall Study|Lost to Follow-up|1|||
170743301|NCT01672853|617066093|FG002|Overall Study|Lost to Follow-up|0|||
170743302|NCT01672853|617066091|FG000|Overall Study|Randomized but Never Treated|0|||
170743303|NCT01672853|617066092|FG001|Overall Study|Randomized but Never Treated|0|||
170743304|NCT01672853|617066093|FG002|Overall Study|Randomized but Never Treated|1|||
170743305|NCT03535337|617066094|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
170743306|NCT03535337|617066095|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
170743307|NCT03535337|617066096|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
170743308|NCT03535337|617066097|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
170743309|NCT03535337|617066098|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
170743310|NCT03535337|617066099|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
170743311|NCT03535337|617066100|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
170743312|NCT03535337|617066101|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
170743313|NCT03535337|617066102|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
170743314|NCT03535337|617066103|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
170743315|NCT02714205|617066104|FG000|Overall Study|Cannot tolerate medication|1|||
170743316|NCT02714205|617066105|FG001|Overall Study|Cannot tolerate medication|0|||
170743317|NCT02714205|617066104|FG000|Overall Study|Adverse Event|2|||
170743318|NCT02714205|617066105|FG001|Overall Study|Adverse Event|0|||
170743319|NCT02714205|617066104|FG000|Overall Study|Too busy|1|||
170743320|NCT02714205|617066105|FG001|Overall Study|Too busy|0|||
170743321|NCT02714205|617066104|FG000|Overall Study|Incomplete outcome data|0|||
170743322|NCT02714205|617066105|FG001|Overall Study|Incomplete outcome data|1|||
170743323|NCT05879198|617066106|FG000|Overall Study|Lost to Follow-up|1|||
170743324|NCT01598298|617066107|FG000|Overall Study|Not eligible|5|||
170743325|NCT01598298|617066108|FG001|Overall Study|Not eligible|5|||
170743326|NCT01598298|617066107|FG000|Overall Study|Adverse Event|21|||
170743327|NCT01598298|617066108|FG001|Overall Study|Adverse Event|19|||
170743328|NCT01598298|617066107|FG000|Overall Study|Progression/relapse|0|||
170743329|NCT01598298|617066108|FG001|Overall Study|Progression/relapse|2|||
170743330|NCT01598298|617066107|FG000|Overall Study|Withdrawal by Subject|10|||
170743331|NCT01598298|617066108|FG001|Overall Study|Withdrawal by Subject|15|||
170743332|NCT01598298|617066107|FG000|Overall Study|Other reason (not protocol specified)|4|||
170743333|NCT01598298|617066108|FG001|Overall Study|Other reason (not protocol specified)|0|||
170743334|NCT02073097|617066109|FG000|Overall Study|Adverse Event|0|||
170743335|NCT02073097|617066110|FG001|Overall Study|Adverse Event|0|||
170743336|NCT02073097|617066111|FG002|Overall Study|Adverse Event|0|||
170743337|NCT02073097|617066112|FG003|Overall Study|Adverse Event|0|||
170856185|NCT01445301|617482236|FG001|Overall Study|Withdrawal by Subject|6|||
170856186|NCT01445301|617482237|FG002|Overall Study|Withdrawal by Subject|4|||
170856187|NCT02996474|617482238|FG000|Overall Study|Physician Decision|5|||
170856188|NCT02679508|617482239|FG000|Healing Phase|Protocol Violation|1|||
170856189|NCT02679508|617482240|FG001|Healing Phase|Protocol Violation|1|||
170856190|NCT02679508|617482239|FG000|Healing Phase|Lost to Follow-up|1|||
170856191|NCT02679508|617482240|FG001|Healing Phase|Lost to Follow-up|0|||
170856192|NCT02679508|617482239|FG000|Maintenance Phase|Adverse Event|12|||
170856193|NCT02679508|617482240|FG001|Maintenance Phase|Adverse Event|2|||
170856194|NCT02679508|617482239|FG000|Maintenance Phase|Lost to Follow-up|0|||
170856195|NCT02679508|617482240|FG001|Maintenance Phase|Lost to Follow-up|1|||
170856196|NCT02679508|617482239|FG000|Maintenance Phase|Withdrawal by Subject|15|||
170856197|NCT02679508|617482240|FG001|Maintenance Phase|Withdrawal by Subject|8|||
170856198|NCT02679508|617482239|FG000|Maintenance Phase|Other|5|||
170856199|NCT02679508|617482240|FG001|Maintenance Phase|Other|4|||
170856200|NCT03683823|617482241|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
170856201|NCT03683823|617482242|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
170856202|NCT03683823|617482241|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
170856203|NCT03683823|617482242|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
170856204|NCT03683823|617482241|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
170856205|NCT03683823|617482242|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
170856206|NCT01323972|617482244|FG000|Overall Study|Withdrawal by Subject|1|||
170856207|NCT01323972|617482245|FG001|Overall Study|Withdrawal by Subject|0|||
170856208|NCT01323972|617482246|FG002|Overall Study|Withdrawal by Subject|1|||
170856209|NCT01323972|617482247|FG003|Overall Study|Withdrawal by Subject|0|||
170856210|NCT01323972|617482244|FG000|Overall Study|Migrated/moved from study area|1|||
170856211|NCT01323972|617482245|FG001|Overall Study|Migrated/moved from study area|2|||
170856212|NCT01323972|617482246|FG002|Overall Study|Migrated/moved from study area|0|||
170856213|NCT01323972|617482247|FG003|Overall Study|Migrated/moved from study area|0|||
170856214|NCT01323972|617482244|FG000|Overall Study|Lost to Follow-up|0|||
170856215|NCT01323972|617482245|FG001|Overall Study|Lost to Follow-up|1|||
170856216|NCT01323972|617482246|FG002|Overall Study|Lost to Follow-up|1|||
170856217|NCT01323972|617482247|FG003|Overall Study|Lost to Follow-up|1|||
170856218|NCT01796548|617482250|FG000|Overall Study|Lost to Follow-up|1|||
170856219|NCT01796548|617482250|FG000|Overall Study|Other|2|||
170856220|NCT02008877|617482251|FG000|Overall Study|Inevaluable|0|||
170856221|NCT02008877|617482252|FG001|Overall Study|Inevaluable|1|||
170856222|NCT02008877|617482253|FG002|Overall Study|Inevaluable|0|||
170856223|NCT01049217|617482256|FG000|Overall Study|Adverse Event|2|||
170856224|NCT01049217|617482257|FG001|Overall Study|Adverse Event|1|||
170856225|NCT01049217|617482256|FG000|Overall Study|Lack of Efficacy|1|||
170856226|NCT01049217|617482257|FG001|Overall Study|Lack of Efficacy|1|||
170856227|NCT01049217|617482256|FG000|Overall Study|Lost to Follow-up|3|||
170856228|NCT01049217|617482257|FG001|Overall Study|Lost to Follow-up|8|||
170856229|NCT01049217|617482256|FG000|Overall Study|Withdrawal by Subject|4|||
170856230|NCT01049217|617482257|FG001|Overall Study|Withdrawal by Subject|3|||
170856231|NCT01049217|617482256|FG000|Overall Study|Protocol Violation|1|||
170856232|NCT01049217|617482257|FG001|Overall Study|Protocol Violation|3|||
170856233|NCT01049217|617482256|FG000|Overall Study|Pregnancy|1|||
170856234|NCT01049217|617482257|FG001|Overall Study|Pregnancy|0|||
170856235|NCT01049217|617482256|FG000|Overall Study|Study Terminated by Sponsor|43|||
170856236|NCT01049217|617482257|FG001|Overall Study|Study Terminated by Sponsor|43|||
170856237|NCT01049217|617482256|FG000|Overall Study|Other|1|||
170856238|NCT01049217|617482257|FG001|Overall Study|Other|2|||
170856239|NCT01049217|617482256|FG000|Overall Study|Randomized but not Treated|0|||
170856240|NCT01049217|617482257|FG001|Overall Study|Randomized but not Treated|2|||
170856241|NCT00925132|617482258|FG000|Overall Study|Withdrawal by Subject|2|||
170856242|NCT00925132|617482259|FG001|Overall Study|Withdrawal by Subject|0|||
170856243|NCT00925132|617482260|FG002|Overall Study|Withdrawal by Subject|0|||
170856244|NCT00925132|617482261|FG003|Overall Study|Withdrawal by Subject|0|||
170856245|NCT00925132|617482262|FG004|Overall Study|Withdrawal by Subject|1|||
170856246|NCT00925132|617482258|FG000|Overall Study|Removed due to disease progression|0|||
170856247|NCT00925132|617482259|FG001|Overall Study|Removed due to disease progression|0|||
170856248|NCT00925132|617482260|FG002|Overall Study|Removed due to disease progression|0|||
170856249|NCT00925132|617482261|FG003|Overall Study|Removed due to disease progression|0|||
170856250|NCT00925132|617482262|FG004|Overall Study|Removed due to disease progression|4|||
170856251|NCT03141905|617482263|FG000|Overall Study|Death|3|||
170856252|NCT03141905|617482264|FG001|Overall Study|Death|2|||
170856253|NCT03141905|617482263|FG000|Overall Study|Withdrawal by Subject|1|||
170856254|NCT03141905|617482264|FG001|Overall Study|Withdrawal by Subject|0|||
170856255|NCT03141905|617482263|FG000|Overall Study|Lost to Follow-up|3|||
170856256|NCT03141905|617482264|FG001|Overall Study|Lost to Follow-up|7|||
170856257|NCT03141905|617482263|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
170856258|NCT03141905|617482264|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
170856259|NCT04617275|617482267|FG000|Treatment Period|Adverse Event|1|||
170856260|NCT04617275|617482268|FG001|Treatment Period|Adverse Event|6|||
170743338|NCT02073097|617066113|FG004|Overall Study|Adverse Event|0|||
170743339|NCT02073097|617066114|FG005|Overall Study|Adverse Event|0|||
170743340|NCT02073097|617066115|FG006|Overall Study|Adverse Event|0|||
170856261|NCT04617275|617482269|FG002|Treatment Period|Adverse Event|4|||
170856262|NCT04617275|617482270|FG003|Treatment Period|Adverse Event|6|||
170856263|NCT04617275|617482271|FG004|Treatment Period|Adverse Event|7|||
170856264|NCT04617275|617482272|FG005|Treatment Period|Adverse Event|8|||
170856265|NCT04617275|617482273|FG006|Treatment Period|Adverse Event|0|||
170856266|NCT04617275|617482274|FG007|Treatment Period|Adverse Event|12|||
170856267|NCT04617275|617482267|FG000|Treatment Period|Lost to Follow-up|0|||
170856268|NCT04617275|617482268|FG001|Treatment Period|Lost to Follow-up|0|||
170856269|NCT04617275|617482269|FG002|Treatment Period|Lost to Follow-up|2|||
170856270|NCT04617275|617482270|FG003|Treatment Period|Lost to Follow-up|0|||
170856271|NCT04617275|617482271|FG004|Treatment Period|Lost to Follow-up|0|||
170856272|NCT04617275|617482272|FG005|Treatment Period|Lost to Follow-up|3|||
170856273|NCT04617275|617482273|FG006|Treatment Period|Lost to Follow-up|0|||
170856274|NCT04617275|617482274|FG007|Treatment Period|Lost to Follow-up|2|||
170856275|NCT04617275|617482267|FG000|Treatment Period|No longer meets eligibility criteria|0|||
170856276|NCT04617275|617482268|FG001|Treatment Period|No longer meets eligibility criteria|0|||
170856277|NCT04617275|617482269|FG002|Treatment Period|No longer meets eligibility criteria|0|||
170856278|NCT04617275|617482270|FG003|Treatment Period|No longer meets eligibility criteria|1|||
170856279|NCT04617275|617482271|FG004|Treatment Period|No longer meets eligibility criteria|0|||
170856280|NCT04617275|617482272|FG005|Treatment Period|No longer meets eligibility criteria|0|||
170856281|NCT04617275|617482273|FG006|Treatment Period|No longer meets eligibility criteria|0|||
170856282|NCT04617275|617482274|FG007|Treatment Period|No longer meets eligibility criteria|0|||
170856283|NCT04617275|617482267|FG000|Treatment Period|Other|0|||
170856284|NCT04617275|617482268|FG001|Treatment Period|Other|1|||
170856285|NCT04617275|617482269|FG002|Treatment Period|Other|0|||
170856286|NCT04617275|617482270|FG003|Treatment Period|Other|0|||
170856287|NCT04617275|617482271|FG004|Treatment Period|Other|0|||
170856288|NCT04617275|617482272|FG005|Treatment Period|Other|0|||
170856289|NCT04617275|617482273|FG006|Treatment Period|Other|0|||
170856290|NCT04617275|617482274|FG007|Treatment Period|Other|0|||
170856291|NCT04617275|617482267|FG000|Treatment Period|Withdrawal by Subject|2|||
170856292|NCT04617275|617482268|FG001|Treatment Period|Withdrawal by Subject|0|||
170856293|NCT04617275|617482269|FG002|Treatment Period|Withdrawal by Subject|0|||
170856294|NCT04617275|617482270|FG003|Treatment Period|Withdrawal by Subject|2|||
170856295|NCT04617275|617482271|FG004|Treatment Period|Withdrawal by Subject|2|||
170856296|NCT04617275|617482272|FG005|Treatment Period|Withdrawal by Subject|0|||
170856297|NCT04617275|617482273|FG006|Treatment Period|Withdrawal by Subject|1|||
170856298|NCT04617275|617482274|FG007|Treatment Period|Withdrawal by Subject|2|||
170856299|NCT04617275|617482267|FG000|Follow-up Period|Adverse Event|1|||
170856300|NCT04617275|617482268|FG001|Follow-up Period|Adverse Event|1|||
170856301|NCT04617275|617482269|FG002|Follow-up Period|Adverse Event|2|||
170856302|NCT04617275|617482270|FG003|Follow-up Period|Adverse Event|3|||
170856303|NCT04617275|617482271|FG004|Follow-up Period|Adverse Event|4|||
170856304|NCT04617275|617482272|FG005|Follow-up Period|Adverse Event|3|||
170856305|NCT04617275|617482273|FG006|Follow-up Period|Adverse Event|0|||
170856306|NCT04617275|617482274|FG007|Follow-up Period|Adverse Event|3|||
170856307|NCT04617275|617482267|FG000|Follow-up Period|Lost to Follow-up|0|||
170856308|NCT04617275|617482268|FG001|Follow-up Period|Lost to Follow-up|1|||
170743341|NCT02073097|617066116|FG007|Overall Study|Adverse Event|2|||
170743342|NCT02073097|617066109|FG000|Overall Study|Withdrawal by Subject|0|||
170743343|NCT02073097|617066110|FG001|Overall Study|Withdrawal by Subject|0|||
170743344|NCT02073097|617066111|FG002|Overall Study|Withdrawal by Subject|0|||
170743345|NCT02073097|617066112|FG003|Overall Study|Withdrawal by Subject|0|||
170743346|NCT02073097|617066113|FG004|Overall Study|Withdrawal by Subject|0|||
170743347|NCT02073097|617066114|FG005|Overall Study|Withdrawal by Subject|0|||
170743348|NCT02073097|617066115|FG006|Overall Study|Withdrawal by Subject|0|||
170743349|NCT02073097|617066116|FG007|Overall Study|Withdrawal by Subject|2|||
170743350|NCT02073097|617066109|FG000|Overall Study|Death|0|||
170743351|NCT02073097|617066110|FG001|Overall Study|Death|0|||
170743352|NCT02073097|617066111|FG002|Overall Study|Death|0|||
170743353|NCT02073097|617066112|FG003|Overall Study|Death|0|||
170743354|NCT02073097|617066113|FG004|Overall Study|Death|0|||
170856309|NCT04617275|617482269|FG002|Follow-up Period|Lost to Follow-up|2|||
170856310|NCT04617275|617482270|FG003|Follow-up Period|Lost to Follow-up|0|||
170743355|NCT02073097|617066114|FG005|Overall Study|Death|0|||
170856311|NCT04617275|617482271|FG004|Follow-up Period|Lost to Follow-up|0|||
170856312|NCT04617275|617482272|FG005|Follow-up Period|Lost to Follow-up|4|||
170856313|NCT04617275|617482273|FG006|Follow-up Period|Lost to Follow-up|0|||
170856314|NCT04617275|617482274|FG007|Follow-up Period|Lost to Follow-up|3|||
170856315|NCT04617275|617482267|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
170856316|NCT04617275|617482268|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
170856317|NCT04617275|617482269|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
170856318|NCT04617275|617482270|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
170856319|NCT04617275|617482271|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
170856320|NCT04617275|617482272|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
170856321|NCT04617275|617482273|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
170856322|NCT04617275|617482274|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
170856323|NCT04617275|617482267|FG000|Follow-up Period|Other|0|||
170856324|NCT04617275|617482268|FG001|Follow-up Period|Other|1|||
170856325|NCT04617275|617482269|FG002|Follow-up Period|Other|0|||
170856326|NCT04617275|617482270|FG003|Follow-up Period|Other|0|||
170856327|NCT04617275|617482271|FG004|Follow-up Period|Other|0|||
170856328|NCT04617275|617482272|FG005|Follow-up Period|Other|0|||
170856329|NCT04617275|617482273|FG006|Follow-up Period|Other|0|||
170856330|NCT04617275|617482274|FG007|Follow-up Period|Other|0|||
170856331|NCT04617275|617482267|FG000|Follow-up Period|Withdrawal by Subject|2|||
170856332|NCT04617275|617482268|FG001|Follow-up Period|Withdrawal by Subject|0|||
170856333|NCT04617275|617482269|FG002|Follow-up Period|Withdrawal by Subject|0|||
170856334|NCT04617275|617482270|FG003|Follow-up Period|Withdrawal by Subject|2|||
170856335|NCT04617275|617482271|FG004|Follow-up Period|Withdrawal by Subject|2|||
170856336|NCT04617275|617482272|FG005|Follow-up Period|Withdrawal by Subject|0|||
170856337|NCT04617275|617482273|FG006|Follow-up Period|Withdrawal by Subject|1|||
170856338|NCT04617275|617482274|FG007|Follow-up Period|Withdrawal by Subject|2|||
170856339|NCT04227704|617482275|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
170856340|NCT04227704|617482276|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
170856341|NCT04227704|617482277|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
170856342|NCT04227704|617482275|FG000|Overall Study|due to C/S being cancelled|1|||
170856343|NCT04227704|617482276|FG001|Overall Study|due to C/S being cancelled|0|||
170856344|NCT04227704|617482277|FG002|Overall Study|due to C/S being cancelled|0|||
170856345|NCT03110224|617482278|FG000|Overall Study|Death|3|||
170856346|NCT03110224|617482278|FG000|Overall Study|Lost to Follow-up|132|||
170856347|NCT03110224|617482278|FG000|Overall Study|Physician Decision|2|||
170856348|NCT03110224|617482278|FG000|Overall Study|Site Closed by Physician|35|||
170856349|NCT03110224|617482278|FG000|Overall Study|Site Closed by Sponsor|202|||
170856350|NCT03110224|617482278|FG000|Overall Study|Withdrawal by Subject|9|||
170856351|NCT01775124|617482279|FG000|Core Period|Disease Progression|0|||
170856352|NCT01775124|617482280|FG001|Core Period|Disease Progression|1|||
170856353|NCT01775124|617482279|FG000|Core Period|Physician Decision|1|||
170856354|NCT01775124|617482280|FG001|Core Period|Physician Decision|1|||
170856355|NCT01775124|617482279|FG000|Core Period|Death|0|||
170856356|NCT01775124|617482280|FG001|Core Period|Death|1|||
170856357|NCT01775124|617482279|FG000|Core Period|Administrative problems|1|||
170856358|NCT01775124|617482280|FG001|Core Period|Administrative problems|0|||
170856359|NCT01775124|617482279|FG000|Core Period|Withdrawal by Subject|4|||
170856360|NCT01775124|617482280|FG001|Core Period|Withdrawal by Subject|2|||
170856361|NCT01775124|617482279|FG000|Core Period|Adverse Event|5|||
170856362|NCT01775124|617482280|FG001|Core Period|Adverse Event|5|||
170856363|NCT01775124|617482279|FG000|Extension Period|Adverse Event|3|||
170856364|NCT01775124|617482280|FG001|Extension Period|Adverse Event|2|||
170856365|NCT01775124|617482279|FG000|Extension Period|Physician Decision|0|||
170856366|NCT01775124|617482280|FG001|Extension Period|Physician Decision|2|||
170856367|NCT01775124|617482279|FG000|Extension Period|Administrative problems|0|||
170856368|NCT01775124|617482280|FG001|Extension Period|Administrative problems|1|||
170856369|NCT01775124|617482279|FG000|Extension Period|Lost to Follow-up|0|||
170856370|NCT01775124|617482280|FG001|Extension Period|Lost to Follow-up|1|||
170856371|NCT01775124|617482279|FG000|Extension Period|Withdrawal by Subject|9|||
170856372|NCT01775124|617482280|FG001|Extension Period|Withdrawal by Subject|12|||
170856373|NCT02317432|617482281|FG000|Overall Study|Death|4|||
170856374|NCT02317432|617482282|FG001|Overall Study|Death|1|||
170856375|NCT02317432|617482281|FG000|Overall Study|Lost to Follow-up|0|||
170856376|NCT02317432|617482282|FG001|Overall Study|Lost to Follow-up|5|||
170856377|NCT02317432|617482281|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
170856378|NCT02317432|617482282|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
170856379|NCT03992846|617482285|FG000|Overall Study|Adverse Event|8|||
170856380|NCT03992846|617482286|FG001|Overall Study|Adverse Event|6|||
170856381|NCT03992846|617482287|FG002|Overall Study|Adverse Event|3|||
170856382|NCT03992846|617482285|FG000|Overall Study|Lost to Follow-up|0|||
170856383|NCT03992846|617482286|FG001|Overall Study|Lost to Follow-up|1|||
170856384|NCT03992846|617482287|FG002|Overall Study|Lost to Follow-up|1|||
170856385|NCT03992846|617482285|FG000|Overall Study|Pregnancy|2|||
170856386|NCT03992846|617482286|FG001|Overall Study|Pregnancy|0|||
170856387|NCT03992846|617482287|FG002|Overall Study|Pregnancy|1|||
170856388|NCT03992846|617482285|FG000|Overall Study|Protocol Violation|1|||
170856389|NCT03992846|617482286|FG001|Overall Study|Protocol Violation|2|||
170856390|NCT03992846|617482287|FG002|Overall Study|Protocol Violation|0|||
170856391|NCT03992846|617482285|FG000|Overall Study|Withdrawal by Subject|8|||
170856392|NCT03992846|617482286|FG001|Overall Study|Withdrawal by Subject|10|||
170856393|NCT03992846|617482287|FG002|Overall Study|Withdrawal by Subject|20|||
170856394|NCT03992846|617482285|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
170856395|NCT03992846|617482286|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
170856396|NCT03992846|617482287|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
170856397|NCT04812548|617483817|FG000|Overall Study|Adverse Event|2|||
170856398|NCT04812548|617483818|FG001|Overall Study|Adverse Event|7|||
170856399|NCT04812548|617483817|FG000|Overall Study|HSCT Planned|2|||
170856400|NCT04812548|617483818|FG001|Overall Study|HSCT Planned|3|||
170856401|NCT04812548|617483817|FG000|Overall Study|Progressive Disease|0|||
170856402|NCT04812548|617483818|FG001|Overall Study|Progressive Disease|2|||
170856403|NCT04812548|617483817|FG000|Overall Study|Death|0|||
170856404|NCT04812548|617483818|FG001|Overall Study|Death|1|||
170856405|NCT04812548|617483817|FG000|Overall Study|Post Study Access to Treatment|0|||
170856406|NCT04812548|617483818|FG001|Overall Study|Post Study Access to Treatment|1|||
170856407|NCT04812548|617483817|FG000|Overall Study|Withdrawal by Subject|0|||
170856408|NCT04812548|617483818|FG001|Overall Study|Withdrawal by Subject|1|||
170856409|NCT04812548|617483817|FG000|Overall Study|Physician Decision|1|||
170856410|NCT04812548|617483818|FG001|Overall Study|Physician Decision|0|||
170856411|NCT01873495|617483821|FG000|Overall Study|Withdrawal by Subject|1|||
170856412|NCT01873495|617483821|FG000|Overall Study|Physician Decision|3|||
170856413|NCT01873495|617483821|FG000|Overall Study|Adverse Event|1|||
170856414|NCT01873495|617483821|FG000|Overall Study|Removed for Transplantation|1|||
170856415|NCT01873495|617483821|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
170856416|NCT03786783|617483825|FG000|Overall Study|Death|1|||
170856417|NCT03786783|617483825|FG000|Overall Study|Physician Decision|6|||
170856418|NCT03786783|617483825|FG000|Overall Study|Withdrawal by Subject|2|||
170856419|NCT03786783|617483825|FG000|Overall Study|Disease Progression|7|||
170856420|NCT03786783|617483825|FG000|Overall Study|Patient/Parent Refusal|4|||
170856421|NCT01776541|617483826|FG000|Overall Study|Administrative Reason|6|||
170856422|NCT01776541|617483827|FG001|Overall Study|Administrative Reason|2|||
170856423|NCT01776541|617483826|FG000|Overall Study|Death|4|||
170856424|NCT01776541|617483827|FG001|Overall Study|Death|0|||
170856425|NCT01776541|617483826|FG000|Overall Study|Lost to Follow-up|27|||
170856426|NCT01776541|617483827|FG001|Overall Study|Lost to Follow-up|48|||
170856427|NCT01776541|617483826|FG000|Overall Study|Unclassified|5|||
170856428|NCT01776541|617483827|FG001|Overall Study|Unclassified|4|||
170856429|NCT01776541|617483826|FG000|Overall Study|Protocol Violation|2|||
170856430|NCT01776541|617483827|FG001|Overall Study|Protocol Violation|1|||
170856431|NCT01776541|617483826|FG000|Overall Study|Withdrawal by Subject|12|||
170856432|NCT01776541|617483827|FG001|Overall Study|Withdrawal by Subject|20|||
170856433|NCT00903006|617483831|FG000|Overall Study|Withdrawal by Subject|2|||
170856434|NCT00903006|617483832|FG001|Overall Study|Withdrawal by Subject|0|||
170743356|NCT02073097|617066115|FG006|Overall Study|Death|0|||
170743357|NCT02073097|617066116|FG007|Overall Study|Death|1|||
170743358|NCT02073097|617066109|FG000|Overall Study|Physician Decision|0|||
170743359|NCT02073097|617066110|FG001|Overall Study|Physician Decision|0|||
170743360|NCT02073097|617066111|FG002|Overall Study|Physician Decision|0|||
170743361|NCT02073097|617066112|FG003|Overall Study|Physician Decision|0|||
170743362|NCT02073097|617066113|FG004|Overall Study|Physician Decision|0|||
170743363|NCT02073097|617066114|FG005|Overall Study|Physician Decision|0|||
170743364|NCT02073097|617066115|FG006|Overall Study|Physician Decision|0|||
170743365|NCT02073097|617066116|FG007|Overall Study|Physician Decision|1|||
170743366|NCT03813147|617066119|FG000|Overall Study|Lack of Efficacy|4|||
170743367|NCT03813147|617066120|FG001|Overall Study|Lack of Efficacy|4|||
170743368|NCT03813147|617066119|FG000|Overall Study|Physician Decision|2|||
170743369|NCT03813147|617066120|FG001|Overall Study|Physician Decision|1|||
170856435|NCT00903006|617483833|FG002|Overall Study|Withdrawal by Subject|0|||
170856436|NCT00903006|617483834|FG003|Overall Study|Withdrawal by Subject|0|||
170856437|NCT00903006|617483831|FG000|Overall Study|Progressive Disease|0|||
170743370|NCT01693692|617066121|FG000|Overall Study|Withdrawal by Subject|12|||
170856438|NCT00903006|617483832|FG001|Overall Study|Progressive Disease|3|||
170856439|NCT00903006|617483833|FG002|Overall Study|Progressive Disease|1|||
170856440|NCT00903006|617483834|FG003|Overall Study|Progressive Disease|0|||
170856441|NCT02518490|617483835|FG000|Overall Study|Withdrawal by Subject|1|||
170856442|NCT02518490|617483836|FG001|Overall Study|Withdrawal by Subject|1|||
170856443|NCT00701220|617483839|FG000|Overall Study|Withdrawal by Subject|0|||
170743371|NCT01693692|617066122|FG001|Overall Study|Withdrawal by Subject|10|||
170743372|NCT01693692|617066123|FG002|Overall Study|Withdrawal by Subject|11|||
170743373|NCT01693692|617066121|FG000|Overall Study|Adverse Event|7|||
170743374|NCT01693692|617066122|FG001|Overall Study|Adverse Event|14|||
170856444|NCT00701220|617483840|FG001|Overall Study|Withdrawal by Subject|2|||
170856445|NCT00701220|617483839|FG000|Overall Study|Protocol Violation|2|||
170743375|NCT01693692|617066123|FG002|Overall Study|Adverse Event|9|||
170856446|NCT00701220|617483840|FG001|Overall Study|Protocol Violation|0|||
170856447|NCT01029652|617483841|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
170856448|NCT01029652|617483842|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
170856449|NCT01029652|617483841|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
170856450|NCT01029652|617483842|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
170856451|NCT01029652|617483841|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
170856452|NCT01029652|617483842|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
170856453|NCT01029652|617483841|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
170856454|NCT01029652|617483842|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
170856455|NCT01029652|617483841|FG000|Core Study (0-12 Weeks)|Death|0|||
170856456|NCT01029652|617483842|FG001|Core Study (0-12 Weeks)|Death|1|||
170856457|NCT01029652|617483841|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
170856458|NCT01029652|617483842|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
170856459|NCT01029652|617483841|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
170856460|NCT01029652|617483842|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
170856461|NCT01029652|617483841|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
170856462|NCT01029652|617483842|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
170856463|NCT01029652|617483841|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
170856464|NCT01029652|617483842|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
170856465|NCT01029652|617483841|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
170856466|NCT01029652|617483842|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
170856467|NCT01029652|617483841|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
170856468|NCT01029652|617483842|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
170856469|NCT01029652|617483841|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
170856470|NCT01029652|617483842|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
170856471|NCT01382706|617483843|FG000|Overall Study|Adverse Event|1|||
170856472|NCT01382706|617483843|FG000|Overall Study|Withdrawal by Subject|1|||
170856473|NCT04018092|617483844|FG000|Overall Study|Withdrawal by Subject|1|||
170856474|NCT04018092|617483845|FG001|Overall Study|Withdrawal by Subject|1|||
170856475|NCT04018092|617483844|FG000|Overall Study|Withdrawal by Subject|1|||
170856476|NCT04018092|617483845|FG001|Overall Study|Withdrawal by Subject|1|||
170856477|NCT06469242|617483846|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
170856478|NCT06469242|617483847|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
170856479|NCT06469242|617483846|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
170856480|NCT06469242|617483847|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
170856481|NCT02679573|617483848|FG000|Overall Study|Adverse Event|13|||
170856482|NCT02679573|617483849|FG001|Overall Study|Adverse Event|6|||
170856483|NCT02679573|617483848|FG000|Overall Study|Lack of Efficacy|12|||
170856484|NCT02679573|617483849|FG001|Overall Study|Lack of Efficacy|15|||
170856485|NCT02679573|617483848|FG000|Overall Study|Could not complete required study visits|6|||
170856486|NCT02679573|617483849|FG001|Overall Study|Could not complete required study visits|2|||
170856487|NCT02679573|617483848|FG000|Overall Study|Withdrawal by Subject|2|||
170856488|NCT02679573|617483849|FG001|Overall Study|Withdrawal by Subject|9|||
170856489|NCT02679573|617483848|FG000|Overall Study|Death|2|||
170856490|NCT02679573|617483849|FG001|Overall Study|Death|0|||
170856491|NCT02679573|617483848|FG000|Overall Study|Physician Decision|2|||
170856492|NCT02679573|617483849|FG001|Overall Study|Physician Decision|4|||
170856493|NCT02679573|617483848|FG000|Overall Study|Lost to Follow-up|0|||
170856494|NCT02679573|617483849|FG001|Overall Study|Lost to Follow-up|3|||
170856495|NCT02208999|617483850|FG000|Overall Study|Lost to Follow-up|1|||
170856496|NCT00986674|617483851|FG000|Overall Study|Lack of Efficacy|28|||
170856497|NCT00986674|617483852|FG001|Overall Study|Lack of Efficacy|25|||
170856498|NCT00986674|617483853|FG002|Overall Study|Lack of Efficacy|23|||
170856499|NCT00986674|617483851|FG000|Overall Study|Adverse Event|4|||
170856500|NCT00986674|617483852|FG001|Overall Study|Adverse Event|8|||
170856501|NCT00986674|617483853|FG002|Overall Study|Adverse Event|9|||
170856502|NCT00986674|617483851|FG000|Overall Study|Death|5|||
170856503|NCT00986674|617483852|FG001|Overall Study|Death|0|||
170856504|NCT00986674|617483853|FG002|Overall Study|Death|4|||
170856505|NCT00986674|617483851|FG000|Overall Study|Withdrawal by Subject|6|||
170856506|NCT00986674|617483852|FG001|Overall Study|Withdrawal by Subject|2|||
170856507|NCT00986674|617483853|FG002|Overall Study|Withdrawal by Subject|1|||
170856508|NCT00986674|617483851|FG000|Overall Study|alternative therapy|0|||
170856509|NCT00986674|617483852|FG001|Overall Study|alternative therapy|0|||
170856510|NCT00986674|617483853|FG002|Overall Study|alternative therapy|1|||
170856511|NCT00986674|617483851|FG000|Overall Study|not start protocol therapy|4|||
170856512|NCT00986674|617483852|FG001|Overall Study|not start protocol therapy|3|||
170856513|NCT00986674|617483853|FG002|Overall Study|not start protocol therapy|1|||
170856514|NCT00986674|617483851|FG000|Overall Study|unknown/not specify|0|||
170856515|NCT00986674|617483852|FG001|Overall Study|unknown/not specify|7|||
170856516|NCT00986674|617483853|FG002|Overall Study|unknown/not specify|9|||
170856517|NCT02483585|617483854|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
170856518|NCT02483585|617483855|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
170743376|NCT01693692|617066121|FG000|Overall Study|Physician Decision|0|||
170743377|NCT01693692|617066122|FG001|Overall Study|Physician Decision|0|||
170743378|NCT01693692|617066123|FG002|Overall Study|Physician Decision|1|||
170743379|NCT01693692|617066121|FG000|Overall Study|Protocol Violation|5|||
170743380|NCT01693692|617066122|FG001|Overall Study|Protocol Violation|4|||
170743381|NCT01693692|617066123|FG002|Overall Study|Protocol Violation|6|||
170743382|NCT01693692|617066121|FG000|Overall Study|Lost to Follow-up|2|||
170743383|NCT01693692|617066122|FG001|Overall Study|Lost to Follow-up|2|||
170743384|NCT01693692|617066123|FG002|Overall Study|Lost to Follow-up|3|||
170743385|NCT01693692|617066121|FG000|Overall Study|Other|4|||
170743386|NCT01693692|617066122|FG001|Overall Study|Other|4|||
170743387|NCT01693692|617066123|FG002|Overall Study|Other|6|||
170743388|NCT00802737|617067843|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
170743389|NCT00802737|617067844|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
170743390|NCT00802737|617067845|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
170743391|NCT00802737|617067843|FG000|Overall Study|Death|6|||
170743392|NCT00802737|617067844|FG001|Overall Study|Death|5|||
170743393|NCT00802737|617067845|FG002|Overall Study|Death|1|||
170743394|NCT00802737|617067843|FG000|Overall Study|Adverse Event|1|||
170743395|NCT00802737|617067844|FG001|Overall Study|Adverse Event|0|||
170856519|NCT02483585|617483854|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
170856520|NCT02483585|617483855|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
170856521|NCT02483585|617483854|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
170856522|NCT02483585|617483855|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
170856523|NCT02483585|617483854|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
170856524|NCT02483585|617483855|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
170856525|NCT02483585|617483854|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
170856526|NCT02483585|617483855|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
170856527|NCT02483585|617483854|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
170856528|NCT02483585|617483855|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
170856529|NCT02483585|617483854|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
170856530|NCT02483585|617483855|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
170856531|NCT00848926|617483861|FG000|Treatment Period|Progressive disease|45|||
170856532|NCT00848926|617483861|FG000|Treatment Period|Adverse Event|20|||
170856533|NCT00848926|617483861|FG000|Treatment Period|Physician Decision|12|||
170856534|NCT00848926|617483861|FG000|Treatment Period|Withdrawal by Subject|7|||
170856535|NCT00848926|617483861|FG000|Follow-up Period|Lost to Follow-up|7|||
170856536|NCT00848926|617483861|FG000|Follow-up Period|Withdrawal by Subject|3|||
170856537|NCT00848926|617483861|FG000|Follow-up Period|Other|2|||
170856538|NCT00903630|617483862|FG000|Phase 2|Adverse Event|0|||
170856539|NCT00903630|617483863|FG001|Phase 2|Adverse Event|0|||
170856540|NCT00903630|617483864|FG002|Phase 2|Adverse Event|1|||
170856541|NCT04025580|617483865|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
170856542|NCT04025580|617483866|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
170856543|NCT04025580|617483867|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
170856544|NCT03658668|617483870|FG000|Overall Study|Time Commitment|1|||
170856545|NCT03658668|617483871|FG001|Overall Study|Time Commitment|1|||
170856546|NCT03305731|617483872|FG000|Overall Study|Protocol Violation|1|||
170856547|NCT04634825|617483873|FG000|Overall Study|Death|10|||
170856548|NCT04634825|617483874|FG001|Overall Study|Death|3|||
170856549|NCT04634825|617483873|FG000|Overall Study|Lost to Follow-up|1|||
170856550|NCT04634825|617483874|FG001|Overall Study|Lost to Follow-up|0|||
170856551|NCT04634825|617483873|FG000|Overall Study|Study terminated by sponsor|35|||
170856552|NCT04634825|617483874|FG001|Overall Study|Study terminated by sponsor|11|||
170856553|NCT04634825|617483873|FG000|Overall Study|Withdrawal by Subject|2|||
170856554|NCT04634825|617483874|FG001|Overall Study|Withdrawal by Subject|0|||
170856555|NCT01100034|617483877|FG000|Overall Study|Lost to Follow-up|11|||
170856556|NCT01100034|617483877|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
170856557|NCT01100034|617483877|FG000|Overall Study|Withdrawal by Subject|4|||
170856558|NCT01100034|617483877|FG000|Overall Study|Sponsor decision|21|||
170856559|NCT01100034|617483877|FG000|Overall Study|Participated in another clinical trial|1|||
170856560|NCT01100034|617483877|FG000|Overall Study|Participants moved to another hospital|4|||
170856561|NCT01100034|617483877|FG000|Overall Study|Site closed due to non-responsiveness|1|||
170856562|NCT01831856|617483878|FG000|Overall Study|Adverse Event|5|||
170856563|NCT01831856|617483879|FG001|Overall Study|Adverse Event|8|||
170856564|NCT01831856|617483878|FG000|Overall Study|Lack of Efficacy|13|||
170856565|NCT01831856|617483879|FG001|Overall Study|Lack of Efficacy|11|||
170856566|NCT01831856|617483878|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
170856567|NCT01831856|617483879|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
170856568|NCT05208866|617483881|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
170856569|NCT00836095|617483882|FG000|Overall Study|Physician Decision|0|||
170856570|NCT00836095|617483883|FG001|Overall Study|Physician Decision|3|||
170856571|NCT00232544|617483885|FG000|Overall Study|Lost to Follow-up|20|||
170856572|NCT00232544|617483886|FG001|Overall Study|Lost to Follow-up|15|||
170856573|NCT02581631|617483887|FG000|Overall Study|Disease progression|29|||
170856574|NCT02581631|617483888|FG001|Overall Study|Disease progression|19|||
170856575|NCT02581631|617483889|FG002|Overall Study|Disease progression|13|||
170856576|NCT02581631|617483890|FG003|Overall Study|Disease progression|5|||
170856577|NCT02581631|617483891|FG004|Overall Study|Disease progression|8|||
170856578|NCT02581631|617483887|FG000|Overall Study|Study drug toxicity|4|||
170856579|NCT02581631|617483888|FG001|Overall Study|Study drug toxicity|6|||
170856580|NCT02581631|617483889|FG002|Overall Study|Study drug toxicity|7|||
170856581|NCT02581631|617483890|FG003|Overall Study|Study drug toxicity|0|||
170856582|NCT02581631|617483891|FG004|Overall Study|Study drug toxicity|3|||
170856583|NCT02581631|617483887|FG000|Overall Study|AE unrelated to study drug|3|||
170856584|NCT02581631|617483888|FG001|Overall Study|AE unrelated to study drug|1|||
170856585|NCT02581631|617483889|FG002|Overall Study|AE unrelated to study drug|1|||
170856586|NCT02581631|617483890|FG003|Overall Study|AE unrelated to study drug|0|||
170856587|NCT02581631|617483891|FG004|Overall Study|AE unrelated to study drug|2|||
170856588|NCT02581631|617483887|FG000|Overall Study|Request to discontinue|1|||
170856589|NCT02581631|617483888|FG001|Overall Study|Request to discontinue|0|||
170856590|NCT02581631|617483889|FG002|Overall Study|Request to discontinue|3|||
170856591|NCT02581631|617483890|FG003|Overall Study|Request to discontinue|0|||
170743396|NCT00802737|617067845|FG002|Overall Study|Adverse Event|0|||
170743397|NCT00802737|617067843|FG000|Overall Study|Received Prohibited Therapy|1|||
170743398|NCT00802737|617067844|FG001|Overall Study|Received Prohibited Therapy|0|||
170743399|NCT00802737|617067845|FG002|Overall Study|Received Prohibited Therapy|0|||
170743400|NCT00802737|617067843|FG000|Overall Study|Ongoing CLL-Treatment|0|||
170743401|NCT00802737|617067844|FG001|Overall Study|Ongoing CLL-Treatment|1|||
170743402|NCT00802737|617067845|FG002|Overall Study|Ongoing CLL-Treatment|0|||
170743403|NCT00802737|617067843|FG000|Overall Study|Participant too Unwell|0|||
170743404|NCT00802737|617067844|FG001|Overall Study|Participant too Unwell|2|||
170743405|NCT00802737|617067845|FG002|Overall Study|Participant too Unwell|0|||
170743406|NCT00445601|617067846|FG000|Overall Study|Withdrawal by Subject|11|||
170743407|NCT00445601|617067847|FG001|Overall Study|Withdrawal by Subject|11|||
170743408|NCT00445601|617067846|FG000|Overall Study|TURBT Complication|12|||
170743409|NCT00445601|617067847|FG001|Overall Study|TURBT Complication|8|||
170743410|NCT00445601|617067846|FG000|Overall Study|Incorrect Disease Status|6|||
170743411|NCT00445601|617067847|FG001|Overall Study|Incorrect Disease Status|6|||
170743412|NCT00445601|617067846|FG000|Overall Study|Drug Delivery Issue|2|||
170743413|NCT00445601|617067847|FG001|Overall Study|Drug Delivery Issue|2|||
170743414|NCT00445601|617067846|FG000|Overall Study|Adverse Event|2|||
170743415|NCT00445601|617067847|FG001|Overall Study|Adverse Event|0|||
170743416|NCT00445601|617067846|FG000|Overall Study|Death prior to TURBT|0|||
170743417|NCT00445601|617067847|FG001|Overall Study|Death prior to TURBT|1|||
170743418|NCT02032173|617067848|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
170743419|NCT03154359|617067855|FG000|Overall Study|Adverse Event|1|||
170743420|NCT03154359|617067855|FG000|Overall Study|Lack of Efficacy|2|||
170743421|NCT03154359|617067855|FG000|Overall Study|Lost to Follow-up|3|||
170743422|NCT03154359|617067855|FG000|Overall Study|Physician Decision|3|||
170743423|NCT03154359|617067855|FG000|Overall Study|Protocol Violation|4|||
170743424|NCT03154359|617067855|FG000|Overall Study|Withdrawal by Subject|5|||
170743425|NCT03154359|617067855|FG000|Overall Study|Disruption of study due to COVID-19|4|||
170743426|NCT01460160|617067856|FG000|Treatment Phase|Lack of Efficacy|3|||
170743427|NCT01460160|617067856|FG000|Treatment Phase|Study Drug Toxicity|2|||
170743428|NCT01460160|617067856|FG000|Treatment Phase|Adverse Event|8|||
170856592|NCT02581631|617483891|FG004|Overall Study|Request to discontinue|1|||
170856593|NCT02581631|617483887|FG000|Overall Study|participant withdrew consent|3|||
170856594|NCT02581631|617483888|FG001|Overall Study|participant withdrew consent|0|||
170856595|NCT02581631|617483889|FG002|Overall Study|participant withdrew consent|1|||
170856596|NCT02581631|617483890|FG003|Overall Study|participant withdrew consent|0|||
170856597|NCT02581631|617483891|FG004|Overall Study|participant withdrew consent|0|||
170856598|NCT02581631|617483887|FG000|Overall Study|Maximum clinical benefit|1|||
170856599|NCT02581631|617483888|FG001|Overall Study|Maximum clinical benefit|7|||
170856600|NCT02581631|617483889|FG002|Overall Study|Maximum clinical benefit|1|||
170856601|NCT02581631|617483890|FG003|Overall Study|Maximum clinical benefit|3|||
170856602|NCT02581631|617483891|FG004|Overall Study|Maximum clinical benefit|13|||
170856603|NCT02581631|617483887|FG000|Overall Study|Other Reasons|1|||
170856604|NCT02581631|617483888|FG001|Overall Study|Other Reasons|0|||
170856605|NCT02581631|617483889|FG002|Overall Study|Other Reasons|2|||
170856606|NCT02581631|617483890|FG003|Overall Study|Other Reasons|2|||
170856607|NCT02581631|617483891|FG004|Overall Study|Other Reasons|3|||
170856608|NCT02581631|617483887|FG000|Overall Study|Poor/Non-Compliance|0|||
170856609|NCT02581631|617483888|FG001|Overall Study|Poor/Non-Compliance|0|||
170856610|NCT02581631|617483889|FG002|Overall Study|Poor/Non-Compliance|1|||
170856611|NCT02581631|617483890|FG003|Overall Study|Poor/Non-Compliance|0|||
170856612|NCT02581631|617483891|FG004|Overall Study|Poor/Non-Compliance|0|||
170856613|NCT00116753|617483892|FG000|Overall Study|Adverse Event|16|||
170856614|NCT00116753|617483893|FG001|Overall Study|Adverse Event|10|||
170856615|NCT00116753|617483894|FG002|Overall Study|Adverse Event|7|||
170856616|NCT00116753|617483892|FG000|Overall Study|Withdrawal by Subject|11|||
170743429|NCT01460160|617067856|FG000|Treatment Phase|Withdrawal by Subject|4|||
170743430|NCT01460160|617067856|FG000|Treatment Phase|Death|2|||
170856617|NCT00116753|617483893|FG001|Overall Study|Withdrawal by Subject|12|||
170856618|NCT00116753|617483894|FG002|Overall Study|Withdrawal by Subject|8|||
170856619|NCT00116753|617483892|FG000|Overall Study|Lost to Follow-up|0|||
170743431|NCT01460160|617067856|FG000|Treatment Phase|Other reasons|9|||
170856620|NCT00116753|617483893|FG001|Overall Study|Lost to Follow-up|2|||
170856621|NCT00116753|617483894|FG002|Overall Study|Lost to Follow-up|1|||
170856622|NCT00116753|617483892|FG000|Overall Study|Protocol Violation|0|||
170856623|NCT00116753|617483893|FG001|Overall Study|Protocol Violation|0|||
170856624|NCT00116753|617483894|FG002|Overall Study|Protocol Violation|1|||
170856625|NCT00116753|617483892|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
170856626|NCT00116753|617483893|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
170856627|NCT00116753|617483894|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
170856628|NCT00116753|617483892|FG000|Overall Study|Disease Progression|3|||
170856629|NCT00116753|617483893|FG001|Overall Study|Disease Progression|4|||
170856630|NCT00116753|617483894|FG002|Overall Study|Disease Progression|3|||
170856631|NCT00116753|617483892|FG000|Overall Study|Abnormal Echocardiogram|0|||
170856632|NCT00116753|617483893|FG001|Overall Study|Abnormal Echocardiogram|0|||
170856633|NCT00116753|617483894|FG002|Overall Study|Abnormal Echocardiogram|1|||
170856634|NCT00116753|617483892|FG000|Overall Study|Progressive Parkinson's Disease|1|||
170856635|NCT00116753|617483893|FG001|Overall Study|Progressive Parkinson's Disease|0|||
170856636|NCT00116753|617483894|FG002|Overall Study|Progressive Parkinson's Disease|0|||
170856637|NCT00116753|617483892|FG000|Overall Study|Dosing Error|0|||
170856638|NCT00116753|617483893|FG001|Overall Study|Dosing Error|1|||
170856639|NCT00116753|617483894|FG002|Overall Study|Dosing Error|0|||
170856640|NCT02150343|617483895|FG000|Overall Study|Adverse Event|2|||
170856641|NCT02150343|617483896|FG001|Overall Study|Adverse Event|0|||
170856642|NCT02150343|617483897|FG002|Overall Study|Adverse Event|1|||
170856643|NCT02150343|617483898|FG003|Overall Study|Adverse Event|1|||
170856644|NCT02150343|617483895|FG000|Overall Study|Withdrawal by Subject|13|||
170856645|NCT02150343|617483896|FG001|Overall Study|Withdrawal by Subject|10|||
170856646|NCT02150343|617483897|FG002|Overall Study|Withdrawal by Subject|9|||
170856647|NCT02150343|617483898|FG003|Overall Study|Withdrawal by Subject|4|||
170856648|NCT02150343|617483895|FG000|Overall Study|Lost to Follow-up|4|||
170856649|NCT02150343|617483896|FG001|Overall Study|Lost to Follow-up|4|||
170856650|NCT02150343|617483897|FG002|Overall Study|Lost to Follow-up|2|||
170856651|NCT02150343|617483898|FG003|Overall Study|Lost to Follow-up|3|||
170856652|NCT02150343|617483895|FG000|Overall Study|Other|2|||
170856653|NCT02150343|617483896|FG001|Overall Study|Other|6|||
170856654|NCT02150343|617483897|FG002|Overall Study|Other|0|||
170856655|NCT02150343|617483898|FG003|Overall Study|Other|2|||
170856656|NCT00190749|617483899|FG000|Overall Study|Lost to Follow-up|8|||
170856657|NCT00190749|617483900|FG001|Overall Study|Lost to Follow-up|11|||
170856658|NCT00190749|617483899|FG000|Overall Study|Withdrawal by Subject|10|||
170856659|NCT00190749|617483900|FG001|Overall Study|Withdrawal by Subject|6|||
170856660|NCT00190749|617483899|FG000|Overall Study|Protocol Violation|5|||
170856661|NCT00190749|617483900|FG001|Overall Study|Protocol Violation|4|||
170856662|NCT00190749|617483899|FG000|Overall Study|Adverse Event|0|||
170856663|NCT00190749|617483900|FG001|Overall Study|Adverse Event|5|||
170856664|NCT00190749|617483899|FG000|Overall Study|Lack of Efficacy|2|||
170856665|NCT00190749|617483900|FG001|Overall Study|Lack of Efficacy|3|||
170856666|NCT00190749|617483899|FG000|Overall Study|Reason Not Specified|0|||
170856667|NCT00190749|617483900|FG001|Overall Study|Reason Not Specified|2|||
170856668|NCT00190749|617483899|FG000|Overall Study|Sponsor Decision|1|||
170856669|NCT00190749|617483900|FG001|Overall Study|Sponsor Decision|0|||
170856670|NCT02729753|617483901|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
170856671|NCT02729753|617483902|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
170856672|NCT00598273|617483903|FG000|Overall Study|Adverse Event|4|||
170856673|NCT00598273|617483904|FG001|Overall Study|Adverse Event|5|||
170856674|NCT00598273|617483905|FG002|Overall Study|Adverse Event|2|||
170856675|NCT00598273|617483903|FG000|Overall Study|Death|6|||
170856676|NCT00598273|617483904|FG001|Overall Study|Death|12|||
170856677|NCT00598273|617483905|FG002|Overall Study|Death|8|||
170856678|NCT00598273|617483903|FG000|Overall Study|Lost to Follow-up|8|||
170856679|NCT00598273|617483904|FG001|Overall Study|Lost to Follow-up|3|||
170856680|NCT00598273|617483905|FG002|Overall Study|Lost to Follow-up|5|||
170856681|NCT00598273|617483903|FG000|Overall Study|Physician Decision|0|||
170856682|NCT00598273|617483904|FG001|Overall Study|Physician Decision|0|||
170856683|NCT00598273|617483905|FG002|Overall Study|Physician Decision|1|||
170856684|NCT00598273|617483903|FG000|Overall Study|Withdrawal by Subject|12|||
170856685|NCT00598273|617483904|FG001|Overall Study|Withdrawal by Subject|10|||
170856686|NCT00598273|617483905|FG002|Overall Study|Withdrawal by Subject|10|||
170856687|NCT00598273|617483903|FG000|Overall Study|Noncompliance|3|||
170856688|NCT00598273|617483904|FG001|Overall Study|Noncompliance|2|||
170856689|NCT00598273|617483905|FG002|Overall Study|Noncompliance|3|||
170856690|NCT00598273|617483903|FG000|Overall Study|Relocation|0|||
170856691|NCT00598273|617483904|FG001|Overall Study|Relocation|2|||
170856692|NCT00598273|617483905|FG002|Overall Study|Relocation|4|||
170856693|NCT00598273|617483903|FG000|Overall Study|Renal transplant|1|||
170856694|NCT00598273|617483904|FG001|Overall Study|Renal transplant|0|||
170856695|NCT00598273|617483905|FG002|Overall Study|Renal transplant|1|||
170856696|NCT00598273|617483903|FG000|Overall Study|Site elected to close|1|||
170856697|NCT00598273|617483904|FG001|Overall Study|Site elected to close|0|||
170856698|NCT00598273|617483905|FG002|Overall Study|Site elected to close|0|||
170856699|NCT00598273|617483903|FG000|Overall Study|Started dialysis|6|||
170856700|NCT00598273|617483904|FG001|Overall Study|Started dialysis|4|||
170856701|NCT00598273|617483905|FG002|Overall Study|Started dialysis|5|||
170856702|NCT01313689|617483906|FG000|24-Week Randomization 1|Adverse Event|10|||
170856703|NCT01313689|617483907|FG001|24-Week Randomization 1|Adverse Event|5|||
170856704|NCT01313689|617483908|FG002|24-Week Randomization 1|Adverse Event|0|||
170856705|NCT01313689|617483909|FG003|24-Week Randomization 1|Adverse Event|0|||
170856706|NCT01313689|617483910|FG004|24-Week Randomization 1|Adverse Event|0|||
170856707|NCT01313689|617483906|FG000|24-Week Randomization 1|Physician Decision|4|||
170856708|NCT01313689|617483907|FG001|24-Week Randomization 1|Physician Decision|5|||
170856709|NCT01313689|617483908|FG002|24-Week Randomization 1|Physician Decision|0|||
170856710|NCT01313689|617483909|FG003|24-Week Randomization 1|Physician Decision|0|||
170856711|NCT01313689|617483910|FG004|24-Week Randomization 1|Physician Decision|0|||
170856712|NCT01313689|617483906|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
170856713|NCT01313689|617483907|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
170856714|NCT01313689|617483908|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
170856715|NCT01313689|617483909|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
170856716|NCT01313689|617483910|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
170856717|NCT01313689|617483906|FG000|24-Week Randomization 2|Adverse Event|0|||
170856718|NCT01313689|617483907|FG001|24-Week Randomization 2|Adverse Event|0|||
170856719|NCT01313689|617483908|FG002|24-Week Randomization 2|Adverse Event|2|||
170856720|NCT01313689|617483909|FG003|24-Week Randomization 2|Adverse Event|0|||
170856721|NCT01313689|617483910|FG004|24-Week Randomization 2|Adverse Event|8|||
170856722|NCT01313689|617483906|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
170856723|NCT01313689|617483907|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
170856724|NCT01313689|617483908|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
170856725|NCT01313689|617483909|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
170856726|NCT01313689|617483910|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
170856727|NCT01313689|617483906|FG000|24-Week Randomization 2|Physician Decision|0|||
170856728|NCT01313689|617483907|FG001|24-Week Randomization 2|Physician Decision|0|||
170856729|NCT01313689|617483908|FG002|24-Week Randomization 2|Physician Decision|0|||
170856730|NCT01313689|617483909|FG003|24-Week Randomization 2|Physician Decision|0|||
170856731|NCT01313689|617483910|FG004|24-Week Randomization 2|Physician Decision|4|||
170856732|NCT01590082|617483911|FG000|Overall Study|Withdrawal by Subject|1|||
170856733|NCT01590082|617483912|FG001|Overall Study|Withdrawal by Subject|0|||
170856734|NCT01590082|617483911|FG000|Overall Study|Ineligible|1|||
170856735|NCT01590082|617483912|FG001|Overall Study|Ineligible|0|||
170856736|NCT01768637|617483913|FG000|Overall Study|Lost to Follow-up|2|||
170856737|NCT01768637|617483914|FG001|Overall Study|Lost to Follow-up|7|||
170856738|NCT01768637|617483913|FG000|Overall Study|Difficult blood draw|1|||
170856739|NCT01768637|617483914|FG001|Overall Study|Difficult blood draw|0|||
170856740|NCT02481947|617483915|FG000|Overall Study|Withdrawal by Subject|24|||
170856741|NCT02481947|617483916|FG001|Overall Study|Withdrawal by Subject|10|||
170856742|NCT02481947|617483915|FG000|Overall Study|Lost to Follow-up|11|||
170856743|NCT02481947|617483916|FG001|Overall Study|Lost to Follow-up|5|||
170856744|NCT02481947|617483915|FG000|Overall Study|Adverse Event|6|||
170856745|NCT02481947|617483916|FG001|Overall Study|Adverse Event|11|||
170856746|NCT02481947|617483915|FG000|Overall Study|Physician Decision|4|||
170856747|NCT02481947|617483916|FG001|Overall Study|Physician Decision|5|||
170856748|NCT02481947|617483915|FG000|Overall Study|Protocol Violation|1|||
170856749|NCT02481947|617483916|FG001|Overall Study|Protocol Violation|5|||
170856750|NCT01007448|617483917|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
170856751|NCT01007448|617483918|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
170856752|NCT01007448|617483917|FG000|Overall Study|Staph Skin Infection Flare|1|||
170856753|NCT01007448|617483918|FG001|Overall Study|Staph Skin Infection Flare|0|||
170856754|NCT01007448|617483917|FG000|Overall Study|Participant Leaving the Country|1|||
170856755|NCT01007448|617483918|FG001|Overall Study|Participant Leaving the Country|0|||
170856756|NCT01007448|617483917|FG000|Overall Study|Participant Given Prohibited Medication|1|||
170856757|NCT01007448|617483918|FG001|Overall Study|Participant Given Prohibited Medication|0|||
170856758|NCT01007448|617483917|FG000|Overall Study|Progressive Disease|1|||
170856759|NCT01007448|617483918|FG001|Overall Study|Progressive Disease|2|||
170856760|NCT01007448|617483917|FG000|Overall Study|Lack of Efficacy|2|||
170856761|NCT01007448|617483918|FG001|Overall Study|Lack of Efficacy|0|||
170856762|NCT01007448|617483917|FG000|Overall Study|Withdrawal by Subject|2|||
170856763|NCT01007448|617483918|FG001|Overall Study|Withdrawal by Subject|3|||
170856764|NCT01007448|617483917|FG000|Overall Study|Adverse Event|1|||
170856765|NCT01007448|617483918|FG001|Overall Study|Adverse Event|4|||
170856766|NCT02951767|617483919|FG000|Overall Study|Study Terminated By Sponsor|9|||
170856767|NCT02951767|617483919|FG000|Overall Study|Withdrawal by Subject|11|||
170856768|NCT02951767|617483919|FG000|Overall Study|Death|96|||
170856769|NCT02951767|617483919|FG000|Overall Study|Lost to Follow-up|2|||
170856770|NCT02951767|617483919|FG000|Overall Study|Physician Decision|1|||
170856771|NCT02751320|617483920|FG000|Overall Study|Adverse Event|2|||
170856772|NCT02751320|617483920|FG000|Overall Study|Withdrawal by Subject|1|||
170856773|NCT02549196|617483921|FG000|Overall Study|Protocol Violation|0|||
170856774|NCT02549196|617483922|FG001|Overall Study|Protocol Violation|0|||
170856775|NCT02549196|617483923|FG002|Overall Study|Protocol Violation|0|||
170856776|NCT02549196|617483924|FG003|Overall Study|Protocol Violation|1|||
170856777|NCT02549196|617483921|FG000|Overall Study|Withdrawal by Subject|1|||
170856778|NCT02549196|617483922|FG001|Overall Study|Withdrawal by Subject|0|||
170856779|NCT02549196|617483923|FG002|Overall Study|Withdrawal by Subject|1|||
170856780|NCT02549196|617483924|FG003|Overall Study|Withdrawal by Subject|0|||
170856781|NCT01442779|617483925|FG000|Overall Study|Withdrawal by Subject|3|||
170856782|NCT01442779|617483925|FG000|Overall Study|Death|3|||
170856783|NCT01442779|617483925|FG000|Overall Study|Non-compliance|1|||
170856784|NCT03426605|617483926|FG000|Overall Study|AML relapse or progression|2|||
170856785|NCT03426605|617483927|FG001|Overall Study|AML relapse or progression|1|||
170856786|NCT03426605|617483928|FG002|Overall Study|AML relapse or progression|2|||
170856787|NCT03426605|617483929|FG003|Overall Study|AML relapse or progression|2|||
170856788|NCT03426605|617483926|FG000|Overall Study|Treatment failure|3|||
170856789|NCT03426605|617483927|FG001|Overall Study|Treatment failure|2|||
170856790|NCT03426605|617483928|FG002|Overall Study|Treatment failure|0|||
170856791|NCT03426605|617483929|FG003|Overall Study|Treatment failure|0|||
170856792|NCT03426605|617483926|FG000|Overall Study|Adverse Event|1|||
170856793|NCT03426605|617483927|FG001|Overall Study|Adverse Event|0|||
170856794|NCT03426605|617483928|FG002|Overall Study|Adverse Event|1|||
170856795|NCT03426605|617483929|FG003|Overall Study|Adverse Event|1|||
170856796|NCT03426605|617483926|FG000|Overall Study|Withdrawal by Subject|0|||
170856797|NCT03426605|617483927|FG001|Overall Study|Withdrawal by Subject|0|||
170856798|NCT03426605|617483928|FG002|Overall Study|Withdrawal by Subject|1|||
170856799|NCT03426605|617483929|FG003|Overall Study|Withdrawal by Subject|1|||
170856800|NCT01815138|617483930|FG000|Overall Study|Withdrawal by Subject|0|||
170856801|NCT01815138|617483931|FG001|Overall Study|Withdrawal by Subject|1|||
170856802|NCT01815138|617483930|FG000|Overall Study|Physician Decision|8|||
170856803|NCT01815138|617483931|FG001|Overall Study|Physician Decision|5|||
170856804|NCT00950950|617483936|FG000|Overall Study|Adverse Event|1|||
170856805|NCT00950950|617483937|FG001|Overall Study|Adverse Event|0|||
170856806|NCT00950950|617483936|FG000|Overall Study|Withdrawal by Subject|0|||
170856807|NCT00950950|617483937|FG001|Overall Study|Withdrawal by Subject|1|||
170856808|NCT02027623|617483938|FG000|Overall Study|Lost to Follow-up|3|||
170856809|NCT02027623|617483939|FG001|Overall Study|Lost to Follow-up|3|||
170856810|NCT02027623|617483938|FG000|Overall Study|Withdrawal by Subject|6|||
170856811|NCT02027623|617483939|FG001|Overall Study|Withdrawal by Subject|9|||
170856812|NCT01588496|617483940|FG000|Overall Study|Withdrawal by Subject|0|||
170856813|NCT01588496|617483941|FG001|Overall Study|Withdrawal by Subject|1|||
170856814|NCT01588496|617483942|FG002|Overall Study|Withdrawal by Subject|0|||
170856815|NCT02003573|617483943|FG000|Overall Study|Progressive disease|2|||
170856816|NCT02003573|617483944|FG001|Overall Study|Progressive disease|0|||
170856817|NCT02003573|617483945|FG002|Overall Study|Progressive disease|1|||
170856818|NCT02003573|617483943|FG000|Overall Study|Other Adverse event|0|||
170856819|NCT02003573|617483944|FG001|Overall Study|Other Adverse event|1|||
170856820|NCT02003573|617483945|FG002|Overall Study|Other Adverse event|1|||
170856821|NCT02003573|617483943|FG000|Overall Study|Refuse to take trial medication|0|||
170856822|NCT02003573|617483944|FG001|Overall Study|Refuse to take trial medication|1|||
170856823|NCT02003573|617483945|FG002|Overall Study|Refuse to take trial medication|1|||
170856824|NCT02003573|617483943|FG000|Overall Study|Other than specified|1|||
170856825|NCT02003573|617483944|FG001|Overall Study|Other than specified|2|||
170856826|NCT02003573|617483945|FG002|Overall Study|Other than specified|3|||
170856827|NCT00994682|617483948|FG000|Double Bilnd|Withdrawal by Subject|5|||
170856828|NCT00994682|617483949|FG001|Double Bilnd|Withdrawal by Subject|6|||
170856829|NCT00994682|617483948|FG000|Double Bilnd|Lost to Follow-up|3|||
170856830|NCT00994682|617483949|FG001|Double Bilnd|Lost to Follow-up|3|||
170856831|NCT00994682|617483948|FG000|Double Bilnd|Adverse Event|1|||
170856832|NCT00994682|617483949|FG001|Double Bilnd|Adverse Event|0|||
170856833|NCT00994682|617483948|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
170856834|NCT00994682|617483949|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
170856835|NCT00994682|617483948|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
170856836|NCT00994682|617483949|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
170856837|NCT00994682|617483948|FG000|Pioglitazone Open Label|Physician Decision|6|||
170856838|NCT00994682|617483949|FG001|Pioglitazone Open Label|Physician Decision|1|||
170856839|NCT05180500|617483950|FG000|Overall Study|Adverse Event|1|||
170856840|NCT05180500|617483951|FG001|Overall Study|Adverse Event|0|||
170856841|NCT05180500|617483950|FG000|Overall Study|Withdrawal by Subject|2|||
170856842|NCT05180500|617483951|FG001|Overall Study|Withdrawal by Subject|0|||
170856843|NCT04927884|617483952|FG000|Overall Study|Progressive Disease|2|||
170856844|NCT05917470|617483953|FG000|Overall Study|Progressive Disease|1|||
170856845|NCT05917470|617483954|FG001|Overall Study|Progressive Disease|1|||
170856846|NCT05917470|617483955|FG002|Overall Study|Progressive Disease|2|||
170856847|NCT05917470|617483956|FG003|Overall Study|Progressive Disease|3|||
170856848|NCT05917470|617483957|FG004|Overall Study|Progressive Disease|1|||
170856849|NCT05917470|617483958|FG005|Overall Study|Progressive Disease|1|||
170856850|NCT05917470|617483959|FG006|Overall Study|Progressive Disease|0|||
170856851|NCT05917470|617483960|FG007|Overall Study|Progressive Disease|0|||
170856852|NCT05917470|617483953|FG000|Overall Study|Withdrawal by Subject|0|||
170856853|NCT05917470|617483954|FG001|Overall Study|Withdrawal by Subject|0|||
170856854|NCT05917470|617483955|FG002|Overall Study|Withdrawal by Subject|1|||
170856855|NCT05917470|617483956|FG003|Overall Study|Withdrawal by Subject|0|||
170856856|NCT05917470|617483957|FG004|Overall Study|Withdrawal by Subject|0|||
170856857|NCT05917470|617483958|FG005|Overall Study|Withdrawal by Subject|0|||
170856858|NCT05917470|617483959|FG006|Overall Study|Withdrawal by Subject|0|||
170856859|NCT05917470|617483960|FG007|Overall Study|Withdrawal by Subject|0|||
170856860|NCT05917470|617483953|FG000|Overall Study|Sponsor Decision|0|||
170856861|NCT05917470|617483954|FG001|Overall Study|Sponsor Decision|0|||
170856862|NCT05917470|617483955|FG002|Overall Study|Sponsor Decision|1|||
170856863|NCT05917470|617483956|FG003|Overall Study|Sponsor Decision|0|||
170856864|NCT05917470|617483957|FG004|Overall Study|Sponsor Decision|2|||
170856865|NCT05917470|617483958|FG005|Overall Study|Sponsor Decision|1|||
170856866|NCT05917470|617483959|FG006|Overall Study|Sponsor Decision|3|||
170856867|NCT05917470|617483960|FG007|Overall Study|Sponsor Decision|3|||
170856868|NCT05917470|617483953|FG000|Overall Study|Adverse Event|0|||
170856869|NCT05917470|617483954|FG001|Overall Study|Adverse Event|0|||
170856870|NCT05917470|617483955|FG002|Overall Study|Adverse Event|0|||
170856871|NCT05917470|617483956|FG003|Overall Study|Adverse Event|0|||
170856872|NCT05917470|617483957|FG004|Overall Study|Adverse Event|0|||
170856873|NCT05917470|617483958|FG005|Overall Study|Adverse Event|1|||
170856874|NCT05917470|617483959|FG006|Overall Study|Adverse Event|0|||
170856875|NCT05917470|617483960|FG007|Overall Study|Adverse Event|0|||
170856876|NCT00031551|617485663|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
170856877|NCT00031551|617485664|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
170856878|NCT01340196|617485665|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
170856879|NCT01440374|617485666|FG000|Part 1: Open-label Phase|Adverse Event|5|||
170856880|NCT01440374|617485667|FG001|Part 1: Open-label Phase|Adverse Event|0|||
170856881|NCT01440374|617485668|FG002|Part 1: Open-label Phase|Adverse Event|0|||
170856882|NCT01440374|617485669|FG003|Part 1: Open-label Phase|Adverse Event|0|||
170856883|NCT01440374|617485666|FG000|Part 1: Open-label Phase|Physician Decision|1|||
170856884|NCT01440374|617485667|FG001|Part 1: Open-label Phase|Physician Decision|0|||
170856885|NCT01440374|617485668|FG002|Part 1: Open-label Phase|Physician Decision|0|||
170856886|NCT01440374|617485669|FG003|Part 1: Open-label Phase|Physician Decision|0|||
170856887|NCT01440374|617485666|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
170856888|NCT01440374|617485667|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
170856889|NCT01440374|617485668|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
170856890|NCT01440374|617485669|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
170856891|NCT01440374|617485666|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
170856892|NCT01440374|617485667|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
170856893|NCT01440374|617485668|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
170856894|NCT01440374|617485669|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
170856895|NCT01440374|617485666|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
170856896|NCT01440374|617485667|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
170856897|NCT01440374|617485668|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
170856898|NCT01440374|617485669|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
170856899|NCT01440374|617485666|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
170856900|NCT01440374|617485667|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
170856901|NCT01440374|617485668|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
170856902|NCT01440374|617485669|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
170856903|NCT01440374|617485666|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
170856904|NCT01440374|617485667|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
170856905|NCT01440374|617485668|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
170856906|NCT01440374|617485669|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
170856907|NCT01440374|617485666|FG000|Part 2; Double-blind Phase|Not treated|0|||
170856908|NCT01440374|617485667|FG001|Part 2; Double-blind Phase|Not treated|0|||
170856909|NCT01440374|617485668|FG002|Part 2; Double-blind Phase|Not treated|1|||
170856910|NCT01440374|617485669|FG003|Part 2; Double-blind Phase|Not treated|0|||
170856911|NCT01440374|617485666|FG000|Part 3: Extension|Withdrawal by Subject|0|||
170856912|NCT01440374|617485667|FG001|Part 3: Extension|Withdrawal by Subject|0|||
170856913|NCT01440374|617485668|FG002|Part 3: Extension|Withdrawal by Subject|0|||
170856914|NCT01440374|617485669|FG003|Part 3: Extension|Withdrawal by Subject|5|||
170856915|NCT01440374|617485666|FG000|Part 3: Extension|Adverse Event|0|||
170856916|NCT01440374|617485667|FG001|Part 3: Extension|Adverse Event|0|||
170856917|NCT01440374|617485668|FG002|Part 3: Extension|Adverse Event|0|||
170856918|NCT01440374|617485669|FG003|Part 3: Extension|Adverse Event|13|||
170856919|NCT01440374|617485666|FG000|Part 3: Extension|Physician Decision|0|||
170856920|NCT01440374|617485667|FG001|Part 3: Extension|Physician Decision|0|||
170856921|NCT01440374|617485668|FG002|Part 3: Extension|Physician Decision|0|||
170856922|NCT01440374|617485669|FG003|Part 3: Extension|Physician Decision|14|||
170856923|NCT00876928|617485670|FG000|Overall Study|Lost to Follow-up|2|||
170856924|NCT00876928|617485671|FG001|Overall Study|Lost to Follow-up|5|||
170856925|NCT00876928|617485670|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
170856926|NCT00876928|617485671|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
170856927|NCT01016977|617485672|FG000|Overall Study|Lost to Follow-up|1|||
170856928|NCT01016977|617485673|FG001|Overall Study|Lost to Follow-up|0|||
170856929|NCT01016977|617485672|FG000|Overall Study|Withdrawal by Subject|2|||
170856930|NCT01016977|617485673|FG001|Overall Study|Withdrawal by Subject|2|||
170856931|NCT00250679|617485676|FG000|Overall Study|Adverse Event|12|||
170856932|NCT00250679|617485677|FG001|Overall Study|Adverse Event|15|||
170856933|NCT00250679|617485678|FG002|Overall Study|Adverse Event|16|||
170856934|NCT00250679|617485676|FG000|Overall Study|Protocol Violation|2|||
170856935|NCT00250679|617485677|FG001|Overall Study|Protocol Violation|4|||
170856936|NCT00250679|617485678|FG002|Overall Study|Protocol Violation|3|||
170856937|NCT00250679|617485676|FG000|Overall Study|Withdrawal by Subject|15|||
170856938|NCT00250679|617485677|FG001|Overall Study|Withdrawal by Subject|18|||
170856939|NCT00250679|617485678|FG002|Overall Study|Withdrawal by Subject|15|||
170856940|NCT00250679|617485676|FG000|Overall Study|Lost to Follow-up|3|||
170856941|NCT00250679|617485677|FG001|Overall Study|Lost to Follow-up|4|||
170856942|NCT00250679|617485678|FG002|Overall Study|Lost to Follow-up|2|||
170856943|NCT00250679|617485676|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
170856944|NCT00250679|617485677|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
170856945|NCT00250679|617485678|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
170856946|NCT00250679|617485676|FG000|Overall Study|Lack of Efficacy|0|||
170856947|NCT00250679|617485677|FG001|Overall Study|Lack of Efficacy|1|||
170856948|NCT00250679|617485678|FG002|Overall Study|Lack of Efficacy|3|||
170856949|NCT00250679|617485676|FG000|Overall Study|Technical Holter issues|1|||
170856950|NCT00250679|617485677|FG001|Overall Study|Technical Holter issues|0|||
170856951|NCT00250679|617485678|FG002|Overall Study|Technical Holter issues|2|||
170856952|NCT00250679|617485676|FG000|Overall Study|Moved|1|||
170856953|NCT00250679|617485677|FG001|Overall Study|Moved|1|||
170856954|NCT00250679|617485678|FG002|Overall Study|Moved|0|||
170856955|NCT00250679|617485676|FG000|Overall Study|Non-compliance|1|||
170856956|NCT00250679|617485677|FG001|Overall Study|Non-compliance|1|||
170856957|NCT00250679|617485678|FG002|Overall Study|Non-compliance|0|||
170856958|NCT00250679|617485676|FG000|Overall Study|various single events: hip surgery,diary|3|||
170856959|NCT00250679|617485677|FG001|Overall Study|various single events: hip surgery,diary|1|||
170856960|NCT00250679|617485678|FG002|Overall Study|various single events: hip surgery,diary|1|||
170856961|NCT01052103|617485680|FG000|Overall Study|Adverse Event|10|||
170856962|NCT01052103|617485681|FG001|Overall Study|Adverse Event|6|||
170856963|NCT01052103|617485680|FG000|Overall Study|Entry Criteria Not Met|3|||
170856964|NCT01052103|617485681|FG001|Overall Study|Entry Criteria Not Met|1|||
170856965|NCT01052103|617485680|FG000|Overall Study|Lost to Follow-up|3|||
170856966|NCT01052103|617485681|FG001|Overall Study|Lost to Follow-up|5|||
170856967|NCT01052103|617485680|FG000|Overall Study|Protocol Violation|10|||
170856968|NCT01052103|617485681|FG001|Overall Study|Protocol Violation|4|||
170856969|NCT01052103|617485680|FG000|Overall Study|Scheduling conflict|2|||
170856970|NCT01052103|617485681|FG001|Overall Study|Scheduling conflict|1|||
170856971|NCT01052103|617485680|FG000|Overall Study|Sponsor Decision|2|||
170856972|NCT01052103|617485681|FG001|Overall Study|Sponsor Decision|0|||
170856973|NCT01052103|617485680|FG000|Overall Study|Withdrawal by Subject|3|||
170856974|NCT01052103|617485681|FG001|Overall Study|Withdrawal by Subject|6|||
170856975|NCT01052103|617485680|FG000|Overall Study|Perceived Lack of Efficacy|1|||
170856976|NCT01052103|617485681|FG001|Overall Study|Perceived Lack of Efficacy|0|||
170856977|NCT00799513|617485689|FG000|Overall Study|Physician Decision|1|||
170856978|NCT00799513|617485689|FG000|Overall Study|Adverse Event|1|||
170856979|NCT01205152|617485693|FG000|Overall Study|Death|1|||
170856980|NCT00319839|617485694|FG000|Overall Study|Adverse Event|5|||
170856981|NCT00319839|617485694|FG000|Overall Study|Withdrawal by Subject|1|||
170856982|NCT02128542|617485695|FG000|Overall Study|Lost to Follow-up|3|||
170856983|NCT02128542|617485696|FG001|Overall Study|Lost to Follow-up|0|||
170856984|NCT02128542|617485695|FG000|Overall Study|Withdrew Consent|1|||
170856985|NCT02128542|617485696|FG001|Overall Study|Withdrew Consent|0|||
170856986|NCT01853137|617485697|FG000|Overall Study|Lost to Follow-up|4|||
170856987|NCT01853137|617485698|FG001|Overall Study|Lost to Follow-up|1|||
170743432|NCT01460160|617067856|FG000|Follow-up Phase|Withdrawal by Subject|4|||
170743433|NCT01460160|617067856|FG000|Follow-up Phase|Death|14|||
170743434|NCT01460160|617067856|FG000|Follow-up Phase|Lost to Follow-up|7|||
170743435|NCT01460160|617067856|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
170743436|NCT01460160|617067856|FG000|Follow-up Phase|Other and not reported reasons|5|||
170743437|NCT02006121|617067859|FG000|Double Blind Phase|Adverse Event|6|||
170743438|NCT02006121|617067860|FG001|Double Blind Phase|Adverse Event|0|||
170743439|NCT02006121|617067859|FG000|Double Blind Phase|Lack of Efficacy|1|||
170743440|NCT02006121|617067860|FG001|Double Blind Phase|Lack of Efficacy|16|||
170743441|NCT02006121|617067859|FG000|Double Blind Phase|Withdrawal by Subject|3|||
170743442|NCT02006121|617067860|FG001|Double Blind Phase|Withdrawal by Subject|4|||
170743443|NCT02006121|617067859|FG000|Double Blind Phase|Non-compliance with study drug|1|||
170743444|NCT02006121|617067860|FG001|Double Blind Phase|Non-compliance with study drug|3|||
170743445|NCT02006121|617067859|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
170743446|NCT02006121|617067860|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
170743447|NCT02006121|617067859|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
170743448|NCT02006121|617067860|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
170743449|NCT02006121|617067859|FG000|Open Label Phase|Adverse Event|15|||
170743450|NCT02006121|617067860|FG001|Open Label Phase|Adverse Event|0|||
170743451|NCT02006121|617067859|FG000|Open Label Phase|Lack of Efficacy|2|||
170743452|NCT02006121|617067860|FG001|Open Label Phase|Lack of Efficacy|0|||
170743453|NCT02006121|617067859|FG000|Open Label Phase|Protocol Violation|2|||
170743454|NCT02006121|617067860|FG001|Open Label Phase|Protocol Violation|0|||
170743455|NCT02006121|617067859|FG000|Open Label Phase|Withdrawal by Subject|3|||
170743456|NCT02006121|617067860|FG001|Open Label Phase|Withdrawal by Subject|0|||
170743457|NCT02006121|617067859|FG000|Open Label Phase|Non-compliance with study drug|3|||
170743458|NCT02006121|617067860|FG001|Open Label Phase|Non-compliance with study drug|0|||
170743459|NCT00114634|617067872|FG000|Overall Study|failure to return forms|3|||
170743460|NCT00245856|617067878|FG000|Period Two|Withdrawal by Subject|0|||
170743461|NCT00245856|617067879|FG001|Period Two|Withdrawal by Subject|1|||
170743462|NCT00557622|617067880|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
170743463|NCT00557622|617067881|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
170743464|NCT00557622|617067880|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
170743465|NCT00557622|617067881|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
170743466|NCT00557622|617067880|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
170743467|NCT00557622|617067881|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
170743468|NCT02765490|617067882|FG000|Overall Study|Lost to Follow-up|1|||
170743469|NCT02765490|617067883|FG001|Overall Study|Lost to Follow-up|1|||
170743470|NCT02765490|617067882|FG000|Overall Study|Other|0|||
170743471|NCT02765490|617067883|FG001|Overall Study|Other|1|||
170743472|NCT02765490|617067882|FG000|Overall Study|Death|0|||
170743473|NCT02765490|617067883|FG001|Overall Study|Death|1|||
170743474|NCT01923389|617067884|FG000|Overall Study|Protocol Violation|1|||
170743475|NCT01923389|617067885|FG001|Overall Study|Protocol Violation|0|||
170743476|NCT03237013|617067888|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
170743477|NCT03237013|617067889|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
170743478|NCT03237013|617067890|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
170743479|NCT00737061|617067891|FG000|Waiting Period|Lost to Follow-up|6|||
170743480|NCT00737061|617067891|FG000|Waiting Period|Withdrawal by Subject|1|||
170743481|NCT00737061|617067891|FG000|Waiting Period|Bilateral placement failure|34|||
170743482|NCT00737061|617067891|FG000|Waiting Period|Deemed patent following HSG|26|||
170743483|NCT00737061|617067891|FG000|Waiting Period|Alternative contraception failure|3|||
170743484|NCT00737061|617067891|FG000|Waiting Period|Elected surgical tubal ligation|5|||
170743485|NCT00737061|617067891|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
170743486|NCT00737061|617067891|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
170743487|NCT00737061|617067891|FG000|1 Year Wearing Period|Discontinued reilance|3|||
170743488|NCT00737061|617067891|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
170743489|NCT05266963|617067892|FG000|Drug Period A|Withdrawal by Subject|0|||
170743490|NCT05266963|617067893|FG001|Drug Period A|Withdrawal by Subject|1|||
170743491|NCT00675506|617067895|FG000|Overall Study|Lost to Follow-up|1|||
170856988|NCT02070588|617485705|FG000|Overall Study|Withdrawal by Subject|29|||
170856989|NCT02070588|617485706|FG001|Overall Study|Withdrawal by Subject|1|||
170856990|NCT02070588|617485707|FG002|Overall Study|Withdrawal by Subject|0|||
170856991|NCT02070588|617485705|FG000|Overall Study|Writhdrawal due to early termination|9|||
170856992|NCT02070588|617485706|FG001|Overall Study|Writhdrawal due to early termination|0|||
170856993|NCT02070588|617485707|FG002|Overall Study|Writhdrawal due to early termination|0|||
170856994|NCT02070588|617485705|FG000|Overall Study|Adverse Event|1|||
170856995|NCT02070588|617485706|FG001|Overall Study|Adverse Event|0|||
170856996|NCT02070588|617485707|FG002|Overall Study|Adverse Event|0|||
170856997|NCT02216357|617485710|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
170856998|NCT02216357|617485711|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
170856999|NCT01602562|617485719|FG000|Overall Study|Adverse Event|3|||
170857000|NCT01602562|617485720|FG001|Overall Study|Adverse Event|1|||
170857001|NCT01602562|617485719|FG000|Overall Study|Physician Decision|1|||
170857002|NCT01602562|617485720|FG001|Overall Study|Physician Decision|1|||
170857003|NCT01602562|617485719|FG000|Overall Study|Withdrawal by Subject|1|||
170857004|NCT01602562|617485720|FG001|Overall Study|Withdrawal by Subject|1|||
170857005|NCT03881553|617485721|FG000|Overall Study|Discharged prior to participation|1|||
170857006|NCT03881553|617485722|FG001|Overall Study|Discharged prior to participation|1|||
170857007|NCT03881553|617485723|FG002|Overall Study|Discharged prior to participation|0|||
170857008|NCT03881553|617485721|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
170857009|NCT03881553|617485722|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
170857010|NCT03881553|617485723|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
170857011|NCT01718353|617485724|FG000|Overall Study|Lost to Follow-up|0|||
170857012|NCT01718353|617485725|FG001|Overall Study|Lost to Follow-up|1|||
170857013|NCT01718353|617485724|FG000|Overall Study|Principal Investigator's Decision|10|||
170857014|NCT01718353|617485725|FG001|Overall Study|Principal Investigator's Decision|4|||
170857015|NCT01718353|617485724|FG000|Overall Study|Randomized but not treated|2|||
170857016|NCT01718353|617485725|FG001|Overall Study|Randomized but not treated|0|||
170857017|NCT00455325|617485726|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
170857018|NCT00455325|617485727|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
170857019|NCT00455325|617485728|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
170857020|NCT00455325|617485729|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
170857021|NCT00455325|617485726|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
170857022|NCT00455325|617485727|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
170857023|NCT00455325|617485728|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
170857024|NCT00455325|617485729|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
170857025|NCT00455325|617485726|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
170857026|NCT00455325|617485727|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
170857027|NCT00455325|617485728|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
170857028|NCT00455325|617485729|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
170857029|NCT00455325|617485726|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
170857030|NCT00455325|617485727|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
170857031|NCT00455325|617485728|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
170857032|NCT00455325|617485729|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
170857033|NCT00455325|617485726|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
170857034|NCT00455325|617485727|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
170857035|NCT00455325|617485728|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
170857036|NCT00455325|617485729|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
170857037|NCT00455325|617485726|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
170857038|NCT00455325|617485727|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
170857039|NCT00455325|617485728|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
170857040|NCT00455325|617485729|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
170857041|NCT00455325|617485726|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
170857042|NCT00455325|617485727|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
170857043|NCT00455325|617485728|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
170857044|NCT00455325|617485729|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
170857045|NCT02435966|617485730|FG000|Overall Study|Withdrawal by Subject|0|||
170857046|NCT02435966|617485731|FG001|Overall Study|Withdrawal by Subject|1|||
170857047|NCT02435966|617485732|FG002|Overall Study|Withdrawal by Subject|0|||
170857048|NCT00928746|617485739|FG000|Overall Study|Adverse Event|2|||
170857049|NCT00928746|617485739|FG000|Overall Study|Protocol Violation|1|||
170857050|NCT00928746|617485739|FG000|Overall Study|Withdrawal by Subject|1|||
170857051|NCT00928746|617485739|FG000|Overall Study|Other|2|||
170857052|NCT02004353|617485747|FG000|Overall Study|Voluntary participation|1334|||
170857053|NCT01191268|617485748|FG000|Overall Study|Withdrawal by Subject|19|||
170857054|NCT01191268|617485749|FG001|Overall Study|Withdrawal by Subject|25|||
170857055|NCT01191268|617485750|FG002|Overall Study|Withdrawal by Subject|21|||
170857056|NCT01191268|617485748|FG000|Overall Study|Adverse Event|21|||
170857057|NCT01191268|617485749|FG001|Overall Study|Adverse Event|13|||
170857058|NCT01191268|617485750|FG002|Overall Study|Adverse Event|8|||
170857059|NCT01191268|617485748|FG000|Overall Study|Physician Decision|6|||
170857060|NCT01191268|617485749|FG001|Overall Study|Physician Decision|8|||
170857061|NCT01191268|617485750|FG002|Overall Study|Physician Decision|9|||
170857062|NCT01191268|617485748|FG000|Overall Study|Lost to Follow-up|8|||
170857063|NCT01191268|617485749|FG001|Overall Study|Lost to Follow-up|5|||
170857064|NCT01191268|617485750|FG002|Overall Study|Lost to Follow-up|9|||
170857065|NCT01191268|617485748|FG000|Overall Study|Entry Criteria Not Met|3|||
170857066|NCT01191268|617485749|FG001|Overall Study|Entry Criteria Not Met|1|||
170857067|NCT01191268|617485750|FG002|Overall Study|Entry Criteria Not Met|1|||
170857068|NCT01191268|617485748|FG000|Overall Study|Death|0|||
170857069|NCT01191268|617485749|FG001|Overall Study|Death|1|||
170857070|NCT01191268|617485750|FG002|Overall Study|Death|3|||
170857071|NCT01191268|617485748|FG000|Overall Study|Protocol Violation|1|||
170857072|NCT01191268|617485749|FG001|Overall Study|Protocol Violation|0|||
170857073|NCT01191268|617485750|FG002|Overall Study|Protocol Violation|1|||
170857074|NCT01191268|617485748|FG000|Overall Study|Sponsor Decision|0|||
170857075|NCT01191268|617485749|FG001|Overall Study|Sponsor Decision|2|||
170857076|NCT01191268|617485750|FG002|Overall Study|Sponsor Decision|0|||
170857077|NCT01054170|617485751|FG000|Overall Study|Protocol Violation|1|||
170857078|NCT01054170|617485752|FG001|Overall Study|Protocol Violation|0|||
170857079|NCT01054170|617485751|FG000|Overall Study|Withdrawal by Subject|3|||
170857080|NCT01054170|617485752|FG001|Overall Study|Withdrawal by Subject|2|||
170857081|NCT01054170|617485751|FG000|Overall Study|Adverse Event|0|||
170857082|NCT01054170|617485752|FG001|Overall Study|Adverse Event|4|||
170857083|NCT02842827|617485755|FG000|Overall Study|Adverse Event|0|||
170857084|NCT02842827|617485756|FG001|Overall Study|Adverse Event|1|||
170857085|NCT02842827|617485757|FG002|Overall Study|Adverse Event|0|||
170857086|NCT02842827|617485758|FG003|Overall Study|Adverse Event|1|||
170857087|NCT02842827|617485759|FG004|Overall Study|Adverse Event|0|||
170857088|NCT02842827|617485760|FG005|Overall Study|Adverse Event|1|||
170857089|NCT02842827|617485761|FG006|Overall Study|Adverse Event|0|||
170857090|NCT02842827|617485762|FG007|Overall Study|Adverse Event|0|||
170857091|NCT02842827|617485755|FG000|Overall Study|Death|1|||
170857092|NCT02842827|617485756|FG001|Overall Study|Death|0|||
170857093|NCT02842827|617485757|FG002|Overall Study|Death|2|||
170857094|NCT02842827|617485758|FG003|Overall Study|Death|3|||
170857095|NCT02842827|617485759|FG004|Overall Study|Death|2|||
170857096|NCT02842827|617485760|FG005|Overall Study|Death|1|||
170857097|NCT02842827|617485761|FG006|Overall Study|Death|0|||
170857098|NCT02842827|617485762|FG007|Overall Study|Death|4|||
170857099|NCT02842827|617485755|FG000|Overall Study|Physician Decision|1|||
170857100|NCT02842827|617485756|FG001|Overall Study|Physician Decision|3|||
170857101|NCT02842827|617485757|FG002|Overall Study|Physician Decision|0|||
170857102|NCT02842827|617485758|FG003|Overall Study|Physician Decision|0|||
170857103|NCT02842827|617485759|FG004|Overall Study|Physician Decision|1|||
170857104|NCT02842827|617485760|FG005|Overall Study|Physician Decision|4|||
170857105|NCT02842827|617485761|FG006|Overall Study|Physician Decision|2|||
170857106|NCT02842827|617485762|FG007|Overall Study|Physician Decision|1|||
170857107|NCT02842827|617485755|FG000|Overall Study|Protocol Defined Disease Progression|0|||
170857108|NCT02842827|617485756|FG001|Overall Study|Protocol Defined Disease Progression|0|||
170857109|NCT02842827|617485757|FG002|Overall Study|Protocol Defined Disease Progression|0|||
170857110|NCT02842827|617485758|FG003|Overall Study|Protocol Defined Disease Progression|0|||
170857111|NCT02842827|617485759|FG004|Overall Study|Protocol Defined Disease Progression|0|||
170857112|NCT02842827|617485760|FG005|Overall Study|Protocol Defined Disease Progression|1|||
170857113|NCT02842827|617485761|FG006|Overall Study|Protocol Defined Disease Progression|0|||
170857114|NCT02842827|617485762|FG007|Overall Study|Protocol Defined Disease Progression|0|||
170857115|NCT02842827|617485755|FG000|Overall Study|Participant Withdrawal of Consent|1|||
170857116|NCT02842827|617485756|FG001|Overall Study|Participant Withdrawal of Consent|2|||
170857117|NCT02842827|617485757|FG002|Overall Study|Participant Withdrawal of Consent|2|||
170857118|NCT02842827|617485758|FG003|Overall Study|Participant Withdrawal of Consent|2|||
170857119|NCT02842827|617485759|FG004|Overall Study|Participant Withdrawal of Consent|2|||
170857120|NCT02842827|617485760|FG005|Overall Study|Participant Withdrawal of Consent|1|||
170857121|NCT02842827|617485761|FG006|Overall Study|Participant Withdrawal of Consent|2|||
170857122|NCT02842827|617485762|FG007|Overall Study|Participant Withdrawal of Consent|1|||
170857123|NCT03426267|617485765|FG000|Overall Study|Physician Decision|1|||
170857124|NCT03426267|617485766|FG001|Overall Study|Physician Decision|4|||
170857125|NCT03426267|617485765|FG000|Overall Study|Lost to Follow-up|1|||
170857126|NCT03426267|617485766|FG001|Overall Study|Lost to Follow-up|0|||
170857127|NCT03426267|617485765|FG000|Overall Study|Withdrawal by Subject|4|||
170857128|NCT03426267|617485766|FG001|Overall Study|Withdrawal by Subject|10|||
170857129|NCT03426267|617485765|FG000|Overall Study|Protocol Violation|1|||
170857130|NCT03426267|617485766|FG001|Overall Study|Protocol Violation|3|||
170857131|NCT03426267|617485765|FG000|Overall Study|Adverse Event|9|||
170857132|NCT03426267|617485766|FG001|Overall Study|Adverse Event|27|||
170857133|NCT03426267|617485765|FG000|Overall Study|Prohibited Treatment Intake|2|||
170857134|NCT03426267|617485766|FG001|Overall Study|Prohibited Treatment Intake|3|||
170857135|NCT03426267|617485765|FG000|Overall Study|Lack of Efficacy|0|||
170857136|NCT03426267|617485766|FG001|Overall Study|Lack of Efficacy|25|||
170857137|NCT03426267|617485765|FG000|Overall Study|other|3|||
170857138|NCT03426267|617485766|FG001|Overall Study|other|0|||
170857139|NCT00609765|617485767|FG000|Overall Study|Study ended prior to 12 months|1|||
170857140|NCT02054520|617485775|FG000|Overall Study|Adverse Event|1|||
170857141|NCT02054520|617485776|FG001|Overall Study|Adverse Event|4|||
170857142|NCT02054520|617485777|FG002|Overall Study|Adverse Event|2|||
170857143|NCT02054520|617485778|FG003|Overall Study|Adverse Event|1|||
170857144|NCT02054520|617485779|FG004|Overall Study|Adverse Event|1|||
170857145|NCT02054520|617485780|FG005|Overall Study|Adverse Event|0|||
170857146|NCT02054520|617485775|FG000|Overall Study|Lack of Efficacy|7|||
170857147|NCT02054520|617485776|FG001|Overall Study|Lack of Efficacy|0|||
170857148|NCT02054520|617485777|FG002|Overall Study|Lack of Efficacy|2|||
170857149|NCT02054520|617485778|FG003|Overall Study|Lack of Efficacy|1|||
170857150|NCT02054520|617485779|FG004|Overall Study|Lack of Efficacy|3|||
170857151|NCT02054520|617485780|FG005|Overall Study|Lack of Efficacy|2|||
170857152|NCT02054520|617485775|FG000|Overall Study|Withdrawal by Subject|1|||
170857153|NCT02054520|617485776|FG001|Overall Study|Withdrawal by Subject|0|||
170857154|NCT02054520|617485777|FG002|Overall Study|Withdrawal by Subject|0|||
170857155|NCT02054520|617485778|FG003|Overall Study|Withdrawal by Subject|2|||
170857156|NCT02054520|617485779|FG004|Overall Study|Withdrawal by Subject|1|||
170857157|NCT02054520|617485780|FG005|Overall Study|Withdrawal by Subject|0|||
170857158|NCT02054520|617485775|FG000|Overall Study|Physician Decision|0|||
170857159|NCT02054520|617485776|FG001|Overall Study|Physician Decision|1|||
170857160|NCT02054520|617485777|FG002|Overall Study|Physician Decision|0|||
170857161|NCT02054520|617485778|FG003|Overall Study|Physician Decision|1|||
170857162|NCT02054520|617485779|FG004|Overall Study|Physician Decision|0|||
170857163|NCT02054520|617485780|FG005|Overall Study|Physician Decision|1|||
170857164|NCT02054520|617485775|FG000|Overall Study|Study terminated by Sponsor|0|||
170857165|NCT02054520|617485776|FG001|Overall Study|Study terminated by Sponsor|0|||
170857166|NCT02054520|617485777|FG002|Overall Study|Study terminated by Sponsor|2|||
170857167|NCT02054520|617485778|FG003|Overall Study|Study terminated by Sponsor|1|||
170857168|NCT02054520|617485779|FG004|Overall Study|Study terminated by Sponsor|0|||
170857169|NCT02054520|617485780|FG005|Overall Study|Study terminated by Sponsor|0|||
170857170|NCT02372136|617485783|FG000|Overall Study|Death|3|||
170857171|NCT02372136|617485784|FG001|Overall Study|Death|1|||
170857172|NCT00985946|617485785|FG000|Overall Study|Lost to Follow-up|6|||
170857173|NCT00985946|617485785|FG000|Overall Study|Withdrawal by Subject|1|||
170857174|NCT03143166|617485786|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
170857175|NCT04217590|617485787|FG000|Overall Study|Other|1|||
170857176|NCT04217590|617485788|FG001|Overall Study|Other|1|||
170857177|NCT04217590|617485787|FG000|Overall Study|Withdrawal by Subject|3|||
170857178|NCT04217590|617485788|FG001|Overall Study|Withdrawal by Subject|1|||
170857179|NCT04217590|617485787|FG000|Overall Study|Death|0|||
170857180|NCT04217590|617485788|FG001|Overall Study|Death|1|||
170857181|NCT00490724|617485793|FG000|Period I|Physician Decision|0|||
170857182|NCT00490724|617485794|FG001|Period I|Physician Decision|0|||
170857183|NCT00490724|617485795|FG002|Period I|Physician Decision|1|||
170857184|NCT00490724|617485793|FG000|Period II|Treatment Discontinuation|3|||
170857185|NCT00490724|617485794|FG001|Period II|Treatment Discontinuation|1|||
170857186|NCT00490724|617485795|FG002|Period II|Treatment Discontinuation|3|||
170857187|NCT01395888|617485796|FG000|2-week Run-in Period|Adverse Event|2|||
170857188|NCT01395888|617485797|FG001|2-week Run-in Period|Adverse Event|0|||
170857189|NCT01395888|617485798|FG002|2-week Run-in Period|Adverse Event|0|||
170857190|NCT01395888|617485796|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
170857191|NCT01395888|617485797|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
170857192|NCT01395888|617485798|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
170857193|NCT01395888|617485796|FG000|2-week Run-in Period|Lost to Follow-up|1|||
170857194|NCT01395888|617485797|FG001|2-week Run-in Period|Lost to Follow-up|0|||
170857195|NCT01395888|617485798|FG002|2-week Run-in Period|Lost to Follow-up|0|||
170857196|NCT01395888|617485796|FG000|2-week Run-in Period|Protocol Violation|2|||
170857197|NCT01395888|617485797|FG001|2-week Run-in Period|Protocol Violation|0|||
170857198|NCT01395888|617485798|FG002|2-week Run-in Period|Protocol Violation|0|||
170857199|NCT01395888|617485796|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
170857200|NCT01395888|617485797|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
170857201|NCT01395888|617485798|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
170857202|NCT01395888|617485796|FG000|Treatment Period (TP)|Adverse Event|0|||
170857203|NCT01395888|617485797|FG001|Treatment Period (TP)|Adverse Event|7|||
170857204|NCT01395888|617485798|FG002|Treatment Period (TP)|Adverse Event|6|||
170857205|NCT01395888|617485796|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
170857206|NCT01395888|617485797|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
170857207|NCT01395888|617485798|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
170857208|NCT01395888|617485796|FG000|Treatment Period (TP)|Protocol Violation|0|||
170857209|NCT01395888|617485797|FG001|Treatment Period (TP)|Protocol Violation|1|||
170857210|NCT01395888|617485798|FG002|Treatment Period (TP)|Protocol Violation|5|||
170857211|NCT01395888|617485796|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
170857212|NCT01395888|617485797|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
170857213|NCT01395888|617485798|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
170857214|NCT01395888|617485796|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
170857215|NCT01395888|617485797|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
170857216|NCT01395888|617485798|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
170857217|NCT03218397|617485799|FG000|Overall Study|Prior positive blood culture|8|||
170857218|NCT03218397|617485800|FG001|Overall Study|Prior positive blood culture|13|||
170857219|NCT03218397|617485799|FG000|Overall Study|Comfort care|8|||
170743492|NCT00675506|617067896|FG001|Overall Study|Lost to Follow-up|5|||
170743493|NCT00675506|617067895|FG000|Overall Study|Lost interest|3|||
170743494|NCT00675506|617067896|FG001|Overall Study|Lost interest|5|||
170743495|NCT00675506|617067895|FG000|Overall Study|Elevated fasting glucose|2|||
170743496|NCT00675506|617067896|FG001|Overall Study|Elevated fasting glucose|1|||
170743497|NCT00675506|617067895|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
170743498|NCT00675506|617067896|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
170743499|NCT00675506|617067895|FG000|Overall Study|Elevated IGF-1|2|||
170743500|NCT00675506|617067896|FG001|Overall Study|Elevated IGF-1|0|||
170743501|NCT00675506|617067895|FG000|Overall Study|Hypersensitivity Reaction|1|||
170743502|NCT00675506|617067896|FG001|Overall Study|Hypersensitivity Reaction|0|||
170743503|NCT00675506|617067895|FG000|Overall Study|Disclosed history of cancer|1|||
170743504|NCT00675506|617067896|FG001|Overall Study|Disclosed history of cancer|0|||
170743505|NCT00675506|617067895|FG000|Overall Study|Declined participation|1|||
170743506|NCT00675506|617067896|FG001|Overall Study|Declined participation|0|||
170743507|NCT00675506|617067895|FG000|Overall Study|Schedule conflict|0|||
170743508|NCT00675506|617067896|FG001|Overall Study|Schedule conflict|1|||
170743509|NCT06173570|617067897|FG000|Overall Study|Adverse Event|1|||
170743510|NCT06173570|617067898|FG001|Overall Study|Adverse Event|0|||
170743511|NCT06173570|617067899|FG002|Overall Study|Adverse Event|0|||
170743512|NCT06173570|617067900|FG003|Overall Study|Adverse Event|2|||
170743513|NCT06173570|617067901|FG004|Overall Study|Adverse Event|0|||
170743514|NCT06173570|617067897|FG000|Overall Study|Lost to Follow-up|1|||
170743515|NCT06173570|617067898|FG001|Overall Study|Lost to Follow-up|0|||
170743516|NCT06173570|617067899|FG002|Overall Study|Lost to Follow-up|0|||
170743517|NCT06173570|617067900|FG003|Overall Study|Lost to Follow-up|0|||
170743518|NCT06173570|617067901|FG004|Overall Study|Lost to Follow-up|2|||
170743519|NCT06173570|617067897|FG000|Overall Study|Protocol Violation|0|||
170743520|NCT06173570|617067898|FG001|Overall Study|Protocol Violation|2|||
170743521|NCT06173570|617067899|FG002|Overall Study|Protocol Violation|0|||
170743522|NCT06173570|617067900|FG003|Overall Study|Protocol Violation|0|||
170743523|NCT06173570|617067901|FG004|Overall Study|Protocol Violation|1|||
170743524|NCT06173570|617067897|FG000|Overall Study|Withdrawal by Subject|0|||
170743525|NCT06173570|617067898|FG001|Overall Study|Withdrawal by Subject|1|||
170743526|NCT06173570|617067899|FG002|Overall Study|Withdrawal by Subject|1|||
170743527|NCT06173570|617067900|FG003|Overall Study|Withdrawal by Subject|1|||
170743528|NCT06173570|617067901|FG004|Overall Study|Withdrawal by Subject|1|||
170857220|NCT03218397|617485800|FG001|Overall Study|Comfort care|5|||
170857221|NCT03218397|617485799|FG000|Overall Study|Comfort care and positive blood culture|1|||
170857222|NCT03218397|617485800|FG001|Overall Study|Comfort care and positive blood culture|0|||
170857223|NCT03218397|617485799|FG000|Overall Study|Comfort care and mixed culture|0|||
170857224|NCT03218397|617485800|FG001|Overall Study|Comfort care and mixed culture|1|||
170857225|NCT03218397|617485799|FG000|Overall Study|Mixed culture|2|||
170857226|NCT03218397|617485800|FG001|Overall Study|Mixed culture|2|||
170857227|NCT03218397|617485799|FG000|Overall Study|Inaccessible hospital records|2|||
170857228|NCT03218397|617485800|FG001|Overall Study|Inaccessible hospital records|5|||
170857229|NCT03218397|617485799|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
170857230|NCT03218397|617485800|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
170857231|NCT03218397|617485799|FG000|Overall Study|Randomized during laboratory off hours|2|||
170857232|NCT03218397|617485800|FG001|Overall Study|Randomized during laboratory off hours|1|||
170857233|NCT01946438|617485801|FG000|Overall Study|Adverse Event|0|||
170857234|NCT01946438|617485802|FG001|Overall Study|Adverse Event|0|||
170857235|NCT01946438|617485803|FG002|Overall Study|Adverse Event|0|||
170857236|NCT01946438|617485804|FG003|Overall Study|Adverse Event|1|||
170857237|NCT01946438|617485801|FG000|Overall Study|Serious Adverse event|1|||
170857238|NCT01946438|617485802|FG001|Overall Study|Serious Adverse event|0|||
170857239|NCT01946438|617485803|FG002|Overall Study|Serious Adverse event|0|||
170857240|NCT01946438|617485804|FG003|Overall Study|Serious Adverse event|0|||
170857241|NCT01946438|617485801|FG000|Overall Study|Protocol Violation|0|||
170857242|NCT01946438|617485802|FG001|Overall Study|Protocol Violation|0|||
170857243|NCT01946438|617485803|FG002|Overall Study|Protocol Violation|1|||
170857244|NCT01946438|617485804|FG003|Overall Study|Protocol Violation|0|||
170857245|NCT01946438|617485801|FG000|Overall Study|Withdrawal by Subject|1|||
170857246|NCT01946438|617485802|FG001|Overall Study|Withdrawal by Subject|0|||
170857247|NCT01946438|617485803|FG002|Overall Study|Withdrawal by Subject|0|||
170857248|NCT01946438|617485804|FG003|Overall Study|Withdrawal by Subject|0|||
170857249|NCT00126503|617485805|FG000|Overall Study|disease progression|23|||
170857250|NCT00126503|617485806|FG001|Overall Study|disease progression|14|||
170857251|NCT00126503|617485805|FG000|Overall Study|Withdrawal by Subject|0|||
170857252|NCT00126503|617485806|FG001|Overall Study|Withdrawal by Subject|1|||
170857253|NCT00126503|617485805|FG000|Overall Study|alternative therapy|1|||
170857254|NCT00126503|617485806|FG001|Overall Study|alternative therapy|1|||
170857255|NCT00126503|617485805|FG000|Overall Study|other complicating disease|4|||
170857256|NCT00126503|617485806|FG001|Overall Study|other complicating disease|1|||
170857257|NCT00126503|617485805|FG000|Overall Study|Death|3|||
170857258|NCT00126503|617485806|FG001|Overall Study|Death|0|||
170857259|NCT00126503|617485805|FG000|Overall Study|Adverse Event|13|||
170857260|NCT00126503|617485806|FG001|Overall Study|Adverse Event|3|||
170857261|NCT00126503|617485805|FG000|Overall Study|non-compliant|1|||
170857262|NCT00126503|617485806|FG001|Overall Study|non-compliant|0|||
170857263|NCT00126503|617485805|FG000|Overall Study|Physician Decision|2|||
170857264|NCT00126503|617485806|FG001|Overall Study|Physician Decision|1|||
170857265|NCT03169101|617485808|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
170857266|NCT03169101|617485809|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
170857267|NCT03169101|617485810|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
170857268|NCT03169101|617485811|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
170857269|NCT00368992|617485814|FG000|Overall Study|Ineligible|5|||
170857270|NCT00368992|617485814|FG000|Overall Study|Refused treatment|3|||
170857271|NCT00368992|617485814|FG000|Overall Study|Lack of Efficacy|63|||
170857272|NCT00368992|617485814|FG000|Overall Study|Adverse Event|26|||
170857273|NCT00368992|617485814|FG000|Overall Study|Death|4|||
170857274|NCT00368992|617485814|FG000|Overall Study|Other|9|||
170857275|NCT05000931|617485816|FG000|Overall Study|Lost to Follow-up|1|||
170857276|NCT02545933|617485817|FG000|Overall Study|Adverse Event|3|||
170857277|NCT02545933|617485818|FG001|Overall Study|Adverse Event|0|||
170857278|NCT02545933|617485819|FG002|Overall Study|Adverse Event|0|||
170857279|NCT02545933|617485817|FG000|Overall Study|Withdrawal by Subject|2|||
170857280|NCT02545933|617485818|FG001|Overall Study|Withdrawal by Subject|3|||
170857281|NCT02545933|617485819|FG002|Overall Study|Withdrawal by Subject|3|||
170857282|NCT02545933|617485817|FG000|Overall Study|Protocol Violation|1|||
170857283|NCT02545933|617485818|FG001|Overall Study|Protocol Violation|0|||
170857284|NCT02545933|617485819|FG002|Overall Study|Protocol Violation|1|||
170857285|NCT03149549|617485820|FG000|Study Discontinuation--Treatment Period|Death|0|||
170857286|NCT03149549|617485821|FG001|Study Discontinuation--Treatment Period|Death|0|||
170857287|NCT03149549|617485822|FG002|Study Discontinuation--Treatment Period|Death|0|||
170857288|NCT03149549|617485823|FG003|Study Discontinuation--Treatment Period|Death|1|||
170857289|NCT03149549|617485824|FG004|Study Discontinuation--Treatment Period|Death|2|||
170857290|NCT03149549|617485825|FG005|Study Discontinuation--Treatment Period|Death|1|||
170857291|NCT03149549|617485826|FG006|Study Discontinuation--Treatment Period|Death|1|||
170857292|NCT03149549|617485827|FG007|Study Discontinuation--Treatment Period|Death|2|||
170857293|NCT03149549|617485828|FG008|Study Discontinuation--Treatment Period|Death|4|||
170857294|NCT03149549|617485829|FG009|Study Discontinuation--Treatment Period|Death|1|||
170857295|NCT03149549|617485830|FG010|Study Discontinuation--Treatment Period|Death|0|||
170857296|NCT03149549|617485831|FG011|Study Discontinuation--Treatment Period|Death|0|||
170857297|NCT03149549|617485832|FG012|Study Discontinuation--Treatment Period|Death|1|||
170857298|NCT03149549|617485820|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857299|NCT03149549|617485821|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170743529|NCT06173570|617067897|FG000|Overall Study|Non-compliance with Study Drug|1|||
170743530|NCT06173570|617067898|FG001|Overall Study|Non-compliance with Study Drug|0|||
170743531|NCT06173570|617067899|FG002|Overall Study|Non-compliance with Study Drug|0|||
170743532|NCT06173570|617067900|FG003|Overall Study|Non-compliance with Study Drug|0|||
170743533|NCT06173570|617067901|FG004|Overall Study|Non-compliance with Study Drug|0|||
170743534|NCT06173570|617067897|FG000|Overall Study|Screen Failure|0|||
170743535|NCT06173570|617067898|FG001|Overall Study|Screen Failure|0|||
170743536|NCT06173570|617067899|FG002|Overall Study|Screen Failure|0|||
170743537|NCT06173570|617067900|FG003|Overall Study|Screen Failure|0|||
170743538|NCT06173570|617067901|FG004|Overall Study|Screen Failure|1|||
170743539|NCT06173570|617067897|FG000|Overall Study|Other|2|||
170743540|NCT06173570|617067898|FG001|Overall Study|Other|1|||
170743541|NCT06173570|617067899|FG002|Overall Study|Other|0|||
170743542|NCT06173570|617067900|FG003|Overall Study|Other|2|||
170743543|NCT06173570|617067901|FG004|Overall Study|Other|0|||
170743544|NCT01844115|617067904|FG000|Overall Study|Adverse Event|4|||
170743545|NCT01844115|617067905|FG001|Overall Study|Adverse Event|22|||
170743546|NCT01844115|617067904|FG000|Overall Study|Lack of Efficacy|1|||
170743547|NCT01844115|617067905|FG001|Overall Study|Lack of Efficacy|4|||
170743548|NCT01844115|617067904|FG000|Overall Study|Protocol Violation|12|||
170743549|NCT01844115|617067905|FG001|Overall Study|Protocol Violation|10|||
170743550|NCT01844115|617067904|FG000|Overall Study|Withdrawal by Subject|11|||
170743551|NCT01844115|617067905|FG001|Overall Study|Withdrawal by Subject|11|||
170743552|NCT01844115|617067904|FG000|Overall Study|Lost to Follow-up|11|||
170743553|NCT01844115|617067905|FG001|Overall Study|Lost to Follow-up|10|||
170743554|NCT01844115|617067904|FG000|Overall Study|Pregnancy|0|||
170743555|NCT01844115|617067905|FG001|Overall Study|Pregnancy|1|||
170743556|NCT00210119|617067906|FG000|Overall Study|Protocol Violation|1|||
170743557|NCT00210119|617067906|FG000|Overall Study|Withdrawal by Subject|1|||
170743558|NCT04091360|617067907|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
170743559|NCT04091360|617067908|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
170743560|NCT04091360|617067909|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
170743561|NCT04091360|617067910|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
170743562|NCT04091360|617067911|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
170743563|NCT04091360|617067912|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
170743564|NCT04091360|617067913|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
170743565|NCT04091360|617067914|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
170743566|NCT04091360|617067915|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
170743567|NCT04091360|617067916|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
170743568|NCT04091360|617067907|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
170743569|NCT04091360|617067908|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
170743570|NCT04091360|617067909|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
170743571|NCT04091360|617067910|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
170743572|NCT04091360|617067911|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
170743573|NCT04091360|617067912|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
170743574|NCT04091360|617067913|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
170743575|NCT04091360|617067914|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
170743576|NCT04091360|617067915|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
170743577|NCT04091360|617067916|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
170743578|NCT04091360|617067907|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
170743579|NCT04091360|617067908|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
170743580|NCT04091360|617067909|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
170743581|NCT04091360|617067910|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
170743582|NCT04091360|617067911|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
170743583|NCT04091360|617067912|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
170743584|NCT04091360|617067913|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
170743585|NCT04091360|617067914|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
170743586|NCT04091360|617067915|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
170743587|NCT04091360|617067916|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
170743588|NCT00951509|617067917|FG000|Overall Study|Withdrawal by Subject|2|||
170743589|NCT03125941|617067919|FG000|Overall Study|did not receive intervention|1|||
170743590|NCT03125941|617067920|FG001|Overall Study|did not receive intervention|2|||
170743591|NCT00582491|617067921|FG000|Overall Study|Withdrawal by Subject|1|||
170743592|NCT00582491|617067922|FG001|Overall Study|Withdrawal by Subject|0|||
170743593|NCT01320735|617067929|FG000|Overall Study|Adverse Event|3|||
170743594|NCT01320735|617067929|FG000|Overall Study|Withdrawal by Subject|3|||
170743595|NCT01320735|617067929|FG000|Overall Study|Lost to Follow-up|13|||
170857300|NCT03149549|617485822|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857301|NCT03149549|617485823|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857302|NCT03149549|617485824|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857303|NCT03149549|617485825|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857304|NCT03149549|617485826|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170743596|NCT01320735|617067929|FG000|Overall Study|Administrative Reason|6|||
170743597|NCT01320735|617067929|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
170743598|NCT01320735|617067929|FG000|Overall Study|Protocol Violation|1|||
170743599|NCT01320735|617067929|FG000|Overall Study|Other|1|||
170743600|NCT01320735|617067929|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
170743601|NCT01320735|617067929|FG000|Overall Study|Investigator Unable to be Contacted|17|||
170743602|NCT04599101|617067933|FG000|Overall Study|Lost to Follow-up|5|||
170743603|NCT04599101|617067934|FG001|Overall Study|Lost to Follow-up|5|||
170743604|NCT05952297|617067935|FG000|Overall Study|Withdrawal by Subject|1|||
170743605|NCT05952297|617067936|FG001|Overall Study|Withdrawal by Subject|0|||
170743606|NCT00406419|617067937|FG000|Overall Study|Death|3|||
170743607|NCT00406419|617067938|FG001|Overall Study|Death|1|||
170743608|NCT00406419|617067939|FG002|Overall Study|Death|4|||
170743609|NCT00406419|617067937|FG000|Overall Study|Protocol Violation|6|||
170743610|NCT00406419|617067938|FG001|Overall Study|Protocol Violation|2|||
170743611|NCT00406419|617067939|FG002|Overall Study|Protocol Violation|5|||
170743612|NCT00406419|617067937|FG000|Overall Study|Study Terminated by Sponsor|260|||
170743613|NCT00406419|617067938|FG001|Overall Study|Study Terminated by Sponsor|288|||
170743614|NCT00406419|617067939|FG002|Overall Study|Study Terminated by Sponsor|282|||
170743615|NCT00406419|617067937|FG000|Overall Study|Withdrawal by Subject|17|||
170743616|NCT00406419|617067938|FG001|Overall Study|Withdrawal by Subject|24|||
170743617|NCT00406419|617067939|FG002|Overall Study|Withdrawal by Subject|26|||
170743618|NCT00406419|617067937|FG000|Overall Study|Lack of Efficacy|12|||
170743619|NCT00406419|617067938|FG001|Overall Study|Lack of Efficacy|1|||
170743620|NCT00406419|617067939|FG002|Overall Study|Lack of Efficacy|6|||
170743621|NCT00406419|617067937|FG000|Overall Study|Non-Compliance with Study Drug|5|||
170743622|NCT00406419|617067938|FG001|Overall Study|Non-Compliance with Study Drug|6|||
170743623|NCT00406419|617067939|FG002|Overall Study|Non-Compliance with Study Drug|3|||
170743624|NCT00406419|617067937|FG000|Overall Study|Adverse Event|10|||
170743625|NCT00406419|617067938|FG001|Overall Study|Adverse Event|12|||
170743626|NCT00406419|617067939|FG002|Overall Study|Adverse Event|16|||
170743627|NCT00406419|617067937|FG000|Overall Study|Lost to Follow-up|11|||
170743628|NCT00406419|617067938|FG001|Overall Study|Lost to Follow-up|10|||
170743629|NCT00406419|617067939|FG002|Overall Study|Lost to Follow-up|5|||
170743630|NCT04362137|617067942|FG000|Overall Study|Death|9|||
170743631|NCT04362137|617067943|FG001|Overall Study|Death|3|||
170743632|NCT04362137|617067942|FG000|Overall Study|Patient decision|6|||
170743633|NCT04362137|617067943|FG001|Overall Study|Patient decision|3|||
170743634|NCT04362137|617067942|FG000|Overall Study|Adverse Event|1|||
170743635|NCT04362137|617067943|FG001|Overall Study|Adverse Event|0|||
170743636|NCT04362137|617067942|FG000|Overall Study|Lost to Follow-up|1|||
170743637|NCT04362137|617067943|FG001|Overall Study|Lost to Follow-up|0|||
170743638|NCT04362137|617067942|FG000|Overall Study|Protocol deviation|1|||
170743639|NCT04362137|617067943|FG001|Overall Study|Protocol deviation|0|||
170743640|NCT05229653|617067947|FG000|Overall Study|Lost to Follow-up|1|||
170743641|NCT05229653|617067948|FG001|Overall Study|Lost to Follow-up|0|||
170743642|NCT03915951|617067949|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
170743643|NCT03915951|617067950|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
170743644|NCT03915951|617067949|FG000|Overall Study|Adverse Event|12|||
170743645|NCT03915951|617067950|FG001|Overall Study|Adverse Event|6|||
170743646|NCT03915951|617067949|FG000|Overall Study|Disease progression (radiological)|17|||
170743647|NCT03915951|617067950|FG001|Overall Study|Disease progression (radiological)|15|||
170743648|NCT03915951|617067949|FG000|Overall Study|Disease progression (clinical)|4|||
170743649|NCT03915951|617067950|FG001|Overall Study|Disease progression (clinical)|1|||
170743650|NCT03915951|617067949|FG000|Overall Study|Patient decision|0|||
170743651|NCT03915951|617067950|FG001|Overall Study|Patient decision|4|||
170743652|NCT03915951|617067949|FG000|Overall Study|Investigator decision|0|||
170743653|NCT03915951|617067950|FG001|Overall Study|Investigator decision|1|||
170743654|NCT03915951|617067949|FG000|Overall Study|Consent withdrawn|1|||
170743655|NCT03915951|617067950|FG001|Overall Study|Consent withdrawn|1|||
170743656|NCT03915951|617067949|FG000|Overall Study|Death|0|||
170743657|NCT03915951|617067950|FG001|Overall Study|Death|3|||
170743658|NCT05408468|617067951|FG000|Overall Study|Lost to Follow-up|3|||
170743659|NCT05408468|617067952|FG001|Overall Study|Lost to Follow-up|1|||
170743660|NCT05408468|617067951|FG000|Overall Study|Physician Decision|1|||
170743661|NCT05408468|617067952|FG001|Overall Study|Physician Decision|0|||
170743662|NCT05408468|617067951|FG000|Overall Study|Overwhelmed by clinical situation|3|||
170743663|NCT05408468|617067952|FG001|Overall Study|Overwhelmed by clinical situation|0|||
170857305|NCT03149549|617485827|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
170743664|NCT05408468|617067951|FG000|Overall Study|Personal illness precluding participation|1|||
170743665|NCT05408468|617067952|FG001|Overall Study|Personal illness precluding participation|0|||
170743666|NCT05408468|617067951|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
170743667|NCT05408468|617067952|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
170743668|NCT04186403|617067954|FG000|Overall Study|Adverse Event|1|||
170743669|NCT04186403|617067955|FG001|Overall Study|Adverse Event|8|||
170743670|NCT04186403|617067954|FG000|Overall Study|Lost to Follow-up|7|||
170743671|NCT04186403|617067955|FG001|Overall Study|Lost to Follow-up|3|||
170743672|NCT04186403|617067954|FG000|Overall Study|Physician Decision|1|||
170743673|NCT04186403|617067955|FG001|Overall Study|Physician Decision|0|||
170743674|NCT04186403|617067954|FG000|Overall Study|Withdrawal by Subject|7|||
170743675|NCT04186403|617067955|FG001|Overall Study|Withdrawal by Subject|8|||
170743676|NCT04186403|617067954|FG000|Overall Study|Other: Not Related to Covid-19|3|||
170743677|NCT04186403|617067955|FG001|Overall Study|Other: Not Related to Covid-19|0|||
170743678|NCT02204579|617067959|FG000|Overall Study|Screen failures|2|||
170743679|NCT01396395|617067960|FG000|Overall Study|Withdrawal by Subject|10|||
170743680|NCT01396395|617067961|FG001|Overall Study|Withdrawal by Subject|12|||
170743681|NCT01396395|617067960|FG000|Overall Study|Protocol Violation|3|||
170743682|NCT01396395|617067961|FG001|Overall Study|Protocol Violation|1|||
170743683|NCT01396395|617067960|FG000|Overall Study|Adverse Event|10|||
170743684|NCT01396395|617067961|FG001|Overall Study|Adverse Event|2|||
170743685|NCT01396395|617067960|FG000|Overall Study|Lost to Follow-up|17|||
170743686|NCT01396395|617067961|FG001|Overall Study|Lost to Follow-up|11|||
170743687|NCT01396395|617067960|FG000|Overall Study|Other|0|||
170743688|NCT01396395|617067961|FG001|Overall Study|Other|1|||
170743689|NCT05067933|617067965|FG000|Overall Study|Withdrawal by Subject|2|||
170743690|NCT05067933|617067966|FG001|Overall Study|Withdrawal by Subject|0|||
170743691|NCT05067933|617067967|FG002|Overall Study|Withdrawal by Subject|0|||
170743692|NCT05067933|617067968|FG003|Overall Study|Withdrawal by Subject|0|||
170743693|NCT05067933|617067969|FG004|Overall Study|Withdrawal by Subject|0|||
170743694|NCT05067933|617067970|FG005|Overall Study|Withdrawal by Subject|0|||
170743695|NCT05067933|617067965|FG000|Overall Study|Lost to Follow-up|1|||
170743696|NCT05067933|617067966|FG001|Overall Study|Lost to Follow-up|1|||
170743697|NCT05067933|617067967|FG002|Overall Study|Lost to Follow-up|1|||
170743698|NCT05067933|617067968|FG003|Overall Study|Lost to Follow-up|2|||
170743699|NCT05067933|617067969|FG004|Overall Study|Lost to Follow-up|1|||
170743700|NCT05067933|617067970|FG005|Overall Study|Lost to Follow-up|0|||
170743701|NCT05067933|617067965|FG000|Overall Study|Miscellaneous|1|||
170743702|NCT05067933|617067966|FG001|Overall Study|Miscellaneous|0|||
170743703|NCT05067933|617067967|FG002|Overall Study|Miscellaneous|0|||
170743704|NCT05067933|617067968|FG003|Overall Study|Miscellaneous|0|||
170743705|NCT05067933|617067969|FG004|Overall Study|Miscellaneous|0|||
170743706|NCT05067933|617067970|FG005|Overall Study|Miscellaneous|0|||
170743707|NCT05067933|617067965|FG000|Overall Study|Death|0|||
170743708|NCT05067933|617067966|FG001|Overall Study|Death|0|||
170743709|NCT05067933|617067967|FG002|Overall Study|Death|0|||
170743710|NCT05067933|617067968|FG003|Overall Study|Death|1|||
170743711|NCT05067933|617067969|FG004|Overall Study|Death|0|||
170743712|NCT05067933|617067970|FG005|Overall Study|Death|0|||
170743713|NCT04152343|617067979|FG000|Overall Study|Transplanted|5|||
170743714|NCT04152343|617067979|FG000|Overall Study|Death|20|||
170743715|NCT04152343|617067979|FG000|Overall Study|Lost to Follow-up|3|||
170743716|NCT00550550|617067980|FG000|Overall Study|Adverse Event|13|||
170743717|NCT00550550|617067981|FG001|Overall Study|Adverse Event|5|||
170743718|NCT00550550|617067980|FG000|Overall Study|Treatment Failure|0|||
170743719|NCT00550550|617067981|FG001|Overall Study|Treatment Failure|1|||
170743720|NCT00550550|617067980|FG000|Overall Study|Lost to Follow-up|4|||
170743721|NCT00550550|617067981|FG001|Overall Study|Lost to Follow-up|0|||
170743722|NCT00550550|617067980|FG000|Overall Study|Withdrawal by Subject|10|||
170743723|NCT00550550|617067981|FG001|Overall Study|Withdrawal by Subject|8|||
170743724|NCT00550550|617067980|FG000|Overall Study|Protocol Violation|5|||
170743725|NCT00550550|617067981|FG001|Overall Study|Protocol Violation|14|||
170743726|NCT00550550|617067980|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
170743727|NCT00550550|617067981|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
170743728|NCT00550550|617067980|FG000|Overall Study|Randomized But Not Treated|1|||
170743729|NCT00550550|617067981|FG001|Overall Study|Randomized But Not Treated|0|||
170743730|NCT00591864|617067982|FG000|Overall Study|Incomplete Imaging|5|||
170743731|NCT00118092|617067987|FG000|Overall Study|Withdrawal by Subject|1|||
170743732|NCT00118092|617067987|FG000|Overall Study|Protocol Violation|1|||
170743733|NCT02459093|617067988|FG000|Overall Study|Protocol Violation|6|||
170857306|NCT03149549|617485828|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857307|NCT03149549|617485829|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857308|NCT03149549|617485830|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857309|NCT03149549|617485831|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
170857310|NCT03149549|617485832|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
170857311|NCT03149549|617485820|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
170743734|NCT02459093|617067989|FG001|Overall Study|Protocol Violation|11|||
170743735|NCT02459093|617067988|FG000|Overall Study|Lost to Follow-up|6|||
170743736|NCT02459093|617067989|FG001|Overall Study|Lost to Follow-up|7|||
170857312|NCT03149549|617485821|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
170857313|NCT03149549|617485822|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
170857314|NCT03149549|617485823|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
170857315|NCT03149549|617485824|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
170857316|NCT03149549|617485825|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
170857317|NCT03149549|617485826|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
170857318|NCT03149549|617485827|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
170857319|NCT03149549|617485828|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
170857320|NCT03149549|617485829|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
170857321|NCT03149549|617485830|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
170857322|NCT03149549|617485831|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
170857323|NCT03149549|617485832|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
170857324|NCT03149549|617485820|FG000|Study Discontinuation--Treatment Period|Other|0|||
170857325|NCT03149549|617485821|FG001|Study Discontinuation--Treatment Period|Other|0|||
170857326|NCT03149549|617485822|FG002|Study Discontinuation--Treatment Period|Other|0|||
170857327|NCT03149549|617485823|FG003|Study Discontinuation--Treatment Period|Other|0|||
170857328|NCT03149549|617485824|FG004|Study Discontinuation--Treatment Period|Other|0|||
170857329|NCT03149549|617485825|FG005|Study Discontinuation--Treatment Period|Other|0|||
170857330|NCT03149549|617485826|FG006|Study Discontinuation--Treatment Period|Other|0|||
170857331|NCT03149549|617485827|FG007|Study Discontinuation--Treatment Period|Other|1|||
170857332|NCT03149549|617485828|FG008|Study Discontinuation--Treatment Period|Other|0|||
170857333|NCT03149549|617485829|FG009|Study Discontinuation--Treatment Period|Other|1|||
170857334|NCT03149549|617485830|FG010|Study Discontinuation--Treatment Period|Other|0|||
170857335|NCT03149549|617485831|FG011|Study Discontinuation--Treatment Period|Other|0|||
170857336|NCT03149549|617485832|FG012|Study Discontinuation--Treatment Period|Other|0|||
170857337|NCT03149549|617485820|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857338|NCT03149549|617485821|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857339|NCT03149549|617485822|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857340|NCT03149549|617485823|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857341|NCT03149549|617485824|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857342|NCT03149549|617485825|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
170857343|NCT03149549|617485826|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
170857344|NCT03149549|617485827|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857345|NCT03149549|617485828|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
170857346|NCT03149549|617485829|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857347|NCT03149549|617485830|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857348|NCT03149549|617485831|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857349|NCT03149549|617485832|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
170857350|NCT03149549|617485820|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
170857351|NCT03149549|617485821|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
170857352|NCT03149549|617485822|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
170857353|NCT03149549|617485823|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
170857354|NCT03149549|617485824|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
170857355|NCT03149549|617485825|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
170857356|NCT03149549|617485826|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
170857357|NCT03149549|617485827|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
170857358|NCT03149549|617485828|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
170857359|NCT03149549|617485829|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
170857360|NCT03149549|617485830|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
170857361|NCT03149549|617485831|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
170857362|NCT03149549|617485832|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
170857363|NCT03149549|617485820|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
170857364|NCT03149549|617485821|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
170857365|NCT03149549|617485822|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
170857366|NCT03149549|617485823|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
170857367|NCT03149549|617485824|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
170857368|NCT03149549|617485825|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
170857369|NCT03149549|617485826|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
170857370|NCT03149549|617485827|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
170857371|NCT03149549|617485828|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
170857372|NCT03149549|617485829|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
170857373|NCT03149549|617485830|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
170857374|NCT03149549|617485831|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
170857375|NCT03149549|617485832|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
170857376|NCT03149549|617485820|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
170857377|NCT03149549|617485821|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
170857378|NCT03149549|617485822|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
170857379|NCT03149549|617485823|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
170857380|NCT03149549|617485824|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
170857381|NCT03149549|617485825|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
170857382|NCT03149549|617485826|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
170857383|NCT03149549|617485827|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
170857384|NCT03149549|617485828|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
170857385|NCT03149549|617485829|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
170857386|NCT03149549|617485830|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
170857387|NCT03149549|617485831|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
170857388|NCT03149549|617485832|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
170857389|NCT03149549|617485820|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
170857390|NCT03149549|617485821|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
170857391|NCT03149549|617485822|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
170857392|NCT03149549|617485823|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
170857393|NCT03149549|617485824|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
170857394|NCT03149549|617485825|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
170857395|NCT03149549|617485826|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
170857396|NCT03149549|617485827|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
170857397|NCT03149549|617485828|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
170857398|NCT03149549|617485829|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
170857399|NCT03149549|617485830|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
170857400|NCT03149549|617485831|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
170857401|NCT03149549|617485832|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
170857402|NCT01892540|617485833|FG000|Overall Study|Did not complete PET/MRI|0|||
170857403|NCT01892540|617485834|FG001|Overall Study|Did not complete PET/MRI|0|||
170743737|NCT01965938|617067990|FG000|Overall Study|Withdrawal by Subject|1|||
170743738|NCT01965938|617067991|FG001|Overall Study|Withdrawal by Subject|0|||
170743739|NCT01103960|617068000|FG000|Overall Study|Adverse Event|2|||
170743740|NCT01103960|617068001|FG001|Overall Study|Adverse Event|1|||
170743741|NCT01103960|617068000|FG000|Overall Study|Withdrawal by Subject|2|||
170743742|NCT01103960|617068001|FG001|Overall Study|Withdrawal by Subject|1|||
170743743|NCT01103960|617068000|FG000|Overall Study|Other|1|||
170743744|NCT01103960|617068001|FG001|Overall Study|Other|0|||
170743745|NCT00539279|617068004|FG000|Treatment|Withdrawal by Subject|10|||
170743746|NCT00539279|617068005|FG001|Treatment|Withdrawal by Subject|8|||
170743747|NCT00539279|617068004|FG000|Treatment|Death|1|||
170743748|NCT00539279|617068005|FG001|Treatment|Death|0|||
170743749|NCT00539279|617068004|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
170743750|NCT00539279|617068005|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
170743751|NCT00539279|617068004|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
170743752|NCT00539279|617068005|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
170743753|NCT03713021|617068006|FG000|Overall Study|Did not have CT sim scan available|6|||
170743754|NCT03713021|617068006|FG000|Overall Study|Not eligible|4|||
170743755|NCT03713021|617068006|FG000|Overall Study|Issues with TraceIT markers|5|||
170743756|NCT03864926|617070025|FG000|Overall Study|Death|0|||
170743757|NCT03864926|617070026|FG001|Overall Study|Death|2|||
170743758|NCT01340482|617070027|FG000|Overall Study|Adverse Event|2|||
170743759|NCT01340482|617070028|FG001|Overall Study|Adverse Event|0|||
170743760|NCT01340482|617070029|FG002|Overall Study|Adverse Event|0|||
170743761|NCT00619476|617070030|FG000|Overall Study|Adverse Event|12|||
170743762|NCT00619476|617070031|FG001|Overall Study|Adverse Event|6|||
170743763|NCT00619476|617070032|FG002|Overall Study|Adverse Event|12|||
170743764|NCT00619476|617070033|FG003|Overall Study|Adverse Event|16|||
170743765|NCT00619476|617070030|FG000|Overall Study|Lack of Efficacy|6|||
170743766|NCT00619476|617070031|FG001|Overall Study|Lack of Efficacy|1|||
170743767|NCT00619476|617070032|FG002|Overall Study|Lack of Efficacy|1|||
170743768|NCT00619476|617070033|FG003|Overall Study|Lack of Efficacy|4|||
170743769|NCT00619476|617070030|FG000|Overall Study|Protocol Violation|5|||
170743770|NCT00619476|617070031|FG001|Overall Study|Protocol Violation|4|||
170743771|NCT00619476|617070032|FG002|Overall Study|Protocol Violation|4|||
170743772|NCT00619476|617070033|FG003|Overall Study|Protocol Violation|9|||
170743773|NCT00619476|617070030|FG000|Overall Study|Lost to Follow-up|1|||
170857404|NCT01892540|617485835|FG002|Overall Study|Did not complete PET/MRI|2|||
170857405|NCT01892540|617485833|FG000|Overall Study|Did not fit in scanner|0|||
170857406|NCT01892540|617485834|FG001|Overall Study|Did not fit in scanner|0|||
170857407|NCT01892540|617485835|FG002|Overall Study|Did not fit in scanner|1|||
170857408|NCT00727311|617485840|FG000|Overall Study|Did not receive drug|316|||
170857409|NCT00727311|617485840|FG000|Overall Study|Missing end of therapy data|205|||
170857410|NCT00727311|617485840|FG000|Overall Study|Adverse Event|58|||
170743774|NCT00619476|617070031|FG001|Overall Study|Lost to Follow-up|2|||
170743775|NCT00619476|617070032|FG002|Overall Study|Lost to Follow-up|0|||
170743776|NCT00619476|617070033|FG003|Overall Study|Lost to Follow-up|1|||
170743777|NCT00619476|617070030|FG000|Overall Study|Investigator Discretion|2|||
170743778|NCT00619476|617070031|FG001|Overall Study|Investigator Discretion|2|||
170743779|NCT00619476|617070032|FG002|Overall Study|Investigator Discretion|2|||
170743780|NCT00619476|617070033|FG003|Overall Study|Investigator Discretion|0|||
170857411|NCT00727311|617485840|FG000|Overall Study|Lack of Efficacy|242|||
170857412|NCT00727311|617485840|FG000|Overall Study|Lost to Follow-up|73|||
170857413|NCT00727311|617485840|FG000|Overall Study|Withdrawal by Subject|77|||
170857414|NCT00727311|617485840|FG000|Overall Study|Other|97|||
170857415|NCT00727311|617485840|FG000|Overall Study|Multiple reasons|39|||
170857416|NCT02141984|617487897|FG000|Overall Study|Lack of Efficacy|2|||
170857417|NCT01060540|617487898|FG000|Overall Study|Withdrawal by Subject|10|||
170857418|NCT01060540|617487899|FG001|Overall Study|Withdrawal by Subject|20|||
170857419|NCT01060540|617487898|FG000|Overall Study|Lost to Follow-up|52|||
170857420|NCT01060540|617487899|FG001|Overall Study|Lost to Follow-up|43|||
170857421|NCT01060540|617487898|FG000|Overall Study|Death|2|||
170857422|NCT01060540|617487899|FG001|Overall Study|Death|1|||
170857423|NCT01060540|617487898|FG000|Overall Study|Physician Decision|0|||
170857424|NCT01060540|617487899|FG001|Overall Study|Physician Decision|1|||
170857425|NCT00816400|617487903|FG000|Overall Study|Death|2|||
170857426|NCT00816400|617487904|FG001|Overall Study|Death|3|||
170857427|NCT00816400|617487905|FG002|Overall Study|Death|3|||
170857428|NCT00816400|617487906|FG003|Overall Study|Death|3|||
170857429|NCT00816400|617487907|FG004|Overall Study|Death|2|||
170857430|NCT00816400|617487908|FG005|Overall Study|Death|3|||
170857431|NCT00816400|617487909|FG006|Overall Study|Death|2|||
170857432|NCT00816400|617487910|FG007|Overall Study|Death|5|||
170857433|NCT00816400|617487911|FG008|Overall Study|Death|6|||
170857434|NCT00816400|617487903|FG000|Overall Study|In hospice care at the end of the study|0|||
170857435|NCT00816400|617487904|FG001|Overall Study|In hospice care at the end of the study|0|||
170857436|NCT00816400|617487905|FG002|Overall Study|In hospice care at the end of the study|2|||
170743781|NCT00619476|617070030|FG000|Overall Study|Withdrawal by Subject|5|||
170743782|NCT00619476|617070031|FG001|Overall Study|Withdrawal by Subject|7|||
170743783|NCT00619476|617070032|FG002|Overall Study|Withdrawal by Subject|5|||
170743784|NCT00619476|617070033|FG003|Overall Study|Withdrawal by Subject|4|||
170743785|NCT01091428|617070034|FG000|Phase 1|Progressive Disease|24|||
170743786|NCT01091428|617070035|FG001|Phase 1|Progressive Disease|8|||
170743787|NCT01091428|617070036|FG002|Phase 1|Progressive Disease|0|||
170743788|NCT01091428|617070037|FG003|Phase 1|Progressive Disease|0|||
170743789|NCT01091428|617070034|FG000|Phase 1|Symptomatic Deterioration|3|||
170743790|NCT01091428|617070035|FG001|Phase 1|Symptomatic Deterioration|2|||
170743791|NCT01091428|617070036|FG002|Phase 1|Symptomatic Deterioration|0|||
170743792|NCT01091428|617070037|FG003|Phase 1|Symptomatic Deterioration|0|||
170743793|NCT01091428|617070034|FG000|Phase 1|Adverse Event|2|||
170743794|NCT01091428|617070035|FG001|Phase 1|Adverse Event|0|||
170743795|NCT01091428|617070036|FG002|Phase 1|Adverse Event|0|||
170743796|NCT01091428|617070037|FG003|Phase 1|Adverse Event|0|||
170743797|NCT01091428|617070034|FG000|Phase 1|Withdrawal by Subject|7|||
170743798|NCT01091428|617070035|FG001|Phase 1|Withdrawal by Subject|0|||
170743799|NCT01091428|617070036|FG002|Phase 1|Withdrawal by Subject|0|||
170743800|NCT01091428|617070037|FG003|Phase 1|Withdrawal by Subject|0|||
170743801|NCT01091428|617070034|FG000|Phase 1|Reason not specified|0|||
170743802|NCT01091428|617070035|FG001|Phase 1|Reason not specified|1|||
170743803|NCT01091428|617070036|FG002|Phase 1|Reason not specified|0|||
170743804|NCT01091428|617070037|FG003|Phase 1|Reason not specified|0|||
170743805|NCT01091428|617070034|FG000|Phase 1|Single-Patient IND|2|||
170743806|NCT01091428|617070035|FG001|Phase 1|Single-Patient IND|0|||
170743807|NCT01091428|617070036|FG002|Phase 1|Single-Patient IND|0|||
170743808|NCT01091428|617070037|FG003|Phase 1|Single-Patient IND|0|||
170743809|NCT01091428|617070034|FG000|Phase 2|Progressive Disease|0|||
170743810|NCT01091428|617070035|FG001|Phase 2|Progressive Disease|0|||
170743811|NCT01091428|617070036|FG002|Phase 2|Progressive Disease|44|||
170743812|NCT01091428|617070037|FG003|Phase 2|Progressive Disease|46|||
170743813|NCT01091428|617070034|FG000|Phase 2|Symptomatic Deterioration|0|||
170743814|NCT01091428|617070035|FG001|Phase 2|Symptomatic Deterioration|0|||
170743815|NCT01091428|617070036|FG002|Phase 2|Symptomatic Deterioration|1|||
170743816|NCT01091428|617070037|FG003|Phase 2|Symptomatic Deterioration|6|||
170743817|NCT01091428|617070034|FG000|Phase 2|Adverse Event|0|||
170743818|NCT01091428|617070035|FG001|Phase 2|Adverse Event|0|||
170743819|NCT01091428|617070036|FG002|Phase 2|Adverse Event|12|||
170743820|NCT01091428|617070037|FG003|Phase 2|Adverse Event|5|||
170857437|NCT00816400|617487906|FG003|Overall Study|In hospice care at the end of the study|0|||
170857438|NCT00816400|617487907|FG004|Overall Study|In hospice care at the end of the study|0|||
170857439|NCT00816400|617487908|FG005|Overall Study|In hospice care at the end of the study|0|||
170857440|NCT00816400|617487909|FG006|Overall Study|In hospice care at the end of the study|0|||
170857441|NCT00816400|617487910|FG007|Overall Study|In hospice care at the end of the study|0|||
170857442|NCT00816400|617487911|FG008|Overall Study|In hospice care at the end of the study|0|||
170857443|NCT03057977|617487912|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
170743821|NCT01091428|617070034|FG000|Phase 2|Withdrawal by Subject|0|||
170857444|NCT03057977|617487913|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
170857445|NCT03057977|617487912|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
170857446|NCT03057977|617487913|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
170857447|NCT03057977|617487912|FG000|Discontinuation From Treatment|Protocol Violation|6|||
170857448|NCT03057977|617487913|FG001|Discontinuation From Treatment|Protocol Violation|5|||
170857449|NCT03057977|617487912|FG000|Discontinuation From Treatment|Not treated|4|||
170857450|NCT03057977|617487913|FG001|Discontinuation From Treatment|Not treated|0|||
170857451|NCT03057977|617487912|FG000|Discontinuation From Treatment|Adverse Event|343|||
170857452|NCT03057977|617487913|FG001|Discontinuation From Treatment|Adverse Event|337|||
170857453|NCT03057977|617487912|FG000|Discontinuation From Treatment|Reason Unknown|0|||
170857454|NCT03057977|617487913|FG001|Discontinuation From Treatment|Reason Unknown|1|||
170857455|NCT03057977|617487912|FG000|Discontinuation From Treatment|Personal Reasons|1|||
170857456|NCT03057977|617487913|FG001|Discontinuation From Treatment|Personal Reasons|1|||
170857457|NCT03057977|617487912|FG000|Discontinuation From Treatment|Unblinded medication|1|||
170857458|NCT03057977|617487913|FG001|Discontinuation From Treatment|Unblinded medication|0|||
170857459|NCT03057977|617487912|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
170857460|NCT03057977|617487913|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
170857461|NCT03057977|617487912|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
170857462|NCT03057977|617487913|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
170857463|NCT03057977|617487912|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
170857464|NCT03057977|617487913|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
170857465|NCT03057977|617487912|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
170857466|NCT03057977|617487913|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
170857467|NCT03057977|617487912|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
170857468|NCT03057977|617487913|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
170857469|NCT03057977|617487912|FG000|Discontinuation From Treatment|Not attending study visit|3|||
170857470|NCT03057977|617487913|FG001|Discontinuation From Treatment|Not attending study visit|10|||
170857471|NCT03057977|617487912|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
170857472|NCT03057977|617487913|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
170857473|NCT03057977|617487912|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
170857474|NCT03057977|617487913|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
170857475|NCT03057977|617487912|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
170857476|NCT03057977|617487913|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
170857477|NCT03057977|617487912|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
170857478|NCT03057977|617487913|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
170857479|NCT03057977|617487912|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
170857480|NCT03057977|617487913|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
170857481|NCT01201317|617487914|FG000|Overall Study|Withdrawal by Subject|5|||
170857482|NCT01201317|617487915|FG001|Overall Study|Withdrawal by Subject|0|||
170857483|NCT01201317|617487916|FG002|Overall Study|Withdrawal by Subject|3|||
170857484|NCT01201317|617487914|FG000|Overall Study|Adverse Event|2|||
170857485|NCT01201317|617487915|FG001|Overall Study|Adverse Event|2|||
170857486|NCT01201317|617487916|FG002|Overall Study|Adverse Event|2|||
170857487|NCT01201317|617487914|FG000|Overall Study|Screen failure|1|||
170857488|NCT01201317|617487915|FG001|Overall Study|Screen failure|1|||
170857489|NCT01201317|617487916|FG002|Overall Study|Screen failure|0|||
170857490|NCT01201317|617487914|FG000|Overall Study|Protocol Violation|0|||
170857491|NCT01201317|617487915|FG001|Overall Study|Protocol Violation|1|||
170857492|NCT01201317|617487916|FG002|Overall Study|Protocol Violation|1|||
170857493|NCT01201317|617487914|FG000|Overall Study|Death|0|||
170857494|NCT01201317|617487915|FG001|Overall Study|Death|1|||
170857495|NCT01201317|617487916|FG002|Overall Study|Death|0|||
170857496|NCT01201317|617487914|FG000|Overall Study|Study-specific withdrawal criteria|0|||
170857497|NCT01201317|617487915|FG001|Overall Study|Study-specific withdrawal criteria|0|||
170857498|NCT01201317|617487916|FG002|Overall Study|Study-specific withdrawal criteria|1|||
170857499|NCT01201317|617487914|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
170857500|NCT01201317|617487915|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
170857501|NCT01201317|617487916|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
170857502|NCT01201317|617487914|FG000|Overall Study|Decrease in renal function|0|||
170857503|NCT01201317|617487915|FG001|Overall Study|Decrease in renal function|1|||
170857504|NCT01201317|617487916|FG002|Overall Study|Decrease in renal function|0|||
170857505|NCT01201317|617487914|FG000|Overall Study|Lack of Efficacy|1|||
170857506|NCT01201317|617487915|FG001|Overall Study|Lack of Efficacy|0|||
170857507|NCT01201317|617487916|FG002|Overall Study|Lack of Efficacy|0|||
170857508|NCT01201317|617487914|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
170857509|NCT01201317|617487915|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
170857510|NCT01201317|617487916|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
170857511|NCT01350336|617487917|FG000|Overall Study|Lost to Follow-up|31|||
170857512|NCT01350336|617487917|FG000|Overall Study|Withdrawal by Subject|14|||
170743822|NCT01091428|617070035|FG001|Phase 2|Withdrawal by Subject|0|||
170743823|NCT01091428|617070036|FG002|Phase 2|Withdrawal by Subject|9|||
170743824|NCT01091428|617070037|FG003|Phase 2|Withdrawal by Subject|8|||
170743825|NCT01091428|617070034|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
170743826|NCT01091428|617070035|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
170743827|NCT01091428|617070036|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
170743828|NCT01091428|617070037|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
170743829|NCT01091428|617070034|FG000|Phase 2|Reason not specified|0|||
170743830|NCT01091428|617070035|FG001|Phase 2|Reason not specified|0|||
170743831|NCT01091428|617070036|FG002|Phase 2|Reason not specified|4|||
170743832|NCT01091428|617070037|FG003|Phase 2|Reason not specified|3|||
170743833|NCT01091428|617070034|FG000|Phase 2|Physician Decision|0|||
170743834|NCT01091428|617070035|FG001|Phase 2|Physician Decision|0|||
170743835|NCT01091428|617070036|FG002|Phase 2|Physician Decision|2|||
170743836|NCT01091428|617070037|FG003|Phase 2|Physician Decision|0|||
170743837|NCT00358215|617070039|FG000|Overall Study|Ineligibility determined|4|||
170743838|NCT00358215|617070040|FG001|Overall Study|Ineligibility determined|3|||
170743839|NCT00358215|617070039|FG000|Overall Study|Adverse Event|83|||
170743840|NCT00358215|617070040|FG001|Overall Study|Adverse Event|65|||
170743841|NCT00358215|617070039|FG000|Overall Study|Withdrawal by Subject|111|||
170743842|NCT00358215|617070040|FG001|Overall Study|Withdrawal by Subject|102|||
170743843|NCT00358215|617070039|FG000|Overall Study|Participant request|65|||
170743844|NCT00358215|617070040|FG001|Overall Study|Participant request|64|||
170743845|NCT00358215|617070039|FG000|Overall Study|Physician Decision|47|||
170743846|NCT00358215|617070040|FG001|Overall Study|Physician Decision|39|||
170743847|NCT00358215|617070039|FG000|Overall Study|Lost to Follow-up|16|||
170743848|NCT00358215|617070040|FG001|Overall Study|Lost to Follow-up|22|||
170743849|NCT00358215|617070039|FG000|Overall Study|Death|265|||
170743850|NCT00358215|617070040|FG001|Overall Study|Death|281|||
170743851|NCT00358215|617070039|FG000|Overall Study|Protocol Violation|64|||
170743852|NCT00358215|617070040|FG001|Overall Study|Protocol Violation|59|||
170743853|NCT00358215|617070039|FG000|Overall Study|Pregnancy|1|||
170743854|NCT00358215|617070040|FG001|Overall Study|Pregnancy|0|||
170743855|NCT00358215|617070039|FG000|Overall Study|Other|21|||
170743856|NCT00358215|617070040|FG001|Overall Study|Other|14|||
170743857|NCT00358215|617070039|FG000|Overall Study|Did not receive investigational product|2|||
170743858|NCT00358215|617070040|FG001|Overall Study|Did not receive investigational product|3|||
170743859|NCT00871351|617070041|FG000|Overall Study|Withdrawal by Subject|1|||
170743860|NCT00871351|617070042|FG001|Overall Study|Withdrawal by Subject|0|||
170743861|NCT00871351|617070043|FG002|Overall Study|Withdrawal by Subject|0|||
170743862|NCT00871351|617070041|FG000|Overall Study|Adverse Event|3|||
170743863|NCT00871351|617070042|FG001|Overall Study|Adverse Event|1|||
170743864|NCT00871351|617070043|FG002|Overall Study|Adverse Event|0|||
170743865|NCT00744237|617070044|FG000|Overall Study|Lack of Efficacy|1|||
170743866|NCT00744237|617070045|FG001|Overall Study|Lack of Efficacy|1|||
170743867|NCT00744237|617070046|FG002|Overall Study|Lack of Efficacy|0|||
170743868|NCT00744237|617070044|FG000|Overall Study|Withdrawal by Subject|9|||
170743869|NCT00744237|617070045|FG001|Overall Study|Withdrawal by Subject|5|||
170743870|NCT00744237|617070046|FG002|Overall Study|Withdrawal by Subject|3|||
170743871|NCT00744237|617070044|FG000|Overall Study|Lost to Follow-up|1|||
170857513|NCT01350336|617487917|FG000|Overall Study|Physician Decision|8|||
170857514|NCT01350336|617487917|FG000|Overall Study|Death|4|||
170857515|NCT02382016|617487924|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
170857516|NCT02382016|617487925|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
170857517|NCT02382016|617487924|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
170857518|NCT02382016|617487925|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
170857519|NCT02382016|617487924|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
170857520|NCT02382016|617487925|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
170857521|NCT02382016|617487924|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
170857522|NCT02382016|617487925|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
170857523|NCT02382016|617487924|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
170857524|NCT02382016|617487925|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
170857525|NCT02382016|617487924|FG000|Open-label (OL) Treatment Period|Death|4|||
170857526|NCT02382016|617487925|FG001|Open-label (OL) Treatment Period|Death|0|||
170857527|NCT02382016|617487924|FG000|OL Extension Period|Physician Decision|3|||
170857528|NCT02382016|617487925|FG001|OL Extension Period|Physician Decision|0|||
170743872|NCT00744237|617070045|FG001|Overall Study|Lost to Follow-up|1|||
170743873|NCT00744237|617070046|FG002|Overall Study|Lost to Follow-up|1|||
170743874|NCT00744237|617070044|FG000|Overall Study|Protocol Violation|3|||
170743875|NCT00744237|617070045|FG001|Overall Study|Protocol Violation|4|||
170857529|NCT02382016|617487924|FG000|OL Extension Period|Death|2|||
170857530|NCT02382016|617487925|FG001|OL Extension Period|Death|0|||
170857531|NCT02382016|617487924|FG000|OL Extension Period|Withdrawal by Subject|1|||
170857532|NCT02382016|617487925|FG001|OL Extension Period|Withdrawal by Subject|0|||
170743876|NCT00744237|617070046|FG002|Overall Study|Protocol Violation|3|||
170857533|NCT01171807|617487929|FG000|Overall Study|Treatment failure|2|||
170743877|NCT00744237|617070044|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
170743878|NCT00744237|617070045|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
170743879|NCT00744237|617070046|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
170743880|NCT00744237|617070044|FG000|Overall Study|Dosing Error|1|||
170743881|NCT00744237|617070045|FG001|Overall Study|Dosing Error|0|||
170743882|NCT00744237|617070046|FG002|Overall Study|Dosing Error|1|||
170743883|NCT00744237|617070044|FG000|Overall Study|Study Drug Error|1|||
170743884|NCT00744237|617070045|FG001|Overall Study|Study Drug Error|0|||
170743885|NCT00744237|617070046|FG002|Overall Study|Study Drug Error|0|||
170743886|NCT00744237|617070044|FG000|Overall Study|Prohibited Concomitant Medication|0|||
170743887|NCT00744237|617070045|FG001|Overall Study|Prohibited Concomitant Medication|0|||
170743888|NCT00744237|617070046|FG002|Overall Study|Prohibited Concomitant Medication|1|||
170743889|NCT00744237|617070044|FG000|Overall Study|Poor Compliance|0|||
170743890|NCT00744237|617070045|FG001|Overall Study|Poor Compliance|2|||
170743891|NCT00744237|617070046|FG002|Overall Study|Poor Compliance|0|||
170743892|NCT00744237|617070044|FG000|Overall Study|Administrative. Site Closed|1|||
170743893|NCT00744237|617070045|FG001|Overall Study|Administrative. Site Closed|1|||
170743894|NCT00744237|617070046|FG002|Overall Study|Administrative. Site Closed|1|||
170743895|NCT00744237|617070044|FG000|Overall Study|Adverse Event|9|||
170743896|NCT00744237|617070045|FG001|Overall Study|Adverse Event|13|||
170743897|NCT00744237|617070046|FG002|Overall Study|Adverse Event|5|||
170743898|NCT02791490|617070047|FG000|Overall Study|Lost to Follow-up|1|||
170743899|NCT02791490|617070048|FG001|Overall Study|Lost to Follow-up|2|||
170743900|NCT02791490|617070047|FG000|Overall Study|Withdrawal by Subject|2|||
170743901|NCT02791490|617070048|FG001|Overall Study|Withdrawal by Subject|6|||
170743902|NCT05340751|617070054|FG000|Overall Study|Physician Decision|3|||
170743903|NCT01118455|617070058|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
170743904|NCT01118455|617070059|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
170743905|NCT05033743|617070066|FG000|Overall Study|Lost to Follow-up|1|||
170743906|NCT05033743|617070066|FG000|Overall Study|Protocol Violation|2|||
170743907|NCT05033743|617070066|FG000|Overall Study|Withdrawal by Subject|1|||
170743908|NCT00919893|617070069|FG000|Overall Study|Protocol Violation|19|||
170743909|NCT00919893|617070070|FG001|Overall Study|Protocol Violation|9|||
170743910|NCT01375959|617070071|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
170743911|NCT01375959|617070072|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
170743912|NCT01375959|617070071|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
170743913|NCT01375959|617070072|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
170743914|NCT01375959|617070071|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
170743915|NCT01375959|617070072|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
170743916|NCT00885352|617070079|FG000|Overall Study|Adverse Event|2|||
170743917|NCT00885352|617070080|FG001|Overall Study|Adverse Event|3|||
170857534|NCT01171807|617487930|FG001|Overall Study|Treatment failure|4|||
170857535|NCT01171807|617487929|FG000|Overall Study|Non compliance|1|||
170857536|NCT01171807|617487930|FG001|Overall Study|Non compliance|0|||
170857537|NCT01171807|617487929|FG000|Overall Study|Lost to Follow-up|3|||
170857538|NCT01171807|617487930|FG001|Overall Study|Lost to Follow-up|0|||
170857539|NCT04964388|617487931|FG000|Overall Study|Lost to Follow-up|3|||
170857540|NCT04964388|617487932|FG001|Overall Study|Lost to Follow-up|2|||
170857541|NCT00448279|617487933|FG000|Overall Study|Lost to Follow-up|2|||
170857542|NCT00448279|617487934|FG001|Overall Study|Lost to Follow-up|2|||
170857543|NCT00448279|617487933|FG000|Overall Study|Adverse Event|1|||
170857544|NCT00448279|617487934|FG001|Overall Study|Adverse Event|1|||
170857545|NCT00448279|617487933|FG000|Overall Study|Disease progression|16|||
170857546|NCT00448279|617487934|FG001|Overall Study|Disease progression|18|||
170857547|NCT00448279|617487933|FG000|Overall Study|Withdrawal by Subject|4|||
170857548|NCT00448279|617487934|FG001|Overall Study|Withdrawal by Subject|3|||
170857549|NCT00448279|617487933|FG000|Overall Study|Other|6|||
170857550|NCT00448279|617487934|FG001|Overall Study|Other|4|||
170857551|NCT00448279|617487933|FG000|Overall Study|Protocol Violation|0|||
170857552|NCT00448279|617487934|FG001|Overall Study|Protocol Violation|1|||
170857553|NCT03907410|617487935|FG000|Overall Study|Lost to Follow-up|4|||
170857554|NCT03907410|617487936|FG001|Overall Study|Lost to Follow-up|1|||
170857555|NCT03907410|617487937|FG002|Overall Study|Lost to Follow-up|1|||
170857556|NCT03907410|617487935|FG000|Overall Study|Lost to follow-up and research burden|0|||
170857557|NCT03907410|617487936|FG001|Overall Study|Lost to follow-up and research burden|0|||
170743918|NCT00885352|617070079|FG000|Overall Study|Lost to Follow-up|2|||
170743919|NCT00885352|617070080|FG001|Overall Study|Lost to Follow-up|2|||
170743920|NCT00885352|617070079|FG000|Overall Study|Physician Decision|0|||
170743921|NCT00885352|617070080|FG001|Overall Study|Physician Decision|3|||
170857558|NCT03907410|617487937|FG002|Overall Study|Lost to follow-up and research burden|1|||
170857559|NCT01155375|617487938|FG000|Overall Study|Adverse Event|1|||
170857560|NCT01155375|617487939|FG001|Overall Study|Adverse Event|0|||
170857561|NCT05062759|617487940|FG000|Overall Study|Death|0|||
170857562|NCT05062759|617487941|FG001|Overall Study|Death|1|||
170743922|NCT00885352|617070079|FG000|Overall Study|Protocol Violation|0|||
170857563|NCT05062759|617487940|FG000|Overall Study|Lost to Follow-up|1|||
170857564|NCT05062759|617487941|FG001|Overall Study|Lost to Follow-up|0|||
170857565|NCT04981366|617487942|FG000|Overall Study|Withdrawal by Subject|5|||
170857566|NCT04981366|617487943|FG001|Overall Study|Withdrawal by Subject|4|||
170857567|NCT04981366|617487944|FG002|Overall Study|Withdrawal by Subject|8|||
170857568|NCT04981366|617487942|FG000|Overall Study|Health issues unrelated to the trial|1|||
170857569|NCT04981366|617487943|FG001|Overall Study|Health issues unrelated to the trial|2|||
170857570|NCT04981366|617487944|FG002|Overall Study|Health issues unrelated to the trial|0|||
170857571|NCT01112306|617487945|FG000|Overall Study|Death|175|||
170857572|NCT01112306|617487945|FG000|Overall Study|Lost to Follow-up|9|||
170857573|NCT01112306|617487945|FG000|Overall Study|Withdrawal by Subject|31|||
170857574|NCT01112306|617487945|FG000|Overall Study|Other|70|||
170857575|NCT03214094|617487946|FG000|Overall Study|Case Report Forms Uncollected|14|||
170857576|NCT03214094|617487946|FG000|Overall Study|Protocol Deviation|46|||
170857577|NCT00655486|617487951|FG000|Overall Study|Adverse Event|10|||
170857578|NCT00655486|617487951|FG000|Overall Study|Lack of Efficacy|8|||
170857579|NCT00655486|617487951|FG000|Overall Study|Withdrawal by Subject|4|||
170857580|NCT00655486|617487951|FG000|Overall Study|Protocol Violation|1|||
170857581|NCT00655486|617487951|FG000|Overall Study|Unsatisfactory compliance|2|||
170857582|NCT00655486|617487951|FG000|Overall Study|Other: Pregnancy|1|||
170857583|NCT00655486|617487951|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
170857584|NCT00655486|617487951|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
170857585|NCT00310037|617487952|FG000|Overall Study|Adverse Event|7|||
170857586|NCT00310037|617487953|FG001|Overall Study|Adverse Event|14|||
170857587|NCT00310037|617487952|FG000|Overall Study|Withdrawal by Subject|4|||
170857588|NCT00310037|617487953|FG001|Overall Study|Withdrawal by Subject|3|||
170857589|NCT00310037|617487952|FG000|Overall Study|Progression|6|||
170857590|NCT00310037|617487953|FG001|Overall Study|Progression|0|||
170857591|NCT00310037|617487952|FG000|Overall Study|Non-protocol treatment|1|||
170857592|NCT00310037|617487953|FG001|Overall Study|Non-protocol treatment|0|||
170857593|NCT05559099|617487964|FG000|Overall Study|Death|5|||
170857594|NCT05559099|617487965|FG001|Overall Study|Death|4|||
170857595|NCT05559099|617487964|FG000|Overall Study|Lost to Follow-up|0|||
170857596|NCT05559099|617487965|FG001|Overall Study|Lost to Follow-up|2|||
170857597|NCT05559099|617487964|FG000|Overall Study|Adverse Event|1|||
170857598|NCT05559099|617487965|FG001|Overall Study|Adverse Event|1|||
170857599|NCT00069108|617487966|FG000|Overall Study|Withdrawal by Subject|5|||
170857600|NCT00069108|617487967|FG001|Overall Study|Withdrawal by Subject|9|||
170857601|NCT00069108|617487966|FG000|Overall Study|Adverse Event|64|||
170857602|NCT00069108|617487967|FG001|Overall Study|Adverse Event|42|||
170857603|NCT00069108|617487966|FG000|Overall Study|Death|6|||
170857604|NCT00069108|617487967|FG001|Overall Study|Death|6|||
170857605|NCT00069108|617487966|FG000|Overall Study|Administration|15|||
170857606|NCT00069108|617487967|FG001|Overall Study|Administration|4|||
170857607|NCT00069108|617487966|FG000|Overall Study|Insufficient therapy|117|||
170857608|NCT00069108|617487967|FG001|Overall Study|Insufficient therapy|144|||
170857609|NCT00069108|617487966|FG000|Overall Study|Violation criteria|1|||
170857610|NCT00069108|617487967|FG001|Overall Study|Violation criteria|4|||
170857611|NCT00069108|617487966|FG000|Overall Study|Refused treatment|5|||
170857612|NCT00069108|617487967|FG001|Overall Study|Refused treatment|10|||
170857613|NCT02783768|617487968|FG000|Overall Study|Lost to Follow-up|1|||
170857614|NCT02783768|617487969|FG001|Overall Study|Lost to Follow-up|0|||
170857615|NCT01790126|617487973|FG000|Overall Study|PSA Progression|12|||
170857616|NCT01790126|617487974|FG001|Overall Study|PSA Progression|16|||
170857617|NCT01790126|617487975|FG002|Overall Study|PSA Progression|16|||
170857618|NCT01790126|617487973|FG000|Overall Study|Other|5|||
170857619|NCT01790126|617487974|FG001|Overall Study|Other|4|||
170857620|NCT01790126|617487975|FG002|Overall Study|Other|8|||
170857621|NCT01790126|617487973|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
170857622|NCT01790126|617487974|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
170857623|NCT01790126|617487975|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
170857624|NCT01790126|617487973|FG000|Overall Study|Withdrawal by Physician|1|||
170857625|NCT01790126|617487974|FG001|Overall Study|Withdrawal by Physician|1|||
170857626|NCT01790126|617487975|FG002|Overall Study|Withdrawal by Physician|2|||
170743923|NCT00885352|617070080|FG001|Overall Study|Protocol Violation|2|||
170743924|NCT00885352|617070079|FG000|Overall Study|Withdrawal by Subject|1|||
170743925|NCT00885352|617070080|FG001|Overall Study|Withdrawal by Subject|5|||
170743926|NCT00885352|617070079|FG000|Overall Study|Contradiction to study medication|0|||
170743927|NCT00885352|617070080|FG001|Overall Study|Contradiction to study medication|2|||
170743928|NCT00885352|617070079|FG000|Overall Study|Excluded medication|2|||
170743929|NCT00885352|617070080|FG001|Overall Study|Excluded medication|2|||
170743930|NCT00885352|617070079|FG000|Overall Study|Lab abnormalities|1|||
170743931|NCT00885352|617070080|FG001|Overall Study|Lab abnormalities|1|||
170743932|NCT04741802|617070081|FG000|Overall Study|Death|1|||
170857627|NCT01790126|617487973|FG000|Overall Study|Withdrawal by Subject|3|||
170857628|NCT01790126|617487974|FG001|Overall Study|Withdrawal by Subject|1|||
170857629|NCT01790126|617487975|FG002|Overall Study|Withdrawal by Subject|2|||
170857630|NCT01790126|617487973|FG000|Overall Study|Lost to Follow-up|1|||
170743933|NCT04741802|617070081|FG000|Overall Study|Lost to Follow-up|11|||
170743934|NCT00708305|617070082|FG000|Period 1|Protocol Violation|1|||
170743935|NCT00708305|617070083|FG001|Period 1|Protocol Violation|0|||
170743936|NCT00708305|617070084|FG002|Period 1|Protocol Violation|1|||
170743937|NCT00708305|617070085|FG003|Period 1|Protocol Violation|0|||
170743938|NCT00708305|617070082|FG000|Period 1|Other Reason|0|||
170743939|NCT00708305|617070083|FG001|Period 1|Other Reason|0|||
170743940|NCT00708305|617070084|FG002|Period 1|Other Reason|0|||
170743941|NCT00708305|617070085|FG003|Period 1|Other Reason|2|||
170743942|NCT00708305|617070082|FG000|Period 2|Lost to Follow-up|0|||
170743943|NCT00708305|617070083|FG001|Period 2|Lost to Follow-up|1|||
170743944|NCT00708305|617070084|FG002|Period 2|Lost to Follow-up|0|||
170743945|NCT00708305|617070085|FG003|Period 2|Lost to Follow-up|0|||
170743946|NCT00708305|617070082|FG000|Period 2|Protocol Violation|0|||
170743947|NCT00708305|617070083|FG001|Period 2|Protocol Violation|1|||
170743948|NCT00708305|617070084|FG002|Period 2|Protocol Violation|0|||
170743949|NCT00708305|617070085|FG003|Period 2|Protocol Violation|0|||
170743950|NCT00708305|617070082|FG000|Period 2|Other Reason|1|||
170743951|NCT00708305|617070083|FG001|Period 2|Other Reason|0|||
170743952|NCT00708305|617070084|FG002|Period 2|Other Reason|0|||
170743953|NCT00708305|617070085|FG003|Period 2|Other Reason|1|||
170743954|NCT00708305|617070082|FG000|Period 3|Protocol Violation|0|||
170743955|NCT00708305|617070083|FG001|Period 3|Protocol Violation|2|||
170743956|NCT00708305|617070084|FG002|Period 3|Protocol Violation|0|||
170743957|NCT00708305|617070085|FG003|Period 3|Protocol Violation|0|||
170743958|NCT00708305|617070082|FG000|Period 3|Other Reason|1|||
170743959|NCT00708305|617070083|FG001|Period 3|Other Reason|0|||
170743960|NCT00708305|617070084|FG002|Period 3|Other Reason|0|||
170743961|NCT00708305|617070085|FG003|Period 3|Other Reason|0|||
170743962|NCT00192023|617070086|FG000|Period III - Double-Blind|Adverse Event|3|||
170743963|NCT00192023|617070087|FG001|Period III - Double-Blind|Adverse Event|0|||
170743964|NCT00192023|617070086|FG000|Period III - Double-Blind|Physician Decision|2|||
170743965|NCT00192023|617070087|FG001|Period III - Double-Blind|Physician Decision|0|||
170743966|NCT00192023|617070086|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
170743967|NCT00192023|617070087|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
170743968|NCT00192023|617070086|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
170743969|NCT00192023|617070087|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
170743970|NCT00192023|617070086|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
170743971|NCT00192023|617070087|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
170743972|NCT00192023|617070086|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
170743973|NCT00192023|617070087|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
170743974|NCT00192023|617070086|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
170743975|NCT00192023|617070087|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
170743976|NCT00192023|617070086|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
170743977|NCT00192023|617070087|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
170743978|NCT00192023|617070086|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
170743979|NCT00192023|617070087|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
170743980|NCT00192023|617070086|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
170743981|NCT00192023|617070087|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
170743982|NCT04789577|617070091|FG000|Overall Study|Withdrawal by Subject|1|||
170743983|NCT04789577|617070092|FG001|Overall Study|Withdrawal by Subject|1|||
170743984|NCT04789577|617070093|FG002|Overall Study|Withdrawal by Subject|1|||
170743985|NCT04789577|617070094|FG003|Overall Study|Withdrawal by Subject|3|||
170743986|NCT04789577|617070095|FG004|Overall Study|Withdrawal by Subject|1|||
170743987|NCT04789577|617070096|FG005|Overall Study|Withdrawal by Subject|7|||
170743988|NCT04789577|617070097|FG006|Overall Study|Withdrawal by Subject|1|||
170743989|NCT04789577|617070091|FG000|Overall Study|Lost to Follow-up|7|||
170743990|NCT04789577|617070092|FG001|Overall Study|Lost to Follow-up|12|||
170743991|NCT04789577|617070093|FG002|Overall Study|Lost to Follow-up|7|||
170743992|NCT04789577|617070094|FG003|Overall Study|Lost to Follow-up|10|||
170743993|NCT04789577|617070095|FG004|Overall Study|Lost to Follow-up|8|||
170743994|NCT04789577|617070096|FG005|Overall Study|Lost to Follow-up|6|||
170743995|NCT04789577|617070097|FG006|Overall Study|Lost to Follow-up|10|||
170743996|NCT04789577|617070091|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
170743997|NCT04789577|617070092|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
170743998|NCT04789577|617070093|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
170743999|NCT04789577|617070094|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
170744000|NCT04789577|617070095|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
170744001|NCT04789577|617070096|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
170744002|NCT04789577|617070097|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
170744003|NCT04789577|617070091|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
170744004|NCT04789577|617070092|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
170744005|NCT04789577|617070093|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
170744006|NCT04789577|617070094|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
170744007|NCT04789577|617070095|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
170857631|NCT01790126|617487974|FG001|Overall Study|Lost to Follow-up|0|||
170857632|NCT01790126|617487975|FG002|Overall Study|Lost to Follow-up|1|||
170857633|NCT01790126|617487973|FG000|Overall Study|Adverse Event|0|||
170857634|NCT01790126|617487974|FG001|Overall Study|Adverse Event|2|||
170857635|NCT01790126|617487975|FG002|Overall Study|Adverse Event|0|||
170857636|NCT01790126|617487973|FG000|Overall Study|Death|2|||
170857637|NCT01790126|617487974|FG001|Overall Study|Death|0|||
170857638|NCT01790126|617487975|FG002|Overall Study|Death|0|||
170857639|NCT01790126|617487973|FG000|Overall Study|Radiographic Progression|3|||
170857640|NCT01790126|617487974|FG001|Overall Study|Radiographic Progression|1|||
170857641|NCT01790126|617487975|FG002|Overall Study|Radiographic Progression|0|||
170857642|NCT00899548|617487979|FG000|Overall Study|Physician Decision|3|||
170857643|NCT00679627|617487983|FG000|Overall Study|Death|41|||
170744008|NCT04789577|617070096|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
170744009|NCT04789577|617070097|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
170744010|NCT00684762|617070098|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
170744011|NCT00684762|617070099|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
170744012|NCT02572817|617070100|FG000|Overall Study|Death|6|||
170744013|NCT02572817|617070101|FG001|Overall Study|Death|3|||
170744014|NCT02572817|617070100|FG000|Overall Study|Lost to Follow-up|3|||
170744015|NCT02572817|617070101|FG001|Overall Study|Lost to Follow-up|3|||
170744016|NCT03662997|617070110|FG000|Overall Study|Adverse Event|0|||
170857644|NCT00679627|617487984|FG001|Overall Study|Death|29|||
170857645|NCT00679627|617487983|FG000|Overall Study|Adverse Event|43|||
170857646|NCT00679627|617487984|FG001|Overall Study|Adverse Event|53|||
170857647|NCT00679627|617487983|FG000|Overall Study|Withdrawal by Subject|168|||
170857648|NCT00679627|617487984|FG001|Overall Study|Withdrawal by Subject|172|||
170857649|NCT00679627|617487983|FG000|Overall Study|Lost to Follow-up|22|||
170857650|NCT00679627|617487984|FG001|Overall Study|Lost to Follow-up|26|||
170857651|NCT00679627|617487983|FG000|Overall Study|Early Study Closure|425|||
170857652|NCT00679627|617487984|FG001|Overall Study|Early Study Closure|405|||
170857653|NCT01272804|617487985|FG000|Overall Study|Adverse Event|1|||
170857654|NCT01272804|617487986|FG001|Overall Study|Adverse Event|0|||
170857655|NCT01272804|617487987|FG002|Overall Study|Adverse Event|0|||
170857656|NCT01272804|617487988|FG003|Overall Study|Adverse Event|0|||
170857657|NCT01272804|617487989|FG004|Overall Study|Adverse Event|2|||
170857658|NCT01272804|617487990|FG005|Overall Study|Adverse Event|1|||
170857659|NCT01886378|617487991|FG000|Overall Study|Adverse Event|1|||
170857660|NCT01886378|617487991|FG000|Overall Study|Withdrawal by Subject|4|||
170857661|NCT02308020|617487992|FG000|Overall Study|Lost to Follow-up|1|||
170857662|NCT02308020|617487993|FG001|Overall Study|Lost to Follow-up|7|||
170857663|NCT02308020|617487994|FG002|Overall Study|Lost to Follow-up|0|||
170857664|NCT02308020|617487995|FG003|Overall Study|Lost to Follow-up|0|||
170857665|NCT02308020|617487996|FG004|Overall Study|Lost to Follow-up|1|||
170857666|NCT02308020|617487997|FG005|Overall Study|Lost to Follow-up|2|||
170857667|NCT02308020|617487992|FG000|Overall Study|Sponsor Decision|0|||
170857668|NCT02308020|617487993|FG001|Overall Study|Sponsor Decision|8|||
170857669|NCT02308020|617487994|FG002|Overall Study|Sponsor Decision|0|||
170857670|NCT02308020|617487995|FG003|Overall Study|Sponsor Decision|2|||
170857671|NCT02308020|617487996|FG004|Overall Study|Sponsor Decision|2|||
170857672|NCT02308020|617487997|FG005|Overall Study|Sponsor Decision|1|||
170857673|NCT02308020|617487992|FG000|Overall Study|Withdrawal by Subject|3|||
170857674|NCT02308020|617487993|FG001|Overall Study|Withdrawal by Subject|5|||
170857675|NCT02308020|617487994|FG002|Overall Study|Withdrawal by Subject|3|||
170857676|NCT02308020|617487995|FG003|Overall Study|Withdrawal by Subject|2|||
170857677|NCT02308020|617487996|FG004|Overall Study|Withdrawal by Subject|1|||
170857678|NCT02308020|617487997|FG005|Overall Study|Withdrawal by Subject|2|||
170857679|NCT03265938|617487998|FG000|Overall Study|Withdrawal by Subject|1|||
170857680|NCT03265938|617487998|FG000|Overall Study|Physician Decision|1|||
170857681|NCT03265938|617487998|FG000|Overall Study|friable mass|6|||
170857682|NCT01270971|617487999|FG000|Overall Study|Withdrawal by Subject|24|||
170857683|NCT01270971|617488000|FG001|Overall Study|Withdrawal by Subject|11|||
170857684|NCT01270971|617487999|FG000|Overall Study|Lost to Follow-up|18|||
170857685|NCT01270971|617488000|FG001|Overall Study|Lost to Follow-up|5|||
170857686|NCT01270971|617487999|FG000|Overall Study|Adverse Event|1|||
170857687|NCT01270971|617488000|FG001|Overall Study|Adverse Event|2|||
170857688|NCT01270971|617487999|FG000|Overall Study|Non compliance|2|||
170857689|NCT01270971|617488000|FG001|Overall Study|Non compliance|2|||
170857690|NCT01270971|617487999|FG000|Overall Study|Non-specific|7|||
170744017|NCT03662997|617070111|FG001|Overall Study|Adverse Event|2|||
170744018|NCT03662997|617070112|FG002|Overall Study|Adverse Event|0|||
170744019|NCT03662997|617070113|FG003|Overall Study|Adverse Event|0|||
170857691|NCT01270971|617488000|FG001|Overall Study|Non-specific|3|||
170857692|NCT02471833|617488001|FG000|Overall Study|Lost to Follow-up|1|||
170857693|NCT02471833|617488002|FG001|Overall Study|Lost to Follow-up|0|||
170857694|NCT02471833|617488003|FG002|Overall Study|Lost to Follow-up|0|||
170857695|NCT02471833|617488001|FG000|Overall Study|Withdrawal by Subject|2|||
170857696|NCT02471833|617488002|FG001|Overall Study|Withdrawal by Subject|1|||
170857697|NCT02471833|617488003|FG002|Overall Study|Withdrawal by Subject|5|||
170857698|NCT02673515|617488004|FG000|Overall Study|Lack of motivation|2|||
170857699|NCT02673515|617488005|FG001|Overall Study|Lack of motivation|1|||
170857700|NCT02457559|617488006|FG000|Overall Study|Progressive Disease|1|||
170857701|NCT02457559|617488007|FG001|Overall Study|Progressive Disease|2|||
170857702|NCT02457559|617488008|FG002|Overall Study|Progressive Disease|3|||
170857703|NCT02457559|617488009|FG003|Overall Study|Progressive Disease|0|||
170857704|NCT02457559|617488010|FG004|Overall Study|Progressive Disease|0|||
170857705|NCT02457559|617488011|FG005|Overall Study|Progressive Disease|2|||
170857706|NCT02457559|617488012|FG006|Overall Study|Progressive Disease|1|||
170857707|NCT02457559|617488013|FG007|Overall Study|Progressive Disease|0|||
170857708|NCT02457559|617488014|FG008|Overall Study|Progressive Disease|1|||
170857709|NCT02457559|617488015|FG009|Overall Study|Progressive Disease|1|||
170857710|NCT02457559|617488016|FG010|Overall Study|Progressive Disease|1|||
170857711|NCT02457559|617488006|FG000|Overall Study|Investigator's Discretion|0|||
170857712|NCT02457559|617488007|FG001|Overall Study|Investigator's Discretion|0|||
170857713|NCT02457559|617488008|FG002|Overall Study|Investigator's Discretion|2|||
170857714|NCT02457559|617488009|FG003|Overall Study|Investigator's Discretion|0|||
170857715|NCT02457559|617488010|FG004|Overall Study|Investigator's Discretion|1|||
170857716|NCT02457559|617488011|FG005|Overall Study|Investigator's Discretion|0|||
170857717|NCT02457559|617488012|FG006|Overall Study|Investigator's Discretion|1|||
170857718|NCT02457559|617488013|FG007|Overall Study|Investigator's Discretion|0|||
170857719|NCT02457559|617488014|FG008|Overall Study|Investigator's Discretion|1|||
170857720|NCT02457559|617488015|FG009|Overall Study|Investigator's Discretion|0|||
170857721|NCT02457559|617488016|FG010|Overall Study|Investigator's Discretion|1|||
170857722|NCT02457559|617488006|FG000|Overall Study|Adverse Event|0|||
170857723|NCT02457559|617488007|FG001|Overall Study|Adverse Event|1|||
170857724|NCT02457559|617488008|FG002|Overall Study|Adverse Event|2|||
170857725|NCT02457559|617488009|FG003|Overall Study|Adverse Event|0|||
170857726|NCT02457559|617488010|FG004|Overall Study|Adverse Event|0|||
170857727|NCT02457559|617488011|FG005|Overall Study|Adverse Event|0|||
170857728|NCT02457559|617488012|FG006|Overall Study|Adverse Event|0|||
170857729|NCT02457559|617488013|FG007|Overall Study|Adverse Event|0|||
170857730|NCT02457559|617488014|FG008|Overall Study|Adverse Event|0|||
170857731|NCT02457559|617488015|FG009|Overall Study|Adverse Event|0|||
170857732|NCT02457559|617488016|FG010|Overall Study|Adverse Event|0|||
170857733|NCT02457559|617488006|FG000|Overall Study|Reason not Specified|1|||
170857734|NCT02457559|617488007|FG001|Overall Study|Reason not Specified|0|||
170857735|NCT02457559|617488008|FG002|Overall Study|Reason not Specified|0|||
170857736|NCT02457559|617488009|FG003|Overall Study|Reason not Specified|0|||
170857737|NCT02457559|617488010|FG004|Overall Study|Reason not Specified|0|||
170857738|NCT02457559|617488011|FG005|Overall Study|Reason not Specified|0|||
170857739|NCT02457559|617488012|FG006|Overall Study|Reason not Specified|0|||
170857740|NCT02457559|617488013|FG007|Overall Study|Reason not Specified|0|||
170857741|NCT02457559|617488014|FG008|Overall Study|Reason not Specified|0|||
170857742|NCT02457559|617488015|FG009|Overall Study|Reason not Specified|2|||
170857743|NCT02457559|617488016|FG010|Overall Study|Reason not Specified|0|||
170857744|NCT02457559|617488006|FG000|Overall Study|Death|0|||
170857745|NCT02457559|617488007|FG001|Overall Study|Death|0|||
170857746|NCT02457559|617488008|FG002|Overall Study|Death|0|||
170857747|NCT02457559|617488009|FG003|Overall Study|Death|0|||
170857748|NCT02457559|617488010|FG004|Overall Study|Death|0|||
170857749|NCT02457559|617488011|FG005|Overall Study|Death|0|||
170857750|NCT02457559|617488012|FG006|Overall Study|Death|0|||
170857751|NCT02457559|617488013|FG007|Overall Study|Death|0|||
170857752|NCT02457559|617488014|FG008|Overall Study|Death|1|||
170857753|NCT02457559|617488015|FG009|Overall Study|Death|1|||
170857754|NCT02457559|617488016|FG010|Overall Study|Death|0|||
170857755|NCT02641496|617488019|FG000|Overall Study|Lost to Follow-up|13|||
170857756|NCT02641496|617488020|FG001|Overall Study|Lost to Follow-up|12|||
170857757|NCT02641496|617488019|FG000|Overall Study|Withdrawal by Subject|1|||
170857758|NCT02641496|617488020|FG001|Overall Study|Withdrawal by Subject|0|||
170857759|NCT02523599|617488021|FG000|Overall Study|Adverse Event|1|||
170857760|NCT02523599|617488022|FG001|Overall Study|Adverse Event|0|||
170857761|NCT02523599|617488021|FG000|Overall Study|Physician Decision|1|||
170857762|NCT02523599|617488022|FG001|Overall Study|Physician Decision|0|||
170857763|NCT02523599|617488021|FG000|Overall Study|Lost to Follow-up|4|||
170857764|NCT02523599|617488022|FG001|Overall Study|Lost to Follow-up|1|||
170857765|NCT02523599|617488021|FG000|Overall Study|Did not return for Day 30 visit|2|||
170857766|NCT02523599|617488022|FG001|Overall Study|Did not return for Day 30 visit|0|||
170857767|NCT01028027|617488023|FG000|Overall Study|Lost to Follow-up|4|||
170857768|NCT01028027|617488024|FG001|Overall Study|Lost to Follow-up|1|||
170857769|NCT01028027|617488023|FG000|Overall Study|Withdrawal by Subject|5|||
170857770|NCT01028027|617488024|FG001|Overall Study|Withdrawal by Subject|3|||
170857771|NCT01028027|617488023|FG000|Overall Study|Adverse Event|4|||
170857772|NCT01028027|617488024|FG001|Overall Study|Adverse Event|7|||
170857773|NCT01028027|617488023|FG000|Overall Study|Protocol Violation|3|||
170857774|NCT01028027|617488024|FG001|Overall Study|Protocol Violation|1|||
170857775|NCT01028027|617488023|FG000|Overall Study|Lack of Efficacy|0|||
170857776|NCT01028027|617488024|FG001|Overall Study|Lack of Efficacy|1|||
170857777|NCT00529958|617488038|FG000|2-Year Follow-up|Lost to Follow-up|1|||
170857778|NCT00529958|617488039|FG001|2-Year Follow-up|Lost to Follow-up|2|||
170857779|NCT00529958|617488040|FG002|2-Year Follow-up|Lost to Follow-up|2|||
170857780|NCT00529958|617488038|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
170857781|NCT00529958|617488039|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
170857782|NCT00529958|617488040|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
170857783|NCT00529958|617488038|FG000|5-Year Follow-up|Lost to Follow-up|2|||
170857784|NCT00529958|617488039|FG001|5-Year Follow-up|Lost to Follow-up|3|||
170857785|NCT00529958|617488040|FG002|5-Year Follow-up|Lost to Follow-up|1|||
170857786|NCT00529958|617488038|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
170857787|NCT00529958|617488039|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
170857788|NCT00529958|617488040|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
170857789|NCT04443153|617488041|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
170857790|NCT04443153|617488042|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
170857791|NCT04443153|617488041|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
170857792|NCT04443153|617488042|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
170857793|NCT04443153|617488041|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
170857794|NCT04443153|617488042|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
170857795|NCT04443153|617488041|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
170857796|NCT04443153|617488042|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
170857797|NCT02572843|617488043|FG000|Accrual|Brain metastasis retrospectively detected|1|||
170857798|NCT02572843|617488043|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
170857799|NCT02572843|617488043|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
170857800|NCT02572843|617488043|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
170857801|NCT02572843|617488043|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
170857802|NCT02572843|617488043|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
170857803|NCT02572843|617488043|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
170857804|NCT02572843|617488043|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
170857805|NCT02572843|617488043|FG000|Surgery|lost to follow up|7|||
170857806|NCT02572843|617488043|FG000|Surgery|Death|1|||
170857807|NCT03464097|617488044|FG000|Overall Study|Withdrawal by Subject|15|||
170857808|NCT03464097|617488045|FG001|Overall Study|Withdrawal by Subject|13|||
170857809|NCT03464097|617488046|FG002|Overall Study|Withdrawal by Subject|11|||
170857810|NCT03464097|617488044|FG000|Overall Study|Study terminated by sponsor|47|||
170857811|NCT03464097|617488045|FG001|Overall Study|Study terminated by sponsor|44|||
170857812|NCT03464097|617488046|FG002|Overall Study|Study terminated by sponsor|40|||
170857813|NCT03464097|617488044|FG000|Overall Study|Pregnancy|0|||
170857814|NCT03464097|617488045|FG001|Overall Study|Pregnancy|1|||
170857815|NCT03464097|617488046|FG002|Overall Study|Pregnancy|0|||
170857816|NCT03464097|617488044|FG000|Overall Study|Other reasons|5|||
170857817|NCT03464097|617488045|FG001|Overall Study|Other reasons|12|||
170857818|NCT03464097|617488046|FG002|Overall Study|Other reasons|14|||
170857819|NCT03464097|617488044|FG000|Overall Study|Lost to Follow-up|0|||
170857820|NCT03464097|617488045|FG001|Overall Study|Lost to Follow-up|1|||
170857821|NCT03464097|617488046|FG002|Overall Study|Lost to Follow-up|1|||
170857822|NCT03464097|617488044|FG000|Overall Study|Lack of Efficacy|11|||
170857823|NCT03464097|617488045|FG001|Overall Study|Lack of Efficacy|18|||
170857824|NCT03464097|617488046|FG002|Overall Study|Lack of Efficacy|30|||
170857825|NCT03464097|617488044|FG000|Overall Study|Death|1|||
170857826|NCT03464097|617488045|FG001|Overall Study|Death|0|||
170857827|NCT03464097|617488046|FG002|Overall Study|Death|0|||
170857828|NCT03464097|617488044|FG000|Overall Study|Adverse Event|13|||
170857829|NCT03464097|617488045|FG001|Overall Study|Adverse Event|6|||
170857830|NCT03464097|617488046|FG002|Overall Study|Adverse Event|8|||
170857831|NCT05572021|617488049|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
170857832|NCT05572021|617488050|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
170857833|NCT04134845|617488051|FG000|Overall Study|withdrawl by PI|12|||
170857834|NCT04134845|617488052|FG001|Overall Study|withdrawl by PI|5|||
170857835|NCT03440320|617490482|FG000|Overall Study|Withdrawal by Subject|0|||
170857836|NCT03440320|617490483|FG001|Overall Study|Withdrawal by Subject|1|||
170857837|NCT02401867|617490484|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
170857838|NCT02401867|617490484|FG000|Analysis|Cervical assay could not be conducted|9|||
170857839|NCT02795429|617490485|FG000|Overall Study|Adverse Event|1|||
170857840|NCT02795429|617490486|FG001|Overall Study|Adverse Event|2|||
170857841|NCT02795429|617490487|FG002|Overall Study|Adverse Event|1|||
170857842|NCT02795429|617490488|FG003|Overall Study|Adverse Event|2|||
170857843|NCT02795429|617490489|FG004|Overall Study|Adverse Event|1|||
170857844|NCT02795429|617490485|FG000|Overall Study|Death|1|||
170857845|NCT02795429|617490486|FG001|Overall Study|Death|0|||
170857846|NCT02795429|617490487|FG002|Overall Study|Death|1|||
170857847|NCT02795429|617490488|FG003|Overall Study|Death|2|||
170857848|NCT02795429|617490489|FG004|Overall Study|Death|1|||
170857849|NCT02795429|617490485|FG000|Overall Study|Physician Decision|0|||
170857850|NCT02795429|617490486|FG001|Overall Study|Physician Decision|0|||
170857851|NCT02795429|617490487|FG002|Overall Study|Physician Decision|2|||
170857852|NCT02795429|617490488|FG003|Overall Study|Physician Decision|1|||
170857853|NCT02795429|617490489|FG004|Overall Study|Physician Decision|5|||
170857854|NCT02795429|617490485|FG000|Overall Study|Progressive disease|3|||
170857855|NCT02795429|617490486|FG001|Overall Study|Progressive disease|7|||
170857856|NCT02795429|617490487|FG002|Overall Study|Progressive disease|6|||
170857857|NCT02795429|617490488|FG003|Overall Study|Progressive disease|26|||
170857858|NCT02795429|617490489|FG004|Overall Study|Progressive disease|20|||
170857859|NCT02795429|617490485|FG000|Overall Study|Subject/guardian decision|1|||
170857860|NCT02795429|617490486|FG001|Overall Study|Subject/guardian decision|1|||
170857861|NCT02795429|617490487|FG002|Overall Study|Subject/guardian decision|1|||
170857862|NCT02795429|617490488|FG003|Overall Study|Subject/guardian decision|1|||
170857863|NCT02795429|617490489|FG004|Overall Study|Subject/guardian decision|3|||
170857864|NCT04363801|617490495|FG000|Overall Study|Death|18|||
170857865|NCT04363801|617490496|FG001|Overall Study|Death|14|||
170857866|NCT04363801|617490497|FG002|Overall Study|Death|16|||
170857867|NCT04363801|617490498|FG003|Overall Study|Death|48|||
170857868|NCT04363801|617490499|FG004|Overall Study|Death|38|||
170857869|NCT04363801|617490495|FG000|Overall Study|Withdrawal by Subject|1|||
170857870|NCT04363801|617490496|FG001|Overall Study|Withdrawal by Subject|6|||
170857871|NCT04363801|617490497|FG002|Overall Study|Withdrawal by Subject|1|||
170857872|NCT04363801|617490498|FG003|Overall Study|Withdrawal by Subject|4|||
170857873|NCT04363801|617490499|FG004|Overall Study|Withdrawal by Subject|14|||
170857874|NCT04363801|617490495|FG000|Overall Study|Sponsor Decision|6|||
170857875|NCT04363801|617490496|FG001|Overall Study|Sponsor Decision|4|||
170857876|NCT04363801|617490497|FG002|Overall Study|Sponsor Decision|10|||
170857877|NCT04363801|617490498|FG003|Overall Study|Sponsor Decision|33|||
170857878|NCT04363801|617490499|FG004|Overall Study|Sponsor Decision|32|||
170857879|NCT04363801|617490495|FG000|Overall Study|Lost to Follow-up|0|||
170857880|NCT04363801|617490496|FG001|Overall Study|Lost to Follow-up|0|||
170857881|NCT04363801|617490497|FG002|Overall Study|Lost to Follow-up|1|||
170857882|NCT04363801|617490498|FG003|Overall Study|Lost to Follow-up|0|||
170857883|NCT04363801|617490499|FG004|Overall Study|Lost to Follow-up|1|||
170857884|NCT01901341|617490500|FG000|Overall Study|Adverse Event|4|||
170857885|NCT01901341|617490501|FG001|Overall Study|Adverse Event|2|||
170857886|NCT01901341|617490500|FG000|Overall Study|Lack of Efficacy|0|||
170857887|NCT01901341|617490501|FG001|Overall Study|Lack of Efficacy|2|||
170857888|NCT01901341|617490500|FG000|Overall Study|Lost to Follow-up|0|||
170857889|NCT01901341|617490501|FG001|Overall Study|Lost to Follow-up|1|||
170857890|NCT01901341|617490500|FG000|Overall Study|Protocol Violation|2|||
170857891|NCT01901341|617490501|FG001|Overall Study|Protocol Violation|0|||
170857892|NCT01901341|617490500|FG000|Overall Study|Study Terminated by Sponsor|13|||
170857893|NCT01901341|617490501|FG001|Overall Study|Study Terminated by Sponsor|15|||
170857894|NCT01901341|617490500|FG000|Overall Study|Withdrawal by Subject|1|||
170857895|NCT01901341|617490501|FG001|Overall Study|Withdrawal by Subject|1|||
170857896|NCT01981473|617490502|FG000|Overall Study|Incorrect diagnosis of RA|0|||
170857897|NCT01981473|617490503|FG001|Overall Study|Incorrect diagnosis of RA|0|||
170857898|NCT01981473|617490504|FG002|Overall Study|Incorrect diagnosis of RA|1|||
170857899|NCT01981473|617490502|FG000|Overall Study|Received treatment for < 6 months|0|||
170857900|NCT01981473|617490503|FG001|Overall Study|Received treatment for < 6 months|0|||
170857901|NCT01981473|617490504|FG002|Overall Study|Received treatment for < 6 months|1|||
170857902|NCT01981473|617490502|FG000|Overall Study|Received treatment for >24 months|2|||
170857903|NCT01981473|617490503|FG001|Overall Study|Received treatment for >24 months|0|||
170857904|NCT01981473|617490504|FG002|Overall Study|Received treatment for >24 months|6|||
170857905|NCT04335812|617490505|FG000|Overall Study|Withdrawal by Subject|1|||
170857906|NCT04335812|617490506|FG001|Overall Study|Withdrawal by Subject|3|||
170857907|NCT04335812|617490505|FG000|Overall Study|Lost to Follow-up|12|||
170857908|NCT04335812|617490506|FG001|Overall Study|Lost to Follow-up|12|||
170857909|NCT04335812|617490505|FG000|Overall Study|Did not engage in the intervention|22|||
170857910|NCT04335812|617490506|FG001|Overall Study|Did not engage in the intervention|18|||
170857911|NCT00757588|617490507|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
170857912|NCT00757588|617490508|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
170857913|NCT00757588|617490507|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
170857914|NCT00757588|617490508|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
170857915|NCT00757588|617490507|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
170857916|NCT00757588|617490508|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
170857917|NCT00757588|617490507|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
170857918|NCT00757588|617490508|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
170857919|NCT00757588|617490507|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
170857920|NCT00757588|617490508|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
170857921|NCT00757588|617490507|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
170857922|NCT00757588|617490508|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
170857923|NCT00757588|617490507|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
170857924|NCT00757588|617490508|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
170857925|NCT00757588|617490507|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
170857926|NCT00757588|617490508|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
170857927|NCT00757588|617490507|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
170857928|NCT00757588|617490508|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
170857929|NCT00757588|617490507|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
170857930|NCT00757588|617490508|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
170857931|NCT00757588|617490507|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
170857932|NCT00757588|617490508|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
170857933|NCT00757588|617490507|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
170857934|NCT00757588|617490508|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
170857935|NCT00757588|617490507|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
170857936|NCT00757588|617490508|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
170857937|NCT00757588|617490507|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
170857938|NCT00757588|617490508|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
170857939|NCT00757588|617490507|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
170857940|NCT00757588|617490508|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
170857941|NCT00757588|617490507|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
170744020|NCT00439179|617070120|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
170744021|NCT00439179|617070121|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
170744022|NCT00439179|617070122|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
170744023|NCT00439179|617070123|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
170744024|NCT02761629|617070124|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
170744025|NCT02761629|617070125|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
170744026|NCT02761629|617070124|FG000|Overall Study|Insufficient Therapeutic Response|2|||
170744027|NCT02761629|617070125|FG001|Overall Study|Insufficient Therapeutic Response|7|||
170744028|NCT02761629|617070124|FG000|Overall Study|Failure to Return|2|||
170744029|NCT02761629|617070125|FG001|Overall Study|Failure to Return|4|||
170744030|NCT02761629|617070124|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
170744031|NCT02761629|617070125|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
170744032|NCT02761629|617070124|FG000|Overall Study|Protocol Violation|2|||
170744033|NCT02761629|617070125|FG001|Overall Study|Protocol Violation|2|||
170744034|NCT02761629|617070124|FG000|Overall Study|Withdrawal by Subject|0|||
170744035|NCT02761629|617070125|FG001|Overall Study|Withdrawal by Subject|3|||
170744036|NCT02761629|617070124|FG000|Overall Study|Other|0|||
170744037|NCT02761629|617070125|FG001|Overall Study|Other|2|||
170744038|NCT02761629|617070124|FG000|Overall Study|Lost to Follow-up|4|||
170744039|NCT02761629|617070125|FG001|Overall Study|Lost to Follow-up|1|||
170744040|NCT02761629|617070124|FG000|Overall Study|Randomized But Not Treated|8|||
170744041|NCT02761629|617070125|FG001|Overall Study|Randomized But Not Treated|4|||
170744042|NCT01830881|617070129|FG000|Overall Study|Changed decision to have an abortion|0|||
170744043|NCT01830881|617070130|FG001|Overall Study|Changed decision to have an abortion|1|||
170744044|NCT03856996|617070131|FG000|Overall Study|Withdrawal by Subject|1|||
170744045|NCT03856996|617070132|FG001|Overall Study|Withdrawal by Subject|0|||
170744046|NCT03856996|617070131|FG000|Overall Study|Lost to Follow-up|0|||
170744047|NCT03856996|617070132|FG001|Overall Study|Lost to Follow-up|1|||
170744048|NCT03856996|617070131|FG000|Overall Study|Adverse Event|1|||
170744049|NCT03856996|617070132|FG001|Overall Study|Adverse Event|1|||
170744050|NCT03856996|617070131|FG000|Overall Study|Other|1|||
170744051|NCT03856996|617070132|FG001|Overall Study|Other|0|||
170744052|NCT00680056|617070150|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
170857942|NCT00757588|617490508|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
170857943|NCT02563522|617490509|FG000|Overall Study|Adverse Event|2|||
170857944|NCT02563522|617490510|FG001|Overall Study|Adverse Event|3|||
170857945|NCT02563522|617490509|FG000|Overall Study|Lost to Follow-up|1|||
170857946|NCT02563522|617490510|FG001|Overall Study|Lost to Follow-up|0|||
170857947|NCT02563522|617490509|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
170857948|NCT02563522|617490510|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
170857949|NCT01480674|617490511|FG000|Overall Study|Death|23|||
170857950|NCT01480674|617490511|FG000|Overall Study|Lost to Follow-up|2|||
170857951|NCT01480674|617490511|FG000|Overall Study|visit not done|10|||
170857952|NCT05754333|617490512|FG000|Overall Study|Miscellaneous|3|||
170857953|NCT05754333|617490513|FG001|Overall Study|Miscellaneous|0|||
170857954|NCT05754333|617490514|FG002|Overall Study|Miscellaneous|0|||
170857955|NCT05754333|617490515|FG003|Overall Study|Miscellaneous|0|||
170857956|NCT05754333|617490512|FG000|Overall Study|Lost to Follow-up|2|||
170857957|NCT05754333|617490513|FG001|Overall Study|Lost to Follow-up|1|||
170857958|NCT05754333|617490514|FG002|Overall Study|Lost to Follow-up|0|||
170857959|NCT05754333|617490515|FG003|Overall Study|Lost to Follow-up|1|||
170857960|NCT03864146|617490516|FG000|Overall Study|Lost to Follow-up|14|||
170857961|NCT03864146|617490517|FG001|Overall Study|Lost to Follow-up|23|||
170857962|NCT03864146|617490516|FG000|Overall Study|Withdrawal by Subject|3|||
170857963|NCT03864146|617490517|FG001|Overall Study|Withdrawal by Subject|2|||
170857964|NCT04874415|617490518|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857965|NCT04874415|617490519|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857966|NCT04874415|617490520|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857967|NCT04874415|617490521|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857968|NCT04874415|617490522|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857969|NCT04874415|617490523|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857970|NCT04874415|617490524|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
170857971|NCT04874415|617490525|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857972|NCT04874415|617490526|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
170857973|NCT04874415|617490527|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
170857974|NCT04874415|617490528|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857975|NCT04874415|617490529|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
170857976|NCT04874415|617490530|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
170857977|NCT04874415|617490531|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
170857978|NCT04874415|617490532|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
170857979|NCT04874415|617490533|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
170857980|NCT04874415|617490518|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
170857981|NCT04874415|617490519|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
170857982|NCT04874415|617490520|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
170857983|NCT04874415|617490521|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
170857984|NCT04874415|617490522|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
170857985|NCT04874415|617490523|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
170857986|NCT04874415|617490524|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
170857987|NCT04874415|617490525|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
170857988|NCT04874415|617490526|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
170857989|NCT04874415|617490527|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
170857990|NCT04874415|617490528|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
170857991|NCT04874415|617490529|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
170857992|NCT04874415|617490530|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
170857993|NCT04874415|617490531|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
170857994|NCT04874415|617490532|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
170857995|NCT04874415|617490533|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
170857996|NCT04874415|617490518|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170857997|NCT04874415|617490519|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170857998|NCT04874415|617490520|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170857999|NCT04874415|617490521|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858000|NCT04874415|617490522|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
170858001|NCT04874415|617490523|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858002|NCT04874415|617490524|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858003|NCT04874415|617490525|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858004|NCT04874415|617490526|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858005|NCT04874415|617490527|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858006|NCT04874415|617490528|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858007|NCT04874415|617490529|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858008|NCT04874415|617490530|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858009|NCT04874415|617490531|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858010|NCT04874415|617490532|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858011|NCT04874415|617490533|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
170858012|NCT04371198|617490534|FG000|Overall Study|inadequate sample|4|||
170858013|NCT00881608|617490535|FG000|Overall Study|Study prematurely terminated|11|||
170858014|NCT00440999|617490536|FG000|Overall Study|Adverse Event|0|||
170858015|NCT00440999|617490537|FG001|Overall Study|Adverse Event|2|||
170858016|NCT00440999|617490536|FG000|Overall Study|Lack of Efficacy|6|||
170858017|NCT00440999|617490537|FG001|Overall Study|Lack of Efficacy|7|||
170858018|NCT00440999|617490536|FG000|Overall Study|Lost to Follow-up|19|||
170858019|NCT00440999|617490537|FG001|Overall Study|Lost to Follow-up|12|||
170858020|NCT00440999|617490536|FG000|Overall Study|Protocol Violation|1|||
170858021|NCT00440999|617490537|FG001|Overall Study|Protocol Violation|0|||
170858022|NCT00440999|617490536|FG000|Overall Study|Withdrawal by Subject|2|||
170858023|NCT00440999|617490537|FG001|Overall Study|Withdrawal by Subject|5|||
170858024|NCT00440999|617490536|FG000|Overall Study|Subjets missed the visit|1|||
170858025|NCT00440999|617490537|FG001|Overall Study|Subjets missed the visit|0|||
170858026|NCT00440999|617490536|FG000|Overall Study|Mixed infection at entry|1|||
170858027|NCT00440999|617490537|FG001|Overall Study|Mixed infection at entry|0|||
170858028|NCT00440999|617490536|FG000|Overall Study|P. falciparum malaria|5|||
170858029|NCT00440999|617490537|FG001|Overall Study|P. falciparum malaria|14|||
170858030|NCT00440999|617490536|FG000|Overall Study|Subj left hosp without inform staff|0|||
170858031|NCT00440999|617490537|FG001|Overall Study|Subj left hosp without inform staff|1|||
170858032|NCT01037244|617490538|FG000|Overall Study|Adverse Event|3|||
170858033|NCT01037244|617490539|FG001|Overall Study|Adverse Event|2|||
170858034|NCT01037244|617490540|FG002|Overall Study|Adverse Event|6|||
170858035|NCT01037244|617490541|FG003|Overall Study|Adverse Event|3|||
170858036|NCT01037244|617490538|FG000|Overall Study|Lack of Efficacy|1|||
170858037|NCT01037244|617490539|FG001|Overall Study|Lack of Efficacy|1|||
170858038|NCT01037244|617490540|FG002|Overall Study|Lack of Efficacy|0|||
170858039|NCT01037244|617490541|FG003|Overall Study|Lack of Efficacy|1|||
170858040|NCT01037244|617490538|FG000|Overall Study|Lost to Follow-up|3|||
170858041|NCT01037244|617490539|FG001|Overall Study|Lost to Follow-up|3|||
170858042|NCT01037244|617490540|FG002|Overall Study|Lost to Follow-up|4|||
170858043|NCT01037244|617490541|FG003|Overall Study|Lost to Follow-up|4|||
170858044|NCT01037244|617490538|FG000|Overall Study|Withdrawal by Subject|1|||
170858045|NCT01037244|617490539|FG001|Overall Study|Withdrawal by Subject|5|||
170858046|NCT01037244|617490540|FG002|Overall Study|Withdrawal by Subject|3|||
170858047|NCT01037244|617490541|FG003|Overall Study|Withdrawal by Subject|5|||
170858048|NCT01037244|617490538|FG000|Overall Study|Partner Withdrew Consent|2|||
170858049|NCT01037244|617490539|FG001|Overall Study|Partner Withdrew Consent|1|||
170858050|NCT01037244|617490540|FG002|Overall Study|Partner Withdrew Consent|0|||
170858051|NCT01037244|617490541|FG003|Overall Study|Partner Withdrew Consent|0|||
170858052|NCT01037244|617490538|FG000|Overall Study|Various|3|||
170858053|NCT01037244|617490539|FG001|Overall Study|Various|2|||
170858054|NCT01037244|617490540|FG002|Overall Study|Various|1|||
170858055|NCT01037244|617490541|FG003|Overall Study|Various|1|||
170858056|NCT01498653|617490544|FG000|Overall Study|Adverse Event|2|||
170858057|NCT01498653|617490545|FG001|Overall Study|Adverse Event|2|||
170858058|NCT01498653|617490544|FG000|Overall Study|Lack of Efficacy|12|||
170858059|NCT01498653|617490545|FG001|Overall Study|Lack of Efficacy|26|||
170858060|NCT01498653|617490544|FG000|Overall Study|Protocol Violation|0|||
170858061|NCT01498653|617490545|FG001|Overall Study|Protocol Violation|4|||
170858062|NCT01498653|617490544|FG000|Overall Study|Lost to Follow-up|1|||
170858063|NCT01498653|617490545|FG001|Overall Study|Lost to Follow-up|0|||
170858064|NCT01498653|617490544|FG000|Overall Study|Physician Decision|2|||
170858065|NCT01498653|617490545|FG001|Overall Study|Physician Decision|0|||
170858066|NCT01498653|617490544|FG000|Overall Study|Withdrawal by Subject|2|||
170858067|NCT01498653|617490545|FG001|Overall Study|Withdrawal by Subject|3|||
170858068|NCT03421431|617490546|FG000|Overall Study|Adverse Event|2|||
170858069|NCT03421431|617490547|FG001|Overall Study|Adverse Event|1|||
170858070|NCT03421431|617490548|FG002|Overall Study|Adverse Event|12|||
170858071|NCT03421431|617490546|FG000|Overall Study|Lost to Follow-up|1|||
170858072|NCT03421431|617490547|FG001|Overall Study|Lost to Follow-up|1|||
170858073|NCT03421431|617490548|FG002|Overall Study|Lost to Follow-up|1|||
170858074|NCT03421431|617490546|FG000|Overall Study|Withdrawal by Subject|3|||
170858075|NCT03421431|617490547|FG001|Overall Study|Withdrawal by Subject|2|||
170858076|NCT03421431|617490548|FG002|Overall Study|Withdrawal by Subject|1|||
170858077|NCT03421431|617490546|FG000|Overall Study|Protocol Violation|0|||
170858078|NCT03421431|617490547|FG001|Overall Study|Protocol Violation|1|||
170858079|NCT03421431|617490548|FG002|Overall Study|Protocol Violation|0|||
170858080|NCT03421431|617490546|FG000|Overall Study|Participant met Stopping Rules|0|||
170858081|NCT03421431|617490547|FG001|Overall Study|Participant met Stopping Rules|1|||
170858082|NCT03421431|617490548|FG002|Overall Study|Participant met Stopping Rules|0|||
170858083|NCT00141726|617490549|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
170858084|NCT01959516|617490554|FG000|Epoch 1|Adverse Event|4|||
170858085|NCT01959516|617490555|FG001|Epoch 1|Adverse Event|1|||
170858086|NCT01959516|617490554|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
170858087|NCT01959516|617490555|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
170858088|NCT01959516|617490554|FG000|Epoch 1|Subject withdrew consent|3|||
170858089|NCT01959516|617490555|FG001|Epoch 1|Subject withdrew consent|2|||
170858090|NCT01959516|617490554|FG000|Epoch 1|Administrative problems|1|||
170858091|NCT01959516|617490555|FG001|Epoch 1|Administrative problems|0|||
170858092|NCT01959516|617490554|FG000|Epoch 1|Use of prohibited treatment|1|||
170858093|NCT01959516|617490555|FG001|Epoch 1|Use of prohibited treatment|0|||
170858094|NCT01959516|617490554|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
170858095|NCT01959516|617490555|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
170858096|NCT01959516|617490554|FG000|Epoch 1|Protocol deviation|0|||
170858097|NCT01959516|617490555|FG001|Epoch 1|Protocol deviation|1|||
170858098|NCT01959516|617490554|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
170858099|NCT01959516|617490555|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
170858100|NCT01959516|617490554|FG000|Epoch 2|Subject withdrew consent|1|||
170858101|NCT01959516|617490555|FG001|Epoch 2|Subject withdrew consent|0|||
170858102|NCT01959516|617490554|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
170858103|NCT01959516|617490555|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
170858104|NCT01477333|617490557|FG000|Overall Study|Adverse Event|1|||
170858105|NCT01477333|617490557|FG000|Overall Study|Withdrawal by Subject|1|||
170858106|NCT01477333|617490557|FG000|Overall Study|Clinical Deterioration|1|||
170858107|NCT01178671|617490558|FG000|Overall Study|Adverse Event|4|||
170858108|NCT01178671|617490559|FG001|Overall Study|Adverse Event|6|||
170858109|NCT01178671|617490558|FG000|Overall Study|Protocol Violation|1|||
170858110|NCT01178671|617490559|FG001|Overall Study|Protocol Violation|1|||
170858111|NCT01178671|617490558|FG000|Overall Study|Lack of Efficacy|0|||
170858112|NCT01178671|617490559|FG001|Overall Study|Lack of Efficacy|1|||
170858113|NCT01178671|617490558|FG000|Overall Study|Lost to Follow-up|3|||
170858114|NCT01178671|617490559|FG001|Overall Study|Lost to Follow-up|1|||
170858115|NCT01178671|617490558|FG000|Overall Study|Physician Decision|4|||
170858116|NCT01178671|617490559|FG001|Overall Study|Physician Decision|6|||
170858117|NCT04620811|617490560|FG000|Overall Study|Withdrawal by Subject|18|||
170858118|NCT04620811|617490561|FG001|Overall Study|Withdrawal by Subject|15|||
170858119|NCT04620811|617490560|FG000|Overall Study|Adverse Event|6|||
170858120|NCT04620811|617490561|FG001|Overall Study|Adverse Event|11|||
170858121|NCT04620811|617490560|FG000|Overall Study|Lost to Follow-up|4|||
170858122|NCT04620811|617490561|FG001|Overall Study|Lost to Follow-up|8|||
170858123|NCT04620811|617490560|FG000|Overall Study|Physician Decision|1|||
170858124|NCT04620811|617490561|FG001|Overall Study|Physician Decision|4|||
170858125|NCT04620811|617490560|FG000|Overall Study|Sponsor Decision|0|||
170858126|NCT04620811|617490561|FG001|Overall Study|Sponsor Decision|1|||
170858127|NCT04620811|617490560|FG000|Overall Study|Elevation of ALT or AST|1|||
170858128|NCT04620811|617490561|FG001|Overall Study|Elevation of ALT or AST|0|||
170858129|NCT04620811|617490560|FG000|Overall Study|Other|3|||
170858130|NCT04620811|617490561|FG001|Overall Study|Other|5|||
170858131|NCT01078675|617490563|FG000|Overall Study|Withdrawal by Subject|7|||
170858132|NCT01078675|617490564|FG001|Overall Study|Withdrawal by Subject|3|||
170858133|NCT01078675|617490563|FG000|Overall Study|Protocol Violation|56|||
170858134|NCT01078675|617490564|FG001|Overall Study|Protocol Violation|0|||
170858135|NCT01078675|617490563|FG000|Overall Study|Provided in CRF for specific reasons|2|||
170858136|NCT01078675|617490564|FG001|Overall Study|Provided in CRF for specific reasons|3|||
170858137|NCT01078675|617490563|FG000|Overall Study|Adverse Event|3|||
170858138|NCT01078675|617490564|FG001|Overall Study|Adverse Event|0|||
170858139|NCT02745392|617490567|FG000|Overall Study|Lost to Follow-up|0|||
170858140|NCT02745392|617490568|FG001|Overall Study|Lost to Follow-up|1|||
170858141|NCT02745392|617490569|FG002|Overall Study|Lost to Follow-up|0|||
170858142|NCT02745392|617490570|FG003|Overall Study|Lost to Follow-up|0|||
170858143|NCT00819390|617490574|FG000|Overall Study|Lost to Follow-up|1|||
170858144|NCT00819390|617490575|FG001|Overall Study|Lost to Follow-up|1|||
170858145|NCT00819390|617490576|FG002|Overall Study|Lost to Follow-up|0|||
170858146|NCT00819390|617490577|FG003|Overall Study|Lost to Follow-up|0|||
170858147|NCT00819390|617490574|FG000|Overall Study|Withdrawal by Subject|2|||
170858148|NCT00819390|617490575|FG001|Overall Study|Withdrawal by Subject|0|||
170858149|NCT00819390|617490576|FG002|Overall Study|Withdrawal by Subject|0|||
170858150|NCT00819390|617490577|FG003|Overall Study|Withdrawal by Subject|0|||
170858151|NCT00819390|617490574|FG000|Overall Study|Adverse Event|0|||
170858152|NCT00819390|617490575|FG001|Overall Study|Adverse Event|0|||
170858153|NCT00819390|617490576|FG002|Overall Study|Adverse Event|1|||
170858154|NCT00819390|617490577|FG003|Overall Study|Adverse Event|0|||
170858155|NCT01759368|617490578|FG000|Overall Study|Lost to Follow-up|1|||
170858156|NCT01759368|617490579|FG001|Overall Study|Lost to Follow-up|0|||
170858157|NCT01200589|617490580|FG000|Overall Study|Withdrawal by Subject|13|||
170858158|NCT01200589|617490581|FG001|Overall Study|Withdrawal by Subject|11|||
170858159|NCT01200589|617490580|FG000|Overall Study|Physician Decision|2|||
170858160|NCT01200589|617490581|FG001|Overall Study|Physician Decision|2|||
170858161|NCT01200589|617490580|FG000|Overall Study|Lost to Follow-up|5|||
170858162|NCT01200589|617490581|FG001|Overall Study|Lost to Follow-up|4|||
170858163|NCT01200589|617490580|FG000|Overall Study|Study terminated|170|||
170858164|NCT01200589|617490581|FG001|Overall Study|Study terminated|172|||
170858165|NCT00336895|617490582|FG000|Overall Study|diarrhea|1|||
170858166|NCT00336895|617490582|FG000|Overall Study|nausea and upset stomach|1|||
170858167|NCT00336895|617490582|FG000|Overall Study|Physician Decision|1|||
170858168|NCT00336895|617490582|FG000|Overall Study|screen failed|1|||
170858169|NCT01959334|617490583|FG000|Second Dose|Adverse Event|1|||
170858170|NCT01959334|617490584|FG001|Second Dose|Adverse Event|0|||
170858171|NCT01959334|617490583|FG000|Third Dose|Adverse Event|0|||
170858172|NCT01959334|617490584|FG001|Third Dose|Adverse Event|1|||
170858173|NCT00986973|617490585|FG000|Overall Study|Withdrawn by study team|1|||
170858174|NCT02294227|617490586|FG000|Overall Study|Death|0|||
170858175|NCT02294227|617490587|FG001|Overall Study|Death|0|||
170858176|NCT02294227|617490588|FG002|Overall Study|Death|1|||
170858177|NCT02294227|617490586|FG000|Overall Study|Subject/Guardian Decision|6|||
170858178|NCT02294227|617490587|FG001|Overall Study|Subject/Guardian Decision|3|||
170858179|NCT02294227|617490588|FG002|Overall Study|Subject/Guardian Decision|7|||
170858180|NCT02294227|617490586|FG000|Overall Study|Physician Decision|1|||
170858181|NCT02294227|617490587|FG001|Overall Study|Physician Decision|2|||
170858182|NCT02294227|617490588|FG002|Overall Study|Physician Decision|1|||
170858183|NCT02294227|617490586|FG000|Overall Study|Lost to Follow-up|1|||
170858184|NCT02294227|617490587|FG001|Overall Study|Lost to Follow-up|0|||
170858185|NCT02294227|617490588|FG002|Overall Study|Lost to Follow-up|0|||
170858186|NCT02294227|617490586|FG000|Overall Study|Lack of Efficacy|11|||
170858187|NCT02294227|617490587|FG001|Overall Study|Lack of Efficacy|12|||
170858188|NCT02294227|617490588|FG002|Overall Study|Lack of Efficacy|8|||
170858189|NCT02294227|617490586|FG000|Overall Study|Adverse Event|6|||
170858190|NCT02294227|617490587|FG001|Overall Study|Adverse Event|8|||
170858191|NCT02294227|617490588|FG002|Overall Study|Adverse Event|2|||
170858192|NCT01337115|617490590|FG000|Overall Study|Protocol Violation|2|||
170858193|NCT01337115|617490591|FG001|Overall Study|Protocol Violation|0|||
170858194|NCT00551460|617490592|FG000|Overall Study|Adverse Event|1|||
170858195|NCT00551460|617490592|FG000|Overall Study|Withdrawal by Subject|1|||
170858196|NCT00551460|617490592|FG000|Overall Study|Physician Decision|1|||
170858197|NCT00551460|617490592|FG000|Overall Study|Death|7|||
170858198|NCT00551460|617490592|FG000|Overall Study|Ineligible|4|||
170858199|NCT00551460|617490592|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
170858200|NCT03801915|617490593|FG000|Overall Study|Screen failure|0|||
170858201|NCT03801915|617490594|FG001|Overall Study|Screen failure|0|||
170858202|NCT03801915|617490595|FG002|Overall Study|Screen failure|1|||
170858203|NCT03801915|617490593|FG000|Overall Study|Ineligible|1|||
170858204|NCT03801915|617490594|FG001|Overall Study|Ineligible|0|||
170858205|NCT03801915|617490595|FG002|Overall Study|Ineligible|0|||
170858206|NCT03801915|617490593|FG000|Overall Study|Physician Decision|2|||
170858207|NCT03801915|617490594|FG001|Overall Study|Physician Decision|1|||
170858208|NCT03801915|617490595|FG002|Overall Study|Physician Decision|0|||
170858209|NCT00818649|617490598|FG000|Overall Study|Declining performance status|2|||
170858210|NCT00818649|617490598|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
170858211|NCT00818649|617490598|FG000|Overall Study|Adverse Event|1|||
170858212|NCT03333837|617490608|FG000|Overall Study|Adverse Event|2|||
170858213|NCT03333837|617490609|FG001|Overall Study|Adverse Event|1|||
170858214|NCT03333837|617490610|FG002|Overall Study|Adverse Event|1|||
170858215|NCT03333837|617490611|FG003|Overall Study|Adverse Event|1|||
170858216|NCT03333837|617490612|FG004|Overall Study|Adverse Event|0|||
170858217|NCT03333837|617490608|FG000|Overall Study|Caregiver withdrew|0|||
170858218|NCT03333837|617490609|FG001|Overall Study|Caregiver withdrew|2|||
170858219|NCT03333837|617490610|FG002|Overall Study|Caregiver withdrew|1|||
170858220|NCT03333837|617490611|FG003|Overall Study|Caregiver withdrew|0|||
170858221|NCT03333837|617490612|FG004|Overall Study|Caregiver withdrew|0|||
170858222|NCT03333837|617490608|FG000|Overall Study|Withdrawal by Subject|0|||
170858223|NCT03333837|617490609|FG001|Overall Study|Withdrawal by Subject|0|||
170858224|NCT03333837|617490610|FG002|Overall Study|Withdrawal by Subject|1|||
170858225|NCT03333837|617490611|FG003|Overall Study|Withdrawal by Subject|1|||
170858226|NCT03333837|617490612|FG004|Overall Study|Withdrawal by Subject|3|||
170858227|NCT03333837|617490608|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
170858228|NCT03333837|617490609|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
170858229|NCT03333837|617490610|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
170858230|NCT03333837|617490611|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
170858231|NCT03333837|617490612|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
170858232|NCT01551212|617490613|FG000|Overall Study|Graft loss/Retransplantation|0|||
170858233|NCT01551212|617490614|FG001|Overall Study|Graft loss/Retransplantation|1|||
170858234|NCT01551212|617490613|FG000|Overall Study|Administrative problems|1|||
170858235|NCT01551212|617490614|FG001|Overall Study|Administrative problems|2|||
170858236|NCT01551212|617490613|FG000|Overall Study|Lost to Follow-up|0|||
170858237|NCT01551212|617490614|FG001|Overall Study|Lost to Follow-up|1|||
170858238|NCT01551212|617490613|FG000|Overall Study|Protocol Violation|0|||
170858239|NCT01551212|617490614|FG001|Overall Study|Protocol Violation|1|||
170858240|NCT01551212|617490613|FG000|Overall Study|Withdrawal by Subject|0|||
170858241|NCT01551212|617490614|FG001|Overall Study|Withdrawal by Subject|7|||
170858242|NCT01551212|617490613|FG000|Overall Study|Death|2|||
170858243|NCT01551212|617490614|FG001|Overall Study|Death|4|||
170858244|NCT01551212|617490613|FG000|Overall Study|Never Received Study Treatment|2|||
170858245|NCT01551212|617490614|FG001|Overall Study|Never Received Study Treatment|4|||
170858246|NCT02232243|617490617|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
170858247|NCT02232243|617490618|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
170858248|NCT02232243|617490619|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
170858249|NCT00600886|617490620|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
170858250|NCT00600886|617490621|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
170858251|NCT00600886|617490620|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
170858252|NCT00600886|617490621|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
170858253|NCT00600886|617490620|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
170858254|NCT00600886|617490621|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
170858255|NCT00600886|617490620|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
170858256|NCT00600886|617490621|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
170858257|NCT00600886|617490620|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
170858258|NCT00600886|617490621|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
170858259|NCT00600886|617490620|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
170858260|NCT00600886|617490621|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
170858261|NCT00600886|617490620|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
170858262|NCT00600886|617490621|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
170858263|NCT00600886|617490620|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
170858264|NCT00600886|617490621|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
170858265|NCT00600886|617490620|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
170858266|NCT00600886|617490621|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
170858267|NCT00600886|617490620|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
170858268|NCT00600886|617490621|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
170858269|NCT00600886|617490620|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
170858270|NCT00600886|617490621|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
170858271|NCT00600886|617490620|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
170858272|NCT00600886|617490621|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
170858273|NCT00600886|617490620|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
170858274|NCT00600886|617490621|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
170858275|NCT00600886|617490620|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
170858276|NCT00600886|617490621|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
170858277|NCT00600886|617490620|FG000|Extension - Same Treatment (FAS)|Death|1|||
170858278|NCT00600886|617490621|FG001|Extension - Same Treatment (FAS)|Death|1|||
170858279|NCT00600886|617490620|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
170858280|NCT00600886|617490621|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
170858281|NCT00600886|617490620|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
170858282|NCT00600886|617490621|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
170858283|NCT00600886|617490620|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
170858284|NCT00600886|617490621|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
170858285|NCT00600886|617490620|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
170858286|NCT00600886|617490621|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
170858287|NCT00600886|617490620|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
170858288|NCT00600886|617490621|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
170858289|NCT00600886|617490620|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
170858290|NCT00600886|617490621|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
170858291|NCT00600886|617490620|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
170858292|NCT00600886|617490621|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
170858293|NCT00600886|617490620|FG000|Extension - After Crossover (CAS)|Death|1|||
170858294|NCT00600886|617490621|FG001|Extension - After Crossover (CAS)|Death|0|||
170858295|NCT03075410|617490622|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
170858296|NCT03075410|617490623|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
170858297|NCT03075410|617490624|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
170858298|NCT03075410|617490625|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
170858299|NCT03075410|617490626|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
170858300|NCT03075410|617490627|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
170858301|NCT03075410|617490628|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
170858302|NCT03075410|617490629|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
170858303|NCT03075410|617490630|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
170858304|NCT03075410|617490622|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
170858305|NCT03075410|617490623|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
170858306|NCT03075410|617490624|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
170858307|NCT03075410|617490625|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
170858308|NCT03075410|617490626|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
170858309|NCT03075410|617490627|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
170858310|NCT03075410|617490628|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
170858311|NCT03075410|617490629|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
170858312|NCT03075410|617490630|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
170858313|NCT02053792|617490631|FG000|Overall Study|Physician Decision|0|||
170858314|NCT02053792|617490632|FG001|Overall Study|Physician Decision|1|||
170858315|NCT02053792|617490631|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
170858316|NCT02053792|617490632|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
170858317|NCT02053792|617490631|FG000|Overall Study|Lack of Efficacy|1|||
170858318|NCT02053792|617490632|FG001|Overall Study|Lack of Efficacy|0|||
170858319|NCT02053792|617490631|FG000|Overall Study|Adverse Event|1|||
170858320|NCT02053792|617490632|FG001|Overall Study|Adverse Event|0|||
170858321|NCT02053792|617490631|FG000|Overall Study|Withdrawal by Subject|2|||
170858322|NCT02053792|617490632|FG001|Overall Study|Withdrawal by Subject|2|||
170858323|NCT02053792|617490631|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
170858324|NCT02053792|617490632|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
170858325|NCT02053792|617490631|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
170858326|NCT02053792|617490632|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
170858327|NCT00790751|617490633|FG000|Overall Study|Protocol non-compliance|16|||
170858328|NCT00790751|617490634|FG001|Overall Study|Protocol non-compliance|16|||
170858329|NCT00790751|617490635|FG002|Overall Study|Protocol non-compliance|10|||
170858330|NCT00790751|617490636|FG003|Overall Study|Protocol non-compliance|11|||
170858331|NCT00790751|617490633|FG000|Overall Study|Lost to Follow-up|4|||
170858332|NCT00790751|617490634|FG001|Overall Study|Lost to Follow-up|9|||
170858333|NCT00790751|617490635|FG002|Overall Study|Lost to Follow-up|4|||
170858334|NCT00790751|617490636|FG003|Overall Study|Lost to Follow-up|5|||
170858335|NCT00790751|617490633|FG000|Overall Study|Adverse Event|5|||
170858336|NCT00790751|617490634|FG001|Overall Study|Adverse Event|3|||
170858337|NCT00790751|617490635|FG002|Overall Study|Adverse Event|5|||
170858338|NCT00790751|617490636|FG003|Overall Study|Adverse Event|4|||
170858339|NCT00790751|617490633|FG000|Overall Study|Requirement for restricted medication|0|||
170858340|NCT00790751|617490634|FG001|Overall Study|Requirement for restricted medication|2|||
170858341|NCT00790751|617490635|FG002|Overall Study|Requirement for restricted medication|0|||
170858342|NCT00790751|617490636|FG003|Overall Study|Requirement for restricted medication|0|||
170858343|NCT00790751|617490633|FG000|Overall Study|Death|0|||
170858344|NCT00790751|617490634|FG001|Overall Study|Death|0|||
170858345|NCT00790751|617490635|FG002|Overall Study|Death|1|||
170858346|NCT00790751|617490636|FG003|Overall Study|Death|0|||
170858347|NCT00790751|617490633|FG000|Overall Study|Physician Decision|0|||
170858348|NCT00790751|617490634|FG001|Overall Study|Physician Decision|0|||
170858349|NCT00790751|617490635|FG002|Overall Study|Physician Decision|0|||
170858350|NCT00790751|617490636|FG003|Overall Study|Physician Decision|1|||
170858351|NCT00585195|617490637|FG000|Overall Study|Adverse Event|0|||
170858352|NCT00585195|617490638|FG001|Overall Study|Adverse Event|0|||
170858353|NCT00585195|617490639|FG002|Overall Study|Adverse Event|0|||
170858354|NCT00585195|617490640|FG003|Overall Study|Adverse Event|0|||
170858355|NCT00585195|617490641|FG004|Overall Study|Adverse Event|2|||
170858356|NCT00585195|617490642|FG005|Overall Study|Adverse Event|1|||
170858357|NCT00585195|617490643|FG006|Overall Study|Adverse Event|0|||
170858358|NCT00585195|617490644|FG007|Overall Study|Adverse Event|1|||
170858359|NCT00585195|617490645|FG008|Overall Study|Adverse Event|0|||
170858360|NCT00585195|617490646|FG009|Overall Study|Adverse Event|0|||
170858361|NCT00585195|617490647|FG010|Overall Study|Adverse Event|3|||
170858362|NCT00585195|617490648|FG011|Overall Study|Adverse Event|0|||
170858363|NCT00585195|617490649|FG012|Overall Study|Adverse Event|8|||
170858364|NCT00585195|617490650|FG013|Overall Study|Adverse Event|6|||
170858365|NCT00585195|617490651|FG014|Overall Study|Adverse Event|4|||
170858366|NCT00585195|617490652|FG015|Overall Study|Adverse Event|1|||
170858367|NCT00585195|617490653|FG016|Overall Study|Adverse Event|14|||
170858368|NCT00585195|617490654|FG017|Overall Study|Adverse Event|9|||
170858369|NCT00585195|617490655|FG018|Overall Study|Adverse Event|2|||
170858370|NCT00585195|617490656|FG019|Overall Study|Adverse Event|3|||
170858371|NCT00585195|617490657|FG020|Overall Study|Adverse Event|1|||
170858372|NCT00585195|617490637|FG000|Overall Study|Progressive Disease|2|||
170858373|NCT00585195|617490638|FG001|Overall Study|Progressive Disease|2|||
170858374|NCT00585195|617490639|FG002|Overall Study|Progressive Disease|5|||
170858375|NCT00585195|617490640|FG003|Overall Study|Progressive Disease|4|||
170858376|NCT00585195|617490641|FG004|Overall Study|Progressive Disease|6|||
170858377|NCT00585195|617490642|FG005|Overall Study|Progressive Disease|4|||
170858378|NCT00585195|617490643|FG006|Overall Study|Progressive Disease|6|||
170858379|NCT00585195|617490644|FG007|Overall Study|Progressive Disease|3|||
170858380|NCT00585195|617490645|FG008|Overall Study|Progressive Disease|0|||
170858381|NCT00585195|617490646|FG009|Overall Study|Progressive Disease|5|||
170858382|NCT00585195|617490647|FG010|Overall Study|Progressive Disease|2|||
170858383|NCT00585195|617490648|FG011|Overall Study|Progressive Disease|25|||
170858384|NCT00585195|617490649|FG012|Overall Study|Progressive Disease|29|||
170858385|NCT00585195|617490650|FG013|Overall Study|Progressive Disease|26|||
170858386|NCT00585195|617490651|FG014|Overall Study|Progressive Disease|21|||
170858387|NCT00585195|617490652|FG015|Overall Study|Progressive Disease|12|||
170858388|NCT00585195|617490653|FG016|Overall Study|Progressive Disease|94|||
170858389|NCT00585195|617490654|FG017|Overall Study|Progressive Disease|42|||
170858390|NCT00585195|617490655|FG018|Overall Study|Progressive Disease|4|||
170858391|NCT00585195|617490656|FG019|Overall Study|Progressive Disease|9|||
170858392|NCT00585195|617490657|FG020|Overall Study|Progressive Disease|8|||
170858393|NCT00585195|617490637|FG000|Overall Study|Withdrawal by Subject|1|||
170858394|NCT00585195|617490638|FG001|Overall Study|Withdrawal by Subject|1|||
170858395|NCT00585195|617490639|FG002|Overall Study|Withdrawal by Subject|2|||
170858396|NCT00585195|617490640|FG003|Overall Study|Withdrawal by Subject|2|||
170858397|NCT00585195|617490641|FG004|Overall Study|Withdrawal by Subject|0|||
170858398|NCT00585195|617490642|FG005|Overall Study|Withdrawal by Subject|0|||
170858399|NCT00585195|617490643|FG006|Overall Study|Withdrawal by Subject|0|||
170858400|NCT00585195|617490644|FG007|Overall Study|Withdrawal by Subject|1|||
170858401|NCT00585195|617490645|FG008|Overall Study|Withdrawal by Subject|0|||
170858402|NCT00585195|617490646|FG009|Overall Study|Withdrawal by Subject|0|||
170858403|NCT00585195|617490647|FG010|Overall Study|Withdrawal by Subject|3|||
170858404|NCT00585195|617490648|FG011|Overall Study|Withdrawal by Subject|8|||
170858405|NCT00585195|617490649|FG012|Overall Study|Withdrawal by Subject|15|||
170858406|NCT00585195|617490650|FG013|Overall Study|Withdrawal by Subject|0|||
170858407|NCT00585195|617490651|FG014|Overall Study|Withdrawal by Subject|3|||
170858408|NCT00585195|617490652|FG015|Overall Study|Withdrawal by Subject|0|||
170858409|NCT00585195|617490653|FG016|Overall Study|Withdrawal by Subject|7|||
170858410|NCT00585195|617490654|FG017|Overall Study|Withdrawal by Subject|1|||
170858411|NCT00585195|617490655|FG018|Overall Study|Withdrawal by Subject|2|||
170858412|NCT00585195|617490656|FG019|Overall Study|Withdrawal by Subject|2|||
170858413|NCT00585195|617490657|FG020|Overall Study|Withdrawal by Subject|0|||
170858414|NCT00585195|617490637|FG000|Overall Study|Other|0|||
170858415|NCT00585195|617490638|FG001|Overall Study|Other|1|||
170858416|NCT00585195|617490639|FG002|Overall Study|Other|1|||
170858417|NCT00585195|617490640|FG003|Overall Study|Other|1|||
170858418|NCT00585195|617490641|FG004|Overall Study|Other|0|||
170858419|NCT00585195|617490642|FG005|Overall Study|Other|1|||
170858420|NCT00585195|617490643|FG006|Overall Study|Other|0|||
170858421|NCT00585195|617490644|FG007|Overall Study|Other|0|||
170858422|NCT00585195|617490645|FG008|Overall Study|Other|2|||
170858423|NCT00585195|617490646|FG009|Overall Study|Other|1|||
170858424|NCT00585195|617490647|FG010|Overall Study|Other|0|||
170858425|NCT00585195|617490648|FG011|Overall Study|Other|19|||
170858426|NCT00585195|617490649|FG012|Overall Study|Other|24|||
170858427|NCT00585195|617490650|FG013|Overall Study|Other|7|||
170858428|NCT00585195|617490651|FG014|Overall Study|Other|11|||
170858429|NCT00585195|617490652|FG015|Overall Study|Other|3|||
170858430|NCT00585195|617490653|FG016|Overall Study|Other|28|||
170858431|NCT00585195|617490654|FG017|Overall Study|Other|12|||
170858432|NCT00585195|617490655|FG018|Overall Study|Other|10|||
170858433|NCT00585195|617490656|FG019|Overall Study|Other|4|||
170858434|NCT00585195|617490657|FG020|Overall Study|Other|2|||
170858435|NCT00585195|617490637|FG000|Overall Study|Randomized not treated|0|||
170858436|NCT00585195|617490638|FG001|Overall Study|Randomized not treated|0|||
170858437|NCT00585195|617490639|FG002|Overall Study|Randomized not treated|1|||
170858438|NCT00585195|617490640|FG003|Overall Study|Randomized not treated|0|||
170858439|NCT00585195|617490641|FG004|Overall Study|Randomized not treated|1|||
170858440|NCT00585195|617490642|FG005|Overall Study|Randomized not treated|0|||
170858441|NCT00585195|617490643|FG006|Overall Study|Randomized not treated|1|||
170858442|NCT00585195|617490644|FG007|Overall Study|Randomized not treated|0|||
170858443|NCT00585195|617490645|FG008|Overall Study|Randomized not treated|0|||
170858444|NCT00585195|617490646|FG009|Overall Study|Randomized not treated|0|||
170858445|NCT00585195|617490647|FG010|Overall Study|Randomized not treated|2|||
170858446|NCT00585195|617490648|FG011|Overall Study|Randomized not treated|0|||
170858447|NCT00585195|617490649|FG012|Overall Study|Randomized not treated|0|||
170858448|NCT00585195|617490650|FG013|Overall Study|Randomized not treated|0|||
170858449|NCT00585195|617490651|FG014|Overall Study|Randomized not treated|0|||
170858450|NCT00585195|617490652|FG015|Overall Study|Randomized not treated|1|||
170858451|NCT00585195|617490653|FG016|Overall Study|Randomized not treated|0|||
170858452|NCT00585195|617490654|FG017|Overall Study|Randomized not treated|1|||
170858453|NCT00585195|617490655|FG018|Overall Study|Randomized not treated|3|||
170858454|NCT00585195|617490656|FG019|Overall Study|Randomized not treated|0|||
170858455|NCT00585195|617490657|FG020|Overall Study|Randomized not treated|2|||
170858456|NCT00585195|617490637|FG000|Overall Study|Death|0|||
170858457|NCT00585195|617490638|FG001|Overall Study|Death|0|||
170858458|NCT00585195|617490639|FG002|Overall Study|Death|0|||
170858459|NCT00585195|617490640|FG003|Overall Study|Death|0|||
170858460|NCT00585195|617490641|FG004|Overall Study|Death|0|||
170858461|NCT00585195|617490642|FG005|Overall Study|Death|0|||
170858462|NCT00585195|617490643|FG006|Overall Study|Death|0|||
170858463|NCT00585195|617490644|FG007|Overall Study|Death|0|||
170858464|NCT00585195|617490645|FG008|Overall Study|Death|1|||
170858465|NCT00585195|617490646|FG009|Overall Study|Death|0|||
170858466|NCT00585195|617490647|FG010|Overall Study|Death|1|||
170858467|NCT00585195|617490648|FG011|Overall Study|Death|1|||
170858468|NCT00585195|617490649|FG012|Overall Study|Death|7|||
170858469|NCT00585195|617490650|FG013|Overall Study|Death|2|||
170858470|NCT00585195|617490651|FG014|Overall Study|Death|8|||
170858471|NCT00585195|617490652|FG015|Overall Study|Death|2|||
170858472|NCT00585195|617490653|FG016|Overall Study|Death|11|||
170858473|NCT00585195|617490654|FG017|Overall Study|Death|0|||
170858474|NCT00585195|617490655|FG018|Overall Study|Death|0|||
170858475|NCT00585195|617490656|FG019|Overall Study|Death|0|||
170858476|NCT00585195|617490657|FG020|Overall Study|Death|1|||
170858477|NCT00585195|617490637|FG000|Overall Study|Lost to Follow-up|0|||
170858478|NCT00585195|617490638|FG001|Overall Study|Lost to Follow-up|0|||
170858479|NCT00585195|617490639|FG002|Overall Study|Lost to Follow-up|0|||
170858480|NCT00585195|617490640|FG003|Overall Study|Lost to Follow-up|0|||
170858481|NCT00585195|617490641|FG004|Overall Study|Lost to Follow-up|0|||
170858482|NCT00585195|617490642|FG005|Overall Study|Lost to Follow-up|0|||
170858483|NCT00585195|617490643|FG006|Overall Study|Lost to Follow-up|0|||
170858484|NCT00585195|617490644|FG007|Overall Study|Lost to Follow-up|0|||
170858485|NCT00585195|617490645|FG008|Overall Study|Lost to Follow-up|0|||
170858486|NCT00585195|617490646|FG009|Overall Study|Lost to Follow-up|0|||
170858487|NCT00585195|617490647|FG010|Overall Study|Lost to Follow-up|0|||
170858488|NCT00585195|617490648|FG011|Overall Study|Lost to Follow-up|0|||
170858489|NCT00585195|617490649|FG012|Overall Study|Lost to Follow-up|1|||
170858490|NCT00585195|617490650|FG013|Overall Study|Lost to Follow-up|0|||
170858491|NCT00585195|617490651|FG014|Overall Study|Lost to Follow-up|0|||
170858492|NCT00585195|617490652|FG015|Overall Study|Lost to Follow-up|0|||
170744053|NCT00680056|617070151|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
170744054|NCT00680056|617070150|FG000|Second Intervention|Protocol Violation|3|||
170744055|NCT00680056|617070151|FG001|Second Intervention|Protocol Violation|1|||
170744056|NCT01821898|617070152|FG000|Overall Study|Withdrawal by Subject|2|||
170744057|NCT01821898|617070153|FG001|Overall Study|Withdrawal by Subject|1|||
170744058|NCT01121484|617070154|FG000|Overall Study|Adverse Event|12|||
170744059|NCT01121484|617070155|FG001|Overall Study|Adverse Event|5|||
170744060|NCT01121484|617070154|FG000|Overall Study|Lack of Efficacy|3|||
170744061|NCT01121484|617070155|FG001|Overall Study|Lack of Efficacy|11|||
170744062|NCT01121484|617070154|FG000|Overall Study|Lost to Follow-up|5|||
170744063|NCT01121484|617070155|FG001|Overall Study|Lost to Follow-up|9|||
170744064|NCT01121484|617070154|FG000|Overall Study|Physician Decision|0|||
170744065|NCT01121484|617070155|FG001|Overall Study|Physician Decision|3|||
170744066|NCT01121484|617070154|FG000|Overall Study|Protocol Violation|1|||
170744067|NCT01121484|617070155|FG001|Overall Study|Protocol Violation|0|||
170744068|NCT01121484|617070154|FG000|Overall Study|Withdrawal by Subject|8|||
170744069|NCT01121484|617070155|FG001|Overall Study|Withdrawal by Subject|7|||
170744070|NCT01121484|617070154|FG000|Overall Study|Discontinuation of study by sponsor|0|||
170744071|NCT01121484|617070155|FG001|Overall Study|Discontinuation of study by sponsor|1|||
170744072|NCT01121484|617070154|FG000|Overall Study|Other|3|||
170744073|NCT01121484|617070155|FG001|Overall Study|Other|3|||
170744074|NCT01121484|617070154|FG000|Overall Study|Randomized, not treated|1|||
170744075|NCT01121484|617070155|FG001|Overall Study|Randomized, not treated|4|||
170744076|NCT06390826|617070156|FG000|Overall Study|Never Start Protocol Therapy|1|||
170744077|NCT06390826|617070156|FG000|Overall Study|Adverse Event|1|||
170744078|NCT06390826|617070156|FG000|Overall Study|Disease Progression|8|||
170744079|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
170744080|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
170744081|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
170744082|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
170744083|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
170744084|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
170744085|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
170744086|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
170744087|NCT01336621|617070157|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
170744088|NCT01336621|617070157|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
170744089|NCT01336621|617070157|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
170744090|NCT01336621|617070157|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
170744091|NCT01336621|617070157|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
170744092|NCT01336621|617070157|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
170744093|NCT01370005|617070158|FG000|Overall Study|Not treated|1|||
170744094|NCT01370005|617070159|FG001|Overall Study|Not treated|0|||
170744095|NCT01370005|617070160|FG002|Overall Study|Not treated|0|||
170744096|NCT01370005|617070158|FG000|Overall Study|Adverse Event|5|||
170744097|NCT01370005|617070159|FG001|Overall Study|Adverse Event|5|||
170744098|NCT01370005|617070160|FG002|Overall Study|Adverse Event|6|||
170744099|NCT01370005|617070158|FG000|Overall Study|Lack of Efficacy|1|||
170744100|NCT01370005|617070159|FG001|Overall Study|Lack of Efficacy|0|||
170744101|NCT01370005|617070160|FG002|Overall Study|Lack of Efficacy|0|||
170744102|NCT01370005|617070158|FG000|Overall Study|Non compliant with protocol|0|||
170744103|NCT01370005|617070159|FG001|Overall Study|Non compliant with protocol|1|||
170744104|NCT01370005|617070160|FG002|Overall Study|Non compliant with protocol|2|||
170744105|NCT01370005|617070158|FG000|Overall Study|Lost to Follow-up|1|||
170744106|NCT01370005|617070159|FG001|Overall Study|Lost to Follow-up|1|||
170744107|NCT01370005|617070160|FG002|Overall Study|Lost to Follow-up|1|||
170744108|NCT01370005|617070158|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
170744109|NCT01370005|617070159|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
170744110|NCT01370005|617070160|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
170744111|NCT01370005|617070158|FG000|Overall Study|Other reason not defined above|3|||
170744112|NCT01370005|617070159|FG001|Overall Study|Other reason not defined above|0|||
170744113|NCT01370005|617070160|FG002|Overall Study|Other reason not defined above|2|||
170744114|NCT02009696|617070161|FG000|Overall Study|Withdrawal by Subject|2|||
170744115|NCT01018563|617070163|FG000|Overall Study|Termination of the study by Sponsor|2|||
170744116|NCT01018563|617070164|FG001|Overall Study|Termination of the study by Sponsor|1|||
170858493|NCT00585195|617490653|FG016|Overall Study|Lost to Follow-up|0|||
170858494|NCT00585195|617490654|FG017|Overall Study|Lost to Follow-up|2|||
170858495|NCT00585195|617490655|FG018|Overall Study|Lost to Follow-up|0|||
170858496|NCT00585195|617490656|FG019|Overall Study|Lost to Follow-up|0|||
170858497|NCT00585195|617490657|FG020|Overall Study|Lost to Follow-up|0|||
170858498|NCT00585195|617490637|FG000|Overall Study|Site Terminated by Sponsor|0|||
170858499|NCT00585195|617490638|FG001|Overall Study|Site Terminated by Sponsor|0|||
170858500|NCT00585195|617490639|FG002|Overall Study|Site Terminated by Sponsor|0|||
170858501|NCT00585195|617490640|FG003|Overall Study|Site Terminated by Sponsor|0|||
170858502|NCT00585195|617490641|FG004|Overall Study|Site Terminated by Sponsor|0|||
170858503|NCT00585195|617490642|FG005|Overall Study|Site Terminated by Sponsor|0|||
170858504|NCT00585195|617490643|FG006|Overall Study|Site Terminated by Sponsor|0|||
170858505|NCT00585195|617490644|FG007|Overall Study|Site Terminated by Sponsor|0|||
170858506|NCT00585195|617490645|FG008|Overall Study|Site Terminated by Sponsor|0|||
170858507|NCT00585195|617490646|FG009|Overall Study|Site Terminated by Sponsor|0|||
170858508|NCT00585195|617490647|FG010|Overall Study|Site Terminated by Sponsor|0|||
170858509|NCT00585195|617490648|FG011|Overall Study|Site Terminated by Sponsor|0|||
170858510|NCT00585195|617490649|FG012|Overall Study|Site Terminated by Sponsor|1|||
170858511|NCT00585195|617490650|FG013|Overall Study|Site Terminated by Sponsor|0|||
170858512|NCT00585195|617490651|FG014|Overall Study|Site Terminated by Sponsor|0|||
170858513|NCT00585195|617490652|FG015|Overall Study|Site Terminated by Sponsor|0|||
170858514|NCT00585195|617490653|FG016|Overall Study|Site Terminated by Sponsor|0|||
170858515|NCT00585195|617490654|FG017|Overall Study|Site Terminated by Sponsor|0|||
170858516|NCT00585195|617490655|FG018|Overall Study|Site Terminated by Sponsor|0|||
170858517|NCT00585195|617490656|FG019|Overall Study|Site Terminated by Sponsor|0|||
170858518|NCT00585195|617490657|FG020|Overall Study|Site Terminated by Sponsor|0|||
170858519|NCT00585195|617490637|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
170858520|NCT00585195|617490638|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
170858521|NCT00585195|617490639|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
170858522|NCT00585195|617490640|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
170858523|NCT00585195|617490641|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
170858524|NCT00585195|617490642|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
170858525|NCT00585195|617490643|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
170858526|NCT00585195|617490644|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
170858527|NCT00585195|617490645|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
170858528|NCT00585195|617490646|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
170858529|NCT00585195|617490647|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
170858530|NCT00585195|617490648|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
170858531|NCT00585195|617490649|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
170858532|NCT00585195|617490650|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
170858533|NCT00585195|617490651|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
170858534|NCT00585195|617490652|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
170858535|NCT00585195|617490653|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
170858536|NCT00585195|617490654|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
170858537|NCT00585195|617490655|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
170858538|NCT00585195|617490656|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
170858539|NCT00585195|617490657|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
170858540|NCT02739360|617490658|FG000|Overall Study|Adverse Event|1|||
170858541|NCT02739360|617490658|FG000|Overall Study|Study terminated by Sponsor|2|||
170858542|NCT01078454|617490667|FG000|Overall Study|Adverse Event|1|||
170858543|NCT01078454|617490668|FG001|Overall Study|Adverse Event|1|||
170858544|NCT01078454|617490667|FG000|Overall Study|Death|0|||
170858545|NCT01078454|617490668|FG001|Overall Study|Death|1|||
170858546|NCT01370590|617490669|FG000|Period 1|Adverse Event|8|||
170858547|NCT01370590|617490670|FG001|Period 1|Adverse Event|4|||
170858548|NCT01370590|617490669|FG000|Period 1|Lost to Follow-up|2|||
170858549|NCT01370590|617490670|FG001|Period 1|Lost to Follow-up|2|||
170858550|NCT01370590|617490669|FG000|Period 1|Protocol Violation|2|||
170858551|NCT01370590|617490670|FG001|Period 1|Protocol Violation|2|||
170858552|NCT01370590|617490669|FG000|Period 1|Withdrawal by Subject|4|||
170858553|NCT01370590|617490670|FG001|Period 1|Withdrawal by Subject|2|||
170858554|NCT01370590|617490669|FG000|Period 1|Could not access randomization system|0|||
170858555|NCT01370590|617490670|FG001|Period 1|Could not access randomization system|1|||
170858556|NCT01370590|617490669|FG000|Crossover Washout Period|Adverse Event|1|||
170858557|NCT01370590|617490670|FG001|Crossover Washout Period|Adverse Event|4|||
170858558|NCT01370590|617490669|FG000|Crossover Washout Period|Lost to Follow-up|2|||
170858559|NCT01370590|617490670|FG001|Crossover Washout Period|Lost to Follow-up|0|||
170858560|NCT01370590|617490669|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
170858561|NCT01370590|617490670|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
170858562|NCT01370590|617490669|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
170858563|NCT01370590|617490670|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
170858564|NCT01370590|617490669|FG000|Period 2|Adverse Event|0|||
170744117|NCT02344537|617070165|FG000|Overall Study|Protocol Violation|1|||
170744118|NCT02344537|617070166|FG001|Overall Study|Protocol Violation|1|||
170744119|NCT02344537|617070165|FG000|Overall Study|Subject started another treatment after wk 6|1|||
170744120|NCT02344537|617070166|FG001|Overall Study|Subject started another treatment after wk 6|0|||
170744121|NCT02344537|617070165|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
170744122|NCT02344537|617070166|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
170744123|NCT00856661|617070173|FG000|Overall Study|Death|15|||
170744124|NCT00856661|617070174|FG001|Overall Study|Death|18|||
170744125|NCT00856661|617070173|FG000|Overall Study|Protocol Violation|2|||
170744126|NCT00856661|617070174|FG001|Overall Study|Protocol Violation|1|||
170744127|NCT00856661|617070173|FG000|Overall Study|Withdrawal by Subject|1|||
170744128|NCT00856661|617070174|FG001|Overall Study|Withdrawal by Subject|2|||
170744129|NCT00856661|617070173|FG000|Overall Study|Lost to Follow-up|1|||
170744130|NCT00856661|617070174|FG001|Overall Study|Lost to Follow-up|3|||
170744131|NCT00856661|617070173|FG000|Overall Study|Physician Judgement|8|||
170744132|NCT00856661|617070174|FG001|Overall Study|Physician Judgement|5|||
170744133|NCT03916744|617070175|FG000|Overall Study|Withdrawal by Subject|0|||
170744134|NCT03916744|617070176|FG001|Overall Study|Withdrawal by Subject|1|||
170744135|NCT03916744|617070177|FG002|Overall Study|Withdrawal by Subject|2|||
170744136|NCT03176238|617070178|FG000|Overall Study|Unacceptable AEs|15|||
170744137|NCT03176238|617070179|FG001|Overall Study|Unacceptable AEs|8|||
170744138|NCT03176238|617070178|FG000|Overall Study|Abnormal lab value(s)|2|||
170744139|NCT03176238|617070179|FG001|Overall Study|Abnormal lab value(s)|0|||
170744140|NCT03176238|617070178|FG000|Overall Study|Inter-current illness|0|||
170744141|NCT03176238|617070179|FG001|Overall Study|Inter-current illness|1|||
170744142|NCT03176238|617070178|FG000|Overall Study|Consent withdrawal|14|||
170744143|NCT03176238|617070179|FG001|Overall Study|Consent withdrawal|2|||
170744144|NCT03176238|617070178|FG000|Overall Study|Lost to Follow-up|3|||
170744145|NCT03176238|617070179|FG001|Overall Study|Lost to Follow-up|0|||
170744146|NCT03176238|617070178|FG000|Overall Study|Administrative problems|1|||
170744147|NCT03176238|617070179|FG001|Overall Study|Administrative problems|0|||
170744148|NCT03176238|617070178|FG000|Overall Study|Death|3|||
170744149|NCT03176238|617070179|FG001|Overall Study|Death|0|||
170744150|NCT03176238|617070178|FG000|Overall Study|Disease Progression|133|||
170744151|NCT03176238|617070179|FG001|Overall Study|Disease Progression|22|||
170744152|NCT03176238|617070178|FG000|Overall Study|Tx duration completed per EAP|0|||
170744153|NCT03176238|617070179|FG001|Overall Study|Tx duration completed per EAP|1|||
170744154|NCT03176238|617070178|FG000|Overall Study|Patient is switched to commercial drug|16|||
170744155|NCT03176238|617070179|FG001|Overall Study|Patient is switched to commercial drug|1|||
170744156|NCT03176238|617070178|FG000|Overall Study|Protocol Violation|1|||
170744157|NCT03176238|617070179|FG001|Overall Study|Protocol Violation|0|||
170744158|NCT03176238|617070178|FG000|Overall Study|Changes in the patient's condition|2|||
170744159|NCT03176238|617070179|FG001|Overall Study|Changes in the patient's condition|1|||
170744160|NCT03176238|617070178|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
170744161|NCT03176238|617070179|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
170744162|NCT03936777|617070180|FG000|Overall Study|Adverse Event|3|||
170744163|NCT03936777|617070180|FG000|Overall Study|Death|3|||
170744164|NCT03936777|617070180|FG000|Overall Study|Lack of Efficacy|24|||
170744165|NCT03936777|617070180|FG000|Overall Study|Lost to Follow-up|3|||
170744166|NCT03936777|617070180|FG000|Overall Study|Physician Decision|1|||
170744167|NCT03936777|617070180|FG000|Overall Study|Withdrawal by Subject|11|||
170744168|NCT03936777|617070180|FG000|Overall Study|Subjected Weaned of ZX008|1|||
170744169|NCT03936777|617070180|FG000|Overall Study|Missing|6|||
170744170|NCT03556358|617070181|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
170744171|NCT03556358|617070182|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
170744172|NCT03556358|617070181|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
170744173|NCT03556358|617070182|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
170744174|NCT03556358|617070181|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
170744175|NCT03556358|617070182|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
170744176|NCT03556358|617070181|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
170744177|NCT03556358|617070182|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
170744178|NCT03556358|617070181|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
170744179|NCT03556358|617070182|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
170744180|NCT03556358|617070181|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
170744181|NCT03556358|617070182|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
170744182|NCT03556358|617070181|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
170744183|NCT03556358|617070182|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
170744184|NCT03311230|617070188|FG000|Overall Study|Withdrawal by Subject|1|||
170744185|NCT03311230|617070189|FG001|Overall Study|Withdrawal by Subject|4|||
170744186|NCT03311230|617070190|FG002|Overall Study|Withdrawal by Subject|2|||
170744187|NCT03311230|617070191|FG003|Overall Study|Withdrawal by Subject|7|||
170858565|NCT01370590|617490670|FG001|Period 2|Adverse Event|1|||
170858566|NCT01370590|617490669|FG000|Period 2|Withdrawal by Subject|1|||
170858567|NCT01370590|617490670|FG001|Period 2|Withdrawal by Subject|1|||
170858568|NCT01340651|617490672|FG000|Overall Study|Adverse Event|3|||
170858569|NCT01340651|617490672|FG000|Overall Study|Consent Withdrawn|2|||
170858570|NCT01340651|617490672|FG000|Overall Study|Commercial Supply per Sponsor|12|||
170858571|NCT01315353|617490673|FG000|Overall Study|Death|2|||
170858572|NCT01315353|617490674|FG001|Overall Study|Death|1|||
170858573|NCT01315353|617490675|FG002|Overall Study|Death|0|||
170858574|NCT01315353|617490673|FG000|Overall Study|Withdrawal by Subject|2|||
170858575|NCT01315353|617490674|FG001|Overall Study|Withdrawal by Subject|6|||
170858576|NCT01315353|617490675|FG002|Overall Study|Withdrawal by Subject|1|||
170858577|NCT01315353|617490673|FG000|Overall Study|Lost to Follow-up|13|||
170858578|NCT01315353|617490674|FG001|Overall Study|Lost to Follow-up|6|||
170858579|NCT01315353|617490675|FG002|Overall Study|Lost to Follow-up|6|||
170858580|NCT01315353|617490673|FG000|Overall Study|Unwilling to adhere to requirements|5|||
170858581|NCT01315353|617490674|FG001|Overall Study|Unwilling to adhere to requirements|5|||
170858582|NCT01315353|617490675|FG002|Overall Study|Unwilling to adhere to requirements|4|||
170858583|NCT01315353|617490673|FG000|Overall Study|Site closing|7|||
170858584|NCT01315353|617490674|FG001|Overall Study|Site closing|4|||
170858585|NCT01315353|617490675|FG002|Overall Study|Site closing|0|||
170858586|NCT01315353|617490673|FG000|Overall Study|Taken off study by site in error|0|||
170858587|NCT01315353|617490674|FG001|Overall Study|Taken off study by site in error|1|||
170858588|NCT01315353|617490675|FG002|Overall Study|Taken off study by site in error|0|||
170858589|NCT01315353|617490673|FG000|Overall Study|Inadvertent randomization/assignment|0|||
170858590|NCT01315353|617490674|FG001|Overall Study|Inadvertent randomization/assignment|0|||
170858591|NCT01315353|617490675|FG002|Overall Study|Inadvertent randomization/assignment|2|||
170858592|NCT03035201|617490676|FG000|Overall Study|Death|9|||
170858593|NCT03035201|617490677|FG001|Overall Study|Death|12|||
170858594|NCT03035201|617490678|FG002|Overall Study|Death|9|||
170858595|NCT03035201|617490679|FG003|Overall Study|Death|10|||
170858596|NCT03035201|617490676|FG000|Overall Study|Withdrawal by Subject|51|||
170858597|NCT03035201|617490677|FG001|Overall Study|Withdrawal by Subject|49|||
170858598|NCT03035201|617490678|FG002|Overall Study|Withdrawal by Subject|37|||
170858599|NCT03035201|617490679|FG003|Overall Study|Withdrawal by Subject|46|||
170858600|NCT03035201|617490676|FG000|Overall Study|Lost to Follow-up|67|||
170858601|NCT03035201|617490677|FG001|Overall Study|Lost to Follow-up|51|||
170858602|NCT03035201|617490678|FG002|Overall Study|Lost to Follow-up|64|||
170858603|NCT03035201|617490679|FG003|Overall Study|Lost to Follow-up|69|||
170858604|NCT03432260|617490686|FG000|Overall Study|Lost to Follow-up|1|||
170858605|NCT03432260|617490687|FG001|Overall Study|Lost to Follow-up|1|||
170858606|NCT03432260|617490688|FG002|Overall Study|Lost to Follow-up|0|||
170858607|NCT03432260|617490689|FG003|Overall Study|Lost to Follow-up|0|||
170858608|NCT03432260|617490690|FG004|Overall Study|Lost to Follow-up|1|||
170858609|NCT01912456|617492367|FG000|Period 1|Physician Decision|0|||
170858610|NCT01912456|617492368|FG001|Period 1|Physician Decision|0|||
170858611|NCT01912456|617492369|FG002|Period 1|Physician Decision|1|||
170858612|NCT01912456|617492370|FG003|Period 1|Physician Decision|0|||
170858613|NCT01912456|617492367|FG000|Period 1|non-compliance|1|||
170858614|NCT01912456|617492368|FG001|Period 1|non-compliance|0|||
170858615|NCT01912456|617492369|FG002|Period 1|non-compliance|0|||
170858616|NCT01912456|617492370|FG003|Period 1|non-compliance|1|||
170858617|NCT01912456|617492367|FG000|Period 1|Adverse Event|1|||
170858618|NCT01912456|617492368|FG001|Period 1|Adverse Event|0|||
170858619|NCT01912456|617492369|FG002|Period 1|Adverse Event|0|||
170858620|NCT01912456|617492370|FG003|Period 1|Adverse Event|1|||
170858621|NCT01912456|617492367|FG000|Period 1|Withdrawal by Subject|0|||
170858622|NCT01912456|617492368|FG001|Period 1|Withdrawal by Subject|1|||
170858623|NCT01912456|617492369|FG002|Period 1|Withdrawal by Subject|1|||
170858624|NCT01912456|617492370|FG003|Period 1|Withdrawal by Subject|1|||
170858625|NCT01912456|617492367|FG000|Period 2|Lack of Efficacy|0|||
170858626|NCT01912456|617492368|FG001|Period 2|Lack of Efficacy|2|||
170858627|NCT01912456|617492369|FG002|Period 2|Lack of Efficacy|0|||
170858628|NCT01912456|617492370|FG003|Period 2|Lack of Efficacy|0|||
170858629|NCT01912456|617492367|FG000|Period 2|Adverse Event|0|||
170858630|NCT01912456|617492368|FG001|Period 2|Adverse Event|0|||
170858631|NCT01912456|617492369|FG002|Period 2|Adverse Event|0|||
170858632|NCT01912456|617492370|FG003|Period 2|Adverse Event|1|||
170858633|NCT00604279|617492376|FG000|Overall Study|Lack of Efficacy|22|||
170858634|NCT00604279|617492377|FG001|Overall Study|Lack of Efficacy|9|||
170858635|NCT00604279|617492376|FG000|Overall Study|Lost to Follow-up|9|||
170858636|NCT00604279|617492377|FG001|Overall Study|Lost to Follow-up|14|||
170858637|NCT00604279|617492376|FG000|Overall Study|Pregnancy|2|||
170858638|NCT00604279|617492377|FG001|Overall Study|Pregnancy|0|||
170858639|NCT00604279|617492376|FG000|Overall Study|Protocol Violation|3|||
170858640|NCT00604279|617492377|FG001|Overall Study|Protocol Violation|1|||
170858641|NCT00604279|617492376|FG000|Overall Study|Withdrawal by Subject|16|||
170858642|NCT00604279|617492377|FG001|Overall Study|Withdrawal by Subject|5|||
170858643|NCT00604279|617492376|FG000|Overall Study|Adverse Event|4|||
170858644|NCT00604279|617492377|FG001|Overall Study|Adverse Event|5|||
170858645|NCT00604279|617492376|FG000|Overall Study|Other|8|||
170858646|NCT00604279|617492377|FG001|Overall Study|Other|4|||
170858647|NCT00355056|617492378|FG000|Randomization Period|Early Termination|4|||
170858648|NCT00355056|617492379|FG001|Randomization Period|Early Termination|6|||
170858649|NCT00596427|617492380|FG000|Overall Study|Withdrawal by Subject|2|||
170858650|NCT00596427|617492381|FG001|Overall Study|Withdrawal by Subject|2|||
170858651|NCT00596427|617492380|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
170858652|NCT00596427|617492381|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
170858653|NCT00596427|617492380|FG000|Overall Study|Protocol Violation|1|||
170858654|NCT00596427|617492381|FG001|Overall Study|Protocol Violation|0|||
170858655|NCT00320541|617492382|FG000|Overall Study|Adverse Event|21|||
170858656|NCT00320541|617492383|FG001|Overall Study|Adverse Event|19|||
170858657|NCT00320541|617492382|FG000|Overall Study|Protocol Violation|0|||
170858658|NCT00320541|617492383|FG001|Overall Study|Protocol Violation|1|||
170858659|NCT00320541|617492382|FG000|Overall Study|Withdrawal by Subject|12|||
170858660|NCT00320541|617492383|FG001|Overall Study|Withdrawal by Subject|16|||
170858661|NCT00320541|617492382|FG000|Overall Study|Physician Decision|9|||
170858662|NCT00320541|617492383|FG001|Overall Study|Physician Decision|13|||
170858663|NCT00320541|617492382|FG000|Overall Study|Other|3|||
170858664|NCT00320541|617492383|FG001|Overall Study|Other|4|||
170858665|NCT00320541|617492382|FG000|Overall Study|Sponsor Decision|2|||
170858666|NCT00320541|617492383|FG001|Overall Study|Sponsor Decision|1|||
170858667|NCT00320541|617492382|FG000|Overall Study|Death due to Study Disease|1|||
170858668|NCT00320541|617492383|FG001|Overall Study|Death due to Study Disease|3|||
170858669|NCT00320541|617492382|FG000|Overall Study|Death due to Adverse Event(s)|1|||
170858670|NCT00320541|617492383|FG001|Overall Study|Death due to Adverse Event(s)|0|||
170858671|NCT00320541|617492382|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
170858672|NCT00320541|617492383|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
170858673|NCT01650246|617492384|FG000|Overall Study|Adverse Event|23|||
170858674|NCT01650246|617492384|FG000|Overall Study|Protocol Violation|5|||
170858675|NCT01650246|617492384|FG000|Overall Study|Sponsor terminated study|53|||
170858676|NCT01650246|617492384|FG000|Overall Study|Lost to Follow-up|5|||
170858677|NCT01650246|617492384|FG000|Overall Study|Withdrawal by Subject|26|||
170858678|NCT01650246|617492384|FG000|Overall Study|Death|1|||
170858679|NCT01650246|617492384|FG000|Overall Study|Lack of Efficacy|30|||
170858680|NCT04281004|617492385|FG000|Overall Study|Physician Decision|1|||
170858681|NCT04281004|617492386|FG001|Overall Study|Physician Decision|0|||
170858682|NCT01716117|617492391|FG000|Overall Study|Death|5|||
170858683|NCT01716117|617492392|FG001|Overall Study|Death|2|||
170858684|NCT01716117|617492391|FG000|Overall Study|Withdrawal by Subject|2|||
170858685|NCT01716117|617492392|FG001|Overall Study|Withdrawal by Subject|0|||
170858686|NCT03645057|617492397|FG000|Randomization to Baseline|Lost to Follow-up|1|||
170858687|NCT03645057|617492398|FG001|Randomization to Baseline|Lost to Follow-up|0|||
170858688|NCT03645057|617492399|FG002|Randomization to Baseline|Lost to Follow-up|1|||
170858689|NCT03645057|617492400|FG003|Randomization to Baseline|Lost to Follow-up|0|||
170858690|NCT03645057|617492397|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
170858691|NCT03645057|617492398|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
170858692|NCT03645057|617492399|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
170858693|NCT03645057|617492400|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
170858694|NCT03645057|617492397|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
170858695|NCT03645057|617492398|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
170858696|NCT03645057|617492399|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
170858697|NCT03645057|617492400|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
170858698|NCT03645057|617492397|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
170858699|NCT03645057|617492398|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
170858700|NCT03645057|617492399|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
170858701|NCT03645057|617492400|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
170858702|NCT01206777|617492401|FG000|Overall Study|Death|1|||
170858703|NCT01206777|617492401|FG000|Overall Study|Adverse Event|1|||
170858704|NCT00876694|617492402|FG000|Overall Study|Adverse Event|10|||
170858705|NCT00876694|617492403|FG001|Overall Study|Adverse Event|7|||
170858706|NCT00876694|617492402|FG000|Overall Study|Subject withdrew consent|6|||
170858707|NCT00876694|617492403|FG001|Overall Study|Subject withdrew consent|4|||
170858708|NCT00876694|617492402|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170858709|NCT00876694|617492403|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170858710|NCT00876694|617492402|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170858711|NCT00876694|617492403|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170858712|NCT00876694|617492402|FG000|Overall Study|Administrative problems|1|||
170858713|NCT00876694|617492403|FG001|Overall Study|Administrative problems|1|||
170858714|NCT00876694|617492402|FG000|Overall Study|Death|1|||
170858715|NCT00876694|617492403|FG001|Overall Study|Death|0|||
170858716|NCT00084266|617492404|FG000|Overall Study|Death|42|||
170858717|NCT00084266|617492405|FG001|Overall Study|Death|39|||
170858718|NCT00084266|617492404|FG000|Overall Study|Adverse Event|8|||
170858719|NCT00084266|617492405|FG001|Overall Study|Adverse Event|5|||
170858720|NCT00084266|617492404|FG000|Overall Study|Lack of Efficacy|2|||
170858721|NCT00084266|617492405|FG001|Overall Study|Lack of Efficacy|4|||
170858722|NCT00084266|617492404|FG000|Overall Study|Lost to Follow-up|5|||
170858723|NCT00084266|617492405|FG001|Overall Study|Lost to Follow-up|3|||
170858724|NCT00084266|617492404|FG000|Overall Study|Participant not willing to participate|3|||
170858725|NCT00084266|617492405|FG001|Overall Study|Participant not willing to participate|8|||
170858726|NCT00084266|617492404|FG000|Overall Study|Other|360|||
170858727|NCT00084266|617492405|FG001|Overall Study|Other|344|||
170858728|NCT00084266|617492404|FG000|Overall Study|Randomized not treated|21|||
170858729|NCT00084266|617492405|FG001|Overall Study|Randomized not treated|20|||
170858730|NCT00730171|617492410|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
170744188|NCT03311230|617070188|FG000|Overall Study|Unrelated injury|0|||
170744189|NCT03311230|617070189|FG001|Overall Study|Unrelated injury|1|||
170744190|NCT03311230|617070190|FG002|Overall Study|Unrelated injury|0|||
170744191|NCT03311230|617070191|FG003|Overall Study|Unrelated injury|0|||
170744192|NCT02294474|617070192|FG000|Overall Study|Adverse Event|7|||
170744193|NCT02294474|617070193|FG001|Overall Study|Adverse Event|7|||
170744194|NCT02294474|617070192|FG000|Overall Study|Lack of Efficacy|2|||
170744195|NCT02294474|617070193|FG001|Overall Study|Lack of Efficacy|1|||
170858731|NCT00730171|617492410|FG000|Overall Study|Adverse Event|193|||
170858732|NCT00730171|617492410|FG000|Overall Study|Protocol Violation|48|||
170858733|NCT00730171|617492410|FG000|Overall Study|Withdrawal by Subject|202|||
170858734|NCT00730171|617492410|FG000|Overall Study|Lost to Follow-up|121|||
170858735|NCT00730171|617492410|FG000|Overall Study|Insufficient Therapeutic Response|141|||
170858736|NCT00730171|617492410|FG000|Overall Study|Other|61|||
170858737|NCT01215422|617492411|FG000|Overall Study|Relocation|1|||
170858738|NCT01215422|617492412|FG001|Overall Study|Relocation|0|||
170858739|NCT01215422|617492413|FG002|Overall Study|Relocation|0|||
170858740|NCT01215422|617492414|FG003|Overall Study|Relocation|0|||
170858741|NCT01215422|617492411|FG000|Overall Study|Failed intubations|0|||
170858742|NCT01215422|617492412|FG001|Overall Study|Failed intubations|0|||
170858743|NCT01215422|617492413|FG002|Overall Study|Failed intubations|3|||
170858744|NCT01215422|617492414|FG003|Overall Study|Failed intubations|8|||
170858745|NCT01215422|617492411|FG000|Overall Study|Did not complete all intubations|7|||
170858746|NCT01215422|617492412|FG001|Overall Study|Did not complete all intubations|0|||
170858747|NCT01215422|617492413|FG002|Overall Study|Did not complete all intubations|0|||
170858748|NCT01215422|617492414|FG003|Overall Study|Did not complete all intubations|0|||
170858749|NCT01729156|617492415|FG000|Overall Study|Withdrawal by Subject|1|||
170858750|NCT01729156|617492416|FG001|Overall Study|Withdrawal by Subject|0|||
170858751|NCT01729156|617492417|FG002|Overall Study|Withdrawal by Subject|0|||
170858752|NCT01256658|617492418|FG000|Period 1|Lost to Follow-up|837|||
170858753|NCT01256658|617492419|FG001|Period 1|Lost to Follow-up|661|||
170858754|NCT01256658|617492418|FG000|Period 1|Withdrawal by Subject|35|||
170858755|NCT01256658|617492419|FG001|Period 1|Withdrawal by Subject|43|||
170858756|NCT01256658|617492418|FG000|Period 1|Death|48|||
170858757|NCT01256658|617492419|FG001|Period 1|Death|44|||
170858758|NCT01146054|617492422|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
170858759|NCT01146054|617492422|FG000|Overall Study|Rapid tumor progression|2|||
170858760|NCT01146054|617492422|FG000|Overall Study|Other illness precluded treatment|2|||
170858761|NCT01146054|617492422|FG000|Overall Study|Lost to Follow-up|1|||
170858762|NCT00762970|617492425|FG000|Overall Study|Withdrawal by Subject|7|||
170858763|NCT00762970|617492426|FG001|Overall Study|Withdrawal by Subject|4|||
170858764|NCT00762970|617492427|FG002|Overall Study|Withdrawal by Subject|0|||
170858765|NCT00762970|617492425|FG000|Overall Study|Protocol Violation|3|||
170858766|NCT00762970|617492426|FG001|Overall Study|Protocol Violation|1|||
170858767|NCT00762970|617492427|FG002|Overall Study|Protocol Violation|1|||
170858768|NCT00762970|617492425|FG000|Overall Study|Lost to Follow-up|1|||
170858769|NCT00762970|617492426|FG001|Overall Study|Lost to Follow-up|2|||
170858770|NCT00762970|617492427|FG002|Overall Study|Lost to Follow-up|0|||
170858771|NCT00762970|617492425|FG000|Overall Study|Difficulty of handling lens|1|||
170858772|NCT00762970|617492426|FG001|Overall Study|Difficulty of handling lens|2|||
170858773|NCT00762970|617492427|FG002|Overall Study|Difficulty of handling lens|0|||
170858774|NCT01920854|617492441|FG000|Overall Study|Withdrawal by Subject|1|||
170858775|NCT01920854|617492442|FG001|Overall Study|Withdrawal by Subject|0|||
170858776|NCT01920854|617492443|FG002|Overall Study|Withdrawal by Subject|0|||
170858777|NCT01920854|617492444|FG003|Overall Study|Withdrawal by Subject|0|||
170858778|NCT01920854|617492445|FG004|Overall Study|Withdrawal by Subject|1|||
170858779|NCT01920854|617492446|FG005|Overall Study|Withdrawal by Subject|0|||
170858780|NCT01920854|617492447|FG006|Overall Study|Withdrawal by Subject|1|||
170858781|NCT01209780|617492448|FG000|Overall Study|Adverse Event|0|||
170858782|NCT01209780|617492449|FG001|Overall Study|Adverse Event|1|||
170858783|NCT01209780|617492450|FG002|Overall Study|Adverse Event|0|||
170858784|NCT01209780|617492451|FG003|Overall Study|Adverse Event|0|||
170858785|NCT01209780|617492452|FG004|Overall Study|Adverse Event|0|||
170858786|NCT01209780|617492448|FG000|Overall Study|Withdrawal by Subject|9|||
170858787|NCT01209780|617492449|FG001|Overall Study|Withdrawal by Subject|2|||
170858788|NCT01209780|617492450|FG002|Overall Study|Withdrawal by Subject|1|||
170858789|NCT01209780|617492451|FG003|Overall Study|Withdrawal by Subject|1|||
170858790|NCT01209780|617492452|FG004|Overall Study|Withdrawal by Subject|0|||
170858791|NCT01209780|617492448|FG000|Overall Study|Lost to Follow-up|17|||
170858792|NCT01209780|617492449|FG001|Overall Study|Lost to Follow-up|12|||
170858793|NCT01209780|617492450|FG002|Overall Study|Lost to Follow-up|3|||
170858794|NCT01209780|617492451|FG003|Overall Study|Lost to Follow-up|9|||
170858795|NCT01209780|617492452|FG004|Overall Study|Lost to Follow-up|4|||
170858796|NCT01209780|617492448|FG000|Overall Study|Protocol Violation|0|||
170858797|NCT01209780|617492449|FG001|Overall Study|Protocol Violation|1|||
170858798|NCT01209780|617492450|FG002|Overall Study|Protocol Violation|0|||
170858799|NCT01209780|617492451|FG003|Overall Study|Protocol Violation|0|||
170858800|NCT01209780|617492452|FG004|Overall Study|Protocol Violation|0|||
170858801|NCT01209780|617492448|FG000|Overall Study|Inappropriate enrollment|0|||
170744196|NCT02294474|617070192|FG000|Overall Study|Protocol Violation|4|||
170744197|NCT02294474|617070193|FG001|Overall Study|Protocol Violation|2|||
170744198|NCT02294474|617070192|FG000|Overall Study|Other than specified above|12|||
170744199|NCT02294474|617070193|FG001|Overall Study|Other than specified above|12|||
170744200|NCT05256381|617070194|FG000|Overall Study|Withdrawal by Subject|4|||
170744201|NCT05256381|617070195|FG001|Overall Study|Withdrawal by Subject|0|||
170744202|NCT05256381|617070196|FG002|Overall Study|Withdrawal by Subject|2|||
170744203|NCT05256381|617070197|FG003|Overall Study|Withdrawal by Subject|2|||
170744204|NCT05256381|617070198|FG004|Overall Study|Withdrawal by Subject|8|||
170744205|NCT05256381|617070199|FG005|Overall Study|Withdrawal by Subject|6|||
170744206|NCT05256381|617070194|FG000|Overall Study|Physician Decision|0|||
170744207|NCT05256381|617070195|FG001|Overall Study|Physician Decision|0|||
170744208|NCT05256381|617070196|FG002|Overall Study|Physician Decision|1|||
170744209|NCT05256381|617070197|FG003|Overall Study|Physician Decision|0|||
170744210|NCT05256381|617070198|FG004|Overall Study|Physician Decision|2|||
170744211|NCT05256381|617070199|FG005|Overall Study|Physician Decision|0|||
170744212|NCT05256381|617070194|FG000|Overall Study|Death|17|||
170744213|NCT05256381|617070195|FG001|Overall Study|Death|3|||
170744214|NCT05256381|617070196|FG002|Overall Study|Death|4|||
170744215|NCT05256381|617070197|FG003|Overall Study|Death|5|||
170744216|NCT05256381|617070198|FG004|Overall Study|Death|24|||
170744217|NCT05256381|617070199|FG005|Overall Study|Death|21|||
170744218|NCT05256381|617070194|FG000|Overall Study|Other, not specified|0|||
170744219|NCT05256381|617070195|FG001|Overall Study|Other, not specified|0|||
170744220|NCT05256381|617070196|FG002|Overall Study|Other, not specified|0|||
170744221|NCT05256381|617070197|FG003|Overall Study|Other, not specified|0|||
170744222|NCT05256381|617070198|FG004|Overall Study|Other, not specified|2|||
170744223|NCT05256381|617070199|FG005|Overall Study|Other, not specified|1|||
170744224|NCT05256381|617070194|FG000|Overall Study|Study terminated by sponsor|18|||
170744225|NCT05256381|617070195|FG001|Overall Study|Study terminated by sponsor|5|||
170744226|NCT05256381|617070196|FG002|Overall Study|Study terminated by sponsor|5|||
170744227|NCT05256381|617070197|FG003|Overall Study|Study terminated by sponsor|5|||
170744228|NCT05256381|617070198|FG004|Overall Study|Study terminated by sponsor|18|||
170744229|NCT05256381|617070199|FG005|Overall Study|Study terminated by sponsor|11|||
170744230|NCT05256381|617070194|FG000|Overall Study|Lost to Follow-up|1|||
170744231|NCT05256381|617070195|FG001|Overall Study|Lost to Follow-up|0|||
170744232|NCT05256381|617070196|FG002|Overall Study|Lost to Follow-up|0|||
170744233|NCT05256381|617070197|FG003|Overall Study|Lost to Follow-up|0|||
170744234|NCT05256381|617070198|FG004|Overall Study|Lost to Follow-up|1|||
170744235|NCT05256381|617070199|FG005|Overall Study|Lost to Follow-up|0|||
170744236|NCT01338012|617070202|FG000|Overall Study|Death|4|||
170744237|NCT01338012|617070202|FG000|Overall Study|Study terminated|4|||
170744238|NCT02089230|617070203|FG000|Overall Study|Death|0|||
170744239|NCT02089230|617070204|FG001|Overall Study|Death|0|||
170744240|NCT02089230|617070205|FG002|Overall Study|Death|2|||
170744241|NCT02089230|617070203|FG000|Overall Study|Seeking Alternative Therapy|0|||
170744242|NCT02089230|617070204|FG001|Overall Study|Seeking Alternative Therapy|0|||
170744243|NCT02089230|617070205|FG002|Overall Study|Seeking Alternative Therapy|4|||
170744244|NCT04921969|617070206|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
170744245|NCT04921969|617070207|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
170744246|NCT04921969|617070208|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
170744247|NCT04921969|617070209|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
170744248|NCT04921969|617070210|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
170744249|NCT04921969|617070211|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
170744250|NCT04921969|617070212|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
170744251|NCT04921969|617070206|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
170744252|NCT04921969|617070207|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170744253|NCT04921969|617070208|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170744254|NCT04921969|617070209|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170744255|NCT04921969|617070210|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170744256|NCT04921969|617070211|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170744257|NCT04921969|617070212|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
170744258|NCT04921969|617070206|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
170744259|NCT04921969|617070207|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
170744260|NCT04921969|617070208|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
170744261|NCT04921969|617070209|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170744262|NCT04921969|617070210|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170744263|NCT04921969|617070211|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170744264|NCT04921969|617070212|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
170744265|NCT04921969|617070206|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
170744266|NCT04921969|617070207|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
170744267|NCT04921969|617070208|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
170744268|NCT04921969|617070209|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
170744269|NCT04921969|617070210|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
170744270|NCT04921969|617070211|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
170744271|NCT04921969|617070212|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
170744272|NCT04921969|617070206|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
170744273|NCT04921969|617070207|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
170744274|NCT04921969|617070208|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
170744275|NCT04921969|617070209|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
170744276|NCT04921969|617070210|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
170744277|NCT04921969|617070211|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
170744278|NCT04921969|617070212|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
170744279|NCT04921969|617070206|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
170744280|NCT04921969|617070207|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
170744281|NCT04921969|617070208|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
170744282|NCT04921969|617070209|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170744283|NCT04921969|617070210|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170744284|NCT04921969|617070211|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170744285|NCT04921969|617070212|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
170744286|NCT04921969|617070206|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
170744287|NCT04921969|617070207|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
170744288|NCT04921969|617070208|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
170744289|NCT04921969|617070209|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
170744290|NCT04921969|617070210|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
170744291|NCT04921969|617070211|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
170744292|NCT04921969|617070212|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
170744293|NCT04921969|617070206|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
170744294|NCT04921969|617070207|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
170744295|NCT04921969|617070208|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
170744296|NCT04921969|617070209|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
170744297|NCT04921969|617070210|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
170744298|NCT04921969|617070211|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
170744299|NCT04921969|617070212|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
170744300|NCT04921969|617070206|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170744301|NCT04921969|617070207|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170744302|NCT04921969|617070208|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170744303|NCT04921969|617070209|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
170744304|NCT04921969|617070210|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
170744305|NCT04921969|617070211|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
170744306|NCT04921969|617070212|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
170744307|NCT04921969|617070206|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170744308|NCT04921969|617070207|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170744309|NCT04921969|617070208|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
170744310|NCT04921969|617070209|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
170744311|NCT04921969|617070210|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
170744312|NCT04921969|617070211|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
170744313|NCT04921969|617070212|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
170744314|NCT04921969|617070206|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
170744315|NCT04921969|617070207|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
170744316|NCT04921969|617070208|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
170744317|NCT04921969|617070209|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
170744318|NCT04921969|617070210|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
170744319|NCT04921969|617070211|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
170744320|NCT04921969|617070212|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
170744321|NCT04921969|617070206|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170744322|NCT04921969|617070207|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170744323|NCT04921969|617070208|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
170744324|NCT04921969|617070209|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
170744325|NCT04921969|617070210|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
170744326|NCT04921969|617070211|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
170744327|NCT04921969|617070212|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
170744328|NCT04921969|617070206|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
170744329|NCT04921969|617070207|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
170744330|NCT04921969|617070208|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
170744331|NCT04921969|617070209|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
170858802|NCT01209780|617492449|FG001|Overall Study|Inappropriate enrollment|2|||
170858803|NCT01209780|617492450|FG002|Overall Study|Inappropriate enrollment|0|||
170858804|NCT01209780|617492451|FG003|Overall Study|Inappropriate enrollment|0|||
170858805|NCT01209780|617492452|FG004|Overall Study|Inappropriate enrollment|1|||
170858806|NCT00448123|617492453|FG000|Overall Study|Lost to Follow-up|9|||
170858807|NCT00448123|617492454|FG001|Overall Study|Lost to Follow-up|6|||
170858808|NCT00448123|617492453|FG000|Overall Study|Physician Decision|6|||
170858809|NCT00448123|617492454|FG001|Overall Study|Physician Decision|6|||
170858810|NCT02318797|617492455|FG000|Overall Study|Death|3|||
170858811|NCT02318797|617492456|FG001|Overall Study|Death|6|||
170858812|NCT02318797|617492455|FG000|Overall Study|Lost to Follow-up|85|||
170858813|NCT02318797|617492456|FG001|Overall Study|Lost to Follow-up|96|||
170858814|NCT02709096|617492461|FG000|Overall Study|non-compliance|1|||
170858815|NCT02709096|617492462|FG001|Overall Study|non-compliance|1|||
170858816|NCT03513588|617492463|FG000|Overall Study|Lost to Follow-up|0|||
170858817|NCT03513588|617492464|FG001|Overall Study|Lost to Follow-up|1|||
170858818|NCT03513588|617492465|FG002|Overall Study|Lost to Follow-up|1|||
170858819|NCT03513588|617492463|FG000|Overall Study|Study dosing paused by sponsor|1|||
170858820|NCT03513588|617492464|FG001|Overall Study|Study dosing paused by sponsor|1|||
170858821|NCT03513588|617492465|FG002|Overall Study|Study dosing paused by sponsor|0|||
170858822|NCT03513588|617492463|FG000|Overall Study|Death|0|||
170858823|NCT03513588|617492464|FG001|Overall Study|Death|0|||
170858824|NCT03513588|617492465|FG002|Overall Study|Death|1|||
170858825|NCT00505284|617492466|FG000|Overall Study|Adverse Event|3|||
170858826|NCT00505284|617492467|FG001|Overall Study|Adverse Event|7|||
170858827|NCT00505284|617492468|FG002|Overall Study|Adverse Event|9|||
170858828|NCT00505284|617492469|FG003|Overall Study|Adverse Event|14|||
170858829|NCT00505284|617492470|FG004|Overall Study|Adverse Event|22|||
170858830|NCT00505284|617492466|FG000|Overall Study|Protocol Violation|0|||
170858831|NCT00505284|617492467|FG001|Overall Study|Protocol Violation|1|||
170858832|NCT00505284|617492468|FG002|Overall Study|Protocol Violation|1|||
170858833|NCT00505284|617492469|FG003|Overall Study|Protocol Violation|0|||
170858834|NCT00505284|617492470|FG004|Overall Study|Protocol Violation|0|||
170858835|NCT00505284|617492466|FG000|Overall Study|Withdrawal by Subject|2|||
170858836|NCT00505284|617492467|FG001|Overall Study|Withdrawal by Subject|6|||
170858837|NCT00505284|617492468|FG002|Overall Study|Withdrawal by Subject|1|||
170858838|NCT00505284|617492469|FG003|Overall Study|Withdrawal by Subject|0|||
170858839|NCT00505284|617492470|FG004|Overall Study|Withdrawal by Subject|6|||
170858840|NCT00505284|617492466|FG000|Overall Study|Lack of Efficacy|0|||
170858841|NCT00505284|617492467|FG001|Overall Study|Lack of Efficacy|1|||
170858842|NCT00505284|617492468|FG002|Overall Study|Lack of Efficacy|1|||
170858843|NCT00505284|617492469|FG003|Overall Study|Lack of Efficacy|1|||
170858844|NCT00505284|617492470|FG004|Overall Study|Lack of Efficacy|1|||
170858845|NCT00505284|617492466|FG000|Overall Study|Physician Decision|0|||
170858846|NCT00505284|617492467|FG001|Overall Study|Physician Decision|1|||
170858847|NCT00505284|617492468|FG002|Overall Study|Physician Decision|0|||
170858848|NCT00505284|617492469|FG003|Overall Study|Physician Decision|0|||
170858849|NCT00505284|617492470|FG004|Overall Study|Physician Decision|0|||
170858850|NCT00505284|617492466|FG000|Overall Study|Other|5|||
170858851|NCT00505284|617492467|FG001|Overall Study|Other|0|||
170858852|NCT00505284|617492468|FG002|Overall Study|Other|0|||
170858853|NCT00505284|617492469|FG003|Overall Study|Other|4|||
170858854|NCT00505284|617492470|FG004|Overall Study|Other|4|||
170858855|NCT01275131|617492471|FG000|Period 1|Withdrawal by Subject|1|||
170858856|NCT01275131|617492472|FG001|Period 1|Withdrawal by Subject|0|||
170858857|NCT01275131|617492473|FG002|Period 1|Withdrawal by Subject|3|||
170858858|NCT01275131|617492474|FG003|Period 1|Withdrawal by Subject|2|||
170858859|NCT01275131|617492471|FG000|Period 1|Physician Decision|1|||
170858860|NCT01275131|617492472|FG001|Period 1|Physician Decision|0|||
170858861|NCT01275131|617492473|FG002|Period 1|Physician Decision|0|||
170858862|NCT01275131|617492474|FG003|Period 1|Physician Decision|0|||
170858863|NCT01275131|617492471|FG000|Period 2 (Crossover)|Adverse Event|0|||
170858864|NCT01275131|617492472|FG001|Period 2 (Crossover)|Adverse Event|1|||
170858865|NCT01275131|617492473|FG002|Period 2 (Crossover)|Adverse Event|0|||
170858866|NCT01275131|617492474|FG003|Period 2 (Crossover)|Adverse Event|0|||
170858867|NCT01275131|617492471|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
170858868|NCT01275131|617492472|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
170858869|NCT01275131|617492473|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
170858870|NCT01275131|617492474|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
170858871|NCT01211288|617492475|FG000|Overall Study|Lost to Follow-up|1|||
170858872|NCT01211288|617492476|FG001|Overall Study|Lost to Follow-up|1|||
170858873|NCT00069238|617492479|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
170858874|NCT00069238|617492480|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
170858875|NCT00069238|617492481|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
170858876|NCT00069238|617492479|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
170858877|NCT00069238|617492480|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
170858878|NCT00069238|617492481|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
170858879|NCT00069238|617492479|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
170858880|NCT00069238|617492480|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
170858881|NCT00069238|617492481|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
170858882|NCT00705523|617492482|FG000|Overall Study|Lost to Follow-up|2|||
170858883|NCT00705523|617492483|FG001|Overall Study|Lost to Follow-up|3|||
170858884|NCT01001832|617492484|FG000|Short-term Period|Adverse Event|2|||
170858885|NCT01001832|617492485|FG001|Short-term Period|Adverse Event|3|||
170858886|NCT01001832|617492484|FG000|Long-term Period|Adverse Event|2|||
170858887|NCT01001832|617492485|FG001|Long-term Period|Adverse Event|1|||
170858888|NCT01001832|617492484|FG000|Long-term Period|Withdrawal by Subject|1|||
170858889|NCT01001832|617492485|FG001|Long-term Period|Withdrawal by Subject|0|||
170858890|NCT01001832|617492484|FG000|Long-term Period|Lack of Efficacy|0|||
170858891|NCT01001832|617492485|FG001|Long-term Period|Lack of Efficacy|2|||
170858892|NCT01001832|617492484|FG000|Long-term Period|Other|1|||
170858893|NCT01001832|617492485|FG001|Long-term Period|Other|2|||
170858894|NCT01001832|617492484|FG000|Follow-up Period|Withdrawal by Subject|1|||
170858895|NCT01001832|617492485|FG001|Follow-up Period|Withdrawal by Subject|0|||
170858896|NCT01001832|617492484|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
170858897|NCT01001832|617492485|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
170858898|NCT01001832|617492484|FG000|Follow-up Period|Other|2|||
170858899|NCT01001832|617492485|FG001|Follow-up Period|Other|1|||
170858900|NCT01013285|617492489|FG000|Overall Study|Death|48|||
170858901|NCT01013285|617492490|FG001|Overall Study|Death|89|||
170858902|NCT02412371|617492494|FG000|Overall Study|Withdrawal by Subject|0|||
170858903|NCT02412371|617492495|FG001|Overall Study|Withdrawal by Subject|2|||
170858904|NCT02412371|617492496|FG002|Overall Study|Withdrawal by Subject|0|||
170858905|NCT02412371|617492497|FG003|Overall Study|Withdrawal by Subject|1|||
170858906|NCT02412371|617492498|FG004|Overall Study|Withdrawal by Subject|1|||
170858907|NCT02412371|617492499|FG005|Overall Study|Withdrawal by Subject|0|||
170858908|NCT02412371|617492494|FG000|Overall Study|Sponsor Discontinued Study|1|||
170858909|NCT02412371|617492495|FG001|Overall Study|Sponsor Discontinued Study|4|||
170858910|NCT02412371|617492496|FG002|Overall Study|Sponsor Discontinued Study|6|||
170858911|NCT02412371|617492497|FG003|Overall Study|Sponsor Discontinued Study|4|||
170858912|NCT02412371|617492498|FG004|Overall Study|Sponsor Discontinued Study|5|||
170858913|NCT02412371|617492499|FG005|Overall Study|Sponsor Discontinued Study|0|||
170858914|NCT02412371|617492494|FG000|Overall Study|Death|4|||
170858915|NCT02412371|617492495|FG001|Overall Study|Death|2|||
170858916|NCT02412371|617492496|FG002|Overall Study|Death|1|||
170858917|NCT02412371|617492497|FG003|Overall Study|Death|3|||
170858918|NCT02412371|617492498|FG004|Overall Study|Death|5|||
170858919|NCT02412371|617492499|FG005|Overall Study|Death|2|||
170858920|NCT02412371|617492494|FG000|Overall Study|Other|2|||
170858921|NCT02412371|617492495|FG001|Overall Study|Other|1|||
170858922|NCT02412371|617492496|FG002|Overall Study|Other|0|||
170858923|NCT02412371|617492497|FG003|Overall Study|Other|0|||
170858924|NCT02412371|617492498|FG004|Overall Study|Other|1|||
170858925|NCT02412371|617492499|FG005|Overall Study|Other|3|||
170858926|NCT02374671|617492500|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
170858927|NCT02374671|617492501|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
170858928|NCT02374671|617492502|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
170858929|NCT02374671|617492500|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
170858930|NCT02374671|617492501|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
170858931|NCT02374671|617492502|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
170858932|NCT02374671|617492500|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
170858933|NCT02374671|617492501|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
170858934|NCT02374671|617492502|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
170858935|NCT02374671|617492500|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
170858936|NCT02374671|617492501|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
170858937|NCT02374671|617492502|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
170858938|NCT02374671|617492500|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
170858939|NCT02374671|617492501|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
170858940|NCT02374671|617492502|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
170858941|NCT03581825|617492504|FG000|Period 1|Lens Discomfort|1|||
170858942|NCT03581825|617492505|FG001|Period 1|Lens Discomfort|0|||
170858943|NCT03581825|617492504|FG000|Period 2|Unsatisfactory Vision to Test|0|||
170858944|NCT03581825|617492505|FG001|Period 2|Unsatisfactory Vision to Test|1|||
170858945|NCT00903682|617492506|FG000|Overall Study|Adverse Event|6|||
170858946|NCT00903682|617492507|FG001|Overall Study|Adverse Event|13|||
170858947|NCT00903682|617492506|FG000|Overall Study|Lost to Follow-up|1|||
170858948|NCT00903682|617492507|FG001|Overall Study|Lost to Follow-up|0|||
170858949|NCT00903682|617492506|FG000|Overall Study|Withdrawal by Subject|5|||
170858950|NCT00903682|617492507|FG001|Overall Study|Withdrawal by Subject|0|||
170858951|NCT00903682|617492506|FG000|Overall Study|Pregnancy|0|||
170858952|NCT00903682|617492507|FG001|Overall Study|Pregnancy|1|||
170858953|NCT00903682|617492506|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
170858954|NCT00903682|617492507|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
170858955|NCT00903682|617492506|FG000|Overall Study|Subject Non-Compliant|1|||
170858956|NCT00903682|617492507|FG001|Overall Study|Subject Non-Compliant|0|||
170858957|NCT00903682|617492506|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
170858958|NCT00903682|617492507|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
170858959|NCT00903682|617492506|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
170858960|NCT00903682|617492507|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
170858961|NCT00511901|617492511|FG000|Overall Study|Withdrawal by Subject|1|||
170858962|NCT00511901|617492512|FG001|Overall Study|Withdrawal by Subject|3|||
170858963|NCT03110185|617492513|FG000|Overall Study|Death|0|||
170858964|NCT03110185|617492514|FG001|Overall Study|Death|1|||
170858965|NCT03110185|617492513|FG000|Overall Study|Withdrawal by Subject|2|||
170858966|NCT03110185|617492514|FG001|Overall Study|Withdrawal by Subject|7|||
170858967|NCT03110185|617492513|FG000|Overall Study|Time Constraints|0|||
170858968|NCT03110185|617492514|FG001|Overall Study|Time Constraints|6|||
170858969|NCT03110185|617492513|FG000|Overall Study|Conflict with care|5|||
170858970|NCT03110185|617492514|FG001|Overall Study|Conflict with care|12|||
170858971|NCT03110185|617492513|FG000|Overall Study|Protocol Violation|1|||
170858972|NCT03110185|617492514|FG001|Overall Study|Protocol Violation|4|||
170858973|NCT03110185|617492513|FG000|Overall Study|MRI Incompatible|2|||
170858974|NCT03110185|617492514|FG001|Overall Study|MRI Incompatible|0|||
170858975|NCT03110185|617492513|FG000|Overall Study|Patient Refusal|0|||
170858976|NCT03110185|617492514|FG001|Overall Study|Patient Refusal|1|||
170858977|NCT01427751|617492517|FG000|Overall Study|Adverse Event|18|||
170858978|NCT01427751|617492518|FG001|Overall Study|Adverse Event|2|||
170858979|NCT01427751|617492517|FG000|Overall Study|No further treatment benefit expected|5|||
170858980|NCT01427751|617492518|FG001|Overall Study|No further treatment benefit expected|1|||
170858981|NCT01427751|617492517|FG000|Overall Study|Lost to Follow-up|3|||
170858982|NCT01427751|617492518|FG001|Overall Study|Lost to Follow-up|1|||
170858983|NCT01427751|617492517|FG000|Overall Study|Withdrawal of consent|2|||
170858984|NCT01427751|617492518|FG001|Overall Study|Withdrawal of consent|2|||
170858985|NCT01427751|617492517|FG000|Overall Study|Protocol Violation|6|||
170858986|NCT01427751|617492518|FG001|Overall Study|Protocol Violation|4|||
170858987|NCT01427751|617492517|FG000|Overall Study|Death|2|||
170858988|NCT01427751|617492518|FG001|Overall Study|Death|0|||
170858989|NCT01427751|617492517|FG000|Overall Study|Other miscellaneous reasons|6|||
170858990|NCT01427751|617492518|FG001|Overall Study|Other miscellaneous reasons|4|||
170858991|NCT05590884|617492523|FG000|Overall Study|Withdrawal by Subject|1|||
170858992|NCT05590884|617492524|FG001|Overall Study|Withdrawal by Subject|0|||
170858993|NCT05590884|617492525|FG002|Overall Study|Withdrawal by Subject|0|||
170858994|NCT02427464|617492526|FG000|Overall Study|Adverse Event|6|||
170858995|NCT02427464|617492527|FG001|Overall Study|Adverse Event|1|||
170858996|NCT02427464|617492526|FG000|Overall Study|Lost to Follow-up|16|||
170858997|NCT02427464|617492527|FG001|Overall Study|Lost to Follow-up|5|||
170858998|NCT02427464|617492526|FG000|Overall Study|Physician Decision|2|||
170858999|NCT02427464|617492527|FG001|Overall Study|Physician Decision|0|||
170859000|NCT02427464|617492526|FG000|Overall Study|Withdrawal by Subject|10|||
170859001|NCT02427464|617492527|FG001|Overall Study|Withdrawal by Subject|8|||
170859002|NCT02427464|617492526|FG000|Overall Study|Noncompliance|16|||
170859003|NCT02427464|617492527|FG001|Overall Study|Noncompliance|10|||
170859004|NCT04737187|617492530|FG000|Overall Study|Switched to marketed drug|32|||
170859005|NCT04737187|617492531|FG001|Overall Study|Switched to marketed drug|4|||
170859006|NCT04737187|617492530|FG000|Overall Study|Radiological Progressive Disease|145|||
170859007|NCT04737187|617492531|FG001|Overall Study|Radiological Progressive Disease|146|||
170859008|NCT04737187|617492530|FG000|Overall Study|Clinical Progressive Disease|20|||
170859009|NCT04737187|617492531|FG001|Overall Study|Clinical Progressive Disease|20|||
170859010|NCT04737187|617492530|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
170859011|NCT04737187|617492531|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
170859012|NCT04737187|617492530|FG000|Overall Study|Adverse Event|16|||
170859013|NCT04737187|617492531|FG001|Overall Study|Adverse Event|16|||
170859014|NCT04737187|617492530|FG000|Overall Study|Physician Decision|2|||
170859015|NCT04737187|617492531|FG001|Overall Study|Physician Decision|0|||
170859016|NCT04737187|617492530|FG000|Overall Study|Withdrawal by Subject|5|||
170859017|NCT04737187|617492531|FG001|Overall Study|Withdrawal by Subject|8|||
170859018|NCT05227703|617492532|FG000|Overall Study|Adverse Event|2|||
170859019|NCT05227703|617492533|FG001|Overall Study|Adverse Event|6|||
170859020|NCT05227703|617492534|FG002|Overall Study|Adverse Event|4|||
170859021|NCT05227703|617492532|FG000|Overall Study|Lack of Efficacy|4|||
170859022|NCT05227703|617492533|FG001|Overall Study|Lack of Efficacy|0|||
170859023|NCT05227703|617492534|FG002|Overall Study|Lack of Efficacy|1|||
170859024|NCT05227703|617492532|FG000|Overall Study|Physician Decision|2|||
170859025|NCT05227703|617492533|FG001|Overall Study|Physician Decision|2|||
170859026|NCT05227703|617492534|FG002|Overall Study|Physician Decision|1|||
170859027|NCT05227703|617492532|FG000|Overall Study|Protocol Violation|2|||
170859028|NCT05227703|617492533|FG001|Overall Study|Protocol Violation|1|||
170859029|NCT05227703|617492534|FG002|Overall Study|Protocol Violation|0|||
170859030|NCT05227703|617492532|FG000|Overall Study|Withdrawal by Subject|17|||
170859031|NCT05227703|617492533|FG001|Overall Study|Withdrawal by Subject|26|||
170859032|NCT05227703|617492534|FG002|Overall Study|Withdrawal by Subject|32|||
170859033|NCT05227703|617492532|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
170859034|NCT05227703|617492533|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
170859035|NCT05227703|617492534|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
170859036|NCT05227703|617492532|FG000|Overall Study|Other|1|||
170859037|NCT05227703|617492533|FG001|Overall Study|Other|1|||
170859038|NCT05227703|617492534|FG002|Overall Study|Other|0|||
170859039|NCT03319849|617492539|FG000|Overall Study|Adverse Event|1|||
170859040|NCT03319849|617492540|FG001|Overall Study|Adverse Event|0|||
170859041|NCT03319849|617492539|FG000|Overall Study|Physician Decision|0|||
170859042|NCT03319849|617492540|FG001|Overall Study|Physician Decision|1|||
170859043|NCT03319849|617492539|FG000|Overall Study|Withdrawal by Subject|0|||
170859044|NCT03319849|617492540|FG001|Overall Study|Withdrawal by Subject|1|||
170859045|NCT03319849|617492539|FG000|Overall Study|COVID-19|0|||
170859046|NCT03319849|617492540|FG001|Overall Study|COVID-19|1|||
170859047|NCT03319849|617492539|FG000|Overall Study|Other|1|||
170859048|NCT03319849|617492540|FG001|Overall Study|Other|2|||
170859049|NCT03319849|617492539|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
170859050|NCT03319849|617492540|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
170859051|NCT03319849|617492539|FG000|Overall Study|Lost to Follow-up|0|||
170859052|NCT03319849|617492540|FG001|Overall Study|Lost to Follow-up|2|||
170859053|NCT00001962|617494450|FG000|Overall Study|Lack of Efficacy|18|||
170859054|NCT00001962|617494450|FG000|Overall Study|Lack of Accrual|6|||
170859055|NCT00001962|617494450|FG000|Overall Study|Death|1|||
170859056|NCT00001962|617494450|FG000|Overall Study|Lost to Follow-up|2|||
170859057|NCT00001962|617494450|FG000|Overall Study|Adverse Event|1|||
170859058|NCT03217266|617494451|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
170859059|NCT03217266|617494452|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
170859060|NCT03217266|617494453|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
170859061|NCT03217266|617494454|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
170859062|NCT03217266|617494451|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
170859063|NCT03217266|617494452|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
170859064|NCT03217266|617494453|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
170859065|NCT03217266|617494454|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
170859066|NCT03217266|617494451|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
170859067|NCT03217266|617494452|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
170859068|NCT03217266|617494453|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
170859069|NCT03217266|617494454|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
170859070|NCT02101034|617494457|FG000|Overall Study|Enrolled but did not start treatment|0|||
170859071|NCT02101034|617494458|FG001|Overall Study|Enrolled but did not start treatment|0|||
170859072|NCT02101034|617494459|FG002|Overall Study|Enrolled but did not start treatment|1|||
170859073|NCT02101034|617494460|FG003|Overall Study|Enrolled but did not start treatment|0|||
170859074|NCT02101034|617494461|FG004|Overall Study|Enrolled but did not start treatment|0|||
170859075|NCT03938545|617494462|FG000|Overall Study|Lost to Follow-up|0|||
170859076|NCT03938545|617494463|FG001|Overall Study|Lost to Follow-up|0|||
170859077|NCT03938545|617494464|FG002|Overall Study|Lost to Follow-up|0|||
170859078|NCT03938545|617494465|FG003|Overall Study|Lost to Follow-up|1|||
170859079|NCT03938545|617494462|FG000|Overall Study|Non-compliance with study drug|0|||
170859080|NCT03938545|617494463|FG001|Overall Study|Non-compliance with study drug|0|||
170859081|NCT03938545|617494464|FG002|Overall Study|Non-compliance with study drug|1|||
170859082|NCT03938545|617494465|FG003|Overall Study|Non-compliance with study drug|0|||
170859083|NCT03938545|617494462|FG000|Overall Study|Pregnancy|1|||
170744332|NCT04921969|617070210|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
170744333|NCT04921969|617070211|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
170744334|NCT04921969|617070212|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
170744335|NCT04921969|617070206|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
170744336|NCT04921969|617070207|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
170744337|NCT04921969|617070208|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
170744338|NCT04921969|617070209|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
170744339|NCT04921969|617070210|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
170744340|NCT04921969|617070211|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
170744341|NCT04921969|617070212|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
170744342|NCT04921969|617070206|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
170744343|NCT04921969|617070207|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
170744344|NCT04921969|617070208|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
170744345|NCT04921969|617070209|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
170744346|NCT04921969|617070210|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
170744347|NCT04921969|617070211|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
170744348|NCT04921969|617070212|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
170744349|NCT04287868|617070213|FG000|Overall Study|Screening fail|1|||
170744350|NCT04287868|617070214|FG001|Overall Study|Screening fail|0|||
170744351|NCT03884231|617071497|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
170744352|NCT03884231|617071497|FG000|Overall Study|Subject Withdrew Consent|1|||
170744353|NCT03884231|617071497|FG000|Overall Study|MRI Scan Not Performed|1|||
170744354|NCT01912781|617071498|FG000|Overall Study|Withdrawal by Subject|2|||
170744355|NCT01912781|617071499|FG001|Overall Study|Withdrawal by Subject|0|||
170744356|NCT01208415|617071539|FG000|Overall Study|Death|1|||
170744357|NCT01208415|617071539|FG000|Overall Study|Lost to Follow-up|2|||
170744358|NCT01208415|617071539|FG000|Overall Study|Withdrawal by Subject|3|||
170744359|NCT01208415|617071539|FG000|Overall Study|Device not placed|1|||
170744360|NCT01208415|617071539|FG000|Overall Study|Still be eligible for follow-up|33|||
170744361|NCT01464255|617071542|FG000|Overall Study|unresolve corneal staining|0|||
170744362|NCT01464255|617071543|FG001|Overall Study|unresolve corneal staining|1|||
170744363|NCT01868074|617071548|FG000|Overall Study|Lost to Follow-up|3|||
170744364|NCT01868074|617071549|FG001|Overall Study|Lost to Follow-up|2|||
170744365|NCT01868074|617071548|FG000|Overall Study|Withdrawal by Subject|4|||
170744366|NCT01868074|617071549|FG001|Overall Study|Withdrawal by Subject|2|||
170744367|NCT03306043|617071550|FG000|Overall Study|Adverse Event|1|||
170859084|NCT03938545|617494463|FG001|Overall Study|Pregnancy|0|||
170744368|NCT03306043|617071550|FG000|Overall Study|Lost to Follow-up|1|||
170744369|NCT03306043|617071550|FG000|Overall Study|Withdrawal by Subject|2|||
170744370|NCT01544491|617071551|FG000|Overall Study|Withdrawal by Subject|3|||
170744371|NCT01544491|617071552|FG001|Overall Study|Withdrawal by Subject|2|||
170744372|NCT01544491|617071551|FG000|Overall Study|Lost to Follow-up|0|||
170744373|NCT01544491|617071552|FG001|Overall Study|Lost to Follow-up|1|||
170859085|NCT03938545|617494464|FG002|Overall Study|Pregnancy|0|||
170859086|NCT03938545|617494465|FG003|Overall Study|Pregnancy|0|||
170859087|NCT03938545|617494462|FG000|Overall Study|Study terminated by sponsor|6|||
170859088|NCT03938545|617494463|FG001|Overall Study|Study terminated by sponsor|4|||
170859089|NCT03938545|617494464|FG002|Overall Study|Study terminated by sponsor|2|||
170859090|NCT03938545|617494465|FG003|Overall Study|Study terminated by sponsor|4|||
170859091|NCT03938545|617494462|FG000|Overall Study|Withdrawal by Subject|0|||
170859092|NCT03938545|617494463|FG001|Overall Study|Withdrawal by Subject|1|||
170859093|NCT03938545|617494464|FG002|Overall Study|Withdrawal by Subject|0|||
170859094|NCT03938545|617494465|FG003|Overall Study|Withdrawal by Subject|0|||
170859095|NCT03938545|617494462|FG000|Overall Study|Adverse Event|1|||
170859096|NCT03938545|617494463|FG001|Overall Study|Adverse Event|0|||
170859097|NCT03938545|617494464|FG002|Overall Study|Adverse Event|0|||
170859098|NCT03938545|617494465|FG003|Overall Study|Adverse Event|0|||
170859099|NCT02647320|617494469|FG000|Overall Study|Adverse Event|0|||
170859100|NCT02647320|617494470|FG001|Overall Study|Adverse Event|1|||
170859101|NCT02647320|617494471|FG002|Overall Study|Adverse Event|3|||
170859102|NCT02647320|617494472|FG003|Overall Study|Adverse Event|2|||
170859103|NCT02647320|617494473|FG004|Overall Study|Adverse Event|1|||
170859104|NCT02647320|617494469|FG000|Overall Study|Protocol Violation|0|||
170859105|NCT02647320|617494470|FG001|Overall Study|Protocol Violation|0|||
170859106|NCT02647320|617494471|FG002|Overall Study|Protocol Violation|3|||
170859107|NCT02647320|617494472|FG003|Overall Study|Protocol Violation|0|||
170859108|NCT02647320|617494473|FG004|Overall Study|Protocol Violation|0|||
170859109|NCT02647320|617494469|FG000|Overall Study|Withdrawal by Subject|7|||
170859110|NCT02647320|617494470|FG001|Overall Study|Withdrawal by Subject|4|||
170859111|NCT02647320|617494471|FG002|Overall Study|Withdrawal by Subject|2|||
170859112|NCT02647320|617494472|FG003|Overall Study|Withdrawal by Subject|2|||
170859113|NCT02647320|617494473|FG004|Overall Study|Withdrawal by Subject|7|||
170859114|NCT02647320|617494469|FG000|Overall Study|Persistent hyperglycemia|0|||
170859115|NCT02647320|617494470|FG001|Overall Study|Persistent hyperglycemia|1|||
170859116|NCT02647320|617494471|FG002|Overall Study|Persistent hyperglycemia|1|||
170744374|NCT01544491|617071551|FG000|Overall Study|administrative problems|2|||
170744375|NCT01544491|617071552|FG001|Overall Study|administrative problems|0|||
170744376|NCT02494206|617071553|FG000|Overall Study|Adverse Event|1|||
170744377|NCT02494206|617071553|FG000|Overall Study|Disease Progression|1|||
170744378|NCT01013792|617071554|FG000|Overall Study|Study suspended|2|||
170744379|NCT01013792|617071555|FG001|Overall Study|Study suspended|1|||
170744380|NCT01013792|617071554|FG000|Overall Study|Adverse Event|0|||
170744381|NCT01013792|617071555|FG001|Overall Study|Adverse Event|3|||
170744382|NCT01013792|617071554|FG000|Overall Study|Lost to Follow-up|0|||
170744383|NCT01013792|617071555|FG001|Overall Study|Lost to Follow-up|1|||
170744384|NCT00896454|617071557|FG000|Overall Study|Death|10|||
170744385|NCT00896454|617071557|FG000|Overall Study|Adverse Event|8|||
170744386|NCT00896454|617071557|FG000|Overall Study|Disease Progression|5|||
170744387|NCT00896454|617071557|FG000|Overall Study|Other|4|||
170744388|NCT00896454|617071557|FG000|Overall Study|Requirement for alternative therapy|3|||
170744389|NCT00896454|617071557|FG000|Overall Study|Ongoing in study|2|||
170744390|NCT00896454|617071557|FG000|Overall Study|Withdrawal by Subject|1|||
170744391|NCT01461993|617071561|FG000|Overall Study|Withdrawal by Subject|60|||
170744392|NCT01461993|617071562|FG001|Overall Study|Withdrawal by Subject|53|||
170744393|NCT01461993|617071563|FG002|Overall Study|Withdrawal by Subject|16|||
170744394|NCT01461993|617071561|FG000|Overall Study|Lost to Follow-up|44|||
170744395|NCT01461993|617071562|FG001|Overall Study|Lost to Follow-up|48|||
170744396|NCT01461993|617071563|FG002|Overall Study|Lost to Follow-up|22|||
170744397|NCT01461993|617071561|FG000|Overall Study|Protocol Violation|10|||
170744398|NCT01461993|617071562|FG001|Overall Study|Protocol Violation|9|||
170744399|NCT01461993|617071563|FG002|Overall Study|Protocol Violation|7|||
170744400|NCT01461993|617071561|FG000|Overall Study|Adverse Event|9|||
170859117|NCT02647320|617494472|FG003|Overall Study|Persistent hyperglycemia|1|||
170859118|NCT02647320|617494473|FG004|Overall Study|Persistent hyperglycemia|1|||
170859119|NCT02647320|617494469|FG000|Overall Study|Study terminated by sponsor|1|||
170744401|NCT01461993|617071562|FG001|Overall Study|Adverse Event|11|||
170744402|NCT01461993|617071563|FG002|Overall Study|Adverse Event|3|||
170744403|NCT01461993|617071561|FG000|Overall Study|No longer met eligibility criteria|13|||
170744404|NCT01461993|617071562|FG001|Overall Study|No longer met eligibility criteria|18|||
170859120|NCT02647320|617494470|FG001|Overall Study|Study terminated by sponsor|1|||
170859121|NCT02647320|617494471|FG002|Overall Study|Study terminated by sponsor|1|||
170859122|NCT02647320|617494472|FG003|Overall Study|Study terminated by sponsor|1|||
170859123|NCT02647320|617494473|FG004|Overall Study|Study terminated by sponsor|2|||
170859124|NCT02647320|617494469|FG000|Overall Study|Reason not provided|0|||
170859125|NCT02647320|617494470|FG001|Overall Study|Reason not provided|0|||
170859126|NCT02647320|617494471|FG002|Overall Study|Reason not provided|1|||
170859127|NCT02647320|617494472|FG003|Overall Study|Reason not provided|0|||
170859128|NCT02647320|617494473|FG004|Overall Study|Reason not provided|2|||
170744405|NCT01461993|617071563|FG002|Overall Study|No longer met eligibility criteria|10|||
170744406|NCT01461993|617071561|FG000|Overall Study|Did not meet entrance criteria|2|||
170744407|NCT01461993|617071562|FG001|Overall Study|Did not meet entrance criteria|3|||
170744408|NCT01461993|617071563|FG002|Overall Study|Did not meet entrance criteria|0|||
170744409|NCT01461993|617071561|FG000|Overall Study|Other|13|||
170859129|NCT02647320|617494469|FG000|Overall Study|Lost to Follow-up|1|||
170859130|NCT02647320|617494470|FG001|Overall Study|Lost to Follow-up|1|||
170859131|NCT02647320|617494471|FG002|Overall Study|Lost to Follow-up|0|||
170859132|NCT02647320|617494472|FG003|Overall Study|Lost to Follow-up|0|||
170859133|NCT02647320|617494473|FG004|Overall Study|Lost to Follow-up|0|||
170859134|NCT02647320|617494469|FG000|Overall Study|Develop anemia|1|||
170859135|NCT02647320|617494470|FG001|Overall Study|Develop anemia|0|||
170859136|NCT02647320|617494471|FG002|Overall Study|Develop anemia|0|||
170859137|NCT02647320|617494472|FG003|Overall Study|Develop anemia|0|||
170859138|NCT02647320|617494473|FG004|Overall Study|Develop anemia|0|||
170859139|NCT02647320|617494469|FG000|Overall Study|Lack of Efficacy|0|||
170859140|NCT02647320|617494470|FG001|Overall Study|Lack of Efficacy|0|||
170859141|NCT02647320|617494471|FG002|Overall Study|Lack of Efficacy|0|||
170859142|NCT02647320|617494472|FG003|Overall Study|Lack of Efficacy|1|||
170859143|NCT02647320|617494473|FG004|Overall Study|Lack of Efficacy|0|||
170859144|NCT02647320|617494469|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
170859145|NCT02647320|617494470|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
170859146|NCT02647320|617494471|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
170859147|NCT02647320|617494472|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
170859148|NCT02647320|617494473|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
170744410|NCT01461993|617071562|FG001|Overall Study|Other|15|||
170744411|NCT01461993|617071563|FG002|Overall Study|Other|6|||
170744412|NCT03688711|617071570|FG000|Overall Study|Withdrawal by Subject|0|||
170744413|NCT03688711|617071571|FG001|Overall Study|Withdrawal by Subject|1|||
170744414|NCT05064735|617071573|FG000|Overall Study|Withdrawal by Subject|7|||
170744415|NCT05064735|617071574|FG001|Overall Study|Withdrawal by Subject|8|||
170744416|NCT05064735|617071573|FG000|Overall Study|Lost to Follow-up|7|||
170744417|NCT05064735|617071574|FG001|Overall Study|Lost to Follow-up|2|||
170744418|NCT05064735|617071573|FG000|Overall Study|Physician Decision|2|||
170744419|NCT05064735|617071574|FG001|Overall Study|Physician Decision|1|||
170744420|NCT05064735|617071573|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
170744421|NCT05064735|617071574|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
170744422|NCT05064735|617071573|FG000|Overall Study|Site Closure|7|||
170744423|NCT05064735|617071574|FG001|Overall Study|Site Closure|2|||
170744424|NCT01265823|617071576|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
170744425|NCT01265823|617071576|FG000|Overall Study|Failure to Return|4|||
170744426|NCT01265823|617071576|FG000|Overall Study|Protocol Violation|1|||
170744427|NCT01265823|617071576|FG000|Overall Study|Participant Request|1|||
170744428|NCT01263106|617071577|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
170744429|NCT01263106|617071578|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
170744430|NCT03691948|617071579|FG000|Overall Study|Lost to Follow-up|1|||
170744431|NCT03691948|617071580|FG001|Overall Study|Lost to Follow-up|3|||
170744432|NCT05490329|617071581|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
170744433|NCT05490329|617071582|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
170744434|NCT05490329|617071581|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
170744435|NCT05490329|617071582|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
170744436|NCT05490329|617071581|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
170744437|NCT05490329|617071582|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
170744438|NCT02120664|617071586|FG000|Overall Study|Withdrawal by Subject|0|||
170744439|NCT02120664|617071587|FG001|Overall Study|Withdrawal by Subject|0|||
170744440|NCT02120664|617071588|FG002|Overall Study|Withdrawal by Subject|0|||
170744441|NCT02120664|617071589|FG003|Overall Study|Withdrawal by Subject|1|||
170744442|NCT02120664|617071590|FG004|Overall Study|Withdrawal by Subject|0|||
170744443|NCT02460263|617071591|FG000|Transition Period|Withdrawal by Subject|1|||
170744444|NCT02460263|617071591|FG000|Transition Period|Death|1|||
170744445|NCT04524598|617071594|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
170744446|NCT04524598|617071595|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
170744447|NCT04524598|617071596|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
170744448|NCT04524598|617071597|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
170744449|NCT04524598|617071598|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
170744450|NCT04524598|617071594|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
170744451|NCT04524598|617071595|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
170744452|NCT04524598|617071596|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744453|NCT04524598|617071597|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744454|NCT04524598|617071598|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744455|NCT04524598|617071594|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
170859149|NCT00081770|617494474|FG000|Overall Study|Adverse Event|130|||
170859150|NCT00081770|617494475|FG001|Overall Study|Adverse Event|98|||
170744456|NCT04524598|617071595|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
170744457|NCT04524598|617071596|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
170744458|NCT04524598|617071597|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
170744459|NCT04524598|617071598|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
170744460|NCT04524598|617071594|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
170744461|NCT04524598|617071595|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
170744462|NCT04524598|617071596|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
170744463|NCT04524598|617071597|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
170744464|NCT04524598|617071598|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
170744465|NCT04524598|617071594|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744466|NCT04524598|617071595|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744467|NCT04524598|617071596|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
170744468|NCT04524598|617071597|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
170744469|NCT04524598|617071598|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744470|NCT04524598|617071594|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
170744471|NCT04524598|617071595|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
170744472|NCT04524598|617071596|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
170744473|NCT04524598|617071597|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
170744474|NCT04524598|617071598|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
170744475|NCT04524598|617071594|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744476|NCT04524598|617071595|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744477|NCT04524598|617071596|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744478|NCT04524598|617071597|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
170744479|NCT04524598|617071598|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
170744480|NCT02301156|617071599|FG000|Overall Study|Adverse Event|13|||
170744481|NCT02301156|617071600|FG001|Overall Study|Adverse Event|14|||
170744482|NCT02301156|617071599|FG000|Overall Study|Death|1|||
170744483|NCT02301156|617071600|FG001|Overall Study|Death|5|||
170744484|NCT02301156|617071599|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
170744485|NCT02301156|617071600|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
170744486|NCT02301156|617071599|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
170744487|NCT02301156|617071600|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
170744488|NCT02301156|617071599|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
170744489|NCT02301156|617071600|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
170744490|NCT02301156|617071599|FG000|Overall Study|Reason not Specified|6|||
170744491|NCT02301156|617071600|FG001|Overall Study|Reason not Specified|3|||
170744492|NCT00785707|617071601|FG000|Overall Study|Lost to Follow-up|7|||
170744493|NCT02306122|617071604|FG000|Initial Physician Randomization|Physician Decision|0|||
170744494|NCT02306122|617071605|FG001|Initial Physician Randomization|Physician Decision|0|||
170744495|NCT02306122|617071606|FG002|Initial Physician Randomization|Physician Decision|0|||
170744496|NCT02306122|617071607|FG003|Initial Physician Randomization|Physician Decision|0|||
170744497|NCT02306122|617071608|FG004|Initial Physician Randomization|Physician Decision|0|||
170744498|NCT02306122|617071609|FG005|Initial Physician Randomization|Physician Decision|0|||
170744499|NCT02306122|617071610|FG006|Initial Physician Randomization|Physician Decision|0|||
170744500|NCT02306122|617071611|FG007|Initial Physician Randomization|Physician Decision|0|||
170744501|NCT02306122|617071612|FG008|Initial Physician Randomization|Physician Decision|1|||
170744502|NCT02306122|617071613|FG009|Initial Physician Randomization|Physician Decision|0|||
170744503|NCT02306122|617071614|FG010|Initial Physician Randomization|Physician Decision|0|||
170744504|NCT02638623|617071617|FG000|Overall Study|Surgery timing|5|||
170744505|NCT02638623|617071618|FG001|Overall Study|Surgery timing|6|||
170744506|NCT02638623|617071617|FG000|Overall Study|Not given intervention|2|||
170744507|NCT02638623|617071618|FG001|Overall Study|Not given intervention|0|||
170744508|NCT05295732|617071621|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
170744509|NCT05295732|617071622|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
170744510|NCT05295732|617071623|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
170744511|NCT05295732|617071624|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
170744512|NCT05295732|617071625|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
170744513|NCT05295732|617071621|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
170744514|NCT05295732|617071622|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
170744515|NCT05295732|617071623|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
170744516|NCT05295732|617071624|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
170744517|NCT05295732|617071625|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
170744518|NCT03797326|617071626|FG000|Overall Study|Lost to Follow-up|1|||
170744519|NCT03797326|617071627|FG001|Overall Study|Lost to Follow-up|0|||
170744520|NCT03797326|617071628|FG002|Overall Study|Lost to Follow-up|0|||
170744521|NCT03797326|617071629|FG003|Overall Study|Lost to Follow-up|1|||
170744522|NCT03797326|617071630|FG004|Overall Study|Lost to Follow-up|0|||
170744523|NCT03797326|617071631|FG005|Overall Study|Lost to Follow-up|0|||
170744524|NCT03797326|617071632|FG006|Overall Study|Lost to Follow-up|0|||
170744525|NCT03797326|617071633|FG007|Overall Study|Lost to Follow-up|0|||
170744526|NCT03797326|617071626|FG000|Overall Study|Withdrawal by Subject|0|||
170859151|NCT00081770|617494476|FG002|Overall Study|Adverse Event|136|||
170859152|NCT00081770|617494474|FG000|Overall Study|Lack of Efficacy|262|||
170859153|NCT00081770|617494475|FG001|Overall Study|Lack of Efficacy|357|||
170859154|NCT00081770|617494476|FG002|Overall Study|Lack of Efficacy|211|||
170859155|NCT00081770|617494474|FG000|Overall Study|Lost to Follow-up|45|||
170859156|NCT00081770|617494475|FG001|Overall Study|Lost to Follow-up|34|||
170859157|NCT00081770|617494476|FG002|Overall Study|Lost to Follow-up|45|||
170859158|NCT00081770|617494474|FG000|Overall Study|Protocol Violation|15|||
170859159|NCT00081770|617494475|FG001|Overall Study|Protocol Violation|10|||
170859160|NCT00081770|617494476|FG002|Overall Study|Protocol Violation|10|||
170859161|NCT00081770|617494474|FG000|Overall Study|Withdrawal by Subject|45|||
170859162|NCT00081770|617494475|FG001|Overall Study|Withdrawal by Subject|40|||
170859163|NCT00081770|617494476|FG002|Overall Study|Withdrawal by Subject|42|||
170859164|NCT00081770|617494474|FG000|Overall Study|Did not meet protocol eligibility|2|||
170859165|NCT00081770|617494475|FG001|Overall Study|Did not meet protocol eligibility|0|||
170859166|NCT00081770|617494476|FG002|Overall Study|Did not meet protocol eligibility|3|||
170859167|NCT00081770|617494474|FG000|Overall Study|Administrative|1|||
170859168|NCT00081770|617494475|FG001|Overall Study|Administrative|0|||
170859169|NCT00081770|617494476|FG002|Overall Study|Administrative|1|||
170859170|NCT00081770|617494474|FG000|Overall Study|Other|2|||
170859171|NCT00081770|617494475|FG001|Overall Study|Other|7|||
170859172|NCT00081770|617494476|FG002|Overall Study|Other|8|||
170859173|NCT03435497|617494477|FG000|Overall Study|Lost to Follow-up|1|||
170744527|NCT03797326|617071627|FG001|Overall Study|Withdrawal by Subject|0|||
170744528|NCT03797326|617071628|FG002|Overall Study|Withdrawal by Subject|1|||
170744529|NCT03797326|617071629|FG003|Overall Study|Withdrawal by Subject|3|||
170744530|NCT03797326|617071630|FG004|Overall Study|Withdrawal by Subject|0|||
170744531|NCT03797326|617071631|FG005|Overall Study|Withdrawal by Subject|2|||
170744532|NCT03797326|617071632|FG006|Overall Study|Withdrawal by Subject|2|||
170744533|NCT03797326|617071633|FG007|Overall Study|Withdrawal by Subject|3|||
170744534|NCT03797326|617071626|FG000|Overall Study|Sponsor Decision|3|||
170744535|NCT03797326|617071627|FG001|Overall Study|Sponsor Decision|3|||
170744536|NCT03797326|617071628|FG002|Overall Study|Sponsor Decision|3|||
170744537|NCT03797326|617071629|FG003|Overall Study|Sponsor Decision|6|||
170744538|NCT03797326|617071630|FG004|Overall Study|Sponsor Decision|0|||
170744539|NCT03797326|617071631|FG005|Overall Study|Sponsor Decision|3|||
170744540|NCT03797326|617071632|FG006|Overall Study|Sponsor Decision|3|||
170744541|NCT03797326|617071633|FG007|Overall Study|Sponsor Decision|2|||
170744542|NCT03797326|617071626|FG000|Overall Study|Death|27|||
170744543|NCT03797326|617071627|FG001|Overall Study|Death|28|||
170744544|NCT03797326|617071628|FG002|Overall Study|Death|95|||
170744545|NCT03797326|617071629|FG003|Overall Study|Death|95|||
170744546|NCT03797326|617071630|FG004|Overall Study|Death|30|||
170744547|NCT03797326|617071631|FG005|Overall Study|Death|96|||
170744548|NCT03797326|617071632|FG006|Overall Study|Death|97|||
170744549|NCT03797326|617071633|FG007|Overall Study|Death|98|||
170744550|NCT03797326|617071626|FG000|Overall Study|Enrolled in error|0|||
170744551|NCT03797326|617071627|FG001|Overall Study|Enrolled in error|0|||
170744552|NCT03797326|617071628|FG002|Overall Study|Enrolled in error|3|||
170744553|NCT03797326|617071629|FG003|Overall Study|Enrolled in error|2|||
170744554|NCT03797326|617071630|FG004|Overall Study|Enrolled in error|2|||
170744555|NCT03797326|617071631|FG005|Overall Study|Enrolled in error|1|||
170744556|NCT03797326|617071632|FG006|Overall Study|Enrolled in error|1|||
170744557|NCT03797326|617071633|FG007|Overall Study|Enrolled in error|0|||
170744558|NCT03012061|617071634|FG000|Overall Study|Withdrawal by Subject|1|||
170744559|NCT03012061|617071635|FG001|Overall Study|Withdrawal by Subject|5|||
170744560|NCT03012061|617071636|FG002|Overall Study|Withdrawal by Subject|4|||
170744561|NCT03012061|617071634|FG000|Overall Study|Investigator Site Closed|1|||
170859174|NCT03435497|617494478|FG001|Overall Study|Lost to Follow-up|0|||
170859175|NCT03435497|617494477|FG000|Overall Study|Death|1|||
170859176|NCT03435497|617494478|FG001|Overall Study|Death|0|||
170859177|NCT03435497|617494477|FG000|Overall Study|Withdrawal by Subject|0|||
170859178|NCT03435497|617494478|FG001|Overall Study|Withdrawal by Subject|4|||
170859179|NCT03435497|617494477|FG000|Overall Study|Wrong survey administered|0|||
170859180|NCT03435497|617494478|FG001|Overall Study|Wrong survey administered|2|||
170859181|NCT00601419|617494479|FG000|Overall Study|Lost to Follow-up|3|||
170859182|NCT00601419|617494479|FG000|Overall Study|Missed Visits|1|||
170859183|NCT00995020|617494488|FG000|Overall Study|margin analysis not performed|2|||
170859184|NCT00995020|617494489|FG001|Overall Study|margin analysis not performed|5|||
170859185|NCT00995020|617494488|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
170859186|NCT00995020|617494489|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
170859187|NCT00701779|617494492|FG000|Overall Study|Adverse Event|6|||
170744562|NCT03012061|617071635|FG001|Overall Study|Investigator Site Closed|2|||
170744563|NCT03012061|617071636|FG002|Overall Study|Investigator Site Closed|0|||
170859188|NCT00701779|617494492|FG000|Overall Study|Lost to Follow-up|1|||
170744564|NCT03012061|617071634|FG000|Overall Study|Lost to Follow-up|2|||
170744565|NCT03012061|617071635|FG001|Overall Study|Lost to Follow-up|1|||
170744566|NCT03012061|617071636|FG002|Overall Study|Lost to Follow-up|0|||
170859189|NCT00701779|617494492|FG000|Overall Study|Withdrawal by Subject|2|||
170744567|NCT03012061|617071634|FG000|Overall Study|Study closed/ Terminated|0|||
170744568|NCT03012061|617071635|FG001|Overall Study|Study closed/ Terminated|0|||
170744569|NCT03012061|617071636|FG002|Overall Study|Study closed/ Terminated|1|||
170744570|NCT03012061|617071634|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
170744571|NCT03012061|617071635|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
170744572|NCT03012061|617071636|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
170744573|NCT03012061|617071634|FG000|Overall Study|Protocol Violation|0|||
170744574|NCT03012061|617071635|FG001|Overall Study|Protocol Violation|0|||
170744575|NCT03012061|617071636|FG002|Overall Study|Protocol Violation|2|||
170744576|NCT03012061|617071634|FG000|Overall Study|Lack of Efficacy|0|||
170744577|NCT03012061|617071635|FG001|Overall Study|Lack of Efficacy|1|||
170744578|NCT03012061|617071636|FG002|Overall Study|Lack of Efficacy|0|||
170744579|NCT03012061|617071634|FG000|Overall Study|Adverse Event|2|||
170744580|NCT03012061|617071635|FG001|Overall Study|Adverse Event|0|||
170744581|NCT03012061|617071636|FG002|Overall Study|Adverse Event|0|||
170744582|NCT02961374|617071641|FG000|Overall Study|Adverse Event|4|||
170744583|NCT05200936|617071642|FG000|Overall Study|Withdrawal by Subject|2|||
170744584|NCT05200936|617071643|FG001|Overall Study|Withdrawal by Subject|2|||
170744585|NCT05200936|617071642|FG000|Overall Study|Lost to Follow-up|2|||
170744586|NCT05200936|617071643|FG001|Overall Study|Lost to Follow-up|0|||
170744587|NCT05200936|617071642|FG000|Overall Study|Pregnancy|0|||
170744588|NCT05200936|617071643|FG001|Overall Study|Pregnancy|1|||
170744589|NCT00127413|617071644|FG000|Overall Study|Lost to Follow-up|6|||
170744590|NCT00127413|617071645|FG001|Overall Study|Lost to Follow-up|4|||
170744591|NCT00127413|617071646|FG002|Overall Study|Lost to Follow-up|8|||
170744592|NCT00127413|617071647|FG003|Overall Study|Lost to Follow-up|2|||
170859190|NCT02245672|617494493|FG000|Overall Study|Adverse Event|4|||
170859191|NCT02245672|617494494|FG001|Overall Study|Adverse Event|4|||
170859192|NCT02245672|617494495|FG002|Overall Study|Adverse Event|4|||
170859193|NCT02245672|617494493|FG000|Overall Study|Lost to Follow-up|3|||
170859194|NCT02245672|617494494|FG001|Overall Study|Lost to Follow-up|5|||
170859195|NCT02245672|617494495|FG002|Overall Study|Lost to Follow-up|1|||
170859196|NCT02245672|617494493|FG000|Overall Study|Withdrawal by Subject|6|||
170859197|NCT02245672|617494494|FG001|Overall Study|Withdrawal by Subject|3|||
170859198|NCT02245672|617494495|FG002|Overall Study|Withdrawal by Subject|0|||
170859199|NCT02245672|617494493|FG000|Overall Study|Randomized in error (not treated)|0|||
170859200|NCT02245672|617494494|FG001|Overall Study|Randomized in error (not treated)|1|||
170859201|NCT02245672|617494495|FG002|Overall Study|Randomized in error (not treated)|0|||
170859202|NCT01640054|617494498|FG000|Overall Study|Study-specific disc criteria|1|||
170859203|NCT01640054|617494498|FG000|Overall Study|Lack of Efficacy|3|||
170859204|NCT01640054|617494498|FG000|Overall Study|Adverse Event|2|||
170859205|NCT00288509|617494499|FG000|Treatment Cycle 1|Adverse Event|1|||
170859206|NCT00288509|617494499|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
170859207|NCT00288509|617494499|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
170859208|NCT00288509|617494499|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
170859209|NCT00288509|617494499|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
170859210|NCT00288509|617494499|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
170859211|NCT00288509|617494499|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
170859212|NCT00288509|617494499|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
170859213|NCT00288509|617494499|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
170859214|NCT00288509|617494499|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
170859215|NCT00288509|617494499|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
170859216|NCT00288509|617494499|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
170859217|NCT00288509|617494499|FG000|Treatment Cycle 4|Physician Decision|4|||
170859218|NCT00288509|617494499|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
170859219|NCT00719563|617494500|FG000|Overall Study|Adverse Event|16|||
170859220|NCT00719563|617494501|FG001|Overall Study|Adverse Event|13|||
170859221|NCT00719563|617494500|FG000|Overall Study|Medical condition changed|3|||
170859222|NCT00719563|617494501|FG001|Overall Study|Medical condition changed|5|||
170859223|NCT00719563|617494500|FG000|Overall Study|Lack of Efficacy|3|||
170859224|NCT00719563|617494501|FG001|Overall Study|Lack of Efficacy|7|||
170859225|NCT00719563|617494500|FG000|Overall Study|Personal reasons|6|||
170859226|NCT00719563|617494501|FG001|Overall Study|Personal reasons|7|||
170859227|NCT00719563|617494500|FG000|Overall Study|Unknown reasons|4|||
170859228|NCT00719563|617494501|FG001|Overall Study|Unknown reasons|6|||
170859229|NCT00719563|617494500|FG000|Overall Study|Noncompliant|1|||
170859230|NCT00719563|617494501|FG001|Overall Study|Noncompliant|1|||
170859231|NCT00719563|617494500|FG000|Overall Study|Lost to Follow-up|5|||
170859232|NCT00719563|617494501|FG001|Overall Study|Lost to Follow-up|3|||
170859233|NCT01386788|617494506|FG000|Overall Study|Lost to Follow-up|2|||
170859234|NCT02120625|617494507|FG000|Overall Study|Physician Decision|2|||
170859235|NCT02901041|617494508|FG000|Overall Study|Withdrawal by PI|4|||
170859236|NCT02901041|617494509|FG001|Overall Study|Withdrawal by PI|8|||
170859237|NCT02901041|617494508|FG000|Overall Study|Withdrawal by Subject|7|||
170859238|NCT02901041|617494509|FG001|Overall Study|Withdrawal by Subject|3|||
170859239|NCT03249714|617494510|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
170859240|NCT03249714|617494511|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
170859241|NCT03249714|617494510|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
170859242|NCT03249714|617494511|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
170859243|NCT03249714|617494510|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
170859244|NCT03249714|617494511|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
170859245|NCT03249714|617494510|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
170859246|NCT03249714|617494511|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
170859247|NCT03818204|617494512|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859248|NCT03818204|617494513|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859249|NCT03818204|617494514|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859250|NCT03818204|617494515|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859251|NCT03818204|617494516|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
170859252|NCT03818204|617494517|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859253|NCT03818204|617494518|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859254|NCT03818204|617494519|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859255|NCT03818204|617494520|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859256|NCT03818204|617494521|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859257|NCT03818204|617494522|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859258|NCT03818204|617494523|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859259|NCT03818204|617494524|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859260|NCT03818204|617494525|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
170859261|NCT03818204|617494526|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859262|NCT03818204|617494527|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859263|NCT03818204|617494528|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859264|NCT03818204|617494529|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859265|NCT03818204|617494530|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
170859266|NCT03818204|617494512|FG000|Overall Study|Physician Decision|0|||
170859267|NCT03818204|617494513|FG001|Overall Study|Physician Decision|0|||
170859268|NCT03818204|617494514|FG002|Overall Study|Physician Decision|0|||
170859269|NCT03818204|617494515|FG003|Overall Study|Physician Decision|0|||
170859270|NCT03818204|617494516|FG004|Overall Study|Physician Decision|0|||
170859271|NCT03818204|617494517|FG005|Overall Study|Physician Decision|0|||
170859272|NCT03818204|617494518|FG006|Overall Study|Physician Decision|0|||
170859273|NCT03818204|617494519|FG007|Overall Study|Physician Decision|0|||
170859274|NCT03818204|617494520|FG008|Overall Study|Physician Decision|0|||
170859275|NCT03818204|617494521|FG009|Overall Study|Physician Decision|0|||
170859276|NCT03818204|617494522|FG010|Overall Study|Physician Decision|0|||
170859277|NCT03818204|617494523|FG011|Overall Study|Physician Decision|0|||
170859278|NCT03818204|617494524|FG012|Overall Study|Physician Decision|0|||
170859279|NCT03818204|617494525|FG013|Overall Study|Physician Decision|0|||
170859280|NCT03818204|617494526|FG014|Overall Study|Physician Decision|1|||
170859281|NCT03818204|617494527|FG015|Overall Study|Physician Decision|0|||
170859282|NCT03818204|617494528|FG016|Overall Study|Physician Decision|0|||
170859283|NCT03818204|617494529|FG017|Overall Study|Physician Decision|0|||
170859284|NCT03818204|617494530|FG018|Overall Study|Physician Decision|0|||
170859285|NCT00667355|617494533|FG000|Overall Study|Adverse Event|5|||
170859286|NCT00667355|617494533|FG000|Overall Study|Lost to Follow-up|1|||
170859287|NCT00667355|617494533|FG000|Overall Study|Other reason was not specified|5|||
170859288|NCT00879762|617494534|FG000|Overall Study|Lost to Follow-up|3|||
170859289|NCT00879762|617494535|FG001|Overall Study|Lost to Follow-up|1|||
170859290|NCT04754477|617494538|FG000|Overall Study|Withdrawal by Subject|1|||
170859291|NCT01313637|617494541|FG000|Overall Study|Adverse Event|17|||
170859292|NCT01313637|617494542|FG001|Overall Study|Adverse Event|24|||
170859293|NCT01313637|617494543|FG002|Overall Study|Adverse Event|25|||
170859294|NCT01313637|617494544|FG003|Overall Study|Adverse Event|18|||
170859295|NCT01313637|617494541|FG000|Overall Study|Lack of Efficacy|44|||
170859296|NCT01313637|617494542|FG001|Overall Study|Lack of Efficacy|38|||
170859297|NCT01313637|617494543|FG002|Overall Study|Lack of Efficacy|37|||
170859298|NCT01313637|617494544|FG003|Overall Study|Lack of Efficacy|24|||
170859299|NCT01313637|617494541|FG000|Overall Study|Protocol Violation|4|||
170859300|NCT01313637|617494542|FG001|Overall Study|Protocol Violation|3|||
170859301|NCT01313637|617494543|FG002|Overall Study|Protocol Violation|11|||
170859302|NCT01313637|617494544|FG003|Overall Study|Protocol Violation|5|||
170859303|NCT01313637|617494541|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
170859304|NCT01313637|617494542|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
170859305|NCT01313637|617494543|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
170859306|NCT01313637|617494544|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
170859307|NCT01313637|617494541|FG000|Overall Study|Lost to Follow-up|0|||
170859308|NCT01313637|617494542|FG001|Overall Study|Lost to Follow-up|2|||
170859309|NCT01313637|617494543|FG002|Overall Study|Lost to Follow-up|1|||
170859310|NCT01313637|617494544|FG003|Overall Study|Lost to Follow-up|3|||
170859311|NCT01313637|617494541|FG000|Overall Study|Withdrawal by Subject|11|||
170859312|NCT01313637|617494542|FG001|Overall Study|Withdrawal by Subject|13|||
170859313|NCT01313637|617494543|FG002|Overall Study|Withdrawal by Subject|18|||
170859314|NCT01313637|617494544|FG003|Overall Study|Withdrawal by Subject|15|||
170859315|NCT04218084|617494546|FG000|Overall Study|Adverse Event|7|||
170859316|NCT04218084|617494547|FG001|Overall Study|Adverse Event|2|||
170859317|NCT04218084|617494546|FG000|Overall Study|Withdrawal of Consent|4|||
170859318|NCT04218084|617494547|FG001|Overall Study|Withdrawal of Consent|5|||
170859319|NCT04218084|617494546|FG000|Overall Study|Physician Decision|1|||
170859320|NCT04218084|617494547|FG001|Overall Study|Physician Decision|1|||
170859321|NCT04218084|617494546|FG000|Overall Study|Lost to Follow-up|1|||
170859322|NCT04218084|617494547|FG001|Overall Study|Lost to Follow-up|1|||
170859323|NCT04218084|617494546|FG000|Overall Study|Non-compliance with study drug|1|||
170859324|NCT04218084|617494547|FG001|Overall Study|Non-compliance with study drug|1|||
170859325|NCT04218084|617494546|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
170859326|NCT04218084|617494547|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
170859327|NCT04218084|617494546|FG000|Overall Study|Other|0|||
170859328|NCT04218084|617494547|FG001|Overall Study|Other|1|||
170859329|NCT04218084|617494546|FG000|Overall Study|Ongoing at data cut-off date|62|||
170859330|NCT04218084|617494547|FG001|Overall Study|Ongoing at data cut-off date|58|||
170859331|NCT04661878|617494548|FG000|Overall Study|Lost to Follow-up|6|||
170859332|NCT04661878|617494549|FG001|Overall Study|Lost to Follow-up|5|||
170859333|NCT05041101|617494550|FG000|Overall Study|Adverse Event|1|||
170859334|NCT05041101|617494551|FG001|Overall Study|Adverse Event|0|||
170859335|NCT05041101|617494552|FG002|Overall Study|Adverse Event|0|||
170859336|NCT05041101|617494550|FG000|Overall Study|Diease Progression|5|||
170859337|NCT05041101|617494551|FG001|Overall Study|Diease Progression|0|||
170859338|NCT05041101|617494552|FG002|Overall Study|Diease Progression|0|||
170859339|NCT03603028|617494555|FG000|Overall Study|Withdrawal by Subject|1|||
170859340|NCT03401229|617494558|FG000|Overall Study|Lost to Follow-up|2|||
170859341|NCT03401229|617494559|FG001|Overall Study|Lost to Follow-up|1|||
170859342|NCT03401229|617494558|FG000|Overall Study|Other|1|||
170859343|NCT03401229|617494559|FG001|Overall Study|Other|3|||
170859344|NCT03401229|617494558|FG000|Overall Study|Adverse Event|8|||
170859345|NCT03401229|617494559|FG001|Overall Study|Adverse Event|6|||
170859346|NCT03401229|617494558|FG000|Overall Study|Withdrawal by Subject|29|||
170859347|NCT03401229|617494559|FG001|Overall Study|Withdrawal by Subject|26|||
170859348|NCT03401229|617494558|FG000|Overall Study|COVID-19|0|||
170859349|NCT03401229|617494559|FG001|Overall Study|COVID-19|1|||
170859350|NCT02963610|617494560|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
170859351|NCT00842985|617494561|FG000|Screening|Did not meet entrance requirements|27|||
170859352|NCT00842985|617494561|FG000|First Intervention|Withdrawal by Subject|3|||
170859353|NCT00842985|617494561|FG000|First Intervention|Protocol Violation|3|||
170859354|NCT00842985|617494561|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
170859355|NCT00842985|617494561|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
170859356|NCT00690820|617494562|FG000|Period 1|Withdrawal by Subject|0|||
170859357|NCT00690820|617494563|FG001|Period 1|Withdrawal by Subject|1|||
170859358|NCT01122862|617494564|FG000|Period 1|Protocol Violation|0|||
170859359|NCT01122862|617494565|FG001|Period 1|Protocol Violation|1|||
170859360|NCT01122862|617494566|FG002|Period 1|Protocol Violation|0|||
170859361|NCT01122862|617494564|FG000|Period 2|Adverse Event|0|||
170859362|NCT01122862|617494565|FG001|Period 2|Adverse Event|0|||
170859363|NCT01122862|617494566|FG002|Period 2|Adverse Event|1|||
170859364|NCT00846391|617494567|FG000|Overall Study|Physician Decision|0|||
170859365|NCT00846391|617494568|FG001|Overall Study|Physician Decision|0|||
170859366|NCT00846391|617494569|FG002|Overall Study|Physician Decision|1|||
170859367|NCT00846391|617494567|FG000|Overall Study|Study Terminated by Sponsor|1|||
170859368|NCT00846391|617494568|FG001|Overall Study|Study Terminated by Sponsor|2|||
170859369|NCT00846391|617494569|FG002|Overall Study|Study Terminated by Sponsor|2|||
170859370|NCT02699983|617494570|FG000|Overall Study|Withdrawal by Subject|1|||
170859371|NCT02699983|617494571|FG001|Overall Study|Withdrawal by Subject|0|||
170859372|NCT01249274|617494572|FG000|Overall Study|Lost to Follow-up|3|||
170859373|NCT01249274|617494573|FG001|Overall Study|Lost to Follow-up|4|||
170859374|NCT01249274|617494572|FG000|Overall Study|Received inpatient substance treatment|1|||
170859375|NCT01249274|617494573|FG001|Overall Study|Received inpatient substance treatment|2|||
170859376|NCT03575143|617494574|FG000|Overall Study|Lost to Follow-up|0|||
170859377|NCT03575143|617494575|FG001|Overall Study|Lost to Follow-up|0|||
170859378|NCT03575143|617494576|FG002|Overall Study|Lost to Follow-up|4|||
170859379|NCT03575143|617494574|FG000|Overall Study|Withdrawal by Subject|0|||
170859380|NCT03575143|617494575|FG001|Overall Study|Withdrawal by Subject|0|||
170859381|NCT03575143|617494576|FG002|Overall Study|Withdrawal by Subject|5|||
170859382|NCT03575143|617494574|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
170859383|NCT03575143|617494575|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
170859384|NCT03575143|617494576|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
170859385|NCT01287065|617494577|FG000|Treatment Period 1|Adverse Event|0|||
170859386|NCT01287065|617494578|FG001|Treatment Period 1|Adverse Event|0|||
170859387|NCT01287065|617494579|FG002|Treatment Period 1|Adverse Event|0|||
170859388|NCT01287065|617494580|FG003|Treatment Period 1|Adverse Event|0|||
170859389|NCT01287065|617494581|FG004|Treatment Period 1|Adverse Event|1|||
170859390|NCT01287065|617494582|FG005|Treatment Period 1|Adverse Event|0|||
170859391|NCT01287065|617494577|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170859392|NCT01287065|617494578|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170859393|NCT01287065|617494579|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170859394|NCT01287065|617494580|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170859395|NCT01287065|617494581|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170859396|NCT01287065|617494582|FG005|Treatment Period 1|Withdrawal by Subject|1|||
170859397|NCT01259726|617494583|FG000|Overall Study|Death|1|||
170859398|NCT01259726|617494584|FG001|Overall Study|Death|0|||
170859399|NCT01259726|617494585|FG002|Overall Study|Death|0|||
170859400|NCT01259726|617494586|FG003|Overall Study|Death|0|||
170859401|NCT01259726|617494583|FG000|Overall Study|Physician Decision|2|||
170859402|NCT01259726|617494584|FG001|Overall Study|Physician Decision|0|||
170859403|NCT01259726|617494585|FG002|Overall Study|Physician Decision|1|||
170859404|NCT01259726|617494586|FG003|Overall Study|Physician Decision|1|||
170859405|NCT01259726|617494583|FG000|Overall Study|Withdrawal by Subject|1|||
170859406|NCT01259726|617494584|FG001|Overall Study|Withdrawal by Subject|3|||
170859407|NCT01259726|617494585|FG002|Overall Study|Withdrawal by Subject|2|||
170859408|NCT01259726|617494586|FG003|Overall Study|Withdrawal by Subject|1|||
170859409|NCT01259726|617494583|FG000|Overall Study|Lost to Follow-up|1|||
170859410|NCT01259726|617494584|FG001|Overall Study|Lost to Follow-up|1|||
170859411|NCT01259726|617494585|FG002|Overall Study|Lost to Follow-up|1|||
170859412|NCT01259726|617494586|FG003|Overall Study|Lost to Follow-up|3|||
170859413|NCT00261846|617494587|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
170859414|NCT00261846|617494588|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
170859415|NCT00261846|617494589|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
170859416|NCT00261846|617494590|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859417|NCT00261846|617494591|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859418|NCT00261846|617494592|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859419|NCT00261846|617494593|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859420|NCT00261846|617494594|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859421|NCT00261846|617494595|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859422|NCT00261846|617494596|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859423|NCT00261846|617494597|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859424|NCT00261846|617494598|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
170859425|NCT00261846|617494587|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859426|NCT00261846|617494588|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859427|NCT00261846|617494589|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859428|NCT00261846|617494590|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
170859429|NCT00261846|617494591|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859430|NCT00261846|617494592|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859431|NCT00261846|617494593|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859432|NCT00261846|617494594|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859433|NCT00261846|617494595|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
170859434|NCT00261846|617494596|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859435|NCT00261846|617494597|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859436|NCT00261846|617494598|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
170859437|NCT00261846|617494587|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
170859438|NCT00261846|617494588|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
170859439|NCT00261846|617494589|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
170859440|NCT00261846|617494590|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
170859441|NCT00261846|617494591|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
170859442|NCT00261846|617494592|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
170859443|NCT00261846|617494593|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
170859444|NCT00261846|617494594|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
170859445|NCT00261846|617494595|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
170859446|NCT00261846|617494596|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
170859447|NCT00261846|617494597|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
170859448|NCT00261846|617494598|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
170859449|NCT00261846|617494587|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
170859450|NCT00261846|617494588|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
170859451|NCT00261846|617494589|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
170859452|NCT00261846|617494590|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
170859453|NCT00261846|617494591|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
170859454|NCT00261846|617494592|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
170859455|NCT00261846|617494593|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
170859456|NCT00261846|617494594|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
170859457|NCT00261846|617494595|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
170859458|NCT00261846|617494596|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
170859459|NCT00261846|617494597|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
170859460|NCT00261846|617494598|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
170859461|NCT00261846|617494587|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
170859462|NCT00261846|617494588|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
170859463|NCT00261846|617494589|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
170859464|NCT00261846|617494590|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
170859465|NCT00261846|617494591|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
170859466|NCT00261846|617494592|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
170859467|NCT00261846|617494593|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
170859468|NCT00261846|617494594|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
170859469|NCT00261846|617494595|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
170859470|NCT00261846|617494596|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
170859471|NCT00261846|617494597|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
170859472|NCT00261846|617494598|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
170859473|NCT00261846|617494587|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
170859474|NCT00261846|617494588|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
170859475|NCT00261846|617494589|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
170859476|NCT00261846|617494590|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
170859477|NCT00261846|617494591|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
170859478|NCT00261846|617494592|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
170859479|NCT00261846|617494593|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
170859480|NCT00261846|617494594|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
170859481|NCT00261846|617494595|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
170859482|NCT00261846|617494596|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
170859483|NCT00261846|617494597|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
170859484|NCT00261846|617494598|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
170859485|NCT00261846|617494587|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
170859486|NCT00261846|617494588|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
170859487|NCT00261846|617494589|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
170859488|NCT00261846|617494590|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
170859489|NCT00261846|617494591|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
170859490|NCT00261846|617494592|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
170859491|NCT00261846|617494593|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
170859492|NCT00261846|617494594|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
170859493|NCT00261846|617494595|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
170859494|NCT00261846|617494596|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
170859495|NCT00261846|617494597|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
170859496|NCT00261846|617494598|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
170859497|NCT01776424|617494601|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
170859498|NCT01776424|617494602|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
170859499|NCT01776424|617494603|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
170859500|NCT01776424|617494601|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
170859501|NCT01776424|617494602|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
170859502|NCT01776424|617494603|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
170859503|NCT01776424|617494601|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
170859504|NCT01776424|617494602|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
170859505|NCT01776424|617494603|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
170859506|NCT01776424|617494601|FG000|LTOLE Part (Open Label)|Refused|5|||
170859507|NCT01776424|617494602|FG001|LTOLE Part (Open Label)|Refused|2|||
170859508|NCT01776424|617494603|FG002|LTOLE Part (Open Label)|Refused|11|||
170859509|NCT01776424|617494601|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
170859510|NCT01776424|617494602|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
170859511|NCT01776424|617494603|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
170859512|NCT02513303|617494605|FG000|Overall Study|Withdrawal by Subject|9|||
170859513|NCT02513303|617494606|FG001|Overall Study|Withdrawal by Subject|7|||
170859514|NCT02513303|617494607|FG002|Overall Study|Withdrawal by Subject|2|||
170859515|NCT02513303|617494605|FG000|Overall Study|Lost to Follow-up|2|||
170859516|NCT02513303|617494606|FG001|Overall Study|Lost to Follow-up|4|||
170859517|NCT02513303|617494607|FG002|Overall Study|Lost to Follow-up|0|||
170859518|NCT02513303|617494605|FG000|Overall Study|Adverse Event|0|||
170859519|NCT02513303|617494606|FG001|Overall Study|Adverse Event|1|||
170859520|NCT02513303|617494607|FG002|Overall Study|Adverse Event|0|||
170859521|NCT02513303|617494605|FG000|Overall Study|Physician Decision|1|||
170859522|NCT02513303|617494606|FG001|Overall Study|Physician Decision|1|||
170859523|NCT02513303|617494607|FG002|Overall Study|Physician Decision|0|||
170859524|NCT02513303|617494605|FG000|Overall Study|Death|8|||
170859525|NCT02513303|617494606|FG001|Overall Study|Death|4|||
170859526|NCT02513303|617494607|FG002|Overall Study|Death|2|||
170859527|NCT01691768|617494608|FG000|Overall Study|Death|0|||
170859528|NCT01691768|617494609|FG001|Overall Study|Death|2|||
170859529|NCT01691768|617494608|FG000|Overall Study|Lost to Follow-up|4|||
170859530|NCT01691768|617494609|FG001|Overall Study|Lost to Follow-up|3|||
170859531|NCT01691768|617494608|FG000|Overall Study|Withdrawal by Subject|10|||
170859532|NCT01691768|617494609|FG001|Overall Study|Withdrawal by Subject|9|||
170859533|NCT01691768|617494608|FG000|Overall Study|Relocated|0|||
170859534|NCT01691768|617494609|FG001|Overall Study|Relocated|1|||
170859535|NCT01691768|617494608|FG000|Overall Study|Investigator decision|1|||
170859536|NCT01691768|617494609|FG001|Overall Study|Investigator decision|1|||
170859537|NCT00887432|617494610|FG000|Overall Study|Start Excluded Therapy|3|||
170859538|NCT00887432|617494611|FG001|Overall Study|Start Excluded Therapy|0|||
170859539|NCT00887432|617494610|FG000|Overall Study|Did not complete treatment|6|||
170859540|NCT00887432|617494611|FG001|Overall Study|Did not complete treatment|8|||
170859541|NCT00887432|617494610|FG000|Overall Study|Protocol Violation|2|||
170859542|NCT00887432|617494611|FG001|Overall Study|Protocol Violation|3|||
170859543|NCT00887432|617494610|FG000|Overall Study|Withdrawal by Subject|3|||
170859544|NCT00887432|617494611|FG001|Overall Study|Withdrawal by Subject|2|||
170859545|NCT00887432|617494610|FG000|Overall Study|Lost to Follow-up|1|||
170859546|NCT00887432|617494611|FG001|Overall Study|Lost to Follow-up|0|||
170859547|NCT00887432|617494610|FG000|Overall Study|No reason provided|0|||
170859548|NCT00887432|617494611|FG001|Overall Study|No reason provided|1|||
170859549|NCT01745848|617494614|FG000|Overall Study|Adverse Event|6|||
170859550|NCT02112708|617494622|FG000|Baseline|Physician Decision|16|||
170859551|NCT02112708|617494623|FG001|Baseline|Physician Decision|11|||
170859552|NCT02112708|617494622|FG000|Baseline|Lost to Follow-up|12|||
170859553|NCT02112708|617494623|FG001|Baseline|Lost to Follow-up|0|||
170859554|NCT02112708|617494622|FG000|4 Month|Death|0|||
170859555|NCT02112708|617494623|FG001|4 Month|Death|1|||
170859556|NCT02112708|617494622|FG000|4 Month|Withdrawal by Subject|12|||
170859557|NCT02112708|617494623|FG001|4 Month|Withdrawal by Subject|0|||
170859558|NCT00953745|617494624|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
170859559|NCT00953745|617494625|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
170859560|NCT00953745|617494624|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
170859561|NCT00953745|617494625|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
170859562|NCT00953745|617494624|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
170859563|NCT00953745|617494625|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
170859564|NCT00953745|617494624|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
170859565|NCT00953745|617494625|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
170859566|NCT00953745|617494624|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
170859567|NCT00953745|617494625|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
170859568|NCT00953745|617494624|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
170859569|NCT00953745|617494625|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
170859570|NCT00704405|617494626|FG000|Overall Study (NC Population)|Adverse Event|1|||
170859571|NCT00704405|617494627|FG001|Overall Study (NC Population)|Adverse Event|0|||
170859572|NCT00704405|617494628|FG002|Overall Study (NC Population)|Adverse Event|0|||
170859573|NCT00704405|617494629|FG003|Overall Study (NC Population)|Adverse Event|0|||
170859574|NCT00704405|617494630|FG004|Overall Study (NC Population)|Adverse Event|0|||
170859575|NCT00704405|617494626|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
170859576|NCT00704405|617494627|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
170859577|NCT00704405|617494628|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
170859578|NCT00704405|617494629|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
170859579|NCT00704405|617494630|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
170859580|NCT00704405|617494626|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
170859581|NCT00704405|617494627|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
170859582|NCT00704405|617494628|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
170859583|NCT00704405|617494629|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
170859584|NCT00704405|617494630|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
170859585|NCT00704405|617494626|FG000|Overall Study (NC Population)|Other|0|||
170859586|NCT00704405|617494627|FG001|Overall Study (NC Population)|Other|0|||
170859587|NCT00704405|617494628|FG002|Overall Study (NC Population)|Other|0|||
170859588|NCT00704405|617494629|FG003|Overall Study (NC Population)|Other|0|||
170859589|NCT00704405|617494630|FG004|Overall Study (NC Population)|Other|1|||
170859590|NCT00704405|617494626|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
170859591|NCT00704405|617494627|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
170859592|NCT00704405|617494628|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
170859593|NCT00704405|617494629|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
170859594|NCT00704405|617494630|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
170859595|NCT00704405|617494626|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
170859596|NCT00704405|617494627|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
170859597|NCT00704405|617494628|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
170859598|NCT00704405|617494629|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
170859599|NCT00704405|617494630|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
170859600|NCT03866473|617494631|FG000|Phase 1|Death|1|||
170859601|NCT03866473|617494632|FG001|Phase 1|Death|0|||
170859602|NCT03866473|617494631|FG000|Phase 2|Death|0|||
170859603|NCT03866473|617494632|FG001|Phase 2|Death|2|||
170859604|NCT03866473|617494631|FG000|Phase 2|Dropped|1|||
170859605|NCT03866473|617494632|FG001|Phase 2|Dropped|1|||
170859606|NCT03866473|617494631|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
170859607|NCT03866473|617494632|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
170859608|NCT03756129|617494638|FG000|Overall Study|Adverse Event|1|||
170859609|NCT03756129|617494639|FG001|Overall Study|Adverse Event|1|||
170859610|NCT03756129|617494640|FG002|Overall Study|Adverse Event|0|||
170859611|NCT03756129|617494641|FG003|Overall Study|Adverse Event|2|||
170859612|NCT03756129|617494642|FG004|Overall Study|Adverse Event|0|||
170859613|NCT03756129|617494643|FG005|Overall Study|Adverse Event|0|||
170859614|NCT03756129|617494638|FG000|Overall Study|Withdrawal by Subject|2|||
170859615|NCT03756129|617494639|FG001|Overall Study|Withdrawal by Subject|1|||
170859616|NCT03756129|617494640|FG002|Overall Study|Withdrawal by Subject|3|||
170859617|NCT03756129|617494641|FG003|Overall Study|Withdrawal by Subject|1|||
170859618|NCT03756129|617494642|FG004|Overall Study|Withdrawal by Subject|1|||
170859619|NCT03756129|617494643|FG005|Overall Study|Withdrawal by Subject|3|||
170859620|NCT03756129|617494638|FG000|Overall Study|Lost to Follow-up|0|||
170859621|NCT03756129|617494639|FG001|Overall Study|Lost to Follow-up|0|||
170859622|NCT03756129|617494640|FG002|Overall Study|Lost to Follow-up|0|||
170859623|NCT03756129|617494641|FG003|Overall Study|Lost to Follow-up|0|||
170859624|NCT03756129|617494642|FG004|Overall Study|Lost to Follow-up|0|||
170859625|NCT03756129|617494643|FG005|Overall Study|Lost to Follow-up|1|||
170859626|NCT03756129|617494638|FG000|Overall Study|Physician Decision|0|||
170859627|NCT03756129|617494639|FG001|Overall Study|Physician Decision|0|||
170859628|NCT03756129|617494640|FG002|Overall Study|Physician Decision|0|||
170859629|NCT03756129|617494641|FG003|Overall Study|Physician Decision|0|||
170859630|NCT03756129|617494642|FG004|Overall Study|Physician Decision|0|||
170859631|NCT03756129|617494643|FG005|Overall Study|Physician Decision|1|||
170398877|NCT05004181|615798317|FG005|Overall Study|Physician Decision|0|||
170398878|NCT05004181|615798318|FG006|Overall Study|Physician Decision|2|||
170398879|NCT05004181|615798319|FG007|Overall Study|Physician Decision|0|||
170398880|NCT05004181|615798320|FG008|Overall Study|Physician Decision|7|||
170398881|NCT05004181|615798321|FG009|Overall Study|Physician Decision|0|||
170398882|NCT05004181|615798322|FG010|Overall Study|Physician Decision|0|||
170398883|NCT05004181|615798323|FG011|Overall Study|Physician Decision|0|||
170398961|NCT00791154|615799842|FG003|Overall Study|Adverse Event|0|||
170398962|NCT00791154|615799843|FG004|Overall Study|Adverse Event|2|||
170398963|NCT00791154|615799844|FG005|Overall Study|Adverse Event|0|||
170398964|NCT00791154|615799845|FG006|Overall Study|Adverse Event|1|||
170399122|NCT02564952|615799895|FG000|Overall Study|Adverse Event|6|||
170399123|NCT02564952|615799895|FG000|Overall Study|Lost to Follow-up|1|||
170399283|NCT03193190|615799940|FG003|Stage 1|Reason not Specified|1|||
170399284|NCT03193190|615799941|FG004|Stage 1|Reason not Specified|0|||
170399285|NCT03193190|615799942|FG005|Stage 1|Reason not Specified|1|||
170399286|NCT03193190|615799943|FG006|Stage 1|Reason not Specified|2|||
170399287|NCT03193190|615799944|FG007|Stage 1|Reason not Specified|2|||
170399288|NCT03193190|615799945|FG008|Stage 1|Reason not Specified|0|||
170340564|NCT01371838|615587199|FG000|Overall Study|Withdrawal by Subject|27|||
170340565|NCT01371838|615587200|FG001|Overall Study|Withdrawal by Subject|33|||
170340566|NCT01371838|615587199|FG000|Overall Study|Lost to Follow-up|10|||
170340567|NCT01371838|615587200|FG001|Overall Study|Lost to Follow-up|20|||
170340568|NCT01371838|615587199|FG000|Overall Study|Death|3|||
170340569|NCT01371838|615587200|FG001|Overall Study|Death|4|||
170340570|NCT01371838|615587199|FG000|Overall Study|Protocol Violation|3|||
170340571|NCT01371838|615587200|FG001|Overall Study|Protocol Violation|0|||
170340572|NCT01371838|615587199|FG000|Overall Study|Investigator Decision|3|||
170340573|NCT01371838|615587200|FG001|Overall Study|Investigator Decision|8|||
170340574|NCT01371838|615587199|FG000|Overall Study|Last follow-up visit not conducted|2|||
170340575|NCT01371838|615587200|FG001|Overall Study|Last follow-up visit not conducted|0|||
170340576|NCT01371838|615587199|FG000|Overall Study|Lack of therapeutic response|0|||
170340577|NCT01371838|615587200|FG001|Overall Study|Lack of therapeutic response|1|||
170340578|NCT01371838|615587199|FG000|Overall Study|Surgery|1|||
170340579|NCT01371838|615587200|FG001|Overall Study|Surgery|0|||
170340580|NCT03088605|615587203|FG000|Overall Study|Withdrawal by Subject|1|||
170340581|NCT03088605|615587204|FG001|Overall Study|Withdrawal by Subject|0|||
170340582|NCT03215264|615587213|FG000|Dose Level 2|Adverse Event|0|||
170340583|NCT03215264|615587214|FG001|Dose Level 2|Adverse Event|1|||
170340584|NCT03215264|615587215|FG002|Dose Level 2|Adverse Event|0|||
170340585|NCT03215264|615587213|FG000|Dose Level 3|Withdrawal by Subject|0|||
170340586|NCT03215264|615587214|FG001|Dose Level 3|Withdrawal by Subject|0|||
170340587|NCT03215264|615587215|FG002|Dose Level 3|Withdrawal by Subject|1|||
170340597|NCT02805907|615587226|FG000|Overall Study|Lost to Follow-up|3|||
170340598|NCT02805907|615587227|FG001|Overall Study|Lost to Follow-up|3|||
170340599|NCT03408873|615587232|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
170340600|NCT03408873|615587232|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
170340601|NCT03408873|615587232|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
170340602|NCT03408873|615587232|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
170340603|NCT03408873|615587232|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
170340604|NCT03408873|615587232|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
170340605|NCT03799718|615587241|FG000|Overall Study|Adverse Event|2|||
170340606|NCT02075255|615587242|FG000|Overall Study|Study specific withdrawal criteria|0|||
170340607|NCT02075255|615587243|FG001|Overall Study|Study specific withdrawal criteria|1|||
170340608|NCT02075255|615587244|FG002|Overall Study|Study specific withdrawal criteria|1|||
170340609|NCT02075255|615587242|FG000|Overall Study|Withdrawal by Subject|4|||
170340610|NCT02075255|615587243|FG001|Overall Study|Withdrawal by Subject|1|||
170340611|NCT02075255|615587244|FG002|Overall Study|Withdrawal by Subject|0|||
170340612|NCT02075255|615587242|FG000|Overall Study|Lost to Follow-up|0|||
170340613|NCT02075255|615587243|FG001|Overall Study|Lost to Follow-up|0|||
170340614|NCT02075255|615587244|FG002|Overall Study|Lost to Follow-up|1|||
170340615|NCT02075255|615587242|FG000|Overall Study|Adverse Event|0|||
170340616|NCT02075255|615587243|FG001|Overall Study|Adverse Event|0|||
170340617|NCT02075255|615587244|FG002|Overall Study|Adverse Event|1|||
170340618|NCT02075255|615587242|FG000|Overall Study|Death|0|||
170340619|NCT02075255|615587243|FG001|Overall Study|Death|2|||
170340620|NCT02075255|615587244|FG002|Overall Study|Death|0|||
170340621|NCT01469013|615587245|FG000|Part A (Treatment Period)|Adverse Event|1|||
170340622|NCT01469013|615587246|FG001|Part A (Treatment Period)|Adverse Event|0|||
170340623|NCT01469013|615587247|FG002|Part A (Treatment Period)|Adverse Event|0|||
170340624|NCT01469013|615587248|FG003|Part A (Treatment Period)|Adverse Event|0|||
170340625|NCT01469013|615587249|FG004|Part A (Treatment Period)|Adverse Event|1|||
170340626|NCT01469013|615587250|FG005|Part A (Treatment Period)|Adverse Event|0|||
170340627|NCT01469013|615587251|FG006|Part A (Treatment Period)|Adverse Event|0|||
170340628|NCT01469013|615587252|FG007|Part A (Treatment Period)|Adverse Event|0|||
170340629|NCT01469013|615587253|FG008|Part A (Treatment Period)|Adverse Event|0|||
170340630|NCT01469013|615587254|FG009|Part A (Treatment Period)|Adverse Event|0|||
170340631|NCT01469013|615587255|FG010|Part A (Treatment Period)|Adverse Event|0|||
170340632|NCT01469013|615587256|FG011|Part A (Treatment Period)|Adverse Event|0|||
170340633|NCT01469013|615587257|FG012|Part A (Treatment Period)|Adverse Event|0|||
170340634|NCT01469013|615587245|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340635|NCT01469013|615587246|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340636|NCT01469013|615587247|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
170340637|NCT01469013|615587248|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340638|NCT01469013|615587249|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340639|NCT01469013|615587250|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340640|NCT01469013|615587251|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340641|NCT01469013|615587252|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340642|NCT01469013|615587253|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340643|NCT01469013|615587254|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340644|NCT01469013|615587255|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340645|NCT01469013|615587256|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340646|NCT01469013|615587257|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
170340647|NCT01469013|615587245|FG000|Part B (Extension Period)|Adverse Event|0|||
170340648|NCT01469013|615587246|FG001|Part B (Extension Period)|Adverse Event|0|||
170340649|NCT01469013|615587247|FG002|Part B (Extension Period)|Adverse Event|0|||
170340650|NCT01469013|615587248|FG003|Part B (Extension Period)|Adverse Event|0|||
170340651|NCT01469013|615587249|FG004|Part B (Extension Period)|Adverse Event|0|||
170340652|NCT01469013|615587250|FG005|Part B (Extension Period)|Adverse Event|2|||
170340653|NCT01469013|615587251|FG006|Part B (Extension Period)|Adverse Event|5|||
170340654|NCT01469013|615587252|FG007|Part B (Extension Period)|Adverse Event|5|||
170340655|NCT01469013|615587253|FG008|Part B (Extension Period)|Adverse Event|3|||
170340656|NCT01469013|615587254|FG009|Part B (Extension Period)|Adverse Event|3|||
170340657|NCT01469013|615587255|FG010|Part B (Extension Period)|Adverse Event|1|||
170340658|NCT01469013|615587256|FG011|Part B (Extension Period)|Adverse Event|6|||
170340659|NCT01469013|615587257|FG012|Part B (Extension Period)|Adverse Event|3|||
170340660|NCT01469013|615587245|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
170340661|NCT01469013|615587246|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
170340662|NCT01469013|615587247|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
170340663|NCT01469013|615587248|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
170340664|NCT01469013|615587249|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
170340665|NCT01469013|615587250|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
170340666|NCT01469013|615587251|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
170340667|NCT01469013|615587252|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
170340668|NCT01469013|615587253|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
170340669|NCT01469013|615587254|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
170340670|NCT01469013|615587255|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
170340671|NCT01469013|615587256|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
170340672|NCT01469013|615587257|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
170340673|NCT01172288|615587258|FG000|Overall Study|Adverse Event|1|||
170340674|NCT01172288|615587259|FG001|Overall Study|Adverse Event|0|||
170340675|NCT01172288|615587258|FG000|Overall Study|Protocol Violation|0|||
170340676|NCT01172288|615587259|FG001|Overall Study|Protocol Violation|1|||
170340677|NCT02902809|615587262|FG000|Overall Study|Discontinuation of asthma program|28|||
170340678|NCT01188798|615587263|FG000|Overall Study|Death|0|||
170340679|NCT01188798|615587264|FG001|Overall Study|Death|1|||
170340680|NCT01188798|615587263|FG000|Overall Study|Required additional transplant|1|||
170340681|NCT01188798|615587264|FG001|Overall Study|Required additional transplant|1|||
170340682|NCT01188798|615587263|FG000|Overall Study|Protocol closure|1|||
170340683|NCT01188798|615587264|FG001|Overall Study|Protocol closure|1|||
170340684|NCT03964415|615587265|FG000|Overall Study|Sponsor's decision|1563|||
170340685|NCT03964415|615587266|FG001|Overall Study|Sponsor's decision|1528|||
170340686|NCT03964415|615587265|FG000|Overall Study|Lost to Follow-up|139|||
170340687|NCT03964415|615587266|FG001|Overall Study|Lost to Follow-up|146|||
170340688|NCT03964415|615587265|FG000|Overall Study|Withdrawal by Subject|68|||
170340689|NCT03964415|615587266|FG001|Overall Study|Withdrawal by Subject|72|||
170340690|NCT03964415|615587265|FG000|Overall Study|Physician Decision|34|||
170340691|NCT03964415|615587266|FG001|Overall Study|Physician Decision|48|||
170340692|NCT03964415|615587265|FG000|Overall Study|Adverse Event|3|||
170340693|NCT03964415|615587266|FG001|Overall Study|Adverse Event|0|||
170340694|NCT03964415|615587265|FG000|Overall Study|Death|4|||
170340695|NCT03964415|615587266|FG001|Overall Study|Death|6|||
170340696|NCT03964415|615587265|FG000|Overall Study|Protocol Violation|1|||
170340697|NCT03964415|615587266|FG001|Overall Study|Protocol Violation|4|||
170340698|NCT03964415|615587265|FG000|Overall Study|Other|35|||
170340699|NCT03964415|615587266|FG001|Overall Study|Other|38|||
170340700|NCT03964415|615587265|FG000|Overall Study|Randomized but not treated|6|||
170340701|NCT03964415|615587266|FG001|Overall Study|Randomized but not treated|7|||
170340702|NCT01024465|615587268|FG000|Overall Study|Adverse Event|2|||
170340703|NCT01024465|615587268|FG000|Overall Study|Physician Decision|1|||
170399289|NCT03193190|615799946|FG009|Stage 1|Reason not Specified|1|||
170340868|NCT05363293|615587316|FG000|Overall Study|Withdrawal by Subject|1|||
170340869|NCT05363293|615587317|FG001|Overall Study|Withdrawal by Subject|0|||
170340870|NCT05363293|615587318|FG002|Overall Study|Withdrawal by Subject|0|||
170340871|NCT05363293|615587319|FG003|Overall Study|Withdrawal by Subject|0|||
170340872|NCT05363293|615587320|FG004|Overall Study|Withdrawal by Subject|0|||
170340873|NCT05363293|615587321|FG005|Overall Study|Withdrawal by Subject|0|||
170340874|NCT05363293|615587322|FG006|Overall Study|Withdrawal by Subject|0|||
170340875|NCT05363293|615587323|FG007|Overall Study|Withdrawal by Subject|0|||
170340876|NCT05363293|615587324|FG008|Overall Study|Withdrawal by Subject|0|||
170340877|NCT05363293|615587325|FG009|Overall Study|Withdrawal by Subject|0|||
170340878|NCT04773041|615587326|FG000|Overall Study|Unable to data match|1|||
170340879|NCT04773041|615587327|FG001|Overall Study|Unable to data match|0|||
170340880|NCT04773041|615587328|FG002|Overall Study|Unable to data match|0|||
170340881|NCT02658656|615587329|FG000|Screening|Failed eligibility criteria|0|||
170340882|NCT02658656|615587330|FG001|Screening|Failed eligibility criteria|0|||
170340883|NCT02658656|615587331|FG002|Screening|Failed eligibility criteria|263|||
170340884|NCT02658656|615587329|FG000|Randomization|Withdrawal by Subject|8|||
170340885|NCT02658656|615587330|FG001|Randomization|Withdrawal by Subject|7|||
170340886|NCT02658656|615587331|FG002|Randomization|Withdrawal by Subject|0|||
170340887|NCT02658656|615587329|FG000|Randomization|Lost to Follow-up|1|||
170340888|NCT02658656|615587330|FG001|Randomization|Lost to Follow-up|3|||
170340889|NCT02658656|615587331|FG002|Randomization|Lost to Follow-up|0|||
170340890|NCT02658656|615587329|FG000|Randomization|Adverse Event|4|||
170340891|NCT02658656|615587330|FG001|Randomization|Adverse Event|0|||
170340892|NCT02658656|615587331|FG002|Randomization|Adverse Event|0|||
170340893|NCT02658656|615587329|FG000|Randomization|Administrative Termination|3|||
170340894|NCT02658656|615587330|FG001|Randomization|Administrative Termination|1|||
170340895|NCT02658656|615587331|FG002|Randomization|Administrative Termination|0|||
170340896|NCT02658656|615587329|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
170340897|NCT02658656|615587330|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
170340898|NCT02658656|615587331|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
170340899|NCT02658656|615587329|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
170340900|NCT02658656|615587330|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
170340901|NCT02658656|615587331|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
170340902|NCT02658656|615587329|FG000|Randomization|Not eligible for Randomization|1|||
170340903|NCT02658656|615587330|FG001|Randomization|Not eligible for Randomization|0|||
170340904|NCT02658656|615587331|FG002|Randomization|Not eligible for Randomization|0|||
170340905|NCT02658656|615587329|FG000|Randomization|Protocol Violation|1|||
170340906|NCT02658656|615587330|FG001|Randomization|Protocol Violation|0|||
170340907|NCT02658656|615587331|FG002|Randomization|Protocol Violation|0|||
170340908|NCT02112448|615587332|FG000|Overall Study|lab values precluding use of ketorolac|2|||
170340909|NCT02112448|615587333|FG001|Overall Study|lab values precluding use of ketorolac|2|||
170340910|NCT02112448|615587332|FG000|Overall Study|Protocol Violation|1|||
170340911|NCT02112448|615587333|FG001|Overall Study|Protocol Violation|2|||
170340912|NCT02112448|615587332|FG000|Overall Study|Physician Decision|4|||
170340913|NCT02112448|615587333|FG001|Overall Study|Physician Decision|6|||
170340914|NCT02112448|615587332|FG000|Overall Study|required heparin so could not use ketoro|1|||
170340915|NCT02112448|615587333|FG001|Overall Study|required heparin so could not use ketoro|0|||
170340916|NCT04400318|615588991|FG000|Overall Study|Adverse Event|1|||
170340917|NCT04400318|615588992|FG001|Overall Study|Adverse Event|0|||
170340918|NCT04400318|615588991|FG000|Overall Study|Withdrawal by Subject|1|||
170340919|NCT04400318|615588992|FG001|Overall Study|Withdrawal by Subject|1|||
170340920|NCT04400318|615588991|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
170340921|NCT04400318|615588992|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
170340922|NCT04359823|615588993|FG000|Overall Study|Lost to Follow-up|0|||
170340923|NCT04359823|615588994|FG001|Overall Study|Lost to Follow-up|1|||
170340924|NCT04359823|615588993|FG000|Overall Study|Withdrawal by Subject|0|||
170340925|NCT04359823|615588994|FG001|Overall Study|Withdrawal by Subject|1|||
170340926|NCT01850563|615588995|FG000|Overall Study|Not eligible|3|||
170340927|NCT01850563|615588996|FG001|Overall Study|Not eligible|0|||
170340928|NCT03151148|615588998|FG000|Overall Study|Lost to Follow-up|1|||
170340929|NCT03151148|615588999|FG001|Overall Study|Lost to Follow-up|0|||
170340930|NCT03151148|615588998|FG000|Overall Study|Withdrawal by Subject|1|||
170340931|NCT03151148|615588999|FG001|Overall Study|Withdrawal by Subject|0|||
170340932|NCT01115569|615589000|FG000|Conversion/Titration Phase|Adverse Event|59|||
170340933|NCT01115569|615589001|FG001|Conversion/Titration Phase|Adverse Event|0|||
170340934|NCT01115569|615589000|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
170340935|NCT01115569|615589001|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
170340936|NCT01115569|615589000|FG000|Conversion/Titration Phase|Physician Decision|5|||
170340937|NCT01115569|615589001|FG001|Conversion/Titration Phase|Physician Decision|0|||
170340938|NCT01115569|615589000|FG000|Conversion/Titration Phase|Protocol Violation|68|||
170340939|NCT01115569|615589001|FG001|Conversion/Titration Phase|Protocol Violation|0|||
170340940|NCT01115569|615589000|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
170340941|NCT01115569|615589001|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
170340942|NCT01115569|615589000|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
170340943|NCT01115569|615589001|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
170340944|NCT01115569|615589000|FG000|Maintenance Phase|Adverse Event|0|||
170340945|NCT01115569|615589001|FG001|Maintenance Phase|Adverse Event|43|||
170340946|NCT01115569|615589000|FG000|Maintenance Phase|Lost to Follow-up|0|||
170340947|NCT01115569|615589001|FG001|Maintenance Phase|Lost to Follow-up|8|||
170340948|NCT01115569|615589000|FG000|Maintenance Phase|Physician Decision|0|||
170340949|NCT01115569|615589001|FG001|Maintenance Phase|Physician Decision|3|||
170340950|NCT01115569|615589000|FG000|Maintenance Phase|Protocol Violation|0|||
170340951|NCT01115569|615589001|FG001|Maintenance Phase|Protocol Violation|9|||
170340952|NCT01115569|615589000|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170340953|NCT01115569|615589001|FG001|Maintenance Phase|Withdrawal by Subject|27|||
170340954|NCT01115569|615589000|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
170340955|NCT01115569|615589001|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
170340956|NCT01115569|615589000|FG000|Maintenance Phase|Administrative|0|||
170340957|NCT01115569|615589001|FG001|Maintenance Phase|Administrative|1|||
170340958|NCT01912872|615589004|FG000|Overall Study|Lost to Follow-up|2|||
170340959|NCT01912872|615589005|FG001|Overall Study|Lost to Follow-up|3|||
170340960|NCT01912872|615589006|FG002|Overall Study|Lost to Follow-up|5|||
170340961|NCT01912872|615589007|FG003|Overall Study|Lost to Follow-up|5|||
170340962|NCT01912872|615589004|FG000|Overall Study|Other unspecified|3|||
170340963|NCT01912872|615589005|FG001|Overall Study|Other unspecified|1|||
170340964|NCT01912872|615589006|FG002|Overall Study|Other unspecified|3|||
170340965|NCT01912872|615589007|FG003|Overall Study|Other unspecified|0|||
170340966|NCT01912872|615589004|FG000|Overall Study|Informed consent withdrawn|0|||
170340967|NCT01912872|615589005|FG001|Overall Study|Informed consent withdrawn|0|||
170340968|NCT01912872|615589006|FG002|Overall Study|Informed consent withdrawn|1|||
170340969|NCT01912872|615589007|FG003|Overall Study|Informed consent withdrawn|1|||
170340970|NCT01912872|615589004|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
170340971|NCT01912872|615589005|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
170340972|NCT01912872|615589006|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
170340973|NCT01912872|615589007|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
170340974|NCT01912872|615589004|FG000|Overall Study|Protocol Violation|0|||
170340975|NCT01912872|615589005|FG001|Overall Study|Protocol Violation|0|||
170340976|NCT01912872|615589006|FG002|Overall Study|Protocol Violation|1|||
170340977|NCT01912872|615589007|FG003|Overall Study|Protocol Violation|0|||
170340978|NCT01912872|615589004|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170340979|NCT01912872|615589005|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170340980|NCT01912872|615589006|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170340981|NCT01912872|615589007|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
170340982|NCT01912872|615589004|FG000|Overall Study|Withdrawal of study medication|0|||
170340983|NCT01912872|615589005|FG001|Overall Study|Withdrawal of study medication|0|||
170340984|NCT01912872|615589006|FG002|Overall Study|Withdrawal of study medication|0|||
170340985|NCT01912872|615589007|FG003|Overall Study|Withdrawal of study medication|2|||
170340986|NCT01912872|615589004|FG000|Overall Study|Missing|0|||
170340987|NCT01912872|615589005|FG001|Overall Study|Missing|0|||
170340988|NCT01912872|615589006|FG002|Overall Study|Missing|0|||
170340989|NCT01912872|615589007|FG003|Overall Study|Missing|1|||
170340990|NCT02778867|615589013|FG000|Phase 1|Withdrawal by Subject|2|||
170340991|NCT02778867|615589014|FG001|Phase 1|Withdrawal by Subject|3|||
170340992|NCT02778867|615589015|FG002|Phase 1|Withdrawal by Subject|0|||
170340993|NCT02778867|615589016|FG003|Phase 1|Withdrawal by Subject|0|||
170340994|NCT02778867|615589013|FG000|Phase 2|Withdrawal by Subject|0|||
170340995|NCT02778867|615589014|FG001|Phase 2|Withdrawal by Subject|0|||
170340996|NCT02778867|615589015|FG002|Phase 2|Withdrawal by Subject|1|||
170340997|NCT02778867|615589016|FG003|Phase 2|Withdrawal by Subject|0|||
170340998|NCT02778867|615589013|FG000|Phase 2|Physician Decision|0|||
170340999|NCT02778867|615589014|FG001|Phase 2|Physician Decision|0|||
170341000|NCT02778867|615589015|FG002|Phase 2|Physician Decision|0|||
170341001|NCT02778867|615589016|FG003|Phase 2|Physician Decision|1|||
170341002|NCT02778867|615589013|FG000|Phase 2|Adverse Event|0|||
170341003|NCT02778867|615589014|FG001|Phase 2|Adverse Event|0|||
170341004|NCT02778867|615589015|FG002|Phase 2|Adverse Event|0|||
170341005|NCT02778867|615589016|FG003|Phase 2|Adverse Event|1|||
170341006|NCT04760314|615589019|FG000|Induction Period|Withdrawal by Subject|0|||
170341007|NCT04760314|615589020|FG001|Induction Period|Withdrawal by Subject|1|||
170341008|NCT04760314|615589021|FG002|Induction Period|Withdrawal by Subject|1|||
170341009|NCT04760314|615589022|FG003|Induction Period|Withdrawal by Subject|0|||
170341010|NCT04760314|615589023|FG004|Induction Period|Withdrawal by Subject|0|||
170341011|NCT04760314|615589024|FG005|Induction Period|Withdrawal by Subject|0|||
170341012|NCT04760314|615589025|FG006|Induction Period|Withdrawal by Subject|0|||
170341013|NCT04760314|615589026|FG007|Induction Period|Withdrawal by Subject|0|||
170341014|NCT04760314|615589027|FG008|Induction Period|Withdrawal by Subject|0|||
170341015|NCT04760314|615589028|FG009|Induction Period|Withdrawal by Subject|0|||
170341016|NCT04760314|615589029|FG010|Induction Period|Withdrawal by Subject|0|||
170341017|NCT04760314|615589019|FG000|Induction Period|Adverse Event|0|||
170341018|NCT04760314|615589020|FG001|Induction Period|Adverse Event|0|||
170341019|NCT04760314|615589021|FG002|Induction Period|Adverse Event|2|||
170341020|NCT04760314|615589022|FG003|Induction Period|Adverse Event|0|||
170341021|NCT04760314|615589023|FG004|Induction Period|Adverse Event|0|||
170341022|NCT04760314|615589024|FG005|Induction Period|Adverse Event|0|||
170341023|NCT04760314|615589025|FG006|Induction Period|Adverse Event|0|||
170341024|NCT04760314|615589026|FG007|Induction Period|Adverse Event|0|||
170341025|NCT04760314|615589027|FG008|Induction Period|Adverse Event|0|||
170341026|NCT04760314|615589028|FG009|Induction Period|Adverse Event|0|||
170341027|NCT04760314|615589029|FG010|Induction Period|Adverse Event|0|||
170341028|NCT04760314|615589019|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
170341029|NCT04760314|615589020|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
170341030|NCT04760314|615589021|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
170341031|NCT04760314|615589022|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
170341032|NCT04760314|615589023|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
170341033|NCT04760314|615589024|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
170341034|NCT04760314|615589025|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
170341035|NCT04760314|615589026|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
170341036|NCT04760314|615589027|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
170341037|NCT04760314|615589028|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
170341038|NCT04760314|615589029|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
170341039|NCT04760314|615589019|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
170341040|NCT04760314|615589020|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
170341041|NCT04760314|615589021|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
170341042|NCT04760314|615589022|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
170341043|NCT04760314|615589023|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
170341044|NCT04760314|615589024|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
170341045|NCT04760314|615589025|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
170341046|NCT04760314|615589026|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
170341047|NCT04760314|615589027|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
170341048|NCT04760314|615589028|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
170341049|NCT04760314|615589029|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
170341050|NCT04760314|615589019|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341051|NCT04760314|615589020|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341052|NCT04760314|615589021|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341053|NCT04760314|615589022|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341054|NCT04760314|615589023|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
170341055|NCT04760314|615589024|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341056|NCT04760314|615589025|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341057|NCT04760314|615589026|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341058|NCT04760314|615589027|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341059|NCT04760314|615589028|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341060|NCT04760314|615589029|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
170341061|NCT04760314|615589019|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
170341062|NCT04760314|615589020|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
170341063|NCT04760314|615589021|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
170341064|NCT04760314|615589022|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
170341065|NCT04760314|615589023|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
170341066|NCT04760314|615589024|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
170341067|NCT04760314|615589025|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
170341068|NCT04760314|615589026|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
170341069|NCT04760314|615589027|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
170341070|NCT04760314|615589028|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
170341071|NCT04760314|615589029|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
170341072|NCT04760314|615589019|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170341073|NCT04760314|615589020|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170341074|NCT04760314|615589021|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170341075|NCT04760314|615589022|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170341076|NCT04760314|615589023|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170341077|NCT04760314|615589024|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170341078|NCT04760314|615589025|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170341079|NCT04760314|615589026|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
170341080|NCT04760314|615589027|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
170341081|NCT04760314|615589028|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
170341082|NCT04760314|615589029|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
170341083|NCT04760314|615589019|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170341084|NCT04760314|615589020|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170341085|NCT04760314|615589021|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170341086|NCT04760314|615589022|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170341087|NCT04760314|615589023|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170341088|NCT04760314|615589024|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170341089|NCT04760314|615589025|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170341090|NCT04760314|615589026|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
170341091|NCT04760314|615589027|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
170341092|NCT04760314|615589028|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
170341093|NCT04760314|615589029|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
170341094|NCT04760314|615589019|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341095|NCT04760314|615589020|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341096|NCT04760314|615589021|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341097|NCT04760314|615589022|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341098|NCT04760314|615589023|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341099|NCT04760314|615589024|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341100|NCT04760314|615589025|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341101|NCT04760314|615589026|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
170341102|NCT04760314|615589027|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341103|NCT04760314|615589028|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341104|NCT04760314|615589029|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
170341105|NCT04760314|615589019|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341106|NCT04760314|615589020|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341107|NCT04760314|615589021|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341108|NCT04760314|615589022|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341109|NCT04760314|615589023|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341110|NCT04760314|615589024|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341111|NCT04760314|615589025|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341112|NCT04760314|615589026|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341113|NCT04760314|615589027|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
170341114|NCT04760314|615589028|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
170341115|NCT04760314|615589029|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
170341116|NCT00960440|615589030|FG000|Overall Study|Death|0|||
170341117|NCT00960440|615589031|FG001|Overall Study|Death|0|||
170341118|NCT00960440|615589032|FG002|Overall Study|Death|0|||
170341119|NCT00960440|615589033|FG003|Overall Study|Death|1|||
170341120|NCT00960440|615589030|FG000|Overall Study|Adverse Event|12|||
170341121|NCT00960440|615589031|FG001|Overall Study|Adverse Event|12|||
170341122|NCT00960440|615589032|FG002|Overall Study|Adverse Event|4|||
170341123|NCT00960440|615589033|FG003|Overall Study|Adverse Event|4|||
170341124|NCT00960440|615589030|FG000|Overall Study|Lack of Efficacy|2|||
170341125|NCT00960440|615589031|FG001|Overall Study|Lack of Efficacy|5|||
170341126|NCT00960440|615589032|FG002|Overall Study|Lack of Efficacy|3|||
170341127|NCT00960440|615589033|FG003|Overall Study|Lack of Efficacy|8|||
170341128|NCT00960440|615589030|FG000|Overall Study|Protocol Violation|2|||
170341129|NCT00960440|615589031|FG001|Overall Study|Protocol Violation|8|||
170341130|NCT00960440|615589032|FG002|Overall Study|Protocol Violation|3|||
170341131|NCT00960440|615589033|FG003|Overall Study|Protocol Violation|4|||
170341132|NCT00960440|615589030|FG000|Overall Study|Withdrawal by Subject|9|||
170341133|NCT00960440|615589031|FG001|Overall Study|Withdrawal by Subject|5|||
170341134|NCT00960440|615589032|FG002|Overall Study|Withdrawal by Subject|2|||
170341135|NCT00960440|615589033|FG003|Overall Study|Withdrawal by Subject|1|||
170341136|NCT00960440|615589030|FG000|Overall Study|Other|1|||
170341137|NCT00960440|615589031|FG001|Overall Study|Other|1|||
170341138|NCT00960440|615589032|FG002|Overall Study|Other|1|||
170341139|NCT00960440|615589033|FG003|Overall Study|Other|0|||
170341140|NCT03504774|615589036|FG000|Overall Study|Adverse Event|2|||
170341141|NCT03504774|615589037|FG001|Overall Study|Adverse Event|0|||
170341142|NCT03504774|615589036|FG000|Overall Study|Lost to Follow-up|0|||
170341143|NCT03504774|615589037|FG001|Overall Study|Lost to Follow-up|1|||
170341144|NCT03504774|615589036|FG000|Overall Study|Protocol Violation|11|||
170341145|NCT03504774|615589037|FG001|Overall Study|Protocol Violation|3|||
170341146|NCT03504774|615589036|FG000|Overall Study|failed wk 52 DBPCFC|1|||
170341147|NCT03504774|615589037|FG001|Overall Study|failed wk 52 DBPCFC|0|||
170341148|NCT00625365|615589040|FG000|Overall Study|Withdrawal by Subject|1|||
170341149|NCT00625365|615589040|FG000|Overall Study|No IV access|5|||
170341150|NCT00625365|615589040|FG000|Overall Study|VSD|1|||
170341151|NCT01781429|615589041|FG000|Overall Study|Death|0|||
170341152|NCT01781429|615589042|FG001|Overall Study|Death|0|||
170341153|NCT01781429|615589043|FG002|Overall Study|Death|0|||
170341154|NCT01781429|615589044|FG003|Overall Study|Death|0|||
170341155|NCT01781429|615589045|FG004|Overall Study|Death|0|||
170341156|NCT01781429|615589046|FG005|Overall Study|Death|0|||
170341157|NCT01781429|615589047|FG006|Overall Study|Death|0|||
170341158|NCT01781429|615589048|FG007|Overall Study|Death|0|||
170341159|NCT01781429|615589049|FG008|Overall Study|Death|0|||
170341160|NCT01781429|615589050|FG009|Overall Study|Death|1|||
170341161|NCT01781429|615589051|FG010|Overall Study|Death|0|||
170341162|NCT01781429|615589052|FG011|Overall Study|Death|0|||
170341163|NCT01781429|615589053|FG012|Overall Study|Death|1|||
170341164|NCT01781429|615589054|FG013|Overall Study|Death|0|||
170341165|NCT01781429|615589055|FG014|Overall Study|Death|1|||
170341166|NCT01781429|615589056|FG015|Overall Study|Death|0|||
170341167|NCT01781429|615589041|FG000|Overall Study|Withdrawal by Subject|0|||
170341168|NCT01781429|615589042|FG001|Overall Study|Withdrawal by Subject|0|||
170341169|NCT01781429|615589043|FG002|Overall Study|Withdrawal by Subject|0|||
170341170|NCT01781429|615589044|FG003|Overall Study|Withdrawal by Subject|0|||
170341171|NCT01781429|615589045|FG004|Overall Study|Withdrawal by Subject|0|||
170341172|NCT01781429|615589046|FG005|Overall Study|Withdrawal by Subject|0|||
170341173|NCT01781429|615589047|FG006|Overall Study|Withdrawal by Subject|0|||
170341174|NCT01781429|615589048|FG007|Overall Study|Withdrawal by Subject|0|||
170341175|NCT01781429|615589049|FG008|Overall Study|Withdrawal by Subject|1|||
170341176|NCT01781429|615589050|FG009|Overall Study|Withdrawal by Subject|3|||
170341177|NCT01781429|615589051|FG010|Overall Study|Withdrawal by Subject|1|||
170341178|NCT01781429|615589052|FG011|Overall Study|Withdrawal by Subject|1|||
170341179|NCT01781429|615589053|FG012|Overall Study|Withdrawal by Subject|5|||
170341180|NCT01781429|615589054|FG013|Overall Study|Withdrawal by Subject|2|||
170341181|NCT01781429|615589055|FG014|Overall Study|Withdrawal by Subject|3|||
170341182|NCT01781429|615589056|FG015|Overall Study|Withdrawal by Subject|0|||
170341183|NCT01781429|615589041|FG000|Overall Study|Disease Progression|1|||
170341184|NCT01781429|615589042|FG001|Overall Study|Disease Progression|0|||
170341185|NCT01781429|615589043|FG002|Overall Study|Disease Progression|1|||
170341186|NCT01781429|615589044|FG003|Overall Study|Disease Progression|1|||
170341187|NCT01781429|615589045|FG004|Overall Study|Disease Progression|1|||
170341188|NCT01781429|615589046|FG005|Overall Study|Disease Progression|4|||
170341189|NCT01781429|615589047|FG006|Overall Study|Disease Progression|7|||
170341190|NCT01781429|615589048|FG007|Overall Study|Disease Progression|4|||
170341191|NCT01781429|615589049|FG008|Overall Study|Disease Progression|6|||
170341192|NCT01781429|615589050|FG009|Overall Study|Disease Progression|15|||
170341193|NCT01781429|615589051|FG010|Overall Study|Disease Progression|15|||
170341194|NCT01781429|615589052|FG011|Overall Study|Disease Progression|15|||
170341195|NCT01781429|615589053|FG012|Overall Study|Disease Progression|15|||
170341196|NCT01781429|615589054|FG013|Overall Study|Disease Progression|4|||
170341197|NCT01781429|615589055|FG014|Overall Study|Disease Progression|11|||
170341198|NCT01781429|615589056|FG015|Overall Study|Disease Progression|0|||
170341199|NCT01781429|615589041|FG000|Overall Study|Unacceptable Toxicity|0|||
170341200|NCT01781429|615589042|FG001|Overall Study|Unacceptable Toxicity|0|||
170341201|NCT01781429|615589043|FG002|Overall Study|Unacceptable Toxicity|0|||
170341202|NCT01781429|615589044|FG003|Overall Study|Unacceptable Toxicity|0|||
170341203|NCT01781429|615589045|FG004|Overall Study|Unacceptable Toxicity|0|||
170341204|NCT01781429|615589046|FG005|Overall Study|Unacceptable Toxicity|0|||
170341205|NCT01781429|615589047|FG006|Overall Study|Unacceptable Toxicity|0|||
170341206|NCT01781429|615589048|FG007|Overall Study|Unacceptable Toxicity|0|||
170341207|NCT01781429|615589049|FG008|Overall Study|Unacceptable Toxicity|0|||
170341208|NCT01781429|615589050|FG009|Overall Study|Unacceptable Toxicity|0|||
170341209|NCT01781429|615589051|FG010|Overall Study|Unacceptable Toxicity|0|||
170341210|NCT01781429|615589052|FG011|Overall Study|Unacceptable Toxicity|2|||
170341211|NCT01781429|615589053|FG012|Overall Study|Unacceptable Toxicity|0|||
170341212|NCT01781429|615589054|FG013|Overall Study|Unacceptable Toxicity|0|||
170341213|NCT01781429|615589055|FG014|Overall Study|Unacceptable Toxicity|0|||
170341214|NCT01781429|615589056|FG015|Overall Study|Unacceptable Toxicity|0|||
170341215|NCT01781429|615589041|FG000|Overall Study|Patient Condition Changed|0|||
170341216|NCT01781429|615589042|FG001|Overall Study|Patient Condition Changed|0|||
170341217|NCT01781429|615589043|FG002|Overall Study|Patient Condition Changed|0|||
170341218|NCT01781429|615589044|FG003|Overall Study|Patient Condition Changed|0|||
170341219|NCT01781429|615589045|FG004|Overall Study|Patient Condition Changed|0|||
170341220|NCT01781429|615589046|FG005|Overall Study|Patient Condition Changed|0|||
170341221|NCT01781429|615589047|FG006|Overall Study|Patient Condition Changed|0|||
170341222|NCT01781429|615589048|FG007|Overall Study|Patient Condition Changed|0|||
170341223|NCT01781429|615589049|FG008|Overall Study|Patient Condition Changed|0|||
170341224|NCT01781429|615589050|FG009|Overall Study|Patient Condition Changed|4|||
170341225|NCT01781429|615589051|FG010|Overall Study|Patient Condition Changed|0|||
170341226|NCT01781429|615589052|FG011|Overall Study|Patient Condition Changed|1|||
170341227|NCT01781429|615589053|FG012|Overall Study|Patient Condition Changed|0|||
170341228|NCT01781429|615589054|FG013|Overall Study|Patient Condition Changed|1|||
170341229|NCT01781429|615589055|FG014|Overall Study|Patient Condition Changed|0|||
170341230|NCT01781429|615589056|FG015|Overall Study|Patient Condition Changed|0|||
170341231|NCT01781429|615589041|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
170341232|NCT01781429|615589042|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
170341233|NCT01781429|615589043|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
170341234|NCT01781429|615589044|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
170341235|NCT01781429|615589045|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
170341236|NCT01781429|615589046|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
170341237|NCT01781429|615589047|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
170399290|NCT03193190|615799947|FG010|Stage 1|Reason not Specified|3|||
170341238|NCT01781429|615589048|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
170341239|NCT01781429|615589049|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
170341240|NCT01781429|615589050|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
170341241|NCT01781429|615589051|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
170341242|NCT01781429|615589052|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
170341243|NCT01781429|615589053|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
170341244|NCT01781429|615589054|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
170341245|NCT01781429|615589055|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
170341246|NCT01781429|615589056|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
170341247|NCT01781429|615589041|FG000|Overall Study|Enrolled, but not treated|0|||
170341248|NCT01781429|615589042|FG001|Overall Study|Enrolled, but not treated|0|||
170341249|NCT01781429|615589043|FG002|Overall Study|Enrolled, but not treated|0|||
170341250|NCT01781429|615589044|FG003|Overall Study|Enrolled, but not treated|0|||
170341251|NCT01781429|615589045|FG004|Overall Study|Enrolled, but not treated|0|||
170341252|NCT01781429|615589046|FG005|Overall Study|Enrolled, but not treated|0|||
170341253|NCT01781429|615589047|FG006|Overall Study|Enrolled, but not treated|0|||
170341254|NCT01781429|615589048|FG007|Overall Study|Enrolled, but not treated|0|||
170341255|NCT01781429|615589049|FG008|Overall Study|Enrolled, but not treated|0|||
170341256|NCT01781429|615589050|FG009|Overall Study|Enrolled, but not treated|0|||
170341257|NCT01781429|615589051|FG010|Overall Study|Enrolled, but not treated|1|||
170341258|NCT01781429|615589052|FG011|Overall Study|Enrolled, but not treated|0|||
170341259|NCT01781429|615589053|FG012|Overall Study|Enrolled, but not treated|0|||
170341260|NCT01781429|615589054|FG013|Overall Study|Enrolled, but not treated|0|||
170341261|NCT01781429|615589055|FG014|Overall Study|Enrolled, but not treated|0|||
170341262|NCT01781429|615589056|FG015|Overall Study|Enrolled, but not treated|0|||
170341263|NCT03238248|615589057|FG000|Overall Study|Death|5|||
170341264|NCT03238248|615589057|FG000|Overall Study|Withdrawal by Subject|7|||
170341265|NCT03238248|615589057|FG000|Overall Study|Participant proceeding to transplant|10|||
170341266|NCT03238248|615589057|FG000|Overall Study|Lack of Efficacy|4|||
170341267|NCT03238248|615589057|FG000|Overall Study|Physician Decision|3|||
170341268|NCT03238248|615589057|FG000|Overall Study|Transitioning to another study|1|||
170341269|NCT03238248|615589057|FG000|Overall Study|No longer benefiting|1|||
170341270|NCT03238248|615589057|FG000|Overall Study|Other complicating disease|1|||
170341271|NCT03238248|615589057|FG000|Overall Study|Adverse Event|5|||
170341272|NCT03238248|615589057|FG000|Overall Study|Disease progression|26|||
170341273|NCT03238248|615589057|FG000|Overall Study|N/A participant is still on treatment|1|||
170341274|NCT03238248|615589057|FG000|Overall Study|Decline in condition|1|||
170341275|NCT03238248|615589057|FG000|Overall Study|Alternative therapy|2|||
170341276|NCT00634543|615589065|FG000|Overall Study|Other|1|||
170341277|NCT00634543|615589066|FG001|Overall Study|Other|2|||
170341278|NCT00634543|615589065|FG000|Overall Study|Protocol Violation|3|||
170341279|NCT00634543|615589066|FG001|Overall Study|Protocol Violation|3|||
170341280|NCT00634543|615589065|FG000|Overall Study|Adverse Event|11|||
170341281|NCT00634543|615589066|FG001|Overall Study|Adverse Event|11|||
170341282|NCT00634543|615589065|FG000|Overall Study|Withdrawal by Subject|4|||
170341283|NCT00634543|615589066|FG001|Overall Study|Withdrawal by Subject|4|||
170341284|NCT00634543|615589065|FG000|Overall Study|Lost to Follow-up|0|||
170341285|NCT00634543|615589066|FG001|Overall Study|Lost to Follow-up|1|||
170341286|NCT01013883|615589067|FG000|Overall Study|Lost to Follow-up|2|||
170341287|NCT01013883|615589068|FG001|Overall Study|Lost to Follow-up|2|||
170341288|NCT03515538|615589076|FG000|Overall Study|Lack of Efficacy|2|||
170341289|NCT03515538|615589077|FG001|Overall Study|Lack of Efficacy|0|||
170341290|NCT03515538|615589078|FG002|Overall Study|Lack of Efficacy|2|||
170341291|NCT03515538|615589079|FG003|Overall Study|Lack of Efficacy|0|||
170341292|NCT03515538|615589076|FG000|Overall Study|Death|0|||
170341293|NCT03515538|615589077|FG001|Overall Study|Death|0|||
170341294|NCT03515538|615589078|FG002|Overall Study|Death|1|||
170341295|NCT03515538|615589079|FG003|Overall Study|Death|0|||
170341296|NCT03515538|615589076|FG000|Overall Study|Protocol Violation|0|||
170341297|NCT03515538|615589077|FG001|Overall Study|Protocol Violation|0|||
170341298|NCT03515538|615589078|FG002|Overall Study|Protocol Violation|0|||
170341299|NCT03515538|615589079|FG003|Overall Study|Protocol Violation|1|||
170341300|NCT03515538|615589076|FG000|Overall Study|Screen failure (baseline dropout)|0|||
170341301|NCT03515538|615589077|FG001|Overall Study|Screen failure (baseline dropout)|1|||
170341302|NCT03515538|615589078|FG002|Overall Study|Screen failure (baseline dropout)|0|||
170341303|NCT03515538|615589079|FG003|Overall Study|Screen failure (baseline dropout)|0|||
170341304|NCT03515538|615589076|FG000|Overall Study|Withdrawal by Subject|2|||
170341305|NCT03515538|615589077|FG001|Overall Study|Withdrawal by Subject|2|||
170341306|NCT03515538|615589078|FG002|Overall Study|Withdrawal by Subject|1|||
170341307|NCT03515538|615589079|FG003|Overall Study|Withdrawal by Subject|3|||
170341308|NCT03515538|615589076|FG000|Overall Study|Physician Decision|1|||
170341309|NCT03515538|615589077|FG001|Overall Study|Physician Decision|0|||
170341310|NCT03515538|615589078|FG002|Overall Study|Physician Decision|0|||
170341311|NCT03515538|615589079|FG003|Overall Study|Physician Decision|1|||
170341312|NCT03952468|615589085|FG000|Overall Study|Death|0|||
170341313|NCT03952468|615589086|FG001|Overall Study|Death|1|||
170341314|NCT03952468|615589085|FG000|Overall Study|Adverse Event|0|||
170341315|NCT03952468|615589086|FG001|Overall Study|Adverse Event|1|||
170341316|NCT03952468|615589085|FG000|Overall Study|Physician Decision|1|||
170341317|NCT03952468|615589086|FG001|Overall Study|Physician Decision|0|||
170341318|NCT03952468|615589085|FG000|Overall Study|Lost to Follow-up|3|||
170341319|NCT03952468|615589086|FG001|Overall Study|Lost to Follow-up|4|||
170341320|NCT03952468|615589085|FG000|Overall Study|Withdrawal by Subject|2|||
170341321|NCT03952468|615589086|FG001|Overall Study|Withdrawal by Subject|1|||
170341322|NCT00546351|615589089|FG000|Overall Study|Adverse Event|76|||
170341323|NCT00546351|615589089|FG000|Overall Study|Lack of Efficacy|15|||
170341324|NCT00546351|615589089|FG000|Overall Study|Withdrawal by Subject|109|||
170341325|NCT00546351|615589089|FG000|Overall Study|Lost to Follow-up|9|||
170341326|NCT00546351|615589089|FG000|Overall Study|Protocol Deviation|1|||
170341327|NCT00546351|615589089|FG000|Overall Study|Unsatisfactory compliance|9|||
170341328|NCT00546351|615589089|FG000|Overall Study|Other reasons for premature termination|17|||
170341329|NCT03350750|615589090|FG000|Overall Study|Death|1|||
170341330|NCT03350750|615589091|FG001|Overall Study|Death|1|||
170341331|NCT05232097|615589092|FG000|Overall Study|Physician Decision|1|||
170341332|NCT00425438|615589093|FG000|Overall Study|Termination by Sponsor|25|||
170341333|NCT00425438|615589094|FG001|Overall Study|Termination by Sponsor|27|||
170341334|NCT00700752|615589095|FG000|First Intervention|Withdrawal by Subject|0|||
170341335|NCT00700752|615589096|FG001|First Intervention|Withdrawal by Subject|2|||
170341336|NCT03662334|615589097|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
170341337|NCT03662334|615589098|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
170341338|NCT01097330|615589103|FG000|Overall Study|Study terminated early|7|||
170341339|NCT01097330|615589104|FG001|Overall Study|Study terminated early|5|||
170341340|NCT02760407|615589107|FG000|Overall Study|Death|2|||
170341341|NCT02760407|615589108|FG001|Overall Study|Death|3|||
170341342|NCT02760407|615589109|FG002|Overall Study|Death|1|||
170341343|NCT02760407|615589110|FG003|Overall Study|Death|1|||
170341344|NCT02760407|615589107|FG000|Overall Study|Lost to Follow-up|1|||
170341345|NCT02760407|615589108|FG001|Overall Study|Lost to Follow-up|7|||
170341346|NCT02760407|615589109|FG002|Overall Study|Lost to Follow-up|4|||
170341347|NCT02760407|615589110|FG003|Overall Study|Lost to Follow-up|6|||
170341348|NCT02760407|615589107|FG000|Overall Study|Withdrawal by Subject|25|||
170341349|NCT02760407|615589108|FG001|Overall Study|Withdrawal by Subject|31|||
170341350|NCT02760407|615589109|FG002|Overall Study|Withdrawal by Subject|37|||
170341351|NCT02760407|615589110|FG003|Overall Study|Withdrawal by Subject|25|||
170341352|NCT02760407|615589107|FG000|Overall Study|Violation of Eligibility criteria|0|||
170341353|NCT02760407|615589108|FG001|Overall Study|Violation of Eligibility criteria|0|||
170341354|NCT02760407|615589109|FG002|Overall Study|Violation of Eligibility criteria|1|||
170341355|NCT02760407|615589110|FG003|Overall Study|Violation of Eligibility criteria|1|||
170341356|NCT02760407|615589107|FG000|Overall Study|Personal reasons|0|||
170341357|NCT02760407|615589108|FG001|Overall Study|Personal reasons|0|||
170341358|NCT02760407|615589109|FG002|Overall Study|Personal reasons|0|||
170341359|NCT02760407|615589110|FG003|Overall Study|Personal reasons|1|||
170341360|NCT02760407|615589107|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
170341361|NCT02760407|615589108|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
170341362|NCT02760407|615589109|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
170341363|NCT02760407|615589110|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
170341364|NCT02760407|615589107|FG000|Overall Study|Use of prohibited Medication|0|||
170341365|NCT02760407|615589108|FG001|Overall Study|Use of prohibited Medication|0|||
170341366|NCT02760407|615589109|FG002|Overall Study|Use of prohibited Medication|1|||
170341367|NCT02760407|615589110|FG003|Overall Study|Use of prohibited Medication|0|||
170341368|NCT02760407|615589107|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
170341369|NCT02760407|615589108|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
170341370|NCT02760407|615589109|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
170341371|NCT02760407|615589110|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
170341372|NCT02760407|615589107|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
170341373|NCT02760407|615589108|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
170341374|NCT02760407|615589109|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
170341375|NCT02760407|615589110|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
170341376|NCT02760407|615589107|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
170341377|NCT02760407|615589108|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
170341378|NCT02760407|615589109|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
170341379|NCT02760407|615589110|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
170341380|NCT02760407|615589107|FG000|Overall Study|Inadequately Enrolled|0|||
170341381|NCT02760407|615589108|FG001|Overall Study|Inadequately Enrolled|0|||
170341382|NCT02760407|615589109|FG002|Overall Study|Inadequately Enrolled|0|||
170341383|NCT02760407|615589110|FG003|Overall Study|Inadequately Enrolled|1|||
170341384|NCT02760407|615589107|FG000|Overall Study|Withdrawal By PI's Decision|0|||
170341385|NCT02760407|615589108|FG001|Overall Study|Withdrawal By PI's Decision|1|||
170341386|NCT02760407|615589109|FG002|Overall Study|Withdrawal By PI's Decision|0|||
170341387|NCT02760407|615589110|FG003|Overall Study|Withdrawal By PI's Decision|0|||
170341388|NCT02760407|615589107|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
170341389|NCT02760407|615589108|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
170341390|NCT02760407|615589109|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
170341391|NCT02760407|615589110|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
170341392|NCT02760407|615589107|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
170341393|NCT02760407|615589108|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
170341394|NCT02760407|615589109|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
170341395|NCT02760407|615589110|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
170341396|NCT02760407|615589107|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
170341397|NCT02760407|615589108|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
170341398|NCT02760407|615589109|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
170341399|NCT02760407|615589110|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
170341400|NCT02760407|615589107|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
170341401|NCT02760407|615589108|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
170341402|NCT02760407|615589109|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
170341403|NCT02760407|615589110|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
170341404|NCT02760407|615589107|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
170341405|NCT02760407|615589108|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
170341406|NCT02760407|615589109|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
170341407|NCT02760407|615589110|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
170341408|NCT02760407|615589107|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
170341409|NCT02760407|615589108|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
170341410|NCT02760407|615589109|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
170341411|NCT02760407|615589110|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
170341412|NCT02760407|615589107|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
170341413|NCT02760407|615589108|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
170341414|NCT02760407|615589109|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
170341415|NCT02760407|615589110|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
170341416|NCT02760407|615589107|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
170341417|NCT02760407|615589108|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
170341418|NCT02760407|615589109|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
170341419|NCT02760407|615589110|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
170341420|NCT02760407|615589107|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
170341421|NCT02760407|615589108|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
170341422|NCT02760407|615589109|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
170341423|NCT02760407|615589110|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
170341424|NCT01921270|615589118|FG000|Overall Study|Withdrawal by Subject|1|||
170341425|NCT02137772|615589120|FG000|Overall Study|Adverse Event|6|||
170341426|NCT02137772|615589121|FG001|Overall Study|Adverse Event|3|||
170341427|NCT02137772|615589120|FG000|Overall Study|Death|71|||
170341428|NCT02137772|615589121|FG001|Overall Study|Death|44|||
170341429|NCT02137772|615589120|FG000|Overall Study|Lost to Follow-up|8|||
170341430|NCT02137772|615589121|FG001|Overall Study|Lost to Follow-up|4|||
170341431|NCT02137772|615589120|FG000|Overall Study|Physician Decision|15|||
170341432|NCT02137772|615589121|FG001|Overall Study|Physician Decision|5|||
170341433|NCT02137772|615589120|FG000|Overall Study|Withdrawal by Subject|28|||
170341434|NCT02137772|615589121|FG001|Overall Study|Withdrawal by Subject|17|||
170341435|NCT02137772|615589120|FG000|Overall Study|Non-compliance with study drug|1|||
170341436|NCT02137772|615589121|FG001|Overall Study|Non-compliance with study drug|0|||
170341437|NCT02137772|615589120|FG000|Overall Study|Not treated|3|||
170341438|NCT02137772|615589121|FG001|Overall Study|Not treated|2|||
170341439|NCT01844700|615589122|FG000|Overall Study|Lack of Efficacy|1|||
170341440|NCT01844700|615589123|FG001|Overall Study|Lack of Efficacy|0|||
170341441|NCT01844700|615589122|FG000|Overall Study|refused medication switch|1|||
170341442|NCT01844700|615589123|FG001|Overall Study|refused medication switch|0|||
170341443|NCT01844700|615589122|FG000|Overall Study|Withdrawal by Subject|1|||
170341444|NCT01844700|615589123|FG001|Overall Study|Withdrawal by Subject|0|||
170341445|NCT01844700|615589122|FG000|Overall Study|stopped taking meds|0|||
170341446|NCT01844700|615589123|FG001|Overall Study|stopped taking meds|1|||
170341447|NCT00864227|615589124|FG000|Overall Study|Withdrawal by Subject|1|||
170341448|NCT00864227|615589124|FG000|Overall Study|Disease Relapse/Progression|3|||
170341449|NCT02124798|615589125|FG000|Overall Study|Adverse Event|3|||
170341450|NCT02124798|615589125|FG000|Overall Study|Lost to Follow-up|1|||
170341451|NCT00487279|615589126|FG000|Overall Study|Death|1|||
170341452|NCT00487279|615589127|FG001|Overall Study|Death|0|||
170341453|NCT00487279|615589126|FG000|Overall Study|Withdrawal by Subject|0|||
170341454|NCT00487279|615589127|FG001|Overall Study|Withdrawal by Subject|2|||
170341455|NCT00501852|615589128|FG000|Overall Study|Adverse Event|3|||
170341456|NCT00501852|615589128|FG000|Overall Study|Withdrawal by Subject|2|||
170341457|NCT01171521|615589130|FG000|Overall Study|Lost to Follow-up|5|||
170341458|NCT01171521|615589130|FG000|Overall Study|screen failure|1|||
170341459|NCT00492921|615589131|FG000|Overall Study|Death|1|||
170341460|NCT00492921|615589132|FG001|Overall Study|Death|0|||
170341461|NCT00492921|615589133|FG002|Overall Study|Death|1|||
170341462|NCT03176966|615589134|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
170341463|NCT03176966|615589135|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
170341464|NCT03176966|615589134|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
170341465|NCT03176966|615589135|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
170341466|NCT03176966|615589134|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
170341467|NCT03176966|615589135|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
170341468|NCT03176966|615589134|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
170341469|NCT03176966|615589135|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
170341470|NCT03176966|615589134|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
170341471|NCT03176966|615589135|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
170341472|NCT03176966|615589134|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
170341473|NCT03176966|615589135|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
170341474|NCT03176966|615589134|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
170341475|NCT03176966|615589135|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
170341476|NCT01422304|615589139|FG000|Overall Study|Adverse Event|0|||
170341477|NCT01422304|615589140|FG001|Overall Study|Adverse Event|1|||
170341478|NCT01422304|615589139|FG000|Overall Study|Lost to Follow-up|14|||
170341479|NCT01422304|615589140|FG001|Overall Study|Lost to Follow-up|20|||
170341480|NCT01422304|615589139|FG000|Overall Study|Never Entered Follow-up|2|||
170341481|NCT01422304|615589140|FG001|Overall Study|Never Entered Follow-up|1|||
170341482|NCT01422304|615589139|FG000|Overall Study|Protocol Violation|1|||
170341483|NCT01422304|615589140|FG001|Overall Study|Protocol Violation|0|||
170341484|NCT01422304|615589139|FG000|Overall Study|Withdrawal by Subject|4|||
170341485|NCT01422304|615589140|FG001|Overall Study|Withdrawal by Subject|2|||
170341486|NCT01422304|615589139|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
170341487|NCT01422304|615589140|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
170341488|NCT01422304|615589139|FG000|Overall Study|Not Treated|3|||
170341489|NCT01422304|615589140|FG001|Overall Study|Not Treated|11|||
170341490|NCT03241173|615589141|FG000|Overall Study|Death|3|||
170341491|NCT03241173|615589142|FG001|Overall Study|Death|2|||
170341492|NCT03241173|615589143|FG002|Overall Study|Death|4|||
170341493|NCT03241173|615589144|FG003|Overall Study|Death|4|||
170341494|NCT03241173|615589145|FG004|Overall Study|Death|2|||
170341495|NCT03241173|615589146|FG005|Overall Study|Death|2|||
170341496|NCT03241173|615589147|FG006|Overall Study|Death|3|||
170341497|NCT03241173|615589148|FG007|Overall Study|Death|1|||
170341498|NCT03241173|615589149|FG008|Overall Study|Death|0|||
170341499|NCT03241173|615589150|FG009|Overall Study|Death|5|||
170341500|NCT03241173|615589151|FG010|Overall Study|Death|4|||
170341501|NCT03241173|615589152|FG011|Overall Study|Death|3|||
170341502|NCT03241173|615589153|FG012|Overall Study|Death|0|||
170341503|NCT03241173|615589154|FG013|Overall Study|Death|0|||
170341504|NCT03241173|615589155|FG014|Overall Study|Death|0|||
170341505|NCT03241173|615589141|FG000|Overall Study|Withdrawal by Subject|0|||
170341506|NCT03241173|615589142|FG001|Overall Study|Withdrawal by Subject|0|||
170341507|NCT03241173|615589143|FG002|Overall Study|Withdrawal by Subject|1|||
170341508|NCT03241173|615589144|FG003|Overall Study|Withdrawal by Subject|0|||
170341509|NCT03241173|615589145|FG004|Overall Study|Withdrawal by Subject|0|||
170341510|NCT03241173|615589146|FG005|Overall Study|Withdrawal by Subject|1|||
170341511|NCT03241173|615589147|FG006|Overall Study|Withdrawal by Subject|0|||
170341512|NCT03241173|615589148|FG007|Overall Study|Withdrawal by Subject|0|||
170341513|NCT03241173|615589149|FG008|Overall Study|Withdrawal by Subject|0|||
170341514|NCT03241173|615589150|FG009|Overall Study|Withdrawal by Subject|0|||
170341515|NCT03241173|615589151|FG010|Overall Study|Withdrawal by Subject|0|||
170341516|NCT03241173|615589152|FG011|Overall Study|Withdrawal by Subject|0|||
170341517|NCT03241173|615589153|FG012|Overall Study|Withdrawal by Subject|0|||
170341518|NCT03241173|615589154|FG013|Overall Study|Withdrawal by Subject|0|||
170341519|NCT03241173|615589155|FG014|Overall Study|Withdrawal by Subject|0|||
170341520|NCT03241173|615589141|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
170341521|NCT03241173|615589142|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
170341522|NCT03241173|615589143|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
170341523|NCT03241173|615589144|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
170399291|NCT03193190|615799948|FG011|Stage 1|Reason not Specified|0|||
170341524|NCT03241173|615589145|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
170341525|NCT03241173|615589146|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
170341526|NCT03241173|615589147|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
170341527|NCT03241173|615589148|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
170341528|NCT03241173|615589149|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
170341529|NCT03241173|615589150|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
170341530|NCT03241173|615589151|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
170341531|NCT03241173|615589152|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
170341532|NCT03241173|615589153|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
170341533|NCT03241173|615589154|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
170341534|NCT03241173|615589155|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
170341535|NCT03241173|615589141|FG000|Overall Study|Lost to Follow-up|0|||
170341536|NCT03241173|615589142|FG001|Overall Study|Lost to Follow-up|0|||
170341537|NCT03241173|615589143|FG002|Overall Study|Lost to Follow-up|0|||
170341538|NCT03241173|615589144|FG003|Overall Study|Lost to Follow-up|0|||
170341539|NCT03241173|615589145|FG004|Overall Study|Lost to Follow-up|1|||
170341540|NCT03241173|615589146|FG005|Overall Study|Lost to Follow-up|0|||
170341541|NCT03241173|615589147|FG006|Overall Study|Lost to Follow-up|0|||
170341542|NCT03241173|615589148|FG007|Overall Study|Lost to Follow-up|0|||
170341543|NCT03241173|615589149|FG008|Overall Study|Lost to Follow-up|0|||
170341544|NCT03241173|615589150|FG009|Overall Study|Lost to Follow-up|1|||
170341545|NCT03241173|615589151|FG010|Overall Study|Lost to Follow-up|0|||
170341546|NCT03241173|615589152|FG011|Overall Study|Lost to Follow-up|0|||
170341547|NCT03241173|615589153|FG012|Overall Study|Lost to Follow-up|0|||
170341548|NCT03241173|615589154|FG013|Overall Study|Lost to Follow-up|0|||
170341549|NCT03241173|615589155|FG014|Overall Study|Lost to Follow-up|0|||
170341550|NCT00564629|615589156|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
170341551|NCT00564629|615589157|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
170341552|NCT02119104|615589158|FG000|Overall Study|Protocol Violation|16|||
170341553|NCT00515463|615589163|FG000|Overall Study|Physician Decision|4|||
170341554|NCT00515463|615589164|FG001|Overall Study|Physician Decision|2|||
170341555|NCT00515463|615589163|FG000|Overall Study|Adverse Event|1|||
170341556|NCT00515463|615589164|FG001|Overall Study|Adverse Event|2|||
170341557|NCT00515463|615589163|FG000|Overall Study|Withdrawal by Subject|3|||
170341558|NCT00515463|615589164|FG001|Overall Study|Withdrawal by Subject|4|||
170341559|NCT00515463|615589163|FG000|Overall Study|Lost to Follow-up|6|||
170341560|NCT00515463|615589164|FG001|Overall Study|Lost to Follow-up|5|||
170341561|NCT00515463|615589163|FG000|Overall Study|Other|0|||
170341562|NCT00515463|615589164|FG001|Overall Study|Other|1|||
170341563|NCT00916721|615589165|FG000|Overall Study|Lost to Follow-up|0|||
170341564|NCT00916721|615589166|FG001|Overall Study|Lost to Follow-up|1|||
170341565|NCT00916721|615589165|FG000|Overall Study|Adverse Event|6|||
170341566|NCT00916721|615589166|FG001|Overall Study|Adverse Event|3|||
170341567|NCT00916721|615589165|FG000|Overall Study|Withdrawal by Subject|2|||
170341568|NCT00916721|615589166|FG001|Overall Study|Withdrawal by Subject|2|||
170341569|NCT00916721|615589165|FG000|Overall Study|Protocol Violation|2|||
170341570|NCT00916721|615589166|FG001|Overall Study|Protocol Violation|4|||
170341571|NCT01519427|615589167|FG000|Overall Study|disease progression|2|||
170341572|NCT00633139|615589177|FG000|Overall Study|Non compliance|0|||
170341573|NCT00633139|615589178|FG001|Overall Study|Non compliance|0|||
170341574|NCT00633139|615589179|FG002|Overall Study|Non compliance|1|||
170341575|NCT00633139|615589177|FG000|Overall Study|Withdrawal by Subject|0|||
170341576|NCT00633139|615589178|FG001|Overall Study|Withdrawal by Subject|1|||
170341577|NCT00633139|615589179|FG002|Overall Study|Withdrawal by Subject|0|||
170341578|NCT03132805|615590782|FG000|Overall Study|Lost to Follow-up|142|||
170341579|NCT03132805|615590783|FG001|Overall Study|Lost to Follow-up|141|||
170341580|NCT03132805|615590784|FG002|Overall Study|Lost to Follow-up|113|||
170341581|NCT00953043|615590785|FG000|Overall Study|Withdrawal by Subject|4|||
170341582|NCT00953043|615590786|FG001|Overall Study|Withdrawal by Subject|0|||
170341583|NCT00953043|615590785|FG000|Overall Study|Physician Decision|0|||
170341584|NCT00953043|615590786|FG001|Overall Study|Physician Decision|2|||
170341585|NCT02322892|615590788|FG000|Overall Study|Surgery cancelled|1|||
170341586|NCT02322892|615590789|FG001|Overall Study|Surgery cancelled|2|||
170341587|NCT02322892|615590788|FG000|Overall Study|Met exclusion criteria|0|||
170341588|NCT02322892|615590789|FG001|Overall Study|Met exclusion criteria|1|||
170341589|NCT02322892|615590788|FG000|Overall Study|Protocol Violation|1|||
170341590|NCT02322892|615590789|FG001|Overall Study|Protocol Violation|0|||
170341591|NCT01746732|615590792|FG000|Lead-In Period|Withdrawal by Subject|1|||
170341592|NCT01746732|615590793|FG001|Lead-In Period|Withdrawal by Subject|0|||
170341593|NCT01746732|615590794|FG002|Lead-In Period|Withdrawal by Subject|0|||
170341594|NCT01746732|615590792|FG000|Period 1|Physician Decision|0|||
170341595|NCT01746732|615590793|FG001|Period 1|Physician Decision|1|||
170341596|NCT01746732|615590794|FG002|Period 1|Physician Decision|0|||
170341597|NCT01746732|615590792|FG000|Period 2|Withdrawal by Subject|0|||
170341598|NCT01746732|615590793|FG001|Period 2|Withdrawal by Subject|0|||
170341599|NCT01746732|615590794|FG002|Period 2|Withdrawal by Subject|2|||
170341600|NCT01746732|615590792|FG000|Period 2|Adverse Event|0|||
170341601|NCT01746732|615590793|FG001|Period 2|Adverse Event|0|||
170341602|NCT01746732|615590794|FG002|Period 2|Adverse Event|1|||
170341603|NCT01746732|615590792|FG000|Period 2|Lost to Follow-up|0|||
170341604|NCT01746732|615590793|FG001|Period 2|Lost to Follow-up|0|||
170341605|NCT01746732|615590794|FG002|Period 2|Lost to Follow-up|1|||
170341606|NCT03509207|615590795|FG000|Overall Study|Death|2|||
170341607|NCT02817555|615590796|FG000|Overall Study|Death|1|||
170341608|NCT02817555|615590797|FG001|Overall Study|Death|3|||
170341609|NCT02817555|615590796|FG000|Overall Study|moved away|1|||
170341610|NCT02817555|615590797|FG001|Overall Study|moved away|0|||
170341611|NCT02817555|615590796|FG000|Overall Study|transplant|1|||
170341612|NCT02817555|615590797|FG001|Overall Study|transplant|1|||
170341613|NCT02817555|615590796|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
170341614|NCT02817555|615590797|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
170341615|NCT01432262|615590798|FG000|Overall Study|Withdrawal by Subject|2|||
170341616|NCT01432262|615590799|FG001|Overall Study|Withdrawal by Subject|1|||
170341617|NCT00165646|615590800|FG000|Overall Study|Adverse Event|1|||
170341618|NCT00165646|615590801|FG001|Overall Study|Adverse Event|1|||
170341619|NCT00165646|615590802|FG002|Overall Study|Adverse Event|1|||
170341620|NCT00165646|615590800|FG000|Overall Study|Lack of Efficacy|1|||
170341621|NCT00165646|615590801|FG001|Overall Study|Lack of Efficacy|2|||
170341622|NCT00165646|615590802|FG002|Overall Study|Lack of Efficacy|0|||
170341623|NCT00165646|615590800|FG000|Overall Study|Withdrawal by Subject|0|||
170341624|NCT00165646|615590801|FG001|Overall Study|Withdrawal by Subject|2|||
170341625|NCT00165646|615590802|FG002|Overall Study|Withdrawal by Subject|1|||
170341626|NCT00165646|615590800|FG000|Overall Study|Physician Decision|2|||
170341627|NCT00165646|615590801|FG001|Overall Study|Physician Decision|0|||
170341628|NCT00165646|615590802|FG002|Overall Study|Physician Decision|2|||
170341629|NCT00165646|615590800|FG000|Overall Study|Protocol Violation|1|||
170341630|NCT00165646|615590801|FG001|Overall Study|Protocol Violation|0|||
170341631|NCT00165646|615590802|FG002|Overall Study|Protocol Violation|0|||
170341632|NCT04657016|615590803|FG000|Overall Study|Adverse Event|2|||
170341633|NCT04657016|615590804|FG001|Overall Study|Adverse Event|4|||
170341634|NCT04657016|615590803|FG000|Overall Study|Death|1|||
170341635|NCT04657016|615590804|FG001|Overall Study|Death|1|||
170341636|NCT04657016|615590803|FG000|Overall Study|Lost to Follow-up|24|||
170341637|NCT04657016|615590804|FG001|Overall Study|Lost to Follow-up|12|||
170341638|NCT04657016|615590803|FG000|Overall Study|Physician Decision|1|||
170341639|NCT04657016|615590804|FG001|Overall Study|Physician Decision|2|||
170341640|NCT04657016|615590803|FG000|Overall Study|Pregnancy|2|||
170341641|NCT04657016|615590804|FG001|Overall Study|Pregnancy|2|||
170341642|NCT04657016|615590803|FG000|Overall Study|Protocol Deviation|1|||
170341643|NCT04657016|615590804|FG001|Overall Study|Protocol Deviation|0|||
170341644|NCT04657016|615590803|FG000|Overall Study|Withdrawal by Subject|28|||
170341645|NCT04657016|615590804|FG001|Overall Study|Withdrawal by Subject|14|||
170341646|NCT04657016|615590803|FG000|Overall Study|Other - as reported by the investigator|6|||
170341647|NCT04657016|615590804|FG001|Overall Study|Other - as reported by the investigator|0|||
170341648|NCT01614769|615590806|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
170341649|NCT01614769|615590807|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
170341650|NCT01614769|615590808|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
170341651|NCT01614769|615590809|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
170341652|NCT01614769|615590810|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
170341653|NCT01614769|615590811|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
170341654|NCT01614769|615590806|FG000|Period 1|Protocol Violation|0|||
170341655|NCT01614769|615590807|FG001|Period 1|Protocol Violation|0|||
170341656|NCT01614769|615590808|FG002|Period 1|Protocol Violation|0|||
170341657|NCT01614769|615590809|FG003|Period 1|Protocol Violation|1|||
170341658|NCT01614769|615590810|FG004|Period 1|Protocol Violation|0|||
170341659|NCT01614769|615590811|FG005|Period 1|Protocol Violation|0|||
170341660|NCT01614769|615590806|FG000|Period 1|Withdrawal by Subject|1|||
170341661|NCT01614769|615590807|FG001|Period 1|Withdrawal by Subject|0|||
170341662|NCT01614769|615590808|FG002|Period 1|Withdrawal by Subject|0|||
170341663|NCT01614769|615590809|FG003|Period 1|Withdrawal by Subject|0|||
170341664|NCT01614769|615590810|FG004|Period 1|Withdrawal by Subject|0|||
170341665|NCT01614769|615590811|FG005|Period 1|Withdrawal by Subject|0|||
170341666|NCT01614769|615590806|FG000|Period 3|Withdrawal by Subject|0|||
170341667|NCT01614769|615590807|FG001|Period 3|Withdrawal by Subject|0|||
170341668|NCT01614769|615590808|FG002|Period 3|Withdrawal by Subject|1|||
170341669|NCT01614769|615590809|FG003|Period 3|Withdrawal by Subject|0|||
170341670|NCT01614769|615590810|FG004|Period 3|Withdrawal by Subject|0|||
170341671|NCT01614769|615590811|FG005|Period 3|Withdrawal by Subject|0|||
170341672|NCT00059215|615590814|FG000|Overall Study|Adverse Event|5|||
170341673|NCT00059215|615590815|FG001|Overall Study|Adverse Event|5|||
170341674|NCT00059215|615590816|FG002|Overall Study|Adverse Event|9|||
170341675|NCT00059215|615590817|FG003|Overall Study|Adverse Event|9|||
170341676|NCT00059215|615590814|FG000|Overall Study|Death|0|||
170341677|NCT00059215|615590815|FG001|Overall Study|Death|0|||
170341678|NCT00059215|615590816|FG002|Overall Study|Death|3|||
170341679|NCT00059215|615590817|FG003|Overall Study|Death|0|||
170341680|NCT00059215|615590814|FG000|Overall Study|Lost to Follow-up|1|||
170341681|NCT00059215|615590815|FG001|Overall Study|Lost to Follow-up|2|||
170341682|NCT00059215|615590816|FG002|Overall Study|Lost to Follow-up|0|||
170341683|NCT00059215|615590817|FG003|Overall Study|Lost to Follow-up|0|||
170341684|NCT00059215|615590814|FG000|Overall Study|Withdrawal by Subject|4|||
170341685|NCT00059215|615590815|FG001|Overall Study|Withdrawal by Subject|4|||
170341686|NCT00059215|615590816|FG002|Overall Study|Withdrawal by Subject|1|||
170341687|NCT00059215|615590817|FG003|Overall Study|Withdrawal by Subject|3|||
170341688|NCT00059215|615590814|FG000|Overall Study|Protocol Violation|1|||
170341689|NCT00059215|615590815|FG001|Overall Study|Protocol Violation|0|||
170341690|NCT00059215|615590816|FG002|Overall Study|Protocol Violation|1|||
170341691|NCT00059215|615590817|FG003|Overall Study|Protocol Violation|0|||
170341692|NCT00059215|615590814|FG000|Overall Study|Protocol entry criteria not met|1|||
170341693|NCT00059215|615590815|FG001|Overall Study|Protocol entry criteria not met|1|||
170341694|NCT00059215|615590816|FG002|Overall Study|Protocol entry criteria not met|0|||
170341695|NCT00059215|615590817|FG003|Overall Study|Protocol entry criteria not met|2|||
170341696|NCT00059215|615590814|FG000|Overall Study|Physician Decision|1|||
170341697|NCT00059215|615590815|FG001|Overall Study|Physician Decision|2|||
170341698|NCT00059215|615590816|FG002|Overall Study|Physician Decision|1|||
170341699|NCT00059215|615590817|FG003|Overall Study|Physician Decision|1|||
170341700|NCT01254604|615590819|FG000|Overall Study|Lost to Follow-up|1|||
170341701|NCT01254604|615590820|FG001|Overall Study|Lost to Follow-up|1|||
170341702|NCT01254604|615590819|FG000|Overall Study|Protocol Violation|2|||
170341703|NCT01254604|615590820|FG001|Overall Study|Protocol Violation|2|||
170341704|NCT01254604|615590819|FG000|Overall Study|Withdrawal by Subject|2|||
170341705|NCT01254604|615590820|FG001|Overall Study|Withdrawal by Subject|4|||
170341706|NCT01254604|615590819|FG000|Overall Study|Adverse Event|3|||
170341707|NCT01254604|615590820|FG001|Overall Study|Adverse Event|2|||
170341708|NCT01277289|615590821|FG000|Overall Study|fragile vein|1|||
170341709|NCT01277289|615590822|FG001|Overall Study|fragile vein|0|||
170341710|NCT01277289|615590821|FG000|Overall Study|Physician Decision|1|||
170341711|NCT01277289|615590822|FG001|Overall Study|Physician Decision|0|||
170341712|NCT01277289|615590821|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
170341713|NCT01277289|615590822|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
170341714|NCT01277289|615590821|FG000|Overall Study|Protocol Violation|1|||
170341715|NCT01277289|615590822|FG001|Overall Study|Protocol Violation|1|||
170341716|NCT01277289|615590821|FG000|Overall Study|Adverse Event|2|||
170341717|NCT01277289|615590822|FG001|Overall Study|Adverse Event|1|||
170341718|NCT01277289|615590821|FG000|Overall Study|consent withdrawn|1|||
170341719|NCT01277289|615590822|FG001|Overall Study|consent withdrawn|1|||
170341720|NCT01277289|615590821|FG000|Overall Study|premature closure of the study|4|||
170341721|NCT01277289|615590822|FG001|Overall Study|premature closure of the study|2|||
170341722|NCT00592358|615590823|FG000|Overall Study|Withdrawal by Subject|2|||
170341723|NCT00592358|615590823|FG000|Overall Study|Adverse Event|1|||
170341724|NCT00592358|615590823|FG000|Overall Study|Lack of Efficacy|2|||
170341725|NCT00592358|615590823|FG000|Overall Study|Inability to swallow pills|1|||
170341726|NCT00084682|615590824|FG000|Overall Study|Withdrawal by Subject|1|||
170341727|NCT02948777|615590825|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
170341728|NCT02311478|615590826|FG000|Overall Study|Withdrawal by Subject|1|||
170341729|NCT02311478|615590826|FG000|Overall Study|Lost to Follow-up|5|||
170341730|NCT02311478|615590826|FG000|Overall Study|Failed IUD Insertion|1|||
170341731|NCT03242928|615590828|FG000|Overall Study|Adverse Event|2|||
170341732|NCT03242928|615590829|FG001|Overall Study|Adverse Event|1|||
170341733|NCT03242928|615590828|FG000|Overall Study|Lost to Follow-up|2|||
170341734|NCT03242928|615590829|FG001|Overall Study|Lost to Follow-up|0|||
170341735|NCT03242928|615590828|FG000|Overall Study|Physician Decision|0|||
170341736|NCT03242928|615590829|FG001|Overall Study|Physician Decision|1|||
170341737|NCT03242928|615590828|FG000|Overall Study|Withdrawal by Subject|5|||
170341738|NCT03242928|615590829|FG001|Overall Study|Withdrawal by Subject|3|||
170341739|NCT00943319|615590832|FG000|Overall Study|Death|1|||
170341740|NCT02043301|615590833|FG000|Overall Study|Discontinued|0|||
170341741|NCT02043301|615590834|FG001|Overall Study|Discontinued|1|||
170341742|NCT02043301|615590835|FG002|Overall Study|Discontinued|0|||
170341743|NCT03703375|615590836|FG000|Randomization Period|Withdrawal by Subject|0|||
170341744|NCT03703375|615590837|FG001|Randomization Period|Withdrawal by Subject|0|||
170341745|NCT03703375|615590838|FG002|Randomization Period|Withdrawal by Subject|0|||
170341746|NCT03703375|615590839|FG003|Randomization Period|Withdrawal by Subject|1|||
170341747|NCT03703375|615590836|FG000|Randomization Period|Completed safety run-in treatment|7|||
170341748|NCT03703375|615590837|FG001|Randomization Period|Completed safety run-in treatment|0|||
170341749|NCT03703375|615590838|FG002|Randomization Period|Completed safety run-in treatment|0|||
170341750|NCT03703375|615590839|FG003|Randomization Period|Completed safety run-in treatment|0|||
170341751|NCT03703375|615590836|FG000|Treatment Period|Other Reasons|0|||
170341752|NCT03703375|615590837|FG001|Treatment Period|Other Reasons|1|||
170341753|NCT03703375|615590838|FG002|Treatment Period|Other Reasons|0|||
170341754|NCT03703375|615590839|FG003|Treatment Period|Other Reasons|3|||
170341755|NCT03703375|615590836|FG000|Treatment Period|Consent Withdrawal|0|||
170341756|NCT03703375|615590837|FG001|Treatment Period|Consent Withdrawal|0|||
170341757|NCT03703375|615590838|FG002|Treatment Period|Consent Withdrawal|0|||
170341758|NCT03703375|615590839|FG003|Treatment Period|Consent Withdrawal|1|||
170341759|NCT03703375|615590836|FG000|Treatment Period|Death|1|||
170341760|NCT03703375|615590837|FG001|Treatment Period|Death|0|||
170341761|NCT03703375|615590838|FG002|Treatment Period|Death|1|||
170341762|NCT03703375|615590839|FG003|Treatment Period|Death|2|||
170341763|NCT03703375|615590836|FG000|Treatment Period|Toxicity of Study Treatment|2|||
170341764|NCT03703375|615590837|FG001|Treatment Period|Toxicity of Study Treatment|0|||
170341765|NCT03703375|615590838|FG002|Treatment Period|Toxicity of Study Treatment|4|||
170341766|NCT03703375|615590839|FG003|Treatment Period|Toxicity of Study Treatment|1|||
170341767|NCT03703375|615590836|FG000|Treatment Period|Progression|32|||
170341768|NCT03703375|615590837|FG001|Treatment Period|Progression|1|||
170341769|NCT03703375|615590838|FG002|Treatment Period|Progression|7|||
170341770|NCT03703375|615590839|FG003|Treatment Period|Progression|11|||
170341771|NCT03703375|615590836|FG000|Treatment Period|Completed treatment|7|||
170341772|NCT03703375|615590837|FG001|Treatment Period|Completed treatment|2|||
170341773|NCT03703375|615590838|FG002|Treatment Period|Completed treatment|0|||
170341774|NCT03703375|615590839|FG003|Treatment Period|Completed treatment|0|||
170341775|NCT04964063|615590840|FG000|Overall Study|Adverse Event|4|||
170341776|NCT04964063|615590840|FG000|Overall Study|Lost to Follow-up|47|||
170341777|NCT04964063|615590840|FG000|Overall Study|Withdrawal by Subject|5|||
170341778|NCT04964063|615590840|FG000|Overall Study|Baseline Tasks Expired|41|||
170341779|NCT04964063|615590840|FG000|Overall Study|Participant withdrawn in error|1|||
170341780|NCT04734873|615590841|FG000|Overall Study|Lost to Follow-up|1|||
170341781|NCT04734873|615590842|FG001|Overall Study|Lost to Follow-up|3|||
170341782|NCT04734873|615590843|FG002|Overall Study|Lost to Follow-up|2|||
170341783|NCT04734873|615590841|FG000|Overall Study|Randomized but not dosed|1|||
170341784|NCT04734873|615590842|FG001|Overall Study|Randomized but not dosed|0|||
170341785|NCT04734873|615590843|FG002|Overall Study|Randomized but not dosed|1|||
170341786|NCT01702363|615590846|FG000|Overall Study|Adverse Event|14|||
170341787|NCT01702363|615590846|FG000|Overall Study|Lack of Efficacy|4|||
170341788|NCT01702363|615590846|FG000|Overall Study|Withdrawal by Subject|2|||
170341789|NCT01525849|615590848|FG000|Overall Study|Lost to Follow-up|3|||
170341790|NCT01525849|615590849|FG001|Overall Study|Lost to Follow-up|2|||
170341791|NCT01525849|615590848|FG000|Overall Study|Withdrawal by Subject|1|||
170341792|NCT01525849|615590849|FG001|Overall Study|Withdrawal by Subject|9|||
170341793|NCT01525849|615590848|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
170341794|NCT01525849|615590849|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
170341795|NCT01525849|615590848|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
170341796|NCT01525849|615590849|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
170341797|NCT00339183|615590850|FG000|Overall Study|Adverse Event|5|||
170341798|NCT00339183|615590851|FG001|Overall Study|Adverse Event|3|||
170341799|NCT00339183|615590850|FG000|Overall Study|Withdrawal by Subject|16|||
170341800|NCT00339183|615590851|FG001|Overall Study|Withdrawal by Subject|19|||
170341801|NCT00339183|615590850|FG000|Overall Study|Physician Decision|2|||
170341802|NCT00339183|615590851|FG001|Overall Study|Physician Decision|4|||
170341803|NCT00339183|615590850|FG000|Overall Study|Lost to Follow-up|17|||
170341804|NCT00339183|615590851|FG001|Overall Study|Lost to Follow-up|17|||
170341805|NCT00339183|615590850|FG000|Overall Study|Protocol-specified criteria|12|||
170341806|NCT00339183|615590851|FG001|Overall Study|Protocol-specified criteria|8|||
170341807|NCT00339183|615590850|FG000|Overall Study|Missing reason|3|||
170341808|NCT00339183|615590851|FG001|Overall Study|Missing reason|1|||
170341809|NCT00339183|615590850|FG000|Overall Study|Other|46|||
170341810|NCT00339183|615590851|FG001|Overall Study|Other|40|||
170341811|NCT00339183|615590850|FG000|Overall Study|Ongoing|20|||
170341812|NCT00339183|615590851|FG001|Overall Study|Ongoing|13|||
170341813|NCT00002663|615590852|FG000|Overall Study|Death|4|||
170341814|NCT00002663|615590853|FG001|Overall Study|Death|1|||
170341815|NCT00002663|615590854|FG002|Overall Study|Death|1|||
170341816|NCT00002663|615590855|FG003|Overall Study|Death|0|||
170341817|NCT00002663|615590856|FG004|Overall Study|Death|0|||
170341818|NCT00002663|615590857|FG005|Overall Study|Death|13|||
170341819|NCT00002663|615590858|FG006|Overall Study|Death|0|||
170341820|NCT00002663|615590859|FG007|Overall Study|Death|1|||
170341821|NCT00002663|615590860|FG008|Overall Study|Death|1|||
170341822|NCT00002663|615590861|FG009|Overall Study|Death|1|||
170341823|NCT00002663|615590852|FG000|Overall Study|Lost to Follow-up|3|||
170341824|NCT00002663|615590853|FG001|Overall Study|Lost to Follow-up|0|||
170341825|NCT00002663|615590854|FG002|Overall Study|Lost to Follow-up|0|||
170341826|NCT00002663|615590855|FG003|Overall Study|Lost to Follow-up|1|||
170341827|NCT00002663|615590856|FG004|Overall Study|Lost to Follow-up|0|||
170341828|NCT00002663|615590857|FG005|Overall Study|Lost to Follow-up|1|||
170341829|NCT00002663|615590858|FG006|Overall Study|Lost to Follow-up|0|||
170341830|NCT00002663|615590859|FG007|Overall Study|Lost to Follow-up|0|||
170341831|NCT00002663|615590860|FG008|Overall Study|Lost to Follow-up|0|||
170341832|NCT00002663|615590861|FG009|Overall Study|Lost to Follow-up|0|||
170341833|NCT00002663|615590852|FG000|Overall Study|Other|0|||
170341834|NCT00002663|615590853|FG001|Overall Study|Other|1|||
170341835|NCT00002663|615590854|FG002|Overall Study|Other|0|||
170341836|NCT00002663|615590855|FG003|Overall Study|Other|0|||
170341837|NCT00002663|615590856|FG004|Overall Study|Other|0|||
170341838|NCT00002663|615590857|FG005|Overall Study|Other|1|||
170341839|NCT00002663|615590858|FG006|Overall Study|Other|1|||
170341840|NCT00002663|615590859|FG007|Overall Study|Other|0|||
170341841|NCT00002663|615590860|FG008|Overall Study|Other|0|||
170341842|NCT00002663|615590861|FG009|Overall Study|Other|0|||
170341843|NCT00002663|615590852|FG000|Overall Study|Physician Decision|0|||
170341844|NCT00002663|615590853|FG001|Overall Study|Physician Decision|0|||
170341845|NCT00002663|615590854|FG002|Overall Study|Physician Decision|0|||
170341846|NCT00002663|615590855|FG003|Overall Study|Physician Decision|0|||
170341847|NCT00002663|615590856|FG004|Overall Study|Physician Decision|1|||
170341848|NCT00002663|615590857|FG005|Overall Study|Physician Decision|0|||
170341849|NCT00002663|615590858|FG006|Overall Study|Physician Decision|0|||
170341850|NCT00002663|615590859|FG007|Overall Study|Physician Decision|0|||
170341851|NCT00002663|615590860|FG008|Overall Study|Physician Decision|1|||
170341852|NCT00002663|615590861|FG009|Overall Study|Physician Decision|1|||
170341853|NCT00002663|615590852|FG000|Overall Study|Adverse Event|0|||
170341854|NCT00002663|615590853|FG001|Overall Study|Adverse Event|0|||
170341855|NCT00002663|615590854|FG002|Overall Study|Adverse Event|0|||
170341856|NCT00002663|615590855|FG003|Overall Study|Adverse Event|1|||
170341857|NCT00002663|615590856|FG004|Overall Study|Adverse Event|0|||
170341858|NCT00002663|615590857|FG005|Overall Study|Adverse Event|0|||
170341859|NCT00002663|615590858|FG006|Overall Study|Adverse Event|0|||
170341860|NCT00002663|615590859|FG007|Overall Study|Adverse Event|1|||
170341861|NCT00002663|615590860|FG008|Overall Study|Adverse Event|0|||
170341862|NCT00002663|615590861|FG009|Overall Study|Adverse Event|0|||
170341863|NCT01327339|615590862|FG000|Overall Study|Protocol Violation|8|||
170341864|NCT05100199|615590865|FG000|Overall Study|Lost to Follow-up|5|||
170341865|NCT05100199|615590866|FG001|Overall Study|Lost to Follow-up|8|||
170341866|NCT05100199|615590867|FG002|Overall Study|Lost to Follow-up|3|||
170341867|NCT05100199|615590868|FG003|Overall Study|Lost to Follow-up|6|||
170341868|NCT05100199|615590865|FG000|Overall Study|Withdrawal by Subject|3|||
170341869|NCT05100199|615590866|FG001|Overall Study|Withdrawal by Subject|3|||
170341870|NCT05100199|615590867|FG002|Overall Study|Withdrawal by Subject|9|||
170341871|NCT05100199|615590868|FG003|Overall Study|Withdrawal by Subject|7|||
170341872|NCT05100199|615590865|FG000|Overall Study|Other|0|||
170341873|NCT05100199|615590866|FG001|Overall Study|Other|0|||
170341874|NCT05100199|615590867|FG002|Overall Study|Other|1|||
170341875|NCT05100199|615590868|FG003|Overall Study|Other|1|||
170341876|NCT01426386|615590869|FG000|Overall Study|Adverse Event|0|||
170341877|NCT01426386|615590870|FG001|Overall Study|Adverse Event|1|||
170341878|NCT01426386|615590871|FG002|Overall Study|Adverse Event|0|||
170341879|NCT01426386|615590872|FG003|Overall Study|Adverse Event|0|||
170341880|NCT01426386|615590873|FG004|Overall Study|Adverse Event|0|||
170341881|NCT01426386|615590874|FG005|Overall Study|Adverse Event|0|||
170341882|NCT01426386|615590869|FG000|Overall Study|Did not attend scheduled visit|1|||
170341883|NCT01426386|615590870|FG001|Overall Study|Did not attend scheduled visit|4|||
170341884|NCT01426386|615590871|FG002|Overall Study|Did not attend scheduled visit|0|||
170341885|NCT01426386|615590872|FG003|Overall Study|Did not attend scheduled visit|0|||
170341886|NCT01426386|615590873|FG004|Overall Study|Did not attend scheduled visit|2|||
170341887|NCT01426386|615590874|FG005|Overall Study|Did not attend scheduled visit|1|||
170341888|NCT01426386|615590869|FG000|Overall Study|Poor response|2|||
170341889|NCT01426386|615590870|FG001|Overall Study|Poor response|1|||
170341890|NCT01426386|615590871|FG002|Overall Study|Poor response|2|||
170341891|NCT01426386|615590872|FG003|Overall Study|Poor response|0|||
170341892|NCT01426386|615590873|FG004|Overall Study|Poor response|1|||
170341893|NCT01426386|615590874|FG005|Overall Study|Poor response|0|||
170341894|NCT01426386|615590869|FG000|Overall Study|Personal reasons|0|||
170341895|NCT01426386|615590870|FG001|Overall Study|Personal reasons|0|||
170341896|NCT01426386|615590871|FG002|Overall Study|Personal reasons|0|||
170341897|NCT01426386|615590872|FG003|Overall Study|Personal reasons|0|||
170341898|NCT01426386|615590873|FG004|Overall Study|Personal reasons|1|||
170341899|NCT01426386|615590874|FG005|Overall Study|Personal reasons|0|||
170341900|NCT02062151|615590876|FG000|Overall Study|screen failure|1|||
170341901|NCT01748760|615590877|FG000|Overall Study|Withdrawal by Subject|1|||
170341902|NCT01748760|615590878|FG001|Overall Study|Withdrawal by Subject|1|||
170341903|NCT01748760|615590877|FG000|Overall Study|Lost to Follow-up|5|||
170341904|NCT01748760|615590878|FG001|Overall Study|Lost to Follow-up|1|||
170341905|NCT01158950|615590879|FG000|1st Intervention (1 Day)|Physician Decision|1|||
170341906|NCT01158950|615590880|FG001|1st Intervention (1 Day)|Physician Decision|2|||
170341907|NCT00945191|615590881|FG000|Overall Study|Did not achieve a complete response|18|||
170341908|NCT00945191|615590881|FG000|Overall Study|Participant relocated to another state|1|||
170341909|NCT00945191|615590881|FG000|Overall Study|Disease progression|3|||
170341910|NCT00945191|615590881|FG000|Overall Study|Serious adverse event or adverse event|1|||
170341911|NCT00945191|615590881|FG000|Overall Study|Investigator's discretion|1|||
170341912|NCT01797432|615590882|FG000|Overall Study|Lost to Follow-up|1|||
170341913|NCT01797432|615590882|FG000|Overall Study|Adverse Event|1|||
170341914|NCT01797432|615590882|FG000|Overall Study|Withdrawal by Subject|1|||
170341915|NCT01797432|615590882|FG000|Overall Study|lived too far from study site|1|||
170341916|NCT02746679|615590892|FG000|Overall Study|Lost to Follow-up|4|||
170341917|NCT02746679|615590893|FG001|Overall Study|Lost to Follow-up|6|||
170341918|NCT01416610|615590896|FG000|Overall Study|Adverse Event|4|||
170341919|NCT01416610|615590896|FG000|Overall Study|Adverse Event -Patient decision|3|||
170341920|NCT01416610|615590896|FG000|Overall Study|Lack of Efficacy|4|||
170341921|NCT01416610|615590896|FG000|Overall Study|No reason given|5|||
170341922|NCT01416610|615590896|FG000|Overall Study|Withdrawal by Subject|13|||
170341923|NCT01416610|615590896|FG000|Overall Study|Lost to Follow-up|7|||
170341924|NCT01416610|615590896|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
170341925|NCT01927562|615590897|FG000|Overall Study|Lost to Follow-up|30|||
170341926|NCT01927562|615590897|FG000|Overall Study|Withdrawal by Subject|3|||
170341927|NCT01927562|615590897|FG000|Overall Study|Physician Decision|5|||
170341928|NCT00642616|615590898|FG000|Overall Study|Adverse Event|2|||
170341929|NCT00642616|615590899|FG001|Overall Study|Adverse Event|0|||
170341930|NCT00642616|615590900|FG002|Overall Study|Adverse Event|1|||
170341931|NCT00642616|615590901|FG003|Overall Study|Adverse Event|0|||
170341932|NCT00642616|615590898|FG000|Overall Study|Study Terminated by Sponsor|7|||
170341933|NCT00642616|615590899|FG001|Overall Study|Study Terminated by Sponsor|6|||
170341934|NCT00642616|615590900|FG002|Overall Study|Study Terminated by Sponsor|4|||
170341935|NCT00642616|615590901|FG003|Overall Study|Study Terminated by Sponsor|5|||
170341936|NCT00642616|615590898|FG000|Overall Study|Withdrawal by Subject|0|||
170341937|NCT00642616|615590899|FG001|Overall Study|Withdrawal by Subject|1|||
170341938|NCT00642616|615590900|FG002|Overall Study|Withdrawal by Subject|1|||
170341939|NCT00642616|615590901|FG003|Overall Study|Withdrawal by Subject|1|||
170341940|NCT00642616|615590898|FG000|Overall Study|Protocol Violation|0|||
170341941|NCT00642616|615590899|FG001|Overall Study|Protocol Violation|0|||
170341942|NCT00642616|615590900|FG002|Overall Study|Protocol Violation|2|||
170341943|NCT00642616|615590901|FG003|Overall Study|Protocol Violation|0|||
170341944|NCT00642616|615590898|FG000|Overall Study|Physician Decision|0|||
170341945|NCT00642616|615590899|FG001|Overall Study|Physician Decision|0|||
170341946|NCT00642616|615590900|FG002|Overall Study|Physician Decision|1|||
170341947|NCT00642616|615590901|FG003|Overall Study|Physician Decision|1|||
170341948|NCT01161524|615590902|FG000|Core Study (23 Weeks)|Adverse Event|3|||
170341949|NCT01161524|615590903|FG001|Core Study (23 Weeks)|Adverse Event|0|||
170341950|NCT01161524|615590904|FG002|Core Study (23 Weeks)|Adverse Event|0|||
170341951|NCT01161524|615590902|FG000|Core Study (23 Weeks)|Other|1|||
170341952|NCT01161524|615590903|FG001|Core Study (23 Weeks)|Other|0|||
170341953|NCT01161524|615590904|FG002|Core Study (23 Weeks)|Other|0|||
170341954|NCT01161524|615590902|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
170341955|NCT01161524|615590903|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
170341956|NCT01161524|615590904|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
170341957|NCT01161524|615590902|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
170341958|NCT01161524|615590903|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
170341959|NCT01161524|615590904|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
170341960|NCT01161524|615590902|FG000|Core Study (23 Weeks)|Subject Choice|3|||
170341961|NCT01161524|615590903|FG001|Core Study (23 Weeks)|Subject Choice|2|||
170341962|NCT01161524|615590904|FG002|Core Study (23 Weeks)|Subject Choice|0|||
170341963|NCT01161524|615590902|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
170341964|NCT01161524|615590903|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
170341965|NCT01161524|615590904|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
170341966|NCT01161524|615590902|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
170341967|NCT01161524|615590903|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
170341968|NCT01161524|615590904|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
170341969|NCT01161524|615590902|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
170341970|NCT01161524|615590903|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
170341971|NCT01161524|615590904|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
170341972|NCT01161524|615590902|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
170341973|NCT01161524|615590903|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
170341974|NCT01161524|615590904|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
170341975|NCT01161524|615590902|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
170341976|NCT01161524|615590903|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
170341977|NCT01161524|615590904|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
170341978|NCT00399802|615590905|FG000|Overall Study|Adverse Event|0|||
170341979|NCT00399802|615590906|FG001|Overall Study|Adverse Event|2|||
170341980|NCT00399802|615590905|FG000|Overall Study|Participant discontinued by mistake|0|||
170341981|NCT00399802|615590906|FG001|Overall Study|Participant discontinued by mistake|1|||
170341982|NCT00652093|615590907|FG000|Overall Study|Withdrawal by Subject|0|||
170341983|NCT00652093|615590908|FG001|Overall Study|Withdrawal by Subject|0|||
170341984|NCT00652093|615590909|FG002|Overall Study|Withdrawal by Subject|1|||
170341985|NCT00652093|615590910|FG003|Overall Study|Withdrawal by Subject|0|||
170341986|NCT00652093|615590911|FG004|Overall Study|Withdrawal by Subject|1|||
170341987|NCT00652093|615590912|FG005|Overall Study|Withdrawal by Subject|0|||
170341988|NCT00652093|615590907|FG000|Overall Study|Physician Decision|0|||
170341989|NCT00652093|615590908|FG001|Overall Study|Physician Decision|0|||
170341990|NCT00652093|615590909|FG002|Overall Study|Physician Decision|0|||
170341991|NCT00652093|615590910|FG003|Overall Study|Physician Decision|0|||
170341992|NCT00652093|615590911|FG004|Overall Study|Physician Decision|1|||
170341993|NCT00652093|615590912|FG005|Overall Study|Physician Decision|0|||
170341994|NCT02239094|615590925|FG000|Overall Study|Withdrawal by Subject|1|||
170341995|NCT02239094|615590925|FG000|Overall Study|Remitted before started|1|||
170341996|NCT01469052|615590926|FG000|Overall Study|Adverse Event|2|||
170341997|NCT01469052|615590927|FG001|Overall Study|Adverse Event|3|||
170341998|NCT01469052|615590928|FG002|Overall Study|Adverse Event|0|||
170341999|NCT01469052|615590929|FG003|Overall Study|Adverse Event|2|||
170342000|NCT01469052|615590930|FG004|Overall Study|Adverse Event|0|||
170342001|NCT01469052|615590931|FG005|Overall Study|Adverse Event|1|||
170342002|NCT01469052|615590926|FG000|Overall Study|Progressive disease|3|||
170342003|NCT01469052|615590927|FG001|Overall Study|Progressive disease|0|||
170342004|NCT01469052|615590928|FG002|Overall Study|Progressive disease|5|||
170342005|NCT01469052|615590929|FG003|Overall Study|Progressive disease|3|||
170342006|NCT01469052|615590930|FG004|Overall Study|Progressive disease|7|||
170342007|NCT01469052|615590931|FG005|Overall Study|Progressive disease|2|||
170342008|NCT01469052|615590926|FG000|Overall Study|Lack of Efficacy|0|||
170342009|NCT01469052|615590927|FG001|Overall Study|Lack of Efficacy|0|||
170342010|NCT01469052|615590928|FG002|Overall Study|Lack of Efficacy|0|||
170342011|NCT01469052|615590929|FG003|Overall Study|Lack of Efficacy|0|||
170342012|NCT01469052|615590930|FG004|Overall Study|Lack of Efficacy|0|||
170342013|NCT01469052|615590931|FG005|Overall Study|Lack of Efficacy|2|||
170342014|NCT01469052|615590926|FG000|Overall Study|Moved to rollover protocol|1|||
170342015|NCT01469052|615590927|FG001|Overall Study|Moved to rollover protocol|0|||
170342016|NCT01469052|615590928|FG002|Overall Study|Moved to rollover protocol|1|||
170342017|NCT01469052|615590929|FG003|Overall Study|Moved to rollover protocol|0|||
170342018|NCT01469052|615590930|FG004|Overall Study|Moved to rollover protocol|0|||
170342019|NCT01469052|615590931|FG005|Overall Study|Moved to rollover protocol|1|||
170342020|NCT01469052|615590926|FG000|Overall Study|Other|0|||
170342021|NCT01469052|615590927|FG001|Overall Study|Other|1|||
170342022|NCT01469052|615590928|FG002|Overall Study|Other|0|||
170342023|NCT01469052|615590929|FG003|Overall Study|Other|0|||
170342024|NCT01469052|615590930|FG004|Overall Study|Other|1|||
170342025|NCT01469052|615590931|FG005|Overall Study|Other|0|||
170342026|NCT02508701|615590932|FG000|Overall Study|Lost to Follow-up|9|||
170342027|NCT02508701|615590933|FG001|Overall Study|Lost to Follow-up|5|||
170342028|NCT02508701|615590934|FG002|Overall Study|Lost to Follow-up|5|||
170342029|NCT02508701|615590935|FG003|Overall Study|Lost to Follow-up|3|||
170342030|NCT03894904|615590936|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
170342031|NCT03894904|615590937|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
170342032|NCT03894904|615590936|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
170342033|NCT03894904|615590937|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
170342034|NCT03117049|615590940|FG000|Overall Study|Continued the follow-up period|109|||
170342035|NCT03117049|615590941|FG001|Overall Study|Continued the follow-up period|129|||
170342036|NCT03117049|615590940|FG000|Overall Study|Died|82|||
170342037|NCT03117049|615590941|FG001|Overall Study|Died|93|||
170342038|NCT03117049|615590940|FG000|Overall Study|Consent withdrawal|7|||
170342039|NCT03117049|615590941|FG001|Overall Study|Consent withdrawal|6|||
170342040|NCT03117049|615590940|FG000|Overall Study|Missing contact|3|||
170342041|NCT03117049|615590941|FG001|Overall Study|Missing contact|3|||
170342042|NCT01000064|615590942|FG000|Overall Study|Withdrawal by Subject|1|||
170342043|NCT01000064|615590943|FG001|Overall Study|Withdrawal by Subject|1|||
170342044|NCT00798967|615590944|FG000|Overall Study|Adverse Event|2|||
170342045|NCT00798967|615590945|FG001|Overall Study|Adverse Event|3|||
170342046|NCT00798967|615590944|FG000|Overall Study|Withdrawal by Subject|0|||
170342047|NCT00798967|615590945|FG001|Overall Study|Withdrawal by Subject|1|||
170342048|NCT00798967|615590944|FG000|Overall Study|Physician Decision|1|||
170342049|NCT00798967|615590945|FG001|Overall Study|Physician Decision|0|||
170342050|NCT00798967|615590944|FG000|Overall Study|Randomized in error by site|1|||
170342051|NCT00798967|615590945|FG001|Overall Study|Randomized in error by site|0|||
170342052|NCT01415440|615590947|FG000|Overall Study|Lost to Follow-up|0|||
170342053|NCT01415440|615590948|FG001|Overall Study|Lost to Follow-up|1|||
170342054|NCT01415440|615590949|FG002|Overall Study|Lost to Follow-up|2|||
170342055|NCT01415440|615590947|FG000|Overall Study|Physician Decision|3|||
170342056|NCT01415440|615590948|FG001|Overall Study|Physician Decision|0|||
170342057|NCT01415440|615590949|FG002|Overall Study|Physician Decision|0|||
170342058|NCT01415440|615590947|FG000|Overall Study|Withdrawal by Subject|1|||
170342059|NCT01415440|615590948|FG001|Overall Study|Withdrawal by Subject|0|||
170342060|NCT01415440|615590949|FG002|Overall Study|Withdrawal by Subject|0|||
170342061|NCT03596177|615590950|FG000|Single Blind Period|Withdrawal by Subject|1|||
170342062|NCT03596177|615590951|FG001|Single Blind Period|Withdrawal by Subject|1|||
170342063|NCT03596177|615590950|FG000|Single Blind Period|Other|1|||
170342064|NCT03596177|615590951|FG001|Single Blind Period|Other|0|||
170342065|NCT03596177|615590950|FG000|Double Blind Period|Withdrawal by Subject|0|||
170342066|NCT03596177|615590951|FG001|Double Blind Period|Withdrawal by Subject|1|||
170342067|NCT03596177|615590950|FG000|Double Blind Period|Other|0|||
170342068|NCT03596177|615590951|FG001|Double Blind Period|Other|4|||
170342069|NCT03596177|615590950|FG000|Double Blind Period|Death during safety follow-up|0|||
170342070|NCT03596177|615590951|FG001|Double Blind Period|Death during safety follow-up|1|||
170342071|NCT01507246|615590952|FG000|Overall Study|Required different surgical procedures|2|||
170342072|NCT01507246|615590953|FG001|Overall Study|Required different surgical procedures|1|||
170342073|NCT03575468|615590955|FG000|Overall Study|Withdrawal by Subject|3|||
170342074|NCT03575468|615590956|FG001|Overall Study|Withdrawal by Subject|0|||
170342075|NCT03575468|615590955|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
170342076|NCT03575468|615590956|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
170342077|NCT03575468|615590955|FG000|Overall Study|Lost to Follow-up|13|||
170342078|NCT03575468|615590956|FG001|Overall Study|Lost to Follow-up|17|||
170342079|NCT01118143|615590957|FG000|Overall Study|Withdrawal by Subject|2|||
170342080|NCT01118143|615590958|FG001|Overall Study|Withdrawal by Subject|5|||
170342081|NCT02078713|615592663|FG000|Overall Study|Lost to Follow-up|49|||
170342082|NCT02078713|615592664|FG001|Overall Study|Lost to Follow-up|55|||
170342083|NCT02078713|615592665|FG002|Overall Study|Lost to Follow-up|0|||
170342084|NCT02078713|615592666|FG003|Overall Study|Lost to Follow-up|0|||
170342085|NCT02078713|615592663|FG000|Overall Study|Pregnant at baseline|3|||
170342086|NCT02078713|615592664|FG001|Overall Study|Pregnant at baseline|5|||
170342087|NCT02078713|615592665|FG002|Overall Study|Pregnant at baseline|0|||
170342088|NCT02078713|615592666|FG003|Overall Study|Pregnant at baseline|0|||
170342089|NCT02078713|615592663|FG000|Overall Study|Enrolled twice|0|||
170342090|NCT02078713|615592664|FG001|Overall Study|Enrolled twice|1|||
170342091|NCT02078713|615592665|FG002|Overall Study|Enrolled twice|0|||
170342092|NCT02078713|615592666|FG003|Overall Study|Enrolled twice|0|||
170342093|NCT01158534|615592673|FG000|Overall Study|Withdrawal by Subject|1|||
170342094|NCT01158534|615592673|FG000|Overall Study|Death|1|||
170342095|NCT01158534|615592673|FG000|Overall Study|Other|1|||
170342096|NCT01989546|615592674|FG000|Overall Study|Clinical Progression|1|||
170342097|NCT01989546|615592674|FG000|Overall Study|Disease progression on study|8|||
170342098|NCT01793051|615592675|FG000|Overall Study|Withdrawal by Subject|6|||
170342099|NCT01793051|615592676|FG001|Overall Study|Withdrawal by Subject|4|||
170342100|NCT01793051|615592675|FG000|Overall Study|Adverse Event|0|||
170342101|NCT01793051|615592676|FG001|Overall Study|Adverse Event|2|||
170342102|NCT01793051|615592675|FG000|Overall Study|Too ill to continue|1|||
170342103|NCT01793051|615592676|FG001|Overall Study|Too ill to continue|0|||
170342104|NCT01793051|615592675|FG000|Overall Study|Switched chemo|1|||
170342105|NCT01793051|615592676|FG001|Overall Study|Switched chemo|1|||
170342106|NCT01793051|615592675|FG000|Overall Study|Lack of compliance|1|||
170342107|NCT01793051|615592676|FG001|Overall Study|Lack of compliance|0|||
170342108|NCT01793051|615592675|FG000|Overall Study|Requested to be removed from the study|1|||
170342109|NCT01793051|615592676|FG001|Overall Study|Requested to be removed from the study|1|||
170342110|NCT04494633|615592677|FG000|Overall Study|Lost to Follow-up|5|||
170342111|NCT04494633|615592678|FG001|Overall Study|Lost to Follow-up|3|||
170342112|NCT04494633|615592677|FG000|Overall Study|Protocol Violation|1|||
170342113|NCT04494633|615592678|FG001|Overall Study|Protocol Violation|1|||
170342114|NCT03074162|615592679|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
170342115|NCT03074162|615592680|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
170342116|NCT03074162|615592681|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
170342117|NCT03074162|615592682|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
170342118|NCT03074162|615592683|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
170342119|NCT03074162|615592684|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
170342120|NCT03074162|615592679|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
170342121|NCT03074162|615592680|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
170342122|NCT03074162|615592681|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
170342123|NCT03074162|615592682|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
170342124|NCT03074162|615592683|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
170342125|NCT03074162|615592684|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
170342126|NCT03074162|615592679|FG000|Period 3|Withdrawal by Subject|1|||
170342127|NCT03074162|615592680|FG001|Period 3|Withdrawal by Subject|0|||
170342128|NCT03074162|615592681|FG002|Period 3|Withdrawal by Subject|0|||
170342129|NCT03074162|615592682|FG003|Period 3|Withdrawal by Subject|0|||
170342130|NCT03074162|615592683|FG004|Period 3|Withdrawal by Subject|1|||
170342131|NCT03074162|615592684|FG005|Period 3|Withdrawal by Subject|0|||
170342132|NCT01958671|615592685|FG000|Overall Study|Adverse Event|1|||
170342133|NCT01958671|615592686|FG001|Overall Study|Adverse Event|1|||
170342134|NCT01958671|615592687|FG002|Overall Study|Adverse Event|5|||
170342135|NCT01958671|615592685|FG000|Overall Study|Death|1|||
170342136|NCT01958671|615592686|FG001|Overall Study|Death|0|||
170342137|NCT01958671|615592687|FG002|Overall Study|Death|0|||
170342138|NCT01958671|615592685|FG000|Overall Study|Excluded medication|0|||
170342139|NCT01958671|615592686|FG001|Overall Study|Excluded medication|0|||
170342140|NCT01958671|615592687|FG002|Overall Study|Excluded medication|1|||
170342141|NCT01958671|615592685|FG000|Overall Study|Hyperglycemia|0|||
170342142|NCT01958671|615592686|FG001|Overall Study|Hyperglycemia|0|||
170342143|NCT01958671|615592687|FG002|Overall Study|Hyperglycemia|2|||
170342144|NCT01958671|615592685|FG000|Overall Study|Lost to Follow-up|7|||
170342145|NCT01958671|615592686|FG001|Overall Study|Lost to Follow-up|11|||
170342146|NCT01958671|615592687|FG002|Overall Study|Lost to Follow-up|7|||
170342147|NCT01958671|615592685|FG000|Overall Study|Non-compliance with study drug|1|||
170342148|NCT01958671|615592686|FG001|Overall Study|Non-compliance with study drug|1|||
170342149|NCT01958671|615592687|FG002|Overall Study|Non-compliance with study drug|1|||
170342150|NCT01958671|615592685|FG000|Overall Study|Pregnancy|0|||
170342151|NCT01958671|615592686|FG001|Overall Study|Pregnancy|0|||
170342152|NCT01958671|615592687|FG002|Overall Study|Pregnancy|1|||
170342153|NCT01958671|615592685|FG000|Overall Study|Protocol Violation|0|||
170342154|NCT01958671|615592686|FG001|Overall Study|Protocol Violation|1|||
170342155|NCT01958671|615592687|FG002|Overall Study|Protocol Violation|0|||
170342156|NCT01958671|615592685|FG000|Overall Study|Study site terminated by sponsor|1|||
170342157|NCT01958671|615592686|FG001|Overall Study|Study site terminated by sponsor|0|||
170342158|NCT01958671|615592687|FG002|Overall Study|Study site terminated by sponsor|1|||
170342159|NCT01958671|615592685|FG000|Overall Study|Participant moved|0|||
170342160|NCT01958671|615592686|FG001|Overall Study|Participant moved|0|||
170342161|NCT01958671|615592687|FG002|Overall Study|Participant moved|1|||
170342162|NCT01958671|615592685|FG000|Overall Study|Withdrawal by Subject|8|||
170342163|NCT01958671|615592686|FG001|Overall Study|Withdrawal by Subject|10|||
170342164|NCT01958671|615592687|FG002|Overall Study|Withdrawal by Subject|13|||
170342165|NCT03276936|615592688|FG000|Overall Study|Adverse Event|4|||
170342166|NCT03276936|615592689|FG001|Overall Study|Adverse Event|2|||
170342167|NCT03276936|615592688|FG000|Overall Study|Lost to Follow-up|16|||
170342168|NCT03276936|615592689|FG001|Overall Study|Lost to Follow-up|13|||
170342169|NCT03276936|615592688|FG000|Overall Study|Withdrawal by Subject|30|||
170342170|NCT03276936|615592689|FG001|Overall Study|Withdrawal by Subject|20|||
170342171|NCT03276936|615592688|FG000|Overall Study|Not mentioned|6|||
170342172|NCT03276936|615592689|FG001|Overall Study|Not mentioned|3|||
170342173|NCT01703286|615592692|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
170342174|NCT01703286|615592693|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
170342175|NCT01703286|615592694|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
170342176|NCT01703286|615592695|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
170342177|NCT01703286|615592696|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
170342178|NCT01703286|615592697|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
170342179|NCT01703286|615592692|FG000|Period 2 Including Washout|Adverse Event|0|||
170342180|NCT01703286|615592693|FG001|Period 2 Including Washout|Adverse Event|0|||
170342181|NCT01703286|615592694|FG002|Period 2 Including Washout|Adverse Event|0|||
170342182|NCT01703286|615592695|FG003|Period 2 Including Washout|Adverse Event|1|||
170342183|NCT01703286|615592696|FG004|Period 2 Including Washout|Adverse Event|0|||
170342184|NCT01703286|615592697|FG005|Period 2 Including Washout|Adverse Event|0|||
170342185|NCT02421120|615592698|FG000|Overall Study|Adverse Event|1|||
170342186|NCT00931892|615592699|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
170342187|NCT00931892|615592700|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
170342188|NCT02207530|615592701|FG000|Overall Study|Worsening condition under investigation|78|||
170342189|NCT02207530|615592701|FG000|Overall Study|Patient decision to stop study treatment|5|||
170342190|NCT02207530|615592701|FG000|Overall Study|Adverse Event|8|||
170342191|NCT00372190|615592702|FG000|Overall Study|Lost to Follow-up|3|||
170342192|NCT00372190|615592703|FG001|Overall Study|Lost to Follow-up|1|||
170342193|NCT01675531|615592704|FG000|Overall Study|Adverse Event|9|||
170342194|NCT01675531|615592704|FG000|Overall Study|Withdrawal by Subject|7|||
170342195|NCT01675531|615592704|FG000|Overall Study|Lack of Efficacy|1|||
170342196|NCT01675531|615592704|FG000|Overall Study|Protocol Violation|8|||
170342197|NCT00623467|615592705|FG000|Overall Study|Lost to Follow-up|1|||
170342198|NCT00623467|615592705|FG000|Overall Study|Protocol Violation|4|||
170342199|NCT00623467|615592705|FG000|Overall Study|Withdrawal by Subject|2|||
170342200|NCT01585961|615592707|FG000|Overall Study|Death|6|||
170342201|NCT01585961|615592707|FG000|Overall Study|Physician Decision|1|||
170342202|NCT01585961|615592707|FG000|Overall Study|Decision to use non-study catheter|1|||
170342203|NCT01585961|615592707|FG000|Overall Study|Withdrawal by Subject|1|||
170342204|NCT01585961|615592707|FG000|Overall Study|Lost to Follow-up|23|||
170342205|NCT01585961|615592707|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
170342206|NCT01505491|615592708|FG000|Overall Study|Other reason not listed|1|||
170342207|NCT01505491|615592709|FG001|Overall Study|Other reason not listed|0|||
170342208|NCT01505491|615592710|FG002|Overall Study|Other reason not listed|0|||
170342209|NCT01505491|615592708|FG000|Overall Study|Withdrawal by Subject|1|||
170342210|NCT01505491|615592709|FG001|Overall Study|Withdrawal by Subject|1|||
170342211|NCT01505491|615592710|FG002|Overall Study|Withdrawal by Subject|4|||
170342212|NCT01505491|615592708|FG000|Overall Study|Lost to Follow-up|0|||
170342213|NCT01505491|615592709|FG001|Overall Study|Lost to Follow-up|0|||
170342214|NCT01505491|615592710|FG002|Overall Study|Lost to Follow-up|1|||
170342215|NCT02202031|615592711|FG000|Overall Study|Lost to Follow-up|1|||
170342216|NCT02202031|615592712|FG001|Overall Study|Lost to Follow-up|0|||
170342217|NCT02202031|615592711|FG000|Overall Study|Too Busy|1|||
170342218|NCT02202031|615592712|FG001|Overall Study|Too Busy|3|||
170342219|NCT02202031|615592711|FG000|Overall Study|Illness/Medical Reason|0|||
170342220|NCT02202031|615592712|FG001|Overall Study|Illness/Medical Reason|2|||
170342221|NCT02202031|615592711|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
170342222|NCT02202031|615592712|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
170342223|NCT00793819|615592715|FG000|Overall Study|Adverse Event|8|||
170342224|NCT00793819|615592716|FG001|Overall Study|Adverse Event|4|||
170342225|NCT00793819|615592715|FG000|Overall Study|Lack of Efficacy|1|||
170342226|NCT00793819|615592716|FG001|Overall Study|Lack of Efficacy|1|||
170342227|NCT00793819|615592715|FG000|Overall Study|Withdrawal by Subject|4|||
170342228|NCT00793819|615592716|FG001|Overall Study|Withdrawal by Subject|3|||
170342229|NCT00793819|615592715|FG000|Overall Study|Lost to Follow-up|1|||
170342230|NCT00793819|615592716|FG001|Overall Study|Lost to Follow-up|1|||
170342231|NCT00446446|615592717|FG000|Overall Study|Death|10|||
170342232|NCT00446446|615592717|FG000|Overall Study|Withdrawal by Subject|6|||
170342233|NCT00446446|615592717|FG000|Overall Study|Other|4|||
170342234|NCT00446446|615592717|FG000|Overall Study|Disease Progession|2|||
170342235|NCT00446446|615592717|FG000|Overall Study|Adverse Event|1|||
170342236|NCT00446446|615592717|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
170342237|NCT00611130|615592721|FG000|Overall Study|Lost to Follow-up|25|||
170342238|NCT00611130|615592722|FG001|Overall Study|Lost to Follow-up|29|||
170342239|NCT00611130|615592721|FG000|Overall Study|Protocol noncompliance|7|||
170342240|NCT00611130|615592722|FG001|Overall Study|Protocol noncompliance|6|||
170342241|NCT00611130|615592721|FG000|Overall Study|Withdrawal by Subject|6|||
170342242|NCT00611130|615592722|FG001|Overall Study|Withdrawal by Subject|5|||
170342243|NCT00611130|615592721|FG000|Overall Study|Other|5|||
170342244|NCT00611130|615592722|FG001|Overall Study|Other|4|||
170342245|NCT00611130|615592721|FG000|Overall Study|Incarceration|3|||
170342246|NCT00611130|615592722|FG001|Overall Study|Incarceration|2|||
170342247|NCT00611130|615592721|FG000|Overall Study|Administrative|1|||
170342248|NCT00611130|615592722|FG001|Overall Study|Administrative|1|||
170342249|NCT00611130|615592721|FG000|Overall Study|Adverse Event|1|||
170342250|NCT00611130|615592722|FG001|Overall Study|Adverse Event|0|||
170342251|NCT00611130|615592721|FG000|Overall Study|Death|1|||
170342252|NCT00611130|615592722|FG001|Overall Study|Death|0|||
170342253|NCT01734993|615592730|FG000|Overall Study|Adverse Event|1|||
170342254|NCT01734993|615592730|FG000|Overall Study|Lack of Efficacy|1|||
170342255|NCT00525148|615592733|FG000|Overall Study|Other Adverse Event|3|||
170342256|NCT00525148|615592734|FG001|Overall Study|Other Adverse Event|5|||
170342257|NCT00525148|615592735|FG002|Overall Study|Other Adverse Event|1|||
170342258|NCT00525148|615592736|FG003|Overall Study|Other Adverse Event|8|||
170342259|NCT00525148|615592733|FG000|Overall Study|Progressive disease|18|||
170342260|NCT00525148|615592734|FG001|Overall Study|Progressive disease|30|||
170342261|NCT00525148|615592735|FG002|Overall Study|Progressive disease|6|||
170342262|NCT00525148|615592736|FG003|Overall Study|Progressive disease|49|||
170342263|NCT00525148|615592733|FG000|Overall Study|Refused continuation of study medication|0|||
170342264|NCT00525148|615592734|FG001|Overall Study|Refused continuation of study medication|2|||
170342265|NCT00525148|615592735|FG002|Overall Study|Refused continuation of study medication|0|||
170342266|NCT00525148|615592736|FG003|Overall Study|Refused continuation of study medication|1|||
170342267|NCT00525148|615592733|FG000|Overall Study|Other than stated|2|||
170342268|NCT00525148|615592734|FG001|Overall Study|Other than stated|1|||
170342269|NCT00525148|615592735|FG002|Overall Study|Other than stated|0|||
170342270|NCT00525148|615592736|FG003|Overall Study|Other than stated|3|||
170342271|NCT03078608|615592737|FG000|Overall Study|Death|1|||
170342272|NCT03078608|615592738|FG001|Overall Study|Death|2|||
170342273|NCT03078608|615592739|FG002|Overall Study|Death|0|||
170342274|NCT03078608|615592740|FG003|Overall Study|Death|0|||
170342275|NCT03078608|615592737|FG000|Overall Study|Withdrawal by Subject|8|||
170342276|NCT03078608|615592738|FG001|Overall Study|Withdrawal by Subject|1|||
170342277|NCT03078608|615592739|FG002|Overall Study|Withdrawal by Subject|0|||
170342278|NCT03078608|615592740|FG003|Overall Study|Withdrawal by Subject|0|||
170342279|NCT03078608|615592737|FG000|Overall Study|Lost to Follow-up|5|||
170342280|NCT03078608|615592738|FG001|Overall Study|Lost to Follow-up|8|||
170342281|NCT03078608|615592739|FG002|Overall Study|Lost to Follow-up|4|||
170342282|NCT03078608|615592740|FG003|Overall Study|Lost to Follow-up|1|||
170342283|NCT00723840|615592741|FG000|Overall Study|Lost to Follow-up|2|||
170342284|NCT00723840|615592741|FG000|Overall Study|Failure to return|18|||
170342285|NCT00723840|615592741|FG000|Overall Study|Withdrawal by Subject|55|||
170342286|NCT00723840|615592741|FG000|Overall Study|Serious Adverse Events|3|||
170342287|NCT00723840|615592741|FG000|Overall Study|Other Medical Event|2|||
170342288|NCT00723840|615592741|FG000|Overall Study|Unspecified reason|2|||
170342289|NCT01455428|615592747|FG000|Overall Study|Protocol Violation|2|||
170342290|NCT01455428|615592748|FG001|Overall Study|Protocol Violation|1|||
170342291|NCT01455428|615592747|FG000|Overall Study|Adverse Event|6|||
170342292|NCT01455428|615592748|FG001|Overall Study|Adverse Event|2|||
170342293|NCT01455428|615592747|FG000|Overall Study|Lost to Follow-up|1|||
170342294|NCT01455428|615592748|FG001|Overall Study|Lost to Follow-up|1|||
170342295|NCT01455428|615592747|FG000|Overall Study|Withdrawal by Subject|2|||
170342296|NCT01455428|615592748|FG001|Overall Study|Withdrawal by Subject|5|||
170342297|NCT01455428|615592747|FG000|Overall Study|Did not meet entrance criteria|0|||
170342298|NCT01455428|615592748|FG001|Overall Study|Did not meet entrance criteria|2|||
170342299|NCT01455428|615592747|FG000|Overall Study|Insufficient clinical response|0|||
170342300|NCT01455428|615592748|FG001|Overall Study|Insufficient clinical response|2|||
170342301|NCT01455428|615592747|FG000|Overall Study|Did not receive treatment|1|||
170342302|NCT01455428|615592748|FG001|Overall Study|Did not receive treatment|1|||
170342303|NCT01455428|615592747|FG000|Overall Study|Other|2|||
170342304|NCT01455428|615592748|FG001|Overall Study|Other|4|||
170342305|NCT03694522|615592749|FG000|Overall Study|Withdrawal by Subject|8|||
170342306|NCT03694522|615592750|FG001|Overall Study|Withdrawal by Subject|10|||
170342307|NCT03694522|615592749|FG000|Overall Study|Physician Decision|53|||
170342308|NCT03694522|615592750|FG001|Overall Study|Physician Decision|54|||
170342309|NCT03694522|615592749|FG000|Overall Study|Other|1|||
170342310|NCT03694522|615592750|FG001|Overall Study|Other|1|||
170342311|NCT03694522|615592749|FG000|Overall Study|Lost to Follow-up|0|||
170342312|NCT03694522|615592750|FG001|Overall Study|Lost to Follow-up|1|||
170342313|NCT00257192|615592751|FG000|Overall Study|Adverse Event|21|||
170342314|NCT00257192|615592752|FG001|Overall Study|Adverse Event|10|||
170342315|NCT00257192|615592751|FG000|Overall Study|Laboratory abnormality|1|||
170342316|NCT00257192|615592752|FG001|Overall Study|Laboratory abnormality|1|||
170342317|NCT00257192|615592751|FG000|Overall Study|Lost to Follow-up|3|||
170342318|NCT00257192|615592752|FG001|Overall Study|Lost to Follow-up|3|||
170342319|NCT00257192|615592751|FG000|Overall Study|Insufficient clinical response|18|||
170342320|NCT00257192|615592752|FG001|Overall Study|Insufficient clinical response|18|||
170342321|NCT00257192|615592751|FG000|Overall Study|Withdrawal by Subject|14|||
170342322|NCT00257192|615592752|FG001|Overall Study|Withdrawal by Subject|2|||
170342323|NCT00257192|615592751|FG000|Overall Study|Randomized but not treated|0|||
170342324|NCT00257192|615592752|FG001|Overall Study|Randomized but not treated|1|||
170342325|NCT00257192|615592751|FG000|Overall Study|Study terminated by sponsor|1|||
170342326|NCT00257192|615592752|FG001|Overall Study|Study terminated by sponsor|0|||
170342327|NCT00257192|615592751|FG000|Overall Study|Miscellaneous|0|||
170342328|NCT00257192|615592752|FG001|Overall Study|Miscellaneous|4|||
170342329|NCT02522377|615592753|FG000|Overall Study|Withdrawal by Subject|1|||
170342330|NCT02522377|615592754|FG001|Overall Study|Withdrawal by Subject|0|||
170342331|NCT02522377|615592753|FG000|Overall Study|Remission Achieved|3|||
170342332|NCT02522377|615592754|FG001|Overall Study|Remission Achieved|0|||
170342333|NCT02092389|615592756|FG000|Overall Study|Adverse Event|1|||
170342334|NCT02092389|615592756|FG000|Overall Study|Other|5|||
170342335|NCT01242020|615592757|FG000|Overall Study|Withdrawal by Subject|2|||
170342336|NCT01242020|615592758|FG001|Overall Study|Withdrawal by Subject|0|||
170342337|NCT01242020|615592757|FG000|Overall Study|Failed screening|1|||
170342338|NCT01242020|615592758|FG001|Overall Study|Failed screening|0|||
170342339|NCT00863928|615592759|FG000|Overall Study|Protocol Violation|26|||
170342340|NCT00863928|615592760|FG001|Overall Study|Protocol Violation|0|||
170342341|NCT00863928|615592759|FG000|Overall Study|Withdrawal by Subject|3|||
170342342|NCT00863928|615592760|FG001|Overall Study|Withdrawal by Subject|0|||
170342343|NCT00863928|615592759|FG000|Overall Study|surgery cancellation|4|||
170342344|NCT00863928|615592760|FG001|Overall Study|surgery cancellation|0|||
170342345|NCT00863928|615592759|FG000|Overall Study|medication allergy|3|||
170342346|NCT00863928|615592760|FG001|Overall Study|medication allergy|0|||
170342347|NCT03290300|615592761|FG000|Overall Study|Lost to Follow-up|3|||
170342348|NCT00638846|615592767|FG000|Overall Study|Adverse Event|0|||
170342349|NCT00638846|615592768|FG001|Overall Study|Adverse Event|1|||
170342350|NCT00638846|615592767|FG000|Overall Study|Lost to Follow-up|3|||
170342351|NCT00638846|615592768|FG001|Overall Study|Lost to Follow-up|2|||
170342352|NCT00638846|615592767|FG000|Overall Study|lens issue|1|||
170342353|NCT00638846|615592768|FG001|Overall Study|lens issue|3|||
170342354|NCT01137435|615592769|FG000|Overall Study|Lost to Follow-up|24|||
170342355|NCT01137435|615592769|FG000|Overall Study|Off label usage|4|||
170342356|NCT01595646|615592770|FG000|Overall Study|Withdrawal by Subject|1|||
170342357|NCT01595646|615592771|FG001|Overall Study|Withdrawal by Subject|0|||
170342358|NCT01595646|615592772|FG002|Overall Study|Withdrawal by Subject|0|||
170342359|NCT01276847|615592774|FG000|Overall Study|Withdrawal by Subject|1|||
170342360|NCT01276847|615592775|FG001|Overall Study|Withdrawal by Subject|0|||
170342361|NCT01276847|615592776|FG002|Overall Study|Withdrawal by Subject|0|||
170342362|NCT00469014|615592777|FG000|Initial Phase Randomization|Disease Progression|0|||
170342363|NCT00469014|615592778|FG001|Initial Phase Randomization|Disease Progression|1|||
170342364|NCT00469014|615592779|FG002|Initial Phase Randomization|Disease Progression|1|||
170342365|NCT00469014|615592780|FG003|Initial Phase Randomization|Disease Progression|0|||
170342366|NCT00469014|615592777|FG000|Initial Phase Randomization|No Response|1|||
170342367|NCT00469014|615592778|FG001|Initial Phase Randomization|No Response|0|||
170342368|NCT00469014|615592779|FG002|Initial Phase Randomization|No Response|0|||
170342369|NCT00469014|615592780|FG003|Initial Phase Randomization|No Response|1|||
170342370|NCT00469014|615592777|FG000|Adaptive Randomization|Not Evaluable|1|||
170342371|NCT00469014|615592778|FG001|Adaptive Randomization|Not Evaluable|0|||
170342372|NCT00469014|615592779|FG002|Adaptive Randomization|Not Evaluable|0|||
170342373|NCT00469014|615592780|FG003|Adaptive Randomization|Not Evaluable|1|||
170342374|NCT00469014|615592777|FG000|Adaptive Randomization|No Response|0|||
170342375|NCT00469014|615592778|FG001|Adaptive Randomization|No Response|1|||
170342376|NCT00469014|615592779|FG002|Adaptive Randomization|No Response|0|||
170342377|NCT00469014|615592780|FG003|Adaptive Randomization|No Response|0|||
170342378|NCT00469014|615592777|FG000|Adaptive Randomization|Death|0|||
170342379|NCT00469014|615592778|FG001|Adaptive Randomization|Death|0|||
170342380|NCT00469014|615592779|FG002|Adaptive Randomization|Death|1|||
170342381|NCT00469014|615592780|FG003|Adaptive Randomization|Death|0|||
170342382|NCT04770155|615592781|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
170342383|NCT04770155|615592782|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
170342384|NCT04770155|615592783|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
170342385|NCT04770155|615592784|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
170342386|NCT04770155|615592785|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
170342387|NCT04770155|615592786|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
170342388|NCT04770155|615592787|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
170342389|NCT04770155|615592788|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
170342390|NCT02021812|615592791|FG000|Overall Study|Death|8|||
170342391|NCT02021812|615592791|FG000|Overall Study|Withdrawal by Subject|3|||
170342392|NCT02021812|615592791|FG000|Overall Study|Lost to Follow-up|2|||
170342393|NCT02021812|615592791|FG000|Overall Study|Refuse to return, COVD 19|2|||
170342394|NCT00504166|615592792|FG000|Overall Study|Adverse Event|1|||
170342395|NCT00504166|615592793|FG001|Overall Study|Adverse Event|4|||
170342396|NCT00504166|615592792|FG000|Overall Study|Withdrawal by Subject|3|||
170342397|NCT00504166|615592793|FG001|Overall Study|Withdrawal by Subject|6|||
170342398|NCT00504166|615592792|FG000|Overall Study|Physician Decision|1|||
170342399|NCT00504166|615592793|FG001|Overall Study|Physician Decision|1|||
170342400|NCT00504166|615592792|FG000|Overall Study|Lost to Follow-up|1|||
170342401|NCT00504166|615592793|FG001|Overall Study|Lost to Follow-up|3|||
170342402|NCT00651118|615592796|FG000|Overall Study|Adverse Event|4|||
170342403|NCT00651118|615592797|FG001|Overall Study|Adverse Event|0|||
170342404|NCT00651118|615592798|FG002|Overall Study|Adverse Event|1|||
170342405|NCT00651118|615592799|FG003|Overall Study|Adverse Event|1|||
170342406|NCT00651118|615592796|FG000|Overall Study|Protocol Violation|2|||
170342407|NCT00651118|615592797|FG001|Overall Study|Protocol Violation|2|||
170342408|NCT00651118|615592798|FG002|Overall Study|Protocol Violation|6|||
170342409|NCT00651118|615592799|FG003|Overall Study|Protocol Violation|2|||
170342410|NCT00651118|615592796|FG000|Overall Study|Lost to Follow-up|2|||
170342411|NCT00651118|615592797|FG001|Overall Study|Lost to Follow-up|0|||
170342412|NCT00651118|615592798|FG002|Overall Study|Lost to Follow-up|1|||
170342413|NCT00651118|615592799|FG003|Overall Study|Lost to Follow-up|2|||
170342414|NCT00651118|615592796|FG000|Overall Study|administrative|1|||
170342415|NCT00651118|615592797|FG001|Overall Study|administrative|4|||
170342416|NCT00651118|615592798|FG002|Overall Study|administrative|2|||
170342417|NCT00651118|615592799|FG003|Overall Study|administrative|1|||
170342418|NCT00651118|615592796|FG000|Overall Study|Withdrawal by Subject|0|||
170342419|NCT00651118|615592797|FG001|Overall Study|Withdrawal by Subject|1|||
170342420|NCT00651118|615592798|FG002|Overall Study|Withdrawal by Subject|1|||
170342421|NCT00651118|615592799|FG003|Overall Study|Withdrawal by Subject|1|||
170342422|NCT01096550|615592800|FG000|Overall Study|discontinued site|10|||
170342423|NCT01096550|615592801|FG001|Overall Study|discontinued site|11|||
170342424|NCT01096550|615592800|FG000|Overall Study|non-regular treatment track at clinic|1|||
170342425|NCT01096550|615592801|FG001|Overall Study|non-regular treatment track at clinic|1|||
170342426|NCT01096550|615592800|FG000|Overall Study|clinic readmission|1|||
170342427|NCT01096550|615592801|FG001|Overall Study|clinic readmission|1|||
170342428|NCT01096550|615592800|FG000|Overall Study|Withdrawal by Subject|0|||
170342429|NCT01096550|615592801|FG001|Overall Study|Withdrawal by Subject|1|||
170342430|NCT01096550|615592800|FG000|Overall Study|non-African American participant|13|||
170342431|NCT01096550|615592801|FG001|Overall Study|non-African American participant|6|||
170342432|NCT01096550|615592800|FG000|Overall Study|Lost to Follow-up|12|||
170342433|NCT01096550|615592801|FG001|Overall Study|Lost to Follow-up|9|||
170342434|NCT00839098|615592804|FG000|Overall Study|Withdrawal by Subject|2|||
170342435|NCT00839098|615592805|FG001|Overall Study|Withdrawal by Subject|1|||
170342436|NCT00839098|615592806|FG002|Overall Study|Withdrawal by Subject|7|||
170342437|NCT00365976|615592807|FG000|Overall Study|Withdrawal by Subject|1|||
170342438|NCT00365976|615592808|FG001|Overall Study|Withdrawal by Subject|5|||
170342439|NCT01345786|615592809|FG000|Overall Study|Adverse Event|0|||
170342440|NCT01345786|615592810|FG001|Overall Study|Adverse Event|1|||
170342441|NCT01345786|615592811|FG002|Overall Study|Adverse Event|3|||
170342442|NCT01345786|615592812|FG003|Overall Study|Adverse Event|1|||
170342443|NCT01345786|615592809|FG000|Overall Study|Subject withdrew consent|2|||
170342444|NCT01345786|615592810|FG001|Overall Study|Subject withdrew consent|2|||
170342445|NCT01345786|615592811|FG002|Overall Study|Subject withdrew consent|1|||
170342446|NCT01345786|615592812|FG003|Overall Study|Subject withdrew consent|0|||
170342447|NCT01345786|615592809|FG000|Overall Study|Noncompliance with protocol|1|||
170342448|NCT01345786|615592810|FG001|Overall Study|Noncompliance with protocol|0|||
170342449|NCT01345786|615592811|FG002|Overall Study|Noncompliance with protocol|1|||
170342450|NCT01345786|615592812|FG003|Overall Study|Noncompliance with protocol|0|||
170342451|NCT01345786|615592809|FG000|Overall Study|Administrative|3|||
170342452|NCT01345786|615592810|FG001|Overall Study|Administrative|5|||
170342453|NCT01345786|615592811|FG002|Overall Study|Administrative|0|||
170342454|NCT01345786|615592812|FG003|Overall Study|Administrative|0|||
170342455|NCT01345786|615592809|FG000|Overall Study|Lost to Follow-up|0|||
170342456|NCT01345786|615592810|FG001|Overall Study|Lost to Follow-up|0|||
170342457|NCT01345786|615592811|FG002|Overall Study|Lost to Follow-up|0|||
170342458|NCT01345786|615592812|FG003|Overall Study|Lost to Follow-up|2|||
170342459|NCT02190435|615592813|FG000|Overall Study|First 12 patients were lead-ins|12|||
170342460|NCT02190435|615592814|FG001|Overall Study|First 12 patients were lead-ins|0|||
170342461|NCT02190435|615592813|FG000|Overall Study|3 consented screen fails|3|||
170342462|NCT02190435|615592814|FG001|Overall Study|3 consented screen fails|0|||
170342463|NCT01963117|615592817|FG000|Overall Study|Death|1|||
170342464|NCT01780389|615592818|FG000|Overall Study|Adverse Event|1|||
170342465|NCT00935220|615592819|FG000|Overall Study|Adverse Event|1|||
170342466|NCT00935220|615592819|FG000|Overall Study|Other reason (not specified)|1|||
170342467|NCT03141307|615592820|FG000|In-Hospital|Withdrawal by Subject|0|||
170342468|NCT03141307|615592821|FG001|In-Hospital|Withdrawal by Subject|2|||
170342469|NCT03141307|615592820|FG000|In-Hospital|Protocol Violation|4|||
170342470|NCT03141307|615592821|FG001|In-Hospital|Protocol Violation|0|||
170342471|NCT03141307|615592820|FG000|Follow-Up|Lost to Follow-up|97|||
170342472|NCT03141307|615592821|FG001|Follow-Up|Lost to Follow-up|54|||
170342473|NCT03090737|615592822|FG000|Overall Study|Other reasons|1|||
170342474|NCT03090737|615592822|FG000|Overall Study|Completed treatment as per protocol|17|||
170342475|NCT03090737|615592822|FG000|Overall Study|Maximum clinical benefit|2|||
170342476|NCT03090737|615592822|FG000|Overall Study|Adverse event unrelated to study drug|7|||
170342477|NCT03090737|615592822|FG000|Overall Study|Study drug toxicity|4|||
170342478|NCT03090737|615592822|FG000|Overall Study|Disease progression|98|||
170342479|NCT02269319|615592826|FG000|Overall Study|Lost to Follow-up|4|||
170342480|NCT02269319|615592827|FG001|Overall Study|Lost to Follow-up|3|||
170342481|NCT02269319|615592826|FG000|Overall Study|Adverse Event|0|||
170342482|NCT02269319|615592827|FG001|Overall Study|Adverse Event|1|||
170342483|NCT02269319|615592826|FG000|Overall Study|Instructions not followed|1|||
170342484|NCT02269319|615592827|FG001|Overall Study|Instructions not followed|0|||
170342485|NCT04083222|615592828|FG000|Overall Study|Voluntary Withdrawal|0|||
170342486|NCT04083222|615592829|FG001|Overall Study|Voluntary Withdrawal|1|||
170342487|NCT04083222|615592828|FG000|Overall Study|Reason not Specified|0|||
170342488|NCT04083222|615592829|FG001|Overall Study|Reason not Specified|1|||
170342489|NCT03103750|615592830|FG000|Overall Study|Adverse Event|1|||
170342490|NCT03103750|615592831|FG001|Overall Study|Adverse Event|0|||
170342491|NCT03103750|615592830|FG000|Overall Study|Lost to Follow-up|1|||
170342492|NCT03103750|615592831|FG001|Overall Study|Lost to Follow-up|0|||
170342493|NCT03103750|615592830|FG000|Overall Study|PET Equipment Related|2|||
170342494|NCT03103750|615592831|FG001|Overall Study|PET Equipment Related|2|||
170342495|NCT02522481|615592832|FG000|Overall Study|discontinued|1|||
170342496|NCT02522481|615592832|FG000|Overall Study|Not dosed|2|||
170342497|NCT03123939|615592837|FG000|Overall Study|Lack of Efficacy|6|||
170342498|NCT03123939|615592837|FG000|Overall Study|Death|5|||
170342499|NCT03123939|615592837|FG000|Overall Study|Physician Decision|2|||
170342500|NCT03123939|615592837|FG000|Overall Study|Subject/guardian decision|2|||
170342501|NCT03123939|615592837|FG000|Overall Study|Lost to Follow-up|1|||
170342502|NCT03123939|615592837|FG000|Overall Study|New therapy for study indication|1|||
170342503|NCT03123939|615592837|FG000|Overall Study|Protocol deviation|1|||
170342504|NCT03123939|615592837|FG000|Overall Study|Progressive disease|18|||
170342505|NCT03123939|615592837|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
170342506|NCT03123939|615592837|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
170342507|NCT01096446|615594481|FG000|Overall Study|Death|1|||
170342508|NCT01096446|615594482|FG001|Overall Study|Death|0|||
170342509|NCT01096446|615594481|FG000|Overall Study|Protocol Violation|2|||
170342510|NCT01096446|615594482|FG001|Overall Study|Protocol Violation|0|||
170342511|NCT00620321|615594483|FG000|Overall Study|Adverse Event|1|||
170342512|NCT00620321|615594484|FG001|Overall Study|Adverse Event|1|||
170342513|NCT00620321|615594483|FG000|Overall Study|Death|1|||
170342514|NCT00620321|615594484|FG001|Overall Study|Death|1|||
170342515|NCT00620321|615594483|FG000|Overall Study|Physician Decision|0|||
170342516|NCT00620321|615594484|FG001|Overall Study|Physician Decision|7|||
170342517|NCT00620321|615594483|FG000|Overall Study|Progressive Disease|5|||
170342518|NCT00620321|615594484|FG001|Overall Study|Progressive Disease|5|||
170342519|NCT00620321|615594483|FG000|Overall Study|Sponsor Decision|0|||
170342520|NCT00620321|615594484|FG001|Overall Study|Sponsor Decision|1|||
170342521|NCT00620321|615594483|FG000|Overall Study|Withdrawal by Subject|1|||
170342522|NCT00620321|615594484|FG001|Overall Study|Withdrawal by Subject|1|||
170342523|NCT02125331|615594490|FG000|Overall Study|Protocol Violation|1|||
170342524|NCT02125331|615594491|FG001|Overall Study|Protocol Violation|0|||
170342525|NCT02125331|615594490|FG000|Overall Study|technical problem|2|||
170342526|NCT02125331|615594491|FG001|Overall Study|technical problem|0|||
170342527|NCT02125331|615594490|FG000|Overall Study|screen failure|2|||
170342528|NCT02125331|615594491|FG001|Overall Study|screen failure|0|||
170342529|NCT00137436|615594492|FG000|Overall Study|Adverse Event|13|||
170342530|NCT00137436|615594492|FG000|Overall Study|Death|2|||
170342531|NCT00137436|615594492|FG000|Overall Study|Lack of Efficacy|17|||
170342532|NCT00137436|615594492|FG000|Overall Study|Withdrawal by Subject|6|||
170342533|NCT00137436|615594492|FG000|Overall Study|Other|5|||
170342534|NCT01605071|615594497|FG000|Overall Study|Withdrawal by Subject|3|||
170342535|NCT01605071|615594498|FG001|Overall Study|Withdrawal by Subject|2|||
170342536|NCT04439838|615594499|FG000|Overall Study|Withdrawal by Subject|0|||
170342537|NCT04439838|615594500|FG001|Overall Study|Withdrawal by Subject|0|||
170342538|NCT04439838|615594501|FG002|Overall Study|Withdrawal by Subject|0|||
170342539|NCT04439838|615594502|FG003|Overall Study|Withdrawal by Subject|0|||
170342540|NCT04439838|615594503|FG004|Overall Study|Withdrawal by Subject|0|||
170342541|NCT04439838|615594504|FG005|Overall Study|Withdrawal by Subject|0|||
170342542|NCT04439838|615594505|FG006|Overall Study|Withdrawal by Subject|0|||
170342543|NCT04439838|615594506|FG007|Overall Study|Withdrawal by Subject|0|||
170342544|NCT04439838|615594507|FG008|Overall Study|Withdrawal by Subject|1|||
170342545|NCT04907539|615594508|FG000|Overall Study|Consent withdrawn|1|||
170342546|NCT04907539|615594509|FG001|Overall Study|Consent withdrawn|0|||
170342547|NCT04907539|615594508|FG000|Overall Study|Death|14|||
170342548|NCT04907539|615594509|FG001|Overall Study|Death|3|||
170342549|NCT00051558|615594510|FG000|Overall Study|Adverse Event|30|||
170342550|NCT00051558|615594511|FG001|Overall Study|Adverse Event|18|||
170342551|NCT00051558|615594510|FG000|Overall Study|Withdrawal by Subject|29|||
170342552|NCT00051558|615594511|FG001|Overall Study|Withdrawal by Subject|42|||
170342553|NCT00051558|615594510|FG000|Overall Study|Death|9|||
170342554|NCT00051558|615594511|FG001|Overall Study|Death|15|||
170342555|NCT00051558|615594510|FG000|Overall Study|Lost to Follow-up|4|||
170342556|NCT00051558|615594511|FG001|Overall Study|Lost to Follow-up|13|||
170342557|NCT00051558|615594510|FG000|Overall Study|Protocol Violation|3|||
170342558|NCT00051558|615594511|FG001|Overall Study|Protocol Violation|4|||
170342559|NCT00051558|615594510|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
170342560|NCT00051558|615594511|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
170342561|NCT00051558|615594510|FG000|Overall Study|Sponsor Decision|6|||
170342562|NCT00051558|615594511|FG001|Overall Study|Sponsor Decision|1|||
170342563|NCT00051558|615594510|FG000|Overall Study|Other|2|||
170342564|NCT00051558|615594511|FG001|Overall Study|Other|1|||
170342565|NCT00051558|615594510|FG000|Overall Study|Significant Lab Value|2|||
170342566|NCT00051558|615594511|FG001|Overall Study|Significant Lab Value|0|||
170342567|NCT00051558|615594510|FG000|Overall Study|Physician Decision|5|||
170342568|NCT00051558|615594511|FG001|Overall Study|Physician Decision|0|||
170342569|NCT02163993|615594513|FG000|Treatment Period|Adverse Event|0|||
170342570|NCT02163993|615594514|FG001|Treatment Period|Adverse Event|1|||
170342571|NCT02163993|615594515|FG002|Treatment Period|Adverse Event|0|||
170342572|NCT02163993|615594516|FG003|Treatment Period|Adverse Event|0|||
170342573|NCT02163993|615594517|FG004|Treatment Period|Adverse Event|1|||
170342574|NCT02163993|615594513|FG000|Treatment Period|Lost to Follow-up|2|||
170342575|NCT02163993|615594514|FG001|Treatment Period|Lost to Follow-up|3|||
170342576|NCT02163993|615594515|FG002|Treatment Period|Lost to Follow-up|1|||
170342577|NCT02163993|615594516|FG003|Treatment Period|Lost to Follow-up|3|||
170342578|NCT02163993|615594517|FG004|Treatment Period|Lost to Follow-up|1|||
170342579|NCT02163993|615594513|FG000|Treatment Period|Physician Decision|1|||
170342580|NCT02163993|615594514|FG001|Treatment Period|Physician Decision|0|||
170342581|NCT02163993|615594515|FG002|Treatment Period|Physician Decision|0|||
170342582|NCT02163993|615594516|FG003|Treatment Period|Physician Decision|0|||
170342583|NCT02163993|615594517|FG004|Treatment Period|Physician Decision|0|||
170342584|NCT02163993|615594513|FG000|Treatment Period|Protocol Violation|2|||
170342585|NCT02163993|615594514|FG001|Treatment Period|Protocol Violation|1|||
170342586|NCT02163993|615594515|FG002|Treatment Period|Protocol Violation|0|||
170342587|NCT02163993|615594516|FG003|Treatment Period|Protocol Violation|1|||
170342588|NCT02163993|615594517|FG004|Treatment Period|Protocol Violation|2|||
170342589|NCT02163993|615594513|FG000|Treatment Period|Withdrawal by Subject|6|||
170342590|NCT02163993|615594514|FG001|Treatment Period|Withdrawal by Subject|4|||
170342591|NCT02163993|615594515|FG002|Treatment Period|Withdrawal by Subject|1|||
170342592|NCT02163993|615594516|FG003|Treatment Period|Withdrawal by Subject|4|||
170342593|NCT02163993|615594517|FG004|Treatment Period|Withdrawal by Subject|1|||
170342594|NCT02163993|615594513|FG000|Treatment Period|Not treated|1|||
170342595|NCT02163993|615594514|FG001|Treatment Period|Not treated|0|||
170342596|NCT02163993|615594515|FG002|Treatment Period|Not treated|0|||
170342597|NCT02163993|615594516|FG003|Treatment Period|Not treated|1|||
170342598|NCT02163993|615594517|FG004|Treatment Period|Not treated|2|||
170342599|NCT02163993|615594513|FG000|Post-treatment Period|Adverse Event|0|||
170342600|NCT02163993|615594514|FG001|Post-treatment Period|Adverse Event|0|||
170342601|NCT02163993|615594515|FG002|Post-treatment Period|Adverse Event|1|||
170342602|NCT02163993|615594516|FG003|Post-treatment Period|Adverse Event|0|||
170342603|NCT02163993|615594517|FG004|Post-treatment Period|Adverse Event|0|||
170342604|NCT02163993|615594513|FG000|Post-treatment Period|Lost to Follow-up|2|||
170342605|NCT02163993|615594514|FG001|Post-treatment Period|Lost to Follow-up|2|||
170342606|NCT02163993|615594515|FG002|Post-treatment Period|Lost to Follow-up|3|||
170342607|NCT02163993|615594516|FG003|Post-treatment Period|Lost to Follow-up|1|||
170342608|NCT02163993|615594517|FG004|Post-treatment Period|Lost to Follow-up|0|||
170342609|NCT02163993|615594513|FG000|Post-treatment Period|Protocol Violation|0|||
170342610|NCT02163993|615594514|FG001|Post-treatment Period|Protocol Violation|0|||
170342611|NCT02163993|615594515|FG002|Post-treatment Period|Protocol Violation|0|||
170342612|NCT02163993|615594516|FG003|Post-treatment Period|Protocol Violation|0|||
170342613|NCT02163993|615594517|FG004|Post-treatment Period|Protocol Violation|1|||
170342614|NCT02163993|615594513|FG000|Post-treatment Period|Withdrawal by Subject|2|||
170342615|NCT02163993|615594514|FG001|Post-treatment Period|Withdrawal by Subject|4|||
170342616|NCT02163993|615594515|FG002|Post-treatment Period|Withdrawal by Subject|0|||
170342617|NCT02163993|615594516|FG003|Post-treatment Period|Withdrawal by Subject|1|||
170342618|NCT02163993|615594517|FG004|Post-treatment Period|Withdrawal by Subject|2|||
170342619|NCT01701583|615594521|FG000|Overall Study|Withdrawal by Subject|2|||
170342620|NCT01701583|615594522|FG001|Overall Study|Withdrawal by Subject|0|||
170342621|NCT01993329|615594523|FG000|Period 2|Adverse Event|0|||
170342622|NCT01993329|615594524|FG001|Period 2|Adverse Event|0|||
170342623|NCT01993329|615594525|FG002|Period 2|Adverse Event|0|||
170342624|NCT01993329|615594526|FG003|Period 2|Adverse Event|0|||
170342625|NCT01993329|615594527|FG004|Period 2|Adverse Event|0|||
170342626|NCT01993329|615594528|FG005|Period 2|Adverse Event|1|||
170342627|NCT01993329|615594523|FG000|Wash-out|Personal reasons|0|||
170342628|NCT01993329|615594524|FG001|Wash-out|Personal reasons|1|||
170342629|NCT01993329|615594525|FG002|Wash-out|Personal reasons|0|||
170342630|NCT01993329|615594526|FG003|Wash-out|Personal reasons|0|||
170342631|NCT01993329|615594527|FG004|Wash-out|Personal reasons|0|||
170342632|NCT01993329|615594528|FG005|Wash-out|Personal reasons|0|||
170342633|NCT05070429|615594529|FG000|Overall Study|Death|0|||
170342634|NCT05070429|615594530|FG001|Overall Study|Death|4|||
170342635|NCT05070429|615594529|FG000|Overall Study|Withdrawal by Subject|2|||
170342636|NCT05070429|615594530|FG001|Overall Study|Withdrawal by Subject|1|||
170342637|NCT05070429|615594529|FG000|Overall Study|Other|15|||
170342638|NCT05070429|615594530|FG001|Overall Study|Other|5|||
170342639|NCT00615290|615594534|FG000|Overall Study|Adverse Event|2|||
170342640|NCT00615290|615594534|FG000|Overall Study|Lost to Follow-up|3|||
170342641|NCT00615290|615594534|FG000|Overall Study|Withdrawal by Subject|1|||
170342642|NCT00615290|615594534|FG000|Overall Study|Other|2|||
170342643|NCT02849990|615594535|FG000|Overall Study|Adverse Event|1|||
170342644|NCT02849990|615594535|FG000|Overall Study|Withdrawal by Subject|1|||
170342645|NCT01252134|615594536|FG000|Period 1, 8 Hours|Personal Reasons|0|||
170342646|NCT01252134|615594537|FG001|Period 1, 8 Hours|Personal Reasons|1|||
170342647|NCT01252134|615594538|FG002|Period 1, 8 Hours|Personal Reasons|1|||
170342648|NCT01252134|615594539|FG003|Period 1, 8 Hours|Personal Reasons|0|||
170342649|NCT01252134|615594540|FG004|Period 1, 8 Hours|Personal Reasons|0|||
170342650|NCT01252134|615594541|FG005|Period 1, 8 Hours|Personal Reasons|0|||
170342651|NCT02678741|615594542|FG000|Overall Study|Death|4|||
170342652|NCT02678741|615594542|FG000|Overall Study|Withdrawal by Subject|1|||
170342653|NCT02678741|615594542|FG000|Overall Study|ineligible|3|||
170342654|NCT02678741|615594542|FG000|Overall Study|Not RECIST Measurable|2|||
170342655|NCT02678741|615594542|FG000|Overall Study|Lack of Efficacy|10|||
170342656|NCT01984346|615594546|FG000|Overall Study|Physician Decision|4|||
170342657|NCT01984346|615594547|FG001|Overall Study|Physician Decision|2|||
170342658|NCT01984346|615594546|FG000|Overall Study|Withdrawal by Subject|2|||
170342659|NCT01984346|615594547|FG001|Overall Study|Withdrawal by Subject|2|||
170342660|NCT01984346|615594546|FG000|Overall Study|Enrollment Closed|8|||
170342661|NCT01984346|615594547|FG001|Overall Study|Enrollment Closed|1|||
170342662|NCT01984346|615594546|FG000|Overall Study|Insurance Coverage|1|||
170342663|NCT01984346|615594547|FG001|Overall Study|Insurance Coverage|0|||
170342664|NCT01984346|615594546|FG000|Overall Study|Intra-operative Exclusion|2|||
170342665|NCT01984346|615594547|FG001|Overall Study|Intra-operative Exclusion|0|||
170342666|NCT02042404|615594548|FG000|Overall Study|Death|1|||
170342667|NCT02042404|615594549|FG001|Overall Study|Death|0|||
170342668|NCT02042404|615594548|FG000|Overall Study|Unrelated Adverse Event|3|||
170342669|NCT02042404|615594549|FG001|Overall Study|Unrelated Adverse Event|0|||
170342670|NCT02042404|615594548|FG000|Overall Study|Inability to meet time requirements|1|||
170342671|NCT02042404|615594549|FG001|Overall Study|Inability to meet time requirements|0|||
170342672|NCT03100942|615594550|FG000|Randomized Treatment Period|Withdrew Consent|4|||
170342673|NCT03100942|615594551|FG001|Randomized Treatment Period|Withdrew Consent|5|||
170342674|NCT03100942|615594552|FG002|Randomized Treatment Period|Withdrew Consent|3|||
170342675|NCT03100942|615594553|FG003|Randomized Treatment Period|Withdrew Consent|3|||
170342676|NCT03100942|615594554|FG004|Randomized Treatment Period|Withdrew Consent|0|||
170342677|NCT03100942|615594555|FG005|Randomized Treatment Period|Withdrew Consent|0|||
170342678|NCT03100942|615594556|FG006|Randomized Treatment Period|Withdrew Consent|0|||
170342679|NCT03100942|615594550|FG000|Randomized Treatment Period|Adverse Event|5|||
170342680|NCT03100942|615594551|FG001|Randomized Treatment Period|Adverse Event|2|||
170342681|NCT03100942|615594552|FG002|Randomized Treatment Period|Adverse Event|1|||
170342682|NCT03100942|615594553|FG003|Randomized Treatment Period|Adverse Event|0|||
170342683|NCT03100942|615594554|FG004|Randomized Treatment Period|Adverse Event|0|||
170342684|NCT03100942|615594555|FG005|Randomized Treatment Period|Adverse Event|0|||
170342685|NCT03100942|615594556|FG006|Randomized Treatment Period|Adverse Event|0|||
170342686|NCT03100942|615594550|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
170342687|NCT03100942|615594551|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
170342688|NCT03100942|615594552|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
170342689|NCT03100942|615594553|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
170342690|NCT03100942|615594554|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
170342691|NCT03100942|615594555|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
170342692|NCT03100942|615594556|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
170342693|NCT03100942|615594550|FG000|Randomized Treatment Period|Protocol Violation|0|||
170342694|NCT03100942|615594551|FG001|Randomized Treatment Period|Protocol Violation|1|||
170342695|NCT03100942|615594552|FG002|Randomized Treatment Period|Protocol Violation|1|||
170342696|NCT03100942|615594553|FG003|Randomized Treatment Period|Protocol Violation|1|||
170342697|NCT03100942|615594554|FG004|Randomized Treatment Period|Protocol Violation|0|||
170342698|NCT03100942|615594555|FG005|Randomized Treatment Period|Protocol Violation|0|||
170342699|NCT03100942|615594556|FG006|Randomized Treatment Period|Protocol Violation|0|||
170342700|NCT03100942|615594550|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
170342701|NCT03100942|615594551|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
170342702|NCT03100942|615594552|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
170342703|NCT03100942|615594553|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
170342704|NCT03100942|615594554|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
170342705|NCT03100942|615594555|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
170342706|NCT03100942|615594556|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
170342707|NCT03100942|615594550|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
170342708|NCT03100942|615594551|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
170342709|NCT03100942|615594552|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
170342710|NCT03100942|615594553|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
170342711|NCT03100942|615594554|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
170342712|NCT03100942|615594555|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
170342713|NCT03100942|615594556|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
170342714|NCT03100942|615594550|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
170342715|NCT03100942|615594551|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
170342716|NCT03100942|615594552|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
170342717|NCT03100942|615594553|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
170342718|NCT03100942|615594554|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
170342719|NCT03100942|615594555|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
170342720|NCT03100942|615594556|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
170342721|NCT02531373|615594557|FG000|Overall Study|Lack of Efficacy|0|||
170342722|NCT02531373|615594558|FG001|Overall Study|Lack of Efficacy|0|||
170342723|NCT02531373|615594559|FG002|Overall Study|Lack of Efficacy|0|||
170342724|NCT02531373|615594560|FG003|Overall Study|Lack of Efficacy|0|||
170342725|NCT02531373|615594561|FG004|Overall Study|Lack of Efficacy|3|||
170342726|NCT02531373|615594562|FG005|Overall Study|Lack of Efficacy|2|||
170342727|NCT02531373|615594563|FG006|Overall Study|Lack of Efficacy|4|||
170342728|NCT02531373|615594564|FG007|Overall Study|Lack of Efficacy|8|||
170342729|NCT02531373|615594565|FG008|Overall Study|Lack of Efficacy|5|||
170342730|NCT02531373|615594557|FG000|Overall Study|Lost to Follow-up|0|||
170342731|NCT02531373|615594558|FG001|Overall Study|Lost to Follow-up|0|||
170342732|NCT02531373|615594559|FG002|Overall Study|Lost to Follow-up|0|||
170342733|NCT02531373|615594560|FG003|Overall Study|Lost to Follow-up|0|||
170342734|NCT02531373|615594561|FG004|Overall Study|Lost to Follow-up|0|||
170342735|NCT02531373|615594562|FG005|Overall Study|Lost to Follow-up|2|||
170342736|NCT02531373|615594563|FG006|Overall Study|Lost to Follow-up|2|||
170342737|NCT02531373|615594564|FG007|Overall Study|Lost to Follow-up|0|||
170342738|NCT02531373|615594565|FG008|Overall Study|Lost to Follow-up|0|||
170342739|NCT02531373|615594557|FG000|Overall Study|Physician Decision|0|||
170342740|NCT02531373|615594558|FG001|Overall Study|Physician Decision|0|||
170342741|NCT02531373|615594559|FG002|Overall Study|Physician Decision|0|||
170342742|NCT02531373|615594560|FG003|Overall Study|Physician Decision|0|||
170342743|NCT02531373|615594561|FG004|Overall Study|Physician Decision|2|||
170342744|NCT02531373|615594562|FG005|Overall Study|Physician Decision|1|||
170342745|NCT02531373|615594563|FG006|Overall Study|Physician Decision|0|||
170342746|NCT02531373|615594564|FG007|Overall Study|Physician Decision|0|||
170342747|NCT02531373|615594565|FG008|Overall Study|Physician Decision|0|||
170342748|NCT02531373|615594557|FG000|Overall Study|Protocol Violation|0|||
170342749|NCT02531373|615594558|FG001|Overall Study|Protocol Violation|0|||
170342750|NCT02531373|615594559|FG002|Overall Study|Protocol Violation|0|||
170342751|NCT02531373|615594560|FG003|Overall Study|Protocol Violation|0|||
170342752|NCT02531373|615594561|FG004|Overall Study|Protocol Violation|0|||
170342753|NCT02531373|615594562|FG005|Overall Study|Protocol Violation|1|||
170342754|NCT02531373|615594563|FG006|Overall Study|Protocol Violation|1|||
170342755|NCT02531373|615594564|FG007|Overall Study|Protocol Violation|0|||
170342756|NCT02531373|615594565|FG008|Overall Study|Protocol Violation|1|||
170342757|NCT02531373|615594557|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170342758|NCT02531373|615594558|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170342759|NCT02531373|615594559|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170342760|NCT02531373|615594560|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170342761|NCT02531373|615594561|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
170342762|NCT02531373|615594562|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
170342763|NCT02531373|615594563|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
170342764|NCT02531373|615594564|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
170342765|NCT02531373|615594565|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
170342766|NCT02531373|615594557|FG000|Overall Study|Withdrawal by Subject|0|||
170342767|NCT02531373|615594558|FG001|Overall Study|Withdrawal by Subject|0|||
170342768|NCT02531373|615594559|FG002|Overall Study|Withdrawal by Subject|0|||
170342769|NCT02531373|615594560|FG003|Overall Study|Withdrawal by Subject|0|||
170342770|NCT02531373|615594561|FG004|Overall Study|Withdrawal by Subject|3|||
170342771|NCT02531373|615594562|FG005|Overall Study|Withdrawal by Subject|0|||
170342772|NCT02531373|615594563|FG006|Overall Study|Withdrawal by Subject|0|||
170342773|NCT02531373|615594564|FG007|Overall Study|Withdrawal by Subject|0|||
170342774|NCT02531373|615594565|FG008|Overall Study|Withdrawal by Subject|0|||
170342775|NCT02795988|615594570|FG000|Phase 1b|Withdrawal by Subject|0|||
170342776|NCT02795988|615594571|FG001|Phase 1b|Withdrawal by Subject|1|||
170342777|NCT02795988|615594572|FG002|Phase 1b|Withdrawal by Subject|0|||
170342778|NCT02795988|615594573|FG003|Phase 1b|Withdrawal by Subject|0|||
170342779|NCT02795988|615594574|FG004|Phase 1b|Withdrawal by Subject|0|||
170342780|NCT02795988|615594575|FG005|Phase 1b|Withdrawal by Subject|0|||
170342781|NCT02795988|615594576|FG006|Phase 1b|Withdrawal by Subject|0|||
170342782|NCT02795988|615594570|FG000|Phase 1b|Death|1|||
170342783|NCT02795988|615594571|FG001|Phase 1b|Death|2|||
170342784|NCT02795988|615594572|FG002|Phase 1b|Death|1|||
170342785|NCT02795988|615594573|FG003|Phase 1b|Death|0|||
170342786|NCT02795988|615594574|FG004|Phase 1b|Death|0|||
170342787|NCT02795988|615594575|FG005|Phase 1b|Death|0|||
170342788|NCT02795988|615594576|FG006|Phase 1b|Death|0|||
170342789|NCT02795988|615594570|FG000|Phase 1b|Physician Decision|0|||
170342790|NCT02795988|615594571|FG001|Phase 1b|Physician Decision|0|||
170342791|NCT02795988|615594572|FG002|Phase 1b|Physician Decision|1|||
170342792|NCT02795988|615594573|FG003|Phase 1b|Physician Decision|0|||
170342793|NCT02795988|615594574|FG004|Phase 1b|Physician Decision|0|||
170342794|NCT02795988|615594575|FG005|Phase 1b|Physician Decision|0|||
170342795|NCT02795988|615594576|FG006|Phase 1b|Physician Decision|0|||
170342796|NCT02795988|615594570|FG000|Phase 1b|Progressive Disease|2|||
170342797|NCT02795988|615594571|FG001|Phase 1b|Progressive Disease|2|||
170342798|NCT02795988|615594572|FG002|Phase 1b|Progressive Disease|0|||
170342799|NCT02795988|615594573|FG003|Phase 1b|Progressive Disease|0|||
170342800|NCT02795988|615594574|FG004|Phase 1b|Progressive Disease|0|||
170342801|NCT02795988|615594575|FG005|Phase 1b|Progressive Disease|0|||
170342802|NCT02795988|615594576|FG006|Phase 1b|Progressive Disease|0|||
170342803|NCT02795988|615594570|FG000|Phase 2|Withdrawal by Subject|0|||
170342804|NCT02795988|615594571|FG001|Phase 2|Withdrawal by Subject|0|||
170342805|NCT02795988|615594572|FG002|Phase 2|Withdrawal by Subject|0|||
170342806|NCT02795988|615594573|FG003|Phase 2|Withdrawal by Subject|1|||
170342807|NCT02795988|615594574|FG004|Phase 2|Withdrawal by Subject|0|||
170342808|NCT02795988|615594575|FG005|Phase 2|Withdrawal by Subject|0|||
170342809|NCT02795988|615594576|FG006|Phase 2|Withdrawal by Subject|0|||
170342810|NCT02795988|615594570|FG000|Phase 2|Death|0|||
170342811|NCT02795988|615594571|FG001|Phase 2|Death|0|||
170342812|NCT02795988|615594572|FG002|Phase 2|Death|0|||
170342813|NCT02795988|615594573|FG003|Phase 2|Death|17|||
170342814|NCT02795988|615594574|FG004|Phase 2|Death|17|||
170342815|NCT02795988|615594575|FG005|Phase 2|Death|0|||
170342816|NCT02795988|615594576|FG006|Phase 2|Death|0|||
170342817|NCT02795988|615594570|FG000|Phase 2|Other|0|||
170342818|NCT02795988|615594571|FG001|Phase 2|Other|0|||
170342819|NCT02795988|615594572|FG002|Phase 2|Other|0|||
170342820|NCT02795988|615594573|FG003|Phase 2|Other|1|||
170342821|NCT02795988|615594574|FG004|Phase 2|Other|0|||
170342822|NCT02795988|615594575|FG005|Phase 2|Other|0|||
170342823|NCT02795988|615594576|FG006|Phase 2|Other|0|||
170342824|NCT02795988|615594570|FG000|Phase 2 Extension|Death|0|||
170342825|NCT02795988|615594571|FG001|Phase 2 Extension|Death|0|||
170342826|NCT02795988|615594572|FG002|Phase 2 Extension|Death|0|||
170342827|NCT02795988|615594573|FG003|Phase 2 Extension|Death|0|||
170342828|NCT02795988|615594574|FG004|Phase 2 Extension|Death|0|||
170342829|NCT02795988|615594575|FG005|Phase 2 Extension|Death|5|||
170342830|NCT02795988|615594576|FG006|Phase 2 Extension|Death|6|||
170342831|NCT02795988|615594570|FG000|Phase 2 Extension|Other reasons|0|||
170342832|NCT02795988|615594571|FG001|Phase 2 Extension|Other reasons|0|||
170342833|NCT02795988|615594572|FG002|Phase 2 Extension|Other reasons|0|||
170342834|NCT02795988|615594573|FG003|Phase 2 Extension|Other reasons|0|||
170342835|NCT02795988|615594574|FG004|Phase 2 Extension|Other reasons|0|||
170342836|NCT02795988|615594575|FG005|Phase 2 Extension|Other reasons|2|||
170342837|NCT02795988|615594576|FG006|Phase 2 Extension|Other reasons|1|||
170342838|NCT01258348|615594580|FG000|Overall Study|Adverse Event|1|||
170342839|NCT01258348|615594581|FG001|Overall Study|Adverse Event|1|||
170342840|NCT01258348|615594582|FG002|Overall Study|Adverse Event|3|||
170342841|NCT01258348|615594583|FG003|Overall Study|Adverse Event|2|||
170342842|NCT01258348|615594584|FG004|Overall Study|Adverse Event|4|||
170342843|NCT01258348|615594580|FG000|Overall Study|Progressive Disease|0|||
170342844|NCT01258348|615594581|FG001|Overall Study|Progressive Disease|3|||
170342845|NCT01258348|615594582|FG002|Overall Study|Progressive Disease|0|||
170342846|NCT01258348|615594583|FG003|Overall Study|Progressive Disease|2|||
170342847|NCT01258348|615594584|FG004|Overall Study|Progressive Disease|2|||
170342848|NCT01258348|615594580|FG000|Overall Study|Physician Decision|0|||
170342849|NCT01258348|615594581|FG001|Overall Study|Physician Decision|0|||
170342850|NCT01258348|615594582|FG002|Overall Study|Physician Decision|0|||
170342851|NCT01258348|615594583|FG003|Overall Study|Physician Decision|2|||
170342852|NCT01258348|615594584|FG004|Overall Study|Physician Decision|0|||
170342853|NCT01258348|615594580|FG000|Overall Study|Withdrawal by Subject|0|||
170342854|NCT01258348|615594581|FG001|Overall Study|Withdrawal by Subject|1|||
170342855|NCT01258348|615594582|FG002|Overall Study|Withdrawal by Subject|0|||
170342856|NCT01258348|615594583|FG003|Overall Study|Withdrawal by Subject|0|||
170342857|NCT01258348|615594584|FG004|Overall Study|Withdrawal by Subject|0|||
170342858|NCT01849848|615594590|FG000|Overall Study|Physician Decision|1|||
170342859|NCT01849848|615594590|FG000|Overall Study|Progression of the primary disease|3|||
170342860|NCT01120093|615594600|FG000|Treatment Period 1|Adverse Event|0|||
170342861|NCT01120093|615594601|FG001|Treatment Period 1|Adverse Event|0|||
170342862|NCT01120093|615594602|FG002|Treatment Period 1|Adverse Event|1|||
170342863|NCT01120093|615594603|FG003|Treatment Period 1|Adverse Event|0|||
170342864|NCT01120093|615594604|FG004|Treatment Period 1|Adverse Event|1|||
170342865|NCT01120093|615594600|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170342866|NCT01120093|615594601|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170342867|NCT01120093|615594602|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170342868|NCT01120093|615594603|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170342869|NCT01120093|615594604|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170342870|NCT01120093|615594600|FG000|Treatment Period 2|Adverse Event|0|||
170342871|NCT01120093|615594601|FG001|Treatment Period 2|Adverse Event|0|||
170342872|NCT01120093|615594602|FG002|Treatment Period 2|Adverse Event|0|||
170342873|NCT01120093|615594603|FG003|Treatment Period 2|Adverse Event|1|||
170342874|NCT01120093|615594604|FG004|Treatment Period 2|Adverse Event|0|||
170342875|NCT01120093|615594600|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170342876|NCT01120093|615594601|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170342877|NCT01120093|615594602|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170342878|NCT01120093|615594603|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170342879|NCT01120093|615594604|FG004|Treatment Period 2|Withdrawal by Subject|1|||
170342880|NCT01120093|615594600|FG000|Treatment Period 3|Lack of Efficacy|0|||
170342881|NCT01120093|615594601|FG001|Treatment Period 3|Lack of Efficacy|0|||
170342882|NCT01120093|615594602|FG002|Treatment Period 3|Lack of Efficacy|0|||
170342883|NCT01120093|615594603|FG003|Treatment Period 3|Lack of Efficacy|1|||
170342884|NCT01120093|615594604|FG004|Treatment Period 3|Lack of Efficacy|0|||
170342885|NCT01120093|615594600|FG000|Treatment Period 3|Adverse Event|0|||
170342886|NCT01120093|615594601|FG001|Treatment Period 3|Adverse Event|0|||
170342887|NCT01120093|615594602|FG002|Treatment Period 3|Adverse Event|0|||
170342888|NCT01120093|615594603|FG003|Treatment Period 3|Adverse Event|0|||
170342889|NCT01120093|615594604|FG004|Treatment Period 3|Adverse Event|1|||
170342890|NCT01120093|615594600|FG000|Treatment Period 3|Withdrawal by Subject|0|||
170342891|NCT01120093|615594601|FG001|Treatment Period 3|Withdrawal by Subject|0|||
170342892|NCT01120093|615594602|FG002|Treatment Period 3|Withdrawal by Subject|1|||
170342893|NCT01120093|615594603|FG003|Treatment Period 3|Withdrawal by Subject|0|||
170342894|NCT01120093|615594604|FG004|Treatment Period 3|Withdrawal by Subject|0|||
170342895|NCT01120093|615594600|FG000|Treatment Period 4|Adverse Event|1|||
170342896|NCT01120093|615594601|FG001|Treatment Period 4|Adverse Event|0|||
170342897|NCT01120093|615594602|FG002|Treatment Period 4|Adverse Event|0|||
170342898|NCT01120093|615594603|FG003|Treatment Period 4|Adverse Event|0|||
170342899|NCT01120093|615594604|FG004|Treatment Period 4|Adverse Event|0|||
170342900|NCT01120093|615594600|FG000|Treatment Period 5|Adverse Event|0|||
170342901|NCT01120093|615594601|FG001|Treatment Period 5|Adverse Event|1|||
170342902|NCT01120093|615594602|FG002|Treatment Period 5|Adverse Event|0|||
170342903|NCT01120093|615594603|FG003|Treatment Period 5|Adverse Event|1|||
170342904|NCT01120093|615594604|FG004|Treatment Period 5|Adverse Event|0|||
170342905|NCT03649321|615594609|FG000|Overall Study|Withdrawal by Subject|1|||
170342906|NCT03649321|615594610|FG001|Overall Study|Withdrawal by Subject|0|||
170342907|NCT03649321|615594609|FG000|Overall Study|Death|1|||
170342908|NCT03649321|615594610|FG001|Overall Study|Death|0|||
170342909|NCT00406315|615594611|FG000|Overall Study|Death|1|||
170342910|NCT00406315|615594611|FG000|Overall Study|Adverse Event|39|||
170342911|NCT00406315|615594611|FG000|Overall Study|Laboratory Abnormality|4|||
170342912|NCT00406315|615594611|FG000|Overall Study|Lack of Efficacy|13|||
170342913|NCT00406315|615594611|FG000|Overall Study|Other|33|||
170342914|NCT00406315|615594611|FG000|Overall Study|Lost to Follow-up|21|||
170342915|NCT00406315|615594611|FG000|Overall Study|Withdrawal by Subject|30|||
170342916|NCT01312428|615594612|FG000|Overall Study|Study Termination|3|||
170342917|NCT01312428|615594613|FG001|Overall Study|Study Termination|4|||
170342918|NCT01797783|615594616|FG000|Overall Study|Adverse Event|1|||
170342919|NCT01797783|615594617|FG001|Overall Study|Adverse Event|1|||
170342920|NCT01797783|615594616|FG000|Overall Study|Withdrawal by Subject|1|||
170342921|NCT01797783|615594617|FG001|Overall Study|Withdrawal by Subject|0|||
170342922|NCT02184143|615594618|FG000|Overall Study|Withdrawal by Subject|4|||
170342923|NCT02184143|615594619|FG001|Overall Study|Withdrawal by Subject|4|||
170342924|NCT02184143|615594618|FG000|Overall Study|Lost to Follow-up|5|||
170342925|NCT02184143|615594619|FG001|Overall Study|Lost to Follow-up|3|||
170342926|NCT02184143|615594618|FG000|Overall Study|Death|1|||
170342927|NCT02184143|615594619|FG001|Overall Study|Death|0|||
170342928|NCT00321984|615594623|FG000|Overall Study|Adverse Event|9|||
170342929|NCT00321984|615594624|FG001|Overall Study|Adverse Event|6|||
170342930|NCT00321984|615594625|FG002|Overall Study|Adverse Event|8|||
170342931|NCT00321984|615594623|FG000|Overall Study|Protocol Violation|0|||
170342932|NCT00321984|615594624|FG001|Overall Study|Protocol Violation|1|||
170342933|NCT00321984|615594625|FG002|Overall Study|Protocol Violation|1|||
170342934|NCT00321984|615594623|FG000|Overall Study|Lost to Follow-up|2|||
170342935|NCT00321984|615594624|FG001|Overall Study|Lost to Follow-up|4|||
170342936|NCT00321984|615594625|FG002|Overall Study|Lost to Follow-up|2|||
170342937|NCT00321984|615594623|FG000|Overall Study|Withdrawal by Subject|8|||
170342938|NCT00321984|615594624|FG001|Overall Study|Withdrawal by Subject|6|||
170342939|NCT00321984|615594625|FG002|Overall Study|Withdrawal by Subject|5|||
170342940|NCT00321984|615594623|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
170342941|NCT00321984|615594624|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
170342942|NCT00321984|615594625|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
170342943|NCT00321984|615594623|FG000|Overall Study|Lack of Efficacy|3|||
170342944|NCT00321984|615594624|FG001|Overall Study|Lack of Efficacy|1|||
170342945|NCT00321984|615594625|FG002|Overall Study|Lack of Efficacy|3|||
170342946|NCT00321984|615594623|FG000|Overall Study|Noncompliant|0|||
170342947|NCT00321984|615594624|FG001|Overall Study|Noncompliant|0|||
170342948|NCT00321984|615594625|FG002|Overall Study|Noncompliant|2|||
170342949|NCT00321984|615594623|FG000|Overall Study|Pregnancy|0|||
170342950|NCT00321984|615594624|FG001|Overall Study|Pregnancy|1|||
170342951|NCT00321984|615594625|FG002|Overall Study|Pregnancy|0|||
170342952|NCT00321984|615594623|FG000|Overall Study|Per Subject Request|1|||
170342953|NCT00321984|615594624|FG001|Overall Study|Per Subject Request|0|||
170342954|NCT00321984|615594625|FG002|Overall Study|Per Subject Request|0|||
170342955|NCT00321984|615594623|FG000|Overall Study|Per Investigator Request|1|||
170342956|NCT00321984|615594624|FG001|Overall Study|Per Investigator Request|0|||
170342957|NCT00321984|615594625|FG002|Overall Study|Per Investigator Request|0|||
170342958|NCT00321984|615594623|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
170342959|NCT00321984|615594624|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
170342960|NCT00321984|615594625|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
170342961|NCT02214186|615594628|FG000|Overall Study|Lost to Follow-up|1|||
170342962|NCT02214186|615594629|FG001|Overall Study|Lost to Follow-up|1|||
170342963|NCT02214186|615594628|FG000|Overall Study|Protocol Violation|1|||
170342964|NCT02214186|615594629|FG001|Overall Study|Protocol Violation|1|||
170342965|NCT00431847|615594633|FG000|Overall Study|completion of less than two study visits|6|||
170342966|NCT00431847|615594634|FG001|Overall Study|completion of less than two study visits|3|||
170342967|NCT00431847|615594635|FG002|Overall Study|completion of less than two study visits|4|||
170342968|NCT00431847|615594636|FG003|Overall Study|completion of less than two study visits|14|||
170342969|NCT00431847|615594637|FG004|Overall Study|completion of less than two study visits|0|||
170342970|NCT00431847|615594633|FG000|Overall Study|Protocol Violation|0|||
170342971|NCT00431847|615594634|FG001|Overall Study|Protocol Violation|0|||
170342972|NCT00431847|615594635|FG002|Overall Study|Protocol Violation|0|||
170342973|NCT00431847|615594636|FG003|Overall Study|Protocol Violation|0|||
170342974|NCT00431847|615594637|FG004|Overall Study|Protocol Violation|1|||
170342975|NCT02142894|615594639|FG000|Overall Study|Protocol Violation|8|||
170342976|NCT01302769|615594646|FG000|Overall Study|Lost to Follow-up|1|||
170342977|NCT01302769|615594647|FG001|Overall Study|Lost to Follow-up|1|||
170342978|NCT01905397|615594648|FG000|Overall Study|Death|0|||
170342979|NCT01905397|615594649|FG001|Overall Study|Death|1|||
170342980|NCT01905397|615594648|FG000|Overall Study|Withdrawal by Subject|2|||
170342981|NCT01905397|615594649|FG001|Overall Study|Withdrawal by Subject|0|||
170342982|NCT01905397|615594648|FG000|Overall Study|Surgery canceled/aborted|9|||
170342983|NCT01905397|615594649|FG001|Overall Study|Surgery canceled/aborted|5|||
170342984|NCT01905397|615594648|FG000|Overall Study|Incision < 7 cm|2|||
170342985|NCT01905397|615594649|FG001|Overall Study|Incision < 7 cm|0|||
170342986|NCT01905397|615594648|FG000|Overall Study|Wrong treatment|1|||
170342987|NCT01905397|615594649|FG001|Overall Study|Wrong treatment|1|||
170342988|NCT01905397|615594648|FG000|Overall Study|Device not applied|3|||
170342989|NCT01905397|615594649|FG001|Overall Study|Device not applied|0|||
170342990|NCT01905397|615594648|FG000|Overall Study|Dressing not applied in operating room|1|||
170342991|NCT01905397|615594649|FG001|Overall Study|Dressing not applied in operating room|0|||
170342992|NCT01905397|615594648|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
170342993|NCT01905397|615594649|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
170342994|NCT00789477|615594650|FG000|Overall Study|Withdrawal by Subject|2|||
170342995|NCT00789477|615594651|FG001|Overall Study|Withdrawal by Subject|1|||
170342996|NCT00789477|615594652|FG002|Overall Study|Withdrawal by Subject|3|||
170342997|NCT00789477|615594653|FG003|Overall Study|Withdrawal by Subject|2|||
170342998|NCT00789477|615594654|FG004|Overall Study|Withdrawal by Subject|3|||
170342999|NCT00789477|615594650|FG000|Overall Study|Protocol Violation|1|||
170343000|NCT00789477|615594651|FG001|Overall Study|Protocol Violation|0|||
170343001|NCT00789477|615594652|FG002|Overall Study|Protocol Violation|0|||
170343002|NCT00789477|615594653|FG003|Overall Study|Protocol Violation|1|||
170343003|NCT00789477|615594654|FG004|Overall Study|Protocol Violation|0|||
170343004|NCT00789477|615594650|FG000|Overall Study|Adverse Event|3|||
170343005|NCT00789477|615594651|FG001|Overall Study|Adverse Event|3|||
170343006|NCT00789477|615594652|FG002|Overall Study|Adverse Event|1|||
170343007|NCT00789477|615594653|FG003|Overall Study|Adverse Event|0|||
170343008|NCT00789477|615594654|FG004|Overall Study|Adverse Event|0|||
170343009|NCT00789477|615594650|FG000|Overall Study|Death|1|||
170343010|NCT00789477|615594651|FG001|Overall Study|Death|1|||
170343011|NCT00789477|615594652|FG002|Overall Study|Death|2|||
170343012|NCT00789477|615594653|FG003|Overall Study|Death|2|||
170343013|NCT00789477|615594654|FG004|Overall Study|Death|0|||
170343014|NCT00789477|615594650|FG000|Overall Study|Lost to Follow-up|0|||
170343015|NCT00789477|615594651|FG001|Overall Study|Lost to Follow-up|1|||
170343016|NCT00789477|615594652|FG002|Overall Study|Lost to Follow-up|4|||
170343017|NCT00789477|615594653|FG003|Overall Study|Lost to Follow-up|2|||
170343018|NCT00789477|615594654|FG004|Overall Study|Lost to Follow-up|4|||
170343019|NCT00789477|615594650|FG000|Overall Study|Lack of Efficacy|2|||
170343020|NCT00789477|615594651|FG001|Overall Study|Lack of Efficacy|0|||
170343021|NCT00789477|615594652|FG002|Overall Study|Lack of Efficacy|0|||
170343022|NCT00789477|615594653|FG003|Overall Study|Lack of Efficacy|0|||
170343023|NCT00789477|615594654|FG004|Overall Study|Lack of Efficacy|0|||
170343024|NCT00789477|615594650|FG000|Overall Study|Other|2|||
170343025|NCT00789477|615594651|FG001|Overall Study|Other|0|||
170343026|NCT00789477|615594652|FG002|Overall Study|Other|1|||
170343027|NCT00789477|615594653|FG003|Overall Study|Other|3|||
170343028|NCT00789477|615594654|FG004|Overall Study|Other|0|||
170343029|NCT02375698|615594655|FG000|Overall Study|Withdrawal by Subject|0|||
170343030|NCT02375698|615594656|FG001|Overall Study|Withdrawal by Subject|2|||
170343031|NCT02375698|615594655|FG000|Overall Study|Physician Decision|2|||
170343032|NCT02375698|615594656|FG001|Overall Study|Physician Decision|0|||
170343033|NCT01696877|615594657|FG000|Overall Study|Adverse Event|0|||
170343034|NCT01696877|615594658|FG001|Overall Study|Adverse Event|1|||
170343035|NCT00081289|615594660|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
170343036|NCT00081289|615594661|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
170343037|NCT00081289|615594660|FG000|Overall Study|Ineligible / no protocol treatment|3|||
170343038|NCT00081289|615594661|FG001|Overall Study|Ineligible / no protocol treatment|4|||
170343039|NCT02399475|615594674|FG000|Overall Study|Physician Decision|1|||
170343040|NCT02399475|615594675|FG001|Overall Study|Physician Decision|0|||
170343041|NCT02260193|615594676|FG000|Overall Study|Lack of Efficacy|0|||
170343042|NCT02260193|615594677|FG001|Overall Study|Lack of Efficacy|1|||
170343043|NCT02260193|615594678|FG002|Overall Study|Lack of Efficacy|6|||
170343044|NCT02260193|615594676|FG000|Overall Study|Adverse Event|3|||
170343045|NCT02260193|615594677|FG001|Overall Study|Adverse Event|4|||
170343046|NCT02260193|615594678|FG002|Overall Study|Adverse Event|1|||
170343047|NCT02260193|615594676|FG000|Overall Study|Protocol Violation|0|||
170343048|NCT02260193|615594677|FG001|Overall Study|Protocol Violation|4|||
170343049|NCT02260193|615594678|FG002|Overall Study|Protocol Violation|0|||
170343050|NCT02260193|615594676|FG000|Overall Study|Withdrawal by Subject|3|||
170343051|NCT02260193|615594677|FG001|Overall Study|Withdrawal by Subject|0|||
170343052|NCT02260193|615594678|FG002|Overall Study|Withdrawal by Subject|2|||
170343053|NCT02260193|615594676|FG000|Overall Study|Kidney Transplantation|0|||
170343054|NCT02260193|615594677|FG001|Overall Study|Kidney Transplantation|0|||
170343055|NCT02260193|615594678|FG002|Overall Study|Kidney Transplantation|1|||
170343056|NCT01095250|615594679|FG000|Overall Study|administrative reasons|8|||
170343057|NCT01095250|615594680|FG001|Overall Study|administrative reasons|10|||
170343058|NCT01095250|615594681|FG002|Overall Study|administrative reasons|7|||
170343059|NCT01095250|615594682|FG003|Overall Study|administrative reasons|5|||
170343060|NCT01095250|615594679|FG000|Overall Study|Withdrawal by Subject|0|||
170343061|NCT01095250|615594680|FG001|Overall Study|Withdrawal by Subject|0|||
170343062|NCT01095250|615594681|FG002|Overall Study|Withdrawal by Subject|1|||
170343063|NCT01095250|615594682|FG003|Overall Study|Withdrawal by Subject|0|||
170398643|NCT01336608|615798227|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
170398644|NCT01336608|615798224|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
170398645|NCT01336608|615798225|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
170398646|NCT01336608|615798226|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
170398647|NCT01336608|615798227|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
170398648|NCT02237118|615798228|FG000|Overall Study|Protocol Violation|0|||
170398649|NCT02237118|615798229|FG001|Overall Study|Protocol Violation|1|||
170398650|NCT02237118|615798228|FG000|Overall Study|consent withdrawn|1|||
170398651|NCT02237118|615798229|FG001|Overall Study|consent withdrawn|0|||
170398652|NCT02957682|615798230|FG000|Overall Study|Adverse Event|64|||
170398653|NCT02957682|615798231|FG001|Overall Study|Adverse Event|67|||
170398654|NCT02957682|615798230|FG000|Overall Study|Poor Compliance to Protocol|30|||
170398655|NCT02957682|615798231|FG001|Overall Study|Poor Compliance to Protocol|26|||
170398656|NCT02957682|615798230|FG000|Overall Study|Physician Decision|4|||
170398657|NCT02957682|615798231|FG001|Overall Study|Physician Decision|4|||
170398658|NCT02957682|615798230|FG000|Overall Study|Study Terminated by Sponsor|4|||
170398659|NCT02957682|615798231|FG001|Overall Study|Study Terminated by Sponsor|3|||
170398660|NCT02957682|615798230|FG000|Overall Study|Subject Moved|10|||
170398661|NCT02957682|615798231|FG001|Overall Study|Subject Moved|16|||
170398662|NCT02957682|615798230|FG000|Overall Study|Withdrawal by Subject|64|||
170398663|NCT02957682|615798231|FG001|Overall Study|Withdrawal by Subject|33|||
170398664|NCT02957682|615798230|FG000|Overall Study|Related to IMP Administration|3|||
170399292|NCT03193190|615799949|FG012|Stage 1|Reason not Specified|1|||
170343064|NCT04920084|615596688|FG000|Overall Study|Adverse Event|1|||
170343065|NCT04920084|615596688|FG000|Overall Study|Lost to Follow-up|2|||
170343066|NCT04920084|615596688|FG000|Overall Study|Withdrawal by Subject|2|||
170343067|NCT04191967|615596689|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
170343068|NCT04191967|615596689|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
170343069|NCT01431144|615596690|FG000|Overall Study|Implant mobility and removal|2|||
170343070|NCT01431144|615596691|FG001|Overall Study|Implant mobility and removal|0|||
170343071|NCT00747617|615596694|FG000|Overall Study|Lost to Follow-up|3|||
170343072|NCT00747617|615596695|FG001|Overall Study|Lost to Follow-up|1|||
170343073|NCT00701727|615596696|FG000|First Treatment Period|Adverse Event|0|||
170343074|NCT00701727|615596697|FG001|First Treatment Period|Adverse Event|0|||
170343075|NCT00701727|615596696|FG000|First Treatment Period|Withdrawal by Subject|1|||
170343076|NCT00701727|615596697|FG001|First Treatment Period|Withdrawal by Subject|0|||
170343077|NCT00701727|615596696|FG000|First Treatment Period|sponsor decision|0|||
170343078|NCT00701727|615596697|FG001|First Treatment Period|sponsor decision|1|||
170343079|NCT00701727|615596696|FG000|First Treatment Period|Lost to Follow-up|0|||
170343080|NCT00701727|615596697|FG001|First Treatment Period|Lost to Follow-up|1|||
170343081|NCT00701727|615596696|FG000|Second Treatment Period|Withdrawal by Subject|2|||
170343082|NCT00701727|615596697|FG001|Second Treatment Period|Withdrawal by Subject|0|||
170343083|NCT01104558|615596700|FG000|Overall Study|Protocol Violation|6|||
170343084|NCT01104558|615596700|FG000|Overall Study|Missing of primary efficacy assessment|10|||
170343085|NCT01104558|615596700|FG000|Overall Study|Missing of genetic analysis results|1|||
170343086|NCT00696657|615596701|FG000|Overall Study|Protocol Violation|0|||
170343087|NCT00696657|615596702|FG001|Overall Study|Protocol Violation|0|||
170343088|NCT00696657|615596703|FG002|Overall Study|Protocol Violation|0|||
170343089|NCT00696657|615596704|FG003|Overall Study|Protocol Violation|0|||
170343090|NCT00696657|615596705|FG004|Overall Study|Protocol Violation|0|||
170343091|NCT00696657|615596706|FG005|Overall Study|Protocol Violation|1|||
170343092|NCT00696657|615596707|FG006|Overall Study|Protocol Violation|0|||
170343093|NCT00696657|615596708|FG007|Overall Study|Protocol Violation|0|||
170343094|NCT00696657|615596709|FG008|Overall Study|Protocol Violation|1|||
170343095|NCT00696657|615596701|FG000|Overall Study|Lack of Efficacy|0|||
170343096|NCT00696657|615596702|FG001|Overall Study|Lack of Efficacy|1|||
170343097|NCT00696657|615596703|FG002|Overall Study|Lack of Efficacy|0|||
170343098|NCT00696657|615596704|FG003|Overall Study|Lack of Efficacy|0|||
170343099|NCT00696657|615596705|FG004|Overall Study|Lack of Efficacy|0|||
170343100|NCT00696657|615596706|FG005|Overall Study|Lack of Efficacy|0|||
170343101|NCT00696657|615596707|FG006|Overall Study|Lack of Efficacy|0|||
170343102|NCT00696657|615596708|FG007|Overall Study|Lack of Efficacy|0|||
170343103|NCT00696657|615596709|FG008|Overall Study|Lack of Efficacy|0|||
170343104|NCT00696657|615596701|FG000|Overall Study|Withdrawal criteria|1|||
170343105|NCT00696657|615596702|FG001|Overall Study|Withdrawal criteria|3|||
170343106|NCT00696657|615596703|FG002|Overall Study|Withdrawal criteria|2|||
170343107|NCT00696657|615596704|FG003|Overall Study|Withdrawal criteria|2|||
170343108|NCT00696657|615596705|FG004|Overall Study|Withdrawal criteria|0|||
170343109|NCT00696657|615596706|FG005|Overall Study|Withdrawal criteria|0|||
170343110|NCT00696657|615596707|FG006|Overall Study|Withdrawal criteria|1|||
170343111|NCT00696657|615596708|FG007|Overall Study|Withdrawal criteria|1|||
170343112|NCT00696657|615596709|FG008|Overall Study|Withdrawal criteria|2|||
170343113|NCT00696657|615596701|FG000|Overall Study|Unclassified|0|||
170343114|NCT00696657|615596702|FG001|Overall Study|Unclassified|1|||
170343115|NCT00696657|615596703|FG002|Overall Study|Unclassified|3|||
170343116|NCT00696657|615596704|FG003|Overall Study|Unclassified|2|||
170343117|NCT00696657|615596705|FG004|Overall Study|Unclassified|4|||
170343118|NCT00696657|615596706|FG005|Overall Study|Unclassified|2|||
170343119|NCT00696657|615596707|FG006|Overall Study|Unclassified|0|||
170343120|NCT00696657|615596708|FG007|Overall Study|Unclassified|0|||
170343121|NCT00696657|615596709|FG008|Overall Study|Unclassified|1|||
170343122|NCT00696657|615596701|FG000|Overall Study|Adverse Event|0|||
170343123|NCT00696657|615596702|FG001|Overall Study|Adverse Event|0|||
170343124|NCT00696657|615596703|FG002|Overall Study|Adverse Event|3|||
170343125|NCT00696657|615596704|FG003|Overall Study|Adverse Event|7|||
170343126|NCT00696657|615596705|FG004|Overall Study|Adverse Event|6|||
170343127|NCT00696657|615596706|FG005|Overall Study|Adverse Event|9|||
170343128|NCT00696657|615596707|FG006|Overall Study|Adverse Event|14|||
170343129|NCT00696657|615596708|FG007|Overall Study|Adverse Event|2|||
170343130|NCT00696657|615596709|FG008|Overall Study|Adverse Event|5|||
170343131|NCT02601001|615596710|FG000|Dosing Period 2|Adverse Event|0|||
170343132|NCT02601001|615596711|FG001|Dosing Period 2|Adverse Event|0|||
170343133|NCT02601001|615596712|FG002|Dosing Period 2|Adverse Event|0|||
170343134|NCT02601001|615596713|FG003|Dosing Period 2|Adverse Event|0|||
170343135|NCT02601001|615596714|FG004|Dosing Period 2|Adverse Event|0|||
170343136|NCT02601001|615596715|FG005|Dosing Period 2|Adverse Event|0|||
170343137|NCT02601001|615596716|FG006|Dosing Period 2|Adverse Event|1|||
170343138|NCT00912015|615596717|FG000|Overall Study|Lack of Efficacy|1|||
170343139|NCT00912015|615596718|FG001|Overall Study|Lack of Efficacy|0|||
170343140|NCT00912015|615596719|FG002|Overall Study|Lack of Efficacy|0|||
170343141|NCT00912015|615596720|FG003|Overall Study|Lack of Efficacy|0|||
170343142|NCT00912015|615596717|FG000|Overall Study|Withdrawal by Subject|8|||
170343143|NCT00912015|615596718|FG001|Overall Study|Withdrawal by Subject|8|||
170343144|NCT00912015|615596719|FG002|Overall Study|Withdrawal by Subject|3|||
170343145|NCT00912015|615596720|FG003|Overall Study|Withdrawal by Subject|0|||
170343146|NCT00912015|615596717|FG000|Overall Study|Protocol Violation|1|||
170343147|NCT00912015|615596718|FG001|Overall Study|Protocol Violation|0|||
170343148|NCT00912015|615596719|FG002|Overall Study|Protocol Violation|0|||
170343149|NCT00912015|615596720|FG003|Overall Study|Protocol Violation|1|||
170343150|NCT00912015|615596717|FG000|Overall Study|Adverse Event|6|||
170343151|NCT00912015|615596718|FG001|Overall Study|Adverse Event|0|||
170343152|NCT00912015|615596719|FG002|Overall Study|Adverse Event|0|||
170343153|NCT00912015|615596720|FG003|Overall Study|Adverse Event|1|||
170343154|NCT01356602|615596724|FG000|Overall Study|Protocol Deviation|0|||
170343155|NCT01356602|615596725|FG001|Overall Study|Protocol Deviation|1|||
170343156|NCT01356602|615596726|FG002|Overall Study|Protocol Deviation|1|||
170343157|NCT01356602|615596724|FG000|Overall Study|Administrative Problems|1|||
170343158|NCT01356602|615596725|FG001|Overall Study|Administrative Problems|4|||
170343159|NCT01356602|615596726|FG002|Overall Study|Administrative Problems|5|||
170343160|NCT01356602|615596724|FG000|Overall Study|Lost to Follow-up|4|||
170343161|NCT01356602|615596725|FG001|Overall Study|Lost to Follow-up|5|||
170343162|NCT01356602|615596726|FG002|Overall Study|Lost to Follow-up|6|||
170343163|NCT01356602|615596724|FG000|Overall Study|Withdrawal by Subject|4|||
170343164|NCT01356602|615596725|FG001|Overall Study|Withdrawal by Subject|3|||
170343165|NCT01356602|615596726|FG002|Overall Study|Withdrawal by Subject|7|||
170343166|NCT01356602|615596724|FG000|Overall Study|Lack of Efficacy|0|||
170343167|NCT01356602|615596725|FG001|Overall Study|Lack of Efficacy|1|||
170343168|NCT01356602|615596726|FG002|Overall Study|Lack of Efficacy|4|||
170343169|NCT01356602|615596724|FG000|Overall Study|Adverse Event|0|||
170343170|NCT01356602|615596725|FG001|Overall Study|Adverse Event|1|||
170343171|NCT01356602|615596726|FG002|Overall Study|Adverse Event|1|||
170343172|NCT03123354|615596727|FG000|Overall Study|Physician Decision|6|||
170343173|NCT01931462|615596728|FG000|Overall Study|Withdrawal by Subject|1|||
170343174|NCT03650452|615596735|FG000|Overall Study|Physician Decision|1|||
170343175|NCT03650452|615596736|FG001|Overall Study|Physician Decision|0|||
170343176|NCT03650452|615596735|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
170343177|NCT03650452|615596736|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170343178|NCT03650452|615596735|FG000|Overall Study|Adverse Event|3|||
170343179|NCT03650452|615596736|FG001|Overall Study|Adverse Event|4|||
170343180|NCT03650452|615596735|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
170343181|NCT03650452|615596736|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
170343182|NCT01795898|615596738|FG000|Overall Study|Adverse Event|27|||
170343183|NCT01795898|615596738|FG000|Overall Study|Lost to Follow-up|20|||
170343184|NCT01795898|615596738|FG000|Overall Study|Withdrawal of consent|6|||
170343185|NCT01795898|615596738|FG000|Overall Study|Diagnosed with metastasis|1|||
170343186|NCT01795898|615596738|FG000|Overall Study|No pain|1|||
170343187|NCT01795898|615596738|FG000|Overall Study|Death|1|||
170343188|NCT01795898|615596738|FG000|Overall Study|Withdrew consent & had adverse events|3|||
170343189|NCT01795898|615596738|FG000|Overall Study|Physician Decision|1|||
170343190|NCT00273858|615596753|FG000|Overall Study|Not completed 24 month observation time|334|||
170343191|NCT00273858|615596753|FG000|Overall Study|Lost to Follow-up|101|||
170343192|NCT00273858|615596753|FG000|Overall Study|Withdrawal by Subject|21|||
170343193|NCT00273858|615596753|FG000|Overall Study|Adverse Event|81|||
170343194|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
170343195|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
170343196|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
170343197|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
170343198|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
170343199|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
170343200|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
170343201|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
170343202|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
170343203|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
170343204|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
170343205|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
170343206|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
170343207|NCT02232516|615596754|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
170343208|NCT02232516|615596754|FG000|Survival Follow-up|Death|15|||
170343209|NCT02232516|615596754|FG000|Survival Follow-up|Withdrawal by Subject|3|||
170343210|NCT02232516|615596754|FG000|Survival Follow-up|Lost to Follow-up|1|||
170343211|NCT02232516|615596754|FG000|Survival Follow-up|Still in follow-up|5|||
170343212|NCT01070550|615596755|FG000|Overall Study|Adverse Event|43|||
170343213|NCT01070550|615596756|FG001|Overall Study|Adverse Event|1|||
170343214|NCT01070550|615596757|FG002|Overall Study|Adverse Event|3|||
170343215|NCT01070550|615596758|FG003|Overall Study|Adverse Event|0|||
170343216|NCT01070550|615596759|FG004|Overall Study|Adverse Event|0|||
170343217|NCT01070550|615596760|FG005|Overall Study|Adverse Event|0|||
170343218|NCT01070550|615596755|FG000|Overall Study|Death|20|||
170343219|NCT01070550|615596756|FG001|Overall Study|Death|4|||
170343220|NCT01070550|615596757|FG002|Overall Study|Death|3|||
170343221|NCT01070550|615596758|FG003|Overall Study|Death|0|||
170343222|NCT01070550|615596759|FG004|Overall Study|Death|0|||
170343223|NCT01070550|615596760|FG005|Overall Study|Death|0|||
170343224|NCT01070550|615596755|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
170343225|NCT01070550|615596756|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
170343226|NCT01070550|615596757|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
170343227|NCT01070550|615596758|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
170343228|NCT01070550|615596759|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
170343229|NCT01070550|615596760|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
170343230|NCT01070550|615596755|FG000|Overall Study|Early termination|3|||
170343231|NCT01070550|615596756|FG001|Overall Study|Early termination|0|||
170343232|NCT01070550|615596757|FG002|Overall Study|Early termination|0|||
170343233|NCT01070550|615596758|FG003|Overall Study|Early termination|0|||
170343234|NCT01070550|615596759|FG004|Overall Study|Early termination|0|||
170343235|NCT01070550|615596760|FG005|Overall Study|Early termination|0|||
170343236|NCT01070550|615596755|FG000|Overall Study|Failed to return|450|||
170343237|NCT01070550|615596756|FG001|Overall Study|Failed to return|33|||
170343238|NCT01070550|615596757|FG002|Overall Study|Failed to return|144|||
170343239|NCT01070550|615596758|FG003|Overall Study|Failed to return|40|||
170343240|NCT01070550|615596759|FG004|Overall Study|Failed to return|1|||
170343241|NCT01070550|615596760|FG005|Overall Study|Failed to return|2|||
170343242|NCT01070550|615596755|FG000|Overall Study|Incomplete treatment|2|||
170343243|NCT01070550|615596756|FG001|Overall Study|Incomplete treatment|0|||
170343244|NCT01070550|615596757|FG002|Overall Study|Incomplete treatment|0|||
170343245|NCT01070550|615596758|FG003|Overall Study|Incomplete treatment|0|||
170343246|NCT01070550|615596759|FG004|Overall Study|Incomplete treatment|0|||
170343247|NCT01070550|615596760|FG005|Overall Study|Incomplete treatment|0|||
170343248|NCT01070550|615596755|FG000|Overall Study|Lab test not done|22|||
170343249|NCT01070550|615596756|FG001|Overall Study|Lab test not done|3|||
170343250|NCT01070550|615596757|FG002|Overall Study|Lab test not done|4|||
170343251|NCT01070550|615596758|FG003|Overall Study|Lab test not done|1|||
170343252|NCT01070550|615596759|FG004|Overall Study|Lab test not done|0|||
170343253|NCT01070550|615596760|FG005|Overall Study|Lab test not done|1|||
170343254|NCT01070550|615596755|FG000|Overall Study|Lack of Efficacy|65|||
170343255|NCT01070550|615596756|FG001|Overall Study|Lack of Efficacy|1|||
170343256|NCT01070550|615596757|FG002|Overall Study|Lack of Efficacy|5|||
170343257|NCT01070550|615596758|FG003|Overall Study|Lack of Efficacy|5|||
170343258|NCT01070550|615596759|FG004|Overall Study|Lack of Efficacy|0|||
170343259|NCT01070550|615596760|FG005|Overall Study|Lack of Efficacy|1|||
170343260|NCT01070550|615596755|FG000|Overall Study|Miscellaneous|12|||
170343261|NCT01070550|615596756|FG001|Overall Study|Miscellaneous|2|||
170343262|NCT01070550|615596757|FG002|Overall Study|Miscellaneous|3|||
170343263|NCT01070550|615596758|FG003|Overall Study|Miscellaneous|1|||
170343264|NCT01070550|615596759|FG004|Overall Study|Miscellaneous|0|||
170343265|NCT01070550|615596760|FG005|Overall Study|Miscellaneous|0|||
170343266|NCT01070550|615596755|FG000|Overall Study|New treatment started|3|||
170343267|NCT01070550|615596756|FG001|Overall Study|New treatment started|1|||
170343268|NCT01070550|615596757|FG002|Overall Study|New treatment started|0|||
170343269|NCT01070550|615596758|FG003|Overall Study|New treatment started|2|||
170343270|NCT01070550|615596759|FG004|Overall Study|New treatment started|0|||
170343271|NCT01070550|615596760|FG005|Overall Study|New treatment started|0|||
170343272|NCT01070550|615596755|FG000|Overall Study|Non-responders|493|||
170343273|NCT01070550|615596756|FG001|Overall Study|Non-responders|4|||
170343274|NCT01070550|615596757|FG002|Overall Study|Non-responders|21|||
170343275|NCT01070550|615596758|FG003|Overall Study|Non-responders|20|||
170343276|NCT01070550|615596759|FG004|Overall Study|Non-responders|0|||
170343277|NCT01070550|615596760|FG005|Overall Study|Non-responders|2|||
170343278|NCT01070550|615596755|FG000|Overall Study|Not categorized|33|||
170343279|NCT01070550|615596756|FG001|Overall Study|Not categorized|2|||
170343280|NCT01070550|615596757|FG002|Overall Study|Not categorized|6|||
170343281|NCT01070550|615596758|FG003|Overall Study|Not categorized|1|||
170343282|NCT01070550|615596759|FG004|Overall Study|Not categorized|0|||
170343283|NCT01070550|615596760|FG005|Overall Study|Not categorized|1|||
170343284|NCT01070550|615596755|FG000|Overall Study|Protocol Violation|15|||
170343285|NCT01070550|615596756|FG001|Overall Study|Protocol Violation|1|||
170343286|NCT01070550|615596757|FG002|Overall Study|Protocol Violation|1|||
170343287|NCT01070550|615596758|FG003|Overall Study|Protocol Violation|1|||
170343288|NCT01070550|615596759|FG004|Overall Study|Protocol Violation|0|||
170343289|NCT01070550|615596760|FG005|Overall Study|Protocol Violation|0|||
170343290|NCT01070550|615596755|FG000|Overall Study|Relapse|44|||
170343291|NCT01070550|615596756|FG001|Overall Study|Relapse|5|||
170343292|NCT01070550|615596757|FG002|Overall Study|Relapse|14|||
170343293|NCT01070550|615596758|FG003|Overall Study|Relapse|4|||
170343294|NCT01070550|615596759|FG004|Overall Study|Relapse|0|||
170343295|NCT01070550|615596760|FG005|Overall Study|Relapse|0|||
170343296|NCT01070550|615596755|FG000|Overall Study|Result not available|3|||
170343297|NCT01070550|615596756|FG001|Overall Study|Result not available|1|||
170343298|NCT01070550|615596757|FG002|Overall Study|Result not available|3|||
170343299|NCT01070550|615596758|FG003|Overall Study|Result not available|0|||
170343300|NCT01070550|615596759|FG004|Overall Study|Result not available|0|||
170343301|NCT01070550|615596760|FG005|Overall Study|Result not available|0|||
170343302|NCT01070550|615596755|FG000|Overall Study|Screen failure|1|||
170343303|NCT01070550|615596756|FG001|Overall Study|Screen failure|0|||
170343304|NCT01070550|615596757|FG002|Overall Study|Screen failure|0|||
170343305|NCT01070550|615596758|FG003|Overall Study|Screen failure|0|||
170343306|NCT01070550|615596759|FG004|Overall Study|Screen failure|0|||
170343307|NCT01070550|615596760|FG005|Overall Study|Screen failure|0|||
170343308|NCT01070550|615596755|FG000|Overall Study|Sponsor decision|1|||
170343309|NCT01070550|615596756|FG001|Overall Study|Sponsor decision|0|||
170343310|NCT01070550|615596757|FG002|Overall Study|Sponsor decision|0|||
170343311|NCT01070550|615596758|FG003|Overall Study|Sponsor decision|0|||
170343312|NCT01070550|615596759|FG004|Overall Study|Sponsor decision|0|||
170343313|NCT01070550|615596760|FG005|Overall Study|Sponsor decision|0|||
170343314|NCT01070550|615596755|FG000|Overall Study|Treatment duration shortened|1|||
170343315|NCT01070550|615596756|FG001|Overall Study|Treatment duration shortened|0|||
170343316|NCT01070550|615596757|FG002|Overall Study|Treatment duration shortened|0|||
170343317|NCT01070550|615596758|FG003|Overall Study|Treatment duration shortened|0|||
170343318|NCT01070550|615596759|FG004|Overall Study|Treatment duration shortened|0|||
170343319|NCT01070550|615596760|FG005|Overall Study|Treatment duration shortened|0|||
170343320|NCT01070550|615596755|FG000|Overall Study|Treatment interrupted|7|||
170343321|NCT01070550|615596756|FG001|Overall Study|Treatment interrupted|0|||
170343322|NCT01070550|615596757|FG002|Overall Study|Treatment interrupted|1|||
170343323|NCT01070550|615596758|FG003|Overall Study|Treatment interrupted|1|||
170343324|NCT01070550|615596759|FG004|Overall Study|Treatment interrupted|0|||
170343325|NCT01070550|615596760|FG005|Overall Study|Treatment interrupted|0|||
170343326|NCT01070550|615596755|FG000|Overall Study|Treatment not started|14|||
170343327|NCT01070550|615596756|FG001|Overall Study|Treatment not started|2|||
170343328|NCT01070550|615596757|FG002|Overall Study|Treatment not started|4|||
170343329|NCT01070550|615596758|FG003|Overall Study|Treatment not started|0|||
170343330|NCT01070550|615596759|FG004|Overall Study|Treatment not started|0|||
170343331|NCT01070550|615596760|FG005|Overall Study|Treatment not started|0|||
170343332|NCT01070550|615596755|FG000|Overall Study|Treatment restarted|0|||
170343333|NCT01070550|615596756|FG001|Overall Study|Treatment restarted|1|||
170343334|NCT01070550|615596757|FG002|Overall Study|Treatment restarted|0|||
170343335|NCT01070550|615596758|FG003|Overall Study|Treatment restarted|0|||
170343336|NCT01070550|615596759|FG004|Overall Study|Treatment restarted|0|||
170343337|NCT01070550|615596760|FG005|Overall Study|Treatment restarted|0|||
170343338|NCT01070550|615596755|FG000|Overall Study|Treatment stopped|3|||
170343339|NCT01070550|615596756|FG001|Overall Study|Treatment stopped|0|||
170343340|NCT01070550|615596757|FG002|Overall Study|Treatment stopped|0|||
170343341|NCT01070550|615596758|FG003|Overall Study|Treatment stopped|0|||
170343342|NCT01070550|615596759|FG004|Overall Study|Treatment stopped|0|||
170343343|NCT01070550|615596760|FG005|Overall Study|Treatment stopped|0|||
170343344|NCT01070550|615596755|FG000|Overall Study|Treatment unavailable|1|||
170343345|NCT01070550|615596756|FG001|Overall Study|Treatment unavailable|0|||
170343346|NCT01070550|615596757|FG002|Overall Study|Treatment unavailable|0|||
170343347|NCT01070550|615596758|FG003|Overall Study|Treatment unavailable|0|||
170343348|NCT01070550|615596759|FG004|Overall Study|Treatment unavailable|0|||
170343349|NCT01070550|615596760|FG005|Overall Study|Treatment unavailable|0|||
170343350|NCT01070550|615596755|FG000|Overall Study|Treatment was stopped early|7|||
170343351|NCT01070550|615596756|FG001|Overall Study|Treatment was stopped early|0|||
170343352|NCT01070550|615596757|FG002|Overall Study|Treatment was stopped early|0|||
170343353|NCT01070550|615596758|FG003|Overall Study|Treatment was stopped early|0|||
170343354|NCT01070550|615596759|FG004|Overall Study|Treatment was stopped early|0|||
170343355|NCT01070550|615596760|FG005|Overall Study|Treatment was stopped early|0|||
170343356|NCT01070550|615596755|FG000|Overall Study|Other|5|||
170343357|NCT01070550|615596756|FG001|Overall Study|Other|0|||
170343358|NCT01070550|615596757|FG002|Overall Study|Other|0|||
170343359|NCT01070550|615596758|FG003|Overall Study|Other|1|||
170343360|NCT01070550|615596759|FG004|Overall Study|Other|0|||
170343361|NCT01070550|615596760|FG005|Overall Study|Other|0|||
170343362|NCT01070550|615596755|FG000|Overall Study|Withdrawal by Subject|35|||
170343363|NCT01070550|615596756|FG001|Overall Study|Withdrawal by Subject|0|||
170343364|NCT01070550|615596757|FG002|Overall Study|Withdrawal by Subject|3|||
170343365|NCT01070550|615596758|FG003|Overall Study|Withdrawal by Subject|0|||
170343366|NCT01070550|615596759|FG004|Overall Study|Withdrawal by Subject|0|||
170343367|NCT01070550|615596760|FG005|Overall Study|Withdrawal by Subject|0|||
170343368|NCT01996319|615596762|FG000|Overall Study|Protocol Violation|1|||
170343369|NCT01996319|615596763|FG001|Overall Study|Protocol Violation|0|||
170343370|NCT01996319|615596762|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
170343371|NCT01996319|615596763|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
170343372|NCT01996319|615596762|FG000|Overall Study|Adverse Event|2|||
170343373|NCT01996319|615596763|FG001|Overall Study|Adverse Event|2|||
170343374|NCT04742907|615596764|FG000|Overall Study|Adverse Event|1|||
170343375|NCT04742907|615596765|FG001|Overall Study|Adverse Event|0|||
170343376|NCT04742907|615596766|FG002|Overall Study|Adverse Event|1|||
170343377|NCT04742907|615596764|FG000|Overall Study|Lost to Follow-up|3|||
170343378|NCT04742907|615596765|FG001|Overall Study|Lost to Follow-up|3|||
170343379|NCT04742907|615596766|FG002|Overall Study|Lost to Follow-up|2|||
170343380|NCT04742907|615596764|FG000|Overall Study|Physician Decision|0|||
170343381|NCT04742907|615596765|FG001|Overall Study|Physician Decision|1|||
170343382|NCT04742907|615596766|FG002|Overall Study|Physician Decision|0|||
170343383|NCT04742907|615596764|FG000|Overall Study|Protocol Violation|1|||
170343384|NCT04742907|615596765|FG001|Overall Study|Protocol Violation|1|||
170343385|NCT04742907|615596766|FG002|Overall Study|Protocol Violation|1|||
170343386|NCT04742907|615596764|FG000|Overall Study|Withdrawal by Subject|5|||
170343387|NCT04742907|615596765|FG001|Overall Study|Withdrawal by Subject|6|||
170343388|NCT04742907|615596766|FG002|Overall Study|Withdrawal by Subject|4|||
170343389|NCT04742907|615596764|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
170343390|NCT04742907|615596765|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
170343391|NCT04742907|615596766|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
170343392|NCT04742907|615596764|FG000|Overall Study|Did Not Receive the Study Drug|2|||
170343393|NCT04742907|615596765|FG001|Overall Study|Did Not Receive the Study Drug|4|||
170343394|NCT04742907|615596766|FG002|Overall Study|Did Not Receive the Study Drug|4|||
170343395|NCT01671085|615596767|FG000|Overall Study|Withdrawal by Subject|1|||
170343396|NCT01671085|615596768|FG001|Overall Study|Withdrawal by Subject|0|||
170343397|NCT00506077|615596769|FG000|Treatment Period 1|Adverse Event|2|||
170343398|NCT00506077|615596770|FG001|Treatment Period 1|Adverse Event|1|||
170343399|NCT00506077|615596769|FG000|Treatment Period 1|Lost to Follow-up|0|||
170343400|NCT00506077|615596770|FG001|Treatment Period 1|Lost to Follow-up|2|||
170343401|NCT00506077|615596769|FG000|Treatment Period 1|Withdrawal by Subject|2|||
170343402|NCT00506077|615596770|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170343403|NCT00506077|615596769|FG000|Treatment Period 2|Adverse Event|0|||
170343404|NCT00506077|615596770|FG001|Treatment Period 2|Adverse Event|1|||
170343405|NCT00506077|615596769|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170343406|NCT00506077|615596770|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170343407|NCT00751101|615596772|FG000|Overall Study|Withdrawal by Subject|1|||
170343408|NCT00751101|615596773|FG001|Overall Study|Withdrawal by Subject|0|||
170343409|NCT00751101|615596772|FG000|Overall Study|No HFS / Never Started Patch/|0|||
170343410|NCT00751101|615596773|FG001|Overall Study|No HFS / Never Started Patch/|4|||
170343411|NCT00751101|615596772|FG000|Overall Study|Never began capecitabine|1|||
170343412|NCT00751101|615596773|FG001|Overall Study|Never began capecitabine|0|||
170343413|NCT00751101|615596772|FG000|Overall Study|Physician Decision|0|||
170343414|NCT00751101|615596773|FG001|Overall Study|Physician Decision|1|||
170343415|NCT02680847|615596774|FG000|Overall Study|Other|2|||
170343416|NCT02680847|615596775|FG001|Overall Study|Other|0|||
170343417|NCT02680847|615596776|FG002|Overall Study|Other|0|||
170343418|NCT02680847|615596774|FG000|Overall Study|No longer met eligibility criteria|2|||
170343419|NCT02680847|615596775|FG001|Overall Study|No longer met eligibility criteria|2|||
170343420|NCT02680847|615596776|FG002|Overall Study|No longer met eligibility criteria|0|||
170343421|NCT02680847|615596774|FG000|Overall Study|Unwilling to participate in study|1|||
170343422|NCT02680847|615596775|FG001|Overall Study|Unwilling to participate in study|1|||
170343423|NCT02680847|615596776|FG002|Overall Study|Unwilling to participate in study|0|||
170343424|NCT02680847|615596774|FG000|Overall Study|Lack of Efficacy|0|||
170343425|NCT02680847|615596775|FG001|Overall Study|Lack of Efficacy|0|||
170343426|NCT02680847|615596776|FG002|Overall Study|Lack of Efficacy|2|||
170343427|NCT02680847|615596774|FG000|Overall Study|Adverse Event|0|||
170343428|NCT02680847|615596775|FG001|Overall Study|Adverse Event|0|||
170343429|NCT02680847|615596776|FG002|Overall Study|Adverse Event|1|||
170343430|NCT01618656|615596780|FG000|Overall Study|Withdrawal by Subject|7|||
170343431|NCT01618656|615596781|FG001|Overall Study|Withdrawal by Subject|3|||
170343432|NCT01618656|615596780|FG000|Overall Study|Physician Decision|1|||
170343433|NCT01618656|615596781|FG001|Overall Study|Physician Decision|1|||
170343434|NCT01899144|615596782|FG000|Treatment Period 2|Other|1|||
170343435|NCT01899144|615596782|FG000|Treatment Period 3|Other|2|||
170343436|NCT01899144|615596782|FG000|Treatment Period 5|Other|1|||
170343437|NCT00751881|615596783|FG000|Core Treatment Period|Not treated|1|||
170343438|NCT00751881|615596784|FG001|Core Treatment Period|Not treated|1|||
170343439|NCT00751881|615596785|FG002|Core Treatment Period|Not treated|2|||
170343440|NCT00751881|615596783|FG000|Core Treatment Period|Adverse Event|26|||
170343441|NCT00751881|615596784|FG001|Core Treatment Period|Adverse Event|54|||
170343442|NCT00751881|615596785|FG002|Core Treatment Period|Adverse Event|58|||
170343443|NCT00751881|615596783|FG000|Core Treatment Period|Lack of Efficacy|37|||
170343444|NCT00751881|615596784|FG001|Core Treatment Period|Lack of Efficacy|30|||
170343445|NCT00751881|615596785|FG002|Core Treatment Period|Lack of Efficacy|20|||
170343446|NCT00751881|615596783|FG000|Core Treatment Period|Poor compliance to protocol|15|||
170343447|NCT00751881|615596784|FG001|Core Treatment Period|Poor compliance to protocol|3|||
170343448|NCT00751881|615596785|FG002|Core Treatment Period|Poor compliance to protocol|4|||
170343449|NCT00751881|615596783|FG000|Core Treatment Period|Lost to Follow-up|6|||
170343450|NCT00751881|615596784|FG001|Core Treatment Period|Lost to Follow-up|4|||
170343451|NCT00751881|615596785|FG002|Core Treatment Period|Lost to Follow-up|3|||
170343452|NCT00751881|615596783|FG000|Core Treatment Period|Other: protocol deviation|3|||
170343453|NCT00751881|615596784|FG001|Core Treatment Period|Other: protocol deviation|3|||
170343454|NCT00751881|615596785|FG002|Core Treatment Period|Other: protocol deviation|7|||
170343455|NCT00751881|615596783|FG000|Core Treatment Period|Other: wish to parent|5|||
170343456|NCT00751881|615596784|FG001|Core Treatment Period|Other: wish to parent|7|||
170343457|NCT00751881|615596785|FG002|Core Treatment Period|Other: wish to parent|4|||
170343458|NCT00751881|615596783|FG000|Core Treatment Period|Other: personal/family constraints|6|||
170343459|NCT00751881|615596784|FG001|Core Treatment Period|Other: personal/family constraints|7|||
170343460|NCT00751881|615596785|FG002|Core Treatment Period|Other: personal/family constraints|10|||
170343461|NCT00751881|615596783|FG000|Core Treatment Period|Other: MS treatment change|6|||
170343462|NCT00751881|615596784|FG001|Core Treatment Period|Other: MS treatment change|4|||
170343463|NCT00751881|615596785|FG002|Core Treatment Period|Other: MS treatment change|4|||
170343464|NCT00751881|615596783|FG000|Core Treatment Period|Other: tolerability complaints|2|||
170343465|NCT00751881|615596784|FG001|Core Treatment Period|Other: tolerability complaints|0|||
170343466|NCT00751881|615596785|FG002|Core Treatment Period|Other: tolerability complaints|0|||
170343467|NCT00751881|615596783|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
170343468|NCT00751881|615596784|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
170343469|NCT00751881|615596785|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
170343470|NCT00751881|615596783|FG000|Extension Study Period|Adverse Event|18|||
170343471|NCT00751881|615596784|FG001|Extension Study Period|Adverse Event|20|||
170343472|NCT00751881|615596785|FG002|Extension Study Period|Adverse Event|21|||
170343473|NCT00751881|615596783|FG000|Extension Study Period|Lack of Efficacy|14|||
170343474|NCT00751881|615596784|FG001|Extension Study Period|Lack of Efficacy|10|||
170343475|NCT00751881|615596785|FG002|Extension Study Period|Lack of Efficacy|20|||
170343476|NCT00751881|615596783|FG000|Extension Study Period|Lost to Follow-up|4|||
170343477|NCT00751881|615596784|FG001|Extension Study Period|Lost to Follow-up|9|||
170343478|NCT00751881|615596785|FG002|Extension Study Period|Lost to Follow-up|6|||
170343479|NCT00751881|615596783|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
170343480|NCT00751881|615596784|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
170343481|NCT00751881|615596785|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
170343482|NCT00751881|615596783|FG000|Extension Study Period|Other than specified above|26|||
170343483|NCT00751881|615596784|FG001|Extension Study Period|Other than specified above|30|||
170343484|NCT00751881|615596785|FG002|Extension Study Period|Other than specified above|18|||
170343485|NCT01765764|615596788|FG000|Treatment Period|Adverse Event|1|||
170343486|NCT01765764|615596789|FG001|Treatment Period|Adverse Event|2|||
170343487|NCT01765764|615596790|FG002|Treatment Period|Adverse Event|1|||
170343488|NCT01765764|615596788|FG000|Treatment Period|Lost to Follow-up|0|||
170343489|NCT01765764|615596789|FG001|Treatment Period|Lost to Follow-up|3|||
170343490|NCT01765764|615596790|FG002|Treatment Period|Lost to Follow-up|2|||
170343491|NCT01765764|615596788|FG000|Treatment Period|Personal Reasons|1|||
170343492|NCT01765764|615596789|FG001|Treatment Period|Personal Reasons|2|||
170343493|NCT01765764|615596790|FG002|Treatment Period|Personal Reasons|1|||
170343494|NCT01765764|615596788|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
170343495|NCT01765764|615596789|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
170343496|NCT01765764|615596790|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
170343497|NCT01651260|615596792|FG000|Overall Study|unable to apply product|3|||
170343498|NCT01952015|615596793|FG000|Induction|Protocol Violation|1|||
170343499|NCT01952015|615596793|FG000|Maintenance|Adverse Event|2|||
170343500|NCT01952015|615596793|FG000|Treatment Period 3|Physician Decision|9|||
170343501|NCT03648996|615596798|FG000|Overall Study|Withdrawal by Subject|0|||
170343502|NCT03648996|615596799|FG001|Overall Study|Withdrawal by Subject|2|||
170343503|NCT03648996|615596800|FG002|Overall Study|Withdrawal by Subject|2|||
170343504|NCT03648996|615596798|FG000|Overall Study|Physician Decision|2|||
170343505|NCT03648996|615596799|FG001|Overall Study|Physician Decision|0|||
170343506|NCT03648996|615596800|FG002|Overall Study|Physician Decision|0|||
170343507|NCT00530712|615596803|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
170343508|NCT00530712|615596803|FG000|30 Day Follow-up Visit|Missed Visit|5|||
170343509|NCT00530712|615596803|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
170343510|NCT00530712|615596803|FG000|6 Month Follow-up Visit|Missed Visit|3|||
170343511|NCT00530712|615596803|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
170343512|NCT00530712|615596803|FG000|6 Month Follow-up Visit|Death|2|||
170343513|NCT00530712|615596803|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
170343514|NCT00530712|615596803|FG000|12 Month Follow-up Visit|Missed Visit|3|||
170343515|NCT00530712|615596803|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
170343516|NCT00530712|615596803|FG000|12 Month Follow-up Visit|Death|9|||
170343517|NCT02749370|615596804|FG000|Overall Study|Withdrawal by Subject|11|||
170343518|NCT02749370|615596804|FG000|Overall Study|Lost to Follow-up|3|||
170343519|NCT03242759|615596809|FG000|Overall Study|Adverse Event|5|||
170343520|NCT03242759|615596810|FG001|Overall Study|Adverse Event|1|||
170343521|NCT03242759|615596809|FG000|Overall Study|Withdrawal by Subject|4|||
170343522|NCT03242759|615596810|FG001|Overall Study|Withdrawal by Subject|3|||
170343523|NCT03242759|615596809|FG000|Overall Study|Lost to Follow-up|3|||
170343524|NCT03242759|615596810|FG001|Overall Study|Lost to Follow-up|1|||
170343525|NCT03242759|615596809|FG000|Overall Study|Administrative problems|1|||
170343526|NCT03242759|615596810|FG001|Overall Study|Administrative problems|1|||
170343527|NCT03242759|615596809|FG000|Overall Study|Death|22|||
170343528|NCT03242759|615596810|FG001|Overall Study|Death|0|||
170343529|NCT03242759|615596809|FG000|Overall Study|Change visit schedule|0|||
170343530|NCT03242759|615596810|FG001|Overall Study|Change visit schedule|1|||
170343531|NCT00933335|615596817|FG000|Overall Study|Lost to Follow-up|1|||
170343532|NCT00933335|615596818|FG001|Overall Study|Lost to Follow-up|3|||
170343533|NCT00933335|615596817|FG000|Overall Study|Withdrawal by Subject|0|||
170343534|NCT00933335|615596818|FG001|Overall Study|Withdrawal by Subject|1|||
170343535|NCT00933335|615596817|FG000|Overall Study|Progressive Disease|0|||
170343536|NCT00933335|615596818|FG001|Overall Study|Progressive Disease|11|||
170343537|NCT00933335|615596817|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
170343538|NCT00933335|615596818|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
170343539|NCT00933335|615596817|FG000|Overall Study|Co-morbid Illness|1|||
170343540|NCT00933335|615596818|FG001|Overall Study|Co-morbid Illness|0|||
170343541|NCT01070784|615596821|FG000|Overall Study|Withdrawal by Subject|6|||
170343542|NCT01070784|615596822|FG001|Overall Study|Withdrawal by Subject|9|||
170343543|NCT01070784|615596821|FG000|Overall Study|Adverse Event|14|||
170343544|NCT01070784|615596822|FG001|Overall Study|Adverse Event|9|||
170343545|NCT02518620|615596823|FG000|Overall Study|Adverse Event|23|||
170343546|NCT02518620|615596824|FG001|Overall Study|Adverse Event|11|||
170343547|NCT02518620|615596823|FG000|Overall Study|Lack of Efficacy|2|||
170343548|NCT02518620|615596824|FG001|Overall Study|Lack of Efficacy|0|||
170343549|NCT02518620|615596823|FG000|Overall Study|Non-Compliance with Study Drug|1|||
170343550|NCT02518620|615596824|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170343551|NCT02518620|615596823|FG000|Overall Study|Physician Decision|1|||
170343552|NCT02518620|615596824|FG001|Overall Study|Physician Decision|1|||
170343553|NCT02518620|615596823|FG000|Overall Study|Sponsor's Decision|0|||
170343554|NCT02518620|615596824|FG001|Overall Study|Sponsor's Decision|3|||
170343555|NCT02518620|615596823|FG000|Overall Study|Lost to Follow-up|1|||
170343556|NCT02518620|615596824|FG001|Overall Study|Lost to Follow-up|1|||
170343557|NCT02518620|615596823|FG000|Overall Study|Withdrawal by Subject|17|||
170343558|NCT02518620|615596824|FG001|Overall Study|Withdrawal by Subject|9|||
170343559|NCT02518620|615596823|FG000|Overall Study|Death|1|||
170343560|NCT02518620|615596824|FG001|Overall Study|Death|0|||
170343561|NCT02518620|615596823|FG000|Overall Study|Pregnancy Wish|3|||
170343562|NCT02518620|615596824|FG001|Overall Study|Pregnancy Wish|0|||
170343563|NCT02518620|615596823|FG000|Overall Study|Pregnancy|1|||
170343564|NCT02518620|615596824|FG001|Overall Study|Pregnancy|0|||
170343565|NCT02518620|615596823|FG000|Overall Study|Relocation|2|||
170343566|NCT02518620|615596824|FG001|Overall Study|Relocation|1|||
170343567|NCT01323673|615596825|FG000|Overall Study|Adverse Event|0|||
170343568|NCT01323673|615596826|FG001|Overall Study|Adverse Event|1|||
170343569|NCT01323673|615596825|FG000|Overall Study|Lost to Follow-up|0|||
170343570|NCT01323673|615596826|FG001|Overall Study|Lost to Follow-up|1|||
170343571|NCT01323673|615596825|FG000|Overall Study|Protocol Violation|1|||
170343572|NCT01323673|615596826|FG001|Overall Study|Protocol Violation|0|||
170343573|NCT01323673|615596825|FG000|Overall Study|Withdrawal by Subject|2|||
170343574|NCT01323673|615596826|FG001|Overall Study|Withdrawal by Subject|3|||
170343575|NCT03844633|615596827|FG000|1 Week FU|Lost to Follow-up|0|||
170343576|NCT03844633|615596828|FG001|1 Week FU|Lost to Follow-up|1|||
170343577|NCT03844633|615596829|FG002|1 Week FU|Lost to Follow-up|4|||
170343578|NCT03844633|615596827|FG000|12-month Follow-up|Lost to Follow-up|7|||
170343579|NCT03844633|615596828|FG001|12-month Follow-up|Lost to Follow-up|5|||
170343580|NCT03844633|615596829|FG002|12-month Follow-up|Lost to Follow-up|8|||
170343581|NCT02588248|615596832|FG000|Overall Study|Physician Decision|4|||
170343582|NCT02588248|615596833|FG001|Overall Study|Physician Decision|3|||
170343583|NCT01355068|615596834|FG000|First Intervention Period|Adverse Event|0|||
170343584|NCT01355068|615596835|FG001|First Intervention Period|Adverse Event|1|||
170343585|NCT01355068|615596834|FG000|First Intervention Period|Withdrawal by Subject|0|||
170343586|NCT01355068|615596835|FG001|First Intervention Period|Withdrawal by Subject|1|||
170343587|NCT00336492|615596838|FG000|Overall Study|Adverse Event|4|||
170343588|NCT00336492|615596839|FG001|Overall Study|Adverse Event|3|||
170343589|NCT00336492|615596840|FG002|Overall Study|Adverse Event|6|||
170343590|NCT00336492|615596838|FG000|Overall Study|Lack of Efficacy|6|||
170343591|NCT00336492|615596839|FG001|Overall Study|Lack of Efficacy|1|||
170343592|NCT00336492|615596840|FG002|Overall Study|Lack of Efficacy|4|||
170343593|NCT00336492|615596838|FG000|Overall Study|Other|5|||
170343594|NCT00336492|615596839|FG001|Overall Study|Other|0|||
170343595|NCT00336492|615596840|FG002|Overall Study|Other|1|||
170343596|NCT01781026|615596841|FG000|Overall Study|Lack of Efficacy|2|||
170343597|NCT00227877|615596842|FG000|Pre-visit Assessment|Technical difficulties|7|||
170343598|NCT00227877|615596843|FG001|Pre-visit Assessment|Technical difficulties|3|||
170343599|NCT00227877|615596844|FG002|Pre-visit Assessment|Technical difficulties|0|||
170343600|NCT00227877|615596845|FG003|Pre-visit Assessment|Technical difficulties|0|||
170343601|NCT00227877|615596842|FG000|Post-visit Checklist|Lost to Follow-up|24|||
170343602|NCT00227877|615596843|FG001|Post-visit Checklist|Lost to Follow-up|13|||
170343603|NCT00227877|615596844|FG002|Post-visit Checklist|Lost to Follow-up|1|||
170343604|NCT00227877|615596845|FG003|Post-visit Checklist|Lost to Follow-up|0|||
170343605|NCT00227877|615596842|FG000|3-months Follow-up|Completed late|135|||
170343606|NCT00227877|615596843|FG001|3-months Follow-up|Completed late|128|||
170343607|NCT00227877|615596844|FG002|3-months Follow-up|Completed late|34|||
170343608|NCT00227877|615596845|FG003|3-months Follow-up|Completed late|8|||
170343609|NCT00227877|615596842|FG000|3-months Follow-up|Lost to Follow-up|178|||
170343610|NCT00227877|615596843|FG001|3-months Follow-up|Lost to Follow-up|139|||
170343611|NCT00227877|615596844|FG002|3-months Follow-up|Lost to Follow-up|18|||
170343612|NCT00227877|615596845|FG003|3-months Follow-up|Lost to Follow-up|13|||
170343613|NCT00227877|615596842|FG000|12-months Follow-up|Completed late|78|||
170343614|NCT00227877|615596843|FG001|12-months Follow-up|Completed late|74|||
170343615|NCT00227877|615596844|FG002|12-months Follow-up|Completed late|1|||
170343616|NCT00227877|615596845|FG003|12-months Follow-up|Completed late|0|||
170343617|NCT00227877|615596842|FG000|12-months Follow-up|Lost to Follow-up|232|||
170343618|NCT00227877|615596843|FG001|12-months Follow-up|Lost to Follow-up|189|||
170343619|NCT00227877|615596844|FG002|12-months Follow-up|Lost to Follow-up|30|||
170343620|NCT00227877|615596845|FG003|12-months Follow-up|Lost to Follow-up|26|||
170343621|NCT01522651|615596849|FG000|Overall Study|Adverse Event|3|||
170343622|NCT01522651|615596850|FG001|Overall Study|Adverse Event|4|||
170343623|NCT01522651|615596851|FG002|Overall Study|Adverse Event|4|||
170343624|NCT01522651|615596852|FG003|Overall Study|Adverse Event|5|||
170343625|NCT01522651|615596853|FG004|Overall Study|Adverse Event|4|||
170343626|NCT01522651|615596849|FG000|Overall Study|Cardioversion|1|||
170343627|NCT01522651|615596850|FG001|Overall Study|Cardioversion|0|||
170343628|NCT01522651|615596851|FG002|Overall Study|Cardioversion|0|||
170343629|NCT01522651|615596852|FG003|Overall Study|Cardioversion|0|||
170343630|NCT01522651|615596853|FG004|Overall Study|Cardioversion|0|||
170343631|NCT01522651|615596849|FG000|Overall Study|Device Malfunction|0|||
170343632|NCT01522651|615596850|FG001|Overall Study|Device Malfunction|1|||
170343633|NCT01522651|615596851|FG002|Overall Study|Device Malfunction|0|||
170343634|NCT01522651|615596852|FG003|Overall Study|Device Malfunction|0|||
170343635|NCT01522651|615596853|FG004|Overall Study|Device Malfunction|0|||
170343636|NCT01522651|615596849|FG000|Overall Study|Investigator's Discretion|0|||
170343637|NCT01522651|615596850|FG001|Overall Study|Investigator's Discretion|1|||
170343638|NCT01522651|615596851|FG002|Overall Study|Investigator's Discretion|0|||
170343639|NCT01522651|615596852|FG003|Overall Study|Investigator's Discretion|0|||
170343640|NCT01522651|615596853|FG004|Overall Study|Investigator's Discretion|0|||
170343641|NCT01522651|615596849|FG000|Overall Study|Protocol Violation|3|||
170343642|NCT01522651|615596850|FG001|Overall Study|Protocol Violation|0|||
170343643|NCT01522651|615596851|FG002|Overall Study|Protocol Violation|0|||
170343644|NCT01522651|615596852|FG003|Overall Study|Protocol Violation|0|||
170343645|NCT01522651|615596853|FG004|Overall Study|Protocol Violation|0|||
170343646|NCT01522651|615596849|FG000|Overall Study|Reason Not Specified|0|||
170343647|NCT01522651|615596850|FG001|Overall Study|Reason Not Specified|0|||
170343648|NCT01522651|615596851|FG002|Overall Study|Reason Not Specified|0|||
170343649|NCT01522651|615596852|FG003|Overall Study|Reason Not Specified|1|||
170343650|NCT01522651|615596853|FG004|Overall Study|Reason Not Specified|0|||
170343651|NCT01522651|615596849|FG000|Overall Study|Participant Non-Compliance|1|||
170343652|NCT01522651|615596850|FG001|Overall Study|Participant Non-Compliance|0|||
170343653|NCT01522651|615596851|FG002|Overall Study|Participant Non-Compliance|0|||
170343654|NCT01522651|615596852|FG003|Overall Study|Participant Non-Compliance|0|||
170343655|NCT01522651|615596853|FG004|Overall Study|Participant Non-Compliance|0|||
170343656|NCT01522651|615596849|FG000|Overall Study|Withdrew Consent|1|||
170343657|NCT01522651|615596850|FG001|Overall Study|Withdrew Consent|1|||
170343658|NCT01522651|615596851|FG002|Overall Study|Withdrew Consent|0|||
170343659|NCT01522651|615596852|FG003|Overall Study|Withdrew Consent|1|||
170343660|NCT01522651|615596853|FG004|Overall Study|Withdrew Consent|1|||
170343661|NCT01522651|615596849|FG000|Overall Study|Randomized but Never Treated|0|||
170343662|NCT01522651|615596850|FG001|Overall Study|Randomized but Never Treated|1|||
170343663|NCT01522651|615596851|FG002|Overall Study|Randomized but Never Treated|0|||
170343664|NCT01522651|615596852|FG003|Overall Study|Randomized but Never Treated|1|||
170343665|NCT01522651|615596853|FG004|Overall Study|Randomized but Never Treated|1|||
170343666|NCT01937130|615598271|FG000|Overall Study|Withdrawal by Subject|0|||
170343667|NCT01937130|615598272|FG001|Overall Study|Withdrawal by Subject|0|||
170343668|NCT01937130|615598273|FG002|Overall Study|Withdrawal by Subject|0|||
170343669|NCT01937130|615598274|FG003|Overall Study|Withdrawal by Subject|1|||
170343670|NCT01937130|615598271|FG000|Overall Study|Adverse Event|0|||
170343671|NCT01937130|615598272|FG001|Overall Study|Adverse Event|1|||
170343672|NCT01937130|615598273|FG002|Overall Study|Adverse Event|0|||
170343673|NCT01937130|615598274|FG003|Overall Study|Adverse Event|1|||
170343674|NCT01937130|615598271|FG000|Overall Study|Death|1|||
170343675|NCT01937130|615598272|FG001|Overall Study|Death|1|||
170343676|NCT01937130|615598273|FG002|Overall Study|Death|1|||
170343677|NCT01937130|615598274|FG003|Overall Study|Death|0|||
170343678|NCT01937130|615598271|FG000|Overall Study|Lost to Follow-up|2|||
170343679|NCT01937130|615598272|FG001|Overall Study|Lost to Follow-up|0|||
170343680|NCT01937130|615598273|FG002|Overall Study|Lost to Follow-up|2|||
170343681|NCT01937130|615598274|FG003|Overall Study|Lost to Follow-up|0|||
170343682|NCT01937130|615598271|FG000|Overall Study|Physician Decision|0|||
170343683|NCT01937130|615598272|FG001|Overall Study|Physician Decision|1|||
170343684|NCT01937130|615598273|FG002|Overall Study|Physician Decision|0|||
170343685|NCT01937130|615598274|FG003|Overall Study|Physician Decision|0|||
170343686|NCT01937130|615598271|FG000|Overall Study|Patients unable to swallow|0|||
170343687|NCT01937130|615598272|FG001|Overall Study|Patients unable to swallow|1|||
170343688|NCT01937130|615598273|FG002|Overall Study|Patients unable to swallow|0|||
170343689|NCT01937130|615598274|FG003|Overall Study|Patients unable to swallow|0|||
170343690|NCT01937130|615598271|FG000|Overall Study|Patient lost to FU due to death|2|||
170343691|NCT01937130|615598272|FG001|Overall Study|Patient lost to FU due to death|0|||
170343692|NCT01937130|615598273|FG002|Overall Study|Patient lost to FU due to death|0|||
170343693|NCT01937130|615598274|FG003|Overall Study|Patient lost to FU due to death|0|||
170343694|NCT02279524|615598275|FG000|Overall Study|Withdrawal by Subject|3|||
170343695|NCT02279524|615598276|FG001|Overall Study|Withdrawal by Subject|6|||
170343696|NCT02279524|615598277|FG002|Overall Study|Withdrawal by Subject|3|||
170343697|NCT02279524|615598275|FG000|Overall Study|Adverse Event|4|||
170343698|NCT02279524|615598276|FG001|Overall Study|Adverse Event|3|||
170343699|NCT02279524|615598277|FG002|Overall Study|Adverse Event|2|||
170343700|NCT02279524|615598275|FG000|Overall Study|Lost to Follow-up|1|||
170343701|NCT02279524|615598276|FG001|Overall Study|Lost to Follow-up|1|||
170343702|NCT02279524|615598277|FG002|Overall Study|Lost to Follow-up|0|||
170343703|NCT02279524|615598275|FG000|Overall Study|Disallowed medication|1|||
170343704|NCT02279524|615598276|FG001|Overall Study|Disallowed medication|1|||
170343705|NCT02279524|615598277|FG002|Overall Study|Disallowed medication|2|||
170343706|NCT02279524|615598275|FG000|Overall Study|Bariatric surgery|1|||
170343707|NCT02279524|615598276|FG001|Overall Study|Bariatric surgery|0|||
170343708|NCT02279524|615598277|FG002|Overall Study|Bariatric surgery|0|||
170343709|NCT01043185|615598278|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
170343710|NCT01043185|615598279|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
170343711|NCT01043185|615598280|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
170343712|NCT01043185|615598281|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
170343713|NCT01043185|615598282|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
170343714|NCT01043185|615598283|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
170343715|NCT01043185|615598284|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
170343716|NCT01043185|615598285|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
170343717|NCT01043185|615598286|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
170343718|NCT01043185|615598287|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
170343719|NCT00523341|615598290|FG000|Overall Study|Withdrawal by Subject|399|||
170343720|NCT00523341|615598291|FG001|Overall Study|Withdrawal by Subject|427|||
170343721|NCT00523341|615598290|FG000|Overall Study|Other|181|||
170343722|NCT00523341|615598291|FG001|Overall Study|Other|198|||
170343723|NCT00523341|615598290|FG000|Overall Study|Adverse Event|122|||
170343724|NCT00523341|615598291|FG001|Overall Study|Adverse Event|155|||
170343725|NCT00523341|615598290|FG000|Overall Study|Death|101|||
170343726|NCT00523341|615598291|FG001|Overall Study|Death|110|||
170343727|NCT00523341|615598290|FG000|Overall Study|Lost to Follow-up|73|||
170343728|NCT00523341|615598291|FG001|Overall Study|Lost to Follow-up|61|||
170343729|NCT00523341|615598290|FG000|Overall Study|Non-compliance|20|||
170343730|NCT00523341|615598291|FG001|Overall Study|Non-compliance|13|||
170343731|NCT00523341|615598290|FG000|Overall Study|Physician Decision|14|||
170343732|NCT00523341|615598291|FG001|Overall Study|Physician Decision|13|||
170343733|NCT00523341|615598290|FG000|Overall Study|Requirement for Alternative Therapy|4|||
170343734|NCT00523341|615598291|FG001|Overall Study|Requirement for Alternative Therapy|14|||
170343735|NCT00523341|615598290|FG000|Overall Study|Protocol Deviation|6|||
170343736|NCT00523341|615598291|FG001|Overall Study|Protocol Deviation|5|||
170343737|NCT00523341|615598290|FG000|Overall Study|Ineligibility Determined|3|||
170343738|NCT00523341|615598291|FG001|Overall Study|Ineligibility Determined|4|||
170343739|NCT00523341|615598290|FG000|Overall Study|Disease Progression|1|||
170343740|NCT00523341|615598291|FG001|Overall Study|Disease Progression|0|||
170343741|NCT01790438|615598292|FG000|Overall Study|Adverse Event|3|||
170343742|NCT01790438|615598293|FG001|Overall Study|Adverse Event|2|||
170343743|NCT01790438|615598292|FG000|Overall Study|Death|4|||
170343744|NCT01790438|615598293|FG001|Overall Study|Death|0|||
170343745|NCT01790438|615598292|FG000|Overall Study|Lost to Follow-up|5|||
170343746|NCT01790438|615598293|FG001|Overall Study|Lost to Follow-up|2|||
170343747|NCT01790438|615598292|FG000|Overall Study|Withdrawal by Subject|13|||
170343748|NCT01790438|615598293|FG001|Overall Study|Withdrawal by Subject|2|||
170343749|NCT01790438|615598292|FG000|Overall Study|Physician Decision|3|||
170343750|NCT01790438|615598293|FG001|Overall Study|Physician Decision|1|||
170343751|NCT01790438|615598292|FG000|Overall Study|Sponsor Decision|0|||
170343752|NCT01790438|615598293|FG001|Overall Study|Sponsor Decision|3|||
170343753|NCT01790438|615598292|FG000|Overall Study|Protocol Required Discontinuation|7|||
170343754|NCT01790438|615598293|FG001|Overall Study|Protocol Required Discontinuation|1|||
170343755|NCT02090114|615598294|FG000|Overall Study|Withdrawal by Subject|3|||
170343756|NCT02090114|615598295|FG001|Overall Study|Withdrawal by Subject|6|||
170343757|NCT02090114|615598296|FG002|Overall Study|Withdrawal by Subject|2|||
170343758|NCT02090114|615598297|FG003|Overall Study|Withdrawal by Subject|1|||
170343759|NCT02090114|615598294|FG000|Overall Study|Physician Decision|5|||
170343760|NCT02090114|615598295|FG001|Overall Study|Physician Decision|0|||
170343761|NCT02090114|615598296|FG002|Overall Study|Physician Decision|1|||
170343762|NCT02090114|615598297|FG003|Overall Study|Physician Decision|1|||
170343763|NCT02090114|615598294|FG000|Overall Study|Adverse Event|1|||
170343764|NCT02090114|615598295|FG001|Overall Study|Adverse Event|2|||
170343765|NCT02090114|615598296|FG002|Overall Study|Adverse Event|2|||
170343766|NCT02090114|615598297|FG003|Overall Study|Adverse Event|0|||
170343767|NCT02090114|615598294|FG000|Overall Study|Progressive Disease|20|||
170343768|NCT02090114|615598295|FG001|Overall Study|Progressive Disease|21|||
170343769|NCT02090114|615598296|FG002|Overall Study|Progressive Disease|23|||
170343770|NCT02090114|615598297|FG003|Overall Study|Progressive Disease|6|||
170343771|NCT02090114|615598294|FG000|Overall Study|Death|1|||
170343772|NCT02090114|615598295|FG001|Overall Study|Death|0|||
170343773|NCT02090114|615598296|FG002|Overall Study|Death|1|||
170343774|NCT02090114|615598297|FG003|Overall Study|Death|0|||
170343775|NCT01808118|615598298|FG000|Period 1|Adverse Event|15|||
170343776|NCT01808118|615598299|FG001|Period 1|Adverse Event|0|||
170343777|NCT01808118|615598300|FG002|Period 1|Adverse Event|0|||
170343778|NCT01808118|615598298|FG000|Period 1|Withdrew consent|24|||
170343779|NCT01808118|615598299|FG001|Period 1|Withdrew consent|0|||
170343780|NCT01808118|615598300|FG002|Period 1|Withdrew consent|0|||
170343781|NCT01808118|615598298|FG000|Period 1|Lost to Follow-up|9|||
170343782|NCT01808118|615598299|FG001|Period 1|Lost to Follow-up|0|||
170343783|NCT01808118|615598300|FG002|Period 1|Lost to Follow-up|0|||
170343784|NCT01808118|615598298|FG000|Period 1|Did not meet criteria for remission|303|||
170343785|NCT01808118|615598299|FG001|Period 1|Did not meet criteria for remission|0|||
170343786|NCT01808118|615598300|FG002|Period 1|Did not meet criteria for remission|0|||
170343787|NCT01808118|615598298|FG000|Period 1|Enrolled in error|7|||
170343788|NCT01808118|615598299|FG001|Period 1|Enrolled in error|0|||
170343789|NCT01808118|615598300|FG002|Period 1|Enrolled in error|0|||
170343790|NCT01808118|615598298|FG000|Period 1|Did not meet inclusion criteria|3|||
170343791|NCT01808118|615598299|FG001|Period 1|Did not meet inclusion criteria|0|||
170343792|NCT01808118|615598300|FG002|Period 1|Did not meet inclusion criteria|0|||
170343793|NCT01808118|615598298|FG000|Period 1|Non-conformance with inclusion criteria|3|||
170343794|NCT01808118|615598299|FG001|Period 1|Non-conformance with inclusion criteria|0|||
170343795|NCT01808118|615598300|FG002|Period 1|Non-conformance with inclusion criteria|0|||
170343796|NCT01808118|615598298|FG000|Period 1|Investigator decision: site closure|2|||
170343797|NCT01808118|615598299|FG001|Period 1|Investigator decision: site closure|0|||
170343798|NCT01808118|615598300|FG002|Period 1|Investigator decision: site closure|0|||
170343799|NCT01808118|615598298|FG000|Period 1|Non-compliance per sponsor|1|||
170343800|NCT01808118|615598299|FG001|Period 1|Non-compliance per sponsor|0|||
170343801|NCT01808118|615598300|FG002|Period 1|Non-compliance per sponsor|0|||
170343802|NCT01808118|615598298|FG000|Period 1|Lack of Efficacy|1|||
170343803|NCT01808118|615598299|FG001|Period 1|Lack of Efficacy|0|||
170343804|NCT01808118|615598300|FG002|Period 1|Lack of Efficacy|0|||
170343805|NCT01808118|615598298|FG000|Period 2|Adverse Event|0|||
170343806|NCT01808118|615598299|FG001|Period 2|Adverse Event|4|||
170343807|NCT01808118|615598300|FG002|Period 2|Adverse Event|0|||
170343808|NCT01808118|615598298|FG000|Period 2|Withdrew consent|0|||
170343809|NCT01808118|615598299|FG001|Period 2|Withdrew consent|7|||
170343810|NCT01808118|615598300|FG002|Period 2|Withdrew consent|6|||
170343811|NCT01808118|615598298|FG000|Period 2|Lost to Follow-up|0|||
170343812|NCT01808118|615598299|FG001|Period 2|Lost to Follow-up|0|||
170343813|NCT01808118|615598300|FG002|Period 2|Lost to Follow-up|2|||
170343814|NCT01808118|615598298|FG000|Period 2|Investigator no longer conducting trials|0|||
170343815|NCT01808118|615598299|FG001|Period 2|Investigator no longer conducting trials|1|||
170343816|NCT01808118|615598300|FG002|Period 2|Investigator no longer conducting trials|0|||
170343817|NCT01808118|615598298|FG000|Period 2|Switched to other therapy|0|||
170343818|NCT01808118|615598299|FG001|Period 2|Switched to other therapy|1|||
170343819|NCT01808118|615598300|FG002|Period 2|Switched to other therapy|0|||
170343820|NCT01441440|615598303|FG000|Overall Study|Death|1|||
170343821|NCT01441440|615598304|FG001|Overall Study|Death|0|||
170343822|NCT01441440|615598305|FG002|Overall Study|Death|1|||
170343823|NCT01441440|615598303|FG000|Overall Study|Adverse Event|2|||
170343824|NCT01441440|615598304|FG001|Overall Study|Adverse Event|9|||
170343825|NCT01441440|615598305|FG002|Overall Study|Adverse Event|9|||
170343826|NCT01441440|615598303|FG000|Overall Study|Lost to Follow-up|0|||
170343827|NCT01441440|615598304|FG001|Overall Study|Lost to Follow-up|2|||
170343828|NCT01441440|615598305|FG002|Overall Study|Lost to Follow-up|1|||
170343829|NCT01441440|615598303|FG000|Overall Study|Withdrawal by Subject|11|||
170343830|NCT01441440|615598304|FG001|Overall Study|Withdrawal by Subject|9|||
170343831|NCT01441440|615598305|FG002|Overall Study|Withdrawal by Subject|9|||
170343832|NCT01441440|615598303|FG000|Overall Study|Pregnancy|1|||
170343833|NCT01441440|615598304|FG001|Overall Study|Pregnancy|0|||
170343834|NCT01441440|615598305|FG002|Overall Study|Pregnancy|0|||
170343835|NCT01441440|615598303|FG000|Overall Study|Lack of Efficacy|1|||
170343836|NCT01441440|615598304|FG001|Overall Study|Lack of Efficacy|0|||
170343837|NCT01441440|615598305|FG002|Overall Study|Lack of Efficacy|1|||
170343838|NCT01441440|615598303|FG000|Overall Study|Moving|0|||
170343839|NCT01441440|615598304|FG001|Overall Study|Moving|1|||
170343840|NCT01441440|615598305|FG002|Overall Study|Moving|1|||
170343841|NCT01441440|615598303|FG000|Overall Study|Work-related matter|0|||
170343842|NCT01441440|615598304|FG001|Overall Study|Work-related matter|1|||
170343843|NCT01441440|615598305|FG002|Overall Study|Work-related matter|0|||
170343844|NCT01441440|615598303|FG000|Overall Study|Difficllty in keeping the schedule|1|||
170343845|NCT01441440|615598304|FG001|Overall Study|Difficllty in keeping the schedule|1|||
170343846|NCT01441440|615598305|FG002|Overall Study|Difficllty in keeping the schedule|0|||
170343847|NCT03041116|615598311|FG000|Double-blind|Death|0|||
170343848|NCT03041116|615598312|FG001|Double-blind|Death|2|||
170343849|NCT03041116|615598311|FG000|Double-blind|Withdrawal by Subject|0|||
170343850|NCT03041116|615598312|FG001|Double-blind|Withdrawal by Subject|4|||
170343851|NCT03041116|615598311|FG000|Open-label|Death|1|||
170343852|NCT03041116|615598312|FG001|Open-label|Death|0|||
170343853|NCT03041116|615598311|FG000|Open-label|Termination of the study by Sponsor|39|||
170343854|NCT03041116|615598312|FG001|Open-label|Termination of the study by Sponsor|37|||
170343855|NCT03041116|615598311|FG000|Open-label|Withdrawal by Subject|1|||
170343856|NCT03041116|615598312|FG001|Open-label|Withdrawal by Subject|0|||
170343857|NCT01345123|615598313|FG000|Overall Study|participants no longer with health plan|79|||
170343858|NCT01345123|615598314|FG001|Overall Study|participants no longer with health plan|85|||
170343859|NCT01345123|615598315|FG002|Overall Study|participants no longer with health plan|88|||
170343860|NCT03097328|615598316|FG000|Overall Study|Still on Therapy|2|||
170343861|NCT03097328|615598316|FG000|Overall Study|Progressive Disease|29|||
170343862|NCT03097328|615598316|FG000|Overall Study|Adverse Event|4|||
170343863|NCT03097328|615598316|FG000|Overall Study|Withdrawal by Subject|1|||
170343864|NCT03097328|615598316|FG000|Overall Study|Physician Decision|1|||
170343865|NCT03097328|615598316|FG000|Overall Study|Patient Decision|1|||
170343866|NCT03097328|615598316|FG000|Overall Study|Ineligible for Study Drug|1|||
170343867|NCT01798134|615598317|FG000|Overall Study|Lost to Follow-up|1|||
170343868|NCT01798134|615598317|FG000|Overall Study|Withdrawal by Subject|3|||
170343869|NCT01798134|615598317|FG000|Overall Study|Death|2|||
170343870|NCT01798134|615598317|FG000|Overall Study|Adverse Event|3|||
170343871|NCT01798134|615598317|FG000|Overall Study|Physician Decision|3|||
170343872|NCT01798134|615598317|FG000|Overall Study|Liver transplant/surgery|4|||
170343873|NCT02023164|615598318|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
170343874|NCT02023164|615598319|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
170343875|NCT02653976|615598320|FG000|Overall Study|Withdrawal by Subject|5|||
170343876|NCT02653976|615598320|FG000|Overall Study|Death|4|||
170343877|NCT02436577|615598321|FG000|Overall Study|Protocol Deviation|0|||
170343878|NCT02436577|615598322|FG001|Overall Study|Protocol Deviation|1|||
170343879|NCT02436577|615598323|FG002|Overall Study|Protocol Deviation|0|||
170343880|NCT02436577|615598324|FG003|Overall Study|Protocol Deviation|0|||
170343881|NCT02436577|615598325|FG004|Overall Study|Protocol Deviation|0|||
170343882|NCT02436577|615598326|FG005|Overall Study|Protocol Deviation|0|||
170343883|NCT01675011|615598327|FG000|Overall Study|Trial terminated by Sponsor|3|||
170343884|NCT01675011|615598328|FG001|Overall Study|Trial terminated by Sponsor|1|||
170343885|NCT02606045|615598332|FG000|Overall Study|Study closed before treament could begin|1|||
170343886|NCT02606045|615598333|FG001|Overall Study|Study closed before treament could begin|2|||
170343887|NCT01234402|615598334|FG000|Overall Study|Lost to Follow-up|0|||
170343888|NCT01234402|615598335|FG001|Overall Study|Lost to Follow-up|1|||
170343889|NCT01234402|615598336|FG002|Overall Study|Lost to Follow-up|3|||
170343890|NCT01234402|615598334|FG000|Overall Study|Withdrawal by Subject|1|||
170343891|NCT01234402|615598335|FG001|Overall Study|Withdrawal by Subject|3|||
170343892|NCT01234402|615598336|FG002|Overall Study|Withdrawal by Subject|4|||
170343893|NCT01234402|615598334|FG000|Overall Study|Never treated: Death|0|||
170343894|NCT01234402|615598335|FG001|Overall Study|Never treated: Death|0|||
170343895|NCT01234402|615598336|FG002|Overall Study|Never treated: Death|1|||
170343896|NCT01234402|615598334|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
170343897|NCT01234402|615598335|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
170343898|NCT01234402|615598336|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
170343899|NCT01234402|615598334|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
170343900|NCT01234402|615598335|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
170343901|NCT01234402|615598336|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
170343902|NCT00365716|615598338|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
170343903|NCT00365716|615598339|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
170343904|NCT00365716|615598340|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
170343905|NCT00365716|615598341|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
170343906|NCT00365716|615598342|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
170343907|NCT00365716|615598343|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
170343908|NCT00365716|615598344|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
170343909|NCT00365716|615598338|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
170343910|NCT00365716|615598339|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
170343911|NCT00365716|615598340|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
170343912|NCT00365716|615598341|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
170343913|NCT00365716|615598342|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
170343914|NCT00365716|615598343|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
170343915|NCT00365716|615598344|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
170343916|NCT00365716|615598338|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
170343917|NCT00365716|615598339|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
170343918|NCT00365716|615598340|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
170343919|NCT00365716|615598341|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
170343920|NCT00365716|615598342|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
170343921|NCT00365716|615598343|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
170343922|NCT00365716|615598344|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
170343923|NCT00365716|615598338|FG000|Base Study (Day 1 to Month 7)|Other|0|||
170343924|NCT00365716|615598339|FG001|Base Study (Day 1 to Month 7)|Other|1|||
170343925|NCT00365716|615598340|FG002|Base Study (Day 1 to Month 7)|Other|0|||
170343926|NCT00365716|615598341|FG003|Base Study (Day 1 to Month 7)|Other|0|||
170343927|NCT00365716|615598342|FG004|Base Study (Day 1 to Month 7)|Other|0|||
170343928|NCT00365716|615598343|FG005|Base Study (Day 1 to Month 7)|Other|0|||
170343929|NCT00365716|615598344|FG006|Base Study (Day 1 to Month 7)|Other|0|||
170343930|NCT00365716|615598338|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
170343931|NCT00365716|615598339|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
170343932|NCT00365716|615598340|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
170343933|NCT00365716|615598341|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
170343934|NCT00365716|615598342|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
170343935|NCT00365716|615598343|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
170343936|NCT00365716|615598344|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
170343937|NCT00365716|615598338|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
170343938|NCT00365716|615598339|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
170343939|NCT00365716|615598340|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
170343940|NCT00365716|615598341|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
170343941|NCT00365716|615598342|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
170343942|NCT00365716|615598343|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
170343943|NCT00365716|615598344|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
170343944|NCT00365716|615598338|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
170343945|NCT00365716|615598339|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
170343946|NCT00365716|615598340|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
170343947|NCT00365716|615598341|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
170343948|NCT00365716|615598342|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
170343949|NCT00365716|615598343|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
170343950|NCT00365716|615598344|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
170343951|NCT00365716|615598338|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
170343952|NCT00365716|615598339|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
170343953|NCT00365716|615598340|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
170343954|NCT00365716|615598341|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
170343955|NCT00365716|615598342|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
170343956|NCT00365716|615598343|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
170343957|NCT00365716|615598344|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
170343958|NCT00365716|615598338|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
170343959|NCT00365716|615598339|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
170343960|NCT00365716|615598340|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
170343961|NCT00365716|615598341|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
170343962|NCT00365716|615598342|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
170343963|NCT00365716|615598343|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
170343964|NCT00365716|615598344|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
170343965|NCT00365716|615598338|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
170343966|NCT00365716|615598339|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
170343967|NCT00365716|615598340|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
170343968|NCT00365716|615598341|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
170343969|NCT00365716|615598342|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
170343970|NCT00365716|615598343|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
170343971|NCT00365716|615598344|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
170343972|NCT00365716|615598338|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
170343973|NCT00365716|615598339|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
170343974|NCT00365716|615598340|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
170343975|NCT00365716|615598341|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
170343976|NCT00365716|615598342|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
170343977|NCT00365716|615598343|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
170343978|NCT00365716|615598344|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
170343979|NCT00365716|615598338|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
170343980|NCT00365716|615598339|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
170343981|NCT00365716|615598340|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
170343982|NCT00365716|615598341|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
170343983|NCT00365716|615598342|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
170343984|NCT00365716|615598343|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
170343985|NCT00365716|615598344|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
170343986|NCT00365716|615598338|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
170343987|NCT00365716|615598339|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
170343988|NCT00365716|615598340|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
170343989|NCT00365716|615598341|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
170343990|NCT00365716|615598342|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
170343991|NCT00365716|615598343|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
170343992|NCT00365716|615598344|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
170343993|NCT00365716|615598338|FG000|Extension 1|Lost to Follow-up|0|||
170343994|NCT00365716|615598339|FG001|Extension 1|Lost to Follow-up|0|||
170343995|NCT00365716|615598340|FG002|Extension 1|Lost to Follow-up|0|||
170343996|NCT00365716|615598341|FG003|Extension 1|Lost to Follow-up|0|||
170343997|NCT00365716|615598342|FG004|Extension 1|Lost to Follow-up|0|||
170343998|NCT00365716|615598343|FG005|Extension 1|Lost to Follow-up|1|||
170343999|NCT00365716|615598344|FG006|Extension 1|Lost to Follow-up|0|||
170344000|NCT00365716|615598338|FG000|Extension 1|Other|0|||
170344001|NCT00365716|615598339|FG001|Extension 1|Other|0|||
170344002|NCT00365716|615598340|FG002|Extension 1|Other|0|||
170344003|NCT00365716|615598341|FG003|Extension 1|Other|0|||
170344004|NCT00365716|615598342|FG004|Extension 1|Other|0|||
170344005|NCT00365716|615598343|FG005|Extension 1|Other|9|||
170344006|NCT00365716|615598344|FG006|Extension 1|Other|0|||
170344007|NCT00365716|615598338|FG000|Extension 1|Moved|0|||
170344008|NCT00365716|615598339|FG001|Extension 1|Moved|0|||
170344009|NCT00365716|615598340|FG002|Extension 1|Moved|0|||
170344010|NCT00365716|615598341|FG003|Extension 1|Moved|0|||
170344011|NCT00365716|615598342|FG004|Extension 1|Moved|0|||
170344012|NCT00365716|615598343|FG005|Extension 1|Moved|4|||
170344013|NCT00365716|615598344|FG006|Extension 1|Moved|0|||
170344014|NCT00365716|615598338|FG000|Extension 1|Withdrawal by Subject|0|||
170344015|NCT00365716|615598339|FG001|Extension 1|Withdrawal by Subject|0|||
170344016|NCT00365716|615598340|FG002|Extension 1|Withdrawal by Subject|0|||
170344017|NCT00365716|615598341|FG003|Extension 1|Withdrawal by Subject|0|||
170344018|NCT00365716|615598342|FG004|Extension 1|Withdrawal by Subject|0|||
170344019|NCT00365716|615598343|FG005|Extension 1|Withdrawal by Subject|3|||
170344020|NCT00365716|615598344|FG006|Extension 1|Withdrawal by Subject|0|||
170344021|NCT00365716|615598338|FG000|Extension 1|Pregnancy|0|||
170344022|NCT00365716|615598339|FG001|Extension 1|Pregnancy|0|||
170344023|NCT00365716|615598340|FG002|Extension 1|Pregnancy|0|||
170344024|NCT00365716|615598341|FG003|Extension 1|Pregnancy|0|||
170344025|NCT00365716|615598342|FG004|Extension 1|Pregnancy|0|||
170344026|NCT00365716|615598343|FG005|Extension 1|Pregnancy|4|||
170344027|NCT00365716|615598344|FG006|Extension 1|Pregnancy|0|||
170344028|NCT00365716|615598338|FG000|Extension 1|Protocol Violation|0|||
170344029|NCT00365716|615598339|FG001|Extension 1|Protocol Violation|0|||
170344030|NCT00365716|615598340|FG002|Extension 1|Protocol Violation|0|||
170344031|NCT00365716|615598341|FG003|Extension 1|Protocol Violation|0|||
170344032|NCT00365716|615598342|FG004|Extension 1|Protocol Violation|0|||
170344033|NCT00365716|615598343|FG005|Extension 1|Protocol Violation|1|||
170344034|NCT00365716|615598344|FG006|Extension 1|Protocol Violation|0|||
170344035|NCT00365716|615598338|FG000|Extension 2|Lost to Follow-up|0|||
170344036|NCT00365716|615598339|FG001|Extension 2|Lost to Follow-up|0|||
170344037|NCT00365716|615598340|FG002|Extension 2|Lost to Follow-up|0|||
170344038|NCT00365716|615598341|FG003|Extension 2|Lost to Follow-up|0|||
170344039|NCT00365716|615598342|FG004|Extension 2|Lost to Follow-up|0|||
170344040|NCT00365716|615598343|FG005|Extension 2|Lost to Follow-up|0|||
170344041|NCT00365716|615598344|FG006|Extension 2|Lost to Follow-up|2|||
170344042|NCT00365716|615598338|FG000|Extension 2|Other|0|||
170344043|NCT00365716|615598339|FG001|Extension 2|Other|0|||
170344044|NCT00365716|615598340|FG002|Extension 2|Other|0|||
170344045|NCT00365716|615598341|FG003|Extension 2|Other|0|||
170344046|NCT00365716|615598342|FG004|Extension 2|Other|0|||
170344047|NCT00365716|615598343|FG005|Extension 2|Other|0|||
170344048|NCT00365716|615598344|FG006|Extension 2|Other|3|||
170344049|NCT00365716|615598338|FG000|Extension 2|Withdrawal by Subject|0|||
170344050|NCT00365716|615598339|FG001|Extension 2|Withdrawal by Subject|0|||
170344051|NCT00365716|615598340|FG002|Extension 2|Withdrawal by Subject|0|||
170344052|NCT00365716|615598341|FG003|Extension 2|Withdrawal by Subject|0|||
170344053|NCT00365716|615598342|FG004|Extension 2|Withdrawal by Subject|0|||
170344054|NCT00365716|615598343|FG005|Extension 2|Withdrawal by Subject|0|||
170344055|NCT00365716|615598344|FG006|Extension 2|Withdrawal by Subject|5|||
170344056|NCT02280291|615598345|FG000|Overall Study|Lost to Follow-up|2|||
170344057|NCT02280291|615598346|FG001|Overall Study|Lost to Follow-up|1|||
170344058|NCT02280291|615598347|FG002|Overall Study|Lost to Follow-up|3|||
170344059|NCT02280291|615598348|FG003|Overall Study|Lost to Follow-up|8|||
170344060|NCT02280291|615598345|FG000|Overall Study|Protocol Violation|1|||
170344061|NCT02280291|615598346|FG001|Overall Study|Protocol Violation|0|||
170344062|NCT02280291|615598347|FG002|Overall Study|Protocol Violation|0|||
170344063|NCT02280291|615598348|FG003|Overall Study|Protocol Violation|0|||
170344064|NCT02280291|615598345|FG000|Overall Study|Other|1|||
170344065|NCT02280291|615598346|FG001|Overall Study|Other|1|||
170344066|NCT02280291|615598347|FG002|Overall Study|Other|0|||
170344067|NCT02280291|615598348|FG003|Overall Study|Other|0|||
170344068|NCT03508622|615598349|FG000|Overall Study|Protocol Violation|1|||
170344069|NCT03508622|615598350|FG001|Overall Study|Protocol Violation|0|||
170344070|NCT03508622|615598349|FG000|Overall Study|Withdrawal by Subject|1|||
170344071|NCT03508622|615598350|FG001|Overall Study|Withdrawal by Subject|0|||
170344072|NCT03508622|615598349|FG000|Overall Study|Lost to Follow-up|16|||
170344073|NCT03508622|615598350|FG001|Overall Study|Lost to Follow-up|0|||
170344074|NCT03508622|615598349|FG000|Overall Study|Incomplete data|0|||
170344075|NCT03508622|615598350|FG001|Overall Study|Incomplete data|24|||
170344076|NCT00316303|615598352|FG000|Overall Study|Lost to Follow-up|11|||
170344077|NCT00316303|615598353|FG001|Overall Study|Lost to Follow-up|16|||
170344078|NCT03196505|615598354|FG000|Overall Study|Physician Decision|26|||
170344079|NCT03196505|615598355|FG001|Overall Study|Physician Decision|26|||
170344080|NCT01005719|615598356|FG000|Period 1|Adverse Event|0|||
170344081|NCT01005719|615598357|FG001|Period 1|Adverse Event|0|||
170344082|NCT01005719|615598358|FG002|Period 1|Adverse Event|0|||
170344083|NCT01005719|615598359|FG003|Period 1|Adverse Event|1|||
170344084|NCT01005719|615598360|FG004|Period 1|Adverse Event|0|||
170344085|NCT01005719|615598361|FG005|Period 1|Adverse Event|0|||
170344086|NCT01005719|615598356|FG000|Period 1|Delay in completing study procedures|0|||
170344087|NCT01005719|615598357|FG001|Period 1|Delay in completing study procedures|0|||
170344088|NCT01005719|615598358|FG002|Period 1|Delay in completing study procedures|0|||
170344089|NCT01005719|615598359|FG003|Period 1|Delay in completing study procedures|0|||
170344090|NCT01005719|615598360|FG004|Period 1|Delay in completing study procedures|0|||
170344091|NCT01005719|615598361|FG005|Period 1|Delay in completing study procedures|1|||
170344092|NCT01005719|615598356|FG000|Period 2|Adverse Event|0|||
170344093|NCT01005719|615598357|FG001|Period 2|Adverse Event|0|||
170344094|NCT01005719|615598358|FG002|Period 2|Adverse Event|0|||
170344095|NCT01005719|615598359|FG003|Period 2|Adverse Event|0|||
170344096|NCT01005719|615598360|FG004|Period 2|Adverse Event|1|||
170344097|NCT01005719|615598361|FG005|Period 2|Adverse Event|1|||
170344098|NCT01753076|615598362|FG000|Overall Study|Adverse Event|17|||
170344099|NCT01753076|615598363|FG001|Overall Study|Adverse Event|18|||
170344100|NCT01753076|615598362|FG000|Overall Study|Lack of Efficacy|3|||
170344101|NCT01753076|615598363|FG001|Overall Study|Lack of Efficacy|1|||
170344102|NCT01753076|615598362|FG000|Overall Study|Lost to Follow-up|2|||
170344103|NCT01753076|615598363|FG001|Overall Study|Lost to Follow-up|1|||
170344104|NCT01753076|615598362|FG000|Overall Study|Physician Decision|4|||
170344105|NCT01753076|615598363|FG001|Overall Study|Physician Decision|2|||
170344106|NCT01753076|615598362|FG000|Overall Study|Withdrawal by Subject|14|||
170344107|NCT01753076|615598363|FG001|Overall Study|Withdrawal by Subject|24|||
170344108|NCT01753076|615598362|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
170344109|NCT01753076|615598363|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
170344110|NCT01259856|615598364|FG000|Overall Study|Adverse Event|12|||
170344111|NCT01259856|615598365|FG001|Overall Study|Adverse Event|9|||
170344112|NCT01259856|615598364|FG000|Overall Study|Death|0|||
170344113|NCT01259856|615598365|FG001|Overall Study|Death|1|||
170344114|NCT01259856|615598364|FG000|Overall Study|Lack of Efficacy|3|||
170344115|NCT01259856|615598365|FG001|Overall Study|Lack of Efficacy|1|||
170344116|NCT01259856|615598364|FG000|Overall Study|Lost to Follow-up|1|||
170344117|NCT01259856|615598365|FG001|Overall Study|Lost to Follow-up|1|||
170344118|NCT01259856|615598364|FG000|Overall Study|Physician Decision|2|||
170344119|NCT01259856|615598365|FG001|Overall Study|Physician Decision|1|||
170344120|NCT01259856|615598364|FG000|Overall Study|Withdrawal by Subject|9|||
170344121|NCT01259856|615598365|FG001|Overall Study|Withdrawal by Subject|10|||
170344122|NCT01259856|615598364|FG000|Overall Study|Treatment never started|0|||
170344123|NCT01259856|615598365|FG001|Overall Study|Treatment never started|6|||
170344124|NCT01259856|615598364|FG000|Overall Study|Study closure by sponsor|40|||
170344125|NCT01259856|615598365|FG001|Overall Study|Study closure by sponsor|41|||
170344126|NCT01259856|615598364|FG000|Overall Study|Patient developed other disease|0|||
170344127|NCT01259856|615598365|FG001|Overall Study|Patient developed other disease|1|||
170344128|NCT01259856|615598364|FG000|Overall Study|Transfer to another study|0|||
170344129|NCT01259856|615598365|FG001|Overall Study|Transfer to another study|1|||
170344130|NCT01259856|615598364|FG000|Overall Study|Unknown/missing|2|||
170344131|NCT01259856|615598365|FG001|Overall Study|Unknown/missing|2|||
170344132|NCT01106534|615598368|FG000|Overall Study|Withdrawal by Subject|18|||
170344133|NCT01106534|615598368|FG000|Overall Study|Lost to Follow-up|2|||
170344134|NCT01106534|615598368|FG000|Overall Study|Death|16|||
170344135|NCT01106534|615598368|FG000|Overall Study|Physician Decision|1|||
170344136|NCT02985450|615598381|FG000|Overall Study|Lost to Follow-up|7|||
170344137|NCT00069576|615598382|FG000|Original Trial|Lost to Follow-up|25|||
170344138|NCT00069576|615598383|FG001|Original Trial|Lost to Follow-up|33|||
170344139|NCT00069576|615598382|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
170344140|NCT00069576|615598383|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
170344141|NCT00905307|615598384|FG000|Overall Study|Switched to Open Label Rescue|7|||
170344142|NCT00905307|615598385|FG001|Overall Study|Switched to Open Label Rescue|17|||
170344143|NCT00905307|615598386|FG002|Overall Study|Switched to Open Label Rescue|11|||
170344144|NCT00905307|615598387|FG003|Overall Study|Switched to Open Label Rescue|11|||
170344145|NCT00905307|615598388|FG004|Overall Study|Switched to Open Label Rescue|4|||
170344146|NCT00905307|615598389|FG005|Overall Study|Switched to Open Label Rescue|15|||
170344147|NCT00905307|615598384|FG000|Overall Study|Lost to Follow-up|0|||
170344148|NCT00905307|615598385|FG001|Overall Study|Lost to Follow-up|0|||
170344149|NCT00905307|615598386|FG002|Overall Study|Lost to Follow-up|0|||
170344150|NCT00905307|615598387|FG003|Overall Study|Lost to Follow-up|0|||
170344151|NCT00905307|615598388|FG004|Overall Study|Lost to Follow-up|1|||
170344152|NCT00905307|615598389|FG005|Overall Study|Lost to Follow-up|1|||
170344153|NCT00905307|615598384|FG000|Overall Study|Adverse Event|3|||
170344154|NCT00905307|615598385|FG001|Overall Study|Adverse Event|4|||
170344155|NCT00905307|615598386|FG002|Overall Study|Adverse Event|5|||
170344156|NCT00905307|615598387|FG003|Overall Study|Adverse Event|11|||
170344157|NCT00905307|615598388|FG004|Overall Study|Adverse Event|3|||
170344158|NCT00905307|615598389|FG005|Overall Study|Adverse Event|5|||
170344159|NCT00905307|615598384|FG000|Overall Study|Withdrawal by Subject|5|||
170344160|NCT00905307|615598385|FG001|Overall Study|Withdrawal by Subject|13|||
170344161|NCT00905307|615598386|FG002|Overall Study|Withdrawal by Subject|15|||
170344162|NCT00905307|615598387|FG003|Overall Study|Withdrawal by Subject|11|||
170344163|NCT00905307|615598388|FG004|Overall Study|Withdrawal by Subject|4|||
170344164|NCT00905307|615598389|FG005|Overall Study|Withdrawal by Subject|13|||
170344165|NCT00905307|615598384|FG000|Overall Study|Protocol Violation|1|||
170344166|NCT00905307|615598385|FG001|Overall Study|Protocol Violation|0|||
170344167|NCT00905307|615598386|FG002|Overall Study|Protocol Violation|1|||
170344168|NCT00905307|615598387|FG003|Overall Study|Protocol Violation|0|||
170344169|NCT00905307|615598388|FG004|Overall Study|Protocol Violation|0|||
170344170|NCT00905307|615598389|FG005|Overall Study|Protocol Violation|0|||
170344171|NCT00905307|615598384|FG000|Overall Study|Lack of Efficacy|6|||
170344172|NCT00905307|615598385|FG001|Overall Study|Lack of Efficacy|3|||
170344173|NCT00905307|615598386|FG002|Overall Study|Lack of Efficacy|5|||
170344174|NCT00905307|615598387|FG003|Overall Study|Lack of Efficacy|4|||
170344175|NCT00905307|615598388|FG004|Overall Study|Lack of Efficacy|4|||
170344176|NCT00905307|615598389|FG005|Overall Study|Lack of Efficacy|8|||
170344177|NCT02086565|615598394|FG000|Overall Study|Lost to Follow-up|9|||
170344178|NCT02086565|615598395|FG001|Overall Study|Lost to Follow-up|7|||
170344179|NCT02086565|615598394|FG000|Overall Study|Withdrawal by Subject|2|||
170344180|NCT02086565|615598395|FG001|Overall Study|Withdrawal by Subject|1|||
170344181|NCT02086565|615598394|FG000|Overall Study|Death|3|||
170344182|NCT02086565|615598395|FG001|Overall Study|Death|2|||
170344183|NCT02086565|615598394|FG000|Overall Study|withdrawn by research team|2|||
170344184|NCT02086565|615598395|FG001|Overall Study|withdrawn by research team|2|||
170344185|NCT00739297|615598396|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
170344186|NCT00739297|615598397|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
170344187|NCT00739297|615598398|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
170344188|NCT00739297|615598399|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
170344189|NCT00739297|615598400|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
170344190|NCT00739297|615598401|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
170344191|NCT00739297|615598402|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
170344192|NCT00739297|615598396|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
170344193|NCT00739297|615598397|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
170344194|NCT00739297|615598398|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
170344195|NCT00739297|615598399|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
170344196|NCT00739297|615598400|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
170344197|NCT00739297|615598401|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
170344198|NCT00739297|615598402|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
170344199|NCT01400971|615598403|FG000|Overall Study|Death|82|||
170344200|NCT01400971|615598403|FG000|Overall Study|Lost to Follow-up|196|||
170344201|NCT01400971|615598403|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
170344202|NCT01400971|615598403|FG000|Overall Study|Physician Decision|57|||
170344203|NCT01400971|615598403|FG000|Overall Study|Withdrawal by Subject|158|||
170344204|NCT01400971|615598403|FG000|Overall Study|Other|422|||
170344205|NCT01757704|615598404|FG000|Overall Study|Protocol Violation|1|||
170344206|NCT01757704|615598405|FG001|Overall Study|Protocol Violation|3|||
170344207|NCT00844428|615598409|FG000|Screening Period|Screen Failure|3|||
170344208|NCT00844428|615598409|FG000|Extension Treatment Period|Death|1|||
170344209|NCT00844428|615598409|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
170344210|NCT00455858|615598410|FG000|Overall Study|Lost to Follow-up|2|||
170344211|NCT00455858|615598410|FG000|Overall Study|Protocol Violation|1|||
170344212|NCT00455858|615598410|FG000|Overall Study|Lack of Efficacy|1|||
170344213|NCT00455858|615598410|FG000|Overall Study|Well controlled FPG without insulin|1|||
170344214|NCT00455858|615598410|FG000|Overall Study|Withdrawal|1|||
170344215|NCT00772967|615598412|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
170344216|NCT00772967|615598413|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
170344217|NCT00772967|615598414|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
170344218|NCT00772967|615598415|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
170344219|NCT00772967|615598416|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
170344220|NCT00772967|615598417|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
170344221|NCT00772967|615598412|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
170344222|NCT00772967|615598413|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
170344223|NCT00772967|615598414|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
170344224|NCT00772967|615598415|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
170344225|NCT00772967|615598416|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
170344226|NCT00772967|615598417|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
170344227|NCT00772967|615598412|FG000|Crossover Treatment 3|Adverse Event|0|||
170344228|NCT00772967|615598413|FG001|Crossover Treatment 3|Adverse Event|0|||
170344229|NCT00772967|615598414|FG002|Crossover Treatment 3|Adverse Event|0|||
170344230|NCT00772967|615598415|FG003|Crossover Treatment 3|Adverse Event|0|||
170344231|NCT00772967|615598416|FG004|Crossover Treatment 3|Adverse Event|1|||
170344232|NCT00772967|615598417|FG005|Crossover Treatment 3|Adverse Event|0|||
170344233|NCT00866294|615598418|FG000|Overall Study|Adverse Event|12|||
170344234|NCT00866294|615598419|FG001|Overall Study|Adverse Event|13|||
170344235|NCT00866294|615598420|FG002|Overall Study|Adverse Event|9|||
170344236|NCT00866294|615598418|FG000|Overall Study|Lack of Efficacy|7|||
170344237|NCT00866294|615598419|FG001|Overall Study|Lack of Efficacy|1|||
170344238|NCT00866294|615598420|FG002|Overall Study|Lack of Efficacy|0|||
170344239|NCT00866294|615598418|FG000|Overall Study|Protocol Violation|2|||
170344240|NCT00866294|615598419|FG001|Overall Study|Protocol Violation|0|||
170344241|NCT00866294|615598420|FG002|Overall Study|Protocol Violation|0|||
170344242|NCT00866294|615598418|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
170344243|NCT00866294|615598419|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
170344244|NCT00866294|615598420|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
170344245|NCT00866294|615598418|FG000|Overall Study|Lost to Follow-up|1|||
170344246|NCT00866294|615598419|FG001|Overall Study|Lost to Follow-up|3|||
170344247|NCT00866294|615598420|FG002|Overall Study|Lost to Follow-up|0|||
170344248|NCT00866294|615598418|FG000|Overall Study|Physician Decision|6|||
170344249|NCT00866294|615598419|FG001|Overall Study|Physician Decision|2|||
170344250|NCT00866294|615598420|FG002|Overall Study|Physician Decision|1|||
170344251|NCT02815397|615598421|FG000|Overall Study|Physician Decision|2|||
170344252|NCT04598165|615598422|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
170344253|NCT04598165|615598423|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
170344254|NCT04598165|615598422|FG000|Completed 6-week Follow-up|Death|2|||
170344255|NCT04598165|615598423|FG001|Completed 6-week Follow-up|Death|1|||
170344256|NCT04598165|615598422|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
170344257|NCT04598165|615598423|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
170344258|NCT04598165|615598422|FG000|Completed 6-week Follow-up|Ineligible|4|||
170344259|NCT04598165|615598423|FG001|Completed 6-week Follow-up|Ineligible|3|||
170344260|NCT04598165|615598422|FG000|Completed 6-week Follow-up|Partner refusal|0|||
170344261|NCT04598165|615598423|FG001|Completed 6-week Follow-up|Partner refusal|1|||
170344262|NCT04598165|615598422|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
170344263|NCT04598165|615598423|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
170344264|NCT00370149|615598426|FG000|Overall Study|Physician Decision|16|||
170344265|NCT00370149|615598427|FG001|Overall Study|Physician Decision|16|||
170344266|NCT00370149|615598426|FG000|Overall Study|Protocol Violation|1|||
170344267|NCT00370149|615598427|FG001|Overall Study|Protocol Violation|0|||
170344268|NCT00370149|615598426|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
170344269|NCT00370149|615598427|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
170344270|NCT00370149|615598426|FG000|Overall Study|Pre-existing infection|0|||
170344271|NCT00370149|615598427|FG001|Overall Study|Pre-existing infection|1|||
170344272|NCT00370149|615598426|FG000|Overall Study|Antibiotic coated dressing placed|0|||
170344273|NCT00370149|615598427|FG001|Overall Study|Antibiotic coated dressing placed|1|||
170344274|NCT04038255|615599877|FG000|Overall Study|Lost to Follow-up|0|||
170344275|NCT04038255|615599878|FG001|Overall Study|Lost to Follow-up|9|||
170344276|NCT04038255|615599879|FG002|Overall Study|Lost to Follow-up|5|||
170344277|NCT04038255|615599877|FG000|Overall Study|Withdrawal by Subject|0|||
170344278|NCT04038255|615599878|FG001|Overall Study|Withdrawal by Subject|0|||
170344279|NCT04038255|615599879|FG002|Overall Study|Withdrawal by Subject|1|||
170344280|NCT00883558|615599883|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
170344281|NCT00883558|615599884|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
170344282|NCT00883558|615599885|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
170344283|NCT00883558|615599883|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
170344284|NCT00883558|615599884|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
170344285|NCT00883558|615599885|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
170344286|NCT00883558|615599883|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
170399293|NCT03193190|615799950|FG013|Stage 1|Reason not Specified|0|||
170344287|NCT00883558|615599884|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
170344288|NCT00883558|615599885|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
170344289|NCT00883558|615599883|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
170344290|NCT00883558|615599884|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
170344291|NCT00883558|615599885|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
170344292|NCT00883558|615599883|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
170344293|NCT00883558|615599884|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
170344294|NCT00883558|615599885|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
170344295|NCT00366548|615599886|FG000|Infant Series|Adverse Event|1|||
170344296|NCT00366548|615599887|FG001|Infant Series|Adverse Event|3|||
170344297|NCT00366548|615599886|FG000|Infant Series|Protocol Violation|0|||
170344298|NCT00366548|615599887|FG001|Infant Series|Protocol Violation|1|||
170344299|NCT00366548|615599886|FG000|Infant Series|Withdrawal by Subject|3|||
170344300|NCT00366548|615599887|FG001|Infant Series|Withdrawal by Subject|1|||
170344301|NCT00366548|615599886|FG000|After Infant Series|Withdrawal by Subject|3|||
170344302|NCT00366548|615599887|FG001|After Infant Series|Withdrawal by Subject|1|||
170344303|NCT00366548|615599886|FG000|After Infant Series|Adverse Event|2|||
170344304|NCT00366548|615599887|FG001|After Infant Series|Adverse Event|0|||
170344305|NCT00366548|615599886|FG000|After Infant Series|Lost to Follow-up|1|||
170344306|NCT00366548|615599887|FG001|After Infant Series|Lost to Follow-up|0|||
170344307|NCT01876732|615599892|FG000|Overall Study|MMA was not over 800mg/dL|75|||
170344308|NCT00536731|615599893|FG000|Overall Study|Adverse Event|3|||
170344309|NCT00536731|615599894|FG001|Overall Study|Adverse Event|2|||
170344310|NCT00536731|615599895|FG002|Overall Study|Adverse Event|3|||
170344311|NCT00536731|615599893|FG000|Overall Study|Withdrawal by Subject|0|||
170344312|NCT00536731|615599894|FG001|Overall Study|Withdrawal by Subject|2|||
170344313|NCT00536731|615599895|FG002|Overall Study|Withdrawal by Subject|0|||
170344314|NCT00536731|615599893|FG000|Overall Study|Intake of prohibited conc. medication|0|||
170344315|NCT00536731|615599894|FG001|Overall Study|Intake of prohibited conc. medication|0|||
170344316|NCT00536731|615599895|FG002|Overall Study|Intake of prohibited conc. medication|1|||
170344317|NCT00536731|615599893|FG000|Overall Study|Safety reasons|0|||
170344318|NCT00536731|615599894|FG001|Overall Study|Safety reasons|0|||
170344319|NCT00536731|615599895|FG002|Overall Study|Safety reasons|1|||
170344320|NCT00536731|615599893|FG000|Overall Study|Other|1|||
170344321|NCT00536731|615599894|FG001|Overall Study|Other|1|||
170344322|NCT00536731|615599895|FG002|Overall Study|Other|0|||
170344323|NCT00718419|615599896|FG000|Overall Study|Adverse Event|2|||
170344324|NCT00718419|615599897|FG001|Overall Study|Adverse Event|1|||
170344325|NCT00718419|615599896|FG000|Overall Study|Physician Decision|1|||
170344326|NCT00718419|615599897|FG001|Overall Study|Physician Decision|6|||
170344327|NCT00718419|615599896|FG000|Overall Study|Sponsor decision|0|||
170344328|NCT00718419|615599897|FG001|Overall Study|Sponsor decision|1|||
170344329|NCT00718419|615599896|FG000|Overall Study|Withdrawal by Subject|0|||
170344330|NCT00718419|615599897|FG001|Overall Study|Withdrawal by Subject|5|||
170344331|NCT00718419|615599896|FG000|Overall Study|Progressive Disease|7|||
170344332|NCT00718419|615599897|FG001|Overall Study|Progressive Disease|25|||
170344333|NCT00718419|615599896|FG000|Overall Study|Death Due to Progressive Disease|2|||
170344334|NCT00718419|615599897|FG001|Overall Study|Death Due to Progressive Disease|0|||
170344335|NCT00718419|615599896|FG000|Overall Study|Death Due to Study Drug Related|0|||
170344336|NCT00718419|615599897|FG001|Overall Study|Death Due to Study Drug Related|1|||
170344337|NCT00718419|615599896|FG000|Overall Study|Death Due to Adverse Events|1|||
170344338|NCT00718419|615599897|FG001|Overall Study|Death Due to Adverse Events|0|||
170344339|NCT01623531|615599898|FG000|Overall Study|Death|1|||
170344340|NCT01623531|615599899|FG001|Overall Study|Death|0|||
170344341|NCT01623531|615599898|FG000|Overall Study|Protocol Violation|2|||
170344342|NCT01623531|615599899|FG001|Overall Study|Protocol Violation|1|||
170344343|NCT01623531|615599898|FG000|Overall Study|Missing data at primary outcome time poi|1|||
170344344|NCT01623531|615599899|FG001|Overall Study|Missing data at primary outcome time poi|1|||
170344345|NCT02834403|615599900|FG000|Overall Study|Physician Decision|2|||
170344346|NCT02834403|615599901|FG001|Overall Study|Physician Decision|1|||
170344347|NCT02834403|615599902|FG002|Overall Study|Physician Decision|2|||
170344348|NCT02834403|615599903|FG003|Overall Study|Physician Decision|1|||
170344349|NCT02834403|615599904|FG004|Overall Study|Physician Decision|1|||
170344350|NCT02834403|615599905|FG005|Overall Study|Physician Decision|2|||
170344351|NCT02834403|615599906|FG006|Overall Study|Physician Decision|12|||
170344352|NCT02834403|615599900|FG000|Overall Study|Adverse Event|0|||
170344353|NCT02834403|615599901|FG001|Overall Study|Adverse Event|0|||
170344354|NCT02834403|615599902|FG002|Overall Study|Adverse Event|0|||
170344355|NCT02834403|615599903|FG003|Overall Study|Adverse Event|0|||
170344356|NCT02834403|615599904|FG004|Overall Study|Adverse Event|1|||
170344357|NCT02834403|615599905|FG005|Overall Study|Adverse Event|1|||
170344358|NCT02834403|615599906|FG006|Overall Study|Adverse Event|3|||
170344359|NCT02834403|615599900|FG000|Overall Study|Withdrawal by Subject|0|||
170344360|NCT02834403|615599901|FG001|Overall Study|Withdrawal by Subject|1|||
170344361|NCT02834403|615599902|FG002|Overall Study|Withdrawal by Subject|0|||
170344362|NCT02834403|615599903|FG003|Overall Study|Withdrawal by Subject|0|||
170344363|NCT02834403|615599904|FG004|Overall Study|Withdrawal by Subject|1|||
170344364|NCT02834403|615599905|FG005|Overall Study|Withdrawal by Subject|0|||
170344365|NCT02834403|615599906|FG006|Overall Study|Withdrawal by Subject|0|||
170344366|NCT02834403|615599900|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
170344367|NCT02834403|615599901|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
170344368|NCT02834403|615599902|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
170344369|NCT02834403|615599903|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
170344370|NCT02834403|615599904|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
170344371|NCT02834403|615599905|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
170344372|NCT02834403|615599906|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
170344373|NCT02750800|615599912|FG000|Overall Study|Adverse Event|18|||
170344374|NCT02750800|615599912|FG000|Overall Study|Lost to Follow-up|12|||
170344375|NCT02750800|615599912|FG000|Overall Study|Investigator decision|53|||
170344376|NCT02750800|615599912|FG000|Overall Study|Patient request|12|||
170344377|NCT02750800|615599912|FG000|Overall Study|Other, not specified|3|||
170344378|NCT00109733|615599918|FG000|Overall Study|Protocol Violation|0|||
170344379|NCT00109733|615599919|FG001|Overall Study|Protocol Violation|1|||
170344380|NCT00109733|615599918|FG000|Overall Study|Stopped taking study drug|1|||
170344381|NCT00109733|615599919|FG001|Overall Study|Stopped taking study drug|1|||
170344382|NCT00109733|615599918|FG000|Overall Study|Non-compliant|0|||
170344383|NCT00109733|615599919|FG001|Overall Study|Non-compliant|1|||
170344384|NCT00109733|615599918|FG000|Overall Study|Could not commit time for study|1|||
170344385|NCT00109733|615599919|FG001|Overall Study|Could not commit time for study|1|||
170344386|NCT00305006|615599924|FG000|Overall Study|Withdrawal by Subject|1|||
170344387|NCT00305006|615599925|FG001|Overall Study|Withdrawal by Subject|0|||
170344388|NCT00305006|615599924|FG000|Overall Study|Failure to complete pretest|0|||
170344389|NCT00305006|615599925|FG001|Overall Study|Failure to complete pretest|1|||
170344390|NCT00879814|615599931|FG000|Overall Study|Adverse Event|0|||
170344391|NCT00879814|615599932|FG001|Overall Study|Adverse Event|1|||
170344392|NCT00879814|615599933|FG002|Overall Study|Adverse Event|0|||
170344393|NCT00879814|615599934|FG003|Overall Study|Adverse Event|0|||
170344394|NCT00879814|615599931|FG000|Overall Study|Lost to Follow-up|1|||
170344395|NCT00879814|615599932|FG001|Overall Study|Lost to Follow-up|0|||
170344396|NCT00879814|615599933|FG002|Overall Study|Lost to Follow-up|0|||
170344397|NCT00879814|615599934|FG003|Overall Study|Lost to Follow-up|2|||
170344398|NCT00879814|615599931|FG000|Overall Study|Participant Failed to Return|0|||
170344399|NCT00879814|615599932|FG001|Overall Study|Participant Failed to Return|0|||
170344400|NCT00879814|615599933|FG002|Overall Study|Participant Failed to Return|0|||
170344401|NCT00879814|615599934|FG003|Overall Study|Participant Failed to Return|1|||
170344402|NCT00879814|615599931|FG000|Overall Study|Withdrawal by Subject|3|||
170344403|NCT00879814|615599932|FG001|Overall Study|Withdrawal by Subject|1|||
170344404|NCT00879814|615599933|FG002|Overall Study|Withdrawal by Subject|1|||
170344405|NCT00879814|615599934|FG003|Overall Study|Withdrawal by Subject|2|||
170344406|NCT00879814|615599931|FG000|Overall Study|Physician Decision|0|||
170344407|NCT00879814|615599932|FG001|Overall Study|Physician Decision|0|||
170344408|NCT00879814|615599933|FG002|Overall Study|Physician Decision|1|||
170344409|NCT00879814|615599934|FG003|Overall Study|Physician Decision|0|||
170344410|NCT00879814|615599931|FG000|Overall Study|Other|0|||
170344411|NCT00879814|615599932|FG001|Overall Study|Other|0|||
170344412|NCT00879814|615599933|FG002|Overall Study|Other|1|||
170344413|NCT00879814|615599934|FG003|Overall Study|Other|0|||
170344414|NCT05628181|615599935|FG000|Overall Study|Death|2|||
170344415|NCT05628181|615599936|FG001|Overall Study|Death|4|||
170344416|NCT05628181|615599937|FG002|Overall Study|Death|0|||
170344417|NCT01603641|615599938|FG000|Overall Study|Did not Receive Treatment|3|||
170344418|NCT01603641|615599938|FG000|Overall Study|Adverse Event|1|||
170344419|NCT01603641|615599938|FG000|Overall Study|Lack of Efficacy|1|||
170344420|NCT01603641|615599938|FG000|Overall Study|Lost to Follow-up|6|||
170344421|NCT01603641|615599938|FG000|Overall Study|Personal Reasons|18|||
170344422|NCT01603641|615599938|FG000|Overall Study|Other Miscellaneous Reasons|6|||
170344423|NCT00114972|615599939|FG000|Overall Study|Withdrawal by Subject|40|||
170344424|NCT00114972|615599940|FG001|Overall Study|Withdrawal by Subject|7|||
170344425|NCT00114972|615599939|FG000|Overall Study|Lost to Follow-up|8|||
170344426|NCT00114972|615599940|FG001|Overall Study|Lost to Follow-up|5|||
170344427|NCT00570739|615599941|FG000|Overall Study|Adverse Event|8|||
170344428|NCT00570739|615599942|FG001|Overall Study|Adverse Event|6|||
170344429|NCT00570739|615599943|FG002|Overall Study|Adverse Event|2|||
170344430|NCT00570739|615599944|FG003|Overall Study|Adverse Event|2|||
170344431|NCT00570739|615599941|FG000|Overall Study|Lost to Follow-up|4|||
170344432|NCT00570739|615599942|FG001|Overall Study|Lost to Follow-up|5|||
170344433|NCT00570739|615599943|FG002|Overall Study|Lost to Follow-up|4|||
170344434|NCT00570739|615599944|FG003|Overall Study|Lost to Follow-up|1|||
170344435|NCT00570739|615599941|FG000|Overall Study|Physician Decision|1|||
170344436|NCT00570739|615599942|FG001|Overall Study|Physician Decision|1|||
170344437|NCT00570739|615599943|FG002|Overall Study|Physician Decision|0|||
170344438|NCT00570739|615599944|FG003|Overall Study|Physician Decision|0|||
170344439|NCT00570739|615599941|FG000|Overall Study|Withdrawal by Subject|7|||
170344440|NCT00570739|615599942|FG001|Overall Study|Withdrawal by Subject|7|||
170344441|NCT00570739|615599943|FG002|Overall Study|Withdrawal by Subject|3|||
170344442|NCT00570739|615599944|FG003|Overall Study|Withdrawal by Subject|5|||
170344443|NCT00570739|615599941|FG000|Overall Study|Required restricted medication|0|||
170344444|NCT00570739|615599942|FG001|Overall Study|Required restricted medication|0|||
170344445|NCT00570739|615599943|FG002|Overall Study|Required restricted medication|1|||
170344446|NCT00570739|615599944|FG003|Overall Study|Required restricted medication|0|||
170344447|NCT00570739|615599941|FG000|Overall Study|Met discontinuation criteria|1|||
170344448|NCT00570739|615599942|FG001|Overall Study|Met discontinuation criteria|0|||
170344449|NCT00570739|615599943|FG002|Overall Study|Met discontinuation criteria|1|||
170344450|NCT00570739|615599944|FG003|Overall Study|Met discontinuation criteria|1|||
170344451|NCT00570739|615599941|FG000|Overall Study|Other|0|||
170344452|NCT00570739|615599942|FG001|Overall Study|Other|2|||
170344453|NCT00570739|615599943|FG002|Overall Study|Other|5|||
170344454|NCT00570739|615599944|FG003|Overall Study|Other|3|||
170344455|NCT02890329|615599947|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
170344456|NCT02890329|615599948|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
170344457|NCT02890329|615599949|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
170344458|NCT02890329|615599950|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
170344459|NCT02890329|615599951|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
170344460|NCT02890329|615599952|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
170344461|NCT02890329|615599947|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
170344462|NCT02890329|615599948|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
170344463|NCT02890329|615599949|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
170344464|NCT02890329|615599950|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
170344465|NCT02890329|615599951|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
170344466|NCT02890329|615599952|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
170344467|NCT02890329|615599947|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
170344468|NCT02890329|615599948|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
170344469|NCT02890329|615599949|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
170344470|NCT02890329|615599950|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
170344471|NCT02890329|615599951|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
170344472|NCT02890329|615599952|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
170344473|NCT02890329|615599947|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
170344474|NCT02890329|615599948|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
170344475|NCT02890329|615599949|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
170344476|NCT02890329|615599950|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
170344477|NCT02890329|615599951|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
170344478|NCT02890329|615599952|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
170344479|NCT01035255|615599953|FG000|Overall Study|Death|724|||
170344480|NCT01035255|615599954|FG001|Overall Study|Death|844|||
170344481|NCT01035255|615599953|FG000|Overall Study|Lost to Follow-up|2|||
170344482|NCT01035255|615599954|FG001|Overall Study|Lost to Follow-up|5|||
170344483|NCT01035255|615599953|FG000|Overall Study|patient's request|15|||
170344484|NCT01035255|615599954|FG001|Overall Study|patient's request|13|||
170344485|NCT01379534|615599957|FG000|Treatment Phase|Withdrawal by Subject|2|||
170344486|NCT01379534|615599958|FG001|Treatment Phase|Withdrawal by Subject|2|||
170344487|NCT01379534|615599957|FG000|Treatment Phase|Progressive disease|13|||
170344488|NCT01379534|615599958|FG001|Treatment Phase|Progressive disease|22|||
170344489|NCT01379534|615599957|FG000|Treatment Phase|Adverse Event|7|||
170344490|NCT01379534|615599958|FG001|Treatment Phase|Adverse Event|7|||
170344491|NCT01379534|615599957|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
170344492|NCT01379534|615599958|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
170344493|NCT01379534|615599957|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
170344494|NCT01379534|615599958|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
170344495|NCT01379534|615599957|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
170344496|NCT01379534|615599958|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
170344497|NCT01379534|615599957|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
170344498|NCT01379534|615599958|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
170344499|NCT02691247|615599959|FG000|Overall Study|Withdrawal by Subject|1|||
170344500|NCT02691247|615599960|FG001|Overall Study|Withdrawal by Subject|2|||
170344501|NCT02691247|615599961|FG002|Overall Study|Withdrawal by Subject|2|||
170344502|NCT02691247|615599959|FG000|Overall Study|Lost to Follow-up|2|||
170344503|NCT02691247|615599960|FG001|Overall Study|Lost to Follow-up|0|||
170344504|NCT02691247|615599961|FG002|Overall Study|Lost to Follow-up|1|||
170344505|NCT01041573|615599966|FG000|Overall Study|Withdrawal by Subject|2|||
170344506|NCT01041573|615599967|FG001|Overall Study|Withdrawal by Subject|5|||
170344507|NCT01041573|615599968|FG002|Overall Study|Withdrawal by Subject|2|||
170344508|NCT01041573|615599969|FG003|Overall Study|Withdrawal by Subject|0|||
170344509|NCT01041573|615599966|FG000|Overall Study|Death|1|||
170344510|NCT01041573|615599967|FG001|Overall Study|Death|0|||
170344511|NCT01041573|615599968|FG002|Overall Study|Death|0|||
170344512|NCT01041573|615599969|FG003|Overall Study|Death|0|||
170344513|NCT01041573|615599966|FG000|Overall Study|Lost to Follow-up|0|||
170344514|NCT01041573|615599967|FG001|Overall Study|Lost to Follow-up|1|||
170344515|NCT01041573|615599968|FG002|Overall Study|Lost to Follow-up|2|||
170344516|NCT01041573|615599969|FG003|Overall Study|Lost to Follow-up|1|||
170344517|NCT01041573|615599966|FG000|Overall Study|Adverse Event|0|||
170344518|NCT01041573|615599967|FG001|Overall Study|Adverse Event|2|||
170344519|NCT01041573|615599968|FG002|Overall Study|Adverse Event|0|||
170344520|NCT01041573|615599969|FG003|Overall Study|Adverse Event|0|||
170344521|NCT01041573|615599966|FG000|Overall Study|relocation|1|||
170344522|NCT01041573|615599967|FG001|Overall Study|relocation|4|||
170344523|NCT01041573|615599968|FG002|Overall Study|relocation|3|||
170344524|NCT01041573|615599969|FG003|Overall Study|relocation|1|||
170344525|NCT01041573|615599966|FG000|Overall Study|further blood extraction|0|||
170344526|NCT01041573|615599967|FG001|Overall Study|further blood extraction|1|||
170344527|NCT01041573|615599968|FG002|Overall Study|further blood extraction|0|||
170344528|NCT01041573|615599969|FG003|Overall Study|further blood extraction|0|||
170344529|NCT01041573|615599966|FG000|Overall Study|positive to anti-HCV|1|||
170344530|NCT01041573|615599967|FG001|Overall Study|positive to anti-HCV|0|||
170344531|NCT01041573|615599968|FG002|Overall Study|positive to anti-HCV|0|||
170344532|NCT01041573|615599969|FG003|Overall Study|positive to anti-HCV|0|||
170344533|NCT00231062|615599970|FG000|Overall Study|Physician Decision|6|||
170344534|NCT00616239|615599972|FG000|Overall Study|Withdrawal by Subject|2|||
170344535|NCT01632878|615599978|FG000|Screening|Physician Decision|268|||
170344536|NCT01632878|615599978|FG000|Treatment|Lost to Follow-up|41|||
170344537|NCT01632878|615599978|FG000|Treatment|Withdrawal by Subject|36|||
170344538|NCT01632878|615599978|FG000|Treatment|Physician Decision|34|||
170344539|NCT01632878|615599978|FG000|Treatment|missing information|4|||
170344540|NCT01632878|615599978|FG000|Treatment|no information on study completion|43|||
170344541|NCT02698423|615599979|FG000|Overall Study|Lost to Follow-up|19|||
170344542|NCT02698423|615599980|FG001|Overall Study|Lost to Follow-up|24|||
170344543|NCT03634072|615599981|FG000|Overall Study|Early termination of overall study|1|||
170344544|NCT03634072|615599982|FG001|Overall Study|Early termination of overall study|0|||
170344545|NCT01558089|615599984|FG000|Overall Study|Adverse Event|1|||
170344546|NCT01558089|615599984|FG000|Overall Study|Lack of Efficacy|1|||
170344547|NCT01558089|615599984|FG000|Overall Study|Lost to Follow-up|5|||
170344548|NCT01558089|615599984|FG000|Overall Study|Withdrawal by Subject|6|||
170344549|NCT01597193|615599985|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
170344550|NCT01597193|615599986|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
170344551|NCT01597193|615599987|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
170344552|NCT01597193|615599988|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
170344553|NCT01597193|615599989|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
170344554|NCT01597193|615599990|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
170344555|NCT01597193|615599991|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
170344556|NCT01597193|615599985|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
170344557|NCT01597193|615599986|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
170344558|NCT01597193|615599987|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
170344559|NCT01597193|615599988|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
170344560|NCT01597193|615599989|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
170344561|NCT01597193|615599990|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
170344562|NCT01597193|615599991|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
170344563|NCT01597193|615599985|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
170344564|NCT01597193|615599986|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
170344565|NCT01597193|615599987|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
170344566|NCT01597193|615599988|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
170344567|NCT01597193|615599989|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
170344568|NCT01597193|615599990|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
170344569|NCT01597193|615599991|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
170344570|NCT01597193|615599985|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
170344571|NCT01597193|615599986|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
170344572|NCT01597193|615599987|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
170344573|NCT01597193|615599988|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
170344574|NCT01597193|615599989|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
170344575|NCT01597193|615599990|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
170344576|NCT01597193|615599991|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
170344577|NCT01597193|615599985|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
170344578|NCT01597193|615599986|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
170344579|NCT01597193|615599987|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
170344580|NCT01597193|615599988|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
170344581|NCT01597193|615599989|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
170344582|NCT01597193|615599990|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
170344583|NCT01597193|615599991|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
170344584|NCT02229864|615599993|FG000|Overall Study|Death|2|||
170344585|NCT02229864|615599993|FG000|Overall Study|Lost to Follow-up|1|||
170344586|NCT02650284|615599996|FG000|Overall Study|Lost to Follow-up|3|||
170344587|NCT02650284|615599997|FG001|Overall Study|Lost to Follow-up|3|||
170344588|NCT02650284|615599996|FG000|Overall Study|Consent incorrectly taken|0|||
170344589|NCT02650284|615599997|FG001|Overall Study|Consent incorrectly taken|1|||
170344590|NCT01555463|615600000|FG000|Treatment|Adverse Event|6|||
170344591|NCT01555463|615600001|FG001|Treatment|Adverse Event|12|||
170344592|NCT01555463|615600000|FG000|Treatment|Withdrawal by Subject|24|||
170344593|NCT01555463|615600001|FG001|Treatment|Withdrawal by Subject|36|||
170344594|NCT01555463|615600000|FG000|Treatment|Lost to Follow-up|28|||
170344595|NCT01555463|615600001|FG001|Treatment|Lost to Follow-up|23|||
170344596|NCT01555463|615600000|FG000|Treatment|Protocol Violation|4|||
170344597|NCT01555463|615600001|FG001|Treatment|Protocol Violation|5|||
170344598|NCT01555463|615600000|FG000|Treatment|Other reason|2|||
170344599|NCT01555463|615600001|FG001|Treatment|Other reason|3|||
170344600|NCT01555463|615600000|FG000|Follow up|Adverse Event|2|||
170344601|NCT01555463|615600001|FG001|Follow up|Adverse Event|5|||
170344602|NCT01555463|615600000|FG000|Follow up|Death|0|||
170344603|NCT01555463|615600001|FG001|Follow up|Death|1|||
170344604|NCT01555463|615600000|FG000|Follow up|Withdrawal by Subject|22|||
170344605|NCT01555463|615600001|FG001|Follow up|Withdrawal by Subject|22|||
170344606|NCT01555463|615600000|FG000|Follow up|Lost to Follow-up|9|||
170344607|NCT01555463|615600001|FG001|Follow up|Lost to Follow-up|10|||
170344608|NCT01555463|615600000|FG000|Follow up|Protocol Violation|2|||
170344609|NCT01555463|615600001|FG001|Follow up|Protocol Violation|4|||
170344610|NCT01555463|615600000|FG000|Follow up|Other reason|3|||
170344611|NCT01555463|615600001|FG001|Follow up|Other reason|3|||
170344612|NCT01108809|615600002|FG000|Overall Study|Adverse Event|3|||
170344613|NCT01108809|615600002|FG000|Overall Study|Lost to Follow-up|1|||
170344614|NCT04229446|615600005|FG000|Overall Study|Death|12|||
170344615|NCT04229446|615600006|FG001|Overall Study|Death|10|||
170344616|NCT04229446|615600005|FG000|Overall Study|Lost to Follow-up|5|||
170344617|NCT04229446|615600006|FG001|Overall Study|Lost to Follow-up|8|||
170344618|NCT01413178|615600007|FG000|Overall Study|Toxicity|1|||
170344619|NCT01413178|615600008|FG001|Overall Study|Toxicity|0|||
170344620|NCT01413178|615600007|FG000|Overall Study|Ineligible|0|||
170344621|NCT01413178|615600008|FG001|Overall Study|Ineligible|2|||
170344622|NCT03643432|615600009|FG000|Overall Study|Lost to Follow-up|1|||
170344623|NCT03643432|615600010|FG001|Overall Study|Lost to Follow-up|0|||
170344624|NCT00705224|615600011|FG000|Overall Study|Adverse Event|1|||
170344625|NCT00705224|615600011|FG000|Overall Study|Lack of Efficacy|2|||
170344626|NCT00705224|615600011|FG000|Overall Study|Withdrawal by Subject|3|||
170344627|NCT00705224|615600011|FG000|Overall Study|Lost to Follow-up|5|||
170344628|NCT03283163|615600012|FG000|Overall Study|Lost to Follow-up|1|||
170344629|NCT03283163|615600012|FG000|Overall Study|other life commitments|6|||
170344630|NCT03283163|615600012|FG000|Overall Study|COVID-19 institution wide halting|1|||
170344631|NCT03283163|615600012|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
170344632|NCT03283163|615600012|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
170344633|NCT04238663|615600013|FG000|Overall Study|Lost to Follow-up|0|||
170344634|NCT04238663|615600014|FG001|Overall Study|Lost to Follow-up|1|||
170344635|NCT04238663|615600015|FG002|Overall Study|Lost to Follow-up|0|||
170344636|NCT02566525|615600016|FG000|Overall Study|Protocol Violation|3|||
170344637|NCT02566525|615600017|FG001|Overall Study|Protocol Violation|5|||
170344638|NCT00337467|615600018|FG000|Overall Study|Adverse Event|3|||
170344639|NCT00337467|615600018|FG000|Overall Study|Subject Withdrew Consent|2|||
170344640|NCT00337467|615600018|FG000|Overall Study|Pregnancy|1|||
170344641|NCT00337467|615600018|FG000|Overall Study|Lost to Follow-up|2|||
170344642|NCT00337467|615600018|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
170344643|NCT01187901|615600019|FG000|Overall Study|Protocol Violation|1|||
170344644|NCT01187901|615600020|FG001|Overall Study|Protocol Violation|0|||
170344645|NCT01187901|615600019|FG000|Overall Study|Lost to Follow-up|1|||
170344646|NCT01187901|615600020|FG001|Overall Study|Lost to Follow-up|2|||
170344647|NCT01187901|615600019|FG000|Overall Study|Unrelated Health Reasons|1|||
170344648|NCT01187901|615600020|FG001|Overall Study|Unrelated Health Reasons|2|||
170344649|NCT01187901|615600019|FG000|Overall Study|Suspected Allergic Reaction|1|||
170344650|NCT01187901|615600020|FG001|Overall Study|Suspected Allergic Reaction|1|||
170344651|NCT01187901|615600019|FG000|Overall Study|Adverse Event|3|||
170344652|NCT01187901|615600020|FG001|Overall Study|Adverse Event|0|||
170344653|NCT01187901|615600019|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
170344654|NCT01187901|615600020|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
170344655|NCT01187901|615600019|FG000|Overall Study|Pregnancy|0|||
170344656|NCT01187901|615600020|FG001|Overall Study|Pregnancy|2|||
170344657|NCT03987620|615600021|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
170344658|NCT03987620|615600022|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
170344659|NCT03987620|615600021|FG000|Overall Study|Adverse Event|3|||
170344660|NCT03987620|615600022|FG001|Overall Study|Adverse Event|0|||
170344661|NCT03987620|615600021|FG000|Overall Study|Lost to Follow-up|1|||
170344662|NCT03987620|615600022|FG001|Overall Study|Lost to Follow-up|2|||
170344663|NCT03987620|615600021|FG000|Overall Study|Physician Decision|0|||
170344664|NCT03987620|615600022|FG001|Overall Study|Physician Decision|1|||
170344665|NCT03987620|615600021|FG000|Overall Study|Pregnancy|1|||
170344666|NCT03987620|615600022|FG001|Overall Study|Pregnancy|0|||
170344667|NCT03987620|615600021|FG000|Overall Study|Withdrawal by Subject|7|||
170344668|NCT03987620|615600022|FG001|Overall Study|Withdrawal by Subject|1|||
170344669|NCT03987620|615600021|FG000|Overall Study|Other|2|||
170344670|NCT03987620|615600022|FG001|Overall Study|Other|5|||
170344671|NCT02149836|615600023|FG000|Overall Study|Withdrawal by Subject|1|||
170344672|NCT01755195|615601384|FG000|Overall Study|Participant noncompliance|2|||
170344673|NCT01755195|615601384|FG000|Overall Study|Switched to alternative treatment|4|||
170344674|NCT01755195|615601384|FG000|Overall Study|Withdrawal by Subject|1|||
170344675|NCT01755195|615601384|FG000|Overall Study|Participant refused to start treatment|1|||
170344676|NCT01755195|615601384|FG000|Overall Study|Participant has been consented for another trial|1|||
170344677|NCT01755195|615601384|FG000|Overall Study|Refused further treatment|3|||
170344678|NCT01755195|615601384|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
170344679|NCT00414310|615601386|FG000|Overall Study|Not treated|1|||
170344680|NCT00414310|615601387|FG001|Overall Study|Not treated|0|||
170344681|NCT03539458|615601391|FG000|Overall Study|Death|1|||
170344682|NCT04184622|615601395|FG000|Primary Treatment Period|Adverse Event|6|||
170344683|NCT04184622|615601396|FG001|Primary Treatment Period|Adverse Event|4|||
170344684|NCT04184622|615601397|FG002|Primary Treatment Period|Adverse Event|8|||
170344685|NCT04184622|615601398|FG003|Primary Treatment Period|Adverse Event|6|||
170344686|NCT04184622|615601395|FG000|Primary Treatment Period|Death|4|||
170344687|NCT04184622|615601396|FG001|Primary Treatment Period|Death|4|||
170344688|NCT04184622|615601397|FG002|Primary Treatment Period|Death|2|||
170344689|NCT04184622|615601398|FG003|Primary Treatment Period|Death|1|||
170344690|NCT04184622|615601395|FG000|Primary Treatment Period|Lost to Follow-up|41|||
170344691|NCT04184622|615601396|FG001|Primary Treatment Period|Lost to Follow-up|17|||
170344692|NCT04184622|615601397|FG002|Primary Treatment Period|Lost to Follow-up|15|||
170344693|NCT04184622|615601398|FG003|Primary Treatment Period|Lost to Follow-up|13|||
170344694|NCT04184622|615601395|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
170344695|NCT04184622|615601396|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
170344696|NCT04184622|615601397|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
170344697|NCT04184622|615601398|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
170344698|NCT04184622|615601395|FG000|Primary Treatment Period|Physician Decision|0|||
170344699|NCT04184622|615601396|FG001|Primary Treatment Period|Physician Decision|0|||
170344700|NCT04184622|615601397|FG002|Primary Treatment Period|Physician Decision|3|||
170344701|NCT04184622|615601398|FG003|Primary Treatment Period|Physician Decision|1|||
170344702|NCT04184622|615601395|FG000|Primary Treatment Period|Pregnancy|4|||
170344703|NCT04184622|615601396|FG001|Primary Treatment Period|Pregnancy|3|||
170344704|NCT04184622|615601397|FG002|Primary Treatment Period|Pregnancy|4|||
170344705|NCT04184622|615601398|FG003|Primary Treatment Period|Pregnancy|1|||
170344706|NCT04184622|615601395|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
170344707|NCT04184622|615601396|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
170344708|NCT04184622|615601397|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
170344709|NCT04184622|615601398|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
170344710|NCT04184622|615601395|FG000|Additional Treatment Period|Adverse Event|1|||
170344711|NCT04184622|615601396|FG001|Additional Treatment Period|Adverse Event|2|||
170344712|NCT04184622|615601397|FG002|Additional Treatment Period|Adverse Event|1|||
170344713|NCT04184622|615601398|FG003|Additional Treatment Period|Adverse Event|0|||
170344714|NCT04184622|615601395|FG000|Additional Treatment Period|Death|0|||
170344715|NCT04184622|615601396|FG001|Additional Treatment Period|Death|0|||
170344716|NCT04184622|615601397|FG002|Additional Treatment Period|Death|1|||
170344717|NCT04184622|615601398|FG003|Additional Treatment Period|Death|1|||
170344718|NCT04184622|615601395|FG000|Additional Treatment Period|Lost to Follow-up|6|||
170344719|NCT04184622|615601396|FG001|Additional Treatment Period|Lost to Follow-up|4|||
170344720|NCT04184622|615601397|FG002|Additional Treatment Period|Lost to Follow-up|8|||
170344721|NCT04184622|615601398|FG003|Additional Treatment Period|Lost to Follow-up|6|||
170344722|NCT04184622|615601395|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
170344723|NCT04184622|615601396|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
170344724|NCT04184622|615601397|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
170344725|NCT04184622|615601398|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
170344726|NCT04184622|615601395|FG000|Additional Treatment Period|Physician Decision|0|||
170344727|NCT04184622|615601396|FG001|Additional Treatment Period|Physician Decision|0|||
170344728|NCT04184622|615601397|FG002|Additional Treatment Period|Physician Decision|1|||
170344729|NCT04184622|615601398|FG003|Additional Treatment Period|Physician Decision|0|||
170344730|NCT04184622|615601395|FG000|Additional Treatment Period|Pregnancy|0|||
170344731|NCT04184622|615601396|FG001|Additional Treatment Period|Pregnancy|0|||
170344732|NCT04184622|615601397|FG002|Additional Treatment Period|Pregnancy|0|||
170344733|NCT04184622|615601398|FG003|Additional Treatment Period|Pregnancy|1|||
170344734|NCT04184622|615601395|FG000|Additional Treatment Period|Protocol deviation|0|||
170344735|NCT04184622|615601396|FG001|Additional Treatment Period|Protocol deviation|0|||
170344736|NCT04184622|615601397|FG002|Additional Treatment Period|Protocol deviation|1|||
170344737|NCT04184622|615601398|FG003|Additional Treatment Period|Protocol deviation|0|||
170344738|NCT04184622|615601395|FG000|Additional Treatment Period|Site closed|1|||
170344739|NCT04184622|615601396|FG001|Additional Treatment Period|Site closed|0|||
170344740|NCT04184622|615601397|FG002|Additional Treatment Period|Site closed|1|||
170344741|NCT04184622|615601398|FG003|Additional Treatment Period|Site closed|0|||
170344742|NCT04184622|615601395|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
170344743|NCT04184622|615601396|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
170344744|NCT04184622|615601397|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
170344745|NCT04184622|615601398|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
170344746|NCT04184622|615601395|FG000|Safety Follow-up Period|Adverse Event|6|||
170344747|NCT04184622|615601396|FG001|Safety Follow-up Period|Adverse Event|8|||
170344748|NCT04184622|615601397|FG002|Safety Follow-up Period|Adverse Event|9|||
170344749|NCT04184622|615601398|FG003|Safety Follow-up Period|Adverse Event|16|||
170344750|NCT04184622|615601395|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
170344751|NCT04184622|615601396|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
170344752|NCT04184622|615601397|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
170344753|NCT04184622|615601398|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
170344754|NCT04184622|615601395|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
170344755|NCT04184622|615601396|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
170344756|NCT04184622|615601397|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
170344757|NCT04184622|615601398|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
170344758|NCT04184622|615601395|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
170344759|NCT04184622|615601396|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
170344760|NCT04184622|615601397|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
170344761|NCT04184622|615601398|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
170344762|NCT04184622|615601395|FG000|Safety Follow-up Period|Physician Decision|1|||
170344763|NCT04184622|615601396|FG001|Safety Follow-up Period|Physician Decision|0|||
170344764|NCT04184622|615601397|FG002|Safety Follow-up Period|Physician Decision|0|||
170344765|NCT04184622|615601398|FG003|Safety Follow-up Period|Physician Decision|1|||
170344766|NCT04184622|615601395|FG000|Safety Follow-up Period|Pregnancy|1|||
170344767|NCT04184622|615601396|FG001|Safety Follow-up Period|Pregnancy|3|||
170344768|NCT04184622|615601397|FG002|Safety Follow-up Period|Pregnancy|0|||
170344769|NCT04184622|615601398|FG003|Safety Follow-up Period|Pregnancy|6|||
170344770|NCT04184622|615601395|FG000|Safety Follow-up Period|Protocol deviation|1|||
170344771|NCT04184622|615601396|FG001|Safety Follow-up Period|Protocol deviation|0|||
170344772|NCT04184622|615601397|FG002|Safety Follow-up Period|Protocol deviation|0|||
170344773|NCT04184622|615601398|FG003|Safety Follow-up Period|Protocol deviation|0|||
170344774|NCT04184622|615601395|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
170344775|NCT04184622|615601396|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
170344776|NCT04184622|615601397|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
170344777|NCT04184622|615601398|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
170344778|NCT00726323|615601403|FG000|Overall Study|Withdrawal by Subject|3|||
170344779|NCT00726323|615601404|FG001|Overall Study|Withdrawal by Subject|1|||
170344780|NCT00726323|615601403|FG000|Overall Study|Physician Decision|1|||
170344781|NCT00726323|615601404|FG001|Overall Study|Physician Decision|0|||
170344782|NCT00726323|615601403|FG000|Overall Study|Progressive disease|23|||
170344783|NCT00726323|615601404|FG001|Overall Study|Progressive disease|16|||
170344784|NCT00726323|615601403|FG000|Overall Study|Clinical progression|0|||
170344785|NCT00726323|615601404|FG001|Overall Study|Clinical progression|3|||
170344786|NCT00726323|615601403|FG000|Overall Study|Adverse Event|9|||
170344787|NCT00726323|615601404|FG001|Overall Study|Adverse Event|9|||
170344788|NCT00726323|615601403|FG000|Overall Study|Death|1|||
170344789|NCT00726323|615601404|FG001|Overall Study|Death|0|||
170344790|NCT00726323|615601403|FG000|Overall Study|Participant wished to discontinue|0|||
170344791|NCT00726323|615601404|FG001|Overall Study|Participant wished to discontinue|1|||
170344792|NCT00726323|615601403|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
170344793|NCT00726323|615601404|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
170344794|NCT02341014|615601405|FG000|Overall Study|Adverse Event|0|||
170344795|NCT02341014|615601406|FG001|Overall Study|Adverse Event|1|||
170344796|NCT02341014|615601407|FG002|Overall Study|Adverse Event|0|||
170344797|NCT02341014|615601408|FG003|Overall Study|Adverse Event|0|||
170344798|NCT02341014|615601409|FG004|Overall Study|Adverse Event|2|||
170344799|NCT04705597|615601410|FG000|Overall Study|Death|16|||
170344800|NCT04705597|615601411|FG001|Overall Study|Death|9|||
170344801|NCT04705597|615601410|FG000|Overall Study|Lost to Follow-up|1|||
170344802|NCT04705597|615601411|FG001|Overall Study|Lost to Follow-up|0|||
170344803|NCT04705597|615601410|FG000|Overall Study|Withdrawal by Subject|1|||
170344804|NCT04705597|615601411|FG001|Overall Study|Withdrawal by Subject|2|||
170344805|NCT00390780|615601412|FG000|Overall Study|Not completed|10|||
170344806|NCT00390780|615601413|FG001|Overall Study|Not completed|4|||
170344807|NCT00390780|615601412|FG000|Overall Study|Protocol Violation|6|||
170344808|NCT00390780|615601413|FG001|Overall Study|Protocol Violation|4|||
170344809|NCT00390780|615601412|FG000|Overall Study|Lost to Follow-up|3|||
170344810|NCT00390780|615601413|FG001|Overall Study|Lost to Follow-up|6|||
170344811|NCT00390780|615601412|FG000|Overall Study|Adverse Event|2|||
170344812|NCT00390780|615601413|FG001|Overall Study|Adverse Event|3|||
170344813|NCT00390780|615601412|FG000|Overall Study|Death|1|||
170344814|NCT00390780|615601413|FG001|Overall Study|Death|3|||
170344815|NCT00390780|615601412|FG000|Overall Study|Withdrawal by Subject|1|||
170344816|NCT00390780|615601413|FG001|Overall Study|Withdrawal by Subject|2|||
170344817|NCT00390780|615601412|FG000|Overall Study|Inclusion criteria not satisfied|0|||
170344818|NCT00390780|615601413|FG001|Overall Study|Inclusion criteria not satisfied|2|||
170344819|NCT00390780|615601412|FG000|Overall Study|Lost to follow up and other reasons|0|||
170344820|NCT00390780|615601413|FG001|Overall Study|Lost to follow up and other reasons|1|||
170344821|NCT00390780|615601412|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
170344822|NCT00390780|615601413|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
170344823|NCT00390780|615601412|FG000|Overall Study|SAE, death|0|||
170344824|NCT00390780|615601413|FG001|Overall Study|SAE, death|1|||
170344825|NCT05058664|615601414|FG000|Overall Study|No follow-up data provided|4|||
170344826|NCT05058664|615601415|FG001|Overall Study|No follow-up data provided|0|||
170344827|NCT05058664|615601416|FG002|Overall Study|No follow-up data provided|2|||
170344828|NCT05058664|615601414|FG000|Overall Study|Withdrawal by Subject|0|||
170344829|NCT05058664|615601415|FG001|Overall Study|Withdrawal by Subject|0|||
170344830|NCT05058664|615601416|FG002|Overall Study|Withdrawal by Subject|1|||
170344831|NCT01617681|615601418|FG000|Period 1 Double Blind|Adverse Event|2|||
170344832|NCT01617681|615601419|FG001|Period 1 Double Blind|Adverse Event|0|||
170344833|NCT01617681|615601420|FG002|Period 1 Double Blind|Adverse Event|0|||
170344834|NCT01617681|615601421|FG003|Period 1 Double Blind|Adverse Event|2|||
170344835|NCT01617681|615601422|FG004|Period 1 Double Blind|Adverse Event|0|||
170344836|NCT01617681|615601418|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
170344837|NCT01617681|615601419|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
170344838|NCT01617681|615601420|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
170344839|NCT01617681|615601421|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
170344840|NCT01617681|615601422|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
170344841|NCT01617681|615601418|FG000|Period 2 Open Label|Adverse Event|0|||
170344842|NCT01617681|615601419|FG001|Period 2 Open Label|Adverse Event|0|||
170344843|NCT01617681|615601420|FG002|Period 2 Open Label|Adverse Event|0|||
170344844|NCT01617681|615601421|FG003|Period 2 Open Label|Adverse Event|0|||
170344845|NCT01617681|615601422|FG004|Period 2 Open Label|Adverse Event|3|||
170344846|NCT01617681|615601418|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
170344847|NCT01617681|615601419|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
170344848|NCT01617681|615601420|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
170344849|NCT01617681|615601421|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
170344850|NCT01617681|615601422|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
170344851|NCT05590793|615601424|FG000|Overall Study|Withdrawal by Subject|6|||
170344852|NCT05590793|615601424|FG000|Overall Study|Physician Decision|1|||
170344853|NCT04060667|615601425|FG000|Overall Study|Lost to Follow-up|75|||
170344854|NCT04060667|615601426|FG001|Overall Study|Lost to Follow-up|10|||
170344855|NCT04488822|615601427|FG000|Overall Study|Adverse Event|8|||
170344856|NCT04488822|615601427|FG000|Overall Study|Withdrawal by Subject|1|||
170344857|NCT03838367|615601428|FG000|Overall Study|Early termination of study|3|||
170344858|NCT03838367|615601429|FG001|Overall Study|Early termination of study|4|||
170344859|NCT03838367|615601430|FG002|Overall Study|Early termination of study|3|||
170344860|NCT03838367|615601431|FG003|Overall Study|Early termination of study|0|||
170344861|NCT03406104|615601434|FG000|Overall Study|Lost to Follow-up|2|||
170344862|NCT03406104|615601434|FG000|Overall Study|Withdrawal by Subject|2|||
170344863|NCT03406104|615601434|FG000|Overall Study|due to Covid patient did not want to travel|1|||
170344864|NCT03406104|615601434|FG000|Overall Study|Death|2|||
170344865|NCT03015610|615601439|FG000|Overall Study|Lost to Follow-up|1|||
170344866|NCT03015610|615601440|FG001|Overall Study|Lost to Follow-up|5|||
170344867|NCT00358917|615601441|FG000|Overall Study|Adverse Event|14|||
170344868|NCT00358917|615601442|FG001|Overall Study|Adverse Event|21|||
170344869|NCT00358917|615601441|FG000|Overall Study|Withdrawal by Subject|5|||
170344870|NCT00358917|615601442|FG001|Overall Study|Withdrawal by Subject|7|||
170344871|NCT00358917|615601441|FG000|Overall Study|Lost to Follow-up|20|||
170344872|NCT00358917|615601442|FG001|Overall Study|Lost to Follow-up|17|||
170344873|NCT00358917|615601441|FG000|Overall Study|Noncompliance|12|||
170344874|NCT00358917|615601442|FG001|Overall Study|Noncompliance|11|||
170344875|NCT00358917|615601441|FG000|Overall Study|Death|2|||
170344876|NCT00358917|615601442|FG001|Overall Study|Death|3|||
170344877|NCT00358917|615601441|FG000|Overall Study|Virologic failure|11|||
170344878|NCT00358917|615601442|FG001|Overall Study|Virologic failure|8|||
170344879|NCT00358917|615601441|FG000|Overall Study|Unable to Continue Participation|2|||
170344880|NCT00358917|615601442|FG001|Overall Study|Unable to Continue Participation|2|||
170344881|NCT01519245|615601452|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
170344882|NCT01519245|615601453|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
170344883|NCT00803244|615601456|FG000|Overall Study|Adverse Event|1|||
170344884|NCT00803244|615601457|FG001|Overall Study|Adverse Event|2|||
170344885|NCT00803244|615601456|FG000|Overall Study|Withdrawal by Subject|2|||
170344886|NCT00803244|615601457|FG001|Overall Study|Withdrawal by Subject|3|||
170344887|NCT00803244|615601456|FG000|Overall Study|Any other reason not above-mentioned|4|||
170344888|NCT00803244|615601457|FG001|Overall Study|Any other reason not above-mentioned|10|||
170344889|NCT03321929|615601458|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
170344890|NCT02873715|615601459|FG000|Overall Study|Lost to Follow-up|84|||
170344891|NCT02873715|615601460|FG001|Overall Study|Lost to Follow-up|94|||
170344892|NCT02873715|615601459|FG000|Overall Study|Withdrawal by Subject|7|||
170344893|NCT02873715|615601460|FG001|Overall Study|Withdrawal by Subject|26|||
170344894|NCT03184701|615601464|FG000|Overall Study|Death|3|||
170344895|NCT03184701|615601464|FG000|Overall Study|Physician Decision|3|||
170344896|NCT03184701|615601464|FG000|Overall Study|Withdrawal by Subject|6|||
170344897|NCT03184701|615601464|FG000|Overall Study|Lost to Follow-up|5|||
170344898|NCT00590681|615601469|FG000|Overall Study|Withdrawal by Subject|7|||
170344899|NCT00590681|615601469|FG000|Overall Study|Adverse Event|8|||
170344900|NCT00590681|615601469|FG000|Overall Study|Death|3|||
170344901|NCT00590681|615601469|FG000|Overall Study|Lost to Follow-up|1|||
170344902|NCT00590681|615601469|FG000|Overall Study|disease progression|1|||
170344903|NCT01259297|615601472|FG000|Double Blind Randomized Period|Death|1|||
170344904|NCT01259297|615601473|FG001|Double Blind Randomized Period|Death|1|||
170399294|NCT03193190|615799951|FG014|Stage 1|Reason not Specified|0|||
170344905|NCT01259297|615601474|FG002|Double Blind Randomized Period|Death|1|||
170344906|NCT01259297|615601475|FG003|Double Blind Randomized Period|Death|2|||
170344907|NCT01259297|615601476|FG004|Double Blind Randomized Period|Death|1|||
170344908|NCT01259297|615601477|FG005|Double Blind Randomized Period|Death|5|||
170344909|NCT01259297|615601478|FG006|Double Blind Randomized Period|Death|2|||
170344910|NCT01259297|615601479|FG007|Double Blind Randomized Period|Death|1|||
170344911|NCT01259297|615601472|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
170344912|NCT01259297|615601473|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
170344913|NCT01259297|615601474|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
170344914|NCT01259297|615601475|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
170344915|NCT01259297|615601476|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
170344916|NCT01259297|615601477|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
170344917|NCT01259297|615601478|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
170344918|NCT01259297|615601479|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
170344919|NCT01259297|615601472|FG000|Double Blind Randomized Period|Other reasons|0|||
170344920|NCT01259297|615601473|FG001|Double Blind Randomized Period|Other reasons|1|||
170344921|NCT01259297|615601474|FG002|Double Blind Randomized Period|Other reasons|0|||
170344922|NCT01259297|615601475|FG003|Double Blind Randomized Period|Other reasons|0|||
170344923|NCT01259297|615601476|FG004|Double Blind Randomized Period|Other reasons|1|||
170344924|NCT01259297|615601477|FG005|Double Blind Randomized Period|Other reasons|2|||
170344925|NCT01259297|615601478|FG006|Double Blind Randomized Period|Other reasons|3|||
170344926|NCT01259297|615601479|FG007|Double Blind Randomized Period|Other reasons|1|||
170344927|NCT00443430|615601482|FG000|Overall Study|Lack of Efficacy|3|||
170344928|NCT00443430|615601483|FG001|Overall Study|Lack of Efficacy|3|||
170344929|NCT00443430|615601482|FG000|Overall Study|Adverse Event|1|||
170344930|NCT00443430|615601483|FG001|Overall Study|Adverse Event|1|||
170344931|NCT00053846|615601484|FG000|Overall Study|Changed mind|8|||
170344932|NCT00053846|615601485|FG001|Overall Study|Changed mind|13|||
170344933|NCT00053846|615601484|FG000|Overall Study|Became too ill|8|||
170344934|NCT00053846|615601485|FG001|Overall Study|Became too ill|7|||
170344935|NCT00053846|615601484|FG000|Overall Study|Expired|5|||
170344936|NCT00053846|615601485|FG001|Overall Study|Expired|0|||
170344937|NCT00053846|615601484|FG000|Overall Study|Became ineligible|3|||
170344938|NCT00053846|615601485|FG001|Overall Study|Became ineligible|1|||
170344939|NCT00053846|615601484|FG000|Overall Study|Did not return data|1|||
170344940|NCT00053846|615601485|FG001|Overall Study|Did not return data|2|||
170344941|NCT00053846|615601484|FG000|Overall Study|Quit due to side effects|1|||
170344942|NCT00053846|615601485|FG001|Overall Study|Quit due to side effects|3|||
170344943|NCT00053846|615601484|FG000|Overall Study|Pills too large|0|||
170344944|NCT00053846|615601485|FG001|Overall Study|Pills too large|1|||
170344945|NCT00592501|615601486|FG000|Overall Study|Withdrawal by Subject|1|||
170344946|NCT00592501|615601486|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
170344947|NCT00064662|615601487|FG000|Overall Study|Death|1|||
170344948|NCT00064662|615601488|FG001|Overall Study|Death|1|||
170344949|NCT00064662|615601487|FG000|Overall Study|Lost to Follow-up|57|||
170344950|NCT00064662|615601488|FG001|Overall Study|Lost to Follow-up|44|||
170344951|NCT00064662|615601487|FG000|Overall Study|Withdrawal by Subject|14|||
170344952|NCT00064662|615601488|FG001|Overall Study|Withdrawal by Subject|14|||
170344953|NCT00064662|615601487|FG000|Overall Study|Administratively withdrawn|2|||
170344954|NCT00064662|615601488|FG001|Overall Study|Administratively withdrawn|2|||
170344955|NCT03880227|615601489|FG000|First Visit|Withdrawal by Subject|1|||
170344956|NCT03880227|615601490|FG001|First Visit|Withdrawal by Subject|0|||
170344957|NCT03880227|615601491|FG002|First Visit|Withdrawal by Subject|0|||
170344958|NCT03880227|615601492|FG003|First Visit|Withdrawal by Subject|0|||
170344959|NCT03880227|615601489|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
170344960|NCT03880227|615601490|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
170344961|NCT03880227|615601491|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
170344962|NCT03880227|615601492|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
170344963|NCT03880227|615601489|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
170344964|NCT03880227|615601490|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
170344965|NCT03880227|615601491|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
170344966|NCT03880227|615601492|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
170344967|NCT03880227|615601489|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
170344968|NCT03880227|615601490|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
170344969|NCT03880227|615601491|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
170344970|NCT03880227|615601492|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
170344971|NCT04590937|615601493|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
170344972|NCT01635933|615601494|FG000|Overall Study|Adverse Event|1|||
170344973|NCT01635933|615601495|FG001|Overall Study|Adverse Event|0|||
170344974|NCT01635933|615601494|FG000|Overall Study|Lost to Follow-up|0|||
170344975|NCT01635933|615601495|FG001|Overall Study|Lost to Follow-up|5|||
170344976|NCT01635933|615601494|FG000|Overall Study|Subject decision|1|||
170344977|NCT01635933|615601495|FG001|Overall Study|Subject decision|1|||
170344978|NCT01635933|615601494|FG000|Overall Study|Noncompliance|0|||
170344979|NCT01635933|615601495|FG001|Overall Study|Noncompliance|1|||
170344980|NCT01635933|615601494|FG000|Overall Study|No longer had transportation|0|||
170344981|NCT01635933|615601495|FG001|Overall Study|No longer had transportation|1|||
170344982|NCT01544595|615601498|FG000|Status at Week 68|Adverse Event|3|||
170344983|NCT01544595|615601499|FG001|Status at Week 68|Adverse Event|2|||
170344984|NCT01544595|615601500|FG002|Status at Week 68|Adverse Event|1|||
170344985|NCT01544595|615601501|FG003|Status at Week 68|Adverse Event|0|||
170344986|NCT01544595|615601502|FG004|Status at Week 68|Adverse Event|0|||
170344987|NCT01544595|615601503|FG005|Status at Week 68|Adverse Event|0|||
170344988|NCT01544595|615601498|FG000|Status at Week 68|Lack of Efficacy|1|||
170344989|NCT01544595|615601499|FG001|Status at Week 68|Lack of Efficacy|0|||
170344990|NCT01544595|615601500|FG002|Status at Week 68|Lack of Efficacy|0|||
170344991|NCT01544595|615601501|FG003|Status at Week 68|Lack of Efficacy|0|||
170344992|NCT01544595|615601502|FG004|Status at Week 68|Lack of Efficacy|0|||
170344993|NCT01544595|615601503|FG005|Status at Week 68|Lack of Efficacy|0|||
170344994|NCT01544595|615601498|FG000|Status at Week 68|Lost to Follow-up|1|||
170344995|NCT01544595|615601499|FG001|Status at Week 68|Lost to Follow-up|1|||
170344996|NCT01544595|615601500|FG002|Status at Week 68|Lost to Follow-up|0|||
170344997|NCT01544595|615601501|FG003|Status at Week 68|Lost to Follow-up|0|||
170344998|NCT01544595|615601502|FG004|Status at Week 68|Lost to Follow-up|0|||
170344999|NCT01544595|615601503|FG005|Status at Week 68|Lost to Follow-up|0|||
170345000|NCT01544595|615601498|FG000|Status at Week 68|Non-compliance with study treatment|1|||
170345001|NCT01544595|615601499|FG001|Status at Week 68|Non-compliance with study treatment|0|||
170345002|NCT01544595|615601500|FG002|Status at Week 68|Non-compliance with study treatment|0|||
170345003|NCT01544595|615601501|FG003|Status at Week 68|Non-compliance with study treatment|1|||
170345004|NCT01544595|615601502|FG004|Status at Week 68|Non-compliance with study treatment|0|||
170345005|NCT01544595|615601503|FG005|Status at Week 68|Non-compliance with study treatment|0|||
170345006|NCT01544595|615601498|FG000|Status at Week 68|Protocol Violation|2|||
170345007|NCT01544595|615601499|FG001|Status at Week 68|Protocol Violation|0|||
170345008|NCT01544595|615601500|FG002|Status at Week 68|Protocol Violation|1|||
170345009|NCT01544595|615601501|FG003|Status at Week 68|Protocol Violation|1|||
170345010|NCT01544595|615601502|FG004|Status at Week 68|Protocol Violation|0|||
170345011|NCT01544595|615601503|FG005|Status at Week 68|Protocol Violation|0|||
170345012|NCT01544595|615601498|FG000|Status at Week 68|Technical problems|1|||
170345013|NCT01544595|615601499|FG001|Status at Week 68|Technical problems|0|||
170345014|NCT01544595|615601500|FG002|Status at Week 68|Technical problems|0|||
170345015|NCT01544595|615601501|FG003|Status at Week 68|Technical problems|1|||
170345016|NCT01544595|615601502|FG004|Status at Week 68|Technical problems|0|||
170345017|NCT01544595|615601503|FG005|Status at Week 68|Technical problems|0|||
170345018|NCT01544595|615601498|FG000|Status at Week 68|Withdrawal by Subject|0|||
170345019|NCT01544595|615601499|FG001|Status at Week 68|Withdrawal by Subject|1|||
170345020|NCT01544595|615601500|FG002|Status at Week 68|Withdrawal by Subject|1|||
170345021|NCT01544595|615601501|FG003|Status at Week 68|Withdrawal by Subject|2|||
170345022|NCT01544595|615601502|FG004|Status at Week 68|Withdrawal by Subject|0|||
170345023|NCT01544595|615601503|FG005|Status at Week 68|Withdrawal by Subject|0|||
170345024|NCT01544595|615601498|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
170345025|NCT01544595|615601499|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
170345026|NCT01544595|615601500|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
170345027|NCT01544595|615601501|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
170345028|NCT01544595|615601502|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
170345029|NCT01544595|615601503|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
170345030|NCT01544595|615601498|FG000|Status at Week 156|Withdrawal by Subject|9|||
170345031|NCT01544595|615601499|FG001|Status at Week 156|Withdrawal by Subject|10|||
170345032|NCT01544595|615601500|FG002|Status at Week 156|Withdrawal by Subject|4|||
170345033|NCT01544595|615601501|FG003|Status at Week 156|Withdrawal by Subject|9|||
170345034|NCT01544595|615601502|FG004|Status at Week 156|Withdrawal by Subject|20|||
170345035|NCT01544595|615601503|FG005|Status at Week 156|Withdrawal by Subject|6|||
170345036|NCT01544595|615601498|FG000|Status at Week 156|Adverse Event|9|||
170345037|NCT01544595|615601499|FG001|Status at Week 156|Adverse Event|11|||
170345038|NCT01544595|615601500|FG002|Status at Week 156|Adverse Event|1|||
170345039|NCT01544595|615601501|FG003|Status at Week 156|Adverse Event|3|||
170345040|NCT01544595|615601502|FG004|Status at Week 156|Adverse Event|4|||
170345041|NCT01544595|615601503|FG005|Status at Week 156|Adverse Event|2|||
170345042|NCT01544595|615601498|FG000|Status at Week 156|Lost to Follow-up|4|||
170345043|NCT01544595|615601499|FG001|Status at Week 156|Lost to Follow-up|4|||
170345044|NCT01544595|615601500|FG002|Status at Week 156|Lost to Follow-up|0|||
170345045|NCT01544595|615601501|FG003|Status at Week 156|Lost to Follow-up|1|||
170345046|NCT01544595|615601502|FG004|Status at Week 156|Lost to Follow-up|4|||
170345047|NCT01544595|615601503|FG005|Status at Week 156|Lost to Follow-up|1|||
170345048|NCT01544595|615601498|FG000|Status at Week 156|Non-compliance with study treatement|0|||
170345049|NCT01544595|615601499|FG001|Status at Week 156|Non-compliance with study treatement|1|||
170345050|NCT01544595|615601500|FG002|Status at Week 156|Non-compliance with study treatement|0|||
170345051|NCT01544595|615601501|FG003|Status at Week 156|Non-compliance with study treatement|1|||
170345052|NCT01544595|615601502|FG004|Status at Week 156|Non-compliance with study treatement|0|||
170345053|NCT01544595|615601503|FG005|Status at Week 156|Non-compliance with study treatement|1|||
170345054|NCT01544595|615601498|FG000|Status at Week 156|Physician Decision|0|||
170345055|NCT01544595|615601499|FG001|Status at Week 156|Physician Decision|3|||
170345056|NCT01544595|615601500|FG002|Status at Week 156|Physician Decision|1|||
170345057|NCT01544595|615601501|FG003|Status at Week 156|Physician Decision|0|||
170345058|NCT01544595|615601502|FG004|Status at Week 156|Physician Decision|0|||
170345059|NCT01544595|615601503|FG005|Status at Week 156|Physician Decision|0|||
170345060|NCT01544595|615601498|FG000|Status at Week 156|Pregnancy|2|||
170345061|NCT01544595|615601499|FG001|Status at Week 156|Pregnancy|3|||
170345062|NCT01544595|615601500|FG002|Status at Week 156|Pregnancy|0|||
170345063|NCT01544595|615601501|FG003|Status at Week 156|Pregnancy|0|||
170345064|NCT01544595|615601502|FG004|Status at Week 156|Pregnancy|0|||
170345065|NCT01544595|615601503|FG005|Status at Week 156|Pregnancy|0|||
170345066|NCT01544595|615601498|FG000|Status at Week 156|Protocol Violation|3|||
170345067|NCT01544595|615601499|FG001|Status at Week 156|Protocol Violation|1|||
170345068|NCT01544595|615601500|FG002|Status at Week 156|Protocol Violation|2|||
170345069|NCT01544595|615601501|FG003|Status at Week 156|Protocol Violation|2|||
170345070|NCT01544595|615601502|FG004|Status at Week 156|Protocol Violation|0|||
170345071|NCT01544595|615601503|FG005|Status at Week 156|Protocol Violation|0|||
170345072|NCT01544595|615601498|FG000|Status at Week 156|Technical problems|3|||
170345073|NCT01544595|615601499|FG001|Status at Week 156|Technical problems|1|||
170345074|NCT01544595|615601500|FG002|Status at Week 156|Technical problems|0|||
170345075|NCT01544595|615601501|FG003|Status at Week 156|Technical problems|1|||
170345076|NCT01544595|615601502|FG004|Status at Week 156|Technical problems|0|||
170345077|NCT01544595|615601503|FG005|Status at Week 156|Technical problems|0|||
170345078|NCT01544595|615601498|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
170345079|NCT01544595|615601499|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
170345080|NCT01544595|615601500|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
170345081|NCT01544595|615601501|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
170345082|NCT01544595|615601502|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
170345083|NCT01544595|615601503|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
170345084|NCT01544595|615601498|FG000|Status at Week 156|Lack of Efficacy|1|||
170345085|NCT01544595|615601499|FG001|Status at Week 156|Lack of Efficacy|0|||
170345086|NCT01544595|615601500|FG002|Status at Week 156|Lack of Efficacy|1|||
170345087|NCT01544595|615601501|FG003|Status at Week 156|Lack of Efficacy|4|||
170345088|NCT01544595|615601502|FG004|Status at Week 156|Lack of Efficacy|10|||
170345089|NCT01544595|615601503|FG005|Status at Week 156|Lack of Efficacy|5|||
170345090|NCT01929044|615601506|FG000|Overall Study|Adverse Event|1|||
170345091|NCT01929044|615601507|FG001|Overall Study|Adverse Event|0|||
170345092|NCT01929044|615601506|FG000|Overall Study|Protocol Violation|9|||
170345093|NCT01929044|615601507|FG001|Overall Study|Protocol Violation|14|||
170345094|NCT01929044|615601506|FG000|Overall Study|Not Treated|1|||
170345095|NCT01929044|615601507|FG001|Overall Study|Not Treated|3|||
170345096|NCT02084134|615601512|FG000|Overall Study|Protocol Violation|4|||
170345097|NCT02084134|615601513|FG001|Overall Study|Protocol Violation|2|||
170345098|NCT02084134|615601512|FG000|Overall Study|Death|0|||
170345099|NCT02084134|615601513|FG001|Overall Study|Death|1|||
170345100|NCT02275026|615601514|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
170345101|NCT02275026|615601514|FG000|Overall Study|Withdrawal by Subject|4|||
170345102|NCT02275026|615601514|FG000|Overall Study|Ineligible due to medical history|13|||
170345103|NCT02275026|615601514|FG000|Overall Study|MRI malfunction precluded testing|1|||
170345104|NCT02275026|615601514|FG000|Overall Study|Ineligible after MRI findings|1|||
170345105|NCT02275026|615601514|FG000|Overall Study|Lost to Follow-up|2|||
170345106|NCT02275026|615601514|FG000|Overall Study|Scanner failure|1|||
170345107|NCT01165203|615601515|FG000|Active Phase|Serious Adverse Event|1|||
170345108|NCT01165203|615601516|FG001|Active Phase|Serious Adverse Event|0|||
170345109|NCT01165203|615601515|FG000|Active Phase|Withdrawal by Subject|2|||
170345110|NCT01165203|615601516|FG001|Active Phase|Withdrawal by Subject|1|||
170345111|NCT01165203|615601515|FG000|Active Phase|Migrated/moved from study area|0|||
170345112|NCT01165203|615601516|FG001|Active Phase|Migrated/moved from study area|1|||
170345113|NCT01165203|615601515|FG000|Active Phase|Lost to Follow-up|2|||
170345114|NCT01165203|615601516|FG001|Active Phase|Lost to Follow-up|0|||
170345115|NCT01165203|615601515|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
170345116|NCT01165203|615601516|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
170345117|NCT01165203|615601515|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
170345118|NCT01165203|615601516|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
170345119|NCT01165203|615601515|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
170345120|NCT01165203|615601516|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
170345121|NCT01165203|615601515|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
170345122|NCT01165203|615601516|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
170345123|NCT01165203|615601515|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
170345124|NCT01165203|615601516|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
170345125|NCT00374907|615601517|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
170345126|NCT00374907|615601518|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
170345127|NCT00374907|615601517|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
170345128|NCT00374907|615601518|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
170345129|NCT00374907|615601517|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
170345130|NCT00374907|615601518|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
170345131|NCT00374907|615601517|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
170345132|NCT00374907|615601518|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
170345133|NCT00374907|615601517|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
170345134|NCT00374907|615601518|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
170345135|NCT01605396|615601519|FG000|Overall Study|Adverse Event|5|||
170345136|NCT01605396|615601520|FG001|Overall Study|Adverse Event|3|||
170345137|NCT01605396|615601519|FG000|Overall Study|Lost to Follow-up|1|||
170345138|NCT01605396|615601520|FG001|Overall Study|Lost to Follow-up|0|||
170345139|NCT01605396|615601519|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170345140|NCT01605396|615601520|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170345141|NCT01605396|615601519|FG000|Overall Study|Physician Decision|2|||
170345142|NCT01605396|615601520|FG001|Overall Study|Physician Decision|2|||
170345143|NCT01605396|615601519|FG000|Overall Study|Progressive Disease|23|||
170345144|NCT01605396|615601520|FG001|Overall Study|Progressive Disease|27|||
170345145|NCT01605396|615601519|FG000|Overall Study|Withdrawal by Subject|4|||
170345146|NCT01605396|615601520|FG001|Overall Study|Withdrawal by Subject|2|||
170345147|NCT01605396|615601519|FG000|Overall Study|Transfer Off Study|4|||
170345148|NCT01605396|615601520|FG001|Overall Study|Transfer Off Study|5|||
170345149|NCT00878072|615601523|FG000|Overall Study|Withdrew consent|2|||
170345150|NCT00237796|615601531|FG000|Overall Study|Baseline and one other ILSS required|10|||
170345151|NCT00237796|615601532|FG001|Overall Study|Baseline and one other ILSS required|5|||
170345152|NCT04160468|615601535|FG000|Overall Study|Lost to Follow-up|19|||
170345153|NCT04160468|615601536|FG001|Overall Study|Lost to Follow-up|4|||
170345154|NCT04160468|615601535|FG000|Overall Study|Randomized but not dosed|6|||
170345155|NCT04160468|615601536|FG001|Overall Study|Randomized but not dosed|0|||
170345156|NCT04160468|615601535|FG000|Overall Study|Withdrawal by Subject|4|||
170345157|NCT04160468|615601536|FG001|Overall Study|Withdrawal by Subject|1|||
170345158|NCT04160468|615601535|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
170345159|NCT04160468|615601536|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
170345160|NCT04160468|615601535|FG000|Overall Study|Participant incarcerated|1|||
170345161|NCT04160468|615601536|FG001|Overall Study|Participant incarcerated|0|||
170345162|NCT04430582|615601542|FG000|Overall Study|Found to meet exclusionary criteria|1|||
170345163|NCT04430582|615601543|FG001|Overall Study|Found to meet exclusionary criteria|0|||
170345164|NCT04430582|615601542|FG000|Overall Study|Withdrawal by Subject|0|||
170345165|NCT04430582|615601543|FG001|Overall Study|Withdrawal by Subject|1|||
170345166|NCT05128162|615601544|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
170345167|NCT05128162|615601544|FG000|Overall Study|Physician Decision|1|||
170345168|NCT02410902|615603011|FG000|Overall Study|Adverse Event|2|||
170345169|NCT02410902|615603012|FG001|Overall Study|Adverse Event|3|||
170345170|NCT02410902|615603011|FG000|Overall Study|Lost to Follow-up|4|||
170345171|NCT02410902|615603012|FG001|Overall Study|Lost to Follow-up|1|||
170345172|NCT02410902|615603011|FG000|Overall Study|Protocol Violation|1|||
170345173|NCT02410902|615603012|FG001|Overall Study|Protocol Violation|4|||
170345174|NCT02410902|615603011|FG000|Overall Study|Withdrawal by Subject|6|||
170345175|NCT02410902|615603012|FG001|Overall Study|Withdrawal by Subject|8|||
170345176|NCT02410902|615603011|FG000|Overall Study|Non-Compliance|8|||
170345177|NCT02410902|615603012|FG001|Overall Study|Non-Compliance|2|||
170345178|NCT00074412|615603013|FG000|Overall Study|Death|30|||
170345179|NCT00074412|615603014|FG001|Overall Study|Death|26|||
170345180|NCT00074412|615603013|FG000|Overall Study|Lost to Follow-up|52|||
170345181|NCT00074412|615603014|FG001|Overall Study|Lost to Follow-up|58|||
170345182|NCT03488472|615603015|FG000|Overall Study|disease progression additional mets|1|||
170345183|NCT01881620|615603018|FG000|Overall Study|Protocol Violation|4|||
170345184|NCT03331666|615603019|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
170345185|NCT03331666|615603020|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
170345186|NCT02326467|615603021|FG000|Overall Study|Withdrawal by Subject|1|||
170345187|NCT00643487|615603027|FG000|Overall Study|Technical difficulty|3|||
170345188|NCT00972478|615603028|FG000|Overall Study|Adverse Event|3|||
170345189|NCT00972478|615603029|FG001|Overall Study|Adverse Event|16|||
170345190|NCT00972478|615603028|FG000|Overall Study|Withdrawal by Subject|1|||
170345191|NCT00972478|615603029|FG001|Overall Study|Withdrawal by Subject|8|||
170345192|NCT00972478|615603028|FG000|Overall Study|Progression/Relapse|0|||
170345193|NCT00972478|615603029|FG001|Overall Study|Progression/Relapse|2|||
170345194|NCT00972478|615603028|FG000|Overall Study|Death|0|||
170345195|NCT00972478|615603029|FG001|Overall Study|Death|2|||
170345196|NCT00972478|615603028|FG000|Overall Study|Not protocol specified|1|||
170345197|NCT00972478|615603029|FG001|Overall Study|Not protocol specified|1|||
170345198|NCT00972478|615603028|FG000|Overall Study|Ineligible|1|||
170345199|NCT00972478|615603029|FG001|Overall Study|Ineligible|7|||
170345200|NCT00972478|615603028|FG000|Overall Study|Not start protocol treatment|1|||
170345201|NCT00972478|615603029|FG001|Overall Study|Not start protocol treatment|2|||
170345202|NCT00637273|615603036|FG000|Overall Study|Adverse Event|11|||
170345203|NCT00637273|615603037|FG001|Overall Study|Adverse Event|5|||
170345204|NCT00637273|615603038|FG002|Overall Study|Adverse Event|7|||
170345205|NCT00637273|615603036|FG000|Overall Study|Lost to Follow-up|8|||
170345206|NCT00637273|615603037|FG001|Overall Study|Lost to Follow-up|9|||
170345207|NCT00637273|615603038|FG002|Overall Study|Lost to Follow-up|13|||
170345208|NCT00637273|615603036|FG000|Overall Study|Protocol Violation|2|||
170345209|NCT00637273|615603037|FG001|Overall Study|Protocol Violation|4|||
170345210|NCT00637273|615603038|FG002|Overall Study|Protocol Violation|1|||
170345211|NCT00637273|615603036|FG000|Overall Study|Withdrawal of Consent|18|||
170345212|NCT00637273|615603037|FG001|Overall Study|Withdrawal of Consent|6|||
170345213|NCT00637273|615603038|FG002|Overall Study|Withdrawal of Consent|18|||
170345214|NCT00637273|615603036|FG000|Overall Study|Investigator Decision|1|||
170345215|NCT00637273|615603037|FG001|Overall Study|Investigator Decision|3|||
170345216|NCT00637273|615603038|FG002|Overall Study|Investigator Decision|1|||
170345217|NCT00637273|615603036|FG000|Overall Study|Administrative|2|||
170345218|NCT00637273|615603037|FG001|Overall Study|Administrative|0|||
170345219|NCT00637273|615603038|FG002|Overall Study|Administrative|0|||
170345220|NCT00637273|615603036|FG000|Overall Study|Loss of Glucose Control|1|||
170345221|NCT00637273|615603037|FG001|Overall Study|Loss of Glucose Control|1|||
170345222|NCT00637273|615603038|FG002|Overall Study|Loss of Glucose Control|1|||
170345223|NCT02575079|615603043|FG000|Overall Study|Death|3|||
170345224|NCT02575079|615603044|FG001|Overall Study|Death|0|||
170345225|NCT02575079|615603043|FG000|Overall Study|Withdrawal by Subject|3|||
170345226|NCT02575079|615603044|FG001|Overall Study|Withdrawal by Subject|0|||
170345227|NCT00788775|615603047|FG000|Overall Study|Progressive Disease|8|||
170345228|NCT00788775|615603048|FG001|Overall Study|Progressive Disease|6|||
170345229|NCT00788775|615603047|FG000|Overall Study|Withdrawal by Subject|0|||
170345230|NCT00788775|615603048|FG001|Overall Study|Withdrawal by Subject|2|||
170345231|NCT00788775|615603047|FG000|Overall Study|Patient Non-Compliance|1|||
170345232|NCT00788775|615603048|FG001|Overall Study|Patient Non-Compliance|0|||
170345233|NCT00788775|615603047|FG000|Overall Study|Patient's measurable disease resected.|1|||
170345234|NCT00788775|615603048|FG001|Overall Study|Patient's measurable disease resected.|0|||
170345235|NCT01293032|615603049|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
170345236|NCT01293032|615603050|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
170345237|NCT01293032|615603051|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
170345238|NCT01293032|615603052|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
170345239|NCT01293032|615603049|FG000|Treatment|Adverse Event|0|||
170345240|NCT01293032|615603050|FG001|Treatment|Adverse Event|0|||
170345241|NCT01293032|615603051|FG002|Treatment|Adverse Event|1|||
170345242|NCT01293032|615603052|FG003|Treatment|Adverse Event|1|||
170345243|NCT01293032|615603049|FG000|Treatment|Withdrawal by Subject|2|||
170345244|NCT01293032|615603050|FG001|Treatment|Withdrawal by Subject|4|||
170345245|NCT01293032|615603051|FG002|Treatment|Withdrawal by Subject|0|||
170345246|NCT01293032|615603052|FG003|Treatment|Withdrawal by Subject|0|||
170345247|NCT01293032|615603049|FG000|Treatment|Disease Progression, relapse|0|||
170345248|NCT01293032|615603050|FG001|Treatment|Disease Progression, relapse|1|||
170345249|NCT01293032|615603051|FG002|Treatment|Disease Progression, relapse|0|||
170345250|NCT01293032|615603052|FG003|Treatment|Disease Progression, relapse|0|||
170345251|NCT01087528|615603055|FG000|Overall Study|Withdrawal by Subject|1|||
170345252|NCT01087528|615603055|FG000|Overall Study|Incomplete CE procedure|6|||
170345253|NCT03116399|615603056|FG000|Overall Study|Death|8|||
170345254|NCT03116399|615603057|FG001|Overall Study|Death|3|||
170345255|NCT03116399|615603056|FG000|Overall Study|Lost to Follow-up|7|||
170345256|NCT03116399|615603057|FG001|Overall Study|Lost to Follow-up|11|||
170345257|NCT03116399|615603056|FG000|Overall Study|Investigator Decision|1|||
170345258|NCT03116399|615603057|FG001|Overall Study|Investigator Decision|1|||
170345259|NCT03116399|615603056|FG000|Overall Study|Withdrawal by Subject|24|||
170345260|NCT03116399|615603057|FG001|Overall Study|Withdrawal by Subject|9|||
170345261|NCT02868216|615603059|FG000|Overall Study|Death|0|||
170345262|NCT02868216|615603060|FG001|Overall Study|Death|1|||
170345263|NCT02868216|615603059|FG000|Overall Study|coronary artery bypass|1|||
170345264|NCT02868216|615603060|FG001|Overall Study|coronary artery bypass|0|||
170345265|NCT02868216|615603059|FG000|Overall Study|Withdrawal by Subject|7|||
170345266|NCT02868216|615603060|FG001|Overall Study|Withdrawal by Subject|5|||
170345267|NCT00987623|615603061|FG000|Overall Study|Lost to Follow-up|2|||
170345268|NCT00987623|615603062|FG001|Overall Study|Lost to Follow-up|1|||
170345269|NCT00987623|615603061|FG000|Overall Study|Time/job conflict|2|||
170345270|NCT00987623|615603062|FG001|Overall Study|Time/job conflict|0|||
170345271|NCT00987623|615603061|FG000|Overall Study|Discomfort|1|||
170345272|NCT00987623|615603062|FG001|Overall Study|Discomfort|0|||
170345273|NCT00987623|615603061|FG000|Overall Study|Biomicroscopy|0|||
170345274|NCT00987623|615603062|FG001|Overall Study|Biomicroscopy|1|||
170345275|NCT00987623|615603061|FG000|Overall Study|Influenza|0|||
170345276|NCT00987623|615603062|FG001|Overall Study|Influenza|1|||
170345277|NCT00938327|615603067|FG000|Overall Study|Adverse Event|2|||
170345278|NCT00938327|615603067|FG000|Overall Study|Protocol Violation|1|||
170345279|NCT00938327|615603067|FG000|Overall Study|Withdrawal by Subject|4|||
170345280|NCT00938327|615603067|FG000|Overall Study|Lost to Follow-up|37|||
170345281|NCT00938327|615603067|FG000|Overall Study|2nd dose received outside of the study|7|||
170345282|NCT00938327|615603067|FG000|Overall Study|Vaccine not received as out of stock|9|||
170345283|NCT01425190|615603068|FG000|Overall Study|Full dose not consumed.|1|||
170345284|NCT01425190|615603069|FG001|Overall Study|Full dose not consumed.|0|||
170345285|NCT01425190|615603070|FG002|Overall Study|Full dose not consumed.|0|||
170345286|NCT00195260|615603075|FG000|Part 1: Dose Escalation|Adverse Event|0|||
170345287|NCT00195260|615603076|FG001|Part 1: Dose Escalation|Adverse Event|1|||
170345288|NCT00195260|615603077|FG002|Part 1: Dose Escalation|Adverse Event|0|||
170345289|NCT00195260|615603078|FG003|Part 1: Dose Escalation|Adverse Event|1|||
170345290|NCT00195260|615603079|FG004|Part 1: Dose Escalation|Adverse Event|1|||
170345291|NCT00195260|615603080|FG005|Part 1: Dose Escalation|Adverse Event|0|||
170345292|NCT00195260|615603081|FG006|Part 1: Dose Escalation|Adverse Event|3|||
170345293|NCT00195260|615603082|FG007|Part 1: Dose Escalation|Adverse Event|0|||
170345294|NCT00195260|615603083|FG008|Part 1: Dose Escalation|Adverse Event|0|||
170345295|NCT00195260|615603084|FG009|Part 1: Dose Escalation|Adverse Event|0|||
170345296|NCT00195260|615603085|FG010|Part 1: Dose Escalation|Adverse Event|0|||
170345297|NCT00195260|615603075|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345298|NCT00195260|615603076|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345299|NCT00195260|615603077|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345300|NCT00195260|615603078|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345301|NCT00195260|615603079|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
170345302|NCT00195260|615603080|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345303|NCT00195260|615603081|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345304|NCT00195260|615603082|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
170345305|NCT00195260|615603083|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345306|NCT00195260|615603084|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345307|NCT00195260|615603085|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
170345308|NCT00195260|615603075|FG000|Part 1: Dose Escalation|Death|0|||
170345309|NCT00195260|615603076|FG001|Part 1: Dose Escalation|Death|0|||
170345310|NCT00195260|615603077|FG002|Part 1: Dose Escalation|Death|0|||
170345311|NCT00195260|615603078|FG003|Part 1: Dose Escalation|Death|0|||
170345312|NCT00195260|615603079|FG004|Part 1: Dose Escalation|Death|0|||
170345313|NCT00195260|615603080|FG005|Part 1: Dose Escalation|Death|0|||
170345314|NCT00195260|615603081|FG006|Part 1: Dose Escalation|Death|0|||
170345315|NCT00195260|615603082|FG007|Part 1: Dose Escalation|Death|1|||
170345316|NCT00195260|615603083|FG008|Part 1: Dose Escalation|Death|0|||
170345317|NCT00195260|615603084|FG009|Part 1: Dose Escalation|Death|0|||
170345318|NCT00195260|615603085|FG010|Part 1: Dose Escalation|Death|0|||
170345319|NCT00195260|615603075|FG000|Part 1: Dose Escalation|Disease Progression|3|||
170345320|NCT00195260|615603076|FG001|Part 1: Dose Escalation|Disease Progression|2|||
170345321|NCT00195260|615603077|FG002|Part 1: Dose Escalation|Disease Progression|5|||
170345322|NCT00195260|615603078|FG003|Part 1: Dose Escalation|Disease Progression|6|||
170345323|NCT00195260|615603079|FG004|Part 1: Dose Escalation|Disease Progression|4|||
170345324|NCT00195260|615603080|FG005|Part 1: Dose Escalation|Disease Progression|6|||
170345325|NCT00195260|615603081|FG006|Part 1: Dose Escalation|Disease Progression|7|||
170345326|NCT00195260|615603082|FG007|Part 1: Dose Escalation|Disease Progression|4|||
170345327|NCT00195260|615603083|FG008|Part 1: Dose Escalation|Disease Progression|0|||
170345328|NCT00195260|615603084|FG009|Part 1: Dose Escalation|Disease Progression|0|||
170345329|NCT00195260|615603085|FG010|Part 1: Dose Escalation|Disease Progression|0|||
170345330|NCT00195260|615603075|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
170345331|NCT00195260|615603076|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
170345332|NCT00195260|615603077|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
170345333|NCT00195260|615603078|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
170345334|NCT00195260|615603079|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
170345335|NCT00195260|615603080|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
170345336|NCT00195260|615603081|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
170345337|NCT00195260|615603082|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
170345338|NCT00195260|615603083|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
170345339|NCT00195260|615603084|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
170345340|NCT00195260|615603085|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
170345341|NCT00195260|615603075|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
170345342|NCT00195260|615603076|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
170345343|NCT00195260|615603077|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
170345344|NCT00195260|615603078|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
170345345|NCT00195260|615603079|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
170345346|NCT00195260|615603080|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
170345347|NCT00195260|615603081|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
170345348|NCT00195260|615603082|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
170345349|NCT00195260|615603083|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
170345350|NCT00195260|615603084|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
170345351|NCT00195260|615603085|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
170345352|NCT00195260|615603075|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
170345353|NCT00195260|615603076|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
170345354|NCT00195260|615603077|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
170345355|NCT00195260|615603078|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
170345356|NCT00195260|615603079|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
170345357|NCT00195260|615603080|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
170345358|NCT00195260|615603081|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
170345359|NCT00195260|615603082|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
170345360|NCT00195260|615603083|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
170345361|NCT00195260|615603084|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
170345362|NCT00195260|615603085|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
170345363|NCT00195260|615603075|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
170345364|NCT00195260|615603076|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
170345365|NCT00195260|615603077|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
170345366|NCT00195260|615603078|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
170345367|NCT00195260|615603079|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
170345368|NCT00195260|615603080|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
170345369|NCT00195260|615603081|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
170345370|NCT00195260|615603082|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
170345371|NCT00195260|615603083|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
170345372|NCT00195260|615603084|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
170345373|NCT00195260|615603085|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
170345374|NCT00195260|615603075|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
170345375|NCT00195260|615603076|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
170345376|NCT00195260|615603077|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
170345377|NCT00195260|615603078|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
170345378|NCT00195260|615603079|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
170345379|NCT00195260|615603080|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
170345380|NCT00195260|615603081|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
170345381|NCT00195260|615603082|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
170345382|NCT00195260|615603083|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
170345383|NCT00195260|615603084|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
170345384|NCT00195260|615603085|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
170345385|NCT02749721|615603086|FG000|Screening|Withdrawal by Subject|1|||
170345386|NCT02749721|615603086|FG000|Screening|Lost to Follow-up|2|||
170345387|NCT02749721|615603086|FG000|Screening|Protocol Violation|3|||
170345388|NCT02749721|615603086|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
170345389|NCT02749721|615603086|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
170345390|NCT02552355|615603087|FG000|Overall Study|Adverse Event|0|||
170345391|NCT02552355|615603088|FG001|Overall Study|Adverse Event|2|||
170345392|NCT02552355|615603089|FG002|Overall Study|Adverse Event|2|||
170345393|NCT02552355|615603090|FG003|Overall Study|Adverse Event|0|||
170345394|NCT02552355|615603087|FG000|Overall Study|Withdrawal by Subject|0|||
170345395|NCT02552355|615603088|FG001|Overall Study|Withdrawal by Subject|0|||
170345396|NCT02552355|615603089|FG002|Overall Study|Withdrawal by Subject|0|||
170345397|NCT02552355|615603090|FG003|Overall Study|Withdrawal by Subject|1|||
170345398|NCT04333433|615603091|FG000|Overall Study|Withdrawal by Subject|6|||
170345399|NCT04333433|615603092|FG001|Overall Study|Withdrawal by Subject|3|||
170345400|NCT04333433|615603091|FG000|Overall Study|Death|3|||
170345401|NCT04333433|615603092|FG001|Overall Study|Death|0|||
170345402|NCT04333433|615603091|FG000|Overall Study|Lost to Follow-up|6|||
170345403|NCT04333433|615603092|FG001|Overall Study|Lost to Follow-up|1|||
170345404|NCT04333433|615603091|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
170345405|NCT04333433|615603092|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
170345406|NCT02026271|615603093|FG000|Overall Study|Adverse Event|2|||
170345407|NCT02026271|615603094|FG001|Overall Study|Adverse Event|3|||
170345408|NCT02026271|615603095|FG002|Overall Study|Adverse Event|2|||
170345409|NCT02026271|615603096|FG003|Overall Study|Adverse Event|3|||
170345410|NCT02026271|615603097|FG004|Overall Study|Adverse Event|0|||
170345411|NCT02026271|615603093|FG000|Overall Study|Withdrawal by Subject|0|||
170345412|NCT02026271|615603094|FG001|Overall Study|Withdrawal by Subject|0|||
170345413|NCT02026271|615603095|FG002|Overall Study|Withdrawal by Subject|0|||
170345414|NCT02026271|615603096|FG003|Overall Study|Withdrawal by Subject|0|||
170345415|NCT02026271|615603097|FG004|Overall Study|Withdrawal by Subject|1|||
170345416|NCT02807454|615603098|FG000|Overall Study|Adverse Event|1|||
170345417|NCT02807454|615603099|FG001|Overall Study|Adverse Event|0|||
170345418|NCT02807454|615603098|FG000|Overall Study|Withdrawal by Subject|0|||
170345419|NCT02807454|615603099|FG001|Overall Study|Withdrawal by Subject|1|||
170345420|NCT02807454|615603098|FG000|Overall Study|Progressive Disease|30|||
170345421|NCT02807454|615603099|FG001|Overall Study|Progressive Disease|3|||
170345422|NCT02807454|615603098|FG000|Overall Study|Other Reasons|1|||
170345423|NCT02807454|615603099|FG001|Overall Study|Other Reasons|1|||
170345424|NCT05468086|615603102|FG000|Overall Study|Withdrawal by Subject|3|||
170345425|NCT05468086|615603102|FG000|Overall Study|Subject was found ineligible after consent|1|||
170345426|NCT00085540|615603112|FG000|Overall Study|Withdrawal by Subject|0|||
170345427|NCT00085540|615603113|FG001|Overall Study|Withdrawal by Subject|1|||
170345428|NCT00085540|615603112|FG000|Overall Study|Protocol Violation|0|||
170345429|NCT00085540|615603113|FG001|Overall Study|Protocol Violation|1|||
170345430|NCT00001262|615603116|FG000|Overall Study|Death|10|||
170345431|NCT00001262|615603117|FG001|Overall Study|Death|11|||
170345432|NCT00001262|615603118|FG002|Overall Study|Death|0|||
170345433|NCT00001262|615603116|FG000|Overall Study|Withdrawal by Subject|0|||
170345434|NCT00001262|615603117|FG001|Overall Study|Withdrawal by Subject|3|||
170345435|NCT00001262|615603118|FG002|Overall Study|Withdrawal by Subject|0|||
170345436|NCT00783705|615603120|FG000|Overall Study|Adverse Event|2|||
170345437|NCT00783705|615603121|FG001|Overall Study|Adverse Event|0|||
170345438|NCT00783705|615603120|FG000|Overall Study|Withdrawal by Subject|3|||
170345439|NCT00783705|615603121|FG001|Overall Study|Withdrawal by Subject|2|||
170345440|NCT00783705|615603120|FG000|Overall Study|Lost to Follow-up|1|||
170345441|NCT00783705|615603121|FG001|Overall Study|Lost to Follow-up|3|||
170345442|NCT02379923|615603122|FG000|Overall Study|Death|5|||
170345443|NCT01193348|615603126|FG000|Screening Period|Screen Failure|5|||
170345444|NCT01193348|615603126|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
170345445|NCT01193348|615603126|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
170345446|NCT01193348|615603126|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
170345447|NCT01193348|615603126|FG000|Extension Treatment Period|Physician Decision|1|||
170345448|NCT01193348|615603126|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
170345449|NCT01721408|615603127|FG000|Overall Study|Adverse Event|6|||
170345450|NCT01721408|615603128|FG001|Overall Study|Adverse Event|1|||
170345451|NCT01721408|615603127|FG000|Overall Study|Death|1|||
170345452|NCT01721408|615603128|FG001|Overall Study|Death|0|||
170345453|NCT01721408|615603127|FG000|Overall Study|Insufficient clinical response|15|||
170345454|NCT01721408|615603128|FG001|Overall Study|Insufficient clinical response|6|||
170345455|NCT01721408|615603127|FG000|Overall Study|No longer willing to participate study|9|||
170345456|NCT01721408|615603128|FG001|Overall Study|No longer willing to participate study|10|||
170345457|NCT01721408|615603127|FG000|Overall Study|Protocol Violation|0|||
170345458|NCT01721408|615603128|FG001|Overall Study|Protocol Violation|2|||
170345459|NCT01721408|615603127|FG000|Overall Study|Other|3|||
170345460|NCT01721408|615603128|FG001|Overall Study|Other|3|||
170345461|NCT01721408|615603127|FG000|Overall Study|Lost to Follow-up|1|||
170345462|NCT01721408|615603128|FG001|Overall Study|Lost to Follow-up|2|||
170345463|NCT01721408|615603127|FG000|Overall Study|Does not meet entrance criteria|1|||
170345464|NCT01721408|615603128|FG001|Overall Study|Does not meet entrance criteria|0|||
170345465|NCT01402284|615603131|FG000|Overall Study|Withdrawal consent|2|||
170345466|NCT01402284|615603131|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
170345467|NCT01402284|615603131|FG000|Overall Study|Physician Decision|1|||
170345468|NCT01402284|615603131|FG000|Overall Study|Disease progression on study|10|||
170345469|NCT01678807|615603133|FG000|Overall Study|Adverse Event|4|||
170345470|NCT01678807|615603134|FG001|Overall Study|Adverse Event|4|||
170345471|NCT01678807|615603135|FG002|Overall Study|Adverse Event|0|||
170345472|NCT01678807|615603133|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
170345473|NCT01678807|615603134|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
170345474|NCT01678807|615603135|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
170345475|NCT01064648|615603136|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
170345476|NCT01064648|615603137|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
170345477|NCT01064648|615603138|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
170345478|NCT01064648|615603139|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
170345479|NCT01064648|615603136|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
170345480|NCT01064648|615603137|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
170345481|NCT01064648|615603138|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
170345482|NCT01064648|615603139|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
170345483|NCT01064648|615603136|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
170345484|NCT01064648|615603137|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
170345485|NCT01064648|615603138|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
170345486|NCT01064648|615603139|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
170345487|NCT01064648|615603136|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
170345488|NCT01064648|615603137|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
170345489|NCT01064648|615603138|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
170345490|NCT01064648|615603139|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
170345491|NCT01064648|615603136|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
170345492|NCT01064648|615603137|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
170345493|NCT01064648|615603138|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
170345494|NCT01064648|615603139|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
170345495|NCT01064648|615603136|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
170345496|NCT01064648|615603137|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
170345497|NCT01064648|615603138|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
170345498|NCT01064648|615603139|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
170345499|NCT01064648|615603136|FG000|Phase II|Adverse Event|0|||
170345500|NCT01064648|615603137|FG001|Phase II|Adverse Event|0|||
170345501|NCT01064648|615603138|FG002|Phase II|Adverse Event|15|||
170345502|NCT01064648|615603139|FG003|Phase II|Adverse Event|8|||
170345503|NCT01064648|615603136|FG000|Phase II|Death|0|||
170345504|NCT01064648|615603137|FG001|Phase II|Death|0|||
170345505|NCT01064648|615603138|FG002|Phase II|Death|4|||
170345506|NCT01064648|615603139|FG003|Phase II|Death|5|||
170345507|NCT01064648|615603136|FG000|Phase II|Withdrawal by Subject|0|||
170345508|NCT01064648|615603137|FG001|Phase II|Withdrawal by Subject|0|||
170345509|NCT01064648|615603138|FG002|Phase II|Withdrawal by Subject|2|||
170345510|NCT01064648|615603139|FG003|Phase II|Withdrawal by Subject|5|||
170345511|NCT01064648|615603136|FG000|Phase II|Progression|0|||
170345512|NCT01064648|615603137|FG001|Phase II|Progression|0|||
170345513|NCT01064648|615603138|FG002|Phase II|Progression|21|||
170345514|NCT01064648|615603139|FG003|Phase II|Progression|27|||
170345515|NCT01064648|615603136|FG000|Phase II|Non-protocol specified|0|||
170345516|NCT01064648|615603137|FG001|Phase II|Non-protocol specified|0|||
170345517|NCT01064648|615603138|FG002|Phase II|Non-protocol specified|5|||
170345518|NCT01064648|615603139|FG003|Phase II|Non-protocol specified|3|||
170345519|NCT01064648|615603136|FG000|Phase II|Under Review|0|||
170345520|NCT01064648|615603137|FG001|Phase II|Under Review|0|||
170345521|NCT01064648|615603138|FG002|Phase II|Under Review|2|||
170345522|NCT01064648|615603139|FG003|Phase II|Under Review|0|||
170345523|NCT03607682|615603140|FG000|Overall Study|Withdrawal by Subject|1|||
170345524|NCT03607682|615603140|FG000|Overall Study|Disease progression|1|||
170345525|NCT01770353|615603141|FG000|Overall Study|Progressive disease|2|||
170345526|NCT01770353|615603142|FG001|Overall Study|Progressive disease|1|||
170345527|NCT01770353|615603141|FG000|Overall Study|Adverse Event|0|||
170345528|NCT01770353|615603142|FG001|Overall Study|Adverse Event|1|||
170345529|NCT01770353|615603141|FG000|Overall Study|Protocol Violation|1|||
170345530|NCT01770353|615603142|FG001|Overall Study|Protocol Violation|0|||
170345531|NCT01770353|615603141|FG000|Overall Study|Physician Decision|0|||
170345532|NCT01770353|615603142|FG001|Overall Study|Physician Decision|3|||
170345533|NCT01770353|615603141|FG000|Overall Study|Clinical deterioration|3|||
170345534|NCT01770353|615603142|FG001|Overall Study|Clinical deterioration|6|||
170345535|NCT01770353|615603141|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
170345536|NCT01770353|615603142|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
170345537|NCT05281523|615603143|FG000|Overall Study|Adverse Event|1|||
170345538|NCT05281523|615603144|FG001|Overall Study|Adverse Event|1|||
170345539|NCT05281523|615603143|FG000|Overall Study|Physician Decision|1|||
170345540|NCT05281523|615603144|FG001|Overall Study|Physician Decision|1|||
170345541|NCT05281523|615603143|FG000|Overall Study|Withdrawal by Subject|5|||
170345542|NCT05281523|615603144|FG001|Overall Study|Withdrawal by Subject|15|||
170345543|NCT05281523|615603143|FG000|Overall Study|GCP violations|3|||
170345544|NCT05281523|615603144|FG001|Overall Study|GCP violations|4|||
170345545|NCT02574312|615603145|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
170345546|NCT02574312|615603146|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
170345547|NCT05183867|615604242|FG000|Overall Study|Withdrawal by Subject|3|||
170345548|NCT05183867|615604243|FG001|Overall Study|Withdrawal by Subject|2|||
170345549|NCT05183867|615604244|FG002|Overall Study|Withdrawal by Subject|0|||
170345550|NCT03987919|615604247|FG000|Overall Study|Adverse Event|1|||
170345551|NCT03987919|615604248|FG001|Overall Study|Adverse Event|4|||
170345552|NCT03987919|615604249|FG002|Overall Study|Adverse Event|1|||
170345553|NCT03987919|615604250|FG003|Overall Study|Adverse Event|3|||
170345554|NCT03987919|615604247|FG000|Overall Study|Death|4|||
170345555|NCT03987919|615604248|FG001|Overall Study|Death|4|||
170345556|NCT03987919|615604249|FG002|Overall Study|Death|4|||
170345557|NCT03987919|615604250|FG003|Overall Study|Death|1|||
170345558|NCT03987919|615604247|FG000|Overall Study|Lost to Follow-up|5|||
170345559|NCT03987919|615604248|FG001|Overall Study|Lost to Follow-up|6|||
170345560|NCT03987919|615604249|FG002|Overall Study|Lost to Follow-up|8|||
170345561|NCT03987919|615604250|FG003|Overall Study|Lost to Follow-up|12|||
170345562|NCT03987919|615604247|FG000|Overall Study|Physician Decision|0|||
170345563|NCT03987919|615604248|FG001|Overall Study|Physician Decision|2|||
170345564|NCT03987919|615604249|FG002|Overall Study|Physician Decision|0|||
170345565|NCT03987919|615604250|FG003|Overall Study|Physician Decision|4|||
170345566|NCT03987919|615604247|FG000|Overall Study|Pregnancy|1|||
170345567|NCT03987919|615604248|FG001|Overall Study|Pregnancy|0|||
170345568|NCT03987919|615604249|FG002|Overall Study|Pregnancy|1|||
170345569|NCT03987919|615604250|FG003|Overall Study|Pregnancy|1|||
170345570|NCT03987919|615604247|FG000|Overall Study|Protocol Violation|0|||
170345571|NCT03987919|615604248|FG001|Overall Study|Protocol Violation|1|||
170345572|NCT03987919|615604249|FG002|Overall Study|Protocol Violation|0|||
170345573|NCT03987919|615604250|FG003|Overall Study|Protocol Violation|0|||
170345574|NCT03987919|615604247|FG000|Overall Study|Site terminated by Sponsor|0|||
170345575|NCT03987919|615604248|FG001|Overall Study|Site terminated by Sponsor|0|||
170345576|NCT03987919|615604249|FG002|Overall Study|Site terminated by Sponsor|0|||
170345577|NCT03987919|615604250|FG003|Overall Study|Site terminated by Sponsor|1|||
170345578|NCT03987919|615604247|FG000|Overall Study|Withdrawal by Subject|7|||
170345579|NCT03987919|615604248|FG001|Overall Study|Withdrawal by Subject|7|||
170345580|NCT03987919|615604249|FG002|Overall Study|Withdrawal by Subject|8|||
170345581|NCT03987919|615604250|FG003|Overall Study|Withdrawal by Subject|4|||
170345582|NCT03987919|615604247|FG000|Overall Study|Other - as reported by the investigator|1|||
170345583|NCT03987919|615604248|FG001|Overall Study|Other - as reported by the investigator|3|||
170345584|NCT03987919|615604249|FG002|Overall Study|Other - as reported by the investigator|2|||
170345585|NCT03987919|615604250|FG003|Overall Study|Other - as reported by the investigator|0|||
170345586|NCT05137041|615604253|FG000|Overall Study|Lost to Follow-up|1|||
170345587|NCT05137041|615604254|FG001|Overall Study|Lost to Follow-up|1|||
170345588|NCT05137041|615604253|FG000|Overall Study|Withdrawal by Subject|0|||
170345589|NCT05137041|615604254|FG001|Overall Study|Withdrawal by Subject|2|||
170345590|NCT05137041|615604253|FG000|Overall Study|Reason not Specified|0|||
170345591|NCT05137041|615604254|FG001|Overall Study|Reason not Specified|1|||
170345592|NCT02433210|615604255|FG000|Overall Study|Physician Decision|1|||
170345593|NCT02433210|615604256|FG001|Overall Study|Physician Decision|0|||
170345594|NCT02433210|615604257|FG002|Overall Study|Physician Decision|0|||
170345595|NCT00392171|615604258|FG000|Overall Study|Did not meet inclusion criteria|4|||
170345596|NCT00392171|615604258|FG000|Overall Study|Disease progression|101|||
170345597|NCT00028002|615604259|FG000|Overall Study|Withdrawal by Subject|3|||
170345598|NCT00028002|615604259|FG000|Overall Study|Ineligible|8|||
170345599|NCT01328249|615604260|FG000|Overall Study|Adverse Event|3|||
170345600|NCT01328249|615604261|FG001|Overall Study|Adverse Event|0|||
170345601|NCT01328249|615604260|FG000|Overall Study|Disease progression|1|||
170345602|NCT01328249|615604261|FG001|Overall Study|Disease progression|0|||
170345603|NCT01328249|615604260|FG000|Overall Study|Withdrawal by Subject|1|||
170345604|NCT01328249|615604261|FG001|Overall Study|Withdrawal by Subject|1|||
170345605|NCT01328249|615604260|FG000|Overall Study|Moved before end of treatment visit|1|||
170345606|NCT01328249|615604261|FG001|Overall Study|Moved before end of treatment visit|0|||
170345607|NCT01328249|615604260|FG000|Overall Study|Subject choice|1|||
170345608|NCT01328249|615604261|FG001|Overall Study|Subject choice|1|||
170345609|NCT01328249|615604260|FG000|Overall Study|Protocol Violation|0|||
170345610|NCT01328249|615604261|FG001|Overall Study|Protocol Violation|1|||
170345611|NCT00748553|615604262|FG000|Overall Study|Adverse Event|0|||
170345612|NCT00748553|615604263|FG001|Overall Study|Adverse Event|1|||
170345613|NCT00748553|615604262|FG000|Overall Study|disease progression|2|||
170345614|NCT00748553|615604263|FG001|Overall Study|disease progression|0|||
170345615|NCT00748553|615604262|FG000|Overall Study|noncompliance|1|||
170345616|NCT00748553|615604263|FG001|Overall Study|noncompliance|0|||
170345617|NCT00745368|615604264|FG000|Overall Study|Unable to provide sample|3|||
170345618|NCT02702518|615604265|FG000|Overall Study|Lost to Follow-up|3|||
170345619|NCT02702518|615604266|FG001|Overall Study|Lost to Follow-up|4|||
170345620|NCT00423085|615604267|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
170345621|NCT00423085|615604268|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
170345622|NCT00423085|615604269|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
170345623|NCT00423085|615604270|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
170345624|NCT00423085|615604267|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
170345625|NCT00423085|615604268|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
170345626|NCT00423085|615604269|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
170345627|NCT00423085|615604270|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
170345628|NCT00423085|615604267|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
170345629|NCT00423085|615604268|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
170345630|NCT00423085|615604269|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
170345631|NCT00423085|615604270|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
170345632|NCT00423085|615604267|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
170345633|NCT00423085|615604268|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
170345634|NCT00423085|615604269|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
170345635|NCT00423085|615604270|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
170345636|NCT00423085|615604267|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
170345637|NCT00423085|615604268|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
170345638|NCT00423085|615604269|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
170345639|NCT00423085|615604270|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
170345640|NCT00423085|615604267|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
170345641|NCT00423085|615604268|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
170345642|NCT00423085|615604269|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
170345643|NCT00423085|615604270|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
170345644|NCT00423085|615604267|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
170345645|NCT00423085|615604268|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
170345646|NCT00423085|615604269|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
170345647|NCT00423085|615604270|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
170345648|NCT00423085|615604267|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
170345649|NCT00423085|615604268|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
170345650|NCT00423085|615604269|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
170345651|NCT00423085|615604270|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
170345652|NCT00423085|615604267|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
170345653|NCT00423085|615604268|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
170345654|NCT00423085|615604269|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
170345655|NCT00423085|615604270|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
170345656|NCT00423085|615604267|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
170345657|NCT00423085|615604268|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
170345658|NCT00423085|615604269|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
170345659|NCT00423085|615604270|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
170345660|NCT00423085|615604267|FG000|52-Week Open-Label Extension Phase|Death|0|||
170345661|NCT00423085|615604268|FG001|52-Week Open-Label Extension Phase|Death|0|||
170345662|NCT00423085|615604269|FG002|52-Week Open-Label Extension Phase|Death|0|||
170345663|NCT00423085|615604270|FG003|52-Week Open-Label Extension Phase|Death|2|||
170345664|NCT02750813|615604272|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
170399295|NCT03193190|615799952|FG015|Stage 1|Reason not Specified|0|||
170345665|NCT02750813|615604273|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
170345666|NCT02750813|615604272|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
170345667|NCT02750813|615604273|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
170345668|NCT01998581|615604274|FG000|Overall Study|Refused repeat treatment|20|||
170345669|NCT01998581|615604275|FG001|Overall Study|Refused repeat treatment|4|||
170345670|NCT01998581|615604274|FG000|Overall Study|Protocol Violation|1|||
170345671|NCT01998581|615604275|FG001|Overall Study|Protocol Violation|0|||
170345672|NCT01998581|615604274|FG000|Overall Study|Withdrawal by Subject|8|||
170345673|NCT01998581|615604275|FG001|Overall Study|Withdrawal by Subject|1|||
170345674|NCT01998581|615604274|FG000|Overall Study|Lost to Follow-up|12|||
170345675|NCT01998581|615604275|FG001|Overall Study|Lost to Follow-up|4|||
170345676|NCT01998581|615604274|FG000|Overall Study|Adverse Event|1|||
170345677|NCT01998581|615604275|FG001|Overall Study|Adverse Event|1|||
170345678|NCT01998581|615604274|FG000|Overall Study|Other reasons|3|||
170345679|NCT01998581|615604275|FG001|Overall Study|Other reasons|2|||
170345680|NCT01998581|615604274|FG000|Overall Study|Randomized but withdrew before treatment|1|||
170345681|NCT01998581|615604275|FG001|Overall Study|Randomized but withdrew before treatment|0|||
170345682|NCT02273752|615604277|FG000|Overall Study|Trial was terminated early|2|||
170345683|NCT00903032|615604278|FG000|Overall Study|Withdrawal by Subject|5|||
170345684|NCT00903032|615604279|FG001|Overall Study|Withdrawal by Subject|3|||
170345685|NCT00903032|615604278|FG000|Overall Study|Lost to Follow-up|2|||
170345686|NCT00903032|615604279|FG001|Overall Study|Lost to Follow-up|2|||
170345687|NCT01429792|615604280|FG000|Overall Study|Other Reasons|67|||
170345688|NCT01429792|615604280|FG000|Overall Study|Unknown Disposition|94|||
170345689|NCT01429792|615604280|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
170345690|NCT01429792|615604280|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
170345691|NCT01429792|615604280|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
170345692|NCT01429792|615604280|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
170345693|NCT01429792|615604280|FG000|Overall Study|Withdrawal by Subject|70|||
170345694|NCT01429792|615604280|FG000|Overall Study|Lost to Follow-up|88|||
170345695|NCT02324842|615604287|FG000|Overall Study|Lost to Follow-up|1|||
170345696|NCT02324842|615604288|FG001|Overall Study|Lost to Follow-up|1|||
170345697|NCT02324842|615604289|FG002|Overall Study|Lost to Follow-up|2|||
170345698|NCT03456713|615604290|FG000|Overall Study|Lost to Follow-up|1|||
170345699|NCT03456713|615604291|FG001|Overall Study|Lost to Follow-up|0|||
170345700|NCT03456713|615604292|FG002|Overall Study|Lost to Follow-up|0|||
170345701|NCT03456713|615604293|FG003|Overall Study|Lost to Follow-up|0|||
170345702|NCT01894477|615604294|FG000|Overall Study|Protocol Violation|0|||
170345703|NCT01894477|615604295|FG001|Overall Study|Protocol Violation|1|||
170345704|NCT01894477|615604294|FG000|Overall Study|protocol changed due SC changed to cord|0|||
170345705|NCT01894477|615604295|FG001|Overall Study|protocol changed due SC changed to cord|1|||
170345706|NCT00630812|615604296|FG000|Randomisation to First Dose|Adverse Event|1|||
170345707|NCT00630812|615604297|FG001|Randomisation to First Dose|Adverse Event|1|||
170345708|NCT00630812|615604296|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
170345709|NCT00630812|615604297|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
170345710|NCT00630812|615604296|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
170345711|NCT00630812|615604297|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
170345712|NCT00630812|615604296|FG000|Randomisation to First Dose|Protocol Violation|4|||
170345713|NCT00630812|615604297|FG001|Randomisation to First Dose|Protocol Violation|1|||
170345714|NCT00630812|615604296|FG000|Double Blind Treatment Period|Adverse Event|13|||
170345715|NCT00630812|615604297|FG001|Double Blind Treatment Period|Adverse Event|5|||
170345716|NCT00630812|615604296|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
170345717|NCT00630812|615604297|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
170345718|NCT00630812|615604296|FG000|Double Blind Treatment Period|Physician Decision|2|||
170345719|NCT00630812|615604297|FG001|Double Blind Treatment Period|Physician Decision|1|||
170345720|NCT00630812|615604296|FG000|Double Blind Treatment Period|Protocol Violation|1|||
170345721|NCT00630812|615604297|FG001|Double Blind Treatment Period|Protocol Violation|0|||
170345722|NCT00630812|615604296|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
170345723|NCT00630812|615604297|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
170345724|NCT00630812|615604296|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
170345725|NCT00630812|615604297|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
170345726|NCT00630812|615604296|FG000|Double Blind Treatment Period|Non-compliance|0|||
170345727|NCT00630812|615604297|FG001|Double Blind Treatment Period|Non-compliance|1|||
170345728|NCT02561000|615604298|FG000|Overall Study|Withdrawal by Subject|2|||
170345729|NCT02561000|615604299|FG001|Overall Study|Withdrawal by Subject|3|||
170345730|NCT02561000|615604300|FG002|Overall Study|Withdrawal by Subject|0|||
170345731|NCT02561000|615604298|FG000|Overall Study|Adverse Event|0|||
170345732|NCT02561000|615604299|FG001|Overall Study|Adverse Event|1|||
170345733|NCT02561000|615604300|FG002|Overall Study|Adverse Event|0|||
170345734|NCT01428063|615604303|FG000|Overall Study|Lack of Efficacy|8|||
170345735|NCT01428063|615604304|FG001|Overall Study|Lack of Efficacy|4|||
170345736|NCT01428063|615604305|FG002|Overall Study|Lack of Efficacy|1|||
170345737|NCT01428063|615604303|FG000|Overall Study|Adverse Event|2|||
170345738|NCT01428063|615604304|FG001|Overall Study|Adverse Event|3|||
170345739|NCT01428063|615604305|FG002|Overall Study|Adverse Event|0|||
170345740|NCT01428063|615604303|FG000|Overall Study|Lost to Follow-up|0|||
170345741|NCT01428063|615604304|FG001|Overall Study|Lost to Follow-up|2|||
170345742|NCT01428063|615604305|FG002|Overall Study|Lost to Follow-up|0|||
170345743|NCT01428063|615604303|FG000|Overall Study|No longer meets study criteria|0|||
170345744|NCT01428063|615604304|FG001|Overall Study|No longer meets study criteria|1|||
170345745|NCT01428063|615604305|FG002|Overall Study|No longer meets study criteria|0|||
170345746|NCT01217190|615604307|FG000|Second Dosing|Withdrawal by Subject|0|||
170345747|NCT01217190|615604308|FG001|Second Dosing|Withdrawal by Subject|2|||
170345748|NCT04891770|615604309|FG000|Overall Study|Withdrew consent|1|||
170345749|NCT04891770|615604310|FG001|Overall Study|Withdrew consent|3|||
170345750|NCT04891770|615604311|FG002|Overall Study|Withdrew consent|0|||
170345751|NCT04891770|615604309|FG000|Overall Study|Enrolled but never treated|0|||
170345752|NCT04891770|615604310|FG001|Overall Study|Enrolled but never treated|0|||
170345753|NCT04891770|615604311|FG002|Overall Study|Enrolled but never treated|1|||
170345754|NCT04891770|615604309|FG000|Overall Study|Investigator's discretion|0|||
170345755|NCT04891770|615604310|FG001|Overall Study|Investigator's discretion|1|||
170345756|NCT04891770|615604311|FG002|Overall Study|Investigator's discretion|0|||
170345757|NCT05114590|615604312|FG000|Overall Study|Adverse Event|1|||
170345758|NCT05114590|615604312|FG000|Overall Study|Investigator decision|1|||
170345759|NCT05114590|615604312|FG000|Overall Study|Lost to Follow-up|5|||
170345760|NCT05114590|615604312|FG000|Overall Study|Withdrawal by Subject|5|||
170345761|NCT05114590|615604312|FG000|Overall Study|Other|2|||
170345762|NCT00850460|615604315|FG000|Overall Study|Lost to Follow-up|4|||
170345763|NCT00850460|615604316|FG001|Overall Study|Lost to Follow-up|4|||
170345764|NCT00748540|615604317|FG000|Overall Study|Physician Decision|1|||
170345765|NCT04743635|615604318|FG000|Overall Study|Lost to Follow-up|2|||
170345766|NCT04743635|615604319|FG001|Overall Study|Lost to Follow-up|0|||
170345767|NCT00426751|615604320|FG000|Overall Study|Adverse Event|8|||
170345768|NCT00426751|615604321|FG001|Overall Study|Adverse Event|1|||
170345769|NCT00426751|615604320|FG000|Overall Study|Lost to Follow-up|7|||
170345770|NCT00426751|615604321|FG001|Overall Study|Lost to Follow-up|6|||
170345771|NCT00426751|615604320|FG000|Overall Study|Consent Withdrawn|0|||
170345772|NCT00426751|615604321|FG001|Overall Study|Consent Withdrawn|1|||
170345773|NCT00426751|615604320|FG000|Overall Study|Other Reasons|7|||
170345774|NCT00426751|615604321|FG001|Overall Study|Other Reasons|12|||
170345775|NCT01200511|615604326|FG000|Overall Study|Lost to Follow-up|3|||
170345776|NCT01200511|615604326|FG000|Overall Study|Withdrawal by Subject|1|||
170345777|NCT01200511|615604326|FG000|Overall Study|Adverse Event|1|||
170345778|NCT03382899|615604327|FG000|Overall Study|Ineligibility Determined|0|||
170345779|NCT03382899|615604328|FG001|Overall Study|Ineligibility Determined|1|||
170345780|NCT03382899|615604327|FG000|Overall Study|Lost to Follow-up|0|||
170345781|NCT03382899|615604328|FG001|Overall Study|Lost to Follow-up|1|||
170345782|NCT03382899|615604327|FG000|Overall Study|Sponsor's decision|31|||
170345783|NCT03382899|615604328|FG001|Overall Study|Sponsor's decision|28|||
170345784|NCT03382899|615604327|FG000|Overall Study|Withdrawal by Subject|0|||
170345785|NCT03382899|615604328|FG001|Overall Study|Withdrawal by Subject|5|||
170345786|NCT03288779|615604329|FG000|Overall Study|Withdrawal by Subject|3|||
170345787|NCT00524745|615604331|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
170345788|NCT00524745|615604332|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
170345789|NCT00524745|615604333|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
170345790|NCT00524745|615604334|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
170345791|NCT02504892|615604335|FG000|Overall Study|Adverse event-pneumonitis|2|||
170345792|NCT00576693|615604336|FG000|Overall Study|Lost to Follow-up|7|||
170345793|NCT00576693|615604337|FG001|Overall Study|Lost to Follow-up|11|||
170345794|NCT00576693|615604336|FG000|Overall Study|Withdrawal by Subject|3|||
170345795|NCT00576693|615604337|FG001|Overall Study|Withdrawal by Subject|13|||
170345796|NCT03141086|615604338|FG000|Overall Study|Study Terminated By Sponsor|1|||
170345797|NCT03141086|615604339|FG001|Overall Study|Study Terminated By Sponsor|1|||
170345798|NCT03141086|615604338|FG000|Overall Study|Withdrawal by Subject|0|||
170345799|NCT03141086|615604339|FG001|Overall Study|Withdrawal by Subject|1|||
170345800|NCT03141086|615604338|FG000|Overall Study|Protocol Violation|0|||
170345801|NCT03141086|615604339|FG001|Overall Study|Protocol Violation|1|||
170345802|NCT03141086|615604338|FG000|Overall Study|Adverse Event|0|||
170345803|NCT03141086|615604339|FG001|Overall Study|Adverse Event|2|||
170345804|NCT04937816|615604340|FG000|Overall Study|Study drug stopped, reason missing|5|||
170345805|NCT04937816|615604341|FG001|Overall Study|Study drug stopped, reason missing|3|||
170345806|NCT04937816|615604342|FG002|Overall Study|Study drug stopped, reason missing|4|||
170345807|NCT04937816|615604343|FG003|Overall Study|Study drug stopped, reason missing|6|||
170345808|NCT04937816|615604344|FG004|Overall Study|Study drug stopped, reason missing|1|||
170345809|NCT04937816|615604345|FG005|Overall Study|Study drug stopped, reason missing|0|||
170345810|NCT04937816|615604346|FG006|Overall Study|Study drug stopped, reason missing|0|||
170345811|NCT04937816|615604340|FG000|Overall Study|Other than stated below|173|||
170345812|NCT04937816|615604341|FG001|Overall Study|Other than stated below|143|||
170345813|NCT04937816|615604342|FG002|Overall Study|Other than stated below|125|||
170345814|NCT04937816|615604343|FG003|Overall Study|Other than stated below|44|||
170399296|NCT03193190|615799937|FG000|Stage 1|Physician Decision|0|||
170345815|NCT04937816|615604344|FG004|Overall Study|Other than stated below|45|||
170345816|NCT04937816|615604345|FG005|Overall Study|Other than stated below|28|||
170345817|NCT04937816|615604346|FG006|Overall Study|Other than stated below|31|||
170345818|NCT04937816|615604340|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
170345819|NCT04937816|615604341|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
170345820|NCT04937816|615604342|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
170345821|NCT04937816|615604343|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
170345822|NCT04937816|615604344|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
170345823|NCT04937816|615604345|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
170345824|NCT04937816|615604346|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
170345825|NCT04937816|615604340|FG000|Overall Study|Lost to Follow-up|15|||
170345826|NCT04937816|615604341|FG001|Overall Study|Lost to Follow-up|9|||
170345827|NCT04937816|615604342|FG002|Overall Study|Lost to Follow-up|6|||
170345828|NCT04937816|615604343|FG003|Overall Study|Lost to Follow-up|6|||
170345829|NCT04937816|615604344|FG004|Overall Study|Lost to Follow-up|16|||
170345830|NCT04937816|615604345|FG005|Overall Study|Lost to Follow-up|11|||
170345831|NCT04937816|615604346|FG006|Overall Study|Lost to Follow-up|17|||
170345832|NCT04937816|615604340|FG000|Overall Study|Protocol Violation|15|||
170345833|NCT04937816|615604341|FG001|Overall Study|Protocol Violation|15|||
170345834|NCT04937816|615604342|FG002|Overall Study|Protocol Violation|12|||
170345835|NCT04937816|615604343|FG003|Overall Study|Protocol Violation|30|||
170345836|NCT04937816|615604344|FG004|Overall Study|Protocol Violation|24|||
170345837|NCT04937816|615604345|FG005|Overall Study|Protocol Violation|5|||
170345838|NCT04937816|615604346|FG006|Overall Study|Protocol Violation|5|||
170345839|NCT04937816|615604340|FG000|Overall Study|Adverse Event|303|||
170345840|NCT04937816|615604341|FG001|Overall Study|Adverse Event|267|||
170345841|NCT04937816|615604342|FG002|Overall Study|Adverse Event|273|||
170345842|NCT04937816|615604343|FG003|Overall Study|Adverse Event|553|||
170345843|NCT04937816|615604344|FG004|Overall Study|Adverse Event|575|||
170345844|NCT04937816|615604345|FG005|Overall Study|Adverse Event|343|||
170345845|NCT04937816|615604346|FG006|Overall Study|Adverse Event|337|||
170345846|NCT04937816|615604340|FG000|Overall Study|Not treated|4|||
170345847|NCT04937816|615604341|FG001|Overall Study|Not treated|2|||
170345848|NCT04937816|615604342|FG002|Overall Study|Not treated|2|||
170345849|NCT04937816|615604343|FG003|Overall Study|Not treated|2|||
170345850|NCT04937816|615604344|FG004|Overall Study|Not treated|1|||
170345851|NCT04937816|615604345|FG005|Overall Study|Not treated|4|||
170345852|NCT04937816|615604346|FG006|Overall Study|Not treated|0|||
170345853|NCT02488759|615604347|FG000|Overall Study|Disease progression|73|||
170345854|NCT02488759|615604348|FG001|Overall Study|Disease progression|111|||
170345855|NCT02488759|615604349|FG002|Overall Study|Disease progression|62|||
170345856|NCT02488759|615604350|FG003|Overall Study|Disease progression|7|||
170345857|NCT02488759|615604351|FG004|Overall Study|Disease progression|4|||
170345858|NCT02488759|615604352|FG005|Overall Study|Disease progression|2|||
170345859|NCT02488759|615604347|FG000|Overall Study|Study drug toxicity|11|||
170345860|NCT02488759|615604348|FG001|Overall Study|Study drug toxicity|33|||
170345861|NCT02488759|615604349|FG002|Overall Study|Study drug toxicity|31|||
170345862|NCT02488759|615604350|FG003|Overall Study|Study drug toxicity|0|||
170345863|NCT02488759|615604351|FG004|Overall Study|Study drug toxicity|0|||
170345864|NCT02488759|615604352|FG005|Overall Study|Study drug toxicity|2|||
170345865|NCT02488759|615604347|FG000|Overall Study|Adverse event unrelated to study drug|9|||
170345866|NCT02488759|615604348|FG001|Overall Study|Adverse event unrelated to study drug|11|||
170345867|NCT02488759|615604349|FG002|Overall Study|Adverse event unrelated to study drug|7|||
170345868|NCT02488759|615604350|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170345869|NCT02488759|615604351|FG004|Overall Study|Adverse event unrelated to study drug|1|||
170345870|NCT02488759|615604352|FG005|Overall Study|Adverse event unrelated to study drug|0|||
170345871|NCT02488759|615604347|FG000|Overall Study|Participant request to discontinue study treatment|6|||
170345872|NCT02488759|615604348|FG001|Overall Study|Participant request to discontinue study treatment|8|||
170345873|NCT02488759|615604349|FG002|Overall Study|Participant request to discontinue study treatment|4|||
170345874|NCT02488759|615604350|FG003|Overall Study|Participant request to discontinue study treatment|0|||
170345875|NCT02488759|615604351|FG004|Overall Study|Participant request to discontinue study treatment|0|||
170345876|NCT02488759|615604352|FG005|Overall Study|Participant request to discontinue study treatment|0|||
170345877|NCT02488759|615604347|FG000|Overall Study|Withdrawal by Subject|4|||
170345878|NCT02488759|615604348|FG001|Overall Study|Withdrawal by Subject|0|||
170345879|NCT02488759|615604349|FG002|Overall Study|Withdrawal by Subject|3|||
170345880|NCT02488759|615604350|FG003|Overall Study|Withdrawal by Subject|0|||
170345881|NCT02488759|615604351|FG004|Overall Study|Withdrawal by Subject|0|||
170345882|NCT02488759|615604352|FG005|Overall Study|Withdrawal by Subject|2|||
170345883|NCT02488759|615604347|FG000|Overall Study|Lost to Follow-up|0|||
170345884|NCT02488759|615604348|FG001|Overall Study|Lost to Follow-up|0|||
170345885|NCT02488759|615604349|FG002|Overall Study|Lost to Follow-up|2|||
170345886|NCT02488759|615604350|FG003|Overall Study|Lost to Follow-up|0|||
170345887|NCT02488759|615604351|FG004|Overall Study|Lost to Follow-up|0|||
170345888|NCT02488759|615604352|FG005|Overall Study|Lost to Follow-up|0|||
170345889|NCT02488759|615604347|FG000|Overall Study|Maximum clinical benefit|3|||
170345890|NCT02488759|615604348|FG001|Overall Study|Maximum clinical benefit|0|||
170345891|NCT02488759|615604349|FG002|Overall Study|Maximum clinical benefit|1|||
170345892|NCT02488759|615604350|FG003|Overall Study|Maximum clinical benefit|0|||
170345893|NCT02488759|615604351|FG004|Overall Study|Maximum clinical benefit|0|||
170345894|NCT02488759|615604352|FG005|Overall Study|Maximum clinical benefit|0|||
170345895|NCT02488759|615604347|FG000|Overall Study|Other reasons|7|||
170345896|NCT02488759|615604348|FG001|Overall Study|Other reasons|32|||
170345897|NCT02488759|615604349|FG002|Overall Study|Other reasons|23|||
170345898|NCT02488759|615604350|FG003|Overall Study|Other reasons|1|||
170345899|NCT02488759|615604351|FG004|Overall Study|Other reasons|1|||
170345900|NCT02488759|615604352|FG005|Overall Study|Other reasons|1|||
170345901|NCT03860844|615604353|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
170345902|NCT03860844|615604354|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
170345903|NCT03860844|615604355|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
170345904|NCT03860844|615604353|FG000|Overall Study|Progressive disease|5|||
170345905|NCT03860844|615604354|FG001|Overall Study|Progressive disease|3|||
170345906|NCT03860844|615604355|FG002|Overall Study|Progressive disease|4|||
170345907|NCT03860844|615604353|FG000|Overall Study|Other, Not related to COVID-19|0|||
170345908|NCT03860844|615604354|FG001|Overall Study|Other, Not related to COVID-19|1|||
170345909|NCT03860844|615604355|FG002|Overall Study|Other, Not related to COVID-19|0|||
170345910|NCT00376688|615604356|FG000|Overall Study|Adverse Event|3|||
170345911|NCT00376688|615604356|FG000|Overall Study|Death|1|||
170345912|NCT05513053|615604357|FG000|Overall Study|Lost to Follow-up|9|||
170345913|NCT05513053|615604358|FG001|Overall Study|Lost to Follow-up|11|||
170345914|NCT05513053|615604357|FG000|Overall Study|Withdrawal by parent/guardian|2|||
170345915|NCT05513053|615604358|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170345916|NCT05513053|615604357|FG000|Overall Study|Withdrawal by Subject|2|||
170345917|NCT05513053|615604358|FG001|Overall Study|Withdrawal by Subject|9|||
170345918|NCT05513053|615604357|FG000|Overall Study|Protocol Violation|6|||
170345919|NCT05513053|615604358|FG001|Overall Study|Protocol Violation|3|||
170345920|NCT05513053|615604357|FG000|Overall Study|Adverse Event|0|||
170345921|NCT05513053|615604358|FG001|Overall Study|Adverse Event|2|||
170345922|NCT04491877|615606422|FG000|Overall Study|Protocol Deviation|1|||
170345923|NCT04491877|615606423|FG001|Overall Study|Protocol Deviation|0|||
170345924|NCT04491877|615606424|FG002|Overall Study|Protocol Deviation|2|||
170345925|NCT04491877|615606425|FG003|Overall Study|Protocol Deviation|0|||
170345926|NCT04491877|615606426|FG004|Overall Study|Protocol Deviation|0|||
170345927|NCT04491877|615606427|FG005|Overall Study|Protocol Deviation|0|||
170345928|NCT04491877|615606428|FG006|Overall Study|Protocol Deviation|1|||
170345929|NCT04491877|615606429|FG007|Overall Study|Protocol Deviation|1|||
170345930|NCT04491877|615606430|FG008|Overall Study|Protocol Deviation|0|||
170345931|NCT04491877|615606422|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170345932|NCT04491877|615606423|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170345933|NCT04491877|615606424|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170345934|NCT04491877|615606425|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
170345935|NCT04491877|615606426|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
170345936|NCT04491877|615606427|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
170345937|NCT04491877|615606428|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
170345938|NCT04491877|615606429|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
170345939|NCT04491877|615606430|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
170345940|NCT04491877|615606422|FG000|Overall Study|Lost to Follow-up|0|||
170345941|NCT04491877|615606423|FG001|Overall Study|Lost to Follow-up|2|||
170345942|NCT04491877|615606424|FG002|Overall Study|Lost to Follow-up|0|||
170345943|NCT04491877|615606425|FG003|Overall Study|Lost to Follow-up|0|||
170345944|NCT04491877|615606426|FG004|Overall Study|Lost to Follow-up|0|||
170345945|NCT04491877|615606427|FG005|Overall Study|Lost to Follow-up|0|||
170345946|NCT04491877|615606428|FG006|Overall Study|Lost to Follow-up|2|||
170345947|NCT04491877|615606429|FG007|Overall Study|Lost to Follow-up|1|||
170345948|NCT04491877|615606430|FG008|Overall Study|Lost to Follow-up|1|||
170345949|NCT03050359|615606431|FG000|Overall Study|Randomized But Not Treated|2|||
170345950|NCT03050359|615606432|FG001|Overall Study|Randomized But Not Treated|0|||
170345951|NCT03050359|615606431|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
170345952|NCT03050359|615606432|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
170345953|NCT03050359|615606431|FG000|Overall Study|Significant Protocol Deviation|2|||
170345954|NCT03050359|615606432|FG001|Overall Study|Significant Protocol Deviation|3|||
170345955|NCT03050359|615606431|FG000|Overall Study|Lost to Follow-up|2|||
170345956|NCT03050359|615606432|FG001|Overall Study|Lost to Follow-up|1|||
170345957|NCT03050359|615606431|FG000|Overall Study|Voluntary Withdrawal|4|||
170345958|NCT03050359|615606432|FG001|Overall Study|Voluntary Withdrawal|6|||
170345959|NCT03050359|615606431|FG000|Overall Study|Pregnancy|1|||
170345960|NCT03050359|615606432|FG001|Overall Study|Pregnancy|0|||
170345961|NCT03050359|615606431|FG000|Overall Study|Reason Not Specified|1|||
170345962|NCT03050359|615606432|FG001|Overall Study|Reason Not Specified|0|||
170345963|NCT03470922|615606434|FG000|Overall Study|Death|107|||
170345964|NCT03470922|615606435|FG001|Overall Study|Death|118|||
170345965|NCT03470922|615606434|FG000|Overall Study|Lost to Follow-up|5|||
170345966|NCT03470922|615606435|FG001|Overall Study|Lost to Follow-up|5|||
170345967|NCT03470922|615606434|FG000|Overall Study|Participant Withdrew Consent|4|||
170345968|NCT03470922|615606435|FG001|Overall Study|Participant Withdrew Consent|9|||
170345969|NCT03470922|615606434|FG000|Overall Study|Other reasons|1|||
170345970|NCT03470922|615606435|FG001|Overall Study|Other reasons|0|||
170345971|NCT03470922|615606434|FG000|Overall Study|Not reported|1|||
170345972|NCT03470922|615606435|FG001|Overall Study|Not reported|0|||
170345973|NCT01826422|615606439|FG000|Overall Study|Withdrawal by Subject|1|||
170345974|NCT01826422|615606440|FG001|Overall Study|Withdrawal by Subject|3|||
170345975|NCT05619172|615606444|FG000|Safety Cohort 1|Death|7|||
170345976|NCT05619172|615606445|FG001|Safety Cohort 1|Death|0|||
170345977|NCT05619172|615606444|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
170345978|NCT05619172|615606445|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
170345979|NCT05619172|615606444|FG000|Safety Cohort 2|Death|0|||
170345980|NCT05619172|615606445|FG001|Safety Cohort 2|Death|1|||
170345981|NCT05619172|615606444|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
170345982|NCT05619172|615606445|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
170345983|NCT04009096|615606446|FG000|Overall Study|Withdrawal by Subject|0|||
170345984|NCT04009096|615606447|FG001|Overall Study|Withdrawal by Subject|7|||
170345985|NCT04009096|615606448|FG002|Overall Study|Withdrawal by Subject|0|||
170345986|NCT04009096|615606446|FG000|Overall Study|Physician Decision|0|||
170345987|NCT04009096|615606447|FG001|Overall Study|Physician Decision|1|||
170345988|NCT04009096|615606448|FG002|Overall Study|Physician Decision|0|||
170345989|NCT04263142|615606449|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
170345990|NCT04263142|615606450|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
170345991|NCT04263142|615606451|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
170345992|NCT04263142|615606452|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
170345993|NCT04263142|615606453|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
170345994|NCT04263142|615606449|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
170345995|NCT04263142|615606450|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
170345996|NCT04263142|615606451|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
170345997|NCT04263142|615606452|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
170345998|NCT04263142|615606453|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
170345999|NCT00450372|615606455|FG000|Overall Study|Physician Decision|1|||
170346000|NCT00520676|615606456|FG000|Overall Study|Death|84|||
170346001|NCT00520676|615606457|FG001|Overall Study|Death|81|||
170346002|NCT00520676|615606456|FG000|Overall Study|Lost to Follow-up|6|||
170346003|NCT00520676|615606457|FG001|Overall Study|Lost to Follow-up|10|||
170346004|NCT00520676|615606456|FG000|Overall Study|Physician Decision|4|||
170346005|NCT00520676|615606457|FG001|Overall Study|Physician Decision|1|||
170346006|NCT00520676|615606456|FG000|Overall Study|Withdrawal by Subject|7|||
170346007|NCT00520676|615606457|FG001|Overall Study|Withdrawal by Subject|11|||
170346008|NCT03484923|615606460|FG000|Overall Study|Adverse Event|3|||
170346009|NCT03484923|615606461|FG001|Overall Study|Adverse Event|3|||
170346010|NCT03484923|615606462|FG002|Overall Study|Adverse Event|5|||
170346011|NCT03484923|615606463|FG003|Overall Study|Adverse Event|11|||
170346012|NCT03484923|615606464|FG004|Overall Study|Adverse Event|1|||
170346013|NCT03484923|615606460|FG000|Overall Study|Death|2|||
170346014|NCT03484923|615606461|FG001|Overall Study|Death|2|||
170346015|NCT03484923|615606462|FG002|Overall Study|Death|3|||
170346016|NCT03484923|615606463|FG003|Overall Study|Death|0|||
170346017|NCT03484923|615606464|FG004|Overall Study|Death|1|||
170346018|NCT03484923|615606460|FG000|Overall Study|Physician Decision|6|||
170346019|NCT03484923|615606461|FG001|Overall Study|Physician Decision|7|||
170346020|NCT03484923|615606462|FG002|Overall Study|Physician Decision|6|||
170346021|NCT03484923|615606463|FG003|Overall Study|Physician Decision|3|||
170346022|NCT03484923|615606464|FG004|Overall Study|Physician Decision|2|||
170346023|NCT03484923|615606460|FG000|Overall Study|Progressive disease|33|||
170346024|NCT03484923|615606461|FG001|Overall Study|Progressive disease|28|||
170346025|NCT03484923|615606462|FG002|Overall Study|Progressive disease|26|||
170346026|NCT03484923|615606463|FG003|Overall Study|Progressive disease|30|||
170346027|NCT03484923|615606464|FG004|Overall Study|Progressive disease|16|||
170346028|NCT03484923|615606460|FG000|Overall Study|Subject Decision|1|||
170346029|NCT03484923|615606461|FG001|Overall Study|Subject Decision|3|||
170346030|NCT03484923|615606462|FG002|Overall Study|Subject Decision|3|||
170346031|NCT03484923|615606463|FG003|Overall Study|Subject Decision|0|||
170346032|NCT03484923|615606464|FG004|Overall Study|Subject Decision|1|||
170346033|NCT05131451|615606467|FG000|Overall Study|Protocol Violation|1|||
170346034|NCT05131451|615606468|FG001|Overall Study|Protocol Violation|0|||
170346035|NCT01856595|615606475|FG000|Overall Study|Withdrawal by Subject|0|||
170346036|NCT01856595|615606476|FG001|Overall Study|Withdrawal by Subject|1|||
170346037|NCT01856595|615606477|FG002|Overall Study|Withdrawal by Subject|0|||
170346038|NCT01856595|615606478|FG003|Overall Study|Withdrawal by Subject|0|||
170346039|NCT01856595|615606479|FG004|Overall Study|Withdrawal by Subject|0|||
170346040|NCT01856595|615606480|FG005|Overall Study|Withdrawal by Subject|0|||
170346041|NCT01856595|615606481|FG006|Overall Study|Withdrawal by Subject|1|||
170346042|NCT01856595|615606482|FG007|Overall Study|Withdrawal by Subject|0|||
170346043|NCT01856595|615606483|FG008|Overall Study|Withdrawal by Subject|0|||
170346044|NCT04426825|615606485|FG000|Overall Study|Death|17|||
170346045|NCT04426825|615606485|FG000|Overall Study|Lost to Follow-up|1|||
170346046|NCT04426825|615606485|FG000|Overall Study|Study terminated by sponsor|5|||
170346047|NCT01763905|615606490|FG000|Overall Study|Withdrawal by Subject|1|||
170346048|NCT01763905|615606491|FG001|Overall Study|Withdrawal by Subject|1|||
170346049|NCT01763905|615606492|FG002|Overall Study|Withdrawal by Subject|0|||
170346050|NCT01763905|615606493|FG003|Overall Study|Withdrawal by Subject|1|||
170346051|NCT01763905|615606490|FG000|Overall Study|Decision by sponsor|5|||
170346052|NCT01763905|615606491|FG001|Overall Study|Decision by sponsor|0|||
170346053|NCT01763905|615606492|FG002|Overall Study|Decision by sponsor|8|||
170346054|NCT01763905|615606493|FG003|Overall Study|Decision by sponsor|0|||
170346055|NCT01763905|615606490|FG000|Overall Study|Lost to Follow-up|0|||
170346056|NCT01763905|615606491|FG001|Overall Study|Lost to Follow-up|0|||
170346057|NCT01763905|615606492|FG002|Overall Study|Lost to Follow-up|1|||
170346058|NCT01763905|615606493|FG003|Overall Study|Lost to Follow-up|0|||
170346059|NCT04346628|615606494|FG000|Overall Study|Lost to Follow-up|4|||
170346060|NCT04346628|615606495|FG001|Overall Study|Lost to Follow-up|4|||
170346061|NCT04346628|615606494|FG000|Overall Study|Withdrew (had personal reasons)|2|||
170346062|NCT04346628|615606495|FG001|Overall Study|Withdrew (had personal reasons)|5|||
170346063|NCT04346628|615606494|FG000|Overall Study|Withdrew (medication intolerant)|0|||
170346064|NCT04346628|615606495|FG001|Overall Study|Withdrew (medication intolerant)|3|||
170346065|NCT04346628|615606494|FG000|Overall Study|Withdrew (declined intervention)|0|||
170346066|NCT04346628|615606495|FG001|Overall Study|Withdrew (declined intervention)|1|||
170346067|NCT03165721|615606496|FG000|Overall Study|Refused further treatment|3|||
170346068|NCT03165721|615606497|FG001|Overall Study|Refused further treatment|0|||
170346069|NCT03165721|615606498|FG002|Overall Study|Refused further treatment|0|||
170346070|NCT03165721|615606496|FG000|Overall Study|Physician Decision|1|||
170346071|NCT03165721|615606497|FG001|Overall Study|Physician Decision|0|||
170346072|NCT03165721|615606498|FG002|Overall Study|Physician Decision|0|||
170346073|NCT01457118|615606500|FG000|Overall Study|Adverse Event|1|||
170346074|NCT01457118|615606501|FG001|Overall Study|Adverse Event|0|||
170346075|NCT01457118|615606502|FG002|Overall Study|Adverse Event|0|||
170346076|NCT01457118|615606503|FG003|Overall Study|Adverse Event|1|||
170346077|NCT01457118|615606500|FG000|Overall Study|Clinical Progression|0|||
170346078|NCT01457118|615606501|FG001|Overall Study|Clinical Progression|1|||
170346079|NCT01457118|615606502|FG002|Overall Study|Clinical Progression|0|||
170346080|NCT01457118|615606503|FG003|Overall Study|Clinical Progression|1|||
170346081|NCT01457118|615606500|FG000|Overall Study|Physician Decision|2|||
170346082|NCT01457118|615606501|FG001|Overall Study|Physician Decision|0|||
170346083|NCT01457118|615606502|FG002|Overall Study|Physician Decision|0|||
170346084|NCT01457118|615606503|FG003|Overall Study|Physician Decision|0|||
170346085|NCT01457118|615606500|FG000|Overall Study|Progressive Disease by RECIST|12|||
170346086|NCT01457118|615606501|FG001|Overall Study|Progressive Disease by RECIST|3|||
170346087|NCT01457118|615606502|FG002|Overall Study|Progressive Disease by RECIST|1|||
170346088|NCT01457118|615606503|FG003|Overall Study|Progressive Disease by RECIST|0|||
170346089|NCT01457118|615606500|FG000|Overall Study|Withdrawal by Subject|5|||
170346090|NCT01457118|615606501|FG001|Overall Study|Withdrawal by Subject|0|||
170346091|NCT01457118|615606502|FG002|Overall Study|Withdrawal by Subject|0|||
170346092|NCT01457118|615606503|FG003|Overall Study|Withdrawal by Subject|0|||
170346093|NCT01202227|615606508|FG000|Overall Study|Adverse Event|16|||
170346094|NCT01202227|615606508|FG000|Overall Study|Withdrawal by Subject|2|||
170346095|NCT01202227|615606508|FG000|Overall Study|Lack of Efficacy|1|||
170346096|NCT03430245|615606510|FG000|Overall Study|Withdrawal by Subject|6|||
170346097|NCT03430245|615606510|FG000|Overall Study|Lost to Follow-up|1|||
170346098|NCT01554956|615606511|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
170346099|NCT01554956|615606512|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
170346100|NCT01554956|615606513|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
170346101|NCT01554956|615606511|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
170346102|NCT01554956|615606512|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
170346103|NCT01554956|615606513|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
170346104|NCT01554956|615606511|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
170346105|NCT01554956|615606512|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
170346106|NCT01554956|615606513|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
170346107|NCT00069095|615606514|FG000|Primary Treatment Phase|Ongoing|0|||
170346108|NCT00069095|615606515|FG001|Primary Treatment Phase|Ongoing|0|||
170346109|NCT00069095|615606516|FG002|Primary Treatment Phase|Ongoing|5|||
170346110|NCT00069095|615606517|FG003|Primary Treatment Phase|Ongoing|7|||
170346111|NCT00069095|615606518|FG004|Primary Treatment Phase|Ongoing|7|||
170346112|NCT00069095|615606519|FG005|Primary Treatment Phase|Ongoing|4|||
170346113|NCT00069095|615606514|FG000|Primary Treatment Phase|Admin/Other|29|||
170346114|NCT00069095|615606515|FG001|Primary Treatment Phase|Admin/Other|38|||
170346115|NCT00069095|615606516|FG002|Primary Treatment Phase|Admin/Other|31|||
170346116|NCT00069095|615606517|FG003|Primary Treatment Phase|Admin/Other|45|||
170346117|NCT00069095|615606518|FG004|Primary Treatment Phase|Admin/Other|48|||
170346118|NCT00069095|615606519|FG005|Primary Treatment Phase|Admin/Other|42|||
170346119|NCT00069095|615606514|FG000|Primary Treatment Phase|Adverse Event|99|||
170346120|NCT00069095|615606515|FG001|Primary Treatment Phase|Adverse Event|92|||
170346121|NCT00069095|615606516|FG002|Primary Treatment Phase|Adverse Event|71|||
170346122|NCT00069095|615606517|FG003|Primary Treatment Phase|Adverse Event|72|||
170346123|NCT00069095|615606518|FG004|Primary Treatment Phase|Adverse Event|109|||
170346124|NCT00069095|615606519|FG005|Primary Treatment Phase|Adverse Event|101|||
170346125|NCT00069095|615606514|FG000|Primary Treatment Phase|Death|14|||
170346126|NCT00069095|615606515|FG001|Primary Treatment Phase|Death|8|||
170346127|NCT00069095|615606516|FG002|Primary Treatment Phase|Death|2|||
170346128|NCT00069095|615606517|FG003|Primary Treatment Phase|Death|5|||
170346129|NCT00069095|615606518|FG004|Primary Treatment Phase|Death|8|||
170346130|NCT00069095|615606519|FG005|Primary Treatment Phase|Death|8|||
170346131|NCT00069095|615606514|FG000|Primary Treatment Phase|Failure to return|5|||
170346132|NCT00069095|615606515|FG001|Primary Treatment Phase|Failure to return|5|||
170346133|NCT00069095|615606516|FG002|Primary Treatment Phase|Failure to return|0|||
170346134|NCT00069095|615606517|FG003|Primary Treatment Phase|Failure to return|0|||
170346135|NCT00069095|615606518|FG004|Primary Treatment Phase|Failure to return|0|||
170346136|NCT00069095|615606519|FG005|Primary Treatment Phase|Failure to return|2|||
170346137|NCT00069095|615606514|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
170346138|NCT00069095|615606515|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
170346139|NCT00069095|615606516|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
170346140|NCT00069095|615606517|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
170346141|NCT00069095|615606518|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
170346142|NCT00069095|615606519|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
170346143|NCT00069095|615606514|FG000|Primary Treatment Phase|Refused treatment|15|||
170346144|NCT00069095|615606515|FG001|Primary Treatment Phase|Refused treatment|26|||
170346145|NCT00069095|615606516|FG002|Primary Treatment Phase|Refused treatment|17|||
170346146|NCT00069095|615606517|FG003|Primary Treatment Phase|Refused treatment|31|||
170346147|NCT00069095|615606518|FG004|Primary Treatment Phase|Refused treatment|24|||
170346148|NCT00069095|615606519|FG005|Primary Treatment Phase|Refused treatment|27|||
170346149|NCT00069095|615606514|FG000|Primary Treatment Phase|Withdrew|2|||
170346150|NCT00069095|615606515|FG001|Primary Treatment Phase|Withdrew|3|||
170346151|NCT00069095|615606516|FG002|Primary Treatment Phase|Withdrew|8|||
170346152|NCT00069095|615606517|FG003|Primary Treatment Phase|Withdrew|2|||
170346153|NCT00069095|615606518|FG004|Primary Treatment Phase|Withdrew|4|||
170346154|NCT00069095|615606519|FG005|Primary Treatment Phase|Withdrew|9|||
170346155|NCT00069095|615606514|FG000|Primary Treatment Phase|Other Violation|0|||
170346156|NCT00069095|615606515|FG001|Primary Treatment Phase|Other Violation|1|||
170346157|NCT00069095|615606516|FG002|Primary Treatment Phase|Other Violation|1|||
170346158|NCT00069095|615606517|FG003|Primary Treatment Phase|Other Violation|1|||
170346159|NCT00069095|615606518|FG004|Primary Treatment Phase|Other Violation|0|||
170346160|NCT00069095|615606519|FG005|Primary Treatment Phase|Other Violation|1|||
170346161|NCT00069095|615606514|FG000|Primary Treatment Phase|Violation criteria|0|||
170346162|NCT00069095|615606515|FG001|Primary Treatment Phase|Violation criteria|2|||
170346163|NCT00069095|615606516|FG002|Primary Treatment Phase|Violation criteria|4|||
170346164|NCT00069095|615606517|FG003|Primary Treatment Phase|Violation criteria|3|||
170346165|NCT00069095|615606518|FG004|Primary Treatment Phase|Violation criteria|1|||
170346166|NCT00069095|615606519|FG005|Primary Treatment Phase|Violation criteria|5|||
170346167|NCT00069095|615606514|FG000|Post-study Treatment Phase|Missing reason|1|||
170346168|NCT00069095|615606515|FG001|Post-study Treatment Phase|Missing reason|3|||
170346169|NCT00069095|615606516|FG002|Post-study Treatment Phase|Missing reason|12|||
170346170|NCT00069095|615606517|FG003|Post-study Treatment Phase|Missing reason|8|||
170346171|NCT00069095|615606518|FG004|Post-study Treatment Phase|Missing reason|18|||
170346172|NCT00069095|615606519|FG005|Post-study Treatment Phase|Missing reason|17|||
170346173|NCT00069095|615606514|FG000|Post-study Treatment Phase|Adverse Event|2|||
170346174|NCT00069095|615606515|FG001|Post-study Treatment Phase|Adverse Event|3|||
170346175|NCT00069095|615606516|FG002|Post-study Treatment Phase|Adverse Event|1|||
170346176|NCT00069095|615606517|FG003|Post-study Treatment Phase|Adverse Event|0|||
170346177|NCT00069095|615606518|FG004|Post-study Treatment Phase|Adverse Event|5|||
170346178|NCT00069095|615606519|FG005|Post-study Treatment Phase|Adverse Event|1|||
170346179|NCT00069095|615606514|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
170346180|NCT00069095|615606515|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
170346181|NCT00069095|615606516|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
170346182|NCT00069095|615606517|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
170346183|NCT00069095|615606518|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
170346184|NCT00069095|615606519|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
170346185|NCT00069095|615606514|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
170346186|NCT00069095|615606515|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
170346187|NCT00069095|615606516|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
170346188|NCT00069095|615606517|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
170346189|NCT00069095|615606518|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
170346190|NCT00069095|615606519|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
170346191|NCT00069095|615606514|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
170399297|NCT03193190|615799938|FG001|Stage 1|Physician Decision|0|||
170346192|NCT00069095|615606515|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
170346193|NCT00069095|615606516|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
170346194|NCT00069095|615606517|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
170346195|NCT00069095|615606518|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
170346196|NCT00069095|615606519|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
170346197|NCT00069095|615606514|FG000|Post-study Treatment Phase|Participant had complete response|1|||
170346198|NCT00069095|615606515|FG001|Post-study Treatment Phase|Participant had complete response|1|||
170346199|NCT00069095|615606516|FG002|Post-study Treatment Phase|Participant had complete response|0|||
170346200|NCT00069095|615606517|FG003|Post-study Treatment Phase|Participant had complete response|0|||
170346201|NCT00069095|615606518|FG004|Post-study Treatment Phase|Participant had complete response|0|||
170346202|NCT00069095|615606519|FG005|Post-study Treatment Phase|Participant had complete response|0|||
170346203|NCT00069095|615606514|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
170346204|NCT00069095|615606515|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
170346205|NCT00069095|615606516|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
170346206|NCT00069095|615606517|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
170346207|NCT00069095|615606518|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
170346208|NCT00069095|615606519|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
170346209|NCT00069095|615606514|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
170346210|NCT00069095|615606515|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
170346211|NCT00069095|615606516|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
170346212|NCT00069095|615606517|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
170346213|NCT00069095|615606518|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
170346214|NCT00069095|615606519|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
170346215|NCT00069095|615606514|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
170346216|NCT00069095|615606515|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
170346217|NCT00069095|615606516|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
170346218|NCT00069095|615606517|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
170346219|NCT00069095|615606518|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
170346220|NCT00069095|615606519|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
170346221|NCT00069095|615606514|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
170346222|NCT00069095|615606515|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
170346223|NCT00069095|615606516|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
170346224|NCT00069095|615606517|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
170346225|NCT00069095|615606518|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
170346226|NCT00069095|615606519|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
170346227|NCT00069095|615606514|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
170346228|NCT00069095|615606515|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
170346229|NCT00069095|615606516|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
170346230|NCT00069095|615606517|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
170346231|NCT00069095|615606518|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
170346232|NCT00069095|615606519|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
170346233|NCT00069095|615606514|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
170346234|NCT00069095|615606515|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
170346235|NCT00069095|615606516|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
170346236|NCT00069095|615606517|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
170346237|NCT00069095|615606518|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
170346238|NCT00069095|615606519|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
170346239|NCT00069095|615606514|FG000|Post-study Treatment Phase|Surgery|0|||
170346240|NCT00069095|615606515|FG001|Post-study Treatment Phase|Surgery|0|||
170346241|NCT00069095|615606516|FG002|Post-study Treatment Phase|Surgery|0|||
170346242|NCT00069095|615606517|FG003|Post-study Treatment Phase|Surgery|1|||
170346243|NCT00069095|615606518|FG004|Post-study Treatment Phase|Surgery|1|||
170346244|NCT00069095|615606519|FG005|Post-study Treatment Phase|Surgery|0|||
170346245|NCT00069095|615606514|FG000|Post-study Treatment Phase|Death|0|||
170346246|NCT00069095|615606515|FG001|Post-study Treatment Phase|Death|0|||
170346247|NCT00069095|615606516|FG002|Post-study Treatment Phase|Death|0|||
170346248|NCT00069095|615606517|FG003|Post-study Treatment Phase|Death|0|||
170346249|NCT00069095|615606518|FG004|Post-study Treatment Phase|Death|1|||
170346250|NCT00069095|615606519|FG005|Post-study Treatment Phase|Death|0|||
170346251|NCT00069095|615606514|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
170346252|NCT00069095|615606515|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
170346253|NCT00069095|615606516|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
170399298|NCT03193190|615799939|FG002|Stage 1|Physician Decision|0|||
170346254|NCT00069095|615606517|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
170346255|NCT00069095|615606518|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
170346256|NCT00069095|615606519|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
170346257|NCT00069095|615606514|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
170346258|NCT00069095|615606515|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
170346259|NCT00069095|615606516|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
170346260|NCT00069095|615606517|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
170346261|NCT00069095|615606518|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
170346262|NCT00069095|615606519|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
170346263|NCT00069095|615606514|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
170346264|NCT00069095|615606515|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
170346265|NCT00069095|615606516|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
170346266|NCT00069095|615606517|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
170346267|NCT00069095|615606518|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
170346268|NCT00069095|615606519|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
170346269|NCT00069095|615606514|FG000|Post-study Treatment Phase|Investigator decision|0|||
170346270|NCT00069095|615606515|FG001|Post-study Treatment Phase|Investigator decision|0|||
170346271|NCT00069095|615606516|FG002|Post-study Treatment Phase|Investigator decision|0|||
170346272|NCT00069095|615606517|FG003|Post-study Treatment Phase|Investigator decision|0|||
170346273|NCT00069095|615606518|FG004|Post-study Treatment Phase|Investigator decision|0|||
170346274|NCT00069095|615606519|FG005|Post-study Treatment Phase|Investigator decision|1|||
170346275|NCT00069095|615606514|FG000|Follow-up Phase|Death|174|||
170346276|NCT00069095|615606515|FG001|Follow-up Phase|Death|206|||
170346277|NCT00069095|615606516|FG002|Follow-up Phase|Death|120|||
170346278|NCT00069095|615606517|FG003|Follow-up Phase|Death|112|||
170346279|NCT00069095|615606518|FG004|Follow-up Phase|Death|92|||
170346280|NCT00069095|615606519|FG005|Follow-up Phase|Death|101|||
170346281|NCT05761444|615606520|FG000|Overall Study|Protocol Violation|2|||
170346282|NCT05761444|615606521|FG001|Overall Study|Protocol Violation|1|||
170346283|NCT05761444|615606520|FG000|Overall Study|Adverse Event|2|||
170346284|NCT05761444|615606521|FG001|Overall Study|Adverse Event|2|||
170346285|NCT05761444|615606520|FG000|Overall Study|Withdrawal by Subject|3|||
170346286|NCT05761444|615606521|FG001|Overall Study|Withdrawal by Subject|2|||
170346287|NCT05761444|615606520|FG000|Overall Study|Other|1|||
170346288|NCT05761444|615606521|FG001|Overall Study|Other|0|||
170346289|NCT05610176|615606522|FG000|Overall Study|Death|6|||
170346290|NCT01727713|615606527|FG000|Overall Study|Lost to Follow-up|5|||
170346291|NCT01727713|615606527|FG000|Overall Study|Adverse Event|10|||
170346292|NCT01727713|615606527|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
170346293|NCT01727713|615606527|FG000|Overall Study|Withdrawal by Subject|13|||
170346294|NCT01727713|615606527|FG000|Overall Study|Protocol Deviation|2|||
170346295|NCT02918266|615606528|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
170346296|NCT02918266|615606529|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
170346297|NCT02918266|615606530|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
170346298|NCT02918266|615606531|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
170346299|NCT02918266|615606532|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
170346300|NCT02918266|615606533|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
170346301|NCT02918266|615606534|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
170346302|NCT02918266|615606535|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
170346303|NCT02918266|615606536|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
170346304|NCT02918266|615606537|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
170346305|NCT02918266|615606538|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
170346306|NCT02389816|615606539|FG000|Overall Study|Randomized but Not Treated|1|||
170346307|NCT02389816|615606540|FG001|Overall Study|Randomized but Not Treated|0|||
170346308|NCT02389816|615606541|FG002|Overall Study|Randomized but Not Treated|0|||
170346309|NCT02389816|615606539|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
170346310|NCT02389816|615606540|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
170346311|NCT02389816|615606541|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
170346312|NCT02389816|615606539|FG000|Overall Study|Major Protocol Deviation|1|||
170346313|NCT02389816|615606540|FG001|Overall Study|Major Protocol Deviation|0|||
170346314|NCT02389816|615606541|FG002|Overall Study|Major Protocol Deviation|0|||
170346315|NCT02389816|615606539|FG000|Overall Study|Lost to Follow-up|1|||
170346316|NCT02389816|615606540|FG001|Overall Study|Lost to Follow-up|0|||
170346317|NCT02389816|615606541|FG002|Overall Study|Lost to Follow-up|0|||
170346318|NCT02389816|615606539|FG000|Overall Study|Withdrawal of Consent|6|||
170346319|NCT02389816|615606540|FG001|Overall Study|Withdrawal of Consent|4|||
170346320|NCT02389816|615606541|FG002|Overall Study|Withdrawal of Consent|4|||
170346321|NCT02389816|615606539|FG000|Overall Study|Lack of Efficacy|1|||
170346322|NCT02389816|615606540|FG001|Overall Study|Lack of Efficacy|0|||
170346323|NCT02389816|615606541|FG002|Overall Study|Lack of Efficacy|0|||
170346324|NCT02389816|615606539|FG000|Overall Study|Non Compliance with Study Drug|1|||
170399299|NCT03193190|615799940|FG003|Stage 1|Physician Decision|0|||
170346325|NCT02389816|615606540|FG001|Overall Study|Non Compliance with Study Drug|1|||
170346326|NCT02389816|615606541|FG002|Overall Study|Non Compliance with Study Drug|1|||
170346327|NCT02389816|615606539|FG000|Overall Study|Reason not Specified|0|||
170346328|NCT02389816|615606540|FG001|Overall Study|Reason not Specified|2|||
170346329|NCT02389816|615606541|FG002|Overall Study|Reason not Specified|0|||
170346330|NCT01842308|615606548|FG000|Overall Study|Withdrawal by Subject|0|||
170346331|NCT01842308|615606549|FG001|Overall Study|Withdrawal by Subject|0|||
170346332|NCT01842308|615606550|FG002|Overall Study|Withdrawal by Subject|0|||
170346333|NCT01842308|615606551|FG003|Overall Study|Withdrawal by Subject|0|||
170346334|NCT01842308|615606552|FG004|Overall Study|Withdrawal by Subject|1|||
170346335|NCT00578864|615606553|FG000|Overall Study|Death|1|||
170346336|NCT00578864|615606554|FG001|Overall Study|Death|0|||
170346337|NCT01253044|615606558|FG000|Overall Study|Lost to Follow-up|38|||
170346338|NCT01253044|615606559|FG001|Overall Study|Lost to Follow-up|29|||
170346339|NCT01594476|615606560|FG000|Overall Study|Protocol Violation|1|||
170346340|NCT01594476|615606561|FG001|Overall Study|Protocol Violation|3|||
170346341|NCT03161678|615606562|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
170346342|NCT03161678|615606563|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
170346343|NCT03161678|615606564|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
170346344|NCT03161678|615606565|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
170346345|NCT03161678|615606566|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
170346346|NCT03161678|615606567|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
170346347|NCT03161678|615606562|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
170346348|NCT03161678|615606563|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
170346349|NCT03161678|615606564|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
170346350|NCT03161678|615606565|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
170346351|NCT03161678|615606566|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
170346352|NCT03161678|615606567|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
170346353|NCT03161678|615606562|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
170346354|NCT03161678|615606563|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
170346355|NCT03161678|615606564|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
170346356|NCT03161678|615606565|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
170346357|NCT03161678|615606566|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
170346358|NCT03161678|615606567|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
170346359|NCT03161678|615606562|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
170346360|NCT03161678|615606563|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
170346361|NCT03161678|615606564|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
170346362|NCT03161678|615606565|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
170346363|NCT03161678|615606566|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
170346364|NCT03161678|615606567|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
170346365|NCT00752609|615606568|FG000|Overall Study|Adverse Event|2|||
170346366|NCT00752609|615606569|FG001|Overall Study|Adverse Event|2|||
170346367|NCT00752609|615606568|FG000|Overall Study|Withdrawal by Subject|3|||
170346368|NCT00752609|615606569|FG001|Overall Study|Withdrawal by Subject|0|||
170346369|NCT00752609|615606568|FG000|Overall Study|Physician Decision|1|||
170346370|NCT00752609|615606569|FG001|Overall Study|Physician Decision|0|||
170346371|NCT00752609|615606568|FG000|Overall Study|Death|1|||
170346372|NCT00752609|615606569|FG001|Overall Study|Death|0|||
170346373|NCT00752609|615606568|FG000|Overall Study|Met exclusion criteria|1|||
170346374|NCT00752609|615606569|FG001|Overall Study|Met exclusion criteria|0|||
170346375|NCT00752609|615606568|FG000|Overall Study|Received Aranesp in error|1|||
170346376|NCT00752609|615606569|FG001|Overall Study|Received Aranesp in error|0|||
170346377|NCT05692154|615606570|FG000|Overall Study|Adverse Event|0|||
170346378|NCT05692154|615606571|FG001|Overall Study|Adverse Event|1|||
170346379|NCT03609359|615606574|FG000|Overall Study|Progression of primary disease (PD)|25|||
170346380|NCT03609359|615606574|FG000|Overall Study|Patient's refusal|1|||
170346381|NCT03609359|615606574|FG000|Overall Study|Physician Decision|1|||
170346382|NCT03609359|615606574|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
170346383|NCT00740779|615606575|FG000|Overall Study|Adverse Event|4|||
170346384|NCT00740779|615606576|FG001|Overall Study|Adverse Event|6|||
170346385|NCT00740779|615606577|FG002|Overall Study|Adverse Event|3|||
170346386|NCT00740779|615606575|FG000|Overall Study|Protocol Violation|1|||
170346387|NCT00740779|615606576|FG001|Overall Study|Protocol Violation|1|||
170346388|NCT00740779|615606577|FG002|Overall Study|Protocol Violation|1|||
170346389|NCT00740779|615606575|FG000|Overall Study|Lack of Efficacy|0|||
170346390|NCT00740779|615606576|FG001|Overall Study|Lack of Efficacy|0|||
170346391|NCT00740779|615606577|FG002|Overall Study|Lack of Efficacy|2|||
170346392|NCT00740779|615606575|FG000|Overall Study|Withdrawal by Subject|2|||
170346393|NCT00740779|615606576|FG001|Overall Study|Withdrawal by Subject|4|||
170346394|NCT00740779|615606577|FG002|Overall Study|Withdrawal by Subject|2|||
170346395|NCT00740779|615606575|FG000|Overall Study|Lost to Follow-up|2|||
170346396|NCT00740779|615606576|FG001|Overall Study|Lost to Follow-up|3|||
170346397|NCT00740779|615606577|FG002|Overall Study|Lost to Follow-up|5|||
170346398|NCT00988559|615606583|FG000|Overall Study|Withdrawal by Subject|1|||
170346399|NCT00988559|615606584|FG001|Overall Study|Withdrawal by Subject|1|||
170346400|NCT00988559|615606585|FG002|Overall Study|Withdrawal by Subject|0|||
170346401|NCT00988559|615606586|FG003|Overall Study|Withdrawal by Subject|1|||
170346402|NCT00988559|615606583|FG000|Overall Study|Pregnancy|0|||
170346403|NCT00988559|615606584|FG001|Overall Study|Pregnancy|1|||
170346404|NCT00988559|615606585|FG002|Overall Study|Pregnancy|1|||
170346405|NCT00988559|615606586|FG003|Overall Study|Pregnancy|0|||
170346406|NCT00988559|615606583|FG000|Overall Study|Lost to Follow-up|0|||
170346407|NCT00988559|615606584|FG001|Overall Study|Lost to Follow-up|0|||
170346408|NCT00988559|615606585|FG002|Overall Study|Lost to Follow-up|1|||
170346409|NCT00988559|615606586|FG003|Overall Study|Lost to Follow-up|0|||
170346410|NCT03007953|615606587|FG000|Overall Study|Withdrawal by Subject|5|||
170346411|NCT03007953|615606588|FG001|Overall Study|Withdrawal by Subject|2|||
170346412|NCT03007953|615606587|FG000|Overall Study|Death|5|||
170346413|NCT03007953|615606588|FG001|Overall Study|Death|7|||
170346414|NCT03007953|615606587|FG000|Overall Study|Lost to Follow-up|3|||
170346415|NCT03007953|615606588|FG001|Overall Study|Lost to Follow-up|2|||
170346416|NCT03007953|615606587|FG000|Overall Study|Enrolled in Hospice|3|||
170346417|NCT03007953|615606588|FG001|Overall Study|Enrolled in Hospice|2|||
170346418|NCT02144220|615606591|FG000|Overall Study|technology incompatibility|9|||
170346419|NCT02144220|615606591|FG000|Overall Study|Lack of Efficacy|4|||
170346420|NCT02144220|615606591|FG000|Overall Study|Physician Decision|3|||
170346421|NCT02144220|615606591|FG000|Overall Study|Withdrawal by Subject|2|||
170346422|NCT02144220|615606591|FG000|Overall Study|Protocol Violation|1|||
170346423|NCT00540449|615606592|FG000|Overall Study|Adverse Event|12|||
170346424|NCT00540449|615606593|FG001|Overall Study|Adverse Event|32|||
170346425|NCT00540449|615606592|FG000|Overall Study|Sponsor's Decision|1|||
170346426|NCT00540449|615606593|FG001|Overall Study|Sponsor's Decision|1|||
170346427|NCT00540449|615606592|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
170346428|NCT00540449|615606593|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
170346429|NCT00540449|615606592|FG000|Overall Study|Lost to Follow-up|19|||
170346430|NCT00540449|615606593|FG001|Overall Study|Lost to Follow-up|17|||
170346431|NCT00540449|615606592|FG000|Overall Study|Subject Non-Compliant|7|||
170346432|NCT00540449|615606593|FG001|Overall Study|Subject Non-Compliant|5|||
170346433|NCT00540449|615606592|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
170346434|NCT00540449|615606593|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
170346435|NCT00540449|615606592|FG000|Overall Study|Withdrawal by Subject|10|||
170346436|NCT00540449|615606593|FG001|Overall Study|Withdrawal by Subject|10|||
170346437|NCT00540449|615606592|FG000|Overall Study|Other|1|||
170346438|NCT00540449|615606593|FG001|Overall Study|Other|4|||
170346439|NCT00804193|615606594|FG000|Overall Study|Lack of baseline fungus|32|||
170346440|NCT00804193|615606595|FG001|Overall Study|Lack of baseline fungus|31|||
170346441|NCT00804193|615606596|FG002|Overall Study|Lack of baseline fungus|19|||
170346442|NCT00804193|615606594|FG000|Overall Study|Adverse Event|0|||
170346443|NCT00804193|615606595|FG001|Overall Study|Adverse Event|0|||
170346444|NCT00804193|615606596|FG002|Overall Study|Adverse Event|2|||
170346445|NCT00804193|615606594|FG000|Overall Study|Lack of Efficacy|1|||
170346446|NCT00804193|615606595|FG001|Overall Study|Lack of Efficacy|1|||
170346447|NCT00804193|615606596|FG002|Overall Study|Lack of Efficacy|3|||
170346448|NCT00804193|615606594|FG000|Overall Study|Protocol Violation|0|||
170346449|NCT00804193|615606595|FG001|Overall Study|Protocol Violation|8|||
170346450|NCT00804193|615606596|FG002|Overall Study|Protocol Violation|2|||
170346451|NCT00804193|615606594|FG000|Overall Study|Lost to Follow-up|3|||
170346452|NCT00804193|615606595|FG001|Overall Study|Lost to Follow-up|3|||
170346453|NCT00804193|615606596|FG002|Overall Study|Lost to Follow-up|4|||
170346454|NCT00804193|615606594|FG000|Overall Study|Withdrawal by Subject|3|||
170346455|NCT00804193|615606595|FG001|Overall Study|Withdrawal by Subject|1|||
170346456|NCT00804193|615606596|FG002|Overall Study|Withdrawal by Subject|2|||
170346457|NCT00968253|615606597|FG000|Overall Study|Death|0|||
170346458|NCT00968253|615606598|FG001|Overall Study|Death|0|||
170346459|NCT00968253|615606599|FG002|Overall Study|Death|2|||
170346460|NCT00968253|615606597|FG000|Overall Study|Withdrawal by Subject|0|||
170346461|NCT00968253|615606598|FG001|Overall Study|Withdrawal by Subject|0|||
170346462|NCT00968253|615606599|FG002|Overall Study|Withdrawal by Subject|1|||
170346463|NCT00968253|615606597|FG000|Overall Study|Disease Progression|0|||
170346464|NCT00968253|615606598|FG001|Overall Study|Disease Progression|3|||
170346465|NCT00968253|615606599|FG002|Overall Study|Disease Progression|3|||
170346466|NCT00968253|615606597|FG000|Overall Study|Adverse Event|0|||
170346467|NCT00968253|615606598|FG001|Overall Study|Adverse Event|0|||
170346468|NCT00968253|615606599|FG002|Overall Study|Adverse Event|1|||
170346469|NCT03342469|615606600|FG000|Overall Study|Withdrawal by Subject|0|||
170346470|NCT03342469|615606601|FG001|Overall Study|Withdrawal by Subject|1|||
170346471|NCT03342469|615606602|FG002|Overall Study|Withdrawal by Subject|0|||
170346472|NCT03342469|615606603|FG003|Overall Study|Withdrawal by Subject|0|||
170346473|NCT02429427|615606608|FG000|Overall Study|Adverse Event|220|||
170346474|NCT02429427|615606609|FG001|Overall Study|Adverse Event|92|||
170346475|NCT02429427|615606608|FG000|Overall Study|Protocol Violation|10|||
170346476|NCT02429427|615606609|FG001|Overall Study|Protocol Violation|6|||
170346477|NCT02429427|615606608|FG000|Overall Study|Lost to Follow-up|15|||
170346478|NCT02429427|615606609|FG001|Overall Study|Lost to Follow-up|6|||
170346479|NCT02429427|615606608|FG000|Overall Study|Withdrawal by Subject|64|||
170346480|NCT02429427|615606609|FG001|Overall Study|Withdrawal by Subject|34|||
170346481|NCT02429427|615606608|FG000|Overall Study|Other|62|||
170346482|NCT02429427|615606609|FG001|Overall Study|Other|41|||
170346483|NCT00309777|615606610|FG000|Overall Study|Adverse Event|13|||
170346484|NCT00309777|615606611|FG001|Overall Study|Adverse Event|2|||
170346485|NCT00309777|615606612|FG002|Overall Study|Adverse Event|8|||
170346486|NCT00309777|615606613|FG003|Overall Study|Adverse Event|1|||
170346487|NCT00309777|615606610|FG000|Overall Study|Protocol Violation|4|||
170346488|NCT00309777|615606611|FG001|Overall Study|Protocol Violation|1|||
170346489|NCT00309777|615606612|FG002|Overall Study|Protocol Violation|3|||
170346490|NCT00309777|615606613|FG003|Overall Study|Protocol Violation|1|||
170346491|NCT00309777|615606610|FG000|Overall Study|Withdrawal by Subject|6|||
170346492|NCT00309777|615606611|FG001|Overall Study|Withdrawal by Subject|5|||
170346493|NCT00309777|615606612|FG002|Overall Study|Withdrawal by Subject|7|||
170346494|NCT00309777|615606613|FG003|Overall Study|Withdrawal by Subject|2|||
170346495|NCT00309777|615606610|FG000|Overall Study|Lost to Follow-up|0|||
170346496|NCT00309777|615606611|FG001|Overall Study|Lost to Follow-up|0|||
170346497|NCT00309777|615606612|FG002|Overall Study|Lost to Follow-up|1|||
170346498|NCT00309777|615606613|FG003|Overall Study|Lost to Follow-up|0|||
170346499|NCT00309777|615606610|FG000|Overall Study|Death|0|||
170346500|NCT00309777|615606611|FG001|Overall Study|Death|1|||
170346501|NCT00309777|615606612|FG002|Overall Study|Death|0|||
170346502|NCT00309777|615606613|FG003|Overall Study|Death|0|||
170346503|NCT05306873|615608452|FG000|Stage 2|Study stopped|1|||
170346504|NCT05306873|615608453|FG001|Stage 2|Study stopped|1|||
170346505|NCT05306873|615608454|FG002|Stage 2|Study stopped|0|||
170346506|NCT05306873|615608455|FG003|Stage 2|Study stopped|0|||
170346507|NCT05306873|615608452|FG000|Stage 2|Stage 2 Treatment Failure|2|||
170346508|NCT05306873|615608453|FG001|Stage 2|Stage 2 Treatment Failure|3|||
170346509|NCT05306873|615608454|FG002|Stage 2|Stage 2 Treatment Failure|0|||
170346510|NCT05306873|615608455|FG003|Stage 2|Stage 2 Treatment Failure|0|||
170346511|NCT05306873|615608452|FG000|Stage 2|Logistical issues due to participant moving|1|||
170346512|NCT05306873|615608453|FG001|Stage 2|Logistical issues due to participant moving|0|||
170346513|NCT05306873|615608454|FG002|Stage 2|Logistical issues due to participant moving|0|||
170346514|NCT05306873|615608455|FG003|Stage 2|Logistical issues due to participant moving|0|||
170346515|NCT05306873|615608452|FG000|Stage 3|Stage 3 Treatment Failure|0|||
170346516|NCT05306873|615608453|FG001|Stage 3|Stage 3 Treatment Failure|0|||
170346517|NCT05306873|615608454|FG002|Stage 3|Stage 3 Treatment Failure|0|||
170346518|NCT05306873|615608455|FG003|Stage 3|Stage 3 Treatment Failure|1|||
170346519|NCT05306873|615608452|FG000|Stage 3|Study Stopped|0|||
170346520|NCT05306873|615608453|FG001|Stage 3|Study Stopped|0|||
170346521|NCT05306873|615608454|FG002|Stage 3|Study Stopped|1|||
170346522|NCT05306873|615608455|FG003|Stage 3|Study Stopped|0|||
170346523|NCT00755846|615608456|FG000|Overall Study|Adverse Event|0|||
170346524|NCT00755846|615608457|FG001|Overall Study|Adverse Event|0|||
170346525|NCT00755846|615608458|FG002|Overall Study|Adverse Event|0|||
170346526|NCT00755846|615608459|FG003|Overall Study|Adverse Event|1|||
170346527|NCT00755846|615608460|FG004|Overall Study|Adverse Event|3|||
170346528|NCT00755846|615608461|FG005|Overall Study|Adverse Event|2|||
170346529|NCT00755846|615608456|FG000|Overall Study|Protocol Violation|1|||
170346530|NCT00755846|615608457|FG001|Overall Study|Protocol Violation|1|||
170346531|NCT00755846|615608458|FG002|Overall Study|Protocol Violation|1|||
170346532|NCT00755846|615608459|FG003|Overall Study|Protocol Violation|1|||
170346533|NCT00755846|615608460|FG004|Overall Study|Protocol Violation|1|||
170346534|NCT00755846|615608461|FG005|Overall Study|Protocol Violation|1|||
170346535|NCT00755846|615608456|FG000|Overall Study|Lost to Follow-up|0|||
170346536|NCT00755846|615608457|FG001|Overall Study|Lost to Follow-up|2|||
170346537|NCT00755846|615608458|FG002|Overall Study|Lost to Follow-up|1|||
170346538|NCT00755846|615608459|FG003|Overall Study|Lost to Follow-up|0|||
170346539|NCT00755846|615608460|FG004|Overall Study|Lost to Follow-up|4|||
170346540|NCT00755846|615608461|FG005|Overall Study|Lost to Follow-up|2|||
170346541|NCT00755846|615608456|FG000|Overall Study|Withdrawal by Subject|2|||
170346542|NCT00755846|615608457|FG001|Overall Study|Withdrawal by Subject|3|||
170346543|NCT00755846|615608458|FG002|Overall Study|Withdrawal by Subject|5|||
170346544|NCT00755846|615608459|FG003|Overall Study|Withdrawal by Subject|2|||
170346545|NCT00755846|615608460|FG004|Overall Study|Withdrawal by Subject|0|||
170346546|NCT00755846|615608461|FG005|Overall Study|Withdrawal by Subject|1|||
170346547|NCT00755846|615608456|FG000|Overall Study|Hyperglycemic Rescue|21|||
170346548|NCT00755846|615608457|FG001|Overall Study|Hyperglycemic Rescue|7|||
170346549|NCT00755846|615608458|FG002|Overall Study|Hyperglycemic Rescue|5|||
170346550|NCT00755846|615608459|FG003|Overall Study|Hyperglycemic Rescue|8|||
170346551|NCT00755846|615608460|FG004|Overall Study|Hyperglycemic Rescue|8|||
170346552|NCT00755846|615608461|FG005|Overall Study|Hyperglycemic Rescue|7|||
170346553|NCT00755846|615608456|FG000|Overall Study|Physician Decision|1|||
170346554|NCT00755846|615608457|FG001|Overall Study|Physician Decision|3|||
170346555|NCT00755846|615608458|FG002|Overall Study|Physician Decision|0|||
170346556|NCT00755846|615608459|FG003|Overall Study|Physician Decision|1|||
170346557|NCT00755846|615608460|FG004|Overall Study|Physician Decision|0|||
170346558|NCT00755846|615608461|FG005|Overall Study|Physician Decision|1|||
170346559|NCT00755846|615608456|FG000|Overall Study|Administrative Error|0|||
170346560|NCT00755846|615608457|FG001|Overall Study|Administrative Error|1|||
170346561|NCT00755846|615608458|FG002|Overall Study|Administrative Error|0|||
170346562|NCT00755846|615608459|FG003|Overall Study|Administrative Error|0|||
170346563|NCT00755846|615608460|FG004|Overall Study|Administrative Error|0|||
170346564|NCT00755846|615608461|FG005|Overall Study|Administrative Error|0|||
170346565|NCT00755846|615608456|FG000|Overall Study|Participant Non-compliance|0|||
170346566|NCT00755846|615608457|FG001|Overall Study|Participant Non-compliance|0|||
170346567|NCT00755846|615608458|FG002|Overall Study|Participant Non-compliance|0|||
170346568|NCT00755846|615608459|FG003|Overall Study|Participant Non-compliance|0|||
170346569|NCT00755846|615608460|FG004|Overall Study|Participant Non-compliance|1|||
170346570|NCT00755846|615608461|FG005|Overall Study|Participant Non-compliance|0|||
170346571|NCT02614287|615608462|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
170346572|NCT02614287|615608463|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
170346573|NCT02614287|615608462|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
170346574|NCT02614287|615608463|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
170346575|NCT02614287|615608462|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
170346576|NCT02614287|615608463|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
170346577|NCT02614287|615608462|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
170346578|NCT02614287|615608463|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
170346579|NCT02614287|615608462|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
170346580|NCT02614287|615608463|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
170346581|NCT02614287|615608462|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
170346582|NCT02614287|615608463|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
170346583|NCT02614287|615608462|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
170346584|NCT02614287|615608463|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
170346585|NCT02614287|615608462|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
170346586|NCT02614287|615608463|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
170346587|NCT00418834|615608464|FG000|Overall Study|Adverse Event|16|||
170346588|NCT00418834|615608465|FG001|Overall Study|Adverse Event|9|||
170346589|NCT00418834|615608464|FG000|Overall Study|Lost to Follow-up|0|||
170346590|NCT00418834|615608465|FG001|Overall Study|Lost to Follow-up|1|||
170346591|NCT00418834|615608464|FG000|Overall Study|Protocol Violation|4|||
170346592|NCT00418834|615608465|FG001|Overall Study|Protocol Violation|3|||
170346593|NCT00418834|615608464|FG000|Overall Study|Withdrawal by Subject|3|||
170346594|NCT00418834|615608465|FG001|Overall Study|Withdrawal by Subject|7|||
170346595|NCT01953328|615608466|FG000|Overall Study|Withdrawal by Subject|0|||
170346596|NCT01953328|615608467|FG001|Overall Study|Withdrawal by Subject|0|||
170346597|NCT01953328|615608468|FG002|Overall Study|Withdrawal by Subject|0|||
170346598|NCT01953328|615608469|FG003|Overall Study|Withdrawal by Subject|0|||
170346599|NCT01953328|615608470|FG004|Overall Study|Withdrawal by Subject|1|||
170346600|NCT01953328|615608471|FG005|Overall Study|Withdrawal by Subject|0|||
170346601|NCT01953328|615608472|FG006|Overall Study|Withdrawal by Subject|0|||
170346602|NCT01953328|615608473|FG007|Overall Study|Withdrawal by Subject|0|||
170346603|NCT01953328|615608466|FG000|Overall Study|Lost to Follow-up|0|||
170346604|NCT01953328|615608467|FG001|Overall Study|Lost to Follow-up|0|||
170346605|NCT01953328|615608468|FG002|Overall Study|Lost to Follow-up|0|||
170346606|NCT01953328|615608469|FG003|Overall Study|Lost to Follow-up|0|||
170346607|NCT01953328|615608470|FG004|Overall Study|Lost to Follow-up|1|||
170346608|NCT01953328|615608471|FG005|Overall Study|Lost to Follow-up|0|||
170346609|NCT01953328|615608472|FG006|Overall Study|Lost to Follow-up|0|||
170346610|NCT01953328|615608473|FG007|Overall Study|Lost to Follow-up|0|||
170346611|NCT05113953|615608479|FG000|Overall Study|Adverse Event|5|||
170346612|NCT05113953|615608480|FG001|Overall Study|Adverse Event|0|||
170346613|NCT05113953|615608481|FG002|Overall Study|Adverse Event|3|||
170346614|NCT05113953|615608479|FG000|Overall Study|Lost to Follow-up|3|||
170346615|NCT05113953|615608480|FG001|Overall Study|Lost to Follow-up|4|||
170346616|NCT05113953|615608481|FG002|Overall Study|Lost to Follow-up|2|||
170346617|NCT05113953|615608479|FG000|Overall Study|Non-compliance with Study Drug|1|||
170346618|NCT05113953|615608480|FG001|Overall Study|Non-compliance with Study Drug|0|||
170346619|NCT05113953|615608481|FG002|Overall Study|Non-compliance with Study Drug|0|||
170346620|NCT05113953|615608479|FG000|Overall Study|Withdrawal by Subject|2|||
170346621|NCT05113953|615608480|FG001|Overall Study|Withdrawal by Subject|6|||
170346622|NCT05113953|615608481|FG002|Overall Study|Withdrawal by Subject|4|||
170346623|NCT05113953|615608479|FG000|Overall Study|Reason not Specified|2|||
170346624|NCT05113953|615608480|FG001|Overall Study|Reason not Specified|0|||
170346625|NCT05113953|615608481|FG002|Overall Study|Reason not Specified|0|||
170346626|NCT01520324|615608487|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
170346627|NCT02340819|615608488|FG000|Overall Study|Adverse Event|1|||
170346628|NCT02340819|615608488|FG000|Overall Study|Withdrawal by Subject|2|||
170346629|NCT02340819|615608488|FG000|Overall Study|Discontinued with other reason|1|||
170346630|NCT00502307|615608491|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
170346631|NCT00502307|615608492|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
170346632|NCT00502307|615608493|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
170346633|NCT00502307|615608491|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
170346634|NCT00502307|615608492|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
170346635|NCT00502307|615608493|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
170346636|NCT00502307|615608491|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
170346637|NCT00502307|615608492|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
170346638|NCT00502307|615608493|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
170346639|NCT00502307|615608491|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
170346640|NCT00502307|615608492|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
170346641|NCT00502307|615608493|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
170346642|NCT00502307|615608491|FG000|Maintenance Period|Progressive disease|80|||
170346643|NCT00502307|615608492|FG001|Maintenance Period|Progressive disease|0|||
170346644|NCT00502307|615608493|FG002|Maintenance Period|Progressive disease|0|||
170346645|NCT00502307|615608491|FG000|Maintenance Period|Discontinued due to other reasons|68|||
170346646|NCT00502307|615608492|FG001|Maintenance Period|Discontinued due to other reasons|0|||
170346647|NCT00502307|615608493|FG002|Maintenance Period|Discontinued due to other reasons|0|||
170346648|NCT00495495|615608495|FG000|Overall Study|Protocol Violation|99|||
170346649|NCT00434512|615608501|FG000|Overall Study|Migrated/moved from study area|0|||
170346650|NCT00434512|615608502|FG001|Overall Study|Migrated/moved from study area|0|||
170346651|NCT00434512|615608503|FG002|Overall Study|Migrated/moved from study area|0|||
170346652|NCT00434512|615608504|FG003|Overall Study|Migrated/moved from study area|1|||
170346653|NCT00434512|615608505|FG004|Overall Study|Migrated/moved from study area|1|||
170346654|NCT00434512|615608506|FG005|Overall Study|Migrated/moved from study area|1|||
170346655|NCT00434512|615608501|FG000|Overall Study|Other|0|||
170346656|NCT00434512|615608502|FG001|Overall Study|Other|1|||
170346657|NCT00434512|615608503|FG002|Overall Study|Other|0|||
170346658|NCT00434512|615608504|FG003|Overall Study|Other|0|||
170346659|NCT00434512|615608505|FG004|Overall Study|Other|0|||
170346660|NCT00434512|615608506|FG005|Overall Study|Other|0|||
170346661|NCT04467164|615608508|FG000|Washout (1 Week)|Lost to Follow-up|2|||
170346662|NCT04467164|615608509|FG001|Washout (1 Week)|Lost to Follow-up|0|||
170346663|NCT02245568|615608511|FG000|Overall Study|Study terminated by Sponsor|346|||
170346664|NCT02245568|615608511|FG000|Overall Study|Adverse Event|144|||
170346665|NCT02245568|615608511|FG000|Overall Study|Lack of Efficacy|98|||
170346666|NCT02245568|615608511|FG000|Overall Study|Withdrawal by Caregiver|85|||
170346667|NCT02245568|615608511|FG000|Overall Study|Withdrawal by Subject|77|||
170346668|NCT02245568|615608511|FG000|Overall Study|Withdrawal by Legal Representative|31|||
170346669|NCT02245568|615608511|FG000|Overall Study|Missing (Site closure)|16|||
170346670|NCT02245568|615608511|FG000|Overall Study|Physician Decision|14|||
170346671|NCT02245568|615608511|FG000|Overall Study|Non-compliance with study drug|11|||
170346672|NCT02245568|615608511|FG000|Overall Study|Death|9|||
170346673|NCT02245568|615608511|FG000|Overall Study|Blue staining|6|||
170346674|NCT02245568|615608511|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
170346675|NCT02245568|615608511|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
170346676|NCT02245568|615608511|FG000|Overall Study|Lost to Follow-up|5|||
170346677|NCT00441441|615608516|FG000|Overall Study|Adverse Event|2|||
170346678|NCT00441441|615608517|FG001|Overall Study|Adverse Event|1|||
170346679|NCT00441441|615608516|FG000|Overall Study|Protocol Violation|4|||
170346680|NCT00441441|615608517|FG001|Overall Study|Protocol Violation|6|||
170346681|NCT00441441|615608516|FG000|Overall Study|Exacerbation of asthma|1|||
170346682|NCT00441441|615608517|FG001|Overall Study|Exacerbation of asthma|2|||
170346683|NCT00441441|615608516|FG000|Overall Study|Withdrawal by Subject|1|||
170346684|NCT00441441|615608517|FG001|Overall Study|Withdrawal by Subject|2|||
170346685|NCT00441441|615608516|FG000|Overall Study|Other|3|||
170346686|NCT00441441|615608517|FG001|Overall Study|Other|3|||
170346687|NCT02273050|615608518|FG000|Overall Study|Adverse Event|4|||
170346688|NCT02273050|615608519|FG001|Overall Study|Adverse Event|3|||
170346689|NCT02273050|615608520|FG002|Overall Study|Adverse Event|3|||
170346690|NCT02273050|615608518|FG000|Overall Study|Death|0|||
170346691|NCT02273050|615608519|FG001|Overall Study|Death|0|||
170346692|NCT02273050|615608520|FG002|Overall Study|Death|1|||
170346693|NCT02273050|615608518|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
170346694|NCT02273050|615608519|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
170346695|NCT02273050|615608520|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
170346696|NCT02273050|615608518|FG000|Overall Study|Lack of Efficacy|0|||
170346697|NCT02273050|615608519|FG001|Overall Study|Lack of Efficacy|1|||
170346698|NCT02273050|615608520|FG002|Overall Study|Lack of Efficacy|1|||
170346699|NCT02273050|615608518|FG000|Overall Study|Withdrawal by Subject|17|||
170346700|NCT02273050|615608519|FG001|Overall Study|Withdrawal by Subject|14|||
170346701|NCT02273050|615608520|FG002|Overall Study|Withdrawal by Subject|16|||
170346702|NCT02273050|615608518|FG000|Overall Study|Lost to Follow-up|0|||
170346703|NCT02273050|615608519|FG001|Overall Study|Lost to Follow-up|2|||
170346704|NCT02273050|615608520|FG002|Overall Study|Lost to Follow-up|3|||
170346705|NCT02273050|615608518|FG000|Overall Study|Protocol Violation|3|||
170346706|NCT02273050|615608519|FG001|Overall Study|Protocol Violation|1|||
170346707|NCT02273050|615608520|FG002|Overall Study|Protocol Violation|4|||
170346708|NCT00262080|615608521|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
170346709|NCT00262080|615608522|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
170346710|NCT00262080|615608523|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
170346711|NCT00262080|615608521|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
170346712|NCT00262080|615608522|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
170346713|NCT00262080|615608523|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
170346714|NCT00262080|615608521|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
170346715|NCT00262080|615608522|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
170346716|NCT00262080|615608523|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
170346717|NCT00262080|615608521|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
170346718|NCT00262080|615608522|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
170346719|NCT00262080|615608523|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
170346720|NCT00262080|615608521|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
170346721|NCT00262080|615608522|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
170346722|NCT00262080|615608523|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
170346723|NCT00262080|615608521|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
170346724|NCT00262080|615608522|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
170346725|NCT00262080|615608523|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
170346726|NCT02044159|615608524|FG000|Overall Study|Consent declined (deferred consent)|2|||
170346727|NCT02044159|615608525|FG001|Overall Study|Consent declined (deferred consent)|4|||
170346728|NCT02044159|615608524|FG000|Overall Study|No longer eligible, drug not given|1|||
170346729|NCT02044159|615608525|FG001|Overall Study|No longer eligible, drug not given|0|||
170346730|NCT02044159|615608524|FG000|Overall Study|Nurse declined to give study drug|1|||
170346731|NCT02044159|615608525|FG001|Overall Study|Nurse declined to give study drug|0|||
170346732|NCT01111539|615608528|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
170346733|NCT01111539|615608529|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
170346734|NCT01111539|615608530|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
170346735|NCT01111539|615608531|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
170346736|NCT01111539|615608532|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
170346737|NCT01111539|615608528|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
170346738|NCT01111539|615608529|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
170346739|NCT01111539|615608530|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
170346740|NCT01111539|615608531|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
170346741|NCT01111539|615608532|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
170346742|NCT01111539|615608528|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
170346743|NCT01111539|615608529|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
170346744|NCT01111539|615608530|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
170346745|NCT01111539|615608531|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
170346746|NCT01111539|615608532|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
170346747|NCT01111539|615608528|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
170346748|NCT01111539|615608529|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
170346749|NCT01111539|615608530|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
170346750|NCT01111539|615608531|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
170346751|NCT01111539|615608532|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
170346752|NCT01111539|615608528|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
170346753|NCT01111539|615608529|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
170346754|NCT01111539|615608530|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
170346755|NCT01111539|615608531|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
170346756|NCT01111539|615608532|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
170346757|NCT01111539|615608528|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
170346758|NCT01111539|615608529|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
170346759|NCT01111539|615608530|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
170346760|NCT01111539|615608531|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
170346761|NCT01111539|615608532|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
170346762|NCT01111539|615608528|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
170346763|NCT01111539|615608529|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
170346764|NCT01111539|615608530|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
170346765|NCT01111539|615608531|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
170346766|NCT01111539|615608532|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
170346767|NCT01111539|615608528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
170346768|NCT01111539|615608529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
170346769|NCT01111539|615608530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
170346770|NCT01111539|615608531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
170346771|NCT01111539|615608532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
170346772|NCT01111539|615608528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170346773|NCT01111539|615608529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170346774|NCT01111539|615608530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
170346775|NCT01111539|615608531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
170346776|NCT01111539|615608532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
170346777|NCT01111539|615608528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
170346778|NCT01111539|615608529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
170346779|NCT01111539|615608530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
170346780|NCT01111539|615608531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
170346781|NCT01111539|615608532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
170346782|NCT01111539|615608528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
170346783|NCT01111539|615608529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
170346784|NCT01111539|615608530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
170346785|NCT01111539|615608531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
170346786|NCT01111539|615608532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
170346787|NCT01111539|615608528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
170346788|NCT01111539|615608529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
170346789|NCT01111539|615608530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
170346790|NCT01111539|615608531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
170346791|NCT01111539|615608532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
170346792|NCT01111539|615608528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
170346793|NCT01111539|615608529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
170346794|NCT01111539|615608530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
170346795|NCT01111539|615608531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
170346796|NCT01111539|615608532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
170346797|NCT01111539|615608528|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
170346798|NCT01111539|615608529|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
170346799|NCT01111539|615608530|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
170346800|NCT01111539|615608531|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
170346801|NCT01111539|615608532|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
170346802|NCT02808312|615608533|FG000|Overall Study|Enrolled but Never Treated|0|||
170346803|NCT02808312|615608534|FG001|Overall Study|Enrolled but Never Treated|0|||
170346804|NCT02808312|615608535|FG002|Overall Study|Enrolled but Never Treated|1|||
170346805|NCT02808312|615608536|FG003|Overall Study|Enrolled but Never Treated|0|||
170346806|NCT02808312|615608537|FG004|Overall Study|Enrolled but Never Treated|0|||
170346807|NCT02420223|615608538|FG000|Overall Study|Adverse Event|1|||
170346808|NCT02420223|615608539|FG001|Overall Study|Adverse Event|0|||
170346809|NCT02420223|615608538|FG000|Overall Study|Physician Decision|0|||
170346810|NCT02420223|615608539|FG001|Overall Study|Physician Decision|2|||
170346811|NCT00769704|615608540|FG000|Overall Study|Lost to Follow-up|3|||
170346812|NCT00769704|615608541|FG001|Overall Study|Lost to Follow-up|2|||
170346813|NCT00769704|615608540|FG000|Overall Study|Death|95|||
170346814|NCT00769704|615608541|FG001|Overall Study|Death|190|||
170346815|NCT00769704|615608540|FG000|Overall Study|Withdrawal by Subject|12|||
170346816|NCT00769704|615608541|FG001|Overall Study|Withdrawal by Subject|5|||
170346817|NCT00769704|615608540|FG000|Overall Study|Other|1|||
170346818|NCT00769704|615608541|FG001|Overall Study|Other|2|||
170346819|NCT03010423|615608542|FG000|Overall Study|Study termination|8|||
170346820|NCT00850759|615608547|FG000|Overall Study|Lost to Follow-up|7|||
170346821|NCT00850759|615608548|FG001|Overall Study|Lost to Follow-up|5|||
170346822|NCT00850759|615608549|FG002|Overall Study|Lost to Follow-up|5|||
170346823|NCT00850759|615608550|FG003|Overall Study|Lost to Follow-up|3|||
170346824|NCT01952834|615608555|FG000|Overall Study|Adverse Event|1|||
170346825|NCT01975272|615608558|FG000|Overall Study|Excluded after protocol amendment|1|||
170346826|NCT01975272|615608559|FG001|Overall Study|Excluded after protocol amendment|1|||
170346827|NCT01975272|615608560|FG002|Overall Study|Excluded after protocol amendment|2|||
170346828|NCT02224846|615608562|FG000|Period 1 (Month 3)|Adverse Event|2|||
170346829|NCT02224846|615608563|FG001|Period 1 (Month 3)|Adverse Event|1|||
170346830|NCT02224846|615608562|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
170346831|NCT02224846|615608563|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
170346832|NCT02224846|615608562|FG000|Period 1 (Month 3)|Protocol Violation|4|||
170346833|NCT02224846|615608563|FG001|Period 1 (Month 3)|Protocol Violation|8|||
170346834|NCT02224846|615608562|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
170346835|NCT02224846|615608563|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
170346836|NCT02224846|615608562|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
170346837|NCT02224846|615608563|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
170346838|NCT02224846|615608562|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
170346839|NCT02224846|615608563|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
170346840|NCT02224846|615608562|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
170346841|NCT02224846|615608563|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
170346842|NCT02224846|615608562|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
170346843|NCT02224846|615608563|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
170346844|NCT02224846|615608562|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
170346845|NCT02224846|615608563|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
170346846|NCT02224846|615608562|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
170346847|NCT02224846|615608563|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
170346848|NCT02224846|615608562|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
170346849|NCT02224846|615608563|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
170346850|NCT02224846|615608562|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
170346851|NCT02224846|615608563|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
170346852|NCT02224846|615608562|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
170346853|NCT02224846|615608563|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
170346854|NCT02224846|615608562|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
170346855|NCT02224846|615608563|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
170346856|NCT02224846|615608562|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
170346857|NCT02224846|615608563|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
170346858|NCT02224846|615608562|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
170346859|NCT02224846|615608563|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
170346860|NCT02224846|615608562|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
170346861|NCT02224846|615608563|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
170346862|NCT03196297|615608565|FG000|Main Period|Withdrawal by Subject|4|||
170346863|NCT03196297|615608565|FG000|Extension Period|Withdrawal by Subject|1|||
170346864|NCT03196297|615608565|FG000|Extension Period|Lack of Efficacy|2|||
170346865|NCT00829166|615608566|FG000|Overall Study|Death|305|||
170346866|NCT00829166|615608567|FG001|Overall Study|Death|333|||
170346867|NCT00829166|615608566|FG000|Overall Study|Lost to Follow-up|5|||
170346868|NCT00829166|615608567|FG001|Overall Study|Lost to Follow-up|4|||
170346869|NCT00829166|615608566|FG000|Overall Study|Physician's Decision|4|||
170346870|NCT00829166|615608567|FG001|Overall Study|Physician's Decision|3|||
170346871|NCT00829166|615608566|FG000|Overall Study|Subject's Decision|41|||
170346872|NCT00829166|615608567|FG001|Overall Study|Subject's Decision|55|||
170346873|NCT00829166|615608566|FG000|Overall Study|Sponsor's Decision|137|||
170346874|NCT00829166|615608567|FG001|Overall Study|Sponsor's Decision|98|||
170346875|NCT00829166|615608566|FG000|Overall Study|Reason Not Specified|3|||
170346876|NCT00829166|615608567|FG001|Overall Study|Reason Not Specified|3|||
170346877|NCT01954121|615608570|FG000|Overall Study|Lack of Efficacy|94|||
170346878|NCT01954121|615608571|FG001|Overall Study|Lack of Efficacy|41|||
170346879|NCT01954121|615608570|FG000|Overall Study|Protocol Violation|0|||
170346880|NCT01954121|615608571|FG001|Overall Study|Protocol Violation|2|||
170346881|NCT01954121|615608570|FG000|Overall Study|Lost to Follow-up|5|||
170346882|NCT01954121|615608571|FG001|Overall Study|Lost to Follow-up|6|||
170346883|NCT01954121|615608570|FG000|Overall Study|Withdrawal by Subject|18|||
170346884|NCT01954121|615608571|FG001|Overall Study|Withdrawal by Subject|12|||
170346885|NCT01954121|615608570|FG000|Overall Study|Pregnancy|1|||
170346886|NCT01954121|615608571|FG001|Overall Study|Pregnancy|1|||
170346887|NCT01954121|615608570|FG000|Overall Study|AE, serious fatal|1|||
170346888|NCT01954121|615608571|FG001|Overall Study|AE, serious fatal|0|||
170346889|NCT01954121|615608570|FG000|Overall Study|AE, non-serious non-fatal|5|||
170346890|NCT01954121|615608571|FG001|Overall Study|AE, non-serious non-fatal|22|||
170346891|NCT01954121|615608570|FG000|Overall Study|SAE, non-fatal|1|||
170346892|NCT01954121|615608571|FG001|Overall Study|SAE, non-fatal|4|||
170346893|NCT01954121|615608570|FG000|Overall Study|Non-compliant with study procedures|1|||
170346894|NCT01954121|615608571|FG001|Overall Study|Non-compliant with study procedures|0|||
170346895|NCT01954121|615608570|FG000|Overall Study|Non-compliant patient|1|||
170346896|NCT01954121|615608571|FG001|Overall Study|Non-compliant patient|1|||
170346897|NCT01954121|615608570|FG000|Overall Study|Subject did not follow instructions|0|||
170346898|NCT01954121|615608571|FG001|Overall Study|Subject did not follow instructions|2|||
170346899|NCT00872170|615608572|FG000|Overall Study|Adverse Event|1|||
170346900|NCT00872170|615608573|FG001|Overall Study|Adverse Event|0|||
170346901|NCT05515601|615608576|FG000|Overall Study|Withdrawal by Subject|1|||
170346902|NCT05515601|615608577|FG001|Overall Study|Withdrawal by Subject|3|||
170346903|NCT05515601|615608578|FG002|Overall Study|Withdrawal by Subject|2|||
170346904|NCT05515601|615608579|FG003|Overall Study|Withdrawal by Subject|1|||
170346905|NCT05515601|615608580|FG004|Overall Study|Withdrawal by Subject|1|||
170346906|NCT05515601|615608581|FG005|Overall Study|Withdrawal by Subject|1|||
170346907|NCT05515601|615608576|FG000|Overall Study|Lost to Follow-up|0|||
170346908|NCT05515601|615608577|FG001|Overall Study|Lost to Follow-up|0|||
170346909|NCT05515601|615608578|FG002|Overall Study|Lost to Follow-up|0|||
170346910|NCT05515601|615608579|FG003|Overall Study|Lost to Follow-up|0|||
170346911|NCT05515601|615608580|FG004|Overall Study|Lost to Follow-up|1|||
170346912|NCT05515601|615608581|FG005|Overall Study|Lost to Follow-up|0|||
170346913|NCT00540436|615608582|FG000|First 12-Week Treatment Period|Adverse Event|1|||
170346914|NCT00540436|615608582|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
170346915|NCT00540436|615608582|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
170346916|NCT00540436|615608582|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
170346917|NCT02928406|615608583|FG000|Overall Study|Death|780|||
170346918|NCT02928406|615608583|FG000|Overall Study|Progressive disease|3|||
170346919|NCT02928406|615608583|FG000|Overall Study|Lost to Follow-up|49|||
170346920|NCT02928406|615608583|FG000|Overall Study|Non-compliance|2|||
170346921|NCT02928406|615608583|FG000|Overall Study|Withdrawal by Subject|40|||
170346922|NCT02928406|615608583|FG000|Overall Study|Study terminated by sponsor|57|||
170346923|NCT02928406|615608583|FG000|Overall Study|Physician Decision|1|||
170346924|NCT02928406|615608583|FG000|Overall Study|Various reasons|72|||
170346925|NCT01515306|615608584|FG000|Overall Study|Adverse Event|3|||
170346926|NCT01515306|615608585|FG001|Overall Study|Adverse Event|2|||
170346927|NCT01515306|615608584|FG000|Overall Study|Progressive Disease|19|||
170346928|NCT01515306|615608585|FG001|Overall Study|Progressive Disease|9|||
170346929|NCT01515306|615608584|FG000|Overall Study|Withdrawal by Subject|1|||
170346930|NCT01515306|615608585|FG001|Overall Study|Withdrawal by Subject|2|||
170346931|NCT01515306|615608584|FG000|Overall Study|Physician Decision|1|||
170346932|NCT01515306|615608585|FG001|Overall Study|Physician Decision|1|||
170346933|NCT01745393|615608587|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
170346934|NCT01745393|615608588|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
170346935|NCT01745393|615608587|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
170346936|NCT01745393|615608588|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
170346937|NCT01745393|615608587|FG000|12-month Follow-up|Lost to Follow-up|6|||
170346938|NCT01745393|615608588|FG001|12-month Follow-up|Lost to Follow-up|5|||
170346939|NCT00905021|615608593|FG000|Overall Study|Adverse Event|2|||
170346940|NCT00786838|615608594|FG000|Overall Study|Physician Decision|4|||
170346941|NCT00786838|615608594|FG000|Overall Study|Death|4|||
170346942|NCT00786838|615608594|FG000|Overall Study|Adverse Event|6|||
170346943|NCT00786838|615608594|FG000|Overall Study|Progressive disease|31|||
170346944|NCT00786838|615608594|FG000|Overall Study|Withdrawal by Subject|4|||
170346945|NCT02678780|615608595|FG000|Overall Study|Adverse Event|11|||
170346946|NCT02678780|615608596|FG001|Overall Study|Adverse Event|14|||
170346947|NCT02678780|615608595|FG000|Overall Study|Withdrawal by Subject|2|||
170346948|NCT02678780|615608596|FG001|Overall Study|Withdrawal by Subject|1|||
170346949|NCT02678780|615608595|FG000|Overall Study|Sponsor discontinuation|7|||
170346950|NCT02678780|615608596|FG001|Overall Study|Sponsor discontinuation|4|||
170346951|NCT02678780|615608595|FG000|Overall Study|Death|1|||
170346952|NCT02678780|615608596|FG001|Overall Study|Death|1|||
170346953|NCT02678780|615608595|FG000|Overall Study|Other|6|||
170346954|NCT02678780|615608596|FG001|Overall Study|Other|8|||
170346955|NCT05513391|615608597|FG000|Overall Study|Adverse Event|1|||
170346956|NCT05513391|615608598|FG001|Overall Study|Adverse Event|0|||
170346957|NCT05513391|615608597|FG000|Overall Study|Protocol Deviation|0|||
170346958|NCT05513391|615608598|FG001|Overall Study|Protocol Deviation|1|||
170346959|NCT05513391|615608597|FG000|Overall Study|Withdrawal by Subject|3|||
170346960|NCT05513391|615608598|FG001|Overall Study|Withdrawal by Subject|1|||
170346961|NCT05513391|615608597|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
170346962|NCT05513391|615608598|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
170346963|NCT05513391|615608597|FG000|Overall Study|Lost to Follow-up|0|||
170346964|NCT05513391|615608598|FG001|Overall Study|Lost to Follow-up|2|||
170346965|NCT00719732|615608599|FG000|Overall Study|Lost to Follow-up|20|||
170346966|NCT00719732|615608599|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
170346967|NCT00719732|615608599|FG000|Overall Study|Illness not associated with device|1|||
170346968|NCT00436215|615608600|FG000|Overall Study|Refused further treatment|3|||
170346969|NCT00436215|615608600|FG000|Overall Study|Small bowel obstruction|1|||
170346970|NCT02429258|615610550|FG000|Overall Study|Withdrawal by Subject|2|||
170346971|NCT02429258|615610551|FG001|Overall Study|Withdrawal by Subject|0|||
170346972|NCT02429258|615610550|FG000|Overall Study|Protocol Violation|0|||
170346973|NCT02429258|615610551|FG001|Overall Study|Protocol Violation|1|||
170346974|NCT00492856|615610552|FG000|Induction|Adverse Event|2|||
170346975|NCT00492856|615610553|FG001|Induction|Adverse Event|0|||
170346976|NCT00492856|615610554|FG002|Induction|Adverse Event|0|||
170346977|NCT00492856|615610555|FG003|Induction|Adverse Event|0|||
170346978|NCT00492856|615610552|FG000|Induction|Withdrawal by Subject|1|||
170346979|NCT00492856|615610553|FG001|Induction|Withdrawal by Subject|0|||
170346980|NCT00492856|615610554|FG002|Induction|Withdrawal by Subject|0|||
170346981|NCT00492856|615610555|FG003|Induction|Withdrawal by Subject|0|||
170346982|NCT00492856|615610552|FG000|Induction|Death|3|||
170346983|NCT00492856|615610553|FG001|Induction|Death|0|||
170346984|NCT00492856|615610554|FG002|Induction|Death|0|||
170346985|NCT00492856|615610555|FG003|Induction|Death|0|||
170346986|NCT00492856|615610552|FG000|Consolidation|Adverse Event|6|||
170346987|NCT00492856|615610553|FG001|Consolidation|Adverse Event|0|||
170346988|NCT00492856|615610554|FG002|Consolidation|Adverse Event|0|||
170346989|NCT00492856|615610555|FG003|Consolidation|Adverse Event|0|||
170346990|NCT00492856|615610552|FG000|Consolidation|Not protocol specified|2|||
170346991|NCT00492856|615610553|FG001|Consolidation|Not protocol specified|0|||
170346992|NCT00492856|615610554|FG002|Consolidation|Not protocol specified|0|||
170346993|NCT00492856|615610555|FG003|Consolidation|Not protocol specified|0|||
170346994|NCT00492856|615610552|FG000|Consolidation|Lost to Follow-up|1|||
170346995|NCT00492856|615610553|FG001|Consolidation|Lost to Follow-up|0|||
170346996|NCT00492856|615610554|FG002|Consolidation|Lost to Follow-up|0|||
170346997|NCT00492856|615610555|FG003|Consolidation|Lost to Follow-up|0|||
170346998|NCT00492856|615610552|FG000|Post-consolidation|Adverse Event|0|||
170346999|NCT00492856|615610553|FG001|Post-consolidation|Adverse Event|4|||
170347000|NCT00492856|615610554|FG002|Post-consolidation|Adverse Event|0|||
170347001|NCT00492856|615610555|FG003|Post-consolidation|Adverse Event|1|||
170347002|NCT00492856|615610552|FG000|Post-consolidation|Withdrawal by Subject|0|||
170347003|NCT00492856|615610553|FG001|Post-consolidation|Withdrawal by Subject|4|||
170347004|NCT00492856|615610554|FG002|Post-consolidation|Withdrawal by Subject|0|||
170347005|NCT00492856|615610555|FG003|Post-consolidation|Withdrawal by Subject|0|||
170347006|NCT00492856|615610552|FG000|Post-consolidation|Death|0|||
170347007|NCT00492856|615610553|FG001|Post-consolidation|Death|1|||
170347008|NCT00492856|615610554|FG002|Post-consolidation|Death|0|||
170347009|NCT00492856|615610555|FG003|Post-consolidation|Death|0|||
170347010|NCT00492856|615610552|FG000|Post-consolidation|Not protocol specified|0|||
170347011|NCT00492856|615610553|FG001|Post-consolidation|Not protocol specified|1|||
170347012|NCT00492856|615610554|FG002|Post-consolidation|Not protocol specified|0|||
170347013|NCT00492856|615610555|FG003|Post-consolidation|Not protocol specified|0|||
170347014|NCT00492856|615610552|FG000|Post-consolidation|Lost to Follow-up|0|||
170347015|NCT00492856|615610553|FG001|Post-consolidation|Lost to Follow-up|2|||
170347016|NCT00492856|615610554|FG002|Post-consolidation|Lost to Follow-up|0|||
170347017|NCT00492856|615610555|FG003|Post-consolidation|Lost to Follow-up|0|||
170347018|NCT00492856|615610552|FG000|Post-consolidation|Observation Arm|0|||
170347019|NCT00492856|615610553|FG001|Post-consolidation|Observation Arm|0|||
170347020|NCT00492856|615610554|FG002|Post-consolidation|Observation Arm|27|||
170347021|NCT00492856|615610555|FG003|Post-consolidation|Observation Arm|0|||
170347022|NCT03725202|615610558|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
170347023|NCT03725202|615610559|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
170347024|NCT03725202|615610560|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
170347025|NCT03725202|615610561|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
170347026|NCT03725202|615610562|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
170347027|NCT03725202|615610563|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
170347028|NCT03725202|615610564|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
170347029|NCT03725202|615610565|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
170347030|NCT03725202|615610558|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
170347031|NCT03725202|615610559|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
170347032|NCT03725202|615610560|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
170347033|NCT03725202|615610561|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
170347034|NCT03725202|615610562|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
170347035|NCT03725202|615610563|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
170347036|NCT03725202|615610564|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
170347037|NCT03725202|615610565|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
170347038|NCT03725202|615610558|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
170347039|NCT03725202|615610559|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
170347040|NCT03725202|615610560|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
170347041|NCT03725202|615610561|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
170347042|NCT03725202|615610562|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
170347043|NCT03725202|615610563|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
170347044|NCT03725202|615610564|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
170347045|NCT03725202|615610565|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
170347046|NCT03725202|615610558|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
170347047|NCT03725202|615610559|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
170347048|NCT03725202|615610560|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
170347049|NCT03725202|615610561|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
170347050|NCT03725202|615610562|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
170347051|NCT03725202|615610563|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
170347052|NCT03725202|615610564|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
170347053|NCT03725202|615610565|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
170347054|NCT03725202|615610558|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
170347055|NCT03725202|615610559|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
170347056|NCT03725202|615610560|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
170347057|NCT03725202|615610561|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
170347058|NCT03725202|615610562|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
170347059|NCT03725202|615610563|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
170347060|NCT03725202|615610564|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
170347061|NCT03725202|615610565|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
170347062|NCT03725202|615610558|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
170347063|NCT03725202|615610559|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
170347064|NCT03725202|615610560|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
170347065|NCT03725202|615610561|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
170347066|NCT03725202|615610562|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
170347067|NCT03725202|615610563|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
170399300|NCT03193190|615799941|FG004|Stage 1|Physician Decision|0|||
170347068|NCT03725202|615610564|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
170347069|NCT03725202|615610565|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
170347070|NCT03725202|615610558|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
170347071|NCT03725202|615610559|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
170347072|NCT03725202|615610560|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
170347073|NCT03725202|615610561|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
170347074|NCT03725202|615610562|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
170347075|NCT03725202|615610563|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
170347076|NCT03725202|615610564|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
170347077|NCT03725202|615610565|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
170347078|NCT03725202|615610558|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
170347079|NCT03725202|615610559|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
170347080|NCT03725202|615610560|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
170347081|NCT03725202|615610561|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
170347082|NCT03725202|615610562|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
170347083|NCT03725202|615610563|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
170347084|NCT03725202|615610564|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
170347085|NCT03725202|615610565|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
170347086|NCT03725202|615610558|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
170347087|NCT03725202|615610559|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
170347088|NCT03725202|615610560|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
170347089|NCT03725202|615610561|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
170347090|NCT03725202|615610562|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
170347091|NCT03725202|615610563|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
170347092|NCT03725202|615610564|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
170347093|NCT03725202|615610565|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
170347094|NCT03725202|615610558|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
170347095|NCT03725202|615610559|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
170347096|NCT03725202|615610560|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
170347097|NCT03725202|615610561|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
170347098|NCT03725202|615610562|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
170347099|NCT03725202|615610563|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
170347100|NCT03725202|615610564|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
170347101|NCT03725202|615610565|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
170347102|NCT03725202|615610558|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
170347103|NCT03725202|615610559|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
170347104|NCT03725202|615610560|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
170347105|NCT03725202|615610561|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
170347106|NCT03725202|615610562|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
170347107|NCT03725202|615610563|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
170347108|NCT03725202|615610564|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
170347109|NCT03725202|615610565|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
170347110|NCT03725202|615610558|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
170347111|NCT03725202|615610559|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
170347112|NCT03725202|615610560|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
170347113|NCT03725202|615610561|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
170347114|NCT03725202|615610562|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
170347115|NCT03725202|615610563|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
170347116|NCT03725202|615610564|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
170347117|NCT03725202|615610565|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
170347118|NCT02626819|615610566|FG000|Overall Study|Lost to Follow-up|3|||
170347119|NCT02626819|615610567|FG001|Overall Study|Lost to Follow-up|2|||
170347120|NCT02626819|615610566|FG000|Overall Study|Withdrawal by Subject|1|||
170347121|NCT02626819|615610567|FG001|Overall Study|Withdrawal by Subject|0|||
170347122|NCT02626819|615610566|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
170347123|NCT02626819|615610567|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
170347124|NCT02361762|615610568|FG000|Overall Study|Withdrawal by Subject|0|||
170347125|NCT02361762|615610569|FG001|Overall Study|Withdrawal by Subject|1|||
170347126|NCT02361762|615610568|FG000|Overall Study|Lost to Follow-up|0|||
170347127|NCT02361762|615610569|FG001|Overall Study|Lost to Follow-up|1|||
170347128|NCT00948818|615610570|FG000|Overall Study|Adverse Event|10|||
170347129|NCT00948818|615610571|FG001|Overall Study|Adverse Event|32|||
170347130|NCT00948818|615610570|FG000|Overall Study|Protocol Violation|9|||
170347131|NCT00948818|615610571|FG001|Overall Study|Protocol Violation|10|||
170347132|NCT00948818|615610570|FG000|Overall Study|Withdrawal by Subject|25|||
170347133|NCT00948818|615610571|FG001|Overall Study|Withdrawal by Subject|25|||
170347134|NCT00948818|615610570|FG000|Overall Study|Lost to Follow-up|10|||
170347135|NCT00948818|615610571|FG001|Overall Study|Lost to Follow-up|17|||
170347136|NCT00948818|615610570|FG000|Overall Study|Lack of Efficacy|4|||
170347137|NCT00948818|615610571|FG001|Overall Study|Lack of Efficacy|5|||
170347138|NCT00948818|615610570|FG000|Overall Study|Other Reason|4|||
170347139|NCT00948818|615610571|FG001|Overall Study|Other Reason|5|||
170347140|NCT02330549|615610572|FG000|Overall Study|Adverse Event|1|||
170347141|NCT02330549|615610573|FG001|Overall Study|Adverse Event|0|||
170347142|NCT02330549|615610572|FG000|Overall Study|Subject withdrew consent|2|||
170347143|NCT02330549|615610573|FG001|Overall Study|Subject withdrew consent|1|||
170347144|NCT02330549|615610572|FG000|Overall Study|Failure to meet randomization criteria|1|||
170347145|NCT02330549|615610573|FG001|Overall Study|Failure to meet randomization criteria|0|||
170347146|NCT02364947|615610574|FG000|Overall Study|Withdrawal by Subject|10|||
170347147|NCT02364947|615610575|FG001|Overall Study|Withdrawal by Subject|8|||
170347148|NCT02364947|615610576|FG002|Overall Study|Withdrawal by Subject|9|||
170347149|NCT02364947|615610574|FG000|Overall Study|Adverse Event|45|||
170347150|NCT02364947|615610575|FG001|Overall Study|Adverse Event|33|||
170347151|NCT02364947|615610576|FG002|Overall Study|Adverse Event|11|||
170347152|NCT02364947|615610574|FG000|Overall Study|Protocol Violation|1|||
170347153|NCT02364947|615610575|FG001|Overall Study|Protocol Violation|1|||
170347154|NCT02364947|615610576|FG002|Overall Study|Protocol Violation|1|||
170347155|NCT02364947|615610574|FG000|Overall Study|Physician Decision|3|||
170347156|NCT02364947|615610575|FG001|Overall Study|Physician Decision|2|||
170347157|NCT02364947|615610576|FG002|Overall Study|Physician Decision|5|||
170347158|NCT02364947|615610574|FG000|Overall Study|Death|0|||
170347159|NCT02364947|615610575|FG001|Overall Study|Death|1|||
170347160|NCT02364947|615610576|FG002|Overall Study|Death|0|||
170347161|NCT00789958|615610577|FG000|Overall Study|Adverse Event|3|||
170347162|NCT00789958|615610577|FG000|Overall Study|Withdrawal by Subject|4|||
170347163|NCT00789958|615610577|FG000|Overall Study|Progression|3|||
170347164|NCT00789958|615610577|FG000|Overall Study|not protocol specified|1|||
170347165|NCT00789958|615610577|FG000|Overall Study|Not eligible/not analyzable|26|||
170347166|NCT01051986|615610580|FG000|Overall Study|Death|1|||
170347167|NCT01051986|615610581|FG001|Overall Study|Death|0|||
170347168|NCT01051986|615610580|FG000|Overall Study|Withdrawal by Subject|2|||
170347169|NCT01051986|615610581|FG001|Overall Study|Withdrawal by Subject|1|||
170347170|NCT01051986|615610580|FG000|Overall Study|Protocol Violation|2|||
170347171|NCT01051986|615610581|FG001|Overall Study|Protocol Violation|3|||
170347172|NCT03580382|615610585|FG000|Overall Study|Early Termination of Study|0|||
170347173|NCT03580382|615610586|FG001|Overall Study|Early Termination of Study|3|||
170347174|NCT03628417|615610587|FG000|Overall Study|Death|1|||
170347175|NCT03628417|615610588|FG001|Overall Study|Death|1|||
170347176|NCT01361009|615610589|FG000|Overall Study|Protocol Violation|116|||
170347177|NCT03439748|615610591|FG000|Overall Study|Withdrawal by Subject|11|||
170347178|NCT03439748|615610592|FG001|Overall Study|Withdrawal by Subject|17|||
170347179|NCT01597557|615610596|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
170347180|NCT01597557|615610597|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
170347181|NCT01863849|615610602|FG000|Overall Study|Lost to Follow-up|1|||
170347182|NCT01863849|615610603|FG001|Overall Study|Lost to Follow-up|0|||
170347183|NCT00115349|615610604|FG000|Overall Study|Study closed due to low enrollment.|11|||
170347184|NCT00115349|615610605|FG001|Overall Study|Study closed due to low enrollment.|9|||
170347185|NCT03298412|615610607|FG000|Run-in Period|Other, Not Specified|1|||
170347186|NCT03298412|615610607|FG000|Run-in Period|Disease Progression|1|||
170347187|NCT03298412|615610607|FG000|Run-in Period|Ineligibility Determined|1|||
170347188|NCT03298412|615610607|FG000|Run-in Period|Decision by Sponsor|6|||
170347189|NCT01263691|615610608|FG000|Overall Study|Lost to Follow-up|1|||
170347190|NCT01263691|615610609|FG001|Overall Study|Lost to Follow-up|0|||
170347191|NCT01263691|615610610|FG002|Overall Study|Lost to Follow-up|1|||
170347192|NCT01263691|615610611|FG003|Overall Study|Lost to Follow-up|1|||
170347193|NCT01263691|615610612|FG004|Overall Study|Lost to Follow-up|0|||
170347194|NCT01263691|615610613|FG005|Overall Study|Lost to Follow-up|0|||
170347195|NCT01263691|615610608|FG000|Overall Study|Withdrawal by Subject|1|||
170347196|NCT01263691|615610609|FG001|Overall Study|Withdrawal by Subject|0|||
170347197|NCT01263691|615610610|FG002|Overall Study|Withdrawal by Subject|0|||
170347198|NCT01263691|615610611|FG003|Overall Study|Withdrawal by Subject|0|||
170347199|NCT01263691|615610612|FG004|Overall Study|Withdrawal by Subject|0|||
170347200|NCT01263691|615610613|FG005|Overall Study|Withdrawal by Subject|0|||
170347201|NCT01263691|615610608|FG000|Overall Study|Adverse Event|1|||
170347202|NCT01263691|615610609|FG001|Overall Study|Adverse Event|0|||
170347203|NCT01263691|615610610|FG002|Overall Study|Adverse Event|0|||
170347204|NCT01263691|615610611|FG003|Overall Study|Adverse Event|0|||
170347205|NCT01263691|615610612|FG004|Overall Study|Adverse Event|0|||
170347206|NCT01263691|615610613|FG005|Overall Study|Adverse Event|0|||
170347207|NCT04402008|615610616|FG000|Overall Study|Adverse Event|0|||
170347208|NCT04402008|615610617|FG001|Overall Study|Adverse Event|0|||
170347209|NCT04402008|615610618|FG002|Overall Study|Adverse Event|0|||
170347210|NCT04402008|615610619|FG003|Overall Study|Adverse Event|1|||
170347211|NCT04402008|615610620|FG004|Overall Study|Adverse Event|0|||
170347212|NCT04402008|615610621|FG005|Overall Study|Adverse Event|0|||
170347213|NCT04402008|615610622|FG006|Overall Study|Adverse Event|0|||
170347214|NCT04402008|615610616|FG000|Overall Study|Disease Progression|3|||
170347215|NCT04402008|615610617|FG001|Overall Study|Disease Progression|2|||
170347216|NCT04402008|615610618|FG002|Overall Study|Disease Progression|3|||
170347217|NCT04402008|615610619|FG003|Overall Study|Disease Progression|3|||
170347218|NCT04402008|615610620|FG004|Overall Study|Disease Progression|4|||
170347219|NCT04402008|615610621|FG005|Overall Study|Disease Progression|3|||
170347220|NCT04402008|615610622|FG006|Overall Study|Disease Progression|10|||
170347221|NCT04402008|615610616|FG000|Overall Study|Withdrawal by Subject|0|||
170347222|NCT04402008|615610617|FG001|Overall Study|Withdrawal by Subject|1|||
170347223|NCT04402008|615610618|FG002|Overall Study|Withdrawal by Subject|0|||
170347224|NCT04402008|615610619|FG003|Overall Study|Withdrawal by Subject|0|||
170347225|NCT04402008|615610620|FG004|Overall Study|Withdrawal by Subject|1|||
170347226|NCT04402008|615610621|FG005|Overall Study|Withdrawal by Subject|0|||
170347227|NCT04402008|615610622|FG006|Overall Study|Withdrawal by Subject|0|||
170347228|NCT04402008|615610616|FG000|Overall Study|Sponsor Decision|0|||
170347229|NCT04402008|615610617|FG001|Overall Study|Sponsor Decision|0|||
170347230|NCT04402008|615610618|FG002|Overall Study|Sponsor Decision|0|||
170347231|NCT04402008|615610619|FG003|Overall Study|Sponsor Decision|0|||
170347232|NCT04402008|615610620|FG004|Overall Study|Sponsor Decision|0|||
170347233|NCT04402008|615610621|FG005|Overall Study|Sponsor Decision|0|||
170347234|NCT04402008|615610622|FG006|Overall Study|Sponsor Decision|3|||
170347235|NCT04402008|615610616|FG000|Overall Study|Death|0|||
170347236|NCT04402008|615610617|FG001|Overall Study|Death|0|||
170347237|NCT04402008|615610618|FG002|Overall Study|Death|0|||
170347238|NCT04402008|615610619|FG003|Overall Study|Death|0|||
170347239|NCT04402008|615610620|FG004|Overall Study|Death|1|||
170347240|NCT04402008|615610621|FG005|Overall Study|Death|0|||
170347241|NCT04402008|615610622|FG006|Overall Study|Death|2|||
170347242|NCT04402008|615610616|FG000|Overall Study|Other|0|||
170347243|NCT04402008|615610617|FG001|Overall Study|Other|0|||
170347244|NCT04402008|615610618|FG002|Overall Study|Other|0|||
170347245|NCT04402008|615610619|FG003|Overall Study|Other|0|||
170347246|NCT04402008|615610620|FG004|Overall Study|Other|0|||
170347247|NCT04402008|615610621|FG005|Overall Study|Other|0|||
170347248|NCT04402008|615610622|FG006|Overall Study|Other|5|||
170347249|NCT01028651|615610627|FG000|Overall Study|Death|2|||
170347250|NCT01028651|615610627|FG000|Overall Study|Adverse Event|1|||
170347251|NCT01533935|615610629|FG000|Overall Study|Adverse Event|5|||
170347252|NCT01533935|615610630|FG001|Overall Study|Adverse Event|7|||
170347253|NCT01533935|615610631|FG002|Overall Study|Adverse Event|1|||
170347254|NCT01533935|615610632|FG003|Overall Study|Adverse Event|5|||
170347255|NCT01533935|615610633|FG004|Overall Study|Adverse Event|3|||
170347256|NCT01533935|615610629|FG000|Overall Study|Protocol Violation|0|||
170347257|NCT01533935|615610630|FG001|Overall Study|Protocol Violation|2|||
170347258|NCT01533935|615610631|FG002|Overall Study|Protocol Violation|0|||
170347259|NCT01533935|615610632|FG003|Overall Study|Protocol Violation|0|||
170347260|NCT01533935|615610633|FG004|Overall Study|Protocol Violation|0|||
170347261|NCT01533935|615610629|FG000|Overall Study|Lost to Follow-up|0|||
170347262|NCT01533935|615610630|FG001|Overall Study|Lost to Follow-up|0|||
170347263|NCT01533935|615610631|FG002|Overall Study|Lost to Follow-up|1|||
170347264|NCT01533935|615610632|FG003|Overall Study|Lost to Follow-up|0|||
170347265|NCT01533935|615610633|FG004|Overall Study|Lost to Follow-up|0|||
170347266|NCT01533935|615610629|FG000|Overall Study|Withdrawal by Subject|0|||
170347267|NCT01533935|615610630|FG001|Overall Study|Withdrawal by Subject|4|||
170347268|NCT01533935|615610631|FG002|Overall Study|Withdrawal by Subject|5|||
170347269|NCT01533935|615610632|FG003|Overall Study|Withdrawal by Subject|2|||
170347270|NCT01533935|615610633|FG004|Overall Study|Withdrawal by Subject|4|||
170347271|NCT01533935|615610629|FG000|Overall Study|Other reason not defined above|1|||
170347272|NCT01533935|615610630|FG001|Overall Study|Other reason not defined above|0|||
170347273|NCT01533935|615610631|FG002|Overall Study|Other reason not defined above|1|||
170347274|NCT01533935|615610632|FG003|Overall Study|Other reason not defined above|0|||
170347275|NCT01533935|615610633|FG004|Overall Study|Other reason not defined above|1|||
170347276|NCT00390416|615610644|FG000|Overall Study|Withdrawal by Subject|1|||
170347277|NCT00390416|615610644|FG000|Overall Study|Not treated|3|||
170347278|NCT01728584|615610649|FG000|Overall Study|Adverse Event|1|||
170347279|NCT01728584|615610650|FG001|Overall Study|Adverse Event|0|||
170347280|NCT01728584|615610651|FG002|Overall Study|Adverse Event|0|||
170347281|NCT01728584|615610652|FG003|Overall Study|Adverse Event|0|||
170347282|NCT01728584|615610649|FG000|Overall Study|Physician Decision|4|||
170347283|NCT01728584|615610650|FG001|Overall Study|Physician Decision|0|||
170347284|NCT01728584|615610651|FG002|Overall Study|Physician Decision|1|||
170347285|NCT01728584|615610652|FG003|Overall Study|Physician Decision|0|||
170347286|NCT01728584|615610649|FG000|Overall Study|Withdrawal by Subject|1|||
170347287|NCT01728584|615610650|FG001|Overall Study|Withdrawal by Subject|0|||
170347288|NCT01728584|615610651|FG002|Overall Study|Withdrawal by Subject|0|||
170347289|NCT01728584|615610652|FG003|Overall Study|Withdrawal by Subject|0|||
170347290|NCT01728584|615610649|FG000|Overall Study|Screen failure|1|||
170347291|NCT01728584|615610650|FG001|Overall Study|Screen failure|0|||
170347292|NCT01728584|615610651|FG002|Overall Study|Screen failure|0|||
170347293|NCT01728584|615610652|FG003|Overall Study|Screen failure|0|||
170347294|NCT01728584|615610649|FG000|Overall Study|Other reason (not specified)|1|||
170347295|NCT01728584|615610650|FG001|Overall Study|Other reason (not specified)|0|||
170347296|NCT01728584|615610651|FG002|Overall Study|Other reason (not specified)|0|||
170347297|NCT01728584|615610652|FG003|Overall Study|Other reason (not specified)|1|||
170347298|NCT02935634|615610653|FG000|Randomization|Participant withdrew consent|0|||
170347299|NCT02935634|615610654|FG001|Randomization|Participant withdrew consent|1|||
170347300|NCT02935634|615610655|FG002|Randomization|Participant withdrew consent|0|||
170347301|NCT02935634|615610656|FG003|Randomization|Participant withdrew consent|0|||
170347302|NCT02935634|615610657|FG004|Randomization|Participant withdrew consent|0|||
170347303|NCT02935634|615610658|FG005|Randomization|Participant withdrew consent|0|||
170347304|NCT02935634|615610653|FG000|Randomization|Death|2|||
170347305|NCT02935634|615610654|FG001|Randomization|Death|1|||
170347306|NCT02935634|615610655|FG002|Randomization|Death|1|||
170347307|NCT02935634|615610656|FG003|Randomization|Death|0|||
170347308|NCT02935634|615610657|FG004|Randomization|Death|0|||
170347309|NCT02935634|615610658|FG005|Randomization|Death|0|||
170347310|NCT02935634|615610653|FG000|Randomization|Other reasons|0|||
170347311|NCT02935634|615610654|FG001|Randomization|Other reasons|2|||
170347312|NCT02935634|615610655|FG002|Randomization|Other reasons|2|||
170347313|NCT02935634|615610656|FG003|Randomization|Other reasons|0|||
170347314|NCT02935634|615610657|FG004|Randomization|Other reasons|0|||
170347315|NCT02935634|615610658|FG005|Randomization|Other reasons|0|||
170347316|NCT02935634|615610653|FG000|Treatment: Track 1|Disease progression|15|||
170347317|NCT02935634|615610654|FG001|Treatment: Track 1|Disease progression|17|||
170347318|NCT02935634|615610655|FG002|Treatment: Track 1|Disease progression|28|||
170347319|NCT02935634|615610656|FG003|Treatment: Track 1|Disease progression|4|||
170347320|NCT02935634|615610657|FG004|Treatment: Track 1|Disease progression|6|||
170347321|NCT02935634|615610658|FG005|Treatment: Track 1|Disease progression|2|||
170347322|NCT02935634|615610653|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
170347323|NCT02935634|615610654|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
170347324|NCT02935634|615610655|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
170347325|NCT02935634|615610656|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
170347326|NCT02935634|615610657|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
170347327|NCT02935634|615610658|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
170347328|NCT02935634|615610653|FG000|Treatment: Track 1|Lost to Follow-up|1|||
170347329|NCT02935634|615610654|FG001|Treatment: Track 1|Lost to Follow-up|0|||
170347330|NCT02935634|615610655|FG002|Treatment: Track 1|Lost to Follow-up|0|||
170347331|NCT02935634|615610656|FG003|Treatment: Track 1|Lost to Follow-up|0|||
170347332|NCT02935634|615610657|FG004|Treatment: Track 1|Lost to Follow-up|0|||
170347333|NCT02935634|615610658|FG005|Treatment: Track 1|Lost to Follow-up|0|||
170347334|NCT02935634|615610653|FG000|Treatment: Track 1|Study drug toxicity|2|||
170347335|NCT02935634|615610654|FG001|Treatment: Track 1|Study drug toxicity|1|||
170347336|NCT02935634|615610655|FG002|Treatment: Track 1|Study drug toxicity|3|||
170347337|NCT02935634|615610656|FG003|Treatment: Track 1|Study drug toxicity|0|||
170347338|NCT02935634|615610657|FG004|Treatment: Track 1|Study drug toxicity|0|||
170347339|NCT02935634|615610658|FG005|Treatment: Track 1|Study drug toxicity|1|||
170347340|NCT02935634|615610653|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
170347341|NCT02935634|615610654|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
170347342|NCT02935634|615610655|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
170347343|NCT02935634|615610656|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
170347344|NCT02935634|615610657|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
170347345|NCT02935634|615610658|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
170347346|NCT02935634|615610653|FG000|Treatment: Track 1|Participant withdrew consent|2|||
170347347|NCT02935634|615610654|FG001|Treatment: Track 1|Participant withdrew consent|0|||
170347348|NCT02935634|615610655|FG002|Treatment: Track 1|Participant withdrew consent|1|||
170347349|NCT02935634|615610656|FG003|Treatment: Track 1|Participant withdrew consent|0|||
170347350|NCT02935634|615610657|FG004|Treatment: Track 1|Participant withdrew consent|1|||
170347351|NCT02935634|615610658|FG005|Treatment: Track 1|Participant withdrew consent|0|||
170347352|NCT02935634|615610653|FG000|Treatment: Track 1|Other reasons|0|||
170347353|NCT02935634|615610654|FG001|Treatment: Track 1|Other reasons|0|||
170347354|NCT02935634|615610655|FG002|Treatment: Track 1|Other reasons|2|||
170347355|NCT02935634|615610656|FG003|Treatment: Track 1|Other reasons|0|||
170347356|NCT02935634|615610657|FG004|Treatment: Track 1|Other reasons|0|||
170347357|NCT02935634|615610658|FG005|Treatment: Track 1|Other reasons|0|||
170347358|NCT02935634|615610653|FG000|Treatment: Track 2|Disease progression|13|||
170347359|NCT02935634|615610654|FG001|Treatment: Track 2|Disease progression|26|||
170347360|NCT02935634|615610655|FG002|Treatment: Track 2|Disease progression|20|||
170347361|NCT02935634|615610656|FG003|Treatment: Track 2|Disease progression|5|||
170347362|NCT02935634|615610657|FG004|Treatment: Track 2|Disease progression|1|||
170347363|NCT02935634|615610658|FG005|Treatment: Track 2|Disease progression|4|||
170347364|NCT02935634|615610653|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
170347365|NCT02935634|615610654|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
170347366|NCT02935634|615610655|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
170347367|NCT02935634|615610656|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
170347368|NCT02935634|615610657|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
170347369|NCT02935634|615610658|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
170347370|NCT02935634|615610653|FG000|Treatment: Track 2|Study drug toxicity|7|||
170347371|NCT02935634|615610654|FG001|Treatment: Track 2|Study drug toxicity|3|||
170347372|NCT02935634|615610655|FG002|Treatment: Track 2|Study drug toxicity|0|||
170347373|NCT02935634|615610656|FG003|Treatment: Track 2|Study drug toxicity|0|||
170347374|NCT02935634|615610657|FG004|Treatment: Track 2|Study drug toxicity|0|||
170347375|NCT02935634|615610658|FG005|Treatment: Track 2|Study drug toxicity|0|||
170347376|NCT02935634|615610653|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
170347377|NCT02935634|615610654|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
170347378|NCT02935634|615610655|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
170347379|NCT02935634|615610656|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
170347380|NCT02935634|615610657|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
170347381|NCT02935634|615610658|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
170347382|NCT02935634|615610653|FG000|Treatment: Track 2|Participant withdrew consent|0|||
170347383|NCT02935634|615610654|FG001|Treatment: Track 2|Participant withdrew consent|1|||
170347384|NCT02935634|615610655|FG002|Treatment: Track 2|Participant withdrew consent|1|||
170347385|NCT02935634|615610656|FG003|Treatment: Track 2|Participant withdrew consent|0|||
170347386|NCT02935634|615610657|FG004|Treatment: Track 2|Participant withdrew consent|1|||
170347387|NCT02935634|615610658|FG005|Treatment: Track 2|Participant withdrew consent|0|||
170347388|NCT05132569|615610660|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
170347389|NCT05132569|615610661|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
170347390|NCT05132569|615610660|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
170347391|NCT05132569|615610661|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
170347392|NCT05132569|615610660|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
170347393|NCT05132569|615610661|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
170347394|NCT04716933|615610668|FG000|Overall Study|Sponsor Decision|36|||
170347395|NCT04716933|615610669|FG001|Overall Study|Sponsor Decision|33|||
170347396|NCT04716933|615610668|FG000|Overall Study|Death|65|||
170347397|NCT04716933|615610669|FG001|Overall Study|Death|67|||
170347398|NCT01327651|615610670|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
170347399|NCT01327651|615610671|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
170347400|NCT01327651|615610672|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
170347401|NCT01327651|615610673|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
170347402|NCT01327651|615610674|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
170347403|NCT01327651|615610675|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
170347404|NCT01327651|615610676|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
170347405|NCT01327651|615610677|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
170347406|NCT01327651|615610678|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
170347407|NCT01327651|615610670|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
170347408|NCT01327651|615610671|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
170347409|NCT01327651|615610672|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
170347410|NCT01327651|615610673|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
170347411|NCT01327651|615610674|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
170347412|NCT01327651|615610675|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
170347413|NCT01327651|615610676|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
170347414|NCT01327651|615610677|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
170347415|NCT01327651|615610678|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
170347416|NCT01327651|615610670|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
170347417|NCT01327651|615610671|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
170347418|NCT01327651|615610672|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
170347419|NCT01327651|615610673|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
170347420|NCT01327651|615610674|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
170347421|NCT01327651|615610675|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
170347422|NCT01327651|615610676|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
170347423|NCT01327651|615610677|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
170347424|NCT01327651|615610678|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
170347425|NCT01327651|615610670|FG000|Post Study Follow-up|Lost to Follow-up|0|||
170347426|NCT01327651|615610671|FG001|Post Study Follow-up|Lost to Follow-up|1|||
170347427|NCT01327651|615610672|FG002|Post Study Follow-up|Lost to Follow-up|1|||
170347428|NCT01327651|615610673|FG003|Post Study Follow-up|Lost to Follow-up|0|||
170347429|NCT01327651|615610674|FG004|Post Study Follow-up|Lost to Follow-up|0|||
170347430|NCT01327651|615610675|FG005|Post Study Follow-up|Lost to Follow-up|0|||
170347431|NCT01327651|615610676|FG006|Post Study Follow-up|Lost to Follow-up|4|||
170347432|NCT01327651|615610677|FG007|Post Study Follow-up|Lost to Follow-up|1|||
170347433|NCT01327651|615610678|FG008|Post Study Follow-up|Lost to Follow-up|2|||
170347434|NCT01912729|615610679|FG000|Overall Study|Withdrawal by Subject|0|||
170347435|NCT01912729|615610680|FG001|Overall Study|Withdrawal by Subject|1|||
170347436|NCT01052012|615610690|FG000|Overall Study|Not treated|2|||
170347437|NCT01052012|615610691|FG001|Overall Study|Not treated|5|||
170347438|NCT01052012|615610692|FG002|Overall Study|Not treated|0|||
170347439|NCT01052012|615610693|FG003|Overall Study|Not treated|0|||
170347440|NCT01052012|615610694|FG004|Overall Study|Not treated|11|||
170347441|NCT01052012|615610695|FG005|Overall Study|Not treated|8|||
170347442|NCT01052012|615610690|FG000|Overall Study|Adverse Event|1|||
170347443|NCT01052012|615610691|FG001|Overall Study|Adverse Event|0|||
170347444|NCT01052012|615610692|FG002|Overall Study|Adverse Event|0|||
170347445|NCT01052012|615610693|FG003|Overall Study|Adverse Event|1|||
170347446|NCT01052012|615610694|FG004|Overall Study|Adverse Event|0|||
170347447|NCT01052012|615610695|FG005|Overall Study|Adverse Event|0|||
170347448|NCT01052012|615610690|FG000|Overall Study|Lost to Follow-up|0|||
170347449|NCT01052012|615610691|FG001|Overall Study|Lost to Follow-up|0|||
170347450|NCT01052012|615610692|FG002|Overall Study|Lost to Follow-up|0|||
170347451|NCT01052012|615610693|FG003|Overall Study|Lost to Follow-up|0|||
170347452|NCT01052012|615610694|FG004|Overall Study|Lost to Follow-up|1|||
170347453|NCT01052012|615610695|FG005|Overall Study|Lost to Follow-up|0|||
170347454|NCT01052012|615610690|FG000|Overall Study|Withdrawal by Subject|1|||
170347455|NCT01052012|615610691|FG001|Overall Study|Withdrawal by Subject|1|||
170347456|NCT01052012|615610692|FG002|Overall Study|Withdrawal by Subject|0|||
170347457|NCT01052012|615610693|FG003|Overall Study|Withdrawal by Subject|0|||
170347458|NCT01052012|615610694|FG004|Overall Study|Withdrawal by Subject|3|||
170347459|NCT01052012|615610695|FG005|Overall Study|Withdrawal by Subject|1|||
170347460|NCT01052012|615610690|FG000|Overall Study|Physician Decision|0|||
170347461|NCT01052012|615610691|FG001|Overall Study|Physician Decision|0|||
170347462|NCT01052012|615610692|FG002|Overall Study|Physician Decision|0|||
170347463|NCT01052012|615610693|FG003|Overall Study|Physician Decision|0|||
170347464|NCT01052012|615610694|FG004|Overall Study|Physician Decision|0|||
170347465|NCT01052012|615610695|FG005|Overall Study|Physician Decision|1|||
170347466|NCT01052012|615610690|FG000|Overall Study|Other|0|||
170347467|NCT01052012|615610691|FG001|Overall Study|Other|0|||
170347468|NCT01052012|615610692|FG002|Overall Study|Other|0|||
170347469|NCT01052012|615610693|FG003|Overall Study|Other|0|||
170347470|NCT01052012|615610694|FG004|Overall Study|Other|1|||
170347471|NCT01052012|615610695|FG005|Overall Study|Other|0|||
170347472|NCT00320385|615610696|FG000|Overall Study|Lost to Follow-up|7|||
170347473|NCT00320385|615610697|FG001|Overall Study|Lost to Follow-up|10|||
170347474|NCT00320385|615610696|FG000|Overall Study|Withdrawal by Subject|6|||
170347475|NCT00320385|615610697|FG001|Overall Study|Withdrawal by Subject|7|||
170347476|NCT00320385|615610696|FG000|Overall Study|Sponsor Terminated Study|2|||
170347477|NCT00320385|615610697|FG001|Overall Study|Sponsor Terminated Study|1|||
170347478|NCT00320385|615610696|FG000|Overall Study|Investigator Decision|0|||
170347479|NCT00320385|615610697|FG001|Overall Study|Investigator Decision|1|||
170347480|NCT00320385|615610696|FG000|Overall Study|Death|1|||
170347481|NCT00320385|615610697|FG001|Overall Study|Death|2|||
170347482|NCT00320385|615610696|FG000|Overall Study|Serious Adverse Event|1|||
170347483|NCT00320385|615610697|FG001|Overall Study|Serious Adverse Event|0|||
170347484|NCT00320385|615610696|FG000|Overall Study|Withdrew Consent|1|||
170347485|NCT00320385|615610697|FG001|Overall Study|Withdrew Consent|0|||
170347486|NCT00320385|615610696|FG000|Overall Study|Adverse Event|0|||
170347487|NCT00320385|615610697|FG001|Overall Study|Adverse Event|1|||
170347488|NCT02582749|615610699|FG000|Overall Study|Study terminated by funder|5|||
170347489|NCT02582749|615610700|FG001|Overall Study|Study terminated by funder|10|||
170347490|NCT02582749|615610699|FG000|Overall Study|Withdrawal by Subject|0|||
170347491|NCT02582749|615610700|FG001|Overall Study|Withdrawal by Subject|1|||
170347492|NCT02213198|615610701|FG000|Baseline|No show for intake|7|||
170347493|NCT02213198|615610702|FG001|Baseline|No show for intake|9|||
170347494|NCT02213198|615610701|FG000|Baseline|Withdrawal by Subject|34|||
170347495|NCT02213198|615610702|FG001|Baseline|Withdrawal by Subject|11|||
170347496|NCT02213198|615610701|FG000|Baseline|transferred out of clinic|7|||
170347497|NCT02213198|615610702|FG001|Baseline|transferred out of clinic|9|||
170347498|NCT02213198|615610701|FG000|Baseline|Lost to Follow-up|40|||
170347499|NCT02213198|615610702|FG001|Baseline|Lost to Follow-up|21|||
170347500|NCT02213198|615610701|FG000|Baseline|incarcerated,violent|0|||
170347501|NCT02213198|615610702|FG001|Baseline|incarcerated,violent|1|||
170347502|NCT02213198|615610701|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
170347503|NCT02213198|615610702|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
170347504|NCT02213198|615610701|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
170347505|NCT02213198|615610702|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
170347506|NCT02213198|615610701|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
170347507|NCT02213198|615610702|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
170347508|NCT02213198|615610701|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
170347509|NCT02213198|615610702|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
170347510|NCT02213198|615610701|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
170347511|NCT02213198|615610702|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
170347512|NCT02213198|615610701|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
170347513|NCT02213198|615610702|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
170347514|NCT01518192|615610703|FG000|Overall Study|Lost to Follow-up|29|||
170347515|NCT01518192|615610704|FG001|Overall Study|Lost to Follow-up|26|||
170347516|NCT01518192|615610705|FG002|Overall Study|Lost to Follow-up|35|||
170347517|NCT01798706|615610706|FG000|Overall Study|Adverse Event|15|||
170347518|NCT01798706|615610707|FG001|Overall Study|Adverse Event|10|||
170347519|NCT01798706|615610706|FG000|Overall Study|Lack of Efficacy|0|||
170347520|NCT01798706|615610707|FG001|Overall Study|Lack of Efficacy|2|||
170347521|NCT01798706|615610706|FG000|Overall Study|Poor compliance to protocol|1|||
170347522|NCT01798706|615610707|FG001|Overall Study|Poor compliance to protocol|0|||
170347523|NCT01798706|615610706|FG000|Overall Study|Other than specified above|5|||
170347524|NCT01798706|615610707|FG001|Overall Study|Other than specified above|9|||
170347525|NCT02028338|615610708|FG000|Overall Study|Withdrawal by Subject|3|||
170347526|NCT02028338|615610709|FG001|Overall Study|Withdrawal by Subject|1|||
170347527|NCT02028338|615610708|FG000|Overall Study|Unable to contact participant|1|||
170347528|NCT02028338|615610709|FG001|Overall Study|Unable to contact participant|0|||
170347529|NCT00601523|615610712|FG000|Overall Study|Adverse Event|42|||
170347530|NCT00601523|615610713|FG001|Overall Study|Adverse Event|14|||
170347531|NCT00601523|615610712|FG000|Overall Study|Lack of Efficacy|3|||
170347532|NCT00601523|615610713|FG001|Overall Study|Lack of Efficacy|0|||
170347533|NCT00601523|615610712|FG000|Overall Study|Protocol Violation|5|||
170347534|NCT00601523|615610713|FG001|Overall Study|Protocol Violation|1|||
170347535|NCT00601523|615610712|FG000|Overall Study|Lost to Follow-up|0|||
170347536|NCT00601523|615610713|FG001|Overall Study|Lost to Follow-up|1|||
170347537|NCT00601523|615610712|FG000|Overall Study|Withdrawal by Subject|18|||
170347538|NCT00601523|615610713|FG001|Overall Study|Withdrawal by Subject|9|||
170347539|NCT00601523|615610712|FG000|Overall Study|Other|9|||
170347540|NCT00601523|615610713|FG001|Overall Study|Other|1|||
170347541|NCT01617434|615610716|FG000|Overall Study|Adverse Event|12|||
170347542|NCT01617434|615610717|FG001|Overall Study|Adverse Event|3|||
170347543|NCT01617434|615610716|FG000|Overall Study|Protocol Violation|8|||
170347544|NCT01617434|615610717|FG001|Overall Study|Protocol Violation|7|||
170347545|NCT01617434|615610716|FG000|Overall Study|Withdrawal Criteria|12|||
170347546|NCT01617434|615610717|FG001|Overall Study|Withdrawal Criteria|37|||
170347547|NCT01617434|615610716|FG000|Overall Study|Unclassified|3|||
170347548|NCT01617434|615610717|FG001|Overall Study|Unclassified|4|||
170347549|NCT01987986|615610718|FG000|Overall Study|Lost to Follow-up|1|||
170347550|NCT01987986|615610719|FG001|Overall Study|Lost to Follow-up|0|||
170347551|NCT01987986|615610720|FG002|Overall Study|Lost to Follow-up|0|||
170347552|NCT01987986|615610721|FG003|Overall Study|Lost to Follow-up|0|||
170347553|NCT01987986|615610718|FG000|Overall Study|Adverse Event|1|||
170347554|NCT01987986|615610719|FG001|Overall Study|Adverse Event|0|||
170347555|NCT01987986|615610720|FG002|Overall Study|Adverse Event|2|||
170347556|NCT01987986|615610721|FG003|Overall Study|Adverse Event|0|||
170347557|NCT04369430|615610725|FG000|Overall Study|Adverse Event|2|||
170347558|NCT04369430|615610726|FG001|Overall Study|Adverse Event|3|||
170347559|NCT04369430|615610725|FG000|Overall Study|Death|1|||
170347560|NCT04369430|615610726|FG001|Overall Study|Death|0|||
170347561|NCT04369430|615610725|FG000|Overall Study|Withdrawal by Subject|4|||
170347562|NCT04369430|615610726|FG001|Overall Study|Withdrawal by Subject|3|||
170347563|NCT04369430|615610725|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
170347564|NCT04369430|615610726|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
170347565|NCT04369430|615610725|FG000|Overall Study|Lost to Follow-up|0|||
170347566|NCT04369430|615610726|FG001|Overall Study|Lost to Follow-up|1|||
170347567|NCT03453151|615610727|FG000|Overall Study|Withdrawal by Subject|1|||
170347568|NCT03453151|615610727|FG000|Overall Study|Physician Decision|3|||
170347569|NCT04594239|615610732|FG000|Overall Study|Withdrawal by Subject|3|||
170347570|NCT04594239|615610733|FG001|Overall Study|Withdrawal by Subject|4|||
170347571|NCT04594239|615610734|FG002|Overall Study|Withdrawal by Subject|2|||
170347572|NCT04594239|615610735|FG003|Overall Study|Withdrawal by Subject|4|||
170347573|NCT04594239|615610732|FG000|Overall Study|Lost to Follow-up|8|||
170347574|NCT04594239|615610733|FG001|Overall Study|Lost to Follow-up|5|||
170347575|NCT04594239|615610734|FG002|Overall Study|Lost to Follow-up|4|||
170347576|NCT04594239|615610735|FG003|Overall Study|Lost to Follow-up|6|||
170347577|NCT04594239|615610732|FG000|Overall Study|Subject relocated|0|||
170347578|NCT04594239|615610733|FG001|Overall Study|Subject relocated|0|||
170347579|NCT04594239|615610734|FG002|Overall Study|Subject relocated|0|||
170347580|NCT04594239|615610735|FG003|Overall Study|Subject relocated|1|||
170347581|NCT02020031|615612510|FG000|Overall Study|Physician Decision|1|||
170347582|NCT02020031|615612511|FG001|Overall Study|Physician Decision|1|||
170347583|NCT00683475|615612526|FG000|Overall Study|Withdrawal by Subject|1|||
170347584|NCT00683475|615612527|FG001|Overall Study|Withdrawal by Subject|0|||
170347585|NCT00683475|615612526|FG000|Overall Study|Never Treated: Adverse Event|2|||
170347586|NCT00683475|615612527|FG001|Overall Study|Never Treated: Adverse Event|3|||
170347587|NCT00683475|615612526|FG000|Overall Study|Never Treated: Progressive Disease|1|||
170347588|NCT00683475|615612527|FG001|Overall Study|Never Treated: Progressive Disease|0|||
170347589|NCT02723604|615612528|FG000|Overall Study|ineligible|1|||
170347590|NCT02723604|615612528|FG000|Overall Study|never received treatment|1|||
170347591|NCT00165841|615612530|FG000|Overall Study|Adverse Event|2|||
170347592|NCT00165841|615612531|FG001|Overall Study|Adverse Event|3|||
170347593|NCT00165841|615612530|FG000|Overall Study|Lack of Efficacy|6|||
170347594|NCT00165841|615612531|FG001|Overall Study|Lack of Efficacy|33|||
170347595|NCT00165841|615612530|FG000|Overall Study|Lost to Follow-up|4|||
170347596|NCT00165841|615612531|FG001|Overall Study|Lost to Follow-up|4|||
170347597|NCT00165841|615612530|FG000|Overall Study|Withdrawal by Subject|7|||
170347598|NCT00165841|615612531|FG001|Overall Study|Withdrawal by Subject|8|||
170347599|NCT00165841|615612530|FG000|Overall Study|Physician Decision|1|||
170347600|NCT00165841|615612531|FG001|Overall Study|Physician Decision|0|||
170347601|NCT00165841|615612530|FG000|Overall Study|Protocol Violation|6|||
170347602|NCT00165841|615612531|FG001|Overall Study|Protocol Violation|8|||
170347603|NCT00165841|615612530|FG000|Overall Study|Other|3|||
170347604|NCT00165841|615612531|FG001|Overall Study|Other|5|||
170347605|NCT00165841|615612530|FG000|Overall Study|Medication Noncompliance|1|||
170347606|NCT00165841|615612531|FG001|Overall Study|Medication Noncompliance|1|||
170347607|NCT00853489|615612532|FG000|Overall Study|Lost to Follow-up|5|||
170347608|NCT00853489|615612533|FG001|Overall Study|Lost to Follow-up|2|||
170347609|NCT01026389|615612538|FG000|Overall Study|Withdrawal by Subject|1|||
170347610|NCT01026389|615612539|FG001|Overall Study|Withdrawal by Subject|3|||
170347611|NCT01026389|615612538|FG000|Overall Study|change of treatment, patient moved|4|||
170347612|NCT01026389|615612539|FG001|Overall Study|change of treatment, patient moved|2|||
170347613|NCT01697267|615612540|FG000|Overall Study|Death|3|||
170347614|NCT01697267|615612541|FG001|Overall Study|Death|1|||
170347615|NCT01697267|615612540|FG000|Overall Study|Withdrawal by Subject|5|||
170347616|NCT01697267|615612541|FG001|Overall Study|Withdrawal by Subject|5|||
170347617|NCT01697267|615612540|FG000|Overall Study|Adverse Event|2|||
170347618|NCT01697267|615612541|FG001|Overall Study|Adverse Event|1|||
170347619|NCT01697267|615612540|FG000|Overall Study|Lost to Follow-up|2|||
170347620|NCT01697267|615612541|FG001|Overall Study|Lost to Follow-up|4|||
170347621|NCT01697267|615612540|FG000|Overall Study|Physician Decision|2|||
170347622|NCT01697267|615612541|FG001|Overall Study|Physician Decision|4|||
170347623|NCT01251276|615612544|FG000|Overall Study|Protocol Violation|1|||
170347624|NCT01251276|615612545|FG001|Overall Study|Protocol Violation|0|||
170347625|NCT01251276|615612544|FG000|Overall Study|Lost to Follow-up|0|||
170347626|NCT01251276|615612545|FG001|Overall Study|Lost to Follow-up|1|||
170347627|NCT01725152|615612546|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
170347628|NCT01725152|615612547|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
170347629|NCT01725152|615612546|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
170347630|NCT01725152|615612547|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
170347631|NCT01725152|615612546|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
170347632|NCT01725152|615612547|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
170347633|NCT01725152|615612546|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
170347634|NCT01725152|615612547|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
170347635|NCT06150573|615612550|FG000|Overall Study|Did not meet study criteria|1|||
170347636|NCT06150573|615612551|FG001|Overall Study|Did not meet study criteria|0|||
170347637|NCT06150573|615612550|FG000|Overall Study|Adverse Event|1|||
170347638|NCT06150573|615612551|FG001|Overall Study|Adverse Event|0|||
170347639|NCT06150573|615612550|FG000|Overall Study|Lost to Follow-up|0|||
170347640|NCT06150573|615612551|FG001|Overall Study|Lost to Follow-up|1|||
170347641|NCT06150573|615612550|FG000|Overall Study|Protocol Violation|0|||
170347642|NCT06150573|615612551|FG001|Overall Study|Protocol Violation|1|||
170347643|NCT06150573|615612550|FG000|Overall Study|Withdrawal by Subject|2|||
170347644|NCT06150573|615612551|FG001|Overall Study|Withdrawal by Subject|0|||
170347645|NCT00913978|615612552|FG000|Overall Study|Surgeon choice|1|||
170347646|NCT00913978|615612553|FG001|Overall Study|Surgeon choice|3|||
170347647|NCT03249792|615612557|FG000|Arms 1, 2, and 4|Death|1|||
170347648|NCT03249792|615612558|FG001|Arms 1, 2, and 4|Death|1|||
170347649|NCT03249792|615612559|FG002|Arms 1, 2, and 4|Death|0|||
170347650|NCT03249792|615612560|FG003|Arms 1, 2, and 4|Death|2|||
170347651|NCT03249792|615612561|FG004|Arms 1, 2, and 4|Death|3|||
170347652|NCT03249792|615612562|FG005|Arms 1, 2, and 4|Death|2|||
170347653|NCT03249792|615612563|FG006|Arms 1, 2, and 4|Death|2|||
170347654|NCT03249792|615612564|FG007|Arms 1, 2, and 4|Death|4|||
170347655|NCT03249792|615612565|FG008|Arms 1, 2, and 4|Death|2|||
170347656|NCT03249792|615612566|FG009|Arms 1, 2, and 4|Death|1|||
170347657|NCT03249792|615612567|FG010|Arms 1, 2, and 4|Death|7|||
170347658|NCT03249792|615612568|FG011|Arms 1, 2, and 4|Death|7|||
170347659|NCT03249792|615612569|FG012|Arms 1, 2, and 4|Death|12|||
170347660|NCT03249792|615612570|FG013|Arms 1, 2, and 4|Death|7|||
170347661|NCT03249792|615612571|FG014|Arms 1, 2, and 4|Death|0|||
170347662|NCT03249792|615612572|FG015|Arms 1, 2, and 4|Death|4|||
170347663|NCT03249792|615612573|FG016|Arms 1, 2, and 4|Death|4|||
170347664|NCT03249792|615612574|FG017|Arms 1, 2, and 4|Death|12|||
170347665|NCT03249792|615612575|FG018|Arms 1, 2, and 4|Death|6|||
170347666|NCT03249792|615612576|FG019|Arms 1, 2, and 4|Death|4|||
170347667|NCT03249792|615612577|FG020|Arms 1, 2, and 4|Death|2|||
170347668|NCT03249792|615612578|FG021|Arms 1, 2, and 4|Death|3|||
170347669|NCT03249792|615612579|FG022|Arms 1, 2, and 4|Death|1|||
170347670|NCT03249792|615612580|FG023|Arms 1, 2, and 4|Death|1|||
170347671|NCT03249792|615612581|FG024|Arms 1, 2, and 4|Death|4|||
170347672|NCT03249792|615612582|FG025|Arms 1, 2, and 4|Death|0|||
170347673|NCT03249792|615612583|FG026|Arms 1, 2, and 4|Death|0|||
170347674|NCT03249792|615612584|FG027|Arms 1, 2, and 4|Death|0|||
170347675|NCT03249792|615612585|FG028|Arms 1, 2, and 4|Death|0|||
170347676|NCT03249792|615612586|FG029|Arms 1, 2, and 4|Death|0|||
170347677|NCT03249792|615612587|FG030|Arms 1, 2, and 4|Death|0|||
170347678|NCT03249792|615612588|FG031|Arms 1, 2, and 4|Death|0|||
170347679|NCT03249792|615612589|FG032|Arms 1, 2, and 4|Death|0|||
170347680|NCT03249792|615612557|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347681|NCT03249792|615612558|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347682|NCT03249792|615612559|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
170347683|NCT03249792|615612560|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347684|NCT03249792|615612561|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347685|NCT03249792|615612562|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
170347686|NCT03249792|615612563|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
170347687|NCT03249792|615612564|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347688|NCT03249792|615612565|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
170347689|NCT03249792|615612566|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
170347690|NCT03249792|615612567|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
170347691|NCT03249792|615612568|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
170347692|NCT03249792|615612569|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
170347693|NCT03249792|615612570|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
170347694|NCT03249792|615612571|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347695|NCT03249792|615612572|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347696|NCT03249792|615612573|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
170347697|NCT03249792|615612574|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347698|NCT03249792|615612575|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
170347699|NCT03249792|615612576|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347700|NCT03249792|615612577|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347701|NCT03249792|615612578|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347702|NCT03249792|615612579|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
170347703|NCT03249792|615612580|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
170347704|NCT03249792|615612581|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347705|NCT03249792|615612582|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347706|NCT03249792|615612583|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347707|NCT03249792|615612584|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347708|NCT03249792|615612585|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347709|NCT03249792|615612586|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347710|NCT03249792|615612587|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347711|NCT03249792|615612588|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347712|NCT03249792|615612589|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
170347713|NCT03249792|615612557|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
170347714|NCT03249792|615612558|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
170347715|NCT03249792|615612559|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
170347716|NCT03249792|615612560|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
170347717|NCT03249792|615612561|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
170347718|NCT03249792|615612562|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
170347719|NCT03249792|615612563|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
170347720|NCT03249792|615612564|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
170347721|NCT03249792|615612565|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
170347722|NCT03249792|615612566|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
170347723|NCT03249792|615612567|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
170347724|NCT03249792|615612568|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
170347725|NCT03249792|615612569|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
170347726|NCT03249792|615612570|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
170347727|NCT03249792|615612571|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
170347728|NCT03249792|615612572|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
170347729|NCT03249792|615612573|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
170347730|NCT03249792|615612574|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
170347731|NCT03249792|615612575|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
170347732|NCT03249792|615612576|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
170347733|NCT03249792|615612577|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
170347734|NCT03249792|615612578|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
170347735|NCT03249792|615612579|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
170347736|NCT03249792|615612580|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
170347737|NCT03249792|615612581|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
170347738|NCT03249792|615612582|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
170347739|NCT03249792|615612583|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
170347740|NCT03249792|615612584|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
170347741|NCT03249792|615612585|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
170347742|NCT03249792|615612586|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
170347743|NCT03249792|615612587|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
170347744|NCT03249792|615612588|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
170347745|NCT03249792|615612589|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
170347746|NCT03249792|615612557|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347747|NCT03249792|615612558|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347748|NCT03249792|615612559|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347749|NCT03249792|615612560|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347750|NCT03249792|615612561|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347751|NCT03249792|615612562|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
170399301|NCT03193190|615799942|FG005|Stage 1|Physician Decision|0|||
170347752|NCT03249792|615612563|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347753|NCT03249792|615612564|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347754|NCT03249792|615612565|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
170347755|NCT03249792|615612566|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347756|NCT03249792|615612567|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347757|NCT03249792|615612568|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347758|NCT03249792|615612569|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347759|NCT03249792|615612570|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347760|NCT03249792|615612571|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347761|NCT03249792|615612572|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347762|NCT03249792|615612573|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
170347763|NCT03249792|615612574|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
170347764|NCT03249792|615612575|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347765|NCT03249792|615612576|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
170347766|NCT03249792|615612577|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347767|NCT03249792|615612578|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347768|NCT03249792|615612579|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347769|NCT03249792|615612580|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347770|NCT03249792|615612581|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347771|NCT03249792|615612582|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347772|NCT03249792|615612583|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347773|NCT03249792|615612584|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347774|NCT03249792|615612585|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347775|NCT03249792|615612586|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347776|NCT03249792|615612587|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347777|NCT03249792|615612588|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347778|NCT03249792|615612589|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
170347779|NCT03249792|615612557|FG000|Switch Over Period|Withdrawal by Subject|0|||
170347780|NCT03249792|615612558|FG001|Switch Over Period|Withdrawal by Subject|0|||
170347781|NCT03249792|615612559|FG002|Switch Over Period|Withdrawal by Subject|0|||
170347782|NCT03249792|615612560|FG003|Switch Over Period|Withdrawal by Subject|0|||
170347783|NCT03249792|615612561|FG004|Switch Over Period|Withdrawal by Subject|0|||
170347784|NCT03249792|615612562|FG005|Switch Over Period|Withdrawal by Subject|0|||
170347785|NCT03249792|615612563|FG006|Switch Over Period|Withdrawal by Subject|0|||
170347786|NCT03249792|615612564|FG007|Switch Over Period|Withdrawal by Subject|0|||
170347787|NCT03249792|615612565|FG008|Switch Over Period|Withdrawal by Subject|0|||
170347788|NCT03249792|615612566|FG009|Switch Over Period|Withdrawal by Subject|0|||
170347789|NCT03249792|615612567|FG010|Switch Over Period|Withdrawal by Subject|0|||
170347790|NCT03249792|615612568|FG011|Switch Over Period|Withdrawal by Subject|0|||
170347791|NCT03249792|615612569|FG012|Switch Over Period|Withdrawal by Subject|0|||
170347792|NCT03249792|615612570|FG013|Switch Over Period|Withdrawal by Subject|0|||
170347793|NCT03249792|615612571|FG014|Switch Over Period|Withdrawal by Subject|0|||
170347794|NCT03249792|615612572|FG015|Switch Over Period|Withdrawal by Subject|0|||
170347795|NCT03249792|615612573|FG016|Switch Over Period|Withdrawal by Subject|0|||
170347796|NCT03249792|615612574|FG017|Switch Over Period|Withdrawal by Subject|0|||
170347797|NCT03249792|615612575|FG018|Switch Over Period|Withdrawal by Subject|0|||
170347798|NCT03249792|615612576|FG019|Switch Over Period|Withdrawal by Subject|0|||
170347799|NCT03249792|615612577|FG020|Switch Over Period|Withdrawal by Subject|0|||
170347800|NCT03249792|615612578|FG021|Switch Over Period|Withdrawal by Subject|0|||
170347801|NCT03249792|615612579|FG022|Switch Over Period|Withdrawal by Subject|0|||
170347802|NCT03249792|615612580|FG023|Switch Over Period|Withdrawal by Subject|0|||
170347803|NCT03249792|615612581|FG024|Switch Over Period|Withdrawal by Subject|0|||
170347804|NCT03249792|615612582|FG025|Switch Over Period|Withdrawal by Subject|0|||
170347805|NCT03249792|615612583|FG026|Switch Over Period|Withdrawal by Subject|0|||
170347806|NCT03249792|615612584|FG027|Switch Over Period|Withdrawal by Subject|0|||
170347807|NCT03249792|615612585|FG028|Switch Over Period|Withdrawal by Subject|0|||
170347808|NCT03249792|615612586|FG029|Switch Over Period|Withdrawal by Subject|0|||
170347809|NCT03249792|615612587|FG030|Switch Over Period|Withdrawal by Subject|0|||
170347810|NCT03249792|615612588|FG031|Switch Over Period|Withdrawal by Subject|1|||
170347811|NCT03249792|615612589|FG032|Switch Over Period|Withdrawal by Subject|0|||
170347812|NCT03249792|615612557|FG000|Switch Over Period|Progressive Disease|0|||
170347813|NCT03249792|615612558|FG001|Switch Over Period|Progressive Disease|0|||
170347814|NCT03249792|615612559|FG002|Switch Over Period|Progressive Disease|0|||
170347815|NCT03249792|615612560|FG003|Switch Over Period|Progressive Disease|0|||
170347816|NCT03249792|615612561|FG004|Switch Over Period|Progressive Disease|0|||
170347817|NCT03249792|615612562|FG005|Switch Over Period|Progressive Disease|0|||
170347818|NCT03249792|615612563|FG006|Switch Over Period|Progressive Disease|0|||
170347819|NCT03249792|615612564|FG007|Switch Over Period|Progressive Disease|0|||
170347820|NCT03249792|615612565|FG008|Switch Over Period|Progressive Disease|0|||
170347821|NCT03249792|615612566|FG009|Switch Over Period|Progressive Disease|0|||
170347822|NCT03249792|615612567|FG010|Switch Over Period|Progressive Disease|0|||
170347823|NCT03249792|615612568|FG011|Switch Over Period|Progressive Disease|0|||
170347824|NCT03249792|615612569|FG012|Switch Over Period|Progressive Disease|0|||
170347825|NCT03249792|615612570|FG013|Switch Over Period|Progressive Disease|0|||
170347826|NCT03249792|615612571|FG014|Switch Over Period|Progressive Disease|0|||
170347827|NCT03249792|615612572|FG015|Switch Over Period|Progressive Disease|0|||
170347828|NCT03249792|615612573|FG016|Switch Over Period|Progressive Disease|0|||
170347829|NCT03249792|615612574|FG017|Switch Over Period|Progressive Disease|0|||
170347830|NCT03249792|615612575|FG018|Switch Over Period|Progressive Disease|0|||
170347831|NCT03249792|615612576|FG019|Switch Over Period|Progressive Disease|0|||
170347832|NCT03249792|615612577|FG020|Switch Over Period|Progressive Disease|0|||
170347833|NCT03249792|615612578|FG021|Switch Over Period|Progressive Disease|0|||
170347834|NCT03249792|615612579|FG022|Switch Over Period|Progressive Disease|0|||
170347835|NCT03249792|615612580|FG023|Switch Over Period|Progressive Disease|0|||
170347836|NCT03249792|615612581|FG024|Switch Over Period|Progressive Disease|0|||
170347837|NCT03249792|615612582|FG025|Switch Over Period|Progressive Disease|0|||
170347838|NCT03249792|615612583|FG026|Switch Over Period|Progressive Disease|1|||
170347839|NCT03249792|615612584|FG027|Switch Over Period|Progressive Disease|0|||
170347840|NCT03249792|615612585|FG028|Switch Over Period|Progressive Disease|1|||
170347841|NCT03249792|615612586|FG029|Switch Over Period|Progressive Disease|2|||
170347842|NCT03249792|615612587|FG030|Switch Over Period|Progressive Disease|1|||
170347843|NCT03249792|615612588|FG031|Switch Over Period|Progressive Disease|0|||
170347844|NCT03249792|615612589|FG032|Switch Over Period|Progressive Disease|1|||
170347845|NCT03249792|615612557|FG000|Switch Over Period|Adverse Event|0|||
170347846|NCT03249792|615612558|FG001|Switch Over Period|Adverse Event|0|||
170347847|NCT03249792|615612559|FG002|Switch Over Period|Adverse Event|0|||
170347848|NCT03249792|615612560|FG003|Switch Over Period|Adverse Event|0|||
170347849|NCT03249792|615612561|FG004|Switch Over Period|Adverse Event|0|||
170347850|NCT03249792|615612562|FG005|Switch Over Period|Adverse Event|0|||
170347851|NCT03249792|615612563|FG006|Switch Over Period|Adverse Event|0|||
170347852|NCT03249792|615612564|FG007|Switch Over Period|Adverse Event|0|||
170347853|NCT03249792|615612565|FG008|Switch Over Period|Adverse Event|0|||
170347854|NCT03249792|615612566|FG009|Switch Over Period|Adverse Event|0|||
170347855|NCT03249792|615612567|FG010|Switch Over Period|Adverse Event|0|||
170347856|NCT03249792|615612568|FG011|Switch Over Period|Adverse Event|0|||
170347857|NCT03249792|615612569|FG012|Switch Over Period|Adverse Event|0|||
170347858|NCT03249792|615612570|FG013|Switch Over Period|Adverse Event|0|||
170347859|NCT03249792|615612571|FG014|Switch Over Period|Adverse Event|0|||
170347860|NCT03249792|615612572|FG015|Switch Over Period|Adverse Event|0|||
170347861|NCT03249792|615612573|FG016|Switch Over Period|Adverse Event|0|||
170347862|NCT03249792|615612574|FG017|Switch Over Period|Adverse Event|0|||
170347863|NCT03249792|615612575|FG018|Switch Over Period|Adverse Event|0|||
170347864|NCT03249792|615612576|FG019|Switch Over Period|Adverse Event|0|||
170347865|NCT03249792|615612577|FG020|Switch Over Period|Adverse Event|0|||
170347866|NCT03249792|615612578|FG021|Switch Over Period|Adverse Event|0|||
170347867|NCT03249792|615612579|FG022|Switch Over Period|Adverse Event|0|||
170347868|NCT03249792|615612580|FG023|Switch Over Period|Adverse Event|0|||
170347869|NCT03249792|615612581|FG024|Switch Over Period|Adverse Event|0|||
170347870|NCT03249792|615612582|FG025|Switch Over Period|Adverse Event|1|||
170347871|NCT03249792|615612583|FG026|Switch Over Period|Adverse Event|0|||
170347872|NCT03249792|615612584|FG027|Switch Over Period|Adverse Event|1|||
170347873|NCT03249792|615612585|FG028|Switch Over Period|Adverse Event|0|||
170347874|NCT03249792|615612586|FG029|Switch Over Period|Adverse Event|0|||
170347875|NCT03249792|615612587|FG030|Switch Over Period|Adverse Event|0|||
170347876|NCT03249792|615612588|FG031|Switch Over Period|Adverse Event|0|||
170347877|NCT03249792|615612589|FG032|Switch Over Period|Adverse Event|0|||
170347878|NCT02284906|615612592|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
170347879|NCT02284906|615612593|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
170347880|NCT02284906|615612594|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
170347881|NCT02284906|615612592|FG000|Overall Study|Major Protocol Deviation|0|||
170347882|NCT02284906|615612593|FG001|Overall Study|Major Protocol Deviation|1|||
170347883|NCT02284906|615612594|FG002|Overall Study|Major Protocol Deviation|0|||
170347884|NCT02284906|615612592|FG000|Overall Study|Voluntary Withdrawal|2|||
170347885|NCT02284906|615612593|FG001|Overall Study|Voluntary Withdrawal|4|||
170347886|NCT02284906|615612594|FG002|Overall Study|Voluntary Withdrawal|5|||
170347887|NCT02284906|615612592|FG000|Overall Study|Study Termination|0|||
170347888|NCT02284906|615612593|FG001|Overall Study|Study Termination|11|||
170347889|NCT02284906|615612594|FG002|Overall Study|Study Termination|14|||
170347890|NCT02284906|615612592|FG000|Overall Study|Reason not Specified|1|||
170347891|NCT02284906|615612593|FG001|Overall Study|Reason not Specified|1|||
170347892|NCT02284906|615612594|FG002|Overall Study|Reason not Specified|0|||
170347893|NCT01409031|615612596|FG000|Overall Study|transferred to other hosp|1|||
170347894|NCT01409031|615612597|FG001|Overall Study|transferred to other hosp|0|||
170347895|NCT00532948|615612598|FG000|Overall Study|Protocol Violation|1|||
170347896|NCT00532948|615612599|FG001|Overall Study|Protocol Violation|0|||
170347897|NCT00532948|615612600|FG002|Overall Study|Protocol Violation|0|||
170347898|NCT00532948|615612598|FG000|Overall Study|Death|3|||
170347899|NCT00532948|615612599|FG001|Overall Study|Death|3|||
170347900|NCT00532948|615612600|FG002|Overall Study|Death|4|||
170347901|NCT00532948|615612598|FG000|Overall Study|Violation of selection criteria at entry|0|||
170347902|NCT00532948|615612599|FG001|Overall Study|Violation of selection criteria at entry|1|||
170347903|NCT00532948|615612600|FG002|Overall Study|Violation of selection criteria at entry|0|||
170347904|NCT00532948|615612598|FG000|Overall Study|Failure to return|0|||
170347905|NCT00532948|615612599|FG001|Overall Study|Failure to return|1|||
170347906|NCT00532948|615612600|FG002|Overall Study|Failure to return|0|||
170347907|NCT00995345|615612601|FG000|Overall Study|Withdrawal by Subject|4|||
170347908|NCT00995345|615612602|FG001|Overall Study|Withdrawal by Subject|2|||
170347909|NCT00995345|615612603|FG002|Overall Study|Withdrawal by Subject|1|||
170347910|NCT00995345|615612604|FG003|Overall Study|Withdrawal by Subject|3|||
170347911|NCT00995345|615612605|FG004|Overall Study|Withdrawal by Subject|1|||
170347912|NCT00995345|615612601|FG000|Overall Study|Adverse Event|3|||
170347913|NCT00995345|615612602|FG001|Overall Study|Adverse Event|1|||
170347914|NCT00995345|615612603|FG002|Overall Study|Adverse Event|2|||
170347915|NCT00995345|615612604|FG003|Overall Study|Adverse Event|0|||
170347916|NCT00995345|615612605|FG004|Overall Study|Adverse Event|1|||
170347917|NCT00995345|615612601|FG000|Overall Study|Lost to Follow-up|2|||
170347918|NCT00995345|615612602|FG001|Overall Study|Lost to Follow-up|2|||
170347919|NCT00995345|615612603|FG002|Overall Study|Lost to Follow-up|2|||
170347920|NCT00995345|615612604|FG003|Overall Study|Lost to Follow-up|1|||
170347921|NCT00995345|615612605|FG004|Overall Study|Lost to Follow-up|0|||
170347922|NCT00995345|615612601|FG000|Overall Study|all other reasons combined|2|||
170347923|NCT00995345|615612602|FG001|Overall Study|all other reasons combined|2|||
170347924|NCT00995345|615612603|FG002|Overall Study|all other reasons combined|2|||
170347925|NCT00995345|615612604|FG003|Overall Study|all other reasons combined|1|||
170347926|NCT00995345|615612605|FG004|Overall Study|all other reasons combined|3|||
170347927|NCT01201798|615612607|FG000|Overall Study|Adverse Event|2|||
170347928|NCT01201798|615612608|FG001|Overall Study|Adverse Event|0|||
170347929|NCT01201798|615612607|FG000|Overall Study|Lost to Follow-up|3|||
170347930|NCT01201798|615612608|FG001|Overall Study|Lost to Follow-up|5|||
170347931|NCT01201798|615612607|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
170347932|NCT01201798|615612608|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
170347933|NCT01201798|615612607|FG000|Overall Study|Noncompliance|1|||
170347934|NCT01201798|615612608|FG001|Overall Study|Noncompliance|0|||
170347935|NCT01201798|615612607|FG000|Overall Study|Protocol Violation|1|||
170347936|NCT01201798|615612608|FG001|Overall Study|Protocol Violation|1|||
170347937|NCT01201798|615612607|FG000|Overall Study|Treatment Failure|1|||
170347938|NCT01201798|615612608|FG001|Overall Study|Treatment Failure|8|||
170347939|NCT02512068|615612613|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
170347940|NCT02512068|615612614|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
170347941|NCT02512068|615612613|FG000|Overall Study|Major Protocol Deviation|1|||
170347942|NCT02512068|615612614|FG001|Overall Study|Major Protocol Deviation|0|||
170347943|NCT02512068|615612613|FG000|Overall Study|Voluntary Withdrawal|0|||
170347944|NCT02512068|615612614|FG001|Overall Study|Voluntary Withdrawal|1|||
170347945|NCT02512068|615612613|FG000|Overall Study|Lack of Efficacy|0|||
170347946|NCT02512068|615612614|FG001|Overall Study|Lack of Efficacy|1|||
170347947|NCT02512068|615612613|FG000|Overall Study|Reason Not Specified|3|||
170347948|NCT02512068|615612614|FG001|Overall Study|Reason Not Specified|5|||
170347949|NCT01276457|615612616|FG000|Core Study|Adverse Event|6|||
170347950|NCT01276457|615612617|FG001|Core Study|Adverse Event|3|||
170347951|NCT01276457|615612616|FG000|Core Study|Lost to Follow-up|1|||
170347952|NCT01276457|615612617|FG001|Core Study|Lost to Follow-up|2|||
170347953|NCT01276457|615612616|FG000|Core Study|Administrative problems|1|||
170347954|NCT01276457|615612617|FG001|Core Study|Administrative problems|1|||
170347955|NCT01276457|615612616|FG000|Core Study|Death|2|||
170347956|NCT01276457|615612617|FG001|Core Study|Death|2|||
170347957|NCT01276457|615612616|FG000|Core Study|Lack of Efficacy|3|||
170347958|NCT01276457|615612617|FG001|Core Study|Lack of Efficacy|12|||
170347959|NCT01276457|615612616|FG000|Extension Study|Lost to Follow-up|3|||
170347960|NCT01276457|615612617|FG001|Extension Study|Lost to Follow-up|0|||
170347961|NCT01276457|615612616|FG000|Extension Study|Death|0|||
170347962|NCT01276457|615612617|FG001|Extension Study|Death|1|||
170347963|NCT01276457|615612616|FG000|Extension Study|Lack of Efficacy|3|||
170347964|NCT01276457|615612617|FG001|Extension Study|Lack of Efficacy|1|||
170347965|NCT02538666|615612623|FG000|Pre-Treatment|Disease progression|1|||
170347966|NCT02538666|615612624|FG001|Pre-Treatment|Disease progression|0|||
170347967|NCT02538666|615612625|FG002|Pre-Treatment|Disease progression|0|||
170347968|NCT02538666|615612623|FG000|Pre-Treatment|no longer meets study criteria|1|||
170347969|NCT02538666|615612624|FG001|Pre-Treatment|no longer meets study criteria|0|||
170347970|NCT02538666|615612625|FG002|Pre-Treatment|no longer meets study criteria|0|||
170347971|NCT02538666|615612623|FG000|Pre-Treatment|Withdrew Consent|0|||
170347972|NCT02538666|615612624|FG001|Pre-Treatment|Withdrew Consent|1|||
170347973|NCT02538666|615612625|FG002|Pre-Treatment|Withdrew Consent|1|||
170347974|NCT02538666|615612623|FG000|Treatment|Disease progression|270|||
170347975|NCT02538666|615612624|FG001|Treatment|Disease progression|227|||
170347976|NCT02538666|615612625|FG002|Treatment|Disease progression|165|||
170347977|NCT02538666|615612623|FG000|Treatment|Study drug toxicity|1|||
170347978|NCT02538666|615612624|FG001|Treatment|Study drug toxicity|29|||
170347979|NCT02538666|615612625|FG002|Treatment|Study drug toxicity|92|||
170347980|NCT02538666|615612623|FG000|Treatment|Death|0|||
170347981|NCT02538666|615612624|FG001|Treatment|Death|2|||
170347982|NCT02538666|615612625|FG002|Treatment|Death|3|||
170347983|NCT02538666|615612623|FG000|Treatment|Adverse event unrelated to study drug|8|||
170347984|NCT02538666|615612624|FG001|Treatment|Adverse event unrelated to study drug|10|||
170347985|NCT02538666|615612625|FG002|Treatment|Adverse event unrelated to study drug|15|||
170347986|NCT02538666|615612623|FG000|Treatment|Participant request to discontinue study treatment|3|||
170347987|NCT02538666|615612624|FG001|Treatment|Participant request to discontinue study treatment|6|||
170347988|NCT02538666|615612625|FG002|Treatment|Participant request to discontinue study treatment|11|||
170347989|NCT02538666|615612623|FG000|Treatment|Participant withdrew consent|2|||
170347990|NCT02538666|615612624|FG001|Treatment|Participant withdrew consent|5|||
170347991|NCT02538666|615612625|FG002|Treatment|Participant withdrew consent|3|||
170347992|NCT02538666|615612623|FG000|Treatment|Lost to Follow-up|0|||
170347993|NCT02538666|615612624|FG001|Treatment|Lost to Follow-up|1|||
170347994|NCT02538666|615612625|FG002|Treatment|Lost to Follow-up|1|||
170347995|NCT02538666|615612623|FG000|Treatment|Maximum clinical benefit|4|||
170347996|NCT02538666|615612624|FG001|Treatment|Maximum clinical benefit|3|||
170347997|NCT02538666|615612625|FG002|Treatment|Maximum clinical benefit|4|||
170347998|NCT02538666|615612623|FG000|Treatment|Poor/non-compliance|0|||
170347999|NCT02538666|615612624|FG001|Treatment|Poor/non-compliance|1|||
170348000|NCT02538666|615612625|FG002|Treatment|Poor/non-compliance|0|||
170348001|NCT02538666|615612623|FG000|Treatment|Participant no longer meets study criteria|0|||
170348002|NCT02538666|615612624|FG001|Treatment|Participant no longer meets study criteria|2|||
170348003|NCT02538666|615612625|FG002|Treatment|Participant no longer meets study criteria|0|||
170348004|NCT02538666|615612623|FG000|Treatment|Administrative reason by sponsor|0|||
170348005|NCT02538666|615612624|FG001|Treatment|Administrative reason by sponsor|0|||
170348006|NCT02538666|615612625|FG002|Treatment|Administrative reason by sponsor|1|||
170348007|NCT02538666|615612623|FG000|Treatment|Other reasons|8|||
170348008|NCT02538666|615612624|FG001|Treatment|Other reasons|15|||
170348009|NCT02538666|615612625|FG002|Treatment|Other reasons|5|||
170348010|NCT02538666|615612623|FG000|Treatment|Not reported|2|||
170348011|NCT02538666|615612624|FG001|Treatment|Not reported|2|||
170348012|NCT02538666|615612625|FG002|Treatment|Not reported|2|||
170348013|NCT04370028|615612626|FG000|Overall Study|Withdrawal by Subject|695|||
170348014|NCT04370028|615612626|FG000|Overall Study|Protocol Violation|9|||
170348015|NCT04370028|615612626|FG000|Overall Study|Adverse Event|3|||
170348016|NCT01915849|615612632|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
170348017|NCT01915849|615612633|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
170348018|NCT01915849|615612634|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
170348019|NCT01915849|615612635|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
170348020|NCT01915849|615612632|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
170348021|NCT01915849|615612633|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
170348022|NCT01915849|615612634|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
170348023|NCT01915849|615612635|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
170348024|NCT00256867|615612643|FG000|Overall Study|Adverse Event|0|||
170348025|NCT00256867|615612644|FG001|Overall Study|Adverse Event|1|||
170348026|NCT00256867|615612645|FG002|Overall Study|Adverse Event|1|||
170348027|NCT00256867|615612646|FG003|Overall Study|Adverse Event|1|||
170348028|NCT00256867|615612647|FG004|Overall Study|Adverse Event|2|||
170348029|NCT00256867|615612648|FG005|Overall Study|Adverse Event|2|||
170348030|NCT00256867|615612649|FG006|Overall Study|Adverse Event|1|||
170348031|NCT00256867|615612650|FG007|Overall Study|Adverse Event|4|||
170348032|NCT00256867|615612643|FG000|Overall Study|Lost to Follow-up|2|||
170348033|NCT00256867|615612644|FG001|Overall Study|Lost to Follow-up|2|||
170348034|NCT00256867|615612645|FG002|Overall Study|Lost to Follow-up|2|||
170348035|NCT00256867|615612646|FG003|Overall Study|Lost to Follow-up|3|||
170348036|NCT00256867|615612647|FG004|Overall Study|Lost to Follow-up|2|||
170348037|NCT00256867|615612648|FG005|Overall Study|Lost to Follow-up|0|||
170348038|NCT00256867|615612649|FG006|Overall Study|Lost to Follow-up|1|||
170348039|NCT00256867|615612650|FG007|Overall Study|Lost to Follow-up|2|||
170348040|NCT00256867|615612643|FG000|Overall Study|Protocol Violation|0|||
170348041|NCT00256867|615612644|FG001|Overall Study|Protocol Violation|0|||
170348042|NCT00256867|615612645|FG002|Overall Study|Protocol Violation|0|||
170348043|NCT00256867|615612646|FG003|Overall Study|Protocol Violation|1|||
170348044|NCT00256867|615612647|FG004|Overall Study|Protocol Violation|0|||
170348045|NCT00256867|615612648|FG005|Overall Study|Protocol Violation|1|||
170348046|NCT00256867|615612649|FG006|Overall Study|Protocol Violation|0|||
170348047|NCT00256867|615612650|FG007|Overall Study|Protocol Violation|1|||
170348048|NCT00256867|615612643|FG000|Overall Study|Withdrawal by Subject|0|||
170348049|NCT00256867|615612644|FG001|Overall Study|Withdrawal by Subject|0|||
170348050|NCT00256867|615612645|FG002|Overall Study|Withdrawal by Subject|1|||
170348051|NCT00256867|615612646|FG003|Overall Study|Withdrawal by Subject|1|||
170348052|NCT00256867|615612647|FG004|Overall Study|Withdrawal by Subject|2|||
170348053|NCT00256867|615612648|FG005|Overall Study|Withdrawal by Subject|2|||
170348054|NCT00256867|615612649|FG006|Overall Study|Withdrawal by Subject|3|||
170348055|NCT00256867|615612650|FG007|Overall Study|Withdrawal by Subject|2|||
170348056|NCT00256867|615612643|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
170348057|NCT00256867|615612644|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
170348058|NCT00256867|615612645|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
170348059|NCT00256867|615612646|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
170348060|NCT00256867|615612647|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
170348061|NCT00256867|615612648|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
170348062|NCT00256867|615612649|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
170348063|NCT00256867|615612650|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
170348064|NCT00256867|615612643|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
170348065|NCT00256867|615612644|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
170348066|NCT00256867|615612645|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
170348067|NCT00256867|615612646|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
170348068|NCT00256867|615612647|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
170348069|NCT00256867|615612648|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
170348070|NCT00256867|615612649|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
170348071|NCT00256867|615612650|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
170348072|NCT00256867|615612643|FG000|Overall Study|Investigator's Decision|0|||
170348073|NCT00256867|615612644|FG001|Overall Study|Investigator's Decision|0|||
170348074|NCT00256867|615612645|FG002|Overall Study|Investigator's Decision|0|||
170348075|NCT00256867|615612646|FG003|Overall Study|Investigator's Decision|0|||
170348076|NCT00256867|615612647|FG004|Overall Study|Investigator's Decision|1|||
170348077|NCT00256867|615612648|FG005|Overall Study|Investigator's Decision|0|||
170348078|NCT00256867|615612649|FG006|Overall Study|Investigator's Decision|0|||
170348079|NCT00256867|615612650|FG007|Overall Study|Investigator's Decision|0|||
170348080|NCT00256867|615612643|FG000|Overall Study|Non-compliance with study medication|0|||
170348081|NCT00256867|615612644|FG001|Overall Study|Non-compliance with study medication|0|||
170348082|NCT00256867|615612645|FG002|Overall Study|Non-compliance with study medication|0|||
170348083|NCT00256867|615612646|FG003|Overall Study|Non-compliance with study medication|0|||
170348084|NCT00256867|615612647|FG004|Overall Study|Non-compliance with study medication|0|||
170348085|NCT00256867|615612648|FG005|Overall Study|Non-compliance with study medication|0|||
170348086|NCT00256867|615612649|FG006|Overall Study|Non-compliance with study medication|0|||
170348087|NCT00256867|615612650|FG007|Overall Study|Non-compliance with study medication|1|||
170348088|NCT00256867|615612643|FG000|Overall Study|Participant travelled Overseas|0|||
170348089|NCT00256867|615612644|FG001|Overall Study|Participant travelled Overseas|1|||
170348090|NCT00256867|615612645|FG002|Overall Study|Participant travelled Overseas|0|||
170348091|NCT00256867|615612646|FG003|Overall Study|Participant travelled Overseas|0|||
170348092|NCT00256867|615612647|FG004|Overall Study|Participant travelled Overseas|0|||
170348093|NCT00256867|615612648|FG005|Overall Study|Participant travelled Overseas|0|||
170348094|NCT00256867|615612649|FG006|Overall Study|Participant travelled Overseas|0|||
170348095|NCT00256867|615612650|FG007|Overall Study|Participant travelled Overseas|0|||
170348096|NCT00256867|615612643|FG000|Overall Study|Participant out of assessment window|0|||
170348097|NCT00256867|615612644|FG001|Overall Study|Participant out of assessment window|0|||
170348098|NCT00256867|615612645|FG002|Overall Study|Participant out of assessment window|1|||
170348099|NCT00256867|615612646|FG003|Overall Study|Participant out of assessment window|0|||
170348100|NCT00256867|615612647|FG004|Overall Study|Participant out of assessment window|0|||
170348101|NCT00256867|615612648|FG005|Overall Study|Participant out of assessment window|0|||
170348102|NCT00256867|615612649|FG006|Overall Study|Participant out of assessment window|0|||
170348103|NCT00256867|615612650|FG007|Overall Study|Participant out of assessment window|0|||
170348104|NCT00256867|615612643|FG000|Overall Study|Withdrawal by participant|0|||
170348105|NCT00256867|615612644|FG001|Overall Study|Withdrawal by participant|0|||
170348106|NCT00256867|615612645|FG002|Overall Study|Withdrawal by participant|0|||
170348107|NCT00256867|615612646|FG003|Overall Study|Withdrawal by participant|0|||
170348108|NCT00256867|615612647|FG004|Overall Study|Withdrawal by participant|0|||
170348109|NCT00256867|615612648|FG005|Overall Study|Withdrawal by participant|1|||
170348110|NCT00256867|615612649|FG006|Overall Study|Withdrawal by participant|0|||
170348111|NCT00256867|615612650|FG007|Overall Study|Withdrawal by participant|0|||
170348112|NCT02689219|615612659|FG000|Overall Study|Death|1|||
170348113|NCT02689219|615612660|FG001|Overall Study|Death|1|||
170348114|NCT02689219|615612659|FG000|Overall Study|Disease Progression|10|||
170348115|NCT02689219|615612660|FG001|Overall Study|Disease Progression|6|||
170348116|NCT01921257|615612666|FG000|Overall Study|Adverse Event|1|||
170348117|NCT01921257|615612666|FG000|Overall Study|Protocol Violation|1|||
170348118|NCT01921257|615612666|FG000|Overall Study|Withdrawal by Subject|1|||
170348119|NCT01912768|615612668|FG000|Overall Study|Adverse Event|2|||
170348120|NCT01912768|615612669|FG001|Overall Study|Adverse Event|0|||
170348121|NCT01912768|615612668|FG000|Overall Study|Lost to Follow-up|2|||
170348122|NCT01912768|615612669|FG001|Overall Study|Lost to Follow-up|1|||
170348123|NCT01912768|615612668|FG000|Overall Study|Withdrawal by Subject|5|||
170348124|NCT01912768|615612669|FG001|Overall Study|Withdrawal by Subject|3|||
170348125|NCT01912768|615612668|FG000|Overall Study|Randomized in error|1|||
170348126|NCT01912768|615612669|FG001|Overall Study|Randomized in error|0|||
170348127|NCT02426658|615612670|FG000|Overall Study|Withdrawal by Subject|1|||
170348128|NCT02426658|615612670|FG000|Overall Study|Patient expired before treatment|2|||
170348129|NCT03255291|615612673|FG000|Overall Study|Determined to be ineligible|10|||
170348130|NCT03255291|615612674|FG001|Overall Study|Determined to be ineligible|12|||
170348131|NCT03255291|615612675|FG002|Overall Study|Determined to be ineligible|6|||
170348132|NCT03255291|615612676|FG003|Overall Study|Determined to be ineligible|6|||
170348133|NCT03255291|615612677|FG004|Overall Study|Determined to be ineligible|5|||
170348134|NCT03255291|615612678|FG005|Overall Study|Determined to be ineligible|10|||
170348135|NCT03255291|615612673|FG000|Overall Study|Baseline data collection issues|3|||
170348136|NCT03255291|615612674|FG001|Overall Study|Baseline data collection issues|0|||
170348137|NCT03255291|615612675|FG002|Overall Study|Baseline data collection issues|0|||
170348138|NCT03255291|615612676|FG003|Overall Study|Baseline data collection issues|0|||
170348139|NCT03255291|615612677|FG004|Overall Study|Baseline data collection issues|2|||
170348140|NCT03255291|615612678|FG005|Overall Study|Baseline data collection issues|0|||
170348141|NCT00634244|615612679|FG000|Overall Study|Never started treatment|0|||
170348142|NCT00634244|615612680|FG001|Overall Study|Never started treatment|1|||
170348143|NCT00634244|615612681|FG002|Overall Study|Never started treatment|0|||
170348144|NCT00634244|615612679|FG000|Overall Study|Death|1|||
170348145|NCT00634244|615612680|FG001|Overall Study|Death|6|||
170348146|NCT00634244|615612681|FG002|Overall Study|Death|0|||
170348147|NCT00634244|615612679|FG000|Overall Study|Adverse Event|0|||
170348148|NCT00634244|615612680|FG001|Overall Study|Adverse Event|2|||
170348149|NCT00634244|615612681|FG002|Overall Study|Adverse Event|0|||
170348150|NCT00634244|615612679|FG000|Overall Study|Withdrawal by Subject|0|||
170348151|NCT00634244|615612680|FG001|Overall Study|Withdrawal by Subject|1|||
170348152|NCT00634244|615612681|FG002|Overall Study|Withdrawal by Subject|0|||
170348153|NCT00634244|615612679|FG000|Overall Study|Physician Decision|0|||
170348154|NCT00634244|615612680|FG001|Overall Study|Physician Decision|1|||
170348155|NCT00634244|615612681|FG002|Overall Study|Physician Decision|0|||
170348156|NCT00634244|615612679|FG000|Overall Study|Disease progression/relapse|0|||
170348157|NCT00634244|615612680|FG001|Overall Study|Disease progression/relapse|1|||
170348158|NCT00634244|615612681|FG002|Overall Study|Disease progression/relapse|0|||
170348159|NCT00634244|615612679|FG000|Overall Study|Other complicating disease|0|||
170348160|NCT00634244|615612680|FG001|Overall Study|Other complicating disease|1|||
170348161|NCT00634244|615612681|FG002|Overall Study|Other complicating disease|0|||
170348162|NCT03591146|615612684|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
170348163|NCT03591146|615612685|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
170348164|NCT03591146|615612686|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
170348165|NCT03591146|615612687|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
170348166|NCT03591146|615612688|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
170348167|NCT03591146|615612684|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
170348168|NCT03591146|615612685|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
170348169|NCT03591146|615612686|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
170348170|NCT03591146|615612687|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
170348171|NCT03591146|615612688|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
170348172|NCT03591146|615612684|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
170348173|NCT03591146|615612685|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
170348174|NCT03591146|615612686|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
170348175|NCT03591146|615612687|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
170348176|NCT03591146|615612688|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
170348177|NCT03591146|615612684|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
170348178|NCT03591146|615612685|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
170348179|NCT03591146|615612686|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
170348180|NCT03591146|615612687|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
170348181|NCT03591146|615612688|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
170348182|NCT01204658|615612689|FG000|Primary Phase|Adverse Event|0|||
170348183|NCT01204658|615612690|FG001|Primary Phase|Adverse Event|0|||
170348184|NCT01204658|615612691|FG002|Primary Phase|Adverse Event|1|||
170348185|NCT01204658|615612692|FG003|Primary Phase|Adverse Event|0|||
170348186|NCT02198651|615614963|FG000|Lead-in Period|Withdrew consent|13|||
170348187|NCT02198651|615614964|FG001|Lead-in Period|Withdrew consent|0|||
170348188|NCT02198651|615614965|FG002|Lead-in Period|Withdrew consent|0|||
170348189|NCT02198651|615614966|FG003|Lead-in Period|Withdrew consent|0|||
170348190|NCT02198651|615614967|FG004|Lead-in Period|Withdrew consent|0|||
170348191|NCT02198651|615614963|FG000|Lead-in Period|Adverse Event|2|||
170348192|NCT02198651|615614964|FG001|Lead-in Period|Adverse Event|0|||
170348193|NCT02198651|615614965|FG002|Lead-in Period|Adverse Event|0|||
170348194|NCT02198651|615614966|FG003|Lead-in Period|Adverse Event|0|||
170348195|NCT02198651|615614967|FG004|Lead-in Period|Adverse Event|0|||
170348196|NCT02198651|615614963|FG000|Lead-in Period|Other, not specified|22|||
170348197|NCT02198651|615614964|FG001|Lead-in Period|Other, not specified|0|||
170348198|NCT02198651|615614965|FG002|Lead-in Period|Other, not specified|0|||
170348199|NCT02198651|615614966|FG003|Lead-in Period|Other, not specified|0|||
170348200|NCT02198651|615614967|FG004|Lead-in Period|Other, not specified|0|||
170348201|NCT02198651|615614963|FG000|Double-blind Period|Withdrew consent|0|||
170348202|NCT02198651|615614964|FG001|Double-blind Period|Withdrew consent|4|||
170348203|NCT02198651|615614965|FG002|Double-blind Period|Withdrew consent|0|||
170348204|NCT02198651|615614966|FG003|Double-blind Period|Withdrew consent|0|||
170348205|NCT02198651|615614967|FG004|Double-blind Period|Withdrew consent|0|||
170348206|NCT02198651|615614963|FG000|Double-blind Period|Adverse Event|0|||
170348207|NCT02198651|615614964|FG001|Double-blind Period|Adverse Event|1|||
170348208|NCT02198651|615614965|FG002|Double-blind Period|Adverse Event|0|||
170348209|NCT02198651|615614966|FG003|Double-blind Period|Adverse Event|0|||
170348210|NCT02198651|615614967|FG004|Double-blind Period|Adverse Event|0|||
170348211|NCT02198651|615614963|FG000|Double-blind Period|Other, not specified|0|||
170348212|NCT02198651|615614964|FG001|Double-blind Period|Other, not specified|4|||
170348213|NCT02198651|615614965|FG002|Double-blind Period|Other, not specified|1|||
170348214|NCT02198651|615614966|FG003|Double-blind Period|Other, not specified|0|||
170348215|NCT02198651|615614967|FG004|Double-blind Period|Other, not specified|0|||
170348216|NCT02198651|615614963|FG000|Open-label Rescue Period|Withdrew consent|0|||
170348217|NCT02198651|615614964|FG001|Open-label Rescue Period|Withdrew consent|0|||
170348218|NCT02198651|615614965|FG002|Open-label Rescue Period|Withdrew consent|0|||
170348219|NCT02198651|615614966|FG003|Open-label Rescue Period|Withdrew consent|2|||
170348220|NCT02198651|615614967|FG004|Open-label Rescue Period|Withdrew consent|0|||
170348221|NCT02198651|615614963|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
170348222|NCT02198651|615614964|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
170348223|NCT02198651|615614965|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
170348224|NCT02198651|615614966|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
170348225|NCT02198651|615614967|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
170348226|NCT02349789|615614968|FG000|Overall Study|Withdrawal by Subject|2|||
170348227|NCT00311181|615614971|FG000|Overall Study|Final DFTs were not obtained|96|||
170348228|NCT02294318|615614972|FG000|Overall Study|Worsening of drinking|3|||
170348229|NCT02294318|615614973|FG001|Overall Study|Worsening of drinking|0|||
170348230|NCT02294318|615614972|FG000|Overall Study|Not exposed to intervention|0|||
170348231|NCT02294318|615614973|FG001|Overall Study|Not exposed to intervention|2|||
170348232|NCT00762372|615614974|FG000|Overall Study|Adverse Event|1|||
170348233|NCT00762372|615614975|FG001|Overall Study|Adverse Event|0|||
170348234|NCT00762372|615614976|FG002|Overall Study|Adverse Event|0|||
170348235|NCT03364335|615614977|FG000|Overall Study|Adverse Event|3|||
170348236|NCT03364335|615614978|FG001|Overall Study|Adverse Event|4|||
170348237|NCT03364335|615614979|FG002|Overall Study|Adverse Event|1|||
170348238|NCT03364335|615614980|FG003|Overall Study|Adverse Event|2|||
170348239|NCT03364335|615614981|FG004|Overall Study|Adverse Event|0|||
170348240|NCT03364335|615614977|FG000|Overall Study|Lost to Follow-up|7|||
170348241|NCT03364335|615614978|FG001|Overall Study|Lost to Follow-up|7|||
170348242|NCT03364335|615614979|FG002|Overall Study|Lost to Follow-up|10|||
170348243|NCT03364335|615614980|FG003|Overall Study|Lost to Follow-up|11|||
170348244|NCT03364335|615614981|FG004|Overall Study|Lost to Follow-up|11|||
170348245|NCT01194804|615614982|FG000|Overall Study|Withdrawal by Subject|1|||
170348246|NCT02670915|615614983|FG000|Overall Study|Withdrawal by Subject|0|||
170348247|NCT02670915|615614984|FG001|Overall Study|Withdrawal by Subject|1|||
170348248|NCT02670915|615614985|FG002|Overall Study|Withdrawal by Subject|4|||
170348249|NCT02670915|615614983|FG000|Overall Study|Withdrawal by parent/guardian|4|||
170348250|NCT02670915|615614984|FG001|Overall Study|Withdrawal by parent/guardian|4|||
170348251|NCT02670915|615614985|FG002|Overall Study|Withdrawal by parent/guardian|1|||
170348252|NCT02670915|615614983|FG000|Overall Study|Unclassified|0|||
170348253|NCT02670915|615614984|FG001|Overall Study|Unclassified|3|||
170348254|NCT02670915|615614985|FG002|Overall Study|Unclassified|0|||
170348255|NCT00818207|615614986|FG000|Overall Study|Adverse Event|6|||
170348256|NCT00818207|615614987|FG001|Overall Study|Adverse Event|0|||
170348257|NCT00818207|615614986|FG000|Overall Study|Lost to Follow-up|160|||
170348258|NCT00818207|615614987|FG001|Overall Study|Lost to Follow-up|146|||
170348259|NCT00818207|615614986|FG000|Overall Study|Multiple reasons|11|||
170348260|NCT00818207|615614987|FG001|Overall Study|Multiple reasons|12|||
170348261|NCT00818207|615614986|FG000|Overall Study|Withdrawal by Subject|42|||
170348262|NCT00818207|615614987|FG001|Overall Study|Withdrawal by Subject|104|||
170348263|NCT00818207|615614986|FG000|Overall Study|Death|3|||
170348264|NCT00818207|615614987|FG001|Overall Study|Death|5|||
170348265|NCT02616185|615614988|FG000|Overall Study|Death|0|||
170348266|NCT02616185|615614989|FG001|Overall Study|Death|0|||
170348267|NCT02616185|615614990|FG002|Overall Study|Death|0|||
170348268|NCT02616185|615614991|FG003|Overall Study|Death|1|||
170348269|NCT02616185|615614992|FG004|Overall Study|Death|2|||
170348270|NCT02616185|615614993|FG005|Overall Study|Death|0|||
170348271|NCT02616185|615614994|FG006|Overall Study|Death|0|||
170348272|NCT02616185|615614995|FG007|Overall Study|Death|2|||
170348273|NCT02616185|615614996|FG008|Overall Study|Death|1|||
170348274|NCT02616185|615614988|FG000|Overall Study|Study terminated by sponsor|0|||
170348275|NCT02616185|615614989|FG001|Overall Study|Study terminated by sponsor|0|||
170348276|NCT02616185|615614990|FG002|Overall Study|Study terminated by sponsor|1|||
170348277|NCT02616185|615614991|FG003|Overall Study|Study terminated by sponsor|0|||
170348278|NCT02616185|615614992|FG004|Overall Study|Study terminated by sponsor|0|||
170348279|NCT02616185|615614993|FG005|Overall Study|Study terminated by sponsor|0|||
170348280|NCT02616185|615614994|FG006|Overall Study|Study terminated by sponsor|5|||
170348281|NCT02616185|615614995|FG007|Overall Study|Study terminated by sponsor|2|||
170348282|NCT02616185|615614996|FG008|Overall Study|Study terminated by sponsor|0|||
170348283|NCT02616185|615614988|FG000|Overall Study|Participant refused further follow-up|1|||
170348284|NCT02616185|615614989|FG001|Overall Study|Participant refused further follow-up|1|||
170348285|NCT02616185|615614990|FG002|Overall Study|Participant refused further follow-up|2|||
170348286|NCT02616185|615614991|FG003|Overall Study|Participant refused further follow-up|3|||
170348287|NCT02616185|615614992|FG004|Overall Study|Participant refused further follow-up|4|||
170348288|NCT02616185|615614993|FG005|Overall Study|Participant refused further follow-up|0|||
170348289|NCT02616185|615614994|FG006|Overall Study|Participant refused further follow-up|3|||
170348290|NCT02616185|615614995|FG007|Overall Study|Participant refused further follow-up|4|||
170348291|NCT02616185|615614996|FG008|Overall Study|Participant refused further follow-up|3|||
170348292|NCT02616185|615614988|FG000|Overall Study|Not reported|0|||
170348293|NCT02616185|615614989|FG001|Overall Study|Not reported|0|||
170348294|NCT02616185|615614990|FG002|Overall Study|Not reported|0|||
170348295|NCT02616185|615614991|FG003|Overall Study|Not reported|1|||
170348296|NCT02616185|615614992|FG004|Overall Study|Not reported|3|||
170348297|NCT02616185|615614993|FG005|Overall Study|Not reported|1|||
170348298|NCT02616185|615614994|FG006|Overall Study|Not reported|0|||
170348299|NCT02616185|615614995|FG007|Overall Study|Not reported|5|||
170348300|NCT02616185|615614996|FG008|Overall Study|Not reported|2|||
170348301|NCT01303380|615614997|FG000|Overall Study|Lack of compliance to study procedures|1|||
170348302|NCT00967226|615614998|FG000|Overall Study|Adverse Event|0|||
170348303|NCT00967226|615614999|FG001|Overall Study|Adverse Event|5|||
170348304|NCT00967226|615614998|FG000|Overall Study|Protocol Violation|2|||
170348305|NCT00967226|615614999|FG001|Overall Study|Protocol Violation|0|||
170348306|NCT00967226|615614998|FG000|Overall Study|Physician Decision|0|||
170348307|NCT00967226|615614999|FG001|Overall Study|Physician Decision|1|||
170348308|NCT01670656|615615000|FG000|Overall Study|Non-compliance with study drug|0|||
170348309|NCT01670656|615615001|FG001|Overall Study|Non-compliance with study drug|0|||
170348310|NCT01670656|615615002|FG002|Overall Study|Non-compliance with study drug|3|||
170348311|NCT01670656|615615003|FG003|Overall Study|Non-compliance with study drug|0|||
170348312|NCT01670656|615615004|FG004|Overall Study|Non-compliance with study drug|1|||
170348313|NCT01670656|615615000|FG000|Overall Study|Pregnancy|0|||
170348314|NCT01670656|615615001|FG001|Overall Study|Pregnancy|0|||
170348315|NCT01670656|615615002|FG002|Overall Study|Pregnancy|0|||
170348316|NCT01670656|615615003|FG003|Overall Study|Pregnancy|0|||
170348317|NCT01670656|615615004|FG004|Overall Study|Pregnancy|1|||
170348318|NCT01670656|615615000|FG000|Overall Study|Withdrawal by Subject|1|||
170348319|NCT01670656|615615001|FG001|Overall Study|Withdrawal by Subject|1|||
170348320|NCT01670656|615615002|FG002|Overall Study|Withdrawal by Subject|0|||
170348321|NCT01670656|615615003|FG003|Overall Study|Withdrawal by Subject|0|||
170348322|NCT01670656|615615004|FG004|Overall Study|Withdrawal by Subject|0|||
170348323|NCT01670656|615615000|FG000|Overall Study|Non-compliance with protocol|0|||
170348324|NCT01670656|615615001|FG001|Overall Study|Non-compliance with protocol|3|||
170348325|NCT01670656|615615002|FG002|Overall Study|Non-compliance with protocol|1|||
170348326|NCT01670656|615615003|FG003|Overall Study|Non-compliance with protocol|1|||
170348327|NCT01670656|615615004|FG004|Overall Study|Non-compliance with protocol|2|||
170348328|NCT01670656|615615000|FG000|Overall Study|Adverse Event|2|||
170348329|NCT01670656|615615001|FG001|Overall Study|Adverse Event|2|||
170348330|NCT01670656|615615002|FG002|Overall Study|Adverse Event|2|||
170348331|NCT01670656|615615003|FG003|Overall Study|Adverse Event|3|||
170348332|NCT01670656|615615004|FG004|Overall Study|Adverse Event|3|||
170348333|NCT01670656|615615000|FG000|Overall Study|Subject withdrew consent|0|||
170348334|NCT01670656|615615001|FG001|Overall Study|Subject withdrew consent|1|||
170348335|NCT01670656|615615002|FG002|Overall Study|Subject withdrew consent|2|||
170348336|NCT01670656|615615003|FG003|Overall Study|Subject withdrew consent|1|||
170348337|NCT01670656|615615004|FG004|Overall Study|Subject withdrew consent|1|||
170348338|NCT01670656|615615000|FG000|Overall Study|Lost to Follow-up|0|||
170348339|NCT01670656|615615001|FG001|Overall Study|Lost to Follow-up|0|||
170348340|NCT01670656|615615002|FG002|Overall Study|Lost to Follow-up|0|||
170348341|NCT01670656|615615003|FG003|Overall Study|Lost to Follow-up|0|||
170348342|NCT01670656|615615004|FG004|Overall Study|Lost to Follow-up|3|||
170348343|NCT01670656|615615000|FG000|Overall Study|Subject moved|0|||
170348344|NCT01670656|615615001|FG001|Overall Study|Subject moved|0|||
170348345|NCT01670656|615615002|FG002|Overall Study|Subject moved|0|||
170348346|NCT01670656|615615003|FG003|Overall Study|Subject moved|1|||
170348347|NCT01670656|615615004|FG004|Overall Study|Subject moved|0|||
170348348|NCT00487084|615615005|FG000|Overall Study|Did not receive intervention|4|||
170348349|NCT00487084|615615006|FG001|Overall Study|Did not receive intervention|3|||
170348350|NCT00487084|615615007|FG002|Overall Study|Did not receive intervention|5|||
170348351|NCT00254293|615615008|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
170348352|NCT00254293|615615009|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
170348353|NCT00254293|615615010|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
170348354|NCT00254293|615615011|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
170348355|NCT00254293|615615012|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
170348356|NCT00254293|615615013|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
170348357|NCT00254293|615615014|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
170348358|NCT00254293|615615008|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
170348359|NCT00254293|615615009|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
170348360|NCT00254293|615615010|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
170348361|NCT00254293|615615011|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
170348362|NCT00254293|615615012|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
170348363|NCT00254293|615615013|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
170348364|NCT00254293|615615014|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
170348365|NCT00254293|615615008|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
170348366|NCT00254293|615615009|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
170348367|NCT00254293|615615010|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
170348368|NCT00254293|615615011|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
170348369|NCT00254293|615615012|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
170348370|NCT00254293|615615013|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
170348371|NCT00254293|615615014|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
170348372|NCT00254293|615615008|FG000|LTE Open Label Variable SC Dosing|Death|0|||
170348373|NCT00254293|615615009|FG001|LTE Open Label Variable SC Dosing|Death|0|||
170348374|NCT00254293|615615010|FG002|LTE Open Label Variable SC Dosing|Death|1|||
170348375|NCT00254293|615615011|FG003|LTE Open Label Variable SC Dosing|Death|0|||
170348376|NCT00254293|615615012|FG004|LTE Open Label Variable SC Dosing|Death|0|||
170348377|NCT00254293|615615013|FG005|LTE Open Label Variable SC Dosing|Death|0|||
170348378|NCT00254293|615615014|FG006|LTE Open Label Variable SC Dosing|Death|0|||
170348379|NCT00254293|615615008|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
170348380|NCT00254293|615615009|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
170348381|NCT00254293|615615010|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
170348382|NCT00254293|615615011|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
170348383|NCT00254293|615615012|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
170348384|NCT00254293|615615013|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
170348385|NCT00254293|615615014|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
170348386|NCT00254293|615615008|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
170348387|NCT00254293|615615009|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
170348388|NCT00254293|615615010|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
170348389|NCT00254293|615615011|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
170348390|NCT00254293|615615012|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
170348391|NCT00254293|615615013|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
170348392|NCT00254293|615615014|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
170348393|NCT00254293|615615008|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
170348394|NCT00254293|615615009|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
170348395|NCT00254293|615615010|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
170348396|NCT00254293|615615011|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
170348397|NCT00254293|615615012|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
170348398|NCT00254293|615615013|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
170348399|NCT00254293|615615014|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
170348400|NCT00254293|615615008|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
170348401|NCT00254293|615615009|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
170348402|NCT00254293|615615010|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
170348403|NCT00254293|615615011|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
170348404|NCT00254293|615615012|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
170348405|NCT00254293|615615013|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
170348406|NCT00254293|615615014|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
170348407|NCT00254293|615615008|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
170348408|NCT00254293|615615009|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
170348409|NCT00254293|615615010|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
170348410|NCT00254293|615615011|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
170348411|NCT00254293|615615012|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
170348412|NCT00254293|615615013|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
170348413|NCT00254293|615615014|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
170348414|NCT00254293|615615008|FG000|LTE Open Label Variable SC Dosing|Other|0|||
170348415|NCT00254293|615615009|FG001|LTE Open Label Variable SC Dosing|Other|0|||
170348416|NCT00254293|615615010|FG002|LTE Open Label Variable SC Dosing|Other|2|||
170348417|NCT00254293|615615011|FG003|LTE Open Label Variable SC Dosing|Other|0|||
170348418|NCT00254293|615615012|FG004|LTE Open Label Variable SC Dosing|Other|0|||
170348419|NCT00254293|615615013|FG005|LTE Open Label Variable SC Dosing|Other|0|||
170348420|NCT00254293|615615014|FG006|LTE Open Label Variable SC Dosing|Other|0|||
170348421|NCT00254293|615615008|FG000|LTE Open Label Fixed Dosing|Death|0|||
170348422|NCT00254293|615615009|FG001|LTE Open Label Fixed Dosing|Death|0|||
170348423|NCT00254293|615615010|FG002|LTE Open Label Fixed Dosing|Death|0|||
170348424|NCT00254293|615615011|FG003|LTE Open Label Fixed Dosing|Death|0|||
170348425|NCT00254293|615615012|FG004|LTE Open Label Fixed Dosing|Death|0|||
170348426|NCT00254293|615615013|FG005|LTE Open Label Fixed Dosing|Death|0|||
170348427|NCT00254293|615615014|FG006|LTE Open Label Fixed Dosing|Death|3|||
170348428|NCT00254293|615615008|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
170348429|NCT00254293|615615009|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
170348430|NCT00254293|615615010|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
170348431|NCT00254293|615615011|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
170348432|NCT00254293|615615012|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
170348433|NCT00254293|615615013|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
170348434|NCT00254293|615615014|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
170348435|NCT00254293|615615008|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
170348436|NCT00254293|615615009|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
170348437|NCT00254293|615615010|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
170348438|NCT00254293|615615011|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
170348439|NCT00254293|615615012|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
170348440|NCT00254293|615615013|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
170348441|NCT00254293|615615014|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
170348442|NCT00254293|615615008|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
170348443|NCT00254293|615615009|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
170348444|NCT00254293|615615010|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
170348445|NCT00254293|615615011|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
170348446|NCT00254293|615615012|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
170348447|NCT00254293|615615013|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
170348448|NCT00254293|615615014|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
170348449|NCT00254293|615615008|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
170348450|NCT00254293|615615009|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
170348451|NCT00254293|615615010|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
170348452|NCT00254293|615615011|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
170348453|NCT00254293|615615012|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
170348454|NCT00254293|615615013|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
170348455|NCT00254293|615615014|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
170348456|NCT00254293|615615008|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
170348457|NCT00254293|615615009|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
170348458|NCT00254293|615615010|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
170348459|NCT00254293|615615011|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
170348460|NCT00254293|615615012|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
170348461|NCT00254293|615615013|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
170348462|NCT00254293|615615014|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
170348463|NCT00254293|615615008|FG000|LTE Open Label Fixed Dosing|Other|0|||
170348464|NCT00254293|615615009|FG001|LTE Open Label Fixed Dosing|Other|0|||
170348465|NCT00254293|615615010|FG002|LTE Open Label Fixed Dosing|Other|0|||
170348466|NCT00254293|615615011|FG003|LTE Open Label Fixed Dosing|Other|0|||
170348467|NCT00254293|615615012|FG004|LTE Open Label Fixed Dosing|Other|0|||
170348468|NCT00254293|615615013|FG005|LTE Open Label Fixed Dosing|Other|0|||
170348469|NCT00254293|615615014|FG006|LTE Open Label Fixed Dosing|Other|1|||
170348470|NCT01575197|615615015|FG000|Overall Study|Migration out of study area|1|||
170348471|NCT01575197|615615016|FG001|Overall Study|Migration out of study area|5|||
170348472|NCT01575197|615615017|FG002|Overall Study|Migration out of study area|4|||
170348473|NCT01575197|615615015|FG000|Overall Study|SAE|0|||
170348474|NCT01575197|615615016|FG001|Overall Study|SAE|1|||
170348475|NCT01575197|615615017|FG002|Overall Study|SAE|0|||
170348476|NCT01575197|615615015|FG000|Overall Study|Lost to Follow-up|0|||
170348477|NCT01575197|615615016|FG001|Overall Study|Lost to Follow-up|1|||
170348478|NCT01575197|615615017|FG002|Overall Study|Lost to Follow-up|0|||
170348479|NCT01575197|615615015|FG000|Overall Study|Withdrawal by Subject|0|||
170348480|NCT01575197|615615016|FG001|Overall Study|Withdrawal by Subject|1|||
170348481|NCT01575197|615615017|FG002|Overall Study|Withdrawal by Subject|1|||
170348482|NCT01575197|615615015|FG000|Overall Study|Protocol Violation|2|||
170348483|NCT01575197|615615016|FG001|Overall Study|Protocol Violation|1|||
170348484|NCT01575197|615615017|FG002|Overall Study|Protocol Violation|1|||
170348485|NCT01000727|615615018|FG000|Overall Study|Lost to Follow-up|41|||
170348486|NCT01000727|615615019|FG001|Overall Study|Lost to Follow-up|43|||
170348487|NCT01000727|615615018|FG000|Overall Study|Withdrawal by Subject|111|||
170348488|NCT01000727|615615019|FG001|Overall Study|Withdrawal by Subject|109|||
170348489|NCT01000727|615615018|FG000|Overall Study|Study closed/terminated|23|||
170348490|NCT01000727|615615019|FG001|Overall Study|Study closed/terminated|24|||
170348491|NCT03196193|615615020|FG000|Overall Study|Adverse Event|1|||
170348492|NCT03196193|615615021|FG001|Overall Study|Adverse Event|0|||
170348493|NCT03196193|615615020|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
170348494|NCT03196193|615615021|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
170348495|NCT00111475|615615022|FG000|Overall Study|Lost to Follow-up|0|||
170348496|NCT00111475|615615023|FG001|Overall Study|Lost to Follow-up|0|||
170348497|NCT00111475|615615024|FG002|Overall Study|Lost to Follow-up|0|||
170348498|NCT00111475|615615025|FG003|Overall Study|Lost to Follow-up|0|||
170348499|NCT00111475|615615026|FG004|Overall Study|Lost to Follow-up|0|||
170348500|NCT00111475|615615027|FG005|Overall Study|Lost to Follow-up|1|||
170348501|NCT00111475|615615028|FG006|Overall Study|Lost to Follow-up|0|||
170348502|NCT00111475|615615029|FG007|Overall Study|Lost to Follow-up|0|||
170348503|NCT00111475|615615030|FG008|Overall Study|Lost to Follow-up|0|||
170348504|NCT00111475|615615031|FG009|Overall Study|Lost to Follow-up|0|||
170348505|NCT03303092|615615032|FG000|Overall Study|Adverse Event|1|||
170348506|NCT03303092|615615033|FG001|Overall Study|Adverse Event|0|||
170348507|NCT03303092|615615034|FG002|Overall Study|Adverse Event|1|||
170348508|NCT03303092|615615032|FG000|Overall Study|Protocol Violation|1|||
170348509|NCT03303092|615615033|FG001|Overall Study|Protocol Violation|5|||
170348510|NCT03303092|615615034|FG002|Overall Study|Protocol Violation|1|||
170348511|NCT03303092|615615032|FG000|Overall Study|Withdrawal by Subject|1|||
170348512|NCT03303092|615615033|FG001|Overall Study|Withdrawal by Subject|1|||
170348513|NCT03303092|615615034|FG002|Overall Study|Withdrawal by Subject|3|||
170348514|NCT01995136|615615038|FG000|Overall Study|Change in residence|1|||
170348515|NCT00833248|615615040|FG000|Overall Study|Adverse Event|3|||
170348516|NCT00833248|615615041|FG001|Overall Study|Adverse Event|0|||
170348517|NCT00833248|615615040|FG000|Overall Study|Protocol Violation|1|||
170348518|NCT00833248|615615041|FG001|Overall Study|Protocol Violation|2|||
170348519|NCT00833248|615615040|FG000|Overall Study|Withdrawal by Subject|0|||
170348520|NCT00833248|615615041|FG001|Overall Study|Withdrawal by Subject|1|||
170348521|NCT00210158|615615044|FG000|Overall Study|Protocol Violation|0|||
170348522|NCT00210158|615615045|FG001|Overall Study|Protocol Violation|2|||
170348523|NCT02651194|615615052|FG000|Overall Study|Lost to Follow-up|3|||
170348524|NCT02651194|615615052|FG000|Overall Study|Other|2|||
170348525|NCT01954251|615615053|FG000|Overall Study|Adverse Event|5|||
170348526|NCT01954251|615615054|FG001|Overall Study|Adverse Event|7|||
170348527|NCT01954251|615615053|FG000|Overall Study|Lost to Follow-up|6|||
170348528|NCT01954251|615615054|FG001|Overall Study|Lost to Follow-up|6|||
170348529|NCT01954251|615615053|FG000|Overall Study|Withdrawal by Subject|2|||
170348530|NCT01954251|615615054|FG001|Overall Study|Withdrawal by Subject|6|||
170348531|NCT02864940|615615055|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
170348532|NCT02864940|615615056|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
170348533|NCT03885726|615615057|FG000|Overall Study|Staffing issues/lost interest|1|||
170348534|NCT03885726|615615057|FG000|Overall Study|Early discharge from hospital|3|||
170348535|NCT04096326|615615058|FG000|Overall Study|Withdrawal by Subject|0|||
170348536|NCT04096326|615615059|FG001|Overall Study|Withdrawal by Subject|0|||
170348537|NCT04096326|615615060|FG002|Overall Study|Withdrawal by Subject|0|||
170348538|NCT04096326|615615061|FG003|Overall Study|Withdrawal by Subject|0|||
170348539|NCT04096326|615615062|FG004|Overall Study|Withdrawal by Subject|0|||
170348540|NCT04096326|615615063|FG005|Overall Study|Withdrawal by Subject|0|||
170348541|NCT04096326|615615064|FG006|Overall Study|Withdrawal by Subject|1|||
170348542|NCT04096326|615615065|FG007|Overall Study|Withdrawal by Subject|0|||
170348543|NCT04096326|615615066|FG008|Overall Study|Withdrawal by Subject|0|||
170348544|NCT04096326|615615067|FG009|Overall Study|Withdrawal by Subject|0|||
170348545|NCT04096326|615615058|FG000|Overall Study|Lost to Follow-up|0|||
170348546|NCT04096326|615615059|FG001|Overall Study|Lost to Follow-up|1|||
170348547|NCT04096326|615615060|FG002|Overall Study|Lost to Follow-up|0|||
170348548|NCT04096326|615615061|FG003|Overall Study|Lost to Follow-up|0|||
170348549|NCT04096326|615615062|FG004|Overall Study|Lost to Follow-up|0|||
170348550|NCT04096326|615615063|FG005|Overall Study|Lost to Follow-up|0|||
170348551|NCT04096326|615615064|FG006|Overall Study|Lost to Follow-up|0|||
170348552|NCT04096326|615615065|FG007|Overall Study|Lost to Follow-up|0|||
170348553|NCT04096326|615615066|FG008|Overall Study|Lost to Follow-up|0|||
170348554|NCT04096326|615615067|FG009|Overall Study|Lost to Follow-up|0|||
170348555|NCT04096326|615615058|FG000|Overall Study|COVID-19-related reasons|0|||
170348556|NCT04096326|615615059|FG001|Overall Study|COVID-19-related reasons|0|||
170348557|NCT04096326|615615060|FG002|Overall Study|COVID-19-related reasons|0|||
170348558|NCT04096326|615615061|FG003|Overall Study|COVID-19-related reasons|0|||
170348559|NCT04096326|615615062|FG004|Overall Study|COVID-19-related reasons|1|||
170348560|NCT04096326|615615063|FG005|Overall Study|COVID-19-related reasons|5|||
170348561|NCT04096326|615615064|FG006|Overall Study|COVID-19-related reasons|0|||
170348562|NCT04096326|615615065|FG007|Overall Study|COVID-19-related reasons|0|||
170348563|NCT04096326|615615066|FG008|Overall Study|COVID-19-related reasons|0|||
170348564|NCT04096326|615615067|FG009|Overall Study|COVID-19-related reasons|0|||
170348565|NCT04804033|615615068|FG000|Period 1: DBT Phase|Adverse Event|1|||
170348566|NCT04804033|615615069|FG001|Period 1: DBT Phase|Adverse Event|5|||
170348567|NCT04804033|615615070|FG002|Period 1: DBT Phase|Adverse Event|3|||
170348568|NCT04804033|615615071|FG003|Period 1: DBT Phase|Adverse Event|4|||
170348569|NCT04804033|615615068|FG000|Period 1: DBT Phase|Death|1|||
170348570|NCT04804033|615615069|FG001|Period 1: DBT Phase|Death|0|||
170348571|NCT04804033|615615070|FG002|Period 1: DBT Phase|Death|0|||
170348572|NCT04804033|615615071|FG003|Period 1: DBT Phase|Death|0|||
170348573|NCT04804033|615615068|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
170348574|NCT04804033|615615069|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
170348575|NCT04804033|615615070|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
170348576|NCT04804033|615615071|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
170348577|NCT04804033|615615068|FG000|Period 1: DBT Phase|Non-compliance|1|||
170348578|NCT04804033|615615069|FG001|Period 1: DBT Phase|Non-compliance|0|||
170348579|NCT04804033|615615070|FG002|Period 1: DBT Phase|Non-compliance|1|||
170348580|NCT04804033|615615071|FG003|Period 1: DBT Phase|Non-compliance|2|||
170348581|NCT04804033|615615068|FG000|Period 1: DBT Phase|Other|0|||
170348582|NCT04804033|615615069|FG001|Period 1: DBT Phase|Other|1|||
170348583|NCT04804033|615615070|FG002|Period 1: DBT Phase|Other|0|||
170348584|NCT04804033|615615071|FG003|Period 1: DBT Phase|Other|0|||
170348585|NCT04804033|615615068|FG000|Period 1: DBT Phase|Pregnancy|2|||
170348586|NCT04804033|615615069|FG001|Period 1: DBT Phase|Pregnancy|0|||
170348587|NCT04804033|615615070|FG002|Period 1: DBT Phase|Pregnancy|0|||
170348588|NCT04804033|615615071|FG003|Period 1: DBT Phase|Pregnancy|0|||
170348589|NCT04804033|615615068|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
170348590|NCT04804033|615615069|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
170348591|NCT04804033|615615070|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
170348592|NCT04804033|615615071|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
170348593|NCT04804033|615615068|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
170348594|NCT04804033|615615069|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
170348595|NCT04804033|615615070|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
170348596|NCT04804033|615615071|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
170348597|NCT04804033|615615068|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
170348598|NCT04804033|615615069|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
170348599|NCT04804033|615615070|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
170348600|NCT04804033|615615071|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
170348601|NCT04804033|615615068|FG000|Period 2: OLE Phase|Adverse Event|3|||
170348602|NCT04804033|615615069|FG001|Period 2: OLE Phase|Adverse Event|4|||
170348603|NCT04804033|615615070|FG002|Period 2: OLE Phase|Adverse Event|2|||
170348604|NCT04804033|615615071|FG003|Period 2: OLE Phase|Adverse Event|0|||
170348605|NCT04804033|615615068|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
170348606|NCT04804033|615615069|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
170348607|NCT04804033|615615070|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
170348608|NCT04804033|615615071|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
170348609|NCT04804033|615615068|FG000|Period 2: OLE Phase|Non-compliance|2|||
170348610|NCT04804033|615615069|FG001|Period 2: OLE Phase|Non-compliance|2|||
170348611|NCT04804033|615615070|FG002|Period 2: OLE Phase|Non-compliance|0|||
170348612|NCT04804033|615615071|FG003|Period 2: OLE Phase|Non-compliance|1|||
170348613|NCT04804033|615615068|FG000|Period 2: OLE Phase|Other|0|||
170348614|NCT04804033|615615069|FG001|Period 2: OLE Phase|Other|2|||
170348615|NCT04804033|615615070|FG002|Period 2: OLE Phase|Other|0|||
170348616|NCT04804033|615615071|FG003|Period 2: OLE Phase|Other|0|||
170348617|NCT04804033|615615068|FG000|Period 2: OLE Phase|Physician Decision|1|||
170348618|NCT04804033|615615069|FG001|Period 2: OLE Phase|Physician Decision|1|||
170348619|NCT04804033|615615070|FG002|Period 2: OLE Phase|Physician Decision|0|||
170348620|NCT04804033|615615071|FG003|Period 2: OLE Phase|Physician Decision|0|||
170348621|NCT04804033|615615068|FG000|Period 2: OLE Phase|Pregnancy|0|||
170348622|NCT04804033|615615069|FG001|Period 2: OLE Phase|Pregnancy|0|||
170348623|NCT04804033|615615070|FG002|Period 2: OLE Phase|Pregnancy|2|||
170348624|NCT04804033|615615071|FG003|Period 2: OLE Phase|Pregnancy|0|||
170348625|NCT04804033|615615068|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
170348626|NCT04804033|615615069|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
170348627|NCT04804033|615615070|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
170348628|NCT04804033|615615071|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
170348629|NCT04804033|615615068|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
170348630|NCT04804033|615615069|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
170348631|NCT04804033|615615070|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
170348632|NCT04804033|615615071|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
170348633|NCT04804033|615615068|FG000|Period 2: OLE Phase|Not reported|0|||
170348634|NCT04804033|615615069|FG001|Period 2: OLE Phase|Not reported|2|||
170348635|NCT04804033|615615070|FG002|Period 2: OLE Phase|Not reported|0|||
170348636|NCT04804033|615615071|FG003|Period 2: OLE Phase|Not reported|0|||
170348637|NCT04804033|615615068|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
170348638|NCT04804033|615615069|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
170348639|NCT04804033|615615070|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
170348640|NCT04804033|615615071|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
170348641|NCT04804033|615615068|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
170348642|NCT04804033|615615069|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
170348643|NCT04804033|615615070|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
170348644|NCT04804033|615615071|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
170348645|NCT04804033|615615068|FG000|Period 3: Follow-up Phase|Other|0|||
170348646|NCT04804033|615615069|FG001|Period 3: Follow-up Phase|Other|1|||
170348647|NCT04804033|615615070|FG002|Period 3: Follow-up Phase|Other|2|||
170348648|NCT04804033|615615071|FG003|Period 3: Follow-up Phase|Other|1|||
170348649|NCT04804033|615615068|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
170348650|NCT04804033|615615069|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
170348651|NCT04804033|615615070|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
170348652|NCT04804033|615615071|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
170348653|NCT04804033|615615068|FG000|Period 3: Follow-up Phase|Not reported|18|||
170348654|NCT04804033|615615069|FG001|Period 3: Follow-up Phase|Not reported|15|||
170348655|NCT04804033|615615070|FG002|Period 3: Follow-up Phase|Not reported|1|||
170348656|NCT04804033|615615071|FG003|Period 3: Follow-up Phase|Not reported|4|||
170348657|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
170348658|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
170348659|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
170348660|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
170348661|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
170348662|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
170348663|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
170348664|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
170348665|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
170348666|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
170348667|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
170348668|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
170348669|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
170348670|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
170348671|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
170348672|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
170348673|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
170348674|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
170348675|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
170348676|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
170348677|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
170348678|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
170348679|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
170348680|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
170348681|NCT01106625|615615077|FG000|Core Period: Baseline to Week 26|Other|8|||
170348682|NCT01106625|615615078|FG001|Core Period: Baseline to Week 26|Other|7|||
170348683|NCT01106625|615615079|FG002|Core Period: Baseline to Week 26|Other|4|||
170348684|NCT01106625|615615077|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
170348685|NCT01106625|615615078|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
170348686|NCT01106625|615615079|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
170348687|NCT01106625|615615077|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
170348688|NCT01106625|615615078|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
170348689|NCT01106625|615615079|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
170348690|NCT01106625|615615077|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
170348691|NCT01106625|615615078|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
170348692|NCT01106625|615615079|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
170348693|NCT01106625|615615077|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170348694|NCT01106625|615615078|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
170348695|NCT01106625|615615079|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
170348696|NCT01106625|615615077|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
170348697|NCT01106625|615615078|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
170348698|NCT01106625|615615079|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
170348699|NCT01106625|615615077|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
170348700|NCT01106625|615615078|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
170348701|NCT01106625|615615079|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
170348702|NCT01106625|615615077|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
170348703|NCT01106625|615615078|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
170348704|NCT01106625|615615079|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
170348705|NCT01106625|615615077|FG000|Extension Period: Week 26 to Week 52|Other|5|||
170348706|NCT01106625|615615078|FG001|Extension Period: Week 26 to Week 52|Other|5|||
170348707|NCT01106625|615615079|FG002|Extension Period: Week 26 to Week 52|Other|4|||
170348708|NCT01864018|615615085|FG000|Overall Study|Ineligible|3|||
170348709|NCT01864018|615615086|FG001|Overall Study|Ineligible|1|||
170348710|NCT02509598|615615087|FG000|Overall Study|Withdrawal by Subject|1|||
170348711|NCT03521687|615615088|FG000|Overall Study|Adverse Event|4|||
170348712|NCT03521687|615615088|FG000|Overall Study|Physician Decision|1|||
170348713|NCT05122650|615615095|FG000|Overall Study|Adverse Event|4|||
170348714|NCT05122650|615615096|FG001|Overall Study|Adverse Event|16|||
170348715|NCT05122650|615615097|FG002|Overall Study|Adverse Event|11|||
170348716|NCT05122650|615615098|FG003|Overall Study|Adverse Event|12|||
170348717|NCT05122650|615615095|FG000|Overall Study|Lack of Efficacy|0|||
170348718|NCT05122650|615615096|FG001|Overall Study|Lack of Efficacy|1|||
170348719|NCT05122650|615615097|FG002|Overall Study|Lack of Efficacy|1|||
170348720|NCT05122650|615615098|FG003|Overall Study|Lack of Efficacy|2|||
170348721|NCT05122650|615615095|FG000|Overall Study|Lost to Follow-up|1|||
170348722|NCT05122650|615615096|FG001|Overall Study|Lost to Follow-up|1|||
170348723|NCT05122650|615615097|FG002|Overall Study|Lost to Follow-up|3|||
170348724|NCT05122650|615615098|FG003|Overall Study|Lost to Follow-up|0|||
170348725|NCT05122650|615615095|FG000|Overall Study|Non-compliance with study intervention|0|||
170348726|NCT05122650|615615096|FG001|Overall Study|Non-compliance with study intervention|0|||
170348727|NCT05122650|615615097|FG002|Overall Study|Non-compliance with study intervention|0|||
170348728|NCT05122650|615615098|FG003|Overall Study|Non-compliance with study intervention|2|||
170348729|NCT05122650|615615095|FG000|Overall Study|Protocol Violation|0|||
170348730|NCT05122650|615615096|FG001|Overall Study|Protocol Violation|1|||
170348731|NCT05122650|615615097|FG002|Overall Study|Protocol Violation|0|||
170348732|NCT05122650|615615098|FG003|Overall Study|Protocol Violation|1|||
170348733|NCT05122650|615615095|FG000|Overall Study|Randomized by mistake|0|||
170348734|NCT05122650|615615096|FG001|Overall Study|Randomized by mistake|0|||
170348735|NCT05122650|615615097|FG002|Overall Study|Randomized by mistake|3|||
170348736|NCT05122650|615615098|FG003|Overall Study|Randomized by mistake|2|||
170348737|NCT05122650|615615095|FG000|Overall Study|Sponsor request|0|||
170348738|NCT05122650|615615096|FG001|Overall Study|Sponsor request|1|||
170348739|NCT05122650|615615097|FG002|Overall Study|Sponsor request|1|||
170348740|NCT05122650|615615098|FG003|Overall Study|Sponsor request|2|||
170348741|NCT05122650|615615095|FG000|Overall Study|Withdrawal by Subject|3|||
170348742|NCT05122650|615615096|FG001|Overall Study|Withdrawal by Subject|7|||
170348743|NCT05122650|615615097|FG002|Overall Study|Withdrawal by Subject|4|||
170348744|NCT05122650|615615098|FG003|Overall Study|Withdrawal by Subject|8|||
170348745|NCT05122650|615615095|FG000|Overall Study|Other|5|||
170348746|NCT05122650|615615096|FG001|Overall Study|Other|0|||
170348747|NCT05122650|615615097|FG002|Overall Study|Other|0|||
170348748|NCT05122650|615615098|FG003|Overall Study|Other|0|||
170348749|NCT00830037|615615099|FG000|Overall Study|Withdrawal by Subject|2|||
170348750|NCT00830037|615615100|FG001|Overall Study|Withdrawal by Subject|3|||
170348751|NCT00830037|615615099|FG000|Overall Study|Lost to Follow-up|1|||
170348752|NCT00830037|615615100|FG001|Overall Study|Lost to Follow-up|2|||
170348753|NCT00830037|615615099|FG000|Overall Study|Active when terminated by DSMB|15|||
170348754|NCT00830037|615615100|FG001|Overall Study|Active when terminated by DSMB|14|||
170348755|NCT04285346|615615105|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
170348756|NCT04285346|615615106|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
170348757|NCT04285346|615615105|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
170348758|NCT04285346|615615106|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
170348759|NCT04285346|615615105|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
170348760|NCT04285346|615615106|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
170348761|NCT04360187|615615107|FG000|Double-Blind Treatment|Adverse Event|9|||
170348762|NCT04360187|615615108|FG001|Double-Blind Treatment|Adverse Event|11|||
170348763|NCT04360187|615615107|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
170348764|NCT04360187|615615108|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
170348765|NCT04360187|615615107|FG000|Double-Blind Treatment|Physician Decision|1|||
170348766|NCT04360187|615615108|FG001|Double-Blind Treatment|Physician Decision|0|||
170348767|NCT04360187|615615107|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
170348768|NCT04360187|615615108|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
170348769|NCT04360187|615615107|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
170348770|NCT04360187|615615108|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
170348771|NCT04360187|615615107|FG000|Follow-Up|Lost to Follow-up|1|||
170348772|NCT04360187|615615108|FG001|Follow-Up|Lost to Follow-up|0|||
170348773|NCT03280550|615615109|FG000|Overall Study|Withdrawal by Subject|2|||
170348774|NCT03280550|615615110|FG001|Overall Study|Withdrawal by Subject|2|||
170348775|NCT03280550|615615109|FG000|Overall Study|Physician Decision|0|||
170348776|NCT03280550|615615110|FG001|Overall Study|Physician Decision|1|||
170348777|NCT05372575|615615111|FG000|Overall Study|Protocol Violation|7|||
170348778|NCT05372575|615615112|FG001|Overall Study|Protocol Violation|16|||
170348779|NCT02203838|615615113|FG000|Overall Study|Lack of Efficacy|7|||
170348780|NCT02203838|615615114|FG001|Overall Study|Lack of Efficacy|0|||
170348781|NCT02203838|615615115|FG002|Overall Study|Lack of Efficacy|1|||
170348782|NCT02203838|615615116|FG003|Overall Study|Lack of Efficacy|1|||
170348783|NCT02203838|615615113|FG000|Overall Study|Adverse Event|46|||
170348784|NCT02203838|615615114|FG001|Overall Study|Adverse Event|6|||
170348785|NCT02203838|615615115|FG002|Overall Study|Adverse Event|3|||
170348786|NCT02203838|615615116|FG003|Overall Study|Adverse Event|2|||
170348787|NCT02203838|615615113|FG000|Overall Study|Lost to Follow-up|39|||
170348788|NCT02203838|615615114|FG001|Overall Study|Lost to Follow-up|3|||
170348789|NCT02203838|615615115|FG002|Overall Study|Lost to Follow-up|2|||
170348790|NCT02203838|615615116|FG003|Overall Study|Lost to Follow-up|1|||
170348791|NCT02203838|615615113|FG000|Overall Study|Protocol Violation|7|||
170348792|NCT02203838|615615114|FG001|Overall Study|Protocol Violation|3|||
170348793|NCT02203838|615615115|FG002|Overall Study|Protocol Violation|0|||
170348794|NCT02203838|615615116|FG003|Overall Study|Protocol Violation|0|||
170348795|NCT02203838|615615113|FG000|Overall Study|Withdrawal by Subject|83|||
170348796|NCT02203838|615615114|FG001|Overall Study|Withdrawal by Subject|10|||
170348797|NCT02203838|615615115|FG002|Overall Study|Withdrawal by Subject|8|||
170348798|NCT02203838|615615116|FG003|Overall Study|Withdrawal by Subject|11|||
170348799|NCT02203838|615615113|FG000|Overall Study|Physician Decision|27|||
170348800|NCT02203838|615615114|FG001|Overall Study|Physician Decision|0|||
170348801|NCT02203838|615615115|FG002|Overall Study|Physician Decision|2|||
170348802|NCT02203838|615615116|FG003|Overall Study|Physician Decision|3|||
170348803|NCT02203838|615615113|FG000|Overall Study|Other|1|||
170348804|NCT02203838|615615114|FG001|Overall Study|Other|0|||
170348805|NCT02203838|615615115|FG002|Overall Study|Other|0|||
170348806|NCT02203838|615615116|FG003|Overall Study|Other|0|||
170348807|NCT02775864|615615125|FG000|Overall Study|Data ended end of 2010|1764|||
170348808|NCT02775864|615615126|FG001|Overall Study|Data ended end of 2010|2880|||
170348809|NCT02775864|615615127|FG002|Overall Study|Data ended end of 2010|1140|||
170348810|NCT02775864|615615128|FG003|Overall Study|Data ended end of 2010|1194|||
170348811|NCT02775864|615615125|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
170348812|NCT02775864|615615126|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
170348813|NCT02775864|615615127|FG002|Overall Study|Medicaid eligibility discontinued|720|||
170348814|NCT02775864|615615128|FG003|Overall Study|Medicaid eligibility discontinued|890|||
170348815|NCT01318083|615615129|FG000|Overall Study|Adverse Event|4|||
170348816|NCT01318083|615615130|FG001|Overall Study|Adverse Event|1|||
170348817|NCT01318083|615615131|FG002|Overall Study|Adverse Event|2|||
170348818|NCT01318083|615615129|FG000|Overall Study|Withdrawal by Subject|1|||
170348819|NCT01318083|615615130|FG001|Overall Study|Withdrawal by Subject|0|||
170348820|NCT01318083|615615131|FG002|Overall Study|Withdrawal by Subject|2|||
170348821|NCT01318083|615615129|FG000|Overall Study|Lack of Efficacy|0|||
170348822|NCT01318083|615615130|FG001|Overall Study|Lack of Efficacy|0|||
170348823|NCT01318083|615615131|FG002|Overall Study|Lack of Efficacy|1|||
170348824|NCT01318083|615615129|FG000|Overall Study|Treatment Complications|1|||
170348825|NCT01318083|615615130|FG001|Overall Study|Treatment Complications|0|||
170348826|NCT01318083|615615131|FG002|Overall Study|Treatment Complications|0|||
170348827|NCT01318083|615615129|FG000|Overall Study|Lack of Study Medication Compliance|0|||
170348828|NCT01318083|615615130|FG001|Overall Study|Lack of Study Medication Compliance|1|||
170348829|NCT01318083|615615131|FG002|Overall Study|Lack of Study Medication Compliance|0|||
170348830|NCT01465178|615615137|FG000|Overall Study|Withdrawal by Subject|1|||
170348831|NCT01465178|615615138|FG001|Overall Study|Withdrawal by Subject|0|||
170348832|NCT00527111|615615139|FG000|Overall Study|Adverse Event|14|||
170348833|NCT00527111|615615140|FG001|Overall Study|Adverse Event|13|||
170348834|NCT00527111|615615139|FG000|Overall Study|Death|0|||
170348835|NCT00527111|615615140|FG001|Overall Study|Death|1|||
170348836|NCT00527111|615615139|FG000|Overall Study|Investigator Request|2|||
170348837|NCT00527111|615615140|FG001|Overall Study|Investigator Request|1|||
170348838|NCT00527111|615615139|FG000|Overall Study|Patient Request|2|||
170348839|NCT00527111|615615140|FG001|Overall Study|Patient Request|5|||
170348840|NCT00527111|615615139|FG000|Overall Study|Other|2|||
170348841|NCT00527111|615615140|FG001|Overall Study|Other|2|||
170348842|NCT04737031|615615144|FG000|Overall Study|Patients who did not have a treatment visit|0|||
170348843|NCT04737031|615615145|FG001|Overall Study|Patients who did not have a treatment visit|31|||
170348844|NCT04737031|615615146|FG002|Overall Study|Patients who did not have a treatment visit|93|||
170348845|NCT04737031|615615147|FG003|Overall Study|Patients who did not have a treatment visit|227|||
170348846|NCT01468909|615615150|FG000|Overall Study|Never Treated|2|||
170348847|NCT01468909|615615151|FG001|Overall Study|Never Treated|2|||
170348848|NCT03229759|615615159|FG000|Overall Study|Screen Failure|30|||
170348849|NCT01830543|615616866|FG000|Overall Study|Subject Decision|19|||
170348850|NCT01830543|615616867|FG001|Overall Study|Subject Decision|21|||
170348851|NCT01830543|615616868|FG002|Overall Study|Subject Decision|57|||
170348852|NCT01830543|615616866|FG000|Overall Study|Adverse Event|91|||
170348853|NCT01830543|615616867|FG001|Overall Study|Adverse Event|77|||
170348854|NCT01830543|615616868|FG002|Overall Study|Adverse Event|76|||
170348855|NCT01830543|615616866|FG000|Overall Study|Death|20|||
170348856|NCT01830543|615616867|FG001|Overall Study|Death|22|||
170348857|NCT01830543|615616868|FG002|Overall Study|Death|22|||
170348858|NCT01830543|615616866|FG000|Overall Study|Protocol Violation|3|||
170348859|NCT01830543|615616867|FG001|Overall Study|Protocol Violation|7|||
170348860|NCT01830543|615616868|FG002|Overall Study|Protocol Violation|7|||
170348861|NCT01830543|615616866|FG000|Overall Study|Physician Decision|11|||
170348862|NCT01830543|615616867|FG001|Overall Study|Physician Decision|5|||
170348863|NCT01830543|615616868|FG002|Overall Study|Physician Decision|12|||
170348864|NCT01830543|615616866|FG000|Overall Study|Withdrawal by consent|3|||
170348865|NCT01830543|615616867|FG001|Overall Study|Withdrawal by consent|3|||
170348866|NCT01830543|615616868|FG002|Overall Study|Withdrawal by consent|3|||
170348867|NCT01830543|615616866|FG000|Overall Study|Other|12|||
170348868|NCT01830543|615616867|FG001|Overall Study|Other|17|||
170348869|NCT01830543|615616868|FG002|Overall Study|Other|37|||
170348870|NCT01626352|615616871|FG000|Overall Study|Disease Progression|3|||
170348871|NCT01626352|615616871|FG000|Overall Study|Intercurrent Illness|2|||
170348872|NCT01626352|615616871|FG000|Overall Study|Death|2|||
170348873|NCT01626352|615616871|FG000|Overall Study|Withdrawal by Subject|1|||
170348874|NCT01626352|615616871|FG000|Overall Study|Non-Compliance|1|||
170348875|NCT01626352|615616871|FG000|Overall Study|Never Treated|1|||
170348876|NCT02681055|615616872|FG000|Weeks 5-12|Adverse Event|1|||
170348877|NCT00377611|615616877|FG000|Overall Study|Adverse Event|2|||
170348878|NCT00377611|615616878|FG001|Overall Study|Adverse Event|9|||
170348879|NCT00377611|615616877|FG000|Overall Study|Protocol Violation|2|||
170348880|NCT00377611|615616878|FG001|Overall Study|Protocol Violation|0|||
170348881|NCT00377611|615616877|FG000|Overall Study|Withdrawal by Subject|0|||
170348882|NCT00377611|615616878|FG001|Overall Study|Withdrawal by Subject|5|||
170348883|NCT00377611|615616877|FG000|Overall Study|Lost to Follow-up|18|||
170348884|NCT00377611|615616878|FG001|Overall Study|Lost to Follow-up|16|||
170348885|NCT00377611|615616877|FG000|Overall Study|Other|0|||
170348886|NCT00377611|615616878|FG001|Overall Study|Other|3|||
170348887|NCT00839423|615616887|FG000|Overall Study|Adverse Event|4|||
170348888|NCT00839423|615616888|FG001|Overall Study|Adverse Event|3|||
170348889|NCT00839423|615616889|FG002|Overall Study|Adverse Event|7|||
170348890|NCT00839423|615616890|FG003|Overall Study|Adverse Event|16|||
170348891|NCT00839423|615616887|FG000|Overall Study|Lack of Efficacy|6|||
170348892|NCT00839423|615616888|FG001|Overall Study|Lack of Efficacy|6|||
170348893|NCT00839423|615616889|FG002|Overall Study|Lack of Efficacy|3|||
170348894|NCT00839423|615616890|FG003|Overall Study|Lack of Efficacy|2|||
170348895|NCT00839423|615616887|FG000|Overall Study|Non-compliance|0|||
170348896|NCT00839423|615616888|FG001|Overall Study|Non-compliance|0|||
170348897|NCT00839423|615616889|FG002|Overall Study|Non-compliance|0|||
170348898|NCT00839423|615616890|FG003|Overall Study|Non-compliance|1|||
170348899|NCT00839423|615616887|FG000|Overall Study|Protocol Violation|0|||
170348900|NCT00839423|615616888|FG001|Overall Study|Protocol Violation|1|||
170348901|NCT00839423|615616889|FG002|Overall Study|Protocol Violation|2|||
170348902|NCT00839423|615616890|FG003|Overall Study|Protocol Violation|0|||
170348903|NCT00839423|615616887|FG000|Overall Study|Withdrawal of consent|4|||
170348904|NCT00839423|615616888|FG001|Overall Study|Withdrawal of consent|0|||
170348905|NCT00839423|615616889|FG002|Overall Study|Withdrawal of consent|4|||
170348906|NCT00839423|615616890|FG003|Overall Study|Withdrawal of consent|1|||
170348907|NCT00839423|615616887|FG000|Overall Study|Lost to Follow-up|1|||
170348908|NCT00839423|615616888|FG001|Overall Study|Lost to Follow-up|0|||
170348909|NCT00839423|615616889|FG002|Overall Study|Lost to Follow-up|1|||
170348910|NCT00839423|615616890|FG003|Overall Study|Lost to Follow-up|0|||
170348911|NCT00839423|615616887|FG000|Overall Study|Administrative or other reasons|3|||
170348912|NCT00839423|615616888|FG001|Overall Study|Administrative or other reasons|0|||
170348913|NCT00839423|615616889|FG002|Overall Study|Administrative or other reasons|1|||
170348914|NCT00839423|615616890|FG003|Overall Study|Administrative or other reasons|0|||
170348915|NCT02585999|615616891|FG000|Overall Study|Lost to Follow-up|1|||
170348916|NCT02585999|615616891|FG000|Overall Study|Protocol Violation|1|||
170348917|NCT01332019|615616892|FG000|Overall Study|Was Not Dosed|1|||
170348918|NCT01332019|615616893|FG001|Overall Study|Was Not Dosed|0|||
170348919|NCT01332019|615616892|FG000|Overall Study|Other|16|||
170348920|NCT01332019|615616893|FG001|Overall Study|Other|18|||
170348921|NCT01332019|615616892|FG000|Overall Study|Death|2|||
170348922|NCT01332019|615616893|FG001|Overall Study|Death|1|||
170348923|NCT01332019|615616892|FG000|Overall Study|Physician Decision|4|||
170348924|NCT01332019|615616893|FG001|Overall Study|Physician Decision|3|||
170348925|NCT01332019|615616892|FG000|Overall Study|Withdrawal by Subject|73|||
170348926|NCT01332019|615616893|FG001|Overall Study|Withdrawal by Subject|71|||
170348927|NCT01332019|615616892|FG000|Overall Study|Lost to Follow-up|4|||
170348928|NCT01332019|615616893|FG001|Overall Study|Lost to Follow-up|7|||
170348929|NCT01332019|615616892|FG000|Overall Study|Adverse Event|13|||
170348930|NCT01332019|615616893|FG001|Overall Study|Adverse Event|22|||
170348931|NCT01369849|615616896|FG000|Overall Study|Ineligible prior to treatment|0|||
170348932|NCT01369849|615616897|FG001|Overall Study|Ineligible prior to treatment|0|||
170348933|NCT01369849|615616898|FG002|Overall Study|Ineligible prior to treatment|1|||
170348934|NCT01369849|615616896|FG000|Overall Study|Ineligible after receiving treatment|0|||
170348935|NCT01369849|615616897|FG001|Overall Study|Ineligible after receiving treatment|1|||
170348936|NCT01369849|615616898|FG002|Overall Study|Ineligible after receiving treatment|0|||
170348937|NCT00756886|615616902|FG000|Overall Study|Lost to Follow-up|1|||
170348938|NCT00756886|615616903|FG001|Overall Study|Lost to Follow-up|0|||
170348939|NCT00756886|615616902|FG000|Overall Study|Adverse Event|0|||
170348940|NCT00756886|615616903|FG001|Overall Study|Adverse Event|3|||
170348941|NCT00756886|615616902|FG000|Overall Study|Lack of Efficacy|1|||
170348942|NCT00756886|615616903|FG001|Overall Study|Lack of Efficacy|0|||
170348943|NCT00756886|615616902|FG000|Overall Study|Ineligible|9|||
170348944|NCT00756886|615616903|FG001|Overall Study|Ineligible|4|||
170348945|NCT00871377|615616905|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
170348946|NCT00871377|615616906|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
170348947|NCT00871377|615616907|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
170348948|NCT00871377|615616908|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
170348949|NCT00871377|615616909|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
170348950|NCT00871377|615616910|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
170348951|NCT00871377|615616905|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
170348952|NCT00871377|615616906|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
170348953|NCT00871377|615616907|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
170348954|NCT00871377|615616908|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
170348955|NCT00871377|615616909|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
170348956|NCT00871377|615616910|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
170348957|NCT00871377|615616905|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
170348958|NCT00871377|615616906|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348959|NCT00871377|615616907|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348960|NCT00871377|615616908|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348961|NCT00871377|615616909|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348962|NCT00871377|615616910|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348963|NCT00871377|615616905|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348964|NCT00871377|615616906|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348965|NCT00871377|615616907|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348966|NCT00871377|615616908|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348967|NCT00871377|615616909|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
170348968|NCT00871377|615616910|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
170348969|NCT00871377|615616905|FG000|Third Intervention (10 Weeks)|Death|0|||
170348970|NCT00871377|615616906|FG001|Third Intervention (10 Weeks)|Death|0|||
170348971|NCT00871377|615616907|FG002|Third Intervention (10 Weeks)|Death|0|||
170348972|NCT00871377|615616908|FG003|Third Intervention (10 Weeks)|Death|1|||
170348973|NCT00871377|615616909|FG004|Third Intervention (10 Weeks)|Death|0|||
170348974|NCT00871377|615616910|FG005|Third Intervention (10 Weeks)|Death|0|||
170348975|NCT04348656|615616911|FG000|Overall Study|Withdrawal by Subject|2|||
170348976|NCT04348656|615616912|FG001|Overall Study|Withdrawal by Subject|0|||
170348977|NCT04348656|615616911|FG000|Overall Study|Lost to Follow-up|11|||
170348978|NCT04348656|615616912|FG001|Overall Study|Lost to Follow-up|6|||
170348979|NCT01395368|615616913|FG000|Overall Study|Physician Decision|14|||
170348980|NCT01395368|615616913|FG000|Overall Study|Withdrawal by Subject|2|||
170348981|NCT00310388|615616916|FG000|Primary Reporting Phase|Adverse Event|101|||
170348982|NCT00310388|615616917|FG001|Primary Reporting Phase|Adverse Event|0|||
170348983|NCT00310388|615616916|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
170348984|NCT00310388|615616917|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
170348985|NCT00310388|615616916|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
170348986|NCT00310388|615616917|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
170348987|NCT00310388|615616916|FG000|Primary Reporting Phase|Protocol Violation|10|||
170348988|NCT00310388|615616917|FG001|Primary Reporting Phase|Protocol Violation|0|||
170348989|NCT00310388|615616916|FG000|Primary Reporting Phase|Pregnancy|3|||
170348990|NCT00310388|615616917|FG001|Primary Reporting Phase|Pregnancy|0|||
170348991|NCT00310388|615616916|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
170348992|NCT00310388|615616917|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
170348993|NCT00310388|615616916|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
170348994|NCT00310388|615616917|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
170348995|NCT00310388|615616916|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
170348996|NCT00310388|615616917|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
170348997|NCT00310388|615616916|FG000|Primary Reporting Phase|Physician Decision|2|||
170348998|NCT00310388|615616917|FG001|Primary Reporting Phase|Physician Decision|0|||
170348999|NCT00310388|615616916|FG000|Primary Reporting Phase|Request of the sponsor|19|||
170349000|NCT00310388|615616917|FG001|Primary Reporting Phase|Request of the sponsor|0|||
170349001|NCT00310388|615616916|FG000|Primary Reporting Phase|Failed to return|8|||
170349002|NCT00310388|615616917|FG001|Primary Reporting Phase|Failed to return|0|||
170349003|NCT00310388|615616916|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
170349004|NCT00310388|615616917|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
170349005|NCT00310388|615616916|FG000|Primary Reporting Phase|Participant request|2|||
170349006|NCT00310388|615616917|FG001|Primary Reporting Phase|Participant request|0|||
170349007|NCT00310388|615616916|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
170349008|NCT00310388|615616917|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
170349009|NCT00310388|615616916|FG000|Primary Reporting Phase|Discontinuation of study|1|||
170349010|NCT00310388|615616917|FG001|Primary Reporting Phase|Discontinuation of study|0|||
170349011|NCT00310388|615616916|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
170349012|NCT00310388|615616917|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
170349013|NCT00310388|615616916|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
170349014|NCT00310388|615616917|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
170349015|NCT00310388|615616916|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
170349016|NCT00310388|615616917|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
170349017|NCT00310388|615616916|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
170349018|NCT00310388|615616917|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
170349019|NCT00310388|615616916|FG000|Primary Reporting Phase|Participant passed away|1|||
170349020|NCT00310388|615616917|FG001|Primary Reporting Phase|Participant passed away|0|||
170349021|NCT00310388|615616916|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
170349022|NCT00310388|615616917|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
170349023|NCT00310388|615616916|FG000|Primary Reporting Phase|Missing|1|||
170349024|NCT00310388|615616917|FG001|Primary Reporting Phase|Missing|0|||
170349025|NCT00310388|615616916|FG000|Primary Reporting Phase|Other|1|||
170349026|NCT00310388|615616917|FG001|Primary Reporting Phase|Other|0|||
170349027|NCT00310388|615616916|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
170349028|NCT00310388|615616917|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
170349029|NCT00310388|615616916|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
170349030|NCT00310388|615616917|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
170349031|NCT00310388|615616916|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
170349032|NCT00310388|615616917|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
170349033|NCT00310388|615616916|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
170349034|NCT00310388|615616917|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
170349035|NCT00288860|615616922|FG000|Overall Study|Did not complete intake|4|||
170349036|NCT00288860|615616923|FG001|Overall Study|Did not complete intake|8|||
170349037|NCT00288860|615616922|FG000|Overall Study|Death|4|||
170349038|NCT00288860|615616923|FG001|Overall Study|Death|3|||
170349039|NCT00288860|615616922|FG000|Overall Study|Withdrawal by Subject|20|||
170349040|NCT00288860|615616923|FG001|Overall Study|Withdrawal by Subject|15|||
170349041|NCT00288860|615616922|FG000|Overall Study|Lost to Follow-up|74|||
170349042|NCT00288860|615616923|FG001|Overall Study|Lost to Follow-up|71|||
170349043|NCT05142332|615616924|FG000|Overall Study|Withdrawal by Subject|0|||
170349044|NCT05142332|615616925|FG001|Overall Study|Withdrawal by Subject|1|||
170349045|NCT05142332|615616926|FG002|Overall Study|Withdrawal by Subject|2|||
170349046|NCT05142332|615616927|FG003|Overall Study|Withdrawal by Subject|0|||
170349047|NCT05142332|615616928|FG004|Overall Study|Withdrawal by Subject|0|||
170349048|NCT05142332|615616929|FG005|Overall Study|Withdrawal by Subject|2|||
170349049|NCT05142332|615616930|FG006|Overall Study|Withdrawal by Subject|6|||
170349050|NCT05142332|615616924|FG000|Overall Study|Left ED|3|||
170349051|NCT05142332|615616925|FG001|Overall Study|Left ED|0|||
170349052|NCT05142332|615616926|FG002|Overall Study|Left ED|4|||
170349053|NCT05142332|615616927|FG003|Overall Study|Left ED|6|||
170349054|NCT05142332|615616928|FG004|Overall Study|Left ED|1|||
170349055|NCT05142332|615616929|FG005|Overall Study|Left ED|2|||
170349056|NCT05142332|615616930|FG006|Overall Study|Left ED|6|||
170349057|NCT05142332|615616924|FG000|Overall Study|Physician Decision|0|||
170349058|NCT05142332|615616925|FG001|Overall Study|Physician Decision|0|||
170349059|NCT05142332|615616926|FG002|Overall Study|Physician Decision|2|||
170349060|NCT05142332|615616927|FG003|Overall Study|Physician Decision|1|||
170349061|NCT05142332|615616928|FG004|Overall Study|Physician Decision|0|||
170349062|NCT05142332|615616929|FG005|Overall Study|Physician Decision|0|||
170349063|NCT05142332|615616930|FG006|Overall Study|Physician Decision|3|||
170349064|NCT05142332|615616924|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
170349065|NCT05142332|615616925|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
170349066|NCT05142332|615616926|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
170349067|NCT05142332|615616927|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
170349068|NCT05142332|615616928|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
170349069|NCT05142332|615616929|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
170349070|NCT05142332|615616930|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
170349071|NCT02116660|615616931|FG000|Overall Study|Deteriorating renal function|0|||
170349072|NCT02116660|615616932|FG001|Overall Study|Deteriorating renal function|1|||
170349073|NCT02116660|615616931|FG000|Overall Study|Adverse Event|1|||
170349074|NCT02116660|615616932|FG001|Overall Study|Adverse Event|1|||
170349075|NCT02116660|615616931|FG000|Overall Study|Withdrawal by Subject|0|||
170349076|NCT02116660|615616932|FG001|Overall Study|Withdrawal by Subject|2|||
170349077|NCT02116660|615616931|FG000|Overall Study|Organization reason|1|||
170349078|NCT02116660|615616932|FG001|Overall Study|Organization reason|0|||
170349079|NCT01718509|615616933|FG000|Overall Study|Lost to Follow-up|18|||
170349080|NCT01718509|615616934|FG001|Overall Study|Lost to Follow-up|15|||
170349081|NCT01718509|615616933|FG000|Overall Study|Withdrawal by Subject|7|||
170349082|NCT01718509|615616934|FG001|Overall Study|Withdrawal by Subject|13|||
170349083|NCT01718509|615616933|FG000|Overall Study|Adverse Event|5|||
170349084|NCT01718509|615616934|FG001|Overall Study|Adverse Event|7|||
170349085|NCT01718509|615616933|FG000|Overall Study|Other|13|||
170349086|NCT01718509|615616934|FG001|Overall Study|Other|11|||
170349087|NCT01718509|615616933|FG000|Overall Study|Protocol Violation|4|||
170349088|NCT01718509|615616934|FG001|Overall Study|Protocol Violation|2|||
170349089|NCT01718509|615616933|FG000|Overall Study|Lack of Efficacy|1|||
170349090|NCT01718509|615616934|FG001|Overall Study|Lack of Efficacy|0|||
170349091|NCT00082758|615616938|FG000|Overall Study|Adverse Event|0|||
170349092|NCT00082758|615616939|FG001|Overall Study|Adverse Event|2|||
170349093|NCT00082758|615616940|FG002|Overall Study|Adverse Event|0|||
170349094|NCT00082758|615616938|FG000|Overall Study|Lack of Efficacy|12|||
170349095|NCT00082758|615616939|FG001|Overall Study|Lack of Efficacy|13|||
170349096|NCT00082758|615616940|FG002|Overall Study|Lack of Efficacy|0|||
170349097|NCT00082758|615616938|FG000|Overall Study|Physician Decision|0|||
170349098|NCT00082758|615616939|FG001|Overall Study|Physician Decision|1|||
170349099|NCT00082758|615616940|FG002|Overall Study|Physician Decision|0|||
170349100|NCT00082758|615616938|FG000|Overall Study|Withdrawal by Subject|3|||
170349101|NCT00082758|615616939|FG001|Overall Study|Withdrawal by Subject|0|||
170349102|NCT00082758|615616940|FG002|Overall Study|Withdrawal by Subject|0|||
170349103|NCT00082758|615616938|FG000|Overall Study|Protocol Violation|0|||
170349104|NCT00082758|615616939|FG001|Overall Study|Protocol Violation|1|||
170349105|NCT00082758|615616940|FG002|Overall Study|Protocol Violation|0|||
170349106|NCT00238303|615616941|FG000|Overall Study|Withdrawal by Subject|11|||
170349107|NCT00238303|615616942|FG001|Overall Study|Withdrawal by Subject|1|||
170349108|NCT00238303|615616943|FG002|Overall Study|Withdrawal by Subject|2|||
170349109|NCT00238303|615616941|FG000|Overall Study|Death|1|||
170349110|NCT00238303|615616942|FG001|Overall Study|Death|0|||
170349111|NCT00238303|615616943|FG002|Overall Study|Death|1|||
170349112|NCT00238303|615616941|FG000|Overall Study|Other Medical Problems|2|||
170349113|NCT00238303|615616942|FG001|Overall Study|Other Medical Problems|0|||
170349114|NCT00238303|615616943|FG002|Overall Study|Other Medical Problems|2|||
170349115|NCT00238303|615616941|FG000|Overall Study|Poor tolerance of study treatment|1|||
170349116|NCT00238303|615616942|FG001|Overall Study|Poor tolerance of study treatment|0|||
170349117|NCT00238303|615616943|FG002|Overall Study|Poor tolerance of study treatment|1|||
170349118|NCT00238303|615616941|FG000|Overall Study|Adverse Event|0|||
170349119|NCT00238303|615616942|FG001|Overall Study|Adverse Event|1|||
170349120|NCT00238303|615616943|FG002|Overall Study|Adverse Event|3|||
170349121|NCT00937560|615616944|FG000|Initial Treatment|Death|6|||
170349122|NCT00937560|615616944|FG000|Initial Treatment|Withdraw consent|3|||
170349123|NCT00937560|615616944|FG000|Initial Treatment|Adverse Event|1|||
170349124|NCT00937560|615616944|FG000|Initial Treatment|Lost to Follow-up|1|||
170349125|NCT00937560|615616944|FG000|Initial Treatment|No end of study page|10|||
170349126|NCT00937560|615616944|FG000|Maintenance Treatment|Death|12|||
170349127|NCT00937560|615616944|FG000|Maintenance Treatment|Withdraw consent|5|||
170349128|NCT00937560|615616944|FG000|Maintenance Treatment|According to protocol|1|||
170349129|NCT00411788|615616945|FG000|Overall Study|Protocol Violation|1|||
170349130|NCT00411788|615616945|FG000|Overall Study|Adverse Event|1|||
170349131|NCT00848549|615616946|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
170349132|NCT00848549|615616947|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
170349133|NCT00848549|615616946|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
170349134|NCT00848549|615616947|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
170349135|NCT00848549|615616946|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
170349136|NCT00848549|615616947|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
170349137|NCT00848549|615616946|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
170349138|NCT00848549|615616947|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
170349139|NCT00848549|615616946|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
170349140|NCT00848549|615616947|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
170349141|NCT00848549|615616946|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
170349142|NCT00848549|615616947|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
170349143|NCT00848549|615616946|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
170349144|NCT00848549|615616947|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
170349145|NCT00848549|615616946|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
170349146|NCT00848549|615616947|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
170349147|NCT00848549|615616946|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
170349148|NCT00848549|615616947|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
170349149|NCT00848549|615616946|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
170349150|NCT00848549|615616947|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
170349151|NCT00848549|615616946|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
170349152|NCT00848549|615616947|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
170349153|NCT00848549|615616946|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
170349154|NCT00848549|615616947|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
170349155|NCT00848549|615616946|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
170349156|NCT00848549|615616947|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
170349157|NCT00848549|615616946|FG000|E2090-E044-314 (Extension Study)|Other|5|||
170349158|NCT00848549|615616947|FG001|E2090-E044-314 (Extension Study)|Other|6|||
170349159|NCT02345252|615616953|FG000|Double-Blind Phase|Adverse Event|2|||
170349160|NCT02345252|615616954|FG001|Double-Blind Phase|Adverse Event|3|||
170349161|NCT02345252|615616953|FG000|Double-Blind Phase|Death|1|||
170349162|NCT02345252|615616954|FG001|Double-Blind Phase|Death|2|||
170349163|NCT02345252|615616953|FG000|Double-Blind Phase|Lack of Efficacy|1|||
170349164|NCT02345252|615616954|FG001|Double-Blind Phase|Lack of Efficacy|0|||
170349165|NCT02345252|615616953|FG000|Double-Blind Phase|Investigator's Discretion|4|||
170349166|NCT02345252|615616954|FG001|Double-Blind Phase|Investigator's Discretion|6|||
170349167|NCT02345252|615616953|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
170349168|NCT02345252|615616954|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
170349169|NCT02345252|615616953|FG000|Double-Blind Phase|Protocol Violation|2|||
170349170|NCT02345252|615616954|FG001|Double-Blind Phase|Protocol Violation|1|||
170349171|NCT02345252|615616953|FG000|Double-Blind Phase|Withdrew Consent|21|||
170349172|NCT02345252|615616954|FG001|Double-Blind Phase|Withdrew Consent|23|||
170349173|NCT02345252|615616953|FG000|Double-Blind Phase|Lost to Follow-up|8|||
170349174|NCT02345252|615616954|FG001|Double-Blind Phase|Lost to Follow-up|10|||
170349175|NCT02345252|615616953|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
170349176|NCT02345252|615616954|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
170349177|NCT00436566|615616955|FG000|Overall Study|Withdrawal by Subject|2|||
170349178|NCT00436566|615616955|FG000|Overall Study|Protocol Violation|1|||
170349179|NCT00471536|615616960|FG000|Overall Study|Withdrawal by Subject|1|||
170349180|NCT01980706|615616963|FG000|Overall Study|Withdrawal by Subject|9|||
170349181|NCT01980706|615616964|FG001|Overall Study|Withdrawal by Subject|6|||
170349182|NCT01980706|615616965|FG002|Overall Study|Withdrawal by Subject|2|||
170349183|NCT01980706|615616963|FG000|Overall Study|Adverse Event|1|||
170349184|NCT01980706|615616964|FG001|Overall Study|Adverse Event|2|||
170349185|NCT01980706|615616965|FG002|Overall Study|Adverse Event|5|||
170349186|NCT01980706|615616963|FG000|Overall Study|Lost to Follow-up|3|||
170349187|NCT01980706|615616964|FG001|Overall Study|Lost to Follow-up|4|||
170349188|NCT01980706|615616965|FG002|Overall Study|Lost to Follow-up|3|||
170349189|NCT01980706|615616963|FG000|Overall Study|miscellaneous|4|||
170349190|NCT01980706|615616964|FG001|Overall Study|miscellaneous|5|||
170349191|NCT01980706|615616965|FG002|Overall Study|miscellaneous|3|||
170349192|NCT02546674|615616966|FG000|Overall Study|Adverse Event|19|||
170349193|NCT02546674|615616966|FG000|Overall Study|Death|1|||
170349194|NCT02546674|615616966|FG000|Overall Study|Lost to Follow-up|1|||
170349195|NCT02546674|615616966|FG000|Overall Study|Physician Decision|13|||
170349196|NCT02546674|615616966|FG000|Overall Study|Pregnancy|1|||
170349197|NCT02546674|615616966|FG000|Overall Study|Progressive Disease|2|||
170349198|NCT02546674|615616966|FG000|Overall Study|Protocol Deviation|2|||
170349199|NCT02546674|615616966|FG000|Overall Study|Subject/Guardian Decision|6|||
170349200|NCT02546674|615616966|FG000|Overall Study|Withdrawal of Informed Consent|3|||
170349201|NCT01094730|615616967|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
170349202|NCT01094730|615616968|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
170349203|NCT01094730|615616967|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
170349204|NCT01094730|615616968|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
170349205|NCT01094730|615616967|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
170349206|NCT01094730|615616968|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
170349207|NCT01094730|615616967|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
170349208|NCT01094730|615616968|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
170349209|NCT01094730|615616967|FG000|Period 2 (14 Days)|Protocol Violation|2|||
170349210|NCT01094730|615616968|FG001|Period 2 (14 Days)|Protocol Violation|0|||
170349211|NCT01094730|615616967|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
170349212|NCT01094730|615616968|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
170349213|NCT01094730|615616967|FG000|Period 2 (14 Days)|Adverse Event|0|||
170349214|NCT01094730|615616968|FG001|Period 2 (14 Days)|Adverse Event|1|||
170349215|NCT01094730|615616967|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
170349216|NCT01094730|615616968|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
170349217|NCT04171037|615616969|FG000|Overall Study|Lost to Follow-up|1|||
170349218|NCT04171037|615616970|FG001|Overall Study|Lost to Follow-up|0|||
170349219|NCT04171037|615616969|FG000|Overall Study|Physician Decision|3|||
170349220|NCT04171037|615616970|FG001|Overall Study|Physician Decision|3|||
170349221|NCT02232087|615616971|FG000|Overall Study|Withdrawal by Subject|2|||
170349222|NCT02232087|615616972|FG001|Overall Study|Withdrawal by Subject|0|||
170349223|NCT02232087|615616973|FG002|Overall Study|Withdrawal by Subject|0|||
170349224|NCT02232087|615616974|FG003|Overall Study|Withdrawal by Subject|0|||
170349225|NCT02232087|615616975|FG004|Overall Study|Withdrawal by Subject|0|||
170349226|NCT02232087|615616976|FG005|Overall Study|Withdrawal by Subject|1|||
170349227|NCT02232087|615616971|FG000|Overall Study|poor inhalation technique|0|||
170349228|NCT02232087|615616972|FG001|Overall Study|poor inhalation technique|1|||
170349229|NCT02232087|615616973|FG002|Overall Study|poor inhalation technique|0|||
170349230|NCT02232087|615616974|FG003|Overall Study|poor inhalation technique|0|||
170349231|NCT02232087|615616975|FG004|Overall Study|poor inhalation technique|0|||
170349232|NCT02232087|615616976|FG005|Overall Study|poor inhalation technique|2|||
170349233|NCT02232087|615616971|FG000|Overall Study|protocol stop criteria|0|||
170349234|NCT02232087|615616972|FG001|Overall Study|protocol stop criteria|1|||
170349235|NCT02232087|615616973|FG002|Overall Study|protocol stop criteria|0|||
170349236|NCT02232087|615616974|FG003|Overall Study|protocol stop criteria|1|||
170349237|NCT02232087|615616975|FG004|Overall Study|protocol stop criteria|0|||
170349238|NCT02232087|615616976|FG005|Overall Study|protocol stop criteria|0|||
170349239|NCT02232087|615616971|FG000|Overall Study|Adverse Event|0|||
170349240|NCT02232087|615616972|FG001|Overall Study|Adverse Event|0|||
170349241|NCT02232087|615616973|FG002|Overall Study|Adverse Event|0|||
170349242|NCT02232087|615616974|FG003|Overall Study|Adverse Event|0|||
170349243|NCT02232087|615616975|FG004|Overall Study|Adverse Event|1|||
170349244|NCT02232087|615616976|FG005|Overall Study|Adverse Event|0|||
170349245|NCT00779324|615616977|FG000|Overall Study|Lost to Follow-up|2|||
170349246|NCT00779324|615616978|FG001|Overall Study|Lost to Follow-up|1|||
170349247|NCT00779324|615616977|FG000|Overall Study|Withdrawal by Subject|4|||
170399302|NCT03193190|615799943|FG006|Stage 1|Physician Decision|0|||
170349248|NCT00779324|615616978|FG001|Overall Study|Withdrawal by Subject|2|||
170349249|NCT00779324|615616977|FG000|Overall Study|Missed visit|1|||
170349250|NCT00779324|615616978|FG001|Overall Study|Missed visit|1|||
170349251|NCT00194025|615616979|FG000|Overall Study|Adverse Event|1|||
170349252|NCT00194025|615616979|FG000|Overall Study|non-adherence with study medication|4|||
170349253|NCT00511342|615616987|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
170349254|NCT00511342|615616988|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
170349255|NCT00511342|615616987|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
170349256|NCT00511342|615616988|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
170349257|NCT00511342|615616987|FG000|Overall Study|Pregnancy|0|||
170349258|NCT00511342|615616988|FG001|Overall Study|Pregnancy|1|||
170349259|NCT00511342|615616987|FG000|Overall Study|Pregnancy wish|0|||
170349260|NCT00511342|615616988|FG001|Overall Study|Pregnancy wish|1|||
170349261|NCT00511342|615616987|FG000|Overall Study|Lost to Follow-up|1|||
170349262|NCT00511342|615616988|FG001|Overall Study|Lost to Follow-up|5|||
170349263|NCT00511342|615616987|FG000|Overall Study|Other Reason|2|||
170349264|NCT00511342|615616988|FG001|Overall Study|Other Reason|2|||
170349265|NCT02496585|615616990|FG000|Overall Study|Death|3|||
170349266|NCT02496585|615616991|FG001|Overall Study|Death|0|||
170349267|NCT02496585|615616990|FG000|Overall Study|Lost to Follow-up|2|||
170349268|NCT02496585|615616991|FG001|Overall Study|Lost to Follow-up|0|||
170349269|NCT02496585|615616990|FG000|Overall Study|Withdrawal by Subject|1|||
170349270|NCT02496585|615616991|FG001|Overall Study|Withdrawal by Subject|2|||
170349271|NCT02496585|615616990|FG000|Overall Study|Progression of Malignancy|4|||
170349272|NCT02496585|615616991|FG001|Overall Study|Progression of Malignancy|1|||
170349273|NCT00718666|615616992|FG000|Booster Phase Year 5|No active participation request|0|||
170349274|NCT00718666|615616993|FG001|Booster Phase Year 5|No active participation request|0|||
170349275|NCT00718666|615616994|FG002|Booster Phase Year 5|No active participation request|1|||
170349276|NCT00718666|615616992|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
170349277|NCT00718666|615616993|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
170349278|NCT00718666|615616994|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
170349279|NCT00718666|615616992|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
170349280|NCT00718666|615616993|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
170349281|NCT00718666|615616994|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
170349282|NCT00718666|615616992|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
170349283|NCT00718666|615616993|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
170349284|NCT00718666|615616994|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
170349285|NCT02702193|615616997|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
170349286|NCT02702193|615616998|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
170349287|NCT02702193|615616997|FG000|4 Month Follow up|Withdrawal by Subject|1|||
170349288|NCT02702193|615616998|FG001|4 Month Follow up|Withdrawal by Subject|0|||
170349289|NCT02702193|615616997|FG000|4 Month Follow up|Lost to Follow-up|17|||
170349290|NCT02702193|615616998|FG001|4 Month Follow up|Lost to Follow-up|18|||
170349291|NCT02702193|615616997|FG000|8 Month Follow up|Withdrawal by Subject|1|||
170349292|NCT02702193|615616998|FG001|8 Month Follow up|Withdrawal by Subject|0|||
170349293|NCT02702193|615616997|FG000|8 Month Follow up|Lost to Follow-up|14|||
170349294|NCT02702193|615616998|FG001|8 Month Follow up|Lost to Follow-up|18|||
170349295|NCT02702193|615616997|FG000|12 Month Follow up|Withdrawal by Subject|1|||
170349296|NCT02702193|615616998|FG001|12 Month Follow up|Withdrawal by Subject|0|||
170349297|NCT02702193|615616997|FG000|12 Month Follow up|Lost to Follow-up|16|||
170349298|NCT02702193|615616998|FG001|12 Month Follow up|Lost to Follow-up|18|||
170349299|NCT04056455|615617000|FG000|Overall Study|Adverse Event|1|||
170349300|NCT04056455|615617001|FG001|Overall Study|Adverse Event|0|||
170349301|NCT00222729|615617012|FG000|Overall Study|Adverse Event|3|||
170349302|NCT05896761|615617013|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
170349303|NCT05896761|615617014|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
170349304|NCT05896761|615617013|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
170349305|NCT05896761|615617014|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
170349306|NCT03552549|615617016|FG000|Overall Study|Disease progression|25|||
170349307|NCT03552549|615617017|FG001|Overall Study|Disease progression|17|||
170349308|NCT03552549|615617016|FG000|Overall Study|Adverse event in first 12 months|12|||
170349309|NCT03552549|615617017|FG001|Overall Study|Adverse event in first 12 months|8|||
170349310|NCT03552549|615617016|FG000|Overall Study|Withdrawal by Subject|7|||
170349311|NCT03552549|615617017|FG001|Overall Study|Withdrawal by Subject|7|||
170349312|NCT03552549|615617016|FG000|Overall Study|Unknown (no reason provided)|4|||
170349313|NCT03552549|615617017|FG001|Overall Study|Unknown (no reason provided)|2|||
170349314|NCT03552549|615617016|FG000|Overall Study|Not in participant's best interest|2|||
170349315|NCT03552549|615617017|FG001|Overall Study|Not in participant's best interest|1|||
170349316|NCT03552549|615617016|FG000|Overall Study|Did not complete study treatment|2|||
170349317|NCT03552549|615617017|FG001|Overall Study|Did not complete study treatment|3|||
170349318|NCT03552549|615617016|FG000|Overall Study|Did not meet eligibility criteria|1|||
170349319|NCT03552549|615617017|FG001|Overall Study|Did not meet eligibility criteria|0|||
170349320|NCT03552549|615617016|FG000|Overall Study|Administrative|0|||
170349321|NCT03552549|615617017|FG001|Overall Study|Administrative|14|||
170349322|NCT02761993|615617018|FG000|Overall Study|Adverse Event|0|||
170349323|NCT02761993|615617019|FG001|Overall Study|Adverse Event|2|||
170349324|NCT02761993|615617020|FG002|Overall Study|Adverse Event|0|||
170349325|NCT02761993|615617018|FG000|Overall Study|Lost to Follow-up|1|||
170349326|NCT02761993|615617019|FG001|Overall Study|Lost to Follow-up|3|||
170349327|NCT02761993|615617020|FG002|Overall Study|Lost to Follow-up|2|||
170349328|NCT02761993|615617018|FG000|Overall Study|Withdrawal by Subject|1|||
170349329|NCT02761993|615617019|FG001|Overall Study|Withdrawal by Subject|1|||
170349330|NCT02761993|615617020|FG002|Overall Study|Withdrawal by Subject|2|||
170349331|NCT02993224|615617021|FG000|Core Phase - Period 1|Adverse Event|4|||
170349332|NCT02993224|615617021|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
170349333|NCT02993224|615617021|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
170349334|NCT02993224|615617021|FG000|Core Phase- Period 2|Adverse Event|1|||
170349335|NCT02993224|615617021|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
170349336|NCT02993224|615617021|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
170349337|NCT02993224|615617021|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
170349338|NCT02993224|615617021|FG000|Extension Phase|Adverse Event|3|||
170349339|NCT02993224|615617021|FG000|Extension Phase|Withdrawal by Subject|3|||
170349340|NCT02993224|615617021|FG000|Extension Phase|Lost to Follow-up|2|||
170349341|NCT02993224|615617021|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
170349342|NCT03807739|615617022|FG000|Overall Study|Adverse Event|1|||
170349343|NCT03807739|615617023|FG001|Overall Study|Adverse Event|0|||
170349344|NCT03807739|615617024|FG002|Overall Study|Adverse Event|0|||
170349345|NCT03807739|615617025|FG003|Overall Study|Adverse Event|0|||
170349346|NCT03807739|615617022|FG000|Overall Study|Withdrawal by Subject|1|||
170349347|NCT03807739|615617023|FG001|Overall Study|Withdrawal by Subject|0|||
170349348|NCT03807739|615617024|FG002|Overall Study|Withdrawal by Subject|0|||
170349349|NCT03807739|615617025|FG003|Overall Study|Withdrawal by Subject|0|||
170349350|NCT00875017|615617026|FG000|First Intervention|Withdrawal by Subject|1|||
170349351|NCT00875017|615617027|FG001|First Intervention|Withdrawal by Subject|0|||
170349352|NCT00875017|615617028|FG002|First Intervention|Withdrawal by Subject|1|||
170349353|NCT00875017|615617029|FG003|First Intervention|Withdrawal by Subject|0|||
170349354|NCT00875017|615617030|FG004|First Intervention|Withdrawal by Subject|0|||
170349355|NCT00875017|615617031|FG005|First Intervention|Withdrawal by Subject|0|||
170349356|NCT00875017|615617026|FG000|First Intervention|Adverse Event|0|||
170349357|NCT00875017|615617027|FG001|First Intervention|Adverse Event|0|||
170349358|NCT00875017|615617028|FG002|First Intervention|Adverse Event|0|||
170349359|NCT00875017|615617029|FG003|First Intervention|Adverse Event|1|||
170349360|NCT00875017|615617030|FG004|First Intervention|Adverse Event|0|||
170349361|NCT00875017|615617031|FG005|First Intervention|Adverse Event|0|||
170349362|NCT00875017|615617026|FG000|First Intervention|Problems collecting rectal effluent|1|||
170349363|NCT00875017|615617027|FG001|First Intervention|Problems collecting rectal effluent|0|||
170349364|NCT00875017|615617028|FG002|First Intervention|Problems collecting rectal effluent|0|||
170349365|NCT00875017|615617029|FG003|First Intervention|Problems collecting rectal effluent|0|||
170349366|NCT00875017|615617030|FG004|First Intervention|Problems collecting rectal effluent|0|||
170349367|NCT00875017|615617031|FG005|First Intervention|Problems collecting rectal effluent|0|||
170349368|NCT00875017|615617026|FG000|First Intervention|Intolerance to nasogastric tube|0|||
170349369|NCT00875017|615617027|FG001|First Intervention|Intolerance to nasogastric tube|0|||
170349370|NCT00875017|615617028|FG002|First Intervention|Intolerance to nasogastric tube|0|||
170349371|NCT00875017|615617029|FG003|First Intervention|Intolerance to nasogastric tube|0|||
170349372|NCT00875017|615617030|FG004|First Intervention|Intolerance to nasogastric tube|1|||
170349373|NCT00875017|615617031|FG005|First Intervention|Intolerance to nasogastric tube|0|||
170349374|NCT00875017|615617026|FG000|Washout|Problem collecting rectal effluent|0|||
170349375|NCT00875017|615617027|FG001|Washout|Problem collecting rectal effluent|0|||
170349376|NCT00875017|615617028|FG002|Washout|Problem collecting rectal effluent|1|||
170349377|NCT00875017|615617029|FG003|Washout|Problem collecting rectal effluent|0|||
170349378|NCT00875017|615617030|FG004|Washout|Problem collecting rectal effluent|0|||
170349379|NCT00875017|615617031|FG005|Washout|Problem collecting rectal effluent|0|||
170349380|NCT00875017|615617026|FG000|Second Intervention|Adverse Event|0|||
170349381|NCT00875017|615617027|FG001|Second Intervention|Adverse Event|0|||
170349382|NCT00875017|615617028|FG002|Second Intervention|Adverse Event|0|||
170349383|NCT00875017|615617029|FG003|Second Intervention|Adverse Event|1|||
170349384|NCT00875017|615617030|FG004|Second Intervention|Adverse Event|0|||
170349385|NCT00875017|615617031|FG005|Second Intervention|Adverse Event|0|||
170349386|NCT00875017|615617026|FG000|Washout|Problems collecting rectal effluent|0|||
170349387|NCT00875017|615617027|FG001|Washout|Problems collecting rectal effluent|1|||
170349388|NCT00875017|615617028|FG002|Washout|Problems collecting rectal effluent|0|||
170349389|NCT00875017|615617029|FG003|Washout|Problems collecting rectal effluent|0|||
170349390|NCT00875017|615617030|FG004|Washout|Problems collecting rectal effluent|0|||
170349391|NCT00875017|615617031|FG005|Washout|Problems collecting rectal effluent|0|||
170349392|NCT00875017|615617026|FG000|Third Intervention|Adverse Event|0|||
170349393|NCT00875017|615617027|FG001|Third Intervention|Adverse Event|1|||
170349394|NCT00875017|615617028|FG002|Third Intervention|Adverse Event|1|||
170349395|NCT00875017|615617029|FG003|Third Intervention|Adverse Event|0|||
170349396|NCT00875017|615617030|FG004|Third Intervention|Adverse Event|0|||
170349397|NCT00875017|615617031|FG005|Third Intervention|Adverse Event|0|||
170349398|NCT00875017|615617026|FG000|Washout|Withdrawal by Subject|0|||
170349399|NCT00875017|615617027|FG001|Washout|Withdrawal by Subject|0|||
170349400|NCT00875017|615617028|FG002|Washout|Withdrawal by Subject|0|||
170349401|NCT00875017|615617029|FG003|Washout|Withdrawal by Subject|0|||
170349402|NCT00875017|615617030|FG004|Washout|Withdrawal by Subject|1|||
170349403|NCT00875017|615617031|FG005|Washout|Withdrawal by Subject|0|||
170349404|NCT00875017|615617026|FG000|Fourth Intervention|Inability to comply with fasting|0|||
170349405|NCT00875017|615617027|FG001|Fourth Intervention|Inability to comply with fasting|0|||
170349406|NCT00875017|615617028|FG002|Fourth Intervention|Inability to comply with fasting|0|||
170349407|NCT00875017|615617029|FG003|Fourth Intervention|Inability to comply with fasting|0|||
170349408|NCT00875017|615617030|FG004|Fourth Intervention|Inability to comply with fasting|0|||
170349409|NCT00875017|615617031|FG005|Fourth Intervention|Inability to comply with fasting|1|||
170349410|NCT00786032|615618718|FG000|Overall Study|Death|4|||
170349411|NCT00786032|615618718|FG000|Overall Study|Withdrawal by Subject|14|||
170349412|NCT00786032|615618718|FG000|Overall Study|Did not complete in the timeframe|6|||
170349413|NCT02922634|615618719|FG000|Overall Study|Withdrawal by Subject|5|||
170349414|NCT02922634|615618719|FG000|Overall Study|Did not have their surgery|5|||
170349415|NCT02625324|615618720|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
170349416|NCT02625324|615618720|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
170349417|NCT02625324|615618720|FG000|6-Month Follow-up Subject Accountability|Death|5|||
170349418|NCT02625324|615618720|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
170349419|NCT02625324|615618720|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
170349420|NCT02625324|615618720|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
170349421|NCT02625324|615618720|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
170349422|NCT02625324|615618720|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
170349423|NCT02625324|615618720|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
170349424|NCT02625324|615618720|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
170349425|NCT02625324|615618720|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
170349426|NCT02625324|615618720|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
170349427|NCT02625324|615618720|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
170349428|NCT02625324|615618720|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
170349429|NCT02625324|615618720|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
170349430|NCT02625324|615618720|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
170349431|NCT02625324|615618720|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
170349432|NCT02669862|615618721|FG000|Overall Study|Lost to Follow-up|0|||
170349433|NCT02669862|615618722|FG001|Overall Study|Lost to Follow-up|2|||
170349434|NCT02669862|615618723|FG002|Overall Study|Lost to Follow-up|1|||
170349435|NCT02669862|615618721|FG000|Overall Study|Withdrawal by Subject|2|||
170349436|NCT02669862|615618722|FG001|Overall Study|Withdrawal by Subject|2|||
170349437|NCT02669862|615618723|FG002|Overall Study|Withdrawal by Subject|3|||
170349438|NCT02669862|615618721|FG000|Overall Study|moved|0|||
170349439|NCT02669862|615618722|FG001|Overall Study|moved|1|||
170349440|NCT02669862|615618723|FG002|Overall Study|moved|0|||
170349441|NCT02669862|615618721|FG000|Overall Study|Protocol Violation|0|||
170349442|NCT02669862|615618722|FG001|Overall Study|Protocol Violation|0|||
170349443|NCT02669862|615618723|FG002|Overall Study|Protocol Violation|1|||
170349444|NCT01215734|615618724|FG000|Overall Study|Death|0|||
170349445|NCT01215734|615618725|FG001|Overall Study|Death|1|||
170349446|NCT01346371|615618726|FG000|Overall Study|Lost to Follow-up|2|||
170349447|NCT01346371|615618727|FG001|Overall Study|Lost to Follow-up|0|||
170349448|NCT01716533|615618728|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
170349449|NCT01716533|615618729|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
170349450|NCT01716533|615618730|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
170349451|NCT01716533|615618731|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
170349452|NCT01716533|615618728|FG000|Overall Study|Withdrawal by Subject|0|||
170349453|NCT01716533|615618729|FG001|Overall Study|Withdrawal by Subject|0|||
170349454|NCT01716533|615618730|FG002|Overall Study|Withdrawal by Subject|0|||
170349455|NCT01716533|615618731|FG003|Overall Study|Withdrawal by Subject|5|||
170349456|NCT01716533|615618728|FG000|Overall Study|Death|0|||
170349457|NCT01716533|615618729|FG001|Overall Study|Death|0|||
170349458|NCT01716533|615618730|FG002|Overall Study|Death|0|||
170349459|NCT01716533|615618731|FG003|Overall Study|Death|2|||
170349460|NCT01716533|615618728|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
170349461|NCT01716533|615618729|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
170349462|NCT01716533|615618730|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
170349463|NCT01716533|615618731|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
170349464|NCT03583372|615618740|FG000|Overall Study|Withdrawal by Subject|6|||
170349465|NCT03583372|615618741|FG001|Overall Study|Withdrawal by Subject|11|||
170349466|NCT03583372|615618742|FG002|Overall Study|Withdrawal by Subject|7|||
170349467|NCT03583372|615618743|FG003|Overall Study|Withdrawal by Subject|8|||
170349468|NCT03583372|615618740|FG000|Overall Study|Lost to Follow-up|4|||
170349469|NCT03583372|615618741|FG001|Overall Study|Lost to Follow-up|6|||
170349470|NCT03583372|615618742|FG002|Overall Study|Lost to Follow-up|3|||
170349471|NCT03583372|615618743|FG003|Overall Study|Lost to Follow-up|2|||
170349472|NCT03583372|615618740|FG000|Overall Study|Adverse Event|1|||
170349473|NCT03583372|615618741|FG001|Overall Study|Adverse Event|3|||
170349474|NCT03583372|615618742|FG002|Overall Study|Adverse Event|4|||
170349475|NCT03583372|615618743|FG003|Overall Study|Adverse Event|4|||
170349476|NCT03583372|615618740|FG000|Overall Study|Physician Decision|0|||
170349477|NCT03583372|615618741|FG001|Overall Study|Physician Decision|1|||
170349478|NCT03583372|615618742|FG002|Overall Study|Physician Decision|1|||
170349479|NCT03583372|615618743|FG003|Overall Study|Physician Decision|1|||
170349480|NCT03583372|615618740|FG000|Overall Study|Lack of Efficacy|0|||
170349481|NCT03583372|615618741|FG001|Overall Study|Lack of Efficacy|1|||
170349482|NCT03583372|615618742|FG002|Overall Study|Lack of Efficacy|0|||
170349483|NCT03583372|615618743|FG003|Overall Study|Lack of Efficacy|1|||
170349484|NCT03583372|615618740|FG000|Overall Study|Death|1|||
170349485|NCT03583372|615618741|FG001|Overall Study|Death|0|||
170349486|NCT03583372|615618742|FG002|Overall Study|Death|0|||
170349487|NCT03583372|615618743|FG003|Overall Study|Death|0|||
170349488|NCT03583372|615618740|FG000|Overall Study|Protocol Violation|0|||
170349489|NCT03583372|615618741|FG001|Overall Study|Protocol Violation|1|||
170349490|NCT03583372|615618742|FG002|Overall Study|Protocol Violation|0|||
170349491|NCT03583372|615618743|FG003|Overall Study|Protocol Violation|0|||
170349492|NCT03583372|615618740|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
170349493|NCT03583372|615618741|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
170349494|NCT03583372|615618742|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
170349495|NCT03583372|615618743|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
170349496|NCT03583372|615618740|FG000|Overall Study|Did Not Receive Study Drug|0|||
170349497|NCT03583372|615618741|FG001|Overall Study|Did Not Receive Study Drug|1|||
170349498|NCT03583372|615618742|FG002|Overall Study|Did Not Receive Study Drug|0|||
170349499|NCT03583372|615618743|FG003|Overall Study|Did Not Receive Study Drug|0|||
170349500|NCT03583372|615618740|FG000|Overall Study|Captured as Other in the Database|1|||
170349501|NCT03583372|615618741|FG001|Overall Study|Captured as Other in the Database|2|||
170349502|NCT03583372|615618742|FG002|Overall Study|Captured as Other in the Database|4|||
170349503|NCT03583372|615618743|FG003|Overall Study|Captured as Other in the Database|1|||
170349504|NCT02796391|615618744|FG000|Overall Study|Lost to Follow-up|2|||
170349505|NCT02796391|615618745|FG001|Overall Study|Lost to Follow-up|2|||
170349506|NCT02796391|615618746|FG002|Overall Study|Lost to Follow-up|13|||
170349507|NCT02796391|615618747|FG003|Overall Study|Lost to Follow-up|8|||
170349508|NCT02796391|615618748|FG004|Overall Study|Lost to Follow-up|14|||
170349509|NCT02796391|615618749|FG005|Overall Study|Lost to Follow-up|13|||
170349510|NCT02796391|615618744|FG000|Overall Study|COVID|0|||
170349511|NCT02796391|615618745|FG001|Overall Study|COVID|0|||
170349512|NCT02796391|615618746|FG002|Overall Study|COVID|5|||
170349513|NCT02796391|615618747|FG003|Overall Study|COVID|5|||
170349514|NCT02796391|615618748|FG004|Overall Study|COVID|2|||
170349515|NCT02796391|615618749|FG005|Overall Study|COVID|4|||
170349516|NCT02796391|615618744|FG000|Overall Study|Participant did not like study cigarettes|0|||
170349517|NCT02796391|615618745|FG001|Overall Study|Participant did not like study cigarettes|0|||
170349518|NCT02796391|615618746|FG002|Overall Study|Participant did not like study cigarettes|3|||
170349519|NCT02796391|615618747|FG003|Overall Study|Participant did not like study cigarettes|0|||
170349520|NCT02796391|615618748|FG004|Overall Study|Participant did not like study cigarettes|0|||
170349521|NCT02796391|615618749|FG005|Overall Study|Participant did not like study cigarettes|0|||
170349522|NCT02796391|615618744|FG000|Overall Study|Withdrawal by Subject|1|||
170349523|NCT02796391|615618745|FG001|Overall Study|Withdrawal by Subject|1|||
170349524|NCT02796391|615618746|FG002|Overall Study|Withdrawal by Subject|4|||
170349525|NCT02796391|615618747|FG003|Overall Study|Withdrawal by Subject|3|||
170349526|NCT02796391|615618748|FG004|Overall Study|Withdrawal by Subject|4|||
170349527|NCT02796391|615618749|FG005|Overall Study|Withdrawal by Subject|3|||
170349528|NCT02796391|615618744|FG000|Overall Study|Adverse Event|0|||
170349529|NCT02796391|615618745|FG001|Overall Study|Adverse Event|0|||
170349530|NCT02796391|615618746|FG002|Overall Study|Adverse Event|0|||
170349531|NCT02796391|615618747|FG003|Overall Study|Adverse Event|1|||
170349532|NCT02796391|615618748|FG004|Overall Study|Adverse Event|0|||
170349533|NCT02796391|615618749|FG005|Overall Study|Adverse Event|0|||
170349534|NCT02796391|615618744|FG000|Overall Study|Protocol Violation|0|||
170349535|NCT02796391|615618745|FG001|Overall Study|Protocol Violation|0|||
170349536|NCT02796391|615618746|FG002|Overall Study|Protocol Violation|0|||
170349537|NCT02796391|615618747|FG003|Overall Study|Protocol Violation|1|||
170349538|NCT02796391|615618748|FG004|Overall Study|Protocol Violation|0|||
170349539|NCT02796391|615618749|FG005|Overall Study|Protocol Violation|0|||
170349540|NCT03446651|615618754|FG000|Overall Study|Lost to Follow-up|4|||
170349541|NCT03446651|615618755|FG001|Overall Study|Lost to Follow-up|0|||
170349542|NCT03446651|615618754|FG000|Overall Study|Open Label Participants|5|||
170349543|NCT03446651|615618755|FG001|Overall Study|Open Label Participants|0|||
170349544|NCT00798655|615618756|FG000|Overall Study|Did not receive at least one dose of pan|2|||
170349545|NCT04831515|615618757|FG000|First Intervention|Adverse Event|0|||
170349546|NCT04831515|615618758|FG001|First Intervention|Adverse Event|1|||
170349547|NCT01030458|615618764|FG000|Overall Study|Lost to Follow-up|9|||
170349548|NCT01030458|615618765|FG001|Overall Study|Lost to Follow-up|10|||
170349549|NCT01030458|615618764|FG000|Overall Study|Withdrawal by Subject|2|||
170349550|NCT01030458|615618765|FG001|Overall Study|Withdrawal by Subject|3|||
170349551|NCT01030458|615618764|FG000|Overall Study|Logistical reasons|9|||
170349552|NCT01030458|615618765|FG001|Overall Study|Logistical reasons|5|||
170349553|NCT01030458|615618764|FG000|Overall Study|Moved or changed job|6|||
170349554|NCT01030458|615618765|FG001|Overall Study|Moved or changed job|13|||
170349555|NCT01030458|615618764|FG000|Overall Study|Side effect of medication|1|||
170349556|NCT01030458|615618765|FG001|Overall Study|Side effect of medication|1|||
170349557|NCT02338492|615618766|FG000|Overall Study|Death|32|||
170349558|NCT02338492|615618766|FG000|Overall Study|Adverse Event|3|||
170349559|NCT02338492|615618766|FG000|Overall Study|Lost to Follow-up|4|||
170349560|NCT02338492|615618766|FG000|Overall Study|Reason not captured above|6|||
170349561|NCT01071096|615618767|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
170349562|NCT01071096|615618768|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
170349563|NCT00882999|615618773|FG000|Overall Study|Adverse Event|0|||
170349564|NCT00882999|615618774|FG001|Overall Study|Adverse Event|0|||
170349565|NCT00882999|615618775|FG002|Overall Study|Adverse Event|0|||
170349566|NCT00882999|615618776|FG003|Overall Study|Adverse Event|0|||
170349567|NCT00882999|615618777|FG004|Overall Study|Adverse Event|1|||
170349568|NCT00882999|615618778|FG005|Overall Study|Adverse Event|0|||
170349569|NCT00882999|615618779|FG006|Overall Study|Adverse Event|0|||
170349570|NCT00882999|615618773|FG000|Overall Study|Death|0|||
170349571|NCT00882999|615618774|FG001|Overall Study|Death|1|||
170349572|NCT00882999|615618775|FG002|Overall Study|Death|0|||
170349573|NCT00882999|615618776|FG003|Overall Study|Death|0|||
170349574|NCT00882999|615618777|FG004|Overall Study|Death|0|||
170349575|NCT00882999|615618778|FG005|Overall Study|Death|0|||
170349576|NCT00882999|615618779|FG006|Overall Study|Death|0|||
170349577|NCT00882999|615618773|FG000|Overall Study|Withdrawal by Subject|7|||
170349578|NCT00882999|615618774|FG001|Overall Study|Withdrawal by Subject|6|||
170349579|NCT00882999|615618775|FG002|Overall Study|Withdrawal by Subject|3|||
170349580|NCT00882999|615618776|FG003|Overall Study|Withdrawal by Subject|3|||
170349581|NCT00882999|615618777|FG004|Overall Study|Withdrawal by Subject|6|||
170349582|NCT00882999|615618778|FG005|Overall Study|Withdrawal by Subject|5|||
170349583|NCT00882999|615618779|FG006|Overall Study|Withdrawal by Subject|5|||
170349584|NCT00882999|615618773|FG000|Overall Study|Lost to Follow-up|0|||
170349585|NCT00882999|615618774|FG001|Overall Study|Lost to Follow-up|1|||
170349586|NCT00882999|615618775|FG002|Overall Study|Lost to Follow-up|1|||
170349587|NCT00882999|615618776|FG003|Overall Study|Lost to Follow-up|2|||
170349588|NCT00882999|615618777|FG004|Overall Study|Lost to Follow-up|1|||
170349589|NCT00882999|615618778|FG005|Overall Study|Lost to Follow-up|1|||
170349590|NCT00882999|615618779|FG006|Overall Study|Lost to Follow-up|2|||
170349591|NCT00882999|615618773|FG000|Overall Study|Physician Decision|1|||
170349592|NCT00882999|615618774|FG001|Overall Study|Physician Decision|0|||
170349593|NCT00882999|615618775|FG002|Overall Study|Physician Decision|0|||
170349594|NCT00882999|615618776|FG003|Overall Study|Physician Decision|0|||
170349595|NCT00882999|615618777|FG004|Overall Study|Physician Decision|0|||
170349596|NCT00882999|615618778|FG005|Overall Study|Physician Decision|1|||
170349597|NCT00882999|615618779|FG006|Overall Study|Physician Decision|1|||
170349598|NCT02561299|615618780|FG000|Overall Study|Death|2|||
170349599|NCT02561299|615618781|FG001|Overall Study|Death|4|||
170349600|NCT02561299|615618780|FG000|Overall Study|Lost to Follow-up|1|||
170349601|NCT02561299|615618781|FG001|Overall Study|Lost to Follow-up|0|||
170349602|NCT02561299|615618780|FG000|Overall Study|Withdrawal by Subject|2|||
170349603|NCT02561299|615618781|FG001|Overall Study|Withdrawal by Subject|2|||
170349604|NCT05631548|615618782|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
170349605|NCT05631548|615618783|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
170349606|NCT01592409|615618784|FG000|Overall Study|Withdrawal by Subject|0|||
170349607|NCT01592409|615618785|FG001|Overall Study|Withdrawal by Subject|1|||
170349608|NCT01219959|615618786|FG000|Overall Study|Adverse Event|6|||
170349609|NCT01219959|615618787|FG001|Overall Study|Adverse Event|14|||
170349610|NCT01219959|615618786|FG000|Overall Study|Physician Decision|0|||
170349611|NCT01219959|615618787|FG001|Overall Study|Physician Decision|4|||
170349612|NCT01219959|615618786|FG000|Overall Study|Withdrawal by Subject|0|||
170349613|NCT01219959|615618787|FG001|Overall Study|Withdrawal by Subject|2|||
170349614|NCT01219959|615618786|FG000|Overall Study|Renal Transplantation|0|||
170349615|NCT01219959|615618787|FG001|Overall Study|Renal Transplantation|3|||
170349616|NCT01219959|615618786|FG000|Overall Study|Other|1|||
170349617|NCT01219959|615618787|FG001|Overall Study|Other|0|||
170349618|NCT05906732|615618788|FG000|Overall Study|Withdrawal by Subject|1|||
170349619|NCT05906732|615618789|FG001|Overall Study|Withdrawal by Subject|0|||
170349620|NCT05906732|615618790|FG002|Overall Study|Withdrawal by Subject|0|||
170349621|NCT05906732|615618791|FG003|Overall Study|Withdrawal by Subject|0|||
170349622|NCT05906732|615618788|FG000|Overall Study|Physician Decision|2|||
170349623|NCT05906732|615618789|FG001|Overall Study|Physician Decision|4|||
170349624|NCT05906732|615618790|FG002|Overall Study|Physician Decision|0|||
170349625|NCT05906732|615618791|FG003|Overall Study|Physician Decision|0|||
170349626|NCT01248130|615618792|FG000|Overall Study|Protocol Violation|1|||
170349627|NCT01248130|615618793|FG001|Overall Study|Protocol Violation|0|||
170349628|NCT01248130|615618792|FG000|Overall Study|Ineligible|1|||
170349629|NCT01248130|615618793|FG001|Overall Study|Ineligible|0|||
170349630|NCT01860534|615618806|FG000|ROP #1|Needed treatment for ROP|0|||
170349631|NCT01860534|615618807|FG001|ROP #1|Needed treatment for ROP|1|||
170349632|NCT01860534|615618806|FG000|ROP #2|discharged prior to ROP #2|1|||
170349633|NCT01860534|615618807|FG001|ROP #2|discharged prior to ROP #2|0|||
170349634|NCT01188564|615618808|FG000|Double-blind Phase|randomized not treated|1|||
170349635|NCT01188564|615618809|FG001|Double-blind Phase|randomized not treated|0|||
170349636|NCT01934894|615618812|FG000|Overall Study|Adverse Event|1|||
170349637|NCT01934894|615618813|FG001|Overall Study|Adverse Event|2|||
170349638|NCT01934894|615618812|FG000|Overall Study|Death|2|||
170349639|NCT01934894|615618813|FG001|Overall Study|Death|0|||
170349640|NCT01934894|615618812|FG000|Overall Study|Withdrawal by Subject|0|||
170349641|NCT01934894|615618813|FG001|Overall Study|Withdrawal by Subject|1|||
170349642|NCT01934894|615618812|FG000|Overall Study|Progressive Disease|3|||
170349643|NCT01934894|615618813|FG001|Overall Study|Progressive Disease|2|||
170349644|NCT02208024|615618819|FG000|Overall Study|Withdrawal by Subject|1|||
170349645|NCT02207556|615618820|FG000|Overall Study|Physician Decision|1|||
170349646|NCT02207556|615618821|FG001|Overall Study|Physician Decision|0|||
170349647|NCT02207556|615618820|FG000|Overall Study|Withdrawal by Subject|1|||
170349648|NCT02207556|615618821|FG001|Overall Study|Withdrawal by Subject|0|||
170349649|NCT02207556|615618820|FG000|Overall Study|Death|0|||
170349650|NCT02207556|615618821|FG001|Overall Study|Death|5|||
170349651|NCT03558555|615618822|FG000|Overall Study|Lost to Follow-up|2|||
170349652|NCT03558555|615618823|FG001|Overall Study|Lost to Follow-up|1|||
170349653|NCT01958125|615618824|FG000|Overall Study|Missing diary data|2|||
170349654|NCT01958125|615618825|FG001|Overall Study|Missing diary data|6|||
170349655|NCT01958125|615618824|FG000|Overall Study|No headache attacks|0|||
170349656|NCT01958125|615618825|FG001|Overall Study|No headache attacks|2|||
170349657|NCT01199055|615618831|FG000|Overall Study|Death|0|||
170349658|NCT01199055|615618832|FG001|Overall Study|Death|1|||
170349659|NCT01199055|615618833|FG002|Overall Study|Death|0|||
170349660|NCT01199055|615618831|FG000|Overall Study|Physician Decision|0|||
170349661|NCT01199055|615618832|FG001|Overall Study|Physician Decision|1|||
170349662|NCT01199055|615618833|FG002|Overall Study|Physician Decision|1|||
170349663|NCT01199055|615618831|FG000|Overall Study|Progressive disease|2|||
170349664|NCT01199055|615618832|FG001|Overall Study|Progressive disease|1|||
170349665|NCT01199055|615618833|FG002|Overall Study|Progressive disease|2|||
170349666|NCT01199055|615618831|FG000|Overall Study|Withdrawal by Subject|0|||
170349667|NCT01199055|615618832|FG001|Overall Study|Withdrawal by Subject|0|||
170349668|NCT01199055|615618833|FG002|Overall Study|Withdrawal by Subject|1|||
170349669|NCT00642746|615618834|FG000|Overall Study|Patient unevaluable|1|||
170349670|NCT00642746|615618835|FG001|Overall Study|Patient unevaluable|0|||
170349671|NCT00424294|615618836|FG000|Overall Study|Adverse Event|4|||
170349672|NCT00424294|615618837|FG001|Overall Study|Adverse Event|10|||
170349673|NCT00424294|615618836|FG000|Overall Study|Lack of Efficacy|2|||
170349674|NCT00424294|615618837|FG001|Overall Study|Lack of Efficacy|1|||
170349675|NCT00424294|615618836|FG000|Overall Study|Withdrawal by Subject|1|||
170349676|NCT00424294|615618837|FG001|Overall Study|Withdrawal by Subject|2|||
170349677|NCT00424294|615618836|FG000|Overall Study|Other|0|||
170349678|NCT00424294|615618837|FG001|Overall Study|Other|2|||
170349679|NCT00424294|615618836|FG000|Overall Study|Randomized but not Treated|1|||
170349680|NCT00424294|615618837|FG001|Overall Study|Randomized but not Treated|0|||
170349681|NCT01401010|615618840|FG000|Overall Study|Could not interpret assay results|1|||
170349682|NCT01401010|615618841|FG001|Overall Study|Could not interpret assay results|0|||
170349683|NCT02841787|615618842|FG000|Overall Study|Lost to Follow-up|1|||
170349684|NCT02841787|615618843|FG001|Overall Study|Lost to Follow-up|0|||
170349685|NCT02841787|615618844|FG002|Overall Study|Lost to Follow-up|0|||
170349686|NCT02841787|615618842|FG000|Overall Study|Symptoms dropped below threshold|1|||
170349687|NCT02841787|615618843|FG001|Overall Study|Symptoms dropped below threshold|0|||
170349688|NCT02841787|615618844|FG002|Overall Study|Symptoms dropped below threshold|0|||
170349689|NCT02841787|615618842|FG000|Overall Study|Withdrawal by Subject|1|||
170349690|NCT02841787|615618843|FG001|Overall Study|Withdrawal by Subject|4|||
170349691|NCT02841787|615618844|FG002|Overall Study|Withdrawal by Subject|0|||
170349692|NCT01474746|615618845|FG000|Overall Study|Lost to Follow-up|1|||
170349693|NCT01474746|615618846|FG001|Overall Study|Lost to Follow-up|1|||
170349694|NCT01474746|615618845|FG000|Overall Study|Withdrawal by Subject|2|||
170349695|NCT01474746|615618846|FG001|Overall Study|Withdrawal by Subject|1|||
170349696|NCT00610935|615618851|FG000|Overall Study|Lost to Follow-up|0|||
170349697|NCT00610935|615618852|FG001|Overall Study|Lost to Follow-up|1|||
170349698|NCT00610935|615618851|FG000|Overall Study|Withdrawal by Subject|0|||
170349699|NCT00610935|615618852|FG001|Overall Study|Withdrawal by Subject|2|||
170349700|NCT00610935|615618851|FG000|Overall Study|Sponsor Discontinuation|1|||
170349701|NCT00610935|615618852|FG001|Overall Study|Sponsor Discontinuation|0|||
170349702|NCT02399813|615618853|FG000|Overall Study|Progressive Disease-Radiographic|2|||
170349703|NCT02399813|615618853|FG000|Overall Study|Death|20|||
170349704|NCT02399813|615618853|FG000|Overall Study|Withdrawal by Subject|3|||
170349705|NCT02399813|615618853|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
170349706|NCT02399813|615618853|FG000|Overall Study|Lost to Follow-up|2|||
170349707|NCT02399813|615618853|FG000|Overall Study|Other than specified|5|||
170349708|NCT00496873|615618856|FG000|Overall Study|Ineligible|2|||
170349709|NCT00496873|615618856|FG000|Overall Study|Death|2|||
170349710|NCT00496873|615618856|FG000|Overall Study|Withdrawal by Subject|3|||
170349711|NCT04072146|615618857|FG000|Overall Study|Adverse Event|0|||
170349712|NCT04072146|615618858|FG001|Overall Study|Adverse Event|1|||
170349713|NCT02402218|615618862|FG000|Overall Study|Did not pickup study medication|12|||
170349714|NCT02402218|615618863|FG001|Overall Study|Did not pickup study medication|9|||
170349715|NCT02402218|615618864|FG002|Overall Study|Did not pickup study medication|13|||
170349716|NCT02402218|615618862|FG000|Overall Study|Lack of Efficacy|0|||
170349717|NCT02402218|615618863|FG001|Overall Study|Lack of Efficacy|1|||
170349718|NCT02402218|615618864|FG002|Overall Study|Lack of Efficacy|1|||
170349719|NCT02402218|615618862|FG000|Overall Study|Death|1|||
170349720|NCT02402218|615618863|FG001|Overall Study|Death|0|||
170349721|NCT02402218|615618864|FG002|Overall Study|Death|0|||
170349722|NCT02402218|615618862|FG000|Overall Study|Reinfection|0|||
170349723|NCT02402218|615618863|FG001|Overall Study|Reinfection|0|||
170349724|NCT02402218|615618864|FG002|Overall Study|Reinfection|1|||
170349725|NCT02402218|615618862|FG000|Overall Study|Adverse Event|0|||
170349726|NCT02402218|615618863|FG001|Overall Study|Adverse Event|2|||
170349727|NCT02402218|615618864|FG002|Overall Study|Adverse Event|1|||
170349728|NCT02402218|615618862|FG000|Overall Study|Withdrawal by Subject|1|||
170349729|NCT02402218|615618863|FG001|Overall Study|Withdrawal by Subject|1|||
170349730|NCT02402218|615618864|FG002|Overall Study|Withdrawal by Subject|1|||
170349731|NCT03827473|615618865|FG000|Overall Study|Withdrawal by Subject|1|||
170349732|NCT03827473|615618866|FG001|Overall Study|Withdrawal by Subject|0|||
170349733|NCT04436822|615618867|FG000|Overall Study|Physician Decision|2|||
170349734|NCT04436822|615618868|FG001|Overall Study|Physician Decision|0|||
170349735|NCT04436822|615618867|FG000|Overall Study|Sponsor request|1|||
170349736|NCT04436822|615618868|FG001|Overall Study|Sponsor request|0|||
170349737|NCT04436822|615618867|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170349738|NCT04436822|615618868|FG001|Overall Study|Withdrawal by parent/guardian|3|||
170349739|NCT04436822|615618867|FG000|Overall Study|Unsuccessful procedure|0|||
170349740|NCT04436822|615618868|FG001|Overall Study|Unsuccessful procedure|1|||
170349741|NCT04436822|615618867|FG000|Overall Study|Withdrawal due to Covid-19|8|||
170349742|NCT04436822|615618868|FG001|Overall Study|Withdrawal due to Covid-19|1|||
170349743|NCT04436822|615618867|FG000|Overall Study|Withdrawal by Subject|1|||
170349744|NCT04436822|615618868|FG001|Overall Study|Withdrawal by Subject|0|||
170349745|NCT04436822|615618867|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
170349746|NCT04436822|615618868|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
170349747|NCT01477892|615618869|FG000|Overall Study|Withdrawal by Subject|0|||
170349748|NCT01477892|615618870|FG001|Overall Study|Withdrawal by Subject|2|||
170349749|NCT00524316|615618871|FG000|Overall Study|Withdrawal by Subject|2|||
170349750|NCT00524316|615618871|FG000|Overall Study|Adverse Event|7|||
170349751|NCT00524316|615618871|FG000|Overall Study|Disease Progression|7|||
170349752|NCT01199263|615618872|FG000|Overall Study|Ineligible|0|||
170349753|NCT01199263|615618873|FG001|Overall Study|Ineligible|2|||
170349754|NCT01199263|615618872|FG000|Overall Study|Never Treated|6|||
170349755|NCT01199263|615618873|FG001|Overall Study|Never Treated|0|||
170349756|NCT01423617|615618874|FG000|Overall Study|Lost to Follow-up|0|||
170349757|NCT01423617|615618875|FG001|Overall Study|Lost to Follow-up|1|||
170349758|NCT02435277|615618876|FG000|Overall Study|Adverse Event|1|||
170349759|NCT02435277|615618877|FG001|Overall Study|Adverse Event|1|||
170349760|NCT02435277|615618878|FG002|Overall Study|Adverse Event|0|||
170349761|NCT02435277|615618879|FG003|Overall Study|Adverse Event|0|||
170349762|NCT02435277|615618876|FG000|Overall Study|Withdrawal by Subject|1|||
170349763|NCT02435277|615618877|FG001|Overall Study|Withdrawal by Subject|0|||
170349764|NCT02435277|615618878|FG002|Overall Study|Withdrawal by Subject|0|||
170349765|NCT02435277|615618879|FG003|Overall Study|Withdrawal by Subject|0|||
170349766|NCT03213626|615618880|FG000|Overall Study|Adverse Event|1|||
170349767|NCT03213626|615618880|FG000|Overall Study|Progressive Disease|6|||
170349768|NCT01005732|615618881|FG000|Overall Study|Lost to Follow-up|10|||
170349769|NCT01005732|615618881|FG000|Overall Study|Death|1|||
170349770|NCT01511419|615618882|FG000|Dose 2|Physician Decision|1|||
170349771|NCT01511419|615618883|FG001|Dose 2|Physician Decision|0|||
170349772|NCT00937768|615618884|FG000|Overall Study|Refused Further Treatment|3|||
170349773|NCT00937768|615618885|FG001|Overall Study|Refused Further Treatment|2|||
170349774|NCT00937768|615618884|FG000|Overall Study|Disease Progression|1|||
170349775|NCT00937768|615618885|FG001|Overall Study|Disease Progression|1|||
170349776|NCT00937768|615618884|FG000|Overall Study|Alternate Treatment|0|||
170349777|NCT00937768|615618885|FG001|Overall Study|Alternate Treatment|1|||
170349778|NCT00937768|615618884|FG000|Overall Study|No Further Funding|4|||
170349779|NCT00937768|615618885|FG001|Overall Study|No Further Funding|4|||
170349780|NCT01687413|615618888|FG000|Overall Study|Withdrawal by Subject|0|||
170349781|NCT01687413|615618889|FG001|Overall Study|Withdrawal by Subject|2|||
170349782|NCT01687413|615618888|FG000|Overall Study|Not eligible|0|||
170349783|NCT01687413|615618889|FG001|Overall Study|Not eligible|2|||
170349784|NCT01687413|615618888|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
170349785|NCT01687413|615618889|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
170349786|NCT00091390|615618892|FG000|Overall Study|Protocol Violation|1|||
170349787|NCT00091390|615618892|FG000|Overall Study|No protocol treatment|3|||
170349788|NCT02397694|615620793|FG000|Double-Blinded Phase|Adverse Event|1|||
170349789|NCT02397694|615620794|FG001|Double-Blinded Phase|Adverse Event|0|||
170349790|NCT02397694|615620793|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
170349791|NCT02397694|615620794|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
170349792|NCT02397694|615620793|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
170349793|NCT02397694|615620794|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
170349794|NCT02397694|615620793|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
170349795|NCT02397694|615620794|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
170349796|NCT02397694|615620793|FG000|Open Label Extension Phase|Protocol Violation|1|||
170349797|NCT02397694|615620794|FG001|Open Label Extension Phase|Protocol Violation|0|||
170349798|NCT02397694|615620793|FG000|Open Label Extension Phase|Withdrew Consent|3|||
170349799|NCT02397694|615620794|FG001|Open Label Extension Phase|Withdrew Consent|1|||
170349800|NCT02397694|615620793|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
170349801|NCT02397694|615620794|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
170349802|NCT01116687|615620796|FG000|Overall Study|Withdrawal by Subject|4|||
170349803|NCT00424528|615620797|FG000|Overall Study|Adverse Event|2|||
170349804|NCT00424528|615620798|FG001|Overall Study|Adverse Event|1|||
170349805|NCT00424528|615620799|FG002|Overall Study|Adverse Event|2|||
170349806|NCT00424528|615620797|FG000|Overall Study|Protocol Violation|1|||
170349807|NCT00424528|615620798|FG001|Overall Study|Protocol Violation|1|||
170349808|NCT00424528|615620799|FG002|Overall Study|Protocol Violation|0|||
170349809|NCT00424528|615620797|FG000|Overall Study|Lost to Follow-up|0|||
170349810|NCT00424528|615620798|FG001|Overall Study|Lost to Follow-up|1|||
170349811|NCT00424528|615620799|FG002|Overall Study|Lost to Follow-up|0|||
170349812|NCT00424528|615620797|FG000|Overall Study|noncompliance with study requirements|2|||
170349813|NCT00424528|615620798|FG001|Overall Study|noncompliance with study requirements|1|||
170349814|NCT00424528|615620799|FG002|Overall Study|noncompliance with study requirements|2|||
170349815|NCT02395653|615620800|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
170349816|NCT02395653|615620800|FG000|Overall Study|Consent Withdrawn at Screening|1|||
170349817|NCT02395653|615620800|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
170349818|NCT02395653|615620800|FG000|Overall Study|Investigator Decision at Screening|1|||
170349819|NCT02395653|615620800|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
170349820|NCT02395653|615620800|FG000|Overall Study|Withdrawal by Subject|1|||
170349821|NCT02395653|615620800|FG000|Overall Study|Lost to Follow-up|1|||
170349822|NCT02494778|615620801|FG000|Overall Study|Death|3|||
170349823|NCT02494778|615620801|FG000|Overall Study|Other|173|||
170349824|NCT02494778|615620801|FG000|Overall Study|Lack of Efficacy|4|||
170349825|NCT02494778|615620801|FG000|Overall Study|Adverse Event|18|||
170349826|NCT02494778|615620801|FG000|Overall Study|Withdrawal by Subject|20|||
170349827|NCT02494778|615620801|FG000|Overall Study|Lost to Follow-up|2|||
170349828|NCT02494778|615620801|FG000|Overall Study|Noncompliant with study drug admin.|1|||
170349829|NCT03621943|615620802|FG000|First Randomized Intervention|Lost to Follow-up|51|||
170349830|NCT03621943|615620803|FG001|First Randomized Intervention|Lost to Follow-up|54|||
170349831|NCT03621943|615620802|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
170349832|NCT03621943|615620803|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
170349833|NCT03621943|615620802|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
170349834|NCT03621943|615620803|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
170349835|NCT03621943|615620802|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
170349836|NCT03621943|615620803|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
170349837|NCT00315705|615620804|FG000|Phase 1|Refused further treatment|1|||
170349838|NCT00315705|615620804|FG000|Phase 1|Failure to achieve response|8|||
170349839|NCT00315705|615620804|FG000|Phase 1|Disease relapse|4|||
170349840|NCT00315705|615620804|FG000|Phase 1|Scheduled for transplant|9|||
170349841|NCT00315705|615620804|FG000|Phase 1|Death|3|||
170349842|NCT00315705|615620804|FG000|Phase 2|Physician Decision|4|||
170349843|NCT00315705|615620804|FG000|Phase 2|Adverse Event|1|||
170349844|NCT00315705|615620804|FG000|Phase 2|Failure to achieve response|3|||
170349845|NCT00315705|615620804|FG000|Phase 2|Disease relapse|1|||
170349846|NCT00315705|615620804|FG000|Phase 2|Scheduled for transplant|8|||
170349847|NCT00315705|615620804|FG000|Phase 2|Other|1|||
170349848|NCT00315705|615620804|FG000|Phase 2|Death|7|||
170349849|NCT02622724|615620805|FG000|Overall Study|Death|51|||
170349850|NCT02622724|615620806|FG001|Overall Study|Death|53|||
170349851|NCT02622724|615620805|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
170349852|NCT02622724|615620806|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
170349853|NCT02622724|615620805|FG000|Overall Study|Early termination of study|38|||
170349854|NCT02622724|615620806|FG001|Overall Study|Early termination of study|43|||
170349855|NCT00343291|615620816|FG000|Overall Study|Adverse Event|13|||
170349856|NCT00343291|615620817|FG001|Overall Study|Adverse Event|13|||
170349857|NCT00343291|615620816|FG000|Overall Study|Death|3|||
170349858|NCT00343291|615620817|FG001|Overall Study|Death|2|||
170349859|NCT00343291|615620816|FG000|Overall Study|Progressive disease|33|||
170349860|NCT00343291|615620817|FG001|Overall Study|Progressive disease|34|||
170349861|NCT00343291|615620816|FG000|Overall Study|Withdrawal by Subject|0|||
170349862|NCT00343291|615620817|FG001|Overall Study|Withdrawal by Subject|2|||
170349863|NCT00343291|615620816|FG000|Overall Study|Other|8|||
170349864|NCT00343291|615620817|FG001|Overall Study|Other|5|||
170349865|NCT03712345|615620818|FG000|Overall Study|Failure to meet randomization criteria|0|||
170349866|NCT03712345|615620819|FG001|Overall Study|Failure to meet randomization criteria|0|||
170349867|NCT03712345|615620820|FG002|Overall Study|Failure to meet randomization criteria|1|||
170349868|NCT00960934|615620821|FG000|Overall Study|Adverse Event|2|||
170349869|NCT00960934|615620822|FG001|Overall Study|Adverse Event|3|||
170349870|NCT00960934|615620823|FG002|Overall Study|Adverse Event|3|||
170349871|NCT00960934|615620824|FG003|Overall Study|Adverse Event|2|||
170349872|NCT00960934|615620825|FG004|Overall Study|Adverse Event|4|||
170349873|NCT00960934|615620826|FG005|Overall Study|Adverse Event|3|||
170349874|NCT00960934|615620821|FG000|Overall Study|Lack of Efficacy|1|||
170349875|NCT00960934|615620822|FG001|Overall Study|Lack of Efficacy|0|||
170349876|NCT00960934|615620823|FG002|Overall Study|Lack of Efficacy|0|||
170349877|NCT00960934|615620824|FG003|Overall Study|Lack of Efficacy|0|||
170349878|NCT00960934|615620825|FG004|Overall Study|Lack of Efficacy|0|||
170349879|NCT00960934|615620826|FG005|Overall Study|Lack of Efficacy|0|||
170349880|NCT00960934|615620821|FG000|Overall Study|Lost to Follow-up|0|||
170349881|NCT00960934|615620822|FG001|Overall Study|Lost to Follow-up|1|||
170349882|NCT00960934|615620823|FG002|Overall Study|Lost to Follow-up|0|||
170349883|NCT00960934|615620824|FG003|Overall Study|Lost to Follow-up|0|||
170349884|NCT00960934|615620825|FG004|Overall Study|Lost to Follow-up|0|||
170349885|NCT00960934|615620826|FG005|Overall Study|Lost to Follow-up|0|||
170349886|NCT00960934|615620821|FG000|Overall Study|Other|2|||
170349887|NCT00960934|615620822|FG001|Overall Study|Other|1|||
170349888|NCT00960934|615620823|FG002|Overall Study|Other|5|||
170349889|NCT00960934|615620824|FG003|Overall Study|Other|4|||
170349890|NCT00960934|615620825|FG004|Overall Study|Other|2|||
170349891|NCT00960934|615620826|FG005|Overall Study|Other|2|||
170349892|NCT00960934|615620821|FG000|Overall Study|Physician Decision|0|||
170349893|NCT00960934|615620822|FG001|Overall Study|Physician Decision|1|||
170349894|NCT00960934|615620823|FG002|Overall Study|Physician Decision|0|||
170349895|NCT00960934|615620824|FG003|Overall Study|Physician Decision|0|||
170349896|NCT00960934|615620825|FG004|Overall Study|Physician Decision|0|||
170349897|NCT00960934|615620826|FG005|Overall Study|Physician Decision|0|||
170349898|NCT00960934|615620821|FG000|Overall Study|Progressive Disease|1|||
170349899|NCT00960934|615620822|FG001|Overall Study|Progressive Disease|1|||
170349900|NCT00960934|615620823|FG002|Overall Study|Progressive Disease|0|||
170349901|NCT00960934|615620824|FG003|Overall Study|Progressive Disease|0|||
170349902|NCT00960934|615620825|FG004|Overall Study|Progressive Disease|1|||
170349903|NCT00960934|615620826|FG005|Overall Study|Progressive Disease|1|||
170349904|NCT00960934|615620821|FG000|Overall Study|Protocol Violation|3|||
170349905|NCT00960934|615620822|FG001|Overall Study|Protocol Violation|4|||
170349906|NCT00960934|615620823|FG002|Overall Study|Protocol Violation|0|||
170349907|NCT00960934|615620824|FG003|Overall Study|Protocol Violation|3|||
170349908|NCT00960934|615620825|FG004|Overall Study|Protocol Violation|3|||
170349909|NCT00960934|615620826|FG005|Overall Study|Protocol Violation|2|||
170349910|NCT00960934|615620821|FG000|Overall Study|Withdrawal by Subject|5|||
170349911|NCT00960934|615620822|FG001|Overall Study|Withdrawal by Subject|6|||
170349912|NCT00960934|615620823|FG002|Overall Study|Withdrawal by Subject|4|||
170349913|NCT00960934|615620824|FG003|Overall Study|Withdrawal by Subject|5|||
170349914|NCT00960934|615620825|FG004|Overall Study|Withdrawal by Subject|5|||
170349915|NCT00960934|615620826|FG005|Overall Study|Withdrawal by Subject|7|||
170349916|NCT00960934|615620821|FG000|Overall Study|Study Terminated by Sponsor|50|||
170349917|NCT00960934|615620822|FG001|Overall Study|Study Terminated by Sponsor|46|||
170349918|NCT00960934|615620823|FG002|Overall Study|Study Terminated by Sponsor|52|||
170349919|NCT00960934|615620824|FG003|Overall Study|Study Terminated by Sponsor|50|||
170349920|NCT00960934|615620825|FG004|Overall Study|Study Terminated by Sponsor|49|||
170349921|NCT00960934|615620826|FG005|Overall Study|Study Terminated by Sponsor|49|||
170349922|NCT00120289|615620828|FG000|Overall Study|Death|96|||
170349923|NCT00120289|615620829|FG001|Overall Study|Death|82|||
170349924|NCT00120289|615620828|FG000|Overall Study|Lost to Follow-up|11|||
170349925|NCT00120289|615620829|FG001|Overall Study|Lost to Follow-up|14|||
170349926|NCT00120289|615620828|FG000|Overall Study|Withdrawal by Subject|14|||
170349927|NCT00120289|615620829|FG001|Overall Study|Withdrawal by Subject|13|||
170349928|NCT04281030|615620831|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
170349929|NCT04281030|615620832|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
170349930|NCT04281030|615620831|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
170349931|NCT04281030|615620832|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
170349932|NCT02179515|615620833|FG000|Overall Study|switched to alternative treatment|0|||
170349933|NCT02179515|615620834|FG001|Overall Study|switched to alternative treatment|1|||
170399303|NCT03193190|615799944|FG007|Stage 1|Physician Decision|0|||
170349934|NCT02179515|615620835|FG002|Overall Study|switched to alternative treatment|1|||
170349935|NCT02179515|615620833|FG000|Overall Study|Death|0|||
170349936|NCT02179515|615620834|FG001|Overall Study|Death|1|||
170349937|NCT02179515|615620835|FG002|Overall Study|Death|1|||
170349938|NCT02179515|615620833|FG000|Overall Study|refused further treatment|0|||
170349939|NCT02179515|615620834|FG001|Overall Study|refused further treatment|3|||
170349940|NCT02179515|615620835|FG002|Overall Study|refused further treatment|4|||
170349941|NCT02179515|615620833|FG000|Overall Study|Disease progression on study|2|||
170349942|NCT02179515|615620834|FG001|Overall Study|Disease progression on study|11|||
170349943|NCT02179515|615620835|FG002|Overall Study|Disease progression on study|8|||
170349944|NCT00782418|615620836|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
170349945|NCT00782418|615620837|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
170349946|NCT00782418|615620838|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
170349947|NCT00782418|615620839|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
170349948|NCT00782418|615620840|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
170349949|NCT00782418|615620841|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
170349950|NCT00782418|615620842|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
170349951|NCT00782418|615620836|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
170349952|NCT00782418|615620837|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
170349953|NCT00782418|615620838|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
170349954|NCT00782418|615620839|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
170349955|NCT00782418|615620840|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
170349956|NCT00782418|615620841|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
170349957|NCT00782418|615620842|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
170349958|NCT01757405|615620843|FG000|Overall Study|Lost to Follow-up|1|||
170349959|NCT01757405|615620844|FG001|Overall Study|Lost to Follow-up|1|||
170349960|NCT01757405|615620843|FG000|Overall Study|Withdrawal by Subject|0|||
170349961|NCT01757405|615620844|FG001|Overall Study|Withdrawal by Subject|1|||
170349962|NCT02488551|615620845|FG000|Overall Study|Lost to Follow-up|4|||
170349963|NCT02488551|615620846|FG001|Overall Study|Lost to Follow-up|7|||
170349964|NCT02488551|615620847|FG002|Overall Study|Lost to Follow-up|0|||
170349965|NCT02488551|615620848|FG003|Overall Study|Lost to Follow-up|0|||
170349966|NCT02488551|615620845|FG000|Overall Study|Military Deployment|1|||
170349967|NCT02488551|615620846|FG001|Overall Study|Military Deployment|1|||
170349968|NCT02488551|615620847|FG002|Overall Study|Military Deployment|0|||
170349969|NCT02488551|615620848|FG003|Overall Study|Military Deployment|0|||
170349970|NCT03364673|615620854|FG000|Overall Study|Withdrawal by Subject|2|||
170349971|NCT03364673|615620854|FG000|Overall Study|Injury unrelated to study|3|||
170349972|NCT00543569|615620855|FG000|Overall Study|Death|2|||
170349973|NCT00543569|615620856|FG001|Overall Study|Death|2|||
170349974|NCT00543569|615620857|FG002|Overall Study|Death|3|||
170349975|NCT00543569|615620858|FG003|Overall Study|Death|1|||
170349976|NCT00543569|615620855|FG000|Overall Study|Lost to Follow-up|0|||
170349977|NCT00543569|615620856|FG001|Overall Study|Lost to Follow-up|0|||
170349978|NCT00543569|615620857|FG002|Overall Study|Lost to Follow-up|1|||
170349979|NCT00543569|615620858|FG003|Overall Study|Lost to Follow-up|1|||
170349980|NCT00543569|615620855|FG000|Overall Study|Miscellaneous Reasons|7|||
170349981|NCT00543569|615620856|FG001|Overall Study|Miscellaneous Reasons|3|||
170349982|NCT00543569|615620857|FG002|Overall Study|Miscellaneous Reasons|11|||
170349983|NCT00543569|615620858|FG003|Overall Study|Miscellaneous Reasons|4|||
170349984|NCT00543569|615620855|FG000|Overall Study|Randomized but never received study drug|3|||
170349985|NCT00543569|615620856|FG001|Overall Study|Randomized but never received study drug|3|||
170349986|NCT00543569|615620857|FG002|Overall Study|Randomized but never received study drug|5|||
170349987|NCT00543569|615620858|FG003|Overall Study|Randomized but never received study drug|3|||
170349988|NCT00668200|615620866|FG000|Overall Study|Withdrawal by Subject|2|||
170349989|NCT00668200|615620866|FG000|Overall Study|Lost to Follow-up|1|||
170349990|NCT01100307|615620870|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
170349991|NCT01100307|615620871|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
170349992|NCT01100307|615620870|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
170349993|NCT01100307|615620871|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
170349994|NCT01100307|615620870|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
170349995|NCT01100307|615620871|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
170349996|NCT01100307|615620870|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
170349997|NCT01100307|615620871|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
170349998|NCT01100307|615620870|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
170349999|NCT01100307|615620871|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
170350000|NCT01100307|615620870|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
170350001|NCT01100307|615620871|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
170350002|NCT00997321|615620872|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
170350003|NCT00997321|615620873|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
170350004|NCT02196038|615620876|FG000|Overall Study|Death|16|||
170350005|NCT02196038|615620877|FG001|Overall Study|Death|21|||
170350006|NCT02196038|615620876|FG000|Overall Study|Withdrawal by Subject|0|||
170350007|NCT02196038|615620877|FG001|Overall Study|Withdrawal by Subject|1|||
170350008|NCT02196038|615620876|FG000|Overall Study|Lost to Follow-up|1|||
170350009|NCT02196038|615620877|FG001|Overall Study|Lost to Follow-up|0|||
170350010|NCT04544709|615620881|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
170350011|NCT03628508|615620882|FG000|Overall Study|Lost to Follow-up|1|||
170350012|NCT03345836|615620883|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
170350013|NCT03345836|615620884|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
170350014|NCT03345836|615620885|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
170350015|NCT03345836|615620886|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
170350016|NCT03345836|615620887|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
170350017|NCT03345836|615620888|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
170350018|NCT03345836|615620883|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
170350019|NCT03345836|615620884|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
170350020|NCT03345836|615620885|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
170350021|NCT03345836|615620886|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
170350022|NCT03345836|615620887|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
170350023|NCT03345836|615620888|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
170350024|NCT03345836|615620883|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
170350025|NCT03345836|615620884|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
170350026|NCT03345836|615620885|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
170350027|NCT03345836|615620886|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
170350028|NCT03345836|615620887|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
170350029|NCT03345836|615620888|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
170350030|NCT03345836|615620883|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
170350031|NCT03345836|615620884|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
170350032|NCT03345836|615620885|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
170350033|NCT03345836|615620886|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
170350034|NCT03345836|615620887|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
170350035|NCT03345836|615620888|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
170350036|NCT03345836|615620883|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
170350037|NCT03345836|615620884|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
170350038|NCT03345836|615620885|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
170350039|NCT03345836|615620886|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
170350040|NCT03345836|615620887|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
170350041|NCT03345836|615620888|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
170350042|NCT03345836|615620883|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
170350043|NCT03345836|615620884|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
170350044|NCT03345836|615620885|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
170350045|NCT03345836|615620886|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
170350046|NCT03345836|615620887|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
170350047|NCT03345836|615620888|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
170350048|NCT03345836|615620883|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
170350049|NCT03345836|615620884|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
170350050|NCT03345836|615620885|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
170350051|NCT03345836|615620886|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
170350052|NCT03345836|615620887|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
170350053|NCT03345836|615620888|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
170350054|NCT03345836|615620883|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
170350055|NCT03345836|615620884|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
170350056|NCT03345836|615620885|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
170350057|NCT03345836|615620886|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
170350058|NCT03345836|615620887|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
170350059|NCT03345836|615620888|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
170350060|NCT03345836|615620883|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
170350061|NCT03345836|615620884|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
170350062|NCT03345836|615620885|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
170350063|NCT03345836|615620886|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
170350064|NCT03345836|615620887|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
170350065|NCT03345836|615620888|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
170350066|NCT03345836|615620883|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
170350067|NCT03345836|615620884|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
170350068|NCT03345836|615620885|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
170350069|NCT03345836|615620886|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
170350070|NCT03345836|615620887|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
170350071|NCT03345836|615620888|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
170350072|NCT03345836|615620883|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
170350073|NCT03345836|615620884|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
170350074|NCT03345836|615620885|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
170350075|NCT03345836|615620886|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
170350076|NCT03345836|615620887|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
170350077|NCT03345836|615620888|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
170350078|NCT03510663|615620889|FG000|Overall Study|Withdrawal by Subject|0|||
170350079|NCT03510663|615620890|FG001|Overall Study|Withdrawal by Subject|1|||
170350080|NCT03510663|615620891|FG002|Overall Study|Withdrawal by Subject|0|||
170350081|NCT03510663|615620892|FG003|Overall Study|Withdrawal by Subject|0|||
170350082|NCT03510663|615620893|FG004|Overall Study|Withdrawal by Subject|0|||
170350083|NCT03510663|615620894|FG005|Overall Study|Withdrawal by Subject|0|||
170350084|NCT03510663|615620895|FG006|Overall Study|Withdrawal by Subject|0|||
170350085|NCT03510663|615620896|FG007|Overall Study|Withdrawal by Subject|0|||
170350086|NCT05091060|615620897|FG000|Overall Study|Lost to Follow-up|1|||
170350087|NCT01842620|615620898|FG000|Period 1|Withdrawal by Subject|1|||
170350088|NCT01842620|615620899|FG001|Period 1|Withdrawal by Subject|0|||
170350089|NCT02739594|615620902|FG000|Overall Study|Undesired Event|3|||
170350090|NCT02739594|615620903|FG001|Overall Study|Undesired Event|4|||
170350091|NCT02739594|615620902|FG000|Overall Study|Violation of Eligibility Criteria|1|||
170350092|NCT02739594|615620903|FG001|Overall Study|Violation of Eligibility Criteria|2|||
170350093|NCT02739594|615620902|FG000|Overall Study|Protocol Violation|5|||
170350094|NCT02739594|615620903|FG001|Overall Study|Protocol Violation|6|||
170350095|NCT02739594|615620902|FG000|Overall Study|Death|4|||
170350096|NCT02739594|615620903|FG001|Overall Study|Death|2|||
170350097|NCT02739594|615620902|FG000|Overall Study|Renal Insufficiency|4|||
170350098|NCT02739594|615620903|FG001|Overall Study|Renal Insufficiency|6|||
170350099|NCT02739594|615620902|FG000|Overall Study|Administrative Reasons|1|||
170350100|NCT02739594|615620903|FG001|Overall Study|Administrative Reasons|3|||
170350101|NCT02739594|615620902|FG000|Overall Study|Withdrawal by Subject|1|||
170350102|NCT02739594|615620903|FG001|Overall Study|Withdrawal by Subject|1|||
170350103|NCT02739594|615620902|FG000|Overall Study|Lost to Follow-up|0|||
170350104|NCT02739594|615620903|FG001|Overall Study|Lost to Follow-up|1|||
170350105|NCT02739594|615620902|FG000|Overall Study|Elevated Serum Creatinine|0|||
170350106|NCT02739594|615620903|FG001|Overall Study|Elevated Serum Creatinine|1|||
170350107|NCT02739594|615620902|FG000|Overall Study|Other|6|||
170350108|NCT02739594|615620903|FG001|Overall Study|Other|2|||
170350109|NCT01814800|615620906|FG000|Overall Study|Adverse Event|2|||
170350110|NCT01814800|615620906|FG000|Overall Study|Pregnancy|1|||
170350111|NCT01814800|615620906|FG000|Overall Study|Sponsor decision|1|||
170350112|NCT01814800|615620906|FG000|Overall Study|Subject relocation|1|||
170350113|NCT01930799|615620907|FG000|Overall Study|Withdrawal by Subject|3|||
170350114|NCT01930799|615620907|FG000|Overall Study|Lost to Follow-up|5|||
170350115|NCT00952289|615620908|FG000|All Participants|Death|9|||
170350116|NCT00952289|615620909|FG001|All Participants|Death|9|||
170350117|NCT00952289|615620908|FG000|All Participants|Adverse Event|8|||
170350118|NCT00952289|615620909|FG001|All Participants|Adverse Event|8|||
170350119|NCT00952289|615620908|FG000|All Participants|Disease progression|3|||
170350120|NCT00952289|615620909|FG001|All Participants|Disease progression|12|||
170350121|NCT00952289|615620908|FG000|All Participants|Withdrawal by Subject|1|||
170350122|NCT00952289|615620909|FG001|All Participants|Withdrawal by Subject|10|||
170350123|NCT00952289|615620908|FG000|All Participants|Data lost during site relocation|0|||
170350124|NCT00952289|615620909|FG001|All Participants|Data lost during site relocation|1|||
170350125|NCT00952289|615620908|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
170350126|NCT00952289|615620909|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
170350127|NCT00952289|615620908|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
170350128|NCT00952289|615620909|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
170350129|NCT00952289|615620908|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
170350130|NCT00952289|615620909|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
170350131|NCT00952289|615620908|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
170350132|NCT00952289|615620909|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
170350133|NCT00952289|615620908|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
170350134|NCT00952289|615620909|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
170350135|NCT03259334|615620910|FG000|Overall Study|Adverse Event|3|||
170350136|NCT03259334|615620911|FG001|Overall Study|Adverse Event|8|||
170350137|NCT03259334|615620912|FG002|Overall Study|Adverse Event|5|||
170350138|NCT03259334|615620910|FG000|Overall Study|Withdrawal by Subject|4|||
170350139|NCT03259334|615620911|FG001|Overall Study|Withdrawal by Subject|2|||
170350140|NCT03259334|615620912|FG002|Overall Study|Withdrawal by Subject|4|||
170350141|NCT03259334|615620910|FG000|Overall Study|Physician Decision|1|||
170350142|NCT03259334|615620911|FG001|Overall Study|Physician Decision|0|||
170350143|NCT03259334|615620912|FG002|Overall Study|Physician Decision|0|||
170350144|NCT03259334|615620910|FG000|Overall Study|Lost to Follow-up|0|||
170350145|NCT03259334|615620911|FG001|Overall Study|Lost to Follow-up|2|||
170350146|NCT03259334|615620912|FG002|Overall Study|Lost to Follow-up|1|||
170350147|NCT03259334|615620910|FG000|Overall Study|Protocol Deviation|0|||
170350148|NCT03259334|615620911|FG001|Overall Study|Protocol Deviation|3|||
170350149|NCT03259334|615620912|FG002|Overall Study|Protocol Deviation|2|||
170350150|NCT03259334|615620910|FG000|Overall Study|Lack of Efficacy|2|||
170350151|NCT03259334|615620911|FG001|Overall Study|Lack of Efficacy|0|||
170350152|NCT03259334|615620912|FG002|Overall Study|Lack of Efficacy|1|||
170350153|NCT03259334|615620910|FG000|Overall Study|Randomized but never treated|0|||
170350154|NCT03259334|615620911|FG001|Overall Study|Randomized but never treated|2|||
170350155|NCT03259334|615620912|FG002|Overall Study|Randomized but never treated|0|||
170350156|NCT02371759|615620913|FG000|Overall Study|Protocol Violation|3|||
170350157|NCT02371759|615620914|FG001|Overall Study|Protocol Violation|1|||
170350158|NCT02371759|615620915|FG002|Overall Study|Protocol Violation|1|||
170350159|NCT02371759|615620916|FG003|Overall Study|Protocol Violation|0|||
170350160|NCT02371759|615620917|FG004|Overall Study|Protocol Violation|3|||
170350161|NCT02371759|615620918|FG005|Overall Study|Protocol Violation|1|||
170350162|NCT02371759|615620919|FG006|Overall Study|Protocol Violation|0|||
170350163|NCT02371759|615620920|FG007|Overall Study|Protocol Violation|3|||
170350164|NCT02371759|615620913|FG000|Overall Study|Withdrawal by Subject|0|||
170350165|NCT02371759|615620914|FG001|Overall Study|Withdrawal by Subject|0|||
170350166|NCT02371759|615620915|FG002|Overall Study|Withdrawal by Subject|0|||
170350167|NCT02371759|615620916|FG003|Overall Study|Withdrawal by Subject|0|||
170350168|NCT02371759|615620917|FG004|Overall Study|Withdrawal by Subject|0|||
170350169|NCT02371759|615620918|FG005|Overall Study|Withdrawal by Subject|0|||
170350170|NCT02371759|615620919|FG006|Overall Study|Withdrawal by Subject|0|||
170350171|NCT02371759|615620920|FG007|Overall Study|Withdrawal by Subject|1|||
170350172|NCT03375112|615620926|FG000|Overall Study|Withdrawal by Subject|3|||
170350173|NCT03375112|615620927|FG001|Overall Study|Withdrawal by Subject|0|||
170350174|NCT03599141|615620928|FG000|Overall Study|Lost to Follow-up|3|||
170350175|NCT03599141|615620929|FG001|Overall Study|Lost to Follow-up|1|||
170350176|NCT00777491|615620932|FG000|Overall Study|Protocol Violation|0|||
170350177|NCT00777491|615620933|FG001|Overall Study|Protocol Violation|2|||
170350178|NCT00777491|615620932|FG000|Overall Study|Did not receive any protocol treatment|2|||
170350179|NCT00777491|615620933|FG001|Overall Study|Did not receive any protocol treatment|0|||
170350180|NCT01689207|615620934|FG000|Overall Study|Adverse Event|0|||
170350181|NCT01689207|615620935|FG001|Overall Study|Adverse Event|1|||
170350182|NCT01689207|615620936|FG002|Overall Study|Adverse Event|0|||
170350183|NCT01689207|615620937|FG003|Overall Study|Adverse Event|0|||
170350184|NCT01689207|615620938|FG004|Overall Study|Adverse Event|2|||
170350185|NCT01689207|615620939|FG005|Overall Study|Adverse Event|1|||
170350186|NCT01689207|615620940|FG006|Overall Study|Adverse Event|0|||
170350187|NCT01689207|615620941|FG007|Overall Study|Adverse Event|0|||
170350188|NCT01689207|615620942|FG008|Overall Study|Adverse Event|1|||
170350189|NCT01689207|615620943|FG009|Overall Study|Adverse Event|0|||
170350190|NCT01689207|615620944|FG010|Overall Study|Adverse Event|0|||
170350191|NCT00364845|615620945|FG000|Overall Study|Adverse Event|1|||
170350192|NCT00364845|615620946|FG001|Overall Study|Adverse Event|0|||
170350193|NCT00364845|615620945|FG000|Overall Study|Withdrawal by Subject|2|||
170350194|NCT00364845|615620946|FG001|Overall Study|Withdrawal by Subject|1|||
170350195|NCT00364845|615620945|FG000|Overall Study|Physician Decision|8|||
170350196|NCT00364845|615620946|FG001|Overall Study|Physician Decision|8|||
170350197|NCT00364845|615620945|FG000|Overall Study|Lost to Follow-up|0|||
170350198|NCT00364845|615620946|FG001|Overall Study|Lost to Follow-up|1|||
170350199|NCT00364845|615620945|FG000|Overall Study|Death|0|||
170350200|NCT00364845|615620946|FG001|Overall Study|Death|1|||
170350201|NCT00369668|615620947|FG000|Overall Study|Lack of Efficacy|4|||
170350202|NCT00369668|615620948|FG001|Overall Study|Lack of Efficacy|5|||
170350203|NCT00369668|615620949|FG002|Overall Study|Lack of Efficacy|7|||
170350204|NCT00303108|615620954|FG000|Overall Study|Adverse Event|5|||
170350205|NCT00303108|615620955|FG001|Overall Study|Adverse Event|6|||
170350206|NCT00303108|615620956|FG002|Overall Study|Adverse Event|7|||
170350207|NCT00303108|615620954|FG000|Overall Study|Patient Request|4|||
170350208|NCT00303108|615620955|FG001|Overall Study|Patient Request|2|||
170350209|NCT00303108|615620956|FG002|Overall Study|Patient Request|8|||
170350210|NCT00303108|615620954|FG000|Overall Study|Failed Entry|1|||
170350211|NCT00303108|615620955|FG001|Overall Study|Failed Entry|0|||
170350212|NCT00303108|615620956|FG002|Overall Study|Failed Entry|1|||
170350213|NCT00303108|615620954|FG000|Overall Study|ineligible|2|||
170350214|NCT00303108|615620955|FG001|Overall Study|ineligible|1|||
170350215|NCT00303108|615620956|FG002|Overall Study|ineligible|0|||
170350216|NCT02427477|615620961|FG000|Period 1|Adverse Event|1|||
170350217|NCT02427477|615620962|FG001|Period 1|Adverse Event|0|||
170350218|NCT01067508|615620963|FG000|Overall Study|Physician Decision|0|||
170350219|NCT01067508|615620964|FG001|Overall Study|Physician Decision|1|||
170350220|NCT01067508|615620963|FG000|Overall Study|Withdrawal by Subject|0|||
170350221|NCT01067508|615620964|FG001|Overall Study|Withdrawal by Subject|1|||
170350222|NCT00444626|615620965|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
170350223|NCT00444626|615620965|FG000|Initial Treatment Period|Adverse Event|1|||
170350224|NCT00444626|615620965|FG000|Initial Treatment Period|Lost to Follow-up|9|||
170350225|NCT00008138|615620968|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
170350226|NCT00008138|615620968|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
170350227|NCT00008138|615620968|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
170350228|NCT00008138|615620968|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
170350229|NCT00008138|615620968|FG000|Interval Debulking|Withdrawal by Subject|2|||
170350230|NCT00008138|615620968|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
170350231|NCT00008138|615620968|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
170350232|NCT00008138|615620968|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
170350233|NCT00142519|615620969|FG000|Overall Study|Not Treated|7|||
170350234|NCT00142519|615620970|FG001|Overall Study|Not Treated|9|||
170350235|NCT00142519|615620969|FG000|Overall Study|Protocol Violation|1|||
170350236|NCT00142519|615620970|FG001|Overall Study|Protocol Violation|0|||
170350237|NCT00142519|615620969|FG000|Overall Study|Withdrawal by Subject|10|||
170350238|NCT00142519|615620970|FG001|Overall Study|Withdrawal by Subject|7|||
170350239|NCT01927744|615622281|FG000|Overall Study|Death|2|||
170350240|NCT01927744|615622282|FG001|Overall Study|Death|9|||
170350241|NCT02457182|615622283|FG000|Overall Study|Lost to Follow-up|1|||
170350242|NCT02457182|615622284|FG001|Overall Study|Lost to Follow-up|0|||
170350243|NCT00352755|615622285|FG000|Overall Study|Physician Decision|1|||
170350244|NCT00352755|615622285|FG000|Overall Study|Adverse Event|1|||
170350245|NCT02115113|615622286|FG000|Participants in Run-in Period|Death|0|||
170350246|NCT02115113|615622287|FG001|Participants in Run-in Period|Death|0|||
170350247|NCT02115113|615622288|FG002|Participants in Run-in Period|Death|1|||
170350248|NCT02115113|615622286|FG000|Participants in Run-in Period|Administrative problems|0|||
170350249|NCT02115113|615622287|FG001|Participants in Run-in Period|Administrative problems|0|||
170350250|NCT02115113|615622288|FG002|Participants in Run-in Period|Administrative problems|1|||
170350251|NCT02115113|615622286|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
170350252|NCT02115113|615622287|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
170350253|NCT02115113|615622288|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
170350254|NCT02115113|615622286|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
170350255|NCT02115113|615622287|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
170350256|NCT02115113|615622288|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
170350257|NCT02115113|615622286|FG000|Participants Randomized|Lost to Follow-up|1|||
170350258|NCT02115113|615622287|FG001|Participants Randomized|Lost to Follow-up|0|||
170350259|NCT02115113|615622288|FG002|Participants Randomized|Lost to Follow-up|0|||
170350260|NCT02115113|615622286|FG000|Participants Randomized|Death|1|||
170350261|NCT02115113|615622287|FG001|Participants Randomized|Death|0|||
170350262|NCT02115113|615622288|FG002|Participants Randomized|Death|0|||
170350263|NCT01694420|615622289|FG000|Overall Study|Lost to Follow-up|3|||
170350264|NCT00789191|615622293|FG000|Overall Study|Adverse Event|2|||
170350265|NCT00789191|615622294|FG001|Overall Study|Adverse Event|4|||
170350266|NCT00789191|615622293|FG000|Overall Study|Lack of Efficacy|0|||
170350267|NCT00789191|615622294|FG001|Overall Study|Lack of Efficacy|5|||
170350268|NCT00789191|615622293|FG000|Overall Study|Protocol Violation|5|||
170350269|NCT00789191|615622294|FG001|Overall Study|Protocol Violation|3|||
170350270|NCT00789191|615622293|FG000|Overall Study|Withdrawal Criteria|2|||
170350271|NCT00789191|615622294|FG001|Overall Study|Withdrawal Criteria|4|||
170350272|NCT00789191|615622293|FG000|Overall Study|Unclassified|5|||
170350273|NCT00789191|615622294|FG001|Overall Study|Unclassified|3|||
170350274|NCT03497429|615622296|FG000|Overall Study|Progressive disease|3|||
170350275|NCT03497429|615622297|FG001|Overall Study|Progressive disease|4|||
170350276|NCT03497429|615622296|FG000|Overall Study|Adverse Event|0|||
170350277|NCT03497429|615622297|FG001|Overall Study|Adverse Event|2|||
170350278|NCT01009983|615622298|FG000|Overall Study|necessary scans not completed|1|||
170350279|NCT00506948|615622299|FG000|Overall Study|Death|4|||
170350280|NCT00506948|615622299|FG000|Overall Study|Adverse Event|5|||
170350281|NCT00506948|615622299|FG000|Overall Study|Physician Decision|1|||
170350282|NCT02174861|615622303|FG000|Overall Study|Decision by sponsor|8|||
170350283|NCT02174861|615622303|FG000|Overall Study|Withdrawal by Subject|124|||
170350284|NCT02174861|615622303|FG000|Overall Study|Lost to Follow-up|26|||
170350285|NCT02709083|615622320|FG000|Overall Study|Original PI left institution|7|||
170350286|NCT03544268|615622321|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
170350287|NCT03544268|615622322|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
170350288|NCT04410198|615622323|FG000|Overall Study|Death|10|||
170350289|NCT04410198|615622323|FG000|Overall Study|Withdrawal by Subject|7|||
170350290|NCT04410198|615622323|FG000|Overall Study|Transferred/Relocation|4|||
170350291|NCT04410198|615622323|FG000|Overall Study|Kidney Transplant|9|||
170350292|NCT04410198|615622323|FG000|Overall Study|Adverse Event|4|||
170350293|NCT04410198|615622323|FG000|Overall Study|Physician Decision|2|||
170350294|NCT04410198|615622323|FG000|Overall Study|Other than specified|1|||
170350295|NCT02871401|615622324|FG000|Overall Study|Adverse Event|1|||
170350296|NCT02871401|615622325|FG001|Overall Study|Adverse Event|0|||
170350297|NCT01120379|615622328|FG000|One Year Timepoint|Withdrawal by Subject|41|||
170350298|NCT01120379|615622328|FG000|One Year Timepoint|Lost to Follow-up|115|||
170350299|NCT01120379|615622328|FG000|One Year Timepoint|Death|108|||
170350300|NCT01120379|615622328|FG000|One Year Timepoint|Physician Decision|9|||
170350301|NCT01120379|615622328|FG000|One Year Timepoint|Any other reason for early termination|5|||
170350302|NCT01120379|615622328|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
170350303|NCT01120379|615622328|FG000|Two Year Timepoint|Lost to Follow-up|87|||
170350304|NCT01120379|615622328|FG000|Two Year Timepoint|Death|123|||
170350305|NCT01120379|615622328|FG000|Two Year Timepoint|Physician Decision|12|||
170350306|NCT01120379|615622328|FG000|Two Year Timepoint|Any other reason for early termination|4|||
170350307|NCT01120379|615622328|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
170350308|NCT01120379|615622328|FG000|Three Year Timepoint|Lost to Follow-up|43|||
170350309|NCT01120379|615622328|FG000|Three Year Timepoint|Death|120|||
170350310|NCT01120379|615622328|FG000|Three Year Timepoint|Physician Decision|9|||
170350311|NCT01120379|615622328|FG000|Three Year Timepoint|Any other reason for early termination|17|||
170350312|NCT01120379|615622328|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
170350313|NCT01120379|615622328|FG000|Four Year Timepoint|Lost to Follow-up|10|||
170350314|NCT01120379|615622328|FG000|Four Year Timepoint|Death|131|||
170350315|NCT01120379|615622328|FG000|Four Year Timepoint|Physician Decision|5|||
170350316|NCT01120379|615622328|FG000|Four Year Timepoint|Any other reason for early termination|217|||
170350317|NCT03162055|615622329|FG000|Overall Study|Adverse Event|6|||
170350318|NCT03162055|615622330|FG001|Overall Study|Adverse Event|5|||
170350319|NCT03162055|615622329|FG000|Overall Study|Death|3|||
170350320|NCT03162055|615622330|FG001|Overall Study|Death|3|||
170350321|NCT03162055|615622329|FG000|Overall Study|Lost to Follow-up|0|||
170350322|NCT03162055|615622330|FG001|Overall Study|Lost to Follow-up|1|||
170350323|NCT03162055|615622329|FG000|Overall Study|Study-specific withdrawal criteria|22|||
170350324|NCT03162055|615622330|FG001|Overall Study|Study-specific withdrawal criteria|14|||
170350325|NCT03162055|615622329|FG000|Overall Study|Withdrawal by Subject|17|||
170350326|NCT03162055|615622330|FG001|Overall Study|Withdrawal by Subject|2|||
170350327|NCT03162055|615622329|FG000|Overall Study|Did not receive treatment|2|||
170350328|NCT03162055|615622330|FG001|Overall Study|Did not receive treatment|0|||
170350329|NCT03162055|615622329|FG000|Overall Study|Incorrect randomization|4|||
170350330|NCT03162055|615622330|FG001|Overall Study|Incorrect randomization|3|||
170350331|NCT03162055|615622329|FG000|Overall Study|Other|8|||
170350332|NCT03162055|615622330|FG001|Overall Study|Other|15|||
170350333|NCT02006667|615622331|FG000|Overall Study|Adverse Event|3|||
170350334|NCT02006667|615622331|FG000|Overall Study|Death|2|||
170350335|NCT02006667|615622331|FG000|Overall Study|Withdrawal by Subject|1|||
170350336|NCT02695524|615622336|FG000|Overall Study|Lost to Follow-up|3|||
170350337|NCT02695524|615622337|FG001|Overall Study|Lost to Follow-up|2|||
170350338|NCT02695524|615622336|FG000|Overall Study|Death|0|||
170350339|NCT02695524|615622337|FG001|Overall Study|Death|1|||
170350340|NCT01774344|615622343|FG000|Overall Study|Withdrawal by Subject|3|||
170350341|NCT01774344|615622344|FG001|Overall Study|Withdrawal by Subject|10|||
170350342|NCT01774344|615622343|FG000|Overall Study|Protocol Violation|0|||
170350343|NCT01774344|615622344|FG001|Overall Study|Protocol Violation|1|||
170350344|NCT01774344|615622343|FG000|Overall Study|Lost to Follow-up|4|||
170350345|NCT01774344|615622344|FG001|Overall Study|Lost to Follow-up|10|||
170350346|NCT01774344|615622343|FG000|Overall Study|End of survival follow-up not available|2|||
170350347|NCT01774344|615622344|FG001|Overall Study|End of survival follow-up not available|2|||
170350348|NCT01774344|615622343|FG000|Overall Study|Data collection finished|4|||
170350349|NCT01774344|615622344|FG001|Overall Study|Data collection finished|14|||
170350350|NCT01774344|615622343|FG000|Overall Study|Other|0|||
170350351|NCT01774344|615622344|FG001|Overall Study|Other|1|||
170350352|NCT01774344|615622343|FG000|Overall Study|Did not enter Survival Follow up|49|||
170350353|NCT01774344|615622344|FG001|Overall Study|Did not enter Survival Follow up|83|||
170350354|NCT00862849|615622345|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
170350355|NCT00862849|615622346|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
170350356|NCT00862849|615622347|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
170350357|NCT00862849|615622348|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
170350358|NCT00862849|615622349|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
170350359|NCT00862849|615622350|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
170350360|NCT00862849|615622345|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
170350361|NCT00862849|615622346|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
170350362|NCT00862849|615622347|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
170350363|NCT00862849|615622348|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
170350364|NCT00862849|615622349|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
170350365|NCT00862849|615622350|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
170350366|NCT00617409|615622351|FG000|Overall Study|Withdrawal by Subject|4|||
170350367|NCT00617409|615622352|FG001|Overall Study|Withdrawal by Subject|1|||
170350368|NCT00617409|615622353|FG002|Overall Study|Withdrawal by Subject|2|||
170350369|NCT00617409|615622351|FG000|Overall Study|Adverse Event|0|||
170350370|NCT00617409|615622352|FG001|Overall Study|Adverse Event|2|||
170350371|NCT00617409|615622353|FG002|Overall Study|Adverse Event|3|||
170350372|NCT00617409|615622351|FG000|Overall Study|Disease Progression|8|||
170350373|NCT00617409|615622352|FG001|Overall Study|Disease Progression|8|||
170350374|NCT00617409|615622353|FG002|Overall Study|Disease Progression|18|||
170350375|NCT00617409|615622351|FG000|Overall Study|Death|3|||
170350376|NCT00617409|615622352|FG001|Overall Study|Death|5|||
170350377|NCT00617409|615622353|FG002|Overall Study|Death|4|||
170350378|NCT00617409|615622351|FG000|Overall Study|Alternative Therapy|1|||
170350379|NCT00617409|615622352|FG001|Overall Study|Alternative Therapy|2|||
170350380|NCT00617409|615622353|FG002|Overall Study|Alternative Therapy|0|||
170350381|NCT02124707|615622357|FG000|Overall Study|Adverse Event|5|||
170350382|NCT02124707|615622357|FG000|Overall Study|Physician Decision|1|||
170350383|NCT02124707|615622357|FG000|Overall Study|Death|1|||
170350384|NCT01363713|615622362|FG000|Overall Study|Adverse Event|1|||
170350385|NCT01363713|615622362|FG000|Overall Study|Protocol Violation|3|||
170350386|NCT01363713|615622362|FG000|Overall Study|Withdrawal by Subject|2|||
170350387|NCT00305253|615622363|FG000|Overall Study|Withdrawal by Subject|0|||
170350388|NCT00305253|615622364|FG001|Overall Study|Withdrawal by Subject|1|||
170350389|NCT03135028|615622367|FG000|Overall Study|Death|6|||
170350390|NCT03135028|615622367|FG000|Overall Study|Study Terminated by Sponsor|2|||
170350391|NCT03135028|615622367|FG000|Overall Study|Withdrew Consent|1|||
170350392|NCT03136185|615622370|FG000|Overall Study|Adverse Event|0|||
170350393|NCT03136185|615622371|FG001|Overall Study|Adverse Event|1|||
170350394|NCT03136185|615622372|FG002|Overall Study|Adverse Event|3|||
170350395|NCT03136185|615622373|FG003|Overall Study|Adverse Event|1|||
170350396|NCT03136185|615622374|FG004|Overall Study|Adverse Event|2|||
170350397|NCT03136185|615622375|FG005|Overall Study|Adverse Event|2|||
170350398|NCT03136185|615622376|FG006|Overall Study|Adverse Event|5|||
170350399|NCT03136185|615622377|FG007|Overall Study|Adverse Event|1|||
170350400|NCT03136185|615622378|FG008|Overall Study|Adverse Event|1|||
170350401|NCT03136185|615622370|FG000|Overall Study|Death|0|||
170350402|NCT03136185|615622371|FG001|Overall Study|Death|0|||
170350403|NCT03136185|615622372|FG002|Overall Study|Death|0|||
170350404|NCT03136185|615622373|FG003|Overall Study|Death|1|||
170350405|NCT03136185|615622374|FG004|Overall Study|Death|1|||
170350406|NCT03136185|615622375|FG005|Overall Study|Death|0|||
170350407|NCT03136185|615622376|FG006|Overall Study|Death|1|||
170350408|NCT03136185|615622377|FG007|Overall Study|Death|0|||
170350409|NCT03136185|615622378|FG008|Overall Study|Death|0|||
170350410|NCT03136185|615622370|FG000|Overall Study|Physician Decision|3|||
170350411|NCT03136185|615622371|FG001|Overall Study|Physician Decision|1|||
170350412|NCT03136185|615622372|FG002|Overall Study|Physician Decision|1|||
170350413|NCT03136185|615622373|FG003|Overall Study|Physician Decision|2|||
170350414|NCT03136185|615622374|FG004|Overall Study|Physician Decision|1|||
170350415|NCT03136185|615622375|FG005|Overall Study|Physician Decision|2|||
170350416|NCT03136185|615622376|FG006|Overall Study|Physician Decision|1|||
170350417|NCT03136185|615622377|FG007|Overall Study|Physician Decision|0|||
170350418|NCT03136185|615622378|FG008|Overall Study|Physician Decision|1|||
170350419|NCT03136185|615622370|FG000|Overall Study|Protocol Defined Disease Progression|0|||
170350420|NCT03136185|615622371|FG001|Overall Study|Protocol Defined Disease Progression|0|||
170350421|NCT03136185|615622372|FG002|Overall Study|Protocol Defined Disease Progression|1|||
170350422|NCT03136185|615622373|FG003|Overall Study|Protocol Defined Disease Progression|0|||
170350423|NCT03136185|615622374|FG004|Overall Study|Protocol Defined Disease Progression|0|||
170350424|NCT03136185|615622375|FG005|Overall Study|Protocol Defined Disease Progression|1|||
170350425|NCT03136185|615622376|FG006|Overall Study|Protocol Defined Disease Progression|0|||
170350426|NCT03136185|615622377|FG007|Overall Study|Protocol Defined Disease Progression|1|||
170350427|NCT03136185|615622378|FG008|Overall Study|Protocol Defined Disease Progression|1|||
170350428|NCT03136185|615622370|FG000|Overall Study|Withdrawal by Subject|1|||
170350429|NCT03136185|615622371|FG001|Overall Study|Withdrawal by Subject|0|||
170350430|NCT03136185|615622372|FG002|Overall Study|Withdrawal by Subject|1|||
170350431|NCT03136185|615622373|FG003|Overall Study|Withdrawal by Subject|1|||
170350432|NCT03136185|615622374|FG004|Overall Study|Withdrawal by Subject|1|||
170350433|NCT03136185|615622375|FG005|Overall Study|Withdrawal by Subject|1|||
170350434|NCT03136185|615622376|FG006|Overall Study|Withdrawal by Subject|2|||
170350435|NCT03136185|615622377|FG007|Overall Study|Withdrawal by Subject|3|||
170350436|NCT03136185|615622378|FG008|Overall Study|Withdrawal by Subject|3|||
170350437|NCT03136185|615622370|FG000|Overall Study|Not Reported|4|||
170350438|NCT03136185|615622371|FG001|Overall Study|Not Reported|1|||
170350439|NCT03136185|615622372|FG002|Overall Study|Not Reported|0|||
170350440|NCT03136185|615622373|FG003|Overall Study|Not Reported|1|||
170350441|NCT03136185|615622374|FG004|Overall Study|Not Reported|0|||
170350442|NCT03136185|615622375|FG005|Overall Study|Not Reported|2|||
170350443|NCT03136185|615622376|FG006|Overall Study|Not Reported|1|||
170350444|NCT03136185|615622377|FG007|Overall Study|Not Reported|1|||
170350445|NCT03136185|615622378|FG008|Overall Study|Not Reported|0|||
170350446|NCT03011840|615622379|FG000|Overall Study|Not received PIL in post PIL phase|0|||
170350447|NCT03011840|615622380|FG001|Overall Study|Not received PIL in post PIL phase|21|||
170350448|NCT05118386|615622386|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
170350449|NCT05118386|615622387|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
170350450|NCT05118386|615622388|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
170350451|NCT05118386|615622389|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
170399304|NCT03193190|615799945|FG008|Stage 1|Physician Decision|0|||
170350452|NCT05118386|615622390|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
170350453|NCT05118386|615622391|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
170350454|NCT05118386|615622386|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
170350455|NCT05118386|615622387|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
170350456|NCT05118386|615622388|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
170350457|NCT05118386|615622389|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
170350458|NCT05118386|615622390|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
170350459|NCT05118386|615622391|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
170350460|NCT00488033|615622392|FG000|Overall Study|Withdrawal by Subject|1|||
170350461|NCT00488033|615622393|FG001|Overall Study|Withdrawal by Subject|0|||
170350462|NCT00894413|615622394|FG000|Overall Study|Physician Decision|0|||
170350463|NCT00894413|615622395|FG001|Overall Study|Physician Decision|2|||
170350464|NCT00894413|615622394|FG000|Overall Study|Adverse Event|0|||
170350465|NCT00894413|615622395|FG001|Overall Study|Adverse Event|2|||
170350466|NCT00894413|615622394|FG000|Overall Study|Withdrawal by Subject|0|||
170350467|NCT00894413|615622395|FG001|Overall Study|Withdrawal by Subject|4|||
170350468|NCT03201198|615622396|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
170350469|NCT03201198|615622397|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
170350470|NCT03201198|615622396|FG000|Overall Study|Withdrawal by Subject|2|||
170350471|NCT03201198|615622397|FG001|Overall Study|Withdrawal by Subject|3|||
170350472|NCT00471445|615622398|FG000|Overall Study|Withdrawal by Subject|1|||
170350473|NCT00471445|615622399|FG001|Overall Study|Withdrawal by Subject|1|||
170350474|NCT00471445|615622398|FG000|Overall Study|Ineligible|1|||
170350475|NCT00471445|615622399|FG001|Overall Study|Ineligible|0|||
170350476|NCT00471445|615622398|FG000|Overall Study|Protocol Violation|0|||
170350477|NCT00471445|615622399|FG001|Overall Study|Protocol Violation|1|||
170350478|NCT04715230|615622405|FG000|Overall Study|Withdrawal by Subject|1|||
170350479|NCT04715230|615622406|FG001|Overall Study|Withdrawal by Subject|0|||
170350480|NCT04715230|615622407|FG002|Overall Study|Withdrawal by Subject|0|||
170350481|NCT04715230|615622405|FG000|Overall Study|Lost to Follow-up|0|||
170350482|NCT04715230|615622406|FG001|Overall Study|Lost to Follow-up|5|||
170350483|NCT04715230|615622407|FG002|Overall Study|Lost to Follow-up|1|||
170350484|NCT01552928|615622412|FG000|Period 3|Adverse Event|0|||
170350485|NCT01552928|615622413|FG001|Period 3|Adverse Event|0|||
170350486|NCT01552928|615622414|FG002|Period 3|Adverse Event|1|||
170350487|NCT01552928|615622415|FG003|Period 3|Adverse Event|0|||
170350488|NCT01331239|615622423|FG000|Part II: Core Study|Adverse Event|0|||
170350489|NCT01331239|615622424|FG001|Part II: Core Study|Adverse Event|3|||
170350490|NCT01331239|615622425|FG002|Part II: Core Study|Adverse Event|0|||
170350491|NCT01331239|615622423|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
170350492|NCT01331239|615622424|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
170350493|NCT01331239|615622425|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
170350494|NCT01331239|615622423|FG000|Part II: Core Study|Withdrawal by Subject|0|||
170350495|NCT01331239|615622424|FG001|Part II: Core Study|Withdrawal by Subject|2|||
170350496|NCT01331239|615622425|FG002|Part II: Core Study|Withdrawal by Subject|0|||
170350497|NCT01331239|615622423|FG000|Part II: Core Study|Administrative problems|0|||
170350498|NCT01331239|615622424|FG001|Part II: Core Study|Administrative problems|1|||
170350499|NCT01331239|615622425|FG002|Part II: Core Study|Administrative problems|0|||
170350500|NCT00406640|615622432|FG000|Acute Phase|Adverse Event|18|||
170350501|NCT00406640|615622433|FG001|Acute Phase|Adverse Event|13|||
170350502|NCT00406640|615622432|FG000|Acute Phase|Failed to Return|5|||
170350503|NCT00406640|615622433|FG001|Acute Phase|Failed to Return|1|||
170350504|NCT00406640|615622432|FG000|Acute Phase|Physician Decision|0|||
170350505|NCT00406640|615622433|FG001|Acute Phase|Physician Decision|1|||
170350506|NCT00406640|615622432|FG000|Acute Phase|Lost to Follow-up|7|||
170350507|NCT00406640|615622433|FG001|Acute Phase|Lost to Follow-up|4|||
170350508|NCT00406640|615622432|FG000|Acute Phase|Protocol deviation|4|||
170350509|NCT00406640|615622433|FG001|Acute Phase|Protocol deviation|10|||
170350510|NCT00406640|615622432|FG000|Acute Phase|Protocol Violation|3|||
170350511|NCT00406640|615622433|FG001|Acute Phase|Protocol Violation|2|||
170350512|NCT00406640|615622432|FG000|Acute Phase|Withdrawal by Subject|11|||
170350513|NCT00406640|615622433|FG001|Acute Phase|Withdrawal by Subject|9|||
170350514|NCT00406640|615622432|FG000|Acute Phase|Lack of Efficacy|3|||
170350515|NCT00406640|615622433|FG001|Acute Phase|Lack of Efficacy|3|||
170350516|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
170350517|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
170350518|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|Death|1|||
170350519|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|Death|0|||
170350520|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
170350521|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
170350522|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
170350523|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
170350524|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
170350525|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
170350526|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|non-compliance|7|||
170350527|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|non-compliance|5|||
170350528|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
170350529|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
170350530|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
170350531|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
170350532|NCT00406640|615622432|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
170350533|NCT00406640|615622433|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
170350534|NCT00406640|615622432|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
170350535|NCT00406640|615622433|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
170350536|NCT00406640|615622432|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
170350537|NCT00406640|615622433|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
170350538|NCT00406640|615622432|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
170350539|NCT00406640|615622433|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
170350540|NCT00406640|615622432|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
170350541|NCT00406640|615622433|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
170350542|NCT00406640|615622432|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
170350543|NCT00406640|615622433|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
170350544|NCT00406640|615622432|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
170350545|NCT00406640|615622433|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
170350546|NCT00406640|615622432|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
170350547|NCT00406640|615622433|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
170350548|NCT00488618|615622434|FG000|Overall Study|Adverse Event|13|||
170350549|NCT00488618|615622435|FG001|Overall Study|Adverse Event|17|||
170350550|NCT00488618|615622434|FG000|Overall Study|Insufficient Therapeutic Response|18|||
170350551|NCT00488618|615622435|FG001|Overall Study|Insufficient Therapeutic Response|11|||
170350552|NCT00488618|615622434|FG000|Overall Study|Protocol Violation|0|||
170350553|NCT00488618|615622435|FG001|Overall Study|Protocol Violation|2|||
170350554|NCT00488618|615622434|FG000|Overall Study|Withdrawal of Consent|15|||
170350555|NCT00488618|615622435|FG001|Overall Study|Withdrawal of Consent|13|||
170350556|NCT00488618|615622434|FG000|Overall Study|Lost to Follow-up|1|||
170350557|NCT00488618|615622435|FG001|Overall Study|Lost to Follow-up|0|||
170350558|NCT00369967|615624333|FG000|Overall Study|Lost to Follow-up|23|||
170350559|NCT00369967|615624334|FG001|Overall Study|Lost to Follow-up|12|||
170350560|NCT00605722|615624337|FG000|Overall Study|Adverse Event|6|||
170350561|NCT00605722|615624337|FG000|Overall Study|Insufficient therapeutic response|44|||
170350562|NCT00605722|615624337|FG000|Overall Study|Failure to return|1|||
170350563|NCT03073213|615624338|FG000|Multiple Dose Period|Protocol Violation|0|||
170350564|NCT03073213|615624339|FG001|Multiple Dose Period|Protocol Violation|0|||
170350565|NCT03073213|615624340|FG002|Multiple Dose Period|Protocol Violation|1|||
170350566|NCT00296725|615624341|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
170350567|NCT00296725|615624341|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
170350568|NCT00296725|615624341|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
170350569|NCT00356863|615624342|FG000|Overall Study|Death|16|||
170350570|NCT00356863|615624343|FG001|Overall Study|Death|32|||
170350571|NCT00356863|615624342|FG000|Overall Study|Lost to Follow-up|76|||
170350572|NCT00356863|615624343|FG001|Overall Study|Lost to Follow-up|43|||
170350573|NCT03137121|615624347|FG000|Overall Study|Withdrawal by Subject|0|||
170350574|NCT03137121|615624348|FG001|Overall Study|Withdrawal by Subject|1|||
170350575|NCT00836277|615624355|FG000|Overall Study|Not evaluable for response|6|||
170350576|NCT00333619|615624356|FG000|Overall Study|Death|12|||
170350577|NCT00333619|615624357|FG001|Overall Study|Death|6|||
170350578|NCT00333619|615624356|FG000|Overall Study|Withdrawal by Subject|6|||
170350579|NCT00333619|615624357|FG001|Overall Study|Withdrawal by Subject|1|||
170350580|NCT00333619|615624356|FG000|Overall Study|Lost to Follow-up|3|||
170350581|NCT00333619|615624357|FG001|Overall Study|Lost to Follow-up|3|||
170350582|NCT00280150|615624358|FG000|Overall Study|Adverse Event|0|||
170350583|NCT00280150|615624359|FG001|Overall Study|Adverse Event|1|||
170350584|NCT00280150|615624360|FG002|Overall Study|Adverse Event|2|||
170350585|NCT00280150|615624361|FG003|Overall Study|Adverse Event|3|||
170350586|NCT00280150|615624358|FG000|Overall Study|Lack of Efficacy|0|||
170350587|NCT00280150|615624359|FG001|Overall Study|Lack of Efficacy|0|||
170350588|NCT00280150|615624360|FG002|Overall Study|Lack of Efficacy|0|||
170350589|NCT00280150|615624361|FG003|Overall Study|Lack of Efficacy|3|||
170350590|NCT00280150|615624358|FG000|Overall Study|Physician Decision|0|||
170350591|NCT00280150|615624359|FG001|Overall Study|Physician Decision|0|||
170350592|NCT00280150|615624360|FG002|Overall Study|Physician Decision|0|||
170350593|NCT00280150|615624361|FG003|Overall Study|Physician Decision|1|||
170350594|NCT00280150|615624358|FG000|Overall Study|Protocol Violation|0|||
170350595|NCT00280150|615624359|FG001|Overall Study|Protocol Violation|0|||
170350596|NCT00280150|615624360|FG002|Overall Study|Protocol Violation|0|||
170350597|NCT00280150|615624361|FG003|Overall Study|Protocol Violation|1|||
170350598|NCT00280150|615624358|FG000|Overall Study|Withdrawal by Subject|0|||
170350599|NCT00280150|615624359|FG001|Overall Study|Withdrawal by Subject|0|||
170350600|NCT00280150|615624360|FG002|Overall Study|Withdrawal by Subject|0|||
170350601|NCT00280150|615624361|FG003|Overall Study|Withdrawal by Subject|1|||
170350602|NCT00280150|615624358|FG000|Overall Study|Did not get consolidation therapy|3|||
170350603|NCT00280150|615624359|FG001|Overall Study|Did not get consolidation therapy|0|||
170350604|NCT00280150|615624360|FG002|Overall Study|Did not get consolidation therapy|3|||
170350605|NCT00280150|615624361|FG003|Overall Study|Did not get consolidation therapy|0|||
170350606|NCT00280150|615624358|FG000|Overall Study|Declining Performance Status|0|||
170350607|NCT00280150|615624359|FG001|Overall Study|Declining Performance Status|0|||
170350608|NCT00280150|615624360|FG002|Overall Study|Declining Performance Status|0|||
170350609|NCT00280150|615624361|FG003|Overall Study|Declining Performance Status|1|||
170350610|NCT04031404|615624369|FG000|Baseline|Lost to Follow-up|0|||
170350611|NCT04031404|615624370|FG001|Baseline|Lost to Follow-up|1|||
170350612|NCT04031404|615624369|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
170350613|NCT04031404|615624370|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
170350614|NCT04031404|615624369|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
170350615|NCT04031404|615624370|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
170350616|NCT04031404|615624369|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
170350617|NCT04031404|615624370|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
170350618|NCT04031404|615624369|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
170350619|NCT04031404|615624370|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
170350620|NCT01993615|615624371|FG000|Overall Study|Death|1|||
170350621|NCT01993615|615624372|FG001|Overall Study|Death|0|||
170350622|NCT02282982|615624375|FG000|Overall Study|Lost to Follow-up|15|||
170350623|NCT02282982|615624375|FG000|Overall Study|Withdrew consent|2|||
170350624|NCT02282982|615624375|FG000|Overall Study|Death|4|||
170350625|NCT02282982|615624375|FG000|Overall Study|Lack of product|156|||
170350626|NCT02282982|615624375|FG000|Overall Study|Palivizumab is ended|11|||
170350627|NCT02282982|615624375|FG000|Overall Study|Other, not specified|18|||
170350628|NCT02939937|615624376|FG000|Overall Study|Adverse Event|5|||
170350629|NCT02939937|615624377|FG001|Overall Study|Adverse Event|0|||
170350630|NCT02939937|615624376|FG000|Overall Study|Lost to Follow-up|1|||
170350631|NCT02939937|615624377|FG001|Overall Study|Lost to Follow-up|3|||
170350632|NCT00568958|615624378|FG000|Allocation|Withdrawal by Subject|7|||
170350633|NCT00568958|615624379|FG001|Allocation|Withdrawal by Subject|3|||
170350634|NCT00568958|615624378|FG000|Allocation|Physician Decision|2|||
170350635|NCT00568958|615624379|FG001|Allocation|Physician Decision|0|||
170350636|NCT00568958|615624378|FG000|Follow-Up|Withdrawal by Subject|6|||
170350637|NCT00568958|615624379|FG001|Follow-Up|Withdrawal by Subject|6|||
170350638|NCT00568958|615624378|FG000|Follow-Up|Physician Decision|1|||
170350639|NCT00568958|615624379|FG001|Follow-Up|Physician Decision|1|||
170350640|NCT00568958|615624378|FG000|Follow-Up|Family Emergency|1|||
170350641|NCT00568958|615624379|FG001|Follow-Up|Family Emergency|0|||
170350642|NCT00568958|615624378|FG000|Follow-Up|Adverse Event|1|||
170350643|NCT00568958|615624379|FG001|Follow-Up|Adverse Event|0|||
170350644|NCT00174785|615624385|FG000|Overall Study|Adverse Event|293|||
170350645|NCT00174785|615624386|FG001|Overall Study|Adverse Event|191|||
170350646|NCT00174785|615624385|FG000|Overall Study|Protocol Violation|14|||
170350647|NCT00174785|615624386|FG001|Overall Study|Protocol Violation|14|||
170350648|NCT00174785|615624385|FG000|Overall Study|Withdrawal by Subject|173|||
170350649|NCT00174785|615624386|FG001|Overall Study|Withdrawal by Subject|175|||
170350650|NCT00174785|615624385|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
170350651|NCT00174785|615624386|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
170350652|NCT00174785|615624385|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
170350653|NCT00174785|615624386|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
170350654|NCT00174785|615624385|FG000|Overall Study|Other prohibited medication|5|||
170350655|NCT00174785|615624386|FG001|Overall Study|Other prohibited medication|3|||
170350656|NCT00174785|615624385|FG000|Overall Study|Family request|6|||
170350657|NCT00174785|615624386|FG001|Overall Study|Family request|8|||
170350658|NCT00174785|615624385|FG000|Overall Study|Not pre-specified/Not coded|56|||
170350659|NCT00174785|615624386|FG001|Overall Study|Not pre-specified/Not coded|70|||
170350660|NCT00848250|615624387|FG000|Overall Study|surgery was completed without cardiopulm|0|||
170350661|NCT00848250|615624388|FG001|Overall Study|surgery was completed without cardiopulm|1|||
170350662|NCT02052778|615624389|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
170350663|NCT02052778|615624390|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
170350664|NCT02052778|615624391|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
170350665|NCT02052778|615624392|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
170350666|NCT02052778|615624393|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
170350667|NCT02052778|615624394|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
170350668|NCT02052778|615624395|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350669|NCT02052778|615624396|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
170350670|NCT02052778|615624397|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
170399305|NCT03193190|615799946|FG009|Stage 1|Physician Decision|0|||
170350671|NCT02052778|615624398|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
170350672|NCT02052778|615624399|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
170350673|NCT02052778|615624400|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
170350674|NCT02052778|615624401|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
170350675|NCT02052778|615624402|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
170350676|NCT02052778|615624403|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350677|NCT02052778|615624404|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350678|NCT02052778|615624405|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350679|NCT02052778|615624406|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350680|NCT02052778|615624407|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350681|NCT02052778|615624408|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350682|NCT02052778|615624409|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350683|NCT02052778|615624410|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350684|NCT02052778|615624411|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
170350685|NCT02052778|615624389|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
170350686|NCT02052778|615624390|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
170350687|NCT02052778|615624391|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
170350688|NCT02052778|615624392|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
170350689|NCT02052778|615624393|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
170350690|NCT02052778|615624394|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
170350691|NCT02052778|615624395|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
170350692|NCT02052778|615624396|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
170350693|NCT02052778|615624397|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
170350694|NCT02052778|615624398|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350695|NCT02052778|615624399|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350696|NCT02052778|615624400|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
170350697|NCT02052778|615624401|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
170350698|NCT02052778|615624402|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
170350699|NCT02052778|615624403|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350700|NCT02052778|615624404|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350701|NCT02052778|615624405|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350702|NCT02052778|615624406|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350703|NCT02052778|615624407|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350704|NCT02052778|615624408|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350705|NCT02052778|615624409|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350706|NCT02052778|615624410|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350707|NCT02052778|615624411|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
170350708|NCT02052778|615624389|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350709|NCT02052778|615624390|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350710|NCT02052778|615624391|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350711|NCT02052778|615624392|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350712|NCT02052778|615624393|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350713|NCT02052778|615624394|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350714|NCT02052778|615624395|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350715|NCT02052778|615624396|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350716|NCT02052778|615624397|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350717|NCT02052778|615624398|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350718|NCT02052778|615624399|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350719|NCT02052778|615624400|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350720|NCT02052778|615624401|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350721|NCT02052778|615624402|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
170350722|NCT02052778|615624403|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350723|NCT02052778|615624404|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350724|NCT02052778|615624405|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350725|NCT02052778|615624406|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350726|NCT02052778|615624407|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350727|NCT02052778|615624408|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350728|NCT02052778|615624409|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350729|NCT02052778|615624410|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350730|NCT02052778|615624411|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
170350731|NCT02052778|615624389|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
170350732|NCT02052778|615624390|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
170350733|NCT02052778|615624391|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
170350734|NCT02052778|615624392|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
170350735|NCT02052778|615624393|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
170350736|NCT02052778|615624394|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
170350737|NCT02052778|615624395|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
170350738|NCT02052778|615624396|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
170350739|NCT02052778|615624397|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
170350740|NCT02052778|615624398|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
170350741|NCT02052778|615624399|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
170350742|NCT02052778|615624400|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
170350743|NCT02052778|615624401|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
170350744|NCT02052778|615624402|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
170350745|NCT02052778|615624403|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
170350746|NCT02052778|615624404|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
170350747|NCT02052778|615624405|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
170350748|NCT02052778|615624406|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
170350749|NCT02052778|615624407|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
170350750|NCT02052778|615624408|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
170350751|NCT02052778|615624409|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
170350752|NCT02052778|615624410|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
170350753|NCT02052778|615624411|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
170350754|NCT02052778|615624389|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350755|NCT02052778|615624390|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350756|NCT02052778|615624391|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350757|NCT02052778|615624392|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350758|NCT02052778|615624393|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350759|NCT02052778|615624394|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350760|NCT02052778|615624395|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350761|NCT02052778|615624396|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350762|NCT02052778|615624397|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
170350763|NCT02052778|615624398|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350764|NCT02052778|615624399|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350765|NCT02052778|615624400|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350766|NCT02052778|615624401|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350767|NCT02052778|615624402|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
170350768|NCT02052778|615624403|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350769|NCT02052778|615624404|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350770|NCT02052778|615624405|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350771|NCT02052778|615624406|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350772|NCT02052778|615624407|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350773|NCT02052778|615624408|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350774|NCT02052778|615624409|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350775|NCT02052778|615624410|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350776|NCT02052778|615624411|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
170350777|NCT02052778|615624389|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350778|NCT02052778|615624390|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350779|NCT02052778|615624391|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350780|NCT02052778|615624392|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350781|NCT02052778|615624393|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350782|NCT02052778|615624394|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
170350783|NCT02052778|615624395|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350784|NCT02052778|615624396|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350785|NCT02052778|615624397|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350786|NCT02052778|615624398|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350787|NCT02052778|615624399|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350788|NCT02052778|615624400|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350789|NCT02052778|615624401|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
170350790|NCT02052778|615624402|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350791|NCT02052778|615624403|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350792|NCT02052778|615624404|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350793|NCT02052778|615624405|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350794|NCT02052778|615624406|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350795|NCT02052778|615624407|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350796|NCT02052778|615624408|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350797|NCT02052778|615624409|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350798|NCT02052778|615624410|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350799|NCT02052778|615624411|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
170350800|NCT02052778|615624389|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350801|NCT02052778|615624390|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350802|NCT02052778|615624391|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350803|NCT02052778|615624392|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350804|NCT02052778|615624393|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350805|NCT02052778|615624394|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350806|NCT02052778|615624395|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350807|NCT02052778|615624396|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350808|NCT02052778|615624397|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350809|NCT02052778|615624398|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350810|NCT02052778|615624399|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350811|NCT02052778|615624400|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350812|NCT02052778|615624401|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350813|NCT02052778|615624402|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350814|NCT02052778|615624403|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
170350815|NCT02052778|615624404|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
170350816|NCT02052778|615624405|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
170350817|NCT02052778|615624406|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
170350818|NCT02052778|615624407|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
170350819|NCT02052778|615624408|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
170350820|NCT02052778|615624409|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
170350821|NCT02052778|615624410|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
170350822|NCT02052778|615624411|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
170350823|NCT02052778|615624389|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350824|NCT02052778|615624390|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350825|NCT02052778|615624391|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350826|NCT02052778|615624392|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350827|NCT02052778|615624393|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350828|NCT02052778|615624394|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350829|NCT02052778|615624395|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350830|NCT02052778|615624396|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350831|NCT02052778|615624397|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350832|NCT02052778|615624398|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350833|NCT02052778|615624399|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350834|NCT02052778|615624400|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350835|NCT02052778|615624401|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350836|NCT02052778|615624402|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350837|NCT02052778|615624403|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
170350838|NCT02052778|615624404|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
170350839|NCT02052778|615624405|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350840|NCT02052778|615624406|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
170350841|NCT02052778|615624407|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
170350842|NCT02052778|615624408|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
170350843|NCT02052778|615624409|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
170350844|NCT02052778|615624410|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
170350845|NCT02052778|615624411|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
170350846|NCT02052778|615624389|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350847|NCT02052778|615624390|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350848|NCT02052778|615624391|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350849|NCT02052778|615624392|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350850|NCT02052778|615624393|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350851|NCT02052778|615624394|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350852|NCT02052778|615624395|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350853|NCT02052778|615624396|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350854|NCT02052778|615624397|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350855|NCT02052778|615624398|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350856|NCT02052778|615624399|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350857|NCT02052778|615624400|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350858|NCT02052778|615624401|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350859|NCT02052778|615624402|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350860|NCT02052778|615624403|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
170350861|NCT02052778|615624404|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
170350862|NCT02052778|615624405|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
170350863|NCT02052778|615624406|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350864|NCT02052778|615624407|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
170350865|NCT02052778|615624408|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
170350866|NCT02052778|615624409|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350867|NCT02052778|615624410|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350868|NCT02052778|615624411|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
170350869|NCT02052778|615624389|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350870|NCT02052778|615624390|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350871|NCT02052778|615624391|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350872|NCT02052778|615624392|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350873|NCT02052778|615624393|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350874|NCT02052778|615624394|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350875|NCT02052778|615624395|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350876|NCT02052778|615624396|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350877|NCT02052778|615624397|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350878|NCT02052778|615624398|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350879|NCT02052778|615624399|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350880|NCT02052778|615624400|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350881|NCT02052778|615624401|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350882|NCT02052778|615624402|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350883|NCT02052778|615624403|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
170350884|NCT02052778|615624404|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
170350885|NCT02052778|615624405|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350886|NCT02052778|615624406|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350887|NCT02052778|615624407|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350888|NCT02052778|615624408|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350889|NCT02052778|615624409|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350890|NCT02052778|615624410|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350891|NCT02052778|615624411|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
170350892|NCT02052778|615624389|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350893|NCT02052778|615624390|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350894|NCT02052778|615624391|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350895|NCT02052778|615624392|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350896|NCT02052778|615624393|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350897|NCT02052778|615624394|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350898|NCT02052778|615624395|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350899|NCT02052778|615624396|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350900|NCT02052778|615624397|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350901|NCT02052778|615624398|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350902|NCT02052778|615624399|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350903|NCT02052778|615624400|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350904|NCT02052778|615624401|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350905|NCT02052778|615624402|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350906|NCT02052778|615624403|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
170350907|NCT02052778|615624404|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
170350908|NCT02052778|615624405|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350909|NCT02052778|615624406|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350910|NCT02052778|615624407|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350911|NCT02052778|615624408|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
170350912|NCT02052778|615624409|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350913|NCT02052778|615624410|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350914|NCT02052778|615624411|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
170350915|NCT02052778|615624389|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
170350916|NCT02052778|615624390|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
170350917|NCT02052778|615624391|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
170350918|NCT02052778|615624392|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
170350919|NCT02052778|615624393|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
170350920|NCT02052778|615624394|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
170350921|NCT02052778|615624395|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
170350922|NCT02052778|615624396|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
170350923|NCT02052778|615624397|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
170350924|NCT02052778|615624398|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
170350925|NCT02052778|615624399|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
170350926|NCT02052778|615624400|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
170350927|NCT02052778|615624401|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
170350928|NCT02052778|615624402|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
170350929|NCT02052778|615624403|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
170350930|NCT02052778|615624404|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
170350931|NCT02052778|615624405|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
170350932|NCT02052778|615624406|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
170350933|NCT02052778|615624407|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
170350934|NCT02052778|615624408|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
170350935|NCT02052778|615624409|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
170350936|NCT02052778|615624410|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
170350937|NCT02052778|615624411|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
170350938|NCT02052778|615624389|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350939|NCT02052778|615624390|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350940|NCT02052778|615624391|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350941|NCT02052778|615624392|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350942|NCT02052778|615624393|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350943|NCT02052778|615624394|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350944|NCT02052778|615624395|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350945|NCT02052778|615624396|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350946|NCT02052778|615624397|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350947|NCT02052778|615624398|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350948|NCT02052778|615624399|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350949|NCT02052778|615624400|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350950|NCT02052778|615624401|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350951|NCT02052778|615624402|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350952|NCT02052778|615624403|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
170350953|NCT02052778|615624404|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
170350954|NCT02052778|615624405|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
170350955|NCT02052778|615624406|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350956|NCT02052778|615624407|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
170350957|NCT02052778|615624408|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350958|NCT02052778|615624409|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350959|NCT02052778|615624410|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350960|NCT02052778|615624411|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
170350961|NCT02052778|615624389|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350962|NCT02052778|615624390|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350963|NCT02052778|615624391|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350964|NCT02052778|615624392|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350965|NCT02052778|615624393|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350966|NCT02052778|615624394|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350967|NCT02052778|615624395|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350968|NCT02052778|615624396|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350969|NCT02052778|615624397|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350970|NCT02052778|615624398|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350971|NCT02052778|615624399|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350972|NCT02052778|615624400|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350973|NCT02052778|615624401|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350974|NCT02052778|615624402|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350975|NCT02052778|615624403|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350976|NCT02052778|615624404|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350977|NCT02052778|615624405|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350978|NCT02052778|615624406|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350979|NCT02052778|615624407|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350980|NCT02052778|615624408|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350981|NCT02052778|615624409|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350982|NCT02052778|615624410|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
170350983|NCT02052778|615624411|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
170350984|NCT02052778|615624389|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350985|NCT02052778|615624390|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350986|NCT02052778|615624391|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350987|NCT02052778|615624392|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350988|NCT02052778|615624393|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350989|NCT02052778|615624394|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350990|NCT02052778|615624395|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350991|NCT02052778|615624396|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350992|NCT02052778|615624397|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350993|NCT02052778|615624398|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350994|NCT02052778|615624399|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350995|NCT02052778|615624400|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350996|NCT02052778|615624401|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350997|NCT02052778|615624402|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350998|NCT02052778|615624403|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170350999|NCT02052778|615624404|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170351000|NCT02052778|615624405|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170351001|NCT02052778|615624406|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170351002|NCT02052778|615624407|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170351003|NCT02052778|615624408|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170351004|NCT02052778|615624409|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170351005|NCT02052778|615624410|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
170351006|NCT02052778|615624411|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
170351007|NCT02052778|615624389|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351008|NCT02052778|615624390|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351009|NCT02052778|615624391|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351010|NCT02052778|615624392|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351011|NCT02052778|615624393|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351012|NCT02052778|615624394|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351013|NCT02052778|615624395|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351014|NCT02052778|615624396|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351015|NCT02052778|615624397|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351016|NCT02052778|615624398|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351017|NCT02052778|615624399|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351018|NCT02052778|615624400|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351019|NCT02052778|615624401|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351020|NCT02052778|615624402|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351021|NCT02052778|615624403|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351022|NCT02052778|615624404|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351023|NCT02052778|615624405|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351024|NCT02052778|615624406|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351025|NCT02052778|615624407|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351026|NCT02052778|615624408|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351027|NCT02052778|615624409|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351028|NCT02052778|615624410|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
170351029|NCT02052778|615624411|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
170351030|NCT02052778|615624389|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351031|NCT02052778|615624390|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351032|NCT02052778|615624391|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351033|NCT02052778|615624392|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351034|NCT02052778|615624393|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351035|NCT02052778|615624394|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351036|NCT02052778|615624395|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351037|NCT02052778|615624396|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351038|NCT02052778|615624397|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351039|NCT02052778|615624398|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351040|NCT02052778|615624399|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351041|NCT02052778|615624400|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351042|NCT02052778|615624401|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351043|NCT02052778|615624402|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351044|NCT02052778|615624403|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351045|NCT02052778|615624404|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351046|NCT02052778|615624405|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351047|NCT02052778|615624406|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351048|NCT02052778|615624407|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351049|NCT02052778|615624408|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351050|NCT02052778|615624409|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351051|NCT02052778|615624410|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
170351052|NCT02052778|615624411|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
170351053|NCT02052778|615624389|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351054|NCT02052778|615624390|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351055|NCT02052778|615624391|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351056|NCT02052778|615624392|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351057|NCT02052778|615624393|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351058|NCT02052778|615624394|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351059|NCT02052778|615624395|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351060|NCT02052778|615624396|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351061|NCT02052778|615624397|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351062|NCT02052778|615624398|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351063|NCT02052778|615624399|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351064|NCT02052778|615624400|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351065|NCT02052778|615624401|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351066|NCT02052778|615624402|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351067|NCT02052778|615624403|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351068|NCT02052778|615624404|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351069|NCT02052778|615624405|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351070|NCT02052778|615624406|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351071|NCT02052778|615624407|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351072|NCT02052778|615624408|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351073|NCT02052778|615624409|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351074|NCT02052778|615624410|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
170351075|NCT02052778|615624411|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
170351076|NCT02052778|615624389|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
170351077|NCT02052778|615624390|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
170351078|NCT02052778|615624391|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
170351079|NCT02052778|615624392|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
170351080|NCT02052778|615624393|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
170351081|NCT02052778|615624394|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
170351082|NCT02052778|615624395|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
170351083|NCT02052778|615624396|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
170351084|NCT02052778|615624397|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
170351085|NCT02052778|615624398|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
170351086|NCT02052778|615624399|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
170351087|NCT02052778|615624400|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
170351088|NCT02052778|615624401|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
170351089|NCT02052778|615624402|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
170351090|NCT02052778|615624403|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
170351091|NCT02052778|615624404|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
170351092|NCT02052778|615624405|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
170351093|NCT02052778|615624406|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
170351094|NCT02052778|615624407|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
170351095|NCT02052778|615624408|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
170351096|NCT02052778|615624409|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
170351097|NCT02052778|615624410|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
170351098|NCT02052778|615624411|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
170351099|NCT02052778|615624389|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351100|NCT02052778|615624390|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351101|NCT02052778|615624391|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351102|NCT02052778|615624392|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351103|NCT02052778|615624393|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351104|NCT02052778|615624394|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351105|NCT02052778|615624395|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351106|NCT02052778|615624396|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351107|NCT02052778|615624397|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351108|NCT02052778|615624398|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351109|NCT02052778|615624399|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351110|NCT02052778|615624400|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351111|NCT02052778|615624401|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351112|NCT02052778|615624402|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351113|NCT02052778|615624403|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351114|NCT02052778|615624404|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351115|NCT02052778|615624405|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351116|NCT02052778|615624406|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351117|NCT02052778|615624407|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351118|NCT02052778|615624408|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351119|NCT02052778|615624409|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351120|NCT02052778|615624410|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
170351121|NCT02052778|615624411|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
170351122|NCT02883049|615624412|FG000|Induction|Adverse Event|52|||
170351123|NCT02883049|615624413|FG001|Induction|Adverse Event|2|||
170351124|NCT02883049|615624414|FG002|Induction|Adverse Event|0|||
170351125|NCT02883049|615624415|FG003|Induction|Adverse Event|0|||
170351126|NCT02883049|615624416|FG004|Induction|Adverse Event|0|||
170351127|NCT02883049|615624417|FG005|Induction|Adverse Event|0|||
170351128|NCT02883049|615624418|FG006|Induction|Adverse Event|0|||
170351129|NCT02883049|615624419|FG007|Induction|Adverse Event|0|||
170351130|NCT02883049|615624420|FG008|Induction|Adverse Event|0|||
170351131|NCT02883049|615624421|FG009|Induction|Adverse Event|0|||
170351132|NCT02883049|615624422|FG010|Induction|Adverse Event|0|||
170351133|NCT02883049|615624423|FG011|Induction|Adverse Event|0|||
170351134|NCT02883049|615624424|FG012|Induction|Adverse Event|0|||
170351135|NCT02883049|615624425|FG013|Induction|Adverse Event|0|||
170351136|NCT02883049|615624426|FG014|Induction|Adverse Event|0|||
170351137|NCT02883049|615624427|FG015|Induction|Adverse Event|0|||
170351138|NCT02883049|615624412|FG000|Induction|Death|76|||
170351139|NCT02883049|615624413|FG001|Induction|Death|8|||
170351140|NCT02883049|615624414|FG002|Induction|Death|0|||
170351141|NCT02883049|615624415|FG003|Induction|Death|0|||
170351142|NCT02883049|615624416|FG004|Induction|Death|0|||
170351143|NCT02883049|615624417|FG005|Induction|Death|0|||
170351144|NCT02883049|615624418|FG006|Induction|Death|0|||
170351145|NCT02883049|615624419|FG007|Induction|Death|0|||
170351146|NCT02883049|615624420|FG008|Induction|Death|0|||
170351147|NCT02883049|615624421|FG009|Induction|Death|0|||
170351148|NCT02883049|615624422|FG010|Induction|Death|0|||
170351149|NCT02883049|615624423|FG011|Induction|Death|0|||
170351150|NCT02883049|615624424|FG012|Induction|Death|0|||
170351151|NCT02883049|615624425|FG013|Induction|Death|0|||
170351152|NCT02883049|615624426|FG014|Induction|Death|0|||
170351153|NCT02883049|615624427|FG015|Induction|Death|0|||
170351154|NCT02883049|615624412|FG000|Induction|Lost to Follow-up|2|||
170351155|NCT02883049|615624413|FG001|Induction|Lost to Follow-up|0|||
170351156|NCT02883049|615624414|FG002|Induction|Lost to Follow-up|0|||
170351157|NCT02883049|615624415|FG003|Induction|Lost to Follow-up|0|||
170351158|NCT02883049|615624416|FG004|Induction|Lost to Follow-up|0|||
170351159|NCT02883049|615624417|FG005|Induction|Lost to Follow-up|0|||
170351160|NCT02883049|615624418|FG006|Induction|Lost to Follow-up|0|||
170351161|NCT02883049|615624419|FG007|Induction|Lost to Follow-up|0|||
170351162|NCT02883049|615624420|FG008|Induction|Lost to Follow-up|0|||
170351163|NCT02883049|615624421|FG009|Induction|Lost to Follow-up|0|||
170351164|NCT02883049|615624422|FG010|Induction|Lost to Follow-up|0|||
170351165|NCT02883049|615624423|FG011|Induction|Lost to Follow-up|0|||
170351166|NCT02883049|615624424|FG012|Induction|Lost to Follow-up|0|||
170351167|NCT02883049|615624425|FG013|Induction|Lost to Follow-up|0|||
170351168|NCT02883049|615624426|FG014|Induction|Lost to Follow-up|0|||
170351169|NCT02883049|615624427|FG015|Induction|Lost to Follow-up|0|||
170351170|NCT02883049|615624412|FG000|Induction|Physician Decision|1407|||
170351171|NCT02883049|615624413|FG001|Induction|Physician Decision|8|||
170351172|NCT02883049|615624414|FG002|Induction|Physician Decision|0|||
170351173|NCT02883049|615624415|FG003|Induction|Physician Decision|0|||
170351174|NCT02883049|615624416|FG004|Induction|Physician Decision|0|||
170351175|NCT02883049|615624417|FG005|Induction|Physician Decision|0|||
170351176|NCT02883049|615624418|FG006|Induction|Physician Decision|0|||
170351177|NCT02883049|615624419|FG007|Induction|Physician Decision|0|||
170351178|NCT02883049|615624420|FG008|Induction|Physician Decision|0|||
170351179|NCT02883049|615624421|FG009|Induction|Physician Decision|0|||
170351180|NCT02883049|615624422|FG010|Induction|Physician Decision|0|||
170351181|NCT02883049|615624423|FG011|Induction|Physician Decision|0|||
170351182|NCT02883049|615624424|FG012|Induction|Physician Decision|0|||
170351183|NCT02883049|615624425|FG013|Induction|Physician Decision|0|||
170351184|NCT02883049|615624426|FG014|Induction|Physician Decision|0|||
170351185|NCT02883049|615624427|FG015|Induction|Physician Decision|0|||
170351186|NCT02883049|615624412|FG000|Induction|Protocol Violation|6|||
170351187|NCT02883049|615624413|FG001|Induction|Protocol Violation|0|||
170351188|NCT02883049|615624414|FG002|Induction|Protocol Violation|0|||
170351189|NCT02883049|615624415|FG003|Induction|Protocol Violation|0|||
170351190|NCT02883049|615624416|FG004|Induction|Protocol Violation|0|||
170351191|NCT02883049|615624417|FG005|Induction|Protocol Violation|0|||
170351192|NCT02883049|615624418|FG006|Induction|Protocol Violation|0|||
170351193|NCT02883049|615624419|FG007|Induction|Protocol Violation|0|||
170351194|NCT02883049|615624420|FG008|Induction|Protocol Violation|0|||
170351195|NCT02883049|615624421|FG009|Induction|Protocol Violation|0|||
170351196|NCT02883049|615624422|FG010|Induction|Protocol Violation|0|||
170351197|NCT02883049|615624423|FG011|Induction|Protocol Violation|0|||
170351198|NCT02883049|615624424|FG012|Induction|Protocol Violation|0|||
170351199|NCT02883049|615624425|FG013|Induction|Protocol Violation|0|||
170351200|NCT02883049|615624426|FG014|Induction|Protocol Violation|0|||
170351201|NCT02883049|615624427|FG015|Induction|Protocol Violation|0|||
170351202|NCT02883049|615624412|FG000|Induction|Withdrawal by Subject|6|||
170351203|NCT02883049|615624413|FG001|Induction|Withdrawal by Subject|0|||
170351204|NCT02883049|615624414|FG002|Induction|Withdrawal by Subject|0|||
170351205|NCT02883049|615624415|FG003|Induction|Withdrawal by Subject|0|||
170351206|NCT02883049|615624416|FG004|Induction|Withdrawal by Subject|0|||
170351207|NCT02883049|615624417|FG005|Induction|Withdrawal by Subject|0|||
170351208|NCT02883049|615624418|FG006|Induction|Withdrawal by Subject|0|||
170351209|NCT02883049|615624419|FG007|Induction|Withdrawal by Subject|0|||
170351210|NCT02883049|615624420|FG008|Induction|Withdrawal by Subject|0|||
170351211|NCT02883049|615624421|FG009|Induction|Withdrawal by Subject|0|||
170351212|NCT02883049|615624422|FG010|Induction|Withdrawal by Subject|0|||
170351213|NCT02883049|615624423|FG011|Induction|Withdrawal by Subject|0|||
170351214|NCT02883049|615624424|FG012|Induction|Withdrawal by Subject|0|||
170351215|NCT02883049|615624425|FG013|Induction|Withdrawal by Subject|0|||
170351216|NCT02883049|615624426|FG014|Induction|Withdrawal by Subject|0|||
170351217|NCT02883049|615624427|FG015|Induction|Withdrawal by Subject|0|||
170351218|NCT02883049|615624412|FG000|Induction|Ineligible|35|||
170351219|NCT02883049|615624413|FG001|Induction|Ineligible|1|||
170351220|NCT02883049|615624414|FG002|Induction|Ineligible|0|||
170351221|NCT02883049|615624415|FG003|Induction|Ineligible|0|||
170351222|NCT02883049|615624416|FG004|Induction|Ineligible|0|||
170351223|NCT02883049|615624417|FG005|Induction|Ineligible|0|||
170351224|NCT02883049|615624418|FG006|Induction|Ineligible|0|||
170351225|NCT02883049|615624419|FG007|Induction|Ineligible|0|||
170351226|NCT02883049|615624420|FG008|Induction|Ineligible|0|||
170351227|NCT02883049|615624421|FG009|Induction|Ineligible|0|||
170351228|NCT02883049|615624422|FG010|Induction|Ineligible|0|||
170351229|NCT02883049|615624423|FG011|Induction|Ineligible|0|||
170351230|NCT02883049|615624424|FG012|Induction|Ineligible|0|||
170351231|NCT02883049|615624425|FG013|Induction|Ineligible|0|||
170351232|NCT02883049|615624426|FG014|Induction|Ineligible|0|||
170351233|NCT02883049|615624427|FG015|Induction|Ineligible|0|||
170351234|NCT02883049|615624412|FG000|Induction|Refusal of further protocol therapy|466|||
170351235|NCT02883049|615624413|FG001|Induction|Refusal of further protocol therapy|2|||
170351236|NCT02883049|615624414|FG002|Induction|Refusal of further protocol therapy|0|||
170351237|NCT02883049|615624415|FG003|Induction|Refusal of further protocol therapy|0|||
170351238|NCT02883049|615624416|FG004|Induction|Refusal of further protocol therapy|0|||
170351239|NCT02883049|615624417|FG005|Induction|Refusal of further protocol therapy|0|||
170351240|NCT02883049|615624418|FG006|Induction|Refusal of further protocol therapy|0|||
170351241|NCT02883049|615624419|FG007|Induction|Refusal of further protocol therapy|0|||
170351242|NCT02883049|615624420|FG008|Induction|Refusal of further protocol therapy|0|||
170351243|NCT02883049|615624421|FG009|Induction|Refusal of further protocol therapy|0|||
170351244|NCT02883049|615624422|FG010|Induction|Refusal of further protocol therapy|0|||
170351245|NCT02883049|615624423|FG011|Induction|Refusal of further protocol therapy|0|||
170351246|NCT02883049|615624424|FG012|Induction|Refusal of further protocol therapy|0|||
170351247|NCT02883049|615624425|FG013|Induction|Refusal of further protocol therapy|0|||
170351248|NCT02883049|615624426|FG014|Induction|Refusal of further protocol therapy|0|||
170351249|NCT02883049|615624427|FG015|Induction|Refusal of further protocol therapy|0|||
170351250|NCT02883049|615624412|FG000|Induction|Identified as Ph+ patients|279|||
170351251|NCT02883049|615624413|FG001|Induction|Identified as Ph+ patients|1|||
170351252|NCT02883049|615624414|FG002|Induction|Identified as Ph+ patients|0|||
170351253|NCT02883049|615624415|FG003|Induction|Identified as Ph+ patients|0|||
170351254|NCT02883049|615624416|FG004|Induction|Identified as Ph+ patients|0|||
170351255|NCT02883049|615624417|FG005|Induction|Identified as Ph+ patients|0|||
170351256|NCT02883049|615624418|FG006|Induction|Identified as Ph+ patients|0|||
170351257|NCT02883049|615624419|FG007|Induction|Identified as Ph+ patients|0|||
170351258|NCT02883049|615624420|FG008|Induction|Identified as Ph+ patients|0|||
170351259|NCT02883049|615624421|FG009|Induction|Identified as Ph+ patients|0|||
170351260|NCT02883049|615624422|FG010|Induction|Identified as Ph+ patients|0|||
170351261|NCT02883049|615624423|FG011|Induction|Identified as Ph+ patients|0|||
170351262|NCT02883049|615624424|FG012|Induction|Identified as Ph+ patients|0|||
170351263|NCT02883049|615624425|FG013|Induction|Identified as Ph+ patients|0|||
170351264|NCT02883049|615624426|FG014|Induction|Identified as Ph+ patients|0|||
170351265|NCT02883049|615624427|FG015|Induction|Identified as Ph+ patients|0|||
170351266|NCT02883049|615624412|FG000|Induction|M3 Marrow at Day29|8|||
170351267|NCT02883049|615624413|FG001|Induction|M3 Marrow at Day29|1|||
170351268|NCT02883049|615624414|FG002|Induction|M3 Marrow at Day29|0|||
170351269|NCT02883049|615624415|FG003|Induction|M3 Marrow at Day29|0|||
170351270|NCT02883049|615624416|FG004|Induction|M3 Marrow at Day29|0|||
170351271|NCT02883049|615624417|FG005|Induction|M3 Marrow at Day29|0|||
170351272|NCT02883049|615624418|FG006|Induction|M3 Marrow at Day29|0|||
170351273|NCT02883049|615624419|FG007|Induction|M3 Marrow at Day29|0|||
170351274|NCT02883049|615624420|FG008|Induction|M3 Marrow at Day29|0|||
170351275|NCT02883049|615624421|FG009|Induction|M3 Marrow at Day29|0|||
170351276|NCT02883049|615624422|FG010|Induction|M3 Marrow at Day29|0|||
170351277|NCT02883049|615624423|FG011|Induction|M3 Marrow at Day29|0|||
170351278|NCT02883049|615624424|FG012|Induction|M3 Marrow at Day29|0|||
170351279|NCT02883049|615624425|FG013|Induction|M3 Marrow at Day29|0|||
170351280|NCT02883049|615624426|FG014|Induction|M3 Marrow at Day29|0|||
170351281|NCT02883049|615624427|FG015|Induction|M3 Marrow at Day29|0|||
170351282|NCT02883049|615624412|FG000|Induction|Inevaluable|33|||
170351283|NCT02883049|615624413|FG001|Induction|Inevaluable|1|||
170351284|NCT02883049|615624414|FG002|Induction|Inevaluable|0|||
170351285|NCT02883049|615624415|FG003|Induction|Inevaluable|0|||
170351286|NCT02883049|615624416|FG004|Induction|Inevaluable|0|||
170351287|NCT02883049|615624417|FG005|Induction|Inevaluable|0|||
170351288|NCT02883049|615624418|FG006|Induction|Inevaluable|0|||
170351289|NCT02883049|615624419|FG007|Induction|Inevaluable|0|||
170351290|NCT02883049|615624420|FG008|Induction|Inevaluable|0|||
170351291|NCT02883049|615624421|FG009|Induction|Inevaluable|0|||
170351292|NCT02883049|615624422|FG010|Induction|Inevaluable|0|||
170351293|NCT02883049|615624423|FG011|Induction|Inevaluable|0|||
170351294|NCT02883049|615624424|FG012|Induction|Inevaluable|0|||
170351295|NCT02883049|615624425|FG013|Induction|Inevaluable|0|||
170351296|NCT02883049|615624426|FG014|Induction|Inevaluable|0|||
170351297|NCT02883049|615624427|FG015|Induction|Inevaluable|0|||
170351298|NCT02883049|615624412|FG000|Induction|Identified as VHR at end of Induction|244|||
170351299|NCT02883049|615624413|FG001|Induction|Identified as VHR at end of Induction|0|||
170351300|NCT02883049|615624414|FG002|Induction|Identified as VHR at end of Induction|0|||
170351301|NCT02883049|615624415|FG003|Induction|Identified as VHR at end of Induction|0|||
170351302|NCT02883049|615624416|FG004|Induction|Identified as VHR at end of Induction|0|||
170351303|NCT02883049|615624417|FG005|Induction|Identified as VHR at end of Induction|0|||
170351304|NCT02883049|615624418|FG006|Induction|Identified as VHR at end of Induction|0|||
170351305|NCT02883049|615624419|FG007|Induction|Identified as VHR at end of Induction|0|||
170351306|NCT02883049|615624420|FG008|Induction|Identified as VHR at end of Induction|0|||
170351307|NCT02883049|615624421|FG009|Induction|Identified as VHR at end of Induction|0|||
170351308|NCT02883049|615624422|FG010|Induction|Identified as VHR at end of Induction|0|||
170351309|NCT02883049|615624423|FG011|Induction|Identified as VHR at end of Induction|0|||
170351310|NCT02883049|615624424|FG012|Induction|Identified as VHR at end of Induction|0|||
170351311|NCT02883049|615624425|FG013|Induction|Identified as VHR at end of Induction|0|||
170351312|NCT02883049|615624426|FG014|Induction|Identified as VHR at end of Induction|0|||
170351313|NCT02883049|615624427|FG015|Induction|Identified as VHR at end of Induction|0|||
170351314|NCT02883049|615624412|FG000|Induction|Moved to another non-COG institution|3|||
170351315|NCT02883049|615624413|FG001|Induction|Moved to another non-COG institution|0|||
170351316|NCT02883049|615624414|FG002|Induction|Moved to another non-COG institution|0|||
170351317|NCT02883049|615624415|FG003|Induction|Moved to another non-COG institution|0|||
170351318|NCT02883049|615624416|FG004|Induction|Moved to another non-COG institution|0|||
170351319|NCT02883049|615624417|FG005|Induction|Moved to another non-COG institution|0|||
170351320|NCT02883049|615624418|FG006|Induction|Moved to another non-COG institution|0|||
170351321|NCT02883049|615624419|FG007|Induction|Moved to another non-COG institution|0|||
170351322|NCT02883049|615624420|FG008|Induction|Moved to another non-COG institution|0|||
170351323|NCT02883049|615624421|FG009|Induction|Moved to another non-COG institution|0|||
170351324|NCT02883049|615624422|FG010|Induction|Moved to another non-COG institution|0|||
170351325|NCT02883049|615624423|FG011|Induction|Moved to another non-COG institution|0|||
170351326|NCT02883049|615624424|FG012|Induction|Moved to another non-COG institution|0|||
170351327|NCT02883049|615624425|FG013|Induction|Moved to another non-COG institution|0|||
170351328|NCT02883049|615624426|FG014|Induction|Moved to another non-COG institution|0|||
170351329|NCT02883049|615624427|FG015|Induction|Moved to another non-COG institution|0|||
170351330|NCT02883049|615624412|FG000|Induction|Randomization closed|41|||
170351331|NCT02883049|615624413|FG001|Induction|Randomization closed|0|||
170351332|NCT02883049|615624414|FG002|Induction|Randomization closed|0|||
170351333|NCT02883049|615624415|FG003|Induction|Randomization closed|0|||
170351334|NCT02883049|615624416|FG004|Induction|Randomization closed|0|||
170351335|NCT02883049|615624417|FG005|Induction|Randomization closed|0|||
170351336|NCT02883049|615624418|FG006|Induction|Randomization closed|0|||
170351337|NCT02883049|615624419|FG007|Induction|Randomization closed|0|||
170351338|NCT02883049|615624420|FG008|Induction|Randomization closed|0|||
170351339|NCT02883049|615624421|FG009|Induction|Randomization closed|0|||
170351340|NCT02883049|615624422|FG010|Induction|Randomization closed|0|||
170351341|NCT02883049|615624423|FG011|Induction|Randomization closed|0|||
170351342|NCT02883049|615624424|FG012|Induction|Randomization closed|0|||
170351343|NCT02883049|615624425|FG013|Induction|Randomization closed|0|||
170351344|NCT02883049|615624426|FG014|Induction|Randomization closed|0|||
170351345|NCT02883049|615624427|FG015|Induction|Randomization closed|0|||
170351346|NCT02883049|615624412|FG000|Induction|MRD negative|36|||
170351347|NCT02883049|615624413|FG001|Induction|MRD negative|0|||
170351348|NCT02883049|615624414|FG002|Induction|MRD negative|0|||
170351349|NCT02883049|615624415|FG003|Induction|MRD negative|0|||
170351350|NCT02883049|615624416|FG004|Induction|MRD negative|0|||
170351351|NCT02883049|615624417|FG005|Induction|MRD negative|0|||
170351352|NCT02883049|615624418|FG006|Induction|MRD negative|0|||
170351353|NCT02883049|615624419|FG007|Induction|MRD negative|0|||
170351354|NCT02883049|615624420|FG008|Induction|MRD negative|0|||
170351355|NCT02883049|615624421|FG009|Induction|MRD negative|0|||
170351356|NCT02883049|615624422|FG010|Induction|MRD negative|0|||
170351357|NCT02883049|615624423|FG011|Induction|MRD negative|0|||
170351358|NCT02883049|615624424|FG012|Induction|MRD negative|0|||
170351359|NCT02883049|615624425|FG013|Induction|MRD negative|0|||
170351360|NCT02883049|615624426|FG014|Induction|MRD negative|0|||
170351361|NCT02883049|615624427|FG015|Induction|MRD negative|0|||
170351362|NCT02883049|615624412|FG000|Induction|Identified as HR patients|165|||
170351363|NCT02883049|615624413|FG001|Induction|Identified as HR patients|0|||
170351364|NCT02883049|615624414|FG002|Induction|Identified as HR patients|0|||
170351365|NCT02883049|615624415|FG003|Induction|Identified as HR patients|0|||
170351366|NCT02883049|615624416|FG004|Induction|Identified as HR patients|0|||
170351367|NCT02883049|615624417|FG005|Induction|Identified as HR patients|0|||
170351368|NCT02883049|615624418|FG006|Induction|Identified as HR patients|0|||
170351369|NCT02883049|615624419|FG007|Induction|Identified as HR patients|0|||
170351370|NCT02883049|615624420|FG008|Induction|Identified as HR patients|0|||
170351371|NCT02883049|615624421|FG009|Induction|Identified as HR patients|0|||
170351372|NCT02883049|615624422|FG010|Induction|Identified as HR patients|0|||
170351373|NCT02883049|615624423|FG011|Induction|Identified as HR patients|0|||
170351374|NCT02883049|615624424|FG012|Induction|Identified as HR patients|0|||
170351375|NCT02883049|615624425|FG013|Induction|Identified as HR patients|0|||
170351376|NCT02883049|615624426|FG014|Induction|Identified as HR patients|0|||
170351377|NCT02883049|615624427|FG015|Induction|Identified as HR patients|0|||
170351378|NCT02883049|615624412|FG000|Induction|Developed SMN|0|||
170351379|NCT02883049|615624413|FG001|Induction|Developed SMN|1|||
170351380|NCT02883049|615624414|FG002|Induction|Developed SMN|0|||
170351381|NCT02883049|615624415|FG003|Induction|Developed SMN|0|||
170351382|NCT02883049|615624416|FG004|Induction|Developed SMN|0|||
170351383|NCT02883049|615624417|FG005|Induction|Developed SMN|0|||
170351384|NCT02883049|615624418|FG006|Induction|Developed SMN|0|||
170351385|NCT02883049|615624419|FG007|Induction|Developed SMN|0|||
170351386|NCT02883049|615624420|FG008|Induction|Developed SMN|0|||
170351387|NCT02883049|615624421|FG009|Induction|Developed SMN|0|||
170351388|NCT02883049|615624422|FG010|Induction|Developed SMN|0|||
170351389|NCT02883049|615624423|FG011|Induction|Developed SMN|0|||
170351390|NCT02883049|615624424|FG012|Induction|Developed SMN|0|||
170351391|NCT02883049|615624425|FG013|Induction|Developed SMN|0|||
170351392|NCT02883049|615624426|FG014|Induction|Developed SMN|0|||
170351393|NCT02883049|615624427|FG015|Induction|Developed SMN|0|||
170351394|NCT02883049|615624412|FG000|Induction|Enrolled onto another COG study|72|||
170351395|NCT02883049|615624413|FG001|Induction|Enrolled onto another COG study|0|||
170351396|NCT02883049|615624414|FG002|Induction|Enrolled onto another COG study|0|||
170351397|NCT02883049|615624415|FG003|Induction|Enrolled onto another COG study|0|||
170351398|NCT02883049|615624416|FG004|Induction|Enrolled onto another COG study|0|||
170351399|NCT02883049|615624417|FG005|Induction|Enrolled onto another COG study|0|||
170351400|NCT02883049|615624418|FG006|Induction|Enrolled onto another COG study|0|||
170351401|NCT02883049|615624419|FG007|Induction|Enrolled onto another COG study|0|||
170351402|NCT02883049|615624420|FG008|Induction|Enrolled onto another COG study|0|||
170351403|NCT02883049|615624421|FG009|Induction|Enrolled onto another COG study|0|||
170351404|NCT02883049|615624422|FG010|Induction|Enrolled onto another COG study|0|||
170351405|NCT02883049|615624423|FG011|Induction|Enrolled onto another COG study|0|||
170351406|NCT02883049|615624424|FG012|Induction|Enrolled onto another COG study|0|||
170351407|NCT02883049|615624425|FG013|Induction|Enrolled onto another COG study|0|||
170351408|NCT02883049|615624426|FG014|Induction|Enrolled onto another COG study|0|||
170351409|NCT02883049|615624427|FG015|Induction|Enrolled onto another COG study|0|||
170351410|NCT02883049|615624412|FG000|Induction|Incomplete induction data|17|||
170351411|NCT02883049|615624413|FG001|Induction|Incomplete induction data|0|||
170351412|NCT02883049|615624414|FG002|Induction|Incomplete induction data|0|||
170351413|NCT02883049|615624415|FG003|Induction|Incomplete induction data|0|||
170351414|NCT02883049|615624416|FG004|Induction|Incomplete induction data|0|||
170351415|NCT02883049|615624417|FG005|Induction|Incomplete induction data|0|||
170351416|NCT02883049|615624418|FG006|Induction|Incomplete induction data|0|||
170351417|NCT02883049|615624419|FG007|Induction|Incomplete induction data|0|||
170351418|NCT02883049|615624420|FG008|Induction|Incomplete induction data|0|||
170351419|NCT02883049|615624421|FG009|Induction|Incomplete induction data|0|||
170351420|NCT02883049|615624422|FG010|Induction|Incomplete induction data|0|||
170351421|NCT02883049|615624423|FG011|Induction|Incomplete induction data|0|||
170351422|NCT02883049|615624424|FG012|Induction|Incomplete induction data|0|||
170351423|NCT02883049|615624425|FG013|Induction|Incomplete induction data|0|||
170351424|NCT02883049|615624426|FG014|Induction|Incomplete induction data|0|||
170351425|NCT02883049|615624427|FG015|Induction|Incomplete induction data|0|||
170351426|NCT02883049|615624412|FG000|Post Induction|Adverse Event|0|||
170351427|NCT02883049|615624413|FG001|Post Induction|Adverse Event|0|||
170351428|NCT02883049|615624414|FG002|Post Induction|Adverse Event|0|||
170351429|NCT02883049|615624415|FG003|Post Induction|Adverse Event|7|||
170351430|NCT02883049|615624416|FG004|Post Induction|Adverse Event|8|||
170351431|NCT02883049|615624417|FG005|Post Induction|Adverse Event|3|||
170351432|NCT02883049|615624418|FG006|Post Induction|Adverse Event|4|||
170351433|NCT02883049|615624419|FG007|Post Induction|Adverse Event|5|||
170351434|NCT02883049|615624420|FG008|Post Induction|Adverse Event|6|||
170351435|NCT02883049|615624421|FG009|Post Induction|Adverse Event|7|||
170351436|NCT02883049|615624422|FG010|Post Induction|Adverse Event|2|||
170351437|NCT02883049|615624423|FG011|Post Induction|Adverse Event|2|||
170351438|NCT02883049|615624424|FG012|Post Induction|Adverse Event|0|||
170351439|NCT02883049|615624425|FG013|Post Induction|Adverse Event|0|||
170351440|NCT02883049|615624426|FG014|Post Induction|Adverse Event|5|||
170351441|NCT02883049|615624427|FG015|Post Induction|Adverse Event|2|||
170351442|NCT02883049|615624412|FG000|Post Induction|Death|0|||
170351443|NCT02883049|615624413|FG001|Post Induction|Death|0|||
170351444|NCT02883049|615624414|FG002|Post Induction|Death|0|||
170351445|NCT02883049|615624415|FG003|Post Induction|Death|9|||
170351446|NCT02883049|615624416|FG004|Post Induction|Death|9|||
170351447|NCT02883049|615624417|FG005|Post Induction|Death|0|||
170351448|NCT02883049|615624418|FG006|Post Induction|Death|1|||
170351449|NCT02883049|615624419|FG007|Post Induction|Death|6|||
170351450|NCT02883049|615624420|FG008|Post Induction|Death|5|||
170351451|NCT02883049|615624421|FG009|Post Induction|Death|3|||
170351452|NCT02883049|615624422|FG010|Post Induction|Death|1|||
170351453|NCT02883049|615624423|FG011|Post Induction|Death|0|||
170351454|NCT02883049|615624424|FG012|Post Induction|Death|1|||
170351455|NCT02883049|615624425|FG013|Post Induction|Death|1|||
170351456|NCT02883049|615624426|FG014|Post Induction|Death|10|||
170351457|NCT02883049|615624427|FG015|Post Induction|Death|2|||
170351458|NCT02883049|615624412|FG000|Post Induction|Lost to Follow-up|0|||
170351459|NCT02883049|615624413|FG001|Post Induction|Lost to Follow-up|0|||
170351460|NCT02883049|615624414|FG002|Post Induction|Lost to Follow-up|0|||
170351461|NCT02883049|615624415|FG003|Post Induction|Lost to Follow-up|0|||
170351462|NCT02883049|615624416|FG004|Post Induction|Lost to Follow-up|1|||
170351463|NCT02883049|615624417|FG005|Post Induction|Lost to Follow-up|1|||
170351464|NCT02883049|615624418|FG006|Post Induction|Lost to Follow-up|0|||
170351465|NCT02883049|615624419|FG007|Post Induction|Lost to Follow-up|0|||
170351466|NCT02883049|615624420|FG008|Post Induction|Lost to Follow-up|3|||
170351467|NCT02883049|615624421|FG009|Post Induction|Lost to Follow-up|0|||
170351468|NCT02883049|615624422|FG010|Post Induction|Lost to Follow-up|1|||
170351469|NCT02883049|615624423|FG011|Post Induction|Lost to Follow-up|0|||
170351470|NCT02883049|615624424|FG012|Post Induction|Lost to Follow-up|0|||
170351471|NCT02883049|615624425|FG013|Post Induction|Lost to Follow-up|0|||
170351472|NCT02883049|615624426|FG014|Post Induction|Lost to Follow-up|0|||
170351473|NCT02883049|615624427|FG015|Post Induction|Lost to Follow-up|0|||
170351474|NCT02883049|615624412|FG000|Post Induction|Physician Decision|0|||
170351475|NCT02883049|615624413|FG001|Post Induction|Physician Decision|0|||
170351476|NCT02883049|615624414|FG002|Post Induction|Physician Decision|0|||
170351477|NCT02883049|615624415|FG003|Post Induction|Physician Decision|27|||
170351478|NCT02883049|615624416|FG004|Post Induction|Physician Decision|27|||
170351479|NCT02883049|615624417|FG005|Post Induction|Physician Decision|23|||
170351480|NCT02883049|615624418|FG006|Post Induction|Physician Decision|30|||
170351481|NCT02883049|615624419|FG007|Post Induction|Physician Decision|56|||
170351482|NCT02883049|615624420|FG008|Post Induction|Physician Decision|85|||
170351483|NCT02883049|615624421|FG009|Post Induction|Physician Decision|12|||
170351484|NCT02883049|615624422|FG010|Post Induction|Physician Decision|5|||
170351485|NCT02883049|615624423|FG011|Post Induction|Physician Decision|14|||
170351486|NCT02883049|615624424|FG012|Post Induction|Physician Decision|1|||
170351487|NCT02883049|615624425|FG013|Post Induction|Physician Decision|11|||
170351488|NCT02883049|615624426|FG014|Post Induction|Physician Decision|19|||
170351489|NCT02883049|615624427|FG015|Post Induction|Physician Decision|5|||
170351490|NCT02883049|615624412|FG000|Post Induction|Protocol Violation|0|||
170351491|NCT02883049|615624413|FG001|Post Induction|Protocol Violation|0|||
170351492|NCT02883049|615624414|FG002|Post Induction|Protocol Violation|0|||
170351493|NCT02883049|615624415|FG003|Post Induction|Protocol Violation|0|||
170351494|NCT02883049|615624416|FG004|Post Induction|Protocol Violation|0|||
170351495|NCT02883049|615624417|FG005|Post Induction|Protocol Violation|0|||
170351496|NCT02883049|615624418|FG006|Post Induction|Protocol Violation|0|||
170351497|NCT02883049|615624419|FG007|Post Induction|Protocol Violation|1|||
170351498|NCT02883049|615624420|FG008|Post Induction|Protocol Violation|0|||
170351499|NCT02883049|615624421|FG009|Post Induction|Protocol Violation|0|||
170351500|NCT02883049|615624422|FG010|Post Induction|Protocol Violation|0|||
170351501|NCT02883049|615624423|FG011|Post Induction|Protocol Violation|0|||
170351502|NCT02883049|615624424|FG012|Post Induction|Protocol Violation|0|||
170351503|NCT02883049|615624425|FG013|Post Induction|Protocol Violation|0|||
170351504|NCT02883049|615624426|FG014|Post Induction|Protocol Violation|0|||
170351505|NCT02883049|615624427|FG015|Post Induction|Protocol Violation|0|||
170351506|NCT02883049|615624412|FG000|Post Induction|Withdrawal by Subject|0|||
170351507|NCT02883049|615624413|FG001|Post Induction|Withdrawal by Subject|0|||
170351508|NCT02883049|615624414|FG002|Post Induction|Withdrawal by Subject|0|||
170351509|NCT02883049|615624415|FG003|Post Induction|Withdrawal by Subject|5|||
170351510|NCT02883049|615624416|FG004|Post Induction|Withdrawal by Subject|2|||
170351511|NCT02883049|615624417|FG005|Post Induction|Withdrawal by Subject|1|||
170351512|NCT02883049|615624418|FG006|Post Induction|Withdrawal by Subject|0|||
170351513|NCT02883049|615624419|FG007|Post Induction|Withdrawal by Subject|0|||
170351514|NCT02883049|615624420|FG008|Post Induction|Withdrawal by Subject|2|||
170351515|NCT02883049|615624421|FG009|Post Induction|Withdrawal by Subject|0|||
170351516|NCT02883049|615624422|FG010|Post Induction|Withdrawal by Subject|1|||
170351517|NCT02883049|615624423|FG011|Post Induction|Withdrawal by Subject|1|||
170351518|NCT02883049|615624424|FG012|Post Induction|Withdrawal by Subject|0|||
170351519|NCT02883049|615624425|FG013|Post Induction|Withdrawal by Subject|0|||
170351520|NCT02883049|615624426|FG014|Post Induction|Withdrawal by Subject|1|||
170351521|NCT02883049|615624427|FG015|Post Induction|Withdrawal by Subject|0|||
170351522|NCT02883049|615624412|FG000|Post Induction|Ineligible|0|||
170351523|NCT02883049|615624413|FG001|Post Induction|Ineligible|0|||
170351524|NCT02883049|615624414|FG002|Post Induction|Ineligible|2|||
170351525|NCT02883049|615624415|FG003|Post Induction|Ineligible|0|||
170351526|NCT02883049|615624416|FG004|Post Induction|Ineligible|0|||
170351527|NCT02883049|615624417|FG005|Post Induction|Ineligible|0|||
170351528|NCT02883049|615624418|FG006|Post Induction|Ineligible|1|||
170351529|NCT02883049|615624419|FG007|Post Induction|Ineligible|0|||
170351530|NCT02883049|615624420|FG008|Post Induction|Ineligible|0|||
170351531|NCT02883049|615624421|FG009|Post Induction|Ineligible|0|||
170351532|NCT02883049|615624422|FG010|Post Induction|Ineligible|1|||
170351533|NCT02883049|615624423|FG011|Post Induction|Ineligible|0|||
170351534|NCT02883049|615624424|FG012|Post Induction|Ineligible|0|||
170351535|NCT02883049|615624425|FG013|Post Induction|Ineligible|0|||
170351536|NCT02883049|615624426|FG014|Post Induction|Ineligible|0|||
170351537|NCT02883049|615624427|FG015|Post Induction|Ineligible|1|||
170351538|NCT02883049|615624412|FG000|Post Induction|Refusal of further protocol therapy|0|||
170351539|NCT02883049|615624413|FG001|Post Induction|Refusal of further protocol therapy|0|||
170351540|NCT02883049|615624414|FG002|Post Induction|Refusal of further protocol therapy|0|||
170351541|NCT02883049|615624415|FG003|Post Induction|Refusal of further protocol therapy|11|||
170351542|NCT02883049|615624416|FG004|Post Induction|Refusal of further protocol therapy|15|||
170351543|NCT02883049|615624417|FG005|Post Induction|Refusal of further protocol therapy|9|||
170351544|NCT02883049|615624418|FG006|Post Induction|Refusal of further protocol therapy|13|||
170351545|NCT02883049|615624419|FG007|Post Induction|Refusal of further protocol therapy|5|||
170351546|NCT02883049|615624420|FG008|Post Induction|Refusal of further protocol therapy|21|||
170351547|NCT02883049|615624421|FG009|Post Induction|Refusal of further protocol therapy|7|||
170351548|NCT02883049|615624422|FG010|Post Induction|Refusal of further protocol therapy|0|||
170351549|NCT02883049|615624423|FG011|Post Induction|Refusal of further protocol therapy|7|||
170351550|NCT02883049|615624424|FG012|Post Induction|Refusal of further protocol therapy|3|||
170351551|NCT02883049|615624425|FG013|Post Induction|Refusal of further protocol therapy|0|||
170351552|NCT02883049|615624426|FG014|Post Induction|Refusal of further protocol therapy|4|||
170351553|NCT02883049|615624427|FG015|Post Induction|Refusal of further protocol therapy|1|||
170351554|NCT02883049|615624412|FG000|Post Induction|Inevaluable|0|||
170351555|NCT02883049|615624413|FG001|Post Induction|Inevaluable|0|||
170351556|NCT02883049|615624414|FG002|Post Induction|Inevaluable|0|||
170351557|NCT02883049|615624415|FG003|Post Induction|Inevaluable|1|||
170351558|NCT02883049|615624416|FG004|Post Induction|Inevaluable|1|||
170351559|NCT02883049|615624417|FG005|Post Induction|Inevaluable|2|||
170351560|NCT02883049|615624418|FG006|Post Induction|Inevaluable|7|||
170351561|NCT02883049|615624419|FG007|Post Induction|Inevaluable|6|||
170351562|NCT02883049|615624420|FG008|Post Induction|Inevaluable|4|||
170351563|NCT02883049|615624421|FG009|Post Induction|Inevaluable|4|||
170351564|NCT02883049|615624422|FG010|Post Induction|Inevaluable|1|||
170351565|NCT02883049|615624423|FG011|Post Induction|Inevaluable|1|||
170351566|NCT02883049|615624424|FG012|Post Induction|Inevaluable|2|||
170351567|NCT02883049|615624425|FG013|Post Induction|Inevaluable|0|||
170351568|NCT02883049|615624426|FG014|Post Induction|Inevaluable|0|||
170351569|NCT02883049|615624427|FG015|Post Induction|Inevaluable|1|||
170351570|NCT02883049|615624412|FG000|Post Induction|Moved to another non-COG institution|0|||
170351571|NCT02883049|615624413|FG001|Post Induction|Moved to another non-COG institution|0|||
170351572|NCT02883049|615624414|FG002|Post Induction|Moved to another non-COG institution|0|||
170351573|NCT02883049|615624415|FG003|Post Induction|Moved to another non-COG institution|0|||
170351574|NCT02883049|615624416|FG004|Post Induction|Moved to another non-COG institution|0|||
170351575|NCT02883049|615624417|FG005|Post Induction|Moved to another non-COG institution|0|||
170351576|NCT02883049|615624418|FG006|Post Induction|Moved to another non-COG institution|0|||
170351577|NCT02883049|615624419|FG007|Post Induction|Moved to another non-COG institution|2|||
170351578|NCT02883049|615624420|FG008|Post Induction|Moved to another non-COG institution|2|||
170351579|NCT02883049|615624421|FG009|Post Induction|Moved to another non-COG institution|0|||
170351580|NCT02883049|615624422|FG010|Post Induction|Moved to another non-COG institution|0|||
170351581|NCT02883049|615624423|FG011|Post Induction|Moved to another non-COG institution|1|||
170351582|NCT02883049|615624424|FG012|Post Induction|Moved to another non-COG institution|0|||
170351583|NCT02883049|615624425|FG013|Post Induction|Moved to another non-COG institution|0|||
170351584|NCT02883049|615624426|FG014|Post Induction|Moved to another non-COG institution|0|||
170351585|NCT02883049|615624427|FG015|Post Induction|Moved to another non-COG institution|0|||
170351586|NCT02883049|615624412|FG000|Post Induction|Randomization closed|0|||
170351587|NCT02883049|615624413|FG001|Post Induction|Randomization closed|0|||
170351588|NCT02883049|615624414|FG002|Post Induction|Randomization closed|0|||
170351589|NCT02883049|615624415|FG003|Post Induction|Randomization closed|0|||
170351590|NCT02883049|615624416|FG004|Post Induction|Randomization closed|0|||
170351591|NCT02883049|615624417|FG005|Post Induction|Randomization closed|0|||
170351592|NCT02883049|615624418|FG006|Post Induction|Randomization closed|0|||
170351593|NCT02883049|615624419|FG007|Post Induction|Randomization closed|20|||
170351594|NCT02883049|615624420|FG008|Post Induction|Randomization closed|0|||
170351595|NCT02883049|615624421|FG009|Post Induction|Randomization closed|0|||
170351596|NCT02883049|615624422|FG010|Post Induction|Randomization closed|0|||
170351597|NCT02883049|615624423|FG011|Post Induction|Randomization closed|0|||
170351598|NCT02883049|615624424|FG012|Post Induction|Randomization closed|0|||
170351599|NCT02883049|615624425|FG013|Post Induction|Randomization closed|0|||
170351600|NCT02883049|615624426|FG014|Post Induction|Randomization closed|0|||
170351601|NCT02883049|615624427|FG015|Post Induction|Randomization closed|0|||
170351602|NCT02883049|615624412|FG000|Post Induction|MRD negative|0|||
170351603|NCT02883049|615624413|FG001|Post Induction|MRD negative|0|||
170351604|NCT02883049|615624414|FG002|Post Induction|MRD negative|0|||
170351605|NCT02883049|615624415|FG003|Post Induction|MRD negative|0|||
170351606|NCT02883049|615624416|FG004|Post Induction|MRD negative|0|||
170351607|NCT02883049|615624417|FG005|Post Induction|MRD negative|0|||
170351608|NCT02883049|615624418|FG006|Post Induction|MRD negative|0|||
170351609|NCT02883049|615624419|FG007|Post Induction|MRD negative|11|||
170351610|NCT02883049|615624420|FG008|Post Induction|MRD negative|0|||
170351611|NCT02883049|615624421|FG009|Post Induction|MRD negative|0|||
170351612|NCT02883049|615624422|FG010|Post Induction|MRD negative|0|||
170351613|NCT02883049|615624423|FG011|Post Induction|MRD negative|0|||
170351614|NCT02883049|615624424|FG012|Post Induction|MRD negative|0|||
170351615|NCT02883049|615624425|FG013|Post Induction|MRD negative|0|||
170351616|NCT02883049|615624426|FG014|Post Induction|MRD negative|0|||
170351617|NCT02883049|615624427|FG015|Post Induction|MRD negative|0|||
170351618|NCT02883049|615624412|FG000|Post Induction|Developed SMN|0|||
170351619|NCT02883049|615624413|FG001|Post Induction|Developed SMN|0|||
170351620|NCT02883049|615624414|FG002|Post Induction|Developed SMN|0|||
170351621|NCT02883049|615624415|FG003|Post Induction|Developed SMN|0|||
170351622|NCT02883049|615624416|FG004|Post Induction|Developed SMN|1|||
170351623|NCT02883049|615624417|FG005|Post Induction|Developed SMN|0|||
170351624|NCT02883049|615624418|FG006|Post Induction|Developed SMN|1|||
170351625|NCT02883049|615624419|FG007|Post Induction|Developed SMN|0|||
170351626|NCT02883049|615624420|FG008|Post Induction|Developed SMN|0|||
170351627|NCT02883049|615624421|FG009|Post Induction|Developed SMN|0|||
170351628|NCT02883049|615624422|FG010|Post Induction|Developed SMN|1|||
170351629|NCT02883049|615624423|FG011|Post Induction|Developed SMN|1|||
170351630|NCT02883049|615624424|FG012|Post Induction|Developed SMN|0|||
170351631|NCT02883049|615624425|FG013|Post Induction|Developed SMN|0|||
170351632|NCT02883049|615624426|FG014|Post Induction|Developed SMN|1|||
170351633|NCT02883049|615624427|FG015|Post Induction|Developed SMN|0|||
170351634|NCT02883049|615624412|FG000|Post Induction|Enrolled onto another COG study|0|||
170351635|NCT02883049|615624413|FG001|Post Induction|Enrolled onto another COG study|0|||
170351636|NCT02883049|615624414|FG002|Post Induction|Enrolled onto another COG study|0|||
170351637|NCT02883049|615624415|FG003|Post Induction|Enrolled onto another COG study|1|||
170351638|NCT02883049|615624416|FG004|Post Induction|Enrolled onto another COG study|1|||
170351639|NCT02883049|615624417|FG005|Post Induction|Enrolled onto another COG study|0|||
170351640|NCT02883049|615624418|FG006|Post Induction|Enrolled onto another COG study|0|||
170351641|NCT02883049|615624419|FG007|Post Induction|Enrolled onto another COG study|4|||
170351642|NCT02883049|615624420|FG008|Post Induction|Enrolled onto another COG study|0|||
170351643|NCT02883049|615624421|FG009|Post Induction|Enrolled onto another COG study|0|||
170351644|NCT02883049|615624422|FG010|Post Induction|Enrolled onto another COG study|0|||
170351645|NCT02883049|615624423|FG011|Post Induction|Enrolled onto another COG study|2|||
170351646|NCT02883049|615624424|FG012|Post Induction|Enrolled onto another COG study|0|||
170351647|NCT02883049|615624425|FG013|Post Induction|Enrolled onto another COG study|1|||
170351648|NCT02883049|615624426|FG014|Post Induction|Enrolled onto another COG study|0|||
170351649|NCT02883049|615624427|FG015|Post Induction|Enrolled onto another COG study|0|||
170351650|NCT02883049|615624412|FG000|Post Induction|Recurrent leukemia|0|||
170351651|NCT02883049|615624413|FG001|Post Induction|Recurrent leukemia|0|||
170351652|NCT02883049|615624414|FG002|Post Induction|Recurrent leukemia|0|||
170351653|NCT02883049|615624415|FG003|Post Induction|Recurrent leukemia|17|||
170351654|NCT02883049|615624416|FG004|Post Induction|Recurrent leukemia|12|||
170351655|NCT02883049|615624417|FG005|Post Induction|Recurrent leukemia|4|||
170351656|NCT02883049|615624418|FG006|Post Induction|Recurrent leukemia|1|||
170351657|NCT02883049|615624419|FG007|Post Induction|Recurrent leukemia|13|||
170351658|NCT02883049|615624420|FG008|Post Induction|Recurrent leukemia|27|||
170351659|NCT02883049|615624421|FG009|Post Induction|Recurrent leukemia|5|||
170351660|NCT02883049|615624422|FG010|Post Induction|Recurrent leukemia|3|||
170351661|NCT02883049|615624423|FG011|Post Induction|Recurrent leukemia|12|||
170351662|NCT02883049|615624424|FG012|Post Induction|Recurrent leukemia|1|||
170351663|NCT02883049|615624425|FG013|Post Induction|Recurrent leukemia|1|||
170351664|NCT02883049|615624426|FG014|Post Induction|Recurrent leukemia|9|||
170351665|NCT02883049|615624427|FG015|Post Induction|Recurrent leukemia|3|||
170351666|NCT02883049|615624412|FG000|Post Induction|Induction Failure|0|||
170351667|NCT02883049|615624413|FG001|Post Induction|Induction Failure|0|||
170351668|NCT02883049|615624414|FG002|Post Induction|Induction Failure|0|||
170351669|NCT02883049|615624415|FG003|Post Induction|Induction Failure|0|||
170351670|NCT02883049|615624416|FG004|Post Induction|Induction Failure|0|||
170351671|NCT02883049|615624417|FG005|Post Induction|Induction Failure|0|||
170351672|NCT02883049|615624418|FG006|Post Induction|Induction Failure|0|||
170351673|NCT02883049|615624419|FG007|Post Induction|Induction Failure|2|||
170351674|NCT02883049|615624420|FG008|Post Induction|Induction Failure|2|||
170351675|NCT02883049|615624421|FG009|Post Induction|Induction Failure|0|||
170351676|NCT02883049|615624422|FG010|Post Induction|Induction Failure|0|||
170351677|NCT02883049|615624423|FG011|Post Induction|Induction Failure|0|||
170351678|NCT02883049|615624424|FG012|Post Induction|Induction Failure|0|||
170351679|NCT02883049|615624425|FG013|Post Induction|Induction Failure|2|||
170351680|NCT02883049|615624426|FG014|Post Induction|Induction Failure|0|||
170351681|NCT02883049|615624427|FG015|Post Induction|Induction Failure|0|||
170351682|NCT03421964|615624428|FG000|Overall Study|Lost to Follow-up|11|||
170351683|NCT03421964|615624429|FG001|Overall Study|Lost to Follow-up|21|||
170351684|NCT03421964|615624428|FG000|Overall Study|Withdrawal by Subject|9|||
170351685|NCT03421964|615624429|FG001|Overall Study|Withdrawal by Subject|3|||
170351686|NCT03421964|615624428|FG000|Overall Study|Incarcerated|1|||
170351687|NCT03421964|615624429|FG001|Overall Study|Incarcerated|0|||
170351688|NCT03421964|615624428|FG000|Overall Study|Inpt Treatment Facility|1|||
170351689|NCT03421964|615624429|FG001|Overall Study|Inpt Treatment Facility|1|||
170351690|NCT03421964|615624428|FG000|Overall Study|Virtual Platform Issues|1|||
170351691|NCT03421964|615624429|FG001|Overall Study|Virtual Platform Issues|1|||
170351692|NCT01911845|615624430|FG000|Overall Study|Adverse Event|2|||
170351693|NCT01911845|615624430|FG000|Overall Study|Lost to Follow-up|1|||
170351694|NCT01911845|615624430|FG000|Overall Study|Other (not specified)|3|||
170351695|NCT01994226|615624431|FG000|Overall Study|Protocol Violation|13|||
170351696|NCT01994226|615624432|FG001|Overall Study|Protocol Violation|10|||
170351697|NCT01994226|615624431|FG000|Overall Study|Early Cessation of treatment|6|||
170351698|NCT01994226|615624432|FG001|Overall Study|Early Cessation of treatment|11|||
170351699|NCT00502320|615624433|FG000|Overall Study|Lost to Follow-up|1|||
170351700|NCT00502320|615624434|FG001|Overall Study|Lost to Follow-up|1|||
170351701|NCT00502320|615624433|FG000|Overall Study|Withdrew Consent|1|||
170351702|NCT00502320|615624434|FG001|Overall Study|Withdrew Consent|0|||
170351703|NCT00502320|615624433|FG000|Overall Study|No longer met criteria|1|||
170351704|NCT00502320|615624434|FG001|Overall Study|No longer met criteria|0|||
170351705|NCT00502320|615624433|FG000|Overall Study|Screen Failure|0|||
170351706|NCT00502320|615624434|FG001|Overall Study|Screen Failure|1|||
170351707|NCT00502320|615624433|FG000|Overall Study|Adverse Event|3|||
170351708|NCT00502320|615624434|FG001|Overall Study|Adverse Event|5|||
170351709|NCT03198754|615624442|FG000|Overall Study|Withdrawal by Subject|5|||
170351710|NCT03198754|615624443|FG001|Overall Study|Withdrawal by Subject|4|||
170351711|NCT03198754|615624442|FG000|Overall Study|Lost to Follow-up|4|||
170351712|NCT03198754|615624443|FG001|Overall Study|Lost to Follow-up|3|||
170351713|NCT03198754|615624442|FG000|Overall Study|Ineligible|2|||
170351714|NCT03198754|615624443|FG001|Overall Study|Ineligible|1|||
170351715|NCT01151579|615624448|FG000|Overall Study|Physician Decision|3|||
170351716|NCT01151579|615624449|FG001|Overall Study|Physician Decision|1|||
170351717|NCT01151579|615624448|FG000|Overall Study|Withdrawal by Subject|3|||
170351718|NCT01151579|615624449|FG001|Overall Study|Withdrawal by Subject|2|||
170351719|NCT01151579|615624448|FG000|Overall Study|Not meet inclusion criteria|6|||
170351720|NCT01151579|615624449|FG001|Overall Study|Not meet inclusion criteria|4|||
170351721|NCT01357915|615624452|FG000|Overall Study|Lost to Follow-up|3|||
170351722|NCT01357915|615624453|FG001|Overall Study|Lost to Follow-up|0|||
170351723|NCT01098461|615624454|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
170351724|NCT01098461|615624455|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
170351725|NCT01098461|615624456|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
170351726|NCT01098461|615624457|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
170351727|NCT01098461|615624454|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
170351728|NCT01098461|615624455|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
170351729|NCT01098461|615624456|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
170351730|NCT01098461|615624457|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
170351731|NCT01098461|615624454|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
170351732|NCT01098461|615624455|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
170351733|NCT01098461|615624456|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
170351734|NCT01098461|615624457|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
170351735|NCT01098461|615624454|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
170351736|NCT01098461|615624455|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
170351737|NCT01098461|615624456|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
170351738|NCT01098461|615624457|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
170351739|NCT01098461|615624454|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
170351740|NCT01098461|615624455|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
170351741|NCT01098461|615624456|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
170351742|NCT01098461|615624457|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
170351743|NCT01098461|615624454|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
170351744|NCT01098461|615624455|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
170351745|NCT01098461|615624456|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
170351746|NCT01098461|615624457|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
170351747|NCT01098461|615624454|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
170351748|NCT01098461|615624455|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
170351749|NCT01098461|615624456|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
170351750|NCT01098461|615624457|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
170351751|NCT02662985|615624458|FG000|Treatment Period 1|Adverse Event|0|||
170351752|NCT02662985|615624459|FG001|Treatment Period 1|Adverse Event|2|||
170351753|NCT02662985|615624458|FG000|Treatment Period 1|Protocol Violation|0|||
170351754|NCT02662985|615624459|FG001|Treatment Period 1|Protocol Violation|1|||
170351755|NCT02662985|615624458|FG000|Treatment Period 1|Physician Decision|1|||
170351756|NCT02662985|615624459|FG001|Treatment Period 1|Physician Decision|0|||
170351757|NCT02662985|615624458|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170351758|NCT02662985|615624459|FG001|Treatment Period 1|Withdrawal by Subject|1|||
170351759|NCT02662985|615624458|FG000|Treatment Period 2|Lack of Efficacy|0|||
170351760|NCT02662985|615624459|FG001|Treatment Period 2|Lack of Efficacy|1|||
170351761|NCT02662985|615624458|FG000|Treatment Period 2|Lost to Follow-up|1|||
170351762|NCT02662985|615624459|FG001|Treatment Period 2|Lost to Follow-up|0|||
170351763|NCT02662985|615624458|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
170351764|NCT02662985|615624459|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
170351765|NCT02662985|615624458|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
170351766|NCT02662985|615624459|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
170351767|NCT02662985|615624458|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
170351768|NCT02662985|615624459|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
170351769|NCT02662985|615624458|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
170351770|NCT02662985|615624459|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
170351771|NCT02662985|615624458|FG000|Treatment Period 3 (Extension Period)|Death|0|||
170351772|NCT02662985|615624459|FG001|Treatment Period 3 (Extension Period)|Death|1|||
170351773|NCT01153763|615624460|FG000|Overall Study|Study Closed|16|||
170351774|NCT01153763|615624460|FG000|Overall Study|Lost to Follow-up|1|||
170351775|NCT01153763|615624460|FG000|Overall Study|Physician Decision|2|||
170351776|NCT01153763|615624460|FG000|Overall Study|Withdrawal by Subject|2|||
170351777|NCT05373706|615624465|FG000|Overall Study|Lost to Follow-up|2|||
170351778|NCT05373706|615624466|FG001|Overall Study|Lost to Follow-up|2|||
170351779|NCT03633227|615624467|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
170351780|NCT03633227|615624468|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
170351781|NCT03633227|615624467|FG000|Double Blind (DB), up to Week 48|Death|2|||
170351782|NCT03633227|615624468|FG001|Double Blind (DB), up to Week 48|Death|1|||
170351783|NCT03633227|615624467|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
170351784|NCT03633227|615624468|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
170351785|NCT03633227|615624467|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
170351786|NCT03633227|615624468|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
170351787|NCT03633227|615624467|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
170351788|NCT03633227|615624468|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
170351789|NCT03633227|615624467|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
170351790|NCT03633227|615624468|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
170351791|NCT03633227|615624467|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
170351792|NCT03633227|615624468|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
170351793|NCT03633227|615624467|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
170351794|NCT03633227|615624468|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
170351795|NCT03633227|615624467|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
170351796|NCT03633227|615624468|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
170351797|NCT03633227|615624467|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
170351798|NCT03633227|615624468|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
170351799|NCT03633227|615624467|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
170351800|NCT03633227|615624468|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
170351801|NCT03633227|615624467|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
170351802|NCT03633227|615624468|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
170351803|NCT01766336|615624476|FG000|Overall Study|Adverse Event|11|||
170351804|NCT01766336|615624477|FG001|Overall Study|Adverse Event|8|||
170351805|NCT01766336|615624476|FG000|Overall Study|Death|4|||
170351806|NCT01766336|615624477|FG001|Overall Study|Death|3|||
170351807|NCT01766336|615624476|FG000|Overall Study|Lost to Follow-up|1|||
170351808|NCT01766336|615624477|FG001|Overall Study|Lost to Follow-up|3|||
170351809|NCT01766336|615624476|FG000|Overall Study|Physician Decision|4|||
170351810|NCT01766336|615624477|FG001|Overall Study|Physician Decision|2|||
170351811|NCT01766336|615624476|FG000|Overall Study|Protocol Violation|0|||
170351812|NCT01766336|615624477|FG001|Overall Study|Protocol Violation|1|||
170351813|NCT01766336|615624476|FG000|Overall Study|Sponsor Decision|52|||
170351814|NCT01766336|615624477|FG001|Overall Study|Sponsor Decision|43|||
170351815|NCT01766336|615624476|FG000|Overall Study|Withdrawal by Subject|18|||
170351816|NCT01766336|615624477|FG001|Overall Study|Withdrawal by Subject|15|||
170351817|NCT03029650|615624478|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
170351818|NCT03029650|615624479|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
170351819|NCT03029650|615624478|FG000|Washout (1 Week)|Physician Decision|0|||
170351820|NCT03029650|615624479|FG001|Washout (1 Week)|Physician Decision|1|||
170351821|NCT01479374|615624481|FG000|Overall Study|Adverse Event|2|||
170351822|NCT01479374|615624482|FG001|Overall Study|Adverse Event|1|||
170351823|NCT01479374|615624483|FG002|Overall Study|Adverse Event|0|||
170351824|NCT01479374|615624481|FG000|Overall Study|Lost to Follow-up|1|||
170351825|NCT01479374|615624482|FG001|Overall Study|Lost to Follow-up|2|||
170351826|NCT01479374|615624483|FG002|Overall Study|Lost to Follow-up|0|||
170351827|NCT01479374|615624481|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
170351828|NCT01479374|615624482|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
170351829|NCT01479374|615624483|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
170351830|NCT01479374|615624481|FG000|Overall Study|Other|0|||
170351831|NCT01479374|615624482|FG001|Overall Study|Other|4|||
170351832|NCT01479374|615624483|FG002|Overall Study|Other|5|||
170351833|NCT01606761|615624484|FG000|Prior to Week 24|Lost to Follow-up|0|||
170351834|NCT01606761|615624485|FG001|Prior to Week 24|Lost to Follow-up|3|||
170351835|NCT01606761|615624486|FG002|Prior to Week 24|Lost to Follow-up|2|||
170351836|NCT01606761|615624487|FG003|Prior to Week 24|Lost to Follow-up|0|||
170351837|NCT01606761|615624488|FG004|Prior to Week 24|Lost to Follow-up|0|||
170351838|NCT01606761|615624484|FG000|Prior to Week 24|Withdrawal by Subject|12|||
170351839|NCT01606761|615624485|FG001|Prior to Week 24|Withdrawal by Subject|10|||
170351840|NCT01606761|615624486|FG002|Prior to Week 24|Withdrawal by Subject|9|||
170351841|NCT01606761|615624487|FG003|Prior to Week 24|Withdrawal by Subject|0|||
170351842|NCT01606761|615624488|FG004|Prior to Week 24|Withdrawal by Subject|0|||
170351843|NCT01606761|615624484|FG000|Prior to Week 24|Adverse Event|11|||
170351844|NCT01606761|615624485|FG001|Prior to Week 24|Adverse Event|18|||
170351845|NCT01606761|615624486|FG002|Prior to Week 24|Adverse Event|22|||
170351846|NCT01606761|615624487|FG003|Prior to Week 24|Adverse Event|0|||
170351847|NCT01606761|615624488|FG004|Prior to Week 24|Adverse Event|0|||
170351848|NCT01606761|615624484|FG000|Prior to Week 24|Lack of Efficacy|15|||
170351849|NCT01606761|615624485|FG001|Prior to Week 24|Lack of Efficacy|14|||
170351850|NCT01606761|615624486|FG002|Prior to Week 24|Lack of Efficacy|8|||
170351851|NCT01606761|615624487|FG003|Prior to Week 24|Lack of Efficacy|0|||
170351852|NCT01606761|615624488|FG004|Prior to Week 24|Lack of Efficacy|0|||
170351853|NCT01606761|615624484|FG000|Prior to Week 24|Physician Decision|0|||
170351854|NCT01606761|615624485|FG001|Prior to Week 24|Physician Decision|3|||
170351855|NCT01606761|615624486|FG002|Prior to Week 24|Physician Decision|1|||
170351856|NCT01606761|615624487|FG003|Prior to Week 24|Physician Decision|0|||
170351857|NCT01606761|615624488|FG004|Prior to Week 24|Physician Decision|0|||
170351858|NCT01606761|615624484|FG000|Prior to Week 24|Other|4|||
170351859|NCT01606761|615624485|FG001|Prior to Week 24|Other|7|||
170351860|NCT01606761|615624486|FG002|Prior to Week 24|Other|5|||
170351861|NCT01606761|615624487|FG003|Prior to Week 24|Other|0|||
170351862|NCT01606761|615624488|FG004|Prior to Week 24|Other|0|||
170351863|NCT01606761|615624484|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
170351864|NCT01606761|615624485|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
170351865|NCT01606761|615624486|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
170351866|NCT01606761|615624487|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
170351867|NCT01606761|615624488|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
170351868|NCT01606761|615624484|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
170351869|NCT01606761|615624485|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
170351870|NCT01606761|615624486|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
170351871|NCT01606761|615624487|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
170351872|NCT01606761|615624488|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
170351873|NCT01606761|615624484|FG000|Week 24 to Week 52|Adverse Event|0|||
170351874|NCT01606761|615624485|FG001|Week 24 to Week 52|Adverse Event|11|||
170351875|NCT01606761|615624486|FG002|Week 24 to Week 52|Adverse Event|14|||
170351876|NCT01606761|615624487|FG003|Week 24 to Week 52|Adverse Event|3|||
170351877|NCT01606761|615624488|FG004|Week 24 to Week 52|Adverse Event|15|||
170351878|NCT01606761|615624484|FG000|Week 24 to Week 52|Death|0|||
170351879|NCT01606761|615624485|FG001|Week 24 to Week 52|Death|0|||
170351880|NCT01606761|615624486|FG002|Week 24 to Week 52|Death|2|||
170351881|NCT01606761|615624487|FG003|Week 24 to Week 52|Death|1|||
170351882|NCT01606761|615624488|FG004|Week 24 to Week 52|Death|0|||
170351883|NCT01606761|615624484|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
170351884|NCT01606761|615624485|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
170351885|NCT01606761|615624486|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
170351886|NCT01606761|615624487|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
170351887|NCT01606761|615624488|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
170351888|NCT01606761|615624484|FG000|Week 24 to Week 52|Physician Decision|0|||
170351889|NCT01606761|615624485|FG001|Week 24 to Week 52|Physician Decision|1|||
170351890|NCT01606761|615624486|FG002|Week 24 to Week 52|Physician Decision|1|||
170351891|NCT01606761|615624487|FG003|Week 24 to Week 52|Physician Decision|0|||
170351892|NCT01606761|615624488|FG004|Week 24 to Week 52|Physician Decision|0|||
170351893|NCT01606761|615624484|FG000|Week 24 to Week 52|Other|0|||
170351894|NCT01606761|615624485|FG001|Week 24 to Week 52|Other|1|||
170351895|NCT01606761|615624486|FG002|Week 24 to Week 52|Other|5|||
170351896|NCT01606761|615624487|FG003|Week 24 to Week 52|Other|2|||
170351897|NCT01606761|615624488|FG004|Week 24 to Week 52|Other|2|||
170351898|NCT01606761|615624484|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
170351899|NCT01606761|615624485|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
170351900|NCT01606761|615624486|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
170351901|NCT01606761|615624487|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
170351902|NCT01606761|615624488|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
170351903|NCT01606761|615624484|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
170351904|NCT01606761|615624485|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
170351905|NCT01606761|615624486|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
170351906|NCT01606761|615624487|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
170351907|NCT01606761|615624488|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
170351908|NCT01606761|615624484|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
170351909|NCT01606761|615624485|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
170351910|NCT01606761|615624486|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
170351911|NCT01606761|615624487|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
170351912|NCT01606761|615624488|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
170351913|NCT01606761|615624484|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
170351914|NCT01606761|615624485|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
170351915|NCT01606761|615624486|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
170351916|NCT01606761|615624487|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
170351917|NCT01606761|615624488|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
170351918|NCT05086289|615624489|FG000|Overall Study|Adverse Event|4|||
170351919|NCT05086289|615624490|FG001|Overall Study|Adverse Event|2|||
170351920|NCT05086289|615624489|FG000|Overall Study|Lost to Follow-up|2|||
170351921|NCT05086289|615624490|FG001|Overall Study|Lost to Follow-up|0|||
170351922|NCT05086289|615624489|FG000|Overall Study|Non-compliance with study drug|2|||
170351923|NCT05086289|615624490|FG001|Overall Study|Non-compliance with study drug|1|||
170351924|NCT05086289|615624489|FG000|Overall Study|Physician Decision|2|||
170351925|NCT05086289|615624490|FG001|Overall Study|Physician Decision|0|||
170351926|NCT05086289|615624489|FG000|Overall Study|Withdrawal by Subject|5|||
170351927|NCT05086289|615624490|FG001|Overall Study|Withdrawal by Subject|2|||
170351928|NCT04533815|615624491|FG000|Overall Study|Adverse Event|2|||
170351929|NCT04533815|615624491|FG000|Overall Study|Site withdrew|5|||
170351930|NCT00488592|615624492|FG000|Overall Study|Withdrawal by Subject|1|||
170351931|NCT00488592|615624492|FG000|Overall Study|Disease progression|1|||
170351932|NCT00488592|615624492|FG000|Overall Study|Enrolled but not treated|1|||
170351933|NCT01996748|615624495|FG000|Overall Study|Personal reason|1|||
170351934|NCT01996748|615624496|FG001|Overall Study|Personal reason|0|||
170351935|NCT01996748|615624495|FG000|Overall Study|Physician Decision|2|||
170351936|NCT01996748|615624496|FG001|Overall Study|Physician Decision|0|||
170351937|NCT01996748|615624495|FG000|Overall Study|Adverse Event|1|||
170351938|NCT01996748|615624496|FG001|Overall Study|Adverse Event|4|||
170351939|NCT01996748|615624495|FG000|Overall Study|Withdrawal by Subject|0|||
170351940|NCT01996748|615624496|FG001|Overall Study|Withdrawal by Subject|1|||
170351941|NCT01996748|615624495|FG000|Overall Study|Lost to Follow-up|4|||
170351942|NCT01996748|615624496|FG001|Overall Study|Lost to Follow-up|1|||
170351943|NCT03238235|615624497|FG000|Overall Study|Adverse Event|2|||
170351944|NCT03238235|615624498|FG001|Overall Study|Adverse Event|0|||
170351945|NCT03238235|615624497|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
170351946|NCT03238235|615624498|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
170351947|NCT03855137|615624501|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
170351948|NCT03855137|615624502|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
170351949|NCT03855137|615624503|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
170351950|NCT03855137|615624501|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
170351951|NCT03855137|615624502|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
170351952|NCT03855137|615624503|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
170351953|NCT03855137|615624501|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
170351954|NCT03855137|615624502|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
170351955|NCT03855137|615624503|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
170351956|NCT03855137|615624501|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
170351957|NCT03855137|615624502|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
170351958|NCT03855137|615624503|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
170351959|NCT03855137|615624501|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
170351960|NCT03855137|615624502|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
170351961|NCT03855137|615624503|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
170351962|NCT03855137|615624501|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
170351963|NCT03855137|615624502|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
170351964|NCT03855137|615624503|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
170351965|NCT03855137|615624501|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
170351966|NCT03855137|615624502|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
170351967|NCT03855137|615624503|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
170351968|NCT03855137|615624501|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
170351969|NCT03855137|615624502|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
170351970|NCT03855137|615624503|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
170351971|NCT03855137|615624501|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
170351972|NCT03855137|615624502|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
170351973|NCT03855137|615624503|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
170351974|NCT03855137|615624501|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
170351975|NCT03855137|615624502|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
170351976|NCT03855137|615624503|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
170351977|NCT02635737|615624504|FG000|Overall Study|Protocol Violation|1|||
170351978|NCT04570657|615624505|FG000|Overall Study|Adverse Event|0|||
170351979|NCT04570657|615624506|FG001|Overall Study|Adverse Event|0|||
170351980|NCT04570657|615624507|FG002|Overall Study|Adverse Event|1|||
170351981|NCT04570657|615624505|FG000|Overall Study|Lost to Follow-up|0|||
170351982|NCT04570657|615624506|FG001|Overall Study|Lost to Follow-up|0|||
170351983|NCT04570657|615624507|FG002|Overall Study|Lost to Follow-up|1|||
170351984|NCT04570657|615624505|FG000|Overall Study|Physician Decision|0|||
170351985|NCT04570657|615624506|FG001|Overall Study|Physician Decision|1|||
170351986|NCT04570657|615624507|FG002|Overall Study|Physician Decision|0|||
170351987|NCT04570657|615624505|FG000|Overall Study|Withdrawal by Subject|1|||
170351988|NCT04570657|615624506|FG001|Overall Study|Withdrawal by Subject|2|||
170351989|NCT04570657|615624507|FG002|Overall Study|Withdrawal by Subject|2|||
170351990|NCT02065622|615624508|FG000|Induction Study|Adverse Event|13|||
170351991|NCT02065622|615624509|FG001|Induction Study|Adverse Event|19|||
170351992|NCT02065622|615624510|FG002|Induction Study|Adverse Event|0|||
170351993|NCT02065622|615624511|FG003|Induction Study|Adverse Event|0|||
170351994|NCT02065622|615624512|FG004|Induction Study|Adverse Event|0|||
170351995|NCT02065622|615624508|FG000|Induction Study|Withdrawal by Subject|3|||
170351996|NCT02065622|615624509|FG001|Induction Study|Withdrawal by Subject|5|||
170351997|NCT02065622|615624510|FG002|Induction Study|Withdrawal by Subject|0|||
170351998|NCT02065622|615624511|FG003|Induction Study|Withdrawal by Subject|0|||
170351999|NCT02065622|615624512|FG004|Induction Study|Withdrawal by Subject|0|||
170352000|NCT02065622|615624508|FG000|Induction Study|Lost to Follow-up|1|||
170352001|NCT02065622|615624509|FG001|Induction Study|Lost to Follow-up|0|||
170352002|NCT02065622|615624510|FG002|Induction Study|Lost to Follow-up|0|||
170352003|NCT02065622|615624511|FG003|Induction Study|Lost to Follow-up|0|||
170352004|NCT02065622|615624512|FG004|Induction Study|Lost to Follow-up|0|||
170352005|NCT02065622|615624508|FG000|Induction Study|Lack of Efficacy|22|||
170352006|NCT02065622|615624509|FG001|Induction Study|Lack of Efficacy|27|||
170352007|NCT02065622|615624510|FG002|Induction Study|Lack of Efficacy|0|||
170352008|NCT02065622|615624511|FG003|Induction Study|Lack of Efficacy|0|||
170352009|NCT02065622|615624512|FG004|Induction Study|Lack of Efficacy|0|||
170352010|NCT02065622|615624508|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
170352011|NCT02065622|615624509|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
170352012|NCT02065622|615624510|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
170352013|NCT02065622|615624511|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
170352014|NCT02065622|615624512|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
170352015|NCT02065622|615624508|FG000|Induction Study|Subject Noncompliance|1|||
170352016|NCT02065622|615624509|FG001|Induction Study|Subject Noncompliance|1|||
170352017|NCT02065622|615624510|FG002|Induction Study|Subject Noncompliance|0|||
170352018|NCT02065622|615624511|FG003|Induction Study|Subject Noncompliance|0|||
170352019|NCT02065622|615624512|FG004|Induction Study|Subject Noncompliance|0|||
170352020|NCT02065622|615624508|FG000|Induction Study|Other, Not Specified|3|||
170352021|NCT02065622|615624509|FG001|Induction Study|Other, Not Specified|2|||
170352022|NCT02065622|615624510|FG002|Induction Study|Other, Not Specified|0|||
170352023|NCT02065622|615624511|FG003|Induction Study|Other, Not Specified|0|||
170352024|NCT02065622|615624512|FG004|Induction Study|Other, Not Specified|0|||
170352025|NCT02065622|615624508|FG000|Maintenance Study|Adverse Event|0|||
170352026|NCT02065622|615624509|FG001|Maintenance Study|Adverse Event|0|||
170352027|NCT02065622|615624510|FG002|Maintenance Study|Adverse Event|25|||
170352028|NCT02065622|615624511|FG003|Maintenance Study|Adverse Event|22|||
170352029|NCT02065622|615624512|FG004|Maintenance Study|Adverse Event|11|||
170352030|NCT02065622|615624508|FG000|Maintenance Study|Withdrawal by Subject|0|||
170352031|NCT02065622|615624509|FG001|Maintenance Study|Withdrawal by Subject|0|||
170352032|NCT02065622|615624510|FG002|Maintenance Study|Withdrawal by Subject|11|||
170352033|NCT02065622|615624511|FG003|Maintenance Study|Withdrawal by Subject|5|||
170352034|NCT02065622|615624512|FG004|Maintenance Study|Withdrawal by Subject|7|||
170352035|NCT02065622|615624508|FG000|Maintenance Study|Lost to Follow-up|0|||
170352036|NCT02065622|615624509|FG001|Maintenance Study|Lost to Follow-up|0|||
170352037|NCT02065622|615624510|FG002|Maintenance Study|Lost to Follow-up|4|||
170352038|NCT02065622|615624511|FG003|Maintenance Study|Lost to Follow-up|1|||
170352039|NCT02065622|615624512|FG004|Maintenance Study|Lost to Follow-up|1|||
170352040|NCT02065622|615624508|FG000|Maintenance Study|Lack of Efficacy|0|||
170352041|NCT02065622|615624509|FG001|Maintenance Study|Lack of Efficacy|0|||
170352042|NCT02065622|615624510|FG002|Maintenance Study|Lack of Efficacy|70|||
170352043|NCT02065622|615624511|FG003|Maintenance Study|Lack of Efficacy|55|||
170352044|NCT02065622|615624512|FG004|Maintenance Study|Lack of Efficacy|19|||
170352045|NCT02065622|615624508|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
170352046|NCT02065622|615624509|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
170352047|NCT02065622|615624510|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
170352048|NCT02065622|615624511|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
170352049|NCT02065622|615624512|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
170352050|NCT02065622|615624508|FG000|Maintenance Study|Subject Non-Compliance|0|||
170352051|NCT02065622|615624509|FG001|Maintenance Study|Subject Non-Compliance|0|||
170352052|NCT02065622|615624510|FG002|Maintenance Study|Subject Non-Compliance|1|||
170352053|NCT02065622|615624511|FG003|Maintenance Study|Subject Non-Compliance|3|||
170352054|NCT02065622|615624512|FG004|Maintenance Study|Subject Non-Compliance|2|||
170352055|NCT02065622|615624508|FG000|Maintenance Study|Other, Not Specified|0|||
170352056|NCT02065622|615624509|FG001|Maintenance Study|Other, Not Specified|0|||
170352057|NCT02065622|615624510|FG002|Maintenance Study|Other, Not Specified|6|||
170352058|NCT02065622|615624511|FG003|Maintenance Study|Other, Not Specified|14|||
170352059|NCT02065622|615624512|FG004|Maintenance Study|Other, Not Specified|2|||
170352060|NCT02065622|615624508|FG000|Maintenance Study|Unknown Reason|0|||
170352061|NCT02065622|615624509|FG001|Maintenance Study|Unknown Reason|0|||
170352062|NCT02065622|615624510|FG002|Maintenance Study|Unknown Reason|0|||
170352063|NCT02065622|615624511|FG003|Maintenance Study|Unknown Reason|1|||
170352064|NCT02065622|615624512|FG004|Maintenance Study|Unknown Reason|0|||
170352065|NCT01274338|615626306|FG000|Overall Study|Lack of Efficacy|72|||
170352066|NCT01274338|615626307|FG001|Overall Study|Lack of Efficacy|108|||
170352067|NCT01274338|615626308|FG002|Overall Study|Lack of Efficacy|116|||
170352068|NCT01274338|615626309|FG003|Overall Study|Lack of Efficacy|0|||
170352069|NCT01274338|615626310|FG004|Overall Study|Lack of Efficacy|0|||
170352070|NCT01274338|615626311|FG005|Overall Study|Lack of Efficacy|0|||
170352071|NCT01274338|615626306|FG000|Overall Study|Adverse Event|272|||
170352072|NCT01274338|615626307|FG001|Overall Study|Adverse Event|105|||
170352073|NCT01274338|615626308|FG002|Overall Study|Adverse Event|180|||
170352074|NCT01274338|615626309|FG003|Overall Study|Adverse Event|1|||
170352075|NCT01274338|615626310|FG004|Overall Study|Adverse Event|0|||
170352076|NCT01274338|615626311|FG005|Overall Study|Adverse Event|0|||
170352077|NCT01274338|615626306|FG000|Overall Study|Death|8|||
170352078|NCT01274338|615626307|FG001|Overall Study|Death|1|||
170352079|NCT01274338|615626308|FG002|Overall Study|Death|0|||
170352080|NCT01274338|615626309|FG003|Overall Study|Death|0|||
170352081|NCT01274338|615626310|FG004|Overall Study|Death|0|||
170352082|NCT01274338|615626311|FG005|Overall Study|Death|0|||
170352083|NCT01274338|615626306|FG000|Overall Study|Withdrawal by Subject|27|||
170352084|NCT01274338|615626307|FG001|Overall Study|Withdrawal by Subject|99|||
170352085|NCT01274338|615626308|FG002|Overall Study|Withdrawal by Subject|17|||
170352086|NCT01274338|615626309|FG003|Overall Study|Withdrawal by Subject|0|||
170352087|NCT01274338|615626310|FG004|Overall Study|Withdrawal by Subject|0|||
170352088|NCT01274338|615626311|FG005|Overall Study|Withdrawal by Subject|0|||
170352089|NCT01274338|615626306|FG000|Overall Study|Did not start treatment|8|||
170352090|NCT01274338|615626307|FG001|Overall Study|Did not start treatment|116|||
170352091|NCT01274338|615626308|FG002|Overall Study|Did not start treatment|7|||
170352092|NCT01274338|615626309|FG003|Overall Study|Did not start treatment|0|||
170352093|NCT01274338|615626310|FG004|Overall Study|Did not start treatment|0|||
170352094|NCT01274338|615626311|FG005|Overall Study|Did not start treatment|0|||
170352095|NCT01274338|615626306|FG000|Overall Study|Alternative therapy|0|||
170352096|NCT01274338|615626307|FG001|Overall Study|Alternative therapy|1|||
170352097|NCT01274338|615626308|FG002|Overall Study|Alternative therapy|0|||
170352098|NCT01274338|615626309|FG003|Overall Study|Alternative therapy|0|||
170352099|NCT01274338|615626310|FG004|Overall Study|Alternative therapy|0|||
170352100|NCT01274338|615626311|FG005|Overall Study|Alternative therapy|0|||
170352101|NCT01274338|615626306|FG000|Overall Study|Other complicating diseases|0|||
170352102|NCT01274338|615626307|FG001|Overall Study|Other complicating diseases|3|||
170352103|NCT01274338|615626308|FG002|Overall Study|Other complicating diseases|1|||
170352104|NCT01274338|615626309|FG003|Overall Study|Other complicating diseases|0|||
170352105|NCT01274338|615626310|FG004|Overall Study|Other complicating diseases|0|||
170352106|NCT01274338|615626311|FG005|Overall Study|Other complicating diseases|0|||
170352107|NCT01274338|615626306|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
170352108|NCT01274338|615626307|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
170352109|NCT01274338|615626308|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
170352110|NCT01274338|615626309|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
170352111|NCT01274338|615626310|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
170352112|NCT01274338|615626311|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
170352113|NCT01274338|615626306|FG000|Overall Study|Pregnancy|0|||
170352114|NCT01274338|615626307|FG001|Overall Study|Pregnancy|0|||
170352115|NCT01274338|615626308|FG002|Overall Study|Pregnancy|1|||
170352116|NCT01274338|615626309|FG003|Overall Study|Pregnancy|0|||
170352117|NCT01274338|615626310|FG004|Overall Study|Pregnancy|0|||
170352118|NCT01274338|615626311|FG005|Overall Study|Pregnancy|0|||
170352119|NCT01274338|615626306|FG000|Overall Study|Reason not reported|12|||
170352120|NCT01274338|615626307|FG001|Overall Study|Reason not reported|21|||
170352121|NCT01274338|615626308|FG002|Overall Study|Reason not reported|3|||
170352122|NCT01274338|615626309|FG003|Overall Study|Reason not reported|0|||
170352123|NCT01274338|615626310|FG004|Overall Study|Reason not reported|1|||
170352124|NCT01274338|615626311|FG005|Overall Study|Reason not reported|0|||
170352125|NCT02064205|615626327|FG000|Overall Study|Withdrawal by Subject|1|||
170352126|NCT00111917|615626331|FG000|Overall Study|Withdrawal by Subject|1|||
170352127|NCT00111917|615626332|FG001|Overall Study|Withdrawal by Subject|1|||
170352128|NCT05254613|615626335|FG000|Overall Study|Lost to Follow-up|0|||
170352129|NCT05254613|615626336|FG001|Overall Study|Lost to Follow-up|0|||
170352130|NCT05254613|615626337|FG002|Overall Study|Lost to Follow-up|1|||
170352131|NCT02387372|615626338|FG000|Overall Study|Not Treated|1|||
170352132|NCT02387372|615626339|FG001|Overall Study|Not Treated|0|||
170352133|NCT01205451|615626347|FG000|Overall Study|Lost to Follow-up|1|||
170352134|NCT01205451|615626348|FG001|Overall Study|Lost to Follow-up|1|||
170352135|NCT01205451|615626347|FG000|Overall Study|Withdrawal by Subject|5|||
170352136|NCT01205451|615626348|FG001|Overall Study|Withdrawal by Subject|9|||
170352137|NCT02226146|615626353|FG000|Overall Study|Received rescue therapy|1|||
170352138|NCT02226146|615626353|FG000|Overall Study|Withdrawal by Subject|2|||
170352139|NCT05464836|615626354|FG000|Overall Study|Progression of Disease|1|||
170352140|NCT05464836|615626354|FG000|Overall Study|Physician Decision|1|||
170352141|NCT01522976|615626355|FG000|Overall Study|Ineligible|4|||
170352142|NCT01522976|615626356|FG001|Overall Study|Ineligible|0|||
170352143|NCT01522976|615626357|FG002|Overall Study|Ineligible|1|||
170352144|NCT01522976|615626355|FG000|Overall Study|Death|7|||
170352145|NCT01522976|615626356|FG001|Overall Study|Death|6|||
170352146|NCT01522976|615626357|FG002|Overall Study|Death|2|||
170352147|NCT01522976|615626355|FG000|Overall Study|Still on treatment|9|||
170352148|NCT01522976|615626356|FG001|Overall Study|Still on treatment|9|||
170352149|NCT01522976|615626357|FG002|Overall Study|Still on treatment|6|||
170352150|NCT01522976|615626355|FG000|Overall Study|Disease progression|28|||
170352151|NCT01522976|615626356|FG001|Overall Study|Disease progression|30|||
170352152|NCT01522976|615626357|FG002|Overall Study|Disease progression|25|||
170352153|NCT01522976|615626355|FG000|Overall Study|Adverse Event|17|||
170352154|NCT01522976|615626356|FG001|Overall Study|Adverse Event|7|||
170352155|NCT01522976|615626357|FG002|Overall Study|Adverse Event|18|||
170352156|NCT01522976|615626355|FG000|Overall Study|Refusal unrelated to adverse event|10|||
170352157|NCT01522976|615626356|FG001|Overall Study|Refusal unrelated to adverse event|13|||
170352158|NCT01522976|615626357|FG002|Overall Study|Refusal unrelated to adverse event|14|||
170352159|NCT01522976|615626355|FG000|Overall Study|Not protocol specified|22|||
170352160|NCT01522976|615626356|FG001|Overall Study|Not protocol specified|27|||
170352161|NCT01522976|615626357|FG002|Overall Study|Not protocol specified|27|||
170352162|NCT02938585|615626360|FG000|Overall Study|Withdrawal by parent or guardian|0|||
170352163|NCT02938585|615626361|FG001|Overall Study|Withdrawal by parent or guardian|1|||
170352164|NCT02938585|615626362|FG002|Overall Study|Withdrawal by parent or guardian|0|||
170352165|NCT02938585|615626363|FG003|Overall Study|Withdrawal by parent or guardian|0|||
170352166|NCT02938585|615626360|FG000|Overall Study|Withdrawal by Subject|0|||
170352167|NCT02938585|615626361|FG001|Overall Study|Withdrawal by Subject|0|||
170352168|NCT02938585|615626362|FG002|Overall Study|Withdrawal by Subject|0|||
170352169|NCT02938585|615626363|FG003|Overall Study|Withdrawal by Subject|5|||
170352170|NCT01576016|615626367|FG000|Lead Safety|Death|132|||
170352171|NCT01576016|615626368|FG001|Lead Safety|Death|0|||
170352172|NCT01576016|615626367|FG000|Lead Safety|Withdrawal by Subject|81|||
170352173|NCT01576016|615626368|FG001|Lead Safety|Withdrawal by Subject|0|||
170352174|NCT01576016|615626367|FG000|Lead Safety|System Explanted without Replacement|24|||
170352175|NCT01576016|615626368|FG001|Lead Safety|System Explanted without Replacement|0|||
170352176|NCT01576016|615626367|FG000|Lead Safety|Physician Decision|14|||
170352177|NCT01576016|615626368|FG001|Lead Safety|Physician Decision|0|||
170352178|NCT01576016|615626367|FG000|Lead Safety|Lost to Follow-up|13|||
170352179|NCT01576016|615626368|FG001|Lead Safety|Lost to Follow-up|0|||
170352180|NCT01576016|615626367|FG000|Lead Safety|Unsuccessful implant|2|||
170352181|NCT01576016|615626368|FG001|Lead Safety|Unsuccessful implant|0|||
170352182|NCT01576016|615626367|FG000|Lead Safety|Sponsor request|1|||
170352183|NCT01576016|615626368|FG001|Lead Safety|Sponsor request|0|||
170352184|NCT01576016|615626367|FG000|Lead Safety|Device replaced with CRT-D|1|||
170352185|NCT01576016|615626368|FG001|Lead Safety|Device replaced with CRT-D|0|||
170352186|NCT01576016|615626367|FG000|Lead Safety|Patient on Palliative Care|1|||
170352187|NCT01576016|615626368|FG001|Lead Safety|Patient on Palliative Care|0|||
170352188|NCT01576016|615626367|FG000|Lead Safety|Patient noncompliance|1|||
170352189|NCT01576016|615626368|FG001|Lead Safety|Patient noncompliance|0|||
170352190|NCT01576016|615626367|FG000|Lead Safety|Too far from study site|1|||
170352191|NCT01576016|615626368|FG001|Lead Safety|Too far from study site|0|||
170352192|NCT01576016|615626367|FG000|Lead Safety|System deactivated|1|||
170352193|NCT01576016|615626368|FG001|Lead Safety|System deactivated|0|||
170352194|NCT01576016|615626367|FG000|Lead Safety|Patient no longer followed by study PI|1|||
170352195|NCT01576016|615626368|FG001|Lead Safety|Patient no longer followed by study PI|0|||
170352196|NCT01576016|615626367|FG000|MRI Safety|Withdrawal by Subject|0|||
170352197|NCT01576016|615626368|FG001|MRI Safety|Withdrawal by Subject|10|||
170399306|NCT03193190|615799947|FG010|Stage 1|Physician Decision|0|||
170352198|NCT01576016|615626367|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
170352199|NCT01576016|615626368|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
170352200|NCT01576016|615626367|FG000|MRI Safety|Has not yet completed MRI scan|0|||
170352201|NCT01576016|615626368|FG001|MRI Safety|Has not yet completed MRI scan|56|||
170352202|NCT01576016|615626367|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
170352203|NCT01576016|615626368|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
170352204|NCT04507867|615626379|FG000|Overall Study|Death|7|||
170352205|NCT04507867|615626380|FG001|Overall Study|Death|1|||
170352206|NCT02504268|615626381|FG000|Overall Study|Adverse Event|18|||
170352207|NCT02504268|615626382|FG001|Overall Study|Adverse Event|8|||
170352208|NCT02504268|615626383|FG002|Overall Study|Adverse Event|14|||
170352209|NCT02504268|615626384|FG003|Overall Study|Adverse Event|0|||
170352210|NCT02504268|615626385|FG004|Overall Study|Adverse Event|0|||
170352211|NCT02504268|615626386|FG005|Overall Study|Adverse Event|0|||
170352212|NCT02504268|615626387|FG006|Overall Study|Adverse Event|0|||
170352213|NCT02504268|615626388|FG007|Overall Study|Adverse Event|0|||
170352214|NCT02504268|615626389|FG008|Overall Study|Adverse Event|0|||
170352215|NCT02504268|615626381|FG000|Overall Study|Withdrawal of Consent|11|||
170352216|NCT02504268|615626382|FG001|Overall Study|Withdrawal of Consent|10|||
170352217|NCT02504268|615626383|FG002|Overall Study|Withdrawal of Consent|3|||
170352218|NCT02504268|615626384|FG003|Overall Study|Withdrawal of Consent|0|||
170352219|NCT02504268|615626385|FG004|Overall Study|Withdrawal of Consent|0|||
170352220|NCT02504268|615626386|FG005|Overall Study|Withdrawal of Consent|0|||
170352221|NCT02504268|615626387|FG006|Overall Study|Withdrawal of Consent|0|||
170352222|NCT02504268|615626388|FG007|Overall Study|Withdrawal of Consent|0|||
170352223|NCT02504268|615626389|FG008|Overall Study|Withdrawal of Consent|0|||
170352224|NCT02504268|615626381|FG000|Overall Study|Pregnancy|2|||
170352225|NCT02504268|615626382|FG001|Overall Study|Pregnancy|0|||
170352226|NCT02504268|615626383|FG002|Overall Study|Pregnancy|0|||
170352227|NCT02504268|615626384|FG003|Overall Study|Pregnancy|0|||
170352228|NCT02504268|615626385|FG004|Overall Study|Pregnancy|0|||
170352229|NCT02504268|615626386|FG005|Overall Study|Pregnancy|0|||
170352230|NCT02504268|615626387|FG006|Overall Study|Pregnancy|0|||
170352231|NCT02504268|615626388|FG007|Overall Study|Pregnancy|0|||
170352232|NCT02504268|615626389|FG008|Overall Study|Pregnancy|0|||
170352233|NCT02504268|615626381|FG000|Overall Study|Lost to Follow-up|3|||
170352234|NCT02504268|615626382|FG001|Overall Study|Lost to Follow-up|6|||
170352235|NCT02504268|615626383|FG002|Overall Study|Lost to Follow-up|4|||
170352236|NCT02504268|615626384|FG003|Overall Study|Lost to Follow-up|0|||
170352237|NCT02504268|615626385|FG004|Overall Study|Lost to Follow-up|0|||
170352238|NCT02504268|615626386|FG005|Overall Study|Lost to Follow-up|0|||
170352239|NCT02504268|615626387|FG006|Overall Study|Lost to Follow-up|0|||
170352240|NCT02504268|615626388|FG007|Overall Study|Lost to Follow-up|0|||
170352241|NCT02504268|615626389|FG008|Overall Study|Lost to Follow-up|0|||
170352242|NCT02504268|615626381|FG000|Overall Study|Death|1|||
170352243|NCT02504268|615626382|FG001|Overall Study|Death|1|||
170352244|NCT02504268|615626383|FG002|Overall Study|Death|0|||
170352245|NCT02504268|615626384|FG003|Overall Study|Death|0|||
170352246|NCT02504268|615626385|FG004|Overall Study|Death|0|||
170352247|NCT02504268|615626386|FG005|Overall Study|Death|0|||
170352248|NCT02504268|615626387|FG006|Overall Study|Death|0|||
170352249|NCT02504268|615626388|FG007|Overall Study|Death|0|||
170352250|NCT02504268|615626389|FG008|Overall Study|Death|0|||
170352251|NCT02504268|615626381|FG000|Overall Study|Subject Request to Discontinue|11|||
170352252|NCT02504268|615626382|FG001|Overall Study|Subject Request to Discontinue|3|||
170352253|NCT02504268|615626383|FG002|Overall Study|Subject Request to Discontinue|6|||
170352254|NCT02504268|615626384|FG003|Overall Study|Subject Request to Discontinue|0|||
170352255|NCT02504268|615626385|FG004|Overall Study|Subject Request to Discontinue|0|||
170352256|NCT02504268|615626386|FG005|Overall Study|Subject Request to Discontinue|0|||
170352257|NCT02504268|615626387|FG006|Overall Study|Subject Request to Discontinue|0|||
170352258|NCT02504268|615626388|FG007|Overall Study|Subject Request to Discontinue|0|||
170352259|NCT02504268|615626389|FG008|Overall Study|Subject Request to Discontinue|0|||
170352260|NCT02504268|615626381|FG000|Overall Study|No Longer Meets Study Criteria|2|||
170352261|NCT02504268|615626382|FG001|Overall Study|No Longer Meets Study Criteria|3|||
170352262|NCT02504268|615626383|FG002|Overall Study|No Longer Meets Study Criteria|0|||
170352263|NCT02504268|615626384|FG003|Overall Study|No Longer Meets Study Criteria|0|||
170352264|NCT02504268|615626385|FG004|Overall Study|No Longer Meets Study Criteria|0|||
170352265|NCT02504268|615626386|FG005|Overall Study|No Longer Meets Study Criteria|0|||
170352266|NCT02504268|615626387|FG006|Overall Study|No Longer Meets Study Criteria|0|||
170352267|NCT02504268|615626388|FG007|Overall Study|No Longer Meets Study Criteria|0|||
170352268|NCT02504268|615626389|FG008|Overall Study|No Longer Meets Study Criteria|0|||
170352269|NCT02504268|615626381|FG000|Overall Study|Lack of Efficacy|11|||
170352270|NCT02504268|615626382|FG001|Overall Study|Lack of Efficacy|35|||
170352271|NCT02504268|615626383|FG002|Overall Study|Lack of Efficacy|9|||
170352272|NCT02504268|615626384|FG003|Overall Study|Lack of Efficacy|0|||
170352273|NCT02504268|615626385|FG004|Overall Study|Lack of Efficacy|0|||
170352274|NCT02504268|615626386|FG005|Overall Study|Lack of Efficacy|0|||
170352275|NCT02504268|615626387|FG006|Overall Study|Lack of Efficacy|0|||
170352276|NCT02504268|615626388|FG007|Overall Study|Lack of Efficacy|0|||
170352277|NCT02504268|615626389|FG008|Overall Study|Lack of Efficacy|0|||
170352278|NCT02504268|615626381|FG000|Overall Study|Poor/Non-Compliance|3|||
170352279|NCT02504268|615626382|FG001|Overall Study|Poor/Non-Compliance|2|||
170352280|NCT02504268|615626383|FG002|Overall Study|Poor/Non-Compliance|3|||
170352281|NCT02504268|615626384|FG003|Overall Study|Poor/Non-Compliance|0|||
170352282|NCT02504268|615626385|FG004|Overall Study|Poor/Non-Compliance|0|||
170352283|NCT02504268|615626386|FG005|Overall Study|Poor/Non-Compliance|0|||
170352284|NCT02504268|615626387|FG006|Overall Study|Poor/Non-Compliance|0|||
170352285|NCT02504268|615626388|FG007|Overall Study|Poor/Non-Compliance|0|||
170352286|NCT02504268|615626389|FG008|Overall Study|Poor/Non-Compliance|0|||
170352287|NCT02504268|615626381|FG000|Overall Study|Not Disclosed|1|||
170352288|NCT02504268|615626382|FG001|Overall Study|Not Disclosed|0|||
170352289|NCT02504268|615626383|FG002|Overall Study|Not Disclosed|2|||
170352290|NCT02504268|615626384|FG003|Overall Study|Not Disclosed|0|||
170352291|NCT02504268|615626385|FG004|Overall Study|Not Disclosed|0|||
170352292|NCT02504268|615626386|FG005|Overall Study|Not Disclosed|0|||
170352293|NCT02504268|615626387|FG006|Overall Study|Not Disclosed|0|||
170352294|NCT02504268|615626388|FG007|Overall Study|Not Disclosed|0|||
170352295|NCT02504268|615626389|FG008|Overall Study|Not Disclosed|0|||
170352296|NCT02432040|615626391|FG000|Overall Study|Lack of Efficacy|3|||
170352297|NCT02432040|615626392|FG001|Overall Study|Lack of Efficacy|0|||
170352298|NCT02432040|615626391|FG000|Overall Study|Lost to Follow-up|4|||
170352299|NCT02432040|615626392|FG001|Overall Study|Lost to Follow-up|5|||
170352300|NCT02432040|615626391|FG000|Overall Study|Physician Decision|1|||
170352301|NCT02432040|615626392|FG001|Overall Study|Physician Decision|1|||
170352302|NCT03247413|615626393|FG000|Overall Study|Lost to Follow-up|28|||
170352303|NCT01496430|615626394|FG000|Overall Study|Adverse Event|0|||
170352304|NCT01496430|615626395|FG001|Overall Study|Adverse Event|0|||
170352305|NCT01496430|615626396|FG002|Overall Study|Adverse Event|1|||
170352306|NCT01496430|615626394|FG000|Overall Study|Major Protocol Deviation|0|||
170352307|NCT01496430|615626395|FG001|Overall Study|Major Protocol Deviation|0|||
170352308|NCT01496430|615626396|FG002|Overall Study|Major Protocol Deviation|1|||
170352309|NCT01496430|615626394|FG000|Overall Study|Lost to Follow-up|2|||
170352310|NCT01496430|615626395|FG001|Overall Study|Lost to Follow-up|3|||
170352311|NCT01496430|615626396|FG002|Overall Study|Lost to Follow-up|1|||
170352312|NCT01496430|615626394|FG000|Overall Study|Voluntary Withdrawal|2|||
170352313|NCT01496430|615626395|FG001|Overall Study|Voluntary Withdrawal|1|||
170352314|NCT01496430|615626396|FG002|Overall Study|Voluntary Withdrawal|6|||
170352315|NCT01496430|615626394|FG000|Overall Study|Principal Investigator Discretion|0|||
170352316|NCT01496430|615626395|FG001|Overall Study|Principal Investigator Discretion|1|||
170352317|NCT01496430|615626396|FG002|Overall Study|Principal Investigator Discretion|1|||
170352318|NCT01496430|615626394|FG000|Overall Study|Other|2|||
170352319|NCT01496430|615626395|FG001|Overall Study|Other|0|||
170352320|NCT01496430|615626396|FG002|Overall Study|Other|0|||
170352321|NCT02108951|615626397|FG000|Overall Study|Lost to Follow-up|1|||
170352322|NCT02108951|615626397|FG000|Overall Study|Patient's/guardian's decision|1|||
170352323|NCT02108951|615626397|FG000|Overall Study|Study Terminated by Sponsor|14|||
170352324|NCT00608530|615626404|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
170352325|NCT00608530|615626405|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
170352326|NCT00608530|615626406|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
170352327|NCT00608530|615626407|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
170352328|NCT00608530|615626404|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
170352329|NCT00608530|615626405|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
170352330|NCT00608530|615626406|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
170352331|NCT00608530|615626407|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
170352332|NCT00608530|615626404|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
170352333|NCT00608530|615626405|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
170352334|NCT00608530|615626406|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
170352335|NCT00608530|615626407|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
170352336|NCT00608530|615626404|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
170352337|NCT00608530|615626405|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
170352338|NCT00608530|615626406|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
170352339|NCT00608530|615626407|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
170352340|NCT00608530|615626404|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
170352341|NCT00608530|615626405|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
170352342|NCT00608530|615626406|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
170352343|NCT00608530|615626407|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
170352344|NCT00608530|615626404|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
170352345|NCT00608530|615626405|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
170352346|NCT00608530|615626406|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
170352347|NCT00608530|615626407|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
170352348|NCT01952730|615626408|FG000|Overall Study|FDA shut down core lab used by study|1|||
170352349|NCT00077610|615626411|FG000|Overall Study|Adverse Event|9|||
170352350|NCT00077610|615626412|FG001|Overall Study|Adverse Event|7|||
170352351|NCT00077610|615626413|FG002|Overall Study|Adverse Event|1|||
170352352|NCT00077610|615626411|FG000|Overall Study|Lost to Follow-up|0|||
170352353|NCT00077610|615626412|FG001|Overall Study|Lost to Follow-up|1|||
170352354|NCT00077610|615626413|FG002|Overall Study|Lost to Follow-up|2|||
170352355|NCT00077610|615626411|FG000|Overall Study|Withdrawal by Subject|4|||
170352356|NCT00077610|615626412|FG001|Overall Study|Withdrawal by Subject|10|||
170352357|NCT00077610|615626413|FG002|Overall Study|Withdrawal by Subject|6|||
170352358|NCT00077610|615626411|FG000|Overall Study|Death|17|||
170352359|NCT00077610|615626412|FG001|Overall Study|Death|13|||
170352360|NCT00077610|615626413|FG002|Overall Study|Death|13|||
170352361|NCT00077610|615626411|FG000|Overall Study|Renal transplant|12|||
170352362|NCT00077610|615626412|FG001|Overall Study|Renal transplant|15|||
170352363|NCT00077610|615626413|FG002|Overall Study|Renal transplant|11|||
170352364|NCT00077610|615626411|FG000|Overall Study|Withdrew from dialysis care|5|||
170352365|NCT00077610|615626412|FG001|Overall Study|Withdrew from dialysis care|0|||
170352366|NCT00077610|615626413|FG002|Overall Study|Withdrew from dialysis care|3|||
170352367|NCT00077610|615626411|FG000|Overall Study|Insufficient Therapeutic Response|1|||
170352368|NCT00077610|615626412|FG001|Overall Study|Insufficient Therapeutic Response|0|||
170352369|NCT00077610|615626413|FG002|Overall Study|Insufficient Therapeutic Response|0|||
170352370|NCT00077610|615626411|FG000|Overall Study|Multiple blood transfusions|0|||
170352371|NCT00077610|615626412|FG001|Overall Study|Multiple blood transfusions|0|||
170352372|NCT00077610|615626413|FG002|Overall Study|Multiple blood transfusions|1|||
170352373|NCT00077610|615626411|FG000|Overall Study|Principal Investigator's decision|1|||
170352374|NCT00077610|615626412|FG001|Overall Study|Principal Investigator's decision|0|||
170352375|NCT00077610|615626413|FG002|Overall Study|Principal Investigator's decision|1|||
170352376|NCT00077610|615626411|FG000|Overall Study|Worsening of health condition|1|||
170352377|NCT00077610|615626412|FG001|Overall Study|Worsening of health condition|1|||
170352378|NCT00077610|615626413|FG002|Overall Study|Worsening of health condition|0|||
170352379|NCT00077610|615626411|FG000|Overall Study|Given Epogen in hospital|1|||
170352380|NCT00077610|615626412|FG001|Overall Study|Given Epogen in hospital|0|||
170352381|NCT00077610|615626413|FG002|Overall Study|Given Epogen in hospital|0|||
170352382|NCT00077610|615626411|FG000|Overall Study|Transferred to other unit|0|||
170352383|NCT00077610|615626412|FG001|Overall Study|Transferred to other unit|0|||
170352384|NCT00077610|615626413|FG002|Overall Study|Transferred to other unit|1|||
170352385|NCT00077610|615626411|FG000|Overall Study|Transferred to nursing home|0|||
170352386|NCT00077610|615626412|FG001|Overall Study|Transferred to nursing home|0|||
170352387|NCT00077610|615626413|FG002|Overall Study|Transferred to nursing home|1|||
170352388|NCT00077610|615626411|FG000|Overall Study|Transfer to satellite unit|1|||
170352389|NCT00077610|615626412|FG001|Overall Study|Transfer to satellite unit|0|||
170352390|NCT00077610|615626413|FG002|Overall Study|Transfer to satellite unit|0|||
170352391|NCT00077610|615626411|FG000|Overall Study|Transfer to other center for surgery|1|||
170352392|NCT00077610|615626412|FG001|Overall Study|Transfer to other center for surgery|0|||
170352393|NCT00077610|615626413|FG002|Overall Study|Transfer to other center for surgery|0|||
170352394|NCT00077610|615626411|FG000|Overall Study|Change in dialysis modality|1|||
170352395|NCT00077610|615626412|FG001|Overall Study|Change in dialysis modality|0|||
170352396|NCT00077610|615626413|FG002|Overall Study|Change in dialysis modality|0|||
170352397|NCT00077610|615626411|FG000|Overall Study|Relocation|0|||
170352398|NCT00077610|615626412|FG001|Overall Study|Relocation|8|||
170352399|NCT00077610|615626413|FG002|Overall Study|Relocation|5|||
170352400|NCT00077610|615626411|FG000|Overall Study|Financial issues|0|||
170352401|NCT00077610|615626412|FG001|Overall Study|Financial issues|1|||
170352402|NCT00077610|615626413|FG002|Overall Study|Financial issues|0|||
170352403|NCT00077610|615626411|FG000|Overall Study|Sponsors decision to withdraw|0|||
170352404|NCT00077610|615626412|FG001|Overall Study|Sponsors decision to withdraw|0|||
170352405|NCT00077610|615626413|FG002|Overall Study|Sponsors decision to withdraw|1|||
170352406|NCT02932332|615626416|FG000|Overall Study|Withdrawal by Subject|1|||
170352407|NCT02932332|615626417|FG001|Overall Study|Withdrawal by Subject|1|||
170352408|NCT02932332|615626418|FG002|Overall Study|Withdrawal by Subject|0|||
170352409|NCT02932332|615626419|FG003|Overall Study|Withdrawal by Subject|1|||
170352410|NCT02932332|615626416|FG000|Overall Study|Chest pain|0|||
170352411|NCT02932332|615626417|FG001|Overall Study|Chest pain|0|||
170352412|NCT02932332|615626418|FG002|Overall Study|Chest pain|0|||
170352413|NCT02932332|615626419|FG003|Overall Study|Chest pain|1|||
170352414|NCT02932332|615626416|FG000|Overall Study|Not Dyspneic cough|1|||
170352415|NCT02932332|615626417|FG001|Overall Study|Not Dyspneic cough|2|||
170352416|NCT02932332|615626418|FG002|Overall Study|Not Dyspneic cough|1|||
170352417|NCT02932332|615626419|FG003|Overall Study|Not Dyspneic cough|0|||
170352418|NCT01486784|615626420|FG000|Overall Study|Withdrawal by Subject|0|||
170352419|NCT01486784|615626421|FG001|Overall Study|Withdrawal by Subject|0|||
170352420|NCT01486784|615626422|FG002|Overall Study|Withdrawal by Subject|1|||
170352421|NCT01486784|615626423|FG003|Overall Study|Withdrawal by Subject|0|||
170352422|NCT01486784|615626424|FG004|Overall Study|Withdrawal by Subject|1|||
170352423|NCT01486784|615626425|FG005|Overall Study|Withdrawal by Subject|2|||
170352424|NCT01486784|615626420|FG000|Overall Study|Subject did not meet entry criteria|0|||
170352425|NCT01486784|615626421|FG001|Overall Study|Subject did not meet entry criteria|0|||
170352426|NCT01486784|615626422|FG002|Overall Study|Subject did not meet entry criteria|0|||
170352427|NCT01486784|615626423|FG003|Overall Study|Subject did not meet entry criteria|0|||
170352428|NCT01486784|615626424|FG004|Overall Study|Subject did not meet entry criteria|1|||
170352429|NCT01486784|615626425|FG005|Overall Study|Subject did not meet entry criteria|0|||
170352430|NCT01486784|615626420|FG000|Overall Study|Death|0|||
170352431|NCT01486784|615626421|FG001|Overall Study|Death|0|||
170352432|NCT01486784|615626422|FG002|Overall Study|Death|0|||
170352433|NCT01486784|615626423|FG003|Overall Study|Death|0|||
170352434|NCT01486784|615626424|FG004|Overall Study|Death|0|||
170352435|NCT01486784|615626425|FG005|Overall Study|Death|1|||
170352436|NCT01069523|615626426|FG000|Overall Study|Withdrawal by Subject|4|||
170352437|NCT01069523|615626427|FG001|Overall Study|Withdrawal by Subject|7|||
170352438|NCT02065869|615626428|FG000|Overall Study|Death|7|||
170352439|NCT02065869|615626428|FG000|Overall Study|Disease relapse|16|||
170352440|NCT02065869|615626428|FG000|Overall Study|Lost to Follow-up|4|||
170352441|NCT02065869|615626428|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
170352442|NCT02065869|615626428|FG000|Overall Study|Withdrawal by Subject|1|||
170352443|NCT00243230|615626431|FG000|Double-Blind Period|Adverse Event|0|||
170352444|NCT00243230|615626432|FG001|Double-Blind Period|Adverse Event|2|||
170352445|NCT00243230|615626433|FG002|Double-Blind Period|Adverse Event|2|||
170352446|NCT00243230|615626434|FG003|Double-Blind Period|Adverse Event|0|||
170352447|NCT00243230|615626431|FG000|Double-Blind Period|Withdrawal by Subject|1|||
170352448|NCT00243230|615626432|FG001|Double-Blind Period|Withdrawal by Subject|0|||
170352449|NCT00243230|615626433|FG002|Double-Blind Period|Withdrawal by Subject|0|||
170352450|NCT00243230|615626434|FG003|Double-Blind Period|Withdrawal by Subject|0|||
170352451|NCT00243230|615626431|FG000|Double-Blind Period|Protocol Violation|0|||
170352452|NCT00243230|615626432|FG001|Double-Blind Period|Protocol Violation|0|||
170352453|NCT00243230|615626433|FG002|Double-Blind Period|Protocol Violation|1|||
170352454|NCT00243230|615626434|FG003|Double-Blind Period|Protocol Violation|0|||
170352455|NCT00243230|615626431|FG000|Double-Blind Period|Randomized but Not Treated|0|||
170352456|NCT00243230|615626432|FG001|Double-Blind Period|Randomized but Not Treated|0|||
170352457|NCT00243230|615626433|FG002|Double-Blind Period|Randomized but Not Treated|2|||
170352458|NCT00243230|615626434|FG003|Double-Blind Period|Randomized but Not Treated|0|||
170352459|NCT00243230|615626431|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
170352460|NCT00243230|615626432|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
170352461|NCT00243230|615626433|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
170352462|NCT00243230|615626434|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
170352463|NCT00243230|615626431|FG000|Open Label Period|Adverse Event|0|||
170352464|NCT00243230|615626432|FG001|Open Label Period|Adverse Event|0|||
170352465|NCT00243230|615626433|FG002|Open Label Period|Adverse Event|0|||
170352466|NCT00243230|615626434|FG003|Open Label Period|Adverse Event|2|||
170352467|NCT00243230|615626431|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
170352468|NCT00243230|615626432|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
170352469|NCT00243230|615626433|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
170352470|NCT00243230|615626434|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
170352471|NCT00243230|615626431|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
170352472|NCT00243230|615626432|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
170352473|NCT00243230|615626433|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
170352474|NCT00243230|615626434|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
170352475|NCT00243230|615626431|FG000|Open Label Period|Lost to Follow-up|0|||
170352476|NCT00243230|615626432|FG001|Open Label Period|Lost to Follow-up|0|||
170352477|NCT00243230|615626433|FG002|Open Label Period|Lost to Follow-up|0|||
170352478|NCT00243230|615626434|FG003|Open Label Period|Lost to Follow-up|2|||
170352479|NCT00243230|615626431|FG000|Open Label Period|Withdrawal by Subject|0|||
170352480|NCT00243230|615626432|FG001|Open Label Period|Withdrawal by Subject|0|||
170352481|NCT00243230|615626433|FG002|Open Label Period|Withdrawal by Subject|0|||
170352482|NCT00243230|615626434|FG003|Open Label Period|Withdrawal by Subject|2|||
170352483|NCT00243230|615626431|FG000|Open Label Period|Protocol Violation|0|||
170352484|NCT00243230|615626432|FG001|Open Label Period|Protocol Violation|0|||
170352485|NCT00243230|615626433|FG002|Open Label Period|Protocol Violation|0|||
170352486|NCT00243230|615626434|FG003|Open Label Period|Protocol Violation|2|||
170352487|NCT00243230|615626431|FG000|Open Label Period|Administrative Reason|0|||
170352488|NCT00243230|615626432|FG001|Open Label Period|Administrative Reason|0|||
170352489|NCT00243230|615626433|FG002|Open Label Period|Administrative Reason|0|||
170352490|NCT00243230|615626434|FG003|Open Label Period|Administrative Reason|63|||
170352491|NCT05836818|615626435|FG000|Overall Study|Physician Decision|1|||
170352492|NCT05836818|615626436|FG001|Overall Study|Physician Decision|1|||
170352493|NCT05836818|615626437|FG002|Overall Study|Physician Decision|0|||
170352494|NCT05836818|615626435|FG000|Overall Study|Withdrawal by Subject|0|||
170352495|NCT05836818|615626436|FG001|Overall Study|Withdrawal by Subject|0|||
170352496|NCT05836818|615626437|FG002|Overall Study|Withdrawal by Subject|1|||
170352497|NCT05836818|615626435|FG000|Overall Study|Later found to be previously vaccinated|0|||
170399307|NCT03193190|615799948|FG011|Stage 1|Physician Decision|1|||
170352498|NCT05836818|615626436|FG001|Overall Study|Later found to be previously vaccinated|1|||
170352499|NCT05836818|615626437|FG002|Overall Study|Later found to be previously vaccinated|3|||
170352500|NCT05836818|615626435|FG000|Overall Study|Pregnancy|0|||
170352501|NCT05836818|615626436|FG001|Overall Study|Pregnancy|1|||
170352502|NCT05836818|615626437|FG002|Overall Study|Pregnancy|0|||
170352503|NCT05836818|615626435|FG000|Overall Study|Allergic to vaccines|0|||
170352504|NCT05836818|615626436|FG001|Overall Study|Allergic to vaccines|1|||
170352505|NCT05836818|615626437|FG002|Overall Study|Allergic to vaccines|0|||
170352506|NCT01627067|615626447|FG000|Overall Study|Screen Failure|1|||
170352507|NCT00926796|615626450|FG000|Overall Study|Did not receive randomized treatment|4|||
170352508|NCT00926796|615626451|FG001|Overall Study|Did not receive randomized treatment|7|||
170352509|NCT00926796|615626450|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
170352510|NCT00926796|615626451|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
170352511|NCT00926796|615626450|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
170352512|NCT00926796|615626451|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
170352513|NCT00926796|615626450|FG000|Overall Study|Adverse Event|7|||
170352514|NCT00926796|615626451|FG001|Overall Study|Adverse Event|14|||
170352515|NCT00926796|615626450|FG000|Overall Study|Lost to Follow-up|22|||
170352516|NCT00926796|615626451|FG001|Overall Study|Lost to Follow-up|13|||
170352517|NCT00926796|615626450|FG000|Overall Study|Protocol Violation|15|||
170352518|NCT00926796|615626451|FG001|Overall Study|Protocol Violation|11|||
170352519|NCT00926796|615626450|FG000|Overall Study|Withdrawal by Subject|1|||
170352520|NCT00926796|615626451|FG001|Overall Study|Withdrawal by Subject|0|||
170352521|NCT00632463|615626455|FG000|Overall Study|Adverse Event|0|||
170352522|NCT00632463|615626456|FG001|Overall Study|Adverse Event|1|||
170352523|NCT00632463|615626457|FG002|Overall Study|Adverse Event|0|||
170352524|NCT01767194|615626465|FG000|Overall Study|Adverse Event|1|||
170352525|NCT01767194|615626466|FG001|Overall Study|Adverse Event|1|||
170352526|NCT01767194|615626465|FG000|Overall Study|Death|0|||
170352527|NCT01767194|615626466|FG001|Overall Study|Death|1|||
170352528|NCT01767194|615626465|FG000|Overall Study|Lack of Efficacy|12|||
170352529|NCT01767194|615626466|FG001|Overall Study|Lack of Efficacy|11|||
170352530|NCT01767194|615626465|FG000|Overall Study|Physician Decision|2|||
170352531|NCT01767194|615626466|FG001|Overall Study|Physician Decision|23|||
170352532|NCT01767194|615626465|FG000|Overall Study|Withdrawal by Subject|0|||
170352533|NCT01767194|615626466|FG001|Overall Study|Withdrawal by Subject|1|||
170352534|NCT01767194|615626465|FG000|Overall Study|Ineligible|1|||
170352535|NCT01767194|615626466|FG001|Overall Study|Ineligible|1|||
170352536|NCT01767194|615626465|FG000|Overall Study|Refusal by patient/parent|2|||
170352537|NCT01767194|615626466|FG001|Overall Study|Refusal by patient/parent|4|||
170352538|NCT01767194|615626465|FG000|Overall Study|Criteria not met on time for next cycle|0|||
170352539|NCT01767194|615626466|FG001|Overall Study|Criteria not met on time for next cycle|1|||
170352540|NCT00621855|615626467|FG000|Overall Study|Adverse Event|32|||
170352541|NCT00621855|615626468|FG001|Overall Study|Adverse Event|31|||
170352542|NCT00621855|615626469|FG002|Overall Study|Adverse Event|48|||
170352543|NCT00621855|615626470|FG003|Overall Study|Adverse Event|34|||
170352544|NCT00621855|615626471|FG004|Overall Study|Adverse Event|31|||
170352545|NCT00621855|615626467|FG000|Overall Study|Lost to Follow-up|0|||
170352546|NCT00621855|615626468|FG001|Overall Study|Lost to Follow-up|1|||
170352547|NCT00621855|615626469|FG002|Overall Study|Lost to Follow-up|3|||
170352548|NCT00621855|615626470|FG003|Overall Study|Lost to Follow-up|4|||
170352549|NCT00621855|615626471|FG004|Overall Study|Lost to Follow-up|1|||
170352550|NCT00621855|615626467|FG000|Overall Study|Protocol Violation|16|||
170352551|NCT00621855|615626468|FG001|Overall Study|Protocol Violation|8|||
170352552|NCT00621855|615626469|FG002|Overall Study|Protocol Violation|6|||
170352553|NCT00621855|615626470|FG003|Overall Study|Protocol Violation|7|||
170352554|NCT00621855|615626471|FG004|Overall Study|Protocol Violation|8|||
170352555|NCT00621855|615626467|FG000|Overall Study|Withdrawal by Subject|16|||
170352556|NCT00621855|615626468|FG001|Overall Study|Withdrawal by Subject|11|||
170352557|NCT00621855|615626469|FG002|Overall Study|Withdrawal by Subject|13|||
170352558|NCT00621855|615626470|FG003|Overall Study|Withdrawal by Subject|13|||
170352559|NCT00621855|615626471|FG004|Overall Study|Withdrawal by Subject|9|||
170352560|NCT00621855|615626467|FG000|Overall Study|Other|9|||
170352561|NCT00621855|615626468|FG001|Overall Study|Other|7|||
170352562|NCT00621855|615626469|FG002|Overall Study|Other|6|||
170352563|NCT00621855|615626470|FG003|Overall Study|Other|5|||
170352564|NCT00621855|615626471|FG004|Overall Study|Other|4|||
170352565|NCT00621855|615626467|FG000|Overall Study|Patients did not receive study drug|3|||
170352566|NCT00621855|615626468|FG001|Overall Study|Patients did not receive study drug|3|||
170352567|NCT00621855|615626469|FG002|Overall Study|Patients did not receive study drug|5|||
170352568|NCT00621855|615626470|FG003|Overall Study|Patients did not receive study drug|4|||
170352569|NCT00621855|615626471|FG004|Overall Study|Patients did not receive study drug|2|||
170352570|NCT03731364|615626472|FG000|Overall Study|Adverse Event|0|||
170352571|NCT03731364|615626473|FG001|Overall Study|Adverse Event|0|||
170352572|NCT03731364|615626474|FG002|Overall Study|Adverse Event|1|||
170352573|NCT03731364|615626475|FG003|Overall Study|Adverse Event|2|||
170352574|NCT03731364|615626476|FG004|Overall Study|Adverse Event|1|||
170352575|NCT04191577|615626480|FG000|Overall Study|Withdrawal by Subject|2|||
170352576|NCT04191577|615626481|FG001|Overall Study|Withdrawal by Subject|2|||
170352577|NCT04191577|615626482|FG002|Overall Study|Withdrawal by Subject|1|||
170352578|NCT04191577|615626480|FG000|Overall Study|Physician Decision|1|||
170352579|NCT04191577|615626481|FG001|Overall Study|Physician Decision|1|||
170352580|NCT04191577|615626482|FG002|Overall Study|Physician Decision|0|||
170352581|NCT04191577|615626480|FG000|Overall Study|Adverse Event|0|||
170352582|NCT04191577|615626481|FG001|Overall Study|Adverse Event|0|||
170352583|NCT04191577|615626482|FG002|Overall Study|Adverse Event|1|||
170352584|NCT04191577|615626480|FG000|Overall Study|Death|0|||
170352585|NCT04191577|615626481|FG001|Overall Study|Death|0|||
170352586|NCT04191577|615626482|FG002|Overall Study|Death|1|||
170352587|NCT04973228|615626483|FG000|Overall Study|Adverse Event|2|||
170352588|NCT04973228|615626484|FG001|Overall Study|Adverse Event|3|||
170352589|NCT04973228|615626483|FG000|Overall Study|Lack of Efficacy|1|||
170352590|NCT04973228|615626484|FG001|Overall Study|Lack of Efficacy|3|||
170352591|NCT04973228|615626483|FG000|Overall Study|Lost to Follow-up|12|||
170352592|NCT04973228|615626484|FG001|Overall Study|Lost to Follow-up|4|||
170352593|NCT04973228|615626483|FG000|Overall Study|Withdrawal by Subject|11|||
170352594|NCT04973228|615626484|FG001|Overall Study|Withdrawal by Subject|4|||
170352595|NCT04973228|615626483|FG000|Overall Study|Did not tolerate application|1|||
170352596|NCT04973228|615626484|FG001|Overall Study|Did not tolerate application|0|||
170352597|NCT04973228|615626483|FG000|Overall Study|Wanted to early terminate and use own product|0|||
170352598|NCT04973228|615626484|FG001|Overall Study|Wanted to early terminate and use own product|1|||
170352599|NCT04973228|615626483|FG000|Overall Study|Missed visits due to new work schedule|1|||
170352600|NCT04973228|615626484|FG001|Overall Study|Missed visits due to new work schedule|0|||
170352601|NCT05674344|615628264|FG000|Overall Study|Screen Fail|21|||
170352602|NCT05674344|615628264|FG000|Overall Study|Incomplete study procedures|3|||
170352603|NCT01944969|615628271|FG000|Overall Study|Adverse Event|1|||
170352604|NCT01944969|615628271|FG000|Overall Study|Lack of Efficacy|1|||
170352605|NCT01944969|615628271|FG000|Overall Study|Non-compliance with IMP|1|||
170352606|NCT01944969|615628271|FG000|Overall Study|Administrative or other reasons|23|||
170352607|NCT04017442|615628273|FG000|Overall Study|Withdrawal by Subject|0|||
170352608|NCT04017442|615628274|FG001|Overall Study|Withdrawal by Subject|3|||
170352609|NCT04017442|615628273|FG000|Overall Study|Lost to Follow-up|21|||
170352610|NCT04017442|615628274|FG001|Overall Study|Lost to Follow-up|19|||
170352611|NCT03225716|615628278|FG000|Overall Study|Withdrawal by Subject|2|||
170352612|NCT03225716|615628279|FG001|Overall Study|Withdrawal by Subject|2|||
170352613|NCT03225716|615628280|FG002|Overall Study|Withdrawal by Subject|0|||
170352614|NCT03225716|615628278|FG000|Overall Study|Lack of Efficacy|1|||
170352615|NCT03225716|615628279|FG001|Overall Study|Lack of Efficacy|0|||
170352616|NCT03225716|615628280|FG002|Overall Study|Lack of Efficacy|0|||
170352617|NCT03225716|615628278|FG000|Overall Study|Adverse Event|2|||
170352618|NCT03225716|615628279|FG001|Overall Study|Adverse Event|0|||
170352619|NCT03225716|615628280|FG002|Overall Study|Adverse Event|1|||
170352620|NCT03225716|615628278|FG000|Overall Study|Study early termination by Sponsor|0|||
170352621|NCT03225716|615628279|FG001|Overall Study|Study early termination by Sponsor|0|||
170352622|NCT03225716|615628280|FG002|Overall Study|Study early termination by Sponsor|2|||
170352623|NCT02106455|615628285|FG000|Overall Study|Case Report Form Uncollected|6|||
170352624|NCT02106455|615628285|FG000|Overall Study|Protocol Deviation|2|||
170352625|NCT00213980|615628286|FG000|Overall Study|Withdrawal by Subject|3|||
170352626|NCT00213980|615628287|FG001|Overall Study|Withdrawal by Subject|1|||
170352627|NCT00213980|615628286|FG000|Overall Study|Adverse Event|1|||
170352628|NCT00213980|615628287|FG001|Overall Study|Adverse Event|1|||
170352629|NCT00213980|615628286|FG000|Overall Study|Disease progression|0|||
170352630|NCT00213980|615628287|FG001|Overall Study|Disease progression|2|||
170352631|NCT00213980|615628286|FG000|Overall Study|Developed ovarian cancer|1|||
170352632|NCT00213980|615628287|FG001|Overall Study|Developed ovarian cancer|0|||
170352633|NCT00213980|615628286|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
170352634|NCT00213980|615628287|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
170352635|NCT03607838|615628288|FG000|Overall Study|Lack of Efficacy|14|||
170352636|NCT03607838|615628289|FG001|Overall Study|Lack of Efficacy|20|||
170352637|NCT03607838|615628288|FG000|Overall Study|Withdrawal by Subject|13|||
170352638|NCT03607838|615628289|FG001|Overall Study|Withdrawal by Subject|8|||
170352639|NCT03607838|615628288|FG000|Overall Study|Lost to Follow-up|6|||
170352640|NCT03607838|615628289|FG001|Overall Study|Lost to Follow-up|11|||
170352641|NCT03607838|615628288|FG000|Overall Study|Adverse Event|2|||
170352642|NCT03607838|615628289|FG001|Overall Study|Adverse Event|2|||
170352643|NCT03607838|615628288|FG000|Overall Study|Physician Decision|2|||
170352644|NCT03607838|615628289|FG001|Overall Study|Physician Decision|0|||
170352645|NCT03607838|615628288|FG000|Overall Study|Failure to meet randomization criteria|1|||
170352646|NCT03607838|615628289|FG001|Overall Study|Failure to meet randomization criteria|2|||
170352647|NCT03607838|615628288|FG000|Overall Study|Pregnancy|1|||
170352648|NCT03607838|615628289|FG001|Overall Study|Pregnancy|0|||
170352649|NCT03607838|615628288|FG000|Overall Study|Protocol Violation|1|||
170352650|NCT03607838|615628289|FG001|Overall Study|Protocol Violation|0|||
170352651|NCT03607838|615628288|FG000|Overall Study|Due to work|1|||
170352652|NCT03607838|615628289|FG001|Overall Study|Due to work|0|||
170352653|NCT03607838|615628288|FG000|Overall Study|Litigation|0|||
170352654|NCT03607838|615628289|FG001|Overall Study|Litigation|1|||
170352655|NCT03607838|615628288|FG000|Overall Study|Temperature excursion for study drug|0|||
170352656|NCT03607838|615628289|FG001|Overall Study|Temperature excursion for study drug|1|||
170352657|NCT03607838|615628288|FG000|Overall Study|Change of mind|0|||
170352658|NCT03607838|615628289|FG001|Overall Study|Change of mind|1|||
170352659|NCT02411201|615628290|FG000|Overall Study|Adverse Event|2|||
170352660|NCT02411201|615628290|FG000|Overall Study|Withdrawal by Subject|2|||
170352661|NCT02411201|615628290|FG000|Overall Study|Age group completed|2|||
170352662|NCT00798694|615628291|FG000|Overall Study|Lost to Follow-up|1|||
170352663|NCT00798694|615628292|FG001|Overall Study|Lost to Follow-up|1|||
170352664|NCT00798694|615628291|FG000|Overall Study|Physician Decision|1|||
170352665|NCT00798694|615628292|FG001|Overall Study|Physician Decision|0|||
170352666|NCT03888391|615628297|FG000|Overall Study|Lost to Follow-up|15|||
170352667|NCT02175771|615628299|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
170352668|NCT02175771|615628300|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170352669|NCT02175771|615628301|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170352670|NCT02175771|615628302|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170352671|NCT02175771|615628303|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170352672|NCT02175771|615628304|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170352673|NCT02175771|615628305|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170352674|NCT02175771|615628306|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170352675|NCT02175771|615628307|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170352676|NCT02175771|615628299|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
170352677|NCT02175771|615628300|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170352678|NCT02175771|615628301|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170352679|NCT02175771|615628302|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170352680|NCT02175771|615628303|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170352681|NCT02175771|615628304|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170352682|NCT02175771|615628305|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170352683|NCT02175771|615628306|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170352684|NCT02175771|615628307|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170352685|NCT02175771|615628299|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
170352686|NCT02175771|615628300|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170352687|NCT02175771|615628301|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170352688|NCT02175771|615628302|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170352689|NCT02175771|615628303|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170352690|NCT02175771|615628304|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170352691|NCT02175771|615628305|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170352692|NCT02175771|615628306|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170352693|NCT02175771|615628307|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170352694|NCT02175771|615628299|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
170352695|NCT02175771|615628300|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
170352696|NCT02175771|615628301|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
170352697|NCT02175771|615628302|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
170352698|NCT02175771|615628303|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
170352699|NCT02175771|615628304|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
170352700|NCT02175771|615628305|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
170352701|NCT02175771|615628306|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
170352702|NCT02175771|615628307|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
170352703|NCT02175771|615628299|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
170352704|NCT02175771|615628300|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170352705|NCT02175771|615628301|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170352706|NCT02175771|615628302|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170352707|NCT02175771|615628303|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170352708|NCT02175771|615628304|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170352709|NCT02175771|615628305|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170352710|NCT02175771|615628306|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170352711|NCT02175771|615628307|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170352712|NCT02175771|615628299|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
170352713|NCT02175771|615628300|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170352714|NCT02175771|615628301|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170352715|NCT02175771|615628302|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170352716|NCT02175771|615628303|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170352717|NCT02175771|615628304|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170352718|NCT02175771|615628305|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170352719|NCT02175771|615628306|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170352720|NCT02175771|615628307|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170352721|NCT02175771|615628299|FG000|Run-In Period (Pre-assignment)|Other|8|||
170352722|NCT02175771|615628300|FG001|Run-In Period (Pre-assignment)|Other|0|||
170352723|NCT02175771|615628301|FG002|Run-In Period (Pre-assignment)|Other|0|||
170352724|NCT02175771|615628302|FG003|Run-In Period (Pre-assignment)|Other|0|||
170352725|NCT02175771|615628303|FG004|Run-In Period (Pre-assignment)|Other|0|||
170352726|NCT02175771|615628304|FG005|Run-In Period (Pre-assignment)|Other|0|||
170352727|NCT02175771|615628305|FG006|Run-In Period (Pre-assignment)|Other|0|||
170352728|NCT02175771|615628306|FG007|Run-In Period (Pre-assignment)|Other|0|||
170352729|NCT02175771|615628307|FG008|Run-In Period (Pre-assignment)|Other|0|||
170352730|NCT02175771|615628299|FG000|Treatment Period|Adverse Event|0|||
170352731|NCT02175771|615628300|FG001|Treatment Period|Adverse Event|2|||
170352732|NCT02175771|615628301|FG002|Treatment Period|Adverse Event|1|||
170352733|NCT02175771|615628302|FG003|Treatment Period|Adverse Event|1|||
170352734|NCT02175771|615628303|FG004|Treatment Period|Adverse Event|1|||
170352735|NCT02175771|615628304|FG005|Treatment Period|Adverse Event|3|||
170352736|NCT02175771|615628305|FG006|Treatment Period|Adverse Event|2|||
170352737|NCT02175771|615628306|FG007|Treatment Period|Adverse Event|0|||
170352738|NCT02175771|615628307|FG008|Treatment Period|Adverse Event|1|||
170352739|NCT02175771|615628299|FG000|Treatment Period|Withdrawal by Subject|0|||
170352740|NCT02175771|615628300|FG001|Treatment Period|Withdrawal by Subject|9|||
170352741|NCT02175771|615628301|FG002|Treatment Period|Withdrawal by Subject|3|||
170352742|NCT02175771|615628302|FG003|Treatment Period|Withdrawal by Subject|6|||
170352743|NCT02175771|615628303|FG004|Treatment Period|Withdrawal by Subject|2|||
170352744|NCT02175771|615628304|FG005|Treatment Period|Withdrawal by Subject|4|||
170352745|NCT02175771|615628305|FG006|Treatment Period|Withdrawal by Subject|2|||
170352746|NCT02175771|615628306|FG007|Treatment Period|Withdrawal by Subject|9|||
170352747|NCT02175771|615628307|FG008|Treatment Period|Withdrawal by Subject|2|||
170352748|NCT02175771|615628299|FG000|Treatment Period|Noncompliance|0|||
170352749|NCT02175771|615628300|FG001|Treatment Period|Noncompliance|1|||
170352750|NCT02175771|615628301|FG002|Treatment Period|Noncompliance|2|||
170352751|NCT02175771|615628302|FG003|Treatment Period|Noncompliance|0|||
170352752|NCT02175771|615628303|FG004|Treatment Period|Noncompliance|0|||
170352753|NCT02175771|615628304|FG005|Treatment Period|Noncompliance|0|||
170352754|NCT02175771|615628305|FG006|Treatment Period|Noncompliance|0|||
170352755|NCT02175771|615628306|FG007|Treatment Period|Noncompliance|0|||
170352756|NCT02175771|615628307|FG008|Treatment Period|Noncompliance|1|||
170352757|NCT02175771|615628299|FG000|Treatment Period|Protocol Violation|0|||
170352758|NCT02175771|615628300|FG001|Treatment Period|Protocol Violation|0|||
170352759|NCT02175771|615628301|FG002|Treatment Period|Protocol Violation|0|||
170352760|NCT02175771|615628302|FG003|Treatment Period|Protocol Violation|0|||
170352761|NCT02175771|615628303|FG004|Treatment Period|Protocol Violation|0|||
170352762|NCT02175771|615628304|FG005|Treatment Period|Protocol Violation|0|||
170352763|NCT02175771|615628305|FG006|Treatment Period|Protocol Violation|0|||
170352764|NCT02175771|615628306|FG007|Treatment Period|Protocol Violation|1|||
170352765|NCT02175771|615628307|FG008|Treatment Period|Protocol Violation|0|||
170352766|NCT02175771|615628299|FG000|Treatment Period|Disease progression|0|||
170352767|NCT02175771|615628300|FG001|Treatment Period|Disease progression|0|||
170352768|NCT02175771|615628301|FG002|Treatment Period|Disease progression|0|||
170352769|NCT02175771|615628302|FG003|Treatment Period|Disease progression|0|||
170352770|NCT02175771|615628303|FG004|Treatment Period|Disease progression|0|||
170352771|NCT02175771|615628304|FG005|Treatment Period|Disease progression|0|||
170352772|NCT02175771|615628305|FG006|Treatment Period|Disease progression|0|||
170352773|NCT02175771|615628306|FG007|Treatment Period|Disease progression|2|||
170352774|NCT02175771|615628307|FG008|Treatment Period|Disease progression|0|||
170352775|NCT02175771|615628299|FG000|Treatment Period|Lost to Follow-up|0|||
170352776|NCT02175771|615628300|FG001|Treatment Period|Lost to Follow-up|3|||
170352777|NCT02175771|615628301|FG002|Treatment Period|Lost to Follow-up|1|||
170352778|NCT02175771|615628302|FG003|Treatment Period|Lost to Follow-up|3|||
170352779|NCT02175771|615628303|FG004|Treatment Period|Lost to Follow-up|1|||
170352780|NCT02175771|615628304|FG005|Treatment Period|Lost to Follow-up|2|||
170352781|NCT02175771|615628305|FG006|Treatment Period|Lost to Follow-up|1|||
170352782|NCT02175771|615628306|FG007|Treatment Period|Lost to Follow-up|2|||
170352783|NCT02175771|615628307|FG008|Treatment Period|Lost to Follow-up|2|||
170352784|NCT02175771|615628299|FG000|Treatment Period|Lack of Efficacy|0|||
170352785|NCT02175771|615628300|FG001|Treatment Period|Lack of Efficacy|0|||
170352786|NCT02175771|615628301|FG002|Treatment Period|Lack of Efficacy|0|||
170352787|NCT02175771|615628302|FG003|Treatment Period|Lack of Efficacy|0|||
170352788|NCT02175771|615628303|FG004|Treatment Period|Lack of Efficacy|0|||
170352789|NCT02175771|615628304|FG005|Treatment Period|Lack of Efficacy|1|||
170352790|NCT02175771|615628305|FG006|Treatment Period|Lack of Efficacy|0|||
170352791|NCT02175771|615628306|FG007|Treatment Period|Lack of Efficacy|1|||
170352792|NCT02175771|615628307|FG008|Treatment Period|Lack of Efficacy|0|||
170352793|NCT02175771|615628299|FG000|Treatment Period|Other|0|||
170352794|NCT02175771|615628300|FG001|Treatment Period|Other|1|||
170352795|NCT02175771|615628301|FG002|Treatment Period|Other|0|||
170352796|NCT02175771|615628302|FG003|Treatment Period|Other|3|||
170352797|NCT02175771|615628303|FG004|Treatment Period|Other|1|||
170352798|NCT02175771|615628304|FG005|Treatment Period|Other|0|||
170352799|NCT02175771|615628305|FG006|Treatment Period|Other|0|||
170352800|NCT02175771|615628306|FG007|Treatment Period|Other|2|||
170352801|NCT02175771|615628307|FG008|Treatment Period|Other|0|||
170352802|NCT03025217|615628310|FG000|Overall Study|Pregnancy|1|||
170352803|NCT03025217|615628310|FG000|Overall Study|Lost to Follow-up|1|||
170352804|NCT03025217|615628310|FG000|Overall Study|Not eligible, poor English|2|||
170352805|NCT03654755|615628314|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
170352806|NCT03654755|615628315|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
170352807|NCT03654755|615628316|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
170352808|NCT03654755|615628314|FG000|Overall Study|Withdrawal by Subject|2|||
170352809|NCT03654755|615628315|FG001|Overall Study|Withdrawal by Subject|4|||
170352810|NCT03654755|615628316|FG002|Overall Study|Withdrawal by Subject|8|||
170352811|NCT03654755|615628314|FG000|Overall Study|Lost to Follow-up|1|||
170352812|NCT03654755|615628315|FG001|Overall Study|Lost to Follow-up|3|||
170352813|NCT03654755|615628316|FG002|Overall Study|Lost to Follow-up|7|||
170352814|NCT03654755|615628314|FG000|Overall Study|Physician Decision|0|||
170352815|NCT03654755|615628315|FG001|Overall Study|Physician Decision|1|||
170352816|NCT03654755|615628316|FG002|Overall Study|Physician Decision|0|||
170352817|NCT03654755|615628314|FG000|Overall Study|Adverse Event|0|||
170352818|NCT03654755|615628315|FG001|Overall Study|Adverse Event|0|||
170352819|NCT03654755|615628316|FG002|Overall Study|Adverse Event|4|||
170352820|NCT03654755|615628314|FG000|Overall Study|Lack of Efficacy|0|||
170352821|NCT03654755|615628315|FG001|Overall Study|Lack of Efficacy|0|||
170352822|NCT03654755|615628316|FG002|Overall Study|Lack of Efficacy|1|||
170352823|NCT02130427|615628317|FG000|Overall Study|Imaging results not interpretable|30|||
170352824|NCT04032171|615628319|FG000|Overall Study|Study Termination|1|||
170352825|NCT04032171|615628320|FG001|Overall Study|Study Termination|0|||
170352826|NCT01088438|615628321|FG000|Overall Study|Withdrawal by Subject|11|||
170352827|NCT01088438|615628322|FG001|Overall Study|Withdrawal by Subject|6|||
170352828|NCT01088438|615628321|FG000|Overall Study|Lost to Follow-up|18|||
170352829|NCT01088438|615628322|FG001|Overall Study|Lost to Follow-up|30|||
170352830|NCT00089479|615628323|FG000|Overall Study|Death|108|||
170352831|NCT00089479|615628324|FG001|Overall Study|Death|75|||
170352832|NCT00089479|615628323|FG000|Overall Study|Withdrawal by Subject|86|||
170352833|NCT00089479|615628324|FG001|Overall Study|Withdrawal by Subject|107|||
170352834|NCT00089479|615628323|FG000|Overall Study|Lost to Follow-up|137|||
170352835|NCT00089479|615628324|FG001|Overall Study|Lost to Follow-up|107|||
170352836|NCT03943953|615628325|FG000|Trial of ITG 1|Lost to Follow-up|19|||
170352837|NCT03943953|615628326|FG001|Trial of ITG 1|Lost to Follow-up|1|||
170352838|NCT03943953|615628325|FG000|Trial of ITG 2|Lost to Follow-up|8|||
170352839|NCT03943953|615628326|FG001|Trial of ITG 2|Lost to Follow-up|0|||
170352840|NCT03943953|615628325|FG000|Trial of ITG 3|Lost to Follow-up|2|||
170352841|NCT03943953|615628326|FG001|Trial of ITG 3|Lost to Follow-up|0|||
170352842|NCT03943953|615628325|FG000|Trial of ITG 4|Lost to Follow-up|2|||
170352843|NCT03943953|615628326|FG001|Trial of ITG 4|Lost to Follow-up|0|||
170352844|NCT00289185|615628327|FG000|Overall Study|Withdrawal by Subject|4|||
170352845|NCT00289185|615628328|FG001|Overall Study|Withdrawal by Subject|8|||
170352846|NCT00289185|615628327|FG000|Overall Study|Lost to Follow-up|23|||
170352847|NCT00289185|615628328|FG001|Overall Study|Lost to Follow-up|17|||
170352848|NCT00289185|615628327|FG000|Overall Study|Death|1|||
170352849|NCT00289185|615628328|FG001|Overall Study|Death|1|||
170352850|NCT03337152|615628332|FG000|Overall Study|Physician Decision|1|||
170352851|NCT03337152|615628333|FG001|Overall Study|Physician Decision|0|||
170352852|NCT03337152|615628332|FG000|Overall Study|Lost to Follow-up|1|||
170352853|NCT03337152|615628333|FG001|Overall Study|Lost to Follow-up|3|||
170352854|NCT03337152|615628332|FG000|Overall Study|Adverse Event|3|||
170352855|NCT03337152|615628333|FG001|Overall Study|Adverse Event|1|||
170352856|NCT03337152|615628332|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
170352857|NCT03337152|615628333|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
170352858|NCT00421343|615628334|FG000|Overall Study|Death|1|||
170352859|NCT00421343|615628334|FG000|Overall Study|Withdrawal by Subject|2|||
170352860|NCT00421343|615628334|FG000|Overall Study|Lost to Follow-up|3|||
170352861|NCT03471767|615628335|FG000|Overall Study|Withdrawal by Subject|3|||
170352862|NCT03471767|615628336|FG001|Overall Study|Withdrawal by Subject|1|||
170352863|NCT03471767|615628335|FG000|Overall Study|Adverse Event|1|||
170352864|NCT03471767|615628336|FG001|Overall Study|Adverse Event|0|||
170352865|NCT03471767|615628335|FG000|Overall Study|Lost to Follow-up|1|||
170352866|NCT03471767|615628336|FG001|Overall Study|Lost to Follow-up|0|||
170352867|NCT03471767|615628335|FG000|Overall Study|PI Withdrawal|1|||
170352868|NCT03471767|615628336|FG001|Overall Study|PI Withdrawal|3|||
170352869|NCT01514188|615628344|FG000|Overall Study|Adverse Event|3|||
170352870|NCT01514188|615628345|FG001|Overall Study|Adverse Event|5|||
170352871|NCT01514188|615628344|FG000|Overall Study|Withdrawal by Subject|2|||
170352872|NCT01514188|615628345|FG001|Overall Study|Withdrawal by Subject|4|||
170352873|NCT01514188|615628344|FG000|Overall Study|Protocol Violation|2|||
170352874|NCT01514188|615628345|FG001|Overall Study|Protocol Violation|4|||
170352875|NCT01514188|615628344|FG000|Overall Study|Physician Decision|0|||
170352876|NCT01514188|615628345|FG001|Overall Study|Physician Decision|2|||
170352877|NCT01514188|615628344|FG000|Overall Study|Disease Progression|13|||
170352878|NCT01514188|615628345|FG001|Overall Study|Disease Progression|14|||
170352879|NCT01514188|615628344|FG000|Overall Study|Death|1|||
170352880|NCT01514188|615628345|FG001|Overall Study|Death|3|||
170352881|NCT01514188|615628344|FG000|Overall Study|Other|2|||
170352882|NCT01514188|615628345|FG001|Overall Study|Other|1|||
170352883|NCT01019486|615628346|FG000|Overall Study|Withdrawal by Subject|1|||
170352884|NCT01019486|615628347|FG001|Overall Study|Withdrawal by Subject|1|||
170352885|NCT01019486|615628348|FG002|Overall Study|Withdrawal by Subject|1|||
170352886|NCT03442829|615628350|FG000|Overall Study|Scheduling clash|3|||
170352887|NCT03442829|615628351|FG001|Overall Study|Scheduling clash|1|||
170352888|NCT03442829|615628350|FG000|Overall Study|Illness unrelated to study|1|||
170352889|NCT03442829|615628351|FG001|Overall Study|Illness unrelated to study|1|||
170352890|NCT03491553|615628352|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
170352891|NCT03491553|615628353|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
170352892|NCT03491553|615628354|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
170352893|NCT03491553|615628355|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
170352894|NCT03491553|615628356|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
170352895|NCT03491553|615628357|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
170352896|NCT03491553|615628352|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
170352897|NCT03491553|615628353|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
170352898|NCT03491553|615628354|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
170352899|NCT03491553|615628355|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
170352900|NCT03491553|615628356|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
170352901|NCT03491553|615628357|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
170352902|NCT02605447|615628360|FG000|Overall Study|Death|66|||
170352903|NCT02605447|615628360|FG000|Overall Study|Physician Decision|1|||
170352904|NCT02605447|615628360|FG000|Overall Study|Lost to Follow-up|24|||
170352905|NCT02605447|615628360|FG000|Overall Study|Withdrawal by Subject|10|||
170352906|NCT02605447|615628360|FG000|Overall Study|Not disclosed|1|||
170352907|NCT02237157|615628362|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
170352908|NCT02237157|615628363|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
170352909|NCT02237157|615628364|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
170352910|NCT02237157|615628365|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
170352911|NCT02237157|615628362|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
170352912|NCT02237157|615628363|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
170352913|NCT02237157|615628364|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
170352914|NCT02237157|615628365|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
170352915|NCT02045212|615628370|FG000|Overall Study|Adverse Event|0|||
170352916|NCT02045212|615628371|FG001|Overall Study|Adverse Event|1|||
170352917|NCT02045212|615628370|FG000|Overall Study|Withdrawal by Subject|1|||
170352918|NCT02045212|615628371|FG001|Overall Study|Withdrawal by Subject|0|||
170352919|NCT02045212|615628370|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
170352920|NCT02045212|615628371|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
170352921|NCT00441103|615628375|FG000|Overall Study|Adverse Event|2|||
170352922|NCT00441103|615628376|FG001|Overall Study|Adverse Event|1|||
170352923|NCT00441103|615628375|FG000|Overall Study|Death|1|||
170352924|NCT00441103|615628376|FG001|Overall Study|Death|0|||
170352925|NCT00441103|615628375|FG000|Overall Study|Disease Progression|2|||
170352926|NCT00441103|615628376|FG001|Overall Study|Disease Progression|0|||
170352927|NCT00441103|615628375|FG000|Overall Study|Lost to Follow-up|1|||
170352928|NCT00441103|615628376|FG001|Overall Study|Lost to Follow-up|0|||
170352929|NCT00441103|615628375|FG000|Overall Study|Protocol Violation|1|||
170352930|NCT00441103|615628376|FG001|Overall Study|Protocol Violation|0|||
170352931|NCT00441103|615628375|FG000|Overall Study|Participant unable to use Rebiject II|1|||
170352932|NCT00441103|615628376|FG001|Overall Study|Participant unable to use Rebiject II|0|||
170352933|NCT00441103|615628375|FG000|Overall Study|Participant refused MRI|1|||
170352934|NCT00441103|615628376|FG001|Overall Study|Participant refused MRI|0|||
170352935|NCT00441103|615628375|FG000|Overall Study|Inclusion criteria absent|1|||
170352936|NCT00441103|615628376|FG001|Overall Study|Inclusion criteria absent|0|||
170352937|NCT00441103|615628375|FG000|Overall Study|Non-compliant|0|||
170352938|NCT00441103|615628376|FG001|Overall Study|Non-compliant|1|||
170352939|NCT00441103|615628375|FG000|Overall Study|Participant decided to withdraw|1|||
170352940|NCT00441103|615628376|FG001|Overall Study|Participant decided to withdraw|0|||
170352941|NCT00441103|615628375|FG000|Overall Study|Participant's reason|0|||
170352942|NCT00441103|615628376|FG001|Overall Study|Participant's reason|1|||
170352943|NCT00441103|615628375|FG000|Overall Study|Participant decided to stop|0|||
170352944|NCT00441103|615628376|FG001|Overall Study|Participant decided to stop|1|||
170352945|NCT00515008|615628377|FG000|Overall Study|Lost to Follow-up|1|||
170352946|NCT00515008|615628378|FG001|Overall Study|Lost to Follow-up|0|||
170352947|NCT00515008|615628377|FG000|Overall Study|Declined|0|||
170352948|NCT00515008|615628378|FG001|Overall Study|Declined|3|||
170352949|NCT00515008|615628377|FG000|Overall Study|Left the Boston Area|1|||
170352950|NCT00515008|615628378|FG001|Overall Study|Left the Boston Area|1|||
170352951|NCT00515008|615628377|FG000|Overall Study|Scheduling conflict|1|||
170352952|NCT00515008|615628378|FG001|Overall Study|Scheduling conflict|0|||
170352953|NCT01081873|615628382|FG000|Overall Study|Death|86|||
170352954|NCT01081873|615628382|FG000|Overall Study|Withdrawal by Subject|10|||
170352955|NCT01081873|615628382|FG000|Overall Study|Lost to Follow-up|142|||
170352956|NCT01081873|615628382|FG000|Overall Study|Progression of prostate cancer|13|||
170352957|NCT01081873|615628382|FG000|Overall Study|Other|47|||
170352958|NCT03738566|615628383|FG000|Initial Study Phase|Withdrawal by Subject|1|||
170352959|NCT03738566|615628384|FG001|Initial Study Phase|Withdrawal by Subject|1|||
170352960|NCT03738566|615628385|FG002|Initial Study Phase|Withdrawal by Subject|2|||
170352961|NCT03738566|615628386|FG003|Initial Study Phase|Withdrawal by Subject|0|||
170352962|NCT03738566|615628383|FG000|Initial Study Phase|Death|0|||
170352963|NCT03738566|615628384|FG001|Initial Study Phase|Death|1|||
170352964|NCT03738566|615628385|FG002|Initial Study Phase|Death|0|||
170352965|NCT03738566|615628386|FG003|Initial Study Phase|Death|0|||
170352966|NCT03738566|615628383|FG000|Initial Study Phase|Treatment failure|5|||
170352967|NCT03738566|615628384|FG001|Initial Study Phase|Treatment failure|0|||
170352968|NCT03738566|615628385|FG002|Initial Study Phase|Treatment failure|0|||
170352969|NCT03738566|615628386|FG003|Initial Study Phase|Treatment failure|0|||
170352970|NCT03738566|615628383|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
170352971|NCT03738566|615628384|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
170352972|NCT03738566|615628385|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
170352973|NCT03738566|615628386|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
170352974|NCT03126539|615628387|FG000|Overall Study|Lost to Follow-up|1|||
170352975|NCT03126539|615628388|FG001|Overall Study|Lost to Follow-up|1|||
170352976|NCT03126539|615628389|FG002|Overall Study|Lost to Follow-up|1|||
170352977|NCT03126539|615628390|FG003|Overall Study|Lost to Follow-up|0|||
170352978|NCT03126539|615628391|FG004|Overall Study|Lost to Follow-up|0|||
170352979|NCT00516269|615628392|FG000|Overall Study|Adverse Event|2|||
170352980|NCT00516269|615628393|FG001|Overall Study|Adverse Event|1|||
170352981|NCT00516269|615628392|FG000|Overall Study|Lost to Follow-up|0|||
170352982|NCT00516269|615628393|FG001|Overall Study|Lost to Follow-up|1|||
170352983|NCT00516269|615628392|FG000|Overall Study|Protocol Violation|0|||
170352984|NCT00516269|615628393|FG001|Overall Study|Protocol Violation|1|||
170352985|NCT02596711|615628394|FG000|Overall Study|Lost to Follow-up|1|||
170352986|NCT02596711|615628395|FG001|Overall Study|Lost to Follow-up|2|||
170352987|NCT02596711|615628396|FG002|Overall Study|Lost to Follow-up|3|||
170352988|NCT00586924|615628398|FG000|Overall Study|Adverse event/serious adverse event|0|||
170352989|NCT00586924|615628399|FG001|Overall Study|Adverse event/serious adverse event|0|||
170352990|NCT00586924|615628400|FG002|Overall Study|Adverse event/serious adverse event|0|||
170352991|NCT00586924|615628401|FG003|Overall Study|Adverse event/serious adverse event|1|||
170352992|NCT00586924|615628402|FG004|Overall Study|Adverse event/serious adverse event|0|||
170352993|NCT00586924|615628403|FG005|Overall Study|Adverse event/serious adverse event|2|||
170352994|NCT00586924|615628398|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
170352995|NCT00586924|615628399|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
170352996|NCT00586924|615628400|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
170352997|NCT00586924|615628401|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
170352998|NCT00586924|615628402|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
170352999|NCT00586924|615628403|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
170353000|NCT00586924|615628398|FG000|Overall Study|Disease progression|0|||
170353001|NCT00586924|615628399|FG001|Overall Study|Disease progression|0|||
170353002|NCT00586924|615628400|FG002|Overall Study|Disease progression|0|||
170353003|NCT00586924|615628401|FG003|Overall Study|Disease progression|1|||
170353004|NCT00586924|615628402|FG004|Overall Study|Disease progression|1|||
170353005|NCT00586924|615628403|FG005|Overall Study|Disease progression|0|||
170353006|NCT00586924|615628398|FG000|Overall Study|Development of neutralizing antibodies|2|||
170353007|NCT00586924|615628399|FG001|Overall Study|Development of neutralizing antibodies|2|||
170353008|NCT00586924|615628400|FG002|Overall Study|Development of neutralizing antibodies|2|||
170353009|NCT00586924|615628401|FG003|Overall Study|Development of neutralizing antibodies|0|||
170353010|NCT00586924|615628402|FG004|Overall Study|Development of neutralizing antibodies|0|||
170353011|NCT00586924|615628403|FG005|Overall Study|Development of neutralizing antibodies|22|||
170353012|NCT00586924|615628398|FG000|Overall Study|Complete response|0|||
170353013|NCT00586924|615628399|FG001|Overall Study|Complete response|1|||
170353014|NCT00586924|615628400|FG002|Overall Study|Complete response|0|||
170353015|NCT00586924|615628401|FG003|Overall Study|Complete response|0|||
170353016|NCT00586924|615628402|FG004|Overall Study|Complete response|2|||
170353017|NCT00586924|615628403|FG005|Overall Study|Complete response|2|||
170353018|NCT00586924|615628398|FG000|Overall Study|Other|1|||
170353019|NCT00586924|615628399|FG001|Overall Study|Other|0|||
170353020|NCT00586924|615628400|FG002|Overall Study|Other|1|||
170353021|NCT00586924|615628401|FG003|Overall Study|Other|1|||
170353022|NCT00586924|615628402|FG004|Overall Study|Other|1|||
170353023|NCT00586924|615628403|FG005|Overall Study|Other|6|||
170353024|NCT01079962|615628404|FG000|Overall Study|Adverse Event|2|||
170353025|NCT01079962|615628405|FG001|Overall Study|Adverse Event|2|||
170353026|NCT01079962|615628404|FG000|Overall Study|Withdrawal by Subject|5|||
170353027|NCT01079962|615628405|FG001|Overall Study|Withdrawal by Subject|7|||
170353028|NCT01079962|615628404|FG000|Overall Study|Protocol Violation|2|||
170353029|NCT01079962|615628405|FG001|Overall Study|Protocol Violation|2|||
170353030|NCT01079962|615628404|FG000|Overall Study|No blood pressure (BP) control|3|||
170353031|NCT01079962|615628405|FG001|Overall Study|No blood pressure (BP) control|0|||
170353032|NCT01079962|615628404|FG000|Overall Study|Inclusion/exclusion criteria|1|||
170353033|NCT01079962|615628405|FG001|Overall Study|Inclusion/exclusion criteria|3|||
170353034|NCT01079962|615628404|FG000|Overall Study|Participant not returning for next visit|1|||
170353035|NCT01079962|615628405|FG001|Overall Study|Participant not returning for next visit|0|||
170353036|NCT01079962|615628404|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
170353037|NCT01079962|615628405|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
170353038|NCT01072539|615628406|FG000|Overall Study|Treated prior to the Site Initiation|1|||
170353039|NCT01072539|615628406|FG000|Overall Study|Protocol Violation|2|||
170353040|NCT00946530|615628407|FG000|Overall Study|Withdrawal by Subject|0|||
170353041|NCT00946530|615628408|FG001|Overall Study|Withdrawal by Subject|3|||
170353042|NCT00946530|615628409|FG002|Overall Study|Withdrawal by Subject|0|||
170353043|NCT00946530|615628410|FG003|Overall Study|Withdrawal by Subject|3|||
170353044|NCT00946530|615628407|FG000|Overall Study|Physician Decision|1|||
170353045|NCT00946530|615628408|FG001|Overall Study|Physician Decision|1|||
170353046|NCT00946530|615628409|FG002|Overall Study|Physician Decision|1|||
170353047|NCT00946530|615628410|FG003|Overall Study|Physician Decision|1|||
170353048|NCT04387136|615628411|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
170353049|NCT04387136|615628412|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
170353050|NCT01029886|615628413|FG000|Overall Study|Adverse Event|12|||
170353051|NCT01029886|615628414|FG001|Overall Study|Adverse Event|25|||
170353052|NCT01029886|615628413|FG000|Overall Study|Lost to Follow-up|1|||
170353053|NCT01029886|615628414|FG001|Overall Study|Lost to Follow-up|0|||
170353054|NCT01029886|615628413|FG000|Overall Study|Physician Decision|2|||
170353055|NCT01029886|615628414|FG001|Overall Study|Physician Decision|6|||
170353056|NCT01029886|615628413|FG000|Overall Study|Protocol Violation|17|||
170353057|NCT01029886|615628414|FG001|Overall Study|Protocol Violation|5|||
170353058|NCT01029886|615628413|FG000|Overall Study|Withdrawal by Subject|8|||
170353059|NCT01029886|615628414|FG001|Overall Study|Withdrawal by Subject|18|||
170353060|NCT01029886|615628413|FG000|Overall Study|Entry Criteria Not Met|13|||
170353061|NCT01029886|615628414|FG001|Overall Study|Entry Criteria Not Met|5|||
170353062|NCT01029886|615628413|FG000|Overall Study|Sponsor Decision|1|||
170353063|NCT01029886|615628414|FG001|Overall Study|Sponsor Decision|0|||
170353064|NCT01029886|615628413|FG000|Overall Study|Loss Glucose Control|7|||
170353065|NCT01029886|615628414|FG001|Overall Study|Loss Glucose Control|1|||
170353066|NCT00417976|615628415|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
170353067|NCT00417976|615628415|FG000|Overall Study|Treatment -related toxicity|2|||
170353068|NCT02720016|615628416|FG000|Overall Study|Separation of couple|6|||
170353069|NCT02720016|615628417|FG001|Overall Study|Separation of couple|8|||
170353070|NCT02720016|615628418|FG002|Overall Study|Separation of couple|2|||
170353071|NCT02720016|615628416|FG000|Overall Study|Withdrawal by Subject|6|||
170353072|NCT02720016|615628417|FG001|Overall Study|Withdrawal by Subject|6|||
170353073|NCT02720016|615628418|FG002|Overall Study|Withdrawal by Subject|4|||
170353074|NCT02720016|615628416|FG000|Overall Study|Scheduling issues|2|||
170353075|NCT02720016|615628417|FG001|Overall Study|Scheduling issues|4|||
170353076|NCT02720016|615628418|FG002|Overall Study|Scheduling issues|7|||
170353077|NCT02720016|615628416|FG000|Overall Study|Childcare|2|||
170353078|NCT02720016|615628417|FG001|Overall Study|Childcare|0|||
170353079|NCT02720016|615628418|FG002|Overall Study|Childcare|2|||
170353080|NCT02720016|615628416|FG000|Overall Study|Withdrawal by PI|2|||
170353081|NCT02720016|615628417|FG001|Overall Study|Withdrawal by PI|2|||
170353082|NCT02720016|615628418|FG002|Overall Study|Withdrawal by PI|0|||
170353083|NCT02720016|615628416|FG000|Overall Study|Moved away|2|||
170353084|NCT02720016|615628417|FG001|Overall Study|Moved away|0|||
170353085|NCT02720016|615628418|FG002|Overall Study|Moved away|0|||
170353086|NCT02720016|615628416|FG000|Overall Study|Not Primary Health Concern|0|||
170353087|NCT02720016|615628417|FG001|Overall Study|Not Primary Health Concern|0|||
170353088|NCT02720016|615628418|FG002|Overall Study|Not Primary Health Concern|2|||
170353089|NCT02720016|615628416|FG000|Overall Study|Transportation issues|0|||
170353090|NCT02720016|615628417|FG001|Overall Study|Transportation issues|0|||
170353091|NCT02720016|615628418|FG002|Overall Study|Transportation issues|1|||
170353092|NCT02720016|615628416|FG000|Overall Study|Other|0|||
170353093|NCT02720016|615628417|FG001|Overall Study|Other|0|||
170353094|NCT02720016|615628418|FG002|Overall Study|Other|2|||
170353095|NCT02358369|615628419|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
170353096|NCT02358369|615628420|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
170353097|NCT02358369|615628421|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
170353098|NCT02358369|615628422|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
170353099|NCT02358369|615628423|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
170353100|NCT02358369|615628419|FG000|Treatment Period A/B|Adverse Event|0|||
170353101|NCT02358369|615628420|FG001|Treatment Period A/B|Adverse Event|0|||
170353102|NCT02358369|615628421|FG002|Treatment Period A/B|Adverse Event|1|||
170353103|NCT02358369|615628422|FG003|Treatment Period A/B|Adverse Event|2|||
170353104|NCT02358369|615628423|FG004|Treatment Period A/B|Adverse Event|0|||
170353105|NCT02358369|615628419|FG000|Treatment Period A/B|Death|0|||
170353106|NCT02358369|615628420|FG001|Treatment Period A/B|Death|0|||
170353107|NCT02358369|615628421|FG002|Treatment Period A/B|Death|1|||
170353108|NCT02358369|615628422|FG003|Treatment Period A/B|Death|0|||
170353109|NCT02358369|615628423|FG004|Treatment Period A/B|Death|0|||
170353110|NCT02358369|615628419|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
170353111|NCT02358369|615628420|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
170353112|NCT02358369|615628421|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
170353113|NCT02358369|615628422|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
170353114|NCT02358369|615628423|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
170353115|NCT02358369|615628419|FG000|Treatment Period C|Adverse Event|0|||
170353116|NCT02358369|615628420|FG001|Treatment Period C|Adverse Event|0|||
170353117|NCT02358369|615628421|FG002|Treatment Period C|Adverse Event|0|||
170353118|NCT02358369|615628422|FG003|Treatment Period C|Adverse Event|0|||
170353119|NCT02358369|615628423|FG004|Treatment Period C|Adverse Event|7|||
170353120|NCT00115765|615628424|FG000|Overall Study|Withdrawal by Subject|22|||
170353121|NCT00115765|615628425|FG001|Overall Study|Withdrawal by Subject|53|||
170353122|NCT00115765|615628426|FG002|Overall Study|Withdrawal by Subject|76|||
170353123|NCT00115765|615628427|FG003|Overall Study|Withdrawal by Subject|15|||
170353124|NCT00115765|615628424|FG000|Overall Study|Physician Decision|4|||
170353125|NCT00115765|615628425|FG001|Overall Study|Physician Decision|15|||
170353126|NCT00115765|615628426|FG002|Overall Study|Physician Decision|18|||
170353127|NCT00115765|615628427|FG003|Overall Study|Physician Decision|13|||
170353128|NCT00115765|615628424|FG000|Overall Study|Lost to Follow-up|3|||
170353129|NCT00115765|615628425|FG001|Overall Study|Lost to Follow-up|20|||
170353130|NCT00115765|615628426|FG002|Overall Study|Lost to Follow-up|18|||
170353131|NCT00115765|615628427|FG003|Overall Study|Lost to Follow-up|1|||
170353132|NCT00115765|615628424|FG000|Overall Study|Other|6|||
170353133|NCT00115765|615628425|FG001|Overall Study|Other|12|||
170353134|NCT00115765|615628426|FG002|Overall Study|Other|9|||
170353135|NCT00115765|615628427|FG003|Overall Study|Other|2|||
170353136|NCT01683071|615628428|FG000|Part 1|Lack of Efficacy|1|||
170353137|NCT01683071|615628429|FG001|Part 1|Lack of Efficacy|0|||
170353138|NCT01683071|615628430|FG002|Part 1|Lack of Efficacy|0|||
170353139|NCT01683071|615628431|FG003|Part 1|Lack of Efficacy|3|||
170353140|NCT01683071|615628432|FG004|Part 1|Lack of Efficacy|0|||
170353141|NCT01683071|615628433|FG005|Part 1|Lack of Efficacy|0|||
170353142|NCT01683071|615628428|FG000|Part 1|Withdrawal by Subject|1|||
170353143|NCT01683071|615628429|FG001|Part 1|Withdrawal by Subject|2|||
170353144|NCT01683071|615628430|FG002|Part 1|Withdrawal by Subject|2|||
170353145|NCT01683071|615628431|FG003|Part 1|Withdrawal by Subject|1|||
170353146|NCT01683071|615628432|FG004|Part 1|Withdrawal by Subject|0|||
170353147|NCT01683071|615628433|FG005|Part 1|Withdrawal by Subject|0|||
170353148|NCT01683071|615628428|FG000|Part 1|Surgery Cancelled|1|||
170353149|NCT01683071|615628429|FG001|Part 1|Surgery Cancelled|0|||
170353150|NCT01683071|615628430|FG002|Part 1|Surgery Cancelled|0|||
170353151|NCT01683071|615628431|FG003|Part 1|Surgery Cancelled|0|||
170353152|NCT01683071|615628432|FG004|Part 1|Surgery Cancelled|0|||
170353153|NCT01683071|615628433|FG005|Part 1|Surgery Cancelled|0|||
170353154|NCT01683071|615628428|FG000|Part 1|Did not receive study drug|1|||
170353155|NCT01683071|615628429|FG001|Part 1|Did not receive study drug|0|||
170353156|NCT01683071|615628430|FG002|Part 1|Did not receive study drug|0|||
170353157|NCT01683071|615628431|FG003|Part 1|Did not receive study drug|1|||
170353158|NCT01683071|615628432|FG004|Part 1|Did not receive study drug|0|||
170353159|NCT01683071|615628433|FG005|Part 1|Did not receive study drug|0|||
170353160|NCT01683071|615628428|FG000|Part 1|Early termination; met exclusion criteria|0|||
170353161|NCT01683071|615628429|FG001|Part 1|Early termination; met exclusion criteria|2|||
170353162|NCT01683071|615628430|FG002|Part 1|Early termination; met exclusion criteria|1|||
170353163|NCT01683071|615628431|FG003|Part 1|Early termination; met exclusion criteria|0|||
170353164|NCT01683071|615628432|FG004|Part 1|Early termination; met exclusion criteria|0|||
170353165|NCT01683071|615628433|FG005|Part 1|Early termination; met exclusion criteria|0|||
170353166|NCT01683071|615628428|FG000|Part 2|Lack of Efficacy|0|||
170353167|NCT01683071|615628429|FG001|Part 2|Lack of Efficacy|0|||
170353168|NCT01683071|615628430|FG002|Part 2|Lack of Efficacy|0|||
170353169|NCT01683071|615628431|FG003|Part 2|Lack of Efficacy|0|||
170353170|NCT01683071|615628432|FG004|Part 2|Lack of Efficacy|3|||
170353171|NCT01683071|615628433|FG005|Part 2|Lack of Efficacy|4|||
170353172|NCT01683071|615628428|FG000|Part 2|Lost to Follow-up|0|||
170353173|NCT01683071|615628429|FG001|Part 2|Lost to Follow-up|0|||
170353174|NCT01683071|615628430|FG002|Part 2|Lost to Follow-up|0|||
170353175|NCT01683071|615628431|FG003|Part 2|Lost to Follow-up|0|||
170353176|NCT01683071|615628432|FG004|Part 2|Lost to Follow-up|2|||
170353177|NCT01683071|615628433|FG005|Part 2|Lost to Follow-up|0|||
170353178|NCT01683071|615628428|FG000|Part 2|Withdrawal by Subject|0|||
170353179|NCT01683071|615628429|FG001|Part 2|Withdrawal by Subject|0|||
170353180|NCT01683071|615628430|FG002|Part 2|Withdrawal by Subject|0|||
170353181|NCT01683071|615628431|FG003|Part 2|Withdrawal by Subject|0|||
170353182|NCT01683071|615628432|FG004|Part 2|Withdrawal by Subject|3|||
170353183|NCT01683071|615628433|FG005|Part 2|Withdrawal by Subject|3|||
170353184|NCT01683071|615628428|FG000|Part 2|Surgery cancelled|0|||
170353185|NCT01683071|615628429|FG001|Part 2|Surgery cancelled|0|||
170353186|NCT01683071|615628430|FG002|Part 2|Surgery cancelled|0|||
170353187|NCT01683071|615628431|FG003|Part 2|Surgery cancelled|0|||
170353188|NCT01683071|615628432|FG004|Part 2|Surgery cancelled|4|||
170353189|NCT01683071|615628433|FG005|Part 2|Surgery cancelled|2|||
170353190|NCT01683071|615628428|FG000|Part 2|Did not receive study drug|0|||
170353191|NCT01683071|615628429|FG001|Part 2|Did not receive study drug|0|||
170353192|NCT01683071|615628430|FG002|Part 2|Did not receive study drug|0|||
170353193|NCT01683071|615628431|FG003|Part 2|Did not receive study drug|0|||
170353194|NCT01683071|615628432|FG004|Part 2|Did not receive study drug|2|||
170353195|NCT01683071|615628433|FG005|Part 2|Did not receive study drug|1|||
170353196|NCT01683071|615628428|FG000|Part 2|Met exclusion criterion|0|||
170353197|NCT01683071|615628429|FG001|Part 2|Met exclusion criterion|0|||
170353198|NCT01683071|615628430|FG002|Part 2|Met exclusion criterion|0|||
170353199|NCT01683071|615628431|FG003|Part 2|Met exclusion criterion|0|||
170353200|NCT01683071|615628432|FG004|Part 2|Met exclusion criterion|1|||
170353201|NCT01683071|615628433|FG005|Part 2|Met exclusion criterion|1|||
170353202|NCT01683071|615628428|FG000|Part 2|Protocol deviation|0|||
170353203|NCT01683071|615628429|FG001|Part 2|Protocol deviation|0|||
170353204|NCT01683071|615628430|FG002|Part 2|Protocol deviation|0|||
170353205|NCT01683071|615628431|FG003|Part 2|Protocol deviation|0|||
170353206|NCT01683071|615628432|FG004|Part 2|Protocol deviation|1|||
170353207|NCT01683071|615628433|FG005|Part 2|Protocol deviation|2|||
170353208|NCT01683071|615628428|FG000|Part 2|Withdrawal by investigator decision|0|||
170353209|NCT01683071|615628429|FG001|Part 2|Withdrawal by investigator decision|0|||
170353210|NCT01683071|615628430|FG002|Part 2|Withdrawal by investigator decision|0|||
170353211|NCT01683071|615628431|FG003|Part 2|Withdrawal by investigator decision|0|||
170353212|NCT01683071|615628432|FG004|Part 2|Withdrawal by investigator decision|1|||
170353213|NCT01683071|615628433|FG005|Part 2|Withdrawal by investigator decision|2|||
170353214|NCT03707158|615628434|FG000|Midtreatment|Lost to Follow-up|16|||
170353215|NCT03707158|615628435|FG001|Midtreatment|Lost to Follow-up|7|||
170353216|NCT03707158|615628434|FG000|Midtreatment|Withdrawal by Subject|28|||
170353217|NCT03707158|615628435|FG001|Midtreatment|Withdrawal by Subject|19|||
170353218|NCT03707158|615628434|FG000|Posttreatment|Lost to Follow-up|0|||
170353219|NCT03707158|615628435|FG001|Posttreatment|Lost to Follow-up|5|||
170353220|NCT03707158|615628434|FG000|Follow-up|Lost to Follow-up|19|||
170353221|NCT03707158|615628435|FG001|Follow-up|Lost to Follow-up|18|||
170353222|NCT03707158|615628434|FG000|Follow-up|Withdrawal by Subject|13|||
170353223|NCT03707158|615628435|FG001|Follow-up|Withdrawal by Subject|6|||
170353224|NCT01968187|615628438|FG000|Overall Study|Adverse Event|0|||
170353225|NCT01968187|615628439|FG001|Overall Study|Adverse Event|1|||
170353226|NCT01968187|615628438|FG000|Overall Study|Randomized but not treated|1|||
170353227|NCT01968187|615628439|FG001|Overall Study|Randomized but not treated|0|||
170353228|NCT00992446|615628441|FG000|Overall Study|Disease Progression|1|||
170353229|NCT00992446|615628441|FG000|Overall Study|Withdrawal by Subject|2|||
170353230|NCT00992446|615628441|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
170353231|NCT01146951|615630016|FG000|Overall Study|Adverse Event|4|||
170353232|NCT01146951|615630017|FG001|Overall Study|Adverse Event|1|||
170353233|NCT01677624|615630022|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
170353234|NCT01617655|615630023|FG000|Overall Study|Adverse Event|2|||
170353235|NCT01617655|615630024|FG001|Overall Study|Adverse Event|3|||
170353236|NCT01617655|615630023|FG000|Overall Study|Poor compliance to protocol|1|||
170353237|NCT01617655|615630024|FG001|Overall Study|Poor compliance to protocol|4|||
170353238|NCT01617655|615630023|FG000|Overall Study|Participants moved|0|||
170353239|NCT01617655|615630024|FG001|Overall Study|Participants moved|4|||
170353240|NCT01617655|615630023|FG000|Overall Study|Consent withdrawn by participant|1|||
170353241|NCT01617655|615630024|FG001|Overall Study|Consent withdrawn by participant|1|||
170353242|NCT01617655|615630023|FG000|Overall Study|Last visit outside protocol visit window|1|||
170353243|NCT01617655|615630024|FG001|Overall Study|Last visit outside protocol visit window|10|||
170353244|NCT01617655|615630023|FG000|Overall Study|Site closure|3|||
170353245|NCT01617655|615630024|FG001|Overall Study|Site closure|5|||
170353246|NCT01617655|615630023|FG000|Overall Study|Other than specified above|1|||
170353247|NCT01617655|615630024|FG001|Overall Study|Other than specified above|2|||
170353248|NCT01354353|615630025|FG000|Overall Study|Adverse Event|1|||
170353249|NCT01354353|615630026|FG001|Overall Study|Adverse Event|0|||
170353250|NCT01354353|615630027|FG002|Overall Study|Adverse Event|0|||
170353251|NCT01354353|615630028|FG003|Overall Study|Adverse Event|4|||
170353252|NCT01354353|615630029|FG004|Overall Study|Adverse Event|0|||
170353253|NCT01354353|615630030|FG005|Overall Study|Adverse Event|5|||
170353254|NCT01354353|615630025|FG000|Overall Study|Entry Criteria Not Met|0|||
170353255|NCT01354353|615630026|FG001|Overall Study|Entry Criteria Not Met|0|||
170353256|NCT01354353|615630027|FG002|Overall Study|Entry Criteria Not Met|0|||
170353257|NCT01354353|615630028|FG003|Overall Study|Entry Criteria Not Met|1|||
170353258|NCT01354353|615630029|FG004|Overall Study|Entry Criteria Not Met|1|||
170353259|NCT01354353|615630030|FG005|Overall Study|Entry Criteria Not Met|0|||
170353260|NCT01354353|615630025|FG000|Overall Study|Physician Decision|0|||
170353261|NCT01354353|615630026|FG001|Overall Study|Physician Decision|1|||
170353262|NCT01354353|615630027|FG002|Overall Study|Physician Decision|1|||
170353263|NCT01354353|615630028|FG003|Overall Study|Physician Decision|0|||
170353264|NCT01354353|615630029|FG004|Overall Study|Physician Decision|0|||
170353265|NCT01354353|615630030|FG005|Overall Study|Physician Decision|0|||
170353266|NCT01354353|615630025|FG000|Overall Study|Withdrawal by Subject|2|||
170353267|NCT01354353|615630026|FG001|Overall Study|Withdrawal by Subject|0|||
170353268|NCT01354353|615630027|FG002|Overall Study|Withdrawal by Subject|1|||
170353269|NCT01354353|615630028|FG003|Overall Study|Withdrawal by Subject|0|||
170353270|NCT01354353|615630029|FG004|Overall Study|Withdrawal by Subject|0|||
170353271|NCT01354353|615630030|FG005|Overall Study|Withdrawal by Subject|1|||
170353272|NCT00831441|615630031|FG000|Randomized|Death|82|||
170353273|NCT00831441|615630032|FG001|Randomized|Death|81|||
170353274|NCT00831441|615630031|FG000|Randomized|Adverse Event|248|||
170353275|NCT00831441|615630032|FG001|Randomized|Adverse Event|321|||
170353276|NCT00831441|615630031|FG000|Randomized|Emergency procedure|2|||
170353277|NCT00831441|615630032|FG001|Randomized|Emergency procedure|2|||
170353278|NCT00831441|615630031|FG000|Randomized|Elective procedure|26|||
170353279|NCT00831441|615630032|FG001|Randomized|Elective procedure|25|||
170353280|NCT00831441|615630031|FG000|Randomized|Physician Decision|26|||
170353281|NCT00831441|615630032|FG001|Randomized|Physician Decision|35|||
170353282|NCT00831441|615630031|FG000|Randomized|No longer met criteria|13|||
170353283|NCT00831441|615630032|FG001|Randomized|No longer met criteria|19|||
170353284|NCT00831441|615630031|FG000|Randomized|Withdrawal by Subject|178|||
170353285|NCT00831441|615630032|FG001|Randomized|Withdrawal by Subject|212|||
170353286|NCT00831441|615630031|FG000|Randomized|Lost to Follow-up|26|||
170353287|NCT00831441|615630032|FG001|Randomized|Lost to Follow-up|35|||
170353288|NCT00831441|615630031|FG000|Randomized|Administrative reason by sponsor|2780|||
170353289|NCT00831441|615630032|FG001|Randomized|Administrative reason by sponsor|2671|||
170353290|NCT00831441|615630031|FG000|Randomized|poor/non-compliance|30|||
170353291|NCT00831441|615630032|FG001|Randomized|poor/non-compliance|38|||
170353292|NCT00831441|615630031|FG000|Randomized|non-specified|276|||
170353293|NCT00831441|615630032|FG001|Randomized|non-specified|266|||
170353294|NCT00831441|615630031|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
170353295|NCT00831441|615630032|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
170353296|NCT00831441|615630031|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
170353297|NCT00831441|615630032|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
170353298|NCT00831441|615630031|FG000|Follow Up (30 Days)|Death|63|||
170353299|NCT00831441|615630032|FG001|Follow Up (30 Days)|Death|86|||
170353300|NCT00831441|615630031|FG000|Follow Up (30 Days)|non-specified|16|||
170353301|NCT00831441|615630032|FG001|Follow Up (30 Days)|non-specified|26|||
170353302|NCT00831441|615630031|FG000|Follow Up (30 Days)|missing end of study status|0|||
170353303|NCT00831441|615630032|FG001|Follow Up (30 Days)|missing end of study status|1|||
170353304|NCT01640925|615630033|FG000|Overall Study|Withdrawal by Subject|1|||
170353305|NCT01640925|615630034|FG001|Overall Study|Withdrawal by Subject|0|||
170353306|NCT01640925|615630033|FG000|Overall Study|Previously enrolled in this trial|13|||
170353307|NCT01640925|615630034|FG001|Overall Study|Previously enrolled in this trial|11|||
170353308|NCT02156492|615630035|FG000|Period 1|No Reason Given|0|||
170353309|NCT02156492|615630036|FG001|Period 1|No Reason Given|1|||
170353310|NCT02156492|615630037|FG002|Period 1|No Reason Given|0|||
170353311|NCT02156492|615630035|FG000|Period 3|Adverse Event|0|||
170353312|NCT02156492|615630036|FG001|Period 3|Adverse Event|1|||
170353313|NCT02156492|615630037|FG002|Period 3|Adverse Event|0|||
170353314|NCT00485589|615630046|FG000|Overall Study|Death|2|||
170353315|NCT00485589|615630047|FG001|Overall Study|Death|2|||
170353316|NCT00485589|615630048|FG002|Overall Study|Death|0|||
170353317|NCT00485589|615630046|FG000|Overall Study|Failure to return|6|||
170353318|NCT00485589|615630047|FG001|Overall Study|Failure to return|5|||
170353319|NCT00485589|615630048|FG002|Overall Study|Failure to return|1|||
170353320|NCT00485589|615630046|FG000|Overall Study|Protocol Violation|1|||
170353321|NCT00485589|615630047|FG001|Overall Study|Protocol Violation|0|||
170353322|NCT00485589|615630048|FG002|Overall Study|Protocol Violation|0|||
170353323|NCT00485589|615630046|FG000|Overall Study|Violation of selection criteria at entry|0|||
170353324|NCT00485589|615630047|FG001|Overall Study|Violation of selection criteria at entry|3|||
170353325|NCT00485589|615630048|FG002|Overall Study|Violation of selection criteria at entry|1|||
170353326|NCT00485589|615630046|FG000|Overall Study|Administrative/Other|1|||
170353327|NCT00485589|615630047|FG001|Overall Study|Administrative/Other|2|||
170353328|NCT00485589|615630048|FG002|Overall Study|Administrative/Other|1|||
170353329|NCT00485589|615630046|FG000|Overall Study|Insufficient therapeutic response|10|||
170353330|NCT00485589|615630047|FG001|Overall Study|Insufficient therapeutic response|3|||
170353331|NCT00485589|615630048|FG002|Overall Study|Insufficient therapeutic response|1|||
170353332|NCT00485589|615630046|FG000|Overall Study|Refused treatment/did not cooperate|1|||
170353333|NCT00485589|615630047|FG001|Overall Study|Refused treatment/did not cooperate|0|||
170353334|NCT00485589|615630048|FG002|Overall Study|Refused treatment/did not cooperate|2|||
170353335|NCT00485589|615630046|FG000|Overall Study|Withdrawal by Subject|3|||
170353336|NCT00485589|615630047|FG001|Overall Study|Withdrawal by Subject|2|||
170353337|NCT00485589|615630048|FG002|Overall Study|Withdrawal by Subject|2|||
170353338|NCT00485589|615630046|FG000|Overall Study|Adverse Event|3|||
170353339|NCT00485589|615630047|FG001|Overall Study|Adverse Event|3|||
170353340|NCT00485589|615630048|FG002|Overall Study|Adverse Event|10|||
170353341|NCT01104584|615630051|FG000|Overall Study|Study drug never administered|21|||
170353342|NCT01104584|615630051|FG000|Overall Study|Study prematurely discontinued|2|||
170353343|NCT02370498|615630052|FG000|Overall Study|Adverse Event|10|||
170353344|NCT02370498|615630053|FG001|Overall Study|Adverse Event|8|||
170353345|NCT02370498|615630052|FG000|Overall Study|Death|263|||
170353346|NCT02370498|615630053|FG001|Overall Study|Death|265|||
170353347|NCT02370498|615630052|FG000|Overall Study|Protocol Violation|1|||
170353348|NCT02370498|615630053|FG001|Overall Study|Protocol Violation|2|||
170353349|NCT02370498|615630052|FG000|Overall Study|Withdrawal by Subject|7|||
170353350|NCT02370498|615630053|FG001|Overall Study|Withdrawal by Subject|12|||
170353351|NCT02370498|615630052|FG000|Overall Study|Sponsor's decision|15|||
170353352|NCT02370498|615630053|FG001|Overall Study|Sponsor's decision|9|||
170353353|NCT01260467|615630054|FG000|Overall Study|Withdrawal by Subject|2|||
170353354|NCT03364608|615630056|FG000|Overall Study|Withdrawal by Subject|4|||
170353355|NCT03364608|615630056|FG000|Overall Study|Protocol Violation|2|||
170353356|NCT03364608|615630056|FG000|Overall Study|Lost to Follow-up|2|||
170353357|NCT01163253|615630059|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
170353358|NCT01163253|615630060|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
170353359|NCT01163253|615630059|FG000|Overall Study|Study Terminated by Sponsor|978|||
170353360|NCT01163253|615630060|FG001|Overall Study|Study Terminated by Sponsor|349|||
170353361|NCT01163253|615630059|FG000|Overall Study|Protocol Violation|43|||
170353362|NCT01163253|615630060|FG001|Overall Study|Protocol Violation|12|||
170353363|NCT01163253|615630059|FG000|Overall Study|Withdrawal by Subject|199|||
170353364|NCT01163253|615630060|FG001|Overall Study|Withdrawal by Subject|50|||
170353365|NCT01163253|615630059|FG000|Overall Study|Medication Error|1|||
170353366|NCT01163253|615630060|FG001|Overall Study|Medication Error|0|||
170353367|NCT01163253|615630059|FG000|Overall Study|Lost to Follow-up|125|||
170353368|NCT01163253|615630060|FG001|Overall Study|Lost to Follow-up|23|||
170353369|NCT01163253|615630059|FG000|Overall Study|Insufficient Clinical Response|423|||
170353370|NCT01163253|615630060|FG001|Overall Study|Insufficient Clinical Response|29|||
170353371|NCT01163253|615630059|FG000|Overall Study|Adverse Event|300|||
170353372|NCT01163253|615630060|FG001|Overall Study|Adverse Event|78|||
170353373|NCT01163253|615630059|FG000|Overall Study|Death|17|||
170353374|NCT01163253|615630060|FG001|Overall Study|Death|5|||
170353375|NCT01163253|615630059|FG000|Overall Study|Ongoing|13|||
170353376|NCT01163253|615630060|FG001|Overall Study|Ongoing|4|||
170353377|NCT01163253|615630059|FG000|Overall Study|Other Unspecified|170|||
170353378|NCT01163253|615630060|FG001|Overall Study|Other Unspecified|34|||
170353379|NCT00190983|615630065|FG000|Overall Study|Inevaluable (never treated)|2|||
170353380|NCT03150095|615630068|FG000|Overall Study|Death|0|||
170353381|NCT03150095|615630069|FG001|Overall Study|Death|1|||
170353382|NCT03150095|615630068|FG000|Overall Study|Lost to Follow-up|1|||
170353383|NCT03150095|615630069|FG001|Overall Study|Lost to Follow-up|1|||
170353384|NCT03150095|615630068|FG000|Overall Study|Withdrawal by Subject|4|||
170353385|NCT03150095|615630069|FG001|Overall Study|Withdrawal by Subject|0|||
170353386|NCT03150095|615630068|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
170353387|NCT03150095|615630069|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
170353388|NCT00992784|615630070|FG000|Overall Study|Adverse Event|2|||
170353389|NCT00992784|615630071|FG001|Overall Study|Adverse Event|1|||
170353390|NCT00992784|615630072|FG002|Overall Study|Adverse Event|0|||
170353391|NCT00992784|615630070|FG000|Overall Study|Withdrawal by Subject|1|||
170353392|NCT00992784|615630071|FG001|Overall Study|Withdrawal by Subject|1|||
170353393|NCT00992784|615630072|FG002|Overall Study|Withdrawal by Subject|1|||
170353394|NCT00781599|615630074|FG000|Overall Study|Lost to Follow-up|7|||
170353395|NCT00781599|615630075|FG001|Overall Study|Lost to Follow-up|4|||
170353396|NCT01124448|615630084|FG000|Overall Study|Lost to Follow-up|0|||
170353397|NCT01124448|615630085|FG001|Overall Study|Lost to Follow-up|3|||
170353398|NCT01124448|615630084|FG000|Overall Study|Protocol Violation|2|||
170353399|NCT01124448|615630085|FG001|Overall Study|Protocol Violation|0|||
170353400|NCT00976950|615630090|FG000|Overall Study|Adverse Event|3|||
170353401|NCT00976950|615630090|FG000|Overall Study|Events with no relationship to Aptivus|3|||
170353402|NCT02951988|615630091|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
170353403|NCT02951988|615630092|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
170353404|NCT02951988|615630093|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
170353405|NCT02951988|615630094|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
170353406|NCT02951988|615630091|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
170353407|NCT02951988|615630092|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
170353408|NCT02951988|615630093|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
170353409|NCT02951988|615630094|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
170353410|NCT02951988|615630091|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
170353411|NCT02951988|615630092|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
170353412|NCT02951988|615630093|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
170353413|NCT02951988|615630094|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
170353414|NCT02951988|615630091|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
170353415|NCT02951988|615630092|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
170353416|NCT02951988|615630093|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
170353417|NCT02951988|615630094|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
170353418|NCT02951988|615630091|FG000|Open-Label Treatment Period|Protocol Violation|22|||
170353419|NCT02951988|615630092|FG001|Open-Label Treatment Period|Protocol Violation|0|||
170353420|NCT02951988|615630093|FG002|Open-Label Treatment Period|Protocol Violation|0|||
170353421|NCT02951988|615630094|FG003|Open-Label Treatment Period|Protocol Violation|0|||
170353422|NCT02951988|615630091|FG000|Open-Label Treatment Period|Pregnancy|2|||
170353423|NCT02951988|615630092|FG001|Open-Label Treatment Period|Pregnancy|0|||
170353424|NCT02951988|615630093|FG002|Open-Label Treatment Period|Pregnancy|0|||
170353425|NCT02951988|615630094|FG003|Open-Label Treatment Period|Pregnancy|0|||
170353426|NCT02951988|615630091|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
170353427|NCT02951988|615630092|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
170353428|NCT02951988|615630093|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
170353429|NCT02951988|615630094|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
170353430|NCT02951988|615630091|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
170353431|NCT02951988|615630092|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
170353432|NCT02951988|615630093|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
170353433|NCT02951988|615630094|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
170353434|NCT02951988|615630091|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
170353435|NCT02951988|615630092|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
170353436|NCT02951988|615630093|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
170353437|NCT02951988|615630094|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
170353438|NCT02951988|615630091|FG000|Open-Label Treatment Period|Adverse Event|45|||
170353439|NCT02951988|615630092|FG001|Open-Label Treatment Period|Adverse Event|0|||
170353440|NCT02951988|615630093|FG002|Open-Label Treatment Period|Adverse Event|0|||
170353441|NCT02951988|615630094|FG003|Open-Label Treatment Period|Adverse Event|0|||
170353442|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
170353443|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
170353444|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
170353445|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
170353446|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
170353447|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
170353448|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
170353449|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
170353450|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
170353451|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
170353452|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
170353453|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
170353454|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
170353455|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
170353456|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
170353457|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
170353458|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Pregnancy|0|||
170353459|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Pregnancy|1|||
170353460|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Pregnancy|1|||
170353461|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Pregnancy|0|||
170353462|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170353463|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
170353464|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
170353465|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
170353466|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170353467|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
170353468|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
170353469|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
170353470|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Adverse Event|0|||
170353471|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Adverse Event|8|||
170353472|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Adverse Event|3|||
170353473|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Adverse Event|6|||
170353474|NCT02951988|615630091|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
170353475|NCT02951988|615630092|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
170353476|NCT02951988|615630093|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
170353477|NCT02951988|615630094|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
170353478|NCT04167306|615630095|FG000|Overall Study|Lost to Follow-up|2|||
170353479|NCT04167306|615630096|FG001|Overall Study|Lost to Follow-up|2|||
170353480|NCT04167306|615630097|FG002|Overall Study|Lost to Follow-up|5|||
170353481|NCT04167306|615630098|FG003|Overall Study|Lost to Follow-up|5|||
170353482|NCT04167306|615630095|FG000|Overall Study|Adverse Event|13|||
170353483|NCT04167306|615630096|FG001|Overall Study|Adverse Event|14|||
170353484|NCT04167306|615630097|FG002|Overall Study|Adverse Event|5|||
170353485|NCT04167306|615630098|FG003|Overall Study|Adverse Event|4|||
170353486|NCT04167306|615630095|FG000|Overall Study|Withdrawal by Subject|4|||
170353487|NCT04167306|615630096|FG001|Overall Study|Withdrawal by Subject|6|||
170353488|NCT04167306|615630097|FG002|Overall Study|Withdrawal by Subject|8|||
170353489|NCT04167306|615630098|FG003|Overall Study|Withdrawal by Subject|3|||
170353490|NCT04167306|615630095|FG000|Overall Study|covid|1|||
170353491|NCT04167306|615630096|FG001|Overall Study|covid|1|||
170353492|NCT04167306|615630097|FG002|Overall Study|covid|2|||
170353493|NCT04167306|615630098|FG003|Overall Study|covid|1|||
170353494|NCT04167306|615630095|FG000|Overall Study|concomitant medication|0|||
170353495|NCT04167306|615630096|FG001|Overall Study|concomitant medication|0|||
170353496|NCT04167306|615630097|FG002|Overall Study|concomitant medication|0|||
170353497|NCT04167306|615630098|FG003|Overall Study|concomitant medication|1|||
170353498|NCT04167306|615630095|FG000|Overall Study|Alcohol treatment|0|||
170353499|NCT04167306|615630096|FG001|Overall Study|Alcohol treatment|4|||
170353500|NCT04167306|615630097|FG002|Overall Study|Alcohol treatment|3|||
170353501|NCT04167306|615630098|FG003|Overall Study|Alcohol treatment|2|||
170353502|NCT04167306|615630095|FG000|Overall Study|non-compliance|0|||
170353503|NCT04167306|615630096|FG001|Overall Study|non-compliance|0|||
170353504|NCT04167306|615630097|FG002|Overall Study|non-compliance|1|||
170353505|NCT04167306|615630098|FG003|Overall Study|non-compliance|0|||
170353506|NCT04167306|615630095|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
170353507|NCT04167306|615630096|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
170353508|NCT04167306|615630097|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
170353509|NCT04167306|615630098|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
170353510|NCT00115804|615630100|FG000|Overall Study|Adverse Event|2|||
170353511|NCT02953782|615630104|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
170353512|NCT02953782|615630105|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
170353513|NCT02953782|615630106|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
170353514|NCT02953782|615630107|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
170353515|NCT02953782|615630108|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
170353516|NCT02953782|615630109|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
170353517|NCT02953782|615630110|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
170353518|NCT02953782|615630111|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
170353519|NCT02953782|615630104|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
170353520|NCT02953782|615630105|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
170353521|NCT02953782|615630106|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
170353522|NCT02953782|615630107|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
170353523|NCT02953782|615630108|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
170353524|NCT02953782|615630109|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
170353525|NCT02953782|615630110|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
170353526|NCT02953782|615630111|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
170353527|NCT02953782|615630104|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
170353528|NCT02953782|615630105|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
170353529|NCT02953782|615630106|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
170353530|NCT02953782|615630107|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
170353531|NCT02953782|615630108|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
170353532|NCT02953782|615630109|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
170353533|NCT02953782|615630110|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
170353534|NCT02953782|615630111|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
170353535|NCT02953782|615630104|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
170353536|NCT02953782|615630105|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
170353537|NCT02953782|615630106|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
170353538|NCT02953782|615630107|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
170353539|NCT02953782|615630108|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
170353540|NCT02953782|615630109|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
170353541|NCT02953782|615630110|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
170353542|NCT02953782|615630111|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
170353543|NCT02953782|615630104|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
170353544|NCT02953782|615630105|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
170353545|NCT02953782|615630106|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
170353546|NCT02953782|615630107|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
170353547|NCT02953782|615630108|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
170353548|NCT02953782|615630109|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
170353549|NCT02953782|615630110|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
170353550|NCT02953782|615630111|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
170353551|NCT02953782|615630104|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
170353552|NCT02953782|615630105|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
170353553|NCT02953782|615630106|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
170353554|NCT02953782|615630107|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
170353555|NCT02953782|615630108|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
170353556|NCT02953782|615630109|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
170353557|NCT02953782|615630110|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
170353558|NCT02953782|615630111|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
170353559|NCT02953782|615630104|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
170353560|NCT02953782|615630105|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
170353561|NCT02953782|615630106|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
170353562|NCT02953782|615630107|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
170353563|NCT02953782|615630108|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
170353564|NCT02953782|615630109|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
170353565|NCT02953782|615630110|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
170353566|NCT02953782|615630111|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
170353567|NCT02953782|615630104|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
170353568|NCT02953782|615630105|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
170353569|NCT02953782|615630106|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
170353570|NCT02953782|615630107|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
170353571|NCT02953782|615630108|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
170353572|NCT02953782|615630109|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
170353573|NCT02953782|615630110|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
170353574|NCT02953782|615630111|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
170353575|NCT00403559|615630112|FG000|Overall Study|Adverse Event|0|||
170353576|NCT00403559|615630113|FG001|Overall Study|Adverse Event|1|||
170353577|NCT00403559|615630112|FG000|Overall Study|Lost to Follow-up|3|||
170353578|NCT00403559|615630113|FG001|Overall Study|Lost to Follow-up|3|||
170353579|NCT00403559|615630112|FG000|Overall Study|Withdrawal by Subject|1|||
170353580|NCT00403559|615630113|FG001|Overall Study|Withdrawal by Subject|0|||
170353581|NCT04633473|615630118|FG000|Overall Study|Withdrawal by Subject|6|||
170353582|NCT01982773|615630120|FG000|Overall Study|Withdrawal by Subject|1|||
170353583|NCT01982773|615630121|FG001|Overall Study|Withdrawal by Subject|3|||
170353584|NCT01982773|615630120|FG000|Overall Study|Lost to Follow-up|7|||
170353585|NCT01982773|615630121|FG001|Overall Study|Lost to Follow-up|1|||
170353586|NCT03294681|615630124|FG000|Overall Study|Withdrawal by Subject|1|||
170353587|NCT01553916|615630125|FG000|Overall Study|Withdrawal by Subject|2|||
170353588|NCT01553916|615630125|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
170353589|NCT04501679|615630126|FG000|Overall Study|Pregnancy|0|||
170353590|NCT04501679|615630127|FG001|Overall Study|Pregnancy|1|||
170353591|NCT04501679|615630126|FG000|Overall Study|Adverse Event|4|||
170353592|NCT04501679|615630127|FG001|Overall Study|Adverse Event|2|||
170353593|NCT04501679|615630126|FG000|Overall Study|Withdrawal by Subject|2|||
170353594|NCT04501679|615630127|FG001|Overall Study|Withdrawal by Subject|0|||
170353595|NCT04501679|615630126|FG000|Overall Study|Physician Decision|1|||
170353596|NCT04501679|615630127|FG001|Overall Study|Physician Decision|0|||
170353597|NCT04501679|615630126|FG000|Overall Study|Lost to Follow-up|2|||
170353598|NCT04501679|615630127|FG001|Overall Study|Lost to Follow-up|0|||
170353599|NCT03259490|615630130|FG000|Period 1|Withdrawal by Subject|0|||
170353600|NCT03259490|615630131|FG001|Period 1|Withdrawal by Subject|1|||
170353601|NCT03259490|615630130|FG000|Period 2|Protocol Violation|1|||
170353602|NCT03259490|615630131|FG001|Period 2|Protocol Violation|0|||
170353603|NCT03095521|615630132|FG000|Overall Study|Withdrawal by Subject|0|||
170353604|NCT03095521|615630133|FG001|Overall Study|Withdrawal by Subject|1|||
170353605|NCT03095521|615630132|FG000|Overall Study|Lost to Follow-up|0|||
170353606|NCT03095521|615630133|FG001|Overall Study|Lost to Follow-up|1|||
170353607|NCT01185249|615630134|FG000|Overall Study|Patients discharged or change in status|42|||
170353608|NCT00064350|615630136|FG000|Induction Treatment|Disease Progression|5|||
170353609|NCT00064350|615630137|FG001|Induction Treatment|Disease Progression|1|||
170353610|NCT00064350|615630138|FG002|Induction Treatment|Disease Progression|110|||
170353611|NCT00064350|615630136|FG000|Induction Treatment|Adverse Event|0|||
170353612|NCT00064350|615630137|FG001|Induction Treatment|Adverse Event|2|||
170353613|NCT00064350|615630138|FG002|Induction Treatment|Adverse Event|49|||
170353614|NCT00064350|615630136|FG000|Induction Treatment|Death|0|||
170353615|NCT00064350|615630137|FG001|Induction Treatment|Death|0|||
170353616|NCT00064350|615630138|FG002|Induction Treatment|Death|9|||
170353617|NCT00064350|615630136|FG000|Induction Treatment|Withdrawal by Subject|0|||
170353618|NCT00064350|615630137|FG001|Induction Treatment|Withdrawal by Subject|0|||
170353619|NCT00064350|615630138|FG002|Induction Treatment|Withdrawal by Subject|21|||
170353620|NCT00064350|615630136|FG000|Induction Treatment|Ineligible or never started treatment|3|||
170353621|NCT00064350|615630137|FG001|Induction Treatment|Ineligible or never started treatment|6|||
170353622|NCT00064350|615630138|FG002|Induction Treatment|Ineligible or never started treatment|34|||
170353623|NCT00064350|615630136|FG000|Induction Treatment|Other|0|||
170353624|NCT00064350|615630137|FG001|Induction Treatment|Other|0|||
170353625|NCT00064350|615630138|FG002|Induction Treatment|Other|13|||
170353626|NCT00064350|615630136|FG000|Randomization|Adverse Event|8|||
170353627|NCT00064350|615630137|FG001|Randomization|Adverse Event|3|||
170353628|NCT00064350|615630138|FG002|Randomization|Adverse Event|0|||
170353629|NCT00064350|615630136|FG000|Randomization|Death|3|||
170353630|NCT00064350|615630137|FG001|Randomization|Death|0|||
170353631|NCT00064350|615630138|FG002|Randomization|Death|0|||
170353632|NCT00064350|615630136|FG000|Randomization|Withdrawal by Subject|1|||
170353633|NCT00064350|615630137|FG001|Randomization|Withdrawal by Subject|0|||
170353634|NCT00064350|615630138|FG002|Randomization|Withdrawal by Subject|0|||
170353635|NCT00064350|615630136|FG000|Randomization|Ineligible or never started treatment|9|||
170353636|NCT00064350|615630137|FG001|Randomization|Ineligible or never started treatment|15|||
170353637|NCT00064350|615630138|FG002|Randomization|Ineligible or never started treatment|0|||
170353638|NCT00064350|615630136|FG000|Randomization|Other|5|||
170353639|NCT00064350|615630137|FG001|Randomization|Other|0|||
170353640|NCT00064350|615630138|FG002|Randomization|Other|0|||
170353641|NCT00064350|615630136|FG000|Cross-Over|Adverse Event|0|||
170353642|NCT00064350|615630137|FG001|Cross-Over|Adverse Event|1|||
170353643|NCT00064350|615630138|FG002|Cross-Over|Adverse Event|0|||
170353644|NCT00064350|615630136|FG000|Cross-Over|Death|1|||
170353645|NCT00064350|615630137|FG001|Cross-Over|Death|3|||
170353646|NCT00064350|615630138|FG002|Cross-Over|Death|0|||
170353647|NCT00064350|615630136|FG000|Cross-Over|Withdrawal by Subject|2|||
170353648|NCT00064350|615630137|FG001|Cross-Over|Withdrawal by Subject|2|||
170353649|NCT00064350|615630138|FG002|Cross-Over|Withdrawal by Subject|0|||
170353650|NCT00064350|615630136|FG000|Cross-Over|Ineligible or never started treatment|3|||
170353651|NCT00064350|615630137|FG001|Cross-Over|Ineligible or never started treatment|6|||
170353652|NCT00064350|615630138|FG002|Cross-Over|Ineligible or never started treatment|0|||
170353653|NCT00064350|615630136|FG000|Cross-Over|Other|0|||
170353654|NCT00064350|615630137|FG001|Cross-Over|Other|2|||
170353655|NCT00064350|615630138|FG002|Cross-Over|Other|0|||
170353656|NCT01454401|615630146|FG000|Overall Study|Death|1|||
170353657|NCT01454401|615630146|FG000|Overall Study|hospitalised|1|||
170353658|NCT01454401|615630146|FG000|Overall Study|osteomyelitis|2|||
170353659|NCT01454401|615630146|FG000|Overall Study|non-adherence|1|||
170353660|NCT03260205|615630149|FG000|Overall Study|Adverse Event|2|||
170353661|NCT03260205|615630150|FG001|Overall Study|Adverse Event|0|||
170353662|NCT03260205|615630151|FG002|Overall Study|Adverse Event|2|||
170353663|NCT03260205|615630152|FG003|Overall Study|Adverse Event|2|||
170353664|NCT03260205|615630153|FG004|Overall Study|Adverse Event|4|||
170353665|NCT03260205|615630149|FG000|Overall Study|Lost to Follow-up|2|||
170353666|NCT03260205|615630150|FG001|Overall Study|Lost to Follow-up|2|||
170353667|NCT03260205|615630151|FG002|Overall Study|Lost to Follow-up|1|||
170353668|NCT03260205|615630152|FG003|Overall Study|Lost to Follow-up|1|||
170353669|NCT03260205|615630153|FG004|Overall Study|Lost to Follow-up|5|||
170353670|NCT03260205|615630149|FG000|Overall Study|Protocol Violation|0|||
170353671|NCT03260205|615630150|FG001|Overall Study|Protocol Violation|0|||
170353672|NCT03260205|615630151|FG002|Overall Study|Protocol Violation|2|||
170353673|NCT03260205|615630152|FG003|Overall Study|Protocol Violation|0|||
170353674|NCT03260205|615630153|FG004|Overall Study|Protocol Violation|1|||
170353675|NCT03260205|615630149|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
170353676|NCT03260205|615630150|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
170353677|NCT03260205|615630151|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
170353678|NCT03260205|615630152|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
170353679|NCT03260205|615630153|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
170353680|NCT03260205|615630149|FG000|Overall Study|Other: Unspecified|0|||
170353681|NCT03260205|615630150|FG001|Overall Study|Other: Unspecified|0|||
170353682|NCT03260205|615630151|FG002|Overall Study|Other: Unspecified|3|||
170353683|NCT03260205|615630152|FG003|Overall Study|Other: Unspecified|1|||
170353684|NCT03260205|615630153|FG004|Overall Study|Other: Unspecified|1|||
170353685|NCT03260205|615630149|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
170353686|NCT03260205|615630150|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
170353687|NCT03260205|615630151|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
170353688|NCT03260205|615630152|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
170353689|NCT03260205|615630153|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
170353690|NCT02180724|615632459|FG000|Overall Study|Death|26|||
170353691|NCT02180724|615632460|FG001|Overall Study|Death|1|||
170353692|NCT02180724|615632459|FG000|Overall Study|Lost to Follow-up|3|||
170353693|NCT02180724|615632460|FG001|Overall Study|Lost to Follow-up|1|||
170353694|NCT02180724|615632459|FG000|Overall Study|Withdrawal by Subject|4|||
170353695|NCT02180724|615632460|FG001|Overall Study|Withdrawal by Subject|2|||
170353696|NCT02180724|615632459|FG000|Overall Study|PI Decision|5|||
170353697|NCT02180724|615632460|FG001|Overall Study|PI Decision|2|||
170353698|NCT02180724|615632459|FG000|Overall Study|Study terminated by sponsor|54|||
170353699|NCT02180724|615632460|FG001|Overall Study|Study terminated by sponsor|8|||
170353700|NCT01255306|615632464|FG000|Overall Study|Physician Decision|1|||
170353701|NCT01255306|615632465|FG001|Overall Study|Physician Decision|1|||
170353702|NCT05195359|615632466|FG000|Overall Study|Lost to Follow-up|124|||
170353703|NCT05195359|615632467|FG001|Overall Study|Lost to Follow-up|34|||
170353704|NCT01747811|615632472|FG000|Overall Study|Lack of Efficacy|2|||
170353705|NCT01747811|615632473|FG001|Overall Study|Lack of Efficacy|4|||
170353706|NCT03363919|615632477|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
170353707|NCT03363919|615632478|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
170353708|NCT03363919|615632477|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
170353709|NCT03363919|615632478|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
170353710|NCT02862548|615632479|FG000|Randomized Phase (Up to Week 48)|Death|0|||
170353711|NCT02862548|615632480|FG001|Randomized Phase (Up to Week 48)|Death|1|||
170353712|NCT02862548|615632479|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
170353713|NCT02862548|615632480|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
170353714|NCT02862548|615632479|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
170353715|NCT02862548|615632480|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
170353716|NCT02862548|615632479|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
170353717|NCT02862548|615632480|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
170353718|NCT01175213|615632481|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
170353719|NCT01175213|615632482|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
170353720|NCT01175213|615632481|FG000|IGSC, 10%/rHuPH20|Death|1|||
170353721|NCT01175213|615632482|FG001|IGSC, 10%/rHuPH20|Death|0|||
170353722|NCT01175213|615632481|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
170353723|NCT01175213|615632482|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
170353724|NCT01175213|615632481|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
170353725|NCT01175213|615632482|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
170353726|NCT01175213|615632481|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
170353727|NCT01175213|615632482|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
170353728|NCT01175213|615632481|FG000|Safety Follow-up|Adverse Event|1|||
170353729|NCT01175213|615632482|FG001|Safety Follow-up|Adverse Event|0|||
170353730|NCT03569449|615632490|FG000|Overall Study|Lost to Follow-up|0|||
170353731|NCT03569449|615632491|FG001|Overall Study|Lost to Follow-up|1|||
170353732|NCT03569449|615632492|FG002|Overall Study|Lost to Follow-up|0|||
170353733|NCT03569449|615632493|FG003|Overall Study|Lost to Follow-up|2|||
170353734|NCT03569449|615632494|FG004|Overall Study|Lost to Follow-up|0|||
170353735|NCT03569449|615632495|FG005|Overall Study|Lost to Follow-up|0|||
170353736|NCT03569449|615632496|FG006|Overall Study|Lost to Follow-up|0|||
170353737|NCT03569449|615632497|FG007|Overall Study|Lost to Follow-up|0|||
170353738|NCT03569449|615632498|FG008|Overall Study|Lost to Follow-up|0|||
170353739|NCT03569449|615632499|FG009|Overall Study|Lost to Follow-up|0|||
170353740|NCT03569449|615632500|FG010|Overall Study|Lost to Follow-up|0|||
170353741|NCT03569449|615632501|FG011|Overall Study|Lost to Follow-up|0|||
170353742|NCT03569449|615632502|FG012|Overall Study|Lost to Follow-up|0|||
170353743|NCT03569449|615632503|FG013|Overall Study|Lost to Follow-up|0|||
170353744|NCT03569449|615632504|FG014|Overall Study|Lost to Follow-up|1|||
170353745|NCT03569449|615632505|FG015|Overall Study|Lost to Follow-up|0|||
170353746|NCT03569449|615632490|FG000|Overall Study|Withdrawal by Subject|0|||
170353747|NCT03569449|615632491|FG001|Overall Study|Withdrawal by Subject|1|||
170353748|NCT03569449|615632492|FG002|Overall Study|Withdrawal by Subject|0|||
170353749|NCT03569449|615632493|FG003|Overall Study|Withdrawal by Subject|0|||
170353750|NCT03569449|615632494|FG004|Overall Study|Withdrawal by Subject|1|||
170353751|NCT03569449|615632495|FG005|Overall Study|Withdrawal by Subject|0|||
170353752|NCT03569449|615632496|FG006|Overall Study|Withdrawal by Subject|0|||
170353753|NCT03569449|615632497|FG007|Overall Study|Withdrawal by Subject|0|||
170353754|NCT03569449|615632498|FG008|Overall Study|Withdrawal by Subject|0|||
170353755|NCT03569449|615632499|FG009|Overall Study|Withdrawal by Subject|0|||
170353756|NCT03569449|615632500|FG010|Overall Study|Withdrawal by Subject|0|||
170353757|NCT03569449|615632501|FG011|Overall Study|Withdrawal by Subject|0|||
170353758|NCT03569449|615632502|FG012|Overall Study|Withdrawal by Subject|0|||
170353759|NCT03569449|615632503|FG013|Overall Study|Withdrawal by Subject|0|||
170353760|NCT03569449|615632504|FG014|Overall Study|Withdrawal by Subject|0|||
170353761|NCT03569449|615632505|FG015|Overall Study|Withdrawal by Subject|0|||
170353762|NCT02924688|615632506|FG000|Overall Study|Adverse Event|9|||
170353763|NCT02924688|615632507|FG001|Overall Study|Adverse Event|3|||
170353764|NCT02924688|615632508|FG002|Overall Study|Adverse Event|2|||
170353765|NCT02924688|615632509|FG003|Overall Study|Adverse Event|2|||
170353766|NCT02924688|615632510|FG004|Overall Study|Adverse Event|3|||
170353767|NCT02924688|615632511|FG005|Overall Study|Adverse Event|2|||
170353768|NCT02924688|615632506|FG000|Overall Study|Lack of Efficacy|2|||
170353769|NCT02924688|615632507|FG001|Overall Study|Lack of Efficacy|3|||
170353770|NCT02924688|615632508|FG002|Overall Study|Lack of Efficacy|4|||
170353771|NCT02924688|615632509|FG003|Overall Study|Lack of Efficacy|2|||
170353772|NCT02924688|615632510|FG004|Overall Study|Lack of Efficacy|1|||
170353773|NCT02924688|615632511|FG005|Overall Study|Lack of Efficacy|1|||
170353774|NCT02924688|615632506|FG000|Overall Study|Protocol Violation|3|||
170353775|NCT02924688|615632507|FG001|Overall Study|Protocol Violation|7|||
170353776|NCT02924688|615632508|FG002|Overall Study|Protocol Violation|5|||
170353777|NCT02924688|615632509|FG003|Overall Study|Protocol Violation|6|||
170353778|NCT02924688|615632510|FG004|Overall Study|Protocol Violation|2|||
170353779|NCT02924688|615632511|FG005|Overall Study|Protocol Violation|2|||
170353780|NCT02924688|615632506|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
170353781|NCT02924688|615632507|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
170353782|NCT02924688|615632508|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
170353783|NCT02924688|615632509|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
170399308|NCT03193190|615799949|FG012|Stage 1|Physician Decision|0|||
170353784|NCT02924688|615632510|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
170353785|NCT02924688|615632511|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
170353786|NCT02924688|615632506|FG000|Overall Study|Lost to Follow-up|2|||
170353787|NCT02924688|615632507|FG001|Overall Study|Lost to Follow-up|4|||
170353788|NCT02924688|615632508|FG002|Overall Study|Lost to Follow-up|2|||
170353789|NCT02924688|615632509|FG003|Overall Study|Lost to Follow-up|4|||
170353790|NCT02924688|615632510|FG004|Overall Study|Lost to Follow-up|2|||
170353791|NCT02924688|615632511|FG005|Overall Study|Lost to Follow-up|4|||
170353792|NCT02924688|615632506|FG000|Overall Study|Physician Decision|2|||
170353793|NCT02924688|615632507|FG001|Overall Study|Physician Decision|1|||
170353794|NCT02924688|615632508|FG002|Overall Study|Physician Decision|0|||
170353795|NCT02924688|615632509|FG003|Overall Study|Physician Decision|1|||
170353796|NCT02924688|615632510|FG004|Overall Study|Physician Decision|1|||
170353797|NCT02924688|615632511|FG005|Overall Study|Physician Decision|1|||
170353798|NCT02924688|615632506|FG000|Overall Study|Withdrawal by Subject|14|||
170353799|NCT02924688|615632507|FG001|Overall Study|Withdrawal by Subject|13|||
170353800|NCT02924688|615632508|FG002|Overall Study|Withdrawal by Subject|9|||
170353801|NCT02924688|615632509|FG003|Overall Study|Withdrawal by Subject|12|||
170353802|NCT02924688|615632510|FG004|Overall Study|Withdrawal by Subject|13|||
170353803|NCT02924688|615632511|FG005|Overall Study|Withdrawal by Subject|14|||
170353804|NCT03072719|615632517|FG000|Overall Study|Adverse Event|1|||
170353805|NCT03072719|615632518|FG001|Overall Study|Adverse Event|1|||
170353806|NCT02586233|615632519|FG000|Overall Study|Randomized but did not receive treatment|0|||
170353807|NCT02586233|615632520|FG001|Overall Study|Randomized but did not receive treatment|1|||
170353808|NCT02586233|615632521|FG002|Overall Study|Randomized but did not receive treatment|0|||
170353809|NCT02586233|615632522|FG003|Overall Study|Randomized but did not receive treatment|0|||
170353810|NCT02586233|615632523|FG004|Overall Study|Randomized but did not receive treatment|0|||
170353811|NCT02586233|615632524|FG005|Overall Study|Randomized but did not receive treatment|2|||
170353812|NCT02586233|615632525|FG006|Overall Study|Randomized but did not receive treatment|2|||
170353813|NCT02586233|615632519|FG000|Overall Study|Death|0|||
170353814|NCT02586233|615632520|FG001|Overall Study|Death|1|||
170353815|NCT02586233|615632521|FG002|Overall Study|Death|0|||
170353816|NCT02586233|615632522|FG003|Overall Study|Death|0|||
170353817|NCT02586233|615632523|FG004|Overall Study|Death|2|||
170353818|NCT02586233|615632524|FG005|Overall Study|Death|0|||
170353819|NCT02586233|615632525|FG006|Overall Study|Death|0|||
170353820|NCT01708941|615632526|FG000|Overall Study|Adverse Event|4|||
170353821|NCT01708941|615632527|FG001|Overall Study|Adverse Event|6|||
170353822|NCT01708941|615632528|FG002|Overall Study|Adverse Event|1|||
170353823|NCT01708941|615632529|FG003|Overall Study|Adverse Event|0|||
170353824|NCT01708941|615632526|FG000|Overall Study|Death|1|||
170353825|NCT01708941|615632527|FG001|Overall Study|Death|1|||
170353826|NCT01708941|615632528|FG002|Overall Study|Death|2|||
170353827|NCT01708941|615632529|FG003|Overall Study|Death|14|||
170353828|NCT01708941|615632526|FG000|Overall Study|Withdrawal by Subject|1|||
170353829|NCT01708941|615632527|FG001|Overall Study|Withdrawal by Subject|0|||
170353830|NCT01708941|615632528|FG002|Overall Study|Withdrawal by Subject|3|||
170353831|NCT01708941|615632529|FG003|Overall Study|Withdrawal by Subject|4|||
170353832|NCT01708941|615632526|FG000|Overall Study|Disease progression|9|||
170353833|NCT01708941|615632527|FG001|Overall Study|Disease progression|10|||
170353834|NCT01708941|615632528|FG002|Overall Study|Disease progression|8|||
170353835|NCT01708941|615632529|FG003|Overall Study|Disease progression|0|||
170353836|NCT01708941|615632526|FG000|Overall Study|Alternative therapy|0|||
170353837|NCT01708941|615632527|FG001|Overall Study|Alternative therapy|0|||
170353838|NCT01708941|615632528|FG002|Overall Study|Alternative therapy|2|||
170353839|NCT01708941|615632529|FG003|Overall Study|Alternative therapy|0|||
170353840|NCT01708941|615632526|FG000|Overall Study|Ineligible and never started treatment|1|||
170353841|NCT01708941|615632527|FG001|Overall Study|Ineligible and never started treatment|0|||
170353842|NCT01708941|615632528|FG002|Overall Study|Ineligible and never started treatment|1|||
170353843|NCT01708941|615632529|FG003|Overall Study|Ineligible and never started treatment|0|||
170353844|NCT01708941|615632526|FG000|Overall Study|Never started treatment|2|||
170353845|NCT01708941|615632527|FG001|Overall Study|Never started treatment|1|||
170353846|NCT01708941|615632528|FG002|Overall Study|Never started treatment|0|||
170353847|NCT01708941|615632529|FG003|Overall Study|Never started treatment|0|||
170353848|NCT01708941|615632526|FG000|Overall Study|Ineligible|0|||
170353849|NCT01708941|615632527|FG001|Overall Study|Ineligible|0|||
170353850|NCT01708941|615632528|FG002|Overall Study|Ineligible|2|||
170353851|NCT01708941|615632529|FG003|Overall Study|Ineligible|0|||
170353852|NCT00579501|615632530|FG000|Overall Study|Death|1|||
170353853|NCT00579501|615632530|FG000|Overall Study|End of neoadjuvant therapy|25|||
170353854|NCT00579501|615632530|FG000|Overall Study|toxicity|1|||
170353855|NCT00579501|615632530|FG000|Overall Study|Secondary lesion|1|||
170353856|NCT00579501|615632530|FG000|Overall Study|Radiation therapy before surgery|1|||
170353857|NCT01742078|615632536|FG000|Overall Study|Withdrawal by Subject|0|||
170353858|NCT01742078|615632537|FG001|Overall Study|Withdrawal by Subject|0|||
170353859|NCT01742078|615632538|FG002|Overall Study|Withdrawal by Subject|0|||
170353860|NCT01742078|615632539|FG003|Overall Study|Withdrawal by Subject|1|||
170353861|NCT01742078|615632540|FG004|Overall Study|Withdrawal by Subject|0|||
170353862|NCT01742078|615632541|FG005|Overall Study|Withdrawal by Subject|0|||
170353863|NCT01742078|615632542|FG006|Overall Study|Withdrawal by Subject|0|||
170353864|NCT01742078|615632543|FG007|Overall Study|Withdrawal by Subject|0|||
170353865|NCT01742078|615632544|FG008|Overall Study|Withdrawal by Subject|0|||
170353866|NCT00678587|615632546|FG000|Overall Study|Adverse Event|3|||
170353867|NCT00678587|615632547|FG001|Overall Study|Adverse Event|3|||
170353868|NCT00678587|615632546|FG000|Overall Study|Lack of Efficacy|1|||
170353869|NCT00678587|615632547|FG001|Overall Study|Lack of Efficacy|0|||
170353870|NCT00678587|615632546|FG000|Overall Study|Protocol Violation|2|||
170353871|NCT00678587|615632547|FG001|Overall Study|Protocol Violation|1|||
170353872|NCT00678587|615632546|FG000|Overall Study|Study Closed/Terminated|1|||
170353873|NCT00678587|615632547|FG001|Overall Study|Study Closed/Terminated|0|||
170353874|NCT00678587|615632546|FG000|Overall Study|Lost to Follow-up|3|||
170353875|NCT00678587|615632547|FG001|Overall Study|Lost to Follow-up|5|||
170353876|NCT00678587|615632546|FG000|Overall Study|Investigator Discretion|2|||
170353877|NCT00678587|615632547|FG001|Overall Study|Investigator Discretion|6|||
170353878|NCT00678587|615632546|FG000|Overall Study|Withdrew Consent|8|||
170353879|NCT00678587|615632547|FG001|Overall Study|Withdrew Consent|3|||
170353880|NCT05600309|615632550|FG000|Overall Study|Death|41|||
170353881|NCT05600309|615632551|FG001|Overall Study|Death|38|||
170353882|NCT05600309|615632550|FG000|Overall Study|Sponsor Decision|9|||
170353883|NCT05600309|615632551|FG001|Overall Study|Sponsor Decision|6|||
170353884|NCT03368664|615632552|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
170353885|NCT03368664|615632552|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
170353886|NCT03368664|615632552|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
170353887|NCT03368664|615632552|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
170353888|NCT01875367|615632553|FG000|Overall Study|Not complete at least 2 questionaries|4|||
170353889|NCT01875367|615632554|FG001|Overall Study|Not complete at least 2 questionaries|2|||
170353890|NCT01875367|615632553|FG000|Overall Study|Not receive study treatment|1|||
170353891|NCT01875367|615632554|FG001|Overall Study|Not receive study treatment|0|||
170353892|NCT01025817|615632555|FG000|Completed Study Medication|Adverse Event|66|||
170353893|NCT01025817|615632556|FG001|Completed Study Medication|Adverse Event|39|||
170353894|NCT01025817|615632555|FG000|Completed Study Medication|Protocol Deviation|9|||
170353895|NCT01025817|615632556|FG001|Completed Study Medication|Protocol Deviation|8|||
170353896|NCT01025817|615632555|FG000|Completed Study Medication|Withdrawal by Subject|8|||
170353897|NCT01025817|615632556|FG001|Completed Study Medication|Withdrawal by Subject|9|||
170353898|NCT01025817|615632555|FG000|Completed Study Medication|Administrative problems|7|||
170353899|NCT01025817|615632556|FG001|Completed Study Medication|Administrative problems|5|||
170353900|NCT01025817|615632555|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
170353901|NCT01025817|615632556|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
170353902|NCT01025817|615632555|FG000|Completed Study Medication|Abnormal test procedure|4|||
170353903|NCT01025817|615632556|FG001|Completed Study Medication|Abnormal test procedure|0|||
170353904|NCT01025817|615632555|FG000|Completed Study Medication|Graft loss|2|||
170353905|NCT01025817|615632556|FG001|Completed Study Medication|Graft loss|5|||
170353906|NCT01025817|615632555|FG000|Completed Study Medication|Death|2|||
170353907|NCT01025817|615632556|FG001|Completed Study Medication|Death|2|||
170353908|NCT01025817|615632555|FG000|Completed Study Medication|Abnormal lab values|0|||
170353909|NCT01025817|615632556|FG001|Completed Study Medication|Abnormal lab values|2|||
170353910|NCT01025817|615632555|FG000|Completed Study Medication|Subject no longer required study drug|0|||
170353911|NCT01025817|615632556|FG001|Completed Study Medication|Subject no longer required study drug|1|||
170353912|NCT01025817|615632555|FG000|Completed Study Medication|Lost to Follow-up|0|||
170353913|NCT01025817|615632556|FG001|Completed Study Medication|Lost to Follow-up|1|||
170353914|NCT01025817|615632555|FG000|Completed Study|Withdrawal by Subject|8|||
170353915|NCT01025817|615632556|FG001|Completed Study|Withdrawal by Subject|16|||
170353916|NCT01025817|615632555|FG000|Completed Study|Death|6|||
170353917|NCT01025817|615632556|FG001|Completed Study|Death|5|||
170353918|NCT01025817|615632555|FG000|Completed Study|Missing|2|||
170353919|NCT01025817|615632556|FG001|Completed Study|Missing|0|||
170353920|NCT01025817|615632555|FG000|Completed Study|Lost to Follow-up|0|||
170353921|NCT01025817|615632556|FG001|Completed Study|Lost to Follow-up|1|||
170353922|NCT03977727|615632559|FG000|Second Treatment|Lost to Follow-up|0|||
170353923|NCT03977727|615632560|FG001|Second Treatment|Lost to Follow-up|3|||
170353924|NCT01419665|615632561|FG000|Combination Treatment|Adverse Event|7|||
170353925|NCT01419665|615632562|FG001|Combination Treatment|Adverse Event|10|||
170353926|NCT01419665|615632561|FG000|Combination Treatment|Physician Decision|5|||
170353927|NCT01419665|615632562|FG001|Combination Treatment|Physician Decision|8|||
170353928|NCT01419665|615632561|FG000|Combination Treatment|Protocol Violation|6|||
170353929|NCT01419665|615632562|FG001|Combination Treatment|Protocol Violation|2|||
170353930|NCT01419665|615632561|FG000|Combination Treatment|disease progression|10|||
170353931|NCT01419665|615632562|FG001|Combination Treatment|disease progression|9|||
170353932|NCT01419665|615632561|FG000|Combination Treatment|Death|5|||
170353933|NCT01419665|615632562|FG001|Combination Treatment|Death|7|||
170353934|NCT01419665|615632561|FG000|Combination Treatment|administrative problems|0|||
170353935|NCT01419665|615632562|FG001|Combination Treatment|administrative problems|1|||
170353936|NCT01419665|615632561|FG000|Combination Treatment|Withdrawal by Subject|5|||
170353937|NCT01419665|615632562|FG001|Combination Treatment|Withdrawal by Subject|4|||
170353938|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
170353939|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
170353940|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
170353941|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
170353942|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
170353943|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
170353944|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
170353945|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
170353946|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
170353947|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
170353948|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
170353949|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
170353950|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|Death|1|||
170353951|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|Death|2|||
170353952|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
170353953|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
170353954|NCT01419665|615632561|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
170353955|NCT01419665|615632562|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
170353956|NCT01419665|615632561|FG000|Open Label Phase|Death|1|||
170353957|NCT01419665|615632562|FG001|Open Label Phase|Death|0|||
170353958|NCT01419665|615632561|FG000|Open Label Phase|disease progression|0|||
170353959|NCT01419665|615632562|FG001|Open Label Phase|disease progression|1|||
170353960|NCT01655823|615632563|FG000|Overall Study|Lost to Follow-up|0|||
170353961|NCT01655823|615632564|FG001|Overall Study|Lost to Follow-up|1|||
170353962|NCT01655823|615632565|FG002|Overall Study|Lost to Follow-up|0|||
170353963|NCT01655823|615632566|FG003|Overall Study|Lost to Follow-up|0|||
170353964|NCT01655823|615632567|FG004|Overall Study|Lost to Follow-up|1|||
170353965|NCT01655823|615632563|FG000|Overall Study|Withdrawal by Subject|0|||
170353966|NCT01655823|615632564|FG001|Overall Study|Withdrawal by Subject|1|||
170353967|NCT01655823|615632565|FG002|Overall Study|Withdrawal by Subject|0|||
170353968|NCT01655823|615632566|FG003|Overall Study|Withdrawal by Subject|1|||
170353969|NCT01655823|615632567|FG004|Overall Study|Withdrawal by Subject|0|||
170353970|NCT01029002|615632568|FG000|Overall Study|Lost to Follow-up|2|||
170353971|NCT01029002|615632569|FG001|Overall Study|Lost to Follow-up|4|||
170353972|NCT01577160|615632570|FG000|Overall Study|Adverse Event|9|||
170353973|NCT01577160|615632570|FG000|Overall Study|Lack of Efficacy|15|||
170353974|NCT01577160|615632570|FG000|Overall Study|Lost to Follow-up|40|||
170353975|NCT01577160|615632570|FG000|Overall Study|Withdrawal by Subject|18|||
170353976|NCT01577160|615632570|FG000|Overall Study|Subject Uncooperative|7|||
170353977|NCT01577160|615632570|FG000|Overall Study|Other|9|||
170353978|NCT02632110|615632578|FG000|Overall Study|Withdrawal by Subject|1|||
170353979|NCT02632110|615632579|FG001|Overall Study|Withdrawal by Subject|1|||
170353980|NCT02632110|615632580|FG002|Overall Study|Withdrawal by Subject|0|||
170353981|NCT02632110|615632581|FG003|Overall Study|Withdrawal by Subject|0|||
170353982|NCT02632110|615632582|FG004|Overall Study|Withdrawal by Subject|1|||
170353983|NCT02632110|615632583|FG005|Overall Study|Withdrawal by Subject|1|||
170353984|NCT02632110|615632584|FG006|Overall Study|Withdrawal by Subject|3|||
170353985|NCT02632110|615632585|FG007|Overall Study|Withdrawal by Subject|3|||
170353986|NCT02632110|615632586|FG008|Overall Study|Withdrawal by Subject|1|||
170353987|NCT02632110|615632587|FG009|Overall Study|Withdrawal by Subject|1|||
170353988|NCT01341652|615632588|FG000|Overall Study|Incorrect Random Assignment|0|||
170353989|NCT01341652|615632589|FG001|Overall Study|Incorrect Random Assignment|1|||
170353990|NCT01341652|615632588|FG000|Overall Study|ineligible; presence metastatic disease|0|||
170353991|NCT01341652|615632589|FG001|Overall Study|ineligible; presence metastatic disease|1|||
170353992|NCT02618928|615632593|FG000|Overall Study|Failure to Return|28|||
170353993|NCT02618928|615632593|FG000|Overall Study|Insufficient Virological Response|1|||
170353994|NCT02618928|615632593|FG000|Overall Study|Withdrawal by Subject|2|||
170353995|NCT02618928|615632593|FG000|Overall Study|Death|3|||
170353996|NCT02618928|615632593|FG000|Overall Study|Other|11|||
170353997|NCT02618928|615632593|FG000|Overall Study|Missing|6|||
170353998|NCT02618928|615632593|FG000|Overall Study|Treatment Never Started|7|||
170353999|NCT00118482|615632599|FG000|Overall Study|Lost to Follow-up|7|||
170354000|NCT00118482|615632600|FG001|Overall Study|Lost to Follow-up|7|||
170354001|NCT00118482|615632599|FG000|Overall Study|Withdrawal by Subject|23|||
170354002|NCT00118482|615632600|FG001|Overall Study|Withdrawal by Subject|22|||
170354003|NCT00547378|615632601|FG000|Randomized Cohort|Withdrawal by Subject|7|||
170354004|NCT00547378|615632602|FG001|Randomized Cohort|Withdrawal by Subject|5|||
170354005|NCT00547378|615632603|FG002|Randomized Cohort|Withdrawal by Subject|0|||
170354006|NCT00547378|615632601|FG000|Randomized Cohort|Death|0|||
170354007|NCT00547378|615632602|FG001|Randomized Cohort|Death|1|||
170354008|NCT00547378|615632603|FG002|Randomized Cohort|Death|0|||
170354009|NCT00547378|615632601|FG000|Randomized Cohort|Lost to Follow-up|1|||
170354010|NCT00547378|615632602|FG001|Randomized Cohort|Lost to Follow-up|0|||
170354011|NCT00547378|615632603|FG002|Randomized Cohort|Lost to Follow-up|0|||
170354012|NCT00547378|615632601|FG000|Randomized Cohort|Adverse Event|1|||
170354013|NCT00547378|615632602|FG001|Randomized Cohort|Adverse Event|0|||
170354014|NCT00547378|615632603|FG002|Randomized Cohort|Adverse Event|0|||
170354015|NCT00547378|615632601|FG000|Randomized Cohort|Other reasons|2|||
170354016|NCT00547378|615632602|FG001|Randomized Cohort|Other reasons|0|||
170354017|NCT00547378|615632603|FG002|Randomized Cohort|Other reasons|0|||
170354018|NCT00547378|615632601|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
170354019|NCT00547378|615632602|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
170354020|NCT00547378|615632603|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
170354021|NCT00547378|615632601|FG000|All Implanted Cohort|Adverse Event|4|||
170354022|NCT00547378|615632602|FG001|All Implanted Cohort|Adverse Event|10|||
170354023|NCT00547378|615632603|FG002|All Implanted Cohort|Adverse Event|17|||
170354024|NCT00547378|615632601|FG000|All Implanted Cohort|Lost to Follow-up|0|||
170354025|NCT00547378|615632602|FG001|All Implanted Cohort|Lost to Follow-up|1|||
170354026|NCT00547378|615632603|FG002|All Implanted Cohort|Lost to Follow-up|14|||
170354027|NCT00547378|615632601|FG000|All Implanted Cohort|Death|3|||
170354028|NCT00547378|615632602|FG001|All Implanted Cohort|Death|1|||
170354029|NCT00547378|615632603|FG002|All Implanted Cohort|Death|4|||
170354030|NCT00547378|615632601|FG000|All Implanted Cohort|Physician Decision|0|||
170354031|NCT00547378|615632602|FG001|All Implanted Cohort|Physician Decision|2|||
170354032|NCT00547378|615632603|FG002|All Implanted Cohort|Physician Decision|6|||
170354033|NCT00547378|615632601|FG000|All Implanted Cohort|Site closure|2|||
170354034|NCT00547378|615632602|FG001|All Implanted Cohort|Site closure|0|||
170354035|NCT00547378|615632603|FG002|All Implanted Cohort|Site closure|1|||
170354036|NCT00547378|615632601|FG000|All Implanted Cohort|Other reasons|1|||
170354037|NCT00547378|615632602|FG001|All Implanted Cohort|Other reasons|0|||
170354038|NCT00547378|615632603|FG002|All Implanted Cohort|Other reasons|1|||
170354039|NCT01449682|615632604|FG000|Overall Study|Death|0|||
170354040|NCT01449682|615632605|FG001|Overall Study|Death|1|||
170354041|NCT01449682|615632604|FG000|Overall Study|Adverse Event|1|||
170354042|NCT01449682|615632605|FG001|Overall Study|Adverse Event|0|||
170354043|NCT02112994|615632606|FG000|Overall Study|Progressive Disease|0|||
170354044|NCT02112994|615632607|FG001|Overall Study|Progressive Disease|0|||
170354045|NCT02112994|615632608|FG002|Overall Study|Progressive Disease|1|||
170354046|NCT02112994|615632606|FG000|Overall Study|Pregnancy|0|||
170354047|NCT02112994|615632607|FG001|Overall Study|Pregnancy|1|||
170354048|NCT02112994|615632608|FG002|Overall Study|Pregnancy|1|||
170354049|NCT02112994|615632606|FG000|Overall Study|Liver Transplant|0|||
170354050|NCT02112994|615632607|FG001|Overall Study|Liver Transplant|1|||
170354051|NCT02112994|615632608|FG002|Overall Study|Liver Transplant|0|||
170354052|NCT02112994|615632606|FG000|Overall Study|Withdrawal by Subject|0|||
170354053|NCT02112994|615632607|FG001|Overall Study|Withdrawal by Subject|0|||
170354054|NCT02112994|615632608|FG002|Overall Study|Withdrawal by Subject|1|||
170354055|NCT02768194|615632609|FG000|Period 1|Adverse Event|0|||
170354056|NCT02768194|615632610|FG001|Period 1|Adverse Event|0|||
170354057|NCT02768194|615632611|FG002|Period 1|Adverse Event|0|||
170354058|NCT02768194|615632612|FG003|Period 1|Adverse Event|1|||
170354059|NCT02768194|615632613|FG004|Period 1|Adverse Event|0|||
170354060|NCT02768194|615632614|FG005|Period 1|Adverse Event|0|||
170354061|NCT02768194|615632609|FG000|Period 2|Other (Reason not specified)|1|||
170354062|NCT02768194|615632610|FG001|Period 2|Other (Reason not specified)|0|||
170354063|NCT02768194|615632611|FG002|Period 2|Other (Reason not specified)|0|||
170354064|NCT02768194|615632612|FG003|Period 2|Other (Reason not specified)|0|||
170354065|NCT02768194|615632613|FG004|Period 2|Other (Reason not specified)|0|||
170354066|NCT02768194|615632614|FG005|Period 2|Other (Reason not specified)|0|||
170354067|NCT02768194|615632609|FG000|Period 3|Other (Reason not specified)|0|||
170354068|NCT02768194|615632610|FG001|Period 3|Other (Reason not specified)|1|||
170354069|NCT02768194|615632611|FG002|Period 3|Other (Reason not specified)|0|||
170354070|NCT02768194|615632612|FG003|Period 3|Other (Reason not specified)|0|||
170354071|NCT02768194|615632613|FG004|Period 3|Other (Reason not specified)|0|||
170354072|NCT02768194|615632614|FG005|Period 3|Other (Reason not specified)|0|||
170354073|NCT03089216|615632615|FG000|Overall Study|Adverse Event|0|||
170354074|NCT03089216|615632616|FG001|Overall Study|Adverse Event|0|||
170354075|NCT03089216|615632617|FG002|Overall Study|Adverse Event|0|||
170354076|NCT03089216|615632618|FG003|Overall Study|Adverse Event|1|||
170354077|NCT02121756|615632622|FG000|Overall Study|Adverse Event|3|||
170354078|NCT02121756|615632623|FG001|Overall Study|Adverse Event|0|||
170354079|NCT02121756|615632622|FG000|Overall Study|Protocol Violation|1|||
170354080|NCT02121756|615632623|FG001|Overall Study|Protocol Violation|1|||
170354081|NCT02121756|615632622|FG000|Overall Study|Physician Decision|2|||
170354082|NCT02121756|615632623|FG001|Overall Study|Physician Decision|1|||
170354083|NCT01536119|615632626|FG000|Overall Study|Lost to Follow-up|17|||
170354084|NCT01536119|615632627|FG001|Overall Study|Lost to Follow-up|14|||
170354085|NCT00448916|615632628|FG000|Overall Study|Adverse Event|2|||
170354086|NCT00448916|615632629|FG001|Overall Study|Adverse Event|2|||
170354087|NCT00448916|615632630|FG002|Overall Study|Adverse Event|3|||
170354088|NCT00448916|615632631|FG003|Overall Study|Adverse Event|2|||
170354089|NCT00448916|615632628|FG000|Overall Study|Lack of Efficacy|1|||
170354090|NCT00448916|615632629|FG001|Overall Study|Lack of Efficacy|0|||
170354091|NCT00448916|615632630|FG002|Overall Study|Lack of Efficacy|2|||
170354092|NCT00448916|615632631|FG003|Overall Study|Lack of Efficacy|1|||
170354093|NCT00448916|615632628|FG000|Overall Study|Withdrawal by Subject|3|||
170354094|NCT00448916|615632629|FG001|Overall Study|Withdrawal by Subject|3|||
170354095|NCT00448916|615632630|FG002|Overall Study|Withdrawal by Subject|1|||
170354096|NCT00448916|615632631|FG003|Overall Study|Withdrawal by Subject|1|||
170354097|NCT00448916|615632628|FG000|Overall Study|Other|1|||
170354098|NCT00448916|615632629|FG001|Overall Study|Other|0|||
170354099|NCT00448916|615632630|FG002|Overall Study|Other|0|||
170354100|NCT00448916|615632631|FG003|Overall Study|Other|0|||
170354101|NCT00448916|615632628|FG000|Overall Study|Lost to Follow-up|0|||
170354102|NCT00448916|615632629|FG001|Overall Study|Lost to Follow-up|1|||
170354103|NCT00448916|615632630|FG002|Overall Study|Lost to Follow-up|0|||
170354104|NCT00448916|615632631|FG003|Overall Study|Lost to Follow-up|1|||
170354105|NCT00448916|615632628|FG000|Overall Study|Protocol Violation|0|||
170354106|NCT00448916|615632629|FG001|Overall Study|Protocol Violation|0|||
170354107|NCT00448916|615632630|FG002|Overall Study|Protocol Violation|0|||
170354108|NCT00448916|615632631|FG003|Overall Study|Protocol Violation|1|||
170354109|NCT03655717|615632632|FG000|Overall Study|Withdrawal by Subject|4|||
170354110|NCT03655717|615632633|FG001|Overall Study|Withdrawal by Subject|8|||
170354111|NCT03655717|615632634|FG002|Overall Study|Withdrawal by Subject|1|||
170354112|NCT03655717|615632635|FG003|Overall Study|Withdrawal by Subject|0|||
170354113|NCT03655717|615632636|FG004|Overall Study|Withdrawal by Subject|0|||
170354114|NCT03655717|615632637|FG005|Overall Study|Withdrawal by Subject|1|||
170354115|NCT03655717|615632638|FG006|Overall Study|Withdrawal by Subject|3|||
170354116|NCT03655717|615632639|FG007|Overall Study|Withdrawal by Subject|1|||
170354117|NCT03655717|615632640|FG008|Overall Study|Withdrawal by Subject|2|||
170354118|NCT03655717|615632641|FG009|Overall Study|Withdrawal by Subject|0|||
170354119|NCT03655717|615632642|FG010|Overall Study|Withdrawal by Subject|0|||
170354120|NCT03655717|615632643|FG011|Overall Study|Withdrawal by Subject|1|||
170354121|NCT03655717|615632644|FG012|Overall Study|Withdrawal by Subject|0|||
170354122|NCT03655717|615632645|FG013|Overall Study|Withdrawal by Subject|3|||
170354123|NCT03655717|615632646|FG014|Overall Study|Withdrawal by Subject|0|||
170354124|NCT03655717|615632647|FG015|Overall Study|Withdrawal by Subject|1|||
170354125|NCT03655717|615632648|FG016|Overall Study|Withdrawal by Subject|0|||
170354126|NCT03655717|615632649|FG017|Overall Study|Withdrawal by Subject|0|||
170354127|NCT03655717|615632650|FG018|Overall Study|Withdrawal by Subject|1|||
170354128|NCT03655717|615632651|FG019|Overall Study|Withdrawal by Subject|0|||
170354129|NCT03655717|615632652|FG020|Overall Study|Withdrawal by Subject|0|||
170354130|NCT03655717|615632653|FG021|Overall Study|Withdrawal by Subject|1|||
170354131|NCT03655717|615632654|FG022|Overall Study|Withdrawal by Subject|2|||
170354132|NCT03655717|615632655|FG023|Overall Study|Withdrawal by Subject|1|||
170354133|NCT03655717|615632656|FG024|Overall Study|Withdrawal by Subject|1|||
170354134|NCT03655717|615632657|FG025|Overall Study|Withdrawal by Subject|0|||
170354135|NCT03655717|615632632|FG000|Overall Study|Physician Decision|3|||
170354136|NCT03655717|615632633|FG001|Overall Study|Physician Decision|3|||
170354137|NCT03655717|615632634|FG002|Overall Study|Physician Decision|0|||
170354138|NCT03655717|615632635|FG003|Overall Study|Physician Decision|0|||
170354139|NCT03655717|615632636|FG004|Overall Study|Physician Decision|0|||
170354140|NCT03655717|615632637|FG005|Overall Study|Physician Decision|0|||
170354141|NCT03655717|615632638|FG006|Overall Study|Physician Decision|0|||
170354142|NCT03655717|615632639|FG007|Overall Study|Physician Decision|0|||
170354143|NCT03655717|615632640|FG008|Overall Study|Physician Decision|0|||
170354144|NCT03655717|615632641|FG009|Overall Study|Physician Decision|1|||
170354145|NCT03655717|615632642|FG010|Overall Study|Physician Decision|0|||
170354146|NCT03655717|615632643|FG011|Overall Study|Physician Decision|0|||
170354147|NCT03655717|615632644|FG012|Overall Study|Physician Decision|0|||
170354148|NCT03655717|615632645|FG013|Overall Study|Physician Decision|0|||
170354149|NCT03655717|615632646|FG014|Overall Study|Physician Decision|0|||
170354150|NCT03655717|615632647|FG015|Overall Study|Physician Decision|0|||
170354151|NCT03655717|615632648|FG016|Overall Study|Physician Decision|0|||
170354152|NCT03655717|615632649|FG017|Overall Study|Physician Decision|0|||
170354153|NCT03655717|615632650|FG018|Overall Study|Physician Decision|0|||
170354154|NCT03655717|615632651|FG019|Overall Study|Physician Decision|1|||
170354155|NCT03655717|615632652|FG020|Overall Study|Physician Decision|0|||
170354156|NCT03655717|615632653|FG021|Overall Study|Physician Decision|0|||
170354157|NCT03655717|615632654|FG022|Overall Study|Physician Decision|0|||
170354158|NCT03655717|615632655|FG023|Overall Study|Physician Decision|1|||
170354159|NCT03655717|615632656|FG024|Overall Study|Physician Decision|0|||
170354160|NCT03655717|615632657|FG025|Overall Study|Physician Decision|0|||
170354161|NCT03655717|615632632|FG000|Overall Study|Lost to Follow-up|3|||
170354162|NCT03655717|615632633|FG001|Overall Study|Lost to Follow-up|1|||
170354163|NCT03655717|615632634|FG002|Overall Study|Lost to Follow-up|0|||
170354164|NCT03655717|615632635|FG003|Overall Study|Lost to Follow-up|1|||
170354165|NCT03655717|615632636|FG004|Overall Study|Lost to Follow-up|0|||
170354166|NCT03655717|615632637|FG005|Overall Study|Lost to Follow-up|1|||
170354167|NCT03655717|615632638|FG006|Overall Study|Lost to Follow-up|0|||
170354168|NCT03655717|615632639|FG007|Overall Study|Lost to Follow-up|0|||
170354169|NCT03655717|615632640|FG008|Overall Study|Lost to Follow-up|0|||
170354170|NCT03655717|615632641|FG009|Overall Study|Lost to Follow-up|0|||
170354171|NCT03655717|615632642|FG010|Overall Study|Lost to Follow-up|0|||
170354172|NCT03655717|615632643|FG011|Overall Study|Lost to Follow-up|1|||
170354173|NCT03655717|615632644|FG012|Overall Study|Lost to Follow-up|0|||
170354174|NCT03655717|615632645|FG013|Overall Study|Lost to Follow-up|0|||
170354175|NCT03655717|615632646|FG014|Overall Study|Lost to Follow-up|0|||
170354176|NCT03655717|615632647|FG015|Overall Study|Lost to Follow-up|0|||
170354177|NCT03655717|615632648|FG016|Overall Study|Lost to Follow-up|0|||
170354178|NCT03655717|615632649|FG017|Overall Study|Lost to Follow-up|0|||
170354179|NCT03655717|615632650|FG018|Overall Study|Lost to Follow-up|0|||
170354180|NCT03655717|615632651|FG019|Overall Study|Lost to Follow-up|0|||
170354181|NCT03655717|615632652|FG020|Overall Study|Lost to Follow-up|0|||
170354182|NCT03655717|615632653|FG021|Overall Study|Lost to Follow-up|0|||
170354183|NCT03655717|615632654|FG022|Overall Study|Lost to Follow-up|0|||
170354184|NCT03655717|615632655|FG023|Overall Study|Lost to Follow-up|0|||
170354185|NCT03655717|615632656|FG024|Overall Study|Lost to Follow-up|0|||
170354186|NCT03655717|615632657|FG025|Overall Study|Lost to Follow-up|0|||
170354187|NCT02365584|615632658|FG000|Overall Study|Adverse Event|2|||
170354188|NCT02365584|615632659|FG001|Overall Study|Adverse Event|2|||
170354189|NCT02365584|615632658|FG000|Overall Study|Withdrawal by Subject|1|||
170354190|NCT02365584|615632659|FG001|Overall Study|Withdrawal by Subject|0|||
170354191|NCT02365584|615632658|FG000|Overall Study|Disease Progression|9|||
170354192|NCT02365584|615632659|FG001|Overall Study|Disease Progression|12|||
170354193|NCT01973452|615632660|FG000|Overall Study|Lack of Efficacy|0|||
170354194|NCT01973452|615632661|FG001|Overall Study|Lack of Efficacy|1|||
170354195|NCT01973452|615632660|FG000|Overall Study|Lost to Follow-up|1|||
170354196|NCT01973452|615632661|FG001|Overall Study|Lost to Follow-up|0|||
170354197|NCT01973452|615632660|FG000|Overall Study|Withdrawal by Subject|10|||
170354198|NCT01973452|615632661|FG001|Overall Study|Withdrawal by Subject|9|||
170354199|NCT01973452|615632660|FG000|Overall Study|Ineligible|1|||
170354200|NCT01973452|615632661|FG001|Overall Study|Ineligible|1|||
170354201|NCT01973452|615632660|FG000|Overall Study|Surgery canceled by participant|5|||
170354202|NCT01973452|615632661|FG001|Overall Study|Surgery canceled by participant|3|||
170354203|NCT00819585|615632662|FG000|Core Study|Adverse Event|2|||
170354204|NCT00819585|615632663|FG001|Core Study|Adverse Event|1|||
170354205|NCT00819585|615632664|FG002|Core Study|Adverse Event|1|||
170354206|NCT00819585|615632665|FG003|Core Study|Adverse Event|4|||
170354207|NCT00819585|615632666|FG004|Core Study|Adverse Event|1|||
170354208|NCT00819585|615632667|FG005|Core Study|Adverse Event|0|||
170354209|NCT00819585|615632668|FG006|Core Study|Adverse Event|2|||
170354210|NCT00819585|615632669|FG007|Core Study|Adverse Event|0|||
170354211|NCT00819585|615632670|FG008|Core Study|Adverse Event|0|||
170354212|NCT00819585|615632671|FG009|Core Study|Adverse Event|0|||
170354213|NCT00819585|615632672|FG010|Core Study|Adverse Event|0|||
170354214|NCT00819585|615632662|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
170354215|NCT00819585|615632663|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
170354216|NCT00819585|615632664|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
170354217|NCT00819585|615632665|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
170354218|NCT00819585|615632666|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
170354219|NCT00819585|615632667|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
170354220|NCT00819585|615632668|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
170354221|NCT00819585|615632669|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
170354222|NCT00819585|615632670|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
170354223|NCT00819585|615632671|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
170354224|NCT00819585|615632672|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
170354225|NCT00819585|615632662|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354226|NCT00819585|615632663|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
170354227|NCT00819585|615632664|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354228|NCT00819585|615632665|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354229|NCT00819585|615632666|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354230|NCT00819585|615632667|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354231|NCT00819585|615632668|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
170354232|NCT00819585|615632669|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354233|NCT00819585|615632670|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354234|NCT00819585|615632671|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354235|NCT00819585|615632672|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
170354236|NCT00819585|615632662|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
170354237|NCT00819585|615632663|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
170354238|NCT00819585|615632664|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
170354239|NCT00819585|615632665|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
170354240|NCT00819585|615632666|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
170354241|NCT00819585|615632667|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
170354242|NCT00819585|615632668|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
170354243|NCT00819585|615632669|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
170354244|NCT00819585|615632670|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
170399309|NCT03193190|615799950|FG013|Stage 1|Physician Decision|0|||
170354245|NCT00819585|615632671|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
170354246|NCT00819585|615632672|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
170354247|NCT00819585|615632662|FG000|Core Study|Subject Withdrew Consent|0|||
170354248|NCT00819585|615632663|FG001|Core Study|Subject Withdrew Consent|3|||
170354249|NCT00819585|615632664|FG002|Core Study|Subject Withdrew Consent|2|||
170354250|NCT00819585|615632665|FG003|Core Study|Subject Withdrew Consent|1|||
170354251|NCT00819585|615632666|FG004|Core Study|Subject Withdrew Consent|0|||
170354252|NCT00819585|615632667|FG005|Core Study|Subject Withdrew Consent|0|||
170354253|NCT00819585|615632668|FG006|Core Study|Subject Withdrew Consent|3|||
170354254|NCT00819585|615632669|FG007|Core Study|Subject Withdrew Consent|0|||
170354255|NCT00819585|615632670|FG008|Core Study|Subject Withdrew Consent|0|||
170354256|NCT00819585|615632671|FG009|Core Study|Subject Withdrew Consent|0|||
170354257|NCT00819585|615632672|FG010|Core Study|Subject Withdrew Consent|0|||
170354258|NCT00819585|615632662|FG000|Core Study|Lost to Follow-up|2|||
170354259|NCT00819585|615632663|FG001|Core Study|Lost to Follow-up|1|||
170354260|NCT00819585|615632664|FG002|Core Study|Lost to Follow-up|2|||
170354261|NCT00819585|615632665|FG003|Core Study|Lost to Follow-up|0|||
170354262|NCT00819585|615632666|FG004|Core Study|Lost to Follow-up|1|||
170354263|NCT00819585|615632667|FG005|Core Study|Lost to Follow-up|1|||
170354264|NCT00819585|615632668|FG006|Core Study|Lost to Follow-up|1|||
170354265|NCT00819585|615632669|FG007|Core Study|Lost to Follow-up|0|||
170354266|NCT00819585|615632670|FG008|Core Study|Lost to Follow-up|0|||
170354267|NCT00819585|615632671|FG009|Core Study|Lost to Follow-up|0|||
170354268|NCT00819585|615632672|FG010|Core Study|Lost to Follow-up|0|||
170354269|NCT00819585|615632662|FG000|Core Study|Administrative Problems|0|||
170354270|NCT00819585|615632663|FG001|Core Study|Administrative Problems|0|||
170354271|NCT00819585|615632664|FG002|Core Study|Administrative Problems|0|||
170354272|NCT00819585|615632665|FG003|Core Study|Administrative Problems|0|||
170354273|NCT00819585|615632666|FG004|Core Study|Administrative Problems|0|||
170354274|NCT00819585|615632667|FG005|Core Study|Administrative Problems|0|||
170354275|NCT00819585|615632668|FG006|Core Study|Administrative Problems|2|||
170354276|NCT00819585|615632669|FG007|Core Study|Administrative Problems|0|||
170354277|NCT00819585|615632670|FG008|Core Study|Administrative Problems|0|||
170354278|NCT00819585|615632671|FG009|Core Study|Administrative Problems|0|||
170354279|NCT00819585|615632672|FG010|Core Study|Administrative Problems|0|||
170354280|NCT00819585|615632662|FG000|Core Study|Death|0|||
170354281|NCT00819585|615632663|FG001|Core Study|Death|0|||
170354282|NCT00819585|615632664|FG002|Core Study|Death|0|||
170354283|NCT00819585|615632665|FG003|Core Study|Death|0|||
170354284|NCT00819585|615632666|FG004|Core Study|Death|0|||
170354285|NCT00819585|615632667|FG005|Core Study|Death|0|||
170354286|NCT00819585|615632668|FG006|Core Study|Death|1|||
170354287|NCT00819585|615632669|FG007|Core Study|Death|0|||
170354288|NCT00819585|615632670|FG008|Core Study|Death|0|||
170354289|NCT00819585|615632671|FG009|Core Study|Death|0|||
170354290|NCT00819585|615632672|FG010|Core Study|Death|0|||
170354291|NCT00819585|615632662|FG000|Core Study|Protocol Violation|0|||
170354292|NCT00819585|615632663|FG001|Core Study|Protocol Violation|0|||
170354293|NCT00819585|615632664|FG002|Core Study|Protocol Violation|1|||
170354294|NCT00819585|615632665|FG003|Core Study|Protocol Violation|0|||
170354295|NCT00819585|615632666|FG004|Core Study|Protocol Violation|0|||
170354296|NCT00819585|615632667|FG005|Core Study|Protocol Violation|1|||
170354297|NCT00819585|615632668|FG006|Core Study|Protocol Violation|3|||
170354298|NCT00819585|615632669|FG007|Core Study|Protocol Violation|0|||
170354299|NCT00819585|615632670|FG008|Core Study|Protocol Violation|0|||
170354300|NCT00819585|615632671|FG009|Core Study|Protocol Violation|0|||
170354301|NCT00819585|615632672|FG010|Core Study|Protocol Violation|0|||
170354302|NCT00819585|615632662|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
170354303|NCT00819585|615632663|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
170354304|NCT00819585|615632664|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
170354305|NCT00819585|615632665|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
170354306|NCT00819585|615632666|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
170354307|NCT00819585|615632667|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
170354308|NCT00819585|615632668|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
170354309|NCT00819585|615632669|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
170354310|NCT00819585|615632670|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
170354311|NCT00819585|615632671|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
170354312|NCT00819585|615632672|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
170354313|NCT00819585|615632662|FG000|Extension Study|Subject Withdrew Consent|0|||
170354314|NCT00819585|615632663|FG001|Extension Study|Subject Withdrew Consent|0|||
170354315|NCT00819585|615632664|FG002|Extension Study|Subject Withdrew Consent|0|||
170354316|NCT00819585|615632665|FG003|Extension Study|Subject Withdrew Consent|0|||
170354317|NCT00819585|615632666|FG004|Extension Study|Subject Withdrew Consent|0|||
170354318|NCT00819585|615632667|FG005|Extension Study|Subject Withdrew Consent|0|||
170354319|NCT00819585|615632668|FG006|Extension Study|Subject Withdrew Consent|0|||
170354320|NCT00819585|615632669|FG007|Extension Study|Subject Withdrew Consent|0|||
170354321|NCT00819585|615632670|FG008|Extension Study|Subject Withdrew Consent|3|||
170354322|NCT00819585|615632671|FG009|Extension Study|Subject Withdrew Consent|0|||
170354323|NCT00819585|615632672|FG010|Extension Study|Subject Withdrew Consent|1|||
170354324|NCT00819585|615632662|FG000|Extension Study|Lost to Follow-up|0|||
170354325|NCT00819585|615632663|FG001|Extension Study|Lost to Follow-up|0|||
170354326|NCT00819585|615632664|FG002|Extension Study|Lost to Follow-up|0|||
170354327|NCT00819585|615632665|FG003|Extension Study|Lost to Follow-up|0|||
170354328|NCT00819585|615632666|FG004|Extension Study|Lost to Follow-up|0|||
170354329|NCT00819585|615632667|FG005|Extension Study|Lost to Follow-up|0|||
170354330|NCT00819585|615632668|FG006|Extension Study|Lost to Follow-up|0|||
170354331|NCT00819585|615632669|FG007|Extension Study|Lost to Follow-up|0|||
170354332|NCT00819585|615632670|FG008|Extension Study|Lost to Follow-up|2|||
170354333|NCT00819585|615632671|FG009|Extension Study|Lost to Follow-up|1|||
170354334|NCT00819585|615632672|FG010|Extension Study|Lost to Follow-up|1|||
170354335|NCT00819585|615632662|FG000|Extension Study|Death|0|||
170354336|NCT00819585|615632663|FG001|Extension Study|Death|0|||
170354337|NCT00819585|615632664|FG002|Extension Study|Death|0|||
170354338|NCT00819585|615632665|FG003|Extension Study|Death|0|||
170354339|NCT00819585|615632666|FG004|Extension Study|Death|0|||
170354340|NCT00819585|615632667|FG005|Extension Study|Death|0|||
170354341|NCT00819585|615632668|FG006|Extension Study|Death|0|||
170354342|NCT00819585|615632669|FG007|Extension Study|Death|0|||
170354343|NCT00819585|615632670|FG008|Extension Study|Death|2|||
170354344|NCT00819585|615632671|FG009|Extension Study|Death|0|||
170354345|NCT00819585|615632672|FG010|Extension Study|Death|0|||
170354346|NCT03521193|615632673|FG000|Overall Study|Withdrawal by Subject|8|||
170354347|NCT03521193|615632674|FG001|Overall Study|Withdrawal by Subject|0|||
170354348|NCT03521193|615632673|FG000|Overall Study|non compliant to ASA treatment|8|||
170354349|NCT03521193|615632674|FG001|Overall Study|non compliant to ASA treatment|0|||
170354350|NCT01877382|615632675|FG000|Dose Escalation|Progressive disease|2|||
170354351|NCT01877382|615632676|FG001|Dose Escalation|Progressive disease|0|||
170354352|NCT01877382|615632677|FG002|Dose Escalation|Progressive disease|1|||
170354353|NCT01877382|615632678|FG003|Dose Escalation|Progressive disease|6|||
170354354|NCT01877382|615632679|FG004|Dose Escalation|Progressive disease|1|||
170354355|NCT01877382|615632680|FG005|Dose Escalation|Progressive disease|0|||
170354356|NCT01877382|615632681|FG006|Dose Escalation|Progressive disease|3|||
170354357|NCT01877382|615632682|FG007|Dose Escalation|Progressive disease|10|||
170354358|NCT01877382|615632683|FG008|Dose Escalation|Progressive disease|4|||
170354359|NCT01877382|615632684|FG009|Dose Escalation|Progressive disease|2|||
170354360|NCT01877382|615632685|FG010|Dose Escalation|Progressive disease|3|||
170354361|NCT01877382|615632686|FG011|Dose Escalation|Progressive disease|3|||
170354362|NCT01877382|615632687|FG012|Dose Escalation|Progressive disease|13|||
170354363|NCT01877382|615632688|FG013|Dose Escalation|Progressive disease|1|||
170354364|NCT01877382|615632689|FG014|Dose Escalation|Progressive disease|0|||
170354365|NCT01877382|615632675|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
170354366|NCT01877382|615632676|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354367|NCT01877382|615632677|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354368|NCT01877382|615632678|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
170354369|NCT01877382|615632679|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354370|NCT01877382|615632680|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354371|NCT01877382|615632681|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
170354372|NCT01877382|615632682|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354373|NCT01877382|615632683|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354374|NCT01877382|615632684|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354375|NCT01877382|615632685|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354376|NCT01877382|615632686|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354377|NCT01877382|615632687|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354378|NCT01877382|615632688|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354379|NCT01877382|615632689|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354380|NCT01877382|615632675|FG000|Dose Escalation|Clinical progression|0|||
170354381|NCT01877382|615632676|FG001|Dose Escalation|Clinical progression|1|||
170354382|NCT01877382|615632677|FG002|Dose Escalation|Clinical progression|0|||
170354383|NCT01877382|615632678|FG003|Dose Escalation|Clinical progression|2|||
170354384|NCT01877382|615632679|FG004|Dose Escalation|Clinical progression|0|||
170354385|NCT01877382|615632680|FG005|Dose Escalation|Clinical progression|0|||
170354386|NCT01877382|615632681|FG006|Dose Escalation|Clinical progression|1|||
170354387|NCT01877382|615632682|FG007|Dose Escalation|Clinical progression|0|||
170354388|NCT01877382|615632683|FG008|Dose Escalation|Clinical progression|0|||
170354389|NCT01877382|615632684|FG009|Dose Escalation|Clinical progression|1|||
170354390|NCT01877382|615632685|FG010|Dose Escalation|Clinical progression|0|||
170354391|NCT01877382|615632686|FG011|Dose Escalation|Clinical progression|0|||
170354392|NCT01877382|615632687|FG012|Dose Escalation|Clinical progression|2|||
170354393|NCT01877382|615632688|FG013|Dose Escalation|Clinical progression|1|||
170354394|NCT01877382|615632689|FG014|Dose Escalation|Clinical progression|0|||
170354395|NCT01877382|615632675|FG000|Dose Escalation|Adverse Event|0|||
170354396|NCT01877382|615632676|FG001|Dose Escalation|Adverse Event|0|||
170354397|NCT01877382|615632677|FG002|Dose Escalation|Adverse Event|0|||
170354398|NCT01877382|615632678|FG003|Dose Escalation|Adverse Event|4|||
170354399|NCT01877382|615632679|FG004|Dose Escalation|Adverse Event|1|||
170354400|NCT01877382|615632680|FG005|Dose Escalation|Adverse Event|2|||
170354401|NCT01877382|615632681|FG006|Dose Escalation|Adverse Event|1|||
170354402|NCT01877382|615632682|FG007|Dose Escalation|Adverse Event|2|||
170354403|NCT01877382|615632683|FG008|Dose Escalation|Adverse Event|0|||
170354404|NCT01877382|615632684|FG009|Dose Escalation|Adverse Event|0|||
170354405|NCT01877382|615632685|FG010|Dose Escalation|Adverse Event|0|||
170354406|NCT01877382|615632686|FG011|Dose Escalation|Adverse Event|0|||
170354407|NCT01877382|615632687|FG012|Dose Escalation|Adverse Event|1|||
170354408|NCT01877382|615632688|FG013|Dose Escalation|Adverse Event|0|||
170354409|NCT01877382|615632689|FG014|Dose Escalation|Adverse Event|0|||
170354410|NCT01877382|615632675|FG000|Dose Escalation|Withdrawal by Subject|0|||
170354411|NCT01877382|615632676|FG001|Dose Escalation|Withdrawal by Subject|0|||
170354412|NCT01877382|615632677|FG002|Dose Escalation|Withdrawal by Subject|0|||
170354413|NCT01877382|615632678|FG003|Dose Escalation|Withdrawal by Subject|0|||
170354414|NCT01877382|615632679|FG004|Dose Escalation|Withdrawal by Subject|0|||
170354415|NCT01877382|615632680|FG005|Dose Escalation|Withdrawal by Subject|3|||
170354416|NCT01877382|615632681|FG006|Dose Escalation|Withdrawal by Subject|2|||
170354417|NCT01877382|615632682|FG007|Dose Escalation|Withdrawal by Subject|1|||
170354418|NCT01877382|615632683|FG008|Dose Escalation|Withdrawal by Subject|1|||
170354419|NCT01877382|615632684|FG009|Dose Escalation|Withdrawal by Subject|0|||
170354420|NCT01877382|615632685|FG010|Dose Escalation|Withdrawal by Subject|0|||
170354421|NCT01877382|615632686|FG011|Dose Escalation|Withdrawal by Subject|0|||
170354422|NCT01877382|615632687|FG012|Dose Escalation|Withdrawal by Subject|0|||
170354423|NCT01877382|615632688|FG013|Dose Escalation|Withdrawal by Subject|0|||
170354424|NCT01877382|615632689|FG014|Dose Escalation|Withdrawal by Subject|0|||
170354425|NCT01877382|615632675|FG000|Dose Escalation|Protocol Violation|0|||
170354426|NCT01877382|615632676|FG001|Dose Escalation|Protocol Violation|0|||
170354427|NCT01877382|615632677|FG002|Dose Escalation|Protocol Violation|0|||
170354428|NCT01877382|615632678|FG003|Dose Escalation|Protocol Violation|0|||
170354429|NCT01877382|615632679|FG004|Dose Escalation|Protocol Violation|0|||
170354430|NCT01877382|615632680|FG005|Dose Escalation|Protocol Violation|0|||
170354431|NCT01877382|615632681|FG006|Dose Escalation|Protocol Violation|1|||
170354432|NCT01877382|615632682|FG007|Dose Escalation|Protocol Violation|0|||
170354433|NCT01877382|615632683|FG008|Dose Escalation|Protocol Violation|0|||
170354434|NCT01877382|615632684|FG009|Dose Escalation|Protocol Violation|0|||
170354435|NCT01877382|615632685|FG010|Dose Escalation|Protocol Violation|0|||
170354436|NCT01877382|615632686|FG011|Dose Escalation|Protocol Violation|0|||
170354437|NCT01877382|615632687|FG012|Dose Escalation|Protocol Violation|0|||
170354438|NCT01877382|615632688|FG013|Dose Escalation|Protocol Violation|0|||
170354439|NCT01877382|615632689|FG014|Dose Escalation|Protocol Violation|0|||
170354440|NCT01877382|615632675|FG000|Dose Escalation|Study terminated by sponsor|0|||
170354441|NCT01877382|615632676|FG001|Dose Escalation|Study terminated by sponsor|0|||
170354442|NCT01877382|615632677|FG002|Dose Escalation|Study terminated by sponsor|0|||
170354443|NCT01877382|615632678|FG003|Dose Escalation|Study terminated by sponsor|0|||
170354444|NCT01877382|615632679|FG004|Dose Escalation|Study terminated by sponsor|0|||
170354445|NCT01877382|615632680|FG005|Dose Escalation|Study terminated by sponsor|0|||
170354446|NCT01877382|615632681|FG006|Dose Escalation|Study terminated by sponsor|0|||
170354447|NCT01877382|615632682|FG007|Dose Escalation|Study terminated by sponsor|1|||
170354448|NCT01877382|615632683|FG008|Dose Escalation|Study terminated by sponsor|1|||
170354449|NCT01877382|615632684|FG009|Dose Escalation|Study terminated by sponsor|0|||
170354450|NCT01877382|615632685|FG010|Dose Escalation|Study terminated by sponsor|0|||
170354451|NCT01877382|615632686|FG011|Dose Escalation|Study terminated by sponsor|0|||
170354452|NCT01877382|615632687|FG012|Dose Escalation|Study terminated by sponsor|3|||
170354453|NCT01877382|615632688|FG013|Dose Escalation|Study terminated by sponsor|0|||
170354454|NCT01877382|615632689|FG014|Dose Escalation|Study terminated by sponsor|0|||
170354455|NCT01877382|615632675|FG000|Dose Escalation|Death|0|||
170354456|NCT01877382|615632676|FG001|Dose Escalation|Death|0|||
170354457|NCT01877382|615632677|FG002|Dose Escalation|Death|0|||
170354458|NCT01877382|615632678|FG003|Dose Escalation|Death|0|||
170354459|NCT01877382|615632679|FG004|Dose Escalation|Death|0|||
170354460|NCT01877382|615632680|FG005|Dose Escalation|Death|0|||
170354461|NCT01877382|615632681|FG006|Dose Escalation|Death|0|||
170354462|NCT01877382|615632682|FG007|Dose Escalation|Death|1|||
170354463|NCT01877382|615632683|FG008|Dose Escalation|Death|0|||
170354464|NCT01877382|615632684|FG009|Dose Escalation|Death|0|||
170354465|NCT01877382|615632685|FG010|Dose Escalation|Death|0|||
170354466|NCT01877382|615632686|FG011|Dose Escalation|Death|0|||
170354467|NCT01877382|615632687|FG012|Dose Escalation|Death|1|||
170354468|NCT01877382|615632688|FG013|Dose Escalation|Death|1|||
170354469|NCT01877382|615632689|FG014|Dose Escalation|Death|0|||
170354470|NCT01877382|615632675|FG000|Dose Expansion|Progressive disease|0|||
170354471|NCT01877382|615632676|FG001|Dose Expansion|Progressive disease|0|||
170354472|NCT01877382|615632677|FG002|Dose Expansion|Progressive disease|0|||
170354473|NCT01877382|615632678|FG003|Dose Expansion|Progressive disease|0|||
170354474|NCT01877382|615632679|FG004|Dose Expansion|Progressive disease|0|||
170354475|NCT01877382|615632680|FG005|Dose Expansion|Progressive disease|0|||
170354476|NCT01877382|615632681|FG006|Dose Expansion|Progressive disease|0|||
170354477|NCT01877382|615632682|FG007|Dose Expansion|Progressive disease|0|||
170354478|NCT01877382|615632683|FG008|Dose Expansion|Progressive disease|0|||
170354479|NCT01877382|615632684|FG009|Dose Expansion|Progressive disease|0|||
170354480|NCT01877382|615632685|FG010|Dose Expansion|Progressive disease|0|||
170354481|NCT01877382|615632686|FG011|Dose Expansion|Progressive disease|0|||
170354482|NCT01877382|615632687|FG012|Dose Expansion|Progressive disease|0|||
170354483|NCT01877382|615632688|FG013|Dose Expansion|Progressive disease|0|||
170354484|NCT01877382|615632689|FG014|Dose Expansion|Progressive disease|11|||
170354485|NCT01877382|615632675|FG000|Dose Expansion|Clinical progression|0|||
170354486|NCT01877382|615632676|FG001|Dose Expansion|Clinical progression|0|||
170354487|NCT01877382|615632677|FG002|Dose Expansion|Clinical progression|0|||
170354488|NCT01877382|615632678|FG003|Dose Expansion|Clinical progression|0|||
170354489|NCT01877382|615632679|FG004|Dose Expansion|Clinical progression|0|||
170354490|NCT01877382|615632680|FG005|Dose Expansion|Clinical progression|0|||
170354491|NCT01877382|615632681|FG006|Dose Expansion|Clinical progression|0|||
170354492|NCT01877382|615632682|FG007|Dose Expansion|Clinical progression|0|||
170354493|NCT01877382|615632683|FG008|Dose Expansion|Clinical progression|0|||
170354494|NCT01877382|615632684|FG009|Dose Expansion|Clinical progression|0|||
170354495|NCT01877382|615632685|FG010|Dose Expansion|Clinical progression|0|||
170354496|NCT01877382|615632686|FG011|Dose Expansion|Clinical progression|0|||
170354497|NCT01877382|615632687|FG012|Dose Expansion|Clinical progression|0|||
170354498|NCT01877382|615632688|FG013|Dose Expansion|Clinical progression|0|||
170354499|NCT01877382|615632689|FG014|Dose Expansion|Clinical progression|6|||
170354500|NCT01877382|615632675|FG000|Dose Expansion|Adverse Event|0|||
170354501|NCT01877382|615632676|FG001|Dose Expansion|Adverse Event|0|||
170354502|NCT01877382|615632677|FG002|Dose Expansion|Adverse Event|0|||
170354503|NCT01877382|615632678|FG003|Dose Expansion|Adverse Event|0|||
170354504|NCT01877382|615632679|FG004|Dose Expansion|Adverse Event|0|||
170354505|NCT01877382|615632680|FG005|Dose Expansion|Adverse Event|0|||
170354506|NCT01877382|615632681|FG006|Dose Expansion|Adverse Event|0|||
170354507|NCT01877382|615632682|FG007|Dose Expansion|Adverse Event|0|||
170354508|NCT01877382|615632683|FG008|Dose Expansion|Adverse Event|0|||
170354509|NCT01877382|615632684|FG009|Dose Expansion|Adverse Event|0|||
170354510|NCT01877382|615632685|FG010|Dose Expansion|Adverse Event|0|||
170354511|NCT01877382|615632686|FG011|Dose Expansion|Adverse Event|0|||
170354512|NCT01877382|615632687|FG012|Dose Expansion|Adverse Event|0|||
170354513|NCT01877382|615632688|FG013|Dose Expansion|Adverse Event|0|||
170354514|NCT01877382|615632689|FG014|Dose Expansion|Adverse Event|1|||
170354515|NCT01877382|615632675|FG000|Dose Expansion|Death|0|||
170354516|NCT01877382|615632676|FG001|Dose Expansion|Death|0|||
170354517|NCT01877382|615632677|FG002|Dose Expansion|Death|0|||
170354518|NCT01877382|615632678|FG003|Dose Expansion|Death|0|||
170354519|NCT01877382|615632679|FG004|Dose Expansion|Death|0|||
170354520|NCT01877382|615632680|FG005|Dose Expansion|Death|0|||
170354521|NCT01877382|615632681|FG006|Dose Expansion|Death|0|||
170354522|NCT01877382|615632682|FG007|Dose Expansion|Death|0|||
170354523|NCT01877382|615632683|FG008|Dose Expansion|Death|0|||
170354524|NCT01877382|615632684|FG009|Dose Expansion|Death|0|||
170354525|NCT01877382|615632685|FG010|Dose Expansion|Death|0|||
170354526|NCT01877382|615632686|FG011|Dose Expansion|Death|0|||
170354527|NCT01877382|615632687|FG012|Dose Expansion|Death|0|||
170354528|NCT01877382|615632688|FG013|Dose Expansion|Death|0|||
170354529|NCT01877382|615632689|FG014|Dose Expansion|Death|1|||
170354530|NCT01877382|615632675|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354531|NCT01877382|615632676|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354532|NCT01877382|615632677|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354533|NCT01877382|615632678|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354534|NCT01877382|615632679|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354535|NCT01877382|615632680|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354536|NCT01877382|615632681|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354537|NCT01877382|615632682|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354538|NCT01877382|615632683|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354539|NCT01877382|615632684|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354540|NCT01877382|615632685|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354541|NCT01877382|615632686|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354542|NCT01877382|615632687|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354543|NCT01877382|615632688|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
170354544|NCT01877382|615632689|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
170354545|NCT00808249|615632690|FG000|Overall Study|Adverse Event|4|||
170354546|NCT00808249|615632691|FG001|Overall Study|Adverse Event|7|||
170354547|NCT00808249|615632692|FG002|Overall Study|Adverse Event|10|||
170354548|NCT00808249|615632693|FG003|Overall Study|Adverse Event|6|||
170354549|NCT00808249|615632690|FG000|Overall Study|Lost to Follow-up|2|||
170354550|NCT00808249|615632691|FG001|Overall Study|Lost to Follow-up|3|||
170354551|NCT00808249|615632692|FG002|Overall Study|Lost to Follow-up|3|||
170354552|NCT00808249|615632693|FG003|Overall Study|Lost to Follow-up|5|||
170354553|NCT00808249|615632690|FG000|Overall Study|Withdrawal by Subject|4|||
170354554|NCT00808249|615632691|FG001|Overall Study|Withdrawal by Subject|0|||
170354555|NCT00808249|615632692|FG002|Overall Study|Withdrawal by Subject|2|||
170354556|NCT00808249|615632693|FG003|Overall Study|Withdrawal by Subject|4|||
170354557|NCT00808249|615632690|FG000|Overall Study|Protocol Violation|3|||
170354558|NCT00808249|615632691|FG001|Overall Study|Protocol Violation|3|||
170354559|NCT00808249|615632692|FG002|Overall Study|Protocol Violation|3|||
170354560|NCT00808249|615632693|FG003|Overall Study|Protocol Violation|0|||
170354561|NCT00808249|615632690|FG000|Overall Study|Lack of Efficacy|1|||
170354562|NCT00808249|615632691|FG001|Overall Study|Lack of Efficacy|1|||
170354563|NCT00808249|615632692|FG002|Overall Study|Lack of Efficacy|0|||
170354564|NCT00808249|615632693|FG003|Overall Study|Lack of Efficacy|0|||
170354565|NCT00808249|615632690|FG000|Overall Study|study specific discontinuation criteria|1|||
170354566|NCT00808249|615632691|FG001|Overall Study|study specific discontinuation criteria|0|||
170354567|NCT00808249|615632692|FG002|Overall Study|study specific discontinuation criteria|1|||
170354568|NCT00808249|615632693|FG003|Overall Study|study specific discontinuation criteria|0|||
170354569|NCT00808249|615632690|FG000|Overall Study|All other reasons|2|||
170354570|NCT00808249|615632691|FG001|Overall Study|All other reasons|1|||
170354571|NCT00808249|615632692|FG002|Overall Study|All other reasons|3|||
170354572|NCT00808249|615632693|FG003|Overall Study|All other reasons|1|||
170354573|NCT05084053|615634102|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
170354574|NCT05084053|615634103|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
170354575|NCT05084053|615634104|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
170354576|NCT05084053|615634105|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
170354577|NCT05084053|615634102|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
170354578|NCT05084053|615634103|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
170354579|NCT05084053|615634104|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
170354580|NCT05084053|615634105|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
170354581|NCT05084053|615634102|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
170354582|NCT05084053|615634103|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
170354583|NCT05084053|615634104|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
170354584|NCT05084053|615634105|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
170354585|NCT03434418|615634108|FG000|Overall Study|Disease Progression|11|||
170354586|NCT03434418|615634108|FG000|Overall Study|Adverse Event|2|||
170354587|NCT03434418|615634108|FG000|Overall Study|Physician Decision|1|||
170354588|NCT03434418|615634108|FG000|Overall Study|Decline in Performance Status (PS)|1|||
170354589|NCT01517412|615634112|FG000|Overall Study|Adverse Event|10|||
170354590|NCT01517412|615634113|FG001|Overall Study|Adverse Event|11|||
170354591|NCT01517412|615634112|FG000|Overall Study|Lack of Efficacy|10|||
170354592|NCT01517412|615634113|FG001|Overall Study|Lack of Efficacy|5|||
170354593|NCT01517412|615634112|FG000|Overall Study|Poor compliance to protocol|8|||
170354594|NCT01517412|615634113|FG001|Overall Study|Poor compliance to protocol|3|||
170354595|NCT01517412|615634112|FG000|Overall Study|Other than specified above|8|||
170354596|NCT01517412|615634113|FG001|Overall Study|Other than specified above|5|||
170354597|NCT01253187|615634114|FG000|Period 2|Withdrawal by Subject|0|||
170354598|NCT01253187|615634115|FG001|Period 2|Withdrawal by Subject|0|||
170354599|NCT01253187|615634116|FG002|Period 2|Withdrawal by Subject|0|||
170354600|NCT01253187|615634117|FG003|Period 2|Withdrawal by Subject|0|||
170354601|NCT01253187|615634118|FG004|Period 2|Withdrawal by Subject|1|||
170354602|NCT01253187|615634119|FG005|Period 2|Withdrawal by Subject|0|||
170354603|NCT01253187|615634114|FG000|Period 3|Pregnancy|1|||
170354604|NCT01253187|615634115|FG001|Period 3|Pregnancy|0|||
170354605|NCT01253187|615634116|FG002|Period 3|Pregnancy|0|||
170354606|NCT01253187|615634117|FG003|Period 3|Pregnancy|0|||
170354607|NCT01253187|615634118|FG004|Period 3|Pregnancy|0|||
170354608|NCT01253187|615634119|FG005|Period 3|Pregnancy|0|||
170354609|NCT01253187|615634114|FG000|Period 3|difficulty with blood sampling|0|||
170354610|NCT01253187|615634115|FG001|Period 3|difficulty with blood sampling|1|||
170354611|NCT01253187|615634116|FG002|Period 3|difficulty with blood sampling|0|||
170354612|NCT01253187|615634117|FG003|Period 3|difficulty with blood sampling|0|||
170354613|NCT01253187|615634118|FG004|Period 3|difficulty with blood sampling|0|||
170354614|NCT01253187|615634119|FG005|Period 3|difficulty with blood sampling|0|||
170354615|NCT01253187|615634114|FG000|Period 3|non-compliance|0|||
170354616|NCT01253187|615634115|FG001|Period 3|non-compliance|0|||
170354617|NCT01253187|615634116|FG002|Period 3|non-compliance|0|||
170354618|NCT01253187|615634117|FG003|Period 3|non-compliance|0|||
170354619|NCT01253187|615634118|FG004|Period 3|non-compliance|1|||
170354620|NCT01253187|615634119|FG005|Period 3|non-compliance|0|||
170354621|NCT05279898|615634120|FG000|Overall Study|Withdrawal by Subject|1|||
170354622|NCT05279898|615634121|FG001|Overall Study|Withdrawal by Subject|0|||
170354623|NCT05279898|615634120|FG000|Overall Study|Physician Decision|1|||
170354624|NCT05279898|615634121|FG001|Overall Study|Physician Decision|1|||
170354625|NCT02680587|615634122|FG000|Overall Study|Withdrawal by Subject|1|||
170354626|NCT02680587|615634123|FG001|Overall Study|Withdrawal by Subject|0|||
170354627|NCT00229203|615634126|FG000|Overall Study|Progressive disease|18|||
170354628|NCT00229203|615634127|FG001|Overall Study|Progressive disease|9|||
170354629|NCT00229203|615634126|FG000|Overall Study|Toxicity|6|||
170354630|NCT00229203|615634127|FG001|Overall Study|Toxicity|1|||
170354631|NCT00229203|615634126|FG000|Overall Study|Death|4|||
170354632|NCT00229203|615634127|FG001|Overall Study|Death|2|||
170354633|NCT00229203|615634126|FG000|Overall Study|Other|3|||
170354634|NCT00229203|615634127|FG001|Overall Study|Other|3|||
170354635|NCT00229203|615634126|FG000|Overall Study|Withdrawal by Subject|1|||
170354636|NCT00229203|615634127|FG001|Overall Study|Withdrawal by Subject|4|||
170354637|NCT03457103|615634128|FG000|Overall Study|illness/hospitalization|4|||
170354638|NCT03457103|615634129|FG001|Overall Study|illness/hospitalization|2|||
170354639|NCT03457103|615634128|FG000|Overall Study|Lost to Follow-up|2|||
170354640|NCT03457103|615634129|FG001|Overall Study|Lost to Follow-up|1|||
170354641|NCT03457103|615634128|FG000|Overall Study|Withdrawal by Subject|1|||
170354642|NCT03457103|615634129|FG001|Overall Study|Withdrawal by Subject|2|||
170354643|NCT03457103|615634128|FG000|Overall Study|financial/ insurance issues|1|||
170354644|NCT03457103|615634129|FG001|Overall Study|financial/ insurance issues|1|||
170354645|NCT03004469|615634130|FG000|Overall Study|Adverse Event|6|||
170354646|NCT03004469|615634131|FG001|Overall Study|Adverse Event|4|||
170354647|NCT03004469|615634132|FG002|Overall Study|Adverse Event|6|||
170354648|NCT03004469|615634130|FG000|Overall Study|Lack of Efficacy|1|||
170354649|NCT03004469|615634131|FG001|Overall Study|Lack of Efficacy|0|||
170354650|NCT03004469|615634132|FG002|Overall Study|Lack of Efficacy|1|||
170354651|NCT03004469|615634130|FG000|Overall Study|Lost to Follow-up|23|||
170354652|NCT03004469|615634131|FG001|Overall Study|Lost to Follow-up|14|||
170354653|NCT03004469|615634132|FG002|Overall Study|Lost to Follow-up|6|||
170354654|NCT03004469|615634130|FG000|Overall Study|Non-Compliance with Study Drug|2|||
170354655|NCT03004469|615634131|FG001|Overall Study|Non-Compliance with Study Drug|0|||
170354656|NCT03004469|615634132|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170354657|NCT03004469|615634130|FG000|Overall Study|Protocol Violation|0|||
170354658|NCT03004469|615634131|FG001|Overall Study|Protocol Violation|0|||
170354659|NCT03004469|615634132|FG002|Overall Study|Protocol Violation|1|||
170354660|NCT03004469|615634130|FG000|Overall Study|Withdrawal by Subject|29|||
170354661|NCT03004469|615634131|FG001|Overall Study|Withdrawal by Subject|27|||
170354662|NCT03004469|615634132|FG002|Overall Study|Withdrawal by Subject|10|||
170354663|NCT03004469|615634130|FG000|Overall Study|Other unspecified reason|0|||
170354664|NCT03004469|615634131|FG001|Overall Study|Other unspecified reason|4|||
170354665|NCT03004469|615634132|FG002|Overall Study|Other unspecified reason|1|||
170354666|NCT01397552|615634133|FG000|Overall Study|Adverse Event|1|||
170354667|NCT01397552|615634134|FG001|Overall Study|Adverse Event|0|||
170354668|NCT01397552|615634133|FG000|Overall Study|Withdrawal by Subject|2|||
170354669|NCT01397552|615634134|FG001|Overall Study|Withdrawal by Subject|1|||
170354670|NCT00423735|615634135|FG000|Overall Study|Ineligible / No protocol treatment|8|||
170354671|NCT00423735|615634136|FG001|Overall Study|Ineligible / No protocol treatment|6|||
170354672|NCT00423735|615634137|FG002|Overall Study|Ineligible / No protocol treatment|0|||
170354673|NCT01089582|615634138|FG000|Overall Study|Death|2|||
170354674|NCT01089582|615634138|FG000|Overall Study|Adverse Event|15|||
170354675|NCT01089582|615634138|FG000|Overall Study|Lost to Follow-up|8|||
170354676|NCT01089582|615634138|FG000|Overall Study|Other|4|||
170354677|NCT01089582|615634138|FG000|Overall Study|Withdrawal by Subject|1|||
170354678|NCT02287402|615634139|FG000|Treatment Period|Adverse Event|17|||
170354679|NCT02287402|615634139|FG000|Treatment Period|Voluntary Withdrawal|10|||
170354680|NCT02287402|615634139|FG000|Follow-up|Lost to Follow-up|1|||
170354681|NCT02287402|615634139|FG000|Follow-up|Voluntary Withdrawal|2|||
170354682|NCT04069156|615634140|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
170354683|NCT04069156|615634141|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
170354684|NCT04069156|615634140|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
170354685|NCT04069156|615634141|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
170354686|NCT04069156|615634140|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
170354687|NCT04069156|615634141|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
170354688|NCT04069156|615634140|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
170354689|NCT04069156|615634141|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
170354690|NCT02394808|615634144|FG000|Period 1|Unsatisfactory lens fitting|0|||
170354691|NCT02394808|615634145|FG001|Period 1|Unsatisfactory lens fitting|1|||
170354692|NCT02394808|615634144|FG000|Period 2|Lost to Follow-up|1|||
170354693|NCT02394808|615634145|FG001|Period 2|Lost to Follow-up|0|||
170354694|NCT04735393|615634146|FG000|Overall Study|Lost to Follow-up|46|||
170354695|NCT04735393|615634147|FG001|Overall Study|Lost to Follow-up|24|||
170354696|NCT04735393|615634146|FG000|Overall Study|Physician Decision|2|||
170354697|NCT04735393|615634147|FG001|Overall Study|Physician Decision|1|||
170354698|NCT04735393|615634146|FG000|Overall Study|Not Detailed|1|||
170354699|NCT04735393|615634147|FG001|Overall Study|Not Detailed|2|||
170354700|NCT04735393|615634146|FG000|Overall Study|Withdrawal by Subject|71|||
170354701|NCT04735393|615634147|FG001|Overall Study|Withdrawal by Subject|28|||
170354702|NCT04735393|615634146|FG000|Overall Study|Adverse Event|56|||
170354703|NCT04735393|615634147|FG001|Overall Study|Adverse Event|7|||
170354704|NCT04735393|615634146|FG000|Overall Study|Protocol Violation|6|||
170354705|NCT04735393|615634147|FG001|Overall Study|Protocol Violation|1|||
170354706|NCT04735393|615634146|FG000|Overall Study|Trial terminated by Sponsor|49|||
170354707|NCT04735393|615634147|FG001|Overall Study|Trial terminated by Sponsor|29|||
170354708|NCT00209170|615634148|FG000|Overall Study|Adverse Event|0|||
170354709|NCT00209170|615634149|FG001|Overall Study|Adverse Event|1|||
170354710|NCT00209170|615634148|FG000|Overall Study|Withdrawal by Subject|2|||
170354711|NCT00209170|615634149|FG001|Overall Study|Withdrawal by Subject|1|||
170354712|NCT00209170|615634148|FG000|Overall Study|Lack of Efficacy|0|||
170354713|NCT00209170|615634149|FG001|Overall Study|Lack of Efficacy|1|||
170354714|NCT02108600|615634154|FG000|Overall Study|Withdrawal by Subject|2|||
170354715|NCT02108600|615634155|FG001|Overall Study|Withdrawal by Subject|0|||
170354716|NCT02108600|615634154|FG000|Overall Study|Lost to Follow-up|1|||
170354717|NCT02108600|615634155|FG001|Overall Study|Lost to Follow-up|1|||
170354718|NCT01295580|615634158|FG000|Overall Study|Protocol Violation|4|||
170354719|NCT01295580|615634159|FG001|Overall Study|Protocol Violation|2|||
170354720|NCT01295580|615634158|FG000|Overall Study|Withdrawal by Subject|1|||
170354721|NCT01295580|615634159|FG001|Overall Study|Withdrawal by Subject|4|||
170354722|NCT01295580|615634158|FG000|Overall Study|Adverse Event|2|||
170354723|NCT01295580|615634159|FG001|Overall Study|Adverse Event|1|||
170354724|NCT01295580|615634158|FG000|Overall Study|Lost to Follow-up|1|||
170354725|NCT01295580|615634159|FG001|Overall Study|Lost to Follow-up|0|||
170354726|NCT01295580|615634158|FG000|Overall Study|Lack of Efficacy|1|||
170354727|NCT01295580|615634159|FG001|Overall Study|Lack of Efficacy|0|||
170354728|NCT01295580|615634158|FG000|Overall Study|Other: inconvenience|1|||
170354729|NCT01295580|615634159|FG001|Overall Study|Other: inconvenience|0|||
170354730|NCT01295580|615634158|FG000|Overall Study|Other: family objection|0|||
170354731|NCT01295580|615634159|FG001|Overall Study|Other: family objection|1|||
170354732|NCT03806179|615634162|FG000|Overall Study|Progressive disease|0|||
170354733|NCT03806179|615634163|FG001|Overall Study|Progressive disease|2|||
170354734|NCT05822830|615634164|FG000|Overall Study|Adverse Event|6|||
170354735|NCT05822830|615634165|FG001|Overall Study|Adverse Event|6|||
170354736|NCT05822830|615634164|FG000|Overall Study|Assigned Treatment by Mistake|5|||
170354737|NCT05822830|615634165|FG001|Overall Study|Assigned Treatment by Mistake|3|||
170354738|NCT05822830|615634164|FG000|Overall Study|Lost to Follow-up|16|||
170354739|NCT05822830|615634165|FG001|Overall Study|Lost to Follow-up|18|||
170354740|NCT05822830|615634164|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170354741|NCT05822830|615634165|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170354742|NCT05822830|615634164|FG000|Overall Study|Participant was Out of the Country|0|||
170354743|NCT05822830|615634165|FG001|Overall Study|Participant was Out of the Country|1|||
170354744|NCT05822830|615634164|FG000|Overall Study|Pregnancy|1|||
170354745|NCT05822830|615634165|FG001|Overall Study|Pregnancy|2|||
170354746|NCT05822830|615634164|FG000|Overall Study|Withdrawal by Subject|27|||
170354747|NCT05822830|615634165|FG001|Overall Study|Withdrawal by Subject|26|||
170354748|NCT01153893|615634168|FG000|Overall Study|Adverse Event|1|||
170354749|NCT01153893|615634169|FG001|Overall Study|Adverse Event|0|||
170354750|NCT00807846|615634170|FG000|Overall Study|Adverse Event|5|||
170354751|NCT00807846|615634171|FG001|Overall Study|Adverse Event|0|||
170354752|NCT00807846|615634170|FG000|Overall Study|Lack of Efficacy|2|||
170354753|NCT00807846|615634171|FG001|Overall Study|Lack of Efficacy|0|||
170354754|NCT00807846|615634170|FG000|Overall Study|Protocol Violation|2|||
170354755|NCT00807846|615634171|FG001|Overall Study|Protocol Violation|1|||
170354756|NCT00807846|615634170|FG000|Overall Study|Withdrawal by Subject|2|||
170354757|NCT00807846|615634171|FG001|Overall Study|Withdrawal by Subject|1|||
170354758|NCT00807846|615634170|FG000|Overall Study|Other|1|||
170354759|NCT00807846|615634171|FG001|Overall Study|Other|2|||
170354760|NCT01165021|615634172|FG000|Overall Study|Death|1|||
170354761|NCT02491073|615634173|FG000|Overall Study|screen failure|1|||
170354762|NCT02491073|615634174|FG001|Overall Study|screen failure|0|||
170354763|NCT04799405|615634175|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
170354764|NCT03352414|615634176|FG000|Overall Study|Ineligible by operative criteria|12|||
170354765|NCT03352414|615634177|FG001|Overall Study|Ineligible by operative criteria|10|||
170354766|NCT01008995|615634178|FG000|Controlled Period|Adverse Event|1|||
170354767|NCT01008995|615634179|FG001|Controlled Period|Adverse Event|2|||
170354768|NCT01008995|615634180|FG002|Controlled Period|Adverse Event|0|||
170354769|NCT01008995|615634181|FG003|Controlled Period|Adverse Event|0|||
170354770|NCT01008995|615634178|FG000|Controlled Period|Other|2|||
170354771|NCT01008995|615634179|FG001|Controlled Period|Other|1|||
170354772|NCT01008995|615634180|FG002|Controlled Period|Other|0|||
170354773|NCT01008995|615634181|FG003|Controlled Period|Other|0|||
170354774|NCT01008995|615634178|FG000|After Controlled Period|Adverse Event|0|||
170354775|NCT01008995|615634179|FG001|After Controlled Period|Adverse Event|0|||
170354776|NCT01008995|615634180|FG002|After Controlled Period|Adverse Event|1|||
170354777|NCT01008995|615634181|FG003|After Controlled Period|Adverse Event|1|||
170354778|NCT01008995|615634178|FG000|After Controlled Period|Other|0|||
170354779|NCT01008995|615634179|FG001|After Controlled Period|Other|0|||
170354780|NCT01008995|615634180|FG002|After Controlled Period|Other|1|||
170354781|NCT01008995|615634181|FG003|After Controlled Period|Other|0|||
170354782|NCT03105700|615634184|FG000|Overall Study|screen fail|3|||
170354783|NCT03105700|615634184|FG000|Overall Study|Lost to Follow-up|4|||
170354784|NCT01822691|615634185|FG000|Overall Study|Withdrawal by Subject|2|||
170354785|NCT05319080|615634186|FG000|Overall Study|Withdrawal by Subject|2|||
170354786|NCT05319080|615634186|FG000|Overall Study|Physician Decision|4|||
170354787|NCT00751114|615634187|FG000|Overall Study|Adverse Event|2|||
170354788|NCT00751114|615634188|FG001|Overall Study|Adverse Event|4|||
170354789|NCT00751114|615634187|FG000|Overall Study|Protocol Violation|8|||
170354790|NCT00751114|615634188|FG001|Overall Study|Protocol Violation|9|||
170354791|NCT00751114|615634187|FG000|Overall Study|Withdrawal by Subject|9|||
170354792|NCT00751114|615634188|FG001|Overall Study|Withdrawal by Subject|4|||
170354793|NCT00751114|615634187|FG000|Overall Study|Lost to Follow-up|4|||
170354794|NCT00751114|615634188|FG001|Overall Study|Lost to Follow-up|7|||
170354795|NCT00751114|615634187|FG000|Overall Study|Lack of Efficacy|0|||
170354796|NCT00751114|615634188|FG001|Overall Study|Lack of Efficacy|7|||
170354797|NCT00751114|615634187|FG000|Overall Study|Not Treated|13|||
170354798|NCT00751114|615634188|FG001|Overall Study|Not Treated|1|||
170354799|NCT00751114|615634187|FG000|Overall Study|Out of country for 2 months|1|||
170354800|NCT00751114|615634188|FG001|Overall Study|Out of country for 2 months|0|||
170354801|NCT00751114|615634187|FG000|Overall Study|Move to another city|1|||
170354802|NCT00751114|615634188|FG001|Overall Study|Move to another city|0|||
170354803|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
170354804|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
170354805|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
170354806|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
170354807|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
170354808|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
170354809|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
170354810|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
170354811|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
170354812|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
170354813|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
170354814|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
170354815|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
170354816|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
170354817|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
170354818|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
170354819|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Missing|3|||
170354820|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Missing|1|||
170354821|NCT00838916|615634189|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
170354822|NCT00838916|615634190|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
170354823|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
170354824|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
170354825|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
170354826|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
170354827|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
170354828|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
170354829|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
170354830|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
170354831|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
170354832|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
170354833|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
170354834|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
170354835|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
170354836|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
170354837|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
170354838|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
170354839|NCT00838916|615634189|FG000|Follow-up Period (8 Weeks)|Missing|3|||
170354840|NCT00838916|615634190|FG001|Follow-up Period (8 Weeks)|Missing|0|||
170354841|NCT01927419|615634191|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
170354842|NCT01927419|615634192|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
170354843|NCT01927419|615634191|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
170354844|NCT01927419|615634192|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
170354845|NCT01927419|615634191|FG000|Treatment Period|Disease progression|17|||
170354846|NCT01927419|615634192|FG001|Treatment Period|Disease progression|20|||
170354847|NCT01927419|615634191|FG000|Treatment Period|Study drug toxicity|48|||
170354848|NCT01927419|615634192|FG001|Treatment Period|Study drug toxicity|10|||
170354849|NCT01927419|615634191|FG000|Treatment Period|Death|0|||
170354850|NCT01927419|615634192|FG001|Treatment Period|Death|1|||
170354851|NCT01927419|615634191|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
170354852|NCT01927419|615634192|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
170354853|NCT01927419|615634191|FG000|Treatment Period|Participant request to discontinue|12|||
170354854|NCT01927419|615634192|FG001|Treatment Period|Participant request to discontinue|4|||
170354855|NCT01927419|615634191|FG000|Treatment Period|Withdrawal by Subject|1|||
170354856|NCT01927419|615634192|FG001|Treatment Period|Withdrawal by Subject|1|||
170354857|NCT01927419|615634191|FG000|Treatment Period|Maximum Clinical Benefit|6|||
170354858|NCT01927419|615634192|FG001|Treatment Period|Maximum Clinical Benefit|2|||
170354859|NCT01927419|615634191|FG000|Treatment Period|Other reasons|3|||
170354860|NCT01927419|615634192|FG001|Treatment Period|Other reasons|4|||
170354861|NCT01927419|615634191|FG000|Treatment Period|Not Reported|1|||
170354862|NCT01927419|615634192|FG001|Treatment Period|Not Reported|1|||
170354863|NCT02773238|615634193|FG000|Overall Study|Lack of Efficacy|4|||
170354864|NCT03423979|615634194|FG000|Overall Study|Death|5|||
170354865|NCT03423979|615634194|FG000|Overall Study|Adverse Event|4|||
170354866|NCT03423979|615634194|FG000|Overall Study|Withdrawal by Subject|3|||
170354867|NCT03423979|615634194|FG000|Overall Study|Lost to Follow-up|16|||
170354868|NCT00430521|615634195|FG000|Overall Study|Adverse Event|0|||
170354869|NCT00430521|615634196|FG001|Overall Study|Adverse Event|0|||
170354870|NCT00430521|615634197|FG002|Overall Study|Adverse Event|0|||
170354871|NCT00430521|615634198|FG003|Overall Study|Adverse Event|0|||
170354872|NCT00430521|615634199|FG004|Overall Study|Adverse Event|0|||
170354873|NCT00430521|615634200|FG005|Overall Study|Adverse Event|2|||
170354874|NCT00430521|615634201|FG006|Overall Study|Adverse Event|1|||
170354875|NCT00430521|615634202|FG007|Overall Study|Adverse Event|0|||
170354876|NCT00430521|615634195|FG000|Overall Study|Lost to Follow-up|7|||
170354877|NCT00430521|615634196|FG001|Overall Study|Lost to Follow-up|8|||
170354878|NCT00430521|615634197|FG002|Overall Study|Lost to Follow-up|3|||
170354879|NCT00430521|615634198|FG003|Overall Study|Lost to Follow-up|5|||
170354880|NCT00430521|615634199|FG004|Overall Study|Lost to Follow-up|5|||
170354881|NCT00430521|615634200|FG005|Overall Study|Lost to Follow-up|2|||
170354882|NCT00430521|615634201|FG006|Overall Study|Lost to Follow-up|8|||
170354883|NCT00430521|615634202|FG007|Overall Study|Lost to Follow-up|10|||
170354884|NCT00430521|615634195|FG000|Overall Study|Pregnancy|0|||
170354885|NCT00430521|615634196|FG001|Overall Study|Pregnancy|0|||
170354886|NCT00430521|615634197|FG002|Overall Study|Pregnancy|0|||
170354887|NCT00430521|615634198|FG003|Overall Study|Pregnancy|0|||
170354888|NCT00430521|615634199|FG004|Overall Study|Pregnancy|0|||
170354889|NCT00430521|615634200|FG005|Overall Study|Pregnancy|0|||
170354890|NCT00430521|615634201|FG006|Overall Study|Pregnancy|1|||
170354891|NCT00430521|615634202|FG007|Overall Study|Pregnancy|0|||
170354892|NCT00430521|615634195|FG000|Overall Study|Vaccine Expired|0|||
170354893|NCT00430521|615634196|FG001|Overall Study|Vaccine Expired|0|||
170354894|NCT00430521|615634197|FG002|Overall Study|Vaccine Expired|0|||
170354895|NCT00430521|615634198|FG003|Overall Study|Vaccine Expired|0|||
170354896|NCT00430521|615634199|FG004|Overall Study|Vaccine Expired|0|||
170354897|NCT00430521|615634200|FG005|Overall Study|Vaccine Expired|1|||
170354898|NCT00430521|615634201|FG006|Overall Study|Vaccine Expired|0|||
170354899|NCT00430521|615634202|FG007|Overall Study|Vaccine Expired|0|||
170354900|NCT00430521|615634195|FG000|Overall Study|Protocol Violation|1|||
170354901|NCT00430521|615634196|FG001|Overall Study|Protocol Violation|0|||
170354902|NCT00430521|615634197|FG002|Overall Study|Protocol Violation|0|||
170354903|NCT00430521|615634198|FG003|Overall Study|Protocol Violation|0|||
170354904|NCT00430521|615634199|FG004|Overall Study|Protocol Violation|0|||
170354905|NCT00430521|615634200|FG005|Overall Study|Protocol Violation|0|||
170354906|NCT00430521|615634201|FG006|Overall Study|Protocol Violation|0|||
170354907|NCT00430521|615634202|FG007|Overall Study|Protocol Violation|0|||
170354908|NCT00430521|615634195|FG000|Overall Study|Withdrawal by Subject|3|||
170354909|NCT00430521|615634196|FG001|Overall Study|Withdrawal by Subject|1|||
170354910|NCT00430521|615634197|FG002|Overall Study|Withdrawal by Subject|0|||
170354911|NCT00430521|615634198|FG003|Overall Study|Withdrawal by Subject|3|||
170354912|NCT00430521|615634199|FG004|Overall Study|Withdrawal by Subject|0|||
170354913|NCT00430521|615634200|FG005|Overall Study|Withdrawal by Subject|0|||
170354914|NCT00430521|615634201|FG006|Overall Study|Withdrawal by Subject|0|||
170354915|NCT00430521|615634202|FG007|Overall Study|Withdrawal by Subject|2|||
170354916|NCT01511107|615634203|FG000|Overall Study|Ineligible|3|||
170354917|NCT01511107|615634204|FG001|Overall Study|Ineligible|2|||
170354918|NCT01511107|615634203|FG000|Overall Study|Lost to Follow-up|10|||
170354919|NCT01511107|615634204|FG001|Overall Study|Lost to Follow-up|19|||
170354920|NCT01511107|615634203|FG000|Overall Study|Withdrawal by Subject|9|||
170354921|NCT01511107|615634204|FG001|Overall Study|Withdrawal by Subject|20|||
170354922|NCT05371912|615634205|FG000|Overall Study|Lost to Follow-up|3|||
170354923|NCT05371912|615634206|FG001|Overall Study|Lost to Follow-up|2|||
170354924|NCT03675737|615634207|FG000|Overall Study|Death|593|||
170354925|NCT03675737|615634208|FG001|Overall Study|Death|660|||
170354926|NCT03675737|615634207|FG000|Overall Study|Lost to Follow-up|1|||
170354927|NCT03675737|615634208|FG001|Overall Study|Lost to Follow-up|5|||
170354928|NCT03675737|615634207|FG000|Overall Study|Physician Decision|1|||
170354929|NCT03675737|615634208|FG001|Overall Study|Physician Decision|0|||
170354930|NCT03675737|615634207|FG000|Overall Study|Withdrawal by Subject|14|||
170354931|NCT03675737|615634208|FG001|Overall Study|Withdrawal by Subject|12|||
170354932|NCT03675737|615634207|FG000|Overall Study|Ongoing in Study|181|||
170354933|NCT03675737|615634208|FG001|Overall Study|Ongoing in Study|112|||
170354934|NCT00975195|615634209|FG000|Overall Study|Adverse Event|108|||
170354935|NCT00975195|615634210|FG001|Overall Study|Adverse Event|101|||
170354936|NCT00975195|615634209|FG000|Overall Study|Lack of Efficacy|6|||
170354937|NCT00975195|615634210|FG001|Overall Study|Lack of Efficacy|6|||
170354938|NCT00975195|615634209|FG000|Overall Study|Protocol Violation|27|||
170354939|NCT00975195|615634210|FG001|Overall Study|Protocol Violation|23|||
170354940|NCT00975195|615634209|FG000|Overall Study|Lost to Follow-up|9|||
170354941|NCT00975195|615634210|FG001|Overall Study|Lost to Follow-up|7|||
170354942|NCT00975195|615634209|FG000|Overall Study|Withdrawal by Subject|48|||
170354943|NCT00975195|615634210|FG001|Overall Study|Withdrawal by Subject|61|||
170354944|NCT00975195|615634209|FG000|Overall Study|Other reason not defined above|29|||
170354945|NCT00975195|615634210|FG001|Overall Study|Other reason not defined above|33|||
170354946|NCT00975195|615634209|FG000|Overall Study|Not treated|1|||
170354947|NCT00975195|615634210|FG001|Overall Study|Not treated|2|||
170354948|NCT03422133|615634215|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
170354949|NCT03422133|615634216|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
170354950|NCT01179347|615636733|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
170354951|NCT01179347|615636734|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
170354952|NCT01179347|615636733|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
170354953|NCT01179347|615636734|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
170354954|NCT01179347|615636733|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
170354955|NCT01179347|615636734|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
170354956|NCT01179347|615636733|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
170354957|NCT01179347|615636734|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
170354958|NCT01179347|615636733|FG000|Double-blind Period (12 Weeks)|Other|2|||
170354959|NCT01179347|615636734|FG001|Double-blind Period (12 Weeks)|Other|4|||
170354960|NCT01179347|615636733|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
170354961|NCT01179347|615636734|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
170354962|NCT01179347|615636733|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
170354963|NCT01179347|615636734|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
170354964|NCT01179347|615636733|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
170354965|NCT01179347|615636734|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
170354966|NCT01179347|615636733|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
170354967|NCT01179347|615636734|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
170354968|NCT01179347|615636733|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
170354969|NCT01179347|615636734|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
170354970|NCT01179347|615636733|FG000|Open-label Period (12 Weeks)|Other|7|||
170354971|NCT01179347|615636734|FG001|Open-label Period (12 Weeks)|Other|4|||
170354972|NCT02109744|615636735|FG000|Overall Study|Death|1|||
170354973|NCT02109744|615636736|FG001|Overall Study|Death|1|||
170354974|NCT02109744|615636735|FG000|Overall Study|no marrow exam|1|||
170354975|NCT02109744|615636736|FG001|Overall Study|no marrow exam|0|||
170354976|NCT01337167|615636740|FG000|Infant Series|Adverse Event|1|||
170354977|NCT01337167|615636741|FG001|Infant Series|Adverse Event|1|||
170354978|NCT01337167|615636740|FG000|Infant Series|Death|1|||
170354979|NCT01337167|615636741|FG001|Infant Series|Death|1|||
170354980|NCT01337167|615636740|FG000|Infant Series|Lost to Follow-up|13|||
170354981|NCT01337167|615636741|FG001|Infant Series|Lost to Follow-up|7|||
170354982|NCT01337167|615636740|FG000|Infant Series|Non-compliance with study drug|2|||
170354983|NCT01337167|615636741|FG001|Infant Series|Non-compliance with study drug|1|||
170354984|NCT01337167|615636740|FG000|Infant Series|Physician Decision|3|||
170354985|NCT01337167|615636741|FG001|Infant Series|Physician Decision|1|||
170354986|NCT01337167|615636740|FG000|Infant Series|Protocol Violation|22|||
170354987|NCT01337167|615636741|FG001|Infant Series|Protocol Violation|9|||
170354988|NCT01337167|615636740|FG000|Infant Series|Withdrawal by Subject|15|||
170354989|NCT01337167|615636741|FG001|Infant Series|Withdrawal by Subject|4|||
170354990|NCT01337167|615636740|FG000|Infant Series|Randomized but not vaccinated|5|||
170354991|NCT01337167|615636741|FG001|Infant Series|Randomized but not vaccinated|3|||
170354992|NCT01337167|615636740|FG000|Interim Period|Lost to Follow-up|51|||
170354993|NCT01337167|615636741|FG001|Interim Period|Lost to Follow-up|23|||
170354994|NCT01337167|615636740|FG000|Interim Period|Non-compliance with study drug|1|||
170354995|NCT01337167|615636741|FG001|Interim Period|Non-compliance with study drug|0|||
170354996|NCT01337167|615636740|FG000|Interim Period|Physician Decision|6|||
170354997|NCT01337167|615636741|FG001|Interim Period|Physician Decision|3|||
170354998|NCT01337167|615636740|FG000|Interim Period|Protocol Violation|5|||
170354999|NCT01337167|615636741|FG001|Interim Period|Protocol Violation|3|||
170355000|NCT01337167|615636740|FG000|Interim Period|Withdrawal by Subject|18|||
170355001|NCT01337167|615636741|FG001|Interim Period|Withdrawal by Subject|10|||
170355002|NCT01337167|615636740|FG000|Interim Period|Other protocol criterion not met|0|||
170355003|NCT01337167|615636741|FG001|Interim Period|Other protocol criterion not met|1|||
170355004|NCT01337167|615636740|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
170355005|NCT01337167|615636741|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
170355006|NCT01337167|615636740|FG000|Toddler Vaccinations|Protocol Violation|0|||
170355007|NCT01337167|615636741|FG001|Toddler Vaccinations|Protocol Violation|1|||
170355008|NCT01337167|615636740|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
170355009|NCT01337167|615636741|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
170355010|NCT03833817|615636742|FG000|Overall Study|Withdrawal by Subject|3|||
170355011|NCT03833817|615636743|FG001|Overall Study|Withdrawal by Subject|3|||
170355012|NCT03833817|615636742|FG000|Overall Study|Lost to Follow-up|3|||
170355013|NCT03833817|615636743|FG001|Overall Study|Lost to Follow-up|3|||
170355014|NCT02126670|615636748|FG000|Overall Study|Withdrawal by Subject|1|||
170355015|NCT02126670|615636749|FG001|Overall Study|Withdrawal by Subject|0|||
170355016|NCT02126670|615636750|FG002|Overall Study|Withdrawal by Subject|0|||
170355017|NCT02126670|615636751|FG003|Overall Study|Withdrawal by Subject|1|||
170355018|NCT01975246|615636752|FG000|Overall Study|Adverse Event|2|||
170355019|NCT01975246|615636753|FG001|Overall Study|Adverse Event|1|||
170355020|NCT01975246|615636752|FG000|Overall Study|Lack of Efficacy|1|||
170355021|NCT01975246|615636753|FG001|Overall Study|Lack of Efficacy|0|||
170355022|NCT01975246|615636752|FG000|Overall Study|Protocol Violation|1|||
170355023|NCT01975246|615636753|FG001|Overall Study|Protocol Violation|0|||
170355024|NCT01975246|615636752|FG000|Overall Study|Other than stated|0|||
170355025|NCT01975246|615636753|FG001|Overall Study|Other than stated|1|||
170355026|NCT01646398|615636754|FG000|Overall Study|Withdrawal by Subject|1|||
170355027|NCT01646398|615636755|FG001|Overall Study|Withdrawal by Subject|0|||
170355028|NCT00424346|615636756|FG000|Core Study|Adverse Event|5|||
170355029|NCT00424346|615636757|FG001|Core Study|Adverse Event|3|||
170355030|NCT00424346|615636758|FG002|Core Study|Adverse Event|1|||
170355031|NCT00424346|615636759|FG003|Core Study|Adverse Event|1|||
170355032|NCT00424346|615636756|FG000|Core Study|Abnormal Laboratory Values|0|||
170355033|NCT00424346|615636757|FG001|Core Study|Abnormal Laboratory Values|1|||
170355034|NCT00424346|615636758|FG002|Core Study|Abnormal Laboratory Values|0|||
170355035|NCT00424346|615636759|FG003|Core Study|Abnormal Laboratory Values|0|||
170355036|NCT00424346|615636756|FG000|Core Study|Lack of Efficacy|1|||
170355037|NCT00424346|615636757|FG001|Core Study|Lack of Efficacy|3|||
170355038|NCT00424346|615636758|FG002|Core Study|Lack of Efficacy|0|||
170355039|NCT00424346|615636759|FG003|Core Study|Lack of Efficacy|4|||
170355040|NCT00424346|615636756|FG000|Core Study|Withdrawal by Subject|1|||
170355041|NCT00424346|615636757|FG001|Core Study|Withdrawal by Subject|0|||
170355042|NCT00424346|615636758|FG002|Core Study|Withdrawal by Subject|0|||
170355043|NCT00424346|615636759|FG003|Core Study|Withdrawal by Subject|2|||
170355044|NCT00424346|615636756|FG000|Core Study|Lost to Follow-up|1|||
170355045|NCT00424346|615636757|FG001|Core Study|Lost to Follow-up|1|||
170355046|NCT00424346|615636758|FG002|Core Study|Lost to Follow-up|0|||
170355047|NCT00424346|615636759|FG003|Core Study|Lost to Follow-up|0|||
170355048|NCT00424346|615636756|FG000|Core Study|Administrative Problems|1|||
170355049|NCT00424346|615636757|FG001|Core Study|Administrative Problems|0|||
170355050|NCT00424346|615636758|FG002|Core Study|Administrative Problems|1|||
170355051|NCT00424346|615636759|FG003|Core Study|Administrative Problems|0|||
170355052|NCT00424346|615636756|FG000|Core Study|Protocol Violation|0|||
170355053|NCT00424346|615636757|FG001|Core Study|Protocol Violation|0|||
170355054|NCT00424346|615636758|FG002|Core Study|Protocol Violation|2|||
170355055|NCT00424346|615636759|FG003|Core Study|Protocol Violation|0|||
170355056|NCT00424346|615636756|FG000|Extension Phase|Adverse Event|0|||
170355057|NCT00424346|615636757|FG001|Extension Phase|Adverse Event|9|||
170355058|NCT00424346|615636758|FG002|Extension Phase|Adverse Event|5|||
170355059|NCT00424346|615636759|FG003|Extension Phase|Adverse Event|4|||
170355060|NCT00424346|615636756|FG000|Extension Phase|Lack of Efficacy|0|||
170355061|NCT00424346|615636757|FG001|Extension Phase|Lack of Efficacy|16|||
170355062|NCT00424346|615636758|FG002|Extension Phase|Lack of Efficacy|14|||
170355063|NCT00424346|615636759|FG003|Extension Phase|Lack of Efficacy|11|||
170355064|NCT00424346|615636756|FG000|Extension Phase|Withdrawal by Subject|0|||
170355065|NCT00424346|615636757|FG001|Extension Phase|Withdrawal by Subject|5|||
170355066|NCT00424346|615636758|FG002|Extension Phase|Withdrawal by Subject|3|||
170355067|NCT00424346|615636759|FG003|Extension Phase|Withdrawal by Subject|4|||
170355068|NCT00424346|615636756|FG000|Extension Phase|Lost to Follow-up|0|||
170355069|NCT00424346|615636757|FG001|Extension Phase|Lost to Follow-up|2|||
170355070|NCT00424346|615636758|FG002|Extension Phase|Lost to Follow-up|0|||
170355071|NCT00424346|615636759|FG003|Extension Phase|Lost to Follow-up|0|||
170355072|NCT00424346|615636756|FG000|Extension Phase|Administrative Problems|0|||
170355073|NCT00424346|615636757|FG001|Extension Phase|Administrative Problems|69|||
170355074|NCT00424346|615636758|FG002|Extension Phase|Administrative Problems|32|||
170355075|NCT00424346|615636759|FG003|Extension Phase|Administrative Problems|35|||
170355076|NCT00424346|615636756|FG000|Extension Phase|Death|0|||
170355077|NCT00424346|615636757|FG001|Extension Phase|Death|0|||
170355078|NCT00424346|615636758|FG002|Extension Phase|Death|0|||
170355079|NCT00424346|615636759|FG003|Extension Phase|Death|1|||
170355080|NCT00424346|615636756|FG000|Extension Phase|Protocol Violation|0|||
170355081|NCT00424346|615636757|FG001|Extension Phase|Protocol Violation|1|||
170355082|NCT00424346|615636758|FG002|Extension Phase|Protocol Violation|1|||
170355083|NCT00424346|615636759|FG003|Extension Phase|Protocol Violation|0|||
170355084|NCT01827319|615636760|FG000|Overall Study|Lost to Follow-up|3|||
170355085|NCT00571519|615636761|FG000|Overall Study|Subject withdrew consent|0|||
170355086|NCT00571519|615636762|FG001|Overall Study|Subject withdrew consent|1|||
170355087|NCT00571519|615636763|FG002|Overall Study|Subject withdrew consent|0|||
170355088|NCT00571519|615636764|FG003|Overall Study|Subject withdrew consent|2|||
170355089|NCT00571519|615636765|FG004|Overall Study|Subject withdrew consent|1|||
170355090|NCT00571519|615636766|FG005|Overall Study|Subject withdrew consent|1|||
170355091|NCT00571519|615636767|FG006|Overall Study|Subject withdrew consent|2|||
170355092|NCT00571519|615636761|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
170355093|NCT00571519|615636762|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
170355094|NCT00571519|615636763|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
170355095|NCT00571519|615636764|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
170355096|NCT00571519|615636765|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
170355097|NCT00571519|615636766|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
170355098|NCT00571519|615636767|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
170355099|NCT00571519|615636761|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
170355100|NCT00571519|615636762|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
170355101|NCT00571519|615636763|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
170355102|NCT00571519|615636764|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
170355103|NCT00571519|615636765|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
170355104|NCT00571519|615636766|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
170355105|NCT00571519|615636767|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
170355106|NCT00571519|615636761|FG000|Overall Study|Termination of study by Sponsor|2|||
170355107|NCT00571519|615636762|FG001|Overall Study|Termination of study by Sponsor|7|||
170355108|NCT00571519|615636763|FG002|Overall Study|Termination of study by Sponsor|10|||
170355109|NCT00571519|615636764|FG003|Overall Study|Termination of study by Sponsor|24|||
170355110|NCT00571519|615636765|FG004|Overall Study|Termination of study by Sponsor|8|||
170355111|NCT00571519|615636766|FG005|Overall Study|Termination of study by Sponsor|9|||
170355112|NCT00571519|615636767|FG006|Overall Study|Termination of study by Sponsor|22|||
170355113|NCT00571519|615636761|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
170355114|NCT00571519|615636762|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
170355115|NCT00571519|615636763|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
170355116|NCT00571519|615636764|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
170355117|NCT00571519|615636765|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
170355118|NCT00571519|615636766|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
170355119|NCT00571519|615636767|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
170355120|NCT00574119|615636768|FG000|Overall Study|Adverse Event|1|||
170355121|NCT00574119|615636768|FG000|Overall Study|Protocol Violation|1|||
170355122|NCT00574119|615636768|FG000|Overall Study|Withdrawal by Subject|1|||
170355123|NCT00574119|615636768|FG000|Overall Study|Physician Decision|1|||
170355124|NCT02690207|615636769|FG000|Overall Study|Lost to Follow-up|48|||
170355125|NCT02690207|615636769|FG000|Overall Study|Withdrawal by Subject|46|||
170355126|NCT02690207|615636769|FG000|Overall Study|Protocol Violation|2|||
170355127|NCT02690207|615636769|FG000|Overall Study|Serious adverse event|110|||
170355128|NCT02690207|615636769|FG000|Overall Study|Non-serious Adverse Event|18|||
170355129|NCT02690207|615636769|FG000|Overall Study|Migrated/moved from study area|5|||
170355130|NCT02690207|615636769|FG000|Overall Study|Suspected HZ Episode|1|||
170355131|NCT02690207|615636769|FG000|Overall Study|Other reasons for withdrawal|23|||
170355132|NCT03287245|615636770|FG000|Overall Study|Study terminated by sponsor|3|||
170355133|NCT03287245|615636771|FG001|Overall Study|Study terminated by sponsor|0|||
170355134|NCT03287245|615636772|FG002|Overall Study|Study terminated by sponsor|3|||
170355135|NCT03287245|615636773|FG003|Overall Study|Study terminated by sponsor|1|||
170355136|NCT03287245|615636770|FG000|Overall Study|Adverse Event|1|||
170355137|NCT03287245|615636771|FG001|Overall Study|Adverse Event|0|||
170355138|NCT03287245|615636772|FG002|Overall Study|Adverse Event|0|||
170355139|NCT03287245|615636773|FG003|Overall Study|Adverse Event|0|||
170355140|NCT03287245|615636770|FG000|Overall Study|Withdrawal by Subject|8|||
170355141|NCT03287245|615636771|FG001|Overall Study|Withdrawal by Subject|3|||
170355142|NCT03287245|615636772|FG002|Overall Study|Withdrawal by Subject|3|||
170355143|NCT03287245|615636773|FG003|Overall Study|Withdrawal by Subject|0|||
170355144|NCT03287245|615636770|FG000|Overall Study|Physician Decision|3|||
170355145|NCT03287245|615636771|FG001|Overall Study|Physician Decision|2|||
170355146|NCT03287245|615636772|FG002|Overall Study|Physician Decision|0|||
170355147|NCT03287245|615636773|FG003|Overall Study|Physician Decision|0|||
170355148|NCT03057951|615636777|FG000|Overall Study|Adverse Event|553|||
170355149|NCT03057951|615636778|FG001|Overall Study|Adverse Event|575|||
170355150|NCT03057951|615636777|FG000|Overall Study|Protocol Violation|30|||
170355151|NCT03057951|615636778|FG001|Overall Study|Protocol Violation|24|||
170355152|NCT03057951|615636777|FG000|Overall Study|Lost to Follow-up|6|||
170355153|NCT03057951|615636778|FG001|Overall Study|Lost to Follow-up|16|||
170355154|NCT03057951|615636777|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
170355155|NCT03057951|615636778|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
170355156|NCT03057951|615636777|FG000|Overall Study|Study drug stopped, reason missing|6|||
170355157|NCT03057951|615636778|FG001|Overall Study|Study drug stopped, reason missing|1|||
170355158|NCT03057951|615636777|FG000|Overall Study|Medical advice|6|||
170355159|NCT03057951|615636778|FG001|Overall Study|Medical advice|2|||
170355160|NCT03057951|615636777|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
170355161|NCT03057951|615636778|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
170355162|NCT03057951|615636777|FG000|Overall Study|Investigator decision|2|||
170355163|NCT03057951|615636778|FG001|Overall Study|Investigator decision|0|||
170355164|NCT03057951|615636777|FG000|Overall Study|Patient decision|5|||
170355165|NCT03057951|615636778|FG001|Overall Study|Patient decision|2|||
170355166|NCT03057951|615636777|FG000|Overall Study|Not attending study visits|3|||
170355167|NCT03057951|615636778|FG001|Overall Study|Not attending study visits|0|||
170355168|NCT03057951|615636777|FG000|Overall Study|Patient moved away|3|||
170355169|NCT03057951|615636778|FG001|Overall Study|Patient moved away|4|||
170355170|NCT03057951|615636777|FG000|Overall Study|Other reason than stated above|23|||
170355171|NCT03057951|615636778|FG001|Overall Study|Other reason than stated above|29|||
170355172|NCT03057951|615636777|FG000|Overall Study|Not treated|2|||
170355173|NCT03057951|615636778|FG001|Overall Study|Not treated|1|||
170355174|NCT00696436|615636779|FG000|Overall Study|Adverse Event|7|||
170355175|NCT00696436|615636780|FG001|Overall Study|Adverse Event|9|||
170355176|NCT00696436|615636781|FG002|Overall Study|Adverse Event|8|||
170355177|NCT00696436|615636782|FG003|Overall Study|Adverse Event|6|||
170355178|NCT00696436|615636783|FG004|Overall Study|Adverse Event|4|||
170355179|NCT00696436|615636779|FG000|Overall Study|Protocol Violation|3|||
170355180|NCT00696436|615636780|FG001|Overall Study|Protocol Violation|2|||
170355181|NCT00696436|615636781|FG002|Overall Study|Protocol Violation|2|||
170355182|NCT00696436|615636782|FG003|Overall Study|Protocol Violation|0|||
170355183|NCT00696436|615636783|FG004|Overall Study|Protocol Violation|1|||
170355184|NCT00696436|615636779|FG000|Overall Study|Lost to Follow-up|1|||
170355185|NCT00696436|615636780|FG001|Overall Study|Lost to Follow-up|6|||
170355186|NCT00696436|615636781|FG002|Overall Study|Lost to Follow-up|2|||
170355187|NCT00696436|615636782|FG003|Overall Study|Lost to Follow-up|4|||
170355188|NCT00696436|615636783|FG004|Overall Study|Lost to Follow-up|3|||
170355189|NCT00696436|615636779|FG000|Overall Study|Withdrawal by Subject|4|||
170355190|NCT00696436|615636780|FG001|Overall Study|Withdrawal by Subject|11|||
170355191|NCT00696436|615636781|FG002|Overall Study|Withdrawal by Subject|5|||
170355192|NCT00696436|615636782|FG003|Overall Study|Withdrawal by Subject|7|||
170355193|NCT00696436|615636783|FG004|Overall Study|Withdrawal by Subject|1|||
170355194|NCT00696436|615636779|FG000|Overall Study|Lack of Efficacy|3|||
170355195|NCT00696436|615636780|FG001|Overall Study|Lack of Efficacy|1|||
170355196|NCT00696436|615636781|FG002|Overall Study|Lack of Efficacy|5|||
170355197|NCT00696436|615636782|FG003|Overall Study|Lack of Efficacy|2|||
170355198|NCT00696436|615636783|FG004|Overall Study|Lack of Efficacy|4|||
170355199|NCT00696436|615636779|FG000|Overall Study|Participant Unavailability|2|||
170355200|NCT00696436|615636780|FG001|Overall Study|Participant Unavailability|0|||
170355201|NCT00696436|615636781|FG002|Overall Study|Participant Unavailability|2|||
170355202|NCT00696436|615636782|FG003|Overall Study|Participant Unavailability|1|||
170355203|NCT00696436|615636783|FG004|Overall Study|Participant Unavailability|0|||
170355204|NCT00696436|615636779|FG000|Overall Study|Administrative Error|2|||
170355205|NCT00696436|615636780|FG001|Overall Study|Administrative Error|0|||
170355206|NCT00696436|615636781|FG002|Overall Study|Administrative Error|2|||
170355207|NCT00696436|615636782|FG003|Overall Study|Administrative Error|0|||
170355208|NCT00696436|615636783|FG004|Overall Study|Administrative Error|0|||
170355209|NCT00696436|615636779|FG000|Overall Study|Participant Non-compliance|0|||
170355210|NCT00696436|615636780|FG001|Overall Study|Participant Non-compliance|0|||
170355211|NCT00696436|615636781|FG002|Overall Study|Participant Non-compliance|1|||
170355212|NCT00696436|615636782|FG003|Overall Study|Participant Non-compliance|2|||
170355213|NCT00696436|615636783|FG004|Overall Study|Participant Non-compliance|0|||
170355214|NCT00696436|615636779|FG000|Overall Study|Administrative Decision|1|||
170355215|NCT00696436|615636780|FG001|Overall Study|Administrative Decision|0|||
170355216|NCT00696436|615636781|FG002|Overall Study|Administrative Decision|0|||
170355217|NCT00696436|615636782|FG003|Overall Study|Administrative Decision|0|||
170355218|NCT00696436|615636783|FG004|Overall Study|Administrative Decision|0|||
170355219|NCT00696436|615636779|FG000|Overall Study|Missing|0|||
170355220|NCT00696436|615636780|FG001|Overall Study|Missing|1|||
170355221|NCT00696436|615636781|FG002|Overall Study|Missing|1|||
170355222|NCT00696436|615636782|FG003|Overall Study|Missing|0|||
170355223|NCT00696436|615636783|FG004|Overall Study|Missing|0|||
170355224|NCT00912340|615636785|FG000|Overall Study|Adverse Event|2|||
170355225|NCT00912340|615636786|FG001|Overall Study|Adverse Event|4|||
170355226|NCT00912340|615636787|FG002|Overall Study|Adverse Event|0|||
170355227|NCT00912340|615636785|FG000|Overall Study|Protocol revised to remove arm|0|||
170355228|NCT00912340|615636786|FG001|Overall Study|Protocol revised to remove arm|0|||
170355229|NCT00912340|615636787|FG002|Overall Study|Protocol revised to remove arm|4|||
170355230|NCT01293006|615636790|FG000|Period 2|Lost to Follow-up|1|||
170355231|NCT01293006|615636791|FG001|Period 2|Lost to Follow-up|0|||
170355232|NCT01293006|615636792|FG002|Period 2|Lost to Follow-up|0|||
170355233|NCT01293006|615636793|FG003|Period 2|Lost to Follow-up|0|||
170355234|NCT04393038|615636802|FG000|Overall Study|Adverse Event|11|||
170355235|NCT04393038|615636803|FG001|Overall Study|Adverse Event|2|||
170355236|NCT04393038|615636802|FG000|Overall Study|Protocol Violation|1|||
170355237|NCT04393038|615636803|FG001|Overall Study|Protocol Violation|0|||
170355238|NCT04393038|615636802|FG000|Overall Study|Death|6|||
170355239|NCT04393038|615636803|FG001|Overall Study|Death|4|||
170355240|NCT04393038|615636802|FG000|Overall Study|Withdrawal by Subject|24|||
170355241|NCT04393038|615636803|FG001|Overall Study|Withdrawal by Subject|8|||
170355242|NCT04393038|615636802|FG000|Overall Study|Lost to Follow-up|5|||
170355243|NCT04393038|615636803|FG001|Overall Study|Lost to Follow-up|4|||
170355244|NCT04393038|615636802|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
170355245|NCT04393038|615636803|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
170355246|NCT04393038|615636802|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
170355247|NCT04393038|615636803|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
170355248|NCT05168813|615636804|FG000|Part A (Open-label)|Lost to Follow-up|21|||
170355249|NCT05168813|615636805|FG001|Part A (Open-label)|Lost to Follow-up|39|||
170355250|NCT05168813|615636806|FG002|Part A (Open-label)|Lost to Follow-up|8|||
170355251|NCT05168813|615636807|FG003|Part A (Open-label)|Lost to Follow-up|26|||
170355252|NCT05168813|615636808|FG004|Part A (Open-label)|Lost to Follow-up|0|||
170355253|NCT05168813|615636809|FG005|Part A (Open-label)|Lost to Follow-up|0|||
170355254|NCT05168813|615636804|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
170355255|NCT05168813|615636805|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
170355256|NCT05168813|615636806|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
170355257|NCT05168813|615636807|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
170355258|NCT05168813|615636808|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
170355259|NCT05168813|615636809|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
170355260|NCT05168813|615636804|FG000|Part A (Open-label)|Death|23|||
170355261|NCT05168813|615636805|FG001|Part A (Open-label)|Death|28|||
170355262|NCT05168813|615636806|FG002|Part A (Open-label)|Death|1|||
170355263|NCT05168813|615636807|FG003|Part A (Open-label)|Death|9|||
170355264|NCT05168813|615636808|FG004|Part A (Open-label)|Death|0|||
170355265|NCT05168813|615636809|FG005|Part A (Open-label)|Death|0|||
170355266|NCT05168813|615636804|FG000|Part A (Open-label)|Physician Decision|0|||
170355267|NCT05168813|615636805|FG001|Part A (Open-label)|Physician Decision|1|||
170355268|NCT05168813|615636806|FG002|Part A (Open-label)|Physician Decision|0|||
170355269|NCT05168813|615636807|FG003|Part A (Open-label)|Physician Decision|2|||
170355270|NCT05168813|615636808|FG004|Part A (Open-label)|Physician Decision|0|||
170355271|NCT05168813|615636809|FG005|Part A (Open-label)|Physician Decision|0|||
170355272|NCT05168813|615636804|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
170355273|NCT05168813|615636805|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
170355274|NCT05168813|615636806|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
170355275|NCT05168813|615636807|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
170355276|NCT05168813|615636808|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
170355277|NCT05168813|615636809|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
170355278|NCT05168813|615636804|FG000|Part A (Open-label)|Protocol Violation|0|||
170355279|NCT05168813|615636805|FG001|Part A (Open-label)|Protocol Violation|1|||
170355280|NCT05168813|615636806|FG002|Part A (Open-label)|Protocol Violation|0|||
170355281|NCT05168813|615636807|FG003|Part A (Open-label)|Protocol Violation|0|||
170355282|NCT05168813|615636808|FG004|Part A (Open-label)|Protocol Violation|0|||
170355283|NCT05168813|615636809|FG005|Part A (Open-label)|Protocol Violation|0|||
170355284|NCT05168813|615636804|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
170355285|NCT05168813|615636805|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
170355286|NCT05168813|615636806|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
170355287|NCT05168813|615636807|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
170355288|NCT05168813|615636808|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
170355289|NCT05168813|615636809|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
170355290|NCT05168813|615636804|FG000|Part A (Open-label)|Other|0|||
170355291|NCT05168813|615636805|FG001|Part A (Open-label)|Other|1|||
170355292|NCT05168813|615636806|FG002|Part A (Open-label)|Other|0|||
170355293|NCT05168813|615636807|FG003|Part A (Open-label)|Other|0|||
170355294|NCT05168813|615636808|FG004|Part A (Open-label)|Other|0|||
170355295|NCT05168813|615636809|FG005|Part A (Open-label)|Other|0|||
170355296|NCT05168813|615636804|FG000|Part B (Blinded)|Lost to Follow-up|0|||
170355297|NCT05168813|615636805|FG001|Part B (Blinded)|Lost to Follow-up|0|||
170355298|NCT05168813|615636806|FG002|Part B (Blinded)|Lost to Follow-up|0|||
170355299|NCT05168813|615636807|FG003|Part B (Blinded)|Lost to Follow-up|0|||
170355300|NCT05168813|615636808|FG004|Part B (Blinded)|Lost to Follow-up|219|||
170355301|NCT05168813|615636809|FG005|Part B (Blinded)|Lost to Follow-up|88|||
170355302|NCT05168813|615636804|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
170355303|NCT05168813|615636805|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
170355304|NCT05168813|615636806|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
170355305|NCT05168813|615636807|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
170355306|NCT05168813|615636808|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
170355307|NCT05168813|615636809|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
170355308|NCT05168813|615636804|FG000|Part B (Blinded)|Death|0|||
170355309|NCT05168813|615636805|FG001|Part B (Blinded)|Death|0|||
170355310|NCT05168813|615636806|FG002|Part B (Blinded)|Death|0|||
170355311|NCT05168813|615636807|FG003|Part B (Blinded)|Death|0|||
170355312|NCT05168813|615636808|FG004|Part B (Blinded)|Death|63|||
170355313|NCT05168813|615636809|FG005|Part B (Blinded)|Death|19|||
170355314|NCT05168813|615636804|FG000|Part B (Blinded)|Physician Decision|0|||
170355315|NCT05168813|615636805|FG001|Part B (Blinded)|Physician Decision|0|||
170355316|NCT05168813|615636806|FG002|Part B (Blinded)|Physician Decision|0|||
170355317|NCT05168813|615636807|FG003|Part B (Blinded)|Physician Decision|0|||
170355318|NCT05168813|615636808|FG004|Part B (Blinded)|Physician Decision|6|||
170355319|NCT05168813|615636809|FG005|Part B (Blinded)|Physician Decision|1|||
170355320|NCT05168813|615636804|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
170355321|NCT05168813|615636805|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
170355322|NCT05168813|615636806|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
170355323|NCT05168813|615636807|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
170355324|NCT05168813|615636808|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
170355325|NCT05168813|615636809|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
170355326|NCT05168813|615636804|FG000|Part B (Blinded)|Pregnancy|0|||
170355327|NCT05168813|615636805|FG001|Part B (Blinded)|Pregnancy|0|||
170355328|NCT05168813|615636806|FG002|Part B (Blinded)|Pregnancy|0|||
170355329|NCT05168813|615636807|FG003|Part B (Blinded)|Pregnancy|0|||
170355330|NCT05168813|615636808|FG004|Part B (Blinded)|Pregnancy|1|||
170355331|NCT05168813|615636809|FG005|Part B (Blinded)|Pregnancy|0|||
170355332|NCT05168813|615636804|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
170355333|NCT05168813|615636805|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
170355334|NCT05168813|615636806|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
170355335|NCT05168813|615636807|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
170355336|NCT05168813|615636808|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
170355337|NCT05168813|615636809|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
170355338|NCT05168813|615636804|FG000|Part B (Blinded)|Other|0|||
170355339|NCT05168813|615636805|FG001|Part B (Blinded)|Other|0|||
170355340|NCT05168813|615636806|FG002|Part B (Blinded)|Other|0|||
170355341|NCT05168813|615636807|FG003|Part B (Blinded)|Other|0|||
170355342|NCT05168813|615636808|FG004|Part B (Blinded)|Other|41|||
170355343|NCT05168813|615636809|FG005|Part B (Blinded)|Other|27|||
170355344|NCT01754922|615636810|FG000|Overall Study|Adverse Event|0|||
170355345|NCT01754922|615636811|FG001|Overall Study|Adverse Event|1|||
170355346|NCT01885078|615636812|FG000|Treatment Period|Adverse Event|52|||
170355347|NCT01885078|615636813|FG001|Treatment Period|Adverse Event|136|||
170355348|NCT01885078|615636814|FG002|Treatment Period|Adverse Event|30|||
170355349|NCT01885078|615636815|FG003|Treatment Period|Adverse Event|73|||
170355350|NCT01885078|615636816|FG004|Treatment Period|Adverse Event|17|||
170355351|NCT01885078|615636817|FG005|Treatment Period|Adverse Event|72|||
170355352|NCT01885078|615636818|FG006|Treatment Period|Adverse Event|24|||
170355353|NCT01885078|615636819|FG007|Treatment Period|Adverse Event|5|||
170355354|NCT01885078|615636820|FG008|Treatment Period|Adverse Event|0|||
170355355|NCT01885078|615636821|FG009|Treatment Period|Adverse Event|0|||
170355356|NCT01885078|615636812|FG000|Treatment Period|Death|13|||
170355357|NCT01885078|615636813|FG001|Treatment Period|Death|33|||
170355358|NCT01885078|615636814|FG002|Treatment Period|Death|5|||
170355359|NCT01885078|615636815|FG003|Treatment Period|Death|9|||
170355360|NCT01885078|615636816|FG004|Treatment Period|Death|2|||
170355361|NCT01885078|615636817|FG005|Treatment Period|Death|10|||
170355362|NCT01885078|615636818|FG006|Treatment Period|Death|3|||
170355363|NCT01885078|615636819|FG007|Treatment Period|Death|2|||
170355364|NCT01885078|615636820|FG008|Treatment Period|Death|0|||
170355365|NCT01885078|615636821|FG009|Treatment Period|Death|0|||
170355366|NCT01885078|615636812|FG000|Treatment Period|Lack of Efficacy|12|||
170355367|NCT01885078|615636813|FG001|Treatment Period|Lack of Efficacy|33|||
170355368|NCT01885078|615636814|FG002|Treatment Period|Lack of Efficacy|10|||
170355369|NCT01885078|615636815|FG003|Treatment Period|Lack of Efficacy|23|||
170355370|NCT01885078|615636816|FG004|Treatment Period|Lack of Efficacy|24|||
170355371|NCT01885078|615636817|FG005|Treatment Period|Lack of Efficacy|58|||
170355372|NCT01885078|615636818|FG006|Treatment Period|Lack of Efficacy|9|||
170355373|NCT01885078|615636819|FG007|Treatment Period|Lack of Efficacy|5|||
170355374|NCT01885078|615636820|FG008|Treatment Period|Lack of Efficacy|0|||
170355375|NCT01885078|615636821|FG009|Treatment Period|Lack of Efficacy|0|||
170355376|NCT01885078|615636812|FG000|Treatment Period|Lost to Follow-up|16|||
170355377|NCT01885078|615636813|FG001|Treatment Period|Lost to Follow-up|19|||
170355378|NCT01885078|615636814|FG002|Treatment Period|Lost to Follow-up|7|||
170355379|NCT01885078|615636815|FG003|Treatment Period|Lost to Follow-up|9|||
170355380|NCT01885078|615636816|FG004|Treatment Period|Lost to Follow-up|2|||
170355381|NCT01885078|615636817|FG005|Treatment Period|Lost to Follow-up|8|||
170355382|NCT01885078|615636818|FG006|Treatment Period|Lost to Follow-up|2|||
170355383|NCT01885078|615636819|FG007|Treatment Period|Lost to Follow-up|0|||
170355384|NCT01885078|615636820|FG008|Treatment Period|Lost to Follow-up|0|||
170355385|NCT01885078|615636821|FG009|Treatment Period|Lost to Follow-up|0|||
170355386|NCT01885078|615636812|FG000|Treatment Period|Physician Decision|19|||
170355387|NCT01885078|615636813|FG001|Treatment Period|Physician Decision|21|||
170355388|NCT01885078|615636814|FG002|Treatment Period|Physician Decision|5|||
170355389|NCT01885078|615636815|FG003|Treatment Period|Physician Decision|12|||
170355390|NCT01885078|615636816|FG004|Treatment Period|Physician Decision|9|||
170355391|NCT01885078|615636817|FG005|Treatment Period|Physician Decision|24|||
170355392|NCT01885078|615636818|FG006|Treatment Period|Physician Decision|4|||
170355393|NCT01885078|615636819|FG007|Treatment Period|Physician Decision|3|||
170355394|NCT01885078|615636820|FG008|Treatment Period|Physician Decision|0|||
170355395|NCT01885078|615636821|FG009|Treatment Period|Physician Decision|0|||
170355396|NCT01885078|615636812|FG000|Treatment Period|Protocol Violation|3|||
170355397|NCT01885078|615636813|FG001|Treatment Period|Protocol Violation|5|||
170355398|NCT01885078|615636814|FG002|Treatment Period|Protocol Violation|0|||
170355399|NCT01885078|615636815|FG003|Treatment Period|Protocol Violation|3|||
170355400|NCT01885078|615636816|FG004|Treatment Period|Protocol Violation|1|||
170355401|NCT01885078|615636817|FG005|Treatment Period|Protocol Violation|6|||
170355402|NCT01885078|615636818|FG006|Treatment Period|Protocol Violation|0|||
170355403|NCT01885078|615636819|FG007|Treatment Period|Protocol Violation|0|||
170355404|NCT01885078|615636820|FG008|Treatment Period|Protocol Violation|0|||
170355405|NCT01885078|615636821|FG009|Treatment Period|Protocol Violation|0|||
170355406|NCT01885078|615636812|FG000|Treatment Period|Sponsor Decision|245|||
170355407|NCT01885078|615636813|FG001|Treatment Period|Sponsor Decision|648|||
170355408|NCT01885078|615636814|FG002|Treatment Period|Sponsor Decision|49|||
170355409|NCT01885078|615636815|FG003|Treatment Period|Sponsor Decision|90|||
170355410|NCT01885078|615636816|FG004|Treatment Period|Sponsor Decision|20|||
170355411|NCT01885078|615636817|FG005|Treatment Period|Sponsor Decision|38|||
170355412|NCT01885078|615636818|FG006|Treatment Period|Sponsor Decision|162|||
170355413|NCT01885078|615636819|FG007|Treatment Period|Sponsor Decision|3|||
170355414|NCT01885078|615636820|FG008|Treatment Period|Sponsor Decision|0|||
170355415|NCT01885078|615636821|FG009|Treatment Period|Sponsor Decision|0|||
170355416|NCT01885078|615636812|FG000|Treatment Period|Withdrawal by Subject|72|||
170355417|NCT01885078|615636813|FG001|Treatment Period|Withdrawal by Subject|132|||
170355418|NCT01885078|615636814|FG002|Treatment Period|Withdrawal by Subject|25|||
170355419|NCT01885078|615636815|FG003|Treatment Period|Withdrawal by Subject|63|||
170355420|NCT01885078|615636816|FG004|Treatment Period|Withdrawal by Subject|15|||
170355421|NCT01885078|615636817|FG005|Treatment Period|Withdrawal by Subject|34|||
170355422|NCT01885078|615636818|FG006|Treatment Period|Withdrawal by Subject|17|||
170355423|NCT01885078|615636819|FG007|Treatment Period|Withdrawal by Subject|10|||
170355424|NCT01885078|615636820|FG008|Treatment Period|Withdrawal by Subject|0|||
170355425|NCT01885078|615636821|FG009|Treatment Period|Withdrawal by Subject|0|||
170355426|NCT01885078|615636812|FG000|Treatment Period|Other|0|||
170355427|NCT01885078|615636813|FG001|Treatment Period|Other|0|||
170355428|NCT01885078|615636814|FG002|Treatment Period|Other|0|||
170355429|NCT01885078|615636815|FG003|Treatment Period|Other|1|||
170355430|NCT01885078|615636816|FG004|Treatment Period|Other|0|||
170355431|NCT01885078|615636817|FG005|Treatment Period|Other|0|||
170355432|NCT01885078|615636818|FG006|Treatment Period|Other|0|||
170355433|NCT01885078|615636819|FG007|Treatment Period|Other|0|||
170355434|NCT01885078|615636820|FG008|Treatment Period|Other|0|||
170355435|NCT01885078|615636821|FG009|Treatment Period|Other|0|||
170355436|NCT01885078|615636812|FG000|Step-down Period|Sponsor Decision|0|||
170355437|NCT01885078|615636813|FG001|Step-down Period|Sponsor Decision|0|||
170355438|NCT01885078|615636814|FG002|Step-down Period|Sponsor Decision|0|||
170355439|NCT01885078|615636815|FG003|Step-down Period|Sponsor Decision|0|||
170355440|NCT01885078|615636816|FG004|Step-down Period|Sponsor Decision|0|||
170355441|NCT01885078|615636817|FG005|Step-down Period|Sponsor Decision|0|||
170355442|NCT01885078|615636818|FG006|Step-down Period|Sponsor Decision|0|||
170355443|NCT01885078|615636819|FG007|Step-down Period|Sponsor Decision|0|||
170355444|NCT01885078|615636820|FG008|Step-down Period|Sponsor Decision|1|||
170355445|NCT01885078|615636821|FG009|Step-down Period|Sponsor Decision|1|||
170355446|NCT01885078|615636812|FG000|Step-down Period|Adverse Event|0|||
170355447|NCT01885078|615636813|FG001|Step-down Period|Adverse Event|0|||
170355448|NCT01885078|615636814|FG002|Step-down Period|Adverse Event|0|||
170355449|NCT01885078|615636815|FG003|Step-down Period|Adverse Event|0|||
170355450|NCT01885078|615636816|FG004|Step-down Period|Adverse Event|0|||
170355451|NCT01885078|615636817|FG005|Step-down Period|Adverse Event|0|||
170355452|NCT01885078|615636818|FG006|Step-down Period|Adverse Event|0|||
170355453|NCT01885078|615636819|FG007|Step-down Period|Adverse Event|0|||
170355454|NCT01885078|615636820|FG008|Step-down Period|Adverse Event|29|||
170355455|NCT01885078|615636821|FG009|Step-down Period|Adverse Event|38|||
170355456|NCT01885078|615636812|FG000|Step-down Period|Withdrawal by Subject|0|||
170355457|NCT01885078|615636813|FG001|Step-down Period|Withdrawal by Subject|0|||
170355458|NCT01885078|615636814|FG002|Step-down Period|Withdrawal by Subject|0|||
170355459|NCT01885078|615636815|FG003|Step-down Period|Withdrawal by Subject|0|||
170355460|NCT01885078|615636816|FG004|Step-down Period|Withdrawal by Subject|0|||
170355461|NCT01885078|615636817|FG005|Step-down Period|Withdrawal by Subject|0|||
170355462|NCT01885078|615636818|FG006|Step-down Period|Withdrawal by Subject|0|||
170355463|NCT01885078|615636819|FG007|Step-down Period|Withdrawal by Subject|0|||
170355464|NCT01885078|615636820|FG008|Step-down Period|Withdrawal by Subject|25|||
170355465|NCT01885078|615636821|FG009|Step-down Period|Withdrawal by Subject|15|||
170355466|NCT01885078|615636812|FG000|Step-down Period|Physician Decision|0|||
170355467|NCT01885078|615636813|FG001|Step-down Period|Physician Decision|0|||
170355468|NCT01885078|615636814|FG002|Step-down Period|Physician Decision|0|||
170355469|NCT01885078|615636815|FG003|Step-down Period|Physician Decision|0|||
170355470|NCT01885078|615636816|FG004|Step-down Period|Physician Decision|0|||
170355471|NCT01885078|615636817|FG005|Step-down Period|Physician Decision|0|||
170355472|NCT01885078|615636818|FG006|Step-down Period|Physician Decision|0|||
170355473|NCT01885078|615636819|FG007|Step-down Period|Physician Decision|0|||
170355474|NCT01885078|615636820|FG008|Step-down Period|Physician Decision|7|||
170355475|NCT01885078|615636821|FG009|Step-down Period|Physician Decision|2|||
170355476|NCT01885078|615636812|FG000|Step-down Period|Death|0|||
170355477|NCT01885078|615636813|FG001|Step-down Period|Death|0|||
170355478|NCT01885078|615636814|FG002|Step-down Period|Death|0|||
170355479|NCT01885078|615636815|FG003|Step-down Period|Death|0|||
170355480|NCT01885078|615636816|FG004|Step-down Period|Death|0|||
170355481|NCT01885078|615636817|FG005|Step-down Period|Death|0|||
170355482|NCT01885078|615636818|FG006|Step-down Period|Death|0|||
170355483|NCT01885078|615636819|FG007|Step-down Period|Death|0|||
170355484|NCT01885078|615636820|FG008|Step-down Period|Death|4|||
170355485|NCT01885078|615636821|FG009|Step-down Period|Death|3|||
170355486|NCT01885078|615636812|FG000|Step-down Period|Lost to Follow-up|0|||
170355487|NCT01885078|615636813|FG001|Step-down Period|Lost to Follow-up|0|||
170355488|NCT01885078|615636814|FG002|Step-down Period|Lost to Follow-up|0|||
170355489|NCT01885078|615636815|FG003|Step-down Period|Lost to Follow-up|0|||
170355490|NCT01885078|615636816|FG004|Step-down Period|Lost to Follow-up|0|||
170355491|NCT01885078|615636817|FG005|Step-down Period|Lost to Follow-up|0|||
170355492|NCT01885078|615636818|FG006|Step-down Period|Lost to Follow-up|0|||
170355493|NCT01885078|615636819|FG007|Step-down Period|Lost to Follow-up|0|||
170355494|NCT01885078|615636820|FG008|Step-down Period|Lost to Follow-up|1|||
170355495|NCT01885078|615636821|FG009|Step-down Period|Lost to Follow-up|1|||
170355496|NCT01885078|615636812|FG000|Step-down Period|Lack of Efficacy|0|||
170355497|NCT01885078|615636813|FG001|Step-down Period|Lack of Efficacy|0|||
170355498|NCT01885078|615636814|FG002|Step-down Period|Lack of Efficacy|0|||
170355499|NCT01885078|615636815|FG003|Step-down Period|Lack of Efficacy|0|||
170355500|NCT01885078|615636816|FG004|Step-down Period|Lack of Efficacy|0|||
170355501|NCT01885078|615636817|FG005|Step-down Period|Lack of Efficacy|0|||
170355502|NCT01885078|615636818|FG006|Step-down Period|Lack of Efficacy|0|||
170355503|NCT01885078|615636819|FG007|Step-down Period|Lack of Efficacy|0|||
170355504|NCT01885078|615636820|FG008|Step-down Period|Lack of Efficacy|1|||
170355505|NCT01885078|615636821|FG009|Step-down Period|Lack of Efficacy|0|||
170355506|NCT01885078|615636812|FG000|Step-down Period|Protocol Violation|0|||
170355507|NCT01885078|615636813|FG001|Step-down Period|Protocol Violation|0|||
170355508|NCT01885078|615636814|FG002|Step-down Period|Protocol Violation|0|||
170355509|NCT01885078|615636815|FG003|Step-down Period|Protocol Violation|0|||
170355510|NCT01885078|615636816|FG004|Step-down Period|Protocol Violation|0|||
170355511|NCT01885078|615636817|FG005|Step-down Period|Protocol Violation|0|||
170355512|NCT01885078|615636818|FG006|Step-down Period|Protocol Violation|0|||
170355513|NCT01885078|615636819|FG007|Step-down Period|Protocol Violation|0|||
170355514|NCT01885078|615636820|FG008|Step-down Period|Protocol Violation|1|||
170355515|NCT01885078|615636821|FG009|Step-down Period|Protocol Violation|1|||
170355516|NCT01677507|615636826|FG000|Initial Assignment|Adverse Event|0|||
170355517|NCT01677507|615636827|FG001|Initial Assignment|Adverse Event|1|||
170355518|NCT01677507|615636826|FG000|Initial Assignment|Protocol Violation|0|||
170355519|NCT01677507|615636827|FG001|Initial Assignment|Protocol Violation|1|||
170355520|NCT01677507|615636826|FG000|Second Assigment|Withdrawal by Subject|2|||
170355521|NCT01677507|615636827|FG001|Second Assigment|Withdrawal by Subject|2|||
170355522|NCT01677507|615636826|FG000|Second Assigment|Adverse Event|1|||
170355523|NCT01677507|615636827|FG001|Second Assigment|Adverse Event|3|||
170355524|NCT00571688|615636828|FG000|Overall Study|Lost to Follow-up|3|||
170355525|NCT00571688|615636829|FG001|Overall Study|Lost to Follow-up|6|||
170355526|NCT00571688|615636828|FG000|Overall Study|subject did not tolerate Consta|1|||
170355527|NCT00571688|615636829|FG001|Overall Study|subject did not tolerate Consta|0|||
170355528|NCT00571688|615636828|FG000|Overall Study|subject moved out of the area|1|||
170355529|NCT00571688|615636829|FG001|Overall Study|subject moved out of the area|0|||
170355530|NCT00469209|615636830|FG000|Overall Study|Adverse Event|1|||
170355531|NCT00469209|615636831|FG001|Overall Study|Adverse Event|0|||
170355532|NCT00469209|615636832|FG002|Overall Study|Adverse Event|1|||
170355533|NCT00259740|615636835|FG000|Overall Study|Physician Decision|1|||
170355534|NCT00259740|615636836|FG001|Overall Study|Physician Decision|1|||
170355535|NCT00259740|615636835|FG000|Overall Study|Adverse Event|0|||
170355536|NCT00259740|615636836|FG001|Overall Study|Adverse Event|2|||
170355537|NCT00259740|615636835|FG000|Overall Study|Withdrawal by Subject|2|||
170355538|NCT00259740|615636836|FG001|Overall Study|Withdrawal by Subject|6|||
170355539|NCT00259740|615636835|FG000|Overall Study|Death|1|||
170355540|NCT00259740|615636836|FG001|Overall Study|Death|1|||
170355541|NCT00259740|615636835|FG000|Overall Study|Disease progression|19|||
170355542|NCT00259740|615636836|FG001|Overall Study|Disease progression|36|||
170355543|NCT00259740|615636835|FG000|Overall Study|Ongoing|17|||
170355544|NCT00259740|615636836|FG001|Overall Study|Ongoing|3|||
170355545|NCT00259740|615636835|FG000|Overall Study|Other|3|||
170355546|NCT00259740|615636836|FG001|Overall Study|Other|0|||
170355547|NCT00259740|615636835|FG000|Overall Study|Requirement for alternative therapy|0|||
170355548|NCT00259740|615636836|FG001|Overall Study|Requirement for alternative therapy|4|||
170355549|NCT02492997|615636837|FG000|Overall Study|Withdrawal by Subject|1|||
170355550|NCT02492997|615636838|FG001|Overall Study|Withdrawal by Subject|0|||
170355551|NCT02492997|615636837|FG000|Overall Study|Gained Weight|1|||
170355552|NCT02492997|615636838|FG001|Overall Study|Gained Weight|0|||
170355553|NCT02492997|615636837|FG000|Overall Study|Lost to Follow-up|0|||
170355554|NCT02492997|615636838|FG001|Overall Study|Lost to Follow-up|1|||
170355555|NCT01844830|615636843|FG000|Overall Study|Withdrawal by Subject|1|||
170355556|NCT01844830|615636844|FG001|Overall Study|Withdrawal by Subject|0|||
170355557|NCT04247815|615636845|FG000|Overall Study|Adverse Event|1|||
170355558|NCT04247815|615636846|FG001|Overall Study|Adverse Event|0|||
170355559|NCT04247815|615636845|FG000|Overall Study|Withdrawal by Subject|1|||
170355560|NCT04247815|615636846|FG001|Overall Study|Withdrawal by Subject|0|||
170355561|NCT04247815|615636845|FG000|Overall Study|Protocol Violation|0|||
170355562|NCT04247815|615636846|FG001|Overall Study|Protocol Violation|1|||
170355563|NCT03224104|615636851|FG000|Overall Study|Lack of Efficacy|2|||
170355564|NCT03224104|615636852|FG001|Overall Study|Lack of Efficacy|6|||
170355565|NCT03224104|615636853|FG002|Overall Study|Lack of Efficacy|3|||
170355566|NCT03224104|615636854|FG003|Overall Study|Lack of Efficacy|4|||
170355567|NCT03224104|615636855|FG004|Overall Study|Lack of Efficacy|42|||
170355568|NCT03224104|615636851|FG000|Overall Study|Withdrawal by Subject|0|||
170355569|NCT03224104|615636852|FG001|Overall Study|Withdrawal by Subject|2|||
170355570|NCT03224104|615636853|FG002|Overall Study|Withdrawal by Subject|0|||
170355571|NCT03224104|615636854|FG003|Overall Study|Withdrawal by Subject|1|||
170355572|NCT03224104|615636855|FG004|Overall Study|Withdrawal by Subject|3|||
170355573|NCT03224104|615636851|FG000|Overall Study|Death|0|||
170355574|NCT03224104|615636852|FG001|Overall Study|Death|1|||
170355575|NCT03224104|615636853|FG002|Overall Study|Death|0|||
170355576|NCT03224104|615636854|FG003|Overall Study|Death|0|||
170355577|NCT03224104|615636855|FG004|Overall Study|Death|0|||
170355578|NCT03224104|615636851|FG000|Overall Study|Adverse Event|1|||
170355579|NCT03224104|615636852|FG001|Overall Study|Adverse Event|0|||
170355580|NCT03224104|615636853|FG002|Overall Study|Adverse Event|0|||
170355581|NCT03224104|615636854|FG003|Overall Study|Adverse Event|1|||
170355582|NCT03224104|615636855|FG004|Overall Study|Adverse Event|3|||
170355583|NCT03224104|615636851|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
170355584|NCT03224104|615636852|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
170355585|NCT03224104|615636853|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
170355586|NCT03224104|615636854|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
170355587|NCT03224104|615636855|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
170355588|NCT03224104|615636851|FG000|Overall Study|Treatment ongoing|0|||
170355589|NCT03224104|615636852|FG001|Overall Study|Treatment ongoing|0|||
170355590|NCT03224104|615636853|FG002|Overall Study|Treatment ongoing|0|||
170355591|NCT03224104|615636854|FG003|Overall Study|Treatment ongoing|0|||
170355592|NCT03224104|615636855|FG004|Overall Study|Treatment ongoing|1|||
170355593|NCT05025787|615636856|FG000|Overall Study|Lack of Efficacy|0|||
170355594|NCT05025787|615636857|FG001|Overall Study|Lack of Efficacy|1|||
170355595|NCT05025787|615636856|FG000|Overall Study|Adverse Event|2|||
170355596|NCT05025787|615636857|FG001|Overall Study|Adverse Event|4|||
170355597|NCT05025787|615636856|FG000|Overall Study|Non compliance|0|||
170355598|NCT05025787|615636857|FG001|Overall Study|Non compliance|1|||
170355599|NCT05025787|615636856|FG000|Overall Study|Protocol Violation|3|||
170355600|NCT05025787|615636857|FG001|Overall Study|Protocol Violation|1|||
170355601|NCT05025787|615636856|FG000|Overall Study|Stopping criteria met|1|||
170355602|NCT05025787|615636857|FG001|Overall Study|Stopping criteria met|1|||
170355603|NCT05025787|615636856|FG000|Overall Study|Withdrawal by Subject|3|||
170355604|NCT05025787|615636857|FG001|Overall Study|Withdrawal by Subject|1|||
170355605|NCT04397718|615636860|FG000|Overall Study|Death|7|||
170355606|NCT04397718|615636861|FG001|Overall Study|Death|11|||
170355607|NCT04397718|615636860|FG000|Overall Study|Lost to Follow-up|0|||
170355608|NCT04397718|615636861|FG001|Overall Study|Lost to Follow-up|4|||
170355609|NCT05441592|615636868|FG000|Overall Study|Lost to Follow-up|1|||
170355610|NCT05441592|615636869|FG001|Overall Study|Lost to Follow-up|5|||
170355611|NCT01021852|615636870|FG000|Treatment Period 1|Adverse Event|3|||
170355612|NCT01021852|615636871|FG001|Treatment Period 1|Adverse Event|1|||
170355613|NCT01021852|615636872|FG002|Treatment Period 1|Adverse Event|1|||
170355614|NCT01021852|615636873|FG003|Treatment Period 1|Adverse Event|0|||
170355615|NCT01021852|615636874|FG004|Treatment Period 1|Adverse Event|2|||
170355616|NCT01021852|615636875|FG005|Treatment Period 1|Adverse Event|2|||
170355617|NCT01021852|615636876|FG006|Treatment Period 1|Adverse Event|0|||
170355618|NCT01021852|615636877|FG007|Treatment Period 1|Adverse Event|0|||
170355619|NCT01021852|615636870|FG000|Treatment Period 1|Pregnancy|0|||
170355620|NCT01021852|615636871|FG001|Treatment Period 1|Pregnancy|0|||
170355621|NCT01021852|615636872|FG002|Treatment Period 1|Pregnancy|1|||
170355622|NCT01021852|615636873|FG003|Treatment Period 1|Pregnancy|0|||
170355623|NCT01021852|615636874|FG004|Treatment Period 1|Pregnancy|0|||
170355624|NCT01021852|615636875|FG005|Treatment Period 1|Pregnancy|0|||
170355625|NCT01021852|615636876|FG006|Treatment Period 1|Pregnancy|0|||
170355626|NCT01021852|615636877|FG007|Treatment Period 1|Pregnancy|0|||
170355627|NCT01021852|615636870|FG000|Treatment Period 1|Withdrawal by Subject|0|||
170355628|NCT01021852|615636871|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170355629|NCT01021852|615636872|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170355630|NCT01021852|615636873|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170355631|NCT01021852|615636874|FG004|Treatment Period 1|Withdrawal by Subject|1|||
170355632|NCT01021852|615636875|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170355633|NCT01021852|615636876|FG006|Treatment Period 1|Withdrawal by Subject|0|||
170355634|NCT01021852|615636877|FG007|Treatment Period 1|Withdrawal by Subject|1|||
170355635|NCT01021852|615636870|FG000|Treatment Period 1|Not Treated|0|||
170355636|NCT01021852|615636871|FG001|Treatment Period 1|Not Treated|0|||
170355637|NCT01021852|615636872|FG002|Treatment Period 1|Not Treated|0|||
170355638|NCT01021852|615636873|FG003|Treatment Period 1|Not Treated|2|||
170355639|NCT01021852|615636874|FG004|Treatment Period 1|Not Treated|0|||
170355640|NCT01021852|615636875|FG005|Treatment Period 1|Not Treated|0|||
170355641|NCT01021852|615636876|FG006|Treatment Period 1|Not Treated|0|||
170355642|NCT01021852|615636877|FG007|Treatment Period 1|Not Treated|0|||
170355643|NCT01021852|615636870|FG000|Washout Period-Placebo|Adverse Event|0|||
170355644|NCT01021852|615636871|FG001|Washout Period-Placebo|Adverse Event|0|||
170355645|NCT01021852|615636872|FG002|Washout Period-Placebo|Adverse Event|0|||
170355646|NCT01021852|615636873|FG003|Washout Period-Placebo|Adverse Event|1|||
170355647|NCT01021852|615636874|FG004|Washout Period-Placebo|Adverse Event|0|||
170355648|NCT01021852|615636875|FG005|Washout Period-Placebo|Adverse Event|1|||
170355649|NCT01021852|615636876|FG006|Washout Period-Placebo|Adverse Event|0|||
170355650|NCT01021852|615636877|FG007|Washout Period-Placebo|Adverse Event|0|||
170355651|NCT01021852|615636870|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
170355652|NCT01021852|615636871|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
170355653|NCT01021852|615636872|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
170355654|NCT01021852|615636873|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
170355655|NCT01021852|615636874|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
170355656|NCT01021852|615636875|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
170355657|NCT01021852|615636876|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
170355658|NCT01021852|615636877|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
170355659|NCT01021852|615636870|FG000|Washout Period-Placebo|Protocol Violation|0|||
170355660|NCT01021852|615636871|FG001|Washout Period-Placebo|Protocol Violation|0|||
170355661|NCT01021852|615636872|FG002|Washout Period-Placebo|Protocol Violation|0|||
170355662|NCT01021852|615636873|FG003|Washout Period-Placebo|Protocol Violation|0|||
170355663|NCT01021852|615636874|FG004|Washout Period-Placebo|Protocol Violation|0|||
170355664|NCT01021852|615636875|FG005|Washout Period-Placebo|Protocol Violation|0|||
170355665|NCT01021852|615636876|FG006|Washout Period-Placebo|Protocol Violation|1|||
170355666|NCT01021852|615636877|FG007|Washout Period-Placebo|Protocol Violation|0|||
170355667|NCT01021852|615636870|FG000|Washout Period-No Drug|Adverse Event|1|||
170355668|NCT01021852|615636871|FG001|Washout Period-No Drug|Adverse Event|0|||
170355669|NCT01021852|615636872|FG002|Washout Period-No Drug|Adverse Event|0|||
170355670|NCT01021852|615636873|FG003|Washout Period-No Drug|Adverse Event|0|||
170355671|NCT01021852|615636874|FG004|Washout Period-No Drug|Adverse Event|0|||
170355672|NCT01021852|615636875|FG005|Washout Period-No Drug|Adverse Event|1|||
170355673|NCT01021852|615636876|FG006|Washout Period-No Drug|Adverse Event|0|||
170355674|NCT01021852|615636877|FG007|Washout Period-No Drug|Adverse Event|0|||
170355675|NCT01021852|615636870|FG000|Treatment Period 2|Adverse Event|0|||
170355676|NCT01021852|615636871|FG001|Treatment Period 2|Adverse Event|1|||
170355677|NCT01021852|615636872|FG002|Treatment Period 2|Adverse Event|0|||
170355678|NCT01021852|615636873|FG003|Treatment Period 2|Adverse Event|0|||
170355679|NCT01021852|615636874|FG004|Treatment Period 2|Adverse Event|1|||
170355680|NCT01021852|615636875|FG005|Treatment Period 2|Adverse Event|0|||
170355681|NCT01021852|615636876|FG006|Treatment Period 2|Adverse Event|1|||
170355682|NCT01021852|615636877|FG007|Treatment Period 2|Adverse Event|0|||
170355683|NCT01021852|615636870|FG000|Treatment Period 2|Lack of Efficacy|0|||
170355684|NCT01021852|615636871|FG001|Treatment Period 2|Lack of Efficacy|0|||
170355685|NCT01021852|615636872|FG002|Treatment Period 2|Lack of Efficacy|0|||
170355686|NCT01021852|615636873|FG003|Treatment Period 2|Lack of Efficacy|0|||
170355687|NCT01021852|615636874|FG004|Treatment Period 2|Lack of Efficacy|0|||
170355688|NCT01021852|615636875|FG005|Treatment Period 2|Lack of Efficacy|1|||
170355689|NCT01021852|615636876|FG006|Treatment Period 2|Lack of Efficacy|0|||
170355690|NCT01021852|615636877|FG007|Treatment Period 2|Lack of Efficacy|0|||
170355691|NCT01021852|615636870|FG000|Treatment Period 2|Physician Decision|0|||
170355692|NCT01021852|615636871|FG001|Treatment Period 2|Physician Decision|0|||
170355693|NCT01021852|615636872|FG002|Treatment Period 2|Physician Decision|1|||
170355694|NCT01021852|615636873|FG003|Treatment Period 2|Physician Decision|0|||
170355695|NCT01021852|615636874|FG004|Treatment Period 2|Physician Decision|0|||
170355696|NCT01021852|615636875|FG005|Treatment Period 2|Physician Decision|0|||
170355697|NCT01021852|615636876|FG006|Treatment Period 2|Physician Decision|0|||
170355698|NCT01021852|615636877|FG007|Treatment Period 2|Physician Decision|0|||
170355699|NCT01021852|615636870|FG000|Treatment Period 2|Protocol Violation|0|||
170355700|NCT01021852|615636871|FG001|Treatment Period 2|Protocol Violation|0|||
170355701|NCT01021852|615636872|FG002|Treatment Period 2|Protocol Violation|0|||
170355702|NCT01021852|615636873|FG003|Treatment Period 2|Protocol Violation|0|||
170355703|NCT01021852|615636874|FG004|Treatment Period 2|Protocol Violation|1|||
170355704|NCT01021852|615636875|FG005|Treatment Period 2|Protocol Violation|0|||
170355705|NCT01021852|615636876|FG006|Treatment Period 2|Protocol Violation|1|||
170355706|NCT01021852|615636877|FG007|Treatment Period 2|Protocol Violation|0|||
170355707|NCT01021852|615636870|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170355708|NCT01021852|615636871|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170355709|NCT01021852|615636872|FG002|Treatment Period 2|Withdrawal by Subject|0|||
170355710|NCT01021852|615636873|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170355711|NCT01021852|615636874|FG004|Treatment Period 2|Withdrawal by Subject|0|||
170355712|NCT01021852|615636875|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170355713|NCT01021852|615636876|FG006|Treatment Period 2|Withdrawal by Subject|1|||
170355714|NCT01021852|615636877|FG007|Treatment Period 2|Withdrawal by Subject|2|||
170355715|NCT01371981|615636878|FG000|Overall Study|Adverse Event|12|||
170355716|NCT01371981|615636879|FG001|Overall Study|Adverse Event|17|||
170355717|NCT01371981|615636880|FG002|Overall Study|Adverse Event|0|||
170355718|NCT01371981|615636881|FG003|Overall Study|Adverse Event|4|||
170355719|NCT01371981|615636882|FG004|Overall Study|Adverse Event|1|||
170355720|NCT01371981|615636883|FG005|Overall Study|Adverse Event|0|||
170355721|NCT01371981|615636878|FG000|Overall Study|Death|22|||
170355722|NCT01371981|615636879|FG001|Overall Study|Death|16|||
170355723|NCT01371981|615636880|FG002|Overall Study|Death|0|||
170355724|NCT01371981|615636881|FG003|Overall Study|Death|0|||
170355725|NCT01371981|615636882|FG004|Overall Study|Death|2|||
170355726|NCT01371981|615636883|FG005|Overall Study|Death|2|||
170355727|NCT01371981|615636878|FG000|Overall Study|Lack of Efficacy|69|||
170355728|NCT01371981|615636879|FG001|Overall Study|Lack of Efficacy|61|||
170355729|NCT01371981|615636880|FG002|Overall Study|Lack of Efficacy|4|||
170355730|NCT01371981|615636881|FG003|Overall Study|Lack of Efficacy|8|||
170355731|NCT01371981|615636882|FG004|Overall Study|Lack of Efficacy|5|||
170355732|NCT01371981|615636883|FG005|Overall Study|Lack of Efficacy|0|||
170355733|NCT01371981|615636878|FG000|Overall Study|Physician Decision|48|||
170355734|NCT01371981|615636879|FG001|Overall Study|Physician Decision|63|||
170355735|NCT01371981|615636880|FG002|Overall Study|Physician Decision|1|||
170355736|NCT01371981|615636881|FG003|Overall Study|Physician Decision|7|||
170355737|NCT01371981|615636882|FG004|Overall Study|Physician Decision|14|||
170355738|NCT01371981|615636883|FG005|Overall Study|Physician Decision|3|||
170355739|NCT01371981|615636878|FG000|Overall Study|Withdrawal by Subject|12|||
170355740|NCT01371981|615636879|FG001|Overall Study|Withdrawal by Subject|19|||
170355741|NCT01371981|615636880|FG002|Overall Study|Withdrawal by Subject|1|||
170355742|NCT01371981|615636881|FG003|Overall Study|Withdrawal by Subject|2|||
170355743|NCT01371981|615636882|FG004|Overall Study|Withdrawal by Subject|10|||
170355744|NCT01371981|615636883|FG005|Overall Study|Withdrawal by Subject|3|||
170355745|NCT01371981|615636878|FG000|Overall Study|Ineligible|19|||
170355746|NCT01371981|615636879|FG001|Overall Study|Ineligible|13|||
170355747|NCT01371981|615636880|FG002|Overall Study|Ineligible|0|||
170355748|NCT01371981|615636881|FG003|Overall Study|Ineligible|0|||
170355749|NCT01371981|615636882|FG004|Overall Study|Ineligible|0|||
170355750|NCT01371981|615636883|FG005|Overall Study|Ineligible|4|||
170355751|NCT01371981|615636878|FG000|Overall Study|Did not start treatment|2|||
170355752|NCT01371981|615636879|FG001|Overall Study|Did not start treatment|3|||
170355753|NCT01371981|615636880|FG002|Overall Study|Did not start treatment|0|||
170355754|NCT01371981|615636881|FG003|Overall Study|Did not start treatment|0|||
170355755|NCT01371981|615636882|FG004|Overall Study|Did not start treatment|0|||
170355756|NCT01371981|615636883|FG005|Overall Study|Did not start treatment|2|||
170355757|NCT02493426|615636884|FG000|Overall Study|Withdrawal by Subject|0|||
170355758|NCT02493426|615636885|FG001|Overall Study|Withdrawal by Subject|1|||
170355759|NCT00603980|615636887|FG000|Study Qualification|Protocol Violation|3|||
170355760|NCT00603980|615636887|FG000|Study Qualification|Inconsistent data reporting|13|||
170355761|NCT00603980|615636887|FG000|Main Study|14th subject completed trial|1|||
170355762|NCT02683525|615636888|FG000|Overall Study|Lost to Follow-up|1|||
170355763|NCT02683525|615636888|FG000|Overall Study|Physician Decision|1|||
170355764|NCT02683525|615636888|FG000|Overall Study|Disease Progression|6|||
170355765|NCT01096849|615636891|FG000|Overall Study|Consent Withdrawn|1|||
170355766|NCT01096849|615636892|FG001|Overall Study|Consent Withdrawn|4|||
170355767|NCT01096849|615636893|FG002|Overall Study|Consent Withdrawn|2|||
170355768|NCT01096849|615636891|FG000|Overall Study|Lack of Efficacy|0|||
170355769|NCT01096849|615636892|FG001|Overall Study|Lack of Efficacy|2|||
170355770|NCT01096849|615636893|FG002|Overall Study|Lack of Efficacy|0|||
170355771|NCT01096849|615636891|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
170355772|NCT01096849|615636892|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
170355773|NCT01096849|615636893|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
170355774|NCT01096849|615636891|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
170355775|NCT01096849|615636892|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
170355776|NCT01096849|615636893|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
170355777|NCT01096849|615636891|FG000|Overall Study|Administrative Reasons|0|||
170355778|NCT01096849|615636892|FG001|Overall Study|Administrative Reasons|1|||
170355779|NCT01096849|615636893|FG002|Overall Study|Administrative Reasons|2|||
170355780|NCT01096849|615636891|FG000|Overall Study|Lost to Follow-up|1|||
170355781|NCT01096849|615636892|FG001|Overall Study|Lost to Follow-up|3|||
170355782|NCT01096849|615636893|FG002|Overall Study|Lost to Follow-up|1|||
170355783|NCT02998554|615636894|FG000|Overall Study|Adverse Event|8|||
170355784|NCT02998554|615636895|FG001|Overall Study|Adverse Event|3|||
170355785|NCT02998554|615636894|FG000|Overall Study|Protocol deviation|1|||
170355786|NCT02998554|615636895|FG001|Overall Study|Protocol deviation|0|||
170355787|NCT02998554|615636894|FG000|Overall Study|Withdrawal by Subject|2|||
170355788|NCT02998554|615636895|FG001|Overall Study|Withdrawal by Subject|6|||
170355789|NCT02998554|615636894|FG000|Overall Study|Lost to Follow-up|0|||
170355790|NCT02998554|615636895|FG001|Overall Study|Lost to Follow-up|1|||
170355791|NCT02998554|615636894|FG000|Overall Study|Lack of Efficacy|0|||
170355792|NCT02998554|615636895|FG001|Overall Study|Lack of Efficacy|1|||
170355793|NCT04146467|615636898|FG000|Overall Study|Adverse Event|0|||
170355794|NCT04146467|615636899|FG001|Overall Study|Adverse Event|1|||
170355795|NCT04146467|615636898|FG000|Overall Study|Lost to Follow-up|0|||
170355796|NCT04146467|615636899|FG001|Overall Study|Lost to Follow-up|2|||
170355797|NCT02128763|615636900|FG000|Overall Study|Death|1|||
170355798|NCT02128763|615636901|FG001|Overall Study|Death|0|||
170355799|NCT02128763|615636900|FG000|Overall Study|Lost to Follow-up|19|||
170355800|NCT02128763|615636901|FG001|Overall Study|Lost to Follow-up|16|||
170355801|NCT04105244|615636907|FG000|Overall Study|Withdrawal by Subject|10|||
170355802|NCT04105244|615636908|FG001|Overall Study|Withdrawal by Subject|12|||
170355803|NCT04105244|615636907|FG000|Overall Study|Lost to Follow-up|20|||
170355804|NCT04105244|615636908|FG001|Overall Study|Lost to Follow-up|15|||
170355805|NCT04105244|615636907|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
170355806|NCT04105244|615636908|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
170355807|NCT04105244|615636907|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
170355808|NCT04105244|615636908|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
170355809|NCT01778127|615636911|FG000|Overall Study|Lost to Follow-up|5|||
170355810|NCT01778127|615636912|FG001|Overall Study|Lost to Follow-up|1|||
170355811|NCT01778127|615636913|FG002|Overall Study|Lost to Follow-up|2|||
170355812|NCT01778127|615636911|FG000|Overall Study|Withdrawal by Subject|3|||
170355813|NCT01778127|615636912|FG001|Overall Study|Withdrawal by Subject|1|||
170355814|NCT01778127|615636913|FG002|Overall Study|Withdrawal by Subject|4|||
170355815|NCT01348425|615636914|FG000|Overall Study|Imaging was not taken.|1|||
170355816|NCT01348425|615636915|FG001|Overall Study|Imaging was not taken.|1|||
170355817|NCT03003403|615636921|FG000|Overall Study|Ineligible|8|||
170355818|NCT03003403|615636922|FG001|Overall Study|Ineligible|7|||
170355819|NCT03003403|615636921|FG000|Overall Study|Withdrawal by Subject|3|||
170355820|NCT03003403|615636922|FG001|Overall Study|Withdrawal by Subject|1|||
170355821|NCT05458011|615639066|FG000|DB Period (12 Weeks)|Adverse Event|2|||
170355822|NCT05458011|615639067|FG001|DB Period (12 Weeks)|Adverse Event|1|||
170355823|NCT05458011|615639068|FG002|DB Period (12 Weeks)|Adverse Event|1|||
170355824|NCT05458011|615639066|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
170355825|NCT05458011|615639067|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
170355826|NCT05458011|615639068|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
170355827|NCT05458011|615639066|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
170355828|NCT05458011|615639067|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
170355829|NCT05458011|615639068|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
170355830|NCT05458011|615639066|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
170355831|NCT05458011|615639067|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
170355832|NCT05458011|615639068|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
170355833|NCT05458011|615639066|FG000|OL Period (12 Weeks)|Adverse Event|1|||
170355834|NCT05458011|615639067|FG001|OL Period (12 Weeks)|Adverse Event|2|||
170355835|NCT05458011|615639068|FG002|OL Period (12 Weeks)|Adverse Event|1|||
170355836|NCT05458011|615639066|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
170355837|NCT05458011|615639067|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
170355838|NCT05458011|615639068|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
170355839|NCT00880763|615639069|FG000|Extension Period (Part 2)|Adverse Event|0|||
170355840|NCT00880763|615639070|FG001|Extension Period (Part 2)|Adverse Event|0|||
170355841|NCT00880763|615639071|FG002|Extension Period (Part 2)|Adverse Event|1|||
170355842|NCT00880763|615639072|FG003|Extension Period (Part 2)|Adverse Event|1|||
170355843|NCT00880763|615639069|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
170355844|NCT00880763|615639070|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
170355845|NCT00880763|615639071|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
170355846|NCT00880763|615639072|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
170355847|NCT00880763|615639069|FG000|Extension Period (Part 2)|Physician Decision|0|||
170355848|NCT00880763|615639070|FG001|Extension Period (Part 2)|Physician Decision|1|||
170355849|NCT00880763|615639071|FG002|Extension Period (Part 2)|Physician Decision|1|||
170355850|NCT00880763|615639072|FG003|Extension Period (Part 2)|Physician Decision|0|||
170355851|NCT00880763|615639069|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
170355852|NCT00880763|615639070|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
170355853|NCT00880763|615639071|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
170355854|NCT00880763|615639072|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
170355855|NCT03039738|615639077|FG000|Overall Study|Incomplete data sets|54|||
170355856|NCT03039738|615639078|FG001|Overall Study|Incomplete data sets|0|||
170355857|NCT01494987|615639081|FG000|Overall Study|Adverse Event|6|||
170355858|NCT01494987|615639082|FG001|Overall Study|Adverse Event|5|||
170355859|NCT01494987|615639081|FG000|Overall Study|Hyperglycemia|6|||
170355860|NCT01494987|615639082|FG001|Overall Study|Hyperglycemia|4|||
170355861|NCT01494987|615639081|FG000|Overall Study|Investigator's Discretion|1|||
170355862|NCT01494987|615639082|FG001|Overall Study|Investigator's Discretion|2|||
170355863|NCT01494987|615639081|FG000|Overall Study|Lost to Follow-up|1|||
170355864|NCT01494987|615639082|FG001|Overall Study|Lost to Follow-up|1|||
170355865|NCT01494987|615639081|FG000|Overall Study|Protocol Violation|3|||
170355866|NCT01494987|615639082|FG001|Overall Study|Protocol Violation|3|||
170355867|NCT01494987|615639081|FG000|Overall Study|Subject Non-Compliance|9|||
170355868|NCT01494987|615639082|FG001|Overall Study|Subject Non-Compliance|10|||
170355869|NCT01494987|615639081|FG000|Overall Study|Subject Withdrew Consent|2|||
170355870|NCT01494987|615639082|FG001|Overall Study|Subject Withdrew Consent|3|||
170355871|NCT00436982|615639083|FG000|Overall Study|Withdrawal by Subject|3|||
170355872|NCT00436982|615639084|FG001|Overall Study|Withdrawal by Subject|1|||
170355873|NCT00436982|615639083|FG000|Overall Study|Did not receive allocated intervention|0|||
170355874|NCT00436982|615639084|FG001|Overall Study|Did not receive allocated intervention|1|||
170355875|NCT00436982|615639083|FG000|Overall Study|no RSA data|1|||
170355876|NCT00436982|615639084|FG001|Overall Study|no RSA data|2|||
170355877|NCT00953225|615639088|FG000|Overall Study|Withdrawal by Subject|2|||
170355878|NCT00953225|615639089|FG001|Overall Study|Withdrawal by Subject|0|||
170355879|NCT02254551|615639092|FG000|Dose Escalation|Physician Decision|1|||
170355880|NCT02254551|615639092|FG000|Dose Escalation|Dose-limiting toxicity|2|||
170355881|NCT02215616|615639093|FG000|Overall Study|Sponsor requested to stop study drug|0|||
170355882|NCT02215616|615639094|FG001|Overall Study|Sponsor requested to stop study drug|0|||
170355883|NCT02215616|615639095|FG002|Overall Study|Sponsor requested to stop study drug|1|||
170355884|NCT02215616|615639096|FG003|Overall Study|Sponsor requested to stop study drug|4|||
170355885|NCT02215616|615639093|FG000|Overall Study|Death|1|||
170355886|NCT02215616|615639094|FG001|Overall Study|Death|0|||
170355887|NCT02215616|615639095|FG002|Overall Study|Death|0|||
170355888|NCT02215616|615639096|FG003|Overall Study|Death|0|||
170355889|NCT02215616|615639093|FG000|Overall Study|Adverse Event|7|||
170355890|NCT02215616|615639094|FG001|Overall Study|Adverse Event|4|||
170355891|NCT02215616|615639095|FG002|Overall Study|Adverse Event|9|||
170355892|NCT02215616|615639096|FG003|Overall Study|Adverse Event|2|||
170355893|NCT02215616|615639093|FG000|Overall Study|Withdrawal by Subject|1|||
170355894|NCT02215616|615639094|FG001|Overall Study|Withdrawal by Subject|8|||
170355895|NCT02215616|615639095|FG002|Overall Study|Withdrawal by Subject|2|||
170355896|NCT02215616|615639096|FG003|Overall Study|Withdrawal by Subject|5|||
170355897|NCT02215616|615639093|FG000|Overall Study|Non-compliance|0|||
170355898|NCT02215616|615639094|FG001|Overall Study|Non-compliance|2|||
170355899|NCT02215616|615639095|FG002|Overall Study|Non-compliance|1|||
170355900|NCT02215616|615639096|FG003|Overall Study|Non-compliance|0|||
170355901|NCT02215616|615639093|FG000|Overall Study|Protocol Violation|0|||
170355902|NCT02215616|615639094|FG001|Overall Study|Protocol Violation|2|||
170355903|NCT02215616|615639095|FG002|Overall Study|Protocol Violation|0|||
170355904|NCT02215616|615639096|FG003|Overall Study|Protocol Violation|0|||
170355905|NCT02215616|615639093|FG000|Overall Study|Lost to Follow-up|1|||
170355906|NCT02215616|615639094|FG001|Overall Study|Lost to Follow-up|1|||
170355907|NCT02215616|615639095|FG002|Overall Study|Lost to Follow-up|0|||
170355908|NCT02215616|615639096|FG003|Overall Study|Lost to Follow-up|1|||
170355909|NCT02215616|615639093|FG000|Overall Study|Other than specified|1|||
170355910|NCT02215616|615639094|FG001|Overall Study|Other than specified|0|||
170355911|NCT02215616|615639095|FG002|Overall Study|Other than specified|1|||
170355912|NCT02215616|615639096|FG003|Overall Study|Other than specified|1|||
170355913|NCT04058158|615639097|FG000|Period 1|Death|1|||
170355914|NCT04058158|615639098|FG001|Period 1|Death|0|||
170355915|NCT04058158|615639097|FG000|Period 1|Adverse Event|1|||
170355916|NCT04058158|615639098|FG001|Period 1|Adverse Event|1|||
170355917|NCT04058158|615639097|FG000|Period 1|Pregnancy|0|||
170355918|NCT04058158|615639098|FG001|Period 1|Pregnancy|1|||
170355919|NCT01634113|615639099|FG000|Overall Study|Not treated|0|||
170355920|NCT01634113|615639100|FG001|Overall Study|Not treated|0|||
170355921|NCT01634113|615639101|FG002|Overall Study|Not treated|1|||
170355922|NCT00520299|615639102|FG000|Overall Study|Withdrawal by Subject|0|||
170355923|NCT00520299|615639103|FG001|Overall Study|Withdrawal by Subject|0|||
170355924|NCT00520299|615639104|FG002|Overall Study|Withdrawal by Subject|2|||
170355925|NCT00520299|615639102|FG000|Overall Study|Progressive disease|0|||
170355926|NCT00520299|615639103|FG001|Overall Study|Progressive disease|3|||
170355927|NCT00520299|615639104|FG002|Overall Study|Progressive disease|4|||
170355928|NCT01830816|615639107|FG000|Overall Study|Progressive Disease|12|||
170355929|NCT01830816|615639108|FG001|Overall Study|Progressive Disease|7|||
170355930|NCT01830816|615639109|FG002|Overall Study|Progressive Disease|7|||
170355931|NCT01830816|615639107|FG000|Overall Study|Adverse Event|3|||
170355932|NCT01830816|615639108|FG001|Overall Study|Adverse Event|4|||
170355933|NCT01830816|615639109|FG002|Overall Study|Adverse Event|0|||
170355934|NCT01830816|615639107|FG000|Overall Study|Study Terminated by Sponsor|1|||
170355935|NCT01830816|615639108|FG001|Overall Study|Study Terminated by Sponsor|1|||
170355936|NCT01830816|615639109|FG002|Overall Study|Study Terminated by Sponsor|0|||
170355937|NCT01830816|615639107|FG000|Overall Study|Withdrawal by Subject|1|||
170355938|NCT01830816|615639108|FG001|Overall Study|Withdrawal by Subject|1|||
170355939|NCT01830816|615639109|FG002|Overall Study|Withdrawal by Subject|0|||
170355940|NCT01830816|615639107|FG000|Overall Study|Lost to Follow-up|0|||
170355941|NCT01830816|615639108|FG001|Overall Study|Lost to Follow-up|1|||
170355942|NCT01830816|615639109|FG002|Overall Study|Lost to Follow-up|0|||
170355943|NCT01830816|615639107|FG000|Overall Study|Symptomatic Deterioration|1|||
170355944|NCT01830816|615639108|FG001|Overall Study|Symptomatic Deterioration|0|||
170355945|NCT01830816|615639109|FG002|Overall Study|Symptomatic Deterioration|0|||
170355946|NCT01830816|615639107|FG000|Overall Study|Reason not Specified|2|||
170355947|NCT01830816|615639108|FG001|Overall Study|Reason not Specified|0|||
170355948|NCT01830816|615639109|FG002|Overall Study|Reason not Specified|0|||
170355949|NCT00205699|615639113|FG000|Overall Study|Lost to Follow-up|1|||
170355950|NCT00205699|615639114|FG001|Overall Study|Lost to Follow-up|3|||
170355951|NCT00205699|615639115|FG002|Overall Study|Lost to Follow-up|5|||
170355952|NCT00205699|615639113|FG000|Overall Study|Adverse Event|1|||
170355953|NCT00205699|615639114|FG001|Overall Study|Adverse Event|0|||
170355954|NCT00205699|615639115|FG002|Overall Study|Adverse Event|0|||
170355955|NCT00205699|615639113|FG000|Overall Study|Withdrawal by Subject|1|||
170355956|NCT00205699|615639114|FG001|Overall Study|Withdrawal by Subject|2|||
170355957|NCT00205699|615639115|FG002|Overall Study|Withdrawal by Subject|1|||
170355958|NCT00205699|615639113|FG000|Overall Study|Lack of Efficacy|0|||
170355959|NCT00205699|615639114|FG001|Overall Study|Lack of Efficacy|1|||
170355960|NCT00205699|615639115|FG002|Overall Study|Lack of Efficacy|0|||
170355961|NCT03587584|615639116|FG000|Overall Study|SOC deviations|4|||
170355962|NCT03587584|615639117|FG001|Overall Study|SOC deviations|6|||
170355963|NCT03587584|615639116|FG000|Overall Study|Incomplete data|0|||
170355964|NCT03587584|615639117|FG001|Overall Study|Incomplete data|3|||
170355965|NCT04580394|615639122|FG000|First Intervention|Incorrectly Randomized|1|||
170355966|NCT04580394|615639122|FG000|First Intervention|Physician Decision|1|||
170355967|NCT04580394|615639122|FG000|First Intervention|Lost to Follow-up|1|||
170355968|NCT04580394|615639122|FG000|Washout (One Week)|Withdrawal by Subject|1|||
170355969|NCT04580394|615639122|FG000|Washout (One Week)|Adverse Event|1|||
170355970|NCT04580394|615639122|FG000|Washout (One Week)|Withdrawal by Subject|2|||
170355971|NCT04580394|615639122|FG000|Third Intervention|Adverse Event|1|||
170355972|NCT04580394|615639122|FG000|Third Intervention|Withdrawal by Subject|1|||
170355973|NCT04580394|615639122|FG000|Washout (One Week)|Withdrawal by Subject|2|||
170355974|NCT03201965|615639123|FG000|Overall Study|Death|5|||
170355975|NCT03201965|615639124|FG001|Overall Study|Death|65|||
170355976|NCT03201965|615639125|FG002|Overall Study|Death|47|||
170355977|NCT03201965|615639123|FG000|Overall Study|Lost to Follow-up|0|||
170355978|NCT03201965|615639124|FG001|Overall Study|Lost to Follow-up|6|||
170355979|NCT03201965|615639125|FG002|Overall Study|Lost to Follow-up|0|||
170355980|NCT03201965|615639123|FG000|Overall Study|Withdrawal by Subject|3|||
170355981|NCT03201965|615639124|FG001|Overall Study|Withdrawal by Subject|23|||
170355982|NCT03201965|615639125|FG002|Overall Study|Withdrawal by Subject|8|||
170355983|NCT03201965|615639123|FG000|Overall Study|Sponsor's Decision|20|||
170355984|NCT03201965|615639124|FG001|Overall Study|Sponsor's Decision|99|||
170355985|NCT03201965|615639125|FG002|Overall Study|Sponsor's Decision|140|||
170355986|NCT01934192|615639128|FG000|Overall Study|Protocol Violation|0|||
170355987|NCT01934192|615639129|FG001|Overall Study|Protocol Violation|0|||
170355988|NCT01934192|615639130|FG002|Overall Study|Protocol Violation|0|||
170355989|NCT01934192|615639131|FG003|Overall Study|Protocol Violation|1|||
170355990|NCT01934192|615639128|FG000|Overall Study|Other: reached stopping criteria|6|||
170355991|NCT01934192|615639129|FG001|Overall Study|Other: reached stopping criteria|5|||
170355992|NCT01934192|615639130|FG002|Overall Study|Other: reached stopping criteria|1|||
170355993|NCT01934192|615639131|FG003|Overall Study|Other: reached stopping criteria|0|||
170355994|NCT01934192|615639128|FG000|Overall Study|Physician Decision|3|||
170355995|NCT01934192|615639129|FG001|Overall Study|Physician Decision|2|||
170355996|NCT01934192|615639130|FG002|Overall Study|Physician Decision|0|||
170355997|NCT01934192|615639131|FG003|Overall Study|Physician Decision|0|||
170355998|NCT01737840|615639132|FG000|Overall Study|Diagnosed with an other pathology|2|||
170355999|NCT01737840|615639133|FG001|Overall Study|Diagnosed with an other pathology|2|||
170356000|NCT02357849|615639134|FG000|Overall Study|Withdrawal by Subject|2|||
170356001|NCT02357849|615639135|FG001|Overall Study|Withdrawal by Subject|3|||
170356002|NCT01253421|615639138|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
170356003|NCT01253421|615639139|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
170356004|NCT01253421|615639140|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
170356005|NCT01253421|615639141|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
170356006|NCT01253421|615639142|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
170356007|NCT01253421|615639138|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
170356008|NCT01253421|615639139|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
170356009|NCT01253421|615639140|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
170356010|NCT01253421|615639141|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
170356011|NCT01253421|615639142|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
170356012|NCT01253421|615639138|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
170356013|NCT01253421|615639139|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
170356014|NCT01253421|615639140|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
170356015|NCT01253421|615639141|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
170356016|NCT01253421|615639142|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
170356017|NCT01253421|615639138|FG000|Assessment and Scheduling|Physician Decision|1|||
170356018|NCT01253421|615639139|FG001|Assessment and Scheduling|Physician Decision|0|||
170356019|NCT01253421|615639140|FG002|Assessment and Scheduling|Physician Decision|0|||
170356020|NCT01253421|615639141|FG003|Assessment and Scheduling|Physician Decision|0|||
170356021|NCT01253421|615639142|FG004|Assessment and Scheduling|Physician Decision|0|||
170356022|NCT01253421|615639138|FG000|Drug+Scanning Visit|Physician Decision|0|||
170356023|NCT01253421|615639139|FG001|Drug+Scanning Visit|Physician Decision|0|||
170356024|NCT01253421|615639140|FG002|Drug+Scanning Visit|Physician Decision|0|||
170356025|NCT01253421|615639141|FG003|Drug+Scanning Visit|Physician Decision|0|||
170356026|NCT01253421|615639142|FG004|Drug+Scanning Visit|Physician Decision|1|||
170356027|NCT04863014|615639143|FG000|Overall Study|Lost to Follow-up|3|||
170356028|NCT04863014|615639144|FG001|Overall Study|Lost to Follow-up|2|||
170356029|NCT04863014|615639143|FG000|Overall Study|Subject Decision|0|||
170356030|NCT04863014|615639144|FG001|Overall Study|Subject Decision|4|||
170356031|NCT01608724|615639145|FG000|Overall Study|Withdrawal by Subject|131|||
170356032|NCT01608724|615639145|FG000|Overall Study|Lost to Follow-up|41|||
170356033|NCT01608724|615639145|FG000|Overall Study|Study-specific discontinuation criteria|32|||
170356034|NCT01608724|615639145|FG000|Overall Study|Adverse Event|29|||
170356035|NCT01608724|615639145|FG000|Overall Study|Protocol Violation|6|||
170356036|NCT01608724|615639145|FG000|Overall Study|bood sugar too high, etc.|3|||
170356037|NCT01608724|615639145|FG000|Overall Study|Safety reasons|1|||
170356038|NCT00099359|615639146|FG000|Overall Study|Death|11|||
170356039|NCT00099359|615639147|FG001|Overall Study|Death|15|||
170356040|NCT00099359|615639148|FG002|Overall Study|Death|17|||
170356041|NCT00099359|615639146|FG000|Overall Study|Withdrawal by Subject|19|||
170356042|NCT00099359|615639147|FG001|Overall Study|Withdrawal by Subject|19|||
170356043|NCT00099359|615639148|FG002|Overall Study|Withdrawal by Subject|23|||
170356044|NCT00099359|615639146|FG000|Overall Study|Lost to Follow-up|15|||
170356045|NCT00099359|615639147|FG001|Overall Study|Lost to Follow-up|24|||
170356046|NCT00099359|615639148|FG002|Overall Study|Lost to Follow-up|24|||
170356047|NCT00099359|615639146|FG000|Overall Study|moved out of area|9|||
170356048|NCT00099359|615639147|FG001|Overall Study|moved out of area|7|||
170356049|NCT00099359|615639148|FG002|Overall Study|moved out of area|4|||
170356050|NCT04465396|615639154|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
170356051|NCT04465396|615639155|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
170356052|NCT04465396|615639156|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
170356053|NCT04465396|615639157|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
170356054|NCT00255086|615639160|FG000|Overall Study|Adverse Event|1|||
170356055|NCT00255086|615639161|FG001|Overall Study|Adverse Event|1|||
170356056|NCT00255086|615639160|FG000|Overall Study|Protocol Violation|1|||
170356057|NCT00255086|615639161|FG001|Overall Study|Protocol Violation|1|||
170356058|NCT01963208|615639162|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
170356059|NCT01963208|615639163|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
170356060|NCT01963208|615639164|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
170356061|NCT01963208|615639165|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
170356062|NCT01963208|615639166|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
170356063|NCT01963208|615639167|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
170356064|NCT01963208|615639162|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
170356065|NCT01963208|615639163|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
170356066|NCT01963208|615639164|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
170356067|NCT01963208|615639165|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
170356068|NCT01963208|615639166|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
170356069|NCT01963208|615639167|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
170356070|NCT01963208|615639162|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
170356071|NCT01963208|615639163|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
170356072|NCT01963208|615639164|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
170356073|NCT01963208|615639165|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
170356074|NCT01963208|615639166|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
170356075|NCT01963208|615639167|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
170356076|NCT01963208|615639162|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
170356077|NCT01963208|615639163|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
170356078|NCT01963208|615639164|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
170356079|NCT01963208|615639165|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
170356080|NCT01963208|615639166|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
170356081|NCT01963208|615639167|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
170356082|NCT01963208|615639162|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
170356083|NCT01963208|615639163|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
170356084|NCT01963208|615639164|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
170356085|NCT01963208|615639165|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
170356086|NCT01963208|615639166|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
170356087|NCT01963208|615639167|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
170356088|NCT01963208|615639162|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
170356089|NCT01963208|615639163|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
170356090|NCT01963208|615639164|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
170356091|NCT01963208|615639165|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
170356092|NCT01963208|615639166|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
170356093|NCT01963208|615639167|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
170356094|NCT01963208|615639162|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
170356095|NCT01963208|615639163|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
170356096|NCT01963208|615639164|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
170356097|NCT01963208|615639165|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
170356098|NCT01963208|615639166|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
170356099|NCT01963208|615639167|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
170356100|NCT01963208|615639162|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
170356101|NCT01963208|615639163|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
170356102|NCT01963208|615639164|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
170356103|NCT01963208|615639165|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
170356104|NCT01963208|615639166|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
170356105|NCT01963208|615639167|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
170356106|NCT01963208|615639162|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
170356107|NCT01963208|615639163|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
170356108|NCT01963208|615639164|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
170356109|NCT01963208|615639165|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
170356110|NCT01963208|615639166|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
170356111|NCT01963208|615639167|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
170356112|NCT01963208|615639162|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
170356113|NCT01963208|615639163|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
170356114|NCT01963208|615639164|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
170356115|NCT01963208|615639165|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
170356116|NCT01963208|615639166|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
170356117|NCT01963208|615639167|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
170356118|NCT01963208|615639162|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
170356119|NCT01963208|615639163|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
170356120|NCT01963208|615639164|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
170356121|NCT01963208|615639165|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
170356122|NCT01963208|615639166|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
170356123|NCT01963208|615639167|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
170356124|NCT01963208|615639162|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
170356125|NCT01963208|615639163|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
170356126|NCT01963208|615639164|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
170356127|NCT01963208|615639165|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
170356128|NCT01963208|615639166|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
170356129|NCT01963208|615639167|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
170356130|NCT01963208|615639162|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
170356131|NCT01963208|615639163|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
170356132|NCT01963208|615639164|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
170356133|NCT01963208|615639165|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
170356134|NCT01963208|615639166|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
170356135|NCT01963208|615639167|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
170356136|NCT01963208|615639162|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
170356137|NCT01963208|615639163|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
170356138|NCT01963208|615639164|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
170356139|NCT01963208|615639165|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
170356140|NCT01963208|615639166|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
170356141|NCT01963208|615639167|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
170356142|NCT00349752|615639170|FG000|Overall Study|Adverse Event|8|||
170356143|NCT00349752|615639171|FG001|Overall Study|Adverse Event|12|||
170356144|NCT00349752|615639170|FG000|Overall Study|Lack of Efficacy|37|||
170356145|NCT00349752|615639171|FG001|Overall Study|Lack of Efficacy|42|||
170356146|NCT00349752|615639170|FG000|Overall Study|Lost to Follow-up|4|||
170356147|NCT00349752|615639171|FG001|Overall Study|Lost to Follow-up|2|||
170356148|NCT00349752|615639170|FG000|Overall Study|Personal reasons|6|||
170356149|NCT00349752|615639171|FG001|Overall Study|Personal reasons|5|||
170356150|NCT00349752|615639170|FG000|Overall Study|Other: Required exclusionary medication|0|||
170356151|NCT00349752|615639171|FG001|Overall Study|Other: Required exclusionary medication|1|||
170356152|NCT00349752|615639170|FG000|Overall Study|Other: Non compliance|0|||
170356153|NCT00349752|615639171|FG001|Overall Study|Other: Non compliance|1|||
170356154|NCT00349752|615639170|FG000|Overall Study|Other: Patient stopped steroids|0|||
170356155|NCT00349752|615639171|FG001|Overall Study|Other: Patient stopped steroids|1|||
170356156|NCT00349752|615639170|FG000|Overall Study|Other: Patient's steroid use|1|||
170356157|NCT00349752|615639171|FG001|Overall Study|Other: Patient's steroid use|0|||
170356158|NCT00349752|615639170|FG000|Overall Study|Other: Ineligible|1|||
170356159|NCT00349752|615639171|FG001|Overall Study|Other: Ineligible|0|||
170356160|NCT00349752|615639170|FG000|Overall Study|Other: Inadvertently unblinded|1|||
170356161|NCT00349752|615639171|FG001|Overall Study|Other: Inadvertently unblinded|0|||
170356162|NCT00349752|615639170|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
170356163|NCT00349752|615639171|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
170356164|NCT00632541|615639172|FG000|Overall Study|Adverse Event|7|||
170356165|NCT01842607|615639173|FG000|Overall Study|Adverse Event|11|||
170356166|NCT01842607|615639173|FG000|Overall Study|Lack of Efficacy|19|||
170356167|NCT01842607|615639173|FG000|Overall Study|Protocol Violation|8|||
170356168|NCT01842607|615639173|FG000|Overall Study|Protocol defined stopping criteria|2|||
170356169|NCT01842607|615639173|FG000|Overall Study|Lost to Follow-up|3|||
170356170|NCT01842607|615639173|FG000|Overall Study|Physician Decision|9|||
170356171|NCT01842607|615639173|FG000|Overall Study|Withdrawal by Subject|14|||
170356172|NCT00012012|615639174|FG000|Overall Study|Protocol Violation|1|||
170356173|NCT00012012|615639175|FG001|Overall Study|Protocol Violation|1|||
170356174|NCT00012012|615639174|FG000|Overall Study|Withdrawal by Subject|0|||
170356175|NCT00012012|615639175|FG001|Overall Study|Withdrawal by Subject|2|||
170356176|NCT02159469|615639176|FG000|Overall Study|Missing Completion status|1|||
170356177|NCT02159469|615639176|FG000|Overall Study|Adverse Event|5|||
170356178|NCT02159469|615639176|FG000|Overall Study|Non-compliance|2|||
170356179|NCT02159469|615639176|FG000|Overall Study|Withdrawal by Subject|9|||
170356180|NCT02159469|615639176|FG000|Overall Study|Lost to Follow-up|1|||
170356181|NCT02159469|615639176|FG000|Overall Study|Sponsor's request|2|||
170356182|NCT02159469|615639176|FG000|Overall Study|Met Stopping Criteria|3|||
170356183|NCT02159469|615639176|FG000|Overall Study|Other|1|||
170356184|NCT02159469|615639176|FG000|Overall Study|Multiple|29|||
170356185|NCT02034474|615639177|FG000|Overall Study|Adverse Event|3|||
170356186|NCT02034474|615639178|FG001|Overall Study|Adverse Event|2|||
170356187|NCT02034474|615639177|FG000|Overall Study|Withdrawal by Subject|1|||
170356188|NCT02034474|615639178|FG001|Overall Study|Withdrawal by Subject|2|||
170356189|NCT00675103|615639179|FG000|Overall Study|Lack of Efficacy|2|||
170356190|NCT00675103|615639179|FG000|Overall Study|Adverse Event|1|||
170356191|NCT03600714|615639180|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
170356192|NCT03814590|615639181|FG000|Overall Study|Adverse Event|0|||
170356193|NCT03814590|615639182|FG001|Overall Study|Adverse Event|0|||
170356194|NCT03814590|615639183|FG002|Overall Study|Adverse Event|0|||
170356195|NCT03814590|615639184|FG003|Overall Study|Adverse Event|0|||
170356196|NCT03814590|615639185|FG004|Overall Study|Adverse Event|0|||
170356197|NCT03814590|615639186|FG005|Overall Study|Adverse Event|1|||
170356198|NCT03814590|615639187|FG006|Overall Study|Adverse Event|1|||
170356199|NCT03814590|615639188|FG007|Overall Study|Adverse Event|1|||
170356200|NCT03814590|615639189|FG008|Overall Study|Adverse Event|0|||
170356201|NCT03814590|615639190|FG009|Overall Study|Adverse Event|0|||
170356202|NCT03814590|615639191|FG010|Overall Study|Adverse Event|1|||
170356203|NCT03814590|615639192|FG011|Overall Study|Adverse Event|0|||
170356204|NCT03814590|615639193|FG012|Overall Study|Adverse Event|3|||
170356205|NCT03814590|615639194|FG013|Overall Study|Adverse Event|0|||
170356206|NCT03814590|615639181|FG000|Overall Study|Lost to Follow-up|0|||
170356207|NCT03814590|615639182|FG001|Overall Study|Lost to Follow-up|2|||
170356208|NCT03814590|615639183|FG002|Overall Study|Lost to Follow-up|1|||
170356209|NCT03814590|615639184|FG003|Overall Study|Lost to Follow-up|0|||
170356210|NCT03814590|615639185|FG004|Overall Study|Lost to Follow-up|1|||
170356211|NCT03814590|615639186|FG005|Overall Study|Lost to Follow-up|1|||
170356212|NCT03814590|615639187|FG006|Overall Study|Lost to Follow-up|1|||
170356213|NCT03814590|615639188|FG007|Overall Study|Lost to Follow-up|1|||
170356214|NCT03814590|615639189|FG008|Overall Study|Lost to Follow-up|0|||
170356215|NCT03814590|615639190|FG009|Overall Study|Lost to Follow-up|0|||
170356216|NCT03814590|615639191|FG010|Overall Study|Lost to Follow-up|1|||
170356217|NCT03814590|615639192|FG011|Overall Study|Lost to Follow-up|0|||
170356218|NCT03814590|615639193|FG012|Overall Study|Lost to Follow-up|0|||
170356219|NCT03814590|615639194|FG013|Overall Study|Lost to Follow-up|1|||
170356220|NCT03814590|615639181|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356221|NCT03814590|615639182|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356222|NCT03814590|615639183|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356223|NCT03814590|615639184|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356224|NCT03814590|615639185|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356225|NCT03814590|615639186|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356226|NCT03814590|615639187|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356227|NCT03814590|615639188|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356228|NCT03814590|615639189|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356229|NCT03814590|615639190|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
170356230|NCT03814590|615639191|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356231|NCT03814590|615639192|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356232|NCT03814590|615639193|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356233|NCT03814590|615639194|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
170356234|NCT03814590|615639181|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
170356235|NCT03814590|615639182|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
170356236|NCT03814590|615639183|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
170356237|NCT03814590|615639184|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
170356238|NCT03814590|615639185|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
170356239|NCT03814590|615639186|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
170356240|NCT03814590|615639187|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
170356241|NCT03814590|615639188|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
170356242|NCT03814590|615639189|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
170356243|NCT03814590|615639190|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
170356244|NCT03814590|615639191|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
170356245|NCT03814590|615639192|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
170356246|NCT03814590|615639193|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
170356247|NCT03814590|615639194|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
170356248|NCT03814590|615639181|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356249|NCT03814590|615639182|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356250|NCT03814590|615639183|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356251|NCT03814590|615639184|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356252|NCT03814590|615639185|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356253|NCT03814590|615639186|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356254|NCT03814590|615639187|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356255|NCT03814590|615639188|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170356256|NCT03814590|615639189|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356257|NCT03814590|615639190|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170356258|NCT03814590|615639191|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356259|NCT03814590|615639192|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356260|NCT03814590|615639193|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356261|NCT03814590|615639194|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170356262|NCT03814590|615639181|FG000|Overall Study|UNKNOWN REASON|0|||
170356263|NCT03814590|615639182|FG001|Overall Study|UNKNOWN REASON|0|||
170356264|NCT03814590|615639183|FG002|Overall Study|UNKNOWN REASON|0|||
170356265|NCT03814590|615639184|FG003|Overall Study|UNKNOWN REASON|0|||
170356266|NCT03814590|615639185|FG004|Overall Study|UNKNOWN REASON|0|||
170356267|NCT03814590|615639186|FG005|Overall Study|UNKNOWN REASON|0|||
170356268|NCT03814590|615639187|FG006|Overall Study|UNKNOWN REASON|0|||
170356269|NCT03814590|615639188|FG007|Overall Study|UNKNOWN REASON|1|||
170356270|NCT03814590|615639189|FG008|Overall Study|UNKNOWN REASON|0|||
170356271|NCT03814590|615639190|FG009|Overall Study|UNKNOWN REASON|0|||
170356272|NCT03814590|615639191|FG010|Overall Study|UNKNOWN REASON|0|||
170356273|NCT03814590|615639192|FG011|Overall Study|UNKNOWN REASON|0|||
170356274|NCT03814590|615639193|FG012|Overall Study|UNKNOWN REASON|0|||
170356275|NCT03814590|615639194|FG013|Overall Study|UNKNOWN REASON|0|||
170356276|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
170356277|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
170356278|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
170356279|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
170356280|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
170356281|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
170356282|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
170356283|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
170356284|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
170356285|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
170356286|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
170356287|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
170356288|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
170356289|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
170356290|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
170356291|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
170356292|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
170356293|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
170356294|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
170356295|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
170356296|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
170356297|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
170356298|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
170356299|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
170356300|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
170356301|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
170356302|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
170356303|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
170356304|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
170356305|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
170356306|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
170356307|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
170356308|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
170356309|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
170356310|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
170356311|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
170356312|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
170356313|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
170356314|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
170356315|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
170356316|NCT00383721|615639195|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
170356317|NCT00383721|615639196|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
170356318|NCT00383721|615639197|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
170356319|NCT00383721|615639198|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
170356320|NCT00383721|615639199|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
170356321|NCT00383721|615639195|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
170356322|NCT00383721|615639196|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
170356323|NCT00383721|615639197|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
170356324|NCT00383721|615639198|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
170356325|NCT00383721|615639199|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
170356326|NCT00383721|615639195|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
170356327|NCT00383721|615639196|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
170356328|NCT00383721|615639197|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
170356329|NCT00383721|615639198|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
170356330|NCT00383721|615639199|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
170356331|NCT00383721|615639195|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
170356332|NCT00383721|615639196|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
170356333|NCT00383721|615639197|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
170356334|NCT00383721|615639198|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
170356335|NCT00383721|615639199|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
170356336|NCT00383721|615639195|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
170356337|NCT00383721|615639196|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
170356338|NCT00383721|615639197|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
170356339|NCT00383721|615639198|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
170356340|NCT00383721|615639199|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
170356341|NCT00383721|615639195|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
170356342|NCT00383721|615639196|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
170356343|NCT00383721|615639197|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
170356344|NCT00383721|615639198|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
170356345|NCT00383721|615639199|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
170356346|NCT00383721|615639195|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
170356347|NCT00383721|615639196|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
170356348|NCT00383721|615639197|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
170356349|NCT00383721|615639198|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
170356350|NCT00383721|615639199|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
170356351|NCT00383721|615639195|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
170356352|NCT00383721|615639196|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
170356353|NCT00383721|615639197|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
170356354|NCT00383721|615639198|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
170356355|NCT00383721|615639199|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
170356356|NCT00383721|615639195|FG000|26-Week Treatment Safety Extension|Administrative|1|||
170356357|NCT00383721|615639196|FG001|26-Week Treatment Safety Extension|Administrative|2|||
170356358|NCT00383721|615639197|FG002|26-Week Treatment Safety Extension|Administrative|3|||
170356359|NCT00383721|615639198|FG003|26-Week Treatment Safety Extension|Administrative|1|||
170356360|NCT00383721|615639199|FG004|26-Week Treatment Safety Extension|Administrative|0|||
170356361|NCT01935336|615639206|FG000|Overall Study|Adverse Event|1|||
170356362|NCT01935336|615639207|FG001|Overall Study|Adverse Event|0|||
170356363|NCT01935336|615639208|FG002|Overall Study|Adverse Event|0|||
170356364|NCT01935336|615639209|FG003|Overall Study|Adverse Event|0|||
170356365|NCT01935336|615639206|FG000|Overall Study|Progressive disease|5|||
170356366|NCT01935336|615639207|FG001|Overall Study|Progressive disease|3|||
170356367|NCT01935336|615639208|FG002|Overall Study|Progressive disease|47|||
170356368|NCT01935336|615639209|FG003|Overall Study|Progressive disease|66|||
170356369|NCT00592553|615639210|FG000|Overall Study|Protocol Noncompliance|1|||
170356370|NCT00592553|615639211|FG001|Overall Study|Protocol Noncompliance|0|||
170356371|NCT00592553|615639212|FG002|Overall Study|Protocol Noncompliance|0|||
170356372|NCT01244191|615639217|FG000|Overall Study|Progressive disease|295|||
170356373|NCT01244191|615639218|FG001|Overall Study|Progressive disease|350|||
170356374|NCT01244191|615639217|FG000|Overall Study|Clinical disease progression|54|||
170356375|NCT01244191|615639218|FG001|Overall Study|Clinical disease progression|36|||
170356376|NCT01244191|615639217|FG000|Overall Study|Adverse Event|65|||
170356377|NCT01244191|615639218|FG001|Overall Study|Adverse Event|48|||
170356378|NCT01244191|615639217|FG000|Overall Study|Death|22|||
170356379|NCT01244191|615639218|FG001|Overall Study|Death|29|||
170356380|NCT01244191|615639217|FG000|Overall Study|Lost to Follow-up|0|||
170356381|NCT01244191|615639218|FG001|Overall Study|Lost to Follow-up|2|||
170356382|NCT01244191|615639217|FG000|Overall Study|Protocol Violation|1|||
170356383|NCT01244191|615639218|FG001|Overall Study|Protocol Violation|2|||
170356384|NCT01244191|615639217|FG000|Overall Study|Withdrawal by Subject|31|||
170356385|NCT01244191|615639218|FG001|Overall Study|Withdrawal by Subject|23|||
170356386|NCT01244191|615639217|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
170356387|NCT01244191|615639218|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
170356388|NCT02164513|615639219|FG000|Overall Study|Adverse Event|162|||
170356389|NCT02164513|615639220|FG001|Overall Study|Adverse Event|180|||
170356390|NCT02164513|615639221|FG002|Overall Study|Adverse Event|111|||
170356391|NCT02164513|615639219|FG000|Overall Study|Other: Study Closed or terminated|5|||
170356392|NCT02164513|615639220|FG001|Overall Study|Other: Study Closed or terminated|2|||
170356393|NCT02164513|615639221|FG002|Overall Study|Other: Study Closed or terminated|4|||
170356394|NCT02164513|615639219|FG000|Overall Study|Lost to Follow-up|30|||
170356395|NCT02164513|615639220|FG001|Overall Study|Lost to Follow-up|36|||
170356396|NCT02164513|615639221|FG002|Overall Study|Lost to Follow-up|22|||
170356397|NCT02164513|615639219|FG000|Overall Study|Physician Decision|47|||
170356398|NCT02164513|615639220|FG001|Overall Study|Physician Decision|57|||
170356399|NCT02164513|615639221|FG002|Overall Study|Physician Decision|28|||
170356400|NCT02164513|615639219|FG000|Overall Study|Withdrawal by Subject|192|||
170356401|NCT02164513|615639220|FG001|Overall Study|Withdrawal by Subject|261|||
170356402|NCT02164513|615639221|FG002|Overall Study|Withdrawal by Subject|130|||
170356403|NCT02164513|615639219|FG000|Overall Study|Other: Reason not provided by site|1|||
170356404|NCT02164513|615639220|FG001|Overall Study|Other: Reason not provided by site|0|||
170356405|NCT02164513|615639221|FG002|Overall Study|Other: Reason not provided by site|0|||
170356406|NCT01810042|615639222|FG000|Overall Study|Lost to Follow-up|10|||
170356407|NCT01208038|615639225|FG000|Overall Study|Withdrawal by Subject|1|||
170356408|NCT05301322|615639228|FG000|Overall Study|Adverse Event|7|||
170356409|NCT05301322|615639229|FG001|Overall Study|Adverse Event|3|||
170356410|NCT05301322|615639228|FG000|Overall Study|Death|0|||
170356411|NCT05301322|615639229|FG001|Overall Study|Death|1|||
170356412|NCT05301322|615639228|FG000|Overall Study|Lost to Follow-up|2|||
170356413|NCT05301322|615639229|FG001|Overall Study|Lost to Follow-up|1|||
170356414|NCT05301322|615639228|FG000|Overall Study|Protocol Violation|3|||
170356415|NCT05301322|615639229|FG001|Overall Study|Protocol Violation|1|||
170356416|NCT05301322|615639228|FG000|Overall Study|Withdrawal by Subject|3|||
170356417|NCT05301322|615639229|FG001|Overall Study|Withdrawal by Subject|0|||
170356418|NCT05301322|615639228|FG000|Overall Study|Other|4|||
170356419|NCT05301322|615639229|FG001|Overall Study|Other|0|||
170356420|NCT05108805|615639230|FG000|Overall Study|T-cell expansion was not successful.|5|||
170356421|NCT04095286|615639231|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356422|NCT04095286|615639232|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
170356423|NCT04095286|615639233|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356424|NCT04095286|615639234|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356425|NCT04095286|615639235|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356426|NCT04095286|615639236|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356427|NCT04095286|615639231|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
170356428|NCT04095286|615639232|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
170356429|NCT04095286|615639233|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
170356430|NCT04095286|615639234|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
170356431|NCT04095286|615639235|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
170356432|NCT04095286|615639236|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
170356433|NCT04095286|615639231|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
170356434|NCT04095286|615639232|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
170356435|NCT04095286|615639233|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
170356436|NCT04095286|615639234|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
170356437|NCT04095286|615639235|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
170356438|NCT04095286|615639236|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
170356439|NCT04095286|615639231|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356440|NCT04095286|615639232|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356441|NCT04095286|615639233|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
170356442|NCT04095286|615639234|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356443|NCT04095286|615639235|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356444|NCT04095286|615639236|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
170356445|NCT04095286|615639231|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
170356446|NCT04095286|615639232|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
170356447|NCT04095286|615639233|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
170356448|NCT04095286|615639234|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
170356449|NCT04095286|615639235|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
170356450|NCT04095286|615639236|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
170356451|NCT00479557|615639237|FG000|Overall Study|Death|0|||
170356452|NCT00479557|615639238|FG001|Overall Study|Death|0|||
170356453|NCT00479557|615639239|FG002|Overall Study|Death|0|||
170356454|NCT00479557|615639240|FG003|Overall Study|Death|0|||
170356455|NCT00479557|615639241|FG004|Overall Study|Death|0|||
170356456|NCT00479557|615639242|FG005|Overall Study|Death|1|||
170356457|NCT00479557|615639243|FG006|Overall Study|Death|0|||
170356458|NCT00479557|615639237|FG000|Overall Study|Lack of Efficacy|1|||
170356459|NCT00479557|615639238|FG001|Overall Study|Lack of Efficacy|0|||
170356460|NCT00479557|615639239|FG002|Overall Study|Lack of Efficacy|0|||
170356461|NCT00479557|615639240|FG003|Overall Study|Lack of Efficacy|0|||
170356462|NCT00479557|615639241|FG004|Overall Study|Lack of Efficacy|0|||
170356463|NCT00479557|615639242|FG005|Overall Study|Lack of Efficacy|0|||
170356464|NCT00479557|615639243|FG006|Overall Study|Lack of Efficacy|0|||
170356465|NCT00479557|615639237|FG000|Overall Study|Lost to Follow-up|0|||
170356466|NCT00479557|615639238|FG001|Overall Study|Lost to Follow-up|2|||
170356467|NCT00479557|615639239|FG002|Overall Study|Lost to Follow-up|0|||
170356468|NCT00479557|615639240|FG003|Overall Study|Lost to Follow-up|2|||
170356469|NCT00479557|615639241|FG004|Overall Study|Lost to Follow-up|0|||
170356470|NCT00479557|615639242|FG005|Overall Study|Lost to Follow-up|0|||
170356471|NCT00479557|615639243|FG006|Overall Study|Lost to Follow-up|0|||
170356472|NCT00479557|615639237|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
170356473|NCT00479557|615639238|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
170356474|NCT00479557|615639239|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
170356475|NCT00479557|615639240|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
170356476|NCT00479557|615639241|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
170356477|NCT00479557|615639242|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
170356478|NCT00479557|615639243|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
170356479|NCT00479557|615639237|FG000|Overall Study|AE not related to Study Drug|1|||
170356480|NCT00479557|615639238|FG001|Overall Study|AE not related to Study Drug|3|||
170356481|NCT00479557|615639239|FG002|Overall Study|AE not related to Study Drug|0|||
170356482|NCT00479557|615639240|FG003|Overall Study|AE not related to Study Drug|0|||
170356483|NCT00479557|615639241|FG004|Overall Study|AE not related to Study Drug|2|||
170356484|NCT00479557|615639242|FG005|Overall Study|AE not related to Study Drug|2|||
170356485|NCT00479557|615639243|FG006|Overall Study|AE not related to Study Drug|1|||
170356486|NCT00479557|615639237|FG000|Overall Study|Caregiver Request|2|||
170356487|NCT00479557|615639238|FG001|Overall Study|Caregiver Request|2|||
170356488|NCT00479557|615639239|FG002|Overall Study|Caregiver Request|2|||
170356489|NCT00479557|615639240|FG003|Overall Study|Caregiver Request|0|||
170356490|NCT00479557|615639241|FG004|Overall Study|Caregiver Request|1|||
170356491|NCT00479557|615639242|FG005|Overall Study|Caregiver Request|2|||
170356492|NCT00479557|615639243|FG006|Overall Study|Caregiver Request|0|||
170356493|NCT00479557|615639237|FG000|Overall Study|Investigator Request|0|||
170356494|NCT00479557|615639238|FG001|Overall Study|Investigator Request|0|||
170356495|NCT00479557|615639239|FG002|Overall Study|Investigator Request|1|||
170356496|NCT00479557|615639240|FG003|Overall Study|Investigator Request|0|||
170356497|NCT00479557|615639241|FG004|Overall Study|Investigator Request|0|||
170356498|NCT00479557|615639242|FG005|Overall Study|Investigator Request|0|||
170356499|NCT00479557|615639243|FG006|Overall Study|Investigator Request|0|||
170356500|NCT00479557|615639237|FG000|Overall Study|Subject Request|3|||
170356501|NCT00479557|615639238|FG001|Overall Study|Subject Request|0|||
170356502|NCT00479557|615639239|FG002|Overall Study|Subject Request|1|||
170356503|NCT00479557|615639240|FG003|Overall Study|Subject Request|1|||
170356504|NCT00479557|615639241|FG004|Overall Study|Subject Request|1|||
170356505|NCT00479557|615639242|FG005|Overall Study|Subject Request|4|||
170356506|NCT00479557|615639243|FG006|Overall Study|Subject Request|1|||
170356507|NCT00479557|615639237|FG000|Overall Study|Other|2|||
170356508|NCT00479557|615639238|FG001|Overall Study|Other|3|||
170356509|NCT00479557|615639239|FG002|Overall Study|Other|1|||
170356510|NCT00479557|615639240|FG003|Overall Study|Other|0|||
170356511|NCT00479557|615639241|FG004|Overall Study|Other|0|||
170356512|NCT00479557|615639242|FG005|Overall Study|Other|3|||
170356513|NCT00479557|615639243|FG006|Overall Study|Other|0|||
170356514|NCT02509494|615639244|FG000|Overall Study|Lost to Follow-up|8|||
170356515|NCT02509494|615639245|FG001|Overall Study|Lost to Follow-up|47|||
170356516|NCT02509494|615639246|FG002|Overall Study|Lost to Follow-up|19|||
170356517|NCT02509494|615639247|FG003|Overall Study|Lost to Follow-up|6|||
170356518|NCT02509494|615639248|FG004|Overall Study|Lost to Follow-up|3|||
170356519|NCT02509494|615639249|FG005|Overall Study|Lost to Follow-up|3|||
170356520|NCT02509494|615639250|FG006|Overall Study|Lost to Follow-up|1|||
170356521|NCT02509494|615639251|FG007|Overall Study|Lost to Follow-up|3|||
170356522|NCT02509494|615639252|FG008|Overall Study|Lost to Follow-up|1|||
170356523|NCT02509494|615639244|FG000|Overall Study|Physician Decision|2|||
170356524|NCT02509494|615639245|FG001|Overall Study|Physician Decision|1|||
170356525|NCT02509494|615639246|FG002|Overall Study|Physician Decision|0|||
170356526|NCT02509494|615639247|FG003|Overall Study|Physician Decision|0|||
170356527|NCT02509494|615639248|FG004|Overall Study|Physician Decision|0|||
170356528|NCT02509494|615639249|FG005|Overall Study|Physician Decision|0|||
170356529|NCT02509494|615639250|FG006|Overall Study|Physician Decision|0|||
170356530|NCT02509494|615639251|FG007|Overall Study|Physician Decision|0|||
170356531|NCT02509494|615639252|FG008|Overall Study|Physician Decision|0|||
170356532|NCT02509494|615639244|FG000|Overall Study|Withdrawal by Subject|4|||
170356533|NCT02509494|615639245|FG001|Overall Study|Withdrawal by Subject|17|||
170356534|NCT02509494|615639246|FG002|Overall Study|Withdrawal by Subject|7|||
170356535|NCT02509494|615639247|FG003|Overall Study|Withdrawal by Subject|5|||
170356536|NCT02509494|615639248|FG004|Overall Study|Withdrawal by Subject|0|||
170356537|NCT02509494|615639249|FG005|Overall Study|Withdrawal by Subject|6|||
170356538|NCT02509494|615639250|FG006|Overall Study|Withdrawal by Subject|1|||
170356539|NCT02509494|615639251|FG007|Overall Study|Withdrawal by Subject|2|||
170356540|NCT02509494|615639252|FG008|Overall Study|Withdrawal by Subject|1|||
170356541|NCT02509494|615639244|FG000|Overall Study|Death|0|||
170356542|NCT02509494|615639245|FG001|Overall Study|Death|1|||
170356543|NCT02509494|615639246|FG002|Overall Study|Death|0|||
170356544|NCT02509494|615639247|FG003|Overall Study|Death|0|||
170356545|NCT02509494|615639248|FG004|Overall Study|Death|1|||
170356546|NCT02509494|615639249|FG005|Overall Study|Death|0|||
170356547|NCT02509494|615639250|FG006|Overall Study|Death|0|||
170356548|NCT02509494|615639251|FG007|Overall Study|Death|1|||
170356549|NCT02509494|615639252|FG008|Overall Study|Death|0|||
170356550|NCT02509494|615639244|FG000|Overall Study|Other|0|||
170356551|NCT02509494|615639245|FG001|Overall Study|Other|4|||
170356552|NCT02509494|615639246|FG002|Overall Study|Other|5|||
170356553|NCT02509494|615639247|FG003|Overall Study|Other|0|||
170356554|NCT02509494|615639248|FG004|Overall Study|Other|0|||
170356555|NCT02509494|615639249|FG005|Overall Study|Other|0|||
170356556|NCT02509494|615639250|FG006|Overall Study|Other|0|||
170356557|NCT02509494|615639251|FG007|Overall Study|Other|0|||
170356558|NCT02509494|615639252|FG008|Overall Study|Other|0|||
170356559|NCT02509494|615639244|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170356560|NCT02509494|615639245|FG001|Overall Study|Non-Compliance With Study Drug|11|||
170356561|NCT02509494|615639246|FG002|Overall Study|Non-Compliance With Study Drug|7|||
170356562|NCT02509494|615639247|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170356563|NCT02509494|615639248|FG004|Overall Study|Non-Compliance With Study Drug|1|||
170356564|NCT02509494|615639249|FG005|Overall Study|Non-Compliance With Study Drug|2|||
170356565|NCT02509494|615639250|FG006|Overall Study|Non-Compliance With Study Drug|1|||
170356566|NCT02509494|615639251|FG007|Overall Study|Non-Compliance With Study Drug|1|||
170356567|NCT02509494|615639252|FG008|Overall Study|Non-Compliance With Study Drug|0|||
170356568|NCT04752189|615639253|FG000|Overall Study|Withdrawal by Subject|0|||
170356569|NCT04752189|615639254|FG001|Overall Study|Withdrawal by Subject|150|||
170356570|NCT04752189|615639253|FG000|Overall Study|Lost to Follow-up|261|||
170356571|NCT04752189|615639254|FG001|Overall Study|Lost to Follow-up|126|||
170356572|NCT00255034|615640994|FG000|Overall Study|Withdrawal by Subject|15|||
170356573|NCT00255034|615640995|FG001|Overall Study|Withdrawal by Subject|38|||
170356574|NCT03947255|615640997|FG000|Overall Study|Study Closure by Sponsor|2|||
170356575|NCT03947255|615640998|FG001|Overall Study|Study Closure by Sponsor|2|||
170356576|NCT03947255|615640997|FG000|Overall Study|Withdrawal by Subject|2|||
170356577|NCT03947255|615640998|FG001|Overall Study|Withdrawal by Subject|2|||
170356578|NCT03947255|615640997|FG000|Overall Study|Lost to Follow-up|2|||
170356579|NCT03947255|615640998|FG001|Overall Study|Lost to Follow-up|0|||
170356580|NCT03947255|615640997|FG000|Overall Study|Death|0|||
170356581|NCT03947255|615640998|FG001|Overall Study|Death|2|||
170356582|NCT02701192|615641007|FG000|Overall Study|Protocol Violation|2|||
170356583|NCT02701192|615641007|FG000|Overall Study|Lost to Follow-up|4|||
170356584|NCT01245764|615641009|FG000|Study Phase A|Other|3|||
170356585|NCT01245764|615641010|FG001|Study Phase A|Other|2|||
170356586|NCT01245764|615641011|FG002|Study Phase A|Other|3|||
170356587|NCT01245764|615641012|FG003|Study Phase A|Other|1|||
170356588|NCT01245764|615641009|FG000|Study Phase A|Protocol Violation|6|||
170356589|NCT01245764|615641010|FG001|Study Phase A|Protocol Violation|3|||
170356590|NCT01245764|615641011|FG002|Study Phase A|Protocol Violation|2|||
170356591|NCT01245764|615641012|FG003|Study Phase A|Protocol Violation|2|||
170356592|NCT01245764|615641009|FG000|Study Phase A|Lost to Follow-up|0|||
170356593|NCT01245764|615641010|FG001|Study Phase A|Lost to Follow-up|0|||
170356594|NCT01245764|615641011|FG002|Study Phase A|Lost to Follow-up|5|||
170356595|NCT01245764|615641012|FG003|Study Phase A|Lost to Follow-up|0|||
170356596|NCT00003476|615641013|FG000|Overall Study|Not evaluable|1|||
170356597|NCT02475850|615641014|FG000|Overall Study|Death|155|||
170356598|NCT02475850|615641015|FG001|Overall Study|Death|141|||
170356599|NCT02475850|615641014|FG000|Overall Study|Lost to Follow-up|217|||
170356600|NCT02475850|615641015|FG001|Overall Study|Lost to Follow-up|188|||
170356601|NCT02475850|615641014|FG000|Overall Study|Withdrawal by Subject|221|||
170356602|NCT02475850|615641015|FG001|Overall Study|Withdrawal by Subject|155|||
170356603|NCT00781963|615641016|FG000|Overall Study|Death|3|||
170356604|NCT00781963|615641017|FG001|Overall Study|Death|0|||
170356605|NCT00781963|615641016|FG000|Overall Study|Lost to Follow-up|2|||
170356606|NCT00781963|615641017|FG001|Overall Study|Lost to Follow-up|1|||
170356607|NCT00781963|615641016|FG000|Overall Study|Withdrawal by Subject|3|||
170356608|NCT00781963|615641017|FG001|Overall Study|Withdrawal by Subject|1|||
170356609|NCT00781963|615641016|FG000|Overall Study|Refused follow-up|9|||
170356610|NCT00781963|615641017|FG001|Overall Study|Refused follow-up|0|||
170356611|NCT03297216|615641018|FG000|Overall Study|Death|0|||
170356612|NCT03297216|615641019|FG001|Overall Study|Death|1|||
170356613|NCT03297216|615641018|FG000|Overall Study|Miscarriage|0|||
170356614|NCT03297216|615641019|FG001|Overall Study|Miscarriage|2|||
170356615|NCT03297216|615641018|FG000|Overall Study|Lost to Follow-up|3|||
170356616|NCT03297216|615641019|FG001|Overall Study|Lost to Follow-up|2|||
170356617|NCT00603733|615641023|FG000|Active Phase ITT|Adverse Event|8|||
170356618|NCT00603733|615641024|FG001|Active Phase ITT|Adverse Event|7|||
170356619|NCT00603733|615641023|FG000|Active Phase ITT|Withdrawal by Subject|0|||
170356620|NCT00603733|615641024|FG001|Active Phase ITT|Withdrawal by Subject|3|||
170356621|NCT00603733|615641023|FG000|Active Phase ITT|Lost to Follow-up|0|||
170356622|NCT00603733|615641024|FG001|Active Phase ITT|Lost to Follow-up|1|||
170356623|NCT00603733|615641023|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
170356624|NCT00603733|615641024|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
170356625|NCT00603733|615641023|FG000|Active Phase ITT|Lack of Efficacy|1|||
170356626|NCT00603733|615641024|FG001|Active Phase ITT|Lack of Efficacy|2|||
170356627|NCT00603733|615641023|FG000|Active Phase ITT|Subject moved, site closed|1|||
170356628|NCT00603733|615641024|FG001|Active Phase ITT|Subject moved, site closed|1|||
170356629|NCT00603733|615641023|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
170356630|NCT00603733|615641024|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
170356631|NCT00603733|615641023|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
170356632|NCT00603733|615641024|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
170356633|NCT00603733|615641023|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
170356634|NCT00603733|615641024|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
170356635|NCT00603733|615641023|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
170356636|NCT00603733|615641024|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
170356637|NCT00603733|615641023|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
170356638|NCT00603733|615641024|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
170356639|NCT00603733|615641023|FG000|Maintenance Phase ITT|Adverse Event|3|||
170356640|NCT00603733|615641024|FG001|Maintenance Phase ITT|Adverse Event|6|||
170356641|NCT00603733|615641023|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
170356642|NCT00603733|615641024|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
170356643|NCT00603733|615641023|FG000|Maintenance Phase ITT|Protocol Violation|1|||
170356644|NCT00603733|615641024|FG001|Maintenance Phase ITT|Protocol Violation|1|||
170356645|NCT00603733|615641023|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
170356646|NCT00603733|615641024|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
170356647|NCT00603733|615641023|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
170356648|NCT00603733|615641024|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
170356649|NCT00603733|615641023|FG000|Maintenance Phase ITT|Physician Decision|0|||
170356650|NCT00603733|615641024|FG001|Maintenance Phase ITT|Physician Decision|1|||
170356651|NCT00603733|615641023|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
170356652|NCT00603733|615641024|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
170356653|NCT02700919|615641025|FG000|Overall Study|Physician Decision|1|||
170356654|NCT02700919|615641026|FG001|Overall Study|Physician Decision|0|||
170356655|NCT02700919|615641027|FG002|Overall Study|Physician Decision|0|||
170356656|NCT02700919|615641025|FG000|Overall Study|Protocol Violation|1|||
170356657|NCT02700919|615641026|FG001|Overall Study|Protocol Violation|0|||
170356658|NCT02700919|615641027|FG002|Overall Study|Protocol Violation|0|||
170356659|NCT02700919|615641025|FG000|Overall Study|Adverse Event|1|||
170356660|NCT02700919|615641026|FG001|Overall Study|Adverse Event|3|||
170356661|NCT02700919|615641027|FG002|Overall Study|Adverse Event|1|||
170356662|NCT02700919|615641025|FG000|Overall Study|Withdrawal by Subject|5|||
170356663|NCT02700919|615641026|FG001|Overall Study|Withdrawal by Subject|8|||
170356664|NCT02700919|615641027|FG002|Overall Study|Withdrawal by Subject|2|||
170356665|NCT02700919|615641025|FG000|Overall Study|Lost to Follow-up|2|||
170356666|NCT02700919|615641026|FG001|Overall Study|Lost to Follow-up|0|||
170356667|NCT02700919|615641027|FG002|Overall Study|Lost to Follow-up|0|||
170356668|NCT02700919|615641025|FG000|Overall Study|Other|2|||
170356669|NCT02700919|615641026|FG001|Overall Study|Other|1|||
170356670|NCT02700919|615641027|FG002|Overall Study|Other|1|||
170356671|NCT01352845|615641030|FG000|Overall Study|Lost to Follow-up|313|||
170356672|NCT01352845|615641031|FG001|Overall Study|Lost to Follow-up|92|||
170356673|NCT01352845|615641030|FG000|Overall Study|No Longer Willing to Participate|205|||
170356674|NCT01352845|615641031|FG001|Overall Study|No Longer Willing to Participate|58|||
170356675|NCT01352845|615641030|FG000|Overall Study|Withdrawal by Subject|48|||
170356676|NCT01352845|615641031|FG001|Overall Study|Withdrawal by Subject|16|||
170356677|NCT01352845|615641030|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
170356678|NCT01352845|615641031|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
170356679|NCT01352845|615641030|FG000|Overall Study|Pregnancy|27|||
170356680|NCT01352845|615641031|FG001|Overall Study|Pregnancy|7|||
170356681|NCT01352845|615641030|FG000|Overall Study|Adverse Event|22|||
170356682|NCT01352845|615641031|FG001|Overall Study|Adverse Event|6|||
170356683|NCT01352845|615641030|FG000|Overall Study|Other|17|||
170356684|NCT01352845|615641031|FG001|Overall Study|Other|7|||
170356685|NCT01352845|615641030|FG000|Overall Study|Protocol Violation|12|||
170356686|NCT01352845|615641031|FG001|Overall Study|Protocol Violation|6|||
170356687|NCT01352845|615641030|FG000|Overall Study|Death|3|||
170356688|NCT01352845|615641031|FG001|Overall Study|Death|0|||
170356689|NCT02062463|615641032|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
170356690|NCT02062463|615641033|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
170356691|NCT02062463|615641034|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
170356692|NCT02062463|615641035|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
170356693|NCT02062463|615641032|FG000|Stage 2|Adverse Event|0|||
170356694|NCT02062463|615641033|FG001|Stage 2|Adverse Event|0|||
170356695|NCT02062463|615641034|FG002|Stage 2|Adverse Event|12|||
170356696|NCT02062463|615641035|FG003|Stage 2|Adverse Event|20|||
170356697|NCT02062463|615641032|FG000|Stage 2|Lack of Efficacy|0|||
170356698|NCT02062463|615641033|FG001|Stage 2|Lack of Efficacy|0|||
170356699|NCT02062463|615641034|FG002|Stage 2|Lack of Efficacy|3|||
170356700|NCT02062463|615641035|FG003|Stage 2|Lack of Efficacy|4|||
170356701|NCT02062463|615641032|FG000|Stage 2|Lost to Follow-up|0|||
170356702|NCT02062463|615641033|FG001|Stage 2|Lost to Follow-up|0|||
170356703|NCT02062463|615641034|FG002|Stage 2|Lost to Follow-up|20|||
170356704|NCT02062463|615641035|FG003|Stage 2|Lost to Follow-up|20|||
170356705|NCT02062463|615641032|FG000|Stage 2|Non-Compliance|0|||
170356706|NCT02062463|615641033|FG001|Stage 2|Non-Compliance|0|||
170356707|NCT02062463|615641034|FG002|Stage 2|Non-Compliance|0|||
170356708|NCT02062463|615641035|FG003|Stage 2|Non-Compliance|1|||
170356709|NCT02062463|615641032|FG000|Stage 2|Other than specified|0|||
170356710|NCT02062463|615641033|FG001|Stage 2|Other than specified|0|||
170356711|NCT02062463|615641034|FG002|Stage 2|Other than specified|3|||
170356712|NCT02062463|615641035|FG003|Stage 2|Other than specified|1|||
170356713|NCT02062463|615641032|FG000|Stage 2|Withdrawal by Subject|0|||
170356714|NCT02062463|615641033|FG001|Stage 2|Withdrawal by Subject|0|||
170356715|NCT02062463|615641034|FG002|Stage 2|Withdrawal by Subject|15|||
170356716|NCT02062463|615641035|FG003|Stage 2|Withdrawal by Subject|10|||
170356717|NCT00600028|615641040|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
170356718|NCT00600028|615641041|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
170356719|NCT00600028|615641040|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
170356720|NCT00600028|615641041|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
170356721|NCT00600028|615641040|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
170356722|NCT00600028|615641041|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
170356723|NCT02293993|615641042|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
170356724|NCT02293993|615641043|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
170356725|NCT02293993|615641044|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
170356726|NCT02293993|615641045|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
170356727|NCT02293993|615641042|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
170356728|NCT02293993|615641043|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
170356729|NCT02293993|615641044|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
170356730|NCT02293993|615641045|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
170356731|NCT02293993|615641042|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
170356732|NCT02293993|615641043|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
170356733|NCT02293993|615641044|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
170356734|NCT02293993|615641045|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
170356735|NCT02293993|615641042|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
170356736|NCT02293993|615641043|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
170356737|NCT02293993|615641044|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
170356738|NCT02293993|615641045|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
170356739|NCT02293993|615641042|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
170356740|NCT02293993|615641043|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
170356741|NCT02293993|615641044|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
170356742|NCT02293993|615641045|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
170356743|NCT01107405|615641049|FG000|Overall Study|Adverse Event|1|||
170356744|NCT01107405|615641050|FG001|Overall Study|Adverse Event|1|||
170356745|NCT01107405|615641051|FG002|Overall Study|Adverse Event|0|||
170356746|NCT01107405|615641052|FG003|Overall Study|Adverse Event|0|||
170356747|NCT01107405|615641053|FG004|Overall Study|Adverse Event|2|||
170356748|NCT01107405|615641049|FG000|Overall Study|Withdrawal by Subject|1|||
170356749|NCT01107405|615641050|FG001|Overall Study|Withdrawal by Subject|0|||
170356750|NCT01107405|615641051|FG002|Overall Study|Withdrawal by Subject|1|||
170356751|NCT01107405|615641052|FG003|Overall Study|Withdrawal by Subject|2|||
170356752|NCT01107405|615641053|FG004|Overall Study|Withdrawal by Subject|1|||
170356753|NCT01107405|615641049|FG000|Overall Study|Protocol Violation|0|||
170356754|NCT01107405|615641050|FG001|Overall Study|Protocol Violation|0|||
170356755|NCT01107405|615641051|FG002|Overall Study|Protocol Violation|1|||
170356756|NCT01107405|615641052|FG003|Overall Study|Protocol Violation|1|||
170356757|NCT01107405|615641053|FG004|Overall Study|Protocol Violation|0|||
170356758|NCT01895452|615641054|FG000|Overall Study|Adverse Event|1|||
170356759|NCT01895452|615641055|FG001|Overall Study|Adverse Event|4|||
170356760|NCT01895452|615641054|FG000|Overall Study|Lost to Follow-up|1|||
170356761|NCT01895452|615641055|FG001|Overall Study|Lost to Follow-up|5|||
170356762|NCT01895452|615641054|FG000|Overall Study|Pregnancy|0|||
170356763|NCT01895452|615641055|FG001|Overall Study|Pregnancy|1|||
170356764|NCT01895452|615641054|FG000|Overall Study|Withdrawal by Subject|2|||
170356765|NCT01895452|615641055|FG001|Overall Study|Withdrawal by Subject|14|||
170356766|NCT01895452|615641054|FG000|Overall Study|Underlying disease|0|||
170356767|NCT01895452|615641055|FG001|Overall Study|Underlying disease|3|||
170356768|NCT01895452|615641054|FG000|Overall Study|Noncompliance with study drug|0|||
170356769|NCT01895452|615641055|FG001|Overall Study|Noncompliance with study drug|1|||
170356770|NCT01188538|615641060|FG000|Overall Study|Lost to Follow-up|0|||
170356771|NCT01188538|615641061|FG001|Overall Study|Lost to Follow-up|1|||
170356772|NCT01170702|615641062|FG000|Overall Study|Exclusion criteria met after consent|1|||
170356773|NCT01170702|615641063|FG001|Overall Study|Exclusion criteria met after consent|2|||
170356774|NCT01170702|615641064|FG002|Overall Study|Exclusion criteria met after consent|0|||
170356775|NCT01170702|615641065|FG003|Overall Study|Exclusion criteria met after consent|2|||
170356776|NCT01194869|615641066|FG000|Overall Study|Disease Progression|2|||
170356777|NCT01194869|615641066|FG000|Overall Study|Toxicity|2|||
170356778|NCT06964165|615641076|FG000|Overall Study|Death|4|||
170356779|NCT06964165|615641077|FG001|Overall Study|Death|4|||
170356780|NCT06964165|615641076|FG000|Overall Study|Physician Decision|1|||
170356781|NCT06964165|615641077|FG001|Overall Study|Physician Decision|1|||
170356782|NCT06964165|615641076|FG000|Overall Study|Withdrawal by Subject|0|||
170356783|NCT06964165|615641077|FG001|Overall Study|Withdrawal by Subject|2|||
170356784|NCT06964165|615641076|FG000|Overall Study|Study terminated by sponsor|12|||
170356785|NCT06964165|615641077|FG001|Overall Study|Study terminated by sponsor|10|||
170356786|NCT06964165|615641076|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
170356787|NCT06964165|615641077|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
170356788|NCT06964165|615641076|FG000|Overall Study|Participant removed due to non-compliance|0|||
170356789|NCT06964165|615641077|FG001|Overall Study|Participant removed due to non-compliance|1|||
170356790|NCT03589326|615641081|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
170356791|NCT03589326|615641082|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
170356792|NCT03589326|615641081|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
170356793|NCT03589326|615641082|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
170356794|NCT03589326|615641081|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
170356795|NCT03589326|615641082|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
170356796|NCT03589326|615641081|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
170356797|NCT03589326|615641082|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
170356798|NCT03589326|615641081|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
170356799|NCT03589326|615641082|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
170356800|NCT00916370|615641095|FG000|Overall Study|Death|3|||
170356801|NCT00916370|615641096|FG001|Overall Study|Death|1|||
170356802|NCT00916370|615641095|FG000|Overall Study|Withdrawal by Subject|2|||
170356803|NCT00916370|615641096|FG001|Overall Study|Withdrawal by Subject|0|||
170356804|NCT00916370|615641095|FG000|Overall Study|Physician Decision|0|||
170356805|NCT00916370|615641096|FG001|Overall Study|Physician Decision|1|||
170356806|NCT01189435|615641097|FG000|Overall Study|Withdrawal by Subject|1|||
170356807|NCT01189435|615641097|FG000|Overall Study|Physician Decision|1|||
170356808|NCT01586156|615641099|FG000|Overall Study|Pregnancy|0|||
170356809|NCT01586156|615641100|FG001|Overall Study|Pregnancy|1|||
170356810|NCT01586156|615641101|FG002|Overall Study|Pregnancy|0|||
170356811|NCT00363246|615641102|FG000|Overall Study|Death|40|||
170356812|NCT00363246|615641102|FG000|Overall Study|Withdrawal by Subject|19|||
170356813|NCT00363246|615641102|FG000|Overall Study|Lost to Follow-up|14|||
170356814|NCT00363246|615641102|FG000|Overall Study|Bad health|6|||
170356815|NCT00363246|615641102|FG000|Overall Study|Stopped using wheelchair|11|||
170356816|NCT00363246|615641102|FG000|Overall Study|Subject expressed security concerns|2|||
170356817|NCT00363246|615641102|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
170356818|NCT00717366|615641105|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
170356819|NCT00717366|615641106|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
170356820|NCT00717366|615641105|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
170356821|NCT00717366|615641106|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
170356822|NCT00717366|615641105|FG000|Core Study Period (20 Weeks)|Death|0|||
170356823|NCT00717366|615641106|FG001|Core Study Period (20 Weeks)|Death|1|||
170356824|NCT00717366|615641105|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
170356825|NCT00717366|615641106|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
170356826|NCT00717366|615641105|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
170356827|NCT00717366|615641106|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
170356828|NCT00717366|615641105|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
170356829|NCT00717366|615641106|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
170356830|NCT00717366|615641105|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
170356831|NCT00717366|615641106|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
170356832|NCT04348591|615641108|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
170356833|NCT04348591|615641109|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
170356834|NCT04348591|615641108|FG000|Imaging Session (120 Min)|Physician Decision|0|||
170356835|NCT04348591|615641109|FG001|Imaging Session (120 Min)|Physician Decision|1|||
170356836|NCT04348591|615641108|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
170356837|NCT04348591|615641109|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
170356838|NCT02104804|615641110|FG000|Overall Study|Did not take study medication|0|||
170356839|NCT02104804|615641111|FG001|Overall Study|Did not take study medication|1|||
170356840|NCT02104804|615641110|FG000|Overall Study|Study specific discontinuation criteria|6|||
170356841|NCT02104804|615641111|FG001|Overall Study|Study specific discontinuation criteria|1|||
170356842|NCT02104804|615641110|FG000|Overall Study|Other listed|2|||
170356843|NCT02104804|615641111|FG001|Overall Study|Other listed|1|||
170356844|NCT02104804|615641110|FG000|Overall Study|Protocol Violation|0|||
170356845|NCT02104804|615641111|FG001|Overall Study|Protocol Violation|1|||
170356846|NCT02104804|615641110|FG000|Overall Study|Adverse Event|4|||
170356847|NCT02104804|615641111|FG001|Overall Study|Adverse Event|3|||
170356848|NCT02104804|615641110|FG000|Overall Study|Withdrawal by Subject|4|||
170356849|NCT02104804|615641111|FG001|Overall Study|Withdrawal by Subject|12|||
170356850|NCT00645567|615641115|FG000|Overall Study|Adverse Event|1|||
170356851|NCT00434122|615641117|FG000|Overall Study|Non-compliance with protocol|0|||
170356852|NCT00434122|615641118|FG001|Overall Study|Non-compliance with protocol|1|||
170356853|NCT00434122|615641117|FG000|Overall Study|loss of subject contact|1|||
170356854|NCT00434122|615641118|FG001|Overall Study|loss of subject contact|1|||
170356855|NCT00434122|615641117|FG000|Overall Study|Personal reasons|1|||
170356856|NCT00434122|615641118|FG001|Overall Study|Personal reasons|1|||
170356857|NCT00434122|615641117|FG000|Overall Study|Large follicle size|2|||
170356858|NCT00434122|615641118|FG001|Overall Study|Large follicle size|2|||
170356859|NCT00434122|615641117|FG000|Overall Study|Low follicular response.|1|||
170356860|NCT00434122|615641118|FG001|Overall Study|Low follicular response.|2|||
170356861|NCT00434122|615641117|FG000|Overall Study|Travelling of subject.|1|||
170356862|NCT00434122|615641118|FG001|Overall Study|Travelling of subject.|0|||
170356863|NCT01364233|615641119|FG000|Overall Study|Lost to Follow-up|1|||
170356864|NCT00438399|615641120|FG000|Overall Study|Lost to Follow-up|2|||
170356865|NCT00438399|615641121|FG001|Overall Study|Lost to Follow-up|2|||
170356866|NCT00438399|615641122|FG002|Overall Study|Lost to Follow-up|1|||
170356867|NCT00438399|615641123|FG003|Overall Study|Lost to Follow-up|1|||
170356868|NCT00438399|615641124|FG004|Overall Study|Lost to Follow-up|1|||
170356869|NCT00438399|615641125|FG005|Overall Study|Lost to Follow-up|1|||
170356870|NCT00438399|615641120|FG000|Overall Study|Adverse Event|0|||
170356871|NCT00438399|615641121|FG001|Overall Study|Adverse Event|0|||
170356872|NCT00438399|615641122|FG002|Overall Study|Adverse Event|1|||
170356873|NCT00438399|615641123|FG003|Overall Study|Adverse Event|1|||
170356874|NCT00438399|615641124|FG004|Overall Study|Adverse Event|0|||
170356875|NCT00438399|615641125|FG005|Overall Study|Adverse Event|1|||
170356876|NCT00438399|615641120|FG000|Overall Study|Withdrawal by Subject|5|||
170356877|NCT00438399|615641121|FG001|Overall Study|Withdrawal by Subject|6|||
170356878|NCT00438399|615641122|FG002|Overall Study|Withdrawal by Subject|3|||
170356879|NCT00438399|615641123|FG003|Overall Study|Withdrawal by Subject|2|||
170356880|NCT00438399|615641124|FG004|Overall Study|Withdrawal by Subject|2|||
170356881|NCT00438399|615641125|FG005|Overall Study|Withdrawal by Subject|2|||
170356882|NCT00438399|615641120|FG000|Overall Study|Protocol Violation|0|||
170356883|NCT00438399|615641121|FG001|Overall Study|Protocol Violation|0|||
170356884|NCT00438399|615641122|FG002|Overall Study|Protocol Violation|1|||
170356885|NCT00438399|615641123|FG003|Overall Study|Protocol Violation|0|||
170356886|NCT00438399|615641124|FG004|Overall Study|Protocol Violation|0|||
170356887|NCT00438399|615641125|FG005|Overall Study|Protocol Violation|1|||
170356888|NCT00438399|615641120|FG000|Overall Study|Subje stopped study|0|||
170356889|NCT00438399|615641121|FG001|Overall Study|Subje stopped study|0|||
170356890|NCT00438399|615641122|FG002|Overall Study|Subje stopped study|1|||
170356891|NCT00438399|615641123|FG003|Overall Study|Subje stopped study|0|||
170356892|NCT00438399|615641124|FG004|Overall Study|Subje stopped study|0|||
170356893|NCT00438399|615641125|FG005|Overall Study|Subje stopped study|0|||
170356894|NCT00438399|615641120|FG000|Overall Study|Pregnancy|0|||
170356895|NCT00438399|615641121|FG001|Overall Study|Pregnancy|0|||
170356896|NCT00438399|615641122|FG002|Overall Study|Pregnancy|0|||
170356897|NCT00438399|615641123|FG003|Overall Study|Pregnancy|0|||
170356898|NCT00438399|615641124|FG004|Overall Study|Pregnancy|0|||
170356899|NCT00438399|615641125|FG005|Overall Study|Pregnancy|1|||
170356900|NCT00438399|615641120|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
170356901|NCT00438399|615641121|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
170356902|NCT00438399|615641122|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
170356903|NCT00438399|615641123|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
170356904|NCT00438399|615641124|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
170356905|NCT00438399|615641125|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
170356906|NCT03334396|615641130|FG000|Overall Study|Adverse Event|1|||
170356907|NCT03334396|615641131|FG001|Overall Study|Adverse Event|0|||
170356908|NCT03334396|615641132|FG002|Overall Study|Adverse Event|1|||
170356909|NCT03334396|615641133|FG003|Overall Study|Adverse Event|0|||
170356910|NCT03334396|615641134|FG004|Overall Study|Adverse Event|0|||
170356911|NCT03334396|615641135|FG005|Overall Study|Adverse Event|0|||
170356912|NCT03334396|615641136|FG006|Overall Study|Adverse Event|0|||
170356913|NCT03334396|615641137|FG007|Overall Study|Adverse Event|0|||
170356914|NCT03334396|615641130|FG000|Overall Study|Lack of Efficacy|10|||
170356915|NCT03334396|615641131|FG001|Overall Study|Lack of Efficacy|4|||
170356916|NCT03334396|615641132|FG002|Overall Study|Lack of Efficacy|1|||
170356917|NCT03334396|615641133|FG003|Overall Study|Lack of Efficacy|3|||
170356918|NCT03334396|615641134|FG004|Overall Study|Lack of Efficacy|1|||
170356919|NCT03334396|615641135|FG005|Overall Study|Lack of Efficacy|0|||
170356920|NCT03334396|615641136|FG006|Overall Study|Lack of Efficacy|0|||
170356921|NCT03334396|615641137|FG007|Overall Study|Lack of Efficacy|1|||
170356922|NCT03334396|615641130|FG000|Overall Study|Lost to Follow-up|0|||
170356923|NCT03334396|615641131|FG001|Overall Study|Lost to Follow-up|0|||
170356924|NCT03334396|615641132|FG002|Overall Study|Lost to Follow-up|1|||
170356925|NCT03334396|615641133|FG003|Overall Study|Lost to Follow-up|0|||
170356926|NCT03334396|615641134|FG004|Overall Study|Lost to Follow-up|0|||
170356927|NCT03334396|615641135|FG005|Overall Study|Lost to Follow-up|0|||
170356928|NCT03334396|615641136|FG006|Overall Study|Lost to Follow-up|1|||
170356929|NCT03334396|615641137|FG007|Overall Study|Lost to Follow-up|0|||
170356930|NCT03334396|615641130|FG000|Overall Study|Physician Decision|1|||
170356931|NCT03334396|615641131|FG001|Overall Study|Physician Decision|0|||
170356932|NCT03334396|615641132|FG002|Overall Study|Physician Decision|0|||
170356933|NCT03334396|615641133|FG003|Overall Study|Physician Decision|0|||
170356934|NCT03334396|615641134|FG004|Overall Study|Physician Decision|0|||
170356935|NCT03334396|615641135|FG005|Overall Study|Physician Decision|0|||
170356936|NCT03334396|615641136|FG006|Overall Study|Physician Decision|0|||
170356937|NCT03334396|615641137|FG007|Overall Study|Physician Decision|0|||
170356938|NCT03334396|615641130|FG000|Overall Study|Withdrawal by Subject|10|||
170356939|NCT03334396|615641131|FG001|Overall Study|Withdrawal by Subject|5|||
170356940|NCT03334396|615641132|FG002|Overall Study|Withdrawal by Subject|7|||
170356941|NCT03334396|615641133|FG003|Overall Study|Withdrawal by Subject|2|||
170356942|NCT03334396|615641134|FG004|Overall Study|Withdrawal by Subject|2|||
170356943|NCT03334396|615641135|FG005|Overall Study|Withdrawal by Subject|1|||
170356944|NCT03334396|615641136|FG006|Overall Study|Withdrawal by Subject|2|||
170356945|NCT03334396|615641137|FG007|Overall Study|Withdrawal by Subject|0|||
170356946|NCT03334396|615641130|FG000|Overall Study|Pregnancy|0|||
170356947|NCT03334396|615641131|FG001|Overall Study|Pregnancy|1|||
170356948|NCT03334396|615641132|FG002|Overall Study|Pregnancy|0|||
170356949|NCT03334396|615641133|FG003|Overall Study|Pregnancy|0|||
170356950|NCT03334396|615641134|FG004|Overall Study|Pregnancy|0|||
170356951|NCT03334396|615641135|FG005|Overall Study|Pregnancy|0|||
170356952|NCT03334396|615641136|FG006|Overall Study|Pregnancy|0|||
170356953|NCT03334396|615641137|FG007|Overall Study|Pregnancy|0|||
170356954|NCT03334396|615641130|FG000|Overall Study|Ineligible|0|||
170356955|NCT03334396|615641131|FG001|Overall Study|Ineligible|1|||
170356956|NCT03334396|615641132|FG002|Overall Study|Ineligible|0|||
170356957|NCT03334396|615641133|FG003|Overall Study|Ineligible|0|||
170356958|NCT03334396|615641134|FG004|Overall Study|Ineligible|0|||
170356959|NCT03334396|615641135|FG005|Overall Study|Ineligible|0|||
170356960|NCT03334396|615641136|FG006|Overall Study|Ineligible|0|||
170356961|NCT03334396|615641137|FG007|Overall Study|Ineligible|0|||
170356962|NCT03334396|615641130|FG000|Overall Study|Started New Job|1|||
170356963|NCT03334396|615641131|FG001|Overall Study|Started New Job|0|||
170356964|NCT03334396|615641132|FG002|Overall Study|Started New Job|0|||
170356965|NCT03334396|615641133|FG003|Overall Study|Started New Job|0|||
170356966|NCT03334396|615641134|FG004|Overall Study|Started New Job|0|||
170356967|NCT03334396|615641135|FG005|Overall Study|Started New Job|0|||
170356968|NCT03334396|615641136|FG006|Overall Study|Started New Job|0|||
170356969|NCT03334396|615641137|FG007|Overall Study|Started New Job|0|||
170356970|NCT01391819|615641144|FG000|Overall Study|Withdrawal by Subject|56|||
170356971|NCT01391819|615641144|FG000|Overall Study|Migrated/moved from study area|82|||
170356972|NCT01391819|615641144|FG000|Overall Study|Lost to Follow-up|252|||
170356973|NCT01391819|615641144|FG000|Overall Study|Death|3|||
170356974|NCT01391819|615641144|FG000|Overall Study|Other|9|||
170356975|NCT03488251|615641146|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
170356976|NCT03488251|615641147|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
170356977|NCT03488251|615641148|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
170356978|NCT03488251|615641149|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
170356979|NCT03488251|615641146|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
170356980|NCT03488251|615641147|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
170356981|NCT03488251|615641148|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
170356982|NCT03488251|615641149|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
170356983|NCT03488251|615641146|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
170356984|NCT03488251|615641147|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
170356985|NCT03488251|615641148|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
170356986|NCT03488251|615641149|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
170356987|NCT03488251|615641146|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
170356988|NCT03488251|615641147|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
170356989|NCT03488251|615641148|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
170356990|NCT03488251|615641149|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
170356991|NCT03488251|615641146|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
170356992|NCT03488251|615641147|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
170356993|NCT03488251|615641148|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
170356994|NCT03488251|615641149|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
170356995|NCT01766817|615641152|FG000|Overall Study|Drug-related adverse event|1|||
170356996|NCT01766817|615641153|FG001|Overall Study|Drug-related adverse event|2|||
170356997|NCT01766817|615641154|FG002|Overall Study|Drug-related adverse event|1|||
170356998|NCT01766817|615641152|FG000|Overall Study|Drug-unrelated adverse event|3|||
170356999|NCT01766817|615641153|FG001|Overall Study|Drug-unrelated adverse event|3|||
170357000|NCT01766817|615641154|FG002|Overall Study|Drug-unrelated adverse event|3|||
170357001|NCT01766817|615641152|FG000|Overall Study|Death|1|||
170357002|NCT01766817|615641153|FG001|Overall Study|Death|1|||
170357003|NCT01766817|615641154|FG002|Overall Study|Death|0|||
170357004|NCT01766817|615641152|FG000|Overall Study|Unable to take study drug|0|||
170357005|NCT01766817|615641153|FG001|Overall Study|Unable to take study drug|1|||
170357006|NCT01766817|615641154|FG002|Overall Study|Unable to take study drug|0|||
170357007|NCT01766817|615641152|FG000|Overall Study|Withdrawal by Subject|2|||
170357008|NCT01766817|615641153|FG001|Overall Study|Withdrawal by Subject|0|||
170357009|NCT01766817|615641154|FG002|Overall Study|Withdrawal by Subject|3|||
170357010|NCT01766817|615641152|FG000|Overall Study|Subject non-compliance|0|||
170357011|NCT01766817|615641153|FG001|Overall Study|Subject non-compliance|1|||
170357012|NCT01766817|615641154|FG002|Overall Study|Subject non-compliance|2|||
170357013|NCT01766817|615641152|FG000|Overall Study|Physician Decision|3|||
170357014|NCT01766817|615641153|FG001|Overall Study|Physician Decision|3|||
170357015|NCT01766817|615641154|FG002|Overall Study|Physician Decision|4|||
170357016|NCT01766817|615641152|FG000|Overall Study|Other|1|||
170357017|NCT01766817|615641153|FG001|Overall Study|Other|0|||
170357018|NCT01766817|615641154|FG002|Overall Study|Other|0|||
170357019|NCT00995670|615641155|FG000|Overall Study|Failed arterial cannulation|1|||
170357020|NCT00995670|615641156|FG001|Overall Study|Failed arterial cannulation|0|||
170357021|NCT00995670|615641157|FG002|Overall Study|Failed arterial cannulation|3|||
170357022|NCT04971785|615641158|FG000|Overall Study|Withdrew Consent|5|||
170357023|NCT04971785|615641159|FG001|Overall Study|Withdrew Consent|5|||
170357024|NCT04971785|615641160|FG002|Overall Study|Withdrew Consent|17|||
170357025|NCT04971785|615641161|FG003|Overall Study|Withdrew Consent|7|||
170357026|NCT04971785|615641158|FG000|Overall Study|Adverse Event|7|||
170357027|NCT04971785|615641159|FG001|Overall Study|Adverse Event|8|||
170357028|NCT04971785|615641160|FG002|Overall Study|Adverse Event|6|||
170357029|NCT04971785|615641161|FG003|Overall Study|Adverse Event|3|||
170357030|NCT04971785|615641158|FG000|Overall Study|Lost to Follow-up|2|||
170357031|NCT04971785|615641159|FG001|Overall Study|Lost to Follow-up|1|||
170357032|NCT04971785|615641160|FG002|Overall Study|Lost to Follow-up|6|||
170357033|NCT04971785|615641161|FG003|Overall Study|Lost to Follow-up|7|||
170357034|NCT04971785|615641158|FG000|Overall Study|Protocol Violation|3|||
170357035|NCT04971785|615641159|FG001|Overall Study|Protocol Violation|1|||
170357036|NCT04971785|615641160|FG002|Overall Study|Protocol Violation|1|||
170357037|NCT04971785|615641161|FG003|Overall Study|Protocol Violation|2|||
170357038|NCT04971785|615641158|FG000|Overall Study|Investigator's Discretion|3|||
170357039|NCT04971785|615641159|FG001|Overall Study|Investigator's Discretion|1|||
170357040|NCT04971785|615641160|FG002|Overall Study|Investigator's Discretion|1|||
170357041|NCT04971785|615641161|FG003|Overall Study|Investigator's Discretion|0|||
170357042|NCT04971785|615641158|FG000|Overall Study|Randomized but Never Treated|1|||
170357043|NCT04971785|615641159|FG001|Overall Study|Randomized but Never Treated|2|||
170357044|NCT04971785|615641160|FG002|Overall Study|Randomized but Never Treated|0|||
170357045|NCT04971785|615641161|FG003|Overall Study|Randomized but Never Treated|1|||
170357046|NCT04971785|615641158|FG000|Overall Study|Death|0|||
170357047|NCT04971785|615641159|FG001|Overall Study|Death|1|||
170357048|NCT04971785|615641160|FG002|Overall Study|Death|1|||
170357049|NCT04971785|615641161|FG003|Overall Study|Death|0|||
170357050|NCT04971785|615641158|FG000|Overall Study|Site Terminated by Sponsor|1|||
170357051|NCT04971785|615641159|FG001|Overall Study|Site Terminated by Sponsor|1|||
170357052|NCT04971785|615641160|FG002|Overall Study|Site Terminated by Sponsor|0|||
170357053|NCT04971785|615641161|FG003|Overall Study|Site Terminated by Sponsor|0|||
170357054|NCT01283997|615642987|FG000|Overall Study|Physician Decision|8|||
170357055|NCT01283997|615642988|FG001|Overall Study|Physician Decision|10|||
170357056|NCT01283997|615642987|FG000|Overall Study|Withdrawal by Subject|3|||
170357057|NCT01283997|615642988|FG001|Overall Study|Withdrawal by Subject|2|||
170357058|NCT01283997|615642987|FG000|Overall Study|Physically unable to continue|0|||
170357059|NCT01283997|615642988|FG001|Overall Study|Physically unable to continue|1|||
170357060|NCT01283997|615642987|FG000|Overall Study|Progressive disease|1|||
170357061|NCT01283997|615642988|FG001|Overall Study|Progressive disease|0|||
170357062|NCT01283997|615642987|FG000|Overall Study|Other|4|||
170357063|NCT01283997|615642988|FG001|Overall Study|Other|4|||
170357064|NCT00646113|615642991|FG000|Overall Study|Lost to Follow-up|5|||
170357065|NCT00646113|615642991|FG000|Overall Study|Adverse Event|3|||
170357066|NCT04092816|615642992|FG000|Overall Study|Lost to Follow-up|1|||
170357067|NCT04092816|615642993|FG001|Overall Study|Lost to Follow-up|2|||
170357068|NCT04095442|615642994|FG000|Overall Study|Lost to Follow-up|0|||
170357069|NCT04095442|615642995|FG001|Overall Study|Lost to Follow-up|1|||
170357070|NCT04095442|615642994|FG000|Overall Study|Screen failure|1|||
170357071|NCT04095442|615642995|FG001|Overall Study|Screen failure|0|||
170357072|NCT00884221|615643000|FG000|Overall Study|Withdrawal by Subject|0|||
170357073|NCT00884221|615643001|FG001|Overall Study|Withdrawal by Subject|3|||
170357074|NCT00884221|615643000|FG000|Overall Study|Adverse Event|6|||
170357075|NCT00884221|615643001|FG001|Overall Study|Adverse Event|3|||
170357076|NCT00884221|615643000|FG000|Overall Study|Protocol Violation|16|||
170357077|NCT00884221|615643001|FG001|Overall Study|Protocol Violation|13|||
170357078|NCT00884221|615643000|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
170357079|NCT00884221|615643001|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
170357080|NCT01263093|615643004|FG000|Washout|Physician Decision|1|||
170357081|NCT01263093|615643005|FG001|Washout|Physician Decision|0|||
170357082|NCT01263093|615643004|FG000|Period 2|Adverse Event|1|||
170357083|NCT01263093|615643005|FG001|Period 2|Adverse Event|0|||
170357084|NCT03927911|615643006|FG000|Overall Study|problems with eDiary|0|||
170357085|NCT03927911|615643007|FG001|Overall Study|problems with eDiary|1|||
170357086|NCT03927911|615643008|FG002|Overall Study|problems with eDiary|0|||
170357087|NCT03927911|615643009|FG003|Overall Study|problems with eDiary|1|||
170357088|NCT03927911|615643010|FG004|Overall Study|problems with eDiary|0|||
170357089|NCT03927911|615643011|FG005|Overall Study|problems with eDiary|4|||
170357090|NCT03927911|615643006|FG000|Overall Study|Adverse Event|0|||
170357091|NCT03927911|615643007|FG001|Overall Study|Adverse Event|0|||
170357092|NCT03927911|615643008|FG002|Overall Study|Adverse Event|0|||
170357093|NCT03927911|615643009|FG003|Overall Study|Adverse Event|0|||
170357094|NCT03927911|615643010|FG004|Overall Study|Adverse Event|0|||
170357095|NCT03927911|615643011|FG005|Overall Study|Adverse Event|1|||
170357096|NCT03927911|615643006|FG000|Overall Study|not treated -study terminated by sponsor|0|||
170357097|NCT03927911|615643007|FG001|Overall Study|not treated -study terminated by sponsor|1|||
170357098|NCT03927911|615643008|FG002|Overall Study|not treated -study terminated by sponsor|0|||
170357099|NCT03927911|615643009|FG003|Overall Study|not treated -study terminated by sponsor|0|||
170357100|NCT03927911|615643010|FG004|Overall Study|not treated -study terminated by sponsor|0|||
170357101|NCT03927911|615643011|FG005|Overall Study|not treated -study terminated by sponsor|0|||
170357102|NCT03927911|615643006|FG000|Overall Study|Surgery cancelled|0|||
170357103|NCT03927911|615643007|FG001|Overall Study|Surgery cancelled|0|||
170357104|NCT03927911|615643008|FG002|Overall Study|Surgery cancelled|0|||
170357105|NCT03927911|615643009|FG003|Overall Study|Surgery cancelled|1|||
170357106|NCT03927911|615643010|FG004|Overall Study|Surgery cancelled|0|||
170357107|NCT03927911|615643011|FG005|Overall Study|Surgery cancelled|1|||
170357108|NCT03927911|615643006|FG000|Overall Study|Protocol Violation|0|||
170357109|NCT03927911|615643007|FG001|Overall Study|Protocol Violation|0|||
170357110|NCT03927911|615643008|FG002|Overall Study|Protocol Violation|0|||
170357111|NCT03927911|615643009|FG003|Overall Study|Protocol Violation|0|||
170357112|NCT03927911|615643010|FG004|Overall Study|Protocol Violation|0|||
170357113|NCT03927911|615643011|FG005|Overall Study|Protocol Violation|1|||
170357114|NCT02499575|615643012|FG000|Overall Study|Protocol Violation|0|||
170357115|NCT02499575|615643013|FG001|Overall Study|Protocol Violation|1|||
170357116|NCT04656418|615643018|FG000|Overall Study|Withdrawal by Subject|1|||
170357117|NCT04656418|615643019|FG001|Overall Study|Withdrawal by Subject|3|||
170357118|NCT02586077|615643020|FG000|Overall Study|Withdrawal by Subject|1|||
170357119|NCT02586077|615643020|FG000|Overall Study|Physician Decision|4|||
170357120|NCT02586077|615643020|FG000|Overall Study|Lost to Follow-up|3|||
170357121|NCT00949910|615643021|FG000|Overall Study|Progressive Disease|3750|||
170357122|NCT00949910|615643021|FG000|Overall Study|Symptomatic Deterioration|1088|||
170357123|NCT00949910|615643021|FG000|Overall Study|Lost to Follow-up|100|||
170357124|NCT00949910|615643021|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
170357125|NCT00949910|615643021|FG000|Overall Study|Participant Refusal|390|||
170357126|NCT00949910|615643021|FG000|Overall Study|Death Due to Malignant Disease|456|||
170357127|NCT00949910|615643021|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
170357128|NCT00949910|615643021|FG000|Overall Study|Death Due to Adverse Event|115|||
170357129|NCT00949910|615643021|FG000|Overall Study|Death Due to Toxicity|3|||
170357130|NCT00949910|615643021|FG000|Overall Study|Death from Unknown Cause|5|||
170357131|NCT00949910|615643021|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
170357132|NCT00949910|615643021|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
170357133|NCT00949910|615643021|FG000|Overall Study|Switched to Commercial Treatment|4|||
170357134|NCT00949910|615643021|FG000|Overall Study|Violation of Eligibility|23|||
170357135|NCT00949910|615643021|FG000|Overall Study|Logistical Reasons|13|||
170357136|NCT00949910|615643021|FG000|Overall Study|Non-Compliance|10|||
170357137|NCT00949910|615643021|FG000|Overall Study|Prolonged Dosing Interruption|4|||
170357138|NCT00949910|615643021|FG000|Overall Study|Adverse Event|83|||
170357139|NCT00949910|615643021|FG000|Overall Study|Serious Adverse Event|6|||
170357140|NCT00949910|615643021|FG000|Overall Study|Physician/Participant Decision|7|||
170357141|NCT00949910|615643021|FG000|Overall Study|Other|4|||
170357142|NCT00949910|615643021|FG000|Overall Study|No Data|9|||
170357143|NCT02667457|615643022|FG000|Overall Study|Withdrawal by Subject|1|||
170357144|NCT02667457|615643023|FG001|Overall Study|Withdrawal by Subject|0|||
170357145|NCT02667457|615643022|FG000|Overall Study|Other Reason|0|||
170357146|NCT02667457|615643023|FG001|Overall Study|Other Reason|2|||
170357147|NCT03097614|615643025|FG000|Overall Study|Adverse Event|3|||
170357148|NCT03172481|615643034|FG000|Double-blind|Withdrawal by Subject|1|||
170357149|NCT03172481|615643035|FG001|Double-blind|Withdrawal by Subject|0|||
170357150|NCT04124692|615643036|FG000|Overall Study|Medical reason|0|||
170357151|NCT04124692|615643037|FG001|Overall Study|Medical reason|1|||
170357152|NCT04124692|615643036|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
170357153|NCT04124692|615643037|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
170357154|NCT04124692|615643036|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
170357155|NCT04124692|615643037|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
170357156|NCT04124692|615643036|FG000|Overall Study|Lost to Follow-up|2|||
170357157|NCT04124692|615643037|FG001|Overall Study|Lost to Follow-up|4|||
170357158|NCT04124692|615643036|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
170357159|NCT04124692|615643037|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
170357160|NCT02716194|615643038|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
170357161|NCT02716194|615643039|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
170357162|NCT02716194|615643040|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
170357163|NCT00363051|615643041|FG000|Overall Study|Adminstrative problems|1|||
170357164|NCT00363051|615643042|FG001|Overall Study|Adminstrative problems|1|||
170357165|NCT00363051|615643041|FG000|Overall Study|Adverse Event|21|||
170357166|NCT00363051|615643042|FG001|Overall Study|Adverse Event|12|||
170357167|NCT00363051|615643041|FG000|Overall Study|New Cancer Therapy|2|||
170357168|NCT00363051|615643042|FG001|Overall Study|New Cancer Therapy|1|||
170357169|NCT00363051|615643041|FG000|Overall Study|Withdrawal by Subject|11|||
170357170|NCT00363051|615643042|FG001|Overall Study|Withdrawal by Subject|3|||
170357171|NCT00363051|615643041|FG000|Overall Study|Lost to Follow-up|0|||
170357172|NCT00363051|615643042|FG001|Overall Study|Lost to Follow-up|1|||
170357173|NCT00363051|615643041|FG000|Overall Study|Protocol Violation|0|||
170357174|NCT00363051|615643042|FG001|Overall Study|Protocol Violation|2|||
170357175|NCT00363051|615643041|FG000|Overall Study|Death|3|||
170357176|NCT00363051|615643042|FG001|Overall Study|Death|2|||
170357177|NCT02528253|615643045|FG000|Overall Study|Adverse Event|3|||
170357178|NCT02528253|615643046|FG001|Overall Study|Adverse Event|4|||
170357179|NCT02528253|615643047|FG002|Overall Study|Adverse Event|4|||
170357180|NCT02528253|615643048|FG003|Overall Study|Adverse Event|8|||
170357181|NCT02528253|615643049|FG004|Overall Study|Adverse Event|18|||
170357182|NCT02528253|615643045|FG000|Overall Study|Death|2|||
170357183|NCT02528253|615643046|FG001|Overall Study|Death|2|||
170357184|NCT02528253|615643047|FG002|Overall Study|Death|1|||
170357185|NCT02528253|615643048|FG003|Overall Study|Death|0|||
170357186|NCT02528253|615643049|FG004|Overall Study|Death|1|||
170357187|NCT02528253|615643045|FG000|Overall Study|Insufficient clinical response|7|||
170357188|NCT02528253|615643046|FG001|Overall Study|Insufficient clinical response|10|||
170357189|NCT02528253|615643047|FG002|Overall Study|Insufficient clinical response|13|||
170357190|NCT02528253|615643048|FG003|Overall Study|Insufficient clinical response|12|||
170357191|NCT02528253|615643049|FG004|Overall Study|Insufficient clinical response|16|||
170357192|NCT02528253|615643045|FG000|Overall Study|Lost to Follow-up|16|||
170357193|NCT02528253|615643046|FG001|Overall Study|Lost to Follow-up|9|||
170357194|NCT02528253|615643047|FG002|Overall Study|Lost to Follow-up|31|||
170357195|NCT02528253|615643048|FG003|Overall Study|Lost to Follow-up|16|||
170357196|NCT02528253|615643049|FG004|Overall Study|Lost to Follow-up|34|||
170357197|NCT02528253|615643045|FG000|Overall Study|Other|21|||
170357198|NCT02528253|615643046|FG001|Overall Study|Other|22|||
170357199|NCT02528253|615643047|FG002|Overall Study|Other|58|||
170357200|NCT02528253|615643048|FG003|Overall Study|Other|52|||
170357201|NCT02528253|615643049|FG004|Overall Study|Other|76|||
170357202|NCT02528253|615643045|FG000|Overall Study|Withdrawal by Subject|25|||
170357203|NCT02528253|615643046|FG001|Overall Study|Withdrawal by Subject|20|||
170357204|NCT02528253|615643047|FG002|Overall Study|Withdrawal by Subject|29|||
170357205|NCT02528253|615643048|FG003|Overall Study|Withdrawal by Subject|48|||
170357206|NCT02528253|615643049|FG004|Overall Study|Withdrawal by Subject|73|||
170357207|NCT02528253|615643045|FG000|Overall Study|Protocol Violation|1|||
170357208|NCT02528253|615643046|FG001|Overall Study|Protocol Violation|2|||
170357209|NCT02528253|615643047|FG002|Overall Study|Protocol Violation|4|||
170357210|NCT02528253|615643048|FG003|Overall Study|Protocol Violation|0|||
170357211|NCT02528253|615643049|FG004|Overall Study|Protocol Violation|4|||
170357212|NCT02528253|615643045|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
170357213|NCT02528253|615643046|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
170357214|NCT02528253|615643047|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
170357215|NCT02528253|615643048|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
170357216|NCT02528253|615643049|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
170357217|NCT00830115|615643050|FG000|Overall Study|Adverse Event|2|||
170357218|NCT00830115|615643050|FG000|Overall Study|Improvement/recovery|1|||
170357219|NCT01925612|615643052|FG000|Overall Study|Progressive Disease|1|||
170357220|NCT01925612|615643053|FG001|Overall Study|Progressive Disease|1|||
170357221|NCT01925612|615643054|FG002|Overall Study|Progressive Disease|1|||
170357222|NCT01925612|615643055|FG003|Overall Study|Progressive Disease|0|||
170357223|NCT01925612|615643056|FG004|Overall Study|Progressive Disease|0|||
170357224|NCT01925612|615643052|FG000|Overall Study|Adverse Event|3|||
170357225|NCT01925612|615643053|FG001|Overall Study|Adverse Event|3|||
170357226|NCT01925612|615643054|FG002|Overall Study|Adverse Event|0|||
170357227|NCT01925612|615643055|FG003|Overall Study|Adverse Event|1|||
170357228|NCT01925612|615643056|FG004|Overall Study|Adverse Event|2|||
170357229|NCT05136170|615643065|FG000|Overall Study|Withdrawal by Subject|2|||
170357230|NCT05136170|615643066|FG001|Overall Study|Withdrawal by Subject|2|||
170357231|NCT05136170|615643065|FG000|Overall Study|Can no longer make office visits|1|||
170357232|NCT05136170|615643066|FG001|Overall Study|Can no longer make office visits|0|||
170357233|NCT01207388|615643067|FG000|Overall Study|Death|67|||
170357234|NCT01207388|615643067|FG000|Overall Study|Withdrawal by Subject|1|||
170357235|NCT01610076|615643068|FG000|Overall Study|Technical issue with video|0|||
170357236|NCT01610076|615643069|FG001|Overall Study|Technical issue with video|1|||
170357237|NCT01610076|615643068|FG000|Overall Study|Lost to Follow-up|3|||
170357238|NCT01610076|615643069|FG001|Overall Study|Lost to Follow-up|4|||
170357239|NCT02168803|615643070|FG000|Overall Study|Lost to Follow-up|1|||
170357240|NCT02168803|615643071|FG001|Overall Study|Lost to Follow-up|0|||
170357241|NCT02168803|615643072|FG002|Overall Study|Lost to Follow-up|1|||
170357242|NCT02168803|615643070|FG000|Overall Study|Withdrawal by Subject|1|||
170357243|NCT02168803|615643071|FG001|Overall Study|Withdrawal by Subject|1|||
170357244|NCT02168803|615643072|FG002|Overall Study|Withdrawal by Subject|2|||
170357245|NCT02168803|615643070|FG000|Overall Study|Physician Decision|0|||
170357246|NCT02168803|615643071|FG001|Overall Study|Physician Decision|1|||
170357247|NCT02168803|615643072|FG002|Overall Study|Physician Decision|0|||
170357248|NCT02168803|615643070|FG000|Overall Study|Adverse Event|0|||
170357249|NCT02168803|615643071|FG001|Overall Study|Adverse Event|1|||
170357250|NCT02168803|615643072|FG002|Overall Study|Adverse Event|1|||
170357251|NCT02168803|615643070|FG000|Overall Study|Death|0|||
170357252|NCT02168803|615643071|FG001|Overall Study|Death|0|||
170357253|NCT02168803|615643072|FG002|Overall Study|Death|1|||
170357254|NCT02168803|615643070|FG000|Overall Study|Sponsor Decision|0|||
170357255|NCT02168803|615643071|FG001|Overall Study|Sponsor Decision|0|||
170357256|NCT02168803|615643072|FG002|Overall Study|Sponsor Decision|1|||
170357257|NCT00980343|615643073|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
170357258|NCT00980343|615643074|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
170357259|NCT02310906|615643077|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
170357260|NCT02310906|615643078|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
170357261|NCT02310906|615643079|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
170357262|NCT02310906|615643080|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
170357263|NCT02310906|615643077|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
170357264|NCT02310906|615643078|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
170357265|NCT02310906|615643079|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
170357266|NCT02310906|615643080|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
170357267|NCT02310906|615643077|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
170357268|NCT02310906|615643078|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
170357269|NCT02310906|615643079|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
170357270|NCT02310906|615643080|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
170357271|NCT02310906|615643077|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
170357272|NCT02310906|615643078|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
170357273|NCT02310906|615643079|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
170357274|NCT02310906|615643080|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
170357275|NCT00433446|615643081|FG000|Overall Study|Adverse Event|4|||
170357276|NCT00433446|615643081|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
170357277|NCT00433446|615643081|FG000|Overall Study|Progression|44|||
170357278|NCT00433446|615643081|FG000|Overall Study|Other - Not Protocol specified|3|||
170357279|NCT00433446|615643081|FG000|Overall Study|Ineligible|9|||
170357280|NCT02899377|615643082|FG000|Overall Study|Adverse Event|1|||
170357281|NCT02899377|615643083|FG001|Overall Study|Adverse Event|0|||
170357282|NCT01231607|615643084|FG000|Overall Study|Adverse Event|0|||
170357283|NCT01231607|615643085|FG001|Overall Study|Adverse Event|8|||
170357284|NCT01231607|615643086|FG002|Overall Study|Adverse Event|4|||
170357285|NCT01231607|615643087|FG003|Overall Study|Adverse Event|4|||
170357286|NCT01231607|615643088|FG004|Overall Study|Adverse Event|5|||
170357287|NCT01231607|615643084|FG000|Overall Study|Lost to Follow-up|13|||
170357288|NCT01231607|615643085|FG001|Overall Study|Lost to Follow-up|11|||
170357289|NCT01231607|615643086|FG002|Overall Study|Lost to Follow-up|10|||
170357290|NCT01231607|615643087|FG003|Overall Study|Lost to Follow-up|10|||
170357291|NCT01231607|615643088|FG004|Overall Study|Lost to Follow-up|4|||
170357292|NCT01231607|615643084|FG000|Overall Study|Physician Decision|4|||
170357293|NCT01231607|615643085|FG001|Overall Study|Physician Decision|4|||
170357294|NCT01231607|615643086|FG002|Overall Study|Physician Decision|3|||
170357295|NCT01231607|615643087|FG003|Overall Study|Physician Decision|5|||
170357296|NCT01231607|615643088|FG004|Overall Study|Physician Decision|4|||
170357297|NCT01231607|615643084|FG000|Overall Study|Protocol Violation|3|||
170357298|NCT01231607|615643085|FG001|Overall Study|Protocol Violation|2|||
170357299|NCT01231607|615643086|FG002|Overall Study|Protocol Violation|0|||
170357300|NCT01231607|615643087|FG003|Overall Study|Protocol Violation|2|||
170357301|NCT01231607|615643088|FG004|Overall Study|Protocol Violation|2|||
170357302|NCT01231607|615643084|FG000|Overall Study|Withdrawal by Subject|9|||
170357303|NCT01231607|615643085|FG001|Overall Study|Withdrawal by Subject|9|||
170357304|NCT01231607|615643086|FG002|Overall Study|Withdrawal by Subject|14|||
170357305|NCT01231607|615643087|FG003|Overall Study|Withdrawal by Subject|17|||
170357306|NCT01231607|615643088|FG004|Overall Study|Withdrawal by Subject|9|||
170357307|NCT06245044|615643094|FG000|No MI help|Technical issues|18|||
170357308|NCT01082367|615643097|FG000|Double-blind Period|Administrative problems|0|||
170357309|NCT01082367|615643098|FG001|Double-blind Period|Administrative problems|1|||
170357310|NCT01082367|615643097|FG000|Double-blind Period|Lack of Efficacy|5|||
170357311|NCT01082367|615643098|FG001|Double-blind Period|Lack of Efficacy|11|||
170357312|NCT01082367|615643097|FG000|Double-blind Period|Adverse Event|0|||
170357313|NCT01082367|615643098|FG001|Double-blind Period|Adverse Event|1|||
170357314|NCT01082367|615643097|FG000|Follow-up (F-U) Period|Administrative problems|1|||
170357315|NCT01082367|615643098|FG001|Follow-up (F-U) Period|Administrative problems|0|||
170357316|NCT01082367|615643097|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
170357317|NCT01082367|615643098|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
170357318|NCT01082367|615643097|FG000|Follow-up (F-U) Period|Adverse Event|0|||
170357319|NCT01082367|615643098|FG001|Follow-up (F-U) Period|Adverse Event|1|||
170357320|NCT00098020|615643101|FG000|Overall Study|Adverse Event|2|||
170357321|NCT00098020|615643101|FG000|Overall Study|Lost to Follow-up|1|||
170357322|NCT00098020|615643101|FG000|Overall Study|elevated liver enzymes|1|||
170357323|NCT00098020|615643101|FG000|Overall Study|Low urine PCR|1|||
170357324|NCT00098020|615643101|FG000|Overall Study|Low epidermal growth factor receptor|1|||
170357325|NCT06087328|615643103|FG000|28-Day Treatment|Lost to Follow-up|7|||
170357326|NCT06087328|615643104|FG001|28-Day Treatment|Lost to Follow-up|3|||
170357327|NCT06087328|615643105|FG002|28-Day Treatment|Lost to Follow-up|4|||
170357328|NCT06087328|615643103|FG000|1-month Follow-up|Lost to Follow-up|0|||
170357329|NCT06087328|615643104|FG001|1-month Follow-up|Lost to Follow-up|1|||
170357330|NCT06087328|615643105|FG002|1-month Follow-up|Lost to Follow-up|1|||
170357331|NCT01551758|615643106|FG000|Overall Study|Adverse Event|29|||
170357332|NCT01551758|615643107|FG001|Overall Study|Adverse Event|43|||
170357333|NCT01551758|615643106|FG000|Overall Study|Lack of Efficacy|0|||
170357334|NCT01551758|615643107|FG001|Overall Study|Lack of Efficacy|1|||
170357335|NCT01551758|615643106|FG000|Overall Study|Protocol Violation|5|||
170357336|NCT01551758|615643107|FG001|Overall Study|Protocol Violation|6|||
170357337|NCT01551758|615643106|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
170357338|NCT01551758|615643107|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
170357339|NCT01551758|615643106|FG000|Overall Study|Lost to Follow-up|29|||
170357340|NCT01551758|615643107|FG001|Overall Study|Lost to Follow-up|25|||
170357341|NCT01551758|615643106|FG000|Overall Study|Physician Decision|9|||
170357342|NCT01551758|615643107|FG001|Overall Study|Physician Decision|3|||
170357343|NCT01551758|615643106|FG000|Overall Study|Withdrawal by Subject|14|||
170357344|NCT01551758|615643107|FG001|Overall Study|Withdrawal by Subject|17|||
170357345|NCT01968954|615643110|FG000|Overall Study|Adverse Event|6|||
170357346|NCT01968954|615643111|FG001|Overall Study|Adverse Event|3|||
170357347|NCT01968954|615643110|FG000|Overall Study|Death|1|||
170357348|NCT01968954|615643111|FG001|Overall Study|Death|2|||
170357349|NCT01968954|615643110|FG000|Overall Study|Lost to Follow-up|6|||
170357350|NCT01968954|615643111|FG001|Overall Study|Lost to Follow-up|4|||
170357351|NCT01968954|615643110|FG000|Overall Study|Withdrawal by Subject|20|||
170357352|NCT01968954|615643111|FG001|Overall Study|Withdrawal by Subject|23|||
170357353|NCT01968954|615643110|FG000|Overall Study|Other|7|||
170357354|NCT01968954|615643111|FG001|Overall Study|Other|8|||
170357355|NCT01968954|615643110|FG000|Overall Study|Protocol Violation|0|||
170357356|NCT01968954|615643111|FG001|Overall Study|Protocol Violation|1|||
170357357|NCT01968954|615643110|FG000|Overall Study|Did not met inclusion criteria|0|||
170357358|NCT01968954|615643111|FG001|Overall Study|Did not met inclusion criteria|2|||
170357359|NCT05294211|615643112|FG000|Overall Study|Withdrawal by Subject|3|||
170357360|NCT05294211|615643112|FG000|Overall Study|Physician Decision|2|||
170357361|NCT05294211|615643112|FG000|Overall Study|Progressed to active labor|1|||
170357362|NCT05294211|615643112|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
170357363|NCT05294211|615643112|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
170357364|NCT03629041|615643113|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
170357365|NCT03629041|615643114|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
170357366|NCT03629041|615643115|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
170357367|NCT03629041|615643116|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
170357368|NCT03519516|615643117|FG000|Overall Study|Adverse Event|0|||
170357369|NCT03519516|615643118|FG001|Overall Study|Adverse Event|1|||
170357370|NCT03829332|615643119|FG000|Overall Study|Death|225|||
170357371|NCT03829332|615643120|FG001|Overall Study|Death|230|||
170357372|NCT03829332|615643119|FG000|Overall Study|Lost to Follow-up|1|||
170357373|NCT03829332|615643120|FG001|Overall Study|Lost to Follow-up|3|||
170357374|NCT03829332|615643119|FG000|Overall Study|Physician Decision|1|||
170357375|NCT03829332|615643120|FG001|Overall Study|Physician Decision|0|||
170357376|NCT03829332|615643119|FG000|Overall Study|Sponsor Decision|71|||
170357377|NCT03829332|615643120|FG001|Overall Study|Sponsor Decision|72|||
170357378|NCT03829332|615643119|FG000|Overall Study|Withdrawal by Subject|11|||
170357379|NCT03829332|615643120|FG001|Overall Study|Withdrawal by Subject|9|||
170357380|NCT05654623|615643951|FG000|Treatment|Randomized but not treated|1|||
170357381|NCT05654623|615643952|FG001|Treatment|Randomized but not treated|4|||
170357382|NCT05654623|615643951|FG000|Treatment|Adverse Event|7|||
170357383|NCT05654623|615643952|FG001|Treatment|Adverse Event|2|||
170357384|NCT05654623|615643951|FG000|Treatment|Death|2|||
170357385|NCT05654623|615643952|FG001|Treatment|Death|0|||
170357386|NCT05654623|615643951|FG000|Treatment|Physician Decision|2|||
170357387|NCT05654623|615643952|FG001|Treatment|Physician Decision|3|||
170357388|NCT05654623|615643951|FG000|Treatment|Progressive disease|189|||
170357389|NCT05654623|615643952|FG001|Treatment|Progressive disease|209|||
170357390|NCT05654623|615643951|FG000|Treatment|Protocol Violation|2|||
170357391|NCT05654623|615643952|FG001|Treatment|Protocol Violation|0|||
170357392|NCT05654623|615643951|FG000|Treatment|Withdrawal by Subject|9|||
170357393|NCT05654623|615643952|FG001|Treatment|Withdrawal by Subject|7|||
170357394|NCT05654623|615643951|FG000|Treatment|Global deterioration of health status|5|||
170357395|NCT05654623|615643952|FG001|Treatment|Global deterioration of health status|9|||
170357396|NCT05654623|615643951|FG000|Treatment|Other|0|||
170357397|NCT05654623|615643952|FG001|Treatment|Other|1|||
170357398|NCT05654623|615643951|FG000|Treatment|Ongoing|96|||
170357399|NCT05654623|615643952|FG001|Treatment|Ongoing|76|||
170357400|NCT05654623|615643951|FG000|Follow-up|Death|43|||
170357401|NCT05654623|615643952|FG001|Follow-up|Death|35|||
170357402|NCT05654623|615643951|FG000|Follow-up|Lost to Follow-up|0|||
170357403|NCT05654623|615643952|FG001|Follow-up|Lost to Follow-up|1|||
170357404|NCT05654623|615643951|FG000|Follow-up|Withdrawal by Subject|1|||
170357405|NCT05654623|615643952|FG001|Follow-up|Withdrawal by Subject|2|||
170357406|NCT05654623|615643951|FG000|Follow-up|Ongoing|161|||
170357407|NCT05654623|615643952|FG001|Follow-up|Ongoing|186|||
170357408|NCT05666713|615643957|FG000|Overall Study|Withdrawal by Subject|1|||
170357409|NCT01956240|615643960|FG000|Overall Study|Lost to Follow-up|6|||
170357410|NCT01956240|615643961|FG001|Overall Study|Lost to Follow-up|20|||
170357411|NCT01956240|615643960|FG000|Overall Study|Adverse Event|17|||
170357412|NCT01956240|615643961|FG001|Overall Study|Adverse Event|4|||
170357413|NCT00971425|615643964|FG000|Overall Study|Adverse Event|1|||
170357414|NCT00971425|615643965|FG001|Overall Study|Adverse Event|1|||
170357415|NCT00971425|615643964|FG000|Overall Study|Withdrawal by Subject|0|||
170357416|NCT00971425|615643965|FG001|Overall Study|Withdrawal by Subject|1|||
170357417|NCT02759562|615643969|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
170357418|NCT02759562|615643970|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
170357419|NCT02759562|615643969|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
170357420|NCT02759562|615643970|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
170357421|NCT01957709|615643971|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
170357422|NCT01061736|615643978|FG000|Overall Study|Dose regimen not selected|0|||
170357423|NCT01061736|615643979|FG001|Overall Study|Dose regimen not selected|0|||
170357424|NCT01061736|615643980|FG002|Overall Study|Dose regimen not selected|0|||
170357425|NCT01061736|615643981|FG003|Overall Study|Dose regimen not selected|0|||
170357426|NCT01061736|615643982|FG004|Overall Study|Dose regimen not selected|0|||
170357427|NCT01061736|615643983|FG005|Overall Study|Dose regimen not selected|0|||
170357428|NCT01061736|615643984|FG006|Overall Study|Dose regimen not selected|79|||
170357429|NCT01061736|615643985|FG007|Overall Study|Dose regimen not selected|0|||
170357430|NCT01061736|615643986|FG008|Overall Study|Dose regimen not selected|0|||
170357431|NCT01061736|615643987|FG009|Overall Study|Dose regimen not selected|0|||
170357432|NCT01061736|615643978|FG000|Overall Study|Adverse Event|13|||
170357433|NCT01061736|615643979|FG001|Overall Study|Adverse Event|1|||
170357434|NCT01061736|615643980|FG002|Overall Study|Adverse Event|3|||
170357435|NCT01061736|615643981|FG003|Overall Study|Adverse Event|2|||
170357436|NCT01061736|615643982|FG004|Overall Study|Adverse Event|4|||
170357437|NCT01061736|615643983|FG005|Overall Study|Adverse Event|1|||
170357438|NCT01061736|615643984|FG006|Overall Study|Adverse Event|4|||
170357439|NCT01061736|615643985|FG007|Overall Study|Adverse Event|63|||
170357440|NCT01061736|615643986|FG008|Overall Study|Adverse Event|67|||
170357441|NCT01061736|615643987|FG009|Overall Study|Adverse Event|34|||
170357442|NCT01061736|615643978|FG000|Overall Study|Lack of Efficacy|0|||
170357443|NCT01061736|615643979|FG001|Overall Study|Lack of Efficacy|2|||
170357444|NCT01061736|615643980|FG002|Overall Study|Lack of Efficacy|1|||
170357445|NCT01061736|615643981|FG003|Overall Study|Lack of Efficacy|1|||
170357446|NCT01061736|615643982|FG004|Overall Study|Lack of Efficacy|1|||
170357447|NCT01061736|615643983|FG005|Overall Study|Lack of Efficacy|2|||
170357448|NCT01061736|615643984|FG006|Overall Study|Lack of Efficacy|1|||
170357449|NCT01061736|615643985|FG007|Overall Study|Lack of Efficacy|9|||
170357450|NCT01061736|615643986|FG008|Overall Study|Lack of Efficacy|9|||
170357451|NCT01061736|615643987|FG009|Overall Study|Lack of Efficacy|10|||
170357452|NCT01061736|615643978|FG000|Overall Study|Poor compliance to protocol|0|||
170357453|NCT01061736|615643979|FG001|Overall Study|Poor compliance to protocol|0|||
170357454|NCT01061736|615643980|FG002|Overall Study|Poor compliance to protocol|0|||
170357455|NCT01061736|615643981|FG003|Overall Study|Poor compliance to protocol|0|||
170357456|NCT01061736|615643982|FG004|Overall Study|Poor compliance to protocol|0|||
170357457|NCT01061736|615643983|FG005|Overall Study|Poor compliance to protocol|0|||
170357458|NCT01061736|615643984|FG006|Overall Study|Poor compliance to protocol|0|||
170357459|NCT01061736|615643985|FG007|Overall Study|Poor compliance to protocol|2|||
170357460|NCT01061736|615643986|FG008|Overall Study|Poor compliance to protocol|5|||
170357461|NCT01061736|615643987|FG009|Overall Study|Poor compliance to protocol|9|||
170357462|NCT01061736|615643978|FG000|Overall Study|Not treated|0|||
170357463|NCT01061736|615643979|FG001|Overall Study|Not treated|0|||
170357464|NCT01061736|615643980|FG002|Overall Study|Not treated|0|||
170357465|NCT01061736|615643981|FG003|Overall Study|Not treated|0|||
170357466|NCT01061736|615643982|FG004|Overall Study|Not treated|1|||
170357467|NCT01061736|615643983|FG005|Overall Study|Not treated|0|||
170357468|NCT01061736|615643984|FG006|Overall Study|Not treated|0|||
170357469|NCT01061736|615643985|FG007|Overall Study|Not treated|2|||
170357470|NCT01061736|615643986|FG008|Overall Study|Not treated|1|||
170357471|NCT01061736|615643987|FG009|Overall Study|Not treated|0|||
170357472|NCT01061736|615643978|FG000|Overall Study|Other than specified above|0|||
170357473|NCT01061736|615643979|FG001|Overall Study|Other than specified above|1|||
170357474|NCT01061736|615643980|FG002|Overall Study|Other than specified above|2|||
170357475|NCT01061736|615643981|FG003|Overall Study|Other than specified above|0|||
170357476|NCT01061736|615643982|FG004|Overall Study|Other than specified above|1|||
170357477|NCT01061736|615643983|FG005|Overall Study|Other than specified above|0|||
170357478|NCT01061736|615643984|FG006|Overall Study|Other than specified above|0|||
170357479|NCT01061736|615643985|FG007|Overall Study|Other than specified above|18|||
170357480|NCT01061736|615643986|FG008|Overall Study|Other than specified above|15|||
170357481|NCT01061736|615643987|FG009|Overall Study|Other than specified above|21|||
170357482|NCT00132314|615643988|FG000|Overall Study|Lost to Follow-up|70|||
170357483|NCT00132314|615643989|FG001|Overall Study|Lost to Follow-up|62|||
170357484|NCT00132314|615643988|FG000|Overall Study|Lacked SSN|1|||
170357485|NCT00132314|615643989|FG001|Overall Study|Lacked SSN|3|||
170357486|NCT00132314|615643988|FG000|Overall Study|Refused intervention at baseline|2|||
170357487|NCT00132314|615643989|FG001|Overall Study|Refused intervention at baseline|7|||
170357488|NCT01093755|615644003|FG000|Overall Study|Withdrawal by Subject|3|||
170357489|NCT01093755|615644004|FG001|Overall Study|Withdrawal by Subject|4|||
170357490|NCT04999969|615644008|FG000|Overall Study|Death|76|||
170357491|NCT04999969|615644008|FG000|Overall Study|Progressive Disease|1|||
170357492|NCT04999969|615644008|FG000|Overall Study|Withdrawal by Subject|8|||
170357493|NCT05998395|615644010|FG000|Overall Study|Physician Decision|1|||
170357494|NCT03659916|615644011|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
170357495|NCT03659916|615644012|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
170357496|NCT03659916|615644013|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
170357497|NCT03659916|615644011|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
170357498|NCT03659916|615644012|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
170357499|NCT03659916|615644013|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
170357500|NCT03659916|615644011|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
170357501|NCT03659916|615644012|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
170357502|NCT03659916|615644013|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
170357503|NCT03659916|615644011|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
170357504|NCT03659916|615644012|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
170357505|NCT03659916|615644013|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
170357506|NCT03659916|615644011|FG000|Treatment Period (72 Weeks)|Other|1|||
170357507|NCT03659916|615644012|FG001|Treatment Period (72 Weeks)|Other|3|||
170357508|NCT03659916|615644013|FG002|Treatment Period (72 Weeks)|Other|9|||
170357509|NCT03659916|615644011|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
170357510|NCT03659916|615644012|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
170357511|NCT03659916|615644013|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
170357512|NCT03659916|615644011|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
170357513|NCT03659916|615644012|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
170357514|NCT03659916|615644013|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
170357515|NCT03659916|615644011|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
170357516|NCT03659916|615644012|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
170357517|NCT03659916|615644013|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
170357518|NCT03659916|615644011|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
170357519|NCT03659916|615644012|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
170357520|NCT03659916|615644013|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
170357521|NCT03659916|615644011|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
170357522|NCT03659916|615644012|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
170357523|NCT03659916|615644013|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
170357524|NCT03659916|615644011|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
170357525|NCT03659916|615644012|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
170357526|NCT03659916|615644013|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
170357527|NCT04308681|615644014|FG000|Pre-Treatment|Not reported|1|||
170357528|NCT04308681|615644015|FG001|Pre-Treatment|Not reported|1|||
170357529|NCT04308681|615644016|FG002|Pre-Treatment|Not reported|0|||
170357530|NCT04308681|615644017|FG003|Pre-Treatment|Not reported|0|||
170357531|NCT04308681|615644018|FG004|Pre-Treatment|Not reported|0|||
170357532|NCT04308681|615644019|FG005|Pre-Treatment|Not reported|2|||
170357533|NCT04308681|615644020|FG006|Pre-Treatment|Not reported|0|||
170357534|NCT04308681|615644021|FG007|Pre-Treatment|Not reported|0|||
170357535|NCT04308681|615644014|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
170357536|NCT04308681|615644015|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
170357537|NCT04308681|615644016|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
170357538|NCT04308681|615644017|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
170357539|NCT04308681|615644018|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
170357540|NCT04308681|615644019|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
170357541|NCT04308681|615644020|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
170357542|NCT04308681|615644021|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
170357543|NCT04308681|615644014|FG000|Treatment up to Week 26|Other reasons|2|||
170357544|NCT04308681|615644015|FG001|Treatment up to Week 26|Other reasons|0|||
170357545|NCT04308681|615644016|FG002|Treatment up to Week 26|Other reasons|0|||
170357546|NCT04308681|615644017|FG003|Treatment up to Week 26|Other reasons|0|||
170357547|NCT04308681|615644018|FG004|Treatment up to Week 26|Other reasons|1|||
170357548|NCT04308681|615644019|FG005|Treatment up to Week 26|Other reasons|1|||
170357549|NCT04308681|615644020|FG006|Treatment up to Week 26|Other reasons|0|||
170357550|NCT04308681|615644021|FG007|Treatment up to Week 26|Other reasons|0|||
170357551|NCT04308681|615644014|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
170357552|NCT04308681|615644015|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
170357553|NCT04308681|615644016|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
170357554|NCT04308681|615644017|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
170357555|NCT04308681|615644018|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
170357556|NCT04308681|615644019|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
170357557|NCT04308681|615644020|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
170357558|NCT04308681|615644021|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
170357559|NCT04308681|615644014|FG000|Treatment up to Week 26|Adverse Event|6|||
170357560|NCT04308681|615644015|FG001|Treatment up to Week 26|Adverse Event|5|||
170357561|NCT04308681|615644016|FG002|Treatment up to Week 26|Adverse Event|5|||
170357562|NCT04308681|615644017|FG003|Treatment up to Week 26|Adverse Event|0|||
170357563|NCT04308681|615644018|FG004|Treatment up to Week 26|Adverse Event|6|||
170357564|NCT04308681|615644019|FG005|Treatment up to Week 26|Adverse Event|1|||
170357565|NCT04308681|615644020|FG006|Treatment up to Week 26|Adverse Event|0|||
170357566|NCT04308681|615644021|FG007|Treatment up to Week 26|Adverse Event|0|||
170357567|NCT04308681|615644014|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
170357568|NCT04308681|615644015|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
170357569|NCT04308681|615644016|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
170357570|NCT04308681|615644017|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
170357571|NCT04308681|615644018|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
170357572|NCT04308681|615644019|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
170357573|NCT04308681|615644020|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
170357574|NCT04308681|615644021|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
170357575|NCT04308681|615644014|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
170357576|NCT04308681|615644015|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
170357577|NCT04308681|615644016|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
170357578|NCT04308681|615644017|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
170357579|NCT04308681|615644018|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
170357580|NCT04308681|615644019|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
170357581|NCT04308681|615644020|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
170357582|NCT04308681|615644021|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
170357583|NCT04308681|615644014|FG000|OTE - 26 Weeks|Death|0|||
170357584|NCT04308681|615644015|FG001|OTE - 26 Weeks|Death|1|||
170357585|NCT04308681|615644016|FG002|OTE - 26 Weeks|Death|0|||
170357586|NCT04308681|615644017|FG003|OTE - 26 Weeks|Death|0|||
170357587|NCT04308681|615644018|FG004|OTE - 26 Weeks|Death|0|||
170357588|NCT04308681|615644019|FG005|OTE - 26 Weeks|Death|0|||
170357589|NCT04308681|615644020|FG006|OTE - 26 Weeks|Death|1|||
170357590|NCT04308681|615644021|FG007|OTE - 26 Weeks|Death|0|||
170357591|NCT04308681|615644014|FG000|OTE - 26 Weeks|Adverse Event|0|||
170357592|NCT04308681|615644015|FG001|OTE - 26 Weeks|Adverse Event|2|||
170357593|NCT04308681|615644016|FG002|OTE - 26 Weeks|Adverse Event|8|||
170357594|NCT04308681|615644017|FG003|OTE - 26 Weeks|Adverse Event|3|||
170357595|NCT04308681|615644018|FG004|OTE - 26 Weeks|Adverse Event|0|||
170357596|NCT04308681|615644019|FG005|OTE - 26 Weeks|Adverse Event|1|||
170357597|NCT04308681|615644020|FG006|OTE - 26 Weeks|Adverse Event|2|||
170357598|NCT04308681|615644021|FG007|OTE - 26 Weeks|Adverse Event|0|||
170357599|NCT04308681|615644014|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
170357600|NCT04308681|615644015|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
170357601|NCT04308681|615644016|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
170357602|NCT04308681|615644017|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
170357603|NCT04308681|615644018|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
170357604|NCT04308681|615644019|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
170357605|NCT04308681|615644020|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
170357606|NCT04308681|615644021|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
170357607|NCT03008278|615644024|FG000|Overall Study|Progressive Disease|0|||
170357608|NCT03008278|615644025|FG001|Overall Study|Progressive Disease|0|||
170357609|NCT03008278|615644026|FG002|Overall Study|Progressive Disease|32|||
170357610|NCT03008278|615644024|FG000|Overall Study|Adverse Event|0|||
170357611|NCT03008278|615644025|FG001|Overall Study|Adverse Event|0|||
170357612|NCT03008278|615644026|FG002|Overall Study|Adverse Event|4|||
170357613|NCT03008278|615644024|FG000|Overall Study|Withdrawal by Subject|0|||
170357614|NCT03008278|615644025|FG001|Overall Study|Withdrawal by Subject|0|||
170357615|NCT03008278|615644026|FG002|Overall Study|Withdrawal by Subject|3|||
170357616|NCT03008278|615644024|FG000|Overall Study|Physician Decision|0|||
170357617|NCT03008278|615644025|FG001|Overall Study|Physician Decision|2|||
170357618|NCT03008278|615644026|FG002|Overall Study|Physician Decision|0|||
170357619|NCT02246621|615644027|FG000|Overall Study|Withdrawal by Subject|28|||
170357620|NCT02246621|615644028|FG001|Overall Study|Withdrawal by Subject|16|||
170357621|NCT02246621|615644027|FG000|Overall Study|Lost to Follow-up|1|||
170357622|NCT02246621|615644028|FG001|Overall Study|Lost to Follow-up|0|||
170357623|NCT02246621|615644027|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
170357624|NCT02246621|615644028|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
170357625|NCT04113018|615644029|FG000|Overall Study|Death|2|||
170357626|NCT04113018|615644029|FG000|Overall Study|Lost to Follow-up|1|||
170357627|NCT04113018|615644029|FG000|Overall Study|Still On Study (on study treatment)|24|||
170357628|NCT04113018|615644029|FG000|Overall Study|Still On Study (in follow up)|12|||
170357629|NCT03670641|615644030|FG000|Overall Study|Lost to Follow-up|3|||
170357630|NCT00264849|615644031|FG000|Overall Study|Adverse Event|7|||
170357631|NCT00264849|615644032|FG001|Overall Study|Adverse Event|2|||
170357632|NCT00264849|615644031|FG000|Overall Study|Withdrawal by Subject|7|||
170357633|NCT00264849|615644032|FG001|Overall Study|Withdrawal by Subject|11|||
170357634|NCT00264849|615644031|FG000|Overall Study|Protocol Violation|5|||
170357635|NCT00264849|615644032|FG001|Overall Study|Protocol Violation|3|||
170357636|NCT00264849|615644031|FG000|Overall Study|Lack of Efficacy|1|||
170357637|NCT00264849|615644032|FG001|Overall Study|Lack of Efficacy|6|||
170357638|NCT00264849|615644031|FG000|Overall Study|Lost to Follow-up|0|||
170357639|NCT00264849|615644032|FG001|Overall Study|Lost to Follow-up|2|||
170357640|NCT00264849|615644031|FG000|Overall Study|Death|0|||
170357641|NCT00264849|615644032|FG001|Overall Study|Death|1|||
170357642|NCT00264849|615644031|FG000|Overall Study|Administrative Problems|2|||
170357643|NCT00264849|615644032|FG001|Overall Study|Administrative Problems|0|||
170357644|NCT00406783|615644034|FG000|Overall Study|Adverse Event|4|||
170357645|NCT00406783|615644035|FG001|Overall Study|Adverse Event|4|||
170357646|NCT00406783|615644034|FG000|Overall Study|Treatment Failure|2|||
170357647|NCT00406783|615644035|FG001|Overall Study|Treatment Failure|3|||
170357648|NCT00406783|615644034|FG000|Overall Study|Lost to Follow-up|3|||
170357649|NCT00406783|615644035|FG001|Overall Study|Lost to Follow-up|0|||
170357650|NCT00406783|615644034|FG000|Overall Study|Withdrawal by Subject|1|||
170357651|NCT00406783|615644035|FG001|Overall Study|Withdrawal by Subject|4|||
170357652|NCT00406783|615644034|FG000|Overall Study|Protocol Violation|4|||
170357653|NCT00406783|615644035|FG001|Overall Study|Protocol Violation|4|||
170357654|NCT03730194|615644036|FG000|First Stage Treatment|Withdrawal by Subject|1|||
170357655|NCT03730194|615644037|FG001|First Stage Treatment|Withdrawal by Subject|1|||
170357656|NCT03730194|615644038|FG002|First Stage Treatment|Withdrawal by Subject|0|||
170357657|NCT03730194|615644039|FG003|First Stage Treatment|Withdrawal by Subject|0|||
170357658|NCT03730194|615644040|FG004|First Stage Treatment|Withdrawal by Subject|0|||
170357659|NCT03730194|615644041|FG005|First Stage Treatment|Withdrawal by Subject|0|||
170357660|NCT03730194|615644036|FG000|First Stage Treatment|Protocol Violation|3|||
170357661|NCT03730194|615644037|FG001|First Stage Treatment|Protocol Violation|3|||
170357662|NCT03730194|615644038|FG002|First Stage Treatment|Protocol Violation|0|||
170357663|NCT03730194|615644039|FG003|First Stage Treatment|Protocol Violation|0|||
170357664|NCT03730194|615644040|FG004|First Stage Treatment|Protocol Violation|0|||
170357665|NCT03730194|615644041|FG005|First Stage Treatment|Protocol Violation|0|||
170357666|NCT01752842|615644042|FG000|Overall Study|Adverse Event|3|||
170357667|NCT01752842|615644043|FG001|Overall Study|Adverse Event|0|||
170357668|NCT01752842|615644042|FG000|Overall Study|Withdrawal by Subject|0|||
170357669|NCT01752842|615644043|FG001|Overall Study|Withdrawal by Subject|2|||
170357670|NCT05584202|615644044|FG000|Overall Study|Withdrawal of Consent|3|||
170357671|NCT05584202|615644045|FG001|Overall Study|Withdrawal of Consent|2|||
170357672|NCT05584202|615644044|FG000|Overall Study|Lost to Follow-up|2|||
170357673|NCT05584202|615644045|FG001|Overall Study|Lost to Follow-up|1|||
170357674|NCT05584202|615644044|FG000|Overall Study|Death|0|||
170357675|NCT05584202|615644045|FG001|Overall Study|Death|1|||
170357676|NCT03287869|615644561|FG000|Overall Study|Adverse Event|14|||
170357677|NCT03287869|615644562|FG001|Overall Study|Adverse Event|12|||
170357678|NCT03287869|615644561|FG000|Overall Study|Lack of Efficacy|1|||
170357679|NCT03287869|615644562|FG001|Overall Study|Lack of Efficacy|0|||
170357680|NCT03287869|615644561|FG000|Overall Study|Lost to Follow-up|13|||
170357681|NCT03287869|615644562|FG001|Overall Study|Lost to Follow-up|19|||
170357682|NCT03287869|615644561|FG000|Overall Study|Non-Compliance With Study Drug|5|||
170357683|NCT03287869|615644562|FG001|Overall Study|Non-Compliance With Study Drug|9|||
170357684|NCT03287869|615644561|FG000|Overall Study|Progressive Disease|1|||
170357685|NCT03287869|615644562|FG001|Overall Study|Progressive Disease|0|||
170357686|NCT03287869|615644561|FG000|Overall Study|Protocol Deviation|2|||
170357687|NCT03287869|615644562|FG001|Overall Study|Protocol Deviation|1|||
170357688|NCT03287869|615644561|FG000|Overall Study|Withdrawal by Subject|36|||
170357689|NCT03287869|615644562|FG001|Overall Study|Withdrawal by Subject|43|||
170357690|NCT03287869|615644561|FG000|Overall Study|Early Closure of the Site|0|||
170357691|NCT03287869|615644562|FG001|Overall Study|Early Closure of the Site|1|||
170357692|NCT03287869|615644561|FG000|Overall Study|Physician Decision|5|||
170357693|NCT03287869|615644562|FG001|Overall Study|Physician Decision|5|||
170357694|NCT03287869|615644561|FG000|Overall Study|Reason not Specified|6|||
170357695|NCT03287869|615644562|FG001|Overall Study|Reason not Specified|3|||
170357696|NCT03115112|615644566|FG000|Overall Study|Adverse Event|5|||
170357697|NCT03115112|615644567|FG001|Overall Study|Adverse Event|1|||
170357698|NCT03115112|615644566|FG000|Overall Study|Withdrawal by Subject|4|||
170357699|NCT03115112|615644567|FG001|Overall Study|Withdrawal by Subject|2|||
170357700|NCT03115112|615644566|FG000|Overall Study|Lost to Follow-up|0|||
170357701|NCT03115112|615644567|FG001|Overall Study|Lost to Follow-up|1|||
170357702|NCT03115112|615644566|FG000|Overall Study|Death|1|||
170357703|NCT03115112|615644567|FG001|Overall Study|Death|0|||
170357704|NCT03115112|615644566|FG000|Overall Study|Pregnancy|1|||
170357705|NCT03115112|615644567|FG001|Overall Study|Pregnancy|0|||
170357706|NCT03115112|615644566|FG000|Overall Study|Site closure|1|||
170357707|NCT03115112|615644567|FG001|Overall Study|Site closure|1|||
170357708|NCT05587296|615644568|FG000|Overall Study|Adverse Event|15|||
170357709|NCT05587296|615644569|FG001|Overall Study|Adverse Event|7|||
170357710|NCT05587296|615644568|FG000|Overall Study|Lack of Efficacy|2|||
170357711|NCT05587296|615644569|FG001|Overall Study|Lack of Efficacy|0|||
170357712|NCT05587296|615644568|FG000|Overall Study|Lost to Follow-up|1|||
170357713|NCT05587296|615644569|FG001|Overall Study|Lost to Follow-up|0|||
170357714|NCT05587296|615644568|FG000|Overall Study|Withdrawal by Subject|14|||
170357715|NCT05587296|615644569|FG001|Overall Study|Withdrawal by Subject|4|||
170357716|NCT05587296|615644568|FG000|Overall Study|miscellaneous|3|||
170357717|NCT05587296|615644569|FG001|Overall Study|miscellaneous|6|||
170357718|NCT05587296|615644568|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
170357719|NCT05587296|615644569|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
170357720|NCT04157348|615644570|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
170357721|NCT04157348|615644571|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
170357722|NCT04157348|615644570|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
170357723|NCT04157348|615644571|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
170357724|NCT04157348|615644570|FG000|Double-blind Treatment Period|Adverse Event|0|||
170357725|NCT04157348|615644571|FG001|Double-blind Treatment Period|Adverse Event|1|||
170357726|NCT04157348|615644570|FG000|Open-label Extension Period|Adverse Event|1|||
170357727|NCT04157348|615644571|FG001|Open-label Extension Period|Adverse Event|1|||
170357728|NCT04157348|615644570|FG000|Open-label Extension Period|Death|0|||
170357729|NCT04157348|615644571|FG001|Open-label Extension Period|Death|1|||
170357730|NCT04157348|615644570|FG000|Open-label Extension Period|Lack of Efficacy|2|||
170357731|NCT04157348|615644571|FG001|Open-label Extension Period|Lack of Efficacy|2|||
170357732|NCT04157348|615644570|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
170357733|NCT04157348|615644571|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
170357734|NCT04157348|615644570|FG000|Open-label Extension Period|Ongoing|60|||
170357735|NCT04157348|615644571|FG001|Open-label Extension Period|Ongoing|57|||
170357736|NCT04157348|615644570|FG000|Open-label Extension Period|other reasons|1|||
170357737|NCT04157348|615644571|FG001|Open-label Extension Period|other reasons|1|||
170357738|NCT05489081|615644574|FG000|Overall Study|student left classroom|0|||
170357739|NCT05489081|615644575|FG001|Overall Study|student left classroom|1|||
170357740|NCT05489081|615644574|FG000|Overall Study|teacher left school|0|||
170357741|NCT05489081|615644575|FG001|Overall Study|teacher left school|2|||
170357742|NCT00400712|615644587|FG000|Overall Study|Death|1|||
170357743|NCT00400712|615644588|FG001|Overall Study|Death|0|||
170357744|NCT00400712|615644587|FG000|Overall Study|Withdrawal by Subject|11|||
170357745|NCT00400712|615644588|FG001|Overall Study|Withdrawal by Subject|12|||
170357746|NCT00400712|615644587|FG000|Overall Study|Physician Decision|5|||
170357747|NCT00400712|615644588|FG001|Overall Study|Physician Decision|4|||
170357748|NCT02670330|615644589|FG000|Overall Study|Protocol Deviation|1|||
170357749|NCT02670330|615644590|FG001|Overall Study|Protocol Deviation|0|||
170357750|NCT02670330|615644589|FG000|Overall Study|Study Terminated By Sponsor|36|||
170357751|NCT02670330|615644590|FG001|Overall Study|Study Terminated By Sponsor|43|||
170357752|NCT02670330|615644589|FG000|Overall Study|Adverse Event|1|||
170357753|NCT02670330|615644590|FG001|Overall Study|Adverse Event|3|||
170357754|NCT02670330|615644589|FG000|Overall Study|Withdrawal by Subject|34|||
170357755|NCT02670330|615644590|FG001|Overall Study|Withdrawal by Subject|29|||
170357756|NCT02670330|615644589|FG000|Overall Study|Lost to Follow-up|3|||
170357757|NCT02670330|615644590|FG001|Overall Study|Lost to Follow-up|2|||
170357758|NCT06605768|615644591|FG000|Overall Study|Adverse Event|1|||
170357759|NCT06605768|615644592|FG001|Overall Study|Adverse Event|1|||
170357760|NCT06605768|615644591|FG000|Overall Study|Lost to Follow-up|0|||
170357761|NCT06605768|615644592|FG001|Overall Study|Lost to Follow-up|1|||
170357762|NCT04647253|615644595|FG000|Overall Study|Death ≤ 365 Days|16|||
170357763|NCT04647253|615644596|FG001|Overall Study|Death ≤ 365 Days|7|||
170357764|NCT04647253|615644595|FG000|Overall Study|Physician Decision|0|||
170357765|NCT04647253|615644596|FG001|Overall Study|Physician Decision|1|||
170357766|NCT04647253|615644595|FG000|Overall Study|Withdrawal by Subject|7|||
170357767|NCT04647253|615644596|FG001|Overall Study|Withdrawal by Subject|2|||
170357768|NCT04647253|615644595|FG000|Overall Study|Missed 12-Month Visit|9|||
170357769|NCT04647253|615644596|FG001|Overall Study|Missed 12-Month Visit|7|||
170357770|NCT04647253|615644595|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
170357771|NCT04647253|615644596|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
170357772|NCT02843178|615645972|FG000|Overall Study|Lost to Follow-up|8|||
170357773|NCT02843178|615645973|FG001|Overall Study|Lost to Follow-up|8|||
170357774|NCT02843178|615645974|FG002|Overall Study|Lost to Follow-up|6|||
170357775|NCT02843178|615645975|FG003|Overall Study|Lost to Follow-up|3|||
170357776|NCT02843178|615645972|FG000|Overall Study|Withdrawal by Subject|0|||
170357777|NCT02843178|615645973|FG001|Overall Study|Withdrawal by Subject|0|||
170357778|NCT02843178|615645974|FG002|Overall Study|Withdrawal by Subject|1|||
170357779|NCT02843178|615645975|FG003|Overall Study|Withdrawal by Subject|1|||
170357780|NCT02420795|615645980|FG000|Overall Study|Withdrawal by Subject|1|||
170357781|NCT02420795|615645981|FG001|Overall Study|Withdrawal by Subject|0|||
170357782|NCT02420795|615645982|FG002|Overall Study|Withdrawal by Subject|0|||
170357783|NCT02420795|615645980|FG000|Overall Study|Adverse Event|1|||
170357784|NCT02420795|615645981|FG001|Overall Study|Adverse Event|0|||
170357785|NCT02420795|615645982|FG002|Overall Study|Adverse Event|0|||
170357786|NCT02420795|615645980|FG000|Overall Study|Progressive disease|2|||
170357787|NCT02420795|615645981|FG001|Overall Study|Progressive disease|2|||
170357788|NCT02420795|615645982|FG002|Overall Study|Progressive disease|4|||
170357789|NCT02420795|615645980|FG000|Overall Study|Death|0|||
170357790|NCT02420795|615645981|FG001|Overall Study|Death|0|||
170357791|NCT02420795|615645982|FG002|Overall Study|Death|1|||
170357792|NCT02658968|615645983|FG000|Received Rituximab|Adverse Event|0|||
170357793|NCT02658968|615645984|FG001|Received Rituximab|Adverse Event|0|||
170357794|NCT02658968|615645985|FG002|Received Rituximab|Adverse Event|0|||
170357795|NCT02658968|615645986|FG003|Received Rituximab|Adverse Event|0|||
170357796|NCT02658968|615645987|FG004|Received Rituximab|Adverse Event|1|||
170357797|NCT02658968|615645983|FG000|Received Rituximab|Progressive disease|0|||
170357798|NCT02658968|615645984|FG001|Received Rituximab|Progressive disease|0|||
170357799|NCT02658968|615645985|FG002|Received Rituximab|Progressive disease|0|||
170357800|NCT02658968|615645986|FG003|Received Rituximab|Progressive disease|0|||
170357801|NCT02658968|615645987|FG004|Received Rituximab|Progressive disease|1|||
170357802|NCT02658968|615645983|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
170357803|NCT02658968|615645984|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
170357804|NCT02658968|615645985|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
170357805|NCT02658968|615645986|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
170357806|NCT02658968|615645987|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
170357807|NCT02658968|615645983|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
170357808|NCT02658968|615645984|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
170357809|NCT02658968|615645985|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
170357810|NCT02658968|615645986|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
170357811|NCT02658968|615645987|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
170357812|NCT02658968|615645983|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
170357813|NCT02658968|615645984|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
170357814|NCT02658968|615645985|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
170357815|NCT02658968|615645986|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
170357816|NCT02658968|615645987|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
170357817|NCT02658968|615645983|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
170357818|NCT02658968|615645984|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
170357819|NCT02658968|615645985|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
170357820|NCT02658968|615645986|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
170357821|NCT02658968|615645987|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
170357822|NCT02658968|615645983|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
170357823|NCT02658968|615645984|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
170357824|NCT02658968|615645985|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
170357825|NCT02658968|615645986|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
170357826|NCT02658968|615645987|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
170357827|NCT00094835|615645993|FG000|Overall Study|Physician Decision|1|||
170357828|NCT00094835|615645994|FG001|Overall Study|Physician Decision|0|||
170357829|NCT00094835|615645995|FG002|Overall Study|Physician Decision|0|||
170357830|NCT00094835|615645996|FG003|Overall Study|Physician Decision|0|||
170357831|NCT00094835|615645997|FG004|Overall Study|Physician Decision|0|||
170357832|NCT00094835|615645998|FG005|Overall Study|Physician Decision|1|||
170357833|NCT00094835|615645999|FG006|Overall Study|Physician Decision|0|||
170357834|NCT00094835|615645993|FG000|Overall Study|Withdrawal by Subject|0|||
170357835|NCT00094835|615645994|FG001|Overall Study|Withdrawal by Subject|0|||
170357836|NCT00094835|615645995|FG002|Overall Study|Withdrawal by Subject|0|||
170357837|NCT00094835|615645996|FG003|Overall Study|Withdrawal by Subject|0|||
170357838|NCT00094835|615645997|FG004|Overall Study|Withdrawal by Subject|0|||
170357839|NCT00094835|615645998|FG005|Overall Study|Withdrawal by Subject|0|||
170357840|NCT00094835|615645999|FG006|Overall Study|Withdrawal by Subject|1|||
170357841|NCT00094835|615645993|FG000|Overall Study|Lost to Follow-up|0|||
170357842|NCT00094835|615645994|FG001|Overall Study|Lost to Follow-up|0|||
170357843|NCT00094835|615645995|FG002|Overall Study|Lost to Follow-up|0|||
170357844|NCT00094835|615645996|FG003|Overall Study|Lost to Follow-up|0|||
170357845|NCT00094835|615645997|FG004|Overall Study|Lost to Follow-up|1|||
170357846|NCT00094835|615645998|FG005|Overall Study|Lost to Follow-up|0|||
170357847|NCT00094835|615645999|FG006|Overall Study|Lost to Follow-up|0|||
170357848|NCT00094835|615645993|FG000|Overall Study|Death|1|||
170357849|NCT00094835|615645994|FG001|Overall Study|Death|0|||
170357850|NCT00094835|615645995|FG002|Overall Study|Death|0|||
170357851|NCT00094835|615645996|FG003|Overall Study|Death|0|||
170357852|NCT00094835|615645997|FG004|Overall Study|Death|1|||
170357853|NCT00094835|615645998|FG005|Overall Study|Death|0|||
170357854|NCT00094835|615645999|FG006|Overall Study|Death|0|||
170357855|NCT00094835|615645993|FG000|Overall Study|Non-compliance|1|||
170357856|NCT00094835|615645994|FG001|Overall Study|Non-compliance|2|||
170357857|NCT00094835|615645995|FG002|Overall Study|Non-compliance|2|||
170357858|NCT00094835|615645996|FG003|Overall Study|Non-compliance|0|||
170357859|NCT00094835|615645997|FG004|Overall Study|Non-compliance|2|||
170357860|NCT00094835|615645998|FG005|Overall Study|Non-compliance|2|||
170357861|NCT00094835|615645999|FG006|Overall Study|Non-compliance|1|||
170357862|NCT00094835|615645993|FG000|Overall Study|Other|1|||
170357863|NCT00094835|615645994|FG001|Overall Study|Other|1|||
170357864|NCT00094835|615645995|FG002|Overall Study|Other|1|||
170357865|NCT00094835|615645996|FG003|Overall Study|Other|1|||
170357866|NCT00094835|615645997|FG004|Overall Study|Other|0|||
170357867|NCT00094835|615645998|FG005|Overall Study|Other|0|||
170357868|NCT00094835|615645999|FG006|Overall Study|Other|0|||
170357869|NCT00387348|615646000|FG000|Overall Study|Death|1|||
170357870|NCT00387348|615646001|FG001|Overall Study|Death|1|||
170357871|NCT00387348|615646002|FG002|Overall Study|Death|0|||
170357872|NCT00387348|615646000|FG000|Overall Study|Physician Decision|1|||
170357873|NCT00387348|615646001|FG001|Overall Study|Physician Decision|0|||
170357874|NCT00387348|615646002|FG002|Overall Study|Physician Decision|1|||
170357875|NCT00387348|615646000|FG000|Overall Study|Withdrawal by Subject|0|||
170357876|NCT00387348|615646001|FG001|Overall Study|Withdrawal by Subject|2|||
170357877|NCT00387348|615646002|FG002|Overall Study|Withdrawal by Subject|2|||
170357878|NCT00387348|615646000|FG000|Overall Study|Adverse Event|1|||
170357879|NCT00387348|615646001|FG001|Overall Study|Adverse Event|0|||
170357880|NCT00387348|615646002|FG002|Overall Study|Adverse Event|1|||
170357881|NCT03628599|615646003|FG000|Overall Study|Adverse Event|0|||
170357882|NCT03628599|615646004|FG001|Overall Study|Adverse Event|1|||
170357883|NCT01624506|615646005|FG000|Overall Study|Lost to Follow-up|29|||
170357884|NCT01624506|615646006|FG001|Overall Study|Lost to Follow-up|15|||
170357885|NCT01624506|615646005|FG000|Overall Study|Withdrawal by Subject|9|||
170357886|NCT01624506|615646006|FG001|Overall Study|Withdrawal by Subject|2|||
170357887|NCT01624506|615646005|FG000|Overall Study|Death|1|||
170357888|NCT01624506|615646006|FG001|Overall Study|Death|0|||
170357889|NCT01624506|615646005|FG000|Overall Study|LINX explants|23|||
170357890|NCT01624506|615646006|FG001|Overall Study|LINX explants|0|||
170357891|NCT01624506|615646005|FG000|Overall Study|Adverse Event|3|||
170357892|NCT01624506|615646006|FG001|Overall Study|Adverse Event|0|||
170357893|NCT01149343|615646007|FG000|Overall Study|Withdrawal by Subject|1|||
170357894|NCT01149343|615646008|FG001|Overall Study|Withdrawal by Subject|1|||
170357895|NCT01149343|615646009|FG002|Overall Study|Withdrawal by Subject|1|||
170357896|NCT01149343|615646010|FG003|Overall Study|Withdrawal by Subject|5|||
170357897|NCT01149343|615646007|FG000|Overall Study|Death|10|||
170357898|NCT01149343|615646008|FG001|Overall Study|Death|13|||
170357899|NCT01149343|615646009|FG002|Overall Study|Death|18|||
170357900|NCT01149343|615646010|FG003|Overall Study|Death|18|||
170357901|NCT01149343|615646007|FG000|Overall Study|Lost to Follow-up|1|||
170357902|NCT01149343|615646008|FG001|Overall Study|Lost to Follow-up|0|||
170357903|NCT01149343|615646009|FG002|Overall Study|Lost to Follow-up|0|||
170357904|NCT01149343|615646010|FG003|Overall Study|Lost to Follow-up|1|||
170357905|NCT01149343|615646007|FG000|Overall Study|Other|8|||
170357906|NCT01149343|615646008|FG001|Overall Study|Other|10|||
170357907|NCT01149343|615646009|FG002|Overall Study|Other|2|||
170357908|NCT01149343|615646010|FG003|Overall Study|Other|14|||
170357909|NCT01149343|615646007|FG000|Overall Study|Sponsor study termination|0|||
170357910|NCT01149343|615646008|FG001|Overall Study|Sponsor study termination|0|||
170357911|NCT01149343|615646009|FG002|Overall Study|Sponsor study termination|0|||
170357912|NCT01149343|615646010|FG003|Overall Study|Sponsor study termination|2|||
170357913|NCT01149343|615646007|FG000|Overall Study|Recurrence / Progressive disease|0|||
170357914|NCT01149343|615646008|FG001|Overall Study|Recurrence / Progressive disease|0|||
170357915|NCT01149343|615646009|FG002|Overall Study|Recurrence / Progressive disease|1|||
170357916|NCT01149343|615646010|FG003|Overall Study|Recurrence / Progressive disease|0|||
170357917|NCT01653158|615646024|FG000|Overall Study|Death|0|||
170357918|NCT01653158|615646025|FG001|Overall Study|Death|0|||
170357919|NCT01653158|615646026|FG002|Overall Study|Death|0|||
170357920|NCT01653158|615646027|FG003|Overall Study|Death|1|||
170357921|NCT01653158|615646028|FG004|Overall Study|Death|0|||
170357922|NCT01653158|615646029|FG005|Overall Study|Death|0|||
170357923|NCT01653158|615646030|FG006|Overall Study|Death|0|||
170357924|NCT01653158|615646031|FG007|Overall Study|Death|2|||
170357925|NCT01653158|615646024|FG000|Overall Study|Adverse Event|0|||
170357926|NCT01653158|615646025|FG001|Overall Study|Adverse Event|0|||
170357927|NCT01653158|615646026|FG002|Overall Study|Adverse Event|0|||
170357928|NCT01653158|615646027|FG003|Overall Study|Adverse Event|1|||
170357929|NCT01653158|615646028|FG004|Overall Study|Adverse Event|0|||
170357930|NCT01653158|615646029|FG005|Overall Study|Adverse Event|0|||
170357931|NCT01653158|615646030|FG006|Overall Study|Adverse Event|0|||
170357932|NCT01653158|615646031|FG007|Overall Study|Adverse Event|3|||
170357933|NCT01653158|615646024|FG000|Overall Study|Other|0|||
170357934|NCT01653158|615646025|FG001|Overall Study|Other|0|||
170357935|NCT01653158|615646026|FG002|Overall Study|Other|0|||
170357936|NCT01653158|615646027|FG003|Overall Study|Other|0|||
170357937|NCT01653158|615646028|FG004|Overall Study|Other|0|||
170357938|NCT01653158|615646029|FG005|Overall Study|Other|0|||
170357939|NCT01653158|615646030|FG006|Overall Study|Other|0|||
170357940|NCT01653158|615646031|FG007|Overall Study|Other|1|||
170357941|NCT01653158|615646024|FG000|Overall Study|Progressive disease|0|||
170357942|NCT01653158|615646025|FG001|Overall Study|Progressive disease|0|||
170357943|NCT01653158|615646026|FG002|Overall Study|Progressive disease|0|||
170357944|NCT01653158|615646027|FG003|Overall Study|Progressive disease|0|||
170357945|NCT01653158|615646028|FG004|Overall Study|Progressive disease|1|||
170357946|NCT01653158|615646029|FG005|Overall Study|Progressive disease|1|||
170357947|NCT01653158|615646030|FG006|Overall Study|Progressive disease|2|||
170357948|NCT01653158|615646031|FG007|Overall Study|Progressive disease|9|||
170357949|NCT01653158|615646024|FG000|Overall Study|Withdrawal by Subject|1|||
170357950|NCT01653158|615646025|FG001|Overall Study|Withdrawal by Subject|0|||
170357951|NCT01653158|615646026|FG002|Overall Study|Withdrawal by Subject|0|||
170357952|NCT01653158|615646027|FG003|Overall Study|Withdrawal by Subject|0|||
170357953|NCT01653158|615646028|FG004|Overall Study|Withdrawal by Subject|0|||
170357954|NCT01653158|615646029|FG005|Overall Study|Withdrawal by Subject|0|||
170357955|NCT01653158|615646030|FG006|Overall Study|Withdrawal by Subject|0|||
170357956|NCT01653158|615646031|FG007|Overall Study|Withdrawal by Subject|0|||
170357957|NCT04116073|615646038|FG000|Overall Study|Withdrawal by Subject|2|||
170357958|NCT04116073|615646038|FG000|Overall Study|failed to maintained eligibility|1|||
170357959|NCT04321252|615646041|FG000|Overall Study|Withdrawal by Subject|0|||
170357960|NCT04321252|615646042|FG001|Overall Study|Withdrawal by Subject|0|||
170357961|NCT04321252|615646043|FG002|Overall Study|Withdrawal by Subject|0|||
170357962|NCT04321252|615646044|FG003|Overall Study|Withdrawal by Subject|0|||
170357963|NCT04321252|615646045|FG004|Overall Study|Withdrawal by Subject|0|||
170357964|NCT04321252|615646046|FG005|Overall Study|Withdrawal by Subject|1|||
170357965|NCT04321252|615646047|FG006|Overall Study|Withdrawal by Subject|0|||
170357966|NCT04321252|615646048|FG007|Overall Study|Withdrawal by Subject|0|||
170357967|NCT04321252|615646049|FG008|Overall Study|Withdrawal by Subject|0|||
170357968|NCT01453998|615646050|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
170357969|NCT01453998|615646051|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
170357970|NCT01453998|615646052|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
170357971|NCT00085917|615646055|FG000|Overall Study|Adverse Event|4|||
170357972|NCT00085917|615646056|FG001|Overall Study|Adverse Event|3|||
170357973|NCT02022033|615646057|FG000|Overall Study|Physician Decision|1|||
170357974|NCT00865189|615646060|FG000|Overall Study|Other|1|||
170357975|NCT00865189|615646061|FG001|Overall Study|Other|2|||
170357976|NCT00865189|615646060|FG000|Overall Study|Death|4|||
170357977|NCT00865189|615646061|FG001|Overall Study|Death|11|||
170357978|NCT00865189|615646060|FG000|Overall Study|Lost to Follow-up|6|||
170357979|NCT00865189|615646061|FG001|Overall Study|Lost to Follow-up|6|||
170357980|NCT00865189|615646060|FG000|Overall Study|Withdrawal by Subject|1|||
170357981|NCT00865189|615646061|FG001|Overall Study|Withdrawal by Subject|0|||
170357982|NCT01658579|615646062|FG000|Treatment Period A|Other|0|||
170357983|NCT01658579|615646063|FG001|Treatment Period A|Other|0|||
170357984|NCT01658579|615646064|FG002|Treatment Period A|Other|1|||
170357985|NCT01658579|615646065|FG003|Treatment Period A|Other|1|||
170357986|NCT01658579|615646062|FG000|Treatment Period A|Adverse Event|1|||
170357987|NCT01658579|615646063|FG001|Treatment Period A|Adverse Event|0|||
170357988|NCT01658579|615646064|FG002|Treatment Period A|Adverse Event|0|||
170357989|NCT01658579|615646065|FG003|Treatment Period A|Adverse Event|0|||
170357990|NCT01658579|615646062|FG000|Treatment Period B|Other|0|||
170357991|NCT01658579|615646063|FG001|Treatment Period B|Other|0|||
170357992|NCT01658579|615646064|FG002|Treatment Period B|Other|0|||
170357993|NCT01658579|615646065|FG003|Treatment Period B|Other|1|||
170357994|NCT05590767|615646066|FG000|Overall Study|Protocol Violation|1|||
170357995|NCT05590767|615646066|FG000|Overall Study|surgery canceled|1|||
170357996|NCT05590767|615646066|FG000|Overall Study|interscalene brachial block not performed|1|||
170357997|NCT00843843|615646067|FG000|Overall Study|Physician Decision|1|||
170357998|NCT00843843|615646068|FG001|Overall Study|Physician Decision|1|||
170357999|NCT00843843|615646067|FG000|Overall Study|Protocol Violation|1|||
170358000|NCT00843843|615646068|FG001|Overall Study|Protocol Violation|1|||
170358001|NCT00418379|615646069|FG000|Year 1|Adverse Event|9|||
170358002|NCT00418379|615646070|FG001|Year 1|Adverse Event|15|||
170358003|NCT00418379|615646071|FG002|Year 1|Adverse Event|3|||
170358004|NCT00418379|615646069|FG000|Year 1|Withdrawal by Subject|7|||
170358005|NCT00418379|615646070|FG001|Year 1|Withdrawal by Subject|8|||
170358006|NCT00418379|615646071|FG002|Year 1|Withdrawal by Subject|5|||
170358007|NCT00418379|615646069|FG000|Year 1|Any other reason not above-mentioned|2|||
170358008|NCT00418379|615646070|FG001|Year 1|Any other reason not above-mentioned|5|||
170358009|NCT00418379|615646071|FG002|Year 1|Any other reason not above-mentioned|7|||
170358010|NCT00418379|615646069|FG000|Year 2|Adverse Event|5|||
170358011|NCT00418379|615646070|FG001|Year 2|Adverse Event|2|||
170358012|NCT00418379|615646071|FG002|Year 2|Adverse Event|1|||
170358013|NCT00418379|615646069|FG000|Year 2|Withdrawal by Subject|1|||
170358014|NCT00418379|615646070|FG001|Year 2|Withdrawal by Subject|1|||
170358015|NCT00418379|615646071|FG002|Year 2|Withdrawal by Subject|3|||
170358016|NCT00418379|615646069|FG000|Year 2|Any other reason not above-mentioned|2|||
170358017|NCT00418379|615646070|FG001|Year 2|Any other reason not above-mentioned|1|||
170358018|NCT00418379|615646071|FG002|Year 2|Any other reason not above-mentioned|6|||
170358019|NCT00418379|615646069|FG000|Year 3|Withdrawal by Subject|1|||
170358020|NCT00418379|615646070|FG001|Year 3|Withdrawal by Subject|1|||
170358021|NCT00418379|615646071|FG002|Year 3|Withdrawal by Subject|2|||
170358022|NCT00418379|615646069|FG000|Year 3|Any other reason not above-mentioned|2|||
170358023|NCT00418379|615646070|FG001|Year 3|Any other reason not above-mentioned|1|||
170358024|NCT00418379|615646071|FG002|Year 3|Any other reason not above-mentioned|1|||
170358025|NCT00418379|615646069|FG000|Year 4|Adverse Event|0|||
170358026|NCT00418379|615646070|FG001|Year 4|Adverse Event|1|||
170358027|NCT00418379|615646071|FG002|Year 4|Adverse Event|0|||
170358028|NCT00418379|615646069|FG000|Year 4|Withdrawal by Subject|2|||
170358029|NCT00418379|615646070|FG001|Year 4|Withdrawal by Subject|3|||
170358030|NCT00418379|615646071|FG002|Year 4|Withdrawal by Subject|2|||
170358031|NCT00418379|615646069|FG000|Year 4|Any other reason not above-mentioned|1|||
170358032|NCT00418379|615646070|FG001|Year 4|Any other reason not above-mentioned|1|||
170358033|NCT00418379|615646071|FG002|Year 4|Any other reason not above-mentioned|0|||
170358034|NCT00418379|615646069|FG000|Year 5|Adverse Event|0|||
170358035|NCT00418379|615646070|FG001|Year 5|Adverse Event|1|||
170358036|NCT00418379|615646071|FG002|Year 5|Adverse Event|0|||
170358037|NCT00418379|615646069|FG000|Year 5|Any other reason not above-mentioned|2|||
170358038|NCT00418379|615646070|FG001|Year 5|Any other reason not above-mentioned|4|||
170358039|NCT00418379|615646071|FG002|Year 5|Any other reason not above-mentioned|3|||
170358040|NCT00565058|615646072|FG000|Overall Study|Adverse Event|1|||
170358041|NCT00565058|615646073|FG001|Overall Study|Adverse Event|0|||
170358042|NCT00304915|615646074|FG000|Overall Study|Lost to Follow-up|11|||
170358043|NCT00304915|615646075|FG001|Overall Study|Lost to Follow-up|11|||
170358044|NCT00304915|615646074|FG000|Overall Study|Death|4|||
170358045|NCT00304915|615646075|FG001|Overall Study|Death|5|||
170358046|NCT00304915|615646074|FG000|Overall Study|Withdrawal by Subject|3|||
170358047|NCT00304915|615646075|FG001|Overall Study|Withdrawal by Subject|0|||
170358048|NCT04526665|615646078|FG000|Overall Study|Withdrawal by Subject|6|||
170358049|NCT04526665|615646079|FG001|Overall Study|Withdrawal by Subject|3|||
170358050|NCT04526665|615646078|FG000|Overall Study|Adverse Event|4|||
170358051|NCT04526665|615646079|FG001|Overall Study|Adverse Event|1|||
170358052|NCT04526665|615646078|FG000|Overall Study|Physician Decision|2|||
170358053|NCT04526665|615646079|FG001|Overall Study|Physician Decision|2|||
170358054|NCT04526665|615646078|FG000|Overall Study|Death|2|||
170358055|NCT04526665|615646079|FG001|Overall Study|Death|0|||
170358056|NCT04526665|615646078|FG000|Overall Study|Other|0|||
170358057|NCT04526665|615646079|FG001|Overall Study|Other|1|||
170358058|NCT00242580|615646080|FG000|Overall Study|Adverse Event|3|||
170358059|NCT00242580|615646081|FG001|Overall Study|Adverse Event|0|||
170358060|NCT00242580|615646082|FG002|Overall Study|Adverse Event|2|||
170358061|NCT00242580|615646080|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170358062|NCT00242580|615646081|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
170358063|NCT00242580|615646082|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
170358064|NCT00242580|615646080|FG000|Overall Study|Protocol Violation|0|||
170358065|NCT00242580|615646081|FG001|Overall Study|Protocol Violation|0|||
170358066|NCT00242580|615646082|FG002|Overall Study|Protocol Violation|1|||
170358067|NCT00242580|615646080|FG000|Overall Study|Subject withdrew consent|2|||
170358068|NCT00242580|615646081|FG001|Overall Study|Subject withdrew consent|2|||
170358069|NCT00242580|615646082|FG002|Overall Study|Subject withdrew consent|5|||
170358070|NCT00242580|615646080|FG000|Overall Study|Lost to Follow-up|0|||
170358071|NCT00242580|615646081|FG001|Overall Study|Lost to Follow-up|3|||
170358072|NCT00242580|615646082|FG002|Overall Study|Lost to Follow-up|0|||
170358073|NCT00242580|615646080|FG000|Overall Study|Death|1|||
170358074|NCT00242580|615646081|FG001|Overall Study|Death|2|||
170358075|NCT00242580|615646082|FG002|Overall Study|Death|1|||
170358076|NCT00125190|615646085|FG000|Overall Study|Subject/Parent Decision|7|||
170358077|NCT00125190|615646085|FG000|Overall Study|Non-compliance|2|||
170358078|NCT00125190|615646085|FG000|Overall Study|Adverse Event|1|||
170358079|NCT00125190|615646085|FG000|Overall Study|Other|1|||
170358080|NCT00125190|615646085|FG000|Overall Study|Lost to Follow-up|4|||
170358081|NCT03666858|615646086|FG000|Cohort 1|Adverse Event|1|||
170358082|NCT03666858|615646087|FG001|Cohort 1|Adverse Event|0|||
170358083|NCT03666858|615646086|FG000|Cohort 2|Adverse Event|0|||
170358084|NCT03666858|615646087|FG001|Cohort 2|Adverse Event|1|||
170358085|NCT03282357|615646088|FG000|Overall Study|Lost to Follow-up|3|||
170358086|NCT03282357|615646088|FG000|Overall Study|Withdrawal by Subject|4|||
170358087|NCT03282357|615646088|FG000|Overall Study|Adverse Event|1|||
170358088|NCT03282357|615646088|FG000|Overall Study|Other|9|||
170358089|NCT01318512|615646089|FG000|Maintenance Period (6 Months)|Death|2|||
170358090|NCT01318512|615646089|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
170358091|NCT03722784|615646090|FG000|Overall Study|Withdrawal by Subject|1|||
170358092|NCT03722784|615646091|FG001|Overall Study|Withdrawal by Subject|0|||
170358093|NCT03722784|615646090|FG000|Overall Study|Physician Decision|1|||
170358094|NCT03722784|615646091|FG001|Overall Study|Physician Decision|1|||
170358095|NCT03722784|615646090|FG000|Overall Study|Protocol Violation|0|||
170358096|NCT03722784|615646091|FG001|Overall Study|Protocol Violation|1|||
170358097|NCT00077376|615646092|FG000|Overall Study|Adverse Event|8|||
170358098|NCT00077376|615646092|FG000|Overall Study|Withdrawal by Subject|2|||
170358099|NCT00077376|615646092|FG000|Overall Study|Death|1|||
170358100|NCT00077376|615646092|FG000|Overall Study|Physician Decision|1|||
170358101|NCT00077376|615646092|FG000|Overall Study|Alternative therapy|5|||
170358102|NCT00077376|615646092|FG000|Overall Study|Complicating disease|1|||
170358103|NCT00077376|615646092|FG000|Overall Study|Still on treatment|1|||
170358104|NCT00077376|615646092|FG000|Overall Study|Symptomatic deterioration|1|||
170358105|NCT00077376|615646092|FG000|Overall Study|Surgery|1|||
170358106|NCT00077376|615646092|FG000|Overall Study|Insurance ran out|1|||
170358107|NCT05757427|615646093|FG000|Overall Study|Adverse Event|1|||
170358108|NCT05757427|615646093|FG000|Overall Study|Device deficiency|1|||
170358109|NCT05757427|615646093|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
170358110|NCT05757427|615646093|FG000|Overall Study|MWBI scan of only 1 breast|3|||
170358111|NCT05757427|615646093|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
170358112|NCT02017899|615647437|FG000|Overall Study|Withdrawal by Subject|0|||
170358113|NCT02017899|615647438|FG001|Overall Study|Withdrawal by Subject|0|||
170358114|NCT02017899|615647439|FG002|Overall Study|Withdrawal by Subject|0|||
170358115|NCT02017899|615647440|FG003|Overall Study|Withdrawal by Subject|1|||
170358116|NCT02017899|615647441|FG004|Overall Study|Withdrawal by Subject|1|||
170358117|NCT02017899|615647442|FG005|Overall Study|Withdrawal by Subject|0|||
170358118|NCT00324740|615647445|FG000|Overall Study|Withdrawal by Subject|1|||
170358119|NCT00324740|615647446|FG001|Overall Study|Withdrawal by Subject|0|||
170358120|NCT00324740|615647447|FG002|Overall Study|Withdrawal by Subject|1|||
170358121|NCT01357980|615647448|FG000|Overall Study|Lack of Efficacy|0|||
170358122|NCT01357980|615647449|FG001|Overall Study|Lack of Efficacy|1|||
170358123|NCT01357980|615647450|FG002|Overall Study|Lack of Efficacy|0|||
170358124|NCT01357980|615647451|FG003|Overall Study|Lack of Efficacy|0|||
170358125|NCT01357980|615647448|FG000|Overall Study|Consent withdrawn|0|||
170358126|NCT01357980|615647449|FG001|Overall Study|Consent withdrawn|0|||
170358127|NCT01357980|615647450|FG002|Overall Study|Consent withdrawn|1|||
170358128|NCT01357980|615647451|FG003|Overall Study|Consent withdrawn|0|||
170358129|NCT03472040|615647454|FG000|Overall Study|Physician Decision|0|||
170358130|NCT03472040|615647455|FG001|Overall Study|Physician Decision|3|||
170358131|NCT03472040|615647454|FG000|Overall Study|Withdrawal by Subject|10|||
170358132|NCT03472040|615647455|FG001|Overall Study|Withdrawal by Subject|23|||
170358133|NCT03472040|615647454|FG000|Overall Study|Perceived Lack of Efficacy|29|||
170358134|NCT03472040|615647455|FG001|Overall Study|Perceived Lack of Efficacy|30|||
170358135|NCT03472040|615647454|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
170358136|NCT03472040|615647455|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
170358137|NCT03472040|615647454|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
170358138|NCT03472040|615647455|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
170358139|NCT03472040|615647454|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
170358140|NCT03472040|615647455|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
170358141|NCT03472040|615647454|FG000|Overall Study|Subject Non-compliance|2|||
170358142|NCT03472040|615647455|FG001|Overall Study|Subject Non-compliance|5|||
170358143|NCT03472040|615647454|FG000|Overall Study|Discontinuation due to Rash|0|||
170358144|NCT03472040|615647455|FG001|Overall Study|Discontinuation due to Rash|1|||
170358145|NCT03472040|615647454|FG000|Overall Study|Subsequent Ineligibility|0|||
170358146|NCT03472040|615647455|FG001|Overall Study|Subsequent Ineligibility|2|||
170358147|NCT03472040|615647454|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
170358148|NCT03472040|615647455|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
170358149|NCT02769832|615647456|FG000|Overall Study|Death|30|||
170358150|NCT04019795|615647460|FG000|Overall Study|Withdrawal by Subject|1|||
170358151|NCT04019795|615647461|FG001|Overall Study|Withdrawal by Subject|2|||
170358152|NCT04019795|615647462|FG002|Overall Study|Withdrawal by Subject|2|||
170358153|NCT04019795|615647463|FG003|Overall Study|Withdrawal by Subject|1|||
170358154|NCT04019795|615647460|FG000|Overall Study|Lost to Follow-up|0|||
170358155|NCT04019795|615647461|FG001|Overall Study|Lost to Follow-up|1|||
170358156|NCT04019795|615647462|FG002|Overall Study|Lost to Follow-up|1|||
170358157|NCT04019795|615647463|FG003|Overall Study|Lost to Follow-up|2|||
170358158|NCT04019795|615647460|FG000|Overall Study|Treatment non-compliance|3|||
170358159|NCT04019795|615647461|FG001|Overall Study|Treatment non-compliance|1|||
170358160|NCT04019795|615647462|FG002|Overall Study|Treatment non-compliance|2|||
170358161|NCT04019795|615647463|FG003|Overall Study|Treatment non-compliance|0|||
170358162|NCT04019795|615647460|FG000|Overall Study|Physician Decision|0|||
170358163|NCT04019795|615647461|FG001|Overall Study|Physician Decision|0|||
170358164|NCT04019795|615647462|FG002|Overall Study|Physician Decision|1|||
170358165|NCT04019795|615647463|FG003|Overall Study|Physician Decision|0|||
170358166|NCT04019795|615647460|FG000|Overall Study|Adverse Event|1|||
170358167|NCT04019795|615647461|FG001|Overall Study|Adverse Event|0|||
170358168|NCT04019795|615647462|FG002|Overall Study|Adverse Event|0|||
170358169|NCT04019795|615647463|FG003|Overall Study|Adverse Event|0|||
170358170|NCT01114373|615647464|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
170358171|NCT01114373|615647465|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
170358172|NCT01114373|615647464|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
170358173|NCT01114373|615647465|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
170358174|NCT01114373|615647464|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
170358175|NCT01114373|615647465|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
170358176|NCT01114373|615647464|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
170358177|NCT01114373|615647465|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
170358178|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
170358179|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
170358180|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
170358181|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
170358182|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
170358183|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
170358184|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
170358185|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
170358186|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
170358187|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
170358188|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
170358189|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
170358190|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
170358191|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
170358192|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
170358193|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
170358194|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
170358195|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
170358196|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
170358197|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
170358198|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
170358199|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
170358200|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
170358201|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
170358202|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
170358203|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
170358204|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
170358205|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
170358206|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
170358207|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
170358208|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
170358209|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
170358210|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
170358211|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
170358212|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
170358213|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
170358214|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
170358215|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
170358216|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
170358217|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
170358218|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
170358219|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
170358220|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
170358221|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
170358222|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
170358223|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
170358224|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
170358225|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
170358226|NCT03444870|615647471|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
170358227|NCT03444870|615647472|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
170358228|NCT03444870|615647473|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
170358229|NCT03444870|615647474|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
170358230|NCT03444870|615647475|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
170358231|NCT03444870|615647476|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
170358232|NCT03444870|615647471|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170358233|NCT03444870|615647472|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170358234|NCT03444870|615647473|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170358235|NCT03444870|615647474|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
170358236|NCT03444870|615647475|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
170358237|NCT03444870|615647476|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
170358238|NCT03444870|615647471|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
170358239|NCT03444870|615647472|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
170358240|NCT03444870|615647473|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
170358241|NCT03444870|615647474|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
170358242|NCT03444870|615647475|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
170358243|NCT03444870|615647476|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
170358244|NCT03444870|615647471|FG000|Open-Label Extension (OLE) Period|Death|0|||
170358245|NCT03444870|615647472|FG001|Open-Label Extension (OLE) Period|Death|0|||
170358246|NCT03444870|615647473|FG002|Open-Label Extension (OLE) Period|Death|0|||
170358247|NCT03444870|615647474|FG003|Open-Label Extension (OLE) Period|Death|0|||
170358248|NCT03444870|615647475|FG004|Open-Label Extension (OLE) Period|Death|1|||
170358249|NCT03444870|615647476|FG005|Open-Label Extension (OLE) Period|Death|0|||
170358250|NCT02034552|615647479|FG000|Overall Study|Never treated|3|||
170358251|NCT02034552|615647480|FG001|Overall Study|Never treated|2|||
170358252|NCT02034552|615647481|FG002|Overall Study|Never treated|0|||
170358253|NCT02034552|615647479|FG000|Overall Study|Radiological progression|3|||
170358254|NCT02034552|615647480|FG001|Overall Study|Radiological progression|5|||
170358255|NCT02034552|615647481|FG002|Overall Study|Radiological progression|4|||
170358256|NCT02034552|615647479|FG000|Overall Study|AE not assoc. with disease progression|1|||
170358257|NCT02034552|615647480|FG001|Overall Study|AE not assoc. with disease progression|4|||
170358258|NCT02034552|615647481|FG002|Overall Study|AE not assoc. with disease progression|2|||
170358259|NCT02034552|615647479|FG000|Overall Study|AE associated with disease progression|0|||
170358260|NCT02034552|615647480|FG001|Overall Study|AE associated with disease progression|1|||
170358261|NCT02034552|615647481|FG002|Overall Study|AE associated with disease progression|0|||
170358262|NCT02034552|615647479|FG000|Overall Study|Withdrawal by Subject|2|||
170358263|NCT02034552|615647480|FG001|Overall Study|Withdrawal by Subject|1|||
170358264|NCT02034552|615647481|FG002|Overall Study|Withdrawal by Subject|1|||
170358265|NCT02034552|615647479|FG000|Overall Study|Non-compliance with study drug|0|||
170358266|NCT02034552|615647480|FG001|Overall Study|Non-compliance with study drug|0|||
170358267|NCT02034552|615647481|FG002|Overall Study|Non-compliance with study drug|1|||
170358268|NCT02034552|615647479|FG000|Overall Study|Clinical progression|5|||
170358269|NCT02034552|615647480|FG001|Overall Study|Clinical progression|7|||
170358270|NCT02034552|615647481|FG002|Overall Study|Clinical progression|9|||
170358271|NCT03819218|615647484|FG000|Overall Study|Protocol Violation|1|||
170358272|NCT01840228|615647492|FG000|Overall Study|Lost to Follow-up|1|||
170358273|NCT01840228|615647493|FG001|Overall Study|Lost to Follow-up|1|||
170358274|NCT03495453|615647494|FG000|Overall Study|Withdrawal by Subject|0|||
170358275|NCT03495453|615647495|FG001|Overall Study|Withdrawal by Subject|1|||
170358276|NCT00712933|615647496|FG000|Overall Study|Adverse Event|69|||
170358277|NCT00712933|615647496|FG000|Overall Study|Lack of Efficacy|6|||
170358278|NCT00712933|615647496|FG000|Overall Study|Lost to Follow-up|22|||
170358279|NCT00712933|615647496|FG000|Overall Study|Non-compliance with study drug|13|||
170358280|NCT00712933|615647496|FG000|Overall Study|Other Pregnancy|37|||
170358281|NCT00712933|615647496|FG000|Overall Study|Sponsor decision|14|||
170358282|NCT00712933|615647496|FG000|Overall Study|Withdrew consent|4|||
170358283|NCT00712933|615647496|FG000|Overall Study|Hip replacement surgery|1|||
170358284|NCT00712933|615647496|FG000|Overall Study|Involved in Clinical research|3|||
170358285|NCT00712933|615647496|FG000|Overall Study|Participant hospitalized|1|||
170358286|NCT00712933|615647496|FG000|Overall Study|Participant travelled overseas|2|||
170358287|NCT00712933|615647496|FG000|Overall Study|Death of patient|1|||
170358288|NCT00712933|615647496|FG000|Overall Study|Other Physician decision|1|||
170358289|NCT00712933|615647496|FG000|Overall Study|Not committed to contraception|1|||
170358290|NCT00712933|615647496|FG000|Overall Study|Participant received medication|1|||
170358291|NCT00712933|615647496|FG000|Overall Study|Physician Decision|36|||
170358292|NCT00712933|615647496|FG000|Overall Study|Protocol Violation|4|||
170358293|NCT00712933|615647496|FG000|Overall Study|Withdrawal by Subject|151|||
170358294|NCT01429077|615647502|FG000|Overall Study|Lost to Follow-up|0|||
170358295|NCT01429077|615647503|FG001|Overall Study|Lost to Follow-up|3|||
170358296|NCT01413542|615647505|FG000|Overall Study|Physician Decision|1|||
170358297|NCT01413542|615647506|FG001|Overall Study|Physician Decision|0|||
170358298|NCT01413542|615647507|FG002|Overall Study|Physician Decision|3|||
170358299|NCT01413542|615647508|FG003|Overall Study|Physician Decision|0|||
170358300|NCT01413542|615647505|FG000|Overall Study|Adverse Event|0|||
170358301|NCT01413542|615647506|FG001|Overall Study|Adverse Event|0|||
170358302|NCT01413542|615647507|FG002|Overall Study|Adverse Event|0|||
170358303|NCT01413542|615647508|FG003|Overall Study|Adverse Event|1|||
170358304|NCT01879319|615647511|FG000|Overall Study|Withdrawal by Subject|1|||
170358305|NCT01879319|615647512|FG001|Overall Study|Withdrawal by Subject|0|||
170358306|NCT01879319|615647511|FG000|Overall Study|Lost to Follow-up|1|||
170358307|NCT01879319|615647512|FG001|Overall Study|Lost to Follow-up|5|||
170358308|NCT03372603|615647513|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
170358309|NCT03372603|615647514|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
170358310|NCT03372603|615647513|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
170358311|NCT03372603|615647514|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
170358312|NCT03341923|615647515|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
170358313|NCT03341923|615647516|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
170358314|NCT02767856|615647520|FG000|Overall Study|Lost to Follow-up|9|||
170358315|NCT02767856|615647521|FG001|Overall Study|Lost to Follow-up|1|||
170358316|NCT02767856|615647520|FG000|Overall Study|Withdrawal by Subject|2|||
170358317|NCT02767856|615647521|FG001|Overall Study|Withdrawal by Subject|1|||
170358318|NCT01464788|615647524|FG000|Overall Study|Lost to Follow-up|0|||
170358319|NCT01464788|615647525|FG001|Overall Study|Lost to Follow-up|1|||
170358320|NCT01464788|615647526|FG002|Overall Study|Lost to Follow-up|0|||
170358321|NCT01464788|615647524|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
170358322|NCT01464788|615647525|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
170358323|NCT01464788|615647526|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
170358324|NCT00065442|615647529|FG000|Overall Study|Lost to Follow-up|1|||
170358325|NCT00065442|615647530|FG001|Overall Study|Lost to Follow-up|1|||
170358326|NCT00065442|615647529|FG000|Overall Study|Death|121|||
170358327|NCT00065442|615647530|FG001|Overall Study|Death|210|||
170358328|NCT00065442|615647529|FG000|Overall Study|Withdrawal by Subject|3|||
170358329|NCT00065442|615647530|FG001|Overall Study|Withdrawal by Subject|9|||
170358330|NCT01797965|615647531|FG000|Overall Study|Adverse Event|104|||
170358331|NCT01797965|615647532|FG001|Overall Study|Adverse Event|129|||
170358332|NCT01797965|615647533|FG002|Overall Study|Adverse Event|4|||
170358333|NCT01797965|615647534|FG003|Overall Study|Adverse Event|21|||
170358334|NCT01797965|615647531|FG000|Overall Study|Lost to Follow-up|9|||
170358335|NCT01797965|615647532|FG001|Overall Study|Lost to Follow-up|8|||
170358336|NCT01797965|615647533|FG002|Overall Study|Lost to Follow-up|1|||
170358337|NCT01797965|615647534|FG003|Overall Study|Lost to Follow-up|2|||
170358338|NCT01797965|615647531|FG000|Overall Study|Consent withdrawn|130|||
170358339|NCT01797965|615647532|FG001|Overall Study|Consent withdrawn|117|||
170358340|NCT01797965|615647533|FG002|Overall Study|Consent withdrawn|3|||
170358341|NCT01797965|615647534|FG003|Overall Study|Consent withdrawn|35|||
170358342|NCT01797965|615647531|FG000|Overall Study|Investigator decision|21|||
170358343|NCT01797965|615647532|FG001|Overall Study|Investigator decision|15|||
170358344|NCT01797965|615647533|FG002|Overall Study|Investigator decision|0|||
170358345|NCT01797965|615647534|FG003|Overall Study|Investigator decision|0|||
170358346|NCT01797965|615647531|FG000|Overall Study|Death|2|||
170358347|NCT01797965|615647532|FG001|Overall Study|Death|4|||
170358348|NCT01797965|615647533|FG002|Overall Study|Death|0|||
170358349|NCT01797965|615647534|FG003|Overall Study|Death|0|||
170358350|NCT01797965|615647531|FG000|Overall Study|Disease progression, defined by protocol|3|||
170358351|NCT01797965|615647532|FG001|Overall Study|Disease progression, defined by protocol|1|||
170358352|NCT01797965|615647533|FG002|Overall Study|Disease progression, defined by protocol|0|||
170358353|NCT01797965|615647534|FG003|Overall Study|Disease progression, defined by protocol|0|||
170358354|NCT01797965|615647531|FG000|Overall Study|Reason Not Specified|280|||
170358355|NCT01797965|615647532|FG001|Overall Study|Reason Not Specified|295|||
170358356|NCT01797965|615647533|FG002|Overall Study|Reason Not Specified|0|||
170358357|NCT01797965|615647534|FG003|Overall Study|Reason Not Specified|15|||
170358358|NCT01764256|615647535|FG000|Received All Vaccinations|Adverse Event|1|||
170358359|NCT01764256|615647536|FG001|Received All Vaccinations|Adverse Event|1|||
170358360|NCT01764256|615647537|FG002|Received All Vaccinations|Adverse Event|0|||
170358361|NCT01764256|615647538|FG003|Received All Vaccinations|Adverse Event|0|||
170358362|NCT01764256|615647535|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
170358363|NCT01764256|615647536|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
170358364|NCT01764256|615647537|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
170358365|NCT01764256|615647538|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
170358366|NCT01764256|615647535|FG000|Received All Vaccinations|Lost to Follow-up|1|||
170358367|NCT01764256|615647536|FG001|Received All Vaccinations|Lost to Follow-up|0|||
170358368|NCT01764256|615647537|FG002|Received All Vaccinations|Lost to Follow-up|0|||
170358369|NCT01764256|615647538|FG003|Received All Vaccinations|Lost to Follow-up|0|||
170358370|NCT01764256|615647535|FG000|Completed Study|Lost to Follow-up|0|||
170358371|NCT01764256|615647536|FG001|Completed Study|Lost to Follow-up|0|||
170358372|NCT01764256|615647537|FG002|Completed Study|Lost to Follow-up|0|||
170358373|NCT01764256|615647538|FG003|Completed Study|Lost to Follow-up|1|||
170358374|NCT02029638|615647539|FG000|Overall Study|Death|0|||
170358375|NCT02029638|615647540|FG001|Overall Study|Death|0|||
170358376|NCT02029638|615647541|FG002|Overall Study|Death|1|||
170358377|NCT02029638|615647539|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
170358378|NCT02029638|615647540|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
170358379|NCT02029638|615647541|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
170358380|NCT01153841|615647542|FG000|Overall Study|Adverse Event|1|||
170358381|NCT01153841|615647543|FG001|Overall Study|Adverse Event|0|||
170358382|NCT01153841|615647542|FG000|Overall Study|Withdrawal by Subject|1|||
170358383|NCT01153841|615647543|FG001|Overall Study|Withdrawal by Subject|0|||
170358384|NCT01153841|615647542|FG000|Overall Study|Protocol Violation|2|||
170358385|NCT01153841|615647543|FG001|Overall Study|Protocol Violation|0|||
170358386|NCT01153841|615647542|FG000|Overall Study|Lost to Follow-up|2|||
170358387|NCT01153841|615647543|FG001|Overall Study|Lost to Follow-up|0|||
170358388|NCT00712322|615647548|FG000|Overall Study|Protocol deviation|0|||
170358389|NCT00712322|615647549|FG001|Overall Study|Protocol deviation|1|||
170358390|NCT00712322|615647550|FG002|Overall Study|Protocol deviation|0|||
170358391|NCT04404010|615647551|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
170398665|NCT02957682|615798231|FG001|Overall Study|Related to IMP Administration|6|||
170358392|NCT04404010|615647552|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
170358393|NCT01599754|615647553|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
170358394|NCT01599754|615647554|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
170358395|NCT01599754|615647553|FG000|Overall Study|Participant noncompliance|4|||
170358396|NCT01599754|615647554|FG001|Overall Study|Participant noncompliance|4|||
170358397|NCT01599754|615647553|FG000|Overall Study|Lost to Follow-up|13|||
170358398|NCT01599754|615647554|FG001|Overall Study|Lost to Follow-up|6|||
170358399|NCT01599754|615647553|FG000|Overall Study|Death|31|||
170358400|NCT01599754|615647554|FG001|Overall Study|Death|33|||
170358401|NCT01599754|615647553|FG000|Overall Study|Adverse Event|3|||
170358402|NCT01599754|615647554|FG001|Overall Study|Adverse Event|2|||
170358403|NCT01599754|615647553|FG000|Overall Study|Investigator decision|1|||
170358404|NCT01599754|615647554|FG001|Overall Study|Investigator decision|3|||
170358405|NCT01599754|615647553|FG000|Overall Study|Withdrawal by Subject|24|||
170358406|NCT01599754|615647554|FG001|Overall Study|Withdrawal by Subject|25|||
170358407|NCT01599754|615647553|FG000|Overall Study|Study terminated by sponsor|282|||
170358408|NCT01599754|615647554|FG001|Overall Study|Study terminated by sponsor|285|||
170358409|NCT00414960|615647555|FG000|Overall Study|Adverse Event|4|||
170358410|NCT00414960|615647556|FG001|Overall Study|Adverse Event|0|||
170358411|NCT00414960|615647555|FG000|Overall Study|Withdrawal by Subject|3|||
170358412|NCT00414960|615647556|FG001|Overall Study|Withdrawal by Subject|0|||
170358413|NCT00414960|615647555|FG000|Overall Study|Physician Decision|0|||
170358414|NCT00414960|615647556|FG001|Overall Study|Physician Decision|1|||
170358415|NCT00622869|615647559|FG000|Overall Study|Subject Withdrew Consent|13|||
170358416|NCT00622869|615647560|FG001|Overall Study|Subject Withdrew Consent|17|||
170358417|NCT00622869|615647561|FG002|Overall Study|Subject Withdrew Consent|11|||
170358418|NCT00622869|615647559|FG000|Overall Study|Administrative Problems|11|||
170358419|NCT00622869|615647560|FG001|Overall Study|Administrative Problems|17|||
170358420|NCT00622869|615647561|FG002|Overall Study|Administrative Problems|13|||
170358421|NCT00622869|615647559|FG000|Overall Study|Death|12|||
170358422|NCT00622869|615647560|FG001|Overall Study|Death|15|||
170358423|NCT00622869|615647561|FG002|Overall Study|Death|10|||
170358424|NCT00622869|615647559|FG000|Overall Study|Lost to Follow-up|2|||
170358425|NCT00622869|615647560|FG001|Overall Study|Lost to Follow-up|4|||
170358426|NCT00622869|615647561|FG002|Overall Study|Lost to Follow-up|2|||
170358427|NCT00622869|615647559|FG000|Overall Study|Graft Loss|5|||
170358428|NCT00622869|615647560|FG001|Overall Study|Graft Loss|3|||
170358429|NCT00622869|615647561|FG002|Overall Study|Graft Loss|2|||
170358430|NCT00622869|615647559|FG000|Overall Study|Missing|0|||
170358431|NCT00622869|615647560|FG001|Overall Study|Missing|1|||
170358432|NCT00622869|615647561|FG002|Overall Study|Missing|1|||
170358433|NCT00910429|615647566|FG000|Overall Study|Death|18|||
170358434|NCT00910429|615647567|FG001|Overall Study|Death|12|||
170358435|NCT00910429|615647566|FG000|Overall Study|Withdrawal by Subject|3|||
170358436|NCT00910429|615647567|FG001|Overall Study|Withdrawal by Subject|2|||
170358437|NCT00910429|615647566|FG000|Overall Study|Protocol Violation|1|||
170358438|NCT00910429|615647567|FG001|Overall Study|Protocol Violation|0|||
170358439|NCT00910429|615647566|FG000|Overall Study|Lost to Follow-up|2|||
170358440|NCT00910429|615647567|FG001|Overall Study|Lost to Follow-up|1|||
170358441|NCT00910429|615647566|FG000|Overall Study|Adverse Event|10|||
170358442|NCT00910429|615647567|FG001|Overall Study|Adverse Event|5|||
170358443|NCT00910429|615647566|FG000|Overall Study|Drug non-compliance|1|||
170358444|NCT00910429|615647567|FG001|Overall Study|Drug non-compliance|0|||
170358445|NCT00910429|615647566|FG000|Overall Study|Lack of Efficacy|4|||
170358446|NCT00910429|615647567|FG001|Overall Study|Lack of Efficacy|1|||
170358447|NCT01317615|615647568|FG000|Overall Study|Disease progression|25|||
170358448|NCT01317615|615647568|FG000|Overall Study|New cancer therapy|5|||
170358449|NCT01317615|615647568|FG000|Overall Study|Death|6|||
170358450|NCT01317615|615647568|FG000|Overall Study|Withdrawal by Subject|5|||
170358451|NCT01317615|615647568|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170358452|NCT01317615|615647568|FG000|Overall Study|Adverse Event|7|||
170358453|NCT02648724|615647572|FG000|Overall Study|Withdrawal by Subject|0|||
170358454|NCT02648724|615647573|FG001|Overall Study|Withdrawal by Subject|1|||
170358455|NCT02648724|615647574|FG002|Overall Study|Withdrawal by Subject|1|||
170358456|NCT02648724|615647575|FG003|Overall Study|Withdrawal by Subject|0|||
170358457|NCT02648724|615647576|FG004|Overall Study|Withdrawal by Subject|1|||
170358458|NCT02648724|615647577|FG005|Overall Study|Withdrawal by Subject|0|||
170358459|NCT02648724|615647578|FG006|Overall Study|Withdrawal by Subject|0|||
170358460|NCT02648724|615647572|FG000|Overall Study|Progressive disease|2|||
170358461|NCT02648724|615647573|FG001|Overall Study|Progressive disease|2|||
170358462|NCT02648724|615647574|FG002|Overall Study|Progressive disease|2|||
170358463|NCT02648724|615647575|FG003|Overall Study|Progressive disease|3|||
170358464|NCT02648724|615647576|FG004|Overall Study|Progressive disease|22|||
170358465|NCT02648724|615647577|FG005|Overall Study|Progressive disease|7|||
170358466|NCT02648724|615647578|FG006|Overall Study|Progressive disease|8|||
170358467|NCT02648724|615647572|FG000|Overall Study|Other reason (unknown)|1|||
170358468|NCT02648724|615647573|FG001|Overall Study|Other reason (unknown)|0|||
170358469|NCT02648724|615647574|FG002|Overall Study|Other reason (unknown)|0|||
170358470|NCT02648724|615647575|FG003|Overall Study|Other reason (unknown)|0|||
170358471|NCT02648724|615647576|FG004|Overall Study|Other reason (unknown)|0|||
170358472|NCT02648724|615647577|FG005|Overall Study|Other reason (unknown)|0|||
170358473|NCT02648724|615647578|FG006|Overall Study|Other reason (unknown)|0|||
170358474|NCT02648724|615647572|FG000|Overall Study|Protocol Violation|0|||
170358475|NCT02648724|615647573|FG001|Overall Study|Protocol Violation|0|||
170358476|NCT02648724|615647574|FG002|Overall Study|Protocol Violation|0|||
170358477|NCT02648724|615647575|FG003|Overall Study|Protocol Violation|0|||
170358478|NCT02648724|615647576|FG004|Overall Study|Protocol Violation|1|||
170358479|NCT02648724|615647577|FG005|Overall Study|Protocol Violation|0|||
170358480|NCT02648724|615647578|FG006|Overall Study|Protocol Violation|0|||
170358481|NCT02648724|615647572|FG000|Overall Study|Death|0|||
170358482|NCT02648724|615647573|FG001|Overall Study|Death|0|||
170358483|NCT02648724|615647574|FG002|Overall Study|Death|0|||
170358484|NCT02648724|615647575|FG003|Overall Study|Death|0|||
170358485|NCT02648724|615647576|FG004|Overall Study|Death|0|||
170358486|NCT02648724|615647577|FG005|Overall Study|Death|0|||
170358487|NCT02648724|615647578|FG006|Overall Study|Death|3|||
170358488|NCT02648724|615647572|FG000|Overall Study|Physician Decision|0|||
170358489|NCT02648724|615647573|FG001|Overall Study|Physician Decision|0|||
170358490|NCT02648724|615647574|FG002|Overall Study|Physician Decision|0|||
170358491|NCT02648724|615647575|FG003|Overall Study|Physician Decision|0|||
170358492|NCT02648724|615647576|FG004|Overall Study|Physician Decision|1|||
170358493|NCT02648724|615647577|FG005|Overall Study|Physician Decision|0|||
170358494|NCT02648724|615647578|FG006|Overall Study|Physician Decision|1|||
170358495|NCT02648724|615647572|FG000|Overall Study|Transferred to named patient program|0|||
170358496|NCT02648724|615647573|FG001|Overall Study|Transferred to named patient program|0|||
170358497|NCT02648724|615647574|FG002|Overall Study|Transferred to named patient program|0|||
170358498|NCT02648724|615647575|FG003|Overall Study|Transferred to named patient program|0|||
170358499|NCT02648724|615647576|FG004|Overall Study|Transferred to named patient program|0|||
170358500|NCT02648724|615647577|FG005|Overall Study|Transferred to named patient program|1|||
170358501|NCT02648724|615647578|FG006|Overall Study|Transferred to named patient program|0|||
170358502|NCT00738374|615647579|FG000|Induction Treatment Phase|Adverse Event|14|||
170358503|NCT00738374|615647580|FG001|Induction Treatment Phase|Adverse Event|0|||
170358504|NCT00738374|615647581|FG002|Induction Treatment Phase|Adverse Event|0|||
170358505|NCT00738374|615647582|FG003|Induction Treatment Phase|Adverse Event|0|||
170358506|NCT00738374|615647579|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
170358507|NCT00738374|615647580|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
170358508|NCT00738374|615647581|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
170358509|NCT00738374|615647582|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
170358510|NCT00738374|615647579|FG000|Induction Treatment Phase|Physician Decision|2|||
170358511|NCT00738374|615647580|FG001|Induction Treatment Phase|Physician Decision|0|||
170358512|NCT00738374|615647581|FG002|Induction Treatment Phase|Physician Decision|0|||
170358513|NCT00738374|615647582|FG003|Induction Treatment Phase|Physician Decision|0|||
170358514|NCT00738374|615647579|FG000|Induction Treatment Phase|Protocol Violation|2|||
170358515|NCT00738374|615647580|FG001|Induction Treatment Phase|Protocol Violation|0|||
170358516|NCT00738374|615647581|FG002|Induction Treatment Phase|Protocol Violation|0|||
170358517|NCT00738374|615647582|FG003|Induction Treatment Phase|Protocol Violation|0|||
170358518|NCT00738374|615647579|FG000|Induction Treatment Phase|Non-compliance|1|||
170358519|NCT00738374|615647580|FG001|Induction Treatment Phase|Non-compliance|0|||
170358520|NCT00738374|615647581|FG002|Induction Treatment Phase|Non-compliance|0|||
170358521|NCT00738374|615647582|FG003|Induction Treatment Phase|Non-compliance|0|||
170358522|NCT00738374|615647579|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
170358523|NCT00738374|615647580|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
170358524|NCT00738374|615647581|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
170358525|NCT00738374|615647582|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
170358526|NCT00738374|615647579|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
170358527|NCT00738374|615647580|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
170358528|NCT00738374|615647581|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
170358529|NCT00738374|615647582|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
170358530|NCT00738374|615647579|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
170358531|NCT00738374|615647580|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
170358532|NCT00738374|615647581|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
170358533|NCT00738374|615647582|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
170358534|NCT00738374|615647579|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
170358535|NCT00738374|615647580|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
170358536|NCT00738374|615647581|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
170358537|NCT00738374|615647582|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
170358538|NCT00738374|615647579|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
170358539|NCT00738374|615647580|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
170358540|NCT00738374|615647581|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
170358541|NCT00738374|615647582|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
170358542|NCT00738374|615647579|FG000|Maintenance Treatment/Observation Phase|Other|0|||
170358543|NCT00738374|615647580|FG001|Maintenance Treatment/Observation Phase|Other|1|||
170358544|NCT00738374|615647581|FG002|Maintenance Treatment/Observation Phase|Other|0|||
170358545|NCT00738374|615647582|FG003|Maintenance Treatment/Observation Phase|Other|0|||
170358546|NCT01518244|615647584|FG000|Overall Study|Adverse Event|3|||
170358547|NCT03245723|615647590|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
170358548|NCT03245723|615647591|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
170358549|NCT03245723|615647590|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
170358550|NCT03245723|615647591|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
170358551|NCT03245723|615647590|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
170358552|NCT03245723|615647591|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
170358553|NCT03245723|615647590|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
170358554|NCT03245723|615647591|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
170358555|NCT01512108|615649166|FG000|Overall Study|Adverse Event|9|||
170358556|NCT01512108|615649167|FG001|Overall Study|Adverse Event|4|||
170358557|NCT01512108|615649166|FG000|Overall Study|Protocol Violation|1|||
170358558|NCT01512108|615649167|FG001|Overall Study|Protocol Violation|2|||
170358559|NCT01512108|615649166|FG000|Overall Study|Withdrawal Criteria|1|||
170358560|NCT01512108|615649167|FG001|Overall Study|Withdrawal Criteria|0|||
170358561|NCT01512108|615649166|FG000|Overall Study|Unclassified|11|||
170358562|NCT01512108|615649167|FG001|Overall Study|Unclassified|3|||
170358563|NCT02197897|615649173|FG000|Overall Study|not eligible|1|||
170358564|NCT02513771|615649174|FG000|Overall Study|Lost to Follow-up|1|||
170358565|NCT02513771|615649175|FG001|Overall Study|Lost to Follow-up|1|||
170358566|NCT02513771|615649174|FG000|Overall Study|Not being able to get to clinic|1|||
170358567|NCT02513771|615649175|FG001|Overall Study|Not being able to get to clinic|0|||
170358568|NCT01797445|615649176|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
170358569|NCT01797445|615649177|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
170358570|NCT01797445|615649176|FG000|Double-Blind Phase|Adverse Event|3|||
170358571|NCT01797445|615649177|FG001|Double-Blind Phase|Adverse Event|0|||
170358572|NCT01797445|615649176|FG000|Double-Blind Phase|Death|5|||
170358573|NCT01797445|615649177|FG001|Double-Blind Phase|Death|4|||
170358574|NCT01797445|615649176|FG000|Double-Blind Phase|Pregnancy|0|||
170358575|NCT01797445|615649177|FG001|Double-Blind Phase|Pregnancy|1|||
170358576|NCT01797445|615649176|FG000|Double-Blind Phase|Lack of Efficacy|1|||
170358577|NCT01797445|615649177|FG001|Double-Blind Phase|Lack of Efficacy|2|||
170358578|NCT01797445|615649176|FG000|Double-Blind Phase|Investigator's Discretion|15|||
170358579|NCT01797445|615649177|FG001|Double-Blind Phase|Investigator's Discretion|17|||
170358580|NCT01797445|615649176|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
170358581|NCT01797445|615649177|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
170358582|NCT01797445|615649176|FG000|Double-Blind Phase|Protocol Violation|0|||
170358583|NCT01797445|615649177|FG001|Double-Blind Phase|Protocol Violation|1|||
170358584|NCT01797445|615649176|FG000|Double-Blind Phase|Withdrew Consent|20|||
170358585|NCT01797445|615649177|FG001|Double-Blind Phase|Withdrew Consent|35|||
170358586|NCT01797445|615649176|FG000|Double-Blind Phase|Lost to Follow-up|34|||
170358587|NCT01797445|615649177|FG001|Double-Blind Phase|Lost to Follow-up|26|||
170358588|NCT01797445|615649176|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
170358589|NCT01797445|615649177|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
170358590|NCT00650091|615649178|FG000|Amended Study Design|Withdrawal by Subject|12|||
170358591|NCT00650091|615649179|FG001|Amended Study Design|Withdrawal by Subject|11|||
170358592|NCT00650091|615649180|FG002|Amended Study Design|Withdrawal by Subject|0|||
170358593|NCT00650091|615649178|FG000|Amended Study Design|Physician Decision|5|||
170358594|NCT00650091|615649179|FG001|Amended Study Design|Physician Decision|0|||
170358595|NCT00650091|615649180|FG002|Amended Study Design|Physician Decision|0|||
170358596|NCT00650091|615649178|FG000|Amended Study Design|Adverse Event|1|||
170358597|NCT00650091|615649179|FG001|Amended Study Design|Adverse Event|4|||
170358598|NCT00650091|615649180|FG002|Amended Study Design|Adverse Event|0|||
170358599|NCT00650091|615649178|FG000|Amended Study Design|Lung transplantation|4|||
170358600|NCT00650091|615649179|FG001|Amended Study Design|Lung transplantation|2|||
170358601|NCT00650091|615649180|FG002|Amended Study Design|Lung transplantation|0|||
170358602|NCT00650091|615649178|FG000|Amended Study Design|Other|1|||
170358603|NCT00650091|615649179|FG001|Amended Study Design|Other|3|||
170358604|NCT00650091|615649180|FG002|Amended Study Design|Other|0|||
170358605|NCT04295356|615649187|FG000|Overall Study|Physician Decision|1|||
170358606|NCT04295356|615649188|FG001|Overall Study|Physician Decision|0|||
170358607|NCT04295356|615649187|FG000|Overall Study|Lost to Follow-up|0|||
170358608|NCT04295356|615649188|FG001|Overall Study|Lost to Follow-up|3|||
170358609|NCT04295356|615649187|FG000|Overall Study|Protocol Violation|0|||
170358610|NCT04295356|615649188|FG001|Overall Study|Protocol Violation|1|||
170358611|NCT01280266|615649189|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
170358612|NCT01280266|615649190|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
170358613|NCT01280266|615649189|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
170358614|NCT01280266|615649190|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
170358615|NCT04268004|615649197|FG000|Overall Study|Excluded from analyses|0|||
170358616|NCT04268004|615649198|FG001|Overall Study|Excluded from analyses|1|||
170358617|NCT02505542|615649199|FG000|Part A: Open-Label Period|Adverse Event|31|||
170358618|NCT02505542|615649200|FG001|Part A: Open-Label Period|Adverse Event|0|||
170358619|NCT02505542|615649201|FG002|Part A: Open-Label Period|Adverse Event|0|||
170358620|NCT02505542|615649202|FG003|Part A: Open-Label Period|Adverse Event|0|||
170358621|NCT02505542|615649199|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
170358622|NCT02505542|615649200|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
170358623|NCT02505542|615649201|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
170358624|NCT02505542|615649202|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
170358625|NCT02505542|615649199|FG000|Part A: Open-Label Period|Protocol Violation|1|||
170358626|NCT02505542|615649200|FG001|Part A: Open-Label Period|Protocol Violation|0|||
170358627|NCT02505542|615649201|FG002|Part A: Open-Label Period|Protocol Violation|0|||
170358628|NCT02505542|615649202|FG003|Part A: Open-Label Period|Protocol Violation|0|||
170358629|NCT02505542|615649199|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
170358630|NCT02505542|615649200|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
170358631|NCT02505542|615649201|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
170358632|NCT02505542|615649202|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
170358633|NCT02505542|615649199|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
170358634|NCT02505542|615649200|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
170358635|NCT02505542|615649201|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
170358636|NCT02505542|615649202|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
170358637|NCT02505542|615649199|FG000|Part A: Open-Label Period|New medical history available|1|||
170358638|NCT02505542|615649200|FG001|Part A: Open-Label Period|New medical history available|0|||
170358639|NCT02505542|615649201|FG002|Part A: Open-Label Period|New medical history available|0|||
170358640|NCT02505542|615649202|FG003|Part A: Open-Label Period|New medical history available|0|||
170358641|NCT02505542|615649199|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
170358642|NCT02505542|615649200|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
170358643|NCT02505542|615649201|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
170358644|NCT02505542|615649202|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
170358645|NCT02505542|615649199|FG000|Part A: Open-Label Period|Pregnancy|2|||
170358646|NCT02505542|615649200|FG001|Part A: Open-Label Period|Pregnancy|0|||
170358647|NCT02505542|615649201|FG002|Part A: Open-Label Period|Pregnancy|0|||
170358648|NCT02505542|615649202|FG003|Part A: Open-Label Period|Pregnancy|0|||
170358649|NCT02505542|615649199|FG000|Part A: Open-Label Period|Sponsor directive|1|||
170358650|NCT02505542|615649200|FG001|Part A: Open-Label Period|Sponsor directive|0|||
170358651|NCT02505542|615649201|FG002|Part A: Open-Label Period|Sponsor directive|0|||
170358652|NCT02505542|615649202|FG003|Part A: Open-Label Period|Sponsor directive|0|||
170358653|NCT02505542|615649199|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
170358654|NCT02505542|615649200|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
170358655|NCT02505542|615649201|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
170358656|NCT02505542|615649202|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
170358657|NCT02505542|615649199|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
170358658|NCT02505542|615649200|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
170358659|NCT02505542|615649201|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
170358660|NCT02505542|615649202|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
170358661|NCT02505542|615649199|FG000|Part A: Open-Label Period|Non-compliance|1|||
170358662|NCT02505542|615649200|FG001|Part A: Open-Label Period|Non-compliance|0|||
170358663|NCT02505542|615649201|FG002|Part A: Open-Label Period|Non-compliance|0|||
170358664|NCT02505542|615649202|FG003|Part A: Open-Label Period|Non-compliance|0|||
170358665|NCT02505542|615649199|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
170358666|NCT02505542|615649200|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
170358667|NCT02505542|615649201|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
170358668|NCT02505542|615649202|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
170358669|NCT02505542|615649199|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
170358670|NCT02505542|615649200|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
170358671|NCT02505542|615649201|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
170358672|NCT02505542|615649202|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
170358673|NCT02505542|615649199|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
170358674|NCT02505542|615649200|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
170358675|NCT02505542|615649201|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
170358676|NCT02505542|615649202|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
170358677|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Adverse Event|0|||
170358678|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Adverse Event|0|||
170358679|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Adverse Event|1|||
170358680|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Adverse Event|3|||
170358681|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
170358682|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
170358683|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
170358684|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
170358685|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
170358686|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
170358687|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
170358688|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
170358689|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
170358690|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
170358691|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
170358692|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
170358693|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
170358694|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
170358695|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
170358696|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
170358697|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
170358698|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
170358699|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
170358700|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
170358701|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
170358702|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
170358703|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
170358704|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
170358705|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Miscalculation|0|||
170358706|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Miscalculation|1|||
170358707|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Miscalculation|0|||
170358708|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Miscalculation|0|||
170358709|NCT02505542|615649199|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
170358710|NCT02505542|615649200|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
170358711|NCT02505542|615649201|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
170358712|NCT02505542|615649202|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
170358713|NCT01103778|615649203|FG000|Overall Study|Lost to Follow-up|1|||
170358714|NCT01103778|615649203|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
170358715|NCT01103778|615649203|FG000|Overall Study|Screen failure|1|||
170358716|NCT04724733|615649204|FG000|Overall Study|Lost to Follow-up|1|||
170358717|NCT04724733|615649205|FG001|Overall Study|Lost to Follow-up|1|||
170358718|NCT04724733|615649206|FG002|Overall Study|Lost to Follow-up|1|||
170358719|NCT03084718|615649207|FG000|Overall Study|Withdrawal by Subject|4|||
170358720|NCT03084718|615649208|FG001|Overall Study|Withdrawal by Subject|3|||
170358721|NCT03084718|615649209|FG002|Overall Study|Withdrawal by Subject|4|||
170358722|NCT03084718|615649210|FG003|Overall Study|Withdrawal by Subject|0|||
170358723|NCT03084718|615649211|FG004|Overall Study|Withdrawal by Subject|0|||
170358724|NCT03084718|615649207|FG000|Overall Study|Physician Decision|1|||
170358725|NCT03084718|615649208|FG001|Overall Study|Physician Decision|0|||
170358726|NCT03084718|615649209|FG002|Overall Study|Physician Decision|0|||
170358727|NCT03084718|615649210|FG003|Overall Study|Physician Decision|0|||
170358728|NCT03084718|615649211|FG004|Overall Study|Physician Decision|0|||
170358729|NCT03084718|615649207|FG000|Overall Study|Adverse Event|3|||
170358730|NCT03084718|615649208|FG001|Overall Study|Adverse Event|5|||
170358731|NCT03084718|615649209|FG002|Overall Study|Adverse Event|5|||
170358732|NCT03084718|615649210|FG003|Overall Study|Adverse Event|8|||
170358733|NCT03084718|615649211|FG004|Overall Study|Adverse Event|2|||
170358734|NCT03084718|615649207|FG000|Overall Study|Lack of Efficacy|2|||
170358735|NCT03084718|615649208|FG001|Overall Study|Lack of Efficacy|0|||
170358736|NCT03084718|615649209|FG002|Overall Study|Lack of Efficacy|1|||
170358737|NCT03084718|615649210|FG003|Overall Study|Lack of Efficacy|4|||
170358738|NCT03084718|615649211|FG004|Overall Study|Lack of Efficacy|0|||
170358739|NCT03084718|615649207|FG000|Overall Study|Lost to Follow-up|0|||
170358740|NCT03084718|615649208|FG001|Overall Study|Lost to Follow-up|1|||
170358741|NCT03084718|615649209|FG002|Overall Study|Lost to Follow-up|0|||
170358742|NCT03084718|615649210|FG003|Overall Study|Lost to Follow-up|0|||
170358743|NCT03084718|615649211|FG004|Overall Study|Lost to Follow-up|2|||
170358744|NCT03084718|615649207|FG000|Overall Study|Protocol Violation|0|||
170358745|NCT03084718|615649208|FG001|Overall Study|Protocol Violation|0|||
170358746|NCT03084718|615649209|FG002|Overall Study|Protocol Violation|1|||
170358747|NCT03084718|615649210|FG003|Overall Study|Protocol Violation|0|||
170358748|NCT03084718|615649211|FG004|Overall Study|Protocol Violation|0|||
170358749|NCT03084718|615649207|FG000|Overall Study|Death|0|||
170358750|NCT03084718|615649208|FG001|Overall Study|Death|1|||
170358751|NCT03084718|615649209|FG002|Overall Study|Death|0|||
170358752|NCT03084718|615649210|FG003|Overall Study|Death|0|||
170358753|NCT03084718|615649211|FG004|Overall Study|Death|0|||
170358754|NCT03084718|615649207|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
170358755|NCT03084718|615649208|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
170398666|NCT02957682|615798230|FG000|Overall Study|Non-disclosed|16|||
170358756|NCT03084718|615649209|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
170358757|NCT03084718|615649210|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
170358758|NCT03084718|615649211|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
170358759|NCT04511819|615649214|FG000|Overall Study|Non-compliance with study drug|5|||
170358760|NCT04511819|615649215|FG001|Overall Study|Non-compliance with study drug|1|||
170358761|NCT04511819|615649214|FG000|Overall Study|Withdrawal by Subject|0|||
170358762|NCT04511819|615649215|FG001|Overall Study|Withdrawal by Subject|3|||
170358763|NCT04511819|615649214|FG000|Overall Study|Adverse Event|0|||
170358764|NCT04511819|615649215|FG001|Overall Study|Adverse Event|1|||
170358765|NCT04511819|615649214|FG000|Overall Study|Protocol deviation|1|||
170358766|NCT04511819|615649215|FG001|Overall Study|Protocol deviation|0|||
170358767|NCT04929613|615649216|FG000|Overall Study|Withdrawal by Subject|12|||
170358768|NCT00844649|615649221|FG000|Overall Study|Progressive Disease|196|||
170358769|NCT00844649|615649222|FG001|Overall Study|Progressive Disease|245|||
170358770|NCT00844649|615649221|FG000|Overall Study|Adverse Event|128|||
170358771|NCT00844649|615649222|FG001|Overall Study|Adverse Event|73|||
170358772|NCT00844649|615649221|FG000|Overall Study|Physician Decision|25|||
170358773|NCT00844649|615649222|FG001|Overall Study|Physician Decision|18|||
170358774|NCT00844649|615649221|FG000|Overall Study|Protocol Violation|10|||
170358775|NCT00844649|615649222|FG001|Overall Study|Protocol Violation|6|||
170358776|NCT00844649|615649221|FG000|Overall Study|Withdrawal by Subject|28|||
170358777|NCT00844649|615649222|FG001|Overall Study|Withdrawal by Subject|39|||
170358778|NCT00844649|615649221|FG000|Overall Study|Other|7|||
170358779|NCT00844649|615649222|FG001|Overall Study|Other|10|||
170358780|NCT00844649|615649221|FG000|Overall Study|Withdrew prior to starting treatment|11|||
170358781|NCT00844649|615649222|FG001|Overall Study|Withdrew prior to starting treatment|27|||
170358782|NCT00664209|615649223|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
170358783|NCT00664209|615649223|FG000|Study Treatment Period|Physician Decision|4|||
170358784|NCT00664209|615649223|FG000|Study Treatment Period|Withdrawal by Subject|2|||
170358785|NCT03428997|615649234|FG000|Overall Study|Sponsor decision.|1|||
170358786|NCT03428997|615649234|FG000|Overall Study|Withdrawal by Subject|3|||
170358787|NCT03428997|615649234|FG000|Overall Study|Lost to Follow-up|4|||
170358788|NCT00493467|615649235|FG000|Overall Study|Death|1|||
170358789|NCT00510068|615649238|FG000|Double-blind Period|Disease progression|98|||
170358790|NCT00510068|615649239|FG001|Double-blind Period|Disease progression|169|||
170358791|NCT00510068|615649238|FG000|Double-blind Period|Final primary analysis|52|||
170358792|NCT00510068|615649239|FG001|Double-blind Period|Final primary analysis|18|||
170358793|NCT00510068|615649238|FG000|Double-blind Period|Adverse Event|37|||
170358794|NCT00510068|615649239|FG001|Double-blind Period|Adverse Event|7|||
170358795|NCT00510068|615649238|FG000|Double-blind Period|Withdrawal by Subject|8|||
170358796|NCT00510068|615649239|FG001|Double-blind Period|Withdrawal by Subject|6|||
170358797|NCT00510068|615649238|FG000|Double-blind Period|Death|4|||
170358798|NCT00510068|615649239|FG001|Double-blind Period|Death|3|||
170358799|NCT00510068|615649238|FG000|Double-blind Period|Abnormal test result (s)|1|||
170358800|NCT00510068|615649239|FG001|Double-blind Period|Abnormal test result (s)|0|||
170358801|NCT00510068|615649238|FG000|Double-blind Period|Lost to Follow-up|1|||
170358802|NCT00510068|615649239|FG001|Double-blind Period|Lost to Follow-up|0|||
170358803|NCT00510068|615649238|FG000|Double-blind Period|Protocol Violation|6|||
170358804|NCT00510068|615649239|FG001|Double-blind Period|Protocol Violation|0|||
170358805|NCT00510068|615649238|FG000|Open-label Period|Disease Progression|124|||
170358806|NCT00510068|615649239|FG001|Open-label Period|Disease Progression|0|||
170358807|NCT00510068|615649238|FG000|Open-label Period|Adverse Event|46|||
170358808|NCT00510068|615649239|FG001|Open-label Period|Adverse Event|0|||
170358809|NCT00510068|615649238|FG000|Open-label Period|Withdrawal by Subject|21|||
170358810|NCT00510068|615649239|FG001|Open-label Period|Withdrawal by Subject|0|||
170358811|NCT00510068|615649238|FG000|Open-label Period|Administrative problems|17|||
170358812|NCT00510068|615649239|FG001|Open-label Period|Administrative problems|0|||
170358813|NCT00510068|615649238|FG000|Open-label Period|Death|7|||
170358814|NCT00510068|615649239|FG001|Open-label Period|Death|0|||
170358815|NCT00510068|615649238|FG000|Open-label Period|New cancer therapy|7|||
170358816|NCT00510068|615649239|FG001|Open-label Period|New cancer therapy|0|||
170358817|NCT00510068|615649238|FG000|Open-label Period|Protocol Violation|2|||
170358818|NCT00510068|615649239|FG001|Open-label Period|Protocol Violation|0|||
170358819|NCT00510068|615649238|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
170358820|NCT00510068|615649239|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
170358821|NCT01397448|615649240|FG000|Overall Study|Adverse Event|4|||
170358822|NCT01397448|615649241|FG001|Overall Study|Adverse Event|4|||
170358823|NCT01397448|615649242|FG002|Overall Study|Adverse Event|6|||
170358824|NCT01397448|615649240|FG000|Overall Study|Withdrawal by Subject|4|||
170358825|NCT01397448|615649241|FG001|Overall Study|Withdrawal by Subject|4|||
170358826|NCT01397448|615649242|FG002|Overall Study|Withdrawal by Subject|3|||
170358827|NCT01397448|615649240|FG000|Overall Study|Lack of Efficacy|2|||
170358828|NCT01397448|615649241|FG001|Overall Study|Lack of Efficacy|0|||
170358829|NCT01397448|615649242|FG002|Overall Study|Lack of Efficacy|5|||
170358830|NCT01397448|615649240|FG000|Overall Study|Other|8|||
170358831|NCT01397448|615649241|FG001|Overall Study|Other|7|||
170358832|NCT01397448|615649242|FG002|Overall Study|Other|4|||
170358833|NCT00973921|615649243|FG000|Overall Study|IVUS results were not available|9|||
170358834|NCT00776555|615649248|FG000|Overall Study|Study terminated|3|||
170358835|NCT00776555|615649249|FG001|Overall Study|Study terminated|0|||
170358836|NCT02855450|615649252|FG000|Overall Study|Adverse Event|1|||
170358837|NCT02855450|615649253|FG001|Overall Study|Adverse Event|0|||
170358838|NCT02855450|615649252|FG000|Overall Study|Lost to Follow-up|4|||
170358839|NCT02855450|615649253|FG001|Overall Study|Lost to Follow-up|0|||
170358840|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
170358841|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
170358842|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
170358843|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
170358844|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
170358845|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
170358846|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Death|1|||
170358847|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Death|3|||
170358848|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
170358849|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
170358850|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
170358851|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
170358852|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
170358853|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
170358854|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
170358855|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
170358856|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
170358857|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
170358858|NCT02553317|615649254|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
170358859|NCT02553317|615649255|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
170358860|NCT00050960|615649261|FG000|Overall Study|Progressive Disease|137|||
170358861|NCT00050960|615649262|FG001|Overall Study|Progressive Disease|93|||
170358862|NCT00050960|615649261|FG000|Overall Study|Stable Disease|19|||
170358863|NCT00050960|615649262|FG001|Overall Study|Stable Disease|48|||
170358864|NCT00050960|615649261|FG000|Overall Study|Partial Response|14|||
170358865|NCT00050960|615649262|FG001|Overall Study|Partial Response|19|||
170358866|NCT00050960|615649261|FG000|Overall Study|Complete Response|0|||
170358867|NCT00050960|615649262|FG001|Overall Study|Complete Response|2|||
170358868|NCT00050960|615649261|FG000|Overall Study|Adverse Event|62|||
170358869|NCT00050960|615649262|FG001|Overall Study|Adverse Event|61|||
170358870|NCT00050960|615649261|FG000|Overall Study|Lost to Follow-up|0|||
170358871|NCT00050960|615649262|FG001|Overall Study|Lost to Follow-up|1|||
170358872|NCT00050960|615649261|FG000|Overall Study|Withdrawal by Subject|23|||
170358873|NCT00050960|615649262|FG001|Overall Study|Withdrawal by Subject|18|||
170358874|NCT00050960|615649261|FG000|Overall Study|Administrative|31|||
170358875|NCT00050960|615649262|FG001|Overall Study|Administrative|46|||
170358876|NCT00050960|615649261|FG000|Overall Study|Non-compliance|3|||
170358877|NCT00050960|615649262|FG001|Overall Study|Non-compliance|1|||
170358878|NCT00050960|615649261|FG000|Overall Study|Death|13|||
170358879|NCT00050960|615649262|FG001|Overall Study|Death|15|||
170358880|NCT02727660|615649263|FG000|Overall Study|Lack of Efficacy|40|||
170358881|NCT02727660|615649264|FG001|Overall Study|Lack of Efficacy|40|||
170358882|NCT02727660|615649265|FG002|Overall Study|Lack of Efficacy|70|||
170358883|NCT02727660|615649263|FG000|Overall Study|Adverse Event|28|||
170358884|NCT02727660|615649264|FG001|Overall Study|Adverse Event|21|||
170358885|NCT02727660|615649265|FG002|Overall Study|Adverse Event|32|||
170358886|NCT02727660|615649263|FG000|Overall Study|Withdrawal by Subject|26|||
170358887|NCT02727660|615649264|FG001|Overall Study|Withdrawal by Subject|25|||
170358888|NCT02727660|615649265|FG002|Overall Study|Withdrawal by Subject|30|||
170358889|NCT02727660|615649263|FG000|Overall Study|Physician Decision|3|||
170358890|NCT02727660|615649264|FG001|Overall Study|Physician Decision|8|||
170358891|NCT02727660|615649265|FG002|Overall Study|Physician Decision|14|||
170358892|NCT02727660|615649263|FG000|Overall Study|Lost to Follow-up|5|||
170358893|NCT02727660|615649264|FG001|Overall Study|Lost to Follow-up|9|||
170358894|NCT02727660|615649265|FG002|Overall Study|Lost to Follow-up|8|||
170358895|NCT02727660|615649263|FG000|Overall Study|Protocol Violation|7|||
170358896|NCT02727660|615649264|FG001|Overall Study|Protocol Violation|5|||
170358897|NCT02727660|615649265|FG002|Overall Study|Protocol Violation|5|||
170358898|NCT02727660|615649263|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
170358899|NCT02727660|615649264|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
170358900|NCT02727660|615649265|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
170358901|NCT02727660|615649263|FG000|Overall Study|Administrative Reasons|2|||
170358902|NCT02727660|615649264|FG001|Overall Study|Administrative Reasons|3|||
170358903|NCT02727660|615649265|FG002|Overall Study|Administrative Reasons|4|||
170358904|NCT01354431|615649266|FG000|Pre-Treatment Period|Not reported|1|||
170358905|NCT01354431|615649267|FG001|Pre-Treatment Period|Not reported|0|||
170358906|NCT01354431|615649268|FG002|Pre-Treatment Period|Not reported|0|||
170358907|NCT01354431|615649266|FG000|Treatment Period|Disease Progression|50|||
170358908|NCT01354431|615649267|FG001|Treatment Period|Disease Progression|40|||
170358909|NCT01354431|615649268|FG002|Treatment Period|Disease Progression|44|||
170358910|NCT01354431|615649266|FG000|Treatment Period|Study Drug Toxicity|5|||
170358911|NCT01354431|615649267|FG001|Treatment Period|Study Drug Toxicity|8|||
170358912|NCT01354431|615649268|FG002|Treatment Period|Study Drug Toxicity|4|||
170358913|NCT01354431|615649266|FG000|Treatment Period|Death|0|||
170358914|NCT01354431|615649267|FG001|Treatment Period|Death|1|||
170358915|NCT01354431|615649268|FG002|Treatment Period|Death|0|||
170358916|NCT01354431|615649266|FG000|Treatment Period|AE unrelated to study drug|1|||
170358917|NCT01354431|615649267|FG001|Treatment Period|AE unrelated to study drug|2|||
170358918|NCT01354431|615649268|FG002|Treatment Period|AE unrelated to study drug|5|||
170358919|NCT01354431|615649266|FG000|Treatment Period|Participant request to discontinue|2|||
170358920|NCT01354431|615649267|FG001|Treatment Period|Participant request to discontinue|2|||
170358921|NCT01354431|615649268|FG002|Treatment Period|Participant request to discontinue|1|||
170358922|NCT01354431|615649266|FG000|Treatment Period|Participant withdrew consent|0|||
170358923|NCT01354431|615649267|FG001|Treatment Period|Participant withdrew consent|1|||
170358924|NCT01354431|615649268|FG002|Treatment Period|Participant withdrew consent|0|||
170358925|NCT01354431|615649266|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
170358926|NCT01354431|615649267|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
170358927|NCT01354431|615649268|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
170358928|NCT03176277|615649269|FG000|Part A Dose Escalation Study|Adverse Event|1|||
170358929|NCT03176277|615649270|FG001|Part A Dose Escalation Study|Adverse Event|0|||
170358930|NCT03176277|615649271|FG002|Part A Dose Escalation Study|Adverse Event|1|||
170358931|NCT03176277|615649272|FG003|Part A Dose Escalation Study|Adverse Event|0|||
170358932|NCT03176277|615649269|FG000|Part A Dose Escalation Study|Physician Decision|1|||
170358933|NCT03176277|615649270|FG001|Part A Dose Escalation Study|Physician Decision|1|||
170358934|NCT03176277|615649271|FG002|Part A Dose Escalation Study|Physician Decision|2|||
170358935|NCT03176277|615649272|FG003|Part A Dose Escalation Study|Physician Decision|0|||
170358936|NCT03176277|615649269|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
170358937|NCT03176277|615649270|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
170358938|NCT03176277|615649271|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
170358939|NCT03176277|615649272|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
170358940|NCT03176277|615649269|FG000|Part A Dose Escalation Study|Progressive disease|3|||
170358941|NCT03176277|615649270|FG001|Part A Dose Escalation Study|Progressive disease|1|||
170358942|NCT03176277|615649271|FG002|Part A Dose Escalation Study|Progressive disease|3|||
170358943|NCT03176277|615649272|FG003|Part A Dose Escalation Study|Progressive disease|0|||
170358944|NCT00634114|615649273|FG000|Overall Study|Adverse Event|6|||
170358945|NCT00634114|615649274|FG001|Overall Study|Adverse Event|8|||
170358946|NCT00634114|615649275|FG002|Overall Study|Adverse Event|3|||
170358947|NCT00634114|615649273|FG000|Overall Study|Withdrawal by Subject|9|||
170358948|NCT00634114|615649274|FG001|Overall Study|Withdrawal by Subject|6|||
170358949|NCT00634114|615649275|FG002|Overall Study|Withdrawal by Subject|11|||
170358950|NCT00634114|615649273|FG000|Overall Study|Lost to Follow-up|0|||
170358951|NCT00634114|615649274|FG001|Overall Study|Lost to Follow-up|0|||
170358952|NCT00634114|615649275|FG002|Overall Study|Lost to Follow-up|1|||
170358953|NCT00634114|615649273|FG000|Overall Study|Protocol Violation|3|||
170358954|NCT00634114|615649274|FG001|Overall Study|Protocol Violation|3|||
170358955|NCT00634114|615649275|FG002|Overall Study|Protocol Violation|1|||
170358956|NCT00634114|615649273|FG000|Overall Study|Pregnancy|1|||
170358957|NCT00634114|615649274|FG001|Overall Study|Pregnancy|0|||
170358958|NCT00634114|615649275|FG002|Overall Study|Pregnancy|0|||
170358959|NCT00634114|615649273|FG000|Overall Study|Incorrect enrolment|0|||
170358960|NCT00634114|615649274|FG001|Overall Study|Incorrect enrolment|1|||
170358961|NCT00634114|615649275|FG002|Overall Study|Incorrect enrolment|0|||
170358962|NCT00634114|615649273|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
170358963|NCT00634114|615649274|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
170358964|NCT00634114|615649275|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
170358965|NCT00634114|615649273|FG000|Overall Study|Difficult to continue|3|||
170358966|NCT00634114|615649274|FG001|Overall Study|Difficult to continue|1|||
170358967|NCT00634114|615649275|FG002|Overall Study|Difficult to continue|1|||
170358968|NCT00634114|615649273|FG000|Overall Study|Other reason|1|||
170358969|NCT00634114|615649274|FG001|Overall Study|Other reason|1|||
170358970|NCT00634114|615649275|FG002|Overall Study|Other reason|1|||
170358971|NCT00702052|615649276|FG000|Overall Study|Adverse Event|23|||
170358972|NCT00702052|615649276|FG000|Overall Study|Disease Progression|30|||
170358973|NCT00702052|615649276|FG000|Overall Study|Withdrawal by Subject|5|||
170358974|NCT03691610|615649277|FG000|Overall Study|Adverse Event|0|||
170358975|NCT03691610|615649278|FG001|Overall Study|Adverse Event|1|||
170358976|NCT03691610|615649279|FG002|Overall Study|Adverse Event|0|||
170358977|NCT03691610|615649280|FG003|Overall Study|Adverse Event|0|||
170358978|NCT03691610|615649277|FG000|Overall Study|Protocol Deviation|15|||
170358979|NCT03691610|615649278|FG001|Overall Study|Protocol Deviation|8|||
170358980|NCT03691610|615649279|FG002|Overall Study|Protocol Deviation|1|||
170358981|NCT03691610|615649280|FG003|Overall Study|Protocol Deviation|2|||
170358982|NCT03691610|615649277|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
170358983|NCT03691610|615649278|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
170358984|NCT03691610|615649279|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
170358985|NCT03691610|615649280|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
170358986|NCT03691610|615649277|FG000|Overall Study|Lost to Follow-up|20|||
170358987|NCT03691610|615649278|FG001|Overall Study|Lost to Follow-up|11|||
170358988|NCT03691610|615649279|FG002|Overall Study|Lost to Follow-up|5|||
170358989|NCT03691610|615649280|FG003|Overall Study|Lost to Follow-up|2|||
170358990|NCT02756650|615649281|FG000|Overall Study|Physician Decision|1|||
170358991|NCT02756650|615649281|FG000|Overall Study|Adverse Event|1|||
170358992|NCT00302718|615649287|FG000|Overall Study|Participant left the hospital|1|||
170358993|NCT00302718|615649288|FG001|Overall Study|Participant left the hospital|0|||
170358994|NCT00302718|615649289|FG002|Overall Study|Participant left the hospital|0|||
170358995|NCT00302718|615649290|FG003|Overall Study|Participant left the hospital|1|||
170358996|NCT00302718|615649287|FG000|Overall Study|Withdrawal by Subject|0|||
170358997|NCT00302718|615649288|FG001|Overall Study|Withdrawal by Subject|1|||
170358998|NCT00302718|615649289|FG002|Overall Study|Withdrawal by Subject|0|||
170358999|NCT00302718|615649290|FG003|Overall Study|Withdrawal by Subject|0|||
170359000|NCT00302718|615649287|FG000|Overall Study|Participant left primary care setting|0|||
170359001|NCT00302718|615649288|FG001|Overall Study|Participant left primary care setting|0|||
170359002|NCT00302718|615649289|FG002|Overall Study|Participant left primary care setting|2|||
170359003|NCT00302718|615649290|FG003|Overall Study|Participant left primary care setting|1|||
170359004|NCT02927873|615649291|FG000|Overall Study|Lost to Follow-up|0|||
170359005|NCT02927873|615649292|FG001|Overall Study|Lost to Follow-up|1|||
170359006|NCT02927873|615649293|FG002|Overall Study|Lost to Follow-up|0|||
170359007|NCT02927873|615649294|FG003|Overall Study|Lost to Follow-up|0|||
170359008|NCT02927873|615649295|FG004|Overall Study|Lost to Follow-up|0|||
170359009|NCT02927873|615649296|FG005|Overall Study|Lost to Follow-up|0|||
170359010|NCT02927873|615649291|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170359011|NCT02927873|615649292|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
170359012|NCT02927873|615649293|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170359013|NCT02927873|615649294|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170359014|NCT02927873|615649295|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170359015|NCT02927873|615649296|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
170359016|NCT02927873|615649291|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170359017|NCT02927873|615649292|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170359018|NCT02927873|615649293|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170359019|NCT02927873|615649294|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170359020|NCT02927873|615649295|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
170359021|NCT02927873|615649296|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
170359022|NCT02927873|615649291|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
170359023|NCT02927873|615649292|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
170359024|NCT02927873|615649293|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
170359025|NCT02927873|615649294|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
170359026|NCT02927873|615649295|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
170359027|NCT02927873|615649296|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
170359028|NCT02927873|615649291|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
170359029|NCT02927873|615649292|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
170359030|NCT02927873|615649293|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
170359031|NCT02927873|615649294|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
170359032|NCT02927873|615649295|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
170359033|NCT02927873|615649296|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
170359034|NCT02927873|615649291|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
170359035|NCT02927873|615649292|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
170359036|NCT02927873|615649293|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
170359037|NCT02927873|615649294|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
170359038|NCT02927873|615649295|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
170359039|NCT02927873|615649296|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
170359040|NCT00393913|615649297|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
170359041|NCT00393913|615649297|FG000|Initial Assessment|Withdrawal by Subject|16|||
170359042|NCT00393913|615649297|FG000|CPAP|Withdrawal by Subject|3|||
170359043|NCT00393913|615649297|FG000|CPAP|Physician Decision|1|||
170359044|NCT00393913|615649297|FG000|CPAP|TEchnical problem with CPAP|3|||
170359045|NCT04900038|615649299|FG000|Overall Study|Adverse Event|1|||
170359046|NCT04900038|615649300|FG001|Overall Study|Adverse Event|0|||
170359047|NCT04900038|615649301|FG002|Overall Study|Adverse Event|1|||
170359048|NCT04900038|615649302|FG003|Overall Study|Adverse Event|1|||
170359049|NCT04900038|615649299|FG000|Overall Study|Withdrawal by Subject|0|||
170359050|NCT04900038|615649300|FG001|Overall Study|Withdrawal by Subject|1|||
170359051|NCT04900038|615649301|FG002|Overall Study|Withdrawal by Subject|0|||
170359052|NCT04900038|615649302|FG003|Overall Study|Withdrawal by Subject|0|||
170359053|NCT04900038|615649299|FG000|Overall Study|Study terminated by sponsor|18|||
170359054|NCT04900038|615649300|FG001|Overall Study|Study terminated by sponsor|15|||
170359055|NCT04900038|615649301|FG002|Overall Study|Study terminated by sponsor|17|||
170359056|NCT04900038|615649302|FG003|Overall Study|Study terminated by sponsor|14|||
170359057|NCT04900038|615649299|FG000|Overall Study|Protocol Deviation|1|||
170359058|NCT04900038|615649300|FG001|Overall Study|Protocol Deviation|1|||
170359059|NCT04900038|615649301|FG002|Overall Study|Protocol Deviation|0|||
170359060|NCT04900038|615649302|FG003|Overall Study|Protocol Deviation|0|||
170359061|NCT04900038|615649299|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
170359062|NCT04900038|615649300|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
170359063|NCT04900038|615649301|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
170359064|NCT04900038|615649302|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
170359065|NCT04900038|615649299|FG000|Overall Study|Lost to Follow-up|0|||
170359066|NCT04900038|615649300|FG001|Overall Study|Lost to Follow-up|0|||
170359067|NCT04900038|615649301|FG002|Overall Study|Lost to Follow-up|0|||
170359068|NCT04900038|615649302|FG003|Overall Study|Lost to Follow-up|1|||
170359069|NCT00594204|615649303|FG000|Overall Study|Adverse Event|15|||
170359070|NCT00594204|615649304|FG001|Overall Study|Adverse Event|3|||
170359071|NCT00594204|615649303|FG000|Overall Study|Lost to Follow-up|9|||
170359072|NCT00594204|615649304|FG001|Overall Study|Lost to Follow-up|5|||
170359073|NCT00594204|615649303|FG000|Overall Study|Withdrawal by Subject|23|||
170359074|NCT00594204|615649304|FG001|Overall Study|Withdrawal by Subject|29|||
170359075|NCT00594204|615649303|FG000|Overall Study|Other|4|||
170359076|NCT00594204|615649304|FG001|Overall Study|Other|3|||
170359077|NCT00594204|615649303|FG000|Overall Study|Lack of Efficacy|3|||
170359078|NCT00594204|615649304|FG001|Overall Study|Lack of Efficacy|4|||
170359079|NCT00594204|615649303|FG000|Overall Study|Randomized but not treated|4|||
170359080|NCT00594204|615649304|FG001|Overall Study|Randomized but not treated|1|||
170359081|NCT01054976|615649309|FG000|Overall Study|Adverse Event|16|||
170359082|NCT01054976|615649309|FG000|Overall Study|Uncooperative participations to study|7|||
170359083|NCT01054976|615649309|FG000|Overall Study|Withdrawal by Subject|4|||
170359084|NCT01054976|615649309|FG000|Overall Study|Other|8|||
170359085|NCT01641991|615649310|FG000|Overall Study|Physician Decision|0|||
170359086|NCT01641991|615649311|FG001|Overall Study|Physician Decision|1|||
170359087|NCT01641991|615649312|FG002|Overall Study|Physician Decision|7|||
170359088|NCT01641991|615649313|FG003|Overall Study|Physician Decision|5|||
170359089|NCT01641991|615649310|FG000|Overall Study|Withdrawal by Subject|4|||
170359090|NCT01641991|615649311|FG001|Overall Study|Withdrawal by Subject|2|||
170359091|NCT01641991|615649312|FG002|Overall Study|Withdrawal by Subject|1|||
170359092|NCT01641991|615649313|FG003|Overall Study|Withdrawal by Subject|5|||
170359093|NCT01641991|615649310|FG000|Overall Study|Adverse Event|2|||
170359094|NCT01641991|615649311|FG001|Overall Study|Adverse Event|1|||
170359095|NCT01641991|615649312|FG002|Overall Study|Adverse Event|2|||
170359096|NCT01641991|615649313|FG003|Overall Study|Adverse Event|1|||
170359097|NCT01641991|615649310|FG000|Overall Study|Lost to Follow-up|0|||
170359098|NCT01641991|615649311|FG001|Overall Study|Lost to Follow-up|2|||
170359099|NCT01641991|615649312|FG002|Overall Study|Lost to Follow-up|3|||
170359100|NCT01641991|615649313|FG003|Overall Study|Lost to Follow-up|1|||
170359101|NCT01641991|615649310|FG000|Overall Study|Protocol Violation|1|||
170359102|NCT01641991|615649311|FG001|Overall Study|Protocol Violation|1|||
170359103|NCT01641991|615649312|FG002|Overall Study|Protocol Violation|3|||
170359104|NCT01641991|615649313|FG003|Overall Study|Protocol Violation|0|||
170359105|NCT01641991|615649310|FG000|Overall Study|Pregnancy|0|||
170359106|NCT01641991|615649311|FG001|Overall Study|Pregnancy|0|||
170359107|NCT01641991|615649312|FG002|Overall Study|Pregnancy|1|||
170359108|NCT01641991|615649313|FG003|Overall Study|Pregnancy|0|||
170359109|NCT01641991|615649310|FG000|Overall Study|no longer eligible|2|||
170359110|NCT01641991|615649311|FG001|Overall Study|no longer eligible|1|||
170359111|NCT01641991|615649312|FG002|Overall Study|no longer eligible|0|||
170359112|NCT01641991|615649313|FG003|Overall Study|no longer eligible|4|||
170359113|NCT00475540|615649317|FG000|36 Months|Lost to Follow-up|4|||
170359114|NCT00475540|615649318|FG001|36 Months|Lost to Follow-up|4|||
170359115|NCT00475540|615649317|FG000|36 Months|Death|1|||
170359116|NCT00475540|615649318|FG001|36 Months|Death|2|||
170359117|NCT00475540|615649317|FG000|36 Months|Censored due to reoperation|3|||
170359118|NCT00475540|615649318|FG001|36 Months|Censored due to reoperation|0|||
170359119|NCT06422377|615650870|FG000|Overall Study|Study Terminated by Sponsor|1|||
170359120|NCT00453180|615650871|FG000|Overall Study|Lost to Follow-up|2|||
170359121|NCT00453180|615650872|FG001|Overall Study|Lost to Follow-up|1|||
170359122|NCT00453180|615650871|FG000|Overall Study|Adverse Event|1|||
170359123|NCT00453180|615650872|FG001|Overall Study|Adverse Event|2|||
170359124|NCT00804843|615650873|FG000|Overall Study|Protocol Violation|1|||
170359125|NCT00804843|615650874|FG001|Overall Study|Protocol Violation|0|||
170359126|NCT00804843|615650873|FG000|Overall Study|Adverse Event|8|||
170359127|NCT00804843|615650874|FG001|Overall Study|Adverse Event|5|||
170359128|NCT00804843|615650873|FG000|Overall Study|Withdrawal by Subject|1|||
170359129|NCT00804843|615650874|FG001|Overall Study|Withdrawal by Subject|2|||
170359130|NCT04507776|615650876|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
170359131|NCT00505752|615650879|FG000|Overall Study|Adverse Event|1|||
170359132|NCT00505752|615650880|FG001|Overall Study|Adverse Event|0|||
170359133|NCT00505752|615650881|FG002|Overall Study|Adverse Event|1|||
170359134|NCT00505752|615650882|FG003|Overall Study|Adverse Event|0|||
170359135|NCT00505752|615650879|FG000|Overall Study|Lost to Follow-up|1|||
170359136|NCT00505752|615650880|FG001|Overall Study|Lost to Follow-up|0|||
170359137|NCT00505752|615650881|FG002|Overall Study|Lost to Follow-up|0|||
170359138|NCT00505752|615650882|FG003|Overall Study|Lost to Follow-up|0|||
170359139|NCT00505752|615650879|FG000|Overall Study|Lack of ovarian response|1|||
170359140|NCT00505752|615650880|FG001|Overall Study|Lack of ovarian response|3|||
170359141|NCT00505752|615650881|FG002|Overall Study|Lack of ovarian response|0|||
170359142|NCT00505752|615650882|FG003|Overall Study|Lack of ovarian response|0|||
170359143|NCT00505752|615650879|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
170359144|NCT00505752|615650880|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
170359145|NCT00505752|615650881|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
170359146|NCT00505752|615650882|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
170359147|NCT00505752|615650879|FG000|Overall Study|No oocytes retrieved|0|||
170359148|NCT00505752|615650880|FG001|Overall Study|No oocytes retrieved|2|||
170359149|NCT00505752|615650881|FG002|Overall Study|No oocytes retrieved|0|||
170359150|NCT00505752|615650882|FG003|Overall Study|No oocytes retrieved|1|||
170359151|NCT00505752|615650879|FG000|Overall Study|No Fertilization|1|||
170359152|NCT00505752|615650880|FG001|Overall Study|No Fertilization|1|||
170359153|NCT00505752|615650881|FG002|Overall Study|No Fertilization|2|||
170359154|NCT00505752|615650882|FG003|Overall Study|No Fertilization|1|||
170359155|NCT00505752|615650879|FG000|Overall Study|All embryos/blastocysts discarded|0|||
170359156|NCT00505752|615650880|FG001|Overall Study|All embryos/blastocysts discarded|0|||
170359157|NCT00505752|615650881|FG002|Overall Study|All embryos/blastocysts discarded|1|||
170359158|NCT00505752|615650882|FG003|Overall Study|All embryos/blastocysts discarded|1|||
170359159|NCT00505752|615650879|FG000|Overall Study|Other|1|||
170359160|NCT00505752|615650880|FG001|Overall Study|Other|2|||
170359161|NCT00505752|615650881|FG002|Overall Study|Other|1|||
170359162|NCT00505752|615650882|FG003|Overall Study|Other|2|||
170359163|NCT05905601|615650883|FG000|Overall Study|Lost to Follow-up|1|||
170359164|NCT05905601|615650884|FG001|Overall Study|Lost to Follow-up|3|||
170359165|NCT00225147|615650885|FG000|Open-label Phase|Lost to Follow-up|0|||
170359166|NCT00225147|615650886|FG001|Open-label Phase|Lost to Follow-up|0|||
170359167|NCT00225147|615650887|FG002|Open-label Phase|Lost to Follow-up|0|||
170359168|NCT00225147|615650888|FG003|Open-label Phase|Lost to Follow-up|4|||
170359169|NCT00225147|615650885|FG000|Open-label Phase|Withdrawal by Subject|0|||
170359170|NCT00225147|615650886|FG001|Open-label Phase|Withdrawal by Subject|0|||
170359171|NCT00225147|615650887|FG002|Open-label Phase|Withdrawal by Subject|0|||
170359172|NCT00225147|615650888|FG003|Open-label Phase|Withdrawal by Subject|6|||
170359173|NCT03625141|615650891|FG000|Overall Study|Adverse Event|0|||
170359174|NCT03625141|615650892|FG001|Overall Study|Adverse Event|2|||
170359175|NCT03625141|615650891|FG000|Overall Study|Study Terminated By Sponsor|1|||
170359176|NCT03625141|615650892|FG001|Overall Study|Study Terminated By Sponsor|13|||
170359177|NCT03625141|615650891|FG000|Overall Study|Withdrawal by Subject|3|||
170359178|NCT03625141|615650892|FG001|Overall Study|Withdrawal by Subject|0|||
170359179|NCT03625141|615650891|FG000|Overall Study|Withdrawal Of Consent|0|||
170359180|NCT03625141|615650892|FG001|Overall Study|Withdrawal Of Consent|1|||
170359181|NCT03625141|615650891|FG000|Overall Study|Death|11|||
170359182|NCT03625141|615650892|FG001|Overall Study|Death|47|||
170359183|NCT03625141|615650891|FG000|Overall Study|Progressive Disease|0|||
170359184|NCT03625141|615650892|FG001|Overall Study|Progressive Disease|2|||
170359185|NCT03250377|615650893|FG000|Overall Study|Adverse Event|2|||
170359186|NCT03250377|615650894|FG001|Overall Study|Adverse Event|4|||
170359187|NCT03250377|615650895|FG002|Overall Study|Adverse Event|0|||
170359188|NCT03250377|615650896|FG003|Overall Study|Adverse Event|4|||
170359189|NCT03250377|615650893|FG000|Overall Study|Lack of Efficacy|5|||
170359190|NCT03250377|615650894|FG001|Overall Study|Lack of Efficacy|14|||
170359191|NCT03250377|615650895|FG002|Overall Study|Lack of Efficacy|1|||
170359192|NCT03250377|615650896|FG003|Overall Study|Lack of Efficacy|3|||
170359193|NCT03250377|615650893|FG000|Overall Study|Protocol Violation|0|||
170359194|NCT03250377|615650894|FG001|Overall Study|Protocol Violation|2|||
170359195|NCT03250377|615650895|FG002|Overall Study|Protocol Violation|0|||
170359196|NCT03250377|615650896|FG003|Overall Study|Protocol Violation|1|||
170359197|NCT03250377|615650893|FG000|Overall Study|Lost to Follow-up|0|||
170359198|NCT03250377|615650894|FG001|Overall Study|Lost to Follow-up|1|||
170359199|NCT03250377|615650895|FG002|Overall Study|Lost to Follow-up|0|||
170359200|NCT03250377|615650896|FG003|Overall Study|Lost to Follow-up|0|||
170359201|NCT03250377|615650893|FG000|Overall Study|Withdrawal by Subject|7|||
170359202|NCT03250377|615650894|FG001|Overall Study|Withdrawal by Subject|7|||
170359203|NCT03250377|615650895|FG002|Overall Study|Withdrawal by Subject|0|||
170359204|NCT03250377|615650896|FG003|Overall Study|Withdrawal by Subject|4|||
170359205|NCT03250377|615650893|FG000|Overall Study|Investigator's Judgment|1|||
170398667|NCT02957682|615798231|FG001|Overall Study|Non-disclosed|12|||
170359206|NCT03250377|615650894|FG001|Overall Study|Investigator's Judgment|0|||
170359207|NCT03250377|615650895|FG002|Overall Study|Investigator's Judgment|0|||
170359208|NCT03250377|615650896|FG003|Overall Study|Investigator's Judgment|0|||
170359209|NCT03250377|615650893|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
170359210|NCT03250377|615650894|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
170359211|NCT03250377|615650895|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
170359212|NCT03250377|615650896|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
170359213|NCT03250377|615650893|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
170359214|NCT03250377|615650894|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
170359215|NCT03250377|615650895|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
170359216|NCT03250377|615650896|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
170359217|NCT03250377|615650893|FG000|Overall Study|Epilepsy Surgery|0|||
170359218|NCT03250377|615650894|FG001|Overall Study|Epilepsy Surgery|1|||
170359219|NCT03250377|615650895|FG002|Overall Study|Epilepsy Surgery|2|||
170359220|NCT03250377|615650896|FG003|Overall Study|Epilepsy Surgery|0|||
170359221|NCT03250377|615650893|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
170359222|NCT03250377|615650894|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
170359223|NCT03250377|615650895|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
170359224|NCT03250377|615650896|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
170359225|NCT03250377|615650893|FG000|Overall Study|Request From The Sponsor|0|||
170359226|NCT03250377|615650894|FG001|Overall Study|Request From The Sponsor|1|||
170359227|NCT03250377|615650895|FG002|Overall Study|Request From The Sponsor|0|||
170359228|NCT03250377|615650896|FG003|Overall Study|Request From The Sponsor|0|||
170359229|NCT03250377|615650893|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
170359230|NCT03250377|615650894|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
170359231|NCT03250377|615650895|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
170359232|NCT03250377|615650896|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
170359233|NCT03250377|615650893|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
170359234|NCT03250377|615650894|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
170359235|NCT03250377|615650895|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
170359236|NCT03250377|615650896|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
170359237|NCT03250377|615650893|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
170359238|NCT03250377|615650894|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
170359239|NCT03250377|615650895|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
170359240|NCT03250377|615650896|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
170359241|NCT03250377|615650893|FG000|Overall Study|Pregnancy Event|0|||
170359242|NCT03250377|615650894|FG001|Overall Study|Pregnancy Event|1|||
170359243|NCT03250377|615650895|FG002|Overall Study|Pregnancy Event|0|||
170359244|NCT03250377|615650896|FG003|Overall Study|Pregnancy Event|0|||
170359245|NCT03250377|615650893|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
170359246|NCT03250377|615650894|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
170359247|NCT03250377|615650895|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
170359248|NCT03250377|615650896|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
170359249|NCT03250377|615650893|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
170359250|NCT03250377|615650894|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
170359251|NCT03250377|615650895|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
170359252|NCT03250377|615650896|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
170359253|NCT03250377|615650893|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
170359254|NCT03250377|615650894|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
170359255|NCT03250377|615650895|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
170359256|NCT03250377|615650896|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
170359257|NCT03250377|615650893|FG000|Overall Study|Patient requested to change hospital|0|||
170359258|NCT03250377|615650894|FG001|Overall Study|Patient requested to change hospital|0|||
170359259|NCT03250377|615650895|FG002|Overall Study|Patient requested to change hospital|0|||
170359260|NCT03250377|615650896|FG003|Overall Study|Patient requested to change hospital|1|||
170359261|NCT03250377|615650893|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
170359262|NCT03250377|615650894|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
170359263|NCT03250377|615650895|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
170359264|NCT03250377|615650896|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
170359265|NCT00868166|615650897|FG000|Overall Study|Death|58|||
170359266|NCT00868166|615650898|FG001|Overall Study|Death|65|||
170359267|NCT00868166|615650897|FG000|Overall Study|Withdrawal by Subject|33|||
170359268|NCT00868166|615650898|FG001|Overall Study|Withdrawal by Subject|25|||
170359269|NCT00868166|615650897|FG000|Overall Study|Protocol Violation|1|||
170359270|NCT00868166|615650898|FG001|Overall Study|Protocol Violation|0|||
170359271|NCT00868166|615650897|FG000|Overall Study|Lost to Follow-up|1|||
170359272|NCT00868166|615650898|FG001|Overall Study|Lost to Follow-up|3|||
170359273|NCT00868166|615650897|FG000|Overall Study|Adverse Event|9|||
170359274|NCT00868166|615650898|FG001|Overall Study|Adverse Event|10|||
170359275|NCT00868166|615650897|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
170359276|NCT00868166|615650898|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
170359277|NCT00868166|615650897|FG000|Overall Study|Non-compliance with IMP|1|||
170359278|NCT00868166|615650898|FG001|Overall Study|Non-compliance with IMP|1|||
170359279|NCT02501902|615650906|FG000|Overall Study|Subject Refused Further Follow-up|0|||
170359280|NCT02501902|615650907|FG001|Overall Study|Subject Refused Further Follow-up|0|||
170359281|NCT02501902|615650908|FG002|Overall Study|Subject Refused Further Follow-up|0|||
170359282|NCT02501902|615650909|FG003|Overall Study|Subject Refused Further Follow-up|0|||
170359283|NCT02501902|615650910|FG004|Overall Study|Subject Refused Further Follow-up|0|||
170359284|NCT02501902|615650911|FG005|Overall Study|Subject Refused Further Follow-up|0|||
170359285|NCT02501902|615650912|FG006|Overall Study|Subject Refused Further Follow-up|0|||
170359286|NCT02501902|615650913|FG007|Overall Study|Subject Refused Further Follow-up|1|||
170359287|NCT02501902|615650906|FG000|Overall Study|Study Terminated by Sponsor|0|||
170359288|NCT02501902|615650907|FG001|Overall Study|Study Terminated by Sponsor|3|||
170359289|NCT02501902|615650908|FG002|Overall Study|Study Terminated by Sponsor|0|||
170359290|NCT02501902|615650909|FG003|Overall Study|Study Terminated by Sponsor|1|||
170359291|NCT02501902|615650910|FG004|Overall Study|Study Terminated by Sponsor|1|||
170359292|NCT02501902|615650911|FG005|Overall Study|Study Terminated by Sponsor|0|||
170359293|NCT02501902|615650912|FG006|Overall Study|Study Terminated by Sponsor|2|||
170359294|NCT02501902|615650913|FG007|Overall Study|Study Terminated by Sponsor|4|||
170359295|NCT02501902|615650906|FG000|Overall Study|Death|3|||
170359296|NCT02501902|615650907|FG001|Overall Study|Death|4|||
170359297|NCT02501902|615650908|FG002|Overall Study|Death|4|||
170359298|NCT02501902|615650909|FG003|Overall Study|Death|10|||
170359299|NCT02501902|615650910|FG004|Overall Study|Death|10|||
170359300|NCT02501902|615650911|FG005|Overall Study|Death|11|||
170359301|NCT02501902|615650912|FG006|Overall Study|Death|7|||
170359302|NCT02501902|615650913|FG007|Overall Study|Death|15|||
170359303|NCT02267278|615650914|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
170359304|NCT02267278|615650914|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
170359305|NCT02267278|615650914|FG000|Overall Study|Developed new cancer diagnoses|2|||
170359306|NCT02267278|615650914|FG000|Overall Study|prescribed prohibited medication|1|||
170359307|NCT03939637|615650920|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
170359308|NCT03939637|615650921|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
170359309|NCT03939637|615650920|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
170359310|NCT03939637|615650921|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
170359311|NCT01381718|615650922|FG000|Overall Study|Withdrawal by Subject|2|||
170359312|NCT01381718|615650923|FG001|Overall Study|Withdrawal by Subject|5|||
170359313|NCT01381718|615650922|FG000|Overall Study|Lost to Follow-up|3|||
170359314|NCT01381718|615650923|FG001|Overall Study|Lost to Follow-up|5|||
170359315|NCT01381718|615650922|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
170359316|NCT01381718|615650923|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
170359317|NCT01360762|615650926|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
170359318|NCT01360762|615650926|FG000|Main Study Period (12-month Treatment)|Death|5|||
170359319|NCT01360762|615650926|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
170359320|NCT01360762|615650926|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
170359321|NCT01360762|615650926|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
170359322|NCT01360762|615650926|FG000|Whole Study Period|Lost to Follow-up|10|||
170359323|NCT01360762|615650926|FG000|Whole Study Period|Death|7|||
170359324|NCT01360762|615650926|FG000|Whole Study Period|Patient relapsed|18|||
170359325|NCT01360762|615650926|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
170359326|NCT03067129|615650927|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
170359327|NCT03067129|615650928|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
170359328|NCT03067129|615650929|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
170359329|NCT03067129|615650930|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
170359330|NCT03067129|615650927|FG000|Overall Study|Withdrawal by Subject|0|||
170359331|NCT03067129|615650928|FG001|Overall Study|Withdrawal by Subject|0|||
170359332|NCT03067129|615650929|FG002|Overall Study|Withdrawal by Subject|1|||
170359333|NCT03067129|615650930|FG003|Overall Study|Withdrawal by Subject|2|||
170359334|NCT03067129|615650927|FG000|Overall Study|Lost to Follow-up|5|||
170359335|NCT03067129|615650928|FG001|Overall Study|Lost to Follow-up|5|||
170359336|NCT03067129|615650929|FG002|Overall Study|Lost to Follow-up|4|||
170359337|NCT03067129|615650930|FG003|Overall Study|Lost to Follow-up|3|||
170359338|NCT03986190|615650931|FG000|Overall Study|Withdrawal by Subject|12|||
170359339|NCT03986190|615650932|FG001|Overall Study|Withdrawal by Subject|0|||
170359340|NCT00091026|615650933|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
170359341|NCT00091026|615650934|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
170359342|NCT00091026|615650933|FG000|Overall Study|Patient withdrew and never received trea|0|||
170359343|NCT00091026|615650934|FG001|Overall Study|Patient withdrew and never received trea|2|||
170359344|NCT00091026|615650933|FG000|Overall Study|Unknown-never received treatment|0|||
170359345|NCT00091026|615650934|FG001|Overall Study|Unknown-never received treatment|1|||
170359346|NCT01588353|615650940|FG000|Step2|Withdrawal by Subject|0|||
170359347|NCT01588353|615650941|FG001|Step2|Withdrawal by Subject|1|||
170359348|NCT01588353|615650942|FG002|Step2|Withdrawal by Subject|0|||
170359349|NCT01588353|615650940|FG000|Step3|Adverse Event|0|||
170359350|NCT01588353|615650941|FG001|Step3|Adverse Event|0|||
170359351|NCT01588353|615650942|FG002|Step3|Adverse Event|2|||
170359352|NCT00830960|615650944|FG000|Overall Study|Death|5|||
170359353|NCT00830960|615650945|FG001|Overall Study|Death|4|||
170359354|NCT00830960|615650946|FG002|Overall Study|Death|3|||
170359355|NCT00830960|615650947|FG003|Overall Study|Death|2|||
170359356|NCT00830960|615650948|FG004|Overall Study|Death|6|||
170359357|NCT00830960|615650949|FG005|Overall Study|Death|1|||
170359358|NCT00830960|615650944|FG000|Overall Study|Lost to Follow-up|1|||
170359359|NCT00830960|615650945|FG001|Overall Study|Lost to Follow-up|1|||
170359360|NCT00830960|615650946|FG002|Overall Study|Lost to Follow-up|1|||
170359361|NCT00830960|615650947|FG003|Overall Study|Lost to Follow-up|0|||
170359362|NCT00830960|615650948|FG004|Overall Study|Lost to Follow-up|0|||
170359363|NCT00830960|615650949|FG005|Overall Study|Lost to Follow-up|1|||
170359364|NCT00830960|615650944|FG000|Overall Study|Withdrawal by Subject|19|||
170359365|NCT00830960|615650945|FG001|Overall Study|Withdrawal by Subject|19|||
170359366|NCT00830960|615650946|FG002|Overall Study|Withdrawal by Subject|18|||
170359367|NCT00830960|615650947|FG003|Overall Study|Withdrawal by Subject|23|||
170359368|NCT00830960|615650948|FG004|Overall Study|Withdrawal by Subject|16|||
170359369|NCT00830960|615650949|FG005|Overall Study|Withdrawal by Subject|21|||
170359370|NCT00830960|615650944|FG000|Overall Study|Sponsor Decision|1|||
170359371|NCT00830960|615650945|FG001|Overall Study|Sponsor Decision|2|||
170359372|NCT00830960|615650946|FG002|Overall Study|Sponsor Decision|3|||
170359373|NCT00830960|615650947|FG003|Overall Study|Sponsor Decision|4|||
170359374|NCT00830960|615650948|FG004|Overall Study|Sponsor Decision|5|||
170359375|NCT00830960|615650949|FG005|Overall Study|Sponsor Decision|7|||
170359376|NCT00830960|615650944|FG000|Overall Study|No study drug received|7|||
170359377|NCT00830960|615650945|FG001|Overall Study|No study drug received|2|||
170359378|NCT00830960|615650946|FG002|Overall Study|No study drug received|4|||
170359379|NCT00830960|615650947|FG003|Overall Study|No study drug received|3|||
170359380|NCT00830960|615650948|FG004|Overall Study|No study drug received|5|||
170359381|NCT00830960|615650949|FG005|Overall Study|No study drug received|7|||
170359382|NCT02120157|615650950|FG000|Overall Study|Death|8|||
170359383|NCT03483116|615650951|FG000|Overall Study|Adverse Event|0|||
170359384|NCT03483116|615650952|FG001|Overall Study|Adverse Event|1|||
170359385|NCT03483116|615650953|FG002|Overall Study|Adverse Event|0|||
170359386|NCT03483116|615650954|FG003|Overall Study|Adverse Event|1|||
170359387|NCT03483116|615650951|FG000|Overall Study|Protocol Violation|1|||
170359388|NCT03483116|615650952|FG001|Overall Study|Protocol Violation|0|||
170359389|NCT03483116|615650953|FG002|Overall Study|Protocol Violation|0|||
170359390|NCT03483116|615650954|FG003|Overall Study|Protocol Violation|7|||
170359391|NCT03483116|615650951|FG000|Overall Study|Lost to Follow-up|9|||
170359392|NCT03483116|615650952|FG001|Overall Study|Lost to Follow-up|4|||
170359393|NCT03483116|615650953|FG002|Overall Study|Lost to Follow-up|9|||
170359394|NCT03483116|615650954|FG003|Overall Study|Lost to Follow-up|5|||
170359395|NCT03483116|615650951|FG000|Overall Study|Death|1|||
170359396|NCT03483116|615650952|FG001|Overall Study|Death|0|||
170359397|NCT03483116|615650953|FG002|Overall Study|Death|2|||
170359398|NCT03483116|615650954|FG003|Overall Study|Death|1|||
170359399|NCT03483116|615650951|FG000|Overall Study|Withdrawal by Subject|14|||
170359400|NCT03483116|615650952|FG001|Overall Study|Withdrawal by Subject|16|||
170359401|NCT03483116|615650953|FG002|Overall Study|Withdrawal by Subject|14|||
170359402|NCT03483116|615650954|FG003|Overall Study|Withdrawal by Subject|16|||
170359403|NCT03483116|615650951|FG000|Overall Study|Unknown other reason|3|||
170359404|NCT03483116|615650952|FG001|Overall Study|Unknown other reason|2|||
170359405|NCT03483116|615650953|FG002|Overall Study|Unknown other reason|1|||
170359406|NCT03483116|615650954|FG003|Overall Study|Unknown other reason|1|||
170359407|NCT01181102|615650955|FG000|Overall Study|Adverse Event|28|||
170359408|NCT01181102|615650956|FG001|Overall Study|Adverse Event|26|||
170359409|NCT01181102|615650955|FG000|Overall Study|Lack of Efficacy|3|||
170359410|NCT01181102|615650956|FG001|Overall Study|Lack of Efficacy|1|||
170359411|NCT01181102|615650955|FG000|Overall Study|Lost to Follow-up|2|||
170359412|NCT01181102|615650956|FG001|Overall Study|Lost to Follow-up|0|||
170359413|NCT01181102|615650955|FG000|Overall Study|Physician Decision|3|||
170359414|NCT01181102|615650956|FG001|Overall Study|Physician Decision|1|||
170359415|NCT01181102|615650955|FG000|Overall Study|Protocol Violation|5|||
170359416|NCT01181102|615650956|FG001|Overall Study|Protocol Violation|6|||
170359417|NCT01181102|615650955|FG000|Overall Study|Withdrawal by Subject|10|||
170359418|NCT01181102|615650956|FG001|Overall Study|Withdrawal by Subject|12|||
170359419|NCT01803711|615650959|FG000|Overall Study|Adverse Event|1|||
170359420|NCT01803711|615650960|FG001|Overall Study|Adverse Event|1|||
170359421|NCT00239837|615650963|FG000|Overall Study|Lost to Follow-up|3|||
170359422|NCT00239837|615650964|FG001|Overall Study|Lost to Follow-up|7|||
170359423|NCT04685499|615650965|FG000|Overall Study|Study Terminated Early|1|||
170359424|NCT03550131|615650966|FG000|Overall Study|Lost to Follow-up|16|||
170359425|NCT03550131|615650967|FG001|Overall Study|Lost to Follow-up|24|||
170359426|NCT03550131|615650966|FG000|Overall Study|Withdrawal by Subject|36|||
170359427|NCT03550131|615650967|FG001|Overall Study|Withdrawal by Subject|28|||
170359428|NCT03550131|615650966|FG000|Overall Study|Illness of dyad member|10|||
170359429|NCT03550131|615650967|FG001|Overall Study|Illness of dyad member|2|||
170359430|NCT03550131|615650966|FG000|Overall Study|Death of person with dementia|4|||
170359431|NCT03550131|615650967|FG001|Overall Study|Death of person with dementia|8|||
170359432|NCT03076190|615650968|FG000|Overall Study|Lost to Follow-up|9|||
170359433|NCT03076190|615650969|FG001|Overall Study|Lost to Follow-up|34|||
170359434|NCT03076190|615650968|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
170359435|NCT03076190|615650969|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
170359436|NCT01441115|615650970|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
170359437|NCT01086150|615650973|FG000|Overall Study|Withdrawal by Subject|0|||
170359438|NCT01086150|615650974|FG001|Overall Study|Withdrawal by Subject|4|||
170359439|NCT01086150|615650975|FG002|Overall Study|Withdrawal by Subject|1|||
170359440|NCT01086150|615650973|FG000|Overall Study|Lost to Follow-up|0|||
170359441|NCT01086150|615650974|FG001|Overall Study|Lost to Follow-up|1|||
170359442|NCT01086150|615650975|FG002|Overall Study|Lost to Follow-up|0|||
170359443|NCT01086150|615650973|FG000|Overall Study|Screen Failure|0|||
170359444|NCT01086150|615650974|FG001|Overall Study|Screen Failure|1|||
170359445|NCT01086150|615650975|FG002|Overall Study|Screen Failure|0|||
170359446|NCT01890512|615650978|FG000|Overall Study|Physician Decision|1|||
170359447|NCT01890512|615650978|FG000|Overall Study|Withdrawal by Subject|1|||
170359448|NCT01890512|615650978|FG000|Overall Study|Protocol Violation|1|||
170359449|NCT03543358|615650979|FG000|Overall Study|Death|1|||
170359450|NCT03543358|615650980|FG001|Overall Study|Death|0|||
170359451|NCT03543358|615650979|FG000|Overall Study|Disease Progression|1|||
170359452|NCT03543358|615650980|FG001|Overall Study|Disease Progression|0|||
170359453|NCT03543358|615650979|FG000|Overall Study|Parent Study Closure|1|||
170359454|NCT03543358|615650980|FG001|Overall Study|Parent Study Closure|0|||
170359455|NCT01401465|615650981|FG000|Treatment Period 1|Adverse Event|4|||
170359456|NCT01401465|615650982|FG001|Treatment Period 1|Adverse Event|1|||
170359457|NCT01401465|615650981|FG000|Treatment Period 1|Pregnancy|0|||
170359458|NCT01401465|615650982|FG001|Treatment Period 1|Pregnancy|1|||
170359459|NCT01401465|615650981|FG000|Treatment Period 1|Protocol Violation|5|||
170359460|NCT01401465|615650982|FG001|Treatment Period 1|Protocol Violation|0|||
170359461|NCT01401465|615650981|FG000|Treatment Period 1|Withdrawal by Subject|1|||
170359462|NCT01401465|615650982|FG001|Treatment Period 1|Withdrawal by Subject|4|||
170359463|NCT01401465|615650981|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
170359464|NCT01401465|615650982|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
170359465|NCT01401465|615650981|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
170359466|NCT01401465|615650982|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
170359467|NCT01401465|615650981|FG000|Treatment Period 1|Scheduling Difficulties|1|||
170359468|NCT01401465|615650982|FG001|Treatment Period 1|Scheduling Difficulties|1|||
170359469|NCT01401465|615650981|FG000|Treatment Period 2|Lost to Follow-up|0|||
170359470|NCT01401465|615650982|FG001|Treatment Period 2|Lost to Follow-up|1|||
170359471|NCT01401465|615650981|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170359472|NCT01401465|615650982|FG001|Treatment Period 2|Withdrawal by Subject|1|||
170359473|NCT01115738|615650983|FG000|Overall Study|Death|1|||
170359474|NCT01115738|615650984|FG001|Overall Study|Death|0|||
170359475|NCT01115738|615650985|FG002|Overall Study|Death|0|||
170359476|NCT01115738|615650983|FG000|Overall Study|Lost to Follow-up|0|||
170359477|NCT01115738|615650984|FG001|Overall Study|Lost to Follow-up|0|||
170359478|NCT01115738|615650985|FG002|Overall Study|Lost to Follow-up|1|||
170359479|NCT01115738|615650983|FG000|Overall Study|Physician Decision|18|||
170359480|NCT01115738|615650984|FG001|Overall Study|Physician Decision|15|||
170359481|NCT01115738|615650985|FG002|Overall Study|Physician Decision|17|||
170359482|NCT01115738|615650983|FG000|Overall Study|Withdrawal by Subject|6|||
170359483|NCT01115738|615650984|FG001|Overall Study|Withdrawal by Subject|6|||
170359484|NCT01115738|615650985|FG002|Overall Study|Withdrawal by Subject|9|||
170359485|NCT00643604|615650991|FG000|Overall Study|Death|1|||
170359486|NCT02702011|615650992|FG000|Overall Study|Withdrawal by Subject|0|||
170359487|NCT02702011|615650993|FG001|Overall Study|Withdrawal by Subject|1|||
170359488|NCT02702011|615650994|FG002|Overall Study|Withdrawal by Subject|0|||
170359489|NCT02702011|615650995|FG003|Overall Study|Withdrawal by Subject|0|||
170359490|NCT02721251|615650997|FG000|Overall Study|Withdrawal by Subject|8|||
170359491|NCT02721251|615650998|FG001|Overall Study|Withdrawal by Subject|7|||
170359492|NCT02721251|615650999|FG002|Overall Study|Withdrawal by Subject|9|||
170359493|NCT02721251|615650997|FG000|Overall Study|poor adherence|2|||
170359494|NCT02721251|615650998|FG001|Overall Study|poor adherence|2|||
170359495|NCT02721251|615650999|FG002|Overall Study|poor adherence|2|||
170359496|NCT02921763|615651000|FG000|Overall Study|Adverse Event|4|||
170359497|NCT02921763|615651000|FG000|Overall Study|Lost to Follow-up|4|||
170359498|NCT02921763|615651000|FG000|Overall Study|Lack of Efficacy|3|||
170359499|NCT02921763|615651000|FG000|Overall Study|Protocol Violation|2|||
170359500|NCT02921763|615651000|FG000|Overall Study|Withdrawal by Subject|2|||
170359501|NCT02921763|615651000|FG000|Overall Study|Physician Decision|1|||
170359502|NCT02921763|615651000|FG000|Overall Study|No data obtained|2|||
170359503|NCT01740388|615651001|FG000|Overall Study|Withdrawal by Subject|1|||
170359504|NCT01740388|615651002|FG001|Overall Study|Withdrawal by Subject|2|||
170359505|NCT01740388|615651001|FG000|Overall Study|Lost to Follow-up|2|||
170359506|NCT01740388|615651002|FG001|Overall Study|Lost to Follow-up|0|||
170359507|NCT01740388|615651001|FG000|Overall Study|Physician Decision|2|||
170359508|NCT01740388|615651002|FG001|Overall Study|Physician Decision|6|||
170359509|NCT01740388|615651001|FG000|Overall Study|Subjects missing data, completed|41|||
170359510|NCT01740388|615651002|FG001|Overall Study|Subjects missing data, completed|36|||
170359511|NCT04142216|615651003|FG000|Overall Study|Hospitalization|0|||
170359512|NCT04142216|615651004|FG001|Overall Study|Hospitalization|2|||
170359513|NCT04142216|615651003|FG000|Overall Study|Death|3|||
170359514|NCT04142216|615651004|FG001|Overall Study|Death|1|||
170359515|NCT04142216|615651003|FG000|Overall Study|Referral to another hemodialysis unit|3|||
170359516|NCT04142216|615651004|FG001|Overall Study|Referral to another hemodialysis unit|2|||
170359517|NCT04142216|615651003|FG000|Overall Study|Use of clove|0|||
170359518|NCT04142216|615651004|FG001|Overall Study|Use of clove|1|||
170359519|NCT01582971|615651007|FG000|Overall Study|Death|2|||
170359520|NCT01582971|615651008|FG001|Overall Study|Death|1|||
170359521|NCT01582971|615651007|FG000|Overall Study|Lost to Follow-up|18|||
170359522|NCT01582971|615651008|FG001|Overall Study|Lost to Follow-up|21|||
170359523|NCT01582971|615651007|FG000|Overall Study|Withdrawal by Subject|4|||
170359524|NCT01582971|615651008|FG001|Overall Study|Withdrawal by Subject|2|||
170359525|NCT01582971|615651007|FG000|Overall Study|Other|15|||
170359526|NCT01582971|615651008|FG001|Overall Study|Other|13|||
170359527|NCT02394795|615651011|FG000|Overall Study|Adverse Event|92|||
170359528|NCT02394795|615651012|FG001|Overall Study|Adverse Event|70|||
170359529|NCT02394795|615651011|FG000|Overall Study|Lost to Follow-up|0|||
170359530|NCT02394795|615651012|FG001|Overall Study|Lost to Follow-up|1|||
170359531|NCT02394795|615651011|FG000|Overall Study|Withdrawal by Subject|17|||
170359532|NCT02394795|615651012|FG001|Overall Study|Withdrawal by Subject|26|||
170359533|NCT02394795|615651011|FG000|Overall Study|Lack of Efficacy|181|||
170359534|NCT02394795|615651012|FG001|Overall Study|Lack of Efficacy|211|||
170359535|NCT02394795|615651011|FG000|Overall Study|Death|4|||
170359536|NCT02394795|615651012|FG001|Overall Study|Death|5|||
170359537|NCT02394795|615651011|FG000|Overall Study|Physician Decision|109|||
170359538|NCT02394795|615651012|FG001|Overall Study|Physician Decision|93|||
170359539|NCT01002742|615652456|FG000|Overall Study|Determined to be ineligible|0|||
170359540|NCT01002742|615652457|FG001|Overall Study|Determined to be ineligible|1|||
170359541|NCT00562640|615652458|FG000|Overall Study|Death|0|||
170359542|NCT00562640|615652459|FG001|Overall Study|Death|1|||
170359543|NCT00562640|615652460|FG002|Overall Study|Death|1|||
170359544|NCT00562640|615652461|FG003|Overall Study|Death|0|||
170359545|NCT05263921|615652462|FG000|Overall Study|Other: family emergency.|0|||
170359546|NCT05263921|615652463|FG001|Overall Study|Other: family emergency.|0|||
170359547|NCT05263921|615652464|FG002|Overall Study|Other: family emergency.|1|||
170359548|NCT05263921|615652465|FG003|Overall Study|Other: family emergency.|0|||
170359549|NCT03127852|615652466|FG000|Overall Study|Withdrawal by Subject|4|||
170359550|NCT03127852|615652467|FG001|Overall Study|Withdrawal by Subject|1|||
170359551|NCT03127852|615652466|FG000|Overall Study|Death|1|||
170359552|NCT03127852|615652467|FG001|Overall Study|Death|1|||
170359553|NCT01297309|615652472|FG000|Overall Study|Eligibility failure|2|||
170359554|NCT01297309|615652472|FG000|Overall Study|Screen failure|2|||
170359555|NCT01297309|615652472|FG000|Overall Study|Withdrawal by Subject|5|||
170359556|NCT01297309|615652472|FG000|Overall Study|Adverse Event|1|||
170359557|NCT01297309|615652472|FG000|Overall Study|Investigator Decision|2|||
170359558|NCT01297309|615652472|FG000|Overall Study|Death|1|||
170359559|NCT01297309|615652472|FG000|Overall Study|Participant not entering extensionperiod|1|||
170359560|NCT02670928|615652473|FG000|Overall Study|Adverse Event|3|||
170359561|NCT02670928|615652474|FG001|Overall Study|Adverse Event|1|||
170359562|NCT02670928|615652473|FG000|Overall Study|Withdrawal by Subject|4|||
170359563|NCT02670928|615652474|FG001|Overall Study|Withdrawal by Subject|0|||
170359564|NCT02670928|615652473|FG000|Overall Study|Lost to Follow-up|1|||
170359565|NCT02670928|615652474|FG001|Overall Study|Lost to Follow-up|0|||
170359566|NCT02670928|615652473|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
170359567|NCT02670928|615652474|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
170359568|NCT02678312|615652475|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
170359569|NCT02678312|615652476|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
170359570|NCT02678312|615652477|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
170359571|NCT02678312|615652478|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
170359572|NCT02678312|615652479|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
170359573|NCT02678312|615652475|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
170359574|NCT02678312|615652476|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
170359575|NCT02678312|615652477|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
170359576|NCT02678312|615652478|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
170359577|NCT02678312|615652479|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
170359578|NCT02678312|615652475|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
170359579|NCT02678312|615652476|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
170359580|NCT02678312|615652477|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
170359581|NCT02678312|615652478|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
170359582|NCT02678312|615652479|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
170359583|NCT02678312|615652475|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
170359584|NCT02678312|615652476|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
170359585|NCT02678312|615652477|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
170359586|NCT02678312|615652478|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
170359587|NCT02678312|615652479|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
170359588|NCT02678312|615652475|FG000|Part 2 Double Blind Epoch|Death|0|||
170359589|NCT02678312|615652476|FG001|Part 2 Double Blind Epoch|Death|0|||
170359590|NCT02678312|615652477|FG002|Part 2 Double Blind Epoch|Death|0|||
170359591|NCT02678312|615652478|FG003|Part 2 Double Blind Epoch|Death|8|||
170359592|NCT02678312|615652479|FG004|Part 2 Double Blind Epoch|Death|12|||
170359593|NCT02678312|615652475|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
170359594|NCT02678312|615652476|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
170359595|NCT02678312|615652477|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
170359596|NCT02678312|615652478|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
170359597|NCT02678312|615652479|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
170359598|NCT02678312|615652475|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
170359599|NCT02678312|615652476|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
170359600|NCT02678312|615652477|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
170359601|NCT02678312|615652478|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
170359602|NCT02678312|615652479|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
170359603|NCT02678312|615652475|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
170359604|NCT02678312|615652476|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
170359605|NCT02678312|615652477|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
170359606|NCT02678312|615652478|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
170359607|NCT02678312|615652479|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
170359608|NCT02591238|615652480|FG000|Overall Study|Pregnancy|1|||
170359609|NCT02591238|615652481|FG001|Overall Study|Pregnancy|0|||
170359610|NCT02591238|615652482|FG002|Overall Study|Pregnancy|0|||
170359611|NCT02591238|615652483|FG003|Overall Study|Pregnancy|0|||
170359612|NCT02591238|615652480|FG000|Overall Study|Withdrawal by Subject|0|||
170359613|NCT02591238|615652481|FG001|Overall Study|Withdrawal by Subject|0|||
170359614|NCT02591238|615652482|FG002|Overall Study|Withdrawal by Subject|0|||
170359615|NCT02591238|615652483|FG003|Overall Study|Withdrawal by Subject|1|||
170359616|NCT02591238|615652480|FG000|Overall Study|influenza|0|||
170359617|NCT02591238|615652481|FG001|Overall Study|influenza|0|||
170359618|NCT02591238|615652482|FG002|Overall Study|influenza|0|||
170359619|NCT02591238|615652483|FG003|Overall Study|influenza|1|||
170359620|NCT02591238|615652480|FG000|Overall Study|personal circumstances|0|||
170359621|NCT02591238|615652481|FG001|Overall Study|personal circumstances|0|||
170359622|NCT02591238|615652482|FG002|Overall Study|personal circumstances|0|||
170359623|NCT02591238|615652483|FG003|Overall Study|personal circumstances|1|||
170359624|NCT02591238|615652480|FG000|Overall Study|personal circumstances|0|||
170359625|NCT02591238|615652481|FG001|Overall Study|personal circumstances|1|||
170359626|NCT02591238|615652482|FG002|Overall Study|personal circumstances|0|||
170359627|NCT02591238|615652483|FG003|Overall Study|personal circumstances|0|||
170359628|NCT04847141|615652486|FG000|Overall Study|Adverse Event|1|||
170359629|NCT04847141|615652487|FG001|Overall Study|Adverse Event|0|||
170359630|NCT04847141|615652488|FG002|Overall Study|Adverse Event|1|||
170359631|NCT04847141|615652486|FG000|Overall Study|Withdrawal by Subject|2|||
170359632|NCT04847141|615652487|FG001|Overall Study|Withdrawal by Subject|4|||
170359633|NCT04847141|615652488|FG002|Overall Study|Withdrawal by Subject|3|||
170359634|NCT04847141|615652486|FG000|Overall Study|Lost to Follow-up|7|||
170359635|NCT04847141|615652487|FG001|Overall Study|Lost to Follow-up|5|||
170359636|NCT04847141|615652488|FG002|Overall Study|Lost to Follow-up|7|||
170359637|NCT04847141|615652486|FG000|Overall Study|Reason not Specified|0|||
170359638|NCT04847141|615652487|FG001|Overall Study|Reason not Specified|1|||
170359639|NCT04847141|615652488|FG002|Overall Study|Reason not Specified|0|||
170359640|NCT04624672|615652494|FG000|Overall Study|Early Study Closure|2|||
170359641|NCT04624672|615652495|FG001|Overall Study|Early Study Closure|1|||
170359642|NCT03024255|615652502|FG000|Overall Study|Adverse Event|1|||
170359643|NCT03024255|615652503|FG001|Overall Study|Adverse Event|4|||
170359644|NCT03024255|615652504|FG002|Overall Study|Adverse Event|8|||
170359645|NCT03024255|615652505|FG003|Overall Study|Adverse Event|0|||
170359646|NCT03024255|615652502|FG000|Overall Study|Withdrawal by Subject|3|||
170359647|NCT03024255|615652503|FG001|Overall Study|Withdrawal by Subject|1|||
170359648|NCT03024255|615652504|FG002|Overall Study|Withdrawal by Subject|0|||
170359649|NCT03024255|615652505|FG003|Overall Study|Withdrawal by Subject|3|||
170359650|NCT03024255|615652502|FG000|Overall Study|Protocol Violation|0|||
170359651|NCT03024255|615652503|FG001|Overall Study|Protocol Violation|0|||
170359652|NCT03024255|615652504|FG002|Overall Study|Protocol Violation|2|||
170359653|NCT03024255|615652505|FG003|Overall Study|Protocol Violation|0|||
170359654|NCT03024255|615652502|FG000|Overall Study|Lost to Follow-up|1|||
170359655|NCT03024255|615652503|FG001|Overall Study|Lost to Follow-up|2|||
170359656|NCT03024255|615652504|FG002|Overall Study|Lost to Follow-up|1|||
170359657|NCT03024255|615652505|FG003|Overall Study|Lost to Follow-up|1|||
170359658|NCT03024255|615652502|FG000|Overall Study|Lack of Efficacy|1|||
170359659|NCT03024255|615652503|FG001|Overall Study|Lack of Efficacy|0|||
170359660|NCT03024255|615652504|FG002|Overall Study|Lack of Efficacy|0|||
170359661|NCT03024255|615652505|FG003|Overall Study|Lack of Efficacy|0|||
170359662|NCT03024255|615652502|FG000|Overall Study|Protocol Noncompliance|1|||
170359663|NCT03024255|615652503|FG001|Overall Study|Protocol Noncompliance|1|||
170359664|NCT03024255|615652504|FG002|Overall Study|Protocol Noncompliance|0|||
170359665|NCT03024255|615652505|FG003|Overall Study|Protocol Noncompliance|1|||
170359666|NCT01188096|615652510|FG000|Overall Study|progression of disease|4|||
170359667|NCT01188096|615652510|FG000|Overall Study|Withdrawal by Subject|2|||
170359668|NCT01878097|615652511|FG000|Baseline|Surveys not fully completed|2497|||
170359669|NCT01878097|615652512|FG001|Baseline|Surveys not fully completed|1800|||
170359670|NCT01878097|615652511|FG000|Implementation Year 1|Surveys not fully completed|3202|||
170359671|NCT01878097|615652512|FG001|Implementation Year 1|Surveys not fully completed|2549|||
170359672|NCT01878097|615652511|FG000|Implementation Year 2|Surveys not fully completed|3281|||
170359673|NCT01878097|615652512|FG001|Implementation Year 2|Surveys not fully completed|2841|||
170359674|NCT01878097|615652511|FG000|Implementation Year 3|Surveys not fully completed|3494|||
170359675|NCT01878097|615652512|FG001|Implementation Year 3|Surveys not fully completed|2980|||
170359676|NCT01878097|615652511|FG000|Implementation Year 4|Surveys not fully completed|3604|||
170359677|NCT01878097|615652512|FG001|Implementation Year 4|Surveys not fully completed|3007|||
170359678|NCT02119026|615652513|FG000|1st-line Treatment|Adverse Event|9|||
170359679|NCT02119026|615652514|FG001|1st-line Treatment|Adverse Event|14|||
170359680|NCT02119026|615652513|FG000|1st-line Treatment|Physician Decision|3|||
170359681|NCT02119026|615652514|FG001|1st-line Treatment|Physician Decision|8|||
170359682|NCT02119026|615652513|FG000|1st-line Treatment|Withdrawal by Subject|4|||
170359683|NCT02119026|615652514|FG001|1st-line Treatment|Withdrawal by Subject|10|||
170359684|NCT02119026|615652513|FG000|1st-line Treatment|Patient condition or compliance|6|||
170359685|NCT02119026|615652514|FG001|1st-line Treatment|Patient condition or compliance|4|||
170359686|NCT02119026|615652513|FG000|1st-line Treatment|Surgery of metastases|2|||
170359687|NCT02119026|615652514|FG001|1st-line Treatment|Surgery of metastases|1|||
170359688|NCT02119026|615652513|FG000|1st-line Treatment|Death|2|||
170359689|NCT02119026|615652514|FG001|1st-line Treatment|Death|1|||
170359690|NCT02119026|615652513|FG000|2nd-line Treatment|Lost to Follow-up|2|||
170359691|NCT02119026|615652514|FG001|2nd-line Treatment|Lost to Follow-up|0|||
170359692|NCT02119026|615652513|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
170359693|NCT02119026|615652514|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
170359694|NCT02119026|615652513|FG000|2nd-line Treatment|Adverse Event|4|||
170359695|NCT02119026|615652514|FG001|2nd-line Treatment|Adverse Event|1|||
170359696|NCT01143714|615652517|FG000|Overall Study|Adverse Event|4|||
170359697|NCT01143714|615652518|FG001|Overall Study|Adverse Event|2|||
170359698|NCT01143714|615652517|FG000|Overall Study|Withdrawal by Subject|1|||
170359699|NCT01143714|615652518|FG001|Overall Study|Withdrawal by Subject|0|||
170359700|NCT01143714|615652517|FG000|Overall Study|Subject non-compliance|0|||
170359701|NCT01143714|615652518|FG001|Overall Study|Subject non-compliance|1|||
170359702|NCT01143714|615652517|FG000|Overall Study|wound closed = deemed healed|1|||
170359703|NCT01143714|615652518|FG001|Overall Study|wound closed = deemed healed|0|||
170359704|NCT01143714|615652517|FG000|Overall Study|wound size increased|1|||
170359705|NCT01143714|615652518|FG001|Overall Study|wound size increased|0|||
170359706|NCT03783442|615652521|FG000|Overall Study|Death|252|||
170359707|NCT03783442|615652522|FG001|Overall Study|Death|268|||
170359708|NCT03783442|615652521|FG000|Overall Study|Withdrawal by Subject|19|||
170359709|NCT03783442|615652522|FG001|Overall Study|Withdrawal by Subject|21|||
170359710|NCT03783442|615652521|FG000|Overall Study|Lost to Follow-up|7|||
170359711|NCT03783442|615652522|FG001|Overall Study|Lost to Follow-up|6|||
170359712|NCT03783442|615652521|FG000|Overall Study|Sponsor Ended Study|48|||
170359713|NCT03783442|615652522|FG001|Overall Study|Sponsor Ended Study|28|||
170359714|NCT04190186|615652523|FG000|Overall Study|ILR is no longer functioning|0|||
170359715|NCT04190186|615652524|FG001|Overall Study|ILR is no longer functioning|1|||
170359716|NCT04190186|615652523|FG000|Overall Study|Lost to Follow-up|0|||
170359717|NCT04190186|615652524|FG001|Overall Study|Lost to Follow-up|1|||
170359718|NCT04190186|615652523|FG000|Overall Study|Withdrawal by Subject|2|||
170359719|NCT04190186|615652524|FG001|Overall Study|Withdrawal by Subject|0|||
170359720|NCT04190186|615652523|FG000|Overall Study|Subject choice to explant|1|||
170359721|NCT04190186|615652524|FG001|Overall Study|Subject choice to explant|0|||
170359722|NCT04190186|615652523|FG000|Overall Study|Physician Decision|0|||
170359723|NCT04190186|615652524|FG001|Overall Study|Physician Decision|1|||
170359724|NCT04190186|615652523|FG000|Overall Study|Study was stopped|4|||
170359725|NCT04190186|615652524|FG001|Overall Study|Study was stopped|5|||
170359726|NCT01213264|615652527|FG000|Overall Study|Adverse Event|1|||
170359727|NCT01213264|615652528|FG001|Overall Study|Adverse Event|0|||
170359728|NCT01213264|615652529|FG002|Overall Study|Adverse Event|0|||
170359729|NCT01213264|615652527|FG000|Overall Study|Lost to Follow-up|1|||
170359730|NCT01213264|615652528|FG001|Overall Study|Lost to Follow-up|2|||
170359731|NCT01213264|615652529|FG002|Overall Study|Lost to Follow-up|6|||
170359732|NCT02806947|615652530|FG000|Overall Study|Withdrawal by Subject|5|||
170359733|NCT02806947|615652531|FG001|Overall Study|Withdrawal by Subject|1|||
170359734|NCT00084929|615652535|FG000|Overall Study|ineligible - medical contraindication|1|||
170359735|NCT00084929|615652535|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
170359736|NCT00084929|615652535|FG000|Overall Study|Ineligible - Medical history|6|||
170359737|NCT00084929|615652535|FG000|Overall Study|Withdrawal by Subject|10|||
170359738|NCT00084929|615652535|FG000|Overall Study|Missing/incomplete CTC exam|9|||
170359739|NCT00084929|615652535|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
170359740|NCT00992186|615652536|FG000|Overall Study|Withdrawal by Subject|2|||
170359741|NCT00992186|615652536|FG000|Overall Study|Protocol Violation|1|||
170359742|NCT00992186|615652536|FG000|Overall Study|Physician Decision|1|||
170359743|NCT00992186|615652536|FG000|Overall Study|Adverse Event|9|||
170359744|NCT00992186|615652536|FG000|Overall Study|Progressive Disease|30|||
170359745|NCT00992186|615652536|FG000|Overall Study|Refusal To Receive Study Agent|3|||
170359746|NCT00168064|615652537|FG000|Overall Study|Adverse Event|26|||
170359747|NCT00168064|615652538|FG001|Overall Study|Adverse Event|22|||
170359748|NCT00168064|615652537|FG000|Overall Study|Withdrawal by Subject|3|||
170359749|NCT00168064|615652538|FG001|Overall Study|Withdrawal by Subject|4|||
170359750|NCT00168064|615652537|FG000|Overall Study|Lack of Efficacy|4|||
170359751|NCT00168064|615652538|FG001|Overall Study|Lack of Efficacy|4|||
170359752|NCT00168064|615652537|FG000|Overall Study|Lost to Follow-up|4|||
170359753|NCT00168064|615652538|FG001|Overall Study|Lost to Follow-up|3|||
170359754|NCT00168064|615652537|FG000|Overall Study|Non-compliance|2|||
170359755|NCT00168064|615652538|FG001|Overall Study|Non-compliance|3|||
170359756|NCT00168064|615652537|FG000|Overall Study|Concurrent Illness|4|||
170359757|NCT00168064|615652538|FG001|Overall Study|Concurrent Illness|3|||
170359758|NCT00168064|615652537|FG000|Overall Study|Subject's Best interest|2|||
170359759|NCT00168064|615652538|FG001|Overall Study|Subject's Best interest|2|||
170359760|NCT00168064|615652537|FG000|Overall Study|Various|4|||
170359761|NCT00168064|615652538|FG001|Overall Study|Various|3|||
170359762|NCT01594333|615652541|FG000|Overall Study|Death|96|||
170359763|NCT01594333|615652542|FG001|Overall Study|Death|83|||
170359764|NCT01594333|615652541|FG000|Overall Study|Lost to Follow-up|5|||
170359765|NCT01594333|615652542|FG001|Overall Study|Lost to Follow-up|5|||
170359766|NCT01594333|615652541|FG000|Overall Study|Withdrawal by Subject|60|||
170359767|NCT01594333|615652542|FG001|Overall Study|Withdrawal by Subject|63|||
170359768|NCT00589979|615652543|FG000|Run-In Period|Adverse Event|5|||
170359769|NCT00589979|615652544|FG001|Run-In Period|Adverse Event|0|||
170359770|NCT00589979|615652545|FG002|Run-In Period|Adverse Event|0|||
170359771|NCT00589979|615652543|FG000|Run-In Period|Protocol Violation|3|||
170359772|NCT00589979|615652544|FG001|Run-In Period|Protocol Violation|0|||
170359773|NCT00589979|615652545|FG002|Run-In Period|Protocol Violation|0|||
170359774|NCT00589979|615652543|FG000|Run-In Period|Did not qualify for randomization|54|||
170359775|NCT00589979|615652544|FG001|Run-In Period|Did not qualify for randomization|0|||
170359776|NCT00589979|615652545|FG002|Run-In Period|Did not qualify for randomization|0|||
170359777|NCT00589979|615652543|FG000|Run-In Period|Withdrawal by Subject|10|||
170359778|NCT00589979|615652544|FG001|Run-In Period|Withdrawal by Subject|0|||
170359779|NCT00589979|615652545|FG002|Run-In Period|Withdrawal by Subject|0|||
170359780|NCT00589979|615652543|FG000|Run-In Period|Informed Consent Withdrawn|4|||
170359781|NCT00589979|615652544|FG001|Run-In Period|Informed Consent Withdrawn|0|||
170359782|NCT00589979|615652545|FG002|Run-In Period|Informed Consent Withdrawn|0|||
170359783|NCT00589979|615652543|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
170359784|NCT00589979|615652544|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
170359785|NCT00589979|615652545|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
170359786|NCT00589979|615652543|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
170359787|NCT00589979|615652544|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
170359788|NCT00589979|615652545|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
170359789|NCT00589979|615652543|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
170359790|NCT00589979|615652544|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
170359791|NCT00589979|615652545|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
170359792|NCT00589979|615652543|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
170359793|NCT00589979|615652544|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
170359794|NCT00589979|615652545|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
170359795|NCT00589979|615652543|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
170359796|NCT00589979|615652544|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
170359797|NCT00589979|615652545|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
170359798|NCT00589979|615652543|FG000|Double-Blind Treatment Period 2|Other|0|||
170359799|NCT00589979|615652544|FG001|Double-Blind Treatment Period 2|Other|0|||
170359800|NCT00589979|615652545|FG002|Double-Blind Treatment Period 2|Other|1|||
170359801|NCT00589979|615652543|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
170359802|NCT00589979|615652544|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
170359803|NCT00589979|615652545|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
170359804|NCT00589979|615652543|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
170359805|NCT00589979|615652544|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
170359806|NCT00589979|615652545|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
170359807|NCT02378883|615652546|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
170359808|NCT02378883|615652546|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
170359809|NCT02378883|615652546|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
170359810|NCT02378883|615652546|FG000|30 Day Follow-Up|Physician Decision|2|||
170359811|NCT02378883|615652546|FG000|30 Day Follow-Up|Missed Visit|2|||
170359812|NCT02378883|615652546|FG000|30 Day Follow-Up|Death|1|||
170359813|NCT02378883|615652546|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
170359814|NCT02378883|615652546|FG000|12 Months Follow-Up|Death|2|||
170359815|NCT00318565|615652547|FG000|Overall Study|Excluded per protocol|24|||
170359816|NCT00225212|615652554|FG000|Overall Study|Disease progression|2|||
170359817|NCT00225212|615652554|FG000|Overall Study|Death|1|||
170359818|NCT00225212|615652554|FG000|Overall Study|Adverse Event|2|||
170359819|NCT00225212|615652554|FG000|Overall Study|Intercurrent illness|1|||
170359820|NCT01335698|615652557|FG000|Treatment Stage 1|Lack of Efficacy|3|||
170359821|NCT01335698|615652558|FG001|Treatment Stage 1|Lack of Efficacy|1|||
170359822|NCT01335698|615652559|FG002|Treatment Stage 1|Lack of Efficacy|3|||
170359823|NCT01335698|615652560|FG003|Treatment Stage 1|Lack of Efficacy|3|||
170359824|NCT01335698|615652561|FG004|Treatment Stage 1|Lack of Efficacy|1|||
170359825|NCT01335698|615652557|FG000|Treatment Stage 1|Adverse Event|1|||
170359826|NCT01335698|615652558|FG001|Treatment Stage 1|Adverse Event|2|||
170359827|NCT01335698|615652559|FG002|Treatment Stage 1|Adverse Event|2|||
170359828|NCT01335698|615652560|FG003|Treatment Stage 1|Adverse Event|1|||
170359829|NCT01335698|615652561|FG004|Treatment Stage 1|Adverse Event|1|||
170359830|NCT01335698|615652557|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
170359831|NCT01335698|615652558|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
170359832|NCT01335698|615652559|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
170359833|NCT01335698|615652560|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
170359834|NCT01335698|615652561|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
170359835|NCT01335698|615652557|FG000|Treatment Stage 1|Lost to Follow-up|1|||
170359836|NCT01335698|615652558|FG001|Treatment Stage 1|Lost to Follow-up|1|||
170359837|NCT01335698|615652559|FG002|Treatment Stage 1|Lost to Follow-up|0|||
170359838|NCT01335698|615652560|FG003|Treatment Stage 1|Lost to Follow-up|0|||
170359839|NCT01335698|615652561|FG004|Treatment Stage 1|Lost to Follow-up|0|||
170359840|NCT01335698|615652557|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
170359841|NCT01335698|615652558|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
170359842|NCT01335698|615652559|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
170359843|NCT01335698|615652560|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
170359844|NCT01335698|615652561|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
170359845|NCT01335698|615652557|FG000|Treatment Stage 1|No longer meets study criteria|1|||
170359846|NCT01335698|615652558|FG001|Treatment Stage 1|No longer meets study criteria|1|||
170359847|NCT01335698|615652559|FG002|Treatment Stage 1|No longer meets study criteria|0|||
170359848|NCT01335698|615652560|FG003|Treatment Stage 1|No longer meets study criteria|1|||
170359849|NCT01335698|615652561|FG004|Treatment Stage 1|No longer meets study criteria|0|||
170359850|NCT01335698|615652557|FG000|Treatment Stage 1|Other|1|||
170359851|NCT01335698|615652558|FG001|Treatment Stage 1|Other|0|||
170359852|NCT01335698|615652559|FG002|Treatment Stage 1|Other|0|||
170359853|NCT01335698|615652560|FG003|Treatment Stage 1|Other|1|||
170359854|NCT01335698|615652561|FG004|Treatment Stage 1|Other|0|||
170359855|NCT01335698|615652557|FG000|Treatment Stage 2|Lack of Efficacy|2|||
170359856|NCT01335698|615652558|FG001|Treatment Stage 2|Lack of Efficacy|1|||
170359857|NCT01335698|615652559|FG002|Treatment Stage 2|Lack of Efficacy|3|||
170359858|NCT01335698|615652560|FG003|Treatment Stage 2|Lack of Efficacy|1|||
170359859|NCT01335698|615652561|FG004|Treatment Stage 2|Lack of Efficacy|0|||
170359860|NCT01335698|615652557|FG000|Treatment Stage 2|Adverse Event|2|||
170359861|NCT01335698|615652558|FG001|Treatment Stage 2|Adverse Event|0|||
170359862|NCT01335698|615652559|FG002|Treatment Stage 2|Adverse Event|0|||
170359863|NCT01335698|615652560|FG003|Treatment Stage 2|Adverse Event|3|||
170359864|NCT01335698|615652561|FG004|Treatment Stage 2|Adverse Event|0|||
170359865|NCT01335698|615652557|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
170359866|NCT01335698|615652558|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
170359867|NCT01335698|615652559|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
170359868|NCT01335698|615652560|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
170359869|NCT01335698|615652561|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
170359870|NCT01335698|615652557|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
170359871|NCT01335698|615652558|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
170359872|NCT01335698|615652559|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
170359873|NCT01335698|615652560|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
170359874|NCT01335698|615652561|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
170359875|NCT01335698|615652557|FG000|Treatment Stage 2|Lost to Follow-up|1|||
170359876|NCT01335698|615652558|FG001|Treatment Stage 2|Lost to Follow-up|0|||
170359877|NCT01335698|615652559|FG002|Treatment Stage 2|Lost to Follow-up|0|||
170359878|NCT01335698|615652560|FG003|Treatment Stage 2|Lost to Follow-up|0|||
170359879|NCT01335698|615652561|FG004|Treatment Stage 2|Lost to Follow-up|0|||
170359880|NCT01335698|615652557|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
170399310|NCT03193190|615799951|FG014|Stage 1|Physician Decision|0|||
170359881|NCT01335698|615652558|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
170359882|NCT01335698|615652559|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
170359883|NCT01335698|615652560|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
170359884|NCT01335698|615652561|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
170359885|NCT01335698|615652557|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
170359886|NCT01335698|615652558|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
170359887|NCT01335698|615652559|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
170359888|NCT01335698|615652560|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
170359889|NCT01335698|615652561|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
170359890|NCT01335698|615652557|FG000|Treatment Stage 2|Switched to another formulation|1|||
170359891|NCT01335698|615652558|FG001|Treatment Stage 2|Switched to another formulation|1|||
170359892|NCT01335698|615652559|FG002|Treatment Stage 2|Switched to another formulation|0|||
170359893|NCT01335698|615652560|FG003|Treatment Stage 2|Switched to another formulation|0|||
170359894|NCT01335698|615652561|FG004|Treatment Stage 2|Switched to another formulation|0|||
170359895|NCT01170221|615652562|FG000|Overall Study|Lost to Follow-up|22|||
170359896|NCT01170221|615652563|FG001|Overall Study|Lost to Follow-up|21|||
170359897|NCT01170221|615652562|FG000|Overall Study|Withdrawal by Subject|9|||
170359898|NCT01170221|615652563|FG001|Overall Study|Withdrawal by Subject|7|||
170359899|NCT01170221|615652562|FG000|Overall Study|Subject completed only screening and LFU|1|||
170359900|NCT01170221|615652563|FG001|Overall Study|Subject completed only screening and LFU|0|||
170359901|NCT01170221|615652562|FG000|Overall Study|Randomized but not treated|1|||
170359902|NCT01170221|615652563|FG001|Overall Study|Randomized but not treated|0|||
170359903|NCT01838590|615652564|FG000|Overall Study|Lack of Efficacy|12|||
170359904|NCT01838590|615652565|FG001|Overall Study|Lack of Efficacy|4|||
170359905|NCT01838590|615652564|FG000|Overall Study|Lost to Follow-up|0|||
170359906|NCT01838590|615652565|FG001|Overall Study|Lost to Follow-up|1|||
170359907|NCT01162304|615652567|FG000|Overall Study|Beck scale to high|11|||
170359908|NCT02802878|615652568|FG000|Overall Study|Withdrawal by Subject|3|||
170359909|NCT02802878|615652569|FG001|Overall Study|Withdrawal by Subject|3|||
170359910|NCT02802878|615652568|FG000|Overall Study|Protocol Violation|1|||
170359911|NCT02802878|615652569|FG001|Overall Study|Protocol Violation|0|||
170359912|NCT00101192|615652570|FG000|Overall Study|Ineligible|6|||
170359913|NCT00101192|615652570|FG000|Overall Study|Inevaluable|1|||
170359914|NCT00536978|615652571|FG000|Overall Study|Not eligible for Adback Infusion|22|||
170359915|NCT01232894|615652572|FG000|Overall Study|Lost to Follow-up|0|||
170359916|NCT01232894|615652573|FG001|Overall Study|Lost to Follow-up|1|||
170359917|NCT01232894|615652572|FG000|Overall Study|Death|1|||
170359918|NCT01232894|615652573|FG001|Overall Study|Death|0|||
170359919|NCT01232894|615652572|FG000|Overall Study|Protocol Violation|1|||
170359920|NCT01232894|615652573|FG001|Overall Study|Protocol Violation|1|||
170359921|NCT01232894|615652572|FG000|Overall Study|Withdrawal by Subject|8|||
170359922|NCT01232894|615652573|FG001|Overall Study|Withdrawal by Subject|5|||
170359923|NCT01232894|615652572|FG000|Overall Study|Physician Decision|2|||
170359924|NCT01232894|615652573|FG001|Overall Study|Physician Decision|1|||
170359925|NCT03970395|615652574|FG000|Overall Study|Withdrawal by Subject|3|||
170359926|NCT03970395|615652575|FG001|Overall Study|Withdrawal by Subject|4|||
170359927|NCT03970395|615652574|FG000|Overall Study|Lost to Follow-up|4|||
170359928|NCT03970395|615652575|FG001|Overall Study|Lost to Follow-up|8|||
170359929|NCT02940626|615652576|FG000|Overall Study|Death|40|||
170359930|NCT02940626|615652577|FG001|Overall Study|Death|32|||
170359931|NCT02940626|615652576|FG000|Overall Study|Lost to Follow-up|5|||
170359932|NCT02940626|615652577|FG001|Overall Study|Lost to Follow-up|2|||
170359933|NCT02940626|615652576|FG000|Overall Study|Withdrawal by Subject|1|||
170359934|NCT02940626|615652577|FG001|Overall Study|Withdrawal by Subject|0|||
170359935|NCT02940626|615652576|FG000|Overall Study|Transfer to Hospice Care|1|||
170359936|NCT02940626|615652577|FG001|Overall Study|Transfer to Hospice Care|0|||
170359937|NCT02940626|615652576|FG000|Overall Study|Prohibited Concomitant Medication|0|||
170359938|NCT02940626|615652577|FG001|Overall Study|Prohibited Concomitant Medication|1|||
170359939|NCT01996904|615652578|FG000|Overall Study|Lost to Follow-up|38|||
170359940|NCT01996904|615652579|FG001|Overall Study|Lost to Follow-up|27|||
170359941|NCT00929734|615652584|FG000|Overall Study|Lost to Follow-up|2|||
170359942|NCT00929734|615652585|FG001|Overall Study|Lost to Follow-up|1|||
170359943|NCT00929734|615652584|FG000|Overall Study|Withdrawal by Subject|0|||
170359944|NCT00929734|615652585|FG001|Overall Study|Withdrawal by Subject|2|||
170359945|NCT00980980|615652586|FG000|Overall Study|Withdrawal by Hospital|0|||
170359946|NCT00980980|615652587|FG001|Overall Study|Withdrawal by Hospital|1|||
170359947|NCT00980980|615652588|FG002|Overall Study|Withdrawal by Hospital|0|||
170359948|NCT02921919|615652589|FG000|Overall Study|Other|5|||
170359949|NCT02921919|615652590|FG001|Overall Study|Other|6|||
170359950|NCT02921919|615652589|FG000|Overall Study|Lost to Follow-up|0|||
170359951|NCT02921919|615652590|FG001|Overall Study|Lost to Follow-up|1|||
170359952|NCT02921919|615652589|FG000|Overall Study|Withdrawal by Subject|5|||
170359953|NCT02921919|615652590|FG001|Overall Study|Withdrawal by Subject|1|||
170359954|NCT02921919|615652589|FG000|Overall Study|Disease Progression|47|||
170359955|NCT02921919|615652590|FG001|Overall Study|Disease Progression|38|||
170359956|NCT02921919|615652589|FG000|Overall Study|Physician Decision|3|||
170359957|NCT02921919|615652590|FG001|Overall Study|Physician Decision|2|||
170359958|NCT02921919|615652589|FG000|Overall Study|Adverse Event|6|||
170359959|NCT02921919|615652590|FG001|Overall Study|Adverse Event|4|||
170359960|NCT00121992|615652591|FG000|Overall Study|Treatment not received|2|||
170359961|NCT00121992|615652592|FG001|Overall Study|Treatment not received|11|||
170359962|NCT01324622|615652593|FG000|Overall Study|Lost to Follow-up|7|||
170359963|NCT01324622|615652594|FG001|Overall Study|Lost to Follow-up|7|||
170359964|NCT01324622|615652593|FG000|Overall Study|Death|1|||
170359965|NCT01324622|615652594|FG001|Overall Study|Death|0|||
170359966|NCT01324622|615652593|FG000|Overall Study|Lack of Efficacy|1|||
170359967|NCT01324622|615652594|FG001|Overall Study|Lack of Efficacy|0|||
170359968|NCT02815293|615652599|FG000|Overall Study|Study termination by sponsor|10|||
170359969|NCT02815293|615652600|FG001|Overall Study|Study termination by sponsor|7|||
170359970|NCT02815293|615652601|FG002|Overall Study|Study termination by sponsor|0|||
170359971|NCT02815293|615652599|FG000|Overall Study|Participants not randomized|0|||
170359972|NCT02815293|615652600|FG001|Overall Study|Participants not randomized|0|||
170359973|NCT02815293|615652601|FG002|Overall Study|Participants not randomized|18|||
170359974|NCT02815293|615652599|FG000|Overall Study|Adverse Event|0|||
170359975|NCT02815293|615652600|FG001|Overall Study|Adverse Event|1|||
170359976|NCT02815293|615652601|FG002|Overall Study|Adverse Event|0|||
170359977|NCT01056341|615652602|FG000|Overall Study|Treatment Intolerance|0|||
170359978|NCT01056341|615652603|FG001|Overall Study|Treatment Intolerance|2|||
170359979|NCT01056341|615652604|FG002|Overall Study|Treatment Intolerance|0|||
170359980|NCT01056341|615652605|FG003|Overall Study|Treatment Intolerance|2|||
170359981|NCT01056341|615652606|FG004|Overall Study|Treatment Intolerance|0|||
170359982|NCT01056341|615652602|FG000|Overall Study|Lack of Efficacy|32|||
170359983|NCT01056341|615652603|FG001|Overall Study|Lack of Efficacy|30|||
170359984|NCT01056341|615652604|FG002|Overall Study|Lack of Efficacy|7|||
170359985|NCT01056341|615652605|FG003|Overall Study|Lack of Efficacy|25|||
170359986|NCT01056341|615652606|FG004|Overall Study|Lack of Efficacy|9|||
170359987|NCT01056341|615652602|FG000|Overall Study|Other reasons|4|||
170359988|NCT01056341|615652603|FG001|Overall Study|Other reasons|4|||
170359989|NCT01056341|615652604|FG002|Overall Study|Other reasons|8|||
170359990|NCT01056341|615652605|FG003|Overall Study|Other reasons|9|||
170359991|NCT01056341|615652606|FG004|Overall Study|Other reasons|5|||
170359992|NCT03454412|615652607|FG000|Baseline Assesment|Physician Decision|12|||
170359993|NCT00862121|615652608|FG000|Overall Study|Adverse Event|1|||
170359994|NCT00862121|615652609|FG001|Overall Study|Adverse Event|2|||
170359995|NCT00862121|615652608|FG000|Overall Study|Lack of Efficacy|0|||
170359996|NCT00862121|615652609|FG001|Overall Study|Lack of Efficacy|3|||
170359997|NCT00862121|615652608|FG000|Overall Study|Protocol Violation|0|||
170359998|NCT00862121|615652609|FG001|Overall Study|Protocol Violation|1|||
170359999|NCT00862121|615652608|FG000|Overall Study|Exclusion criterion violation|0|||
170360000|NCT00862121|615652609|FG001|Overall Study|Exclusion criterion violation|1|||
170360001|NCT00862121|615652608|FG000|Overall Study|Incorrect randomisation|0|||
170360002|NCT00862121|615652609|FG001|Overall Study|Incorrect randomisation|1|||
170360003|NCT00377429|615652610|FG000|Overall Study|Withdrawal by Subject|5|||
170360004|NCT00377429|615652610|FG000|Overall Study|Adverse Event|8|||
170360005|NCT00377429|615652610|FG000|Overall Study|Physician Decision|1|||
170360006|NCT00377429|615652610|FG000|Overall Study|Patient non-compliance|1|||
170360007|NCT06025396|615654207|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
170360008|NCT06025396|615654208|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
170360009|NCT06025396|615654209|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
170360010|NCT06025396|615654210|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
170360011|NCT06025396|615654211|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
170360012|NCT06025396|615654207|FG000|Overall Study|Withdrawal by Subject|0|||
170360013|NCT06025396|615654208|FG001|Overall Study|Withdrawal by Subject|1|||
170360014|NCT06025396|615654209|FG002|Overall Study|Withdrawal by Subject|1|||
170360015|NCT06025396|615654210|FG003|Overall Study|Withdrawal by Subject|0|||
170360016|NCT06025396|615654211|FG004|Overall Study|Withdrawal by Subject|0|||
170360017|NCT03326869|615654216|FG000|Overall Study|Study data has been lost to natural disa|1|||
170360018|NCT03326869|615654217|FG001|Overall Study|Study data has been lost to natural disa|1|||
170360019|NCT00640146|615654221|FG000|Overall Study|Adverse Event|2|||
170360020|NCT00640146|615654222|FG001|Overall Study|Adverse Event|0|||
170360021|NCT00640146|615654221|FG000|Overall Study|Lost to Follow-up|0|||
170360022|NCT00640146|615654222|FG001|Overall Study|Lost to Follow-up|1|||
170360023|NCT00640146|615654221|FG000|Overall Study|Lack of Efficacy|0|||
170360024|NCT00640146|615654222|FG001|Overall Study|Lack of Efficacy|1|||
170360025|NCT00640146|615654221|FG000|Overall Study|Withdrawal by Subject|1|||
170360026|NCT00640146|615654222|FG001|Overall Study|Withdrawal by Subject|1|||
170360027|NCT00640146|615654221|FG000|Overall Study|Randomized but not treated|1|||
170360028|NCT00640146|615654222|FG001|Overall Study|Randomized but not treated|3|||
170360029|NCT00525785|615654224|FG000|Overall Study|Withdrawal by Subject|1|||
170360030|NCT00525785|615654224|FG000|Overall Study|Lack of Efficacy|1|||
170360031|NCT00525785|615654224|FG000|Overall Study|Physician Decision|1|||
170360032|NCT03382262|615654226|FG000|Overall Study|Physician Decision|0|||
170360033|NCT03382262|615654227|FG001|Overall Study|Physician Decision|0|||
170360034|NCT03382262|615654228|FG002|Overall Study|Physician Decision|1|||
170360035|NCT03382262|615654229|FG003|Overall Study|Physician Decision|0|||
170360036|NCT03382262|615654226|FG000|Overall Study|Withdrawal by Subject|0|||
170360037|NCT03382262|615654227|FG001|Overall Study|Withdrawal by Subject|0|||
170360038|NCT03382262|615654228|FG002|Overall Study|Withdrawal by Subject|0|||
170360039|NCT03382262|615654229|FG003|Overall Study|Withdrawal by Subject|1|||
170360040|NCT00093470|615654232|FG000|Overall Study|Disease progression|39|||
170360041|NCT00093470|615654233|FG001|Overall Study|Disease progression|0|||
170360042|NCT00093470|615654232|FG000|Overall Study|Adverse Event|15|||
170360043|NCT00093470|615654233|FG001|Overall Study|Adverse Event|0|||
170360044|NCT00093470|615654232|FG000|Overall Study|Death|2|||
170360045|NCT00093470|615654233|FG001|Overall Study|Death|0|||
170360046|NCT00093470|615654232|FG000|Overall Study|Withdrawal by Subject|8|||
170360047|NCT00093470|615654233|FG001|Overall Study|Withdrawal by Subject|0|||
170360048|NCT00093470|615654232|FG000|Overall Study|Alternative therapy|2|||
170360049|NCT00093470|615654233|FG001|Overall Study|Alternative therapy|0|||
170360050|NCT00093470|615654232|FG000|Overall Study|Other complicating disease|3|||
170360051|NCT00093470|615654233|FG001|Overall Study|Other complicating disease|0|||
170360052|NCT00093470|615654232|FG000|Overall Study|Physician Decision|2|||
170360053|NCT00093470|615654233|FG001|Overall Study|Physician Decision|0|||
170360054|NCT00093470|615654232|FG000|Overall Study|Never started treatment|1|||
170360055|NCT00093470|615654233|FG001|Overall Study|Never started treatment|0|||
170360056|NCT00093470|615654232|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
170360057|NCT00093470|615654233|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
170360058|NCT00010803|615654234|FG000|Overall Study|Withdrawal by Subject|97|||
170360059|NCT00010803|615654235|FG001|Overall Study|Withdrawal by Subject|98|||
170360060|NCT03657810|615654236|FG000|Overall Study|Adverse Event|0|||
170360061|NCT03657810|615654237|FG001|Overall Study|Adverse Event|1|||
170360062|NCT03657810|615654238|FG002|Overall Study|Adverse Event|0|||
170360063|NCT03657810|615654236|FG000|Overall Study|Lack of Efficacy|4|||
170360064|NCT03657810|615654237|FG001|Overall Study|Lack of Efficacy|1|||
170360065|NCT03657810|615654238|FG002|Overall Study|Lack of Efficacy|3|||
170360066|NCT03657810|615654236|FG000|Overall Study|Protocol Violation|1|||
170360067|NCT03657810|615654237|FG001|Overall Study|Protocol Violation|0|||
170360068|NCT03657810|615654238|FG002|Overall Study|Protocol Violation|0|||
170360069|NCT03657810|615654236|FG000|Overall Study|Lost to Follow-up|0|||
170360070|NCT03657810|615654237|FG001|Overall Study|Lost to Follow-up|1|||
170360071|NCT03657810|615654238|FG002|Overall Study|Lost to Follow-up|0|||
170360072|NCT03657810|615654236|FG000|Overall Study|Not provided|0|||
170360073|NCT03657810|615654237|FG001|Overall Study|Not provided|1|||
170360074|NCT03657810|615654238|FG002|Overall Study|Not provided|0|||
170360075|NCT00688545|615654239|FG000|Overall Study|Lost to Follow-up|1|||
170360076|NCT00688545|615654240|FG001|Overall Study|Lost to Follow-up|4|||
170360077|NCT00688545|615654239|FG000|Overall Study|Insurance/cost of drug|0|||
170360078|NCT00688545|615654240|FG001|Overall Study|Insurance/cost of drug|1|||
170360079|NCT00688545|615654239|FG000|Overall Study|Withdrawal by Subject|2|||
170360080|NCT00688545|615654240|FG001|Overall Study|Withdrawal by Subject|3|||
170360081|NCT00688545|615654239|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
170360082|NCT00688545|615654240|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
170360083|NCT01595438|615654241|FG000|Overall Study|Lost to Follow-up|20|||
170360084|NCT01595438|615654242|FG001|Overall Study|Lost to Follow-up|20|||
170360085|NCT01595438|615654241|FG000|Overall Study|Withdrawal by Subject|12|||
170360086|NCT01595438|615654242|FG001|Overall Study|Withdrawal by Subject|12|||
170360087|NCT01595438|615654241|FG000|Overall Study|Other Eligibility criteria|11|||
170360088|NCT01595438|615654242|FG001|Overall Study|Other Eligibility criteria|9|||
170360089|NCT00367341|615654243|FG000|Overall Study|Physician Decision|1|||
170360090|NCT00367341|615654244|FG001|Overall Study|Physician Decision|0|||
170360091|NCT00367341|615654243|FG000|Overall Study|Protocol Violation|1|||
170360092|NCT00367341|615654244|FG001|Overall Study|Protocol Violation|0|||
170360093|NCT01204697|615654245|FG000|Overall Study|Death|26|||
170360094|NCT01204697|615654246|FG001|Overall Study|Death|27|||
170360095|NCT01204697|615654245|FG000|Overall Study|Lost to Follow-up|3|||
170360096|NCT01204697|615654246|FG001|Overall Study|Lost to Follow-up|4|||
170360097|NCT01204697|615654245|FG000|Overall Study|Withdrawal by Subject|2|||
170360098|NCT01204697|615654246|FG001|Overall Study|Withdrawal by Subject|4|||
170360099|NCT01204697|615654245|FG000|Overall Study|Randomized, but not treated|0|||
170360100|NCT01204697|615654246|FG001|Overall Study|Randomized, but not treated|1|||
170360101|NCT01705587|615654249|FG000|Overall Study|Withdrawal by Subject|0|||
170360102|NCT01705587|615654250|FG001|Overall Study|Withdrawal by Subject|1|||
170360103|NCT01373918|615654255|FG000|Overall Study|Physician Decision|0|||
170360104|NCT01373918|615654256|FG001|Overall Study|Physician Decision|1|||
170360105|NCT00291499|615654258|FG000|Overall Study|Adverse Event|3|||
170360106|NCT00291499|615654259|FG001|Overall Study|Adverse Event|8|||
170360107|NCT00291499|615654258|FG000|Overall Study|Change to other therapy|2|||
170360108|NCT00291499|615654259|FG001|Overall Study|Change to other therapy|1|||
170360109|NCT00291499|615654258|FG000|Overall Study|Intercurrent illness|1|||
170360110|NCT00291499|615654259|FG001|Overall Study|Intercurrent illness|0|||
170360111|NCT00291499|615654258|FG000|Overall Study|Protocol Violation|2|||
170360112|NCT00291499|615654259|FG001|Overall Study|Protocol Violation|2|||
170360113|NCT00291499|615654258|FG000|Overall Study|Other reasons|1|||
170360114|NCT00291499|615654259|FG001|Overall Study|Other reasons|4|||
170360115|NCT02786836|615654260|FG000|Overall Study|Death|1|||
170360116|NCT02786836|615654260|FG000|Overall Study|Lack of Efficacy|2|||
170360117|NCT02786836|615654260|FG000|Overall Study|Protocol Violation|3|||
170360118|NCT02786836|615654260|FG000|Overall Study|Withdrawal by Subject|3|||
170360119|NCT02786836|615654260|FG000|Overall Study|Liver Transplantation|2|||
170360120|NCT02786836|615654260|FG000|Overall Study|Device or Pharmacy Issues|3|||
170360121|NCT05224076|615654268|FG000|Overall Study|Lost to Follow-up|24|||
170360122|NCT03017846|615654269|FG000|Overall Study|Lost to Follow-up|3|||
170360123|NCT03017846|615654269|FG000|Overall Study|Adverse Event|2|||
170360124|NCT02151682|615654272|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
170360125|NCT02151682|615654273|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
170360126|NCT02151682|615654274|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
170360127|NCT02151682|615654275|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
170360128|NCT02151682|615654276|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
170360129|NCT02151682|615654277|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
170360130|NCT02151682|615654272|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
170360131|NCT02151682|615654273|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
170360132|NCT02151682|615654274|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
170360133|NCT02151682|615654275|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
170360134|NCT02151682|615654276|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
170360135|NCT02151682|615654277|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
170360136|NCT02151682|615654272|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
170360137|NCT02151682|615654273|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
170360138|NCT02151682|615654274|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
170360139|NCT02151682|615654275|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
170360140|NCT02151682|615654276|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
170360141|NCT02151682|615654277|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
170360142|NCT02151682|615654272|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
170360143|NCT02151682|615654273|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
170360144|NCT02151682|615654274|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
170360145|NCT02151682|615654275|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
170360146|NCT02151682|615654276|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
170360147|NCT02151682|615654277|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
170360148|NCT02151682|615654272|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
170360149|NCT02151682|615654273|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
170360150|NCT02151682|615654274|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
170360151|NCT02151682|615654275|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
170360152|NCT02151682|615654276|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
170360153|NCT02151682|615654277|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
170360154|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
170360155|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
170360156|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
170360157|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
170360158|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
170360159|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
170360160|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
170360161|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
170360162|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
170360163|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
170360164|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
170360165|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
170360166|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
170360167|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
170360168|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
170360169|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
170360170|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
170360171|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
170360172|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
170360173|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
170360174|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
170360175|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
170360176|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
170360177|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
170360178|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
170399311|NCT03193190|615799952|FG015|Stage 1|Physician Decision|0|||
170360179|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
170360180|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
170360181|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
170360182|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
170360183|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
170360184|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
170360185|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
170360186|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
170360187|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
170360188|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
170360189|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
170360190|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
170360191|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
170360192|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
170360193|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
170360194|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
170360195|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
170360196|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
170360197|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
170360198|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
170360199|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
170360200|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
170360201|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
170360202|NCT02151682|615654272|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
170360203|NCT02151682|615654273|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
170360204|NCT02151682|615654274|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
170360205|NCT02151682|615654275|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
170360206|NCT02151682|615654276|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
170360207|NCT02151682|615654277|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
170360208|NCT02151682|615654272|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
170360209|NCT02151682|615654273|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
170360210|NCT02151682|615654274|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
170360211|NCT02151682|615654275|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
170360212|NCT02151682|615654276|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
170360213|NCT02151682|615654277|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
170360214|NCT02151682|615654272|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
170360215|NCT02151682|615654273|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
170360216|NCT02151682|615654274|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
170360217|NCT02151682|615654275|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
170360218|NCT02151682|615654276|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
170360219|NCT02151682|615654277|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
170360220|NCT02151682|615654272|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
170360221|NCT02151682|615654273|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
170360222|NCT02151682|615654274|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
170360223|NCT02151682|615654275|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
170360224|NCT02151682|615654276|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
170360225|NCT02151682|615654277|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
170360226|NCT02151682|615654272|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
170360227|NCT02151682|615654273|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
170360228|NCT02151682|615654274|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
170360229|NCT02151682|615654275|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
170360230|NCT02151682|615654276|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
170360231|NCT02151682|615654277|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
170360232|NCT01306032|615654278|FG000|First Intervention|Adverse Event|1|||
170360233|NCT01306032|615654279|FG001|First Intervention|Adverse Event|0|||
170360234|NCT01306032|615654280|FG002|First Intervention|Adverse Event|1|||
170360235|NCT01306032|615654281|FG003|First Intervention|Adverse Event|0|||
170360236|NCT01306032|615654282|FG004|First Intervention|Adverse Event|0|||
170360237|NCT01306032|615654283|FG005|First Intervention|Adverse Event|1|||
170360238|NCT01306032|615654278|FG000|First Intervention|Withdrawal by Subject|0|||
170360239|NCT01306032|615654279|FG001|First Intervention|Withdrawal by Subject|2|||
170360240|NCT01306032|615654280|FG002|First Intervention|Withdrawal by Subject|0|||
170360241|NCT01306032|615654281|FG003|First Intervention|Withdrawal by Subject|1|||
170360242|NCT01306032|615654282|FG004|First Intervention|Withdrawal by Subject|0|||
170360243|NCT01306032|615654283|FG005|First Intervention|Withdrawal by Subject|0|||
170360244|NCT01306032|615654278|FG000|First Intervention|Death|0|||
170360245|NCT01306032|615654279|FG001|First Intervention|Death|0|||
170360246|NCT01306032|615654280|FG002|First Intervention|Death|1|||
170360247|NCT01306032|615654281|FG003|First Intervention|Death|0|||
170360248|NCT01306032|615654282|FG004|First Intervention|Death|0|||
170360249|NCT01306032|615654283|FG005|First Intervention|Death|0|||
170360250|NCT01306032|615654278|FG000|First Intervention|Ineligible|0|||
170360251|NCT01306032|615654279|FG001|First Intervention|Ineligible|0|||
170360252|NCT01306032|615654280|FG002|First Intervention|Ineligible|0|||
170360253|NCT01306032|615654281|FG003|First Intervention|Ineligible|0|||
170360254|NCT01306032|615654282|FG004|First Intervention|Ineligible|0|||
170360255|NCT01306032|615654283|FG005|First Intervention|Ineligible|1|||
170360256|NCT01306032|615654278|FG000|First Intervention|Progressive disease|0|||
170360257|NCT01306032|615654279|FG001|First Intervention|Progressive disease|0|||
170360258|NCT01306032|615654280|FG002|First Intervention|Progressive disease|0|||
170360259|NCT01306032|615654281|FG003|First Intervention|Progressive disease|0|||
170360260|NCT01306032|615654282|FG004|First Intervention|Progressive disease|2|||
170360261|NCT01306032|615654283|FG005|First Intervention|Progressive disease|0|||
170360262|NCT01306032|615654278|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
170360263|NCT01306032|615654279|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
170360264|NCT01306032|615654280|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
170360265|NCT01306032|615654281|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
170360266|NCT01306032|615654282|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
170360267|NCT01306032|615654283|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
170360268|NCT01306032|615654278|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
170360269|NCT01306032|615654279|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
170360270|NCT01306032|615654280|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
170360271|NCT01306032|615654281|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
170360272|NCT01306032|615654282|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
170360273|NCT01306032|615654283|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
170360274|NCT03260894|615654286|FG000|Overall Study|Death|6|||
170360275|NCT03260894|615654287|FG001|Overall Study|Death|8|||
170360276|NCT03260894|615654286|FG000|Overall Study|Withdrawal by Subject|4|||
170360277|NCT03260894|615654287|FG001|Overall Study|Withdrawal by Subject|11|||
170360278|NCT03260894|615654286|FG000|Overall Study|On-going at clinical cut off date|36|||
170360279|NCT03260894|615654287|FG001|Overall Study|On-going at clinical cut off date|31|||
170360280|NCT00830804|615654292|FG000|Overall Study|Lost to Follow-up|4|||
170360281|NCT00830804|615654292|FG000|Overall Study|Death|1|||
170360282|NCT00830804|615654292|FG000|Overall Study|Unable to get to clinic|7|||
170360283|NCT00830804|615654292|FG000|Overall Study|Consent withdrawn|2|||
170360284|NCT00830804|615654292|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
170360285|NCT01438307|615654293|FG000|Overall Study|Death|1|||
170360286|NCT01438307|615654294|FG001|Overall Study|Death|1|||
170360287|NCT00555568|615654295|FG000|Overall Study|Lost to Follow-up|26|||
170360288|NCT00555568|615654296|FG001|Overall Study|Lost to Follow-up|16|||
170360289|NCT00555568|615654297|FG002|Overall Study|Lost to Follow-up|16|||
170360290|NCT00171314|615654303|FG000|Overall Study|Adverse Event|44|||
170360291|NCT00171314|615654304|FG001|Overall Study|Adverse Event|41|||
170360292|NCT00171314|615654303|FG000|Overall Study|Lack of Efficacy|19|||
170360293|NCT00171314|615654304|FG001|Overall Study|Lack of Efficacy|14|||
170360294|NCT00171314|615654303|FG000|Overall Study|Withdrawal by Subject|9|||
170360295|NCT00171314|615654304|FG001|Overall Study|Withdrawal by Subject|6|||
170360296|NCT00171314|615654303|FG000|Overall Study|Abnormal Test Procedure Results|9|||
170360297|NCT00171314|615654304|FG001|Overall Study|Abnormal Test Procedure Results|3|||
170360298|NCT00171314|615654303|FG000|Overall Study|Protocol Violation|3|||
170360299|NCT00171314|615654304|FG001|Overall Study|Protocol Violation|7|||
170360300|NCT00171314|615654303|FG000|Overall Study|Administrative Problems|4|||
170360301|NCT00171314|615654304|FG001|Overall Study|Administrative Problems|3|||
170360302|NCT00171314|615654303|FG000|Overall Study|Lost to Follow-up|1|||
170360303|NCT00171314|615654304|FG001|Overall Study|Lost to Follow-up|3|||
170360304|NCT00171314|615654303|FG000|Overall Study|Death|2|||
170360305|NCT00171314|615654304|FG001|Overall Study|Death|1|||
170360306|NCT02677220|615654308|FG000|Overall Study|Adverse Event|1|||
170360307|NCT01504971|615654313|FG000|Overall Study|Physician Decision|13|||
170360308|NCT05159362|615654316|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
170360309|NCT05159362|615654317|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
170360310|NCT05159362|615654318|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
170360311|NCT01376245|615654319|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
170360312|NCT01376245|615654320|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
170360313|NCT01376245|615654321|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
170360314|NCT01376245|615654322|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
170360315|NCT01376245|615654323|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
170360316|NCT01376245|615654319|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
170360317|NCT01376245|615654320|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
170360318|NCT01376245|615654321|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
170360319|NCT01376245|615654322|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
170360320|NCT01376245|615654323|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
170360321|NCT01376245|615654319|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
170360322|NCT01376245|615654320|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
170360323|NCT01376245|615654321|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
170360324|NCT01376245|615654322|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
170360325|NCT01376245|615654323|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
170360326|NCT01376245|615654319|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
170360327|NCT01376245|615654320|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
170360328|NCT01376245|615654321|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
170360329|NCT01376245|615654322|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
170360330|NCT01376245|615654323|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
170360331|NCT01376245|615654319|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
170360332|NCT01376245|615654320|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
170360333|NCT01376245|615654321|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
170360334|NCT01376245|615654322|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
170360335|NCT01376245|615654323|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
170360336|NCT01376245|615654319|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
170360337|NCT01376245|615654320|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
170360338|NCT01376245|615654321|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
170360339|NCT01376245|615654322|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
170360340|NCT01376245|615654323|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
170360341|NCT01376245|615654319|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
170360342|NCT01376245|615654320|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
170360343|NCT01376245|615654321|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
170360344|NCT01376245|615654322|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
170360345|NCT01376245|615654323|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
170360346|NCT01376245|615654319|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
170360347|NCT01376245|615654320|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
170360348|NCT01376245|615654321|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
170360349|NCT01376245|615654322|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
170360350|NCT01376245|615654323|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
170360351|NCT01376245|615654319|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
170360352|NCT01376245|615654320|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
170360353|NCT01376245|615654321|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
170360354|NCT01376245|615654322|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
170360355|NCT01376245|615654323|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
170360356|NCT01376245|615654319|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170360357|NCT01376245|615654320|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
170360358|NCT01376245|615654321|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170360359|NCT01376245|615654322|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
170360360|NCT01376245|615654323|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
170360361|NCT01376245|615654319|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
170360362|NCT01376245|615654320|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
170360363|NCT01376245|615654321|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
170360364|NCT01376245|615654322|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
170360365|NCT01376245|615654323|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
170360366|NCT01376245|615654319|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
170360367|NCT01376245|615654320|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
170360368|NCT01376245|615654321|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
170360369|NCT01376245|615654322|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
170360370|NCT01376245|615654323|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
170360371|NCT01357889|615654324|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
170360372|NCT01357889|615654325|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
170360373|NCT01357889|615654324|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
170360374|NCT01357889|615654325|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
170360375|NCT01357889|615654324|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
170360376|NCT01357889|615654325|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
170360377|NCT01357889|615654324|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
170360378|NCT01357889|615654325|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
170360379|NCT01357889|615654324|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
170360380|NCT01357889|615654325|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
170360381|NCT01357889|615654324|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
170399312|NCT03193190|615799937|FG000|Stage 1|Progressive Disease|1|||
170360382|NCT01357889|615654325|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
170360383|NCT01357889|615654324|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
170360384|NCT01357889|615654325|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
170360385|NCT01357889|615654324|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
170360386|NCT01357889|615654325|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
170360387|NCT01357889|615654324|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
170360388|NCT01357889|615654325|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
170360389|NCT01357889|615654324|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
170360390|NCT01357889|615654325|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
170360391|NCT01357889|615654324|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
170360392|NCT01357889|615654325|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
170360393|NCT01357889|615654324|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
170360394|NCT01357889|615654325|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
170360395|NCT01357889|615654324|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
170360396|NCT01357889|615654325|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
170360397|NCT02693691|615654326|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
170360398|NCT02693691|615654326|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
170360399|NCT02693691|615654326|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
170360400|NCT02693691|615654326|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
170360401|NCT02693691|615654326|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
170360402|NCT02693691|615654326|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
170360403|NCT02693691|615654326|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
170360404|NCT00585923|615654330|FG000|Overall Study|Physician decided not to continue|31|||
170360405|NCT00585923|615654331|FG001|Overall Study|Physician decided not to continue|33|||
170360406|NCT04664855|615654332|FG000|Overall Study|Withdrawal by Subject|0|||
170360407|NCT04664855|615654333|FG001|Overall Study|Withdrawal by Subject|2|||
170360408|NCT01361919|615654336|FG000|Overall Study|technical issues|10|||
170360409|NCT01361919|615654337|FG001|Overall Study|technical issues|12|||
170360410|NCT01361919|615654338|FG002|Overall Study|technical issues|10|||
170360411|NCT02475395|615654339|FG000|Overall Study|Protocol Violation|30|||
170360412|NCT02475395|615654340|FG001|Overall Study|Protocol Violation|3|||
170360413|NCT01167582|615654341|FG000|Overall Study|Lost to Follow-up|0|||
170360414|NCT01167582|615654342|FG001|Overall Study|Lost to Follow-up|1|||
170360415|NCT01681576|615654343|FG000|Period 1|Adverse Event|1|||
170360416|NCT01681576|615654344|FG001|Period 1|Adverse Event|0|||
170360417|NCT01681576|615654343|FG000|Period 1|Protocol Deviation|1|||
170360418|NCT01681576|615654344|FG001|Period 1|Protocol Deviation|0|||
170360419|NCT01681576|615654343|FG000|Period 2|subject/guardian decision|3|||
170360420|NCT01681576|615654344|FG001|Period 2|subject/guardian decision|1|||
170360421|NCT01681576|615654343|FG000|Period 2|Non-compliance with study treatment|1|||
170360422|NCT01681576|615654344|FG001|Period 2|Non-compliance with study treatment|0|||
170360423|NCT00870818|615654346|FG000|Overall Study|Lost to Follow-up|3|||
170360424|NCT00870818|615654347|FG001|Overall Study|Lost to Follow-up|2|||
170360425|NCT00870818|615654348|FG002|Overall Study|Lost to Follow-up|1|||
170360426|NCT00870818|615654349|FG003|Overall Study|Lost to Follow-up|0|||
170360427|NCT00870818|615654350|FG004|Overall Study|Lost to Follow-up|0|||
170360428|NCT00870818|615654346|FG000|Overall Study|Withdrawal by Subject|0|||
170360429|NCT00870818|615654347|FG001|Overall Study|Withdrawal by Subject|0|||
170360430|NCT00870818|615654348|FG002|Overall Study|Withdrawal by Subject|1|||
170360431|NCT00870818|615654349|FG003|Overall Study|Withdrawal by Subject|2|||
170360432|NCT00870818|615654350|FG004|Overall Study|Withdrawal by Subject|0|||
170360433|NCT00870818|615654346|FG000|Overall Study|Terminated by sponsor|29|||
170360434|NCT00870818|615654347|FG001|Overall Study|Terminated by sponsor|70|||
170360435|NCT00870818|615654348|FG002|Overall Study|Terminated by sponsor|36|||
170360436|NCT00870818|615654349|FG003|Overall Study|Terminated by sponsor|36|||
170360437|NCT00870818|615654350|FG004|Overall Study|Terminated by sponsor|38|||
170360438|NCT00870818|615654346|FG000|Overall Study|Other|0|||
170360439|NCT00870818|615654347|FG001|Overall Study|Other|1|||
170360440|NCT00870818|615654348|FG002|Overall Study|Other|0|||
170360441|NCT00870818|615654349|FG003|Overall Study|Other|0|||
170360442|NCT00870818|615654350|FG004|Overall Study|Other|0|||
170360443|NCT04093258|615654351|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
170360444|NCT04093258|615654352|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
170360445|NCT00293423|615654353|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
170360446|NCT00293423|615654354|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
170360447|NCT00293423|615654353|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
170360448|NCT00293423|615654354|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
170360449|NCT00293423|615654353|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
170360450|NCT00293423|615654354|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
170360451|NCT00293423|615654353|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
170360452|NCT00293423|615654354|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
170399313|NCT03193190|615799938|FG001|Stage 1|Progressive Disease|0|||
170360453|NCT00293423|615654353|FG000|Surgical Resection|processing error during surgical resection|1|||
170360454|NCT00293423|615654354|FG001|Surgical Resection|processing error during surgical resection|0|||
170360455|NCT00293423|615654353|FG000|Surgical Resection|Withdrawal by Subject|4|||
170360456|NCT00293423|615654354|FG001|Surgical Resection|Withdrawal by Subject|0|||
170360457|NCT00293423|615654353|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
170360458|NCT00293423|615654354|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
170360459|NCT00805545|615654355|FG000|Overall Study|Protocol Violation|3|||
170360460|NCT00805545|615654356|FG001|Overall Study|Protocol Violation|2|||
170360461|NCT00805545|615654355|FG000|Overall Study|Protocol Violation|3|||
170360462|NCT00805545|615654356|FG001|Overall Study|Protocol Violation|1|||
170360463|NCT03448224|615654357|FG000|Overall Study|Provided same answer to every question|1|||
170360464|NCT03448224|615654358|FG001|Overall Study|Provided same answer to every question|0|||
170360465|NCT00575094|615654359|FG000|Overall Study|Adverse Event|2|||
170360466|NCT00575094|615654359|FG000|Overall Study|Withdrawal by Subject|1|||
170360467|NCT02247401|615654360|FG000|Overall Study|Adverse Event|1|||
170360468|NCT02247401|615654361|FG001|Overall Study|Adverse Event|0|||
170360469|NCT02247401|615654362|FG002|Overall Study|Adverse Event|0|||
170360470|NCT02247401|615654360|FG000|Overall Study|Withdrawal by Subject|4|||
170360471|NCT02247401|615654361|FG001|Overall Study|Withdrawal by Subject|1|||
170360472|NCT02247401|615654362|FG002|Overall Study|Withdrawal by Subject|1|||
170360473|NCT02247401|615654360|FG000|Overall Study|Lost to Follow-up|1|||
170360474|NCT02247401|615654361|FG001|Overall Study|Lost to Follow-up|1|||
170360475|NCT02247401|615654362|FG002|Overall Study|Lost to Follow-up|1|||
170360476|NCT02133742|615654366|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
170360477|NCT02133742|615654366|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
170360478|NCT02133742|615654366|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
170360479|NCT02133742|615654366|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
170360480|NCT02133742|615654366|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
170360481|NCT03479216|615654367|FG000|Overall Study|Withdrawal by Subject|3|||
170360482|NCT03479216|615654368|FG001|Overall Study|Withdrawal by Subject|2|||
170360483|NCT03479216|615654367|FG000|Overall Study|Physician Decision|2|||
170360484|NCT03479216|615654368|FG001|Overall Study|Physician Decision|3|||
170360485|NCT03074149|615654370|FG000|Overall Study|Reason unknown|22|||
170360486|NCT03074149|615654371|FG001|Overall Study|Reason unknown|35|||
170360487|NCT03074149|615654370|FG000|Overall Study|Death|10|||
170360488|NCT03074149|615654371|FG001|Overall Study|Death|45|||
170360489|NCT02180217|615654372|FG000|Overall Study|Adverse Event|3|||
170360490|NCT02180217|615654373|FG001|Overall Study|Adverse Event|2|||
170360491|NCT02180217|615654374|FG002|Overall Study|Adverse Event|22|||
170360492|NCT02180217|615654372|FG000|Overall Study|Death|1|||
170360493|NCT02180217|615654373|FG001|Overall Study|Death|1|||
170360494|NCT02180217|615654374|FG002|Overall Study|Death|0|||
170360495|NCT02180217|615654372|FG000|Overall Study|Withdrawal by Subject|1|||
170360496|NCT02180217|615654373|FG001|Overall Study|Withdrawal by Subject|1|||
170360497|NCT02180217|615654374|FG002|Overall Study|Withdrawal by Subject|4|||
170360498|NCT02180217|615654372|FG000|Overall Study|Subject/Guardian decision|5|||
170360499|NCT02180217|615654373|FG001|Overall Study|Subject/Guardian decision|3|||
170360500|NCT02180217|615654374|FG002|Overall Study|Subject/Guardian decision|6|||
170360501|NCT02180217|615654372|FG000|Overall Study|Physician Decision|1|||
170360502|NCT02180217|615654373|FG001|Overall Study|Physician Decision|1|||
170360503|NCT02180217|615654374|FG002|Overall Study|Physician Decision|6|||
170360504|NCT02180217|615654372|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170360505|NCT02180217|615654373|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170360506|NCT02180217|615654374|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
170360507|NCT03784027|615654375|FG000|Period 1|Withdrawal by Subject|0|||
170360508|NCT03784027|615654376|FG001|Period 1|Withdrawal by Subject|1|||
170360509|NCT05691829|615656414|FG000|Overall Study|Physician Decision|2|||
170360510|NCT05691829|615656414|FG000|Overall Study|Eligibility criteria not met|3|||
170360511|NCT01770145|615656415|FG000|Baseline|Adverse Event|20|||
170360512|NCT01770145|615656415|FG000|Baseline|Withdrawal by Subject|1|||
170360513|NCT01770145|615656415|FG000|Baseline|Lost to Follow-up|1|||
170360514|NCT01770145|615656415|FG000|Baseline|Unable to define optimal dose|4|||
170360515|NCT01770145|615656415|FG000|Treatment|Adverse Event|3|||
170360516|NCT01770145|615656415|FG000|Treatment|Withdrawal by Subject|1|||
170360517|NCT01102140|615656416|FG000|Overall Study|Lost to Follow-up|1|||
170360518|NCT01102140|615656417|FG001|Overall Study|Lost to Follow-up|0|||
170360519|NCT01102140|615656416|FG000|Overall Study|Investigator terminated study|2|||
170360520|NCT01102140|615656417|FG001|Overall Study|Investigator terminated study|2|||
170360521|NCT00656084|615656418|FG000|Overall Study|Adverse Event|4|||
170360522|NCT00656084|615656418|FG000|Overall Study|Withdrawal by Subject|1|||
170360523|NCT00656084|615656418|FG000|Overall Study|Patient Request|1|||
170360524|NCT00656084|615656418|FG000|Overall Study|Investigator Request|1|||
170360525|NCT02455388|615656419|FG000|Overall Study|Protocol Violation|1|||
170360526|NCT02455388|615656420|FG001|Overall Study|Protocol Violation|0|||
170360527|NCT02455388|615656421|FG002|Overall Study|Protocol Violation|4|||
170360528|NCT02455388|615656419|FG000|Overall Study|Withdrawal by Subject|0|||
170360529|NCT02455388|615656420|FG001|Overall Study|Withdrawal by Subject|0|||
170360530|NCT02455388|615656421|FG002|Overall Study|Withdrawal by Subject|7|||
170360531|NCT01019252|615656425|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
170360532|NCT01019252|615656426|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
170360533|NCT01019252|615656425|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
170360534|NCT01019252|615656426|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
170360535|NCT01019252|615656425|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
170360536|NCT01019252|615656426|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
170360537|NCT01019252|615656425|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
170360538|NCT01019252|615656426|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
170360539|NCT02514772|615656427|FG000|Overall Study|Adverse Event|1|||
170360540|NCT02514772|615656428|FG001|Overall Study|Adverse Event|0|||
170360541|NCT02514772|615656427|FG000|Overall Study|Death|0|||
170360542|NCT02514772|615656428|FG001|Overall Study|Death|1|||
170360543|NCT02514772|615656427|FG000|Overall Study|Withdrawal by Subject|2|||
170360544|NCT02514772|615656428|FG001|Overall Study|Withdrawal by Subject|1|||
170360545|NCT04671342|615656429|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
170360546|NCT04671342|615656429|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
170360547|NCT04671342|615656429|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
170360548|NCT04671342|615656429|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
170360549|NCT04671342|615656429|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
170360550|NCT04671342|615656429|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
170360551|NCT03583606|615656430|FG000|Overall Study|Lost to Follow-up|0|||
170360552|NCT03583606|615656431|FG001|Overall Study|Lost to Follow-up|1|||
170360553|NCT03583606|615656432|FG002|Overall Study|Lost to Follow-up|0|||
170360554|NCT03583606|615656430|FG000|Overall Study|Ineligible at baseline|1|||
170360555|NCT03583606|615656431|FG001|Overall Study|Ineligible at baseline|0|||
170360556|NCT03583606|615656432|FG002|Overall Study|Ineligible at baseline|0|||
170360557|NCT01415908|615656433|FG000|Overall Study|Withdrawal by Subject|1|||
170360558|NCT01415908|615656434|FG001|Overall Study|Withdrawal by Subject|0|||
170360559|NCT02685995|615656435|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
170360560|NCT02685995|615656436|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
170360561|NCT00817206|615656438|FG000|Overall Study|Adverse Event|10|||
170360562|NCT00817206|615656439|FG001|Overall Study|Adverse Event|3|||
170360563|NCT00817206|615656438|FG000|Overall Study|Protocol Violation|0|||
170360564|NCT00817206|615656439|FG001|Overall Study|Protocol Violation|2|||
170360565|NCT00817206|615656438|FG000|Overall Study|Lost to Follow-up|0|||
170360566|NCT00817206|615656439|FG001|Overall Study|Lost to Follow-up|1|||
170360567|NCT00817206|615656438|FG000|Overall Study|Death|2|||
170360568|NCT00817206|615656439|FG001|Overall Study|Death|0|||
170360569|NCT00817206|615656438|FG000|Overall Study|Withdrawal by Subject|7|||
170360570|NCT00817206|615656439|FG001|Overall Study|Withdrawal by Subject|3|||
170360571|NCT00817206|615656438|FG000|Overall Study|Physician Decision|2|||
170360572|NCT00817206|615656439|FG001|Overall Study|Physician Decision|0|||
170360573|NCT00793182|615656440|FG000|Overall Study|Adverse Event|0|||
170360574|NCT00793182|615656441|FG001|Overall Study|Adverse Event|1|||
170360575|NCT02273037|615656442|FG000|Overall Study|Lost to Follow-up|1|||
170360576|NCT02273037|615656443|FG001|Overall Study|Lost to Follow-up|0|||
170360577|NCT02273037|615656442|FG000|Overall Study|Delivered before monitoring initiated|1|||
170360578|NCT02273037|615656443|FG001|Overall Study|Delivered before monitoring initiated|3|||
170360579|NCT02273037|615656442|FG000|Overall Study|Breech delivery|2|||
170360580|NCT02273037|615656443|FG001|Overall Study|Breech delivery|3|||
170360581|NCT02273037|615656442|FG000|Overall Study|Multiple delivery|2|||
170360582|NCT02273037|615656443|FG001|Overall Study|Multiple delivery|2|||
170360583|NCT02273037|615656442|FG000|Overall Study|Other complication|2|||
170360584|NCT02273037|615656443|FG001|Overall Study|Other complication|0|||
170360585|NCT00851253|615656444|FG000|Overall Study|Disease Progression|1|||
170360586|NCT00851253|615656445|FG001|Overall Study|Disease Progression|0|||
170360587|NCT01527110|615656446|FG000|Overall Study|Adverse Event|1|||
170360588|NCT00985738|615656447|FG000|Overall Study|Study closed prematurely|8|||
170360589|NCT00985738|615656448|FG001|Overall Study|Study closed prematurely|8|||
170360590|NCT03325556|615656449|FG000|Open-label Period|Lack of Response in OL period|70|||
170360591|NCT03325556|615656450|FG001|Open-label Period|Lack of Response in OL period|0|||
170360592|NCT03325556|615656451|FG002|Open-label Period|Lack of Response in OL period|0|||
170360593|NCT03325556|615656449|FG000|Open-label Period|Adverse Event|27|||
170360594|NCT03325556|615656450|FG001|Open-label Period|Adverse Event|0|||
170360595|NCT03325556|615656451|FG002|Open-label Period|Adverse Event|0|||
170360596|NCT03325556|615656449|FG000|Open-label Period|Death|1|||
170360597|NCT03325556|615656450|FG001|Open-label Period|Death|0|||
170360598|NCT03325556|615656451|FG002|Open-label Period|Death|0|||
170360599|NCT03325556|615656449|FG000|Open-label Period|Lost to Follow-up|1|||
170360600|NCT03325556|615656450|FG001|Open-label Period|Lost to Follow-up|0|||
170360601|NCT03325556|615656451|FG002|Open-label Period|Lost to Follow-up|0|||
170360602|NCT03325556|615656449|FG000|Open-label Period|Non-compliance with study drug|5|||
170360603|NCT03325556|615656450|FG001|Open-label Period|Non-compliance with study drug|0|||
170360604|NCT03325556|615656451|FG002|Open-label Period|Non-compliance with study drug|0|||
170360605|NCT03325556|615656449|FG000|Open-label Period|Use of prohibited medication|1|||
170360606|NCT03325556|615656450|FG001|Open-label Period|Use of prohibited medication|0|||
170360607|NCT03325556|615656451|FG002|Open-label Period|Use of prohibited medication|0|||
170360608|NCT03325556|615656449|FG000|Open-label Period|Protocol Violation|4|||
170360609|NCT03325556|615656450|FG001|Open-label Period|Protocol Violation|0|||
170360610|NCT03325556|615656451|FG002|Open-label Period|Protocol Violation|0|||
170360611|NCT03325556|615656449|FG000|Open-label Period|Withdrawal by Subject|17|||
170360612|NCT03325556|615656450|FG001|Open-label Period|Withdrawal by Subject|0|||
170360613|NCT03325556|615656451|FG002|Open-label Period|Withdrawal by Subject|0|||
170360614|NCT03325556|615656449|FG000|Open-label Period|Not otherwise specified|8|||
170360615|NCT03325556|615656450|FG001|Open-label Period|Not otherwise specified|0|||
170360616|NCT03325556|615656451|FG002|Open-label Period|Not otherwise specified|0|||
170360617|NCT03325556|615656449|FG000|Open-label Period|Administrative discont. at study termination|41|||
170360618|NCT03325556|615656450|FG001|Open-label Period|Administrative discont. at study termination|0|||
170360619|NCT03325556|615656451|FG002|Open-label Period|Administrative discont. at study termination|0|||
170360620|NCT03325556|615656449|FG000|Double-blind Period|Relapse|0|||
170360621|NCT03325556|615656450|FG001|Double-blind Period|Relapse|15|||
170360622|NCT03325556|615656451|FG002|Double-blind Period|Relapse|34|||
170360623|NCT03325556|615656449|FG000|Double-blind Period|Adverse Event|0|||
170360624|NCT03325556|615656450|FG001|Double-blind Period|Adverse Event|3|||
170360625|NCT03325556|615656451|FG002|Double-blind Period|Adverse Event|1|||
170360626|NCT03325556|615656449|FG000|Double-blind Period|Noncompliance with study drug|0|||
170360627|NCT03325556|615656450|FG001|Double-blind Period|Noncompliance with study drug|0|||
170360628|NCT03325556|615656451|FG002|Double-blind Period|Noncompliance with study drug|1|||
170360629|NCT03325556|615656449|FG000|Double-blind Period|Use of prohibited medication|0|||
170360630|NCT03325556|615656450|FG001|Double-blind Period|Use of prohibited medication|1|||
170360631|NCT03325556|615656451|FG002|Double-blind Period|Use of prohibited medication|0|||
170360632|NCT03325556|615656449|FG000|Double-blind Period|Physician Decision|0|||
170360633|NCT03325556|615656450|FG001|Double-blind Period|Physician Decision|0|||
170360634|NCT03325556|615656451|FG002|Double-blind Period|Physician Decision|1|||
170360635|NCT03325556|615656449|FG000|Double-blind Period|Withdrawal by Subject|0|||
170360636|NCT03325556|615656450|FG001|Double-blind Period|Withdrawal by Subject|6|||
170360637|NCT03325556|615656451|FG002|Double-blind Period|Withdrawal by Subject|4|||
170360638|NCT03325556|615656449|FG000|Double-blind Period|Not otherwise specified|0|||
170360639|NCT03325556|615656450|FG001|Double-blind Period|Not otherwise specified|1|||
170360640|NCT03325556|615656451|FG002|Double-blind Period|Not otherwise specified|5|||
170360641|NCT03325556|615656449|FG000|Double-blind Period|Administrative discont. at study termination|0|||
170360642|NCT03325556|615656450|FG001|Double-blind Period|Administrative discont. at study termination|35|||
170360643|NCT03325556|615656451|FG002|Double-blind Period|Administrative discont. at study termination|31|||
170360644|NCT00762268|615656452|FG000|Overall Study|Withdrawal by Subject|3|||
170360645|NCT00762268|615656453|FG001|Overall Study|Withdrawal by Subject|3|||
170360646|NCT02016898|615656454|FG000|Overall Study|Death|1|||
170360647|NCT02016898|615656455|FG001|Overall Study|Death|1|||
170360648|NCT02016898|615656454|FG000|Overall Study|Lost to Follow-up|4|||
170360649|NCT02016898|615656455|FG001|Overall Study|Lost to Follow-up|4|||
170360650|NCT04603391|615656456|FG000|First Intervention (4 Days)|Adverse Event|1|||
170360651|NCT04603391|615656457|FG001|First Intervention (4 Days)|Adverse Event|0|||
170360652|NCT04603391|615656456|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
170360653|NCT04603391|615656457|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
170360654|NCT02759861|615656458|FG000|Overall Study|Death|1|||
170360655|NCT02988219|615656459|FG000|Overall Study|Lack of Efficacy|1|||
170360656|NCT02988219|615656460|FG001|Overall Study|Lack of Efficacy|1|||
170360657|NCT02988219|615656459|FG000|Overall Study|Withdrawal by Subject|0|||
170360658|NCT02988219|615656460|FG001|Overall Study|Withdrawal by Subject|2|||
170360659|NCT00050622|615656461|FG000|Overall Study|Adverse Event|1|||
170360660|NCT00936117|615656462|FG000|Overall Study|Adverse Event|7|||
170360661|NCT00936117|615656462|FG000|Overall Study|Unable to continue oral medication|3|||
170360662|NCT04581863|615656463|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
170360663|NCT04581863|615656464|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
170360664|NCT01309841|615656471|FG000|Overall Study|Other|0|||
170360665|NCT01309841|615656472|FG001|Overall Study|Other|1|||
170360666|NCT01309841|615656473|FG002|Overall Study|Other|1|||
170360667|NCT01309841|615656471|FG000|Overall Study|Lost to Follow-up|7|||
170360668|NCT01309841|615656472|FG001|Overall Study|Lost to Follow-up|6|||
170360669|NCT01309841|615656473|FG002|Overall Study|Lost to Follow-up|4|||
170360670|NCT01309841|615656471|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
170360671|NCT01309841|615656472|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
170360672|NCT01309841|615656473|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
170360673|NCT01309841|615656471|FG000|Overall Study|Lack of Efficacy|0|||
170360674|NCT01309841|615656472|FG001|Overall Study|Lack of Efficacy|0|||
170360675|NCT01309841|615656473|FG002|Overall Study|Lack of Efficacy|2|||
170360676|NCT01309841|615656471|FG000|Overall Study|Adverse Event|9|||
170360677|NCT01309841|615656472|FG001|Overall Study|Adverse Event|22|||
170360678|NCT01309841|615656473|FG002|Overall Study|Adverse Event|11|||
170360679|NCT01309841|615656471|FG000|Overall Study|Death|1|||
170360680|NCT01309841|615656472|FG001|Overall Study|Death|0|||
170360681|NCT01309841|615656473|FG002|Overall Study|Death|0|||
170360682|NCT01309841|615656471|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
170360683|NCT01309841|615656472|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
170360684|NCT01309841|615656473|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
170360685|NCT01309841|615656471|FG000|Overall Study|Withdrawal by Subject|17|||
170360686|NCT01309841|615656472|FG001|Overall Study|Withdrawal by Subject|6|||
170360687|NCT01309841|615656473|FG002|Overall Study|Withdrawal by Subject|13|||
170360688|NCT01309841|615656471|FG000|Overall Study|Did Not Receive Treatment|2|||
170360689|NCT01309841|615656472|FG001|Overall Study|Did Not Receive Treatment|0|||
170360690|NCT01309841|615656473|FG002|Overall Study|Did Not Receive Treatment|1|||
170360691|NCT01309841|615656471|FG000|Overall Study|Severe non-compliance with protocol|0|||
170360692|NCT01309841|615656472|FG001|Overall Study|Severe non-compliance with protocol|5|||
170360693|NCT01309841|615656473|FG002|Overall Study|Severe non-compliance with protocol|2|||
170360694|NCT01315847|615656474|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
170360695|NCT01315847|615656475|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
170360696|NCT01315847|615656474|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
170360697|NCT01315847|615656475|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
170360698|NCT00878215|615656476|FG000|Overall Study|Determined to be ineligible|0|||
170360699|NCT00878215|615656477|FG001|Overall Study|Determined to be ineligible|10|||
170360700|NCT00878215|615656478|FG002|Overall Study|Determined to be ineligible|0|||
170360701|NCT00878215|615656479|FG003|Overall Study|Determined to be ineligible|0|||
170360702|NCT00138424|615656480|FG000|Overall Study|Physician Decision|0|||
170360703|NCT00138424|615656481|FG001|Overall Study|Physician Decision|1|||
170360704|NCT00138424|615656482|FG002|Overall Study|Physician Decision|0|||
170360705|NCT00138424|615656483|FG003|Overall Study|Physician Decision|0|||
170360706|NCT00574496|615656490|FG000|Overall Study|Withdrawal by Subject|1|||
170360707|NCT00413062|615656491|FG000|Overall Study|Adverse event/serious adverse event|289|||
170360708|NCT00413062|615656492|FG001|Overall Study|Adverse event/serious adverse event|56|||
170360709|NCT00413062|615656491|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
170360710|NCT00413062|615656492|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
170360711|NCT00413062|615656491|FG000|Overall Study|Withdrawal of informed consent|111|||
170360712|NCT00413062|615656492|FG001|Overall Study|Withdrawal of informed consent|36|||
170360713|NCT00413062|615656491|FG000|Overall Study|Pregnancy|15|||
170360714|NCT00413062|615656492|FG001|Overall Study|Pregnancy|5|||
170360715|NCT00413062|615656491|FG000|Overall Study|Pregnancy wish|17|||
170360716|NCT00413062|615656492|FG001|Overall Study|Pregnancy wish|6|||
170360717|NCT00413062|615656491|FG000|Overall Study|Lost to Follow-up|175|||
170360718|NCT00413062|615656492|FG001|Overall Study|Lost to Follow-up|73|||
170360719|NCT00413062|615656491|FG000|Overall Study|Other reason|70|||
170360720|NCT00413062|615656492|FG001|Overall Study|Other reason|34|||
170360721|NCT02176291|615656493|FG000|Overall Study|Death|1|||
170360722|NCT02176291|615656494|FG001|Overall Study|Death|0|||
170360723|NCT02176291|615656493|FG000|Overall Study|non compliance with protocol|2|||
170360724|NCT02176291|615656494|FG001|Overall Study|non compliance with protocol|0|||
170360725|NCT02176291|615656493|FG000|Overall Study|Withdrawal by Subject|2|||
170360726|NCT02176291|615656494|FG001|Overall Study|Withdrawal by Subject|0|||
170360727|NCT00178464|615656495|FG000|Overall Study|Withdrawal by Subject|1|||
170360728|NCT00178464|615656495|FG000|Overall Study|Physician Decision|1|||
170360729|NCT02486952|615656498|FG000|Overall Study|Not Started Induction Therapy|3|||
170360730|NCT02486952|615656498|FG000|Overall Study|Adverse Event|1|||
170360731|NCT02486952|615656498|FG000|Overall Study|Death|15|||
170360732|NCT02486952|615656498|FG000|Overall Study|Lack of Efficacy|3|||
170360733|NCT02486952|615656498|FG000|Overall Study|Lost to Follow-up|26|||
170360734|NCT02486952|615656498|FG000|Overall Study|Other|2|||
170360735|NCT03589885|615656499|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
170360736|NCT03589885|615656500|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
170360737|NCT03589885|615656501|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
170360738|NCT03589885|615656502|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
170360739|NCT03589885|615656503|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
170360740|NCT03589885|615656499|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
170360741|NCT03589885|615656500|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
170360742|NCT03589885|615656501|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
170360743|NCT03589885|615656502|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
170360744|NCT03589885|615656503|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
170360745|NCT03589885|615656499|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
170360746|NCT03589885|615656500|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
170360747|NCT03589885|615656501|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
170360748|NCT03589885|615656502|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
170360749|NCT03589885|615656503|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
170360750|NCT03589885|615656499|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
170360751|NCT03589885|615656500|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
170360752|NCT03589885|615656501|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
170360753|NCT03589885|615656502|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
170360754|NCT03589885|615656503|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
170360755|NCT03589885|615656499|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
170360756|NCT03589885|615656500|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
170360757|NCT03589885|615656501|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
170360758|NCT03589885|615656502|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
170360759|NCT03589885|615656503|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
170360760|NCT03589885|615656499|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
170360761|NCT03589885|615656500|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
170360762|NCT03589885|615656501|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
170360763|NCT03589885|615656502|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
170360764|NCT03589885|615656503|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
170360765|NCT03589885|615656499|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
170360766|NCT03589885|615656500|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
170360767|NCT03589885|615656501|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
170360768|NCT03589885|615656502|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
170360769|NCT03589885|615656503|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
170360770|NCT03589885|615656499|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
170360771|NCT03589885|615656500|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
170360772|NCT03589885|615656501|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
170360773|NCT03589885|615656502|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
170360774|NCT03589885|615656503|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
170360775|NCT04111107|615656504|FG000|Overall Study|Withdrawal by Subject|6|||
170360776|NCT04111107|615656504|FG000|Overall Study|Declining Health|5|||
170360777|NCT00567541|615656505|FG000|Overall Study|Adverse Event|0|||
170360778|NCT00567541|615656506|FG001|Overall Study|Adverse Event|1|||
170360779|NCT01529385|615656507|FG000|Overall Study|Lost to Follow-up|2|||
170360780|NCT01529385|615656508|FG001|Overall Study|Lost to Follow-up|1|||
170360781|NCT00986427|615656509|FG000|Overall Study|Lost to Follow-up|2|||
170360782|NCT00986427|615656510|FG001|Overall Study|Lost to Follow-up|0|||
170360783|NCT00986427|615656509|FG000|Overall Study|Lack of Efficacy|1|||
170360784|NCT00986427|615656510|FG001|Overall Study|Lack of Efficacy|0|||
170360785|NCT00986427|615656509|FG000|Overall Study|Withdrawal by Subject|1|||
170360786|NCT00986427|615656510|FG001|Overall Study|Withdrawal by Subject|0|||
170360787|NCT02379390|615656516|FG000|Overall Study|Adverse Event|1|||
170360788|NCT02379390|615656517|FG001|Overall Study|Adverse Event|1|||
170360789|NCT02379390|615656516|FG000|Overall Study|Investigator's decision|1|||
170360790|NCT02379390|615656517|FG001|Overall Study|Investigator's decision|0|||
170360791|NCT02379390|615656516|FG000|Overall Study|Study Termination|0|||
170360792|NCT02379390|615656517|FG001|Overall Study|Study Termination|1|||
170360793|NCT03103906|615656518|FG000|Overall Study|Adverse Event|2|||
170360794|NCT03103906|615656519|FG001|Overall Study|Adverse Event|3|||
170360795|NCT03103906|615656518|FG000|Overall Study|Other|2|||
170360796|NCT03103906|615656519|FG001|Overall Study|Other|0|||
170360797|NCT03571256|615656520|FG000|Overall Study|Adverse Event|3|||
170360798|NCT03571256|615656521|FG001|Overall Study|Adverse Event|0|||
170360799|NCT03571256|615656522|FG002|Overall Study|Adverse Event|1|||
170360800|NCT03571256|615656520|FG000|Overall Study|Withdrawal by Subject|3|||
170360801|NCT03571256|615656521|FG001|Overall Study|Withdrawal by Subject|1|||
170360802|NCT03571256|615656522|FG002|Overall Study|Withdrawal by Subject|1|||
170360803|NCT03571256|615656520|FG000|Overall Study|Other than specified|0|||
170360804|NCT03571256|615656521|FG001|Overall Study|Other than specified|1|||
170360805|NCT03571256|615656522|FG002|Overall Study|Other than specified|1|||
170360806|NCT03571256|615656520|FG000|Overall Study|Protocol Violation|0|||
170360807|NCT03571256|615656521|FG001|Overall Study|Protocol Violation|1|||
170360808|NCT03571256|615656522|FG002|Overall Study|Protocol Violation|1|||
170360809|NCT00764478|615656523|FG000|Overall Study|Adverse Event|1|||
170360810|NCT00764478|615656524|FG001|Overall Study|Adverse Event|1|||
170360811|NCT00764478|615656525|FG002|Overall Study|Adverse Event|1|||
170360812|NCT00764478|615656523|FG000|Overall Study|Withdrawal by Subject|7|||
170360813|NCT00764478|615656524|FG001|Overall Study|Withdrawal by Subject|12|||
170360814|NCT00764478|615656525|FG002|Overall Study|Withdrawal by Subject|1|||
170360815|NCT00764478|615656523|FG000|Overall Study|Lost to Follow-up|7|||
170360816|NCT00764478|615656524|FG001|Overall Study|Lost to Follow-up|8|||
170360817|NCT00764478|615656525|FG002|Overall Study|Lost to Follow-up|5|||
170360818|NCT00764478|615656523|FG000|Overall Study|Protocol Violation|0|||
170360819|NCT00764478|615656524|FG001|Overall Study|Protocol Violation|1|||
170360820|NCT00764478|615656525|FG002|Overall Study|Protocol Violation|1|||
170360821|NCT02270684|615656528|FG000|Overall Study|Lost to Follow-up|0|||
170360822|NCT02270684|615656529|FG001|Overall Study|Lost to Follow-up|3|||
170360823|NCT02270684|615656528|FG000|Overall Study|Study terminated|1|||
170360824|NCT02270684|615656529|FG001|Overall Study|Study terminated|0|||
170360825|NCT03498287|615656535|FG000|Overall Study|Withdrawal by Subject|3|||
170360826|NCT03498287|615656536|FG001|Overall Study|Withdrawal by Subject|0|||
170360827|NCT03498287|615656535|FG000|Overall Study|Protocol Violation|0|||
170360828|NCT03498287|615656536|FG001|Overall Study|Protocol Violation|4|||
170360829|NCT03498287|615656535|FG000|Overall Study|Adverse Event|0|||
170360830|NCT03498287|615656536|FG001|Overall Study|Adverse Event|1|||
170360831|NCT04169061|615656539|FG000|Overall Study|Adverse Event|2|||
170360832|NCT04169061|615656539|FG000|Overall Study|Death|1|||
170360833|NCT04169061|615656539|FG000|Overall Study|Withdrawal by Subject|1|||
170360834|NCT04169061|615656539|FG000|Overall Study|Protocol Violation|1|||
170360835|NCT02007954|615656540|FG000|Overall Study|Received liver transplant|3|||
170360836|NCT02007954|615656540|FG000|Overall Study|Switch in treatment modality|2|||
170360837|NCT02007954|615656540|FG000|Overall Study|Disease progression and unrelated AE|1|||
170360838|NCT02007954|615656540|FG000|Overall Study|Death|1|||
170360839|NCT02807363|615656542|FG000|Dosing Period|Adverse Event|0|||
170360840|NCT02807363|615656543|FG001|Dosing Period|Adverse Event|1|||
170360841|NCT02807363|615656544|FG002|Dosing Period|Adverse Event|0|||
170360842|NCT02807363|615656545|FG003|Dosing Period|Adverse Event|0|||
170360843|NCT01195363|615656546|FG000|Overall Study|Lost to Follow-up|7|||
170360844|NCT01195363|615656547|FG001|Overall Study|Lost to Follow-up|4|||
170360845|NCT01195363|615656546|FG000|Overall Study|Adverse Event|3|||
170360846|NCT01195363|615656547|FG001|Overall Study|Adverse Event|1|||
170360847|NCT01195363|615656546|FG000|Overall Study|Lack of Efficacy|0|||
170360848|NCT01195363|615656547|FG001|Overall Study|Lack of Efficacy|4|||
170360849|NCT01195363|615656546|FG000|Overall Study|incarceration|1|||
170360850|NCT01195363|615656547|FG001|Overall Study|incarceration|0|||
170360851|NCT02188719|615656549|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
170360852|NCT02188719|615656550|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
170360853|NCT02188719|615656551|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
170360854|NCT02188719|615656552|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
170360855|NCT01763866|615656553|FG000|Overall Study|Withdrawal by Subject|2|||
170360856|NCT01763866|615656554|FG001|Overall Study|Withdrawal by Subject|1|||
170360857|NCT01763866|615656555|FG002|Overall Study|Withdrawal by Subject|4|||
170360858|NCT01763866|615656556|FG003|Overall Study|Withdrawal by Subject|0|||
170360859|NCT01763866|615656557|FG004|Overall Study|Withdrawal by Subject|0|||
170360860|NCT01763866|615656558|FG005|Overall Study|Withdrawal by Subject|3|||
170360861|NCT01763866|615656559|FG006|Overall Study|Withdrawal by Subject|4|||
170360862|NCT01763866|615656560|FG007|Overall Study|Withdrawal by Subject|0|||
170360863|NCT01763866|615656561|FG008|Overall Study|Withdrawal by Subject|1|||
170360864|NCT01763866|615656562|FG009|Overall Study|Withdrawal by Subject|1|||
170360865|NCT01763866|615656563|FG010|Overall Study|Withdrawal by Subject|2|||
170360866|NCT01763866|615656564|FG011|Overall Study|Withdrawal by Subject|2|||
170360867|NCT01763866|615656565|FG012|Overall Study|Withdrawal by Subject|2|||
170360868|NCT01763866|615656566|FG013|Overall Study|Withdrawal by Subject|0|||
170360869|NCT01763866|615656567|FG014|Overall Study|Withdrawal by Subject|6|||
170360870|NCT01763866|615656568|FG015|Overall Study|Withdrawal by Subject|3|||
170360871|NCT01763866|615656569|FG016|Overall Study|Withdrawal by Subject|0|||
170360872|NCT01763866|615656570|FG017|Overall Study|Withdrawal by Subject|1|||
170360873|NCT01763866|615656571|FG018|Overall Study|Withdrawal by Subject|1|||
170360874|NCT01763866|615656572|FG019|Overall Study|Withdrawal by Subject|1|||
170360875|NCT01763866|615656573|FG020|Overall Study|Withdrawal by Subject|2|||
170360876|NCT01763866|615656574|FG021|Overall Study|Withdrawal by Subject|1|||
170360877|NCT01763866|615656575|FG022|Overall Study|Withdrawal by Subject|2|||
170360878|NCT01763866|615656576|FG023|Overall Study|Withdrawal by Subject|1|||
170360879|NCT01763866|615656553|FG000|Overall Study|Decision by sponsor|0|||
170360880|NCT01763866|615656554|FG001|Overall Study|Decision by sponsor|0|||
170360881|NCT01763866|615656555|FG002|Overall Study|Decision by sponsor|1|||
170360882|NCT01763866|615656556|FG003|Overall Study|Decision by sponsor|0|||
170360883|NCT01763866|615656557|FG004|Overall Study|Decision by sponsor|2|||
170360884|NCT01763866|615656558|FG005|Overall Study|Decision by sponsor|0|||
170360885|NCT01763866|615656559|FG006|Overall Study|Decision by sponsor|2|||
170360886|NCT01763866|615656560|FG007|Overall Study|Decision by sponsor|0|||
170360887|NCT01763866|615656561|FG008|Overall Study|Decision by sponsor|2|||
170360888|NCT01763866|615656562|FG009|Overall Study|Decision by sponsor|0|||
170360889|NCT01763866|615656563|FG010|Overall Study|Decision by sponsor|6|||
170360890|NCT01763866|615656564|FG011|Overall Study|Decision by sponsor|0|||
170360891|NCT01763866|615656565|FG012|Overall Study|Decision by sponsor|1|||
170360892|NCT01763866|615656566|FG013|Overall Study|Decision by sponsor|0|||
170360893|NCT01763866|615656567|FG014|Overall Study|Decision by sponsor|5|||
170360894|NCT01763866|615656568|FG015|Overall Study|Decision by sponsor|0|||
170360895|NCT01763866|615656569|FG016|Overall Study|Decision by sponsor|0|||
170360896|NCT01763866|615656570|FG017|Overall Study|Decision by sponsor|0|||
170360897|NCT01763866|615656571|FG018|Overall Study|Decision by sponsor|4|||
170360898|NCT01763866|615656572|FG019|Overall Study|Decision by sponsor|0|||
170360899|NCT01763866|615656573|FG020|Overall Study|Decision by sponsor|2|||
170360900|NCT01763866|615656574|FG021|Overall Study|Decision by sponsor|0|||
170360901|NCT01763866|615656575|FG022|Overall Study|Decision by sponsor|1|||
170360902|NCT01763866|615656576|FG023|Overall Study|Decision by sponsor|0|||
170360903|NCT01763866|615656553|FG000|Overall Study|Lost to Follow-up|0|||
170360904|NCT01763866|615656554|FG001|Overall Study|Lost to Follow-up|0|||
170360905|NCT01763866|615656555|FG002|Overall Study|Lost to Follow-up|0|||
170360906|NCT01763866|615656556|FG003|Overall Study|Lost to Follow-up|0|||
170360907|NCT01763866|615656557|FG004|Overall Study|Lost to Follow-up|0|||
170360908|NCT01763866|615656558|FG005|Overall Study|Lost to Follow-up|0|||
170360909|NCT01763866|615656559|FG006|Overall Study|Lost to Follow-up|1|||
170360910|NCT01763866|615656560|FG007|Overall Study|Lost to Follow-up|0|||
170360911|NCT01763866|615656561|FG008|Overall Study|Lost to Follow-up|0|||
170360912|NCT01763866|615656562|FG009|Overall Study|Lost to Follow-up|0|||
170360913|NCT01763866|615656563|FG010|Overall Study|Lost to Follow-up|0|||
170360914|NCT01763866|615656564|FG011|Overall Study|Lost to Follow-up|0|||
170360915|NCT01763866|615656565|FG012|Overall Study|Lost to Follow-up|1|||
170360916|NCT01763866|615656566|FG013|Overall Study|Lost to Follow-up|0|||
170360917|NCT01763866|615656567|FG014|Overall Study|Lost to Follow-up|1|||
170360918|NCT01763866|615656568|FG015|Overall Study|Lost to Follow-up|0|||
170360919|NCT01763866|615656569|FG016|Overall Study|Lost to Follow-up|0|||
170360920|NCT01763866|615656570|FG017|Overall Study|Lost to Follow-up|0|||
170360921|NCT01763866|615656571|FG018|Overall Study|Lost to Follow-up|1|||
170360922|NCT01763866|615656572|FG019|Overall Study|Lost to Follow-up|1|||
170360923|NCT01763866|615656573|FG020|Overall Study|Lost to Follow-up|0|||
170360924|NCT01763866|615656574|FG021|Overall Study|Lost to Follow-up|0|||
170360925|NCT01763866|615656575|FG022|Overall Study|Lost to Follow-up|0|||
170360926|NCT01763866|615656576|FG023|Overall Study|Lost to Follow-up|1|||
170360927|NCT01763866|615656553|FG000|Overall Study|Death|0|||
170360928|NCT01763866|615656554|FG001|Overall Study|Death|0|||
170360929|NCT01763866|615656555|FG002|Overall Study|Death|0|||
170360930|NCT01763866|615656556|FG003|Overall Study|Death|0|||
170360931|NCT01763866|615656557|FG004|Overall Study|Death|0|||
170360932|NCT01763866|615656558|FG005|Overall Study|Death|0|||
170360933|NCT01763866|615656559|FG006|Overall Study|Death|0|||
170360934|NCT01763866|615656560|FG007|Overall Study|Death|0|||
170360935|NCT01763866|615656561|FG008|Overall Study|Death|0|||
170360936|NCT01763866|615656562|FG009|Overall Study|Death|0|||
170360937|NCT01763866|615656563|FG010|Overall Study|Death|0|||
170360938|NCT01763866|615656564|FG011|Overall Study|Death|0|||
170360939|NCT01763866|615656565|FG012|Overall Study|Death|0|||
170360940|NCT01763866|615656566|FG013|Overall Study|Death|0|||
170360941|NCT01763866|615656567|FG014|Overall Study|Death|0|||
170360942|NCT01763866|615656568|FG015|Overall Study|Death|0|||
170360943|NCT01763866|615656569|FG016|Overall Study|Death|1|||
170360944|NCT01763866|615656570|FG017|Overall Study|Death|0|||
170360945|NCT01763866|615656571|FG018|Overall Study|Death|0|||
170360946|NCT01763866|615656572|FG019|Overall Study|Death|0|||
170360947|NCT01763866|615656573|FG020|Overall Study|Death|0|||
170360948|NCT01763866|615656574|FG021|Overall Study|Death|0|||
170360949|NCT01763866|615656575|FG022|Overall Study|Death|0|||
170360950|NCT01763866|615656576|FG023|Overall Study|Death|0|||
170360951|NCT01164865|615656579|FG000|Overall Study|Lost to Follow-up|2|||
170360952|NCT01164865|615656580|FG001|Overall Study|Lost to Follow-up|1|||
170360953|NCT02939599|615656584|FG000|Overall Study|Adverse Event|1|||
170360954|NCT02939599|615656585|FG001|Overall Study|Adverse Event|0|||
170360955|NCT02939599|615656584|FG000|Overall Study|Study Terminated By Sponsor|2|||
170360956|NCT02939599|615656585|FG001|Overall Study|Study Terminated By Sponsor|2|||
170360957|NCT02031432|615656595|FG000|Overall Study|Protocol Violation|1|||
170360958|NCT02031432|615656595|FG000|Overall Study|Lack of Efficacy|5|||
170360959|NCT02031432|615656595|FG000|Overall Study|Cancer Progression|2|||
170360960|NCT02031432|615656595|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
170360961|NCT02031432|615656595|FG000|Overall Study|Adverse Event|8|||
170360962|NCT02031432|615656595|FG000|Overall Study|Withdrawal by Subject|5|||
170360963|NCT02031432|615656595|FG000|Overall Study|Lost to Follow-up|1|||
170360964|NCT02031432|615656595|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
170360965|NCT02031432|615656595|FG000|Overall Study|Death|10|||
170360966|NCT01617187|615656597|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
170360967|NCT01617187|615656598|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
170360968|NCT01617187|615656599|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
170360969|NCT01617187|615656600|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
170360970|NCT01617187|615656597|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
170360971|NCT01617187|615656598|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
170360972|NCT01617187|615656599|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
170360973|NCT01617187|615656600|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
170360974|NCT01617187|615656597|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
170360975|NCT01617187|615656598|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
170360976|NCT01617187|615656599|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
170360977|NCT01617187|615656600|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
170360978|NCT01617187|615656597|FG000|Treatment Through Study Completion|Adverse Event|1|||
170360979|NCT01617187|615656598|FG001|Treatment Through Study Completion|Adverse Event|1|||
170360980|NCT01617187|615656599|FG002|Treatment Through Study Completion|Adverse Event|0|||
170360981|NCT01617187|615656600|FG003|Treatment Through Study Completion|Adverse Event|1|||
170360982|NCT01617187|615656597|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
170360983|NCT01617187|615656598|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
170360984|NCT01617187|615656599|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
170360985|NCT01617187|615656600|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
170360986|NCT01617187|615656597|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
170360987|NCT01617187|615656598|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
170360988|NCT01617187|615656599|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
170360989|NCT01617187|615656600|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
170360990|NCT01617187|615656597|FG000|Treatment Through Study Completion|Protocol Violation|1|||
170360991|NCT01617187|615656598|FG001|Treatment Through Study Completion|Protocol Violation|0|||
170360992|NCT01617187|615656599|FG002|Treatment Through Study Completion|Protocol Violation|0|||
170360993|NCT01617187|615656600|FG003|Treatment Through Study Completion|Protocol Violation|1|||
170360994|NCT01265420|615656601|FG000|Overall Study|Lost to Follow-up|1|||
170360995|NCT02559206|615656604|FG000|Overall Study|Adverse Event|0|||
170360996|NCT02559206|615656605|FG001|Overall Study|Adverse Event|4|||
170360997|NCT02559206|615656606|FG002|Overall Study|Adverse Event|1|||
170360998|NCT02559206|615656607|FG003|Overall Study|Adverse Event|5|||
170360999|NCT02559206|615656608|FG004|Overall Study|Adverse Event|3|||
170361000|NCT02559206|615656609|FG005|Overall Study|Adverse Event|0|||
170361001|NCT02559206|615656610|FG006|Overall Study|Adverse Event|1|||
170361002|NCT02559206|615656611|FG007|Overall Study|Adverse Event|0|||
170361003|NCT02559206|615656604|FG000|Overall Study|Protocol Violation|1|||
170361004|NCT02559206|615656605|FG001|Overall Study|Protocol Violation|0|||
170361005|NCT02559206|615656606|FG002|Overall Study|Protocol Violation|1|||
170361006|NCT02559206|615656607|FG003|Overall Study|Protocol Violation|0|||
170361007|NCT02559206|615656608|FG004|Overall Study|Protocol Violation|0|||
170361008|NCT02559206|615656609|FG005|Overall Study|Protocol Violation|2|||
170361009|NCT02559206|615656610|FG006|Overall Study|Protocol Violation|0|||
170361010|NCT02559206|615656611|FG007|Overall Study|Protocol Violation|0|||
170361011|NCT02559206|615656604|FG000|Overall Study|Withdrawal by Subject|3|||
170361012|NCT02559206|615656605|FG001|Overall Study|Withdrawal by Subject|3|||
170361013|NCT02559206|615656606|FG002|Overall Study|Withdrawal by Subject|1|||
170361014|NCT02559206|615656607|FG003|Overall Study|Withdrawal by Subject|3|||
170361015|NCT02559206|615656608|FG004|Overall Study|Withdrawal by Subject|5|||
170361016|NCT02559206|615656609|FG005|Overall Study|Withdrawal by Subject|4|||
170361017|NCT02559206|615656610|FG006|Overall Study|Withdrawal by Subject|1|||
170361018|NCT02559206|615656611|FG007|Overall Study|Withdrawal by Subject|2|||
170361019|NCT02559206|615656604|FG000|Overall Study|Lost to Follow-up|3|||
170361020|NCT02559206|615656605|FG001|Overall Study|Lost to Follow-up|5|||
170361021|NCT02559206|615656606|FG002|Overall Study|Lost to Follow-up|3|||
170361022|NCT02559206|615656607|FG003|Overall Study|Lost to Follow-up|3|||
170361023|NCT02559206|615656608|FG004|Overall Study|Lost to Follow-up|2|||
170361024|NCT02559206|615656609|FG005|Overall Study|Lost to Follow-up|5|||
170361025|NCT02559206|615656610|FG006|Overall Study|Lost to Follow-up|1|||
170361026|NCT02559206|615656611|FG007|Overall Study|Lost to Follow-up|4|||
170361027|NCT02559206|615656604|FG000|Overall Study|Lack of Efficacy|1|||
170361028|NCT02559206|615656605|FG001|Overall Study|Lack of Efficacy|0|||
170361029|NCT02559206|615656606|FG002|Overall Study|Lack of Efficacy|3|||
170361030|NCT02559206|615656607|FG003|Overall Study|Lack of Efficacy|2|||
170361031|NCT02559206|615656608|FG004|Overall Study|Lack of Efficacy|2|||
170361032|NCT02559206|615656609|FG005|Overall Study|Lack of Efficacy|3|||
170361033|NCT02559206|615656610|FG006|Overall Study|Lack of Efficacy|3|||
170361034|NCT02559206|615656611|FG007|Overall Study|Lack of Efficacy|3|||
170361035|NCT02559206|615656604|FG000|Overall Study|Other Not Specified|0|||
170361036|NCT02559206|615656605|FG001|Overall Study|Other Not Specified|0|||
170361037|NCT02559206|615656606|FG002|Overall Study|Other Not Specified|0|||
170361038|NCT02559206|615656607|FG003|Overall Study|Other Not Specified|1|||
170361039|NCT02559206|615656608|FG004|Overall Study|Other Not Specified|0|||
170361040|NCT02559206|615656609|FG005|Overall Study|Other Not Specified|0|||
170361041|NCT02559206|615656610|FG006|Overall Study|Other Not Specified|0|||
170361042|NCT02559206|615656611|FG007|Overall Study|Other Not Specified|0|||
170361043|NCT01561560|615656612|FG000|First Two Weeks of Wear|Time/job conflict|0|||
170361044|NCT01561560|615656613|FG001|First Two Weeks of Wear|Time/job conflict|1|||
170361045|NCT01561560|615656612|FG000|First Two Weeks of Wear|Adverse Event|0|||
170361046|NCT01561560|615656613|FG001|First Two Weeks of Wear|Adverse Event|1|||
170361047|NCT01561560|615656612|FG000|Second Two Weeks of Wear|Adverse Event|0|||
170361048|NCT01561560|615656613|FG001|Second Two Weeks of Wear|Adverse Event|1|||
170361049|NCT01412151|615658458|FG000|Week 0 - 306 - Treatment Period|Death|1|||
170361050|NCT01412151|615658458|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
170361051|NCT01412151|615658458|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
170361052|NCT01412151|615658458|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
170361053|NCT01136746|615658461|FG000|Overall Study|Lost to Follow-up|0|||
170361054|NCT01136746|615658462|FG001|Overall Study|Lost to Follow-up|2|||
170361055|NCT01136746|615658461|FG000|Overall Study|Protocol Violation|2|||
170361056|NCT01136746|615658462|FG001|Overall Study|Protocol Violation|1|||
170361057|NCT01136746|615658461|FG000|Overall Study|Death|1|||
170361058|NCT01136746|615658462|FG001|Overall Study|Death|0|||
170361059|NCT00092677|615658463|FG000|Overall Study|Lost to Follow-up|0|||
170361060|NCT00092677|615658464|FG001|Overall Study|Lost to Follow-up|2|||
170361061|NCT00092677|615658463|FG000|Overall Study|Adminstrative|5|||
170361062|NCT00092677|615658464|FG001|Overall Study|Adminstrative|9|||
170361063|NCT01090102|615658465|FG000|First 12 Weeks|Withdrawal by Subject|1|||
170361064|NCT01090102|615658466|FG001|First 12 Weeks|Withdrawal by Subject|1|||
170361065|NCT01090102|615658465|FG000|First 12 Weeks|Adverse Event|2|||
170361066|NCT01090102|615658466|FG001|First 12 Weeks|Adverse Event|0|||
170361067|NCT01090102|615658465|FG000|First 12 Weeks|Death|1|||
170361068|NCT01090102|615658466|FG001|First 12 Weeks|Death|1|||
170361069|NCT01090102|615658465|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
170361070|NCT01090102|615658466|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
170361071|NCT03518034|615658469|FG000|Overall Study|Not Treated|5|||
170361072|NCT03518034|615658470|FG001|Overall Study|Not Treated|1|||
170361073|NCT03518034|615658469|FG000|Overall Study|Withdrawal by Subject|309|||
170361074|NCT03518034|615658470|FG001|Overall Study|Withdrawal by Subject|351|||
170361075|NCT03518034|615658469|FG000|Overall Study|Lost to Follow-up|446|||
170361076|NCT03518034|615658470|FG001|Overall Study|Lost to Follow-up|458|||
170361077|NCT03518034|615658469|FG000|Overall Study|Adverse Event|138|||
170361078|NCT03518034|615658470|FG001|Overall Study|Adverse Event|130|||
170361079|NCT03518034|615658469|FG000|Overall Study|Lack of Efficacy|11|||
170361080|NCT03518034|615658470|FG001|Overall Study|Lack of Efficacy|23|||
170361081|NCT03518034|615658469|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
170361082|NCT03518034|615658470|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
170361083|NCT03518034|615658469|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
170361084|NCT03518034|615658470|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
170361085|NCT03518034|615658469|FG000|Overall Study|Other, Not Specified|84|||
170361086|NCT03518034|615658470|FG001|Overall Study|Other, Not Specified|53|||
170361087|NCT03518034|615658469|FG000|Overall Study|Reason Missing|2|||
170361088|NCT03518034|615658470|FG001|Overall Study|Reason Missing|3|||
170361089|NCT00877006|615658476|FG000|Treatment Period|Death|2|||
170361090|NCT00877006|615658477|FG001|Treatment Period|Death|1|||
170361091|NCT00877006|615658476|FG000|Treatment Period|Adverse Event|10|||
170361092|NCT00877006|615658477|FG001|Treatment Period|Adverse Event|3|||
170361093|NCT00877006|615658476|FG000|Treatment Period|Withdrawal by Subject|2|||
170361094|NCT00877006|615658477|FG001|Treatment Period|Withdrawal by Subject|3|||
170361095|NCT00877006|615658476|FG000|Treatment Period|Protocol Violation|1|||
170361096|NCT00877006|615658477|FG001|Treatment Period|Protocol Violation|0|||
170361097|NCT00877006|615658476|FG000|Treatment Period|Lost to Follow-up|0|||
170361098|NCT00877006|615658477|FG001|Treatment Period|Lost to Follow-up|1|||
170361099|NCT00877006|615658476|FG000|Treatment Period|Disease Progression|1|||
170361100|NCT00877006|615658477|FG001|Treatment Period|Disease Progression|2|||
170361101|NCT00877006|615658476|FG000|Treatment Period|Started New Treatment Regimen|2|||
170361102|NCT00877006|615658477|FG001|Treatment Period|Started New Treatment Regimen|5|||
170361103|NCT00877006|615658476|FG000|Treatment Period|Other|4|||
170361104|NCT00877006|615658477|FG001|Treatment Period|Other|4|||
170361105|NCT00877006|615658476|FG000|Treatment Period|Randomized but Not Treated|3|||
170361106|NCT00877006|615658477|FG001|Treatment Period|Randomized but Not Treated|8|||
170361107|NCT00877006|615658476|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
170361108|NCT00877006|615658477|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
170361109|NCT00877006|615658476|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
170361110|NCT00877006|615658477|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
170361111|NCT00877006|615658476|FG000|Long-Term Follow-up Period|Death|26|||
170361112|NCT00877006|615658477|FG001|Long-Term Follow-up Period|Death|18|||
170361113|NCT00877006|615658476|FG000|Long-Term Follow-up Period|Other|7|||
170361114|NCT00877006|615658477|FG001|Long-Term Follow-up Period|Other|9|||
170361115|NCT00126581|615658478|FG000|Overall Study|Adverse Event|3|||
170361116|NCT00126581|615658479|FG001|Overall Study|Adverse Event|7|||
170361117|NCT00126581|615658478|FG000|Overall Study|Death|3|||
170361118|NCT00126581|615658479|FG001|Overall Study|Death|2|||
170361119|NCT00126581|615658478|FG000|Overall Study|Withdrawal by Subject|1|||
170361120|NCT00126581|615658479|FG001|Overall Study|Withdrawal by Subject|4|||
170361121|NCT00126581|615658478|FG000|Overall Study|Alternative therapy|3|||
170361122|NCT00126581|615658479|FG001|Overall Study|Alternative therapy|3|||
170361123|NCT00126581|615658478|FG000|Overall Study|Other illness/MD discretion|3|||
170361124|NCT00126581|615658479|FG001|Overall Study|Other illness/MD discretion|4|||
170361125|NCT01779648|615658481|FG000|Overall Study|Protocol Violation|1|||
170361126|NCT01779648|615658482|FG001|Overall Study|Protocol Violation|0|||
170361127|NCT02384395|615658483|FG000|Overall Study|Physician Decision|4|||
170361128|NCT02384395|615658483|FG000|Overall Study|Withdrawal by Subject|3|||
170361129|NCT02384395|615658483|FG000|Overall Study|Lost to Follow-up|3|||
170361130|NCT03485222|615658484|FG000|Overall Study|Death|0|||
170361131|NCT03485222|615658485|FG001|Overall Study|Death|1|||
170361132|NCT03485222|615658484|FG000|Overall Study|Lost to Follow-up|2|||
170361133|NCT03485222|615658485|FG001|Overall Study|Lost to Follow-up|1|||
170361134|NCT01590212|615658486|FG000|Overall Study|Withdrawal by Subject|2|||
170361135|NCT01590212|615658487|FG001|Overall Study|Withdrawal by Subject|2|||
170361136|NCT01590212|615658488|FG002|Overall Study|Withdrawal by Subject|2|||
170361137|NCT01590212|615658486|FG000|Overall Study|Lost to Follow-up|1|||
170361138|NCT01590212|615658487|FG001|Overall Study|Lost to Follow-up|2|||
170361139|NCT01590212|615658488|FG002|Overall Study|Lost to Follow-up|3|||
170361140|NCT00340834|615658489|FG000|Core Phase of Study|Adverse Event|26|||
170361141|NCT00340834|615658490|FG001|Core Phase of Study|Adverse Event|9|||
170361142|NCT00340834|615658491|FG002|Core Phase of Study|Adverse Event|9|||
170361143|NCT00340834|615658492|FG003|Core Phase of Study|Adverse Event|0|||
170361144|NCT00340834|615658493|FG004|Core Phase of Study|Adverse Event|0|||
170361145|NCT00340834|615658489|FG000|Core Phase of Study|Withdrawal by Subject|11|||
170361146|NCT00340834|615658490|FG001|Core Phase of Study|Withdrawal by Subject|9|||
170361147|NCT00340834|615658491|FG002|Core Phase of Study|Withdrawal by Subject|16|||
170361148|NCT00340834|615658492|FG003|Core Phase of Study|Withdrawal by Subject|0|||
170361149|NCT00340834|615658493|FG004|Core Phase of Study|Withdrawal by Subject|0|||
170361150|NCT00340834|615658489|FG000|Core Phase of Study|Administrative Problems|6|||
170361151|NCT00340834|615658490|FG001|Core Phase of Study|Administrative Problems|2|||
170361152|NCT00340834|615658491|FG002|Core Phase of Study|Administrative Problems|7|||
170361153|NCT00340834|615658492|FG003|Core Phase of Study|Administrative Problems|0|||
170361154|NCT00340834|615658493|FG004|Core Phase of Study|Administrative Problems|0|||
170361155|NCT00340834|615658489|FG000|Core Phase of Study|Lack of Efficacy|3|||
170361156|NCT00340834|615658490|FG001|Core Phase of Study|Lack of Efficacy|3|||
170361157|NCT00340834|615658491|FG002|Core Phase of Study|Lack of Efficacy|7|||
170361158|NCT00340834|615658492|FG003|Core Phase of Study|Lack of Efficacy|0|||
170361159|NCT00340834|615658493|FG004|Core Phase of Study|Lack of Efficacy|0|||
170361160|NCT00340834|615658489|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
170361161|NCT00340834|615658490|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
170361162|NCT00340834|615658491|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
170361163|NCT00340834|615658492|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
170361164|NCT00340834|615658493|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
170361165|NCT00340834|615658489|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
170361166|NCT00340834|615658490|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
170361167|NCT00340834|615658491|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
170361168|NCT00340834|615658492|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
170361169|NCT00340834|615658493|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
170361170|NCT00340834|615658489|FG000|Core Phase of Study|Lost to Follow-up|1|||
170361171|NCT00340834|615658490|FG001|Core Phase of Study|Lost to Follow-up|1|||
170361172|NCT00340834|615658491|FG002|Core Phase of Study|Lost to Follow-up|4|||
170361173|NCT00340834|615658492|FG003|Core Phase of Study|Lost to Follow-up|0|||
170361174|NCT00340834|615658493|FG004|Core Phase of Study|Lost to Follow-up|0|||
170361175|NCT00340834|615658489|FG000|Core Phase of Study|Death|2|||
170361176|NCT00340834|615658490|FG001|Core Phase of Study|Death|0|||
170361177|NCT00340834|615658491|FG002|Core Phase of Study|Death|0|||
170361178|NCT00340834|615658492|FG003|Core Phase of Study|Death|0|||
170361179|NCT00340834|615658493|FG004|Core Phase of Study|Death|0|||
170361180|NCT00340834|615658489|FG000|Core Phase of Study|Protocol Violation|0|||
170361181|NCT00340834|615658490|FG001|Core Phase of Study|Protocol Violation|0|||
170361182|NCT00340834|615658491|FG002|Core Phase of Study|Protocol Violation|2|||
170361183|NCT00340834|615658492|FG003|Core Phase of Study|Protocol Violation|0|||
170361184|NCT00340834|615658493|FG004|Core Phase of Study|Protocol Violation|0|||
170361185|NCT00340834|615658489|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
170361186|NCT00340834|615658490|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
170361187|NCT00340834|615658491|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
170361188|NCT00340834|615658492|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
170361189|NCT00340834|615658493|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
170361190|NCT00340834|615658489|FG000|Extension Phase of Study|Subject withdrew consent|26|||
170361191|NCT00340834|615658490|FG001|Extension Phase of Study|Subject withdrew consent|31|||
170361192|NCT00340834|615658491|FG002|Extension Phase of Study|Subject withdrew consent|0|||
170361193|NCT00340834|615658492|FG003|Extension Phase of Study|Subject withdrew consent|12|||
170361194|NCT00340834|615658493|FG004|Extension Phase of Study|Subject withdrew consent|15|||
170361195|NCT00340834|615658489|FG000|Extension Phase of Study|Adverse Event|21|||
170361196|NCT00340834|615658490|FG001|Extension Phase of Study|Adverse Event|22|||
170361197|NCT00340834|615658491|FG002|Extension Phase of Study|Adverse Event|0|||
170361198|NCT00340834|615658492|FG003|Extension Phase of Study|Adverse Event|19|||
170361199|NCT00340834|615658493|FG004|Extension Phase of Study|Adverse Event|7|||
170361200|NCT00340834|615658489|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
170361201|NCT00340834|615658490|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
170361202|NCT00340834|615658491|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
170361203|NCT00340834|615658492|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
170361204|NCT00340834|615658493|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
170361205|NCT00340834|615658489|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
170361206|NCT00340834|615658490|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
170361207|NCT00340834|615658491|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
170361208|NCT00340834|615658492|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
170361209|NCT00340834|615658493|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
170361210|NCT00340834|615658489|FG000|Extension Phase of Study|Lost to Follow-up|1|||
170361211|NCT00340834|615658490|FG001|Extension Phase of Study|Lost to Follow-up|1|||
170361212|NCT00340834|615658491|FG002|Extension Phase of Study|Lost to Follow-up|0|||
170361213|NCT00340834|615658492|FG003|Extension Phase of Study|Lost to Follow-up|2|||
170361214|NCT00340834|615658493|FG004|Extension Phase of Study|Lost to Follow-up|3|||
170361215|NCT00340834|615658489|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
170361216|NCT00340834|615658490|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
170361217|NCT00340834|615658491|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
170361218|NCT00340834|615658492|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
170361219|NCT00340834|615658493|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
170361220|NCT00340834|615658489|FG000|Extension Phase of Study|Administrative problems|3|||
170361221|NCT00340834|615658490|FG001|Extension Phase of Study|Administrative problems|0|||
170361222|NCT00340834|615658491|FG002|Extension Phase of Study|Administrative problems|0|||
170361223|NCT00340834|615658492|FG003|Extension Phase of Study|Administrative problems|1|||
170361224|NCT00340834|615658493|FG004|Extension Phase of Study|Administrative problems|1|||
170361225|NCT00340834|615658489|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
170361226|NCT00340834|615658490|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
170361227|NCT00340834|615658491|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
170361228|NCT00340834|615658492|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
170361229|NCT00340834|615658493|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
170361230|NCT00340834|615658489|FG000|Extension Phase of Study|Protocol Violation|3|||
170361231|NCT00340834|615658490|FG001|Extension Phase of Study|Protocol Violation|0|||
170361232|NCT00340834|615658491|FG002|Extension Phase of Study|Protocol Violation|0|||
170361233|NCT00340834|615658492|FG003|Extension Phase of Study|Protocol Violation|0|||
170361234|NCT00340834|615658493|FG004|Extension Phase of Study|Protocol Violation|0|||
170361235|NCT00340834|615658489|FG000|Extension Phase of Study|Death|0|||
170361236|NCT00340834|615658490|FG001|Extension Phase of Study|Death|0|||
170361237|NCT00340834|615658491|FG002|Extension Phase of Study|Death|0|||
170361238|NCT00340834|615658492|FG003|Extension Phase of Study|Death|0|||
170361239|NCT00340834|615658493|FG004|Extension Phase of Study|Death|1|||
170361240|NCT01807949|615658505|FG000|Overall Study|Adverse Event|1|||
170361241|NCT01807949|615658506|FG001|Overall Study|Adverse Event|2|||
170361242|NCT01807949|615658507|FG002|Overall Study|Adverse Event|2|||
170361243|NCT01807949|615658505|FG000|Overall Study|Withdrawal by Subject|1|||
170361244|NCT01807949|615658506|FG001|Overall Study|Withdrawal by Subject|2|||
170361245|NCT01807949|615658507|FG002|Overall Study|Withdrawal by Subject|2|||
170361246|NCT01807949|615658505|FG000|Overall Study|Non-Compliance|0|||
170361247|NCT01807949|615658506|FG001|Overall Study|Non-Compliance|0|||
170361248|NCT01807949|615658507|FG002|Overall Study|Non-Compliance|1|||
170361249|NCT01807949|615658505|FG000|Overall Study|Undefined|0|||
170361250|NCT01807949|615658506|FG001|Overall Study|Undefined|1|||
170361251|NCT01807949|615658507|FG002|Overall Study|Undefined|2|||
170361252|NCT01807949|615658505|FG000|Overall Study|Randomized But Not Treated|0|||
170361253|NCT01807949|615658506|FG001|Overall Study|Randomized But Not Treated|2|||
170361254|NCT01807949|615658507|FG002|Overall Study|Randomized But Not Treated|2|||
170361255|NCT00881361|615658510|FG000|Overall Study|Terminated prior to surgery|27|||
170361256|NCT00881361|615658511|FG001|Overall Study|Terminated prior to surgery|7|||
170361257|NCT00881361|615658512|FG002|Overall Study|Terminated prior to surgery|0|||
170361258|NCT00881361|615658510|FG000|Overall Study|Ineligible|17|||
170361259|NCT00881361|615658511|FG001|Overall Study|Ineligible|2|||
170361260|NCT00881361|615658512|FG002|Overall Study|Ineligible|2|||
170361261|NCT01457924|615658515|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
170361262|NCT01457924|615658516|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
170361263|NCT01457924|615658517|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
170361264|NCT01457924|615658518|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
170361265|NCT01457924|615658519|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
170361266|NCT01457924|615658515|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
170361267|NCT01457924|615658516|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
170361268|NCT01457924|615658517|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
170361269|NCT01457924|615658518|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
170361270|NCT01457924|615658519|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
170361271|NCT01457924|615658515|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
170361272|NCT01457924|615658516|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
170361273|NCT01457924|615658517|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
170361274|NCT01457924|615658518|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
170361275|NCT01457924|615658519|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
170361276|NCT01457924|615658515|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
170361277|NCT01457924|615658516|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
170361278|NCT01457924|615658517|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
170361279|NCT01457924|615658518|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
170361280|NCT01457924|615658519|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
170361281|NCT01457924|615658515|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
170361282|NCT01457924|615658516|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
170361283|NCT01457924|615658517|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
170361284|NCT01457924|615658518|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
170361285|NCT01457924|615658519|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
170361286|NCT01457924|615658515|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
170361287|NCT01457924|615658516|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
170361288|NCT01457924|615658517|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
170361289|NCT01457924|615658518|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
170361290|NCT01457924|615658519|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
170361291|NCT01457924|615658515|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
170361292|NCT01457924|615658516|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
170361293|NCT01457924|615658517|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
170361294|NCT01457924|615658518|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
170361295|NCT01457924|615658519|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
170361296|NCT01457924|615658515|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
170361297|NCT01457924|615658516|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
170361298|NCT01457924|615658517|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
170361299|NCT01457924|615658518|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
170361300|NCT01457924|615658519|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
170361301|NCT01457924|615658515|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
170361302|NCT01457924|615658516|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
170361303|NCT01457924|615658517|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
170361304|NCT01457924|615658518|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
170361305|NCT01457924|615658519|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
170361306|NCT01457924|615658515|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
170361307|NCT01457924|615658516|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
170361308|NCT01457924|615658517|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
170361309|NCT01457924|615658518|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
170361310|NCT01457924|615658519|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
170361311|NCT01457924|615658515|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
170361312|NCT01457924|615658516|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
170361313|NCT01457924|615658517|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
170361314|NCT01457924|615658518|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
170361315|NCT01457924|615658519|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
170361316|NCT01457924|615658515|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
170361317|NCT01457924|615658516|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
170361318|NCT01457924|615658517|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
170361319|NCT01457924|615658518|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
170361320|NCT01457924|615658519|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
170361321|NCT01457924|615658515|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
170361322|NCT01457924|615658516|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
170361323|NCT01457924|615658517|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
170361324|NCT01457924|615658518|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
170361325|NCT01457924|615658519|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
170361326|NCT00448760|615658522|FG000|Overall Study|Death|3|||
170361327|NCT00561340|615658523|FG000|Overall Study|refused to drink pediasure|6|||
170361328|NCT00561340|615658524|FG001|Overall Study|refused to drink pediasure|0|||
170361329|NCT00618995|615658527|FG000|Period 1|Adverse Event|0|||
170361330|NCT00618995|615658528|FG001|Period 1|Adverse Event|0|||
170361331|NCT00618995|615658529|FG002|Period 1|Adverse Event|1|||
170361332|NCT00618995|615658530|FG003|Period 1|Adverse Event|0|||
170361333|NCT00618995|615658527|FG000|Period 1|Protocol Violation|0|||
170361334|NCT00618995|615658528|FG001|Period 1|Protocol Violation|1|||
170361335|NCT00618995|615658529|FG002|Period 1|Protocol Violation|1|||
170361336|NCT00618995|615658530|FG003|Period 1|Protocol Violation|0|||
170361337|NCT00618995|615658527|FG000|Period 2|Protocol Violation|0|||
170361338|NCT00618995|615658528|FG001|Period 2|Protocol Violation|0|||
170361339|NCT00618995|615658529|FG002|Period 2|Protocol Violation|1|||
170361340|NCT00618995|615658530|FG003|Period 2|Protocol Violation|0|||
170361341|NCT00618995|615658527|FG000|Period 4|Adverse Event|1|||
170361342|NCT00618995|615658528|FG001|Period 4|Adverse Event|0|||
170361343|NCT00618995|615658529|FG002|Period 4|Adverse Event|0|||
170361344|NCT00618995|615658530|FG003|Period 4|Adverse Event|0|||
170361345|NCT01522443|615658531|FG000|Overall Study|No longer receiving clinical benefit|36|||
170361346|NCT01522443|615658532|FG001|Overall Study|No longer receiving clinical benefit|28|||
170361347|NCT01522443|615658531|FG000|Overall Study|Adverse Event|10|||
170361348|NCT01522443|615658532|FG001|Overall Study|Adverse Event|15|||
170361349|NCT01522443|615658531|FG000|Overall Study|Withdrawal by Subject|5|||
170361350|NCT01522443|615658532|FG001|Overall Study|Withdrawal by Subject|8|||
170361351|NCT01522443|615658531|FG000|Overall Study|No study treatment given|1|||
170361352|NCT01522443|615658532|FG001|Overall Study|No study treatment given|1|||
170361353|NCT01522443|615658531|FG000|Overall Study|Other|1|||
170361354|NCT01522443|615658532|FG001|Overall Study|Other|3|||
170361355|NCT05014542|615658533|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
170361356|NCT05014542|615658534|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
170361357|NCT05014542|615658533|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
170361358|NCT05014542|615658534|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
170361359|NCT05014542|615658533|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
170361360|NCT05014542|615658534|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
170361361|NCT05014542|615658533|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
170361362|NCT05014542|615658534|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
170361363|NCT00973622|615658535|FG000|Overall Study|did not attend MRI|14|||
170361364|NCT00973622|615658536|FG001|Overall Study|did not attend MRI|3|||
170361365|NCT00973622|615658535|FG000|Overall Study|did not pass MRI screen|6|||
170361366|NCT00973622|615658536|FG001|Overall Study|did not pass MRI screen|0|||
170361367|NCT00973622|615658535|FG000|Overall Study|did not complete rTMS sessions|11|||
170361368|NCT00973622|615658536|FG001|Overall Study|did not complete rTMS sessions|2|||
170361369|NCT02563925|615658538|FG000|Overall Study|Withdrawal by Subject|2|||
170361370|NCT01409993|615658539|FG000|Overall Study|Adverse Event|4|||
170361371|NCT01409993|615658540|FG001|Overall Study|Adverse Event|4|||
170361372|NCT01409993|615658541|FG002|Overall Study|Adverse Event|3|||
170361373|NCT01409993|615658542|FG003|Overall Study|Adverse Event|1|||
170361374|NCT01409993|615658539|FG000|Overall Study|Withdrawal by Subject|0|||
170361375|NCT01409993|615658540|FG001|Overall Study|Withdrawal by Subject|0|||
170361376|NCT01409993|615658541|FG002|Overall Study|Withdrawal by Subject|0|||
170361377|NCT01409993|615658542|FG003|Overall Study|Withdrawal by Subject|4|||
170361378|NCT01409993|615658539|FG000|Overall Study|Lost to Follow-up|0|||
170361379|NCT01409993|615658540|FG001|Overall Study|Lost to Follow-up|1|||
170361380|NCT01409993|615658541|FG002|Overall Study|Lost to Follow-up|0|||
170361381|NCT01409993|615658542|FG003|Overall Study|Lost to Follow-up|0|||
170361382|NCT01148693|615658543|FG000|Overall Study|Attempts for cannulation were failed|13|||
170361383|NCT01148693|615658544|FG001|Overall Study|Attempts for cannulation were failed|10|||
170361384|NCT01074658|615658545|FG000|Overall Study|No implant attempted|19|||
170361385|NCT00764946|615658546|FG000|Overall Study|Lack of Efficacy|1|||
170361386|NCT00764946|615658547|FG001|Overall Study|Lack of Efficacy|0|||
170361387|NCT00764946|615658548|FG002|Overall Study|Lack of Efficacy|0|||
170361388|NCT00764946|615658546|FG000|Overall Study|Lost to Follow-up|3|||
170361389|NCT00764946|615658547|FG001|Overall Study|Lost to Follow-up|4|||
170361390|NCT00764946|615658548|FG002|Overall Study|Lost to Follow-up|0|||
170361391|NCT00764946|615658546|FG000|Overall Study|Physician Decision|2|||
170361392|NCT00764946|615658547|FG001|Overall Study|Physician Decision|4|||
170361393|NCT00764946|615658548|FG002|Overall Study|Physician Decision|0|||
170361394|NCT00764946|615658546|FG000|Overall Study|Adverse Event|3|||
170361395|NCT00764946|615658547|FG001|Overall Study|Adverse Event|2|||
170361396|NCT00764946|615658548|FG002|Overall Study|Adverse Event|1|||
170361397|NCT00764946|615658546|FG000|Overall Study|Withdrawal by Subject|3|||
170361398|NCT00764946|615658547|FG001|Overall Study|Withdrawal by Subject|6|||
170361399|NCT00764946|615658548|FG002|Overall Study|Withdrawal by Subject|2|||
170361400|NCT00764946|615658546|FG000|Overall Study|Never Treated|1|||
170361401|NCT00764946|615658547|FG001|Overall Study|Never Treated|1|||
170361402|NCT00764946|615658548|FG002|Overall Study|Never Treated|1|||
170361403|NCT00006604|615658551|FG000|Overall Study|Met study objective - no further FU|1|||
170361404|NCT00006604|615658552|FG001|Overall Study|Met study objective - no further FU|0|||
170361405|NCT00006604|615658553|FG002|Overall Study|Met study objective - no further FU|0|||
170361406|NCT00006604|615658554|FG003|Overall Study|Met study objective - no further FU|0|||
170361407|NCT00006604|615658555|FG004|Overall Study|Met study objective - no further FU|0|||
170361408|NCT00006604|615658556|FG005|Overall Study|Met study objective - no further FU|0|||
170361409|NCT00006604|615658557|FG006|Overall Study|Met study objective - no further FU|0|||
170361410|NCT00006604|615658558|FG007|Overall Study|Met study objective - no further FU|0|||
170361411|NCT00006604|615658559|FG008|Overall Study|Met study objective - no further FU|0|||
170361412|NCT00006604|615658560|FG009|Overall Study|Met study objective - no further FU|0|||
170361413|NCT00006604|615658561|FG010|Overall Study|Met study objective - no further FU|0|||
170361414|NCT00006604|615658562|FG011|Overall Study|Met study objective - no further FU|0|||
170361415|NCT00006604|615658563|FG012|Overall Study|Met study objective - no further FU|0|||
170361416|NCT00006604|615658564|FG013|Overall Study|Met study objective - no further FU|0|||
170361417|NCT00006604|615658565|FG014|Overall Study|Met study objective - no further FU|1|||
170361418|NCT00006604|615658566|FG015|Overall Study|Met study objective - no further FU|1|||
170361419|NCT00006604|615658567|FG016|Overall Study|Met study objective - no further FU|0|||
170361420|NCT00006604|615658551|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
170361421|NCT00006604|615658552|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
170361422|NCT00006604|615658553|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
170361423|NCT00006604|615658554|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
170361424|NCT00006604|615658555|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
170361425|NCT00006604|615658556|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
170361426|NCT00006604|615658557|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
170361427|NCT00006604|615658558|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
170361428|NCT00006604|615658559|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
170361429|NCT00006604|615658560|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
170361430|NCT00006604|615658561|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
170361431|NCT00006604|615658562|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
170361432|NCT00006604|615658563|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
170361433|NCT00006604|615658564|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
170361434|NCT00006604|615658565|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
170361435|NCT00006604|615658566|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
170361436|NCT00006604|615658567|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
170361437|NCT00006604|615658551|FG000|Overall Study|Death|0|||
170361438|NCT00006604|615658552|FG001|Overall Study|Death|0|||
170361439|NCT00006604|615658553|FG002|Overall Study|Death|0|||
170361440|NCT00006604|615658554|FG003|Overall Study|Death|0|||
170361441|NCT00006604|615658555|FG004|Overall Study|Death|0|||
170361442|NCT00006604|615658556|FG005|Overall Study|Death|0|||
170361443|NCT00006604|615658557|FG006|Overall Study|Death|0|||
170361444|NCT00006604|615658558|FG007|Overall Study|Death|0|||
170361445|NCT00006604|615658559|FG008|Overall Study|Death|0|||
170361446|NCT00006604|615658560|FG009|Overall Study|Death|1|||
170361447|NCT00006604|615658561|FG010|Overall Study|Death|1|||
170361448|NCT00006604|615658562|FG011|Overall Study|Death|1|||
170361449|NCT00006604|615658563|FG012|Overall Study|Death|0|||
170361450|NCT00006604|615658564|FG013|Overall Study|Death|0|||
170361451|NCT00006604|615658565|FG014|Overall Study|Death|0|||
170361452|NCT00006604|615658566|FG015|Overall Study|Death|0|||
170361453|NCT00006604|615658567|FG016|Overall Study|Death|0|||
170361454|NCT00006604|615658551|FG000|Overall Study|Severe debilitation, unable to continue|0|||
170361455|NCT00006604|615658552|FG001|Overall Study|Severe debilitation, unable to continue|0|||
170361456|NCT00006604|615658553|FG002|Overall Study|Severe debilitation, unable to continue|0|||
170361457|NCT00006604|615658554|FG003|Overall Study|Severe debilitation, unable to continue|0|||
170361458|NCT00006604|615658555|FG004|Overall Study|Severe debilitation, unable to continue|0|||
170361459|NCT00006604|615658556|FG005|Overall Study|Severe debilitation, unable to continue|0|||
170361460|NCT00006604|615658557|FG006|Overall Study|Severe debilitation, unable to continue|3|||
170361461|NCT00006604|615658558|FG007|Overall Study|Severe debilitation, unable to continue|0|||
170361462|NCT00006604|615658559|FG008|Overall Study|Severe debilitation, unable to continue|0|||
170361463|NCT00006604|615658560|FG009|Overall Study|Severe debilitation, unable to continue|5|||
170361464|NCT00006604|615658561|FG010|Overall Study|Severe debilitation, unable to continue|0|||
170361465|NCT00006604|615658562|FG011|Overall Study|Severe debilitation, unable to continue|2|||
170361466|NCT00006604|615658563|FG012|Overall Study|Severe debilitation, unable to continue|1|||
170361467|NCT00006604|615658564|FG013|Overall Study|Severe debilitation, unable to continue|0|||
170361468|NCT00006604|615658565|FG014|Overall Study|Severe debilitation, unable to continue|2|||
170361469|NCT00006604|615658566|FG015|Overall Study|Severe debilitation, unable to continue|0|||
170361470|NCT00006604|615658567|FG016|Overall Study|Severe debilitation, unable to continue|0|||
170361471|NCT00006604|615658551|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
170361472|NCT00006604|615658552|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
170361473|NCT00006604|615658553|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
170361474|NCT00006604|615658554|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
170361475|NCT00006604|615658555|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
170361476|NCT00006604|615658556|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
170361477|NCT00006604|615658557|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
170361478|NCT00006604|615658558|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
170361479|NCT00006604|615658559|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
170361480|NCT00006604|615658560|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
170361481|NCT00006604|615658561|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
170361482|NCT00006604|615658562|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
170361483|NCT00006604|615658563|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
170361484|NCT00006604|615658564|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
170361485|NCT00006604|615658565|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
170361486|NCT00006604|615658566|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
170361487|NCT00006604|615658567|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
170361488|NCT00006604|615658551|FG000|Overall Study|Site closing|0|||
170361489|NCT00006604|615658552|FG001|Overall Study|Site closing|0|||
170361490|NCT00006604|615658553|FG002|Overall Study|Site closing|1|||
170361491|NCT00006604|615658554|FG003|Overall Study|Site closing|1|||
170361492|NCT00006604|615658555|FG004|Overall Study|Site closing|0|||
170361493|NCT00006604|615658556|FG005|Overall Study|Site closing|0|||
170361494|NCT00006604|615658557|FG006|Overall Study|Site closing|0|||
170361495|NCT00006604|615658558|FG007|Overall Study|Site closing|1|||
170361496|NCT00006604|615658559|FG008|Overall Study|Site closing|0|||
170361497|NCT00006604|615658560|FG009|Overall Study|Site closing|0|||
170361498|NCT00006604|615658561|FG010|Overall Study|Site closing|0|||
170361499|NCT00006604|615658562|FG011|Overall Study|Site closing|1|||
170361500|NCT00006604|615658563|FG012|Overall Study|Site closing|1|||
170361501|NCT00006604|615658564|FG013|Overall Study|Site closing|1|||
170361502|NCT00006604|615658565|FG014|Overall Study|Site closing|0|||
170361503|NCT00006604|615658566|FG015|Overall Study|Site closing|0|||
170361504|NCT00006604|615658567|FG016|Overall Study|Site closing|1|||
170361505|NCT00006604|615658551|FG000|Overall Study|Withdrawal by Subject|1|||
170361506|NCT00006604|615658552|FG001|Overall Study|Withdrawal by Subject|0|||
170361507|NCT00006604|615658553|FG002|Overall Study|Withdrawal by Subject|2|||
170361508|NCT00006604|615658554|FG003|Overall Study|Withdrawal by Subject|0|||
170361509|NCT00006604|615658555|FG004|Overall Study|Withdrawal by Subject|1|||
170361510|NCT00006604|615658556|FG005|Overall Study|Withdrawal by Subject|2|||
170361511|NCT00006604|615658557|FG006|Overall Study|Withdrawal by Subject|2|||
170361512|NCT00006604|615658558|FG007|Overall Study|Withdrawal by Subject|0|||
170361513|NCT00006604|615658559|FG008|Overall Study|Withdrawal by Subject|1|||
170361514|NCT00006604|615658560|FG009|Overall Study|Withdrawal by Subject|3|||
170361515|NCT00006604|615658561|FG010|Overall Study|Withdrawal by Subject|2|||
170361516|NCT00006604|615658562|FG011|Overall Study|Withdrawal by Subject|0|||
170361517|NCT00006604|615658563|FG012|Overall Study|Withdrawal by Subject|1|||
170361518|NCT00006604|615658564|FG013|Overall Study|Withdrawal by Subject|2|||
170361519|NCT00006604|615658565|FG014|Overall Study|Withdrawal by Subject|1|||
170361520|NCT00006604|615658566|FG015|Overall Study|Withdrawal by Subject|0|||
170361521|NCT00006604|615658567|FG016|Overall Study|Withdrawal by Subject|1|||
170361522|NCT00006604|615658551|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
170361523|NCT00006604|615658552|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
170361524|NCT00006604|615658553|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
170361525|NCT00006604|615658554|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
170361526|NCT00006604|615658555|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
170361527|NCT00006604|615658556|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
170361528|NCT00006604|615658557|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
170361529|NCT00006604|615658558|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
170361530|NCT00006604|615658559|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
170361531|NCT00006604|615658560|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
170361532|NCT00006604|615658561|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
170361533|NCT00006604|615658562|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
170361534|NCT00006604|615658563|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
170361535|NCT00006604|615658564|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
170361536|NCT00006604|615658565|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
170361537|NCT00006604|615658566|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
170361538|NCT00006604|615658567|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
170361539|NCT00006604|615658551|FG000|Overall Study|Lost to Follow-up|0|||
170361540|NCT00006604|615658552|FG001|Overall Study|Lost to Follow-up|0|||
170361541|NCT00006604|615658553|FG002|Overall Study|Lost to Follow-up|0|||
170361542|NCT00006604|615658554|FG003|Overall Study|Lost to Follow-up|0|||
170361543|NCT00006604|615658555|FG004|Overall Study|Lost to Follow-up|0|||
170361544|NCT00006604|615658556|FG005|Overall Study|Lost to Follow-up|0|||
170361545|NCT00006604|615658557|FG006|Overall Study|Lost to Follow-up|0|||
170361546|NCT00006604|615658558|FG007|Overall Study|Lost to Follow-up|1|||
170361547|NCT00006604|615658559|FG008|Overall Study|Lost to Follow-up|0|||
170361548|NCT00006604|615658560|FG009|Overall Study|Lost to Follow-up|2|||
170361549|NCT00006604|615658561|FG010|Overall Study|Lost to Follow-up|0|||
170361550|NCT00006604|615658562|FG011|Overall Study|Lost to Follow-up|0|||
170361551|NCT00006604|615658563|FG012|Overall Study|Lost to Follow-up|0|||
170361552|NCT00006604|615658564|FG013|Overall Study|Lost to Follow-up|0|||
170361553|NCT00006604|615658565|FG014|Overall Study|Lost to Follow-up|0|||
170361554|NCT00006604|615658566|FG015|Overall Study|Lost to Follow-up|1|||
170361555|NCT00006604|615658567|FG016|Overall Study|Lost to Follow-up|3|||
170361556|NCT00006604|615658551|FG000|Overall Study|Other Reason|0|||
170361557|NCT00006604|615658552|FG001|Overall Study|Other Reason|0|||
170361558|NCT00006604|615658553|FG002|Overall Study|Other Reason|0|||
170361559|NCT00006604|615658554|FG003|Overall Study|Other Reason|0|||
170361560|NCT00006604|615658555|FG004|Overall Study|Other Reason|0|||
170361561|NCT00006604|615658556|FG005|Overall Study|Other Reason|1|||
170361562|NCT00006604|615658557|FG006|Overall Study|Other Reason|0|||
170361563|NCT00006604|615658558|FG007|Overall Study|Other Reason|0|||
170361564|NCT00006604|615658559|FG008|Overall Study|Other Reason|0|||
170361565|NCT00006604|615658560|FG009|Overall Study|Other Reason|1|||
170361566|NCT00006604|615658561|FG010|Overall Study|Other Reason|0|||
170361567|NCT00006604|615658562|FG011|Overall Study|Other Reason|0|||
170361568|NCT00006604|615658563|FG012|Overall Study|Other Reason|0|||
170361569|NCT00006604|615658564|FG013|Overall Study|Other Reason|0|||
170361570|NCT00006604|615658565|FG014|Overall Study|Other Reason|0|||
170361571|NCT00006604|615658566|FG015|Overall Study|Other Reason|0|||
170361572|NCT00006604|615658567|FG016|Overall Study|Other Reason|0|||
170361573|NCT02227108|615658570|FG000|Overall Study|Did not receive treatment|2|||
170361574|NCT02227108|615658570|FG000|Overall Study|Other|3|||
170361575|NCT02227108|615658570|FG000|Overall Study|Progressive disease|17|||
170361576|NCT02227108|615658570|FG000|Overall Study|Initiation of alternative therapy|2|||
170361577|NCT02227108|615658570|FG000|Overall Study|Investigator discretion|1|||
170361578|NCT02227108|615658570|FG000|Overall Study|Adverse Event|6|||
170361579|NCT01928485|615658571|FG000|Overall Study|Physician Decision|0|||
170361580|NCT01928485|615658572|FG001|Overall Study|Physician Decision|1|||
170361581|NCT03956225|615658573|FG000|Overall Study|Lack of Efficacy|1|||
170361582|NCT03956225|615658574|FG001|Overall Study|Lack of Efficacy|1|||
170361583|NCT03956225|615658573|FG000|Overall Study|Lost to Follow-up|0|||
170361584|NCT03956225|615658574|FG001|Overall Study|Lost to Follow-up|1|||
170361585|NCT03956225|615658573|FG000|Overall Study|Withdrawal by Subject|2|||
170361586|NCT03956225|615658574|FG001|Overall Study|Withdrawal by Subject|1|||
170361587|NCT03956225|615658573|FG000|Overall Study|Other Reasons|2|||
170361588|NCT03956225|615658574|FG001|Overall Study|Other Reasons|1|||
170361589|NCT02260648|615658575|FG000|Overall Study|Adverse Event|3|||
170361590|NCT02260648|615658576|FG001|Overall Study|Adverse Event|0|||
170361591|NCT02260648|615658577|FG002|Overall Study|Adverse Event|1|||
170361592|NCT02260648|615658575|FG000|Overall Study|Withdrawal by Subject|1|||
170361593|NCT02260648|615658576|FG001|Overall Study|Withdrawal by Subject|1|||
170361594|NCT02260648|615658577|FG002|Overall Study|Withdrawal by Subject|0|||
170361595|NCT02260648|615658575|FG000|Overall Study|Protocol Violation|1|||
170361596|NCT02260648|615658576|FG001|Overall Study|Protocol Violation|0|||
170361597|NCT02260648|615658577|FG002|Overall Study|Protocol Violation|0|||
170361598|NCT02260648|615658575|FG000|Overall Study|Discontinue Due to Study Termination|13|||
170361599|NCT02260648|615658576|FG001|Overall Study|Discontinue Due to Study Termination|12|||
170361600|NCT02260648|615658577|FG002|Overall Study|Discontinue Due to Study Termination|7|||
170361601|NCT00039741|615658578|FG000|Overall Study|Death|0|||
170361602|NCT00039741|615658579|FG001|Overall Study|Death|1|||
170361603|NCT00039741|615658580|FG002|Overall Study|Death|0|||
170361604|NCT00039741|615658581|FG003|Overall Study|Death|0|||
170361605|NCT00039741|615658578|FG000|Overall Study|Lost to Follow-up|3|||
170361606|NCT00039741|615658579|FG001|Overall Study|Lost to Follow-up|1|||
170361607|NCT00039741|615658580|FG002|Overall Study|Lost to Follow-up|5|||
170361608|NCT00039741|615658581|FG003|Overall Study|Lost to Follow-up|2|||
170361609|NCT00039741|615658578|FG000|Overall Study|Confounding medical condition|1|||
170361610|NCT00039741|615658579|FG001|Overall Study|Confounding medical condition|0|||
170361611|NCT00039741|615658580|FG002|Overall Study|Confounding medical condition|0|||
170361612|NCT00039741|615658581|FG003|Overall Study|Confounding medical condition|0|||
170361613|NCT00039741|615658578|FG000|Overall Study|Not able to get to clinic|5|||
170361614|NCT00039741|615658579|FG001|Overall Study|Not able to get to clinic|2|||
170361615|NCT00039741|615658580|FG002|Overall Study|Not able to get to clinic|0|||
170361616|NCT00039741|615658581|FG003|Overall Study|Not able to get to clinic|3|||
170361617|NCT00039741|615658578|FG000|Overall Study|Moved|3|||
170361618|NCT00039741|615658579|FG001|Overall Study|Moved|2|||
170361619|NCT00039741|615658580|FG002|Overall Study|Moved|3|||
170361620|NCT00039741|615658581|FG003|Overall Study|Moved|6|||
170361621|NCT00039741|615658578|FG000|Overall Study|Non-compliance with protocol|1|||
170361622|NCT00039741|615658579|FG001|Overall Study|Non-compliance with protocol|0|||
170361623|NCT00039741|615658580|FG002|Overall Study|Non-compliance with protocol|1|||
170361624|NCT00039741|615658581|FG003|Overall Study|Non-compliance with protocol|0|||
170361625|NCT00039741|615658578|FG000|Overall Study|Withdrew consent|0|||
170361626|NCT00039741|615658579|FG001|Overall Study|Withdrew consent|5|||
170361627|NCT00039741|615658580|FG002|Overall Study|Withdrew consent|0|||
170361628|NCT00039741|615658581|FG003|Overall Study|Withdrew consent|1|||
170361629|NCT00039741|615658578|FG000|Overall Study|Missed final visit|2|||
170361630|NCT00039741|615658579|FG001|Overall Study|Missed final visit|1|||
170361631|NCT00039741|615658580|FG002|Overall Study|Missed final visit|2|||
170361632|NCT00039741|615658581|FG003|Overall Study|Missed final visit|2|||
170361633|NCT00946881|615658584|FG000|First Treatment|Withdrawal by Subject|1|||
170361634|NCT00946881|615658584|FG000|First Treatment|Patient relocated to another state|1|||
170361635|NCT00946881|615658584|FG000|Retreatment|Withdrawal by Subject|1|||
170361636|NCT01182337|615658591|FG000|Overall Study|Withdrawal by Subject|3|||
170361637|NCT01182337|615658592|FG001|Overall Study|Withdrawal by Subject|1|||
170361638|NCT01182337|615658591|FG000|Overall Study|Lost to Follow-up|0|||
170361639|NCT01182337|615658592|FG001|Overall Study|Lost to Follow-up|1|||
170361640|NCT02157506|615658593|FG000|Overall Study|Adverse Event|0|||
170361641|NCT02157506|615658594|FG001|Overall Study|Adverse Event|1|||
170361642|NCT02157506|615658595|FG002|Overall Study|Adverse Event|0|||
170361643|NCT02157506|615658596|FG003|Overall Study|Adverse Event|0|||
170361644|NCT02157506|615658597|FG004|Overall Study|Adverse Event|0|||
170361645|NCT02157506|615658593|FG000|Overall Study|Lost to Follow-up|0|||
170361646|NCT02157506|615658594|FG001|Overall Study|Lost to Follow-up|0|||
170361647|NCT02157506|615658595|FG002|Overall Study|Lost to Follow-up|1|||
170361648|NCT02157506|615658596|FG003|Overall Study|Lost to Follow-up|0|||
170361649|NCT02157506|615658597|FG004|Overall Study|Lost to Follow-up|0|||
170361650|NCT01714817|615658598|FG000|Year 1 Period|Lack of Efficacy|11|||
170361651|NCT01714817|615658599|FG001|Year 1 Period|Lack of Efficacy|9|||
170361652|NCT01714817|615658598|FG000|Year 1 Period|Adverse Event|20|||
170361653|NCT01714817|615658599|FG001|Year 1 Period|Adverse Event|17|||
170361654|NCT01714817|615658598|FG000|Year 1 Period|Withdrawal by Subject|6|||
170361655|NCT01714817|615658599|FG001|Year 1 Period|Withdrawal by Subject|7|||
170361656|NCT01714817|615658598|FG000|Year 1 Period|Death|1|||
170361657|NCT01714817|615658599|FG001|Year 1 Period|Death|1|||
170361658|NCT01714817|615658598|FG000|Year 1 Period|Lost to Follow-up|0|||
170361659|NCT01714817|615658599|FG001|Year 1 Period|Lost to Follow-up|2|||
170361660|NCT01714817|615658598|FG000|Year 1 Period|Poor / non-compliance|0|||
170361661|NCT01714817|615658599|FG001|Year 1 Period|Poor / non-compliance|1|||
170361662|NCT01714817|615658598|FG000|Year 1 Period|Pregnancy|2|||
170361663|NCT01714817|615658599|FG001|Year 1 Period|Pregnancy|0|||
170361664|NCT01714817|615658598|FG000|Year 1 Period|Participant no longer meets criteria|6|||
170361665|NCT01714817|615658599|FG001|Year 1 Period|Participant no longer meets criteria|2|||
170361666|NCT01714817|615658598|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
170361667|NCT01714817|615658599|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
170361668|NCT01714817|615658598|FG000|Year 1 Period|Change in Concomitant Medication|0|||
170361669|NCT01714817|615658599|FG001|Year 1 Period|Change in Concomitant Medication|1|||
170361670|NCT01714817|615658598|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
170361671|NCT01714817|615658599|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
170361672|NCT01714817|615658598|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
170361673|NCT01714817|615658599|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
170361674|NCT01714817|615658598|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
170361675|NCT01714817|615658599|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
170361676|NCT01714817|615658598|FG000|Year 2 Period|Lack of Efficacy|4|||
170361677|NCT01714817|615658599|FG001|Year 2 Period|Lack of Efficacy|12|||
170361678|NCT01714817|615658598|FG000|Year 2 Period|Adverse Event|7|||
170361679|NCT01714817|615658599|FG001|Year 2 Period|Adverse Event|6|||
170361680|NCT01714817|615658598|FG000|Year 2 Period|Participant request to stop treatment|4|||
170361681|NCT01714817|615658599|FG001|Year 2 Period|Participant request to stop treatment|4|||
170361682|NCT01714817|615658598|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
170361683|NCT01714817|615658599|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
170361684|NCT01714817|615658598|FG000|Year 2 Period|Participant withdrew consent|1|||
170361685|NCT01714817|615658599|FG001|Year 2 Period|Participant withdrew consent|5|||
170361686|NCT01714817|615658598|FG000|Year 2 Period|Participant no longer meets criteria|1|||
170361687|NCT01714817|615658599|FG001|Year 2 Period|Participant no longer meets criteria|4|||
170361688|NCT01714817|615658598|FG000|Year 2 Period|Lost to Follow-up|2|||
170361689|NCT01714817|615658599|FG001|Year 2 Period|Lost to Follow-up|0|||
170361690|NCT01714817|615658598|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
170361691|NCT01714817|615658599|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
170361692|NCT01714817|615658598|FG000|Year 2 Period|Pregnancy|1|||
170361693|NCT01714817|615658599|FG001|Year 2 Period|Pregnancy|1|||
170361694|NCT01714817|615658598|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
170361695|NCT01714817|615658599|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
170361696|NCT01714817|615658598|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
170361697|NCT01714817|615658599|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
170361698|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
170361699|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
170361700|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
170361701|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
170361702|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
170361703|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
170361704|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
170361705|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
170361706|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
170361707|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
170361708|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
170361709|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
170361710|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
170361711|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
170361712|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
170361713|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
170361714|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
170361715|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
170361716|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
170361717|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
170361718|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
170361719|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
170361720|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
170361721|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
170361722|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
170361723|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
170361724|NCT01714817|615658598|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
170361725|NCT01714817|615658599|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
170361726|NCT00599027|615658601|FG000|Overall Study|Withdrawal by Subject|1|||
170361727|NCT00599027|615658602|FG001|Overall Study|Withdrawal by Subject|1|||
170361728|NCT00599027|615658601|FG000|Overall Study|Adverse Event|0|||
170361729|NCT00599027|615658602|FG001|Overall Study|Adverse Event|1|||
170361730|NCT00599027|615658601|FG000|Overall Study|Treatment Failure|0|||
170361731|NCT00599027|615658602|FG001|Overall Study|Treatment Failure|1|||
170361732|NCT00476996|615658609|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
170361733|NCT00476996|615658610|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
170361734|NCT00476996|615658611|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
170361735|NCT00476996|615658612|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
170361736|NCT00476996|615658609|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
170361737|NCT00476996|615658610|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
170361738|NCT00476996|615658611|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
170361739|NCT00476996|615658612|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
170361740|NCT00476996|615658609|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
170361741|NCT00476996|615658610|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
170361742|NCT00476996|615658611|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
170361743|NCT00476996|615658612|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
170361744|NCT00476996|615658609|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
170361745|NCT00476996|615658610|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
170361746|NCT00476996|615658611|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
170361747|NCT00476996|615658612|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
170361748|NCT00476996|615658609|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
170361749|NCT00476996|615658610|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
170361750|NCT00476996|615658611|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
170361751|NCT00476996|615658612|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
170361752|NCT00476996|615658609|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
170361753|NCT00476996|615658610|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
170361754|NCT00476996|615658611|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
170361755|NCT00476996|615658612|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
170361756|NCT00476996|615658609|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
170361757|NCT00476996|615658610|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
170361758|NCT00476996|615658611|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
170361759|NCT00476996|615658612|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
170361760|NCT00476996|615658609|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
170361761|NCT00476996|615658610|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
170361762|NCT00476996|615658611|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
170361763|NCT00476996|615658612|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
170361764|NCT00476996|615658609|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
170361765|NCT00476996|615658610|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
170361766|NCT00476996|615658611|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
170361767|NCT00476996|615658612|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
170361768|NCT00476996|615658609|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
170361769|NCT00476996|615658610|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
170361770|NCT00476996|615658611|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
170361771|NCT00476996|615658612|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
170361772|NCT00476996|615658609|FG000|OLE Phase (From Week 48)|Death|0|||
170361773|NCT00476996|615658610|FG001|OLE Phase (From Week 48)|Death|0|||
170361774|NCT00476996|615658611|FG002|OLE Phase (From Week 48)|Death|0|||
170361775|NCT00476996|615658612|FG003|OLE Phase (From Week 48)|Death|7|||
170361776|NCT00476996|615658609|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
170361777|NCT00476996|615658610|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
170361778|NCT00476996|615658611|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
170361779|NCT00476996|615658612|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
170361780|NCT00476996|615658609|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
170361781|NCT00476996|615658610|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
170361782|NCT00476996|615658611|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
170361783|NCT00476996|615658612|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
170361784|NCT00476996|615658609|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
170361785|NCT00476996|615658610|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
170361786|NCT00476996|615658611|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
170361787|NCT00476996|615658612|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
170361788|NCT00476996|615658609|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
170361789|NCT00476996|615658610|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
170361790|NCT00476996|615658611|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
170361791|NCT00476996|615658612|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
170361792|NCT02148211|615658614|FG000|Overall Study|Lost to Follow-up|352|||
170361793|NCT03337139|615658615|FG000|Phase I|Withdrawal by Subject|10|||
170361794|NCT03337139|615658616|FG001|Phase I|Withdrawal by Subject|0|||
170361795|NCT02554253|615658617|FG000|Overall Study|ineligible after enrollment|1|||
170361796|NCT02554253|615658618|FG001|Overall Study|ineligible after enrollment|0|||
170361797|NCT02554253|615658617|FG000|Overall Study|converted to transcatheter procedure|0|||
170361798|NCT02554253|615658618|FG001|Overall Study|converted to transcatheter procedure|1|||
170361799|NCT02554253|615658617|FG000|Overall Study|received both drugs|0|||
170361800|NCT02554253|615658618|FG001|Overall Study|received both drugs|1|||
170361801|NCT03288493|615658622|FG000|Overall Study|Withdrawal by Subject|4|||
170361802|NCT03288493|615658623|FG001|Overall Study|Withdrawal by Subject|0|||
170361803|NCT03288493|615658624|FG002|Overall Study|Withdrawal by Subject|0|||
170361804|NCT03288493|615658625|FG003|Overall Study|Withdrawal by Subject|0|||
170361805|NCT03288493|615658626|FG004|Overall Study|Withdrawal by Subject|0|||
170361806|NCT03288493|615658627|FG005|Overall Study|Withdrawal by Subject|2|||
170361807|NCT03288493|615658628|FG006|Overall Study|Withdrawal by Subject|0|||
170361808|NCT03288493|615658622|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
170361809|NCT03288493|615658623|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
170361810|NCT03288493|615658624|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
170361811|NCT03288493|615658625|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
170361812|NCT03288493|615658626|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
170361813|NCT03288493|615658627|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
170361814|NCT03288493|615658628|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
170361815|NCT03288493|615658622|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
170361816|NCT03288493|615658623|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
170361817|NCT03288493|615658624|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
170361818|NCT03288493|615658625|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
170361819|NCT03288493|615658626|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
170361820|NCT03288493|615658627|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
170361821|NCT03288493|615658628|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
170361822|NCT03288493|615658622|FG000|Overall Study|Death|2|||
170361823|NCT03288493|615658623|FG001|Overall Study|Death|0|||
170361824|NCT03288493|615658624|FG002|Overall Study|Death|0|||
170361825|NCT03288493|615658625|FG003|Overall Study|Death|0|||
170361826|NCT03288493|615658626|FG004|Overall Study|Death|0|||
170361827|NCT03288493|615658627|FG005|Overall Study|Death|0|||
170361828|NCT03288493|615658628|FG006|Overall Study|Death|0|||
170361829|NCT03288493|615658622|FG000|Overall Study|other reason not listed above|2|||
170361830|NCT03288493|615658623|FG001|Overall Study|other reason not listed above|0|||
170361831|NCT03288493|615658624|FG002|Overall Study|other reason not listed above|0|||
170361832|NCT03288493|615658625|FG003|Overall Study|other reason not listed above|0|||
170361833|NCT03288493|615658626|FG004|Overall Study|other reason not listed above|0|||
170361834|NCT03288493|615658627|FG005|Overall Study|other reason not listed above|0|||
170361835|NCT03288493|615658628|FG006|Overall Study|other reason not listed above|0|||
170361836|NCT01871896|615658629|FG000|Overall Study|Lost to Follow-up|1|||
170361837|NCT01375647|615660561|FG000|Overall Study|Lost to Follow-up|3|||
170361838|NCT01375647|615660562|FG001|Overall Study|Lost to Follow-up|3|||
170361839|NCT01375647|615660563|FG002|Overall Study|Lost to Follow-up|7|||
170361840|NCT01375647|615660564|FG003|Overall Study|Lost to Follow-up|10|||
170361841|NCT01375647|615660561|FG000|Overall Study|Death|1|||
170361842|NCT01375647|615660562|FG001|Overall Study|Death|2|||
170361843|NCT01375647|615660563|FG002|Overall Study|Death|1|||
170361844|NCT01375647|615660564|FG003|Overall Study|Death|0|||
170361845|NCT01375647|615660561|FG000|Overall Study|Withdrawal by Subject|17|||
170361846|NCT01375647|615660562|FG001|Overall Study|Withdrawal by Subject|20|||
170361847|NCT01375647|615660563|FG002|Overall Study|Withdrawal by Subject|26|||
170361848|NCT01375647|615660564|FG003|Overall Study|Withdrawal by Subject|14|||
170361849|NCT01375647|615660561|FG000|Overall Study|Physician Decision|1|||
170361850|NCT01375647|615660562|FG001|Overall Study|Physician Decision|0|||
170361851|NCT01375647|615660563|FG002|Overall Study|Physician Decision|0|||
170361852|NCT01375647|615660564|FG003|Overall Study|Physician Decision|0|||
170361853|NCT03788967|615660565|FG000|Overall Study|Lost to Follow-up|14|||
170361854|NCT03788967|615660566|FG001|Overall Study|Lost to Follow-up|10|||
170361855|NCT03788967|615660565|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
170361856|NCT03788967|615660566|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
170361857|NCT03788967|615660565|FG000|Overall Study|Participant Withdrawal of Consent|13|||
170361858|NCT03788967|615660566|FG001|Overall Study|Participant Withdrawal of Consent|5|||
170361859|NCT03788967|615660565|FG000|Overall Study|Adverse Event|1|||
170361860|NCT03788967|615660566|FG001|Overall Study|Adverse Event|1|||
170361861|NCT03788967|615660565|FG000|Overall Study|COVID-19|1|||
170361862|NCT03788967|615660566|FG001|Overall Study|COVID-19|2|||
170361863|NCT03621189|615660569|FG000|Overall Study|Withdrawal by Subject|0|||
170361864|NCT03621189|615660570|FG001|Overall Study|Withdrawal by Subject|3|||
170361865|NCT03621189|615660569|FG000|Overall Study|Physician Decision|0|||
170361866|NCT03621189|615660570|FG001|Overall Study|Physician Decision|2|||
170361867|NCT01824693|615660571|FG000|Overall Study|Death|0|||
170361868|NCT01824693|615660572|FG001|Overall Study|Death|1|||
170361869|NCT01824693|615660573|FG002|Overall Study|Death|0|||
170361870|NCT01824693|615660571|FG000|Overall Study|Physician Decision|1|||
170361871|NCT01824693|615660572|FG001|Overall Study|Physician Decision|1|||
170361872|NCT01824693|615660573|FG002|Overall Study|Physician Decision|1|||
170361873|NCT01824693|615660571|FG000|Overall Study|Withdrawal by Subject|0|||
170361874|NCT01824693|615660572|FG001|Overall Study|Withdrawal by Subject|0|||
170361875|NCT01824693|615660573|FG002|Overall Study|Withdrawal by Subject|1|||
170361876|NCT01824693|615660571|FG000|Overall Study|Progressive Disease|0|||
170361877|NCT01824693|615660572|FG001|Overall Study|Progressive Disease|5|||
170361878|NCT01824693|615660573|FG002|Overall Study|Progressive Disease|0|||
170361879|NCT01824693|615660571|FG000|Overall Study|Ineligible|0|||
170361880|NCT01824693|615660572|FG001|Overall Study|Ineligible|0|||
170361881|NCT01824693|615660573|FG002|Overall Study|Ineligible|3|||
170361882|NCT01824693|615660571|FG000|Overall Study|No Transplant Planned|0|||
170361883|NCT01824693|615660572|FG001|Overall Study|No Transplant Planned|0|||
170361884|NCT01824693|615660573|FG002|Overall Study|No Transplant Planned|10|||
170361885|NCT01316939|615660574|FG000|Overall Study|Study closed/terminated|26|||
170361886|NCT01316939|615660575|FG001|Overall Study|Study closed/terminated|25|||
170361887|NCT01316939|615660576|FG002|Overall Study|Study closed/terminated|23|||
170361888|NCT01316939|615660574|FG000|Overall Study|Lack of Efficacy|24|||
170361889|NCT01316939|615660575|FG001|Overall Study|Lack of Efficacy|25|||
170361890|NCT01316939|615660576|FG002|Overall Study|Lack of Efficacy|25|||
170361891|NCT01316939|615660574|FG000|Overall Study|Adverse Event|9|||
170361892|NCT01316939|615660575|FG001|Overall Study|Adverse Event|12|||
170361893|NCT01316939|615660576|FG002|Overall Study|Adverse Event|11|||
170361894|NCT01316939|615660574|FG000|Overall Study|Withdrawal by Subject|1|||
170361895|NCT01316939|615660575|FG001|Overall Study|Withdrawal by Subject|3|||
170361896|NCT01316939|615660576|FG002|Overall Study|Withdrawal by Subject|6|||
170361897|NCT01316939|615660574|FG000|Overall Study|Physician Decision|2|||
170361898|NCT01316939|615660575|FG001|Overall Study|Physician Decision|2|||
170361899|NCT01316939|615660576|FG002|Overall Study|Physician Decision|1|||
170361900|NCT01316939|615660574|FG000|Overall Study|Lost to Follow-up|0|||
170361901|NCT01316939|615660575|FG001|Overall Study|Lost to Follow-up|0|||
170361902|NCT01316939|615660576|FG002|Overall Study|Lost to Follow-up|2|||
170361903|NCT01316939|615660574|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
170361904|NCT01316939|615660575|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
170361905|NCT01316939|615660576|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
170361906|NCT01316939|615660574|FG000|Overall Study|Protocol Violation|0|||
170361907|NCT01316939|615660575|FG001|Overall Study|Protocol Violation|1|||
170361908|NCT01316939|615660576|FG002|Overall Study|Protocol Violation|0|||
170361909|NCT01432457|615660577|FG000|Overall Study|Adverse Event|7|||
170361910|NCT01432457|615660578|FG001|Overall Study|Adverse Event|10|||
170361911|NCT01432457|615660579|FG002|Overall Study|Adverse Event|16|||
170361912|NCT01432457|615660577|FG000|Overall Study|Lack of Efficacy|2|||
170361913|NCT01432457|615660578|FG001|Overall Study|Lack of Efficacy|1|||
170361914|NCT01432457|615660579|FG002|Overall Study|Lack of Efficacy|1|||
170361915|NCT01432457|615660577|FG000|Overall Study|Lost to Follow-up|11|||
170361916|NCT01432457|615660578|FG001|Overall Study|Lost to Follow-up|15|||
170361917|NCT01432457|615660579|FG002|Overall Study|Lost to Follow-up|20|||
170361918|NCT01432457|615660577|FG000|Overall Study|Protocol Violation|3|||
170361919|NCT01432457|615660578|FG001|Overall Study|Protocol Violation|2|||
170361920|NCT01432457|615660579|FG002|Overall Study|Protocol Violation|6|||
170361921|NCT01432457|615660577|FG000|Overall Study|Withdrawal by Subject|6|||
170361922|NCT01432457|615660578|FG001|Overall Study|Withdrawal by Subject|11|||
170361923|NCT01432457|615660579|FG002|Overall Study|Withdrawal by Subject|9|||
170361924|NCT01432457|615660577|FG000|Overall Study|Reasons not defined|2|||
170361925|NCT01432457|615660578|FG001|Overall Study|Reasons not defined|3|||
170361926|NCT01432457|615660579|FG002|Overall Study|Reasons not defined|4|||
170361927|NCT01432457|615660577|FG000|Overall Study|Did not take study drug|6|||
170361928|NCT01432457|615660578|FG001|Overall Study|Did not take study drug|6|||
170361929|NCT01432457|615660579|FG002|Overall Study|Did not take study drug|3|||
170361930|NCT04134728|615660580|FG000|Overall Study|Adverse Event|3|||
170361931|NCT04134728|615660581|FG001|Overall Study|Adverse Event|2|||
170361932|NCT04134728|615660582|FG002|Overall Study|Adverse Event|9|||
170361933|NCT04134728|615660583|FG003|Overall Study|Adverse Event|0|||
170361934|NCT04134728|615660584|FG004|Overall Study|Adverse Event|0|||
170361935|NCT04134728|615660585|FG005|Overall Study|Adverse Event|0|||
170361936|NCT04134728|615660580|FG000|Overall Study|Lack of Efficacy|3|||
170361937|NCT04134728|615660581|FG001|Overall Study|Lack of Efficacy|3|||
170361938|NCT04134728|615660582|FG002|Overall Study|Lack of Efficacy|1|||
170361939|NCT04134728|615660583|FG003|Overall Study|Lack of Efficacy|2|||
170361940|NCT04134728|615660584|FG004|Overall Study|Lack of Efficacy|0|||
170361941|NCT04134728|615660585|FG005|Overall Study|Lack of Efficacy|0|||
170361942|NCT04134728|615660580|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
170361943|NCT04134728|615660581|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170361944|NCT04134728|615660582|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
170361945|NCT04134728|615660583|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170361946|NCT04134728|615660584|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170361947|NCT04134728|615660585|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
170361948|NCT04134728|615660580|FG000|Overall Study|Protocol Deviation|0|||
170361949|NCT04134728|615660581|FG001|Overall Study|Protocol Deviation|0|||
170361950|NCT04134728|615660582|FG002|Overall Study|Protocol Deviation|1|||
170361951|NCT04134728|615660583|FG003|Overall Study|Protocol Deviation|0|||
170361952|NCT04134728|615660584|FG004|Overall Study|Protocol Deviation|0|||
170361953|NCT04134728|615660585|FG005|Overall Study|Protocol Deviation|0|||
170361954|NCT04134728|615660580|FG000|Overall Study|Informed Consent Withdrawn|3|||
170361955|NCT04134728|615660581|FG001|Overall Study|Informed Consent Withdrawn|6|||
170361956|NCT04134728|615660582|FG002|Overall Study|Informed Consent Withdrawn|8|||
170361957|NCT04134728|615660583|FG003|Overall Study|Informed Consent Withdrawn|1|||
170361958|NCT04134728|615660584|FG004|Overall Study|Informed Consent Withdrawn|1|||
170361959|NCT04134728|615660585|FG005|Overall Study|Informed Consent Withdrawn|0|||
170361960|NCT04134728|615660580|FG000|Overall Study|Physician Decision|2|||
170361961|NCT04134728|615660581|FG001|Overall Study|Physician Decision|0|||
170361962|NCT04134728|615660582|FG002|Overall Study|Physician Decision|0|||
170361963|NCT04134728|615660583|FG003|Overall Study|Physician Decision|0|||
170361964|NCT04134728|615660584|FG004|Overall Study|Physician Decision|0|||
170361965|NCT04134728|615660585|FG005|Overall Study|Physician Decision|0|||
170361966|NCT04134728|615660580|FG000|Overall Study|Lost to Follow-up|1|||
170361967|NCT04134728|615660581|FG001|Overall Study|Lost to Follow-up|2|||
170361968|NCT04134728|615660582|FG002|Overall Study|Lost to Follow-up|1|||
170361969|NCT04134728|615660583|FG003|Overall Study|Lost to Follow-up|0|||
170361970|NCT04134728|615660584|FG004|Overall Study|Lost to Follow-up|0|||
170361971|NCT04134728|615660585|FG005|Overall Study|Lost to Follow-up|1|||
170361972|NCT04134728|615660580|FG000|Overall Study|Investigator Site Closed|0|||
170361973|NCT04134728|615660581|FG001|Overall Study|Investigator Site Closed|1|||
170361974|NCT04134728|615660582|FG002|Overall Study|Investigator Site Closed|1|||
170361975|NCT04134728|615660583|FG003|Overall Study|Investigator Site Closed|0|||
170361976|NCT04134728|615660584|FG004|Overall Study|Investigator Site Closed|0|||
170361977|NCT04134728|615660585|FG005|Overall Study|Investigator Site Closed|0|||
170361978|NCT01175590|615660588|FG000|Overall Study|Lost to Follow-up|1|||
170361979|NCT01175590|615660589|FG001|Overall Study|Lost to Follow-up|0|||
170361980|NCT01175590|615660588|FG000|Overall Study|Withdrawal by Subject|0|||
170361981|NCT01175590|615660589|FG001|Overall Study|Withdrawal by Subject|2|||
170361982|NCT01175590|615660588|FG000|Overall Study|Adverse Event|4|||
170361983|NCT01175590|615660589|FG001|Overall Study|Adverse Event|0|||
170361984|NCT01175590|615660588|FG000|Overall Study|Physician Decision|1|||
170361985|NCT01175590|615660589|FG001|Overall Study|Physician Decision|4|||
170361986|NCT01175590|615660588|FG000|Overall Study|Lack of Efficacy|1|||
170361987|NCT01175590|615660589|FG001|Overall Study|Lack of Efficacy|1|||
170361988|NCT01175590|615660588|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
170361989|NCT01175590|615660589|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
170361990|NCT01175590|615660588|FG000|Overall Study|Treated not as randomized|3|||
170361991|NCT01175590|615660589|FG001|Overall Study|Treated not as randomized|2|||
170361992|NCT01175590|615660588|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
170361993|NCT01175590|615660589|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
170361994|NCT01175590|615660588|FG000|Overall Study|Protocol Violation|0|||
170361995|NCT01175590|615660589|FG001|Overall Study|Protocol Violation|1|||
170361996|NCT02966353|615660590|FG000|Overall Study|Withdrawal by Subject|7|||
170361997|NCT02966353|615660590|FG000|Overall Study|Adverse Event|4|||
170361998|NCT02966353|615660590|FG000|Overall Study|Death|4|||
170361999|NCT02966353|615660590|FG000|Overall Study|Physician Decision|3|||
170362000|NCT02966353|615660590|FG000|Overall Study|Progressive disease|2|||
170362001|NCT02966353|615660590|FG000|Overall Study|Protocol deviation|2|||
170362002|NCT03728140|615660591|FG000|Overall Study|Abnormal embryo transfer operation|10|||
170362003|NCT03728140|615660592|FG001|Overall Study|Abnormal embryo transfer operation|7|||
170362004|NCT02062398|615660593|FG000|Overall Study|Implant removal|1|||
170362005|NCT02007252|615660603|FG000|Overall Study|Administrative problems|3|||
170362006|NCT02007252|615660604|FG001|Overall Study|Administrative problems|7|||
170362007|NCT02007252|615660603|FG000|Overall Study|Abnormal laboratory value(s)|1|||
170362008|NCT02007252|615660604|FG001|Overall Study|Abnormal laboratory value(s)|0|||
170362009|NCT02007252|615660603|FG000|Overall Study|Adverse Event|7|||
170362010|NCT02007252|615660604|FG001|Overall Study|Adverse Event|4|||
170362011|NCT02657434|615660605|FG000|Overall Study|Study Terminated By Sponsor|64|||
170362012|NCT02657434|615660606|FG001|Overall Study|Study Terminated By Sponsor|82|||
170362013|NCT02657434|615660605|FG000|Overall Study|Death|189|||
170362014|NCT02657434|615660606|FG001|Overall Study|Death|190|||
170362015|NCT02657434|615660605|FG000|Overall Study|Lost to Follow-up|2|||
170362016|NCT02657434|615660606|FG001|Overall Study|Lost to Follow-up|2|||
170362017|NCT02657434|615660605|FG000|Overall Study|Randomization by Error|2|||
170362018|NCT02657434|615660606|FG001|Overall Study|Randomization by Error|0|||
170362019|NCT02657434|615660605|FG000|Overall Study|Withdrawal by Subject|28|||
170362020|NCT02657434|615660606|FG001|Overall Study|Withdrawal by Subject|17|||
170362021|NCT02657434|615660605|FG000|Overall Study|Protocol Violation|1|||
170362022|NCT02657434|615660606|FG001|Overall Study|Protocol Violation|0|||
170362023|NCT02657434|615660605|FG000|Overall Study|Physician Decision|0|||
170362024|NCT02657434|615660606|FG001|Overall Study|Physician Decision|1|||
170362025|NCT00608881|615660607|FG000|Overall Study|Death|22|||
170362026|NCT00608881|615660608|FG001|Overall Study|Death|13|||
170362027|NCT00608881|615660607|FG000|Overall Study|Adverse Event|5|||
170362028|NCT00608881|615660608|FG001|Overall Study|Adverse Event|3|||
170362029|NCT00608881|615660607|FG000|Overall Study|Lost to Follow-up|28|||
170362030|NCT00608881|615660608|FG001|Overall Study|Lost to Follow-up|14|||
170362031|NCT00608881|615660607|FG000|Overall Study|Withdrawal by Subject|18|||
170362032|NCT00608881|615660608|FG001|Overall Study|Withdrawal by Subject|29|||
170362033|NCT00608881|615660607|FG000|Overall Study|Physician Decision|5|||
170362034|NCT00608881|615660608|FG001|Overall Study|Physician Decision|5|||
170362035|NCT00608881|615660607|FG000|Overall Study|Institutionalized|1|||
170362036|NCT00608881|615660608|FG001|Overall Study|Institutionalized|2|||
170362037|NCT00510484|615660611|FG000|Wash-out Period|Adverse Event|0|||
170362038|NCT00510484|615660612|FG001|Wash-out Period|Adverse Event|1|||
170362039|NCT02533401|615660613|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
170362040|NCT02533401|615660613|FG000|Overall Study|Death|5|||
170362041|NCT02533401|615660613|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
170362042|NCT02533401|615660613|FG000|Overall Study|Lost to Follow-up|1|||
170362043|NCT02533401|615660613|FG000|Overall Study|Violation of Selection Criteria|1|||
170362044|NCT01106391|615660614|FG000|Overall Study|Death|12|||
170362045|NCT01106391|615660614|FG000|Overall Study|Withdrawal by Subject|7|||
170362046|NCT01387074|615660617|FG000|Overall Study|Lost to Follow-up|7|||
170362047|NCT01387074|615660617|FG000|Overall Study|Lack of Efficacy|1|||
170362048|NCT02147691|615660618|FG000|Overall Study|Withdrawal by Subject|2|||
170362049|NCT02147691|615660619|FG001|Overall Study|Withdrawal by Subject|0|||
170362050|NCT02147691|615660618|FG000|Overall Study|Adverse Event|2|||
170362051|NCT02147691|615660619|FG001|Overall Study|Adverse Event|0|||
170362052|NCT02147691|615660618|FG000|Overall Study|Lost to Follow-up|0|||
170362053|NCT02147691|615660619|FG001|Overall Study|Lost to Follow-up|1|||
170362054|NCT01392742|615660622|FG000|Overall Study|Premature study termination|42|||
170362055|NCT01392742|615660622|FG000|Overall Study|Failure to return|35|||
170362056|NCT01392742|615660622|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
170362057|NCT01392742|615660622|FG000|Overall Study|Lost to Follow-up|34|||
170362058|NCT01392742|615660622|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
170362059|NCT01392742|615660622|FG000|Overall Study|ITR and Protocol deviation|1|||
170362060|NCT01392742|615660622|FG000|Overall Study|Adverse event/intercurrent illness|17|||
170362061|NCT01392742|615660622|FG000|Overall Study|Protocol Violation|14|||
170362062|NCT01392742|615660622|FG000|Overall Study|Other|3|||
170362063|NCT01392742|615660622|FG000|Overall Study|Missing information|13|||
170362064|NCT03892707|615660625|FG000|Overall Study|Screen failure|6|||
170362065|NCT03892707|615660626|FG001|Overall Study|Screen failure|0|||
170362066|NCT03892707|615660625|FG000|Overall Study|Pain resolution|0|||
170362067|NCT03892707|615660626|FG001|Overall Study|Pain resolution|4|||
170362068|NCT03892707|615660625|FG000|Overall Study|Withdrawal by Subject|0|||
170362069|NCT03892707|615660626|FG001|Overall Study|Withdrawal by Subject|1|||
170362070|NCT03892707|615660625|FG000|Overall Study|Other (long business trip)|0|||
170362071|NCT03892707|615660626|FG001|Overall Study|Other (long business trip)|1|||
170362072|NCT04325906|615660627|FG000|Overall Study|Withdrawal by Subject|2|||
170362073|NCT04325906|615660628|FG001|Overall Study|Withdrawal by Subject|0|||
170362074|NCT02137837|615660629|FG000|Overall Study|Adverse Event|0|||
170362075|NCT02137837|615660630|FG001|Overall Study|Adverse Event|2|||
170362076|NCT02137837|615660631|FG002|Overall Study|Adverse Event|1|||
170362077|NCT02137837|615660629|FG000|Overall Study|Refusal unrelated to adverse event|2|||
170362078|NCT02137837|615660630|FG001|Overall Study|Refusal unrelated to adverse event|2|||
170362079|NCT02137837|615660631|FG002|Overall Study|Refusal unrelated to adverse event|1|||
170362080|NCT02137837|615660629|FG000|Overall Study|Progression/relapse|9|||
170362081|NCT02137837|615660630|FG001|Overall Study|Progression/relapse|7|||
170362082|NCT02137837|615660631|FG002|Overall Study|Progression/relapse|7|||
170362083|NCT02137837|615660629|FG000|Overall Study|Not protocol specified|2|||
170362084|NCT02137837|615660630|FG001|Overall Study|Not protocol specified|1|||
170362085|NCT02137837|615660631|FG002|Overall Study|Not protocol specified|3|||
170362086|NCT02141217|615660632|FG000|Overall Study|Adverse Event|1|||
170362087|NCT02141217|615660633|FG001|Overall Study|Adverse Event|2|||
170362088|NCT02141217|615660632|FG000|Overall Study|Protocol Violation|1|||
170362089|NCT02141217|615660633|FG001|Overall Study|Protocol Violation|4|||
170362090|NCT02141217|615660632|FG000|Overall Study|Withdrawal by Subject|6|||
170362091|NCT02141217|615660633|FG001|Overall Study|Withdrawal by Subject|0|||
170362092|NCT02141217|615660632|FG000|Overall Study|Lost to Follow-up|1|||
170362093|NCT02141217|615660633|FG001|Overall Study|Lost to Follow-up|1|||
170362094|NCT02141217|615660632|FG000|Overall Study|Physician Decision|1|||
170362095|NCT02141217|615660633|FG001|Overall Study|Physician Decision|0|||
170362096|NCT02141217|615660632|FG000|Overall Study|Surgical Intervention|1|||
170362097|NCT02141217|615660633|FG001|Overall Study|Surgical Intervention|1|||
170362098|NCT01181141|615660634|FG000|Overall Study|Adverse Event|2|||
170362099|NCT01181141|615660635|FG001|Overall Study|Adverse Event|1|||
170362100|NCT01181141|615660634|FG000|Overall Study|Lack of Efficacy|1|||
170362101|NCT01181141|615660635|FG001|Overall Study|Lack of Efficacy|0|||
170362102|NCT01181141|615660634|FG000|Overall Study|Lost to Follow-up|1|||
170362103|NCT01181141|615660635|FG001|Overall Study|Lost to Follow-up|1|||
170362104|NCT01181141|615660634|FG000|Overall Study|Physician Decision|2|||
170362105|NCT01181141|615660635|FG001|Overall Study|Physician Decision|0|||
170362106|NCT01181141|615660634|FG000|Overall Study|Protocol Violation|3|||
170362107|NCT01181141|615660635|FG001|Overall Study|Protocol Violation|1|||
170362108|NCT01181141|615660634|FG000|Overall Study|Withdrawal by Subject|3|||
170362109|NCT01181141|615660635|FG001|Overall Study|Withdrawal by Subject|1|||
170362110|NCT01628393|615660636|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
170362111|NCT01628393|615660637|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
170362112|NCT01628393|615660638|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
170362113|NCT01628393|615660639|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
170362114|NCT01628393|615660640|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
170362115|NCT01628393|615660636|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
170362116|NCT01628393|615660637|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
170362117|NCT01628393|615660638|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
170362118|NCT01628393|615660639|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
170362119|NCT01628393|615660640|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
170362120|NCT01628393|615660636|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
170362121|NCT01628393|615660637|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
170362122|NCT01628393|615660638|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
170362123|NCT01628393|615660639|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
170362124|NCT01628393|615660640|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
170362125|NCT01628393|615660636|FG000|Blinded Active Extension Period|Adverse Event|0|||
170362126|NCT01628393|615660637|FG001|Blinded Active Extension Period|Adverse Event|1|||
170362127|NCT01628393|615660638|FG002|Blinded Active Extension Period|Adverse Event|0|||
170362128|NCT01628393|615660639|FG003|Blinded Active Extension Period|Adverse Event|2|||
170362129|NCT01628393|615660640|FG004|Blinded Active Extension Period|Adverse Event|2|||
170362130|NCT01628393|615660636|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
170362131|NCT01628393|615660637|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
170362132|NCT01628393|615660638|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
170362133|NCT01628393|615660639|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
170362134|NCT01628393|615660640|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
170362135|NCT01628393|615660636|FG000|Blinded Active Extension Period|Physician Decision|0|||
170362136|NCT01628393|615660637|FG001|Blinded Active Extension Period|Physician Decision|3|||
170362137|NCT01628393|615660638|FG002|Blinded Active Extension Period|Physician Decision|0|||
170362138|NCT01628393|615660639|FG003|Blinded Active Extension Period|Physician Decision|1|||
170362139|NCT01628393|615660640|FG004|Blinded Active Extension Period|Physician Decision|0|||
170362140|NCT01628393|615660636|FG000|Blinded Active Extension Period|Protocol Violation|0|||
170362141|NCT01628393|615660637|FG001|Blinded Active Extension Period|Protocol Violation|0|||
170362142|NCT01628393|615660638|FG002|Blinded Active Extension Period|Protocol Violation|2|||
170362143|NCT01628393|615660639|FG003|Blinded Active Extension Period|Protocol Violation|1|||
170362144|NCT01628393|615660640|FG004|Blinded Active Extension Period|Protocol Violation|0|||
170362145|NCT01628393|615660636|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
170362146|NCT01628393|615660637|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
170362147|NCT01628393|615660638|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
170362148|NCT01628393|615660639|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
170362149|NCT01628393|615660640|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
170362150|NCT01329341|615660641|FG000|Overall Study|Withdrawal by Subject|44|||
170362151|NCT00290589|615660646|FG000|Overall Study|Lost to Follow-up|2|||
170362152|NCT00290589|615660647|FG001|Overall Study|Lost to Follow-up|2|||
170362153|NCT00118911|615660648|FG000|Overall Study|Withdrawal by Subject|2|||
170362154|NCT00118911|615660649|FG001|Overall Study|Withdrawal by Subject|5|||
170362155|NCT06000501|615660650|FG000|Overall Study|Screen failure|3|||
170362156|NCT06000501|615660650|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
170362157|NCT06000501|615660650|FG000|Overall Study|Physician Decision|4|||
170362158|NCT06000501|615660650|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
170362159|NCT06000501|615660650|FG000|Overall Study|Scheduling issues|2|||
170362160|NCT03496662|615660651|FG000|Overall Study|Adverse Event|0|||
170362161|NCT03496662|615660652|FG001|Overall Study|Adverse Event|0|||
170362162|NCT03496662|615660653|FG002|Overall Study|Adverse Event|4|||
170362163|NCT03496662|615660651|FG000|Overall Study|Withdrawal by Subject|1|||
170362164|NCT03496662|615660652|FG001|Overall Study|Withdrawal by Subject|0|||
170362165|NCT03496662|615660653|FG002|Overall Study|Withdrawal by Subject|2|||
170362166|NCT03496662|615660651|FG000|Overall Study|Death|0|||
170362167|NCT03496662|615660652|FG001|Overall Study|Death|0|||
170362168|NCT03496662|615660653|FG002|Overall Study|Death|2|||
170362169|NCT03496662|615660651|FG000|Overall Study|Noncompliance|0|||
170362170|NCT03496662|615660652|FG001|Overall Study|Noncompliance|0|||
170362171|NCT03496662|615660653|FG002|Overall Study|Noncompliance|1|||
170362172|NCT01467661|615660654|FG000|Overall Study|Adverse Event|16|||
170362173|NCT01467661|615660654|FG000|Overall Study|Withdrawal by Subject|1|||
170362174|NCT01467661|615660654|FG000|Overall Study|Lack of Efficacy|3|||
170362175|NCT01467661|615660654|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
170362176|NCT03814005|615660658|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
170362177|NCT03814005|615660659|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
170362178|NCT03814005|615660660|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
170362179|NCT03814005|615660658|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
170362180|NCT03814005|615660659|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
170362181|NCT03814005|615660660|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
170362182|NCT03814005|615660658|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
170362183|NCT03814005|615660659|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
170362184|NCT03814005|615660660|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
170362185|NCT03814005|615660658|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
170362186|NCT03814005|615660659|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
170362187|NCT03814005|615660660|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
170362188|NCT03814005|615660658|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
170362189|NCT03814005|615660659|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
170362190|NCT03814005|615660660|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
170362191|NCT03814005|615660658|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
170362192|NCT03814005|615660659|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
170362193|NCT03814005|615660660|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
170362194|NCT03395223|615660661|FG000|Overall Study|Lost to Follow-up|3|||
170362195|NCT03395223|615660661|FG000|Overall Study|Other|1|||
170362196|NCT01700985|615660662|FG000|Overall Study|Incarcerated|0|||
170362197|NCT01700985|615660663|FG001|Overall Study|Incarcerated|1|||
170362198|NCT00067470|615660664|FG000|Overall Study|Withdrawal by Subject|0|||
170362199|NCT00067470|615660665|FG001|Overall Study|Withdrawal by Subject|1|||
170362200|NCT00432562|615660667|FG000|Overall Study|Death|3|||
170362201|NCT00432562|615660668|FG001|Overall Study|Death|0|||
170362202|NCT00416312|615660670|FG000|Overall Study|tumors not visible on imaging|2|||
170362203|NCT01192204|615660676|FG000|Overall Study|could not keep recall appointments|1|||
170362204|NCT01192204|615660677|FG001|Overall Study|could not keep recall appointments|0|||
170362205|NCT02146248|615660678|FG000|Overall Study|Withdrawal by Subject|2|||
170362206|NCT02219087|615660680|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
170362207|NCT02219087|615660681|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
170362208|NCT05127421|615660682|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
170362209|NCT05127421|615660683|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
170362210|NCT05127421|615660684|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
170362211|NCT05127421|615660685|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
170362212|NCT05127421|615660682|FG000|4-Week Double-Blind Period|Physician Decision|1|||
170362213|NCT05127421|615660683|FG001|4-Week Double-Blind Period|Physician Decision|0|||
170362214|NCT05127421|615660684|FG002|4-Week Double-Blind Period|Physician Decision|0|||
170362215|NCT05127421|615660685|FG003|4-Week Double-Blind Period|Physician Decision|0|||
170362216|NCT05127421|615660682|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
170362217|NCT05127421|615660683|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
170362218|NCT05127421|615660684|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
170362219|NCT05127421|615660685|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
170362220|NCT05127421|615660682|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
170362221|NCT05127421|615660683|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
170362222|NCT05127421|615660684|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
170362223|NCT05127421|615660685|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
170362224|NCT05127421|615660682|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
170362225|NCT05127421|615660683|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
170362226|NCT05127421|615660684|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
170362227|NCT05127421|615660685|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
170362228|NCT05127421|615660682|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
170362229|NCT05127421|615660683|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
170362230|NCT05127421|615660684|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
170362231|NCT05127421|615660685|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
170362232|NCT05127421|615660682|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
170362233|NCT05127421|615660683|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
170362234|NCT05127421|615660684|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
170362235|NCT05127421|615660685|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
170362236|NCT05127421|615660682|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
170362237|NCT05127421|615660683|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
170362238|NCT05127421|615660684|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
170362239|NCT05127421|615660685|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
170362240|NCT00618449|615660686|FG000|Overall Study|Lost to Follow-up|98|||
170362241|NCT00618449|615660687|FG001|Overall Study|Lost to Follow-up|110|||
170362242|NCT04311177|615660688|FG000|Overall Study|Adverse Event|3|||
170362243|NCT04311177|615660689|FG001|Overall Study|Adverse Event|1|||
170362244|NCT04311177|615660688|FG000|Overall Study|Physician Decision|4|||
170362245|NCT04311177|615660689|FG001|Overall Study|Physician Decision|3|||
170362246|NCT04311177|615660688|FG000|Overall Study|Withdrawal by Subject|1|||
170362247|NCT04311177|615660689|FG001|Overall Study|Withdrawal by Subject|0|||
170362248|NCT01969799|615660690|FG000|Overall Study|Adverse Event|0|||
170362249|NCT01969799|615660691|FG001|Overall Study|Adverse Event|1|||
170362250|NCT01969799|615660690|FG000|Overall Study|Death|16|||
170362251|NCT01969799|615660691|FG001|Overall Study|Death|11|||
170362252|NCT01969799|615660690|FG000|Overall Study|Lost to Follow-up|0|||
170362253|NCT01969799|615660691|FG001|Overall Study|Lost to Follow-up|2|||
170362254|NCT01969799|615660690|FG000|Overall Study|Physician Decision|1|||
170362255|NCT01969799|615660691|FG001|Overall Study|Physician Decision|0|||
170362256|NCT02431468|615660692|FG000|Overall Study|Adverse Event|2|||
170362257|NCT02431468|615660693|FG001|Overall Study|Adverse Event|4|||
170362258|NCT02431468|615660694|FG002|Overall Study|Adverse Event|5|||
170362259|NCT02431468|615660692|FG000|Overall Study|Withdrawal by Subject|4|||
170362260|NCT02431468|615660693|FG001|Overall Study|Withdrawal by Subject|12|||
170362261|NCT02431468|615660694|FG002|Overall Study|Withdrawal by Subject|2|||
170362262|NCT02431468|615660692|FG000|Overall Study|noncompliance, investigator termination,|2|||
170362263|NCT02431468|615660693|FG001|Overall Study|noncompliance, investigator termination,|2|||
170362264|NCT02431468|615660694|FG002|Overall Study|noncompliance, investigator termination,|2|||
170362265|NCT03101514|615660695|FG000|Overall Study|Withdrawal by Subject|4|||
170362266|NCT03101514|615660695|FG000|Overall Study|Protocol Violation|2|||
170362267|NCT03101514|615660695|FG000|Overall Study|patient's information was incomplete|1|||
170362268|NCT01374217|615660696|FG000|Overall Study|Lack of Efficacy|13|||
170362269|NCT02555657|615660699|FG000|Overall Study|Death|274|||
170362270|NCT02555657|615660700|FG001|Overall Study|Death|262|||
170362271|NCT02555657|615660699|FG000|Overall Study|Physician Decision|0|||
170362272|NCT02555657|615660700|FG001|Overall Study|Physician Decision|1|||
170362273|NCT02555657|615660699|FG000|Overall Study|Sponsor Decision|27|||
170362274|NCT02555657|615660700|FG001|Overall Study|Sponsor Decision|15|||
170362275|NCT02555657|615660699|FG000|Overall Study|Withdrawal by Subject|11|||
170362276|NCT02555657|615660700|FG001|Overall Study|Withdrawal by Subject|32|||
170362277|NCT00192036|615660703|FG000|Overall Study|Protocol Violation|3|||
170362278|NCT00192036|615660703|FG000|Overall Study|Adverse Event|6|||
170362279|NCT00192036|615660703|FG000|Overall Study|Patient/Physician Perception|1|||
170362280|NCT00192036|615660703|FG000|Overall Study|Objective Tumor Progression|4|||
170362281|NCT00192036|615660703|FG000|Overall Study|Clinical Disease Progression|1|||
170362282|NCT00192036|615660703|FG000|Overall Study|Death|1|||
170362283|NCT00192036|615660703|FG000|Overall Study|Unknown or Not Specified|5|||
170362284|NCT03371732|615660704|FG000|Overall Study|Withdrawal by Subject|9|||
170362285|NCT03371732|615660705|FG001|Overall Study|Withdrawal by Subject|3|||
170362286|NCT03371732|615660704|FG000|Overall Study|Refusal to continue|3|||
170362287|NCT03371732|615660705|FG001|Overall Study|Refusal to continue|4|||
170362288|NCT01669811|615660710|FG000|Overall Study|Investigator decision|0|||
170362289|NCT01669811|615660711|FG001|Overall Study|Investigator decision|1|||
170362290|NCT01669811|615660710|FG000|Overall Study|Withdrawal by Subject|1|||
170362291|NCT01669811|615660711|FG001|Overall Study|Withdrawal by Subject|2|||
170362292|NCT01669811|615660710|FG000|Overall Study|Adverse Event|2|||
170362293|NCT01669811|615660711|FG001|Overall Study|Adverse Event|6|||
170362294|NCT01669811|615660710|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
170362295|NCT01669811|615660711|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
170362296|NCT03862131|615660714|FG000|Overall Study|Lost to Follow-up|1|||
170362297|NCT03862131|615660715|FG001|Overall Study|Lost to Follow-up|0|||
170362298|NCT03862131|615660716|FG002|Overall Study|Lost to Follow-up|1|||
170362299|NCT03862131|615660714|FG000|Overall Study|Determined to be ineligible|0|||
170362300|NCT03862131|615660715|FG001|Overall Study|Determined to be ineligible|0|||
170362301|NCT03862131|615660716|FG002|Overall Study|Determined to be ineligible|5|||
170362302|NCT03862131|615660714|FG000|Overall Study|Death|4|||
170362303|NCT03862131|615660715|FG001|Overall Study|Death|4|||
170362304|NCT03862131|615660716|FG002|Overall Study|Death|0|||
170362305|NCT03862131|615660714|FG000|Overall Study|Withdrawal by Subject|5|||
170362306|NCT03862131|615660715|FG001|Overall Study|Withdrawal by Subject|3|||
170362307|NCT03862131|615660716|FG002|Overall Study|Withdrawal by Subject|0|||
170362308|NCT03862131|615660714|FG000|Overall Study|Physician Decision|0|||
170362309|NCT03862131|615660715|FG001|Overall Study|Physician Decision|1|||
170362310|NCT03862131|615660716|FG002|Overall Study|Physician Decision|0|||
170362311|NCT05406440|615662722|FG000|Overall Study|Lost to Follow-up|0|||
170362312|NCT05406440|615662723|FG001|Overall Study|Lost to Follow-up|0|||
170362313|NCT05406440|615662724|FG002|Overall Study|Lost to Follow-up|0|||
170362314|NCT05406440|615662725|FG003|Overall Study|Lost to Follow-up|0|||
170362315|NCT05406440|615662726|FG004|Overall Study|Lost to Follow-up|2|||
170362316|NCT05406440|615662727|FG005|Overall Study|Lost to Follow-up|0|||
170362317|NCT05406440|615662728|FG006|Overall Study|Lost to Follow-up|0|||
170362318|NCT05406440|615662722|FG000|Overall Study|Physician Decision|0|||
170362319|NCT05406440|615662723|FG001|Overall Study|Physician Decision|0|||
170362320|NCT05406440|615662724|FG002|Overall Study|Physician Decision|0|||
170362321|NCT05406440|615662725|FG003|Overall Study|Physician Decision|0|||
170362322|NCT05406440|615662726|FG004|Overall Study|Physician Decision|1|||
170362323|NCT05406440|615662727|FG005|Overall Study|Physician Decision|0|||
170362324|NCT05406440|615662728|FG006|Overall Study|Physician Decision|0|||
170362325|NCT05406440|615662722|FG000|Overall Study|Withdrawal by Subject|0|||
170362326|NCT05406440|615662723|FG001|Overall Study|Withdrawal by Subject|0|||
170362327|NCT05406440|615662724|FG002|Overall Study|Withdrawal by Subject|0|||
170362328|NCT05406440|615662725|FG003|Overall Study|Withdrawal by Subject|0|||
170362329|NCT05406440|615662726|FG004|Overall Study|Withdrawal by Subject|0|||
170362330|NCT05406440|615662727|FG005|Overall Study|Withdrawal by Subject|2|||
170362331|NCT05406440|615662728|FG006|Overall Study|Withdrawal by Subject|0|||
170362332|NCT04432376|615662734|FG000|Double-blind Treatment Period|Adverse Event|2|||
170362333|NCT04432376|615662735|FG001|Double-blind Treatment Period|Adverse Event|6|||
170362334|NCT04432376|615662736|FG002|Double-blind Treatment Period|Adverse Event|0|||
170362335|NCT04432376|615662734|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
170362336|NCT04432376|615662735|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
170362337|NCT04432376|615662736|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
170362338|NCT04432376|615662734|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
170362339|NCT04432376|615662735|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
170362340|NCT04432376|615662736|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170362341|NCT04432376|615662734|FG000|Double-blind Treatment Period|Protocol Violation|0|||
170362342|NCT04432376|615662735|FG001|Double-blind Treatment Period|Protocol Violation|1|||
170362343|NCT04432376|615662736|FG002|Double-blind Treatment Period|Protocol Violation|0|||
170362344|NCT04432376|615662734|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
170362345|NCT04432376|615662735|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
170362346|NCT04432376|615662736|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
170362347|NCT02150213|615662737|FG000|Overall Study|Lost to Follow-up|1|||
170362348|NCT02150213|615662737|FG000|Overall Study|Withdrawal by Subject|1|||
170362349|NCT03488238|615662738|FG000|Overall Study|Equipment malfunction|1|||
170362350|NCT03488238|615662738|FG000|Overall Study|Adverse Event|1|||
170362351|NCT00379236|615662741|FG000|Double-blind|Adverse Event|11|||
170362352|NCT00379236|615662742|FG001|Double-blind|Adverse Event|6|||
170362353|NCT00379236|615662743|FG002|Double-blind|Adverse Event|0|||
170362354|NCT00379236|615662741|FG000|Double-blind|Protocol Violation|3|||
170362355|NCT00379236|615662742|FG001|Double-blind|Protocol Violation|3|||
170362356|NCT00379236|615662743|FG002|Double-blind|Protocol Violation|0|||
170362357|NCT00379236|615662741|FG000|Double-blind|Withdrawal by Subject|12|||
170362358|NCT00379236|615662742|FG001|Double-blind|Withdrawal by Subject|13|||
170362359|NCT00379236|615662743|FG002|Double-blind|Withdrawal by Subject|0|||
170362360|NCT00379236|615662741|FG000|Double-blind|Lost to Follow-up|4|||
170362361|NCT00379236|615662742|FG001|Double-blind|Lost to Follow-up|3|||
170362362|NCT00379236|615662743|FG002|Double-blind|Lost to Follow-up|0|||
170362363|NCT00379236|615662741|FG000|Double-blind|Use of exclusionary medication|1|||
170362364|NCT00379236|615662742|FG001|Double-blind|Use of exclusionary medication|2|||
170362365|NCT00379236|615662743|FG002|Double-blind|Use of exclusionary medication|0|||
170362366|NCT00379236|615662741|FG000|Double-blind|Other|3|||
170362367|NCT00379236|615662742|FG001|Double-blind|Other|7|||
170362368|NCT00379236|615662743|FG002|Double-blind|Other|0|||
170362369|NCT00379236|615662741|FG000|Double-blind|Data could not be retrieved|2|||
170362370|NCT00379236|615662742|FG001|Double-blind|Data could not be retrieved|2|||
170362371|NCT00379236|615662743|FG002|Double-blind|Data could not be retrieved|0|||
170362372|NCT00379236|615662741|FG000|Open-label Extension|Adverse Event|0|||
170362373|NCT00379236|615662742|FG001|Open-label Extension|Adverse Event|0|||
170362374|NCT00379236|615662743|FG002|Open-label Extension|Adverse Event|13|||
170362375|NCT00379236|615662741|FG000|Open-label Extension|Protocol Violation|0|||
170362376|NCT00379236|615662742|FG001|Open-label Extension|Protocol Violation|0|||
170362377|NCT00379236|615662743|FG002|Open-label Extension|Protocol Violation|7|||
170362378|NCT00379236|615662741|FG000|Open-label Extension|Withdrawal by Subject|0|||
170362379|NCT00379236|615662742|FG001|Open-label Extension|Withdrawal by Subject|0|||
170362380|NCT00379236|615662743|FG002|Open-label Extension|Withdrawal by Subject|13|||
170362381|NCT00379236|615662741|FG000|Open-label Extension|Lost to Follow-up|0|||
170362382|NCT00379236|615662742|FG001|Open-label Extension|Lost to Follow-up|0|||
170362383|NCT00379236|615662743|FG002|Open-label Extension|Lost to Follow-up|12|||
170362384|NCT00379236|615662741|FG000|Open-label Extension|Use of exclusionary medication|0|||
170362385|NCT00379236|615662742|FG001|Open-label Extension|Use of exclusionary medication|0|||
170362386|NCT00379236|615662743|FG002|Open-label Extension|Use of exclusionary medication|3|||
170362387|NCT00379236|615662741|FG000|Open-label Extension|Other|0|||
170362388|NCT00379236|615662742|FG001|Open-label Extension|Other|0|||
170362389|NCT00379236|615662743|FG002|Open-label Extension|Other|7|||
170362390|NCT00948194|615662745|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
170362391|NCT00948194|615662746|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
170362392|NCT02431793|615662747|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
170362393|NCT02431793|615662748|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
170362394|NCT02431793|615662749|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
170362395|NCT02431793|615662747|FG000|Overall Study|Withdrawal by Subject|7|||
170362396|NCT02431793|615662748|FG001|Overall Study|Withdrawal by Subject|5|||
170362397|NCT02431793|615662749|FG002|Overall Study|Withdrawal by Subject|5|||
170362398|NCT02431793|615662747|FG000|Overall Study|Lost to Follow-up|101|||
170362399|NCT02431793|615662748|FG001|Overall Study|Lost to Follow-up|122|||
170362400|NCT02431793|615662749|FG002|Overall Study|Lost to Follow-up|104|||
170362401|NCT00801892|615662753|FG000|Main Study Period|Withdrawal by Subject|0|||
170362402|NCT00801892|615662754|FG001|Main Study Period|Withdrawal by Subject|1|||
170362403|NCT00801892|615662753|FG000|Sham Crossover Period|Lost to Follow-up|0|||
170362404|NCT00801892|615662754|FG001|Sham Crossover Period|Lost to Follow-up|2|||
170362405|NCT01563107|615662759|FG000|Overall Study|Physician Decision|0|||
170362406|NCT01563107|615662760|FG001|Overall Study|Physician Decision|1|||
170362407|NCT01563107|615662761|FG002|Overall Study|Physician Decision|1|||
170362408|NCT01563107|615662762|FG003|Overall Study|Physician Decision|3|||
170362409|NCT01563107|615662759|FG000|Overall Study|Withdrawal by Subject|1|||
170362410|NCT01563107|615662760|FG001|Overall Study|Withdrawal by Subject|2|||
170362411|NCT01563107|615662761|FG002|Overall Study|Withdrawal by Subject|1|||
170362412|NCT01563107|615662762|FG003|Overall Study|Withdrawal by Subject|2|||
170362413|NCT05355818|615662763|FG000|Overall Study|Adverse Event|1|||
170362414|NCT05355818|615662764|FG001|Overall Study|Adverse Event|1|||
170362415|NCT05355818|615662763|FG000|Overall Study|Lack of Efficacy|2|||
170362416|NCT05355818|615662764|FG001|Overall Study|Lack of Efficacy|1|||
170362417|NCT05355818|615662763|FG000|Overall Study|Lost to Follow-up|0|||
170362418|NCT05355818|615662764|FG001|Overall Study|Lost to Follow-up|1|||
170362419|NCT02707601|615662765|FG000|Overall Study|Death|0|||
170362420|NCT02707601|615662766|FG001|Overall Study|Death|1|||
170362421|NCT02707601|615662765|FG000|Overall Study|Lack of Efficacy|0|||
170362422|NCT02707601|615662766|FG001|Overall Study|Lack of Efficacy|1|||
170362423|NCT02707601|615662765|FG000|Overall Study|Investigator's Discretion|1|||
170362424|NCT02707601|615662766|FG001|Overall Study|Investigator's Discretion|0|||
170362425|NCT02707601|615662765|FG000|Overall Study|Withdrew Consent|0|||
170362426|NCT02707601|615662766|FG001|Overall Study|Withdrew Consent|1|||
170362427|NCT02707601|615662765|FG000|Overall Study|Lost to Follow-up|1|||
170362428|NCT02707601|615662766|FG001|Overall Study|Lost to Follow-up|1|||
170362429|NCT02707601|615662765|FG000|Overall Study|Participants Randomized but Not Treated|2|||
170362430|NCT02707601|615662766|FG001|Overall Study|Participants Randomized but Not Treated|0|||
170362431|NCT03351478|615662769|FG000|Overall Study|At the subject's own request|11|||
170362432|NCT03351478|615662770|FG001|Overall Study|At the subject's own request|12|||
170362433|NCT03351478|615662771|FG002|Overall Study|At the subject's own request|5|||
170362434|NCT03351478|615662769|FG000|Overall Study|Adverse Event|1|||
170362435|NCT03351478|615662770|FG001|Overall Study|Adverse Event|2|||
170362436|NCT03351478|615662771|FG002|Overall Study|Adverse Event|1|||
170362437|NCT03351478|615662769|FG000|Overall Study|Poor compliance to protocol|1|||
170362438|NCT03351478|615662770|FG001|Overall Study|Poor compliance to protocol|0|||
170362439|NCT03351478|615662771|FG002|Overall Study|Poor compliance to protocol|0|||
170362440|NCT03351478|615662769|FG000|Overall Study|Reason not Specified|1|||
170362441|NCT03351478|615662770|FG001|Overall Study|Reason not Specified|3|||
170362442|NCT03351478|615662771|FG002|Overall Study|Reason not Specified|0|||
170362443|NCT03351478|615662769|FG000|Overall Study|Lost to Follow-up|0|||
170362444|NCT03351478|615662770|FG001|Overall Study|Lost to Follow-up|0|||
170362445|NCT03351478|615662771|FG002|Overall Study|Lost to Follow-up|1|||
170362446|NCT03004976|615662773|FG000|Overall Study|Lost to Follow-up|7|||
170362447|NCT03004976|615662774|FG001|Overall Study|Lost to Follow-up|5|||
170362448|NCT03004976|615662773|FG000|Overall Study|Physician Decision|1|||
170362449|NCT03004976|615662774|FG001|Overall Study|Physician Decision|0|||
170362450|NCT03004976|615662773|FG000|Overall Study|Withdrawal by Subject|1|||
170362451|NCT03004976|615662774|FG001|Overall Study|Withdrawal by Subject|0|||
170362452|NCT03004976|615662773|FG000|Overall Study|Death|4|||
170362453|NCT03004976|615662774|FG001|Overall Study|Death|1|||
170362454|NCT04897594|615662776|FG000|Overall Study|Lost to Follow-up|0|||
170362455|NCT04897594|615662777|FG001|Overall Study|Lost to Follow-up|1|||
170362456|NCT04897594|615662778|FG002|Overall Study|Lost to Follow-up|1|||
170362457|NCT04897594|615662776|FG000|Overall Study|Sponsor Decision|0|||
170362458|NCT04897594|615662777|FG001|Overall Study|Sponsor Decision|0|||
170362459|NCT04897594|615662778|FG002|Overall Study|Sponsor Decision|1|||
170362460|NCT04897594|615662776|FG000|Overall Study|Withdrawal by Subject|1|||
170362461|NCT04897594|615662777|FG001|Overall Study|Withdrawal by Subject|0|||
170362462|NCT04897594|615662778|FG002|Overall Study|Withdrawal by Subject|1|||
170362463|NCT00150345|615662781|FG000|Overall Study|Death|5|||
170362464|NCT00150345|615662782|FG001|Overall Study|Death|2|||
170362465|NCT00150345|615662781|FG000|Overall Study|Adverse Event|8|||
170362466|NCT00150345|615662782|FG001|Overall Study|Adverse Event|6|||
170362467|NCT00150345|615662781|FG000|Overall Study|Lack of Efficacy|5|||
170362468|NCT00150345|615662782|FG001|Overall Study|Lack of Efficacy|4|||
170362469|NCT00150345|615662781|FG000|Overall Study|Withdrawal by Subject|3|||
170362470|NCT00150345|615662782|FG001|Overall Study|Withdrawal by Subject|4|||
170362471|NCT00150345|615662781|FG000|Overall Study|Laboratory abnormality|1|||
170362472|NCT00150345|615662782|FG001|Overall Study|Laboratory abnormality|2|||
170362473|NCT00150345|615662781|FG000|Overall Study|Other|12|||
170362474|NCT00150345|615662782|FG001|Overall Study|Other|14|||
170362475|NCT01998958|615662783|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362476|NCT01998958|615662784|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
170362477|NCT01998958|615662785|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362478|NCT01998958|615662786|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362479|NCT01998958|615662787|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362480|NCT01998958|615662788|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362481|NCT01998958|615662789|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362482|NCT01998958|615662790|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362483|NCT01998958|615662791|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362484|NCT01998958|615662792|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362485|NCT01998958|615662793|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362486|NCT01998958|615662794|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362487|NCT01998958|615662795|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362488|NCT01998958|615662796|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362489|NCT01998958|615662797|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362490|NCT01998958|615662798|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362491|NCT01998958|615662799|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362492|NCT01998958|615662800|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362493|NCT01998958|615662801|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362494|NCT01998958|615662802|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362495|NCT01998958|615662803|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362496|NCT01998958|615662804|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362497|NCT01998958|615662805|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362498|NCT01998958|615662806|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362499|NCT01998958|615662807|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362500|NCT01998958|615662808|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362501|NCT01998958|615662809|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362502|NCT01998958|615662810|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362503|NCT01998958|615662811|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362504|NCT01998958|615662812|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362505|NCT01998958|615662813|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362506|NCT01998958|615662814|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
170362507|NCT01998958|615662783|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362508|NCT01998958|615662784|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
170362509|NCT01998958|615662785|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362510|NCT01998958|615662786|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362511|NCT01998958|615662787|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362512|NCT01998958|615662788|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362513|NCT01998958|615662789|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362514|NCT01998958|615662790|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362515|NCT01998958|615662791|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362516|NCT01998958|615662792|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362517|NCT01998958|615662793|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362518|NCT01998958|615662794|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362519|NCT01998958|615662795|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362520|NCT01998958|615662796|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362521|NCT01998958|615662797|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362522|NCT01998958|615662798|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362523|NCT01998958|615662799|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362524|NCT01998958|615662800|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362525|NCT01998958|615662801|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362526|NCT01998958|615662802|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362527|NCT01998958|615662803|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362528|NCT01998958|615662804|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362529|NCT01998958|615662805|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362530|NCT01998958|615662806|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362531|NCT01998958|615662807|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362532|NCT01998958|615662808|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362533|NCT01998958|615662809|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362534|NCT01998958|615662810|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362535|NCT01998958|615662811|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362536|NCT01998958|615662812|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362537|NCT01998958|615662813|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362538|NCT01998958|615662814|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
170362539|NCT01998958|615662783|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
170362540|NCT01998958|615662784|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
170362541|NCT01998958|615662785|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
170362542|NCT01998958|615662786|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
170362543|NCT01998958|615662787|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
170362544|NCT01998958|615662788|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
170362545|NCT01998958|615662789|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
170362546|NCT01998958|615662790|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
170362547|NCT01998958|615662791|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
170362548|NCT01998958|615662792|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
170362549|NCT01998958|615662793|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
170362550|NCT01998958|615662794|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
170362551|NCT01998958|615662795|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
170362552|NCT01998958|615662796|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
170362553|NCT01998958|615662797|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
170362554|NCT01998958|615662798|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
170362555|NCT01998958|615662799|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
170362556|NCT01998958|615662800|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
170362557|NCT01998958|615662801|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
170362558|NCT01998958|615662802|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
170362559|NCT01998958|615662803|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
170362560|NCT01998958|615662804|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
170362561|NCT01998958|615662805|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
170362562|NCT01998958|615662806|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
170362563|NCT01998958|615662807|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
170362564|NCT01998958|615662808|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
170362565|NCT01998958|615662809|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
170362566|NCT01998958|615662810|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
170362567|NCT01998958|615662811|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
170362568|NCT01998958|615662812|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
170362569|NCT01998958|615662813|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
170362570|NCT01998958|615662814|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
170362571|NCT01998958|615662783|FG000|Period 1 (Panel A and B)|Other|1|||
170362572|NCT01998958|615662784|FG001|Period 1 (Panel A and B)|Other|0|||
170362573|NCT01998958|615662785|FG002|Period 1 (Panel A and B)|Other|0|||
170362574|NCT01998958|615662786|FG003|Period 1 (Panel A and B)|Other|0|||
170362575|NCT01998958|615662787|FG004|Period 1 (Panel A and B)|Other|0|||
170362576|NCT01998958|615662788|FG005|Period 1 (Panel A and B)|Other|0|||
170362577|NCT01998958|615662789|FG006|Period 1 (Panel A and B)|Other|0|||
170362578|NCT01998958|615662790|FG007|Period 1 (Panel A and B)|Other|0|||
170362579|NCT01998958|615662791|FG008|Period 1 (Panel A and B)|Other|0|||
170362580|NCT01998958|615662792|FG009|Period 1 (Panel A and B)|Other|0|||
170362581|NCT01998958|615662793|FG010|Period 1 (Panel A and B)|Other|0|||
170362582|NCT01998958|615662794|FG011|Period 1 (Panel A and B)|Other|0|||
170362583|NCT01998958|615662795|FG012|Period 1 (Panel A and B)|Other|0|||
170362584|NCT01998958|615662796|FG013|Period 1 (Panel A and B)|Other|0|||
170362585|NCT01998958|615662797|FG014|Period 1 (Panel A and B)|Other|0|||
170362586|NCT01998958|615662798|FG015|Period 1 (Panel A and B)|Other|0|||
170362587|NCT01998958|615662799|FG016|Period 1 (Panel A and B)|Other|0|||
170362588|NCT01998958|615662800|FG017|Period 1 (Panel A and B)|Other|0|||
170362589|NCT01998958|615662801|FG018|Period 1 (Panel A and B)|Other|0|||
170362590|NCT01998958|615662802|FG019|Period 1 (Panel A and B)|Other|0|||
170362591|NCT01998958|615662803|FG020|Period 1 (Panel A and B)|Other|0|||
170362592|NCT01998958|615662804|FG021|Period 1 (Panel A and B)|Other|0|||
170362593|NCT01998958|615662805|FG022|Period 1 (Panel A and B)|Other|0|||
170362594|NCT01998958|615662806|FG023|Period 1 (Panel A and B)|Other|0|||
170362595|NCT01998958|615662807|FG024|Period 1 (Panel A and B)|Other|0|||
170362596|NCT01998958|615662808|FG025|Period 1 (Panel A and B)|Other|0|||
170362597|NCT01998958|615662809|FG026|Period 1 (Panel A and B)|Other|0|||
170362598|NCT01998958|615662810|FG027|Period 1 (Panel A and B)|Other|0|||
170362599|NCT01998958|615662811|FG028|Period 1 (Panel A and B)|Other|0|||
170362600|NCT01998958|615662812|FG029|Period 1 (Panel A and B)|Other|0|||
170362601|NCT01998958|615662813|FG030|Period 1 (Panel A and B)|Other|0|||
170362602|NCT01998958|615662814|FG031|Period 1 (Panel A and B)|Other|0|||
170362603|NCT01998958|615662783|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
170362604|NCT01998958|615662784|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
170362605|NCT01998958|615662785|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
170362606|NCT01998958|615662786|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
170362607|NCT01998958|615662787|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
170362608|NCT01998958|615662788|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
170362609|NCT01998958|615662789|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
170362610|NCT01998958|615662790|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
170362611|NCT01998958|615662791|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
170362612|NCT01998958|615662792|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
170362613|NCT01998958|615662793|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
170362614|NCT01998958|615662794|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
170362615|NCT01998958|615662795|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
170362616|NCT01998958|615662796|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
170362617|NCT01998958|615662797|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
170362618|NCT01998958|615662798|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
170362619|NCT01998958|615662799|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
170362620|NCT01998958|615662800|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
170362621|NCT01998958|615662801|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
170362622|NCT01998958|615662802|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
170362623|NCT01998958|615662803|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
170362624|NCT01998958|615662804|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
170362625|NCT01998958|615662805|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
170362626|NCT01998958|615662806|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
170362627|NCT01998958|615662807|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
170362628|NCT01998958|615662808|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
170362629|NCT01998958|615662809|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
170362630|NCT01998958|615662810|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
170362631|NCT01998958|615662811|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
170362632|NCT01998958|615662812|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
170362633|NCT01998958|615662813|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
170362634|NCT01998958|615662814|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
170362635|NCT01998958|615662783|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362636|NCT01998958|615662784|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362637|NCT01998958|615662785|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362638|NCT01998958|615662786|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362639|NCT01998958|615662787|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362640|NCT01998958|615662788|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362641|NCT01998958|615662789|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362642|NCT01998958|615662790|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362643|NCT01998958|615662791|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362644|NCT01998958|615662792|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362645|NCT01998958|615662793|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362646|NCT01998958|615662794|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362647|NCT01998958|615662795|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362648|NCT01998958|615662796|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362649|NCT01998958|615662797|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
170362650|NCT01998958|615662798|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362651|NCT01998958|615662799|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362652|NCT01998958|615662800|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362653|NCT01998958|615662801|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
170362654|NCT01998958|615662802|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362655|NCT01998958|615662803|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362656|NCT01998958|615662804|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362657|NCT01998958|615662805|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362658|NCT01998958|615662806|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362659|NCT01998958|615662807|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362660|NCT01998958|615662808|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362661|NCT01998958|615662809|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362662|NCT01998958|615662810|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362663|NCT01998958|615662811|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362664|NCT01998958|615662812|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362665|NCT01998958|615662813|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362666|NCT01998958|615662814|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
170362667|NCT01998958|615662783|FG000|Open Label Phase (Optional)|Adverse Event|0|||
170362668|NCT01998958|615662784|FG001|Open Label Phase (Optional)|Adverse Event|0|||
170362669|NCT01998958|615662785|FG002|Open Label Phase (Optional)|Adverse Event|0|||
170362670|NCT01998958|615662786|FG003|Open Label Phase (Optional)|Adverse Event|0|||
170362671|NCT01998958|615662787|FG004|Open Label Phase (Optional)|Adverse Event|0|||
170362672|NCT01998958|615662788|FG005|Open Label Phase (Optional)|Adverse Event|0|||
170362673|NCT01998958|615662789|FG006|Open Label Phase (Optional)|Adverse Event|0|||
170362674|NCT01998958|615662790|FG007|Open Label Phase (Optional)|Adverse Event|0|||
170362675|NCT01998958|615662791|FG008|Open Label Phase (Optional)|Adverse Event|0|||
170362676|NCT01998958|615662792|FG009|Open Label Phase (Optional)|Adverse Event|0|||
170362677|NCT01998958|615662793|FG010|Open Label Phase (Optional)|Adverse Event|0|||
170362678|NCT01998958|615662794|FG011|Open Label Phase (Optional)|Adverse Event|0|||
170362679|NCT01998958|615662795|FG012|Open Label Phase (Optional)|Adverse Event|0|||
170362680|NCT01998958|615662796|FG013|Open Label Phase (Optional)|Adverse Event|0|||
170362681|NCT01998958|615662797|FG014|Open Label Phase (Optional)|Adverse Event|0|||
170362682|NCT01998958|615662798|FG015|Open Label Phase (Optional)|Adverse Event|0|||
170362683|NCT01998958|615662799|FG016|Open Label Phase (Optional)|Adverse Event|0|||
170362684|NCT01998958|615662800|FG017|Open Label Phase (Optional)|Adverse Event|0|||
170362685|NCT01998958|615662801|FG018|Open Label Phase (Optional)|Adverse Event|0|||
170362686|NCT01998958|615662802|FG019|Open Label Phase (Optional)|Adverse Event|0|||
170362687|NCT01998958|615662803|FG020|Open Label Phase (Optional)|Adverse Event|0|||
170362688|NCT01998958|615662804|FG021|Open Label Phase (Optional)|Adverse Event|0|||
170362689|NCT01998958|615662805|FG022|Open Label Phase (Optional)|Adverse Event|0|||
170362690|NCT01998958|615662806|FG023|Open Label Phase (Optional)|Adverse Event|1|||
170362691|NCT01998958|615662807|FG024|Open Label Phase (Optional)|Adverse Event|0|||
170362692|NCT01998958|615662808|FG025|Open Label Phase (Optional)|Adverse Event|0|||
170362693|NCT01998958|615662809|FG026|Open Label Phase (Optional)|Adverse Event|0|||
170362694|NCT01998958|615662810|FG027|Open Label Phase (Optional)|Adverse Event|0|||
170362695|NCT01998958|615662811|FG028|Open Label Phase (Optional)|Adverse Event|0|||
170362696|NCT01998958|615662812|FG029|Open Label Phase (Optional)|Adverse Event|0|||
170362697|NCT01998958|615662813|FG030|Open Label Phase (Optional)|Adverse Event|0|||
170362698|NCT01998958|615662814|FG031|Open Label Phase (Optional)|Adverse Event|0|||
170362699|NCT01998958|615662783|FG000|Open Label Phase (Optional)|Other|0|||
170362700|NCT01998958|615662784|FG001|Open Label Phase (Optional)|Other|0|||
170362701|NCT01998958|615662785|FG002|Open Label Phase (Optional)|Other|0|||
170362702|NCT01998958|615662786|FG003|Open Label Phase (Optional)|Other|0|||
170362703|NCT01998958|615662787|FG004|Open Label Phase (Optional)|Other|0|||
170362704|NCT01998958|615662788|FG005|Open Label Phase (Optional)|Other|0|||
170362705|NCT01998958|615662789|FG006|Open Label Phase (Optional)|Other|0|||
170362706|NCT01998958|615662790|FG007|Open Label Phase (Optional)|Other|0|||
170362707|NCT01998958|615662791|FG008|Open Label Phase (Optional)|Other|0|||
170362708|NCT01998958|615662792|FG009|Open Label Phase (Optional)|Other|0|||
170362709|NCT01998958|615662793|FG010|Open Label Phase (Optional)|Other|0|||
170362710|NCT01998958|615662794|FG011|Open Label Phase (Optional)|Other|0|||
170362711|NCT01998958|615662795|FG012|Open Label Phase (Optional)|Other|0|||
170362712|NCT01998958|615662796|FG013|Open Label Phase (Optional)|Other|0|||
170362713|NCT01998958|615662797|FG014|Open Label Phase (Optional)|Other|0|||
170362714|NCT01998958|615662798|FG015|Open Label Phase (Optional)|Other|0|||
170362715|NCT01998958|615662799|FG016|Open Label Phase (Optional)|Other|0|||
170362716|NCT01998958|615662800|FG017|Open Label Phase (Optional)|Other|0|||
170362717|NCT01998958|615662801|FG018|Open Label Phase (Optional)|Other|0|||
170362718|NCT01998958|615662802|FG019|Open Label Phase (Optional)|Other|0|||
170362719|NCT01998958|615662803|FG020|Open Label Phase (Optional)|Other|0|||
170362720|NCT01998958|615662804|FG021|Open Label Phase (Optional)|Other|0|||
170362721|NCT01998958|615662805|FG022|Open Label Phase (Optional)|Other|5|||
170362722|NCT01998958|615662806|FG023|Open Label Phase (Optional)|Other|1|||
170362723|NCT01998958|615662807|FG024|Open Label Phase (Optional)|Other|0|||
170362724|NCT01998958|615662808|FG025|Open Label Phase (Optional)|Other|0|||
170362725|NCT01998958|615662809|FG026|Open Label Phase (Optional)|Other|0|||
170362726|NCT01998958|615662810|FG027|Open Label Phase (Optional)|Other|0|||
170362727|NCT01998958|615662811|FG028|Open Label Phase (Optional)|Other|0|||
170362728|NCT01998958|615662812|FG029|Open Label Phase (Optional)|Other|0|||
170362729|NCT01998958|615662813|FG030|Open Label Phase (Optional)|Other|0|||
170362730|NCT01998958|615662814|FG031|Open Label Phase (Optional)|Other|0|||
170362731|NCT01998958|615662783|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362732|NCT01998958|615662784|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362733|NCT01998958|615662785|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362734|NCT01998958|615662786|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362735|NCT01998958|615662787|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362736|NCT01998958|615662788|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362737|NCT01998958|615662789|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362738|NCT01998958|615662790|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362739|NCT01998958|615662791|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362740|NCT01998958|615662792|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362741|NCT01998958|615662793|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362742|NCT01998958|615662794|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362743|NCT01998958|615662795|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362744|NCT01998958|615662796|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362745|NCT01998958|615662797|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362746|NCT01998958|615662798|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362747|NCT01998958|615662799|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362748|NCT01998958|615662800|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362749|NCT01998958|615662801|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362750|NCT01998958|615662802|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362751|NCT01998958|615662803|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362752|NCT01998958|615662804|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362753|NCT01998958|615662805|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
170362754|NCT01998958|615662806|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362755|NCT01998958|615662807|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362756|NCT01998958|615662808|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362757|NCT01998958|615662809|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362758|NCT01998958|615662810|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362759|NCT01998958|615662811|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362760|NCT01998958|615662812|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362761|NCT01998958|615662813|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362762|NCT01998958|615662814|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
170362763|NCT01998958|615662783|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362764|NCT01998958|615662784|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362765|NCT01998958|615662785|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362766|NCT01998958|615662786|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362767|NCT01998958|615662787|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362768|NCT01998958|615662788|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362769|NCT01998958|615662789|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362770|NCT01998958|615662790|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362771|NCT01998958|615662791|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362772|NCT01998958|615662792|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362773|NCT01998958|615662793|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362774|NCT01998958|615662794|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362775|NCT01998958|615662795|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362776|NCT01998958|615662796|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362777|NCT01998958|615662797|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362778|NCT01998958|615662798|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362779|NCT01998958|615662799|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362780|NCT01998958|615662800|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362781|NCT01998958|615662801|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362782|NCT01998958|615662802|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362783|NCT01998958|615662803|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362784|NCT01998958|615662804|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
170362785|NCT01998958|615662805|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
170362786|NCT01998958|615662806|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362787|NCT01998958|615662807|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362788|NCT01998958|615662808|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362789|NCT01998958|615662809|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362790|NCT01998958|615662810|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362791|NCT01998958|615662811|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362792|NCT01998958|615662812|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362793|NCT01998958|615662813|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362794|NCT01998958|615662814|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
170362795|NCT01998958|615662783|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362796|NCT01998958|615662784|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362797|NCT01998958|615662785|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362798|NCT01998958|615662786|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362799|NCT01998958|615662787|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362800|NCT01998958|615662788|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362801|NCT01998958|615662789|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362802|NCT01998958|615662790|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362803|NCT01998958|615662791|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362804|NCT01998958|615662792|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362805|NCT01998958|615662793|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362806|NCT01998958|615662794|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362807|NCT01998958|615662795|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362808|NCT01998958|615662796|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362809|NCT01998958|615662797|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362810|NCT01998958|615662798|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362811|NCT01998958|615662799|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362812|NCT01998958|615662800|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362813|NCT01998958|615662801|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362814|NCT01998958|615662802|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362815|NCT01998958|615662803|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362816|NCT01998958|615662804|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
170362817|NCT01998958|615662805|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
170362818|NCT01998958|615662806|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
170362819|NCT01998958|615662807|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362820|NCT01998958|615662808|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362821|NCT01998958|615662809|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362822|NCT01998958|615662810|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362823|NCT01998958|615662811|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362824|NCT01998958|615662812|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362825|NCT01998958|615662813|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362826|NCT01998958|615662814|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
170362827|NCT02432703|615662815|FG000|Overall Study|Adverse Event|1|||
170362828|NCT02432703|615662816|FG001|Overall Study|Adverse Event|4|||
170362829|NCT02432703|615662815|FG000|Overall Study|Lack of Efficacy|1|||
170362830|NCT02432703|615662816|FG001|Overall Study|Lack of Efficacy|0|||
170362831|NCT02432703|615662815|FG000|Overall Study|Lost to Follow-up|5|||
170362832|NCT02432703|615662816|FG001|Overall Study|Lost to Follow-up|3|||
170362833|NCT02432703|615662815|FG000|Overall Study|Withdrawal by Subject|9|||
170362834|NCT02432703|615662816|FG001|Overall Study|Withdrawal by Subject|6|||
170362835|NCT02432703|615662815|FG000|Overall Study|Other|6|||
170362836|NCT02432703|615662816|FG001|Overall Study|Other|5|||
170362837|NCT01665768|615662820|FG000|Overall Study|Adverse Event|3|||
170362838|NCT01665768|615662820|FG000|Overall Study|Lack of Efficacy|19|||
170362839|NCT01665768|615662820|FG000|Overall Study|Withdrawal by Subject|1|||
170362840|NCT00691093|615662821|FG000|Overall Study|Adverse Event|1|||
170362841|NCT00691093|615662821|FG000|Overall Study|Lost to Follow-up|1|||
170362842|NCT00691093|615662821|FG000|Overall Study|Lack of Efficacy|1|||
170362843|NCT00691093|615662821|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
170362844|NCT00810810|615662825|FG000|Overall Study|Withdrawal by Subject|0|||
170362845|NCT00810810|615662826|FG001|Overall Study|Withdrawal by Subject|8|||
170362846|NCT00810810|615662827|FG002|Overall Study|Withdrawal by Subject|10|||
170362847|NCT00810810|615662828|FG003|Overall Study|Withdrawal by Subject|8|||
170362848|NCT00810810|615662825|FG000|Overall Study|Physician Decision|0|||
170362849|NCT00810810|615662826|FG001|Overall Study|Physician Decision|3|||
170362850|NCT00810810|615662827|FG002|Overall Study|Physician Decision|1|||
170362851|NCT00810810|615662828|FG003|Overall Study|Physician Decision|5|||
170362852|NCT01896856|615662829|FG000|Overall Study|Transportation issues / Non-compliance|0|||
170362853|NCT01896856|615662830|FG001|Overall Study|Transportation issues / Non-compliance|0|||
170362854|NCT01896856|615662831|FG002|Overall Study|Transportation issues / Non-compliance|1|||
170362855|NCT01896856|615662832|FG003|Overall Study|Transportation issues / Non-compliance|0|||
170362856|NCT01896856|615662833|FG004|Overall Study|Transportation issues / Non-compliance|0|||
170362857|NCT01896856|615662834|FG005|Overall Study|Transportation issues / Non-compliance|0|||
170362858|NCT01156532|615662835|FG000|Overall Study|Family Reasons|1|||
170362859|NCT01156532|615662835|FG000|Overall Study|Lost to Follow-up|1|||
170362860|NCT00282867|615662841|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
170362861|NCT00282867|615662842|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
170362862|NCT00282867|615662843|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
170362863|NCT00965146|615662844|FG000|Overall Study|Death|7|||
170362864|NCT00965146|615662844|FG000|Overall Study|Lost to Follow-up|22|||
170362865|NCT00965146|615662844|FG000|Overall Study|Withdrawal by Subject|17|||
170362866|NCT00965146|615662844|FG000|Overall Study|Unable to return|1|||
170362867|NCT00965146|615662844|FG000|Overall Study|Unwilling to return|11|||
170362868|NCT00965146|615662844|FG000|Overall Study|Intercurrent illness|1|||
170362869|NCT00965146|615662844|FG000|Overall Study|Revision / Removal of Study Implant|6|||
170362870|NCT00965146|615662844|FG000|Overall Study|Overall Study Termination|145|||
170362871|NCT05067452|615662845|FG000|Overall Study|Lost to Follow-up|0|||
170362872|NCT05067452|615662846|FG001|Overall Study|Lost to Follow-up|4|||
170362873|NCT01135017|615662847|FG000|Overall Study|Adverse Event|3|||
170362874|NCT01135017|615662848|FG001|Overall Study|Adverse Event|8|||
170362875|NCT01135017|615662847|FG000|Overall Study|Other than above|3|||
170362876|NCT01135017|615662848|FG001|Overall Study|Other than above|4|||
170362877|NCT01342952|615662850|FG000|Overall Study|Adverse Event|0|||
170362878|NCT01342952|615662851|FG001|Overall Study|Adverse Event|5|||
170362879|NCT01342952|615662852|FG002|Overall Study|Adverse Event|1|||
170362880|NCT01342952|615662853|FG003|Overall Study|Adverse Event|0|||
170362881|NCT01342952|615662850|FG000|Overall Study|Lost to Follow-up|0|||
170362882|NCT01342952|615662851|FG001|Overall Study|Lost to Follow-up|2|||
170362883|NCT01342952|615662852|FG002|Overall Study|Lost to Follow-up|0|||
170362884|NCT01342952|615662853|FG003|Overall Study|Lost to Follow-up|0|||
170362885|NCT01342952|615662850|FG000|Overall Study|Withdrawal by Subject|1|||
170362886|NCT01342952|615662851|FG001|Overall Study|Withdrawal by Subject|1|||
170362887|NCT01342952|615662852|FG002|Overall Study|Withdrawal by Subject|0|||
170362888|NCT01342952|615662853|FG003|Overall Study|Withdrawal by Subject|0|||
170362889|NCT01342952|615662850|FG000|Overall Study|Physician Decision|3|||
170362890|NCT01342952|615662851|FG001|Overall Study|Physician Decision|3|||
170362891|NCT01342952|615662852|FG002|Overall Study|Physician Decision|1|||
170362892|NCT01342952|615662853|FG003|Overall Study|Physician Decision|0|||
170362893|NCT00426556|615662854|FG000|Phase I - Core Phase|Disease Progression|0|||
170362894|NCT00426556|615662855|FG001|Phase I - Core Phase|Disease Progression|6|||
170362895|NCT00426556|615662856|FG002|Phase I - Core Phase|Disease Progression|2|||
170362896|NCT00426556|615662857|FG003|Phase I - Core Phase|Disease Progression|0|||
170362897|NCT00426556|615662854|FG000|Phase I - Core Phase|Adverse Event|1|||
170362898|NCT00426556|615662855|FG001|Phase I - Core Phase|Adverse Event|3|||
170362899|NCT00426556|615662856|FG002|Phase I - Core Phase|Adverse Event|1|||
170362900|NCT00426556|615662857|FG003|Phase I - Core Phase|Adverse Event|0|||
170362901|NCT00426556|615662854|FG000|Phase I - Core Phase|Death|0|||
170362902|NCT00426556|615662855|FG001|Phase I - Core Phase|Death|1|||
170362903|NCT00426556|615662856|FG002|Phase I - Core Phase|Death|0|||
170362904|NCT00426556|615662857|FG003|Phase I - Core Phase|Death|0|||
170362905|NCT00426556|615662854|FG000|Phase I - Extension Phase|Adverse Event|0|||
170362906|NCT00426556|615662855|FG001|Phase I - Extension Phase|Adverse Event|1|||
170362907|NCT00426556|615662856|FG002|Phase I - Extension Phase|Adverse Event|1|||
170362908|NCT00426556|615662857|FG003|Phase I - Extension Phase|Adverse Event|0|||
170362909|NCT00426556|615662854|FG000|Phase I - Extension Phase|Disease Progression|5|||
170362910|NCT00426556|615662855|FG001|Phase I - Extension Phase|Disease Progression|5|||
170362911|NCT00426556|615662856|FG002|Phase I - Extension Phase|Disease Progression|6|||
170362912|NCT00426556|615662857|FG003|Phase I - Extension Phase|Disease Progression|0|||
170362913|NCT00426556|615662854|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
170362914|NCT00426556|615662855|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
170362915|NCT00426556|615662856|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
170362916|NCT00426556|615662857|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
170362917|NCT00426556|615662854|FG000|Phase II - Core Phase|Disease Progression|0|||
170362918|NCT00426556|615662855|FG001|Phase II - Core Phase|Disease Progression|0|||
170362919|NCT00426556|615662856|FG002|Phase II - Core Phase|Disease Progression|0|||
170362920|NCT00426556|615662857|FG003|Phase II - Core Phase|Disease Progression|16|||
170362921|NCT00426556|615662854|FG000|Phase II - Core Phase|Adverse Event|0|||
170362922|NCT00426556|615662855|FG001|Phase II - Core Phase|Adverse Event|0|||
170362923|NCT00426556|615662856|FG002|Phase II - Core Phase|Adverse Event|0|||
170362924|NCT00426556|615662857|FG003|Phase II - Core Phase|Adverse Event|8|||
170362925|NCT00426556|615662854|FG000|Phase II - Extension Phase|Disease Progression|0|||
170362926|NCT00426556|615662855|FG001|Phase II - Extension Phase|Disease Progression|0|||
170362927|NCT00426556|615662856|FG002|Phase II - Extension Phase|Disease Progression|0|||
170362928|NCT00426556|615662857|FG003|Phase II - Extension Phase|Disease Progression|21|||
170362929|NCT00426556|615662854|FG000|Phase II - Extension Phase|Adverse Event|0|||
170362930|NCT00426556|615662855|FG001|Phase II - Extension Phase|Adverse Event|0|||
170362931|NCT00426556|615662856|FG002|Phase II - Extension Phase|Adverse Event|0|||
170362932|NCT00426556|615662857|FG003|Phase II - Extension Phase|Adverse Event|2|||
170362933|NCT03970824|615662863|FG000|Overall Study|Withdrawal by Subject|1|||
170362934|NCT03970824|615662864|FG001|Overall Study|Withdrawal by Subject|1|||
170362935|NCT03970824|615662865|FG002|Overall Study|Withdrawal by Subject|3|||
170362936|NCT03970824|615662863|FG000|Overall Study|Lost to Follow-up|0|||
170362937|NCT03970824|615662864|FG001|Overall Study|Lost to Follow-up|2|||
170362938|NCT03970824|615662865|FG002|Overall Study|Lost to Follow-up|1|||
170362939|NCT03970824|615662863|FG000|Overall Study|Adverse Event|1|||
170362940|NCT03970824|615662864|FG001|Overall Study|Adverse Event|0|||
170362941|NCT03970824|615662865|FG002|Overall Study|Adverse Event|0|||
170362942|NCT00425100|615662868|FG000|Overall Study|Adverse Event|36|||
170362943|NCT00425100|615662868|FG000|Overall Study|Lack of Efficacy|4|||
170362944|NCT00425100|615662868|FG000|Overall Study|Lost to Follow-up|2|||
170362945|NCT00425100|615662868|FG000|Overall Study|Protocol Violation|4|||
170362946|NCT00425100|615662868|FG000|Overall Study|Withdrawal by Subject|7|||
170362947|NCT03699631|615662871|FG000|Overall Study|Adverse Event|3|||
170362948|NCT00964158|615662872|FG000|Overall Study|Lost to Follow-up|0|||
170362949|NCT00964158|615662873|FG001|Overall Study|Lost to Follow-up|1|||
170362950|NCT00964158|615662874|FG002|Overall Study|Lost to Follow-up|2|||
170362951|NCT00964158|615662872|FG000|Overall Study|Withdrawal by Subject|0|||
170362952|NCT00964158|615662873|FG001|Overall Study|Withdrawal by Subject|0|||
170362953|NCT00964158|615662874|FG002|Overall Study|Withdrawal by Subject|6|||
170362954|NCT00507416|615662875|FG000|Overall Study|Adverse Event|58|||
170362955|NCT00507416|615662876|FG001|Overall Study|Adverse Event|67|||
170362956|NCT00507416|615662877|FG002|Overall Study|Adverse Event|65|||
170362957|NCT00507416|615662875|FG000|Overall Study|Protocol Violation|1|||
170362958|NCT00507416|615662876|FG001|Overall Study|Protocol Violation|2|||
170362959|NCT00507416|615662877|FG002|Overall Study|Protocol Violation|0|||
170362960|NCT00507416|615662875|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
170362961|NCT00507416|615662876|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
170362962|NCT00507416|615662877|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
170362963|NCT00507416|615662875|FG000|Overall Study|Progressive Disease|20|||
170362964|NCT00507416|615662876|FG001|Overall Study|Progressive Disease|10|||
170362965|NCT00507416|615662877|FG002|Overall Study|Progressive Disease|13|||
170362966|NCT00507416|615662875|FG000|Overall Study|Patient declined further treatment|18|||
170362967|NCT00507416|615662876|FG001|Overall Study|Patient declined further treatment|14|||
170362968|NCT00507416|615662877|FG002|Overall Study|Patient declined further treatment|11|||
170362969|NCT00507416|615662875|FG000|Overall Study|Other|11|||
170362970|NCT00507416|615662876|FG001|Overall Study|Other|16|||
170362971|NCT00507416|615662877|FG002|Overall Study|Other|13|||
170362972|NCT00507416|615662875|FG000|Overall Study|Did not Receive Study Treatment|3|||
170362973|NCT00507416|615662876|FG001|Overall Study|Did not Receive Study Treatment|9|||
170362974|NCT00507416|615662877|FG002|Overall Study|Did not Receive Study Treatment|4|||
170362975|NCT02581982|615662883|FG000|Overall Study|Lack of Efficacy|12|||
170362976|NCT02581982|615662883|FG000|Overall Study|Adverse Event|3|||
170362977|NCT02581982|615662883|FG000|Overall Study|Physician Decision|1|||
170362978|NCT04682353|615662886|FG000|Overall Study|Lost to Follow-up|0|||
170362979|NCT04682353|615662887|FG001|Overall Study|Lost to Follow-up|1|||
170362980|NCT04682353|615662888|FG002|Overall Study|Lost to Follow-up|0|||
170362981|NCT04682353|615662889|FG003|Overall Study|Lost to Follow-up|1|||
170362982|NCT04682353|615662886|FG000|Overall Study|Personal reasons|0|||
170362983|NCT04682353|615662887|FG001|Overall Study|Personal reasons|1|||
170362984|NCT04682353|615662888|FG002|Overall Study|Personal reasons|0|||
170362985|NCT04682353|615662889|FG003|Overall Study|Personal reasons|0|||
170362986|NCT00405821|615662890|FG000|Overall Study|Death|5|||
170362987|NCT00405821|615662891|FG001|Overall Study|Death|7|||
170362988|NCT00405821|615662890|FG000|Overall Study|Lost to Follow-up|7|||
170362989|NCT00405821|615662891|FG001|Overall Study|Lost to Follow-up|7|||
170362990|NCT00405821|615662890|FG000|Overall Study|Protocol Violation|1|||
170362991|NCT00405821|615662891|FG001|Overall Study|Protocol Violation|0|||
170362992|NCT00405821|615662890|FG000|Overall Study|initiated ART|9|||
170362993|NCT00405821|615662891|FG001|Overall Study|initiated ART|8|||
170362994|NCT01586806|615662892|FG000|Overall Study|Protocol Violation|0|||
170362995|NCT01586806|615662893|FG001|Overall Study|Protocol Violation|1|||
170362996|NCT01586806|615662894|FG002|Overall Study|Protocol Violation|0|||
170362997|NCT01586806|615662892|FG000|Overall Study|Withdrawal by Subject|1|||
170362998|NCT01586806|615662893|FG001|Overall Study|Withdrawal by Subject|0|||
170362999|NCT01586806|615662894|FG002|Overall Study|Withdrawal by Subject|0|||
170363000|NCT01586806|615662892|FG000|Overall Study|Lost to Follow-up|2|||
170363001|NCT01586806|615662893|FG001|Overall Study|Lost to Follow-up|3|||
170363002|NCT01586806|615662894|FG002|Overall Study|Lost to Follow-up|2|||
170363003|NCT01769469|615662895|FG000|Overall Study|Consent Withdrawn|5|||
170363004|NCT01769469|615662895|FG000|Overall Study|Moved Out Of Area|3|||
170363005|NCT01769469|615662895|FG000|Overall Study|Lost to Follow-up|17|||
170363006|NCT01769469|615662895|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
170363007|NCT01769469|615662895|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
170363008|NCT02713789|615662908|FG000|Overall Study|Lost to Follow-up|0|||
170363009|NCT02713789|615662909|FG001|Overall Study|Lost to Follow-up|1|||
170363010|NCT02713789|615662910|FG002|Overall Study|Lost to Follow-up|1|||
170363011|NCT00888615|615662914|FG000|Overall Study|No treatment|2|||
170363012|NCT00141037|615662915|FG000|Overall Study|Physician Decision|1|||
170363013|NCT00141037|615662916|FG001|Overall Study|Physician Decision|2|||
170363014|NCT00141037|615662915|FG000|Overall Study|Lost to Follow-up|3|||
170363015|NCT00141037|615662916|FG001|Overall Study|Lost to Follow-up|1|||
170363016|NCT00141037|615662915|FG000|Overall Study|Protocol Violation|0|||
170363017|NCT00141037|615662916|FG001|Overall Study|Protocol Violation|2|||
170363018|NCT00141037|615662915|FG000|Overall Study|Withdrawal by Subject|2|||
170363019|NCT00141037|615662916|FG001|Overall Study|Withdrawal by Subject|1|||
170363020|NCT00141037|615662915|FG000|Overall Study|Other|0|||
170363021|NCT00141037|615662916|FG001|Overall Study|Other|1|||
170363022|NCT00141037|615662915|FG000|Overall Study|Moved from area|1|||
170363023|NCT00141037|615662916|FG001|Overall Study|Moved from area|7|||
170363024|NCT00141037|615662915|FG000|Overall Study|Graft Failure|3|||
170363025|NCT00141037|615662916|FG001|Overall Study|Graft Failure|4|||
170363026|NCT02940860|615664584|FG000|Overall Study|Non-serious AE|1|||
170363027|NCT02940860|615664585|FG001|Overall Study|Non-serious AE|2|||
170363028|NCT02940860|615664584|FG000|Overall Study|Serious AE|7|||
170363029|NCT02940860|615664585|FG001|Overall Study|Serious AE|3|||
170363030|NCT02940860|615664584|FG000|Overall Study|Withdrawal by Subject|19|||
170363031|NCT02940860|615664585|FG001|Overall Study|Withdrawal by Subject|9|||
170363032|NCT02940860|615664584|FG000|Overall Study|Lost to Follow-up|13|||
170363033|NCT02940860|615664585|FG001|Overall Study|Lost to Follow-up|7|||
170363034|NCT02940860|615664584|FG000|Overall Study|Physician Decision|5|||
170363035|NCT02940860|615664585|FG001|Overall Study|Physician Decision|3|||
170363036|NCT02940860|615664584|FG000|Overall Study|Sponsor Decision|0|||
170363037|NCT02940860|615664585|FG001|Overall Study|Sponsor Decision|1|||
170363038|NCT02940860|615664584|FG000|Overall Study|Protocol Violation|0|||
170363039|NCT02940860|615664585|FG001|Overall Study|Protocol Violation|2|||
170363040|NCT02940860|615664584|FG000|Overall Study|Death|3|||
170363041|NCT02940860|615664585|FG001|Overall Study|Death|2|||
170363042|NCT02940860|615664584|FG000|Overall Study|Moved, poor venous access, transport|6|||
170363043|NCT02940860|615664585|FG001|Overall Study|Moved, poor venous access, transport|4|||
170363044|NCT02940860|615664584|FG000|Overall Study|Not treated|2|||
170363045|NCT02940860|615664585|FG001|Overall Study|Not treated|2|||
170363046|NCT02715804|615664586|FG000|Overall Study|Death|222|||
170363047|NCT02715804|615664587|FG001|Overall Study|Death|106|||
170363048|NCT02715804|615664586|FG000|Overall Study|Withdrawal by Subject|5|||
170363049|NCT02715804|615664587|FG001|Overall Study|Withdrawal by Subject|4|||
170363050|NCT02715804|615664586|FG000|Overall Study|Other than specified|2|||
170363051|NCT02715804|615664587|FG001|Overall Study|Other than specified|3|||
170363052|NCT01281189|615664602|FG000|Overall Study|Adverse Event|7|||
170363053|NCT01281189|615664603|FG001|Overall Study|Adverse Event|9|||
170363054|NCT01281189|615664602|FG000|Overall Study|Lost to Follow-up|6|||
170363055|NCT01281189|615664603|FG001|Overall Study|Lost to Follow-up|4|||
170363056|NCT01281189|615664602|FG000|Overall Study|Withdrawal by Subject|21|||
170363057|NCT01281189|615664603|FG001|Overall Study|Withdrawal by Subject|24|||
170363058|NCT01281189|615664602|FG000|Overall Study|Physician Decision|2|||
170363059|NCT01281189|615664603|FG001|Overall Study|Physician Decision|3|||
170363060|NCT01281189|615664602|FG000|Overall Study|Death|103|||
170363061|NCT01281189|615664603|FG001|Overall Study|Death|91|||
170363062|NCT01281189|615664602|FG000|Overall Study|Other|8|||
170363063|NCT01281189|615664603|FG001|Overall Study|Other|12|||
170363064|NCT00063986|615664606|FG000|Overall Study|Withdrawal by Subject|1|||
170363065|NCT00063986|615664606|FG000|Overall Study|Ineligible|1|||
170363066|NCT00063986|615664606|FG000|Overall Study|Intra-operatively ineligible|4|||
170363067|NCT00247273|615664607|FG000|Overall Study|Adverse Event|85|||
170363068|NCT00247273|615664608|FG001|Overall Study|Adverse Event|80|||
170363069|NCT00247273|615664607|FG000|Overall Study|Physician Decision|6|||
170363070|NCT00247273|615664608|FG001|Overall Study|Physician Decision|3|||
170363071|NCT00247273|615664607|FG000|Overall Study|Lost to Follow-up|7|||
170363072|NCT00247273|615664608|FG001|Overall Study|Lost to Follow-up|7|||
170363073|NCT00247273|615664607|FG000|Overall Study|Withdrawal by Subject|46|||
170363074|NCT00247273|615664608|FG001|Overall Study|Withdrawal by Subject|47|||
170363075|NCT00247273|615664607|FG000|Overall Study|Did not take any study drug|2|||
170363076|NCT00247273|615664608|FG001|Overall Study|Did not take any study drug|0|||
170363077|NCT03911869|615664612|FG000|Safety Lead-in Phase|Death|7|||
170363078|NCT03911869|615664613|FG001|Safety Lead-in Phase|Death|0|||
170363079|NCT03911869|615664614|FG002|Safety Lead-in Phase|Death|0|||
170363080|NCT03911869|615664612|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
170363081|NCT03911869|615664613|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
170363082|NCT03911869|615664614|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
170363083|NCT03911869|615664612|FG000|Safety Lead-in Phase|Other|1|||
170363084|NCT03911869|615664613|FG001|Safety Lead-in Phase|Other|0|||
170363085|NCT03911869|615664614|FG002|Safety Lead-in Phase|Other|0|||
170363086|NCT03911869|615664612|FG000|Phase 2|Death|0|||
170363087|NCT03911869|615664613|FG001|Phase 2|Death|3|||
170363088|NCT03911869|615664614|FG002|Phase 2|Death|0|||
170363089|NCT01709708|615664627|FG000|Overall Study|Protocol Violation|1|||
170363090|NCT01709708|615664628|FG001|Overall Study|Protocol Violation|2|||
170363091|NCT00527072|615664629|FG000|Overall Study|Adverse Event|13|||
170363092|NCT00527072|615664629|FG000|Overall Study|Lack of Efficacy|11|||
170363093|NCT00527072|615664629|FG000|Overall Study|Lost to Follow-up|3|||
170363094|NCT00527072|615664629|FG000|Overall Study|Protocol Violation|2|||
170363095|NCT00527072|615664629|FG000|Overall Study|Withdrawal by Subject|7|||
170363096|NCT02954952|615664631|FG000|Overall Study|Withdrawal by Subject|1|||
170363097|NCT02954952|615664632|FG001|Overall Study|Withdrawal by Subject|0|||
170363098|NCT02954952|615664633|FG002|Overall Study|Withdrawal by Subject|0|||
170363099|NCT02954952|615664631|FG000|Overall Study|No data collected|0|||
170363100|NCT02954952|615664632|FG001|Overall Study|No data collected|1|||
170363101|NCT02954952|615664633|FG002|Overall Study|No data collected|0|||
170363102|NCT01675141|615664636|FG000|Overall Study|Lenalidomide outside NIH|3|||
170363103|NCT01675141|615664636|FG000|Overall Study|Withdrawal by Subject|3|||
170363104|NCT01675141|615664636|FG000|Overall Study|Physician Decision|4|||
170363105|NCT01675141|615664636|FG000|Overall Study|No treatment, per protocol|1|||
170363106|NCT01981109|615664639|FG000|Overall Study|Death|36|||
170363107|NCT01981109|615664639|FG000|Overall Study|Withdrawal by Subject|40|||
170363108|NCT01981109|615664639|FG000|Overall Study|Lost to Follow-up|9|||
170363109|NCT01981109|615664639|FG000|Overall Study|No Discontinuation Documentation|37|||
170363110|NCT01981109|615664639|FG000|Overall Study|Study Termination|100|||
170363111|NCT01981109|615664639|FG000|Overall Study|No data available|2|||
170363112|NCT03407170|615664640|FG000|Overall Study|Adverse Event|1|||
170363113|NCT04585451|615664648|FG000|Overall Study|Withdrawal by Subject|26|||
170363114|NCT04585451|615664649|FG001|Overall Study|Withdrawal by Subject|0|||
170363115|NCT00493974|615664650|FG000|Overall Study|Death|1|||
170363116|NCT00493974|615664651|FG001|Overall Study|Death|2|||
170363117|NCT00493974|615664650|FG000|Overall Study|Withdrawal by Subject|8|||
170363118|NCT00493974|615664651|FG001|Overall Study|Withdrawal by Subject|6|||
170363119|NCT00493974|615664650|FG000|Overall Study|Lost to Follow-up|4|||
170363120|NCT00493974|615664651|FG001|Overall Study|Lost to Follow-up|6|||
170363121|NCT00326417|615664652|FG000|Overall Study|Withdrawal by Subject|0|||
170363122|NCT00326417|615664653|FG001|Overall Study|Withdrawal by Subject|0|||
170363123|NCT00326417|615664654|FG002|Overall Study|Withdrawal by Subject|1|||
170363124|NCT00326417|615664655|FG003|Overall Study|Withdrawal by Subject|0|||
170363125|NCT00326417|615664652|FG000|Overall Study|Arm Closed|7|||
170363126|NCT00326417|615664653|FG001|Overall Study|Arm Closed|0|||
170363127|NCT00326417|615664654|FG002|Overall Study|Arm Closed|0|||
170363128|NCT00326417|615664655|FG003|Overall Study|Arm Closed|3|||
170363129|NCT00326417|615664652|FG000|Overall Study|Death|7|||
170363130|NCT00326417|615664653|FG001|Overall Study|Death|0|||
170363131|NCT00326417|615664654|FG002|Overall Study|Death|0|||
170363132|NCT00326417|615664655|FG003|Overall Study|Death|0|||
170363133|NCT01578785|615664658|FG000|Overall Study|Withdrawal by Subject|0|||
170363134|NCT01578785|615664659|FG001|Overall Study|Withdrawal by Subject|1|||
170363135|NCT01578785|615664658|FG000|Overall Study|Study terminated by sponsor|59|||
170363136|NCT01578785|615664659|FG001|Overall Study|Study terminated by sponsor|118|||
170363137|NCT00966693|615664660|FG000|Overall Study|Adverse Event|0|||
170363138|NCT00966693|615664661|FG001|Overall Study|Adverse Event|0|||
170363139|NCT00966693|615664662|FG002|Overall Study|Adverse Event|1|||
170363140|NCT00966693|615664663|FG003|Overall Study|Adverse Event|2|||
170363141|NCT00966693|615664660|FG000|Overall Study|Death|0|||
170363142|NCT00966693|615664661|FG001|Overall Study|Death|0|||
170363143|NCT00966693|615664662|FG002|Overall Study|Death|1|||
170363144|NCT00966693|615664663|FG003|Overall Study|Death|0|||
170363145|NCT00966693|615664660|FG000|Overall Study|Withdrawal by Subject|1|||
170363146|NCT00966693|615664661|FG001|Overall Study|Withdrawal by Subject|0|||
170363147|NCT00966693|615664662|FG002|Overall Study|Withdrawal by Subject|0|||
170363148|NCT00966693|615664663|FG003|Overall Study|Withdrawal by Subject|5|||
170363149|NCT00966693|615664660|FG000|Overall Study|Disease Progression|0|||
170363150|NCT00966693|615664661|FG001|Overall Study|Disease Progression|0|||
170363151|NCT00966693|615664662|FG002|Overall Study|Disease Progression|1|||
170363152|NCT00966693|615664663|FG003|Overall Study|Disease Progression|16|||
170363153|NCT00844285|615664664|FG000|Overall Study|Other|0|||
170363154|NCT00844285|615664665|FG001|Overall Study|Other|1|||
170363155|NCT00844285|615664666|FG002|Overall Study|Other|0|||
170363156|NCT00844285|615664664|FG000|Overall Study|Other than specified|95|||
170363157|NCT00844285|615664665|FG001|Overall Study|Other than specified|129|||
170363158|NCT00844285|615664666|FG002|Overall Study|Other than specified|12|||
170363159|NCT00844285|615664664|FG000|Overall Study|Site closure|256|||
170363160|NCT00844285|615664665|FG001|Overall Study|Site closure|450|||
170363161|NCT00844285|615664666|FG002|Overall Study|Site closure|50|||
170363162|NCT00844285|615664664|FG000|Overall Study|Follow-up < 8 years|16|||
170363163|NCT00844285|615664665|FG001|Overall Study|Follow-up < 8 years|23|||
170363164|NCT00844285|615664666|FG002|Overall Study|Follow-up < 8 years|4|||
170363165|NCT00844285|615664664|FG000|Overall Study|Protocol Violation|26|||
170363166|NCT00844285|615664665|FG001|Overall Study|Protocol Violation|28|||
170363167|NCT00844285|615664666|FG002|Overall Study|Protocol Violation|54|||
170363168|NCT00844285|615664664|FG000|Overall Study|Death|22|||
170363169|NCT00844285|615664665|FG001|Overall Study|Death|21|||
170363170|NCT00844285|615664666|FG002|Overall Study|Death|8|||
170363171|NCT00844285|615664664|FG000|Overall Study|Withdrew Consent|344|||
170363172|NCT00844285|615664665|FG001|Overall Study|Withdrew Consent|466|||
170363173|NCT00844285|615664666|FG002|Overall Study|Withdrew Consent|70|||
170363174|NCT00844285|615664664|FG000|Overall Study|Lost to Follow-up|330|||
170363175|NCT00844285|615664665|FG001|Overall Study|Lost to Follow-up|486|||
170363176|NCT00844285|615664666|FG002|Overall Study|Lost to Follow-up|74|||
170363177|NCT00555906|615664669|FG000|Phase 1|Objective Progression or Relapse|3|||
170363178|NCT00555906|615664670|FG001|Phase 1|Objective Progression or Relapse|5|||
170363179|NCT00555906|615664671|FG002|Phase 1|Objective Progression or Relapse|3|||
170363180|NCT00555906|615664672|FG003|Phase 1|Objective Progression or Relapse|1|||
170363181|NCT00555906|615664673|FG004|Phase 1|Objective Progression or Relapse|0|||
170363182|NCT00555906|615664669|FG000|Phase 1|Global Deterioration of Health Status|0|||
170363183|NCT00555906|615664670|FG001|Phase 1|Global Deterioration of Health Status|1|||
170363184|NCT00555906|615664671|FG002|Phase 1|Global Deterioration of Health Status|1|||
170363185|NCT00555906|615664672|FG003|Phase 1|Global Deterioration of Health Status|1|||
170363186|NCT00555906|615664673|FG004|Phase 1|Global Deterioration of Health Status|0|||
170363187|NCT00555906|615664669|FG000|Phase 1|Adverse Event|0|||
170363188|NCT00555906|615664670|FG001|Phase 1|Adverse Event|0|||
170363189|NCT00555906|615664671|FG002|Phase 1|Adverse Event|3|||
170363190|NCT00555906|615664672|FG003|Phase 1|Adverse Event|2|||
170363191|NCT00555906|615664673|FG004|Phase 1|Adverse Event|0|||
170363192|NCT00555906|615664669|FG000|Phase 1|Withdrawal by Subject|0|||
170363193|NCT00555906|615664670|FG001|Phase 1|Withdrawal by Subject|0|||
170363194|NCT00555906|615664671|FG002|Phase 1|Withdrawal by Subject|0|||
170363195|NCT00555906|615664672|FG003|Phase 1|Withdrawal by Subject|1|||
170363196|NCT00555906|615664673|FG004|Phase 1|Withdrawal by Subject|0|||
170363197|NCT00555906|615664669|FG000|Phase 2|Adverse Event|0|||
170363198|NCT00555906|615664670|FG001|Phase 2|Adverse Event|0|||
170363199|NCT00555906|615664671|FG002|Phase 2|Adverse Event|0|||
170363200|NCT00555906|615664672|FG003|Phase 2|Adverse Event|0|||
170363201|NCT00555906|615664673|FG004|Phase 2|Adverse Event|4|||
170363202|NCT00555906|615664669|FG000|Phase 2|Global Deterioration of Health Status|0|||
170363203|NCT00555906|615664670|FG001|Phase 2|Global Deterioration of Health Status|0|||
170363204|NCT00555906|615664671|FG002|Phase 2|Global Deterioration of Health Status|0|||
170363205|NCT00555906|615664672|FG003|Phase 2|Global Deterioration of Health Status|0|||
170363206|NCT00555906|615664673|FG004|Phase 2|Global Deterioration of Health Status|2|||
170363207|NCT00555906|615664669|FG000|Phase 2|Objective Progression or Relapse|0|||
170363208|NCT00555906|615664670|FG001|Phase 2|Objective Progression or Relapse|0|||
170363209|NCT00555906|615664671|FG002|Phase 2|Objective Progression or Relapse|0|||
170363210|NCT00555906|615664672|FG003|Phase 2|Objective Progression or Relapse|0|||
170363211|NCT00555906|615664673|FG004|Phase 2|Objective Progression or Relapse|16|||
170363212|NCT00555906|615664669|FG000|Phase 2|Withdrawal by Subject|0|||
170363213|NCT00555906|615664670|FG001|Phase 2|Withdrawal by Subject|0|||
170363214|NCT00555906|615664671|FG002|Phase 2|Withdrawal by Subject|0|||
170363215|NCT00555906|615664672|FG003|Phase 2|Withdrawal by Subject|0|||
170363216|NCT00555906|615664673|FG004|Phase 2|Withdrawal by Subject|2|||
170363217|NCT00555906|615664669|FG000|Phase 2|Other|0|||
170363218|NCT00555906|615664670|FG001|Phase 2|Other|0|||
170363219|NCT00555906|615664671|FG002|Phase 2|Other|0|||
170363220|NCT00555906|615664672|FG003|Phase 2|Other|0|||
170363221|NCT00555906|615664673|FG004|Phase 2|Other|6|||
170363222|NCT00555906|615664669|FG000|Phase 2|Randomized but not Treated|0|||
170363223|NCT00555906|615664670|FG001|Phase 2|Randomized but not Treated|0|||
170363224|NCT00555906|615664671|FG002|Phase 2|Randomized but not Treated|0|||
170363225|NCT00555906|615664672|FG003|Phase 2|Randomized but not Treated|0|||
170363226|NCT00555906|615664673|FG004|Phase 2|Randomized but not Treated|2|||
170363227|NCT02193828|615664674|FG000|Overall Study|Withdrawal by Subject|0|||
170363228|NCT02193828|615664675|FG001|Overall Study|Withdrawal by Subject|0|||
170363229|NCT02193828|615664676|FG002|Overall Study|Withdrawal by Subject|1|||
170363230|NCT02193828|615664677|FG003|Overall Study|Withdrawal by Subject|1|||
170363231|NCT02447458|615664689|FG000|Overall Study|Other|0|||
170363232|NCT02447458|615664690|FG001|Overall Study|Other|0|||
170363233|NCT02447458|615664691|FG002|Overall Study|Other|1|||
170363234|NCT02447458|615664692|FG003|Overall Study|Other|0|||
170363235|NCT02447458|615664693|FG004|Overall Study|Other|0|||
170363236|NCT02447458|615664694|FG005|Overall Study|Other|0|||
170363237|NCT00405652|615664697|FG000|Overall Study|Adverse Event|4|||
170363238|NCT03505749|615664699|FG000|Overall Study|Lost to Follow-up|7|||
170363239|NCT03505749|615664700|FG001|Overall Study|Lost to Follow-up|11|||
170363240|NCT03505749|615664699|FG000|Overall Study|Withdrawal by Subject|6|||
170363241|NCT03505749|615664700|FG001|Overall Study|Withdrawal by Subject|0|||
170363242|NCT03505749|615664699|FG000|Overall Study|Discharged from treatment|3|||
170363243|NCT03505749|615664700|FG001|Overall Study|Discharged from treatment|6|||
170363244|NCT00004732|615664701|FG000|Overall Study|Withdrawal by Subject|36|||
170363245|NCT00004732|615664702|FG001|Overall Study|Withdrawal by Subject|64|||
170363246|NCT00004732|615664701|FG000|Overall Study|Lost to Follow-up|33|||
170363247|NCT00004732|615664702|FG001|Overall Study|Lost to Follow-up|47|||
170363248|NCT00367432|615664705|FG000|First Period (16 Weeks)|Adverse Event|6|||
170363249|NCT00367432|615664706|FG001|First Period (16 Weeks)|Adverse Event|0|||
170363250|NCT00367432|615664705|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
170363251|NCT00367432|615664706|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
170363252|NCT00367432|615664705|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
170363253|NCT00367432|615664706|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
170363254|NCT00367432|615664705|FG000|First Period (16 Weeks)|Other Reason|2|||
170363255|NCT00367432|615664706|FG001|First Period (16 Weeks)|Other Reason|0|||
170363256|NCT00367432|615664705|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
170363257|NCT00367432|615664706|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
170363258|NCT00367432|615664705|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
170363259|NCT00367432|615664706|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
170363260|NCT00367432|615664705|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
170363261|NCT00367432|615664706|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
170363262|NCT00367432|615664705|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
170363263|NCT00367432|615664706|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
170363264|NCT00367432|615664705|FG000|Second Period (up to 54 Months)|Other Reason|6|||
170363265|NCT00367432|615664706|FG001|Second Period (up to 54 Months)|Other Reason|2|||
170363266|NCT00014911|615664707|FG000|Overall Study|Adverse Event|1|||
170363267|NCT00014911|615664707|FG000|Overall Study|Lost to Follow-up|1|||
170363268|NCT00014911|615664707|FG000|Overall Study|Withdrawal by Subject|6|||
170363269|NCT00014911|615664707|FG000|Overall Study|Unknown Reasons|2|||
170363270|NCT00014911|615664707|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
170363271|NCT02983799|615664713|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
170363272|NCT02983799|615664714|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
170363273|NCT02983799|615664715|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
170363274|NCT02983799|615664716|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
170363275|NCT02983799|615664717|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
170363276|NCT02983799|615664713|FG000|Overall Study|Death|20|||
170363277|NCT02983799|615664714|FG001|Overall Study|Death|5|||
170363278|NCT02983799|615664715|FG002|Overall Study|Death|23|||
170363279|NCT02983799|615664716|FG003|Overall Study|Death|47|||
170363280|NCT02983799|615664717|FG004|Overall Study|Death|7|||
170363281|NCT02983799|615664713|FG000|Overall Study|Withdrawal by Subject|1|||
170363282|NCT02983799|615664714|FG001|Overall Study|Withdrawal by Subject|0|||
170363283|NCT02983799|615664715|FG002|Overall Study|Withdrawal by Subject|3|||
170363284|NCT02983799|615664716|FG003|Overall Study|Withdrawal by Subject|4|||
170363285|NCT02983799|615664717|FG004|Overall Study|Withdrawal by Subject|1|||
170363286|NCT02983799|615664713|FG000|Overall Study|Protocol Violation|0|||
170363287|NCT02983799|615664714|FG001|Overall Study|Protocol Violation|1|||
170363288|NCT02983799|615664715|FG002|Overall Study|Protocol Violation|0|||
170363289|NCT02983799|615664716|FG003|Overall Study|Protocol Violation|0|||
170363290|NCT02983799|615664717|FG004|Overall Study|Protocol Violation|1|||
170363291|NCT02983799|615664713|FG000|Overall Study|Lost to Follow-up|1|||
170363292|NCT02983799|615664714|FG001|Overall Study|Lost to Follow-up|0|||
170363293|NCT02983799|615664715|FG002|Overall Study|Lost to Follow-up|1|||
170363294|NCT02983799|615664716|FG003|Overall Study|Lost to Follow-up|0|||
170363295|NCT02983799|615664717|FG004|Overall Study|Lost to Follow-up|0|||
170363296|NCT01079195|615664720|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
170363297|NCT01079195|615664720|FG000|Overall Study|No Documentation Available|437|||
170363298|NCT01079195|615664720|FG000|Overall Study|Adverse Event|157|||
170363299|NCT01079195|615664720|FG000|Overall Study|Reason Unknown|39|||
170363300|NCT01079195|615664720|FG000|Overall Study|Withdrawal by Subject|18|||
170363301|NCT01079195|615664720|FG000|Overall Study|Financial Reasons|15|||
170363302|NCT01079195|615664720|FG000|Overall Study|Lack of Effectiveness|12|||
170363303|NCT01079195|615664720|FG000|Overall Study|Physician Decision|4|||
170363304|NCT01079195|615664720|FG000|Overall Study|Improved Status of Participant|4|||
170363305|NCT01079195|615664720|FG000|Overall Study|No Follow-up Documentation Available|4|||
170363306|NCT01079195|615664720|FG000|Overall Study|Non-compliance|2|||
170363307|NCT01184846|615664721|FG000|Overall Study|Adverse Event|2|||
170363308|NCT01184846|615664721|FG000|Overall Study|Insufficient response|1|||
170363309|NCT01736254|615664723|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
170363310|NCT01736254|615664723|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
170363311|NCT01135394|615666422|FG000|Screening|Lost to Follow-up|2|||
170363312|NCT01135394|615666422|FG000|Screening|Withdrawal by Subject|10|||
170363313|NCT01135394|615666422|FG000|Screening|Screening failure|16|||
170363314|NCT01135394|615666422|FG000|Screening|Physician Decision|5|||
170363315|NCT01135394|615666422|FG000|Baseline Assessment|Withdrawal by Subject|9|||
170363316|NCT01135394|615666422|FG000|Baseline Assessment|Physician Decision|3|||
170363317|NCT01135394|615666422|FG000|Baseline Assessment|Lost to Follow-up|2|||
170363318|NCT01135394|615666422|FG000|Baseline Assessment|Adverse Event|1|||
170363319|NCT01135394|615666422|FG000|Study Treatment|Withdrawal by Subject|1|||
170363320|NCT01135394|615666422|FG000|Study Treatment|Physician Decision|1|||
170363321|NCT01135394|615666422|FG000|Study Treatment|Adverse Event|2|||
170363322|NCT01673490|615666423|FG000|Overall Study|Lost to Follow-up|1|||
170363323|NCT01673490|615666423|FG000|Overall Study|Adverse Event|3|||
170363324|NCT01673490|615666423|FG000|Overall Study|Withdrawal by Subject|3|||
170363325|NCT02971007|615666426|FG000|Overall Study|Adverse Event|1|||
170363326|NCT02971007|615666427|FG001|Overall Study|Adverse Event|0|||
170363327|NCT02971007|615666428|FG002|Overall Study|Adverse Event|0|||
170363328|NCT02971007|615666426|FG000|Overall Study|Lost to Follow-up|0|||
170363329|NCT02971007|615666427|FG001|Overall Study|Lost to Follow-up|1|||
170363330|NCT02971007|615666428|FG002|Overall Study|Lost to Follow-up|1|||
170363331|NCT02971007|615666426|FG000|Overall Study|Withdrawal by Subject|0|||
170363332|NCT02971007|615666427|FG001|Overall Study|Withdrawal by Subject|1|||
170363333|NCT02971007|615666428|FG002|Overall Study|Withdrawal by Subject|0|||
170363334|NCT02971007|615666426|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
170363335|NCT02971007|615666427|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
170363336|NCT02971007|615666428|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
170363337|NCT02971007|615666426|FG000|Overall Study|Patient discontinued study drug|0|||
170363338|NCT02971007|615666427|FG001|Overall Study|Patient discontinued study drug|1|||
170363339|NCT02971007|615666428|FG002|Overall Study|Patient discontinued study drug|0|||
170363340|NCT01625611|615666429|FG000|Overall Study|No adlib drinks Lab 1|3|||
170363341|NCT01625611|615666430|FG001|Overall Study|No adlib drinks Lab 1|0|||
170363342|NCT01625611|615666429|FG000|Overall Study|Technical issues with PET|1|||
170363343|NCT01625611|615666430|FG001|Overall Study|Technical issues with PET|0|||
170363344|NCT01625611|615666429|FG000|Overall Study|Unable to complete study procedures|1|||
170363345|NCT01625611|615666430|FG001|Overall Study|Unable to complete study procedures|0|||
170363346|NCT01625611|615666429|FG000|Overall Study|Withdrawal by Subject|3|||
170363347|NCT01625611|615666430|FG001|Overall Study|Withdrawal by Subject|0|||
170363348|NCT00233324|615666431|FG000|Main Study|Death|68|||
170363349|NCT00233324|615666432|FG001|Main Study|Death|60|||
170363350|NCT00233324|615666433|FG002|Main Study|Death|62|||
170363351|NCT00233324|615666434|FG003|Main Study|Death|47|||
170363352|NCT00233324|615666431|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
170363353|NCT00233324|615666432|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
170363354|NCT00233324|615666433|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
170363355|NCT00233324|615666434|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
170363356|NCT00233324|615666431|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
170363357|NCT00233324|615666432|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
170363358|NCT00233324|615666433|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
170363359|NCT00233324|615666434|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
170363360|NCT00728936|615666435|FG000|Overall Study|Withdrawal by Subject|0|||
170363361|NCT00728936|615666436|FG001|Overall Study|Withdrawal by Subject|0|||
170363362|NCT00728936|615666437|FG002|Overall Study|Withdrawal by Subject|0|||
170363363|NCT00728936|615666438|FG003|Overall Study|Withdrawal by Subject|0|||
170363364|NCT00728936|615666439|FG004|Overall Study|Withdrawal by Subject|0|||
170363365|NCT00728936|615666440|FG005|Overall Study|Withdrawal by Subject|1|||
170363366|NCT00728936|615666441|FG006|Overall Study|Withdrawal by Subject|0|||
170363367|NCT00438464|615666442|FG000|Overall Study|Terminated Early|14|||
170363368|NCT00438464|615666443|FG001|Overall Study|Terminated Early|5|||
170363369|NCT00438464|615666442|FG000|Overall Study|Incomplete data submission|0|||
170363370|NCT00438464|615666443|FG001|Overall Study|Incomplete data submission|2|||
170363371|NCT02853123|615666448|FG000|Treatment Period 1|Adverse Event|0|||
170363372|NCT02853123|615666449|FG001|Treatment Period 1|Adverse Event|3|||
170363373|NCT02853123|615666448|FG000|Washout Period|Worsening of COPD|0|||
170363374|NCT02853123|615666449|FG001|Washout Period|Worsening of COPD|3|||
170363375|NCT02853123|615666448|FG000|Washout Period|Adverse Event|1|||
170363376|NCT02853123|615666449|FG001|Washout Period|Adverse Event|0|||
170363377|NCT02471586|615666454|FG000|Overall Study|Lost to Follow-up|3|||
170363378|NCT02471586|615666455|FG001|Overall Study|Lost to Follow-up|8|||
170363379|NCT02471586|615666456|FG002|Overall Study|Lost to Follow-up|4|||
170363380|NCT02471586|615666454|FG000|Overall Study|Death|2|||
170363381|NCT02471586|615666455|FG001|Overall Study|Death|2|||
170363382|NCT02471586|615666456|FG002|Overall Study|Death|0|||
170363383|NCT01601704|615666457|FG000|Overall Study|Randomized but not dispensed study med|1|||
170363384|NCT01601704|615666458|FG001|Overall Study|Randomized but not dispensed study med|4|||
170363385|NCT04209530|615666461|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
170363386|NCT04209530|615666462|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
170363387|NCT04209530|615666461|FG000|Overall Study|Withdrawal by Subject|0|||
170363388|NCT04209530|615666462|FG001|Overall Study|Withdrawal by Subject|1|||
170363389|NCT03276572|615666463|FG000|Overall Study|In follow-up|0|||
170363390|NCT03276572|615666464|FG001|Overall Study|In follow-up|0|||
170363391|NCT03276572|615666465|FG002|Overall Study|In follow-up|0|||
170363392|NCT03276572|615666466|FG003|Overall Study|In follow-up|0|||
170363393|NCT03276572|615666467|FG004|Overall Study|In follow-up|0|||
170363394|NCT03276572|615666468|FG005|Overall Study|In follow-up|1|||
170363395|NCT03276572|615666469|FG006|Overall Study|In follow-up|1|||
170363396|NCT03276572|615666463|FG000|Overall Study|Lost to Follow-up|0|||
170363397|NCT03276572|615666464|FG001|Overall Study|Lost to Follow-up|0|||
170363398|NCT03276572|615666465|FG002|Overall Study|Lost to Follow-up|0|||
170363399|NCT03276572|615666466|FG003|Overall Study|Lost to Follow-up|0|||
170363400|NCT03276572|615666467|FG004|Overall Study|Lost to Follow-up|0|||
170363401|NCT03276572|615666468|FG005|Overall Study|Lost to Follow-up|0|||
170363402|NCT03276572|615666469|FG006|Overall Study|Lost to Follow-up|1|||
170363403|NCT01001572|615666470|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
170363404|NCT01001572|615666471|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
170363405|NCT01001572|615666472|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
170363406|NCT01001572|615666470|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
170363407|NCT01001572|615666471|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
170363408|NCT01001572|615666472|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
170363409|NCT01001572|615666470|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
170363410|NCT01001572|615666471|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
170363411|NCT01001572|615666472|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
170363412|NCT01001572|615666470|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
170363413|NCT01001572|615666471|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
170363414|NCT01001572|615666472|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
170363415|NCT01001572|615666470|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
170363416|NCT01001572|615666471|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
170363417|NCT01001572|615666472|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
170363418|NCT01001572|615666470|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
170363419|NCT01001572|615666471|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
170363420|NCT01001572|615666472|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
170363421|NCT01001572|615666470|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
170363422|NCT01001572|615666471|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
170363423|NCT01001572|615666472|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
170363424|NCT01001572|615666470|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
170363425|NCT01001572|615666471|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
170363426|NCT01001572|615666472|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
170363427|NCT01001572|615666470|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
170363428|NCT01001572|615666471|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
170363429|NCT01001572|615666472|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
170363430|NCT01001572|615666470|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
170363431|NCT01001572|615666471|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
170363432|NCT01001572|615666472|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
170363433|NCT01001572|615666470|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
170363434|NCT01001572|615666471|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
170363435|NCT01001572|615666472|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
170363436|NCT01001572|615666470|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
170363437|NCT01001572|615666471|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
170363438|NCT01001572|615666472|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
170363439|NCT01001572|615666470|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
170363440|NCT01001572|615666471|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
170363441|NCT01001572|615666472|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
170363442|NCT01001572|615666470|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170363443|NCT01001572|615666471|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170363444|NCT01001572|615666472|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
170363445|NCT02911519|615666473|FG000|Overall Study|Lost to Follow-up|2|||
170363446|NCT02911519|615666474|FG001|Overall Study|Lost to Follow-up|2|||
170363447|NCT02911519|615666473|FG000|Overall Study|Death|0|||
170363448|NCT02911519|615666474|FG001|Overall Study|Death|2|||
170363449|NCT00445341|615666476|FG000|Overall Study|refused further treatment|1|||
170363450|NCT00445341|615666476|FG000|Overall Study|taken off treatment too early|1|||
170363451|NCT00105183|615666477|FG000|Overall Study|Death|19|||
170363452|NCT00105183|615666478|FG001|Overall Study|Death|13|||
170363453|NCT00105183|615666479|FG002|Overall Study|Death|15|||
170363454|NCT00105183|615666477|FG000|Overall Study|Withdrawal by Subject|1|||
170363455|NCT00105183|615666478|FG001|Overall Study|Withdrawal by Subject|1|||
170363456|NCT00105183|615666479|FG002|Overall Study|Withdrawal by Subject|4|||
170363457|NCT00105183|615666477|FG000|Overall Study|Physician Decision|1|||
170363458|NCT00105183|615666478|FG001|Overall Study|Physician Decision|2|||
170363459|NCT00105183|615666479|FG002|Overall Study|Physician Decision|3|||
170363460|NCT00105183|615666477|FG000|Overall Study|Lost to Follow-up|0|||
170363461|NCT00105183|615666478|FG001|Overall Study|Lost to Follow-up|1|||
170363462|NCT00105183|615666479|FG002|Overall Study|Lost to Follow-up|1|||
170363463|NCT00105183|615666477|FG000|Overall Study|Other reason|1|||
170363464|NCT00105183|615666478|FG001|Overall Study|Other reason|2|||
170363465|NCT00105183|615666479|FG002|Overall Study|Other reason|0|||
170363466|NCT04737759|615666484|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
170363467|NCT04737759|615666485|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
170363468|NCT04737759|615666484|FG000|Overall Study|Death|2|||
170363469|NCT04737759|615666485|FG001|Overall Study|Death|0|||
170363470|NCT04737759|615666484|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
170363471|NCT04737759|615666485|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
170363472|NCT04737759|615666484|FG000|Overall Study|Lost to Follow-up|4|||
170363473|NCT04737759|615666485|FG001|Overall Study|Lost to Follow-up|12|||
170363474|NCT02443805|615666488|FG000|Overall Study|Adverse Event|100|||
170363475|NCT02443805|615666489|FG001|Overall Study|Adverse Event|18|||
170363476|NCT02443805|615666488|FG000|Overall Study|Withdrawal by Subject|73|||
170363477|NCT02443805|615666489|FG001|Overall Study|Withdrawal by Subject|74|||
170363478|NCT02443805|615666488|FG000|Overall Study|Lost to Follow-up|19|||
170363479|NCT02443805|615666489|FG001|Overall Study|Lost to Follow-up|14|||
170363480|NCT02443805|615666488|FG000|Overall Study|Pregnancy|6|||
170363481|NCT02443805|615666489|FG001|Overall Study|Pregnancy|5|||
170363482|NCT02443805|615666488|FG000|Overall Study|Protocol Violation|2|||
170363483|NCT02443805|615666489|FG001|Overall Study|Protocol Violation|4|||
170363484|NCT02443805|615666488|FG000|Overall Study|Lack of Efficacy|1|||
170363485|NCT02443805|615666489|FG001|Overall Study|Lack of Efficacy|1|||
170363486|NCT02443805|615666488|FG000|Overall Study|Non-compliance with study drug|6|||
170363487|NCT02443805|615666489|FG001|Overall Study|Non-compliance with study drug|4|||
170363488|NCT02443805|615666488|FG000|Overall Study|Withdrawal by parent/guardian|3|||
170363489|NCT02443805|615666489|FG001|Overall Study|Withdrawal by parent/guardian|5|||
170363490|NCT02443805|615666488|FG000|Overall Study|Any other reason not above-mentioned|3|||
170363491|NCT02443805|615666489|FG001|Overall Study|Any other reason not above-mentioned|2|||
170363492|NCT00961116|615666490|FG000|Washout Period of 7 Days|Adverse Event|1|||
170363493|NCT00961116|615666491|FG001|Washout Period of 7 Days|Adverse Event|1|||
170363494|NCT00961116|615666490|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
170363495|NCT00961116|615666491|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
170363496|NCT00961116|615666490|FG000|Washout Period of 7 Days|Protocol Violation|0|||
170363497|NCT00961116|615666491|FG001|Washout Period of 7 Days|Protocol Violation|1|||
170363498|NCT02708966|615666492|FG000|Overall Study|Lost to Follow-up|2|||
170363499|NCT02708966|615666493|FG001|Overall Study|Lost to Follow-up|2|||
170363500|NCT00636441|615666495|FG000|Overall Study|Adverse Event|0|||
170363501|NCT00636441|615666496|FG001|Overall Study|Adverse Event|1|||
170363502|NCT00636441|615666497|FG002|Overall Study|Adverse Event|1|||
170363503|NCT00636441|615666498|FG003|Overall Study|Adverse Event|0|||
170363504|NCT00636441|615666499|FG004|Overall Study|Adverse Event|0|||
170363505|NCT00636441|615666500|FG005|Overall Study|Adverse Event|1|||
170363506|NCT00636441|615666501|FG006|Overall Study|Adverse Event|0|||
170363507|NCT00636441|615666495|FG000|Overall Study|Late, ineligible|0|||
170363508|NCT00636441|615666496|FG001|Overall Study|Late, ineligible|0|||
170363509|NCT00636441|615666497|FG002|Overall Study|Late, ineligible|0|||
170363510|NCT00636441|615666498|FG003|Overall Study|Late, ineligible|0|||
170363511|NCT00636441|615666499|FG004|Overall Study|Late, ineligible|0|||
170363512|NCT00636441|615666500|FG005|Overall Study|Late, ineligible|0|||
170363513|NCT00636441|615666501|FG006|Overall Study|Late, ineligible|1|||
170363514|NCT00636441|615666495|FG000|Overall Study|Screen Failure|0|||
170363515|NCT00636441|615666496|FG001|Overall Study|Screen Failure|0|||
170363516|NCT00636441|615666497|FG002|Overall Study|Screen Failure|0|||
170363517|NCT00636441|615666498|FG003|Overall Study|Screen Failure|0|||
170363518|NCT00636441|615666499|FG004|Overall Study|Screen Failure|0|||
170363519|NCT00636441|615666500|FG005|Overall Study|Screen Failure|0|||
170363520|NCT00636441|615666501|FG006|Overall Study|Screen Failure|17|||
170363521|NCT01851863|615666504|FG000|Overall Study|Did not receive study medication|2|||
170363522|NCT01851863|615666505|FG001|Overall Study|Did not receive study medication|5|||
170363523|NCT01851863|615666506|FG002|Overall Study|Did not receive study medication|3|||
170363524|NCT01851863|615666507|FG003|Overall Study|Did not receive study medication|0|||
170363525|NCT01851863|615666504|FG000|Overall Study|Lost to Follow-up|3|||
170363526|NCT01851863|615666505|FG001|Overall Study|Lost to Follow-up|4|||
170363527|NCT01851863|615666506|FG002|Overall Study|Lost to Follow-up|2|||
170363528|NCT01851863|615666507|FG003|Overall Study|Lost to Follow-up|3|||
170363529|NCT01767519|615666511|FG000|Overall Study|Other Reasons|4|||
170363530|NCT01767519|615666512|FG001|Overall Study|Other Reasons|4|||
170363531|NCT01767519|615666513|FG002|Overall Study|Other Reasons|2|||
170363532|NCT01767519|615666511|FG000|Overall Study|Protocol Violation|0|||
170363533|NCT01767519|615666512|FG001|Overall Study|Protocol Violation|3|||
170363534|NCT01767519|615666513|FG002|Overall Study|Protocol Violation|0|||
170363535|NCT01767519|615666511|FG000|Overall Study|Personal Reasons|1|||
170363536|NCT01767519|615666512|FG001|Overall Study|Personal Reasons|0|||
170363537|NCT01767519|615666513|FG002|Overall Study|Personal Reasons|0|||
170363538|NCT01767519|615666511|FG000|Overall Study|Lost to Follow-up|3|||
170363539|NCT01767519|615666512|FG001|Overall Study|Lost to Follow-up|1|||
170363540|NCT01767519|615666513|FG002|Overall Study|Lost to Follow-up|2|||
170363541|NCT01767519|615666511|FG000|Overall Study|Lack of Efficacy|1|||
170363542|NCT01767519|615666512|FG001|Overall Study|Lack of Efficacy|0|||
170363543|NCT01767519|615666513|FG002|Overall Study|Lack of Efficacy|0|||
170363544|NCT01767519|615666511|FG000|Overall Study|Adverse Event|5|||
170363545|NCT01767519|615666512|FG001|Overall Study|Adverse Event|5|||
170363546|NCT01767519|615666513|FG002|Overall Study|Adverse Event|1|||
170363547|NCT01021813|615666514|FG000|DB Treatment Phase|Adverse Event|60|||
170363548|NCT01021813|615666515|FG001|DB Treatment Phase|Adverse Event|22|||
170363549|NCT01021813|615666516|FG002|DB Treatment Phase|Adverse Event|0|||
170363550|NCT01021813|615666517|FG003|DB Treatment Phase|Adverse Event|0|||
170363551|NCT01021813|615666518|FG004|DB Treatment Phase|Adverse Event|0|||
170363552|NCT01021813|615666514|FG000|DB Treatment Phase|Lack of Efficacy|44|||
170363553|NCT01021813|615666515|FG001|DB Treatment Phase|Lack of Efficacy|28|||
170363554|NCT01021813|615666516|FG002|DB Treatment Phase|Lack of Efficacy|0|||
170363555|NCT01021813|615666517|FG003|DB Treatment Phase|Lack of Efficacy|0|||
170363556|NCT01021813|615666518|FG004|DB Treatment Phase|Lack of Efficacy|0|||
170363557|NCT01021813|615666514|FG000|DB Treatment Phase|Lost to Follow-up|14|||
170363558|NCT01021813|615666515|FG001|DB Treatment Phase|Lost to Follow-up|12|||
170363559|NCT01021813|615666516|FG002|DB Treatment Phase|Lost to Follow-up|0|||
170363560|NCT01021813|615666517|FG003|DB Treatment Phase|Lost to Follow-up|0|||
170363561|NCT01021813|615666518|FG004|DB Treatment Phase|Lost to Follow-up|0|||
170363562|NCT01021813|615666514|FG000|DB Treatment Phase|Physician Decision|17|||
170363563|NCT01021813|615666515|FG001|DB Treatment Phase|Physician Decision|8|||
170363564|NCT01021813|615666516|FG002|DB Treatment Phase|Physician Decision|0|||
170363565|NCT01021813|615666517|FG003|DB Treatment Phase|Physician Decision|0|||
170363566|NCT01021813|615666518|FG004|DB Treatment Phase|Physician Decision|0|||
170363567|NCT01021813|615666514|FG000|DB Treatment Phase|Pregnancy|1|||
170363568|NCT01021813|615666515|FG001|DB Treatment Phase|Pregnancy|0|||
170363569|NCT01021813|615666516|FG002|DB Treatment Phase|Pregnancy|0|||
170363570|NCT01021813|615666517|FG003|DB Treatment Phase|Pregnancy|0|||
170363571|NCT01021813|615666518|FG004|DB Treatment Phase|Pregnancy|0|||
170363572|NCT01021813|615666514|FG000|DB Treatment Phase|Protocol Violation|4|||
170363573|NCT01021813|615666515|FG001|DB Treatment Phase|Protocol Violation|3|||
170363574|NCT01021813|615666516|FG002|DB Treatment Phase|Protocol Violation|0|||
170363575|NCT01021813|615666517|FG003|DB Treatment Phase|Protocol Violation|0|||
170363576|NCT01021813|615666518|FG004|DB Treatment Phase|Protocol Violation|0|||
170363577|NCT01021813|615666514|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
170363578|NCT01021813|615666515|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
170363579|NCT01021813|615666516|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
170363580|NCT01021813|615666517|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
170363581|NCT01021813|615666518|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
170363582|NCT01021813|615666514|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
170363583|NCT01021813|615666515|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
170363584|NCT01021813|615666516|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
170363585|NCT01021813|615666517|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
170363586|NCT01021813|615666518|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
170363587|NCT01021813|615666514|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
170363588|NCT01021813|615666515|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
170363589|NCT01021813|615666516|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
170363590|NCT01021813|615666517|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
170363591|NCT01021813|615666518|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
170363592|NCT01021813|615666514|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
170363593|NCT01021813|615666515|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
170363594|NCT01021813|615666516|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
170363595|NCT01021813|615666517|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
170363596|NCT01021813|615666518|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
170399314|NCT03193190|615799939|FG002|Stage 1|Progressive Disease|0|||
170363597|NCT01021813|615666514|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
170363598|NCT01021813|615666515|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
170363599|NCT01021813|615666516|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
170363600|NCT01021813|615666517|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
170363601|NCT01021813|615666518|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
170363602|NCT01021813|615666514|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
170363603|NCT01021813|615666515|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
170363604|NCT01021813|615666516|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
170363605|NCT01021813|615666517|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
170363606|NCT01021813|615666518|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
170363607|NCT01117012|615666521|FG000|Overall Study|Adverse Event|0|||
170363608|NCT01117012|615666522|FG001|Overall Study|Adverse Event|1|||
170363609|NCT01117012|615666521|FG000|Overall Study|Death|1|||
170363610|NCT01117012|615666522|FG001|Overall Study|Death|1|||
170363611|NCT01117012|615666521|FG000|Overall Study|Withdrawal by Subject|3|||
170363612|NCT01117012|615666522|FG001|Overall Study|Withdrawal by Subject|0|||
170363613|NCT01117012|615666521|FG000|Overall Study|Undefined|4|||
170363614|NCT01117012|615666522|FG001|Overall Study|Undefined|3|||
170363615|NCT03695393|615666523|FG000|Overall Study|Death|3|||
170363616|NCT03695393|615666524|FG001|Overall Study|Death|1|||
170363617|NCT03695393|615666523|FG000|Overall Study|Lost to Follow-up|0|||
170363618|NCT03695393|615666524|FG001|Overall Study|Lost to Follow-up|1|||
170363619|NCT00673894|615666525|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
170363620|NCT00673894|615666526|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
170363621|NCT00673894|615666525|FG000|First Intervention 4 Weeks|Adverse Event|1|||
170363622|NCT00673894|615666526|FG001|First Intervention 4 Weeks|Adverse Event|0|||
170363623|NCT00996593|615666527|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
170363624|NCT00996593|615666527|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
170363625|NCT00996593|615666527|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
170363626|NCT00996593|615666527|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
170363627|NCT00996593|615666527|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
170363628|NCT00996593|615666527|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
170363629|NCT00996593|615666527|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
170363630|NCT00996593|615666527|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
170363631|NCT00996593|615666527|FG000|Long-Term Follow-Up|Site Closed|1|||
170363632|NCT01033487|615666528|FG000|Fourth Intervention Period|Adverse Event|0|||
170363633|NCT01033487|615666529|FG001|Fourth Intervention Period|Adverse Event|0|||
170363634|NCT01033487|615666530|FG002|Fourth Intervention Period|Adverse Event|0|||
170363635|NCT01033487|615666531|FG003|Fourth Intervention Period|Adverse Event|0|||
170363636|NCT01033487|615666532|FG004|Fourth Intervention Period|Adverse Event|0|||
170363637|NCT01033487|615666533|FG005|Fourth Intervention Period|Adverse Event|0|||
170363638|NCT01033487|615666534|FG006|Fourth Intervention Period|Adverse Event|0|||
170363639|NCT01033487|615666535|FG007|Fourth Intervention Period|Adverse Event|0|||
170363640|NCT01033487|615666536|FG008|Fourth Intervention Period|Adverse Event|1|||
170363641|NCT01033487|615666537|FG009|Fourth Intervention Period|Adverse Event|0|||
170363642|NCT00862654|615666538|FG000|Overall Study|Lack of Efficacy|1|||
170363643|NCT00862654|615666539|FG001|Overall Study|Lack of Efficacy|0|||
170363644|NCT00862654|615666540|FG002|Overall Study|Lack of Efficacy|1|||
170363645|NCT00862654|615666541|FG003|Overall Study|Lack of Efficacy|0|||
170363646|NCT00862654|615666538|FG000|Overall Study|Lost to Follow-up|1|||
170363647|NCT00862654|615666539|FG001|Overall Study|Lost to Follow-up|2|||
170363648|NCT00862654|615666540|FG002|Overall Study|Lost to Follow-up|1|||
170363649|NCT00862654|615666541|FG003|Overall Study|Lost to Follow-up|3|||
170363650|NCT00862654|615666538|FG000|Overall Study|Adverse Event|0|||
170363651|NCT00862654|615666539|FG001|Overall Study|Adverse Event|1|||
170363652|NCT00862654|615666540|FG002|Overall Study|Adverse Event|1|||
170363653|NCT00862654|615666541|FG003|Overall Study|Adverse Event|0|||
170363654|NCT00862654|615666538|FG000|Overall Study|Pregnancy|1|||
170363655|NCT00862654|615666539|FG001|Overall Study|Pregnancy|1|||
170363656|NCT00862654|615666540|FG002|Overall Study|Pregnancy|0|||
170363657|NCT00862654|615666541|FG003|Overall Study|Pregnancy|0|||
170363658|NCT00862654|615666538|FG000|Overall Study|Withdrawal by Subject|2|||
170363659|NCT00862654|615666539|FG001|Overall Study|Withdrawal by Subject|2|||
170363660|NCT00862654|615666540|FG002|Overall Study|Withdrawal by Subject|2|||
170363661|NCT00862654|615666541|FG003|Overall Study|Withdrawal by Subject|3|||
170363662|NCT00862654|615666538|FG000|Overall Study|Subject mistake|0|||
170363663|NCT00862654|615666539|FG001|Overall Study|Subject mistake|1|||
170363664|NCT00862654|615666540|FG002|Overall Study|Subject mistake|0|||
170363665|NCT00862654|615666541|FG003|Overall Study|Subject mistake|0|||
170363666|NCT00862654|615666538|FG000|Overall Study|Familly constraint|0|||
170363667|NCT00862654|615666539|FG001|Overall Study|Familly constraint|1|||
170363668|NCT00862654|615666540|FG002|Overall Study|Familly constraint|0|||
170363669|NCT00862654|615666541|FG003|Overall Study|Familly constraint|0|||
170363670|NCT00862654|615666538|FG000|Overall Study|Never used study drugs|1|||
170363671|NCT00862654|615666539|FG001|Overall Study|Never used study drugs|0|||
170363672|NCT00862654|615666540|FG002|Overall Study|Never used study drugs|0|||
170363673|NCT00862654|615666541|FG003|Overall Study|Never used study drugs|0|||
170363674|NCT00862654|615666538|FG000|Overall Study|Included after end of inclusions|0|||
170363675|NCT00862654|615666539|FG001|Overall Study|Included after end of inclusions|0|||
170363676|NCT00862654|615666540|FG002|Overall Study|Included after end of inclusions|1|||
170363677|NCT00862654|615666541|FG003|Overall Study|Included after end of inclusions|0|||
170363678|NCT03219567|615666542|FG000|Overall Study|Withdrawal by Subject|0|||
170363679|NCT03219567|615666543|FG001|Overall Study|Withdrawal by Subject|1|||
170363680|NCT02849626|615666544|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
170363681|NCT02849626|615666545|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
170363682|NCT02849626|615666546|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
170363683|NCT02849626|615666547|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
170363684|NCT02849626|615666544|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
170363685|NCT02849626|615666545|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
170363686|NCT02849626|615666546|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
170363687|NCT02849626|615666547|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
170363688|NCT02849626|615666544|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
170363689|NCT02849626|615666545|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
170363690|NCT02849626|615666546|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
170363691|NCT02849626|615666547|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
170363692|NCT02849626|615666544|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
170363693|NCT02849626|615666545|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
170363694|NCT02849626|615666546|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
170363695|NCT02849626|615666547|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
170363696|NCT02849626|615666544|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
170363697|NCT02849626|615666545|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
170363698|NCT02849626|615666546|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
170363699|NCT02849626|615666547|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
170363700|NCT02849626|615666544|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
170363701|NCT02849626|615666545|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
170363702|NCT02849626|615666546|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
170363703|NCT02849626|615666547|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
170363704|NCT02849626|615666544|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
170363705|NCT02849626|615666545|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
170363706|NCT02849626|615666546|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
170363707|NCT02849626|615666547|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
170363708|NCT02849626|615666544|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
170363709|NCT02849626|615666545|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
170363710|NCT02849626|615666546|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
170363711|NCT02849626|615666547|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
170363712|NCT02849626|615666544|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
170363713|NCT02849626|615666545|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
170363714|NCT02849626|615666546|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
170363715|NCT02849626|615666547|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
170363716|NCT02849626|615666544|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
170363717|NCT02849626|615666545|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
170363718|NCT02849626|615666546|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
170363719|NCT02849626|615666547|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
170363720|NCT02849626|615666544|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
170363721|NCT02849626|615666545|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
170363722|NCT02849626|615666546|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
170363723|NCT02849626|615666547|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
170363724|NCT01313208|615666548|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
170363725|NCT01313208|615666549|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
170363726|NCT01313208|615666548|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
170363727|NCT01313208|615666549|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
170363728|NCT01313208|615666548|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
170363729|NCT01313208|615666549|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
170363730|NCT01313208|615666548|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
170363731|NCT01313208|615666549|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
170363732|NCT01313208|615666548|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
170363733|NCT01313208|615666549|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
170363734|NCT01313208|615666548|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
170363735|NCT01313208|615666549|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
170363736|NCT01313208|615666548|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
170363737|NCT01313208|615666549|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
170363738|NCT01313208|615666548|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
170363739|NCT01313208|615666549|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
170363740|NCT01313208|615666548|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
170399315|NCT03193190|615799940|FG003|Stage 1|Progressive Disease|0|||
170363741|NCT01313208|615666549|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
170363742|NCT02726113|615666554|FG000|Total Enrollment|Physician Decision|0|||
170363743|NCT02726113|615666555|FG001|Total Enrollment|Physician Decision|1|||
170363744|NCT02726113|615666554|FG000|Total Enrollment|Protocol Violation|1|||
170363745|NCT02726113|615666555|FG001|Total Enrollment|Protocol Violation|0|||
170363746|NCT02726113|615666554|FG000|Total Enrollment|Withdrawal by Subject|2|||
170363747|NCT02726113|615666555|FG001|Total Enrollment|Withdrawal by Subject|1|||
170363748|NCT02726113|615666554|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
170363749|NCT02726113|615666555|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
170363750|NCT02726113|615666554|FG000|Genomic Analysis|Protocol Violation|1|||
170363751|NCT02726113|615666555|FG001|Genomic Analysis|Protocol Violation|0|||
170363752|NCT02726113|615666554|FG000|Genomic Analysis|Withdrawal by Subject|2|||
170363753|NCT02726113|615666555|FG001|Genomic Analysis|Withdrawal by Subject|1|||
170363754|NCT02726113|615666554|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
170363755|NCT02726113|615666555|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
170363756|NCT03549117|615666558|FG000|Overall Study|Withdrawal by Subject|1|||
170363757|NCT03549117|615666559|FG001|Overall Study|Withdrawal by Subject|0|||
170363758|NCT02661464|615666560|FG000|Overall Study|Lost to Follow-up|28|||
170363759|NCT02661464|615666561|FG001|Overall Study|Lost to Follow-up|0|||
170363760|NCT02661464|615666562|FG002|Overall Study|Lost to Follow-up|0|||
170363761|NCT02661464|615666563|FG003|Overall Study|Lost to Follow-up|0|||
170363762|NCT02661464|615666560|FG000|Overall Study|Withdrawal by Subject|3|||
170363763|NCT02661464|615666561|FG001|Overall Study|Withdrawal by Subject|1|||
170363764|NCT02661464|615666562|FG002|Overall Study|Withdrawal by Subject|0|||
170363765|NCT02661464|615666563|FG003|Overall Study|Withdrawal by Subject|0|||
170363766|NCT02661464|615666560|FG000|Overall Study|Participants terminated prematurely|288|||
170363767|NCT02661464|615666561|FG001|Overall Study|Participants terminated prematurely|52|||
170363768|NCT02661464|615666562|FG002|Overall Study|Participants terminated prematurely|1|||
170363769|NCT02661464|615666563|FG003|Overall Study|Participants terminated prematurely|1|||
170363770|NCT02661464|615666560|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
170363771|NCT02661464|615666561|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
170363772|NCT02661464|615666562|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
170363773|NCT02661464|615666563|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
170363774|NCT03148756|615666564|FG000|Overall Study|Study Terminated|0|||
170363775|NCT03148756|615666565|FG001|Overall Study|Study Terminated|1|||
170363776|NCT02177175|615666571|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
170363777|NCT02177175|615666572|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
170363778|NCT01924299|615666573|FG000|Period 2|Withdrawal by Subject|1|||
170363779|NCT01924299|615666574|FG001|Period 2|Withdrawal by Subject|0|||
170363780|NCT01924299|615666573|FG000|Period 2|Adverse Event|0|||
170363781|NCT01924299|615666574|FG001|Period 2|Adverse Event|1|||
170363782|NCT04199793|615666575|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
170363783|NCT04199793|615666576|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
170363784|NCT04199793|615666575|FG000|Overall Study|Withdrawal by Subject|1|||
170363785|NCT04199793|615666576|FG001|Overall Study|Withdrawal by Subject|1|||
170363786|NCT03820726|615666581|FG000|Overall Study|Other than listed|23|||
170363787|NCT03820726|615666581|FG000|Overall Study|Withdrawal by Subject|37|||
170363788|NCT03820726|615666581|FG000|Overall Study|Lost to Follow-up|3|||
170363789|NCT03820726|615666581|FG000|Overall Study|Protocol deviation|1|||
170363790|NCT03820726|615666581|FG000|Overall Study|Adverse Event|146|||
170363791|NCT03820726|615666581|FG000|Overall Study|Not treated|1|||
170363792|NCT00861380|615666586|FG000|Overall Study|Withdrawal Information not recorded|8427|||
170363793|NCT00861380|615666587|FG001|Overall Study|Withdrawal Information not recorded|9112|||
170363794|NCT00861380|615666588|FG002|Overall Study|Withdrawal Information not recorded|8872|||
170363795|NCT00861380|615666589|FG003|Overall Study|Withdrawal Information not recorded|3689|||
170363796|NCT00861380|615666590|FG004|Overall Study|Withdrawal Information not recorded|1812|||
170363797|NCT00861380|615666591|FG005|Overall Study|Withdrawal Information not recorded|6249|||
170363798|NCT00861380|615666592|FG006|Overall Study|Withdrawal Information not recorded|3020|||
170363799|NCT00628758|615666593|FG000|Overall Study|Adverse Event|2|||
170363800|NCT00628758|615666594|FG001|Overall Study|Adverse Event|3|||
170363801|NCT00628758|615666593|FG000|Overall Study|Withdrawal by Subject|6|||
170363802|NCT00628758|615666594|FG001|Overall Study|Withdrawal by Subject|3|||
170363803|NCT00628758|615666593|FG000|Overall Study|Death|1|||
170363804|NCT00628758|615666594|FG001|Overall Study|Death|0|||
170363805|NCT00628758|615666593|FG000|Overall Study|Protocol Violation|5|||
170363806|NCT00628758|615666594|FG001|Overall Study|Protocol Violation|1|||
170363807|NCT00628758|615666593|FG000|Overall Study|Lost to Follow-up|25|||
170363808|NCT00628758|615666594|FG001|Overall Study|Lost to Follow-up|31|||
170363809|NCT00628758|615666593|FG000|Overall Study|Pregnancy|2|||
170363810|NCT00628758|615666594|FG001|Overall Study|Pregnancy|2|||
170363811|NCT00628758|615666593|FG000|Overall Study|Investigator Moved|3|||
170363812|NCT00628758|615666594|FG001|Overall Study|Investigator Moved|0|||
170363813|NCT00628758|615666593|FG000|Overall Study|Treatment Failure|0|||
170363814|NCT00628758|615666594|FG001|Overall Study|Treatment Failure|2|||
170363815|NCT00637377|615666595|FG000|Overall Study|Adverse Event|2|||
170363816|NCT00637377|615666596|FG001|Overall Study|Adverse Event|6|||
170363817|NCT00637377|615666597|FG002|Overall Study|Adverse Event|8|||
170363818|NCT00637377|615666598|FG003|Overall Study|Adverse Event|9|||
170363819|NCT00637377|615666595|FG000|Overall Study|Death|1|||
170363820|NCT00637377|615666596|FG001|Overall Study|Death|3|||
170363821|NCT00637377|615666597|FG002|Overall Study|Death|2|||
170363822|NCT00637377|615666598|FG003|Overall Study|Death|1|||
170363823|NCT00637377|615666595|FG000|Overall Study|Lack of Efficacy|0|||
170363824|NCT00637377|615666596|FG001|Overall Study|Lack of Efficacy|0|||
170363825|NCT00637377|615666597|FG002|Overall Study|Lack of Efficacy|1|||
170363826|NCT00637377|615666598|FG003|Overall Study|Lack of Efficacy|1|||
170363827|NCT00637377|615666595|FG000|Overall Study|Lost to Follow-up|4|||
170363828|NCT00637377|615666596|FG001|Overall Study|Lost to Follow-up|1|||
170363829|NCT00637377|615666597|FG002|Overall Study|Lost to Follow-up|2|||
170363830|NCT00637377|615666598|FG003|Overall Study|Lost to Follow-up|2|||
170363831|NCT00637377|615666595|FG000|Overall Study|Protocol Violation|2|||
170363832|NCT00637377|615666596|FG001|Overall Study|Protocol Violation|1|||
170363833|NCT00637377|615666597|FG002|Overall Study|Protocol Violation|1|||
170363834|NCT00637377|615666598|FG003|Overall Study|Protocol Violation|0|||
170363835|NCT00637377|615666595|FG000|Overall Study|Withdrawal by Subject|11|||
170363836|NCT00637377|615666596|FG001|Overall Study|Withdrawal by Subject|15|||
170363837|NCT00637377|615666597|FG002|Overall Study|Withdrawal by Subject|13|||
170363838|NCT00637377|615666598|FG003|Overall Study|Withdrawal by Subject|11|||
170363839|NCT00637377|615666595|FG000|Overall Study|Other (no further information available)|7|||
170363840|NCT00637377|615666596|FG001|Overall Study|Other (no further information available)|6|||
170363841|NCT00637377|615666597|FG002|Overall Study|Other (no further information available)|10|||
170363842|NCT00637377|615666598|FG003|Overall Study|Other (no further information available)|5|||
170363843|NCT01293084|615666605|FG000|Overall Study|Physician Decision|3|||
170363844|NCT01293084|615666605|FG000|Overall Study|Withdrawal by Subject|2|||
170363845|NCT04021706|615668759|FG000|Overall Study|Adverse Event|2|||
170363846|NCT04021706|615668760|FG001|Overall Study|Adverse Event|0|||
170363847|NCT04021706|615668759|FG000|Overall Study|Withdrawal by Subject|1|||
170363848|NCT04021706|615668760|FG001|Overall Study|Withdrawal by Subject|2|||
170363849|NCT04021706|615668759|FG000|Overall Study|Physician Decision|1|||
170363850|NCT04021706|615668760|FG001|Overall Study|Physician Decision|0|||
170363851|NCT02332798|615668763|FG000|Overall Study|Unwilling to Participate in Study|0|||
170363852|NCT02332798|615668764|FG001|Overall Study|Unwilling to Participate in Study|1|||
170363853|NCT02332798|615668765|FG002|Overall Study|Unwilling to Participate in Study|1|||
170363854|NCT02332798|615668763|FG000|Overall Study|Positive Urine Drug Test|0|||
170363855|NCT02332798|615668764|FG001|Overall Study|Positive Urine Drug Test|1|||
170363856|NCT02332798|615668765|FG002|Overall Study|Positive Urine Drug Test|0|||
170363857|NCT02332798|615668763|FG000|Overall Study|Abnormal Laboratory Findings|1|||
170363858|NCT02332798|615668764|FG001|Overall Study|Abnormal Laboratory Findings|0|||
170363859|NCT02332798|615668765|FG002|Overall Study|Abnormal Laboratory Findings|0|||
170363860|NCT00595868|615668766|FG000|Overall Study|Lost to Follow-up|45|||
170363861|NCT00595868|615668767|FG001|Overall Study|Lost to Follow-up|50|||
170363862|NCT02688153|615668768|FG000|Overall Study|Death|7|||
170363863|NCT02688153|615668769|FG001|Overall Study|Death|5|||
170363864|NCT02688153|615668768|FG000|Overall Study|Withdrawal by Subject|4|||
170363865|NCT02688153|615668769|FG001|Overall Study|Withdrawal by Subject|2|||
170363866|NCT02688153|615668768|FG000|Overall Study|Valve Explant|1|||
170363867|NCT02688153|615668769|FG001|Overall Study|Valve Explant|0|||
170363868|NCT02688153|615668768|FG000|Overall Study|Conversion to Commercial Valve|3|||
170363869|NCT02688153|615668769|FG001|Overall Study|Conversion to Commercial Valve|0|||
170363870|NCT00107172|615668770|FG000|Overall Study|Withdrawal by Subject|1|||
170363871|NCT00107172|615668771|FG001|Overall Study|Withdrawal by Subject|0|||
170363872|NCT00107172|615668770|FG000|Overall Study|Death|0|||
170363873|NCT00107172|615668771|FG001|Overall Study|Death|2|||
170363874|NCT00107172|615668770|FG000|Overall Study|Other Reason|4|||
170363875|NCT00107172|615668771|FG001|Overall Study|Other Reason|3|||
170363876|NCT04268303|615668772|FG000|Overall Study|Lost to Follow-up|1|||
170363877|NCT04268303|615668773|FG001|Overall Study|Lost to Follow-up|1|||
170363878|NCT04268303|615668774|FG002|Overall Study|Lost to Follow-up|2|||
170363879|NCT04268303|615668772|FG000|Overall Study|Withdrawal by Subject|0|||
170363880|NCT04268303|615668773|FG001|Overall Study|Withdrawal by Subject|1|||
170363881|NCT04268303|615668774|FG002|Overall Study|Withdrawal by Subject|1|||
170363882|NCT04268303|615668772|FG000|Overall Study|Adverse Event|2|||
170363883|NCT04268303|615668773|FG001|Overall Study|Adverse Event|0|||
170363884|NCT04268303|615668774|FG002|Overall Study|Adverse Event|0|||
170363885|NCT00355134|615668775|FG000|Core Phase|Withdrawal by Subject|35|||
170363886|NCT00355134|615668776|FG001|Core Phase|Withdrawal by Subject|24|||
170363887|NCT00355134|615668777|FG002|Core Phase|Withdrawal by Subject|35|||
170363888|NCT00355134|615668778|FG003|Core Phase|Withdrawal by Subject|0|||
170363889|NCT00355134|615668779|FG004|Core Phase|Withdrawal by Subject|0|||
170363890|NCT00355134|615668775|FG000|Core Phase|Adverse Event|28|||
170363891|NCT00355134|615668776|FG001|Core Phase|Adverse Event|22|||
170363892|NCT00355134|615668777|FG002|Core Phase|Adverse Event|16|||
170363893|NCT00355134|615668778|FG003|Core Phase|Adverse Event|0|||
170363894|NCT00355134|615668779|FG004|Core Phase|Adverse Event|0|||
170363895|NCT00355134|615668775|FG000|Core Phase|Lost to Follow-up|17|||
170363896|NCT00355134|615668776|FG001|Core Phase|Lost to Follow-up|13|||
170363897|NCT00355134|615668777|FG002|Core Phase|Lost to Follow-up|21|||
170363898|NCT00355134|615668778|FG003|Core Phase|Lost to Follow-up|0|||
170363899|NCT00355134|615668779|FG004|Core Phase|Lost to Follow-up|0|||
170363900|NCT00355134|615668775|FG000|Core Phase|Abnormal laboratory value(s)|19|||
170363901|NCT00355134|615668776|FG001|Core Phase|Abnormal laboratory value(s)|14|||
170363902|NCT00355134|615668777|FG002|Core Phase|Abnormal laboratory value(s)|2|||
170363903|NCT00355134|615668778|FG003|Core Phase|Abnormal laboratory value(s)|0|||
170363904|NCT00355134|615668779|FG004|Core Phase|Abnormal laboratory value(s)|0|||
170363905|NCT00355134|615668775|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
170363906|NCT00355134|615668776|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
170363907|NCT00355134|615668777|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
170363908|NCT00355134|615668778|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
170363909|NCT00355134|615668779|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
170363910|NCT00355134|615668775|FG000|Core Phase|Administrative problems|5|||
170363911|NCT00355134|615668776|FG001|Core Phase|Administrative problems|3|||
170363912|NCT00355134|615668777|FG002|Core Phase|Administrative problems|5|||
170363913|NCT00355134|615668778|FG003|Core Phase|Administrative problems|0|||
170363914|NCT00355134|615668779|FG004|Core Phase|Administrative problems|0|||
170363915|NCT00355134|615668775|FG000|Core Phase|Protocol Violation|3|||
170363916|NCT00355134|615668776|FG001|Core Phase|Protocol Violation|2|||
170363917|NCT00355134|615668777|FG002|Core Phase|Protocol Violation|2|||
170363918|NCT00355134|615668778|FG003|Core Phase|Protocol Violation|0|||
170363919|NCT00355134|615668779|FG004|Core Phase|Protocol Violation|0|||
170363920|NCT00355134|615668775|FG000|Core Phase|Abnormal test procedure result(s)|1|||
170363921|NCT00355134|615668776|FG001|Core Phase|Abnormal test procedure result(s)|2|||
170363922|NCT00355134|615668777|FG002|Core Phase|Abnormal test procedure result(s)|1|||
170363923|NCT00355134|615668778|FG003|Core Phase|Abnormal test procedure result(s)|0|||
170363924|NCT00355134|615668779|FG004|Core Phase|Abnormal test procedure result(s)|0|||
170363925|NCT00355134|615668775|FG000|Core Phase|Condition no longer requires study drug|1|||
170363926|NCT00355134|615668776|FG001|Core Phase|Condition no longer requires study drug|0|||
170363927|NCT00355134|615668777|FG002|Core Phase|Condition no longer requires study drug|1|||
170363928|NCT00355134|615668778|FG003|Core Phase|Condition no longer requires study drug|0|||
170363929|NCT00355134|615668779|FG004|Core Phase|Condition no longer requires study drug|0|||
170363930|NCT00355134|615668775|FG000|Extension Phase|Withdrawal by Subject|7|||
170363931|NCT00355134|615668776|FG001|Extension Phase|Withdrawal by Subject|11|||
170363932|NCT00355134|615668777|FG002|Extension Phase|Withdrawal by Subject|0|||
170363933|NCT00355134|615668778|FG003|Extension Phase|Withdrawal by Subject|7|||
170363934|NCT00355134|615668779|FG004|Extension Phase|Withdrawal by Subject|5|||
170363935|NCT00355134|615668775|FG000|Extension Phase|Adverse Event|13|||
170363936|NCT00355134|615668776|FG001|Extension Phase|Adverse Event|9|||
170363937|NCT00355134|615668777|FG002|Extension Phase|Adverse Event|0|||
170363938|NCT00355134|615668778|FG003|Extension Phase|Adverse Event|3|||
170363939|NCT00355134|615668779|FG004|Extension Phase|Adverse Event|5|||
170363940|NCT00355134|615668775|FG000|Extension Phase|Lost to Follow-up|2|||
170363941|NCT00355134|615668776|FG001|Extension Phase|Lost to Follow-up|6|||
170363942|NCT00355134|615668777|FG002|Extension Phase|Lost to Follow-up|0|||
170363943|NCT00355134|615668778|FG003|Extension Phase|Lost to Follow-up|2|||
170363944|NCT00355134|615668779|FG004|Extension Phase|Lost to Follow-up|4|||
170363945|NCT00355134|615668775|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
170363946|NCT00355134|615668776|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
170363947|NCT00355134|615668777|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
170363948|NCT00355134|615668778|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
170363949|NCT00355134|615668779|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
170363950|NCT00355134|615668775|FG000|Extension Phase|Administrative problems|2|||
170363951|NCT00355134|615668776|FG001|Extension Phase|Administrative problems|4|||
170363952|NCT00355134|615668777|FG002|Extension Phase|Administrative problems|0|||
170363953|NCT00355134|615668778|FG003|Extension Phase|Administrative problems|1|||
170363954|NCT00355134|615668779|FG004|Extension Phase|Administrative problems|1|||
170363955|NCT00355134|615668775|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
170363956|NCT00355134|615668776|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
170363957|NCT00355134|615668777|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
170363958|NCT00355134|615668778|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
170363959|NCT00355134|615668779|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
170363960|NCT00355134|615668775|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
170363961|NCT00355134|615668776|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
170363962|NCT00355134|615668777|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
170363963|NCT00355134|615668778|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
170363964|NCT00355134|615668779|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
170363965|NCT00355134|615668775|FG000|Extension Phase|Protocol Violation|0|||
170363966|NCT00355134|615668776|FG001|Extension Phase|Protocol Violation|0|||
170363967|NCT00355134|615668777|FG002|Extension Phase|Protocol Violation|0|||
170363968|NCT00355134|615668778|FG003|Extension Phase|Protocol Violation|1|||
170363969|NCT00355134|615668779|FG004|Extension Phase|Protocol Violation|0|||
170363970|NCT00859573|615668780|FG000|Overall Study|Withdrawal by Subject|4|||
170363971|NCT00859573|615668781|FG001|Overall Study|Withdrawal by Subject|1|||
170363972|NCT00859573|615668780|FG000|Overall Study|Physician Decision|1|||
170363973|NCT00859573|615668781|FG001|Overall Study|Physician Decision|1|||
170363974|NCT00462488|615668793|FG000|Overall Study|Protocol Violation|1|||
170363975|NCT00462488|615668794|FG001|Overall Study|Protocol Violation|0|||
170363976|NCT00462488|615668793|FG000|Overall Study|Lack of Efficacy|19|||
170363977|NCT00462488|615668794|FG001|Overall Study|Lack of Efficacy|17|||
170363978|NCT05742841|615668797|FG000|Overall Study|Withdrawal by Subject|1|||
170363979|NCT05742841|615668797|FG000|Overall Study|Lost to Follow-up|1|||
170363980|NCT03750240|615668799|FG000|Overall Study|Technical Difficulties|2|||
170363981|NCT03706040|615668800|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
170363982|NCT03706040|615668801|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
170363983|NCT03706040|615668802|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
170363984|NCT03706040|615668803|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
170363985|NCT03706040|615668804|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
170363986|NCT03706040|615668805|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
170363987|NCT03706040|615668806|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
170363988|NCT03706040|615668800|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
170363989|NCT03706040|615668801|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
170363990|NCT03706040|615668802|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
170363991|NCT03706040|615668803|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
170363992|NCT03706040|615668804|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
170363993|NCT03706040|615668805|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
170363994|NCT03706040|615668806|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
170363995|NCT03706040|615668800|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
170363996|NCT03706040|615668801|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
170363997|NCT03706040|615668802|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
170363998|NCT03706040|615668803|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
170363999|NCT03706040|615668804|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
170364000|NCT03706040|615668805|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
170364001|NCT03706040|615668806|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
170364002|NCT03706040|615668800|FG000|Period A (Week 0 to Week 16)|Other|2|||
170364003|NCT03706040|615668801|FG001|Period A (Week 0 to Week 16)|Other|0|||
170364004|NCT03706040|615668802|FG002|Period A (Week 0 to Week 16)|Other|2|||
170364005|NCT03706040|615668803|FG003|Period A (Week 0 to Week 16)|Other|0|||
170364006|NCT03706040|615668804|FG004|Period A (Week 0 to Week 16)|Other|0|||
170364007|NCT03706040|615668805|FG005|Period A (Week 0 to Week 16)|Other|0|||
170364008|NCT03706040|615668806|FG006|Period A (Week 0 to Week 16)|Other|0|||
170364009|NCT03706040|615668800|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
170364010|NCT03706040|615668801|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
170364011|NCT03706040|615668802|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
170364012|NCT03706040|615668803|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
170364013|NCT03706040|615668804|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
170364014|NCT03706040|615668805|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
170364015|NCT03706040|615668806|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
170364016|NCT03706040|615668800|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
170364017|NCT03706040|615668801|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
170364018|NCT03706040|615668802|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
170364019|NCT03706040|615668803|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
170364020|NCT03706040|615668804|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
170364021|NCT03706040|615668805|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
170364022|NCT03706040|615668806|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
170364023|NCT03706040|615668800|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
170364024|NCT03706040|615668801|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
170364025|NCT03706040|615668802|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
170364026|NCT03706040|615668803|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
170364027|NCT03706040|615668804|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
170364028|NCT03706040|615668805|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
170364029|NCT03706040|615668806|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
170364030|NCT03706040|615668800|FG000|Period B (Week 16 to Week 52)|Other|0|||
170364031|NCT03706040|615668801|FG001|Period B (Week 16 to Week 52)|Other|0|||
170364032|NCT03706040|615668802|FG002|Period B (Week 16 to Week 52)|Other|0|||
170364033|NCT03706040|615668803|FG003|Period B (Week 16 to Week 52)|Other|4|||
170364034|NCT03706040|615668804|FG004|Period B (Week 16 to Week 52)|Other|5|||
170364035|NCT03706040|615668805|FG005|Period B (Week 16 to Week 52)|Other|23|||
170364036|NCT03706040|615668806|FG006|Period B (Week 16 to Week 52)|Other|17|||
170364037|NCT00927758|615668807|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
170364038|NCT00927758|615668808|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
170364039|NCT00927758|615668809|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
170364040|NCT00927758|615668810|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
170364041|NCT00927758|615668811|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
170364042|NCT00927758|615668812|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
170364043|NCT00927758|615668807|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
170364044|NCT00927758|615668808|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
170364045|NCT00927758|615668809|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
170364046|NCT00927758|615668810|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
170364047|NCT00927758|615668811|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
170364048|NCT00927758|615668812|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
170364049|NCT00439725|615668813|FG000|Treatment Period|Withdrawal by Subject|22|||
170364050|NCT00439725|615668814|FG001|Treatment Period|Withdrawal by Subject|19|||
170364051|NCT00439725|615668813|FG000|Treatment Period|Study terminated by sponsor|156|||
170364052|NCT00439725|615668814|FG001|Treatment Period|Study terminated by sponsor|148|||
170364053|NCT00439725|615668813|FG000|Treatment Period|Site closed by investigator|1|||
170364054|NCT00439725|615668814|FG001|Treatment Period|Site closed by investigator|2|||
170364055|NCT00439725|615668813|FG000|Treatment Period|Adverse Event|39|||
170364056|NCT00439725|615668814|FG001|Treatment Period|Adverse Event|18|||
170364057|NCT00439725|615668813|FG000|Treatment Period|Physician Decision|1|||
170364058|NCT00439725|615668814|FG001|Treatment Period|Physician Decision|1|||
170364059|NCT00439725|615668813|FG000|Treatment Period|Protocol Violation|2|||
170364060|NCT00439725|615668814|FG001|Treatment Period|Protocol Violation|1|||
170364061|NCT00439725|615668813|FG000|Treatment Period|Clinical endpoint reached|6|||
170364062|NCT00439725|615668814|FG001|Treatment Period|Clinical endpoint reached|50|||
170364063|NCT00439725|615668813|FG000|Treatment Period|Technical problems|1|||
170364064|NCT00439725|615668814|FG001|Treatment Period|Technical problems|0|||
170364065|NCT00439725|615668813|FG000|Treatment Period|Lost to Follow-up|1|||
170364066|NCT00439725|615668814|FG001|Treatment Period|Lost to Follow-up|1|||
170364067|NCT00439725|615668813|FG000|Treatment Period|Participant convenience|1|||
170364068|NCT00439725|615668814|FG001|Treatment Period|Participant convenience|0|||
170364069|NCT00439725|615668813|FG000|Treatment Period|Protocol driven decision point|1|||
170364070|NCT00439725|615668814|FG001|Treatment Period|Protocol driven decision point|1|||
170364071|NCT00439725|615668813|FG000|Treatment Period|Death|1|||
170364072|NCT00439725|615668814|FG001|Treatment Period|Death|1|||
170364073|NCT00439725|615668813|FG000|Treatment Period|Participant did not receive treatment|4|||
170364074|NCT00439725|615668814|FG001|Treatment Period|Participant did not receive treatment|4|||
170364075|NCT00439725|615668813|FG000|Observational Period|Withdrawal by Subject|2|||
170364076|NCT00439725|615668814|FG001|Observational Period|Withdrawal by Subject|2|||
170364077|NCT00439725|615668813|FG000|Observational Period|Lost to Follow-up|0|||
170364078|NCT00439725|615668814|FG001|Observational Period|Lost to Follow-up|1|||
170364079|NCT00439725|615668813|FG000|Observational Period|Death|0|||
170364080|NCT00439725|615668814|FG001|Observational Period|Death|2|||
170364081|NCT00439725|615668813|FG000|Observational Period|Study termination by sponsor|1|||
170364082|NCT00439725|615668814|FG001|Observational Period|Study termination by sponsor|1|||
170364083|NCT00439725|615668813|FG000|Observational Period|Clinical endpoint reached|3|||
170364084|NCT00439725|615668814|FG001|Observational Period|Clinical endpoint reached|1|||
170364085|NCT00439725|615668813|FG000|Observational Period|Technical problems|1|||
170364086|NCT00439725|615668814|FG001|Observational Period|Technical problems|0|||
170364087|NCT00439725|615668813|FG000|Observational Period|Participant convenience|1|||
170364088|NCT00439725|615668814|FG001|Observational Period|Participant convenience|0|||
170364089|NCT03984812|615668816|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364090|NCT03984812|615668817|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364091|NCT03984812|615668818|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
170364092|NCT03984812|615668819|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364093|NCT03984812|615668820|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364094|NCT03984812|615668821|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364095|NCT03984812|615668822|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364096|NCT03984812|615668823|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364097|NCT03984812|615668824|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364098|NCT03984812|615668825|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364099|NCT03984812|615668826|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
170364100|NCT03510910|615668827|FG000|Overall Study|Incomplete Survey|2|||
170364101|NCT03510910|615668828|FG001|Overall Study|Incomplete Survey|3|||
170364102|NCT04914819|615668836|FG000|Overall Study|Pregnancy|3|||
170364103|NCT04914819|615668837|FG001|Overall Study|Pregnancy|1|||
170364104|NCT04914819|615668836|FG000|Overall Study|Discontinued study|4|||
170364105|NCT04914819|615668837|FG001|Overall Study|Discontinued study|1|||
170364106|NCT04914819|615668836|FG000|Overall Study|Lost to Follow-up|7|||
170364107|NCT04914819|615668837|FG001|Overall Study|Lost to Follow-up|0|||
170364108|NCT01711541|615668838|FG000|Overall Study|Cancel prior to treatment|0|||
170364109|NCT01711541|615668839|FG001|Overall Study|Cancel prior to treatment|0|||
170364110|NCT01711541|615668840|FG002|Overall Study|Cancel prior to treatment|0|||
170364111|NCT01711541|615668841|FG003|Overall Study|Cancel prior to treatment|1|||
170364112|NCT01711541|615668842|FG004|Overall Study|Cancel prior to treatment|0|||
170364113|NCT01711541|615668838|FG000|Overall Study|Ineligible|0|||
170364114|NCT01711541|615668839|FG001|Overall Study|Ineligible|1|||
170364115|NCT01711541|615668840|FG002|Overall Study|Ineligible|0|||
170364116|NCT01711541|615668841|FG003|Overall Study|Ineligible|0|||
170364117|NCT01711541|615668842|FG004|Overall Study|Ineligible|0|||
170364118|NCT03943446|615668843|FG000|Overall Study|Lost to Follow-up|0|||
170364119|NCT03943446|615668844|FG001|Overall Study|Lost to Follow-up|0|||
170364120|NCT03943446|615668845|FG002|Overall Study|Lost to Follow-up|1|||
170364121|NCT03943446|615668843|FG000|Overall Study|Withdrawal by Subject|1|||
170364122|NCT03943446|615668844|FG001|Overall Study|Withdrawal by Subject|1|||
170364123|NCT03943446|615668845|FG002|Overall Study|Withdrawal by Subject|2|||
170364124|NCT03943446|615668843|FG000|Overall Study|Study Terminated by Sponsor|1|||
170364125|NCT03943446|615668844|FG001|Overall Study|Study Terminated by Sponsor|2|||
170364126|NCT03943446|615668845|FG002|Overall Study|Study Terminated by Sponsor|1|||
170364127|NCT03943446|615668843|FG000|Overall Study|Reason not Specified|5|||
170364128|NCT03943446|615668844|FG001|Overall Study|Reason not Specified|1|||
170364129|NCT03943446|615668845|FG002|Overall Study|Reason not Specified|3|||
170364130|NCT03170258|615668846|FG000|Overall Study|Physician Decision|4|||
170364131|NCT03170258|615668847|FG001|Overall Study|Physician Decision|0|||
170364132|NCT03170258|615668846|FG000|Overall Study|Equipment issues|1|||
170364133|NCT03170258|615668847|FG001|Overall Study|Equipment issues|0|||
170364134|NCT03170258|615668846|FG000|Overall Study|Medication|1|||
170364135|NCT03170258|615668847|FG001|Overall Study|Medication|0|||
170364136|NCT03170258|615668846|FG000|Overall Study|Sleep issues|1|||
170364137|NCT03170258|615668847|FG001|Overall Study|Sleep issues|0|||
170364138|NCT02905825|615668848|FG000|Overall Study|Protocol Violation|11|||
170364139|NCT02905825|615668848|FG000|Overall Study|Device Malfunction|1|||
170364140|NCT00666536|615668849|FG000|Overall Study|Adverse Event|9|||
170364141|NCT00666536|615668850|FG001|Overall Study|Adverse Event|19|||
170364142|NCT00666536|615668849|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
170364143|NCT00666536|615668850|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
170364144|NCT00666536|615668849|FG000|Overall Study|Protocol deviation(s)|8|||
170364145|NCT00666536|615668850|FG001|Overall Study|Protocol deviation(s)|6|||
170364146|NCT00666536|615668849|FG000|Overall Study|Withdrawal by Subject|10|||
170364147|NCT00666536|615668850|FG001|Overall Study|Withdrawal by Subject|9|||
170364148|NCT00666536|615668849|FG000|Overall Study|Lost to Follow-up|4|||
170364149|NCT00666536|615668850|FG001|Overall Study|Lost to Follow-up|3|||
170364150|NCT02580240|615668856|FG000|Overall Study|Physician Decision|2|||
170364151|NCT02580240|615668857|FG001|Overall Study|Physician Decision|0|||
170364152|NCT01100658|615668858|FG000|Overall Study|Withdrawal by Subject|1|||
170364153|NCT01784211|615668859|FG000|Part A (Days 1-15)|Adverse Event|1|||
170364154|NCT01784211|615668860|FG001|Part A (Days 1-15)|Adverse Event|1|||
170364155|NCT01784211|615668861|FG002|Part A (Days 1-15)|Adverse Event|0|||
170364156|NCT01784211|615668862|FG003|Part A (Days 1-15)|Adverse Event|0|||
170364157|NCT01784211|615668863|FG004|Part A (Days 1-15)|Adverse Event|0|||
170364158|NCT01784211|615668864|FG005|Part A (Days 1-15)|Adverse Event|0|||
170364159|NCT01784211|615668859|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
170364160|NCT01784211|615668860|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
170364161|NCT01784211|615668861|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
170364162|NCT01784211|615668862|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
170364163|NCT01784211|615668863|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
170364164|NCT01784211|615668864|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
170364165|NCT00239356|615668865|FG000|Overall Study|Lack of Efficacy|1|||
170364166|NCT00239356|615668866|FG001|Overall Study|Lack of Efficacy|0|||
170364167|NCT00239356|615668865|FG000|Overall Study|Adverse Event|6|||
170364168|NCT00239356|615668866|FG001|Overall Study|Adverse Event|0|||
170364169|NCT00239356|615668865|FG000|Overall Study|Withdrawal by Subject|15|||
170364170|NCT00239356|615668866|FG001|Overall Study|Withdrawal by Subject|6|||
170364171|NCT00239356|615668865|FG000|Overall Study|Lost to Follow-up|3|||
170364172|NCT00239356|615668866|FG001|Overall Study|Lost to Follow-up|0|||
170364173|NCT00239356|615668865|FG000|Overall Study|poor/non-compliance|2|||
170364174|NCT00239356|615668866|FG001|Overall Study|poor/non-compliance|0|||
170364175|NCT00239356|615668865|FG000|Overall Study|Pregnancy|1|||
170364176|NCT00239356|615668866|FG001|Overall Study|Pregnancy|0|||
170364177|NCT00239356|615668865|FG000|Overall Study|Administrative reason|0|||
170364178|NCT00239356|615668866|FG001|Overall Study|Administrative reason|1|||
170364179|NCT00239356|615668865|FG000|Overall Study|Drug available on market|11|||
170364180|NCT00239356|615668866|FG001|Overall Study|Drug available on market|2|||
170364181|NCT01094808|615668867|FG000|Overall Study|Withdrawal by Subject|1|||
170364182|NCT01094808|615668868|FG001|Overall Study|Withdrawal by Subject|1|||
170364183|NCT01094808|615668869|FG002|Overall Study|Withdrawal by Subject|0|||
170364184|NCT02044822|615668870|FG000|Overall Study|Study Terminated by Sponsor|77|||
170364185|NCT02044822|615668870|FG000|Overall Study|Investigator's Discretion|10|||
170364186|NCT02044822|615668870|FG000|Overall Study|Withdrew Consent|3|||
170364187|NCT02044822|615668870|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
170364188|NCT02044822|615668870|FG000|Overall Study|Lost to Follow-up|1|||
170364189|NCT02025530|615668871|FG000|Overall Study|No longer met elligibility criteria|5|||
170364190|NCT02025530|615668872|FG001|Overall Study|No longer met elligibility criteria|1|||
170364191|NCT03051217|615668880|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
170364192|NCT03051217|615668881|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170364193|NCT03051217|615668882|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
170364194|NCT03051217|615668883|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170364195|NCT03051217|615668884|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170364196|NCT03051217|615668885|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170364197|NCT03051217|615668886|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
170364198|NCT03051217|615668880|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
170364199|NCT03051217|615668881|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
170364200|NCT03051217|615668882|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
170364201|NCT03051217|615668883|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
170364202|NCT03051217|615668884|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
170364203|NCT03051217|615668885|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
170364204|NCT03051217|615668886|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
170364205|NCT03051217|615668880|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
170364206|NCT03051217|615668881|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
170364207|NCT03051217|615668882|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
170364208|NCT03051217|615668883|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170364209|NCT03051217|615668884|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170364210|NCT03051217|615668885|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170364211|NCT03051217|615668886|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
170364212|NCT03051217|615668880|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
170364213|NCT03051217|615668881|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
170364214|NCT03051217|615668882|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
170364215|NCT03051217|615668883|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
170364216|NCT03051217|615668884|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
170364217|NCT03051217|615668885|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
170364218|NCT03051217|615668886|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
170364219|NCT03051217|615668880|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
170364220|NCT03051217|615668881|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
170364221|NCT03051217|615668882|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
170364222|NCT03051217|615668883|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
170364223|NCT03051217|615668884|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
170364224|NCT03051217|615668885|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
170364225|NCT03051217|615668886|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
170364226|NCT03051217|615668880|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
170364227|NCT03051217|615668881|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
170364228|NCT03051217|615668882|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
170364229|NCT03051217|615668883|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
170364230|NCT03051217|615668884|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
170364231|NCT03051217|615668885|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
170364232|NCT03051217|615668886|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
170364233|NCT03051217|615668880|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
170364234|NCT03051217|615668881|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
170364235|NCT03051217|615668882|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
170364236|NCT03051217|615668883|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
170364237|NCT03051217|615668884|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
170364238|NCT03051217|615668885|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
170364239|NCT03051217|615668886|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
170364240|NCT03051217|615668880|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
170364241|NCT03051217|615668881|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
170364242|NCT03051217|615668882|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
170364243|NCT03051217|615668883|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
170364244|NCT03051217|615668884|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
170364245|NCT03051217|615668885|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
170364246|NCT03051217|615668886|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
170364247|NCT04702984|615668895|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
170364248|NCT00064077|615668898|FG000|Overall Study|Improper prior treatment|1|||
170364249|NCT00064077|615668899|FG001|Overall Study|Improper prior treatment|0|||
170364250|NCT00064077|615668900|FG002|Overall Study|Improper prior treatment|0|||
170364251|NCT00064077|615668901|FG003|Overall Study|Improper prior treatment|0|||
170364252|NCT00064077|615668898|FG000|Overall Study|Poor risk|2|||
170364253|NCT00064077|615668899|FG001|Overall Study|Poor risk|0|||
170364254|NCT00064077|615668900|FG002|Overall Study|Poor risk|1|||
170364255|NCT00064077|615668901|FG003|Overall Study|Poor risk|1|||
170364256|NCT00064077|615668898|FG000|Overall Study|Pathology|10|||
170364257|NCT00064077|615668899|FG001|Overall Study|Pathology|7|||
170364258|NCT00064077|615668900|FG002|Overall Study|Pathology|3|||
170364259|NCT00064077|615668901|FG003|Overall Study|Pathology|4|||
170364260|NCT00064077|615668898|FG000|Overall Study|No surgery|0|||
170364261|NCT00064077|615668899|FG001|Overall Study|No surgery|0|||
170364262|NCT00064077|615668900|FG002|Overall Study|No surgery|1|||
170364263|NCT00064077|615668901|FG003|Overall Study|No surgery|0|||
170364264|NCT00064077|615668898|FG000|Overall Study|No tumor|0|||
170364265|NCT00064077|615668899|FG001|Overall Study|No tumor|0|||
170364266|NCT00064077|615668900|FG002|Overall Study|No tumor|1|||
170364267|NCT00064077|615668901|FG003|Overall Study|No tumor|0|||
170364268|NCT00064077|615668898|FG000|Overall Study|Other reasons|2|||
170364269|NCT00064077|615668899|FG001|Overall Study|Other reasons|2|||
170364270|NCT00064077|615668900|FG002|Overall Study|Other reasons|1|||
170364271|NCT00064077|615668901|FG003|Overall Study|Other reasons|2|||
170364272|NCT00615914|615668902|FG000|Overall Study|Adverse Event|274|||
170364273|NCT00615914|615668902|FG000|Overall Study|Death|20|||
170364274|NCT00615914|615668902|FG000|Overall Study|Lack of Efficacy|59|||
170364275|NCT00615914|615668902|FG000|Overall Study|Lost to Follow-up|187|||
170364276|NCT00615914|615668902|FG000|Overall Study|Withdrawal by Subject|16|||
170364277|NCT00615914|615668902|FG000|Overall Study|Physician Decision|4|||
170364278|NCT00615914|615668902|FG000|Overall Study|No data was collected.|65|||
170364279|NCT00615914|615668902|FG000|Overall Study|No treatment|2|||
170364280|NCT00615914|615668902|FG000|Overall Study|Irregularly enrolled patients|10|||
170364281|NCT03037307|615668903|FG000|Period 1|Did Not Meet Study Criteria|0|||
170364282|NCT03037307|615668904|FG001|Period 1|Did Not Meet Study Criteria|0|||
170364283|NCT03037307|615668905|FG002|Period 1|Did Not Meet Study Criteria|0|||
170364284|NCT03037307|615668906|FG003|Period 1|Did Not Meet Study Criteria|1|||
170364285|NCT03037307|615668907|FG004|Period 1|Did Not Meet Study Criteria|0|||
170364286|NCT03037307|615668908|FG005|Period 1|Did Not Meet Study Criteria|0|||
170364287|NCT04397796|615668909|FG000|Overall Study|Death|3|||
170364288|NCT04397796|615668910|FG001|Overall Study|Death|1|||
170364289|NCT02156804|615668911|FG000|Overall Study|Withdrawal by Subject|1|||
170364290|NCT01484561|615668913|FG000|Overall Study|Lack of Efficacy|3|||
170364291|NCT01484561|615668914|FG001|Overall Study|Lack of Efficacy|1|||
170364292|NCT01484561|615668913|FG000|Overall Study|Lost to Follow-up|1|||
170364293|NCT01484561|615668914|FG001|Overall Study|Lost to Follow-up|0|||
170364294|NCT01484561|615668913|FG000|Overall Study|Withdrawal by Subject|3|||
170364295|NCT01484561|615668914|FG001|Overall Study|Withdrawal by Subject|0|||
170364296|NCT01484561|615668913|FG000|Overall Study|Other|1|||
170364297|NCT01484561|615668914|FG001|Overall Study|Other|1|||
170364298|NCT01484561|615668913|FG000|Overall Study|Adverse Event|1|||
170364299|NCT01484561|615668914|FG001|Overall Study|Adverse Event|4|||
170364300|NCT00968708|615668915|FG000|Overall Study|Adverse Event|169|||
170364301|NCT00968708|615668916|FG001|Overall Study|Adverse Event|150|||
170364302|NCT00968708|615668915|FG000|Overall Study|Major Protocol Deviation|0|||
170364303|NCT00968708|615668916|FG001|Overall Study|Major Protocol Deviation|1|||
170364304|NCT00968708|615668915|FG000|Overall Study|Lost to Follow-up|19|||
170364305|NCT00968708|615668916|FG001|Overall Study|Lost to Follow-up|11|||
170364306|NCT00968708|615668915|FG000|Overall Study|Voluntary Withdrawal|104|||
170364307|NCT00968708|615668916|FG001|Overall Study|Voluntary Withdrawal|101|||
170364308|NCT00968708|615668915|FG000|Overall Study|Investigator Discretion|0|||
170364309|NCT00968708|615668916|FG001|Overall Study|Investigator Discretion|1|||
170364310|NCT00968708|615668915|FG000|Overall Study|Other|26|||
170364311|NCT00968708|615668916|FG001|Overall Study|Other|34|||
170364312|NCT00389441|615668917|FG000|Overall Study|Adverse Event|7|||
170364313|NCT00389441|615668917|FG000|Overall Study|Death|4|||
170364314|NCT00389441|615668917|FG000|Overall Study|Lost to Follow-up|2|||
170364315|NCT00389441|615668917|FG000|Overall Study|Withdrawal by Subject|4|||
170364316|NCT00389441|615668917|FG000|Overall Study|Physician Decision|1|||
170364317|NCT00389441|615668917|FG000|Overall Study|Protocol Violation|1|||
170364318|NCT00389441|615668917|FG000|Overall Study|Global deterioration of health status|4|||
170364319|NCT00389441|615668917|FG000|Overall Study|Objective progression or relapse|26|||
170364320|NCT00389441|615668917|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
170364321|NCT00389441|615668917|FG000|Overall Study|Clinical progression|1|||
170364322|NCT00105560|615668918|FG000|Overall Study|Lost to Follow-up|1|||
170364323|NCT00305604|615668919|FG000|Overall Study|Adverse Event|6|||
170364324|NCT00305604|615668920|FG001|Overall Study|Adverse Event|3|||
170364325|NCT00305604|615668919|FG000|Overall Study|Lack of Efficacy|11|||
170364326|NCT00305604|615668920|FG001|Overall Study|Lack of Efficacy|18|||
170364327|NCT00305604|615668919|FG000|Overall Study|Lost to Follow-up|0|||
170364328|NCT00305604|615668920|FG001|Overall Study|Lost to Follow-up|4|||
170364329|NCT00305604|615668919|FG000|Overall Study|Protocol Violation|2|||
170364330|NCT00305604|615668920|FG001|Overall Study|Protocol Violation|1|||
170364331|NCT00305604|615668919|FG000|Overall Study|Withdrawal by Subject|12|||
170364332|NCT00305604|615668920|FG001|Overall Study|Withdrawal by Subject|21|||
170364333|NCT00305604|615668919|FG000|Overall Study|Patient moved|1|||
170364334|NCT00305604|615668920|FG001|Overall Study|Patient moved|0|||
170364335|NCT02559713|615668921|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
170364336|NCT04176445|615668922|FG000|Overall Study|Adverse Event|0|||
170364337|NCT04176445|615668923|FG001|Overall Study|Adverse Event|1|||
170364338|NCT04176445|615668922|FG000|Overall Study|change plans weaning after first intervention|0|||
170364339|NCT04176445|615668923|FG001|Overall Study|change plans weaning after first intervention|1|||
170364340|NCT04377672|615668924|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
170364341|NCT03954444|615668925|FG000|Overall Study|Withdrawal by Subject|5|||
170364342|NCT03954444|615668926|FG001|Overall Study|Withdrawal by Subject|5|||
170364343|NCT03954444|615668927|FG002|Overall Study|Withdrawal by Subject|5|||
170364344|NCT03954444|615668925|FG000|Overall Study|Adverse Event|1|||
170364345|NCT03954444|615668926|FG001|Overall Study|Adverse Event|3|||
170364346|NCT03954444|615668927|FG002|Overall Study|Adverse Event|2|||
170364347|NCT03954444|615668925|FG000|Overall Study|Protocol Violation|0|||
170364348|NCT03954444|615668926|FG001|Overall Study|Protocol Violation|3|||
170364349|NCT03954444|615668927|FG002|Overall Study|Protocol Violation|5|||
170364350|NCT03954444|615668925|FG000|Overall Study|Use of prohibited therapy|1|||
170364351|NCT03954444|615668926|FG001|Overall Study|Use of prohibited therapy|1|||
170364352|NCT03954444|615668927|FG002|Overall Study|Use of prohibited therapy|2|||
170364353|NCT03954444|615668925|FG000|Overall Study|Lost to Follow-up|1|||
170364354|NCT03954444|615668926|FG001|Overall Study|Lost to Follow-up|0|||
170364355|NCT03954444|615668927|FG002|Overall Study|Lost to Follow-up|1|||
170364356|NCT03954444|615668925|FG000|Overall Study|Non-compliant with study drug application|2|||
170364357|NCT03954444|615668926|FG001|Overall Study|Non-compliant with study drug application|2|||
170364358|NCT03954444|615668927|FG002|Overall Study|Non-compliant with study drug application|0|||
170364359|NCT03954444|615668925|FG000|Overall Study|Administrative reasons|0|||
170364360|NCT03954444|615668926|FG001|Overall Study|Administrative reasons|0|||
170364361|NCT03954444|615668927|FG002|Overall Study|Administrative reasons|1|||
170364362|NCT03954444|615668925|FG000|Overall Study|Miscellaneous|3|||
170364363|NCT03954444|615668926|FG001|Overall Study|Miscellaneous|2|||
170364364|NCT03954444|615668927|FG002|Overall Study|Miscellaneous|1|||
170364365|NCT05109702|615668928|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
170364366|NCT05109702|615668929|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
170364367|NCT05109702|615668930|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
170364368|NCT05109702|615668928|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
170364369|NCT05109702|615668929|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
170364370|NCT05109702|615668930|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
170364371|NCT05109702|615668928|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
170364372|NCT05109702|615668929|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
170364373|NCT05109702|615668930|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
170364374|NCT05109702|615668928|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
170364375|NCT05109702|615668929|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
170364376|NCT05109702|615668930|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
170364377|NCT05109702|615668928|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
170364378|NCT05109702|615668929|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
170364379|NCT05109702|615668930|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
170364380|NCT01412060|615668934|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
170364381|NCT01412060|615668935|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
170364382|NCT01412060|615668936|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
170364383|NCT01412060|615668934|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
170364384|NCT01412060|615668935|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
170364385|NCT01412060|615668936|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
170364386|NCT01412060|615668934|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
170364387|NCT01412060|615668935|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
170364388|NCT01412060|615668936|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
170364389|NCT01412060|615668934|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
170364390|NCT01412060|615668935|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
170364391|NCT01412060|615668936|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
170364392|NCT01412060|615668934|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
170364393|NCT01412060|615668935|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
170364394|NCT01412060|615668936|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
170364395|NCT01412060|615668934|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
170364396|NCT01412060|615668935|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
170364397|NCT01412060|615668936|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
170364398|NCT01412060|615668934|FG000|Period Between RIP and SP|Adverse Event|4|||
170364399|NCT01412060|615668935|FG001|Period Between RIP and SP|Adverse Event|0|||
170364400|NCT01412060|615668936|FG002|Period Between RIP and SP|Adverse Event|0|||
170364401|NCT01412060|615668934|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
170364402|NCT01412060|615668935|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
170364403|NCT01412060|615668936|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
170364404|NCT01412060|615668934|FG000|Period Between RIP and SP|Protocol Violation|2|||
170364405|NCT01412060|615668935|FG001|Period Between RIP and SP|Protocol Violation|0|||
170364406|NCT01412060|615668936|FG002|Period Between RIP and SP|Protocol Violation|0|||
170364407|NCT01412060|615668934|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
170364408|NCT01412060|615668935|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
170364409|NCT01412060|615668936|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
170364410|NCT01412060|615668934|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
170364411|NCT01412060|615668935|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
170364412|NCT01412060|615668936|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
170364413|NCT01412060|615668934|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
170364414|NCT01412060|615668935|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
170364415|NCT01412060|615668936|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
170364416|NCT01412060|615668934|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
170364417|NCT01412060|615668935|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
170364418|NCT01412060|615668936|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
170364419|NCT01412060|615668934|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
170364420|NCT01412060|615668935|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
170364421|NCT01412060|615668936|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
170364422|NCT01412060|615668934|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
170364423|NCT01412060|615668935|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
170364424|NCT01412060|615668936|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
170364425|NCT01412060|615668934|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
170364426|NCT01412060|615668935|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
170364427|NCT01412060|615668936|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
170364428|NCT01412060|615668934|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
170364429|NCT01412060|615668935|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
170364430|NCT01412060|615668936|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
170364431|NCT01412060|615668934|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
170364432|NCT01412060|615668935|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
170364433|NCT01412060|615668936|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
170364434|NCT01412060|615668934|FG000|Period Between SP and DBP|Protocol Violation|2|||
170364435|NCT01412060|615668935|FG001|Period Between SP and DBP|Protocol Violation|0|||
170364436|NCT01412060|615668936|FG002|Period Between SP and DBP|Protocol Violation|0|||
170364437|NCT01412060|615668934|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
170364438|NCT01412060|615668935|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
170364439|NCT01412060|615668936|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
170364440|NCT01412060|615668934|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
170364441|NCT01412060|615668935|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
170364442|NCT01412060|615668936|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
170364443|NCT01412060|615668934|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
170364444|NCT01412060|615668935|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
170364445|NCT01412060|615668936|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
170364446|NCT01412060|615668934|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
170364447|NCT01412060|615668935|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
170364448|NCT01412060|615668936|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
170364449|NCT01412060|615668934|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
170364450|NCT01412060|615668935|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
170364451|NCT01412060|615668936|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
170364452|NCT01412060|615668934|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
170364453|NCT01412060|615668935|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
170364454|NCT01412060|615668936|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
170364455|NCT01412060|615668934|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
170364456|NCT01412060|615668935|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
170364457|NCT01412060|615668936|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
170364458|NCT01412060|615668934|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
170364459|NCT01412060|615668935|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
170364460|NCT01412060|615668936|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
170364461|NCT01412060|615668934|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
170364462|NCT01412060|615668935|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
170364463|NCT01412060|615668936|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
170364464|NCT01412060|615668934|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
170364465|NCT01412060|615668935|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
170364466|NCT01412060|615668936|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
170364467|NCT01468701|615668938|FG000|Overall Study|Not eligible|91|||
170364468|NCT01468701|615668939|FG001|Overall Study|Not eligible|140|||
170364469|NCT01468701|615668940|FG002|Overall Study|Not eligible|29|||
170364470|NCT01468701|615668941|FG003|Overall Study|Not eligible|12|||
170364471|NCT01468701|615668942|FG004|Overall Study|Not eligible|22|||
170364472|NCT01468701|615668943|FG005|Overall Study|Not eligible|2|||
170364473|NCT01468701|615668944|FG006|Overall Study|Not eligible|39|||
170364474|NCT01468701|615668945|FG007|Overall Study|Not eligible|1|||
170364475|NCT01468701|615668946|FG008|Overall Study|Not eligible|40|||
170364476|NCT01468701|615668947|FG009|Overall Study|Not eligible|126|||
170364477|NCT01468701|615668948|FG010|Overall Study|Not eligible|39|||
170364478|NCT01468701|615668949|FG011|Overall Study|Not eligible|33|||
170364479|NCT01468701|615668950|FG012|Overall Study|Not eligible|1|||
170364480|NCT01468701|615668951|FG013|Overall Study|Not eligible|19|||
170364481|NCT01468701|615668952|FG014|Overall Study|Not eligible|1|||
170364482|NCT01468701|615668953|FG015|Overall Study|Not eligible|32|||
170364483|NCT01468701|615668954|FG016|Overall Study|Not eligible|0|||
170364484|NCT01468701|615668938|FG000|Overall Study|Lost to Follow-up|306|||
170364485|NCT01468701|615668939|FG001|Overall Study|Lost to Follow-up|0|||
170364486|NCT01468701|615668940|FG002|Overall Study|Lost to Follow-up|0|||
170364487|NCT01468701|615668941|FG003|Overall Study|Lost to Follow-up|0|||
170364488|NCT01468701|615668942|FG004|Overall Study|Lost to Follow-up|0|||
170364489|NCT01468701|615668943|FG005|Overall Study|Lost to Follow-up|0|||
170364490|NCT01468701|615668944|FG006|Overall Study|Lost to Follow-up|0|||
170364491|NCT01468701|615668945|FG007|Overall Study|Lost to Follow-up|0|||
170364492|NCT01468701|615668946|FG008|Overall Study|Lost to Follow-up|215|||
170364493|NCT01468701|615668947|FG009|Overall Study|Lost to Follow-up|309|||
170364494|NCT01468701|615668948|FG010|Overall Study|Lost to Follow-up|224|||
170364495|NCT01468701|615668949|FG011|Overall Study|Lost to Follow-up|212|||
170364496|NCT01468701|615668950|FG012|Overall Study|Lost to Follow-up|11|||
170364497|NCT01468701|615668951|FG013|Overall Study|Lost to Follow-up|164|||
170364498|NCT01468701|615668952|FG014|Overall Study|Lost to Follow-up|17|||
170364499|NCT01468701|615668953|FG015|Overall Study|Lost to Follow-up|127|||
170364500|NCT01468701|615668954|FG016|Overall Study|Lost to Follow-up|1|||
170364501|NCT01468701|615668938|FG000|Overall Study|Withdrawal by Subject|165|||
170364502|NCT01468701|615668939|FG001|Overall Study|Withdrawal by Subject|0|||
170364503|NCT01468701|615668940|FG002|Overall Study|Withdrawal by Subject|0|||
170364504|NCT01468701|615668941|FG003|Overall Study|Withdrawal by Subject|0|||
170364505|NCT01468701|615668942|FG004|Overall Study|Withdrawal by Subject|0|||
170364506|NCT01468701|615668943|FG005|Overall Study|Withdrawal by Subject|0|||
170364507|NCT01468701|615668944|FG006|Overall Study|Withdrawal by Subject|0|||
170364508|NCT01468701|615668945|FG007|Overall Study|Withdrawal by Subject|0|||
170364509|NCT01468701|615668946|FG008|Overall Study|Withdrawal by Subject|83|||
170364510|NCT01468701|615668947|FG009|Overall Study|Withdrawal by Subject|88|||
170364511|NCT01468701|615668948|FG010|Overall Study|Withdrawal by Subject|100|||
170364512|NCT01468701|615668949|FG011|Overall Study|Withdrawal by Subject|114|||
170364513|NCT01468701|615668950|FG012|Overall Study|Withdrawal by Subject|9|||
170364514|NCT01468701|615668951|FG013|Overall Study|Withdrawal by Subject|47|||
170364515|NCT01468701|615668952|FG014|Overall Study|Withdrawal by Subject|6|||
170364516|NCT01468701|615668953|FG015|Overall Study|Withdrawal by Subject|31|||
170364517|NCT01468701|615668954|FG016|Overall Study|Withdrawal by Subject|0|||
170364518|NCT01468701|615668938|FG000|Overall Study|Other reasons than listed|437|||
170364519|NCT01468701|615668939|FG001|Overall Study|Other reasons than listed|0|||
170364520|NCT01468701|615668940|FG002|Overall Study|Other reasons than listed|0|||
170364521|NCT01468701|615668941|FG003|Overall Study|Other reasons than listed|0|||
170364522|NCT01468701|615668942|FG004|Overall Study|Other reasons than listed|0|||
170364523|NCT01468701|615668943|FG005|Overall Study|Other reasons than listed|0|||
170364524|NCT01468701|615668944|FG006|Overall Study|Other reasons than listed|0|||
170364525|NCT01468701|615668945|FG007|Overall Study|Other reasons than listed|0|||
170364526|NCT01468701|615668946|FG008|Overall Study|Other reasons than listed|318|||
170364527|NCT01468701|615668947|FG009|Overall Study|Other reasons than listed|658|||
170364528|NCT01468701|615668948|FG010|Overall Study|Other reasons than listed|433|||
170364529|NCT01468701|615668949|FG011|Overall Study|Other reasons than listed|504|||
170364530|NCT01468701|615668950|FG012|Overall Study|Other reasons than listed|28|||
170364531|NCT01468701|615668951|FG013|Overall Study|Other reasons than listed|239|||
170364532|NCT01468701|615668952|FG014|Overall Study|Other reasons than listed|39|||
170364533|NCT01468701|615668953|FG015|Overall Study|Other reasons than listed|172|||
170364534|NCT01468701|615668954|FG016|Overall Study|Other reasons than listed|0|||
170364535|NCT01468701|615668938|FG000|Overall Study|No end of study case report form|0|||
170364536|NCT01468701|615668939|FG001|Overall Study|No end of study case report form|0|||
170364537|NCT01468701|615668940|FG002|Overall Study|No end of study case report form|0|||
170364538|NCT01468701|615668941|FG003|Overall Study|No end of study case report form|0|||
170364539|NCT01468701|615668942|FG004|Overall Study|No end of study case report form|0|||
170364540|NCT01468701|615668943|FG005|Overall Study|No end of study case report form|0|||
170364541|NCT01468701|615668944|FG006|Overall Study|No end of study case report form|0|||
170364542|NCT01468701|615668945|FG007|Overall Study|No end of study case report form|0|||
170364543|NCT01468701|615668946|FG008|Overall Study|No end of study case report form|4|||
170364544|NCT01468701|615668947|FG009|Overall Study|No end of study case report form|1|||
170364545|NCT01468701|615668948|FG010|Overall Study|No end of study case report form|2|||
170364546|NCT01468701|615668949|FG011|Overall Study|No end of study case report form|3|||
170364547|NCT01468701|615668950|FG012|Overall Study|No end of study case report form|0|||
170364548|NCT01468701|615668951|FG013|Overall Study|No end of study case report form|1|||
170364549|NCT01468701|615668952|FG014|Overall Study|No end of study case report form|0|||
170364550|NCT01468701|615668953|FG015|Overall Study|No end of study case report form|0|||
170364551|NCT01468701|615668954|FG016|Overall Study|No end of study case report form|0|||
170364552|NCT01468701|615668938|FG000|Overall Study|Not being followed up|0|||
170364553|NCT01468701|615668939|FG001|Overall Study|Not being followed up|4963|||
170364554|NCT01468701|615668940|FG002|Overall Study|Not being followed up|1755|||
170364555|NCT01468701|615668941|FG003|Overall Study|Not being followed up|703|||
170364556|NCT01468701|615668942|FG004|Overall Study|Not being followed up|1714|||
170364557|NCT01468701|615668943|FG005|Overall Study|Not being followed up|126|||
170364558|NCT01468701|615668944|FG006|Overall Study|Not being followed up|1170|||
170364559|NCT01468701|615668945|FG007|Overall Study|Not being followed up|4|||
170364560|NCT01468701|615668946|FG008|Overall Study|Not being followed up|0|||
170364561|NCT01468701|615668947|FG009|Overall Study|Not being followed up|0|||
170364562|NCT01468701|615668948|FG010|Overall Study|Not being followed up|0|||
170364563|NCT01468701|615668949|FG011|Overall Study|Not being followed up|0|||
170364564|NCT01468701|615668950|FG012|Overall Study|Not being followed up|0|||
170364565|NCT01468701|615668951|FG013|Overall Study|Not being followed up|0|||
170364566|NCT01468701|615668952|FG014|Overall Study|Not being followed up|0|||
170364567|NCT01468701|615668953|FG015|Overall Study|Not being followed up|0|||
170364568|NCT01468701|615668954|FG016|Overall Study|Not being followed up|0|||
170364569|NCT00970268|615668955|FG000|Overall Study|Withdrawal by Subject|12|||
170364570|NCT00970268|615668956|FG001|Overall Study|Withdrawal by Subject|19|||
170364571|NCT00970268|615668955|FG000|Overall Study|Adverse Event|15|||
170364572|NCT00970268|615668956|FG001|Overall Study|Adverse Event|12|||
170364573|NCT00970268|615668955|FG000|Overall Study|Lack of Efficacy|3|||
170364574|NCT00970268|615668956|FG001|Overall Study|Lack of Efficacy|6|||
170364575|NCT00970268|615668955|FG000|Overall Study|Protocol Violation|4|||
170364576|NCT00970268|615668956|FG001|Overall Study|Protocol Violation|7|||
170364577|NCT00970268|615668955|FG000|Overall Study|Other Reason|3|||
170364578|NCT00970268|615668956|FG001|Overall Study|Other Reason|1|||
170364579|NCT00970268|615668955|FG000|Overall Study|COPD Exacerbation|4|||
170364580|NCT00970268|615668956|FG001|Overall Study|COPD Exacerbation|2|||
170364581|NCT00970268|615668955|FG000|Overall Study|Lost to Follow-up|1|||
170364582|NCT00970268|615668956|FG001|Overall Study|Lost to Follow-up|2|||
170364583|NCT00970268|615668955|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
170364584|NCT00970268|615668956|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
170364585|NCT04186663|615668958|FG000|Overall Study|Lost to Follow-up|1|||
170364586|NCT04186663|615668958|FG000|Overall Study|Unable to complete blood draw|3|||
170364587|NCT00719862|615668967|FG000|Overall Study|Adverse Event|1|||
170364588|NCT00719862|615668968|FG001|Overall Study|Adverse Event|2|||
170364589|NCT00719862|615668967|FG000|Overall Study|Lack of Efficacy|3|||
170364590|NCT00719862|615668968|FG001|Overall Study|Lack of Efficacy|0|||
170364591|NCT00719862|615668967|FG000|Overall Study|Non-Compliance|1|||
170364592|NCT00719862|615668968|FG001|Overall Study|Non-Compliance|0|||
170364593|NCT00719862|615668967|FG000|Overall Study|Withdrawal by Subject|1|||
170364594|NCT00719862|615668968|FG001|Overall Study|Withdrawal by Subject|0|||
170364595|NCT00719862|615668967|FG000|Overall Study|Lost to Follow-up|0|||
170364596|NCT00719862|615668968|FG001|Overall Study|Lost to Follow-up|1|||
170364597|NCT00719862|615668967|FG000|Overall Study|Other|2|||
170364598|NCT00719862|615668968|FG001|Overall Study|Other|3|||
170364599|NCT01626989|615668969|FG000|Screening Period|Screen Failure|15|||
170364600|NCT01626989|615668970|FG001|Screening Period|Screen Failure|0|||
170364601|NCT01626989|615668971|FG002|Screening Period|Screen Failure|0|||
170364602|NCT01626989|615668969|FG000|Screening Period|Withdrawal by Subject|2|||
170364603|NCT01626989|615668970|FG001|Screening Period|Withdrawal by Subject|0|||
170364604|NCT01626989|615668971|FG002|Screening Period|Withdrawal by Subject|0|||
170364605|NCT02293902|615668972|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
170364606|NCT02293902|615668973|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
170364607|NCT02293902|615668974|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
170364608|NCT02293902|615668975|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
170364609|NCT02293902|615668976|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
170364610|NCT02293902|615668972|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
170364611|NCT02293902|615668973|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
170364612|NCT02293902|615668974|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
170364613|NCT02293902|615668975|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
170364614|NCT02293902|615668976|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
170364615|NCT02293902|615668972|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
170364616|NCT02293902|615668973|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
170364617|NCT02293902|615668974|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
170364618|NCT02293902|615668975|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
170364619|NCT02293902|615668976|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
170364620|NCT02293902|615668972|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
170364621|NCT02293902|615668973|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
170364622|NCT02293902|615668974|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
170364623|NCT02293902|615668975|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
170364624|NCT02293902|615668976|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
170364625|NCT02293902|615668972|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
170364626|NCT02293902|615668973|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
170364627|NCT02293902|615668974|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
170364628|NCT02293902|615668975|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
170364629|NCT02293902|615668976|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
170364630|NCT03906136|615670829|FG000|Overall Study|Adverse Event|1|||
170364631|NCT03906136|615670830|FG001|Overall Study|Adverse Event|0|||
170364632|NCT03906136|615670829|FG000|Overall Study|Lost to Follow-up|7|||
170364633|NCT03906136|615670830|FG001|Overall Study|Lost to Follow-up|4|||
170364634|NCT03906136|615670829|FG000|Overall Study|Physician Decision|1|||
170364635|NCT03906136|615670830|FG001|Overall Study|Physician Decision|0|||
170364636|NCT03906136|615670829|FG000|Overall Study|Withdrawal by Subject|3|||
170364637|NCT03906136|615670830|FG001|Overall Study|Withdrawal by Subject|7|||
170364638|NCT03366844|615670833|FG000|Overall Study|Physician Decision|1|||
170364639|NCT03366844|615670833|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
170364640|NCT02687711|615670836|FG000|Overall Study|Adverse Event|89|||
170364641|NCT02687711|615670836|FG000|Overall Study|Lack of Efficacy|70|||
170364642|NCT02687711|615670836|FG000|Overall Study|Lost to Follow-up|20|||
170364643|NCT02687711|615670836|FG000|Overall Study|Consent withdrawn|15|||
170364644|NCT02687711|615670836|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
170364645|NCT02687711|615670836|FG000|Overall Study|Too expensive|4|||
170364646|NCT02687711|615670836|FG000|Overall Study|Participant moved abroad|1|||
170364647|NCT02687711|615670836|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
170364648|NCT02687711|615670836|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
170364649|NCT02687711|615670836|FG000|Overall Study|Disliked taste|1|||
170364650|NCT02687711|615670836|FG000|Overall Study|Low mood|1|||
170364651|NCT02687711|615670836|FG000|Overall Study|Side effects|1|||
170364652|NCT02687711|615670836|FG000|Overall Study|Change of Hospital|1|||
170364653|NCT02687711|615670836|FG000|Overall Study|Liver Encephalopathy|1|||
170364654|NCT02687711|615670836|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
170364655|NCT02687711|615670836|FG000|Overall Study|Withdrawn due to intake interruption|1|||
170364656|NCT02687711|615670836|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
170364657|NCT02687711|615670836|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
170364658|NCT02687711|615670836|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
170364659|NCT01742091|615670839|FG000|Overall Study|Adverse Event|0|||
170364660|NCT01742091|615670840|FG001|Overall Study|Adverse Event|0|||
170364661|NCT01742091|615670841|FG002|Overall Study|Adverse Event|0|||
170364662|NCT01742091|615670842|FG003|Overall Study|Adverse Event|0|||
170364663|NCT01742091|615670843|FG004|Overall Study|Adverse Event|1|||
170364664|NCT01742091|615670844|FG005|Overall Study|Adverse Event|0|||
170364665|NCT01742091|615670839|FG000|Overall Study|Physician Decision|0|||
170364666|NCT01742091|615670840|FG001|Overall Study|Physician Decision|0|||
170364667|NCT01742091|615670841|FG002|Overall Study|Physician Decision|0|||
170364668|NCT01742091|615670842|FG003|Overall Study|Physician Decision|0|||
170364669|NCT01742091|615670843|FG004|Overall Study|Physician Decision|0|||
170364670|NCT01742091|615670844|FG005|Overall Study|Physician Decision|1|||
170364671|NCT01742091|615670839|FG000|Overall Study|Withdrawal by Subject|0|||
170364672|NCT01742091|615670840|FG001|Overall Study|Withdrawal by Subject|0|||
170364673|NCT01742091|615670841|FG002|Overall Study|Withdrawal by Subject|0|||
170364674|NCT01742091|615670842|FG003|Overall Study|Withdrawal by Subject|1|||
170364675|NCT01742091|615670843|FG004|Overall Study|Withdrawal by Subject|0|||
170364676|NCT01742091|615670844|FG005|Overall Study|Withdrawal by Subject|0|||
170364677|NCT01742091|615670839|FG000|Overall Study|Lost to Follow-up|0|||
170364678|NCT01742091|615670840|FG001|Overall Study|Lost to Follow-up|0|||
170364679|NCT01742091|615670841|FG002|Overall Study|Lost to Follow-up|0|||
170364680|NCT01742091|615670842|FG003|Overall Study|Lost to Follow-up|0|||
170364681|NCT01742091|615670843|FG004|Overall Study|Lost to Follow-up|0|||
170364682|NCT01742091|615670844|FG005|Overall Study|Lost to Follow-up|1|||
170364683|NCT02088541|615670845|FG000|Overall Study|Adverse Event|3|||
170364684|NCT02088541|615670846|FG001|Overall Study|Adverse Event|0|||
170364685|NCT02088541|615670847|FG002|Overall Study|Adverse Event|3|||
170364686|NCT02088541|615670848|FG003|Overall Study|Adverse Event|3|||
170364687|NCT02088541|615670849|FG004|Overall Study|Adverse Event|0|||
170364688|NCT02088541|615670845|FG000|Overall Study|Death|51|||
170364689|NCT02088541|615670846|FG001|Overall Study|Death|21|||
170364690|NCT02088541|615670847|FG002|Overall Study|Death|85|||
170364691|NCT02088541|615670848|FG003|Overall Study|Death|28|||
170364692|NCT02088541|615670849|FG004|Overall Study|Death|38|||
170364693|NCT02088541|615670845|FG000|Overall Study|Lost to Follow-up|2|||
170364694|NCT02088541|615670846|FG001|Overall Study|Lost to Follow-up|0|||
170364695|NCT02088541|615670847|FG002|Overall Study|Lost to Follow-up|1|||
170364696|NCT02088541|615670848|FG003|Overall Study|Lost to Follow-up|0|||
170364697|NCT02088541|615670849|FG004|Overall Study|Lost to Follow-up|0|||
170364698|NCT02088541|615670845|FG000|Overall Study|Physician Decision|2|||
170364699|NCT02088541|615670846|FG001|Overall Study|Physician Decision|1|||
170364700|NCT02088541|615670847|FG002|Overall Study|Physician Decision|2|||
170364701|NCT02088541|615670848|FG003|Overall Study|Physician Decision|0|||
170364702|NCT02088541|615670849|FG004|Overall Study|Physician Decision|2|||
170364703|NCT02088541|615670845|FG000|Overall Study|Disease progression|7|||
170364704|NCT02088541|615670846|FG001|Overall Study|Disease progression|1|||
170364705|NCT02088541|615670847|FG002|Overall Study|Disease progression|2|||
170364706|NCT02088541|615670848|FG003|Overall Study|Disease progression|3|||
170364707|NCT02088541|615670849|FG004|Overall Study|Disease progression|1|||
170364708|NCT02088541|615670845|FG000|Overall Study|Study terminated by sponsor|1|||
170364709|NCT02088541|615670846|FG001|Overall Study|Study terminated by sponsor|1|||
170364710|NCT02088541|615670847|FG002|Overall Study|Study terminated by sponsor|12|||
170364711|NCT02088541|615670848|FG003|Overall Study|Study terminated by sponsor|2|||
170364712|NCT02088541|615670849|FG004|Overall Study|Study terminated by sponsor|6|||
170364713|NCT02088541|615670845|FG000|Overall Study|Withdrawal by Subject|3|||
170364714|NCT02088541|615670846|FG001|Overall Study|Withdrawal by Subject|2|||
170364715|NCT02088541|615670847|FG002|Overall Study|Withdrawal by Subject|9|||
170364716|NCT02088541|615670848|FG003|Overall Study|Withdrawal by Subject|7|||
170364717|NCT02088541|615670849|FG004|Overall Study|Withdrawal by Subject|10|||
170364718|NCT02088541|615670845|FG000|Overall Study|Other|2|||
170364719|NCT02088541|615670846|FG001|Overall Study|Other|1|||
170364720|NCT02088541|615670847|FG002|Overall Study|Other|3|||
170364721|NCT02088541|615670848|FG003|Overall Study|Other|1|||
170364722|NCT02088541|615670849|FG004|Overall Study|Other|1|||
170364723|NCT03551626|615670850|FG000|Overall Study|Adverse Event|88|||
170364724|NCT03551626|615670850|FG000|Overall Study|Disease relapse|18|||
170364725|NCT03551626|615670850|FG000|Overall Study|Withdrawal of informed consent|6|||
170364726|NCT03551626|615670850|FG000|Overall Study|Patient decision|5|||
170364727|NCT03551626|615670850|FG000|Overall Study|Physician Decision|4|||
170364728|NCT03551626|615670850|FG000|Overall Study|Lost to Follow-up|3|||
170364729|NCT03551626|615670850|FG000|Overall Study|Pregnancy|1|||
170364730|NCT03551626|615670850|FG000|Overall Study|Protocol deviation|1|||
170364731|NCT03551626|615670850|FG000|Overall Study|Technical problems|1|||
170364732|NCT00653328|615670851|FG000|Overall Study|Withdrawal by Subject|1|||
170364733|NCT00653328|615670851|FG000|Overall Study|Adverse Event|2|||
170364734|NCT00653328|615670851|FG000|Overall Study|Disease progression|10|||
170364735|NCT00653328|615670851|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
170364736|NCT00724815|615670861|FG000|Overall Study|Randomized, not treated|31|||
170364737|NCT00724815|615670862|FG001|Overall Study|Randomized, not treated|30|||
170364738|NCT00724815|615670861|FG000|Overall Study|Adverse Event|5|||
170364739|NCT00724815|615670862|FG001|Overall Study|Adverse Event|3|||
170364740|NCT00724815|615670861|FG000|Overall Study|Lost to Follow-up|4|||
170364741|NCT00724815|615670862|FG001|Overall Study|Lost to Follow-up|1|||
170364742|NCT00724815|615670861|FG000|Overall Study|Other Various|3|||
170364743|NCT00724815|615670862|FG001|Overall Study|Other Various|5|||
170364744|NCT00810043|615670863|FG000|Overall Study|Withdrawal by Subject|1|||
170364745|NCT00810043|615670864|FG001|Overall Study|Withdrawal by Subject|0|||
170364746|NCT00810043|615670865|FG002|Overall Study|Withdrawal by Subject|2|||
170364747|NCT00810043|615670863|FG000|Overall Study|Lost to Follow-up|1|||
170364748|NCT00810043|615670864|FG001|Overall Study|Lost to Follow-up|0|||
170364749|NCT00810043|615670865|FG002|Overall Study|Lost to Follow-up|0|||
170364750|NCT00810043|615670863|FG000|Overall Study|Physician Decision|0|||
170364751|NCT00810043|615670864|FG001|Overall Study|Physician Decision|0|||
170364752|NCT00810043|615670865|FG002|Overall Study|Physician Decision|2|||
170364753|NCT00810043|615670863|FG000|Overall Study|Death|2|||
170364754|NCT00810043|615670864|FG001|Overall Study|Death|0|||
170364755|NCT00810043|615670865|FG002|Overall Study|Death|0|||
170364756|NCT00810043|615670863|FG000|Overall Study|Unrelated medical problem|0|||
170364757|NCT00810043|615670864|FG001|Overall Study|Unrelated medical problem|1|||
170364758|NCT00810043|615670865|FG002|Overall Study|Unrelated medical problem|0|||
170364759|NCT00810043|615670863|FG000|Overall Study|Non-medical problem|0|||
170364760|NCT00810043|615670864|FG001|Overall Study|Non-medical problem|0|||
170364761|NCT00810043|615670865|FG002|Overall Study|Non-medical problem|1|||
170364762|NCT00810043|615670863|FG000|Overall Study|No longer met enrollment criteria|0|||
170364763|NCT00810043|615670864|FG001|Overall Study|No longer met enrollment criteria|0|||
170364764|NCT00810043|615670865|FG002|Overall Study|No longer met enrollment criteria|3|||
170364765|NCT00443846|615670866|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
170364766|NCT00443846|615670867|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
170364767|NCT00443846|615670866|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
170364768|NCT00443846|615670867|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
170364769|NCT00443846|615670866|FG000|Overall Study|Adverse Event|0|||
170364770|NCT00443846|615670867|FG001|Overall Study|Adverse Event|1|||
170364771|NCT00443846|615670866|FG000|Overall Study|Personal reason|8|||
170364772|NCT00443846|615670867|FG001|Overall Study|Personal reason|3|||
170364773|NCT00443846|615670866|FG000|Overall Study|Lost to Follow-up|1|||
170364774|NCT00443846|615670867|FG001|Overall Study|Lost to Follow-up|2|||
170364775|NCT02001688|615670871|FG000|Overall Study|Withdrawal by Subject|0|||
170364776|NCT02001688|615670872|FG001|Overall Study|Withdrawal by Subject|0|||
170364777|NCT02001688|615670873|FG002|Overall Study|Withdrawal by Subject|1|||
170364778|NCT02001688|615670871|FG000|Overall Study|Adverse Event|0|||
170364779|NCT02001688|615670872|FG001|Overall Study|Adverse Event|1|||
170364780|NCT02001688|615670873|FG002|Overall Study|Adverse Event|0|||
170364781|NCT00641706|615670874|FG000|Overall Study|Adverse Event|2|||
170364782|NCT00641706|615670875|FG001|Overall Study|Adverse Event|1|||
170364783|NCT00641706|615670874|FG000|Overall Study|Withdrawal by Subject|6|||
170364784|NCT00641706|615670875|FG001|Overall Study|Withdrawal by Subject|1|||
170364785|NCT00641706|615670874|FG000|Overall Study|Clinical Decline|1|||
170364786|NCT00641706|615670875|FG001|Overall Study|Clinical Decline|0|||
170364787|NCT00641706|615670874|FG000|Overall Study|Lead Investigator Decision|0|||
170364788|NCT00641706|615670875|FG001|Overall Study|Lead Investigator Decision|1|||
170364789|NCT00109772|615670876|FG000|Double-blind Treatment|Adverse Event|14|||
170364790|NCT00109772|615670877|FG001|Double-blind Treatment|Adverse Event|5|||
170364791|NCT00109772|615670876|FG000|Double-blind Treatment|Lack of Efficacy|1|||
170364792|NCT00109772|615670877|FG001|Double-blind Treatment|Lack of Efficacy|0|||
170364793|NCT00109772|615670876|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
170364794|NCT00109772|615670877|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
170364795|NCT00109772|615670876|FG000|Double-blind Treatment|Lost to Follow-up|2|||
170364796|NCT00109772|615670877|FG001|Double-blind Treatment|Lost to Follow-up|3|||
170364797|NCT00109772|615670876|FG000|Double-blind Treatment|Protocol Violation|0|||
170364798|NCT00109772|615670877|FG001|Double-blind Treatment|Protocol Violation|1|||
170364799|NCT00109772|615670876|FG000|Double-blind Treatment|Other|0|||
170364800|NCT00109772|615670877|FG001|Double-blind Treatment|Other|4|||
170364801|NCT00109772|615670876|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
170364802|NCT00109772|615670877|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
170364803|NCT00109772|615670876|FG000|Open-label Extension|Adverse Event|10|||
170364804|NCT00109772|615670877|FG001|Open-label Extension|Adverse Event|19|||
170364805|NCT00109772|615670876|FG000|Open-label Extension|Lack of Efficacy|19|||
170364806|NCT00109772|615670877|FG001|Open-label Extension|Lack of Efficacy|11|||
170364807|NCT00109772|615670876|FG000|Open-label Extension|Withdrawal by Subject|9|||
170364808|NCT00109772|615670877|FG001|Open-label Extension|Withdrawal by Subject|6|||
170364809|NCT00109772|615670876|FG000|Open-label Extension|Lost to Follow-up|1|||
170364810|NCT00109772|615670877|FG001|Open-label Extension|Lost to Follow-up|0|||
170364811|NCT00109772|615670876|FG000|Open-label Extension|Death|0|||
170364812|NCT00109772|615670877|FG001|Open-label Extension|Death|1|||
170364813|NCT00109772|615670876|FG000|Open-label Extension|Protocol Violation|2|||
170364814|NCT00109772|615670877|FG001|Open-label Extension|Protocol Violation|2|||
170364815|NCT00109772|615670876|FG000|Open-label Extension|Other|4|||
170364816|NCT00109772|615670877|FG001|Open-label Extension|Other|10|||
170364817|NCT01989754|615670878|FG000|Overall Study|Withdrawal by Subject|10|||
170364818|NCT01989754|615670879|FG001|Overall Study|Withdrawal by Subject|14|||
170364819|NCT01989754|615670878|FG000|Overall Study|Lost to Follow-up|28|||
170364820|NCT01989754|615670879|FG001|Overall Study|Lost to Follow-up|20|||
170364821|NCT01989754|615670878|FG000|Overall Study|Closed Site|1|||
170364822|NCT01989754|615670879|FG001|Overall Study|Closed Site|1|||
170364823|NCT00391807|615670885|FG000|Overall Study|Did not receive study medication|23|||
170364824|NCT00391807|615670885|FG000|Overall Study|Adverse Event|177|||
170364825|NCT00391807|615670885|FG000|Overall Study|Pregnancy|25|||
170364826|NCT00391807|615670885|FG000|Overall Study|Lost to Follow-up|227|||
170364827|NCT00391807|615670885|FG000|Overall Study|Withdrawal by Subject|147|||
170364828|NCT00391807|615670885|FG000|Overall Study|Protocol Violation|20|||
170364829|NCT00391807|615670885|FG000|Overall Study|Various|96|||
170364830|NCT00813917|615670886|FG000|Overall Study|Adverse Event|0|||
170364831|NCT00813917|615670887|FG001|Overall Study|Adverse Event|1|||
170364832|NCT00813917|615670886|FG000|Overall Study|Withdrawal by Subject|3|||
170364833|NCT00813917|615670887|FG001|Overall Study|Withdrawal by Subject|4|||
170364834|NCT00813917|615670886|FG000|Overall Study|Lost to Follow-up|3|||
170364835|NCT00813917|615670887|FG001|Overall Study|Lost to Follow-up|1|||
170364836|NCT01359046|615670888|FG000|Overall Study|Did not receive allocated intervention|6|||
170364837|NCT01359046|615670889|FG001|Overall Study|Did not receive allocated intervention|6|||
170364838|NCT01359046|615670888|FG000|Overall Study|Physician Decision|1|||
170364839|NCT01359046|615670889|FG001|Overall Study|Physician Decision|11|||
170364840|NCT01369225|615670896|FG000|Overall Study|Withdrawal by Subject|1|||
170364841|NCT01369225|615670897|FG001|Overall Study|Withdrawal by Subject|0|||
170364842|NCT01369225|615670898|FG002|Overall Study|Withdrawal by Subject|2|||
170364843|NCT01369225|615670899|FG003|Overall Study|Withdrawal by Subject|1|||
170364844|NCT01369225|615670900|FG004|Overall Study|Withdrawal by Subject|0|||
170364845|NCT01369225|615670901|FG005|Overall Study|Withdrawal by Subject|0|||
170364846|NCT01369225|615670896|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
170364847|NCT01369225|615670897|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
170364848|NCT01369225|615670898|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
170364849|NCT01369225|615670899|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
170364850|NCT01369225|615670900|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
170364851|NCT01369225|615670901|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
170364852|NCT01369225|615670896|FG000|Overall Study|Other|1|||
170364853|NCT01369225|615670897|FG001|Overall Study|Other|0|||
170364854|NCT01369225|615670898|FG002|Overall Study|Other|0|||
170364855|NCT01369225|615670899|FG003|Overall Study|Other|0|||
170364856|NCT01369225|615670900|FG004|Overall Study|Other|1|||
170364857|NCT01369225|615670901|FG005|Overall Study|Other|0|||
170364858|NCT01369225|615670896|FG000|Overall Study|Adverse Event|0|||
170364859|NCT01369225|615670897|FG001|Overall Study|Adverse Event|0|||
170364860|NCT01369225|615670898|FG002|Overall Study|Adverse Event|0|||
170364861|NCT01369225|615670899|FG003|Overall Study|Adverse Event|1|||
170364862|NCT01369225|615670900|FG004|Overall Study|Adverse Event|1|||
170364863|NCT01369225|615670901|FG005|Overall Study|Adverse Event|0|||
170364864|NCT00270998|615670905|FG000|3 Month Follow-up|Adverse Event|1|||
170364865|NCT00270998|615670906|FG001|3 Month Follow-up|Adverse Event|0|||
170364866|NCT00270998|615670907|FG002|3 Month Follow-up|Adverse Event|0|||
170364867|NCT00270998|615670905|FG000|3 Month Follow-up|Lack of Efficacy|1|||
170364868|NCT00270998|615670906|FG001|3 Month Follow-up|Lack of Efficacy|2|||
170364869|NCT00270998|615670907|FG002|3 Month Follow-up|Lack of Efficacy|1|||
170364870|NCT00270998|615670905|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
170364871|NCT00270998|615670906|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
170364872|NCT00270998|615670907|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
170364873|NCT00270998|615670905|FG000|3 Month Follow-up|Pessary did not fit|12|||
170364874|NCT00270998|615670906|FG001|3 Month Follow-up|Pessary did not fit|0|||
170364875|NCT00270998|615670907|FG002|3 Month Follow-up|Pessary did not fit|0|||
170364876|NCT00270998|615670905|FG000|3 Month Follow-up|Personal/family health|1|||
170364877|NCT00270998|615670906|FG001|3 Month Follow-up|Personal/family health|1|||
170364878|NCT00270998|615670907|FG002|3 Month Follow-up|Personal/family health|0|||
170364879|NCT00270998|615670905|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
170364880|NCT00270998|615670906|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
170364881|NCT00270998|615670907|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
170364882|NCT00270998|615670905|FG000|12 Month Follow-up|Lack of Efficacy|5|||
170364883|NCT00270998|615670906|FG001|12 Month Follow-up|Lack of Efficacy|4|||
170364884|NCT00270998|615670907|FG002|12 Month Follow-up|Lack of Efficacy|3|||
170364885|NCT00270998|615670905|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
170364886|NCT00270998|615670906|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
170364887|NCT00270998|615670907|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
170364888|NCT00270998|615670905|FG000|12 Month Follow-up|Pessary did not fit|1|||
170364889|NCT00270998|615670906|FG001|12 Month Follow-up|Pessary did not fit|0|||
170364890|NCT00270998|615670907|FG002|12 Month Follow-up|Pessary did not fit|0|||
170364891|NCT00270998|615670905|FG000|12 Month Follow-up|Personal/family health|0|||
170364892|NCT00270998|615670906|FG001|12 Month Follow-up|Personal/family health|5|||
170364893|NCT00270998|615670907|FG002|12 Month Follow-up|Personal/family health|1|||
170364894|NCT00270998|615670905|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
170364895|NCT00270998|615670906|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
170364896|NCT00270998|615670907|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
170364897|NCT04075396|615670910|FG000|Overall Study|Death|11|||
170364898|NCT04075396|615670911|FG001|Overall Study|Death|9|||
170364899|NCT04075396|615670910|FG000|Overall Study|Withdrawal by Subject|1|||
170364900|NCT04075396|615670911|FG001|Overall Study|Withdrawal by Subject|2|||
170364901|NCT04075396|615670910|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
170364902|NCT04075396|615670911|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
170364903|NCT04075396|615670910|FG000|Overall Study|Enrolled but not-treated|0|||
170364904|NCT04075396|615670911|FG001|Overall Study|Enrolled but not-treated|1|||
170364905|NCT03000686|615670912|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
170364906|NCT03000686|615670913|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
170364907|NCT03000686|615670914|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
170364908|NCT03000686|615670915|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
170364909|NCT01112982|615670918|FG000|Overall Study|Withdrawal by Subject|1|||
170364910|NCT01112982|615670918|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
170364911|NCT03371251|615670919|FG000|Overall Study|Withdrawal by Subject|1|||
170364912|NCT03371251|615670920|FG001|Overall Study|Withdrawal by Subject|0|||
170364913|NCT03371251|615670921|FG002|Overall Study|Withdrawal by Subject|1|||
170364914|NCT03371251|615670922|FG003|Overall Study|Withdrawal by Subject|0|||
170364915|NCT03371251|615670923|FG004|Overall Study|Withdrawal by Subject|2|||
170364916|NCT03371251|615670924|FG005|Overall Study|Withdrawal by Subject|2|||
170364917|NCT03371251|615670919|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
170364918|NCT03371251|615670920|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
170364919|NCT03371251|615670921|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
170364920|NCT03371251|615670922|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
170364921|NCT03371251|615670923|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
170364922|NCT03371251|615670924|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
170364923|NCT03371251|615670919|FG000|Overall Study|Adverse Event|0|||
170364924|NCT03371251|615670920|FG001|Overall Study|Adverse Event|0|||
170364925|NCT03371251|615670921|FG002|Overall Study|Adverse Event|0|||
170364926|NCT03371251|615670922|FG003|Overall Study|Adverse Event|0|||
170364927|NCT03371251|615670923|FG004|Overall Study|Adverse Event|1|||
170364928|NCT03371251|615670924|FG005|Overall Study|Adverse Event|0|||
170364929|NCT03371251|615670919|FG000|Overall Study|Decision by Sponsor|0|||
170364930|NCT03371251|615670920|FG001|Overall Study|Decision by Sponsor|0|||
170364931|NCT03371251|615670921|FG002|Overall Study|Decision by Sponsor|0|||
170364932|NCT03371251|615670922|FG003|Overall Study|Decision by Sponsor|0|||
170364933|NCT03371251|615670923|FG004|Overall Study|Decision by Sponsor|2|||
170364934|NCT03371251|615670924|FG005|Overall Study|Decision by Sponsor|0|||
170364935|NCT00294684|615670925|FG000|Overall Study|Lost to Follow-up|5|||
170364936|NCT00294684|615670926|FG001|Overall Study|Lost to Follow-up|8|||
170364937|NCT01248364|615670927|FG000|Overall Study|Adverse Event|0|||
170364938|NCT01248364|615670928|FG001|Overall Study|Adverse Event|1|||
170364939|NCT01248364|615670929|FG002|Overall Study|Adverse Event|0|||
170364940|NCT01248364|615670930|FG003|Overall Study|Adverse Event|0|||
170364941|NCT01611298|615670931|FG000|Overall Study|Relapsed|2|||
170364942|NCT03238352|615670932|FG000|Overall Study|Lost to Follow-up|0|||
170364943|NCT03238352|615670933|FG001|Overall Study|Lost to Follow-up|2|||
170364944|NCT03238352|615670934|FG002|Overall Study|Lost to Follow-up|1|||
170364945|NCT03238352|615670932|FG000|Overall Study|Withdrawal by Subject|0|||
170364946|NCT03238352|615670933|FG001|Overall Study|Withdrawal by Subject|1|||
170364947|NCT03238352|615670934|FG002|Overall Study|Withdrawal by Subject|0|||
170364948|NCT05425719|615670935|FG000|Overall Study|Lost to Follow-up|4|||
170364949|NCT05425719|615670936|FG001|Overall Study|Lost to Follow-up|0|||
170364950|NCT05425719|615670935|FG000|Overall Study|Withdrew consent|1|||
170364951|NCT05425719|615670936|FG001|Overall Study|Withdrew consent|1|||
170364952|NCT01185704|615670937|FG000|Overall Study|Randomized but not treated|3|||
170364953|NCT01185704|615670938|FG001|Overall Study|Randomized but not treated|3|||
170364954|NCT01185704|615670937|FG000|Overall Study|Lack of ovarian response|5|||
170364955|NCT01185704|615670938|FG001|Overall Study|Lack of ovarian response|1|||
170364956|NCT01185704|615670937|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
170364957|NCT01185704|615670938|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
170364958|NCT01185704|615670937|FG000|Overall Study|Ectopic pregnancy|0|||
170364959|NCT01185704|615670938|FG001|Overall Study|Ectopic pregnancy|1|||
170364960|NCT00871572|615670939|FG000|Overall Study|Adverse Event|0|||
170364961|NCT00871572|615670940|FG001|Overall Study|Adverse Event|2|||
170364962|NCT00871572|615670941|FG002|Overall Study|Adverse Event|0|||
170364963|NCT00871572|615670942|FG003|Overall Study|Adverse Event|3|||
170364964|NCT00871572|615670939|FG000|Overall Study|Investigator Decision|0|||
170364965|NCT00871572|615670940|FG001|Overall Study|Investigator Decision|1|||
170364966|NCT00871572|615670941|FG002|Overall Study|Investigator Decision|0|||
170364967|NCT00871572|615670942|FG003|Overall Study|Investigator Decision|1|||
170364968|NCT00871572|615670939|FG000|Overall Study|Lost to Follow-up|0|||
170364969|NCT00871572|615670940|FG001|Overall Study|Lost to Follow-up|1|||
170364970|NCT00871572|615670941|FG002|Overall Study|Lost to Follow-up|0|||
170364971|NCT00871572|615670942|FG003|Overall Study|Lost to Follow-up|1|||
170364972|NCT00871572|615670939|FG000|Overall Study|Protocol Violation|0|||
170364973|NCT00871572|615670940|FG001|Overall Study|Protocol Violation|0|||
170364974|NCT00871572|615670941|FG002|Overall Study|Protocol Violation|1|||
170364975|NCT00871572|615670942|FG003|Overall Study|Protocol Violation|1|||
170364976|NCT00871572|615670939|FG000|Overall Study|Sponsor Decision|1|||
170364977|NCT00871572|615670940|FG001|Overall Study|Sponsor Decision|0|||
170364978|NCT00871572|615670941|FG002|Overall Study|Sponsor Decision|0|||
170364979|NCT00871572|615670942|FG003|Overall Study|Sponsor Decision|0|||
170364980|NCT00871572|615670939|FG000|Overall Study|Withdrawal by Subject|1|||
170364981|NCT00871572|615670940|FG001|Overall Study|Withdrawal by Subject|2|||
170364982|NCT00871572|615670941|FG002|Overall Study|Withdrawal by Subject|3|||
170364983|NCT00871572|615670942|FG003|Overall Study|Withdrawal by Subject|1|||
170364984|NCT01957787|615670943|FG000|Overall Study|Death|18|||
170364985|NCT01957787|615670943|FG000|Overall Study|Lost to Follow-up|3|||
170364986|NCT01957787|615670943|FG000|Overall Study|Withdrawal by Subject|3|||
170364987|NCT01957787|615670943|FG000|Overall Study|Entered Hospice or Similar Program|2|||
170364988|NCT01957787|615670943|FG000|Overall Study|Index Tumor(s) Resected|2|||
170364989|NCT01957787|615670943|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
170364990|NCT01957787|615670943|FG000|Overall Study|Local therapy, not cryoablation|6|||
170364991|NCT00187889|615670944|FG000|Overall Study|Withdrawal by Subject|6|||
170364992|NCT00187889|615670945|FG001|Overall Study|Withdrawal by Subject|4|||
170364993|NCT00435994|615670949|FG000|Overall Study|Lost to Follow-up|7|||
170364994|NCT00435994|615670950|FG001|Overall Study|Lost to Follow-up|0|||
170364995|NCT00435994|615670951|FG002|Overall Study|Lost to Follow-up|0|||
170364996|NCT01151540|615670952|FG000|Overall Study|Other|2|||
170364997|NCT01151540|615670952|FG000|Overall Study|Adverse event, non-fatal|4|||
170364998|NCT01151540|615670952|FG000|Overall Study|Withdrawal by Subject|7|||
170364999|NCT03846219|615670955|FG000|Overall Study|Withdrawal by Subject|3|||
170365000|NCT03846219|615670956|FG001|Overall Study|Withdrawal by Subject|2|||
170365001|NCT03846219|615670957|FG002|Overall Study|Withdrawal by Subject|2|||
170399316|NCT03193190|615799941|FG004|Stage 1|Progressive Disease|0|||
170365002|NCT03846219|615670955|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
170365003|NCT03846219|615670956|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
170365004|NCT03846219|615670957|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
170365005|NCT03846219|615670955|FG000|Overall Study|Physician Decision|0|||
170365006|NCT03846219|615670956|FG001|Overall Study|Physician Decision|0|||
170365007|NCT03846219|615670957|FG002|Overall Study|Physician Decision|2|||
170365008|NCT02248857|615670958|FG000|3 Month|Withdrawal by Subject|9|||
170365009|NCT02248857|615670959|FG001|3 Month|Withdrawal by Subject|3|||
170365010|NCT02248857|615670960|FG002|3 Month|Withdrawal by Subject|4|||
170365011|NCT02248857|615670958|FG000|3 Month|Unable to reach for 3 month|35|||
170365012|NCT02248857|615670959|FG001|3 Month|Unable to reach for 3 month|29|||
170365013|NCT02248857|615670960|FG002|3 Month|Unable to reach for 3 month|26|||
170365014|NCT02248857|615670958|FG000|3 Month|Partially completed, unable to finish|2|||
170365015|NCT02248857|615670959|FG001|3 Month|Partially completed, unable to finish|2|||
170365016|NCT02248857|615670960|FG002|3 Month|Partially completed, unable to finish|1|||
170365017|NCT02248857|615670958|FG000|6 Month|Lost to Follow-up|27|||
170365018|NCT02248857|615670959|FG001|6 Month|Lost to Follow-up|26|||
170365019|NCT02248857|615670960|FG002|6 Month|Lost to Follow-up|15|||
170365020|NCT02248857|615670958|FG000|6 Month|Partially completed, unable to finish|0|||
170365021|NCT02248857|615670959|FG001|6 Month|Partially completed, unable to finish|1|||
170365022|NCT02248857|615670960|FG002|6 Month|Partially completed, unable to finish|0|||
170365023|NCT02248857|615670958|FG000|6 Month|Withdrawal by Subject|0|||
170365024|NCT02248857|615670959|FG001|6 Month|Withdrawal by Subject|2|||
170365025|NCT02248857|615670960|FG002|6 Month|Withdrawal by Subject|2|||
170365026|NCT02248857|615670958|FG000|6 Month|Death|1|||
170365027|NCT02248857|615670959|FG001|6 Month|Death|0|||
170365028|NCT02248857|615670960|FG002|6 Month|Death|0|||
170365029|NCT01688635|615670961|FG000|Washout 1|Withdrawal by Subject|1|||
170365030|NCT01688635|615670962|FG001|Washout 1|Withdrawal by Subject|0|||
170365031|NCT01688635|615670961|FG000|Washout 1|Adverse Event|0|||
170365032|NCT01688635|615670962|FG001|Washout 1|Adverse Event|1|||
170365033|NCT01688635|615670961|FG000|Washout 1|Physician Decision|0|||
170365034|NCT01688635|615670962|FG001|Washout 1|Physician Decision|1|||
170365035|NCT01688635|615670961|FG000|Washout 2|Physician Decision|1|||
170365036|NCT01688635|615670962|FG001|Washout 2|Physician Decision|0|||
170365037|NCT01688635|615670961|FG000|Washout 2|Withdrawal by Subject|1|||
170365038|NCT01688635|615670962|FG001|Washout 2|Withdrawal by Subject|0|||
170365039|NCT01688635|615670961|FG000|Washout 2|Sponsor Decision|1|||
170365040|NCT01688635|615670962|FG001|Washout 2|Sponsor Decision|2|||
170365041|NCT01688635|615670961|FG000|Washout 3|Withdrawal by Subject|1|||
170365042|NCT01688635|615670962|FG001|Washout 3|Withdrawal by Subject|0|||
170365043|NCT02674685|615670963|FG000|Overall Study|Withdrawal by Subject|4|||
170365044|NCT01181778|615670964|FG000|Overall Study|Physician Decision|48|||
170365045|NCT00903370|615670965|FG000|Overall Study|Death|13|||
170365046|NCT00903370|615670966|FG001|Overall Study|Death|10|||
170365047|NCT00903370|615670965|FG000|Overall Study|Withdrawal by Subject|9|||
170365048|NCT00903370|615670966|FG001|Overall Study|Withdrawal by Subject|6|||
170365049|NCT00903370|615670965|FG000|Overall Study|Lost to Follow-up|6|||
170365050|NCT00903370|615670966|FG001|Overall Study|Lost to Follow-up|8|||
170365051|NCT05567393|615670968|FG000|Overall Study|Voluntary Withdrawal|0|||
170365052|NCT05567393|615670969|FG001|Overall Study|Voluntary Withdrawal|0|||
170365053|NCT05567393|615670970|FG002|Overall Study|Voluntary Withdrawal|0|||
170365054|NCT05567393|615670971|FG003|Overall Study|Voluntary Withdrawal|0|||
170365055|NCT05567393|615670972|FG004|Overall Study|Voluntary Withdrawal|0|||
170365056|NCT05567393|615670973|FG005|Overall Study|Voluntary Withdrawal|0|||
170365057|NCT05567393|615670974|FG006|Overall Study|Voluntary Withdrawal|0|||
170365058|NCT05567393|615670975|FG007|Overall Study|Voluntary Withdrawal|0|||
170365059|NCT05567393|615670976|FG008|Overall Study|Voluntary Withdrawal|0|||
170365060|NCT05567393|615670977|FG009|Overall Study|Voluntary Withdrawal|0|||
170365061|NCT05567393|615670978|FG010|Overall Study|Voluntary Withdrawal|0|||
170365062|NCT05567393|615670979|FG011|Overall Study|Voluntary Withdrawal|0|||
170365063|NCT05567393|615670980|FG012|Overall Study|Voluntary Withdrawal|0|||
170365064|NCT05567393|615670981|FG013|Overall Study|Voluntary Withdrawal|1|||
170365065|NCT05567393|615670982|FG014|Overall Study|Voluntary Withdrawal|0|||
170365066|NCT05567393|615670983|FG015|Overall Study|Voluntary Withdrawal|0|||
170365067|NCT05567393|615670984|FG016|Overall Study|Voluntary Withdrawal|0|||
170365068|NCT05567393|615670985|FG017|Overall Study|Voluntary Withdrawal|0|||
170365069|NCT00659126|615670986|FG000|Overall Study|Adverse Event|2|||
170365070|NCT00659126|615670987|FG001|Overall Study|Adverse Event|2|||
170365071|NCT00659126|615670986|FG000|Overall Study|Screen failure|1|||
170365072|NCT00659126|615670987|FG001|Overall Study|Screen failure|1|||
170365073|NCT00659126|615670986|FG000|Overall Study|Technical problems with MRI|0|||
170365074|NCT00659126|615670987|FG001|Overall Study|Technical problems with MRI|1|||
170365075|NCT04179786|615670991|FG000|Overall Study|Withdrawal by Subject|8|||
170365076|NCT03310580|615670992|FG000|Overall Study|Adverse Event|0|||
170365077|NCT03310580|615670993|FG001|Overall Study|Adverse Event|1|||
170365078|NCT03310580|615670994|FG002|Overall Study|Adverse Event|0|||
170365079|NCT02925312|615670995|FG000|Overall Study|Lost to Follow-up|25|||
170365080|NCT02925312|615670996|FG001|Overall Study|Lost to Follow-up|0|||
170365081|NCT02925312|615670995|FG000|Overall Study|Adverse Event|2|||
170365082|NCT02925312|615670996|FG001|Overall Study|Adverse Event|0|||
170365083|NCT03205982|615670999|FG000|Overall Study|Lost to Follow-up|20|||
170365084|NCT03205982|615671000|FG001|Overall Study|Lost to Follow-up|19|||
170365085|NCT03205982|615670999|FG000|Overall Study|Withdrawal by Subject|4|||
170365086|NCT03205982|615671000|FG001|Overall Study|Withdrawal by Subject|3|||
170365087|NCT03205982|615670999|FG000|Overall Study|Withdrawal by PI|0|||
170365088|NCT03205982|615671000|FG001|Overall Study|Withdrawal by PI|1|||
170365089|NCT02848313|615673262|FG000|Overall Study|Adverse Event|1|||
170365090|NCT02848313|615673263|FG001|Overall Study|Adverse Event|2|||
170365091|NCT02848313|615673262|FG000|Overall Study|Lack of Efficacy|0|||
170365092|NCT02848313|615673263|FG001|Overall Study|Lack of Efficacy|1|||
170365093|NCT02848313|615673262|FG000|Overall Study|Withdrawal by Subject|1|||
170365094|NCT02848313|615673263|FG001|Overall Study|Withdrawal by Subject|1|||
170365095|NCT02848313|615673262|FG000|Overall Study|Lost to follow up|1|||
170365096|NCT02848313|615673263|FG001|Overall Study|Lost to follow up|0|||
170365097|NCT02038790|615673268|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
170365098|NCT02038790|615673269|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
170365099|NCT04402385|615673275|FG000|Overall Study|Withdrawal by Subject|4|||
170365100|NCT04402385|615673276|FG001|Overall Study|Withdrawal by Subject|4|||
170365101|NCT04402385|615673275|FG000|Overall Study|Lost to Follow-up|1|||
170365102|NCT04402385|615673276|FG001|Overall Study|Lost to Follow-up|1|||
170365103|NCT04402385|615673275|FG000|Overall Study|Physician Decision|0|||
170365104|NCT04402385|615673276|FG001|Overall Study|Physician Decision|1|||
170365105|NCT00607919|615673283|FG000|Acute Phase|Adverse Event|9|||
170365106|NCT00607919|615673284|FG001|Acute Phase|Adverse Event|2|||
170365107|NCT00607919|615673283|FG000|Acute Phase|Entry Criteria Not Met|1|||
170365108|NCT00607919|615673284|FG001|Acute Phase|Entry Criteria Not Met|1|||
170365109|NCT00607919|615673283|FG000|Acute Phase|Lack of Efficacy|1|||
170365110|NCT00607919|615673284|FG001|Acute Phase|Lack of Efficacy|2|||
170365111|NCT00607919|615673283|FG000|Acute Phase|Lost to Follow-up|9|||
170365112|NCT00607919|615673284|FG001|Acute Phase|Lost to Follow-up|3|||
170365113|NCT00607919|615673283|FG000|Acute Phase|Parent/Caregiver Decision|6|||
170365114|NCT00607919|615673284|FG001|Acute Phase|Parent/Caregiver Decision|4|||
170365115|NCT00607919|615673283|FG000|Acute Phase|Protocol Violation|5|||
170365116|NCT00607919|615673284|FG001|Acute Phase|Protocol Violation|1|||
170365117|NCT00607919|615673283|FG000|Acute Phase|Withdrawal by Subject|3|||
170365118|NCT00607919|615673284|FG001|Acute Phase|Withdrawal by Subject|3|||
170365119|NCT00607919|615673283|FG000|Open-Label Phase|Adverse Event|1|||
170365120|NCT00607919|615673284|FG001|Open-Label Phase|Adverse Event|5|||
170365121|NCT00607919|615673283|FG000|Open-Label Phase|Lost to Follow-up|4|||
170365122|NCT00607919|615673284|FG001|Open-Label Phase|Lost to Follow-up|1|||
170365123|NCT00607919|615673283|FG000|Open-Label Phase|Protocol Violation|2|||
170365124|NCT00607919|615673284|FG001|Open-Label Phase|Protocol Violation|2|||
170365125|NCT00607919|615673283|FG000|Open-Label Phase|Withdrawal by Subject|2|||
170365126|NCT00607919|615673284|FG001|Open-Label Phase|Withdrawal by Subject|2|||
170365127|NCT00607919|615673283|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
170365128|NCT00607919|615673284|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
170365129|NCT00633893|615673287|FG000|Overall Study|Death|1|||
170365130|NCT00633893|615673288|FG001|Overall Study|Death|3|||
170365131|NCT00633893|615673289|FG002|Overall Study|Death|9|||
170365132|NCT00633893|615673287|FG000|Overall Study|Adverse Event|65|||
170365133|NCT00633893|615673288|FG001|Overall Study|Adverse Event|58|||
170365134|NCT00633893|615673289|FG002|Overall Study|Adverse Event|126|||
170365135|NCT00633893|615673287|FG000|Overall Study|Withdrawal by Subject|7|||
170365136|NCT00633893|615673288|FG001|Overall Study|Withdrawal by Subject|12|||
170365137|NCT00633893|615673289|FG002|Overall Study|Withdrawal by Subject|6|||
170365138|NCT00633893|615673287|FG000|Overall Study|Lost to Follow-up|2|||
170365139|NCT00633893|615673288|FG001|Overall Study|Lost to Follow-up|4|||
170365140|NCT00633893|615673289|FG002|Overall Study|Lost to Follow-up|8|||
170365141|NCT00633893|615673287|FG000|Overall Study|Poor/non-compliance|5|||
170365142|NCT00633893|615673288|FG001|Overall Study|Poor/non-compliance|12|||
170365143|NCT00633893|615673289|FG002|Overall Study|Poor/non-compliance|3|||
170365144|NCT00633893|615673287|FG000|Overall Study|Pregnancy|2|||
170365145|NCT00633893|615673288|FG001|Overall Study|Pregnancy|1|||
170365146|NCT00633893|615673289|FG002|Overall Study|Pregnancy|1|||
170365147|NCT00633893|615673287|FG000|Overall Study|Not meet/no longer meets criteria|4|||
170365148|NCT00633893|615673288|FG001|Overall Study|Not meet/no longer meets criteria|6|||
170365149|NCT00633893|615673289|FG002|Overall Study|Not meet/no longer meets criteria|4|||
170365150|NCT00633893|615673287|FG000|Overall Study|Other|28|||
170365151|NCT00633893|615673288|FG001|Overall Study|Other|33|||
170365152|NCT00633893|615673289|FG002|Overall Study|Other|31|||
170365153|NCT02741310|615673294|FG000|Overall Study|Sponsor Decision|2|||
170365154|NCT02741310|615673295|FG001|Overall Study|Sponsor Decision|2|||
170365155|NCT02603172|615673296|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
170365156|NCT02603172|615673297|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
170365157|NCT02603172|615673298|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
170365158|NCT02603172|615673299|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
170365159|NCT02603172|615673300|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
170365160|NCT02603172|615673301|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
170365161|NCT02603172|615673302|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
170365162|NCT02603172|615673303|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
170365163|NCT00863317|615673304|FG000|Overall Study|Lost to Follow-up|8|||
170365164|NCT00863317|615673305|FG001|Overall Study|Lost to Follow-up|9|||
170365165|NCT00369278|615673312|FG000|Overall Study|Adverse Event|14|||
170365166|NCT00369278|615673313|FG001|Overall Study|Adverse Event|11|||
170365167|NCT00369278|615673312|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
170365168|NCT00369278|615673313|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
170365169|NCT00369278|615673312|FG000|Overall Study|Protocol Violation|2|||
170365170|NCT00369278|615673313|FG001|Overall Study|Protocol Violation|1|||
170365171|NCT00369278|615673312|FG000|Overall Study|Withdrawal by Subject|2|||
170365172|NCT00369278|615673313|FG001|Overall Study|Withdrawal by Subject|2|||
170365173|NCT00369278|615673312|FG000|Overall Study|Lost to Follow-up|1|||
170365174|NCT00369278|615673313|FG001|Overall Study|Lost to Follow-up|0|||
170365175|NCT00369278|615673312|FG000|Overall Study|Graft loss|1|||
170365176|NCT00369278|615673313|FG001|Overall Study|Graft loss|2|||
170365177|NCT00511108|615673314|FG000|Overall Study|Adverse Event|2|||
170365178|NCT00511108|615673315|FG001|Overall Study|Adverse Event|0|||
170365179|NCT00511108|615673316|FG002|Overall Study|Adverse Event|1|||
170365180|NCT00511108|615673317|FG003|Overall Study|Adverse Event|2|||
170365181|NCT00511108|615673314|FG000|Overall Study|Lost to Follow-up|0|||
170365182|NCT00511108|615673315|FG001|Overall Study|Lost to Follow-up|2|||
170365183|NCT00511108|615673316|FG002|Overall Study|Lost to Follow-up|1|||
170365184|NCT00511108|615673317|FG003|Overall Study|Lost to Follow-up|0|||
170365185|NCT00511108|615673314|FG000|Overall Study|Physician Decision|0|||
170365186|NCT00511108|615673315|FG001|Overall Study|Physician Decision|0|||
170365187|NCT00511108|615673316|FG002|Overall Study|Physician Decision|0|||
170365188|NCT00511108|615673317|FG003|Overall Study|Physician Decision|1|||
170365189|NCT00511108|615673314|FG000|Overall Study|Withdrawal by Subject|4|||
170365190|NCT00511108|615673315|FG001|Overall Study|Withdrawal by Subject|0|||
170365191|NCT00511108|615673316|FG002|Overall Study|Withdrawal by Subject|3|||
170365192|NCT00511108|615673317|FG003|Overall Study|Withdrawal by Subject|2|||
170365193|NCT01237223|615673320|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
170365194|NCT01237223|615673321|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
170365195|NCT01237223|615673322|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
170365196|NCT01237223|615673323|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
170365197|NCT01237223|615673324|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
170365198|NCT01237223|615673325|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
170365199|NCT01237223|615673320|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
170365200|NCT01237223|615673321|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
170365201|NCT01237223|615673322|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
170365202|NCT01237223|615673323|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
170365203|NCT01237223|615673324|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
170365204|NCT01237223|615673325|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
170365205|NCT01237223|615673320|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
170365206|NCT01237223|615673321|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
170365207|NCT01237223|615673322|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
170365208|NCT01237223|615673323|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
170365209|NCT01237223|615673324|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
170365210|NCT01237223|615673325|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
170365211|NCT01237223|615673320|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
170365212|NCT01237223|615673321|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
170365213|NCT01237223|615673322|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
170365214|NCT01237223|615673323|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
170365215|NCT01237223|615673324|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
170365216|NCT01237223|615673325|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
170365217|NCT01237223|615673320|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
170365218|NCT01237223|615673321|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
170365219|NCT01237223|615673322|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
170365220|NCT01237223|615673323|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
170365221|NCT01237223|615673324|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
170365222|NCT01237223|615673325|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
170365223|NCT01237223|615673320|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
170365224|NCT01237223|615673321|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
170365225|NCT01237223|615673322|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
170365226|NCT01237223|615673323|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
170365227|NCT01237223|615673324|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
170365228|NCT01237223|615673325|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
170365229|NCT01237223|615673320|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
170365230|NCT01237223|615673321|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
170365231|NCT01237223|615673322|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
170365232|NCT01237223|615673323|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
170365233|NCT01237223|615673324|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
170365234|NCT01237223|615673325|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
170365235|NCT01237223|615673320|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
170365236|NCT01237223|615673321|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
170365237|NCT01237223|615673322|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
170365238|NCT01237223|615673323|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
170365239|NCT01237223|615673324|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
170365240|NCT01237223|615673325|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
170365241|NCT01237223|615673320|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
170365242|NCT01237223|615673321|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
170365243|NCT01237223|615673322|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
170365244|NCT01237223|615673323|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
170365245|NCT01237223|615673324|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
170365246|NCT01237223|615673325|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
170365247|NCT01237223|615673320|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
170365248|NCT01237223|615673321|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
170365249|NCT01237223|615673322|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
170365250|NCT01237223|615673323|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
170365251|NCT01237223|615673324|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
170365252|NCT01237223|615673325|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
170365253|NCT01017549|615673328|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
170365254|NCT01017549|615673328|FG000|One-year Follow-up|Lost to Follow-up|2|||
170365255|NCT01017549|615673328|FG000|One-year Follow-up|Withdrawal by Subject|5|||
170365256|NCT01017549|615673328|FG000|5 Year Follow-up|Lost to Follow-up|9|||
170365257|NCT01017549|615673328|FG000|5 Year Follow-up|Mastectomy|3|||
170365258|NCT05441540|615673329|FG000|Overall Study|Withdrawal by Subject|2|||
170365259|NCT04539262|615673331|FG000|Overall Study|Adverse Event|0|||
170365260|NCT04539262|615673332|FG001|Overall Study|Adverse Event|0|||
170365261|NCT04539262|615673333|FG002|Overall Study|Adverse Event|1|||
170365262|NCT04539262|615673334|FG003|Overall Study|Adverse Event|0|||
170365263|NCT04539262|615673335|FG004|Overall Study|Adverse Event|0|||
170365264|NCT04539262|615673336|FG005|Overall Study|Adverse Event|0|||
170365265|NCT04539262|615673337|FG006|Overall Study|Adverse Event|0|||
170365266|NCT04539262|615673338|FG007|Overall Study|Adverse Event|0|||
170365267|NCT04539262|615673331|FG000|Overall Study|Withdrew Consent|0|||
170365268|NCT04539262|615673332|FG001|Overall Study|Withdrew Consent|0|||
170365269|NCT04539262|615673333|FG002|Overall Study|Withdrew Consent|0|||
170365270|NCT04539262|615673334|FG003|Overall Study|Withdrew Consent|1|||
170365271|NCT04539262|615673335|FG004|Overall Study|Withdrew Consent|0|||
170365272|NCT04539262|615673336|FG005|Overall Study|Withdrew Consent|0|||
170365273|NCT04539262|615673337|FG006|Overall Study|Withdrew Consent|0|||
170365274|NCT04539262|615673338|FG007|Overall Study|Withdrew Consent|0|||
170365275|NCT04539262|615673331|FG000|Overall Study|Randomized, Not treated|0|||
170365276|NCT04539262|615673332|FG001|Overall Study|Randomized, Not treated|1|||
170365277|NCT04539262|615673333|FG002|Overall Study|Randomized, Not treated|0|||
170365278|NCT04539262|615673334|FG003|Overall Study|Randomized, Not treated|0|||
170365279|NCT04539262|615673335|FG004|Overall Study|Randomized, Not treated|0|||
170365280|NCT04539262|615673336|FG005|Overall Study|Randomized, Not treated|0|||
170365281|NCT04539262|615673337|FG006|Overall Study|Randomized, Not treated|1|||
170365282|NCT04539262|615673338|FG007|Overall Study|Randomized, Not treated|0|||
170365283|NCT00792701|615673339|FG000|Overall Study|Adverse Event|0|||
170365284|NCT00792701|615673340|FG001|Overall Study|Adverse Event|22|||
170365285|NCT00792701|615673339|FG000|Overall Study|Ineligible|1|||
170365286|NCT00792701|615673340|FG001|Overall Study|Ineligible|3|||
170365287|NCT00792701|615673339|FG000|Overall Study|Withdrawal by Subject|1|||
170365288|NCT00792701|615673340|FG001|Overall Study|Withdrawal by Subject|19|||
170365289|NCT00792701|615673339|FG000|Overall Study|Not protocol specified|17|||
170365290|NCT00792701|615673340|FG001|Overall Study|Not protocol specified|0|||
170365291|NCT02980692|615673341|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
170365292|NCT02980692|615673342|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
170365293|NCT02980692|615673343|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
170365294|NCT02980692|615673344|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
170365295|NCT02980692|615673345|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
170365296|NCT02980692|615673341|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
170399317|NCT03193190|615799942|FG005|Stage 1|Progressive Disease|0|||
170365297|NCT02980692|615673342|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
170365298|NCT02980692|615673343|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
170365299|NCT02980692|615673344|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
170365300|NCT02980692|615673345|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
170365301|NCT02980692|615673341|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
170365302|NCT02980692|615673342|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
170365303|NCT02980692|615673343|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
170365304|NCT02980692|615673344|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
170365305|NCT02980692|615673345|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
170365306|NCT02980692|615673341|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
170365307|NCT02980692|615673342|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
170365308|NCT02980692|615673343|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
170365309|NCT02980692|615673344|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
170365310|NCT02980692|615673345|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
170365311|NCT02980692|615673341|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
170365312|NCT02980692|615673342|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
170365313|NCT02980692|615673343|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
170365314|NCT02980692|615673344|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
170365315|NCT02980692|615673345|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
170365316|NCT02980692|615673341|FG000|Double Blind Placebo Controlled Period|Other|1|||
170365317|NCT02980692|615673342|FG001|Double Blind Placebo Controlled Period|Other|0|||
170365318|NCT02980692|615673343|FG002|Double Blind Placebo Controlled Period|Other|0|||
170365319|NCT02980692|615673344|FG003|Double Blind Placebo Controlled Period|Other|0|||
170365320|NCT02980692|615673345|FG004|Double Blind Placebo Controlled Period|Other|1|||
170365321|NCT02980692|615673341|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
170365322|NCT02980692|615673342|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
170365323|NCT02980692|615673343|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
170365324|NCT02980692|615673344|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
170365325|NCT02980692|615673345|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
170365326|NCT02980692|615673341|FG000|Double-blind Follow-up Period|Adverse Event|0|||
170365327|NCT02980692|615673342|FG001|Double-blind Follow-up Period|Adverse Event|0|||
170365328|NCT02980692|615673343|FG002|Double-blind Follow-up Period|Adverse Event|0|||
170365329|NCT02980692|615673344|FG003|Double-blind Follow-up Period|Adverse Event|1|||
170365330|NCT02980692|615673345|FG004|Double-blind Follow-up Period|Adverse Event|1|||
170365331|NCT02980692|615673341|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
170365332|NCT02980692|615673342|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
170365333|NCT02980692|615673343|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
170365334|NCT02980692|615673344|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
170365335|NCT02980692|615673345|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
170365336|NCT02980692|615673341|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
170365337|NCT02980692|615673342|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
170365338|NCT02980692|615673343|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
170365339|NCT02980692|615673344|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
170365340|NCT02980692|615673345|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
170365341|NCT02980692|615673341|FG000|Double-blind Follow-up Period|Pregnancy|0|||
170365342|NCT02980692|615673342|FG001|Double-blind Follow-up Period|Pregnancy|0|||
170365343|NCT02980692|615673343|FG002|Double-blind Follow-up Period|Pregnancy|1|||
170365344|NCT02980692|615673344|FG003|Double-blind Follow-up Period|Pregnancy|1|||
170365345|NCT02980692|615673345|FG004|Double-blind Follow-up Period|Pregnancy|0|||
170365346|NCT02980692|615673341|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
170365347|NCT02980692|615673342|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
170365348|NCT02980692|615673343|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
170365349|NCT02980692|615673344|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
170365350|NCT02980692|615673345|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
170365351|NCT02980692|615673341|FG000|Double-blind Follow-up Period|Other|0|||
170365352|NCT02980692|615673342|FG001|Double-blind Follow-up Period|Other|0|||
170365353|NCT02980692|615673343|FG002|Double-blind Follow-up Period|Other|1|||
170365354|NCT02980692|615673344|FG003|Double-blind Follow-up Period|Other|1|||
170365355|NCT02980692|615673345|FG004|Double-blind Follow-up Period|Other|3|||
170365356|NCT05507580|615673346|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
170365357|NCT05507580|615673347|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
170365358|NCT05507580|615673348|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
170365359|NCT05507580|615673349|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
170365360|NCT05507580|615673350|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
170365361|NCT05507580|615673351|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
170365362|NCT05507580|615673346|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
170365363|NCT05507580|615673347|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
170365364|NCT05507580|615673348|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170365365|NCT05507580|615673349|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170365366|NCT05507580|615673350|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170365367|NCT05507580|615673351|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
170365368|NCT05507580|615673346|FG000|Double-Blind Treatment Period|Other, not specified|5|||
170365369|NCT05507580|615673347|FG001|Double-Blind Treatment Period|Other, not specified|4|||
170365370|NCT05507580|615673348|FG002|Double-Blind Treatment Period|Other, not specified|0|||
170365371|NCT05507580|615673349|FG003|Double-Blind Treatment Period|Other, not specified|0|||
170365372|NCT05507580|615673350|FG004|Double-Blind Treatment Period|Other, not specified|0|||
170365373|NCT05507580|615673351|FG005|Double-Blind Treatment Period|Other, not specified|0|||
170365374|NCT05507580|615673346|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
170365375|NCT05507580|615673347|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
170365376|NCT05507580|615673348|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
170365377|NCT05507580|615673349|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
170365378|NCT05507580|615673350|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
170365379|NCT05507580|615673351|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
170365380|NCT05507580|615673346|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
170365381|NCT05507580|615673347|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
170365382|NCT05507580|615673348|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
170365383|NCT05507580|615673349|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
170365384|NCT05507580|615673350|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
170365385|NCT05507580|615673351|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
170365386|NCT05507580|615673346|FG000|Single-Blind Treatment Period|Other, not specified|0|||
170365387|NCT05507580|615673347|FG001|Single-Blind Treatment Period|Other, not specified|0|||
170365388|NCT05507580|615673348|FG002|Single-Blind Treatment Period|Other, not specified|2|||
170365389|NCT05507580|615673349|FG003|Single-Blind Treatment Period|Other, not specified|7|||
170365390|NCT05507580|615673350|FG004|Single-Blind Treatment Period|Other, not specified|3|||
170365391|NCT05507580|615673351|FG005|Single-Blind Treatment Period|Other, not specified|5|||
170365392|NCT03228394|615673354|FG000|Overall Study|Lost to Follow-up|0|||
170365393|NCT03228394|615673355|FG001|Overall Study|Lost to Follow-up|0|||
170365394|NCT03228394|615673356|FG002|Overall Study|Lost to Follow-up|1|||
170365395|NCT03228394|615673357|FG003|Overall Study|Lost to Follow-up|1|||
170365396|NCT03228394|615673358|FG004|Overall Study|Lost to Follow-up|0|||
170365397|NCT03228394|615673359|FG005|Overall Study|Lost to Follow-up|0|||
170365398|NCT03228394|615673360|FG006|Overall Study|Lost to Follow-up|2|||
170365399|NCT03228394|615673361|FG007|Overall Study|Lost to Follow-up|0|||
170365400|NCT03228394|615673354|FG000|Overall Study|Withdrawal by Subject|0|||
170365401|NCT03228394|615673355|FG001|Overall Study|Withdrawal by Subject|0|||
170365402|NCT03228394|615673356|FG002|Overall Study|Withdrawal by Subject|1|||
170365403|NCT03228394|615673357|FG003|Overall Study|Withdrawal by Subject|0|||
170365404|NCT03228394|615673358|FG004|Overall Study|Withdrawal by Subject|0|||
170365405|NCT03228394|615673359|FG005|Overall Study|Withdrawal by Subject|0|||
170365406|NCT03228394|615673360|FG006|Overall Study|Withdrawal by Subject|1|||
170365407|NCT03228394|615673361|FG007|Overall Study|Withdrawal by Subject|3|||
170365408|NCT03228394|615673354|FG000|Overall Study|Protocol Violation|0|||
170365409|NCT03228394|615673355|FG001|Overall Study|Protocol Violation|0|||
170365410|NCT03228394|615673356|FG002|Overall Study|Protocol Violation|0|||
170365411|NCT03228394|615673357|FG003|Overall Study|Protocol Violation|1|||
170365412|NCT03228394|615673358|FG004|Overall Study|Protocol Violation|0|||
170365413|NCT03228394|615673359|FG005|Overall Study|Protocol Violation|0|||
170365414|NCT03228394|615673360|FG006|Overall Study|Protocol Violation|0|||
170365415|NCT03228394|615673361|FG007|Overall Study|Protocol Violation|0|||
170365416|NCT03228394|615673354|FG000|Overall Study|Physician Decision|0|||
170365417|NCT03228394|615673355|FG001|Overall Study|Physician Decision|0|||
170365418|NCT03228394|615673356|FG002|Overall Study|Physician Decision|0|||
170365419|NCT03228394|615673357|FG003|Overall Study|Physician Decision|0|||
170365420|NCT03228394|615673358|FG004|Overall Study|Physician Decision|0|||
170365421|NCT03228394|615673359|FG005|Overall Study|Physician Decision|0|||
170365422|NCT03228394|615673360|FG006|Overall Study|Physician Decision|1|||
170365423|NCT03228394|615673361|FG007|Overall Study|Physician Decision|0|||
170365424|NCT03228394|615673354|FG000|Overall Study|Noncompliance|0|||
170365425|NCT03228394|615673355|FG001|Overall Study|Noncompliance|0|||
170365426|NCT03228394|615673356|FG002|Overall Study|Noncompliance|0|||
170365427|NCT03228394|615673357|FG003|Overall Study|Noncompliance|0|||
170365428|NCT03228394|615673358|FG004|Overall Study|Noncompliance|0|||
170365429|NCT03228394|615673359|FG005|Overall Study|Noncompliance|0|||
170365430|NCT03228394|615673360|FG006|Overall Study|Noncompliance|1|||
170365431|NCT03228394|615673361|FG007|Overall Study|Noncompliance|0|||
170365432|NCT04685538|615673362|FG000|Overall Study|Adverse Event|0|||
170365433|NCT04685538|615673363|FG001|Overall Study|Adverse Event|1|||
170365434|NCT04685538|615673362|FG000|Overall Study|Lost to Follow-up|0|||
170365435|NCT04685538|615673363|FG001|Overall Study|Lost to Follow-up|2|||
170365436|NCT02920450|615673364|FG000|Overall Study|Death|1|||
170365437|NCT02920450|615673365|FG001|Overall Study|Death|0|||
170365438|NCT02920450|615673366|FG002|Overall Study|Death|0|||
170365439|NCT02920450|615673367|FG003|Overall Study|Death|0|||
170365440|NCT02920450|615673364|FG000|Overall Study|Withdrawal by Subject|1|||
170365441|NCT02920450|615673365|FG001|Overall Study|Withdrawal by Subject|0|||
170365442|NCT02920450|615673366|FG002|Overall Study|Withdrawal by Subject|0|||
170365443|NCT02920450|615673367|FG003|Overall Study|Withdrawal by Subject|0|||
170365444|NCT00770224|615673372|FG000|Step 1: Induction|Adverse Event|3|||
170365445|NCT00770224|615673373|FG001|Step 1: Induction|Adverse Event|0|||
170365446|NCT00770224|615673372|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
170365447|NCT00770224|615673373|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
170365448|NCT00770224|615673372|FG000|Step 1: Induction|Other reason not protocol specified|2|||
170365449|NCT00770224|615673373|FG001|Step 1: Induction|Other reason not protocol specified|0|||
170365450|NCT00770224|615673372|FG000|Step 1: Induction|Ineligible|2|||
170365451|NCT00770224|615673373|FG001|Step 1: Induction|Ineligible|0|||
170365452|NCT00770224|615673372|FG000|Step 1: Induction|No protocol treatment given|1|||
170365453|NCT00770224|615673373|FG001|Step 1: Induction|No protocol treatment given|0|||
170365454|NCT00770224|615673372|FG000|Step 2: Maintenance|Adverse Event|0|||
170365455|NCT00770224|615673373|FG001|Step 2: Maintenance|Adverse Event|10|||
170365456|NCT00770224|615673372|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
170365457|NCT00770224|615673373|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
170365458|NCT00770224|615673372|FG000|Step 2: Maintenance|Progression/relapse|0|||
170365459|NCT00770224|615673373|FG001|Step 2: Maintenance|Progression/relapse|1|||
170365460|NCT00770224|615673372|FG000|Step 2: Maintenance|Death|0|||
170365461|NCT00770224|615673373|FG001|Step 2: Maintenance|Death|2|||
170365462|NCT00770224|615673372|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
170365463|NCT00770224|615673373|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
170365464|NCT00770224|615673372|FG000|Step 2: Maintenance|Ineligible|0|||
170365465|NCT00770224|615673373|FG001|Step 2: Maintenance|Ineligible|2|||
170365466|NCT00291187|615673374|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
170365467|NCT00291187|615673375|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
170365468|NCT00291187|615673376|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
170365469|NCT00291187|615673377|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
170365470|NCT01505114|615673378|FG000|Overall Study|Withdrawal by Subject|5|||
170365471|NCT01505114|615673379|FG001|Overall Study|Withdrawal by Subject|4|||
170365472|NCT01505114|615673380|FG002|Overall Study|Withdrawal by Subject|4|||
170365473|NCT01505114|615673381|FG003|Overall Study|Withdrawal by Subject|7|||
170365474|NCT01505114|615673378|FG000|Overall Study|Death|1|||
170365475|NCT01505114|615673379|FG001|Overall Study|Death|0|||
170365476|NCT01505114|615673380|FG002|Overall Study|Death|0|||
170365477|NCT01505114|615673381|FG003|Overall Study|Death|1|||
170365478|NCT01505114|615673378|FG000|Overall Study|unable to adhere to visit schedule|3|||
170365479|NCT01505114|615673379|FG001|Overall Study|unable to adhere to visit schedule|2|||
170365480|NCT01505114|615673380|FG002|Overall Study|unable to adhere to visit schedule|3|||
170365481|NCT01505114|615673381|FG003|Overall Study|unable to adhere to visit schedule|3|||
170365482|NCT01505114|615673378|FG000|Overall Study|Lost to Follow-up|11|||
170365483|NCT01505114|615673379|FG001|Overall Study|Lost to Follow-up|5|||
170365484|NCT01505114|615673380|FG002|Overall Study|Lost to Follow-up|8|||
170365485|NCT01505114|615673381|FG003|Overall Study|Lost to Follow-up|7|||
170365486|NCT01505114|615673378|FG000|Overall Study|relocated|4|||
170365487|NCT01505114|615673379|FG001|Overall Study|relocated|2|||
170365488|NCT01505114|615673380|FG002|Overall Study|relocated|2|||
170365489|NCT01505114|615673381|FG003|Overall Study|relocated|3|||
170365490|NCT01505114|615673378|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
170365491|NCT01505114|615673379|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
170365492|NCT01505114|615673380|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
170365493|NCT01505114|615673381|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
170365494|NCT01505114|615673378|FG000|Overall Study|staff safety concerns|0|||
170365495|NCT01505114|615673379|FG001|Overall Study|staff safety concerns|0|||
170365496|NCT01505114|615673380|FG002|Overall Study|staff safety concerns|0|||
170365497|NCT01505114|615673381|FG003|Overall Study|staff safety concerns|1|||
170365498|NCT01505114|615673378|FG000|Overall Study|investigator decision|1|||
170365499|NCT01505114|615673379|FG001|Overall Study|investigator decision|0|||
170365500|NCT01505114|615673380|FG002|Overall Study|investigator decision|1|||
170365501|NCT01505114|615673381|FG003|Overall Study|investigator decision|0|||
170365502|NCT01040845|615673384|FG000|Overall Study|Withdrawal by Subject|1|||
170365503|NCT01040845|615673385|FG001|Overall Study|Withdrawal by Subject|1|||
170365504|NCT01040845|615673384|FG000|Overall Study|Physician Decision|1|||
170365505|NCT01040845|615673385|FG001|Overall Study|Physician Decision|0|||
170365506|NCT04362813|615673386|FG000|Overall Study|Death|12|||
170365507|NCT04362813|615673387|FG001|Overall Study|Death|16|||
170365508|NCT04362813|615673386|FG000|Overall Study|Withdrawal by Subject|3|||
170365509|NCT04362813|615673387|FG001|Overall Study|Withdrawal by Subject|1|||
170365510|NCT04362813|615673386|FG000|Overall Study|Protocol Violation|0|||
170365511|NCT04362813|615673387|FG001|Overall Study|Protocol Violation|3|||
170365512|NCT04362813|615673386|FG000|Overall Study|Lost to Follow-up|1|||
170365513|NCT04362813|615673387|FG001|Overall Study|Lost to Follow-up|1|||
170365514|NCT04362813|615673386|FG000|Overall Study|Enrolled but did not receive treatment|2|||
170365515|NCT04362813|615673387|FG001|Overall Study|Enrolled but did not receive treatment|4|||
170365516|NCT02260388|615673391|FG000|Overall Study|Lost to Follow-up|2|||
170365517|NCT02260388|615673392|FG001|Overall Study|Lost to Follow-up|8|||
170365518|NCT02260388|615673393|FG002|Overall Study|Lost to Follow-up|3|||
170365519|NCT02260388|615673394|FG003|Overall Study|Lost to Follow-up|4|||
170365520|NCT01732107|615673396|FG000|Overall Study|Adverse Event|2|||
170365521|NCT01732107|615673396|FG000|Overall Study|Disease Progression|8|||
170365522|NCT01732107|615673396|FG000|Overall Study|Physician Decision|1|||
170365523|NCT01732107|615673396|FG000|Overall Study|Withdrawal by Subject|2|||
170365524|NCT02023268|615673397|FG000|Overall Study|Lack of Efficacy|0|||
170365525|NCT02023268|615673398|FG001|Overall Study|Lack of Efficacy|1|||
170365526|NCT02023268|615673397|FG000|Overall Study|Adverse Event|0|||
170365527|NCT02023268|615673398|FG001|Overall Study|Adverse Event|2|||
170365528|NCT02023268|615673397|FG000|Overall Study|Withdrawal by Subject|0|||
170365529|NCT02023268|615673398|FG001|Overall Study|Withdrawal by Subject|1|||
170365530|NCT04445688|615673399|FG000|Washout (One Week)|Adverse Event|2|||
170365531|NCT04445688|615673399|FG000|Washout (One Week)|Withdrawal by Subject|1|||
170365532|NCT00126672|615673402|FG000|Overall Study|Adverse Event|4|||
170365533|NCT00126672|615673402|FG000|Overall Study|Lost to Follow-up|4|||
170365534|NCT01001234|615673404|FG000|Overall Study|Withdrawal by Subject|2|||
170365535|NCT01001234|615673405|FG001|Overall Study|Withdrawal by Subject|0|||
170365536|NCT01001234|615673406|FG002|Overall Study|Withdrawal by Subject|3|||
170365537|NCT01001234|615673407|FG003|Overall Study|Withdrawal by Subject|0|||
170365538|NCT01001234|615673408|FG004|Overall Study|Withdrawal by Subject|0|||
170365539|NCT01001234|615673404|FG000|Overall Study|Protocol Violation|34|||
170365540|NCT01001234|615673405|FG001|Overall Study|Protocol Violation|3|||
170365541|NCT01001234|615673406|FG002|Overall Study|Protocol Violation|19|||
170365542|NCT01001234|615673407|FG003|Overall Study|Protocol Violation|18|||
170365543|NCT01001234|615673408|FG004|Overall Study|Protocol Violation|0|||
170365544|NCT01001234|615673404|FG000|Overall Study|Lost to Follow-up|0|||
170365545|NCT01001234|615673405|FG001|Overall Study|Lost to Follow-up|0|||
170365546|NCT01001234|615673406|FG002|Overall Study|Lost to Follow-up|1|||
170365547|NCT01001234|615673407|FG003|Overall Study|Lost to Follow-up|2|||
170365548|NCT01001234|615673408|FG004|Overall Study|Lost to Follow-up|0|||
170365549|NCT01001234|615673404|FG000|Overall Study|Physician Decision|1|||
170365550|NCT01001234|615673405|FG001|Overall Study|Physician Decision|0|||
170365551|NCT01001234|615673406|FG002|Overall Study|Physician Decision|0|||
170365552|NCT01001234|615673407|FG003|Overall Study|Physician Decision|0|||
170365553|NCT01001234|615673408|FG004|Overall Study|Physician Decision|0|||
170365554|NCT01001234|615673404|FG000|Overall Study|Not Treated: Adverse Event|1|||
170365555|NCT01001234|615673405|FG001|Overall Study|Not Treated: Adverse Event|0|||
170365556|NCT01001234|615673406|FG002|Overall Study|Not Treated: Adverse Event|0|||
170365557|NCT01001234|615673407|FG003|Overall Study|Not Treated: Adverse Event|0|||
170365558|NCT01001234|615673408|FG004|Overall Study|Not Treated: Adverse Event|0|||
170365559|NCT01001234|615673404|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
170365560|NCT01001234|615673405|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
170365561|NCT01001234|615673406|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
170365562|NCT01001234|615673407|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
170365563|NCT01001234|615673408|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
170365564|NCT01001234|615673404|FG000|Overall Study|Not Treated: Protocol Violation|3|||
170365565|NCT01001234|615673405|FG001|Overall Study|Not Treated: Protocol Violation|0|||
170365566|NCT01001234|615673406|FG002|Overall Study|Not Treated: Protocol Violation|0|||
170365567|NCT01001234|615673407|FG003|Overall Study|Not Treated: Protocol Violation|0|||
170365568|NCT01001234|615673408|FG004|Overall Study|Not Treated: Protocol Violation|0|||
170365569|NCT01001234|615673404|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
170365570|NCT01001234|615673405|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
170365571|NCT01001234|615673406|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
170365572|NCT01001234|615673407|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
170365573|NCT01001234|615673408|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
170365574|NCT01001234|615673404|FG000|Overall Study|Not Treated: Pregnancy|3|||
170365575|NCT01001234|615673405|FG001|Overall Study|Not Treated: Pregnancy|0|||
170365576|NCT01001234|615673406|FG002|Overall Study|Not Treated: Pregnancy|0|||
170365577|NCT01001234|615673407|FG003|Overall Study|Not Treated: Pregnancy|0|||
170365578|NCT01001234|615673408|FG004|Overall Study|Not Treated: Pregnancy|0|||
170365579|NCT01001234|615673404|FG000|Overall Study|Not Treated: Physician Decision|37|||
170365580|NCT01001234|615673405|FG001|Overall Study|Not Treated: Physician Decision|4|||
170365581|NCT01001234|615673406|FG002|Overall Study|Not Treated: Physician Decision|0|||
170365582|NCT01001234|615673407|FG003|Overall Study|Not Treated: Physician Decision|0|||
170365583|NCT01001234|615673408|FG004|Overall Study|Not Treated: Physician Decision|0|||
170365584|NCT01001234|615673404|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
170365585|NCT01001234|615673405|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
170399318|NCT03193190|615799943|FG006|Stage 1|Progressive Disease|0|||
170365586|NCT01001234|615673406|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
170365587|NCT01001234|615673407|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
170365588|NCT01001234|615673408|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
170365589|NCT03379376|615673409|FG000|Overall Study|Lost to Follow-up|2|||
170365590|NCT03379376|615673409|FG000|Overall Study|Did not wish to complete follow up|1|||
170365591|NCT03379376|615673409|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
170365592|NCT03379376|615673409|FG000|Overall Study|Death|1|||
170365593|NCT00753623|615673410|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
170365594|NCT00753623|615673411|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
170365595|NCT00753623|615673410|FG000|Phase I (14 Days)|Physician Decision|1|||
170365596|NCT00753623|615673411|FG001|Phase I (14 Days)|Physician Decision|2|||
170365597|NCT00753623|615673410|FG000|Phase I (14 Days)|Adverse Event|0|||
170365598|NCT00753623|615673411|FG001|Phase I (14 Days)|Adverse Event|1|||
170365599|NCT00753623|615673410|FG000|Washout (7 Days)|Physician Decision|1|||
170365600|NCT00753623|615673411|FG001|Washout (7 Days)|Physician Decision|0|||
170365601|NCT00753623|615673410|FG000|Phase II (14 Days)|Physician Decision|0|||
170365602|NCT00753623|615673411|FG001|Phase II (14 Days)|Physician Decision|1|||
170365603|NCT03383614|615673412|FG000|Overall Study|Withdrawal by Subject|0|||
170365604|NCT03383614|615673413|FG001|Overall Study|Withdrawal by Subject|1|||
170365605|NCT03383614|615673414|FG002|Overall Study|Withdrawal by Subject|0|||
170365606|NCT03383614|615673415|FG003|Overall Study|Withdrawal by Subject|0|||
170365607|NCT01296698|615673418|FG000|Overall Study|Adverse Event|1|||
170365608|NCT01296698|615673419|FG001|Overall Study|Adverse Event|0|||
170365609|NCT01296698|615673418|FG000|Overall Study|Death|1|||
170365610|NCT01296698|615673419|FG001|Overall Study|Death|0|||
170365611|NCT01296698|615673418|FG000|Overall Study|Lost to Follow-up|19|||
170365612|NCT01296698|615673419|FG001|Overall Study|Lost to Follow-up|1|||
170365613|NCT01296698|615673418|FG000|Overall Study|Withdrawal by Subject|12|||
170365614|NCT01296698|615673419|FG001|Overall Study|Withdrawal by Subject|0|||
170365615|NCT01296698|615673418|FG000|Overall Study|Difficulty Contacting Subject|2|||
170365616|NCT01296698|615673419|FG001|Overall Study|Difficulty Contacting Subject|0|||
170365617|NCT01296698|615673418|FG000|Overall Study|Study Terminated by Sponsor|209|||
170365618|NCT01296698|615673419|FG001|Overall Study|Study Terminated by Sponsor|12|||
170365619|NCT01975675|615673422|FG000|Overall Study|Death|0|||
170365620|NCT01975675|615673423|FG001|Overall Study|Death|1|||
170365621|NCT01975675|615673424|FG002|Overall Study|Death|0|||
170365622|NCT01975675|615673425|FG003|Overall Study|Death|0|||
170365623|NCT03639987|615673426|FG000|Overall Study|Study terminated by sponsor|26|||
170365624|NCT03639987|615673427|FG001|Overall Study|Study terminated by sponsor|25|||
170365625|NCT03639987|615673426|FG000|Overall Study|Lost to Follow-up|0|||
170365626|NCT03639987|615673427|FG001|Overall Study|Lost to Follow-up|1|||
170365627|NCT00889681|615673428|FG000|Overall Study|Not meeting qualification Criteria|2|||
170365628|NCT00889681|615673428|FG000|Overall Study|Insurance disapproval|1|||
170365629|NCT01686958|615673429|FG000|Overall Study|Withdrawal by Subject|1|||
170365630|NCT04046341|615673430|FG000|Overall Study|Lost to Follow-up|2|||
170365631|NCT04046341|615673430|FG000|Overall Study|Withdrawal by Subject|1|||
170365632|NCT03094832|615673435|FG000|Overall Study|Lost to Follow-up|0|||
170365633|NCT03094832|615673436|FG001|Overall Study|Lost to Follow-up|0|||
170365634|NCT03094832|615673437|FG002|Overall Study|Lost to Follow-up|0|||
170365635|NCT03094832|615673438|FG003|Overall Study|Lost to Follow-up|1|||
170365636|NCT03094832|615673439|FG004|Overall Study|Lost to Follow-up|1|||
170365637|NCT03094832|615673435|FG000|Overall Study|Death|1|||
170365638|NCT03094832|615673436|FG001|Overall Study|Death|0|||
170365639|NCT03094832|615673437|FG002|Overall Study|Death|0|||
170365640|NCT03094832|615673438|FG003|Overall Study|Death|0|||
170365641|NCT03094832|615673439|FG004|Overall Study|Death|0|||
170365642|NCT03094832|615673435|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
170365643|NCT03094832|615673436|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
170365644|NCT03094832|615673437|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
170365645|NCT03094832|615673438|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
170365646|NCT03094832|615673439|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
170365647|NCT03094832|615673435|FG000|Overall Study|Other|13|||
170365648|NCT03094832|615673436|FG001|Overall Study|Other|20|||
170365649|NCT03094832|615673437|FG002|Overall Study|Other|1|||
170365650|NCT03094832|615673438|FG003|Overall Study|Other|7|||
170365651|NCT03094832|615673439|FG004|Overall Study|Other|1|||
170365652|NCT02322411|615673440|FG000|Overall Study|Lost to Follow-up|4|||
170365653|NCT02322411|615673441|FG001|Overall Study|Lost to Follow-up|7|||
170365654|NCT02322411|615673440|FG000|Overall Study|Withdrawal by Subject|1|||
170365655|NCT02322411|615673441|FG001|Overall Study|Withdrawal by Subject|0|||
170365656|NCT01392378|615673442|FG000|Infant Series|Adverse Event|0|||
170365657|NCT01392378|615673443|FG001|Infant Series|Adverse Event|0|||
170365658|NCT01392378|615673444|FG002|Infant Series|Adverse Event|0|||
170365659|NCT01392378|615673445|FG003|Infant Series|Adverse Event|1|||
170365660|NCT01392378|615673446|FG004|Infant Series|Adverse Event|0|||
170365661|NCT01392378|615673442|FG000|Infant Series|Lost to Follow-up|0|||
170365662|NCT01392378|615673443|FG001|Infant Series|Lost to Follow-up|0|||
170365663|NCT01392378|615673444|FG002|Infant Series|Lost to Follow-up|0|||
170365664|NCT01392378|615673445|FG003|Infant Series|Lost to Follow-up|1|||
170365665|NCT01392378|615673446|FG004|Infant Series|Lost to Follow-up|0|||
170365666|NCT01392378|615673442|FG000|Infant Series|Protocol Violation|0|||
170365667|NCT01392378|615673443|FG001|Infant Series|Protocol Violation|1|||
170365668|NCT01392378|615673444|FG002|Infant Series|Protocol Violation|0|||
170365669|NCT01392378|615673445|FG003|Infant Series|Protocol Violation|0|||
170365670|NCT01392378|615673446|FG004|Infant Series|Protocol Violation|0|||
170365671|NCT01392378|615673442|FG000|Infant Series|Withdrawal by Parent|4|||
170365672|NCT01392378|615673443|FG001|Infant Series|Withdrawal by Parent|1|||
170365673|NCT01392378|615673444|FG002|Infant Series|Withdrawal by Parent|0|||
170365674|NCT01392378|615673445|FG003|Infant Series|Withdrawal by Parent|0|||
170365675|NCT01392378|615673446|FG004|Infant Series|Withdrawal by Parent|0|||
170365676|NCT01392378|615673442|FG000|After Infant Series|Lost to Follow-up|0|||
170365677|NCT01392378|615673443|FG001|After Infant Series|Lost to Follow-up|0|||
170365678|NCT01392378|615673444|FG002|After Infant Series|Lost to Follow-up|1|||
170365679|NCT01392378|615673445|FG003|After Infant Series|Lost to Follow-up|0|||
170365680|NCT01392378|615673446|FG004|After Infant Series|Lost to Follow-up|0|||
170365681|NCT01392378|615673442|FG000|After Infant Series|Withdrawal by Parent|0|||
170365682|NCT01392378|615673443|FG001|After Infant Series|Withdrawal by Parent|1|||
170365683|NCT01392378|615673444|FG002|After Infant Series|Withdrawal by Parent|1|||
170365684|NCT01392378|615673445|FG003|After Infant Series|Withdrawal by Parent|0|||
170365685|NCT01392378|615673446|FG004|After Infant Series|Withdrawal by Parent|1|||
170365686|NCT01392378|615673442|FG000|Toddler Dose|Lost to Follow-up|0|||
170365687|NCT01392378|615673443|FG001|Toddler Dose|Lost to Follow-up|0|||
170365688|NCT01392378|615673444|FG002|Toddler Dose|Lost to Follow-up|0|||
170365689|NCT01392378|615673445|FG003|Toddler Dose|Lost to Follow-up|1|||
170365690|NCT01392378|615673446|FG004|Toddler Dose|Lost to Follow-up|0|||
170365691|NCT01392378|615673442|FG000|Toddler Dose|Withdrawal by Parent|0|||
170365692|NCT01392378|615673443|FG001|Toddler Dose|Withdrawal by Parent|1|||
170365693|NCT01392378|615673444|FG002|Toddler Dose|Withdrawal by Parent|0|||
170365694|NCT01392378|615673445|FG003|Toddler Dose|Withdrawal by Parent|1|||
170365695|NCT01392378|615673446|FG004|Toddler Dose|Withdrawal by Parent|1|||
170365696|NCT02671461|615673449|FG000|Treatment|Adverse Event|0|||
170365697|NCT02671461|615673450|FG001|Treatment|Adverse Event|0|||
170365698|NCT02671461|615673451|FG002|Treatment|Adverse Event|1|||
170365699|NCT02671461|615673449|FG000|Treatment|Administrative Reason by Sponsor|1|||
170365700|NCT02671461|615673450|FG001|Treatment|Administrative Reason by Sponsor|3|||
170365701|NCT02671461|615673451|FG002|Treatment|Administrative Reason by Sponsor|4|||
170365702|NCT02671461|615673449|FG000|Treatment|Randomized, not treated|1|||
170365703|NCT02671461|615673450|FG001|Treatment|Randomized, not treated|0|||
170365704|NCT02671461|615673451|FG002|Treatment|Randomized, not treated|0|||
170365705|NCT02671461|615673449|FG000|Follow-up|Withdrawal by Subject|1|||
170365706|NCT02671461|615673450|FG001|Follow-up|Withdrawal by Subject|0|||
170365707|NCT02671461|615673451|FG002|Follow-up|Withdrawal by Subject|0|||
170365708|NCT02671461|615673449|FG000|Follow-up|Lost to Follow-up|0|||
170365709|NCT02671461|615673450|FG001|Follow-up|Lost to Follow-up|0|||
170365710|NCT02671461|615673451|FG002|Follow-up|Lost to Follow-up|1|||
170365711|NCT02671461|615673449|FG000|Follow-up|Administrative Reason by Sponsor|0|||
170365712|NCT02671461|615673450|FG001|Follow-up|Administrative Reason by Sponsor|1|||
170365713|NCT02671461|615673451|FG002|Follow-up|Administrative Reason by Sponsor|0|||
170365714|NCT02261883|615673452|FG000|Overall Study|Death|3|||
170365715|NCT02261883|615673453|FG001|Overall Study|Death|2|||
170365716|NCT02261883|615673452|FG000|Overall Study|Physician Decision|1|||
170365717|NCT02261883|615673453|FG001|Overall Study|Physician Decision|0|||
170365718|NCT02261883|615673452|FG000|Overall Study|Protocol Violation|1|||
170365719|NCT02261883|615673453|FG001|Overall Study|Protocol Violation|0|||
170365720|NCT02261883|615673452|FG000|Overall Study|Withdrawal by Subject|0|||
170365721|NCT02261883|615673453|FG001|Overall Study|Withdrawal by Subject|1|||
170365722|NCT02261883|615673452|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
170365723|NCT02261883|615673453|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
170365724|NCT04294095|615673455|FG000|Overall Study|Adverse Event|1|||
170365725|NCT04294095|615673456|FG001|Overall Study|Adverse Event|0|||
170365726|NCT00345540|615673459|FG000|Overall Study|Withdrawal by Subject|1|||
170365727|NCT02228564|615673460|FG000|Overall Study|Withdrawal by Subject|10|||
170365728|NCT02228564|615673460|FG000|Overall Study|Death|11|||
170365729|NCT02228564|615673460|FG000|Overall Study|Physician Decision|5|||
170365730|NCT02228564|615673460|FG000|Overall Study|Lost to Follow-up|17|||
170365731|NCT02228564|615673460|FG000|Overall Study|Other|6|||
170365732|NCT01696396|615675508|FG000|Overall Study|Withdrawal by Subject|19|||
170365733|NCT01696396|615675509|FG001|Overall Study|Withdrawal by Subject|5|||
170365734|NCT01696396|615675510|FG002|Overall Study|Withdrawal by Subject|19|||
170365735|NCT01696396|615675511|FG003|Overall Study|Withdrawal by Subject|11|||
170365736|NCT01696396|615675508|FG000|Overall Study|Decision by Sponsor|3|||
170365737|NCT01696396|615675509|FG001|Overall Study|Decision by Sponsor|1|||
170365738|NCT01696396|615675510|FG002|Overall Study|Decision by Sponsor|2|||
170365739|NCT01696396|615675511|FG003|Overall Study|Decision by Sponsor|2|||
170365740|NCT01696396|615675508|FG000|Overall Study|Lost to Follow-up|9|||
170365741|NCT01696396|615675509|FG001|Overall Study|Lost to Follow-up|1|||
170365742|NCT01696396|615675510|FG002|Overall Study|Lost to Follow-up|4|||
170365743|NCT01696396|615675511|FG003|Overall Study|Lost to Follow-up|1|||
170365744|NCT01696396|615675508|FG000|Overall Study|Death|0|||
170365745|NCT01696396|615675509|FG001|Overall Study|Death|0|||
170365746|NCT01696396|615675510|FG002|Overall Study|Death|1|||
170365747|NCT01696396|615675511|FG003|Overall Study|Death|0|||
170365748|NCT02371980|615675517|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
170365749|NCT02371980|615675518|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
170365750|NCT02371980|615675519|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
170365751|NCT02371980|615675520|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
170365752|NCT02371980|615675521|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
170365753|NCT02371980|615675517|FG000|Open-label Period|Significant Protocol Deviation|19|||
170365754|NCT02371980|615675518|FG001|Open-label Period|Significant Protocol Deviation|0|||
170365755|NCT02371980|615675519|FG002|Open-label Period|Significant Protocol Deviation|0|||
170365756|NCT02371980|615675520|FG003|Open-label Period|Significant Protocol Deviation|0|||
170365757|NCT02371980|615675521|FG004|Open-label Period|Significant Protocol Deviation|0|||
170365758|NCT02371980|615675517|FG000|Open-label Period|Noncompliance with Study Drug|10|||
170365759|NCT02371980|615675518|FG001|Open-label Period|Noncompliance with Study Drug|0|||
170365760|NCT02371980|615675519|FG002|Open-label Period|Noncompliance with Study Drug|0|||
170365761|NCT02371980|615675520|FG003|Open-label Period|Noncompliance with Study Drug|0|||
170365762|NCT02371980|615675521|FG004|Open-label Period|Noncompliance with Study Drug|0|||
170365763|NCT02371980|615675517|FG000|Open-label Period|Lost to Follow-up|55|||
170365764|NCT02371980|615675518|FG001|Open-label Period|Lost to Follow-up|0|||
170365765|NCT02371980|615675519|FG002|Open-label Period|Lost to Follow-up|0|||
170365766|NCT02371980|615675520|FG003|Open-label Period|Lost to Follow-up|0|||
170365767|NCT02371980|615675521|FG004|Open-label Period|Lost to Follow-up|0|||
170365768|NCT02371980|615675517|FG000|Open-label Period|Voluntary Withdrawal|91|||
170365769|NCT02371980|615675518|FG001|Open-label Period|Voluntary Withdrawal|0|||
170365770|NCT02371980|615675519|FG002|Open-label Period|Voluntary Withdrawal|0|||
170365771|NCT02371980|615675520|FG003|Open-label Period|Voluntary Withdrawal|0|||
170365772|NCT02371980|615675521|FG004|Open-label Period|Voluntary Withdrawal|0|||
170365773|NCT02371980|615675517|FG000|Open-label Period|Pregnancy|1|||
170365774|NCT02371980|615675518|FG001|Open-label Period|Pregnancy|0|||
170365775|NCT02371980|615675519|FG002|Open-label Period|Pregnancy|0|||
170365776|NCT02371980|615675520|FG003|Open-label Period|Pregnancy|0|||
170365777|NCT02371980|615675521|FG004|Open-label Period|Pregnancy|0|||
170365778|NCT02371980|615675517|FG000|Open-label Period|Lack of Efficacy|116|||
170365779|NCT02371980|615675518|FG001|Open-label Period|Lack of Efficacy|0|||
170365780|NCT02371980|615675519|FG002|Open-label Period|Lack of Efficacy|0|||
170365781|NCT02371980|615675520|FG003|Open-label Period|Lack of Efficacy|0|||
170365782|NCT02371980|615675521|FG004|Open-label Period|Lack of Efficacy|0|||
170365783|NCT02371980|615675517|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
170365784|NCT02371980|615675518|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
170365785|NCT02371980|615675519|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
170365786|NCT02371980|615675520|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
170365787|NCT02371980|615675521|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
170365788|NCT02371980|615675517|FG000|Open-label Period|Reason not Specified|9|||
170365789|NCT02371980|615675518|FG001|Open-label Period|Reason not Specified|0|||
170365790|NCT02371980|615675519|FG002|Open-label Period|Reason not Specified|0|||
170365791|NCT02371980|615675520|FG003|Open-label Period|Reason not Specified|0|||
170365792|NCT02371980|615675521|FG004|Open-label Period|Reason not Specified|0|||
170365793|NCT02371980|615675517|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
170365794|NCT02371980|615675518|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
170365795|NCT02371980|615675519|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
170365796|NCT02371980|615675520|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
170365797|NCT02371980|615675521|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
170365798|NCT02371980|615675517|FG000|Double-blind Period|Significant Protocol Deviation|0|||
170365799|NCT02371980|615675518|FG001|Double-blind Period|Significant Protocol Deviation|2|||
170365800|NCT02371980|615675519|FG002|Double-blind Period|Significant Protocol Deviation|7|||
170365801|NCT02371980|615675520|FG003|Double-blind Period|Significant Protocol Deviation|3|||
170365802|NCT02371980|615675521|FG004|Double-blind Period|Significant Protocol Deviation|3|||
170365803|NCT02371980|615675517|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
170365804|NCT02371980|615675518|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
170365805|NCT02371980|615675519|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
170365806|NCT02371980|615675520|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
170365807|NCT02371980|615675521|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
170365808|NCT02371980|615675517|FG000|Double-blind Period|Lost to Follow-up|0|||
170365809|NCT02371980|615675518|FG001|Double-blind Period|Lost to Follow-up|8|||
170365810|NCT02371980|615675519|FG002|Double-blind Period|Lost to Follow-up|8|||
170365811|NCT02371980|615675520|FG003|Double-blind Period|Lost to Follow-up|6|||
170365812|NCT02371980|615675521|FG004|Double-blind Period|Lost to Follow-up|5|||
170365813|NCT02371980|615675517|FG000|Double-blind Period|Voluntary Withdrawal|0|||
170365814|NCT02371980|615675518|FG001|Double-blind Period|Voluntary Withdrawal|12|||
170365815|NCT02371980|615675519|FG002|Double-blind Period|Voluntary Withdrawal|8|||
170365816|NCT02371980|615675520|FG003|Double-blind Period|Voluntary Withdrawal|9|||
170365817|NCT02371980|615675521|FG004|Double-blind Period|Voluntary Withdrawal|11|||
170365818|NCT02371980|615675517|FG000|Double-blind Period|Relapse|0|||
170365819|NCT02371980|615675518|FG001|Double-blind Period|Relapse|50|||
170365820|NCT02371980|615675519|FG002|Double-blind Period|Relapse|25|||
170365821|NCT02371980|615675520|FG003|Double-blind Period|Relapse|25|||
170365822|NCT02371980|615675521|FG004|Double-blind Period|Relapse|26|||
170365823|NCT02371980|615675517|FG000|Double-blind Period|Reason not Specified|0|||
170365824|NCT02371980|615675518|FG001|Double-blind Period|Reason not Specified|3|||
170365825|NCT02371980|615675519|FG002|Double-blind Period|Reason not Specified|3|||
170365826|NCT02371980|615675520|FG003|Double-blind Period|Reason not Specified|2|||
170365827|NCT02371980|615675521|FG004|Double-blind Period|Reason not Specified|1|||
170365828|NCT02371980|615675517|FG000|Double-blind Period|Missing|0|||
170365829|NCT02371980|615675518|FG001|Double-blind Period|Missing|1|||
170365830|NCT02371980|615675519|FG002|Double-blind Period|Missing|0|||
170365831|NCT02371980|615675520|FG003|Double-blind Period|Missing|0|||
170365832|NCT02371980|615675521|FG004|Double-blind Period|Missing|0|||
170365833|NCT01594749|615675522|FG000|Overall Study|Adverse Event|2|||
170365834|NCT01594749|615675523|FG001|Overall Study|Adverse Event|1|||
170365835|NCT01594749|615675522|FG000|Overall Study|Withdrawal by Subject|2|||
170365836|NCT01594749|615675523|FG001|Overall Study|Withdrawal by Subject|2|||
170365837|NCT01594749|615675522|FG000|Overall Study|Protocol Violation|2|||
170365838|NCT01594749|615675523|FG001|Overall Study|Protocol Violation|0|||
170365839|NCT01594749|615675522|FG000|Overall Study|Physician Decision|1|||
170365840|NCT01594749|615675523|FG001|Overall Study|Physician Decision|1|||
170365841|NCT01594749|615675522|FG000|Overall Study|Non-compliance with Protocol|0|||
170365842|NCT01594749|615675523|FG001|Overall Study|Non-compliance with Protocol|1|||
170365843|NCT01594749|615675522|FG000|Overall Study|Lost to Follow-up|1|||
170365844|NCT01594749|615675523|FG001|Overall Study|Lost to Follow-up|0|||
170365845|NCT01594749|615675522|FG000|Overall Study|Death|9|||
170365846|NCT01594749|615675523|FG001|Overall Study|Death|3|||
170365847|NCT01594749|615675522|FG000|Overall Study|Not Treated|4|||
170365848|NCT01594749|615675523|FG001|Overall Study|Not Treated|10|||
170365849|NCT01594749|615675522|FG000|Overall Study|Lost Source Documentation|1|||
170365850|NCT01594749|615675523|FG001|Overall Study|Lost Source Documentation|0|||
170365851|NCT03682055|615675524|FG000|Overall Study|Lack of Efficacy|1|||
170365852|NCT03682055|615675525|FG001|Overall Study|Lack of Efficacy|2|||
170365853|NCT03682055|615675526|FG002|Overall Study|Lack of Efficacy|1|||
170365854|NCT03682055|615675527|FG003|Overall Study|Lack of Efficacy|2|||
170365855|NCT03682055|615675528|FG004|Overall Study|Lack of Efficacy|1|||
170365856|NCT03682055|615675529|FG005|Overall Study|Lack of Efficacy|3|||
170365857|NCT03682055|615675524|FG000|Overall Study|Withdrawal by Subject|0|||
170365858|NCT03682055|615675525|FG001|Overall Study|Withdrawal by Subject|0|||
170365859|NCT03682055|615675526|FG002|Overall Study|Withdrawal by Subject|0|||
170365860|NCT03682055|615675527|FG003|Overall Study|Withdrawal by Subject|0|||
170365861|NCT03682055|615675528|FG004|Overall Study|Withdrawal by Subject|0|||
170365862|NCT03682055|615675529|FG005|Overall Study|Withdrawal by Subject|1|||
170365863|NCT03682055|615675524|FG000|Overall Study|Termination of Study by Sponsor|0|||
170365864|NCT03682055|615675525|FG001|Overall Study|Termination of Study by Sponsor|0|||
170365865|NCT03682055|615675526|FG002|Overall Study|Termination of Study by Sponsor|0|||
170365866|NCT03682055|615675527|FG003|Overall Study|Termination of Study by Sponsor|0|||
170365867|NCT03682055|615675528|FG004|Overall Study|Termination of Study by Sponsor|0|||
170365868|NCT03682055|615675529|FG005|Overall Study|Termination of Study by Sponsor|3|||
170365869|NCT02578992|615675530|FG000|Overall Study|equipment not available or malfunction|3|||
170365870|NCT02578992|615675531|FG001|Overall Study|equipment not available or malfunction|3|||
170365871|NCT00784459|615675534|FG000|Overall Study|Adverse Event|0|||
170365872|NCT00784459|615675535|FG001|Overall Study|Adverse Event|2|||
170365873|NCT00405275|615675536|FG000|Overall Study|Death|1|||
170365874|NCT00405275|615675537|FG001|Overall Study|Death|0|||
170365875|NCT00405275|615675536|FG000|Overall Study|Lost to Follow-up|5|||
170365876|NCT00405275|615675537|FG001|Overall Study|Lost to Follow-up|1|||
170365877|NCT00405275|615675536|FG000|Overall Study|Withdrawal by Subject|7|||
170365878|NCT00405275|615675537|FG001|Overall Study|Withdrawal by Subject|9|||
170365879|NCT00405275|615675536|FG000|Overall Study|Unwilling to continue|10|||
170365880|NCT00405275|615675537|FG001|Overall Study|Unwilling to continue|9|||
170365881|NCT01419015|615675538|FG000|Overall Study|Death|2|||
170365882|NCT04839393|615675539|FG000|Overall Study|Adverse Event|0|||
170365883|NCT04839393|615675540|FG001|Overall Study|Adverse Event|0|||
170365884|NCT04839393|615675541|FG002|Overall Study|Adverse Event|2|||
170365885|NCT04839393|615675539|FG000|Overall Study|Withdrawal by participant|0|||
170365886|NCT04839393|615675540|FG001|Overall Study|Withdrawal by participant|0|||
170365887|NCT04839393|615675541|FG002|Overall Study|Withdrawal by participant|1|||
170365888|NCT00441727|615675544|FG000|Overall Study|Protocol Violation|19|||
170365889|NCT00441727|615675545|FG001|Overall Study|Protocol Violation|28|||
170365890|NCT00441727|615675546|FG002|Overall Study|Protocol Violation|32|||
170365891|NCT00441727|615675544|FG000|Overall Study|Adverse Event|26|||
170365892|NCT00441727|615675545|FG001|Overall Study|Adverse Event|33|||
170365893|NCT00441727|615675546|FG002|Overall Study|Adverse Event|28|||
170365894|NCT00441727|615675544|FG000|Overall Study|Lack of Efficacy|7|||
170365895|NCT00441727|615675545|FG001|Overall Study|Lack of Efficacy|8|||
170365896|NCT00441727|615675546|FG002|Overall Study|Lack of Efficacy|48|||
170365897|NCT00441727|615675544|FG000|Overall Study|Withdrawal by Subject|40|||
170365898|NCT00441727|615675545|FG001|Overall Study|Withdrawal by Subject|34|||
170365899|NCT00441727|615675546|FG002|Overall Study|Withdrawal by Subject|47|||
170365900|NCT00441727|615675544|FG000|Overall Study|Lost to Follow-up|5|||
170365901|NCT00441727|615675545|FG001|Overall Study|Lost to Follow-up|6|||
170365902|NCT00441727|615675546|FG002|Overall Study|Lost to Follow-up|5|||
170365903|NCT00441727|615675544|FG000|Overall Study|Safety Reasons|3|||
170365904|NCT00441727|615675545|FG001|Overall Study|Safety Reasons|1|||
170365905|NCT00441727|615675546|FG002|Overall Study|Safety Reasons|3|||
170365906|NCT00441727|615675544|FG000|Overall Study|Various reason specified|6|||
170365907|NCT00441727|615675545|FG001|Overall Study|Various reason specified|8|||
170365908|NCT00441727|615675546|FG002|Overall Study|Various reason specified|5|||
170365909|NCT03417505|615675549|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
170365910|NCT03417505|615675550|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
170365911|NCT02133001|615675551|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
170365912|NCT02133001|615675552|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
170365913|NCT02133001|615675551|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
170365914|NCT02133001|615675552|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
170365915|NCT02133001|615675551|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
170365916|NCT02133001|615675552|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
170365917|NCT02133001|615675551|FG000|Double Blind (Day 1-25)|Other|2|||
170365918|NCT02133001|615675552|FG001|Double Blind (Day 1-25)|Other|2|||
170365919|NCT02133001|615675551|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
170365920|NCT02133001|615675552|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
170365921|NCT02133001|615675551|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
170365922|NCT02133001|615675552|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
170365923|NCT02133001|615675551|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
170365924|NCT02133001|615675552|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
170365925|NCT02133001|615675551|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
170365926|NCT02133001|615675552|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
170365927|NCT04211961|615675553|FG000|Overall Study|Death|0|||
170365928|NCT04211961|615675554|FG001|Overall Study|Death|1|||
170365929|NCT04211961|615675553|FG000|Overall Study|Lost to Follow-up|0|||
170365930|NCT04211961|615675554|FG001|Overall Study|Lost to Follow-up|1|||
170365931|NCT04211961|615675553|FG000|Overall Study|Withdrawal by Subject|0|||
170365932|NCT04211961|615675554|FG001|Overall Study|Withdrawal by Subject|1|||
170365933|NCT03235726|615675559|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365934|NCT03235726|615675560|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365935|NCT03235726|615675561|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365936|NCT03235726|615675562|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365937|NCT03235726|615675563|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
170365938|NCT03235726|615675564|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365939|NCT03235726|615675565|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365940|NCT03235726|615675566|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365941|NCT03235726|615675567|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365942|NCT03235726|615675568|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
170365943|NCT03235726|615675559|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365944|NCT03235726|615675560|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365945|NCT03235726|615675561|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365946|NCT03235726|615675562|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365947|NCT03235726|615675563|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
170365948|NCT03235726|615675564|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365949|NCT03235726|615675565|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365950|NCT03235726|615675566|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365951|NCT03235726|615675567|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365952|NCT03235726|615675568|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
170365953|NCT02143141|615675574|FG000|Overall Study|pain scores at 24 hours not collected|1|||
170365954|NCT02143141|615675575|FG001|Overall Study|pain scores at 24 hours not collected|0|||
170365955|NCT01809197|615675576|FG000|Overall Study|Lost to Follow-up|4|||
170365956|NCT01809197|615675577|FG001|Overall Study|Lost to Follow-up|2|||
170365957|NCT01809197|615675576|FG000|Overall Study|Adverse Event|2|||
170365958|NCT01809197|615675577|FG001|Overall Study|Adverse Event|3|||
170365959|NCT01809197|615675576|FG000|Overall Study|Failed slit lamp exam|1|||
170365960|NCT01809197|615675577|FG001|Overall Study|Failed slit lamp exam|0|||
170365961|NCT01809197|615675576|FG000|Overall Study|Non-Compliance|1|||
170365962|NCT01809197|615675577|FG001|Overall Study|Non-Compliance|1|||
170365963|NCT01809197|615675576|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
170365964|NCT01809197|615675577|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
170365965|NCT01809197|615675576|FG000|Overall Study|Withdrawal by Subject|1|||
170365966|NCT01809197|615675577|FG001|Overall Study|Withdrawal by Subject|1|||
170365967|NCT01809197|615675576|FG000|Overall Study|Product not available|0|||
170365968|NCT01809197|615675577|FG001|Overall Study|Product not available|1|||
170365969|NCT01855945|615675578|FG000|Overall Study|Adverse Event|0|||
170365970|NCT01855945|615675579|FG001|Overall Study|Adverse Event|0|||
170365971|NCT01855945|615675580|FG002|Overall Study|Adverse Event|0|||
170365972|NCT01855945|615675581|FG003|Overall Study|Adverse Event|0|||
170365973|NCT01855945|615675582|FG004|Overall Study|Adverse Event|0|||
170365974|NCT01855945|615675583|FG005|Overall Study|Adverse Event|0|||
170365975|NCT01855945|615675584|FG006|Overall Study|Adverse Event|1|||
170365976|NCT01855945|615675585|FG007|Overall Study|Adverse Event|0|||
170365977|NCT01855945|615675586|FG008|Overall Study|Adverse Event|0|||
170365978|NCT01855945|615675587|FG009|Overall Study|Adverse Event|0|||
170365979|NCT01855945|615675588|FG010|Overall Study|Adverse Event|0|||
170365980|NCT01855945|615675589|FG011|Overall Study|Adverse Event|0|||
170365981|NCT01855945|615675578|FG000|Overall Study|Death|0|||
170365982|NCT01855945|615675579|FG001|Overall Study|Death|0|||
170365983|NCT01855945|615675580|FG002|Overall Study|Death|0|||
170365984|NCT01855945|615675581|FG003|Overall Study|Death|0|||
170365985|NCT01855945|615675582|FG004|Overall Study|Death|0|||
170365986|NCT01855945|615675583|FG005|Overall Study|Death|0|||
170365987|NCT01855945|615675584|FG006|Overall Study|Death|2|||
170365988|NCT01855945|615675585|FG007|Overall Study|Death|0|||
170365989|NCT01855945|615675586|FG008|Overall Study|Death|0|||
170365990|NCT01855945|615675587|FG009|Overall Study|Death|0|||
170365991|NCT01855945|615675588|FG010|Overall Study|Death|0|||
170365992|NCT01855945|615675589|FG011|Overall Study|Death|0|||
170365993|NCT01855945|615675578|FG000|Overall Study|Lost to Follow-up|11|||
170365994|NCT01855945|615675579|FG001|Overall Study|Lost to Follow-up|10|||
170365995|NCT01855945|615675580|FG002|Overall Study|Lost to Follow-up|7|||
170365996|NCT01855945|615675581|FG003|Overall Study|Lost to Follow-up|3|||
170365997|NCT01855945|615675582|FG004|Overall Study|Lost to Follow-up|0|||
170365998|NCT01855945|615675583|FG005|Overall Study|Lost to Follow-up|3|||
170365999|NCT01855945|615675584|FG006|Overall Study|Lost to Follow-up|4|||
170366000|NCT01855945|615675585|FG007|Overall Study|Lost to Follow-up|7|||
170366001|NCT01855945|615675586|FG008|Overall Study|Lost to Follow-up|2|||
170366002|NCT01855945|615675587|FG009|Overall Study|Lost to Follow-up|0|||
170366003|NCT01855945|615675588|FG010|Overall Study|Lost to Follow-up|0|||
170366004|NCT01855945|615675589|FG011|Overall Study|Lost to Follow-up|2|||
170366005|NCT01855945|615675578|FG000|Overall Study|Other - Unclassified|1|||
170366006|NCT01855945|615675579|FG001|Overall Study|Other - Unclassified|1|||
170366007|NCT01855945|615675580|FG002|Overall Study|Other - Unclassified|1|||
170366008|NCT01855945|615675581|FG003|Overall Study|Other - Unclassified|0|||
170366009|NCT01855945|615675582|FG004|Overall Study|Other - Unclassified|0|||
170366010|NCT01855945|615675583|FG005|Overall Study|Other - Unclassified|0|||
170366011|NCT01855945|615675584|FG006|Overall Study|Other - Unclassified|2|||
170366012|NCT01855945|615675585|FG007|Overall Study|Other - Unclassified|1|||
170366013|NCT01855945|615675586|FG008|Overall Study|Other - Unclassified|0|||
170366014|NCT01855945|615675587|FG009|Overall Study|Other - Unclassified|0|||
170366015|NCT01855945|615675588|FG010|Overall Study|Other - Unclassified|1|||
170366016|NCT01855945|615675589|FG011|Overall Study|Other - Unclassified|0|||
170366017|NCT01855945|615675578|FG000|Overall Study|Withdrawal by Subject|4|||
170366018|NCT01855945|615675579|FG001|Overall Study|Withdrawal by Subject|0|||
170366019|NCT01855945|615675580|FG002|Overall Study|Withdrawal by Subject|4|||
170366020|NCT01855945|615675581|FG003|Overall Study|Withdrawal by Subject|1|||
170366021|NCT01855945|615675582|FG004|Overall Study|Withdrawal by Subject|1|||
170366022|NCT01855945|615675583|FG005|Overall Study|Withdrawal by Subject|0|||
170366023|NCT01855945|615675584|FG006|Overall Study|Withdrawal by Subject|1|||
170366024|NCT01855945|615675585|FG007|Overall Study|Withdrawal by Subject|0|||
170366025|NCT01855945|615675586|FG008|Overall Study|Withdrawal by Subject|0|||
170366026|NCT01855945|615675587|FG009|Overall Study|Withdrawal by Subject|2|||
170366027|NCT01855945|615675588|FG010|Overall Study|Withdrawal by Subject|4|||
170366028|NCT01855945|615675589|FG011|Overall Study|Withdrawal by Subject|1|||
170366029|NCT00425113|615675592|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
170366030|NCT00425113|615675593|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
170366031|NCT00425113|615675592|FG000|Overall Study|diagnosis of abdominal TB|0|||
170366032|NCT00425113|615675593|FG001|Overall Study|diagnosis of abdominal TB|1|||
170366033|NCT00425113|615675592|FG000|Overall Study|missing study drug more than 14 days|0|||
170366034|NCT00425113|615675593|FG001|Overall Study|missing study drug more than 14 days|1|||
170366035|NCT00425113|615675592|FG000|Overall Study|Withdrawal by Subject|1|||
170366036|NCT00425113|615675593|FG001|Overall Study|Withdrawal by Subject|0|||
170366037|NCT00918346|615675596|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
170366038|NCT00918346|615675597|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
170366039|NCT02475629|615675598|FG000|Overall Study|Adverse Event|1|||
170366040|NCT02475629|615675598|FG000|Overall Study|Death|4|||
170366041|NCT02475629|615675598|FG000|Overall Study|Physician Decision|1|||
170366042|NCT02475629|615675598|FG000|Overall Study|Withdrawal by Subject|1|||
170366043|NCT02475629|615675598|FG000|Overall Study|Lost to Follow-up|1|||
170366044|NCT02475629|615675598|FG000|Overall Study|Subject non-compliance|1|||
170366045|NCT04083794|615675599|FG000|Overall Study|Lost to Follow-up|9|||
170366046|NCT03495817|615675601|FG000|26 Week Open Label|Adverse Event|3|||
170366047|NCT03495817|615675601|FG000|26 Week Open Label|Withdrawal by Subject|4|||
170366048|NCT03495817|615675601|FG000|26 Week Open Label|Lost to Follow-up|1|||
170366049|NCT03495817|615675601|FG000|26 Week Extension|Lost to Follow-up|2|||
170366050|NCT01654523|615675602|FG000|Overall Study|Withdrawal by Subject|1|||
170366051|NCT00788697|615675606|FG000|Overall Study|No study drug administered|12|||
170366052|NCT00788697|615675606|FG000|Overall Study|Training Patients|74|||
170366053|NCT00788697|615675606|FG000|Overall Study|no truth standard procedure available|5|||
170366054|NCT00788697|615675606|FG000|Overall Study|Technically inadequate truth standard|1|||
170366055|NCT00788697|615675606|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
170366056|NCT01998880|615675607|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
170366057|NCT01998880|615675608|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
170366058|NCT01998880|615675607|FG000|Overall Study|Disease Progression|1|||
170366059|NCT01998880|615675608|FG001|Overall Study|Disease Progression|8|||
170366060|NCT01998880|615675607|FG000|Overall Study|Withdrew Consent|2|||
170366061|NCT01998880|615675608|FG001|Overall Study|Withdrew Consent|1|||
170366062|NCT01998880|615675607|FG000|Overall Study|Death|3|||
170366063|NCT01998880|615675608|FG001|Overall Study|Death|6|||
170366064|NCT01998880|615675607|FG000|Overall Study|Insufficient Therapeutic Response|1|||
170366065|NCT01998880|615675608|FG001|Overall Study|Insufficient Therapeutic Response|5|||
170366066|NCT01998880|615675607|FG000|Overall Study|Administrative/Other|1|||
170366067|NCT01998880|615675608|FG001|Overall Study|Administrative/Other|1|||
170366068|NCT01998880|615675607|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
170366069|NCT01998880|615675608|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
170366070|NCT01998880|615675607|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
170366071|NCT01998880|615675608|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
170366072|NCT01998880|615675607|FG000|Overall Study|Did Not Receive Treatment|3|||
170366073|NCT01998880|615675608|FG001|Overall Study|Did Not Receive Treatment|2|||
170366074|NCT03199638|615675614|FG000|Overall Study|inability to drink glutamine during regularly|0|||
170366075|NCT03199638|615675615|FG001|Overall Study|inability to drink glutamine during regularly|2|||
170366076|NCT02807844|615675616|FG000|Overall Study|Physician Decision|0|||
170366077|NCT02807844|615675617|FG001|Overall Study|Physician Decision|0|||
170366078|NCT02807844|615675618|FG002|Overall Study|Physician Decision|0|||
170366079|NCT02807844|615675619|FG003|Overall Study|Physician Decision|0|||
170366080|NCT02807844|615675620|FG004|Overall Study|Physician Decision|0|||
170366081|NCT02807844|615675621|FG005|Overall Study|Physician Decision|0|||
170366082|NCT02807844|615675622|FG006|Overall Study|Physician Decision|3|||
170366083|NCT02807844|615675623|FG007|Overall Study|Physician Decision|0|||
170366084|NCT02807844|615675624|FG008|Overall Study|Physician Decision|1|||
170366085|NCT02807844|615675625|FG009|Overall Study|Physician Decision|2|||
170366086|NCT02807844|615675616|FG000|Overall Study|Death|0|||
170366087|NCT02807844|615675617|FG001|Overall Study|Death|0|||
170366088|NCT02807844|615675618|FG002|Overall Study|Death|2|||
170366089|NCT02807844|615675619|FG003|Overall Study|Death|4|||
170366090|NCT02807844|615675620|FG004|Overall Study|Death|1|||
170366091|NCT02807844|615675621|FG005|Overall Study|Death|2|||
170366092|NCT02807844|615675622|FG006|Overall Study|Death|1|||
170366093|NCT02807844|615675623|FG007|Overall Study|Death|2|||
170366094|NCT02807844|615675624|FG008|Overall Study|Death|0|||
170366095|NCT02807844|615675625|FG009|Overall Study|Death|1|||
170366096|NCT02807844|615675616|FG000|Overall Study|Withdrawal by Subject|0|||
170366097|NCT02807844|615675617|FG001|Overall Study|Withdrawal by Subject|0|||
170366098|NCT02807844|615675618|FG002|Overall Study|Withdrawal by Subject|2|||
170366099|NCT02807844|615675619|FG003|Overall Study|Withdrawal by Subject|1|||
170366100|NCT02807844|615675620|FG004|Overall Study|Withdrawal by Subject|1|||
170366101|NCT02807844|615675621|FG005|Overall Study|Withdrawal by Subject|0|||
170366102|NCT02807844|615675622|FG006|Overall Study|Withdrawal by Subject|1|||
170366103|NCT02807844|615675623|FG007|Overall Study|Withdrawal by Subject|0|||
170366104|NCT02807844|615675624|FG008|Overall Study|Withdrawal by Subject|0|||
170366105|NCT02807844|615675625|FG009|Overall Study|Withdrawal by Subject|0|||
170366106|NCT02807844|615675616|FG000|Overall Study|Progressive disease|5|||
170366107|NCT02807844|615675617|FG001|Overall Study|Progressive disease|12|||
170366108|NCT02807844|615675618|FG002|Overall Study|Progressive disease|8|||
170366109|NCT02807844|615675619|FG003|Overall Study|Progressive disease|8|||
170366110|NCT02807844|615675620|FG004|Overall Study|Progressive disease|3|||
170366111|NCT02807844|615675621|FG005|Overall Study|Progressive disease|8|||
170366112|NCT02807844|615675622|FG006|Overall Study|Progressive disease|14|||
170366113|NCT02807844|615675623|FG007|Overall Study|Progressive disease|17|||
170366114|NCT02807844|615675624|FG008|Overall Study|Progressive disease|19|||
170366115|NCT02807844|615675625|FG009|Overall Study|Progressive disease|15|||
170366116|NCT02807844|615675616|FG000|Overall Study|Adverse Event|1|||
170366117|NCT02807844|615675617|FG001|Overall Study|Adverse Event|0|||
170366118|NCT02807844|615675618|FG002|Overall Study|Adverse Event|0|||
170366119|NCT02807844|615675619|FG003|Overall Study|Adverse Event|0|||
170366120|NCT02807844|615675620|FG004|Overall Study|Adverse Event|1|||
170366121|NCT02807844|615675621|FG005|Overall Study|Adverse Event|1|||
170366122|NCT02807844|615675622|FG006|Overall Study|Adverse Event|1|||
170366123|NCT02807844|615675623|FG007|Overall Study|Adverse Event|1|||
170366124|NCT02807844|615675624|FG008|Overall Study|Adverse Event|1|||
170366125|NCT02807844|615675625|FG009|Overall Study|Adverse Event|2|||
170366126|NCT01125293|615675634|FG000|Overall Study|Disease Progression|1|||
170366127|NCT01125293|615675635|FG001|Overall Study|Disease Progression|3|||
170366128|NCT01125293|615675636|FG002|Overall Study|Disease Progression|4|||
170366129|NCT01125293|615675637|FG003|Overall Study|Disease Progression|3|||
170366130|NCT01125293|615675638|FG004|Overall Study|Disease Progression|5|||
170366131|NCT01125293|615675639|FG005|Overall Study|Disease Progression|12|||
170366132|NCT01125293|615675634|FG000|Overall Study|Adverse Event|1|||
170366133|NCT01125293|615675635|FG001|Overall Study|Adverse Event|0|||
170366134|NCT01125293|615675636|FG002|Overall Study|Adverse Event|0|||
170366135|NCT01125293|615675637|FG003|Overall Study|Adverse Event|0|||
170366136|NCT01125293|615675638|FG004|Overall Study|Adverse Event|2|||
170366137|NCT01125293|615675639|FG005|Overall Study|Adverse Event|8|||
170366138|NCT01125293|615675634|FG000|Overall Study|Symptomatic Deterioration|1|||
170366139|NCT01125293|615675635|FG001|Overall Study|Symptomatic Deterioration|0|||
170366140|NCT01125293|615675636|FG002|Overall Study|Symptomatic Deterioration|0|||
170366141|NCT01125293|615675637|FG003|Overall Study|Symptomatic Deterioration|0|||
170366142|NCT01125293|615675638|FG004|Overall Study|Symptomatic Deterioration|0|||
170366143|NCT01125293|615675639|FG005|Overall Study|Symptomatic Deterioration|0|||
170366144|NCT01125293|615675634|FG000|Overall Study|Death|0|||
170366145|NCT01125293|615675635|FG001|Overall Study|Death|0|||
170366146|NCT01125293|615675636|FG002|Overall Study|Death|0|||
170366147|NCT01125293|615675637|FG003|Overall Study|Death|0|||
170366148|NCT01125293|615675638|FG004|Overall Study|Death|1|||
170366149|NCT01125293|615675639|FG005|Overall Study|Death|0|||
170366150|NCT01125293|615675634|FG000|Overall Study|Withdrawal by Subject|0|||
170366151|NCT01125293|615675635|FG001|Overall Study|Withdrawal by Subject|0|||
170366152|NCT01125293|615675636|FG002|Overall Study|Withdrawal by Subject|0|||
170366153|NCT01125293|615675637|FG003|Overall Study|Withdrawal by Subject|0|||
170366154|NCT01125293|615675638|FG004|Overall Study|Withdrawal by Subject|2|||
170366155|NCT01125293|615675639|FG005|Overall Study|Withdrawal by Subject|1|||
170366156|NCT01125293|615675634|FG000|Overall Study|Physician Decision|0|||
170366157|NCT01125293|615675635|FG001|Overall Study|Physician Decision|0|||
170366158|NCT01125293|615675636|FG002|Overall Study|Physician Decision|0|||
170366159|NCT01125293|615675637|FG003|Overall Study|Physician Decision|0|||
170366160|NCT01125293|615675638|FG004|Overall Study|Physician Decision|0|||
170366161|NCT01125293|615675639|FG005|Overall Study|Physician Decision|2|||
170366162|NCT02224638|615675640|FG000|Overall Study|Adverse Event|1|||
170366163|NCT02224638|615675641|FG001|Overall Study|Adverse Event|1|||
170366164|NCT01270958|615675642|FG000|Overall Study|Lost to Follow-up|2|||
170366165|NCT01270958|615675642|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
170366166|NCT01938001|615675643|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
170366167|NCT01938001|615675644|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
170366168|NCT01938001|615675643|FG000|Pre-Treatment|Death|1|||
170366169|NCT01938001|615675644|FG001|Pre-Treatment|Death|0|||
170366170|NCT01938001|615675643|FG000|Treatment|Death|2|||
170366171|NCT01938001|615675644|FG001|Treatment|Death|0|||
170366172|NCT01938001|615675643|FG000|Treatment|Adverse Event|14|||
170366173|NCT01938001|615675644|FG001|Treatment|Adverse Event|8|||
170366174|NCT01938001|615675643|FG000|Treatment|Progressive Disease|21|||
170366175|NCT01938001|615675644|FG001|Treatment|Progressive Disease|54|||
170366176|NCT01938001|615675643|FG000|Treatment|Withdrawal by Subject|13|||
170366177|NCT01938001|615675644|FG001|Treatment|Withdrawal by Subject|7|||
170366178|NCT01938001|615675643|FG000|Treatment|Other reasons|2|||
170366179|NCT01938001|615675644|FG001|Treatment|Other reasons|1|||
170366180|NCT02142504|615675646|FG000|Overall Study|Protocol Violation|2|||
170366181|NCT02142504|615675647|FG001|Overall Study|Protocol Violation|1|||
170366182|NCT02142504|615675648|FG002|Overall Study|Protocol Violation|2|||
170366183|NCT02142504|615675646|FG000|Overall Study|Adverse Event|2|||
170366184|NCT02142504|615675647|FG001|Overall Study|Adverse Event|3|||
170366185|NCT02142504|615675648|FG002|Overall Study|Adverse Event|4|||
170366186|NCT02142504|615675646|FG000|Overall Study|Lost to Follow-up|12|||
170366187|NCT02142504|615675647|FG001|Overall Study|Lost to Follow-up|19|||
170366188|NCT02142504|615675648|FG002|Overall Study|Lost to Follow-up|17|||
170366189|NCT02142504|615675646|FG000|Overall Study|Withdrawal by Subject|7|||
170366190|NCT02142504|615675647|FG001|Overall Study|Withdrawal by Subject|9|||
170366191|NCT02142504|615675648|FG002|Overall Study|Withdrawal by Subject|11|||
170366192|NCT02142504|615675646|FG000|Overall Study|Pregnancy|4|||
170366193|NCT02142504|615675647|FG001|Overall Study|Pregnancy|4|||
170366194|NCT02142504|615675648|FG002|Overall Study|Pregnancy|2|||
170366195|NCT02142504|615675646|FG000|Overall Study|Physician Decision|0|||
170366196|NCT02142504|615675647|FG001|Overall Study|Physician Decision|1|||
170366197|NCT02142504|615675648|FG002|Overall Study|Physician Decision|3|||
170366198|NCT02142504|615675646|FG000|Overall Study|Reason Not Specified|4|||
170366199|NCT02142504|615675647|FG001|Overall Study|Reason Not Specified|5|||
170366200|NCT02142504|615675648|FG002|Overall Study|Reason Not Specified|4|||
170366201|NCT04114539|615675656|FG000|Overall Study|Adverse Event|14|||
170366202|NCT04114539|615675656|FG000|Overall Study|Lost to Follow-up|2|||
170366203|NCT04114539|615675656|FG000|Overall Study|Non-compliance with Protocol|2|||
170366204|NCT04114539|615675656|FG000|Overall Study|Non-compliance with Study Drug|1|||
170366205|NCT04114539|615675656|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
170366206|NCT04114539|615675656|FG000|Overall Study|Withdrew consent|10|||
170366207|NCT04114539|615675656|FG000|Overall Study|Others not specified|5|||
170366208|NCT04114539|615675656|FG000|Overall Study|Investigator Decision|2|||
170366209|NCT00719537|615675662|FG000|Overall Study|Withdrawal by Subject|1|||
170366210|NCT00719537|615675663|FG001|Overall Study|Withdrawal by Subject|0|||
170366211|NCT00719537|615675662|FG000|Overall Study|Lost to Follow-up|0|||
170366212|NCT00719537|615675663|FG001|Overall Study|Lost to Follow-up|1|||
170366213|NCT01459068|615675664|FG000|Overall Study|Withdrawal by Subject|8|||
170366214|NCT01459068|615675665|FG001|Overall Study|Withdrawal by Subject|18|||
170366215|NCT01459068|615675664|FG000|Overall Study|Lost to Follow-up|31|||
170366216|NCT01459068|615675665|FG001|Overall Study|Lost to Follow-up|15|||
170366217|NCT01459068|615675664|FG000|Overall Study|Death|0|||
170366218|NCT01459068|615675665|FG001|Overall Study|Death|1|||
170366219|NCT02910219|615675666|FG000|Overall Study|Withdrawal by Subject|1|||
170366220|NCT02910219|615675667|FG001|Overall Study|Withdrawal by Subject|1|||
170366221|NCT00701441|615675671|FG000|Overall Study|failure in cpap compliance|0|||
170366222|NCT00701441|615675672|FG001|Overall Study|failure in cpap compliance|4|||
170366223|NCT03034057|615675673|FG000|Overall Study|Withdrawal by Subject|10|||
170366224|NCT03034057|615675673|FG000|Overall Study|Protocol Violation|1|||
170366225|NCT03034057|615675673|FG000|Overall Study|Not defined|2|||
170366226|NCT03034057|615675673|FG000|Overall Study|Lost to Follow-up|19|||
170366227|NCT03034057|615675673|FG000|Overall Study|Adverse Event|22|||
170366228|NCT03034057|615675673|FG000|Overall Study|Medication error without associated AE|1|||
170366229|NCT02762708|615675675|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
170366230|NCT02762708|615675676|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
170366231|NCT02762708|615675677|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
170366232|NCT02762708|615675678|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
170366233|NCT00718523|615675679|FG000|Overall Study|Withdrawal by Subject|5|||
170366234|NCT00718523|615675680|FG001|Overall Study|Withdrawal by Subject|7|||
170366235|NCT00718523|615675679|FG000|Overall Study|Death|13|||
170366236|NCT00718523|615675680|FG001|Overall Study|Death|17|||
170366237|NCT00631540|615675681|FG000|Overall Study|Withdrawal by Subject|5|||
170366238|NCT00631540|615675681|FG000|Overall Study|Death|4|||
170366239|NCT00631540|615675681|FG000|Overall Study|Lost to Follow-up|2|||
170366240|NCT00631540|615675681|FG000|Overall Study|Core Lab Data Unavailable|3|||
170366241|NCT01041404|615675683|FG000|Overall Study|Adverse Event|45|||
170366242|NCT01041404|615675684|FG001|Overall Study|Adverse Event|35|||
170366243|NCT01041404|615675683|FG000|Overall Study|Lack of Efficacy|200|||
170366244|NCT01041404|615675684|FG001|Overall Study|Lack of Efficacy|210|||
170366245|NCT01041404|615675683|FG000|Overall Study|Violation of Selection Criteria|0|||
170366246|NCT01041404|615675684|FG001|Overall Study|Violation of Selection Criteria|1|||
170366247|NCT01041404|615675683|FG000|Overall Study|Protocol Violation|4|||
170366248|NCT01041404|615675684|FG001|Overall Study|Protocol Violation|0|||
170366249|NCT01041404|615675683|FG000|Overall Study|Withdrawal by Subject|29|||
170366250|NCT01041404|615675684|FG001|Overall Study|Withdrawal by Subject|23|||
170366251|NCT01041404|615675683|FG000|Overall Study|Failure to Return|1|||
170366252|NCT01041404|615675684|FG001|Overall Study|Failure to Return|2|||
170366253|NCT01041404|615675683|FG000|Overall Study|Other|11|||
170366254|NCT01041404|615675684|FG001|Overall Study|Other|23|||
170366255|NCT01750840|615675685|FG000|Overall Study|Lost to Follow-up|4|||
170366256|NCT00651313|615675688|FG000|Overall Study|Adverse Event|0|||
170366257|NCT00651313|615675689|FG001|Overall Study|Adverse Event|1|||
170366258|NCT00651313|615675688|FG000|Overall Study|Withdrawal by Subject|3|||
170366259|NCT00651313|615675689|FG001|Overall Study|Withdrawal by Subject|1|||
170366260|NCT00651313|615675688|FG000|Overall Study|Lost to Follow-up|1|||
170366261|NCT00651313|615675689|FG001|Overall Study|Lost to Follow-up|1|||
170366262|NCT00651313|615675688|FG000|Overall Study|Adminstrative Discontinuation|2|||
170366263|NCT00651313|615675689|FG001|Overall Study|Adminstrative Discontinuation|3|||
170366264|NCT01999946|615675690|FG000|Overall Study|Participant not released from jail|2|||
170366265|NCT01999946|615675691|FG001|Overall Study|Participant not released from jail|2|||
170366266|NCT01999946|615675692|FG002|Overall Study|Participant not released from jail|0|||
170366267|NCT01999946|615675690|FG000|Overall Study|Not included in primary outcome analysis|0|||
170366268|NCT01999946|615675691|FG001|Overall Study|Not included in primary outcome analysis|0|||
170366269|NCT01999946|615675692|FG002|Overall Study|Not included in primary outcome analysis|79|||
170366270|NCT00719953|615675695|FG000|Overall Study|Adverse Event|4|||
170366271|NCT03726333|615675699|FG000|Overall Study|Progressive Disease|0|||
170366272|NCT03726333|615675700|FG001|Overall Study|Progressive Disease|0|||
170366273|NCT03726333|615675701|FG002|Overall Study|Progressive Disease|1|||
170366274|NCT03726333|615675702|FG003|Overall Study|Progressive Disease|0|||
170366275|NCT03726333|615675703|FG004|Overall Study|Progressive Disease|0|||
170366276|NCT01731990|615677944|FG000|Overall Study|Adverse Event|1|||
170366277|NCT01731990|615677945|FG001|Overall Study|Adverse Event|5|||
170366278|NCT01731990|615677944|FG000|Overall Study|Withdrawal by Subject|1|||
170366279|NCT01731990|615677945|FG001|Overall Study|Withdrawal by Subject|1|||
170366280|NCT01731990|615677944|FG000|Overall Study|Protocol deviation|1|||
170366281|NCT01731990|615677945|FG001|Overall Study|Protocol deviation|2|||
170366282|NCT01731990|615677944|FG000|Overall Study|Death|1|||
170366283|NCT01731990|615677945|FG001|Overall Study|Death|0|||
170366284|NCT01280812|615677946|FG000|Overall Study|Withdrawal by Subject|2|||
170366285|NCT01280812|615677947|FG001|Overall Study|Withdrawal by Subject|1|||
170366286|NCT01280812|615677948|FG002|Overall Study|Withdrawal by Subject|0|||
170366287|NCT01280812|615677946|FG000|Overall Study|Lost to Follow-up|1|||
170366288|NCT01280812|615677947|FG001|Overall Study|Lost to Follow-up|1|||
170366289|NCT01280812|615677948|FG002|Overall Study|Lost to Follow-up|1|||
170366290|NCT01183104|615677954|FG000|Overall Study|Adverse Event|8|||
170366291|NCT01183104|615677955|FG001|Overall Study|Adverse Event|6|||
170366292|NCT01183104|615677954|FG000|Overall Study|Death|0|||
170366293|NCT01183104|615677955|FG001|Overall Study|Death|1|||
170366294|NCT01183104|615677954|FG000|Overall Study|Lost to Follow-up|14|||
170366295|NCT01183104|615677955|FG001|Overall Study|Lost to Follow-up|7|||
170366296|NCT01183104|615677954|FG000|Overall Study|Physician Decision|5|||
170366297|NCT01183104|615677955|FG001|Overall Study|Physician Decision|8|||
170366298|NCT01183104|615677954|FG000|Overall Study|Withdrawal by Subject|6|||
170366299|NCT01183104|615677955|FG001|Overall Study|Withdrawal by Subject|11|||
170366300|NCT01183104|615677954|FG000|Overall Study|Nonparticipation in Extension Study|39|||
170366301|NCT01183104|615677955|FG001|Overall Study|Nonparticipation in Extension Study|50|||
170366302|NCT01183104|615677954|FG000|Overall Study|Did not receive study drug|5|||
170366303|NCT01183104|615677955|FG001|Overall Study|Did not receive study drug|9|||
170366304|NCT00959894|615677956|FG000|Overall Study|Lost to Follow-up|10|||
170366305|NCT00959894|615677956|FG000|Overall Study|Adverse Event|3|||
170366306|NCT00959894|615677956|FG000|Overall Study|Withdrawal by Subject|1|||
170366307|NCT00959894|615677956|FG000|Overall Study|Need for contraindicated medication|1|||
170366308|NCT00959894|615677956|FG000|Overall Study|Subject moved out of town|1|||
170366309|NCT00323310|615677957|FG000|Overall Study|Withdrawal by Subject|1|||
170366310|NCT00323310|615677957|FG000|Overall Study|a parent refused blood draw|1|||
170366311|NCT00323310|615677957|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
170366312|NCT00212758|615677958|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
170366313|NCT00212758|615677959|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
170366314|NCT00212758|615677958|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
170366315|NCT00212758|615677959|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
170366316|NCT02574481|615677960|FG000|Overall Study|Withdrawal by Subject|29|||
170366317|NCT02574481|615677961|FG001|Overall Study|Withdrawal by Subject|15|||
170366318|NCT02574481|615677962|FG002|Overall Study|Withdrawal by Subject|4|||
170366319|NCT02574481|615677963|FG003|Overall Study|Withdrawal by Subject|1|||
170366320|NCT02574481|615677960|FG000|Overall Study|Adverse Event|5|||
170366321|NCT02574481|615677961|FG001|Overall Study|Adverse Event|1|||
170366322|NCT02574481|615677962|FG002|Overall Study|Adverse Event|1|||
170366323|NCT02574481|615677963|FG003|Overall Study|Adverse Event|0|||
170366324|NCT02574481|615677960|FG000|Overall Study|Visit Missed|15|||
170366325|NCT02574481|615677961|FG001|Overall Study|Visit Missed|7|||
170366326|NCT02574481|615677962|FG002|Overall Study|Visit Missed|5|||
170366327|NCT02574481|615677963|FG003|Overall Study|Visit Missed|0|||
170366328|NCT02574481|615677960|FG000|Overall Study|Other|7|||
170366329|NCT02574481|615677961|FG001|Overall Study|Other|2|||
170366330|NCT02574481|615677962|FG002|Overall Study|Other|0|||
170366331|NCT02574481|615677963|FG003|Overall Study|Other|0|||
170366332|NCT02574481|615677960|FG000|Overall Study|Death|48|||
170366333|NCT02574481|615677961|FG001|Overall Study|Death|26|||
170366334|NCT02574481|615677962|FG002|Overall Study|Death|12|||
170366335|NCT02574481|615677963|FG003|Overall Study|Death|4|||
170366336|NCT02574481|615677960|FG000|Overall Study|Physician Decision|5|||
170366337|NCT02574481|615677961|FG001|Overall Study|Physician Decision|2|||
170366338|NCT02574481|615677962|FG002|Overall Study|Physician Decision|0|||
170366339|NCT02574481|615677963|FG003|Overall Study|Physician Decision|0|||
170366340|NCT02574481|615677960|FG000|Overall Study|Lost to Follow-up|5|||
170366341|NCT02574481|615677961|FG001|Overall Study|Lost to Follow-up|1|||
170366342|NCT02574481|615677962|FG002|Overall Study|Lost to Follow-up|3|||
170366343|NCT02574481|615677963|FG003|Overall Study|Lost to Follow-up|0|||
170366344|NCT01105936|615677967|FG000|Period 1|Adverse Event|0|||
170366345|NCT01105936|615677968|FG001|Period 1|Adverse Event|0|||
170366346|NCT01105936|615677969|FG002|Period 1|Adverse Event|0|||
170366347|NCT01105936|615677970|FG003|Period 1|Adverse Event|1|||
170366348|NCT01105936|615677967|FG000|Period 2|Adverse Event|1|||
170366349|NCT01105936|615677968|FG001|Period 2|Adverse Event|0|||
170366350|NCT01105936|615677969|FG002|Period 2|Adverse Event|0|||
170366351|NCT01105936|615677970|FG003|Period 2|Adverse Event|0|||
170366352|NCT01105936|615677967|FG000|Period 3|Protocol Violation|0|||
170366353|NCT01105936|615677968|FG001|Period 3|Protocol Violation|2|||
170366354|NCT01105936|615677969|FG002|Period 3|Protocol Violation|0|||
170366355|NCT01105936|615677970|FG003|Period 3|Protocol Violation|0|||
170366356|NCT00446641|615677971|FG000|Overall Study|Withdrawal by Subject|8|||
170366357|NCT00446641|615677972|FG001|Overall Study|Withdrawal by Subject|3|||
170366358|NCT00446641|615677971|FG000|Overall Study|poor compliance|8|||
170366359|NCT00446641|615677972|FG001|Overall Study|poor compliance|6|||
170366360|NCT00446641|615677971|FG000|Overall Study|Lost to Follow-up|1|||
170366361|NCT00446641|615677972|FG001|Overall Study|Lost to Follow-up|1|||
170366362|NCT01826448|615677974|FG000|Overall Study|Adverse Event|1|||
170366363|NCT01826448|615677975|FG001|Overall Study|Adverse Event|3|||
170366364|NCT01826448|615677974|FG000|Overall Study|Disease progression|2|||
170366365|NCT01826448|615677975|FG001|Overall Study|Disease progression|4|||
170366366|NCT01826448|615677974|FG000|Overall Study|Withdrawal by Subject|1|||
170366367|NCT01826448|615677975|FG001|Overall Study|Withdrawal by Subject|0|||
170366368|NCT01826448|615677974|FG000|Overall Study|Physician Decision|0|||
170366369|NCT01826448|615677975|FG001|Overall Study|Physician Decision|1|||
170366370|NCT01826448|615677974|FG000|Overall Study|2 active cancers|0|||
170366371|NCT01826448|615677975|FG001|Overall Study|2 active cancers|1|||
170366372|NCT00880100|615677978|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
170366373|NCT00880100|615677978|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
170366374|NCT00880100|615677978|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
170366375|NCT04038385|615677980|FG000|Overall Study|Completed baseline assessment only|7|||
170366376|NCT04038385|615677981|FG001|Overall Study|Completed baseline assessment only|4|||
170366377|NCT04038385|615677980|FG000|Overall Study|Moved out of area|4|||
170366378|NCT04038385|615677981|FG001|Overall Study|Moved out of area|2|||
170366379|NCT04038385|615677980|FG000|Overall Study|Discontinued study involvement|6|||
170366380|NCT04038385|615677981|FG001|Overall Study|Discontinued study involvement|1|||
170366381|NCT00402285|615677985|FG000|Overall Study|insufficient RNA quality|7|||
170366382|NCT00402285|615677986|FG001|Overall Study|insufficient RNA quality|6|||
170366383|NCT00402285|615677987|FG002|Overall Study|insufficient RNA quality|2|||
170366384|NCT02431702|615677988|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
170366385|NCT02431702|615677989|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
170366386|NCT02431702|615677990|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
170366387|NCT02431702|615677991|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
170366388|NCT02431702|615677992|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
170366389|NCT02431702|615677993|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
170366390|NCT02431702|615677994|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
170366391|NCT02431702|615677988|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
170366392|NCT02431702|615677989|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
170366393|NCT02431702|615677990|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
170366394|NCT02431702|615677991|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
170366395|NCT02431702|615677992|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
170366396|NCT02431702|615677993|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
170366397|NCT02431702|615677994|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
170366398|NCT02431702|615677988|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
170366399|NCT02431702|615677989|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
170366400|NCT02431702|615677990|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
170366401|NCT02431702|615677991|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
170366402|NCT02431702|615677992|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
170366403|NCT02431702|615677993|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
170366404|NCT02431702|615677994|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
170366405|NCT02431702|615677988|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
170366406|NCT02431702|615677989|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
170366407|NCT02431702|615677990|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
170366408|NCT02431702|615677991|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
170366409|NCT02431702|615677992|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
170366410|NCT02431702|615677993|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
170366411|NCT02431702|615677994|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
170366412|NCT02431702|615677988|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
170366413|NCT02431702|615677989|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
170366414|NCT02431702|615677990|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
170366415|NCT02431702|615677991|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
170366416|NCT02431702|615677992|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
170366417|NCT02431702|615677993|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
170366418|NCT02431702|615677994|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
170366419|NCT02431702|615677988|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
170366420|NCT02431702|615677989|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
170366421|NCT02431702|615677990|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
170366422|NCT02431702|615677991|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
170366423|NCT02431702|615677992|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
170366424|NCT02431702|615677993|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
170366425|NCT02431702|615677994|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
170366426|NCT02431702|615677988|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
170366427|NCT02431702|615677989|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
170366428|NCT02431702|615677990|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
170366429|NCT02431702|615677991|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
170366430|NCT02431702|615677992|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
170366431|NCT02431702|615677993|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
170366432|NCT02431702|615677994|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
170366433|NCT02431702|615677988|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
170366434|NCT02431702|615677989|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
170366435|NCT02431702|615677990|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
170366436|NCT02431702|615677991|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
170366437|NCT02431702|615677992|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
170366438|NCT02431702|615677993|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
170366439|NCT02431702|615677994|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
170366440|NCT02431702|615677988|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
170366441|NCT02431702|615677989|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
170366442|NCT02431702|615677990|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
170366443|NCT02431702|615677991|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
170366444|NCT02431702|615677992|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
170366445|NCT02431702|615677993|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
170366446|NCT02431702|615677994|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
170366447|NCT02431702|615677988|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
170366448|NCT02431702|615677989|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
170366449|NCT02431702|615677990|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
170366450|NCT02431702|615677991|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
170366451|NCT02431702|615677992|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
170366452|NCT02431702|615677993|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
170366453|NCT02431702|615677994|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
170366454|NCT02431702|615677988|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
170366455|NCT02431702|615677989|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
170366456|NCT02431702|615677990|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
170366457|NCT02431702|615677991|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
170366458|NCT02431702|615677992|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
170366459|NCT02431702|615677993|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
170366460|NCT02431702|615677994|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
170366461|NCT02431702|615677988|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
170366462|NCT02431702|615677989|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
170366463|NCT02431702|615677990|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
170366464|NCT02431702|615677991|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
170366465|NCT02431702|615677992|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
170366466|NCT02431702|615677993|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
170366467|NCT02431702|615677994|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
170366468|NCT02431702|615677988|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
170366469|NCT02431702|615677989|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
170366470|NCT02431702|615677990|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
170366471|NCT02431702|615677991|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
170366472|NCT02431702|615677992|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
170366473|NCT02431702|615677993|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
170366474|NCT02431702|615677994|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
170366475|NCT02431702|615677988|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
170366476|NCT02431702|615677989|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
170366477|NCT02431702|615677990|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
170366478|NCT02431702|615677991|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
170366479|NCT02431702|615677992|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
170366480|NCT02431702|615677993|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
170366481|NCT02431702|615677994|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
170366482|NCT02431702|615677988|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
170366483|NCT02431702|615677989|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
170366484|NCT02431702|615677990|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
170366485|NCT02431702|615677991|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
170366486|NCT02431702|615677992|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
170366487|NCT02431702|615677993|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
170366488|NCT02431702|615677994|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
170366489|NCT00731666|615677995|FG000|Overall Study|Adverse Event|2|||
170366490|NCT00731666|615677995|FG000|Overall Study|Lost to Follow-up|8|||
170366491|NCT00731666|615677995|FG000|Overall Study|Withdrawal by Subject|2|||
170366492|NCT00088595|615677996|FG000|Overall Study|Adverse Event|11|||
170366493|NCT00088595|615677996|FG000|Overall Study|Withdrawal by Subject|8|||
170366494|NCT00088595|615677996|FG000|Overall Study|Ongoing (After Core)|7|||
170366495|NCT00088595|615677996|FG000|Overall Study|New Cancer Therapy|2|||
170366496|NCT01308853|615678004|FG000|Overall Study|Adverse Event|1|||
170366497|NCT01308853|615678004|FG000|Overall Study|Lost to Follow-up|2|||
170366498|NCT01308853|615678004|FG000|Overall Study|Insertion of permanent implants|1|||
170366499|NCT01376388|615678011|FG000|Overall Study|Adverse Event|13|||
170366500|NCT01376388|615678011|FG000|Overall Study|Lack of Efficacy|2|||
170366501|NCT01376388|615678011|FG000|Overall Study|Withdrawal by Subject|3|||
170366502|NCT02009930|615678019|FG000|Overall Study|withdrawn|5|||
170366503|NCT03907969|615678023|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
170366504|NCT03907969|615678024|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
170366505|NCT03907969|615678025|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
170366506|NCT03907969|615678026|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
170366507|NCT03907969|615678027|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
170366508|NCT03907969|615678028|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
170366509|NCT03907969|615678029|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
170366510|NCT03907969|615678030|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
170366511|NCT03907969|615678031|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
170366512|NCT03907969|615678032|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
170366513|NCT03907969|615678033|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
170366514|NCT03907969|615678023|FG000|Monotherapy Part A|Progressive Disease|0|||
170366515|NCT03907969|615678024|FG001|Monotherapy Part A|Progressive Disease|1|||
170366516|NCT03907969|615678025|FG002|Monotherapy Part A|Progressive Disease|0|||
170366517|NCT03907969|615678026|FG003|Monotherapy Part A|Progressive Disease|0|||
170366518|NCT03907969|615678027|FG004|Monotherapy Part A|Progressive Disease|0|||
170366519|NCT03907969|615678028|FG005|Monotherapy Part A|Progressive Disease|1|||
170366520|NCT03907969|615678029|FG006|Monotherapy Part A|Progressive Disease|2|||
170366521|NCT03907969|615678030|FG007|Monotherapy Part A|Progressive Disease|0|||
170366522|NCT03907969|615678031|FG008|Monotherapy Part A|Progressive Disease|0|||
170366523|NCT03907969|615678032|FG009|Monotherapy Part A|Progressive Disease|0|||
170366524|NCT03907969|615678033|FG010|Monotherapy Part A|Progressive Disease|0|||
170366525|NCT03907969|615678023|FG000|Monotherapy Part A|Death|0|||
170366526|NCT03907969|615678024|FG001|Monotherapy Part A|Death|0|||
170366527|NCT03907969|615678025|FG002|Monotherapy Part A|Death|1|||
170366528|NCT03907969|615678026|FG003|Monotherapy Part A|Death|1|||
170366529|NCT03907969|615678027|FG004|Monotherapy Part A|Death|0|||
170366530|NCT03907969|615678028|FG005|Monotherapy Part A|Death|1|||
170366531|NCT03907969|615678029|FG006|Monotherapy Part A|Death|0|||
170366532|NCT03907969|615678030|FG007|Monotherapy Part A|Death|0|||
170366533|NCT03907969|615678031|FG008|Monotherapy Part A|Death|0|||
170366534|NCT03907969|615678032|FG009|Monotherapy Part A|Death|0|||
170366535|NCT03907969|615678033|FG010|Monotherapy Part A|Death|0|||
170366536|NCT03907969|615678023|FG000|Combination Therapy Part A|Adverse Event|0|||
170366537|NCT03907969|615678024|FG001|Combination Therapy Part A|Adverse Event|0|||
170366538|NCT03907969|615678025|FG002|Combination Therapy Part A|Adverse Event|0|||
170366539|NCT03907969|615678026|FG003|Combination Therapy Part A|Adverse Event|0|||
170366540|NCT03907969|615678027|FG004|Combination Therapy Part A|Adverse Event|0|||
170366541|NCT03907969|615678028|FG005|Combination Therapy Part A|Adverse Event|0|||
170366542|NCT03907969|615678029|FG006|Combination Therapy Part A|Adverse Event|0|||
170366543|NCT03907969|615678030|FG007|Combination Therapy Part A|Adverse Event|0|||
170366544|NCT03907969|615678031|FG008|Combination Therapy Part A|Adverse Event|0|||
170366545|NCT03907969|615678032|FG009|Combination Therapy Part A|Adverse Event|1|||
170366546|NCT03907969|615678033|FG010|Combination Therapy Part A|Adverse Event|1|||
170366547|NCT03907969|615678023|FG000|Combination Therapy Part A|Progressive disease|0|||
170366548|NCT03907969|615678024|FG001|Combination Therapy Part A|Progressive disease|0|||
170366549|NCT03907969|615678025|FG002|Combination Therapy Part A|Progressive disease|0|||
170366550|NCT03907969|615678026|FG003|Combination Therapy Part A|Progressive disease|0|||
170366551|NCT03907969|615678027|FG004|Combination Therapy Part A|Progressive disease|0|||
170366552|NCT03907969|615678028|FG005|Combination Therapy Part A|Progressive disease|0|||
170366553|NCT03907969|615678029|FG006|Combination Therapy Part A|Progressive disease|0|||
170366554|NCT03907969|615678030|FG007|Combination Therapy Part A|Progressive disease|1|||
170366555|NCT03907969|615678031|FG008|Combination Therapy Part A|Progressive disease|0|||
170366556|NCT03907969|615678032|FG009|Combination Therapy Part A|Progressive disease|2|||
170366557|NCT03907969|615678033|FG010|Combination Therapy Part A|Progressive disease|3|||
170366558|NCT03907969|615678023|FG000|Combination Therapy Part A|Death|0|||
170366559|NCT03907969|615678024|FG001|Combination Therapy Part A|Death|0|||
170366560|NCT03907969|615678025|FG002|Combination Therapy Part A|Death|0|||
170366561|NCT03907969|615678026|FG003|Combination Therapy Part A|Death|0|||
170366562|NCT03907969|615678027|FG004|Combination Therapy Part A|Death|0|||
170366563|NCT03907969|615678028|FG005|Combination Therapy Part A|Death|0|||
170366564|NCT03907969|615678029|FG006|Combination Therapy Part A|Death|0|||
170366565|NCT03907969|615678030|FG007|Combination Therapy Part A|Death|0|||
170366566|NCT03907969|615678031|FG008|Combination Therapy Part A|Death|1|||
170366567|NCT03907969|615678032|FG009|Combination Therapy Part A|Death|0|||
170366568|NCT03907969|615678033|FG010|Combination Therapy Part A|Death|1|||
170366569|NCT03907969|615678023|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
170366570|NCT03907969|615678024|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
170366571|NCT03907969|615678025|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
170366572|NCT03907969|615678026|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
170366573|NCT03907969|615678027|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
170366574|NCT03907969|615678028|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
170366575|NCT03907969|615678029|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
170366576|NCT03907969|615678030|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
170366577|NCT03907969|615678031|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
170366578|NCT03907969|615678032|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
170366579|NCT03907969|615678033|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
170366580|NCT03907969|615678023|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
170366581|NCT03907969|615678024|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
170366582|NCT03907969|615678025|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
170366583|NCT03907969|615678026|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
170366584|NCT03907969|615678027|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
170366585|NCT03907969|615678028|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
170366586|NCT03907969|615678029|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
170366587|NCT03907969|615678030|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
170366588|NCT03907969|615678031|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
170366589|NCT03907969|615678032|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
170366590|NCT03907969|615678033|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
170366591|NCT03907969|615678023|FG000|Combination Therapy Part A|Physician Decision|0|||
170366592|NCT03907969|615678024|FG001|Combination Therapy Part A|Physician Decision|0|||
170366593|NCT03907969|615678025|FG002|Combination Therapy Part A|Physician Decision|0|||
170366594|NCT03907969|615678026|FG003|Combination Therapy Part A|Physician Decision|0|||
170366595|NCT03907969|615678027|FG004|Combination Therapy Part A|Physician Decision|0|||
170366596|NCT03907969|615678028|FG005|Combination Therapy Part A|Physician Decision|0|||
170366597|NCT03907969|615678029|FG006|Combination Therapy Part A|Physician Decision|0|||
170366598|NCT03907969|615678030|FG007|Combination Therapy Part A|Physician Decision|1|||
170366599|NCT03907969|615678031|FG008|Combination Therapy Part A|Physician Decision|0|||
170366600|NCT03907969|615678032|FG009|Combination Therapy Part A|Physician Decision|0|||
170366601|NCT03907969|615678033|FG010|Combination Therapy Part A|Physician Decision|1|||
170366602|NCT01473355|615678038|FG000|Overall Study|Protocol Violation|2|||
170366603|NCT01473355|615678038|FG000|Overall Study|Adverse Event|2|||
170366604|NCT01473355|615678038|FG000|Overall Study|Lost to Follow-up|2|||
170366605|NCT03250624|615678039|FG000|Overall Study|Lack of Efficacy|1|||
170366606|NCT03250624|615678040|FG001|Overall Study|Lack of Efficacy|4|||
170366607|NCT03250624|615678039|FG000|Overall Study|Adverse Event|0|||
170366608|NCT03250624|615678040|FG001|Overall Study|Adverse Event|1|||
170366609|NCT03250624|615678039|FG000|Overall Study|Other|1|||
170366610|NCT03250624|615678040|FG001|Overall Study|Other|2|||
170366611|NCT01510028|615678045|FG000|Overall Study|Lack of Efficacy|1|||
170366612|NCT01510028|615678046|FG001|Overall Study|Lack of Efficacy|0|||
170366613|NCT01510028|615678047|FG002|Overall Study|Lack of Efficacy|0|||
170366614|NCT01510028|615678048|FG003|Overall Study|Lack of Efficacy|0|||
170366615|NCT01599806|615678049|FG000|Overall Study|Lost to Follow-up|20|||
170366616|NCT01599806|615678050|FG001|Overall Study|Lost to Follow-up|20|||
170366617|NCT01599806|615678049|FG000|Overall Study|Withdrawal by Subject|12|||
170366618|NCT01599806|615678050|FG001|Overall Study|Withdrawal by Subject|12|||
170366619|NCT01599806|615678049|FG000|Overall Study|Other Eligibility criteria|11|||
170366620|NCT01599806|615678050|FG001|Overall Study|Other Eligibility criteria|9|||
170366621|NCT03862495|615678051|FG000|Overall Study|Lost to Follow-up|37|||
170366622|NCT03862495|615678052|FG001|Overall Study|Lost to Follow-up|35|||
170366623|NCT01057862|615678055|FG000|Overall Study|Withdrawal by Subject|1|||
170366624|NCT01057862|615678056|FG001|Overall Study|Withdrawal by Subject|2|||
170366625|NCT00802867|615678057|FG000|Overall Study|Lost to Follow-up|6|||
170366626|NCT00802867|615678057|FG000|Overall Study|Protocol Violation|6|||
170366627|NCT00802867|615678057|FG000|Overall Study|Withdrawal by Subject|1|||
170366628|NCT01061567|615678058|FG000|Overall Study|Adverse Event|32|||
170366629|NCT01061567|615678058|FG000|Overall Study|Death|2|||
170366630|NCT01061567|615678058|FG000|Overall Study|Lack of Efficacy|3|||
170366631|NCT01061567|615678058|FG000|Overall Study|Lost to Follow-up|24|||
170366632|NCT01061567|615678058|FG000|Overall Study|Protocol Violation|1|||
170366633|NCT01061567|615678058|FG000|Overall Study|Withdrawal by Subject|11|||
170366634|NCT01061567|615678058|FG000|Overall Study|Other reason than stated above|3|||
170366635|NCT00563368|615678059|FG000|Overall Study|Lost to Follow-up|14|||
170366636|NCT00563368|615678060|FG001|Overall Study|Lost to Follow-up|14|||
170366637|NCT00563368|615678061|FG002|Overall Study|Lost to Follow-up|12|||
170366638|NCT00563368|615678062|FG003|Overall Study|Lost to Follow-up|6|||
170366639|NCT00563368|615678063|FG004|Overall Study|Lost to Follow-up|9|||
170366640|NCT00563368|615678064|FG005|Overall Study|Lost to Follow-up|8|||
170366641|NCT00563368|615678065|FG006|Overall Study|Lost to Follow-up|9|||
170366642|NCT00563368|615678059|FG000|Overall Study|Adverse Event|3|||
170366643|NCT00563368|615678060|FG001|Overall Study|Adverse Event|4|||
170366644|NCT00563368|615678061|FG002|Overall Study|Adverse Event|5|||
170366645|NCT00563368|615678062|FG003|Overall Study|Adverse Event|9|||
170366646|NCT00563368|615678063|FG004|Overall Study|Adverse Event|6|||
170366647|NCT00563368|615678064|FG005|Overall Study|Adverse Event|10|||
170366648|NCT00563368|615678065|FG006|Overall Study|Adverse Event|17|||
170366649|NCT00563368|615678059|FG000|Overall Study|Withdrawal by Subject|11|||
170366650|NCT00563368|615678060|FG001|Overall Study|Withdrawal by Subject|6|||
170366651|NCT00563368|615678061|FG002|Overall Study|Withdrawal by Subject|5|||
170366652|NCT00563368|615678062|FG003|Overall Study|Withdrawal by Subject|7|||
170366653|NCT00563368|615678063|FG004|Overall Study|Withdrawal by Subject|8|||
170366654|NCT00563368|615678064|FG005|Overall Study|Withdrawal by Subject|5|||
170366655|NCT00563368|615678065|FG006|Overall Study|Withdrawal by Subject|4|||
170366656|NCT00563368|615678059|FG000|Overall Study|protocol non-compliance|1|||
170366657|NCT00563368|615678060|FG001|Overall Study|protocol non-compliance|1|||
170366658|NCT00563368|615678061|FG002|Overall Study|protocol non-compliance|2|||
170366659|NCT00563368|615678062|FG003|Overall Study|protocol non-compliance|1|||
170366660|NCT00563368|615678063|FG004|Overall Study|protocol non-compliance|0|||
170366661|NCT00563368|615678064|FG005|Overall Study|protocol non-compliance|1|||
170366662|NCT00563368|615678065|FG006|Overall Study|protocol non-compliance|3|||
170366663|NCT00563368|615678059|FG000|Overall Study|Pregnancy|1|||
170366664|NCT00563368|615678060|FG001|Overall Study|Pregnancy|0|||
170366665|NCT00563368|615678061|FG002|Overall Study|Pregnancy|1|||
170366666|NCT00563368|615678062|FG003|Overall Study|Pregnancy|2|||
170366667|NCT00563368|615678063|FG004|Overall Study|Pregnancy|1|||
170366668|NCT00563368|615678064|FG005|Overall Study|Pregnancy|2|||
170366669|NCT00563368|615678065|FG006|Overall Study|Pregnancy|0|||
170366670|NCT00563368|615678059|FG000|Overall Study|requirement for restricted medication|0|||
170366671|NCT00563368|615678060|FG001|Overall Study|requirement for restricted medication|0|||
170366672|NCT00563368|615678061|FG002|Overall Study|requirement for restricted medication|2|||
170366673|NCT00563368|615678062|FG003|Overall Study|requirement for restricted medication|0|||
170366674|NCT00563368|615678063|FG004|Overall Study|requirement for restricted medication|0|||
170366675|NCT00563368|615678064|FG005|Overall Study|requirement for restricted medication|0|||
170366676|NCT00563368|615678065|FG006|Overall Study|requirement for restricted medication|0|||
170366677|NCT00563368|615678059|FG000|Overall Study|Other|5|||
170366678|NCT00563368|615678060|FG001|Overall Study|Other|5|||
170366679|NCT00563368|615678061|FG002|Overall Study|Other|3|||
170366680|NCT00563368|615678062|FG003|Overall Study|Other|4|||
170366681|NCT00563368|615678063|FG004|Overall Study|Other|4|||
170366682|NCT00563368|615678064|FG005|Overall Study|Other|4|||
170366683|NCT00563368|615678065|FG006|Overall Study|Other|0|||
170366684|NCT03363165|615678068|FG000|3-month Follow-up|Death|0|||
170366685|NCT03363165|615678069|FG001|3-month Follow-up|Death|1|||
170366686|NCT03363165|615678068|FG000|6-month Follow-up|Death|0|||
170366687|NCT03363165|615678069|FG001|6-month Follow-up|Death|1|||
170366688|NCT03363165|615678068|FG000|6-month Follow-up|Withdrawal by Subject|1|||
170366689|NCT03363165|615678069|FG001|6-month Follow-up|Withdrawal by Subject|1|||
170366690|NCT03363165|615678068|FG000|12-month Follow-up|Death|1|||
170366691|NCT03363165|615678069|FG001|12-month Follow-up|Death|1|||
170366692|NCT03363165|615678068|FG000|12-month Follow-up|Withdrawal by Subject|1|||
170366693|NCT03363165|615678069|FG001|12-month Follow-up|Withdrawal by Subject|1|||
170366694|NCT02255760|615678070|FG000|Overall Study|Lost to Follow-up|0|||
170366695|NCT02255760|615678071|FG001|Overall Study|Lost to Follow-up|1|||
170366696|NCT02255760|615678072|FG002|Overall Study|Lost to Follow-up|0|||
170366697|NCT02255760|615678073|FG003|Overall Study|Lost to Follow-up|0|||
170366698|NCT02255760|615678074|FG004|Overall Study|Lost to Follow-up|0|||
170366699|NCT00618813|615678075|FG000|Overall Study|Lack of Efficacy|1|||
170366700|NCT00618813|615678075|FG000|Overall Study|Physician Decision|2|||
170366701|NCT00618813|615678075|FG000|Overall Study|Withdrawal by Subject|1|||
170366702|NCT00003838|615678076|FG000|Overall Study|Death|0|||
170366703|NCT00003838|615678077|FG001|Overall Study|Death|12|||
170366704|NCT00003838|615678078|FG002|Overall Study|Death|7|||
170366705|NCT00003838|615678076|FG000|Overall Study|Lost to Follow-up|0|||
170366706|NCT00003838|615678077|FG001|Overall Study|Lost to Follow-up|1|||
170366707|NCT00003838|615678078|FG002|Overall Study|Lost to Follow-up|1|||
170366708|NCT00003838|615678076|FG000|Overall Study|Disease Progression|0|||
170366709|NCT00003838|615678077|FG001|Overall Study|Disease Progression|12|||
170366710|NCT00003838|615678078|FG002|Overall Study|Disease Progression|0|||
170366711|NCT01819506|615678079|FG000|Overall Study|Physician Decision|5|||
170366712|NCT01819506|615678080|FG001|Overall Study|Physician Decision|2|||
170366713|NCT01819506|615678079|FG000|Overall Study|Withdrawal by Subject|3|||
170366714|NCT01819506|615678080|FG001|Overall Study|Withdrawal by Subject|3|||
170366715|NCT00879437|615678084|FG000|Overall Study|Protocol Violation|0|||
170366716|NCT00879437|615678085|FG001|Overall Study|Protocol Violation|1|||
170366717|NCT00879437|615678084|FG000|Overall Study|Death|1|||
170366718|NCT00879437|615678085|FG001|Overall Study|Death|0|||
170366719|NCT00268463|615678086|FG000|Overall Study|study terminated due to low accrual|10|||
170366720|NCT00268463|615678087|FG001|Overall Study|study terminated due to low accrual|12|||
170366721|NCT02076334|615678094|FG000|Overall Study|Protocol Violation|1|||
170366722|NCT02076334|615678095|FG001|Overall Study|Protocol Violation|0|||
170366723|NCT02076334|615678096|FG002|Overall Study|Protocol Violation|0|||
170366724|NCT02076334|615678097|FG003|Overall Study|Protocol Violation|0|||
170366725|NCT02076334|615678094|FG000|Overall Study|Lost to Follow-up|0|||
170366726|NCT02076334|615678095|FG001|Overall Study|Lost to Follow-up|1|||
170366727|NCT02076334|615678096|FG002|Overall Study|Lost to Follow-up|1|||
170366728|NCT02076334|615678097|FG003|Overall Study|Lost to Follow-up|0|||
170366729|NCT02076334|615678094|FG000|Overall Study|muscle soreness|0|||
170366730|NCT02076334|615678095|FG001|Overall Study|muscle soreness|0|||
170366731|NCT02076334|615678096|FG002|Overall Study|muscle soreness|0|||
170366732|NCT02076334|615678097|FG003|Overall Study|muscle soreness|1|||
170366733|NCT00928512|615678098|FG000|Overall Study|Adverse Event|4|||
170366734|NCT00928512|615678099|FG001|Overall Study|Adverse Event|3|||
170366735|NCT00928512|615678100|FG002|Overall Study|Adverse Event|2|||
170366736|NCT00928512|615678101|FG003|Overall Study|Adverse Event|8|||
170366737|NCT00928512|615678102|FG004|Overall Study|Adverse Event|6|||
170366738|NCT00928512|615678098|FG000|Overall Study|Lack of Efficacy|2|||
170366739|NCT00928512|615678099|FG001|Overall Study|Lack of Efficacy|0|||
170366740|NCT00928512|615678100|FG002|Overall Study|Lack of Efficacy|4|||
170366741|NCT00928512|615678101|FG003|Overall Study|Lack of Efficacy|7|||
170366742|NCT00928512|615678102|FG004|Overall Study|Lack of Efficacy|3|||
170366743|NCT00928512|615678098|FG000|Overall Study|Protocol Violation|0|||
170366744|NCT00928512|615678099|FG001|Overall Study|Protocol Violation|1|||
170366745|NCT00928512|615678100|FG002|Overall Study|Protocol Violation|0|||
170366746|NCT00928512|615678101|FG003|Overall Study|Protocol Violation|1|||
170366747|NCT00928512|615678102|FG004|Overall Study|Protocol Violation|3|||
170366748|NCT00928512|615678098|FG000|Overall Study|Withdrawal by Subject|3|||
170366749|NCT00928512|615678099|FG001|Overall Study|Withdrawal by Subject|0|||
170366750|NCT00928512|615678100|FG002|Overall Study|Withdrawal by Subject|3|||
170366751|NCT00928512|615678101|FG003|Overall Study|Withdrawal by Subject|4|||
170366752|NCT00928512|615678102|FG004|Overall Study|Withdrawal by Subject|0|||
170366753|NCT00928512|615678098|FG000|Overall Study|Lost to Follow-up|1|||
170366754|NCT00928512|615678099|FG001|Overall Study|Lost to Follow-up|1|||
170366755|NCT00928512|615678100|FG002|Overall Study|Lost to Follow-up|2|||
170366756|NCT00928512|615678101|FG003|Overall Study|Lost to Follow-up|1|||
170366757|NCT00928512|615678102|FG004|Overall Study|Lost to Follow-up|3|||
170366758|NCT00928512|615678098|FG000|Overall Study|Administrative Problems|0|||
170366759|NCT00928512|615678099|FG001|Overall Study|Administrative Problems|1|||
170366760|NCT00928512|615678100|FG002|Overall Study|Administrative Problems|0|||
170366761|NCT00928512|615678101|FG003|Overall Study|Administrative Problems|0|||
170366762|NCT00928512|615678102|FG004|Overall Study|Administrative Problems|0|||
170366763|NCT04153929|615678103|FG000|Overall Study|Other than listed|2|||
170366764|NCT04153929|615678104|FG001|Overall Study|Other than listed|2|||
170366765|NCT04153929|615678105|FG002|Overall Study|Other than listed|0|||
170366766|NCT04153929|615678106|FG003|Overall Study|Other than listed|1|||
170366767|NCT04153929|615678107|FG004|Overall Study|Other than listed|0|||
170366768|NCT04153929|615678108|FG005|Overall Study|Other than listed|2|||
170366769|NCT04153929|615678109|FG006|Overall Study|Other than listed|2|||
170366770|NCT04153929|615678110|FG007|Overall Study|Other than listed|1|||
170366771|NCT04153929|615678103|FG000|Overall Study|Lost to Follow-up|2|||
170366772|NCT04153929|615678104|FG001|Overall Study|Lost to Follow-up|1|||
170366773|NCT04153929|615678105|FG002|Overall Study|Lost to Follow-up|0|||
170366774|NCT04153929|615678106|FG003|Overall Study|Lost to Follow-up|1|||
170366775|NCT04153929|615678107|FG004|Overall Study|Lost to Follow-up|1|||
170366776|NCT04153929|615678108|FG005|Overall Study|Lost to Follow-up|0|||
170366777|NCT04153929|615678109|FG006|Overall Study|Lost to Follow-up|0|||
170366778|NCT04153929|615678110|FG007|Overall Study|Lost to Follow-up|0|||
170366779|NCT04153929|615678103|FG000|Overall Study|Withdrawal by Subject|3|||
170366780|NCT04153929|615678104|FG001|Overall Study|Withdrawal by Subject|1|||
170366781|NCT04153929|615678105|FG002|Overall Study|Withdrawal by Subject|0|||
170366782|NCT04153929|615678106|FG003|Overall Study|Withdrawal by Subject|3|||
170366783|NCT04153929|615678107|FG004|Overall Study|Withdrawal by Subject|1|||
170366784|NCT04153929|615678108|FG005|Overall Study|Withdrawal by Subject|0|||
170366785|NCT04153929|615678109|FG006|Overall Study|Withdrawal by Subject|1|||
170366786|NCT04153929|615678110|FG007|Overall Study|Withdrawal by Subject|0|||
170366787|NCT04153929|615678103|FG000|Overall Study|Protocol Violation|0|||
170366788|NCT04153929|615678104|FG001|Overall Study|Protocol Violation|0|||
170366789|NCT04153929|615678105|FG002|Overall Study|Protocol Violation|0|||
170366790|NCT04153929|615678106|FG003|Overall Study|Protocol Violation|0|||
170366791|NCT04153929|615678107|FG004|Overall Study|Protocol Violation|0|||
170366792|NCT04153929|615678108|FG005|Overall Study|Protocol Violation|0|||
170366793|NCT04153929|615678109|FG006|Overall Study|Protocol Violation|1|||
170366794|NCT04153929|615678110|FG007|Overall Study|Protocol Violation|2|||
170366795|NCT04153929|615678103|FG000|Overall Study|Adverse Event|3|||
170366796|NCT04153929|615678104|FG001|Overall Study|Adverse Event|5|||
170366797|NCT04153929|615678105|FG002|Overall Study|Adverse Event|5|||
170366798|NCT04153929|615678106|FG003|Overall Study|Adverse Event|11|||
170366799|NCT04153929|615678107|FG004|Overall Study|Adverse Event|15|||
170366800|NCT04153929|615678108|FG005|Overall Study|Adverse Event|4|||
170366801|NCT04153929|615678109|FG006|Overall Study|Adverse Event|8|||
170366802|NCT04153929|615678110|FG007|Overall Study|Adverse Event|2|||
170366803|NCT04153929|615678103|FG000|Overall Study|Not treated|1|||
170366804|NCT04153929|615678104|FG001|Overall Study|Not treated|0|||
170366805|NCT04153929|615678105|FG002|Overall Study|Not treated|0|||
170366806|NCT04153929|615678106|FG003|Overall Study|Not treated|0|||
170366807|NCT04153929|615678107|FG004|Overall Study|Not treated|0|||
170366808|NCT04153929|615678108|FG005|Overall Study|Not treated|0|||
170366809|NCT04153929|615678109|FG006|Overall Study|Not treated|1|||
170366810|NCT04153929|615678110|FG007|Overall Study|Not treated|0|||
170366811|NCT03332303|615678111|FG000|Overall Study|Participant did not dose|1|||
170366812|NCT03332303|615678112|FG001|Overall Study|Participant did not dose|2|||
170366813|NCT03332303|615678113|FG002|Overall Study|Participant did not dose|0|||
170366814|NCT03332303|615678111|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
170366815|NCT03332303|615678112|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
170366816|NCT03332303|615678113|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
170366817|NCT03332303|615678111|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
170366818|NCT03332303|615678112|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
170366819|NCT03332303|615678113|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
170366820|NCT03332303|615678111|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
170366821|NCT03332303|615678112|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
170366822|NCT03332303|615678113|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
170366823|NCT03332303|615678111|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
170366824|NCT03332303|615678112|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
170366825|NCT03332303|615678113|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
170366826|NCT03332303|615678111|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
170366827|NCT03332303|615678112|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
170366828|NCT03332303|615678113|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
170366829|NCT03332303|615678111|FG000|Overall Study|Participant had a significant protocol deviation|0|||
170366830|NCT03332303|615678112|FG001|Overall Study|Participant had a significant protocol deviation|1|||
170366831|NCT03332303|615678113|FG002|Overall Study|Participant had a significant protocol deviation|0|||
170366832|NCT03549429|615678118|FG000|Overall Study|Protocol Violation|5|||
170366833|NCT03549429|615678119|FG001|Overall Study|Protocol Violation|3|||
170366834|NCT01202760|615678120|FG000|Overall Study|Entry Criteria Not Met|0|||
170366835|NCT01202760|615678121|FG001|Overall Study|Entry Criteria Not Met|3|||
170366836|NCT01202760|615678122|FG002|Overall Study|Entry Criteria Not Met|1|||
170366837|NCT01202760|615678120|FG000|Overall Study|Adverse Event|11|||
170366838|NCT01202760|615678121|FG001|Overall Study|Adverse Event|9|||
170366839|NCT01202760|615678122|FG002|Overall Study|Adverse Event|10|||
170366840|NCT01202760|615678120|FG000|Overall Study|Death|2|||
170366841|NCT01202760|615678121|FG001|Overall Study|Death|1|||
170366842|NCT01202760|615678122|FG002|Overall Study|Death|0|||
170366843|NCT01202760|615678120|FG000|Overall Study|Lack of Efficacy|6|||
170366844|NCT01202760|615678121|FG001|Overall Study|Lack of Efficacy|8|||
170366845|NCT01202760|615678122|FG002|Overall Study|Lack of Efficacy|7|||
170366846|NCT01202760|615678120|FG000|Overall Study|Lost to Follow-up|0|||
170366847|NCT01202760|615678121|FG001|Overall Study|Lost to Follow-up|2|||
170366848|NCT01202760|615678122|FG002|Overall Study|Lost to Follow-up|1|||
170366849|NCT01202760|615678120|FG000|Overall Study|Parent / Caregiver Decision|0|||
170366850|NCT01202760|615678121|FG001|Overall Study|Parent / Caregiver Decision|1|||
170366851|NCT01202760|615678122|FG002|Overall Study|Parent / Caregiver Decision|0|||
170366852|NCT01202760|615678120|FG000|Overall Study|Withdrawal by Subject|17|||
170366853|NCT01202760|615678121|FG001|Overall Study|Withdrawal by Subject|18|||
170366854|NCT01202760|615678122|FG002|Overall Study|Withdrawal by Subject|14|||
170366855|NCT01202760|615678120|FG000|Overall Study|Physician Decision|0|||
170366856|NCT01202760|615678121|FG001|Overall Study|Physician Decision|1|||
170366857|NCT01202760|615678122|FG002|Overall Study|Physician Decision|0|||
170366858|NCT01202760|615678120|FG000|Overall Study|Protocol Violation|7|||
170366859|NCT01202760|615678121|FG001|Overall Study|Protocol Violation|5|||
170366860|NCT01202760|615678122|FG002|Overall Study|Protocol Violation|2|||
170366861|NCT01202760|615678120|FG000|Overall Study|Sponsor Decision|4|||
170366862|NCT01202760|615678121|FG001|Overall Study|Sponsor Decision|4|||
170366863|NCT01202760|615678122|FG002|Overall Study|Sponsor Decision|0|||
170366864|NCT00373490|615678123|FG000|Overall Study|Adverse Event|0|||
170366865|NCT00373490|615678124|FG001|Overall Study|Adverse Event|1|||
170366866|NCT00373490|615678123|FG000|Overall Study|Lack of Efficacy|9|||
170366867|NCT00373490|615678124|FG001|Overall Study|Lack of Efficacy|4|||
170366868|NCT00373490|615678123|FG000|Overall Study|Withdrawal by Subject|0|||
170366869|NCT00373490|615678124|FG001|Overall Study|Withdrawal by Subject|1|||
170366870|NCT00753688|615678125|FG000|Overall Study|Death|102|||
170366871|NCT00753688|615678126|FG001|Overall Study|Death|203|||
170366872|NCT00753688|615678125|FG000|Overall Study|Missing|4|||
170366873|NCT00753688|615678126|FG001|Overall Study|Missing|9|||
170366874|NCT00753688|615678125|FG000|Overall Study|Participant Withdrew Consent|2|||
170366875|NCT00753688|615678126|FG001|Overall Study|Participant Withdrew Consent|2|||
170366876|NCT00753688|615678125|FG000|Overall Study|Ongoing - in Follow-up|15|||
170366877|NCT00753688|615678126|FG001|Overall Study|Ongoing - in Follow-up|31|||
170366878|NCT00753688|615678125|FG000|Overall Study|Adverse Event|0|||
170366879|NCT00753688|615678126|FG001|Overall Study|Adverse Event|1|||
170366880|NCT00108953|615678127|FG000|Follow-up|Death|18|||
170366881|NCT00108953|615678128|FG001|Follow-up|Death|26|||
170366882|NCT00108953|615678127|FG000|Follow-up|Lost to Follow-up|1|||
170366883|NCT00108953|615678128|FG001|Follow-up|Lost to Follow-up|1|||
170366884|NCT00108953|615678127|FG000|Follow-up|Study terminated by sponsor|10|||
170366885|NCT00108953|615678128|FG001|Follow-up|Study terminated by sponsor|6|||
170366886|NCT00293241|615678130|FG000|Overall Study|Lost to Follow-up|9|||
170366887|NCT00293241|615678131|FG001|Overall Study|Lost to Follow-up|16|||
170366888|NCT00293241|615678130|FG000|Overall Study|Physician Decision|23|||
170366889|NCT00293241|615678131|FG001|Overall Study|Physician Decision|17|||
170366890|NCT00293241|615678130|FG000|Overall Study|Withdrawal by Subject|4|||
170366891|NCT00293241|615678131|FG001|Overall Study|Withdrawal by Subject|8|||
170366892|NCT03803202|615678132|FG000|Overall Study|Other|0|||
170366893|NCT03803202|615678133|FG001|Overall Study|Other|1|||
170366894|NCT03803202|615678134|FG002|Overall Study|Other|0|||
170366895|NCT03803202|615678135|FG003|Overall Study|Other|0|||
170366896|NCT03803202|615678136|FG004|Overall Study|Other|0|||
170366897|NCT03803202|615678137|FG005|Overall Study|Other|0|||
170366898|NCT03803202|615678138|FG006|Overall Study|Other|0|||
170366899|NCT03803202|615678139|FG007|Overall Study|Other|0|||
170366900|NCT03803202|615678140|FG008|Overall Study|Other|0|||
170366901|NCT03803202|615678132|FG000|Overall Study|Death|0|||
170366902|NCT03803202|615678133|FG001|Overall Study|Death|0|||
170366903|NCT03803202|615678134|FG002|Overall Study|Death|0|||
170366904|NCT03803202|615678135|FG003|Overall Study|Death|0|||
170366905|NCT03803202|615678136|FG004|Overall Study|Death|0|||
170366906|NCT03803202|615678137|FG005|Overall Study|Death|1|||
170366907|NCT03803202|615678138|FG006|Overall Study|Death|0|||
170366908|NCT03803202|615678139|FG007|Overall Study|Death|0|||
170366909|NCT03803202|615678140|FG008|Overall Study|Death|0|||
170366910|NCT03803202|615678132|FG000|Overall Study|Withdrawal by Subject|0|||
170366911|NCT03803202|615678133|FG001|Overall Study|Withdrawal by Subject|0|||
170366912|NCT03803202|615678134|FG002|Overall Study|Withdrawal by Subject|1|||
170366913|NCT03803202|615678135|FG003|Overall Study|Withdrawal by Subject|0|||
170366914|NCT03803202|615678136|FG004|Overall Study|Withdrawal by Subject|0|||
170366915|NCT03803202|615678137|FG005|Overall Study|Withdrawal by Subject|0|||
170366916|NCT03803202|615678138|FG006|Overall Study|Withdrawal by Subject|0|||
170366917|NCT03803202|615678139|FG007|Overall Study|Withdrawal by Subject|1|||
170366918|NCT03803202|615678140|FG008|Overall Study|Withdrawal by Subject|0|||
170366919|NCT03803202|615678132|FG000|Overall Study|Lost to Follow-up|0|||
170366920|NCT03803202|615678133|FG001|Overall Study|Lost to Follow-up|0|||
170366921|NCT03803202|615678134|FG002|Overall Study|Lost to Follow-up|0|||
170366922|NCT03803202|615678135|FG003|Overall Study|Lost to Follow-up|1|||
170366923|NCT03803202|615678136|FG004|Overall Study|Lost to Follow-up|1|||
170366924|NCT03803202|615678137|FG005|Overall Study|Lost to Follow-up|0|||
170366925|NCT03803202|615678138|FG006|Overall Study|Lost to Follow-up|1|||
170366926|NCT03803202|615678139|FG007|Overall Study|Lost to Follow-up|0|||
170366927|NCT03803202|615678140|FG008|Overall Study|Lost to Follow-up|0|||
170366928|NCT03595384|615678141|FG000|Overall Study|Other time commitments|8|||
170366929|NCT03595384|615678141|FG000|Overall Study|Changes to session time|7|||
170366930|NCT03595384|615678141|FG000|Overall Study|Relocation out of country|1|||
170366931|NCT01406652|615678142|FG000|Overall Study|Lost-to-follow-up|3|||
170366932|NCT01406652|615678143|FG001|Overall Study|Lost-to-follow-up|4|||
170366933|NCT01406652|615678142|FG000|Overall Study|Withdrawal by Subject|2|||
170366934|NCT01406652|615678143|FG001|Overall Study|Withdrawal by Subject|2|||
170366935|NCT01406652|615678142|FG000|Overall Study|Insufficient follow-up|5|||
170366936|NCT01406652|615678143|FG001|Overall Study|Insufficient follow-up|4|||
170366937|NCT01406652|615678142|FG000|Overall Study|Infection not sure|10|||
170366938|NCT01406652|615678143|FG001|Overall Study|Infection not sure|10|||
170366939|NCT02633046|615678146|FG000|Overall Study|Adverse Event|8|||
170366940|NCT02633046|615678146|FG000|Overall Study|Physician Decision|7|||
170366941|NCT02633046|615678146|FG000|Overall Study|Withdrawal by Subject|8|||
170366942|NCT02633046|615678146|FG000|Overall Study|Increased proteinuria|2|||
170366943|NCT02633046|615678146|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
170366944|NCT02633046|615678146|FG000|Overall Study|Mutual decision patient and physician|1|||
170366945|NCT00418717|615678147|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
170366946|NCT00418717|615678147|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
170366947|NCT01400139|615678148|FG000|HYD Core Study|Adverse Event|210|||
170366948|NCT01400139|615678148|FG000|HYD Core Study|Lack of Efficacy|59|||
170366949|NCT01400139|615678148|FG000|HYD Core Study|Withdrawal by Subject|114|||
170366950|NCT01400139|615678148|FG000|HYD Core Study|Lost to Follow-up|39|||
170366951|NCT01400139|615678148|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
170366952|NCT01400139|615678148|FG000|HYD Core Study|Administrative|56|||
170366953|NCT01400139|615678148|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
170366954|NCT01400139|615678148|FG000|HYD Extension Period|Adverse Event|8|||
170366955|NCT01400139|615678148|FG000|HYD Extension Period|Withdrawal by Subject|5|||
170366956|NCT01400139|615678148|FG000|HYD Extension Period|Administrative|10|||
170366957|NCT00351819|615678149|FG000|Overall Study|Lost to Follow-up|4|||
170366958|NCT00351819|615678150|FG001|Overall Study|Lost to Follow-up|4|||
170366959|NCT00351819|615678149|FG000|Overall Study|Withdrawal by Subject|0|||
170366960|NCT00351819|615678150|FG001|Overall Study|Withdrawal by Subject|4|||
170366961|NCT00351819|615678149|FG000|Overall Study|Elevated PSA|1|||
170366962|NCT00351819|615678150|FG001|Overall Study|Elevated PSA|1|||
170366963|NCT00351819|615678149|FG000|Overall Study|Traumatic ankle fracture|1|||
170366964|NCT00351819|615678150|FG001|Overall Study|Traumatic ankle fracture|0|||
170366965|NCT00351819|615678149|FG000|Overall Study|Unprofessional behavior|1|||
170366966|NCT00351819|615678150|FG001|Overall Study|Unprofessional behavior|0|||
170366967|NCT00351819|615678149|FG000|Overall Study|Non-compliance|0|||
170366968|NCT00351819|615678150|FG001|Overall Study|Non-compliance|1|||
170366969|NCT00351819|615678149|FG000|Overall Study|Incarcerated|0|||
170366970|NCT00351819|615678150|FG001|Overall Study|Incarcerated|1|||
170366971|NCT00351819|615678149|FG000|Overall Study|Enrolled in another trial|0|||
170366972|NCT00351819|615678150|FG001|Overall Study|Enrolled in another trial|1|||
170366973|NCT02023112|615678153|FG000|Overall Study|Withdrawal by Subject|2|||
170366974|NCT02023112|615678154|FG001|Overall Study|Withdrawal by Subject|1|||
170366975|NCT02096042|615678155|FG000|Overall Study|Disease Progression|1|||
170366976|NCT02096042|615678156|FG001|Overall Study|Disease Progression|0|||
170366977|NCT02096042|615678157|FG002|Overall Study|Disease Progression|0|||
170366978|NCT04624243|615679980|FG000|Overall Study|Death|0|||
170366979|NCT04624243|615679981|FG001|Overall Study|Death|1|||
170366980|NCT04624243|615679982|FG002|Overall Study|Death|0|||
170366981|NCT04624243|615679983|FG003|Overall Study|Death|0|||
170366982|NCT04624243|615679984|FG004|Overall Study|Death|0|||
170366983|NCT04624243|615679980|FG000|Overall Study|Lost to Follow-up|2|||
170366984|NCT04624243|615679981|FG001|Overall Study|Lost to Follow-up|3|||
170366985|NCT04624243|615679982|FG002|Overall Study|Lost to Follow-up|7|||
170366986|NCT04624243|615679983|FG003|Overall Study|Lost to Follow-up|1|||
170366987|NCT04624243|615679984|FG004|Overall Study|Lost to Follow-up|3|||
170366988|NCT04624243|615679980|FG000|Overall Study|Physician Decision|3|||
170366989|NCT04624243|615679981|FG001|Overall Study|Physician Decision|8|||
170366990|NCT04624243|615679982|FG002|Overall Study|Physician Decision|15|||
170366991|NCT04624243|615679983|FG003|Overall Study|Physician Decision|2|||
170366992|NCT04624243|615679984|FG004|Overall Study|Physician Decision|11|||
170366993|NCT04624243|615679980|FG000|Overall Study|Withdrawal by Subject|19|||
170366994|NCT04624243|615679981|FG001|Overall Study|Withdrawal by Subject|44|||
170366995|NCT04624243|615679982|FG002|Overall Study|Withdrawal by Subject|40|||
170366996|NCT04624243|615679983|FG003|Overall Study|Withdrawal by Subject|21|||
170366997|NCT04624243|615679984|FG004|Overall Study|Withdrawal by Subject|39|||
170366998|NCT04624243|615679980|FG000|Overall Study|Miscellaneous|3|||
170366999|NCT04624243|615679981|FG001|Overall Study|Miscellaneous|12|||
170367000|NCT04624243|615679982|FG002|Overall Study|Miscellaneous|9|||
170367001|NCT04624243|615679983|FG003|Overall Study|Miscellaneous|4|||
170367002|NCT04624243|615679984|FG004|Overall Study|Miscellaneous|6|||
170367003|NCT04006145|615679988|FG000|Overall Study|Lost to Follow-up|0|||
170367004|NCT04006145|615679989|FG001|Overall Study|Lost to Follow-up|1|||
170367005|NCT04006145|615679988|FG000|Overall Study|Other|1|||
170367006|NCT04006145|615679989|FG001|Overall Study|Other|2|||
170367007|NCT00922974|615679995|FG000|Phase II Component|Protocol Violation|2|||
170367008|NCT00922974|615679996|FG001|Phase II Component|Protocol Violation|0|||
170367009|NCT00922974|615679995|FG000|Phase II Component|Not evaluable for treatment review|5|||
170367010|NCT00922974|615679996|FG001|Phase II Component|Not evaluable for treatment review|0|||
170367011|NCT00922974|615679995|FG000|Phase III Component|Protocol Violation|8|||
170367012|NCT00922974|615679996|FG001|Phase III Component|Protocol Violation|6|||
170367013|NCT00191386|615679997|FG000|Overall Study|Adverse Event|16|||
170367014|NCT00191386|615679997|FG000|Overall Study|Lost to Follow-up|1|||
170367015|NCT00191386|615679997|FG000|Overall Study|Entry Criteria Exclusion|3|||
170367016|NCT00191386|615679997|FG000|Overall Study|Protocol Violation|18|||
170367017|NCT00191386|615679997|FG000|Overall Study|Withdrawal by Subject|96|||
170367018|NCT00191386|615679997|FG000|Overall Study|Physician Decision|11|||
170367019|NCT00191386|615679997|FG000|Overall Study|Lack of Efficacy|15|||
170367020|NCT03077243|615679999|FG000|Overall Study|Death|1|||
170367021|NCT03077243|615680000|FG001|Overall Study|Death|2|||
170367022|NCT03077243|615680001|FG002|Overall Study|Death|0|||
170367023|NCT03077243|615680002|FG003|Overall Study|Death|0|||
170367024|NCT03077243|615679999|FG000|Overall Study|Withdrawal by Subject|1|||
170367025|NCT03077243|615680000|FG001|Overall Study|Withdrawal by Subject|3|||
170367026|NCT03077243|615680001|FG002|Overall Study|Withdrawal by Subject|0|||
170367027|NCT03077243|615680002|FG003|Overall Study|Withdrawal by Subject|0|||
170367028|NCT03077243|615679999|FG000|Overall Study|Physician Decision|1|||
170367029|NCT03077243|615680000|FG001|Overall Study|Physician Decision|0|||
170367030|NCT03077243|615680001|FG002|Overall Study|Physician Decision|0|||
170367031|NCT03077243|615680002|FG003|Overall Study|Physician Decision|0|||
170367032|NCT03077243|615679999|FG000|Overall Study|Research at two study sites terminated early|0|||
170367033|NCT03077243|615680000|FG001|Overall Study|Research at two study sites terminated early|0|||
170367034|NCT03077243|615680001|FG002|Overall Study|Research at two study sites terminated early|0|||
170367035|NCT03077243|615680002|FG003|Overall Study|Research at two study sites terminated early|69|||
170367036|NCT01544478|615680003|FG000|Overall Study|Adverse Event|1|||
170367037|NCT01544478|615680003|FG000|Overall Study|Death|1|||
170367038|NCT01544478|615680003|FG000|Overall Study|Lost to Follow-up|48|||
170367039|NCT01544478|615680003|FG000|Overall Study|Physician Decision|15|||
170367040|NCT01544478|615680003|FG000|Overall Study|Pregnancy|1|||
170367041|NCT01544478|615680003|FG000|Overall Study|Withdrawal by Subject|52|||
170367042|NCT03565991|615680004|FG000|Overall Study|Other|11|||
170367043|NCT03565991|615680005|FG001|Overall Study|Other|0|||
170367044|NCT03565991|615680004|FG000|Overall Study|Global deterioration of health status|14|||
170367045|NCT03565991|615680005|FG001|Overall Study|Global deterioration of health status|4|||
170367046|NCT03565991|615680004|FG000|Overall Study|Withdrawal by Subject|2|||
170367047|NCT03565991|615680005|FG001|Overall Study|Withdrawal by Subject|6|||
170367048|NCT03565991|615680004|FG000|Overall Study|Progressive disease|121|||
170367049|NCT03565991|615680005|FG001|Overall Study|Progressive disease|29|||
170367050|NCT03565991|615680004|FG000|Overall Study|Death|3|||
170367051|NCT03565991|615680005|FG001|Overall Study|Death|0|||
170367052|NCT03565991|615680004|FG000|Overall Study|Adverse Event|7|||
170367053|NCT03565991|615680005|FG001|Overall Study|Adverse Event|2|||
170367054|NCT02944513|615680006|FG000|Overall Study|Withdrawal by Subject|4|||
170367055|NCT02944513|615680007|FG001|Overall Study|Withdrawal by Subject|1|||
170367056|NCT00937326|615680008|FG000|Overall Study|Adverse Event|0|||
170367057|NCT00937326|615680009|FG001|Overall Study|Adverse Event|3|||
170367058|NCT00937326|615680010|FG002|Overall Study|Adverse Event|1|||
170367059|NCT00937326|615680011|FG003|Overall Study|Adverse Event|1|||
170367060|NCT00937326|615680012|FG004|Overall Study|Adverse Event|2|||
170367061|NCT00937326|615680008|FG000|Overall Study|Death|0|||
170367062|NCT00937326|615680009|FG001|Overall Study|Death|0|||
170367063|NCT00937326|615680010|FG002|Overall Study|Death|1|||
170367064|NCT00937326|615680011|FG003|Overall Study|Death|0|||
170367065|NCT00937326|615680012|FG004|Overall Study|Death|0|||
170367066|NCT00937326|615680008|FG000|Overall Study|Withdrawal by Subject|3|||
170367067|NCT00937326|615680009|FG001|Overall Study|Withdrawal by Subject|4|||
170367068|NCT00937326|615680010|FG002|Overall Study|Withdrawal by Subject|1|||
170367069|NCT00937326|615680011|FG003|Overall Study|Withdrawal by Subject|4|||
170367070|NCT00937326|615680012|FG004|Overall Study|Withdrawal by Subject|3|||
170367071|NCT00937326|615680008|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
170367072|NCT00937326|615680009|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
170367073|NCT00937326|615680010|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
170367074|NCT00937326|615680011|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
170367075|NCT00937326|615680012|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
170367076|NCT00790218|615680013|FG000|Overall Study|Death|1|||
170367077|NCT00790218|615680014|FG001|Overall Study|Death|0|||
170367078|NCT00790218|615680015|FG002|Overall Study|Death|0|||
170367079|NCT00086385|615680016|FG000|Overall Study|Death|2|||
170367080|NCT00086385|615680017|FG001|Overall Study|Death|2|||
170367081|NCT00086385|615680018|FG002|Overall Study|Death|1|||
170367082|NCT00086385|615680019|FG003|Overall Study|Death|1|||
170367083|NCT00136357|615680024|FG000|Overall Study|Withdrawal by Subject|3|||
170367084|NCT00136357|615680025|FG001|Overall Study|Withdrawal by Subject|2|||
170367085|NCT05091918|615680026|FG000|Overall Study|Adverse Event|1|||
170367086|NCT05091918|615680026|FG000|Overall Study|Withdrawal by Subject|81|||
170367087|NCT02918318|615680029|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
170367088|NCT02918318|615680030|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
170367089|NCT02918318|615680031|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
170367090|NCT02918318|615680032|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
170367091|NCT02918318|615680033|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
170367092|NCT02918318|615680029|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
170367093|NCT02918318|615680030|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
170367094|NCT02918318|615680031|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
170367095|NCT02918318|615680032|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
170367096|NCT02918318|615680033|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
170367097|NCT02918318|615680029|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
170367098|NCT02918318|615680030|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
170367099|NCT02918318|615680031|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
170367100|NCT02918318|615680032|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
170367101|NCT02918318|615680033|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
170367102|NCT02918318|615680029|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
170367103|NCT02918318|615680030|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
170367104|NCT02918318|615680031|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
170367105|NCT02918318|615680032|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
170367106|NCT02918318|615680033|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
170367107|NCT02918318|615680029|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
170367108|NCT02918318|615680030|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
170367109|NCT02918318|615680031|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
170367110|NCT02918318|615680032|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
170367111|NCT02918318|615680033|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
170367112|NCT02918318|615680029|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
170367113|NCT02918318|615680030|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
170367114|NCT02918318|615680031|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
170367115|NCT02918318|615680032|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
170367116|NCT02918318|615680033|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
170367117|NCT02918318|615680029|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
170367118|NCT02918318|615680030|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
170367119|NCT02918318|615680031|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
170367120|NCT02918318|615680032|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
170367121|NCT02918318|615680033|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
170367122|NCT02918318|615680029|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
170367123|NCT02918318|615680030|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
170367124|NCT02918318|615680031|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
170367125|NCT02918318|615680032|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
170367126|NCT02918318|615680033|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
170367127|NCT02918318|615680029|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
170367128|NCT02918318|615680030|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
170367129|NCT02918318|615680031|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
170367130|NCT02918318|615680032|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
170367131|NCT02918318|615680033|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
170367132|NCT02918318|615680029|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
170367133|NCT02918318|615680030|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
170367134|NCT02918318|615680031|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
170367135|NCT02918318|615680032|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
170367136|NCT02918318|615680033|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
170367137|NCT02918318|615680029|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
170367138|NCT02918318|615680030|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
170367139|NCT02918318|615680031|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
170367140|NCT02918318|615680032|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
170367141|NCT02918318|615680033|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
170367142|NCT02918318|615680029|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
170367143|NCT02918318|615680030|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
170367144|NCT02918318|615680031|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
170367145|NCT02918318|615680032|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
170367146|NCT02918318|615680033|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
170367147|NCT03725293|615680036|FG000|Overall Study|Physician Decision|9|||
170367148|NCT03725293|615680037|FG001|Overall Study|Physician Decision|6|||
170367149|NCT03725293|615680036|FG000|Overall Study|alternative vascular access needs|1|||
170367150|NCT03725293|615680037|FG001|Overall Study|alternative vascular access needs|2|||
170367151|NCT03725293|615680036|FG000|Overall Study|venous anatomy screen failures|2|||
170367152|NCT03725293|615680037|FG001|Overall Study|venous anatomy screen failures|1|||
170367153|NCT02873208|615680038|FG000|Overall Study|Withdrawal by Subject|36|||
170367154|NCT02873208|615680038|FG000|Overall Study|Lost to Follow-up|22|||
170367155|NCT02873208|615680038|FG000|Overall Study|Adverse Event|15|||
170367156|NCT02873208|615680038|FG000|Overall Study|Non-compliance with study drug|12|||
170367157|NCT02873208|615680038|FG000|Overall Study|Protocol Violation|8|||
170367158|NCT02873208|615680038|FG000|Overall Study|Pregnancy|2|||
170367159|NCT02873208|615680038|FG000|Overall Study|Incarceration|1|||
170367160|NCT02873208|615680038|FG000|Overall Study|Lack of Efficacy|1|||
170367161|NCT02873208|615680038|FG000|Overall Study|Physician Decision|1|||
170367162|NCT03673956|615680039|FG000|Overall Study|Lost to Follow-up|1|||
170367163|NCT03673956|615680040|FG001|Overall Study|Lost to Follow-up|0|||
170367164|NCT03673956|615680041|FG002|Overall Study|Lost to Follow-up|0|||
170367165|NCT03673956|615680042|FG003|Overall Study|Lost to Follow-up|0|||
170367166|NCT03673956|615680039|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
170367167|NCT03673956|615680040|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
170367168|NCT03673956|615680041|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
170367169|NCT03673956|615680042|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
170367170|NCT00415584|615680043|FG000|Overall Study|Withdrawal by Subject|1|||
170367171|NCT01831804|615680044|FG000|Overall Study|Adverse Event|0|||
170367172|NCT01831804|615680045|FG001|Overall Study|Adverse Event|0|||
170367173|NCT01831804|615680046|FG002|Overall Study|Adverse Event|0|||
170367174|NCT01831804|615680047|FG003|Overall Study|Adverse Event|0|||
170367175|NCT01831804|615680048|FG004|Overall Study|Adverse Event|0|||
170367176|NCT01831804|615680049|FG005|Overall Study|Adverse Event|0|||
170367177|NCT01831804|615680050|FG006|Overall Study|Adverse Event|1|||
170367178|NCT01831804|615680051|FG007|Overall Study|Adverse Event|0|||
170367179|NCT01831804|615680052|FG008|Overall Study|Adverse Event|1|||
170367180|NCT01831804|615680044|FG000|Overall Study|Protocol Violation|0|||
170367181|NCT01831804|615680045|FG001|Overall Study|Protocol Violation|0|||
170367182|NCT01831804|615680046|FG002|Overall Study|Protocol Violation|2|||
170367183|NCT01831804|615680047|FG003|Overall Study|Protocol Violation|0|||
170367184|NCT01831804|615680048|FG004|Overall Study|Protocol Violation|0|||
170367185|NCT01831804|615680049|FG005|Overall Study|Protocol Violation|0|||
170367186|NCT01831804|615680050|FG006|Overall Study|Protocol Violation|0|||
170367187|NCT01831804|615680051|FG007|Overall Study|Protocol Violation|0|||
170367188|NCT01831804|615680052|FG008|Overall Study|Protocol Violation|0|||
170367189|NCT01831804|615680044|FG000|Overall Study|Protocol defined stopping criteria|1|||
170367190|NCT01831804|615680045|FG001|Overall Study|Protocol defined stopping criteria|1|||
170367191|NCT01831804|615680046|FG002|Overall Study|Protocol defined stopping criteria|3|||
170367192|NCT01831804|615680047|FG003|Overall Study|Protocol defined stopping criteria|0|||
170367193|NCT01831804|615680048|FG004|Overall Study|Protocol defined stopping criteria|1|||
170367194|NCT01831804|615680049|FG005|Overall Study|Protocol defined stopping criteria|0|||
170367195|NCT01831804|615680050|FG006|Overall Study|Protocol defined stopping criteria|0|||
170367196|NCT01831804|615680051|FG007|Overall Study|Protocol defined stopping criteria|0|||
170367197|NCT01831804|615680052|FG008|Overall Study|Protocol defined stopping criteria|0|||
170367198|NCT01831804|615680044|FG000|Overall Study|Lost to Follow-up|0|||
170367199|NCT01831804|615680045|FG001|Overall Study|Lost to Follow-up|0|||
170367200|NCT01831804|615680046|FG002|Overall Study|Lost to Follow-up|1|||
170367201|NCT01831804|615680047|FG003|Overall Study|Lost to Follow-up|0|||
170367202|NCT01831804|615680048|FG004|Overall Study|Lost to Follow-up|0|||
170367203|NCT01831804|615680049|FG005|Overall Study|Lost to Follow-up|0|||
170367204|NCT01831804|615680050|FG006|Overall Study|Lost to Follow-up|0|||
170367205|NCT01831804|615680051|FG007|Overall Study|Lost to Follow-up|0|||
170367206|NCT01831804|615680052|FG008|Overall Study|Lost to Follow-up|1|||
170367207|NCT01831804|615680044|FG000|Overall Study|Investigator discretion|0|||
170367208|NCT01831804|615680045|FG001|Overall Study|Investigator discretion|0|||
170367209|NCT01831804|615680046|FG002|Overall Study|Investigator discretion|0|||
170367210|NCT01831804|615680047|FG003|Overall Study|Investigator discretion|0|||
170367211|NCT01831804|615680048|FG004|Overall Study|Investigator discretion|1|||
170367212|NCT01831804|615680049|FG005|Overall Study|Investigator discretion|0|||
170367213|NCT01831804|615680050|FG006|Overall Study|Investigator discretion|0|||
170367214|NCT01831804|615680051|FG007|Overall Study|Investigator discretion|1|||
170367215|NCT01831804|615680052|FG008|Overall Study|Investigator discretion|0|||
170367216|NCT01831804|615680044|FG000|Overall Study|Withdrew Consent|0|||
170367217|NCT01831804|615680045|FG001|Overall Study|Withdrew Consent|1|||
170367218|NCT01831804|615680046|FG002|Overall Study|Withdrew Consent|0|||
170367219|NCT01831804|615680047|FG003|Overall Study|Withdrew Consent|0|||
170367220|NCT01831804|615680048|FG004|Overall Study|Withdrew Consent|0|||
170367221|NCT01831804|615680049|FG005|Overall Study|Withdrew Consent|0|||
170367222|NCT01831804|615680050|FG006|Overall Study|Withdrew Consent|0|||
170367223|NCT01831804|615680051|FG007|Overall Study|Withdrew Consent|2|||
170367224|NCT01831804|615680052|FG008|Overall Study|Withdrew Consent|0|||
170367225|NCT00114218|615680054|FG000|Overall Study|Wrong Cell Type|2|||
170367226|NCT00114218|615680054|FG000|Overall Study|Wrong Primary|1|||
170367227|NCT00114218|615680054|FG000|Overall Study|Never Treated|1|||
170367228|NCT02017704|615680062|FG000|Overall Study|Withdrawal by Subject|2|||
170367229|NCT02017704|615680063|FG001|Overall Study|Withdrawal by Subject|0|||
170367230|NCT01641081|615680064|FG000|Period 1|Sponsor request (potential unblinding)|0|||
170367231|NCT01641081|615680065|FG001|Period 1|Sponsor request (potential unblinding)|0|||
170367232|NCT01641081|615680066|FG002|Period 1|Sponsor request (potential unblinding)|0|||
170367233|NCT01641081|615680067|FG003|Period 1|Sponsor request (potential unblinding)|0|||
170367234|NCT01641081|615680068|FG004|Period 1|Sponsor request (potential unblinding)|0|||
170367235|NCT01641081|615680069|FG005|Period 1|Sponsor request (potential unblinding)|0|||
170367236|NCT01641081|615680070|FG006|Period 1|Sponsor request (potential unblinding)|1|||
170367237|NCT01641081|615680071|FG007|Period 1|Sponsor request (potential unblinding)|0|||
170367238|NCT01641081|615680072|FG008|Period 1|Sponsor request (potential unblinding)|0|||
170367239|NCT01641081|615680073|FG009|Period 1|Sponsor request (potential unblinding)|0|||
170367240|NCT01641081|615680064|FG000|Period 1|Protocol Violation|0|||
170367241|NCT01641081|615680065|FG001|Period 1|Protocol Violation|0|||
170367242|NCT01641081|615680066|FG002|Period 1|Protocol Violation|0|||
170367243|NCT01641081|615680067|FG003|Period 1|Protocol Violation|0|||
170367244|NCT01641081|615680068|FG004|Period 1|Protocol Violation|1|||
170367245|NCT01641081|615680069|FG005|Period 1|Protocol Violation|0|||
170367246|NCT01641081|615680070|FG006|Period 1|Protocol Violation|0|||
170367247|NCT01641081|615680071|FG007|Period 1|Protocol Violation|1|||
170367248|NCT01641081|615680072|FG008|Period 1|Protocol Violation|0|||
170367249|NCT01641081|615680073|FG009|Period 1|Protocol Violation|0|||
170367250|NCT01641081|615680064|FG000|Period 1|Adverse Event|1|||
170367251|NCT01641081|615680065|FG001|Period 1|Adverse Event|0|||
170367252|NCT01641081|615680066|FG002|Period 1|Adverse Event|0|||
170367253|NCT01641081|615680067|FG003|Period 1|Adverse Event|0|||
170367254|NCT01641081|615680068|FG004|Period 1|Adverse Event|0|||
170367255|NCT01641081|615680069|FG005|Period 1|Adverse Event|0|||
170367256|NCT01641081|615680070|FG006|Period 1|Adverse Event|0|||
170367257|NCT01641081|615680071|FG007|Period 1|Adverse Event|2|||
170367258|NCT01641081|615680072|FG008|Period 1|Adverse Event|0|||
170367259|NCT01641081|615680073|FG009|Period 1|Adverse Event|0|||
170367260|NCT01641081|615680064|FG000|Period 2|Adverse Event|0|||
170367261|NCT01641081|615680065|FG001|Period 2|Adverse Event|0|||
170367262|NCT01641081|615680066|FG002|Period 2|Adverse Event|0|||
170367263|NCT01641081|615680067|FG003|Period 2|Adverse Event|0|||
170367264|NCT01641081|615680068|FG004|Period 2|Adverse Event|0|||
170367265|NCT01641081|615680069|FG005|Period 2|Adverse Event|1|||
170367266|NCT01641081|615680070|FG006|Period 2|Adverse Event|0|||
170367267|NCT01641081|615680071|FG007|Period 2|Adverse Event|0|||
170367268|NCT01641081|615680072|FG008|Period 2|Adverse Event|0|||
170367269|NCT01641081|615680073|FG009|Period 2|Adverse Event|0|||
170367270|NCT01641081|615680064|FG000|Period 2|Withdrawal by Subject|0|||
170367271|NCT01641081|615680065|FG001|Period 2|Withdrawal by Subject|0|||
170367272|NCT01641081|615680066|FG002|Period 2|Withdrawal by Subject|0|||
170367273|NCT01641081|615680067|FG003|Period 2|Withdrawal by Subject|1|||
170367274|NCT01641081|615680068|FG004|Period 2|Withdrawal by Subject|0|||
170367275|NCT01641081|615680069|FG005|Period 2|Withdrawal by Subject|0|||
170367276|NCT01641081|615680070|FG006|Period 2|Withdrawal by Subject|2|||
170367277|NCT01641081|615680071|FG007|Period 2|Withdrawal by Subject|0|||
170367278|NCT01641081|615680072|FG008|Period 2|Withdrawal by Subject|0|||
170367279|NCT01641081|615680073|FG009|Period 2|Withdrawal by Subject|0|||
170367280|NCT01641081|615680064|FG000|Period 2|Protocol Violation|1|||
170367281|NCT01641081|615680065|FG001|Period 2|Protocol Violation|0|||
170367282|NCT01641081|615680066|FG002|Period 2|Protocol Violation|0|||
170367283|NCT01641081|615680067|FG003|Period 2|Protocol Violation|0|||
170367284|NCT01641081|615680068|FG004|Period 2|Protocol Violation|0|||
170367285|NCT01641081|615680069|FG005|Period 2|Protocol Violation|0|||
170367286|NCT01641081|615680070|FG006|Period 2|Protocol Violation|0|||
170367287|NCT01641081|615680071|FG007|Period 2|Protocol Violation|0|||
170367288|NCT01641081|615680072|FG008|Period 2|Protocol Violation|0|||
170367289|NCT01641081|615680073|FG009|Period 2|Protocol Violation|0|||
170367290|NCT01641081|615680064|FG000|Period 3|Adverse Event|0|||
170367291|NCT01641081|615680065|FG001|Period 3|Adverse Event|0|||
170367292|NCT01641081|615680066|FG002|Period 3|Adverse Event|1|||
170367293|NCT01641081|615680067|FG003|Period 3|Adverse Event|0|||
170367294|NCT01641081|615680068|FG004|Period 3|Adverse Event|0|||
170367295|NCT01641081|615680069|FG005|Period 3|Adverse Event|0|||
170367296|NCT01641081|615680070|FG006|Period 3|Adverse Event|0|||
170367297|NCT01641081|615680071|FG007|Period 3|Adverse Event|0|||
170367298|NCT01641081|615680072|FG008|Period 3|Adverse Event|0|||
170367299|NCT01641081|615680073|FG009|Period 3|Adverse Event|0|||
170367300|NCT01641081|615680064|FG000|Period 3|Withdrawal by Subject|0|||
170367301|NCT01641081|615680065|FG001|Period 3|Withdrawal by Subject|0|||
170367302|NCT01641081|615680066|FG002|Period 3|Withdrawal by Subject|0|||
170367303|NCT01641081|615680067|FG003|Period 3|Withdrawal by Subject|0|||
170367304|NCT01641081|615680068|FG004|Period 3|Withdrawal by Subject|0|||
170367305|NCT01641081|615680069|FG005|Period 3|Withdrawal by Subject|0|||
170367306|NCT01641081|615680070|FG006|Period 3|Withdrawal by Subject|0|||
170367307|NCT01641081|615680071|FG007|Period 3|Withdrawal by Subject|0|||
170367308|NCT01641081|615680072|FG008|Period 3|Withdrawal by Subject|1|||
170367309|NCT01641081|615680073|FG009|Period 3|Withdrawal by Subject|0|||
170367310|NCT01641081|615680064|FG000|Period 4|Adverse Event|0|||
170367311|NCT01641081|615680065|FG001|Period 4|Adverse Event|1|||
170367312|NCT01641081|615680066|FG002|Period 4|Adverse Event|0|||
170367313|NCT01641081|615680067|FG003|Period 4|Adverse Event|1|||
170367314|NCT01641081|615680068|FG004|Period 4|Adverse Event|0|||
170367315|NCT01641081|615680069|FG005|Period 4|Adverse Event|0|||
170367316|NCT01641081|615680070|FG006|Period 4|Adverse Event|0|||
170367317|NCT01641081|615680071|FG007|Period 4|Adverse Event|0|||
170367318|NCT01641081|615680072|FG008|Period 4|Adverse Event|0|||
170367319|NCT01641081|615680073|FG009|Period 4|Adverse Event|0|||
170367320|NCT01641081|615680064|FG000|Period 5|Adverse Event|0|||
170367321|NCT01641081|615680065|FG001|Period 5|Adverse Event|0|||
170367322|NCT01641081|615680066|FG002|Period 5|Adverse Event|2|||
170367323|NCT01641081|615680067|FG003|Period 5|Adverse Event|0|||
170367324|NCT01641081|615680068|FG004|Period 5|Adverse Event|0|||
170367325|NCT01641081|615680069|FG005|Period 5|Adverse Event|0|||
170367326|NCT01641081|615680070|FG006|Period 5|Adverse Event|0|||
170367327|NCT01641081|615680071|FG007|Period 5|Adverse Event|0|||
170367328|NCT01641081|615680072|FG008|Period 5|Adverse Event|0|||
170367329|NCT01641081|615680073|FG009|Period 5|Adverse Event|0|||
170367330|NCT01963780|615680074|FG000|Overall Study|Death|7|||
170367331|NCT01095666|615680075|FG000|Overall Study|Lack of Efficacy|0|||
170367332|NCT01095666|615680076|FG001|Overall Study|Lack of Efficacy|0|||
170367333|NCT01095666|615680077|FG002|Overall Study|Lack of Efficacy|1|||
170367334|NCT01095666|615680075|FG000|Overall Study|Adverse Event|2|||
170367335|NCT01095666|615680076|FG001|Overall Study|Adverse Event|1|||
170367336|NCT01095666|615680077|FG002|Overall Study|Adverse Event|3|||
170367337|NCT01095666|615680075|FG000|Overall Study|Lost to Follow-up|2|||
170367338|NCT01095666|615680076|FG001|Overall Study|Lost to Follow-up|2|||
170367339|NCT01095666|615680077|FG002|Overall Study|Lost to Follow-up|0|||
170367340|NCT01095666|615680075|FG000|Overall Study|Withdrawal by Subject|6|||
170367341|NCT01095666|615680076|FG001|Overall Study|Withdrawal by Subject|6|||
170367342|NCT01095666|615680077|FG002|Overall Study|Withdrawal by Subject|1|||
170367343|NCT01095666|615680075|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
170367344|NCT01095666|615680076|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
170367345|NCT01095666|615680077|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
170367346|NCT02810951|615680078|FG000|Overall Study|Adverse Event|1|||
170367347|NCT00260429|615680079|FG000|Overall Study|failure to follow appointments|1|||
170367348|NCT00260429|615680080|FG001|Overall Study|failure to follow appointments|0|||
170367349|NCT00260429|615680079|FG000|Overall Study|scheduled hand surgery|1|||
170367350|NCT00260429|615680080|FG001|Overall Study|scheduled hand surgery|0|||
170367351|NCT00994162|615680082|FG000|Overall Study|Withdrawal by Subject|1|||
170367352|NCT00994162|615680082|FG000|Overall Study|Lost to Follow-up|2|||
170367353|NCT00994162|615680082|FG000|Overall Study|Product Complaint|1|||
170367354|NCT00994162|615680082|FG000|Overall Study|Poor Compliance|5|||
170367355|NCT00994162|615680082|FG000|Overall Study|Lack of Response|3|||
170367356|NCT00994162|615680082|FG000|Overall Study|Discharged from Hospital|4|||
170367357|NCT00994162|615680082|FG000|Overall Study|Death|2|||
170367358|NCT00994162|615680082|FG000|Overall Study|Care Transferred to Another Physician|2|||
170367359|NCT00994162|615680082|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
170367360|NCT00994162|615680082|FG000|Overall Study|Physician Decision|2|||
170367361|NCT00994162|615680082|FG000|Overall Study|Surrounding Wound Erythematous|1|||
170367362|NCT00994162|615680082|FG000|Overall Study|Machine Losing Vaccum|1|||
170367363|NCT00994162|615680082|FG000|Overall Study|Patient Lived Too Far Away|1|||
170367364|NCT00994162|615680082|FG000|Overall Study|Above Knee Amputation|1|||
170367365|NCT00994162|615680082|FG000|Overall Study|Reason Not Reported By Site|1|||
170367366|NCT00588523|615680083|FG000|Overall Study|Not treated|3|||
170367367|NCT03339401|615680086|FG000|Overall Study|Death|2|||
170367368|NCT03339401|615680087|FG001|Overall Study|Death|1|||
170367369|NCT03339401|615680086|FG000|Overall Study|Withdrawal by Subject|2|||
170367370|NCT03339401|615680087|FG001|Overall Study|Withdrawal by Subject|0|||
170367371|NCT03339401|615680086|FG000|Overall Study|Study terminated|4|||
170367372|NCT03339401|615680087|FG001|Overall Study|Study terminated|3|||
170367373|NCT03339401|615680086|FG000|Overall Study|Investigator Decision|1|||
170367374|NCT03339401|615680087|FG001|Overall Study|Investigator Decision|0|||
170367375|NCT01313078|615680088|FG000|Overall Study|Death|1|||
170367376|NCT01313078|615680088|FG000|Overall Study|Discontinued study drug|1|||
170367377|NCT01313078|615680088|FG000|Overall Study|Withdrawal by Subject|1|||
170367378|NCT00910728|615680089|FG000|Overall Study|Lack of Efficacy|2|||
170367379|NCT00910728|615680090|FG001|Overall Study|Lack of Efficacy|3|||
170367380|NCT00910728|615680091|FG002|Overall Study|Lack of Efficacy|1|||
170367381|NCT00910728|615680092|FG003|Overall Study|Lack of Efficacy|2|||
170367382|NCT00910728|615680093|FG004|Overall Study|Lack of Efficacy|1|||
170367383|NCT00910728|615680094|FG005|Overall Study|Lack of Efficacy|0|||
170367384|NCT00910728|615680095|FG006|Overall Study|Lack of Efficacy|2|||
170367385|NCT00910728|615680096|FG007|Overall Study|Lack of Efficacy|2|||
170367386|NCT00910728|615680097|FG008|Overall Study|Lack of Efficacy|2|||
170367387|NCT00910728|615680089|FG000|Overall Study|Withdrawal by Subject|0|||
170367388|NCT00910728|615680090|FG001|Overall Study|Withdrawal by Subject|0|||
170367389|NCT00910728|615680091|FG002|Overall Study|Withdrawal by Subject|0|||
170367390|NCT00910728|615680092|FG003|Overall Study|Withdrawal by Subject|0|||
170367391|NCT00910728|615680093|FG004|Overall Study|Withdrawal by Subject|3|||
170367392|NCT00910728|615680094|FG005|Overall Study|Withdrawal by Subject|1|||
170367393|NCT00910728|615680095|FG006|Overall Study|Withdrawal by Subject|2|||
170367394|NCT00910728|615680096|FG007|Overall Study|Withdrawal by Subject|0|||
170367395|NCT00910728|615680097|FG008|Overall Study|Withdrawal by Subject|0|||
170367396|NCT00910728|615680089|FG000|Overall Study|(not specified)|2|||
170367397|NCT00910728|615680090|FG001|Overall Study|(not specified)|0|||
170367398|NCT00910728|615680091|FG002|Overall Study|(not specified)|1|||
170367399|NCT00910728|615680092|FG003|Overall Study|(not specified)|0|||
170367400|NCT00910728|615680093|FG004|Overall Study|(not specified)|1|||
170367401|NCT00910728|615680094|FG005|Overall Study|(not specified)|0|||
170367402|NCT00910728|615680095|FG006|Overall Study|(not specified)|0|||
170367403|NCT00910728|615680096|FG007|Overall Study|(not specified)|0|||
170367404|NCT00910728|615680097|FG008|Overall Study|(not specified)|0|||
170367405|NCT00910728|615680089|FG000|Overall Study|Adverse Event|2|||
170367406|NCT00910728|615680090|FG001|Overall Study|Adverse Event|0|||
170367407|NCT00910728|615680091|FG002|Overall Study|Adverse Event|1|||
170367408|NCT00910728|615680092|FG003|Overall Study|Adverse Event|1|||
170367409|NCT00910728|615680093|FG004|Overall Study|Adverse Event|0|||
170367410|NCT00910728|615680094|FG005|Overall Study|Adverse Event|0|||
170367411|NCT00910728|615680095|FG006|Overall Study|Adverse Event|2|||
170367412|NCT00910728|615680096|FG007|Overall Study|Adverse Event|1|||
170367413|NCT00910728|615680097|FG008|Overall Study|Adverse Event|1|||
170367414|NCT01068717|615680099|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
170367415|NCT01068717|615680100|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
170367416|NCT01068717|615680101|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
170367417|NCT01068717|615680102|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
170367418|NCT01822223|615680105|FG000|Overall Study|Death|0|||
170367419|NCT01822223|615680106|FG001|Overall Study|Death|1|||
170367420|NCT00795509|615680118|FG000|Overall Study|Protocol Violation|31|||
170367421|NCT03404518|615680119|FG000|Overall Study|Lost to Follow-up|28|||
170367422|NCT03404518|615680120|FG001|Overall Study|Lost to Follow-up|30|||
170367423|NCT03404518|615680119|FG000|Overall Study|Protocol Violation|13|||
170367424|NCT03404518|615680120|FG001|Overall Study|Protocol Violation|6|||
170367425|NCT03136367|615680123|FG000|T1 Consultation|discontinued mistakenly included|2|||
170367426|NCT03136367|615680124|FG001|T1 Consultation|discontinued mistakenly included|6|||
170367427|NCT03136367|615680125|FG002|T1 Consultation|discontinued mistakenly included|1|||
170367428|NCT03136367|615680123|FG000|T1 Consultation|Discontinued other|0|||
170367429|NCT03136367|615680124|FG001|T1 Consultation|Discontinued other|1|||
170367430|NCT03136367|615680125|FG002|T1 Consultation|Discontinued other|0|||
170367431|NCT03136367|615680123|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
170367432|NCT03136367|615680124|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
170367433|NCT03136367|615680125|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
170367434|NCT03136367|615680123|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
170367435|NCT03136367|615680124|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
170367436|NCT03136367|615680125|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
170367437|NCT03136367|615680123|FG000|T2 Post-consultation|Discontinued other|0|||
170367438|NCT03136367|615680124|FG001|T2 Post-consultation|Discontinued other|2|||
170367439|NCT03136367|615680125|FG002|T2 Post-consultation|Discontinued other|6|||
170367440|NCT03136367|615680123|FG000|T2 Post-consultation|Discontinued transferred care|0|||
170367441|NCT03136367|615680124|FG001|T2 Post-consultation|Discontinued transferred care|0|||
170367442|NCT03136367|615680125|FG002|T2 Post-consultation|Discontinued transferred care|3|||
170367443|NCT03136367|615680123|FG000|T2 Post-consultation|Discontinued lost contact|0|||
170367444|NCT03136367|615680124|FG001|T2 Post-consultation|Discontinued lost contact|1|||
170367445|NCT03136367|615680125|FG002|T2 Post-consultation|Discontinued lost contact|0|||
170367446|NCT03136367|615680123|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
170367447|NCT03136367|615680124|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
170367448|NCT03136367|615680125|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
170367449|NCT03136367|615680123|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
170367450|NCT03136367|615680124|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
170367451|NCT03136367|615680125|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
170367452|NCT03136367|615680123|FG000|T3 1 Week After Surgery|other discontinued|2|||
170367453|NCT03136367|615680124|FG001|T3 1 Week After Surgery|other discontinued|4|||
170367454|NCT03136367|615680125|FG002|T3 1 Week After Surgery|other discontinued|3|||
170367455|NCT03136367|615680123|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
170367456|NCT03136367|615680124|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
170367457|NCT03136367|615680125|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
170367458|NCT03136367|615680123|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
170367459|NCT03136367|615680124|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
170367460|NCT03136367|615680125|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
170367461|NCT03136367|615680123|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
170367462|NCT03136367|615680124|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
170367463|NCT03136367|615680125|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
170367464|NCT03136367|615680123|FG000|T4 12 Weeks After Surgery|Death|0|||
170367465|NCT03136367|615680124|FG001|T4 12 Weeks After Surgery|Death|1|||
170367466|NCT03136367|615680125|FG002|T4 12 Weeks After Surgery|Death|3|||
170367467|NCT03136367|615680123|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
170367468|NCT03136367|615680124|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
170367469|NCT03136367|615680125|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
170367470|NCT03136367|615680123|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
170367471|NCT03136367|615680124|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
170367472|NCT03136367|615680125|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
170367473|NCT03136367|615680123|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
170367474|NCT03136367|615680124|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
170367475|NCT03136367|615680125|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
170367476|NCT03136367|615680123|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
170367477|NCT03136367|615680124|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
170367478|NCT03136367|615680125|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
170367479|NCT03136367|615680123|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
170367480|NCT03136367|615680124|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
170367481|NCT03136367|615680125|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
170367482|NCT03136367|615680123|FG000|T5 1 Year After Surgery|Death|0|||
170367483|NCT03136367|615680124|FG001|T5 1 Year After Surgery|Death|0|||
170367484|NCT03136367|615680125|FG002|T5 1 Year After Surgery|Death|1|||
170367485|NCT03136367|615680123|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
170367486|NCT03136367|615680124|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
170367487|NCT03136367|615680125|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
170367488|NCT03136367|615680123|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
170367489|NCT03136367|615680124|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
170367490|NCT03136367|615680125|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
170367491|NCT03136367|615680123|FG000|T5 1 Year After Surgery|study ended before due|31|||
170367492|NCT03136367|615680124|FG001|T5 1 Year After Surgery|study ended before due|103|||
170367493|NCT03136367|615680125|FG002|T5 1 Year After Surgery|study ended before due|110|||
170367494|NCT03136367|615680123|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
170367495|NCT03136367|615680124|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
170367496|NCT03136367|615680125|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
170367497|NCT03693404|615680126|FG000|Overall Study|Withdrawal by Subject|1|||
170367498|NCT03693404|615680127|FG001|Overall Study|Withdrawal by Subject|0|||
170367499|NCT03693404|615680126|FG000|Overall Study|Lost to Follow-up|0|||
170367500|NCT03693404|615680127|FG001|Overall Study|Lost to Follow-up|5|||
170367501|NCT03693404|615680126|FG000|Overall Study|Excluded from Analysis|0|||
170367502|NCT03693404|615680127|FG001|Overall Study|Excluded from Analysis|1|||
170367503|NCT01176240|615680128|FG000|Study 306A|Lack of Efficacy|2|||
170367504|NCT01176240|615680129|FG001|Study 306A|Lack of Efficacy|1|||
170367505|NCT01176240|615680128|FG000|Study 306A|Protocol Violation|0|||
170367506|NCT01176240|615680129|FG001|Study 306A|Protocol Violation|1|||
170367507|NCT01176240|615680128|FG000|Study 306A|Withdrawal by Subject|0|||
170367508|NCT01176240|615680129|FG001|Study 306A|Withdrawal by Subject|1|||
170367509|NCT01176240|615680128|FG000|Study 306A|Stop due to diverse problems|1|||
170367510|NCT01176240|615680129|FG001|Study 306A|Stop due to diverse problems|0|||
170367511|NCT01176240|615680128|FG000|Study 306B|Lack of Efficacy|5|||
170367512|NCT01176240|615680129|FG001|Study 306B|Lack of Efficacy|3|||
170367513|NCT01176240|615680128|FG000|Study 306B|Adverse Event|10|||
170367514|NCT01176240|615680129|FG001|Study 306B|Adverse Event|5|||
170367515|NCT01176240|615680128|FG000|Study 306B|Protocol Violation|2|||
170367516|NCT01176240|615680129|FG001|Study 306B|Protocol Violation|3|||
170367517|NCT01176240|615680128|FG000|Study 306B|Withdrawal by Subject|4|||
170367518|NCT01176240|615680129|FG001|Study 306B|Withdrawal by Subject|1|||
170367519|NCT01176240|615680128|FG000|Study 306B|Physician Decision|2|||
170367520|NCT01176240|615680129|FG001|Study 306B|Physician Decision|1|||
170367521|NCT01176240|615680128|FG000|Study 306B|Supine Hypertension|1|||
170367522|NCT01176240|615680129|FG001|Study 306B|Supine Hypertension|2|||
170367523|NCT01176240|615680128|FG000|Study 306B|Lost to Follow-up|0|||
170367524|NCT01176240|615680129|FG001|Study 306B|Lost to Follow-up|1|||
170367525|NCT01176240|615680128|FG000|Study 306B|withdrew prior to dosing|2|||
170367526|NCT01176240|615680129|FG001|Study 306B|withdrew prior to dosing|1|||
170367527|NCT02947022|615680139|FG000|Overall Study|Study Stopped|1|||
170367528|NCT04742673|615681156|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
170367529|NCT04742673|615681157|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
170367530|NCT02102867|615681158|FG000|Overall Study|Pregnancy|1|||
170367531|NCT02102867|615681159|FG001|Overall Study|Pregnancy|0|||
170367532|NCT02102867|615681158|FG000|Overall Study|Withdrawal by Subject|2|||
170367533|NCT02102867|615681159|FG001|Overall Study|Withdrawal by Subject|0|||
170367534|NCT04988295|615681160|FG000|Overall Study|Withdrawal by Subject|9|||
170367535|NCT04988295|615681161|FG001|Overall Study|Withdrawal by Subject|29|||
170367536|NCT04988295|615681162|FG002|Overall Study|Withdrawal by Subject|6|||
170367537|NCT04988295|615681163|FG003|Overall Study|Withdrawal by Subject|0|||
170367538|NCT04988295|615681160|FG000|Overall Study|Lost to Follow-up|1|||
170367539|NCT04988295|615681161|FG001|Overall Study|Lost to Follow-up|0|||
170367540|NCT04988295|615681162|FG002|Overall Study|Lost to Follow-up|0|||
170367541|NCT04988295|615681163|FG003|Overall Study|Lost to Follow-up|0|||
170367542|NCT04988295|615681160|FG000|Overall Study|Study participation ongoing|186|||
170367543|NCT04988295|615681161|FG001|Overall Study|Study participation ongoing|169|||
170367544|NCT04988295|615681162|FG002|Overall Study|Study participation ongoing|99|||
170367545|NCT04988295|615681163|FG003|Overall Study|Study participation ongoing|119|||
170367546|NCT03713593|615681164|FG000|Overall Study|Sponsor Decision|73|||
170367547|NCT03713593|615681165|FG001|Overall Study|Sponsor Decision|41|||
170367548|NCT03713593|615681164|FG000|Overall Study|Lost to Follow-up|2|||
170367549|NCT03713593|615681165|FG001|Overall Study|Lost to Follow-up|1|||
170367550|NCT03713593|615681164|FG000|Overall Study|Death|314|||
170367551|NCT03713593|615681165|FG001|Overall Study|Death|349|||
170367552|NCT03713593|615681164|FG000|Overall Study|Withdrawal by Subject|6|||
170367553|NCT03713593|615681165|FG001|Overall Study|Withdrawal by Subject|8|||
170367554|NCT04776148|615681166|FG000|Overall Study|Death|249|||
170367555|NCT04776148|615681167|FG001|Overall Study|Death|260|||
170367556|NCT04776148|615681166|FG000|Overall Study|Lost to Follow-up|0|||
170367557|NCT04776148|615681167|FG001|Overall Study|Lost to Follow-up|1|||
170367558|NCT04776148|615681166|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
170367559|NCT04776148|615681167|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
170367560|NCT04776148|615681166|FG000|Overall Study|Withdrawal by Subject|3|||
170367561|NCT04776148|615681167|FG001|Overall Study|Withdrawal by Subject|4|||
170367562|NCT04776148|615681166|FG000|Overall Study|Sponsor Decision|30|||
170367563|NCT04776148|615681167|FG001|Overall Study|Sponsor Decision|15|||
170367564|NCT04918147|615681168|FG000|Overall Study|Disease flare as defined in protocol|0|||
170367565|NCT04918147|615681169|FG001|Overall Study|Disease flare as defined in protocol|2|||
170367566|NCT03925077|615681170|FG000|Feasibility Phase|Lost to Follow-up|7|||
170367567|NCT03925077|615681171|FG001|Feasibility Phase|Lost to Follow-up|4|||
170367568|NCT03925077|615681172|FG002|Feasibility Phase|Lost to Follow-up|4|||
170367569|NCT03925077|615681173|FG003|Feasibility Phase|Lost to Follow-up|0|||
170367570|NCT03925077|615681174|FG004|Feasibility Phase|Lost to Follow-up|0|||
170367571|NCT03925077|615681170|FG000|Effectiveness Phase|Lost to Follow-up|0|||
170367572|NCT03925077|615681171|FG001|Effectiveness Phase|Lost to Follow-up|0|||
170367573|NCT03925077|615681172|FG002|Effectiveness Phase|Lost to Follow-up|0|||
170367574|NCT03925077|615681173|FG003|Effectiveness Phase|Lost to Follow-up|9|||
170367575|NCT03925077|615681174|FG004|Effectiveness Phase|Lost to Follow-up|8|||
170367576|NCT03898180|615681175|FG000|Overall Study|Death|178|||
170367577|NCT03898180|615681176|FG001|Overall Study|Death|173|||
170367578|NCT03898180|615681175|FG000|Overall Study|Physician Decision|1|||
170367579|NCT03898180|615681176|FG001|Overall Study|Physician Decision|0|||
170367580|NCT03898180|615681175|FG000|Overall Study|Sponsor Decision|3|||
170367581|NCT03898180|615681176|FG001|Overall Study|Sponsor Decision|0|||
170367582|NCT03898180|615681175|FG000|Overall Study|Lost to Follow-up|1|||
170367583|NCT03898180|615681176|FG001|Overall Study|Lost to Follow-up|0|||
170367584|NCT03898180|615681175|FG000|Overall Study|Withdrawal by Subject|5|||
170367585|NCT03898180|615681176|FG001|Overall Study|Withdrawal by Subject|4|||
170367586|NCT05119855|615681177|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
170367587|NCT05119855|615681178|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
170367588|NCT05119855|615681177|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
170367589|NCT05119855|615681178|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
170367590|NCT05119855|615681177|FG000|Overall Study|Lost to Follow-up|6|||
170367591|NCT05119855|615681178|FG001|Overall Study|Lost to Follow-up|8|||
170367592|NCT04404192|615681179|FG000|Overall Study|Adverse Event|1|||
170367593|NCT04404192|615681180|FG001|Overall Study|Adverse Event|0|||
170367594|NCT04404192|615681179|FG000|Overall Study|Lost to Follow-up|1|||
170367595|NCT04404192|615681180|FG001|Overall Study|Lost to Follow-up|1|||
170367596|NCT04404192|615681179|FG000|Overall Study|Withdrawal by Subject|1|||
170367597|NCT04404192|615681180|FG001|Overall Study|Withdrawal by Subject|2|||
170367598|NCT04404192|615681179|FG000|Overall Study|Missed 2 or more consecutive visits during 4-week treatment period|1|||
170367599|NCT04404192|615681180|FG001|Overall Study|Missed 2 or more consecutive visits during 4-week treatment period|0|||
170367600|NCT04656652|615681181|FG000|Overall Study|Lost to Follow-up|2|||
170367601|NCT04656652|615681182|FG001|Overall Study|Lost to Follow-up|2|||
170367602|NCT04656652|615681181|FG000|Overall Study|Death|213|||
170367603|NCT04656652|615681182|FG001|Overall Study|Death|212|||
170367604|NCT04656652|615681181|FG000|Overall Study|Other|1|||
170367605|NCT04656652|615681182|FG001|Overall Study|Other|0|||
170367606|NCT04656652|615681181|FG000|Overall Study|Withdrawal by Subject|15|||
170367607|NCT04656652|615681182|FG001|Overall Study|Withdrawal by Subject|29|||
170367608|NCT03763838|615681183|FG000|Overall Study|Lost to Follow-up|12|||
170367609|NCT03763838|615681184|FG001|Overall Study|Lost to Follow-up|9|||
170367610|NCT03763838|615681185|FG002|Overall Study|Lost to Follow-up|5|||
170367611|NCT03763838|615681183|FG000|Overall Study|Withdrawal by Subject|4|||
170367612|NCT03763838|615681184|FG001|Overall Study|Withdrawal by Subject|3|||
170367613|NCT03763838|615681185|FG002|Overall Study|Withdrawal by Subject|0|||
170367614|NCT03763838|615681183|FG000|Overall Study|Adverse Event|0|||
170367615|NCT03763838|615681184|FG001|Overall Study|Adverse Event|2|||
170367616|NCT03763838|615681185|FG002|Overall Study|Adverse Event|0|||
170367617|NCT03763838|615681183|FG000|Overall Study|Disease Reoccurrence|0|||
170367618|NCT03763838|615681184|FG001|Overall Study|Disease Reoccurrence|2|||
170367619|NCT03763838|615681185|FG002|Overall Study|Disease Reoccurrence|0|||
170367620|NCT03763838|615681183|FG000|Overall Study|participants did not start treatment.|5|||
170367621|NCT03763838|615681184|FG001|Overall Study|participants did not start treatment.|2|||
170367622|NCT03763838|615681185|FG002|Overall Study|participants did not start treatment.|4|||
170367623|NCT06004895|615681186|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
170367624|NCT06004895|615681186|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
170367637|NCT01081951|615681193|FG000|Overall Study|Death|54|||
170367638|NCT01081951|615681194|FG001|Overall Study|Death|47|||
170367639|NCT01081951|615681193|FG000|Overall Study|Withdrawal by Subject|2|||
170367640|NCT01081951|615681194|FG001|Overall Study|Withdrawal by Subject|6|||
170367641|NCT01081951|615681193|FG000|Overall Study|Allocated treatment but did not take it|0|||
170367642|NCT01081951|615681194|FG001|Overall Study|Allocated treatment but did not take it|1|||
170367643|NCT01081951|615681193|FG000|Overall Study|Lost to Follow-up|0|||
170367644|NCT01081951|615681194|FG001|Overall Study|Lost to Follow-up|1|||
170367645|NCT05226598|615681195|FG000|Overall Study|Death|186|||
170367646|NCT05226598|615681196|FG001|Overall Study|Death|191|||
170367647|NCT05226598|615681195|FG000|Overall Study|Withdrawal by Subject|6|||
170367648|NCT05226598|615681196|FG001|Overall Study|Withdrawal by Subject|6|||
170367649|NCT05226598|615681195|FG000|Overall Study|Ongoing|174|||
170367650|NCT05226598|615681196|FG001|Overall Study|Ongoing|176|||
170367651|NCT05470881|615681199|FG000|Overall Study|Adherence under 90%|2|||
170367652|NCT02763566|615681201|FG000|Overall Study|Lost to Follow-up|1|||
170367653|NCT02763566|615681202|FG001|Overall Study|Lost to Follow-up|4|||
170367654|NCT02763566|615681203|FG002|Overall Study|Lost to Follow-up|0|||
170367655|NCT02763566|615681204|FG003|Overall Study|Lost to Follow-up|1|||
170367656|NCT02763566|615681201|FG000|Overall Study|On study treatment at study conclusion|114|||
170367657|NCT02763566|615681202|FG001|Overall Study|On study treatment at study conclusion|34|||
170367658|NCT02763566|615681203|FG002|Overall Study|On study treatment at study conclusion|54|||
170367659|NCT02763566|615681204|FG003|Overall Study|On study treatment at study conclusion|13|||
170367660|NCT02763566|615681201|FG000|Overall Study|Withdrawal by Subject|3|||
170367661|NCT02763566|615681202|FG001|Overall Study|Withdrawal by Subject|1|||
170367662|NCT02763566|615681203|FG002|Overall Study|Withdrawal by Subject|0|||
170367663|NCT02763566|615681204|FG003|Overall Study|Withdrawal by Subject|0|||
170367664|NCT03016533|615681205|FG000|Overall Study|Protocol Violation|1|||
170367665|NCT03016533|615681206|FG001|Overall Study|Protocol Violation|0|||
170367666|NCT03016533|615681205|FG000|Overall Study|Physician Decision|5|||
170367667|NCT03016533|615681206|FG001|Overall Study|Physician Decision|10|||
170367668|NCT03016533|615681205|FG000|Overall Study|Withdrawal by Subject|2|||
170367669|NCT03016533|615681206|FG001|Overall Study|Withdrawal by Subject|0|||
170367670|NCT01574274|615681207|FG000|Overall Study|Ineligible|0|||
170367671|NCT01574274|615681208|FG001|Overall Study|Ineligible|1|||
170367672|NCT01574274|615681207|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
170367673|NCT01574274|615681208|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
170367674|NCT01574274|615681207|FG000|Overall Study|Ph+ B-ALL|3|||
170367675|NCT01574274|615681208|FG001|Overall Study|Ph+ B-ALL|4|||
170367676|NCT01574274|615681207|FG000|Overall Study|Induction Death|2|||
170367677|NCT01574274|615681208|FG001|Overall Study|Induction Death|0|||
170367678|NCT01574274|615681207|FG000|Overall Study|Induction Failure|4|||
170367679|NCT01574274|615681208|FG001|Overall Study|Induction Failure|1|||
170367680|NCT01574274|615681207|FG000|Overall Study|Adverse Event|16|||
170367681|NCT01574274|615681208|FG001|Overall Study|Adverse Event|13|||
170367682|NCT01574274|615681207|FG000|Overall Study|Remission Death|1|||
170367683|NCT01574274|615681208|FG001|Overall Study|Remission Death|0|||
170367684|NCT01574274|615681207|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
170367685|NCT01574274|615681208|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
170367686|NCT01574274|615681207|FG000|Overall Study|Other, unknown|3|||
170367687|NCT01574274|615681208|FG001|Overall Study|Other, unknown|2|||
170367688|NCT03969901|615681211|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170367689|NCT03969901|615681212|FG001|Overall Study|Withdrawal by parent/guardian|0|||
170367690|NCT03969901|615681213|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170367691|NCT03969901|615681214|FG003|Overall Study|Withdrawal by parent/guardian|0|||
170367692|NCT03969901|615681215|FG004|Overall Study|Withdrawal by parent/guardian|1|||
170367693|NCT03969901|615681216|FG005|Overall Study|Withdrawal by parent/guardian|0|||
170367694|NCT03969901|615681217|FG006|Overall Study|Withdrawal by parent/guardian|0|||
170367695|NCT03969901|615681218|FG007|Overall Study|Withdrawal by parent/guardian|1|||
170367696|NCT03969901|615681219|FG008|Overall Study|Withdrawal by parent/guardian|1|||
170367697|NCT03969901|615681220|FG009|Overall Study|Withdrawal by parent/guardian|0|||
170367698|NCT05393037|615681221|FG000|Part A|Death|1|||
170367699|NCT05393037|615681222|FG001|Part A|Death|0|||
170367700|NCT05393037|615681221|FG000|Part A|Lost to Follow-up|1|||
170367701|NCT05393037|615681222|FG001|Part A|Lost to Follow-up|1|||
170367702|NCT05393037|615681221|FG000|Part A|Withdrawal by Subject|2|||
170367703|NCT05393037|615681222|FG001|Part A|Withdrawal by Subject|4|||
170367704|NCT05393037|615681221|FG000|Part B|Lost to Follow-up|1|||
170367705|NCT05393037|615681222|FG001|Part B|Lost to Follow-up|0|||
170367706|NCT01796197|615681223|FG000|Overall Study|Lost to Follow-up|1|||
170367707|NCT01796197|615681223|FG000|Overall Study|Lack of Efficacy|1|||
170367708|NCT03673501|615681224|FG000|Overall Study|Participants ongoing.|36|||
170367709|NCT03673501|615681225|FG001|Overall Study|Participants ongoing.|24|||
170367710|NCT00980538|615681226|FG000|Overall Study|Lost to Follow-up|20|||
170367711|NCT00980538|615681226|FG000|Overall Study|Sponsor's Decision|4|||
170367712|NCT00980538|615681226|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
170367713|NCT00980538|615681226|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
170367714|NCT00980538|615681226|FG000|Overall Study|Switch to Commercially Available Medication|25|||
170367715|NCT00980538|615681226|FG000|Overall Study|Participant Non-Compliant|9|||
170367716|NCT00980538|615681226|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
170367717|NCT00980538|615681226|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
170367718|NCT00980538|615681226|FG000|Overall Study|Other|60|||
170367719|NCT00980538|615681226|FG000|Overall Study|Other|1|||
170367720|NCT05044546|615681227|FG000|AIM 3 Pilot Study|Lost to Follow-up|0|||
170367721|NCT05044546|615681228|FG001|AIM 3 Pilot Study|Lost to Follow-up|0|||
170367722|NCT05044546|615681229|FG002|AIM 3 Pilot Study|Lost to Follow-up|1|||
170367723|NCT05044546|615681230|FG003|AIM 3 Pilot Study|Lost to Follow-up|0|||
170367724|NCT05044546|615681231|FG004|AIM 3 Pilot Study|Lost to Follow-up|0|||
170367725|NCT03141359|615681232|FG000|Overall Study|Death|32|||
170367726|NCT03141359|615681232|FG000|Overall Study|Still On Study (in follow up)|29|||
170367727|NCT03307629|615681233|FG000|Overall Study|Withdrawal by Subject|0|||
170367728|NCT03307629|615681234|FG001|Overall Study|Withdrawal by Subject|0|||
170367729|NCT03307629|615681235|FG002|Overall Study|Withdrawal by Subject|0|||
170367730|NCT03307629|615681236|FG003|Overall Study|Withdrawal by Subject|2|||
170367731|NCT03307629|615681233|FG000|Overall Study|Disease Progression|0|||
170367732|NCT03307629|615681234|FG001|Overall Study|Disease Progression|0|||
170367733|NCT03307629|615681235|FG002|Overall Study|Disease Progression|0|||
170367734|NCT03307629|615681236|FG003|Overall Study|Disease Progression|3|||
170367735|NCT03307629|615681233|FG000|Overall Study|Death|0|||
170367736|NCT03307629|615681234|FG001|Overall Study|Death|3|||
170367737|NCT03307629|615681235|FG002|Overall Study|Death|0|||
170367738|NCT03307629|615681236|FG003|Overall Study|Death|1|||
170367739|NCT04049760|615681613|FG000|Overall Study|Withdrawal by Subject|1|||
170367740|NCT05528510|615681614|FG000|Overall Study|Death|1|||
170367741|NCT05528510|615681615|FG001|Overall Study|Death|0|||
170367742|NCT05528510|615681616|FG002|Overall Study|Death|0|||
170367743|NCT05528510|615681614|FG000|Overall Study|Lost to Follow-up|1|||
170367744|NCT05528510|615681615|FG001|Overall Study|Lost to Follow-up|0|||
170367745|NCT05528510|615681616|FG002|Overall Study|Lost to Follow-up|0|||
170367746|NCT05528510|615681614|FG000|Overall Study|Withdrawal by Subject|4|||
170367747|NCT05528510|615681615|FG001|Overall Study|Withdrawal by Subject|1|||
170367748|NCT05528510|615681616|FG002|Overall Study|Withdrawal by Subject|3|||
170367749|NCT05528510|615681614|FG000|Overall Study|Other|2|||
170367750|NCT05528510|615681615|FG001|Overall Study|Other|2|||
170367751|NCT05528510|615681616|FG002|Overall Study|Other|1|||
170367752|NCT03829319|615681617|FG000|Overall Study|Sponsor's Decision|4|||
170367753|NCT03829319|615681618|FG001|Overall Study|Sponsor's Decision|90|||
170367754|NCT03829319|615681619|FG002|Overall Study|Sponsor's Decision|102|||
170367755|NCT03829319|615681617|FG000|Overall Study|Withdrawal by Subject|1|||
170367756|NCT03829319|615681618|FG001|Overall Study|Withdrawal by Subject|5|||
170367757|NCT03829319|615681619|FG002|Overall Study|Withdrawal by Subject|4|||
170367758|NCT03829319|615681617|FG000|Overall Study|Physician Decision|0|||
170367759|NCT03829319|615681618|FG001|Overall Study|Physician Decision|3|||
170367760|NCT03829319|615681619|FG002|Overall Study|Physician Decision|0|||
170367761|NCT03829319|615681617|FG000|Overall Study|Lost to Follow-up|0|||
170367762|NCT03829319|615681618|FG001|Overall Study|Lost to Follow-up|0|||
170367763|NCT03829319|615681619|FG002|Overall Study|Lost to Follow-up|1|||
170367764|NCT03829319|615681617|FG000|Overall Study|Death|8|||
170367765|NCT03829319|615681618|FG001|Overall Study|Death|277|||
170367766|NCT03829319|615681619|FG002|Overall Study|Death|266|||
170367767|NCT03260023|615681620|FG000|Overall Study|Adverse Event|0|||
170367768|NCT03260023|615681621|FG001|Overall Study|Adverse Event|0|||
170367769|NCT03260023|615681622|FG002|Overall Study|Adverse Event|4|||
170367770|NCT03260023|615681623|FG003|Overall Study|Adverse Event|4|||
170367771|NCT03260023|615681624|FG004|Overall Study|Adverse Event|4|||
170367772|NCT03260023|615681625|FG005|Overall Study|Adverse Event|1|||
170367773|NCT03260023|615681626|FG006|Overall Study|Adverse Event|2|||
170367774|NCT03260023|615681620|FG000|Overall Study|Clinical Progression|0|||
170367775|NCT03260023|615681621|FG001|Overall Study|Clinical Progression|1|||
170367776|NCT03260023|615681622|FG002|Overall Study|Clinical Progression|3|||
170367777|NCT03260023|615681623|FG003|Overall Study|Clinical Progression|1|||
170367778|NCT03260023|615681624|FG004|Overall Study|Clinical Progression|0|||
170367779|NCT03260023|615681625|FG005|Overall Study|Clinical Progression|0|||
170367780|NCT03260023|615681626|FG006|Overall Study|Clinical Progression|0|||
170367781|NCT03260023|615681620|FG000|Overall Study|Physician Decision|0|||
170367782|NCT03260023|615681621|FG001|Overall Study|Physician Decision|0|||
170367783|NCT03260023|615681622|FG002|Overall Study|Physician Decision|0|||
170367784|NCT03260023|615681623|FG003|Overall Study|Physician Decision|1|||
170367785|NCT03260023|615681624|FG004|Overall Study|Physician Decision|1|||
170367786|NCT03260023|615681625|FG005|Overall Study|Physician Decision|0|||
170367787|NCT03260023|615681626|FG006|Overall Study|Physician Decision|0|||
170367788|NCT03260023|615681620|FG000|Overall Study|Withdrawal by Subject|0|||
170367789|NCT03260023|615681621|FG001|Overall Study|Withdrawal by Subject|0|||
170367790|NCT03260023|615681622|FG002|Overall Study|Withdrawal by Subject|0|||
170367791|NCT03260023|615681623|FG003|Overall Study|Withdrawal by Subject|0|||
170367792|NCT03260023|615681624|FG004|Overall Study|Withdrawal by Subject|3|||
170367793|NCT03260023|615681625|FG005|Overall Study|Withdrawal by Subject|0|||
170367794|NCT03260023|615681626|FG006|Overall Study|Withdrawal by Subject|0|||
170367795|NCT03260023|615681620|FG000|Overall Study|Under trial intervention|0|||
170367796|NCT03260023|615681621|FG001|Overall Study|Under trial intervention|0|||
170367797|NCT03260023|615681622|FG002|Overall Study|Under trial intervention|2|||
170367798|NCT03260023|615681623|FG003|Overall Study|Under trial intervention|5|||
170367799|NCT03260023|615681624|FG004|Overall Study|Under trial intervention|3|||
170367800|NCT03260023|615681625|FG005|Overall Study|Under trial intervention|0|||
170367801|NCT03260023|615681626|FG006|Overall Study|Under trial intervention|0|||
170367802|NCT02486718|615681628|FG000|Enrollment Phase|Death|19|||
170367803|NCT02486718|615681629|FG001|Enrollment Phase|Death|0|||
170367804|NCT02486718|615681630|FG002|Enrollment Phase|Death|0|||
170367805|NCT02486718|615681628|FG000|Enrollment Phase|Symptomatic deterioration|1|||
170367806|NCT02486718|615681629|FG001|Enrollment Phase|Symptomatic deterioration|0|||
170367807|NCT02486718|615681630|FG002|Enrollment Phase|Symptomatic deterioration|0|||
170367808|NCT02486718|615681628|FG000|Enrollment Phase|Withdrawal by Subject|86|||
170367809|NCT02486718|615681629|FG001|Enrollment Phase|Withdrawal by Subject|0|||
170367810|NCT02486718|615681630|FG002|Enrollment Phase|Withdrawal by Subject|0|||
170367811|NCT02486718|615681628|FG000|Enrollment Phase|Protocol Violation|18|||
170367812|NCT02486718|615681629|FG001|Enrollment Phase|Protocol Violation|0|||
170367813|NCT02486718|615681630|FG002|Enrollment Phase|Protocol Violation|0|||
170367814|NCT02486718|615681628|FG000|Enrollment Phase|Physician Decision|18|||
170367815|NCT02486718|615681629|FG001|Enrollment Phase|Physician Decision|0|||
170367816|NCT02486718|615681630|FG002|Enrollment Phase|Physician Decision|0|||
170367817|NCT02486718|615681628|FG000|Enrollment Phase|Reason not provided|41|||
170367818|NCT02486718|615681629|FG001|Enrollment Phase|Reason not provided|0|||
170367819|NCT02486718|615681630|FG002|Enrollment Phase|Reason not provided|0|||
170367820|NCT02486718|615681628|FG000|Enrollment Phase|Disease relapse|54|||
170367821|NCT02486718|615681629|FG001|Enrollment Phase|Disease relapse|0|||
170367822|NCT02486718|615681630|FG002|Enrollment Phase|Disease relapse|0|||
170367823|NCT02486718|615681628|FG000|Enrollment Phase|Lost to Follow-up|4|||
170367824|NCT02486718|615681629|FG001|Enrollment Phase|Lost to Follow-up|0|||
170367825|NCT02486718|615681630|FG002|Enrollment Phase|Lost to Follow-up|0|||
170367826|NCT02486718|615681628|FG000|Enrollment Phase|Adverse Event|34|||
170367827|NCT02486718|615681629|FG001|Enrollment Phase|Adverse Event|0|||
170367828|NCT02486718|615681630|FG002|Enrollment Phase|Adverse Event|0|||
170367829|NCT02486718|615681628|FG000|Randomized Phase|Withdrawal by Subject|0|||
170367830|NCT02486718|615681629|FG001|Randomized Phase|Withdrawal by Subject|44|||
170367831|NCT02486718|615681630|FG002|Randomized Phase|Withdrawal by Subject|47|||
170367832|NCT02486718|615681628|FG000|Randomized Phase|Protocol Violation|0|||
170367833|NCT02486718|615681629|FG001|Randomized Phase|Protocol Violation|2|||
170367834|NCT02486718|615681630|FG002|Randomized Phase|Protocol Violation|0|||
170367835|NCT02486718|615681628|FG000|Randomized Phase|Physician Decision|0|||
170367836|NCT02486718|615681629|FG001|Randomized Phase|Physician Decision|0|||
170367837|NCT02486718|615681630|FG002|Randomized Phase|Physician Decision|3|||
170367838|NCT02486718|615681628|FG000|Randomized Phase|Lost to Follow-up|0|||
170367839|NCT02486718|615681629|FG001|Randomized Phase|Lost to Follow-up|5|||
170367840|NCT02486718|615681630|FG002|Randomized Phase|Lost to Follow-up|11|||
170367841|NCT02486718|615681628|FG000|Randomized Phase|Disease Relapse|0|||
170367842|NCT02486718|615681629|FG001|Randomized Phase|Disease Relapse|1|||
170367843|NCT02486718|615681630|FG002|Randomized Phase|Disease Relapse|0|||
170367844|NCT02486718|615681628|FG000|Randomized Phase|Death|0|||
170367845|NCT02486718|615681629|FG001|Randomized Phase|Death|154|||
170367846|NCT02486718|615681630|FG002|Randomized Phase|Death|155|||
170367847|NCT02486718|615681628|FG000|Randomized Phase|Ongoing|0|||
170367848|NCT02486718|615681629|FG001|Randomized Phase|Ongoing|301|||
170367849|NCT02486718|615681630|FG002|Randomized Phase|Ongoing|282|||
170367850|NCT03211416|615681635|FG000|Overall Study|Adverse Event|7|||
170367851|NCT03211416|615681635|FG000|Overall Study|Lack of Efficacy|2|||
170367852|NCT03211416|615681635|FG000|Overall Study|Physician Decision|1|||
170367853|NCT05592275|615681636|FG000|Overall Study|Study Terminated by Sponsor|17|||
170367854|NCT05592275|615681637|FG001|Overall Study|Study Terminated by Sponsor|22|||
170367855|NCT05592275|615681638|FG002|Overall Study|Study Terminated by Sponsor|21|||
170367856|NCT05592275|615681639|FG003|Overall Study|Study Terminated by Sponsor|27|||
170367857|NCT05592275|615681636|FG000|Overall Study|Site Terminated by Sponsor|6|||
170367858|NCT05592275|615681637|FG001|Overall Study|Site Terminated by Sponsor|6|||
170367859|NCT05592275|615681638|FG002|Overall Study|Site Terminated by Sponsor|7|||
170367860|NCT05592275|615681639|FG003|Overall Study|Site Terminated by Sponsor|5|||
170367861|NCT05592275|615681636|FG000|Overall Study|Withdrawal by Subject|3|||
170367862|NCT05592275|615681637|FG001|Overall Study|Withdrawal by Subject|2|||
170367863|NCT05592275|615681638|FG002|Overall Study|Withdrawal by Subject|6|||
170367864|NCT05592275|615681639|FG003|Overall Study|Withdrawal by Subject|3|||
170367865|NCT05592275|615681636|FG000|Overall Study|Death|3|||
170367866|NCT05592275|615681637|FG001|Overall Study|Death|2|||
170367867|NCT05592275|615681638|FG002|Overall Study|Death|3|||
170367868|NCT05592275|615681639|FG003|Overall Study|Death|2|||
170367869|NCT05592275|615681636|FG000|Overall Study|Assigned Treatment by Mistake|1|||
170367870|NCT05592275|615681637|FG001|Overall Study|Assigned Treatment by Mistake|2|||
170367871|NCT05592275|615681638|FG002|Overall Study|Assigned Treatment by Mistake|1|||
170367872|NCT05592275|615681639|FG003|Overall Study|Assigned Treatment by Mistake|0|||
170367873|NCT05592275|615681636|FG000|Overall Study|Adverse Event|0|||
170367874|NCT05592275|615681637|FG001|Overall Study|Adverse Event|1|||
170367875|NCT05592275|615681638|FG002|Overall Study|Adverse Event|0|||
170367876|NCT05592275|615681639|FG003|Overall Study|Adverse Event|2|||
170367877|NCT05592275|615681636|FG000|Overall Study|Physician Decision|1|||
170367878|NCT05592275|615681637|FG001|Overall Study|Physician Decision|0|||
170367879|NCT05592275|615681638|FG002|Overall Study|Physician Decision|0|||
170367880|NCT05592275|615681639|FG003|Overall Study|Physician Decision|0|||
170367881|NCT05592275|615681636|FG000|Overall Study|Non-compliance With Study Drug|1|||
170367882|NCT05592275|615681637|FG001|Overall Study|Non-compliance With Study Drug|0|||
170367883|NCT05592275|615681638|FG002|Overall Study|Non-compliance With Study Drug|0|||
170367884|NCT05592275|615681639|FG003|Overall Study|Non-compliance With Study Drug|0|||
170367885|NCT05592275|615681636|FG000|Overall Study|Did not Follow Schedule of Activities by Uploading Echocardiograms Within Time|1|||
170367886|NCT05592275|615681637|FG001|Overall Study|Did not Follow Schedule of Activities by Uploading Echocardiograms Within Time|0|||
170367887|NCT05592275|615681638|FG002|Overall Study|Did not Follow Schedule of Activities by Uploading Echocardiograms Within Time|0|||
170367888|NCT05592275|615681639|FG003|Overall Study|Did not Follow Schedule of Activities by Uploading Echocardiograms Within Time|0|||
170367889|NCT05592275|615681636|FG000|Overall Study|pro B-type Natriuretic Peptide was not Collected on Time|1|||
170367890|NCT05592275|615681637|FG001|Overall Study|pro B-type Natriuretic Peptide was not Collected on Time|0|||
170367891|NCT05592275|615681638|FG002|Overall Study|pro B-type Natriuretic Peptide was not Collected on Time|0|||
170367892|NCT05592275|615681639|FG003|Overall Study|pro B-type Natriuretic Peptide was not Collected on Time|0|||
170367893|NCT05592275|615681636|FG000|Overall Study|Sponsor Decision to Discontinue the Participant|0|||
170367894|NCT05592275|615681637|FG001|Overall Study|Sponsor Decision to Discontinue the Participant|0|||
170367895|NCT05592275|615681638|FG002|Overall Study|Sponsor Decision to Discontinue the Participant|0|||
170367896|NCT05592275|615681639|FG003|Overall Study|Sponsor Decision to Discontinue the Participant|1|||
170367897|NCT05592275|615681636|FG000|Overall Study|Participant Refused to Participant in Study|0|||
170367898|NCT05592275|615681637|FG001|Overall Study|Participant Refused to Participant in Study|0|||
170367899|NCT05592275|615681638|FG002|Overall Study|Participant Refused to Participant in Study|0|||
170367900|NCT05592275|615681639|FG003|Overall Study|Participant Refused to Participant in Study|1|||
170367901|NCT05592275|615681636|FG000|Overall Study|Participant is Travelling|0|||
170367902|NCT05592275|615681637|FG001|Overall Study|Participant is Travelling|0|||
170367903|NCT05592275|615681638|FG002|Overall Study|Participant is Travelling|0|||
170367904|NCT05592275|615681639|FG003|Overall Study|Participant is Travelling|1|||
170367905|NCT05592275|615681636|FG000|Overall Study|Protocol Deviation|0|||
170367906|NCT05592275|615681637|FG001|Overall Study|Protocol Deviation|0|||
170367907|NCT05592275|615681638|FG002|Overall Study|Protocol Deviation|0|||
170367908|NCT05592275|615681639|FG003|Overall Study|Protocol Deviation|1|||
170367909|NCT04810091|615681640|FG000|Overall Study|Adverse Event|1|||
170367910|NCT04810091|615681641|FG001|Overall Study|Adverse Event|1|||
170367911|NCT04810091|615681640|FG000|Overall Study|Death|1|||
170367912|NCT04810091|615681641|FG001|Overall Study|Death|0|||
170367913|NCT04810091|615681640|FG000|Overall Study|Lost to Follow-up|1|||
170367914|NCT04810091|615681641|FG001|Overall Study|Lost to Follow-up|1|||
170367915|NCT04810091|615681640|FG000|Overall Study|Physician Decision|2|||
170367916|NCT04810091|615681641|FG001|Overall Study|Physician Decision|3|||
170367917|NCT04810091|615681640|FG000|Overall Study|Withdrawal by Subject|4|||
170367918|NCT04810091|615681641|FG001|Overall Study|Withdrawal by Subject|2|||
170367919|NCT04810091|615681640|FG000|Overall Study|Ineligible|0|||
170367920|NCT04810091|615681641|FG001|Overall Study|Ineligible|1|||
170367921|NCT04810091|615681640|FG000|Overall Study|Non-compliance|0|||
170367922|NCT04810091|615681641|FG001|Overall Study|Non-compliance|1|||
170367923|NCT04810091|615681640|FG000|Overall Study|Prescribed Xermelo by local oncologist|1|||
170367924|NCT04810091|615681641|FG001|Overall Study|Prescribed Xermelo by local oncologist|0|||
170367925|NCT04810091|615681640|FG000|Overall Study|Progressive disease|0|||
170367926|NCT04810091|615681641|FG001|Overall Study|Progressive disease|1|||
170367927|NCT03424044|615682287|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
170367928|NCT03424044|615682288|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
170367929|NCT03424044|615682289|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
170367930|NCT03424044|615682290|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
170367931|NCT03424044|615682291|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
170367932|NCT03424044|615682292|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
170367933|NCT03424044|615682293|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
170367934|NCT03424044|615682294|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
170367935|NCT03424044|615682295|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
170367936|NCT03424044|615682287|FG000|First Intervention (76 Hours)|Adverse Event|0|||
170367937|NCT03424044|615682288|FG001|First Intervention (76 Hours)|Adverse Event|0|||
170367938|NCT03424044|615682289|FG002|First Intervention (76 Hours)|Adverse Event|0|||
170367939|NCT03424044|615682290|FG003|First Intervention (76 Hours)|Adverse Event|0|||
170367940|NCT03424044|615682291|FG004|First Intervention (76 Hours)|Adverse Event|1|||
170367941|NCT03424044|615682292|FG005|First Intervention (76 Hours)|Adverse Event|0|||
170367942|NCT03424044|615682293|FG006|First Intervention (76 Hours)|Adverse Event|0|||
170367943|NCT03424044|615682294|FG007|First Intervention (76 Hours)|Adverse Event|0|||
170367944|NCT03424044|615682295|FG008|First Intervention (76 Hours)|Adverse Event|0|||
170367945|NCT03424044|615682287|FG000|First Intervention (76 Hours)|device issues|0|||
170367946|NCT03424044|615682288|FG001|First Intervention (76 Hours)|device issues|0|||
170367947|NCT03424044|615682289|FG002|First Intervention (76 Hours)|device issues|0|||
170367948|NCT03424044|615682290|FG003|First Intervention (76 Hours)|device issues|0|||
170367949|NCT03424044|615682291|FG004|First Intervention (76 Hours)|device issues|0|||
170367950|NCT03424044|615682292|FG005|First Intervention (76 Hours)|device issues|0|||
170367951|NCT03424044|615682293|FG006|First Intervention (76 Hours)|device issues|1|||
170367952|NCT03424044|615682294|FG007|First Intervention (76 Hours)|device issues|1|||
170367953|NCT03424044|615682295|FG008|First Intervention (76 Hours)|device issues|1|||
170367954|NCT03424044|615682287|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
170367955|NCT03424044|615682288|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
170367956|NCT03424044|615682289|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
170367957|NCT03424044|615682290|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
170367958|NCT03424044|615682291|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
170367959|NCT03424044|615682292|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
170367960|NCT03424044|615682293|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
170367961|NCT03424044|615682294|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
170367962|NCT03424044|615682295|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
170367963|NCT03424044|615682287|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
170367964|NCT03424044|615682288|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
170367965|NCT03424044|615682289|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
170367966|NCT03424044|615682290|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
170367967|NCT03424044|615682291|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
170367968|NCT03424044|615682292|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
170367969|NCT03424044|615682293|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
170367970|NCT03424044|615682294|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
170367971|NCT03424044|615682295|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
170367972|NCT00990249|615682296|FG000|Overall Study|Disease Progression|8|||
170367973|NCT00990249|615682296|FG000|Overall Study|Non-Compliance|1|||
170367974|NCT00990249|615682296|FG000|Overall Study|Death|2|||
170367975|NCT00990249|615682296|FG000|Overall Study|Not treated|2|||
170367976|NCT01192100|615682297|FG000|Overall Study|Withdrawal by Subject|0|||
170367977|NCT01192100|615682298|FG001|Overall Study|Withdrawal by Subject|0|||
170367978|NCT01192100|615682299|FG002|Overall Study|Withdrawal by Subject|0|||
170367979|NCT01192100|615682300|FG003|Overall Study|Withdrawal by Subject|0|||
170367980|NCT01192100|615682301|FG004|Overall Study|Withdrawal by Subject|1|||
170367981|NCT01192100|615682302|FG005|Overall Study|Withdrawal by Subject|0|||
170367982|NCT01192100|615682297|FG000|Overall Study|Protocol Violation|0|||
170367983|NCT01192100|615682298|FG001|Overall Study|Protocol Violation|0|||
170367984|NCT01192100|615682299|FG002|Overall Study|Protocol Violation|0|||
170367985|NCT01192100|615682300|FG003|Overall Study|Protocol Violation|1|||
170367986|NCT01192100|615682301|FG004|Overall Study|Protocol Violation|0|||
170367987|NCT01192100|615682302|FG005|Overall Study|Protocol Violation|0|||
170367988|NCT02057068|615682303|FG000|Overall Study|Withdrawal by Subject|2|||
170367989|NCT02057068|615682304|FG001|Overall Study|Withdrawal by Subject|2|||
170367990|NCT02057068|615682303|FG000|Overall Study|Caregiver (CG) Health|0|||
170367991|NCT02057068|615682304|FG001|Overall Study|Caregiver (CG) Health|2|||
170367992|NCT02057068|615682303|FG000|Overall Study|Carepartner (CP) Health|4|||
170367993|NCT02057068|615682304|FG001|Overall Study|Carepartner (CP) Health|2|||
170367994|NCT02057068|615682303|FG000|Overall Study|Lost to Follow-up|2|||
170367995|NCT02057068|615682304|FG001|Overall Study|Lost to Follow-up|2|||
170367996|NCT00615459|615682314|FG000|Period I|Adverse Event|2|||
170367997|NCT00615459|615682315|FG001|Period I|Adverse Event|0|||
170367998|NCT00615459|615682316|FG002|Period I|Adverse Event|1|||
170367999|NCT00615459|615682317|FG003|Period I|Adverse Event|0|||
170368000|NCT00615459|615682314|FG000|Period I|Subject withdrew consent|1|||
170368001|NCT00615459|615682315|FG001|Period I|Subject withdrew consent|0|||
170368002|NCT00615459|615682316|FG002|Period I|Subject withdrew consent|0|||
170368003|NCT00615459|615682317|FG003|Period I|Subject withdrew consent|1|||
170368004|NCT00615459|615682314|FG000|Period I|Abnormal test procedure results|1|||
170368005|NCT00615459|615682315|FG001|Period I|Abnormal test procedure results|1|||
170368006|NCT00615459|615682316|FG002|Period I|Abnormal test procedure results|1|||
170368007|NCT00615459|615682317|FG003|Period I|Abnormal test procedure results|0|||
170368008|NCT00615459|615682314|FG000|Period II|Adverse Event|1|||
170368009|NCT00615459|615682315|FG001|Period II|Adverse Event|0|||
170368010|NCT00615459|615682316|FG002|Period II|Adverse Event|0|||
170368011|NCT00615459|615682317|FG003|Period II|Adverse Event|0|||
170368012|NCT00615459|615682314|FG000|Period II|Lost to Follow-up|0|||
170368013|NCT00615459|615682315|FG001|Period II|Lost to Follow-up|0|||
170368014|NCT00615459|615682316|FG002|Period II|Lost to Follow-up|0|||
170368015|NCT00615459|615682317|FG003|Period II|Lost to Follow-up|1|||
170368016|NCT00615459|615682314|FG000|Period III|Adverse Event|0|||
170368017|NCT00615459|615682315|FG001|Period III|Adverse Event|1|||
170368018|NCT00615459|615682316|FG002|Period III|Adverse Event|0|||
170368019|NCT00615459|615682317|FG003|Period III|Adverse Event|0|||
170368020|NCT00615459|615682314|FG000|Period III|Administrative problems|0|||
170368021|NCT00615459|615682315|FG001|Period III|Administrative problems|1|||
170368022|NCT00615459|615682316|FG002|Period III|Administrative problems|1|||
170368023|NCT00615459|615682317|FG003|Period III|Administrative problems|0|||
170368024|NCT00615459|615682314|FG000|Period III|Unsatisfactory therapeutic effect|0|||
170368025|NCT00615459|615682315|FG001|Period III|Unsatisfactory therapeutic effect|1|||
170368026|NCT00615459|615682316|FG002|Period III|Unsatisfactory therapeutic effect|0|||
170368027|NCT00615459|615682317|FG003|Period III|Unsatisfactory therapeutic effect|0|||
170368028|NCT01235728|615682318|FG000|Overall Study|Protocol Violation|0|||
170368029|NCT01235728|615682319|FG001|Overall Study|Protocol Violation|0|||
170368030|NCT01235728|615682320|FG002|Overall Study|Protocol Violation|0|||
170368031|NCT01235728|615682321|FG003|Overall Study|Protocol Violation|1|||
170368032|NCT01235728|615682322|FG004|Overall Study|Protocol Violation|0|||
170368033|NCT01235728|615682323|FG005|Overall Study|Protocol Violation|0|||
170368034|NCT01235728|615682324|FG006|Overall Study|Protocol Violation|0|||
170368035|NCT01235728|615682325|FG007|Overall Study|Protocol Violation|0|||
170368036|NCT01000025|615682326|FG000|Overall Study|Adverse Event|43|||
170368037|NCT01000025|615682327|FG001|Overall Study|Adverse Event|2|||
170368038|NCT01000025|615682326|FG000|Overall Study|Withdrawal by Subject|13|||
170368039|NCT01000025|615682327|FG001|Overall Study|Withdrawal by Subject|8|||
170368040|NCT01000025|615682326|FG000|Overall Study|Death|23|||
170368041|NCT01000025|615682327|FG001|Overall Study|Death|13|||
170368042|NCT01000025|615682326|FG000|Overall Study|Lack of Efficacy|363|||
170368043|NCT01000025|615682327|FG001|Overall Study|Lack of Efficacy|208|||
170368044|NCT01000025|615682326|FG000|Overall Study|Intercurrent Illness|26|||
170368045|NCT01000025|615682327|FG001|Overall Study|Intercurrent Illness|7|||
170368046|NCT04423757|615682328|FG000|Overall Study|Adverse Event|2|||
170368047|NCT04423757|615682329|FG001|Overall Study|Adverse Event|0|||
170368048|NCT04423757|615682328|FG000|Overall Study|Not treated|1|||
170368049|NCT04423757|615682329|FG001|Overall Study|Not treated|1|||
170368050|NCT02460978|615682334|FG000|Overall Study|Adverse Event|17|||
170368051|NCT02460978|615682335|FG001|Overall Study|Adverse Event|11|||
170368052|NCT02460978|615682336|FG002|Overall Study|Adverse Event|11|||
170368053|NCT02460978|615682334|FG000|Overall Study|Withdrawal by Subject|5|||
170368054|NCT02460978|615682335|FG001|Overall Study|Withdrawal by Subject|5|||
170368055|NCT02460978|615682336|FG002|Overall Study|Withdrawal by Subject|14|||
170368056|NCT02460978|615682334|FG000|Overall Study|Lost to Follow-up|2|||
170368057|NCT02460978|615682335|FG001|Overall Study|Lost to Follow-up|3|||
170368058|NCT02460978|615682336|FG002|Overall Study|Lost to Follow-up|1|||
170368059|NCT02460978|615682334|FG000|Overall Study|Protocol Violation|1|||
170368060|NCT02460978|615682335|FG001|Overall Study|Protocol Violation|1|||
170368061|NCT02460978|615682336|FG002|Overall Study|Protocol Violation|1|||
170368062|NCT02460978|615682334|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
170368063|NCT02460978|615682335|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
170368064|NCT02460978|615682336|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
170368065|NCT02460978|615682334|FG000|Overall Study|Pregnancy|0|||
170368066|NCT02460978|615682335|FG001|Overall Study|Pregnancy|0|||
170368067|NCT02460978|615682336|FG002|Overall Study|Pregnancy|2|||
170368068|NCT01142193|615682337|FG000|Overall Study|Adverse Event|12|||
170368069|NCT01142193|615682338|FG001|Overall Study|Adverse Event|4|||
170368070|NCT01142193|615682337|FG000|Overall Study|Lack of Efficacy|2|||
170368071|NCT01142193|615682338|FG001|Overall Study|Lack of Efficacy|1|||
170368072|NCT01142193|615682337|FG000|Overall Study|Physician Decision|1|||
170368073|NCT01142193|615682338|FG001|Overall Study|Physician Decision|1|||
170368074|NCT01142193|615682337|FG000|Overall Study|Withdrawal by Subject|4|||
170368075|NCT01142193|615682338|FG001|Overall Study|Withdrawal by Subject|3|||
170368076|NCT01142193|615682337|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
170368077|NCT01142193|615682338|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
170368078|NCT01142193|615682337|FG000|Overall Study|Other|1|||
170368079|NCT01142193|615682338|FG001|Overall Study|Other|2|||
170368080|NCT01225172|615682339|FG000|Overall Study|Subject decision to stop|1|||
170368081|NCT01225172|615682340|FG001|Overall Study|Subject decision to stop|0|||
170368082|NCT01225172|615682339|FG000|Overall Study|Subject request to discontinue treatment|3|||
170368083|NCT01225172|615682340|FG001|Overall Study|Subject request to discontinue treatment|1|||
170368084|NCT01225172|615682339|FG000|Overall Study|Subject no longer meets study criteria|1|||
170368085|NCT01225172|615682340|FG001|Overall Study|Subject no longer meets study criteria|0|||
170368086|NCT01225172|615682339|FG000|Overall Study|Withdrawal by Subject|1|||
170368087|NCT01225172|615682340|FG001|Overall Study|Withdrawal by Subject|0|||
170368088|NCT01449955|615682341|FG000|Overall Study|Withdrawal by Subject|1|||
170368089|NCT01449955|615682342|FG001|Overall Study|Withdrawal by Subject|2|||
170368090|NCT00431496|615682348|FG000|Overall Study|Adverse Event|3|||
170368091|NCT00431496|615682348|FG000|Overall Study|Lost to Follow-up|1|||
170368092|NCT00431496|615682348|FG000|Overall Study|Withdrawal by Subject|2|||
170368093|NCT00431496|615682348|FG000|Overall Study|Protocol-specified criteria|5|||
170368094|NCT05041062|615682349|FG000|Overall Study|Adverse Event|2|||
170368095|NCT04968353|615682355|FG000|Overall Study|Non-compliance|1|||
170368096|NCT04968353|615682356|FG001|Overall Study|Non-compliance|0|||
170368097|NCT04968353|615682357|FG002|Overall Study|Non-compliance|2|||
170368098|NCT04968353|615682358|FG003|Overall Study|Non-compliance|0|||
170368099|NCT00318370|615682359|FG000|Period 1|Lack of Efficacy|5|||
170368100|NCT00318370|615682360|FG001|Period 1|Lack of Efficacy|0|||
170368101|NCT00318370|615682361|FG002|Period 1|Lack of Efficacy|0|||
170368102|NCT00318370|615682359|FG000|Period 1|Physician Decision|1|||
170368103|NCT00318370|615682360|FG001|Period 1|Physician Decision|0|||
170368104|NCT00318370|615682361|FG002|Period 1|Physician Decision|0|||
170368105|NCT00318370|615682359|FG000|Period 1|Withdrawal by Subject|1|||
170368106|NCT00318370|615682360|FG001|Period 1|Withdrawal by Subject|0|||
170368107|NCT00318370|615682361|FG002|Period 1|Withdrawal by Subject|0|||
170368108|NCT00318370|615682359|FG000|Period 2|Adverse Event|0|||
170368109|NCT00318370|615682360|FG001|Period 2|Adverse Event|3|||
170368110|NCT00318370|615682361|FG002|Period 2|Adverse Event|0|||
170368111|NCT00318370|615682359|FG000|Period 2|Lack of Efficacy|0|||
170368112|NCT00318370|615682360|FG001|Period 2|Lack of Efficacy|5|||
170368113|NCT00318370|615682361|FG002|Period 2|Lack of Efficacy|0|||
170368114|NCT00318370|615682359|FG000|Period 2|Physician Decision|0|||
170368115|NCT00318370|615682360|FG001|Period 2|Physician Decision|1|||
170368116|NCT00318370|615682361|FG002|Period 2|Physician Decision|0|||
170368117|NCT00318370|615682359|FG000|Period 2|Withdrawal by Subject|0|||
170368118|NCT00318370|615682360|FG001|Period 2|Withdrawal by Subject|1|||
170368119|NCT00318370|615682361|FG002|Period 2|Withdrawal by Subject|0|||
170368120|NCT00318370|615682359|FG000|Period 2|Other|0|||
170368121|NCT00318370|615682360|FG001|Period 2|Other|1|||
170368122|NCT00318370|615682361|FG002|Period 2|Other|0|||
170368123|NCT00318370|615682359|FG000|Period 3|Adverse Event|0|||
170368124|NCT00318370|615682360|FG001|Period 3|Adverse Event|0|||
170368125|NCT00318370|615682361|FG002|Period 3|Adverse Event|1|||
170368126|NCT00318370|615682359|FG000|Period 3|Lack of Efficacy|0|||
170368127|NCT00318370|615682360|FG001|Period 3|Lack of Efficacy|0|||
170368128|NCT00318370|615682361|FG002|Period 3|Lack of Efficacy|24|||
170368129|NCT00318370|615682359|FG000|Period 3|Death|0|||
170368130|NCT00318370|615682360|FG001|Period 3|Death|0|||
170368131|NCT00318370|615682361|FG002|Period 3|Death|1|||
170368132|NCT00318370|615682359|FG000|Period 3|Physician Decision|0|||
170368133|NCT00318370|615682360|FG001|Period 3|Physician Decision|0|||
170368134|NCT00318370|615682361|FG002|Period 3|Physician Decision|1|||
170368135|NCT00318370|615682359|FG000|Period 3|Withdrawal by Subject|0|||
170368136|NCT00318370|615682360|FG001|Period 3|Withdrawal by Subject|0|||
170368137|NCT00318370|615682361|FG002|Period 3|Withdrawal by Subject|3|||
170368138|NCT00318370|615682359|FG000|Period 3|Other|0|||
170368139|NCT00318370|615682360|FG001|Period 3|Other|0|||
170368140|NCT00318370|615682361|FG002|Period 3|Other|3|||
170368141|NCT00807014|615682362|FG000|Overall Study|Participant Considered Disease Cured|13|||
170368142|NCT00807014|615682363|FG001|Overall Study|Participant Considered Disease Cured|2|||
170368143|NCT00807014|615682362|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
170368144|NCT00807014|615682363|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
170368145|NCT00807014|615682362|FG000|Overall Study|Protocol Violation|2|||
170368146|NCT00807014|615682363|FG001|Overall Study|Protocol Violation|8|||
170368147|NCT00807014|615682362|FG000|Overall Study|Adverse Event|0|||
170368148|NCT00807014|615682363|FG001|Overall Study|Adverse Event|2|||
170368149|NCT00807014|615682362|FG000|Overall Study|Lost to Follow-up|9|||
170368150|NCT00807014|615682363|FG001|Overall Study|Lost to Follow-up|7|||
170368151|NCT00807014|615682362|FG000|Overall Study|Recovery|1|||
170368152|NCT00807014|615682363|FG001|Overall Study|Recovery|0|||
170368153|NCT00807014|615682362|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
170368154|NCT00807014|615682363|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
170368155|NCT02853032|615682369|FG000|Overall Study|Adverse Event|4|||
170368156|NCT02853032|615682370|FG001|Overall Study|Adverse Event|0|||
170368157|NCT02853032|615682369|FG000|Overall Study|Withdrawal by Subject|3|||
170368158|NCT02853032|615682370|FG001|Overall Study|Withdrawal by Subject|1|||
170368159|NCT02853032|615682369|FG000|Overall Study|Requested to withdraw from all treatment|2|||
170368160|NCT02853032|615682370|FG001|Overall Study|Requested to withdraw from all treatment|2|||
170368161|NCT03175562|615682371|FG000|Overall Study|Adverse Event|1|||
170368162|NCT03175562|615682371|FG000|Overall Study|Lost to Follow-up|3|||
170368163|NCT03175562|615682371|FG000|Overall Study|Withdrawal by Subject|7|||
170368164|NCT03175562|615682371|FG000|Overall Study|Other (Not Specified)|5|||
170368165|NCT03170349|615682372|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
170368166|NCT03170349|615682372|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
170368167|NCT03170349|615682372|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
170368168|NCT03170349|615682372|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
170368169|NCT03170349|615682372|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
170368170|NCT03170349|615682372|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
170368171|NCT03170349|615682372|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
170368172|NCT03170349|615682372|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
170368173|NCT03170349|615682372|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
170399319|NCT03193190|615799944|FG007|Stage 1|Progressive Disease|0|||
170368174|NCT03170349|615682372|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
170368175|NCT03170349|615682372|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
170368176|NCT03170349|615682372|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
170368177|NCT03170349|615682372|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
170368178|NCT03170349|615682372|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
170368179|NCT03170349|615682372|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
170368180|NCT03170349|615682372|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
170368181|NCT01230749|615682376|FG000|Overall Study|Adverse Event|0|||
170368182|NCT01230749|615682377|FG001|Overall Study|Adverse Event|0|||
170368183|NCT01230749|615682378|FG002|Overall Study|Adverse Event|0|||
170368184|NCT01230749|615682379|FG003|Overall Study|Adverse Event|1|||
170368185|NCT01230749|615682376|FG000|Overall Study|Physician Decision|0|||
170368186|NCT01230749|615682377|FG001|Overall Study|Physician Decision|0|||
170368187|NCT01230749|615682378|FG002|Overall Study|Physician Decision|1|||
170368188|NCT01230749|615682379|FG003|Overall Study|Physician Decision|0|||
170368189|NCT01230749|615682376|FG000|Overall Study|Withdrawal by Subject|0|||
170368190|NCT01230749|615682377|FG001|Overall Study|Withdrawal by Subject|1|||
170368191|NCT01230749|615682378|FG002|Overall Study|Withdrawal by Subject|0|||
170368192|NCT01230749|615682379|FG003|Overall Study|Withdrawal by Subject|0|||
170368193|NCT01230749|615682376|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
170368194|NCT01230749|615682377|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
170368195|NCT01230749|615682378|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
170368196|NCT01230749|615682379|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
170368197|NCT07245277|615682380|FG000|Overall Study|Death|8|||
170368198|NCT07245277|615682381|FG001|Overall Study|Death|0|||
170368199|NCT07245277|615682382|FG002|Overall Study|Death|1|||
170368200|NCT07245277|615682380|FG000|Overall Study|Achieved enteral nutrition tolerance during monitoring|4|||
170368201|NCT07245277|615682381|FG001|Overall Study|Achieved enteral nutrition tolerance during monitoring|0|||
170368202|NCT07245277|615682382|FG002|Overall Study|Achieved enteral nutrition tolerance during monitoring|0|||
170368203|NCT07245277|615682380|FG000|Overall Study|Transitioned to nil per os status during monitoring|0|||
170368204|NCT07245277|615682381|FG001|Overall Study|Transitioned to nil per os status during monitoring|1|||
170368205|NCT07245277|615682382|FG002|Overall Study|Transitioned to nil per os status during monitoring|3|||
170368206|NCT02959970|615683888|FG000|Overall Study|Adverse Event|1|||
170368207|NCT02959970|615683889|FG001|Overall Study|Adverse Event|0|||
170368208|NCT02959970|615683888|FG000|Overall Study|Withdrawal by Subject|0|||
170368209|NCT02959970|615683889|FG001|Overall Study|Withdrawal by Subject|2|||
170368210|NCT02959970|615683888|FG000|Overall Study|Lost to Follow-up|1|||
170368211|NCT02959970|615683889|FG001|Overall Study|Lost to Follow-up|5|||
170368212|NCT00606177|615683893|FG000|Overall Study|Adverse Event|9|||
170368213|NCT00606177|615683894|FG001|Overall Study|Adverse Event|5|||
170368214|NCT00606177|615683893|FG000|Overall Study|Lack of Efficacy|3|||
170368215|NCT00606177|615683894|FG001|Overall Study|Lack of Efficacy|7|||
170368216|NCT00606177|615683893|FG000|Overall Study|Physician Decision|1|||
170368217|NCT00606177|615683894|FG001|Overall Study|Physician Decision|0|||
170368218|NCT00606177|615683893|FG000|Overall Study|Protocol Violation|1|||
170368219|NCT00606177|615683894|FG001|Overall Study|Protocol Violation|4|||
170368220|NCT00606177|615683893|FG000|Overall Study|Withdrawal by Subject|5|||
170368221|NCT00606177|615683894|FG001|Overall Study|Withdrawal by Subject|6|||
170368222|NCT00606177|615683893|FG000|Overall Study|Progression to depressive phase|6|||
170368223|NCT00606177|615683894|FG001|Overall Study|Progression to depressive phase|1|||
170368224|NCT00606177|615683893|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
170368225|NCT00606177|615683894|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
170368226|NCT00606177|615683893|FG000|Overall Study|Change of residence or other commitments|1|||
170368227|NCT00606177|615683894|FG001|Overall Study|Change of residence or other commitments|1|||
170368228|NCT01224106|615683897|FG000|Double-Blind Treatment Phase|Death|3|||
170368229|NCT01224106|615683898|FG001|Double-Blind Treatment Phase|Death|0|||
170368230|NCT01224106|615683899|FG002|Double-Blind Treatment Phase|Death|0|||
170368231|NCT01224106|615683900|FG003|Double-Blind Treatment Phase|Death|0|||
170368232|NCT01224106|615683901|FG004|Double-Blind Treatment Phase|Death|0|||
170368233|NCT01224106|615683897|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
170368234|NCT01224106|615683898|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
170368235|NCT01224106|615683899|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
170368236|NCT01224106|615683900|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
170368237|NCT01224106|615683901|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
170368238|NCT01224106|615683897|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
170368239|NCT01224106|615683898|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
170368240|NCT01224106|615683899|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
170368241|NCT01224106|615683900|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
170368242|NCT01224106|615683901|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
170368243|NCT01224106|615683897|FG000|Double-Blind Treatment Phase|Other|0|||
170368244|NCT01224106|615683898|FG001|Double-Blind Treatment Phase|Other|0|||
170368245|NCT01224106|615683899|FG002|Double-Blind Treatment Phase|Other|1|||
170368246|NCT01224106|615683900|FG003|Double-Blind Treatment Phase|Other|0|||
170368247|NCT01224106|615683901|FG004|Double-Blind Treatment Phase|Other|0|||
170368248|NCT01224106|615683897|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
170368249|NCT01224106|615683898|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
170368250|NCT01224106|615683899|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
170368251|NCT01224106|615683900|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
170368252|NCT01224106|615683901|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
170368253|NCT01224106|615683897|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
170368254|NCT01224106|615683898|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
170368255|NCT01224106|615683899|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
170368256|NCT01224106|615683900|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
170368257|NCT01224106|615683901|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
170368258|NCT01224106|615683897|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
170368259|NCT01224106|615683898|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170368260|NCT01224106|615683899|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
170368261|NCT01224106|615683900|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170368262|NCT01224106|615683901|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170368263|NCT01224106|615683897|FG000|Open-Label Extension (OLE) Phase|Death|0|||
170368264|NCT01224106|615683898|FG001|Open-Label Extension (OLE) Phase|Death|0|||
170368265|NCT01224106|615683899|FG002|Open-Label Extension (OLE) Phase|Death|0|||
170368266|NCT01224106|615683900|FG003|Open-Label Extension (OLE) Phase|Death|1|||
170368267|NCT01224106|615683901|FG004|Open-Label Extension (OLE) Phase|Death|3|||
170368268|NCT01224106|615683897|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
170368269|NCT01224106|615683898|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
170368270|NCT01224106|615683899|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
170368271|NCT01224106|615683900|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
170368272|NCT01224106|615683901|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
170368273|NCT01224106|615683897|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
170368274|NCT01224106|615683898|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
170368275|NCT01224106|615683899|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
170368276|NCT01224106|615683900|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
170368277|NCT01224106|615683901|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
170368278|NCT01224106|615683897|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
170368279|NCT01224106|615683898|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
170368280|NCT01224106|615683899|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
170368281|NCT01224106|615683900|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
170368282|NCT01224106|615683901|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
170368283|NCT01224106|615683897|FG000|Open-Label Extension (OLE) Phase|Other|0|||
170368284|NCT01224106|615683898|FG001|Open-Label Extension (OLE) Phase|Other|0|||
170368285|NCT01224106|615683899|FG002|Open-Label Extension (OLE) Phase|Other|0|||
170368286|NCT01224106|615683900|FG003|Open-Label Extension (OLE) Phase|Other|5|||
170368287|NCT01224106|615683901|FG004|Open-Label Extension (OLE) Phase|Other|3|||
170368288|NCT00939341|615683908|FG000|Overall Study|Adverse Event|15|||
170368289|NCT00939341|615683908|FG000|Overall Study|Pregnancy|1|||
170368290|NCT00939341|615683908|FG000|Overall Study|Lost to Follow-up|23|||
170368291|NCT00939341|615683908|FG000|Overall Study|Withdrawal by Subject|13|||
170368292|NCT00939341|615683908|FG000|Overall Study|Protocol Violation|6|||
170368293|NCT00939341|615683908|FG000|Overall Study|Incorrect enrolment|8|||
170368294|NCT03006926|615683909|FG000|Overall Study|Adverse Event|0|||
170368295|NCT03006926|615683910|FG001|Overall Study|Adverse Event|27|||
170368296|NCT03006926|615683909|FG000|Overall Study|Withdrawal by Subject|0|||
170368297|NCT03006926|615683910|FG001|Overall Study|Withdrawal by Subject|1|||
170368298|NCT03006926|615683909|FG000|Overall Study|Radiological Disease Progression|0|||
170368299|NCT03006926|615683910|FG001|Overall Study|Radiological Disease Progression|52|||
170368300|NCT03006926|615683909|FG000|Overall Study|Clinical Disease Progression|0|||
170368301|NCT03006926|615683910|FG001|Overall Study|Clinical Disease Progression|10|||
170368302|NCT03006926|615683909|FG000|Overall Study|Other|0|||
170368303|NCT03006926|615683910|FG001|Overall Study|Other|8|||
170368304|NCT01408732|615683911|FG000|Overall Study|Withdrawal by Subject|2|||
170368305|NCT01408732|615683912|FG001|Overall Study|Withdrawal by Subject|2|||
170368306|NCT01838213|615683913|FG000|Overall Study|Ineligible|166|||
170368307|NCT01838213|615683914|FG001|Overall Study|Ineligible|191|||
170368308|NCT04882072|615683915|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
170368309|NCT04882072|615683916|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
170368310|NCT04882072|615683915|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
170368311|NCT04882072|615683916|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
170368312|NCT04882072|615683915|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
170368313|NCT04882072|615683916|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
170368314|NCT04080752|615683917|FG000|Overall Study|Adverse Event|2|||
170368315|NCT04080752|615683918|FG001|Overall Study|Adverse Event|3|||
170368316|NCT04080752|615683917|FG000|Overall Study|Lack of Efficacy|1|||
170368317|NCT04080752|615683918|FG001|Overall Study|Lack of Efficacy|0|||
170368318|NCT04080752|615683917|FG000|Overall Study|Lost to Follow-up|1|||
170368319|NCT04080752|615683918|FG001|Overall Study|Lost to Follow-up|0|||
170368320|NCT04080752|615683917|FG000|Overall Study|Pregnancy|0|||
170368321|NCT04080752|615683918|FG001|Overall Study|Pregnancy|1|||
170368322|NCT04080752|615683917|FG000|Overall Study|Withdrawal by Subject|7|||
170368323|NCT04080752|615683918|FG001|Overall Study|Withdrawal by Subject|0|||
170368324|NCT04080752|615683917|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170368325|NCT04080752|615683918|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170368326|NCT04080752|615683917|FG000|Overall Study|Other|2|||
170368327|NCT04080752|615683918|FG001|Overall Study|Other|1|||
170368328|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
170368329|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
170368330|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
170368331|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
170368332|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
170368333|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
170368334|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
170368335|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
170368336|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
170368337|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
170368338|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
170368339|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
170368340|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
170368341|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
170368342|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
170368343|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
170368344|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
170368345|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
170368346|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
170368347|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
170368348|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
170368349|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
170368350|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
170368351|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
170368352|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Other|0|||
170368353|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Other|1|||
170368354|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Other|0|||
170368355|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Other|0|||
170368356|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
170368357|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
170368358|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
170368359|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
170368360|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
170368361|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
170368362|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
170368363|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
170368364|NCT01194414|615683919|FG000|24 Weeks Double Blind Period|Death|0|||
170368365|NCT01194414|615683920|FG001|24 Weeks Double Blind Period|Death|1|||
170368366|NCT01194414|615683921|FG002|24 Weeks Double Blind Period|Death|0|||
170368367|NCT01194414|615683922|FG003|24 Weeks Double Blind Period|Death|0|||
170368368|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
170368369|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
170368370|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
170368371|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
170368372|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
170368373|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
170368374|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
170368375|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
170368376|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
170368377|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
170368378|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
170368379|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
170368380|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
170368381|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
170368382|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
170368383|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
170368384|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
170398693|NCT03981614|615798255|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
170368385|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
170368386|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
170368387|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
170368388|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
170368389|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
170368390|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
170368391|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
170368392|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Other|2|||
170368393|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Other|1|||
170368394|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Other|0|||
170368395|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Other|0|||
170368396|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
170368397|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
170368398|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
170368399|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
170368400|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
170368401|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
170368402|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
170368403|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
170368404|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
170368405|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
170368406|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
170368407|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
170368408|NCT01194414|615683919|FG000|72 Weeks Open Label Extension|Death|1|||
170368409|NCT01194414|615683920|FG001|72 Weeks Open Label Extension|Death|2|||
170368410|NCT01194414|615683921|FG002|72 Weeks Open Label Extension|Death|0|||
170368411|NCT01194414|615683922|FG003|72 Weeks Open Label Extension|Death|2|||
170368412|NCT01235507|615683923|FG000|Overall Study|Adverse Event|1|||
170368413|NCT01235507|615683923|FG000|Overall Study|Withdrawal by Subject|1|||
170368414|NCT01749800|615683933|FG000|Overall Study|not meeting inclusion criteria|3|||
170368415|NCT01749800|615683934|FG001|Overall Study|not meeting inclusion criteria|0|||
170368416|NCT01749800|615683935|FG002|Overall Study|not meeting inclusion criteria|0|||
170368417|NCT01749800|615683933|FG000|Overall Study|Withdrawal by Subject|0|||
170368418|NCT01749800|615683934|FG001|Overall Study|Withdrawal by Subject|1|||
170368419|NCT01749800|615683935|FG002|Overall Study|Withdrawal by Subject|0|||
170368420|NCT00224003|615683937|FG000|Overall Study|Adverse Event|1|||
170368421|NCT00224003|615683937|FG000|Overall Study|Protocol Violation|2|||
170368422|NCT00224003|615683937|FG000|Overall Study|Withdrawal by Subject|1|||
170368423|NCT00224003|615683937|FG000|Overall Study|unk|3|||
170368424|NCT00841672|615683940|FG000|Overall Study|Adverse Event|7|||
170368425|NCT00841672|615683941|FG001|Overall Study|Adverse Event|16|||
170368426|NCT00841672|615683940|FG000|Overall Study|Abnormal test procedure result(s)|0|||
170368427|NCT00841672|615683941|FG001|Overall Study|Abnormal test procedure result(s)|1|||
170368428|NCT00841672|615683940|FG000|Overall Study|Subject withdrew consent|2|||
170368429|NCT00841672|615683941|FG001|Overall Study|Subject withdrew consent|4|||
170368430|NCT00841672|615683940|FG000|Overall Study|Lost to Follow-up|1|||
170368431|NCT00841672|615683941|FG001|Overall Study|Lost to Follow-up|1|||
170368432|NCT00841672|615683940|FG000|Overall Study|Administrative problems|9|||
170368433|NCT00841672|615683941|FG001|Overall Study|Administrative problems|9|||
170368434|NCT00841672|615683940|FG000|Overall Study|Misrandomized|1|||
170368435|NCT00841672|615683941|FG001|Overall Study|Misrandomized|0|||
170368436|NCT00841672|615683940|FG000|Overall Study|Protocol Deviation|0|||
170368437|NCT00841672|615683941|FG001|Overall Study|Protocol Deviation|1|||
170368438|NCT00729326|615683951|FG000|Overall Study|Lost to Follow-up|2|||
170368439|NCT00729326|615683952|FG001|Overall Study|Lost to Follow-up|0|||
170368440|NCT00729326|615683951|FG000|Overall Study|Physician Decision|0|||
170368441|NCT00729326|615683952|FG001|Overall Study|Physician Decision|1|||
170368442|NCT00729326|615683951|FG000|Overall Study|Protocol Violation|3|||
170368443|NCT00729326|615683952|FG001|Overall Study|Protocol Violation|2|||
170368444|NCT00729326|615683951|FG000|Overall Study|Subject Decision|4|||
170368445|NCT00729326|615683952|FG001|Overall Study|Subject Decision|4|||
170368446|NCT00729326|615683951|FG000|Overall Study|Sponsor Decision|1|||
170368447|NCT00729326|615683952|FG001|Overall Study|Sponsor Decision|2|||
170368448|NCT02738580|615683953|FG000|Overall Study|Adverse Event|1|||
170368449|NCT02738580|615683954|FG001|Overall Study|Adverse Event|0|||
170368450|NCT02738580|615683953|FG000|Overall Study|Lack of Efficacy|3|||
170368451|NCT02738580|615683954|FG001|Overall Study|Lack of Efficacy|2|||
170368452|NCT02738580|615683953|FG000|Overall Study|Withdrawal by Subject|0|||
170368453|NCT02738580|615683954|FG001|Overall Study|Withdrawal by Subject|1|||
170368454|NCT02738580|615683953|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
170368455|NCT02738580|615683954|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
170368456|NCT04354155|615683955|FG000|Overall Study|Withdrawal by Subject|1|||
170368457|NCT04354155|615683955|FG000|Overall Study|Did not meet criteria for study intervention|1|||
170368458|NCT01575899|615683958|FG000|Overall Study|Lost to Follow-up|3|||
170368459|NCT01575899|615683959|FG001|Overall Study|Lost to Follow-up|4|||
170368460|NCT01575899|615683960|FG002|Overall Study|Lost to Follow-up|2|||
170368461|NCT01575899|615683958|FG000|Overall Study|Protocol Violation|2|||
170368462|NCT01575899|615683959|FG001|Overall Study|Protocol Violation|1|||
170368463|NCT01575899|615683960|FG002|Overall Study|Protocol Violation|0|||
170368464|NCT01015820|615683961|FG000|Overall Study|Suboptimal measurements|1|||
170368465|NCT01015820|615683962|FG001|Overall Study|Suboptimal measurements|0|||
170368466|NCT03097029|615683963|FG000|Overall Study|Withdrawal by Subject|1|||
170368467|NCT00709124|615683964|FG000|Overall Study|Death|3|||
170368468|NCT00709124|615683965|FG001|Overall Study|Death|1|||
170368469|NCT00709124|615683964|FG000|Overall Study|encephalopathy; can't do assessment|1|||
170368470|NCT00709124|615683965|FG001|Overall Study|encephalopathy; can't do assessment|0|||
170368471|NCT01250756|615683966|FG000|Infant Series|Withdrawal by Subject|4|||
170368472|NCT01250756|615683967|FG001|Infant Series|Withdrawal by Subject|5|||
170368473|NCT01250756|615683966|FG000|Infant Series|Randomized, Not Vaccinated|2|||
170368474|NCT01250756|615683967|FG001|Infant Series|Randomized, Not Vaccinated|2|||
170368475|NCT01250756|615683966|FG000|Infant Series|Other|22|||
170368476|NCT01250756|615683967|FG001|Infant Series|Other|0|||
170368477|NCT01250756|615683966|FG000|After Infant Series|Adverse Event|5|||
170368478|NCT01250756|615683967|FG001|After Infant Series|Adverse Event|2|||
170368479|NCT01250756|615683966|FG000|After Infant Series|Withdrawal by Subject|4|||
170368480|NCT01250756|615683967|FG001|After Infant Series|Withdrawal by Subject|1|||
170368481|NCT01250756|615683966|FG000|After Infant Series|Other|2|||
170368482|NCT01250756|615683967|FG001|After Infant Series|Other|1|||
170368483|NCT01250756|615683966|FG000|Toddler Dose|Adverse Event|0|||
170368484|NCT01250756|615683967|FG001|Toddler Dose|Adverse Event|1|||
170368485|NCT01250756|615683966|FG000|After Toddler Dose|Adverse Event|0|||
170368486|NCT01250756|615683967|FG001|After Toddler Dose|Adverse Event|1|||
170368487|NCT02999100|615683970|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
170368488|NCT02999100|615683971|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
170368489|NCT02999100|615683972|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
170368490|NCT02999100|615683973|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
170368491|NCT02999100|615683974|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
170368492|NCT02999100|615683975|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
170368493|NCT02999100|615683970|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
170368494|NCT02999100|615683971|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
170368495|NCT02999100|615683972|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
170368496|NCT02999100|615683973|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
170368497|NCT02999100|615683974|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
170368498|NCT02999100|615683975|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
170368499|NCT02999100|615683970|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
170368500|NCT02999100|615683971|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
170368501|NCT02999100|615683972|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
170368502|NCT02999100|615683973|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
170368503|NCT02999100|615683974|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
170368504|NCT02999100|615683975|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
170368505|NCT05563714|615683977|FG000|Overall Study|Death|2|||
170368506|NCT05563714|615683978|FG001|Overall Study|Death|2|||
170368507|NCT05563714|615683979|FG002|Overall Study|Death|0|||
170368508|NCT05563714|615683980|FG003|Overall Study|Death|0|||
170368509|NCT05563714|615683977|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
170368510|NCT05563714|615683978|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
170368511|NCT05563714|615683979|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
170368512|NCT05563714|615683980|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
170368513|NCT05563714|615683977|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
170368514|NCT05563714|615683978|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
170368515|NCT05563714|615683979|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
170368516|NCT05563714|615683980|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
170368517|NCT05563714|615683977|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
170368518|NCT05563714|615683978|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
170368519|NCT05563714|615683979|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
170368520|NCT05563714|615683980|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
170368521|NCT05563714|615683977|FG000|Overall Study|Lost to Follow-up|22|||
170368522|NCT05563714|615683978|FG001|Overall Study|Lost to Follow-up|19|||
170368523|NCT05563714|615683979|FG002|Overall Study|Lost to Follow-up|0|||
170368524|NCT05563714|615683980|FG003|Overall Study|Lost to Follow-up|0|||
170368525|NCT01998399|615683987|FG000|Overall Study|Lost to Follow-up|1|||
170368526|NCT01998399|615683988|FG001|Overall Study|Lost to Follow-up|3|||
170368527|NCT01998399|615683987|FG000|Overall Study|Death|4|||
170368528|NCT01998399|615683988|FG001|Overall Study|Death|2|||
170368529|NCT01998399|615683987|FG000|Overall Study|Study stopped before dosing completed|3|||
170368530|NCT01998399|615683988|FG001|Overall Study|Study stopped before dosing completed|3|||
170368531|NCT01998399|615683987|FG000|Overall Study|Withdrawal by Subject|0|||
170368532|NCT01998399|615683988|FG001|Overall Study|Withdrawal by Subject|1|||
170368533|NCT00617591|615683989|FG000|Overall Study|Withdrew consent during Induction|4|||
170368534|NCT00617591|615683989|FG000|Overall Study|Withdrew consent during Maintenance|6|||
170368535|NCT00376246|615683990|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
170368536|NCT00376246|615683991|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
170368537|NCT00376246|615683990|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
170368538|NCT00376246|615683991|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
170368539|NCT00376246|615683990|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
170368540|NCT00376246|615683991|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
170368541|NCT01455415|615683992|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
170368542|NCT01455415|615683993|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
170368543|NCT01455415|615683992|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
170368544|NCT01455415|615683993|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
170368545|NCT01455415|615683992|FG000|Period 1|Drug Error not Associated to AE|0|||
170368546|NCT01455415|615683993|FG001|Period 1|Drug Error not Associated to AE|1|||
170368547|NCT01455415|615683992|FG000|Period 1|AE Not Related to Study Drug|2|||
170368548|NCT01455415|615683993|FG001|Period 1|AE Not Related to Study Drug|6|||
170368549|NCT01455415|615683992|FG000|Period 1|Withdrawal by Subject|4|||
170368550|NCT01455415|615683993|FG001|Period 1|Withdrawal by Subject|5|||
170368551|NCT01455415|615683992|FG000|Period 1|Unspecified Reason|1|||
170368552|NCT01455415|615683993|FG001|Period 1|Unspecified Reason|1|||
170368553|NCT01455415|615683992|FG000|Period 1|Protocol Violation|0|||
170368554|NCT01455415|615683993|FG001|Period 1|Protocol Violation|2|||
170368555|NCT01455415|615683992|FG000|Washout|AE Related to Study Drug|2|||
170368556|NCT01455415|615683993|FG001|Washout|AE Related to Study Drug|0|||
170368557|NCT01455415|615683992|FG000|Washout|Lost to Follow-up|1|||
170368558|NCT01455415|615683993|FG001|Washout|Lost to Follow-up|0|||
170368559|NCT01455415|615683992|FG000|Washout|Drug Error not Associated to AE|2|||
170368560|NCT01455415|615683993|FG001|Washout|Drug Error not Associated to AE|1|||
170368561|NCT01455415|615683992|FG000|Washout|AE Not Related to Study Drug|2|||
170368562|NCT01455415|615683993|FG001|Washout|AE Not Related to Study Drug|3|||
170368563|NCT01455415|615683992|FG000|Washout|Unspecified Reason|1|||
170368564|NCT01455415|615683993|FG001|Washout|Unspecified Reason|2|||
170368565|NCT01455415|615683992|FG000|Washout|Protocol Violation|0|||
170368566|NCT01455415|615683993|FG001|Washout|Protocol Violation|1|||
170368567|NCT01455415|615683992|FG000|Period 2|AE Related to Study Drug|1|||
170368568|NCT01455415|615683993|FG001|Period 2|AE Related to Study Drug|2|||
170368569|NCT01455415|615683992|FG000|Period 2|Lost to Follow-up|2|||
170368570|NCT01455415|615683993|FG001|Period 2|Lost to Follow-up|1|||
170368571|NCT01455415|615683992|FG000|Period 2|AE Not Related to Study Drug|2|||
170368572|NCT01455415|615683993|FG001|Period 2|AE Not Related to Study Drug|1|||
170368573|NCT01455415|615683992|FG000|Period 2|Lack of Efficacy|2|||
170368574|NCT01455415|615683993|FG001|Period 2|Lack of Efficacy|0|||
170368575|NCT01455415|615683992|FG000|Period 2|Withdrawal by Subject|2|||
170368576|NCT01455415|615683993|FG001|Period 2|Withdrawal by Subject|3|||
170368577|NCT01455415|615683992|FG000|Period 2|Unspecified Reason|2|||
170368578|NCT01455415|615683993|FG001|Period 2|Unspecified Reason|3|||
170368579|NCT01455415|615683992|FG000|Period 2|Protocol Violation|2|||
170368580|NCT01455415|615683993|FG001|Period 2|Protocol Violation|0|||
170368581|NCT01455415|615683992|FG000|Follow-up|AE Related to Study Drug|0|||
170368582|NCT01455415|615683993|FG001|Follow-up|AE Related to Study Drug|1|||
170368583|NCT01455415|615683992|FG000|Follow-up|Lack of Efficacy|0|||
170368584|NCT01455415|615683993|FG001|Follow-up|Lack of Efficacy|1|||
170368585|NCT01455415|615683992|FG000|Follow-up|Withdrawal by Subject|2|||
170368586|NCT01455415|615683993|FG001|Follow-up|Withdrawal by Subject|0|||
170368587|NCT01455415|615683992|FG000|Follow-up|Unspecified Reason|1|||
170368588|NCT01455415|615683993|FG001|Follow-up|Unspecified Reason|0|||
170368589|NCT00587301|615683996|FG000|Overall Study|Screen Failure|9|||
170368590|NCT00587301|615683996|FG000|Overall Study|Lost to Follow-up|22|||
170368591|NCT00587301|615683996|FG000|Overall Study|Withdrawal by Subject|7|||
170368592|NCT00587301|615683996|FG000|Overall Study|Protocol Violation|7|||
170368593|NCT02758613|615683997|FG000|Treatment|Physician and Sponsor Decision|1|||
170368594|NCT02758613|615683998|FG001|Treatment|Physician and Sponsor Decision|0|||
170368595|NCT02758613|615683999|FG002|Treatment|Physician and Sponsor Decision|0|||
170368596|NCT02758613|615684000|FG003|Treatment|Physician and Sponsor Decision|0|||
170368597|NCT02758613|615683997|FG000|Treatment|Withdrawal by Subject|1|||
170368598|NCT02758613|615683998|FG001|Treatment|Withdrawal by Subject|0|||
170368599|NCT02758613|615683999|FG002|Treatment|Withdrawal by Subject|1|||
170368600|NCT02758613|615684000|FG003|Treatment|Withdrawal by Subject|0|||
170368601|NCT00196196|615684005|FG000|Overall Study|Withdrawal by Subject|2|||
170368602|NCT00196196|615684005|FG000|Overall Study|Did not have required condition (hydroce|5|||
170368603|NCT01425749|615684006|FG000|Overall Study|progression of melanoma|0|||
170368604|NCT01425749|615684007|FG001|Overall Study|progression of melanoma|1|||
170368605|NCT03271307|615684012|FG000|Overall Study|Lost to Follow-up|0|||
170368606|NCT03271307|615684013|FG001|Overall Study|Lost to Follow-up|0|||
170368607|NCT03271307|615684014|FG002|Overall Study|Lost to Follow-up|0|||
170368608|NCT03271307|615684015|FG003|Overall Study|Lost to Follow-up|28|||
170368609|NCT03271307|615684016|FG004|Overall Study|Lost to Follow-up|91|||
170368610|NCT02712008|615685776|FG000|Baseline (Day 1) up to Week 12|Death|3|||
170368611|NCT02712008|615685777|FG001|Baseline (Day 1) up to Week 12|Death|0|||
170368612|NCT02712008|615685778|FG002|Baseline (Day 1) up to Week 12|Death|0|||
170368613|NCT02712008|615685779|FG003|Baseline (Day 1) up to Week 12|Death|0|||
170368614|NCT02712008|615685780|FG004|Baseline (Day 1) up to Week 12|Death|0|||
170368615|NCT02712008|615685781|FG005|Baseline (Day 1) up to Week 12|Death|0|||
170368616|NCT02712008|615685782|FG006|Baseline (Day 1) up to Week 12|Death|0|||
170368617|NCT02712008|615685783|FG007|Baseline (Day 1) up to Week 12|Death|0|||
170368618|NCT02712008|615685776|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170368619|NCT02712008|615685777|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
170368620|NCT02712008|615685778|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
170368621|NCT02712008|615685779|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170368622|NCT02712008|615685780|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170368623|NCT02712008|615685781|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170368624|NCT02712008|615685782|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170368625|NCT02712008|615685783|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
170368626|NCT02712008|615685776|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
170368627|NCT02712008|615685777|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170368628|NCT02712008|615685778|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
170368629|NCT02712008|615685779|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170368630|NCT02712008|615685780|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170368631|NCT02712008|615685781|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170368632|NCT02712008|615685782|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170368633|NCT02712008|615685783|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
170368634|NCT02712008|615685776|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
170368635|NCT02712008|615685777|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
170368636|NCT02712008|615685778|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
170368637|NCT02712008|615685779|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
170368638|NCT02712008|615685780|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
170368639|NCT02712008|615685781|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
170368640|NCT02712008|615685782|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
170368641|NCT02712008|615685783|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
170368642|NCT02712008|615685776|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
170368643|NCT02712008|615685777|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
170368644|NCT02712008|615685778|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
170368645|NCT02712008|615685779|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
170368646|NCT02712008|615685780|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
170368647|NCT02712008|615685781|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
170368648|NCT02712008|615685782|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
170368649|NCT02712008|615685783|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
170368650|NCT02712008|615685776|FG000|From Week 12 up to Week 36|Adverse Event|0|||
170368651|NCT02712008|615685777|FG001|From Week 12 up to Week 36|Adverse Event|0|||
170368652|NCT02712008|615685778|FG002|From Week 12 up to Week 36|Adverse Event|0|||
170368653|NCT02712008|615685779|FG003|From Week 12 up to Week 36|Adverse Event|0|||
170368654|NCT02712008|615685780|FG004|From Week 12 up to Week 36|Adverse Event|1|||
170368655|NCT02712008|615685781|FG005|From Week 12 up to Week 36|Adverse Event|0|||
170368656|NCT02712008|615685782|FG006|From Week 12 up to Week 36|Adverse Event|0|||
170368657|NCT02712008|615685783|FG007|From Week 12 up to Week 36|Adverse Event|2|||
170368658|NCT02712008|615685776|FG000|From Week 12 up to Week 36|Death|1|||
170368659|NCT02712008|615685777|FG001|From Week 12 up to Week 36|Death|0|||
170368660|NCT02712008|615685778|FG002|From Week 12 up to Week 36|Death|0|||
170368661|NCT02712008|615685779|FG003|From Week 12 up to Week 36|Death|0|||
170368662|NCT02712008|615685780|FG004|From Week 12 up to Week 36|Death|0|||
170368663|NCT02712008|615685781|FG005|From Week 12 up to Week 36|Death|0|||
170368664|NCT02712008|615685782|FG006|From Week 12 up to Week 36|Death|1|||
170368665|NCT02712008|615685783|FG007|From Week 12 up to Week 36|Death|0|||
170368666|NCT02712008|615685776|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
170368667|NCT02712008|615685777|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
170368668|NCT02712008|615685778|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
170368669|NCT02712008|615685779|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
170368670|NCT02712008|615685780|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
170368671|NCT02712008|615685781|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
170368672|NCT02712008|615685782|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
170368673|NCT02712008|615685783|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
170368674|NCT02712008|615685776|FG000|From Week 12 up to Week 36|Physician Decision|0|||
170368675|NCT02712008|615685777|FG001|From Week 12 up to Week 36|Physician Decision|0|||
170368676|NCT02712008|615685778|FG002|From Week 12 up to Week 36|Physician Decision|0|||
170368677|NCT02712008|615685779|FG003|From Week 12 up to Week 36|Physician Decision|1|||
170368678|NCT02712008|615685780|FG004|From Week 12 up to Week 36|Physician Decision|1|||
170368679|NCT02712008|615685781|FG005|From Week 12 up to Week 36|Physician Decision|0|||
170368680|NCT02712008|615685782|FG006|From Week 12 up to Week 36|Physician Decision|0|||
170368681|NCT02712008|615685783|FG007|From Week 12 up to Week 36|Physician Decision|0|||
170368682|NCT02712008|615685776|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
170368683|NCT02712008|615685777|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
170368684|NCT02712008|615685778|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
170368685|NCT02712008|615685779|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
170368686|NCT02712008|615685780|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
170368687|NCT02712008|615685781|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
170368688|NCT02712008|615685782|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
170368689|NCT02712008|615685783|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
170368690|NCT00364351|615685784|FG000|Overall Study|Adverse Event|90|||
170368691|NCT00364351|615685785|FG001|Overall Study|Adverse Event|44|||
170368692|NCT00364351|615685784|FG000|Overall Study|Condition under investigation worsened|469|||
170368693|NCT00364351|615685785|FG001|Overall Study|Condition under investigation worsened|497|||
170368694|NCT00364351|615685784|FG000|Overall Study|Prohibited concomitant medication|0|||
170368695|NCT00364351|615685785|FG001|Overall Study|Prohibited concomitant medication|2|||
170368696|NCT00364351|615685784|FG000|Overall Study|Lost to Follow-up|1|||
170368697|NCT00364351|615685785|FG001|Overall Study|Lost to Follow-up|1|||
170368698|NCT00364351|615685784|FG000|Overall Study|Withdrawal by Subject|30|||
170368699|NCT00364351|615685785|FG001|Overall Study|Withdrawal by Subject|29|||
170368700|NCT00364351|615685784|FG000|Overall Study|Incorrect enrollment|1|||
170368701|NCT00364351|615685785|FG001|Overall Study|Incorrect enrollment|1|||
170368702|NCT00364351|615685784|FG000|Overall Study|Sponsor decision|1|||
170368703|NCT00364351|615685785|FG001|Overall Study|Sponsor decision|0|||
170368704|NCT00364351|615685784|FG000|Overall Study|Poor treatment compliance|0|||
170368705|NCT00364351|615685785|FG001|Overall Study|Poor treatment compliance|3|||
170368706|NCT00364351|615685784|FG000|Overall Study|Investigator error|0|||
170368707|NCT00364351|615685785|FG001|Overall Study|Investigator error|2|||
170368708|NCT00364351|615685784|FG000|Overall Study|Patient could not travel to site|0|||
170368709|NCT00364351|615685785|FG001|Overall Study|Patient could not travel to site|1|||
170368710|NCT00364351|615685784|FG000|Overall Study|Randomised treatment not started|0|||
170368711|NCT00364351|615685785|FG001|Overall Study|Randomised treatment not started|3|||
170368712|NCT01305941|615685786|FG000|Overall Study|Adverse Event|6|||
170368713|NCT01305941|615685786|FG000|Overall Study|Clinical decline|2|||
170368714|NCT01305941|615685786|FG000|Overall Study|Withdrawal by Subject|1|||
170368715|NCT01305941|615685786|FG000|Overall Study|Death|1|||
170368716|NCT00430027|615685787|FG000|Overall Study|Study terminated|8|||
170368717|NCT02667236|615685792|FG000|Overall Study|Adverse Event|1|||
170368718|NCT02667236|615685793|FG001|Overall Study|Adverse Event|1|||
170368719|NCT02667236|615685792|FG000|Overall Study|Withdrawal by Subject|2|||
170368720|NCT02667236|615685793|FG001|Overall Study|Withdrawal by Subject|0|||
170368721|NCT00106249|615685798|FG000|Overall Study|Lost to Follow-up|3|||
170368722|NCT00106249|615685799|FG001|Overall Study|Lost to Follow-up|2|||
170368723|NCT00948428|615685800|FG000|Overall Study|Withdrawal by Subject|6|||
170368724|NCT00948428|615685801|FG001|Overall Study|Withdrawal by Subject|12|||
170368725|NCT00948428|615685802|FG002|Overall Study|Withdrawal by Subject|7|||
170368726|NCT00948428|615685800|FG000|Overall Study|Adverse Event|6|||
170368727|NCT00948428|615685801|FG001|Overall Study|Adverse Event|3|||
170368728|NCT00948428|615685802|FG002|Overall Study|Adverse Event|0|||
170368729|NCT00948428|615685800|FG000|Overall Study|Lost to Follow-up|2|||
170368730|NCT00948428|615685801|FG001|Overall Study|Lost to Follow-up|1|||
170368731|NCT00948428|615685802|FG002|Overall Study|Lost to Follow-up|1|||
170368732|NCT00948428|615685800|FG000|Overall Study|Death|2|||
170368733|NCT00948428|615685801|FG001|Overall Study|Death|0|||
170368734|NCT00948428|615685802|FG002|Overall Study|Death|0|||
170368735|NCT00948428|615685800|FG000|Overall Study|Intercurrent Illness|1|||
170368736|NCT00948428|615685801|FG001|Overall Study|Intercurrent Illness|0|||
170368737|NCT00948428|615685802|FG002|Overall Study|Intercurrent Illness|0|||
170368738|NCT00948428|615685800|FG000|Overall Study|Non-compliance|1|||
170368739|NCT00948428|615685801|FG001|Overall Study|Non-compliance|2|||
170368740|NCT00948428|615685802|FG002|Overall Study|Non-compliance|0|||
170368741|NCT05283499|615685803|FG000|Overall Study|Did not receive intervention|1|||
170368742|NCT05283499|615685804|FG001|Overall Study|Did not receive intervention|2|||
170368743|NCT01495689|615685806|FG000|Overall Study|Death|0|||
170368744|NCT01495689|615685807|FG001|Overall Study|Death|1|||
170368745|NCT01495689|615685806|FG000|Overall Study|Withdrawal by Subject|3|||
170368746|NCT01495689|615685807|FG001|Overall Study|Withdrawal by Subject|0|||
170368747|NCT01495689|615685806|FG000|Overall Study|Lost to Follow-up|7|||
170368748|NCT01495689|615685807|FG001|Overall Study|Lost to Follow-up|6|||
170368749|NCT05516134|615685814|FG000|Overall Study|Lost to Follow-up|1|||
170368750|NCT05516134|615685815|FG001|Overall Study|Lost to Follow-up|0|||
170368751|NCT05516134|615685816|FG002|Overall Study|Lost to Follow-up|0|||
170368752|NCT00254163|615685823|FG000|Overall Study|Adverse Event|29|||
170368753|NCT00254163|615685824|FG001|Overall Study|Adverse Event|26|||
170398848|NCT05004181|615798312|FG000|Overall Study|Lost to Follow-up|2|||
170368754|NCT00254163|615685823|FG000|Overall Study|Patient request/withdrew consent|6|||
170368755|NCT00254163|615685824|FG001|Overall Study|Patient request/withdrew consent|4|||
170368756|NCT00254163|615685823|FG000|Overall Study|Investigator request|1|||
170368757|NCT00254163|615685824|FG001|Overall Study|Investigator request|3|||
170368758|NCT00254163|615685823|FG000|Overall Study|Failed entry|1|||
170368759|NCT00254163|615685824|FG001|Overall Study|Failed entry|3|||
170368760|NCT00254163|615685823|FG000|Overall Study|Progressive disease|0|||
170368761|NCT00254163|615685824|FG001|Overall Study|Progressive disease|1|||
170368762|NCT00254163|615685823|FG000|Overall Study|Death|0|||
170368763|NCT00254163|615685824|FG001|Overall Study|Death|1|||
170368764|NCT00254163|615685823|FG000|Overall Study|Other|8|||
170368765|NCT00254163|615685824|FG001|Overall Study|Other|8|||
170368766|NCT01119963|615685825|FG000|Overall Study|Lost to Follow-up|1|||
170368767|NCT01119963|615685826|FG001|Overall Study|Lost to Follow-up|1|||
170368768|NCT01843205|615685831|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
170368769|NCT01843205|615685832|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
170368770|NCT01355497|615685833|FG000|Overall Study|Death|19|||
170368771|NCT01355497|615685834|FG001|Overall Study|Death|18|||
170368772|NCT01355497|615685833|FG000|Overall Study|Lost to Follow-up|3|||
170368773|NCT01355497|615685834|FG001|Overall Study|Lost to Follow-up|0|||
170368774|NCT01355497|615685833|FG000|Overall Study|Protocol Violation|0|||
170368775|NCT01355497|615685834|FG001|Overall Study|Protocol Violation|1|||
170368776|NCT01355497|615685833|FG000|Overall Study|other-not provided|9|||
170368777|NCT01355497|615685834|FG001|Overall Study|other-not provided|4|||
170368778|NCT01355497|615685833|FG000|Overall Study|Withdrawal by Subject|12|||
170368779|NCT01355497|615685834|FG001|Overall Study|Withdrawal by Subject|20|||
170368780|NCT01355497|615685833|FG000|Overall Study|noncompliance|1|||
170368781|NCT01355497|615685834|FG001|Overall Study|noncompliance|2|||
170368782|NCT01355497|615685833|FG000|Overall Study|progressive disease|11|||
170368783|NCT01355497|615685834|FG001|Overall Study|progressive disease|8|||
170368784|NCT01355497|615685833|FG000|Overall Study|Adverse Event|11|||
170368785|NCT01355497|615685834|FG001|Overall Study|Adverse Event|10|||
170368786|NCT01518309|615685835|FG000|Overall Study|Adverse Event|6|||
170368787|NCT01518309|615685835|FG000|Overall Study|Death|6|||
170368788|NCT01518309|615685835|FG000|Overall Study|Lack of Efficacy|7|||
170368789|NCT01518309|615685835|FG000|Overall Study|Withdrawal by Subject|6|||
170368790|NCT01518309|615685835|FG000|Overall Study|Physician Decision|3|||
170368791|NCT01518309|615685835|FG000|Overall Study|Sponsor Decision|2|||
170368792|NCT01518309|615685835|FG000|Overall Study|Not in Predefined Categories|9|||
170368793|NCT02579863|615685837|FG000|Overall Study|Final Disposition Unknown|2|||
170368794|NCT02579863|615685838|FG001|Overall Study|Final Disposition Unknown|1|||
170368795|NCT02579863|615685837|FG000|Overall Study|Adverse Event|18|||
170368796|NCT02579863|615685838|FG001|Overall Study|Adverse Event|11|||
170368797|NCT02579863|615685837|FG000|Overall Study|Death|31|||
170368798|NCT02579863|615685838|FG001|Overall Study|Death|29|||
170368799|NCT02579863|615685837|FG000|Overall Study|Lost to Follow-up|2|||
170368800|NCT02579863|615685838|FG001|Overall Study|Lost to Follow-up|1|||
170368801|NCT02579863|615685837|FG000|Overall Study|Physician Decision|1|||
170368802|NCT02579863|615685838|FG001|Overall Study|Physician Decision|2|||
170368803|NCT02579863|615685837|FG000|Overall Study|Screen Failure|0|||
170368804|NCT02579863|615685838|FG001|Overall Study|Screen Failure|2|||
170368805|NCT02579863|615685837|FG000|Overall Study|Study Terminated at Selected Sites|82|||
170368806|NCT02579863|615685838|FG001|Overall Study|Study Terminated at Selected Sites|88|||
170368807|NCT02579863|615685837|FG000|Overall Study|Withdrawal by Subject|20|||
170368808|NCT02579863|615685838|FG001|Overall Study|Withdrawal by Subject|20|||
170368809|NCT00216086|615685843|FG000|Overall Study|Protocol Violation|1|||
170368810|NCT00216086|615685843|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
170368811|NCT00216086|615685843|FG000|Overall Study|Social Reasons|2|||
170368812|NCT00038142|615685844|FG000|Overall Study|Ineligible|1|||
170368813|NCT00038142|615685845|FG001|Overall Study|Ineligible|0|||
170368814|NCT00038142|615685844|FG000|Overall Study|Progressive Disease|11|||
170368815|NCT00038142|615685845|FG001|Overall Study|Progressive Disease|7|||
170368816|NCT00038142|615685844|FG000|Overall Study|Death|1|||
170368817|NCT00038142|615685845|FG001|Overall Study|Death|0|||
170368818|NCT00038142|615685844|FG000|Overall Study|Adverse Event|1|||
170368819|NCT00038142|615685845|FG001|Overall Study|Adverse Event|0|||
170368820|NCT00038142|615685844|FG000|Overall Study|Unknown Reason|8|||
170368821|NCT00038142|615685845|FG001|Overall Study|Unknown Reason|0|||
170368822|NCT00809614|615685862|FG000|Overall Study|Lack of Efficacy|2|||
170368823|NCT00809614|615685863|FG001|Overall Study|Lack of Efficacy|3|||
170368824|NCT00809614|615685862|FG000|Overall Study|Withdrawal by Subject|1|||
170368825|NCT00809614|615685863|FG001|Overall Study|Withdrawal by Subject|1|||
170368826|NCT01080625|615685864|FG000|Overall Study|Physician Decision|0|||
170368827|NCT01080625|615685865|FG001|Overall Study|Physician Decision|2|||
170368828|NCT01080625|615685866|FG002|Overall Study|Physician Decision|1|||
170368829|NCT00446797|615685867|FG000|Overall Study|Lack of Efficacy|0|||
170368830|NCT00446797|615685868|FG001|Overall Study|Lack of Efficacy|2|||
170368831|NCT00446797|615685867|FG000|Overall Study|Lost to Follow-up|5|||
170368832|NCT00446797|615685868|FG001|Overall Study|Lost to Follow-up|3|||
170368833|NCT00446797|615685867|FG000|Overall Study|Withdrawal by Subject|2|||
170368834|NCT00446797|615685868|FG001|Overall Study|Withdrawal by Subject|2|||
170368835|NCT00446797|615685867|FG000|Overall Study|Protocol Violation|1|||
170368836|NCT00446797|615685868|FG001|Overall Study|Protocol Violation|3|||
170368837|NCT00446797|615685867|FG000|Overall Study|subject entered at another site|0|||
170368838|NCT00446797|615685868|FG001|Overall Study|subject entered at another site|1|||
170368839|NCT00446797|615685867|FG000|Overall Study|did not meet entrance criteria|0|||
170368840|NCT00446797|615685868|FG001|Overall Study|did not meet entrance criteria|1|||
170368841|NCT03210220|615685869|FG000|Overall Study|Physician Decision|1|||
170368842|NCT03210220|615685870|FG001|Overall Study|Physician Decision|0|||
170368843|NCT00420342|615685871|FG000|Overall Study|Lost to Follow-up|1|||
170368844|NCT00420342|615685872|FG001|Overall Study|Lost to Follow-up|0|||
170368845|NCT00420342|615685873|FG002|Overall Study|Lost to Follow-up|1|||
170368846|NCT00420342|615685871|FG000|Overall Study|Withdrawal by Subject|0|||
170368847|NCT00420342|615685872|FG001|Overall Study|Withdrawal by Subject|2|||
170368848|NCT00420342|615685873|FG002|Overall Study|Withdrawal by Subject|0|||
170368849|NCT00839436|615685878|FG000|Overall Study|Developed exclusionary condition|1|||
170368850|NCT00839436|615685879|FG001|Overall Study|Developed exclusionary condition|0|||
170368851|NCT00839436|615685880|FG002|Overall Study|Developed exclusionary condition|0|||
170368852|NCT00839436|615685878|FG000|Overall Study|Withdrawal by Subject|0|||
170368853|NCT00839436|615685879|FG001|Overall Study|Withdrawal by Subject|1|||
170368854|NCT00839436|615685880|FG002|Overall Study|Withdrawal by Subject|0|||
170368855|NCT00839436|615685878|FG000|Overall Study|Study drug no longer available|0|||
170368856|NCT00839436|615685879|FG001|Overall Study|Study drug no longer available|0|||
170368857|NCT00839436|615685880|FG002|Overall Study|Study drug no longer available|1|||
170368858|NCT01440972|615685881|FG000|Overall Study|Withdrawal by Subject|3|||
170368859|NCT01440972|615685882|FG001|Overall Study|Withdrawal by Subject|2|||
170368860|NCT03933215|615685883|FG000|Overall Study|Other|6|||
170368861|NCT03933215|615685883|FG000|Overall Study|Sponsor decision|5|||
170368862|NCT03933215|615685883|FG000|Overall Study|Protocol Violation|5|||
170368863|NCT03933215|615685883|FG000|Overall Study|Withdrawal by Subject|6|||
170368864|NCT03933215|615685883|FG000|Overall Study|Lost to Follow-up|6|||
170368865|NCT03933215|615685883|FG000|Overall Study|Enrolled but not treated|38|||
170368866|NCT04097028|615685886|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
170368867|NCT04097028|615685886|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
170368868|NCT04097028|615685886|FG000|Overall Study|Disease Progression prior to Surgery|2|||
170368869|NCT04097028|615685886|FG000|Overall Study|Adverse Event prior to Surgery|1|||
170368870|NCT04072575|615685887|FG000|Overall Study|Physician Decision|1|||
170368871|NCT04072575|615685887|FG000|Overall Study|Adverse Event|7|||
170368872|NCT04072575|615685887|FG000|Overall Study|Withdrawal by Subject|14|||
170368873|NCT04072575|615685887|FG000|Overall Study|Other|2|||
170368874|NCT05784129|615685888|FG000|Overall Study|Study terminated by sponsor|2|||
170368875|NCT05784129|615685889|FG001|Overall Study|Study terminated by sponsor|2|||
170368876|NCT00407550|615685890|FG000|Overall Study|Adverse Event|0|||
170368877|NCT00407550|615685891|FG001|Overall Study|Adverse Event|1|||
170368878|NCT00407550|615685890|FG000|Overall Study|Withdrawal by Subject|0|||
170368879|NCT00407550|615685891|FG001|Overall Study|Withdrawal by Subject|2|||
170368880|NCT00407550|615685890|FG000|Overall Study|Death|1|||
170368881|NCT00407550|615685891|FG001|Overall Study|Death|0|||
170368882|NCT00407550|615685890|FG000|Overall Study|Insurance or Other medical condition|2|||
170368883|NCT00407550|615685891|FG001|Overall Study|Insurance or Other medical condition|1|||
170368884|NCT02580591|615685893|FG000|Overall Study|Adverse Event|0|||
170368885|NCT02580591|615685894|FG001|Overall Study|Adverse Event|1|||
170368886|NCT02580591|615685895|FG002|Overall Study|Adverse Event|2|||
170368887|NCT02580591|615685896|FG003|Overall Study|Adverse Event|5|||
170368888|NCT02580591|615685893|FG000|Overall Study|Protocol Violation|3|||
170368889|NCT02580591|615685894|FG001|Overall Study|Protocol Violation|2|||
170368890|NCT02580591|615685895|FG002|Overall Study|Protocol Violation|1|||
170368891|NCT02580591|615685896|FG003|Overall Study|Protocol Violation|1|||
170368892|NCT02580591|615685893|FG000|Overall Study|Lost to Follow-up|5|||
170368893|NCT02580591|615685894|FG001|Overall Study|Lost to Follow-up|3|||
170368894|NCT02580591|615685895|FG002|Overall Study|Lost to Follow-up|3|||
170368895|NCT02580591|615685896|FG003|Overall Study|Lost to Follow-up|1|||
170368896|NCT02580591|615685893|FG000|Overall Study|Withdrawal by Subject|6|||
170368897|NCT02580591|615685894|FG001|Overall Study|Withdrawal by Subject|1|||
170368898|NCT02580591|615685895|FG002|Overall Study|Withdrawal by Subject|2|||
170368899|NCT02580591|615685896|FG003|Overall Study|Withdrawal by Subject|3|||
170368900|NCT02580591|615685893|FG000|Overall Study|Not treated|1|||
170368901|NCT02580591|615685894|FG001|Overall Study|Not treated|1|||
170368902|NCT02580591|615685895|FG002|Overall Study|Not treated|0|||
170368903|NCT02580591|615685896|FG003|Overall Study|Not treated|0|||
170368904|NCT02580591|615685893|FG000|Overall Study|Other than specified|3|||
170368905|NCT02580591|615685894|FG001|Overall Study|Other than specified|2|||
170368906|NCT02580591|615685895|FG002|Overall Study|Other than specified|5|||
170368907|NCT02580591|615685896|FG003|Overall Study|Other than specified|2|||
170368908|NCT03745989|615685898|FG000|Overall Study|Death|3|||
170368909|NCT03745989|615685899|FG001|Overall Study|Death|7|||
170368910|NCT03745989|615685900|FG002|Overall Study|Death|4|||
170368911|NCT03745989|615685898|FG000|Overall Study|Lost to Follow-up|0|||
170368912|NCT03745989|615685899|FG001|Overall Study|Lost to Follow-up|2|||
170368913|NCT03745989|615685900|FG002|Overall Study|Lost to Follow-up|0|||
170368914|NCT03745989|615685898|FG000|Overall Study|Sponsor Decision|0|||
170368915|NCT03745989|615685899|FG001|Overall Study|Sponsor Decision|2|||
170368916|NCT03745989|615685900|FG002|Overall Study|Sponsor Decision|8|||
170368917|NCT03745989|615685898|FG000|Overall Study|Withdrawal by Subject|0|||
170368918|NCT03745989|615685899|FG001|Overall Study|Withdrawal by Subject|1|||
170368919|NCT03745989|615685900|FG002|Overall Study|Withdrawal by Subject|3|||
170368920|NCT00735072|615685903|FG000|Overall Study|interrupted study med during ARV change|1|||
170368921|NCT00735072|615685904|FG001|Overall Study|interrupted study med during ARV change|0|||
170368922|NCT00735072|615685903|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
170368923|NCT00735072|615685904|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
170368924|NCT00911144|615685908|FG000|Overall Study|Withdrawal by Subject|16|||
170368925|NCT00911144|615685909|FG001|Overall Study|Withdrawal by Subject|5|||
170368926|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
170368927|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
170368928|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
170368929|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
170368930|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
170368931|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
170368932|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
170368933|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
170368934|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
170368935|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
170368936|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
170368937|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
170368938|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
170368939|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
170368940|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
170368941|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
170368942|NCT01291511|615685910|FG000|Cross-Titration and Stabilization Phase|Death|1|||
170368943|NCT01291511|615685911|FG001|Cross-Titration and Stabilization Phase|Death|0|||
170368944|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
170368945|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
170368946|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
170368947|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
170368948|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
170368949|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
170368950|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
170368951|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
170368952|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
170368953|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
170368954|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
170368955|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
170368956|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
170368957|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
170368958|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
170368959|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
170368960|NCT01291511|615685910|FG000|Double-blind Relapse Prevention Phase|Death|1|||
170368961|NCT01291511|615685911|FG001|Double-blind Relapse Prevention Phase|Death|0|||
170368962|NCT01366534|615685912|FG000|Overall Study|Lost to Follow-up|1|||
170368963|NCT01366534|615685913|FG001|Overall Study|Lost to Follow-up|0|||
170368964|NCT01366534|615685914|FG002|Overall Study|Lost to Follow-up|0|||
170368965|NCT01366534|615685912|FG000|Overall Study|Migrated|1|||
170368966|NCT01366534|615685913|FG001|Overall Study|Migrated|1|||
170368967|NCT01366534|615685914|FG002|Overall Study|Migrated|0|||
170368968|NCT01366534|615685912|FG000|Overall Study|Declined challenged|0|||
170368969|NCT01366534|615685913|FG001|Overall Study|Declined challenged|1|||
170368970|NCT01366534|615685914|FG002|Overall Study|Declined challenged|0|||
170368971|NCT01266070|615685915|FG000|Overall Study|Adverse Event|3|||
170368972|NCT01266070|615685915|FG000|Overall Study|Protocol Violation|1|||
170368973|NCT03185819|615685916|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
170368974|NCT03185819|615685917|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
170368975|NCT03185819|615685918|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
170368976|NCT03185819|615685919|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
170368977|NCT03185819|615685916|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
170368978|NCT03185819|615685917|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
170368979|NCT03185819|615685918|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
170368980|NCT03185819|615685919|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
170368981|NCT03185819|615685916|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
170368982|NCT03185819|615685917|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
170368983|NCT03185819|615685918|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
170368984|NCT03185819|615685919|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
170368985|NCT03185819|615685916|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
170368986|NCT03185819|615685917|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
170368987|NCT03185819|615685918|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
170368988|NCT03185819|615685919|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
170368989|NCT03185819|615685916|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
170368990|NCT03185819|615685917|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
170368991|NCT03185819|615685918|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
170368992|NCT03185819|615685919|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
170368993|NCT03185819|615685916|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
170368994|NCT03185819|615685917|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
170368995|NCT03185819|615685918|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
170368996|NCT03185819|615685919|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
170368997|NCT03185819|615685916|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
170368998|NCT03185819|615685917|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
170368999|NCT03185819|615685918|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
170369000|NCT03185819|615685919|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
170369001|NCT03185819|615685916|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
170369002|NCT03185819|615685917|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
170369003|NCT03185819|615685918|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
170369004|NCT03185819|615685919|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
170369005|NCT03185819|615685916|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
170369006|NCT03185819|615685917|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
170369007|NCT03185819|615685918|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
170369008|NCT03185819|615685919|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
170369009|NCT03185819|615685916|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
170369010|NCT03185819|615685917|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
170369011|NCT03185819|615685918|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
170369012|NCT03185819|615685919|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
170369013|NCT03185819|615685916|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
170369014|NCT03185819|615685917|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
170369015|NCT03185819|615685918|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
170369016|NCT03185819|615685919|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
170369017|NCT03185819|615685916|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
170369018|NCT03185819|615685917|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
170369019|NCT03185819|615685918|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
170369020|NCT03185819|615685919|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
170369021|NCT03185819|615685916|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
170369022|NCT03185819|615685917|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
170369023|NCT03185819|615685918|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
170369024|NCT03185819|615685919|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
170369025|NCT02910089|615685920|FG000|Overall Study|Lost insurance eligibility|22|||
170369026|NCT02910089|615685921|FG001|Overall Study|Lost insurance eligibility|16|||
170369027|NCT00329784|615685924|FG000|Overall Study|Lost to Follow-up|0|||
170369028|NCT00329784|615685925|FG001|Overall Study|Lost to Follow-up|1|||
170369029|NCT00329784|615685926|FG002|Overall Study|Lost to Follow-up|0|||
170369030|NCT00329784|615685927|FG003|Overall Study|Lost to Follow-up|0|||
170369031|NCT00329784|615685924|FG000|Overall Study|Withdrawal by Subject|4|||
170369032|NCT00329784|615685925|FG001|Overall Study|Withdrawal by Subject|2|||
170369033|NCT00329784|615685926|FG002|Overall Study|Withdrawal by Subject|0|||
170369034|NCT00329784|615685927|FG003|Overall Study|Withdrawal by Subject|0|||
170369035|NCT00329784|615685924|FG000|Overall Study|Other|1|||
170369036|NCT00329784|615685925|FG001|Overall Study|Other|2|||
170369037|NCT00329784|615685926|FG002|Overall Study|Other|0|||
170369038|NCT00329784|615685927|FG003|Overall Study|Other|0|||
170369039|NCT03168555|615685928|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
170369040|NCT03168555|615685928|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
170369041|NCT03168555|615685928|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
170369042|NCT03168555|615685928|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
170369043|NCT02959190|615685933|FG000|Open Label|Adverse Event|5|||
170369044|NCT02959190|615685934|FG001|Open Label|Adverse Event|7|||
170369045|NCT02959190|615685935|FG002|Open Label|Adverse Event|3|||
170369046|NCT02959190|615685936|FG003|Open Label|Adverse Event|4|||
170369047|NCT02959190|615685933|FG000|Open Label|Pregnancy|0|||
170369048|NCT02959190|615685934|FG001|Open Label|Pregnancy|1|||
170369049|NCT02959190|615685935|FG002|Open Label|Pregnancy|0|||
170369050|NCT02959190|615685936|FG003|Open Label|Pregnancy|0|||
170369051|NCT02959190|615685933|FG000|Open Label|Withdrawal by Subject|2|||
170369052|NCT02959190|615685934|FG001|Open Label|Withdrawal by Subject|8|||
170369053|NCT02959190|615685935|FG002|Open Label|Withdrawal by Subject|0|||
170369054|NCT02959190|615685936|FG003|Open Label|Withdrawal by Subject|0|||
170369055|NCT02959190|615685933|FG000|Open Label|Physician Decision|0|||
170369056|NCT02959190|615685934|FG001|Open Label|Physician Decision|0|||
170369057|NCT02959190|615685935|FG002|Open Label|Physician Decision|1|||
170369058|NCT02959190|615685936|FG003|Open Label|Physician Decision|0|||
170369059|NCT02959190|615685933|FG000|Open Label|Protocol Violation|0|||
170369060|NCT02959190|615685934|FG001|Open Label|Protocol Violation|0|||
170369061|NCT02959190|615685935|FG002|Open Label|Protocol Violation|0|||
170369062|NCT02959190|615685936|FG003|Open Label|Protocol Violation|2|||
170369063|NCT02959190|615685933|FG000|Post Treatment Follow Up|Adverse Event|1|||
170369064|NCT02959190|615685934|FG001|Post Treatment Follow Up|Adverse Event|1|||
170369065|NCT02959190|615685935|FG002|Post Treatment Follow Up|Adverse Event|0|||
170369066|NCT02959190|615685936|FG003|Post Treatment Follow Up|Adverse Event|0|||
170369067|NCT02959190|615685933|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
170369068|NCT02959190|615685934|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
170369069|NCT02959190|615685935|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
170369070|NCT02959190|615685936|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
170369071|NCT02679781|615685937|FG000|Overall Study|Lost to Follow-up|1|||
170369072|NCT02679781|615685938|FG001|Overall Study|Lost to Follow-up|2|||
170369073|NCT02679781|615685937|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
170369074|NCT02679781|615685938|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
170369075|NCT01042938|615685939|FG000|Overall Study|Withdrawal by Subject|1|||
170369076|NCT01042938|615685940|FG001|Overall Study|Withdrawal by Subject|1|||
170369077|NCT01042938|615685939|FG000|Overall Study|Protocol Violation|1|||
170369078|NCT01042938|615685940|FG001|Overall Study|Protocol Violation|1|||
170369079|NCT01042938|615685939|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
170369080|NCT01042938|615685940|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
170369081|NCT00023712|615685941|FG000|Overall Study|Not platinum sensitive|1|||
170369082|NCT00023712|615685942|FG001|Overall Study|Not platinum sensitive|0|||
170369083|NCT00023712|615685941|FG000|Overall Study|Never treated|1|||
170369084|NCT00023712|615685942|FG001|Overall Study|Never treated|1|||
170369085|NCT03136484|615685943|FG000|Overall Study|Withdrawal by Subject|19|||
170369086|NCT03136484|615685944|FG001|Overall Study|Withdrawal by Subject|14|||
170369087|NCT03136484|615685943|FG000|Overall Study|Lost to Follow-up|7|||
170369088|NCT03136484|615685944|FG001|Overall Study|Lost to Follow-up|8|||
170369089|NCT03136484|615685943|FG000|Overall Study|Death|1|||
170369090|NCT03136484|615685944|FG001|Overall Study|Death|0|||
170369091|NCT04209400|615685945|FG000|Overall Study|Withdrawal by Subject|0|||
170369092|NCT04209400|615685946|FG001|Overall Study|Withdrawal by Subject|1|||
170369093|NCT01496274|615685949|FG000|Overall Study|Protocol Violation|0|||
170369094|NCT01496274|615685950|FG001|Overall Study|Protocol Violation|1|||
170369095|NCT01496274|615685949|FG000|Overall Study|Adverse Event|1|||
170369096|NCT01496274|615685950|FG001|Overall Study|Adverse Event|1|||
170369097|NCT01496274|615685949|FG000|Overall Study|Withdrawal by Subject|2|||
170369098|NCT01496274|615685950|FG001|Overall Study|Withdrawal by Subject|0|||
170369099|NCT01496274|615685949|FG000|Overall Study|Lost to Follow-up|0|||
170369100|NCT01496274|615685950|FG001|Overall Study|Lost to Follow-up|3|||
170369101|NCT03032510|615685955|FG000|Overall Study|Adverse Event|5|||
170369102|NCT03032510|615685956|FG001|Overall Study|Adverse Event|2|||
170369103|NCT03032510|615685955|FG000|Overall Study|Lost to Follow-up|8|||
170369104|NCT03032510|615685956|FG001|Overall Study|Lost to Follow-up|7|||
170369105|NCT03032510|615685955|FG000|Overall Study|Withdrawal by Subject|8|||
170369106|NCT03032510|615685956|FG001|Overall Study|Withdrawal by Subject|7|||
170369107|NCT03032510|615685955|FG000|Overall Study|Subject noncompliance|4|||
170369108|NCT03032510|615685956|FG001|Overall Study|Subject noncompliance|2|||
170369109|NCT03032510|615685955|FG000|Overall Study|Physician Decision|2|||
170369110|NCT03032510|615685956|FG001|Overall Study|Physician Decision|0|||
170369111|NCT02146833|615685963|FG000|Overall Study|Death|10|||
170369112|NCT02146833|615685963|FG000|Overall Study|No longer consented to study treatment|1|||
170369113|NCT00676208|615685966|FG000|Overall Study|Lost to Follow-up|0|||
170369114|NCT00676208|615685967|FG001|Overall Study|Lost to Follow-up|2|||
170369115|NCT00676208|615685966|FG000|Overall Study|Incomplete data|2|||
170369116|NCT00676208|615685967|FG001|Overall Study|Incomplete data|4|||
170369117|NCT03700736|615685970|FG000|Overall Study|Pregnancy|1|||
170369118|NCT03700736|615685971|FG001|Overall Study|Pregnancy|1|||
170369119|NCT03700736|615685970|FG000|Overall Study|Withdrawal by Subject|2|||
170369120|NCT03700736|615685971|FG001|Overall Study|Withdrawal by Subject|6|||
170369121|NCT00617656|615685972|FG000|Overall Study|Inclusion error|4|||
170369122|NCT00617656|615685973|FG001|Overall Study|Inclusion error|4|||
170369123|NCT00617656|615685974|FG002|Overall Study|Inclusion error|0|||
170369124|NCT00617656|615685975|FG003|Overall Study|Inclusion error|0|||
170369125|NCT00617656|615685972|FG000|Overall Study|Missing data|44|||
170369126|NCT00617656|615685973|FG001|Overall Study|Missing data|30|||
170369127|NCT00617656|615685974|FG002|Overall Study|Missing data|13|||
170369128|NCT00617656|615685975|FG003|Overall Study|Missing data|6|||
170369129|NCT00617656|615685972|FG000|Overall Study|Withdrawal by Subject|0|||
170369130|NCT00617656|615685973|FG001|Overall Study|Withdrawal by Subject|2|||
170369131|NCT00617656|615685974|FG002|Overall Study|Withdrawal by Subject|0|||
170369132|NCT00617656|615685975|FG003|Overall Study|Withdrawal by Subject|0|||
170369133|NCT01946412|615685976|FG000|Overall Study|Adverse Event|1|||
170369134|NCT01946412|615685976|FG000|Overall Study|Non-Compliance|1|||
170369135|NCT01946412|615685976|FG000|Overall Study|Continued with commercial Kalydeco|2|||
170369136|NCT01946412|615685976|FG000|Overall Study|Difficulty in swallowing|1|||
170369137|NCT04483544|615687570|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
170369138|NCT04483544|615687570|FG000|Post-Treatment|Admitted to hospice|2|||
170369139|NCT04483544|615687570|FG000|Post-Treatment|Study terminated|3|||
170369140|NCT01977040|615687572|FG000|Overall Study|Vasa previa not confirmed|2|||
170369141|NCT03597503|615687576|FG000|Overall Study|Withdrawal by Subject|0|||
170369142|NCT03597503|615687577|FG001|Overall Study|Withdrawal by Subject|2|||
170369143|NCT03597503|615687576|FG000|Overall Study|Lost to Follow-up|1|||
170369144|NCT03597503|615687577|FG001|Overall Study|Lost to Follow-up|2|||
170369145|NCT03597503|615687576|FG000|Overall Study|Protocol Violation|1|||
170369146|NCT03597503|615687577|FG001|Overall Study|Protocol Violation|0|||
170369147|NCT03654560|615687586|FG000|Overall Study|Death|3|||
170369148|NCT03654560|615687587|FG001|Overall Study|Death|1|||
170369149|NCT03654560|615687586|FG000|Overall Study|Lost to Follow-up|1|||
170369150|NCT03654560|615687587|FG001|Overall Study|Lost to Follow-up|0|||
170369151|NCT00693420|615687588|FG000|Overall Study|Adverse Event|4|||
170369152|NCT00693420|615687589|FG001|Overall Study|Adverse Event|4|||
170369153|NCT00693420|615687588|FG000|Overall Study|Lost to Follow-up|0|||
170369154|NCT00693420|615687589|FG001|Overall Study|Lost to Follow-up|3|||
170369155|NCT00693420|615687588|FG000|Overall Study|Withdrawal by Subject|1|||
170369156|NCT00693420|615687589|FG001|Overall Study|Withdrawal by Subject|0|||
170369157|NCT00693420|615687588|FG000|Overall Study|Protocol Violation|0|||
170369158|NCT00693420|615687589|FG001|Overall Study|Protocol Violation|2|||
170369159|NCT00693420|615687588|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
170369160|NCT00693420|615687589|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
170369161|NCT00693420|615687588|FG000|Overall Study|Personal Reasons|1|||
170369162|NCT00693420|615687589|FG001|Overall Study|Personal Reasons|4|||
170369163|NCT02828644|615687591|FG000|Overall Study|Lost to Follow-up|23|||
170369164|NCT02828644|615687592|FG001|Overall Study|Lost to Follow-up|22|||
170369165|NCT02996110|615687593|FG000|Pre-Treatment|Other Reasons|0|||
170369166|NCT02996110|615687594|FG001|Pre-Treatment|Other Reasons|1|||
170369167|NCT02996110|615687595|FG002|Pre-Treatment|Other Reasons|0|||
170369168|NCT02996110|615687596|FG003|Pre-Treatment|Other Reasons|0|||
170369169|NCT02996110|615687597|FG004|Pre-Treatment|Other Reasons|1|||
170369170|NCT02996110|615687593|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
170369171|NCT02996110|615687594|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
170369172|NCT02996110|615687595|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
170369173|NCT02996110|615687596|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
170369174|NCT02996110|615687597|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
170369175|NCT02996110|615687593|FG000|Track 1|Disease Progression|15|||
170369176|NCT02996110|615687594|FG001|Track 1|Disease Progression|17|||
170369177|NCT02996110|615687595|FG002|Track 1|Disease Progression|0|||
170369178|NCT02996110|615687596|FG003|Track 1|Disease Progression|0|||
170369179|NCT02996110|615687597|FG004|Track 1|Disease Progression|0|||
170369180|NCT02996110|615687593|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
170369181|NCT02996110|615687594|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
170369182|NCT02996110|615687595|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
170369183|NCT02996110|615687596|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
170369184|NCT02996110|615687597|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
170369185|NCT02996110|615687593|FG000|Track 1|Study Drug Toxicity|5|||
170369186|NCT02996110|615687594|FG001|Track 1|Study Drug Toxicity|3|||
170369187|NCT02996110|615687595|FG002|Track 1|Study Drug Toxicity|0|||
170369188|NCT02996110|615687596|FG003|Track 1|Study Drug Toxicity|0|||
170369189|NCT02996110|615687597|FG004|Track 1|Study Drug Toxicity|0|||
170369190|NCT02996110|615687593|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
170369191|NCT02996110|615687594|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
170369192|NCT02996110|615687595|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
170369193|NCT02996110|615687596|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
170369194|NCT02996110|615687597|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
170369195|NCT02996110|615687593|FG000|Track 1|Administrative Reason by Sponsor|0|||
170369196|NCT02996110|615687594|FG001|Track 1|Administrative Reason by Sponsor|1|||
170369197|NCT02996110|615687595|FG002|Track 1|Administrative Reason by Sponsor|0|||
170369198|NCT02996110|615687596|FG003|Track 1|Administrative Reason by Sponsor|0|||
170369199|NCT02996110|615687597|FG004|Track 1|Administrative Reason by Sponsor|0|||
170369200|NCT02996110|615687593|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
170369201|NCT02996110|615687594|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
170369202|NCT02996110|615687595|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
170369203|NCT02996110|615687596|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
170369204|NCT02996110|615687597|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
170369205|NCT02996110|615687593|FG000|Track 2|Disease Progression|33|||
170369206|NCT02996110|615687594|FG001|Track 2|Disease Progression|26|||
170369207|NCT02996110|615687595|FG002|Track 2|Disease Progression|19|||
170369208|NCT02996110|615687596|FG003|Track 2|Disease Progression|16|||
170369209|NCT02996110|615687597|FG004|Track 2|Disease Progression|15|||
170369210|NCT02996110|615687593|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
170369211|NCT02996110|615687594|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
170369212|NCT02996110|615687595|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
170369213|NCT02996110|615687596|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
170369214|NCT02996110|615687597|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
170369215|NCT02996110|615687593|FG000|Track 2|Death|0|||
170369216|NCT02996110|615687594|FG001|Track 2|Death|0|||
170369217|NCT02996110|615687595|FG002|Track 2|Death|1|||
170369218|NCT02996110|615687596|FG003|Track 2|Death|0|||
170369219|NCT02996110|615687597|FG004|Track 2|Death|1|||
170369220|NCT02996110|615687593|FG000|Track 2|Study Drug Toxicity|4|||
170369221|NCT02996110|615687594|FG001|Track 2|Study Drug Toxicity|1|||
170369222|NCT02996110|615687595|FG002|Track 2|Study Drug Toxicity|4|||
170369223|NCT02996110|615687596|FG003|Track 2|Study Drug Toxicity|1|||
170369224|NCT02996110|615687597|FG004|Track 2|Study Drug Toxicity|0|||
170369225|NCT02996110|615687593|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
170369226|NCT02996110|615687594|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
170369227|NCT02996110|615687595|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
170369228|NCT02996110|615687596|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
170369229|NCT02996110|615687597|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
170369230|NCT02996110|615687593|FG000|Track 2|Participant Withdrew Consent|1|||
170369231|NCT02996110|615687594|FG001|Track 2|Participant Withdrew Consent|2|||
170369232|NCT02996110|615687595|FG002|Track 2|Participant Withdrew Consent|3|||
170369233|NCT02996110|615687596|FG003|Track 2|Participant Withdrew Consent|1|||
170369234|NCT02996110|615687597|FG004|Track 2|Participant Withdrew Consent|1|||
170369235|NCT02996110|615687593|FG000|Track 2|Other Reasons|0|||
170369236|NCT02996110|615687594|FG001|Track 2|Other Reasons|0|||
170369237|NCT02996110|615687595|FG002|Track 2|Other Reasons|1|||
170369238|NCT02996110|615687596|FG003|Track 2|Other Reasons|0|||
170369239|NCT02996110|615687597|FG004|Track 2|Other Reasons|1|||
170369240|NCT02436915|615687600|FG000|Overall Study|Withdrawal by Subject|0|||
170369241|NCT02436915|615687601|FG001|Overall Study|Withdrawal by Subject|1|||
170369242|NCT06048809|615687608|FG000|Overall Study|Adverse Event|2|||
170369243|NCT06048809|615687609|FG001|Overall Study|Adverse Event|0|||
170369244|NCT06048809|615687608|FG000|Overall Study|Withdrawal by Subject|1|||
170369245|NCT06048809|615687609|FG001|Overall Study|Withdrawal by Subject|1|||
170369246|NCT01117181|615687611|FG000|Overall Study|Lost to Follow-up|1|||
170369247|NCT01117181|615687612|FG001|Overall Study|Lost to Follow-up|0|||
170369248|NCT01117181|615687611|FG000|Overall Study|Withdrawal by Subject|0|||
170369249|NCT01117181|615687612|FG001|Overall Study|Withdrawal by Subject|2|||
170369250|NCT02158728|615687614|FG000|Overall Study|no procedure according to CIP done|3|||
170369251|NCT02158728|615687614|FG000|Overall Study|no qualified dataset|24|||
170369252|NCT03805971|615687617|FG000|Overall Study|Withdrawal by Subject|1|||
170369253|NCT03805971|615687617|FG000|Overall Study|Protocol Violation|2|||
170369254|NCT03938636|615687622|FG000|Overall Study|Protocol Violation|0|||
170369255|NCT03938636|615687623|FG001|Overall Study|Protocol Violation|1|||
170369256|NCT03938636|615687624|FG002|Overall Study|Protocol Violation|1|||
170369257|NCT03938636|615687622|FG000|Overall Study|Subject withdrew due to death in family|0|||
170369258|NCT03938636|615687623|FG001|Overall Study|Subject withdrew due to death in family|1|||
170369259|NCT03938636|615687624|FG002|Overall Study|Subject withdrew due to death in family|0|||
170369260|NCT03938636|615687622|FG000|Overall Study|Missed visit|0|||
170369261|NCT03938636|615687623|FG001|Overall Study|Missed visit|1|||
170369262|NCT03938636|615687624|FG002|Overall Study|Missed visit|0|||
170369263|NCT03938636|615687622|FG000|Overall Study|Adverse Event|0|||
170369264|NCT03938636|615687623|FG001|Overall Study|Adverse Event|0|||
170369265|NCT03938636|615687624|FG002|Overall Study|Adverse Event|1|||
170369266|NCT03938636|615687622|FG000|Overall Study|Lost to Follow-up|0|||
170369267|NCT03938636|615687623|FG001|Overall Study|Lost to Follow-up|0|||
170369268|NCT03938636|615687624|FG002|Overall Study|Lost to Follow-up|1|||
170369269|NCT00364832|615687625|FG000|Core Period|Early Withdrawals|2|||
170369270|NCT00364832|615687626|FG001|Core Period|Early Withdrawals|2|||
170369271|NCT00364832|615687627|FG002|Core Period|Early Withdrawals|1|||
170369272|NCT00364832|615687628|FG003|Core Period|Early Withdrawals|1|||
170369273|NCT00364832|615687629|FG004|Core Period|Early Withdrawals|0|||
170369274|NCT00364832|615687630|FG005|Core Period|Early Withdrawals|0|||
170369275|NCT00364832|615687631|FG006|Core Period|Early Withdrawals|4|||
170369276|NCT00364832|615687632|FG007|Core Period|Early Withdrawals|1|||
170369277|NCT00364832|615687633|FG008|Core Period|Early Withdrawals|0|||
170369278|NCT00364832|615687634|FG009|Core Period|Early Withdrawals|0|||
170369279|NCT00364832|615687635|FG010|Core Period|Early Withdrawals|0|||
170369280|NCT00364832|615687636|FG011|Core Period|Early Withdrawals|0|||
170369281|NCT00364832|615687625|FG000|Extension Year 1|Early Withdrawals|0|||
170369282|NCT00364832|615687626|FG001|Extension Year 1|Early Withdrawals|0|||
170369283|NCT00364832|615687627|FG002|Extension Year 1|Early Withdrawals|0|||
170369284|NCT00364832|615687628|FG003|Extension Year 1|Early Withdrawals|0|||
170369285|NCT00364832|615687629|FG004|Extension Year 1|Early Withdrawals|0|||
170369286|NCT00364832|615687630|FG005|Extension Year 1|Early Withdrawals|0|||
170369287|NCT00364832|615687631|FG006|Extension Year 1|Early Withdrawals|0|||
170369288|NCT00364832|615687632|FG007|Extension Year 1|Early Withdrawals|0|||
170369289|NCT00364832|615687633|FG008|Extension Year 1|Early Withdrawals|0|||
170369290|NCT00364832|615687634|FG009|Extension Year 1|Early Withdrawals|4|||
170369291|NCT00364832|615687635|FG010|Extension Year 1|Early Withdrawals|2|||
170369292|NCT00364832|615687636|FG011|Extension Year 1|Early Withdrawals|10|||
170369293|NCT00364832|615687625|FG000|Extension Year 2|Early Withdrawals|0|||
170369294|NCT00364832|615687626|FG001|Extension Year 2|Early Withdrawals|0|||
170369295|NCT00364832|615687627|FG002|Extension Year 2|Early Withdrawals|0|||
170369296|NCT00364832|615687628|FG003|Extension Year 2|Early Withdrawals|0|||
170369297|NCT00364832|615687629|FG004|Extension Year 2|Early Withdrawals|0|||
170369298|NCT00364832|615687630|FG005|Extension Year 2|Early Withdrawals|0|||
170369299|NCT00364832|615687631|FG006|Extension Year 2|Early Withdrawals|0|||
170369300|NCT00364832|615687632|FG007|Extension Year 2|Early Withdrawals|0|||
170369301|NCT00364832|615687633|FG008|Extension Year 2|Early Withdrawals|0|||
170369302|NCT00364832|615687634|FG009|Extension Year 2|Early Withdrawals|5|||
170369303|NCT00364832|615687635|FG010|Extension Year 2|Early Withdrawals|5|||
170369304|NCT00364832|615687636|FG011|Extension Year 2|Early Withdrawals|3|||
170369305|NCT01536418|615687637|FG000|Overall Study|Protocol Violation|2|||
170369306|NCT01536418|615687638|FG001|Overall Study|Protocol Violation|3|||
170369307|NCT01536418|615687637|FG000|Overall Study|Physician Decision|1|||
170369308|NCT01536418|615687638|FG001|Overall Study|Physician Decision|3|||
170369309|NCT01536418|615687637|FG000|Overall Study|Study closed/terminated|41|||
170369310|NCT01536418|615687638|FG001|Overall Study|Study closed/terminated|37|||
170369311|NCT01536418|615687637|FG000|Overall Study|Lack of Efficacy|10|||
170369312|NCT01536418|615687638|FG001|Overall Study|Lack of Efficacy|16|||
170369313|NCT01536418|615687637|FG000|Overall Study|Adverse Event|9|||
170369314|NCT01536418|615687638|FG001|Overall Study|Adverse Event|4|||
170369315|NCT01536418|615687637|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
170369316|NCT01536418|615687638|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
170369317|NCT01536418|615687637|FG000|Overall Study|Withdrawal by Subject|5|||
170369318|NCT01536418|615687638|FG001|Overall Study|Withdrawal by Subject|3|||
170369319|NCT01444898|615687641|FG000|Overall Study|Withdrawal by Subject|1|||
170369320|NCT02244619|615687642|FG000|Overall Study|Did not receive study intervention|8|||
170369321|NCT02244619|615687643|FG001|Overall Study|Did not receive study intervention|21|||
170369322|NCT03135262|615687644|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
170369323|NCT03135262|615687645|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
170369324|NCT03135262|615687646|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
170369325|NCT03135262|615687647|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
170369326|NCT03135262|615687648|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
170369327|NCT03135262|615687644|FG000|Overall Study|Progression of disease|0|||
170369328|NCT03135262|615687645|FG001|Overall Study|Progression of disease|0|||
170369329|NCT03135262|615687646|FG002|Overall Study|Progression of disease|0|||
170369330|NCT03135262|615687647|FG003|Overall Study|Progression of disease|1|||
170369331|NCT03135262|615687648|FG004|Overall Study|Progression of disease|0|||
170369332|NCT03135262|615687644|FG000|Overall Study|Death|6|||
170369333|NCT03135262|615687645|FG001|Overall Study|Death|2|||
170369334|NCT03135262|615687646|FG002|Overall Study|Death|2|||
170369335|NCT03135262|615687647|FG003|Overall Study|Death|2|||
170369336|NCT03135262|615687648|FG004|Overall Study|Death|0|||
170369337|NCT03135262|615687644|FG000|Overall Study|Withdrawal by Subject|0|||
170369338|NCT03135262|615687645|FG001|Overall Study|Withdrawal by Subject|0|||
170369339|NCT03135262|615687646|FG002|Overall Study|Withdrawal by Subject|1|||
170369340|NCT03135262|615687647|FG003|Overall Study|Withdrawal by Subject|0|||
170369341|NCT03135262|615687648|FG004|Overall Study|Withdrawal by Subject|1|||
170369342|NCT03135262|615687644|FG000|Overall Study|Study terminated by sponsor|2|||
170369343|NCT03135262|615687645|FG001|Overall Study|Study terminated by sponsor|4|||
170369344|NCT03135262|615687646|FG002|Overall Study|Study terminated by sponsor|4|||
170369345|NCT03135262|615687647|FG003|Overall Study|Study terminated by sponsor|3|||
170369346|NCT03135262|615687648|FG004|Overall Study|Study terminated by sponsor|0|||
170369347|NCT00068822|615687650|FG000|First Randomized Intervention|Lost to Follow-up|1|||
170369348|NCT00068822|615687651|FG001|First Randomized Intervention|Lost to Follow-up|2|||
170369349|NCT01548417|615687657|FG000|Overall Study|Withdrawal by Subject|0|||
170369350|NCT01548417|615687658|FG001|Overall Study|Withdrawal by Subject|2|||
170369351|NCT04583969|615687659|FG000|Overall Study|Death|31|||
170369352|NCT04583969|615687660|FG001|Overall Study|Death|38|||
170369353|NCT04583969|615687659|FG000|Overall Study|Lost to Follow-up|16|||
170369354|NCT04583969|615687660|FG001|Overall Study|Lost to Follow-up|13|||
170369355|NCT04583969|615687659|FG000|Overall Study|Protocol Violation|1|||
170369356|NCT04583969|615687660|FG001|Overall Study|Protocol Violation|0|||
170369357|NCT04583969|615687659|FG000|Overall Study|Withdrawal by Subject|3|||
170369358|NCT04583969|615687660|FG001|Overall Study|Withdrawal by Subject|3|||
170369359|NCT04583969|615687659|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
170369360|NCT04583969|615687660|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
170369361|NCT04583969|615687659|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
170369362|NCT04583969|615687660|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
170369363|NCT04583969|615687659|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
170369364|NCT04583969|615687660|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
170369365|NCT04583969|615687659|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
170369366|NCT04583969|615687660|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
170369367|NCT04583969|615687659|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
170369368|NCT04583969|615687660|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
170369369|NCT00865046|615687661|FG000|Overall Study|Lost to Follow-up|1|||
170369370|NCT00865046|615687662|FG001|Overall Study|Lost to Follow-up|4|||
170369371|NCT00865046|615687663|FG002|Overall Study|Lost to Follow-up|0|||
170369372|NCT00865046|615687661|FG000|Overall Study|Death|0|||
170369373|NCT00865046|615687662|FG001|Overall Study|Death|1|||
170369374|NCT00865046|615687663|FG002|Overall Study|Death|1|||
170369375|NCT00865046|615687661|FG000|Overall Study|Withdrawal by Subject|5|||
170369376|NCT00865046|615687662|FG001|Overall Study|Withdrawal by Subject|0|||
170369377|NCT00865046|615687663|FG002|Overall Study|Withdrawal by Subject|0|||
170369378|NCT01421069|615687664|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
170369379|NCT01421069|615687664|FG000|Parent Study|Failed to return|3|||
170369380|NCT01421069|615687664|FG000|Parent Study|Withdrawal by Subject|1|||
170369381|NCT01421069|615687664|FG000|Parent Study|Lost to Follow-up|2|||
170369382|NCT01421069|615687664|FG000|Parent Study|Lack of Efficacy|1|||
170369383|NCT01421069|615687664|FG000|Overall Period for Extension Study|Other|2|||
170369384|NCT01421069|615687664|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
170369385|NCT01421069|615687664|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
170369386|NCT01421069|615687664|FG000|Overall Period for Extension Study|Pregnancy|1|||
170369387|NCT01421069|615687664|FG000|Overall Period for Extension Study|Adverse Event|1|||
170369388|NCT01421069|615687664|FG000|Overall Period for Extension Study|Protocol Violation|1|||
170369389|NCT01421069|615687664|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
170369390|NCT01421069|615687664|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
170369391|NCT01421069|615687664|FG000|Active Treatment Period|Other|1|||
170369392|NCT01421069|615687664|FG000|Active Treatment Period|No longer willing to participate in study|8|||
170369393|NCT01421069|615687664|FG000|Active Treatment Period|Insufficient clinical response|1|||
170369394|NCT01421069|615687664|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
170369395|NCT01421069|615687664|FG000|Active Treatment Period|Pregnancy|1|||
170369396|NCT01421069|615687664|FG000|Active Treatment Period|Adverse Event|1|||
170369397|NCT01421069|615687664|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
170369398|NCT01421069|615687664|FG000|Active Treatment Period|Enrolled in observational period|29|||
170369399|NCT01421069|615687664|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
170369400|NCT01421069|615687664|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
170369401|NCT01421069|615687664|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
170369402|NCT01421069|615687664|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
170369403|NCT01421069|615687664|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
170369404|NCT01421069|615687664|FG000|2b. Retreatment Period|Protocol Violation|1|||
170369405|NCT01421069|615687664|FG000|Observational Period|Other|1|||
170369406|NCT01421069|615687664|FG000|Observational Period|No longer willing to participate in study|4|||
170369407|NCT01421069|615687664|FG000|Observational Period|Lost to Follow-up|3|||
170369408|NCT00741260|615687666|FG000|Overall Study|Disease Progression|3|||
170369409|NCT00741260|615687667|FG001|Overall Study|Disease Progression|5|||
170369410|NCT00741260|615687668|FG002|Overall Study|Disease Progression|3|||
170369411|NCT00741260|615687669|FG003|Overall Study|Disease Progression|3|||
170369412|NCT00741260|615687670|FG004|Overall Study|Disease Progression|5|||
170369413|NCT00741260|615687671|FG005|Overall Study|Disease Progression|37|||
170369414|NCT00741260|615687672|FG006|Overall Study|Disease Progression|4|||
170369415|NCT00741260|615687666|FG000|Overall Study|Death|0|||
170369416|NCT00741260|615687667|FG001|Overall Study|Death|1|||
170369417|NCT00741260|615687668|FG002|Overall Study|Death|0|||
170369418|NCT00741260|615687669|FG003|Overall Study|Death|1|||
170369419|NCT00741260|615687670|FG004|Overall Study|Death|2|||
170369420|NCT00741260|615687671|FG005|Overall Study|Death|2|||
170369421|NCT00741260|615687672|FG006|Overall Study|Death|1|||
170369422|NCT00741260|615687666|FG000|Overall Study|Withdrawal by Subject|0|||
170369423|NCT00741260|615687667|FG001|Overall Study|Withdrawal by Subject|0|||
170369424|NCT00741260|615687668|FG002|Overall Study|Withdrawal by Subject|0|||
170369425|NCT00741260|615687669|FG003|Overall Study|Withdrawal by Subject|0|||
170369426|NCT00741260|615687670|FG004|Overall Study|Withdrawal by Subject|1|||
170369427|NCT00741260|615687671|FG005|Overall Study|Withdrawal by Subject|3|||
170369428|NCT00741260|615687672|FG006|Overall Study|Withdrawal by Subject|1|||
170369429|NCT00741260|615687666|FG000|Overall Study|Physician Decision|1|||
170369430|NCT00741260|615687667|FG001|Overall Study|Physician Decision|1|||
170369431|NCT00741260|615687668|FG002|Overall Study|Physician Decision|0|||
170369432|NCT00741260|615687669|FG003|Overall Study|Physician Decision|0|||
170369433|NCT00741260|615687670|FG004|Overall Study|Physician Decision|0|||
170369434|NCT00741260|615687671|FG005|Overall Study|Physician Decision|0|||
170369435|NCT00741260|615687672|FG006|Overall Study|Physician Decision|0|||
170369436|NCT00741260|615687666|FG000|Overall Study|Other|2|||
170369437|NCT00741260|615687667|FG001|Overall Study|Other|1|||
170369438|NCT00741260|615687668|FG002|Overall Study|Other|1|||
170369439|NCT00741260|615687669|FG003|Overall Study|Other|2|||
170369440|NCT00741260|615687670|FG004|Overall Study|Other|1|||
170369441|NCT00741260|615687671|FG005|Overall Study|Other|3|||
170369442|NCT00741260|615687672|FG006|Overall Study|Other|1|||
170369443|NCT02565615|615687673|FG000|Overall Study|Death|0|||
170369444|NCT02565615|615687674|FG001|Overall Study|Death|1|||
170369445|NCT02565615|615687675|FG002|Overall Study|Death|0|||
170369446|NCT02565615|615687676|FG003|Overall Study|Death|0|||
170369447|NCT02565615|615687677|FG004|Overall Study|Death|4|||
170369448|NCT02565615|615687673|FG000|Overall Study|Not willing to participate in study|2|||
170369449|NCT02565615|615687674|FG001|Overall Study|Not willing to participate in study|21|||
170369450|NCT02565615|615687675|FG002|Overall Study|Not willing to participate in study|0|||
170369451|NCT02565615|615687676|FG003|Overall Study|Not willing to participate in study|1|||
170369452|NCT02565615|615687677|FG004|Overall Study|Not willing to participate in study|169|||
170369453|NCT02565615|615687673|FG000|Overall Study|Lost to Follow-up|0|||
170369454|NCT02565615|615687674|FG001|Overall Study|Lost to Follow-up|4|||
170369455|NCT02565615|615687675|FG002|Overall Study|Lost to Follow-up|0|||
170369456|NCT02565615|615687676|FG003|Overall Study|Lost to Follow-up|1|||
170369457|NCT02565615|615687677|FG004|Overall Study|Lost to Follow-up|765|||
170369458|NCT02565615|615687673|FG000|Overall Study|Not meeting eligibility criteria|0|||
170369459|NCT02565615|615687674|FG001|Overall Study|Not meeting eligibility criteria|7|||
170369460|NCT02565615|615687675|FG002|Overall Study|Not meeting eligibility criteria|0|||
170369461|NCT02565615|615687676|FG003|Overall Study|Not meeting eligibility criteria|0|||
170369462|NCT02565615|615687677|FG004|Overall Study|Not meeting eligibility criteria|25|||
170369463|NCT02565615|615687673|FG000|Overall Study|Reason not defined|0|||
170369464|NCT02565615|615687674|FG001|Overall Study|Reason not defined|2|||
170369465|NCT02565615|615687675|FG002|Overall Study|Reason not defined|0|||
170369466|NCT02565615|615687676|FG003|Overall Study|Reason not defined|1|||
170369467|NCT02565615|615687677|FG004|Overall Study|Reason not defined|62|||
170369468|NCT02565615|615687673|FG000|Overall Study|Adverse Event|1|||
170369469|NCT02565615|615687674|FG001|Overall Study|Adverse Event|1|||
170369470|NCT02565615|615687675|FG002|Overall Study|Adverse Event|0|||
170369471|NCT02565615|615687676|FG003|Overall Study|Adverse Event|0|||
170369472|NCT02565615|615687677|FG004|Overall Study|Adverse Event|9|||
170369473|NCT02565615|615687673|FG000|Overall Study|Untreated|0|||
170369474|NCT02565615|615687674|FG001|Overall Study|Untreated|0|||
170369475|NCT02565615|615687675|FG002|Overall Study|Untreated|0|||
170369476|NCT02565615|615687676|FG003|Overall Study|Untreated|0|||
170369477|NCT02565615|615687677|FG004|Overall Study|Untreated|567|||
170369478|NCT01928082|615687679|FG000|Overall Study|Study terminated.|1|||
170369479|NCT02120352|615687682|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
170369480|NCT02120352|615687683|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
170369481|NCT02120352|615687684|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
170369482|NCT02120352|615687685|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
170369483|NCT02120352|615687686|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
170369484|NCT02120352|615687687|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
170369485|NCT02120352|615687688|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
170369486|NCT02120352|615687682|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
170369487|NCT02120352|615687683|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
170369488|NCT02120352|615687684|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
170369489|NCT02120352|615687685|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
170369490|NCT02120352|615687686|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
170369491|NCT02120352|615687687|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
170369492|NCT02120352|615687688|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
170369493|NCT02120352|615687682|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
170369494|NCT02120352|615687683|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
170369495|NCT02120352|615687684|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
170369496|NCT02120352|615687685|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
170369497|NCT02120352|615687686|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
170369498|NCT02120352|615687687|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
170369499|NCT02120352|615687688|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
170369500|NCT02120352|615687682|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
170369501|NCT02120352|615687683|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
170369502|NCT02120352|615687684|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
170369503|NCT02120352|615687685|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
170369504|NCT02120352|615687686|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
170369505|NCT02120352|615687687|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
170369506|NCT02120352|615687688|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
170369507|NCT02120352|615687682|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
170369508|NCT02120352|615687683|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
170369509|NCT02120352|615687684|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
170369510|NCT02120352|615687685|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
170369511|NCT02120352|615687686|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
170369512|NCT02120352|615687687|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
170369513|NCT02120352|615687688|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
170369514|NCT02120352|615687682|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
170369515|NCT02120352|615687683|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
170369516|NCT02120352|615687684|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
170369517|NCT02120352|615687685|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
170369518|NCT02120352|615687686|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
170369519|NCT02120352|615687687|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
170369520|NCT02120352|615687688|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
170369521|NCT02120352|615687682|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
170369522|NCT02120352|615687683|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
170369523|NCT02120352|615687684|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
170369524|NCT02120352|615687685|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
170369525|NCT02120352|615687686|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
170369526|NCT02120352|615687687|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
170369527|NCT02120352|615687688|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
170369528|NCT02120352|615687682|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
170369529|NCT02120352|615687683|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
170369530|NCT02120352|615687684|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
170369531|NCT02120352|615687685|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
170369532|NCT02120352|615687686|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
170369533|NCT02120352|615687687|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
170369534|NCT02120352|615687688|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
170369535|NCT02120352|615687682|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
170369536|NCT02120352|615687683|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
170369537|NCT02120352|615687684|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
170369538|NCT02120352|615687685|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
170369539|NCT02120352|615687686|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
170369540|NCT02120352|615687687|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
170369541|NCT02120352|615687688|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
170369542|NCT02120352|615687682|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
170369543|NCT02120352|615687683|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
170369544|NCT02120352|615687684|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
170369545|NCT02120352|615687685|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
170369546|NCT02120352|615687686|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
170369547|NCT02120352|615687687|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
170369548|NCT02120352|615687688|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
170369549|NCT02120352|615687682|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
170369550|NCT02120352|615687683|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
170369551|NCT02120352|615687684|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
170369552|NCT02120352|615687685|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
170369553|NCT02120352|615687686|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
170369554|NCT02120352|615687687|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
170369555|NCT02120352|615687688|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
170369556|NCT02120352|615687682|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
170369557|NCT02120352|615687683|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
170369558|NCT02120352|615687684|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
170369559|NCT02120352|615687685|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
170369560|NCT02120352|615687686|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
170369561|NCT02120352|615687687|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
170369562|NCT02120352|615687688|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
170369563|NCT02120352|615687682|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
170369564|NCT02120352|615687683|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
170369565|NCT02120352|615687684|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
170369566|NCT02120352|615687685|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
170369567|NCT02120352|615687686|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
170369568|NCT02120352|615687687|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
170369569|NCT02120352|615687688|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
170369570|NCT02120352|615687682|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
170369571|NCT02120352|615687683|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
170369572|NCT02120352|615687684|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
170369573|NCT02120352|615687685|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
170369574|NCT02120352|615687686|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
170369575|NCT02120352|615687687|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
170369576|NCT02120352|615687688|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
170369577|NCT02120352|615687682|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
170369578|NCT02120352|615687683|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
170369579|NCT02120352|615687684|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
170369580|NCT02120352|615687685|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
170369581|NCT02120352|615687686|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
170369582|NCT02120352|615687687|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
170369583|NCT02120352|615687688|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
170369584|NCT02120352|615687682|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
170369585|NCT02120352|615687683|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
170369586|NCT02120352|615687684|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
170369587|NCT02120352|615687685|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
170369588|NCT02120352|615687686|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
170369589|NCT02120352|615687687|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
170369590|NCT02120352|615687688|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
170369591|NCT02120352|615687682|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
170369592|NCT02120352|615687683|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
170369593|NCT02120352|615687684|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
170369594|NCT02120352|615687685|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
170369595|NCT02120352|615687686|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
170369596|NCT02120352|615687687|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
170369597|NCT02120352|615687688|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
170369598|NCT02120352|615687682|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
170369599|NCT02120352|615687683|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
170369600|NCT02120352|615687684|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
170369601|NCT02120352|615687685|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
170369602|NCT02120352|615687686|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
170369603|NCT02120352|615687687|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
170369604|NCT02120352|615687688|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
170369605|NCT02120352|615687682|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
170369606|NCT02120352|615687683|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
170369607|NCT02120352|615687684|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
170369608|NCT02120352|615687685|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
170369609|NCT02120352|615687686|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
170369610|NCT02120352|615687687|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
170369611|NCT02120352|615687688|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
170369612|NCT02120352|615687682|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
170369613|NCT02120352|615687683|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
170369614|NCT02120352|615687684|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
170369615|NCT02120352|615687685|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
170369616|NCT02120352|615687686|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
170369617|NCT02120352|615687687|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
170369618|NCT02120352|615687688|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
170369619|NCT02120352|615687682|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
170369620|NCT02120352|615687683|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
170369621|NCT02120352|615687684|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
170369622|NCT02120352|615687685|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
170369623|NCT02120352|615687686|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
170369624|NCT02120352|615687687|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
170369625|NCT02120352|615687688|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
170369626|NCT02120352|615687682|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
170369627|NCT02120352|615687683|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
170369628|NCT02120352|615687684|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
170369629|NCT02120352|615687685|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
170369630|NCT02120352|615687686|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
170398849|NCT05004181|615798313|FG001|Overall Study|Lost to Follow-up|4|||
170369631|NCT02120352|615687687|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
170369632|NCT02120352|615687688|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
170369633|NCT00166517|615687691|FG000|Overall Study|Lost to Follow-up|1|||
170369634|NCT00166517|615687692|FG001|Overall Study|Lost to Follow-up|0|||
170369635|NCT00166517|615687691|FG000|Overall Study|Protocol Violation|4|||
170369636|NCT00166517|615687692|FG001|Overall Study|Protocol Violation|1|||
170369637|NCT00166517|615687691|FG000|Overall Study|Withdrawal by Subject|0|||
170369638|NCT00166517|615687692|FG001|Overall Study|Withdrawal by Subject|1|||
170369639|NCT03094611|615687696|FG000|Overall Study|Lack of Efficacy|1|||
170369640|NCT03094611|615687696|FG000|Overall Study|Stem Cell Transplant|1|||
170369641|NCT02186561|615687697|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
170369642|NCT02186561|615687697|FG000|Enrollment|Enrollment Cap Reached|5|||
170369643|NCT02186561|615687697|FG000|Enrollment|Insurance Denial|2|||
170369644|NCT02186561|615687697|FG000|Enrollment|Withdrawal by Subject|2|||
170369645|NCT02186561|615687697|FG000|Enrollment|Investigator Withdrew Consent|1|||
170369646|NCT02186561|615687697|FG000|30-Day Post Index Procedure Visit|Death|1|||
170369647|NCT02186561|615687697|FG000|1- Year Post Index Procedure Visit|Death|1|||
170369648|NCT02186561|615687697|FG000|1- Year Post Index Procedure Visit|Missed|1|||
170369649|NCT02671760|615687704|FG000|Overall Study|Lost to Follow-up|0|||
170369650|NCT02671760|615687705|FG001|Overall Study|Lost to Follow-up|1|||
170369651|NCT02671760|615687706|FG002|Overall Study|Lost to Follow-up|0|||
170369652|NCT02079519|615687709|FG000|Overall Study|Disease Progression|9|||
170369653|NCT02079519|615687709|FG000|Overall Study|Adverse Event|1|||
170369654|NCT01802515|615687710|FG000|Overall Study|Withdrawal by Subject|3|||
170369655|NCT01802515|615687711|FG001|Overall Study|Withdrawal by Subject|0|||
170369656|NCT01802515|615687712|FG002|Overall Study|Withdrawal by Subject|0|||
170369657|NCT01931150|615687715|FG000|Overall Study|Withdrawal by Subject|1|||
170369658|NCT01931150|615687716|FG001|Overall Study|Withdrawal by Subject|2|||
170369659|NCT00845845|615687719|FG000|Overall Study|Lost to Follow-up|0|||
170369660|NCT00845845|615687720|FG001|Overall Study|Lost to Follow-up|4|||
170369661|NCT01685203|615687721|FG000|Overall Study|Lost to Follow-up|3|||
170369662|NCT01685203|615687722|FG001|Overall Study|Lost to Follow-up|3|||
170369663|NCT01685203|615687723|FG002|Overall Study|Lost to Follow-up|0|||
170369664|NCT01685203|615687724|FG003|Overall Study|Lost to Follow-up|1|||
170369665|NCT01685203|615687725|FG004|Overall Study|Lost to Follow-up|0|||
170369666|NCT01685203|615687726|FG005|Overall Study|Lost to Follow-up|0|||
170369667|NCT01685203|615687727|FG006|Overall Study|Lost to Follow-up|0|||
170369668|NCT01685203|615687721|FG000|Overall Study|Adverse Event|0|||
170369669|NCT01685203|615687722|FG001|Overall Study|Adverse Event|0|||
170369670|NCT01685203|615687723|FG002|Overall Study|Adverse Event|0|||
170369671|NCT01685203|615687724|FG003|Overall Study|Adverse Event|0|||
170369672|NCT01685203|615687725|FG004|Overall Study|Adverse Event|0|||
170369673|NCT01685203|615687726|FG005|Overall Study|Adverse Event|2|||
170369674|NCT01685203|615687727|FG006|Overall Study|Adverse Event|0|||
170369675|NCT01685203|615687721|FG000|Overall Study|Adverse event and withdrew consent|1|||
170369676|NCT01685203|615687722|FG001|Overall Study|Adverse event and withdrew consent|0|||
170369677|NCT01685203|615687723|FG002|Overall Study|Adverse event and withdrew consent|0|||
170369678|NCT01685203|615687724|FG003|Overall Study|Adverse event and withdrew consent|0|||
170369679|NCT01685203|615687725|FG004|Overall Study|Adverse event and withdrew consent|0|||
170369680|NCT01685203|615687726|FG005|Overall Study|Adverse event and withdrew consent|0|||
170369681|NCT01685203|615687727|FG006|Overall Study|Adverse event and withdrew consent|0|||
170369682|NCT01685203|615687721|FG000|Overall Study|Patient's decision|0|||
170369683|NCT01685203|615687722|FG001|Overall Study|Patient's decision|0|||
170369684|NCT01685203|615687723|FG002|Overall Study|Patient's decision|0|||
170369685|NCT01685203|615687724|FG003|Overall Study|Patient's decision|0|||
170369686|NCT01685203|615687725|FG004|Overall Study|Patient's decision|0|||
170369687|NCT01685203|615687726|FG005|Overall Study|Patient's decision|1|||
170369688|NCT01685203|615687727|FG006|Overall Study|Patient's decision|0|||
170369689|NCT01570309|615687728|FG000|Overall Study|Withdrawal by Subject|3|||
170369690|NCT01570309|615687729|FG001|Overall Study|Withdrawal by Subject|3|||
170369691|NCT04095793|615687730|FG000|Overall Study|Adverse Event|3|||
170369692|NCT04095793|615687730|FG000|Overall Study|Study Terminated by Sponsor|103|||
170369693|NCT04095793|615687730|FG000|Overall Study|Withdrawal by Subject|4|||
170369694|NCT03619837|615687731|FG000|Screening|received organs from HCV-negative donors|47|||
170369695|NCT03619837|615687731|FG000|Screening|died on the wait-list|2|||
170369696|NCT03619837|615687731|FG000|Screening|remained on the wait list|40|||
170369697|NCT03619837|615687731|FG000|Screening|didn't meet eligibility criteria|3|||
170369698|NCT03619837|615687731|FG000|Screening|withdrew consent|2|||
170369699|NCT03619837|615687731|FG000|Screening|never listed for HCV-viremic donor|1|||
170369700|NCT03619837|615687731|FG000|Screening|developed exclusion criteria|2|||
170369701|NCT03619837|615687731|FG000|Screening|excluded by the investigator due to non-compliance|1|||
170369702|NCT00642018|615687732|FG000|Overall Study|Adverse Event|11|||
170369703|NCT00642018|615687733|FG001|Overall Study|Adverse Event|36|||
170369704|NCT00642018|615687732|FG000|Overall Study|Withdrawal by Subject|4|||
170369705|NCT00642018|615687733|FG001|Overall Study|Withdrawal by Subject|10|||
170369706|NCT00642018|615687732|FG000|Overall Study|Progressive Disease|13|||
170369707|NCT00642018|615687733|FG001|Overall Study|Progressive Disease|18|||
170369708|NCT00642018|615687732|FG000|Overall Study|Physician Decision|0|||
170369709|NCT00642018|615687733|FG001|Overall Study|Physician Decision|10|||
170369710|NCT00642018|615687732|FG000|Overall Study|Protocol Violation|0|||
170369711|NCT00642018|615687733|FG001|Overall Study|Protocol Violation|1|||
170369712|NCT00642018|615687732|FG000|Overall Study|Death|0|||
170369713|NCT00642018|615687733|FG001|Overall Study|Death|3|||
170369714|NCT00642018|615687732|FG000|Overall Study|Entry Criteria Not Met|0|||
170369715|NCT00642018|615687733|FG001|Overall Study|Entry Criteria Not Met|1|||
170369716|NCT01410799|615687734|FG000|Overall Study|PI decision|13|||
170369717|NCT04507360|615689928|FG000|Week 1|Lost to Follow-up|0|||
170369718|NCT04507360|615689929|FG001|Week 1|Lost to Follow-up|0|||
170369719|NCT04507360|615689930|FG002|Week 1|Lost to Follow-up|0|||
170369720|NCT04507360|615689931|FG003|Week 1|Lost to Follow-up|0|||
170369721|NCT04507360|615689932|FG004|Week 1|Lost to Follow-up|0|||
170369722|NCT04507360|615689933|FG005|Week 1|Lost to Follow-up|0|||
170369723|NCT04507360|615689934|FG006|Week 1|Lost to Follow-up|0|||
170369724|NCT04507360|615689935|FG007|Week 1|Lost to Follow-up|0|||
170369725|NCT04507360|615689936|FG008|Week 1|Lost to Follow-up|72|||
170369726|NCT04507360|615689937|FG009|Week 1|Lost to Follow-up|22|||
170369727|NCT04507360|615689938|FG010|Week 1|Lost to Follow-up|10|||
170369728|NCT04507360|615689928|FG000|Week 2|Lost to Follow-up|0|||
170369729|NCT04507360|615689929|FG001|Week 2|Lost to Follow-up|0|||
170369730|NCT04507360|615689930|FG002|Week 2|Lost to Follow-up|0|||
170369731|NCT04507360|615689931|FG003|Week 2|Lost to Follow-up|0|||
170369732|NCT04507360|615689932|FG004|Week 2|Lost to Follow-up|0|||
170369733|NCT04507360|615689933|FG005|Week 2|Lost to Follow-up|0|||
170369734|NCT04507360|615689934|FG006|Week 2|Lost to Follow-up|0|||
170369735|NCT04507360|615689935|FG007|Week 2|Lost to Follow-up|0|||
170369736|NCT04507360|615689936|FG008|Week 2|Lost to Follow-up|121|||
170369737|NCT04507360|615689937|FG009|Week 2|Lost to Follow-up|85|||
170369738|NCT04507360|615689938|FG010|Week 2|Lost to Follow-up|82|||
170369739|NCT04507360|615689928|FG000|Week 3|Lost to Follow-up|0|||
170369740|NCT04507360|615689929|FG001|Week 3|Lost to Follow-up|0|||
170369741|NCT04507360|615689930|FG002|Week 3|Lost to Follow-up|0|||
170369742|NCT04507360|615689931|FG003|Week 3|Lost to Follow-up|0|||
170369743|NCT04507360|615689932|FG004|Week 3|Lost to Follow-up|0|||
170369744|NCT04507360|615689933|FG005|Week 3|Lost to Follow-up|0|||
170369745|NCT04507360|615689934|FG006|Week 3|Lost to Follow-up|0|||
170369746|NCT04507360|615689935|FG007|Week 3|Lost to Follow-up|0|||
170369747|NCT04507360|615689936|FG008|Week 3|Lost to Follow-up|123|||
170369748|NCT04507360|615689937|FG009|Week 3|Lost to Follow-up|92|||
170369749|NCT04507360|615689938|FG010|Week 3|Lost to Follow-up|84|||
170369750|NCT04507360|615689928|FG000|Week 4|Lost to Follow-up|0|||
170369751|NCT04507360|615689929|FG001|Week 4|Lost to Follow-up|0|||
170369752|NCT04507360|615689930|FG002|Week 4|Lost to Follow-up|0|||
170369753|NCT04507360|615689931|FG003|Week 4|Lost to Follow-up|0|||
170369754|NCT04507360|615689932|FG004|Week 4|Lost to Follow-up|0|||
170369755|NCT04507360|615689933|FG005|Week 4|Lost to Follow-up|0|||
170369756|NCT04507360|615689934|FG006|Week 4|Lost to Follow-up|0|||
170369757|NCT04507360|615689935|FG007|Week 4|Lost to Follow-up|0|||
170369758|NCT04507360|615689936|FG008|Week 4|Lost to Follow-up|131|||
170369759|NCT04507360|615689937|FG009|Week 4|Lost to Follow-up|115|||
170369760|NCT04507360|615689938|FG010|Week 4|Lost to Follow-up|102|||
170369761|NCT04507360|615689928|FG000|Week 5|Lost to Follow-up|0|||
170369762|NCT04507360|615689929|FG001|Week 5|Lost to Follow-up|0|||
170369763|NCT04507360|615689930|FG002|Week 5|Lost to Follow-up|0|||
170369764|NCT04507360|615689931|FG003|Week 5|Lost to Follow-up|0|||
170369765|NCT04507360|615689932|FG004|Week 5|Lost to Follow-up|0|||
170369766|NCT04507360|615689933|FG005|Week 5|Lost to Follow-up|0|||
170369767|NCT04507360|615689934|FG006|Week 5|Lost to Follow-up|0|||
170369768|NCT04507360|615689935|FG007|Week 5|Lost to Follow-up|0|||
170369769|NCT04507360|615689936|FG008|Week 5|Lost to Follow-up|103|||
170369770|NCT04507360|615689937|FG009|Week 5|Lost to Follow-up|135|||
170369771|NCT04507360|615689938|FG010|Week 5|Lost to Follow-up|143|||
170369772|NCT04507360|615689928|FG000|Week 8|Lost to Follow-up|0|||
170369773|NCT04507360|615689929|FG001|Week 8|Lost to Follow-up|0|||
170369774|NCT04507360|615689930|FG002|Week 8|Lost to Follow-up|0|||
170369775|NCT04507360|615689931|FG003|Week 8|Lost to Follow-up|0|||
170369776|NCT04507360|615689932|FG004|Week 8|Lost to Follow-up|0|||
170369777|NCT04507360|615689933|FG005|Week 8|Lost to Follow-up|0|||
170369778|NCT04507360|615689934|FG006|Week 8|Lost to Follow-up|0|||
170369779|NCT04507360|615689935|FG007|Week 8|Lost to Follow-up|0|||
170369780|NCT04507360|615689936|FG008|Week 8|Lost to Follow-up|139|||
170369781|NCT04507360|615689937|FG009|Week 8|Lost to Follow-up|145|||
170369782|NCT04507360|615689938|FG010|Week 8|Lost to Follow-up|152|||
170369783|NCT01432756|615689939|FG000|Overall Study|Lost to Follow-up|1|||
170369784|NCT01432756|615689940|FG001|Overall Study|Lost to Follow-up|0|||
170369785|NCT01432756|615689941|FG002|Overall Study|Lost to Follow-up|2|||
170369786|NCT01432756|615689942|FG003|Overall Study|Lost to Follow-up|1|||
170369787|NCT01998906|615689943|FG000|Overall Study|Participants ongoing in follow-up|77|||
170369788|NCT01998906|615689944|FG001|Overall Study|Participants ongoing in follow-up|60|||
170369789|NCT01998906|615689945|FG002|Overall Study|Participants ongoing in follow-up|58|||
170369790|NCT01998906|615689943|FG000|Overall Study|Death|21|||
170369791|NCT01998906|615689944|FG001|Overall Study|Death|30|||
170369792|NCT01998906|615689945|FG002|Overall Study|Death|17|||
170369793|NCT01998906|615689943|FG000|Overall Study|Lack of Efficacy|10|||
170369794|NCT01998906|615689944|FG001|Overall Study|Lack of Efficacy|9|||
170369795|NCT01998906|615689945|FG002|Overall Study|Lack of Efficacy|8|||
170369796|NCT01998906|615689943|FG000|Overall Study|Failure to return|0|||
170369797|NCT01998906|615689944|FG001|Overall Study|Failure to return|2|||
170369798|NCT01998906|615689945|FG002|Overall Study|Failure to return|4|||
170369799|NCT01998906|615689943|FG000|Overall Study|Violation of Selection Criteria|0|||
170369800|NCT01998906|615689944|FG001|Overall Study|Violation of Selection Criteria|0|||
170369801|NCT01998906|615689945|FG002|Overall Study|Violation of Selection Criteria|1|||
170369802|NCT01998906|615689943|FG000|Overall Study|Withdrawal by Subject|1|||
170369803|NCT01998906|615689944|FG001|Overall Study|Withdrawal by Subject|4|||
170369804|NCT01998906|615689945|FG002|Overall Study|Withdrawal by Subject|3|||
170369805|NCT01998906|615689943|FG000|Overall Study|Administrative/Other|2|||
170369806|NCT01998906|615689944|FG001|Overall Study|Administrative/Other|1|||
170369807|NCT01998906|615689945|FG002|Overall Study|Administrative/Other|3|||
170369808|NCT01998906|615689943|FG000|Overall Study|Other|3|||
170369809|NCT01998906|615689944|FG001|Overall Study|Other|8|||
170369810|NCT01998906|615689945|FG002|Overall Study|Other|4|||
170369811|NCT01235338|615689947|FG000|Overall Study|Adverse Event|3|||
170369812|NCT01235338|615689948|FG001|Overall Study|Adverse Event|2|||
170369813|NCT01235338|615689947|FG000|Overall Study|Protocol Violation|1|||
170369814|NCT01235338|615689948|FG001|Overall Study|Protocol Violation|1|||
170369815|NCT01235338|615689947|FG000|Overall Study|Withdrawal by Subject|5|||
170369816|NCT01235338|615689948|FG001|Overall Study|Withdrawal by Subject|0|||
170369817|NCT01235338|615689947|FG000|Overall Study|Exclusion criteria violations|1|||
170369818|NCT01235338|615689948|FG001|Overall Study|Exclusion criteria violations|1|||
170369819|NCT01235338|615689947|FG000|Overall Study|Positive drug screen|0|||
170369820|NCT01235338|615689948|FG001|Overall Study|Positive drug screen|1|||
170369821|NCT01235338|615689947|FG000|Overall Study|Prohibited meds|1|||
170369822|NCT01235338|615689948|FG001|Overall Study|Prohibited meds|0|||
170369823|NCT00517413|615689952|FG000|Overall Study|Adverse Event|7|||
170369824|NCT00517413|615689952|FG000|Overall Study|Death|13|||
170369825|NCT00517413|615689952|FG000|Overall Study|Protocol Violation|15|||
170369826|NCT00517413|615689952|FG000|Overall Study|Withdrawal by Subject|2|||
170369827|NCT00517413|615689952|FG000|Overall Study|Failure to return|1|||
170369828|NCT00517413|615689952|FG000|Overall Study|Other-Reasons|23|||
170369829|NCT00429572|615689953|FG000|Overall Study|Disease progression|1|||
170369830|NCT01929018|615689955|FG000|Overall Study|Lost to Follow-up|1|||
170369831|NCT01929018|615689956|FG001|Overall Study|Lost to Follow-up|0|||
170369832|NCT01929018|615689955|FG000|Overall Study|Hospitalization|0|||
170369833|NCT01929018|615689956|FG001|Overall Study|Hospitalization|1|||
170369834|NCT02635867|615689957|FG000|Overall Study|Lost to Follow-up|4|||
170369835|NCT02635867|615689958|FG001|Overall Study|Lost to Follow-up|3|||
170369836|NCT02635867|615689959|FG002|Overall Study|Lost to Follow-up|3|||
170369837|NCT02635867|615689960|FG003|Overall Study|Lost to Follow-up|4|||
170369838|NCT02635867|615689961|FG004|Overall Study|Lost to Follow-up|1|||
170369839|NCT03447821|615689972|FG000|Overall Study|Withdrawal by Subject|1|||
170369840|NCT03447821|615689973|FG001|Overall Study|Withdrawal by Subject|1|||
170369841|NCT03447821|615689974|FG002|Overall Study|Withdrawal by Subject|0|||
170369842|NCT03447821|615689972|FG000|Overall Study|Lost to Follow-up|0|||
170369843|NCT03447821|615689973|FG001|Overall Study|Lost to Follow-up|0|||
170369844|NCT03447821|615689974|FG002|Overall Study|Lost to Follow-up|1|||
170369845|NCT02977507|615689977|FG000|Overall Study|Protocol Deviation|1|||
170369846|NCT02977507|615689978|FG001|Overall Study|Protocol Deviation|0|||
170369847|NCT02977507|615689977|FG000|Overall Study|Lost to Follow-up|1|||
170369848|NCT02977507|615689978|FG001|Overall Study|Lost to Follow-up|0|||
170369849|NCT01098032|615689981|FG000|Overall Study|Withdrawal by Subject|1|||
170369850|NCT01098032|615689982|FG001|Overall Study|Withdrawal by Subject|1|||
170369851|NCT00654420|615689983|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
170369852|NCT00654420|615689984|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
170369853|NCT00654420|615689985|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
170369854|NCT00654420|615689986|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
170369855|NCT00654420|615689983|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
170369856|NCT00654420|615689984|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
170369857|NCT00654420|615689985|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
170369858|NCT00654420|615689986|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
170369859|NCT00654420|615689983|FG000|Phase II|Adverse Event|0|||
170369860|NCT00654420|615689984|FG001|Phase II|Adverse Event|0|||
170369861|NCT00654420|615689985|FG002|Phase II|Adverse Event|3|||
170369862|NCT00654420|615689986|FG003|Phase II|Adverse Event|3|||
170369863|NCT00654420|615689983|FG000|Phase II|Lost to Follow-up|0|||
170369864|NCT00654420|615689984|FG001|Phase II|Lost to Follow-up|0|||
170369865|NCT00654420|615689985|FG002|Phase II|Lost to Follow-up|0|||
170369866|NCT00654420|615689986|FG003|Phase II|Lost to Follow-up|1|||
170369867|NCT00654420|615689983|FG000|Phase II|Physician Decision|0|||
170369868|NCT00654420|615689984|FG001|Phase II|Physician Decision|0|||
170369869|NCT00654420|615689985|FG002|Phase II|Physician Decision|0|||
170369870|NCT00654420|615689986|FG003|Phase II|Physician Decision|4|||
170369871|NCT00654420|615689983|FG000|Phase II|Progressive Disease|0|||
170369872|NCT00654420|615689984|FG001|Phase II|Progressive Disease|0|||
170369873|NCT00654420|615689985|FG002|Phase II|Progressive Disease|29|||
170369874|NCT00654420|615689986|FG003|Phase II|Progressive Disease|29|||
170369875|NCT00654420|615689983|FG000|Phase II|Withdrawal by Subject|0|||
170369876|NCT00654420|615689984|FG001|Phase II|Withdrawal by Subject|0|||
170369877|NCT00654420|615689985|FG002|Phase II|Withdrawal by Subject|4|||
170369878|NCT00654420|615689986|FG003|Phase II|Withdrawal by Subject|1|||
170369879|NCT00654420|615689983|FG000|Phase II|Missing Disposition Record|0|||
170369880|NCT00654420|615689984|FG001|Phase II|Missing Disposition Record|0|||
170369881|NCT00654420|615689985|FG002|Phase II|Missing Disposition Record|1|||
170369882|NCT00654420|615689986|FG003|Phase II|Missing Disposition Record|0|||
170369883|NCT01587274|615689988|FG000|Overall Study|Lost to Follow-up|4|||
170369884|NCT01587274|615689989|FG001|Overall Study|Lost to Follow-up|5|||
170369885|NCT01587274|615689990|FG002|Overall Study|Lost to Follow-up|3|||
170369886|NCT02348840|615689994|FG000|Overall Study|Withdrawal by Subject|2|||
170369887|NCT02348840|615689995|FG001|Overall Study|Withdrawal by Subject|1|||
170369888|NCT02348840|615689996|FG002|Overall Study|Withdrawal by Subject|0|||
170369889|NCT02348840|615689997|FG003|Overall Study|Withdrawal by Subject|0|||
170369890|NCT01025232|615690000|FG000|Overall Study|Study drug no longer available|3|||
170369891|NCT01025232|615690001|FG001|Overall Study|Study drug no longer available|6|||
170369892|NCT01347073|615690004|FG000|Overall Study|Adverse Event|1|||
170369893|NCT01347073|615690004|FG000|Overall Study|Liver Transplant|1|||
170369894|NCT03236506|615690005|FG000|Overall Study|Death|1|||
170369895|NCT03236506|615690006|FG001|Overall Study|Death|1|||
170369896|NCT03236506|615690007|FG002|Overall Study|Death|1|||
170369897|NCT03236506|615690005|FG000|Overall Study|Withdrawal by Subject|3|||
170369898|NCT03236506|615690006|FG001|Overall Study|Withdrawal by Subject|3|||
170369899|NCT03236506|615690007|FG002|Overall Study|Withdrawal by Subject|4|||
170369900|NCT03236506|615690005|FG000|Overall Study|Did not initiate treatment|2|||
170369901|NCT03236506|615690006|FG001|Overall Study|Did not initiate treatment|1|||
170369902|NCT03236506|615690007|FG002|Overall Study|Did not initiate treatment|2|||
170369903|NCT01815580|615690019|FG000|Overall Study|Lost to Follow-up|4|||
170369904|NCT01815580|615690020|FG001|Overall Study|Lost to Follow-up|7|||
170369905|NCT01815580|615690019|FG000|Overall Study|Withdrawal by Subject|3|||
170369906|NCT01815580|615690020|FG001|Overall Study|Withdrawal by Subject|4|||
170369907|NCT01815580|615690019|FG000|Overall Study|Excluded from analysis|5|||
170369908|NCT01815580|615690020|FG001|Overall Study|Excluded from analysis|4|||
170369909|NCT02427100|615690021|FG000|Overall Study|Lost to Follow-up|0|||
170369910|NCT02427100|615690022|FG001|Overall Study|Lost to Follow-up|2|||
170369911|NCT01610206|615690023|FG000|Overall Study|Adverse Event|10|||
170369912|NCT01610206|615690024|FG001|Overall Study|Adverse Event|30|||
170369913|NCT04285853|615690025|FG000|Overall Study|Withdrawal by Subject|1|||
170369914|NCT04285853|615690026|FG001|Overall Study|Withdrawal by Subject|0|||
170369915|NCT04285853|615690025|FG000|Overall Study|Lost to Follow-up|9|||
170369916|NCT04285853|615690026|FG001|Overall Study|Lost to Follow-up|5|||
170369917|NCT01072448|615690027|FG000|Overall Study|Adverse Event|9|||
170369918|NCT01072448|615690028|FG001|Overall Study|Adverse Event|10|||
170369919|NCT01072448|615690027|FG000|Overall Study|Subject withdrew consent|4|||
170369920|NCT01072448|615690028|FG001|Overall Study|Subject withdrew consent|9|||
170369921|NCT01072448|615690027|FG000|Overall Study|Protocol deviation|3|||
170369922|NCT01072448|615690028|FG001|Overall Study|Protocol deviation|4|||
170369923|NCT01072448|615690027|FG000|Overall Study|Abnormal test procedure result(s)|1|||
170369924|NCT01072448|615690028|FG001|Overall Study|Abnormal test procedure result(s)|0|||
170369925|NCT01072448|615690027|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170369926|NCT01072448|615690028|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
170369927|NCT01072448|615690027|FG000|Overall Study|Lost to Follow-up|1|||
170369928|NCT01072448|615690028|FG001|Overall Study|Lost to Follow-up|1|||
170369929|NCT01072448|615690027|FG000|Overall Study|Abnormal laboratory value(s)|0|||
170369930|NCT01072448|615690028|FG001|Overall Study|Abnormal laboratory value(s)|1|||
170369931|NCT01072448|615690027|FG000|Overall Study|Death|0|||
170369932|NCT01072448|615690028|FG001|Overall Study|Death|2|||
170369933|NCT00249795|615690029|FG000|Overall Study|Not treated|16|||
170369934|NCT00249795|615690030|FG001|Overall Study|Not treated|14|||
170369935|NCT00249795|615690029|FG000|Overall Study|Symptomatic hypotension|127|||
170369936|NCT00249795|615690030|FG001|Overall Study|Symptomatic hypotension|64|||
170369937|NCT00249795|615690029|FG000|Overall Study|Other Serious Adverse Event|84|||
170369938|NCT00249795|615690030|FG001|Overall Study|Other Serious Adverse Event|93|||
170369939|NCT00249795|615690029|FG000|Overall Study|Qualifying condition not present|26|||
170369940|NCT00249795|615690030|FG001|Overall Study|Qualifying condition not present|29|||
170369941|NCT00249795|615690029|FG000|Overall Study|Withdrawal by Subject|678|||
170369942|NCT00249795|615690030|FG001|Overall Study|Withdrawal by Subject|742|||
170369943|NCT00249795|615690029|FG000|Overall Study|Thromboembolic / outcome event|39|||
170369944|NCT00249795|615690030|FG001|Overall Study|Thromboembolic / outcome event|45|||
170369945|NCT00249795|615690029|FG000|Overall Study|Oral anticoagulant required|2|||
170369946|NCT00249795|615690030|FG001|Overall Study|Oral anticoagulant required|0|||
170369947|NCT00249795|615690029|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
170369948|NCT00249795|615690030|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
170369949|NCT00249795|615690029|FG000|Overall Study|Non-compliance|71|||
170369950|NCT00249795|615690030|FG001|Overall Study|Non-compliance|69|||
170369951|NCT00249795|615690029|FG000|Overall Study|Study drug intolerance|3|||
170369952|NCT00249795|615690030|FG001|Overall Study|Study drug intolerance|3|||
170369953|NCT00249795|615690029|FG000|Overall Study|Other adverse events (non-serious)|188|||
170369954|NCT00249795|615690030|FG001|Overall Study|Other adverse events (non-serious)|159|||
170369955|NCT00249795|615690029|FG000|Overall Study|Physician withdrew consent|71|||
170369956|NCT00249795|615690030|FG001|Overall Study|Physician withdrew consent|63|||
170369957|NCT00249795|615690029|FG000|Overall Study|Surgery / procedure|4|||
170369958|NCT00249795|615690030|FG001|Overall Study|Surgery / procedure|5|||
170369959|NCT00249795|615690029|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
170369960|NCT00249795|615690030|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
170369961|NCT00249795|615690029|FG000|Overall Study|Lightheadedness / dizziness|15|||
170369962|NCT00249795|615690030|FG001|Overall Study|Lightheadedness / dizziness|11|||
170369963|NCT00249795|615690029|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
170369964|NCT00249795|615690030|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
170369965|NCT00249795|615690029|FG000|Overall Study|Other contraindicated medication|1|||
170369966|NCT00249795|615690030|FG001|Overall Study|Other contraindicated medication|1|||
170369967|NCT00249795|615690029|FG000|Overall Study|Event related to cardiac condition|17|||
170369968|NCT00249795|615690030|FG001|Overall Study|Event related to cardiac condition|16|||
170369969|NCT00249795|615690029|FG000|Overall Study|Patient not wish to continue after May08|4|||
170369970|NCT00249795|615690030|FG001|Overall Study|Patient not wish to continue after May08|6|||
170369971|NCT00249795|615690029|FG000|Overall Study|Site not agree to continue after May08|1|||
170369972|NCT00249795|615690030|FG001|Overall Study|Site not agree to continue after May08|1|||
170369973|NCT00249795|615690029|FG000|Overall Study|Lost to Follow-up|0|||
170369974|NCT00249795|615690030|FG001|Overall Study|Lost to Follow-up|2|||
170369975|NCT00249795|615690029|FG000|Overall Study|Missing|0|||
170369976|NCT00249795|615690030|FG001|Overall Study|Missing|1|||
170369977|NCT01814826|615690034|FG000|Overall Study|Other|3|||
170369978|NCT01814826|615690035|FG001|Overall Study|Other|5|||
170369979|NCT01814826|615690036|FG002|Overall Study|Other|0|||
170369980|NCT01814826|615690034|FG000|Overall Study|Death|29|||
170369981|NCT01814826|615690035|FG001|Overall Study|Death|24|||
170369982|NCT01814826|615690036|FG002|Overall Study|Death|3|||
170369983|NCT02917629|615690037|FG000|Overall Study|Withdrawal by Subject|0|||
170369984|NCT02917629|615690038|FG001|Overall Study|Withdrawal by Subject|1|||
170369985|NCT00437203|615690039|FG000|Overall Study|Death|0|||
170369986|NCT00437203|615690040|FG001|Overall Study|Death|0|||
170369987|NCT00437203|615690041|FG002|Overall Study|Death|1|||
170369988|NCT00437203|615690042|FG003|Overall Study|Death|0|||
170369989|NCT00437203|615690043|FG004|Overall Study|Death|0|||
170369990|NCT00437203|615690044|FG005|Overall Study|Death|0|||
170369991|NCT00437203|615690045|FG006|Overall Study|Death|0|||
170369992|NCT00437203|615690046|FG007|Overall Study|Death|1|||
170369993|NCT00437203|615690047|FG008|Overall Study|Death|0|||
170369994|NCT00437203|615690048|FG009|Overall Study|Death|1|||
170369995|NCT00437203|615690039|FG000|Overall Study|Adverse Event|1|||
170369996|NCT00437203|615690040|FG001|Overall Study|Adverse Event|1|||
170369997|NCT00437203|615690041|FG002|Overall Study|Adverse Event|0|||
170369998|NCT00437203|615690042|FG003|Overall Study|Adverse Event|0|||
170369999|NCT00437203|615690043|FG004|Overall Study|Adverse Event|0|||
170370000|NCT00437203|615690044|FG005|Overall Study|Adverse Event|0|||
170370001|NCT00437203|615690045|FG006|Overall Study|Adverse Event|0|||
170370002|NCT00437203|615690046|FG007|Overall Study|Adverse Event|1|||
170370003|NCT00437203|615690047|FG008|Overall Study|Adverse Event|0|||
170370004|NCT00437203|615690048|FG009|Overall Study|Adverse Event|1|||
170370005|NCT00437203|615690039|FG000|Overall Study|Study terminated by sponsor|0|||
170370006|NCT00437203|615690040|FG001|Overall Study|Study terminated by sponsor|0|||
170370007|NCT00437203|615690041|FG002|Overall Study|Study terminated by sponsor|0|||
170370008|NCT00437203|615690042|FG003|Overall Study|Study terminated by sponsor|0|||
170370009|NCT00437203|615690043|FG004|Overall Study|Study terminated by sponsor|0|||
170370010|NCT00437203|615690044|FG005|Overall Study|Study terminated by sponsor|0|||
170370011|NCT00437203|615690045|FG006|Overall Study|Study terminated by sponsor|0|||
170370012|NCT00437203|615690046|FG007|Overall Study|Study terminated by sponsor|0|||
170370013|NCT00437203|615690047|FG008|Overall Study|Study terminated by sponsor|1|||
170370014|NCT00437203|615690048|FG009|Overall Study|Study terminated by sponsor|0|||
170370015|NCT00437203|615690039|FG000|Overall Study|Objective progression or relapse|5|||
170370016|NCT00437203|615690040|FG001|Overall Study|Objective progression or relapse|6|||
170370017|NCT00437203|615690041|FG002|Overall Study|Objective progression or relapse|2|||
170370018|NCT00437203|615690042|FG003|Overall Study|Objective progression or relapse|3|||
170370019|NCT00437203|615690043|FG004|Overall Study|Objective progression or relapse|3|||
170370020|NCT00437203|615690044|FG005|Overall Study|Objective progression or relapse|3|||
170370021|NCT00437203|615690045|FG006|Overall Study|Objective progression or relapse|6|||
170370022|NCT00437203|615690046|FG007|Overall Study|Objective progression or relapse|1|||
170370023|NCT00437203|615690047|FG008|Overall Study|Objective progression or relapse|2|||
170370024|NCT00437203|615690048|FG009|Overall Study|Objective progression or relapse|2|||
170370025|NCT00437203|615690039|FG000|Overall Study|Other|0|||
170370026|NCT00437203|615690040|FG001|Overall Study|Other|1|||
170370027|NCT00437203|615690041|FG002|Overall Study|Other|0|||
170370028|NCT00437203|615690042|FG003|Overall Study|Other|0|||
170370029|NCT00437203|615690043|FG004|Overall Study|Other|0|||
170370030|NCT00437203|615690044|FG005|Overall Study|Other|0|||
170370031|NCT00437203|615690045|FG006|Overall Study|Other|1|||
170370032|NCT00437203|615690046|FG007|Overall Study|Other|0|||
170370033|NCT00437203|615690047|FG008|Overall Study|Other|0|||
170370034|NCT00437203|615690048|FG009|Overall Study|Other|0|||
170370035|NCT03997760|615690049|FG000|Overall Study|Protocol Deviation|0|||
170370036|NCT03997760|615690050|FG001|Overall Study|Protocol Deviation|1|||
170370037|NCT03997760|615690051|FG002|Overall Study|Protocol Deviation|0|||
170370038|NCT03997760|615690052|FG003|Overall Study|Protocol Deviation|0|||
170370039|NCT01601470|615690053|FG000|Period 2 - LCZ696|Physician Decision|1|||
170370040|NCT04018612|615690054|FG000|Overall Study|Withdrawal by Subject|1|||
170370041|NCT04018612|615690055|FG001|Overall Study|Withdrawal by Subject|0|||
170370042|NCT04018612|615690056|FG002|Overall Study|Withdrawal by Subject|1|||
170370043|NCT02343952|615690057|FG000|Study Treatment|Disease Progression|23|||
170370044|NCT02343952|615690057|FG000|Study Treatment|Death|3|||
170370045|NCT02343952|615690057|FG000|Study Treatment|Adverse Event|19|||
170370046|NCT02343952|615690057|FG000|Study Treatment|Withdrawal by Subject|7|||
170370047|NCT02343952|615690057|FG000|Study Treatment|other complicating Diseases|1|||
170370048|NCT02343952|615690057|FG000|Follow up|Withdrawal by Subject|3|||
170370049|NCT02343952|615690057|FG000|Follow up|Death|33|||
170370050|NCT02343952|615690057|FG000|Follow up|Patient does not meet eligibility for study.|1|||
170370051|NCT02343952|615690057|FG000|Follow up|Research department closed by the practice.|5|||
170370052|NCT02343952|615690057|FG000|Follow up|Patient went home to Russia|1|||
170370053|NCT02343952|615690057|FG000|Follow up|Disease Progression|1|||
170370054|NCT02343952|615690057|FG000|Follow up|study terminated|1|||
170370055|NCT00361218|615690058|FG000|Overall Study|Lost to Follow-up|11|||
170370056|NCT00361218|615690058|FG000|Overall Study|Personal Reasons|7|||
170370057|NCT00361218|615690058|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
170370058|NCT00479167|615690059|FG000|Overall Study|Withdrawal by Subject|1|||
170370059|NCT01602549|615690061|FG000|Overall Study|Protocol Violation|0|||
170370060|NCT01602549|615690062|FG001|Overall Study|Protocol Violation|1|||
170370061|NCT01602549|615690061|FG000|Overall Study|Withdrawal by Subject|1|||
170370062|NCT01602549|615690062|FG001|Overall Study|Withdrawal by Subject|0|||
170370063|NCT05200455|615690063|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
170370064|NCT01576406|615690064|FG000|Overall Study|Lost to Follow-up|1|||
170370065|NCT01576406|615690065|FG001|Overall Study|Lost to Follow-up|2|||
170370066|NCT01576406|615690066|FG002|Overall Study|Lost to Follow-up|0|||
170370067|NCT01576406|615690067|FG003|Overall Study|Lost to Follow-up|0|||
170370068|NCT01576406|615690068|FG004|Overall Study|Lost to Follow-up|0|||
170370069|NCT01576406|615690069|FG005|Overall Study|Lost to Follow-up|0|||
170370070|NCT01576406|615690064|FG000|Overall Study|Death|3|||
170370071|NCT01576406|615690065|FG001|Overall Study|Death|4|||
170370072|NCT01576406|615690066|FG002|Overall Study|Death|8|||
170370073|NCT01576406|615690067|FG003|Overall Study|Death|5|||
170370074|NCT01576406|615690068|FG004|Overall Study|Death|7|||
170370075|NCT01576406|615690069|FG005|Overall Study|Death|9|||
170370076|NCT01576406|615690064|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
170370077|NCT01576406|615690065|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
170370078|NCT01576406|615690066|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
170370079|NCT01576406|615690067|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
170370080|NCT01576406|615690068|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
170370081|NCT01576406|615690069|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
170370082|NCT01576406|615690064|FG000|Overall Study|Withdrawal the consent|2|||
170370083|NCT01576406|615690065|FG001|Overall Study|Withdrawal the consent|2|||
170370084|NCT01576406|615690066|FG002|Overall Study|Withdrawal the consent|5|||
170370085|NCT01576406|615690067|FG003|Overall Study|Withdrawal the consent|1|||
170370086|NCT01576406|615690068|FG004|Overall Study|Withdrawal the consent|1|||
170370087|NCT01576406|615690069|FG005|Overall Study|Withdrawal the consent|3|||
170370088|NCT01576406|615690064|FG000|Overall Study|Other|0|||
170370089|NCT01576406|615690065|FG001|Overall Study|Other|0|||
170370090|NCT01576406|615690066|FG002|Overall Study|Other|2|||
170370091|NCT01576406|615690067|FG003|Overall Study|Other|2|||
170370092|NCT01576406|615690068|FG004|Overall Study|Other|0|||
170370093|NCT01576406|615690069|FG005|Overall Study|Other|0|||
170370094|NCT00892957|615690071|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
170370095|NCT00892957|615690072|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
170370096|NCT00892957|615690071|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
170370097|NCT00892957|615690072|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
170370098|NCT02091921|615690073|FG000|Overall Study|Adverse Event|3|||
170370099|NCT02483078|615690074|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
170370100|NCT02483078|615690075|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
170370101|NCT02483078|615690074|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
170370102|NCT02483078|615690075|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
170370103|NCT02483078|615690074|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
170370104|NCT02483078|615690075|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
170370105|NCT02483078|615690074|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
170370106|NCT02483078|615690075|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
170370107|NCT02483078|615690074|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
170370108|NCT02483078|615690075|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
170370109|NCT02483078|615690074|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
170370110|NCT02483078|615690075|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
170370111|NCT04876599|615690078|FG000|Overall Study|Missed|2|||
170370112|NCT04876599|615690079|FG001|Overall Study|Missed|0|||
170370113|NCT04876599|615690078|FG000|Overall Study|Declined|2|||
170370114|NCT04876599|615690079|FG001|Overall Study|Declined|3|||
170370115|NCT01627782|615690084|FG000|Overall Study|Adverse Event|1|||
170370116|NCT01627782|615690085|FG001|Overall Study|Adverse Event|2|||
170370117|NCT01627782|615690086|FG002|Overall Study|Adverse Event|0|||
170370118|NCT01627782|615690087|FG003|Overall Study|Adverse Event|1|||
170370119|NCT01627782|615690084|FG000|Overall Study|Lack of Efficacy|11|||
170370120|NCT01627782|615690085|FG001|Overall Study|Lack of Efficacy|1|||
170370121|NCT01627782|615690086|FG002|Overall Study|Lack of Efficacy|15|||
170370122|NCT01627782|615690087|FG003|Overall Study|Lack of Efficacy|2|||
170370123|NCT01627782|615690084|FG000|Overall Study|Protocol Violation|1|||
170370124|NCT01627782|615690085|FG001|Overall Study|Protocol Violation|0|||
170370125|NCT01627782|615690086|FG002|Overall Study|Protocol Violation|0|||
170370126|NCT01627782|615690087|FG003|Overall Study|Protocol Violation|0|||
170370127|NCT01627782|615690084|FG000|Overall Study|Withdrawal by Subject|2|||
170370128|NCT01627782|615690085|FG001|Overall Study|Withdrawal by Subject|1|||
170370129|NCT01627782|615690086|FG002|Overall Study|Withdrawal by Subject|0|||
170370130|NCT01627782|615690087|FG003|Overall Study|Withdrawal by Subject|0|||
170370131|NCT01627782|615690084|FG000|Overall Study|Other|0|||
170370132|NCT01627782|615690085|FG001|Overall Study|Other|2|||
170370133|NCT01627782|615690086|FG002|Overall Study|Other|0|||
170370134|NCT01627782|615690087|FG003|Overall Study|Other|3|||
170370135|NCT01627782|615690084|FG000|Overall Study|Randomized But Not Treated|1|||
170370136|NCT01627782|615690085|FG001|Overall Study|Randomized But Not Treated|0|||
170370137|NCT01627782|615690086|FG002|Overall Study|Randomized But Not Treated|0|||
170370138|NCT01627782|615690087|FG003|Overall Study|Randomized But Not Treated|0|||
170370139|NCT00669032|615690088|FG000|Overall Study|Lost to Follow-up|6|||
170370140|NCT00669032|615690089|FG001|Overall Study|Lost to Follow-up|5|||
170370141|NCT00669032|615690088|FG000|Overall Study|Lack of Efficacy|8|||
170370142|NCT00669032|615690089|FG001|Overall Study|Lack of Efficacy|19|||
170370143|NCT00669032|615690088|FG000|Overall Study|Withdrawal by Subject|12|||
170370144|NCT00669032|615690089|FG001|Overall Study|Withdrawal by Subject|13|||
170370145|NCT00669032|615690088|FG000|Overall Study|Adverse Event|12|||
170370146|NCT00669032|615690089|FG001|Overall Study|Adverse Event|16|||
170370147|NCT00669032|615690088|FG000|Overall Study|Physician Decision|1|||
170370148|NCT00669032|615690089|FG001|Overall Study|Physician Decision|1|||
170370149|NCT00669032|615690088|FG000|Overall Study|No fulfilment of the selection criteria|5|||
170370150|NCT00669032|615690089|FG001|Overall Study|No fulfilment of the selection criteria|5|||
170370151|NCT01607073|615690090|FG000|Overall Study|Adverse Event|1|||
170370152|NCT03627494|615690091|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
170370153|NCT03627494|615690092|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370154|NCT03627494|615690093|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
170370155|NCT03627494|615690094|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370156|NCT03627494|615690095|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370157|NCT03627494|615690096|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370158|NCT03627494|615690097|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370159|NCT03627494|615690098|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370160|NCT03627494|615690099|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370161|NCT03627494|615690100|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370162|NCT03627494|615690101|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370163|NCT03627494|615690102|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
170370164|NCT03627494|615690091|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370165|NCT03627494|615690092|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370166|NCT03627494|615690093|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370167|NCT03627494|615690094|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370168|NCT03627494|615690095|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370169|NCT03627494|615690096|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370170|NCT03627494|615690097|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370171|NCT03627494|615690098|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370172|NCT03627494|615690099|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
170370173|NCT03627494|615690100|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370174|NCT03627494|615690101|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370175|NCT03627494|615690102|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
170370176|NCT03627494|615690091|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370177|NCT03627494|615690092|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370178|NCT03627494|615690093|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370179|NCT03627494|615690094|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370180|NCT03627494|615690095|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370181|NCT03627494|615690096|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370182|NCT03627494|615690097|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370183|NCT03627494|615690098|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370184|NCT03627494|615690099|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370185|NCT03627494|615690100|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
170370186|NCT03627494|615690101|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
170370187|NCT03627494|615690102|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
170370188|NCT04126031|615690104|FG000|Part A|Withdrawal by Subject|0|||
170370189|NCT04126031|615690105|FG001|Part A|Withdrawal by Subject|0|||
170370190|NCT04126031|615690106|FG002|Part A|Withdrawal by Subject|1|||
170370191|NCT04126031|615690107|FG003|Part A|Withdrawal by Subject|0|||
170370192|NCT04126031|615690108|FG004|Part A|Withdrawal by Subject|0|||
170370193|NCT04126031|615690109|FG005|Part A|Withdrawal by Subject|0|||
170370194|NCT04126031|615690104|FG000|Part A|Other|1|||
170370195|NCT04126031|615690105|FG001|Part A|Other|0|||
170370196|NCT04126031|615690106|FG002|Part A|Other|0|||
170370197|NCT04126031|615690107|FG003|Part A|Other|0|||
170370198|NCT04126031|615690108|FG004|Part A|Other|0|||
170370199|NCT04126031|615690109|FG005|Part A|Other|0|||
170370200|NCT04126031|615690104|FG000|Part B|Adverse Event|0|||
170370201|NCT04126031|615690105|FG001|Part B|Adverse Event|0|||
170370202|NCT04126031|615690106|FG002|Part B|Adverse Event|0|||
170370203|NCT04126031|615690107|FG003|Part B|Adverse Event|0|||
170370204|NCT04126031|615690108|FG004|Part B|Adverse Event|0|||
170370205|NCT04126031|615690109|FG005|Part B|Adverse Event|2|||
170370206|NCT04126031|615690104|FG000|Part B|Pre-existing hypertransaminasemia|0|||
170370207|NCT04126031|615690105|FG001|Part B|Pre-existing hypertransaminasemia|0|||
170370208|NCT04126031|615690106|FG002|Part B|Pre-existing hypertransaminasemia|0|||
170370209|NCT04126031|615690107|FG003|Part B|Pre-existing hypertransaminasemia|0|||
170370210|NCT04126031|615690108|FG004|Part B|Pre-existing hypertransaminasemia|1|||
170370211|NCT04126031|615690109|FG005|Part B|Pre-existing hypertransaminasemia|0|||
170370212|NCT00131664|615690110|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
170370213|NCT00131664|615690111|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
170370214|NCT00131664|615690112|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
170370215|NCT00131664|615690113|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
170370216|NCT00131664|615690114|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
170370217|NCT00131664|615690115|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
170370218|NCT00131664|615690110|FG000|First Period (First 6 Months)|Death|0|||
170370219|NCT00131664|615690111|FG001|First Period (First 6 Months)|Death|1|||
170370220|NCT00131664|615690112|FG002|First Period (First 6 Months)|Death|0|||
170370221|NCT00131664|615690113|FG003|First Period (First 6 Months)|Death|0|||
170370222|NCT00131664|615690114|FG004|First Period (First 6 Months)|Death|0|||
170370223|NCT00131664|615690115|FG005|First Period (First 6 Months)|Death|0|||
170370224|NCT00131664|615690110|FG000|First Period (First 6 Months)|Protocol Violation|2|||
170370225|NCT00131664|615690111|FG001|First Period (First 6 Months)|Protocol Violation|2|||
170370226|NCT00131664|615690112|FG002|First Period (First 6 Months)|Protocol Violation|1|||
170370227|NCT00131664|615690113|FG003|First Period (First 6 Months)|Protocol Violation|0|||
170370228|NCT00131664|615690114|FG004|First Period (First 6 Months)|Protocol Violation|0|||
170370229|NCT00131664|615690115|FG005|First Period (First 6 Months)|Protocol Violation|0|||
170370230|NCT00131664|615690110|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
170370231|NCT00131664|615690111|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
170370232|NCT00131664|615690112|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
170370233|NCT00131664|615690113|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
170370234|NCT00131664|615690114|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
170370235|NCT00131664|615690115|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
170370236|NCT00131664|615690110|FG000|First Period (First 6 Months)|Adverse Event|9|||
170370237|NCT00131664|615690111|FG001|First Period (First 6 Months)|Adverse Event|4|||
170370238|NCT00131664|615690112|FG002|First Period (First 6 Months)|Adverse Event|5|||
170370239|NCT00131664|615690113|FG003|First Period (First 6 Months)|Adverse Event|0|||
170370240|NCT00131664|615690114|FG004|First Period (First 6 Months)|Adverse Event|0|||
170370241|NCT00131664|615690115|FG005|First Period (First 6 Months)|Adverse Event|0|||
170370242|NCT00131664|615690110|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
170370243|NCT00131664|615690111|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
170370244|NCT00131664|615690112|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
170370245|NCT00131664|615690113|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
170370246|NCT00131664|615690114|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
170370247|NCT00131664|615690115|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
170370248|NCT00131664|615690110|FG000|First Period (First 6 Months)|Administrative reasons|2|||
170370249|NCT00131664|615690111|FG001|First Period (First 6 Months)|Administrative reasons|0|||
170370250|NCT00131664|615690112|FG002|First Period (First 6 Months)|Administrative reasons|5|||
170370251|NCT00131664|615690113|FG003|First Period (First 6 Months)|Administrative reasons|0|||
170370252|NCT00131664|615690114|FG004|First Period (First 6 Months)|Administrative reasons|0|||
170370253|NCT00131664|615690115|FG005|First Period (First 6 Months)|Administrative reasons|0|||
170370254|NCT00131664|615690110|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
170370255|NCT00131664|615690111|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
170370256|NCT00131664|615690112|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
170370257|NCT00131664|615690113|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
170370258|NCT00131664|615690114|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
170370259|NCT00131664|615690115|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
170370260|NCT00131664|615690110|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
170370261|NCT00131664|615690111|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
170370262|NCT00131664|615690112|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
170370263|NCT00131664|615690113|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
170370264|NCT00131664|615690114|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
170370265|NCT00131664|615690115|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
170370266|NCT00131664|615690110|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
170370267|NCT00131664|615690111|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
170370268|NCT00131664|615690112|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
170370269|NCT00131664|615690113|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
170370270|NCT00131664|615690114|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
170370271|NCT00131664|615690115|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
170370272|NCT00131664|615690110|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
170370273|NCT00131664|615690111|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
170370274|NCT00131664|615690112|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
170370275|NCT00131664|615690113|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
170370276|NCT00131664|615690114|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
170370277|NCT00131664|615690115|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
170370278|NCT00131664|615690110|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
170370279|NCT00131664|615690111|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
170370280|NCT00131664|615690112|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
170370281|NCT00131664|615690113|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
170370282|NCT00131664|615690114|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
170370283|NCT00131664|615690115|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
170370284|NCT00131664|615690110|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
170370285|NCT00131664|615690111|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
170370286|NCT00131664|615690112|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
170370287|NCT00131664|615690113|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
170370288|NCT00131664|615690114|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
170370289|NCT00131664|615690115|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
170370290|NCT03695471|615692424|FG000|Overall Study|Cancellation|1|||
170370291|NCT02859558|615692425|FG000|Step 1|Not Eligible|0|||
170370292|NCT02859558|615692426|FG001|Step 1|Not Eligible|0|||
170370293|NCT02859558|615692427|FG002|Step 1|Not Eligible|0|||
170370294|NCT02859558|615692428|FG003|Step 1|Not Eligible|0|||
170370295|NCT02859558|615692429|FG004|Step 1|Not Eligible|3|||
170370296|NCT02859558|615692425|FG000|Step 1|Lost to Follow-up|1|||
170370297|NCT02859558|615692426|FG001|Step 1|Lost to Follow-up|3|||
170370298|NCT02859558|615692427|FG002|Step 1|Lost to Follow-up|3|||
170370299|NCT02859558|615692428|FG003|Step 1|Lost to Follow-up|0|||
170370300|NCT02859558|615692429|FG004|Step 1|Lost to Follow-up|0|||
170370301|NCT02859558|615692425|FG000|Step 1|Did Not Return to Clinic|2|||
170370302|NCT02859558|615692426|FG001|Step 1|Did Not Return to Clinic|3|||
170370303|NCT02859558|615692427|FG002|Step 1|Did Not Return to Clinic|4|||
170370304|NCT02859558|615692428|FG003|Step 1|Did Not Return to Clinic|0|||
170370305|NCT02859558|615692429|FG004|Step 1|Did Not Return to Clinic|0|||
170370306|NCT02859558|615692425|FG000|Step 1|Moved|0|||
170370307|NCT02859558|615692426|FG001|Step 1|Moved|1|||
170370308|NCT02859558|615692427|FG002|Step 1|Moved|1|||
170370309|NCT02859558|615692428|FG003|Step 1|Moved|0|||
170370310|NCT02859558|615692429|FG004|Step 1|Moved|0|||
170370311|NCT02859558|615692425|FG000|Step 1|Withdrawal By Participant|1|||
170370312|NCT02859558|615692426|FG001|Step 1|Withdrawal By Participant|2|||
170370313|NCT02859558|615692427|FG002|Step 1|Withdrawal By Participant|1|||
170370314|NCT02859558|615692428|FG003|Step 1|Withdrawal By Participant|0|||
170370315|NCT02859558|615692429|FG004|Step 1|Withdrawal By Participant|0|||
170370316|NCT02859558|615692425|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
170370317|NCT02859558|615692426|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
170370318|NCT02859558|615692427|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
170370319|NCT02859558|615692428|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
170370320|NCT02859558|615692429|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
170370321|NCT02859558|615692425|FG000|Step 1|Incarceration|0|||
170370322|NCT02859558|615692426|FG001|Step 1|Incarceration|1|||
170370323|NCT02859558|615692427|FG002|Step 1|Incarceration|0|||
170370324|NCT02859558|615692428|FG003|Step 1|Incarceration|0|||
170370325|NCT02859558|615692429|FG004|Step 1|Incarceration|0|||
170370326|NCT02859558|615692425|FG000|Step 1|Non-Adherence to Study Drug|2|||
170370327|NCT02859558|615692426|FG001|Step 1|Non-Adherence to Study Drug|0|||
170370328|NCT02859558|615692427|FG002|Step 1|Non-Adherence to Study Drug|1|||
170370329|NCT02859558|615692428|FG003|Step 1|Non-Adherence to Study Drug|0|||
170370330|NCT02859558|615692429|FG004|Step 1|Non-Adherence to Study Drug|0|||
170370331|NCT02859558|615692425|FG000|Step 1|Non-Adherence to Study Requirements|3|||
170370332|NCT02859558|615692426|FG001|Step 1|Non-Adherence to Study Requirements|1|||
170370333|NCT02859558|615692427|FG002|Step 1|Non-Adherence to Study Requirements|0|||
170370334|NCT02859558|615692428|FG003|Step 1|Non-Adherence to Study Requirements|0|||
170370335|NCT02859558|615692429|FG004|Step 1|Non-Adherence to Study Requirements|0|||
170370336|NCT02859558|615692425|FG000|Step 1|Virologic Failure|2|||
170370337|NCT02859558|615692426|FG001|Step 1|Virologic Failure|1|||
170370338|NCT02859558|615692427|FG002|Step 1|Virologic Failure|1|||
170370339|NCT02859558|615692428|FG003|Step 1|Virologic Failure|0|||
170370340|NCT02859558|615692429|FG004|Step 1|Virologic Failure|0|||
170370341|NCT02859558|615692425|FG000|Step 2|Lost to Follow-up|3|||
170370342|NCT02859558|615692426|FG001|Step 2|Lost to Follow-up|3|||
170370343|NCT02859558|615692427|FG002|Step 2|Lost to Follow-up|1|||
170370344|NCT02859558|615692428|FG003|Step 2|Lost to Follow-up|0|||
170370345|NCT02859558|615692429|FG004|Step 2|Lost to Follow-up|0|||
170370346|NCT02859558|615692425|FG000|Step 2|Withdrawal by Subject|0|||
170370347|NCT02859558|615692426|FG001|Step 2|Withdrawal by Subject|1|||
170370348|NCT02859558|615692427|FG002|Step 2|Withdrawal by Subject|1|||
170370349|NCT02859558|615692428|FG003|Step 2|Withdrawal by Subject|0|||
170370350|NCT02859558|615692429|FG004|Step 2|Withdrawal by Subject|0|||
170370351|NCT02859558|615692425|FG000|Step 2|Unexpected Closure of Site|0|||
170370352|NCT02859558|615692426|FG001|Step 2|Unexpected Closure of Site|1|||
170370353|NCT02859558|615692427|FG002|Step 2|Unexpected Closure of Site|1|||
170370354|NCT02859558|615692428|FG003|Step 2|Unexpected Closure of Site|0|||
170370355|NCT02859558|615692429|FG004|Step 2|Unexpected Closure of Site|0|||
170370356|NCT02859558|615692425|FG000|Step 2|Death|1|||
170370357|NCT02859558|615692426|FG001|Step 2|Death|0|||
170370358|NCT02859558|615692427|FG002|Step 2|Death|0|||
170370359|NCT02859558|615692428|FG003|Step 2|Death|0|||
170370360|NCT02859558|615692429|FG004|Step 2|Death|0|||
170370361|NCT02859558|615692425|FG000|Step 2|Incarceration|0|||
170370362|NCT02859558|615692426|FG001|Step 2|Incarceration|0|||
170370363|NCT02859558|615692427|FG002|Step 2|Incarceration|1|||
170370364|NCT02859558|615692428|FG003|Step 2|Incarceration|0|||
170370365|NCT02859558|615692429|FG004|Step 2|Incarceration|0|||
170370416|NCT02358863|615692439|FG000|Overall Study|Physician Decision|3|||
170370417|NCT01004159|615692446|FG000|Overall Study|Adverse Event|2|||
170370418|NCT01004159|615692446|FG000|Overall Study|Disease Progression|18|||
170370419|NCT01131078|615692447|FG000|Overall Study|Adverse Event|22|||
170370420|NCT01131078|615692448|FG001|Overall Study|Adverse Event|12|||
170370421|NCT01131078|615692449|FG002|Overall Study|Adverse Event|17|||
170370422|NCT01131078|615692447|FG000|Overall Study|Progressive Disease|58|||
170370423|NCT01131078|615692448|FG001|Overall Study|Progressive Disease|77|||
170370424|NCT01131078|615692449|FG002|Overall Study|Progressive Disease|71|||
170370425|NCT01131078|615692447|FG000|Overall Study|Protocol Violation|1|||
170370426|NCT01131078|615692448|FG001|Overall Study|Protocol Violation|0|||
170370427|NCT01131078|615692449|FG002|Overall Study|Protocol Violation|0|||
170370428|NCT01131078|615692447|FG000|Overall Study|Lost to Follow-up|1|||
170370429|NCT01131078|615692448|FG001|Overall Study|Lost to Follow-up|1|||
170370430|NCT01131078|615692449|FG002|Overall Study|Lost to Follow-up|1|||
170370431|NCT01131078|615692447|FG000|Overall Study|Withdrawal by Subject|2|||
170370432|NCT01131078|615692448|FG001|Overall Study|Withdrawal by Subject|4|||
170370433|NCT01131078|615692449|FG002|Overall Study|Withdrawal by Subject|3|||
170370434|NCT01131078|615692447|FG000|Overall Study|Non-compliance|3|||
170370435|NCT01131078|615692448|FG001|Overall Study|Non-compliance|0|||
170370436|NCT01131078|615692449|FG002|Overall Study|Non-compliance|0|||
170370437|NCT01131078|615692447|FG000|Overall Study|Physician Decision|10|||
170370438|NCT01131078|615692448|FG001|Overall Study|Physician Decision|6|||
170370439|NCT01131078|615692449|FG002|Overall Study|Physician Decision|8|||
170370440|NCT01131078|615692447|FG000|Overall Study|Death|4|||
170370441|NCT01131078|615692448|FG001|Overall Study|Death|0|||
170370442|NCT01131078|615692449|FG002|Overall Study|Death|2|||
170370443|NCT01131078|615692447|FG000|Overall Study|Other|0|||
170370444|NCT01131078|615692448|FG001|Overall Study|Other|1|||
170370445|NCT01131078|615692449|FG002|Overall Study|Other|0|||
170370446|NCT00736385|615692450|FG000|Overall Study|Withdrawal by Subject|2|||
170370447|NCT00736385|615692451|FG001|Overall Study|Withdrawal by Subject|2|||
170370448|NCT00736385|615692450|FG000|Overall Study|Adverse Event|0|||
170370449|NCT00736385|615692451|FG001|Overall Study|Adverse Event|1|||
170370450|NCT03050307|615692452|FG000|Overall Study|Adverse Event|4|||
170370451|NCT03050307|615692453|FG001|Overall Study|Adverse Event|2|||
170370452|NCT03050307|615692452|FG000|Overall Study|Significant Protocol Deviation|0|||
170370453|NCT03050307|615692453|FG001|Overall Study|Significant Protocol Deviation|1|||
170370454|NCT03050307|615692452|FG000|Overall Study|Lost to Follow-up|0|||
170370455|NCT03050307|615692453|FG001|Overall Study|Lost to Follow-up|1|||
170370456|NCT03050307|615692452|FG000|Overall Study|Voluntary Withdrawal|3|||
170370457|NCT03050307|615692453|FG001|Overall Study|Voluntary Withdrawal|4|||
170370458|NCT03050307|615692452|FG000|Overall Study|Reason not Specified|1|||
170370459|NCT03050307|615692453|FG001|Overall Study|Reason not Specified|1|||
170370460|NCT02177786|615692454|FG000|Overall Study|Withdrew Consent|2|||
170370461|NCT02177786|615692455|FG001|Overall Study|Withdrew Consent|6|||
170370462|NCT02177786|615692456|FG002|Overall Study|Withdrew Consent|9|||
170370463|NCT02177786|615692457|FG003|Overall Study|Withdrew Consent|5|||
170370464|NCT02177786|615692454|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
170370465|NCT02177786|615692455|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
170370466|NCT02177786|615692456|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
170370467|NCT02177786|615692457|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
170370468|NCT02177786|615692454|FG000|Overall Study|Adverse Event|1|||
170370469|NCT02177786|615692455|FG001|Overall Study|Adverse Event|1|||
170370470|NCT02177786|615692456|FG002|Overall Study|Adverse Event|2|||
170370471|NCT02177786|615692457|FG003|Overall Study|Adverse Event|3|||
170370472|NCT02177786|615692454|FG000|Overall Study|Death|1|||
170370473|NCT02177786|615692455|FG001|Overall Study|Death|1|||
170370474|NCT02177786|615692456|FG002|Overall Study|Death|1|||
170370475|NCT02177786|615692457|FG003|Overall Study|Death|1|||
170370476|NCT02177786|615692454|FG000|Overall Study|Lost to Follow-up|0|||
170370477|NCT02177786|615692455|FG001|Overall Study|Lost to Follow-up|0|||
170370478|NCT02177786|615692456|FG002|Overall Study|Lost to Follow-up|2|||
170370479|NCT02177786|615692457|FG003|Overall Study|Lost to Follow-up|2|||
170370480|NCT02177786|615692454|FG000|Overall Study|Non-Compliance with Study Drug|0|||
170370481|NCT02177786|615692455|FG001|Overall Study|Non-Compliance with Study Drug|1|||
170370482|NCT02177786|615692456|FG002|Overall Study|Non-Compliance with Study Drug|0|||
170370483|NCT02177786|615692457|FG003|Overall Study|Non-Compliance with Study Drug|1|||
170370484|NCT02177786|615692454|FG000|Overall Study|Protocol Violation|0|||
170370485|NCT02177786|615692455|FG001|Overall Study|Protocol Violation|0|||
170370486|NCT02177786|615692456|FG002|Overall Study|Protocol Violation|2|||
170370487|NCT02177786|615692457|FG003|Overall Study|Protocol Violation|0|||
170370488|NCT02177786|615692454|FG000|Overall Study|Progressive Disease|0|||
170370489|NCT02177786|615692455|FG001|Overall Study|Progressive Disease|1|||
170370490|NCT02177786|615692456|FG002|Overall Study|Progressive Disease|0|||
170370491|NCT02177786|615692457|FG003|Overall Study|Progressive Disease|0|||
170370492|NCT02177786|615692454|FG000|Overall Study|Missing study completion status|0|||
170370493|NCT02177786|615692455|FG001|Overall Study|Missing study completion status|1|||
170370494|NCT02177786|615692456|FG002|Overall Study|Missing study completion status|0|||
170370495|NCT02177786|615692457|FG003|Overall Study|Missing study completion status|0|||
170370496|NCT02892734|615692458|FG000|Treatment on Study|Progressive Disease|2|||
170370497|NCT02892734|615692458|FG000|Follow up for 2 Years|Death|2|||
170370498|NCT02892734|615692458|FG000|Follow up for 2 Years|Study closed early|1|||
170370499|NCT00439309|615692459|FG000|Follow-Up|Death|1|||
170370500|NCT00439309|615692460|FG001|Follow-Up|Death|0|||
170370501|NCT00439309|615692459|FG000|Follow-Up|Lost to Follow-up|2|||
170370502|NCT00439309|615692460|FG001|Follow-Up|Lost to Follow-up|0|||
170370503|NCT00439309|615692459|FG000|Follow-Up|Withdrawal by Subject|0|||
170370504|NCT00439309|615692460|FG001|Follow-Up|Withdrawal by Subject|1|||
170370505|NCT00439309|615692459|FG000|Follow-Up|Late response by subject|0|||
170370506|NCT00439309|615692460|FG001|Follow-Up|Late response by subject|1|||
170370507|NCT02043509|615692461|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
170370508|NCT02043509|615692462|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
170370509|NCT02043509|615692461|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
170370510|NCT02043509|615692462|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
170370511|NCT02043509|615692461|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
170370512|NCT02043509|615692462|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
170370513|NCT02043509|615692461|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
170370514|NCT02043509|615692462|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
170370515|NCT00608244|615692465|FG000|Overall Study|Adverse Event|1|||
170370516|NCT00608244|615692465|FG000|Overall Study|Low trough levels|1|||
170370517|NCT01957215|615692466|FG000|Overall Study|Adverse Event|2|||
170370518|NCT01957215|615692467|FG001|Overall Study|Adverse Event|2|||
170370519|NCT01957215|615692466|FG000|Overall Study|Lost to Follow-up|3|||
170370520|NCT01957215|615692467|FG001|Overall Study|Lost to Follow-up|3|||
170370521|NCT01957215|615692466|FG000|Overall Study|Protocol Violation|1|||
170370522|NCT01957215|615692467|FG001|Overall Study|Protocol Violation|2|||
170370523|NCT01957215|615692466|FG000|Overall Study|Withdrawal by Subject|7|||
170370524|NCT01957215|615692467|FG001|Overall Study|Withdrawal by Subject|5|||
170370525|NCT01685060|615692469|FG000|Overall Study|Rollover patients|16|||
170370526|NCT01685060|615692469|FG000|Overall Study|Adverse Event|12|||
170370527|NCT01685060|615692469|FG000|Overall Study|Progressive disease|69|||
170370528|NCT01685060|615692469|FG000|Overall Study|Physician Decision|14|||
170370529|NCT01685060|615692469|FG000|Overall Study|Subject/guardian decision|20|||
170370530|NCT01685060|615692469|FG000|Overall Study|Lost to Follow-up|1|||
170370531|NCT01685060|615692469|FG000|Overall Study|Death|8|||
170370532|NCT02443155|615692472|FG000|Overall Study|Adverse Event|3|||
170370533|NCT02443155|615692473|FG001|Overall Study|Adverse Event|4|||
170370534|NCT02443155|615692474|FG002|Overall Study|Adverse Event|1|||
170370535|NCT02443155|615692475|FG003|Overall Study|Adverse Event|2|||
170370536|NCT02443155|615692472|FG000|Overall Study|Unclassified|0|||
170370537|NCT02443155|615692473|FG001|Overall Study|Unclassified|0|||
170370538|NCT02443155|615692474|FG002|Overall Study|Unclassified|2|||
170370539|NCT02443155|615692475|FG003|Overall Study|Unclassified|1|||
170370540|NCT02443155|615692472|FG000|Overall Study|Withdrawal by Subject|4|||
170370541|NCT02443155|615692473|FG001|Overall Study|Withdrawal by Subject|7|||
170370542|NCT02443155|615692474|FG002|Overall Study|Withdrawal by Subject|3|||
170370543|NCT02443155|615692475|FG003|Overall Study|Withdrawal by Subject|9|||
170370544|NCT02443155|615692472|FG000|Overall Study|Pregnancy|3|||
170370545|NCT02443155|615692473|FG001|Overall Study|Pregnancy|1|||
170370546|NCT02443155|615692474|FG002|Overall Study|Pregnancy|1|||
170370547|NCT02443155|615692475|FG003|Overall Study|Pregnancy|2|||
170370548|NCT02443155|615692472|FG000|Overall Study|Lost to Follow-up|1|||
170370549|NCT02443155|615692473|FG001|Overall Study|Lost to Follow-up|2|||
170370550|NCT02443155|615692474|FG002|Overall Study|Lost to Follow-up|0|||
170370551|NCT02443155|615692475|FG003|Overall Study|Lost to Follow-up|1|||
170370552|NCT02443155|615692472|FG000|Overall Study|Protocol Violation|1|||
170370553|NCT02443155|615692473|FG001|Overall Study|Protocol Violation|0|||
170370554|NCT02443155|615692474|FG002|Overall Study|Protocol Violation|1|||
170370555|NCT02443155|615692475|FG003|Overall Study|Protocol Violation|1|||
170370556|NCT02443155|615692472|FG000|Overall Study|Death|0|||
170370557|NCT02443155|615692473|FG001|Overall Study|Death|0|||
170370558|NCT02443155|615692474|FG002|Overall Study|Death|1|||
170370559|NCT02443155|615692475|FG003|Overall Study|Death|0|||
170370560|NCT00688623|615692476|FG000|Overall Study|Adverse Event|22|||
170370561|NCT00688623|615692476|FG000|Overall Study|abnormal lab value|1|||
170370562|NCT00688623|615692476|FG000|Overall Study|Withdrawal by Subject|4|||
170370563|NCT00688623|615692476|FG000|Overall Study|Death|3|||
170370564|NCT00688623|615692476|FG000|Overall Study|disease progression|23|||
170370565|NCT00688623|615692476|FG000|Overall Study|Protocol Violation|2|||
170370566|NCT02000219|615692477|FG000|14-Week Study Period|Physician Decision|1|||
170370567|NCT02000219|615692477|FG000|14-Week Study Period|Adverse Event|1|||
170370568|NCT02000219|615692477|FG000|14-Week Study Period|Underwent transplantation|1|||
170370569|NCT02000219|615692477|FG000|Continuation Period|Withdrawal by Subject|1|||
170370570|NCT02000219|615692477|FG000|Continuation Period|Had liver transplant|2|||
170370571|NCT02000219|615692477|FG000|Continuation Period|Non-compliance with study drug|2|||
170370572|NCT00464620|615692478|FG000|Overall Study|Physician Decision|1|||
170370573|NCT00464620|615692479|FG001|Overall Study|Physician Decision|0|||
170370574|NCT00464620|615692480|FG002|Overall Study|Physician Decision|0|||
170370575|NCT00464620|615692478|FG000|Overall Study|Withdrawal by Subject|1|||
170370576|NCT00464620|615692479|FG001|Overall Study|Withdrawal by Subject|0|||
170370577|NCT00464620|615692480|FG002|Overall Study|Withdrawal by Subject|3|||
170370578|NCT00464620|615692478|FG000|Overall Study|Ineligible sarcoma subtype|0|||
170370579|NCT00464620|615692479|FG001|Overall Study|Ineligible sarcoma subtype|2|||
170370580|NCT00464620|615692480|FG002|Overall Study|Ineligible sarcoma subtype|2|||
170370581|NCT00464620|615692478|FG000|Overall Study|Use of prohibited concomitant medication|0|||
170370582|NCT00464620|615692479|FG001|Overall Study|Use of prohibited concomitant medication|0|||
170370583|NCT00464620|615692480|FG002|Overall Study|Use of prohibited concomitant medication|2|||
170370584|NCT00634751|615692481|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
170370585|NCT00634751|615692482|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
170370586|NCT00634751|615692483|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
170370587|NCT00634751|615692484|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
170370588|NCT00634751|615692481|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
170370589|NCT00634751|615692482|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
170370590|NCT00634751|615692483|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
170370591|NCT00634751|615692484|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
170370592|NCT00634751|615692481|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
170370593|NCT00634751|615692482|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
170370594|NCT00634751|615692483|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
170370595|NCT00634751|615692484|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
170370596|NCT00608894|615692485|FG000|Overall Study|Withdrawal by Subject|0|||
170370597|NCT00608894|615692486|FG001|Overall Study|Withdrawal by Subject|2|||
170370598|NCT01572844|615692487|FG000|Overall Study|Physician Decision|1|||
170370599|NCT01572844|615692488|FG001|Overall Study|Physician Decision|1|||
170370600|NCT00209092|615692493|FG000|Overall Study|Progression of disease|7|||
170370601|NCT00209092|615692494|FG001|Overall Study|Progression of disease|1|||
170370602|NCT00209092|615692493|FG000|Overall Study|Adverse Event|0|||
170370603|NCT00209092|615692494|FG001|Overall Study|Adverse Event|1|||
170370604|NCT00209092|615692493|FG000|Overall Study|Withdrawal by Subject|1|||
170370605|NCT00209092|615692494|FG001|Overall Study|Withdrawal by Subject|0|||
170370606|NCT02809118|615692495|FG000|Overall Study|Withdrawal by Subject|0|||
170370607|NCT02809118|615692496|FG001|Overall Study|Withdrawal by Subject|1|||
170370608|NCT02809118|615692497|FG002|Overall Study|Withdrawal by Subject|1|||
170370609|NCT00509028|615692498|FG000|Overall Study|Adverse Event|2|||
170370610|NCT00509028|615692499|FG001|Overall Study|Adverse Event|0|||
170370611|NCT00509028|615692498|FG000|Overall Study|Withdrawal by Subject|4|||
170370612|NCT00509028|615692499|FG001|Overall Study|Withdrawal by Subject|3|||
170370613|NCT00509028|615692498|FG000|Overall Study|Lost to Follow-up|0|||
170370614|NCT00509028|615692499|FG001|Overall Study|Lost to Follow-up|1|||
170370615|NCT00509028|615692498|FG000|Overall Study|Protocol Violation|4|||
170370616|NCT00509028|615692499|FG001|Overall Study|Protocol Violation|2|||
170370617|NCT00509028|615692498|FG000|Overall Study|Non-compliance|2|||
170370618|NCT00509028|615692499|FG001|Overall Study|Non-compliance|1|||
170370619|NCT02408484|615692500|FG000|Overall Study|Withdrawal by Subject|3|||
170370620|NCT02408484|615692500|FG000|Overall Study|Not treated during study period|1|||
170370621|NCT04960202|615692508|FG000|Overall Study|Other|5|||
170370622|NCT04960202|615692509|FG001|Overall Study|Other|0|||
170370623|NCT04960202|615692508|FG000|Overall Study|Withdrawal by Subject|37|||
170370624|NCT04960202|615692509|FG001|Overall Study|Withdrawal by Subject|43|||
170370625|NCT04960202|615692508|FG000|Overall Study|Lost to Follow-up|20|||
170370626|NCT04960202|615692509|FG001|Overall Study|Lost to Follow-up|16|||
170370627|NCT04960202|615692508|FG000|Overall Study|Death|0|||
170370628|NCT04960202|615692509|FG001|Overall Study|Death|15|||
170370629|NCT00524043|615692512|FG000|Overall Study|Lack of Efficacy|15|||
170370630|NCT00524043|615692513|FG001|Overall Study|Lack of Efficacy|13|||
170370631|NCT00524043|615692514|FG002|Overall Study|Lack of Efficacy|14|||
170370632|NCT00524043|615692512|FG000|Overall Study|Withdrawal by Subject|5|||
170370633|NCT00524043|615692513|FG001|Overall Study|Withdrawal by Subject|7|||
170370634|NCT00524043|615692514|FG002|Overall Study|Withdrawal by Subject|7|||
170370635|NCT00524043|615692512|FG000|Overall Study|Adverse Event|5|||
170370636|NCT00524043|615692513|FG001|Overall Study|Adverse Event|2|||
170370637|NCT00524043|615692514|FG002|Overall Study|Adverse Event|7|||
170370638|NCT00524043|615692512|FG000|Overall Study|Lost to Follow-up|3|||
170370639|NCT00524043|615692513|FG001|Overall Study|Lost to Follow-up|5|||
170370640|NCT00524043|615692514|FG002|Overall Study|Lost to Follow-up|3|||
170370641|NCT00524043|615692512|FG000|Overall Study|Various (eg, incarceration)|2|||
170370642|NCT00524043|615692513|FG001|Overall Study|Various (eg, incarceration)|1|||
170370643|NCT00524043|615692514|FG002|Overall Study|Various (eg, incarceration)|0|||
170370644|NCT00711412|615692519|FG000|Induction Treatment|Death|2|||
170370645|NCT00711412|615692519|FG000|Induction Treatment|Adverse Event|1|||
170370646|NCT00711412|615692519|FG000|Induction Treatment|Other|1|||
170370647|NCT00711412|615692519|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
170370648|NCT00711412|615692519|FG000|Evaluated for Combination Treatment|Death|1|||
170370649|NCT00711412|615692519|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
170370650|NCT00711412|615692519|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
170370651|NCT00711412|615692519|FG000|Combination Treatment|Progressive Disease|1|||
170370652|NCT00711412|615692519|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
170370653|NCT00711412|615692519|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
170370654|NCT00711412|615692519|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
170370655|NCT00711412|615692519|FG000|Evaluation for Response and Surgery|Death|1|||
170370656|NCT00711412|615692519|FG000|Survival Follow up Until Death|Other|12|||
170370657|NCT02473289|615692522|FG000|Overall Study|Adverse Event|2|||
170370658|NCT02473289|615692523|FG001|Overall Study|Adverse Event|3|||
170370659|NCT02473289|615692522|FG000|Overall Study|Lost to Follow-up|1|||
170370660|NCT02473289|615692523|FG001|Overall Study|Lost to Follow-up|1|||
170370661|NCT02473289|615692522|FG000|Overall Study|Protocol Violation|0|||
170370662|NCT02473289|615692523|FG001|Overall Study|Protocol Violation|1|||
170370663|NCT02473289|615692522|FG000|Overall Study|Withdrawal of consent|6|||
170370664|NCT02473289|615692523|FG001|Overall Study|Withdrawal of consent|7|||
170370665|NCT02473289|615692522|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
170370666|NCT02473289|615692523|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
170370667|NCT02473289|615692522|FG000|Overall Study|Other|2|||
170370668|NCT02473289|615692523|FG001|Overall Study|Other|0|||
170370669|NCT01156363|615692524|FG000|Overall Study|Adverse Event|6|||
170370670|NCT01156363|615692524|FG000|Overall Study|Insufficient Therapeutic Response|5|||
170370671|NCT01156363|615692524|FG000|Overall Study|Failure to Return|1|||
170370672|NCT01156363|615692524|FG000|Overall Study|Refused Treatment|4|||
170370673|NCT01156363|615692524|FG000|Overall Study|Other|6|||
170370674|NCT00047008|615692525|FG000|Overall Study|Withdrawn consent|2|||
170370675|NCT00047008|615692526|FG001|Overall Study|Withdrawn consent|3|||
170370676|NCT00047008|615692525|FG000|Overall Study|Ineligible|9|||
170370677|NCT00047008|615692526|FG001|Overall Study|Ineligible|8|||
170370678|NCT02773368|615692527|FG000|Overall Study|Lost to Follow-up|4|||
170370679|NCT02773368|615692528|FG001|Overall Study|Lost to Follow-up|1|||
170370680|NCT02773368|615692527|FG000|Overall Study|Withdrawal by Subject|5|||
170370681|NCT02773368|615692528|FG001|Overall Study|Withdrawal by Subject|1|||
170370682|NCT02773368|615692527|FG000|Overall Study|Unclassified|1|||
170370683|NCT02773368|615692528|FG001|Overall Study|Unclassified|1|||
170370684|NCT02773368|615692527|FG000|Overall Study|Missing|0|||
170370685|NCT02773368|615692528|FG001|Overall Study|Missing|1|||
170370686|NCT01047436|615692542|FG000|Overall Study|Protocol Violation|1|||
170370687|NCT01047436|615692543|FG001|Overall Study|Protocol Violation|0|||
170370688|NCT02565576|615692547|FG000|Overall Study|abnormal lab value|2|||
170370689|NCT02565576|615692548|FG001|Overall Study|abnormal lab value|0|||
170370690|NCT02565576|615692547|FG000|Overall Study|subject / guardian decision|1|||
170370691|NCT02565576|615692548|FG001|Overall Study|subject / guardian decision|3|||
170370692|NCT02565576|615692547|FG000|Overall Study|Lost to Follow-up|1|||
170370693|NCT02565576|615692548|FG001|Overall Study|Lost to Follow-up|0|||
170370694|NCT02565576|615692547|FG000|Overall Study|Death|0|||
170370695|NCT02565576|615692548|FG001|Overall Study|Death|2|||
170370696|NCT02565576|615692547|FG000|Overall Study|Adverse Event|1|||
170370697|NCT02565576|615692548|FG001|Overall Study|Adverse Event|0|||
170370698|NCT00282568|615692549|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
170370699|NCT00282568|615692549|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
170370700|NCT00282568|615692549|FG000|Extended Treatment Period|Adverse Event|17|||
170370701|NCT00282568|615692549|FG000|Extended Treatment Period|Non-compliance|4|||
170370702|NCT00282568|615692549|FG000|Extended Treatment Period|Physician Decision|1|||
170370703|NCT00282568|615692549|FG000|Extended Treatment Period|Lost to Follow-up|2|||
170370704|NCT02417064|615692554|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
170370705|NCT02417064|615692555|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
170370706|NCT02417064|615692556|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
170370707|NCT02417064|615692554|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
170370708|NCT02417064|615692555|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
170370709|NCT02417064|615692556|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
170370710|NCT02417064|615692554|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
170370711|NCT02417064|615692555|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
170370712|NCT02417064|615692556|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
170370713|NCT02417064|615692554|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
170370714|NCT02417064|615692555|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
170370715|NCT02417064|615692556|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
170370716|NCT02417064|615692554|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
170370717|NCT02417064|615692555|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
170398850|NCT05004181|615798314|FG002|Overall Study|Lost to Follow-up|2|||
170370718|NCT02417064|615692556|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
170370719|NCT02417064|615692554|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
170370720|NCT02417064|615692555|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
170370721|NCT02417064|615692556|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
170370722|NCT02417064|615692554|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
170370723|NCT02417064|615692555|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
170370724|NCT02417064|615692556|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
170370725|NCT02417064|615692554|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
170370726|NCT02417064|615692555|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
170370727|NCT02417064|615692556|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
170370728|NCT02417064|615692554|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
170370729|NCT02417064|615692555|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
170370730|NCT02417064|615692556|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
170370731|NCT02417064|615692554|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
170370732|NCT02417064|615692555|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
170370733|NCT02417064|615692556|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
170370734|NCT02417064|615692554|FG000|Follow-up Phase (24 Weeks)|Other|2|||
170370735|NCT02417064|615692555|FG001|Follow-up Phase (24 Weeks)|Other|2|||
170370736|NCT02417064|615692556|FG002|Follow-up Phase (24 Weeks)|Other|3|||
170370737|NCT02437162|615692561|FG000|Overall Study|Protocol Violation|0|||
170370738|NCT02437162|615692562|FG001|Overall Study|Protocol Violation|1|||
170370739|NCT02437162|615692563|FG002|Overall Study|Protocol Violation|0|||
170370740|NCT02437162|615692561|FG000|Overall Study|Randomized but not treated|0|||
170370741|NCT02437162|615692562|FG001|Overall Study|Randomized but not treated|0|||
170370742|NCT02437162|615692563|FG002|Overall Study|Randomized but not treated|1|||
170370743|NCT02437162|615692561|FG000|Overall Study|Study discontinued by Sponsor|93|||
170370744|NCT02437162|615692562|FG001|Overall Study|Study discontinued by Sponsor|98|||
170370745|NCT02437162|615692563|FG002|Overall Study|Study discontinued by Sponsor|97|||
170370746|NCT02437162|615692561|FG000|Overall Study|Withdrawal by Subject|13|||
170370747|NCT02437162|615692562|FG001|Overall Study|Withdrawal by Subject|7|||
170370748|NCT02437162|615692563|FG002|Overall Study|Withdrawal by Subject|9|||
170370749|NCT02437162|615692561|FG000|Overall Study|Adverse Event|0|||
170370750|NCT02437162|615692562|FG001|Overall Study|Adverse Event|1|||
170370751|NCT02437162|615692563|FG002|Overall Study|Adverse Event|0|||
170370752|NCT02437162|615692561|FG000|Overall Study|Lost to Follow-up|1|||
170370753|NCT02437162|615692562|FG001|Overall Study|Lost to Follow-up|0|||
170370754|NCT02437162|615692563|FG002|Overall Study|Lost to Follow-up|1|||
170370755|NCT02437162|615692561|FG000|Overall Study|Death|0|||
170370756|NCT02437162|615692562|FG001|Overall Study|Death|1|||
170370757|NCT02437162|615692563|FG002|Overall Study|Death|0|||
170370758|NCT02437162|615692561|FG000|Overall Study|Other|0|||
170370759|NCT02437162|615692562|FG001|Overall Study|Other|0|||
170370760|NCT02437162|615692563|FG002|Overall Study|Other|1|||
170370761|NCT02438787|615692564|FG000|Overall Study|Adverse Event|1|||
170370762|NCT02438787|615692565|FG001|Overall Study|Adverse Event|0|||
170370763|NCT02438787|615692566|FG002|Overall Study|Adverse Event|2|||
170370764|NCT02438787|615692564|FG000|Overall Study|Lack of Efficacy|1|||
170370765|NCT02438787|615692565|FG001|Overall Study|Lack of Efficacy|2|||
170370766|NCT02438787|615692566|FG002|Overall Study|Lack of Efficacy|0|||
170370767|NCT02438787|615692564|FG000|Overall Study|Lost to Follow-up|0|||
170370768|NCT02438787|615692565|FG001|Overall Study|Lost to Follow-up|1|||
170370769|NCT02438787|615692566|FG002|Overall Study|Lost to Follow-up|0|||
170370770|NCT02438787|615692564|FG000|Overall Study|Protocol Violation|0|||
170370771|NCT02438787|615692565|FG001|Overall Study|Protocol Violation|0|||
170370772|NCT02438787|615692566|FG002|Overall Study|Protocol Violation|1|||
170370773|NCT02438787|615692564|FG000|Overall Study|Withdrawal by Subject|15|||
170370774|NCT02438787|615692565|FG001|Overall Study|Withdrawal by Subject|7|||
170370775|NCT02438787|615692566|FG002|Overall Study|Withdrawal by Subject|10|||
170370776|NCT02438787|615692564|FG000|Overall Study|Study discontinued by sponsor|64|||
170370777|NCT02438787|615692565|FG001|Overall Study|Study discontinued by sponsor|72|||
170370778|NCT02438787|615692566|FG002|Overall Study|Study discontinued by sponsor|69|||
170370779|NCT02438787|615692564|FG000|Overall Study|Other|0|||
170370780|NCT02438787|615692565|FG001|Overall Study|Other|1|||
170370781|NCT02438787|615692566|FG002|Overall Study|Other|0|||
170370782|NCT02438787|615692564|FG000|Overall Study|Site terminated by sponsor|0|||
170370783|NCT02438787|615692565|FG001|Overall Study|Site terminated by sponsor|0|||
170370784|NCT02438787|615692566|FG002|Overall Study|Site terminated by sponsor|1|||
170370785|NCT03412565|615692567|FG000|Overall Study|Lost to Follow-up|0|||
170370786|NCT03412565|615692568|FG001|Overall Study|Lost to Follow-up|0|||
170370787|NCT03412565|615692569|FG002|Overall Study|Lost to Follow-up|1|||
170370788|NCT03412565|615692570|FG003|Overall Study|Lost to Follow-up|0|||
170370789|NCT03412565|615692567|FG000|Overall Study|Physician Decision|0|||
170370790|NCT03412565|615692568|FG001|Overall Study|Physician Decision|0|||
170370791|NCT03412565|615692569|FG002|Overall Study|Physician Decision|0|||
170370792|NCT03412565|615692570|FG003|Overall Study|Physician Decision|1|||
170370793|NCT03412565|615692567|FG000|Overall Study|Withdrawal by Subject|0|||
170370794|NCT03412565|615692568|FG001|Overall Study|Withdrawal by Subject|4|||
170370795|NCT03412565|615692569|FG002|Overall Study|Withdrawal by Subject|5|||
170370796|NCT03412565|615692570|FG003|Overall Study|Withdrawal by Subject|5|||
170370797|NCT03412565|615692567|FG000|Overall Study|Death|1|||
170370798|NCT03412565|615692568|FG001|Overall Study|Death|3|||
170370799|NCT03412565|615692569|FG002|Overall Study|Death|4|||
170370800|NCT03412565|615692570|FG003|Overall Study|Death|5|||
170370801|NCT03412565|615692567|FG000|Overall Study|Data collection ended|0|||
170370802|NCT03412565|615692568|FG001|Overall Study|Data collection ended|41|||
170370803|NCT03412565|615692569|FG002|Overall Study|Data collection ended|41|||
170370804|NCT03412565|615692570|FG003|Overall Study|Data collection ended|40|||
170370805|NCT03321526|615692571|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
170370806|NCT03321526|615692572|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
170370807|NCT03321526|615692571|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
170370808|NCT03321526|615692572|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
170370809|NCT03321526|615692571|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
170370810|NCT03321526|615692572|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
170370811|NCT03321526|615692571|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
170370812|NCT03321526|615692572|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
170370813|NCT03321526|615692571|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
170370814|NCT03321526|615692572|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
170370815|NCT03321526|615692571|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
170370816|NCT03321526|615692572|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
170370817|NCT03321526|615692571|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
170370818|NCT03321526|615692572|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
170370819|NCT03321526|615692571|FG000|Follow-up Phase (2 Weeks)|Other|24|||
170370820|NCT03321526|615692572|FG001|Follow-up Phase (2 Weeks)|Other|24|||
170370821|NCT03097133|615692573|FG000|Overall Study|Lost to Follow-up|3|||
170370822|NCT03097133|615692574|FG001|Overall Study|Lost to Follow-up|2|||
170370823|NCT03097133|615692573|FG000|Overall Study|Withdrawal by Subject|2|||
170370824|NCT03097133|615692574|FG001|Overall Study|Withdrawal by Subject|5|||
170370825|NCT03097133|615692573|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
170370826|NCT03097133|615692574|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
170370827|NCT03097133|615692573|FG000|Overall Study|Other|3|||
170370828|NCT03097133|615692574|FG001|Overall Study|Other|2|||
170370829|NCT03097133|615692573|FG000|Overall Study|Adverse Event|1|||
170370830|NCT03097133|615692574|FG001|Overall Study|Adverse Event|0|||
170370831|NCT00732641|615692577|FG000|Overall Study|Relapse or Progressive Disease|65|||
170370832|NCT00732641|615692578|FG001|Overall Study|Relapse or Progressive Disease|101|||
170370833|NCT00732641|615692577|FG000|Overall Study|Serious Adverse Events|12|||
170370834|NCT00732641|615692578|FG001|Overall Study|Serious Adverse Events|3|||
170370835|NCT00732641|615692577|FG000|Overall Study|Physician Decision|6|||
170370836|NCT00732641|615692578|FG001|Overall Study|Physician Decision|0|||
170370837|NCT00732641|615692577|FG000|Overall Study|Withdrawal by Subject|4|||
170370838|NCT00732641|615692578|FG001|Overall Study|Withdrawal by Subject|2|||
170370839|NCT00732641|615692577|FG000|Overall Study|Unable to Complete|1|||
170370840|NCT00732641|615692578|FG001|Overall Study|Unable to Complete|1|||
170370841|NCT00732641|615692577|FG000|Overall Study|Other|18|||
170370842|NCT00732641|615692578|FG001|Overall Study|Other|5|||
170370843|NCT02939976|615692579|FG000|Overall Study|Lost to Follow-up|7|||
170370844|NCT02939976|615692580|FG001|Overall Study|Lost to Follow-up|1|||
170370845|NCT02939976|615692581|FG002|Overall Study|Lost to Follow-up|1|||
170370846|NCT02939976|615692582|FG003|Overall Study|Lost to Follow-up|2|||
170370847|NCT02939976|615692579|FG000|Overall Study|Withdrawal by Subject|4|||
170370848|NCT02939976|615692580|FG001|Overall Study|Withdrawal by Subject|0|||
170370849|NCT02939976|615692581|FG002|Overall Study|Withdrawal by Subject|2|||
170370850|NCT02939976|615692582|FG003|Overall Study|Withdrawal by Subject|4|||
170370851|NCT02939976|615692579|FG000|Overall Study|Due to early study closure|4|||
170370852|NCT02939976|615692580|FG001|Overall Study|Due to early study closure|3|||
170370853|NCT02939976|615692581|FG002|Overall Study|Due to early study closure|2|||
170370854|NCT02939976|615692582|FG003|Overall Study|Due to early study closure|3|||
170370855|NCT01585168|615692589|FG000|Overall Study|Lost to Follow-up|3|||
170370856|NCT01585168|615692590|FG001|Overall Study|Lost to Follow-up|1|||
170370857|NCT01585168|615692591|FG002|Overall Study|Lost to Follow-up|1|||
170370858|NCT01585168|615692592|FG003|Overall Study|Lost to Follow-up|1|||
170370859|NCT00373880|615692593|FG000|Overall Study|Physician Decision|3|||
170370860|NCT00373880|615692593|FG000|Overall Study|Arrested|1|||
170370861|NCT00373880|615692593|FG000|Overall Study|Protocol Violation|14|||
170370862|NCT03748420|615692594|FG000|Overall Study|No 12 month medication adherence data available|0|||
170370863|NCT03748420|615692595|FG001|Overall Study|No 12 month medication adherence data available|1|||
170370864|NCT03748420|615692594|FG000|Overall Study|Death|24|||
170370865|NCT03748420|615692595|FG001|Overall Study|Death|28|||
170370866|NCT03748420|615692594|FG000|Overall Study|Lost to Follow-up|231|||
170370867|NCT03748420|615692595|FG001|Overall Study|Lost to Follow-up|230|||
170370868|NCT01203787|615692599|FG000|Overall Study|Death|12|||
170370869|NCT01203787|615692600|FG001|Overall Study|Death|10|||
170370870|NCT01203787|615692599|FG000|Overall Study|Withdrawal by Subject|6|||
170370871|NCT01203787|615692600|FG001|Overall Study|Withdrawal by Subject|2|||
170370872|NCT01203787|615692599|FG000|Overall Study|Lost to Follow-up|2|||
170370873|NCT01203787|615692600|FG001|Overall Study|Lost to Follow-up|0|||
170370874|NCT01203787|615692599|FG000|Overall Study|Adverse Event|11|||
170370875|NCT01203787|615692600|FG001|Overall Study|Adverse Event|15|||
170370876|NCT02566109|615692602|FG000|Overall Study|Withdrawal by Subject|1|||
170370877|NCT01906476|615692603|FG000|Overall Study|Lost to Follow-up|17|||
170370878|NCT01906476|615692604|FG001|Overall Study|Lost to Follow-up|16|||
170370879|NCT01993667|615692605|FG000|Overall Study|Insufficient data to analyze|16|||
170370880|NCT01993667|615692606|FG001|Overall Study|Insufficient data to analyze|16|||
170370881|NCT01993667|615692605|FG000|Overall Study|Insufficient altitude reached|3|||
170370882|NCT01993667|615692606|FG001|Overall Study|Insufficient altitude reached|1|||
170370883|NCT01993667|615692605|FG000|Overall Study|Lost to Follow-up|2|||
170370884|NCT01993667|615692606|FG001|Overall Study|Lost to Follow-up|2|||
170370885|NCT01199198|615694382|FG000|Overall Study|Adverse Event|3|||
170370886|NCT01199198|615694383|FG001|Overall Study|Adverse Event|0|||
170370887|NCT01199198|615694382|FG000|Overall Study|Lost to Follow-up|1|||
170370888|NCT01199198|615694383|FG001|Overall Study|Lost to Follow-up|5|||
170370889|NCT01199198|615694382|FG000|Overall Study|Withdrawal by Subject|1|||
170370890|NCT01199198|615694383|FG001|Overall Study|Withdrawal by Subject|2|||
170370891|NCT01199198|615694382|FG000|Overall Study|ICU Transfer|1|||
170370892|NCT01199198|615694383|FG001|Overall Study|ICU Transfer|2|||
170370893|NCT01199198|615694382|FG000|Overall Study|Hospice-care transfer|1|||
170370894|NCT01199198|615694383|FG001|Overall Study|Hospice-care transfer|2|||
170370895|NCT00653068|615694390|FG000|Overall Study|Death|9|||
170370896|NCT00653068|615694390|FG000|Overall Study|Lack of Efficacy|34|||
170370897|NCT00653068|615694390|FG000|Overall Study|Physician Decision|4|||
170370898|NCT00653068|615694390|FG000|Overall Study|Withdrawal by Subject|1|||
170370899|NCT00653068|615694390|FG000|Overall Study|Ineligible|2|||
170370900|NCT03950440|615694391|FG000|Overall Study|Death|8|||
170370901|NCT03950440|615694392|FG001|Overall Study|Death|2|||
170370902|NCT03950440|615694393|FG002|Overall Study|Death|1|||
170370903|NCT02658149|615694398|FG000|Overall Study|Physician Decision|1|||
170370904|NCT02658149|615694399|FG001|Overall Study|Physician Decision|0|||
170370905|NCT02234050|615694401|FG000|Overall Study|Lack of Efficacy|38|||
170370906|NCT02234050|615694402|FG001|Overall Study|Lack of Efficacy|22|||
170370907|NCT02234050|615694401|FG000|Overall Study|Adverse Event|13|||
170370908|NCT02234050|615694402|FG001|Overall Study|Adverse Event|1|||
170370909|NCT02234050|615694401|FG000|Overall Study|Withdrawal by Subject|4|||
170370910|NCT02234050|615694402|FG001|Overall Study|Withdrawal by Subject|2|||
170370911|NCT02234050|615694401|FG000|Overall Study|Sponsor's decision|6|||
170370912|NCT02234050|615694402|FG001|Overall Study|Sponsor's decision|0|||
170370913|NCT01680991|615694403|FG000|Overall Study|Adverse Event|1|||
170370914|NCT01680991|615694404|FG001|Overall Study|Adverse Event|0|||
170370915|NCT01680991|615694405|FG002|Overall Study|Adverse Event|0|||
170370916|NCT01680991|615694403|FG000|Overall Study|Death|1|||
170370917|NCT01680991|615694404|FG001|Overall Study|Death|0|||
170370918|NCT01680991|615694405|FG002|Overall Study|Death|1|||
170370919|NCT01680991|615694403|FG000|Overall Study|Protocol Violation|0|||
170370920|NCT01680991|615694404|FG001|Overall Study|Protocol Violation|1|||
170370921|NCT01680991|615694405|FG002|Overall Study|Protocol Violation|0|||
170370922|NCT01680991|615694403|FG000|Overall Study|Withdrawal by Subject|5|||
170370923|NCT01680991|615694404|FG001|Overall Study|Withdrawal by Subject|1|||
170370924|NCT01680991|615694405|FG002|Overall Study|Withdrawal by Subject|0|||
170370925|NCT01680991|615694403|FG000|Overall Study|Progressive disease (PD)|0|||
170370926|NCT01680991|615694404|FG001|Overall Study|Progressive disease (PD)|10|||
170370927|NCT01680991|615694405|FG002|Overall Study|Progressive disease (PD)|0|||
170370928|NCT01680991|615694403|FG000|Overall Study|Physician Decision|0|||
170370929|NCT01680991|615694404|FG001|Overall Study|Physician Decision|7|||
170370930|NCT01680991|615694405|FG002|Overall Study|Physician Decision|2|||
170370931|NCT01680991|615694403|FG000|Overall Study|Bad physical condition|0|||
170370932|NCT01680991|615694404|FG001|Overall Study|Bad physical condition|0|||
170370933|NCT01680991|615694405|FG002|Overall Study|Bad physical condition|1|||
170370934|NCT01680991|615694403|FG000|Overall Study|PD confirmed in other hospital|1|||
170370935|NCT01680991|615694404|FG001|Overall Study|PD confirmed in other hospital|0|||
170370936|NCT01680991|615694405|FG002|Overall Study|PD confirmed in other hospital|0|||
170370937|NCT02498392|615694406|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
170370938|NCT02498392|615694407|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
170370939|NCT02498392|615694406|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
170370940|NCT02498392|615694407|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
170370941|NCT02498392|615694406|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
170370942|NCT02498392|615694407|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
170370943|NCT02498392|615694406|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
170370944|NCT02498392|615694407|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
170370945|NCT02498392|615694406|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
170370946|NCT02498392|615694407|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
170370947|NCT02498392|615694406|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
170370948|NCT02498392|615694407|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
170370949|NCT00246376|615694412|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
170370950|NCT00246376|615694413|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
170370951|NCT00246376|615694414|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
170370952|NCT00246376|615694415|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
170370953|NCT00246376|615694416|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
170370954|NCT00246376|615694412|FG000|Overall Study|Adverse Event|2|||
170370955|NCT00246376|615694413|FG001|Overall Study|Adverse Event|3|||
170370956|NCT00246376|615694414|FG002|Overall Study|Adverse Event|1|||
170370957|NCT00246376|615694415|FG003|Overall Study|Adverse Event|3|||
170370958|NCT00246376|615694416|FG004|Overall Study|Adverse Event|1|||
170370959|NCT00246376|615694412|FG000|Overall Study|Lost to Follow-up|2|||
170370960|NCT00246376|615694413|FG001|Overall Study|Lost to Follow-up|11|||
170370961|NCT00246376|615694414|FG002|Overall Study|Lost to Follow-up|11|||
170370962|NCT00246376|615694415|FG003|Overall Study|Lost to Follow-up|16|||
170370963|NCT00246376|615694416|FG004|Overall Study|Lost to Follow-up|13|||
170370964|NCT01872897|615694421|FG000|Overall Study|Withdrawal by Subject|1|||
170370965|NCT01872897|615694422|FG001|Overall Study|Withdrawal by Subject|0|||
170370966|NCT02640755|615694425|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
170370967|NCT02640755|615694426|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
170370968|NCT02640755|615694425|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
170370969|NCT02640755|615694426|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
170370970|NCT02640755|615694425|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
170370971|NCT02640755|615694426|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
170370972|NCT03434041|615694427|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
170370973|NCT03434041|615694428|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
170370974|NCT03434041|615694427|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
170370975|NCT03434041|615694428|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
170370976|NCT03434041|615694427|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
170370977|NCT03434041|615694428|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
170370978|NCT03434041|615694427|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
170370979|NCT03434041|615694428|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
170370980|NCT03434041|615694427|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
170370981|NCT03434041|615694428|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
170370982|NCT03434041|615694427|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
170370983|NCT03434041|615694428|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
170370984|NCT03434041|615694427|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
170370985|NCT03434041|615694428|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
170370986|NCT03434041|615694427|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
170370987|NCT03434041|615694428|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
170370988|NCT03434041|615694427|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
170370989|NCT03434041|615694428|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
170370990|NCT03434041|615694427|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
170370991|NCT03434041|615694428|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
170370992|NCT03434041|615694427|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
170370993|NCT03434041|615694428|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
170370994|NCT04159701|615694429|FG000|Period 1: Treatment Period|Pregnancy|1|||
170370995|NCT04159701|615694430|FG001|Period 1: Treatment Period|Pregnancy|0|||
170370996|NCT04159701|615694429|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
170370997|NCT04159701|615694430|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
170370998|NCT04159701|615694429|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
170370999|NCT04159701|615694430|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
170371000|NCT04159701|615694429|FG000|Washout Period|site terminated by sponsor|0|||
170371001|NCT04159701|615694430|FG001|Washout Period|site terminated by sponsor|1|||
170371002|NCT04159701|615694429|FG000|Washout Period|study terminated by sponsor|10|||
170371003|NCT04159701|615694430|FG001|Washout Period|study terminated by sponsor|3|||
170371004|NCT04159701|615694429|FG000|Washout Period|Withdrawal by Subject|1|||
170371005|NCT04159701|615694430|FG001|Washout Period|Withdrawal by Subject|0|||
170371006|NCT04159701|615694429|FG000|Washout Period|Inadvertent Enrollment|1|||
170371007|NCT04159701|615694430|FG001|Washout Period|Inadvertent Enrollment|0|||
170371008|NCT04159701|615694429|FG000|Washout Period|Miscellaneous|1|||
170371009|NCT04159701|615694430|FG001|Washout Period|Miscellaneous|0|||
170371010|NCT04159701|615694429|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
170371011|NCT04159701|615694430|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
170371012|NCT04159701|615694429|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
170398851|NCT05004181|615798315|FG003|Overall Study|Lost to Follow-up|3|||
170371013|NCT04159701|615694430|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
170371014|NCT04159701|615694429|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
170371015|NCT04159701|615694430|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
170371016|NCT04159701|615694429|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
170371017|NCT04159701|615694430|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
170371018|NCT04159701|615694429|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
170371019|NCT04159701|615694430|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
170371020|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
170371021|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
170371022|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
170371023|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
170371024|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
170371025|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
170371026|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
170371027|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
170371028|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
170371029|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
170371030|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
170371031|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
170371032|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
170371033|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
170371034|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
170371035|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
170371036|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
170371037|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
170371038|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
170371039|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
170371040|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
170371041|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
170371042|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
170371043|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
170371044|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
170371045|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
170371046|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
170371047|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
170371048|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
170371049|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
170371050|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
170371051|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
170371052|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
170371053|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
170371054|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
170371055|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
170371056|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
170371057|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
170371058|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
170371059|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
170371060|NCT03605836|615694431|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
170371061|NCT03605836|615694432|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
170371062|NCT03605836|615694433|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
170371063|NCT03605836|615694434|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
170371064|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
170371065|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
170371066|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
170371067|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
170371068|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
170371069|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
170371070|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
170371071|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
170371072|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
170371073|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
170371074|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
170371075|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
170371076|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
170371077|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
170371078|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
170371079|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
170371080|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
170371081|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
170371082|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
170371083|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
170371084|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
170371085|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
170371086|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
170371087|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
170371088|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
170371089|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
170371090|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
170371091|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
170371092|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
170371093|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
170371094|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
170371095|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
170371096|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
170371097|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
170371098|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
170371099|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
170371100|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
170371101|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
170371102|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
170371103|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
170371104|NCT03605836|615694431|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
170371105|NCT03605836|615694432|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
170371106|NCT03605836|615694433|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
170371107|NCT03605836|615694434|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
170371108|NCT00633360|615694437|FG000|Overall Study|Lost to Follow-up|1|||
170371109|NCT00633360|615694438|FG001|Overall Study|Lost to Follow-up|1|||
170371110|NCT00633360|615694437|FG000|Overall Study|Adverse Event|3|||
170371111|NCT00633360|615694438|FG001|Overall Study|Adverse Event|1|||
170371112|NCT00633360|615694437|FG000|Overall Study|Protocol Violation|0|||
170371113|NCT00633360|615694438|FG001|Overall Study|Protocol Violation|1|||
170371114|NCT00610207|615694439|FG000|Overall Study|Lost to Follow-up|3|||
170371115|NCT04599972|615694442|FG000|Overall Study|Withdrawal by Subject|6|||
170371116|NCT04599972|615694443|FG001|Overall Study|Withdrawal by Subject|1|||
170371117|NCT04599972|615694442|FG000|Overall Study|Adverse Event|1|||
170371118|NCT04599972|615694443|FG001|Overall Study|Adverse Event|1|||
170371119|NCT04599972|615694442|FG000|Overall Study|Lost to Follow-up|1|||
170371120|NCT04599972|615694443|FG001|Overall Study|Lost to Follow-up|6|||
170371121|NCT04599972|615694442|FG000|Overall Study|Protocol Violation|1|||
170371122|NCT04599972|615694443|FG001|Overall Study|Protocol Violation|0|||
170371123|NCT04599972|615694442|FG000|Overall Study|Other reason|1|||
170371124|NCT04599972|615694443|FG001|Overall Study|Other reason|0|||
170371125|NCT00621244|615694451|FG000|Overall Study|Withdrawal by Subject|7|||
170371126|NCT00621244|615694452|FG001|Overall Study|Withdrawal by Subject|3|||
170371127|NCT00621244|615694453|FG002|Overall Study|Withdrawal by Subject|3|||
170371128|NCT00621244|615694454|FG003|Overall Study|Withdrawal by Subject|3|||
170371129|NCT00621244|615694451|FG000|Overall Study|Disease progression|44|||
170371130|NCT00621244|615694452|FG001|Overall Study|Disease progression|20|||
170371131|NCT00621244|615694453|FG002|Overall Study|Disease progression|20|||
170371132|NCT00621244|615694454|FG003|Overall Study|Disease progression|15|||
170371133|NCT00621244|615694451|FG000|Overall Study|Death|3|||
170371134|NCT00621244|615694452|FG001|Overall Study|Death|3|||
170371135|NCT00621244|615694453|FG002|Overall Study|Death|1|||
170371136|NCT00621244|615694454|FG003|Overall Study|Death|1|||
170371137|NCT00621244|615694451|FG000|Overall Study|Adverse Event|27|||
170371138|NCT00621244|615694452|FG001|Overall Study|Adverse Event|7|||
170371139|NCT00621244|615694453|FG002|Overall Study|Adverse Event|9|||
170371140|NCT00621244|615694454|FG003|Overall Study|Adverse Event|2|||
170371141|NCT00621244|615694451|FG000|Overall Study|Administrative problems|5|||
170371142|NCT00621244|615694452|FG001|Overall Study|Administrative problems|1|||
170371143|NCT00621244|615694453|FG002|Overall Study|Administrative problems|0|||
170371144|NCT00621244|615694454|FG003|Overall Study|Administrative problems|2|||
170371145|NCT01690988|615694455|FG000|Overall Study|Withdrawal by Subject|2|||
170371146|NCT01690988|615694456|FG001|Overall Study|Withdrawal by Subject|2|||
170371147|NCT01690988|615694457|FG002|Overall Study|Withdrawal by Subject|3|||
170371148|NCT01690988|615694455|FG000|Overall Study|Physician Decision|0|||
170371149|NCT01690988|615694456|FG001|Overall Study|Physician Decision|0|||
170371150|NCT01690988|615694457|FG002|Overall Study|Physician Decision|1|||
170371151|NCT01690988|615694455|FG000|Overall Study|Operation Cancelled|1|||
170371152|NCT01690988|615694456|FG001|Overall Study|Operation Cancelled|1|||
170371153|NCT01690988|615694457|FG002|Overall Study|Operation Cancelled|0|||
170371154|NCT01690988|615694455|FG000|Overall Study|Determined ineligible|1|||
170371155|NCT01690988|615694456|FG001|Overall Study|Determined ineligible|0|||
170371156|NCT01690988|615694457|FG002|Overall Study|Determined ineligible|0|||
170371157|NCT01690988|615694455|FG000|Overall Study|Death|1|||
170371158|NCT01690988|615694456|FG001|Overall Study|Death|1|||
170371159|NCT01690988|615694457|FG002|Overall Study|Death|1|||
170371160|NCT01690988|615694455|FG000|Overall Study|Sedated|1|||
170371161|NCT01690988|615694456|FG001|Overall Study|Sedated|1|||
170371162|NCT01690988|615694457|FG002|Overall Study|Sedated|2|||
170371163|NCT00312728|615694462|FG000|Overall Study|Progressive disease|53|||
170371164|NCT00312728|615694462|FG000|Overall Study|Adverse Event|32|||
170371165|NCT00312728|615694462|FG000|Overall Study|Withdrawal by Subject|10|||
170371166|NCT00312728|615694462|FG000|Overall Study|Required non-protocol cancer treatment|2|||
170371167|NCT00312728|615694462|FG000|Overall Study|Protocol Violation|2|||
170371168|NCT00312728|615694462|FG000|Overall Study|Other|10|||
170371169|NCT00312728|615694462|FG000|Overall Study|Other|1|||
170371170|NCT03696576|615694463|FG000|Overall Study|Soreness of throat after therapy|1|||
170371171|NCT03696576|615694464|FG001|Overall Study|Soreness of throat after therapy|1|||
170371172|NCT03696576|615694463|FG000|Overall Study|Lost to Follow-up|2|||
170371173|NCT03696576|615694464|FG001|Overall Study|Lost to Follow-up|4|||
170371174|NCT01634100|615694467|FG000|Overall Study|Withdrawal by Subject|1|||
170371175|NCT01634100|615694468|FG001|Overall Study|Withdrawal by Subject|0|||
170371176|NCT01634100|615694469|FG002|Overall Study|Withdrawal by Subject|1|||
170371177|NCT01634100|615694470|FG003|Overall Study|Withdrawal by Subject|0|||
170371178|NCT01634100|615694471|FG004|Overall Study|Withdrawal by Subject|0|||
170371179|NCT01634100|615694472|FG005|Overall Study|Withdrawal by Subject|0|||
170371180|NCT00338806|615694473|FG000|Acute Phase|Withdrawal by Subject|0|||
170371181|NCT00338806|615694474|FG001|Acute Phase|Withdrawal by Subject|1|||
170371182|NCT00338806|615694473|FG000|Follow-up|Lost to Follow-up|1|||
170371183|NCT00338806|615694474|FG001|Follow-up|Lost to Follow-up|3|||
170371184|NCT00744991|615694475|FG000|Overall Study|Progressive Disease|11|||
170371185|NCT00744991|615694475|FG000|Overall Study|Withdrawal by Subject|8|||
170371186|NCT00744991|615694475|FG000|Overall Study|Physician Decision|3|||
170371187|NCT00744991|615694475|FG000|Overall Study|Adverse Event|2|||
170371188|NCT00744991|615694475|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
170371189|NCT00422669|615694481|FG000|Overall Study|The study was terminated early.|98|||
170371190|NCT00422669|615694482|FG001|Overall Study|The study was terminated early.|100|||
170371191|NCT00422669|615694483|FG002|Overall Study|The study was terminated early.|7|||
170371192|NCT02709109|615694484|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
170371193|NCT02709109|615694485|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
170371194|NCT02709109|615694486|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
170371195|NCT02709109|615694487|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
170371196|NCT02709109|615694484|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
170371197|NCT02709109|615694485|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
170371198|NCT02709109|615694486|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
170371199|NCT02709109|615694487|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
170371200|NCT02709109|615694484|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
170371201|NCT02709109|615694485|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
170371202|NCT02709109|615694486|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
170371203|NCT02709109|615694487|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
170371204|NCT02709109|615694484|FG000|Washout Period (28 Days)|Other|2|||
170371205|NCT02709109|615694485|FG001|Washout Period (28 Days)|Other|2|||
170371206|NCT02709109|615694486|FG002|Washout Period (28 Days)|Other|3|||
170371207|NCT02709109|615694487|FG003|Washout Period (28 Days)|Other|0|||
170371208|NCT02709109|615694484|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
170371209|NCT02709109|615694485|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
170371210|NCT02709109|615694486|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
170371211|NCT02709109|615694487|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
170371212|NCT02709109|615694484|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
170371213|NCT02709109|615694485|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
170371214|NCT02709109|615694486|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
170371215|NCT02709109|615694487|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
170371216|NCT02709109|615694484|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
170371217|NCT02709109|615694485|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
170371218|NCT02709109|615694486|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
170371219|NCT02709109|615694487|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
170371220|NCT02709109|615694484|FG000|Treatment Period 2 (28 Days)|Other|0|||
170371221|NCT02709109|615694485|FG001|Treatment Period 2 (28 Days)|Other|0|||
170371222|NCT02709109|615694486|FG002|Treatment Period 2 (28 Days)|Other|1|||
170371223|NCT02709109|615694487|FG003|Treatment Period 2 (28 Days)|Other|0|||
170371224|NCT00842361|615694498|FG000|Overall Study|Protocol Violation|1|||
170371225|NCT00842361|615694499|FG001|Overall Study|Protocol Violation|0|||
170371226|NCT00842361|615694498|FG000|Overall Study|Unclassified|0|||
170371227|NCT00842361|615694499|FG001|Overall Study|Unclassified|2|||
170371228|NCT04449276|615694502|FG000|Overall Study|Adverse Event|1|||
170371229|NCT04449276|615694503|FG001|Overall Study|Adverse Event|2|||
170371230|NCT04449276|615694504|FG002|Overall Study|Adverse Event|0|||
170371231|NCT04449276|615694505|FG003|Overall Study|Adverse Event|0|||
170371232|NCT04449276|615694506|FG004|Overall Study|Adverse Event|2|||
170371233|NCT04449276|615694507|FG005|Overall Study|Adverse Event|0|||
170371234|NCT04449276|615694508|FG006|Overall Study|Adverse Event|0|||
170371235|NCT04449276|615694509|FG007|Overall Study|Adverse Event|1|||
170371236|NCT04449276|615694502|FG000|Overall Study|Withdrawal by Subject|2|||
170371237|NCT04449276|615694503|FG001|Overall Study|Withdrawal by Subject|0|||
170371238|NCT04449276|615694504|FG002|Overall Study|Withdrawal by Subject|0|||
170371239|NCT04449276|615694505|FG003|Overall Study|Withdrawal by Subject|1|||
170371240|NCT04449276|615694506|FG004|Overall Study|Withdrawal by Subject|0|||
170371241|NCT04449276|615694507|FG005|Overall Study|Withdrawal by Subject|0|||
170371242|NCT04449276|615694508|FG006|Overall Study|Withdrawal by Subject|0|||
170371243|NCT04449276|615694509|FG007|Overall Study|Withdrawal by Subject|0|||
170371244|NCT04449276|615694502|FG000|Overall Study|Other|0|||
170371245|NCT04449276|615694503|FG001|Overall Study|Other|2|||
170371246|NCT04449276|615694504|FG002|Overall Study|Other|3|||
170371247|NCT04449276|615694505|FG003|Overall Study|Other|2|||
170371248|NCT04449276|615694506|FG004|Overall Study|Other|0|||
170371249|NCT04449276|615694507|FG005|Overall Study|Other|0|||
170371250|NCT04449276|615694508|FG006|Overall Study|Other|0|||
170371251|NCT04449276|615694509|FG007|Overall Study|Other|1|||
170371252|NCT01929707|615694510|FG000|Intervention Period 1|Lost to Follow-up|0|||
170371253|NCT01929707|615694511|FG001|Intervention Period 1|Lost to Follow-up|0|||
170371254|NCT01929707|615694512|FG002|Intervention Period 1|Lost to Follow-up|0|||
170371255|NCT01929707|615694513|FG003|Intervention Period 1|Lost to Follow-up|1|||
170371256|NCT01929707|615694514|FG004|Intervention Period 1|Lost to Follow-up|0|||
170371257|NCT01929707|615694515|FG005|Intervention Period 1|Lost to Follow-up|0|||
170371258|NCT01929707|615694516|FG006|Intervention Period 1|Lost to Follow-up|0|||
170371259|NCT01929707|615694517|FG007|Intervention Period 1|Lost to Follow-up|0|||
170371260|NCT01929707|615694510|FG000|Intervention Period 1|Withdrawal by Subject|0|||
170371261|NCT01929707|615694511|FG001|Intervention Period 1|Withdrawal by Subject|0|||
170371262|NCT01929707|615694512|FG002|Intervention Period 1|Withdrawal by Subject|0|||
170371263|NCT01929707|615694513|FG003|Intervention Period 1|Withdrawal by Subject|2|||
170371264|NCT01929707|615694514|FG004|Intervention Period 1|Withdrawal by Subject|0|||
170371265|NCT01929707|615694515|FG005|Intervention Period 1|Withdrawal by Subject|0|||
170371266|NCT01929707|615694516|FG006|Intervention Period 1|Withdrawal by Subject|0|||
170371267|NCT01929707|615694517|FG007|Intervention Period 1|Withdrawal by Subject|0|||
170371268|NCT01929707|615694510|FG000|Intervention Period 2|Withdrawal by Subject|0|||
170371269|NCT01929707|615694511|FG001|Intervention Period 2|Withdrawal by Subject|0|||
170371270|NCT01929707|615694512|FG002|Intervention Period 2|Withdrawal by Subject|0|||
170371271|NCT01929707|615694513|FG003|Intervention Period 2|Withdrawal by Subject|0|||
170371272|NCT01929707|615694514|FG004|Intervention Period 2|Withdrawal by Subject|0|||
170371273|NCT01929707|615694515|FG005|Intervention Period 2|Withdrawal by Subject|2|||
170371274|NCT01929707|615694516|FG006|Intervention Period 2|Withdrawal by Subject|0|||
170371275|NCT01929707|615694517|FG007|Intervention Period 2|Withdrawal by Subject|0|||
170371276|NCT00856986|615694524|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
170371277|NCT00856986|615694525|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
170371278|NCT00856986|615694526|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
170371279|NCT00856986|615694527|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
170371280|NCT00856986|615694528|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
170371281|NCT00856986|615694524|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
170371282|NCT00856986|615694525|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
170371283|NCT00856986|615694526|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
170371284|NCT00856986|615694527|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
170371285|NCT00856986|615694528|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
170371286|NCT00856986|615694524|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
170371287|NCT00856986|615694525|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
170371288|NCT00856986|615694526|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
170371289|NCT00856986|615694527|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
170371290|NCT00856986|615694528|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
170371291|NCT00856986|615694524|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
170371292|NCT00856986|615694525|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
170371293|NCT00856986|615694526|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
170371294|NCT00856986|615694527|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
170371295|NCT00856986|615694528|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
170371296|NCT00856986|615694524|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
170371297|NCT00856986|615694525|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
170371298|NCT00856986|615694526|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
170371299|NCT00856986|615694527|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
170371300|NCT00856986|615694528|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
170371301|NCT00856986|615694524|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
170371302|NCT00856986|615694525|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
170371303|NCT00856986|615694526|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
170371304|NCT00856986|615694527|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
170371305|NCT00856986|615694528|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
170371306|NCT00856986|615694524|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
170371307|NCT00856986|615694525|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
170371308|NCT00856986|615694526|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
170371309|NCT00856986|615694527|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
170371310|NCT00856986|615694528|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
170371311|NCT00856986|615694524|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
170371312|NCT00856986|615694525|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
170371313|NCT00856986|615694526|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
170371314|NCT00856986|615694527|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
170371315|NCT00856986|615694528|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
170371316|NCT00856986|615694524|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
170371317|NCT00856986|615694525|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
170371318|NCT00856986|615694526|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
170371319|NCT00856986|615694527|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
170371320|NCT00856986|615694528|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
170371321|NCT00856986|615694524|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
170371322|NCT00856986|615694525|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
170371323|NCT00856986|615694526|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
170371324|NCT00856986|615694527|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
170371325|NCT00856986|615694528|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
170371326|NCT00856986|615694524|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
170371327|NCT00856986|615694525|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
170371328|NCT00856986|615694526|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
170371329|NCT00856986|615694527|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
170371330|NCT00856986|615694528|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
170371331|NCT00856986|615694524|FG000|Main Period, Weeks 0-26|Unclassified|7|||
170371332|NCT00856986|615694525|FG001|Main Period, Weeks 0-26|Unclassified|6|||
170371333|NCT00856986|615694526|FG002|Main Period, Weeks 0-26|Unclassified|7|||
170371334|NCT00856986|615694527|FG003|Main Period, Weeks 0-26|Unclassified|0|||
170371335|NCT00856986|615694528|FG004|Main Period, Weeks 0-26|Unclassified|0|||
170371336|NCT00856986|615694524|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
170371337|NCT00856986|615694525|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
170371338|NCT00856986|615694526|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
170371339|NCT00856986|615694527|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
170371340|NCT00856986|615694528|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
170371341|NCT00856986|615694524|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
170371342|NCT00856986|615694525|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
170371343|NCT00856986|615694526|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
170371344|NCT00856986|615694527|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
170371345|NCT00856986|615694528|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
170371346|NCT00856986|615694524|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
170371347|NCT00856986|615694525|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
170371348|NCT00856986|615694526|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
170371349|NCT00856986|615694527|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
170371350|NCT00856986|615694528|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
170371351|NCT00856986|615694524|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
170371352|NCT00856986|615694525|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
170371353|NCT00856986|615694526|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
170371354|NCT00856986|615694527|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
170371355|NCT00856986|615694528|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
170371356|NCT00856986|615694524|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
170371357|NCT00856986|615694525|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
170371358|NCT00856986|615694526|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
170371359|NCT00856986|615694527|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
170371360|NCT00856986|615694528|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
170371361|NCT00856986|615694524|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
170371362|NCT00856986|615694525|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
170371363|NCT00856986|615694526|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
170371364|NCT00856986|615694527|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
170371365|NCT00856986|615694528|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
170371366|NCT01915095|615694529|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
170371367|NCT01915095|615694530|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
170371368|NCT01915095|615694531|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
170371369|NCT01915095|615694532|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
170371370|NCT01915095|615694533|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
170371371|NCT02067533|615694534|FG000|Overall Study|Lost to Follow-up|4|||
170371372|NCT02067533|615694535|FG001|Overall Study|Lost to Follow-up|2|||
170371373|NCT02999191|615694536|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
170371374|NCT02999191|615694537|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
170371375|NCT02999191|615694538|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
170371376|NCT02632344|615696826|FG000|Overall Study|Adverse Event|3|||
170371377|NCT02632344|615696826|FG000|Overall Study|Lack of Efficacy|3|||
170371378|NCT02632344|615696826|FG000|Overall Study|Withdrawal by Subject|2|||
170371379|NCT00777257|615696827|FG000|Overall Study|Adverse Event|3|||
170371380|NCT00777257|615696828|FG001|Overall Study|Adverse Event|1|||
170371381|NCT00777257|615696829|FG002|Overall Study|Adverse Event|0|||
170371382|NCT00777257|615696827|FG000|Overall Study|Lost to Follow-up|3|||
170371383|NCT00777257|615696828|FG001|Overall Study|Lost to Follow-up|3|||
170371384|NCT00777257|615696829|FG002|Overall Study|Lost to Follow-up|2|||
170371385|NCT00777257|615696827|FG000|Overall Study|Protocol Violation|2|||
170371386|NCT00777257|615696828|FG001|Overall Study|Protocol Violation|2|||
170371387|NCT00777257|615696829|FG002|Overall Study|Protocol Violation|2|||
170371388|NCT00777257|615696827|FG000|Overall Study|Withdrawal by Subject|3|||
170371389|NCT00777257|615696828|FG001|Overall Study|Withdrawal by Subject|6|||
170371390|NCT00777257|615696829|FG002|Overall Study|Withdrawal by Subject|5|||
170371391|NCT04315298|615696830|FG000|Overall Study|Withdrawal by Subject|0|||
170371392|NCT04315298|615696831|FG001|Overall Study|Withdrawal by Subject|0|||
170371393|NCT04315298|615696832|FG002|Overall Study|Withdrawal by Subject|0|||
170371394|NCT04315298|615696833|FG003|Overall Study|Withdrawal by Subject|2|||
170371395|NCT04315298|615696834|FG004|Overall Study|Withdrawal by Subject|2|||
170371396|NCT04315298|615696835|FG005|Overall Study|Withdrawal by Subject|2|||
170371397|NCT04315298|615696836|FG006|Overall Study|Withdrawal by Subject|0|||
170371398|NCT04315298|615696837|FG007|Overall Study|Withdrawal by Subject|1|||
170371399|NCT04315298|615696838|FG008|Overall Study|Withdrawal by Subject|1|||
170371400|NCT04315298|615696839|FG009|Overall Study|Withdrawal by Subject|1|||
170371401|NCT04315298|615696840|FG010|Overall Study|Withdrawal by Subject|0|||
170371402|NCT04315298|615696841|FG011|Overall Study|Withdrawal by Subject|0|||
170371403|NCT04315298|615696842|FG012|Overall Study|Withdrawal by Subject|0|||
170371404|NCT04315298|615696843|FG013|Overall Study|Withdrawal by Subject|0|||
170371405|NCT04315298|615696844|FG014|Overall Study|Withdrawal by Subject|0|||
170371406|NCT04315298|615696845|FG015|Overall Study|Withdrawal by Subject|0|||
170371407|NCT04315298|615696846|FG016|Overall Study|Withdrawal by Subject|0|||
170371408|NCT04315298|615696847|FG017|Overall Study|Withdrawal by Subject|0|||
170371409|NCT04315298|615696848|FG018|Overall Study|Withdrawal by Subject|0|||
170371410|NCT04315298|615696830|FG000|Overall Study|Physician Decision|0|||
170371411|NCT04315298|615696831|FG001|Overall Study|Physician Decision|0|||
170371412|NCT04315298|615696832|FG002|Overall Study|Physician Decision|0|||
170371413|NCT04315298|615696833|FG003|Overall Study|Physician Decision|0|||
170371414|NCT04315298|615696834|FG004|Overall Study|Physician Decision|1|||
170371415|NCT04315298|615696835|FG005|Overall Study|Physician Decision|0|||
170371416|NCT04315298|615696836|FG006|Overall Study|Physician Decision|0|||
170371417|NCT04315298|615696837|FG007|Overall Study|Physician Decision|0|||
170371418|NCT04315298|615696838|FG008|Overall Study|Physician Decision|0|||
170371419|NCT04315298|615696839|FG009|Overall Study|Physician Decision|0|||
170371420|NCT04315298|615696840|FG010|Overall Study|Physician Decision|0|||
170371421|NCT04315298|615696841|FG011|Overall Study|Physician Decision|0|||
170371422|NCT04315298|615696842|FG012|Overall Study|Physician Decision|0|||
170371423|NCT04315298|615696843|FG013|Overall Study|Physician Decision|0|||
170371424|NCT04315298|615696844|FG014|Overall Study|Physician Decision|0|||
170371425|NCT04315298|615696845|FG015|Overall Study|Physician Decision|0|||
170371426|NCT04315298|615696846|FG016|Overall Study|Physician Decision|0|||
170371427|NCT04315298|615696847|FG017|Overall Study|Physician Decision|0|||
170371428|NCT04315298|615696848|FG018|Overall Study|Physician Decision|0|||
170371429|NCT04315298|615696830|FG000|Overall Study|Lost to Follow-up|5|||
170371430|NCT04315298|615696831|FG001|Overall Study|Lost to Follow-up|10|||
170371431|NCT04315298|615696832|FG002|Overall Study|Lost to Follow-up|6|||
170371432|NCT04315298|615696833|FG003|Overall Study|Lost to Follow-up|8|||
170371433|NCT04315298|615696834|FG004|Overall Study|Lost to Follow-up|12|||
170371434|NCT04315298|615696835|FG005|Overall Study|Lost to Follow-up|13|||
170371435|NCT04315298|615696836|FG006|Overall Study|Lost to Follow-up|9|||
170371436|NCT04315298|615696837|FG007|Overall Study|Lost to Follow-up|16|||
170371437|NCT04315298|615696838|FG008|Overall Study|Lost to Follow-up|14|||
170371438|NCT04315298|615696839|FG009|Overall Study|Lost to Follow-up|0|||
170371439|NCT04315298|615696840|FG010|Overall Study|Lost to Follow-up|2|||
170371440|NCT04315298|615696841|FG011|Overall Study|Lost to Follow-up|1|||
170371441|NCT04315298|615696842|FG012|Overall Study|Lost to Follow-up|0|||
170371442|NCT04315298|615696843|FG013|Overall Study|Lost to Follow-up|0|||
170371443|NCT04315298|615696844|FG014|Overall Study|Lost to Follow-up|0|||
170371444|NCT04315298|615696845|FG015|Overall Study|Lost to Follow-up|2|||
170371445|NCT04315298|615696846|FG016|Overall Study|Lost to Follow-up|0|||
170371446|NCT04315298|615696847|FG017|Overall Study|Lost to Follow-up|0|||
170371447|NCT04315298|615696848|FG018|Overall Study|Lost to Follow-up|0|||
170371448|NCT04315298|615696830|FG000|Overall Study|Death|24|||
170371449|NCT04315298|615696831|FG001|Overall Study|Death|60|||
170371450|NCT04315298|615696832|FG002|Overall Study|Death|49|||
170371451|NCT04315298|615696833|FG003|Overall Study|Death|59|||
170371452|NCT04315298|615696834|FG004|Overall Study|Death|70|||
170371453|NCT04315298|615696835|FG005|Overall Study|Death|114|||
170371454|NCT04315298|615696836|FG006|Overall Study|Death|9|||
170371455|NCT04315298|615696837|FG007|Overall Study|Death|12|||
170371456|NCT04315298|615696838|FG008|Overall Study|Death|21|||
170371457|NCT04315298|615696839|FG009|Overall Study|Death|16|||
170371458|NCT04315298|615696840|FG010|Overall Study|Death|40|||
170371459|NCT04315298|615696841|FG011|Overall Study|Death|40|||
170371460|NCT04315298|615696842|FG012|Overall Study|Death|3|||
170371461|NCT04315298|615696843|FG013|Overall Study|Death|4|||
170371462|NCT04315298|615696844|FG014|Overall Study|Death|6|||
170371463|NCT04315298|615696845|FG015|Overall Study|Death|4|||
170371464|NCT04315298|615696846|FG016|Overall Study|Death|3|||
170371465|NCT04315298|615696847|FG017|Overall Study|Death|1|||
170371466|NCT04315298|615696848|FG018|Overall Study|Death|0|||
170371467|NCT00098865|615696849|FG000|Overall Study|Progressive Disease|6|||
170371468|NCT00098865|615696849|FG000|Overall Study|Adverse Event|2|||
170371469|NCT00098865|615696849|FG000|Overall Study|Alternative Therapy|1|||
170371470|NCT03267511|615696850|FG000|Overall Study|Lost to Follow-up|0|||
170371471|NCT03267511|615696851|FG001|Overall Study|Lost to Follow-up|0|||
170371472|NCT03267511|615696852|FG002|Overall Study|Lost to Follow-up|0|||
170371473|NCT03267511|615696853|FG003|Overall Study|Lost to Follow-up|1|||
170371474|NCT05426460|615696854|FG000|Overall Study|Protocol Violation|1|||
170371475|NCT05426460|615696855|FG001|Overall Study|Protocol Violation|1|||
170371476|NCT05426460|615696856|FG002|Overall Study|Protocol Violation|1|||
170371477|NCT05426460|615696857|FG003|Overall Study|Protocol Violation|0|||
170371478|NCT00444951|615696866|FG000|Overall Study|Lost to Follow-up|1|||
170371479|NCT00444951|615696867|FG001|Overall Study|Lost to Follow-up|1|||
170371480|NCT00444951|615696868|FG002|Overall Study|Lost to Follow-up|0|||
170371481|NCT00444951|615696866|FG000|Overall Study|Withdrawal by Subject|4|||
170371482|NCT00444951|615696867|FG001|Overall Study|Withdrawal by Subject|5|||
170371483|NCT00444951|615696868|FG002|Overall Study|Withdrawal by Subject|3|||
170371484|NCT02710422|615696869|FG000|Overall Study|Termination of study|9|||
170371485|NCT02710422|615696870|FG001|Overall Study|Termination of study|9|||
170371486|NCT04984876|615696871|FG000|Overall Study|Subject decision|2|||
170371487|NCT04984876|615696872|FG001|Overall Study|Subject decision|10|||
170371488|NCT04984876|615696873|FG002|Overall Study|Subject decision|3|||
170371489|NCT04984876|615696874|FG003|Overall Study|Subject decision|3|||
170371490|NCT04984876|615696875|FG004|Overall Study|Subject decision|3|||
170371491|NCT04984876|615696876|FG005|Overall Study|Subject decision|0|||
170371492|NCT04984876|615696871|FG000|Overall Study|Guardian decision|0|||
170371493|NCT04984876|615696872|FG001|Overall Study|Guardian decision|1|||
170371494|NCT04984876|615696873|FG002|Overall Study|Guardian decision|0|||
170371495|NCT04984876|615696874|FG003|Overall Study|Guardian decision|2|||
170371496|NCT04984876|615696875|FG004|Overall Study|Guardian decision|0|||
170371497|NCT04984876|615696876|FG005|Overall Study|Guardian decision|1|||
170371498|NCT04984876|615696871|FG000|Overall Study|Lost to Follow-up|0|||
170371499|NCT04984876|615696872|FG001|Overall Study|Lost to Follow-up|0|||
170371500|NCT04984876|615696873|FG002|Overall Study|Lost to Follow-up|1|||
170371501|NCT04984876|615696874|FG003|Overall Study|Lost to Follow-up|1|||
170371502|NCT04984876|615696875|FG004|Overall Study|Lost to Follow-up|0|||
170371503|NCT04984876|615696876|FG005|Overall Study|Lost to Follow-up|0|||
170371504|NCT04984876|615696871|FG000|Overall Study|Physician Decision|1|||
170371505|NCT04984876|615696872|FG001|Overall Study|Physician Decision|0|||
170371506|NCT04984876|615696873|FG002|Overall Study|Physician Decision|0|||
170371507|NCT04984876|615696874|FG003|Overall Study|Physician Decision|1|||
170371508|NCT04984876|615696875|FG004|Overall Study|Physician Decision|0|||
170371509|NCT04984876|615696876|FG005|Overall Study|Physician Decision|0|||
170371510|NCT04984876|615696871|FG000|Overall Study|Adverse Event|0|||
170371511|NCT04984876|615696872|FG001|Overall Study|Adverse Event|0|||
170371512|NCT04984876|615696873|FG002|Overall Study|Adverse Event|1|||
170371513|NCT04984876|615696874|FG003|Overall Study|Adverse Event|0|||
170371514|NCT04984876|615696875|FG004|Overall Study|Adverse Event|0|||
170371515|NCT04984876|615696876|FG005|Overall Study|Adverse Event|0|||
170371516|NCT02204410|615696877|FG000|Overall Study|Lost to Follow-up|5|||
170371517|NCT02204410|615696877|FG000|Overall Study|Physician Decision|2|||
170371518|NCT02204410|615696877|FG000|Overall Study|Protocol Violation|1|||
170371519|NCT02204410|615696877|FG000|Overall Study|Withdrawal by Subject|3|||
170371520|NCT01405027|615696880|FG000|Overall Study|Withdrawn consent|3|||
170371521|NCT01405027|615696881|FG001|Overall Study|Withdrawn consent|0|||
170371522|NCT01405027|615696880|FG000|Overall Study|Lost to Follow-up|16|||
170371523|NCT01405027|615696881|FG001|Overall Study|Lost to Follow-up|24|||
170371524|NCT01405027|615696880|FG000|Overall Study|Investigator judgement|0|||
170371525|NCT01405027|615696881|FG001|Overall Study|Investigator judgement|2|||
170371526|NCT01405027|615696880|FG000|Overall Study|Death|1|||
170371527|NCT01405027|615696881|FG001|Overall Study|Death|0|||
170371528|NCT01405027|615696880|FG000|Overall Study|Other or Unknown|12|||
170371529|NCT01405027|615696881|FG001|Overall Study|Other or Unknown|25|||
170371530|NCT00378534|615696885|FG000|Overall Study|Participants did not receive transplant|3|||
170371531|NCT00378534|615696886|FG001|Overall Study|Participants did not receive transplant|0|||
170371532|NCT06073054|615696889|FG000|Overall Study|Withdrawal by Subject|2|||
170371533|NCT03687827|615696890|FG000|Treatment Period 1|Death|0|||
170371534|NCT03687827|615696891|FG001|Treatment Period 1|Death|1|||
170371535|NCT03687827|615696890|FG000|Treatment Period 1|Lost to Follow-up|2|||
170371536|NCT03687827|615696891|FG001|Treatment Period 1|Lost to Follow-up|2|||
170371537|NCT03687827|615696890|FG000|Treatment Period 1|Physician Decision|5|||
170371538|NCT03687827|615696891|FG001|Treatment Period 1|Physician Decision|2|||
170371539|NCT03687827|615696890|FG000|Treatment Period 1|Withdrawal by Subject|7|||
170371540|NCT03687827|615696891|FG001|Treatment Period 1|Withdrawal by Subject|3|||
170371541|NCT03687827|615696890|FG000|Treatment Period 2|Physician Decision|4|||
170371542|NCT03687827|615696891|FG001|Treatment Period 2|Physician Decision|1|||
170371543|NCT03687827|615696890|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170371544|NCT03687827|615696891|FG001|Treatment Period 2|Withdrawal by Subject|2|||
170371545|NCT02728206|615696892|FG000|Overall Study|Death|1|||
170371546|NCT00424099|615696898|FG000|Overall Study|Adverse Event|0|||
170371547|NCT00424099|615696899|FG001|Overall Study|Adverse Event|1|||
170371548|NCT00424099|615696900|FG002|Overall Study|Adverse Event|1|||
170371549|NCT00424099|615696901|FG003|Overall Study|Adverse Event|0|||
170371550|NCT00424099|615696898|FG000|Overall Study|Death|0|||
170371551|NCT00424099|615696899|FG001|Overall Study|Death|1|||
170371552|NCT00424099|615696900|FG002|Overall Study|Death|0|||
170371553|NCT00424099|615696901|FG003|Overall Study|Death|0|||
170371554|NCT00424099|615696898|FG000|Overall Study|Illness|2|||
170371555|NCT00424099|615696899|FG001|Overall Study|Illness|0|||
170371556|NCT00424099|615696900|FG002|Overall Study|Illness|1|||
170371557|NCT00424099|615696901|FG003|Overall Study|Illness|4|||
170371558|NCT00424099|615696898|FG000|Overall Study|Lost to Follow-up|0|||
170371559|NCT00424099|615696899|FG001|Overall Study|Lost to Follow-up|0|||
170371560|NCT00424099|615696900|FG002|Overall Study|Lost to Follow-up|3|||
170371561|NCT00424099|615696901|FG003|Overall Study|Lost to Follow-up|0|||
170371562|NCT00424099|615696898|FG000|Overall Study|Hospitalized|1|||
170371563|NCT00424099|615696899|FG001|Overall Study|Hospitalized|2|||
170371564|NCT00424099|615696900|FG002|Overall Study|Hospitalized|1|||
170371565|NCT00424099|615696901|FG003|Overall Study|Hospitalized|3|||
170371566|NCT00424099|615696898|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
170371567|NCT00424099|615696899|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
170371568|NCT00424099|615696900|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
170371569|NCT00424099|615696901|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
170371570|NCT00424099|615696898|FG000|Overall Study|Withdrawal by Subject|1|||
170371571|NCT00424099|615696899|FG001|Overall Study|Withdrawal by Subject|9|||
170371572|NCT00424099|615696900|FG002|Overall Study|Withdrawal by Subject|4|||
170371573|NCT00424099|615696901|FG003|Overall Study|Withdrawal by Subject|6|||
170371574|NCT00424099|615696898|FG000|Overall Study|Physician Decision|0|||
170371575|NCT00424099|615696899|FG001|Overall Study|Physician Decision|0|||
170371576|NCT00424099|615696900|FG002|Overall Study|Physician Decision|1|||
170371577|NCT00424099|615696901|FG003|Overall Study|Physician Decision|0|||
170371578|NCT00424099|615696898|FG000|Overall Study|Missing|0|||
170371579|NCT00424099|615696899|FG001|Overall Study|Missing|0|||
170371580|NCT00424099|615696900|FG002|Overall Study|Missing|1|||
170371581|NCT00424099|615696901|FG003|Overall Study|Missing|0|||
170371582|NCT03377452|615696902|FG000|Overall Study|Refused assessment|0|||
170371583|NCT03377452|615696903|FG001|Overall Study|Refused assessment|2|||
170371584|NCT03377452|615696902|FG000|Overall Study|Lost to Follow-up|5|||
170371585|NCT03377452|615696903|FG001|Overall Study|Lost to Follow-up|4|||
170371586|NCT00764322|615696904|FG000|Overall Study|Withdrawal by Subject|11|||
170371587|NCT00764322|615696904|FG000|Overall Study|No CYP2D6 genotyping|9|||
170371588|NCT00796003|615696905|FG000|Overall Study|Disease Progression|2|||
170371589|NCT00796003|615696906|FG001|Overall Study|Disease Progression|13|||
170371590|NCT00796003|615696905|FG000|Overall Study|Adverse Event|1|||
170371591|NCT00796003|615696906|FG001|Overall Study|Adverse Event|7|||
170371592|NCT00796003|615696905|FG000|Overall Study|Specified organ function not met|0|||
170371593|NCT00796003|615696906|FG001|Overall Study|Specified organ function not met|1|||
170371594|NCT00796003|615696905|FG000|Overall Study|Physician Decision|0|||
170371595|NCT00796003|615696906|FG001|Overall Study|Physician Decision|4|||
170371596|NCT00796003|615696905|FG000|Overall Study|Withdrawal by Subject|0|||
170371597|NCT00796003|615696906|FG001|Overall Study|Withdrawal by Subject|1|||
170371598|NCT00796003|615696905|FG000|Overall Study|Other|0|||
170371599|NCT00796003|615696906|FG001|Overall Study|Other|1|||
170371600|NCT00796003|615696905|FG000|Overall Study|Participants Not treated|0|||
170371601|NCT00796003|615696906|FG001|Overall Study|Participants Not treated|2|||
170371602|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
170371603|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
170371604|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
170371605|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
170371606|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
170371607|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
170371608|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
170371609|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
170371610|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
170371611|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
170371612|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
170371613|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
170371614|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
170371615|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
170371616|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
170371617|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
170371618|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
170371619|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
170371620|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
170371621|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
170371622|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
170371623|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
170371624|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
170371625|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
170371626|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
170371627|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
170371628|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
170371629|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
170371630|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
170371631|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
170371632|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
170371633|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
170371634|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
170371635|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
170371636|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
170371637|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
170371638|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
170371639|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
170371640|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
170371641|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
170371642|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
170371643|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
170371644|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
170371645|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
170371646|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
170371647|NCT03689972|615696907|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
170371648|NCT03689972|615696908|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
170371649|NCT03689972|615696909|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
170371650|NCT03689972|615696910|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
170371651|NCT03689972|615696911|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
170371652|NCT03689972|615696907|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
170371653|NCT03689972|615696908|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
170371654|NCT03689972|615696909|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
170371655|NCT03689972|615696910|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
170371656|NCT03689972|615696911|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
170371657|NCT03689972|615696907|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
170371658|NCT03689972|615696908|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
170371659|NCT03689972|615696909|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
170371660|NCT03689972|615696910|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
170371661|NCT03689972|615696911|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
170371662|NCT03689972|615696907|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
170371663|NCT03689972|615696908|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
170371664|NCT03689972|615696909|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
170371665|NCT03689972|615696910|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
170371666|NCT03689972|615696911|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
170371667|NCT03689972|615696907|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
170371668|NCT03689972|615696908|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
170371669|NCT03689972|615696909|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
170371670|NCT03689972|615696910|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
170371671|NCT03689972|615696911|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
170371672|NCT03689972|615696907|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
170371673|NCT03689972|615696908|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
170371674|NCT03689972|615696909|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
170371675|NCT03689972|615696910|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
170371676|NCT03689972|615696911|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
170371677|NCT03689972|615696907|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
170371678|NCT03689972|615696908|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
170371679|NCT03689972|615696909|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
170371680|NCT03689972|615696910|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
170371681|NCT03689972|615696911|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
170371682|NCT03689972|615696907|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
170371683|NCT03689972|615696908|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
170371684|NCT03689972|615696909|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
170371685|NCT03689972|615696910|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
170371686|NCT03689972|615696911|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
170371687|NCT03689972|615696907|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
170371688|NCT03689972|615696908|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
170371689|NCT03689972|615696909|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
170371690|NCT03689972|615696910|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
170371691|NCT03689972|615696911|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
170371692|NCT03689972|615696907|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
170371693|NCT03689972|615696908|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
170371694|NCT03689972|615696909|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
170371695|NCT03689972|615696910|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
170371696|NCT03689972|615696911|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
170371697|NCT01131130|615696912|FG000|Period 1 - Baseline|Pregnancy|1|||
170371698|NCT01131130|615696912|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
170371699|NCT03981744|615696913|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
170371700|NCT03981744|615696914|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
170371701|NCT03981744|615696915|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
170371702|NCT03981744|615696916|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
170371703|NCT03981744|615696913|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
170371704|NCT03981744|615696914|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
170371705|NCT03981744|615696915|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
170371706|NCT03981744|615696916|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
170371707|NCT03981744|615696913|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
170371708|NCT03981744|615696914|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
170371709|NCT03981744|615696915|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
170371710|NCT03981744|615696916|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
170371711|NCT04338321|615696917|FG000|Overall Study|Adverse Event|4|||
170371712|NCT04338321|615696918|FG001|Overall Study|Adverse Event|10|||
170371713|NCT04338321|615696917|FG000|Overall Study|Death|1|||
170371714|NCT04338321|615696918|FG001|Overall Study|Death|1|||
170371715|NCT04338321|615696917|FG000|Overall Study|Lost to Follow-up|4|||
170371716|NCT04338321|615696918|FG001|Overall Study|Lost to Follow-up|9|||
170371717|NCT04338321|615696917|FG000|Overall Study|Withdrawal by Subject|45|||
170371718|NCT04338321|615696918|FG001|Overall Study|Withdrawal by Subject|69|||
170371719|NCT04338321|615696917|FG000|Overall Study|Physician Decision|5|||
170371720|NCT04338321|615696918|FG001|Overall Study|Physician Decision|9|||
170371721|NCT04338321|615696917|FG000|Overall Study|Other|3|||
170371722|NCT04338321|615696918|FG001|Overall Study|Other|10|||
170371723|NCT01989572|615696921|FG000|Overall Study|Lack of Efficacy|35|||
170371724|NCT01989572|615696922|FG001|Overall Study|Lack of Efficacy|48|||
170371725|NCT01989572|615696923|FG002|Overall Study|Lack of Efficacy|48|||
170371726|NCT01989572|615696924|FG003|Overall Study|Lack of Efficacy|43|||
170371727|NCT01989572|615696925|FG004|Overall Study|Lack of Efficacy|71|||
170371728|NCT01989572|615696926|FG005|Overall Study|Lack of Efficacy|79|||
170371729|NCT01989572|615696921|FG000|Overall Study|Adverse Event|2|||
170371730|NCT01989572|615696922|FG001|Overall Study|Adverse Event|1|||
170371731|NCT01989572|615696923|FG002|Overall Study|Adverse Event|3|||
170371732|NCT01989572|615696924|FG003|Overall Study|Adverse Event|0|||
170371733|NCT01989572|615696925|FG004|Overall Study|Adverse Event|3|||
170371734|NCT01989572|615696926|FG005|Overall Study|Adverse Event|0|||
170371735|NCT01989572|615696921|FG000|Overall Study|Death|0|||
170371736|NCT01989572|615696922|FG001|Overall Study|Death|0|||
170371737|NCT01989572|615696923|FG002|Overall Study|Death|0|||
170371738|NCT01989572|615696924|FG003|Overall Study|Death|0|||
170371739|NCT01989572|615696925|FG004|Overall Study|Death|1|||
170371740|NCT01989572|615696926|FG005|Overall Study|Death|0|||
170371741|NCT01989572|615696921|FG000|Overall Study|Withdrawal by Subject|4|||
170371742|NCT01989572|615696922|FG001|Overall Study|Withdrawal by Subject|1|||
170371743|NCT01989572|615696923|FG002|Overall Study|Withdrawal by Subject|5|||
170371744|NCT01989572|615696924|FG003|Overall Study|Withdrawal by Subject|1|||
170371745|NCT01989572|615696925|FG004|Overall Study|Withdrawal by Subject|12|||
170371746|NCT01989572|615696926|FG005|Overall Study|Withdrawal by Subject|4|||
170371747|NCT01989572|615696921|FG000|Overall Study|complicating disease|1|||
170371748|NCT01989572|615696922|FG001|Overall Study|complicating disease|1|||
170371749|NCT01989572|615696923|FG002|Overall Study|complicating disease|2|||
170371750|NCT01989572|615696924|FG003|Overall Study|complicating disease|0|||
170371751|NCT01989572|615696925|FG004|Overall Study|complicating disease|1|||
170371752|NCT01989572|615696926|FG005|Overall Study|complicating disease|0|||
170371753|NCT01989572|615696921|FG000|Overall Study|error|2|||
170371754|NCT01989572|615696922|FG001|Overall Study|error|1|||
170371755|NCT01989572|615696923|FG002|Overall Study|error|1|||
170371756|NCT01989572|615696924|FG003|Overall Study|error|1|||
170371757|NCT01989572|615696925|FG004|Overall Study|error|1|||
170371758|NCT01989572|615696926|FG005|Overall Study|error|1|||
170371759|NCT01989572|615696921|FG000|Overall Study|maximum dose reached|0|||
170371760|NCT01989572|615696922|FG001|Overall Study|maximum dose reached|1|||
170371761|NCT01989572|615696923|FG002|Overall Study|maximum dose reached|0|||
170371762|NCT01989572|615696924|FG003|Overall Study|maximum dose reached|0|||
170371763|NCT01989572|615696925|FG004|Overall Study|maximum dose reached|1|||
170371764|NCT01989572|615696926|FG005|Overall Study|maximum dose reached|0|||
170371765|NCT01989572|615696921|FG000|Overall Study|unknown/not specify|3|||
170371766|NCT01989572|615696922|FG001|Overall Study|unknown/not specify|4|||
170371767|NCT01989572|615696923|FG002|Overall Study|unknown/not specify|1|||
170371768|NCT01989572|615696924|FG003|Overall Study|unknown/not specify|3|||
170371769|NCT01989572|615696925|FG004|Overall Study|unknown/not specify|3|||
170371770|NCT01989572|615696926|FG005|Overall Study|unknown/not specify|5|||
170371771|NCT01989572|615696921|FG000|Overall Study|not start protocol therapy|5|||
170371772|NCT01989572|615696922|FG001|Overall Study|not start protocol therapy|1|||
170371773|NCT01989572|615696923|FG002|Overall Study|not start protocol therapy|2|||
170371774|NCT01989572|615696924|FG003|Overall Study|not start protocol therapy|3|||
170371775|NCT01989572|615696925|FG004|Overall Study|not start protocol therapy|4|||
170371776|NCT01989572|615696926|FG005|Overall Study|not start protocol therapy|18|||
170371777|NCT01989572|615696921|FG000|Overall Study|alternative therapy|3|||
170371778|NCT01989572|615696922|FG001|Overall Study|alternative therapy|0|||
170371779|NCT01989572|615696923|FG002|Overall Study|alternative therapy|0|||
170371780|NCT01989572|615696924|FG003|Overall Study|alternative therapy|0|||
170371781|NCT01989572|615696925|FG004|Overall Study|alternative therapy|1|||
170371782|NCT01989572|615696926|FG005|Overall Study|alternative therapy|3|||
170371783|NCT00732238|615696931|FG000|Overall Study|Bacteremia|4|||
170371784|NCT00732238|615696932|FG001|Overall Study|Bacteremia|1|||
170371785|NCT00732238|615696931|FG000|Overall Study|Asymptomatic bacteriuria|1|||
170371786|NCT00732238|615696932|FG001|Overall Study|Asymptomatic bacteriuria|0|||
170371787|NCT02280096|615696933|FG000|Overall Study|Pregnancy|1|||
170371788|NCT02280096|615696934|FG001|Overall Study|Pregnancy|0|||
170371789|NCT02280096|615696933|FG000|Overall Study|Functional neurological disorder|1|||
170371790|NCT02280096|615696934|FG001|Overall Study|Functional neurological disorder|0|||
170371791|NCT02280096|615696933|FG000|Overall Study|Lack of attachment|0|||
170371792|NCT02280096|615696934|FG001|Overall Study|Lack of attachment|1|||
170371793|NCT01782885|615696935|FG000|Overall Study|Lost to Follow-up|4|||
170371794|NCT01782885|615696936|FG001|Overall Study|Lost to Follow-up|6|||
170371795|NCT01849562|615696937|FG000|Overall Study|Lost to Follow-up|1|||
170371796|NCT01849562|615696938|FG001|Overall Study|Lost to Follow-up|0|||
170371797|NCT01849562|615696939|FG002|Overall Study|Lost to Follow-up|0|||
170371798|NCT01849562|615696937|FG000|Overall Study|Non-compliance with Study Drug|1|||
170371799|NCT01849562|615696938|FG001|Overall Study|Non-compliance with Study Drug|0|||
170371800|NCT01849562|615696939|FG002|Overall Study|Non-compliance with Study Drug|0|||
170371801|NCT00638690|615696942|FG000|Overall Study|Death|655|||
170371802|NCT00638690|615696943|FG001|Overall Study|Death|335|||
170371803|NCT00638690|615696942|FG000|Overall Study|Withdrawal by Subject|22|||
170371804|NCT00638690|615696943|FG001|Overall Study|Withdrawal by Subject|5|||
170371805|NCT00638690|615696942|FG000|Overall Study|Lost to Follow-up|4|||
170371806|NCT00638690|615696943|FG001|Overall Study|Lost to Follow-up|2|||
170371807|NCT02203916|615696944|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
170371808|NCT02203916|615696945|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
170371809|NCT02203916|615696946|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
170371810|NCT02203916|615696944|FG000|Overall Study|Major Protocol Deviation|1|||
170371811|NCT02203916|615696945|FG001|Overall Study|Major Protocol Deviation|1|||
170371812|NCT02203916|615696946|FG002|Overall Study|Major Protocol Deviation|0|||
170371813|NCT02203916|615696944|FG000|Overall Study|Lost to Follow-up|0|||
170371814|NCT02203916|615696945|FG001|Overall Study|Lost to Follow-up|1|||
170371815|NCT02203916|615696946|FG002|Overall Study|Lost to Follow-up|0|||
170371816|NCT02203916|615696944|FG000|Overall Study|Voluntary Withdrawal|3|||
170371817|NCT02203916|615696945|FG001|Overall Study|Voluntary Withdrawal|3|||
170371818|NCT02203916|615696946|FG002|Overall Study|Voluntary Withdrawal|8|||
170371819|NCT02203916|615696944|FG000|Overall Study|Lack of Efficacy|3|||
170371820|NCT02203916|615696945|FG001|Overall Study|Lack of Efficacy|0|||
170371821|NCT02203916|615696946|FG002|Overall Study|Lack of Efficacy|0|||
170371822|NCT02203916|615696944|FG000|Overall Study|Reason Not Specified|0|||
170371823|NCT02203916|615696945|FG001|Overall Study|Reason Not Specified|2|||
170371824|NCT02203916|615696946|FG002|Overall Study|Reason Not Specified|1|||
170371825|NCT00552344|615696955|FG000|Overall Study|Lack of Efficacy|55|||
170371826|NCT00552344|615696955|FG000|Overall Study|Loss of efficacy|75|||
170371827|NCT00552344|615696955|FG000|Overall Study|Lost to Follow-up|8|||
170371828|NCT00552344|615696955|FG000|Overall Study|Withdrawal by Subject|48|||
170371829|NCT00552344|615696955|FG000|Overall Study|SAE, non-fatal|6|||
170371830|NCT00552344|615696955|FG000|Overall Study|AE, non-serious non-fatal|38|||
170371831|NCT00552344|615696955|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
170371832|NCT00552344|615696955|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
170371833|NCT00552344|615696955|FG000|Overall Study|Other Reason|22|||
170371834|NCT01487863|615696956|FG000|Overall Study|Death|19|||
170371835|NCT01487863|615696957|FG001|Overall Study|Death|19|||
170371836|NCT01594411|615696958|FG000|Overall Study|Lost to Follow-up|2|||
170371837|NCT01975376|615696959|FG000|Overall Study|Adverse Event|5|||
170371838|NCT01975376|615696960|FG001|Overall Study|Adverse Event|5|||
170371839|NCT01975376|615696959|FG000|Overall Study|Death|65|||
170371840|NCT01975376|615696960|FG001|Overall Study|Death|72|||
170371841|NCT01975376|615696959|FG000|Overall Study|Lost to Follow-up|70|||
170371842|NCT01975376|615696960|FG001|Overall Study|Lost to Follow-up|66|||
170371843|NCT01975376|615696959|FG000|Overall Study|Withdrew consent|68|||
170371844|NCT01975376|615696960|FG001|Overall Study|Withdrew consent|62|||
170371845|NCT01975376|615696959|FG000|Overall Study|Other|2|||
170371846|NCT01975376|615696960|FG001|Overall Study|Other|4|||
170371847|NCT01975376|615696959|FG000|Overall Study|Randomized, Not Treated|16|||
170371848|NCT01975376|615696960|FG001|Overall Study|Randomized, Not Treated|8|||
170371849|NCT01819194|615696961|FG000|Overall Study|Loss of study articles|2|||
170371850|NCT00045630|615696962|FG000|Overall Study|Adverse Event|1|||
170371851|NCT00045630|615696962|FG000|Overall Study|Refusal unrelated to adverse event|1|||
170371852|NCT00045630|615696962|FG000|Overall Study|Progression/relapse|1|||
170371853|NCT00045630|615696962|FG000|Overall Study|Death|1|||
170371854|NCT00045630|615696962|FG000|Overall Study|Ineligible|2|||
170371855|NCT00924729|615696963|FG000|Overall Study|insufficient volume for analysis|1|||
170371856|NCT00924729|615696964|FG001|Overall Study|insufficient volume for analysis|0|||
170371857|NCT00924729|615696963|FG000|Overall Study|Protocol Violation|1|||
170371858|NCT00924729|615696964|FG001|Overall Study|Protocol Violation|0|||
170371859|NCT00701103|615696970|FG000|Overall Study|Adverse Event|0|||
170371860|NCT00701103|615696971|FG001|Overall Study|Adverse Event|0|||
170371861|NCT00701103|615696972|FG002|Overall Study|Adverse Event|1|||
170371862|NCT00701103|615696973|FG003|Overall Study|Adverse Event|1|||
170371863|NCT00701103|615696974|FG004|Overall Study|Adverse Event|0|||
170371864|NCT00701103|615696975|FG005|Overall Study|Adverse Event|1|||
170371865|NCT00701103|615696976|FG006|Overall Study|Adverse Event|1|||
170371866|NCT00701103|615696977|FG007|Overall Study|Adverse Event|0|||
170371867|NCT00701103|615696978|FG008|Overall Study|Adverse Event|0|||
170371868|NCT00701103|615696979|FG009|Overall Study|Adverse Event|2|||
170371869|NCT00701103|615696980|FG010|Overall Study|Adverse Event|0|||
170371870|NCT00701103|615696970|FG000|Overall Study|Progressive Disease|5|||
170371871|NCT00701103|615696971|FG001|Overall Study|Progressive Disease|2|||
170371872|NCT00701103|615696972|FG002|Overall Study|Progressive Disease|6|||
170371873|NCT00701103|615696973|FG003|Overall Study|Progressive Disease|5|||
170371874|NCT00701103|615696974|FG004|Overall Study|Progressive Disease|6|||
170371875|NCT00701103|615696975|FG005|Overall Study|Progressive Disease|5|||
170371876|NCT00701103|615696976|FG006|Overall Study|Progressive Disease|7|||
170371877|NCT00701103|615696977|FG007|Overall Study|Progressive Disease|7|||
170371878|NCT00701103|615696978|FG008|Overall Study|Progressive Disease|8|||
170371879|NCT00701103|615696979|FG009|Overall Study|Progressive Disease|8|||
170371880|NCT00701103|615696980|FG010|Overall Study|Progressive Disease|11|||
170371881|NCT00701103|615696970|FG000|Overall Study|Withdrawal by Subject|0|||
170371882|NCT00701103|615696971|FG001|Overall Study|Withdrawal by Subject|1|||
170371883|NCT00701103|615696972|FG002|Overall Study|Withdrawal by Subject|1|||
170371884|NCT00701103|615696973|FG003|Overall Study|Withdrawal by Subject|0|||
170371885|NCT00701103|615696974|FG004|Overall Study|Withdrawal by Subject|0|||
170371886|NCT00701103|615696975|FG005|Overall Study|Withdrawal by Subject|0|||
170371887|NCT00701103|615696976|FG006|Overall Study|Withdrawal by Subject|0|||
170371888|NCT00701103|615696977|FG007|Overall Study|Withdrawal by Subject|0|||
170371889|NCT00701103|615696978|FG008|Overall Study|Withdrawal by Subject|0|||
170371890|NCT00701103|615696979|FG009|Overall Study|Withdrawal by Subject|0|||
170371891|NCT00701103|615696980|FG010|Overall Study|Withdrawal by Subject|0|||
170371892|NCT00701103|615696970|FG000|Overall Study|Other|0|||
170371893|NCT00701103|615696971|FG001|Overall Study|Other|0|||
170371894|NCT00701103|615696972|FG002|Overall Study|Other|0|||
170371895|NCT00701103|615696973|FG003|Overall Study|Other|0|||
170371896|NCT00701103|615696974|FG004|Overall Study|Other|0|||
170371897|NCT00701103|615696975|FG005|Overall Study|Other|0|||
170371898|NCT00701103|615696976|FG006|Overall Study|Other|0|||
170371899|NCT00701103|615696977|FG007|Overall Study|Other|0|||
170371900|NCT00701103|615696978|FG008|Overall Study|Other|1|||
170371901|NCT00701103|615696979|FG009|Overall Study|Other|1|||
170371902|NCT00701103|615696980|FG010|Overall Study|Other|0|||
170371903|NCT00179517|615696981|FG000|Overall Study|Withdrawal by Subject|2|||
170371904|NCT00179517|615696982|FG001|Overall Study|Withdrawal by Subject|1|||
170371905|NCT00565812|615696984|FG000|Overall Study|Death|2|||
170371906|NCT00565812|615696985|FG001|Overall Study|Death|1|||
170371907|NCT00565812|615696986|FG002|Overall Study|Death|3|||
170371908|NCT00565812|615696984|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
170371909|NCT00565812|615696985|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
170371910|NCT00565812|615696986|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
170371911|NCT00565812|615696984|FG000|Overall Study|Lost to Follow-up|10|||
170371912|NCT00565812|615696985|FG001|Overall Study|Lost to Follow-up|8|||
170371913|NCT00565812|615696986|FG002|Overall Study|Lost to Follow-up|8|||
170371914|NCT00565812|615696984|FG000|Overall Study|Withdrawal by Subject|58|||
170371915|NCT00565812|615696985|FG001|Overall Study|Withdrawal by Subject|47|||
170371916|NCT00565812|615696986|FG002|Overall Study|Withdrawal by Subject|48|||
170371917|NCT00565812|615696984|FG000|Overall Study|Work Schedule|5|||
170371918|NCT00565812|615696985|FG001|Overall Study|Work Schedule|3|||
170371919|NCT00565812|615696986|FG002|Overall Study|Work Schedule|1|||
170371920|NCT00565812|615696984|FG000|Overall Study|Protocol Violation|2|||
170371921|NCT00565812|615696985|FG001|Overall Study|Protocol Violation|6|||
170371922|NCT00565812|615696986|FG002|Overall Study|Protocol Violation|4|||
170371923|NCT00565812|615696984|FG000|Overall Study|Adverse Event|41|||
170371924|NCT00565812|615696985|FG001|Overall Study|Adverse Event|54|||
170371925|NCT00565812|615696986|FG002|Overall Study|Adverse Event|40|||
170371926|NCT00565812|615696984|FG000|Overall Study|Jury Duty|1|||
170371927|NCT00565812|615696985|FG001|Overall Study|Jury Duty|0|||
170371928|NCT00565812|615696986|FG002|Overall Study|Jury Duty|0|||
170371929|NCT00565812|615696984|FG000|Overall Study|Relocated Out of Area|5|||
170371930|NCT00565812|615696985|FG001|Overall Study|Relocated Out of Area|8|||
170371931|NCT00565812|615696986|FG002|Overall Study|Relocated Out of Area|9|||
170371932|NCT00565812|615696984|FG000|Overall Study|Sponsor Decision|1|||
170371933|NCT00565812|615696985|FG001|Overall Study|Sponsor Decision|5|||
170371934|NCT00565812|615696986|FG002|Overall Study|Sponsor Decision|1|||
170371935|NCT00565812|615696984|FG000|Overall Study|Domestic Reasons|7|||
170371936|NCT00565812|615696985|FG001|Overall Study|Domestic Reasons|1|||
170371937|NCT00565812|615696986|FG002|Overall Study|Domestic Reasons|3|||
170371938|NCT00565812|615696984|FG000|Overall Study|Research Site Closure|6|||
170371939|NCT00565812|615696985|FG001|Overall Study|Research Site Closure|1|||
170371940|NCT00565812|615696986|FG002|Overall Study|Research Site Closure|8|||
170371941|NCT00565812|615696984|FG000|Overall Study|Surgical Intervention|0|||
170371942|NCT00565812|615696985|FG001|Overall Study|Surgical Intervention|1|||
170371943|NCT00565812|615696986|FG002|Overall Study|Surgical Intervention|2|||
170371944|NCT00565812|615696984|FG000|Overall Study|Low Compliance|1|||
170371945|NCT00565812|615696985|FG001|Overall Study|Low Compliance|0|||
170371946|NCT00565812|615696986|FG002|Overall Study|Low Compliance|1|||
170371947|NCT00565812|615696984|FG000|Overall Study|Follow-up Visit Not Completed|2|||
170371948|NCT00565812|615696985|FG001|Overall Study|Follow-up Visit Not Completed|0|||
170371949|NCT00565812|615696986|FG002|Overall Study|Follow-up Visit Not Completed|1|||
170371950|NCT00565812|615696984|FG000|Overall Study|Physician Decision|2|||
170371951|NCT00565812|615696985|FG001|Overall Study|Physician Decision|0|||
170371952|NCT00565812|615696986|FG002|Overall Study|Physician Decision|0|||
170371953|NCT04857892|615696989|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
170371954|NCT04857892|615696990|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
170371955|NCT04857892|615696991|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
170371956|NCT04857892|615696992|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
170371957|NCT04857892|615696993|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
170371958|NCT04857892|615696989|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
170371959|NCT04857892|615696990|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
170371960|NCT04857892|615696991|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
170371961|NCT04857892|615696992|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
170371962|NCT04857892|615696993|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
170371963|NCT04857892|615696989|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
170371964|NCT04857892|615696990|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
170371965|NCT04857892|615696991|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
170371966|NCT04857892|615696992|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
170371967|NCT04857892|615696993|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
170371968|NCT00899678|615696994|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
170371969|NCT00899678|615696995|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
170371970|NCT00899678|615696996|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
170371971|NCT00899678|615696994|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
170371972|NCT00899678|615696995|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
170371973|NCT00899678|615696996|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
170371974|NCT00899678|615696994|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
170371975|NCT00899678|615696995|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
170371976|NCT00899678|615696996|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
170371977|NCT00899678|615696994|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
170371978|NCT00899678|615696995|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
170371979|NCT00899678|615696996|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
170371980|NCT00899678|615696994|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
170371981|NCT00899678|615696995|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
170371982|NCT00899678|615696996|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
170371983|NCT00899678|615696994|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
170371984|NCT00899678|615696995|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
170371985|NCT00899678|615696996|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
170371986|NCT00899678|615696994|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
170371987|NCT00899678|615696995|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
170371988|NCT00899678|615696996|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
170371989|NCT00899678|615696994|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
170371990|NCT00899678|615696995|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
170371991|NCT00899678|615696996|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
170371992|NCT00899678|615696994|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
170371993|NCT00899678|615696995|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
170371994|NCT00899678|615696996|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
170371995|NCT00368472|615697002|FG000|Overall Study|Adverse Event|22|||
170371996|NCT00368472|615697002|FG000|Overall Study|Medication non-compliance|4|||
170371997|NCT00368472|615697002|FG000|Overall Study|Protocol Violation|2|||
170371998|NCT00368472|615697002|FG000|Overall Study|Request of Investigator or Sponsor|3|||
170371999|NCT00368472|615697002|FG000|Overall Study|Withdrawal by Subject|40|||
170372000|NCT00368472|615697002|FG000|Overall Study|Diary non-compliance|1|||
170372001|NCT00368472|615697002|FG000|Overall Study|Other|32|||
170372002|NCT00368472|615697002|FG000|Overall Study|Missing Final Disposition Date|1|||
170398668|NCT02957682|615798230|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
170398669|NCT02957682|615798231|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
170398670|NCT03349437|615798233|FG000|Screening|Screen Fail|4|||
170398671|NCT03349437|615798234|FG001|Screening|Screen Fail|0|||
170398672|NCT03349437|615798235|FG002|Screening|Screen Fail|0|||
170398673|NCT03349437|615798233|FG000|Screening|Withdrawn|1|||
170398674|NCT03349437|615798234|FG001|Screening|Withdrawn|0|||
170398675|NCT03349437|615798235|FG002|Screening|Withdrawn|0|||
170398676|NCT02962739|615798236|FG000|Overall Study|Withdrawal by Subject|0|||
170398677|NCT02962739|615798237|FG001|Overall Study|Withdrawal by Subject|1|||
170398678|NCT02962739|615798238|FG002|Overall Study|Withdrawal by Subject|0|||
170398679|NCT02962739|615798239|FG003|Overall Study|Withdrawal by Subject|0|||
170398680|NCT02962739|615798240|FG004|Overall Study|Withdrawal by Subject|0|||
170398681|NCT02962739|615798241|FG005|Overall Study|Withdrawal by Subject|0|||
170398682|NCT02962739|615798236|FG000|Overall Study|Protocol Violation|0|||
170398683|NCT02962739|615798237|FG001|Overall Study|Protocol Violation|0|||
170398684|NCT02962739|615798238|FG002|Overall Study|Protocol Violation|1|||
170398685|NCT02962739|615798239|FG003|Overall Study|Protocol Violation|0|||
170398686|NCT02962739|615798240|FG004|Overall Study|Protocol Violation|1|||
170398687|NCT02962739|615798241|FG005|Overall Study|Protocol Violation|0|||
170372003|NCT04888507|615698828|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
170372004|NCT00636155|615698829|FG000|Overall Study|Adverse Event|8|||
170372005|NCT00636155|615698829|FG000|Overall Study|Lack of Efficacy|1|||
170372006|NCT00636155|615698829|FG000|Overall Study|Withdrawal by Subject|3|||
170372007|NCT00636155|615698829|FG000|Overall Study|Stem cell transplant|1|||
170372008|NCT00636155|615698829|FG000|Overall Study|Physician Decision|5|||
170372009|NCT05643170|615698835|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
170372010|NCT05643170|615698835|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
170372011|NCT02973997|615698836|FG000|Overall Study|Withdrawal by Subject|4|||
170372012|NCT02973997|615698837|FG001|Overall Study|Withdrawal by Subject|0|||
170372013|NCT02973997|615698836|FG000|Overall Study|Adverse Event|4|||
170372014|NCT02973997|615698837|FG001|Overall Study|Adverse Event|1|||
170372015|NCT02973997|615698836|FG000|Overall Study|Disease Progression|11|||
170372016|NCT02973997|615698837|FG001|Overall Study|Disease Progression|20|||
170372017|NCT02973997|615698836|FG000|Overall Study|Alternative Therapy|3|||
170372018|NCT02973997|615698837|FG001|Overall Study|Alternative Therapy|0|||
170372019|NCT02973997|615698836|FG000|Overall Study|Other complicating disease|0|||
170372020|NCT02973997|615698837|FG001|Overall Study|Other complicating disease|1|||
170372021|NCT02973997|615698836|FG000|Overall Study|Death|0|||
170372022|NCT02973997|615698837|FG001|Overall Study|Death|1|||
170372023|NCT01370499|615698838|FG000|Overall Study|Adverse Event|38|||
170372024|NCT01370499|615698839|FG001|Overall Study|Adverse Event|12|||
170372025|NCT01370499|615698838|FG000|Overall Study|Lack of Efficacy|4|||
170372026|NCT01370499|615698839|FG001|Overall Study|Lack of Efficacy|2|||
170372027|NCT01370499|615698838|FG000|Overall Study|Lost to Follow-up|2|||
170372028|NCT01370499|615698839|FG001|Overall Study|Lost to Follow-up|1|||
170372029|NCT01370499|615698838|FG000|Overall Study|Physician Decision|3|||
170372030|NCT01370499|615698839|FG001|Overall Study|Physician Decision|3|||
170372031|NCT01370499|615698838|FG000|Overall Study|Protocol Violation|5|||
170372032|NCT01370499|615698839|FG001|Overall Study|Protocol Violation|4|||
170372033|NCT01370499|615698838|FG000|Overall Study|Withdrawal by Subject|18|||
170372034|NCT01370499|615698839|FG001|Overall Study|Withdrawal by Subject|7|||
170372035|NCT01370499|615698838|FG000|Overall Study|Sponsor Decision|41|||
170372036|NCT01370499|615698839|FG001|Overall Study|Sponsor Decision|15|||
170372037|NCT00887822|615698840|FG000|Overall Study|Insufficient therapeutic response|53|||
170372038|NCT00887822|615698841|FG001|Overall Study|Insufficient therapeutic response|55|||
170372039|NCT00887822|615698840|FG000|Overall Study|Adverse Event|14|||
170372040|NCT00887822|615698841|FG001|Overall Study|Adverse Event|17|||
170372041|NCT00887822|615698840|FG000|Overall Study|Failure to return|11|||
170372042|NCT00887822|615698841|FG001|Overall Study|Failure to return|11|||
170372043|NCT00887822|615698840|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
170372044|NCT00887822|615698841|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
170372045|NCT00887822|615698840|FG000|Overall Study|Administrative/Other than specified|5|||
170372046|NCT00887822|615698841|FG001|Overall Study|Administrative/Other than specified|4|||
170372047|NCT00887822|615698840|FG000|Overall Study|Death|2|||
170372048|NCT00887822|615698841|FG001|Overall Study|Death|3|||
170372049|NCT00887822|615698840|FG000|Overall Study|Protocol Violation|0|||
170372050|NCT00887822|615698841|FG001|Overall Study|Protocol Violation|1|||
170372051|NCT00887822|615698840|FG000|Overall Study|Randomized but not treated|0|||
170372052|NCT00887822|615698841|FG001|Overall Study|Randomized but not treated|1|||
170372061|NCT01462045|615698847|FG000|Overall Study|Family matter|0|||
170372062|NCT01462045|615698848|FG001|Overall Study|Family matter|1|||
170372063|NCT01462045|615698849|FG002|Overall Study|Family matter|0|||
170372064|NCT03558828|615698852|FG000|Overall Study|Lost to Follow-up|4|||
170372065|NCT03558828|615698853|FG001|Overall Study|Lost to Follow-up|3|||
170372066|NCT03558828|615698854|FG002|Overall Study|Lost to Follow-up|3|||
170372067|NCT03558828|615698855|FG003|Overall Study|Lost to Follow-up|5|||
170372068|NCT03558828|615698856|FG004|Overall Study|Lost to Follow-up|2|||
170372069|NCT03558828|615698857|FG005|Overall Study|Lost to Follow-up|3|||
170372070|NCT03558828|615698852|FG000|Overall Study|dropped before the intervention|1|||
170372071|NCT03558828|615698853|FG001|Overall Study|dropped before the intervention|1|||
170372072|NCT03558828|615698854|FG002|Overall Study|dropped before the intervention|0|||
170372073|NCT03558828|615698855|FG003|Overall Study|dropped before the intervention|0|||
170372074|NCT03558828|615698856|FG004|Overall Study|dropped before the intervention|0|||
170372075|NCT03558828|615698857|FG005|Overall Study|dropped before the intervention|0|||
170372076|NCT03671148|615698861|FG000|Overall Study|Adverse Event|3|||
170372077|NCT03671148|615698862|FG001|Overall Study|Adverse Event|2|||
170372078|NCT03671148|615698861|FG000|Overall Study|Withdrawal by Subject|8|||
170372079|NCT03671148|615698862|FG001|Overall Study|Withdrawal by Subject|2|||
170372080|NCT03671148|615698861|FG000|Overall Study|Lost to Follow-up|1|||
170372081|NCT03671148|615698862|FG001|Overall Study|Lost to Follow-up|2|||
170372082|NCT03671148|615698861|FG000|Overall Study|Lack of Efficacy|7|||
170372083|NCT03671148|615698862|FG001|Overall Study|Lack of Efficacy|2|||
170372084|NCT03671148|615698861|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
170372085|NCT03671148|615698862|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
170372086|NCT03671148|615698861|FG000|Overall Study|Other|1|||
170372087|NCT03671148|615698862|FG001|Overall Study|Other|0|||
170372088|NCT03671148|615698861|FG000|Overall Study|Incomplete Randomization Visit|1|||
170372089|NCT03671148|615698862|FG001|Overall Study|Incomplete Randomization Visit|0|||
170372090|NCT00425945|615698863|FG000|Overall Study|Concern about Supplement|2|||
170372091|NCT00425945|615698864|FG001|Overall Study|Concern about Supplement|0|||
170372092|NCT00425945|615698863|FG000|Overall Study|Inconvenience|0|||
170372093|NCT00425945|615698864|FG001|Overall Study|Inconvenience|2|||
170372094|NCT00425945|615698863|FG000|Overall Study|Lost to Follow-up|0|||
170372095|NCT00425945|615698864|FG001|Overall Study|Lost to Follow-up|2|||
170372096|NCT00425945|615698863|FG000|Overall Study|Began hypertension medication|1|||
170372097|NCT00425945|615698864|FG001|Overall Study|Began hypertension medication|0|||
170372098|NCT00425945|615698863|FG000|Overall Study|Began cancer treatments|1|||
170372099|NCT00425945|615698864|FG001|Overall Study|Began cancer treatments|0|||
170372100|NCT00425945|615698863|FG000|Overall Study|Moved from area|0|||
170372101|NCT00425945|615698864|FG001|Overall Study|Moved from area|1|||
170372102|NCT03878160|615698870|FG000|Overall Study|Lost to Follow-up|1|||
170372103|NCT03878160|615698871|FG001|Overall Study|Lost to Follow-up|1|||
170372104|NCT03878160|615698872|FG002|Overall Study|Lost to Follow-up|1|||
170372105|NCT03878160|615698870|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
170372106|NCT03878160|615698871|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
170372107|NCT03878160|615698872|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
170372108|NCT00673816|615698873|FG000|Overall Study|Adverse Event|1|||
170372109|NCT00673816|615698873|FG000|Overall Study|Withdrawal by Subject|1|||
170372110|NCT06048367|615698879|FG000|Overall Study|Withdrawal by Subject|0|||
170372111|NCT06048367|615698880|FG001|Overall Study|Withdrawal by Subject|1|||
170372112|NCT06048367|615698881|FG002|Overall Study|Withdrawal by Subject|0|||
170372113|NCT06048367|615698882|FG003|Overall Study|Withdrawal by Subject|0|||
170372114|NCT06048367|615698883|FG004|Overall Study|Withdrawal by Subject|0|||
170372115|NCT06048367|615698879|FG000|Overall Study|Withdrawal by Subject|0|||
170372116|NCT06048367|615698880|FG001|Overall Study|Withdrawal by Subject|0|||
170372117|NCT06048367|615698881|FG002|Overall Study|Withdrawal by Subject|1|||
170372118|NCT06048367|615698882|FG003|Overall Study|Withdrawal by Subject|0|||
170372119|NCT06048367|615698883|FG004|Overall Study|Withdrawal by Subject|0|||
170372120|NCT06048367|615698879|FG000|Overall Study|Withdrawal by Subject|0|||
170372121|NCT06048367|615698880|FG001|Overall Study|Withdrawal by Subject|0|||
170372122|NCT06048367|615698881|FG002|Overall Study|Withdrawal by Subject|0|||
170372123|NCT06048367|615698882|FG003|Overall Study|Withdrawal by Subject|1|||
170372124|NCT06048367|615698883|FG004|Overall Study|Withdrawal by Subject|0|||
170372125|NCT06048367|615698879|FG000|Overall Study|Withdrawal by Subject|0|||
170372126|NCT06048367|615698880|FG001|Overall Study|Withdrawal by Subject|0|||
170372127|NCT06048367|615698881|FG002|Overall Study|Withdrawal by Subject|0|||
170372128|NCT06048367|615698882|FG003|Overall Study|Withdrawal by Subject|1|||
170372129|NCT06048367|615698883|FG004|Overall Study|Withdrawal by Subject|0|||
170372130|NCT03285490|615698884|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
170372131|NCT03285490|615698885|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
170372132|NCT03285490|615698884|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
170372133|NCT03285490|615698885|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
170372134|NCT00981292|615698888|FG000|Day 1|Protocol Violation|1|||
170372135|NCT00981292|615698889|FG001|Day 1|Protocol Violation|0|||
170372136|NCT00981292|615698890|FG002|Day 1|Protocol Violation|0|||
170372137|NCT00981292|615698891|FG003|Day 1|Protocol Violation|0|||
170372138|NCT00981292|615698892|FG004|Day 1|Protocol Violation|0|||
170372139|NCT00981292|615698893|FG005|Day 1|Protocol Violation|2|||
170372140|NCT00981292|615698888|FG000|Day 2|Protocol Violation|2|||
170372141|NCT00981292|615698889|FG001|Day 2|Protocol Violation|0|||
170372142|NCT00981292|615698890|FG002|Day 2|Protocol Violation|0|||
170372143|NCT00981292|615698891|FG003|Day 2|Protocol Violation|0|||
170372144|NCT00981292|615698892|FG004|Day 2|Protocol Violation|0|||
170372145|NCT00981292|615698893|FG005|Day 2|Protocol Violation|0|||
170372146|NCT00981292|615698888|FG000|Day 3|Protocol Violation|0|||
170372147|NCT00981292|615698889|FG001|Day 3|Protocol Violation|0|||
170372148|NCT00981292|615698890|FG002|Day 3|Protocol Violation|0|||
170372149|NCT00981292|615698891|FG003|Day 3|Protocol Violation|0|||
170372150|NCT00981292|615698892|FG004|Day 3|Protocol Violation|0|||
170372151|NCT00981292|615698893|FG005|Day 3|Protocol Violation|1|||
170372152|NCT02155712|615698896|FG000|Overall Study|Death|12|||
170372153|NCT02155712|615698897|FG001|Overall Study|Death|0|||
170372154|NCT02155712|615698896|FG000|Overall Study|Lost to Follow-up|37|||
170372155|NCT02155712|615698897|FG001|Overall Study|Lost to Follow-up|22|||
170372156|NCT02155712|615698896|FG000|Overall Study|Revision of device|4|||
170372157|NCT02155712|615698897|FG001|Overall Study|Revision of device|3|||
170372158|NCT02155712|615698896|FG000|Overall Study|Withdrawal by Subject|39|||
170372159|NCT02155712|615698897|FG001|Overall Study|Withdrawal by Subject|21|||
170372160|NCT02155712|615698896|FG000|Overall Study|Site termination|77|||
170372161|NCT02155712|615698897|FG001|Overall Study|Site termination|19|||
170372162|NCT02155712|615698896|FG000|Overall Study|Sponsor terminated study early|150|||
170372163|NCT02155712|615698897|FG001|Overall Study|Sponsor terminated study early|0|||
170372164|NCT02155712|615698896|FG000|Overall Study|Missed final 5-year protocol visit|0|||
170372165|NCT02155712|615698897|FG001|Overall Study|Missed final 5-year protocol visit|32|||
170372166|NCT02155712|615698896|FG000|Overall Study|Censored because surgery cancelled|6|||
170372167|NCT02155712|615698897|FG001|Overall Study|Censored because surgery cancelled|10|||
170372168|NCT02155712|615698896|FG000|Overall Study|Censored because study device was not implanted|61|||
170372169|NCT02155712|615698897|FG001|Overall Study|Censored because study device was not implanted|66|||
170372170|NCT02155712|615698896|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
170372171|NCT02155712|615698897|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
170372172|NCT02418585|615698901|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
170372173|NCT02418585|615698902|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
170372174|NCT02418585|615698901|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
170372175|NCT02418585|615698902|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
170372176|NCT02418585|615698901|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
170372177|NCT02418585|615698902|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
170372178|NCT02418585|615698901|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
170372179|NCT02418585|615698902|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
170372180|NCT02418585|615698901|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
170372181|NCT02418585|615698902|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
170372182|NCT02418585|615698901|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
170372183|NCT02418585|615698902|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
170372184|NCT02418585|615698901|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
170372185|NCT02418585|615698902|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
170372186|NCT02418585|615698901|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
170372187|NCT02418585|615698902|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
170372188|NCT02418585|615698901|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
170372189|NCT02418585|615698902|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
170372190|NCT02418585|615698901|FG000|Follow-up Phase (24 Weeks)|Other|3|||
170372191|NCT02418585|615698902|FG001|Follow-up Phase (24 Weeks)|Other|2|||
170372192|NCT02040857|615698903|FG000|Overall Study|Adverse Event|14|||
170372193|NCT02040857|615698903|FG000|Overall Study|Physician Decision|5|||
170372194|NCT02040857|615698903|FG000|Overall Study|Withdrawal by Subject|31|||
170372195|NCT02040857|615698903|FG000|Overall Study|patient non-compliance|3|||
170372196|NCT02040857|615698903|FG000|Overall Study|Lost to Follow-up|2|||
170372197|NCT02040857|615698903|FG000|Overall Study|recurrence|4|||
170372198|NCT02040857|615698903|FG000|Overall Study|ineligible|1|||
170372199|NCT00608842|615698904|FG000|Overall Study|Participant's Request|0|||
170372200|NCT00608842|615698905|FG001|Overall Study|Participant's Request|1|||
170372201|NCT00608842|615698906|FG002|Overall Study|Participant's Request|2|||
170372202|NCT00608842|615698907|FG003|Overall Study|Participant's Request|1|||
170372203|NCT00608842|615698904|FG000|Overall Study|Lost to Follow-up|1|||
170372204|NCT00608842|615698905|FG001|Overall Study|Lost to Follow-up|0|||
170372205|NCT00608842|615698906|FG002|Overall Study|Lost to Follow-up|0|||
170372206|NCT00608842|615698907|FG003|Overall Study|Lost to Follow-up|0|||
170372207|NCT03146403|615698908|FG000|Overall Study|Withdrawal by Subject|0|||
170372208|NCT03146403|615698909|FG001|Overall Study|Withdrawal by Subject|3|||
170372209|NCT03146403|615698908|FG000|Overall Study|Lost to Follow-up|2|||
170372210|NCT03146403|615698909|FG001|Overall Study|Lost to Follow-up|0|||
170372211|NCT02768103|615698910|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
170372212|NCT02266004|615698929|FG000|Overall Study|unrelated adverse event|1|||
170372213|NCT02266004|615698929|FG000|Overall Study|Physician Decision|1|||
170372214|NCT02972593|615698935|FG000|Overall Study|Lost to Follow-up|19|||
170372215|NCT02972593|615698936|FG001|Overall Study|Lost to Follow-up|15|||
170372216|NCT02972593|615698935|FG000|Overall Study|Protocol Violation|1|||
170372217|NCT02972593|615698936|FG001|Overall Study|Protocol Violation|0|||
170372218|NCT02148952|615698942|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
170372219|NCT02148952|615698943|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
170372220|NCT02148952|615698942|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
170372221|NCT02148952|615698943|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
170372222|NCT02148952|615698942|FG000|Follow-Up|Lost to Follow-up|219|||
170372223|NCT02148952|615698943|FG001|Follow-Up|Lost to Follow-up|231|||
170372224|NCT02148952|615698942|FG000|Follow-Up|Withdrawal by Subject|46|||
170372225|NCT02148952|615698943|FG001|Follow-Up|Withdrawal by Subject|48|||
170372226|NCT01899768|615698945|FG000|Part A|Adverse Event|2|||
170372227|NCT01899768|615698945|FG000|Part A|Withdrawal by Subject|1|||
170372228|NCT01899768|615698945|FG000|Part B|Adverse Event|1|||
170372229|NCT01899768|615698945|FG000|Part B|Withdrawal by Subject|1|||
170372230|NCT03152110|615698950|FG000|Overall Study|Withdrawal by Subject|3|||
170372231|NCT01614795|615698960|FG000|Overall Study|Adverse Event|0|||
170372232|NCT01614795|615698961|FG001|Overall Study|Adverse Event|0|||
170372233|NCT01614795|615698962|FG002|Overall Study|Adverse Event|1|||
170372234|NCT01614795|615698963|FG003|Overall Study|Adverse Event|1|||
170372235|NCT01614795|615698960|FG000|Overall Study|Lack of Efficacy|10|||
170372236|NCT01614795|615698961|FG001|Overall Study|Lack of Efficacy|10|||
170372237|NCT01614795|615698962|FG002|Overall Study|Lack of Efficacy|9|||
170372238|NCT01614795|615698963|FG003|Overall Study|Lack of Efficacy|8|||
170372239|NCT01614795|615698960|FG000|Overall Study|Physician Decision|1|||
170372240|NCT01614795|615698961|FG001|Overall Study|Physician Decision|0|||
170372241|NCT01614795|615698962|FG002|Overall Study|Physician Decision|1|||
170372242|NCT01614795|615698963|FG003|Overall Study|Physician Decision|1|||
170372243|NCT01614795|615698960|FG000|Overall Study|Withdrawal by Subject|0|||
170372244|NCT01614795|615698961|FG001|Overall Study|Withdrawal by Subject|1|||
170372245|NCT01614795|615698962|FG002|Overall Study|Withdrawal by Subject|0|||
170372246|NCT01614795|615698963|FG003|Overall Study|Withdrawal by Subject|2|||
170372247|NCT01614795|615698960|FG000|Overall Study|Ineligible|0|||
170372248|NCT01614795|615698961|FG001|Overall Study|Ineligible|1|||
170372249|NCT01614795|615698962|FG002|Overall Study|Ineligible|0|||
170372250|NCT01614795|615698963|FG003|Overall Study|Ineligible|0|||
170372251|NCT02384993|615698968|FG000|Overall Study|Adverse Event|0|||
170372252|NCT02384993|615698969|FG001|Overall Study|Adverse Event|1|||
170372253|NCT01922739|615698970|FG000|Titration/Adjustment Period|Adverse Event|3|||
170372254|NCT01922739|615698970|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
170372255|NCT01922739|615698970|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
170372256|NCT01922739|615698970|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
170372257|NCT01922739|615698970|FG000|Open-label Treatment Period|Adverse Event|6|||
170372258|NCT01922739|615698970|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
170372259|NCT01922739|615698970|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
170372260|NCT01922739|615698970|FG000|Open-label Treatment Period|Protocol Violation|5|||
170372261|NCT01922739|615698970|FG000|Open-label Treatment Period|Pregnancy|1|||
170372262|NCT01922739|615698970|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
170372263|NCT01922739|615698970|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
170372264|NCT01922739|615698970|FG000|Open-label Treatment Period|Physician Decision|1|||
170372265|NCT01922739|615698970|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
170372266|NCT00044213|615698971|FG000|Overall Study|Withdrawal by Subject|50|||
170372267|NCT00044213|615698972|FG001|Overall Study|Withdrawal by Subject|65|||
170372268|NCT00044213|615698973|FG002|Overall Study|Withdrawal by Subject|91|||
170372269|NCT00044213|615698974|FG003|Overall Study|Withdrawal by Subject|83|||
170372270|NCT00044213|615698971|FG000|Overall Study|Death|42|||
170372271|NCT00044213|615698972|FG001|Overall Study|Death|42|||
170372272|NCT00044213|615698973|FG002|Overall Study|Death|42|||
170372273|NCT00044213|615698974|FG003|Overall Study|Death|49|||
170372274|NCT00044213|615698971|FG000|Overall Study|Lost to Follow-up|8|||
170372275|NCT00044213|615698972|FG001|Overall Study|Lost to Follow-up|5|||
170372276|NCT00044213|615698973|FG002|Overall Study|Lost to Follow-up|5|||
170372277|NCT00044213|615698974|FG003|Overall Study|Lost to Follow-up|4|||
170372278|NCT00880607|615698976|FG000|Overall Study|Physician Decision|2|||
170372279|NCT00880607|615698977|FG001|Overall Study|Physician Decision|2|||
170372280|NCT00880607|615698976|FG000|Overall Study|Protocol Violation|2|||
170372281|NCT00880607|615698977|FG001|Overall Study|Protocol Violation|1|||
170372282|NCT00880607|615698976|FG000|Overall Study|surgery did not extend past L1 level|3|||
170372283|NCT00880607|615698977|FG001|Overall Study|surgery did not extend past L1 level|0|||
170372284|NCT05104749|615698978|FG000|Overall Study|Lost to Follow-up|2|||
170372285|NCT05104749|615698979|FG001|Overall Study|Lost to Follow-up|3|||
170372286|NCT02963766|615698980|FG000|Double-Blind Period|Adverse Event|1|||
170372287|NCT02963766|615698981|FG001|Double-Blind Period|Adverse Event|0|||
170372288|NCT02963766|615698982|FG002|Double-Blind Period|Adverse Event|1|||
170372289|NCT02963766|615698980|FG000|Double-Blind Period|Physician Decision|1|||
170372290|NCT02963766|615698981|FG001|Double-Blind Period|Physician Decision|0|||
170372291|NCT02963766|615698982|FG002|Double-Blind Period|Physician Decision|0|||
170372292|NCT02963766|615698980|FG000|Double-Blind Period|Withdrawal by Subject|1|||
170372293|NCT02963766|615698981|FG001|Double-Blind Period|Withdrawal by Subject|1|||
170372294|NCT02963766|615698982|FG002|Double-Blind Period|Withdrawal by Subject|0|||
170372295|NCT02963766|615698980|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
170372296|NCT02963766|615698981|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
170372297|NCT02963766|615698982|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
170372298|NCT02963766|615698980|FG000|Double-Blind Period|Protocol Violation|1|||
170372299|NCT02963766|615698981|FG001|Double-Blind Period|Protocol Violation|0|||
170372300|NCT02963766|615698982|FG002|Double-Blind Period|Protocol Violation|0|||
170372301|NCT02963766|615698980|FG000|Double-Blind Period|Lost to Follow-up|0|||
170372302|NCT02963766|615698981|FG001|Double-Blind Period|Lost to Follow-up|1|||
170372303|NCT02963766|615698982|FG002|Double-Blind Period|Lost to Follow-up|0|||
170372304|NCT02963766|615698980|FG000|Open Label Extension (OLE)|Physician Decision|1|||
170372305|NCT02963766|615698981|FG001|Open Label Extension (OLE)|Physician Decision|2|||
170372306|NCT02963766|615698982|FG002|Open Label Extension (OLE)|Physician Decision|2|||
170372307|NCT02963766|615698980|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
170372308|NCT02963766|615698981|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
170372309|NCT02963766|615698982|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
170372310|NCT00901394|615698983|FG000|Overall Study|Physician Decision|1|||
170372311|NCT00901394|615698984|FG001|Overall Study|Physician Decision|1|||
170372312|NCT00901394|615698985|FG002|Overall Study|Physician Decision|2|||
170372313|NCT02650895|615698989|FG000|Overall Study|Withdrawal by Subject|0|||
170372314|NCT02650895|615698990|FG001|Overall Study|Withdrawal by Subject|1|||
170372315|NCT02650895|615698991|FG002|Overall Study|Withdrawal by Subject|0|||
170372316|NCT02650895|615698992|FG003|Overall Study|Withdrawal by Subject|0|||
170372317|NCT02650895|615698993|FG004|Overall Study|Withdrawal by Subject|0|||
170372318|NCT02650895|615698994|FG005|Overall Study|Withdrawal by Subject|0|||
170372319|NCT03039192|615698999|FG000|Overall Study|Lost to Follow-up|4|||
170372320|NCT03039192|615699000|FG001|Overall Study|Lost to Follow-up|4|||
170372321|NCT03039192|615698999|FG000|Overall Study|Adverse event, serious fatal|0|||
170372322|NCT03039192|615699000|FG001|Overall Study|Adverse event, serious fatal|1|||
170372323|NCT03039192|615698999|FG000|Overall Study|Adverse event, non-fatal|0|||
170372324|NCT03039192|615699000|FG001|Overall Study|Adverse event, non-fatal|2|||
170372325|NCT03039192|615698999|FG000|Overall Study|Withdrawal by Subject|6|||
170372326|NCT03039192|615699000|FG001|Overall Study|Withdrawal by Subject|9|||
170372327|NCT03039192|615698999|FG000|Overall Study|Discontinued from treatment phase|19|||
170372328|NCT03039192|615699000|FG001|Overall Study|Discontinued from treatment phase|12|||
170372329|NCT03039192|615698999|FG000|Overall Study|Other|3|||
170372330|NCT03039192|615699000|FG001|Overall Study|Other|2|||
170372331|NCT00643448|615699001|FG000|Overall Study|Lack of Efficacy|2|||
170372332|NCT00643448|615699002|FG001|Overall Study|Lack of Efficacy|0|||
170372333|NCT00643448|615699003|FG002|Overall Study|Lack of Efficacy|4|||
170372334|NCT00643448|615699001|FG000|Overall Study|Adverse Event|2|||
170372335|NCT00643448|615699002|FG001|Overall Study|Adverse Event|2|||
170372336|NCT00643448|615699003|FG002|Overall Study|Adverse Event|2|||
170372337|NCT00643448|615699001|FG000|Overall Study|QTcF>550 ms|0|||
170372338|NCT00643448|615699002|FG001|Overall Study|QTcF>550 ms|3|||
170372339|NCT00643448|615699003|FG002|Overall Study|QTcF>550 ms|0|||
170372340|NCT01167153|615699004|FG000|Overall Study|Non-effective therapy|1|||
170372341|NCT01167153|615699005|FG001|Overall Study|Non-effective therapy|4|||
170372342|NCT01167153|615699004|FG000|Overall Study|AE including clinical laboratory AE|2|||
170372343|NCT01167153|615699005|FG001|Overall Study|AE including clinical laboratory AE|8|||
170372344|NCT01167153|615699004|FG000|Overall Study|Hypotension|1|||
170372345|NCT01167153|615699005|FG001|Overall Study|Hypotension|0|||
170372346|NCT01167153|615699004|FG000|Overall Study|Lost to Follow-up|7|||
170372347|NCT01167153|615699005|FG001|Overall Study|Lost to Follow-up|9|||
170372348|NCT01167153|615699004|FG000|Overall Study|Non-compliance to concomitant medication|0|||
170372349|NCT01167153|615699005|FG001|Overall Study|Non-compliance to concomitant medication|2|||
170372350|NCT01167153|615699004|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
170372351|NCT01167153|615699005|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
170372352|NCT01167153|615699004|FG000|Overall Study|Withdrawal consent|1|||
170372353|NCT01167153|615699005|FG001|Overall Study|Withdrawal consent|1|||
170372354|NCT01167153|615699004|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
170372355|NCT01167153|615699005|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
170372356|NCT00981682|615699006|FG000|Overall Study|Adverse Event|48|||
170372357|NCT00981682|615699006|FG000|Overall Study|Withdrawal by Subject|52|||
170372358|NCT00981682|615699006|FG000|Overall Study|Lost to Follow-up|14|||
170372359|NCT00981682|615699006|FG000|Overall Study|Lack of Efficacy|13|||
170372360|NCT00981682|615699006|FG000|Overall Study|Protocol Violation|6|||
170372361|NCT00981682|615699006|FG000|Overall Study|administrative|9|||
170372362|NCT00766142|615701477|FG000|Overall Study|Protocol Violation|4|||
170372363|NCT01431521|615701481|FG000|Overall Study|Withdrawal by Subject|0|||
170372364|NCT01431521|615701482|FG001|Overall Study|Withdrawal by Subject|0|||
170372365|NCT01431521|615701483|FG002|Overall Study|Withdrawal by Subject|1|||
170372366|NCT01431521|615701484|FG003|Overall Study|Withdrawal by Subject|0|||
170372367|NCT02045979|615701485|FG000|Overall Study|Informed Consent Withdrawn|2|||
170372368|NCT02045979|615701486|FG001|Overall Study|Informed Consent Withdrawn|0|||
170372369|NCT02045979|615701487|FG002|Overall Study|Informed Consent Withdrawn|1|||
170372370|NCT02045979|615701485|FG000|Overall Study|not specified above|0|||
170372371|NCT02045979|615701486|FG001|Overall Study|not specified above|1|||
170372372|NCT02045979|615701487|FG002|Overall Study|not specified above|0|||
170372373|NCT05618808|615701493|FG000|Overall Study|Withdrawal by Subject|3|||
170372374|NCT05618808|615701494|FG001|Overall Study|Withdrawal by Subject|1|||
170372375|NCT05618808|615701495|FG002|Overall Study|Withdrawal by Subject|3|||
170372376|NCT01804842|615701501|FG000|Overall Study|Adverse Event|1|||
170372377|NCT01804842|615701502|FG001|Overall Study|Adverse Event|1|||
170372378|NCT01804842|615701503|FG002|Overall Study|Adverse Event|0|||
170372379|NCT01804842|615701501|FG000|Overall Study|Lost to Follow-up|1|||
170372380|NCT01804842|615701502|FG001|Overall Study|Lost to Follow-up|0|||
170372381|NCT01804842|615701503|FG002|Overall Study|Lost to Follow-up|0|||
170372382|NCT01804842|615701501|FG000|Overall Study|Non-Compliance|1|||
170372383|NCT01804842|615701502|FG001|Overall Study|Non-Compliance|1|||
170372384|NCT01804842|615701503|FG002|Overall Study|Non-Compliance|0|||
170372385|NCT01804842|615701501|FG000|Overall Study|Personal Reason|0|||
170372386|NCT01804842|615701502|FG001|Overall Study|Personal Reason|0|||
170372387|NCT01804842|615701503|FG002|Overall Study|Personal Reason|1|||
170372388|NCT02365506|615701506|FG000|Overall Study|Investigator's Discretion|0|||
170372389|NCT02365506|615701507|FG001|Overall Study|Investigator's Discretion|0|||
170372390|NCT02365506|615701508|FG002|Overall Study|Investigator's Discretion|1|||
170372391|NCT03774875|615701509|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
170372392|NCT03774875|615701510|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
170372393|NCT03774875|615701509|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
170372394|NCT03774875|615701510|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
170372395|NCT03774875|615701509|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
170372396|NCT03774875|615701510|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
170372397|NCT03774875|615701509|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
170372398|NCT03774875|615701510|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
170372399|NCT03774875|615701509|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
170372400|NCT03774875|615701510|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
170372401|NCT03774875|615701509|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
170372402|NCT03774875|615701510|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
170372403|NCT03774875|615701509|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
170372404|NCT03774875|615701510|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
170372405|NCT03774875|615701509|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
170372406|NCT03774875|615701510|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
170372407|NCT03774875|615701509|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
170372408|NCT03774875|615701510|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
170372409|NCT03774875|615701509|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
170372410|NCT03774875|615701510|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
170372411|NCT03774875|615701509|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
170372412|NCT03774875|615701510|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
170372413|NCT03774875|615701509|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
170372414|NCT03774875|615701510|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
170372415|NCT03774875|615701509|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
170372416|NCT03774875|615701510|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
170372417|NCT02352090|615701511|FG000|Overall Study|general malaise|1|||
170372418|NCT02352090|615701512|FG001|Overall Study|general malaise|0|||
170372419|NCT02352090|615701513|FG002|Overall Study|general malaise|0|||
170372420|NCT02352090|615701511|FG000|Overall Study|non-specified mild side-effects|0|||
170372421|NCT02352090|615701512|FG001|Overall Study|non-specified mild side-effects|0|||
170372422|NCT02352090|615701513|FG002|Overall Study|non-specified mild side-effects|2|||
170372423|NCT00413777|615701516|FG000|Fixed-dose Period|Lost to Follow-up|1|||
170372424|NCT00413777|615701517|FG001|Fixed-dose Period|Lost to Follow-up|1|||
170372425|NCT00413777|615701516|FG000|Fixed-dose Period|Adverse Event|2|||
170372426|NCT00413777|615701517|FG001|Fixed-dose Period|Adverse Event|1|||
170372427|NCT00413777|615701516|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
170372428|NCT00413777|615701517|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
170372429|NCT00413777|615701516|FG000|Fixed-dose Period|Withdrew Consent|0|||
170372430|NCT00413777|615701517|FG001|Fixed-dose Period|Withdrew Consent|1|||
170372431|NCT05179057|615701520|FG000|Overall Study|Adverse Event|3|||
170372432|NCT05179057|615701521|FG001|Overall Study|Adverse Event|2|||
170372433|NCT05179057|615701520|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
170372434|NCT05179057|615701521|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
170372435|NCT05179057|615701520|FG000|Overall Study|Study terminated|13|||
170372436|NCT05179057|615701521|FG001|Overall Study|Study terminated|7|||
170372437|NCT05179057|615701520|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
170372438|NCT05179057|615701521|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
170372439|NCT05179057|615701520|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
170372440|NCT05179057|615701521|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
170372441|NCT03345342|615701522|FG000|Open-Label Phase|Adverse Event|30|||
170372442|NCT03345342|615701523|FG001|Open-Label Phase|Adverse Event|0|||
170372443|NCT03345342|615701524|FG002|Open-Label Phase|Adverse Event|0|||
170372444|NCT03345342|615701525|FG003|Open-Label Phase|Adverse Event|0|||
170372445|NCT03345342|615701526|FG004|Open-Label Phase|Adverse Event|0|||
170372446|NCT03345342|615701522|FG000|Open-Label Phase|Death|1|||
170372447|NCT03345342|615701523|FG001|Open-Label Phase|Death|0|||
170372448|NCT03345342|615701524|FG002|Open-Label Phase|Death|0|||
170372449|NCT03345342|615701525|FG003|Open-Label Phase|Death|0|||
170372450|NCT03345342|615701526|FG004|Open-Label Phase|Death|0|||
170372451|NCT03345342|615701522|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
170372452|NCT03345342|615701523|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
170372453|NCT03345342|615701524|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
170372454|NCT03345342|615701525|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
170372455|NCT03345342|615701526|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
170372456|NCT03345342|615701522|FG000|Open-Label Phase|Lack of Efficacy|6|||
170372457|NCT03345342|615701523|FG001|Open-Label Phase|Lack of Efficacy|0|||
170372458|NCT03345342|615701524|FG002|Open-Label Phase|Lack of Efficacy|0|||
170372459|NCT03345342|615701525|FG003|Open-Label Phase|Lack of Efficacy|0|||
170372460|NCT03345342|615701526|FG004|Open-Label Phase|Lack of Efficacy|0|||
170372461|NCT03345342|615701522|FG000|Open-Label Phase|Lost to Follow-up|9|||
170372462|NCT03345342|615701523|FG001|Open-Label Phase|Lost to Follow-up|0|||
170372463|NCT03345342|615701524|FG002|Open-Label Phase|Lost to Follow-up|0|||
170372464|NCT03345342|615701525|FG003|Open-Label Phase|Lost to Follow-up|0|||
170372465|NCT03345342|615701526|FG004|Open-Label Phase|Lost to Follow-up|0|||
170372466|NCT03345342|615701522|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
170372467|NCT03345342|615701523|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
170372468|NCT03345342|615701524|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
170372469|NCT03345342|615701525|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
170372470|NCT03345342|615701526|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
170372471|NCT03345342|615701522|FG000|Open-Label Phase|Physician Decision|4|||
170372472|NCT03345342|615701523|FG001|Open-Label Phase|Physician Decision|0|||
170372473|NCT03345342|615701524|FG002|Open-Label Phase|Physician Decision|0|||
170372474|NCT03345342|615701525|FG003|Open-Label Phase|Physician Decision|0|||
170372475|NCT03345342|615701526|FG004|Open-Label Phase|Physician Decision|0|||
170372476|NCT03345342|615701522|FG000|Open-Label Phase|Protocol Violation|8|||
170372477|NCT03345342|615701523|FG001|Open-Label Phase|Protocol Violation|0|||
170372478|NCT03345342|615701524|FG002|Open-Label Phase|Protocol Violation|0|||
170372479|NCT03345342|615701525|FG003|Open-Label Phase|Protocol Violation|0|||
170372480|NCT03345342|615701526|FG004|Open-Label Phase|Protocol Violation|0|||
170372481|NCT03345342|615701522|FG000|Open-Label Phase|Withdrawal by Subject|57|||
170372482|NCT03345342|615701523|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170372483|NCT03345342|615701524|FG002|Open-Label Phase|Withdrawal by Subject|0|||
170372484|NCT03345342|615701525|FG003|Open-Label Phase|Withdrawal by Subject|0|||
170372485|NCT03345342|615701526|FG004|Open-Label Phase|Withdrawal by Subject|0|||
170372486|NCT03345342|615701522|FG000|Open-Label Phase|Other|15|||
170372487|NCT03345342|615701523|FG001|Open-Label Phase|Other|0|||
170372488|NCT03345342|615701524|FG002|Open-Label Phase|Other|0|||
170372489|NCT03345342|615701525|FG003|Open-Label Phase|Other|0|||
170372490|NCT03345342|615701526|FG004|Open-Label Phase|Other|0|||
170372491|NCT03345342|615701522|FG000|Double-Blind Phase|Adverse Event|0|||
170372492|NCT03345342|615701523|FG001|Double-Blind Phase|Adverse Event|1|||
170372493|NCT03345342|615701524|FG002|Double-Blind Phase|Adverse Event|6|||
170372494|NCT03345342|615701525|FG003|Double-Blind Phase|Adverse Event|0|||
170372495|NCT03345342|615701526|FG004|Double-Blind Phase|Adverse Event|0|||
170372496|NCT03345342|615701522|FG000|Double-Blind Phase|Death|0|||
170372497|NCT03345342|615701523|FG001|Double-Blind Phase|Death|2|||
170372498|NCT03345342|615701524|FG002|Double-Blind Phase|Death|1|||
170372499|NCT03345342|615701525|FG003|Double-Blind Phase|Death|0|||
170372500|NCT03345342|615701526|FG004|Double-Blind Phase|Death|0|||
170372501|NCT03345342|615701522|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
170372502|NCT03345342|615701523|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
170372503|NCT03345342|615701524|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
170372504|NCT03345342|615701525|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
170372505|NCT03345342|615701526|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
170372506|NCT03345342|615701522|FG000|Double-Blind Phase|Lost to Follow-up|0|||
170372507|NCT03345342|615701523|FG001|Double-Blind Phase|Lost to Follow-up|1|||
170372508|NCT03345342|615701524|FG002|Double-Blind Phase|Lost to Follow-up|7|||
170372509|NCT03345342|615701525|FG003|Double-Blind Phase|Lost to Follow-up|0|||
170372510|NCT03345342|615701526|FG004|Double-Blind Phase|Lost to Follow-up|0|||
170372511|NCT03345342|615701522|FG000|Double-Blind Phase|Physician Decision|0|||
170372512|NCT03345342|615701523|FG001|Double-Blind Phase|Physician Decision|1|||
170372513|NCT03345342|615701524|FG002|Double-Blind Phase|Physician Decision|4|||
170372514|NCT03345342|615701525|FG003|Double-Blind Phase|Physician Decision|0|||
170372515|NCT03345342|615701526|FG004|Double-Blind Phase|Physician Decision|0|||
170372516|NCT03345342|615701522|FG000|Double-Blind Phase|Protocol Violation|0|||
170372517|NCT03345342|615701523|FG001|Double-Blind Phase|Protocol Violation|0|||
170372518|NCT03345342|615701524|FG002|Double-Blind Phase|Protocol Violation|1|||
170372519|NCT03345342|615701525|FG003|Double-Blind Phase|Protocol Violation|0|||
170372520|NCT03345342|615701526|FG004|Double-Blind Phase|Protocol Violation|0|||
170372521|NCT03345342|615701522|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
170372522|NCT03345342|615701523|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
170372523|NCT03345342|615701524|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
170372524|NCT03345342|615701525|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
170372525|NCT03345342|615701526|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
170372526|NCT03345342|615701522|FG000|Double-Blind Phase|Other|0|||
170372527|NCT03345342|615701523|FG001|Double-Blind Phase|Other|1|||
170372528|NCT03345342|615701524|FG002|Double-Blind Phase|Other|3|||
170372529|NCT03345342|615701525|FG003|Double-Blind Phase|Other|0|||
170372530|NCT03345342|615701526|FG004|Double-Blind Phase|Other|0|||
170372531|NCT03345342|615701522|FG000|Follow-Up Phase|Adverse Event|0|||
170372532|NCT03345342|615701523|FG001|Follow-Up Phase|Adverse Event|0|||
170372533|NCT03345342|615701524|FG002|Follow-Up Phase|Adverse Event|0|||
170372534|NCT03345342|615701525|FG003|Follow-Up Phase|Adverse Event|0|||
170372535|NCT03345342|615701526|FG004|Follow-Up Phase|Adverse Event|4|||
170372536|NCT03345342|615701522|FG000|Follow-Up Phase|Lost to Follow-up|0|||
170372537|NCT03345342|615701523|FG001|Follow-Up Phase|Lost to Follow-up|0|||
170372538|NCT03345342|615701524|FG002|Follow-Up Phase|Lost to Follow-up|0|||
170372539|NCT03345342|615701525|FG003|Follow-Up Phase|Lost to Follow-up|0|||
170372540|NCT03345342|615701526|FG004|Follow-Up Phase|Lost to Follow-up|6|||
170372541|NCT03345342|615701522|FG000|Follow-Up Phase|Physician Decision|0|||
170372542|NCT03345342|615701523|FG001|Follow-Up Phase|Physician Decision|0|||
170372543|NCT03345342|615701524|FG002|Follow-Up Phase|Physician Decision|0|||
170372544|NCT03345342|615701525|FG003|Follow-Up Phase|Physician Decision|0|||
170372545|NCT03345342|615701526|FG004|Follow-Up Phase|Physician Decision|5|||
170372546|NCT03345342|615701522|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
170372547|NCT03345342|615701523|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
170372548|NCT03345342|615701524|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
170372549|NCT03345342|615701525|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
170372550|NCT03345342|615701526|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
170372551|NCT03345342|615701522|FG000|Follow-Up Phase|Other|0|||
170372552|NCT03345342|615701523|FG001|Follow-Up Phase|Other|0|||
170372553|NCT03345342|615701524|FG002|Follow-Up Phase|Other|0|||
170372554|NCT03345342|615701525|FG003|Follow-Up Phase|Other|3|||
170372555|NCT03345342|615701526|FG004|Follow-Up Phase|Other|1|||
170372556|NCT03375203|615701527|FG000|Overall Study|Protocol Violation|0|||
170372557|NCT03375203|615701528|FG001|Overall Study|Protocol Violation|0|||
170372558|NCT03375203|615701529|FG002|Overall Study|Protocol Violation|1|||
170372559|NCT03375203|615701530|FG003|Overall Study|Protocol Violation|0|||
170372560|NCT03375203|615701531|FG004|Overall Study|Protocol Violation|0|||
170372561|NCT03375203|615701527|FG000|Overall Study|Adverse Event|2|||
170372562|NCT03375203|615701528|FG001|Overall Study|Adverse Event|3|||
170372563|NCT03375203|615701529|FG002|Overall Study|Adverse Event|0|||
170372564|NCT03375203|615701530|FG003|Overall Study|Adverse Event|2|||
170372565|NCT03375203|615701531|FG004|Overall Study|Adverse Event|2|||
170372566|NCT03375203|615701527|FG000|Overall Study|Withdrawal by Subject|3|||
170372567|NCT03375203|615701528|FG001|Overall Study|Withdrawal by Subject|0|||
170372568|NCT03375203|615701529|FG002|Overall Study|Withdrawal by Subject|1|||
170372569|NCT03375203|615701530|FG003|Overall Study|Withdrawal by Subject|0|||
170372570|NCT03375203|615701531|FG004|Overall Study|Withdrawal by Subject|2|||
170372571|NCT03375203|615701527|FG000|Overall Study|Non-compliance with study drug|1|||
170372572|NCT03375203|615701528|FG001|Overall Study|Non-compliance with study drug|0|||
170372573|NCT03375203|615701529|FG002|Overall Study|Non-compliance with study drug|0|||
170372574|NCT03375203|615701530|FG003|Overall Study|Non-compliance with study drug|0|||
170372575|NCT03375203|615701531|FG004|Overall Study|Non-compliance with study drug|0|||
170372576|NCT03375203|615701527|FG000|Overall Study|Randomized, not treated.|0|||
170372577|NCT03375203|615701528|FG001|Overall Study|Randomized, not treated.|1|||
170372578|NCT03375203|615701529|FG002|Overall Study|Randomized, not treated.|0|||
170372579|NCT03375203|615701530|FG003|Overall Study|Randomized, not treated.|0|||
170372580|NCT03375203|615701531|FG004|Overall Study|Randomized, not treated.|0|||
170372581|NCT03107793|615701532|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
170372582|NCT03107793|615701533|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
170372583|NCT03107793|615701534|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
170372584|NCT03107793|615701535|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
170372585|NCT03107793|615701536|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
170372586|NCT03107793|615701532|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
170372587|NCT03107793|615701533|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
170372588|NCT03107793|615701534|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
170372589|NCT03107793|615701535|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
170372590|NCT03107793|615701536|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
170372591|NCT03107793|615701532|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
170372592|NCT03107793|615701533|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
170372593|NCT03107793|615701534|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
170372594|NCT03107793|615701535|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
170372595|NCT03107793|615701536|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
170372596|NCT03107793|615701532|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
170372597|NCT03107793|615701533|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170372598|NCT03107793|615701534|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170372599|NCT03107793|615701535|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170372600|NCT03107793|615701536|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
170372601|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
170372602|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
170372603|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
170372604|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
170372605|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
170372606|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
170372607|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
170372608|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
170372609|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
170372610|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
170372611|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
170372612|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
170372613|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
170372614|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
170372615|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
170372616|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
170372617|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
170372618|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
170372619|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
170372620|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
170372621|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
170372622|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
170372623|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
170372624|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
170372625|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
170372626|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
170372627|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
170372628|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
170372629|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
170372630|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
170372631|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170372632|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
170372633|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170372634|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170372635|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
170372636|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
170372637|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
170372638|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
170372639|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
170372640|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
170372641|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
170372642|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
170372643|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
170372644|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
170372645|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
170372646|NCT03107793|615701532|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
170372647|NCT03107793|615701533|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
170372648|NCT03107793|615701534|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
170372649|NCT03107793|615701535|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
170372650|NCT03107793|615701536|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
170372651|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
170372652|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
170372653|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
170372654|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
170372655|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
170372656|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
170372657|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
170372658|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
170372659|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
170372660|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
170372661|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
170372662|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
170372663|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
170372664|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
170372665|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
170372666|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Death|0|||
170372667|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Death|0|||
170372668|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Death|0|||
170372669|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Death|0|||
170372670|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Death|1|||
170372671|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
170372672|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
170372673|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
170372674|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
170372675|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
170372676|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
170372677|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
170372678|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
170372679|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
170372680|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
170372681|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
170372682|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
170372683|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
170372684|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
170372685|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
170372686|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
170372687|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
170372688|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
170372689|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
170372690|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
170372691|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
170372692|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
170372693|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
170372694|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
170372695|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
170372696|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Other|0|||
170372697|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Other|0|||
170372698|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Other|0|||
170372699|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Other|1|||
170372700|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Other|3|||
170372701|NCT03107793|615701532|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
170372702|NCT03107793|615701533|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
170372703|NCT03107793|615701534|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
170372704|NCT03107793|615701535|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
170372705|NCT03107793|615701536|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
170372706|NCT05180721|615701540|FG000|Overall Study|Lost to Follow-up|4|||
170372707|NCT00976963|615701541|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
170372708|NCT00976963|615701542|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
170372709|NCT00976963|615701541|FG000|Overall Study|administrative error|1|||
170372710|NCT00976963|615701542|FG001|Overall Study|administrative error|0|||
170372711|NCT00976963|615701541|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
170372712|NCT00976963|615701542|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
170372713|NCT01688999|615701546|FG000|Overall Study|Withdrawal by Subject|5|||
170372714|NCT01688999|615701547|FG001|Overall Study|Withdrawal by Subject|1|||
170372715|NCT01688999|615701548|FG002|Overall Study|Withdrawal by Subject|1|||
170372716|NCT01688999|615701546|FG000|Overall Study|Adverse Event|2|||
170372717|NCT01688999|615701547|FG001|Overall Study|Adverse Event|0|||
170372718|NCT01688999|615701548|FG002|Overall Study|Adverse Event|2|||
170372719|NCT01688999|615701546|FG000|Overall Study|Ineligible/Not treated|1|||
170372720|NCT01688999|615701547|FG001|Overall Study|Ineligible/Not treated|0|||
170372721|NCT01688999|615701548|FG002|Overall Study|Ineligible/Not treated|0|||
170372722|NCT00481988|615701549|FG000|Overall Study|Withdrawal by Subject|1|||
170372723|NCT00481988|615701550|FG001|Overall Study|Withdrawal by Subject|1|||
170372724|NCT02182999|615701551|FG000|Overall Study|Adverse Event|4|||
170372725|NCT02182999|615701552|FG001|Overall Study|Adverse Event|3|||
170372726|NCT02182999|615701551|FG000|Overall Study|Physician Decision|1|||
170372727|NCT02182999|615701552|FG001|Overall Study|Physician Decision|0|||
170372728|NCT02252588|615701553|FG000|Overall Study|Withdrawal by Subject|4|||
170372729|NCT02252588|615701554|FG001|Overall Study|Withdrawal by Subject|0|||
170372730|NCT03039790|615701556|FG000|Overall Study|Lost to Follow-up|2|||
170372731|NCT03039790|615701557|FG001|Overall Study|Lost to Follow-up|0|||
170372732|NCT03039790|615701558|FG002|Overall Study|Lost to Follow-up|1|||
170372733|NCT03039790|615701559|FG003|Overall Study|Lost to Follow-up|1|||
170372734|NCT03039790|615701560|FG004|Overall Study|Lost to Follow-up|0|||
170372735|NCT03039790|615701561|FG005|Overall Study|Lost to Follow-up|1|||
170372736|NCT03039790|615701562|FG006|Overall Study|Lost to Follow-up|1|||
170372737|NCT03039790|615701563|FG007|Overall Study|Lost to Follow-up|1|||
170372738|NCT03039790|615701564|FG008|Overall Study|Lost to Follow-up|0|||
170372739|NCT03039790|615701565|FG009|Overall Study|Lost to Follow-up|1|||
170372740|NCT03039790|615701566|FG010|Overall Study|Lost to Follow-up|1|||
170372741|NCT03039790|615701567|FG011|Overall Study|Lost to Follow-up|0|||
170372742|NCT03039790|615701568|FG012|Overall Study|Lost to Follow-up|1|||
170372743|NCT03039790|615701569|FG013|Overall Study|Lost to Follow-up|0|||
170372744|NCT03039790|615701570|FG014|Overall Study|Lost to Follow-up|3|||
170372745|NCT03039790|615701571|FG015|Overall Study|Lost to Follow-up|1|||
170372746|NCT03039790|615701572|FG016|Overall Study|Lost to Follow-up|2|||
170372747|NCT03039790|615701573|FG017|Overall Study|Lost to Follow-up|2|||
170372748|NCT03039790|615701574|FG018|Overall Study|Lost to Follow-up|1|||
170372749|NCT03039790|615701575|FG019|Overall Study|Lost to Follow-up|3|||
170372750|NCT03039790|615701556|FG000|Overall Study|Withdrawal of Consent|1|||
170372751|NCT03039790|615701557|FG001|Overall Study|Withdrawal of Consent|0|||
170372752|NCT03039790|615701558|FG002|Overall Study|Withdrawal of Consent|0|||
170372753|NCT03039790|615701559|FG003|Overall Study|Withdrawal of Consent|1|||
170372754|NCT03039790|615701560|FG004|Overall Study|Withdrawal of Consent|0|||
170372755|NCT03039790|615701561|FG005|Overall Study|Withdrawal of Consent|0|||
170372756|NCT03039790|615701562|FG006|Overall Study|Withdrawal of Consent|0|||
170372757|NCT03039790|615701563|FG007|Overall Study|Withdrawal of Consent|0|||
170372758|NCT03039790|615701564|FG008|Overall Study|Withdrawal of Consent|0|||
170372759|NCT03039790|615701565|FG009|Overall Study|Withdrawal of Consent|1|||
170372760|NCT03039790|615701566|FG010|Overall Study|Withdrawal of Consent|0|||
170372761|NCT03039790|615701567|FG011|Overall Study|Withdrawal of Consent|0|||
170372762|NCT03039790|615701568|FG012|Overall Study|Withdrawal of Consent|2|||
170372763|NCT03039790|615701569|FG013|Overall Study|Withdrawal of Consent|0|||
170372764|NCT03039790|615701570|FG014|Overall Study|Withdrawal of Consent|1|||
170372765|NCT03039790|615701571|FG015|Overall Study|Withdrawal of Consent|5|||
170372766|NCT03039790|615701572|FG016|Overall Study|Withdrawal of Consent|3|||
170372767|NCT03039790|615701573|FG017|Overall Study|Withdrawal of Consent|0|||
170372768|NCT03039790|615701574|FG018|Overall Study|Withdrawal of Consent|2|||
170372769|NCT03039790|615701575|FG019|Overall Study|Withdrawal of Consent|5|||
170372770|NCT03039790|615701556|FG000|Overall Study|Death|0|||
170372771|NCT03039790|615701557|FG001|Overall Study|Death|0|||
170372772|NCT03039790|615701558|FG002|Overall Study|Death|0|||
170372773|NCT03039790|615701559|FG003|Overall Study|Death|0|||
170372774|NCT03039790|615701560|FG004|Overall Study|Death|0|||
170372775|NCT03039790|615701561|FG005|Overall Study|Death|0|||
170372776|NCT03039790|615701562|FG006|Overall Study|Death|0|||
170372777|NCT03039790|615701563|FG007|Overall Study|Death|0|||
170372778|NCT03039790|615701564|FG008|Overall Study|Death|0|||
170372779|NCT03039790|615701565|FG009|Overall Study|Death|0|||
170372780|NCT03039790|615701566|FG010|Overall Study|Death|0|||
170372781|NCT03039790|615701567|FG011|Overall Study|Death|0|||
170372782|NCT03039790|615701568|FG012|Overall Study|Death|0|||
170372783|NCT03039790|615701569|FG013|Overall Study|Death|0|||
170372784|NCT03039790|615701570|FG014|Overall Study|Death|0|||
170372785|NCT03039790|615701571|FG015|Overall Study|Death|1|||
170372786|NCT03039790|615701572|FG016|Overall Study|Death|3|||
170372787|NCT03039790|615701573|FG017|Overall Study|Death|0|||
170372788|NCT03039790|615701574|FG018|Overall Study|Death|2|||
170372789|NCT03039790|615701575|FG019|Overall Study|Death|0|||
170372790|NCT03039790|615701556|FG000|Overall Study|Reason, not Specified|1|||
170372791|NCT03039790|615701557|FG001|Overall Study|Reason, not Specified|0|||
170372792|NCT03039790|615701558|FG002|Overall Study|Reason, not Specified|0|||
170372793|NCT03039790|615701559|FG003|Overall Study|Reason, not Specified|0|||
170372794|NCT03039790|615701560|FG004|Overall Study|Reason, not Specified|0|||
170372795|NCT03039790|615701561|FG005|Overall Study|Reason, not Specified|0|||
170372796|NCT03039790|615701562|FG006|Overall Study|Reason, not Specified|0|||
170372797|NCT03039790|615701563|FG007|Overall Study|Reason, not Specified|0|||
170372798|NCT03039790|615701564|FG008|Overall Study|Reason, not Specified|0|||
170372799|NCT03039790|615701565|FG009|Overall Study|Reason, not Specified|0|||
170372800|NCT03039790|615701566|FG010|Overall Study|Reason, not Specified|0|||
170372801|NCT03039790|615701567|FG011|Overall Study|Reason, not Specified|0|||
170372802|NCT03039790|615701568|FG012|Overall Study|Reason, not Specified|0|||
170372803|NCT03039790|615701569|FG013|Overall Study|Reason, not Specified|0|||
170372804|NCT03039790|615701570|FG014|Overall Study|Reason, not Specified|0|||
170372805|NCT03039790|615701571|FG015|Overall Study|Reason, not Specified|0|||
170372806|NCT03039790|615701572|FG016|Overall Study|Reason, not Specified|2|||
170372807|NCT03039790|615701573|FG017|Overall Study|Reason, not Specified|0|||
170372808|NCT03039790|615701574|FG018|Overall Study|Reason, not Specified|1|||
170372809|NCT03039790|615701575|FG019|Overall Study|Reason, not Specified|0|||
170372810|NCT00537771|615701585|FG000|Overall Study|Withdrawal by Subject|6|||
170372811|NCT00537771|615701586|FG001|Overall Study|Withdrawal by Subject|23|||
170372812|NCT00537771|615701585|FG000|Overall Study|Adverse Event|8|||
170372813|NCT00537771|615701586|FG001|Overall Study|Adverse Event|15|||
170372814|NCT00537771|615701585|FG000|Overall Study|Lost to Follow-up|9|||
170372815|NCT00537771|615701586|FG001|Overall Study|Lost to Follow-up|15|||
170372816|NCT00537771|615701585|FG000|Overall Study|Protocol Violation|2|||
170372817|NCT00537771|615701586|FG001|Overall Study|Protocol Violation|6|||
170372818|NCT00537771|615701585|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
170372819|NCT00537771|615701586|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
170372820|NCT02736929|615701589|FG000|Main Study|Lost to Follow-up|7|||
170372821|NCT02736929|615701590|FG001|Main Study|Lost to Follow-up|1|||
170372822|NCT02736929|615701591|FG002|Main Study|Lost to Follow-up|0|||
170372823|NCT02736929|615701589|FG000|Main Study|Withdrawal by Subject|1|||
170372824|NCT02736929|615701590|FG001|Main Study|Withdrawal by Subject|1|||
170372825|NCT02736929|615701591|FG002|Main Study|Withdrawal by Subject|0|||
170372826|NCT02736929|615701589|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
170372827|NCT02736929|615701590|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
170372828|NCT02736929|615701591|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
170372829|NCT00693693|615701594|FG000|Overall Study|Lost to Follow-up|1|||
170372830|NCT00693693|615701595|FG001|Overall Study|Lost to Follow-up|1|||
170372831|NCT00693693|615701596|FG002|Overall Study|Lost to Follow-up|2|||
170372832|NCT01600105|615701601|FG000|Total Participants|Withdrawal by Subject|1|||
170372833|NCT01600105|615701602|FG001|Total Participants|Withdrawal by Subject|0|||
170372834|NCT01600105|615701601|FG000|Total Participants|No images in PACS|10|||
170372835|NCT01600105|615701602|FG001|Total Participants|No images in PACS|0|||
170372836|NCT01600105|615701601|FG000|Total Participants|Insufficient image quality|30|||
170372837|NCT01600105|615701602|FG001|Total Participants|Insufficient image quality|10|||
170372838|NCT01600105|615701601|FG000|Sub Study I|Insufficient image quality|0|||
170372839|NCT01600105|615701602|FG001|Sub Study I|Insufficient image quality|10|||
170372840|NCT01600105|615701601|FG000|Sub Study II|Withdrawal by Subject|1|||
170372841|NCT01600105|615701602|FG001|Sub Study II|Withdrawal by Subject|0|||
170372842|NCT01600105|615701601|FG000|Sub Study II|No images in PACS|1|||
170372843|NCT01600105|615701602|FG001|Sub Study II|No images in PACS|0|||
170372844|NCT01600105|615701601|FG000|Sub Study II|Insufficient image quality|3|||
170372845|NCT01600105|615701602|FG001|Sub Study II|Insufficient image quality|0|||
170372846|NCT01600105|615701601|FG000|Sub Study III|Insufficient image quality|5|||
170372847|NCT01600105|615701602|FG001|Sub Study III|Insufficient image quality|0|||
170372848|NCT01600105|615701601|FG000|Sub Study V|Poor Image Quality|2|||
170372849|NCT01600105|615701602|FG001|Sub Study V|Poor Image Quality|0|||
170372850|NCT01263444|615701603|FG000|Overall Study|Adverse Event|8|||
170372851|NCT01263444|615701603|FG000|Overall Study|Withdrawal by Subject|1|||
170372852|NCT01263444|615701603|FG000|Overall Study|Protocol Violation|1|||
170372853|NCT04007367|615701604|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
170372854|NCT04007367|615701605|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
170372855|NCT04007367|615701606|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
170372856|NCT04007367|615701604|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
170372857|NCT04007367|615701605|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
170372858|NCT04007367|615701606|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
170372859|NCT04007367|615701604|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
170372860|NCT04007367|615701605|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
170372861|NCT04007367|615701606|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
170372862|NCT04007367|615701604|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
170372863|NCT04007367|615701605|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
170372864|NCT04007367|615701606|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
170372865|NCT04007367|615701604|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
170372866|NCT04007367|615701605|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
170372867|NCT04007367|615701606|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
170372868|NCT01764022|615701608|FG000|Overall Study|Death|3|||
170372869|NCT01764022|615701609|FG001|Overall Study|Death|5|||
170372870|NCT01764022|615701608|FG000|Overall Study|Withdrawal by Subject|2|||
170372871|NCT01764022|615701609|FG001|Overall Study|Withdrawal by Subject|6|||
170372872|NCT01764022|615701608|FG000|Overall Study|Lack of Efficacy|0|||
170372873|NCT01764022|615701609|FG001|Overall Study|Lack of Efficacy|1|||
170372874|NCT01764022|615701608|FG000|Overall Study|Physician Decision|0|||
170372875|NCT01764022|615701609|FG001|Overall Study|Physician Decision|2|||
170372876|NCT01764022|615701608|FG000|Overall Study|Lost to Follow-up|2|||
170372877|NCT01764022|615701609|FG001|Overall Study|Lost to Follow-up|0|||
170372878|NCT01764022|615701608|FG000|Overall Study|Protocol Violation|1|||
170372879|NCT01764022|615701609|FG001|Overall Study|Protocol Violation|0|||
170372880|NCT02010567|615701610|FG000|Overall Study|Adverse Event|0|||
170372881|NCT02010567|615701611|FG001|Overall Study|Adverse Event|0|||
170372882|NCT02010567|615701612|FG002|Overall Study|Adverse Event|1|||
170372883|NCT02010567|615701613|FG003|Overall Study|Adverse Event|0|||
170372884|NCT02010567|615701614|FG004|Overall Study|Adverse Event|1|||
170372885|NCT04043416|615701615|FG000|Washout|Change in health condition|0|||
170372886|NCT04043416|615701616|FG001|Washout|Change in health condition|1|||
170372887|NCT01925014|615701617|FG000|Overall Study|Inappropriate enrollment|4|||
170372888|NCT01925014|615701618|FG001|Overall Study|Inappropriate enrollment|6|||
170372889|NCT01925014|615701617|FG000|Overall Study|Withdrawal by Subject|5|||
170372890|NCT01925014|615701618|FG001|Overall Study|Withdrawal by Subject|13|||
170372891|NCT01196091|615701622|FG000|Overall Study|Adverse Event|22|||
170372892|NCT01196091|615701623|FG001|Overall Study|Adverse Event|27|||
170372893|NCT01196091|615701624|FG002|Overall Study|Adverse Event|26|||
170372894|NCT01196091|615701622|FG000|Overall Study|Death|3|||
170372895|NCT01196091|615701623|FG001|Overall Study|Death|2|||
170372896|NCT01196091|615701624|FG002|Overall Study|Death|2|||
170372897|NCT01196091|615701622|FG000|Overall Study|Entry Criteria Not Met|11|||
170372898|NCT01196091|615701623|FG001|Overall Study|Entry Criteria Not Met|11|||
170372899|NCT01196091|615701624|FG002|Overall Study|Entry Criteria Not Met|10|||
170372900|NCT01196091|615701622|FG000|Overall Study|Lack of Efficacy|15|||
170372901|NCT01196091|615701623|FG001|Overall Study|Lack of Efficacy|12|||
170372902|NCT01196091|615701624|FG002|Overall Study|Lack of Efficacy|17|||
170372903|NCT01196091|615701622|FG000|Overall Study|Lost to Follow-up|5|||
170372904|NCT01196091|615701623|FG001|Overall Study|Lost to Follow-up|5|||
170372905|NCT01196091|615701624|FG002|Overall Study|Lost to Follow-up|6|||
170372906|NCT01196091|615701622|FG000|Overall Study|Parent/Caregiver Decision|0|||
170372907|NCT01196091|615701623|FG001|Overall Study|Parent/Caregiver Decision|0|||
170372908|NCT01196091|615701624|FG002|Overall Study|Parent/Caregiver Decision|1|||
170372909|NCT01196091|615701622|FG000|Overall Study|Withdrawal by Subject|16|||
170372910|NCT01196091|615701623|FG001|Overall Study|Withdrawal by Subject|19|||
170372911|NCT01196091|615701624|FG002|Overall Study|Withdrawal by Subject|22|||
170372912|NCT01196091|615701622|FG000|Overall Study|Physician Decision|3|||
170372913|NCT01196091|615701623|FG001|Overall Study|Physician Decision|3|||
170372914|NCT01196091|615701624|FG002|Overall Study|Physician Decision|4|||
170372915|NCT01196091|615701622|FG000|Overall Study|Protocol Violation|1|||
170372916|NCT01196091|615701623|FG001|Overall Study|Protocol Violation|3|||
170372917|NCT01196091|615701624|FG002|Overall Study|Protocol Violation|3|||
170372918|NCT01196091|615701622|FG000|Overall Study|Sponsor Decision|6|||
170372919|NCT01196091|615701623|FG001|Overall Study|Sponsor Decision|5|||
170372920|NCT01196091|615701624|FG002|Overall Study|Sponsor Decision|4|||
170372921|NCT01196091|615701622|FG000|Overall Study|Excluded Site|5|||
170372922|NCT01196091|615701623|FG001|Overall Study|Excluded Site|11|||
170372923|NCT01196091|615701624|FG002|Overall Study|Excluded Site|8|||
170372924|NCT01196091|615701622|FG000|Overall Study|Randomized, No Study Drug Received|1|||
170372925|NCT01196091|615701623|FG001|Overall Study|Randomized, No Study Drug Received|0|||
170372926|NCT01196091|615701624|FG002|Overall Study|Randomized, No Study Drug Received|1|||
170372927|NCT01662986|615701625|FG000|Overall Study|Adverse Event|5|||
170372928|NCT01662986|615701626|FG001|Overall Study|Adverse Event|4|||
170372929|NCT01662986|615701625|FG000|Overall Study|Protocol Violation|2|||
170372930|NCT01662986|615701626|FG001|Overall Study|Protocol Violation|3|||
170372931|NCT01662986|615701625|FG000|Overall Study|Lost to Follow-up|5|||
170372932|NCT01662986|615701626|FG001|Overall Study|Lost to Follow-up|4|||
170372933|NCT01662986|615701625|FG000|Overall Study|Withdrawal by Subject|2|||
170372934|NCT01662986|615701626|FG001|Overall Study|Withdrawal by Subject|2|||
170372935|NCT01662986|615701625|FG000|Overall Study|Not Treated|1|||
170372936|NCT01662986|615701626|FG001|Overall Study|Not Treated|0|||
170372937|NCT01662986|615701625|FG000|Overall Study|Other than stated above|3|||
170372938|NCT01662986|615701626|FG001|Overall Study|Other than stated above|0|||
170372939|NCT04247828|615701627|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
170372940|NCT03077711|615701628|FG000|Overall Study|Lost to Follow-up|2|||
170372941|NCT03077711|615701629|FG001|Overall Study|Lost to Follow-up|2|||
170372942|NCT03077711|615701628|FG000|Overall Study|noncompliant taking medication|2|||
170372943|NCT03077711|615701629|FG001|Overall Study|noncompliant taking medication|0|||
170372944|NCT01451398|615701631|FG000|Overall Study|Adverse Event|7|||
170372945|NCT01451398|615701632|FG001|Overall Study|Adverse Event|9|||
170372946|NCT01451398|615701631|FG000|Overall Study|Protocol Violation|1|||
170372947|NCT01451398|615701632|FG001|Overall Study|Protocol Violation|2|||
170372948|NCT01451398|615701631|FG000|Overall Study|Physician Decision|1|||
170372949|NCT01451398|615701632|FG001|Overall Study|Physician Decision|1|||
170372950|NCT01451398|615701631|FG000|Overall Study|Withdrawal by Subject|10|||
170372951|NCT01451398|615701632|FG001|Overall Study|Withdrawal by Subject|14|||
170372952|NCT01451398|615701631|FG000|Overall Study|Lost to Follow-up|6|||
170372953|NCT01451398|615701632|FG001|Overall Study|Lost to Follow-up|4|||
170372954|NCT01451398|615701631|FG000|Overall Study|Non-compliance with study drug|1|||
170372955|NCT01451398|615701632|FG001|Overall Study|Non-compliance with study drug|3|||
170372956|NCT01451398|615701631|FG000|Overall Study|Non-compliance with protocol|1|||
170372957|NCT01451398|615701632|FG001|Overall Study|Non-compliance with protocol|1|||
170372958|NCT01451398|615701631|FG000|Overall Study|Moved out of country|0|||
170372959|NCT01451398|615701632|FG001|Overall Study|Moved out of country|1|||
170372960|NCT01451398|615701631|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
170372961|NCT01451398|615701632|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
170372962|NCT01451398|615701631|FG000|Overall Study|Lack of Efficacy|0|||
170372963|NCT01451398|615701632|FG001|Overall Study|Lack of Efficacy|1|||
170372964|NCT00981747|615701633|FG000|Losartan|Withdrawal by Subject|1|||
170372965|NCT00981747|615701633|FG000|Losartan|Death|1|||
170372966|NCT00981747|615701633|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
170372967|NCT02896192|615701642|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
170372968|NCT02896192|615701642|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
170372969|NCT02896192|615701642|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
170372970|NCT00383708|615701647|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
170372971|NCT00383708|615701647|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
170372972|NCT00383708|615701647|FG000|Run-in Period|Protocol Violation|4|||
170372973|NCT00383708|615701647|FG000|Run-in Period|Adverse Event|2|||
170372974|NCT00383708|615701647|FG000|Run-in Period|Claustrophobia|1|||
170372975|NCT00383708|615701647|FG000|Co-administration Period|Adverse Event|5|||
170372976|NCT02033850|615701648|FG000|Overall Study|Death|1|||
170372977|NCT02033850|615701649|FG001|Overall Study|Death|0|||
170372978|NCT02033850|615701648|FG000|Overall Study|unrelated medical reason|1|||
170372979|NCT02033850|615701649|FG001|Overall Study|unrelated medical reason|1|||
170372980|NCT02820038|615701653|FG000|Overall Study|Lost to Follow-up|7|||
170372981|NCT02820038|615701654|FG001|Overall Study|Lost to Follow-up|11|||
170372982|NCT02820038|615701655|FG002|Overall Study|Lost to Follow-up|2|||
170372983|NCT02820038|615701656|FG003|Overall Study|Lost to Follow-up|9|||
170372984|NCT02820038|615701653|FG000|Overall Study|Withdrawal by Subject|3|||
170372985|NCT02820038|615701654|FG001|Overall Study|Withdrawal by Subject|14|||
170372986|NCT02820038|615701655|FG002|Overall Study|Withdrawal by Subject|3|||
170372987|NCT02820038|615701656|FG003|Overall Study|Withdrawal by Subject|13|||
170372988|NCT03215667|615701657|FG000|Overall Study|Physician Decision|4|||
170372989|NCT03934203|615701660|FG000|Overall Study|Adverse Event|0|||
170372990|NCT03934203|615701661|FG001|Overall Study|Adverse Event|0|||
170372991|NCT03934203|615701662|FG002|Overall Study|Adverse Event|1|||
170372992|NCT03934203|615701663|FG003|Overall Study|Adverse Event|0|||
170372993|NCT03934203|615701664|FG004|Overall Study|Adverse Event|1|||
170372994|NCT03934203|615701665|FG005|Overall Study|Adverse Event|0|||
170372995|NCT03934203|615701666|FG006|Overall Study|Adverse Event|2|||
170372996|NCT03934203|615701667|FG007|Overall Study|Adverse Event|0|||
170372997|NCT03934203|615701668|FG008|Overall Study|Adverse Event|0|||
170372998|NCT03934203|615701669|FG009|Overall Study|Adverse Event|0|||
170372999|NCT03934203|615701670|FG010|Overall Study|Adverse Event|0|||
170373000|NCT03934203|615701671|FG011|Overall Study|Adverse Event|0|||
170373001|NCT03934203|615701672|FG012|Overall Study|Adverse Event|0|||
170373002|NCT03934203|615701673|FG013|Overall Study|Adverse Event|1|||
170373003|NCT03934203|615701674|FG014|Overall Study|Adverse Event|0|||
170373004|NCT00560794|615701678|FG000|Overall Study|Adverse Event|2|||
170373005|NCT00560794|615701678|FG000|Overall Study|Patient was not Compliant|1|||
170373006|NCT00560794|615701678|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
170373007|NCT00560794|615701678|FG000|Overall Study|Hematological Relapse|1|||
170373008|NCT00560794|615701678|FG000|Overall Study|Received Bone Marrow Transplant|6|||
170373009|NCT00614991|615701679|FG000|Overall Study|Adverse Event|3|||
170373010|NCT00614991|615701680|FG001|Overall Study|Adverse Event|3|||
170373011|NCT00614991|615701681|FG002|Overall Study|Adverse Event|0|||
170373012|NCT00614991|615701682|FG003|Overall Study|Adverse Event|0|||
170373013|NCT00614991|615701683|FG004|Overall Study|Adverse Event|1|||
170373014|NCT00614991|615701684|FG005|Overall Study|Adverse Event|0|||
170373015|NCT00441480|615701685|FG000|Overall Study|Protocol Violation|1|||
170373016|NCT00441480|615701686|FG001|Overall Study|Protocol Violation|1|||
170373017|NCT00441480|615701685|FG000|Overall Study|Withdrawal by Subject|2|||
170373018|NCT00441480|615701686|FG001|Overall Study|Withdrawal by Subject|3|||
170373019|NCT01390038|615701689|FG000|Overall Study|Death|1|||
170373020|NCT01390038|615701689|FG000|Overall Study|Lost to Follow-up|1|||
170373021|NCT01390038|615701689|FG000|Overall Study|Withdrawal by Subject|4|||
170373022|NCT01390038|615701689|FG000|Overall Study|Simpliciti System Removal|2|||
170373023|NCT03799627|615701694|FG000|Overall Study|Adverse Event|1|||
170373024|NCT03799627|615701695|FG001|Overall Study|Adverse Event|2|||
170373025|NCT03799627|615701696|FG002|Overall Study|Adverse Event|0|||
170373026|NCT03799627|615701697|FG003|Overall Study|Adverse Event|0|||
170373027|NCT03799627|615701698|FG004|Overall Study|Adverse Event|2|||
170373028|NCT03799627|615701699|FG005|Overall Study|Adverse Event|5|||
170373029|NCT03799627|615701700|FG006|Overall Study|Adverse Event|0|||
170373030|NCT03799627|615701701|FG007|Overall Study|Adverse Event|2|||
170373031|NCT03799627|615701702|FG008|Overall Study|Adverse Event|0|||
170373032|NCT03799627|615701694|FG000|Overall Study|Physician Decision|2|||
170373033|NCT03799627|615701695|FG001|Overall Study|Physician Decision|2|||
170373034|NCT03799627|615701696|FG002|Overall Study|Physician Decision|0|||
170373035|NCT03799627|615701697|FG003|Overall Study|Physician Decision|0|||
170373036|NCT03799627|615701698|FG004|Overall Study|Physician Decision|2|||
170373037|NCT03799627|615701699|FG005|Overall Study|Physician Decision|2|||
170373038|NCT03799627|615701700|FG006|Overall Study|Physician Decision|0|||
170373039|NCT03799627|615701701|FG007|Overall Study|Physician Decision|0|||
170373040|NCT03799627|615701702|FG008|Overall Study|Physician Decision|0|||
170373041|NCT03799627|615701694|FG000|Overall Study|Withdrawal by Subject|1|||
170373042|NCT03799627|615701695|FG001|Overall Study|Withdrawal by Subject|1|||
170373043|NCT03799627|615701696|FG002|Overall Study|Withdrawal by Subject|0|||
170373044|NCT03799627|615701697|FG003|Overall Study|Withdrawal by Subject|2|||
170373045|NCT03799627|615701698|FG004|Overall Study|Withdrawal by Subject|0|||
170373046|NCT03799627|615701699|FG005|Overall Study|Withdrawal by Subject|3|||
170373047|NCT03799627|615701700|FG006|Overall Study|Withdrawal by Subject|0|||
170373048|NCT03799627|615701701|FG007|Overall Study|Withdrawal by Subject|0|||
170373049|NCT03799627|615701702|FG008|Overall Study|Withdrawal by Subject|0|||
170373050|NCT03799627|615701694|FG000|Overall Study|Lack of Efficacy|0|||
170373051|NCT03799627|615701695|FG001|Overall Study|Lack of Efficacy|0|||
170373052|NCT03799627|615701696|FG002|Overall Study|Lack of Efficacy|0|||
170373053|NCT03799627|615701697|FG003|Overall Study|Lack of Efficacy|1|||
170373054|NCT03799627|615701698|FG004|Overall Study|Lack of Efficacy|0|||
170373055|NCT03799627|615701699|FG005|Overall Study|Lack of Efficacy|0|||
170373056|NCT03799627|615701700|FG006|Overall Study|Lack of Efficacy|0|||
170373057|NCT03799627|615701701|FG007|Overall Study|Lack of Efficacy|0|||
170373058|NCT03799627|615701702|FG008|Overall Study|Lack of Efficacy|0|||
170373059|NCT03799627|615701694|FG000|Overall Study|Lost to Follow-up|0|||
170373060|NCT03799627|615701695|FG001|Overall Study|Lost to Follow-up|0|||
170373061|NCT03799627|615701696|FG002|Overall Study|Lost to Follow-up|0|||
170373062|NCT03799627|615701697|FG003|Overall Study|Lost to Follow-up|0|||
170373063|NCT03799627|615701698|FG004|Overall Study|Lost to Follow-up|0|||
170373064|NCT03799627|615701699|FG005|Overall Study|Lost to Follow-up|0|||
170373065|NCT03799627|615701700|FG006|Overall Study|Lost to Follow-up|1|||
170373066|NCT03799627|615701701|FG007|Overall Study|Lost to Follow-up|0|||
170373067|NCT03799627|615701702|FG008|Overall Study|Lost to Follow-up|1|||
170373068|NCT03799627|615701694|FG000|Overall Study|Death|0|||
170373069|NCT03799627|615701695|FG001|Overall Study|Death|0|||
170373070|NCT03799627|615701696|FG002|Overall Study|Death|0|||
170373071|NCT03799627|615701697|FG003|Overall Study|Death|1|||
170373072|NCT03799627|615701698|FG004|Overall Study|Death|0|||
170373073|NCT03799627|615701699|FG005|Overall Study|Death|0|||
170373074|NCT03799627|615701700|FG006|Overall Study|Death|0|||
170373075|NCT03799627|615701701|FG007|Overall Study|Death|0|||
170373076|NCT03799627|615701702|FG008|Overall Study|Death|0|||
170373077|NCT03799627|615701694|FG000|Overall Study|Study Drug Put on Hold|1|||
170373078|NCT03799627|615701695|FG001|Overall Study|Study Drug Put on Hold|0|||
170373079|NCT03799627|615701696|FG002|Overall Study|Study Drug Put on Hold|0|||
170373080|NCT03799627|615701697|FG003|Overall Study|Study Drug Put on Hold|0|||
170373081|NCT03799627|615701698|FG004|Overall Study|Study Drug Put on Hold|0|||
170373082|NCT03799627|615701699|FG005|Overall Study|Study Drug Put on Hold|0|||
170373083|NCT03799627|615701700|FG006|Overall Study|Study Drug Put on Hold|0|||
170373084|NCT03799627|615701701|FG007|Overall Study|Study Drug Put on Hold|0|||
170373085|NCT03799627|615701702|FG008|Overall Study|Study Drug Put on Hold|0|||
170373086|NCT03799627|615701694|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
170373087|NCT03799627|615701695|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
170373088|NCT03799627|615701696|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
170373089|NCT03799627|615701697|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
170373090|NCT03799627|615701698|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
170373091|NCT03799627|615701699|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
170373092|NCT03799627|615701700|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
170373093|NCT03799627|615701701|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
170373094|NCT03799627|615701702|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
170373095|NCT03799627|615701694|FG000|Overall Study|Kidney Transplantation|1|||
170373096|NCT03799627|615701695|FG001|Overall Study|Kidney Transplantation|0|||
170373097|NCT03799627|615701696|FG002|Overall Study|Kidney Transplantation|0|||
170373098|NCT03799627|615701697|FG003|Overall Study|Kidney Transplantation|1|||
170373099|NCT03799627|615701698|FG004|Overall Study|Kidney Transplantation|1|||
170373100|NCT03799627|615701699|FG005|Overall Study|Kidney Transplantation|0|||
170373101|NCT03799627|615701700|FG006|Overall Study|Kidney Transplantation|0|||
170373102|NCT03799627|615701701|FG007|Overall Study|Kidney Transplantation|0|||
170373103|NCT03799627|615701702|FG008|Overall Study|Kidney Transplantation|0|||
170373104|NCT03799627|615701694|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
170373105|NCT03799627|615701695|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
170373106|NCT03799627|615701696|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
170373107|NCT03799627|615701697|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
170373108|NCT03799627|615701698|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
170373109|NCT03799627|615701699|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
170373110|NCT03799627|615701700|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
170373111|NCT03799627|615701701|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
170373112|NCT03799627|615701702|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
170373113|NCT03799627|615701694|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
170373114|NCT03799627|615701695|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
170373115|NCT03799627|615701696|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
170373116|NCT03799627|615701697|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
170373117|NCT03799627|615701698|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
170373118|NCT03799627|615701699|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
170373119|NCT03799627|615701700|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
170373120|NCT03799627|615701701|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
170373121|NCT03799627|615701702|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
170373122|NCT03799627|615701694|FG000|Overall Study|Met Exclusion Criteria|0|||
170373123|NCT03799627|615701695|FG001|Overall Study|Met Exclusion Criteria|0|||
170398688|NCT00306852|615798246|FG000|Overall Study|Death|14|||
170373124|NCT03799627|615701696|FG002|Overall Study|Met Exclusion Criteria|0|||
170373125|NCT03799627|615701697|FG003|Overall Study|Met Exclusion Criteria|1|||
170373126|NCT03799627|615701698|FG004|Overall Study|Met Exclusion Criteria|0|||
170373127|NCT03799627|615701699|FG005|Overall Study|Met Exclusion Criteria|0|||
170373128|NCT03799627|615701700|FG006|Overall Study|Met Exclusion Criteria|0|||
170373129|NCT03799627|615701701|FG007|Overall Study|Met Exclusion Criteria|0|||
170373130|NCT03799627|615701702|FG008|Overall Study|Met Exclusion Criteria|0|||
170373131|NCT03799627|615701694|FG000|Overall Study|Investigational Product Noncompliance|0|||
170373132|NCT03799627|615701695|FG001|Overall Study|Investigational Product Noncompliance|0|||
170373133|NCT03799627|615701696|FG002|Overall Study|Investigational Product Noncompliance|0|||
170373134|NCT03799627|615701697|FG003|Overall Study|Investigational Product Noncompliance|1|||
170373135|NCT03799627|615701698|FG004|Overall Study|Investigational Product Noncompliance|0|||
170373136|NCT03799627|615701699|FG005|Overall Study|Investigational Product Noncompliance|0|||
170373137|NCT03799627|615701700|FG006|Overall Study|Investigational Product Noncompliance|0|||
170373138|NCT03799627|615701701|FG007|Overall Study|Investigational Product Noncompliance|0|||
170373139|NCT03799627|615701702|FG008|Overall Study|Investigational Product Noncompliance|0|||
170373140|NCT03799627|615701694|FG000|Overall Study|Participant Relocation|0|||
170373141|NCT03799627|615701695|FG001|Overall Study|Participant Relocation|0|||
170373142|NCT03799627|615701696|FG002|Overall Study|Participant Relocation|0|||
170373143|NCT03799627|615701697|FG003|Overall Study|Participant Relocation|1|||
170373144|NCT03799627|615701698|FG004|Overall Study|Participant Relocation|0|||
170373145|NCT03799627|615701699|FG005|Overall Study|Participant Relocation|1|||
170373146|NCT03799627|615701700|FG006|Overall Study|Participant Relocation|0|||
170373147|NCT03799627|615701701|FG007|Overall Study|Participant Relocation|0|||
170373148|NCT03799627|615701702|FG008|Overall Study|Participant Relocation|0|||
170373149|NCT03799627|615701694|FG000|Overall Study|Eurofin Issue|0|||
170373150|NCT03799627|615701695|FG001|Overall Study|Eurofin Issue|0|||
170373151|NCT03799627|615701696|FG002|Overall Study|Eurofin Issue|0|||
170373152|NCT03799627|615701697|FG003|Overall Study|Eurofin Issue|0|||
170373153|NCT03799627|615701698|FG004|Overall Study|Eurofin Issue|1|||
170373154|NCT03799627|615701699|FG005|Overall Study|Eurofin Issue|0|||
170373155|NCT03799627|615701700|FG006|Overall Study|Eurofin Issue|0|||
170373156|NCT03799627|615701701|FG007|Overall Study|Eurofin Issue|0|||
170373157|NCT03799627|615701702|FG008|Overall Study|Eurofin Issue|0|||
170373158|NCT03799627|615701694|FG000|Overall Study|Noncompliance with Site Instructions|0|||
170373159|NCT03799627|615701695|FG001|Overall Study|Noncompliance with Site Instructions|0|||
170373160|NCT03799627|615701696|FG002|Overall Study|Noncompliance with Site Instructions|0|||
170373161|NCT03799627|615701697|FG003|Overall Study|Noncompliance with Site Instructions|0|||
170373162|NCT03799627|615701698|FG004|Overall Study|Noncompliance with Site Instructions|1|||
170373163|NCT03799627|615701699|FG005|Overall Study|Noncompliance with Site Instructions|0|||
170373164|NCT03799627|615701700|FG006|Overall Study|Noncompliance with Site Instructions|0|||
170373165|NCT03799627|615701701|FG007|Overall Study|Noncompliance with Site Instructions|0|||
170373166|NCT03799627|615701702|FG008|Overall Study|Noncompliance with Site Instructions|0|||
170373167|NCT03799627|615701694|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
170373168|NCT03799627|615701695|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
170373169|NCT03799627|615701696|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
170373170|NCT03799627|615701697|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
170373171|NCT03799627|615701698|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
170373172|NCT03799627|615701699|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
170373173|NCT03799627|615701700|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
170373174|NCT03799627|615701701|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
170373175|NCT03799627|615701702|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
170373176|NCT03799627|615701694|FG000|Overall Study|Changes In Hemoglobin Values|1|||
170373177|NCT03799627|615701695|FG001|Overall Study|Changes In Hemoglobin Values|2|||
170373178|NCT03799627|615701696|FG002|Overall Study|Changes In Hemoglobin Values|1|||
170373179|NCT03799627|615701697|FG003|Overall Study|Changes In Hemoglobin Values|0|||
170373180|NCT03799627|615701698|FG004|Overall Study|Changes In Hemoglobin Values|0|||
170373181|NCT03799627|615701699|FG005|Overall Study|Changes In Hemoglobin Values|2|||
170373182|NCT03799627|615701700|FG006|Overall Study|Changes In Hemoglobin Values|1|||
170373183|NCT03799627|615701701|FG007|Overall Study|Changes In Hemoglobin Values|0|||
170373184|NCT03799627|615701702|FG008|Overall Study|Changes In Hemoglobin Values|1|||
170373185|NCT00422240|615701708|FG000|Overall Study|Lack of Efficacy|1|||
170373186|NCT00422240|615701709|FG001|Overall Study|Lack of Efficacy|2|||
170373187|NCT00422240|615701710|FG002|Overall Study|Lack of Efficacy|0|||
170373188|NCT00422240|615701711|FG003|Overall Study|Lack of Efficacy|1|||
170373189|NCT00422240|615701708|FG000|Overall Study|Adverse Event|11|||
170373190|NCT00422240|615701709|FG001|Overall Study|Adverse Event|4|||
170373191|NCT00422240|615701710|FG002|Overall Study|Adverse Event|5|||
170373192|NCT00422240|615701711|FG003|Overall Study|Adverse Event|2|||
170373193|NCT00422240|615701708|FG000|Overall Study|Subject request|21|||
170373194|NCT00422240|615701709|FG001|Overall Study|Subject request|17|||
170373195|NCT00422240|615701710|FG002|Overall Study|Subject request|18|||
170373196|NCT00422240|615701711|FG003|Overall Study|Subject request|30|||
170373197|NCT00422240|615701708|FG000|Overall Study|Protocol Violation|0|||
170373198|NCT00422240|615701709|FG001|Overall Study|Protocol Violation|1|||
170373199|NCT00422240|615701710|FG002|Overall Study|Protocol Violation|0|||
170373200|NCT00422240|615701711|FG003|Overall Study|Protocol Violation|1|||
170373201|NCT00422240|615701708|FG000|Overall Study|Lost to Follow-up|31|||
170373202|NCT00422240|615701709|FG001|Overall Study|Lost to Follow-up|32|||
170373203|NCT00422240|615701710|FG002|Overall Study|Lost to Follow-up|19|||
170373204|NCT00422240|615701711|FG003|Overall Study|Lost to Follow-up|34|||
170373205|NCT00422240|615701708|FG000|Overall Study|Other|1|||
170373206|NCT00422240|615701709|FG001|Overall Study|Other|0|||
170373207|NCT00422240|615701710|FG002|Overall Study|Other|0|||
170373208|NCT00422240|615701711|FG003|Overall Study|Other|1|||
170373209|NCT00422240|615701708|FG000|Overall Study|Pregnancy|3|||
170373210|NCT00422240|615701709|FG001|Overall Study|Pregnancy|1|||
170373211|NCT00422240|615701710|FG002|Overall Study|Pregnancy|1|||
170373212|NCT00422240|615701711|FG003|Overall Study|Pregnancy|2|||
170373213|NCT03209362|615701712|FG000|Overall Study|Adverse Event|0|||
170373214|NCT03209362|615701713|FG001|Overall Study|Adverse Event|1|||
170373215|NCT03209362|615701712|FG000|Overall Study|Lost to Follow-up|0|||
170373216|NCT03209362|615701713|FG001|Overall Study|Lost to Follow-up|1|||
170373217|NCT03209362|615701712|FG000|Overall Study|Withdrawal by Subject|2|||
170373218|NCT03209362|615701713|FG001|Overall Study|Withdrawal by Subject|0|||
170373219|NCT03209362|615701712|FG000|Overall Study|Other|0|||
170373220|NCT03209362|615701713|FG001|Overall Study|Other|1|||
170373221|NCT01938391|615703450|FG000|6 Month Follow up|Withdrawal by Subject|1|||
170373222|NCT01938391|615703450|FG000|12 Month Follow up|Physician Decision|1|||
170373223|NCT01938391|615703450|FG000|12 Month Follow up|Withdrawal by Subject|1|||
170373224|NCT01077193|615703451|FG000|Overall Study|Lost to Follow-up|1|||
170373225|NCT01077193|615703451|FG000|Overall Study|Withdrawal by Subject|2|||
170373226|NCT01077193|615703451|FG000|Overall Study|Lack of Efficacy|1|||
170373227|NCT01077193|615703451|FG000|Overall Study|Study Terminated by Sponsor|40|||
170373228|NCT04924114|615703456|FG000|Overall Study|Withdrawal by Subject|0|||
170373229|NCT04924114|615703457|FG001|Overall Study|Withdrawal by Subject|2|||
170373230|NCT04924114|615703458|FG002|Overall Study|Withdrawal by Subject|2|||
170373231|NCT04924114|615703459|FG003|Overall Study|Withdrawal by Subject|0|||
170373232|NCT04924114|615703460|FG004|Overall Study|Withdrawal by Subject|2|||
170373233|NCT05298774|615703461|FG000|Overall Study|Physician Decision|3|||
170373234|NCT05298774|615703461|FG000|Overall Study|Withdrawal by Subject|2|||
170373235|NCT05298774|615703461|FG000|Overall Study|Lost to Follow-up|3|||
170373236|NCT05298774|615703461|FG000|Overall Study|Screen failure|1|||
170373237|NCT04992507|615703462|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
170373238|NCT04992507|615703463|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
170373239|NCT04992507|615703462|FG000|Overall Study|Death|0|||
170373240|NCT04992507|615703463|FG001|Overall Study|Death|1|||
170373241|NCT01678313|615703464|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
170373242|NCT01678313|615703465|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
170373243|NCT01678313|615703464|FG000|Completed the 3-month Therapy|Physician Decision|3|||
170373244|NCT01678313|615703465|FG001|Completed the 3-month Therapy|Physician Decision|4|||
170373245|NCT01678313|615703464|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
170373246|NCT01678313|615703465|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
170373247|NCT01678313|615703464|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
170373248|NCT01678313|615703465|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
170373249|NCT03287830|615703470|FG000|Overall Study|Withdrawal by Subject|1|||
170373250|NCT03287830|615703471|FG001|Overall Study|Withdrawal by Subject|1|||
170373251|NCT03287830|615703470|FG000|Overall Study|not meeting inclusion criteria|5|||
170373252|NCT03287830|615703471|FG001|Overall Study|not meeting inclusion criteria|12|||
170373253|NCT05505734|615703472|FG000|Overall Study|Withdrawal by Subject|51|||
170373254|NCT05505734|615703473|FG001|Overall Study|Withdrawal by Subject|64|||
170373255|NCT05505734|615703472|FG000|Overall Study|Adverse Event|6|||
170373256|NCT05505734|615703473|FG001|Overall Study|Adverse Event|20|||
170373257|NCT05505734|615703472|FG000|Overall Study|Protocol Violation|8|||
170373258|NCT05505734|615703473|FG001|Overall Study|Protocol Violation|15|||
170373259|NCT05505734|615703472|FG000|Overall Study|Lack of therapeutic response|0|||
170373260|NCT05505734|615703473|FG001|Overall Study|Lack of therapeutic response|1|||
170373261|NCT05505734|615703472|FG000|Overall Study|Lost to Follow-up|247|||
170373262|NCT05505734|615703473|FG001|Overall Study|Lost to Follow-up|237|||
170373263|NCT05505734|615703472|FG000|Overall Study|Physician Decision|22|||
170373264|NCT05505734|615703473|FG001|Overall Study|Physician Decision|13|||
170373265|NCT05505734|615703472|FG000|Overall Study|Death|2|||
170373266|NCT05505734|615703473|FG001|Overall Study|Death|1|||
170373267|NCT05505734|615703472|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170373268|NCT05505734|615703473|FG001|Overall Study|Withdrawal by parent/guardian|1|||
170373269|NCT05505734|615703472|FG000|Overall Study|Pregnancy|1|||
170373270|NCT05505734|615703473|FG001|Overall Study|Pregnancy|0|||
170373271|NCT05505734|615703472|FG000|Overall Study|Other|17|||
170373272|NCT05505734|615703473|FG001|Overall Study|Other|13|||
170373273|NCT03598140|615703474|FG000|Overall Study|enrolled but didn't start|1|||
170373274|NCT03598140|615703475|FG001|Overall Study|enrolled but didn't start|0|||
170373275|NCT02782104|615703479|FG000|Overall Study|Other|215|||
170373276|NCT02782104|615703479|FG000|Overall Study|Induction Day 28 Non Responder|9|||
170373277|NCT02782104|615703479|FG000|Overall Study|Non-Compliance with Study Drug|2|||
170373278|NCT02782104|615703479|FG000|Overall Study|Death|8|||
170373279|NCT02782104|615703479|FG000|Overall Study|Pregnancy|6|||
170373280|NCT02782104|615703479|FG000|Overall Study|Withdrawal by Subject|63|||
170373281|NCT02782104|615703479|FG000|Overall Study|Protocol Violation|7|||
170373282|NCT02782104|615703479|FG000|Overall Study|Lack of Efficacy|61|||
170373283|NCT02782104|615703479|FG000|Overall Study|Lost to Follow-up|23|||
170373284|NCT02782104|615703479|FG000|Overall Study|Adverse Event|74|||
170373285|NCT03464136|615703480|FG000|Overall Study|Lost to Follow-up|5|||
170373286|NCT03464136|615703481|FG001|Overall Study|Lost to Follow-up|8|||
170373287|NCT03464136|615703480|FG000|Overall Study|Withdrawal by Subject|16|||
170373288|NCT03464136|615703481|FG001|Overall Study|Withdrawal by Subject|13|||
170373289|NCT03464136|615703480|FG000|Overall Study|Death|1|||
170373290|NCT03464136|615703481|FG001|Overall Study|Death|0|||
170373291|NCT03464136|615703480|FG000|Overall Study|Other|8|||
170373292|NCT03464136|615703481|FG001|Overall Study|Other|4|||
170373293|NCT03277105|615703482|FG000|Overall Study|Death|129|||
170373294|NCT03277105|615703483|FG001|Overall Study|Death|124|||
170373295|NCT03277105|615703482|FG000|Overall Study|Lost to Follow-up|2|||
170373296|NCT03277105|615703483|FG001|Overall Study|Lost to Follow-up|4|||
170373297|NCT03277105|615703482|FG000|Overall Study|Withdrawal by Subject|10|||
170373298|NCT03277105|615703483|FG001|Overall Study|Withdrawal by Subject|10|||
170373299|NCT03277105|615703482|FG000|Overall Study|Other|118|||
170373300|NCT03277105|615703483|FG001|Overall Study|Other|125|||
170373301|NCT02060903|615703485|FG000|Overall Study|Lost to Follow-up|4|||
170373302|NCT02060903|615703486|FG001|Overall Study|Lost to Follow-up|0|||
170373303|NCT02060903|615703485|FG000|Overall Study|Withdrawal by Subject|0|||
170373304|NCT02060903|615703486|FG001|Overall Study|Withdrawal by Subject|7|||
170373305|NCT01426009|615703488|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
170373306|NCT01426009|615703488|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
170373307|NCT01426009|615703488|FG000|Washout 1|Withdrawal by Subject|1|||
170373308|NCT01426009|615703488|FG000|Washout 1|Personal Reasons|1|||
170373309|NCT01426009|615703488|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
170373310|NCT01426009|615703488|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
170373311|NCT01426009|615703488|FG000|Washout 2|electrive surgery|1|||
170373312|NCT01426009|615703488|FG000|Washout 3|personal reasons|1|||
170373313|NCT01426009|615703488|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
170373314|NCT01426009|615703488|FG000|Washout 4|Lost to Follow-up|1|||
170373315|NCT01024920|615703491|FG000|Overall Study|Progressive disease|47|||
170373316|NCT01024920|615703492|FG001|Overall Study|Progressive disease|25|||
170373317|NCT01024920|615703491|FG000|Overall Study|Adverse Event|8|||
170373318|NCT01024920|615703492|FG001|Overall Study|Adverse Event|4|||
170373319|NCT01024920|615703491|FG000|Overall Study|Lost to Follow-up|0|||
170373320|NCT01024920|615703492|FG001|Overall Study|Lost to Follow-up|1|||
170373321|NCT01024920|615703491|FG000|Overall Study|Patient refusal to continue|4|||
170373322|NCT01024920|615703492|FG001|Overall Study|Patient refusal to continue|0|||
170373323|NCT01024920|615703491|FG000|Overall Study|Other than listed|5|||
170373324|NCT01024920|615703492|FG001|Overall Study|Other than listed|1|||
170373325|NCT01024920|615703491|FG000|Overall Study|Not treated|3|||
170373326|NCT01024920|615703492|FG001|Overall Study|Not treated|0|||
170373327|NCT01024920|615703491|FG000|Overall Study|Protocol Violation|0|||
170373328|NCT01024920|615703492|FG001|Overall Study|Protocol Violation|1|||
170373329|NCT00557323|615703493|FG000|Overall Study|Death|3|||
170373330|NCT00557323|615703493|FG000|Overall Study|Withdrawal by Subject|2|||
170373331|NCT00557323|615703493|FG000|Overall Study|Administrative change|2|||
170373332|NCT00498368|615703494|FG000|Overall Study|Withdrawal by Subject|3|||
170373333|NCT00498368|615703495|FG001|Overall Study|Withdrawal by Subject|2|||
170373334|NCT02465489|615703496|FG000|Overall Study|Adverse Event|5|||
170373335|NCT00285649|615703497|FG000|Overall Study|Lost to Follow-up|6|||
170373336|NCT00285649|615703498|FG001|Overall Study|Lost to Follow-up|4|||
170373337|NCT00285649|615703499|FG002|Overall Study|Lost to Follow-up|4|||
170373338|NCT00285649|615703497|FG000|Overall Study|Withdrawal by Subject|3|||
170373339|NCT00285649|615703498|FG001|Overall Study|Withdrawal by Subject|2|||
170373340|NCT00285649|615703499|FG002|Overall Study|Withdrawal by Subject|2|||
170373341|NCT01855425|615703504|FG000|Overall Study|Physician Decision|20|||
170373342|NCT00118040|615703508|FG000|Overall Study|Adverse Event|0|||
170373343|NCT00118040|615703509|FG001|Overall Study|Adverse Event|1|||
170373344|NCT00118040|615703510|FG002|Overall Study|Adverse Event|0|||
170373345|NCT00118040|615703508|FG000|Overall Study|Withdrawal by Subject|0|||
170373346|NCT00118040|615703509|FG001|Overall Study|Withdrawal by Subject|0|||
170373347|NCT00118040|615703510|FG002|Overall Study|Withdrawal by Subject|2|||
170373348|NCT00118040|615703508|FG000|Overall Study|Medical Contraindication|0|||
170373349|NCT00118040|615703509|FG001|Overall Study|Medical Contraindication|0|||
170373350|NCT00118040|615703510|FG002|Overall Study|Medical Contraindication|1|||
170373351|NCT00118040|615703508|FG000|Overall Study|Non-Compliant Participant|1|||
170373352|NCT00118040|615703509|FG001|Overall Study|Non-Compliant Participant|1|||
170373353|NCT00118040|615703510|FG002|Overall Study|Non-Compliant Participant|2|||
170373354|NCT00118040|615703508|FG000|Overall Study|Other|0|||
170373355|NCT00118040|615703509|FG001|Overall Study|Other|0|||
170373356|NCT00118040|615703510|FG002|Overall Study|Other|1|||
170373357|NCT03733249|615703511|FG000|Overall Study|Death|7|||
170373358|NCT03733249|615703511|FG000|Overall Study|Disease relapse|16|||
170373359|NCT03733249|615703511|FG000|Overall Study|Lost to Follow-up|4|||
170373360|NCT03733249|615703511|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
170373361|NCT03733249|615703511|FG000|Overall Study|Withdrawal by Subject|1|||
170373362|NCT04476108|615703512|FG000|Overall Study|Adverse Event|4|||
170373363|NCT04476108|615703513|FG001|Overall Study|Adverse Event|1|||
170373364|NCT04476108|615703512|FG000|Overall Study|Lost to Follow-up|1|||
170373365|NCT04476108|615703513|FG001|Overall Study|Lost to Follow-up|0|||
170373366|NCT04476108|615703512|FG000|Overall Study|Inadvertent Enrollment|1|||
170373367|NCT04476108|615703513|FG001|Overall Study|Inadvertent Enrollment|0|||
170373368|NCT04476108|615703512|FG000|Overall Study|Protocol Violation|1|||
170373369|NCT04476108|615703513|FG001|Overall Study|Protocol Violation|1|||
170373370|NCT04476108|615703512|FG000|Overall Study|Withdrawal by Subject|1|||
170373371|NCT04476108|615703513|FG001|Overall Study|Withdrawal by Subject|1|||
170373372|NCT00850135|615703514|FG000|Overall Study|Physician Decision|1|||
170373373|NCT02253992|615703515|FG000|Overall Study|Study drug toxicity|1|||
170373374|NCT02253992|615703516|FG001|Overall Study|Study drug toxicity|0|||
170373375|NCT02253992|615703517|FG002|Overall Study|Study drug toxicity|10|||
170373376|NCT02253992|615703515|FG000|Overall Study|Disease progression|4|||
170373377|NCT02253992|615703516|FG001|Overall Study|Disease progression|3|||
170373378|NCT02253992|615703517|FG002|Overall Study|Disease progression|98|||
170373379|NCT02253992|615703515|FG000|Overall Study|Withdrawal by Subject|0|||
170373380|NCT02253992|615703516|FG001|Overall Study|Withdrawal by Subject|0|||
170373381|NCT02253992|615703517|FG002|Overall Study|Withdrawal by Subject|3|||
170373382|NCT02253992|615703515|FG000|Overall Study|Adverse Event|0|||
170373383|NCT02253992|615703516|FG001|Overall Study|Adverse Event|0|||
170373384|NCT02253992|615703517|FG002|Overall Study|Adverse Event|8|||
170373385|NCT02253992|615703515|FG000|Overall Study|Death|0|||
170373386|NCT02253992|615703516|FG001|Overall Study|Death|0|||
170373387|NCT02253992|615703517|FG002|Overall Study|Death|1|||
170373388|NCT02253992|615703515|FG000|Overall Study|Subject discontinued study drug|1|||
170373389|NCT02253992|615703516|FG001|Overall Study|Subject discontinued study drug|0|||
170373390|NCT02253992|615703517|FG002|Overall Study|Subject discontinued study drug|1|||
170373391|NCT02253992|615703515|FG000|Overall Study|Completed treatment as per protocol|0|||
170373392|NCT02253992|615703516|FG001|Overall Study|Completed treatment as per protocol|1|||
170373393|NCT02253992|615703517|FG002|Overall Study|Completed treatment as per protocol|22|||
170373394|NCT02253992|615703515|FG000|Overall Study|Other|0|||
170373395|NCT02253992|615703516|FG001|Overall Study|Other|0|||
170373396|NCT02253992|615703517|FG002|Overall Study|Other|1|||
170373397|NCT03083470|615703519|FG000|Overall Study|Lost to Follow-up|0|||
170373398|NCT03083470|615703520|FG001|Overall Study|Lost to Follow-up|0|||
170373399|NCT03083470|615703521|FG002|Overall Study|Lost to Follow-up|0|||
170373400|NCT03083470|615703522|FG003|Overall Study|Lost to Follow-up|0|||
170373401|NCT03083470|615703523|FG004|Overall Study|Lost to Follow-up|1|||
170373402|NCT03083470|615703519|FG000|Overall Study|Withdrawal by Subject|0|||
170373403|NCT03083470|615703520|FG001|Overall Study|Withdrawal by Subject|0|||
170373404|NCT03083470|615703521|FG002|Overall Study|Withdrawal by Subject|0|||
170373405|NCT03083470|615703522|FG003|Overall Study|Withdrawal by Subject|0|||
170373406|NCT03083470|615703523|FG004|Overall Study|Withdrawal by Subject|1|||
170373407|NCT01448707|615703529|FG000|Overall Study|Adverse Event|3|||
170373408|NCT01448707|615703530|FG001|Overall Study|Adverse Event|1|||
170373409|NCT01448707|615703529|FG000|Overall Study|Lost to Follow-up|2|||
170373410|NCT01448707|615703530|FG001|Overall Study|Lost to Follow-up|6|||
170373411|NCT01448707|615703529|FG000|Overall Study|Withdrawal by Subject|6|||
170373412|NCT01448707|615703530|FG001|Overall Study|Withdrawal by Subject|7|||
170373413|NCT01448707|615703529|FG000|Overall Study|Other|7|||
170373414|NCT01448707|615703530|FG001|Overall Study|Other|4|||
170373415|NCT00333970|615703532|FG000|Overall Study|Withdrawal by Subject|13|||
170373416|NCT00333970|615703533|FG001|Overall Study|Withdrawal by Subject|7|||
170373417|NCT02699125|615703534|FG000|Placebo|Lost to Follow-up|2|||
170373418|NCT02699125|615703535|FG001|Placebo|Lost to Follow-up|0|||
170373419|NCT02699125|615703534|FG000|Placebo|Protocol Violation|1|||
170373420|NCT02699125|615703535|FG001|Placebo|Protocol Violation|0|||
170373421|NCT02699125|615703534|FG000|Placebo|Withdrawal by Subject|0|||
170373422|NCT02699125|615703535|FG001|Placebo|Withdrawal by Subject|4|||
170373423|NCT02699125|615703534|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
170373424|NCT02699125|615703535|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
170373425|NCT03418376|615703536|FG000|Overall Study|Musculoskeletal injury|1|||
170373426|NCT03418376|615703537|FG001|Overall Study|Musculoskeletal injury|2|||
170373427|NCT03418376|615703538|FG002|Overall Study|Musculoskeletal injury|1|||
170373428|NCT03418376|615703539|FG003|Overall Study|Musculoskeletal injury|0|||
170373429|NCT03418376|615703536|FG000|Overall Study|Personal reasons|0|||
170373430|NCT03418376|615703537|FG001|Overall Study|Personal reasons|2|||
170373431|NCT03418376|615703538|FG002|Overall Study|Personal reasons|2|||
170373432|NCT03418376|615703539|FG003|Overall Study|Personal reasons|1|||
170373433|NCT03418376|615703536|FG000|Overall Study|Exacerbation|0|||
170373434|NCT03418376|615703537|FG001|Overall Study|Exacerbation|1|||
170373435|NCT03418376|615703538|FG002|Overall Study|Exacerbation|0|||
170373436|NCT03418376|615703539|FG003|Overall Study|Exacerbation|0|||
170373437|NCT01307046|615703547|FG000|Overall Study|Adverse Event|3|||
170373438|NCT01307046|615703548|FG001|Overall Study|Adverse Event|3|||
170373439|NCT01307046|615703547|FG000|Overall Study|Lack of Efficacy|0|||
170373440|NCT01307046|615703548|FG001|Overall Study|Lack of Efficacy|2|||
170373441|NCT01307046|615703547|FG000|Overall Study|Physician Decision|2|||
170373442|NCT01307046|615703548|FG001|Overall Study|Physician Decision|0|||
170373443|NCT01307046|615703547|FG000|Overall Study|Withdrawal by Subject|1|||
170373444|NCT01307046|615703548|FG001|Overall Study|Withdrawal by Subject|1|||
170373445|NCT01307046|615703547|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
170373446|NCT01307046|615703548|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
170373447|NCT01307046|615703547|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
170373448|NCT01307046|615703548|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
170373449|NCT01474889|615703549|FG000|Overall Study|Physician Decision|1|||
170373450|NCT01474889|615703550|FG001|Overall Study|Physician Decision|0|||
170373451|NCT01474889|615703551|FG002|Overall Study|Physician Decision|0|||
170373452|NCT01474889|615703549|FG000|Overall Study|Did not meet inclusion|1|||
170373453|NCT01474889|615703550|FG001|Overall Study|Did not meet inclusion|0|||
170373454|NCT01474889|615703551|FG002|Overall Study|Did not meet inclusion|0|||
170373455|NCT01474889|615703549|FG000|Overall Study|Withdrawal by Subject|0|||
170373456|NCT01474889|615703550|FG001|Overall Study|Withdrawal by Subject|1|||
170373457|NCT01474889|615703551|FG002|Overall Study|Withdrawal by Subject|0|||
170373458|NCT04035473|615703553|FG000|Screening/Baseline|Death|0|||
170373459|NCT04035473|615703554|FG001|Screening/Baseline|Death|1|||
170373460|NCT04035473|615703553|FG000|Screening/Baseline|Adverse Event|0|||
170373461|NCT04035473|615703554|FG001|Screening/Baseline|Adverse Event|1|||
170373462|NCT04035473|615703553|FG000|Follow-up Period|Adverse Event|2|||
170373463|NCT04035473|615703554|FG001|Follow-up Period|Adverse Event|0|||
170373464|NCT02290340|615703555|FG000|Overall Study|Lost to Follow-up|0|||
170373465|NCT02290340|615703556|FG001|Overall Study|Lost to Follow-up|0|||
170373466|NCT02290340|615703557|FG002|Overall Study|Lost to Follow-up|0|||
170373467|NCT02290340|615703558|FG003|Overall Study|Lost to Follow-up|1|||
170373468|NCT02290340|615703555|FG000|Overall Study|Withdrawal by Subject|1|||
170373469|NCT02290340|615703556|FG001|Overall Study|Withdrawal by Subject|0|||
170373470|NCT02290340|615703557|FG002|Overall Study|Withdrawal by Subject|0|||
170373471|NCT02290340|615703558|FG003|Overall Study|Withdrawal by Subject|0|||
170373472|NCT02290340|615703555|FG000|Overall Study|Other|1|||
170373473|NCT02290340|615703556|FG001|Overall Study|Other|0|||
170373474|NCT02290340|615703557|FG002|Overall Study|Other|0|||
170373475|NCT02290340|615703558|FG003|Overall Study|Other|1|||
170373476|NCT00397891|615703559|FG000|Overall Study|Withdrawal by Subject|1|||
170373477|NCT00397891|615703560|FG001|Overall Study|Withdrawal by Subject|0|||
170373478|NCT00397891|615703561|FG002|Overall Study|Withdrawal by Subject|0|||
170373479|NCT00397891|615703562|FG003|Overall Study|Withdrawal by Subject|0|||
170373480|NCT00397891|615703563|FG004|Overall Study|Withdrawal by Subject|1|||
170373481|NCT02116361|615703566|FG000|Overall Study|Pregnancy|0|||
170373482|NCT02116361|615703567|FG001|Overall Study|Pregnancy|0|||
170373483|NCT02116361|615703568|FG002|Overall Study|Pregnancy|0|||
170373484|NCT02116361|615703569|FG003|Overall Study|Pregnancy|1|||
170373485|NCT02116361|615703566|FG000|Overall Study|Protocol Violation|1|||
170373486|NCT02116361|615703567|FG001|Overall Study|Protocol Violation|0|||
170373487|NCT02116361|615703568|FG002|Overall Study|Protocol Violation|0|||
170373488|NCT02116361|615703569|FG003|Overall Study|Protocol Violation|2|||
170373489|NCT02116361|615703566|FG000|Overall Study|Physician Decision|2|||
170373490|NCT02116361|615703567|FG001|Overall Study|Physician Decision|3|||
170373491|NCT02116361|615703568|FG002|Overall Study|Physician Decision|0|||
170373492|NCT02116361|615703569|FG003|Overall Study|Physician Decision|0|||
170373493|NCT02116361|615703566|FG000|Overall Study|Adverse Event|1|||
170373494|NCT02116361|615703567|FG001|Overall Study|Adverse Event|0|||
170373495|NCT02116361|615703568|FG002|Overall Study|Adverse Event|0|||
170373496|NCT02116361|615703569|FG003|Overall Study|Adverse Event|3|||
170373497|NCT02116361|615703566|FG000|Overall Study|Other Reasons|3|||
170373498|NCT02116361|615703567|FG001|Overall Study|Other Reasons|3|||
170373499|NCT02116361|615703568|FG002|Overall Study|Other Reasons|3|||
170373500|NCT02116361|615703569|FG003|Overall Study|Other Reasons|3|||
170373501|NCT02116361|615703566|FG000|Overall Study|Lack of Efficacy|5|||
170373502|NCT02116361|615703567|FG001|Overall Study|Lack of Efficacy|7|||
170373503|NCT02116361|615703568|FG002|Overall Study|Lack of Efficacy|4|||
170373504|NCT02116361|615703569|FG003|Overall Study|Lack of Efficacy|3|||
170373505|NCT02116361|615703566|FG000|Overall Study|Lost to Follow-up|4|||
170373506|NCT02116361|615703567|FG001|Overall Study|Lost to Follow-up|5|||
170373507|NCT02116361|615703568|FG002|Overall Study|Lost to Follow-up|7|||
170373508|NCT02116361|615703569|FG003|Overall Study|Lost to Follow-up|5|||
170373509|NCT02116361|615703566|FG000|Overall Study|Personal Reasons|6|||
170373510|NCT02116361|615703567|FG001|Overall Study|Personal Reasons|6|||
170373511|NCT02116361|615703568|FG002|Overall Study|Personal Reasons|4|||
170373512|NCT02116361|615703569|FG003|Overall Study|Personal Reasons|9|||
170373513|NCT02116361|615703566|FG000|Overall Study|Investigator Decision - Relapse|9|||
170373514|NCT02116361|615703567|FG001|Overall Study|Investigator Decision - Relapse|7|||
170373515|NCT02116361|615703568|FG002|Overall Study|Investigator Decision - Relapse|8|||
170373516|NCT02116361|615703569|FG003|Overall Study|Investigator Decision - Relapse|5|||
170373517|NCT02493868|615703570|FG000|Induction Phase: DE Participants|Adverse Event|22|||
170373518|NCT02493868|615703571|FG001|Induction Phase: DE Participants|Adverse Event|0|||
170373519|NCT02493868|615703570|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
170373520|NCT02493868|615703571|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
170373521|NCT02493868|615703570|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
170373522|NCT02493868|615703571|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
170373523|NCT02493868|615703570|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
170373524|NCT02493868|615703571|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
170373525|NCT02493868|615703570|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
170373526|NCT02493868|615703571|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
170373527|NCT02493868|615703570|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
170373528|NCT02493868|615703571|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
170373529|NCT02493868|615703570|FG000|Induction Phase: DE Participants|Other|8|||
170373530|NCT02493868|615703571|FG001|Induction Phase: DE Participants|Other|0|||
170373531|NCT02493868|615703570|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
170373532|NCT02493868|615703571|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
170373533|NCT02493868|615703570|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
170373534|NCT02493868|615703571|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
170373535|NCT02493868|615703570|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
170373536|NCT02493868|615703571|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
170373537|NCT02493868|615703570|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
170373538|NCT02493868|615703571|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
170373539|NCT02493868|615703570|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
170373540|NCT02493868|615703571|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
170373541|NCT02493868|615703570|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
170373542|NCT02493868|615703571|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
170373543|NCT02493868|615703570|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
170373544|NCT02493868|615703571|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
170373545|NCT02493868|615703570|FG000|Optimization Phase: DE+TE Participants|Other|10|||
170373546|NCT02493868|615703571|FG001|Optimization Phase: DE+TE Participants|Other|2|||
170373547|NCT02493868|615703570|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
170373548|NCT02493868|615703571|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
170373549|NCT02493868|615703570|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
170373550|NCT02493868|615703571|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
170373551|NCT02493868|615703570|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
170373552|NCT02493868|615703571|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
170373553|NCT02493868|615703570|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
170373554|NCT02493868|615703571|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
170373555|NCT02493868|615703570|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
170373556|NCT02493868|615703571|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
170373557|NCT02493868|615703570|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
170373558|NCT02493868|615703571|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
170373559|NCT02493868|615703570|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
170373560|NCT02493868|615703571|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
170373561|NCT02493868|615703570|FG000|Follow-up Phase|Lost to Follow-up|1|||
170373562|NCT02493868|615703571|FG001|Follow-up Phase|Lost to Follow-up|0|||
170373563|NCT02493868|615703570|FG000|Follow-up Phase|Withdrawal by Subject|3|||
170373564|NCT02493868|615703571|FG001|Follow-up Phase|Withdrawal by Subject|0|||
170373565|NCT02493868|615703570|FG000|Follow-up Phase|Investigator Decision|5|||
170373566|NCT02493868|615703571|FG001|Follow-up Phase|Investigator Decision|1|||
170373567|NCT02493868|615703570|FG000|Follow-up Phase|Other|2|||
170373568|NCT02493868|615703571|FG001|Follow-up Phase|Other|1|||
170373569|NCT02407236|615703572|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
170373570|NCT02407236|615703573|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
170373571|NCT02407236|615703574|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
170373572|NCT02407236|615703575|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
170373573|NCT02407236|615703576|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
170373574|NCT02407236|615703577|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
170373575|NCT02407236|615703578|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
170373576|NCT02407236|615703579|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
170373577|NCT02407236|615703580|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
170373578|NCT02407236|615703581|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
170373579|NCT02407236|615703582|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
170373580|NCT02407236|615703583|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
170373581|NCT02407236|615703584|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
170373582|NCT02407236|615703572|FG000|Induction Study (8 Weeks)|Death|0|||
170373583|NCT02407236|615703573|FG001|Induction Study (8 Weeks)|Death|0|||
170373584|NCT02407236|615703574|FG002|Induction Study (8 Weeks)|Death|1|||
170373585|NCT02407236|615703575|FG003|Induction Study (8 Weeks)|Death|0|||
170373586|NCT02407236|615703576|FG004|Induction Study (8 Weeks)|Death|0|||
170373587|NCT02407236|615703577|FG005|Induction Study (8 Weeks)|Death|0|||
170373588|NCT02407236|615703578|FG006|Induction Study (8 Weeks)|Death|0|||
170373589|NCT02407236|615703579|FG007|Induction Study (8 Weeks)|Death|0|||
170373590|NCT02407236|615703580|FG008|Induction Study (8 Weeks)|Death|0|||
170373591|NCT02407236|615703581|FG009|Induction Study (8 Weeks)|Death|0|||
170373592|NCT02407236|615703582|FG010|Induction Study (8 Weeks)|Death|0|||
170373593|NCT02407236|615703583|FG011|Induction Study (8 Weeks)|Death|0|||
170373594|NCT02407236|615703584|FG012|Induction Study (8 Weeks)|Death|0|||
170373595|NCT02407236|615703572|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
170373596|NCT02407236|615703573|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
170373597|NCT02407236|615703574|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
170373598|NCT02407236|615703575|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373599|NCT02407236|615703576|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373600|NCT02407236|615703577|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373601|NCT02407236|615703578|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373602|NCT02407236|615703579|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373603|NCT02407236|615703580|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373604|NCT02407236|615703581|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373605|NCT02407236|615703582|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373606|NCT02407236|615703583|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373607|NCT02407236|615703584|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
170373608|NCT02407236|615703572|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373609|NCT02407236|615703573|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373610|NCT02407236|615703574|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
170373611|NCT02407236|615703575|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373612|NCT02407236|615703576|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373613|NCT02407236|615703577|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373614|NCT02407236|615703578|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373615|NCT02407236|615703579|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373616|NCT02407236|615703580|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373617|NCT02407236|615703581|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373618|NCT02407236|615703582|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373619|NCT02407236|615703583|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373620|NCT02407236|615703584|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
170373621|NCT02407236|615703572|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
170373622|NCT02407236|615703573|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
170373623|NCT02407236|615703574|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
170373624|NCT02407236|615703575|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
170373625|NCT02407236|615703576|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
170373626|NCT02407236|615703577|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
170373627|NCT02407236|615703578|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
170373628|NCT02407236|615703579|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
170373629|NCT02407236|615703580|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
170373630|NCT02407236|615703581|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
170373631|NCT02407236|615703582|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
170373632|NCT02407236|615703583|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
170373633|NCT02407236|615703584|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
170373634|NCT02407236|615703572|FG000|Induction Study (8 Weeks)|Other|2|||
170373635|NCT02407236|615703573|FG001|Induction Study (8 Weeks)|Other|1|||
170373636|NCT02407236|615703574|FG002|Induction Study (8 Weeks)|Other|5|||
170373637|NCT02407236|615703575|FG003|Induction Study (8 Weeks)|Other|0|||
170373638|NCT02407236|615703576|FG004|Induction Study (8 Weeks)|Other|0|||
170373639|NCT02407236|615703577|FG005|Induction Study (8 Weeks)|Other|0|||
170373640|NCT02407236|615703578|FG006|Induction Study (8 Weeks)|Other|0|||
170373641|NCT02407236|615703579|FG007|Induction Study (8 Weeks)|Other|0|||
170373642|NCT02407236|615703580|FG008|Induction Study (8 Weeks)|Other|0|||
170373643|NCT02407236|615703581|FG009|Induction Study (8 Weeks)|Other|0|||
170373644|NCT02407236|615703582|FG010|Induction Study (8 Weeks)|Other|0|||
170373645|NCT02407236|615703583|FG011|Induction Study (8 Weeks)|Other|0|||
170373646|NCT02407236|615703584|FG012|Induction Study (8 Weeks)|Other|0|||
170373647|NCT02407236|615703572|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
170373648|NCT02407236|615703573|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
170373649|NCT02407236|615703574|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
170373650|NCT02407236|615703575|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
170373651|NCT02407236|615703576|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
170373652|NCT02407236|615703577|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
170373653|NCT02407236|615703578|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
170373654|NCT02407236|615703579|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
170373655|NCT02407236|615703580|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
170373656|NCT02407236|615703581|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
170373657|NCT02407236|615703582|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
170373658|NCT02407236|615703583|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
170373659|NCT02407236|615703584|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
170373660|NCT02407236|615703572|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
170373661|NCT02407236|615703573|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
170373662|NCT02407236|615703574|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
170373663|NCT02407236|615703575|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
170373664|NCT02407236|615703576|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
170373665|NCT02407236|615703577|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
170373666|NCT02407236|615703578|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
170373667|NCT02407236|615703579|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
170373668|NCT02407236|615703580|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
170373669|NCT02407236|615703581|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
170373670|NCT02407236|615703582|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
170373671|NCT02407236|615703583|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
170373672|NCT02407236|615703584|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
170373673|NCT02407236|615703572|FG000|Maintenance Study (44 Weeks)|Other|0|||
170373674|NCT02407236|615703573|FG001|Maintenance Study (44 Weeks)|Other|0|||
170373675|NCT02407236|615703574|FG002|Maintenance Study (44 Weeks)|Other|0|||
170373676|NCT02407236|615703575|FG003|Maintenance Study (44 Weeks)|Other|5|||
170373677|NCT02407236|615703576|FG004|Maintenance Study (44 Weeks)|Other|7|||
170373678|NCT02407236|615703577|FG005|Maintenance Study (44 Weeks)|Other|8|||
170373679|NCT02407236|615703578|FG006|Maintenance Study (44 Weeks)|Other|4|||
170373680|NCT02407236|615703579|FG007|Maintenance Study (44 Weeks)|Other|6|||
170373681|NCT02407236|615703580|FG008|Maintenance Study (44 Weeks)|Other|0|||
170373682|NCT02407236|615703581|FG009|Maintenance Study (44 Weeks)|Other|0|||
170373683|NCT02407236|615703582|FG010|Maintenance Study (44 Weeks)|Other|0|||
170373684|NCT02407236|615703583|FG011|Maintenance Study (44 Weeks)|Other|0|||
170373685|NCT02407236|615703584|FG012|Maintenance Study (44 Weeks)|Other|0|||
170373686|NCT02407236|615703572|FG000|Maintenance Study (44 Weeks)|Death|0|||
170373687|NCT02407236|615703573|FG001|Maintenance Study (44 Weeks)|Death|0|||
170373688|NCT02407236|615703574|FG002|Maintenance Study (44 Weeks)|Death|0|||
170373689|NCT02407236|615703575|FG003|Maintenance Study (44 Weeks)|Death|0|||
170373690|NCT02407236|615703576|FG004|Maintenance Study (44 Weeks)|Death|0|||
170373691|NCT02407236|615703577|FG005|Maintenance Study (44 Weeks)|Death|0|||
170373692|NCT02407236|615703578|FG006|Maintenance Study (44 Weeks)|Death|0|||
170373693|NCT02407236|615703579|FG007|Maintenance Study (44 Weeks)|Death|1|||
170373694|NCT02407236|615703580|FG008|Maintenance Study (44 Weeks)|Death|0|||
170373695|NCT02407236|615703581|FG009|Maintenance Study (44 Weeks)|Death|0|||
170373696|NCT02407236|615703582|FG010|Maintenance Study (44 Weeks)|Death|0|||
170373697|NCT02407236|615703583|FG011|Maintenance Study (44 Weeks)|Death|0|||
170373698|NCT02407236|615703584|FG012|Maintenance Study (44 Weeks)|Death|0|||
170373699|NCT02407236|615703572|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
170373700|NCT02407236|615703573|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
170373701|NCT02407236|615703574|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
170373702|NCT02407236|615703575|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
170373703|NCT02407236|615703576|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
170373704|NCT02407236|615703577|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
170373705|NCT02407236|615703578|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
170373706|NCT02407236|615703579|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
170373707|NCT02407236|615703580|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
170373708|NCT02407236|615703581|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
170373709|NCT02407236|615703582|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
170373710|NCT02407236|615703583|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
170373711|NCT02407236|615703584|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
170373712|NCT02407236|615703572|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373713|NCT02407236|615703573|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373714|NCT02407236|615703574|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373715|NCT02407236|615703575|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373716|NCT02407236|615703576|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373717|NCT02407236|615703577|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373718|NCT02407236|615703578|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373719|NCT02407236|615703579|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373720|NCT02407236|615703580|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373721|NCT02407236|615703581|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373722|NCT02407236|615703582|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
170373723|NCT02407236|615703583|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373724|NCT02407236|615703584|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
170373725|NCT02407236|615703572|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
170373726|NCT02407236|615703573|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
170373727|NCT02407236|615703574|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
170373728|NCT02407236|615703575|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
170373729|NCT02407236|615703576|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
170373730|NCT02407236|615703577|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
170373731|NCT02407236|615703578|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
170373732|NCT02407236|615703579|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
170373733|NCT02407236|615703580|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
170373734|NCT02407236|615703581|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
170373735|NCT02407236|615703582|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
170373736|NCT02407236|615703583|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
170373737|NCT02407236|615703584|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
170373738|NCT02407236|615703572|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
170373739|NCT02407236|615703573|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
170373740|NCT02407236|615703574|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
170373741|NCT02407236|615703575|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
170373742|NCT02407236|615703576|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
170373743|NCT02407236|615703577|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
170373744|NCT02407236|615703578|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
170373745|NCT02407236|615703579|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
170373746|NCT02407236|615703580|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
170373747|NCT02407236|615703581|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
170373748|NCT02407236|615703582|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
170373749|NCT02407236|615703583|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
170373750|NCT02407236|615703584|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
170373751|NCT03277794|615703589|FG000|Overall Study|Lost to Follow-up|2|||
170373752|NCT03277794|615703590|FG001|Overall Study|Lost to Follow-up|4|||
170373753|NCT03277794|615703589|FG000|Overall Study|Withdrew due to high acuity|1|||
170373754|NCT03277794|615703590|FG001|Overall Study|Withdrew due to high acuity|0|||
170373755|NCT02254304|615703596|FG000|Overall Study|Adverse Event|2|||
170373756|NCT02254304|615703597|FG001|Overall Study|Adverse Event|1|||
170373757|NCT02254304|615703596|FG000|Overall Study|Lost to Follow-up|2|||
170373758|NCT02254304|615703597|FG001|Overall Study|Lost to Follow-up|2|||
170373759|NCT02254304|615703596|FG000|Overall Study|Protocol Violation|1|||
170373760|NCT02254304|615703597|FG001|Overall Study|Protocol Violation|0|||
170373761|NCT02254304|615703596|FG000|Overall Study|Withdrawal by Subject|3|||
170373762|NCT02254304|615703597|FG001|Overall Study|Withdrawal by Subject|0|||
170373763|NCT02254304|615703596|FG000|Overall Study|Injection site pain and Injection fear|1|||
170373764|NCT02254304|615703597|FG001|Overall Study|Injection site pain and Injection fear|0|||
170373765|NCT02254304|615703596|FG000|Overall Study|Personal causes|4|||
170373766|NCT02254304|615703597|FG001|Overall Study|Personal causes|1|||
170373767|NCT02254304|615703596|FG000|Overall Study|Personal decision|1|||
170373768|NCT02254304|615703597|FG001|Overall Study|Personal decision|0|||
170373769|NCT00952419|615703598|FG000|Overall Study|Adverse Event|2|||
170373770|NCT00952419|615703599|FG001|Overall Study|Adverse Event|0|||
170373771|NCT00952419|615703600|FG002|Overall Study|Adverse Event|0|||
170373772|NCT00952419|615703598|FG000|Overall Study|Protocol Violation|3|||
170373773|NCT00952419|615703599|FG001|Overall Study|Protocol Violation|7|||
170373774|NCT00952419|615703600|FG002|Overall Study|Protocol Violation|0|||
170373775|NCT00952419|615703598|FG000|Overall Study|Withdrawal by Subject|1|||
170373776|NCT00952419|615703599|FG001|Overall Study|Withdrawal by Subject|3|||
170373777|NCT00952419|615703600|FG002|Overall Study|Withdrawal by Subject|0|||
170373778|NCT04969900|615705658|FG000|Overall Study|Physician Decision|1|||
170373779|NCT04969900|615705659|FG001|Overall Study|Physician Decision|1|||
170373780|NCT04969900|615705658|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
170373781|NCT04969900|615705659|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
170373782|NCT03261037|615705662|FG000|Overall Study|Withdrawal by Subject|2|||
170373783|NCT03261037|615705663|FG001|Overall Study|Withdrawal by Subject|13|||
170373784|NCT03261037|615705664|FG002|Overall Study|Withdrawal by Subject|0|||
170373785|NCT03261037|615705665|FG003|Overall Study|Withdrawal by Subject|18|||
170373786|NCT03261037|615705662|FG000|Overall Study|Non-compliance with study procedures|0|||
170373787|NCT03261037|615705663|FG001|Overall Study|Non-compliance with study procedures|2|||
170373788|NCT03261037|615705664|FG002|Overall Study|Non-compliance with study procedures|0|||
170373789|NCT03261037|615705665|FG003|Overall Study|Non-compliance with study procedures|6|||
170373790|NCT03261037|615705662|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
170373791|NCT03261037|615705663|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
170373792|NCT03261037|615705664|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
170398689|NCT00306852|615798247|FG001|Overall Study|Death|14|||
170373793|NCT03261037|615705665|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
170373794|NCT03261037|615705662|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
170373795|NCT03261037|615705663|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
170373796|NCT03261037|615705664|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
170373797|NCT03261037|615705665|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
170373798|NCT03261037|615705662|FG000|Overall Study|Diagnosed but protocol deviation|1|||
170373799|NCT03261037|615705663|FG001|Overall Study|Diagnosed but protocol deviation|0|||
170373800|NCT03261037|615705664|FG002|Overall Study|Diagnosed but protocol deviation|0|||
170373801|NCT03261037|615705665|FG003|Overall Study|Diagnosed but protocol deviation|0|||
170373802|NCT03261037|615705662|FG000|Overall Study|Participant did not want to continue the study|0|||
170373803|NCT03261037|615705663|FG001|Overall Study|Participant did not want to continue the study|1|||
170373804|NCT03261037|615705664|FG002|Overall Study|Participant did not want to continue the study|0|||
170373805|NCT03261037|615705665|FG003|Overall Study|Participant did not want to continue the study|0|||
170373806|NCT03261037|615705662|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
170373807|NCT03261037|615705663|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
170373808|NCT03261037|615705664|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
170373809|NCT03261037|615705665|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
170373810|NCT03261037|615705662|FG000|Overall Study|Participant presented clinical improvement|0|||
170373811|NCT03261037|615705663|FG001|Overall Study|Participant presented clinical improvement|2|||
170373812|NCT03261037|615705664|FG002|Overall Study|Participant presented clinical improvement|0|||
170373813|NCT03261037|615705665|FG003|Overall Study|Participant presented clinical improvement|0|||
170373814|NCT03261037|615705662|FG000|Overall Study|Technical difficulties|0|||
170373815|NCT03261037|615705663|FG001|Overall Study|Technical difficulties|0|||
170373816|NCT03261037|615705664|FG002|Overall Study|Technical difficulties|0|||
170373817|NCT03261037|615705665|FG003|Overall Study|Technical difficulties|1|||
170373818|NCT03261037|615705662|FG000|Overall Study|Equipment failed to work|0|||
170373819|NCT03261037|615705663|FG001|Overall Study|Equipment failed to work|0|||
170373820|NCT03261037|615705664|FG002|Overall Study|Equipment failed to work|0|||
170373821|NCT03261037|615705665|FG003|Overall Study|Equipment failed to work|1|||
170373822|NCT03261037|615705662|FG000|Overall Study|End of study for participant and no follow up|0|||
170373823|NCT03261037|615705663|FG001|Overall Study|End of study for participant and no follow up|0|||
170373824|NCT03261037|615705664|FG002|Overall Study|End of study for participant and no follow up|0|||
170373825|NCT03261037|615705665|FG003|Overall Study|End of study for participant and no follow up|1|||
170373826|NCT03261037|615705662|FG000|Overall Study|Participant was too weak to continue in study|1|||
170373827|NCT03261037|615705663|FG001|Overall Study|Participant was too weak to continue in study|0|||
170373828|NCT03261037|615705664|FG002|Overall Study|Participant was too weak to continue in study|0|||
170373829|NCT03261037|615705665|FG003|Overall Study|Participant was too weak to continue in study|0|||
170373830|NCT04423718|615705666|FG000|Main Study|Adverse Event|9|||
170373831|NCT04423718|615705667|FG001|Main Study|Adverse Event|5|||
170373832|NCT04423718|615705668|FG002|Main Study|Adverse Event|8|||
170373833|NCT04423718|615705666|FG000|Main Study|Physician Decision|3|||
170373834|NCT04423718|615705667|FG001|Main Study|Physician Decision|3|||
170373835|NCT04423718|615705668|FG002|Main Study|Physician Decision|2|||
170373836|NCT04423718|615705666|FG000|Main Study|Protocol Violation|0|||
170373837|NCT04423718|615705667|FG001|Main Study|Protocol Violation|0|||
170373838|NCT04423718|615705668|FG002|Main Study|Protocol Violation|1|||
170373839|NCT04423718|615705666|FG000|Main Study|Lost to Follow-up|3|||
170373840|NCT04423718|615705667|FG001|Main Study|Lost to Follow-up|3|||
170373841|NCT04423718|615705668|FG002|Main Study|Lost to Follow-up|4|||
170373842|NCT04423718|615705666|FG000|Main Study|Lack of Efficacy|2|||
170373843|NCT04423718|615705667|FG001|Main Study|Lack of Efficacy|1|||
170373844|NCT04423718|615705668|FG002|Main Study|Lack of Efficacy|0|||
170373845|NCT04423718|615705666|FG000|Main Study|Withdrawal by Subject|14|||
170373846|NCT04423718|615705667|FG001|Main Study|Withdrawal by Subject|20|||
170373847|NCT04423718|615705668|FG002|Main Study|Withdrawal by Subject|20|||
170373848|NCT04423718|615705666|FG000|Main Study|Death|10|||
170373849|NCT04423718|615705667|FG001|Main Study|Death|7|||
170373850|NCT04423718|615705668|FG002|Main Study|Death|7|||
170373851|NCT04423718|615705666|FG000|Main Study|COVID-19 pandemic|2|||
170373852|NCT04423718|615705667|FG001|Main Study|COVID-19 pandemic|2|||
170373853|NCT04423718|615705668|FG002|Main Study|COVID-19 pandemic|2|||
170373854|NCT04423718|615705666|FG000|Main Study|Other|7|||
170373855|NCT04423718|615705667|FG001|Main Study|Other|3|||
170373856|NCT04423718|615705668|FG002|Main Study|Other|2|||
170373857|NCT04423718|615705666|FG000|Extension Phase|Other|1|||
170373858|NCT04423718|615705667|FG001|Extension Phase|Other|0|||
170373859|NCT04423718|615705668|FG002|Extension Phase|Other|0|||
170373860|NCT04423718|615705666|FG000|Extension Phase|Logistical problems|0|||
170373861|NCT04423718|615705667|FG001|Extension Phase|Logistical problems|1|||
170373862|NCT04423718|615705668|FG002|Extension Phase|Logistical problems|1|||
170373863|NCT04423718|615705666|FG000|Extension Phase|Physician Decision|1|||
170373864|NCT04423718|615705667|FG001|Extension Phase|Physician Decision|0|||
170373865|NCT04423718|615705668|FG002|Extension Phase|Physician Decision|1|||
170373866|NCT04423718|615705666|FG000|Extension Phase|Lack of Efficacy|2|||
170373867|NCT04423718|615705667|FG001|Extension Phase|Lack of Efficacy|0|||
170373868|NCT04423718|615705668|FG002|Extension Phase|Lack of Efficacy|1|||
170373869|NCT04423718|615705666|FG000|Extension Phase|Lost to Follow-up|0|||
170373870|NCT04423718|615705667|FG001|Extension Phase|Lost to Follow-up|2|||
170373871|NCT04423718|615705668|FG002|Extension Phase|Lost to Follow-up|3|||
170373872|NCT04423718|615705666|FG000|Extension Phase|Adverse Event|2|||
170373873|NCT04423718|615705667|FG001|Extension Phase|Adverse Event|3|||
170373874|NCT04423718|615705668|FG002|Extension Phase|Adverse Event|1|||
170373875|NCT04423718|615705666|FG000|Extension Phase|Death|4|||
170373876|NCT04423718|615705667|FG001|Extension Phase|Death|7|||
170373877|NCT04423718|615705668|FG002|Extension Phase|Death|2|||
170373878|NCT04423718|615705666|FG000|Extension Phase|Withdrawal by Subject|11|||
170373879|NCT04423718|615705667|FG001|Extension Phase|Withdrawal by Subject|11|||
170373880|NCT04423718|615705668|FG002|Extension Phase|Withdrawal by Subject|7|||
170373881|NCT02623699|615705670|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373882|NCT02623699|615705671|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
170373883|NCT02623699|615705672|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373884|NCT02623699|615705673|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373885|NCT02623699|615705674|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373886|NCT02623699|615705675|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373887|NCT02623699|615705676|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373888|NCT02623699|615705677|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373889|NCT02623699|615705678|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373890|NCT02623699|615705679|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373891|NCT02623699|615705680|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373892|NCT02623699|615705681|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
170373893|NCT02623699|615705670|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373894|NCT02623699|615705671|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373895|NCT02623699|615705672|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373896|NCT02623699|615705673|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373897|NCT02623699|615705674|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373898|NCT02623699|615705675|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373899|NCT02623699|615705676|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
170373900|NCT02623699|615705677|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373901|NCT02623699|615705678|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373902|NCT02623699|615705679|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373903|NCT02623699|615705680|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373904|NCT02623699|615705681|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
170373905|NCT02623699|615705670|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373906|NCT02623699|615705671|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373907|NCT02623699|615705672|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373908|NCT02623699|615705673|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373909|NCT02623699|615705674|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373910|NCT02623699|615705675|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
170373911|NCT02623699|615705676|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373912|NCT02623699|615705677|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373913|NCT02623699|615705678|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373914|NCT02623699|615705679|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373915|NCT02623699|615705680|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373916|NCT02623699|615705681|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
170373917|NCT02623699|615705670|FG000|Part B (Up to 289 Days)|Death|0|||
170373918|NCT02623699|615705671|FG001|Part B (Up to 289 Days)|Death|0|||
170373919|NCT02623699|615705672|FG002|Part B (Up to 289 Days)|Death|0|||
170373920|NCT02623699|615705673|FG003|Part B (Up to 289 Days)|Death|0|||
170373921|NCT02623699|615705674|FG004|Part B (Up to 289 Days)|Death|0|||
170373922|NCT02623699|615705675|FG005|Part B (Up to 289 Days)|Death|1|||
170373923|NCT02623699|615705676|FG006|Part B (Up to 289 Days)|Death|1|||
170373924|NCT02623699|615705677|FG007|Part B (Up to 289 Days)|Death|0|||
170373925|NCT02623699|615705678|FG008|Part B (Up to 289 Days)|Death|1|||
170373926|NCT02623699|615705679|FG009|Part B (Up to 289 Days)|Death|0|||
170373927|NCT02623699|615705680|FG010|Part B (Up to 289 Days)|Death|0|||
170373928|NCT02623699|615705681|FG011|Part B (Up to 289 Days)|Death|0|||
170373929|NCT02623699|615705670|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
170373930|NCT02623699|615705671|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
170373931|NCT02623699|615705672|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
170373932|NCT02623699|615705673|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
170373933|NCT02623699|615705674|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
170373934|NCT02623699|615705675|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
170373935|NCT02623699|615705676|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
170373936|NCT02623699|615705677|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
170373937|NCT02623699|615705678|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
170373938|NCT02623699|615705679|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
170373939|NCT02623699|615705680|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
170373940|NCT02623699|615705681|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
170373941|NCT02623699|615705670|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373942|NCT02623699|615705671|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373943|NCT02623699|615705672|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373944|NCT02623699|615705673|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373945|NCT02623699|615705674|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373946|NCT02623699|615705675|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373947|NCT02623699|615705676|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373948|NCT02623699|615705677|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373949|NCT02623699|615705678|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373950|NCT02623699|615705679|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
170373951|NCT02623699|615705680|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
170373952|NCT02623699|615705681|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
170373953|NCT02623699|615705670|FG000|Part C (Up to 236 Days)|Death|0|||
170373954|NCT02623699|615705671|FG001|Part C (Up to 236 Days)|Death|0|||
170373955|NCT02623699|615705672|FG002|Part C (Up to 236 Days)|Death|0|||
170373956|NCT02623699|615705673|FG003|Part C (Up to 236 Days)|Death|0|||
170373957|NCT02623699|615705674|FG004|Part C (Up to 236 Days)|Death|0|||
170373958|NCT02623699|615705675|FG005|Part C (Up to 236 Days)|Death|0|||
170373959|NCT02623699|615705676|FG006|Part C (Up to 236 Days)|Death|0|||
170373960|NCT02623699|615705677|FG007|Part C (Up to 236 Days)|Death|0|||
170373961|NCT02623699|615705678|FG008|Part C (Up to 236 Days)|Death|0|||
170373962|NCT02623699|615705679|FG009|Part C (Up to 236 Days)|Death|0|||
170373963|NCT02623699|615705680|FG010|Part C (Up to 236 Days)|Death|0|||
170373964|NCT02623699|615705681|FG011|Part C (Up to 236 Days)|Death|1|||
170373965|NCT02623699|615705670|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
170373966|NCT02623699|615705671|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
170373967|NCT02623699|615705672|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
170373968|NCT02623699|615705673|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
170373969|NCT02623699|615705674|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
170373970|NCT02623699|615705675|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
170373971|NCT02623699|615705676|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
170373972|NCT02623699|615705677|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
170373973|NCT02623699|615705678|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
170373974|NCT02623699|615705679|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
170373975|NCT02623699|615705680|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
170373976|NCT02623699|615705681|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
170373977|NCT03342404|615705682|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
170373978|NCT03342404|615705683|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
170373979|NCT03342404|615705682|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
170373980|NCT03342404|615705683|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
170373981|NCT03342404|615705682|FG000|Blinded Treatment Phase|Adverse Event|5|||
170373982|NCT03342404|615705683|FG001|Blinded Treatment Phase|Adverse Event|4|||
170373983|NCT03342404|615705682|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
170373984|NCT03342404|615705683|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
170373985|NCT03342404|615705682|FG000|Blinded Treatment Phase|Other reasons|1|||
170373986|NCT03342404|615705683|FG001|Blinded Treatment Phase|Other reasons|0|||
170373987|NCT03342404|615705682|FG000|Blinded Treatment Phase|Physician Decision|1|||
170373988|NCT03342404|615705683|FG001|Blinded Treatment Phase|Physician Decision|0|||
170373989|NCT03342404|615705682|FG000|Blinded Treatment Phase|Death|1|||
170373990|NCT03342404|615705683|FG001|Blinded Treatment Phase|Death|0|||
170373991|NCT03342404|615705682|FG000|Open-Label Phase|Lost to Follow-up|0|||
170373992|NCT03342404|615705683|FG001|Open-Label Phase|Lost to Follow-up|1|||
170373993|NCT03342404|615705682|FG000|Open-Label Phase|Other reasons|0|||
170373994|NCT03342404|615705683|FG001|Open-Label Phase|Other reasons|1|||
170373995|NCT03342404|615705682|FG000|Open-Label Phase|Adverse Event|0|||
170373996|NCT03342404|615705683|FG001|Open-Label Phase|Adverse Event|3|||
170373997|NCT03342404|615705682|FG000|Open-Label Phase|Withdrawal by Subject|0|||
170373998|NCT03342404|615705683|FG001|Open-Label Phase|Withdrawal by Subject|6|||
170373999|NCT02865928|615705687|FG000|Overall Study|Withdrawal by Subject|1|||
170374000|NCT02865928|615705688|FG001|Overall Study|Withdrawal by Subject|0|||
170374001|NCT02865928|615705687|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
170374002|NCT02865928|615705688|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
170374003|NCT02865928|615705687|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
170374004|NCT02865928|615705688|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
170374005|NCT00471276|615705689|FG000|Overall Study|Death|2|||
170374006|NCT00471276|615705689|FG000|Overall Study|Adverse Event|16|||
170374007|NCT00471276|615705689|FG000|Overall Study|Protocol Violation|1|||
170374008|NCT00471276|615705689|FG000|Overall Study|Objective progression or relapse|54|||
170374009|NCT00471276|615705689|FG000|Overall Study|Global deterioration of health status|1|||
170374010|NCT00471276|615705689|FG000|Overall Study|Other|3|||
170374011|NCT00471276|615705689|FG000|Overall Study|Refused treatment|6|||
170374012|NCT02324049|615705690|FG000|Part C|Study terminated|11|||
170374013|NCT02159365|615705691|FG000|Overall Study|Disease Progression|23|||
170374014|NCT02159365|615705691|FG000|Overall Study|Other reasons|11|||
170374015|NCT02159365|615705691|FG000|Overall Study|Administrative reason by Sponsor|9|||
170374016|NCT02159365|615705691|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
170374017|NCT02159365|615705691|FG000|Overall Study|Study drug toxicity|7|||
170374018|NCT02159365|615705691|FG000|Overall Study|Maximum clinical benefit|3|||
170374019|NCT02159365|615705691|FG000|Overall Study|Subject request to discontinue treatment|3|||
170374020|NCT02159365|615705691|FG000|Overall Study|Subject withdrew consent|3|||
170374021|NCT02159365|615705691|FG000|Overall Study|Death|1|||
170374022|NCT02159365|615705691|FG000|Overall Study|Lost to Follow-up|1|||
170374023|NCT03198728|615705692|FG000|Overall Study|Adverse Event|10|||
170374024|NCT03198728|615705693|FG001|Overall Study|Adverse Event|5|||
170374025|NCT03198728|615705692|FG000|Overall Study|Lost to Follow-up|21|||
170374026|NCT03198728|615705693|FG001|Overall Study|Lost to Follow-up|7|||
170374027|NCT03198728|615705692|FG000|Overall Study|Physician Decision|7|||
170374028|NCT03198728|615705693|FG001|Overall Study|Physician Decision|2|||
170374029|NCT03198728|615705692|FG000|Overall Study|Withdrawal by Subject|14|||
170374030|NCT03198728|615705693|FG001|Overall Study|Withdrawal by Subject|10|||
170374031|NCT02139280|615705696|FG000|Overall Study|No longer eligible|2|||
170374032|NCT02139280|615705697|FG001|Overall Study|No longer eligible|0|||
170374033|NCT00736450|615705704|FG000|Overall Study|Not ABC gene eligible|19|||
170374034|NCT00736450|615705704|FG000|Overall Study|Withdrawal by Subject|5|||
170374035|NCT00736450|615705704|FG000|Overall Study|Physician Decision|1|||
170374036|NCT04731922|615705708|FG000|Overall Study|Adverse Event|0|||
170374037|NCT04731922|615705709|FG001|Overall Study|Adverse Event|0|||
170374038|NCT04731922|615705710|FG002|Overall Study|Adverse Event|0|||
170374039|NCT04731922|615705711|FG003|Overall Study|Adverse Event|0|||
170374040|NCT04731922|615705712|FG004|Overall Study|Adverse Event|0|||
170374041|NCT04731922|615705713|FG005|Overall Study|Adverse Event|0|||
170374042|NCT04731922|615705714|FG006|Overall Study|Adverse Event|0|||
170374043|NCT04731922|615705715|FG007|Overall Study|Adverse Event|0|||
170374044|NCT04731922|615705716|FG008|Overall Study|Adverse Event|0|||
170374045|NCT04731922|615705717|FG009|Overall Study|Adverse Event|0|||
170374046|NCT04731922|615705718|FG010|Overall Study|Adverse Event|1|||
170374047|NCT04731922|615705719|FG011|Overall Study|Adverse Event|0|||
170374048|NCT04731922|615705720|FG012|Overall Study|Adverse Event|0|||
170374049|NCT04731922|615705721|FG013|Overall Study|Adverse Event|0|||
170374050|NCT04731922|615705722|FG014|Overall Study|Adverse Event|0|||
170374051|NCT04731922|615705723|FG015|Overall Study|Adverse Event|0|||
170374052|NCT04731922|615705724|FG016|Overall Study|Adverse Event|0|||
170374053|NCT04731922|615705708|FG000|Overall Study|Lost to Follow-up|0|||
170374054|NCT04731922|615705709|FG001|Overall Study|Lost to Follow-up|0|||
170374055|NCT04731922|615705710|FG002|Overall Study|Lost to Follow-up|0|||
170374056|NCT04731922|615705711|FG003|Overall Study|Lost to Follow-up|1|||
170374057|NCT04731922|615705712|FG004|Overall Study|Lost to Follow-up|0|||
170374058|NCT04731922|615705713|FG005|Overall Study|Lost to Follow-up|1|||
170374059|NCT04731922|615705714|FG006|Overall Study|Lost to Follow-up|0|||
170374060|NCT04731922|615705715|FG007|Overall Study|Lost to Follow-up|0|||
170374061|NCT04731922|615705716|FG008|Overall Study|Lost to Follow-up|0|||
170374062|NCT04731922|615705717|FG009|Overall Study|Lost to Follow-up|0|||
170374063|NCT04731922|615705718|FG010|Overall Study|Lost to Follow-up|0|||
170374064|NCT04731922|615705719|FG011|Overall Study|Lost to Follow-up|0|||
170374065|NCT04731922|615705720|FG012|Overall Study|Lost to Follow-up|0|||
170374066|NCT04731922|615705721|FG013|Overall Study|Lost to Follow-up|0|||
170374067|NCT04731922|615705722|FG014|Overall Study|Lost to Follow-up|0|||
170374068|NCT04731922|615705723|FG015|Overall Study|Lost to Follow-up|0|||
170374069|NCT04731922|615705724|FG016|Overall Study|Lost to Follow-up|0|||
170374070|NCT04731922|615705708|FG000|Overall Study|Withdrawal by Subject|1|||
170374071|NCT04731922|615705709|FG001|Overall Study|Withdrawal by Subject|0|||
170374072|NCT04731922|615705710|FG002|Overall Study|Withdrawal by Subject|0|||
170374073|NCT04731922|615705711|FG003|Overall Study|Withdrawal by Subject|0|||
170374074|NCT04731922|615705712|FG004|Overall Study|Withdrawal by Subject|1|||
170374075|NCT04731922|615705713|FG005|Overall Study|Withdrawal by Subject|0|||
170374076|NCT04731922|615705714|FG006|Overall Study|Withdrawal by Subject|1|||
170374077|NCT04731922|615705715|FG007|Overall Study|Withdrawal by Subject|0|||
170374078|NCT04731922|615705716|FG008|Overall Study|Withdrawal by Subject|0|||
170374079|NCT04731922|615705717|FG009|Overall Study|Withdrawal by Subject|0|||
170374080|NCT04731922|615705718|FG010|Overall Study|Withdrawal by Subject|0|||
170374081|NCT04731922|615705719|FG011|Overall Study|Withdrawal by Subject|0|||
170374082|NCT04731922|615705720|FG012|Overall Study|Withdrawal by Subject|0|||
170374083|NCT04731922|615705721|FG013|Overall Study|Withdrawal by Subject|1|||
170374084|NCT04731922|615705722|FG014|Overall Study|Withdrawal by Subject|0|||
170374085|NCT04731922|615705723|FG015|Overall Study|Withdrawal by Subject|0|||
170374086|NCT04731922|615705724|FG016|Overall Study|Withdrawal by Subject|0|||
170374087|NCT04731922|615705708|FG000|Overall Study|Other|0|||
170374088|NCT04731922|615705709|FG001|Overall Study|Other|0|||
170374089|NCT04731922|615705710|FG002|Overall Study|Other|0|||
170374090|NCT04731922|615705711|FG003|Overall Study|Other|0|||
170374091|NCT04731922|615705712|FG004|Overall Study|Other|0|||
170374092|NCT04731922|615705713|FG005|Overall Study|Other|0|||
170374093|NCT04731922|615705714|FG006|Overall Study|Other|1|||
170374094|NCT04731922|615705715|FG007|Overall Study|Other|0|||
170374095|NCT04731922|615705716|FG008|Overall Study|Other|0|||
170374096|NCT04731922|615705717|FG009|Overall Study|Other|0|||
170374097|NCT04731922|615705718|FG010|Overall Study|Other|0|||
170374098|NCT04731922|615705719|FG011|Overall Study|Other|0|||
170374099|NCT04731922|615705720|FG012|Overall Study|Other|0|||
170374100|NCT04731922|615705721|FG013|Overall Study|Other|0|||
170374101|NCT04731922|615705722|FG014|Overall Study|Other|0|||
170374102|NCT04731922|615705723|FG015|Overall Study|Other|0|||
170374103|NCT04731922|615705724|FG016|Overall Study|Other|0|||
170374104|NCT04157751|615705725|FG000|Overall Study|Withdrawal by Subject|12|||
170374105|NCT04157751|615705726|FG001|Overall Study|Withdrawal by Subject|17|||
170374106|NCT04157751|615705725|FG000|Overall Study|Lost to Follow-up|6|||
170374107|NCT04157751|615705726|FG001|Overall Study|Lost to Follow-up|2|||
170374108|NCT04157751|615705725|FG000|Overall Study|Adverse Event|34|||
170374109|NCT04157751|615705726|FG001|Overall Study|Adverse Event|23|||
170374110|NCT04157751|615705725|FG000|Overall Study|Not treated|1|||
170374111|NCT04157751|615705726|FG001|Overall Study|Not treated|5|||
170374112|NCT04157751|615705725|FG000|Overall Study|Other reason not stated above|10|||
170374113|NCT04157751|615705726|FG001|Overall Study|Other reason not stated above|10|||
170374114|NCT01997281|615705729|FG000|Overall Study|Withdrawal by Subject|1|||
170374115|NCT01997281|615705730|FG001|Overall Study|Withdrawal by Subject|0|||
170374116|NCT01810380|615705731|FG000|Overall Study|Randomised not treated|2|||
170374117|NCT01810380|615705732|FG001|Overall Study|Randomised not treated|1|||
170374118|NCT01810380|615705733|FG002|Overall Study|Randomised not treated|1|||
170374119|NCT01810380|615705731|FG000|Overall Study|Adverse Event|11|||
170374120|NCT01810380|615705732|FG001|Overall Study|Adverse Event|14|||
170374121|NCT01810380|615705733|FG002|Overall Study|Adverse Event|4|||
170374122|NCT01810380|615705731|FG000|Overall Study|Lack of Efficacy|24|||
170374123|NCT01810380|615705732|FG001|Overall Study|Lack of Efficacy|10|||
170374124|NCT01810380|615705733|FG002|Overall Study|Lack of Efficacy|11|||
170374125|NCT01810380|615705731|FG000|Overall Study|Protocol Violation|1|||
170374126|NCT01810380|615705732|FG001|Overall Study|Protocol Violation|0|||
170374127|NCT01810380|615705733|FG002|Overall Study|Protocol Violation|1|||
170374128|NCT01810380|615705731|FG000|Overall Study|Withdrawal by Subject|6|||
170374129|NCT01810380|615705732|FG001|Overall Study|Withdrawal by Subject|0|||
170374130|NCT01810380|615705733|FG002|Overall Study|Withdrawal by Subject|6|||
170374131|NCT01810380|615705731|FG000|Overall Study|Administrative or other reasons|11|||
170374132|NCT01810380|615705732|FG001|Overall Study|Administrative or other reasons|13|||
170374133|NCT01810380|615705733|FG002|Overall Study|Administrative or other reasons|9|||
170374134|NCT00033371|615705734|FG000|Overall Study|Adverse Event|1|||
170374135|NCT00033371|615705735|FG001|Overall Study|Adverse Event|5|||
170374136|NCT00033371|615705734|FG000|Overall Study|Lost to Follow-up|2|||
170374137|NCT00033371|615705735|FG001|Overall Study|Lost to Follow-up|1|||
170374138|NCT00033371|615705734|FG000|Overall Study|Withdrawal by Subject|3|||
170374139|NCT00033371|615705735|FG001|Overall Study|Withdrawal by Subject|3|||
170374140|NCT00033371|615705734|FG000|Overall Study|Disease Progression|0|||
170374141|NCT00033371|615705735|FG001|Overall Study|Disease Progression|1|||
170374142|NCT03148795|615705739|FG000|Overall Study|Progressive Disease|1|||
170374143|NCT01927068|615705743|FG000|Overall Study|Death|37|||
170374144|NCT01927068|615705744|FG001|Overall Study|Death|3|||
170374145|NCT01927068|615705743|FG000|Overall Study|Withdrawal by Subject|50|||
170374146|NCT01927068|615705744|FG001|Overall Study|Withdrawal by Subject|3|||
170374147|NCT01927068|615705743|FG000|Overall Study|Lost to Follow-up|10|||
170374148|NCT01927068|615705744|FG001|Overall Study|Lost to Follow-up|2|||
170374149|NCT01927068|615705743|FG000|Overall Study|Physician Decision|9|||
170374150|NCT01927068|615705744|FG001|Overall Study|Physician Decision|0|||
170374151|NCT01927068|615705743|FG000|Overall Study|Missed last follow-up visit|2|||
170374152|NCT01927068|615705744|FG001|Overall Study|Missed last follow-up visit|0|||
170374153|NCT00441012|615705745|FG000|Overall Study|Adverse Event|0|||
170374154|NCT00441012|615705746|FG001|Overall Study|Adverse Event|1|||
170374155|NCT00441012|615705745|FG000|Overall Study|Lost to Follow-up|3|||
170374156|NCT00441012|615705746|FG001|Overall Study|Lost to Follow-up|3|||
170374157|NCT00441012|615705745|FG000|Overall Study|Protocol Violation|10|||
170374158|NCT00441012|615705746|FG001|Overall Study|Protocol Violation|9|||
170374159|NCT00441012|615705745|FG000|Overall Study|Withdrawal by Subject|4|||
170374160|NCT00441012|615705746|FG001|Overall Study|Withdrawal by Subject|0|||
170374161|NCT00441012|615705745|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
170374162|NCT00441012|615705746|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
170374163|NCT04489940|615705747|FG000|Overall Study|Other|2|||
170374164|NCT04489940|615705747|FG000|Overall Study|Withdrawal by Subject|2|||
170374165|NCT04489940|615705747|FG000|Overall Study|Death|5|||
170374166|NCT04489940|615705747|FG000|Overall Study|Lost to Follow-up|1|||
170374167|NCT04498468|615705748|FG000|Overall Study|Lost to Follow-up|3|||
170374168|NCT02725268|615705749|FG000|Overall Study|Death|58|||
170374169|NCT02725268|615705750|FG001|Overall Study|Death|59|||
170374170|NCT02725268|615705751|FG002|Overall Study|Death|30|||
170374171|NCT02725268|615705752|FG003|Overall Study|Death|16|||
170374172|NCT02725268|615705749|FG000|Overall Study|Lost to Follow-up|4|||
170374173|NCT02725268|615705750|FG001|Overall Study|Lost to Follow-up|3|||
170374174|NCT02725268|615705751|FG002|Overall Study|Lost to Follow-up|0|||
170374175|NCT02725268|615705752|FG003|Overall Study|Lost to Follow-up|1|||
170374176|NCT02725268|615705749|FG000|Overall Study|Site Terminated by Sponsor|0|||
170374177|NCT02725268|615705750|FG001|Overall Study|Site Terminated by Sponsor|1|||
170374178|NCT02725268|615705751|FG002|Overall Study|Site Terminated by Sponsor|0|||
170374179|NCT02725268|615705752|FG003|Overall Study|Site Terminated by Sponsor|0|||
170374180|NCT02725268|615705749|FG000|Overall Study|Withdrawal by Subject|8|||
170374181|NCT02725268|615705750|FG001|Overall Study|Withdrawal by Subject|6|||
170374182|NCT02725268|615705751|FG002|Overall Study|Withdrawal by Subject|8|||
170374183|NCT02725268|615705752|FG003|Overall Study|Withdrawal by Subject|1|||
170374184|NCT02725268|615705749|FG000|Overall Study|Reason not Specified|2|||
170374185|NCT02725268|615705750|FG001|Overall Study|Reason not Specified|1|||
170374186|NCT02725268|615705751|FG002|Overall Study|Reason not Specified|0|||
170374187|NCT02725268|615705752|FG003|Overall Study|Reason not Specified|0|||
170374188|NCT01624467|615705753|FG000|Overall Study|Withdrawal by Subject|2|||
170374189|NCT01624467|615705753|FG000|Overall Study|Lost to Follow-up|1|||
170374190|NCT01624467|615705753|FG000|Overall Study|Adverse Event|7|||
170374191|NCT01624467|615705753|FG000|Overall Study|Progressive Disease|19|||
170374192|NCT01624467|615705753|FG000|Overall Study|Per Sponsor Requirement|1|||
170374193|NCT01624467|615705753|FG000|Overall Study|Subject Withdrew from Treatment|1|||
170374194|NCT00262314|615705754|FG000|Overall Study|Changing physicians|38|||
170374195|NCT00262314|615705754|FG000|Overall Study|Death|12|||
170374196|NCT00262314|615705754|FG000|Overall Study|Patient's decision|92|||
170374197|NCT00262314|615705754|FG000|Overall Study|Other|95|||
170374198|NCT00262314|615705754|FG000|Overall Study|Lost to Follow-up|70|||
170374199|NCT00262314|615705754|FG000|Overall Study|Administrative withdrawal|30|||
170374200|NCT03964493|615705755|FG000|Overall Study|Withdrawal by Subject|4|||
170374201|NCT03964493|615705756|FG001|Overall Study|Withdrawal by Subject|1|||
170374202|NCT03964493|615705755|FG000|Overall Study|Lost to Follow-up|13|||
170374203|NCT03964493|615705756|FG001|Overall Study|Lost to Follow-up|4|||
170374204|NCT02092324|615705757|FG000|Overall Study|Adverse Event|1|||
170374205|NCT02092324|615705757|FG000|Overall Study|Lack of Efficacy|6|||
170374206|NCT02092324|615705757|FG000|Overall Study|Proceed to Transplant|3|||
170374207|NCT02092324|615705757|FG000|Overall Study|Physician Decision|7|||
170374208|NCT02092324|615705757|FG000|Overall Study|Misdiagnosis|2|||
170374209|NCT00398138|615705758|FG000|Overall Study|Adverse Event|2|||
170374210|NCT00117572|615705761|FG000|Overall Study|Site withdrew before starting treatment|2|||
170374211|NCT00117572|615705762|FG001|Overall Study|Site withdrew before starting treatment|3|||
170374212|NCT00117572|615705761|FG000|Overall Study|Withdrawal by Subject|3|||
170374213|NCT00117572|615705762|FG001|Overall Study|Withdrawal by Subject|3|||
170374214|NCT00117572|615705761|FG000|Overall Study|Protocol Violation|1|||
170374215|NCT00117572|615705762|FG001|Overall Study|Protocol Violation|0|||
170374216|NCT02224274|615705767|FG000|Overall Study|Death|1|||
170374217|NCT02224274|615705768|FG001|Overall Study|Death|0|||
170374218|NCT00887068|615705769|FG000|Overall Study|Withdrawal by Subject|2|||
170374219|NCT00887068|615705770|FG001|Overall Study|Withdrawal by Subject|0|||
170374220|NCT00887068|615705769|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
170374221|NCT00887068|615705770|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
170374222|NCT00499460|615705771|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
170374223|NCT00499460|615705772|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
170374224|NCT00499460|615705771|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
170374225|NCT00499460|615705772|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
170374226|NCT00499460|615705771|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
170374227|NCT00499460|615705772|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
170374228|NCT00090766|615705780|FG000|Overall Study|Nephrectomy Planned|0|||
170374229|NCT00090766|615705781|FG001|Overall Study|Nephrectomy Planned|0|||
170374230|NCT00090766|615705782|FG002|Overall Study|Nephrectomy Planned|1|||
170374231|NCT00090766|615705780|FG000|Overall Study|Death|1|||
170374232|NCT00090766|615705781|FG001|Overall Study|Death|0|||
170374233|NCT00090766|615705782|FG002|Overall Study|Death|0|||
170374234|NCT00090766|615705780|FG000|Overall Study|Admin|0|||
170374235|NCT00090766|615705781|FG001|Overall Study|Admin|2|||
170374236|NCT00090766|615705782|FG002|Overall Study|Admin|0|||
170374237|NCT00090766|615705780|FG000|Overall Study|Lost to Follow-up|2|||
170374238|NCT00090766|615705781|FG001|Overall Study|Lost to Follow-up|0|||
170374239|NCT00090766|615705782|FG002|Overall Study|Lost to Follow-up|2|||
170374240|NCT00654368|615705783|FG000|Overall Study|Ineligibility determined|6|||
170374241|NCT00654368|615705784|FG001|Overall Study|Ineligibility determined|0|||
170374242|NCT00654368|615705785|FG002|Overall Study|Ineligibility determined|0|||
170374243|NCT00654368|615705783|FG000|Overall Study|Protocol deviation|3|||
170374244|NCT00654368|615705784|FG001|Overall Study|Protocol deviation|2|||
170374245|NCT00654368|615705785|FG002|Overall Study|Protocol deviation|1|||
170374246|NCT00654368|615705783|FG000|Overall Study|Non-compliance|2|||
170374247|NCT00654368|615705784|FG001|Overall Study|Non-compliance|1|||
170374248|NCT00654368|615705785|FG002|Overall Study|Non-compliance|2|||
170374249|NCT00654368|615705783|FG000|Overall Study|Withdrawal by Subject|5|||
170374250|NCT00654368|615705784|FG001|Overall Study|Withdrawal by Subject|2|||
170374251|NCT00654368|615705785|FG002|Overall Study|Withdrawal by Subject|2|||
170374252|NCT00654368|615705783|FG000|Overall Study|Disease progression|21|||
170374253|NCT00654368|615705784|FG001|Overall Study|Disease progression|31|||
170374254|NCT00654368|615705785|FG002|Overall Study|Disease progression|13|||
170374255|NCT00654368|615705783|FG000|Overall Study|Requirement for alternative therapy|1|||
170374256|NCT00654368|615705784|FG001|Overall Study|Requirement for alternative therapy|1|||
170374257|NCT00654368|615705785|FG002|Overall Study|Requirement for alternative therapy|1|||
170374258|NCT00654368|615705783|FG000|Overall Study|Physician Decision|0|||
170374259|NCT00654368|615705784|FG001|Overall Study|Physician Decision|0|||
170374260|NCT00654368|615705785|FG002|Overall Study|Physician Decision|2|||
170374261|NCT00654368|615705783|FG000|Overall Study|Death|1|||
170374262|NCT00654368|615705784|FG001|Overall Study|Death|0|||
170374263|NCT00654368|615705785|FG002|Overall Study|Death|0|||
170374264|NCT00654368|615705783|FG000|Overall Study|Pregnancy|0|||
170374265|NCT00654368|615705784|FG001|Overall Study|Pregnancy|0|||
170374266|NCT00654368|615705785|FG002|Overall Study|Pregnancy|2|||
170374267|NCT00654368|615705783|FG000|Overall Study|Other|0|||
170374268|NCT00654368|615705784|FG001|Overall Study|Other|2|||
170374269|NCT00654368|615705785|FG002|Overall Study|Other|3|||
170374270|NCT00654368|615705783|FG000|Overall Study|Adverse Event|14|||
170374271|NCT00654368|615705784|FG001|Overall Study|Adverse Event|9|||
170374272|NCT00654368|615705785|FG002|Overall Study|Adverse Event|6|||
170374273|NCT00804986|615705786|FG000|Overall Study|Adverse Event|0|||
170374274|NCT00804986|615705787|FG001|Overall Study|Adverse Event|1|||
170374275|NCT00804986|615705788|FG002|Overall Study|Adverse Event|2|||
170374276|NCT00804986|615705789|FG003|Overall Study|Adverse Event|1|||
170374277|NCT00804986|615705790|FG004|Overall Study|Adverse Event|3|||
170374278|NCT00804986|615705791|FG005|Overall Study|Adverse Event|0|||
170374279|NCT00804986|615705786|FG000|Overall Study|Lack of Efficacy|0|||
170374280|NCT00804986|615705787|FG001|Overall Study|Lack of Efficacy|0|||
170374281|NCT00804986|615705788|FG002|Overall Study|Lack of Efficacy|0|||
170374282|NCT00804986|615705789|FG003|Overall Study|Lack of Efficacy|1|||
170374283|NCT00804986|615705790|FG004|Overall Study|Lack of Efficacy|0|||
170374284|NCT00804986|615705791|FG005|Overall Study|Lack of Efficacy|3|||
170374285|NCT00804986|615705786|FG000|Overall Study|Lost to Follow-up|0|||
170374286|NCT00804986|615705787|FG001|Overall Study|Lost to Follow-up|0|||
170374287|NCT00804986|615705788|FG002|Overall Study|Lost to Follow-up|0|||
170374288|NCT00804986|615705789|FG003|Overall Study|Lost to Follow-up|1|||
170374289|NCT00804986|615705790|FG004|Overall Study|Lost to Follow-up|1|||
170374290|NCT00804986|615705791|FG005|Overall Study|Lost to Follow-up|3|||
170374291|NCT00804986|615705786|FG000|Overall Study|Protocol Violation|0|||
170374292|NCT00804986|615705787|FG001|Overall Study|Protocol Violation|1|||
170374293|NCT00804986|615705788|FG002|Overall Study|Protocol Violation|0|||
170374294|NCT00804986|615705789|FG003|Overall Study|Protocol Violation|1|||
170374295|NCT00804986|615705790|FG004|Overall Study|Protocol Violation|0|||
170374296|NCT00804986|615705791|FG005|Overall Study|Protocol Violation|0|||
170374297|NCT00804986|615705786|FG000|Overall Study|Withdrawal by Subject|0|||
170374298|NCT00804986|615705787|FG001|Overall Study|Withdrawal by Subject|3|||
170374299|NCT00804986|615705788|FG002|Overall Study|Withdrawal by Subject|0|||
170374300|NCT00804986|615705789|FG003|Overall Study|Withdrawal by Subject|3|||
170374301|NCT00804986|615705790|FG004|Overall Study|Withdrawal by Subject|5|||
170374302|NCT00804986|615705791|FG005|Overall Study|Withdrawal by Subject|3|||
170374303|NCT00804986|615705786|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
170374304|NCT00804986|615705787|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
170374305|NCT00804986|615705788|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
170374306|NCT00804986|615705789|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
170374307|NCT00804986|615705790|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
170374308|NCT00804986|615705791|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
170374309|NCT00804986|615705786|FG000|Overall Study|Sponsor Decision|0|||
170374310|NCT00804986|615705787|FG001|Overall Study|Sponsor Decision|1|||
170374311|NCT00804986|615705788|FG002|Overall Study|Sponsor Decision|0|||
170374312|NCT00804986|615705789|FG003|Overall Study|Sponsor Decision|0|||
170374313|NCT00804986|615705790|FG004|Overall Study|Sponsor Decision|0|||
170374314|NCT00804986|615705791|FG005|Overall Study|Sponsor Decision|0|||
170374315|NCT00804986|615705786|FG000|Overall Study|Physician Decision|1|||
170374316|NCT00804986|615705787|FG001|Overall Study|Physician Decision|0|||
170374317|NCT00804986|615705788|FG002|Overall Study|Physician Decision|0|||
170374318|NCT00804986|615705789|FG003|Overall Study|Physician Decision|0|||
170374319|NCT00804986|615705790|FG004|Overall Study|Physician Decision|0|||
170374320|NCT00804986|615705791|FG005|Overall Study|Physician Decision|0|||
170374321|NCT04228445|615705793|FG000|Overall Study|Lost to Follow-up|1|||
170374322|NCT04228445|615705794|FG001|Overall Study|Lost to Follow-up|1|||
170374323|NCT04228445|615705793|FG000|Overall Study|Physician Decision|1|||
170374324|NCT04228445|615705794|FG001|Overall Study|Physician Decision|2|||
170374325|NCT04228445|615705793|FG000|Overall Study|Withdrawal by Subject|0|||
170374326|NCT04228445|615705794|FG001|Overall Study|Withdrawal by Subject|1|||
170374327|NCT04228445|615705793|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
170374328|NCT04228445|615705794|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
170374329|NCT00814307|615705795|FG000|Overall Study|Randomized but not treated|1|||
170374330|NCT00814307|615705796|FG001|Overall Study|Randomized but not treated|0|||
170374331|NCT00814307|615705797|FG002|Overall Study|Randomized but not treated|0|||
170374332|NCT00814307|615705798|FG003|Overall Study|Randomized but not treated|0|||
170374333|NCT00814307|615705795|FG000|Overall Study|Adverse Event|3|||
170374334|NCT00814307|615705796|FG001|Overall Study|Adverse Event|9|||
170374335|NCT00814307|615705797|FG002|Overall Study|Adverse Event|3|||
170374336|NCT00814307|615705798|FG003|Overall Study|Adverse Event|2|||
170374337|NCT00814307|615705795|FG000|Overall Study|Lack of Efficacy|1|||
170374338|NCT00814307|615705796|FG001|Overall Study|Lack of Efficacy|1|||
170374339|NCT00814307|615705797|FG002|Overall Study|Lack of Efficacy|3|||
170374340|NCT00814307|615705798|FG003|Overall Study|Lack of Efficacy|4|||
170374341|NCT00814307|615705795|FG000|Overall Study|Other|1|||
170374342|NCT00814307|615705796|FG001|Overall Study|Other|2|||
170374343|NCT00814307|615705797|FG002|Overall Study|Other|0|||
170374344|NCT00814307|615705798|FG003|Overall Study|Other|1|||
170374345|NCT00814307|615705795|FG000|Overall Study|Protocol Violation|2|||
170374346|NCT00814307|615705796|FG001|Overall Study|Protocol Violation|8|||
170374347|NCT00814307|615705797|FG002|Overall Study|Protocol Violation|1|||
170374348|NCT00814307|615705798|FG003|Overall Study|Protocol Violation|1|||
170374349|NCT00814307|615705795|FG000|Overall Study|Withdrawal by Subject|4|||
170374350|NCT00814307|615705796|FG001|Overall Study|Withdrawal by Subject|6|||
170374351|NCT00814307|615705797|FG002|Overall Study|Withdrawal by Subject|0|||
170374352|NCT00814307|615705798|FG003|Overall Study|Withdrawal by Subject|2|||
170374353|NCT00814307|615705795|FG000|Overall Study|Death|0|||
170374354|NCT00814307|615705796|FG001|Overall Study|Death|1|||
170374355|NCT00814307|615705797|FG002|Overall Study|Death|0|||
170374356|NCT00814307|615705798|FG003|Overall Study|Death|0|||
170374357|NCT01387594|615705804|FG000|Overall Study|Withdrawal by Subject|0|||
170374358|NCT01387594|615705805|FG001|Overall Study|Withdrawal by Subject|2|||
170374359|NCT01387594|615705804|FG000|Overall Study|Lost to Follow-up|0|||
170374360|NCT01387594|615705805|FG001|Overall Study|Lost to Follow-up|1|||
170374361|NCT03073200|615705808|FG000|Double Blind Treatment Period|Protocol Violation|1|||
170374362|NCT03073200|615705809|FG001|Double Blind Treatment Period|Protocol Violation|0|||
170374363|NCT03073200|615705810|FG002|Double Blind Treatment Period|Protocol Violation|0|||
170374364|NCT03073200|615705811|FG003|Double Blind Treatment Period|Protocol Violation|0|||
170374365|NCT03073200|615705812|FG004|Double Blind Treatment Period|Protocol Violation|0|||
170374366|NCT03073200|615705813|FG005|Double Blind Treatment Period|Protocol Violation|0|||
170374367|NCT03073200|615705814|FG006|Double Blind Treatment Period|Protocol Violation|0|||
170374368|NCT03073200|615705815|FG007|Double Blind Treatment Period|Protocol Violation|0|||
170374369|NCT03073200|615705816|FG008|Double Blind Treatment Period|Protocol Violation|0|||
170374370|NCT03073200|615705817|FG009|Double Blind Treatment Period|Protocol Violation|0|||
170374371|NCT03073200|615705818|FG010|Double Blind Treatment Period|Protocol Violation|0|||
170374372|NCT03073200|615705819|FG011|Double Blind Treatment Period|Protocol Violation|0|||
170374373|NCT03073200|615705820|FG012|Double Blind Treatment Period|Protocol Violation|0|||
170374374|NCT03073200|615705821|FG013|Double Blind Treatment Period|Protocol Violation|0|||
170374375|NCT03073200|615705822|FG014|Double Blind Treatment Period|Protocol Violation|0|||
170374376|NCT03073200|615705808|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374377|NCT03073200|615705809|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
170374378|NCT03073200|615705810|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374379|NCT03073200|615705811|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374380|NCT03073200|615705812|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374381|NCT03073200|615705813|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374382|NCT03073200|615705814|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374383|NCT03073200|615705815|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374384|NCT03073200|615705816|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374385|NCT03073200|615705817|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374386|NCT03073200|615705818|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374387|NCT03073200|615705819|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374388|NCT03073200|615705820|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374389|NCT03073200|615705821|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374390|NCT03073200|615705822|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
170374391|NCT03073200|615705808|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
170374392|NCT03073200|615705809|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374393|NCT03073200|615705810|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374394|NCT03073200|615705811|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374395|NCT03073200|615705812|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374396|NCT03073200|615705813|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374397|NCT03073200|615705814|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374398|NCT03073200|615705815|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374399|NCT03073200|615705816|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374400|NCT03073200|615705817|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
170398690|NCT00306852|615798246|FG000|Overall Study|Lost to Follow-up|15|||
170374401|NCT03073200|615705818|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374402|NCT03073200|615705819|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374403|NCT03073200|615705820|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374404|NCT03073200|615705821|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374405|NCT03073200|615705822|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
170374406|NCT03073200|615705808|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374407|NCT03073200|615705809|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374408|NCT03073200|615705810|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374409|NCT03073200|615705811|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
170374410|NCT03073200|615705812|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
170374411|NCT03073200|615705813|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374412|NCT03073200|615705814|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374413|NCT03073200|615705815|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374414|NCT03073200|615705816|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374415|NCT03073200|615705817|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374416|NCT03073200|615705818|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374417|NCT03073200|615705819|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374418|NCT03073200|615705820|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374419|NCT03073200|615705821|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374420|NCT03073200|615705822|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
170374421|NCT03073200|615705808|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
170374422|NCT03073200|615705809|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
170374423|NCT03073200|615705810|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
170374424|NCT03073200|615705811|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
170374425|NCT03073200|615705812|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
170374426|NCT03073200|615705813|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
170374427|NCT03073200|615705814|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
170374428|NCT03073200|615705815|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
170374429|NCT03073200|615705816|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
170374430|NCT03073200|615705817|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
170374431|NCT03073200|615705818|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
170374432|NCT03073200|615705819|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
170374433|NCT03073200|615705820|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
170374434|NCT03073200|615705821|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
170374435|NCT03073200|615705822|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
170374436|NCT03073200|615705808|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374437|NCT03073200|615705809|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374438|NCT03073200|615705810|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374439|NCT03073200|615705811|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374440|NCT03073200|615705812|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
170374441|NCT03073200|615705813|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374442|NCT03073200|615705814|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374443|NCT03073200|615705815|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374444|NCT03073200|615705816|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374445|NCT03073200|615705817|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374446|NCT03073200|615705818|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374447|NCT03073200|615705819|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374448|NCT03073200|615705820|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374449|NCT03073200|615705821|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374450|NCT03073200|615705822|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
170374451|NCT03073200|615705808|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374452|NCT03073200|615705809|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374453|NCT03073200|615705810|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374454|NCT03073200|615705811|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
170374455|NCT03073200|615705812|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
170374456|NCT03073200|615705813|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374457|NCT03073200|615705814|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374458|NCT03073200|615705815|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374459|NCT03073200|615705816|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374460|NCT03073200|615705817|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374461|NCT03073200|615705818|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374462|NCT03073200|615705819|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374463|NCT03073200|615705820|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374464|NCT03073200|615705821|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374465|NCT03073200|615705822|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
170374466|NCT03073200|615705808|FG000|Extension Period|Lost to Follow-up|0|||
170374467|NCT03073200|615705809|FG001|Extension Period|Lost to Follow-up|0|||
170374468|NCT03073200|615705810|FG002|Extension Period|Lost to Follow-up|0|||
170374469|NCT03073200|615705811|FG003|Extension Period|Lost to Follow-up|0|||
170374470|NCT03073200|615705812|FG004|Extension Period|Lost to Follow-up|0|||
170374471|NCT03073200|615705813|FG005|Extension Period|Lost to Follow-up|0|||
170374472|NCT03073200|615705814|FG006|Extension Period|Lost to Follow-up|1|||
170374473|NCT03073200|615705815|FG007|Extension Period|Lost to Follow-up|1|||
170374474|NCT03073200|615705816|FG008|Extension Period|Lost to Follow-up|0|||
170374475|NCT03073200|615705817|FG009|Extension Period|Lost to Follow-up|0|||
170374476|NCT03073200|615705818|FG010|Extension Period|Lost to Follow-up|0|||
170374477|NCT03073200|615705819|FG011|Extension Period|Lost to Follow-up|0|||
170374478|NCT03073200|615705820|FG012|Extension Period|Lost to Follow-up|0|||
170374479|NCT03073200|615705821|FG013|Extension Period|Lost to Follow-up|0|||
170374480|NCT03073200|615705822|FG014|Extension Period|Lost to Follow-up|0|||
170374481|NCT03073200|615705808|FG000|Extension Period|Sponsor Decision|0|||
170374482|NCT03073200|615705809|FG001|Extension Period|Sponsor Decision|0|||
170374483|NCT03073200|615705810|FG002|Extension Period|Sponsor Decision|0|||
170374484|NCT03073200|615705811|FG003|Extension Period|Sponsor Decision|0|||
170374485|NCT03073200|615705812|FG004|Extension Period|Sponsor Decision|0|||
170374486|NCT03073200|615705813|FG005|Extension Period|Sponsor Decision|0|||
170374487|NCT03073200|615705814|FG006|Extension Period|Sponsor Decision|0|||
170374488|NCT03073200|615705815|FG007|Extension Period|Sponsor Decision|0|||
170374489|NCT03073200|615705816|FG008|Extension Period|Sponsor Decision|1|||
170374490|NCT03073200|615705817|FG009|Extension Period|Sponsor Decision|0|||
170374491|NCT03073200|615705818|FG010|Extension Period|Sponsor Decision|0|||
170374492|NCT03073200|615705819|FG011|Extension Period|Sponsor Decision|0|||
170374493|NCT03073200|615705820|FG012|Extension Period|Sponsor Decision|0|||
170374494|NCT03073200|615705821|FG013|Extension Period|Sponsor Decision|0|||
170374495|NCT03073200|615705822|FG014|Extension Period|Sponsor Decision|0|||
170374496|NCT03073200|615705808|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
170374497|NCT03073200|615705809|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
170374498|NCT03073200|615705810|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
170374499|NCT03073200|615705811|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
170374500|NCT03073200|615705812|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
170374501|NCT03073200|615705813|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
170374502|NCT03073200|615705814|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
170374503|NCT03073200|615705815|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
170374504|NCT03073200|615705816|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
170374505|NCT03073200|615705817|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
170374506|NCT03073200|615705818|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
170374507|NCT03073200|615705819|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
170374508|NCT03073200|615705820|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
170374509|NCT03073200|615705821|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
170374510|NCT03073200|615705822|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
170374511|NCT03073200|615705808|FG000|Extension Period|Withdrawal by Subject|0|||
170374512|NCT03073200|615705809|FG001|Extension Period|Withdrawal by Subject|0|||
170374513|NCT03073200|615705810|FG002|Extension Period|Withdrawal by Subject|0|||
170374514|NCT03073200|615705811|FG003|Extension Period|Withdrawal by Subject|0|||
170374515|NCT03073200|615705812|FG004|Extension Period|Withdrawal by Subject|0|||
170374516|NCT03073200|615705813|FG005|Extension Period|Withdrawal by Subject|0|||
170374517|NCT03073200|615705814|FG006|Extension Period|Withdrawal by Subject|1|||
170374518|NCT03073200|615705815|FG007|Extension Period|Withdrawal by Subject|2|||
170374519|NCT03073200|615705816|FG008|Extension Period|Withdrawal by Subject|0|||
170374520|NCT03073200|615705817|FG009|Extension Period|Withdrawal by Subject|0|||
170374521|NCT03073200|615705818|FG010|Extension Period|Withdrawal by Subject|0|||
170374522|NCT03073200|615705819|FG011|Extension Period|Withdrawal by Subject|0|||
170374523|NCT03073200|615705820|FG012|Extension Period|Withdrawal by Subject|0|||
170374524|NCT03073200|615705821|FG013|Extension Period|Withdrawal by Subject|0|||
170374525|NCT03073200|615705822|FG014|Extension Period|Withdrawal by Subject|0|||
170374526|NCT03073200|615705808|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374527|NCT03073200|615705809|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374528|NCT03073200|615705810|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374529|NCT03073200|615705811|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374530|NCT03073200|615705812|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374531|NCT03073200|615705813|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374532|NCT03073200|615705814|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374533|NCT03073200|615705815|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374534|NCT03073200|615705816|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374535|NCT03073200|615705817|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374536|NCT03073200|615705818|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374537|NCT03073200|615705819|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
170374538|NCT03073200|615705820|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374539|NCT03073200|615705821|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374540|NCT03073200|615705822|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
170374541|NCT03073200|615705808|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374542|NCT03073200|615705809|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374543|NCT03073200|615705810|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374544|NCT03073200|615705811|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374545|NCT03073200|615705812|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374546|NCT03073200|615705813|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374547|NCT03073200|615705814|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374548|NCT03073200|615705815|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374549|NCT03073200|615705816|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374550|NCT03073200|615705817|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374551|NCT03073200|615705818|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374552|NCT03073200|615705819|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
170374553|NCT03073200|615705820|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374554|NCT03073200|615705821|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374555|NCT03073200|615705822|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
170374556|NCT03073200|615705808|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374557|NCT03073200|615705809|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374558|NCT03073200|615705810|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374559|NCT03073200|615705811|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374560|NCT03073200|615705812|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374561|NCT03073200|615705813|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374562|NCT03073200|615705814|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374563|NCT03073200|615705815|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374564|NCT03073200|615705816|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374565|NCT03073200|615705817|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374566|NCT03073200|615705818|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
170374567|NCT03073200|615705819|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
170374568|NCT03073200|615705820|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374569|NCT03073200|615705821|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374570|NCT03073200|615705822|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
170374571|NCT03073200|615705808|FG000|Randomized Withdrawal Period|Adverse Event|0|||
170374572|NCT03073200|615705809|FG001|Randomized Withdrawal Period|Adverse Event|0|||
170374573|NCT03073200|615705810|FG002|Randomized Withdrawal Period|Adverse Event|0|||
170374574|NCT03073200|615705811|FG003|Randomized Withdrawal Period|Adverse Event|0|||
170374575|NCT03073200|615705812|FG004|Randomized Withdrawal Period|Adverse Event|0|||
170374576|NCT03073200|615705813|FG005|Randomized Withdrawal Period|Adverse Event|0|||
170374577|NCT03073200|615705814|FG006|Randomized Withdrawal Period|Adverse Event|0|||
170374578|NCT03073200|615705815|FG007|Randomized Withdrawal Period|Adverse Event|0|||
170374579|NCT03073200|615705816|FG008|Randomized Withdrawal Period|Adverse Event|0|||
170374580|NCT03073200|615705817|FG009|Randomized Withdrawal Period|Adverse Event|0|||
170374581|NCT03073200|615705818|FG010|Randomized Withdrawal Period|Adverse Event|1|||
170374582|NCT03073200|615705819|FG011|Randomized Withdrawal Period|Adverse Event|0|||
170374583|NCT03073200|615705820|FG012|Randomized Withdrawal Period|Adverse Event|0|||
170374584|NCT03073200|615705821|FG013|Randomized Withdrawal Period|Adverse Event|0|||
170374585|NCT03073200|615705822|FG014|Randomized Withdrawal Period|Adverse Event|0|||
170374586|NCT03073200|615705808|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374587|NCT03073200|615705809|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374588|NCT03073200|615705810|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374589|NCT03073200|615705811|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374590|NCT03073200|615705812|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374591|NCT03073200|615705813|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374592|NCT03073200|615705814|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374593|NCT03073200|615705815|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374594|NCT03073200|615705816|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374595|NCT03073200|615705817|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374596|NCT03073200|615705818|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374597|NCT03073200|615705819|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374598|NCT03073200|615705820|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374599|NCT03073200|615705821|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
170374600|NCT03073200|615705822|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
170374601|NCT03073200|615705808|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374602|NCT03073200|615705809|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374603|NCT03073200|615705810|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374604|NCT03073200|615705811|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374605|NCT03073200|615705812|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374606|NCT03073200|615705813|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374607|NCT03073200|615705814|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374608|NCT03073200|615705815|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374609|NCT03073200|615705816|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374610|NCT03073200|615705817|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374611|NCT03073200|615705818|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374612|NCT03073200|615705819|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374613|NCT03073200|615705820|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374614|NCT03073200|615705821|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
170374615|NCT03073200|615705822|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
170374616|NCT03073200|615705808|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374617|NCT03073200|615705809|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374618|NCT03073200|615705810|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374619|NCT03073200|615705811|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374620|NCT03073200|615705812|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374621|NCT03073200|615705813|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374622|NCT03073200|615705814|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374623|NCT03073200|615705815|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374624|NCT03073200|615705816|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374625|NCT03073200|615705817|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374626|NCT03073200|615705818|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374627|NCT03073200|615705819|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374628|NCT03073200|615705820|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374629|NCT03073200|615705821|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
170374630|NCT03073200|615705822|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
170374631|NCT03073200|615705808|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374632|NCT03073200|615705809|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374633|NCT03073200|615705810|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374634|NCT03073200|615705811|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374635|NCT03073200|615705812|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374636|NCT03073200|615705813|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374637|NCT03073200|615705814|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374638|NCT03073200|615705815|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374639|NCT03073200|615705816|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374640|NCT03073200|615705817|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374641|NCT03073200|615705818|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374642|NCT03073200|615705819|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374643|NCT03073200|615705820|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374644|NCT03073200|615705821|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
170374645|NCT03073200|615705822|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
170374646|NCT03073200|615705808|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374647|NCT03073200|615705809|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374648|NCT03073200|615705810|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374649|NCT03073200|615705811|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374650|NCT03073200|615705812|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374651|NCT03073200|615705813|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374652|NCT03073200|615705814|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374653|NCT03073200|615705815|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374654|NCT03073200|615705816|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374655|NCT03073200|615705817|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374656|NCT03073200|615705818|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374657|NCT03073200|615705819|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374658|NCT03073200|615705820|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374659|NCT03073200|615705821|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
170374660|NCT03073200|615705822|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
170374661|NCT03073200|615705808|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374662|NCT03073200|615705809|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374663|NCT03073200|615705810|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374664|NCT03073200|615705811|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374665|NCT03073200|615705812|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374666|NCT03073200|615705813|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374667|NCT03073200|615705814|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374668|NCT03073200|615705815|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374669|NCT03073200|615705816|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374670|NCT03073200|615705817|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374671|NCT03073200|615705818|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374672|NCT03073200|615705819|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374673|NCT03073200|615705820|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374674|NCT03073200|615705821|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
170374675|NCT03073200|615705822|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
170374676|NCT03073200|615705808|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374677|NCT03073200|615705809|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374678|NCT03073200|615705810|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374679|NCT03073200|615705811|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374680|NCT03073200|615705812|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374681|NCT03073200|615705813|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374682|NCT03073200|615705814|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374683|NCT03073200|615705815|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374684|NCT03073200|615705816|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374685|NCT03073200|615705817|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374686|NCT03073200|615705818|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374687|NCT03073200|615705819|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374688|NCT03073200|615705820|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374689|NCT03073200|615705821|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
170374690|NCT03073200|615705822|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
170374691|NCT03073200|615705808|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374692|NCT03073200|615705809|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374693|NCT03073200|615705810|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374694|NCT03073200|615705811|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374695|NCT03073200|615705812|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374696|NCT03073200|615705813|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374697|NCT03073200|615705814|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374698|NCT03073200|615705815|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374699|NCT03073200|615705816|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374700|NCT03073200|615705817|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374701|NCT03073200|615705818|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374702|NCT03073200|615705819|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374703|NCT03073200|615705820|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374704|NCT03073200|615705821|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
170374705|NCT03073200|615705822|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
170374706|NCT04757376|615705823|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
170374707|NCT04757376|615705824|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
170374708|NCT04757376|615705825|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
170374709|NCT04757376|615705826|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
170374710|NCT04757376|615705827|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
170374711|NCT04757376|615705823|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
170374712|NCT04757376|615705824|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
170374713|NCT04757376|615705825|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
170374714|NCT04757376|615705826|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
170374715|NCT04757376|615705827|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
170374716|NCT04757376|615705823|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
170374717|NCT04757376|615705824|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
170374718|NCT04757376|615705825|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
170374719|NCT04757376|615705826|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
170374720|NCT04757376|615705827|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
170374721|NCT04757376|615705823|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
170374722|NCT04757376|615705824|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
170374723|NCT04757376|615705825|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
170374724|NCT04757376|615705826|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
170374725|NCT04757376|615705827|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
170374726|NCT04757376|615705823|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
170374727|NCT04757376|615705824|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
170374728|NCT04757376|615705825|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
170374729|NCT04757376|615705826|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
170374730|NCT04757376|615705827|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
170374731|NCT04757376|615705823|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
170374732|NCT04757376|615705824|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
170374733|NCT04757376|615705825|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
170374734|NCT04757376|615705826|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
170374735|NCT04757376|615705827|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
170374736|NCT04757376|615705823|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
170374737|NCT04757376|615705824|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
170374738|NCT04757376|615705825|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
170374739|NCT04757376|615705826|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
170374740|NCT04757376|615705827|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
170374741|NCT04757376|615705823|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
170374742|NCT04757376|615705824|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
170374743|NCT04757376|615705825|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
170374744|NCT04757376|615705826|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
170374745|NCT04757376|615705827|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
170374746|NCT03898323|615705828|FG000|Overall Study|Physician Decision|1|||
170374747|NCT04964557|615705836|FG000|Overall Study|Withdrawal by Subject|3|||
170374748|NCT04964557|615705837|FG001|Overall Study|Withdrawal by Subject|2|||
170374749|NCT04964557|615705836|FG000|Overall Study|Lost to Follow-up|1|||
170374750|NCT04964557|615705837|FG001|Overall Study|Lost to Follow-up|2|||
170374751|NCT04964557|615705836|FG000|Overall Study|Physician Decision|2|||
170374752|NCT04964557|615705837|FG001|Overall Study|Physician Decision|0|||
170374753|NCT04964557|615705836|FG000|Overall Study|Death|3|||
170374754|NCT04964557|615705837|FG001|Overall Study|Death|0|||
170374755|NCT04964557|615705836|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
170374756|NCT04964557|615705837|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
170374757|NCT02406027|615705841|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
170374758|NCT02406027|615705842|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
170374759|NCT02406027|615705843|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
170374760|NCT02406027|615705844|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
170374761|NCT02406027|615705845|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
170374762|NCT02406027|615705846|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
170374763|NCT02406027|615705847|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
170374764|NCT02406027|615705841|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
170374765|NCT02406027|615705842|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
170374766|NCT02406027|615705843|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
170374767|NCT02406027|615705844|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
170374768|NCT02406027|615705845|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
170374769|NCT02406027|615705846|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
170374770|NCT02406027|615705847|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
170374771|NCT02406027|615705841|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
170374772|NCT02406027|615705842|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
170374773|NCT02406027|615705843|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
170374774|NCT02406027|615705844|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
170374775|NCT02406027|615705845|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
170374776|NCT02406027|615705846|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
170374777|NCT02406027|615705847|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
170374778|NCT02406027|615705841|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
170374779|NCT02406027|615705842|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
170374780|NCT02406027|615705843|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
170374781|NCT02406027|615705844|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
170374782|NCT02406027|615705845|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
170374783|NCT02406027|615705846|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
170374784|NCT02406027|615705847|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
170374785|NCT02406027|615705841|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
170374786|NCT02406027|615705842|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
170374787|NCT02406027|615705843|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
170374788|NCT02406027|615705844|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
170374789|NCT02406027|615705845|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
170374790|NCT02406027|615705846|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
170374791|NCT02406027|615705847|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
170374792|NCT02406027|615705841|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
170374793|NCT02406027|615705842|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
170374794|NCT02406027|615705843|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
170374795|NCT02406027|615705844|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
170374796|NCT02406027|615705845|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
170374797|NCT02406027|615705846|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
170374798|NCT02406027|615705847|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
170374799|NCT02406027|615705841|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
170374800|NCT02406027|615705842|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
170374801|NCT02406027|615705843|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
170374802|NCT02406027|615705844|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
170374803|NCT02406027|615705845|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
170374804|NCT02406027|615705846|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
170374805|NCT02406027|615705847|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
170374806|NCT02406027|615705841|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
170374807|NCT02406027|615705842|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
170374808|NCT02406027|615705843|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
170374809|NCT02406027|615705844|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
170374810|NCT02406027|615705845|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
170374811|NCT02406027|615705846|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
170374812|NCT02406027|615705847|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
170374813|NCT02406027|615705841|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
170374814|NCT02406027|615705842|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
170374815|NCT02406027|615705843|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
170374816|NCT02406027|615705844|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
170374817|NCT02406027|615705845|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
170374818|NCT02406027|615705846|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
170374819|NCT02406027|615705847|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
170374820|NCT02406027|615705841|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
170374821|NCT02406027|615705842|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
170374822|NCT02406027|615705843|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
170374823|NCT02406027|615705844|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
170374824|NCT02406027|615705845|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
170374825|NCT02406027|615705846|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
170374826|NCT02406027|615705847|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
170374827|NCT03782376|615705848|FG000|Overall Study|Lost to Follow-up|2|||
170374828|NCT03782376|615705849|FG001|Overall Study|Lost to Follow-up|2|||
170374829|NCT03782376|615705848|FG000|Overall Study|Withdrawal by Subject|7|||
170374830|NCT03782376|615705849|FG001|Overall Study|Withdrawal by Subject|11|||
170374831|NCT03782376|615705848|FG000|Overall Study|Death|1|||
170374832|NCT03782376|615705849|FG001|Overall Study|Death|0|||
170374833|NCT03782376|615705848|FG000|Overall Study|Other|16|||
170374834|NCT03782376|615705849|FG001|Overall Study|Other|17|||
170374835|NCT02659098|615705850|FG000|Overall Study|Withdrawal by Subject|7|||
170374836|NCT03559192|615705851|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
170374837|NCT03559192|615705852|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
170374838|NCT03559192|615705853|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
170374839|NCT03559192|615705851|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
170374840|NCT03559192|615705852|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
170374841|NCT03559192|615705853|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
170374842|NCT03559192|615705851|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
170374843|NCT03559192|615705852|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
170374844|NCT03559192|615705853|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
170374845|NCT03559192|615705851|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
170374846|NCT03559192|615705852|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
170374847|NCT03559192|615705853|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
170374848|NCT03559192|615705851|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
170374849|NCT03559192|615705852|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
170374850|NCT03559192|615705853|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
170374851|NCT03559192|615705851|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
170374852|NCT03559192|615705852|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
170374853|NCT03559192|615705853|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
170374854|NCT03559192|615705851|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
170374855|NCT03559192|615705852|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
170374856|NCT03559192|615705853|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
170374857|NCT03559192|615705851|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
170374858|NCT03559192|615705852|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
170374859|NCT03559192|615705853|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
170374860|NCT03559192|615705851|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
170374861|NCT03559192|615705852|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
170374862|NCT03559192|615705853|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
170374863|NCT04418427|615708556|FG000|Overall Study|Death|0|||
170374864|NCT04418427|615708557|FG001|Overall Study|Death|1|||
170374865|NCT04418427|615708558|FG002|Overall Study|Death|0|||
170374866|NCT04418427|615708556|FG000|Overall Study|Lost to Follow-up|0|||
170374867|NCT04418427|615708557|FG001|Overall Study|Lost to Follow-up|2|||
170374868|NCT04418427|615708558|FG002|Overall Study|Lost to Follow-up|2|||
170374869|NCT04418427|615708556|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
170374870|NCT04418427|615708557|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
170374871|NCT04418427|615708558|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
170374872|NCT04418427|615708556|FG000|Overall Study|Pre-existing medical condition|0|||
170374873|NCT04418427|615708557|FG001|Overall Study|Pre-existing medical condition|1|||
170374874|NCT04418427|615708558|FG002|Overall Study|Pre-existing medical condition|0|||
170374875|NCT01673373|615708559|FG000|Overall Study|Death|2|||
170374876|NCT00366444|615708561|FG000|Overall Study|Withdrawal by Subject|1|||
170374877|NCT00366444|615708562|FG001|Overall Study|Withdrawal by Subject|1|||
170374878|NCT00366444|615708561|FG000|Overall Study|Lack of Efficacy|0|||
170374879|NCT00366444|615708562|FG001|Overall Study|Lack of Efficacy|1|||
170374880|NCT01320033|615708563|FG000|Overall Study|Lack of Efficacy|0|||
170374881|NCT01320033|615708564|FG001|Overall Study|Lack of Efficacy|0|||
170374882|NCT01320033|615708565|FG002|Overall Study|Lack of Efficacy|1|||
170374883|NCT01320033|615708563|FG000|Overall Study|Adverse Event|9|||
170374884|NCT01320033|615708564|FG001|Overall Study|Adverse Event|7|||
170374885|NCT01320033|615708565|FG002|Overall Study|Adverse Event|8|||
170374886|NCT01320033|615708563|FG000|Overall Study|Withdrawal by Subject|22|||
170374887|NCT01320033|615708564|FG001|Overall Study|Withdrawal by Subject|23|||
170374888|NCT01320033|615708565|FG002|Overall Study|Withdrawal by Subject|23|||
170374889|NCT01320033|615708563|FG000|Overall Study|Protocol Violation|3|||
170374890|NCT01320033|615708564|FG001|Overall Study|Protocol Violation|5|||
170374891|NCT01320033|615708565|FG002|Overall Study|Protocol Violation|3|||
170374892|NCT01320033|615708563|FG000|Overall Study|Lost to Follow-up|22|||
170374893|NCT01320033|615708564|FG001|Overall Study|Lost to Follow-up|26|||
170374894|NCT01320033|615708565|FG002|Overall Study|Lost to Follow-up|17|||
170374895|NCT01320033|615708563|FG000|Overall Study|Other|2|||
170374896|NCT01320033|615708564|FG001|Overall Study|Other|3|||
170374897|NCT01320033|615708565|FG002|Overall Study|Other|1|||
170374898|NCT01654224|615708566|FG000|Overall Study|Lost to Follow-up|2|||
170374899|NCT01654224|615708567|FG001|Overall Study|Lost to Follow-up|2|||
170374900|NCT01654224|615708566|FG000|Overall Study|Did not receive allocation|1|||
170374901|NCT01654224|615708567|FG001|Overall Study|Did not receive allocation|8|||
170374902|NCT01654224|615708566|FG000|Overall Study|Insufficient blood sample|3|||
170374903|NCT01654224|615708567|FG001|Overall Study|Insufficient blood sample|2|||
170374904|NCT00166504|615708568|FG000|Overall Study|Adverse Event|3|||
170374905|NCT00166504|615708569|FG001|Overall Study|Adverse Event|3|||
170374906|NCT00166504|615708568|FG000|Overall Study|Lost to Follow-up|1|||
170374907|NCT00166504|615708569|FG001|Overall Study|Lost to Follow-up|1|||
170374908|NCT00166504|615708568|FG000|Overall Study|Withdrawal by Subject|1|||
170374909|NCT00166504|615708569|FG001|Overall Study|Withdrawal by Subject|0|||
170374910|NCT02145429|615708570|FG000|Overall Study|Death|4|||
170374911|NCT02145429|615708571|FG001|Overall Study|Death|5|||
170374912|NCT02145429|615708570|FG000|Overall Study|Lost to Follow-up|4|||
170374913|NCT02145429|615708571|FG001|Overall Study|Lost to Follow-up|3|||
170374914|NCT02145429|615708570|FG000|Overall Study|Withdrawal by Subject|8|||
170374915|NCT02145429|615708571|FG001|Overall Study|Withdrawal by Subject|3|||
170374916|NCT02200510|615708572|FG000|Overall Study|Death|1|||
170374917|NCT02200510|615708573|FG001|Overall Study|Death|1|||
170374918|NCT02200510|615708572|FG000|Overall Study|Protocol Violation|0|||
170374919|NCT02200510|615708573|FG001|Overall Study|Protocol Violation|1|||
170374920|NCT02200510|615708572|FG000|Overall Study|Lost to Follow-up|7|||
170374921|NCT02200510|615708573|FG001|Overall Study|Lost to Follow-up|1|||
170374922|NCT02200510|615708572|FG000|Overall Study|potential COI - joined study team|1|||
170374923|NCT02200510|615708573|FG001|Overall Study|potential COI - joined study team|0|||
170374924|NCT02943577|615708576|FG000|Overall Study|Protocol Violation|0|||
170374925|NCT02943577|615708577|FG001|Overall Study|Protocol Violation|1|||
170374926|NCT02943577|615708576|FG000|Overall Study|Adverse Event|3|||
170374927|NCT02943577|615708577|FG001|Overall Study|Adverse Event|2|||
170374928|NCT02943577|615708576|FG000|Overall Study|Lost to Follow-up|0|||
170374929|NCT02943577|615708577|FG001|Overall Study|Lost to Follow-up|1|||
170374930|NCT02943577|615708576|FG000|Overall Study|Withdrawal by Subject|1|||
170374931|NCT02943577|615708577|FG001|Overall Study|Withdrawal by Subject|1|||
170374932|NCT02943577|615708576|FG000|Overall Study|Pregnancy|1|||
170374933|NCT02943577|615708577|FG001|Overall Study|Pregnancy|0|||
170374934|NCT00584987|615708582|FG000|Overall Study|Protocol Violation|1|||
170374935|NCT00584987|615708583|FG001|Overall Study|Protocol Violation|1|||
170374936|NCT00584987|615708584|FG002|Overall Study|Protocol Violation|1|||
170374937|NCT00584987|615708585|FG003|Overall Study|Protocol Violation|0|||
170374938|NCT00584987|615708582|FG000|Overall Study|Adverse Event|0|||
170374939|NCT00584987|615708583|FG001|Overall Study|Adverse Event|0|||
170374940|NCT00584987|615708584|FG002|Overall Study|Adverse Event|0|||
170374941|NCT00584987|615708585|FG003|Overall Study|Adverse Event|1|||
170374942|NCT02881151|615708586|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
170374943|NCT00589602|615708590|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
170374944|NCT04284787|615708592|FG000|Overall Study|Disease Progression|9|||
170374945|NCT04284787|615708593|FG001|Overall Study|Disease Progression|12|||
170374946|NCT04284787|615708592|FG000|Overall Study|Physician Decision|12|||
170374947|NCT04284787|615708593|FG001|Overall Study|Physician Decision|7|||
170374948|NCT04284787|615708592|FG000|Overall Study|Transplant|5|||
170374949|NCT04284787|615708593|FG001|Overall Study|Transplant|4|||
170374950|NCT04284787|615708592|FG000|Overall Study|Death|1|||
170374951|NCT04284787|615708593|FG001|Overall Study|Death|2|||
170374952|NCT04284787|615708592|FG000|Overall Study|Adverse Event|0|||
170374953|NCT04284787|615708593|FG001|Overall Study|Adverse Event|4|||
170374954|NCT04284787|615708592|FG000|Overall Study|Non-adherence|2|||
170374955|NCT04284787|615708593|FG001|Overall Study|Non-adherence|0|||
170374956|NCT04284787|615708592|FG000|Overall Study|Lack of Efficacy|2|||
170374957|NCT04284787|615708593|FG001|Overall Study|Lack of Efficacy|0|||
170374958|NCT01874353|615708594|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
170374959|NCT01874353|615708595|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
170374960|NCT01874353|615708596|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
170374961|NCT01874353|615708597|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
170374962|NCT01874353|615708594|FG000|Overall Study|Lost to Follow-up|2|||
170374963|NCT01874353|615708595|FG001|Overall Study|Lost to Follow-up|2|||
170374964|NCT01874353|615708596|FG002|Overall Study|Lost to Follow-up|2|||
170374965|NCT01874353|615708597|FG003|Overall Study|Lost to Follow-up|0|||
170374966|NCT01874353|615708594|FG000|Overall Study|Death|110|||
170374967|NCT01874353|615708595|FG001|Overall Study|Death|60|||
170374968|NCT01874353|615708596|FG002|Overall Study|Death|13|||
170374969|NCT01874353|615708597|FG003|Overall Study|Death|7|||
170374970|NCT01874353|615708594|FG000|Overall Study|Withdrawal by Subject|13|||
170374971|NCT01874353|615708595|FG001|Overall Study|Withdrawal by Subject|11|||
170374972|NCT01874353|615708596|FG002|Overall Study|Withdrawal by Subject|0|||
170374973|NCT01874353|615708597|FG003|Overall Study|Withdrawal by Subject|0|||
170374974|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
170374975|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
170374976|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|Death|1|||
170374977|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|Death|1|||
170374978|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
170374979|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
170374980|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
170374981|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
170374982|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
170374983|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
170374984|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
170374985|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
170374986|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
170374987|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
170374988|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
170374989|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
170374990|NCT03728881|615708598|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
170374991|NCT03728881|615708599|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
170374992|NCT03728881|615708598|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
170374993|NCT03728881|615708599|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
170374994|NCT03728881|615708598|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
170374995|NCT03728881|615708599|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
170374996|NCT04517253|615708602|FG000|Primary Treatment Period|Adverse Event|1|||
170374997|NCT04517253|615708603|FG001|Primary Treatment Period|Adverse Event|0|||
170374998|NCT04517253|615708604|FG002|Primary Treatment Period|Adverse Event|0|||
170374999|NCT04517253|615708602|FG000|Primary Treatment Period|Death|0|||
170375000|NCT04517253|615708603|FG001|Primary Treatment Period|Death|1|||
170375001|NCT04517253|615708604|FG002|Primary Treatment Period|Death|0|||
170375002|NCT04517253|615708602|FG000|Maintenance Period|Withdrawal by Subject|1|||
170375003|NCT04517253|615708603|FG001|Maintenance Period|Withdrawal by Subject|0|||
170375004|NCT04517253|615708604|FG002|Maintenance Period|Withdrawal by Subject|0|||
170375005|NCT04517253|615708602|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
170375006|NCT04517253|615708603|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
170375007|NCT04517253|615708604|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
170375008|NCT01108263|615708605|FG000|Overall Study|Adverse Event|0|||
170375009|NCT01108263|615708606|FG001|Overall Study|Adverse Event|1|||
170375010|NCT02974621|615708607|FG000|Overall Study|Didn't receive study treatment|1|||
170375011|NCT02974621|615708608|FG001|Overall Study|Didn't receive study treatment|10|||
170375012|NCT00732472|615708609|FG000|Overall Study|Adverse Event|0|||
170375013|NCT00732472|615708610|FG001|Overall Study|Adverse Event|1|||
170375014|NCT00732472|615708611|FG002|Overall Study|Adverse Event|1|||
170375015|NCT00732472|615708612|FG003|Overall Study|Adverse Event|1|||
170375016|NCT00732472|615708609|FG000|Overall Study|Protocol Violation|0|||
170375017|NCT00732472|615708610|FG001|Overall Study|Protocol Violation|0|||
170375018|NCT00732472|615708611|FG002|Overall Study|Protocol Violation|0|||
170375019|NCT00732472|615708612|FG003|Overall Study|Protocol Violation|1|||
170375020|NCT00732472|615708609|FG000|Overall Study|Withdrawal by Subject|0|||
170375021|NCT00732472|615708610|FG001|Overall Study|Withdrawal by Subject|2|||
170375022|NCT00732472|615708611|FG002|Overall Study|Withdrawal by Subject|0|||
170375023|NCT00732472|615708612|FG003|Overall Study|Withdrawal by Subject|1|||
170375024|NCT02559115|615708614|FG000|Overall Study|Withdrawal by Subject|3|||
170375025|NCT01266876|615708615|FG000|Overall Study|Adverse Event|0|||
170375026|NCT01266876|615708616|FG001|Overall Study|Adverse Event|0|||
170375027|NCT01266876|615708617|FG002|Overall Study|Adverse Event|0|||
170375028|NCT01266876|615708618|FG003|Overall Study|Adverse Event|1|||
170375029|NCT01266876|615708619|FG004|Overall Study|Adverse Event|0|||
170375030|NCT01058395|615708620|FG000|Overall Study|Death|2|||
170375031|NCT01058395|615708621|FG001|Overall Study|Death|1|||
170375032|NCT01058395|615708620|FG000|Overall Study|Lost to Follow-up|1|||
170375033|NCT01058395|615708621|FG001|Overall Study|Lost to Follow-up|0|||
170375034|NCT05016037|615708622|FG000|Overall Study|Lost to Follow-up|2|||
170375035|NCT01996865|615708623|FG000|Induction Period|Protocol Violation|1|||
170375036|NCT01996865|615708624|FG001|Induction Period|Protocol Violation|0|||
170375037|NCT01996865|615708625|FG002|Induction Period|Protocol Violation|0|||
170375038|NCT01996865|615708623|FG000|Induction Period|Progressive Disease|4|||
170375039|NCT01996865|615708624|FG001|Induction Period|Progressive Disease|0|||
170375040|NCT01996865|615708625|FG002|Induction Period|Progressive Disease|0|||
170375041|NCT01996865|615708623|FG000|Induction Period|Lost to Follow-up|10|||
170375042|NCT01996865|615708624|FG001|Induction Period|Lost to Follow-up|0|||
170375043|NCT01996865|615708625|FG002|Induction Period|Lost to Follow-up|0|||
170375044|NCT01996865|615708623|FG000|Induction Period|Other Reasons|13|||
170375045|NCT01996865|615708624|FG001|Induction Period|Other Reasons|0|||
170375046|NCT01996865|615708625|FG002|Induction Period|Other Reasons|0|||
170375047|NCT01996865|615708623|FG000|Induction Period|Adverse Event|20|||
170375048|NCT01996865|615708624|FG001|Induction Period|Adverse Event|0|||
170375049|NCT01996865|615708625|FG002|Induction Period|Adverse Event|0|||
170375050|NCT01996865|615708623|FG000|Induction Period|Withdrawal by Subject|60|||
170375051|NCT01996865|615708624|FG001|Induction Period|Withdrawal by Subject|0|||
170375052|NCT01996865|615708625|FG002|Induction Period|Withdrawal by Subject|0|||
170375053|NCT01996865|615708623|FG000|Induction Period|Death|111|||
170375054|NCT01996865|615708624|FG001|Induction Period|Death|0|||
170375055|NCT01996865|615708625|FG002|Induction Period|Death|0|||
170375056|NCT01996865|615708623|FG000|Maintenance Period|Protocol Violation|0|||
170375057|NCT01996865|615708624|FG001|Maintenance Period|Protocol Violation|1|||
170375058|NCT01996865|615708625|FG002|Maintenance Period|Protocol Violation|1|||
170375059|NCT01996865|615708623|FG000|Maintenance Period|Other reasons|0|||
170375060|NCT01996865|615708624|FG001|Maintenance Period|Other reasons|8|||
170375061|NCT01996865|615708625|FG002|Maintenance Period|Other reasons|5|||
170375062|NCT01996865|615708623|FG000|Maintenance Period|Progressive Disease|0|||
170375063|NCT01996865|615708624|FG001|Maintenance Period|Progressive Disease|6|||
170375064|NCT01996865|615708625|FG002|Maintenance Period|Progressive Disease|23|||
170375065|NCT01996865|615708623|FG000|Maintenance Period|Withdrawal by Subject|0|||
170375066|NCT01996865|615708624|FG001|Maintenance Period|Withdrawal by Subject|18|||
170375067|NCT01996865|615708625|FG002|Maintenance Period|Withdrawal by Subject|4|||
170375068|NCT01996865|615708623|FG000|Maintenance Period|Adverse Event|0|||
170375069|NCT01996865|615708624|FG001|Maintenance Period|Adverse Event|7|||
170375070|NCT01996865|615708625|FG002|Maintenance Period|Adverse Event|7|||
170375071|NCT01996865|615708623|FG000|Maintenance Period|Death|0|||
170375072|NCT01996865|615708624|FG001|Maintenance Period|Death|15|||
170375073|NCT01996865|615708625|FG002|Maintenance Period|Death|3|||
170375074|NCT01996865|615708623|FG000|Maintenance Period|Lost to Follow-up|0|||
170375075|NCT01996865|615708624|FG001|Maintenance Period|Lost to Follow-up|2|||
170375076|NCT01996865|615708625|FG002|Maintenance Period|Lost to Follow-up|0|||
170375077|NCT03575351|615708628|FG000|Overall Study|Adverse Event|1|||
170375078|NCT03575351|615708629|FG001|Overall Study|Adverse Event|0|||
170375079|NCT03575351|615708628|FG000|Overall Study|Death|2|||
170375080|NCT03575351|615708629|FG001|Overall Study|Death|2|||
170375081|NCT03575351|615708628|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
170375082|NCT03575351|615708629|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
170375083|NCT03575351|615708628|FG000|Overall Study|Lack of Efficacy|28|||
170375084|NCT03575351|615708629|FG001|Overall Study|Lack of Efficacy|0|||
170375085|NCT03575351|615708628|FG000|Overall Study|Withdrawal by Subject|1|||
170375086|NCT03575351|615708629|FG001|Overall Study|Withdrawal by Subject|1|||
170375087|NCT03575351|615708628|FG000|Overall Study|Physician Decision|3|||
170375088|NCT03575351|615708629|FG001|Overall Study|Physician Decision|0|||
170375089|NCT03575351|615708628|FG000|Overall Study|Disease relapse|15|||
170375090|NCT03575351|615708629|FG001|Overall Study|Disease relapse|6|||
170375091|NCT03575351|615708628|FG000|Overall Study|Study drug manufacturing failure|0|||
170375092|NCT03575351|615708629|FG001|Overall Study|Study drug manufacturing failure|1|||
170375093|NCT03575351|615708628|FG000|Overall Study|other reasons|5|||
170375094|NCT03575351|615708629|FG001|Overall Study|other reasons|0|||
170375095|NCT04288089|615708630|FG000|Overall Study|Ongoing Treatment|2|||
170375096|NCT04288089|615708631|FG001|Overall Study|Ongoing Treatment|1|||
170375097|NCT04288089|615708632|FG002|Overall Study|Ongoing Treatment|1|||
170375098|NCT04288089|615708633|FG003|Overall Study|Ongoing Treatment|4|||
170375099|NCT03715205|615708634|FG000|Overall Study|Death|13|||
170375100|NCT03715205|615708634|FG000|Overall Study|Lost to Follow-up|2|||
170375101|NCT03715205|615708634|FG000|Overall Study|Physician Decision|93|||
170375102|NCT03715205|615708634|FG000|Overall Study|Withdrawal by Subject|26|||
170375103|NCT05304611|615708635|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375104|NCT05304611|615708636|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375105|NCT05304611|615708637|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375106|NCT05304611|615708638|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375107|NCT05304611|615708639|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375108|NCT05304611|615708640|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375109|NCT05304611|615708641|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
170375110|NCT05304611|615708642|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375111|NCT05304611|615708643|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
170375112|NCT05304611|615708644|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375113|NCT05304611|615708645|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375114|NCT05304611|615708646|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
170375115|NCT05304611|615708635|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
170375116|NCT05304611|615708636|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
170375117|NCT05304611|615708637|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
170375118|NCT05304611|615708638|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
170375119|NCT05304611|615708639|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
170375120|NCT05304611|615708640|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
170375121|NCT05304611|615708641|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
170375122|NCT05304611|615708642|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
170375123|NCT05304611|615708643|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
170375124|NCT05304611|615708644|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
170375125|NCT05304611|615708645|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
170375126|NCT05304611|615708646|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
170375127|NCT05304611|615708635|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
170375128|NCT05304611|615708636|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
170375129|NCT05304611|615708637|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
170375130|NCT05304611|615708638|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
170375131|NCT05304611|615708639|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
170375132|NCT05304611|615708640|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
170375133|NCT05304611|615708641|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
170375134|NCT05304611|615708642|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
170375135|NCT05304611|615708643|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
170375136|NCT05304611|615708644|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
170375137|NCT05304611|615708645|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
170375138|NCT05304611|615708646|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
170375139|NCT00963820|615708647|FG000|Dose Escalation Phase|Progressive Disease|3|||
170375140|NCT00963820|615708648|FG001|Dose Escalation Phase|Progressive Disease|3|||
170375141|NCT00963820|615708649|FG002|Dose Escalation Phase|Progressive Disease|3|||
170375142|NCT00963820|615708650|FG003|Dose Escalation Phase|Progressive Disease|3|||
170375143|NCT00963820|615708651|FG004|Dose Escalation Phase|Progressive Disease|4|||
170375144|NCT00963820|615708652|FG005|Dose Escalation Phase|Progressive Disease|3|||
170375145|NCT00963820|615708653|FG006|Dose Escalation Phase|Progressive Disease|3|||
170375146|NCT00963820|615708654|FG007|Dose Escalation Phase|Progressive Disease|2|||
170375147|NCT00963820|615708655|FG008|Dose Escalation Phase|Progressive Disease|0|||
170375148|NCT00963820|615708656|FG009|Dose Escalation Phase|Progressive Disease|0|||
170375149|NCT00963820|615708657|FG010|Dose Escalation Phase|Progressive Disease|0|||
170375150|NCT00963820|615708658|FG011|Dose Escalation Phase|Progressive Disease|0|||
170375151|NCT00963820|615708647|FG000|Dose Escalation Phase|Adverse Event|0|||
170375152|NCT00963820|615708648|FG001|Dose Escalation Phase|Adverse Event|0|||
170375153|NCT00963820|615708649|FG002|Dose Escalation Phase|Adverse Event|0|||
170375154|NCT00963820|615708650|FG003|Dose Escalation Phase|Adverse Event|0|||
170375155|NCT00963820|615708651|FG004|Dose Escalation Phase|Adverse Event|0|||
170375156|NCT00963820|615708652|FG005|Dose Escalation Phase|Adverse Event|0|||
170375157|NCT00963820|615708653|FG006|Dose Escalation Phase|Adverse Event|3|||
170375158|NCT00963820|615708654|FG007|Dose Escalation Phase|Adverse Event|1|||
170375159|NCT00963820|615708655|FG008|Dose Escalation Phase|Adverse Event|0|||
170375160|NCT00963820|615708656|FG009|Dose Escalation Phase|Adverse Event|0|||
170375161|NCT00963820|615708657|FG010|Dose Escalation Phase|Adverse Event|0|||
170375162|NCT00963820|615708658|FG011|Dose Escalation Phase|Adverse Event|0|||
170375163|NCT00963820|615708647|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
170375164|NCT00963820|615708648|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
170375165|NCT00963820|615708649|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
170375166|NCT00963820|615708650|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
170375167|NCT00963820|615708651|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
170375168|NCT00963820|615708652|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
170375169|NCT00963820|615708653|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
170375170|NCT00963820|615708654|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
170375171|NCT00963820|615708655|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
170375172|NCT00963820|615708656|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
170375173|NCT00963820|615708657|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
170375174|NCT00963820|615708658|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
170375175|NCT00963820|615708647|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375176|NCT00963820|615708648|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375177|NCT00963820|615708649|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375178|NCT00963820|615708650|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375179|NCT00963820|615708651|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375180|NCT00963820|615708652|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375181|NCT00963820|615708653|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
170375182|NCT00963820|615708654|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375183|NCT00963820|615708655|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375184|NCT00963820|615708656|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375185|NCT00963820|615708657|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375186|NCT00963820|615708658|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
170375187|NCT00963820|615708647|FG000|Expansion Phase|Progressive Disease|0|||
170375188|NCT00963820|615708648|FG001|Expansion Phase|Progressive Disease|0|||
170375189|NCT00963820|615708649|FG002|Expansion Phase|Progressive Disease|0|||
170375190|NCT00963820|615708650|FG003|Expansion Phase|Progressive Disease|0|||
170375191|NCT00963820|615708651|FG004|Expansion Phase|Progressive Disease|0|||
170375192|NCT00963820|615708652|FG005|Expansion Phase|Progressive Disease|0|||
170375193|NCT00963820|615708653|FG006|Expansion Phase|Progressive Disease|0|||
170375194|NCT00963820|615708654|FG007|Expansion Phase|Progressive Disease|0|||
170375195|NCT00963820|615708655|FG008|Expansion Phase|Progressive Disease|8|||
170375196|NCT00963820|615708656|FG009|Expansion Phase|Progressive Disease|6|||
170375197|NCT00963820|615708657|FG010|Expansion Phase|Progressive Disease|4|||
170375198|NCT00963820|615708658|FG011|Expansion Phase|Progressive Disease|2|||
170375199|NCT00963820|615708647|FG000|Expansion Phase|Adverse Event|0|||
170375200|NCT00963820|615708648|FG001|Expansion Phase|Adverse Event|0|||
170375201|NCT00963820|615708649|FG002|Expansion Phase|Adverse Event|0|||
170375202|NCT00963820|615708650|FG003|Expansion Phase|Adverse Event|0|||
170375203|NCT00963820|615708651|FG004|Expansion Phase|Adverse Event|0|||
170375204|NCT00963820|615708652|FG005|Expansion Phase|Adverse Event|0|||
170375205|NCT00963820|615708653|FG006|Expansion Phase|Adverse Event|0|||
170375206|NCT00963820|615708654|FG007|Expansion Phase|Adverse Event|0|||
170375207|NCT00963820|615708655|FG008|Expansion Phase|Adverse Event|1|||
170375208|NCT00963820|615708656|FG009|Expansion Phase|Adverse Event|3|||
170375209|NCT00963820|615708657|FG010|Expansion Phase|Adverse Event|0|||
170375210|NCT00963820|615708658|FG011|Expansion Phase|Adverse Event|0|||
170375211|NCT00963820|615708647|FG000|Expansion Phase|Withdrawal by Subject|0|||
170375212|NCT00963820|615708648|FG001|Expansion Phase|Withdrawal by Subject|0|||
170375213|NCT00963820|615708649|FG002|Expansion Phase|Withdrawal by Subject|0|||
170375214|NCT00963820|615708650|FG003|Expansion Phase|Withdrawal by Subject|0|||
170375215|NCT00963820|615708651|FG004|Expansion Phase|Withdrawal by Subject|0|||
170375216|NCT00963820|615708652|FG005|Expansion Phase|Withdrawal by Subject|0|||
170375217|NCT00963820|615708653|FG006|Expansion Phase|Withdrawal by Subject|0|||
170375218|NCT00963820|615708654|FG007|Expansion Phase|Withdrawal by Subject|0|||
170375219|NCT00963820|615708655|FG008|Expansion Phase|Withdrawal by Subject|1|||
170375220|NCT00963820|615708656|FG009|Expansion Phase|Withdrawal by Subject|0|||
170375221|NCT00963820|615708657|FG010|Expansion Phase|Withdrawal by Subject|1|||
170375222|NCT00963820|615708658|FG011|Expansion Phase|Withdrawal by Subject|1|||
170375223|NCT00963820|615708647|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375224|NCT00963820|615708648|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375225|NCT00963820|615708649|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375226|NCT00963820|615708650|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375227|NCT00963820|615708651|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375228|NCT00963820|615708652|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375229|NCT00963820|615708653|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375230|NCT00963820|615708654|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375231|NCT00963820|615708655|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375232|NCT00963820|615708656|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375233|NCT00963820|615708657|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
170375234|NCT00963820|615708658|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
170375235|NCT02354690|615708659|FG000|Overall Study|Physician Decision|1|||
170375236|NCT04556175|615708663|FG000|Overall Study|Study terminated due to COVID-19|8|||
170375237|NCT04556175|615708664|FG001|Overall Study|Study terminated due to COVID-19|8|||
170375238|NCT05549505|615708665|FG000|Overall Study|Lost to Follow-up|2|||
170375239|NCT05549505|615708666|FG001|Overall Study|Lost to Follow-up|0|||
170375240|NCT05549505|615708665|FG000|Overall Study|Withdrawal by Subject|3|||
170375241|NCT05549505|615708666|FG001|Overall Study|Withdrawal by Subject|3|||
170375242|NCT05549505|615708665|FG000|Overall Study|Other: Miscellaneous|3|||
170375243|NCT05549505|615708666|FG001|Overall Study|Other: Miscellaneous|6|||
170375244|NCT00372489|615708672|FG000|Overall Study|Adverse Event|18|||
170375245|NCT00372489|615708672|FG000|Overall Study|Lack of Efficacy|1|||
170375246|NCT00372489|615708672|FG000|Overall Study|Lost to Follow-up|3|||
170375247|NCT00372489|615708672|FG000|Overall Study|Physician Decision|3|||
170375248|NCT00372489|615708672|FG000|Overall Study|Withdrawal by Subject|5|||
170375249|NCT00372489|615708672|FG000|Overall Study|Patient Relocation|2|||
170375250|NCT00372489|615708672|FG000|Overall Study|Renal transplant|6|||
170375251|NCT00372489|615708672|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
170375252|NCT00355615|615708681|FG000|Randomized Double Blind Period|Adverse Event|1|||
170375253|NCT00355615|615708682|FG001|Randomized Double Blind Period|Adverse Event|0|||
170375254|NCT00355615|615708683|FG002|Randomized Double Blind Period|Adverse Event|0|||
170375255|NCT00355615|615708684|FG003|Randomized Double Blind Period|Adverse Event|0|||
170375256|NCT00355615|615708685|FG004|Randomized Double Blind Period|Adverse Event|0|||
170375257|NCT00355615|615708681|FG000|Randomized Double Blind Period|Protocol Violation|0|||
170375258|NCT00355615|615708682|FG001|Randomized Double Blind Period|Protocol Violation|0|||
170375259|NCT00355615|615708683|FG002|Randomized Double Blind Period|Protocol Violation|1|||
170375260|NCT00355615|615708684|FG003|Randomized Double Blind Period|Protocol Violation|1|||
170375261|NCT00355615|615708685|FG004|Randomized Double Blind Period|Protocol Violation|0|||
170375262|NCT00355615|615708681|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
170375263|NCT00355615|615708682|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
170375264|NCT00355615|615708683|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
170375265|NCT00355615|615708684|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
170375266|NCT00355615|615708685|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
170375267|NCT00355615|615708681|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
170375268|NCT00355615|615708682|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
170375269|NCT00355615|615708683|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
170375270|NCT00355615|615708684|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
170375271|NCT00355615|615708685|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
170375272|NCT00355615|615708681|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
170375273|NCT00355615|615708682|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
170375274|NCT00355615|615708683|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
170375275|NCT00355615|615708684|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
170375276|NCT00355615|615708685|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
170375277|NCT00355615|615708681|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
170375278|NCT00355615|615708682|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
170375279|NCT00355615|615708683|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
170375280|NCT00355615|615708684|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
170375281|NCT00355615|615708685|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
170375282|NCT04259346|615708688|FG000|Overall Study|Lost to Follow-up|1|||
170375283|NCT04259346|615708689|FG001|Overall Study|Lost to Follow-up|3|||
170375284|NCT04259346|615708688|FG000|Overall Study|Protocol Violation|1|||
170375285|NCT04259346|615708689|FG001|Overall Study|Protocol Violation|0|||
170375286|NCT04259346|615708688|FG000|Overall Study|Withdrawal by Subject|1|||
170375287|NCT04259346|615708689|FG001|Overall Study|Withdrawal by Subject|0|||
170375288|NCT04259346|615708688|FG000|Overall Study|Adverse Event|1|||
170375289|NCT04259346|615708689|FG001|Overall Study|Adverse Event|1|||
170375290|NCT00085644|615708690|FG000|Double-Blind Period|Adverse Event|5|||
170375291|NCT00085644|615708691|FG001|Double-Blind Period|Adverse Event|2|||
170375292|NCT00085644|615708692|FG002|Double-Blind Period|Adverse Event|0|||
170375293|NCT00085644|615708690|FG000|Double-Blind Period|Withdrawal by Subject|3|||
170375294|NCT00085644|615708691|FG001|Double-Blind Period|Withdrawal by Subject|0|||
170375295|NCT00085644|615708692|FG002|Double-Blind Period|Withdrawal by Subject|0|||
170375296|NCT00085644|615708690|FG000|Double-Blind Period|Lost to Follow-up|2|||
170375297|NCT00085644|615708691|FG001|Double-Blind Period|Lost to Follow-up|1|||
170375298|NCT00085644|615708692|FG002|Double-Blind Period|Lost to Follow-up|0|||
170375299|NCT00085644|615708690|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
170375300|NCT00085644|615708691|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
170375301|NCT00085644|615708692|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
170375302|NCT00085644|615708690|FG000|Double-Blind Period|Contemplating pregnancy|1|||
170375303|NCT00085644|615708691|FG001|Double-Blind Period|Contemplating pregnancy|0|||
170375304|NCT00085644|615708692|FG002|Double-Blind Period|Contemplating pregnancy|0|||
170375305|NCT00085644|615708690|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
170375306|NCT00085644|615708691|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
170375307|NCT00085644|615708692|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
170375308|NCT00085644|615708690|FG000|Open-Label Period|Adverse Event|0|||
170375309|NCT00085644|615708691|FG001|Open-Label Period|Adverse Event|0|||
170375310|NCT00085644|615708692|FG002|Open-Label Period|Adverse Event|38|||
170375311|NCT00085644|615708690|FG000|Open-Label Period|Withdrawal by Subject|0|||
170375312|NCT00085644|615708691|FG001|Open-Label Period|Withdrawal by Subject|0|||
170375313|NCT00085644|615708692|FG002|Open-Label Period|Withdrawal by Subject|29|||
170375314|NCT00085644|615708690|FG000|Open-Label Period|Lost to Follow-up|0|||
170375315|NCT00085644|615708691|FG001|Open-Label Period|Lost to Follow-up|0|||
170375316|NCT00085644|615708692|FG002|Open-Label Period|Lost to Follow-up|13|||
170375317|NCT00085644|615708690|FG000|Open-Label Period|Lack of Efficacy|0|||
170375318|NCT00085644|615708691|FG001|Open-Label Period|Lack of Efficacy|0|||
170375319|NCT00085644|615708692|FG002|Open-Label Period|Lack of Efficacy|15|||
170375320|NCT00085644|615708690|FG000|Open-Label Period|Pregnancy|0|||
170375321|NCT00085644|615708691|FG001|Open-Label Period|Pregnancy|0|||
170375322|NCT00085644|615708692|FG002|Open-Label Period|Pregnancy|3|||
170375323|NCT00085644|615708690|FG000|Open-Label Period|Contemplating pregnancy|0|||
170375324|NCT00085644|615708691|FG001|Open-Label Period|Contemplating pregnancy|0|||
170375325|NCT00085644|615708692|FG002|Open-Label Period|Contemplating pregnancy|3|||
170375326|NCT00085644|615708690|FG000|Open-Label Period|Protocol Violation|0|||
170375327|NCT00085644|615708691|FG001|Open-Label Period|Protocol Violation|0|||
170375328|NCT00085644|615708692|FG002|Open-Label Period|Protocol Violation|4|||
170375329|NCT00085644|615708690|FG000|Open-Label Period|Personal reason|0|||
170375330|NCT00085644|615708691|FG001|Open-Label Period|Personal reason|0|||
170375331|NCT00085644|615708692|FG002|Open-Label Period|Personal reason|4|||
170375332|NCT03330106|615708700|FG000|Part A|Withdrawal by Subject|1|||
170375333|NCT03330106|615708701|FG001|Part A|Withdrawal by Subject|1|||
170375334|NCT03330106|615708702|FG002|Part A|Withdrawal by Subject|0|||
170375335|NCT03330106|615708703|FG003|Part A|Withdrawal by Subject|0|||
170375336|NCT03330106|615708700|FG000|Part A|Death|2|||
170375337|NCT03330106|615708701|FG001|Part A|Death|1|||
170375338|NCT03330106|615708702|FG002|Part A|Death|0|||
170375339|NCT03330106|615708703|FG003|Part A|Death|0|||
170375340|NCT03330106|615708700|FG000|Part A|Adverse Event|0|||
170375341|NCT03330106|615708701|FG001|Part A|Adverse Event|1|||
170375342|NCT03330106|615708702|FG002|Part A|Adverse Event|0|||
170375343|NCT03330106|615708703|FG003|Part A|Adverse Event|0|||
170375344|NCT03330106|615708700|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
170375345|NCT03330106|615708701|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
170375346|NCT03330106|615708702|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
170375347|NCT03330106|615708703|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
170375348|NCT03330106|615708700|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
170375349|NCT03330106|615708701|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
170375350|NCT03330106|615708702|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
170375351|NCT03330106|615708703|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
170375352|NCT03330106|615708700|FG000|Part A|Progressive Disease|0|||
170375353|NCT03330106|615708701|FG001|Part A|Progressive Disease|1|||
170375354|NCT03330106|615708702|FG002|Part A|Progressive Disease|0|||
170375355|NCT03330106|615708703|FG003|Part A|Progressive Disease|0|||
170375356|NCT03330106|615708700|FG000|Part B|Lost to Follow-up|0|||
170375357|NCT03330106|615708701|FG001|Part B|Lost to Follow-up|0|||
170375358|NCT03330106|615708702|FG002|Part B|Lost to Follow-up|0|||
170375359|NCT03330106|615708703|FG003|Part B|Lost to Follow-up|1|||
170375360|NCT03330106|615708700|FG000|Part B|Withdrawal by Subject|0|||
170375361|NCT03330106|615708701|FG001|Part B|Withdrawal by Subject|0|||
170375362|NCT03330106|615708702|FG002|Part B|Withdrawal by Subject|4|||
170375363|NCT03330106|615708703|FG003|Part B|Withdrawal by Subject|0|||
170375364|NCT03330106|615708700|FG000|Part B|Death|0|||
170375365|NCT03330106|615708701|FG001|Part B|Death|0|||
170375366|NCT03330106|615708702|FG002|Part B|Death|2|||
170375367|NCT03330106|615708703|FG003|Part B|Death|0|||
170375368|NCT03330106|615708700|FG000|Part B|Clinical Progression|0|||
170375369|NCT03330106|615708701|FG001|Part B|Clinical Progression|0|||
170375370|NCT03330106|615708702|FG002|Part B|Clinical Progression|1|||
170375371|NCT03330106|615708703|FG003|Part B|Clinical Progression|1|||
170375372|NCT03330106|615708700|FG000|Part B|Symptomatic Deterioration|0|||
170375373|NCT03330106|615708701|FG001|Part B|Symptomatic Deterioration|0|||
170375374|NCT03330106|615708702|FG002|Part B|Symptomatic Deterioration|0|||
170375375|NCT03330106|615708703|FG003|Part B|Symptomatic Deterioration|1|||
170375376|NCT03330106|615708700|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
170375377|NCT03330106|615708701|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
170375378|NCT03330106|615708702|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
170375379|NCT03330106|615708703|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
170375380|NCT03330106|615708700|FG000|Part B|Progressive Disease|0|||
170375381|NCT03330106|615708701|FG001|Part B|Progressive Disease|0|||
170375382|NCT03330106|615708702|FG002|Part B|Progressive Disease|11|||
170375383|NCT03330106|615708703|FG003|Part B|Progressive Disease|4|||
170375384|NCT00623766|615708706|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
170375385|NCT00623766|615708707|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
170375386|NCT00623766|615708706|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
170375387|NCT00623766|615708707|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
170375388|NCT00623766|615708706|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
170375389|NCT00623766|615708707|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
170375390|NCT00623766|615708706|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
170375391|NCT00623766|615708707|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
170375392|NCT00623766|615708706|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
170375393|NCT00623766|615708707|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
170375394|NCT00486889|615708711|FG000|Overall Study|Death|3|||
170375395|NCT00486889|615708711|FG000|Overall Study|Non-compliant|2|||
170375396|NCT00486889|615708711|FG000|Overall Study|Withdrawal by Subject|6|||
170375397|NCT02750501|615708712|FG000|Overall Study|Adverse Event|4|||
170375398|NCT02750501|615708712|FG000|Overall Study|Physician Decision|1|||
170375399|NCT02750501|615708712|FG000|Overall Study|Protocol Violation|1|||
170375400|NCT02750501|615708712|FG000|Overall Study|G-tube came out|1|||
170375401|NCT02750501|615708712|FG000|Overall Study|Non-compliant use of PERT|1|||
170375402|NCT00893763|615708713|FG000|Overall Study|extubated|110|||
170375403|NCT00893763|615708714|FG001|Overall Study|extubated|110|||
170375404|NCT01738594|615708715|FG000|Registration and Treatment Start|Adverse Event|0|||
170375405|NCT01738594|615708716|FG001|Registration and Treatment Start|Adverse Event|1|||
170375406|NCT01738594|615708717|FG002|Registration and Treatment Start|Adverse Event|0|||
170375407|NCT01738594|615708718|FG003|Registration and Treatment Start|Adverse Event|0|||
170375408|NCT01738594|615708719|FG004|Registration and Treatment Start|Adverse Event|0|||
170375409|NCT01738594|615708720|FG005|Registration and Treatment Start|Adverse Event|0|||
170375410|NCT01738594|615708721|FG006|Registration and Treatment Start|Adverse Event|0|||
170375411|NCT01738594|615708722|FG007|Registration and Treatment Start|Adverse Event|0|||
170375412|NCT01738594|615708715|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
170375413|NCT01738594|615708716|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
170375414|NCT01738594|615708717|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
170375415|NCT01738594|615708718|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
170375416|NCT01738594|615708719|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
170375417|NCT01738594|615708720|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
170375418|NCT01738594|615708721|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
170375419|NCT01738594|615708722|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
170375420|NCT01738594|615708715|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
170375421|NCT01738594|615708716|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
170375422|NCT01738594|615708717|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
170375423|NCT01738594|615708718|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
170375424|NCT01738594|615708719|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
170375425|NCT01738594|615708720|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
170375426|NCT01738594|615708721|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
170375427|NCT01738594|615708722|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
170375428|NCT01738594|615708715|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
170375429|NCT01738594|615708716|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
170375430|NCT01738594|615708717|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
170375431|NCT01738594|615708718|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
170375432|NCT01738594|615708719|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
170375433|NCT01738594|615708720|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
170375434|NCT01738594|615708721|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
170375435|NCT01738594|615708722|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
170375436|NCT01738594|615708715|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
170375437|NCT01738594|615708716|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
170375438|NCT01738594|615708717|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
170375439|NCT01738594|615708718|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
170375440|NCT01738594|615708719|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
170375441|NCT01738594|615708720|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
170375442|NCT01738594|615708721|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
170375443|NCT01738594|615708722|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
170375444|NCT01738594|615708715|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
170375445|NCT01738594|615708716|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
170375446|NCT01738594|615708717|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
170375447|NCT01738594|615708718|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
170375448|NCT01738594|615708719|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
170375449|NCT01738594|615708720|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
170375450|NCT01738594|615708721|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
170375451|NCT01738594|615708722|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
170375452|NCT01738594|615708715|FG000|Follow up for 1 Year|Death|0|||
170375453|NCT01738594|615708716|FG001|Follow up for 1 Year|Death|0|||
170375454|NCT01738594|615708717|FG002|Follow up for 1 Year|Death|0|||
170375455|NCT01738594|615708718|FG003|Follow up for 1 Year|Death|0|||
170375456|NCT01738594|615708719|FG004|Follow up for 1 Year|Death|0|||
170375457|NCT01738594|615708720|FG005|Follow up for 1 Year|Death|1|||
170375458|NCT01738594|615708721|FG006|Follow up for 1 Year|Death|0|||
170375459|NCT01738594|615708722|FG007|Follow up for 1 Year|Death|0|||
170375460|NCT01738594|615708715|FG000|Follow up for 1 Year|Other|0|||
170375461|NCT01738594|615708716|FG001|Follow up for 1 Year|Other|0|||
170375462|NCT01738594|615708717|FG002|Follow up for 1 Year|Other|0|||
170375463|NCT01738594|615708718|FG003|Follow up for 1 Year|Other|0|||
170375464|NCT01738594|615708719|FG004|Follow up for 1 Year|Other|0|||
170375465|NCT01738594|615708720|FG005|Follow up for 1 Year|Other|2|||
170375466|NCT01738594|615708721|FG006|Follow up for 1 Year|Other|0|||
170375467|NCT01738594|615708722|FG007|Follow up for 1 Year|Other|0|||
170375468|NCT00796549|615708723|FG000|Overall Study|Adverse Event|11|||
170375469|NCT00796549|615708723|FG000|Overall Study|not entered|149|||
170375470|NCT00796549|615708723|FG000|Overall Study|Other|2|||
170375471|NCT00796549|615708723|FG000|Overall Study|Progressive disease|56|||
170375472|NCT04051944|615708725|FG000|Overall Study|Study ending|1|||
170375473|NCT04051944|615708726|FG001|Overall Study|Study ending|1|||
170375474|NCT04051944|615708725|FG000|Overall Study|Early study termination by participant|1|||
170375475|NCT04051944|615708726|FG001|Overall Study|Early study termination by participant|0|||
170375476|NCT04051944|615708725|FG000|Overall Study|Withdrawal by Subject|2|||
170375477|NCT04051944|615708726|FG001|Overall Study|Withdrawal by Subject|2|||
170375478|NCT04051944|615708725|FG000|Overall Study|Lack of Efficacy|3|||
170375479|NCT04051944|615708726|FG001|Overall Study|Lack of Efficacy|0|||
170375480|NCT04051944|615708725|FG000|Overall Study|Adverse event, non- fatal|1|||
170375481|NCT04051944|615708726|FG001|Overall Study|Adverse event, non- fatal|1|||
170375482|NCT01512693|615708727|FG000|Overall Study|Withdrawal by Subject|0|||
170375483|NCT01512693|615708728|FG001|Overall Study|Withdrawal by Subject|1|||
170375484|NCT00942422|615708729|FG000|Overall Study|Withdrawal by Subject|1|||
170375485|NCT00942422|615708729|FG000|Overall Study|Death|1|||
170375486|NCT00942422|615708729|FG000|Overall Study|Progressive diease|1|||
170375487|NCT01437267|615708730|FG000|Overall Study|Withdrawal by Subject|0|||
170375488|NCT01437267|615708731|FG001|Overall Study|Withdrawal by Subject|0|||
170375489|NCT01437267|615708732|FG002|Overall Study|Withdrawal by Subject|0|||
170375490|NCT01437267|615708733|FG003|Overall Study|Withdrawal by Subject|1|||
170375491|NCT01437267|615708734|FG004|Overall Study|Withdrawal by Subject|0|||
170375492|NCT01437267|615708735|FG005|Overall Study|Withdrawal by Subject|0|||
170375493|NCT01437267|615708730|FG000|Overall Study|Protocol Violation|0|||
170375494|NCT01437267|615708731|FG001|Overall Study|Protocol Violation|1|||
170375495|NCT01437267|615708732|FG002|Overall Study|Protocol Violation|0|||
170375496|NCT01437267|615708733|FG003|Overall Study|Protocol Violation|0|||
170375497|NCT01437267|615708734|FG004|Overall Study|Protocol Violation|0|||
170375498|NCT01437267|615708735|FG005|Overall Study|Protocol Violation|0|||
170375499|NCT02774291|615708739|FG000|Overall Study|Lost to Follow-up|1|||
170375500|NCT00149890|615708743|FG000|Overall Study|Adverse Event|1|||
170375501|NCT00149890|615708744|FG001|Overall Study|Adverse Event|8|||
170375502|NCT00149890|615708743|FG000|Overall Study|Lack of Efficacy|8|||
170375503|NCT00149890|615708744|FG001|Overall Study|Lack of Efficacy|9|||
170375504|NCT00149890|615708743|FG000|Overall Study|Protocol Violation|1|||
170375505|NCT00149890|615708744|FG001|Overall Study|Protocol Violation|0|||
170375506|NCT00149890|615708743|FG000|Overall Study|Lost to Follow-up|1|||
170375507|NCT00149890|615708744|FG001|Overall Study|Lost to Follow-up|0|||
170375508|NCT00149890|615708743|FG000|Overall Study|Graft Loss|2|||
170375509|NCT00149890|615708744|FG001|Overall Study|Graft Loss|1|||
170375510|NCT00712270|615708745|FG000|Overall Study|Withdrawal by Subject|11|||
170375511|NCT00712270|615708745|FG000|Overall Study|Screen Failure|3|||
170375512|NCT04412668|615708748|FG000|Overall Study|Death - multiple comorbidities|2|||
170375513|NCT04412668|615708749|FG001|Overall Study|Death - multiple comorbidities|0|||
170375514|NCT04412668|615708750|FG002|Overall Study|Death - multiple comorbidities|0|||
170375515|NCT04412668|615708748|FG000|Overall Study|Withdrawal by Subject|3|||
170375516|NCT04412668|615708749|FG001|Overall Study|Withdrawal by Subject|0|||
170375517|NCT04412668|615708750|FG002|Overall Study|Withdrawal by Subject|0|||
170375518|NCT04412668|615708748|FG000|Overall Study|Other than Specified|2|||
170375519|NCT04412668|615708749|FG001|Overall Study|Other than Specified|0|||
170375520|NCT04412668|615708750|FG002|Overall Study|Other than Specified|0|||
170375521|NCT00796224|615708754|FG000|Overall Study|Adverse Event|1|||
170375522|NCT00796224|615708755|FG001|Overall Study|Adverse Event|0|||
170375523|NCT00796224|615708754|FG000|Overall Study|Protocol Violation|0|||
170375524|NCT00796224|615708755|FG001|Overall Study|Protocol Violation|1|||
170375525|NCT00251589|615708756|FG000|Overall Study|Adverse Event|5|||
170375526|NCT00251589|615708757|FG001|Overall Study|Adverse Event|1|||
170375527|NCT00251589|615708758|FG002|Overall Study|Adverse Event|2|||
170375528|NCT00251589|615708759|FG003|Overall Study|Adverse Event|1|||
170375529|NCT00251589|615708756|FG000|Overall Study|Withdrawal by Subject|1|||
170375530|NCT00251589|615708757|FG001|Overall Study|Withdrawal by Subject|1|||
170375531|NCT00251589|615708758|FG002|Overall Study|Withdrawal by Subject|0|||
170375532|NCT00251589|615708759|FG003|Overall Study|Withdrawal by Subject|0|||
170375533|NCT00251589|615708756|FG000|Overall Study|Discontinued due to progressive disease|9|||
170375534|NCT00251589|615708757|FG001|Overall Study|Discontinued due to progressive disease|1|||
170375535|NCT00251589|615708758|FG002|Overall Study|Discontinued due to progressive disease|0|||
170375536|NCT00251589|615708759|FG003|Overall Study|Discontinued due to progressive disease|1|||
170375537|NCT03227224|615708760|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
170375538|NCT03227224|615708761|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
170375539|NCT03227224|615708762|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
170375540|NCT03227224|615708763|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
170375541|NCT03227224|615708760|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
170375542|NCT03227224|615708761|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
170375543|NCT03227224|615708762|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
170375544|NCT03227224|615708763|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
170375545|NCT03227224|615708760|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
170375546|NCT03227224|615708761|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
170375547|NCT03227224|615708762|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
170375548|NCT03227224|615708763|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
170375549|NCT03227224|615708760|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
170375550|NCT03227224|615708761|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
170375551|NCT03227224|615708762|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
170375552|NCT03227224|615708763|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
170375553|NCT03227224|615708760|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
170375554|NCT03227224|615708761|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
170375555|NCT03227224|615708762|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
170375556|NCT03227224|615708763|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
170375557|NCT03227224|615708760|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
170375558|NCT03227224|615708761|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
170375559|NCT03227224|615708762|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
170375560|NCT03227224|615708763|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
170375561|NCT03227224|615708760|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
170375562|NCT03227224|615708761|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
170375563|NCT03227224|615708762|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
170375564|NCT03227224|615708763|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
170375565|NCT03227224|615708760|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
170375566|NCT03227224|615708761|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
170375567|NCT03227224|615708762|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
170375568|NCT03227224|615708763|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
170375569|NCT03227224|615708760|FG000|Follow-up Phase (2 Weeks)|Other|4|||
170375570|NCT03227224|615708761|FG001|Follow-up Phase (2 Weeks)|Other|4|||
170375571|NCT03227224|615708762|FG002|Follow-up Phase (2 Weeks)|Other|6|||
170375572|NCT03227224|615708763|FG003|Follow-up Phase (2 Weeks)|Other|3|||
170375573|NCT04195750|615708764|FG000|Overall Study|Death|245|||
170375574|NCT04195750|615708765|FG001|Overall Study|Death|253|||
170375575|NCT04195750|615708766|FG002|Overall Study|Death|5|||
170375576|NCT04195750|615708764|FG000|Overall Study|Physician Decision|0|||
170375577|NCT04195750|615708765|FG001|Overall Study|Physician Decision|1|||
170375578|NCT04195750|615708766|FG002|Overall Study|Physician Decision|0|||
170375579|NCT04195750|615708764|FG000|Overall Study|Withdrawal by Subject|9|||
170375580|NCT04195750|615708765|FG001|Overall Study|Withdrawal by Subject|8|||
170375581|NCT04195750|615708766|FG002|Overall Study|Withdrawal by Subject|0|||
170375582|NCT04195750|615708764|FG000|Overall Study|Ongoing|120|||
170375583|NCT04195750|615708765|FG001|Overall Study|Ongoing|110|||
170375584|NCT04195750|615708766|FG002|Overall Study|Ongoing|4|||
170375585|NCT04363944|615708767|FG000|Overall Study|Withdrawal by Subject|2|||
170375586|NCT04363944|615708768|FG001|Overall Study|Withdrawal by Subject|0|||
170375587|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
170375588|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
170375589|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Death|0|||
170375590|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Death|4|||
170375591|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
170375592|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
170375593|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
170375594|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
170375595|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
170375596|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
170375597|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
170375598|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
170375599|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
170375600|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
170375601|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Other|4|||
170375602|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Other|3|||
170375603|NCT03517722|615708769|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
170375604|NCT03517722|615708770|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
170375605|NCT03517722|615708769|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
170375606|NCT03517722|615708770|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
170375607|NCT03517722|615708769|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
170375608|NCT03517722|615708770|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
170375609|NCT03517722|615708769|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
170375610|NCT03517722|615708770|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
170375611|NCT03517722|615708769|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
170375612|NCT03517722|615708770|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
170375613|NCT02177812|615708773|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
170375614|NCT02177812|615708774|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
170375615|NCT02177812|615708775|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
170375616|NCT02177812|615708776|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
170375617|NCT02177812|615708777|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
170375618|NCT02177812|615708778|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
170375619|NCT02177812|615708779|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
170375620|NCT02177812|615708780|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
170375621|NCT02177812|615708781|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
170375622|NCT02177812|615708773|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
170375623|NCT02177812|615708774|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
170375624|NCT02177812|615708775|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
170375625|NCT02177812|615708776|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
170375626|NCT02177812|615708777|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
170375627|NCT02177812|615708778|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
170375628|NCT02177812|615708779|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
170375629|NCT02177812|615708780|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
170375630|NCT02177812|615708781|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
170375631|NCT02177812|615708773|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
170375632|NCT02177812|615708774|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
170375633|NCT02177812|615708775|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
170375634|NCT02177812|615708776|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
170375635|NCT02177812|615708777|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
170375636|NCT02177812|615708778|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
170375637|NCT02177812|615708779|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
170375638|NCT02177812|615708780|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
170375639|NCT02177812|615708781|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
170375640|NCT00089999|615708782|FG000|Overall Study|Adverse Event|4|||
170375641|NCT00089999|615708783|FG001|Overall Study|Adverse Event|7|||
170375642|NCT00089999|615708782|FG000|Overall Study|Withdrawal by Subject|0|||
170375643|NCT00089999|615708783|FG001|Overall Study|Withdrawal by Subject|4|||
170375644|NCT00089999|615708782|FG000|Overall Study|Lost to Follow-up|2|||
170375645|NCT00089999|615708783|FG001|Overall Study|Lost to Follow-up|1|||
170375646|NCT00089999|615708782|FG000|Overall Study|Radiological Progression of Cancer|52|||
170375647|NCT00089999|615708783|FG001|Overall Study|Radiological Progression of Cancer|44|||
170375648|NCT00089999|615708782|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
170375649|NCT00089999|615708783|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
170375650|NCT00089999|615708782|FG000|Overall Study|Death|3|||
170375651|NCT00089999|615708783|FG001|Overall Study|Death|3|||
170375652|NCT00089999|615708782|FG000|Overall Study|Poor General Condition|1|||
170375653|NCT00089999|615708783|FG001|Overall Study|Poor General Condition|0|||
170375654|NCT00089999|615708782|FG000|Overall Study|Clinical Progression|1|||
170375655|NCT00089999|615708783|FG001|Overall Study|Clinical Progression|2|||
170375656|NCT00089999|615708782|FG000|Overall Study|Physician Decision|2|||
170375657|NCT00089999|615708783|FG001|Overall Study|Physician Decision|2|||
170375658|NCT00089999|615708782|FG000|Overall Study|Patient Underwent Surgery|2|||
170375659|NCT00089999|615708783|FG001|Overall Study|Patient Underwent Surgery|0|||
170375660|NCT00089999|615708782|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
170375661|NCT00089999|615708783|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
170375662|NCT03039569|615708784|FG000|Overall Study|Lost to Follow-up|5|||
170375663|NCT03039569|615708785|FG001|Overall Study|Lost to Follow-up|4|||
170375664|NCT04076579|615710177|FG000|Overall Study|Adverse Event|2|||
170375665|NCT04076579|615710178|FG001|Overall Study|Adverse Event|0|||
170375666|NCT04076579|615710177|FG000|Overall Study|discontinued due to toxicity|1|||
170375667|NCT04076579|615710178|FG001|Overall Study|discontinued due to toxicity|0|||
170375668|NCT04076579|615710177|FG000|Overall Study|Physician Decision|1|||
170375669|NCT04076579|615710178|FG001|Overall Study|Physician Decision|0|||
170375670|NCT04076579|615710177|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
170375671|NCT04076579|615710178|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
170375672|NCT04076579|615710177|FG000|Overall Study|Noncompliance|0|||
170375673|NCT04076579|615710178|FG001|Overall Study|Noncompliance|1|||
170375674|NCT04076579|615710177|FG000|Overall Study|Withdrawal by Subject|0|||
170375675|NCT04076579|615710178|FG001|Overall Study|Withdrawal by Subject|2|||
170375676|NCT00934791|615710182|FG000|Overall Study|Withdrawal by Subject|1|||
170375677|NCT00934791|615710183|FG001|Overall Study|Withdrawal by Subject|0|||
170375678|NCT00963469|615710184|FG000|Overall Study|Adverse Event|15|||
170375679|NCT00963469|615710185|FG001|Overall Study|Adverse Event|11|||
170375680|NCT00963469|615710186|FG002|Overall Study|Adverse Event|1|||
170375681|NCT00963469|615710184|FG000|Overall Study|Lack of Efficacy|10|||
170375682|NCT00963469|615710185|FG001|Overall Study|Lack of Efficacy|7|||
170375683|NCT00963469|615710186|FG002|Overall Study|Lack of Efficacy|2|||
170375684|NCT00963469|615710184|FG000|Overall Study|Lost to Follow-up|1|||
170375685|NCT00963469|615710185|FG001|Overall Study|Lost to Follow-up|1|||
170375686|NCT00963469|615710186|FG002|Overall Study|Lost to Follow-up|0|||
170375687|NCT00963469|615710184|FG000|Overall Study|Protocol Violation|5|||
170375688|NCT00963469|615710185|FG001|Overall Study|Protocol Violation|5|||
170375689|NCT00963469|615710186|FG002|Overall Study|Protocol Violation|3|||
170375690|NCT00963469|615710184|FG000|Overall Study|Withdrawal by Subject|4|||
170375691|NCT00963469|615710185|FG001|Overall Study|Withdrawal by Subject|1|||
170375692|NCT00963469|615710186|FG002|Overall Study|Withdrawal by Subject|1|||
170375693|NCT00963469|615710184|FG000|Overall Study|Pre-randomization Adverse Event|1|||
170375694|NCT00963469|615710185|FG001|Overall Study|Pre-randomization Adverse Event|2|||
170375695|NCT00963469|615710186|FG002|Overall Study|Pre-randomization Adverse Event|0|||
170375696|NCT00963469|615710184|FG000|Overall Study|Moved|1|||
170375697|NCT00963469|615710185|FG001|Overall Study|Moved|0|||
170375698|NCT00963469|615710186|FG002|Overall Study|Moved|0|||
170375699|NCT00963469|615710184|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
170375700|NCT00963469|615710185|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
170375701|NCT00963469|615710186|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
170375702|NCT04124952|615710188|FG000|Overall Study|Lost to Follow-up|1|||
170375703|NCT03763942|615710190|FG000|Overall Study|Lost to Follow-up|114|||
170375704|NCT03763942|615710191|FG001|Overall Study|Lost to Follow-up|54|||
170375705|NCT03763942|615710190|FG000|Overall Study|Protocol Violation|1|||
170375706|NCT03763942|615710191|FG001|Overall Study|Protocol Violation|0|||
170375707|NCT03763942|615710190|FG000|Overall Study|Withdrawal by Subject|2|||
170375708|NCT03763942|615710191|FG001|Overall Study|Withdrawal by Subject|0|||
170375709|NCT03763942|615710190|FG000|Overall Study|Other|2|||
170375710|NCT03763942|615710191|FG001|Overall Study|Other|3|||
170375711|NCT00939055|615710196|FG000|Overall Study|Discontinuation prior to procedure|4|||
170375712|NCT00939055|615710197|FG001|Overall Study|Discontinuation prior to procedure|0|||
170375713|NCT01944462|615710201|FG000|PPPP Educational Program|Lost to Follow-up|60|||
170375714|NCT00808028|615710202|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
170375715|NCT00808028|615710203|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
170375716|NCT00808028|615710204|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
170375717|NCT00808028|615710205|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
170375718|NCT00808028|615710202|FG000|Stage 1 (6 Months)|Other|1|||
170375719|NCT00808028|615710203|FG001|Stage 1 (6 Months)|Other|0|||
170375720|NCT00808028|615710204|FG002|Stage 1 (6 Months)|Other|2|||
170375721|NCT00808028|615710205|FG003|Stage 1 (6 Months)|Other|4|||
170375722|NCT00808028|615710202|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
170375723|NCT00808028|615710203|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
170375724|NCT00808028|615710204|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
170375725|NCT00808028|615710205|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
170375726|NCT00808028|615710202|FG000|Stage 1 (6 Months)|Adverse Event|0|||
170375727|NCT00808028|615710203|FG001|Stage 1 (6 Months)|Adverse Event|0|||
170375728|NCT00808028|615710204|FG002|Stage 1 (6 Months)|Adverse Event|1|||
170375729|NCT00808028|615710205|FG003|Stage 1 (6 Months)|Adverse Event|2|||
170375730|NCT00808028|615710202|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
170375731|NCT00808028|615710203|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
170375732|NCT00808028|615710204|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
170375733|NCT00808028|615710205|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
170375734|NCT00808028|615710202|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
170375735|NCT00808028|615710203|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
170375736|NCT00808028|615710204|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
170375737|NCT00808028|615710205|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
170375738|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
170375739|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
170375740|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
170375741|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
170375742|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
170375743|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
170375744|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
170375745|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
170398691|NCT00306852|615798247|FG001|Overall Study|Lost to Follow-up|24|||
170375746|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
170375747|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
170375748|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
170375749|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
170375750|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
170375751|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
170375752|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
170375753|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
170375754|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
170375755|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
170375756|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
170375757|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
170375758|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
170375759|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
170375760|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
170375761|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
170375762|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
170375763|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
170375764|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
170375765|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
170375766|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
170375767|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
170375768|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
170375769|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
170375770|NCT00808028|615710202|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
170375771|NCT00808028|615710203|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
170375772|NCT00808028|615710204|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
170375773|NCT00808028|615710205|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
170375774|NCT04651777|615710206|FG000|Overall Study|Adverse Event|1|||
170375775|NCT04651777|615710206|FG000|Overall Study|Withdrawal by Subject|2|||
170375776|NCT00610714|615710207|FG000|Overall Study|Adverse Event|3|||
170375777|NCT00610714|615710208|FG001|Overall Study|Adverse Event|1|||
170375778|NCT00610714|615710207|FG000|Overall Study|Death|12|||
170375779|NCT00610714|615710208|FG001|Overall Study|Death|18|||
170375780|NCT00610714|615710207|FG000|Overall Study|Withdrawal by Subject|9|||
170375781|NCT00610714|615710208|FG001|Overall Study|Withdrawal by Subject|3|||
170375782|NCT00610714|615710207|FG000|Overall Study|Study completion at 120 PFS events|2|||
170375783|NCT00610714|615710208|FG001|Overall Study|Study completion at 120 PFS events|2|||
170375784|NCT01023516|615710210|FG000|Overall Study|Voluntary discontinuation|7|||
170375785|NCT01023516|615710211|FG001|Overall Study|Voluntary discontinuation|5|||
170375786|NCT01023516|615710210|FG000|Overall Study|Adverse Event|9|||
170375787|NCT01023516|615710211|FG001|Overall Study|Adverse Event|6|||
170375788|NCT01023516|615710210|FG000|Overall Study|Safety reason|0|||
170375789|NCT01023516|615710211|FG001|Overall Study|Safety reason|3|||
170375790|NCT01023516|615710210|FG000|Overall Study|Study-specific criteria|4|||
170375791|NCT01023516|615710211|FG001|Overall Study|Study-specific criteria|2|||
170375792|NCT01023516|615710210|FG000|Overall Study|Incorrect enrolment|4|||
170375793|NCT01023516|615710211|FG001|Overall Study|Incorrect enrolment|2|||
170375794|NCT00515099|615710212|FG000|Overall Study|Lost to Follow-up|0|||
170375795|NCT00515099|615710213|FG001|Overall Study|Lost to Follow-up|4|||
170375796|NCT00515099|615710212|FG000|Overall Study|Withdrawal by Subject|2|||
170375797|NCT00515099|615710213|FG001|Overall Study|Withdrawal by Subject|0|||
170375798|NCT00515099|615710212|FG000|Overall Study|IRB Recommendation|1|||
170375799|NCT00515099|615710213|FG001|Overall Study|IRB Recommendation|0|||
170375800|NCT00592072|615710214|FG000|Wash Out Period|Lost to Follow-up|1|||
170375801|NCT00592072|615710215|FG001|Wash Out Period|Lost to Follow-up|1|||
170375802|NCT00414973|615710218|FG000|Overall Study|Withdrawal by Subject|14|||
170375803|NCT00414973|615710219|FG001|Overall Study|Withdrawal by Subject|4|||
170375804|NCT00414973|615710220|FG002|Overall Study|Withdrawal by Subject|1|||
170375805|NCT00414973|615710221|FG003|Overall Study|Withdrawal by Subject|0|||
170375806|NCT00414973|615710218|FG000|Overall Study|Adverse Event|10|||
170375807|NCT00414973|615710219|FG001|Overall Study|Adverse Event|0|||
170375808|NCT00414973|615710220|FG002|Overall Study|Adverse Event|1|||
170375809|NCT00414973|615710221|FG003|Overall Study|Adverse Event|0|||
170375810|NCT00414973|615710218|FG000|Overall Study|Protocol Violation|3|||
170375811|NCT00414973|615710219|FG001|Overall Study|Protocol Violation|4|||
170375812|NCT00414973|615710220|FG002|Overall Study|Protocol Violation|0|||
170375813|NCT00414973|615710221|FG003|Overall Study|Protocol Violation|0|||
170375814|NCT00414973|615710218|FG000|Overall Study|Lost to Follow-up|0|||
170375815|NCT00414973|615710219|FG001|Overall Study|Lost to Follow-up|2|||
170375816|NCT00414973|615710220|FG002|Overall Study|Lost to Follow-up|0|||
170375817|NCT00414973|615710221|FG003|Overall Study|Lost to Follow-up|0|||
170375818|NCT00414973|615710218|FG000|Overall Study|Sponsor Decision|1|||
170375819|NCT00414973|615710219|FG001|Overall Study|Sponsor Decision|0|||
170375820|NCT00414973|615710220|FG002|Overall Study|Sponsor Decision|0|||
170375821|NCT00414973|615710221|FG003|Overall Study|Sponsor Decision|0|||
170375822|NCT00414973|615710218|FG000|Overall Study|Death|0|||
170375823|NCT00414973|615710219|FG001|Overall Study|Death|0|||
170375824|NCT00414973|615710220|FG002|Overall Study|Death|1|||
170375825|NCT00414973|615710221|FG003|Overall Study|Death|0|||
170375826|NCT01466062|615710222|FG000|Overall Study|Adverse Event|1|||
170375827|NCT01466062|615710222|FG000|Overall Study|Withdrawal by Subject|1|||
170375828|NCT00403390|615710223|FG000|Overall Study|Withdrawal by Subject|1|||
170375829|NCT00403390|615710224|FG001|Overall Study|Withdrawal by Subject|0|||
170375830|NCT00403390|615710223|FG000|Overall Study|samples lost|1|||
170375831|NCT00403390|615710224|FG001|Overall Study|samples lost|0|||
170375832|NCT00403390|615710223|FG000|Overall Study|non-compliant|1|||
170375833|NCT00403390|615710224|FG001|Overall Study|non-compliant|0|||
170375834|NCT03523715|615710225|FG000|Overall Study|Lost to Follow-up|11|||
170375835|NCT03523715|615710226|FG001|Overall Study|Lost to Follow-up|14|||
170375836|NCT03523715|615710225|FG000|Overall Study|Did not meet inclusion criteria|1|||
170375837|NCT03523715|615710226|FG001|Overall Study|Did not meet inclusion criteria|0|||
170375838|NCT03523715|615710225|FG000|Overall Study|Internally inconsistent reporting|0|||
170375839|NCT03523715|615710226|FG001|Overall Study|Internally inconsistent reporting|2|||
170375840|NCT00606229|615710227|FG000|Overall Study|Adverse Event|11|||
170375841|NCT00606229|615710227|FG000|Overall Study|Lack of Efficacy|1|||
170375842|NCT00606229|615710227|FG000|Overall Study|Withdrawal by Subject|4|||
170375843|NCT00606229|615710227|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
170375844|NCT00606229|615710227|FG000|Overall Study|change of residence or other commitments|2|||
170375845|NCT01526928|615710228|FG000|Overall Study|Progressive Disease|35|||
170375846|NCT01526928|615710229|FG001|Overall Study|Progressive Disease|17|||
170375847|NCT01526928|615710230|FG002|Overall Study|Progressive Disease|150|||
170375848|NCT01526928|615710231|FG003|Overall Study|Progressive Disease|182|||
170375849|NCT01526928|615710232|FG004|Overall Study|Progressive Disease|76|||
170375850|NCT01526928|615710233|FG005|Overall Study|Progressive Disease|4|||
170375851|NCT01526928|615710228|FG000|Overall Study|Adverse Event|2|||
170375852|NCT01526928|615710229|FG001|Overall Study|Adverse Event|1|||
170375853|NCT01526928|615710230|FG002|Overall Study|Adverse Event|29|||
170375854|NCT01526928|615710231|FG003|Overall Study|Adverse Event|40|||
170375855|NCT01526928|615710232|FG004|Overall Study|Adverse Event|13|||
170375856|NCT01526928|615710233|FG005|Overall Study|Adverse Event|2|||
170375857|NCT01526928|615710228|FG000|Overall Study|Death|0|||
170375858|NCT01526928|615710229|FG001|Overall Study|Death|0|||
170375859|NCT01526928|615710230|FG002|Overall Study|Death|3|||
170375860|NCT01526928|615710231|FG003|Overall Study|Death|0|||
170375861|NCT01526928|615710232|FG004|Overall Study|Death|0|||
170375862|NCT01526928|615710233|FG005|Overall Study|Death|0|||
170375863|NCT01526928|615710228|FG000|Overall Study|Withdrawal by Subject|1|||
170375864|NCT01526928|615710229|FG001|Overall Study|Withdrawal by Subject|0|||
170375865|NCT01526928|615710230|FG002|Overall Study|Withdrawal by Subject|13|||
170375866|NCT01526928|615710231|FG003|Overall Study|Withdrawal by Subject|11|||
170375867|NCT01526928|615710232|FG004|Overall Study|Withdrawal by Subject|3|||
170375868|NCT01526928|615710233|FG005|Overall Study|Withdrawal by Subject|0|||
170375869|NCT01526928|615710228|FG000|Overall Study|Physician Decision|0|||
170375870|NCT01526928|615710229|FG001|Overall Study|Physician Decision|0|||
170375871|NCT01526928|615710230|FG002|Overall Study|Physician Decision|2|||
170375872|NCT01526928|615710231|FG003|Overall Study|Physician Decision|5|||
170375873|NCT01526928|615710232|FG004|Overall Study|Physician Decision|0|||
170375874|NCT01526928|615710233|FG005|Overall Study|Physician Decision|0|||
170375875|NCT01526928|615710228|FG000|Overall Study|Other Reason|0|||
170375876|NCT01526928|615710229|FG001|Overall Study|Other Reason|1|||
170375877|NCT01526928|615710230|FG002|Overall Study|Other Reason|11|||
170375878|NCT01526928|615710231|FG003|Overall Study|Other Reason|4|||
170375879|NCT01526928|615710232|FG004|Overall Study|Other Reason|1|||
170375880|NCT01526928|615710233|FG005|Overall Study|Other Reason|0|||
170375881|NCT01526928|615710228|FG000|Overall Study|Lost to Follow-up|0|||
170375882|NCT01526928|615710229|FG001|Overall Study|Lost to Follow-up|0|||
170375883|NCT01526928|615710230|FG002|Overall Study|Lost to Follow-up|0|||
170375884|NCT01526928|615710231|FG003|Overall Study|Lost to Follow-up|1|||
170375885|NCT01526928|615710232|FG004|Overall Study|Lost to Follow-up|0|||
170375886|NCT01526928|615710233|FG005|Overall Study|Lost to Follow-up|0|||
170375887|NCT01526928|615710228|FG000|Overall Study|Protocol Deviation|0|||
170375888|NCT01526928|615710229|FG001|Overall Study|Protocol Deviation|0|||
170375889|NCT01526928|615710230|FG002|Overall Study|Protocol Deviation|0|||
170375890|NCT01526928|615710231|FG003|Overall Study|Protocol Deviation|2|||
170375891|NCT01526928|615710232|FG004|Overall Study|Protocol Deviation|0|||
170375892|NCT01526928|615710233|FG005|Overall Study|Protocol Deviation|0|||
170375893|NCT01526928|615710228|FG000|Overall Study|Missing|0|||
170375894|NCT01526928|615710229|FG001|Overall Study|Missing|0|||
170375895|NCT01526928|615710230|FG002|Overall Study|Missing|1|||
170375896|NCT01526928|615710231|FG003|Overall Study|Missing|0|||
170375897|NCT01526928|615710232|FG004|Overall Study|Missing|2|||
170375898|NCT01526928|615710233|FG005|Overall Study|Missing|0|||
170375899|NCT01842334|615710234|FG000|Overall Study|Withdrawal by Subject|3|||
170375900|NCT01842334|615710235|FG001|Overall Study|Withdrawal by Subject|3|||
170375901|NCT01842334|615710234|FG000|Overall Study|Moved away mid-study|0|||
170375902|NCT01842334|615710235|FG001|Overall Study|Moved away mid-study|1|||
170375903|NCT00376675|615710236|FG000|Overall Study|Withdrawal by Subject|9|||
170375904|NCT00376675|615710237|FG001|Overall Study|Withdrawal by Subject|2|||
170375905|NCT00376675|615710236|FG000|Overall Study|Adverse Event|10|||
170375906|NCT00376675|615710237|FG001|Overall Study|Adverse Event|5|||
170375907|NCT00376675|615710236|FG000|Overall Study|Other Reason|1|||
170375908|NCT00376675|615710237|FG001|Overall Study|Other Reason|7|||
170375909|NCT01332851|615710240|FG000|Overall Study|Withdrawal by Subject|4|||
170375910|NCT01332851|615710241|FG001|Overall Study|Withdrawal by Subject|2|||
170375911|NCT01332851|615710240|FG000|Overall Study|Lost to Follow-up|7|||
170375912|NCT01332851|615710241|FG001|Overall Study|Lost to Follow-up|11|||
170375913|NCT05559203|615710247|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
170375914|NCT00422903|615710250|FG000|Overall Study|Disease Progression|3|||
170375915|NCT00422903|615710251|FG001|Overall Study|Disease Progression|1|||
170375916|NCT00422903|615710250|FG000|Overall Study|Adverse Event|0|||
170375917|NCT00422903|615710251|FG001|Overall Study|Adverse Event|2|||
170375918|NCT00422903|615710250|FG000|Overall Study|Informed Consent Withdrawn|1|||
170375919|NCT00422903|615710251|FG001|Overall Study|Informed Consent Withdrawn|2|||
170375920|NCT03446612|615710252|FG000|Overall Study|Protocol defined stopping criteria|0|||
170375921|NCT03446612|615710253|FG001|Overall Study|Protocol defined stopping criteria|1|||
170375922|NCT02829775|615710258|FG000|Overall Study|Death|1|||
170375923|NCT02829775|615710258|FG000|Overall Study|Withdrawal by Subject|3|||
170375924|NCT02829775|615710258|FG000|Overall Study|Disease remission|1|||
170375925|NCT03796195|615710261|FG000|Overall Study|Study closed early|1|||
170375926|NCT04445051|615710262|FG000|Overall Study|Adverse Event|0|||
170375927|NCT04445051|615710263|FG001|Overall Study|Adverse Event|0|||
170375928|NCT04445051|615710264|FG002|Overall Study|Adverse Event|1|||
170375929|NCT04445051|615710265|FG003|Overall Study|Adverse Event|0|||
170375930|NCT04445051|615710266|FG004|Overall Study|Adverse Event|0|||
170375931|NCT04445051|615710267|FG005|Overall Study|Adverse Event|0|||
170375932|NCT02392468|615710274|FG000|Overall Study|Adverse Event|0|||
170375933|NCT02392468|615710275|FG001|Overall Study|Adverse Event|1|||
170375934|NCT02392468|615710276|FG002|Overall Study|Adverse Event|0|||
170375935|NCT02392468|615710277|FG003|Overall Study|Adverse Event|0|||
170375936|NCT02392468|615710278|FG004|Overall Study|Adverse Event|0|||
170375937|NCT02392468|615710279|FG005|Overall Study|Adverse Event|1|||
170375938|NCT01039428|615710280|FG000|Overall Study|Protocol Violation|1|||
170375939|NCT01039428|615710281|FG001|Overall Study|Protocol Violation|0|||
170375940|NCT01039428|615710280|FG000|Overall Study|Withdrawal by Subject|1|||
170375941|NCT01039428|615710281|FG001|Overall Study|Withdrawal by Subject|0|||
170375942|NCT01313039|615710282|FG000|Overall Study|Physician Decision|1|||
170375943|NCT01313039|615710282|FG000|Overall Study|Adverse Event|1|||
170375944|NCT05083949|615710283|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
170375945|NCT05083949|615710284|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
170375946|NCT05083949|615710283|FG000|Period 1|Adverse Event|1|||
170375947|NCT05083949|615710284|FG001|Period 1|Adverse Event|1|||
170375948|NCT05083949|615710283|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
170375949|NCT05083949|615710284|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
170375950|NCT05083949|615710283|FG000|Period 2|Adverse Event|0|||
170375951|NCT05083949|615710284|FG001|Period 2|Adverse Event|2|||
170375952|NCT04973085|615710291|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
170375953|NCT04973085|615710292|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
170375954|NCT01188811|615710293|FG000|Overall Study|Withdrawal by Subject|0|||
170375955|NCT01188811|615710294|FG001|Overall Study|Withdrawal by Subject|2|||
170375956|NCT01188811|615710293|FG000|Overall Study|Adverse Event|6|||
170375957|NCT01188811|615710294|FG001|Overall Study|Adverse Event|0|||
170375958|NCT01316380|615710296|FG000|Overall Study|Adverse Event|0|||
170375959|NCT01316380|615710297|FG001|Overall Study|Adverse Event|2|||
170375960|NCT01316380|615710298|FG002|Overall Study|Adverse Event|1|||
170375961|NCT01316380|615710296|FG000|Overall Study|Protocol Violation|0|||
170375962|NCT01316380|615710297|FG001|Overall Study|Protocol Violation|0|||
170375963|NCT01316380|615710298|FG002|Overall Study|Protocol Violation|1|||
170375964|NCT01316380|615710296|FG000|Overall Study|Withdrawal by Subject|1|||
170375965|NCT01316380|615710297|FG001|Overall Study|Withdrawal by Subject|2|||
170375966|NCT01316380|615710298|FG002|Overall Study|Withdrawal by Subject|0|||
170375967|NCT01316380|615710296|FG000|Overall Study|Other|0|||
170375968|NCT01316380|615710297|FG001|Overall Study|Other|1|||
170375969|NCT01316380|615710298|FG002|Overall Study|Other|1|||
170375970|NCT01316380|615710296|FG000|Overall Study|Not treated|1|||
170375971|NCT01316380|615710297|FG001|Overall Study|Not treated|0|||
170375972|NCT01316380|615710298|FG002|Overall Study|Not treated|0|||
170375973|NCT05116683|615710300|FG000|Overall Study|Physician Decision|4|||
170375974|NCT02569398|615710311|FG000|Overall Study|Adverse Event|0|||
170375975|NCT02569398|615710312|FG001|Overall Study|Adverse Event|1|||
170375976|NCT02569398|615710313|FG002|Overall Study|Adverse Event|6|||
170375977|NCT02569398|615710311|FG000|Overall Study|Withdrawal by Subject|43|||
170375978|NCT02569398|615710312|FG001|Overall Study|Withdrawal by Subject|43|||
170375979|NCT02569398|615710313|FG002|Overall Study|Withdrawal by Subject|30|||
170375980|NCT02569398|615710311|FG000|Overall Study|Study terminated by sponsor|130|||
170375981|NCT02569398|615710312|FG001|Overall Study|Study terminated by sponsor|131|||
170375982|NCT02569398|615710313|FG002|Overall Study|Study terminated by sponsor|134|||
170375983|NCT02569398|615710311|FG000|Overall Study|Other|12|||
170375984|NCT02569398|615710312|FG001|Overall Study|Other|14|||
170375985|NCT02569398|615710313|FG002|Overall Study|Other|13|||
170375986|NCT02571972|615710316|FG000|Overall Study|Protocol Violation|2|||
170375987|NCT02571972|615710316|FG000|Overall Study|Withdrawal by Subject|2|||
170375988|NCT03573804|615710321|FG000|Overall Study|claustrophobia or MRI table problems|10|||
170375989|NCT01592773|615712278|FG000|Overall Study|Study Terminated by Sponsor|582|||
170375990|NCT01592773|615712278|FG000|Overall Study|Withdrawal by Subject|35|||
170375991|NCT01592773|615712278|FG000|Overall Study|Lost to Follow-up|19|||
170375992|NCT01592773|615712278|FG000|Overall Study|Adverse Event|17|||
170375993|NCT01592773|615712278|FG000|Overall Study|Lack of Efficacy|9|||
170375994|NCT01592773|615712278|FG000|Overall Study|Protocol Violation|2|||
170375995|NCT01592773|615712278|FG000|Overall Study|Inclusion/exclusion not meet|1|||
170375996|NCT01592773|615712278|FG000|Overall Study|Other Reason|1|||
170375997|NCT02972658|615712279|FG000|Overall Study|Adverse Event|0|||
170375998|NCT02972658|615712280|FG001|Overall Study|Adverse Event|3|||
170375999|NCT02972658|615712281|FG002|Overall Study|Adverse Event|0|||
170376000|NCT02972658|615712282|FG003|Overall Study|Adverse Event|2|||
170376001|NCT02972658|615712279|FG000|Overall Study|Other-determined by Investigator|1|||
170376002|NCT02972658|615712280|FG001|Overall Study|Other-determined by Investigator|1|||
170376003|NCT02972658|615712281|FG002|Overall Study|Other-determined by Investigator|0|||
170376004|NCT02972658|615712282|FG003|Overall Study|Other-determined by Investigator|0|||
170376005|NCT02972658|615712279|FG000|Overall Study|Death|0|||
170376006|NCT02972658|615712280|FG001|Overall Study|Death|0|||
170376007|NCT02972658|615712281|FG002|Overall Study|Death|0|||
170376008|NCT02972658|615712282|FG003|Overall Study|Death|1|||
170376009|NCT02972658|615712279|FG000|Overall Study|Lost to Follow-up|0|||
170376010|NCT02972658|615712280|FG001|Overall Study|Lost to Follow-up|1|||
170376011|NCT02972658|615712281|FG002|Overall Study|Lost to Follow-up|1|||
170376012|NCT02972658|615712282|FG003|Overall Study|Lost to Follow-up|2|||
170376013|NCT02972658|615712279|FG000|Overall Study|Progressive Disease|0|||
170376014|NCT02972658|615712280|FG001|Overall Study|Progressive Disease|1|||
170376015|NCT02972658|615712281|FG002|Overall Study|Progressive Disease|0|||
170376016|NCT02972658|615712282|FG003|Overall Study|Progressive Disease|1|||
170376017|NCT02972658|615712279|FG000|Overall Study|Withdrawal by Subject|4|||
170376018|NCT02972658|615712280|FG001|Overall Study|Withdrawal by Subject|4|||
170376019|NCT02972658|615712281|FG002|Overall Study|Withdrawal by Subject|1|||
170376020|NCT02972658|615712282|FG003|Overall Study|Withdrawal by Subject|6|||
170376021|NCT02972658|615712279|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
170376022|NCT02972658|615712280|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
170376023|NCT02972658|615712281|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
170376024|NCT02972658|615712282|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
170376025|NCT02972658|615712279|FG000|Overall Study|Sponsor Decision|70|||
170376026|NCT02972658|615712280|FG001|Overall Study|Sponsor Decision|127|||
170376027|NCT02972658|615712281|FG002|Overall Study|Sponsor Decision|72|||
170376028|NCT02972658|615712282|FG003|Overall Study|Sponsor Decision|119|||
170376029|NCT00740116|615712286|FG000|Overall Study|Withdrawal by Subject|1|||
170376030|NCT00740116|615712287|FG001|Overall Study|Withdrawal by Subject|1|||
170376031|NCT00740116|615712286|FG000|Overall Study|Protocol Violation|1|||
170376032|NCT00740116|615712287|FG001|Overall Study|Protocol Violation|4|||
170376033|NCT03958149|615712288|FG000|Overall Study|Withdrawal by Subject|0|||
170376034|NCT03958149|615712289|FG001|Overall Study|Withdrawal by Subject|1|||
170376035|NCT02785588|615712290|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
170376036|NCT02785588|615712290|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
170376037|NCT03037489|615712291|FG000|Overall Study|Adverse Event|4|||
170376038|NCT03037489|615712292|FG001|Overall Study|Adverse Event|0|||
170376039|NCT03037489|615712291|FG000|Overall Study|Withdrawal by Subject|3|||
170376040|NCT03037489|615712292|FG001|Overall Study|Withdrawal by Subject|0|||
170376041|NCT00621764|615712293|FG000|Overall Study|Protocol Violation|0|||
170376042|NCT00621764|615712294|FG001|Overall Study|Protocol Violation|0|||
170376043|NCT00621764|615712295|FG002|Overall Study|Protocol Violation|0|||
170376044|NCT00621764|615712296|FG003|Overall Study|Protocol Violation|1|||
170376045|NCT02499172|615712297|FG000|Overall Study|Financial reason|0|||
170376046|NCT02499172|615712298|FG001|Overall Study|Financial reason|0|||
170376047|NCT02499172|615712299|FG002|Overall Study|Financial reason|523|||
170376048|NCT02499172|615712300|FG003|Overall Study|Financial reason|436|||
170376049|NCT02499172|615712297|FG000|Overall Study|Lost to Follow-up|65|||
170376050|NCT02499172|615712298|FG001|Overall Study|Lost to Follow-up|64|||
170376051|NCT02499172|615712299|FG002|Overall Study|Lost to Follow-up|0|||
170376052|NCT02499172|615712300|FG003|Overall Study|Lost to Follow-up|0|||
170376053|NCT01293123|615712301|FG000|Overall Study|Lost to Follow-up|0|||
170376054|NCT01293123|615712302|FG001|Overall Study|Lost to Follow-up|1|||
170376055|NCT00121485|615712303|FG000|Overall Study|Not implanted|1|||
170376056|NCT00121485|615712304|FG001|Overall Study|Not implanted|5|||
170376057|NCT00121485|615712303|FG000|Overall Study|Crossover|0|||
170376058|NCT00121485|615712304|FG001|Overall Study|Crossover|2|||
170376059|NCT03031327|615712311|FG000|Overall Study|Withdrawal by Subject|0|||
170376060|NCT03031327|615712312|FG001|Overall Study|Withdrawal by Subject|1|||
170376061|NCT03031327|615712313|FG002|Overall Study|Withdrawal by Subject|1|||
170376062|NCT01888965|615712317|FG000|Overall Study|Adverse Event|5|||
170376063|NCT01888965|615712317|FG000|Overall Study|Lack of Efficacy|4|||
170376064|NCT02531633|615712318|FG000|Part A (52 Weeks)|Sponsor request|24|||
170376065|NCT02531633|615712319|FG001|Part A (52 Weeks)|Sponsor request|24|||
170376066|NCT02531633|615712320|FG002|Part A (52 Weeks)|Sponsor request|18|||
170376067|NCT02531633|615712321|FG003|Part A (52 Weeks)|Sponsor request|18|||
170376068|NCT02531633|615712322|FG004|Part A (52 Weeks)|Sponsor request|19|||
170376069|NCT02531633|615712323|FG005|Part A (52 Weeks)|Sponsor request|0|||
170376070|NCT02531633|615712324|FG006|Part A (52 Weeks)|Sponsor request|0|||
170376071|NCT02531633|615712325|FG007|Part A (52 Weeks)|Sponsor request|0|||
170376072|NCT02531633|615712326|FG008|Part A (52 Weeks)|Sponsor request|0|||
170376073|NCT02531633|615712327|FG009|Part A (52 Weeks)|Sponsor request|0|||
170376074|NCT02531633|615712318|FG000|Part A (52 Weeks)|Protocol Violation|1|||
170376075|NCT02531633|615712319|FG001|Part A (52 Weeks)|Protocol Violation|0|||
170376076|NCT02531633|615712320|FG002|Part A (52 Weeks)|Protocol Violation|0|||
170376077|NCT02531633|615712321|FG003|Part A (52 Weeks)|Protocol Violation|0|||
170376078|NCT02531633|615712322|FG004|Part A (52 Weeks)|Protocol Violation|0|||
170376079|NCT02531633|615712323|FG005|Part A (52 Weeks)|Protocol Violation|0|||
170376080|NCT02531633|615712324|FG006|Part A (52 Weeks)|Protocol Violation|0|||
170376081|NCT02531633|615712325|FG007|Part A (52 Weeks)|Protocol Violation|0|||
170376082|NCT02531633|615712326|FG008|Part A (52 Weeks)|Protocol Violation|0|||
170376083|NCT02531633|615712327|FG009|Part A (52 Weeks)|Protocol Violation|0|||
170376084|NCT02531633|615712318|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
170376085|NCT02531633|615712319|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
170376086|NCT02531633|615712320|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
170376087|NCT02531633|615712321|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
170376088|NCT02531633|615712322|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
170376089|NCT02531633|615712323|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
170376090|NCT02531633|615712324|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
170376091|NCT02531633|615712325|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
170376092|NCT02531633|615712326|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
170376093|NCT02531633|615712327|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
170376094|NCT02531633|615712318|FG000|Part A (52 Weeks)|Physician Decision|1|||
170376095|NCT02531633|615712319|FG001|Part A (52 Weeks)|Physician Decision|4|||
170376096|NCT02531633|615712320|FG002|Part A (52 Weeks)|Physician Decision|3|||
170376097|NCT02531633|615712321|FG003|Part A (52 Weeks)|Physician Decision|1|||
170376098|NCT02531633|615712322|FG004|Part A (52 Weeks)|Physician Decision|0|||
170376099|NCT02531633|615712323|FG005|Part A (52 Weeks)|Physician Decision|0|||
170376100|NCT02531633|615712324|FG006|Part A (52 Weeks)|Physician Decision|0|||
170376101|NCT02531633|615712325|FG007|Part A (52 Weeks)|Physician Decision|0|||
170376102|NCT02531633|615712326|FG008|Part A (52 Weeks)|Physician Decision|0|||
170376103|NCT02531633|615712327|FG009|Part A (52 Weeks)|Physician Decision|0|||
170376104|NCT02531633|615712318|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
170376105|NCT02531633|615712319|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
170376106|NCT02531633|615712320|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
170376107|NCT02531633|615712321|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
170376108|NCT02531633|615712322|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
170376109|NCT02531633|615712323|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
170376110|NCT02531633|615712324|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
170376111|NCT02531633|615712325|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
170376112|NCT02531633|615712326|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
170376113|NCT02531633|615712327|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
170376114|NCT02531633|615712318|FG000|Part A (52 Weeks)|Other|2|||
170376115|NCT02531633|615712319|FG001|Part A (52 Weeks)|Other|0|||
170376116|NCT02531633|615712320|FG002|Part A (52 Weeks)|Other|0|||
170376117|NCT02531633|615712321|FG003|Part A (52 Weeks)|Other|0|||
170376118|NCT02531633|615712322|FG004|Part A (52 Weeks)|Other|0|||
170376119|NCT02531633|615712323|FG005|Part A (52 Weeks)|Other|0|||
170376120|NCT02531633|615712324|FG006|Part A (52 Weeks)|Other|0|||
170376121|NCT02531633|615712325|FG007|Part A (52 Weeks)|Other|0|||
170376122|NCT02531633|615712326|FG008|Part A (52 Weeks)|Other|0|||
170376123|NCT02531633|615712327|FG009|Part A (52 Weeks)|Other|0|||
170376124|NCT02531633|615712318|FG000|Part B (104 Weeks)|Sponsor request|0|||
170376125|NCT02531633|615712319|FG001|Part B (104 Weeks)|Sponsor request|0|||
170376126|NCT02531633|615712320|FG002|Part B (104 Weeks)|Sponsor request|0|||
170376127|NCT02531633|615712321|FG003|Part B (104 Weeks)|Sponsor request|0|||
170376128|NCT02531633|615712322|FG004|Part B (104 Weeks)|Sponsor request|0|||
170376129|NCT02531633|615712323|FG005|Part B (104 Weeks)|Sponsor request|8|||
170376130|NCT02531633|615712324|FG006|Part B (104 Weeks)|Sponsor request|5|||
170376131|NCT02531633|615712325|FG007|Part B (104 Weeks)|Sponsor request|3|||
170376132|NCT02531633|615712326|FG008|Part B (104 Weeks)|Sponsor request|5|||
170376133|NCT02531633|615712327|FG009|Part B (104 Weeks)|Sponsor request|4|||
170376134|NCT02531633|615712318|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
170376135|NCT02531633|615712319|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
170376136|NCT02531633|615712320|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
170376137|NCT02531633|615712321|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
170376138|NCT02531633|615712322|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
170376139|NCT02531633|615712323|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
170376140|NCT02531633|615712324|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
170376141|NCT02531633|615712325|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
170376142|NCT02531633|615712326|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
170376143|NCT02531633|615712327|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
170376144|NCT04097925|615712328|FG000|Overall Study|Withdrawal by Subject|1|||
170376145|NCT01736176|615712332|FG000|Overall Study|Adverse Event|3|||
170376146|NCT01736176|615712332|FG000|Overall Study|Withdrawal by Subject|4|||
170376147|NCT01736176|615712332|FG000|Overall Study|Lack of Efficacy|3|||
170376148|NCT01736176|615712332|FG000|Overall Study|Unable to Complete PEG Placement|1|||
170376149|NCT00768040|615712333|FG000|Overall Study|Adverse Event|3|||
170376150|NCT00768040|615712334|FG001|Overall Study|Adverse Event|2|||
170376151|NCT00768040|615712333|FG000|Overall Study|Abnormal laboratory value|1|||
170376152|NCT00768040|615712334|FG001|Overall Study|Abnormal laboratory value|1|||
170376153|NCT03650387|615712335|FG000|Overall Study|Withdrawal by Subject|13|||
170376154|NCT03650387|615712335|FG000|Overall Study|Lost to Follow-up|12|||
170376155|NCT03650387|615712335|FG000|Overall Study|Adverse Event (Not related)|1|||
170376156|NCT03650387|615712335|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
170376157|NCT00417248|615712336|FG000|Overall Study|Study Terminated|6|||
170376158|NCT00417248|615712336|FG000|Overall Study|Death|1|||
170376159|NCT00417248|615712336|FG000|Overall Study|Lack of Efficacy|1|||
170376160|NCT03661983|615712339|FG000|Open Label Stabilization Phase|Adverse Event|5|||
170376161|NCT03661983|615712340|FG001|Open Label Stabilization Phase|Adverse Event|0|||
170376162|NCT03661983|615712341|FG002|Open Label Stabilization Phase|Adverse Event|0|||
170376163|NCT03661983|615712342|FG003|Open Label Stabilization Phase|Adverse Event|0|||
170376164|NCT03661983|615712339|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
170376165|NCT03661983|615712340|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
170376166|NCT03661983|615712341|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
170376167|NCT03661983|615712342|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
170376168|NCT03661983|615712339|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
170376169|NCT03661983|615712340|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
170376170|NCT03661983|615712341|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
170376171|NCT03661983|615712342|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
170376172|NCT03661983|615712339|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
170376173|NCT03661983|615712340|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
170376174|NCT03661983|615712341|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
170376175|NCT03661983|615712342|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
170376176|NCT03661983|615712339|FG000|Double-blind Randomized Phase|Adverse Event|0|||
170376177|NCT03661983|615712340|FG001|Double-blind Randomized Phase|Adverse Event|1|||
170376178|NCT03661983|615712341|FG002|Double-blind Randomized Phase|Adverse Event|0|||
170376179|NCT03661983|615712342|FG003|Double-blind Randomized Phase|Adverse Event|0|||
170376180|NCT03661983|615712339|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
170376181|NCT03661983|615712340|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
170376182|NCT03661983|615712341|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
170376183|NCT03661983|615712342|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
170376184|NCT03661983|615712339|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
170376185|NCT03661983|615712340|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
170376186|NCT03661983|615712341|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
170376187|NCT03661983|615712342|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
170376188|NCT03661983|615712339|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
170376189|NCT03661983|615712340|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
170376190|NCT03661983|615712341|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
170376191|NCT03661983|615712342|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
170376192|NCT02425891|615712343|FG000|Overall Study|Death|333|||
170376193|NCT02425891|615712344|FG001|Overall Study|Death|314|||
170376194|NCT02425891|615712343|FG000|Overall Study|Lost to Follow-up|4|||
170376195|NCT02425891|615712344|FG001|Overall Study|Lost to Follow-up|6|||
170376196|NCT02425891|615712343|FG000|Overall Study|Non-Compliance|1|||
170376197|NCT02425891|615712344|FG001|Overall Study|Non-Compliance|1|||
170376198|NCT02425891|615712343|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
170376199|NCT02425891|615712344|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
170376200|NCT02425891|615712343|FG000|Overall Study|Physician Decision|0|||
170376201|NCT02425891|615712344|FG001|Overall Study|Physician Decision|1|||
170376202|NCT02425891|615712343|FG000|Overall Study|Protocol Violation|1|||
170376203|NCT02425891|615712344|FG001|Overall Study|Protocol Violation|1|||
170376204|NCT02425891|615712343|FG000|Overall Study|Study Terminated By Sponsor|85|||
170376205|NCT02425891|615712344|FG001|Overall Study|Study Terminated By Sponsor|95|||
170376206|NCT02425891|615712343|FG000|Overall Study|Withdrawal by Subject|27|||
170376207|NCT02425891|615712344|FG001|Overall Study|Withdrawal by Subject|32|||
170376208|NCT03093350|615712352|FG000|Overall Study|Death|1|||
170376209|NCT03093350|615712352|FG000|Overall Study|Signed consent, never began treartment|1|||
170376210|NCT03887052|615712353|FG000|Overall Study|Adverse Event|2|||
170376211|NCT03887052|615712353|FG000|Overall Study|Physician Decision|2|||
170376212|NCT03887052|615712353|FG000|Overall Study|Withdrawal by Subject|3|||
170376213|NCT03887052|615712353|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
170376214|NCT03887052|615712353|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
170376215|NCT00081263|615712354|FG000|Overall Study|clerical error|1|||
170376216|NCT00081263|615712355|FG001|Overall Study|clerical error|0|||
170376217|NCT00081263|615712354|FG000|Overall Study|wrong cell type|7|||
170376218|NCT00081263|615712355|FG001|Overall Study|wrong cell type|5|||
170376219|NCT00081263|615712354|FG000|Overall Study|improper pre-protocol therapy|0|||
170376220|NCT00081263|615712355|FG001|Overall Study|improper pre-protocol therapy|1|||
170376221|NCT00081263|615712354|FG000|Overall Study|Inadequate pathology|0|||
170376222|NCT00081263|615712355|FG001|Overall Study|Inadequate pathology|1|||
170376223|NCT00081263|615712354|FG000|Overall Study|Never treated|4|||
170376224|NCT00081263|615712355|FG001|Overall Study|Never treated|5|||
170376225|NCT00081263|615712354|FG000|Overall Study|Inadequate data|5|||
170376226|NCT00081263|615712355|FG001|Overall Study|Inadequate data|10|||
170376227|NCT01852591|615712356|FG000|Overall Study|Withdrawal by Subject|2|||
170376228|NCT01852591|615712356|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
170376229|NCT00777036|615712363|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
170376230|NCT00777036|615712364|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
170376231|NCT00777036|615712365|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
170376232|NCT00777036|615712366|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
170376233|NCT00777036|615712363|FG000|On Treatment|Administrative Reason By Sponsor|1|||
170376234|NCT00777036|615712364|FG001|On Treatment|Administrative Reason By Sponsor|0|||
170376235|NCT00777036|615712365|FG002|On Treatment|Administrative Reason By Sponsor|9|||
170376236|NCT00777036|615712366|FG003|On Treatment|Administrative Reason By Sponsor|0|||
170376237|NCT00777036|615712363|FG000|On Treatment|Failure to Meet Study Criteria|0|||
170376238|NCT00777036|615712364|FG001|On Treatment|Failure to Meet Study Criteria|1|||
170376239|NCT00777036|615712365|FG002|On Treatment|Failure to Meet Study Criteria|4|||
170376240|NCT00777036|615712366|FG003|On Treatment|Failure to Meet Study Criteria|0|||
170376241|NCT00777036|615712363|FG000|On Treatment|Pregnancy|1|||
170376242|NCT00777036|615712364|FG001|On Treatment|Pregnancy|0|||
170376243|NCT00777036|615712365|FG002|On Treatment|Pregnancy|1|||
170376244|NCT00777036|615712366|FG003|On Treatment|Pregnancy|0|||
170376245|NCT00777036|615712363|FG000|On Treatment|Non-compliance with Study Drug|1|||
170376246|NCT00777036|615712364|FG001|On Treatment|Non-compliance with Study Drug|0|||
170376247|NCT00777036|615712365|FG002|On Treatment|Non-compliance with Study Drug|1|||
170376248|NCT00777036|615712366|FG003|On Treatment|Non-compliance with Study Drug|0|||
170376249|NCT00777036|615712363|FG000|On Treatment|Maximum Clinical Benefit|2|||
170376250|NCT00777036|615712364|FG001|On Treatment|Maximum Clinical Benefit|0|||
170376251|NCT00777036|615712365|FG002|On Treatment|Maximum Clinical Benefit|5|||
170376252|NCT00777036|615712366|FG003|On Treatment|Maximum Clinical Benefit|0|||
170376253|NCT00777036|615712363|FG000|On Treatment|Withdrawal by Subject|0|||
170376254|NCT00777036|615712364|FG001|On Treatment|Withdrawal by Subject|2|||
170376255|NCT00777036|615712365|FG002|On Treatment|Withdrawal by Subject|2|||
170376256|NCT00777036|615712366|FG003|On Treatment|Withdrawal by Subject|0|||
170376257|NCT00777036|615712363|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
170376258|NCT00777036|615712364|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
170376259|NCT00777036|615712365|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
170376260|NCT00777036|615712366|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
170376261|NCT00777036|615712363|FG000|On Treatment|Death|0|||
170376262|NCT00777036|615712364|FG001|On Treatment|Death|2|||
170376263|NCT00777036|615712365|FG002|On Treatment|Death|0|||
170376264|NCT00777036|615712366|FG003|On Treatment|Death|0|||
170376265|NCT00777036|615712363|FG000|On Treatment|Study Drug Toxicity|1|||
170376266|NCT00777036|615712364|FG001|On Treatment|Study Drug Toxicity|0|||
170376267|NCT00777036|615712365|FG002|On Treatment|Study Drug Toxicity|4|||
170376268|NCT00777036|615712366|FG003|On Treatment|Study Drug Toxicity|0|||
170376269|NCT00777036|615712363|FG000|On Treatment|Progressive Disease|6|||
170376270|NCT00777036|615712364|FG001|On Treatment|Progressive Disease|4|||
170376271|NCT00777036|615712365|FG002|On Treatment|Progressive Disease|7|||
170376272|NCT00777036|615712366|FG003|On Treatment|Progressive Disease|0|||
170376273|NCT00777036|615712363|FG000|On Treatment|Not Reported|0|||
170376274|NCT00777036|615712364|FG001|On Treatment|Not Reported|0|||
170376275|NCT00777036|615712365|FG002|On Treatment|Not Reported|2|||
170376276|NCT00777036|615712366|FG003|On Treatment|Not Reported|0|||
170376277|NCT00777036|615712363|FG000|On Treatment|Site Closed|0|||
170376278|NCT00777036|615712364|FG001|On Treatment|Site Closed|1|||
170376279|NCT00777036|615712365|FG002|On Treatment|Site Closed|1|||
170376280|NCT00777036|615712366|FG003|On Treatment|Site Closed|0|||
170376281|NCT00777036|615712363|FG000|Follow-Up|Withdrawal by Subject|0|||
170376282|NCT00777036|615712364|FG001|Follow-Up|Withdrawal by Subject|0|||
170376283|NCT00777036|615712365|FG002|Follow-Up|Withdrawal by Subject|5|||
170376284|NCT00777036|615712366|FG003|Follow-Up|Withdrawal by Subject|0|||
170376285|NCT00777036|615712363|FG000|Follow-Up|Death|1|||
170376286|NCT00777036|615712364|FG001|Follow-Up|Death|9|||
170376287|NCT00777036|615712365|FG002|Follow-Up|Death|0|||
170376288|NCT00777036|615712366|FG003|Follow-Up|Death|0|||
170376289|NCT00777036|615712363|FG000|Follow-Up|Lost to Follow-up|3|||
170376290|NCT00777036|615712364|FG001|Follow-Up|Lost to Follow-up|0|||
170376291|NCT00777036|615712365|FG002|Follow-Up|Lost to Follow-up|0|||
170376292|NCT00777036|615712366|FG003|Follow-Up|Lost to Follow-up|0|||
170376293|NCT00777036|615712363|FG000|Follow-Up|Reason Not Specified|4|||
170376294|NCT00777036|615712364|FG001|Follow-Up|Reason Not Specified|0|||
170376295|NCT00777036|615712365|FG002|Follow-Up|Reason Not Specified|13|||
170376296|NCT00777036|615712366|FG003|Follow-Up|Reason Not Specified|0|||
170376297|NCT00777036|615712363|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
170376298|NCT00777036|615712364|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
170376299|NCT00777036|615712365|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
170376300|NCT00777036|615712366|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
170376301|NCT01267955|615712367|FG000|Stage 1 (6 Months)|Death|3|||
170376302|NCT01267955|615712367|FG000|Stage 2 (6 Months)|Death|5|||
170376303|NCT01267955|615712367|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
170376304|NCT05564039|615712368|FG000|Overall Study|Adverse Event|1|||
170376305|NCT05564039|615712369|FG001|Overall Study|Adverse Event|0|||
170376306|NCT05564039|615712368|FG000|Overall Study|Death|1|||
170376307|NCT05564039|615712369|FG001|Overall Study|Death|1|||
170376308|NCT05564039|615712368|FG000|Overall Study|Lost to Follow-up|3|||
170376309|NCT05564039|615712369|FG001|Overall Study|Lost to Follow-up|2|||
170376310|NCT05564039|615712368|FG000|Overall Study|Withdrawal by Subject|2|||
170376311|NCT05564039|615712369|FG001|Overall Study|Withdrawal by Subject|0|||
170376312|NCT05564039|615712368|FG000|Overall Study|Inadvertent enrollment|3|||
170376313|NCT05564039|615712369|FG001|Overall Study|Inadvertent enrollment|6|||
170376314|NCT01263470|615712371|FG000|Overall Study|Adverse Event|2|||
170376315|NCT01263470|615712372|FG001|Overall Study|Adverse Event|2|||
170376316|NCT01263470|615712373|FG002|Overall Study|Adverse Event|1|||
170376317|NCT01263470|615712374|FG003|Overall Study|Adverse Event|1|||
170376318|NCT01263470|615712375|FG004|Overall Study|Adverse Event|2|||
170376319|NCT01263470|615712376|FG005|Overall Study|Adverse Event|2|||
170376320|NCT01263470|615712371|FG000|Overall Study|Protocol Violation|0|||
170376321|NCT01263470|615712372|FG001|Overall Study|Protocol Violation|1|||
170376322|NCT01263470|615712373|FG002|Overall Study|Protocol Violation|0|||
170376323|NCT01263470|615712374|FG003|Overall Study|Protocol Violation|0|||
170376324|NCT01263470|615712375|FG004|Overall Study|Protocol Violation|0|||
170376325|NCT01263470|615712376|FG005|Overall Study|Protocol Violation|1|||
170376326|NCT01263470|615712371|FG000|Overall Study|Withdrawal by Subject|0|||
170376327|NCT01263470|615712372|FG001|Overall Study|Withdrawal by Subject|1|||
170376328|NCT01263470|615712373|FG002|Overall Study|Withdrawal by Subject|1|||
170376329|NCT01263470|615712374|FG003|Overall Study|Withdrawal by Subject|2|||
170376330|NCT01263470|615712375|FG004|Overall Study|Withdrawal by Subject|0|||
170376331|NCT01263470|615712376|FG005|Overall Study|Withdrawal by Subject|2|||
170376332|NCT01263470|615712371|FG000|Overall Study|Lack of Efficacy|0|||
170376333|NCT01263470|615712372|FG001|Overall Study|Lack of Efficacy|0|||
170376334|NCT01263470|615712373|FG002|Overall Study|Lack of Efficacy|2|||
170376335|NCT01263470|615712374|FG003|Overall Study|Lack of Efficacy|0|||
170376336|NCT01263470|615712375|FG004|Overall Study|Lack of Efficacy|0|||
170376337|NCT01263470|615712376|FG005|Overall Study|Lack of Efficacy|0|||
170376338|NCT01263470|615712371|FG000|Overall Study|Participant Unavailability|0|||
170376339|NCT01263470|615712372|FG001|Overall Study|Participant Unavailability|1|||
170376340|NCT01263470|615712373|FG002|Overall Study|Participant Unavailability|0|||
170376341|NCT01263470|615712374|FG003|Overall Study|Participant Unavailability|0|||
170376342|NCT01263470|615712375|FG004|Overall Study|Participant Unavailability|0|||
170376343|NCT01263470|615712376|FG005|Overall Study|Participant Unavailability|0|||
170376344|NCT01263470|615712371|FG000|Overall Study|Study Drug Non-compliance|0|||
170376345|NCT01263470|615712372|FG001|Overall Study|Study Drug Non-compliance|0|||
170376346|NCT01263470|615712373|FG002|Overall Study|Study Drug Non-compliance|0|||
170376347|NCT01263470|615712374|FG003|Overall Study|Study Drug Non-compliance|0|||
170376348|NCT01263470|615712375|FG004|Overall Study|Study Drug Non-compliance|1|||
170376349|NCT01263470|615712376|FG005|Overall Study|Study Drug Non-compliance|0|||
170376350|NCT01327573|615712377|FG000|Overall Study|Physician Decision|3|||
170376351|NCT01327573|615712378|FG001|Overall Study|Physician Decision|1|||
170376352|NCT01685372|615712379|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
170376353|NCT01685372|615712380|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
170376354|NCT00772889|615712382|FG000|Overall Study|Adverse Event|7|||
170376355|NCT00772889|615712383|FG001|Overall Study|Adverse Event|4|||
170376356|NCT00772889|615712384|FG002|Overall Study|Adverse Event|0|||
170376357|NCT00772889|615712382|FG000|Overall Study|Withdrawal by Subject|9|||
170376358|NCT00772889|615712383|FG001|Overall Study|Withdrawal by Subject|8|||
170376359|NCT00772889|615712384|FG002|Overall Study|Withdrawal by Subject|9|||
170376360|NCT00772889|615712382|FG000|Overall Study|Lost to Follow-up|6|||
170376361|NCT00772889|615712383|FG001|Overall Study|Lost to Follow-up|6|||
170376362|NCT00772889|615712384|FG002|Overall Study|Lost to Follow-up|7|||
170376363|NCT03323086|615712385|FG000|Overall Study|Lost to Follow-up|3|||
170376364|NCT03323086|615712386|FG001|Overall Study|Lost to Follow-up|2|||
170376365|NCT01796106|615712388|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
170376366|NCT01796106|615712389|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
170376367|NCT04430036|615712390|FG000|Safety Run in Phase|Progression of disease|2|||
170376368|NCT04107935|615712391|FG000|Overall Study|Death|1|||
170376369|NCT04107935|615712392|FG001|Overall Study|Death|0|||
170376370|NCT01947894|615712396|FG000|Overall Study|Other|3|||
170376371|NCT01947894|615712397|FG001|Overall Study|Other|4|||
170376372|NCT01947894|615712398|FG002|Overall Study|Other|3|||
170376373|NCT01947894|615712396|FG000|Overall Study|Withdrawal by Subject|12|||
170376374|NCT01947894|615712397|FG001|Overall Study|Withdrawal by Subject|4|||
170376375|NCT01947894|615712398|FG002|Overall Study|Withdrawal by Subject|1|||
170376376|NCT01947894|615712396|FG000|Overall Study|Death|12|||
170376377|NCT01947894|615712397|FG001|Overall Study|Death|1|||
170376378|NCT01947894|615712398|FG002|Overall Study|Death|0|||
170376379|NCT01947894|615712396|FG000|Overall Study|Physician Decision|2|||
170376380|NCT01947894|615712397|FG001|Overall Study|Physician Decision|0|||
170376381|NCT01947894|615712398|FG002|Overall Study|Physician Decision|0|||
170376382|NCT01947894|615712396|FG000|Overall Study|Adverse Event|5|||
170376383|NCT01947894|615712397|FG001|Overall Study|Adverse Event|1|||
170376384|NCT01947894|615712398|FG002|Overall Study|Adverse Event|0|||
170376385|NCT01947894|615712396|FG000|Overall Study|Switched to other growth hormone brand|53|||
170376386|NCT01947894|615712397|FG001|Overall Study|Switched to other growth hormone brand|8|||
170376387|NCT01947894|615712398|FG002|Overall Study|Switched to other growth hormone brand|23|||
170376388|NCT03630016|615712400|FG000|Overall Study|Poor Sensor Placement|1|||
170376389|NCT02470429|615712407|FG000|Overall Study|Adverse Event|1|||
170376390|NCT02470429|615712408|FG001|Overall Study|Adverse Event|0|||
170376391|NCT02470429|615712407|FG000|Overall Study|Withdrawal by Subject|1|||
170376392|NCT02470429|615712408|FG001|Overall Study|Withdrawal by Subject|0|||
170376393|NCT01602744|615712409|FG000|Overall Study|Death|17|||
170376394|NCT01602744|615712410|FG001|Overall Study|Death|15|||
170376395|NCT01602744|615712409|FG000|Overall Study|Lost to Follow-up|13|||
170376396|NCT01602744|615712410|FG001|Overall Study|Lost to Follow-up|8|||
170376397|NCT03924427|615712411|FG000|Overall Study|Adverse Event|4|||
170376398|NCT03924427|615712411|FG000|Overall Study|Lack of Efficacy|1|||
170376399|NCT03924427|615712411|FG000|Overall Study|Withdrawal by Subject|1|||
170376400|NCT01976624|615712412|FG000|Overall Study|Participants contraindicated|2|||
170376401|NCT01976624|615712412|FG000|Overall Study|Participants age less than 19 years|12|||
170376402|NCT01894776|615712413|FG000|Overall Study|Withdrawal by Subject|1|||
170376403|NCT00471315|615712414|FG000|Overall Study|Adverse Event|7|||
170376404|NCT00471315|615712414|FG000|Overall Study|Withdrawal by Subject|1|||
170376405|NCT00609167|615712418|FG000|Overall Study|Withdrawal by Subject|1|||
170376406|NCT00609167|615712419|FG001|Overall Study|Withdrawal by Subject|0|||
170376407|NCT00609167|615712418|FG000|Overall Study|Lack of Efficacy|1|||
170376408|NCT00609167|615712419|FG001|Overall Study|Lack of Efficacy|0|||
170376409|NCT00609167|615712418|FG000|Overall Study|Adverse Event|5|||
170376410|NCT00609167|615712419|FG001|Overall Study|Adverse Event|1|||
170376411|NCT00609167|615712418|FG000|Overall Study|Disease Progression|1|||
170376412|NCT00609167|615712419|FG001|Overall Study|Disease Progression|0|||
170376413|NCT00609167|615712418|FG000|Overall Study|Stem Cell Transplant|0|||
170376414|NCT00609167|615712419|FG001|Overall Study|Stem Cell Transplant|6|||
170376415|NCT02574520|615712420|FG000|Overall Study|Not dosed|2|||
170376416|NCT02574520|615712421|FG001|Overall Study|Not dosed|0|||
170376417|NCT02574520|615712422|FG002|Overall Study|Not dosed|5|||
170376418|NCT02574520|615712423|FG003|Overall Study|Not dosed|4|||
170376419|NCT02574520|615712420|FG000|Overall Study|Adverse Event|0|||
170376420|NCT02574520|615712421|FG001|Overall Study|Adverse Event|0|||
170376421|NCT02574520|615712422|FG002|Overall Study|Adverse Event|0|||
170376422|NCT02574520|615712423|FG003|Overall Study|Adverse Event|1|||
170376423|NCT02574520|615712420|FG000|Overall Study|Withdrawal by Subject|0|||
170376424|NCT02574520|615712421|FG001|Overall Study|Withdrawal by Subject|0|||
170376425|NCT02574520|615712422|FG002|Overall Study|Withdrawal by Subject|0|||
170376426|NCT02574520|615712423|FG003|Overall Study|Withdrawal by Subject|1|||
170376427|NCT02574520|615712420|FG000|Overall Study|Other|0|||
170376428|NCT02574520|615712421|FG001|Overall Study|Other|0|||
170376429|NCT02574520|615712422|FG002|Overall Study|Other|0|||
170376430|NCT02574520|615712423|FG003|Overall Study|Other|2|||
170376431|NCT01365091|615712426|FG000|Period 1|Adverse Event|1|||
170376432|NCT01365091|615712427|FG001|Period 1|Adverse Event|0|||
170376433|NCT01365091|615712428|FG002|Period 1|Adverse Event|2|||
170376434|NCT01365091|615712429|FG003|Period 1|Adverse Event|3|||
170376435|NCT01365091|615712426|FG000|Period 1|Positive test result for drugs of abuse|1|||
170376436|NCT01365091|615712427|FG001|Period 1|Positive test result for drugs of abuse|0|||
170376437|NCT01365091|615712428|FG002|Period 1|Positive test result for drugs of abuse|0|||
170376438|NCT01365091|615712429|FG003|Period 1|Positive test result for drugs of abuse|0|||
170376439|NCT01365091|615712426|FG000|Period 1|No longer met study criteria|0|||
170376440|NCT01365091|615712427|FG001|Period 1|No longer met study criteria|1|||
170376441|NCT01365091|615712428|FG002|Period 1|No longer met study criteria|0|||
170376442|NCT01365091|615712429|FG003|Period 1|No longer met study criteria|0|||
170376443|NCT01365091|615712426|FG000|Period 1|Withdrawal by Subject|0|||
170376444|NCT01365091|615712427|FG001|Period 1|Withdrawal by Subject|1|||
170376445|NCT01365091|615712428|FG002|Period 1|Withdrawal by Subject|0|||
170376446|NCT01365091|615712429|FG003|Period 1|Withdrawal by Subject|0|||
170376447|NCT01365091|615712426|FG000|Period 1|Personal reasons|0|||
170376448|NCT01365091|615712427|FG001|Period 1|Personal reasons|0|||
170376449|NCT01365091|615712428|FG002|Period 1|Personal reasons|1|||
170376450|NCT01365091|615712429|FG003|Period 1|Personal reasons|0|||
170376451|NCT01365091|615712426|FG000|Period 2|Withdrawal by Subject|1|||
170376452|NCT01365091|615712427|FG001|Period 2|Withdrawal by Subject|0|||
170376453|NCT01365091|615712428|FG002|Period 2|Withdrawal by Subject|0|||
170376454|NCT01365091|615712429|FG003|Period 2|Withdrawal by Subject|0|||
170376455|NCT01365091|615712426|FG000|Period 2|Adverse Event|0|||
170376456|NCT01365091|615712427|FG001|Period 2|Adverse Event|0|||
170376457|NCT01365091|615712428|FG002|Period 2|Adverse Event|1|||
170376458|NCT01365091|615712429|FG003|Period 2|Adverse Event|0|||
170376459|NCT05307523|615712431|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
170376460|NCT05307523|615712432|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
170376461|NCT05307523|615712431|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
170376462|NCT05307523|615712432|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
170376463|NCT03935594|615712437|FG000|Overall Study|Physician Decision|3|||
170376464|NCT02059174|615713809|FG000|Period 1|Withdrawal by Subject|0|||
170376465|NCT02059174|615713810|FG001|Period 1|Withdrawal by Subject|2|||
170376466|NCT02059174|615713809|FG000|Period 2|Withdrawal by Subject|0|||
170376467|NCT02059174|615713810|FG001|Period 2|Withdrawal by Subject|2|||
170376468|NCT02059174|615713809|FG000|Period 2|Protocol Violation|1|||
170376469|NCT02059174|615713810|FG001|Period 2|Protocol Violation|0|||
170376470|NCT02059174|615713809|FG000|Period 3|Physician Decision|1|||
170376471|NCT02059174|615713810|FG001|Period 3|Physician Decision|0|||
170376472|NCT00186121|615713815|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
170376473|NCT00186121|615713815|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
170376474|NCT00186121|615713815|FG000|Overall Study|Not eligible (no treatment)|1|||
170376475|NCT01569568|615713816|FG000|Overall Study|Physician Decision|0|||
170376476|NCT01569568|615713817|FG001|Overall Study|Physician Decision|2|||
170376477|NCT05815758|615713818|FG000|Overall Study|Adverse Event|6|||
170376478|NCT05815758|615713819|FG001|Overall Study|Adverse Event|2|||
170376479|NCT05815758|615713818|FG000|Overall Study|Lost to Follow-up|14|||
170376480|NCT05815758|615713819|FG001|Overall Study|Lost to Follow-up|1|||
170376481|NCT05815758|615713818|FG000|Overall Study|Withdrawal by Subject|6|||
170376482|NCT05815758|615713819|FG001|Overall Study|Withdrawal by Subject|6|||
170376483|NCT05815758|615713818|FG000|Overall Study|Protocol Violation|1|||
170376484|NCT05815758|615713819|FG001|Overall Study|Protocol Violation|1|||
170376485|NCT05815758|615713818|FG000|Overall Study|Discontinued|4|||
170376486|NCT05815758|615713819|FG001|Overall Study|Discontinued|4|||
170376487|NCT02903966|615713820|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
170376488|NCT02903966|615713821|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
170376489|NCT02903966|615713820|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
170376490|NCT02903966|615713821|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
170376491|NCT02903966|615713820|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
170376492|NCT02903966|615713821|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
170376493|NCT03345849|615713823|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
170376494|NCT03345849|615713824|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
170376495|NCT03345849|615713825|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
170376496|NCT03345849|615713826|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
170376497|NCT03345849|615713823|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
170376498|NCT03345849|615713824|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
170376499|NCT03345849|615713825|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
170376500|NCT03345849|615713826|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
170376501|NCT03345849|615713823|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
170376502|NCT03345849|615713824|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
170376503|NCT03345849|615713825|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
170376504|NCT03345849|615713826|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
170376505|NCT03345849|615713823|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
170376506|NCT03345849|615713824|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
170376507|NCT03345849|615713825|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
170376508|NCT03345849|615713826|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
170376509|NCT03345849|615713823|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
170376510|NCT03345849|615713824|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
170376511|NCT03345849|615713825|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
170376512|NCT03345849|615713826|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
170376513|NCT03345849|615713823|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
170376514|NCT03345849|615713824|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
170376515|NCT03345849|615713825|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
170376516|NCT03345849|615713826|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
170376517|NCT03345849|615713823|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
170376518|NCT03345849|615713824|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
170376519|NCT03345849|615713825|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
170376520|NCT03345849|615713826|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
170376521|NCT03345849|615713823|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
170376522|NCT03345849|615713824|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
170376523|NCT03345849|615713825|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
170376524|NCT03345849|615713826|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
170376525|NCT03345849|615713823|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
170376526|NCT03345849|615713824|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
170376527|NCT03345849|615713825|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
170376528|NCT03345849|615713826|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
170376529|NCT03345849|615713823|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
170376530|NCT03345849|615713824|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
170376531|NCT03345849|615713825|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
170376532|NCT03345849|615713826|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
170376533|NCT03345849|615713823|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
170376534|NCT03345849|615713824|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
170376535|NCT03345849|615713825|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
170376536|NCT03345849|615713826|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
170376537|NCT02511106|615713827|FG000|Overall Study|Lost to Follow-up|6|||
170376538|NCT02511106|615713828|FG001|Overall Study|Lost to Follow-up|4|||
170376539|NCT02511106|615713827|FG000|Overall Study|Withdrawal by Subject|24|||
170376540|NCT02511106|615713828|FG001|Overall Study|Withdrawal by Subject|21|||
170376541|NCT02511106|615713827|FG000|Overall Study|Death|42|||
170376542|NCT02511106|615713828|FG001|Overall Study|Death|82|||
170376543|NCT02511106|615713827|FG000|Overall Study|Ongoing study at data cut-off|3|||
170376544|NCT02511106|615713828|FG001|Overall Study|Ongoing study at data cut-off|2|||
170376545|NCT02511106|615713827|FG000|Overall Study|Without specified reason|3|||
170376546|NCT02511106|615713828|FG001|Overall Study|Without specified reason|0|||
170376547|NCT03991936|615713829|FG000|Overall Study|Lost to Follow-up|1|||
170376548|NCT03991936|615713830|FG001|Overall Study|Lost to Follow-up|1|||
170376549|NCT03991936|615713831|FG002|Overall Study|Lost to Follow-up|1|||
170376550|NCT03991936|615713832|FG003|Overall Study|Lost to Follow-up|1|||
170376551|NCT03991936|615713833|FG004|Overall Study|Lost to Follow-up|1|||
170376552|NCT00723489|615713834|FG000|Overall Study|Physician Decision|0|||
170376553|NCT00723489|615713835|FG001|Overall Study|Physician Decision|1|||
170376554|NCT00723489|615713836|FG002|Overall Study|Physician Decision|0|||
170376555|NCT00723489|615713837|FG003|Overall Study|Physician Decision|0|||
170376556|NCT00723489|615713834|FG000|Overall Study|Pregnancy|0|||
170376557|NCT00723489|615713835|FG001|Overall Study|Pregnancy|0|||
170376558|NCT00723489|615713836|FG002|Overall Study|Pregnancy|0|||
170376559|NCT00723489|615713837|FG003|Overall Study|Pregnancy|1|||
170376560|NCT00723489|615713834|FG000|Overall Study|Withdrawal by Subject|0|||
170376561|NCT00723489|615713835|FG001|Overall Study|Withdrawal by Subject|0|||
170376562|NCT00723489|615713836|FG002|Overall Study|Withdrawal by Subject|0|||
170376563|NCT00723489|615713837|FG003|Overall Study|Withdrawal by Subject|1|||
170376564|NCT00723489|615713834|FG000|Overall Study|Seropositive at baseline|1|||
170376565|NCT00723489|615713835|FG001|Overall Study|Seropositive at baseline|0|||
170376566|NCT00723489|615713836|FG002|Overall Study|Seropositive at baseline|0|||
170376567|NCT00723489|615713837|FG003|Overall Study|Seropositive at baseline|0|||
170376568|NCT00723489|615713834|FG000|Overall Study|Prohibited Medication|0|||
170376569|NCT00723489|615713835|FG001|Overall Study|Prohibited Medication|0|||
170376570|NCT00723489|615713836|FG002|Overall Study|Prohibited Medication|0|||
170376571|NCT00723489|615713837|FG003|Overall Study|Prohibited Medication|1|||
170376572|NCT00723489|615713834|FG000|Overall Study|Samples Collected Out of Window|0|||
170376573|NCT00723489|615713835|FG001|Overall Study|Samples Collected Out of Window|3|||
170376574|NCT00723489|615713836|FG002|Overall Study|Samples Collected Out of Window|0|||
170376575|NCT00723489|615713837|FG003|Overall Study|Samples Collected Out of Window|0|||
170376576|NCT01599585|615713838|FG000|Overall Study|Withdrawal by Subject|16|||
170376577|NCT01599585|615713839|FG001|Overall Study|Withdrawal by Subject|9|||
170376578|NCT01599585|615713838|FG000|Overall Study|Lost to Follow-up|3|||
170376579|NCT01599585|615713839|FG001|Overall Study|Lost to Follow-up|5|||
170376580|NCT01599585|615713838|FG000|Overall Study|randomized did not start treatment|3|||
170376581|NCT01599585|615713839|FG001|Overall Study|randomized did not start treatment|3|||
170376582|NCT00729560|615713844|FG000|Overall Study|Withdrawal by Subject|3|||
170376583|NCT03662789|615713845|FG000|Overall Study|Lost to Follow-up|1|||
170376584|NCT03662789|615713846|FG001|Overall Study|Lost to Follow-up|2|||
170376585|NCT03662789|615713845|FG000|Overall Study|Could not perform treadmill test|4|||
170376586|NCT03662789|615713846|FG001|Overall Study|Could not perform treadmill test|4|||
170376587|NCT03662789|615713845|FG000|Overall Study|Death|0|||
170376588|NCT03662789|615713846|FG001|Overall Study|Death|1|||
170376589|NCT01626859|615713847|FG000|Overall Study|Adverse Event|1|||
170376590|NCT01626859|615713848|FG001|Overall Study|Adverse Event|3|||
170376591|NCT01626859|615713849|FG002|Overall Study|Adverse Event|2|||
170376592|NCT01626859|615713847|FG000|Overall Study|Physician Decision|0|||
170376593|NCT01626859|615713848|FG001|Overall Study|Physician Decision|1|||
170376594|NCT01626859|615713849|FG002|Overall Study|Physician Decision|0|||
170376595|NCT01626859|615713847|FG000|Overall Study|Withdrawal by Subject|1|||
170376596|NCT01626859|615713848|FG001|Overall Study|Withdrawal by Subject|4|||
170376597|NCT01626859|615713849|FG002|Overall Study|Withdrawal by Subject|2|||
170376598|NCT02136134|615713850|FG000|Overall Study|Death|170|||
170376599|NCT02136134|615713851|FG001|Overall Study|Death|148|||
170376600|NCT02136134|615713850|FG000|Overall Study|Withdrawal by Subject|19|||
170376601|NCT02136134|615713851|FG001|Overall Study|Withdrawal by Subject|10|||
170376602|NCT02136134|615713850|FG000|Overall Study|Lost to Follow-up|3|||
170376603|NCT02136134|615713851|FG001|Overall Study|Lost to Follow-up|3|||
170376604|NCT02136134|615713850|FG000|Overall Study|Uspecified|55|||
170376605|NCT02136134|615713851|FG001|Overall Study|Uspecified|90|||
170376606|NCT03070119|615713852|FG000|Overall Study|Adverse Event|0|||
170376607|NCT03070119|615713853|FG001|Overall Study|Adverse Event|0|||
170376608|NCT03070119|615713854|FG002|Overall Study|Adverse Event|1|||
170376609|NCT03070119|615713852|FG000|Overall Study|Lost to Follow-up|0|||
170376610|NCT03070119|615713853|FG001|Overall Study|Lost to Follow-up|1|||
170376611|NCT03070119|615713854|FG002|Overall Study|Lost to Follow-up|0|||
170376612|NCT03070119|615713852|FG000|Overall Study|Consent Withdrawn|6|||
170376613|NCT03070119|615713853|FG001|Overall Study|Consent Withdrawn|5|||
170376614|NCT03070119|615713854|FG002|Overall Study|Consent Withdrawn|3|||
170376615|NCT03070119|615713852|FG000|Overall Study|Investigator Decision|0|||
170376616|NCT03070119|615713853|FG001|Overall Study|Investigator Decision|0|||
170376617|NCT03070119|615713854|FG002|Overall Study|Investigator Decision|1|||
170376618|NCT03070119|615713852|FG000|Overall Study|Death|7|||
170376619|NCT03070119|615713853|FG001|Overall Study|Death|14|||
170376620|NCT03070119|615713854|FG002|Overall Study|Death|5|||
170376621|NCT03070119|615713852|FG000|Overall Study|Disease Progression|5|||
170376622|NCT03070119|615713853|FG001|Overall Study|Disease Progression|7|||
170376623|NCT03070119|615713854|FG002|Overall Study|Disease Progression|7|||
170376624|NCT03070119|615713852|FG000|Overall Study|Reason not Specified|2|||
170376625|NCT03070119|615713853|FG001|Overall Study|Reason not Specified|2|||
170376626|NCT03070119|615713854|FG002|Overall Study|Reason not Specified|1|||
170376627|NCT05245071|615713855|FG000|Overall Study|Progressive disease|18|||
170376628|NCT05245071|615713855|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
170376629|NCT05245071|615713855|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
170376630|NCT01602822|615713860|FG000|Overall Study|Adverse Event|11|||
170376631|NCT03737318|615713862|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
170376632|NCT03737318|615713863|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
170376633|NCT03737318|615713864|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
170376634|NCT02756845|615713865|FG000|Overall Study|Death|12|||
170376635|NCT02756845|615713866|FG001|Overall Study|Death|2|||
170376636|NCT02756845|615713865|FG000|Overall Study|Withdrawal by Subject|1|||
170376637|NCT02756845|615713866|FG001|Overall Study|Withdrawal by Subject|0|||
170376638|NCT05333289|615713867|FG000|Overall Study|Other|1|||
170376639|NCT05333289|615713868|FG001|Overall Study|Other|0|||
170376640|NCT05333289|615713869|FG002|Overall Study|Other|0|||
170376641|NCT05333289|615713870|FG003|Overall Study|Other|1|||
170376642|NCT05333289|615713871|FG004|Overall Study|Other|1|||
170376643|NCT05333289|615713872|FG005|Overall Study|Other|2|||
170376644|NCT05333289|615713873|FG006|Overall Study|Other|2|||
170376645|NCT05333289|615713874|FG007|Overall Study|Other|0|||
170376646|NCT05333289|615713867|FG000|Overall Study|Withdrawal by Subject|1|||
170376647|NCT05333289|615713868|FG001|Overall Study|Withdrawal by Subject|2|||
170376648|NCT05333289|615713869|FG002|Overall Study|Withdrawal by Subject|2|||
170376649|NCT05333289|615713870|FG003|Overall Study|Withdrawal by Subject|1|||
170376650|NCT05333289|615713871|FG004|Overall Study|Withdrawal by Subject|1|||
170376651|NCT05333289|615713872|FG005|Overall Study|Withdrawal by Subject|2|||
170376652|NCT05333289|615713873|FG006|Overall Study|Withdrawal by Subject|1|||
170376653|NCT05333289|615713874|FG007|Overall Study|Withdrawal by Subject|3|||
170376654|NCT05333289|615713867|FG000|Overall Study|Protocol Violation|1|||
170376655|NCT05333289|615713868|FG001|Overall Study|Protocol Violation|0|||
170376656|NCT05333289|615713869|FG002|Overall Study|Protocol Violation|0|||
170376657|NCT05333289|615713870|FG003|Overall Study|Protocol Violation|0|||
170376658|NCT05333289|615713871|FG004|Overall Study|Protocol Violation|0|||
170376659|NCT05333289|615713872|FG005|Overall Study|Protocol Violation|0|||
170376660|NCT05333289|615713873|FG006|Overall Study|Protocol Violation|0|||
170376661|NCT05333289|615713874|FG007|Overall Study|Protocol Violation|0|||
170376662|NCT05333289|615713867|FG000|Overall Study|Physician Decision|0|||
170376663|NCT05333289|615713868|FG001|Overall Study|Physician Decision|0|||
170376664|NCT05333289|615713869|FG002|Overall Study|Physician Decision|1|||
170376665|NCT05333289|615713870|FG003|Overall Study|Physician Decision|0|||
170376666|NCT05333289|615713871|FG004|Overall Study|Physician Decision|0|||
170376667|NCT05333289|615713872|FG005|Overall Study|Physician Decision|2|||
170376668|NCT05333289|615713873|FG006|Overall Study|Physician Decision|0|||
170376669|NCT05333289|615713874|FG007|Overall Study|Physician Decision|0|||
170376670|NCT05333289|615713867|FG000|Overall Study|Lost to Follow-up|6|||
170376671|NCT05333289|615713868|FG001|Overall Study|Lost to Follow-up|0|||
170376672|NCT05333289|615713869|FG002|Overall Study|Lost to Follow-up|1|||
170376673|NCT05333289|615713870|FG003|Overall Study|Lost to Follow-up|6|||
170376674|NCT05333289|615713871|FG004|Overall Study|Lost to Follow-up|3|||
170376675|NCT05333289|615713872|FG005|Overall Study|Lost to Follow-up|3|||
170376676|NCT05333289|615713873|FG006|Overall Study|Lost to Follow-up|2|||
170376677|NCT05333289|615713874|FG007|Overall Study|Lost to Follow-up|1|||
170376678|NCT05333289|615713867|FG000|Overall Study|Death|1|||
170376679|NCT05333289|615713868|FG001|Overall Study|Death|0|||
170376680|NCT05333289|615713869|FG002|Overall Study|Death|0|||
170376681|NCT05333289|615713870|FG003|Overall Study|Death|0|||
170376682|NCT05333289|615713871|FG004|Overall Study|Death|0|||
170376683|NCT05333289|615713872|FG005|Overall Study|Death|0|||
170376684|NCT05333289|615713873|FG006|Overall Study|Death|0|||
170376685|NCT05333289|615713874|FG007|Overall Study|Death|0|||
170376686|NCT02005211|615713879|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
170376687|NCT02005211|615713880|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
170376688|NCT02005211|615713881|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
170376689|NCT02005211|615713882|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
170376690|NCT02005211|615713883|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
170376691|NCT02005211|615713884|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
170376692|NCT02005211|615713885|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
170376693|NCT00528840|615713887|FG000|Overall Study|Lost to Follow-up|10|||
170376694|NCT00528840|615713887|FG000|Overall Study|Adverse Event|1|||
170376695|NCT00528840|615713887|FG000|Overall Study|Withdrawal by Subject|17|||
170376696|NCT00528840|615713887|FG000|Overall Study|Death|2|||
170376697|NCT00528840|615713887|FG000|Overall Study|Administrative Reasons|1|||
170376698|NCT00528840|615713887|FG000|Overall Study|Other|2|||
170376699|NCT00397631|615713889|FG000|Overall Study|Adverse Event|5|||
170376700|NCT00397631|615713890|FG001|Overall Study|Adverse Event|6|||
170376701|NCT00397631|615713889|FG000|Overall Study|Lack of Efficacy|7|||
170376702|NCT00397631|615713890|FG001|Overall Study|Lack of Efficacy|10|||
170376703|NCT00397631|615713889|FG000|Overall Study|Lost to Follow-up|8|||
170376704|NCT00397631|615713890|FG001|Overall Study|Lost to Follow-up|9|||
170376705|NCT00397631|615713889|FG000|Overall Study|Physician Decision|2|||
170376706|NCT00397631|615713890|FG001|Overall Study|Physician Decision|0|||
170376707|NCT00397631|615713889|FG000|Overall Study|Protocol Violation|0|||
170376708|NCT00397631|615713890|FG001|Overall Study|Protocol Violation|1|||
170376709|NCT00397631|615713889|FG000|Overall Study|Withdrawal by Subject|7|||
170376710|NCT00397631|615713890|FG001|Overall Study|Withdrawal by Subject|14|||
170376711|NCT00397631|615713889|FG000|Overall Study|protocol discontinuation criteria|1|||
170376712|NCT00397631|615713890|FG001|Overall Study|protocol discontinuation criteria|4|||
170376713|NCT02202161|615713891|FG000|Overall Study|Adverse Event|1|||
170376714|NCT02202161|615713892|FG001|Overall Study|Adverse Event|1|||
170376715|NCT02202161|615713893|FG002|Overall Study|Adverse Event|0|||
170376716|NCT02202161|615713894|FG003|Overall Study|Adverse Event|0|||
170376717|NCT02202161|615713895|FG004|Overall Study|Adverse Event|0|||
170376718|NCT02202161|615713896|FG005|Overall Study|Adverse Event|1|||
170376719|NCT02202161|615713897|FG006|Overall Study|Adverse Event|0|||
170376720|NCT02202161|615713898|FG007|Overall Study|Adverse Event|0|||
170376721|NCT02202161|615713891|FG000|Overall Study|Did not meet continuation criteria|0|||
170376722|NCT02202161|615713892|FG001|Overall Study|Did not meet continuation criteria|0|||
170376723|NCT02202161|615713893|FG002|Overall Study|Did not meet continuation criteria|0|||
170376724|NCT02202161|615713894|FG003|Overall Study|Did not meet continuation criteria|0|||
170376725|NCT02202161|615713895|FG004|Overall Study|Did not meet continuation criteria|0|||
170376726|NCT02202161|615713896|FG005|Overall Study|Did not meet continuation criteria|0|||
170376727|NCT02202161|615713897|FG006|Overall Study|Did not meet continuation criteria|0|||
170376728|NCT02202161|615713898|FG007|Overall Study|Did not meet continuation criteria|3|||
170376729|NCT02202161|615713891|FG000|Overall Study|Physician Decision|0|||
170376730|NCT02202161|615713892|FG001|Overall Study|Physician Decision|0|||
170376731|NCT02202161|615713893|FG002|Overall Study|Physician Decision|0|||
170376732|NCT02202161|615713894|FG003|Overall Study|Physician Decision|0|||
170376733|NCT02202161|615713895|FG004|Overall Study|Physician Decision|0|||
170376734|NCT02202161|615713896|FG005|Overall Study|Physician Decision|0|||
170376735|NCT02202161|615713897|FG006|Overall Study|Physician Decision|0|||
170376736|NCT02202161|615713898|FG007|Overall Study|Physician Decision|3|||
170376737|NCT02202161|615713891|FG000|Overall Study|Withdrawal by Subject|0|||
170376738|NCT02202161|615713892|FG001|Overall Study|Withdrawal by Subject|0|||
170376739|NCT02202161|615713893|FG002|Overall Study|Withdrawal by Subject|0|||
170376740|NCT02202161|615713894|FG003|Overall Study|Withdrawal by Subject|0|||
170376741|NCT02202161|615713895|FG004|Overall Study|Withdrawal by Subject|1|||
170376742|NCT02202161|615713896|FG005|Overall Study|Withdrawal by Subject|0|||
170376743|NCT02202161|615713897|FG006|Overall Study|Withdrawal by Subject|0|||
170376744|NCT02202161|615713898|FG007|Overall Study|Withdrawal by Subject|0|||
170376745|NCT01603628|615713901|FG000|Overall Study|Personal Reasons|1|||
170376746|NCT01603628|615713902|FG001|Overall Study|Personal Reasons|1|||
170376747|NCT01603628|615713903|FG002|Overall Study|Personal Reasons|2|||
170376748|NCT01603628|615713901|FG000|Overall Study|Protocol Violation|1|||
170376749|NCT01603628|615713902|FG001|Overall Study|Protocol Violation|1|||
170376750|NCT01603628|615713903|FG002|Overall Study|Protocol Violation|0|||
170376751|NCT01603628|615713901|FG000|Overall Study|Lost to Follow-up|0|||
170376752|NCT01603628|615713902|FG001|Overall Study|Lost to Follow-up|1|||
170376753|NCT01603628|615713903|FG002|Overall Study|Lost to Follow-up|0|||
170376754|NCT01603628|615713901|FG000|Overall Study|Other Miscellaneous Reason|1|||
170376755|NCT01603628|615713902|FG001|Overall Study|Other Miscellaneous Reason|0|||
170376756|NCT01603628|615713903|FG002|Overall Study|Other Miscellaneous Reason|0|||
170376757|NCT01969565|615713904|FG000|Overall Study|Withdrawal by Subject|1|||
170376758|NCT00832091|615713905|FG000|Overall Study|Adverse Event|1|||
170376759|NCT00832091|615713906|FG001|Overall Study|Adverse Event|1|||
170376760|NCT00832091|615713905|FG000|Overall Study|Protocol Violation|1|||
170376761|NCT00832091|615713906|FG001|Overall Study|Protocol Violation|0|||
170376762|NCT00832091|615713905|FG000|Overall Study|Withdrawal by Subject|2|||
170376763|NCT00832091|615713906|FG001|Overall Study|Withdrawal by Subject|1|||
170376764|NCT00832091|615713905|FG000|Overall Study|Prohibited Medication|1|||
170376765|NCT00832091|615713906|FG001|Overall Study|Prohibited Medication|0|||
170376766|NCT03797144|615713907|FG000|Enrollment|Protocol Violation|4|||
170376767|NCT03797144|615713908|FG001|Enrollment|Protocol Violation|1|||
170376768|NCT03797144|615713907|FG000|Surgery|Protocol Violation|1|||
170376769|NCT03797144|615713908|FG001|Surgery|Protocol Violation|0|||
170376770|NCT03797144|615713907|FG000|3 Month|Early termination cut-off date|2|||
170376771|NCT03797144|615713908|FG001|3 Month|Early termination cut-off date|0|||
170376772|NCT03797144|615713907|FG000|12 Month|Early termination cut-off date|8|||
170376773|NCT03797144|615713908|FG001|12 Month|Early termination cut-off date|9|||
170376774|NCT03797144|615713907|FG000|24 Month|Early termination cut-off date|1|||
170376775|NCT03797144|615713908|FG001|24 Month|Early termination cut-off date|1|||
170376776|NCT01878175|615713909|FG000|Overall Study|Developed contraindicated health problem|2|||
170376777|NCT02943668|615713911|FG000|Overall Study|Disease Progression|1|||
170376778|NCT01302691|615713914|FG000|Overall Study|Adverse Event|2|||
170376779|NCT01302691|615713915|FG001|Overall Study|Adverse Event|0|||
170376780|NCT01302691|615713914|FG000|Overall Study|Death|0|||
170376781|NCT01302691|615713915|FG001|Overall Study|Death|1|||
170376782|NCT01302691|615713914|FG000|Overall Study|Lost to Follow-up|1|||
170376783|NCT01302691|615713915|FG001|Overall Study|Lost to Follow-up|0|||
170376784|NCT01302691|615713914|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
170376785|NCT01302691|615713915|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
170376786|NCT01302691|615713914|FG000|Overall Study|Physician Decision|0|||
170376787|NCT01302691|615713915|FG001|Overall Study|Physician Decision|1|||
170376788|NCT01302691|615713914|FG000|Overall Study|Protocol Violation|1|||
170376789|NCT01302691|615713915|FG001|Overall Study|Protocol Violation|0|||
170376790|NCT00423592|615713916|FG000|Overall Study|Adverse Event (through Week 12)|2|||
170376791|NCT00423592|615713916|FG000|Overall Study|Adverse Event (post Week 12)|5|||
170376792|NCT01249157|615713917|FG000|Overall Study|Withdrawal by Subject|1|||
170376793|NCT00255008|615713920|FG000|Overall Study|Adverse Event|1|||
170376794|NCT00255008|615713921|FG001|Overall Study|Adverse Event|1|||
170376795|NCT00255008|615713922|FG002|Overall Study|Adverse Event|2|||
170376796|NCT00255008|615713923|FG003|Overall Study|Adverse Event|0|||
170376797|NCT00255008|615713920|FG000|Overall Study|Lost to Follow-up|1|||
170376798|NCT00255008|615713921|FG001|Overall Study|Lost to Follow-up|0|||
170376799|NCT00255008|615713922|FG002|Overall Study|Lost to Follow-up|1|||
170376800|NCT00255008|615713923|FG003|Overall Study|Lost to Follow-up|2|||
170376801|NCT00255008|615713920|FG000|Overall Study|Did not meet viral reduction criteria|4|||
170376802|NCT00255008|615713921|FG001|Overall Study|Did not meet viral reduction criteria|5|||
170376803|NCT00255008|615713922|FG002|Overall Study|Did not meet viral reduction criteria|0|||
170376804|NCT00255008|615713923|FG003|Overall Study|Did not meet viral reduction criteria|1|||
170376805|NCT00255008|615713920|FG000|Overall Study|Withdrew consent|0|||
170376806|NCT00255008|615713921|FG001|Overall Study|Withdrew consent|0|||
170376807|NCT00255008|615713922|FG002|Overall Study|Withdrew consent|2|||
170376808|NCT00255008|615713923|FG003|Overall Study|Withdrew consent|0|||
170376809|NCT00255008|615713920|FG000|Overall Study|Sponsor request|18|||
170376810|NCT00255008|615713921|FG001|Overall Study|Sponsor request|3|||
170376811|NCT00255008|615713922|FG002|Overall Study|Sponsor request|8|||
170376812|NCT00255008|615713923|FG003|Overall Study|Sponsor request|17|||
170376813|NCT00255008|615713920|FG000|Overall Study|Adverse lab experience|1|||
170376814|NCT00255008|615713921|FG001|Overall Study|Adverse lab experience|0|||
170376815|NCT00255008|615713922|FG002|Overall Study|Adverse lab experience|0|||
170376816|NCT00255008|615713923|FG003|Overall Study|Adverse lab experience|0|||
170376817|NCT00255008|615713920|FG000|Overall Study|Other|7|||
170376818|NCT00255008|615713921|FG001|Overall Study|Other|0|||
170376819|NCT00255008|615713922|FG002|Overall Study|Other|3|||
170376820|NCT00255008|615713923|FG003|Overall Study|Other|2|||
170376821|NCT02201472|615713927|FG000|Overall Study|Lack of Efficacy|2|||
170376822|NCT01300767|615713929|FG000|Overall Study|Discomfort|2|||
170376823|NCT01300767|615713929|FG000|Overall Study|Biomicroscopy|1|||
170376824|NCT01300767|615713929|FG000|Overall Study|Unacceptable fit|1|||
170376825|NCT00959699|615713933|FG000|Treatment Period|Adverse Event|3|||
170376826|NCT00959699|615713934|FG001|Treatment Period|Adverse Event|13|||
170376827|NCT00959699|615713933|FG000|Treatment Period|Lack of Efficacy|15|||
170376828|NCT00959699|615713934|FG001|Treatment Period|Lack of Efficacy|6|||
170376829|NCT00959699|615713933|FG000|Treatment Period|Lost to Follow-up|0|||
170376830|NCT00959699|615713934|FG001|Treatment Period|Lost to Follow-up|1|||
170376831|NCT00959699|615713933|FG000|Treatment Period|Withdrawal by Subject|1|||
170376832|NCT00959699|615713934|FG001|Treatment Period|Withdrawal by Subject|3|||
170376833|NCT00959699|615713933|FG000|Treatment Period|Non-Compliance with Protocol|0|||
170376834|NCT00959699|615713934|FG001|Treatment Period|Non-Compliance with Protocol|1|||
170376835|NCT00959699|615713933|FG000|Treatment Period|Did not receive treatment|0|||
170376836|NCT00959699|615713934|FG001|Treatment Period|Did not receive treatment|1|||
170376837|NCT00959699|615713933|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
170376838|NCT00959699|615713934|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
170376839|NCT00959699|615713933|FG000|Follow-up Period|Lost to Follow-up|3|||
170376840|NCT00959699|615713934|FG001|Follow-up Period|Lost to Follow-up|2|||
170376841|NCT00959699|615713933|FG000|Follow-up Period|Withdrawal by Subject|3|||
170376842|NCT00959699|615713934|FG001|Follow-up Period|Withdrawal by Subject|4|||
170376843|NCT00606294|615713937|FG000|Overall Study|Withdrawal by Subject|36|||
170376844|NCT00606294|615713938|FG001|Overall Study|Withdrawal by Subject|0|||
170376845|NCT01885104|615713939|FG000|Overall Study|Withdrawal of Consent|1|||
170376846|NCT01885104|615713940|FG001|Overall Study|Withdrawal of Consent|0|||
170376847|NCT01885104|615713939|FG000|Overall Study|Lost to Follow-up|0|||
170376848|NCT01885104|615713940|FG001|Overall Study|Lost to Follow-up|1|||
170376849|NCT01885104|615713939|FG000|Overall Study|Physician Decision|1|||
170376850|NCT01885104|615713940|FG001|Overall Study|Physician Decision|0|||
170376851|NCT00126425|615713941|FG000|Overall Study|Withdrawal by Subject|17|||
170376852|NCT00126425|615713942|FG001|Overall Study|Withdrawal by Subject|1|||
170376853|NCT00126425|615713941|FG000|Overall Study|Lost to Follow-up|8|||
170376854|NCT00126425|615713942|FG001|Overall Study|Lost to Follow-up|4|||
170376855|NCT00126425|615713941|FG000|Overall Study|Protocol Violation|9|||
170376856|NCT00126425|615713942|FG001|Overall Study|Protocol Violation|6|||
170376857|NCT00126425|615713941|FG000|Overall Study|Adverse Event|1|||
170376858|NCT00126425|615713942|FG001|Overall Study|Adverse Event|0|||
170376859|NCT00126425|615713941|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
170376860|NCT00126425|615713942|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
170376861|NCT00126425|615713941|FG000|Overall Study|Other|5|||
170376862|NCT00126425|615713942|FG001|Overall Study|Other|0|||
170376863|NCT01435122|615713943|FG000|Overall Study|Early withdrawal due to toxicity|8|||
170376864|NCT03954704|615713944|FG000|Overall Study|Death|1|||
170376865|NCT03954704|615713945|FG001|Overall Study|Death|1|||
170376866|NCT03954704|615713946|FG002|Overall Study|Death|1|||
170376867|NCT03954704|615713947|FG003|Overall Study|Death|3|||
170376868|NCT03954704|615713948|FG004|Overall Study|Death|2|||
170376869|NCT03954704|615713949|FG005|Overall Study|Death|2|||
170376870|NCT03954704|615713950|FG006|Overall Study|Death|0|||
170376871|NCT03954704|615713944|FG000|Overall Study|Withdrew Consent|0|||
170376872|NCT03954704|615713945|FG001|Overall Study|Withdrew Consent|0|||
170376873|NCT03954704|615713946|FG002|Overall Study|Withdrew Consent|1|||
170376874|NCT03954704|615713947|FG003|Overall Study|Withdrew Consent|0|||
170376875|NCT03954704|615713948|FG004|Overall Study|Withdrew Consent|0|||
170376876|NCT03954704|615713949|FG005|Overall Study|Withdrew Consent|1|||
170376877|NCT03954704|615713950|FG006|Overall Study|Withdrew Consent|0|||
170376878|NCT03954704|615713944|FG000|Overall Study|Lost to Follow-up|0|||
170376879|NCT03954704|615713945|FG001|Overall Study|Lost to Follow-up|0|||
170376880|NCT03954704|615713946|FG002|Overall Study|Lost to Follow-up|0|||
170376881|NCT03954704|615713947|FG003|Overall Study|Lost to Follow-up|0|||
170376882|NCT03954704|615713948|FG004|Overall Study|Lost to Follow-up|0|||
170376883|NCT03954704|615713949|FG005|Overall Study|Lost to Follow-up|0|||
170376884|NCT03954704|615713950|FG006|Overall Study|Lost to Follow-up|1|||
170376885|NCT03954704|615713944|FG000|Overall Study|Study Terminated by Sponsor|0|||
170376886|NCT03954704|615713945|FG001|Overall Study|Study Terminated by Sponsor|0|||
170376887|NCT03954704|615713946|FG002|Overall Study|Study Terminated by Sponsor|1|||
170376888|NCT03954704|615713947|FG003|Overall Study|Study Terminated by Sponsor|0|||
170376889|NCT03954704|615713948|FG004|Overall Study|Study Terminated by Sponsor|1|||
170376890|NCT03954704|615713949|FG005|Overall Study|Study Terminated by Sponsor|4|||
170376891|NCT03954704|615713950|FG006|Overall Study|Study Terminated by Sponsor|2|||
170376892|NCT03954704|615713944|FG000|Overall Study|Enrolled but not Treated|0|||
170376893|NCT03954704|615713945|FG001|Overall Study|Enrolled but not Treated|0|||
170376894|NCT03954704|615713946|FG002|Overall Study|Enrolled but not Treated|0|||
170376895|NCT03954704|615713947|FG003|Overall Study|Enrolled but not Treated|0|||
170376896|NCT03954704|615713948|FG004|Overall Study|Enrolled but not Treated|0|||
170376897|NCT03954704|615713949|FG005|Overall Study|Enrolled but not Treated|1|||
170376898|NCT03954704|615713950|FG006|Overall Study|Enrolled but not Treated|0|||
170376899|NCT01226472|615713952|FG000|Overall Study|Progressive Disease|1|||
170376900|NCT03128307|615713955|FG000|Overall Study|Lost to Follow-up|29|||
170376901|NCT03128307|615713955|FG000|Overall Study|Withdrawal by Subject|5|||
170376902|NCT05166603|615713956|FG000|Overall Study|Withdrawal by Subject|68|||
170376903|NCT05166603|615713957|FG001|Overall Study|Withdrawal by Subject|0|||
170376904|NCT03053180|615715400|FG000|Overall Study|Failure to Return|1|||
170376905|NCT01855919|615715401|FG000|Overall Study|Adverse Event|16|||
170376906|NCT01855919|615715402|FG001|Overall Study|Adverse Event|8|||
170376907|NCT01855919|615715401|FG000|Overall Study|Lack of Efficacy|1|||
170376908|NCT01855919|615715402|FG001|Overall Study|Lack of Efficacy|3|||
170376909|NCT01855919|615715401|FG000|Overall Study|Withdrawal by Subject|4|||
170376910|NCT01855919|615715402|FG001|Overall Study|Withdrawal by Subject|10|||
170376911|NCT01855919|615715401|FG000|Overall Study|Entry Criteria Not Met|1|||
170376912|NCT01855919|615715402|FG001|Overall Study|Entry Criteria Not Met|1|||
170376913|NCT01855919|615715401|FG000|Overall Study|Protocol Violation|1|||
170376914|NCT01855919|615715402|FG001|Overall Study|Protocol Violation|4|||
170376915|NCT02314637|615715411|FG000|Overall Study|Adverse Event|4|||
170376916|NCT02314637|615715412|FG001|Overall Study|Adverse Event|8|||
170376917|NCT02314637|615715411|FG000|Overall Study|Lack of Efficacy|1|||
170376918|NCT02314637|615715412|FG001|Overall Study|Lack of Efficacy|0|||
170376919|NCT02314637|615715411|FG000|Overall Study|Physician Decision|5|||
170376920|NCT02314637|615715412|FG001|Overall Study|Physician Decision|2|||
170376921|NCT02314637|615715411|FG000|Overall Study|Withdrawal by Subject|5|||
170376922|NCT02314637|615715412|FG001|Overall Study|Withdrawal by Subject|4|||
170376923|NCT02314637|615715411|FG000|Overall Study|Other Reason|1|||
170376924|NCT02314637|615715412|FG001|Overall Study|Other Reason|0|||
170376925|NCT00724243|615715417|FG000|Overall Study|Lack of Efficacy|10|||
170376926|NCT00724243|615715417|FG000|Overall Study|Adverse Event|5|||
170376927|NCT00211536|615715418|FG000|Overall Study|Withdrawal by Subject|2|||
170376928|NCT00211536|615715419|FG001|Overall Study|Withdrawal by Subject|2|||
170376929|NCT00211536|615715418|FG000|Overall Study|Physician Decision|0|||
170376930|NCT00211536|615715419|FG001|Overall Study|Physician Decision|5|||
170376931|NCT00211536|615715418|FG000|Overall Study|Adverse Event|2|||
170376932|NCT00211536|615715419|FG001|Overall Study|Adverse Event|0|||
170376933|NCT00669240|615715420|FG000|Overall Study|Lack of Efficacy|33|||
170376934|NCT00669240|615715420|FG000|Overall Study|Withdrawal by Subject|42|||
170376935|NCT00669240|615715420|FG000|Overall Study|Lost to Follow-up|34|||
170376936|NCT00669240|615715420|FG000|Overall Study|Adverse Event|21|||
170376937|NCT00669240|615715420|FG000|Overall Study|Other|19|||
170376938|NCT00669240|615715420|FG000|Overall Study|Enrolled but not treated|15|||
170376939|NCT00669240|615715420|FG000|Overall Study|Enrolled but no dosing record|1|||
170376940|NCT02583399|615715421|FG000|Overall Study|Able to be discharged|3|||
170376941|NCT02583399|615715421|FG000|Overall Study|Wanted to use a restricted medication|3|||
170376942|NCT01997892|615715423|FG000|Overall Study|Physician Decision|2|||
170376943|NCT01997892|615715423|FG000|Overall Study|Lost to Follow-up|6|||
170376944|NCT01997892|615715423|FG000|Overall Study|Death|14|||
170376945|NCT01997892|615715423|FG000|Overall Study|Renal transplant|8|||
170376946|NCT01997892|615715423|FG000|Overall Study|Other|3|||
170376947|NCT01997892|615715423|FG000|Overall Study|Study completion data not recorded|35|||
170376948|NCT00364611|615715424|FG000|Overall Study|Did not receive study medication|0|||
170376949|NCT00364611|615715425|FG001|Overall Study|Did not receive study medication|1|||
170376950|NCT00364611|615715424|FG000|Overall Study|Adverse Event|7|||
170376951|NCT00364611|615715425|FG001|Overall Study|Adverse Event|4|||
170376952|NCT00364611|615715424|FG000|Overall Study|Participant's Request|3|||
170376953|NCT00364611|615715425|FG001|Overall Study|Participant's Request|4|||
170376954|NCT00364611|615715424|FG000|Overall Study|Disease Progression|38|||
170376955|NCT00364611|615715425|FG001|Overall Study|Disease Progression|8|||
170376956|NCT00364611|615715424|FG000|Overall Study|Investigator decision|2|||
170376957|NCT00364611|615715425|FG001|Overall Study|Investigator decision|2|||
170376958|NCT00364611|615715424|FG000|Overall Study|Found Ineligible|1|||
170376959|NCT00364611|615715425|FG001|Overall Study|Found Ineligible|0|||
170376960|NCT00364611|615715424|FG000|Overall Study|Presumed CR on Study|0|||
170376961|NCT00364611|615715425|FG001|Overall Study|Presumed CR on Study|1|||
170376962|NCT00364611|615715424|FG000|Overall Study|Receiving Liver Ablation|0|||
170376963|NCT00364611|615715425|FG001|Overall Study|Receiving Liver Ablation|1|||
170376964|NCT02608099|615715437|FG000|Overall Study|Ablation procedure not initiated|3|||
170376965|NCT02608099|615715438|FG001|Overall Study|Ablation procedure not initiated|2|||
170376966|NCT00087594|615715439|FG000|Overall Study|Adverse Event|2|||
170376967|NCT00087594|615715440|FG001|Overall Study|Adverse Event|3|||
170376968|NCT00087594|615715439|FG000|Overall Study|Lost to Follow-up|0|||
170376969|NCT00087594|615715440|FG001|Overall Study|Lost to Follow-up|2|||
170376970|NCT00087594|615715439|FG000|Overall Study|Withdrawal by Subject|4|||
170376971|NCT00087594|615715440|FG001|Overall Study|Withdrawal by Subject|2|||
170376972|NCT00087594|615715439|FG000|Overall Study|Lack of Efficacy|2|||
170376973|NCT00087594|615715440|FG001|Overall Study|Lack of Efficacy|5|||
170376974|NCT01952041|615715441|FG000|Overall Study|Lost to Follow-up|9|||
170376975|NCT01952041|615715442|FG001|Overall Study|Lost to Follow-up|16|||
170376976|NCT01952041|615715441|FG000|Overall Study|Withdrawal by Subject|7|||
170376977|NCT01952041|615715442|FG001|Overall Study|Withdrawal by Subject|5|||
170376978|NCT01952041|615715441|FG000|Overall Study|Death|1|||
170376979|NCT01952041|615715442|FG001|Overall Study|Death|0|||
170376980|NCT00290355|615715446|FG000|Overall Study|Serious adverse event|7|||
170376981|NCT00290355|615715447|FG001|Overall Study|Serious adverse event|4|||
170376982|NCT00290355|615715446|FG000|Overall Study|Study product reactogenicity|1|||
170376983|NCT00290355|615715447|FG001|Overall Study|Study product reactogenicity|0|||
170376984|NCT00290355|615715446|FG000|Overall Study|Protocol Violation|1|||
170376985|NCT00290355|615715447|FG001|Overall Study|Protocol Violation|0|||
170376986|NCT00290355|615715446|FG000|Overall Study|Withdrawal by Subject|2|||
170376987|NCT00290355|615715447|FG001|Overall Study|Withdrawal by Subject|0|||
170376988|NCT00290355|615715446|FG000|Overall Study|Migrated / moved from the study area|1|||
170376989|NCT00290355|615715447|FG001|Overall Study|Migrated / moved from the study area|0|||
170376990|NCT00290355|615715446|FG000|Overall Study|Lost to Follow-up|3|||
170376991|NCT00290355|615715447|FG001|Overall Study|Lost to Follow-up|1|||
170376992|NCT00290355|615715446|FG000|Overall Study|Other|2|||
170376993|NCT00290355|615715447|FG001|Overall Study|Other|0|||
170376994|NCT01222767|615715450|FG000|Overall Study|Progressive disease|13|||
170376995|NCT01222767|615715450|FG000|Overall Study|Adverse Event|2|||
170376996|NCT01222767|615715450|FG000|Overall Study|Surgical resection|1|||
170376997|NCT01222767|615715450|FG000|Overall Study|Never treated|1|||
170376998|NCT00508001|615715457|FG000|Overall Study|Adverse Event|2|||
170376999|NCT00508001|615715458|FG001|Overall Study|Adverse Event|0|||
170377000|NCT00508001|615715459|FG002|Overall Study|Adverse Event|4|||
170377001|NCT00508001|615715457|FG000|Overall Study|condition under investigation worsened|13|||
170377002|NCT00508001|615715458|FG001|Overall Study|condition under investigation worsened|7|||
170377003|NCT00508001|615715459|FG002|Overall Study|condition under investigation worsened|1|||
170377004|NCT00508001|615715457|FG000|Overall Study|Death|0|||
170377005|NCT00508001|615715458|FG001|Overall Study|Death|1|||
170377006|NCT00508001|615715459|FG002|Overall Study|Death|1|||
170377007|NCT00508001|615715457|FG000|Overall Study|Withdrawal by Subject|4|||
170377008|NCT00508001|615715458|FG001|Overall Study|Withdrawal by Subject|4|||
170377009|NCT00508001|615715459|FG002|Overall Study|Withdrawal by Subject|1|||
170377010|NCT03657576|615715460|FG000|Overall Study|Death|0|||
170377011|NCT03657576|615715461|FG001|Overall Study|Death|1|||
170377012|NCT03657576|615715462|FG002|Overall Study|Death|1|||
170377013|NCT03657576|615715463|FG003|Overall Study|Death|0|||
170377014|NCT03657576|615715464|FG004|Overall Study|Death|0|||
170377015|NCT03657576|615715465|FG005|Overall Study|Death|0|||
170377016|NCT03657576|615715460|FG000|Overall Study|Withdrawal by Subject|0|||
170377017|NCT03657576|615715461|FG001|Overall Study|Withdrawal by Subject|0|||
170377018|NCT03657576|615715462|FG002|Overall Study|Withdrawal by Subject|0|||
170377019|NCT03657576|615715463|FG003|Overall Study|Withdrawal by Subject|1|||
170377020|NCT03657576|615715464|FG004|Overall Study|Withdrawal by Subject|0|||
170377021|NCT03657576|615715465|FG005|Overall Study|Withdrawal by Subject|0|||
170377022|NCT03657576|615715460|FG000|Overall Study|Screen Fail|0|||
170377023|NCT03657576|615715461|FG001|Overall Study|Screen Fail|0|||
170377024|NCT03657576|615715462|FG002|Overall Study|Screen Fail|0|||
170377025|NCT03657576|615715463|FG003|Overall Study|Screen Fail|0|||
170377026|NCT03657576|615715464|FG004|Overall Study|Screen Fail|0|||
170377027|NCT03657576|615715465|FG005|Overall Study|Screen Fail|5|||
170377028|NCT03657576|615715460|FG000|Overall Study|Disease Progression|1|||
170377029|NCT03657576|615715461|FG001|Overall Study|Disease Progression|1|||
170377030|NCT03657576|615715462|FG002|Overall Study|Disease Progression|0|||
170377031|NCT03657576|615715463|FG003|Overall Study|Disease Progression|5|||
170377032|NCT03657576|615715464|FG004|Overall Study|Disease Progression|0|||
170377033|NCT03657576|615715465|FG005|Overall Study|Disease Progression|0|||
170377034|NCT03657576|615715460|FG000|Overall Study|Insurance Coverage|0|||
170377035|NCT03657576|615715461|FG001|Overall Study|Insurance Coverage|0|||
170377036|NCT03657576|615715462|FG002|Overall Study|Insurance Coverage|0|||
170377037|NCT03657576|615715463|FG003|Overall Study|Insurance Coverage|1|||
170377038|NCT03657576|615715464|FG004|Overall Study|Insurance Coverage|0|||
170377039|NCT03657576|615715465|FG005|Overall Study|Insurance Coverage|0|||
170377040|NCT04437511|615715466|FG000|Overall Study|Adverse Event|50|||
170377041|NCT04437511|615715467|FG001|Overall Study|Adverse Event|21|||
170377042|NCT04437511|615715466|FG000|Overall Study|Death|15|||
170377043|NCT04437511|615715467|FG001|Overall Study|Death|10|||
170377044|NCT04437511|615715466|FG000|Overall Study|Lost to Follow-up|11|||
170377045|NCT04437511|615715467|FG001|Overall Study|Lost to Follow-up|11|||
170377046|NCT04437511|615715466|FG000|Overall Study|Physician Decision|19|||
170377047|NCT04437511|615715467|FG001|Overall Study|Physician Decision|10|||
170377048|NCT04437511|615715466|FG000|Overall Study|Progressive Disease|4|||
170377049|NCT04437511|615715467|FG001|Overall Study|Progressive Disease|7|||
170377050|NCT04437511|615715466|FG000|Overall Study|Withdrawal by Subject|111|||
170377051|NCT04437511|615715467|FG001|Overall Study|Withdrawal by Subject|94|||
170377052|NCT04437511|615715466|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
170377053|NCT04437511|615715467|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
170377054|NCT04437511|615715466|FG000|Overall Study|Continuing Study|7|||
170377055|NCT04437511|615715467|FG001|Overall Study|Continuing Study|5|||
170377056|NCT05492877|615715483|FG000|Overall Study|Adverse Event|11|||
170377057|NCT05492877|615715484|FG001|Overall Study|Adverse Event|7|||
170377058|NCT05492877|615715483|FG000|Overall Study|Death|1|||
170377059|NCT05492877|615715484|FG001|Overall Study|Death|0|||
170377060|NCT05492877|615715483|FG000|Overall Study|Lost to Follow-up|1|||
170377061|NCT05492877|615715484|FG001|Overall Study|Lost to Follow-up|1|||
170377062|NCT05492877|615715483|FG000|Overall Study|Physician Decision|1|||
170377063|NCT05492877|615715484|FG001|Overall Study|Physician Decision|2|||
170377064|NCT05492877|615715483|FG000|Overall Study|Protocol Violation|1|||
170377065|NCT05492877|615715484|FG001|Overall Study|Protocol Violation|1|||
170377066|NCT05492877|615715483|FG000|Overall Study|Withdrawal by Subject|3|||
170377067|NCT05492877|615715484|FG001|Overall Study|Withdrawal by Subject|7|||
170377068|NCT05492877|615715483|FG000|Overall Study|Reason not specified|6|||
170377069|NCT05492877|615715484|FG001|Overall Study|Reason not specified|4|||
170377070|NCT02477800|615715485|FG000|Placebo-Controlled Period|Adverse Event|16|||
170377071|NCT02477800|615715486|FG001|Placebo-Controlled Period|Adverse Event|25|||
170377072|NCT02477800|615715487|FG002|Placebo-Controlled Period|Adverse Event|28|||
170377073|NCT02477800|615715488|FG003|Placebo-Controlled Period|Adverse Event|0|||
170377074|NCT02477800|615715489|FG004|Placebo-Controlled Period|Adverse Event|0|||
170377075|NCT02477800|615715490|FG005|Placebo-Controlled Period|Adverse Event|0|||
170377076|NCT02477800|615715491|FG006|Placebo-Controlled Period|Adverse Event|0|||
170377077|NCT02477800|615715485|FG000|Placebo-Controlled Period|Change of Treatment|1|||
170377078|NCT02477800|615715486|FG001|Placebo-Controlled Period|Change of Treatment|2|||
170377079|NCT02477800|615715487|FG002|Placebo-Controlled Period|Change of Treatment|1|||
170377080|NCT02477800|615715488|FG003|Placebo-Controlled Period|Change of Treatment|0|||
170377081|NCT02477800|615715489|FG004|Placebo-Controlled Period|Change of Treatment|0|||
170377082|NCT02477800|615715490|FG005|Placebo-Controlled Period|Change of Treatment|0|||
170377083|NCT02477800|615715491|FG006|Placebo-Controlled Period|Change of Treatment|0|||
170377084|NCT02477800|615715485|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
170377085|NCT02477800|615715486|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
170377086|NCT02477800|615715487|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
170377087|NCT02477800|615715488|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
170377088|NCT02477800|615715489|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
170377089|NCT02477800|615715490|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
170377090|NCT02477800|615715491|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
170377091|NCT02477800|615715485|FG000|Placebo-Controlled Period|Death|0|||
170377092|NCT02477800|615715486|FG001|Placebo-Controlled Period|Death|3|||
170377093|NCT02477800|615715487|FG002|Placebo-Controlled Period|Death|2|||
170377094|NCT02477800|615715488|FG003|Placebo-Controlled Period|Death|0|||
170377095|NCT02477800|615715489|FG004|Placebo-Controlled Period|Death|0|||
170377096|NCT02477800|615715490|FG005|Placebo-Controlled Period|Death|0|||
170377097|NCT02477800|615715491|FG006|Placebo-Controlled Period|Death|0|||
170377098|NCT02477800|615715485|FG000|Placebo-Controlled Period|Disease Progression|1|||
170377099|NCT02477800|615715486|FG001|Placebo-Controlled Period|Disease Progression|0|||
170377100|NCT02477800|615715487|FG002|Placebo-Controlled Period|Disease Progression|1|||
170377101|NCT02477800|615715488|FG003|Placebo-Controlled Period|Disease Progression|0|||
170377102|NCT02477800|615715489|FG004|Placebo-Controlled Period|Disease Progression|0|||
170377103|NCT02477800|615715490|FG005|Placebo-Controlled Period|Disease Progression|0|||
170377104|NCT02477800|615715491|FG006|Placebo-Controlled Period|Disease Progression|0|||
170377105|NCT02477800|615715485|FG000|Placebo-Controlled Period|Investigator Decision|3|||
170377106|NCT02477800|615715486|FG001|Placebo-Controlled Period|Investigator Decision|2|||
170377107|NCT02477800|615715487|FG002|Placebo-Controlled Period|Investigator Decision|1|||
170377108|NCT02477800|615715488|FG003|Placebo-Controlled Period|Investigator Decision|0|||
170377109|NCT02477800|615715489|FG004|Placebo-Controlled Period|Investigator Decision|0|||
170377110|NCT02477800|615715490|FG005|Placebo-Controlled Period|Investigator Decision|0|||
170377111|NCT02477800|615715491|FG006|Placebo-Controlled Period|Investigator Decision|0|||
170377112|NCT02477800|615715485|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
170377113|NCT02477800|615715486|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
170377114|NCT02477800|615715487|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
170377115|NCT02477800|615715488|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
170377116|NCT02477800|615715489|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
170377117|NCT02477800|615715490|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
170377118|NCT02477800|615715491|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
170377119|NCT02477800|615715485|FG000|Placebo-Controlled Period|Relocation|2|||
170377120|NCT02477800|615715486|FG001|Placebo-Controlled Period|Relocation|0|||
170377121|NCT02477800|615715487|FG002|Placebo-Controlled Period|Relocation|0|||
170377122|NCT02477800|615715488|FG003|Placebo-Controlled Period|Relocation|0|||
170377123|NCT02477800|615715489|FG004|Placebo-Controlled Period|Relocation|0|||
170377124|NCT02477800|615715490|FG005|Placebo-Controlled Period|Relocation|0|||
170377125|NCT02477800|615715491|FG006|Placebo-Controlled Period|Relocation|0|||
170377126|NCT02477800|615715485|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
170377127|NCT02477800|615715486|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
170377128|NCT02477800|615715487|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
170398852|NCT05004181|615798316|FG004|Overall Study|Lost to Follow-up|5|||
170377129|NCT02477800|615715488|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
170377130|NCT02477800|615715489|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
170377131|NCT02477800|615715490|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
170377132|NCT02477800|615715491|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
170377133|NCT02477800|615715485|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
170377134|NCT02477800|615715486|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
170377135|NCT02477800|615715487|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
170377136|NCT02477800|615715488|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
170377137|NCT02477800|615715489|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
170377138|NCT02477800|615715490|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
170377139|NCT02477800|615715491|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
170377140|NCT02477800|615715485|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
170377141|NCT02477800|615715486|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
170377142|NCT02477800|615715487|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
170377143|NCT02477800|615715488|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
170377144|NCT02477800|615715489|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
170377145|NCT02477800|615715490|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
170377146|NCT02477800|615715491|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
170377147|NCT02477800|615715485|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
170377148|NCT02477800|615715486|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
170377149|NCT02477800|615715487|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
170377150|NCT02477800|615715488|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170377151|NCT02477800|615715489|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170377152|NCT02477800|615715490|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170377153|NCT02477800|615715491|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
170377154|NCT02477800|615715485|FG000|Placebo-Controlled Period|Reason not Specified|161|||
170377155|NCT02477800|615715486|FG001|Placebo-Controlled Period|Reason not Specified|161|||
170377156|NCT02477800|615715487|FG002|Placebo-Controlled Period|Reason not Specified|189|||
170377157|NCT02477800|615715488|FG003|Placebo-Controlled Period|Reason not Specified|0|||
170377158|NCT02477800|615715489|FG004|Placebo-Controlled Period|Reason not Specified|0|||
170377159|NCT02477800|615715490|FG005|Placebo-Controlled Period|Reason not Specified|0|||
170377160|NCT02477800|615715491|FG006|Placebo-Controlled Period|Reason not Specified|0|||
170377161|NCT02477800|615715485|FG000|Long Term Extension Period|Adverse Event|0|||
170377162|NCT02477800|615715486|FG001|Long Term Extension Period|Adverse Event|0|||
170377163|NCT02477800|615715487|FG002|Long Term Extension Period|Adverse Event|0|||
170377164|NCT02477800|615715488|FG003|Long Term Extension Period|Adverse Event|6|||
170377165|NCT02477800|615715489|FG004|Long Term Extension Period|Adverse Event|2|||
170377166|NCT02477800|615715490|FG005|Long Term Extension Period|Adverse Event|4|||
170377167|NCT02477800|615715491|FG006|Long Term Extension Period|Adverse Event|3|||
170377168|NCT02477800|615715485|FG000|Long Term Extension Period|Death|0|||
170377169|NCT02477800|615715486|FG001|Long Term Extension Period|Death|0|||
170377170|NCT02477800|615715487|FG002|Long Term Extension Period|Death|0|||
170377171|NCT02477800|615715488|FG003|Long Term Extension Period|Death|1|||
170377172|NCT02477800|615715489|FG004|Long Term Extension Period|Death|1|||
170377173|NCT02477800|615715490|FG005|Long Term Extension Period|Death|1|||
170377174|NCT02477800|615715491|FG006|Long Term Extension Period|Death|2|||
170377175|NCT02477800|615715485|FG000|Long Term Extension Period|Consent Withdrawn|0|||
170377176|NCT02477800|615715486|FG001|Long Term Extension Period|Consent Withdrawn|0|||
170377177|NCT02477800|615715487|FG002|Long Term Extension Period|Consent Withdrawn|0|||
170377178|NCT02477800|615715488|FG003|Long Term Extension Period|Consent Withdrawn|10|||
170377179|NCT02477800|615715489|FG004|Long Term Extension Period|Consent Withdrawn|4|||
170377180|NCT02477800|615715490|FG005|Long Term Extension Period|Consent Withdrawn|13|||
170377181|NCT02477800|615715491|FG006|Long Term Extension Period|Consent Withdrawn|16|||
170377182|NCT02477800|615715485|FG000|Long Term Extension Period|Disease Progression|0|||
170377183|NCT02477800|615715486|FG001|Long Term Extension Period|Disease Progression|0|||
170377184|NCT02477800|615715487|FG002|Long Term Extension Period|Disease Progression|0|||
170377185|NCT02477800|615715488|FG003|Long Term Extension Period|Disease Progression|3|||
170377186|NCT02477800|615715489|FG004|Long Term Extension Period|Disease Progression|1|||
170377187|NCT02477800|615715490|FG005|Long Term Extension Period|Disease Progression|1|||
170377188|NCT02477800|615715491|FG006|Long Term Extension Period|Disease Progression|0|||
170377189|NCT02477800|615715485|FG000|Long Term Extension Period|Investigator Decision|0|||
170377190|NCT02477800|615715486|FG001|Long Term Extension Period|Investigator Decision|0|||
170377191|NCT02477800|615715487|FG002|Long Term Extension Period|Investigator Decision|0|||
170377192|NCT02477800|615715488|FG003|Long Term Extension Period|Investigator Decision|0|||
170377193|NCT02477800|615715489|FG004|Long Term Extension Period|Investigator Decision|0|||
170377194|NCT02477800|615715490|FG005|Long Term Extension Period|Investigator Decision|0|||
170377195|NCT02477800|615715491|FG006|Long Term Extension Period|Investigator Decision|2|||
170377196|NCT02477800|615715485|FG000|Long Term Extension Period|Lost to Follow-up|0|||
170377197|NCT02477800|615715486|FG001|Long Term Extension Period|Lost to Follow-up|0|||
170377198|NCT02477800|615715487|FG002|Long Term Extension Period|Lost to Follow-up|0|||
170377199|NCT02477800|615715488|FG003|Long Term Extension Period|Lost to Follow-up|0|||
170377200|NCT02477800|615715489|FG004|Long Term Extension Period|Lost to Follow-up|1|||
170377201|NCT02477800|615715490|FG005|Long Term Extension Period|Lost to Follow-up|3|||
170377202|NCT02477800|615715491|FG006|Long Term Extension Period|Lost to Follow-up|0|||
170377203|NCT02477800|615715485|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
170377204|NCT02477800|615715486|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
170377205|NCT02477800|615715487|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
170377206|NCT02477800|615715488|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
170377207|NCT02477800|615715489|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
170377208|NCT02477800|615715490|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
170377209|NCT02477800|615715491|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
170377210|NCT02477800|615715485|FG000|Long Term Extension Period|Study Visit Burden|0|||
170377211|NCT02477800|615715486|FG001|Long Term Extension Period|Study Visit Burden|0|||
170377212|NCT02477800|615715487|FG002|Long Term Extension Period|Study Visit Burden|0|||
170377213|NCT02477800|615715488|FG003|Long Term Extension Period|Study Visit Burden|3|||
170377214|NCT02477800|615715489|FG004|Long Term Extension Period|Study Visit Burden|0|||
170377215|NCT02477800|615715490|FG005|Long Term Extension Period|Study Visit Burden|2|||
170377216|NCT02477800|615715491|FG006|Long Term Extension Period|Study Visit Burden|2|||
170377217|NCT02477800|615715485|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
170377218|NCT02477800|615715486|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
170377219|NCT02477800|615715487|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
170377220|NCT02477800|615715488|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
170377221|NCT02477800|615715489|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
170377222|NCT02477800|615715490|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
170377223|NCT02477800|615715491|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
170377224|NCT02477800|615715485|FG000|Long Term Extension Period|Reason not Specified|0|||
170377225|NCT02477800|615715486|FG001|Long Term Extension Period|Reason not Specified|0|||
170377226|NCT02477800|615715487|FG002|Long Term Extension Period|Reason not Specified|0|||
170377227|NCT02477800|615715488|FG003|Long Term Extension Period|Reason not Specified|126|||
170377228|NCT02477800|615715489|FG004|Long Term Extension Period|Reason not Specified|140|||
170377229|NCT02477800|615715490|FG005|Long Term Extension Period|Reason not Specified|270|||
170377230|NCT02477800|615715491|FG006|Long Term Extension Period|Reason not Specified|224|||
170377231|NCT02871791|615715492|FG000|Phase 1b|Death|0|||
170377232|NCT02871791|615715493|FG001|Phase 1b|Death|1|||
170377233|NCT02871791|615715492|FG000|Phase 1b|progressive disease|6|||
170377234|NCT02871791|615715493|FG001|Phase 1b|progressive disease|2|||
170377235|NCT02871791|615715492|FG000|Phase 2|Death|1|||
170377236|NCT02871791|615715493|FG001|Phase 2|Death|0|||
170377237|NCT02871791|615715492|FG000|Phase 2|Lost to Follow-up|2|||
170377238|NCT02871791|615715493|FG001|Phase 2|Lost to Follow-up|0|||
170377239|NCT00002981|615715496|FG000|Overall Study|Inevaluable|6|||
170377240|NCT01828567|615715499|FG000|Overall Study|Lost to Follow-up|27|||
170377241|NCT01828567|615715500|FG001|Overall Study|Lost to Follow-up|9|||
170377242|NCT01828567|615715499|FG000|Overall Study|Excluded - did not meet criteria|4|||
170377243|NCT01828567|615715500|FG001|Overall Study|Excluded - did not meet criteria|1|||
170377244|NCT02415595|615715503|FG000|Overall Study|Administrative reason by sponsor|39|||
170377245|NCT02415595|615715504|FG001|Overall Study|Administrative reason by sponsor|40|||
170377246|NCT02415595|615715505|FG002|Overall Study|Administrative reason by sponsor|41|||
170377247|NCT02415595|615715506|FG003|Overall Study|Administrative reason by sponsor|39|||
170377248|NCT02415595|615715503|FG000|Overall Study|Adverse Event|1|||
170377249|NCT02415595|615715504|FG001|Overall Study|Adverse Event|3|||
170377250|NCT02415595|615715505|FG002|Overall Study|Adverse Event|5|||
170377251|NCT02415595|615715506|FG003|Overall Study|Adverse Event|10|||
170377252|NCT02415595|615715503|FG000|Overall Study|Lack of Efficacy|4|||
170377253|NCT02415595|615715504|FG001|Overall Study|Lack of Efficacy|4|||
170377254|NCT02415595|615715505|FG002|Overall Study|Lack of Efficacy|0|||
170377255|NCT02415595|615715506|FG003|Overall Study|Lack of Efficacy|0|||
170377256|NCT02415595|615715503|FG000|Overall Study|Lost to Follow-up|1|||
170377257|NCT02415595|615715504|FG001|Overall Study|Lost to Follow-up|3|||
170377258|NCT02415595|615715505|FG002|Overall Study|Lost to Follow-up|1|||
170377259|NCT02415595|615715506|FG003|Overall Study|Lost to Follow-up|1|||
170377260|NCT02415595|615715503|FG000|Overall Study|Poor/Non-compliance|1|||
170377261|NCT02415595|615715504|FG001|Overall Study|Poor/Non-compliance|0|||
170377262|NCT02415595|615715505|FG002|Overall Study|Poor/Non-compliance|1|||
170377263|NCT02415595|615715506|FG003|Overall Study|Poor/Non-compliance|0|||
170377264|NCT02415595|615715503|FG000|Overall Study|Reached stopping criteria|0|||
170377265|NCT02415595|615715504|FG001|Overall Study|Reached stopping criteria|1|||
170377266|NCT02415595|615715505|FG002|Overall Study|Reached stopping criteria|1|||
170377267|NCT02415595|615715506|FG003|Overall Study|Reached stopping criteria|0|||
170377268|NCT02415595|615715503|FG000|Overall Study|Withdrawal by Subject|4|||
170377269|NCT02415595|615715504|FG001|Overall Study|Withdrawal by Subject|0|||
170377270|NCT02415595|615715505|FG002|Overall Study|Withdrawal by Subject|1|||
170377271|NCT02415595|615715506|FG003|Overall Study|Withdrawal by Subject|3|||
170377272|NCT02415595|615715503|FG000|Overall Study|Other|0|||
170377273|NCT02415595|615715504|FG001|Overall Study|Other|1|||
170377274|NCT02415595|615715505|FG002|Overall Study|Other|1|||
170377275|NCT02415595|615715506|FG003|Overall Study|Other|0|||
170377276|NCT02614261|615715507|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
170377277|NCT02614261|615715508|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
170377278|NCT02614261|615715509|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
170377279|NCT02614261|615715510|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
170377280|NCT02614261|615715507|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
170377281|NCT02614261|615715508|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
170377282|NCT02614261|615715509|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
170377283|NCT02614261|615715510|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
170377284|NCT02614261|615715507|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
170377285|NCT02614261|615715508|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
170377286|NCT02614261|615715509|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
170377287|NCT02614261|615715510|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
170377288|NCT02614261|615715507|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
170377289|NCT02614261|615715508|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
170377290|NCT02614261|615715509|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
170377291|NCT02614261|615715510|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
170377292|NCT02614261|615715507|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
170377293|NCT02614261|615715508|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
170377294|NCT02614261|615715509|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
170377295|NCT02614261|615715510|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
170377296|NCT02614261|615715507|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
170377297|NCT02614261|615715508|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
170377298|NCT02614261|615715509|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
170377299|NCT02614261|615715510|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
170377300|NCT02614261|615715507|FG000|Double-Blind Treatment Phase|Screen failure|0|||
170377301|NCT02614261|615715508|FG001|Double-Blind Treatment Phase|Screen failure|1|||
170377302|NCT02614261|615715509|FG002|Double-Blind Treatment Phase|Screen failure|2|||
170377303|NCT02614261|615715510|FG003|Double-Blind Treatment Phase|Screen failure|0|||
170377304|NCT02614261|615715507|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
170377305|NCT02614261|615715508|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
170377306|NCT02614261|615715509|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
170377307|NCT02614261|615715510|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
170377308|NCT02614261|615715507|FG000|Open-Label Extension Phase|Adverse Event|23|||
170377309|NCT02614261|615715508|FG001|Open-Label Extension Phase|Adverse Event|12|||
170377310|NCT02614261|615715509|FG002|Open-Label Extension Phase|Adverse Event|11|||
170377311|NCT02614261|615715510|FG003|Open-Label Extension Phase|Adverse Event|0|||
170377312|NCT02614261|615715507|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
170377313|NCT02614261|615715508|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
170377314|NCT02614261|615715509|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
170377315|NCT02614261|615715510|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
170377316|NCT02614261|615715507|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
170377317|NCT02614261|615715508|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
170377318|NCT02614261|615715509|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
170377319|NCT02614261|615715510|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
170377320|NCT02614261|615715507|FG000|Open-Label Extension Phase|Physician Decision|2|||
170377321|NCT02614261|615715508|FG001|Open-Label Extension Phase|Physician Decision|0|||
170377322|NCT02614261|615715509|FG002|Open-Label Extension Phase|Physician Decision|0|||
170377323|NCT02614261|615715510|FG003|Open-Label Extension Phase|Physician Decision|0|||
170377324|NCT02614261|615715507|FG000|Open-Label Extension Phase|Pregnancy|1|||
170377325|NCT02614261|615715508|FG001|Open-Label Extension Phase|Pregnancy|2|||
170377326|NCT02614261|615715509|FG002|Open-Label Extension Phase|Pregnancy|1|||
170377327|NCT02614261|615715510|FG003|Open-Label Extension Phase|Pregnancy|0|||
170377328|NCT02614261|615715507|FG000|Open-Label Extension Phase|Protocol Violation|3|||
170377329|NCT02614261|615715508|FG001|Open-Label Extension Phase|Protocol Violation|4|||
170377330|NCT02614261|615715509|FG002|Open-Label Extension Phase|Protocol Violation|1|||
170377331|NCT02614261|615715510|FG003|Open-Label Extension Phase|Protocol Violation|0|||
170377332|NCT02614261|615715507|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
170377333|NCT02614261|615715508|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
170377334|NCT02614261|615715509|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
170377335|NCT02614261|615715510|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
170377336|NCT02614261|615715507|FG000|Follow-up Phase|Adverse Event|2|||
170377337|NCT02614261|615715508|FG001|Follow-up Phase|Adverse Event|0|||
170377338|NCT02614261|615715509|FG002|Follow-up Phase|Adverse Event|1|||
170377339|NCT02614261|615715510|FG003|Follow-up Phase|Adverse Event|0|||
170377340|NCT02614261|615715507|FG000|Follow-up Phase|Lost to Follow-up|12|||
170377341|NCT02614261|615715508|FG001|Follow-up Phase|Lost to Follow-up|5|||
170377342|NCT02614261|615715509|FG002|Follow-up Phase|Lost to Follow-up|2|||
170377343|NCT02614261|615715510|FG003|Follow-up Phase|Lost to Follow-up|0|||
170377344|NCT02614261|615715507|FG000|Follow-up Phase|Physician Decision|5|||
170377345|NCT02614261|615715508|FG001|Follow-up Phase|Physician Decision|1|||
170377346|NCT02614261|615715509|FG002|Follow-up Phase|Physician Decision|0|||
170377347|NCT02614261|615715510|FG003|Follow-up Phase|Physician Decision|0|||
170377348|NCT02614261|615715507|FG000|Follow-up Phase|Pregnancy|0|||
170377349|NCT02614261|615715508|FG001|Follow-up Phase|Pregnancy|1|||
170377350|NCT02614261|615715509|FG002|Follow-up Phase|Pregnancy|0|||
170377351|NCT02614261|615715510|FG003|Follow-up Phase|Pregnancy|0|||
170377352|NCT02614261|615715507|FG000|Follow-up Phase|Protocol Violation|1|||
170377353|NCT02614261|615715508|FG001|Follow-up Phase|Protocol Violation|0|||
170377354|NCT02614261|615715509|FG002|Follow-up Phase|Protocol Violation|0|||
170377355|NCT02614261|615715510|FG003|Follow-up Phase|Protocol Violation|0|||
170377356|NCT02614261|615715507|FG000|Follow-up Phase|Withdrawal by Subject|12|||
170377357|NCT02614261|615715508|FG001|Follow-up Phase|Withdrawal by Subject|4|||
170377358|NCT02614261|615715509|FG002|Follow-up Phase|Withdrawal by Subject|11|||
170377359|NCT02614261|615715510|FG003|Follow-up Phase|Withdrawal by Subject|0|||
170377360|NCT02614261|615715507|FG000|Israel Addendum|Withdrawal by Subject|0|||
170377361|NCT02614261|615715508|FG001|Israel Addendum|Withdrawal by Subject|0|||
170377362|NCT02614261|615715509|FG002|Israel Addendum|Withdrawal by Subject|0|||
170377363|NCT02614261|615715510|FG003|Israel Addendum|Withdrawal by Subject|4|||
170377364|NCT01700140|615715512|FG000|Overall Study|Use of rescue drugs|3|||
170377365|NCT01700140|615715513|FG001|Overall Study|Use of rescue drugs|3|||
170377366|NCT01700140|615715514|FG002|Overall Study|Use of rescue drugs|1|||
170377367|NCT01700140|615715512|FG000|Overall Study|Discontinuation of radiotherapy|1|||
170377368|NCT01700140|615715513|FG001|Overall Study|Discontinuation of radiotherapy|0|||
170377369|NCT01700140|615715514|FG002|Overall Study|Discontinuation of radiotherapy|0|||
170377370|NCT01700140|615715512|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
170377371|NCT01700140|615715513|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
170377372|NCT01700140|615715514|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
170377373|NCT01700140|615715512|FG000|Overall Study|Aggravation of symptoms|1|||
170377374|NCT01700140|615715513|FG001|Overall Study|Aggravation of symptoms|0|||
170377375|NCT01700140|615715514|FG002|Overall Study|Aggravation of symptoms|0|||
170377376|NCT01700140|615715512|FG000|Overall Study|Adverse Event|0|||
170377377|NCT01700140|615715513|FG001|Overall Study|Adverse Event|1|||
170377378|NCT01700140|615715514|FG002|Overall Study|Adverse Event|0|||
170377379|NCT01700140|615715512|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
170377380|NCT01700140|615715513|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
170377381|NCT01700140|615715514|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
170377382|NCT01060124|615715515|FG000|Overall Study|Other|16|||
170377383|NCT01060124|615715515|FG000|Overall Study|Adverse Event|14|||
170377384|NCT01060124|615715515|FG000|Overall Study|Withdrawal by Subject|7|||
170377385|NCT03864627|615715520|FG000|Overall Study|Adverse Event|0|||
170377386|NCT03864627|615715521|FG001|Overall Study|Adverse Event|1|||
170377387|NCT03864627|615715520|FG000|Overall Study|Lack of Efficacy|0|||
170377388|NCT03864627|615715521|FG001|Overall Study|Lack of Efficacy|1|||
170377389|NCT03864627|615715520|FG000|Overall Study|Lost to Follow-up|0|||
170377390|NCT03864627|615715521|FG001|Overall Study|Lost to Follow-up|1|||
170377391|NCT03864627|615715520|FG000|Overall Study|Withdrawal by Subject|4|||
170377392|NCT03864627|615715521|FG001|Overall Study|Withdrawal by Subject|8|||
170377393|NCT03864627|615715520|FG000|Overall Study|Study terminated by sponsor|0|||
170377394|NCT03864627|615715521|FG001|Overall Study|Study terminated by sponsor|1|||
170377395|NCT01388491|615715522|FG000|Overall Study|Adverse Event|10|||
170377396|NCT01388491|615715523|FG001|Overall Study|Adverse Event|9|||
170377397|NCT01388491|615715522|FG000|Overall Study|Sponsor Request|9|||
170377398|NCT01388491|615715523|FG001|Overall Study|Sponsor Request|7|||
170377399|NCT01388491|615715522|FG000|Overall Study|Withdrawal by Subject|6|||
170377400|NCT01388491|615715523|FG001|Overall Study|Withdrawal by Subject|10|||
170377401|NCT01388491|615715522|FG000|Overall Study|Lost to Follow-up|4|||
170377402|NCT01388491|615715523|FG001|Overall Study|Lost to Follow-up|3|||
170377403|NCT01388491|615715522|FG000|Overall Study|Protocol Violation|2|||
170377404|NCT01388491|615715523|FG001|Overall Study|Protocol Violation|0|||
170377405|NCT01388491|615715522|FG000|Overall Study|Noncompliance|2|||
170377406|NCT01388491|615715523|FG001|Overall Study|Noncompliance|0|||
170377407|NCT01388491|615715522|FG000|Overall Study|Pregnancy|1|||
170377408|NCT01388491|615715523|FG001|Overall Study|Pregnancy|0|||
170377409|NCT00112840|615715524|FG000|Overall Study|Physician Decision|1|||
170377410|NCT00112840|615715525|FG001|Overall Study|Physician Decision|0|||
170377411|NCT00112840|615715526|FG002|Overall Study|Physician Decision|0|||
170377412|NCT00112840|615715524|FG000|Overall Study|Withdrawal by Subject|1|||
170377413|NCT00112840|615715525|FG001|Overall Study|Withdrawal by Subject|0|||
170377414|NCT00112840|615715526|FG002|Overall Study|Withdrawal by Subject|1|||
170377415|NCT00112840|615715524|FG000|Overall Study|Protocol Violation|0|||
170377416|NCT00112840|615715525|FG001|Overall Study|Protocol Violation|0|||
170377417|NCT00112840|615715526|FG002|Overall Study|Protocol Violation|5|||
170377418|NCT00412113|615715528|FG000|Overall Study|Adverse Event|11|||
170377419|NCT00412113|615715529|FG001|Overall Study|Adverse Event|15|||
170377420|NCT00412113|615715528|FG000|Overall Study|did not receive treatment|1|||
170377421|NCT00412113|615715529|FG001|Overall Study|did not receive treatment|0|||
170377422|NCT01201967|615715530|FG000|Overall Study|Lost to Follow-up|6|||
170377423|NCT01201967|615715531|FG001|Overall Study|Lost to Follow-up|5|||
170377424|NCT01465958|615717435|FG000|Run-in Phase|Protocol Violation|1|||
170377425|NCT01465958|615717436|FG001|Run-in Phase|Protocol Violation|0|||
170377426|NCT01465958|615717435|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
170377427|NCT01465958|615717436|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
170377428|NCT01625897|615717437|FG000|Overall Study|Adverse Event|27|||
170377429|NCT01625897|615717438|FG001|Overall Study|Adverse Event|10|||
170377430|NCT01625897|615717437|FG000|Overall Study|Physician Decision|0|||
170377431|NCT01625897|615717438|FG001|Overall Study|Physician Decision|1|||
170377432|NCT01625897|615717437|FG000|Overall Study|Withdrawal by Subject|25|||
170377433|NCT01625897|615717438|FG001|Overall Study|Withdrawal by Subject|3|||
170377434|NCT03455530|615717439|FG000|Overall Study|Withdrawal by Subject|9|||
170377435|NCT03455530|615717440|FG001|Overall Study|Withdrawal by Subject|1|||
170377436|NCT03455530|615717441|FG002|Overall Study|Withdrawal by Subject|3|||
170377437|NCT03455530|615717442|FG003|Overall Study|Withdrawal by Subject|3|||
170377438|NCT01004861|615717448|FG000|Overall Study|Disease progression|3|||
170377439|NCT01004861|615717449|FG001|Overall Study|Disease progression|4|||
170377440|NCT01004861|615717450|FG002|Overall Study|Disease progression|5|||
170377441|NCT01004861|615717451|FG003|Overall Study|Disease progression|4|||
170377442|NCT01004861|615717452|FG004|Overall Study|Disease progression|4|||
170377443|NCT01004861|615717453|FG005|Overall Study|Disease progression|4|||
170377444|NCT01004861|615717454|FG006|Overall Study|Disease progression|5|||
170377445|NCT01004861|615717455|FG007|Overall Study|Disease progression|1|||
170377446|NCT01004861|615717456|FG008|Overall Study|Disease progression|4|||
170377447|NCT01004861|615717457|FG009|Overall Study|Disease progression|7|||
170377448|NCT01004861|615717458|FG010|Overall Study|Disease progression|6|||
170377449|NCT01004861|615717459|FG011|Overall Study|Disease progression|3|||
170377450|NCT01004861|615717460|FG012|Overall Study|Disease progression|8|||
170377451|NCT01004861|615717448|FG000|Overall Study|Physician Decision|0|||
170377452|NCT01004861|615717449|FG001|Overall Study|Physician Decision|2|||
170377453|NCT01004861|615717450|FG002|Overall Study|Physician Decision|1|||
170377454|NCT01004861|615717451|FG003|Overall Study|Physician Decision|1|||
170377455|NCT01004861|615717452|FG004|Overall Study|Physician Decision|1|||
170377456|NCT01004861|615717453|FG005|Overall Study|Physician Decision|0|||
170377457|NCT01004861|615717454|FG006|Overall Study|Physician Decision|0|||
170377458|NCT01004861|615717455|FG007|Overall Study|Physician Decision|1|||
170377459|NCT01004861|615717456|FG008|Overall Study|Physician Decision|0|||
170377460|NCT01004861|615717457|FG009|Overall Study|Physician Decision|0|||
170377461|NCT01004861|615717458|FG010|Overall Study|Physician Decision|0|||
170377462|NCT01004861|615717459|FG011|Overall Study|Physician Decision|0|||
170377463|NCT01004861|615717460|FG012|Overall Study|Physician Decision|3|||
170377464|NCT01004861|615717448|FG000|Overall Study|Adverse Event|0|||
170377465|NCT01004861|615717449|FG001|Overall Study|Adverse Event|0|||
170377466|NCT01004861|615717450|FG002|Overall Study|Adverse Event|0|||
170377467|NCT01004861|615717451|FG003|Overall Study|Adverse Event|1|||
170377468|NCT01004861|615717452|FG004|Overall Study|Adverse Event|0|||
170377469|NCT01004861|615717453|FG005|Overall Study|Adverse Event|2|||
170377470|NCT01004861|615717454|FG006|Overall Study|Adverse Event|1|||
170377471|NCT01004861|615717455|FG007|Overall Study|Adverse Event|1|||
170377472|NCT01004861|615717456|FG008|Overall Study|Adverse Event|13|||
170377473|NCT01004861|615717457|FG009|Overall Study|Adverse Event|1|||
170377474|NCT01004861|615717458|FG010|Overall Study|Adverse Event|1|||
170377475|NCT01004861|615717459|FG011|Overall Study|Adverse Event|0|||
170377476|NCT01004861|615717460|FG012|Overall Study|Adverse Event|2|||
170377477|NCT01004861|615717448|FG000|Overall Study|Protocol Violation|0|||
170377478|NCT01004861|615717449|FG001|Overall Study|Protocol Violation|0|||
170377479|NCT01004861|615717450|FG002|Overall Study|Protocol Violation|0|||
170377480|NCT01004861|615717451|FG003|Overall Study|Protocol Violation|0|||
170377481|NCT01004861|615717452|FG004|Overall Study|Protocol Violation|1|||
170377482|NCT01004861|615717453|FG005|Overall Study|Protocol Violation|0|||
170377483|NCT01004861|615717454|FG006|Overall Study|Protocol Violation|0|||
170377484|NCT01004861|615717455|FG007|Overall Study|Protocol Violation|0|||
170377485|NCT01004861|615717456|FG008|Overall Study|Protocol Violation|0|||
170377486|NCT01004861|615717457|FG009|Overall Study|Protocol Violation|0|||
170377487|NCT01004861|615717458|FG010|Overall Study|Protocol Violation|0|||
170377488|NCT01004861|615717459|FG011|Overall Study|Protocol Violation|0|||
170377489|NCT01004861|615717460|FG012|Overall Study|Protocol Violation|0|||
170377490|NCT01004861|615717448|FG000|Overall Study|Lost to Follow-up|0|||
170377491|NCT01004861|615717449|FG001|Overall Study|Lost to Follow-up|0|||
170377492|NCT01004861|615717450|FG002|Overall Study|Lost to Follow-up|0|||
170377493|NCT01004861|615717451|FG003|Overall Study|Lost to Follow-up|0|||
170377494|NCT01004861|615717452|FG004|Overall Study|Lost to Follow-up|0|||
170377495|NCT01004861|615717453|FG005|Overall Study|Lost to Follow-up|0|||
170377496|NCT01004861|615717454|FG006|Overall Study|Lost to Follow-up|0|||
170377497|NCT01004861|615717455|FG007|Overall Study|Lost to Follow-up|1|||
170377498|NCT01004861|615717456|FG008|Overall Study|Lost to Follow-up|3|||
170377499|NCT01004861|615717457|FG009|Overall Study|Lost to Follow-up|0|||
170377500|NCT01004861|615717458|FG010|Overall Study|Lost to Follow-up|0|||
170377501|NCT01004861|615717459|FG011|Overall Study|Lost to Follow-up|1|||
170377502|NCT01004861|615717460|FG012|Overall Study|Lost to Follow-up|0|||
170377503|NCT01004861|615717448|FG000|Overall Study|Non-compliance|0|||
170377504|NCT01004861|615717449|FG001|Overall Study|Non-compliance|0|||
170377505|NCT01004861|615717450|FG002|Overall Study|Non-compliance|0|||
170377506|NCT01004861|615717451|FG003|Overall Study|Non-compliance|0|||
170377507|NCT01004861|615717452|FG004|Overall Study|Non-compliance|0|||
170377508|NCT01004861|615717453|FG005|Overall Study|Non-compliance|0|||
170377509|NCT01004861|615717454|FG006|Overall Study|Non-compliance|0|||
170377510|NCT01004861|615717455|FG007|Overall Study|Non-compliance|0|||
170377511|NCT01004861|615717456|FG008|Overall Study|Non-compliance|5|||
170377512|NCT01004861|615717457|FG009|Overall Study|Non-compliance|0|||
170377513|NCT01004861|615717458|FG010|Overall Study|Non-compliance|0|||
170377514|NCT01004861|615717459|FG011|Overall Study|Non-compliance|0|||
170377515|NCT01004861|615717460|FG012|Overall Study|Non-compliance|1|||
170377516|NCT01004861|615717448|FG000|Overall Study|Other|0|||
170377517|NCT01004861|615717449|FG001|Overall Study|Other|0|||
170377518|NCT01004861|615717450|FG002|Overall Study|Other|0|||
170377519|NCT01004861|615717451|FG003|Overall Study|Other|0|||
170377520|NCT01004861|615717452|FG004|Overall Study|Other|0|||
170377521|NCT01004861|615717453|FG005|Overall Study|Other|0|||
170377522|NCT01004861|615717454|FG006|Overall Study|Other|0|||
170377523|NCT01004861|615717455|FG007|Overall Study|Other|0|||
170377524|NCT01004861|615717456|FG008|Overall Study|Other|0|||
170377525|NCT01004861|615717457|FG009|Overall Study|Other|2|||
170377526|NCT01004861|615717458|FG010|Overall Study|Other|1|||
170377527|NCT01004861|615717459|FG011|Overall Study|Other|2|||
170377528|NCT01004861|615717460|FG012|Overall Study|Other|3|||
170377529|NCT01004861|615717448|FG000|Overall Study|Patient decision|0|||
170377530|NCT01004861|615717449|FG001|Overall Study|Patient decision|0|||
170377531|NCT01004861|615717450|FG002|Overall Study|Patient decision|0|||
170377532|NCT01004861|615717451|FG003|Overall Study|Patient decision|0|||
170377533|NCT01004861|615717452|FG004|Overall Study|Patient decision|1|||
170377534|NCT01004861|615717453|FG005|Overall Study|Patient decision|0|||
170377535|NCT01004861|615717454|FG006|Overall Study|Patient decision|1|||
170377536|NCT01004861|615717455|FG007|Overall Study|Patient decision|0|||
170377537|NCT01004861|615717456|FG008|Overall Study|Patient decision|7|||
170377538|NCT01004861|615717457|FG009|Overall Study|Patient decision|1|||
170377539|NCT01004861|615717458|FG010|Overall Study|Patient decision|1|||
170377540|NCT01004861|615717459|FG011|Overall Study|Patient decision|2|||
170377541|NCT01004861|615717460|FG012|Overall Study|Patient decision|3|||
170377542|NCT01004861|615717448|FG000|Overall Study|Transitioned to Phase 4 study|0|||
170377543|NCT01004861|615717449|FG001|Overall Study|Transitioned to Phase 4 study|0|||
170377544|NCT01004861|615717450|FG002|Overall Study|Transitioned to Phase 4 study|0|||
170377545|NCT01004861|615717451|FG003|Overall Study|Transitioned to Phase 4 study|0|||
170377546|NCT01004861|615717452|FG004|Overall Study|Transitioned to Phase 4 study|0|||
170377547|NCT01004861|615717453|FG005|Overall Study|Transitioned to Phase 4 study|0|||
170377548|NCT01004861|615717454|FG006|Overall Study|Transitioned to Phase 4 study|0|||
170377549|NCT01004861|615717455|FG007|Overall Study|Transitioned to Phase 4 study|0|||
170377550|NCT01004861|615717456|FG008|Overall Study|Transitioned to Phase 4 study|2|||
170377551|NCT01004861|615717457|FG009|Overall Study|Transitioned to Phase 4 study|0|||
170377552|NCT01004861|615717458|FG010|Overall Study|Transitioned to Phase 4 study|0|||
170377553|NCT01004861|615717459|FG011|Overall Study|Transitioned to Phase 4 study|0|||
170377554|NCT01004861|615717460|FG012|Overall Study|Transitioned to Phase 4 study|0|||
170377555|NCT01004861|615717448|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377556|NCT01004861|615717449|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377557|NCT01004861|615717450|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377558|NCT01004861|615717451|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377559|NCT01004861|615717452|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377560|NCT01004861|615717453|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377561|NCT01004861|615717454|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377562|NCT01004861|615717455|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377563|NCT01004861|615717456|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
170377564|NCT01004861|615717457|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377565|NCT01004861|615717458|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377566|NCT01004861|615717459|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377567|NCT01004861|615717460|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
170377568|NCT01004861|615717448|FG000|Overall Study|Patient withdrew|0|||
170377569|NCT01004861|615717449|FG001|Overall Study|Patient withdrew|0|||
170377570|NCT01004861|615717450|FG002|Overall Study|Patient withdrew|0|||
170377571|NCT01004861|615717451|FG003|Overall Study|Patient withdrew|0|||
170377572|NCT01004861|615717452|FG004|Overall Study|Patient withdrew|0|||
170377573|NCT01004861|615717453|FG005|Overall Study|Patient withdrew|0|||
170377574|NCT01004861|615717454|FG006|Overall Study|Patient withdrew|0|||
170377575|NCT01004861|615717455|FG007|Overall Study|Patient withdrew|0|||
170377576|NCT01004861|615717456|FG008|Overall Study|Patient withdrew|1|||
170377577|NCT01004861|615717457|FG009|Overall Study|Patient withdrew|0|||
170377578|NCT01004861|615717458|FG010|Overall Study|Patient withdrew|0|||
170377579|NCT01004861|615717459|FG011|Overall Study|Patient withdrew|0|||
170377580|NCT01004861|615717460|FG012|Overall Study|Patient withdrew|0|||
170377581|NCT01004861|615717448|FG000|Overall Study|Surgical resection|0|||
170377582|NCT01004861|615717449|FG001|Overall Study|Surgical resection|0|||
170377583|NCT01004861|615717450|FG002|Overall Study|Surgical resection|0|||
170377584|NCT01004861|615717451|FG003|Overall Study|Surgical resection|0|||
170377585|NCT01004861|615717452|FG004|Overall Study|Surgical resection|0|||
170377586|NCT01004861|615717453|FG005|Overall Study|Surgical resection|0|||
170377587|NCT01004861|615717454|FG006|Overall Study|Surgical resection|0|||
170377588|NCT01004861|615717455|FG007|Overall Study|Surgical resection|0|||
170377589|NCT01004861|615717456|FG008|Overall Study|Surgical resection|1|||
170377590|NCT01004861|615717457|FG009|Overall Study|Surgical resection|0|||
170377591|NCT01004861|615717458|FG010|Overall Study|Surgical resection|0|||
170377592|NCT01004861|615717459|FG011|Overall Study|Surgical resection|0|||
170377593|NCT01004861|615717460|FG012|Overall Study|Surgical resection|0|||
170377594|NCT01004861|615717448|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377595|NCT01004861|615717449|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377596|NCT01004861|615717450|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377597|NCT01004861|615717451|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377598|NCT01004861|615717452|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377599|NCT01004861|615717453|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377600|NCT01004861|615717454|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377601|NCT01004861|615717455|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377602|NCT01004861|615717456|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
170377603|NCT01004861|615717457|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377604|NCT01004861|615717458|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377605|NCT01004861|615717459|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377606|NCT01004861|615717460|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
170377607|NCT01004861|615717448|FG000|Overall Study|Study termination by Sponsor|0|||
170377608|NCT01004861|615717449|FG001|Overall Study|Study termination by Sponsor|0|||
170377609|NCT01004861|615717450|FG002|Overall Study|Study termination by Sponsor|0|||
170377610|NCT01004861|615717451|FG003|Overall Study|Study termination by Sponsor|0|||
170377611|NCT01004861|615717452|FG004|Overall Study|Study termination by Sponsor|0|||
170377612|NCT01004861|615717453|FG005|Overall Study|Study termination by Sponsor|0|||
170377613|NCT01004861|615717454|FG006|Overall Study|Study termination by Sponsor|0|||
170377614|NCT01004861|615717455|FG007|Overall Study|Study termination by Sponsor|0|||
170377615|NCT01004861|615717456|FG008|Overall Study|Study termination by Sponsor|1|||
170377616|NCT01004861|615717457|FG009|Overall Study|Study termination by Sponsor|0|||
170377617|NCT01004861|615717458|FG010|Overall Study|Study termination by Sponsor|0|||
170377618|NCT01004861|615717459|FG011|Overall Study|Study termination by Sponsor|0|||
170377619|NCT01004861|615717460|FG012|Overall Study|Study termination by Sponsor|0|||
170377620|NCT00686699|615717461|FG000|Treatment Period 1|Adverse Event|0|||
170377621|NCT00686699|615717462|FG001|Treatment Period 1|Adverse Event|2|||
170377622|NCT04610827|615717464|FG000|Overall Study|Withdrawal by Subject|1|||
170377623|NCT04610827|615717465|FG001|Overall Study|Withdrawal by Subject|1|||
170377624|NCT04610827|615717466|FG002|Overall Study|Withdrawal by Subject|0|||
170377625|NCT00908895|615717467|FG000|Overall Study|Lost to Follow-up|1|||
170377626|NCT00908895|615717468|FG001|Overall Study|Lost to Follow-up|3|||
170377627|NCT00908895|615717467|FG000|Overall Study|algodystrophy|2|||
170377628|NCT00908895|615717468|FG001|Overall Study|algodystrophy|2|||
170377629|NCT00908895|615717467|FG000|Overall Study|Adverse Event|1|||
170377630|NCT00908895|615717468|FG001|Overall Study|Adverse Event|1|||
170377631|NCT03793010|615717469|FG000|Overall Study|Withdrawal by Subject|5|||
170377632|NCT03793010|615717470|FG001|Overall Study|Withdrawal by Subject|7|||
170377633|NCT03793010|615717469|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
170377634|NCT03793010|615717470|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
170377635|NCT03793010|615717469|FG000|Overall Study|Lost to Follow-up|1|||
170377636|NCT03793010|615717470|FG001|Overall Study|Lost to Follow-up|2|||
170377637|NCT03793010|615717469|FG000|Overall Study|Patient couldn't sit still for injection|1|||
170377638|NCT03793010|615717470|FG001|Overall Study|Patient couldn't sit still for injection|0|||
170377639|NCT03793010|615717469|FG000|Overall Study|Withdrew to pursue other treatment|1|||
170377640|NCT03793010|615717470|FG001|Overall Study|Withdrew to pursue other treatment|0|||
170377641|NCT03793010|615717469|FG000|Overall Study|Did not meet eligibility criteria|1|||
170377642|NCT03793010|615717470|FG001|Overall Study|Did not meet eligibility criteria|0|||
170377643|NCT00805194|615717475|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
170377644|NCT00805194|615717476|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
170377645|NCT00805194|615717475|FG000|Overall Study|Worsening or AE of underlying disease|64|||
170377646|NCT00805194|615717476|FG001|Overall Study|Worsening or AE of underlying disease|70|||
170377647|NCT00805194|615717475|FG000|Overall Study|Other AE|84|||
170377648|NCT00805194|615717476|FG001|Overall Study|Other AE|73|||
170377649|NCT00805194|615717475|FG000|Overall Study|Protocol Violation|9|||
170377650|NCT00805194|615717476|FG001|Overall Study|Protocol Violation|9|||
170377651|NCT00805194|615717475|FG000|Overall Study|Lost to Follow-up|5|||
170377652|NCT00805194|615717476|FG001|Overall Study|Lost to Follow-up|5|||
170377653|NCT00805194|615717475|FG000|Overall Study|Withdrawal by Subject|60|||
170377654|NCT00805194|615717476|FG001|Overall Study|Withdrawal by Subject|42|||
170377655|NCT00805194|615717475|FG000|Overall Study|Not treated|3|||
170377656|NCT00805194|615717476|FG001|Overall Study|Not treated|4|||
170377657|NCT00805194|615717475|FG000|Overall Study|Reasons other than stated above|20|||
170377658|NCT00805194|615717476|FG001|Overall Study|Reasons other than stated above|16|||
170377659|NCT02185040|615717477|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
170377660|NCT02185040|615717478|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
170377661|NCT02185040|615717479|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
170377662|NCT02185040|615717480|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
170377663|NCT02185040|615717481|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
170377664|NCT02185040|615717482|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
170377665|NCT02185040|615717483|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
170377666|NCT02185040|615717477|FG000|Part 1 Treatment Phase|Adverse Event|1|||
170377667|NCT02185040|615717478|FG001|Part 1 Treatment Phase|Adverse Event|0|||
170377668|NCT02185040|615717479|FG002|Part 1 Treatment Phase|Adverse Event|0|||
170377669|NCT02185040|615717480|FG003|Part 1 Treatment Phase|Adverse Event|2|||
170377670|NCT02185040|615717481|FG004|Part 1 Treatment Phase|Adverse Event|3|||
170377671|NCT02185040|615717482|FG005|Part 1 Treatment Phase|Adverse Event|0|||
170377672|NCT02185040|615717483|FG006|Part 1 Treatment Phase|Adverse Event|0|||
170377673|NCT02185040|615717477|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
170377674|NCT02185040|615717478|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
170377675|NCT02185040|615717479|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
170377676|NCT02185040|615717480|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
170377677|NCT02185040|615717481|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
170377678|NCT02185040|615717482|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
170377679|NCT02185040|615717483|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
170377680|NCT02185040|615717477|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
170377681|NCT02185040|615717478|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
170377682|NCT02185040|615717479|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
170377683|NCT02185040|615717480|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
170377684|NCT02185040|615717481|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
170377685|NCT02185040|615717482|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
170377686|NCT02185040|615717483|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
170377687|NCT02185040|615717477|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
170377688|NCT02185040|615717478|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
170377689|NCT02185040|615717479|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
170377690|NCT02185040|615717480|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
170377691|NCT02185040|615717481|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
170377692|NCT02185040|615717482|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
170377693|NCT02185040|615717483|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
170377694|NCT02185040|615717477|FG000|Active Treatment Extension Phase|Adverse Event|0|||
170377695|NCT02185040|615717478|FG001|Active Treatment Extension Phase|Adverse Event|0|||
170377696|NCT02185040|615717479|FG002|Active Treatment Extension Phase|Adverse Event|0|||
170377697|NCT02185040|615717480|FG003|Active Treatment Extension Phase|Adverse Event|0|||
170377698|NCT02185040|615717481|FG004|Active Treatment Extension Phase|Adverse Event|0|||
170377699|NCT02185040|615717482|FG005|Active Treatment Extension Phase|Adverse Event|1|||
170377700|NCT02185040|615717483|FG006|Active Treatment Extension Phase|Adverse Event|4|||
170377701|NCT02185040|615717477|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
170377702|NCT02185040|615717478|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
170377703|NCT02185040|615717479|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
170377704|NCT02185040|615717480|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
170377705|NCT02185040|615717481|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
170377706|NCT02185040|615717482|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
170377707|NCT02185040|615717483|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
170377708|NCT02185040|615717477|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
170377709|NCT02185040|615717478|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
170377710|NCT02185040|615717479|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
170377711|NCT02185040|615717480|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
170377712|NCT02185040|615717481|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
170377713|NCT02185040|615717482|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
170377714|NCT02185040|615717483|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
170377715|NCT00718887|615717486|FG000|Overall Study|Withdrawal by Subject|3|||
170377716|NCT00718887|615717487|FG001|Overall Study|Withdrawal by Subject|2|||
170377717|NCT00718887|615717486|FG000|Overall Study|Not identified|2|||
170377718|NCT00718887|615717487|FG001|Overall Study|Not identified|7|||
170377719|NCT02646891|615717488|FG000|Overall Study|Adverse Event|0|||
170377720|NCT02646891|615717489|FG001|Overall Study|Adverse Event|1|||
170377721|NCT02646891|615717490|FG002|Overall Study|Adverse Event|0|||
170377722|NCT02646891|615717491|FG003|Overall Study|Adverse Event|0|||
170377723|NCT02646891|615717492|FG004|Overall Study|Adverse Event|0|||
170377724|NCT02646891|615717493|FG005|Overall Study|Adverse Event|0|||
170377725|NCT02646891|615717494|FG006|Overall Study|Adverse Event|0|||
170377726|NCT02646891|615717495|FG007|Overall Study|Adverse Event|0|||
170377727|NCT02646891|615717496|FG008|Overall Study|Adverse Event|0|||
170377728|NCT02646891|615717497|FG009|Overall Study|Adverse Event|0|||
170377729|NCT02646891|615717488|FG000|Overall Study|Lost to Follow-up|0|||
170377730|NCT02646891|615717489|FG001|Overall Study|Lost to Follow-up|0|||
170377731|NCT02646891|615717490|FG002|Overall Study|Lost to Follow-up|0|||
170377732|NCT02646891|615717491|FG003|Overall Study|Lost to Follow-up|0|||
170377733|NCT02646891|615717492|FG004|Overall Study|Lost to Follow-up|0|||
170377734|NCT02646891|615717493|FG005|Overall Study|Lost to Follow-up|0|||
170377735|NCT02646891|615717494|FG006|Overall Study|Lost to Follow-up|2|||
170377736|NCT02646891|615717495|FG007|Overall Study|Lost to Follow-up|2|||
170377737|NCT02646891|615717496|FG008|Overall Study|Lost to Follow-up|2|||
170377738|NCT02646891|615717497|FG009|Overall Study|Lost to Follow-up|2|||
170377739|NCT02646891|615717488|FG000|Overall Study|Protocol Violation|0|||
170377740|NCT02646891|615717489|FG001|Overall Study|Protocol Violation|0|||
170377741|NCT02646891|615717490|FG002|Overall Study|Protocol Violation|0|||
170377742|NCT02646891|615717491|FG003|Overall Study|Protocol Violation|0|||
170377743|NCT02646891|615717492|FG004|Overall Study|Protocol Violation|0|||
170377744|NCT02646891|615717493|FG005|Overall Study|Protocol Violation|0|||
170377745|NCT02646891|615717494|FG006|Overall Study|Protocol Violation|1|||
170377746|NCT02646891|615717495|FG007|Overall Study|Protocol Violation|1|||
170377747|NCT02646891|615717496|FG008|Overall Study|Protocol Violation|0|||
170377748|NCT02646891|615717497|FG009|Overall Study|Protocol Violation|0|||
170377749|NCT02646891|615717488|FG000|Overall Study|Withdrawal by Subject|2|||
170377750|NCT02646891|615717489|FG001|Overall Study|Withdrawal by Subject|0|||
170377751|NCT02646891|615717490|FG002|Overall Study|Withdrawal by Subject|1|||
170377752|NCT02646891|615717491|FG003|Overall Study|Withdrawal by Subject|0|||
170377753|NCT02646891|615717492|FG004|Overall Study|Withdrawal by Subject|0|||
170377754|NCT02646891|615717493|FG005|Overall Study|Withdrawal by Subject|0|||
170377755|NCT02646891|615717494|FG006|Overall Study|Withdrawal by Subject|5|||
170377756|NCT02646891|615717495|FG007|Overall Study|Withdrawal by Subject|9|||
170377757|NCT02646891|615717496|FG008|Overall Study|Withdrawal by Subject|7|||
170377758|NCT02646891|615717497|FG009|Overall Study|Withdrawal by Subject|3|||
170377759|NCT02646891|615717488|FG000|Overall Study|Death|0|||
170377760|NCT02646891|615717489|FG001|Overall Study|Death|0|||
170377761|NCT02646891|615717490|FG002|Overall Study|Death|0|||
170377762|NCT02646891|615717491|FG003|Overall Study|Death|0|||
170377763|NCT02646891|615717492|FG004|Overall Study|Death|0|||
170377764|NCT02646891|615717493|FG005|Overall Study|Death|0|||
170377765|NCT02646891|615717494|FG006|Overall Study|Death|1|||
170377766|NCT02646891|615717495|FG007|Overall Study|Death|1|||
170377767|NCT02646891|615717496|FG008|Overall Study|Death|1|||
170377768|NCT02646891|615717497|FG009|Overall Study|Death|0|||
170377769|NCT01542632|615717498|FG000|Overall Study|Withdrawal of Consent|0|||
170377770|NCT01542632|615717499|FG001|Overall Study|Withdrawal of Consent|0|||
170377771|NCT01542632|615717500|FG002|Overall Study|Withdrawal of Consent|0|||
170377772|NCT01542632|615717501|FG003|Overall Study|Withdrawal of Consent|2|||
170377773|NCT01542632|615717502|FG004|Overall Study|Withdrawal of Consent|3|||
170377774|NCT01542632|615717503|FG005|Overall Study|Withdrawal of Consent|0|||
170377775|NCT01542632|615717498|FG000|Overall Study|Adverse Event|0|||
170377776|NCT01542632|615717499|FG001|Overall Study|Adverse Event|0|||
170377777|NCT01542632|615717500|FG002|Overall Study|Adverse Event|1|||
170377778|NCT01542632|615717501|FG003|Overall Study|Adverse Event|0|||
170377779|NCT01542632|615717502|FG004|Overall Study|Adverse Event|0|||
170377780|NCT01542632|615717503|FG005|Overall Study|Adverse Event|0|||
170377781|NCT01542632|615717498|FG000|Overall Study|Lost to Follow-up|0|||
170377782|NCT01542632|615717499|FG001|Overall Study|Lost to Follow-up|1|||
170377783|NCT01542632|615717500|FG002|Overall Study|Lost to Follow-up|0|||
170377784|NCT01542632|615717501|FG003|Overall Study|Lost to Follow-up|0|||
170377785|NCT01542632|615717502|FG004|Overall Study|Lost to Follow-up|0|||
170377786|NCT01542632|615717503|FG005|Overall Study|Lost to Follow-up|0|||
170377787|NCT01542632|615717498|FG000|Overall Study|Sponsor/Investigator Decision|0|||
170377788|NCT01542632|615717499|FG001|Overall Study|Sponsor/Investigator Decision|0|||
170377789|NCT01542632|615717500|FG002|Overall Study|Sponsor/Investigator Decision|0|||
170377790|NCT01542632|615717501|FG003|Overall Study|Sponsor/Investigator Decision|0|||
170377791|NCT01542632|615717502|FG004|Overall Study|Sponsor/Investigator Decision|1|||
170377792|NCT01542632|615717503|FG005|Overall Study|Sponsor/Investigator Decision|0|||
170377793|NCT00033514|615717504|FG000|Overall Study|Lost to Follow-up|1|||
170377794|NCT00033514|615717505|FG001|Overall Study|Lost to Follow-up|1|||
170377795|NCT00033514|615717504|FG000|Overall Study|Withdrawal by Subject|0|||
170377796|NCT00033514|615717505|FG001|Overall Study|Withdrawal by Subject|3|||
170377797|NCT03225833|615717508|FG000|Overall Study|Adverse Event|0|||
170377798|NCT03225833|615717509|FG001|Overall Study|Adverse Event|1|||
170377799|NCT03225833|615717510|FG002|Overall Study|Adverse Event|2|||
170377800|NCT03225833|615717511|FG003|Overall Study|Adverse Event|0|||
170377801|NCT03225833|615717512|FG004|Overall Study|Adverse Event|0|||
170377802|NCT03225833|615717513|FG005|Overall Study|Adverse Event|2|||
170377803|NCT03225833|615717508|FG000|Overall Study|Withdrawal by Subject|1|||
170377804|NCT03225833|615717509|FG001|Overall Study|Withdrawal by Subject|0|||
170377805|NCT03225833|615717510|FG002|Overall Study|Withdrawal by Subject|0|||
170377806|NCT03225833|615717511|FG003|Overall Study|Withdrawal by Subject|0|||
170377807|NCT03225833|615717512|FG004|Overall Study|Withdrawal by Subject|1|||
170377808|NCT03225833|615717513|FG005|Overall Study|Withdrawal by Subject|0|||
170377809|NCT03225833|615717508|FG000|Overall Study|Termination of Study by Sponsor|4|||
170377810|NCT03225833|615717509|FG001|Overall Study|Termination of Study by Sponsor|0|||
170377811|NCT03225833|615717510|FG002|Overall Study|Termination of Study by Sponsor|0|||
170377812|NCT03225833|615717511|FG003|Overall Study|Termination of Study by Sponsor|0|||
170377813|NCT03225833|615717512|FG004|Overall Study|Termination of Study by Sponsor|0|||
170377814|NCT03225833|615717513|FG005|Overall Study|Termination of Study by Sponsor|7|||
170377815|NCT03225833|615717508|FG000|Overall Study|Sponsor Decision|0|||
170377816|NCT03225833|615717509|FG001|Overall Study|Sponsor Decision|0|||
170377817|NCT03225833|615717510|FG002|Overall Study|Sponsor Decision|0|||
170377818|NCT03225833|615717511|FG003|Overall Study|Sponsor Decision|0|||
170377819|NCT03225833|615717512|FG004|Overall Study|Sponsor Decision|0|||
170377820|NCT03225833|615717513|FG005|Overall Study|Sponsor Decision|1|||
170377821|NCT02773849|615717515|FG000|Overall Study|Lost to Follow-up|11|||
170377822|NCT02773849|615717515|FG000|Overall Study|Death|26|||
170377823|NCT02773849|615717515|FG000|Overall Study|Withdrawal by Subject|5|||
170377824|NCT02773849|615717515|FG000|Overall Study|Withdrawal of Consent|9|||
170377825|NCT02773849|615717515|FG000|Overall Study|Other: not due to lack of tolerability|11|||
170377826|NCT02274311|615717516|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
170377827|NCT01626872|615717522|FG000|Overall Study|Physician Decision|13|||
170377828|NCT01626872|615717523|FG001|Overall Study|Physician Decision|9|||
170377829|NCT01626872|615717524|FG002|Overall Study|Physician Decision|6|||
170377830|NCT01626872|615717522|FG000|Overall Study|Withdrawal by Subject|19|||
170377831|NCT01626872|615717523|FG001|Overall Study|Withdrawal by Subject|27|||
170377832|NCT01626872|615717524|FG002|Overall Study|Withdrawal by Subject|8|||
170377833|NCT01626872|615717522|FG000|Overall Study|Adverse Event (including Death)|20|||
170377834|NCT01626872|615717523|FG001|Overall Study|Adverse Event (including Death)|28|||
170377835|NCT01626872|615717524|FG002|Overall Study|Adverse Event (including Death)|8|||
170377836|NCT01626872|615717522|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
170377837|NCT01626872|615717523|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
170377838|NCT01626872|615717524|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
170377839|NCT03912064|615717527|FG000|Overall Study|Withdrawal by Subject|2|||
170377840|NCT03912064|615717528|FG001|Overall Study|Withdrawal by Subject|0|||
170377841|NCT03912064|615717529|FG002|Overall Study|Withdrawal by Subject|0|||
170377842|NCT03912064|615717527|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
170377843|NCT03912064|615717528|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
170377844|NCT03912064|615717529|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
170377845|NCT03912064|615717527|FG000|Overall Study|Progression/Relapse|7|||
170377846|NCT03912064|615717528|FG001|Overall Study|Progression/Relapse|3|||
170377847|NCT03912064|615717529|FG002|Overall Study|Progression/Relapse|0|||
170377848|NCT03912064|615717527|FG000|Overall Study|Prolonged treatment delays|3|||
170377849|NCT03912064|615717528|FG001|Overall Study|Prolonged treatment delays|2|||
170377850|NCT03912064|615717529|FG002|Overall Study|Prolonged treatment delays|0|||
170377851|NCT03912064|615717527|FG000|Overall Study|Prohibited concomitant treatments|3|||
170377852|NCT03912064|615717528|FG001|Overall Study|Prohibited concomitant treatments|1|||
170377853|NCT03912064|615717529|FG002|Overall Study|Prohibited concomitant treatments|0|||
170377854|NCT01026194|615717530|FG000|Period 1：Double Blind Period|Adverse Event|2|||
170377855|NCT01026194|615717531|FG001|Period 1：Double Blind Period|Adverse Event|1|||
170377856|NCT01026194|615717530|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
170377857|NCT01026194|615717531|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
170377858|NCT01026194|615717530|FG000|Period 1：Double Blind Period|Physician Decision|0|||
170377859|NCT01026194|615717531|FG001|Period 1：Double Blind Period|Physician Decision|4|||
170377860|NCT01026194|615717530|FG000|Period 2：Open-label Period|Adverse Event|4|||
170377861|NCT01026194|615717531|FG001|Period 2：Open-label Period|Adverse Event|5|||
170377862|NCT01026194|615717530|FG000|Period 2：Open-label Period|Physician Decision|3|||
170377863|NCT01026194|615717531|FG001|Period 2：Open-label Period|Physician Decision|1|||
170377864|NCT01026194|615717530|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
170377865|NCT01026194|615717531|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
170377866|NCT04295759|615717532|FG000|Overall Study|Lack of Efficacy|9|||
170377867|NCT04295759|615717532|FG000|Overall Study|Death|1|||
170377868|NCT04295759|615717532|FG000|Overall Study|Withdrawal by Subject|2|||
170377869|NCT04295759|615717532|FG000|Overall Study|Deemed ineligible|1|||
170377870|NCT03233308|615717533|FG000|Overall Study|Adverse Event|1|||
170377871|NCT03233308|615717533|FG000|Overall Study|Protocol Violation|1|||
170377872|NCT00638989|615717534|FG000|Overall Study|Lost to Follow-up|0|||
170377873|NCT00638989|615717535|FG001|Overall Study|Lost to Follow-up|0|||
170377874|NCT00638989|615717536|FG002|Overall Study|Lost to Follow-up|1|||
170377875|NCT05616221|615717539|FG000|Overall Study|Withdrawal by Subject|0|||
170377876|NCT05616221|615717540|FG001|Overall Study|Withdrawal by Subject|1|||
170377877|NCT05616221|615717541|FG002|Overall Study|Withdrawal by Subject|0|||
170377878|NCT05616221|615717542|FG003|Overall Study|Withdrawal by Subject|0|||
170377879|NCT05616221|615717543|FG004|Overall Study|Withdrawal by Subject|0|||
170377880|NCT05616221|615717544|FG005|Overall Study|Withdrawal by Subject|0|||
170377881|NCT05616221|615717539|FG000|Overall Study|Adverse Event|0|||
170377882|NCT05616221|615717540|FG001|Overall Study|Adverse Event|2|||
170377883|NCT05616221|615717541|FG002|Overall Study|Adverse Event|0|||
170377884|NCT05616221|615717542|FG003|Overall Study|Adverse Event|0|||
170377885|NCT05616221|615717543|FG004|Overall Study|Adverse Event|2|||
170377886|NCT05616221|615717544|FG005|Overall Study|Adverse Event|0|||
170377887|NCT04880733|615717545|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
170377888|NCT04880733|615717546|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
170377889|NCT04880733|615717547|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
170377890|NCT04880733|615717545|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
170377891|NCT04880733|615717546|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
170377892|NCT04880733|615717547|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
170377893|NCT04880733|615717545|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
170377894|NCT04880733|615717546|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
170377895|NCT04880733|615717547|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
170377896|NCT04880733|615717545|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
170377897|NCT04880733|615717546|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
170377898|NCT04880733|615717547|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
170377899|NCT04880733|615717545|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
170377900|NCT04880733|615717546|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
170377901|NCT04880733|615717547|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
170377902|NCT00853112|615717550|FG000|Overall Study|Randomized but not treated|0|||
170377903|NCT00853112|615717551|FG001|Overall Study|Randomized but not treated|1|||
170377904|NCT00853112|615717552|FG002|Overall Study|Randomized but not treated|0|||
170377905|NCT00853112|615717553|FG003|Overall Study|Randomized but not treated|2|||
170377906|NCT00853112|615717554|FG004|Overall Study|Randomized but not treated|0|||
170377907|NCT00853112|615717555|FG005|Overall Study|Randomized but not treated|0|||
170377908|NCT00853112|615717556|FG006|Overall Study|Randomized but not treated|1|||
170377909|NCT01553591|615717557|FG000|Overall Study|Voluntarily withdrew|94|||
170377910|NCT01553591|615717558|FG001|Overall Study|Voluntarily withdrew|79|||
170377911|NCT01553591|615717559|FG002|Overall Study|Voluntarily withdrew|96|||
170377912|NCT01553591|615717557|FG000|Overall Study|Adverse Event|36|||
170377913|NCT01553591|615717558|FG001|Overall Study|Adverse Event|45|||
170377914|NCT01553591|615717559|FG002|Overall Study|Adverse Event|16|||
170377915|NCT01553591|615717557|FG000|Overall Study|Lost to Follow-up|25|||
170377916|NCT01553591|615717558|FG001|Overall Study|Lost to Follow-up|23|||
170377917|NCT01553591|615717559|FG002|Overall Study|Lost to Follow-up|16|||
170377918|NCT01553591|615717557|FG000|Overall Study|Physician decision: other|11|||
170377919|NCT01553591|615717558|FG001|Overall Study|Physician decision: other|14|||
170377920|NCT01553591|615717559|FG002|Overall Study|Physician decision: other|16|||
170377921|NCT01553591|615717557|FG000|Overall Study|Physician decision: lack of efficacy|2|||
170377922|NCT01553591|615717558|FG001|Overall Study|Physician decision: lack of efficacy|3|||
170377923|NCT01553591|615717559|FG002|Overall Study|Physician decision: lack of efficacy|7|||
170377924|NCT01553591|615717557|FG000|Overall Study|Protocol Violation|3|||
170377925|NCT01553591|615717558|FG001|Overall Study|Protocol Violation|4|||
170377926|NCT01553591|615717559|FG002|Overall Study|Protocol Violation|4|||
170377927|NCT01553591|615717557|FG000|Overall Study|Sponsor decision|1|||
170377928|NCT01553591|615717558|FG001|Overall Study|Sponsor decision|0|||
170377929|NCT01553591|615717559|FG002|Overall Study|Sponsor decision|3|||
170377930|NCT01553591|615717557|FG000|Overall Study|Randomized and never dispensed drug|0|||
170377931|NCT01553591|615717558|FG001|Overall Study|Randomized and never dispensed drug|1|||
170377932|NCT01553591|615717559|FG002|Overall Study|Randomized and never dispensed drug|0|||
170377933|NCT00958191|615717561|FG000|Overall Study|Death|4|||
170377934|NCT00958191|615717561|FG000|Overall Study|Lost to Follow-up|5|||
170377935|NCT00958191|615717561|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
170377936|NCT00958191|615717561|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
170377937|NCT00958191|615717561|FG000|Overall Study|Revision of study device|4|||
170377938|NCT00958191|615717561|FG000|Overall Study|Site termination|11|||
170377939|NCT00958191|615717561|FG000|Overall Study|No 5 yr x-rays|56|||
170377940|NCT03685643|615717562|FG000|Overall Study|Lost to Follow-up|14|||
170377941|NCT03685643|615717563|FG001|Overall Study|Lost to Follow-up|22|||
170377942|NCT02087241|615717565|FG000|Overall Study|Death|2|||
170377943|NCT02087241|615717566|FG001|Overall Study|Death|1|||
170377944|NCT02087241|615717567|FG002|Overall Study|Death|1|||
170377945|NCT02087241|615717568|FG003|Overall Study|Death|1|||
170377946|NCT02087241|615717565|FG000|Overall Study|Withdrawal by Subject|1|||
170377947|NCT02087241|615717566|FG001|Overall Study|Withdrawal by Subject|0|||
170377948|NCT02087241|615717567|FG002|Overall Study|Withdrawal by Subject|0|||
170377949|NCT02087241|615717568|FG003|Overall Study|Withdrawal by Subject|1|||
170377950|NCT02087241|615717565|FG000|Overall Study|Progressive Disease|0|||
170377951|NCT02087241|615717566|FG001|Overall Study|Progressive Disease|0|||
170377952|NCT02087241|615717567|FG002|Overall Study|Progressive Disease|0|||
170377953|NCT02087241|615717568|FG003|Overall Study|Progressive Disease|1|||
170377954|NCT02087241|615717565|FG000|Overall Study|Study Terminated by Sponsor|0|||
170377955|NCT02087241|615717566|FG001|Overall Study|Study Terminated by Sponsor|2|||
170377956|NCT02087241|615717567|FG002|Overall Study|Study Terminated by Sponsor|0|||
170377957|NCT02087241|615717568|FG003|Overall Study|Study Terminated by Sponsor|4|||
170377958|NCT00836953|615717569|FG000|Overall Study|Withdrawal by Subject|1|||
170377959|NCT00836953|615717569|FG000|Overall Study|Lost to Follow-up|1|||
170377960|NCT00062647|615717570|FG000|Overall Study|Death|2|||
170377961|NCT00062647|615717571|FG001|Overall Study|Death|2|||
170377962|NCT00062647|615717570|FG000|Overall Study|Adverse Event|1|||
170377963|NCT00062647|615717571|FG001|Overall Study|Adverse Event|1|||
170377964|NCT00062647|615717570|FG000|Overall Study|Withdrawal by Subject|2|||
170377965|NCT00062647|615717571|FG001|Overall Study|Withdrawal by Subject|1|||
170377966|NCT00062647|615717570|FG000|Overall Study|Protocol Violation|1|||
170377967|NCT00062647|615717571|FG001|Overall Study|Protocol Violation|0|||
170377968|NCT00062647|615717570|FG000|Overall Study|Lost to Follow-up|1|||
170377969|NCT00062647|615717571|FG001|Overall Study|Lost to Follow-up|2|||
170377970|NCT00062647|615717570|FG000|Overall Study|Failed continuation criteria|4|||
170377971|NCT00062647|615717571|FG001|Overall Study|Failed continuation criteria|2|||
170377972|NCT00062647|615717570|FG000|Overall Study|Other|4|||
170377973|NCT00062647|615717571|FG001|Overall Study|Other|4|||
170377974|NCT00062647|615717570|FG000|Overall Study|Never received study treatment|1|||
170377975|NCT00062647|615717571|FG001|Overall Study|Never received study treatment|1|||
170377976|NCT03457636|615717576|FG000|Overall Study|Lost to Follow-up|2|||
170377977|NCT01678560|615717577|FG000|Overall Study|Physician Decision|4|||
170377978|NCT01678560|615717578|FG001|Overall Study|Physician Decision|4|||
170377979|NCT01678560|615717577|FG000|Overall Study|Death|0|||
170377980|NCT01678560|615717578|FG001|Overall Study|Death|1|||
170377981|NCT01678560|615717577|FG000|Overall Study|Withdrawal by Subject|0|||
170377982|NCT01678560|615717578|FG001|Overall Study|Withdrawal by Subject|1|||
170377983|NCT03512275|615717585|FG000|Overall Study|Withdrawal by Subject|1|||
170377984|NCT03512275|615717586|FG001|Overall Study|Withdrawal by Subject|3|||
170377985|NCT03512275|615717585|FG000|Overall Study|Physician Decision|0|||
170377986|NCT03512275|615717586|FG001|Overall Study|Physician Decision|1|||
170377987|NCT03512275|615717585|FG000|Overall Study|Lost to Follow-up|0|||
170377988|NCT03512275|615717586|FG001|Overall Study|Lost to Follow-up|3|||
170377989|NCT03512275|615717585|FG000|Overall Study|Other|1|||
170377990|NCT03512275|615717586|FG001|Overall Study|Other|0|||
170377991|NCT00320190|615717587|FG000|First 12 Months|Completed but did not enter extension|5|||
170377992|NCT00320190|615717588|FG001|First 12 Months|Completed but did not enter extension|3|||
170377993|NCT00320190|615717587|FG000|First 12 Months|Sponsor terminated study|2|||
170377994|NCT00320190|615717588|FG001|First 12 Months|Sponsor terminated study|2|||
170377995|NCT00320190|615717587|FG000|First 12 Months|Lost to Follow-up|0|||
170377996|NCT00320190|615717588|FG001|First 12 Months|Lost to Follow-up|1|||
170377997|NCT00320190|615717587|FG000|First 12 Months|Enrollment failure|0|||
170377998|NCT00320190|615717588|FG001|First 12 Months|Enrollment failure|1|||
170377999|NCT00320190|615717587|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
170378000|NCT00320190|615717588|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
170378001|NCT00320190|615717587|FG000|First 12 Months|Investigator request|0|||
170378002|NCT00320190|615717588|FG001|First 12 Months|Investigator request|1|||
170378003|NCT00320190|615717587|FG000|First 12 Months|Study drug toxicity|0|||
170378004|NCT00320190|615717588|FG001|First 12 Months|Study drug toxicity|1|||
170378005|NCT00320190|615717587|FG000|First 12 Months|Withdrawal by Subject|0|||
170378006|NCT00320190|615717588|FG001|First 12 Months|Withdrawal by Subject|1|||
170378007|NCT00320190|615717587|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
170378008|NCT00320190|615717588|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
170378009|NCT00320190|615717587|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
170378010|NCT00320190|615717588|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
170378011|NCT00320190|615717587|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
170378012|NCT00320190|615717588|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
170378013|NCT00102804|615717589|FG000|Overall Study|Progressive Disease (PD)|307|||
170378014|NCT00102804|615717590|FG001|Overall Study|Progressive Disease (PD)|196|||
170378015|NCT00102804|615717589|FG000|Overall Study|Withdrawal by Subject|46|||
170378016|NCT00102804|615717590|FG001|Overall Study|Withdrawal by Subject|7|||
170378017|NCT00102804|615717589|FG000|Overall Study|Adverse Event|37|||
170378018|NCT00102804|615717590|FG001|Overall Study|Adverse Event|3|||
170378019|NCT00102804|615717589|FG000|Overall Study|Physician Decision|24|||
170378020|NCT00102804|615717590|FG001|Overall Study|Physician Decision|6|||
170378021|NCT00102804|615717589|FG000|Overall Study|Death|5|||
170378022|NCT00102804|615717590|FG001|Overall Study|Death|6|||
170378023|NCT00102804|615717589|FG000|Overall Study|Enrollment Criteria Not Met|6|||
170378024|NCT00102804|615717590|FG001|Overall Study|Enrollment Criteria Not Met|0|||
170378025|NCT00102804|615717589|FG000|Overall Study|Lost to Follow-up|4|||
170378026|NCT00102804|615717590|FG001|Overall Study|Lost to Follow-up|1|||
170378027|NCT00102804|615717589|FG000|Overall Study|Protocol Violation|2|||
170378028|NCT00102804|615717590|FG001|Overall Study|Protocol Violation|1|||
170378029|NCT00102804|615717589|FG000|Overall Study|Satisfactory Response|2|||
170378030|NCT00102804|615717590|FG001|Overall Study|Satisfactory Response|0|||
170378031|NCT00102804|615717589|FG000|Overall Study|Sponsor Decision|1|||
170378032|NCT00102804|615717590|FG001|Overall Study|Sponsor Decision|0|||
170378033|NCT00102804|615717589|FG000|Overall Study|Alive, Receiving Treatment|7|||
170378034|NCT00102804|615717590|FG001|Overall Study|Alive, Receiving Treatment|2|||
170378035|NCT02299206|615717597|FG000|Overall Study|Lost to Follow-up|1|||
170378036|NCT02299206|615717597|FG000|Overall Study|Withdrawal by Subject|1|||
170378037|NCT00683774|615717598|FG000|Overall Study|Withdrawal by Subject|0|||
170378038|NCT00683774|615717599|FG001|Overall Study|Withdrawal by Subject|1|||
170378039|NCT00683774|615717598|FG000|Overall Study|Physician Decision|3|||
170378040|NCT00683774|615717599|FG001|Overall Study|Physician Decision|0|||
170378041|NCT02875366|615717600|FG000|Overall Study|Adverse Event|0|||
170378042|NCT02875366|615717601|FG001|Overall Study|Adverse Event|2|||
170378043|NCT02875366|615717600|FG000|Overall Study|Noncompliance|0|||
170378044|NCT02875366|615717601|FG001|Overall Study|Noncompliance|1|||
170378045|NCT00691054|615717602|FG000|Overall Study|Withdrawal by Subject|1|||
170378046|NCT03595176|615717603|FG000|Overall Study|Death|0|||
170378047|NCT03595176|615717604|FG001|Overall Study|Death|2|||
170378048|NCT03595176|615717603|FG000|Overall Study|Lost to Follow-up|0|||
170378049|NCT03595176|615717604|FG001|Overall Study|Lost to Follow-up|1|||
170378050|NCT00518336|615717605|FG000|Year 7|Lost to Follow-up|2|||
170378051|NCT00518336|615717606|FG001|Year 7|Lost to Follow-up|0|||
170378052|NCT00518336|615717605|FG000|Year 7|Could not attend in time|0|||
170378053|NCT00518336|615717606|FG001|Year 7|Could not attend in time|3|||
170378054|NCT00518336|615717605|FG000|Year 8|Lost to Follow-up|1|||
170378055|NCT00518336|615717606|FG001|Year 8|Lost to Follow-up|1|||
170378056|NCT00518336|615717605|FG000|Year 8|Could not attend in time|0|||
170378057|NCT00518336|615717606|FG001|Year 8|Could not attend in time|1|||
170378058|NCT00518336|615717605|FG000|Year 9|Migrated/moved from study area|1|||
170378059|NCT00518336|615717606|FG001|Year 9|Migrated/moved from study area|1|||
170378060|NCT00518336|615717605|FG000|Year 9|Lost to Follow-up|3|||
170378061|NCT00518336|615717606|FG001|Year 9|Lost to Follow-up|0|||
170378062|NCT00518336|615717605|FG000|Year 9|Personal reasons|1|||
170378063|NCT00518336|615717606|FG001|Year 9|Personal reasons|0|||
170378064|NCT02735044|615717607|FG000|Overall Study|Adverse Event|3|||
170378065|NCT02735044|615717608|FG001|Overall Study|Adverse Event|3|||
170378066|NCT02735044|615717607|FG000|Overall Study|Lack of Efficacy|1|||
170378067|NCT02735044|615717608|FG001|Overall Study|Lack of Efficacy|0|||
170378068|NCT02735044|615717607|FG000|Overall Study|Poor compliance to protocol|7|||
170378069|NCT02735044|615717608|FG001|Overall Study|Poor compliance to protocol|7|||
170378070|NCT02735044|615717607|FG000|Overall Study|Randomized and not treated|0|||
170378071|NCT02735044|615717608|FG001|Overall Study|Randomized and not treated|2|||
170378072|NCT02735044|615717607|FG000|Overall Study|Other, not specified above|5|||
170378073|NCT02735044|615717608|FG001|Overall Study|Other, not specified above|11|||
170378074|NCT01682759|615717609|FG000|Overall Study|Death|2|||
170378075|NCT01682759|615717610|FG001|Overall Study|Death|1|||
170378076|NCT01682759|615717609|FG000|Overall Study|Lost to Follow-up|10|||
170378077|NCT01682759|615717610|FG001|Overall Study|Lost to Follow-up|13|||
170378078|NCT01682759|615717609|FG000|Overall Study|Physician Decision|1|||
170378079|NCT01682759|615717610|FG001|Overall Study|Physician Decision|1|||
170378080|NCT01682759|615717609|FG000|Overall Study|Withdrawal by Subject|56|||
170378081|NCT01682759|615717610|FG001|Overall Study|Withdrawal by Subject|55|||
170378082|NCT02141854|615717612|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
170378083|NCT02141854|615717613|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170378084|NCT02141854|615717614|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170378085|NCT02141854|615717615|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170378086|NCT02141854|615717616|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170378087|NCT02141854|615717617|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
170378088|NCT02141854|615717612|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
170378089|NCT02141854|615717613|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170378090|NCT02141854|615717614|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170378091|NCT02141854|615717615|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170378092|NCT02141854|615717616|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170378093|NCT02141854|615717617|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
170378094|NCT02141854|615717612|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
170378095|NCT02141854|615717613|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170378096|NCT02141854|615717614|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170398853|NCT05004181|615798317|FG005|Overall Study|Lost to Follow-up|2|||
170378097|NCT02141854|615717615|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170378098|NCT02141854|615717616|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170378099|NCT02141854|615717617|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
170378100|NCT02141854|615717612|FG000|Run-In Period (Pre-assignment)|Other|14|||
170378101|NCT02141854|615717613|FG001|Run-In Period (Pre-assignment)|Other|0|||
170378102|NCT02141854|615717614|FG002|Run-In Period (Pre-assignment)|Other|0|||
170378103|NCT02141854|615717615|FG003|Run-In Period (Pre-assignment)|Other|0|||
170378104|NCT02141854|615717616|FG004|Run-In Period (Pre-assignment)|Other|0|||
170378105|NCT02141854|615717617|FG005|Run-In Period (Pre-assignment)|Other|0|||
170378106|NCT02141854|615717612|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
170378107|NCT02141854|615717613|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
170378108|NCT02141854|615717614|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
170378109|NCT02141854|615717615|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
170378110|NCT02141854|615717616|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
170378111|NCT02141854|615717617|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
170378112|NCT02141854|615717612|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
170378113|NCT02141854|615717613|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170378114|NCT02141854|615717614|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170378115|NCT02141854|615717615|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170378116|NCT02141854|615717616|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170378117|NCT02141854|615717617|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
170378118|NCT02141854|615717612|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
170378119|NCT02141854|615717613|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170378120|NCT02141854|615717614|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170378121|NCT02141854|615717615|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170378122|NCT02141854|615717616|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170378123|NCT02141854|615717617|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
170378124|NCT02141854|615717612|FG000|Treatment Period|Protocol Violation|0|||
170378125|NCT02141854|615717613|FG001|Treatment Period|Protocol Violation|1|||
170378126|NCT02141854|615717614|FG002|Treatment Period|Protocol Violation|0|||
170378127|NCT02141854|615717615|FG003|Treatment Period|Protocol Violation|2|||
170378128|NCT02141854|615717616|FG004|Treatment Period|Protocol Violation|2|||
170378129|NCT02141854|615717617|FG005|Treatment Period|Protocol Violation|1|||
170378130|NCT02141854|615717612|FG000|Treatment Period|Noncompliance|0|||
170378131|NCT02141854|615717613|FG001|Treatment Period|Noncompliance|0|||
170378132|NCT02141854|615717614|FG002|Treatment Period|Noncompliance|0|||
170378133|NCT02141854|615717615|FG003|Treatment Period|Noncompliance|1|||
170378134|NCT02141854|615717616|FG004|Treatment Period|Noncompliance|0|||
170378135|NCT02141854|615717617|FG005|Treatment Period|Noncompliance|0|||
170378136|NCT02141854|615717612|FG000|Treatment Period|Lack of Efficacy|0|||
170378137|NCT02141854|615717613|FG001|Treatment Period|Lack of Efficacy|0|||
170378138|NCT02141854|615717614|FG002|Treatment Period|Lack of Efficacy|0|||
170378139|NCT02141854|615717615|FG003|Treatment Period|Lack of Efficacy|1|||
170378140|NCT02141854|615717616|FG004|Treatment Period|Lack of Efficacy|1|||
170378141|NCT02141854|615717617|FG005|Treatment Period|Lack of Efficacy|7|||
170378142|NCT02141854|615717612|FG000|Treatment Period|Pregnancy|0|||
170378143|NCT02141854|615717613|FG001|Treatment Period|Pregnancy|1|||
170378144|NCT02141854|615717614|FG002|Treatment Period|Pregnancy|0|||
170378145|NCT02141854|615717615|FG003|Treatment Period|Pregnancy|0|||
170378146|NCT02141854|615717616|FG004|Treatment Period|Pregnancy|0|||
170378147|NCT02141854|615717617|FG005|Treatment Period|Pregnancy|0|||
170378148|NCT02141854|615717612|FG000|Treatment Period|Other|0|||
170378149|NCT02141854|615717613|FG001|Treatment Period|Other|1|||
170378150|NCT02141854|615717614|FG002|Treatment Period|Other|2|||
170378151|NCT02141854|615717615|FG003|Treatment Period|Other|0|||
170378152|NCT02141854|615717616|FG004|Treatment Period|Other|1|||
170378153|NCT02141854|615717617|FG005|Treatment Period|Other|2|||
170378154|NCT02141854|615717612|FG000|Treatment Period|Adverse Event|0|||
170378155|NCT02141854|615717613|FG001|Treatment Period|Adverse Event|2|||
170378156|NCT02141854|615717614|FG002|Treatment Period|Adverse Event|2|||
170378157|NCT02141854|615717615|FG003|Treatment Period|Adverse Event|0|||
170378158|NCT02141854|615717616|FG004|Treatment Period|Adverse Event|2|||
170378159|NCT02141854|615717617|FG005|Treatment Period|Adverse Event|2|||
170378160|NCT02141854|615717612|FG000|Treatment Period|Withdrawal by Subject|0|||
170378161|NCT02141854|615717613|FG001|Treatment Period|Withdrawal by Subject|2|||
170378162|NCT02141854|615717614|FG002|Treatment Period|Withdrawal by Subject|3|||
170378163|NCT02141854|615717615|FG003|Treatment Period|Withdrawal by Subject|3|||
170378164|NCT02141854|615717616|FG004|Treatment Period|Withdrawal by Subject|4|||
170378165|NCT02141854|615717617|FG005|Treatment Period|Withdrawal by Subject|7|||
170378166|NCT02141854|615717612|FG000|Treatment Period|Disease progression|0|||
170378167|NCT02141854|615717613|FG001|Treatment Period|Disease progression|2|||
170378168|NCT02141854|615717614|FG002|Treatment Period|Disease progression|1|||
170378169|NCT02141854|615717615|FG003|Treatment Period|Disease progression|3|||
170378170|NCT02141854|615717616|FG004|Treatment Period|Disease progression|0|||
170378171|NCT02141854|615717617|FG005|Treatment Period|Disease progression|18|||
170378172|NCT02141854|615717612|FG000|Treatment Period|Lost to Follow-up|0|||
170378173|NCT02141854|615717613|FG001|Treatment Period|Lost to Follow-up|1|||
170378174|NCT02141854|615717614|FG002|Treatment Period|Lost to Follow-up|1|||
170378175|NCT02141854|615717615|FG003|Treatment Period|Lost to Follow-up|1|||
170378176|NCT02141854|615717616|FG004|Treatment Period|Lost to Follow-up|0|||
170378177|NCT02141854|615717617|FG005|Treatment Period|Lost to Follow-up|1|||
170378178|NCT01868594|615717618|FG000|Overall Study|Do not meet inclusion criteria|4|||
170378179|NCT01868594|615717619|FG001|Overall Study|Do not meet inclusion criteria|3|||
170378180|NCT02691468|615717622|FG000|Overall Study|Bronchial blocker use|2|||
170378181|NCT02691468|615717623|FG001|Overall Study|Bronchial blocker use|1|||
170378182|NCT02691468|615717622|FG000|Overall Study|Lost to Follow-up|2|||
170378183|NCT02691468|615717623|FG001|Overall Study|Lost to Follow-up|1|||
170378184|NCT02691468|615717622|FG000|Overall Study|Failure to advance FOB|2|||
170378185|NCT02691468|615717623|FG001|Overall Study|Failure to advance FOB|0|||
170378186|NCT02497287|615717628|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
170378187|NCT02497287|615717628|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
170378188|NCT02497287|615717628|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
170378189|NCT02497287|615717628|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
170378190|NCT02497287|615717628|FG000|Induction Phase (4 Weeks)|Other|13|||
170378191|NCT02497287|615717628|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
170378192|NCT02497287|615717628|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
170378193|NCT02497287|615717628|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
170378194|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
170378195|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
170378196|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
170378197|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
170378198|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
170378199|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
170378200|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
170378201|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
170378202|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
170378203|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
170378204|NCT02497287|615717628|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
170378205|NCT02497287|615717628|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
170378206|NCT02497287|615717628|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
170378207|NCT02497287|615717628|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
170378208|NCT02497287|615717628|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
170378209|NCT02497287|615717628|FG000|Follow-up Phase (4 Week)|Other|1|||
170378210|NCT01823991|615719200|FG000|Overall Study|Withdrawal by Subject|8|||
170378211|NCT01823991|615719201|FG001|Overall Study|Withdrawal by Subject|5|||
170378212|NCT03557801|615719208|FG000|Overall Study|Protocol Violation|1|||
170378213|NCT03557801|615719209|FG001|Overall Study|Protocol Violation|0|||
170378214|NCT03557801|615719210|FG002|Overall Study|Protocol Violation|0|||
170378215|NCT03557801|615719208|FG000|Overall Study|Withdrawal by Subject|1|||
170378216|NCT03557801|615719209|FG001|Overall Study|Withdrawal by Subject|0|||
170378217|NCT03557801|615719210|FG002|Overall Study|Withdrawal by Subject|3|||
170378218|NCT03557801|615719208|FG000|Overall Study|Lost to Follow-up|0|||
170378219|NCT03557801|615719209|FG001|Overall Study|Lost to Follow-up|1|||
170378220|NCT03557801|615719210|FG002|Overall Study|Lost to Follow-up|0|||
170378221|NCT00535236|615719211|FG000|Overall Study|Adverse Event|1|||
170378222|NCT00535236|615719212|FG001|Overall Study|Adverse Event|0|||
170378223|NCT00535236|615719213|FG002|Overall Study|Adverse Event|9|||
170378224|NCT00535236|615719214|FG003|Overall Study|Adverse Event|3|||
170378225|NCT00535236|615719215|FG004|Overall Study|Adverse Event|3|||
170378226|NCT00535236|615719216|FG005|Overall Study|Adverse Event|0|||
170378227|NCT00535236|615719217|FG006|Overall Study|Adverse Event|5|||
170378228|NCT00535236|615719218|FG007|Overall Study|Adverse Event|1|||
170378229|NCT00535236|615719219|FG008|Overall Study|Adverse Event|2|||
170378230|NCT00535236|615719220|FG009|Overall Study|Adverse Event|1|||
170378231|NCT00535236|615719211|FG000|Overall Study|Lost to Follow-up|1|||
170378232|NCT00535236|615719212|FG001|Overall Study|Lost to Follow-up|2|||
170378233|NCT00535236|615719213|FG002|Overall Study|Lost to Follow-up|0|||
170378234|NCT00535236|615719214|FG003|Overall Study|Lost to Follow-up|0|||
170378235|NCT00535236|615719215|FG004|Overall Study|Lost to Follow-up|2|||
170378236|NCT00535236|615719216|FG005|Overall Study|Lost to Follow-up|0|||
170378237|NCT00535236|615719217|FG006|Overall Study|Lost to Follow-up|0|||
170378238|NCT00535236|615719218|FG007|Overall Study|Lost to Follow-up|0|||
170378239|NCT00535236|615719219|FG008|Overall Study|Lost to Follow-up|6|||
170378240|NCT00535236|615719220|FG009|Overall Study|Lost to Follow-up|1|||
170378241|NCT00535236|615719211|FG000|Overall Study|Physician Decision|0|||
170378242|NCT00535236|615719212|FG001|Overall Study|Physician Decision|0|||
170378243|NCT00535236|615719213|FG002|Overall Study|Physician Decision|0|||
170378244|NCT00535236|615719214|FG003|Overall Study|Physician Decision|0|||
170378245|NCT00535236|615719215|FG004|Overall Study|Physician Decision|1|||
170378246|NCT00535236|615719216|FG005|Overall Study|Physician Decision|0|||
170378247|NCT00535236|615719217|FG006|Overall Study|Physician Decision|1|||
170378248|NCT00535236|615719218|FG007|Overall Study|Physician Decision|0|||
170378249|NCT00535236|615719219|FG008|Overall Study|Physician Decision|0|||
170378250|NCT00535236|615719220|FG009|Overall Study|Physician Decision|0|||
170378251|NCT00535236|615719211|FG000|Overall Study|Protocol Violation|2|||
170378252|NCT00535236|615719212|FG001|Overall Study|Protocol Violation|0|||
170378253|NCT00535236|615719213|FG002|Overall Study|Protocol Violation|1|||
170378254|NCT00535236|615719214|FG003|Overall Study|Protocol Violation|0|||
170378255|NCT00535236|615719215|FG004|Overall Study|Protocol Violation|0|||
170378256|NCT00535236|615719216|FG005|Overall Study|Protocol Violation|0|||
170378257|NCT00535236|615719217|FG006|Overall Study|Protocol Violation|0|||
170378258|NCT00535236|615719218|FG007|Overall Study|Protocol Violation|0|||
170378259|NCT00535236|615719219|FG008|Overall Study|Protocol Violation|1|||
170378260|NCT00535236|615719220|FG009|Overall Study|Protocol Violation|0|||
170378261|NCT00535236|615719211|FG000|Overall Study|Withdrawal by Subject|3|||
170378262|NCT00535236|615719212|FG001|Overall Study|Withdrawal by Subject|0|||
170378263|NCT00535236|615719213|FG002|Overall Study|Withdrawal by Subject|2|||
170378264|NCT00535236|615719214|FG003|Overall Study|Withdrawal by Subject|1|||
170378265|NCT00535236|615719215|FG004|Overall Study|Withdrawal by Subject|6|||
170378266|NCT00535236|615719216|FG005|Overall Study|Withdrawal by Subject|1|||
170378267|NCT00535236|615719217|FG006|Overall Study|Withdrawal by Subject|5|||
170378268|NCT00535236|615719218|FG007|Overall Study|Withdrawal by Subject|0|||
170378269|NCT00535236|615719219|FG008|Overall Study|Withdrawal by Subject|4|||
170378270|NCT00535236|615719220|FG009|Overall Study|Withdrawal by Subject|2|||
170378271|NCT03558503|615719222|FG000|Overall Study|Adverse Event|1|||
170378272|NCT03558503|615719222|FG000|Overall Study|Death|1|||
170378273|NCT03558503|615719222|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
170378274|NCT00561795|615719223|FG000|Overall Study|Adverse Event|3|||
170378275|NCT00561795|615719224|FG001|Overall Study|Adverse Event|3|||
170378276|NCT00561795|615719225|FG002|Overall Study|Adverse Event|0|||
170378277|NCT00561795|615719226|FG003|Overall Study|Adverse Event|0|||
170378278|NCT00561795|615719223|FG000|Overall Study|Study Closed/Terminated|0|||
170378279|NCT00561795|615719224|FG001|Overall Study|Study Closed/Terminated|3|||
170378280|NCT00561795|615719225|FG002|Overall Study|Study Closed/Terminated|0|||
170378281|NCT00561795|615719226|FG003|Overall Study|Study Closed/Terminated|0|||
170378282|NCT00561795|615719223|FG000|Overall Study|Physician Decision|1|||
170378283|NCT00561795|615719224|FG001|Overall Study|Physician Decision|0|||
170378284|NCT00561795|615719225|FG002|Overall Study|Physician Decision|0|||
170378285|NCT00561795|615719226|FG003|Overall Study|Physician Decision|0|||
170378286|NCT02094612|615719227|FG000|Overall Study|Lost to Follow-up|47|||
170378287|NCT02094612|615719228|FG001|Overall Study|Lost to Follow-up|47|||
170378288|NCT02094612|615719227|FG000|Overall Study|Never started ADHD medication|32|||
170378289|NCT02094612|615719228|FG001|Overall Study|Never started ADHD medication|23|||
170378290|NCT04221945|615719229|FG000|Overall Study|Death|103|||
170378291|NCT04221945|615719230|FG001|Overall Study|Death|140|||
170378292|NCT04221945|615719229|FG000|Overall Study|Lost to Follow-up|5|||
170378293|NCT04221945|615719230|FG001|Overall Study|Lost to Follow-up|8|||
170378294|NCT04221945|615719229|FG000|Overall Study|Withdrawal by Subject|21|||
170378295|NCT04221945|615719230|FG001|Overall Study|Withdrawal by Subject|11|||
170378296|NCT04221945|615719229|FG000|Overall Study|Participants Ongoing|400|||
170378297|NCT04221945|615719230|FG001|Overall Study|Participants Ongoing|372|||
170378298|NCT00974090|615719231|FG000|Period 1: Double Blind Period|Adverse Event|2|||
170378299|NCT00974090|615719232|FG001|Period 1: Double Blind Period|Adverse Event|1|||
170378300|NCT00974090|615719231|FG000|Period 1: Double Blind Period|Physician Decision|1|||
170378301|NCT00974090|615719232|FG001|Period 1: Double Blind Period|Physician Decision|0|||
170378302|NCT00974090|615719231|FG000|Period 2: Open-label Period|Adverse Event|4|||
170378303|NCT00974090|615719232|FG001|Period 2: Open-label Period|Adverse Event|6|||
170378304|NCT00974090|615719231|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
170378305|NCT00974090|615719232|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
170378306|NCT00974090|615719231|FG000|Period 2: Open-label Period|Physician Decision|0|||
170378307|NCT00974090|615719232|FG001|Period 2: Open-label Period|Physician Decision|3|||
170378308|NCT00974090|615719231|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
170378309|NCT00974090|615719232|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
170378310|NCT04785144|615719233|FG000|Overall Study|Withdrawal by Subject|4|||
170378311|NCT04785144|615719234|FG001|Overall Study|Withdrawal by Subject|1|||
170378312|NCT04785144|615719235|FG002|Overall Study|Withdrawal by Subject|0|||
170378313|NCT04785144|615719236|FG003|Overall Study|Withdrawal by Subject|0|||
170378314|NCT04785144|615719237|FG004|Overall Study|Withdrawal by Subject|0|||
170378315|NCT04785144|615719238|FG005|Overall Study|Withdrawal by Subject|2|||
170378316|NCT04785144|615719239|FG006|Overall Study|Withdrawal by Subject|2|||
170378317|NCT04785144|615719240|FG007|Overall Study|Withdrawal by Subject|0|||
170378318|NCT04785144|615719241|FG008|Overall Study|Withdrawal by Subject|1|||
170378319|NCT04785144|615719242|FG009|Overall Study|Withdrawal by Subject|0|||
170378320|NCT04785144|615719233|FG000|Overall Study|Lost to Follow-up|1|||
170378321|NCT04785144|615719234|FG001|Overall Study|Lost to Follow-up|0|||
170378322|NCT04785144|615719235|FG002|Overall Study|Lost to Follow-up|0|||
170378323|NCT04785144|615719236|FG003|Overall Study|Lost to Follow-up|0|||
170378324|NCT04785144|615719237|FG004|Overall Study|Lost to Follow-up|1|||
170378325|NCT04785144|615719238|FG005|Overall Study|Lost to Follow-up|2|||
170378326|NCT04785144|615719239|FG006|Overall Study|Lost to Follow-up|1|||
170378327|NCT04785144|615719240|FG007|Overall Study|Lost to Follow-up|2|||
170378328|NCT04785144|615719241|FG008|Overall Study|Lost to Follow-up|4|||
170378329|NCT04785144|615719242|FG009|Overall Study|Lost to Follow-up|1|||
170378330|NCT04785144|615719233|FG000|Overall Study|Protocol Violation|0|||
170378331|NCT04785144|615719234|FG001|Overall Study|Protocol Violation|0|||
170378332|NCT04785144|615719235|FG002|Overall Study|Protocol Violation|0|||
170378333|NCT04785144|615719236|FG003|Overall Study|Protocol Violation|0|||
170378334|NCT04785144|615719237|FG004|Overall Study|Protocol Violation|0|||
170378335|NCT04785144|615719238|FG005|Overall Study|Protocol Violation|0|||
170378336|NCT04785144|615719239|FG006|Overall Study|Protocol Violation|1|||
170378337|NCT04785144|615719240|FG007|Overall Study|Protocol Violation|0|||
170378338|NCT04785144|615719241|FG008|Overall Study|Protocol Violation|0|||
170378339|NCT04785144|615719242|FG009|Overall Study|Protocol Violation|0|||
170378340|NCT04785144|615719233|FG000|Overall Study|Physician Decision|0|||
170378341|NCT04785144|615719234|FG001|Overall Study|Physician Decision|0|||
170378342|NCT04785144|615719235|FG002|Overall Study|Physician Decision|0|||
170378343|NCT04785144|615719236|FG003|Overall Study|Physician Decision|0|||
170378344|NCT04785144|615719237|FG004|Overall Study|Physician Decision|0|||
170378345|NCT04785144|615719238|FG005|Overall Study|Physician Decision|0|||
170378346|NCT04785144|615719239|FG006|Overall Study|Physician Decision|0|||
170378347|NCT04785144|615719240|FG007|Overall Study|Physician Decision|0|||
170378348|NCT04785144|615719241|FG008|Overall Study|Physician Decision|0|||
170378349|NCT04785144|615719242|FG009|Overall Study|Physician Decision|1|||
170378350|NCT04785144|615719233|FG000|Overall Study|Unable to continue due to work schedule|0|||
170378351|NCT04785144|615719234|FG001|Overall Study|Unable to continue due to work schedule|0|||
170378352|NCT04785144|615719235|FG002|Overall Study|Unable to continue due to work schedule|0|||
170378353|NCT04785144|615719236|FG003|Overall Study|Unable to continue due to work schedule|0|||
170378354|NCT04785144|615719237|FG004|Overall Study|Unable to continue due to work schedule|0|||
170378355|NCT04785144|615719238|FG005|Overall Study|Unable to continue due to work schedule|0|||
170378356|NCT04785144|615719239|FG006|Overall Study|Unable to continue due to work schedule|0|||
170378357|NCT04785144|615719240|FG007|Overall Study|Unable to continue due to work schedule|0|||
170378358|NCT04785144|615719241|FG008|Overall Study|Unable to continue due to work schedule|0|||
170378359|NCT04785144|615719242|FG009|Overall Study|Unable to continue due to work schedule|1|||
170378360|NCT01029691|615719245|FG000|Continued APAP to Delivery|Death|0|||
170378361|NCT01029691|615719246|FG001|Continued APAP to Delivery|Death|0|||
170378362|NCT01029691|615719247|FG002|Continued APAP to Delivery|Death|1|||
170378363|NCT00862992|615719248|FG000|Overall Study|Adverse Event|2|||
170378364|NCT00862992|615719249|FG001|Overall Study|Adverse Event|1|||
170378365|NCT00862992|615719250|FG002|Overall Study|Adverse Event|1|||
170378366|NCT00862992|615719248|FG000|Overall Study|Physician Decision|1|||
170378367|NCT00862992|615719249|FG001|Overall Study|Physician Decision|0|||
170378368|NCT00862992|615719250|FG002|Overall Study|Physician Decision|0|||
170378369|NCT00862992|615719248|FG000|Overall Study|Withdrawal by Subject|0|||
170378370|NCT00862992|615719249|FG001|Overall Study|Withdrawal by Subject|0|||
170378371|NCT00862992|615719250|FG002|Overall Study|Withdrawal by Subject|2|||
170378372|NCT04005755|615719258|FG000|Overall Study|Adverse Event|6|||
170378373|NCT04005755|615719258|FG000|Overall Study|Physician Decision|3|||
170378374|NCT04005755|615719258|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
170378375|NCT04005755|615719258|FG000|Overall Study|Withdrawal by Subject|3|||
170378376|NCT04005755|615719258|FG000|Overall Study|Lost to Follow-up|1|||
170378377|NCT02289833|615719259|FG000|Overall Study|Study discontinuation|0|||
170378378|NCT02289833|615719260|FG001|Overall Study|Study discontinuation|1|||
170378379|NCT02289833|615719259|FG000|Overall Study|Lost to Follow-up|4|||
170378380|NCT02289833|615719260|FG001|Overall Study|Lost to Follow-up|0|||
170378381|NCT02289833|615719259|FG000|Overall Study|Death|23|||
170378382|NCT02289833|615719260|FG001|Overall Study|Death|16|||
170378383|NCT01197794|615719266|FG000|Overall Study|Adverse Event|3|||
170378384|NCT01197794|615719267|FG001|Overall Study|Adverse Event|2|||
170378385|NCT01197794|615719268|FG002|Overall Study|Adverse Event|4|||
170378386|NCT01197794|615719269|FG003|Overall Study|Adverse Event|4|||
170378387|NCT01197794|615719270|FG004|Overall Study|Adverse Event|4|||
170378388|NCT01197794|615719271|FG005|Overall Study|Adverse Event|2|||
170378389|NCT01197794|615719272|FG006|Overall Study|Adverse Event|3|||
170378390|NCT01197794|615719266|FG000|Overall Study|Protocol Violation|0|||
170378391|NCT01197794|615719267|FG001|Overall Study|Protocol Violation|0|||
170378392|NCT01197794|615719268|FG002|Overall Study|Protocol Violation|0|||
170378393|NCT01197794|615719269|FG003|Overall Study|Protocol Violation|0|||
170378394|NCT01197794|615719270|FG004|Overall Study|Protocol Violation|2|||
170378395|NCT01197794|615719271|FG005|Overall Study|Protocol Violation|0|||
170378396|NCT01197794|615719272|FG006|Overall Study|Protocol Violation|1|||
170378397|NCT01197794|615719266|FG000|Overall Study|Development of study withdrawal criteria|3|||
170378398|NCT01197794|615719267|FG001|Overall Study|Development of study withdrawal criteria|0|||
170378399|NCT01197794|615719268|FG002|Overall Study|Development of study withdrawal criteria|0|||
170378400|NCT01197794|615719269|FG003|Overall Study|Development of study withdrawal criteria|1|||
170378401|NCT01197794|615719270|FG004|Overall Study|Development of study withdrawal criteria|0|||
170378402|NCT01197794|615719271|FG005|Overall Study|Development of study withdrawal criteria|0|||
170378403|NCT01197794|615719272|FG006|Overall Study|Development of study withdrawal criteria|1|||
170378404|NCT01197794|615719266|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
170378405|NCT01197794|615719267|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
170378406|NCT01197794|615719268|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
170378407|NCT01197794|615719269|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
170378408|NCT01197794|615719270|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
170378409|NCT01197794|615719271|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
170378410|NCT01197794|615719272|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
170378411|NCT01197794|615719266|FG000|Overall Study|Withdrawal by Subject|3|||
170378412|NCT01197794|615719267|FG001|Overall Study|Withdrawal by Subject|3|||
170378413|NCT01197794|615719268|FG002|Overall Study|Withdrawal by Subject|4|||
170378414|NCT01197794|615719269|FG003|Overall Study|Withdrawal by Subject|1|||
170378415|NCT01197794|615719270|FG004|Overall Study|Withdrawal by Subject|1|||
170378416|NCT01197794|615719271|FG005|Overall Study|Withdrawal by Subject|5|||
170378417|NCT01197794|615719272|FG006|Overall Study|Withdrawal by Subject|6|||
170378418|NCT01197794|615719266|FG000|Overall Study|Lost to Follow-up|1|||
170378419|NCT01197794|615719267|FG001|Overall Study|Lost to Follow-up|1|||
170378420|NCT01197794|615719268|FG002|Overall Study|Lost to Follow-up|0|||
170378421|NCT01197794|615719269|FG003|Overall Study|Lost to Follow-up|1|||
170378422|NCT01197794|615719270|FG004|Overall Study|Lost to Follow-up|0|||
170378423|NCT01197794|615719271|FG005|Overall Study|Lost to Follow-up|1|||
170378424|NCT01197794|615719272|FG006|Overall Study|Lost to Follow-up|0|||
170378425|NCT01197794|615719266|FG000|Overall Study|Other|1|||
170378426|NCT01197794|615719267|FG001|Overall Study|Other|1|||
170378427|NCT01197794|615719268|FG002|Overall Study|Other|3|||
170378428|NCT01197794|615719269|FG003|Overall Study|Other|0|||
170378429|NCT01197794|615719270|FG004|Overall Study|Other|2|||
170378430|NCT01197794|615719271|FG005|Overall Study|Other|2|||
170378431|NCT01197794|615719272|FG006|Overall Study|Other|4|||
170378432|NCT01833806|615719279|FG000|Overall Study|Alternative treatment|2|||
170378433|NCT01833806|615719279|FG000|Overall Study|Death|5|||
170378434|NCT01833806|615719279|FG000|Overall Study|Physician Decision|1|||
170378435|NCT01833806|615719279|FG000|Overall Study|Lost to Follow-up|1|||
170378436|NCT00322387|615719281|FG000|Treatment Period|Adverse Event|0|||
170378437|NCT00322387|615719282|FG001|Treatment Period|Adverse Event|1|||
170378438|NCT00322387|615719281|FG000|Follow-up Period|Final assessment not done|1|||
170378439|NCT00322387|615719282|FG001|Follow-up Period|Final assessment not done|3|||
170378440|NCT00322387|615719281|FG000|Follow-up Period|Death|1|||
170378441|NCT00322387|615719282|FG001|Follow-up Period|Death|0|||
170378442|NCT02332876|615719296|FG000|Overall Study|Lost to Follow-up|1|||
170378443|NCT02332876|615719297|FG001|Overall Study|Lost to Follow-up|1|||
170378444|NCT03325010|615719298|FG000|Overall Study|Adverse Event|3|||
170378445|NCT03325010|615719299|FG001|Overall Study|Adverse Event|8|||
170378446|NCT03325010|615719298|FG000|Overall Study|Protocol Violation|1|||
170378447|NCT03325010|615719299|FG001|Overall Study|Protocol Violation|8|||
170378448|NCT03325010|615719298|FG000|Overall Study|Withdrawal by Subject|1|||
170378449|NCT03325010|615719299|FG001|Overall Study|Withdrawal by Subject|3|||
170378450|NCT03325010|615719298|FG000|Overall Study|Lost to Follow-up|1|||
170378451|NCT03325010|615719299|FG001|Overall Study|Lost to Follow-up|0|||
170378452|NCT03325010|615719298|FG000|Overall Study|Physician Decision|1|||
170378453|NCT03325010|615719299|FG001|Overall Study|Physician Decision|1|||
170378454|NCT03325010|615719298|FG000|Overall Study|Lack of Efficacy|2|||
170378455|NCT03325010|615719299|FG001|Overall Study|Lack of Efficacy|0|||
170378456|NCT04350372|615719305|FG000|Overall Study|Death|1|||
170378457|NCT04474366|615719306|FG000|Overall Study|Lost to Follow-up|2|||
170378458|NCT04474366|615719307|FG001|Overall Study|Lost to Follow-up|5|||
170378459|NCT03049852|615719317|FG000|Overall Study|Lost to Follow-up|0|||
170378460|NCT03049852|615719318|FG001|Overall Study|Lost to Follow-up|1|||
170378461|NCT03049852|615719319|FG002|Overall Study|Lost to Follow-up|0|||
170378462|NCT00925522|615719320|FG000|Overall Study|study closed -- business decision|20|||
170378463|NCT02561572|615719325|FG000|Overall Study|Inadequate time before surgery|2|||
170378464|NCT02561572|615719326|FG001|Overall Study|Inadequate time before surgery|1|||
170378465|NCT02561572|615719325|FG000|Overall Study|Protocol Violation|0|||
170378466|NCT02561572|615719326|FG001|Overall Study|Protocol Violation|1|||
170378467|NCT01190020|615719327|FG000|Overall Study|Adverse Event|2|||
170378468|NCT01190020|615719328|FG001|Overall Study|Adverse Event|0|||
170378469|NCT01190020|615719327|FG000|Overall Study|Lost to Follow-up|2|||
170378470|NCT01190020|615719328|FG001|Overall Study|Lost to Follow-up|0|||
170378471|NCT01190020|615719327|FG000|Overall Study|Withdrawal by Subject|3|||
170378472|NCT01190020|615719328|FG001|Overall Study|Withdrawal by Subject|0|||
170378473|NCT04490057|615719329|FG000|Stage 1|Death|1|||
170378474|NCT04490057|615719330|FG001|Stage 1|Death|2|||
170378475|NCT04490057|615719331|FG002|Stage 1|Death|0|||
170378476|NCT04490057|615719332|FG003|Stage 1|Death|0|||
170378477|NCT04490057|615719333|FG004|Stage 1|Death|0|||
170378478|NCT04490057|615719334|FG005|Stage 1|Death|0|||
170378479|NCT04490057|615719335|FG006|Stage 1|Death|0|||
170378480|NCT04490057|615719336|FG007|Stage 1|Death|0|||
170378481|NCT04490057|615719329|FG000|Stage 1|Withdrawal by Subject|2|||
170378482|NCT04490057|615719330|FG001|Stage 1|Withdrawal by Subject|0|||
170378483|NCT04490057|615719331|FG002|Stage 1|Withdrawal by Subject|0|||
170378484|NCT04490057|615719332|FG003|Stage 1|Withdrawal by Subject|0|||
170378485|NCT04490057|615719333|FG004|Stage 1|Withdrawal by Subject|0|||
170378486|NCT04490057|615719334|FG005|Stage 1|Withdrawal by Subject|0|||
170378487|NCT04490057|615719335|FG006|Stage 1|Withdrawal by Subject|0|||
170378488|NCT04490057|615719336|FG007|Stage 1|Withdrawal by Subject|0|||
170378489|NCT04490057|615719329|FG000|Stage 2|Death|0|||
170378490|NCT04490057|615719330|FG001|Stage 2|Death|0|||
170378491|NCT04490057|615719331|FG002|Stage 2|Death|0|||
170378492|NCT04490057|615719332|FG003|Stage 2|Death|0|||
170378493|NCT04490057|615719333|FG004|Stage 2|Death|1|||
170378494|NCT04490057|615719334|FG005|Stage 2|Death|0|||
170378495|NCT04490057|615719335|FG006|Stage 2|Death|0|||
170378496|NCT04490057|615719336|FG007|Stage 2|Death|0|||
170378497|NCT04490057|615719329|FG000|Stage 2|Lost to Follow-up|0|||
170378498|NCT04490057|615719330|FG001|Stage 2|Lost to Follow-up|0|||
170378499|NCT04490057|615719331|FG002|Stage 2|Lost to Follow-up|0|||
170378500|NCT04490057|615719332|FG003|Stage 2|Lost to Follow-up|11|||
170378501|NCT04490057|615719333|FG004|Stage 2|Lost to Follow-up|17|||
170378502|NCT04490057|615719334|FG005|Stage 2|Lost to Follow-up|4|||
170378503|NCT04490057|615719335|FG006|Stage 2|Lost to Follow-up|21|||
170378504|NCT04490057|615719336|FG007|Stage 2|Lost to Follow-up|14|||
170378505|NCT03074318|615719337|FG000|Overall Study|Adverse Event|0|||
170378506|NCT03074318|615719338|FG001|Overall Study|Adverse Event|1|||
170378507|NCT03074318|615719339|FG002|Overall Study|Adverse Event|1|||
170378508|NCT03074318|615719340|FG003|Overall Study|Adverse Event|1|||
170378509|NCT03074318|615719337|FG000|Overall Study|Death|1|||
170378510|NCT03074318|615719338|FG001|Overall Study|Death|0|||
170378511|NCT03074318|615719339|FG002|Overall Study|Death|0|||
170378512|NCT03074318|615719340|FG003|Overall Study|Death|0|||
170378513|NCT03074318|615719337|FG000|Overall Study|Withdrawal by Subject|1|||
170378514|NCT03074318|615719338|FG001|Overall Study|Withdrawal by Subject|2|||
170378515|NCT03074318|615719339|FG002|Overall Study|Withdrawal by Subject|2|||
170378516|NCT03074318|615719340|FG003|Overall Study|Withdrawal by Subject|4|||
170378517|NCT03074318|615719337|FG000|Overall Study|Trial Closure|2|||
170378518|NCT03074318|615719338|FG001|Overall Study|Trial Closure|2|||
170378519|NCT03074318|615719339|FG002|Overall Study|Trial Closure|3|||
170378520|NCT03074318|615719340|FG003|Overall Study|Trial Closure|11|||
170378521|NCT03399786|615719341|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
170378522|NCT03399786|615719342|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
170378523|NCT03399786|615719343|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
170378524|NCT03399786|615719344|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
170378525|NCT03399786|615719341|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
170378526|NCT03399786|615719342|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
170378527|NCT03399786|615719343|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
170378528|NCT03399786|615719344|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
170378529|NCT03399786|615719341|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
170378530|NCT03399786|615719342|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
170378531|NCT03399786|615719343|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
170378532|NCT03399786|615719344|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
170378533|NCT00829010|615721156|FG000|Overall Study|Adverse Event|1|||
170378534|NCT00829010|615721157|FG001|Overall Study|Adverse Event|0|||
170378535|NCT00829010|615721158|FG002|Overall Study|Adverse Event|0|||
170378536|NCT00829010|615721159|FG003|Overall Study|Adverse Event|0|||
170378537|NCT00829010|615721160|FG004|Overall Study|Adverse Event|0|||
170378538|NCT00829010|615721156|FG000|Overall Study|Withdrawal by Subject|0|||
170378539|NCT00829010|615721157|FG001|Overall Study|Withdrawal by Subject|1|||
170378540|NCT00829010|615721158|FG002|Overall Study|Withdrawal by Subject|1|||
170378541|NCT00829010|615721159|FG003|Overall Study|Withdrawal by Subject|0|||
170378542|NCT00829010|615721160|FG004|Overall Study|Withdrawal by Subject|2|||
170378543|NCT00829010|615721156|FG000|Overall Study|Lost to Follow-up|1|||
170378544|NCT00829010|615721157|FG001|Overall Study|Lost to Follow-up|0|||
170378545|NCT00829010|615721158|FG002|Overall Study|Lost to Follow-up|2|||
170378546|NCT00829010|615721159|FG003|Overall Study|Lost to Follow-up|0|||
170378547|NCT00829010|615721160|FG004|Overall Study|Lost to Follow-up|0|||
170378548|NCT00829010|615721156|FG000|Overall Study|Fatality|5|||
170378549|NCT00829010|615721157|FG001|Overall Study|Fatality|4|||
170378550|NCT00829010|615721158|FG002|Overall Study|Fatality|0|||
170378551|NCT00829010|615721159|FG003|Overall Study|Fatality|3|||
170378552|NCT00829010|615721160|FG004|Overall Study|Fatality|0|||
170378553|NCT00829010|615721156|FG000|Overall Study|Migrated/Moved from study area|3|||
170378554|NCT00829010|615721157|FG001|Overall Study|Migrated/Moved from study area|4|||
170378555|NCT00829010|615721158|FG002|Overall Study|Migrated/Moved from study area|0|||
170378556|NCT00829010|615721159|FG003|Overall Study|Migrated/Moved from study area|5|||
170378557|NCT00829010|615721160|FG004|Overall Study|Migrated/Moved from study area|0|||
170378558|NCT06210035|615721161|FG000|Overall Study|Withdrawal by Subject|3|||
170378559|NCT06210035|615721162|FG001|Overall Study|Withdrawal by Subject|0|||
170378560|NCT06210035|615721163|FG002|Overall Study|Withdrawal by Subject|0|||
170378561|NCT02061540|615721169|FG000|Overall Study|Adverse Event|2|||
170378562|NCT02061540|615721169|FG000|Overall Study|Withdrawal by Subject|2|||
170378563|NCT01642004|615721172|FG000|Randomization|Adverse Event unrelated to study drug|1|||
170378564|NCT01642004|615721173|FG001|Randomization|Adverse Event unrelated to study drug|0|||
170378565|NCT01642004|615721172|FG000|Randomization|Participant withdrew consent|1|||
170378566|NCT01642004|615721173|FG001|Randomization|Participant withdrew consent|6|||
170378567|NCT01642004|615721172|FG000|Randomization|No longer meets study criteria|2|||
170378568|NCT01642004|615721173|FG001|Randomization|No longer meets study criteria|2|||
170378569|NCT01642004|615721172|FG000|Treatment|Disease progression|95|||
170378570|NCT01642004|615721173|FG001|Treatment|Disease progression|79|||
170378571|NCT01642004|615721172|FG000|Treatment|Study drug toxicity|10|||
170378572|NCT01642004|615721173|FG001|Treatment|Study drug toxicity|13|||
170378573|NCT01642004|615721172|FG000|Treatment|Death|1|||
170378574|NCT01642004|615721173|FG001|Treatment|Death|1|||
170378575|NCT01642004|615721172|FG000|Treatment|Adverse event unrelated to study drug|9|||
170378576|NCT01642004|615721173|FG001|Treatment|Adverse event unrelated to study drug|13|||
170378577|NCT01642004|615721172|FG000|Treatment|Maximum clinical benefit|1|||
170378578|NCT01642004|615721173|FG001|Treatment|Maximum clinical benefit|9|||
170378579|NCT01642004|615721172|FG000|Treatment|Poor/non-compliance|1|||
170378580|NCT01642004|615721173|FG001|Treatment|Poor/non-compliance|0|||
170378581|NCT01642004|615721172|FG000|Treatment|No longer meets study criteria|1|||
170378582|NCT01642004|615721173|FG001|Treatment|No longer meets study criteria|2|||
170378583|NCT01642004|615721172|FG000|Treatment|Other reasons|2|||
170378584|NCT01642004|615721173|FG001|Treatment|Other reasons|0|||
170378585|NCT01642004|615721172|FG000|Treatment|Not reported|0|||
170378586|NCT01642004|615721173|FG001|Treatment|Not reported|3|||
170378587|NCT01642004|615721172|FG000|Treatment|Participant request to discontinue study treatment|6|||
170378588|NCT01642004|615721173|FG001|Treatment|Participant request to discontinue study treatment|4|||
170378589|NCT01642004|615721172|FG000|Treatment|Participant withdrew consent|5|||
170378590|NCT01642004|615721173|FG001|Treatment|Participant withdrew consent|5|||
170378591|NCT02795182|615721178|FG000|Overall Study|Death|5|||
170378592|NCT02795182|615721179|FG001|Overall Study|Death|4|||
170378593|NCT02795182|615721180|FG002|Overall Study|Death|4|||
170378594|NCT02795182|615721181|FG003|Overall Study|Death|18|||
170378595|NCT02795182|615721178|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
170378596|NCT02795182|615721179|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
170378597|NCT02795182|615721180|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
170378598|NCT02795182|615721181|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
170378599|NCT02795182|615721178|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
170378600|NCT02795182|615721179|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
170378601|NCT02795182|615721180|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
170378602|NCT02795182|615721181|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
170378603|NCT02795182|615721178|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
170378604|NCT02795182|615721179|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
170378605|NCT02795182|615721180|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
170378606|NCT02795182|615721181|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
170378607|NCT02795182|615721178|FG000|Overall Study|Withdrawal by Subject|4|||
170378608|NCT02795182|615721179|FG001|Overall Study|Withdrawal by Subject|0|||
170378609|NCT02795182|615721180|FG002|Overall Study|Withdrawal by Subject|0|||
170378610|NCT02795182|615721181|FG003|Overall Study|Withdrawal by Subject|3|||
170378611|NCT02795182|615721178|FG000|Overall Study|Lost to Follow-up|0|||
170378612|NCT02795182|615721179|FG001|Overall Study|Lost to Follow-up|0|||
170378613|NCT02795182|615721180|FG002|Overall Study|Lost to Follow-up|1|||
170378614|NCT02795182|615721181|FG003|Overall Study|Lost to Follow-up|1|||
170378615|NCT02795182|615721178|FG000|Overall Study|Roll Over to Long Term Extension|3|||
170378616|NCT02795182|615721179|FG001|Overall Study|Roll Over to Long Term Extension|3|||
170378617|NCT02795182|615721180|FG002|Overall Study|Roll Over to Long Term Extension|2|||
170378618|NCT02795182|615721181|FG003|Overall Study|Roll Over to Long Term Extension|5|||
170378619|NCT02795182|615721178|FG000|Overall Study|Progressive Disease|0|||
170378620|NCT02795182|615721179|FG001|Overall Study|Progressive Disease|1|||
170378621|NCT02795182|615721180|FG002|Overall Study|Progressive Disease|0|||
170378622|NCT02795182|615721181|FG003|Overall Study|Progressive Disease|4|||
170378623|NCT02795182|615721178|FG000|Overall Study|Physician Decision|0|||
170378624|NCT02795182|615721179|FG001|Overall Study|Physician Decision|0|||
170378625|NCT02795182|615721180|FG002|Overall Study|Physician Decision|0|||
170378626|NCT02795182|615721181|FG003|Overall Study|Physician Decision|1|||
170378627|NCT00696774|615721182|FG000|Period II|Adverse Event|0|||
170378628|NCT00696774|615721183|FG001|Period II|Adverse Event|0|||
170378629|NCT00696774|615721184|FG002|Period II|Adverse Event|15|||
170378630|NCT00696774|615721182|FG000|Period II|Lost to Follow-up|0|||
170378631|NCT00696774|615721183|FG001|Period II|Lost to Follow-up|0|||
170378632|NCT00696774|615721184|FG002|Period II|Lost to Follow-up|4|||
170378633|NCT00696774|615721182|FG000|Period II|Protocol Violation|0|||
170378634|NCT00696774|615721183|FG001|Period II|Protocol Violation|0|||
170378635|NCT00696774|615721184|FG002|Period II|Protocol Violation|11|||
170378636|NCT00696774|615721182|FG000|Period II|Withdrawal by Subject|0|||
170378637|NCT00696774|615721183|FG001|Period II|Withdrawal by Subject|0|||
170378638|NCT00696774|615721184|FG002|Period II|Withdrawal by Subject|4|||
170378639|NCT00696774|615721182|FG000|Period II|Sponsor Decision|0|||
170378640|NCT00696774|615721183|FG001|Period II|Sponsor Decision|0|||
170378641|NCT00696774|615721184|FG002|Period II|Sponsor Decision|0|||
170378642|NCT00696774|615721182|FG000|Period II|Lack of Efficacy|0|||
170378643|NCT00696774|615721183|FG001|Period II|Lack of Efficacy|0|||
170378644|NCT00696774|615721184|FG002|Period II|Lack of Efficacy|2|||
170378645|NCT00696774|615721182|FG000|Period III|Adverse Event|1|||
170378646|NCT00696774|615721183|FG001|Period III|Adverse Event|1|||
170378647|NCT00696774|615721184|FG002|Period III|Adverse Event|0|||
170378648|NCT00696774|615721182|FG000|Period III|Lost to Follow-up|2|||
170378649|NCT00696774|615721183|FG001|Period III|Lost to Follow-up|1|||
170378650|NCT00696774|615721184|FG002|Period III|Lost to Follow-up|0|||
170378651|NCT00696774|615721182|FG000|Period III|Protocol Violation|1|||
170378652|NCT00696774|615721183|FG001|Period III|Protocol Violation|1|||
170378653|NCT00696774|615721184|FG002|Period III|Protocol Violation|0|||
170378654|NCT00696774|615721182|FG000|Period III|Withdrawal by Subject|1|||
170378655|NCT00696774|615721183|FG001|Period III|Withdrawal by Subject|2|||
170378656|NCT00696774|615721184|FG002|Period III|Withdrawal by Subject|0|||
170378657|NCT00696774|615721182|FG000|Period III|Sponsor Decision|2|||
170378658|NCT00696774|615721183|FG001|Period III|Sponsor Decision|0|||
170378659|NCT00696774|615721184|FG002|Period III|Sponsor Decision|0|||
170378660|NCT00696774|615721182|FG000|Period III|Lack of Efficacy|0|||
170378661|NCT00696774|615721183|FG001|Period III|Lack of Efficacy|2|||
170378662|NCT00696774|615721184|FG002|Period III|Lack of Efficacy|0|||
170378663|NCT00033293|615721185|FG000|Overall Study|Death|0|||
170378664|NCT00033293|615721186|FG001|Overall Study|Death|1|||
170378665|NCT00033293|615721185|FG000|Overall Study|Lack of Efficacy|5|||
170378666|NCT00033293|615721186|FG001|Overall Study|Lack of Efficacy|8|||
170378667|NCT00033293|615721185|FG000|Overall Study|Lost to Follow-up|0|||
170378668|NCT00033293|615721186|FG001|Overall Study|Lost to Follow-up|1|||
170378669|NCT00033293|615721185|FG000|Overall Study|Physician Decision|3|||
170378670|NCT00033293|615721186|FG001|Overall Study|Physician Decision|1|||
170378671|NCT00033293|615721185|FG000|Overall Study|Withdrawal by Subject|1|||
170378672|NCT00033293|615721186|FG001|Overall Study|Withdrawal by Subject|0|||
170378673|NCT00033293|615721185|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
170378674|NCT00033293|615721186|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
170378675|NCT00033293|615721185|FG000|Overall Study|Treatment refused|0|||
170378676|NCT00033293|615721186|FG001|Overall Study|Treatment refused|6|||
170378677|NCT01955005|615721187|FG000|Overall Study|Withdrawal by Subject|3|||
170378678|NCT01955005|615721188|FG001|Overall Study|Withdrawal by Subject|5|||
170378679|NCT02711553|615721189|FG000|Overall Study|Withdrawal by Subject|2|||
170378680|NCT02711553|615721190|FG001|Overall Study|Withdrawal by Subject|1|||
170378681|NCT02711553|615721191|FG002|Overall Study|Withdrawal by Subject|1|||
170378682|NCT02711553|615721192|FG003|Overall Study|Withdrawal by Subject|0|||
170378683|NCT02711553|615721189|FG000|Overall Study|Lost to Follow-up|3|||
170378684|NCT02711553|615721190|FG001|Overall Study|Lost to Follow-up|3|||
170378685|NCT02711553|615721191|FG002|Overall Study|Lost to Follow-up|6|||
170378686|NCT02711553|615721192|FG003|Overall Study|Lost to Follow-up|3|||
170378687|NCT02711553|615721189|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
170378688|NCT02711553|615721190|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
170378689|NCT02711553|615721191|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
170378690|NCT02711553|615721192|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
170378691|NCT04048876|615721195|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
170378692|NCT04048876|615721196|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
170378693|NCT04048876|615721197|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
170378694|NCT04048876|615721198|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
170378695|NCT04048876|615721195|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
170378696|NCT04048876|615721196|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
170378697|NCT04048876|615721197|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
170378698|NCT04048876|615721198|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
170378699|NCT04048876|615721195|FG000|Placebo Controlled Phase|Adverse Event|0|||
170378700|NCT04048876|615721196|FG001|Placebo Controlled Phase|Adverse Event|1|||
170378701|NCT04048876|615721197|FG002|Placebo Controlled Phase|Adverse Event|0|||
170378702|NCT04048876|615721198|FG003|Placebo Controlled Phase|Adverse Event|0|||
170378703|NCT04048876|615721195|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
170378704|NCT04048876|615721196|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
170378705|NCT04048876|615721197|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
170378706|NCT04048876|615721198|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
170378707|NCT02724111|615721199|FG000|Overall Study|Protocol Violation|2|||
170378708|NCT02724111|615721200|FG001|Overall Study|Protocol Violation|5|||
170378709|NCT02996500|615721201|FG000|Overall Study|Adverse Event|1|||
170378710|NCT02996500|615721202|FG001|Overall Study|Adverse Event|1|||
170378711|NCT02996500|615721203|FG002|Overall Study|Adverse Event|4|||
170378712|NCT02996500|615721204|FG003|Overall Study|Adverse Event|3|||
170378713|NCT02996500|615721205|FG004|Overall Study|Adverse Event|1|||
170378714|NCT02996500|615721206|FG005|Overall Study|Adverse Event|2|||
170378715|NCT02996500|615721201|FG000|Overall Study|Lack of Efficacy|0|||
170378716|NCT02996500|615721202|FG001|Overall Study|Lack of Efficacy|0|||
170378717|NCT02996500|615721203|FG002|Overall Study|Lack of Efficacy|0|||
170378718|NCT02996500|615721204|FG003|Overall Study|Lack of Efficacy|0|||
170378719|NCT02996500|615721205|FG004|Overall Study|Lack of Efficacy|2|||
170378720|NCT02996500|615721206|FG005|Overall Study|Lack of Efficacy|0|||
170378721|NCT02996500|615721201|FG000|Overall Study|Lost to Follow-up|1|||
170378722|NCT02996500|615721202|FG001|Overall Study|Lost to Follow-up|0|||
170378723|NCT02996500|615721203|FG002|Overall Study|Lost to Follow-up|0|||
170378724|NCT02996500|615721204|FG003|Overall Study|Lost to Follow-up|0|||
170378725|NCT02996500|615721205|FG004|Overall Study|Lost to Follow-up|0|||
170378726|NCT02996500|615721206|FG005|Overall Study|Lost to Follow-up|1|||
170378727|NCT02996500|615721201|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
170378728|NCT02996500|615721202|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
170378729|NCT02996500|615721203|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
170378730|NCT02996500|615721204|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
170378731|NCT02996500|615721205|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
170378732|NCT02996500|615721206|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
170378733|NCT02996500|615721201|FG000|Overall Study|Non-Compliance With Study Drug|0|||
170378734|NCT02996500|615721202|FG001|Overall Study|Non-Compliance With Study Drug|0|||
170378735|NCT02996500|615721203|FG002|Overall Study|Non-Compliance With Study Drug|0|||
170378736|NCT02996500|615721204|FG003|Overall Study|Non-Compliance With Study Drug|0|||
170378737|NCT02996500|615721205|FG004|Overall Study|Non-Compliance With Study Drug|0|||
170378738|NCT02996500|615721206|FG005|Overall Study|Non-Compliance With Study Drug|1|||
170378739|NCT02996500|615721201|FG000|Overall Study|Progressive Disease|1|||
170378740|NCT02996500|615721202|FG001|Overall Study|Progressive Disease|0|||
170378741|NCT02996500|615721203|FG002|Overall Study|Progressive Disease|0|||
170378742|NCT02996500|615721204|FG003|Overall Study|Progressive Disease|0|||
170378743|NCT02996500|615721205|FG004|Overall Study|Progressive Disease|0|||
170378744|NCT02996500|615721206|FG005|Overall Study|Progressive Disease|0|||
170378745|NCT02996500|615721201|FG000|Overall Study|Other|2|||
170378746|NCT02996500|615721202|FG001|Overall Study|Other|0|||
170378747|NCT02996500|615721203|FG002|Overall Study|Other|2|||
170378748|NCT02996500|615721204|FG003|Overall Study|Other|0|||
170378749|NCT02996500|615721205|FG004|Overall Study|Other|0|||
170378750|NCT02996500|615721206|FG005|Overall Study|Other|0|||
170378751|NCT02996500|615721201|FG000|Overall Study|Protocol Violation|0|||
170378752|NCT02996500|615721202|FG001|Overall Study|Protocol Violation|0|||
170378753|NCT02996500|615721203|FG002|Overall Study|Protocol Violation|0|||
170378754|NCT02996500|615721204|FG003|Overall Study|Protocol Violation|1|||
170378755|NCT02996500|615721205|FG004|Overall Study|Protocol Violation|0|||
170378756|NCT02996500|615721206|FG005|Overall Study|Protocol Violation|0|||
170378757|NCT02996500|615721201|FG000|Overall Study|Withdrawal by Subject|3|||
170378758|NCT02996500|615721202|FG001|Overall Study|Withdrawal by Subject|0|||
170378759|NCT02996500|615721203|FG002|Overall Study|Withdrawal by Subject|3|||
170378760|NCT02996500|615721204|FG003|Overall Study|Withdrawal by Subject|0|||
170378761|NCT02996500|615721205|FG004|Overall Study|Withdrawal by Subject|2|||
170378762|NCT02996500|615721206|FG005|Overall Study|Withdrawal by Subject|0|||
170378763|NCT00707486|615721211|FG000|Overall Study|Withdrawal by Subject|1|||
170378764|NCT02187224|615721212|FG000|Overall Study|Did not show up for test day|1|||
170378765|NCT02187224|615721213|FG001|Overall Study|Did not show up for test day|0|||
170378766|NCT01347840|615721214|FG000|Overall Study|Withdrawal by Subject|1|||
170378767|NCT01010776|615721215|FG000|Main Phase|Withdrawal by Subject|14|||
170378768|NCT01010776|615721215|FG000|Main Phase|Lack of Efficacy|8|||
170378769|NCT01010776|615721215|FG000|Main Phase|Adverse Event|7|||
170378770|NCT01010776|615721215|FG000|Main Phase|Lost to Follow-up|6|||
170378771|NCT01010776|615721215|FG000|Main Phase|Non-compliance to study medication|5|||
170378772|NCT01010776|615721215|FG000|Main Phase|Selection failure|2|||
170378773|NCT01010776|615721215|FG000|Main Phase|Inform consent withdrawal|1|||
170378774|NCT01010776|615721215|FG000|Main Phase|Other|1|||
170378775|NCT01010776|615721215|FG000|Main Phase|Did not received study medication|5|||
170378776|NCT01010776|615721215|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
170378777|NCT01010776|615721215|FG000|Extension Phase|Other|3|||
170378778|NCT00113555|615721220|FG000|Overall Study|Baseline Failure|59|||
170378779|NCT00113555|615721220|FG000|Overall Study|Permanently Explanted|7|||
170378780|NCT00113555|615721220|FG000|Overall Study|Death|1|||
170378781|NCT00113555|615721220|FG000|Overall Study|Missed Followup|4|||
170378782|NCT00113555|615721220|FG000|Overall Study|Lost to Follow-up|8|||
170378783|NCT04063865|615721221|FG000|Overall Study|Physician Decision|1|||
170378784|NCT04063865|615721222|FG001|Overall Study|Physician Decision|3|||
170378785|NCT04063865|615721221|FG000|Overall Study|Study Closed Prior to Completion|4|||
170378786|NCT04063865|615721222|FG001|Overall Study|Study Closed Prior to Completion|4|||
170398854|NCT05004181|615798318|FG006|Overall Study|Lost to Follow-up|15|||
170378787|NCT04063865|615721221|FG000|Overall Study|Withdrawal by Subject|1|||
170378788|NCT04063865|615721222|FG001|Overall Study|Withdrawal by Subject|1|||
170378789|NCT01708915|615721228|FG000|Overall Study|Adverse Event|1|||
170378790|NCT01708915|615721229|FG001|Overall Study|Adverse Event|0|||
170378791|NCT01708915|615721230|FG002|Overall Study|Adverse Event|9|||
170378792|NCT01708915|615721231|FG003|Overall Study|Adverse Event|13|||
170378793|NCT01708915|615721228|FG000|Overall Study|Lack of Efficacy|84|||
170378794|NCT01708915|615721229|FG001|Overall Study|Lack of Efficacy|60|||
170378795|NCT01708915|615721230|FG002|Overall Study|Lack of Efficacy|35|||
170378796|NCT01708915|615721231|FG003|Overall Study|Lack of Efficacy|15|||
170378797|NCT01708915|615721228|FG000|Overall Study|Protocol Violation|0|||
170378798|NCT01708915|615721229|FG001|Overall Study|Protocol Violation|0|||
170378799|NCT01708915|615721230|FG002|Overall Study|Protocol Violation|0|||
170378800|NCT01708915|615721231|FG003|Overall Study|Protocol Violation|1|||
170378801|NCT01708915|615721228|FG000|Overall Study|Withdrawal by Subject|0|||
170378802|NCT01708915|615721229|FG001|Overall Study|Withdrawal by Subject|1|||
170378803|NCT01708915|615721230|FG002|Overall Study|Withdrawal by Subject|2|||
170378804|NCT01708915|615721231|FG003|Overall Study|Withdrawal by Subject|2|||
170378805|NCT01708915|615721228|FG000|Overall Study|Other reasons than stated above|1|||
170378806|NCT01708915|615721229|FG001|Overall Study|Other reasons than stated above|1|||
170378807|NCT01708915|615721230|FG002|Overall Study|Other reasons than stated above|0|||
170378808|NCT01708915|615721231|FG003|Overall Study|Other reasons than stated above|2|||
170378809|NCT03267576|615721232|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
170378810|NCT03267576|615721233|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
170378811|NCT03267576|615721232|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
170378812|NCT03267576|615721233|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
170378813|NCT01369069|615721234|FG000|Overall Study|Lost to Follow-up|8|||
170378814|NCT01369069|615721235|FG001|Overall Study|Lost to Follow-up|9|||
170378815|NCT01369069|615721234|FG000|Overall Study|Withdrawal by Subject|9|||
170378816|NCT01369069|615721235|FG001|Overall Study|Withdrawal by Subject|7|||
170378817|NCT02573012|615721238|FG000|Overall Study|Adverse Event|5|||
170378818|NCT02573012|615721239|FG001|Overall Study|Adverse Event|5|||
170378819|NCT02573012|615721238|FG000|Overall Study|Lack of Efficacy|5|||
170378820|NCT02573012|615721239|FG001|Overall Study|Lack of Efficacy|4|||
170378821|NCT02573012|615721238|FG000|Overall Study|Non-compliance|1|||
170378822|NCT02573012|615721239|FG001|Overall Study|Non-compliance|2|||
170378823|NCT02573012|615721238|FG000|Overall Study|Withdrawal by Subject|2|||
170378824|NCT02573012|615721239|FG001|Overall Study|Withdrawal by Subject|2|||
170378825|NCT02573012|615721238|FG000|Overall Study|Study Ended per Protocol|1|||
170378826|NCT02573012|615721239|FG001|Overall Study|Study Ended per Protocol|0|||
170378827|NCT02573012|615721238|FG000|Overall Study|Physician Decision|1|||
170378828|NCT02573012|615721239|FG001|Overall Study|Physician Decision|2|||
170378829|NCT00882362|615721240|FG000|Overall Study|Adverse Event|13|||
170378830|NCT00882362|615721241|FG001|Overall Study|Adverse Event|10|||
170378831|NCT00882362|615721240|FG000|Overall Study|Withdrawal by Subject|13|||
170378832|NCT00882362|615721241|FG001|Overall Study|Withdrawal by Subject|10|||
170378833|NCT00882362|615721240|FG000|Overall Study|Lack of Efficacy|3|||
170378834|NCT00882362|615721241|FG001|Overall Study|Lack of Efficacy|0|||
170378835|NCT00882362|615721240|FG000|Overall Study|Protocol Violation|7|||
170378836|NCT00882362|615721241|FG001|Overall Study|Protocol Violation|2|||
170378837|NCT00882362|615721240|FG000|Overall Study|Pregnancy|1|||
170378838|NCT00882362|615721241|FG001|Overall Study|Pregnancy|0|||
170378839|NCT00882362|615721240|FG000|Overall Study|Physician Decision|5|||
170378840|NCT00882362|615721241|FG001|Overall Study|Physician Decision|1|||
170378841|NCT00882362|615721240|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
170378842|NCT00882362|615721241|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
170378843|NCT00882362|615721240|FG000|Overall Study|change of residence or other commitments|5|||
170378844|NCT00882362|615721241|FG001|Overall Study|change of residence or other commitments|0|||
170378845|NCT01268514|615721242|FG000|Overall Study|Adverse Event|20|||
170378846|NCT01268514|615721242|FG000|Overall Study|Death|8|||
170378847|NCT01268514|615721242|FG000|Overall Study|Lost to Follow-up|5|||
170378848|NCT01268514|615721242|FG000|Overall Study|Withdrawal by Subject|3|||
170378849|NCT01268514|615721242|FG000|Overall Study|Withdrawal by Surgeon|5|||
170378850|NCT03231228|615721243|FG000|Overall Study|Lost to Follow-up|2|||
170378851|NCT03231228|615721244|FG001|Overall Study|Lost to Follow-up|0|||
170378852|NCT03231228|615721243|FG000|Overall Study|Physician Decision|1|||
170378853|NCT03231228|615721244|FG001|Overall Study|Physician Decision|0|||
170378854|NCT02463331|615721248|FG000|Overall Study|Adverse Event|4|||
170378855|NCT02463331|615721249|FG001|Overall Study|Adverse Event|2|||
170378856|NCT02463331|615721248|FG000|Overall Study|Lost to Follow-up|1|||
170378857|NCT02463331|615721249|FG001|Overall Study|Lost to Follow-up|1|||
170378858|NCT02463331|615721248|FG000|Overall Study|Pregnancy|2|||
170378859|NCT02463331|615721249|FG001|Overall Study|Pregnancy|3|||
170378860|NCT02463331|615721248|FG000|Overall Study|Lack of Efficacy|6|||
170378861|NCT02463331|615721249|FG001|Overall Study|Lack of Efficacy|0|||
170378862|NCT02463331|615721248|FG000|Overall Study|Physician Decision|3|||
170378863|NCT02463331|615721249|FG001|Overall Study|Physician Decision|0|||
170378864|NCT02382276|615721250|FG000|Overall Study|Withdrawal by Subject|4|||
170378865|NCT02382276|615721251|FG001|Overall Study|Withdrawal by Subject|8|||
170378866|NCT02382276|615721252|FG002|Overall Study|Withdrawal by Subject|5|||
170378867|NCT02382276|615721250|FG000|Overall Study|Adverse Event|7|||
170378868|NCT02382276|615721251|FG001|Overall Study|Adverse Event|2|||
170378869|NCT02382276|615721252|FG002|Overall Study|Adverse Event|32|||
170378870|NCT02382276|615721250|FG000|Overall Study|Physician Decision|0|||
170378871|NCT02382276|615721251|FG001|Overall Study|Physician Decision|0|||
170378872|NCT02382276|615721252|FG002|Overall Study|Physician Decision|2|||
170378873|NCT01222416|615721253|FG000|Overall Study|ineligible;metastasis|3|||
170378874|NCT01222416|615721254|FG001|Overall Study|ineligible;metastasis|0|||
170378875|NCT01222416|615721253|FG000|Overall Study|Adverse Event|4|||
170378876|NCT01222416|615721254|FG001|Overall Study|Adverse Event|0|||
170378877|NCT01222416|615721253|FG000|Overall Study|Withdrawal by Subject|5|||
170378878|NCT01222416|615721254|FG001|Overall Study|Withdrawal by Subject|0|||
170378879|NCT01222416|615721253|FG000|Overall Study|scheduling|6|||
170378880|NCT01222416|615721254|FG001|Overall Study|scheduling|0|||
170378881|NCT01222416|615721253|FG000|Overall Study|missed view/scan|1|||
170378882|NCT01222416|615721254|FG001|Overall Study|missed view/scan|0|||
170378883|NCT01222416|615721253|FG000|Overall Study|Death|1|||
170378884|NCT01222416|615721254|FG001|Overall Study|Death|0|||
170378885|NCT00281528|615721255|FG000|Overall Study|Progressive Disease|28|||
170378886|NCT00281528|615721256|FG001|Overall Study|Progressive Disease|18|||
170378887|NCT00281528|615721257|FG002|Overall Study|Progressive Disease|27|||
170378888|NCT00281528|615721255|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
170378889|NCT00281528|615721256|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
170378890|NCT00281528|615721257|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
170378891|NCT00281528|615721255|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
170378892|NCT00281528|615721256|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
170378893|NCT00281528|615721257|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
170378894|NCT00281528|615721255|FG000|Overall Study|Physician Decision|11|||
170378895|NCT00281528|615721256|FG001|Overall Study|Physician Decision|4|||
170378896|NCT00281528|615721257|FG002|Overall Study|Physician Decision|5|||
170378897|NCT00281528|615721255|FG000|Overall Study|Protocol Violation|1|||
170378898|NCT00281528|615721256|FG001|Overall Study|Protocol Violation|0|||
170378899|NCT00281528|615721257|FG002|Overall Study|Protocol Violation|1|||
170378900|NCT00281528|615721255|FG000|Overall Study|Withdrawal by Subject|5|||
170378901|NCT00281528|615721256|FG001|Overall Study|Withdrawal by Subject|5|||
170378902|NCT00281528|615721257|FG002|Overall Study|Withdrawal by Subject|7|||
170378903|NCT00281528|615721255|FG000|Overall Study|Other|6|||
170378904|NCT00281528|615721256|FG001|Overall Study|Other|3|||
170378905|NCT00281528|615721257|FG002|Overall Study|Other|5|||
170378906|NCT02709889|615721269|FG000|Overall Study|Withdrawal by Subject|11|||
170378907|NCT02709889|615721270|FG001|Overall Study|Withdrawal by Subject|10|||
170378908|NCT02709889|615721271|FG002|Overall Study|Withdrawal by Subject|2|||
170378909|NCT02709889|615721272|FG003|Overall Study|Withdrawal by Subject|12|||
170378910|NCT02709889|615721269|FG000|Overall Study|Death|25|||
170378911|NCT02709889|615721270|FG001|Overall Study|Death|38|||
170378912|NCT02709889|615721271|FG002|Overall Study|Death|4|||
170378913|NCT02709889|615721272|FG003|Overall Study|Death|44|||
170378914|NCT02709889|615721269|FG000|Overall Study|Physician Decision|1|||
170378915|NCT02709889|615721270|FG001|Overall Study|Physician Decision|2|||
170378916|NCT02709889|615721271|FG002|Overall Study|Physician Decision|3|||
170378917|NCT02709889|615721272|FG003|Overall Study|Physician Decision|5|||
170378918|NCT02709889|615721269|FG000|Overall Study|Lost to Follow-up|2|||
170378919|NCT02709889|615721270|FG001|Overall Study|Lost to Follow-up|0|||
170378920|NCT02709889|615721271|FG002|Overall Study|Lost to Follow-up|0|||
170378921|NCT02709889|615721272|FG003|Overall Study|Lost to Follow-up|4|||
170378922|NCT02709889|615721269|FG000|Overall Study|Study Terminated by Sponsor|4|||
170378923|NCT02709889|615721270|FG001|Overall Study|Study Terminated by Sponsor|6|||
170378924|NCT02709889|615721271|FG002|Overall Study|Study Terminated by Sponsor|2|||
170378925|NCT02709889|615721272|FG003|Overall Study|Study Terminated by Sponsor|17|||
170378926|NCT02709889|615721269|FG000|Overall Study|Other, Not Specified|0|||
170378927|NCT02709889|615721270|FG001|Overall Study|Other, Not Specified|1|||
170378928|NCT02709889|615721271|FG002|Overall Study|Other, Not Specified|1|||
170378929|NCT02709889|615721272|FG003|Overall Study|Other, Not Specified|6|||
170378930|NCT03452397|615721277|FG000|Overall Study|Adverse Event|1|||
170378931|NCT03452397|615721278|FG001|Overall Study|Adverse Event|0|||
170378932|NCT03452397|615721279|FG002|Overall Study|Adverse Event|0|||
170378933|NCT03452397|615721280|FG003|Overall Study|Adverse Event|0|||
170378934|NCT03452397|615721277|FG000|Overall Study|Administrative reason|0|||
170378935|NCT03452397|615721278|FG001|Overall Study|Administrative reason|0|||
170378936|NCT03452397|615721279|FG002|Overall Study|Administrative reason|1|||
170378937|NCT03452397|615721280|FG003|Overall Study|Administrative reason|1|||
170378938|NCT03452397|615721277|FG000|Overall Study|Withdrawal by Subject|0|||
170378939|NCT03452397|615721278|FG001|Overall Study|Withdrawal by Subject|0|||
170378940|NCT03452397|615721279|FG002|Overall Study|Withdrawal by Subject|1|||
170378941|NCT03452397|615721280|FG003|Overall Study|Withdrawal by Subject|0|||
170378942|NCT00125268|615721281|FG000|Overall Study|Withdrawal by Subject|1|||
170378943|NCT00125268|615721282|FG001|Overall Study|Withdrawal by Subject|1|||
170378944|NCT03258762|615721283|FG000|Overall Study|Lost to Follow-up|0|||
170378945|NCT03258762|615721284|FG001|Overall Study|Lost to Follow-up|1|||
170378946|NCT04191096|615721297|FG000|Overall Study|Death|102|||
170378947|NCT04191096|615721298|FG001|Overall Study|Death|89|||
170378948|NCT04191096|615721297|FG000|Overall Study|Lost to Follow-up|1|||
170378949|NCT04191096|615721298|FG001|Overall Study|Lost to Follow-up|1|||
170378950|NCT04191096|615721297|FG000|Overall Study|Withdrawal by Subject|5|||
170378951|NCT04191096|615721298|FG001|Overall Study|Withdrawal by Subject|5|||
170378952|NCT04191096|615721297|FG000|Overall Study|Participants Ongoing|518|||
170378953|NCT04191096|615721298|FG001|Overall Study|Participants Ongoing|530|||
170378954|NCT00027027|615723459|FG000|Overall Study|Adverse Event|0|||
170378955|NCT00027027|615723460|FG001|Overall Study|Adverse Event|0|||
170378956|NCT00027027|615723461|FG002|Overall Study|Adverse Event|1|||
170378957|NCT00027027|615723462|FG003|Overall Study|Adverse Event|0|||
170378958|NCT00027027|615723463|FG004|Overall Study|Adverse Event|1|||
170378959|NCT00027027|615723459|FG000|Overall Study|Admitted for Signs of PD|0|||
170378960|NCT00027027|615723460|FG001|Overall Study|Admitted for Signs of PD|0|||
170378961|NCT00027027|615723461|FG002|Overall Study|Admitted for Signs of PD|0|||
170378962|NCT00027027|615723462|FG003|Overall Study|Admitted for Signs of PD|0|||
170378963|NCT00027027|615723463|FG004|Overall Study|Admitted for Signs of PD|1|||
170378964|NCT00027027|615723459|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
170378965|NCT00027027|615723460|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
170378966|NCT00027027|615723461|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
170378967|NCT00027027|615723462|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
170378968|NCT00027027|615723463|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
170378969|NCT00027027|615723459|FG000|Overall Study|PD Requiring Surgery|0|||
170378970|NCT00027027|615723460|FG001|Overall Study|PD Requiring Surgery|0|||
170378971|NCT00027027|615723461|FG002|Overall Study|PD Requiring Surgery|1|||
170378972|NCT00027027|615723462|FG003|Overall Study|PD Requiring Surgery|0|||
170378973|NCT00027027|615723463|FG004|Overall Study|PD Requiring Surgery|0|||
170378974|NCT00027027|615723459|FG000|Overall Study|Physician Decision Due To PD|2|||
170378975|NCT00027027|615723460|FG001|Overall Study|Physician Decision Due To PD|3|||
170378976|NCT00027027|615723461|FG002|Overall Study|Physician Decision Due To PD|2|||
170378977|NCT00027027|615723462|FG003|Overall Study|Physician Decision Due To PD|3|||
170378978|NCT00027027|615723463|FG004|Overall Study|Physician Decision Due To PD|5|||
170378979|NCT00027027|615723459|FG000|Overall Study|Withdrawal by Subject|0|||
170378980|NCT00027027|615723460|FG001|Overall Study|Withdrawal by Subject|0|||
170378981|NCT00027027|615723461|FG002|Overall Study|Withdrawal by Subject|0|||
170378982|NCT00027027|615723462|FG003|Overall Study|Withdrawal by Subject|0|||
170378983|NCT00027027|615723463|FG004|Overall Study|Withdrawal by Subject|1|||
170378984|NCT02442765|615723467|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
170378985|NCT02442765|615723468|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
170378986|NCT02442765|615723469|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
170378987|NCT02442765|615723470|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
170378988|NCT02442765|615723471|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
170378989|NCT02442765|615723472|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
170378990|NCT02442765|615723473|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
170378991|NCT02442765|615723474|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
170378992|NCT02442765|615723467|FG000|Stage 2- (Days 43 to 85)|Death|0|||
170378993|NCT02442765|615723468|FG001|Stage 2- (Days 43 to 85)|Death|0|||
170378994|NCT02442765|615723469|FG002|Stage 2- (Days 43 to 85)|Death|0|||
170378995|NCT02442765|615723470|FG003|Stage 2- (Days 43 to 85)|Death|1|||
170378996|NCT02442765|615723471|FG004|Stage 2- (Days 43 to 85)|Death|1|||
170378997|NCT02442765|615723472|FG005|Stage 2- (Days 43 to 85)|Death|0|||
170378998|NCT02442765|615723473|FG006|Stage 2- (Days 43 to 85)|Death|2|||
170378999|NCT02442765|615723474|FG007|Stage 2- (Days 43 to 85)|Death|0|||
170379000|NCT02442765|615723467|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
170379001|NCT02442765|615723468|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
170379002|NCT02442765|615723469|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
170379003|NCT02442765|615723470|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
170379004|NCT02442765|615723471|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
170379005|NCT02442765|615723472|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
170379006|NCT02442765|615723473|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
170379007|NCT02442765|615723474|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
170379008|NCT02442765|615723467|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
170379009|NCT02442765|615723468|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
170379010|NCT02442765|615723469|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
170379011|NCT02442765|615723470|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
170379012|NCT02442765|615723471|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
170379013|NCT02442765|615723472|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
170379014|NCT02442765|615723473|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
170379015|NCT02442765|615723474|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
170379016|NCT02442765|615723467|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
170398855|NCT05004181|615798319|FG007|Overall Study|Lost to Follow-up|12|||
170379017|NCT02442765|615723468|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
170379018|NCT02442765|615723469|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
170379019|NCT02442765|615723470|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
170379020|NCT02442765|615723471|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
170379021|NCT02442765|615723472|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
170379022|NCT02442765|615723473|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
170379023|NCT02442765|615723474|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
170379024|NCT02442765|615723467|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
170379025|NCT02442765|615723468|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
170379026|NCT02442765|615723469|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
170379027|NCT02442765|615723470|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
170379028|NCT02442765|615723471|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
170379029|NCT02442765|615723472|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
170379030|NCT02442765|615723473|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
170379031|NCT02442765|615723474|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
170379032|NCT02442765|615723467|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
170379033|NCT02442765|615723468|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
170379034|NCT02442765|615723469|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
170379035|NCT02442765|615723470|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
170379036|NCT02442765|615723471|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
170379037|NCT02442765|615723472|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
170379038|NCT02442765|615723473|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
170379039|NCT02442765|615723474|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
170379040|NCT02442765|615723467|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
170379041|NCT02442765|615723468|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
170379042|NCT02442765|615723469|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
170379043|NCT02442765|615723470|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
170379044|NCT02442765|615723471|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
170379045|NCT02442765|615723472|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
170379046|NCT02442765|615723473|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
170379047|NCT02442765|615723474|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
170379048|NCT00003389|615723475|FG000|Overall Study|Disease progression|6|||
170379049|NCT00003389|615723476|FG001|Overall Study|Disease progression|1|||
170379050|NCT00003389|615723475|FG000|Overall Study|Adverse Event|13|||
170379051|NCT00003389|615723476|FG001|Overall Study|Adverse Event|2|||
170379052|NCT00003389|615723475|FG000|Overall Study|Death|0|||
170379053|NCT00003389|615723476|FG001|Overall Study|Death|3|||
170379054|NCT00003389|615723475|FG000|Overall Study|Withdrawal by Subject|12|||
170379055|NCT00003389|615723476|FG001|Overall Study|Withdrawal by Subject|5|||
170379056|NCT00003389|615723475|FG000|Overall Study|Alternative therapy|2|||
170379057|NCT00003389|615723476|FG001|Overall Study|Alternative therapy|1|||
170379058|NCT00003389|615723475|FG000|Overall Study|Complicating disease|1|||
170379059|NCT00003389|615723476|FG001|Overall Study|Complicating disease|0|||
170379060|NCT00003389|615723475|FG000|Overall Study|Off-treatment reason missing|31|||
170379061|NCT00003389|615723476|FG001|Overall Study|Off-treatment reason missing|21|||
170379062|NCT00003389|615723475|FG000|Overall Study|Ineligible|33|||
170379063|NCT00003389|615723476|FG001|Overall Study|Ineligible|27|||
170379064|NCT01693562|615723477|FG000|Escalation Phase|Withdrawal by Subject|0|||
170379065|NCT01693562|615723478|FG001|Escalation Phase|Withdrawal by Subject|1|||
170379066|NCT01693562|615723479|FG002|Escalation Phase|Withdrawal by Subject|0|||
170379067|NCT01693562|615723480|FG003|Escalation Phase|Withdrawal by Subject|0|||
170379068|NCT01693562|615723481|FG004|Escalation Phase|Withdrawal by Subject|0|||
170379069|NCT01693562|615723482|FG005|Escalation Phase|Withdrawal by Subject|2|||
170379070|NCT01693562|615723483|FG006|Escalation Phase|Withdrawal by Subject|0|||
170379071|NCT01693562|615723484|FG007|Escalation Phase|Withdrawal by Subject|0|||
170379072|NCT01693562|615723485|FG008|Escalation Phase|Withdrawal by Subject|0|||
170379073|NCT01693562|615723486|FG009|Escalation Phase|Withdrawal by Subject|0|||
170379074|NCT01693562|615723487|FG010|Escalation Phase|Withdrawal by Subject|0|||
170379075|NCT01693562|615723488|FG011|Escalation Phase|Withdrawal by Subject|0|||
170379076|NCT01693562|615723489|FG012|Escalation Phase|Withdrawal by Subject|0|||
170379077|NCT01693562|615723490|FG013|Escalation Phase|Withdrawal by Subject|0|||
170379078|NCT01693562|615723491|FG014|Escalation Phase|Withdrawal by Subject|0|||
170379079|NCT01693562|615723492|FG015|Escalation Phase|Withdrawal by Subject|0|||
170379080|NCT01693562|615723493|FG016|Escalation Phase|Withdrawal by Subject|0|||
170379081|NCT01693562|615723494|FG017|Escalation Phase|Withdrawal by Subject|0|||
170379082|NCT01693562|615723495|FG018|Escalation Phase|Withdrawal by Subject|0|||
170379083|NCT01693562|615723496|FG019|Escalation Phase|Withdrawal by Subject|0|||
170379084|NCT01693562|615723497|FG020|Escalation Phase|Withdrawal by Subject|0|||
170379085|NCT01693562|615723498|FG021|Escalation Phase|Withdrawal by Subject|0|||
170379086|NCT01693562|615723499|FG022|Escalation Phase|Withdrawal by Subject|0|||
170379087|NCT01693562|615723477|FG000|Escalation Phase|Death|4|||
170379088|NCT01693562|615723478|FG001|Escalation Phase|Death|2|||
170379089|NCT01693562|615723479|FG002|Escalation Phase|Death|0|||
170379090|NCT01693562|615723480|FG003|Escalation Phase|Death|3|||
170379091|NCT01693562|615723481|FG004|Escalation Phase|Death|6|||
170379092|NCT01693562|615723482|FG005|Escalation Phase|Death|4|||
170379093|NCT01693562|615723483|FG006|Escalation Phase|Death|0|||
170379094|NCT01693562|615723484|FG007|Escalation Phase|Death|0|||
170379095|NCT01693562|615723485|FG008|Escalation Phase|Death|0|||
170379096|NCT01693562|615723486|FG009|Escalation Phase|Death|0|||
170379097|NCT01693562|615723487|FG010|Escalation Phase|Death|0|||
170379098|NCT01693562|615723488|FG011|Escalation Phase|Death|0|||
170379099|NCT01693562|615723489|FG012|Escalation Phase|Death|0|||
170379100|NCT01693562|615723490|FG013|Escalation Phase|Death|0|||
170379101|NCT01693562|615723491|FG014|Escalation Phase|Death|0|||
170379102|NCT01693562|615723492|FG015|Escalation Phase|Death|0|||
170379103|NCT01693562|615723493|FG016|Escalation Phase|Death|0|||
170379104|NCT01693562|615723494|FG017|Escalation Phase|Death|0|||
170379105|NCT01693562|615723495|FG018|Escalation Phase|Death|0|||
170379106|NCT01693562|615723496|FG019|Escalation Phase|Death|0|||
170379107|NCT01693562|615723497|FG020|Escalation Phase|Death|0|||
170379108|NCT01693562|615723498|FG021|Escalation Phase|Death|0|||
170379109|NCT01693562|615723499|FG022|Escalation Phase|Death|0|||
170379110|NCT01693562|615723477|FG000|Escalation Phase|Lost to Follow-up|0|||
170379111|NCT01693562|615723478|FG001|Escalation Phase|Lost to Follow-up|1|||
170379112|NCT01693562|615723479|FG002|Escalation Phase|Lost to Follow-up|1|||
170379113|NCT01693562|615723480|FG003|Escalation Phase|Lost to Follow-up|0|||
170379114|NCT01693562|615723481|FG004|Escalation Phase|Lost to Follow-up|0|||
170379115|NCT01693562|615723482|FG005|Escalation Phase|Lost to Follow-up|0|||
170379116|NCT01693562|615723483|FG006|Escalation Phase|Lost to Follow-up|0|||
170379117|NCT01693562|615723484|FG007|Escalation Phase|Lost to Follow-up|0|||
170379118|NCT01693562|615723485|FG008|Escalation Phase|Lost to Follow-up|0|||
170379119|NCT01693562|615723486|FG009|Escalation Phase|Lost to Follow-up|0|||
170379120|NCT01693562|615723487|FG010|Escalation Phase|Lost to Follow-up|0|||
170379121|NCT01693562|615723488|FG011|Escalation Phase|Lost to Follow-up|0|||
170379122|NCT01693562|615723489|FG012|Escalation Phase|Lost to Follow-up|0|||
170379123|NCT01693562|615723490|FG013|Escalation Phase|Lost to Follow-up|0|||
170379124|NCT01693562|615723491|FG014|Escalation Phase|Lost to Follow-up|0|||
170379125|NCT01693562|615723492|FG015|Escalation Phase|Lost to Follow-up|0|||
170379126|NCT01693562|615723493|FG016|Escalation Phase|Lost to Follow-up|0|||
170379127|NCT01693562|615723494|FG017|Escalation Phase|Lost to Follow-up|0|||
170379128|NCT01693562|615723495|FG018|Escalation Phase|Lost to Follow-up|0|||
170379129|NCT01693562|615723496|FG019|Escalation Phase|Lost to Follow-up|0|||
170379130|NCT01693562|615723497|FG020|Escalation Phase|Lost to Follow-up|0|||
170379131|NCT01693562|615723498|FG021|Escalation Phase|Lost to Follow-up|0|||
170379132|NCT01693562|615723499|FG022|Escalation Phase|Lost to Follow-up|0|||
170379133|NCT01693562|615723477|FG000|Escalation Phase|Other|0|||
170379134|NCT01693562|615723478|FG001|Escalation Phase|Other|0|||
170379135|NCT01693562|615723479|FG002|Escalation Phase|Other|2|||
170379136|NCT01693562|615723480|FG003|Escalation Phase|Other|0|||
170379137|NCT01693562|615723481|FG004|Escalation Phase|Other|0|||
170379138|NCT01693562|615723482|FG005|Escalation Phase|Other|1|||
170379139|NCT01693562|615723483|FG006|Escalation Phase|Other|0|||
170379140|NCT01693562|615723484|FG007|Escalation Phase|Other|0|||
170379141|NCT01693562|615723485|FG008|Escalation Phase|Other|0|||
170379142|NCT01693562|615723486|FG009|Escalation Phase|Other|0|||
170379143|NCT01693562|615723487|FG010|Escalation Phase|Other|0|||
170379144|NCT01693562|615723488|FG011|Escalation Phase|Other|0|||
170379145|NCT01693562|615723489|FG012|Escalation Phase|Other|0|||
170379146|NCT01693562|615723490|FG013|Escalation Phase|Other|0|||
170379147|NCT01693562|615723491|FG014|Escalation Phase|Other|0|||
170379148|NCT01693562|615723492|FG015|Escalation Phase|Other|0|||
170379149|NCT01693562|615723493|FG016|Escalation Phase|Other|0|||
170379150|NCT01693562|615723494|FG017|Escalation Phase|Other|0|||
170379151|NCT01693562|615723495|FG018|Escalation Phase|Other|0|||
170379152|NCT01693562|615723496|FG019|Escalation Phase|Other|0|||
170379153|NCT01693562|615723497|FG020|Escalation Phase|Other|0|||
170379154|NCT01693562|615723498|FG021|Escalation Phase|Other|0|||
170379155|NCT01693562|615723499|FG022|Escalation Phase|Other|0|||
170379156|NCT01693562|615723477|FG000|Exploration Phase|Withdrawal by Subject|0|||
170379157|NCT01693562|615723478|FG001|Exploration Phase|Withdrawal by Subject|0|||
170379158|NCT01693562|615723479|FG002|Exploration Phase|Withdrawal by Subject|0|||
170379159|NCT01693562|615723480|FG003|Exploration Phase|Withdrawal by Subject|0|||
170379160|NCT01693562|615723481|FG004|Exploration Phase|Withdrawal by Subject|0|||
170379161|NCT01693562|615723482|FG005|Exploration Phase|Withdrawal by Subject|0|||
170379162|NCT01693562|615723483|FG006|Exploration Phase|Withdrawal by Subject|2|||
170379163|NCT01693562|615723484|FG007|Exploration Phase|Withdrawal by Subject|0|||
170379164|NCT01693562|615723485|FG008|Exploration Phase|Withdrawal by Subject|0|||
170379165|NCT01693562|615723486|FG009|Exploration Phase|Withdrawal by Subject|0|||
170379166|NCT01693562|615723487|FG010|Exploration Phase|Withdrawal by Subject|0|||
170379167|NCT01693562|615723488|FG011|Exploration Phase|Withdrawal by Subject|0|||
170379168|NCT01693562|615723489|FG012|Exploration Phase|Withdrawal by Subject|0|||
170379169|NCT01693562|615723490|FG013|Exploration Phase|Withdrawal by Subject|0|||
170379170|NCT01693562|615723491|FG014|Exploration Phase|Withdrawal by Subject|0|||
170379171|NCT01693562|615723492|FG015|Exploration Phase|Withdrawal by Subject|0|||
170379172|NCT01693562|615723493|FG016|Exploration Phase|Withdrawal by Subject|0|||
170379173|NCT01693562|615723494|FG017|Exploration Phase|Withdrawal by Subject|0|||
170379174|NCT01693562|615723495|FG018|Exploration Phase|Withdrawal by Subject|0|||
170379175|NCT01693562|615723496|FG019|Exploration Phase|Withdrawal by Subject|0|||
170379176|NCT01693562|615723497|FG020|Exploration Phase|Withdrawal by Subject|0|||
170379177|NCT01693562|615723498|FG021|Exploration Phase|Withdrawal by Subject|0|||
170379178|NCT01693562|615723499|FG022|Exploration Phase|Withdrawal by Subject|0|||
170379179|NCT01693562|615723477|FG000|Exploration Phase|Death|0|||
170379180|NCT01693562|615723478|FG001|Exploration Phase|Death|0|||
170379181|NCT01693562|615723479|FG002|Exploration Phase|Death|0|||
170379182|NCT01693562|615723480|FG003|Exploration Phase|Death|0|||
170379183|NCT01693562|615723481|FG004|Exploration Phase|Death|0|||
170379184|NCT01693562|615723482|FG005|Exploration Phase|Death|0|||
170379185|NCT01693562|615723483|FG006|Exploration Phase|Death|17|||
170379186|NCT01693562|615723484|FG007|Exploration Phase|Death|0|||
170379187|NCT01693562|615723485|FG008|Exploration Phase|Death|0|||
170379188|NCT01693562|615723486|FG009|Exploration Phase|Death|0|||
170379189|NCT01693562|615723487|FG010|Exploration Phase|Death|0|||
170379190|NCT01693562|615723488|FG011|Exploration Phase|Death|0|||
170379191|NCT01693562|615723489|FG012|Exploration Phase|Death|0|||
170379192|NCT01693562|615723490|FG013|Exploration Phase|Death|0|||
170379193|NCT01693562|615723491|FG014|Exploration Phase|Death|0|||
170379194|NCT01693562|615723492|FG015|Exploration Phase|Death|0|||
170379195|NCT01693562|615723493|FG016|Exploration Phase|Death|0|||
170379196|NCT01693562|615723494|FG017|Exploration Phase|Death|0|||
170379197|NCT01693562|615723495|FG018|Exploration Phase|Death|0|||
170379198|NCT01693562|615723496|FG019|Exploration Phase|Death|0|||
170379199|NCT01693562|615723497|FG020|Exploration Phase|Death|0|||
170379200|NCT01693562|615723498|FG021|Exploration Phase|Death|0|||
170379201|NCT01693562|615723499|FG022|Exploration Phase|Death|0|||
170379202|NCT01693562|615723477|FG000|Exploration Phase|Other|0|||
170379203|NCT01693562|615723478|FG001|Exploration Phase|Other|0|||
170379204|NCT01693562|615723479|FG002|Exploration Phase|Other|0|||
170379205|NCT01693562|615723480|FG003|Exploration Phase|Other|0|||
170379206|NCT01693562|615723481|FG004|Exploration Phase|Other|0|||
170379207|NCT01693562|615723482|FG005|Exploration Phase|Other|0|||
170379208|NCT01693562|615723483|FG006|Exploration Phase|Other|2|||
170379209|NCT01693562|615723484|FG007|Exploration Phase|Other|0|||
170379210|NCT01693562|615723485|FG008|Exploration Phase|Other|0|||
170379211|NCT01693562|615723486|FG009|Exploration Phase|Other|0|||
170379212|NCT01693562|615723487|FG010|Exploration Phase|Other|0|||
170379213|NCT01693562|615723488|FG011|Exploration Phase|Other|0|||
170379214|NCT01693562|615723489|FG012|Exploration Phase|Other|0|||
170379215|NCT01693562|615723490|FG013|Exploration Phase|Other|0|||
170379216|NCT01693562|615723491|FG014|Exploration Phase|Other|0|||
170379217|NCT01693562|615723492|FG015|Exploration Phase|Other|0|||
170379218|NCT01693562|615723493|FG016|Exploration Phase|Other|0|||
170379219|NCT01693562|615723494|FG017|Exploration Phase|Other|0|||
170379220|NCT01693562|615723495|FG018|Exploration Phase|Other|0|||
170379221|NCT01693562|615723496|FG019|Exploration Phase|Other|0|||
170379222|NCT01693562|615723497|FG020|Exploration Phase|Other|0|||
170379223|NCT01693562|615723498|FG021|Exploration Phase|Other|0|||
170379224|NCT01693562|615723499|FG022|Exploration Phase|Other|0|||
170379225|NCT01693562|615723477|FG000|Expansion Phase|Withdrawal by Subject|0|||
170379226|NCT01693562|615723478|FG001|Expansion Phase|Withdrawal by Subject|0|||
170379227|NCT01693562|615723479|FG002|Expansion Phase|Withdrawal by Subject|0|||
170379228|NCT01693562|615723480|FG003|Expansion Phase|Withdrawal by Subject|0|||
170379229|NCT01693562|615723481|FG004|Expansion Phase|Withdrawal by Subject|0|||
170379230|NCT01693562|615723482|FG005|Expansion Phase|Withdrawal by Subject|0|||
170379231|NCT01693562|615723483|FG006|Expansion Phase|Withdrawal by Subject|0|||
170379232|NCT01693562|615723484|FG007|Expansion Phase|Withdrawal by Subject|16|||
170379233|NCT01693562|615723485|FG008|Expansion Phase|Withdrawal by Subject|2|||
170379234|NCT01693562|615723486|FG009|Expansion Phase|Withdrawal by Subject|54|||
170379235|NCT01693562|615723487|FG010|Expansion Phase|Withdrawal by Subject|2|||
170379236|NCT01693562|615723488|FG011|Expansion Phase|Withdrawal by Subject|2|||
170379237|NCT01693562|615723489|FG012|Expansion Phase|Withdrawal by Subject|3|||
170379238|NCT01693562|615723490|FG013|Expansion Phase|Withdrawal by Subject|5|||
170379239|NCT01693562|615723491|FG014|Expansion Phase|Withdrawal by Subject|16|||
170379240|NCT01693562|615723492|FG015|Expansion Phase|Withdrawal by Subject|7|||
170379241|NCT01693562|615723493|FG016|Expansion Phase|Withdrawal by Subject|40|||
170379242|NCT01693562|615723494|FG017|Expansion Phase|Withdrawal by Subject|4|||
170379243|NCT01693562|615723495|FG018|Expansion Phase|Withdrawal by Subject|8|||
170379244|NCT01693562|615723496|FG019|Expansion Phase|Withdrawal by Subject|3|||
170379245|NCT01693562|615723497|FG020|Expansion Phase|Withdrawal by Subject|1|||
170379246|NCT01693562|615723498|FG021|Expansion Phase|Withdrawal by Subject|8|||
170379247|NCT01693562|615723499|FG022|Expansion Phase|Withdrawal by Subject|1|||
170379248|NCT01693562|615723477|FG000|Expansion Phase|Death|0|||
170379249|NCT01693562|615723478|FG001|Expansion Phase|Death|0|||
170379250|NCT01693562|615723479|FG002|Expansion Phase|Death|0|||
170379251|NCT01693562|615723480|FG003|Expansion Phase|Death|0|||
170379252|NCT01693562|615723481|FG004|Expansion Phase|Death|0|||
170379253|NCT01693562|615723482|FG005|Expansion Phase|Death|0|||
170379254|NCT01693562|615723483|FG006|Expansion Phase|Death|0|||
170379255|NCT01693562|615723484|FG007|Expansion Phase|Death|42|||
170379256|NCT01693562|615723485|FG008|Expansion Phase|Death|17|||
170379257|NCT01693562|615723486|FG009|Expansion Phase|Death|208|||
170379258|NCT01693562|615723487|FG010|Expansion Phase|Death|30|||
170379259|NCT01693562|615723488|FG011|Expansion Phase|Death|8|||
170379260|NCT01693562|615723489|FG012|Expansion Phase|Death|19|||
170379261|NCT01693562|615723490|FG013|Expansion Phase|Death|42|||
170379262|NCT01693562|615723491|FG014|Expansion Phase|Death|23|||
170379263|NCT01693562|615723492|FG015|Expansion Phase|Death|23|||
170379264|NCT01693562|615723493|FG016|Expansion Phase|Death|128|||
170379265|NCT01693562|615723494|FG017|Expansion Phase|Death|16|||
170379266|NCT01693562|615723495|FG018|Expansion Phase|Death|36|||
170379267|NCT01693562|615723496|FG019|Expansion Phase|Death|16|||
170379268|NCT01693562|615723497|FG020|Expansion Phase|Death|17|||
170379269|NCT01693562|615723498|FG021|Expansion Phase|Death|35|||
170379270|NCT01693562|615723499|FG022|Expansion Phase|Death|7|||
170379271|NCT01693562|615723477|FG000|Expansion Phase|Lost to Follow-up|0|||
170379272|NCT01693562|615723478|FG001|Expansion Phase|Lost to Follow-up|0|||
170379273|NCT01693562|615723479|FG002|Expansion Phase|Lost to Follow-up|0|||
170379274|NCT01693562|615723480|FG003|Expansion Phase|Lost to Follow-up|0|||
170379275|NCT01693562|615723481|FG004|Expansion Phase|Lost to Follow-up|0|||
170379276|NCT01693562|615723482|FG005|Expansion Phase|Lost to Follow-up|0|||
170379277|NCT01693562|615723483|FG006|Expansion Phase|Lost to Follow-up|0|||
170379278|NCT01693562|615723484|FG007|Expansion Phase|Lost to Follow-up|1|||
170379279|NCT01693562|615723485|FG008|Expansion Phase|Lost to Follow-up|2|||
170379280|NCT01693562|615723486|FG009|Expansion Phase|Lost to Follow-up|10|||
170379281|NCT01693562|615723487|FG010|Expansion Phase|Lost to Follow-up|4|||
170379282|NCT01693562|615723488|FG011|Expansion Phase|Lost to Follow-up|4|||
170379283|NCT01693562|615723489|FG012|Expansion Phase|Lost to Follow-up|1|||
170379284|NCT01693562|615723490|FG013|Expansion Phase|Lost to Follow-up|3|||
170379285|NCT01693562|615723491|FG014|Expansion Phase|Lost to Follow-up|0|||
170379286|NCT01693562|615723492|FG015|Expansion Phase|Lost to Follow-up|1|||
170379287|NCT01693562|615723493|FG016|Expansion Phase|Lost to Follow-up|1|||
170379288|NCT01693562|615723494|FG017|Expansion Phase|Lost to Follow-up|0|||
170379289|NCT01693562|615723495|FG018|Expansion Phase|Lost to Follow-up|2|||
170379290|NCT01693562|615723496|FG019|Expansion Phase|Lost to Follow-up|1|||
170379291|NCT01693562|615723497|FG020|Expansion Phase|Lost to Follow-up|2|||
170379292|NCT01693562|615723498|FG021|Expansion Phase|Lost to Follow-up|2|||
170379293|NCT01693562|615723499|FG022|Expansion Phase|Lost to Follow-up|1|||
170379294|NCT01693562|615723477|FG000|Expansion Phase|Other|0|||
170379295|NCT01693562|615723478|FG001|Expansion Phase|Other|0|||
170379296|NCT01693562|615723479|FG002|Expansion Phase|Other|0|||
170379297|NCT01693562|615723480|FG003|Expansion Phase|Other|0|||
170379298|NCT01693562|615723481|FG004|Expansion Phase|Other|0|||
170379299|NCT01693562|615723482|FG005|Expansion Phase|Other|0|||
170379300|NCT01693562|615723483|FG006|Expansion Phase|Other|0|||
170379301|NCT01693562|615723484|FG007|Expansion Phase|Other|3|||
170379302|NCT01693562|615723485|FG008|Expansion Phase|Other|1|||
170379303|NCT01693562|615723486|FG009|Expansion Phase|Other|28|||
170379304|NCT01693562|615723487|FG010|Expansion Phase|Other|4|||
170379305|NCT01693562|615723488|FG011|Expansion Phase|Other|7|||
170379306|NCT01693562|615723489|FG012|Expansion Phase|Other|0|||
170379307|NCT01693562|615723490|FG013|Expansion Phase|Other|1|||
170379308|NCT01693562|615723491|FG014|Expansion Phase|Other|1|||
170379309|NCT01693562|615723492|FG015|Expansion Phase|Other|0|||
170379310|NCT01693562|615723493|FG016|Expansion Phase|Other|28|||
170379311|NCT01693562|615723494|FG017|Expansion Phase|Other|0|||
170379312|NCT01693562|615723495|FG018|Expansion Phase|Other|1|||
170379313|NCT01693562|615723496|FG019|Expansion Phase|Other|0|||
170379314|NCT01693562|615723497|FG020|Expansion Phase|Other|1|||
170379315|NCT01693562|615723498|FG021|Expansion Phase|Other|17|||
170379316|NCT01693562|615723499|FG022|Expansion Phase|Other|1|||
170379317|NCT05466240|615723500|FG000|Overall Study|Adverse Event|1|||
170379318|NCT05466240|615723501|FG001|Overall Study|Adverse Event|0|||
170379319|NCT05466240|615723500|FG000|Overall Study|Withdrawal by Subject|1|||
170379320|NCT05466240|615723501|FG001|Overall Study|Withdrawal by Subject|0|||
170379321|NCT02759939|615723502|FG000|Overall Study|Missing data on first outcome assessed|11|||
170379322|NCT02759939|615723503|FG001|Overall Study|Missing data on first outcome assessed|2|||
170379323|NCT02759939|615723504|FG002|Overall Study|Missing data on first outcome assessed|5|||
170379324|NCT02759939|615723505|FG003|Overall Study|Missing data on first outcome assessed|2|||
170379325|NCT02759939|615723502|FG000|Overall Study|Ineligible for T2 and T3|310|||
170379326|NCT02759939|615723503|FG001|Overall Study|Ineligible for T2 and T3|179|||
170379327|NCT02759939|615723504|FG002|Overall Study|Ineligible for T2 and T3|366|||
170379328|NCT02759939|615723505|FG003|Overall Study|Ineligible for T2 and T3|391|||
170379329|NCT02759939|615723502|FG000|Overall Study|Lost to Follow-up|735|||
170379330|NCT02759939|615723503|FG001|Overall Study|Lost to Follow-up|791|||
170379331|NCT02759939|615723504|FG002|Overall Study|Lost to Follow-up|783|||
170379332|NCT02759939|615723505|FG003|Overall Study|Lost to Follow-up|650|||
170379333|NCT04735432|615723506|FG000|Overall Study|Other - due to personal reason|1|||
170379334|NCT04735432|615723507|FG001|Overall Study|Other - due to personal reason|0|||
170379335|NCT04735432|615723506|FG000|Overall Study|Adverse Event|2|||
170379336|NCT04735432|615723507|FG001|Overall Study|Adverse Event|0|||
170379337|NCT05158244|615723516|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
170379338|NCT05158244|615723517|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
170379339|NCT05158244|615723518|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
170379340|NCT05158244|615723519|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
170379341|NCT05158244|615723520|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
170379342|NCT05158244|615723516|FG000|Overall Study|Withdrawal by Subject|0|||
170379343|NCT05158244|615723517|FG001|Overall Study|Withdrawal by Subject|0|||
170379344|NCT05158244|615723518|FG002|Overall Study|Withdrawal by Subject|1|||
170379345|NCT05158244|615723519|FG003|Overall Study|Withdrawal by Subject|0|||
170379346|NCT05158244|615723520|FG004|Overall Study|Withdrawal by Subject|0|||
170379347|NCT00775138|615723521|FG000|Overall Study|Withdrawal by Subject|0|||
170379348|NCT00775138|615723522|FG001|Overall Study|Withdrawal by Subject|0|||
170379349|NCT00775138|615723523|FG002|Overall Study|Withdrawal by Subject|2|||
170379350|NCT00775138|615723524|FG003|Overall Study|Withdrawal by Subject|2|||
170379351|NCT00775138|615723521|FG000|Overall Study|Adverse Event|0|||
170379352|NCT00775138|615723522|FG001|Overall Study|Adverse Event|0|||
170379353|NCT00775138|615723523|FG002|Overall Study|Adverse Event|1|||
170379354|NCT00775138|615723524|FG003|Overall Study|Adverse Event|0|||
170379355|NCT04167514|615723525|FG000|Overall Study|Adverse event, not serious|0|||
170379356|NCT04167514|615723526|FG001|Overall Study|Adverse event, not serious|1|||
170379357|NCT04167514|615723525|FG000|Overall Study|Lost to Follow-up|1|||
170379358|NCT04167514|615723526|FG001|Overall Study|Lost to Follow-up|0|||
170379359|NCT04167514|615723525|FG000|Overall Study|Participant Decision|2|||
170379360|NCT04167514|615723526|FG001|Overall Study|Participant Decision|4|||
170379361|NCT04167514|615723525|FG000|Overall Study|Physician Decision|3|||
170379362|NCT04167514|615723526|FG001|Overall Study|Physician Decision|2|||
170379363|NCT04167514|615723525|FG000|Overall Study|Death|14|||
170379364|NCT04167514|615723526|FG001|Overall Study|Death|18|||
170379365|NCT04167514|615723525|FG000|Overall Study|Enrolled but treatment not administered|2|||
170379366|NCT04167514|615723526|FG001|Overall Study|Enrolled but treatment not administered|0|||
170379367|NCT04167514|615723525|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
170379368|NCT04167514|615723526|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
170379369|NCT04167514|615723525|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
170379370|NCT04167514|615723526|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
170379371|NCT04564027|615723527|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
170379372|NCT04564027|615723528|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
170379373|NCT04564027|615723529|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
170379374|NCT04564027|615723530|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
170379375|NCT05626751|615723531|FG000|Overall Study|Lost to Follow-up|1|||
170379376|NCT05626751|615723532|FG001|Overall Study|Lost to Follow-up|2|||
170379377|NCT05626751|615723533|FG002|Overall Study|Lost to Follow-up|1|||
170379378|NCT05626751|615723531|FG000|Overall Study|Trial Terminated by Sponsor|39|||
170379379|NCT05626751|615723532|FG001|Overall Study|Trial Terminated by Sponsor|30|||
170379380|NCT05626751|615723533|FG002|Overall Study|Trial Terminated by Sponsor|37|||
170379381|NCT05626751|615723531|FG000|Overall Study|Withdrawal by Subject|7|||
170379382|NCT05626751|615723532|FG001|Overall Study|Withdrawal by Subject|5|||
170379383|NCT05626751|615723533|FG002|Overall Study|Withdrawal by Subject|5|||
170379384|NCT06029127|615723534|FG000|Overall Study|Withdrawal by Subject|2|||
170379385|NCT06029127|615723535|FG001|Overall Study|Withdrawal by Subject|0|||
170379386|NCT06029127|615723534|FG000|Overall Study|Lost to Follow-up|1|||
170379387|NCT06029127|615723535|FG001|Overall Study|Lost to Follow-up|0|||
170379388|NCT06029127|615723534|FG000|Overall Study|Study Closed by Sponsor|6|||
170379389|NCT06029127|615723535|FG001|Overall Study|Study Closed by Sponsor|6|||
170379390|NCT06029127|615723534|FG000|Overall Study|Death|12|||
170379391|NCT06029127|615723535|FG001|Overall Study|Death|7|||
170379392|NCT06029127|615723534|FG000|Overall Study|Declined Follow-Up Contact|0|||
170379393|NCT06029127|615723535|FG001|Overall Study|Declined Follow-Up Contact|1|||
170379394|NCT01625000|615723536|FG000|Overall Study|Physician Decision|15|||
170379395|NCT01625000|615723537|FG001|Overall Study|Physician Decision|7|||
170379396|NCT01625000|615723538|FG002|Overall Study|Physician Decision|7|||
170379397|NCT01625000|615723539|FG003|Overall Study|Physician Decision|2|||
170379398|NCT01625000|615723540|FG004|Overall Study|Physician Decision|15|||
170379399|NCT01625000|615723536|FG000|Overall Study|Protocol Violation|3|||
170379400|NCT01625000|615723537|FG001|Overall Study|Protocol Violation|10|||
170379401|NCT01625000|615723538|FG002|Overall Study|Protocol Violation|4|||
170379402|NCT01625000|615723539|FG003|Overall Study|Protocol Violation|1|||
170379403|NCT01625000|615723540|FG004|Overall Study|Protocol Violation|2|||
170379404|NCT01625000|615723536|FG000|Overall Study|Withdrawal by Subject|19|||
170379405|NCT01625000|615723537|FG001|Overall Study|Withdrawal by Subject|16|||
170379406|NCT01625000|615723538|FG002|Overall Study|Withdrawal by Subject|11|||
170379407|NCT01625000|615723539|FG003|Overall Study|Withdrawal by Subject|9|||
170379408|NCT01625000|615723540|FG004|Overall Study|Withdrawal by Subject|17|||
170379409|NCT01625000|615723536|FG000|Overall Study|Adverse Event (including Death)|15|||
170379410|NCT01625000|615723537|FG001|Overall Study|Adverse Event (including Death)|19|||
170379411|NCT01625000|615723538|FG002|Overall Study|Adverse Event (including Death)|11|||
170379412|NCT01625000|615723539|FG003|Overall Study|Adverse Event (including Death)|7|||
170379413|NCT01625000|615723540|FG004|Overall Study|Adverse Event (including Death)|21|||
170379414|NCT05740566|615723543|FG000|Overall Study|Death|151|||
170379415|NCT05740566|615723544|FG001|Overall Study|Death|111|||
170379416|NCT05740566|615723543|FG000|Overall Study|Withdrawal by Subject|2|||
170379417|NCT05740566|615723544|FG001|Overall Study|Withdrawal by Subject|0|||
170379418|NCT05740566|615723543|FG000|Overall Study|Ongoing in study|102|||
170379419|NCT05740566|615723544|FG001|Overall Study|Ongoing in study|143|||
170379420|NCT00137267|615723545|FG000|Overall Study|Lost to Follow-up|15|||
170379421|NCT00137267|615723546|FG001|Overall Study|Lost to Follow-up|21|||
170379422|NCT00129376|615723550|FG000|Overall Study|Adverse Event|1|||
170379423|NCT00129376|615723550|FG000|Overall Study|Lack of Efficacy|1|||
170379424|NCT02561273|615723558|FG000|Overall Study|Protocol Violation|1|||
170379425|NCT02561273|615723559|FG001|Overall Study|Protocol Violation|0|||
170379426|NCT02723019|615723560|FG000|Overall Study|Death|17|||
170379427|NCT02723019|615723561|FG001|Overall Study|Death|13|||
170379428|NCT02723019|615723560|FG000|Overall Study|Withdrawal by Subject|11|||
170379429|NCT02723019|615723561|FG001|Overall Study|Withdrawal by Subject|7|||
170379430|NCT02723019|615723560|FG000|Overall Study|Lost to Follow-up|57|||
170379431|NCT02723019|615723561|FG001|Overall Study|Lost to Follow-up|70|||
170379432|NCT00611767|615723562|FG000|Overall Study|Withdrawal by Subject|4|||
170379433|NCT00611767|615723563|FG001|Overall Study|Withdrawal by Subject|1|||
170379434|NCT00611767|615723562|FG000|Overall Study|Thiopental not available|3|||
170379435|NCT00611767|615723563|FG001|Overall Study|Thiopental not available|0|||
170379436|NCT00611767|615723562|FG000|Overall Study|didn't like the medication|1|||
170379437|NCT00611767|615723563|FG001|Overall Study|didn't like the medication|1|||
170379438|NCT00611767|615723562|FG000|Overall Study|Physician Decision|1|||
170379439|NCT00611767|615723563|FG001|Overall Study|Physician Decision|0|||
170379440|NCT02718625|615723564|FG000|Overall Study|Adverse Event|0|||
170379441|NCT02718625|615723565|FG001|Overall Study|Adverse Event|1|||
170379442|NCT02718625|615723564|FG000|Overall Study|Termination of Study by Sponsor|0|||
170379443|NCT02718625|615723565|FG001|Overall Study|Termination of Study by Sponsor|1|||
170379444|NCT01818765|615723566|FG000|Overall Study|Death|2|||
170379445|NCT00811395|615723567|FG000|Extension Treatment|Adverse Event|1|||
170379446|NCT00811395|615723568|FG001|Extension Treatment|Adverse Event|2|||
170379447|NCT00811395|615723569|FG002|Extension Treatment|Adverse Event|2|||
170379448|NCT00811395|615723570|FG003|Extension Treatment|Adverse Event|2|||
170379449|NCT00811395|615723571|FG004|Extension Treatment|Adverse Event|0|||
170379450|NCT00811395|615723572|FG005|Extension Treatment|Adverse Event|1|||
170379451|NCT00811395|615723567|FG000|Extension Treatment|Progressive disease|1|||
170379452|NCT00811395|615723568|FG001|Extension Treatment|Progressive disease|1|||
170379453|NCT00811395|615723569|FG002|Extension Treatment|Progressive disease|0|||
170379454|NCT00811395|615723570|FG003|Extension Treatment|Progressive disease|0|||
170379455|NCT00811395|615723571|FG004|Extension Treatment|Progressive disease|0|||
170379456|NCT00811395|615723572|FG005|Extension Treatment|Progressive disease|0|||
170379457|NCT00811395|615723567|FG000|Extension Treatment|Participant did not wish to continue|0|||
170379458|NCT00811395|615723568|FG001|Extension Treatment|Participant did not wish to continue|3|||
170379459|NCT00811395|615723569|FG002|Extension Treatment|Participant did not wish to continue|0|||
170379460|NCT00811395|615723570|FG003|Extension Treatment|Participant did not wish to continue|1|||
170379461|NCT00811395|615723571|FG004|Extension Treatment|Participant did not wish to continue|0|||
170379462|NCT00811395|615723572|FG005|Extension Treatment|Participant did not wish to continue|1|||
170379463|NCT00811395|615723567|FG000|Extension Treatment|Other than above|0|||
170379464|NCT00811395|615723568|FG001|Extension Treatment|Other than above|0|||
170379465|NCT00811395|615723569|FG002|Extension Treatment|Other than above|1|||
170379466|NCT00811395|615723570|FG003|Extension Treatment|Other than above|0|||
170379467|NCT00811395|615723571|FG004|Extension Treatment|Other than above|0|||
170379468|NCT00811395|615723572|FG005|Extension Treatment|Other than above|0|||
170379469|NCT01947127|615723573|FG000|Overall Study|Protocol Violation|18|||
170379470|NCT01947127|615723574|FG001|Overall Study|Protocol Violation|38|||
170379471|NCT01947127|615723573|FG000|Overall Study|Withdrawal by Subject|1|||
170379472|NCT01947127|615723574|FG001|Overall Study|Withdrawal by Subject|1|||
170379473|NCT01947127|615723573|FG000|Overall Study|Data loss|4|||
170379474|NCT01947127|615723574|FG001|Overall Study|Data loss|4|||
170379475|NCT03018340|615723575|FG000|Overall Study|Adverse Event|1|||
170379476|NCT03018340|615723576|FG001|Overall Study|Adverse Event|2|||
170379477|NCT03018340|615723575|FG000|Overall Study|Withdrawal by Subject|0|||
170379478|NCT03018340|615723576|FG001|Overall Study|Withdrawal by Subject|8|||
170379479|NCT03018340|615723575|FG000|Overall Study|Lack of Efficacy|0|||
170379480|NCT03018340|615723576|FG001|Overall Study|Lack of Efficacy|1|||
170379481|NCT03018340|615723575|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
170379482|NCT03018340|615723576|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
170379483|NCT03018340|615723575|FG000|Overall Study|Lost to Follow-up|1|||
170379484|NCT03018340|615723576|FG001|Overall Study|Lost to Follow-up|7|||
170379485|NCT03018340|615723575|FG000|Overall Study|Protocol Violation|3|||
170379486|NCT03018340|615723576|FG001|Overall Study|Protocol Violation|7|||
170379487|NCT03018340|615723575|FG000|Overall Study|Not further specified|0|||
170379488|NCT03018340|615723576|FG001|Overall Study|Not further specified|1|||
170379489|NCT04652102|615723577|FG000|Overall Study|Adverse Event|14|||
170379490|NCT04652102|615723578|FG001|Overall Study|Adverse Event|13|||
170379491|NCT04652102|615723577|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
170379492|NCT04652102|615723578|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
170379493|NCT04652102|615723577|FG000|Overall Study|Physician Decision|78|||
170379494|NCT04652102|615723578|FG001|Overall Study|Physician Decision|40|||
170379495|NCT04652102|615723577|FG000|Overall Study|Study Ended by Sponsor|64|||
170379496|NCT04652102|615723578|FG001|Overall Study|Study Ended by Sponsor|17|||
170379497|NCT04652102|615723577|FG000|Overall Study|Withdrawal by Subject|4625|||
170379498|NCT04652102|615723578|FG001|Overall Study|Withdrawal by Subject|5594|||
170379499|NCT04652102|615723577|FG000|Overall Study|Lost to Follow-up|2019|||
170379500|NCT04652102|615723578|FG001|Overall Study|Lost to Follow-up|1082|||
170379501|NCT04652102|615723577|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
170379502|NCT04652102|615723578|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
170379503|NCT04652102|615723577|FG000|Overall Study|Miscellaneous|80|||
170379504|NCT04652102|615723578|FG001|Overall Study|Miscellaneous|64|||
170379505|NCT01766401|615723587|FG000|Overall Study|Adverse Event|7|||
170379506|NCT01766401|615723588|FG001|Overall Study|Adverse Event|22|||
170379507|NCT01766401|615723587|FG000|Overall Study|Lack of Efficacy|1|||
170379508|NCT01766401|615723588|FG001|Overall Study|Lack of Efficacy|2|||
170379509|NCT01766401|615723587|FG000|Overall Study|Protocol Violation|3|||
170379510|NCT01766401|615723588|FG001|Overall Study|Protocol Violation|8|||
170379511|NCT01766401|615723587|FG000|Overall Study|Withdrawal by Subject|15|||
170379512|NCT01766401|615723588|FG001|Overall Study|Withdrawal by Subject|12|||
170379513|NCT01766401|615723587|FG000|Overall Study|Lost to Follow-up|10|||
170379514|NCT01766401|615723588|FG001|Overall Study|Lost to Follow-up|11|||
170379515|NCT01766401|615723587|FG000|Overall Study|Pregnancy|1|||
170379516|NCT01766401|615723588|FG001|Overall Study|Pregnancy|1|||
170379517|NCT01021553|615723589|FG000|Overall Study|Adverse Event|1|||
170379518|NCT01021553|615723590|FG001|Overall Study|Adverse Event|0|||
170379519|NCT01021553|615723591|FG002|Overall Study|Adverse Event|0|||
170379520|NCT01021553|615723589|FG000|Overall Study|Lack of Efficacy|2|||
170379521|NCT01021553|615723590|FG001|Overall Study|Lack of Efficacy|2|||
170379522|NCT01021553|615723591|FG002|Overall Study|Lack of Efficacy|0|||
170379523|NCT01021553|615723589|FG000|Overall Study|Protocol Violation|0|||
170379524|NCT01021553|615723590|FG001|Overall Study|Protocol Violation|2|||
170379525|NCT01021553|615723591|FG002|Overall Study|Protocol Violation|2|||
170379526|NCT01021553|615723589|FG000|Overall Study|Lost to Follow-up|0|||
170379527|NCT01021553|615723590|FG001|Overall Study|Lost to Follow-up|0|||
170379528|NCT01021553|615723591|FG002|Overall Study|Lost to Follow-up|1|||
170379529|NCT01021553|615723589|FG000|Overall Study|Withdrawal by Subject|1|||
170379530|NCT01021553|615723590|FG001|Overall Study|Withdrawal by Subject|1|||
170379531|NCT01021553|615723591|FG002|Overall Study|Withdrawal by Subject|0|||
170379532|NCT01950364|615723592|FG000|Overall Study|Adverse Event|3|||
170379533|NCT01950364|615723593|FG001|Overall Study|Adverse Event|0|||
170379534|NCT01950364|615723592|FG000|Overall Study|Stem Cell Transplant|2|||
170379535|NCT01950364|615723593|FG001|Overall Study|Stem Cell Transplant|6|||
170379536|NCT01950364|615723592|FG000|Overall Study|Disease Progression|5|||
170379537|NCT01950364|615723593|FG001|Overall Study|Disease Progression|2|||
170379538|NCT01950364|615723592|FG000|Overall Study|Withdrawal by Subject|0|||
170379539|NCT01950364|615723593|FG001|Overall Study|Withdrawal by Subject|1|||
170379540|NCT01950364|615723592|FG000|Overall Study|Protocol Violation|0|||
170379541|NCT01950364|615723593|FG001|Overall Study|Protocol Violation|1|||
170379542|NCT00890201|615723600|FG000|Overall Study|Protocol Violation|5|||
170379543|NCT00890201|615723601|FG001|Overall Study|Protocol Violation|56|||
170379544|NCT00935701|615723602|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
170379545|NCT00887913|615723603|FG000|Overall Study|Withdrawal by Subject|6|||
170379546|NCT01469637|615723604|FG000|First Intervention|Unacceptable behavior|0|||
170379547|NCT01469637|615723605|FG001|First Intervention|Unacceptable behavior|1|||
170379548|NCT01469637|615723604|FG000|Second Intervention|Incarcerated|1|||
170379549|NCT01469637|615723605|FG001|Second Intervention|Incarcerated|0|||
170379550|NCT01200758|615723606|FG000|Stage I|Death|0|||
170379551|NCT01200758|615723607|FG001|Stage I|Death|1|||
170379552|NCT01200758|615723608|FG002|Stage I|Death|0|||
170379553|NCT01200758|615723609|FG003|Stage I|Death|0|||
170379554|NCT01200758|615723606|FG000|Stage I|Physician Decision|1|||
170379555|NCT01200758|615723607|FG001|Stage I|Physician Decision|1|||
170379556|NCT01200758|615723608|FG002|Stage I|Physician Decision|0|||
170379557|NCT01200758|615723609|FG003|Stage I|Physician Decision|0|||
170379558|NCT01200758|615723606|FG000|Stage I|Lack of Efficacy|2|||
170379559|NCT01200758|615723607|FG001|Stage I|Lack of Efficacy|1|||
170379560|NCT01200758|615723608|FG002|Stage I|Lack of Efficacy|0|||
170379561|NCT01200758|615723609|FG003|Stage I|Lack of Efficacy|0|||
170379562|NCT01200758|615723606|FG000|Stage I|Adverse Event|5|||
170379563|NCT01200758|615723607|FG001|Stage I|Adverse Event|5|||
170379564|NCT01200758|615723608|FG002|Stage I|Adverse Event|0|||
170379565|NCT01200758|615723609|FG003|Stage I|Adverse Event|0|||
170379566|NCT01200758|615723606|FG000|Stage I|Withdrawal by Subject|1|||
170379567|NCT01200758|615723607|FG001|Stage I|Withdrawal by Subject|2|||
170379568|NCT01200758|615723608|FG002|Stage I|Withdrawal by Subject|0|||
170379569|NCT01200758|615723609|FG003|Stage I|Withdrawal by Subject|0|||
170379570|NCT01200758|615723606|FG000|Stage I|Disease Progression|9|||
170379571|NCT01200758|615723607|FG001|Stage I|Disease Progression|7|||
170379572|NCT01200758|615723608|FG002|Stage I|Disease Progression|0|||
170379573|NCT01200758|615723609|FG003|Stage I|Disease Progression|0|||
170379574|NCT01200758|615723606|FG000|Stage 2|Disease Progression|0|||
170379575|NCT01200758|615723607|FG001|Stage 2|Disease Progression|0|||
170379576|NCT01200758|615723608|FG002|Stage 2|Disease Progression|16|||
170379577|NCT01200758|615723609|FG003|Stage 2|Disease Progression|21|||
170379578|NCT01200758|615723606|FG000|Stage 2|Lack of Efficacy|0|||
170379579|NCT01200758|615723607|FG001|Stage 2|Lack of Efficacy|0|||
170379580|NCT01200758|615723608|FG002|Stage 2|Lack of Efficacy|4|||
170379581|NCT01200758|615723609|FG003|Stage 2|Lack of Efficacy|2|||
170379582|NCT01200758|615723606|FG000|Stage 2|Physician Decision|0|||
170379583|NCT01200758|615723607|FG001|Stage 2|Physician Decision|0|||
170379584|NCT01200758|615723608|FG002|Stage 2|Physician Decision|5|||
170379585|NCT01200758|615723609|FG003|Stage 2|Physician Decision|7|||
170379586|NCT01200758|615723606|FG000|Stage 2|Adverse Event|0|||
170379587|NCT01200758|615723607|FG001|Stage 2|Adverse Event|0|||
170379588|NCT01200758|615723608|FG002|Stage 2|Adverse Event|5|||
170379589|NCT01200758|615723609|FG003|Stage 2|Adverse Event|9|||
170379590|NCT01200758|615723606|FG000|Stage 2|Withdrawal by Subject|0|||
170379591|NCT01200758|615723607|FG001|Stage 2|Withdrawal by Subject|0|||
170379592|NCT01200758|615723608|FG002|Stage 2|Withdrawal by Subject|4|||
170379593|NCT01200758|615723609|FG003|Stage 2|Withdrawal by Subject|1|||
170379594|NCT01200758|615723606|FG000|Stage 2|Lost to Follow-up|0|||
170379595|NCT01200758|615723607|FG001|Stage 2|Lost to Follow-up|0|||
170379596|NCT01200758|615723608|FG002|Stage 2|Lost to Follow-up|3|||
170379597|NCT01200758|615723609|FG003|Stage 2|Lost to Follow-up|1|||
170379598|NCT01200758|615723606|FG000|Stage 2|Protocol Violation|0|||
170379599|NCT01200758|615723607|FG001|Stage 2|Protocol Violation|0|||
170379600|NCT01200758|615723608|FG002|Stage 2|Protocol Violation|1|||
170379601|NCT01200758|615723609|FG003|Stage 2|Protocol Violation|4|||
170379602|NCT01200758|615723606|FG000|Stage 2|Death|0|||
170379603|NCT01200758|615723607|FG001|Stage 2|Death|0|||
170379604|NCT01200758|615723608|FG002|Stage 2|Death|3|||
170379605|NCT01200758|615723609|FG003|Stage 2|Death|5|||
170379606|NCT01371721|615723610|FG000|Overall Study|Adverse Event|5|||
170379607|NCT01371721|615723611|FG001|Overall Study|Adverse Event|4|||
170379608|NCT01371721|615723612|FG002|Overall Study|Adverse Event|5|||
170379609|NCT01371721|615723610|FG000|Overall Study|Protocol Violation|6|||
170379610|NCT01371721|615723611|FG001|Overall Study|Protocol Violation|4|||
170379611|NCT01371721|615723612|FG002|Overall Study|Protocol Violation|5|||
170379612|NCT01371721|615723610|FG000|Overall Study|Lost to Follow-up|8|||
170379613|NCT01371721|615723611|FG001|Overall Study|Lost to Follow-up|2|||
170379614|NCT01371721|615723612|FG002|Overall Study|Lost to Follow-up|6|||
170379615|NCT01371721|615723610|FG000|Overall Study|Withdrawal by Subject|5|||
170379616|NCT01371721|615723611|FG001|Overall Study|Withdrawal by Subject|7|||
170379617|NCT01371721|615723612|FG002|Overall Study|Withdrawal by Subject|11|||
170379618|NCT01371721|615723610|FG000|Overall Study|Other|2|||
170379619|NCT01371721|615723611|FG001|Overall Study|Other|3|||
170379620|NCT01371721|615723612|FG002|Overall Study|Other|0|||
170379621|NCT01371721|615723610|FG000|Overall Study|Lack of Efficacy|2|||
170379622|NCT01371721|615723611|FG001|Overall Study|Lack of Efficacy|4|||
170379623|NCT01371721|615723612|FG002|Overall Study|Lack of Efficacy|3|||
170379624|NCT01371721|615723610|FG000|Overall Study|Randomized but not treated|1|||
170379625|NCT01371721|615723611|FG001|Overall Study|Randomized but not treated|0|||
170379626|NCT01371721|615723612|FG002|Overall Study|Randomized but not treated|0|||
170379627|NCT02201251|615723615|FG000|Overall Study|Adverse Event|1|||
170379628|NCT02201251|615723616|FG001|Overall Study|Adverse Event|1|||
170379629|NCT02201251|615723615|FG000|Overall Study|Protocol Violation|1|||
170379630|NCT02201251|615723616|FG001|Overall Study|Protocol Violation|0|||
170379631|NCT02201251|615723615|FG000|Overall Study|Noncompliance with Study Drug|0|||
170379632|NCT02201251|615723616|FG001|Overall Study|Noncompliance with Study Drug|1|||
170379633|NCT02201251|615723615|FG000|Overall Study|Withdrawal by Subject|2|||
170379634|NCT02201251|615723616|FG001|Overall Study|Withdrawal by Subject|1|||
170379635|NCT02877134|615723619|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379636|NCT02877134|615723620|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
170379637|NCT02877134|615723621|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379638|NCT02877134|615723622|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379639|NCT02877134|615723623|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379640|NCT02877134|615723624|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
170379641|NCT02877134|615723625|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379642|NCT02877134|615723626|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379643|NCT02877134|615723627|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379644|NCT02877134|615723628|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379645|NCT02877134|615723629|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379646|NCT02877134|615723630|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
170379647|NCT02877134|615723619|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379648|NCT02877134|615723620|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
170379649|NCT02877134|615723621|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379650|NCT02877134|615723622|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
170379651|NCT02877134|615723623|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379652|NCT02877134|615723624|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379653|NCT02877134|615723625|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
170379654|NCT02877134|615723626|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379655|NCT02877134|615723627|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379656|NCT02877134|615723628|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379657|NCT02877134|615723629|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379658|NCT02877134|615723630|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
170379659|NCT02877134|615723619|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
170379660|NCT02877134|615723620|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
170379661|NCT02877134|615723621|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
170379662|NCT02877134|615723622|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
170379663|NCT02877134|615723623|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
170379664|NCT02877134|615723624|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
170379665|NCT02877134|615723625|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
170379666|NCT02877134|615723626|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
170379667|NCT02877134|615723627|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
170379668|NCT02877134|615723628|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
170379669|NCT02877134|615723629|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
170379670|NCT02877134|615723630|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
170379671|NCT02877134|615723619|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
170379672|NCT02877134|615723620|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
170379673|NCT02877134|615723621|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
170379674|NCT02877134|615723622|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
170379675|NCT02877134|615723623|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
170379676|NCT02877134|615723624|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
170379677|NCT02877134|615723625|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
170379678|NCT02877134|615723626|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
170379679|NCT02877134|615723627|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
170379680|NCT02877134|615723628|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
170379681|NCT02877134|615723629|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
170379682|NCT02877134|615723630|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
170379683|NCT02877134|615723619|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379684|NCT02877134|615723620|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379685|NCT02877134|615723621|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379686|NCT02877134|615723622|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379687|NCT02877134|615723623|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379688|NCT02877134|615723624|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379689|NCT02877134|615723625|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379690|NCT02877134|615723626|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379691|NCT02877134|615723627|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
170379692|NCT02877134|615723628|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379693|NCT02877134|615723629|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379694|NCT02877134|615723630|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
170379695|NCT02877134|615723619|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
170379696|NCT02877134|615723620|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
170379697|NCT02877134|615723621|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
170379698|NCT02877134|615723622|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
170379699|NCT02877134|615723623|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
170379700|NCT02877134|615723624|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
170379701|NCT02877134|615723625|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
170379702|NCT02877134|615723626|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
170379703|NCT02877134|615723627|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
170379704|NCT02877134|615723628|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
170379705|NCT02877134|615723629|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
170379706|NCT02877134|615723630|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
170379707|NCT02877134|615723619|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379708|NCT02877134|615723620|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379709|NCT02877134|615723621|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379710|NCT02877134|615723622|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379711|NCT02877134|615723623|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379712|NCT02877134|615723624|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379713|NCT02877134|615723625|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379714|NCT02877134|615723626|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
170379715|NCT02877134|615723627|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
170379716|NCT02877134|615723628|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
170379717|NCT02877134|615723629|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379718|NCT02877134|615723630|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
170379719|NCT02877134|615723619|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
170379720|NCT02877134|615723620|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
170379721|NCT02877134|615723621|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
170379722|NCT02877134|615723622|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
170379723|NCT02877134|615723623|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
170379724|NCT02877134|615723624|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
170379725|NCT02877134|615723625|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
170379726|NCT02877134|615723626|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
170379727|NCT02877134|615723627|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
170379728|NCT02877134|615723628|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
170379729|NCT02877134|615723629|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
170379730|NCT02877134|615723630|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
170379731|NCT01289028|615723635|FG000|Overall Study|Progressive Disease|49|||
170379732|NCT01289028|615723635|FG000|Overall Study|Adverse Event|14|||
170379733|NCT01289028|615723635|FG000|Overall Study|Withdrawal by Subject|6|||
170379734|NCT01289028|615723635|FG000|Overall Study|Death|4|||
170379735|NCT01289028|615723635|FG000|Overall Study|Lack of Efficacy|2|||
170379736|NCT01289028|615723635|FG000|Overall Study|No longer required|2|||
170379737|NCT01289028|615723635|FG000|Overall Study|Lost to Follow-up|2|||
170379738|NCT01289028|615723635|FG000|Overall Study|New Cancer Therapy|2|||
170379739|NCT01289028|615723635|FG000|Overall Study|Abnormal Lab Value|1|||
170379740|NCT01289028|615723635|FG000|Overall Study|Missing reason for discon|1|||
170379741|NCT03858686|615723637|FG000|Period 1|Adverse Event|1|||
170379742|NCT03858686|615723638|FG001|Period 1|Adverse Event|1|||
170379743|NCT03858686|615723637|FG000|Period 1|Lack of compliance|0|||
170379744|NCT03858686|615723638|FG001|Period 1|Lack of compliance|1|||
170379745|NCT03858686|615723637|FG000|Period 1|Adverse Event|0|||
170379746|NCT03858686|615723638|FG001|Period 1|Adverse Event|1|||
170379747|NCT03858686|615723637|FG000|Period 2|Adverse Event|0|||
170379748|NCT03858686|615723638|FG001|Period 2|Adverse Event|1|||
170379749|NCT00542425|615723640|FG000|Initial 24 Weeks|Administrative reasons|0|||
170379750|NCT00542425|615723641|FG001|Initial 24 Weeks|Administrative reasons|0|||
170379751|NCT00542425|615723642|FG002|Initial 24 Weeks|Administrative reasons|1|||
170379752|NCT00542425|615723643|FG003|Initial 24 Weeks|Administrative reasons|1|||
170379753|NCT00542425|615723644|FG004|Initial 24 Weeks|Administrative reasons|0|||
170379754|NCT00542425|615723640|FG000|Initial 24 Weeks|Adverse Event|0|||
170379755|NCT00542425|615723641|FG001|Initial 24 Weeks|Adverse Event|1|||
170379756|NCT00542425|615723642|FG002|Initial 24 Weeks|Adverse Event|1|||
170379757|NCT00542425|615723643|FG003|Initial 24 Weeks|Adverse Event|3|||
170379758|NCT00542425|615723644|FG004|Initial 24 Weeks|Adverse Event|2|||
170379759|NCT00542425|615723640|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
170379760|NCT00542425|615723641|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
170379761|NCT00542425|615723642|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
170379762|NCT00542425|615723643|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
170379763|NCT00542425|615723644|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
170379764|NCT00542425|615723640|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
170379765|NCT00542425|615723641|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
170379766|NCT00542425|615723642|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
170379767|NCT00542425|615723643|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
170379768|NCT00542425|615723644|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
170379769|NCT00542425|615723640|FG000|Initial 24 Weeks|Non-compliance|0|||
170379770|NCT00542425|615723641|FG001|Initial 24 Weeks|Non-compliance|0|||
170379771|NCT00542425|615723642|FG002|Initial 24 Weeks|Non-compliance|0|||
170379772|NCT00542425|615723643|FG003|Initial 24 Weeks|Non-compliance|1|||
170379773|NCT00542425|615723644|FG004|Initial 24 Weeks|Non-compliance|1|||
170379774|NCT00542425|615723640|FG000|Initial 24 Weeks|Protocol Violation|0|||
170379775|NCT00542425|615723641|FG001|Initial 24 Weeks|Protocol Violation|0|||
170379776|NCT00542425|615723642|FG002|Initial 24 Weeks|Protocol Violation|0|||
170379777|NCT00542425|615723643|FG003|Initial 24 Weeks|Protocol Violation|1|||
170379778|NCT00542425|615723644|FG004|Initial 24 Weeks|Protocol Violation|0|||
170379779|NCT00542425|615723640|FG000|Initial 24 Weeks|Refusal of treatment|2|||
170379780|NCT00542425|615723641|FG001|Initial 24 Weeks|Refusal of treatment|2|||
170379781|NCT00542425|615723642|FG002|Initial 24 Weeks|Refusal of treatment|1|||
170379782|NCT00542425|615723643|FG003|Initial 24 Weeks|Refusal of treatment|4|||
170379783|NCT00542425|615723644|FG004|Initial 24 Weeks|Refusal of treatment|1|||
170379784|NCT00542425|615723640|FG000|Initial 24 Weeks|Other|0|||
170379785|NCT00542425|615723641|FG001|Initial 24 Weeks|Other|2|||
170379786|NCT00542425|615723642|FG002|Initial 24 Weeks|Other|1|||
170379787|NCT00542425|615723643|FG003|Initial 24 Weeks|Other|0|||
170379788|NCT00542425|615723644|FG004|Initial 24 Weeks|Other|0|||
170379789|NCT00542425|615723640|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
170379790|NCT00542425|615723641|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
170379791|NCT00542425|615723642|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
170379792|NCT00542425|615723643|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
170379793|NCT00542425|615723644|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
170379794|NCT00542425|615723640|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
170379795|NCT00542425|615723641|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
170379796|NCT00542425|615723642|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
170379797|NCT00542425|615723643|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
170379798|NCT00542425|615723644|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
170379799|NCT00542425|615723640|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
170379800|NCT00542425|615723641|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
170379801|NCT00542425|615723642|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
170379802|NCT00542425|615723643|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
170379803|NCT00542425|615723644|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
170379804|NCT00542425|615723640|FG000|Extended 24 Weeks of Treatment|Other|1|||
170379805|NCT00542425|615723641|FG001|Extended 24 Weeks of Treatment|Other|1|||
170379806|NCT00542425|615723642|FG002|Extended 24 Weeks of Treatment|Other|0|||
170379807|NCT00542425|615723643|FG003|Extended 24 Weeks of Treatment|Other|0|||
170379808|NCT00542425|615723644|FG004|Extended 24 Weeks of Treatment|Other|1|||
170379809|NCT01432938|615723645|FG000|First Intervention|Protocol Violation|1|||
170379810|NCT01432938|615723646|FG001|First Intervention|Protocol Violation|0|||
170379811|NCT01432938|615723645|FG000|First Intervention|Physician Decision|1|||
170379812|NCT01432938|615723646|FG001|First Intervention|Physician Decision|0|||
170379813|NCT01432938|615723645|FG000|Second Intervention|Adverse Event|1|||
170379814|NCT01432938|615723646|FG001|Second Intervention|Adverse Event|0|||
170379815|NCT02096471|615723652|FG000|Overall Study|Adverse Event|1|||
170379816|NCT02096471|615723652|FG000|Overall Study|Lack of Efficacy|7|||
170379817|NCT02096471|615723652|FG000|Overall Study|Withdrawal by Subject|3|||
170379818|NCT02096471|615723652|FG000|Overall Study|Non-Compliant|2|||
170379819|NCT03032523|615723655|FG000|Overall Study|Withdrawal by Subject|2|||
170379820|NCT03032523|615723656|FG001|Overall Study|Withdrawal by Subject|2|||
170379821|NCT03032523|615723655|FG000|Overall Study|Physician Decision|1|||
170379822|NCT03032523|615723656|FG001|Overall Study|Physician Decision|0|||
170379823|NCT05281094|615723659|FG000|Overall Study|Adverse Event|1|||
170379824|NCT05281094|615723660|FG001|Overall Study|Adverse Event|0|||
170379825|NCT05281094|615723659|FG000|Overall Study|Lost to Follow-up|29|||
170379826|NCT05281094|615723660|FG001|Overall Study|Lost to Follow-up|22|||
170379827|NCT05281094|615723659|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
170379828|NCT05281094|615723660|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
170379829|NCT05281094|615723659|FG000|Overall Study|Death|1|||
170379830|NCT05281094|615723660|FG001|Overall Study|Death|2|||
170379831|NCT05281094|615723659|FG000|Overall Study|Not pre-specified reason|8|||
170379832|NCT05281094|615723660|FG001|Overall Study|Not pre-specified reason|5|||
170379833|NCT02598661|615723661|FG000|Overall Study|Death|27|||
170379834|NCT02598661|615723662|FG001|Overall Study|Death|34|||
170379835|NCT02598661|615723663|FG002|Overall Study|Death|14|||
170379836|NCT02598661|615723664|FG003|Overall Study|Death|1|||
170379837|NCT02598661|615723665|FG004|Overall Study|Death|0|||
170379838|NCT02598661|615723661|FG000|Overall Study|Lost to Follow-up|2|||
170379839|NCT02598661|615723662|FG001|Overall Study|Lost to Follow-up|3|||
170379840|NCT02598661|615723663|FG002|Overall Study|Lost to Follow-up|2|||
170379841|NCT02598661|615723664|FG003|Overall Study|Lost to Follow-up|0|||
170379842|NCT02598661|615723665|FG004|Overall Study|Lost to Follow-up|0|||
170379843|NCT02598661|615723661|FG000|Overall Study|Withdrawal by Subject|13|||
170379844|NCT02598661|615723662|FG001|Overall Study|Withdrawal by Subject|24|||
170379845|NCT02598661|615723663|FG002|Overall Study|Withdrawal by Subject|14|||
170379846|NCT02598661|615723664|FG003|Overall Study|Withdrawal by Subject|1|||
170379847|NCT02598661|615723665|FG004|Overall Study|Withdrawal by Subject|1|||
170379848|NCT02598661|615723661|FG000|Overall Study|Adverse Event|0|||
170379849|NCT02598661|615723662|FG001|Overall Study|Adverse Event|0|||
170379850|NCT02598661|615723663|FG002|Overall Study|Adverse Event|1|||
170379851|NCT02598661|615723664|FG003|Overall Study|Adverse Event|0|||
170379852|NCT02598661|615723665|FG004|Overall Study|Adverse Event|0|||
170379853|NCT02598661|615723661|FG000|Overall Study|Randomized, Never Treated|0|||
170379854|NCT02598661|615723662|FG001|Overall Study|Randomized, Never Treated|0|||
170379855|NCT02598661|615723663|FG002|Overall Study|Randomized, Never Treated|0|||
170379856|NCT02598661|615723664|FG003|Overall Study|Randomized, Never Treated|0|||
170379857|NCT02598661|615723665|FG004|Overall Study|Randomized, Never Treated|1|||
170379858|NCT03893630|615723669|FG000|Overall Study|Lost to Follow-up|5|||
170379859|NCT03893630|615723670|FG001|Overall Study|Lost to Follow-up|4|||
170379860|NCT03893630|615723671|FG002|Overall Study|Lost to Follow-up|2|||
170379861|NCT03893630|615723669|FG000|Overall Study|Withdrawal by Subject|3|||
170379862|NCT03893630|615723670|FG001|Overall Study|Withdrawal by Subject|6|||
170379863|NCT03893630|615723671|FG002|Overall Study|Withdrawal by Subject|3|||
170379864|NCT03893630|615723669|FG000|Overall Study|Discontinued Intervention|0|||
170379865|NCT03893630|615723670|FG001|Overall Study|Discontinued Intervention|4|||
170379866|NCT03893630|615723671|FG002|Overall Study|Discontinued Intervention|2|||
170379867|NCT02390167|615724986|FG000|Overall Study|Lost to Follow-up|1|||
170379868|NCT01265719|615724988|FG000|Overall Study|Does not meet entrance criteria|0|||
170379869|NCT01265719|615724989|FG001|Overall Study|Does not meet entrance criteria|3|||
170379870|NCT01265719|615724988|FG000|Overall Study|Other reasons|2|||
170379871|NCT01265719|615724989|FG001|Overall Study|Other reasons|0|||
170379872|NCT01265719|615724988|FG000|Overall Study|Withdrawal by Subject|8|||
170379873|NCT01265719|615724989|FG001|Overall Study|Withdrawal by Subject|3|||
170379874|NCT01265719|615724988|FG000|Overall Study|Lost to Follow-up|2|||
170379875|NCT01265719|615724989|FG001|Overall Study|Lost to Follow-up|7|||
170379876|NCT01265719|615724988|FG000|Overall Study|Adverse Event|2|||
170379877|NCT01265719|615724989|FG001|Overall Study|Adverse Event|0|||
170379878|NCT04335929|615724990|FG000|Overall Study|Lost to Follow-up|10|||
170379879|NCT00303602|615724991|FG000|Overall Study|Adverse Event|2|||
170379880|NCT00303602|615724992|FG001|Overall Study|Adverse Event|2|||
170379881|NCT00303602|615724991|FG000|Overall Study|Withdrawal by Subject|5|||
170379882|NCT00303602|615724992|FG001|Overall Study|Withdrawal by Subject|6|||
170379883|NCT00303602|615724991|FG000|Overall Study|Lost to Follow-up|5|||
170379884|NCT00303602|615724992|FG001|Overall Study|Lost to Follow-up|2|||
170379885|NCT00303602|615724991|FG000|Overall Study|Protocol entry criteria not met|2|||
170379886|NCT00303602|615724992|FG001|Overall Study|Protocol entry criteria not met|2|||
170379887|NCT00303602|615724991|FG000|Overall Study|Physician Decision|2|||
170379888|NCT00303602|615724992|FG001|Overall Study|Physician Decision|1|||
170379889|NCT00303602|615724991|FG000|Overall Study|Noncompliance|2|||
170379890|NCT00303602|615724992|FG001|Overall Study|Noncompliance|2|||
170379891|NCT00303602|615724991|FG000|Overall Study|Protocol Violation|1|||
170379892|NCT00303602|615724992|FG001|Overall Study|Protocol Violation|0|||
170379893|NCT02491463|615724993|FG000|Overall Study|Withdrawal by Subject|1|||
170379894|NCT02491463|615724994|FG001|Overall Study|Withdrawal by Subject|2|||
170379895|NCT02491463|615724995|FG002|Overall Study|Withdrawal by Subject|0|||
170379896|NCT02491463|615724996|FG003|Overall Study|Withdrawal by Subject|0|||
170379897|NCT02491463|615724993|FG000|Overall Study|Migrated/moved from study area|1|||
170379898|NCT02491463|615724994|FG001|Overall Study|Migrated/moved from study area|5|||
170379899|NCT02491463|615724995|FG002|Overall Study|Migrated/moved from study area|1|||
170379900|NCT02491463|615724996|FG003|Overall Study|Migrated/moved from study area|1|||
170379901|NCT02491463|615724993|FG000|Overall Study|Lost to Follow-up|0|||
170379902|NCT02491463|615724994|FG001|Overall Study|Lost to Follow-up|3|||
170379903|NCT02491463|615724995|FG002|Overall Study|Lost to Follow-up|3|||
170379904|NCT02491463|615724996|FG003|Overall Study|Lost to Follow-up|0|||
170379905|NCT01491802|615724997|FG000|Overall Study|Adverse Event|1|||
170379906|NCT01491802|615724998|FG001|Overall Study|Adverse Event|1|||
170379907|NCT01491802|615724997|FG000|Overall Study|Withdrawal by Subject|0|||
170379908|NCT01491802|615724998|FG001|Overall Study|Withdrawal by Subject|1|||
170379909|NCT01864746|615724999|FG000|Overall Study|Disease recurrence|25|||
170379910|NCT01864746|615725000|FG001|Overall Study|Disease recurrence|40|||
170379911|NCT01864746|615724999|FG000|Overall Study|Second primary invasive nonbreast|2|||
170379912|NCT01864746|615725000|FG001|Overall Study|Second primary invasive nonbreast|3|||
170379913|NCT01864746|615724999|FG000|Overall Study|Death|2|||
170379914|NCT01864746|615725000|FG001|Overall Study|Death|1|||
170379915|NCT01864746|615724999|FG000|Overall Study|Adverse Event|33|||
170379916|NCT01864746|615725000|FG001|Overall Study|Adverse Event|5|||
170379917|NCT01864746|615724999|FG000|Overall Study|Withdrawal by Subject|56|||
170379918|NCT01864746|615725000|FG001|Overall Study|Withdrawal by Subject|41|||
170379919|NCT01864746|615724999|FG000|Overall Study|Physician Decision|5|||
170379920|NCT01864746|615725000|FG001|Overall Study|Physician Decision|6|||
170379921|NCT04397757|615725004|FG000|Overall Study|Death|3|||
170379922|NCT04397757|615725005|FG001|Overall Study|Death|11|||
170379923|NCT04397757|615725004|FG000|Overall Study|Withdrawal by Subject|2|||
170379924|NCT04397757|615725005|FG001|Overall Study|Withdrawal by Subject|0|||
170379925|NCT04397757|615725004|FG000|Overall Study|Lost to Follow-up|4|||
170379926|NCT04397757|615725005|FG001|Overall Study|Lost to Follow-up|3|||
170379927|NCT01562327|615725011|FG000|Overall Study|Adverse Event|2|||
170379928|NCT01562327|615725011|FG000|Overall Study|Lack of Efficacy|1|||
170379929|NCT01562327|615725011|FG000|Overall Study|Participant drop-out|1|||
170379930|NCT01562327|615725011|FG000|Overall Study|Infusion not received at 6 month window|4|||
170379931|NCT00170846|615725012|FG000|Overall Study|Subject withdrew Informed Consent|5|||
170379932|NCT00170846|615725013|FG001|Overall Study|Subject withdrew Informed Consent|12|||
170379933|NCT00170846|615725014|FG002|Overall Study|Subject withdrew Informed Consent|8|||
170379934|NCT00170846|615725012|FG000|Overall Study|Lost to Follow-up|6|||
170379935|NCT00170846|615725013|FG001|Overall Study|Lost to Follow-up|3|||
170379936|NCT00170846|615725014|FG002|Overall Study|Lost to Follow-up|2|||
170379937|NCT00170846|615725012|FG000|Overall Study|Death|0|||
170379938|NCT00170846|615725013|FG001|Overall Study|Death|3|||
170379939|NCT00170846|615725014|FG002|Overall Study|Death|3|||
170379940|NCT00170846|615725012|FG000|Overall Study|Reason Missing|0|||
170379941|NCT00170846|615725013|FG001|Overall Study|Reason Missing|1|||
170379942|NCT00170846|615725014|FG002|Overall Study|Reason Missing|0|||
170379943|NCT01970540|615725015|FG000|Overall Study|Non-treatment-related AE|0|||
170379944|NCT01970540|615725016|FG001|Overall Study|Non-treatment-related AE|0|||
170379945|NCT01970540|615725017|FG002|Overall Study|Non-treatment-related AE|1|||
170379946|NCT01970540|615725015|FG000|Overall Study|Progressive disease|55|||
170379947|NCT01970540|615725016|FG001|Overall Study|Progressive disease|23|||
170379948|NCT01970540|615725017|FG002|Overall Study|Progressive disease|10|||
170379949|NCT01970540|615725015|FG000|Overall Study|Treatment delay over protocol|0|||
170379950|NCT01970540|615725016|FG001|Overall Study|Treatment delay over protocol|0|||
170379951|NCT01970540|615725017|FG002|Overall Study|Treatment delay over protocol|1|||
170379952|NCT01970540|615725015|FG000|Overall Study|Physician Decision|7|||
170379953|NCT01970540|615725016|FG001|Overall Study|Physician Decision|2|||
170379954|NCT01970540|615725017|FG002|Overall Study|Physician Decision|0|||
170379955|NCT01970540|615725015|FG000|Overall Study|Clinical progression|0|||
170379956|NCT01970540|615725016|FG001|Overall Study|Clinical progression|1|||
170379957|NCT01970540|615725017|FG002|Overall Study|Clinical progression|1|||
170379958|NCT01970540|615725015|FG000|Overall Study|End of study|2|||
170379959|NCT01970540|615725016|FG001|Overall Study|End of study|0|||
170379960|NCT01970540|615725017|FG002|Overall Study|End of study|2|||
170379961|NCT01970540|615725015|FG000|Overall Study|Adverse Event|0|||
170379962|NCT01970540|615725016|FG001|Overall Study|Adverse Event|2|||
170379963|NCT01970540|615725017|FG002|Overall Study|Adverse Event|1|||
170379964|NCT01970540|615725015|FG000|Overall Study|Treatment-related AE|4|||
170379965|NCT01970540|615725016|FG001|Overall Study|Treatment-related AE|0|||
170379966|NCT01970540|615725017|FG002|Overall Study|Treatment-related AE|2|||
170379967|NCT01970540|615725015|FG000|Overall Study|Withdrawal by Subject|4|||
170379968|NCT01970540|615725016|FG001|Overall Study|Withdrawal by Subject|0|||
170379969|NCT01970540|615725017|FG002|Overall Study|Withdrawal by Subject|1|||
170379970|NCT01970540|615725015|FG000|Overall Study|Clinical deterioration|1|||
170379971|NCT01970540|615725016|FG001|Overall Study|Clinical deterioration|0|||
170379972|NCT01970540|615725017|FG002|Overall Study|Clinical deterioration|0|||
170379973|NCT01756833|615725018|FG000|Overall Study|Withdrawal by Subject|4|||
170379974|NCT01756833|615725019|FG001|Overall Study|Withdrawal by Subject|3|||
170379975|NCT00952588|615725020|FG000|Overall Study|Death|28|||
170379976|NCT00952588|615725021|FG001|Overall Study|Death|13|||
170379977|NCT00952588|615725020|FG000|Overall Study|Withdrawal by Subject|2|||
170379978|NCT00952588|615725021|FG001|Overall Study|Withdrawal by Subject|5|||
170379979|NCT00952588|615725020|FG000|Overall Study|Adverse Event|2|||
170379980|NCT00952588|615725021|FG001|Overall Study|Adverse Event|3|||
170379981|NCT00952588|615725020|FG000|Overall Study|Lost to Follow-up|2|||
170379982|NCT00952588|615725021|FG001|Overall Study|Lost to Follow-up|0|||
170379983|NCT00952588|615725020|FG000|Overall Study|Physician Decision|0|||
170379984|NCT00952588|615725021|FG001|Overall Study|Physician Decision|1|||
170379985|NCT00952588|615725020|FG000|Overall Study|Lack of Efficacy|2|||
170379986|NCT00952588|615725021|FG001|Overall Study|Lack of Efficacy|2|||
170379987|NCT04554394|615725022|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
170379988|NCT04554394|615725023|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
170379989|NCT04554394|615725022|FG000|Overall Study|Withdrawal by Subject|2|||
170379990|NCT04554394|615725023|FG001|Overall Study|Withdrawal by Subject|2|||
170379991|NCT04554394|615725022|FG000|Overall Study|Lost to Follow-up|2|||
170379992|NCT04554394|615725023|FG001|Overall Study|Lost to Follow-up|2|||
170379993|NCT04554394|615725022|FG000|Overall Study|Physician Decision|1|||
170379994|NCT04554394|615725023|FG001|Overall Study|Physician Decision|1|||
170379995|NCT00886587|615725024|FG000|Overall Study|Adverse Event|2|||
170379996|NCT00886587|615725025|FG001|Overall Study|Adverse Event|1|||
170379997|NCT00886587|615725024|FG000|Overall Study|Protocol Violation|2|||
170379998|NCT00886587|615725025|FG001|Overall Study|Protocol Violation|0|||
170379999|NCT00886587|615725024|FG000|Overall Study|Withdrawal by Subject|0|||
170380000|NCT00886587|615725025|FG001|Overall Study|Withdrawal by Subject|1|||
170380001|NCT01108068|615725029|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
170380002|NCT01108068|615725030|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
170380003|NCT00398086|615725033|FG000|Overall Study|Unacceptable Toxicity|2|||
170380004|NCT00398086|615725034|FG001|Overall Study|Unacceptable Toxicity|8|||
170380005|NCT00398086|615725035|FG002|Overall Study|Unacceptable Toxicity|2|||
170380006|NCT00398086|615725033|FG000|Overall Study|Adverse Event|1|||
170380007|NCT00398086|615725034|FG001|Overall Study|Adverse Event|4|||
170380008|NCT00398086|615725035|FG002|Overall Study|Adverse Event|0|||
170380009|NCT00398086|615725033|FG000|Overall Study|Physician Decision|1|||
170380010|NCT00398086|615725034|FG001|Overall Study|Physician Decision|4|||
170380011|NCT00398086|615725035|FG002|Overall Study|Physician Decision|0|||
170380012|NCT00398086|615725033|FG000|Overall Study|Withdrawal by Subject|5|||
170380013|NCT00398086|615725034|FG001|Overall Study|Withdrawal by Subject|7|||
170380014|NCT00398086|615725035|FG002|Overall Study|Withdrawal by Subject|0|||
170380015|NCT00135694|615725042|FG000|Overall Study|Adverse Event|17|||
170380016|NCT00135694|615725043|FG001|Overall Study|Adverse Event|4|||
170380017|NCT00135694|615725044|FG002|Overall Study|Adverse Event|0|||
170380018|NCT00135694|615725042|FG000|Overall Study|Death|14|||
170380019|NCT00135694|615725043|FG001|Overall Study|Death|1|||
170380020|NCT00135694|615725044|FG002|Overall Study|Death|2|||
170380021|NCT00135694|615725042|FG000|Overall Study|Lost to Follow-up|8|||
170380022|NCT00135694|615725043|FG001|Overall Study|Lost to Follow-up|7|||
170380023|NCT00135694|615725044|FG002|Overall Study|Lost to Follow-up|1|||
170380024|NCT00135694|615725042|FG000|Overall Study|Withdrawal by Subject|41|||
170380025|NCT00135694|615725043|FG001|Overall Study|Withdrawal by Subject|7|||
170380026|NCT00135694|615725044|FG002|Overall Study|Withdrawal by Subject|4|||
170380027|NCT00135694|615725042|FG000|Overall Study|Protocol Violation|19|||
170380028|NCT00135694|615725043|FG001|Overall Study|Protocol Violation|1|||
170380029|NCT00135694|615725044|FG002|Overall Study|Protocol Violation|0|||
170380030|NCT00135694|615725042|FG000|Overall Study|Hepatitis C related reasons|39|||
170380031|NCT00135694|615725043|FG001|Overall Study|Hepatitis C related reasons|1|||
170380032|NCT00135694|615725044|FG002|Overall Study|Hepatitis C related reasons|0|||
170380033|NCT00135694|615725042|FG000|Overall Study|Ineligible for Random assignment|42|||
170380034|NCT00135694|615725043|FG001|Overall Study|Ineligible for Random assignment|0|||
170380035|NCT00135694|615725044|FG002|Overall Study|Ineligible for Random assignment|0|||
170380036|NCT02584660|615725045|FG000|Overall Study|Adverse Event|4|||
170380037|NCT02584660|615725046|FG001|Overall Study|Adverse Event|0|||
170380038|NCT02584660|615725045|FG000|Overall Study|Lost to Follow-up|3|||
170380039|NCT02584660|615725046|FG001|Overall Study|Lost to Follow-up|4|||
170380040|NCT02584660|615725045|FG000|Overall Study|Protocol Violation|0|||
170380041|NCT02584660|615725046|FG001|Overall Study|Protocol Violation|1|||
170380042|NCT02584660|615725045|FG000|Overall Study|Withdrawal by Subject|0|||
170380043|NCT02584660|615725046|FG001|Overall Study|Withdrawal by Subject|2|||
170380044|NCT02584660|615725045|FG000|Overall Study|Other|0|||
170380045|NCT02584660|615725046|FG001|Overall Study|Other|1|||
170380046|NCT00461552|615725047|FG000|Overall Study|Drug Dispensing error|0|||
170380047|NCT00461552|615725048|FG001|Overall Study|Drug Dispensing error|2|||
170380048|NCT00523744|615725051|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
170380049|NCT00523744|615725051|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
170380050|NCT00523744|615725051|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
170380051|NCT00523744|615725051|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
170380052|NCT00523744|615725051|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
170380053|NCT00523744|615725051|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
170380054|NCT01055457|615725052|FG000|Overall Study|Lost to Follow-up|0|||
170380055|NCT01055457|615725053|FG001|Overall Study|Lost to Follow-up|1|||
170380056|NCT01055457|615725054|FG002|Overall Study|Lost to Follow-up|0|||
170380057|NCT01055457|615725055|FG003|Overall Study|Lost to Follow-up|0|||
170380058|NCT01055457|615725056|FG004|Overall Study|Lost to Follow-up|0|||
170380059|NCT01055457|615725057|FG005|Overall Study|Lost to Follow-up|1|||
170380060|NCT01055457|615725058|FG006|Overall Study|Lost to Follow-up|0|||
170380061|NCT01055457|615725059|FG007|Overall Study|Lost to Follow-up|0|||
170380062|NCT01055457|615725060|FG008|Overall Study|Lost to Follow-up|0|||
170380063|NCT01055457|615725061|FG009|Overall Study|Lost to Follow-up|0|||
170380064|NCT01055457|615725052|FG000|Overall Study|Protocol Violation|0|||
170380065|NCT01055457|615725053|FG001|Overall Study|Protocol Violation|0|||
170380066|NCT01055457|615725054|FG002|Overall Study|Protocol Violation|1|||
170380067|NCT01055457|615725055|FG003|Overall Study|Protocol Violation|1|||
170380068|NCT01055457|615725056|FG004|Overall Study|Protocol Violation|1|||
170380069|NCT01055457|615725057|FG005|Overall Study|Protocol Violation|2|||
170380070|NCT01055457|615725058|FG006|Overall Study|Protocol Violation|1|||
170380071|NCT01055457|615725059|FG007|Overall Study|Protocol Violation|0|||
170380072|NCT01055457|615725060|FG008|Overall Study|Protocol Violation|0|||
170380073|NCT01055457|615725061|FG009|Overall Study|Protocol Violation|1|||
170380074|NCT01055457|615725052|FG000|Overall Study|Subject Disinterest|0|||
170380075|NCT01055457|615725053|FG001|Overall Study|Subject Disinterest|0|||
170380076|NCT01055457|615725054|FG002|Overall Study|Subject Disinterest|0|||
170380077|NCT01055457|615725055|FG003|Overall Study|Subject Disinterest|0|||
170380078|NCT01055457|615725056|FG004|Overall Study|Subject Disinterest|0|||
170380079|NCT01055457|615725057|FG005|Overall Study|Subject Disinterest|0|||
170380080|NCT01055457|615725058|FG006|Overall Study|Subject Disinterest|0|||
170380081|NCT01055457|615725059|FG007|Overall Study|Subject Disinterest|1|||
170380082|NCT01055457|615725060|FG008|Overall Study|Subject Disinterest|0|||
170380083|NCT01055457|615725061|FG009|Overall Study|Subject Disinterest|0|||
170380084|NCT01055457|615725052|FG000|Overall Study|Subject Ineligible|1|||
170380085|NCT01055457|615725053|FG001|Overall Study|Subject Ineligible|0|||
170380086|NCT01055457|615725054|FG002|Overall Study|Subject Ineligible|1|||
170380087|NCT01055457|615725055|FG003|Overall Study|Subject Ineligible|0|||
170380088|NCT01055457|615725056|FG004|Overall Study|Subject Ineligible|1|||
170380089|NCT01055457|615725057|FG005|Overall Study|Subject Ineligible|0|||
170380090|NCT01055457|615725058|FG006|Overall Study|Subject Ineligible|0|||
170380091|NCT01055457|615725059|FG007|Overall Study|Subject Ineligible|0|||
170380092|NCT01055457|615725060|FG008|Overall Study|Subject Ineligible|0|||
170380093|NCT01055457|615725061|FG009|Overall Study|Subject Ineligible|0|||
170380094|NCT01055457|615725052|FG000|Overall Study|Discomfort|0|||
170380095|NCT01055457|615725053|FG001|Overall Study|Discomfort|0|||
170380096|NCT01055457|615725054|FG002|Overall Study|Discomfort|0|||
170380097|NCT01055457|615725055|FG003|Overall Study|Discomfort|0|||
170380098|NCT01055457|615725056|FG004|Overall Study|Discomfort|1|||
170380099|NCT01055457|615725057|FG005|Overall Study|Discomfort|0|||
170380100|NCT01055457|615725058|FG006|Overall Study|Discomfort|0|||
170380101|NCT01055457|615725059|FG007|Overall Study|Discomfort|0|||
170380102|NCT01055457|615725060|FG008|Overall Study|Discomfort|0|||
170380103|NCT01055457|615725061|FG009|Overall Study|Discomfort|0|||
170380104|NCT01055457|615725052|FG000|Overall Study|Pregnancy|0|||
170380105|NCT01055457|615725053|FG001|Overall Study|Pregnancy|0|||
170380106|NCT01055457|615725054|FG002|Overall Study|Pregnancy|0|||
170380107|NCT01055457|615725055|FG003|Overall Study|Pregnancy|1|||
170380108|NCT01055457|615725056|FG004|Overall Study|Pregnancy|0|||
170380109|NCT01055457|615725057|FG005|Overall Study|Pregnancy|0|||
170380110|NCT01055457|615725058|FG006|Overall Study|Pregnancy|0|||
170380111|NCT01055457|615725059|FG007|Overall Study|Pregnancy|0|||
170380112|NCT01055457|615725060|FG008|Overall Study|Pregnancy|0|||
170380113|NCT01055457|615725061|FG009|Overall Study|Pregnancy|0|||
170380114|NCT01055457|615725052|FG000|Overall Study|Adverse Event|0|||
170380115|NCT01055457|615725053|FG001|Overall Study|Adverse Event|0|||
170380116|NCT01055457|615725054|FG002|Overall Study|Adverse Event|0|||
170380117|NCT01055457|615725055|FG003|Overall Study|Adverse Event|1|||
170380118|NCT01055457|615725056|FG004|Overall Study|Adverse Event|0|||
170380119|NCT01055457|615725057|FG005|Overall Study|Adverse Event|0|||
170380120|NCT01055457|615725058|FG006|Overall Study|Adverse Event|0|||
170380121|NCT01055457|615725059|FG007|Overall Study|Adverse Event|0|||
170380122|NCT01055457|615725060|FG008|Overall Study|Adverse Event|0|||
170380123|NCT01055457|615725061|FG009|Overall Study|Adverse Event|0|||
170380124|NCT00374127|615725066|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
170380125|NCT00374127|615725066|FG000|Overall Study|Blood could not be drawn.|2|||
170380126|NCT00374127|615725066|FG000|Overall Study|Protocol Violation|5|||
170380127|NCT00374127|615725066|FG000|Overall Study|Pregnancy|1|||
170380128|NCT02520141|615725067|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
170380129|NCT01225211|615725068|FG000|Overall Study|Adverse Event|0|||
170380130|NCT01225211|615725069|FG001|Overall Study|Adverse Event|0|||
170380131|NCT01225211|615725070|FG002|Overall Study|Adverse Event|1|||
170380132|NCT01225211|615725071|FG003|Overall Study|Adverse Event|0|||
170380133|NCT01225211|615725072|FG004|Overall Study|Adverse Event|0|||
170380134|NCT01225211|615725073|FG005|Overall Study|Adverse Event|0|||
170380135|NCT01225211|615725074|FG006|Overall Study|Adverse Event|0|||
170380136|NCT01225211|615725075|FG007|Overall Study|Adverse Event|0|||
170380137|NCT01225211|615725076|FG008|Overall Study|Adverse Event|0|||
170380138|NCT01225211|615725077|FG009|Overall Study|Adverse Event|1|||
170380139|NCT01225211|615725068|FG000|Overall Study|Withdrawal by Subject|0|||
170380140|NCT01225211|615725069|FG001|Overall Study|Withdrawal by Subject|0|||
170380141|NCT01225211|615725070|FG002|Overall Study|Withdrawal by Subject|0|||
170380142|NCT01225211|615725071|FG003|Overall Study|Withdrawal by Subject|0|||
170380143|NCT01225211|615725072|FG004|Overall Study|Withdrawal by Subject|0|||
170380144|NCT01225211|615725073|FG005|Overall Study|Withdrawal by Subject|0|||
170380145|NCT01225211|615725074|FG006|Overall Study|Withdrawal by Subject|1|||
170380146|NCT01225211|615725075|FG007|Overall Study|Withdrawal by Subject|0|||
170380147|NCT01225211|615725076|FG008|Overall Study|Withdrawal by Subject|1|||
170380148|NCT01225211|615725077|FG009|Overall Study|Withdrawal by Subject|3|||
170380149|NCT01225211|615725068|FG000|Overall Study|Other|0|||
170380150|NCT01225211|615725069|FG001|Overall Study|Other|0|||
170380151|NCT01225211|615725070|FG002|Overall Study|Other|0|||
170380152|NCT01225211|615725071|FG003|Overall Study|Other|0|||
170380153|NCT01225211|615725072|FG004|Overall Study|Other|0|||
170380154|NCT01225211|615725073|FG005|Overall Study|Other|0|||
170380155|NCT01225211|615725074|FG006|Overall Study|Other|0|||
170380156|NCT01225211|615725075|FG007|Overall Study|Other|0|||
170380157|NCT01225211|615725076|FG008|Overall Study|Other|0|||
170380158|NCT01225211|615725077|FG009|Overall Study|Other|1|||
170380159|NCT01984294|615725080|FG000|Overall Study|Randomized but Never Treated|0|||
170380160|NCT01984294|615725081|FG001|Overall Study|Randomized but Never Treated|0|||
170380161|NCT01984294|615725082|FG002|Overall Study|Randomized but Never Treated|1|||
170380162|NCT01984294|615725080|FG000|Overall Study|Lack of Efficacy|4|||
170380163|NCT01984294|615725081|FG001|Overall Study|Lack of Efficacy|2|||
170380164|NCT01984294|615725082|FG002|Overall Study|Lack of Efficacy|6|||
170380165|NCT01984294|615725080|FG000|Overall Study|Adverse Event|0|||
170380166|NCT01984294|615725081|FG001|Overall Study|Adverse Event|1|||
170380167|NCT01984294|615725082|FG002|Overall Study|Adverse Event|0|||
170380168|NCT01987609|615725083|FG000|Overall Study|Adverse Event|1|||
170380169|NCT01066546|615725088|FG000|Overall Study|Study terminated by sponsor|5|||
170380170|NCT02545049|615725090|FG000|Overall Study|Withdrawal by Subject|1|||
170380171|NCT02545049|615725091|FG001|Overall Study|Withdrawal by Subject|7|||
170380172|NCT02545049|615725090|FG000|Overall Study|Lost to Follow-up|4|||
170380173|NCT02545049|615725091|FG001|Overall Study|Lost to Follow-up|6|||
170380174|NCT02545049|615725090|FG000|Overall Study|GCP violations|37|||
170380175|NCT02545049|615725091|FG001|Overall Study|GCP violations|48|||
170380176|NCT01436357|615725093|FG000|Overall Study|Death|5|||
170380177|NCT01436357|615725094|FG001|Overall Study|Death|1|||
170380178|NCT01436357|615725093|FG000|Overall Study|Enrolled but not vaccinated|1|||
170380179|NCT01436357|615725094|FG001|Overall Study|Enrolled but not vaccinated|1|||
170380180|NCT01436357|615725093|FG000|Overall Study|Incarceration|18|||
170380181|NCT01436357|615725094|FG001|Overall Study|Incarceration|20|||
170380182|NCT01436357|615725093|FG000|Overall Study|Lost to Follow-up|67|||
170380183|NCT01436357|615725094|FG001|Overall Study|Lost to Follow-up|61|||
170380184|NCT01436357|615725093|FG000|Overall Study|Protocol Violation|1|||
170380185|NCT01436357|615725094|FG001|Overall Study|Protocol Violation|0|||
170380186|NCT01436357|615725093|FG000|Overall Study|Withdrawal by Subject|26|||
170380187|NCT01436357|615725094|FG001|Overall Study|Withdrawal by Subject|38|||
170380188|NCT01436357|615725093|FG000|Overall Study|Physician Decision|3|||
170380189|NCT01436357|615725094|FG001|Overall Study|Physician Decision|4|||
170380190|NCT01436357|615725093|FG000|Overall Study|Moved out of area|1|||
170380191|NCT01436357|615725094|FG001|Overall Study|Moved out of area|2|||
170380192|NCT01436357|615725093|FG000|Overall Study|Subject in rehab|0|||
170380193|NCT01436357|615725094|FG001|Overall Study|Subject in rehab|1|||
170380194|NCT00656799|615725096|FG000|Overall Study|Death|2|||
170380195|NCT02422186|615725097|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
170380196|NCT02422186|615725098|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
170380197|NCT02422186|615725097|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
170380198|NCT02422186|615725098|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
170380199|NCT02422186|615725097|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
170380200|NCT02422186|615725098|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
170380201|NCT02422186|615725097|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
170380202|NCT02422186|615725098|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
170380203|NCT02422186|615725097|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
170380204|NCT02422186|615725098|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
170380205|NCT02422186|615725097|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
170380206|NCT02422186|615725098|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
170380207|NCT02422186|615725097|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
170380208|NCT02422186|615725098|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
170380209|NCT02422186|615725097|FG000|Follow-up Phase (2 Weeks)|Other|3|||
170380210|NCT02422186|615725098|FG001|Follow-up Phase (2 Weeks)|Other|0|||
170380211|NCT01021293|615725101|FG000|Overall Study|Serious Adverse Event|2|||
170380212|NCT01021293|615725102|FG001|Overall Study|Serious Adverse Event|1|||
170380213|NCT01021293|615725101|FG000|Overall Study|Adverse Event|2|||
170380214|NCT01021293|615725102|FG001|Overall Study|Adverse Event|1|||
170380215|NCT01021293|615725101|FG000|Overall Study|Withdrawal by Subject|1|||
170380216|NCT01021293|615725102|FG001|Overall Study|Withdrawal by Subject|3|||
170380217|NCT01021293|615725101|FG000|Overall Study|Migrated/moved from study area|6|||
170380218|NCT01021293|615725102|FG001|Overall Study|Migrated/moved from study area|18|||
170380219|NCT01021293|615725101|FG000|Overall Study|Lost to Follow-up|1|||
170380220|NCT01021293|615725102|FG001|Overall Study|Lost to Follow-up|1|||
170380221|NCT02683668|615725107|FG000|Period 2|Withdrawal by Subject|0|||
170380222|NCT02683668|615725108|FG001|Period 2|Withdrawal by Subject|1|||
170380223|NCT02683668|615725109|FG002|Period 2|Withdrawal by Subject|0|||
170380224|NCT00027846|615726990|FG000|Overall Study|Lost to Follow-up|0|||
170380225|NCT00027846|615726991|FG001|Overall Study|Lost to Follow-up|41|||
170380226|NCT00027846|615726992|FG002|Overall Study|Lost to Follow-up|9|||
170380227|NCT00027846|615726990|FG000|Overall Study|Withdrawal by Subject|0|||
170380228|NCT00027846|615726991|FG001|Overall Study|Withdrawal by Subject|14|||
170380229|NCT00027846|615726992|FG002|Overall Study|Withdrawal by Subject|7|||
170380230|NCT00027846|615726990|FG000|Overall Study|Ineligible for study|2|||
170380231|NCT00027846|615726991|FG001|Overall Study|Ineligible for study|6|||
170380232|NCT00027846|615726992|FG002|Overall Study|Ineligible for study|14|||
170380233|NCT00027846|615726990|FG000|Overall Study|Entry into another COG therapeutic study|0|||
170380234|NCT00027846|615726991|FG001|Overall Study|Entry into another COG therapeutic study|5|||
170380235|NCT00027846|615726992|FG002|Overall Study|Entry into another COG therapeutic study|2|||
170380236|NCT00027846|615726990|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
170380237|NCT00027846|615726991|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
170380238|NCT00027846|615726992|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
170380239|NCT00663208|615726994|FG000|Treatment Period|Lost to Follow-up|0|||
170380240|NCT00663208|615726995|FG001|Treatment Period|Lost to Follow-up|1|||
170380241|NCT00663208|615726996|FG002|Treatment Period|Lost to Follow-up|0|||
170380242|NCT00663208|615726997|FG003|Treatment Period|Lost to Follow-up|0|||
170380243|NCT00663208|615726998|FG004|Treatment Period|Lost to Follow-up|0|||
170380244|NCT00663208|615726999|FG005|Treatment Period|Lost to Follow-up|0|||
170380245|NCT00663208|615727000|FG006|Treatment Period|Lost to Follow-up|0|||
170380246|NCT00663208|615726994|FG000|Follow-up Period|Lost to Follow-up|2|||
170380247|NCT00663208|615726995|FG001|Follow-up Period|Lost to Follow-up|0|||
170380248|NCT00663208|615726996|FG002|Follow-up Period|Lost to Follow-up|3|||
170380249|NCT00663208|615726997|FG003|Follow-up Period|Lost to Follow-up|2|||
170380250|NCT00663208|615726998|FG004|Follow-up Period|Lost to Follow-up|0|||
170380251|NCT00663208|615726999|FG005|Follow-up Period|Lost to Follow-up|0|||
170380252|NCT00663208|615727000|FG006|Follow-up Period|Lost to Follow-up|0|||
170380253|NCT00663208|615726994|FG000|Follow-up Period|Other reason|1|||
170380254|NCT00663208|615726995|FG001|Follow-up Period|Other reason|0|||
170380255|NCT00663208|615726996|FG002|Follow-up Period|Other reason|0|||
170380256|NCT00663208|615726997|FG003|Follow-up Period|Other reason|0|||
170380257|NCT00663208|615726998|FG004|Follow-up Period|Other reason|0|||
170380258|NCT00663208|615726999|FG005|Follow-up Period|Other reason|0|||
170380259|NCT00663208|615727000|FG006|Follow-up Period|Other reason|1|||
170380260|NCT00039377|615727001|FG000|Initial Registration|Adverse Event|2|||
170380261|NCT00039377|615727002|FG001|Initial Registration|Adverse Event|0|||
170380262|NCT00039377|615727003|FG002|Initial Registration|Adverse Event|0|||
170380263|NCT00039377|615727004|FG003|Initial Registration|Adverse Event|0|||
170380264|NCT00039377|615727001|FG000|Initial Registration|Relapsed|6|||
170380265|NCT00039377|615727002|FG001|Initial Registration|Relapsed|0|||
170380266|NCT00039377|615727003|FG002|Initial Registration|Relapsed|0|||
170380267|NCT00039377|615727004|FG003|Initial Registration|Relapsed|0|||
170380268|NCT00039377|615727001|FG000|Initial Registration|Received non-protocol therapy|11|||
170380269|NCT00039377|615727002|FG001|Initial Registration|Received non-protocol therapy|0|||
170380270|NCT00039377|615727003|FG002|Initial Registration|Received non-protocol therapy|0|||
170380271|NCT00039377|615727004|FG003|Initial Registration|Received non-protocol therapy|0|||
170380272|NCT00039377|615727001|FG000|Initial Registration|Withdrawal by Subject|3|||
170380273|NCT00039377|615727002|FG001|Initial Registration|Withdrawal by Subject|0|||
170380274|NCT00039377|615727003|FG002|Initial Registration|Withdrawal by Subject|0|||
170380275|NCT00039377|615727004|FG003|Initial Registration|Withdrawal by Subject|0|||
170380276|NCT01347931|615727005|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
170380277|NCT01249404|615727006|FG000|Overall Study|Study treatment not received|0|||
170380278|NCT01249404|615727007|FG001|Overall Study|Study treatment not received|1|||
170380279|NCT01249404|615727008|FG002|Overall Study|Study treatment not received|2|||
170380280|NCT01249404|615727006|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
170380281|NCT01249404|615727007|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
170380282|NCT01249404|615727008|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
170380283|NCT01249404|615727006|FG000|Overall Study|Adverse Event|2|||
170380284|NCT01249404|615727007|FG001|Overall Study|Adverse Event|2|||
170380285|NCT01249404|615727008|FG002|Overall Study|Adverse Event|2|||
170380286|NCT01249404|615727006|FG000|Overall Study|Withdrawal by Subject|2|||
170380287|NCT01249404|615727007|FG001|Overall Study|Withdrawal by Subject|2|||
170380288|NCT01249404|615727008|FG002|Overall Study|Withdrawal by Subject|0|||
170380289|NCT01249404|615727006|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
170380290|NCT01249404|615727007|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
170380291|NCT01249404|615727008|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
170380292|NCT01249404|615727006|FG000|Overall Study|Non compliance to visit schedule|0|||
170380293|NCT01249404|615727007|FG001|Overall Study|Non compliance to visit schedule|1|||
170380294|NCT01249404|615727008|FG002|Overall Study|Non compliance to visit schedule|0|||
170380295|NCT02554721|615727009|FG000|Overall Study|Adverse Event|1|||
170380296|NCT02554721|615727010|FG001|Overall Study|Adverse Event|0|||
170380297|NCT02554721|615727011|FG002|Overall Study|Adverse Event|0|||
170380298|NCT02554721|615727012|FG003|Overall Study|Adverse Event|0|||
170380299|NCT02554721|615727013|FG004|Overall Study|Adverse Event|1|||
170380300|NCT02554721|615727009|FG000|Overall Study|Noncompliance|0|||
170380301|NCT02554721|615727010|FG001|Overall Study|Noncompliance|0|||
170380302|NCT02554721|615727011|FG002|Overall Study|Noncompliance|0|||
170380303|NCT02554721|615727012|FG003|Overall Study|Noncompliance|0|||
170380304|NCT02554721|615727013|FG004|Overall Study|Noncompliance|1|||
170380305|NCT03419741|615727015|FG000|Overall Study|Adverse Event|1|||
170380306|NCT03419741|615727016|FG001|Overall Study|Adverse Event|0|||
170380307|NCT03419741|615727015|FG000|Overall Study|Withdrawal by Subject|1|||
170380308|NCT03419741|615727016|FG001|Overall Study|Withdrawal by Subject|2|||
170380309|NCT02306148|615727019|FG000|Overall Study|Adverse Event|12|||
170380310|NCT02306148|615727020|FG001|Overall Study|Adverse Event|6|||
170380311|NCT02306148|615727019|FG000|Overall Study|Lost to Follow-up|1|||
170380312|NCT02306148|615727020|FG001|Overall Study|Lost to Follow-up|4|||
170380313|NCT04657003|615727021|FG000|Overall Study|Adverse Event|5|||
170380314|NCT04657003|615727022|FG001|Overall Study|Adverse Event|1|||
170380315|NCT04657003|615727023|FG002|Overall Study|Adverse Event|5|||
170380316|NCT04657003|615727021|FG000|Overall Study|Death|0|||
170380317|NCT04657003|615727022|FG001|Overall Study|Death|2|||
170380318|NCT04657003|615727023|FG002|Overall Study|Death|0|||
170380319|NCT04657003|615727021|FG000|Overall Study|Lost to Follow-up|8|||
170380320|NCT04657003|615727022|FG001|Overall Study|Lost to Follow-up|4|||
170380321|NCT04657003|615727023|FG002|Overall Study|Lost to Follow-up|10|||
170380322|NCT04657003|615727021|FG000|Overall Study|Other - As Reported by Investigator|3|||
170380323|NCT04657003|615727022|FG001|Overall Study|Other - As Reported by Investigator|2|||
170380324|NCT04657003|615727023|FG002|Overall Study|Other - As Reported by Investigator|2|||
170380325|NCT04657003|615727021|FG000|Overall Study|Pregnancy|2|||
170380326|NCT04657003|615727022|FG001|Overall Study|Pregnancy|0|||
170380327|NCT04657003|615727023|FG002|Overall Study|Pregnancy|2|||
170380328|NCT04657003|615727021|FG000|Overall Study|Withdrawal by Subject|16|||
170380329|NCT04657003|615727022|FG001|Overall Study|Withdrawal by Subject|7|||
170380330|NCT04657003|615727023|FG002|Overall Study|Withdrawal by Subject|10|||
170380331|NCT02408016|615727025|FG000|Overall Study|Death|6|||
170380332|NCT02408016|615727026|FG001|Overall Study|Death|1|||
170380333|NCT02408016|615727027|FG002|Overall Study|Death|0|||
170380334|NCT02408016|615727025|FG000|Overall Study|Physician Decision|0|||
170380335|NCT02408016|615727026|FG001|Overall Study|Physician Decision|2|||
170380336|NCT02408016|615727027|FG002|Overall Study|Physician Decision|0|||
170380337|NCT02500901|615727029|FG000|Overall Study|Disease ProgressionDD|2|||
170380338|NCT03347279|615727036|FG000|Overall Study|Withdrawal by Subject|8|||
170380339|NCT03347279|615727037|FG001|Overall Study|Withdrawal by Subject|15|||
170380340|NCT03347279|615727036|FG000|Overall Study|Death|0|||
170380341|NCT03347279|615727037|FG001|Overall Study|Death|2|||
170380342|NCT03347279|615727036|FG000|Overall Study|Lost to Follow-up|5|||
170380343|NCT03347279|615727037|FG001|Overall Study|Lost to Follow-up|2|||
170380344|NCT03347279|615727036|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
170380345|NCT03347279|615727037|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
170380346|NCT03818399|615727038|FG000|Overall Study|Lost to Follow-up|11|||
170380347|NCT03818399|615727038|FG000|Overall Study|Withdrawal by Subject|1|||
170380348|NCT03818399|615727038|FG000|Overall Study|Protocol Violation|2|||
170380349|NCT00141297|615727040|FG000|Overall Study|Adverse Event|0|||
170380350|NCT00141297|615727041|FG001|Overall Study|Adverse Event|0|||
170380351|NCT00141297|615727042|FG002|Overall Study|Adverse Event|1|||
170380352|NCT00141297|615727043|FG003|Overall Study|Adverse Event|0|||
170380353|NCT00141297|615727044|FG004|Overall Study|Adverse Event|1|||
170380354|NCT00141297|615727045|FG005|Overall Study|Adverse Event|1|||
170380355|NCT00141297|615727046|FG006|Overall Study|Adverse Event|0|||
170380356|NCT00141297|615727047|FG007|Overall Study|Adverse Event|1|||
170380357|NCT00141297|615727048|FG008|Overall Study|Adverse Event|1|||
170380358|NCT00141297|615727049|FG009|Overall Study|Adverse Event|0|||
170380359|NCT00141297|615727040|FG000|Overall Study|Death|1|||
170380360|NCT00141297|615727041|FG001|Overall Study|Death|0|||
170380361|NCT00141297|615727042|FG002|Overall Study|Death|0|||
170380362|NCT00141297|615727043|FG003|Overall Study|Death|0|||
170380363|NCT00141297|615727044|FG004|Overall Study|Death|0|||
170380364|NCT00141297|615727045|FG005|Overall Study|Death|0|||
170380365|NCT00141297|615727046|FG006|Overall Study|Death|0|||
170380366|NCT00141297|615727047|FG007|Overall Study|Death|0|||
170380367|NCT00141297|615727048|FG008|Overall Study|Death|1|||
170380368|NCT00141297|615727049|FG009|Overall Study|Death|0|||
170380369|NCT00141297|615727040|FG000|Overall Study|Withdrawal by Subject|0|||
170380370|NCT00141297|615727041|FG001|Overall Study|Withdrawal by Subject|0|||
170380371|NCT00141297|615727042|FG002|Overall Study|Withdrawal by Subject|0|||
170380372|NCT00141297|615727043|FG003|Overall Study|Withdrawal by Subject|0|||
170380373|NCT00141297|615727044|FG004|Overall Study|Withdrawal by Subject|0|||
170380374|NCT00141297|615727045|FG005|Overall Study|Withdrawal by Subject|0|||
170380375|NCT00141297|615727046|FG006|Overall Study|Withdrawal by Subject|0|||
170380376|NCT00141297|615727047|FG007|Overall Study|Withdrawal by Subject|0|||
170380377|NCT00141297|615727048|FG008|Overall Study|Withdrawal by Subject|1|||
170380378|NCT00141297|615727049|FG009|Overall Study|Withdrawal by Subject|0|||
170380379|NCT00141297|615727040|FG000|Overall Study|Other|0|||
170380380|NCT00141297|615727041|FG001|Overall Study|Other|0|||
170380381|NCT00141297|615727042|FG002|Overall Study|Other|0|||
170380382|NCT00141297|615727043|FG003|Overall Study|Other|1|||
170380383|NCT00141297|615727044|FG004|Overall Study|Other|5|||
170380384|NCT00141297|615727045|FG005|Overall Study|Other|0|||
170380385|NCT00141297|615727046|FG006|Overall Study|Other|0|||
170380386|NCT00141297|615727047|FG007|Overall Study|Other|0|||
170380387|NCT00141297|615727048|FG008|Overall Study|Other|2|||
170380388|NCT00141297|615727049|FG009|Overall Study|Other|0|||
170380389|NCT00141297|615727040|FG000|Overall Study|Progressive Disease|2|||
170380390|NCT00141297|615727041|FG001|Overall Study|Progressive Disease|3|||
170380391|NCT00141297|615727042|FG002|Overall Study|Progressive Disease|6|||
170380392|NCT00141297|615727043|FG003|Overall Study|Progressive Disease|2|||
170380393|NCT00141297|615727044|FG004|Overall Study|Progressive Disease|15|||
170380394|NCT00141297|615727045|FG005|Overall Study|Progressive Disease|2|||
170380395|NCT00141297|615727046|FG006|Overall Study|Progressive Disease|3|||
170380396|NCT00141297|615727047|FG007|Overall Study|Progressive Disease|3|||
170380397|NCT00141297|615727048|FG008|Overall Study|Progressive Disease|15|||
170380398|NCT00141297|615727049|FG009|Overall Study|Progressive Disease|6|||
170380399|NCT00141297|615727040|FG000|Overall Study|Transitioned|0|||
170380400|NCT00141297|615727041|FG001|Overall Study|Transitioned|0|||
170380401|NCT00141297|615727042|FG002|Overall Study|Transitioned|0|||
170380402|NCT00141297|615727043|FG003|Overall Study|Transitioned|0|||
170380403|NCT00141297|615727044|FG004|Overall Study|Transitioned|1|||
170380404|NCT00141297|615727045|FG005|Overall Study|Transitioned|0|||
170380405|NCT00141297|615727046|FG006|Overall Study|Transitioned|0|||
170380406|NCT00141297|615727047|FG007|Overall Study|Transitioned|0|||
170380407|NCT00141297|615727048|FG008|Overall Study|Transitioned|0|||
170380408|NCT00141297|615727049|FG009|Overall Study|Transitioned|0|||
170380409|NCT02807376|615727050|FG000|Overall Study|Intra-operative exclusion criteria|3|||
170380410|NCT02807376|615727051|FG001|Overall Study|Intra-operative exclusion criteria|0|||
170380411|NCT02807376|615727050|FG000|Overall Study|Lost to Follow-up|0|||
170380412|NCT02807376|615727051|FG001|Overall Study|Lost to Follow-up|1|||
170380413|NCT00125138|615727052|FG000|Overall Study|Adverse Event|1|||
170380414|NCT00125138|615727053|FG001|Overall Study|Adverse Event|0|||
170380415|NCT00125138|615727054|FG002|Overall Study|Adverse Event|3|||
170380416|NCT00125138|615727055|FG003|Overall Study|Adverse Event|2|||
170380417|NCT00125138|615727052|FG000|Overall Study|Withdrawal by Subject|2|||
170380418|NCT00125138|615727053|FG001|Overall Study|Withdrawal by Subject|3|||
170380419|NCT00125138|615727054|FG002|Overall Study|Withdrawal by Subject|1|||
170380420|NCT00125138|615727055|FG003|Overall Study|Withdrawal by Subject|1|||
170380421|NCT00125138|615727052|FG000|Overall Study|Lack of Efficacy|0|||
170380422|NCT00125138|615727053|FG001|Overall Study|Lack of Efficacy|0|||
170380423|NCT00125138|615727054|FG002|Overall Study|Lack of Efficacy|0|||
170380424|NCT00125138|615727055|FG003|Overall Study|Lack of Efficacy|1|||
170380425|NCT00125138|615727052|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
170380426|NCT00125138|615727053|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
170380427|NCT00125138|615727054|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
170380428|NCT00125138|615727055|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
170380429|NCT03228836|615727062|FG000|Overall Study|Adverse Event|3|||
170380430|NCT03228836|615727062|FG000|Overall Study|Withdrawal by Subject|1|||
170380431|NCT03228836|615727062|FG000|Overall Study|Death|1|||
170380432|NCT03228836|615727062|FG000|Overall Study|Physician Decision|1|||
170380433|NCT03228836|615727062|FG000|Overall Study|Disease Progression|7|||
170380434|NCT03228836|615727062|FG000|Overall Study|Other|4|||
170380435|NCT00948389|615727063|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
170380436|NCT00948389|615727064|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
170380437|NCT00948389|615727065|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
170380438|NCT00948389|615727066|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
170380439|NCT00948389|615727067|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
170380440|NCT00948389|615727063|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
170380441|NCT00948389|615727064|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
170380442|NCT00948389|615727065|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
170380443|NCT00948389|615727066|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
170380444|NCT00948389|615727067|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
170380445|NCT00948389|615727063|FG000|Overall Study|Both Progression and Toxicity|1|||
170380446|NCT00948389|615727064|FG001|Overall Study|Both Progression and Toxicity|0|||
170380447|NCT00948389|615727065|FG002|Overall Study|Both Progression and Toxicity|0|||
170380448|NCT00948389|615727066|FG003|Overall Study|Both Progression and Toxicity|0|||
170380449|NCT00948389|615727067|FG004|Overall Study|Both Progression and Toxicity|0|||
170380450|NCT00348686|615727068|FG000|Overall Study|Withdrawal by Subject|45|||
170380451|NCT00348686|615727068|FG000|Overall Study|Adverse Event|5|||
170380452|NCT00348686|615727068|FG000|Overall Study|Protocol Violation|6|||
170380453|NCT00348686|615727068|FG000|Overall Study|Lost to Follow-up|2|||
170380454|NCT00348686|615727068|FG000|Overall Study|Multiple Reasons|8|||
170380455|NCT01258738|615727071|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
170380456|NCT01258738|615727072|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
170380457|NCT01258738|615727071|FG000|Double-blind Period|Withdrawal by Subject|2|||
170380458|NCT01258738|615727072|FG001|Double-blind Period|Withdrawal by Subject|2|||
170380459|NCT01258738|615727071|FG000|Double-blind Period|Protocol Violation|1|||
170380460|NCT01258738|615727072|FG001|Double-blind Period|Protocol Violation|1|||
170380461|NCT01258738|615727071|FG000|Double-blind Period|Adverse Event|3|||
170380462|NCT01258738|615727072|FG001|Double-blind Period|Adverse Event|1|||
170380463|NCT01258738|615727071|FG000|Open-label Period|Did not meet inclusion criteria|0|||
170380464|NCT01258738|615727072|FG001|Open-label Period|Did not meet inclusion criteria|1|||
170380465|NCT01258738|615727071|FG000|Open-label Period|Insufficient clinical response|5|||
170380466|NCT01258738|615727072|FG001|Open-label Period|Insufficient clinical response|3|||
170380467|NCT01258738|615727071|FG000|Open-label Period|Lost to Follow-up|0|||
170380468|NCT01258738|615727072|FG001|Open-label Period|Lost to Follow-up|2|||
170380469|NCT01258738|615727071|FG000|Open-label Period|Withdrawal by Subject|5|||
170380470|NCT01258738|615727072|FG001|Open-label Period|Withdrawal by Subject|6|||
170380471|NCT01258738|615727071|FG000|Open-label Period|Protocol Violation|2|||
170380472|NCT01258738|615727072|FG001|Open-label Period|Protocol Violation|2|||
170380473|NCT01258738|615727071|FG000|Open-label Period|Adverse Event|4|||
170380474|NCT01258738|615727072|FG001|Open-label Period|Adverse Event|5|||
170380475|NCT01258738|615727071|FG000|Open-label Period|Other Reasons|0|||
170380476|NCT01258738|615727072|FG001|Open-label Period|Other Reasons|1|||
170380477|NCT01258738|615727071|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
170380478|NCT01258738|615727072|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
170380479|NCT02967562|615727075|FG000|Overall Study|Consent not obtained|1|||
170380480|NCT02967562|615727076|FG001|Overall Study|Consent not obtained|0|||
170380481|NCT02967562|615727075|FG000|Overall Study|High leak precluding analysis|1|||
170380482|NCT02967562|615727076|FG001|Overall Study|High leak precluding analysis|1|||
170380483|NCT05827978|615727089|FG000|Overall Study|Adverse Event|1|||
170380484|NCT05827978|615727090|FG001|Overall Study|Adverse Event|0|||
170380485|NCT05827978|615727091|FG002|Overall Study|Adverse Event|0|||
170380486|NCT05827978|615727092|FG003|Overall Study|Adverse Event|1|||
170380487|NCT05827978|615727093|FG004|Overall Study|Adverse Event|0|||
170380488|NCT05827978|615727094|FG005|Overall Study|Adverse Event|0|||
170380489|NCT05827978|615727089|FG000|Overall Study|Death|1|||
170380490|NCT05827978|615727090|FG001|Overall Study|Death|5|||
170380491|NCT05827978|615727091|FG002|Overall Study|Death|2|||
170380492|NCT05827978|615727092|FG003|Overall Study|Death|3|||
170380493|NCT05827978|615727093|FG004|Overall Study|Death|1|||
170380494|NCT05827978|615727094|FG005|Overall Study|Death|3|||
170380495|NCT05827978|615727089|FG000|Overall Study|Lost to Follow-up|57|||
170380496|NCT05827978|615727090|FG001|Overall Study|Lost to Follow-up|88|||
170380497|NCT05827978|615727091|FG002|Overall Study|Lost to Follow-up|54|||
170380498|NCT05827978|615727092|FG003|Overall Study|Lost to Follow-up|47|||
170380499|NCT05827978|615727093|FG004|Overall Study|Lost to Follow-up|25|||
170380500|NCT05827978|615727094|FG005|Overall Study|Lost to Follow-up|10|||
170380501|NCT05827978|615727089|FG000|Overall Study|Noncompliance with Study Procedures|0|||
170380502|NCT05827978|615727090|FG001|Overall Study|Noncompliance with Study Procedures|1|||
170380503|NCT05827978|615727091|FG002|Overall Study|Noncompliance with Study Procedures|1|||
170380504|NCT05827978|615727092|FG003|Overall Study|Noncompliance with Study Procedures|1|||
170380505|NCT05827978|615727093|FG004|Overall Study|Noncompliance with Study Procedures|1|||
170380506|NCT05827978|615727094|FG005|Overall Study|Noncompliance with Study Procedures|0|||
170380507|NCT05827978|615727089|FG000|Overall Study|Physician Decision|2|||
170380508|NCT05827978|615727090|FG001|Overall Study|Physician Decision|0|||
170380509|NCT05827978|615727091|FG002|Overall Study|Physician Decision|1|||
170380510|NCT05827978|615727092|FG003|Overall Study|Physician Decision|2|||
170380511|NCT05827978|615727093|FG004|Overall Study|Physician Decision|1|||
170380512|NCT05827978|615727094|FG005|Overall Study|Physician Decision|1|||
170380513|NCT05827978|615727089|FG000|Overall Study|Protocol Violation|5|||
170380514|NCT05827978|615727090|FG001|Overall Study|Protocol Violation|2|||
170380515|NCT05827978|615727091|FG002|Overall Study|Protocol Violation|0|||
170380516|NCT05827978|615727092|FG003|Overall Study|Protocol Violation|0|||
170380517|NCT05827978|615727093|FG004|Overall Study|Protocol Violation|0|||
170380518|NCT05827978|615727094|FG005|Overall Study|Protocol Violation|0|||
170380519|NCT05827978|615727089|FG000|Overall Study|Withdrawal by Subject|17|||
170380520|NCT05827978|615727090|FG001|Overall Study|Withdrawal by Subject|16|||
170380521|NCT05827978|615727091|FG002|Overall Study|Withdrawal by Subject|10|||
170380522|NCT05827978|615727092|FG003|Overall Study|Withdrawal by Subject|12|||
170380523|NCT05827978|615727093|FG004|Overall Study|Withdrawal by Subject|10|||
170380524|NCT05827978|615727094|FG005|Overall Study|Withdrawal by Subject|9|||
170380525|NCT05827978|615727089|FG000|Overall Study|Other Than Specified|0|||
170380526|NCT05827978|615727090|FG001|Overall Study|Other Than Specified|0|||
170380527|NCT05827978|615727091|FG002|Overall Study|Other Than Specified|1|||
170380528|NCT05827978|615727092|FG003|Overall Study|Other Than Specified|0|||
170380529|NCT05827978|615727093|FG004|Overall Study|Other Than Specified|2|||
170380530|NCT05827978|615727094|FG005|Overall Study|Other Than Specified|0|||
170380531|NCT00286156|615727095|FG000|Overall Study|Missed 12 month visit|0|||
170380532|NCT00286156|615727096|FG001|Overall Study|Missed 12 month visit|0|||
170380533|NCT00286156|615727097|FG002|Overall Study|Missed 12 month visit|1|||
170380534|NCT00286156|615727095|FG000|Overall Study|AE: pulmonary embolus|0|||
170380535|NCT00286156|615727096|FG001|Overall Study|AE: pulmonary embolus|1|||
170380536|NCT00286156|615727097|FG002|Overall Study|AE: pulmonary embolus|0|||
170380537|NCT00286156|615727095|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
170380538|NCT00286156|615727096|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
170380539|NCT00286156|615727097|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
170380540|NCT00286156|615727095|FG000|Overall Study|AE: pneumonia|1|||
170380541|NCT00286156|615727096|FG001|Overall Study|AE: pneumonia|0|||
170380542|NCT00286156|615727097|FG002|Overall Study|AE: pneumonia|0|||
170380543|NCT00712712|615727098|FG000|Overall Study|Protocol Violation|11|||
170380544|NCT00712712|615727098|FG000|Overall Study|Radiofrequency not done|3|||
170380545|NCT00712712|615727098|FG000|Overall Study|Death|8|||
170380546|NCT00712712|615727098|FG000|Overall Study|Withdrawal by Subject|1|||
170380547|NCT02381795|615727099|FG000|Overall Study|Withdrawal by Subject|1|||
170380548|NCT02381795|615727099|FG000|Overall Study|Study Terminated|2|||
170380549|NCT02908841|615727100|FG000|Overall Study|Physician Decision|4|||
170380550|NCT02908841|615727101|FG001|Overall Study|Physician Decision|0|||
170380551|NCT00750867|615727102|FG000|Overall Study|Adverse Event|2|||
170380552|NCT00394654|615727103|FG000|Overall Study|Lost to Follow-up|1|||
170380553|NCT00394654|615727104|FG001|Overall Study|Lost to Follow-up|0|||
170380554|NCT00394654|615727103|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
170380555|NCT00394654|615727104|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
170380556|NCT00474539|615727105|FG000|Infant Series|Withdrawal by Subject|3|||
170380557|NCT00474539|615727106|FG001|Infant Series|Withdrawal by Subject|4|||
170380558|NCT00474539|615727105|FG000|Infant Series|Randomization error|5|||
170380559|NCT00474539|615727106|FG001|Infant Series|Randomization error|0|||
170380560|NCT00474539|615727105|FG000|Infant Series|Lost to Follow-up|2|||
170380561|NCT00474539|615727106|FG001|Infant Series|Lost to Follow-up|1|||
170380562|NCT00474539|615727105|FG000|Infant Series|Protocol Violation|0|||
170380563|NCT00474539|615727106|FG001|Infant Series|Protocol Violation|1|||
170380564|NCT00474539|615727105|FG000|After Infant Series|Lost to Follow-up|3|||
170380565|NCT00474539|615727106|FG001|After Infant Series|Lost to Follow-up|0|||
170380566|NCT00474539|615727105|FG000|After Infant Series|Withdrawal by Subject|1|||
170380567|NCT00474539|615727106|FG001|After Infant Series|Withdrawal by Subject|0|||
170380568|NCT00474539|615727105|FG000|Toddler Dose|Protocol Violation|1|||
170380569|NCT00474539|615727106|FG001|Toddler Dose|Protocol Violation|0|||
170380570|NCT01117428|615727107|FG000|Overall Study|Lack of Efficacy|1|||
170380571|NCT01117428|615727108|FG001|Overall Study|Lack of Efficacy|0|||
170380572|NCT01117428|615727109|FG002|Overall Study|Lack of Efficacy|0|||
170380573|NCT01117428|615727110|FG003|Overall Study|Lack of Efficacy|0|||
170380574|NCT01117428|615727111|FG004|Overall Study|Lack of Efficacy|0|||
170380575|NCT01117428|615727112|FG005|Overall Study|Lack of Efficacy|0|||
170380576|NCT01117428|615727107|FG000|Overall Study|Adverse Event|4|||
170380577|NCT01117428|615727108|FG001|Overall Study|Adverse Event|0|||
170380578|NCT01117428|615727109|FG002|Overall Study|Adverse Event|0|||
170380579|NCT01117428|615727110|FG003|Overall Study|Adverse Event|0|||
170380580|NCT01117428|615727111|FG004|Overall Study|Adverse Event|1|||
170380581|NCT01117428|615727112|FG005|Overall Study|Adverse Event|2|||
170380582|NCT01117428|615727107|FG000|Overall Study|Death|0|||
170380583|NCT01117428|615727108|FG001|Overall Study|Death|1|||
170380584|NCT01117428|615727109|FG002|Overall Study|Death|2|||
170380585|NCT01117428|615727110|FG003|Overall Study|Death|0|||
170380586|NCT01117428|615727111|FG004|Overall Study|Death|0|||
170380587|NCT01117428|615727112|FG005|Overall Study|Death|1|||
170380588|NCT01117428|615727107|FG000|Overall Study|Physician Decision|0|||
170380589|NCT01117428|615727108|FG001|Overall Study|Physician Decision|1|||
170380590|NCT01117428|615727109|FG002|Overall Study|Physician Decision|0|||
170380591|NCT01117428|615727110|FG003|Overall Study|Physician Decision|0|||
170380592|NCT01117428|615727111|FG004|Overall Study|Physician Decision|0|||
170380593|NCT01117428|615727112|FG005|Overall Study|Physician Decision|0|||
170380594|NCT01117428|615727107|FG000|Overall Study|Withdrawal by Subject|0|||
170380595|NCT01117428|615727108|FG001|Overall Study|Withdrawal by Subject|0|||
170380596|NCT01117428|615727109|FG002|Overall Study|Withdrawal by Subject|1|||
170380597|NCT01117428|615727110|FG003|Overall Study|Withdrawal by Subject|0|||
170380598|NCT01117428|615727111|FG004|Overall Study|Withdrawal by Subject|0|||
170380599|NCT01117428|615727112|FG005|Overall Study|Withdrawal by Subject|0|||
170380600|NCT01117428|615727107|FG000|Overall Study|Progressive disease|15|||
170380601|NCT01117428|615727108|FG001|Overall Study|Progressive disease|27|||
170380602|NCT01117428|615727109|FG002|Overall Study|Progressive disease|10|||
170380603|NCT01117428|615727110|FG003|Overall Study|Progressive disease|12|||
170380604|NCT01117428|615727111|FG004|Overall Study|Progressive disease|16|||
170380605|NCT01117428|615727112|FG005|Overall Study|Progressive disease|17|||
170380606|NCT01836549|615727115|FG000|Overall Study|Did not receive study drug|0|||
170380607|NCT01836549|615727116|FG001|Overall Study|Did not receive study drug|0|||
170380608|NCT01836549|615727117|FG002|Overall Study|Did not receive study drug|1|||
170380609|NCT01836549|615727118|FG003|Overall Study|Did not receive study drug|0|||
170380610|NCT01836549|615727119|FG004|Overall Study|Did not receive study drug|0|||
170380611|NCT01836549|615727120|FG005|Overall Study|Did not receive study drug|0|||
170380612|NCT01836549|615727121|FG006|Overall Study|Did not receive study drug|0|||
170380613|NCT01836549|615727115|FG000|Overall Study|Patient declared ineligible|0|||
170380614|NCT01836549|615727116|FG001|Overall Study|Patient declared ineligible|0|||
170380615|NCT01836549|615727117|FG002|Overall Study|Patient declared ineligible|0|||
170380616|NCT01836549|615727118|FG003|Overall Study|Patient declared ineligible|1|||
170380617|NCT01836549|615727119|FG004|Overall Study|Patient declared ineligible|0|||
170380618|NCT01836549|615727120|FG005|Overall Study|Patient declared ineligible|0|||
170380619|NCT01836549|615727121|FG006|Overall Study|Patient declared ineligible|0|||
170380620|NCT01836549|615727115|FG000|Overall Study|Patient inevaluable to start therapy|0|||
170380621|NCT01836549|615727116|FG001|Overall Study|Patient inevaluable to start therapy|0|||
170380622|NCT01836549|615727117|FG002|Overall Study|Patient inevaluable to start therapy|0|||
170380623|NCT01836549|615727118|FG003|Overall Study|Patient inevaluable to start therapy|0|||
170380624|NCT01836549|615727119|FG004|Overall Study|Patient inevaluable to start therapy|0|||
170380625|NCT01836549|615727120|FG005|Overall Study|Patient inevaluable to start therapy|0|||
170380626|NCT01836549|615727121|FG006|Overall Study|Patient inevaluable to start therapy|1|||
170380627|NCT02192190|615727124|FG000|Overall Study|Adverse Event|1|||
170380628|NCT02192190|615727125|FG001|Overall Study|Adverse Event|1|||
170380629|NCT02192190|615727126|FG002|Overall Study|Adverse Event|0|||
170380630|NCT02192190|615727127|FG003|Overall Study|Adverse Event|0|||
170380631|NCT02192190|615727128|FG004|Overall Study|Adverse Event|0|||
170380632|NCT02192190|615727129|FG005|Overall Study|Adverse Event|0|||
170380633|NCT02192190|615727124|FG000|Overall Study|Lost to Follow-up|3|||
170380634|NCT02192190|615727125|FG001|Overall Study|Lost to Follow-up|3|||
170380635|NCT02192190|615727126|FG002|Overall Study|Lost to Follow-up|2|||
170380636|NCT02192190|615727127|FG003|Overall Study|Lost to Follow-up|1|||
170380637|NCT02192190|615727128|FG004|Overall Study|Lost to Follow-up|4|||
170380638|NCT02192190|615727129|FG005|Overall Study|Lost to Follow-up|3|||
170380639|NCT02192190|615727124|FG000|Overall Study|Physician Decision|2|||
170380640|NCT02192190|615727125|FG001|Overall Study|Physician Decision|0|||
170380641|NCT02192190|615727126|FG002|Overall Study|Physician Decision|0|||
170380642|NCT02192190|615727127|FG003|Overall Study|Physician Decision|0|||
170380643|NCT02192190|615727128|FG004|Overall Study|Physician Decision|0|||
170380644|NCT02192190|615727129|FG005|Overall Study|Physician Decision|0|||
170380645|NCT02192190|615727124|FG000|Overall Study|Terminated by Sponsor|43|||
170380646|NCT02192190|615727125|FG001|Overall Study|Terminated by Sponsor|23|||
170380647|NCT02192190|615727126|FG002|Overall Study|Terminated by Sponsor|20|||
170380648|NCT02192190|615727127|FG003|Overall Study|Terminated by Sponsor|23|||
170380649|NCT02192190|615727128|FG004|Overall Study|Terminated by Sponsor|21|||
170380650|NCT02192190|615727129|FG005|Overall Study|Terminated by Sponsor|23|||
170380651|NCT02192190|615727124|FG000|Overall Study|Withdrawal by Subject|4|||
170380652|NCT02192190|615727125|FG001|Overall Study|Withdrawal by Subject|1|||
170380653|NCT02192190|615727126|FG002|Overall Study|Withdrawal by Subject|2|||
170380654|NCT02192190|615727127|FG003|Overall Study|Withdrawal by Subject|1|||
170380655|NCT02192190|615727128|FG004|Overall Study|Withdrawal by Subject|5|||
170380656|NCT02192190|615727129|FG005|Overall Study|Withdrawal by Subject|3|||
170380657|NCT02192190|615727124|FG000|Overall Study|Could not Keep Visit Schedule|1|||
170380658|NCT02192190|615727125|FG001|Overall Study|Could not Keep Visit Schedule|0|||
170380659|NCT02192190|615727126|FG002|Overall Study|Could not Keep Visit Schedule|0|||
170380660|NCT02192190|615727127|FG003|Overall Study|Could not Keep Visit Schedule|0|||
170380661|NCT02192190|615727128|FG004|Overall Study|Could not Keep Visit Schedule|0|||
170380662|NCT02192190|615727129|FG005|Overall Study|Could not Keep Visit Schedule|0|||
170380663|NCT02192190|615727124|FG000|Overall Study|Positive Drug Screen|0|||
170380664|NCT02192190|615727125|FG001|Overall Study|Positive Drug Screen|0|||
170380665|NCT02192190|615727126|FG002|Overall Study|Positive Drug Screen|0|||
170380666|NCT02192190|615727127|FG003|Overall Study|Positive Drug Screen|1|||
170380667|NCT02192190|615727128|FG004|Overall Study|Positive Drug Screen|0|||
170380668|NCT02192190|615727129|FG005|Overall Study|Positive Drug Screen|0|||
170380669|NCT02192190|615727124|FG000|Overall Study|Inadequate Pain Relief|0|||
170380670|NCT02192190|615727125|FG001|Overall Study|Inadequate Pain Relief|1|||
170380671|NCT02192190|615727126|FG002|Overall Study|Inadequate Pain Relief|1|||
170380672|NCT02192190|615727127|FG003|Overall Study|Inadequate Pain Relief|0|||
170380673|NCT02192190|615727128|FG004|Overall Study|Inadequate Pain Relief|0|||
170380674|NCT02192190|615727129|FG005|Overall Study|Inadequate Pain Relief|0|||
170380675|NCT01657253|615727130|FG000|Overall Study|Lost to Follow-up|6|||
170380676|NCT01657253|615727131|FG001|Overall Study|Lost to Follow-up|5|||
170380677|NCT01657253|615727130|FG000|Overall Study|Withdrawal by Subject|11|||
170380678|NCT01657253|615727131|FG001|Overall Study|Withdrawal by Subject|12|||
170380679|NCT01657253|615727130|FG000|Overall Study|Adverse Event|0|||
170380680|NCT01657253|615727131|FG001|Overall Study|Adverse Event|1|||
170380681|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Adverse Event|30|||
170380682|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Adverse Event|25|||
170380683|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Adverse Event|23|||
170380684|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Adverse Event|14|||
170380685|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Death|0|||
170380686|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Death|0|||
170380687|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Death|1|||
170380688|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Death|0|||
170380689|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Physician Decision|0|||
170380690|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Physician Decision|1|||
170380691|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Physician Decision|0|||
170380692|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Physician Decision|1|||
170380693|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
170380694|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
170380695|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
170380696|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
170380697|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Other|6|||
170380698|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Other|1|||
170380699|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Other|0|||
170380700|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Other|2|||
170380701|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
170380702|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
170380703|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
170380704|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
170380705|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
170380706|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
170380707|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
170380708|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
170380709|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
170380710|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
170380711|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
170380712|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
170380713|NCT00242710|615727132|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
170380714|NCT00242710|615727133|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
170380715|NCT00242710|615727134|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
170380716|NCT00242710|615727135|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
170380717|NCT00242710|615727132|FG000|Period Between Core Study and Extension|Adverse Event|2|||
170380718|NCT00242710|615727133|FG001|Period Between Core Study and Extension|Adverse Event|3|||
170380719|NCT00242710|615727134|FG002|Period Between Core Study and Extension|Adverse Event|5|||
170380720|NCT00242710|615727135|FG003|Period Between Core Study and Extension|Adverse Event|2|||
170380721|NCT00242710|615727132|FG000|Period Between Core Study and Extension|Physician Decision|1|||
170380722|NCT00242710|615727133|FG001|Period Between Core Study and Extension|Physician Decision|1|||
170380723|NCT00242710|615727134|FG002|Period Between Core Study and Extension|Physician Decision|0|||
170380724|NCT00242710|615727135|FG003|Period Between Core Study and Extension|Physician Decision|0|||
170380725|NCT00242710|615727132|FG000|Period Between Core Study and Extension|Other|24|||
170380726|NCT00242710|615727133|FG001|Period Between Core Study and Extension|Other|24|||
170380727|NCT00242710|615727134|FG002|Period Between Core Study and Extension|Other|9|||
170380728|NCT00242710|615727135|FG003|Period Between Core Study and Extension|Other|11|||
170380729|NCT00242710|615727132|FG000|Period Between Core Study and Extension|Extension not Available|17|||
170380730|NCT00242710|615727133|FG001|Period Between Core Study and Extension|Extension not Available|21|||
170380731|NCT00242710|615727134|FG002|Period Between Core Study and Extension|Extension not Available|8|||
170380732|NCT00242710|615727135|FG003|Period Between Core Study and Extension|Extension not Available|7|||
170380733|NCT00242710|615727132|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
170380734|NCT00242710|615727133|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
170380735|NCT00242710|615727134|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
170380736|NCT00242710|615727135|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
170380737|NCT00242710|615727132|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
170380738|NCT00242710|615727133|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
170380739|NCT00242710|615727134|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
170380740|NCT00242710|615727135|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
170380741|NCT00242710|615727132|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
170380742|NCT00242710|615727133|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
170380743|NCT00242710|615727134|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
170380744|NCT00242710|615727135|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
170380745|NCT00242710|615727132|FG000|Study Extension (up to Year 2)|Death|0|||
170380746|NCT00242710|615727133|FG001|Study Extension (up to Year 2)|Death|0|||
170380747|NCT00242710|615727134|FG002|Study Extension (up to Year 2)|Death|0|||
170380748|NCT00242710|615727135|FG003|Study Extension (up to Year 2)|Death|1|||
170380749|NCT00242710|615727132|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
170380750|NCT00242710|615727133|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
170380751|NCT00242710|615727134|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
170380752|NCT00242710|615727135|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
170380753|NCT00242710|615727132|FG000|Study Extension (up to Year 2)|Other|3|||
170380754|NCT00242710|615727133|FG001|Study Extension (up to Year 2)|Other|5|||
170380755|NCT00242710|615727134|FG002|Study Extension (up to Year 2)|Other|4|||
170380756|NCT00242710|615727135|FG003|Study Extension (up to Year 2)|Other|3|||
170380757|NCT00242710|615727132|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
170380758|NCT00242710|615727133|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
170380759|NCT00242710|615727134|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
170380760|NCT00242710|615727135|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
170380761|NCT00242710|615727132|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
170380762|NCT00242710|615727133|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
170380763|NCT00242710|615727134|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
170380764|NCT00242710|615727135|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
170380765|NCT00808132|615727136|FG000|Overall Study|Adverse Event|34|||
170380766|NCT00808132|615727137|FG001|Overall Study|Adverse Event|33|||
170380767|NCT00808132|615727138|FG002|Overall Study|Adverse Event|16|||
170380768|NCT00808132|615727139|FG003|Overall Study|Adverse Event|31|||
170380769|NCT00808132|615727140|FG004|Overall Study|Adverse Event|33|||
170380770|NCT00808132|615727136|FG000|Overall Study|Death|0|||
170380771|NCT00808132|615727137|FG001|Overall Study|Death|0|||
170380772|NCT00808132|615727138|FG002|Overall Study|Death|0|||
170380773|NCT00808132|615727139|FG003|Overall Study|Death|0|||
170380774|NCT00808132|615727140|FG004|Overall Study|Death|1|||
170380775|NCT00808132|615727136|FG000|Overall Study|Physician Decision|0|||
170380776|NCT00808132|615727137|FG001|Overall Study|Physician Decision|1|||
170380777|NCT00808132|615727138|FG002|Overall Study|Physician Decision|0|||
170380778|NCT00808132|615727139|FG003|Overall Study|Physician Decision|0|||
170380779|NCT00808132|615727140|FG004|Overall Study|Physician Decision|0|||
170380780|NCT00808132|615727136|FG000|Overall Study|Lost to Follow-up|8|||
170380781|NCT00808132|615727137|FG001|Overall Study|Lost to Follow-up|10|||
170380782|NCT00808132|615727138|FG002|Overall Study|Lost to Follow-up|11|||
170380783|NCT00808132|615727139|FG003|Overall Study|Lost to Follow-up|8|||
170380784|NCT00808132|615727140|FG004|Overall Study|Lost to Follow-up|9|||
170380785|NCT00808132|615727136|FG000|Overall Study|Protocol Violation|8|||
170380786|NCT00808132|615727137|FG001|Overall Study|Protocol Violation|9|||
170380787|NCT00808132|615727138|FG002|Overall Study|Protocol Violation|4|||
170380788|NCT00808132|615727139|FG003|Overall Study|Protocol Violation|9|||
170380789|NCT00808132|615727140|FG004|Overall Study|Protocol Violation|5|||
170380790|NCT00808132|615727136|FG000|Overall Study|Withdrawal by Subject|27|||
170380791|NCT00808132|615727137|FG001|Overall Study|Withdrawal by Subject|18|||
170380792|NCT00808132|615727138|FG002|Overall Study|Withdrawal by Subject|2|||
170380793|NCT00808132|615727139|FG003|Overall Study|Withdrawal by Subject|7|||
170380794|NCT00808132|615727140|FG004|Overall Study|Withdrawal by Subject|16|||
170380795|NCT00808132|615727136|FG000|Overall Study|Other|6|||
170380796|NCT00808132|615727137|FG001|Overall Study|Other|4|||
170380797|NCT00808132|615727138|FG002|Overall Study|Other|6|||
170380798|NCT00808132|615727139|FG003|Overall Study|Other|2|||
170380799|NCT00808132|615727140|FG004|Overall Study|Other|15|||
170380800|NCT00808132|615727136|FG000|Overall Study|Randomized, but not treated|10|||
170380801|NCT00808132|615727137|FG001|Overall Study|Randomized, but not treated|7|||
170380802|NCT00808132|615727138|FG002|Overall Study|Randomized, but not treated|9|||
170380803|NCT00808132|615727139|FG003|Overall Study|Randomized, but not treated|8|||
170380804|NCT00808132|615727140|FG004|Overall Study|Randomized, but not treated|9|||
170380805|NCT00808132|615727136|FG000|Overall Study|Unsatisfactory response|5|||
170380806|NCT00808132|615727137|FG001|Overall Study|Unsatisfactory response|6|||
170380807|NCT00808132|615727138|FG002|Overall Study|Unsatisfactory response|6|||
170380808|NCT00808132|615727139|FG003|Overall Study|Unsatisfactory response|4|||
170380809|NCT00808132|615727140|FG004|Overall Study|Unsatisfactory response|12|||
170380810|NCT02181504|615727141|FG000|Overall Study|Adverse Event|1|||
170380811|NCT02181504|615727142|FG001|Overall Study|Adverse Event|1|||
170380812|NCT02181504|615727143|FG002|Overall Study|Adverse Event|1|||
170380813|NCT00702949|615727144|FG000|Overall Study|Refusal|3|||
170380814|NCT00702949|615727145|FG001|Overall Study|Refusal|2|||
170380815|NCT00702949|615727146|FG002|Overall Study|Refusal|2|||
170380816|NCT00702949|615727144|FG000|Overall Study|Adverse Event|1|||
170380817|NCT00702949|615727145|FG001|Overall Study|Adverse Event|6|||
170380818|NCT00702949|615727146|FG002|Overall Study|Adverse Event|3|||
170380819|NCT00702949|615727144|FG000|Overall Study|Other Medical Reason/unknown|1|||
170380820|NCT00702949|615727145|FG001|Overall Study|Other Medical Reason/unknown|1|||
170380821|NCT00702949|615727146|FG002|Overall Study|Other Medical Reason/unknown|3|||
170380822|NCT00598585|615727147|FG000|Overall Study|Lost to Follow-up|1|||
170380823|NCT00598585|615727148|FG001|Overall Study|Lost to Follow-up|0|||
170380824|NCT00545584|615727149|FG000|Overall Study|Only one reason for discontinuation|62|||
170380825|NCT00545584|615727150|FG001|Overall Study|Only one reason for discontinuation|61|||
170380826|NCT00545584|615727151|FG002|Overall Study|Only one reason for discontinuation|48|||
170380827|NCT00545584|615727149|FG000|Overall Study|Two or more reasons for discontinuation|17|||
170380828|NCT00545584|615727150|FG001|Overall Study|Two or more reasons for discontinuation|19|||
170380829|NCT00545584|615727151|FG002|Overall Study|Two or more reasons for discontinuation|8|||
170380830|NCT00374452|615727154|FG000|Overall Study|Left clinic before intervention started|4|||
170380831|NCT00374452|615727155|FG001|Overall Study|Left clinic before intervention started|1|||
170380832|NCT00374452|615727154|FG000|Overall Study|Change in job role before intervention|0|||
170380833|NCT00374452|615727155|FG001|Overall Study|Change in job role before intervention|1|||
170380834|NCT00374452|615727154|FG000|Overall Study|Left clinic after intervention started|1|||
170380835|NCT00374452|615727155|FG001|Overall Study|Left clinic after intervention started|1|||
170380836|NCT00374452|615727154|FG000|Overall Study|Withdrawal by Subject|0|||
170380837|NCT00374452|615727155|FG001|Overall Study|Withdrawal by Subject|2|||
170380838|NCT04055844|615727156|FG000|Overall Study|Adverse Event|12|||
170380839|NCT04055844|615727156|FG000|Overall Study|Poor Performance|1|||
170380840|NCT04055844|615727156|FG000|Overall Study|Death|1|||
170380841|NCT00572728|615727157|FG000|Overall Study|Withdrawal by Subject|10|||
170380842|NCT00572728|615727157|FG000|Overall Study|Ineligible|3|||
170380843|NCT00572728|615727157|FG000|Overall Study|Enrolled under Amendment 4|5|||
170380844|NCT00572728|615727157|FG000|Overall Study|Offstudy due to complicating disease|1|||
170380845|NCT00572728|615727157|FG000|Overall Study|FLT1 not completed|4|||
170380846|NCT00572728|615727157|FG000|Overall Study|First Chemotherapy not initiated|2|||
170380847|NCT00572728|615727157|FG000|Overall Study|FLT2 not completed|5|||
170380848|NCT00572728|615727157|FG000|Overall Study|Second chemotherapy not initiated|1|||
170380849|NCT00572728|615727157|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
170380850|NCT00572728|615727157|FG000|Overall Study|Pathology missing|1|||
170380851|NCT00537810|615727163|FG000|Overall Study|Withdrawal by Subject|4|||
170380852|NCT00537810|615727164|FG001|Overall Study|Withdrawal by Subject|11|||
170380853|NCT00537810|615727165|FG002|Overall Study|Withdrawal by Subject|4|||
170380854|NCT00537810|615727166|FG003|Overall Study|Withdrawal by Subject|3|||
170380855|NCT00537810|615727163|FG000|Overall Study|Medically withdrawn|2|||
170380856|NCT00537810|615727164|FG001|Overall Study|Medically withdrawn|2|||
170380857|NCT00537810|615727165|FG002|Overall Study|Medically withdrawn|0|||
170380858|NCT00537810|615727166|FG003|Overall Study|Medically withdrawn|1|||
170380859|NCT02449915|615727167|FG000|Overall Study|Exclusion criteria - drug use|1|||
170380860|NCT02449915|615727168|FG001|Overall Study|Exclusion criteria - drug use|0|||
170380861|NCT02449915|615727167|FG000|Overall Study|Withdrawal by Subject|0|||
170380862|NCT02449915|615727168|FG001|Overall Study|Withdrawal by Subject|2|||
170380863|NCT02449915|615727167|FG000|Overall Study|Intraoperative surgical findings|1|||
170380864|NCT02449915|615727168|FG001|Overall Study|Intraoperative surgical findings|1|||
170380865|NCT02449915|615727167|FG000|Overall Study|Abnormal preop lab|0|||
170380866|NCT02449915|615727168|FG001|Overall Study|Abnormal preop lab|1|||
170380867|NCT01060150|615728635|FG000|Overall Study|Adverse Event|6|||
170380868|NCT01060150|615728635|FG000|Overall Study|Lost to Follow-up|1|||
170380869|NCT01060150|615728635|FG000|Overall Study|Protocol Violation|6|||
170380870|NCT01060150|615728635|FG000|Overall Study|Withdrawal by Subject|8|||
170380871|NCT01060150|615728635|FG000|Overall Study|Enrolled, but not treated|2|||
170380872|NCT02555722|615728645|FG000|Week 2|Adverse Event|0|||
170380873|NCT02555722|615728646|FG001|Week 2|Adverse Event|1|||
170380874|NCT02555722|615728645|FG000|Week 2|Withdrawal by Subject|1|||
170380875|NCT02555722|615728646|FG001|Week 2|Withdrawal by Subject|0|||
170380876|NCT02555722|615728645|FG000|Month 1|Lens Discomfort|1|||
170380877|NCT02555722|615728646|FG001|Month 1|Lens Discomfort|0|||
170380878|NCT02555722|615728645|FG000|Month 2|Withdrawal by Subject|3|||
170380879|NCT02555722|615728646|FG001|Month 2|Withdrawal by Subject|0|||
170380880|NCT02555722|615728645|FG000|Month 2|Lost to Follow-up|1|||
170380881|NCT02555722|615728646|FG001|Month 2|Lost to Follow-up|0|||
170380882|NCT00660816|615728650|FG000|Overall Study|Adverse Event|1|||
170380883|NCT00660816|615728651|FG001|Overall Study|Adverse Event|2|||
170380884|NCT00660816|615728650|FG000|Overall Study|Withdrawal by Subject|1|||
170380885|NCT00660816|615728651|FG001|Overall Study|Withdrawal by Subject|0|||
170380886|NCT00660816|615728650|FG000|Overall Study|Death|0|||
170380887|NCT00660816|615728651|FG001|Overall Study|Death|2|||
170380888|NCT00660816|615728650|FG000|Overall Study|Lack of Efficacy|1|||
170380889|NCT00660816|615728651|FG001|Overall Study|Lack of Efficacy|0|||
170380890|NCT00660816|615728650|FG000|Overall Study|Physician Decision|0|||
170380891|NCT00660816|615728651|FG001|Overall Study|Physician Decision|2|||
170380892|NCT00660816|615728650|FG000|Overall Study|Protocol Violation|1|||
170380893|NCT00660816|615728651|FG001|Overall Study|Protocol Violation|0|||
170380894|NCT00660816|615728650|FG000|Overall Study|Disease Progression|16|||
170380895|NCT00660816|615728651|FG001|Overall Study|Disease Progression|12|||
170380896|NCT00660816|615728650|FG000|Overall Study|Complicating Disease|0|||
170380897|NCT00660816|615728651|FG001|Overall Study|Complicating Disease|1|||
170380898|NCT00998985|615728655|FG000|Overall Study|Withdrawal by Subject|0|||
170380899|NCT00998985|615728656|FG001|Overall Study|Withdrawal by Subject|0|||
170380900|NCT00998985|615728657|FG002|Overall Study|Withdrawal by Subject|0|||
170380901|NCT00998985|615728658|FG003|Overall Study|Withdrawal by Subject|0|||
170380902|NCT00998985|615728659|FG004|Overall Study|Withdrawal by Subject|0|||
170380903|NCT00998985|615728660|FG005|Overall Study|Withdrawal by Subject|0|||
170380904|NCT00998985|615728661|FG006|Overall Study|Withdrawal by Subject|0|||
170380905|NCT00998985|615728662|FG007|Overall Study|Withdrawal by Subject|0|||
170380906|NCT00998985|615728663|FG008|Overall Study|Withdrawal by Subject|1|||
170380907|NCT00998985|615728664|FG009|Overall Study|Withdrawal by Subject|0|||
170380908|NCT00998985|615728665|FG010|Overall Study|Withdrawal by Subject|0|||
170380909|NCT00998985|615728666|FG011|Overall Study|Withdrawal by Subject|0|||
170380910|NCT00998985|615728667|FG012|Overall Study|Withdrawal by Subject|0|||
170380911|NCT00998985|615728668|FG013|Overall Study|Withdrawal by Subject|0|||
170380912|NCT00998985|615728655|FG000|Overall Study|Protocol Violation|0|||
170380913|NCT00998985|615728656|FG001|Overall Study|Protocol Violation|0|||
170380914|NCT00998985|615728657|FG002|Overall Study|Protocol Violation|0|||
170380915|NCT00998985|615728658|FG003|Overall Study|Protocol Violation|0|||
170380916|NCT00998985|615728659|FG004|Overall Study|Protocol Violation|0|||
170380917|NCT00998985|615728660|FG005|Overall Study|Protocol Violation|1|||
170380918|NCT00998985|615728661|FG006|Overall Study|Protocol Violation|0|||
170380919|NCT00998985|615728662|FG007|Overall Study|Protocol Violation|0|||
170380920|NCT00998985|615728663|FG008|Overall Study|Protocol Violation|0|||
170380921|NCT00998985|615728664|FG009|Overall Study|Protocol Violation|0|||
170380922|NCT00998985|615728665|FG010|Overall Study|Protocol Violation|0|||
170380923|NCT00998985|615728666|FG011|Overall Study|Protocol Violation|0|||
170380924|NCT00998985|615728667|FG012|Overall Study|Protocol Violation|0|||
170380925|NCT00998985|615728668|FG013|Overall Study|Protocol Violation|0|||
170380926|NCT01040728|615728669|FG000|Overall Study|Adverse Event|4|||
170380927|NCT01040728|615728670|FG001|Overall Study|Adverse Event|8|||
170380928|NCT01040728|615728671|FG002|Overall Study|Adverse Event|0|||
170380929|NCT01040728|615728672|FG003|Overall Study|Adverse Event|4|||
170380930|NCT01040728|615728669|FG000|Overall Study|Withdrawal by Subject|0|||
170380931|NCT01040728|615728670|FG001|Overall Study|Withdrawal by Subject|1|||
170380932|NCT01040728|615728671|FG002|Overall Study|Withdrawal by Subject|1|||
170380933|NCT01040728|615728672|FG003|Overall Study|Withdrawal by Subject|0|||
170380934|NCT01040728|615728669|FG000|Overall Study|Protocol Violation|0|||
170380935|NCT01040728|615728670|FG001|Overall Study|Protocol Violation|0|||
170380936|NCT01040728|615728671|FG002|Overall Study|Protocol Violation|0|||
170380937|NCT01040728|615728672|FG003|Overall Study|Protocol Violation|1|||
170380938|NCT01040728|615728669|FG000|Overall Study|Lack of Efficacy|0|||
170380939|NCT01040728|615728670|FG001|Overall Study|Lack of Efficacy|1|||
170380940|NCT01040728|615728671|FG002|Overall Study|Lack of Efficacy|0|||
170380941|NCT01040728|615728672|FG003|Overall Study|Lack of Efficacy|1|||
170380942|NCT01040728|615728669|FG000|Overall Study|Other reasons not listed above|0|||
170380943|NCT01040728|615728670|FG001|Overall Study|Other reasons not listed above|1|||
170380944|NCT01040728|615728671|FG002|Overall Study|Other reasons not listed above|0|||
170380945|NCT01040728|615728672|FG003|Overall Study|Other reasons not listed above|0|||
170380946|NCT00415623|615728678|FG000|Overall Study|Adverse Event|3|||
170380947|NCT00415623|615728679|FG001|Overall Study|Adverse Event|4|||
170380948|NCT00415623|615728678|FG000|Overall Study|Death|1|||
170380949|NCT00415623|615728679|FG001|Overall Study|Death|0|||
170380950|NCT00415623|615728678|FG000|Overall Study|Withdrawal by Subject|1|||
170380951|NCT00415623|615728679|FG001|Overall Study|Withdrawal by Subject|1|||
170380952|NCT01846208|615728680|FG000|Overall Study|Withdrew prior to treatment|1|||
170380953|NCT01846208|615728681|FG001|Overall Study|Withdrew prior to treatment|1|||
170380954|NCT01846208|615728682|FG002|Overall Study|Withdrew prior to treatment|1|||
170380955|NCT01846208|615728680|FG000|Overall Study|Dosing Symptoms|1|||
170380956|NCT01846208|615728681|FG001|Overall Study|Dosing Symptoms|2|||
170380957|NCT01846208|615728682|FG002|Overall Study|Dosing Symptoms|6|||
170380958|NCT01846208|615728680|FG000|Overall Study|Withdrawal by Subject|5|||
170380959|NCT01846208|615728681|FG001|Overall Study|Withdrawal by Subject|0|||
170380960|NCT01846208|615728682|FG002|Overall Study|Withdrawal by Subject|0|||
170380961|NCT01846208|615728680|FG000|Overall Study|Non-compliance|1|||
170380962|NCT01846208|615728681|FG001|Overall Study|Non-compliance|1|||
170380963|NCT01846208|615728682|FG002|Overall Study|Non-compliance|0|||
170380964|NCT01846208|615728680|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
170380965|NCT01846208|615728681|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
170380966|NCT01846208|615728682|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
170380967|NCT01846208|615728680|FG000|Overall Study|Refused SU OFC|0|||
170380968|NCT01846208|615728681|FG001|Overall Study|Refused SU OFC|0|||
170380969|NCT01846208|615728682|FG002|Overall Study|Refused SU OFC|1|||
170380970|NCT01424306|615728683|FG000|Overall Study|Protocol Violation|0|||
170380971|NCT01424306|615728684|FG001|Overall Study|Protocol Violation|0|||
170380972|NCT01424306|615728685|FG002|Overall Study|Protocol Violation|0|||
170380973|NCT01424306|615728686|FG003|Overall Study|Protocol Violation|0|||
170380974|NCT01424306|615728687|FG004|Overall Study|Protocol Violation|1|||
170380975|NCT01424306|615728688|FG005|Overall Study|Protocol Violation|0|||
170380976|NCT01601873|615728691|FG000|Overall Study|Lost to Follow-up|2|||
170380977|NCT01601873|615728692|FG001|Overall Study|Lost to Follow-up|3|||
170380978|NCT01875874|615728693|FG000|Overall Study|Death|3|||
170380979|NCT03196973|615728694|FG000|Overall Study|Adverse Event|1|||
170380980|NCT03196973|615728695|FG001|Overall Study|Adverse Event|1|||
170380981|NCT03196973|615728696|FG002|Overall Study|Adverse Event|2|||
170380982|NCT03196973|615728694|FG000|Overall Study|Lack of Efficacy|2|||
170380983|NCT03196973|615728695|FG001|Overall Study|Lack of Efficacy|6|||
170380984|NCT03196973|615728696|FG002|Overall Study|Lack of Efficacy|1|||
170380985|NCT03196973|615728694|FG000|Overall Study|Lost to Follow-up|4|||
170380986|NCT03196973|615728695|FG001|Overall Study|Lost to Follow-up|3|||
170380987|NCT03196973|615728696|FG002|Overall Study|Lost to Follow-up|2|||
170380988|NCT03196973|615728694|FG000|Overall Study|Consent withdrawn|2|||
170380989|NCT03196973|615728695|FG001|Overall Study|Consent withdrawn|1|||
170380990|NCT03196973|615728696|FG002|Overall Study|Consent withdrawn|0|||
170380991|NCT03196973|615728694|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
170380992|NCT03196973|615728695|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
170380993|NCT03196973|615728696|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
170380994|NCT03344562|615728697|FG000|Overall Study|Withdrawal by Subject|2|||
170380995|NCT03344562|615728698|FG001|Overall Study|Withdrawal by Subject|0|||
170380996|NCT01610414|615728699|FG000|Study Start - Month 13|Serious Adverse Event|65|||
170380997|NCT01610414|615728700|FG001|Study Start - Month 13|Serious Adverse Event|67|||
170380998|NCT01610414|615728699|FG000|Study Start - Month 13|Adverse Event|14|||
170380999|NCT01610414|615728700|FG001|Study Start - Month 13|Adverse Event|14|||
170381000|NCT01610414|615728699|FG000|Study Start - Month 13|Protocol Violation|3|||
170381001|NCT01610414|615728700|FG001|Study Start - Month 13|Protocol Violation|1|||
170381002|NCT01610414|615728699|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
170381003|NCT01610414|615728700|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
170381004|NCT01610414|615728699|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
170381005|NCT01610414|615728700|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
170381006|NCT01610414|615728699|FG000|Study Start - Month 13|Lost to Follow-up|4|||
170381007|NCT01610414|615728700|FG001|Study Start - Month 13|Lost to Follow-up|6|||
170381008|NCT01610414|615728699|FG000|Study Start - Month 13|Suspected HZ episode|1|||
170381009|NCT01610414|615728700|FG001|Study Start - Month 13|Suspected HZ episode|3|||
170381010|NCT01610414|615728699|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
170381011|NCT01610414|615728700|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
170381012|NCT01610414|615728699|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
170381013|NCT01610414|615728700|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
170381014|NCT01610414|615728699|FG000|Month 13 - Month 25|Adverse Event|8|||
170381015|NCT01610414|615728700|FG001|Month 13 - Month 25|Adverse Event|4|||
170381016|NCT01610414|615728699|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
170381017|NCT01610414|615728700|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
170381018|NCT01610414|615728699|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
170381019|NCT01610414|615728700|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
170381020|NCT01610414|615728699|FG000|Month 13 - Month 25|Protocol Violation|0|||
170381021|NCT01610414|615728700|FG001|Month 13 - Month 25|Protocol Violation|2|||
170381022|NCT01610414|615728699|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
170381023|NCT01610414|615728700|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
170381024|NCT01610414|615728699|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
170381025|NCT01610414|615728700|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
170381026|NCT01610414|615728699|FG000|After Month 25|Study end not reached|48|||
170381027|NCT01610414|615728700|FG001|After Month 25|Study end not reached|53|||
170381028|NCT02736474|615728702|FG000|Overall Study|Lost to Follow-up|0|||
170381029|NCT02736474|615728703|FG001|Overall Study|Lost to Follow-up|1|||
170381030|NCT00472043|615728705|FG000|Overall Study|Withdrawal by Subject|1|||
170381031|NCT00472043|615728706|FG001|Overall Study|Withdrawal by Subject|0|||
170381032|NCT00472043|615728705|FG000|Overall Study|Death|1|||
170381033|NCT00472043|615728706|FG001|Overall Study|Death|0|||
170381034|NCT04009824|615728708|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
170381035|NCT04009824|615728709|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
170381036|NCT04009824|615728710|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
170381037|NCT04009824|615728711|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
170381038|NCT04009824|615728712|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
170381039|NCT03147495|615728713|FG000|Overall Study|Physician Decision|0|||
170381040|NCT03147495|615728714|FG001|Overall Study|Physician Decision|6|||
170381041|NCT01024946|615728715|FG000|Overall Study|Screen Failure|3|||
170381042|NCT01024946|615728715|FG000|Overall Study|Withdrawal by Subject|1|||
170381043|NCT01024946|615728715|FG000|Overall Study|Adverse Event|1|||
170381044|NCT02483611|615728716|FG000|Overall Study|Protocol Violation|0|||
170381045|NCT02483611|615728717|FG001|Overall Study|Protocol Violation|0|||
170381046|NCT02483611|615728718|FG002|Overall Study|Protocol Violation|1|||
170381047|NCT02608892|615728719|FG000|Overall Study|Lost to Follow-up|1|||
170381048|NCT02608892|615728720|FG001|Overall Study|Lost to Follow-up|0|||
170381049|NCT02590406|615728721|FG000|Overall Study|Adverse Event|1|||
170381050|NCT02590406|615728722|FG001|Overall Study|Adverse Event|0|||
170381051|NCT02590406|615728721|FG000|Overall Study|Saturometer malfunction|0|||
170381052|NCT02590406|615728722|FG001|Overall Study|Saturometer malfunction|1|||
170381053|NCT05375838|615728723|FG000|Overall Study|Other|0|||
170381054|NCT05375838|615728724|FG001|Overall Study|Other|0|||
170381055|NCT05375838|615728725|FG002|Overall Study|Other|0|||
170381056|NCT05375838|615728726|FG003|Overall Study|Other|1|||
170381057|NCT05375838|615728727|FG004|Overall Study|Other|1|||
170381058|NCT05375838|615728728|FG005|Overall Study|Other|0|||
170381059|NCT05375838|615728723|FG000|Overall Study|Withdrawal by Subject|2|||
170381060|NCT05375838|615728724|FG001|Overall Study|Withdrawal by Subject|1|||
170381061|NCT05375838|615728725|FG002|Overall Study|Withdrawal by Subject|3|||
170381062|NCT05375838|615728726|FG003|Overall Study|Withdrawal by Subject|2|||
170381063|NCT05375838|615728727|FG004|Overall Study|Withdrawal by Subject|2|||
170381064|NCT05375838|615728728|FG005|Overall Study|Withdrawal by Subject|0|||
170381065|NCT05375838|615728723|FG000|Overall Study|Protocol Violation|0|||
170381066|NCT05375838|615728724|FG001|Overall Study|Protocol Violation|0|||
170381067|NCT05375838|615728725|FG002|Overall Study|Protocol Violation|0|||
170381068|NCT05375838|615728726|FG003|Overall Study|Protocol Violation|0|||
170381069|NCT05375838|615728727|FG004|Overall Study|Protocol Violation|1|||
170381070|NCT05375838|615728728|FG005|Overall Study|Protocol Violation|0|||
170381071|NCT05375838|615728723|FG000|Overall Study|Physician Decision|0|||
170381072|NCT05375838|615728724|FG001|Overall Study|Physician Decision|1|||
170381073|NCT05375838|615728725|FG002|Overall Study|Physician Decision|0|||
170381074|NCT05375838|615728726|FG003|Overall Study|Physician Decision|0|||
170381075|NCT05375838|615728727|FG004|Overall Study|Physician Decision|0|||
170381076|NCT05375838|615728728|FG005|Overall Study|Physician Decision|1|||
170381077|NCT05375838|615728723|FG000|Overall Study|Lost to Follow-up|2|||
170381078|NCT05375838|615728724|FG001|Overall Study|Lost to Follow-up|7|||
170381079|NCT05375838|615728725|FG002|Overall Study|Lost to Follow-up|0|||
170381080|NCT05375838|615728726|FG003|Overall Study|Lost to Follow-up|4|||
170381081|NCT05375838|615728727|FG004|Overall Study|Lost to Follow-up|2|||
170381082|NCT05375838|615728728|FG005|Overall Study|Lost to Follow-up|3|||
170381083|NCT00957723|615728729|FG000|Overall Study|Death|3|||
170381084|NCT00957723|615728729|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
170381085|NCT00957723|615728729|FG000|Overall Study|Lost to Follow-up|8|||
170381086|NCT00957723|615728729|FG000|Overall Study|Withdrawal by Subject|24|||
170381087|NCT00957723|615728729|FG000|Overall Study|Investigative Site Terminated|61|||
170381088|NCT00957723|615728729|FG000|Overall Study|Intercurrent Illness|2|||
170381089|NCT00957723|615728729|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
170381090|NCT00877890|615728730|FG000|Overall Study|Adverse Event|6|||
170381091|NCT00877890|615728731|FG001|Overall Study|Adverse Event|6|||
170381092|NCT00877890|615728730|FG000|Overall Study|Lost to Follow-up|5|||
170381093|NCT00877890|615728731|FG001|Overall Study|Lost to Follow-up|5|||
170381094|NCT00877890|615728730|FG000|Overall Study|Protocol Violation|0|||
170381095|NCT00877890|615728731|FG001|Overall Study|Protocol Violation|1|||
170381096|NCT00877890|615728730|FG000|Overall Study|Withdrawal of Consent|6|||
170381097|NCT00877890|615728731|FG001|Overall Study|Withdrawal of Consent|12|||
170381098|NCT00877890|615728730|FG000|Overall Study|Investigator Decision|0|||
170381099|NCT00877890|615728731|FG001|Overall Study|Investigator Decision|2|||
170381100|NCT00877890|615728730|FG000|Overall Study|Loss of Glucose Control|3|||
170381101|NCT00877890|615728731|FG001|Overall Study|Loss of Glucose Control|4|||
170381102|NCT00984009|615728732|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
170381103|NCT02036476|615728739|FG000|Overall Study|Withdrawal by Subject|2|||
170381104|NCT02036476|615728739|FG000|Overall Study|Progressive Disease|4|||
170381105|NCT02036476|615728739|FG000|Overall Study|Unacceptable Toxicity|2|||
170381106|NCT00703781|615728740|FG000|Overall Study|Withdrawal by Subject|1|||
170381107|NCT00703781|615728741|FG001|Overall Study|Withdrawal by Subject|2|||
170381108|NCT00703781|615728740|FG000|Overall Study|Cancelled surgery|1|||
170381109|NCT00703781|615728741|FG001|Overall Study|Cancelled surgery|0|||
170381110|NCT02168816|615728742|FG000|Overall Study|Lost to Follow-up|2|||
170381111|NCT02168816|615728743|FG001|Overall Study|Lost to Follow-up|2|||
170381112|NCT02067104|615728746|FG000|Overall Study|Study termination due to low accrual|4|||
170381113|NCT02067104|615728747|FG001|Overall Study|Study termination due to low accrual|5|||
170381114|NCT01385098|615728748|FG000|Overall Study|Adverse Event|10|||
170381115|NCT01385098|615728748|FG000|Overall Study|Lost to Follow-up|4|||
170381116|NCT02698176|615728749|FG000|Overall Study|Progressive disease|4|||
170381117|NCT02698176|615728750|FG001|Overall Study|Progressive disease|3|||
170381118|NCT02698176|615728751|FG002|Overall Study|Progressive disease|1|||
170381119|NCT02698176|615728752|FG003|Overall Study|Progressive disease|0|||
170381120|NCT02698176|615728749|FG000|Overall Study|Adverse Event|2|||
170381121|NCT02698176|615728750|FG001|Overall Study|Adverse Event|0|||
170381122|NCT02698176|615728751|FG002|Overall Study|Adverse Event|0|||
170381123|NCT02698176|615728752|FG003|Overall Study|Adverse Event|0|||
170381124|NCT02698176|615728749|FG000|Overall Study|Clinical progression|3|||
170381125|NCT02698176|615728750|FG001|Overall Study|Clinical progression|0|||
170381126|NCT02698176|615728751|FG002|Overall Study|Clinical progression|0|||
170381127|NCT02698176|615728752|FG003|Overall Study|Clinical progression|0|||
170381128|NCT00795717|615728753|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
170381129|NCT00795717|615728754|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
170381130|NCT00795717|615728753|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
170381131|NCT00795717|615728754|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
170381132|NCT00795717|615728753|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
170381133|NCT00795717|615728754|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
170381134|NCT00795717|615728753|FG000|Phase II|too busy|0|||
170381135|NCT00795717|615728754|FG001|Phase II|too busy|1|||
170381136|NCT00410514|615728757|FG000|Overall Study|Adverse Event|2|||
170381137|NCT00410514|615728758|FG001|Overall Study|Adverse Event|2|||
170381138|NCT00410514|615728759|FG002|Overall Study|Adverse Event|2|||
170381139|NCT00410514|615728757|FG000|Overall Study|Protocol Violation|0|||
170381140|NCT00410514|615728758|FG001|Overall Study|Protocol Violation|1|||
170381141|NCT00410514|615728759|FG002|Overall Study|Protocol Violation|1|||
170381142|NCT00410514|615728757|FG000|Overall Study|Lost to Follow-up|0|||
170381143|NCT00410514|615728758|FG001|Overall Study|Lost to Follow-up|0|||
170381144|NCT00410514|615728759|FG002|Overall Study|Lost to Follow-up|2|||
170381145|NCT00410514|615728757|FG000|Overall Study|Non-compliant with study procedures|0|||
170381146|NCT00410514|615728758|FG001|Overall Study|Non-compliant with study procedures|0|||
170381147|NCT00410514|615728759|FG002|Overall Study|Non-compliant with study procedures|2|||
170381148|NCT00122317|615728761|FG000|Overall Study|Death|3|||
170381149|NCT00122317|615728761|FG000|Overall Study|Adverse Event|4|||
170381150|NCT00122317|615728761|FG000|Overall Study|Physician Decision|2|||
170381151|NCT00122317|615728761|FG000|Overall Study|patient non-compliance|1|||
170381152|NCT00122317|615728761|FG000|Overall Study|Withdrawal by Subject|1|||
170381153|NCT03756285|615728762|FG000|Overall Study|Lost to Follow-up|0|||
170381154|NCT03756285|615728763|FG001|Overall Study|Lost to Follow-up|1|||
170381155|NCT03756285|615728762|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
170381156|NCT03756285|615728763|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
170381157|NCT03756285|615728762|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
170381158|NCT03756285|615728763|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
170381159|NCT06334055|615728764|FG000|Overall Study|Adverse Event|4|||
170381160|NCT06334055|615728764|FG000|Overall Study|Disqualified|72|||
170381161|NCT02985684|615728765|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
170381162|NCT02985684|615728765|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
170381163|NCT02985684|615728765|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
170381164|NCT00631969|615728768|FG000|Overall Study|Adverse Event|3|||
170381165|NCT00631969|615728769|FG001|Overall Study|Adverse Event|1|||
170381166|NCT00631969|615728768|FG000|Overall Study|Lack of Efficacy|2|||
170381167|NCT00631969|615728769|FG001|Overall Study|Lack of Efficacy|8|||
170381168|NCT00631969|615728768|FG000|Overall Study|Lost to Follow-up|2|||
170381169|NCT00631969|615728769|FG001|Overall Study|Lost to Follow-up|1|||
170381170|NCT00631969|615728768|FG000|Overall Study|Protocol Violation|1|||
170381171|NCT00631969|615728769|FG001|Overall Study|Protocol Violation|1|||
170381172|NCT00631969|615728768|FG000|Overall Study|Consent Withdrawn|5|||
170381173|NCT00631969|615728769|FG001|Overall Study|Consent Withdrawn|7|||
170381174|NCT00631969|615728768|FG000|Overall Study|Noncompliant With Study Medication|0|||
170381175|NCT00631969|615728769|FG001|Overall Study|Noncompliant With Study Medication|1|||
170381176|NCT00631969|615728768|FG000|Overall Study|No Drug Exposure|2|||
170381177|NCT00631969|615728769|FG001|Overall Study|No Drug Exposure|2|||
170381178|NCT04223778|615728770|FG000|Overall Study|Death|1|||
170381179|NCT04223778|615728771|FG001|Overall Study|Death|1|||
170381180|NCT04223778|615728770|FG000|Overall Study|Lost to Follow-up|4|||
170381181|NCT04223778|615728771|FG001|Overall Study|Lost to Follow-up|5|||
170381182|NCT04223778|615728770|FG000|Overall Study|Physician Decision|10|||
170381183|NCT04223778|615728771|FG001|Overall Study|Physician Decision|6|||
170381184|NCT04223778|615728770|FG000|Overall Study|Withdrawal by Subject|35|||
170381185|NCT04223778|615728771|FG001|Overall Study|Withdrawal by Subject|17|||
170381186|NCT04223778|615728770|FG000|Overall Study|Not Reported|7|||
170381187|NCT04223778|615728771|FG001|Overall Study|Not Reported|8|||
170381188|NCT00711009|615730669|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
170381189|NCT00711009|615730670|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
170381190|NCT00711009|615730669|FG000|Overall Study|Withdrawal by Subject|4|||
170381191|NCT00711009|615730670|FG001|Overall Study|Withdrawal by Subject|2|||
170381192|NCT00711009|615730669|FG000|Overall Study|Lost to Follow-up|3|||
170381193|NCT00711009|615730670|FG001|Overall Study|Lost to Follow-up|9|||
170381194|NCT00711009|615730669|FG000|Overall Study|Participant Noncompliant|0|||
170381195|NCT00711009|615730670|FG001|Overall Study|Participant Noncompliant|1|||
170381196|NCT00711009|615730669|FG000|Overall Study|Virologic Failure|2|||
170381197|NCT00711009|615730670|FG001|Overall Study|Virologic Failure|1|||
170381198|NCT00711009|615730669|FG000|Overall Study|Pregnancy|1|||
170381199|NCT00711009|615730670|FG001|Overall Study|Pregnancy|0|||
170381200|NCT00711009|615730669|FG000|Overall Study|Site closing|0|||
170381201|NCT00711009|615730670|FG001|Overall Study|Site closing|1|||
170381202|NCT00711009|615730669|FG000|Overall Study|Dose adjustment|1|||
170381203|NCT00711009|615730670|FG001|Overall Study|Dose adjustment|0|||
170381204|NCT01005966|615730671|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
170381205|NCT01005966|615730672|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
170381206|NCT01005966|615730673|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
170381207|NCT01005966|615730674|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
170381208|NCT01005966|615730675|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
170381209|NCT01005966|615730671|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
170381210|NCT01005966|615730672|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
170381211|NCT01005966|615730673|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
170381212|NCT01005966|615730674|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
170381213|NCT01005966|615730675|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
170381214|NCT01005966|615730671|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
170381215|NCT01005966|615730672|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
170381216|NCT01005966|615730673|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
170381217|NCT01005966|615730674|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
170381218|NCT01005966|615730675|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
170381219|NCT01005966|615730671|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
170381220|NCT01005966|615730672|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
170381221|NCT01005966|615730673|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
170381222|NCT01005966|615730674|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
170381223|NCT01005966|615730675|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
170381224|NCT01005966|615730671|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170381225|NCT01005966|615730672|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170381226|NCT01005966|615730673|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170381227|NCT01005966|615730674|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
170381228|NCT01005966|615730675|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
170381229|NCT01005966|615730671|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
170381230|NCT01005966|615730672|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
170381231|NCT01005966|615730673|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
170381232|NCT01005966|615730674|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
170381233|NCT01005966|615730675|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
170381234|NCT01005966|615730671|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
170381235|NCT01005966|615730672|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
170381236|NCT01005966|615730673|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
170381237|NCT01005966|615730674|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
170381238|NCT01005966|615730675|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
170381239|NCT01005966|615730671|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
170381240|NCT01005966|615730672|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
170381241|NCT01005966|615730673|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
170381242|NCT01005966|615730674|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
170381243|NCT01005966|615730675|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
170381244|NCT01005966|615730671|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
170381245|NCT01005966|615730672|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
170381246|NCT01005966|615730673|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
170381247|NCT01005966|615730674|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
170381248|NCT01005966|615730675|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
170381249|NCT01451203|615730677|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
170381250|NCT01451203|615730678|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
170381251|NCT01451203|615730677|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
170381252|NCT01451203|615730678|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
170381253|NCT01451203|615730677|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
170381254|NCT01451203|615730678|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
170381255|NCT01451203|615730677|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
170381256|NCT01451203|615730678|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
170381257|NCT01451203|615730677|FG000|Double-blind Treatment Period|Adverse Event|6|||
170381258|NCT01451203|615730678|FG001|Double-blind Treatment Period|Adverse Event|9|||
170381259|NCT01451203|615730677|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
170381260|NCT01451203|615730678|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
170381261|NCT01451203|615730677|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
170381262|NCT01451203|615730678|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
170381263|NCT01451203|615730677|FG000|Double-blind Treatment Period|Investigator decision|2|||
170381264|NCT01451203|615730678|FG001|Double-blind Treatment Period|Investigator decision|0|||
170381265|NCT01451203|615730677|FG000|Post-treatment Period|Consent withdrawn|2|||
170381266|NCT01451203|615730678|FG001|Post-treatment Period|Consent withdrawn|4|||
170381267|NCT01451203|615730677|FG000|Post-treatment Period|Lack of Efficacy|12|||
170381268|NCT01451203|615730678|FG001|Post-treatment Period|Lack of Efficacy|28|||
170381269|NCT01451203|615730677|FG000|Post-treatment Period|Adverse Event|0|||
170381270|NCT01451203|615730678|FG001|Post-treatment Period|Adverse Event|1|||
170381271|NCT01451203|615730677|FG000|Post-treatment Period|Investigator decision|0|||
170381272|NCT01451203|615730678|FG001|Post-treatment Period|Investigator decision|1|||
170381273|NCT04067310|615730679|FG000|Overall Study|Physician Decision|2|||
170381274|NCT04067310|615730680|FG001|Overall Study|Physician Decision|6|||
170381275|NCT04067310|615730679|FG000|Overall Study|Lost to Follow-up|0|||
170381276|NCT04067310|615730680|FG001|Overall Study|Lost to Follow-up|1|||
170381277|NCT04067310|615730679|FG000|Overall Study|Withdrawal by Subject|3|||
170381278|NCT04067310|615730680|FG001|Overall Study|Withdrawal by Subject|0|||
170381279|NCT02528643|615730681|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
170381280|NCT02528643|615730682|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
170381281|NCT02528643|615730681|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
170381282|NCT02528643|615730682|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
170381283|NCT02528643|615730681|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
170381284|NCT02528643|615730682|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
170381285|NCT02528643|615730681|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
170381286|NCT02528643|615730682|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
170381287|NCT02528643|615730681|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
170381288|NCT02528643|615730682|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
170381289|NCT02528643|615730681|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
170381290|NCT02528643|615730682|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
170381291|NCT02528643|615730681|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
170381292|NCT02528643|615730682|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
170381293|NCT02058940|615730683|FG000|Overall Study|Discharged from Critical Care Unit|1|||
170381294|NCT04144140|615730684|FG000|Overall Study|Other|0|||
170381295|NCT04144140|615730685|FG001|Overall Study|Other|0|||
170381296|NCT04144140|615730686|FG002|Overall Study|Other|0|||
170381297|NCT04144140|615730687|FG003|Overall Study|Other|0|||
170381298|NCT04144140|615730688|FG004|Overall Study|Other|0|||
170381299|NCT04144140|615730689|FG005|Overall Study|Other|1|||
170381300|NCT04144140|615730690|FG006|Overall Study|Other|0|||
170381301|NCT00960323|615730691|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
170381302|NCT00959192|615730692|FG000|Overall Study|Adverse Event|1|||
170381303|NCT00959192|615730693|FG001|Overall Study|Adverse Event|1|||
170381304|NCT00959192|615730694|FG002|Overall Study|Adverse Event|1|||
170381305|NCT00959192|615730695|FG003|Overall Study|Adverse Event|0|||
170381306|NCT00959192|615730692|FG000|Overall Study|Investigator Request|1|||
170381307|NCT00959192|615730693|FG001|Overall Study|Investigator Request|0|||
170381308|NCT00959192|615730694|FG002|Overall Study|Investigator Request|0|||
170381309|NCT00959192|615730695|FG003|Overall Study|Investigator Request|0|||
170381310|NCT00959192|615730692|FG000|Overall Study|Caregiver Request|0|||
170381311|NCT00959192|615730693|FG001|Overall Study|Caregiver Request|0|||
170381312|NCT00959192|615730694|FG002|Overall Study|Caregiver Request|2|||
170381313|NCT00959192|615730695|FG003|Overall Study|Caregiver Request|1|||
170381314|NCT03384316|615730697|FG000|Overall Study|Screen failure|0|||
170381315|NCT03384316|615730698|FG001|Overall Study|Screen failure|1|||
170381316|NCT00626327|615730703|FG000|Overall Study|Withdrawal by Subject|21|||
170381317|NCT00626327|615730704|FG001|Overall Study|Withdrawal by Subject|29|||
170381318|NCT00626327|615730705|FG002|Overall Study|Withdrawal by Subject|30|||
170381319|NCT00626327|615730703|FG000|Overall Study|Adverse Event|1|||
170381320|NCT00626327|615730704|FG001|Overall Study|Adverse Event|0|||
170381321|NCT00626327|615730705|FG002|Overall Study|Adverse Event|0|||
170381322|NCT00626327|615730703|FG000|Overall Study|Lost to Follow-up|24|||
170381323|NCT00626327|615730704|FG001|Overall Study|Lost to Follow-up|21|||
170381324|NCT00626327|615730705|FG002|Overall Study|Lost to Follow-up|23|||
170381325|NCT00626327|615730703|FG000|Overall Study|Inappropriate enrollment|4|||
170381326|NCT00626327|615730704|FG001|Overall Study|Inappropriate enrollment|5|||
170381327|NCT00626327|615730705|FG002|Overall Study|Inappropriate enrollment|3|||
170381328|NCT00626327|615730703|FG000|Overall Study|Administrative Reason|2|||
170381329|NCT00626327|615730704|FG001|Overall Study|Administrative Reason|0|||
170381330|NCT00626327|615730705|FG002|Overall Study|Administrative Reason|6|||
170381331|NCT00626327|615730703|FG000|Overall Study|Protocol Violation|26|||
170381332|NCT00626327|615730704|FG001|Overall Study|Protocol Violation|4|||
170381333|NCT00626327|615730705|FG002|Overall Study|Protocol Violation|26|||
170381334|NCT04450394|615730706|FG000|Overall Study|Adverse Event|2|||
170381335|NCT04450394|615730707|FG001|Overall Study|Adverse Event|0|||
170381336|NCT04450394|615730708|FG002|Overall Study|Adverse Event|0|||
170381337|NCT04450394|615730706|FG000|Overall Study|Death|0|||
170381338|NCT04450394|615730707|FG001|Overall Study|Death|1|||
170381339|NCT04450394|615730708|FG002|Overall Study|Death|0|||
170381340|NCT04450394|615730706|FG000|Overall Study|Lost to Follow-up|0|||
170381341|NCT04450394|615730707|FG001|Overall Study|Lost to Follow-up|3|||
170381342|NCT04450394|615730708|FG002|Overall Study|Lost to Follow-up|0|||
170381343|NCT04450394|615730706|FG000|Overall Study|Physician Decision|0|||
170381344|NCT04450394|615730707|FG001|Overall Study|Physician Decision|1|||
170381345|NCT04450394|615730708|FG002|Overall Study|Physician Decision|0|||
170381346|NCT04450394|615730706|FG000|Overall Study|Protocol Violation|2|||
170381347|NCT04450394|615730707|FG001|Overall Study|Protocol Violation|0|||
170381348|NCT04450394|615730708|FG002|Overall Study|Protocol Violation|0|||
170381349|NCT04450394|615730706|FG000|Overall Study|Withdrawal by Subject|6|||
170381350|NCT04450394|615730707|FG001|Overall Study|Withdrawal by Subject|9|||
170381351|NCT04450394|615730708|FG002|Overall Study|Withdrawal by Subject|0|||
170381352|NCT01066819|615730709|FG000|Overall Study|Adverse Event|18|||
170381353|NCT01066819|615730710|FG001|Overall Study|Adverse Event|1|||
170381354|NCT01066819|615730711|FG002|Overall Study|Adverse Event|6|||
170381355|NCT01066819|615730712|FG003|Overall Study|Adverse Event|0|||
170381356|NCT01066819|615730713|FG004|Overall Study|Adverse Event|0|||
170381357|NCT01066819|615730714|FG005|Overall Study|Adverse Event|0|||
170381358|NCT01066819|615730709|FG000|Overall Study|Death|5|||
170381359|NCT01066819|615730710|FG001|Overall Study|Death|0|||
170381360|NCT01066819|615730711|FG002|Overall Study|Death|1|||
170381361|NCT01066819|615730712|FG003|Overall Study|Death|0|||
170381362|NCT01066819|615730713|FG004|Overall Study|Death|0|||
170381363|NCT01066819|615730714|FG005|Overall Study|Death|0|||
170381364|NCT01066819|615730709|FG000|Overall Study|Lack of Efficacy|22|||
170381365|NCT01066819|615730710|FG001|Overall Study|Lack of Efficacy|1|||
170381366|NCT01066819|615730711|FG002|Overall Study|Lack of Efficacy|2|||
170381367|NCT01066819|615730712|FG003|Overall Study|Lack of Efficacy|1|||
170381368|NCT01066819|615730713|FG004|Overall Study|Lack of Efficacy|0|||
170381369|NCT01066819|615730714|FG005|Overall Study|Lack of Efficacy|0|||
170381370|NCT01066819|615730709|FG000|Overall Study|Physician Decision|6|||
170381371|NCT01066819|615730710|FG001|Overall Study|Physician Decision|2|||
170381372|NCT01066819|615730711|FG002|Overall Study|Physician Decision|3|||
170381373|NCT01066819|615730712|FG003|Overall Study|Physician Decision|0|||
170381374|NCT01066819|615730713|FG004|Overall Study|Physician Decision|0|||
170381375|NCT01066819|615730714|FG005|Overall Study|Physician Decision|0|||
170381376|NCT01066819|615730709|FG000|Overall Study|Protocol Violation|12|||
170381377|NCT01066819|615730710|FG001|Overall Study|Protocol Violation|6|||
170381378|NCT01066819|615730711|FG002|Overall Study|Protocol Violation|0|||
170381379|NCT01066819|615730712|FG003|Overall Study|Protocol Violation|0|||
170381380|NCT01066819|615730713|FG004|Overall Study|Protocol Violation|0|||
170381381|NCT01066819|615730714|FG005|Overall Study|Protocol Violation|0|||
170381382|NCT01066819|615730709|FG000|Overall Study|Withdrawal by Subject|29|||
170381383|NCT01066819|615730710|FG001|Overall Study|Withdrawal by Subject|11|||
170381384|NCT01066819|615730711|FG002|Overall Study|Withdrawal by Subject|6|||
170381385|NCT01066819|615730712|FG003|Overall Study|Withdrawal by Subject|0|||
170381386|NCT01066819|615730713|FG004|Overall Study|Withdrawal by Subject|0|||
170381387|NCT01066819|615730714|FG005|Overall Study|Withdrawal by Subject|0|||
170381388|NCT01066819|615730709|FG000|Overall Study|Administrative|6|||
170381389|NCT01066819|615730710|FG001|Overall Study|Administrative|4|||
170381390|NCT01066819|615730711|FG002|Overall Study|Administrative|2|||
170381391|NCT01066819|615730712|FG003|Overall Study|Administrative|0|||
170381392|NCT01066819|615730713|FG004|Overall Study|Administrative|0|||
170381393|NCT01066819|615730714|FG005|Overall Study|Administrative|0|||
170381394|NCT01066819|615730709|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
170381395|NCT01066819|615730710|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
170381396|NCT01066819|615730711|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
170381397|NCT01066819|615730712|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
170381398|NCT01066819|615730713|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
170381399|NCT01066819|615730714|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
170381400|NCT01066819|615730709|FG000|Overall Study|Early termination|2|||
170381401|NCT01066819|615730710|FG001|Overall Study|Early termination|0|||
170381402|NCT01066819|615730711|FG002|Overall Study|Early termination|0|||
170381403|NCT01066819|615730712|FG003|Overall Study|Early termination|0|||
170381404|NCT01066819|615730713|FG004|Overall Study|Early termination|0|||
170381405|NCT01066819|615730714|FG005|Overall Study|Early termination|0|||
170381406|NCT01066819|615730709|FG000|Overall Study|Failed to return|298|||
170381407|NCT01066819|615730710|FG001|Overall Study|Failed to return|107|||
170381408|NCT01066819|615730711|FG002|Overall Study|Failed to return|68|||
170381409|NCT01066819|615730712|FG003|Overall Study|Failed to return|7|||
170381410|NCT01066819|615730713|FG004|Overall Study|Failed to return|2|||
170381411|NCT01066819|615730714|FG005|Overall Study|Failed to return|3|||
170381412|NCT01066819|615730709|FG000|Overall Study|Lab test not done|9|||
170381413|NCT01066819|615730710|FG001|Overall Study|Lab test not done|0|||
170381414|NCT01066819|615730711|FG002|Overall Study|Lab test not done|2|||
170381415|NCT01066819|615730712|FG003|Overall Study|Lab test not done|1|||
170381416|NCT01066819|615730713|FG004|Overall Study|Lab test not done|0|||
170381417|NCT01066819|615730714|FG005|Overall Study|Lab test not done|0|||
170381418|NCT01066819|615730709|FG000|Overall Study|Miscellaneous|28|||
170381419|NCT01066819|615730710|FG001|Overall Study|Miscellaneous|10|||
170381420|NCT01066819|615730711|FG002|Overall Study|Miscellaneous|18|||
170381421|NCT01066819|615730712|FG003|Overall Study|Miscellaneous|1|||
170381422|NCT01066819|615730713|FG004|Overall Study|Miscellaneous|0|||
170381423|NCT01066819|615730714|FG005|Overall Study|Miscellaneous|0|||
170381424|NCT01066819|615730709|FG000|Overall Study|Non responders|123|||
170381425|NCT01066819|615730710|FG001|Overall Study|Non responders|2|||
170381426|NCT01066819|615730711|FG002|Overall Study|Non responders|7|||
170381427|NCT01066819|615730712|FG003|Overall Study|Non responders|2|||
170381428|NCT01066819|615730713|FG004|Overall Study|Non responders|0|||
170381429|NCT01066819|615730714|FG005|Overall Study|Non responders|1|||
170381430|NCT01066819|615730709|FG000|Overall Study|Not categorised|9|||
170381431|NCT01066819|615730710|FG001|Overall Study|Not categorised|2|||
170381432|NCT01066819|615730711|FG002|Overall Study|Not categorised|6|||
170381433|NCT01066819|615730712|FG003|Overall Study|Not categorised|1|||
170381434|NCT01066819|615730713|FG004|Overall Study|Not categorised|0|||
170381435|NCT01066819|615730714|FG005|Overall Study|Not categorised|0|||
170381436|NCT01066819|615730709|FG000|Overall Study|Relapse|16|||
170381437|NCT01066819|615730710|FG001|Overall Study|Relapse|4|||
170381438|NCT01066819|615730711|FG002|Overall Study|Relapse|3|||
170381439|NCT01066819|615730712|FG003|Overall Study|Relapse|0|||
170381440|NCT01066819|615730713|FG004|Overall Study|Relapse|0|||
170381441|NCT01066819|615730714|FG005|Overall Study|Relapse|0|||
170381442|NCT01066819|615730709|FG000|Overall Study|Results not available|1|||
170381443|NCT01066819|615730710|FG001|Overall Study|Results not available|0|||
170381444|NCT01066819|615730711|FG002|Overall Study|Results not available|0|||
170381445|NCT01066819|615730712|FG003|Overall Study|Results not available|0|||
170381446|NCT01066819|615730713|FG004|Overall Study|Results not available|0|||
170381447|NCT01066819|615730714|FG005|Overall Study|Results not available|0|||
170381448|NCT01066819|615730709|FG000|Overall Study|Screen failure|1|||
170381449|NCT01066819|615730710|FG001|Overall Study|Screen failure|0|||
170381450|NCT01066819|615730711|FG002|Overall Study|Screen failure|0|||
170381451|NCT01066819|615730712|FG003|Overall Study|Screen failure|0|||
170381452|NCT01066819|615730713|FG004|Overall Study|Screen failure|0|||
170381453|NCT01066819|615730714|FG005|Overall Study|Screen failure|0|||
170381454|NCT01066819|615730709|FG000|Overall Study|Spontaneous cure|1|||
170381455|NCT01066819|615730710|FG001|Overall Study|Spontaneous cure|0|||
170381456|NCT01066819|615730711|FG002|Overall Study|Spontaneous cure|0|||
170381457|NCT01066819|615730712|FG003|Overall Study|Spontaneous cure|0|||
170381458|NCT01066819|615730713|FG004|Overall Study|Spontaneous cure|0|||
170381459|NCT01066819|615730714|FG005|Overall Study|Spontaneous cure|0|||
170381460|NCT01066819|615730709|FG000|Overall Study|Treatment never started|85|||
170381461|NCT01066819|615730710|FG001|Overall Study|Treatment never started|19|||
170381462|NCT01066819|615730711|FG002|Overall Study|Treatment never started|19|||
170381463|NCT01066819|615730712|FG003|Overall Study|Treatment never started|3|||
170381464|NCT01066819|615730713|FG004|Overall Study|Treatment never started|2|||
170381465|NCT01066819|615730714|FG005|Overall Study|Treatment never started|2|||
170381466|NCT01066819|615730709|FG000|Overall Study|Treatment stopped|12|||
170381467|NCT01066819|615730710|FG001|Overall Study|Treatment stopped|1|||
170381468|NCT01066819|615730711|FG002|Overall Study|Treatment stopped|2|||
170381469|NCT01066819|615730712|FG003|Overall Study|Treatment stopped|1|||
170381470|NCT01066819|615730713|FG004|Overall Study|Treatment stopped|0|||
170381471|NCT01066819|615730714|FG005|Overall Study|Treatment stopped|0|||
170381472|NCT01066819|615730709|FG000|Overall Study|Other|5|||
170381473|NCT01066819|615730710|FG001|Overall Study|Other|1|||
170381474|NCT01066819|615730711|FG002|Overall Study|Other|1|||
170381475|NCT01066819|615730712|FG003|Overall Study|Other|0|||
170381476|NCT01066819|615730713|FG004|Overall Study|Other|0|||
170381477|NCT01066819|615730714|FG005|Overall Study|Other|0|||
170381478|NCT02719028|615730718|FG000|Overall Study|Adverse Event|2|||
170381479|NCT02719028|615730719|FG001|Overall Study|Adverse Event|1|||
170381480|NCT02719028|615730720|FG002|Overall Study|Adverse Event|4|||
170381481|NCT02719028|615730721|FG003|Overall Study|Adverse Event|8|||
170381482|NCT02719028|615730718|FG000|Overall Study|Physician Decision|0|||
170381483|NCT02719028|615730719|FG001|Overall Study|Physician Decision|1|||
170381484|NCT02719028|615730720|FG002|Overall Study|Physician Decision|1|||
170381485|NCT02719028|615730721|FG003|Overall Study|Physician Decision|1|||
170381486|NCT02719028|615730718|FG000|Overall Study|Use of prohibited medication|0|||
170381487|NCT02719028|615730719|FG001|Overall Study|Use of prohibited medication|0|||
170381488|NCT02719028|615730720|FG002|Overall Study|Use of prohibited medication|1|||
170381489|NCT02719028|615730721|FG003|Overall Study|Use of prohibited medication|0|||
170381490|NCT02719028|615730718|FG000|Overall Study|Protocol Violation|0|||
170381491|NCT02719028|615730719|FG001|Overall Study|Protocol Violation|0|||
170381492|NCT02719028|615730720|FG002|Overall Study|Protocol Violation|0|||
170381493|NCT02719028|615730721|FG003|Overall Study|Protocol Violation|1|||
170381494|NCT00298766|615730724|FG000|Overall Study|Adverse Event|18|||
170381495|NCT00298766|615730724|FG000|Overall Study|Death|2|||
170381496|NCT00298766|615730724|FG000|Overall Study|Withdrawal by Subject|9|||
170381497|NCT00298766|615730724|FG000|Overall Study|Treatment ongoing|4|||
170381498|NCT00298766|615730724|FG000|Overall Study|Progression of amyloid markers|4|||
170381499|NCT00298766|615730724|FG000|Overall Study|Deterioration in KPS and organ function|1|||
170381500|NCT00298766|615730724|FG000|Overall Study|Subjects overall condition deterioration|4|||
170381501|NCT00298766|615730724|FG000|Overall Study|Other|4|||
170381502|NCT03287960|615730731|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
170381503|NCT03287960|615730731|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
170381504|NCT03812224|615730732|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
170381505|NCT03812224|615730733|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
170381506|NCT03812224|615730732|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
170381507|NCT03812224|615730733|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
170381508|NCT03812224|615730732|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
170381509|NCT03812224|615730733|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
170381510|NCT03812224|615730732|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
170381511|NCT03812224|615730733|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
170381512|NCT00303719|615730734|FG000|Overall Study|Not evaluable, prior therapies|0|||
170381513|NCT00303719|615730735|FG001|Overall Study|Not evaluable, prior therapies|30|||
170381514|NCT00303719|615730734|FG000|Overall Study|Lost to Follow-up|0|||
170381515|NCT00303719|615730735|FG001|Overall Study|Lost to Follow-up|7|||
170381516|NCT01641952|615730736|FG000|Overall Study|Lost to Follow-up|28|||
170381517|NCT01641952|615730736|FG000|Overall Study|Adverse Event|6|||
170381518|NCT00656136|615730737|FG000|Overall Study|Progressive disease|177|||
170381519|NCT00656136|615730738|FG001|Overall Study|Progressive disease|322|||
170381520|NCT00656136|615730737|FG000|Overall Study|Other Adverse Event|5|||
170381521|NCT00656136|615730738|FG001|Overall Study|Other Adverse Event|51|||
170381522|NCT00656136|615730737|FG000|Overall Study|Protocol Violation|2|||
170381523|NCT00656136|615730738|FG001|Overall Study|Protocol Violation|3|||
170381524|NCT00656136|615730737|FG000|Overall Study|Patient refused to take study medication|7|||
170381525|NCT00656136|615730738|FG001|Overall Study|Patient refused to take study medication|10|||
170381526|NCT00656136|615730737|FG000|Overall Study|Unknown and others|4|||
170381527|NCT00656136|615730738|FG001|Overall Study|Unknown and others|4|||
170381528|NCT01191190|615730739|FG000|Overall Study|Withdrawal by Subject|1|||
170381529|NCT03633461|615730747|FG000|Overall Study|Lost to Follow-up|0|||
170381530|NCT03633461|615730748|FG001|Overall Study|Lost to Follow-up|1|||
170381531|NCT04880642|615730750|FG000|Randomization|Withdrawal by Subject|2|||
170381532|NCT04880642|615730751|FG001|Randomization|Withdrawal by Subject|3|||
170381533|NCT04880642|615730750|FG000|Treatment Period|Adverse Event|0|||
170381534|NCT04880642|615730751|FG001|Treatment Period|Adverse Event|1|||
170381535|NCT04880642|615730750|FG000|Treatment Period|Death|6|||
170381536|NCT04880642|615730751|FG001|Treatment Period|Death|6|||
170381537|NCT04880642|615730750|FG000|Treatment Period|Lost to Follow-up|1|||
170381538|NCT04880642|615730751|FG001|Treatment Period|Lost to Follow-up|0|||
170381539|NCT04880642|615730750|FG000|Treatment Period|Protocol Violation|0|||
170381540|NCT04880642|615730751|FG001|Treatment Period|Protocol Violation|1|||
170381541|NCT04880642|615730750|FG000|Treatment Period|Withdrawal by Subject|5|||
170381542|NCT04880642|615730751|FG001|Treatment Period|Withdrawal by Subject|3|||
170381543|NCT04880642|615730750|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
170381544|NCT04880642|615730751|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
170381545|NCT04880642|615730750|FG000|Follow-up|Death|4|||
170381546|NCT04880642|615730751|FG001|Follow-up|Death|3|||
170381547|NCT04880642|615730750|FG000|Follow-up|Withdrawal by Subject|1|||
170381548|NCT04880642|615730751|FG001|Follow-up|Withdrawal by Subject|0|||
170381549|NCT02987205|615730752|FG000|Overall Study|Adverse Event|1|||
170381550|NCT02987205|615730752|FG000|Overall Study|Withdrawal by Subject|3|||
170381551|NCT01716585|615730753|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
170381552|NCT01716585|615730754|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
170381553|NCT01716585|615730753|FG000|Double-blind Treatment|Adverse Event|2|||
170381554|NCT01716585|615730754|FG001|Double-blind Treatment|Adverse Event|1|||
170381555|NCT01716585|615730753|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
170381556|NCT01716585|615730754|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
170381557|NCT01716585|615730753|FG000|Double-blind Treatment|Lost to Follow-up|2|||
170381558|NCT01716585|615730754|FG001|Double-blind Treatment|Lost to Follow-up|0|||
170381559|NCT01716585|615730753|FG000|Double-blind Treatment|Subject Noncompliant|1|||
170381560|NCT01716585|615730754|FG001|Double-blind Treatment|Subject Noncompliant|0|||
170381561|NCT01716585|615730753|FG000|Double-blind Treatment|Other|1|||
170381562|NCT01716585|615730754|FG001|Double-blind Treatment|Other|0|||
170381563|NCT01716585|615730753|FG000|Open-label Treatment|Adverse Event|0|||
170381564|NCT01716585|615730754|FG001|Open-label Treatment|Adverse Event|2|||
170381565|NCT01716585|615730753|FG000|Open-label Treatment|Virologic Failure|0|||
170381566|NCT01716585|615730754|FG001|Open-label Treatment|Virologic Failure|2|||
170381567|NCT01716585|615730753|FG000|Open-label Treatment|Withdrawal by Subject|0|||
170381568|NCT01716585|615730754|FG001|Open-label Treatment|Withdrawal by Subject|3|||
170381569|NCT00689611|615730758|FG000|Overall Study|Death|6|||
170381570|NCT00689611|615730759|FG001|Overall Study|Death|9|||
170381571|NCT00689611|615730758|FG000|Overall Study|Withdrawal by Subject|8|||
170381572|NCT00689611|615730759|FG001|Overall Study|Withdrawal by Subject|9|||
170381573|NCT00689611|615730758|FG000|Overall Study|Lost to Follow-up|27|||
170381574|NCT00689611|615730759|FG001|Overall Study|Lost to Follow-up|28|||
170381575|NCT00568399|615730761|FG000|Overall Study|Death|2|||
170381576|NCT00568399|615730761|FG000|Overall Study|Adverse Event|5|||
170381577|NCT00568399|615730761|FG000|Overall Study|Withdrawal by Subject|8|||
170381578|NCT00405756|615730766|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
170381579|NCT00405756|615730767|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
170381580|NCT00405756|615730768|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
170381581|NCT00405756|615730766|FG000|Double-blind Treatment|Adverse Event|31|||
170381582|NCT00405756|615730767|FG001|Double-blind Treatment|Adverse Event|27|||
170381583|NCT00405756|615730768|FG002|Double-blind Treatment|Adverse Event|12|||
170381584|NCT00405756|615730766|FG000|Double-blind Treatment|Disease Progression|47|||
170381585|NCT00405756|615730767|FG001|Double-blind Treatment|Disease Progression|81|||
170381586|NCT00405756|615730768|FG002|Double-blind Treatment|Disease Progression|102|||
170381587|NCT00405756|615730766|FG000|Double-blind Treatment|Lack of Efficacy|1|||
170381588|NCT00405756|615730767|FG001|Double-blind Treatment|Lack of Efficacy|4|||
170381589|NCT00405756|615730768|FG002|Double-blind Treatment|Lack of Efficacy|2|||
170381590|NCT00405756|615730766|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
170381591|NCT00405756|615730767|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
170381592|NCT00405756|615730768|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
170381593|NCT00405756|615730766|FG000|Double-blind Treatment|Lost to Follow-up|1|||
170381594|NCT00405756|615730767|FG001|Double-blind Treatment|Lost to Follow-up|0|||
170381595|NCT00405756|615730768|FG002|Double-blind Treatment|Lost to Follow-up|0|||
170381596|NCT00405756|615730766|FG000|Double-blind Treatment|Death|4|||
170381597|NCT00405756|615730767|FG001|Double-blind Treatment|Death|4|||
170381598|NCT00405756|615730768|FG002|Double-blind Treatment|Death|4|||
170381599|NCT00405756|615730766|FG000|Double-blind Treatment|Protocol Violation|1|||
170381600|NCT00405756|615730767|FG001|Double-blind Treatment|Protocol Violation|0|||
170381601|NCT00405756|615730768|FG002|Double-blind Treatment|Protocol Violation|2|||
170381602|NCT00405756|615730766|FG000|Double-blind Treatment|Other|7|||
170381603|NCT00405756|615730767|FG001|Double-blind Treatment|Other|4|||
170381604|NCT00405756|615730768|FG002|Double-blind Treatment|Other|4|||
170381605|NCT00405756|615730766|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
170381606|NCT00405756|615730767|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
170381607|NCT00405756|615730768|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
170381608|NCT00405756|615730766|FG000|Open-label Extension|Adverse Event|1|||
170381609|NCT00405756|615730767|FG001|Open-label Extension|Adverse Event|3|||
170381610|NCT00405756|615730768|FG002|Open-label Extension|Adverse Event|7|||
170381611|NCT00405756|615730766|FG000|Open-label Extension|Disease Progression|8|||
170381612|NCT00405756|615730767|FG001|Open-label Extension|Disease Progression|23|||
170381613|NCT00405756|615730768|FG002|Open-label Extension|Disease Progression|26|||
170381614|NCT00405756|615730766|FG000|Open-label Extension|Withdrawal by Subject|2|||
170381615|NCT00405756|615730767|FG001|Open-label Extension|Withdrawal by Subject|3|||
170381616|NCT00405756|615730768|FG002|Open-label Extension|Withdrawal by Subject|3|||
170381617|NCT00405756|615730766|FG000|Open-label Extension|Death|1|||
170381618|NCT00405756|615730767|FG001|Open-label Extension|Death|2|||
170381619|NCT00405756|615730768|FG002|Open-label Extension|Death|4|||
170381620|NCT00405756|615730766|FG000|Open-label Extension|Other|0|||
170381621|NCT00405756|615730767|FG001|Open-label Extension|Other|1|||
170381622|NCT00405756|615730768|FG002|Open-label Extension|Other|7|||
170381623|NCT00405756|615730766|FG000|Follow-up|Ongoing in Follow-up Period|52|||
170381624|NCT00405756|615730767|FG001|Follow-up|Ongoing in Follow-up Period|51|||
170381625|NCT00405756|615730768|FG002|Follow-up|Ongoing in Follow-up Period|60|||
170381626|NCT00405756|615730766|FG000|Follow-up|Death|21|||
170381627|NCT00405756|615730767|FG001|Follow-up|Death|31|||
170381628|NCT00405756|615730768|FG002|Follow-up|Death|24|||
170381629|NCT00405756|615730766|FG000|Follow-up|Lost to Follow-up|2|||
170381630|NCT00405756|615730767|FG001|Follow-up|Lost to Follow-up|8|||
170381631|NCT00405756|615730768|FG002|Follow-up|Lost to Follow-up|4|||
170381632|NCT02870348|615730775|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
170381633|NCT01051856|615730776|FG000|Overall Study|Withdrawal by Subject|1|||
170381634|NCT01051856|615730777|FG001|Overall Study|Withdrawal by Subject|0|||
170381635|NCT03798366|615730791|FG000|Overall Study|Lost to Follow-up|0|||
170381636|NCT03798366|615730792|FG001|Overall Study|Lost to Follow-up|1|||
170381637|NCT04005885|615730797|FG000|First Intervention|Withdrawal by Subject|1|||
170381638|NCT04005885|615730798|FG001|First Intervention|Withdrawal by Subject|1|||
170381639|NCT04005885|615730797|FG000|Second Intervention|Withdrawal by Subject|0|||
170381640|NCT04005885|615730798|FG001|Second Intervention|Withdrawal by Subject|2|||
170381641|NCT01412333|615730799|FG000|Overall Study|Adverse Event|40|||
170381642|NCT01412333|615730800|FG001|Overall Study|Adverse Event|42|||
170381643|NCT01412333|615730799|FG000|Overall Study|Death|5|||
170381644|NCT01412333|615730800|FG001|Overall Study|Death|6|||
170381645|NCT01412333|615730799|FG000|Overall Study|Lack of Efficacy|22|||
170381646|NCT01412333|615730800|FG001|Overall Study|Lack of Efficacy|10|||
170381647|NCT01412333|615730799|FG000|Overall Study|Lost to Follow-up|15|||
170381648|NCT01412333|615730800|FG001|Overall Study|Lost to Follow-up|12|||
170381649|NCT01412333|615730799|FG000|Overall Study|Non-Compliance|3|||
170381650|NCT01412333|615730800|FG001|Overall Study|Non-Compliance|7|||
170381651|NCT01412333|615730799|FG000|Overall Study|Non-Compliance With Study Drug|1|||
170381652|NCT01412333|615730800|FG001|Overall Study|Non-Compliance With Study Drug|1|||
170381653|NCT01412333|615730799|FG000|Overall Study|Other|30|||
170381654|NCT01412333|615730800|FG001|Overall Study|Other|33|||
170381655|NCT01412333|615730799|FG000|Overall Study|Physician Decision|11|||
170381656|NCT01412333|615730800|FG001|Overall Study|Physician Decision|16|||
170381657|NCT01412333|615730799|FG000|Overall Study|Pregnancy|6|||
170381658|NCT01412333|615730800|FG001|Overall Study|Pregnancy|4|||
170381659|NCT01412333|615730799|FG000|Overall Study|Protocol Violation|1|||
170381660|NCT01412333|615730800|FG001|Overall Study|Protocol Violation|2|||
170381661|NCT01412333|615730799|FG000|Overall Study|Study Terminated By Sponsor|3|||
170381662|NCT01412333|615730800|FG001|Overall Study|Study Terminated By Sponsor|2|||
170381663|NCT01412333|615730799|FG000|Overall Study|Withdrawal by Subject|51|||
170381664|NCT01412333|615730800|FG001|Overall Study|Withdrawal by Subject|54|||
170381665|NCT01412333|615730799|FG000|Overall Study|Missing|1|||
170381666|NCT01412333|615730800|FG001|Overall Study|Missing|3|||
170381667|NCT02195531|615730803|FG000|Overall Study|Withdrawal by Subject|1|||
170381668|NCT02195531|615730804|FG001|Overall Study|Withdrawal by Subject|1|||
170381669|NCT02195531|615730805|FG002|Overall Study|Withdrawal by Subject|1|||
170381670|NCT01038635|615730806|FG000|Overall Study|Disease Progression|2|||
170381671|NCT01038635|615730807|FG001|Overall Study|Disease Progression|0|||
170381672|NCT01038635|615730808|FG002|Overall Study|Disease Progression|0|||
170381673|NCT01038635|615730809|FG003|Overall Study|Disease Progression|0|||
170381674|NCT01038635|615730810|FG004|Overall Study|Disease Progression|0|||
170381675|NCT01038635|615730811|FG005|Overall Study|Disease Progression|0|||
170381676|NCT01038635|615730812|FG006|Overall Study|Disease Progression|1|||
170381677|NCT01038635|615730813|FG007|Overall Study|Disease Progression|4|||
170381678|NCT01038635|615730814|FG008|Overall Study|Disease Progression|0|||
170381679|NCT01038635|615730806|FG000|Overall Study|Death|0|||
170381680|NCT01038635|615730807|FG001|Overall Study|Death|0|||
170381681|NCT01038635|615730808|FG002|Overall Study|Death|0|||
170381682|NCT01038635|615730809|FG003|Overall Study|Death|0|||
170381683|NCT01038635|615730810|FG004|Overall Study|Death|1|||
170381684|NCT01038635|615730811|FG005|Overall Study|Death|0|||
170381685|NCT01038635|615730812|FG006|Overall Study|Death|1|||
170381686|NCT01038635|615730813|FG007|Overall Study|Death|1|||
170381687|NCT01038635|615730814|FG008|Overall Study|Death|2|||
170381688|NCT01227252|615730815|FG000|Overall Study|Sponsor Decision|0|||
170381689|NCT01227252|615730816|FG001|Overall Study|Sponsor Decision|1|||
170381690|NCT01227252|615730817|FG002|Overall Study|Sponsor Decision|0|||
170381691|NCT01227252|615730818|FG003|Overall Study|Sponsor Decision|0|||
170381692|NCT01227252|615730815|FG000|Overall Study|Lost to Follow-up|0|||
170381693|NCT01227252|615730816|FG001|Overall Study|Lost to Follow-up|1|||
170381694|NCT01227252|615730817|FG002|Overall Study|Lost to Follow-up|0|||
170381695|NCT01227252|615730818|FG003|Overall Study|Lost to Follow-up|0|||
170381696|NCT01227252|615730815|FG000|Overall Study|Withdrawal by Subject|0|||
170381697|NCT01227252|615730816|FG001|Overall Study|Withdrawal by Subject|1|||
170381698|NCT01227252|615730817|FG002|Overall Study|Withdrawal by Subject|0|||
170381699|NCT01227252|615730818|FG003|Overall Study|Withdrawal by Subject|0|||
170381700|NCT03442595|615730822|FG000|Overall Study|Lost to Follow-up|94|||
170381701|NCT03442595|615730823|FG001|Overall Study|Lost to Follow-up|0|||
170381702|NCT01034709|615730826|FG000|Overall Study|Protocol Violation|9|||
170381703|NCT01034709|615730827|FG001|Overall Study|Protocol Violation|16|||
170381704|NCT02516306|615730828|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
170381705|NCT02516306|615730829|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
170381706|NCT02447952|615730832|FG000|Overall Study|Adverse Event|2|||
170381707|NCT02447952|615730832|FG000|Overall Study|Physician Decision|1|||
170381708|NCT02447952|615730832|FG000|Overall Study|Withdrawal by Subject|4|||
170381709|NCT01683058|615730833|FG000|Overall Study|Lost to Follow-up|9|||
170381710|NCT01683058|615730833|FG000|Overall Study|Adverse Event|6|||
170381711|NCT01683058|615730833|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
170381712|NCT01683058|615730833|FG000|Overall Study|Withdrawal by Subject|7|||
170381713|NCT01683058|615730833|FG000|Overall Study|Lack of Efficacy|2|||
170381714|NCT01057394|615730834|FG000|Overall Study|Not eligible|0|||
170381715|NCT01057394|615730835|FG001|Overall Study|Not eligible|2|||
170381716|NCT01195636|615730836|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
170381717|NCT01195636|615730837|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
170381718|NCT01195636|615730836|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
170381719|NCT01195636|615730837|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
170381720|NCT01195636|615730836|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
170381721|NCT01195636|615730837|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
170381722|NCT01195636|615730836|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
170381723|NCT01195636|615730837|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
170381724|NCT01195636|615730836|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
170381725|NCT01195636|615730837|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
170381726|NCT01195636|615730836|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
170381727|NCT01195636|615730837|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
170381728|NCT01195636|615730836|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
170381729|NCT01195636|615730837|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
170381730|NCT01195636|615730836|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
170381731|NCT01195636|615730837|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
170381732|NCT00579527|615730838|FG000|Overall Study|Death|4|||
170381733|NCT00381706|615730839|FG000|Overall Study|Never treated|7|||
170381734|NCT00381706|615730840|FG001|Overall Study|Never treated|2|||
170381735|NCT00381706|615730841|FG002|Overall Study|Never treated|1|||
170381736|NCT02364999|615730851|FG000|Overall Study|Death|136|||
170381737|NCT02364999|615730852|FG001|Overall Study|Death|138|||
170381738|NCT02364999|615730851|FG000|Overall Study|Lost to Follow-up|10|||
170381739|NCT02364999|615730852|FG001|Overall Study|Lost to Follow-up|15|||
170381740|NCT02364999|615730851|FG000|Overall Study|Protocol Violation|3|||
170381741|NCT02364999|615730852|FG001|Overall Study|Protocol Violation|2|||
170381742|NCT02364999|615730851|FG000|Overall Study|Withdrawal by Subject|14|||
170381743|NCT02364999|615730852|FG001|Overall Study|Withdrawal by Subject|14|||
170381744|NCT02364999|615730851|FG000|Overall Study|Other|0|||
170381745|NCT02364999|615730852|FG001|Overall Study|Other|1|||
170381746|NCT02364999|615730851|FG000|Overall Study|Randomized but did not receive treatment|2|||
170381747|NCT02364999|615730852|FG001|Overall Study|Randomized but did not receive treatment|3|||
170381748|NCT01566981|615730853|FG000|Overall Study|Lost to Follow-up|5|||
170381749|NCT01566981|615730854|FG001|Overall Study|Lost to Follow-up|8|||
170381750|NCT02177942|615730855|FG000|Overall Study|Adverse Event|1|||
170381751|NCT02177942|615730856|FG001|Overall Study|Adverse Event|0|||
170381752|NCT02177942|615730855|FG000|Overall Study|Lost to Follow-up|1|||
170381753|NCT02177942|615730856|FG001|Overall Study|Lost to Follow-up|1|||
170381754|NCT02177942|615730855|FG000|Overall Study|Protocol Violation|4|||
170381755|NCT02177942|615730856|FG001|Overall Study|Protocol Violation|6|||
170381756|NCT02177942|615730855|FG000|Overall Study|Withdrawal by Subject|71|||
170381757|NCT02177942|615730856|FG001|Overall Study|Withdrawal by Subject|81|||
170381758|NCT00550615|615730857|FG000|Overall Study|Withdrawal by Subject|0|||
170381759|NCT00550615|615730858|FG001|Overall Study|Withdrawal by Subject|0|||
170381760|NCT00550615|615730859|FG002|Overall Study|Withdrawal by Subject|2|||
170381761|NCT00550615|615730860|FG003|Overall Study|Withdrawal by Subject|3|||
170381762|NCT00550615|615730857|FG000|Overall Study|Not evaluable|0|||
170381763|NCT00550615|615730858|FG001|Overall Study|Not evaluable|0|||
170381764|NCT00550615|615730859|FG002|Overall Study|Not evaluable|2|||
170381765|NCT00550615|615730860|FG003|Overall Study|Not evaluable|7|||
170381766|NCT01084096|615732361|FG000|Overall Study|Lost to Follow-up|1501|||
170381767|NCT01084096|615732362|FG001|Overall Study|Lost to Follow-up|1833|||
170381768|NCT01084096|615732361|FG000|Overall Study|Withdrawal by Subject|3|||
170381769|NCT01084096|615732362|FG001|Overall Study|Withdrawal by Subject|0|||
170381770|NCT01084096|615732361|FG000|Overall Study|Woman had a miscarriage|21|||
170381771|NCT01084096|615732362|FG001|Overall Study|Woman had a miscarriage|17|||
170381772|NCT02033369|615732363|FG000|Overall Study|Physician Decision|1|||
170381773|NCT02033369|615732364|FG001|Overall Study|Physician Decision|2|||
170381774|NCT02033369|615732363|FG000|Overall Study|Not a good demographic match|0|||
170381775|NCT02033369|615732364|FG001|Overall Study|Not a good demographic match|2|||
170381776|NCT02033369|615732363|FG000|Overall Study|Withdrawal by Subject|1|||
170381777|NCT02033369|615732364|FG001|Overall Study|Withdrawal by Subject|1|||
170381778|NCT02033369|615732363|FG000|Overall Study|Lost to Follow-up|1|||
170381779|NCT02033369|615732364|FG001|Overall Study|Lost to Follow-up|0|||
170381780|NCT02033369|615732363|FG000|Overall Study|Protocol Violation|2|||
170381781|NCT02033369|615732364|FG001|Overall Study|Protocol Violation|0|||
170381782|NCT02534324|615732371|FG000|Overall Study|Protocol Violation|4|||
170381783|NCT02534324|615732372|FG001|Overall Study|Protocol Violation|1|||
170381784|NCT02534324|615732371|FG000|Overall Study|Lost to Follow-up|20|||
170381785|NCT02534324|615732372|FG001|Overall Study|Lost to Follow-up|7|||
170381786|NCT02534324|615732371|FG000|Overall Study|Adverse Event|1|||
170381787|NCT02534324|615732372|FG001|Overall Study|Adverse Event|0|||
170381788|NCT01459016|615732375|FG000|Overall Study|Withdrawal by Subject|11|||
170381789|NCT01459016|615732375|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
170381790|NCT02551874|615732385|FG000|Overall Study|Lost to Follow-up|0|||
170381791|NCT02551874|615732386|FG001|Overall Study|Lost to Follow-up|2|||
170381792|NCT02551874|615732385|FG000|Overall Study|Pregnancy|0|||
170381793|NCT02551874|615732386|FG001|Overall Study|Pregnancy|1|||
170381794|NCT02551874|615732385|FG000|Overall Study|Reason not reported|10|||
170381795|NCT02551874|615732386|FG001|Overall Study|Reason not reported|4|||
170381796|NCT02551874|615732385|FG000|Overall Study|Did not receive randomized treatment|0|||
170381797|NCT02551874|615732386|FG001|Overall Study|Did not receive randomized treatment|7|||
170381798|NCT02551874|615732385|FG000|Overall Study|Did not enter long-term study|18|||
170381799|NCT02551874|615732386|FG001|Overall Study|Did not enter long-term study|25|||
170381800|NCT01041027|615732387|FG000|Overall Study|Withdrawal by Subject|2|||
170381801|NCT01041027|615732387|FG000|Overall Study|Protocol Violation|1|||
170381802|NCT01041027|615732387|FG000|Overall Study|Delayed Radiation Therapy|1|||
170381803|NCT01041027|615732387|FG000|Overall Study|Adverse Event|4|||
170381804|NCT02493712|615732388|FG000|Overall Study|Withdrawal by Subject|1|||
170381805|NCT02493712|615732389|FG001|Overall Study|Withdrawal by Subject|0|||
170381806|NCT02493712|615732390|FG002|Overall Study|Withdrawal by Subject|2|||
170381807|NCT02493712|615732388|FG000|Overall Study|Protocol Violation|0|||
170381808|NCT02493712|615732389|FG001|Overall Study|Protocol Violation|0|||
170381809|NCT02493712|615732390|FG002|Overall Study|Protocol Violation|1|||
170381810|NCT02493712|615732388|FG000|Overall Study|Lost to Follow-up|1|||
170381811|NCT02493712|615732389|FG001|Overall Study|Lost to Follow-up|0|||
170381812|NCT02493712|615732390|FG002|Overall Study|Lost to Follow-up|0|||
170381813|NCT02493712|615732388|FG000|Overall Study|Physician Decision|0|||
170381814|NCT02493712|615732389|FG001|Overall Study|Physician Decision|1|||
170381815|NCT02493712|615732390|FG002|Overall Study|Physician Decision|0|||
170381816|NCT02493712|615732388|FG000|Overall Study|Lack of Efficacy|0|||
170381817|NCT02493712|615732389|FG001|Overall Study|Lack of Efficacy|5|||
170381818|NCT02493712|615732390|FG002|Overall Study|Lack of Efficacy|3|||
170381819|NCT03890731|615732391|FG000|Overall Study|Progressive disease|1|||
170381820|NCT03890731|615732391|FG000|Overall Study|Patient's decision|1|||
170381821|NCT03890731|615732391|FG000|Overall Study|Adverse Event|4|||
170381822|NCT02927990|615732392|FG000|Overall Study|Protocol Violation|4|||
170381823|NCT02927990|615732392|FG000|Overall Study|Physician Decision|9|||
170381824|NCT02927990|615732392|FG000|Overall Study|Room switched and therefore no study device available|15|||
170381825|NCT02927990|615732392|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
170381826|NCT02146274|615732393|FG000|Overall Study|Protocol Violation|73|||
170381827|NCT02039687|615732396|FG000|Overall Study|Adverse Event|0|||
170381828|NCT02039687|615732397|FG001|Overall Study|Adverse Event|0|||
170381829|NCT02039687|615732398|FG002|Overall Study|Adverse Event|1|||
170381830|NCT02039687|615732399|FG003|Overall Study|Adverse Event|0|||
170381831|NCT02039687|615732396|FG000|Overall Study|Withdrawal by Subject|0|||
170381832|NCT02039687|615732397|FG001|Overall Study|Withdrawal by Subject|1|||
170381833|NCT02039687|615732398|FG002|Overall Study|Withdrawal by Subject|0|||
170381834|NCT02039687|615732399|FG003|Overall Study|Withdrawal by Subject|0|||
170381835|NCT02039687|615732396|FG000|Overall Study|treatment assignment could not be confir|0|||
170381836|NCT02039687|615732397|FG001|Overall Study|treatment assignment could not be confir|0|||
170381837|NCT02039687|615732398|FG002|Overall Study|treatment assignment could not be confir|2|||
170381838|NCT02039687|615732399|FG003|Overall Study|treatment assignment could not be confir|0|||
170381839|NCT03758612|615732409|FG000|Washout Period|Withdrawal by Subject|0|||
170381840|NCT03758612|615732410|FG001|Washout Period|Withdrawal by Subject|0|||
170381841|NCT03758612|615732411|FG002|Washout Period|Withdrawal by Subject|2|||
170381842|NCT03758612|615732412|FG003|Washout Period|Withdrawal by Subject|0|||
170381843|NCT03758612|615732413|FG004|Washout Period|Withdrawal by Subject|0|||
170381844|NCT03758612|615732414|FG005|Washout Period|Withdrawal by Subject|0|||
170381845|NCT03758612|615732415|FG006|Washout Period|Withdrawal by Subject|0|||
170381846|NCT03758612|615732416|FG007|Washout Period|Withdrawal by Subject|0|||
170381847|NCT03758612|615732417|FG008|Washout Period|Withdrawal by Subject|0|||
170381848|NCT03758612|615732418|FG009|Washout Period|Withdrawal by Subject|0|||
170381849|NCT03758612|615732419|FG010|Washout Period|Withdrawal by Subject|0|||
170381850|NCT03758612|615732420|FG011|Washout Period|Withdrawal by Subject|0|||
170381851|NCT03758612|615732409|FG000|Period 2|Protocol Violation|0|||
170381852|NCT03758612|615732410|FG001|Period 2|Protocol Violation|0|||
170381853|NCT03758612|615732411|FG002|Period 2|Protocol Violation|0|||
170381854|NCT03758612|615732412|FG003|Period 2|Protocol Violation|0|||
170381855|NCT03758612|615732413|FG004|Period 2|Protocol Violation|1|||
170381856|NCT03758612|615732414|FG005|Period 2|Protocol Violation|0|||
170381857|NCT03758612|615732415|FG006|Period 2|Protocol Violation|0|||
170381858|NCT03758612|615732416|FG007|Period 2|Protocol Violation|0|||
170381859|NCT03758612|615732417|FG008|Period 2|Protocol Violation|0|||
170381860|NCT03758612|615732418|FG009|Period 2|Protocol Violation|0|||
170381861|NCT03758612|615732419|FG010|Period 2|Protocol Violation|0|||
170381862|NCT03758612|615732420|FG011|Period 2|Protocol Violation|0|||
170381863|NCT00772031|615732421|FG000|Overall Study|Early termination of trial|12|||
170381864|NCT00772031|615732422|FG001|Overall Study|Early termination of trial|10|||
170381865|NCT00772031|615732421|FG000|Overall Study|Lost to Follow-up|20|||
170381866|NCT00772031|615732422|FG001|Overall Study|Lost to Follow-up|33|||
170381867|NCT01967134|615732423|FG000|Overall Study|Lost to Follow-up|0|||
170381868|NCT01967134|615732424|FG001|Overall Study|Lost to Follow-up|1|||
170381869|NCT01967134|615732425|FG002|Overall Study|Lost to Follow-up|0|||
170381870|NCT00443534|615732426|FG000|Overall Study|Lack of Efficacy|67|||
170381871|NCT00443534|615732426|FG000|Overall Study|Adverse Event|16|||
170381872|NCT00443534|615732426|FG000|Overall Study|Death|9|||
170381873|NCT00443534|615732426|FG000|Overall Study|Withdrawal by Subject|8|||
170381874|NCT00443534|615732426|FG000|Overall Study|Study Terminated by Sponsor|12|||
170381875|NCT00443534|615732426|FG000|Overall Study|Other|10|||
170381876|NCT00443534|615732426|FG000|Overall Study|Enrolled, Not Treated|1|||
170381877|NCT01603615|615732427|FG000|Overall Study|Did not Receive Treatment|7|||
170381878|NCT01603615|615732427|FG000|Overall Study|Lost to Follow-up|9|||
170381879|NCT01603615|615732427|FG000|Overall Study|Personal Reasons|17|||
170381880|NCT01603615|615732427|FG000|Overall Study|Other Miscellaneous|1|||
170381881|NCT00305773|615732428|FG000|Overall Study|Death|3|||
170381882|NCT00305773|615732429|FG001|Overall Study|Death|2|||
170381883|NCT00305773|615732428|FG000|Overall Study|Adverse Event|1|||
170381884|NCT00305773|615732429|FG001|Overall Study|Adverse Event|2|||
170381885|NCT00305773|615732428|FG000|Overall Study|Alternative Treatment|4|||
170381886|NCT00305773|615732429|FG001|Overall Study|Alternative Treatment|4|||
170381887|NCT00305773|615732428|FG000|Overall Study|Physician Decision|1|||
170381888|NCT00305773|615732429|FG001|Overall Study|Physician Decision|1|||
170381889|NCT00305773|615732428|FG000|Overall Study|Withdrawal by Subject|1|||
170381890|NCT00305773|615732429|FG001|Overall Study|Withdrawal by Subject|4|||
170381891|NCT00305773|615732428|FG000|Overall Study|Disease Progression|1|||
170381892|NCT00305773|615732429|FG001|Overall Study|Disease Progression|3|||
170381893|NCT00305773|615732428|FG000|Overall Study|All other reasons|3|||
170381894|NCT00305773|615732429|FG001|Overall Study|All other reasons|2|||
170381895|NCT02679222|615732430|FG000|Overall Study|No time for project|1|||
170381896|NCT00413231|615732431|FG000|0 to 30-day Post Treatment|Death|5|||
170381897|NCT00413231|615732431|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
170381898|NCT00413231|615732431|FG000|30-day to 365-day Post Treatment|Death|13|||
170381899|NCT00413231|615732431|FG000|365-day to 60-month Post Treatment|Death|36|||
170381900|NCT00413231|615732431|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
170381901|NCT00413231|615732431|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
170381902|NCT00413231|615732431|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
170381903|NCT00945945|615732432|FG000|Overall Study|Adverse Event|15|||
170381904|NCT00945945|615732433|FG001|Overall Study|Adverse Event|35|||
170381905|NCT00945945|615732432|FG000|Overall Study|Withdrawal by Subject|7|||
170381906|NCT00945945|615732433|FG001|Overall Study|Withdrawal by Subject|10|||
170381907|NCT00945945|615732432|FG000|Overall Study|Lost to Follow-up|4|||
170381908|NCT00945945|615732433|FG001|Overall Study|Lost to Follow-up|5|||
170381909|NCT00945945|615732432|FG000|Overall Study|Lack of Efficacy|6|||
170381910|NCT00945945|615732433|FG001|Overall Study|Lack of Efficacy|2|||
170381911|NCT00945945|615732432|FG000|Overall Study|Protocol Violation|4|||
170381912|NCT00945945|615732433|FG001|Overall Study|Protocol Violation|2|||
170381913|NCT00945945|615732432|FG000|Overall Study|Entry Criteria Not Met|0|||
170381914|NCT00945945|615732433|FG001|Overall Study|Entry Criteria Not Met|1|||
170381915|NCT02194699|615732434|FG000|Randomised|Did not receive treatment|1|||
170381916|NCT02194699|615732435|FG001|Randomised|Did not receive treatment|5|||
170381917|NCT02194699|615732434|FG000|Randomised|Without potential for 52 weeks of IP|5|||
170381918|NCT02194699|615732435|FG001|Randomised|Without potential for 52 weeks of IP|5|||
170381919|NCT02194699|615732434|FG000|Randomised|Duplicate patient|2|||
170381920|NCT02194699|615732435|FG001|Randomised|Duplicate patient|1|||
170381921|NCT02194699|615732434|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
170381922|NCT02194699|615732435|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
170381923|NCT02194699|615732434|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
170381924|NCT02194699|615732435|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
170381925|NCT02194699|615732434|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
170381926|NCT02194699|615732435|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
170381927|NCT02194699|615732434|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
170381928|NCT02194699|615732435|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
170381929|NCT02194699|615732434|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
170381930|NCT02194699|615732435|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
170381931|NCT02194699|615732434|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
170381932|NCT02194699|615732435|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
170381933|NCT01101321|615732442|FG000|Period 1|Withdrawal by Subject|1|||
170381934|NCT01101321|615732443|FG001|Period 1|Withdrawal by Subject|1|||
170381935|NCT01101321|615732442|FG000|Period 1|Adverse Event|3|||
170381936|NCT01101321|615732443|FG001|Period 1|Adverse Event|3|||
170381937|NCT00561912|615732447|FG000|Overall Study|ineligible|1|||
170381938|NCT03938857|615732448|FG000|Overall Study|Physician Decision|1|||
170381939|NCT03938857|615732449|FG001|Overall Study|Physician Decision|0|||
170381940|NCT03938857|615732450|FG002|Overall Study|Physician Decision|0|||
170381941|NCT03938857|615732451|FG003|Overall Study|Physician Decision|0|||
170381942|NCT02516605|615732452|FG000|Overall Study|Protocol Violation|0|||
170381943|NCT02516605|615732453|FG001|Overall Study|Protocol Violation|0|||
170381944|NCT02516605|615732454|FG002|Overall Study|Protocol Violation|0|||
170381945|NCT02516605|615732455|FG003|Overall Study|Protocol Violation|0|||
170381946|NCT02516605|615732456|FG004|Overall Study|Protocol Violation|1|||
170381947|NCT02516605|615732452|FG000|Overall Study|Withdrawal by Subject|0|||
170381948|NCT02516605|615732453|FG001|Overall Study|Withdrawal by Subject|0|||
170381949|NCT02516605|615732454|FG002|Overall Study|Withdrawal by Subject|0|||
170381950|NCT02516605|615732455|FG003|Overall Study|Withdrawal by Subject|1|||
170381951|NCT02516605|615732456|FG004|Overall Study|Withdrawal by Subject|0|||
170381952|NCT01398176|615732458|FG000|Overall Study|Lost to Follow-up|1|||
170381953|NCT01398176|615732459|FG001|Overall Study|Lost to Follow-up|3|||
170381954|NCT01398176|615732458|FG000|Overall Study|Physician Decision|2|||
170381955|NCT01398176|615732459|FG001|Overall Study|Physician Decision|3|||
170381956|NCT04235959|615732460|FG000|Overall Study|Protocol Violation|0|||
170381957|NCT04235959|615732461|FG001|Overall Study|Protocol Violation|1|||
170381958|NCT04235959|615732462|FG002|Overall Study|Protocol Violation|0|||
170381959|NCT04235959|615732460|FG000|Overall Study|Adverse Event|1|||
170381960|NCT04235959|615732461|FG001|Overall Study|Adverse Event|0|||
170381961|NCT04235959|615732462|FG002|Overall Study|Adverse Event|0|||
170381962|NCT01072500|615732463|FG000|Overall Study|Death|2|||
170381963|NCT01072500|615732464|FG001|Overall Study|Death|2|||
170381964|NCT01072500|615732463|FG000|Overall Study|Lost to Follow-up|5|||
170381965|NCT01072500|615732464|FG001|Overall Study|Lost to Follow-up|2|||
170381966|NCT01072500|615732463|FG000|Overall Study|Withdrawal by Subject|17|||
170381967|NCT01072500|615732464|FG001|Overall Study|Withdrawal by Subject|10|||
170381968|NCT03227692|615732469|FG000|Overall Study|Protocol Violation|1|||
170381969|NCT03227692|615732470|FG001|Overall Study|Protocol Violation|1|||
170381970|NCT03227692|615732469|FG000|Overall Study|Lost to Follow-up|4|||
170381971|NCT03227692|615732470|FG001|Overall Study|Lost to Follow-up|2|||
170381972|NCT03227692|615732469|FG000|Overall Study|Adverse Event|0|||
170381973|NCT03227692|615732470|FG001|Overall Study|Adverse Event|2|||
170381974|NCT00203294|615732472|FG000|Overall Study|Withdrawal by Subject|8|||
170381975|NCT00203294|615732473|FG001|Overall Study|Withdrawal by Subject|13|||
170381976|NCT02405091|615732474|FG000|Overall Study|Adverse Event|16|||
170381977|NCT02405091|615732475|FG001|Overall Study|Adverse Event|10|||
170381978|NCT02405091|615732476|FG002|Overall Study|Adverse Event|0|||
170381979|NCT02405091|615732474|FG000|Overall Study|Protocol Violation|1|||
170381980|NCT02405091|615732475|FG001|Overall Study|Protocol Violation|0|||
170381981|NCT02405091|615732476|FG002|Overall Study|Protocol Violation|0|||
170381982|NCT02405091|615732474|FG000|Overall Study|Noncompliance|1|||
170381983|NCT02405091|615732475|FG001|Overall Study|Noncompliance|6|||
170381984|NCT02405091|615732476|FG002|Overall Study|Noncompliance|2|||
170381985|NCT02405091|615732474|FG000|Overall Study|Withdrawal by Subject|4|||
170381986|NCT02405091|615732475|FG001|Overall Study|Withdrawal by Subject|8|||
170381987|NCT02405091|615732476|FG002|Overall Study|Withdrawal by Subject|0|||
170381988|NCT02405091|615732474|FG000|Overall Study|Death|0|||
170381989|NCT02405091|615732475|FG001|Overall Study|Death|1|||
170381990|NCT02405091|615732476|FG002|Overall Study|Death|0|||
170381991|NCT02405091|615732474|FG000|Overall Study|Lost to Follow-up|5|||
170381992|NCT02405091|615732475|FG001|Overall Study|Lost to Follow-up|6|||
170381993|NCT02405091|615732476|FG002|Overall Study|Lost to Follow-up|0|||
170381994|NCT02405091|615732474|FG000|Overall Study|Physician Decision|2|||
170381995|NCT02405091|615732475|FG001|Overall Study|Physician Decision|2|||
170381996|NCT02405091|615732476|FG002|Overall Study|Physician Decision|0|||
170381997|NCT01948791|615732477|FG000|Overall Study|Adverse Event|12|||
170381998|NCT01948791|615732477|FG000|Overall Study|Lack of Efficacy|3|||
170381999|NCT01948791|615732477|FG000|Overall Study|Protocol Violation|2|||
170382000|NCT01948791|615732477|FG000|Overall Study|Withdrawal by Subject|5|||
170382001|NCT01948791|615732477|FG000|Overall Study|Lost to Follow-up|6|||
170382002|NCT01948791|615732477|FG000|Overall Study|Management issues|1|||
170382003|NCT01948791|615732477|FG000|Overall Study|Others|7|||
170382004|NCT01948791|615732477|FG000|Overall Study|Screening failure|35|||
170382005|NCT01234337|615732478|FG000|Overall Study|Adverse Event|58|||
170382006|NCT01234337|615732479|FG001|Overall Study|Adverse Event|21|||
170382007|NCT01234337|615732478|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
170382008|NCT01234337|615732479|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
170382009|NCT01234337|615732478|FG000|Overall Study|Investi. decision not protocol driven|5|||
170382010|NCT01234337|615732479|FG001|Overall Study|Investi. decision not protocol driven|6|||
170382011|NCT01234337|615732478|FG000|Overall Study|Non-compliant with study medication|3|||
170382012|NCT01234337|615732479|FG001|Overall Study|Non-compliant with study medication|2|||
170382013|NCT01234337|615732478|FG000|Overall Study|Randomized but not treated|6|||
170382014|NCT01234337|615732479|FG001|Overall Study|Randomized but not treated|4|||
170382015|NCT01234337|615732478|FG000|Overall Study|Lost to Follow-up|0|||
170382016|NCT01234337|615732479|FG001|Overall Study|Lost to Follow-up|1|||
170382017|NCT01234337|615732478|FG000|Overall Study|Protocol Violation|2|||
170382018|NCT01234337|615732479|FG001|Overall Study|Protocol Violation|3|||
170382019|NCT01234337|615732478|FG000|Overall Study|Withdrawal by Subject|11|||
170382020|NCT01234337|615732479|FG001|Overall Study|Withdrawal by Subject|9|||
170382021|NCT01234337|615732478|FG000|Overall Study|Death|0|||
170382022|NCT01234337|615732479|FG001|Overall Study|Death|1|||
170382023|NCT01234337|615732478|FG000|Overall Study|Switch to commercial drug|0|||
170382024|NCT01234337|615732479|FG001|Overall Study|Switch to commercial drug|1|||
170382025|NCT00247962|615732488|FG000|Overall Study|Adverse Event|15|||
170382026|NCT00247962|615732489|FG001|Overall Study|Adverse Event|12|||
170382027|NCT00247962|615732488|FG000|Overall Study|Lost to Follow-up|3|||
170382028|NCT00247962|615732489|FG001|Overall Study|Lost to Follow-up|1|||
170382029|NCT00247962|615732488|FG000|Overall Study|Physician Decision|0|||
170382030|NCT00247962|615732489|FG001|Overall Study|Physician Decision|1|||
170382031|NCT00247962|615732488|FG000|Overall Study|Protocol Violation|1|||
170382032|NCT00247962|615732489|FG001|Overall Study|Protocol Violation|1|||
170382033|NCT00247962|615732488|FG000|Overall Study|Withdrawal by Subject|3|||
170382034|NCT00247962|615732489|FG001|Overall Study|Withdrawal by Subject|2|||
170382035|NCT00247962|615732488|FG000|Overall Study|Lack of Efficacy|4|||
170382036|NCT00247962|615732489|FG001|Overall Study|Lack of Efficacy|2|||
170382037|NCT02120469|615732491|FG000|Overall Study|HER-2/neu-amplified|1|||
170382038|NCT02120469|615732492|FG001|Overall Study|HER-2/neu-amplified|0|||
170382039|NCT02120469|615732493|FG002|Overall Study|HER-2/neu-amplified|1|||
170382040|NCT01981096|615732495|FG000|Overall Study|Parent illness|1|||
170382041|NCT01981096|615732496|FG001|Overall Study|Parent illness|0|||
170382042|NCT01981096|615732495|FG000|Overall Study|Withdrawal by Subject|0|||
170382043|NCT01981096|615732496|FG001|Overall Study|Withdrawal by Subject|1|||
170382044|NCT01981096|615732495|FG000|Overall Study|Lost to Follow-up|2|||
170382045|NCT01981096|615732496|FG001|Overall Study|Lost to Follow-up|0|||
170382046|NCT04129242|615732497|FG000|Overall Study|Physician Decision|1|||
170382047|NCT04129242|615732498|FG001|Overall Study|Physician Decision|1|||
170382048|NCT04129242|615732497|FG000|Overall Study|Protocol Violation|0|||
170382049|NCT04129242|615732498|FG001|Overall Study|Protocol Violation|1|||
170382050|NCT00392210|615732500|FG000|First Voiding Trial|Physician Decision|2|||
170382051|NCT00392210|615732501|FG001|First Voiding Trial|Physician Decision|2|||
170382052|NCT02610231|615732507|FG000|Overall Study|Withdrawal by Subject|27|||
170382053|NCT02610231|615732507|FG000|Overall Study|Adverse Event|20|||
170382054|NCT02610231|615732507|FG000|Overall Study|Death|5|||
170382055|NCT02610231|615732507|FG000|Overall Study|Surgery|2|||
170382056|NCT02610231|615732507|FG000|Overall Study|Physician Decision|1|||
170382057|NCT02610231|615732507|FG000|Overall Study|Non Compliance|2|||
170382058|NCT02610231|615732507|FG000|Overall Study|Other|3|||
170382059|NCT01279954|615732510|FG000|Overall Study|Lack of Efficacy|3|||
170382060|NCT01279954|615732511|FG001|Overall Study|Lack of Efficacy|4|||
170382061|NCT02140762|615732512|FG000|Overall Study|Adverse Event|1|||
170382062|NCT02140762|615732513|FG001|Overall Study|Adverse Event|1|||
170382063|NCT02140762|615732512|FG000|Overall Study|Lost to Follow-up|9|||
170382064|NCT02140762|615732513|FG001|Overall Study|Lost to Follow-up|5|||
170382065|NCT02140762|615732512|FG000|Overall Study|Protocol Violation|1|||
170382066|NCT02140762|615732513|FG001|Overall Study|Protocol Violation|1|||
170382067|NCT02140762|615732512|FG000|Overall Study|Withdrawal by Subject|6|||
170382068|NCT02140762|615732513|FG001|Overall Study|Withdrawal by Subject|4|||
170382069|NCT02140762|615732512|FG000|Overall Study|Other|0|||
170382070|NCT02140762|615732513|FG001|Overall Study|Other|1|||
170382071|NCT01503229|615734317|FG000|Overall Study|Withdrew consent|1|||
170382072|NCT01354964|615734318|FG000|Overall Study|Lost to Follow-up|2|||
170382073|NCT01354964|615734319|FG001|Overall Study|Lost to Follow-up|0|||
170382074|NCT01354964|615734318|FG000|Overall Study|IV access issues|1|||
170382075|NCT01354964|615734319|FG001|Overall Study|IV access issues|1|||
170382076|NCT01354964|615734318|FG000|Overall Study|Physician Decision|1|||
170382077|NCT01354964|615734319|FG001|Overall Study|Physician Decision|0|||
170382078|NCT04524663|615734320|FG000|Overall Study|Withdrawal by Subject|0|||
170382079|NCT04524663|615734321|FG001|Overall Study|Withdrawal by Subject|2|||
170382080|NCT05604781|615734323|FG000|Overall Study|Lost to Follow-up|3|||
170382081|NCT05604781|615734323|FG000|Overall Study|Adverse Event|1|||
170382082|NCT01519700|615734334|FG000|Overall Study|Death|1|||
170382083|NCT01519700|615734335|FG001|Overall Study|Death|0|||
170382084|NCT01519700|615734336|FG002|Overall Study|Death|0|||
170382085|NCT01519700|615734337|FG003|Overall Study|Death|0|||
170382086|NCT01519700|615734334|FG000|Overall Study|Lost to Follow-up|0|||
170382087|NCT01519700|615734335|FG001|Overall Study|Lost to Follow-up|0|||
170382088|NCT01519700|615734336|FG002|Overall Study|Lost to Follow-up|1|||
170382089|NCT01519700|615734337|FG003|Overall Study|Lost to Follow-up|1|||
170382090|NCT01519700|615734334|FG000|Overall Study|Physician Decision|1|||
170382091|NCT01519700|615734335|FG001|Overall Study|Physician Decision|1|||
170382092|NCT01519700|615734336|FG002|Overall Study|Physician Decision|3|||
170382093|NCT01519700|615734337|FG003|Overall Study|Physician Decision|0|||
170382094|NCT01519700|615734334|FG000|Overall Study|Withdrawal by Subject|5|||
170382095|NCT01519700|615734335|FG001|Overall Study|Withdrawal by Subject|3|||
170382096|NCT01519700|615734336|FG002|Overall Study|Withdrawal by Subject|3|||
170382097|NCT01519700|615734337|FG003|Overall Study|Withdrawal by Subject|2|||
170382098|NCT01519700|615734334|FG000|Overall Study|Other Reason|2|||
170382099|NCT01519700|615734335|FG001|Overall Study|Other Reason|2|||
170382100|NCT01519700|615734336|FG002|Overall Study|Other Reason|0|||
170382101|NCT01519700|615734337|FG003|Overall Study|Other Reason|4|||
170382102|NCT01640353|615734352|FG000|Overall Study|Withdrew prior to treatment|10|||
170382103|NCT01640353|615734352|FG000|Overall Study|Withdrawn from analysis at term site|12|||
170382104|NCT01640353|615734352|FG000|Overall Study|Withdrawal by Subject|5|||
170382105|NCT01640353|615734352|FG000|Overall Study|Death|2|||
170382106|NCT01640353|615734352|FG000|Overall Study|Early site termination|3|||
170382107|NCT01640353|615734352|FG000|Overall Study|Lost to Follow-up|12|||
170382108|NCT01640353|615734352|FG000|Overall Study|Physician Decision|1|||
170382109|NCT01667731|615734357|FG000|Overall Study|Enrolled but not treated|0|||
170382110|NCT01667731|615734358|FG001|Overall Study|Enrolled but not treated|0|||
170382111|NCT01667731|615734359|FG002|Overall Study|Enrolled but not treated|0|||
170382112|NCT01667731|615734360|FG003|Overall Study|Enrolled but not treated|0|||
170382113|NCT01667731|615734361|FG004|Overall Study|Enrolled but not treated|1|||
170382114|NCT01667731|615734357|FG000|Overall Study|Efficacy Failure|1|||
170382115|NCT01667731|615734358|FG001|Overall Study|Efficacy Failure|12|||
170382116|NCT01667731|615734359|FG002|Overall Study|Efficacy Failure|0|||
170382117|NCT01667731|615734360|FG003|Overall Study|Efficacy Failure|1|||
170382118|NCT01667731|615734361|FG004|Overall Study|Efficacy Failure|24|||
170382119|NCT01667731|615734357|FG000|Overall Study|Lost to Follow-up|2|||
170382120|NCT01667731|615734358|FG001|Overall Study|Lost to Follow-up|3|||
170382121|NCT01667731|615734359|FG002|Overall Study|Lost to Follow-up|1|||
170382122|NCT01667731|615734360|FG003|Overall Study|Lost to Follow-up|1|||
170382123|NCT01667731|615734361|FG004|Overall Study|Lost to Follow-up|2|||
170382124|NCT01667731|615734357|FG000|Overall Study|Subject Withdrew Consent|2|||
170382125|NCT01667731|615734358|FG001|Overall Study|Subject Withdrew Consent|0|||
170382126|NCT01667731|615734359|FG002|Overall Study|Subject Withdrew Consent|1|||
170382127|NCT01667731|615734360|FG003|Overall Study|Subject Withdrew Consent|0|||
170382128|NCT01667731|615734361|FG004|Overall Study|Subject Withdrew Consent|1|||
170382129|NCT01667731|615734357|FG000|Overall Study|Death|0|||
170382130|NCT01667731|615734358|FG001|Overall Study|Death|1|||
170382131|NCT01667731|615734359|FG002|Overall Study|Death|0|||
170382132|NCT01667731|615734360|FG003|Overall Study|Death|0|||
170382133|NCT01667731|615734361|FG004|Overall Study|Death|0|||
170382134|NCT01710709|615734364|FG000|Overall Study|Lost to Follow-up|29|||
170382135|NCT01710709|615734364|FG000|Overall Study|Adverse Event|48|||
170382136|NCT01710709|615734364|FG000|Overall Study|Participant met withdrawal criteria|33|||
170382137|NCT01710709|615734364|FG000|Overall Study|Participant withdrawn by investigator|2|||
170382138|NCT01710709|615734364|FG000|Overall Study|Withdrawal by Subject|53|||
170382139|NCT01710709|615734364|FG000|Overall Study|Protocol Violation|5|||
170382140|NCT01710709|615734364|FG000|Overall Study|Lack of Efficacy|3|||
170382141|NCT00542321|615734365|FG000|Overall Study|Death|0|||
170382142|NCT00542321|615734366|FG001|Overall Study|Death|1|||
170382143|NCT01871870|615734370|FG000|Overall Study|Hardware issues|7|||
170382144|NCT01871870|615734370|FG000|Overall Study|hyperglycemia|2|||
170382145|NCT00525499|615734376|FG000|Overall Study|Lost to Follow-up|2|||
170382146|NCT00525499|615734377|FG001|Overall Study|Lost to Follow-up|4|||
170382147|NCT00525499|615734378|FG002|Overall Study|Lost to Follow-up|1|||
170382148|NCT00525499|615734379|FG003|Overall Study|Lost to Follow-up|4|||
170382149|NCT00525499|615734376|FG000|Overall Study|Adverse Event|0|||
170382150|NCT00525499|615734377|FG001|Overall Study|Adverse Event|1|||
170382151|NCT00525499|615734378|FG002|Overall Study|Adverse Event|0|||
170382152|NCT00525499|615734379|FG003|Overall Study|Adverse Event|1|||
170382153|NCT00525499|615734376|FG000|Overall Study|Withdrawal by Subject|5|||
170382154|NCT00525499|615734377|FG001|Overall Study|Withdrawal by Subject|1|||
170382155|NCT00525499|615734378|FG002|Overall Study|Withdrawal by Subject|5|||
170382156|NCT00525499|615734379|FG003|Overall Study|Withdrawal by Subject|2|||
170382157|NCT00525499|615734376|FG000|Overall Study|Protocol Violation|0|||
170382158|NCT00525499|615734377|FG001|Overall Study|Protocol Violation|1|||
170382159|NCT00525499|615734378|FG002|Overall Study|Protocol Violation|1|||
170382160|NCT00525499|615734379|FG003|Overall Study|Protocol Violation|0|||
170382161|NCT03339999|615734380|FG000|Overall Study|Adverse Event|1|||
170382162|NCT03339999|615734381|FG001|Overall Study|Adverse Event|2|||
170382163|NCT03339999|615734382|FG002|Overall Study|Adverse Event|2|||
170382164|NCT03339999|615734383|FG003|Overall Study|Adverse Event|1|||
170382165|NCT03339999|615734380|FG000|Overall Study|Lack of Efficacy|0|||
170382166|NCT03339999|615734381|FG001|Overall Study|Lack of Efficacy|1|||
170382167|NCT03339999|615734382|FG002|Overall Study|Lack of Efficacy|0|||
170382168|NCT03339999|615734383|FG003|Overall Study|Lack of Efficacy|0|||
170382169|NCT03339999|615734380|FG000|Overall Study|Lost to Follow-up|0|||
170382170|NCT03339999|615734381|FG001|Overall Study|Lost to Follow-up|0|||
170382171|NCT03339999|615734382|FG002|Overall Study|Lost to Follow-up|0|||
170382172|NCT03339999|615734383|FG003|Overall Study|Lost to Follow-up|1|||
170382173|NCT03339999|615734380|FG000|Overall Study|Study Terminated by Sponsor|6|||
170382174|NCT03339999|615734381|FG001|Overall Study|Study Terminated by Sponsor|3|||
170382175|NCT03339999|615734382|FG002|Overall Study|Study Terminated by Sponsor|4|||
170382176|NCT03339999|615734383|FG003|Overall Study|Study Terminated by Sponsor|3|||
170382177|NCT00253747|615734384|FG000|Overall Study|Lost to Follow-up|13|||
170382178|NCT00253747|615734385|FG001|Overall Study|Lost to Follow-up|14|||
170382179|NCT00253747|615734384|FG000|Overall Study|Withdrawal by Subject|10|||
170382180|NCT00253747|615734385|FG001|Overall Study|Withdrawal by Subject|11|||
170382181|NCT00253747|615734384|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
170382182|NCT00253747|615734385|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
170382183|NCT03287089|615734388|FG000|Overall Study|Lost to Follow-up|0|||
170382184|NCT03287089|615734389|FG001|Overall Study|Lost to Follow-up|2|||
170382185|NCT03287089|615734388|FG000|Overall Study|Physician Decision|0|||
170382186|NCT03287089|615734389|FG001|Overall Study|Physician Decision|2|||
170382187|NCT03287089|615734388|FG000|Overall Study|Withdrawal by Subject|0|||
170382188|NCT03287089|615734389|FG001|Overall Study|Withdrawal by Subject|2|||
170382189|NCT05102734|615734390|FG000|Overall Study|Did not require vasopressors|1|||
170382190|NCT05102734|615734391|FG001|Overall Study|Did not require vasopressors|0|||
170382191|NCT05102734|615734390|FG000|Overall Study|Did not have functioning PA catheter|1|||
170382192|NCT05102734|615734391|FG001|Overall Study|Did not have functioning PA catheter|0|||
170382193|NCT05102734|615734390|FG000|Overall Study|Inadequate video quality|2|||
170382194|NCT05102734|615734391|FG001|Overall Study|Inadequate video quality|0|||
170382195|NCT00490815|615734393|FG000|Overall Study|Adverse Event|2|||
170382196|NCT00490815|615734394|FG001|Overall Study|Adverse Event|3|||
170382197|NCT00490815|615734393|FG000|Overall Study|Withdrawal by Subject|4|||
170382198|NCT00490815|615734394|FG001|Overall Study|Withdrawal by Subject|0|||
170382199|NCT00490815|615734393|FG000|Overall Study|Lost to Follow-up|1|||
170382200|NCT00490815|615734394|FG001|Overall Study|Lost to Follow-up|3|||
170382201|NCT00490815|615734393|FG000|Overall Study|Death|1|||
170382202|NCT00490815|615734394|FG001|Overall Study|Death|3|||
170382203|NCT00732199|615734400|FG000|Overall Study|Withdrawal by Subject|25|||
170382204|NCT00732199|615734401|FG001|Overall Study|Withdrawal by Subject|18|||
170382205|NCT00732199|615734400|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
170382206|NCT00732199|615734401|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
170382207|NCT00672139|615734407|FG000|Overall Study|Death|14|||
170382208|NCT00672139|615734408|FG001|Overall Study|Death|23|||
170382209|NCT00672139|615734407|FG000|Overall Study|Withdrawal by Subject|2|||
170382210|NCT00672139|615734408|FG001|Overall Study|Withdrawal by Subject|11|||
170382211|NCT00672139|615734407|FG000|Overall Study|Adverse Event|4|||
170382212|NCT00672139|615734408|FG001|Overall Study|Adverse Event|7|||
170382213|NCT00672139|615734407|FG000|Overall Study|Physician Decision|2|||
170382214|NCT00672139|615734408|FG001|Overall Study|Physician Decision|0|||
170382215|NCT00672139|615734407|FG000|Overall Study|Lack of Efficacy|4|||
170382216|NCT00672139|615734408|FG001|Overall Study|Lack of Efficacy|1|||
170382217|NCT00672139|615734407|FG000|Overall Study|Protocol Violation|1|||
170382218|NCT00672139|615734408|FG001|Overall Study|Protocol Violation|1|||
170382219|NCT00672139|615734407|FG000|Overall Study|hospice discharge, caregiver requests|3|||
170382220|NCT00672139|615734408|FG001|Overall Study|hospice discharge, caregiver requests|2|||
170382221|NCT02176226|615734409|FG000|Overall Study|Lost to Follow-up|3|||
170382222|NCT02176226|615734409|FG000|Overall Study|Withdrew prior to treatment|6|||
170382223|NCT01351415|615734415|FG000|Overall Study|Withdrawal by Subject|15|||
170382224|NCT01351415|615734416|FG001|Overall Study|Withdrawal by Subject|17|||
170382225|NCT01351415|615734415|FG000|Overall Study|Trial termination by the Sponsor|28|||
170382226|NCT01351415|615734416|FG001|Overall Study|Trial termination by the Sponsor|19|||
170382227|NCT01351415|615734415|FG000|Overall Study|Lost to Follow-up|5|||
170382228|NCT01351415|615734416|FG001|Overall Study|Lost to Follow-up|7|||
170382229|NCT01351415|615734415|FG000|Overall Study|Death|190|||
170382230|NCT01351415|615734416|FG001|Overall Study|Death|187|||
170382231|NCT01351415|615734415|FG000|Overall Study|Physician Decision|2|||
170382232|NCT01351415|615734416|FG001|Overall Study|Physician Decision|3|||
170382233|NCT01351415|615734415|FG000|Overall Study|Reason unknown|0|||
170382234|NCT01351415|615734416|FG001|Overall Study|Reason unknown|2|||
170382235|NCT01351415|615734415|FG000|Overall Study|Never Started|5|||
170382236|NCT01351415|615734416|FG001|Overall Study|Never Started|5|||
170382237|NCT00994890|615734417|FG000|Overall Study|Adverse Event|13|||
170382238|NCT00994890|615734418|FG001|Overall Study|Adverse Event|9|||
170382239|NCT00994890|615734419|FG002|Overall Study|Adverse Event|11|||
170382240|NCT00994890|615734417|FG000|Overall Study|Lack of Efficacy|0|||
170382241|NCT00994890|615734418|FG001|Overall Study|Lack of Efficacy|0|||
170382242|NCT00994890|615734419|FG002|Overall Study|Lack of Efficacy|1|||
170382243|NCT00994890|615734417|FG000|Overall Study|Lost to Follow-up|6|||
170382244|NCT00994890|615734418|FG001|Overall Study|Lost to Follow-up|1|||
170382245|NCT00994890|615734419|FG002|Overall Study|Lost to Follow-up|3|||
170382246|NCT00994890|615734417|FG000|Overall Study|No longer willing to participate|8|||
170382247|NCT00994890|615734418|FG001|Overall Study|No longer willing to participate|5|||
170382248|NCT00994890|615734419|FG002|Overall Study|No longer willing to participate|13|||
170382249|NCT00994890|615734417|FG000|Overall Study|Protocol Violation|2|||
170382250|NCT00994890|615734418|FG001|Overall Study|Protocol Violation|4|||
170382251|NCT00994890|615734419|FG002|Overall Study|Protocol Violation|0|||
170382252|NCT00994890|615734417|FG000|Overall Study|Study terminated by sponsor|199|||
170382253|NCT00994890|615734418|FG001|Overall Study|Study terminated by sponsor|201|||
170382254|NCT00994890|615734419|FG002|Overall Study|Study terminated by sponsor|197|||
170382255|NCT00994890|615734417|FG000|Overall Study|Randomized, but not treated|1|||
170382256|NCT00994890|615734418|FG001|Overall Study|Randomized, but not treated|0|||
170382257|NCT00994890|615734419|FG002|Overall Study|Randomized, but not treated|0|||
170382258|NCT00994890|615734417|FG000|Overall Study|Other|2|||
170382259|NCT00994890|615734418|FG001|Overall Study|Other|2|||
170382260|NCT00994890|615734419|FG002|Overall Study|Other|1|||
170382261|NCT00699582|615734420|FG000|Overall Study|Adverse Event|4|||
170382262|NCT00699582|615734421|FG001|Overall Study|Adverse Event|11|||
170382263|NCT00699582|615734422|FG002|Overall Study|Adverse Event|23|||
170382264|NCT00699582|615734420|FG000|Overall Study|Withdrawal by Subject|6|||
170382265|NCT00699582|615734421|FG001|Overall Study|Withdrawal by Subject|7|||
170382266|NCT00699582|615734422|FG002|Overall Study|Withdrawal by Subject|4|||
170382267|NCT00699582|615734420|FG000|Overall Study|Lack of Efficacy|1|||
170382268|NCT00699582|615734421|FG001|Overall Study|Lack of Efficacy|0|||
170382269|NCT00699582|615734422|FG002|Overall Study|Lack of Efficacy|1|||
170382270|NCT00699582|615734420|FG000|Overall Study|Progressive Disease|1|||
170382271|NCT00699582|615734421|FG001|Overall Study|Progressive Disease|0|||
170382272|NCT00699582|615734422|FG002|Overall Study|Progressive Disease|0|||
170382273|NCT00699582|615734420|FG000|Overall Study|Administrative/Other|4|||
170382274|NCT00699582|615734421|FG001|Overall Study|Administrative/Other|3|||
170382275|NCT00699582|615734422|FG002|Overall Study|Administrative/Other|0|||
170382276|NCT00699582|615734420|FG000|Overall Study|Randomized, Not Treated|2|||
170382277|NCT00699582|615734421|FG001|Overall Study|Randomized, Not Treated|1|||
170382278|NCT00699582|615734422|FG002|Overall Study|Randomized, Not Treated|0|||
170382279|NCT03525613|615734426|FG000|Overall Study|Adverse Event|11|||
170382280|NCT03525613|615734427|FG001|Overall Study|Adverse Event|8|||
170382281|NCT03525613|615734428|FG002|Overall Study|Adverse Event|3|||
170382282|NCT03525613|615734429|FG003|Overall Study|Adverse Event|3|||
170382283|NCT03525613|615734426|FG000|Overall Study|Lost to Follow-up|4|||
170382284|NCT03525613|615734427|FG001|Overall Study|Lost to Follow-up|5|||
170382285|NCT03525613|615734428|FG002|Overall Study|Lost to Follow-up|3|||
170382286|NCT03525613|615734429|FG003|Overall Study|Lost to Follow-up|2|||
170382287|NCT03525613|615734426|FG000|Overall Study|Physician Decision|0|||
170382288|NCT03525613|615734427|FG001|Overall Study|Physician Decision|1|||
170382289|NCT03525613|615734428|FG002|Overall Study|Physician Decision|0|||
170382290|NCT03525613|615734429|FG003|Overall Study|Physician Decision|1|||
170382291|NCT03525613|615734426|FG000|Overall Study|Consent Withdrawal|25|||
170382292|NCT03525613|615734427|FG001|Overall Study|Consent Withdrawal|16|||
170382293|NCT03525613|615734428|FG002|Overall Study|Consent Withdrawal|12|||
170382294|NCT03525613|615734429|FG003|Overall Study|Consent Withdrawal|9|||
170382295|NCT03525613|615734426|FG000|Overall Study|Death|20|||
170382296|NCT03525613|615734427|FG001|Overall Study|Death|9|||
170382297|NCT03525613|615734428|FG002|Overall Study|Death|7|||
170382298|NCT03525613|615734429|FG003|Overall Study|Death|1|||
170382299|NCT03525613|615734426|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
170382300|NCT03525613|615734427|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
170382301|NCT03525613|615734428|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
170382302|NCT03525613|615734429|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
170382303|NCT04212221|615734434|FG000|Overall Study|Remained on Treatment|0|||
170382304|NCT04212221|615734435|FG001|Overall Study|Remained on Treatment|0|||
170382305|NCT04212221|615734436|FG002|Overall Study|Remained on Treatment|0|||
170382306|NCT04212221|615734437|FG003|Overall Study|Remained on Treatment|1|||
170382307|NCT04212221|615734438|FG004|Overall Study|Remained on Treatment|0|||
170382308|NCT04212221|615734439|FG005|Overall Study|Remained on Treatment|0|||
170382309|NCT04212221|615734440|FG006|Overall Study|Remained on Treatment|3|||
170382310|NCT04212221|615734441|FG007|Overall Study|Remained on Treatment|9|||
170382311|NCT04212221|615734434|FG000|Overall Study|Adverse Event|0|||
170382312|NCT04212221|615734435|FG001|Overall Study|Adverse Event|0|||
170382313|NCT04212221|615734436|FG002|Overall Study|Adverse Event|0|||
170382314|NCT04212221|615734437|FG003|Overall Study|Adverse Event|0|||
170382315|NCT04212221|615734438|FG004|Overall Study|Adverse Event|0|||
170382316|NCT04212221|615734439|FG005|Overall Study|Adverse Event|0|||
170382317|NCT04212221|615734440|FG006|Overall Study|Adverse Event|2|||
170382318|NCT04212221|615734441|FG007|Overall Study|Adverse Event|3|||
170382319|NCT04212221|615734434|FG000|Overall Study|Death|0|||
170382320|NCT04212221|615734435|FG001|Overall Study|Death|0|||
170382321|NCT04212221|615734436|FG002|Overall Study|Death|0|||
170382322|NCT04212221|615734437|FG003|Overall Study|Death|0|||
170382323|NCT04212221|615734438|FG004|Overall Study|Death|0|||
170382324|NCT04212221|615734439|FG005|Overall Study|Death|0|||
170382325|NCT04212221|615734440|FG006|Overall Study|Death|0|||
170382326|NCT04212221|615734441|FG007|Overall Study|Death|2|||
170382327|NCT04212221|615734434|FG000|Overall Study|Disease progression according to irRECIST|1|||
170382328|NCT04212221|615734435|FG001|Overall Study|Disease progression according to irRECIST|2|||
170382329|NCT04212221|615734436|FG002|Overall Study|Disease progression according to irRECIST|3|||
170382330|NCT04212221|615734437|FG003|Overall Study|Disease progression according to irRECIST|3|||
170382331|NCT04212221|615734438|FG004|Overall Study|Disease progression according to irRECIST|2|||
170382332|NCT04212221|615734439|FG005|Overall Study|Disease progression according to irRECIST|2|||
170382333|NCT04212221|615734440|FG006|Overall Study|Disease progression according to irRECIST|21|||
170382334|NCT04212221|615734441|FG007|Overall Study|Disease progression according to irRECIST|17|||
170382335|NCT04212221|615734434|FG000|Overall Study|Global Deterioration of Health Status|0|||
170382336|NCT04212221|615734435|FG001|Overall Study|Global Deterioration of Health Status|0|||
170382337|NCT04212221|615734436|FG002|Overall Study|Global Deterioration of Health Status|0|||
170382338|NCT04212221|615734437|FG003|Overall Study|Global Deterioration of Health Status|0|||
170382339|NCT04212221|615734438|FG004|Overall Study|Global Deterioration of Health Status|0|||
170382340|NCT04212221|615734439|FG005|Overall Study|Global Deterioration of Health Status|0|||
170382341|NCT04212221|615734440|FG006|Overall Study|Global Deterioration of Health Status|0|||
170382342|NCT04212221|615734441|FG007|Overall Study|Global Deterioration of Health Status|2|||
170382343|NCT04212221|615734434|FG000|Overall Study|Investigator's Decision|0|||
170382344|NCT04212221|615734435|FG001|Overall Study|Investigator's Decision|0|||
170382345|NCT04212221|615734436|FG002|Overall Study|Investigator's Decision|0|||
170382346|NCT04212221|615734437|FG003|Overall Study|Investigator's Decision|1|||
170382347|NCT04212221|615734438|FG004|Overall Study|Investigator's Decision|0|||
170382348|NCT04212221|615734439|FG005|Overall Study|Investigator's Decision|0|||
170382349|NCT04212221|615734440|FG006|Overall Study|Investigator's Decision|3|||
170382350|NCT04212221|615734441|FG007|Overall Study|Investigator's Decision|0|||
170382351|NCT04212221|615734434|FG000|Overall Study|Participant refused to continue treatment|0|||
170382352|NCT04212221|615734435|FG001|Overall Study|Participant refused to continue treatment|1|||
170382353|NCT04212221|615734436|FG002|Overall Study|Participant refused to continue treatment|0|||
170382354|NCT04212221|615734437|FG003|Overall Study|Participant refused to continue treatment|1|||
170382355|NCT04212221|615734438|FG004|Overall Study|Participant refused to continue treatment|1|||
170382356|NCT04212221|615734439|FG005|Overall Study|Participant refused to continue treatment|2|||
170382357|NCT04212221|615734440|FG006|Overall Study|Participant refused to continue treatment|4|||
170382358|NCT04212221|615734441|FG007|Overall Study|Participant refused to continue treatment|2|||
170382359|NCT04212221|615734434|FG000|Overall Study|Protocol Violation|0|||
170382360|NCT04212221|615734435|FG001|Overall Study|Protocol Violation|0|||
170382361|NCT04212221|615734436|FG002|Overall Study|Protocol Violation|0|||
170382362|NCT04212221|615734437|FG003|Overall Study|Protocol Violation|0|||
170382363|NCT04212221|615734438|FG004|Overall Study|Protocol Violation|0|||
170382364|NCT04212221|615734439|FG005|Overall Study|Protocol Violation|0|||
170382365|NCT04212221|615734440|FG006|Overall Study|Protocol Violation|0|||
170382366|NCT04212221|615734441|FG007|Overall Study|Protocol Violation|1|||
170382367|NCT03117309|615734449|FG000|Overall Study|Not meeting inclusion criteria|0|||
170382368|NCT03117309|615734450|FG001|Overall Study|Not meeting inclusion criteria|1|||
170382369|NCT02583711|615734451|FG000|Overall Study|Withdrawal by Subject|0|||
170382370|NCT02583711|615734452|FG001|Overall Study|Withdrawal by Subject|10|||
170382371|NCT02583711|615734453|FG002|Overall Study|Withdrawal by Subject|0|||
170382372|NCT01012037|615734454|FG000|Overall Study|Adverse Event|0|||
170382373|NCT01012037|615734455|FG001|Overall Study|Adverse Event|8|||
170382374|NCT01012037|615734456|FG002|Overall Study|Adverse Event|3|||
170382375|NCT01012037|615734454|FG000|Overall Study|Protocol Violation|0|||
170382376|NCT01012037|615734455|FG001|Overall Study|Protocol Violation|3|||
170382377|NCT01012037|615734456|FG002|Overall Study|Protocol Violation|5|||
170382378|NCT01012037|615734454|FG000|Overall Study|Withdrawal by Subject|0|||
170382379|NCT01012037|615734455|FG001|Overall Study|Withdrawal by Subject|4|||
170382380|NCT01012037|615734456|FG002|Overall Study|Withdrawal by Subject|1|||
170382381|NCT01012037|615734454|FG000|Overall Study|Other reason (not specified)|1|||
170382382|NCT01012037|615734455|FG001|Overall Study|Other reason (not specified)|1|||
170382383|NCT01012037|615734456|FG002|Overall Study|Other reason (not specified)|1|||
170382384|NCT02692560|615734459|FG000|Overall Study|Withdrawal by Subject|0|||
170382385|NCT02692560|615734460|FG001|Overall Study|Withdrawal by Subject|6|||
170382386|NCT00590031|615734461|FG000|Overall Study|Adverse Event|3|||
170382387|NCT00590031|615734461|FG000|Overall Study|Withdrawal by Subject|1|||
170382388|NCT00590031|615734461|FG000|Overall Study|Metastatic Disease|1|||
170382389|NCT00590031|615734461|FG000|Overall Study|Admin Hold|1|||
170382390|NCT01809327|615734462|FG000|Overall Study|Lost to Follow-up|5|||
170382391|NCT01809327|615734463|FG001|Overall Study|Lost to Follow-up|2|||
170382392|NCT01809327|615734464|FG002|Overall Study|Lost to Follow-up|4|||
170382393|NCT01809327|615734465|FG003|Overall Study|Lost to Follow-up|2|||
170382394|NCT01809327|615734466|FG004|Overall Study|Lost to Follow-up|3|||
170382395|NCT01809327|615734462|FG000|Overall Study|Withdrawal by Subject|6|||
170382396|NCT01809327|615734463|FG001|Overall Study|Withdrawal by Subject|4|||
170382397|NCT01809327|615734464|FG002|Overall Study|Withdrawal by Subject|4|||
170382398|NCT01809327|615734465|FG003|Overall Study|Withdrawal by Subject|2|||
170382399|NCT01809327|615734466|FG004|Overall Study|Withdrawal by Subject|5|||
170382400|NCT01809327|615734462|FG000|Overall Study|Adverse Event|4|||
170382401|NCT01809327|615734463|FG001|Overall Study|Adverse Event|3|||
170382402|NCT01809327|615734464|FG002|Overall Study|Adverse Event|7|||
170382403|NCT01809327|615734465|FG003|Overall Study|Adverse Event|4|||
170382404|NCT01809327|615734466|FG004|Overall Study|Adverse Event|8|||
170382405|NCT01809327|615734462|FG000|Overall Study|Death|1|||
170382406|NCT01809327|615734463|FG001|Overall Study|Death|0|||
170382407|NCT01809327|615734464|FG002|Overall Study|Death|0|||
170382408|NCT01809327|615734465|FG003|Overall Study|Death|0|||
170382409|NCT01809327|615734466|FG004|Overall Study|Death|0|||
170382410|NCT01809327|615734462|FG000|Overall Study|Protocol Violation|0|||
170382411|NCT01809327|615734463|FG001|Overall Study|Protocol Violation|1|||
170382412|NCT01809327|615734464|FG002|Overall Study|Protocol Violation|0|||
170382413|NCT01809327|615734465|FG003|Overall Study|Protocol Violation|0|||
170382414|NCT01809327|615734466|FG004|Overall Study|Protocol Violation|0|||
170382415|NCT01809327|615734462|FG000|Overall Study|Physician Decision|1|||
170382416|NCT01809327|615734463|FG001|Overall Study|Physician Decision|1|||
170382417|NCT01809327|615734464|FG002|Overall Study|Physician Decision|0|||
170382418|NCT01809327|615734465|FG003|Overall Study|Physician Decision|0|||
170382419|NCT01809327|615734466|FG004|Overall Study|Physician Decision|0|||
170382420|NCT01809327|615734462|FG000|Overall Study|Pregnancy|1|||
170382421|NCT01809327|615734463|FG001|Overall Study|Pregnancy|0|||
170382422|NCT01809327|615734464|FG002|Overall Study|Pregnancy|0|||
170382423|NCT01809327|615734465|FG003|Overall Study|Pregnancy|0|||
170382424|NCT01809327|615734466|FG004|Overall Study|Pregnancy|0|||
170382425|NCT01809327|615734462|FG000|Overall Study|Other|14|||
170382426|NCT01809327|615734463|FG001|Overall Study|Other|15|||
170382427|NCT01809327|615734464|FG002|Overall Study|Other|7|||
170382428|NCT01809327|615734465|FG003|Overall Study|Other|4|||
170382429|NCT01809327|615734466|FG004|Overall Study|Other|9|||
170382430|NCT02802735|615734480|FG000|Overall Study|Withdrawal by Subject|0|||
170382431|NCT02802735|615734481|FG001|Overall Study|Withdrawal by Subject|1|||
170382432|NCT02802735|615734482|FG002|Overall Study|Withdrawal by Subject|0|||
170382433|NCT02802735|615734483|FG003|Overall Study|Withdrawal by Subject|0|||
170382434|NCT02802735|615734484|FG004|Overall Study|Withdrawal by Subject|0|||
170382435|NCT01166386|615734485|FG000|Overall Study|Withdrawal by Subject|3|||
170382436|NCT01166386|615734486|FG001|Overall Study|Withdrawal by Subject|5|||
170382437|NCT03922711|615734489|FG000|Overall Study|Adverse Event|3|||
170382438|NCT03922711|615734490|FG001|Overall Study|Adverse Event|2|||
170382439|NCT03922711|615734491|FG002|Overall Study|Adverse Event|2|||
170382440|NCT03922711|615734489|FG000|Overall Study|Protocol Violation|1|||
170382441|NCT03922711|615734490|FG001|Overall Study|Protocol Violation|0|||
170382442|NCT03922711|615734491|FG002|Overall Study|Protocol Violation|0|||
170382443|NCT03922711|615734489|FG000|Overall Study|Withdrawal by Subject|0|||
170382444|NCT03922711|615734490|FG001|Overall Study|Withdrawal by Subject|3|||
170382445|NCT03922711|615734491|FG002|Overall Study|Withdrawal by Subject|1|||
170382446|NCT03922711|615734489|FG000|Overall Study|Not further specified|0|||
170382447|NCT03922711|615734490|FG001|Overall Study|Not further specified|0|||
170382448|NCT03922711|615734491|FG002|Overall Study|Not further specified|1|||
170382449|NCT00420212|615734492|FG000|Overall Study|Adverse Event|22|||
170382450|NCT00420212|615734493|FG001|Overall Study|Adverse Event|40|||
170382451|NCT00420212|615734494|FG002|Overall Study|Adverse Event|36|||
170382452|NCT00420212|615734492|FG000|Overall Study|Lost to Follow-up|9|||
170382453|NCT00420212|615734493|FG001|Overall Study|Lost to Follow-up|11|||
170382454|NCT00420212|615734494|FG002|Overall Study|Lost to Follow-up|11|||
170382455|NCT00420212|615734492|FG000|Overall Study|Withdrawal by Subject|31|||
170382456|NCT00420212|615734493|FG001|Overall Study|Withdrawal by Subject|22|||
170382457|NCT00420212|615734494|FG002|Overall Study|Withdrawal by Subject|19|||
170382458|NCT00420212|615734492|FG000|Overall Study|Physician Decision|4|||
170382459|NCT00420212|615734493|FG001|Overall Study|Physician Decision|4|||
170382460|NCT00420212|615734494|FG002|Overall Study|Physician Decision|3|||
170382461|NCT00420212|615734492|FG000|Overall Study|Protocol Violation|4|||
170382462|NCT00420212|615734493|FG001|Overall Study|Protocol Violation|4|||
170382463|NCT00420212|615734494|FG002|Overall Study|Protocol Violation|8|||
170382464|NCT00420212|615734492|FG000|Overall Study|Death|0|||
170382465|NCT00420212|615734493|FG001|Overall Study|Death|0|||
170382466|NCT00420212|615734494|FG002|Overall Study|Death|1|||
170382467|NCT00420212|615734492|FG000|Overall Study|Other-Unspecified|21|||
170382468|NCT00420212|615734493|FG001|Overall Study|Other-Unspecified|14|||
170382469|NCT00420212|615734494|FG002|Overall Study|Other-Unspecified|18|||
170382470|NCT02390362|615734495|FG000|Overall Study|Withdrawal by Subject|0|||
170382471|NCT02390362|615734496|FG001|Overall Study|Withdrawal by Subject|1|||
170382472|NCT01142791|615734506|FG000|Overall Study|Alternative Treatment|1|||
170382473|NCT01142791|615734507|FG001|Overall Study|Alternative Treatment|0|||
170382474|NCT01142791|615734506|FG000|Overall Study|Lost to Follow-up|1|||
170382475|NCT01142791|615734507|FG001|Overall Study|Lost to Follow-up|0|||
170382476|NCT01142791|615734506|FG000|Overall Study|Withdrawal by Subject|5|||
170382477|NCT01142791|615734507|FG001|Overall Study|Withdrawal by Subject|0|||
170382478|NCT01142791|615734506|FG000|Overall Study|Received only 1 sonication|0|||
170382479|NCT01142791|615734507|FG001|Overall Study|Received only 1 sonication|6|||
170382480|NCT02178592|615734508|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
170382481|NCT02178592|615734509|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
170382482|NCT02178592|615734508|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
170382483|NCT02178592|615734509|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
170382484|NCT02178592|615734508|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
170382485|NCT02178592|615734509|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
170382486|NCT02178592|615734508|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
170382487|NCT02178592|615734509|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
170382488|NCT02178592|615734508|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
170382489|NCT02178592|615734509|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
170382490|NCT02178592|615734508|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
170382491|NCT02178592|615734509|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
170382492|NCT02178592|615734508|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
170382493|NCT02178592|615734509|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
170382494|NCT02178592|615734508|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
170382495|NCT02178592|615734509|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
170382496|NCT02178592|615734508|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
170382497|NCT02178592|615734509|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
170382498|NCT02178592|615734508|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
170382499|NCT02178592|615734509|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
170382500|NCT02178592|615734508|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
170382501|NCT02178592|615734509|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
170382502|NCT02178592|615734508|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
170382503|NCT02178592|615734509|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
170382504|NCT02975206|615734513|FG000|Overall Study|Withdrawal by Subject|14|||
170382505|NCT02975206|615734514|FG001|Overall Study|Withdrawal by Subject|11|||
170382506|NCT02975206|615734515|FG002|Overall Study|Withdrawal by Subject|11|||
170382507|NCT02975206|615734513|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
170382508|NCT02975206|615734514|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
170382509|NCT02975206|615734515|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
170382510|NCT01899729|615734520|FG000|Overall Study|Adverse Event|1|||
170382511|NCT01899729|615734521|FG001|Overall Study|Adverse Event|0|||
170382512|NCT01899729|615734522|FG002|Overall Study|Adverse Event|0|||
170382513|NCT01899729|615734523|FG003|Overall Study|Adverse Event|0|||
170382514|NCT01899729|615734524|FG004|Overall Study|Adverse Event|1|||
170382515|NCT01899729|615734520|FG000|Overall Study|Withdrawal by Subject|1|||
170382516|NCT01899729|615734521|FG001|Overall Study|Withdrawal by Subject|2|||
170382517|NCT01899729|615734522|FG002|Overall Study|Withdrawal by Subject|0|||
170382518|NCT01899729|615734523|FG003|Overall Study|Withdrawal by Subject|0|||
170382519|NCT01899729|615734524|FG004|Overall Study|Withdrawal by Subject|0|||
170382520|NCT01899729|615734520|FG000|Overall Study|Lack of Efficacy|0|||
170382521|NCT01899729|615734521|FG001|Overall Study|Lack of Efficacy|0|||
170382522|NCT01899729|615734522|FG002|Overall Study|Lack of Efficacy|2|||
170382523|NCT01899729|615734523|FG003|Overall Study|Lack of Efficacy|0|||
170382524|NCT01899729|615734524|FG004|Overall Study|Lack of Efficacy|1|||
170382525|NCT01711359|615734525|FG000|Treatment Period|Withdrawal by Subject|18|||
170382526|NCT01711359|615734526|FG001|Treatment Period|Withdrawal by Subject|7|||
170382527|NCT01711359|615734527|FG002|Treatment Period|Withdrawal by Subject|13|||
170382528|NCT01711359|615734525|FG000|Treatment Period|Lack of Efficacy|13|||
170382529|NCT01711359|615734526|FG001|Treatment Period|Lack of Efficacy|2|||
170382530|NCT01711359|615734527|FG002|Treatment Period|Lack of Efficacy|2|||
170382531|NCT01711359|615734525|FG000|Treatment Period|Adverse Event|8|||
170382532|NCT01711359|615734526|FG001|Treatment Period|Adverse Event|10|||
170382533|NCT01711359|615734527|FG002|Treatment Period|Adverse Event|24|||
170382534|NCT01711359|615734525|FG000|Treatment Period|Physician Decision|4|||
170382535|NCT01711359|615734526|FG001|Treatment Period|Physician Decision|3|||
170382536|NCT01711359|615734527|FG002|Treatment Period|Physician Decision|2|||
170382537|NCT01711359|615734525|FG000|Treatment Period|Death|3|||
170382538|NCT01711359|615734526|FG001|Treatment Period|Death|0|||
170382539|NCT01711359|615734527|FG002|Treatment Period|Death|0|||
170382540|NCT01711359|615734525|FG000|Treatment Period|Entry Criteria Not Met|1|||
170382541|NCT01711359|615734526|FG001|Treatment Period|Entry Criteria Not Met|0|||
170382542|NCT01711359|615734527|FG002|Treatment Period|Entry Criteria Not Met|0|||
170382543|NCT01711359|615734525|FG000|Treatment Period|Sponsor Decision|1|||
170382544|NCT01711359|615734526|FG001|Treatment Period|Sponsor Decision|0|||
170382545|NCT01711359|615734527|FG002|Treatment Period|Sponsor Decision|0|||
170382546|NCT01711359|615734525|FG000|Treatment Period|Lost to Follow-up|1|||
170382547|NCT01711359|615734526|FG001|Treatment Period|Lost to Follow-up|1|||
170382548|NCT01711359|615734527|FG002|Treatment Period|Lost to Follow-up|1|||
170382549|NCT01711359|615734525|FG000|Treatment Period|Randomized, Not Treated|3|||
170382550|NCT01711359|615734526|FG001|Treatment Period|Randomized, Not Treated|1|||
170382551|NCT01711359|615734527|FG002|Treatment Period|Randomized, Not Treated|0|||
170382552|NCT01021423|615734528|FG000|Overall Study|Study terminated|4|||
170382553|NCT01021423|615734529|FG001|Overall Study|Study terminated|5|||
170382554|NCT03922945|615736231|FG000|Overall Study|Adverse Event|1|||
170382555|NCT03922945|615736232|FG001|Overall Study|Adverse Event|1|||
170382556|NCT03922945|615736233|FG002|Overall Study|Adverse Event|2|||
170382557|NCT03922945|615736231|FG000|Overall Study|Lost to Follow-up|13|||
170382558|NCT03922945|615736232|FG001|Overall Study|Lost to Follow-up|9|||
170382559|NCT03922945|615736233|FG002|Overall Study|Lost to Follow-up|20|||
170382560|NCT03922945|615736231|FG000|Overall Study|Lack of Efficacy|2|||
170382561|NCT03922945|615736232|FG001|Overall Study|Lack of Efficacy|0|||
170382562|NCT03922945|615736233|FG002|Overall Study|Lack of Efficacy|1|||
170382563|NCT03922945|615736231|FG000|Overall Study|Protocol Non-Compliance|0|||
170382564|NCT03922945|615736232|FG001|Overall Study|Protocol Non-Compliance|0|||
170382565|NCT03922945|615736233|FG002|Overall Study|Protocol Non-Compliance|1|||
170382566|NCT03922945|615736231|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
170382567|NCT03922945|615736232|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
170382568|NCT03922945|615736233|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
170382569|NCT03922945|615736231|FG000|Overall Study|All Other Personal Reasons|1|||
170382570|NCT03922945|615736232|FG001|Overall Study|All Other Personal Reasons|1|||
170382571|NCT03922945|615736233|FG002|Overall Study|All Other Personal Reasons|2|||
170382572|NCT02889861|615736234|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
170382573|NCT00911508|615736235|FG000|Overall Study|Lost to Follow-up|27|||
170382574|NCT00911508|615736236|FG001|Overall Study|Lost to Follow-up|18|||
170382575|NCT00911508|615736235|FG000|Overall Study|Withdrawal by Subject|79|||
170382576|NCT00911508|615736236|FG001|Overall Study|Withdrawal by Subject|112|||
170382577|NCT00313716|615736237|FG000|Overall Study|Death|3|||
170382578|NCT00313716|615736238|FG001|Overall Study|Death|2|||
170382579|NCT00313716|615736239|FG002|Overall Study|Death|9|||
170382580|NCT00313716|615736240|FG003|Overall Study|Death|3|||
170382581|NCT00313716|615736241|FG004|Overall Study|Death|5|||
170382582|NCT00313716|615736242|FG005|Overall Study|Death|9|||
170382583|NCT00313716|615736237|FG000|Overall Study|Lost to Follow-up|2|||
170382584|NCT00313716|615736238|FG001|Overall Study|Lost to Follow-up|5|||
170382585|NCT00313716|615736239|FG002|Overall Study|Lost to Follow-up|2|||
170382586|NCT00313716|615736240|FG003|Overall Study|Lost to Follow-up|1|||
170382587|NCT00313716|615736241|FG004|Overall Study|Lost to Follow-up|0|||
170382588|NCT00313716|615736242|FG005|Overall Study|Lost to Follow-up|4|||
170382589|NCT00313716|615736237|FG000|Overall Study|Withdrawal by Subject|0|||
170382590|NCT00313716|615736238|FG001|Overall Study|Withdrawal by Subject|1|||
170382591|NCT00313716|615736239|FG002|Overall Study|Withdrawal by Subject|1|||
170382592|NCT00313716|615736240|FG003|Overall Study|Withdrawal by Subject|0|||
170382593|NCT00313716|615736241|FG004|Overall Study|Withdrawal by Subject|1|||
170382594|NCT00313716|615736242|FG005|Overall Study|Withdrawal by Subject|0|||
170382595|NCT04308668|615736247|FG000|Overall Study|Lost to Follow-up|32|||
170382596|NCT04308668|615736248|FG001|Overall Study|Lost to Follow-up|38|||
170382597|NCT04308668|615736247|FG000|Overall Study|Withdrawal by Subject|4|||
170382598|NCT04308668|615736248|FG001|Overall Study|Withdrawal by Subject|4|||
170382599|NCT01266967|615736249|FG000|Overall Study|Death|69|||
170382600|NCT01266967|615736250|FG001|Overall Study|Death|61|||
170382601|NCT01266967|615736249|FG000|Overall Study|Study Closed/Terminated|15|||
170382602|NCT01266967|615736250|FG001|Overall Study|Study Closed/Terminated|17|||
170382603|NCT01266967|615736249|FG000|Overall Study|Lost to Follow-up|2|||
170382604|NCT01266967|615736250|FG001|Overall Study|Lost to Follow-up|1|||
170382605|NCT01266967|615736249|FG000|Overall Study|Physician Decision|0|||
170382606|NCT01266967|615736250|FG001|Overall Study|Physician Decision|1|||
170382607|NCT01266967|615736249|FG000|Overall Study|Withdrawal by Subject|3|||
170382608|NCT01266967|615736250|FG001|Overall Study|Withdrawal by Subject|3|||
170382609|NCT01524900|615736261|FG000|Overall Study|Lost to Follow-up|3|||
170382610|NCT01524900|615736262|FG001|Overall Study|Lost to Follow-up|12|||
170382611|NCT01524900|615736263|FG002|Overall Study|Lost to Follow-up|1|||
170382612|NCT01524900|615736264|FG003|Overall Study|Lost to Follow-up|0|||
170382613|NCT01524900|615736265|FG004|Overall Study|Lost to Follow-up|0|||
170382614|NCT01524900|615736261|FG000|Overall Study|Other reason than stated above|1|||
170382615|NCT01524900|615736262|FG001|Overall Study|Other reason than stated above|1|||
170382616|NCT01524900|615736263|FG002|Overall Study|Other reason than stated above|0|||
170382617|NCT01524900|615736264|FG003|Overall Study|Other reason than stated above|0|||
170382618|NCT01524900|615736265|FG004|Overall Study|Other reason than stated above|0|||
170382619|NCT01524900|615736261|FG000|Overall Study|No reason documented|2|||
170382620|NCT01524900|615736262|FG001|Overall Study|No reason documented|1|||
170382621|NCT01524900|615736263|FG002|Overall Study|No reason documented|0|||
170382622|NCT01524900|615736264|FG003|Overall Study|No reason documented|1|||
170382623|NCT01524900|615736265|FG004|Overall Study|No reason documented|0|||
170382624|NCT00532441|615736266|FG000|Overall Study|Death|1|||
170382625|NCT00532441|615736267|FG001|Overall Study|Death|0|||
170382626|NCT00303329|615736268|FG000|Overall Study|Adverse Event|7|||
170382627|NCT00303329|615736269|FG001|Overall Study|Adverse Event|14|||
170382628|NCT00303329|615736268|FG000|Overall Study|Abnormal Laboratory Values|0|||
170382629|NCT00303329|615736269|FG001|Overall Study|Abnormal Laboratory Values|1|||
170382630|NCT00303329|615736268|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
170382631|NCT00303329|615736269|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
170382632|NCT00303329|615736268|FG000|Overall Study|Condition no longer requires study drug|0|||
170382633|NCT00303329|615736269|FG001|Overall Study|Condition no longer requires study drug|8|||
170382634|NCT00303329|615736268|FG000|Overall Study|Protocol Violation|3|||
170382635|NCT00303329|615736269|FG001|Overall Study|Protocol Violation|0|||
170382636|NCT00303329|615736268|FG000|Overall Study|Withdrawal by Subject|9|||
170382637|NCT00303329|615736269|FG001|Overall Study|Withdrawal by Subject|15|||
170382638|NCT00303329|615736268|FG000|Overall Study|Lost to Follow-up|0|||
170382639|NCT00303329|615736269|FG001|Overall Study|Lost to Follow-up|1|||
170382640|NCT00303329|615736268|FG000|Overall Study|Administrative problems|1|||
170382641|NCT00303329|615736269|FG001|Overall Study|Administrative problems|0|||
170382642|NCT00303329|615736268|FG000|Overall Study|Death|2|||
170382643|NCT00303329|615736269|FG001|Overall Study|Death|12|||
170382644|NCT00303329|615736268|FG000|Overall Study|Stopped at end of core|3|||
170382645|NCT00303329|615736269|FG001|Overall Study|Stopped at end of core|9|||
170382646|NCT00303329|615736268|FG000|Overall Study|Stopped at end of extension 1|1|||
170382647|NCT00303329|615736269|FG001|Overall Study|Stopped at end of extension 1|0|||
170382648|NCT04354870|615736272|FG000|Overall Study|Lost to Follow-up|32|||
170382649|NCT04354870|615736273|FG001|Overall Study|Lost to Follow-up|12|||
170382650|NCT04354870|615736272|FG000|Overall Study|Withdrawal by Subject|10|||
170382651|NCT04354870|615736273|FG001|Overall Study|Withdrawal by Subject|16|||
170382652|NCT04354870|615736272|FG000|Overall Study|Did not complete all study visits|6|||
170382653|NCT04354870|615736273|FG001|Overall Study|Did not complete all study visits|5|||
170382654|NCT01539720|615736278|FG000|Overall Study|Screen Fail|15|||
170382655|NCT01539720|615736279|FG001|Overall Study|Screen Fail|3|||
170382656|NCT01539720|615736278|FG000|Overall Study|Lost to Follow-up|14|||
170382657|NCT01539720|615736279|FG001|Overall Study|Lost to Follow-up|7|||
170382658|NCT00386152|615736284|FG000|Overall Study|Adverse Event|6|||
170382659|NCT00386152|615736285|FG001|Overall Study|Adverse Event|5|||
170382660|NCT00386152|615736286|FG002|Overall Study|Adverse Event|4|||
170382661|NCT00386152|615736284|FG000|Overall Study|Chang from original chemo stratification|4|||
170382662|NCT00386152|615736285|FG001|Overall Study|Chang from original chemo stratification|5|||
170382663|NCT00386152|615736286|FG002|Overall Study|Chang from original chemo stratification|6|||
170382664|NCT00386152|615736284|FG000|Overall Study|Death|3|||
170382665|NCT00386152|615736285|FG001|Overall Study|Death|0|||
170382666|NCT00386152|615736286|FG002|Overall Study|Death|1|||
170382667|NCT00386152|615736284|FG000|Overall Study|Disease progression|7|||
170382668|NCT00386152|615736285|FG001|Overall Study|Disease progression|4|||
170382669|NCT00386152|615736286|FG002|Overall Study|Disease progression|5|||
170382670|NCT00386152|615736284|FG000|Overall Study|Physician Decision|13|||
170382671|NCT00386152|615736285|FG001|Overall Study|Physician Decision|10|||
170382672|NCT00386152|615736286|FG002|Overall Study|Physician Decision|4|||
170382673|NCT00386152|615736284|FG000|Overall Study|Lost to Follow-up|1|||
170382674|NCT00386152|615736285|FG001|Overall Study|Lost to Follow-up|0|||
170382675|NCT00386152|615736286|FG002|Overall Study|Lost to Follow-up|0|||
170382676|NCT00386152|615736284|FG000|Overall Study|Completed chemotherapy|4|||
170382677|NCT00386152|615736285|FG001|Overall Study|Completed chemotherapy|5|||
170382678|NCT00386152|615736286|FG002|Overall Study|Completed chemotherapy|1|||
170382679|NCT00386152|615736284|FG000|Overall Study|Protocol Violation|3|||
170382680|NCT00386152|615736285|FG001|Overall Study|Protocol Violation|5|||
170382681|NCT00386152|615736286|FG002|Overall Study|Protocol Violation|2|||
170382682|NCT00386152|615736284|FG000|Overall Study|Withdrawal by Subject|3|||
170382683|NCT00386152|615736285|FG001|Overall Study|Withdrawal by Subject|6|||
170382684|NCT00386152|615736286|FG002|Overall Study|Withdrawal by Subject|10|||
170382685|NCT02643420|615736287|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
170382686|NCT02643420|615736288|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
170382687|NCT02643420|615736287|FG000|Overall Study|Withdrawal by Subject|25|||
170382688|NCT02643420|615736288|FG001|Overall Study|Withdrawal by Subject|19|||
170382689|NCT02643420|615736287|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
170382690|NCT02643420|615736288|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
170382691|NCT02643420|615736287|FG000|Overall Study|Lost to Follow-up|6|||
170382692|NCT02643420|615736288|FG001|Overall Study|Lost to Follow-up|10|||
170382693|NCT02643420|615736287|FG000|Overall Study|Investigator Decision|2|||
170382694|NCT02643420|615736288|FG001|Overall Study|Investigator Decision|4|||
170382695|NCT02643420|615736287|FG000|Overall Study|Sponsor decision|1|||
170382696|NCT02643420|615736288|FG001|Overall Study|Sponsor decision|1|||
170382697|NCT02643420|615736287|FG000|Overall Study|Death|0|||
170382698|NCT02643420|615736288|FG001|Overall Study|Death|2|||
170382699|NCT02643420|615736287|FG000|Overall Study|Reason not Specified|8|||
170382700|NCT02643420|615736288|FG001|Overall Study|Reason not Specified|7|||
170382701|NCT02127970|615736289|FG000|Overall Study|Adverse Event|2|||
170382702|NCT02127970|615736290|FG001|Overall Study|Adverse Event|1|||
170382703|NCT02127970|615736289|FG000|Overall Study|Death|1|||
170382704|NCT02127970|615736290|FG001|Overall Study|Death|1|||
170382705|NCT02127970|615736289|FG000|Overall Study|Lost to Follow-up|14|||
170382706|NCT02127970|615736290|FG001|Overall Study|Lost to Follow-up|14|||
170382707|NCT02127970|615736289|FG000|Overall Study|Reason not Specified|4|||
170382708|NCT02127970|615736290|FG001|Overall Study|Reason not Specified|7|||
170382709|NCT02127970|615736289|FG000|Overall Study|Pregnancy|0|||
170382710|NCT02127970|615736290|FG001|Overall Study|Pregnancy|1|||
170382711|NCT02127970|615736289|FG000|Overall Study|Subject Withdrew Consent|5|||
170382712|NCT02127970|615736290|FG001|Overall Study|Subject Withdrew Consent|3|||
170382713|NCT01856920|615736291|FG000|Overall Study|Disease Progression On Study|3|||
170382714|NCT01856920|615736292|FG001|Overall Study|Disease Progression On Study|4|||
170382715|NCT01856920|615736291|FG000|Overall Study|Disease Progression before Treatment|1|||
170382716|NCT01856920|615736292|FG001|Overall Study|Disease Progression before Treatment|0|||
170382717|NCT01856920|615736291|FG000|Overall Study|Ineligible|0|||
170382718|NCT01856920|615736292|FG001|Overall Study|Ineligible|1|||
170382719|NCT01856920|615736291|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
170382720|NCT01856920|615736292|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
170382721|NCT01856920|615736291|FG000|Overall Study|Refused further Treatment|5|||
170382722|NCT01856920|615736292|FG001|Overall Study|Refused further Treatment|1|||
170382723|NCT01856920|615736291|FG000|Overall Study|Other Reasons|0|||
170382724|NCT01856920|615736292|FG001|Overall Study|Other Reasons|1|||
170382725|NCT01856920|615736291|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
170382726|NCT01856920|615736292|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
170382727|NCT01729559|615736298|FG000|Overall Study|Protocol Violation|31|||
170382728|NCT01729559|615736299|FG001|Overall Study|Protocol Violation|28|||
170382729|NCT02452034|615736304|FG000|Overall Study|Adverse Event|0|||
170382730|NCT02452034|615736305|FG001|Overall Study|Adverse Event|0|||
170382731|NCT02452034|615736306|FG002|Overall Study|Adverse Event|0|||
170382732|NCT02452034|615736307|FG003|Overall Study|Adverse Event|0|||
170382733|NCT02452034|615736308|FG004|Overall Study|Adverse Event|0|||
170382734|NCT02452034|615736309|FG005|Overall Study|Adverse Event|1|||
170382735|NCT02452034|615736304|FG000|Overall Study|Death|0|||
170382736|NCT02452034|615736305|FG001|Overall Study|Death|0|||
170382737|NCT02452034|615736306|FG002|Overall Study|Death|0|||
170382738|NCT02452034|615736307|FG003|Overall Study|Death|0|||
170382739|NCT02452034|615736308|FG004|Overall Study|Death|1|||
170382740|NCT02452034|615736309|FG005|Overall Study|Death|1|||
170382741|NCT02452034|615736304|FG000|Overall Study|Physician Decision|0|||
170382742|NCT02452034|615736305|FG001|Overall Study|Physician Decision|1|||
170382743|NCT02452034|615736306|FG002|Overall Study|Physician Decision|1|||
170382744|NCT02452034|615736307|FG003|Overall Study|Physician Decision|0|||
170382745|NCT02452034|615736308|FG004|Overall Study|Physician Decision|0|||
170382746|NCT02452034|615736309|FG005|Overall Study|Physician Decision|0|||
170382747|NCT02452034|615736304|FG000|Overall Study|Protocol Violation|0|||
170382748|NCT02452034|615736305|FG001|Overall Study|Protocol Violation|0|||
170382749|NCT02452034|615736306|FG002|Overall Study|Protocol Violation|0|||
170382750|NCT02452034|615736307|FG003|Overall Study|Protocol Violation|0|||
170382751|NCT02452034|615736308|FG004|Overall Study|Protocol Violation|0|||
170382752|NCT02452034|615736309|FG005|Overall Study|Protocol Violation|1|||
170382753|NCT02452034|615736304|FG000|Overall Study|Screen Failure|1|||
170382754|NCT02452034|615736305|FG001|Overall Study|Screen Failure|0|||
170382755|NCT02452034|615736306|FG002|Overall Study|Screen Failure|0|||
170382756|NCT02452034|615736307|FG003|Overall Study|Screen Failure|1|||
170382757|NCT02452034|615736308|FG004|Overall Study|Screen Failure|0|||
170382758|NCT02452034|615736309|FG005|Overall Study|Screen Failure|0|||
170382759|NCT02452034|615736304|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
170382760|NCT02452034|615736305|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
170382761|NCT02452034|615736306|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
170382762|NCT02452034|615736307|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
170382763|NCT02452034|615736308|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
170382764|NCT02452034|615736309|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
170382765|NCT04601194|615736319|FG000|Overall Study|Lost to Follow-up|7|||
170382766|NCT01014442|615736320|FG000|Overall Study|Adverse Event|0|||
170382767|NCT01014442|615736321|FG001|Overall Study|Adverse Event|8|||
170382768|NCT01014442|615736320|FG000|Overall Study|Withdrawal by Subject|4|||
170382769|NCT01014442|615736321|FG001|Overall Study|Withdrawal by Subject|4|||
170382770|NCT01014442|615736320|FG000|Overall Study|Protocol Violation|2|||
170382771|NCT01014442|615736321|FG001|Overall Study|Protocol Violation|5|||
170382772|NCT01014442|615736320|FG000|Overall Study|Lack of Compliance|0|||
170382773|NCT01014442|615736321|FG001|Overall Study|Lack of Compliance|1|||
170382774|NCT01014442|615736320|FG000|Overall Study|Unspecified Reason|1|||
170382775|NCT01014442|615736321|FG001|Overall Study|Unspecified Reason|1|||
170382776|NCT00846027|615736322|FG000|Overall Study|Death|3|||
170382777|NCT00846027|615736322|FG000|Overall Study|Disease Progression|30|||
170382778|NCT00846027|615736322|FG000|Overall Study|Toxicity|12|||
170382779|NCT00846027|615736322|FG000|Overall Study|Patient Decision|7|||
170382780|NCT00846027|615736322|FG000|Overall Study|Investigator Discretion|29|||
170382781|NCT00846027|615736322|FG000|Overall Study|Protocol Violation|2|||
170382782|NCT00846027|615736322|FG000|Overall Study|Subject Not Treated|7|||
170382783|NCT04905563|615736325|FG000|Overall Study|Withdrawal by Subject|1|||
170382784|NCT04905563|615736326|FG001|Overall Study|Withdrawal by Subject|0|||
170382785|NCT04905563|615736325|FG000|Overall Study|Standard of care orders entered by resident|1|||
170382786|NCT04905563|615736326|FG001|Overall Study|Standard of care orders entered by resident|0|||
170382787|NCT04905563|615736325|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
170382788|NCT04905563|615736326|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
170382789|NCT04905563|615736325|FG000|Overall Study|Withdrawal by Subject|0|||
170382790|NCT04905563|615736326|FG001|Overall Study|Withdrawal by Subject|1|||
170382791|NCT02074059|615736327|FG000|Overall Study|Death|0|||
170382792|NCT02074059|615736328|FG001|Overall Study|Death|0|||
170382793|NCT02074059|615736329|FG002|Overall Study|Death|0|||
170382794|NCT02074059|615736330|FG003|Overall Study|Death|0|||
170382795|NCT02074059|615736331|FG004|Overall Study|Death|1|||
170382796|NCT02074059|615736332|FG005|Overall Study|Death|1|||
170382797|NCT01797302|615736333|FG000|Overall Study|Lost to Follow-up|16|||
170382798|NCT01797302|615736334|FG001|Overall Study|Lost to Follow-up|23|||
170382799|NCT01797302|615736335|FG002|Overall Study|Lost to Follow-up|22|||
170382800|NCT01797302|615736333|FG000|Overall Study|Withdrawal by Subject|1|||
170382801|NCT01797302|615736334|FG001|Overall Study|Withdrawal by Subject|3|||
170382802|NCT01797302|615736335|FG002|Overall Study|Withdrawal by Subject|4|||
170382803|NCT02418000|615736337|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
170382804|NCT02418000|615736338|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
170382805|NCT02418000|615736339|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
170382806|NCT02418000|615736340|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
170382807|NCT02418000|615736341|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
170382808|NCT02418000|615736337|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
170382809|NCT02418000|615736338|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
170382810|NCT02418000|615736339|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
170382811|NCT02418000|615736340|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
170382812|NCT02418000|615736341|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
170382813|NCT02418000|615736337|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
170382814|NCT02418000|615736338|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
170382815|NCT02418000|615736339|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
170382816|NCT02418000|615736340|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
170382817|NCT02418000|615736341|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
170382818|NCT02418000|615736337|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
170382819|NCT02418000|615736338|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
170382820|NCT02418000|615736339|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
170382821|NCT02418000|615736340|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
170382822|NCT02418000|615736341|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
170382823|NCT02418000|615736337|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
170382824|NCT02418000|615736338|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
170382825|NCT02418000|615736339|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
170382826|NCT02418000|615736340|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
170382827|NCT02418000|615736341|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
170382828|NCT02418000|615736337|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382829|NCT02418000|615736338|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382830|NCT02418000|615736339|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
170382831|NCT02418000|615736340|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382832|NCT02418000|615736341|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382833|NCT02418000|615736337|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382834|NCT02418000|615736338|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382835|NCT02418000|615736339|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382836|NCT02418000|615736340|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
170382837|NCT02418000|615736341|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382838|NCT02418000|615736337|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
170382839|NCT02418000|615736338|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
170382840|NCT02418000|615736339|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
170382841|NCT02418000|615736340|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
170382842|NCT02418000|615736341|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
170382843|NCT02418000|615736337|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382844|NCT02418000|615736338|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382845|NCT02418000|615736339|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382846|NCT02418000|615736340|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
170382847|NCT02418000|615736341|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
170382848|NCT02764229|615736342|FG000|Overall Study|Withdrawal by Subject|15|||
170382849|NCT02764229|615736342|FG000|Overall Study|Adverse Event|9|||
170382850|NCT02764229|615736342|FG000|Overall Study|Physician Decision|5|||
170382851|NCT02764229|615736342|FG000|Overall Study|Lost to Follow-up|3|||
170382852|NCT02764229|615736342|FG000|Overall Study|Lack of Efficacy|1|||
170382853|NCT02764229|615736342|FG000|Overall Study|Study Stopped by Sponsor|69|||
170382854|NCT01904760|615736343|FG000|Overall Study|Protocol Violation|1|||
170382855|NCT01904760|615736344|FG001|Overall Study|Protocol Violation|0|||
170382856|NCT01488994|615736348|FG000|Overall Study|Withdrawal by Subject|0|||
170382857|NCT01488994|615736349|FG001|Overall Study|Withdrawal by Subject|1|||
170382858|NCT00103207|615736350|FG000|Overall Study|Adverse Event|3|||
170382859|NCT00103207|615736350|FG000|Overall Study|Death|1|||
170382860|NCT00103207|615736350|FG000|Overall Study|Withdrawal by Subject|2|||
170382861|NCT00103207|615736350|FG000|Overall Study|Other complicating disease|1|||
170382862|NCT00103207|615736350|FG000|Overall Study|Ineligible|4|||
170382863|NCT00103207|615736350|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
170382864|NCT01611558|615736351|FG000|Induction Phase|Study drug toxicity|15|||
170382865|NCT01611558|615736351|FG000|Induction Phase|Disease progression|18|||
170382866|NCT01611558|615736351|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
170382867|NCT01611558|615736351|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
170382868|NCT01611558|615736351|FG000|Induction Phase|Death|1|||
170382869|NCT01611558|615736351|FG000|Maintenance Phase|Withdrawal by Subject|1|||
170382870|NCT01611558|615736351|FG000|Maintenance Phase|Elevated Uric acid|1|||
170382871|NCT01284127|615736353|FG000|Overall Study|Adverse Event|2|||
170382872|NCT01284127|615736353|FG000|Overall Study|Withdrawal by Subject|4|||
170382873|NCT01284127|615736353|FG000|Overall Study|Physician Decision|1|||
170382874|NCT02607865|615736355|FG000|Overall Study|Lost to Follow-up|9|||
170382875|NCT02607865|615736356|FG001|Overall Study|Lost to Follow-up|7|||
170382876|NCT02607865|615736357|FG002|Overall Study|Lost to Follow-up|7|||
170382877|NCT02607865|615736358|FG003|Overall Study|Lost to Follow-up|5|||
170382878|NCT02607865|615736355|FG000|Overall Study|Withdrawal by Subject|18|||
170382879|NCT02607865|615736356|FG001|Overall Study|Withdrawal by Subject|18|||
170382880|NCT02607865|615736357|FG002|Overall Study|Withdrawal by Subject|17|||
170382881|NCT02607865|615736358|FG003|Overall Study|Withdrawal by Subject|8|||
170382882|NCT02607865|615736355|FG000|Overall Study|Death|5|||
170382883|NCT02607865|615736356|FG001|Overall Study|Death|4|||
170382884|NCT02607865|615736357|FG002|Overall Study|Death|1|||
170382885|NCT02607865|615736358|FG003|Overall Study|Death|3|||
170382886|NCT02607865|615736355|FG000|Overall Study|Unclassified|1|||
170382887|NCT02607865|615736356|FG001|Overall Study|Unclassified|1|||
170382888|NCT02607865|615736357|FG002|Overall Study|Unclassified|2|||
170382889|NCT02607865|615736358|FG003|Overall Study|Unclassified|0|||
170382890|NCT02813681|615736359|FG000|Overall Study|Physician Decision|5|||
170382891|NCT02813681|615736360|FG001|Overall Study|Physician Decision|5|||
170382892|NCT02813681|615736361|FG002|Overall Study|Physician Decision|0|||
170382893|NCT02813681|615736359|FG000|Overall Study|Lost to Follow-up|0|||
170382894|NCT02813681|615736360|FG001|Overall Study|Lost to Follow-up|1|||
170382895|NCT02813681|615736361|FG002|Overall Study|Lost to Follow-up|0|||
170382896|NCT00256204|615736367|FG000|Overall Study|Adverse Event|10|||
170382897|NCT00256204|615736368|FG001|Overall Study|Adverse Event|14|||
170382898|NCT00256204|615736369|FG002|Overall Study|Adverse Event|16|||
170382899|NCT00256204|615736370|FG003|Overall Study|Adverse Event|14|||
170382900|NCT00256204|615736367|FG000|Overall Study|Death|0|||
170382901|NCT00256204|615736368|FG001|Overall Study|Death|1|||
170382902|NCT00256204|615736369|FG002|Overall Study|Death|0|||
170382903|NCT00256204|615736370|FG003|Overall Study|Death|0|||
170382904|NCT00256204|615736367|FG000|Overall Study|Lost to Follow-up|1|||
170382905|NCT00256204|615736368|FG001|Overall Study|Lost to Follow-up|1|||
170382906|NCT00256204|615736369|FG002|Overall Study|Lost to Follow-up|1|||
170382907|NCT00256204|615736370|FG003|Overall Study|Lost to Follow-up|2|||
170382908|NCT00256204|615736367|FG000|Overall Study|Protocol Violation|1|||
170382909|NCT00256204|615736368|FG001|Overall Study|Protocol Violation|0|||
170382910|NCT00256204|615736369|FG002|Overall Study|Protocol Violation|2|||
170382911|NCT00256204|615736370|FG003|Overall Study|Protocol Violation|1|||
170382912|NCT00256204|615736367|FG000|Overall Study|Physician Decision|0|||
170382913|NCT00256204|615736368|FG001|Overall Study|Physician Decision|0|||
170382914|NCT00256204|615736369|FG002|Overall Study|Physician Decision|1|||
170382915|NCT00256204|615736370|FG003|Overall Study|Physician Decision|2|||
170382916|NCT00256204|615736367|FG000|Overall Study|Withdrawal by Subject|17|||
170382917|NCT00256204|615736368|FG001|Overall Study|Withdrawal by Subject|6|||
170382918|NCT00256204|615736369|FG002|Overall Study|Withdrawal by Subject|7|||
170382919|NCT00256204|615736370|FG003|Overall Study|Withdrawal by Subject|5|||
170382920|NCT00256204|615736367|FG000|Overall Study|Need for additional prohibited treatment|38|||
170382921|NCT00256204|615736368|FG001|Overall Study|Need for additional prohibited treatment|28|||
170382922|NCT00256204|615736369|FG002|Overall Study|Need for additional prohibited treatment|27|||
170382923|NCT00256204|615736370|FG003|Overall Study|Need for additional prohibited treatment|25|||
170382924|NCT03395704|615736376|FG000|Overall Study|Adverse Event|2|||
170382925|NCT03395704|615736377|FG001|Overall Study|Adverse Event|1|||
170382926|NCT03395704|615736376|FG000|Overall Study|Withdrawal by Subject|2|||
170382927|NCT03395704|615736377|FG001|Overall Study|Withdrawal by Subject|1|||
170382928|NCT03395704|615736376|FG000|Overall Study|Physician Decision|0|||
170382929|NCT03395704|615736377|FG001|Overall Study|Physician Decision|1|||
170382930|NCT03359811|615737901|FG000|Overall Study|Protocol Violation|2|||
170382931|NCT03359811|615737902|FG001|Overall Study|Protocol Violation|0|||
170382932|NCT05111548|615737905|FG000|Overall Study|Withdrawal by Subject|2|||
170382933|NCT05111548|615737906|FG001|Overall Study|Withdrawal by Subject|1|||
170382934|NCT05111548|615737905|FG000|Overall Study|Adverse Event|1|||
170382935|NCT05111548|615737906|FG001|Overall Study|Adverse Event|0|||
170382936|NCT02577107|615737917|FG000|Overall Study|Protocol deviation|0|||
170382937|NCT02577107|615737918|FG001|Overall Study|Protocol deviation|1|||
170382938|NCT00577382|615737919|FG000|Overall Study|Adverse Event|0|||
170382939|NCT00577382|615737920|FG001|Overall Study|Adverse Event|6|||
170382940|NCT00577382|615737919|FG000|Overall Study|Withdrawal by Subject|0|||
170382941|NCT00577382|615737920|FG001|Overall Study|Withdrawal by Subject|1|||
170382942|NCT00577382|615737919|FG000|Overall Study|Progressive Disease|17|||
170382943|NCT00577382|615737920|FG001|Overall Study|Progressive Disease|19|||
170382944|NCT00577382|615737919|FG000|Overall Study|Intercurrent Illness|1|||
170382945|NCT00577382|615737920|FG001|Overall Study|Intercurrent Illness|2|||
170382946|NCT00577382|615737919|FG000|Overall Study|Death|1|||
170382947|NCT00577382|615737920|FG001|Overall Study|Death|1|||
170382948|NCT00577382|615737919|FG000|Overall Study|Lost to Follow-up|2|||
170382949|NCT00577382|615737920|FG001|Overall Study|Lost to Follow-up|2|||
170382950|NCT01345162|615737921|FG000|Overall Study|Protocol Violation|2|||
170382951|NCT01345162|615737922|FG001|Overall Study|Protocol Violation|4|||
170382952|NCT03007472|615737924|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
170382953|NCT03007472|615737924|FG000|Overall Study|Death|2|||
170382954|NCT03007472|615737924|FG000|Overall Study|Loss to Follow Up|1|||
170382955|NCT02988115|615737925|FG000|Overall Study|Adverse Event|6|||
170382956|NCT02988115|615737926|FG001|Overall Study|Adverse Event|1|||
170382957|NCT02988115|615737925|FG000|Overall Study|Sponsor Decision|5|||
170382958|NCT02988115|615737926|FG001|Overall Study|Sponsor Decision|2|||
170382959|NCT02988115|615737925|FG000|Overall Study|Withdrawal by Subject|1|||
170382960|NCT02988115|615737926|FG001|Overall Study|Withdrawal by Subject|1|||
170382961|NCT02988115|615737925|FG000|Overall Study|Withdrawn by Mistake|1|||
170382962|NCT02988115|615737926|FG001|Overall Study|Withdrawn by Mistake|0|||
170382963|NCT02988115|615737925|FG000|Overall Study|Lost to Follow-up|1|||
170382964|NCT02988115|615737926|FG001|Overall Study|Lost to Follow-up|0|||
170382965|NCT01731951|615737927|FG000|Overall Study|Documented Disease Progression|1|||
170382966|NCT01731951|615737928|FG001|Overall Study|Documented Disease Progression|0|||
170382967|NCT01731951|615737929|FG002|Overall Study|Documented Disease Progression|0|||
170382968|NCT01731951|615737930|FG003|Overall Study|Documented Disease Progression|0|||
170382969|NCT01731951|615737931|FG004|Overall Study|Documented Disease Progression|0|||
170382970|NCT01731951|615737932|FG005|Overall Study|Documented Disease Progression|0|||
170382971|NCT01731951|615737927|FG000|Overall Study|Lost to Follow-up|2|||
170382972|NCT01731951|615737928|FG001|Overall Study|Lost to Follow-up|0|||
170382973|NCT01731951|615737929|FG002|Overall Study|Lost to Follow-up|0|||
170382974|NCT01731951|615737930|FG003|Overall Study|Lost to Follow-up|1|||
170382975|NCT01731951|615737931|FG004|Overall Study|Lost to Follow-up|3|||
170382976|NCT01731951|615737932|FG005|Overall Study|Lost to Follow-up|1|||
170382977|NCT01731951|615737927|FG000|Overall Study|Withdrawal of Consent|1|||
170382978|NCT01731951|615737928|FG001|Overall Study|Withdrawal of Consent|0|||
170382979|NCT01731951|615737929|FG002|Overall Study|Withdrawal of Consent|0|||
170382980|NCT01731951|615737930|FG003|Overall Study|Withdrawal of Consent|0|||
170382981|NCT01731951|615737931|FG004|Overall Study|Withdrawal of Consent|0|||
170382982|NCT01731951|615737932|FG005|Overall Study|Withdrawal of Consent|2|||
170382983|NCT01731951|615737927|FG000|Overall Study|Death|13|||
170382984|NCT01731951|615737928|FG001|Overall Study|Death|15|||
170382985|NCT01731951|615737929|FG002|Overall Study|Death|9|||
170382986|NCT01731951|615737930|FG003|Overall Study|Death|8|||
170382987|NCT01731951|615737931|FG004|Overall Study|Death|9|||
170382988|NCT01731951|615737932|FG005|Overall Study|Death|6|||
170382989|NCT00649220|615737939|FG000|Overall Study|Adverse Event|2|||
170382990|NCT00649220|615737939|FG000|Overall Study|Withdrawal by Subject|1|||
170382991|NCT00608426|615737942|FG000|Overall Study|Death|32|||
170382992|NCT00608426|615737943|FG001|Overall Study|Death|36|||
170382993|NCT00608426|615737942|FG000|Overall Study|Lost to Follow-up|485|||
170382994|NCT00608426|615737943|FG001|Overall Study|Lost to Follow-up|521|||
170382995|NCT00608426|615737942|FG000|Overall Study|refused, health issues, wrong address|319|||
170382996|NCT00608426|615737943|FG001|Overall Study|refused, health issues, wrong address|348|||
170382997|NCT02630459|615737944|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
170382998|NCT02630459|615737945|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
170382999|NCT02630459|615737946|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
170383000|NCT02630459|615737947|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
170383001|NCT02630459|615737948|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
170383002|NCT02630459|615737949|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
170383003|NCT02630459|615737950|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
170383004|NCT02630459|615737951|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
170383005|NCT02630459|615737944|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
170383006|NCT02630459|615737945|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
170383007|NCT02630459|615737946|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
170383008|NCT02630459|615737947|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
170383009|NCT02630459|615737948|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
170383010|NCT02630459|615737949|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
170383011|NCT02630459|615737950|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
170383012|NCT02630459|615737951|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
170383013|NCT02630459|615737944|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
170383014|NCT02630459|615737945|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
170383015|NCT02630459|615737946|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
170383016|NCT02630459|615737947|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
170383017|NCT02630459|615737948|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
170383018|NCT02630459|615737949|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
170383019|NCT02630459|615737950|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
170383020|NCT02630459|615737951|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
170383021|NCT02630459|615737944|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
170383022|NCT02630459|615737945|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
170383023|NCT02630459|615737946|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
170383024|NCT02630459|615737947|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
170383025|NCT02630459|615737948|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
170383026|NCT02630459|615737949|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
170383027|NCT02630459|615737950|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
170383028|NCT02630459|615737951|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
170383029|NCT02630459|615737944|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
170383030|NCT02630459|615737945|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
170383031|NCT02630459|615737946|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
170383032|NCT02630459|615737947|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
170383033|NCT02630459|615737948|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
170383034|NCT02630459|615737949|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
170383035|NCT02630459|615737950|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
170383036|NCT02630459|615737951|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
170383037|NCT02630459|615737944|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
170383038|NCT02630459|615737945|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
170383039|NCT02630459|615737946|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
170383040|NCT02630459|615737947|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
170383041|NCT02630459|615737948|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
170383042|NCT02630459|615737949|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
170383043|NCT02630459|615737950|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
170383044|NCT02630459|615737951|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
170383045|NCT02630459|615737944|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
170383046|NCT02630459|615737945|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
170383047|NCT02630459|615737946|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
170383048|NCT02630459|615737947|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
170383049|NCT02630459|615737948|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
170383050|NCT02630459|615737949|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
170383051|NCT02630459|615737950|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
170383052|NCT02630459|615737951|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
170383053|NCT02519777|615737965|FG000|Overall Study|Death|1|||
170383054|NCT02519777|615737966|FG001|Overall Study|Death|0|||
170383055|NCT02519777|615737967|FG002|Overall Study|Death|0|||
170383056|NCT02519777|615737965|FG000|Overall Study|Lost to Follow-up|0|||
170383057|NCT02519777|615737966|FG001|Overall Study|Lost to Follow-up|4|||
170383058|NCT02519777|615737967|FG002|Overall Study|Lost to Follow-up|2|||
170383059|NCT02519777|615737965|FG000|Overall Study|Withdrawal by Subject|3|||
170383060|NCT02519777|615737966|FG001|Overall Study|Withdrawal by Subject|1|||
170383061|NCT02519777|615737967|FG002|Overall Study|Withdrawal by Subject|0|||
170383062|NCT02519777|615737965|FG000|Overall Study|Severe Debilitation|1|||
170383063|NCT02519777|615737966|FG001|Overall Study|Severe Debilitation|1|||
170383064|NCT02519777|615737967|FG002|Overall Study|Severe Debilitation|1|||
170383065|NCT02519777|615737965|FG000|Overall Study|Not able to get to clinic|1|||
170383066|NCT02519777|615737966|FG001|Overall Study|Not able to get to clinic|2|||
170383067|NCT02519777|615737967|FG002|Overall Study|Not able to get to clinic|1|||
170383068|NCT01756846|615737968|FG000|Overall Study|Lost to Follow-up|5|||
170383069|NCT01756846|615737969|FG001|Overall Study|Lost to Follow-up|10|||
170383070|NCT01756846|615737968|FG000|Overall Study|Withdrawal by Subject|1|||
170383071|NCT01756846|615737969|FG001|Overall Study|Withdrawal by Subject|2|||
170383072|NCT03490734|615737983|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
170383073|NCT03490734|615737984|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
170383074|NCT03490734|615737985|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
170383075|NCT03490734|615737986|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
170383076|NCT03490734|615737983|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
170383077|NCT03490734|615737984|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
170383078|NCT03490734|615737985|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
170383079|NCT03490734|615737986|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
170383080|NCT03490734|615737983|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
170383081|NCT03490734|615737984|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
170383082|NCT03490734|615737985|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
170383083|NCT03490734|615737986|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
170383084|NCT03490734|615737983|FG000|Post-intervention Scan Visit|Adverse Event|2|||
170383085|NCT03490734|615737984|FG001|Post-intervention Scan Visit|Adverse Event|0|||
170383086|NCT03490734|615737985|FG002|Post-intervention Scan Visit|Adverse Event|0|||
170383087|NCT03490734|615737986|FG003|Post-intervention Scan Visit|Adverse Event|0|||
170383088|NCT03490734|615737983|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
170383089|NCT03490734|615737984|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
170383090|NCT03490734|615737985|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
170383091|NCT03490734|615737986|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
170383092|NCT03490734|615737983|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
170383093|NCT03490734|615737984|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
170383094|NCT03490734|615737985|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
170383095|NCT03490734|615737986|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
170383096|NCT01849289|615737994|FG000|Overall Study|Adverse Event|3|||
170383097|NCT01849289|615737995|FG001|Overall Study|Adverse Event|3|||
170383098|NCT01849289|615737994|FG000|Overall Study|Protocol Violation|3|||
170383099|NCT01849289|615737995|FG001|Overall Study|Protocol Violation|3|||
170383100|NCT01849289|615737994|FG000|Overall Study|Withdrawal criteria|1|||
170383101|NCT01849289|615737995|FG001|Overall Study|Withdrawal criteria|0|||
170383102|NCT01849289|615737994|FG000|Overall Study|Unclassified|25|||
170383103|NCT01849289|615737995|FG001|Overall Study|Unclassified|18|||
170383104|NCT04118127|615737996|FG000|Overall Study|Trial terminated by sponsor|0|||
170383105|NCT04118127|615737997|FG001|Overall Study|Trial terminated by sponsor|12|||
170383106|NCT04118127|615737996|FG000|Overall Study|Adverse Event|1|||
170383107|NCT04118127|615737997|FG001|Overall Study|Adverse Event|2|||
170383108|NCT04118127|615737996|FG000|Overall Study|Physician Decision|0|||
170383109|NCT04118127|615737997|FG001|Overall Study|Physician Decision|1|||
170383110|NCT04118127|615737996|FG000|Overall Study|Withdrawal by Subject|2|||
170383111|NCT04118127|615737997|FG001|Overall Study|Withdrawal by Subject|1|||
170383112|NCT03480360|615737998|FG000|Overall Study|Death|2|||
170383113|NCT03099304|615738000|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
170383114|NCT03099304|615738001|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
170383115|NCT03099304|615738002|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
170383116|NCT03099304|615738003|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
170383117|NCT03099304|615738004|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
170383118|NCT03099304|615738005|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
170383119|NCT03099304|615738000|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
170383120|NCT03099304|615738001|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
170383121|NCT03099304|615738002|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
170383122|NCT03099304|615738003|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
170383123|NCT03099304|615738004|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
170383124|NCT03099304|615738005|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
170383125|NCT03099304|615738000|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
170383126|NCT03099304|615738001|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
170383127|NCT03099304|615738002|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
170383128|NCT03099304|615738003|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
170383129|NCT03099304|615738004|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
170383130|NCT03099304|615738005|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
170383131|NCT03099304|615738000|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
170383132|NCT03099304|615738001|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
170383133|NCT03099304|615738002|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
170383134|NCT03099304|615738003|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
170383135|NCT03099304|615738004|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
170383136|NCT03099304|615738005|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
170383137|NCT03099304|615738000|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
170383138|NCT03099304|615738001|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
170383139|NCT03099304|615738002|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
170383140|NCT03099304|615738003|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
170383141|NCT03099304|615738004|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
170383142|NCT03099304|615738005|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
170383143|NCT03099304|615738000|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
170383144|NCT03099304|615738001|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
170383145|NCT03099304|615738002|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
170383146|NCT03099304|615738003|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
170383147|NCT03099304|615738004|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
170383148|NCT03099304|615738005|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
170383149|NCT03099304|615738000|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
170383150|NCT03099304|615738001|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
170383151|NCT03099304|615738002|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
170383152|NCT03099304|615738003|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
170383153|NCT03099304|615738004|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
170383154|NCT03099304|615738005|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
170383155|NCT03099304|615738000|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
170383156|NCT03099304|615738001|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
170383157|NCT03099304|615738002|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
170383158|NCT03099304|615738003|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
170383159|NCT03099304|615738004|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
170383160|NCT03099304|615738005|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
170383161|NCT03099304|615738000|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
170383162|NCT03099304|615738001|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
170383163|NCT03099304|615738002|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
170383164|NCT03099304|615738003|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
170383165|NCT03099304|615738004|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
170383166|NCT03099304|615738005|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
170383167|NCT03099304|615738000|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
170383168|NCT03099304|615738001|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
170383169|NCT03099304|615738002|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
170383170|NCT03099304|615738003|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
170383171|NCT03099304|615738004|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
170383172|NCT03099304|615738005|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
170383173|NCT03099304|615738000|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
170383174|NCT03099304|615738001|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
170383175|NCT03099304|615738002|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
170383176|NCT03099304|615738003|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
170383177|NCT03099304|615738004|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
170383178|NCT03099304|615738005|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
170383179|NCT03099304|615738000|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
170383180|NCT03099304|615738001|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
170383181|NCT03099304|615738002|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
170383182|NCT03099304|615738003|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
170383183|NCT03099304|615738004|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
170383184|NCT03099304|615738005|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
170383185|NCT03099304|615738000|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
170383186|NCT03099304|615738001|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
170383187|NCT03099304|615738002|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
170383188|NCT03099304|615738003|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
170383189|NCT03099304|615738004|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
170383190|NCT03099304|615738005|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
170383191|NCT03099304|615738000|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
170383192|NCT03099304|615738001|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
170383193|NCT03099304|615738002|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
170383194|NCT03099304|615738003|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
170383195|NCT03099304|615738004|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
170383196|NCT03099304|615738005|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
170383197|NCT03099304|615738000|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
170383198|NCT03099304|615738001|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
170383199|NCT03099304|615738002|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
170383200|NCT03099304|615738003|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
170383201|NCT03099304|615738004|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
170383202|NCT03099304|615738005|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
170383203|NCT03099304|615738000|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
170383204|NCT03099304|615738001|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
170383205|NCT03099304|615738002|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
170383206|NCT03099304|615738003|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
170383207|NCT03099304|615738004|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
170383208|NCT03099304|615738005|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
170383209|NCT03099304|615738000|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
170383210|NCT03099304|615738001|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
170383211|NCT03099304|615738002|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
170383212|NCT03099304|615738003|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
170383213|NCT03099304|615738004|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
170383214|NCT03099304|615738005|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
170383215|NCT02274766|615738012|FG000|Overall Study|Withdrawal by Subject|3|||
170383216|NCT02274766|615738013|FG001|Overall Study|Withdrawal by Subject|6|||
170383217|NCT02274766|615738012|FG000|Overall Study|Did Not Receive Study Drug|1|||
170383218|NCT02274766|615738013|FG001|Overall Study|Did Not Receive Study Drug|1|||
170383219|NCT02274766|615738012|FG000|Overall Study|Subject Unwilling to Proceed|0|||
170383220|NCT02274766|615738013|FG001|Overall Study|Subject Unwilling to Proceed|1|||
170383221|NCT02274766|615738012|FG000|Overall Study|Adverse Event|0|||
170383222|NCT02274766|615738013|FG001|Overall Study|Adverse Event|1|||
170383223|NCT01454531|615738018|FG000|Overall Study|Adverse Event|14|||
170383224|NCT01454531|615738018|FG000|Overall Study|Withdrawal by Subject|5|||
170383225|NCT01454531|615738018|FG000|Overall Study|Lost to Follow-up|1|||
170383226|NCT01454531|615738018|FG000|Overall Study|Physician Decision|1|||
170383227|NCT01454531|615738018|FG000|Overall Study|Delay in IMP administration|1|||
170383228|NCT01454531|615738018|FG000|Overall Study|Other|1|||
170383229|NCT00989664|615738019|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
170383230|NCT00989664|615738019|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
170383231|NCT00989664|615738019|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
170383232|NCT00989664|615738019|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
170383233|NCT00989664|615738019|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
170383234|NCT00989664|615738019|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
170383235|NCT00989664|615738019|FG000|Long-Term Follow-Up|Death|3|||
170383236|NCT02646332|615738022|FG000|Overall Study|Lost to Follow-up|0|||
170383237|NCT02646332|615738023|FG001|Overall Study|Lost to Follow-up|3|||
170383238|NCT02363322|615738024|FG000|Overall Study|Lost to Follow-up|1|||
170383239|NCT02363322|615738025|FG001|Overall Study|Lost to Follow-up|0|||
170383240|NCT01775995|615738026|FG000|Overall Study|Lost to Follow-up|1|||
170383241|NCT01775995|615738027|FG001|Overall Study|Lost to Follow-up|1|||
170383242|NCT02909504|615738028|FG000|Overall Study|Adverse Event|2|||
170383243|NCT02909504|615738028|FG000|Overall Study|Lack of Efficacy|3|||
170383244|NCT02909504|615738028|FG000|Overall Study|Withdrawal by Subject|4|||
170383245|NCT02909504|615738028|FG000|Overall Study|Pregnancy|1|||
170383246|NCT02909504|615738028|FG000|Overall Study|Subject moved|1|||
170383247|NCT02909504|615738028|FG000|Overall Study|Lost to Follow-up|1|||
170383248|NCT02504424|615738031|FG000|Overall Study|Withdrawal by Subject|2|||
170383249|NCT01277666|615738032|FG000|Overall Study|Adverse Event|26|||
170383250|NCT01277666|615738033|FG001|Overall Study|Adverse Event|25|||
170383251|NCT01277666|615738034|FG002|Overall Study|Adverse Event|20|||
170383252|NCT01277666|615738032|FG000|Overall Study|Lack of Efficacy|8|||
170383253|NCT01277666|615738033|FG001|Overall Study|Lack of Efficacy|20|||
170383254|NCT01277666|615738034|FG002|Overall Study|Lack of Efficacy|12|||
170383255|NCT01277666|615738032|FG000|Overall Study|Protocol Violation|2|||
170383256|NCT01277666|615738033|FG001|Overall Study|Protocol Violation|3|||
170383257|NCT01277666|615738034|FG002|Overall Study|Protocol Violation|2|||
170383258|NCT01277666|615738032|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
170383259|NCT01277666|615738033|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
170383260|NCT01277666|615738034|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
170383261|NCT01277666|615738032|FG000|Overall Study|Lost to Follow-up|1|||
170383262|NCT01277666|615738033|FG001|Overall Study|Lost to Follow-up|1|||
170383263|NCT01277666|615738034|FG002|Overall Study|Lost to Follow-up|2|||
170383264|NCT01277666|615738032|FG000|Overall Study|Withdrawal by Subject|7|||
170383265|NCT01277666|615738033|FG001|Overall Study|Withdrawal by Subject|8|||
170383266|NCT01277666|615738034|FG002|Overall Study|Withdrawal by Subject|6|||
170383267|NCT01277666|615738032|FG000|Overall Study|Death|0|||
170383268|NCT01277666|615738033|FG001|Overall Study|Death|0|||
170383269|NCT01277666|615738034|FG002|Overall Study|Death|1|||
170383270|NCT00554840|615738038|FG000|Overall Study|Physician Decision|0|||
170383271|NCT00554840|615738039|FG001|Overall Study|Physician Decision|1|||
170383272|NCT02993783|615738042|FG000|Overall Study|Reason not Specified|6|||
170383273|NCT02993783|615738043|FG001|Overall Study|Reason not Specified|9|||
170383274|NCT02886338|615738044|FG000|Overall Study|Withdrawal by Subject|1|||
170383275|NCT04728815|615738049|FG000|Overall Study|Lost to Follow-up|3|||
170383276|NCT04728815|615738050|FG001|Overall Study|Lost to Follow-up|0|||
170383277|NCT04728815|615738051|FG002|Overall Study|Lost to Follow-up|0|||
170383278|NCT04728815|615738052|FG003|Overall Study|Lost to Follow-up|1|||
170383279|NCT04728815|615738053|FG004|Overall Study|Lost to Follow-up|1|||
170383280|NCT04728815|615738054|FG005|Overall Study|Lost to Follow-up|0|||
170383281|NCT04728815|615738055|FG006|Overall Study|Lost to Follow-up|2|||
170383282|NCT04728815|615738056|FG007|Overall Study|Lost to Follow-up|0|||
170383283|NCT04728815|615738049|FG000|Overall Study|Physician Decision|0|||
170383284|NCT04728815|615738050|FG001|Overall Study|Physician Decision|0|||
170383285|NCT04728815|615738051|FG002|Overall Study|Physician Decision|1|||
170383286|NCT04728815|615738052|FG003|Overall Study|Physician Decision|0|||
170383287|NCT04728815|615738053|FG004|Overall Study|Physician Decision|0|||
170383288|NCT04728815|615738054|FG005|Overall Study|Physician Decision|0|||
170383289|NCT04728815|615738055|FG006|Overall Study|Physician Decision|0|||
170383290|NCT04728815|615738056|FG007|Overall Study|Physician Decision|0|||
170383291|NCT04728815|615738049|FG000|Overall Study|Treatment drop|0|||
170383292|NCT04728815|615738050|FG001|Overall Study|Treatment drop|2|||
170383293|NCT04728815|615738051|FG002|Overall Study|Treatment drop|1|||
170383294|NCT04728815|615738052|FG003|Overall Study|Treatment drop|0|||
170383295|NCT04728815|615738053|FG004|Overall Study|Treatment drop|3|||
170383296|NCT04728815|615738054|FG005|Overall Study|Treatment drop|1|||
170383297|NCT04728815|615738055|FG006|Overall Study|Treatment drop|3|||
170383298|NCT04728815|615738056|FG007|Overall Study|Treatment drop|0|||
170383299|NCT04728815|615738049|FG000|Overall Study|Study drop|0|||
170383300|NCT04728815|615738050|FG001|Overall Study|Study drop|3|||
170383301|NCT04728815|615738051|FG002|Overall Study|Study drop|3|||
170383302|NCT04728815|615738052|FG003|Overall Study|Study drop|0|||
170383303|NCT04728815|615738053|FG004|Overall Study|Study drop|0|||
170383304|NCT04728815|615738054|FG005|Overall Study|Study drop|0|||
170383305|NCT04728815|615738055|FG006|Overall Study|Study drop|7|||
170383306|NCT04728815|615738056|FG007|Overall Study|Study drop|0|||
170383307|NCT00957034|615738057|FG000|Overall Study|Adverse Event|0|||
170383308|NCT00957034|615738058|FG001|Overall Study|Adverse Event|1|||
170383309|NCT00957034|615738059|FG002|Overall Study|Adverse Event|1|||
170383310|NCT00957034|615738057|FG000|Overall Study|Sponsor Terminated Study|6|||
170383311|NCT00957034|615738058|FG001|Overall Study|Sponsor Terminated Study|1|||
170383312|NCT00957034|615738059|FG002|Overall Study|Sponsor Terminated Study|5|||
170383313|NCT00957034|615738057|FG000|Overall Study|Withdrawal by Subject|0|||
170383314|NCT00957034|615738058|FG001|Overall Study|Withdrawal by Subject|2|||
170383315|NCT00957034|615738059|FG002|Overall Study|Withdrawal by Subject|0|||
170383316|NCT05315297|615738060|FG000|Overall Study|Lost to Follow-up|6|||
170383317|NCT05315297|615738061|FG001|Overall Study|Lost to Follow-up|4|||
170383318|NCT05315297|615738060|FG000|Overall Study|Withdrawal by Subject|0|||
170383319|NCT05315297|615738061|FG001|Overall Study|Withdrawal by Subject|1|||
170383320|NCT03726320|615741287|FG000|Overall Study|Lost to Follow-up|2|||
170383321|NCT03726320|615741288|FG001|Overall Study|Lost to Follow-up|4|||
170383322|NCT03726320|615741289|FG002|Overall Study|Lost to Follow-up|0|||
170383323|NCT03726320|615741287|FG000|Overall Study|Time Constraints|4|||
170383324|NCT03726320|615741288|FG001|Overall Study|Time Constraints|1|||
170383325|NCT03726320|615741289|FG002|Overall Study|Time Constraints|0|||
170383326|NCT03726320|615741287|FG000|Overall Study|Ineligible after enrollment|3|||
170383327|NCT03726320|615741288|FG001|Overall Study|Ineligible after enrollment|3|||
170383328|NCT03726320|615741289|FG002|Overall Study|Ineligible after enrollment|0|||
170383329|NCT03726320|615741287|FG000|Overall Study|Clinic / insurance issue|2|||
170383330|NCT03726320|615741288|FG001|Overall Study|Clinic / insurance issue|0|||
170383331|NCT03726320|615741289|FG002|Overall Study|Clinic / insurance issue|0|||
170383332|NCT03726320|615741287|FG000|Overall Study|Language barrier|1|||
170383333|NCT03726320|615741288|FG001|Overall Study|Language barrier|0|||
170383334|NCT03726320|615741289|FG002|Overall Study|Language barrier|0|||
170383335|NCT03726320|615741287|FG000|Overall Study|Provider left the clinic|0|||
170383336|NCT03726320|615741288|FG001|Overall Study|Provider left the clinic|0|||
170383337|NCT03726320|615741289|FG002|Overall Study|Provider left the clinic|1|||
170383338|NCT03691831|615741292|FG000|Overall Study|Lost to Follow-up|16|||
170383339|NCT03691831|615741293|FG001|Overall Study|Lost to Follow-up|12|||
170383340|NCT03691831|615741292|FG000|Overall Study|Withdrawal by Subject|9|||
170383341|NCT03691831|615741293|FG001|Overall Study|Withdrawal by Subject|17|||
170383342|NCT03691831|615741292|FG000|Overall Study|Investigator Decision|2|||
170383343|NCT03691831|615741293|FG001|Overall Study|Investigator Decision|2|||
170383344|NCT02198040|615741294|FG000|Overall Study|Work reasons|0|||
170383345|NCT02198040|615741295|FG001|Overall Study|Work reasons|1|||
170383346|NCT02198040|615741296|FG002|Overall Study|Work reasons|0|||
170383347|NCT02198040|615741294|FG000|Overall Study|Withdrawal by Subject|0|||
170383348|NCT02198040|615741295|FG001|Overall Study|Withdrawal by Subject|0|||
170383349|NCT02198040|615741296|FG002|Overall Study|Withdrawal by Subject|1|||
170383350|NCT04120116|615741297|FG000|Overall Study|Lost to Follow-up|0|||
170383351|NCT04120116|615741298|FG001|Overall Study|Lost to Follow-up|1|||
170383352|NCT04120116|615741299|FG002|Overall Study|Lost to Follow-up|0|||
170383353|NCT04120116|615741300|FG003|Overall Study|Lost to Follow-up|2|||
170383354|NCT04120116|615741297|FG000|Overall Study|Withdrawal by Subject|1|||
170383355|NCT04120116|615741298|FG001|Overall Study|Withdrawal by Subject|0|||
170383356|NCT04120116|615741299|FG002|Overall Study|Withdrawal by Subject|1|||
170383357|NCT04120116|615741300|FG003|Overall Study|Withdrawal by Subject|1|||
170383358|NCT04120116|615741297|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
170383359|NCT04120116|615741298|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
170383360|NCT04120116|615741299|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
170383361|NCT04120116|615741300|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
170383362|NCT01855607|615741301|FG000|Overall Study|Withdrawal by Subject|1|||
170383363|NCT01855607|615741301|FG000|Overall Study|Study was terminated|11|||
170383364|NCT02528331|615741302|FG000|Overall Study|Withdrawal by Subject|2|||
170383365|NCT02210559|615741303|FG000|Overall Study|Progressive Disease|3|||
170383366|NCT02210559|615741304|FG001|Overall Study|Progressive Disease|2|||
170383367|NCT02210559|615741303|FG000|Overall Study|Adverse Event|2|||
170383368|NCT02210559|615741304|FG001|Overall Study|Adverse Event|2|||
170383369|NCT02210559|615741303|FG000|Overall Study|Physician Decision|1|||
170383370|NCT02210559|615741304|FG001|Overall Study|Physician Decision|0|||
170383371|NCT02210559|615741303|FG000|Overall Study|Withdrawal by Subject|0|||
170383372|NCT02210559|615741304|FG001|Overall Study|Withdrawal by Subject|1|||
170383373|NCT02210559|615741303|FG000|Overall Study|Other than specified|0|||
170383374|NCT02210559|615741304|FG001|Overall Study|Other than specified|1|||
170383375|NCT00792467|615741305|FG000|Overall Study|progression of disease|17|||
170383376|NCT00792467|615741305|FG000|Overall Study|Adverse Event|1|||
170383377|NCT00792467|615741305|FG000|Overall Study|patient request|1|||
170383378|NCT00792467|615741305|FG000|Overall Study|Lost to Follow-up|1|||
170383379|NCT00792467|615741305|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
170383380|NCT00792467|615741305|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
170383381|NCT01098266|615741306|FG000|Overall Study|Physician Decision|1|||
170383382|NCT01098266|615741307|FG001|Overall Study|Physician Decision|0|||
170383383|NCT01098266|615741306|FG000|Overall Study|Death|3|||
170383384|NCT01098266|615741307|FG001|Overall Study|Death|2|||
170383385|NCT01098266|615741306|FG000|Overall Study|Withdrawal by Subject|3|||
170383386|NCT01098266|615741307|FG001|Overall Study|Withdrawal by Subject|5|||
170383387|NCT01977651|615741308|FG000|4 Month Treatment Period|Adverse Event|34|||
170383388|NCT01977651|615741308|FG000|4 Month Treatment Period|Death|3|||
170383389|NCT01977651|615741308|FG000|4 Month Treatment Period|Progressive Disease|43|||
170383390|NCT01977651|615741308|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
170383391|NCT01977651|615741308|FG000|4 Month Treatment Period|Physician Decision|4|||
170383392|NCT01977651|615741308|FG000|1 Year Extension Period|Adverse Event|14|||
170383393|NCT01977651|615741308|FG000|1 Year Extension Period|Death|10|||
170383394|NCT01977651|615741308|FG000|1 Year Extension Period|Lost to Follow-up|2|||
170383395|NCT01977651|615741308|FG000|1 Year Extension Period|Progressive Disease|86|||
170383396|NCT01977651|615741308|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
170383397|NCT01977651|615741308|FG000|1 Year Extension Period|Physician Decision|6|||
170383398|NCT01977651|615741308|FG000|1 Year Extension Period|Miscellaneous|1|||
170383399|NCT01977651|615741308|FG000|Post 1 Year Extension Period|Adverse Event|5|||
170383400|NCT01977651|615741308|FG000|Post 1 Year Extension Period|Death|13|||
170383401|NCT01977651|615741308|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
170383402|NCT01977651|615741308|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
170383403|NCT01977651|615741308|FG000|Post 1 Year Extension Period|Physician Decision|4|||
170383404|NCT01977651|615741308|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
170383405|NCT03380091|615741312|FG000|Overall Study|Withdrawal by Subject|2|||
170383406|NCT03380091|615741313|FG001|Overall Study|Withdrawal by Subject|1|||
170383407|NCT04594213|615741319|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
170383408|NCT04594213|615741320|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
170383409|NCT04594213|615741321|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
170383410|NCT04594213|615741322|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
170383411|NCT04594213|615741323|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
170383412|NCT04594213|615741324|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
170383413|NCT04594213|615741319|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
170383414|NCT04594213|615741320|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
170383415|NCT04594213|615741321|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
170383416|NCT04594213|615741322|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
170383417|NCT04594213|615741323|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
170383418|NCT04594213|615741324|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
170383419|NCT04594213|615741319|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
170383420|NCT04594213|615741320|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
170383421|NCT04594213|615741321|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
170383422|NCT04594213|615741322|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
170383423|NCT04594213|615741323|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
170383424|NCT04594213|615741324|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
170383425|NCT04594213|615741319|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170383426|NCT04594213|615741320|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170383427|NCT04594213|615741321|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170383428|NCT04594213|615741322|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170383429|NCT04594213|615741323|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
170383430|NCT04594213|615741324|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
170383431|NCT04594213|615741319|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
170383432|NCT04594213|615741320|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
170383433|NCT04594213|615741321|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
170383434|NCT04594213|615741322|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
170383435|NCT04594213|615741323|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
170383436|NCT04594213|615741324|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
170383437|NCT04594213|615741319|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170383438|NCT04594213|615741320|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170383439|NCT04594213|615741321|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170383440|NCT04594213|615741322|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170383441|NCT04594213|615741323|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
170383442|NCT04594213|615741324|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
170383443|NCT04594213|615741319|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170383444|NCT04594213|615741320|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170383445|NCT04594213|615741321|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170383446|NCT04594213|615741322|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
170383447|NCT04594213|615741323|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170398856|NCT05004181|615798320|FG008|Overall Study|Lost to Follow-up|38|||
170383448|NCT04594213|615741324|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
170383449|NCT04594213|615741319|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
170383450|NCT04594213|615741320|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
170383451|NCT04594213|615741321|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
170383452|NCT04594213|615741322|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
170383453|NCT04594213|615741323|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
170383454|NCT04594213|615741324|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
170383455|NCT04594213|615741319|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
170383456|NCT04594213|615741320|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
170383457|NCT04594213|615741321|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
170383458|NCT04594213|615741322|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
170383459|NCT04594213|615741323|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
170383460|NCT04594213|615741324|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
170383461|NCT04594213|615741319|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
170383462|NCT04594213|615741320|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
170383463|NCT04594213|615741321|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
170383464|NCT04594213|615741322|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
170383465|NCT04594213|615741323|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
170383466|NCT04594213|615741324|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
170383467|NCT04594213|615741319|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
170383468|NCT04594213|615741320|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
170383469|NCT04594213|615741321|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
170383470|NCT04594213|615741322|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
170383471|NCT04594213|615741323|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
170383472|NCT04594213|615741324|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
170383473|NCT01980056|615741326|FG000|Overall Study|Death|1|||
170383474|NCT01980056|615741327|FG001|Overall Study|Death|1|||
170383475|NCT01980056|615741328|FG002|Overall Study|Death|0|||
170383476|NCT00104299|615741329|FG000|Overall Study|Adverse Event|3|||
170383477|NCT00104299|615741330|FG001|Overall Study|Adverse Event|1|||
170383478|NCT00104299|615741329|FG000|Overall Study|Death|2|||
170383479|NCT00104299|615741330|FG001|Overall Study|Death|2|||
170383480|NCT00104299|615741329|FG000|Overall Study|Withdrawal by Subject|2|||
170383481|NCT00104299|615741330|FG001|Overall Study|Withdrawal by Subject|6|||
170383482|NCT00104299|615741329|FG000|Overall Study|Physician Decision|1|||
170383483|NCT00104299|615741330|FG001|Overall Study|Physician Decision|1|||
170383484|NCT00104299|615741329|FG000|Overall Study|To have renal transplant|1|||
170383485|NCT00104299|615741330|FG001|Overall Study|To have renal transplant|0|||
170383486|NCT02906644|615741331|FG000|First 2 Weeks|Withdrawal by Subject|0|||
170383487|NCT02906644|615741332|FG001|First 2 Weeks|Withdrawal by Subject|2|||
170383488|NCT02906644|615741331|FG000|First 2 Weeks|Physician Decision|1|||
170383489|NCT02906644|615741332|FG001|First 2 Weeks|Physician Decision|1|||
170383490|NCT02906644|615741331|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
170383491|NCT02906644|615741332|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
170383492|NCT02906644|615741331|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
170383493|NCT02906644|615741332|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
170383494|NCT02275052|615741333|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170383495|NCT02275052|615741334|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
170383496|NCT02275052|615741335|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170383497|NCT02275052|615741336|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
170383498|NCT02275052|615741333|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
170383499|NCT02275052|615741334|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
170383500|NCT02275052|615741335|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
170383501|NCT02275052|615741336|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
170383502|NCT02275052|615741333|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
170383503|NCT02275052|615741334|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
170383504|NCT02275052|615741335|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170383505|NCT02275052|615741336|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
170383506|NCT02275052|615741333|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
170383507|NCT02275052|615741334|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
170383508|NCT02275052|615741335|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
170383509|NCT02275052|615741336|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
170383510|NCT02275052|615741333|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
170383511|NCT02275052|615741334|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
170383512|NCT02275052|615741335|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
170383513|NCT02275052|615741336|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
170383514|NCT02275052|615741333|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
170383515|NCT02275052|615741334|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
170383516|NCT02275052|615741335|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
170383517|NCT02275052|615741336|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
170383518|NCT02275052|615741333|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
170383519|NCT02275052|615741334|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
170383520|NCT02275052|615741335|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
170383521|NCT02275052|615741336|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
170383522|NCT02275052|615741333|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
170383523|NCT02275052|615741334|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
170383524|NCT02275052|615741335|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
170383525|NCT02275052|615741336|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
170383526|NCT02275052|615741333|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170383527|NCT02275052|615741334|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
170383528|NCT02275052|615741335|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
170383529|NCT02275052|615741336|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
170383530|NCT02275052|615741333|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
170383531|NCT02275052|615741334|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
170383532|NCT02275052|615741335|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
170383533|NCT02275052|615741336|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
170383534|NCT02275052|615741333|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
170383535|NCT02275052|615741334|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
170383536|NCT02275052|615741335|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
170383537|NCT02275052|615741336|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
170383538|NCT01707667|615741337|FG000|Period 1|expulsion of colonic sensor catheter|1|||
170383539|NCT01707667|615741338|FG001|Period 1|expulsion of colonic sensor catheter|0|||
170383540|NCT03055806|615741341|FG000|Overall Study|Adverse Event|0|||
170383541|NCT03055806|615741342|FG001|Overall Study|Adverse Event|0|||
170383542|NCT03055806|615741343|FG002|Overall Study|Adverse Event|1|||
170383543|NCT03055806|615741344|FG003|Overall Study|Adverse Event|1|||
170383544|NCT03055806|615741341|FG000|Overall Study|Lost to Follow-up|0|||
170383545|NCT03055806|615741342|FG001|Overall Study|Lost to Follow-up|3|||
170383546|NCT03055806|615741343|FG002|Overall Study|Lost to Follow-up|6|||
170383547|NCT03055806|615741344|FG003|Overall Study|Lost to Follow-up|7|||
170383548|NCT03055806|615741341|FG000|Overall Study|Physician Decision|1|||
170383549|NCT03055806|615741342|FG001|Overall Study|Physician Decision|0|||
170383550|NCT03055806|615741343|FG002|Overall Study|Physician Decision|0|||
170383551|NCT03055806|615741344|FG003|Overall Study|Physician Decision|1|||
170383552|NCT03055806|615741341|FG000|Overall Study|Protocol Violation|1|||
170383553|NCT03055806|615741342|FG001|Overall Study|Protocol Violation|0|||
170383554|NCT03055806|615741343|FG002|Overall Study|Protocol Violation|0|||
170383555|NCT03055806|615741344|FG003|Overall Study|Protocol Violation|0|||
170383556|NCT03055806|615741341|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
170383557|NCT03055806|615741342|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
170383558|NCT03055806|615741343|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
170383559|NCT03055806|615741344|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
170383560|NCT03055806|615741341|FG000|Overall Study|Withdrawal of consent to continue study|2|||
170383561|NCT03055806|615741342|FG001|Overall Study|Withdrawal of consent to continue study|3|||
170383562|NCT03055806|615741343|FG002|Overall Study|Withdrawal of consent to continue study|4|||
170383563|NCT03055806|615741344|FG003|Overall Study|Withdrawal of consent to continue study|6|||
170383564|NCT03055806|615741341|FG000|Overall Study|Partner not willing to try intercourse|1|||
170383565|NCT03055806|615741342|FG001|Overall Study|Partner not willing to try intercourse|0|||
170383566|NCT03055806|615741343|FG002|Overall Study|Partner not willing to try intercourse|0|||
170383567|NCT03055806|615741344|FG003|Overall Study|Partner not willing to try intercourse|0|||
170383568|NCT01453439|615741345|FG000|Treatment Phase|Withdrawal by Subject|13|||
170383569|NCT01453439|615741346|FG001|Treatment Phase|Withdrawal by Subject|10|||
170383570|NCT01453439|615741345|FG000|Treatment Phase|Suicidal Ideation|2|||
170383571|NCT01453439|615741346|FG001|Treatment Phase|Suicidal Ideation|0|||
170383572|NCT01453439|615741345|FG000|Treatment Phase|Need for higher level of care|1|||
170383573|NCT01453439|615741346|FG001|Treatment Phase|Need for higher level of care|1|||
170383574|NCT01453439|615741345|FG000|Treatment Phase|Therapist conflict of interest|1|||
170383575|NCT01453439|615741346|FG001|Treatment Phase|Therapist conflict of interest|0|||
170383576|NCT01453439|615741345|FG000|Follow-up|Withdrawal by Subject|0|||
170383577|NCT01453439|615741346|FG001|Follow-up|Withdrawal by Subject|1|||
170383578|NCT01453439|615741345|FG000|Follow-up|Lost to Follow-up|5|||
170383579|NCT01453439|615741346|FG001|Follow-up|Lost to Follow-up|10|||
170383580|NCT04249076|615741360|FG000|Overall Study|Adverse Event|1|||
170383581|NCT04249076|615741361|FG001|Overall Study|Adverse Event|1|||
170383582|NCT04249076|615741360|FG000|Overall Study|Protocol Violation|1|||
170383583|NCT04249076|615741361|FG001|Overall Study|Protocol Violation|2|||
170383584|NCT04249076|615741360|FG000|Overall Study|Lack of Efficacy|0|||
170383585|NCT04249076|615741361|FG001|Overall Study|Lack of Efficacy|1|||
170383586|NCT04249076|615741360|FG000|Overall Study|Withdrawal by Subject|0|||
170383587|NCT04249076|615741361|FG001|Overall Study|Withdrawal by Subject|1|||
170383588|NCT00783263|615741362|FG000|Overall Study|Adverse Event|3|||
170383589|NCT00783263|615741363|FG001|Overall Study|Adverse Event|0|||
170383590|NCT00783263|615741364|FG002|Overall Study|Adverse Event|2|||
170383591|NCT00783263|615741365|FG003|Overall Study|Adverse Event|1|||
170383592|NCT00783263|615741362|FG000|Overall Study|Lost to Follow-up|1|||
170383593|NCT00783263|615741363|FG001|Overall Study|Lost to Follow-up|1|||
170383594|NCT00783263|615741364|FG002|Overall Study|Lost to Follow-up|0|||
170383595|NCT00783263|615741365|FG003|Overall Study|Lost to Follow-up|0|||
170383596|NCT00783263|615741362|FG000|Overall Study|Withdrawal by Subject|0|||
170383597|NCT00783263|615741363|FG001|Overall Study|Withdrawal by Subject|1|||
170383598|NCT00783263|615741364|FG002|Overall Study|Withdrawal by Subject|1|||
170383599|NCT00783263|615741365|FG003|Overall Study|Withdrawal by Subject|2|||
170383600|NCT00106626|615741366|FG000|Overall Study|Adverse Event|5|||
170383601|NCT00106626|615741367|FG001|Overall Study|Adverse Event|4|||
170383602|NCT00106626|615741368|FG002|Overall Study|Adverse Event|3|||
170383603|NCT00106626|615741369|FG003|Overall Study|Adverse Event|3|||
170383604|NCT00106626|615741366|FG000|Overall Study|Progressive Disease|4|||
170383605|NCT00106626|615741367|FG001|Overall Study|Progressive Disease|1|||
170383606|NCT00106626|615741368|FG002|Overall Study|Progressive Disease|9|||
170383607|NCT00106626|615741369|FG003|Overall Study|Progressive Disease|10|||
170383608|NCT00106626|615741366|FG000|Overall Study|Received radiation on new therapy|1|||
170383609|NCT00106626|615741367|FG001|Overall Study|Received radiation on new therapy|0|||
170383610|NCT00106626|615741368|FG002|Overall Study|Received radiation on new therapy|0|||
170383611|NCT00106626|615741369|FG003|Overall Study|Received radiation on new therapy|0|||
170383612|NCT00106626|615741366|FG000|Overall Study|> 14 day delay in therapy start|0|||
170383613|NCT00106626|615741367|FG001|Overall Study|> 14 day delay in therapy start|1|||
170383614|NCT00106626|615741368|FG002|Overall Study|> 14 day delay in therapy start|0|||
170383615|NCT00106626|615741369|FG003|Overall Study|> 14 day delay in therapy start|0|||
170383616|NCT00565721|615741380|FG000|Overall Study|Screen Failure|2|||
170383617|NCT00565721|615741380|FG000|Overall Study|Lost to Follow-up|6|||
170383618|NCT00565721|615741380|FG000|Overall Study|Technical Problems|1|||
170383619|NCT00565721|615741380|FG000|Overall Study|Physician Decision|2|||
170383620|NCT00565721|615741380|FG000|Overall Study|Other reasons|6|||
170383621|NCT00529152|615741381|FG000|Overall Study|Adverse Event|2|||
170383622|NCT00529152|615741381|FG000|Overall Study|Withdrawal by Subject|2|||
170383623|NCT00529152|615741381|FG000|Overall Study|Lost to Follow-up|1|||
170383624|NCT04062240|615741382|FG000|Overall Study|equipment malfunction|1|||
170383625|NCT04491591|615741385|FG000|Overall Study|Accidently randomized|3|||
170383626|NCT04491591|615741386|FG001|Overall Study|Accidently randomized|1|||
170383627|NCT04491591|615741387|FG002|Overall Study|Accidently randomized|0|||
170383628|NCT04491591|615741385|FG000|Overall Study|Did not complete survey|28|||
170383629|NCT04491591|615741386|FG001|Overall Study|Did not complete survey|20|||
170383630|NCT04491591|615741387|FG002|Overall Study|Did not complete survey|3|||
170383631|NCT01874288|615741388|FG000|Overall Study|Withdrawal by Subject|1|||
170383632|NCT01874288|615741389|FG001|Overall Study|Withdrawal by Subject|0|||
170383633|NCT01874288|615741390|FG002|Overall Study|Withdrawal by Subject|2|||
170383634|NCT01874288|615741391|FG003|Overall Study|Withdrawal by Subject|1|||
170383635|NCT01874288|615741392|FG004|Overall Study|Withdrawal by Subject|1|||
170383636|NCT01874288|615741388|FG000|Overall Study|Physician Decision|0|||
170383637|NCT01874288|615741389|FG001|Overall Study|Physician Decision|0|||
170383638|NCT01874288|615741390|FG002|Overall Study|Physician Decision|0|||
170383639|NCT01874288|615741391|FG003|Overall Study|Physician Decision|1|||
170383640|NCT01874288|615741392|FG004|Overall Study|Physician Decision|0|||
170383641|NCT01874288|615741388|FG000|Overall Study|Progressive disease|2|||
170383642|NCT01874288|615741389|FG001|Overall Study|Progressive disease|0|||
170383643|NCT01874288|615741390|FG002|Overall Study|Progressive disease|3|||
170383644|NCT01874288|615741391|FG003|Overall Study|Progressive disease|5|||
170383645|NCT01874288|615741392|FG004|Overall Study|Progressive disease|1|||
170383646|NCT01326910|615741393|FG000|Overall Study|Withdrawal by Subject|3|||
170383647|NCT01326910|615741394|FG001|Overall Study|Withdrawal by Subject|2|||
170383648|NCT01326910|615741393|FG000|Overall Study|Protocol Violation|1|||
170383649|NCT01326910|615741394|FG001|Overall Study|Protocol Violation|1|||
170383650|NCT01681836|615741395|FG000|Second Intervention|Withdrawal by Subject|0|||
170383651|NCT01681836|615741396|FG001|Second Intervention|Withdrawal by Subject|1|||
170383652|NCT00742391|615741397|FG000|Overall Study|Adverse Event|2|||
170383653|NCT00742391|615741398|FG001|Overall Study|Adverse Event|1|||
170383654|NCT00742391|615741397|FG000|Overall Study|Lost to Follow-up|1|||
170383655|NCT00742391|615741398|FG001|Overall Study|Lost to Follow-up|0|||
170383656|NCT00742391|615741397|FG000|Overall Study|Protocol Violation|1|||
170383657|NCT00742391|615741398|FG001|Overall Study|Protocol Violation|0|||
170383658|NCT02394028|615741399|FG000|Induction Phase|Adverse Event|2|||
170383659|NCT02394028|615741400|FG001|Induction Phase|Adverse Event|4|||
170383660|NCT02394028|615741401|FG002|Induction Phase|Adverse Event|1|||
170383661|NCT02394028|615741402|FG003|Induction Phase|Adverse Event|2|||
170383662|NCT02394028|615741403|FG004|Induction Phase|Adverse Event|5|||
170383663|NCT02394028|615741404|FG005|Induction Phase|Adverse Event|2|||
170383664|NCT02394028|615741405|FG006|Induction Phase|Adverse Event|0|||
170383665|NCT02394028|615741406|FG007|Induction Phase|Adverse Event|0|||
170383666|NCT02394028|615741407|FG008|Induction Phase|Adverse Event|0|||
170383667|NCT02394028|615741408|FG009|Induction Phase|Adverse Event|0|||
170383668|NCT02394028|615741409|FG010|Induction Phase|Adverse Event|0|||
170383669|NCT02394028|615741399|FG000|Induction Phase|Lack of Efficacy|3|||
170383670|NCT02394028|615741400|FG001|Induction Phase|Lack of Efficacy|6|||
170383671|NCT02394028|615741401|FG002|Induction Phase|Lack of Efficacy|2|||
170383672|NCT02394028|615741402|FG003|Induction Phase|Lack of Efficacy|17|||
170383673|NCT02394028|615741403|FG004|Induction Phase|Lack of Efficacy|14|||
170383674|NCT02394028|615741404|FG005|Induction Phase|Lack of Efficacy|8|||
170383675|NCT02394028|615741405|FG006|Induction Phase|Lack of Efficacy|17|||
170383676|NCT02394028|615741406|FG007|Induction Phase|Lack of Efficacy|23|||
170383677|NCT02394028|615741407|FG008|Induction Phase|Lack of Efficacy|0|||
170383678|NCT02394028|615741408|FG009|Induction Phase|Lack of Efficacy|0|||
170383679|NCT02394028|615741409|FG010|Induction Phase|Lack of Efficacy|0|||
170383680|NCT02394028|615741399|FG000|Induction Phase|Lost to Follow-up|1|||
170383681|NCT02394028|615741400|FG001|Induction Phase|Lost to Follow-up|0|||
170383682|NCT02394028|615741401|FG002|Induction Phase|Lost to Follow-up|0|||
170383683|NCT02394028|615741402|FG003|Induction Phase|Lost to Follow-up|1|||
170383684|NCT02394028|615741403|FG004|Induction Phase|Lost to Follow-up|0|||
170383685|NCT02394028|615741404|FG005|Induction Phase|Lost to Follow-up|0|||
170383686|NCT02394028|615741405|FG006|Induction Phase|Lost to Follow-up|1|||
170383687|NCT02394028|615741406|FG007|Induction Phase|Lost to Follow-up|0|||
170383688|NCT02394028|615741407|FG008|Induction Phase|Lost to Follow-up|0|||
170383689|NCT02394028|615741408|FG009|Induction Phase|Lost to Follow-up|0|||
170383690|NCT02394028|615741409|FG010|Induction Phase|Lost to Follow-up|0|||
170383691|NCT02394028|615741399|FG000|Induction Phase|Non-compliance|0|||
170383692|NCT02394028|615741400|FG001|Induction Phase|Non-compliance|1|||
170383693|NCT02394028|615741401|FG002|Induction Phase|Non-compliance|3|||
170383694|NCT02394028|615741402|FG003|Induction Phase|Non-compliance|1|||
170383695|NCT02394028|615741403|FG004|Induction Phase|Non-compliance|3|||
170383696|NCT02394028|615741404|FG005|Induction Phase|Non-compliance|0|||
170383697|NCT02394028|615741405|FG006|Induction Phase|Non-compliance|1|||
170383698|NCT02394028|615741406|FG007|Induction Phase|Non-compliance|1|||
170383699|NCT02394028|615741407|FG008|Induction Phase|Non-compliance|0|||
170383700|NCT02394028|615741408|FG009|Induction Phase|Non-compliance|0|||
170383701|NCT02394028|615741409|FG010|Induction Phase|Non-compliance|0|||
170383702|NCT02394028|615741399|FG000|Induction Phase|Physician Decision|0|||
170383703|NCT02394028|615741400|FG001|Induction Phase|Physician Decision|0|||
170383704|NCT02394028|615741401|FG002|Induction Phase|Physician Decision|1|||
170383705|NCT02394028|615741402|FG003|Induction Phase|Physician Decision|4|||
170383706|NCT02394028|615741403|FG004|Induction Phase|Physician Decision|0|||
170383707|NCT02394028|615741404|FG005|Induction Phase|Physician Decision|2|||
170383708|NCT02394028|615741405|FG006|Induction Phase|Physician Decision|1|||
170383709|NCT02394028|615741406|FG007|Induction Phase|Physician Decision|0|||
170383710|NCT02394028|615741407|FG008|Induction Phase|Physician Decision|0|||
170383711|NCT02394028|615741408|FG009|Induction Phase|Physician Decision|0|||
170383712|NCT02394028|615741409|FG010|Induction Phase|Physician Decision|0|||
170383713|NCT02394028|615741399|FG000|Induction Phase|Protocol Violation|0|||
170383714|NCT02394028|615741400|FG001|Induction Phase|Protocol Violation|2|||
170383715|NCT02394028|615741401|FG002|Induction Phase|Protocol Violation|0|||
170383716|NCT02394028|615741402|FG003|Induction Phase|Protocol Violation|3|||
170383717|NCT02394028|615741403|FG004|Induction Phase|Protocol Violation|0|||
170383718|NCT02394028|615741404|FG005|Induction Phase|Protocol Violation|1|||
170383719|NCT02394028|615741405|FG006|Induction Phase|Protocol Violation|1|||
170383720|NCT02394028|615741406|FG007|Induction Phase|Protocol Violation|0|||
170383721|NCT02394028|615741407|FG008|Induction Phase|Protocol Violation|0|||
170383722|NCT02394028|615741408|FG009|Induction Phase|Protocol Violation|0|||
170383723|NCT02394028|615741409|FG010|Induction Phase|Protocol Violation|0|||
170383724|NCT02394028|615741399|FG000|Induction Phase|Withdrawal by Subject|1|||
170383725|NCT02394028|615741400|FG001|Induction Phase|Withdrawal by Subject|2|||
170383726|NCT02394028|615741401|FG002|Induction Phase|Withdrawal by Subject|4|||
170383727|NCT02394028|615741402|FG003|Induction Phase|Withdrawal by Subject|6|||
170383728|NCT02394028|615741403|FG004|Induction Phase|Withdrawal by Subject|7|||
170383729|NCT02394028|615741404|FG005|Induction Phase|Withdrawal by Subject|4|||
170383730|NCT02394028|615741405|FG006|Induction Phase|Withdrawal by Subject|3|||
170383731|NCT02394028|615741406|FG007|Induction Phase|Withdrawal by Subject|6|||
170383732|NCT02394028|615741407|FG008|Induction Phase|Withdrawal by Subject|0|||
170383733|NCT02394028|615741408|FG009|Induction Phase|Withdrawal by Subject|0|||
170383734|NCT02394028|615741409|FG010|Induction Phase|Withdrawal by Subject|0|||
170383735|NCT02394028|615741399|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383736|NCT02394028|615741400|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383737|NCT02394028|615741401|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383738|NCT02394028|615741402|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383739|NCT02394028|615741403|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383740|NCT02394028|615741404|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383741|NCT02394028|615741405|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
170383742|NCT02394028|615741406|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383743|NCT02394028|615741407|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383744|NCT02394028|615741408|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383745|NCT02394028|615741409|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
170383746|NCT02394028|615741399|FG000|Induction Phase|Sponsor decision|0|||
170383747|NCT02394028|615741400|FG001|Induction Phase|Sponsor decision|1|||
170383748|NCT02394028|615741401|FG002|Induction Phase|Sponsor decision|2|||
170383749|NCT02394028|615741402|FG003|Induction Phase|Sponsor decision|0|||
170383750|NCT02394028|615741403|FG004|Induction Phase|Sponsor decision|0|||
170383751|NCT02394028|615741404|FG005|Induction Phase|Sponsor decision|0|||
170383752|NCT02394028|615741405|FG006|Induction Phase|Sponsor decision|0|||
170383753|NCT02394028|615741406|FG007|Induction Phase|Sponsor decision|0|||
170383754|NCT02394028|615741407|FG008|Induction Phase|Sponsor decision|0|||
170383755|NCT02394028|615741408|FG009|Induction Phase|Sponsor decision|0|||
170383756|NCT02394028|615741409|FG010|Induction Phase|Sponsor decision|0|||
170383757|NCT02394028|615741399|FG000|Induction Phase|Technical reason|0|||
170383758|NCT02394028|615741400|FG001|Induction Phase|Technical reason|0|||
170383759|NCT02394028|615741401|FG002|Induction Phase|Technical reason|0|||
170383760|NCT02394028|615741402|FG003|Induction Phase|Technical reason|1|||
170383761|NCT02394028|615741403|FG004|Induction Phase|Technical reason|0|||
170383762|NCT02394028|615741404|FG005|Induction Phase|Technical reason|0|||
170383763|NCT02394028|615741405|FG006|Induction Phase|Technical reason|0|||
170383764|NCT02394028|615741406|FG007|Induction Phase|Technical reason|0|||
170383765|NCT02394028|615741407|FG008|Induction Phase|Technical reason|0|||
170383766|NCT02394028|615741408|FG009|Induction Phase|Technical reason|0|||
170383767|NCT02394028|615741409|FG010|Induction Phase|Technical reason|0|||
170383768|NCT02394028|615741399|FG000|Induction Phase|:ack of calculation|0|||
170383769|NCT02394028|615741400|FG001|Induction Phase|:ack of calculation|0|||
170383770|NCT02394028|615741401|FG002|Induction Phase|:ack of calculation|0|||
170383771|NCT02394028|615741402|FG003|Induction Phase|:ack of calculation|0|||
170383772|NCT02394028|615741403|FG004|Induction Phase|:ack of calculation|0|||
170383773|NCT02394028|615741404|FG005|Induction Phase|:ack of calculation|0|||
170383774|NCT02394028|615741405|FG006|Induction Phase|:ack of calculation|0|||
170383775|NCT02394028|615741406|FG007|Induction Phase|:ack of calculation|1|||
170383776|NCT02394028|615741407|FG008|Induction Phase|:ack of calculation|0|||
170383777|NCT02394028|615741408|FG009|Induction Phase|:ack of calculation|0|||
170383778|NCT02394028|615741409|FG010|Induction Phase|:ack of calculation|0|||
170383779|NCT02394028|615741399|FG000|Maintenance Phase|Protocol Violation|0|||
170383780|NCT02394028|615741400|FG001|Maintenance Phase|Protocol Violation|0|||
170383781|NCT02394028|615741401|FG002|Maintenance Phase|Protocol Violation|0|||
170383782|NCT02394028|615741402|FG003|Maintenance Phase|Protocol Violation|0|||
170383783|NCT02394028|615741403|FG004|Maintenance Phase|Protocol Violation|0|||
170383784|NCT02394028|615741404|FG005|Maintenance Phase|Protocol Violation|0|||
170383785|NCT02394028|615741405|FG006|Maintenance Phase|Protocol Violation|0|||
170383786|NCT02394028|615741406|FG007|Maintenance Phase|Protocol Violation|0|||
170383787|NCT02394028|615741407|FG008|Maintenance Phase|Protocol Violation|0|||
170383788|NCT02394028|615741408|FG009|Maintenance Phase|Protocol Violation|0|||
170383789|NCT02394028|615741409|FG010|Maintenance Phase|Protocol Violation|1|||
170383790|NCT02394028|615741399|FG000|Maintenance Phase|Physician Decision|0|||
170383791|NCT02394028|615741400|FG001|Maintenance Phase|Physician Decision|0|||
170383792|NCT02394028|615741401|FG002|Maintenance Phase|Physician Decision|0|||
170383793|NCT02394028|615741402|FG003|Maintenance Phase|Physician Decision|0|||
170383794|NCT02394028|615741403|FG004|Maintenance Phase|Physician Decision|0|||
170383795|NCT02394028|615741404|FG005|Maintenance Phase|Physician Decision|0|||
170383796|NCT02394028|615741405|FG006|Maintenance Phase|Physician Decision|0|||
170383797|NCT02394028|615741406|FG007|Maintenance Phase|Physician Decision|0|||
170383798|NCT02394028|615741407|FG008|Maintenance Phase|Physician Decision|1|||
170383799|NCT02394028|615741408|FG009|Maintenance Phase|Physician Decision|3|||
170383800|NCT02394028|615741409|FG010|Maintenance Phase|Physician Decision|2|||
170383801|NCT02394028|615741399|FG000|Maintenance Phase|Lack of Efficacy|0|||
170383802|NCT02394028|615741400|FG001|Maintenance Phase|Lack of Efficacy|0|||
170383803|NCT02394028|615741401|FG002|Maintenance Phase|Lack of Efficacy|0|||
170383804|NCT02394028|615741402|FG003|Maintenance Phase|Lack of Efficacy|0|||
170383805|NCT02394028|615741403|FG004|Maintenance Phase|Lack of Efficacy|0|||
170383806|NCT02394028|615741404|FG005|Maintenance Phase|Lack of Efficacy|0|||
170383807|NCT02394028|615741405|FG006|Maintenance Phase|Lack of Efficacy|0|||
170383808|NCT02394028|615741406|FG007|Maintenance Phase|Lack of Efficacy|0|||
170383809|NCT02394028|615741407|FG008|Maintenance Phase|Lack of Efficacy|7|||
170383810|NCT02394028|615741408|FG009|Maintenance Phase|Lack of Efficacy|25|||
170383811|NCT02394028|615741409|FG010|Maintenance Phase|Lack of Efficacy|33|||
170383812|NCT02394028|615741399|FG000|Maintenance Phase|Death|0|||
170383813|NCT02394028|615741400|FG001|Maintenance Phase|Death|0|||
170383814|NCT02394028|615741401|FG002|Maintenance Phase|Death|0|||
170383815|NCT02394028|615741402|FG003|Maintenance Phase|Death|0|||
170383816|NCT02394028|615741403|FG004|Maintenance Phase|Death|0|||
170383817|NCT02394028|615741404|FG005|Maintenance Phase|Death|0|||
170383818|NCT02394028|615741405|FG006|Maintenance Phase|Death|0|||
170383819|NCT02394028|615741406|FG007|Maintenance Phase|Death|0|||
170383820|NCT02394028|615741407|FG008|Maintenance Phase|Death|0|||
170383821|NCT02394028|615741408|FG009|Maintenance Phase|Death|0|||
170383822|NCT02394028|615741409|FG010|Maintenance Phase|Death|1|||
170383823|NCT02394028|615741399|FG000|Maintenance Phase|Adverse Event|0|||
170383824|NCT02394028|615741400|FG001|Maintenance Phase|Adverse Event|0|||
170383825|NCT02394028|615741401|FG002|Maintenance Phase|Adverse Event|0|||
170383826|NCT02394028|615741402|FG003|Maintenance Phase|Adverse Event|0|||
170383827|NCT02394028|615741403|FG004|Maintenance Phase|Adverse Event|0|||
170383828|NCT02394028|615741404|FG005|Maintenance Phase|Adverse Event|0|||
170383829|NCT02394028|615741405|FG006|Maintenance Phase|Adverse Event|0|||
170383830|NCT02394028|615741406|FG007|Maintenance Phase|Adverse Event|0|||
170383831|NCT02394028|615741407|FG008|Maintenance Phase|Adverse Event|1|||
170383832|NCT02394028|615741408|FG009|Maintenance Phase|Adverse Event|1|||
170383833|NCT02394028|615741409|FG010|Maintenance Phase|Adverse Event|3|||
170383834|NCT02394028|615741399|FG000|Maintenance Phase|Site closure|0|||
170383835|NCT02394028|615741400|FG001|Maintenance Phase|Site closure|0|||
170383836|NCT02394028|615741401|FG002|Maintenance Phase|Site closure|0|||
170383837|NCT02394028|615741402|FG003|Maintenance Phase|Site closure|0|||
170383838|NCT02394028|615741403|FG004|Maintenance Phase|Site closure|0|||
170383839|NCT02394028|615741404|FG005|Maintenance Phase|Site closure|0|||
170383840|NCT02394028|615741405|FG006|Maintenance Phase|Site closure|0|||
170383841|NCT02394028|615741406|FG007|Maintenance Phase|Site closure|0|||
170383842|NCT02394028|615741407|FG008|Maintenance Phase|Site closure|0|||
170383843|NCT02394028|615741408|FG009|Maintenance Phase|Site closure|1|||
170383844|NCT02394028|615741409|FG010|Maintenance Phase|Site closure|0|||
170383845|NCT02394028|615741399|FG000|Maintenance Phase|Withdrawal by Subject|0|||
170383846|NCT02394028|615741400|FG001|Maintenance Phase|Withdrawal by Subject|0|||
170383847|NCT02394028|615741401|FG002|Maintenance Phase|Withdrawal by Subject|0|||
170383848|NCT02394028|615741402|FG003|Maintenance Phase|Withdrawal by Subject|0|||
170383849|NCT02394028|615741403|FG004|Maintenance Phase|Withdrawal by Subject|0|||
170383850|NCT02394028|615741404|FG005|Maintenance Phase|Withdrawal by Subject|0|||
170383851|NCT02394028|615741405|FG006|Maintenance Phase|Withdrawal by Subject|0|||
170383852|NCT02394028|615741406|FG007|Maintenance Phase|Withdrawal by Subject|0|||
170383853|NCT02394028|615741407|FG008|Maintenance Phase|Withdrawal by Subject|3|||
170383854|NCT02394028|615741408|FG009|Maintenance Phase|Withdrawal by Subject|12|||
170383855|NCT02394028|615741409|FG010|Maintenance Phase|Withdrawal by Subject|12|||
170383856|NCT02142712|615741412|FG000|Overall Study|Lost to Follow-up|1|||
170383857|NCT02142712|615741413|FG001|Overall Study|Lost to Follow-up|1|||
170383858|NCT02142712|615741414|FG002|Overall Study|Lost to Follow-up|1|||
170383859|NCT02142712|615741415|FG003|Overall Study|Lost to Follow-up|0|||
170383860|NCT02355665|615741425|FG000|Overall Study|Adverse Event|16|||
170383861|NCT02355665|615741426|FG001|Overall Study|Adverse Event|24|||
170383862|NCT02355665|615741425|FG000|Overall Study|Protocol Violation|2|||
170383863|NCT02355665|615741426|FG001|Overall Study|Protocol Violation|0|||
170383864|NCT02355665|615741425|FG000|Overall Study|Withdrawal by Subject|90|||
170383865|NCT02355665|615741426|FG001|Overall Study|Withdrawal by Subject|100|||
170383866|NCT02355665|615741425|FG000|Overall Study|Lost to Follow-up|131|||
170383867|NCT02355665|615741426|FG001|Overall Study|Lost to Follow-up|103|||
170383868|NCT02355665|615741425|FG000|Overall Study|Death|4|||
170383869|NCT02355665|615741426|FG001|Overall Study|Death|2|||
170383870|NCT02355665|615741425|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
170383871|NCT02355665|615741426|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
170383872|NCT01058356|615741431|FG000|Overall Study|Adverse Event|5|||
170383873|NCT01058356|615741431|FG000|Overall Study|Administration of contraindicated drugs|12|||
170383874|NCT01058356|615741431|FG000|Overall Study|Withdrawal by Subject|21|||
170383875|NCT01058356|615741431|FG000|Overall Study|Lost to Follow-up|4|||
170383876|NCT03480841|615741434|FG000|Overall Study|Lost to Follow-up|2|||
170383877|NCT01362049|615741435|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
170383878|NCT01362049|615741436|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
170383879|NCT01362049|615741437|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
170383880|NCT01362049|615741438|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
170383881|NCT01362049|615741435|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
170383882|NCT01362049|615741436|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
170383883|NCT01362049|615741437|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
170383884|NCT01362049|615741438|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
170383885|NCT02417935|615741439|FG000|Treatment Period|Adverse Event|12|||
170383886|NCT02417935|615741440|FG001|Treatment Period|Adverse Event|10|||
170383887|NCT02417935|615741439|FG000|Treatment Period|Lost to Follow-up|1|||
170383888|NCT02417935|615741440|FG001|Treatment Period|Lost to Follow-up|0|||
170383889|NCT02417935|615741439|FG000|Treatment Period|Entry Criteria not met|0|||
170383890|NCT02417935|615741440|FG001|Treatment Period|Entry Criteria not met|1|||
170383891|NCT02417935|615741439|FG000|Treatment Period|Protocol Violation|2|||
170383892|NCT02417935|615741440|FG001|Treatment Period|Protocol Violation|1|||
170383893|NCT02417935|615741439|FG000|Treatment Period|Withdrawal by Subject|3|||
170383894|NCT02417935|615741440|FG001|Treatment Period|Withdrawal by Subject|3|||
170383895|NCT02417935|615741439|FG000|Treatment Period|Physician Decision|3|||
170383896|NCT02417935|615741440|FG001|Treatment Period|Physician Decision|1|||
170383897|NCT02850276|615741441|FG000|Overall Study|screen failure|43|||
170383898|NCT02850276|615741441|FG000|Overall Study|Withdrawal by Subject|14|||
170383899|NCT02850276|615741441|FG000|Overall Study|Physician Decision|2|||
170383900|NCT02850276|615741441|FG000|Overall Study|Lost to Follow-up|2|||
170383901|NCT00095836|615741445|FG000|Overall Study|Lost to Follow-up|1|||
170383902|NCT00095836|615741445|FG000|Overall Study|Adverse Event|1|||
170383903|NCT00095836|615741445|FG000|Overall Study|Death|2|||
170383904|NCT00962780|615741446|FG000|Overall Study|Death|0|||
170383905|NCT00962780|615741447|FG001|Overall Study|Death|1|||
170383906|NCT00962780|615741446|FG000|Overall Study|Protocol Violation|9|||
170383907|NCT00962780|615741447|FG001|Overall Study|Protocol Violation|4|||
170383908|NCT00962780|615741446|FG000|Overall Study|Withdrawal by Subject|1|||
170383909|NCT00962780|615741447|FG001|Overall Study|Withdrawal by Subject|8|||
170383910|NCT00962780|615741446|FG000|Overall Study|Other|0|||
170383911|NCT00962780|615741447|FG001|Overall Study|Other|1|||
170383912|NCT02055976|615741448|FG000|Overall Study|Other|0|||
170383913|NCT02055976|615741449|FG001|Overall Study|Other|0|||
170383914|NCT02055976|615741450|FG002|Overall Study|Other|1|||
170383915|NCT02055976|615741451|FG003|Overall Study|Other|0|||
170383916|NCT02055976|615741452|FG004|Overall Study|Other|0|||
170383917|NCT02055976|615741453|FG005|Overall Study|Other|0|||
170383918|NCT02055976|615741454|FG006|Overall Study|Other|0|||
170383919|NCT02055976|615741455|FG007|Overall Study|Other|0|||
170383920|NCT02055976|615741456|FG008|Overall Study|Other|0|||
170383921|NCT02055976|615741448|FG000|Overall Study|Adverse Event|0|||
170383922|NCT02055976|615741449|FG001|Overall Study|Adverse Event|0|||
170383923|NCT02055976|615741450|FG002|Overall Study|Adverse Event|0|||
170383924|NCT02055976|615741451|FG003|Overall Study|Adverse Event|0|||
170383925|NCT02055976|615741452|FG004|Overall Study|Adverse Event|0|||
170383926|NCT02055976|615741453|FG005|Overall Study|Adverse Event|1|||
170383927|NCT02055976|615741454|FG006|Overall Study|Adverse Event|1|||
170383928|NCT02055976|615741455|FG007|Overall Study|Adverse Event|0|||
170383929|NCT02055976|615741456|FG008|Overall Study|Adverse Event|0|||
170383930|NCT02055976|615741448|FG000|Overall Study|Does not meet entrance criteria|0|||
170383931|NCT02055976|615741449|FG001|Overall Study|Does not meet entrance criteria|0|||
170383932|NCT02055976|615741450|FG002|Overall Study|Does not meet entrance criteria|0|||
170383933|NCT02055976|615741451|FG003|Overall Study|Does not meet entrance criteria|0|||
170383934|NCT02055976|615741452|FG004|Overall Study|Does not meet entrance criteria|0|||
170383935|NCT02055976|615741453|FG005|Overall Study|Does not meet entrance criteria|0|||
170383936|NCT02055976|615741454|FG006|Overall Study|Does not meet entrance criteria|1|||
170383937|NCT02055976|615741455|FG007|Overall Study|Does not meet entrance criteria|0|||
170383938|NCT02055976|615741456|FG008|Overall Study|Does not meet entrance criteria|0|||
170383939|NCT02055976|615741448|FG000|Overall Study|Lost to Follow-up|0|||
170383940|NCT02055976|615741449|FG001|Overall Study|Lost to Follow-up|0|||
170383941|NCT02055976|615741450|FG002|Overall Study|Lost to Follow-up|0|||
170383942|NCT02055976|615741451|FG003|Overall Study|Lost to Follow-up|1|||
170383943|NCT02055976|615741452|FG004|Overall Study|Lost to Follow-up|0|||
170383944|NCT02055976|615741453|FG005|Overall Study|Lost to Follow-up|0|||
170383945|NCT02055976|615741454|FG006|Overall Study|Lost to Follow-up|0|||
170383946|NCT02055976|615741455|FG007|Overall Study|Lost to Follow-up|0|||
170383947|NCT02055976|615741456|FG008|Overall Study|Lost to Follow-up|0|||
170383948|NCT01657903|615741460|FG000|Overall Study|Lost to Follow-up|1|||
170383949|NCT01657903|615741460|FG000|Overall Study|Withdrawal by Subject|1|||
170383950|NCT00983827|615741461|FG000|Overall Study|Withdrawal by Subject|1|||
170383951|NCT00591786|615741462|FG000|Overall Study|Withdrawal of Informed Consent|0|||
170383952|NCT00591786|615741463|FG001|Overall Study|Withdrawal of Informed Consent|0|||
170383953|NCT00591786|615741464|FG002|Overall Study|Withdrawal of Informed Consent|1|||
170383954|NCT00591786|615741465|FG003|Overall Study|Withdrawal of Informed Consent|0|||
170383955|NCT00591786|615741466|FG004|Overall Study|Withdrawal of Informed Consent|0|||
170383956|NCT00591786|615741467|FG005|Overall Study|Withdrawal of Informed Consent|0|||
170383957|NCT00591786|615741468|FG006|Overall Study|Withdrawal of Informed Consent|0|||
170383958|NCT00591786|615741469|FG007|Overall Study|Withdrawal of Informed Consent|0|||
170383959|NCT00591786|615741470|FG008|Overall Study|Withdrawal of Informed Consent|0|||
170383960|NCT00591786|615741471|FG009|Overall Study|Withdrawal of Informed Consent|0|||
170383961|NCT01920061|615741472|FG000|Overall Study|Death|1|||
170383962|NCT01920061|615741473|FG001|Overall Study|Death|1|||
170383963|NCT01920061|615741474|FG002|Overall Study|Death|0|||
170383964|NCT01920061|615741475|FG003|Overall Study|Death|1|||
170383965|NCT01920061|615741476|FG004|Overall Study|Death|1|||
170383966|NCT01920061|615741477|FG005|Overall Study|Death|0|||
170383967|NCT01920061|615741478|FG006|Overall Study|Death|0|||
170383968|NCT01920061|615741479|FG007|Overall Study|Death|1|||
170383969|NCT01920061|615741480|FG008|Overall Study|Death|0|||
170383970|NCT01920061|615741481|FG009|Overall Study|Death|1|||
170383971|NCT01920061|615741482|FG010|Overall Study|Death|0|||
170383972|NCT01920061|615741483|FG011|Overall Study|Death|1|||
170383973|NCT01920061|615741484|FG012|Overall Study|Death|0|||
170383974|NCT01920061|615741485|FG013|Overall Study|Death|2|||
170383975|NCT01920061|615741486|FG014|Overall Study|Death|0|||
170383976|NCT01920061|615741487|FG015|Overall Study|Death|0|||
170383977|NCT01920061|615741488|FG016|Overall Study|Death|0|||
170383978|NCT01920061|615741489|FG017|Overall Study|Death|0|||
170383979|NCT01920061|615741490|FG018|Overall Study|Death|1|||
170383980|NCT01920061|615741491|FG019|Overall Study|Death|0|||
170383981|NCT01920061|615741472|FG000|Overall Study|Lost to Follow-up|0|||
170383982|NCT01920061|615741473|FG001|Overall Study|Lost to Follow-up|2|||
170383983|NCT01920061|615741474|FG002|Overall Study|Lost to Follow-up|0|||
170383984|NCT01920061|615741475|FG003|Overall Study|Lost to Follow-up|0|||
170383985|NCT01920061|615741476|FG004|Overall Study|Lost to Follow-up|0|||
170383986|NCT01920061|615741477|FG005|Overall Study|Lost to Follow-up|0|||
170383987|NCT01920061|615741478|FG006|Overall Study|Lost to Follow-up|1|||
170383988|NCT01920061|615741479|FG007|Overall Study|Lost to Follow-up|0|||
170383989|NCT01920061|615741480|FG008|Overall Study|Lost to Follow-up|0|||
170383990|NCT01920061|615741481|FG009|Overall Study|Lost to Follow-up|0|||
170383991|NCT01920061|615741482|FG010|Overall Study|Lost to Follow-up|3|||
170383992|NCT01920061|615741483|FG011|Overall Study|Lost to Follow-up|0|||
170383993|NCT01920061|615741484|FG012|Overall Study|Lost to Follow-up|0|||
170383994|NCT01920061|615741485|FG013|Overall Study|Lost to Follow-up|0|||
170383995|NCT01920061|615741486|FG014|Overall Study|Lost to Follow-up|0|||
170383996|NCT01920061|615741487|FG015|Overall Study|Lost to Follow-up|0|||
170383997|NCT01920061|615741488|FG016|Overall Study|Lost to Follow-up|0|||
170383998|NCT01920061|615741489|FG017|Overall Study|Lost to Follow-up|1|||
170383999|NCT01920061|615741490|FG018|Overall Study|Lost to Follow-up|4|||
170384000|NCT01920061|615741491|FG019|Overall Study|Lost to Follow-up|3|||
170384001|NCT01920061|615741472|FG000|Overall Study|Other|1|||
170384002|NCT01920061|615741473|FG001|Overall Study|Other|1|||
170384003|NCT01920061|615741474|FG002|Overall Study|Other|2|||
170384004|NCT01920061|615741475|FG003|Overall Study|Other|1|||
170384005|NCT01920061|615741476|FG004|Overall Study|Other|0|||
170384006|NCT01920061|615741477|FG005|Overall Study|Other|1|||
170384007|NCT01920061|615741478|FG006|Overall Study|Other|0|||
170384008|NCT01920061|615741479|FG007|Overall Study|Other|0|||
170384009|NCT01920061|615741480|FG008|Overall Study|Other|0|||
170384010|NCT01920061|615741481|FG009|Overall Study|Other|1|||
170384011|NCT01920061|615741482|FG010|Overall Study|Other|1|||
170384012|NCT01920061|615741483|FG011|Overall Study|Other|2|||
170384013|NCT01920061|615741484|FG012|Overall Study|Other|1|||
170384014|NCT01920061|615741485|FG013|Overall Study|Other|4|||
170384015|NCT01920061|615741486|FG014|Overall Study|Other|0|||
170384016|NCT01920061|615741487|FG015|Overall Study|Other|1|||
170384017|NCT01920061|615741488|FG016|Overall Study|Other|1|||
170384018|NCT01920061|615741489|FG017|Overall Study|Other|0|||
170384019|NCT01920061|615741490|FG018|Overall Study|Other|1|||
170384020|NCT01920061|615741491|FG019|Overall Study|Other|1|||
170384021|NCT01920061|615741472|FG000|Overall Study|Participant refused further follow-up|0|||
170384022|NCT01920061|615741473|FG001|Overall Study|Participant refused further follow-up|0|||
170384023|NCT01920061|615741474|FG002|Overall Study|Participant refused further follow-up|0|||
170384024|NCT01920061|615741475|FG003|Overall Study|Participant refused further follow-up|0|||
170384025|NCT01920061|615741476|FG004|Overall Study|Participant refused further follow-up|1|||
170384026|NCT01920061|615741477|FG005|Overall Study|Participant refused further follow-up|1|||
170384027|NCT01920061|615741478|FG006|Overall Study|Participant refused further follow-up|0|||
170384028|NCT01920061|615741479|FG007|Overall Study|Participant refused further follow-up|0|||
170384029|NCT01920061|615741480|FG008|Overall Study|Participant refused further follow-up|1|||
170384030|NCT01920061|615741481|FG009|Overall Study|Participant refused further follow-up|0|||
170384031|NCT01920061|615741482|FG010|Overall Study|Participant refused further follow-up|1|||
170384032|NCT01920061|615741483|FG011|Overall Study|Participant refused further follow-up|0|||
170384033|NCT01920061|615741484|FG012|Overall Study|Participant refused further follow-up|1|||
170384034|NCT01920061|615741485|FG013|Overall Study|Participant refused further follow-up|0|||
170384035|NCT01920061|615741486|FG014|Overall Study|Participant refused further follow-up|1|||
170384036|NCT01920061|615741487|FG015|Overall Study|Participant refused further follow-up|2|||
170384037|NCT01920061|615741488|FG016|Overall Study|Participant refused further follow-up|1|||
170384038|NCT01920061|615741489|FG017|Overall Study|Participant refused further follow-up|1|||
170384039|NCT01920061|615741490|FG018|Overall Study|Participant refused further follow-up|0|||
170384040|NCT01920061|615741491|FG019|Overall Study|Participant refused further follow-up|0|||
170384041|NCT02828982|615741492|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
170384042|NCT02828982|615741493|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
170384043|NCT02312934|615741494|FG000|Overall Study|Lost to Follow-up|1|||
170384044|NCT02312934|615741495|FG001|Overall Study|Lost to Follow-up|0|||
170384045|NCT02312934|615741494|FG000|Overall Study|Physician Decision|1|||
170384046|NCT02312934|615741495|FG001|Overall Study|Physician Decision|0|||
170384047|NCT00337935|615744293|FG000|Overall Study|Adverse Event|2|||
170384048|NCT00337935|615744294|FG001|Overall Study|Adverse Event|5|||
170384049|NCT00337935|615744293|FG000|Overall Study|Death|2|||
170384050|NCT00337935|615744294|FG001|Overall Study|Death|8|||
170384051|NCT00337935|615744293|FG000|Overall Study|Physician Decision|1|||
170384052|NCT00337935|615744294|FG001|Overall Study|Physician Decision|1|||
170384053|NCT00337935|615744293|FG000|Overall Study|Lost to Follow-up|0|||
170384054|NCT00337935|615744294|FG001|Overall Study|Lost to Follow-up|1|||
170384055|NCT00337935|615744293|FG000|Overall Study|Protocol Violation|4|||
170384056|NCT00337935|615744294|FG001|Overall Study|Protocol Violation|3|||
170384057|NCT00337935|615744293|FG000|Overall Study|Withdrawal by Subject|1|||
170384058|NCT00337935|615744294|FG001|Overall Study|Withdrawal by Subject|7|||
170384059|NCT00337935|615744293|FG000|Overall Study|Other|0|||
170384060|NCT00337935|615744294|FG001|Overall Study|Other|1|||
170384061|NCT00337935|615744293|FG000|Overall Study|Lack of Efficacy|0|||
170384062|NCT00337935|615744294|FG001|Overall Study|Lack of Efficacy|1|||
170384063|NCT01884675|615744295|FG000|Overall Study|Study closed/terminated|3|||
170384064|NCT01884675|615744296|FG001|Overall Study|Study closed/terminated|2|||
170384065|NCT02361307|615744297|FG000|Overall Study|Unstable medical condition.|0|||
170384066|NCT02361307|615744298|FG001|Overall Study|Unstable medical condition.|1|||
170384067|NCT01189201|615744305|FG000|Overall Study|Adverse Event|1|||
170384068|NCT01277757|615744306|FG000|Overall Study|Disease Progression|1|||
170384069|NCT01277757|615744306|FG000|Overall Study|Withdrawal by Subject|1|||
170384070|NCT00240331|615744307|FG000|Overall Study|Withdrawal by Subject|125|||
170384071|NCT00240331|615744308|FG001|Overall Study|Withdrawal by Subject|132|||
170384072|NCT00240331|615744307|FG000|Overall Study|Option selected by investigator|1|||
170384073|NCT00240331|615744308|FG001|Overall Study|Option selected by investigator|2|||
170384074|NCT01409382|615744309|FG000|Overall Study|Lost to Follow-up|1|||
170384075|NCT01409382|615744310|FG001|Overall Study|Lost to Follow-up|1|||
170384076|NCT01409382|615744309|FG000|Overall Study|Protocol Violation|0|||
170384077|NCT01409382|615744310|FG001|Overall Study|Protocol Violation|3|||
170384078|NCT01409382|615744309|FG000|Overall Study|Multiple pregnancy|2|||
170384079|NCT01409382|615744310|FG001|Overall Study|Multiple pregnancy|4|||
170384080|NCT01409382|615744309|FG000|Overall Study|Still pregnant when study ended|13|||
170384081|NCT01409382|615744310|FG001|Overall Study|Still pregnant when study ended|2|||
170384082|NCT01409382|615744309|FG000|Overall Study|Did not manage to get pregnant|64|||
170384083|NCT01409382|615744310|FG001|Overall Study|Did not manage to get pregnant|70|||
170384084|NCT01409382|615744309|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
170384085|NCT01409382|615744310|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
170384086|NCT01425268|615744314|FG000|Overall Study|Withdrawal by Subject|2|||
170384087|NCT01425268|615744315|FG001|Overall Study|Withdrawal by Subject|0|||
170384088|NCT01425268|615744314|FG000|Overall Study|Sponsor Decision|5|||
170384089|NCT01425268|615744315|FG001|Overall Study|Sponsor Decision|0|||
170384090|NCT01425268|615744314|FG000|Overall Study|Physician Decision|1|||
170384091|NCT01425268|615744315|FG001|Overall Study|Physician Decision|0|||
170384092|NCT00719706|615744316|FG000|Overall Study|Adverse Event|5|||
170384093|NCT00719706|615744317|FG001|Overall Study|Adverse Event|4|||
170384094|NCT00719706|615744316|FG000|Overall Study|Withdrawal by Subject|1|||
170384095|NCT00719706|615744317|FG001|Overall Study|Withdrawal by Subject|2|||
170384096|NCT00719706|615744316|FG000|Overall Study|Protocol Violation|3|||
170384097|NCT00719706|615744317|FG001|Overall Study|Protocol Violation|0|||
170384098|NCT00508872|615744318|FG000|Overall Study|Lost to Follow-up|1|||
170384099|NCT00508872|615744318|FG000|Overall Study|Physician Decision|1|||
170384100|NCT02546193|615744319|FG000|Overall Study|Withdrawal by Subject|2|||
170384101|NCT02546193|615744320|FG001|Overall Study|Withdrawal by Subject|0|||
170384102|NCT02546193|615744321|FG002|Overall Study|Withdrawal by Subject|1|||
170384103|NCT02546193|615744322|FG003|Overall Study|Withdrawal by Subject|0|||
170384104|NCT02546193|615744319|FG000|Overall Study|Not eligible at time of induction|4|||
170384105|NCT02546193|615744320|FG001|Overall Study|Not eligible at time of induction|6|||
170384106|NCT02546193|615744321|FG002|Overall Study|Not eligible at time of induction|1|||
170384107|NCT02546193|615744322|FG003|Overall Study|Not eligible at time of induction|0|||
170384108|NCT01287403|615744326|FG000|1st Intervention (1 Day)|Adverse Event|1|||
170384109|NCT00438815|615744330|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
170384110|NCT00438815|615744330|FG000|Overall Study|3-month follow-up no longer required|12|||
170384111|NCT00438815|615744330|FG000|Overall Study|Noncompliance with protocol requirements|9|||
170384112|NCT00438815|615744330|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
170384113|NCT00438815|615744330|FG000|Overall Study|Lost to Follow-up|6|||
170384114|NCT00438815|615744330|FG000|Overall Study|Withdrawal by Subject|6|||
170384115|NCT00438815|615744330|FG000|Overall Study|Death|1|||
170384116|NCT01733758|615744331|FG000|Overall Study|Adverse Event|5|||
170384117|NCT01733758|615744332|FG001|Overall Study|Adverse Event|7|||
170384118|NCT01733758|615744333|FG002|Overall Study|Adverse Event|8|||
170384119|NCT01733758|615744334|FG003|Overall Study|Adverse Event|1|||
170384120|NCT01733758|615744331|FG000|Overall Study|Withdrawal by Subject|1|||
170384121|NCT01733758|615744332|FG001|Overall Study|Withdrawal by Subject|1|||
170384122|NCT01733758|615744333|FG002|Overall Study|Withdrawal by Subject|5|||
170384123|NCT01733758|615744334|FG003|Overall Study|Withdrawal by Subject|3|||
170384124|NCT01733758|615744331|FG000|Overall Study|Persistent Hyperglycemia|3|||
170384125|NCT01733758|615744332|FG001|Overall Study|Persistent Hyperglycemia|2|||
170384126|NCT01733758|615744333|FG002|Overall Study|Persistent Hyperglycemia|0|||
170384127|NCT01733758|615744334|FG003|Overall Study|Persistent Hyperglycemia|0|||
170384128|NCT01733758|615744331|FG000|Overall Study|Protocol Violation|0|||
170384129|NCT01733758|615744332|FG001|Overall Study|Protocol Violation|1|||
170384130|NCT01733758|615744333|FG002|Overall Study|Protocol Violation|2|||
170384131|NCT01733758|615744334|FG003|Overall Study|Protocol Violation|2|||
170384132|NCT01733758|615744331|FG000|Overall Study|Non-compliance|1|||
170384133|NCT01733758|615744332|FG001|Overall Study|Non-compliance|0|||
170384134|NCT01733758|615744333|FG002|Overall Study|Non-compliance|0|||
170384135|NCT01733758|615744334|FG003|Overall Study|Non-compliance|0|||
170384136|NCT01733758|615744331|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
170384137|NCT01733758|615744332|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
170384138|NCT01733758|615744333|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
170384139|NCT01733758|615744334|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
170384140|NCT01733758|615744331|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
170384141|NCT01733758|615744332|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
170384142|NCT01733758|615744333|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
170384143|NCT01733758|615744334|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
170384144|NCT02545270|615744335|FG000|Overall Study|technical difficulties|0|||
170384145|NCT02545270|615744336|FG001|Overall Study|technical difficulties|1|||
170384146|NCT02545270|615744337|FG002|Overall Study|technical difficulties|0|||
170384147|NCT02545270|615744335|FG000|Overall Study|Videos being too similar to other|0|||
170384148|NCT02545270|615744336|FG001|Overall Study|Videos being too similar to other|0|||
170384149|NCT02545270|615744337|FG002|Overall Study|Videos being too similar to other|2|||
170384150|NCT00727246|615744338|FG000|Overall Study|could not complete MRI|0|||
170384151|NCT00727246|615744339|FG001|Overall Study|could not complete MRI|1|||
170384152|NCT00727246|615744340|FG002|Overall Study|could not complete MRI|0|||
170384153|NCT00727246|615744341|FG003|Overall Study|could not complete MRI|1|||
170384154|NCT00727246|615744338|FG000|Overall Study|incidental finding|0|||
170384155|NCT00727246|615744339|FG001|Overall Study|incidental finding|0|||
170384156|NCT00727246|615744340|FG002|Overall Study|incidental finding|0|||
170384157|NCT00727246|615744341|FG003|Overall Study|incidental finding|1|||
170384158|NCT00727246|615744338|FG000|Overall Study|withdrawn|0|||
170384159|NCT00727246|615744339|FG001|Overall Study|withdrawn|0|||
170384160|NCT00727246|615744340|FG002|Overall Study|withdrawn|1|||
170384161|NCT00727246|615744341|FG003|Overall Study|withdrawn|0|||
170384162|NCT00661362|615744342|FG000|Overall Study|Adverse Event|5|||
170384163|NCT00661362|615744343|FG001|Overall Study|Adverse Event|4|||
170384164|NCT00661362|615744342|FG000|Overall Study|Incorrect enrollment|2|||
170384165|NCT00661362|615744343|FG001|Overall Study|Incorrect enrollment|0|||
170384166|NCT00661362|615744342|FG000|Overall Study|Study specific discontinuation criteria|4|||
170384167|NCT00661362|615744343|FG001|Overall Study|Study specific discontinuation criteria|11|||
170384168|NCT00661362|615744342|FG000|Overall Study|Withdrawal by Subject|13|||
170384169|NCT00661362|615744343|FG001|Overall Study|Withdrawal by Subject|23|||
170384170|NCT00661362|615744342|FG000|Overall Study|Lost to Follow-up|3|||
170384171|NCT00661362|615744343|FG001|Overall Study|Lost to Follow-up|1|||
170384172|NCT00661362|615744342|FG000|Overall Study|Severe non-compliance to protocol|0|||
170384173|NCT00661362|615744343|FG001|Overall Study|Severe non-compliance to protocol|1|||
170384174|NCT00661362|615744342|FG000|Overall Study|Safety reasons|1|||
170384175|NCT00661362|615744343|FG001|Overall Study|Safety reasons|0|||
170384176|NCT00661362|615744342|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
170384177|NCT00661362|615744343|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
170384178|NCT03672006|615744346|FG000|Overall Study|exclusion criteria met|0|||
170384179|NCT03672006|615744347|FG001|Overall Study|exclusion criteria met|1|||
170384180|NCT03288987|615744348|FG000|Overall Study|Protocol Violation|10|||
170384181|NCT03288987|615744349|FG001|Overall Study|Protocol Violation|4|||
170384182|NCT00761891|615744350|FG000|Overall Study|Withdrawal by Subject|10|||
170384183|NCT01654666|615744351|FG000|Overall Study|Protocol Violation|7|||
170384184|NCT01654666|615744352|FG001|Overall Study|Protocol Violation|4|||
170384185|NCT01654666|615744353|FG002|Overall Study|Protocol Violation|8|||
170384186|NCT01654666|615744351|FG000|Overall Study|Lost to Follow-up|4|||
170384187|NCT01654666|615744352|FG001|Overall Study|Lost to Follow-up|5|||
170384188|NCT01654666|615744353|FG002|Overall Study|Lost to Follow-up|5|||
170384189|NCT01654666|615744351|FG000|Overall Study|Withdrawal by Subject|4|||
170384190|NCT01654666|615744352|FG001|Overall Study|Withdrawal by Subject|4|||
170384191|NCT01654666|615744353|FG002|Overall Study|Withdrawal by Subject|1|||
170384192|NCT00368069|615744355|FG000|Overall Study|Adverse Event|5|||
170384193|NCT00368069|615744356|FG001|Overall Study|Adverse Event|2|||
170384194|NCT00368069|615744355|FG000|Overall Study|Lack of Efficacy|0|||
170384195|NCT00368069|615744356|FG001|Overall Study|Lack of Efficacy|1|||
170384196|NCT00368069|615744355|FG000|Overall Study|Lost to Follow-up|1|||
170384197|NCT00368069|615744356|FG001|Overall Study|Lost to Follow-up|0|||
170384198|NCT00368069|615744355|FG000|Overall Study|Protocol Violation|0|||
170384199|NCT00368069|615744356|FG001|Overall Study|Protocol Violation|2|||
170384200|NCT00368069|615744355|FG000|Overall Study|Withdrawal of Consent|2|||
170384201|NCT00368069|615744356|FG001|Overall Study|Withdrawal of Consent|1|||
170384202|NCT00368069|615744355|FG000|Overall Study|no blood sampling possible|0|||
170384203|NCT00368069|615744356|FG001|Overall Study|no blood sampling possible|1|||
170384204|NCT03432819|615744357|FG000|Overall Study|Lost to Follow-up|2|||
170384205|NCT03432819|615744358|FG001|Overall Study|Lost to Follow-up|2|||
170384206|NCT03432819|615744357|FG000|Overall Study|Withdrawal by Subject|5|||
170384207|NCT03432819|615744358|FG001|Overall Study|Withdrawal by Subject|3|||
170384208|NCT00672490|615744361|FG000|Overall Study|Withdrawal by Subject|8|||
170384209|NCT00672490|615744362|FG001|Overall Study|Withdrawal by Subject|8|||
170384210|NCT00672490|615744361|FG000|Overall Study|Lack of Compliance|2|||
170384211|NCT00672490|615744362|FG001|Overall Study|Lack of Compliance|7|||
170384212|NCT00672490|615744361|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
170384213|NCT00672490|615744362|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
170384214|NCT00672490|615744361|FG000|Overall Study|Adverse Event|5|||
170384215|NCT00672490|615744362|FG001|Overall Study|Adverse Event|8|||
170384216|NCT00672490|615744361|FG000|Overall Study|Violation of Concomitant Medicine|1|||
170384217|NCT00672490|615744362|FG001|Overall Study|Violation of Concomitant Medicine|0|||
170384218|NCT00672490|615744361|FG000|Overall Study|Intolerance|0|||
170384219|NCT00672490|615744362|FG001|Overall Study|Intolerance|2|||
170384220|NCT00672490|615744361|FG000|Overall Study|Lost to Follow-up|1|||
170384221|NCT00672490|615744362|FG001|Overall Study|Lost to Follow-up|5|||
170384222|NCT00672490|615744361|FG000|Overall Study|No reason was provided|6|||
170384223|NCT00672490|615744362|FG001|Overall Study|No reason was provided|2|||
170384224|NCT02030067|615744363|FG000|Overall Study|Disease Progression|1|||
170384225|NCT02030067|615744364|FG001|Overall Study|Disease Progression|1|||
170384226|NCT02030067|615744365|FG002|Overall Study|Disease Progression|2|||
170384227|NCT02030067|615744366|FG003|Overall Study|Disease Progression|2|||
170384228|NCT02030067|615744367|FG004|Overall Study|Disease Progression|3|||
170384229|NCT02030067|615744368|FG005|Overall Study|Disease Progression|2|||
170384230|NCT02030067|615744369|FG006|Overall Study|Disease Progression|3|||
170384231|NCT02030067|615744370|FG007|Overall Study|Disease Progression|3|||
170384232|NCT02030067|615744371|FG008|Overall Study|Disease Progression|4|||
170384233|NCT02030067|615744372|FG009|Overall Study|Disease Progression|3|||
170384234|NCT02030067|615744373|FG010|Overall Study|Disease Progression|7|||
170384235|NCT02030067|615744374|FG011|Overall Study|Disease Progression|2|||
170384236|NCT02030067|615744375|FG012|Overall Study|Disease Progression|59|||
170384237|NCT02030067|615744363|FG000|Overall Study|Withdrawal by Subject|0|||
170384238|NCT02030067|615744364|FG001|Overall Study|Withdrawal by Subject|0|||
170384239|NCT02030067|615744365|FG002|Overall Study|Withdrawal by Subject|0|||
170384240|NCT02030067|615744366|FG003|Overall Study|Withdrawal by Subject|1|||
170384241|NCT02030067|615744367|FG004|Overall Study|Withdrawal by Subject|0|||
170384242|NCT02030067|615744368|FG005|Overall Study|Withdrawal by Subject|0|||
170384243|NCT02030067|615744369|FG006|Overall Study|Withdrawal by Subject|0|||
170384244|NCT02030067|615744370|FG007|Overall Study|Withdrawal by Subject|1|||
170384245|NCT02030067|615744371|FG008|Overall Study|Withdrawal by Subject|0|||
170384246|NCT02030067|615744372|FG009|Overall Study|Withdrawal by Subject|0|||
170384247|NCT02030067|615744373|FG010|Overall Study|Withdrawal by Subject|3|||
170384248|NCT02030067|615744374|FG011|Overall Study|Withdrawal by Subject|0|||
170384249|NCT02030067|615744375|FG012|Overall Study|Withdrawal by Subject|6|||
170384250|NCT02030067|615744363|FG000|Overall Study|Physician Decision|0|||
170384251|NCT02030067|615744364|FG001|Overall Study|Physician Decision|0|||
170384252|NCT02030067|615744365|FG002|Overall Study|Physician Decision|0|||
170384253|NCT02030067|615744366|FG003|Overall Study|Physician Decision|0|||
170384254|NCT02030067|615744367|FG004|Overall Study|Physician Decision|0|||
170384255|NCT02030067|615744368|FG005|Overall Study|Physician Decision|0|||
170384256|NCT02030067|615744369|FG006|Overall Study|Physician Decision|0|||
170384257|NCT02030067|615744370|FG007|Overall Study|Physician Decision|0|||
170384258|NCT02030067|615744371|FG008|Overall Study|Physician Decision|0|||
170384259|NCT02030067|615744372|FG009|Overall Study|Physician Decision|0|||
170384260|NCT02030067|615744373|FG010|Overall Study|Physician Decision|1|||
170384261|NCT02030067|615744374|FG011|Overall Study|Physician Decision|0|||
170384262|NCT02030067|615744375|FG012|Overall Study|Physician Decision|3|||
170384263|NCT02030067|615744363|FG000|Overall Study|other reasons|0|||
170384264|NCT02030067|615744364|FG001|Overall Study|other reasons|0|||
170384265|NCT02030067|615744365|FG002|Overall Study|other reasons|0|||
170384266|NCT02030067|615744366|FG003|Overall Study|other reasons|0|||
170384267|NCT02030067|615744367|FG004|Overall Study|other reasons|0|||
170384268|NCT02030067|615744368|FG005|Overall Study|other reasons|1|||
170384269|NCT02030067|615744369|FG006|Overall Study|other reasons|0|||
170384270|NCT02030067|615744370|FG007|Overall Study|other reasons|0|||
170384271|NCT02030067|615744371|FG008|Overall Study|other reasons|2|||
170384272|NCT02030067|615744372|FG009|Overall Study|other reasons|0|||
170384273|NCT02030067|615744373|FG010|Overall Study|other reasons|0|||
170384274|NCT02030067|615744374|FG011|Overall Study|other reasons|0|||
170384275|NCT02030067|615744375|FG012|Overall Study|other reasons|4|||
170384276|NCT02030067|615744363|FG000|Overall Study|Adverse Event|0|||
170384277|NCT02030067|615744364|FG001|Overall Study|Adverse Event|0|||
170384278|NCT02030067|615744365|FG002|Overall Study|Adverse Event|0|||
170384279|NCT02030067|615744366|FG003|Overall Study|Adverse Event|0|||
170384280|NCT02030067|615744367|FG004|Overall Study|Adverse Event|0|||
170384281|NCT02030067|615744368|FG005|Overall Study|Adverse Event|0|||
170384282|NCT02030067|615744369|FG006|Overall Study|Adverse Event|0|||
170384283|NCT02030067|615744370|FG007|Overall Study|Adverse Event|0|||
170384284|NCT02030067|615744371|FG008|Overall Study|Adverse Event|0|||
170384285|NCT02030067|615744372|FG009|Overall Study|Adverse Event|0|||
170384286|NCT02030067|615744373|FG010|Overall Study|Adverse Event|0|||
170384287|NCT02030067|615744374|FG011|Overall Study|Adverse Event|1|||
170384288|NCT02030067|615744375|FG012|Overall Study|Adverse Event|8|||
170384289|NCT00265382|615744376|FG000|Overall Study|Adverse Event|21|||
170384290|NCT00265382|615744376|FG000|Overall Study|Laboratory Abnormality|1|||
170384291|NCT00265382|615744376|FG000|Overall Study|Lost to Follow-up|3|||
170384292|NCT00265382|615744376|FG000|Overall Study|Lack of Efficacy|6|||
170384293|NCT00265382|615744376|FG000|Overall Study|Miscellaneous|6|||
170384294|NCT00265382|615744376|FG000|Overall Study|Withdrawal by Subject|13|||
170384295|NCT00265382|615744376|FG000|Overall Study|Study terminated by sponsor|94|||
170384296|NCT00265382|615744376|FG000|Overall Study|Death|1|||
170384297|NCT01474993|615744377|FG000|Overall Study|Lost to Follow-up|1|||
170384298|NCT01474993|615744378|FG001|Overall Study|Lost to Follow-up|2|||
170384299|NCT01474993|615744377|FG000|Overall Study|Adverse Event|0|||
170384300|NCT01474993|615744378|FG001|Overall Study|Adverse Event|1|||
170384301|NCT00760994|615744379|FG000|Overall Study|Lost to Follow-up|4|||
170384302|NCT00760994|615744380|FG001|Overall Study|Lost to Follow-up|4|||
170384303|NCT00760994|615744381|FG002|Overall Study|Lost to Follow-up|3|||
170384304|NCT03258710|615744382|FG000|Overall Study|Adverse Event|1|||
170384305|NCT03258710|615744382|FG000|Overall Study|Protocol-defined stopping criteria|1|||
170384306|NCT03258710|615744382|FG000|Overall Study|Physician Decision|1|||
170384307|NCT02242305|615744383|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
170384308|NCT02242305|615744384|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
170384309|NCT02242305|615744383|FG000|Overall Study|Adverse Event|1|||
170384310|NCT02242305|615744384|FG001|Overall Study|Adverse Event|0|||
170384311|NCT02242305|615744383|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
170384312|NCT02242305|615744384|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
170384313|NCT02242305|615744383|FG000|Overall Study|Subject withdraws inform consent|0|||
170384314|NCT02242305|615744384|FG001|Overall Study|Subject withdraws inform consent|4|||
170384315|NCT02242305|615744383|FG000|Overall Study|Lost to Follow-up|2|||
170384316|NCT02242305|615744384|FG001|Overall Study|Lost to Follow-up|0|||
170384317|NCT03451630|615744385|FG000|Overall Study|Death|15|||
170384318|NCT03451630|615744386|FG001|Overall Study|Death|16|||
170384319|NCT03451630|615744387|FG002|Overall Study|Death|11|||
170384320|NCT03451630|615744385|FG000|Overall Study|Lost to Follow-up|9|||
170384321|NCT03451630|615744386|FG001|Overall Study|Lost to Follow-up|0|||
170384322|NCT03451630|615744387|FG002|Overall Study|Lost to Follow-up|4|||
170384323|NCT03451630|615744385|FG000|Overall Study|Withdrawal by Subject|0|||
170384324|NCT03451630|615744386|FG001|Overall Study|Withdrawal by Subject|3|||
170384325|NCT03451630|615744387|FG002|Overall Study|Withdrawal by Subject|0|||
170384326|NCT03451630|615744385|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
170384327|NCT03451630|615744386|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
170384328|NCT03451630|615744387|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
170384329|NCT03018028|615744388|FG000|Overall Study|Withdrawal by Subject|3|||
170384330|NCT03018028|615744389|FG001|Overall Study|Withdrawal by Subject|0|||
170384331|NCT03018028|615744390|FG002|Overall Study|Withdrawal by Subject|1|||
170384332|NCT03018028|615744391|FG003|Overall Study|Withdrawal by Subject|2|||
170384333|NCT03018028|615744392|FG004|Overall Study|Withdrawal by Subject|0|||
170384334|NCT02543801|615744393|FG000|Overall Study|Protocol Violation|1|||
170384335|NCT02543801|615744394|FG001|Overall Study|Protocol Violation|2|||
170384336|NCT02543801|615744395|FG002|Overall Study|Protocol Violation|0|||
170384337|NCT02543801|615744396|FG003|Overall Study|Protocol Violation|0|||
170384338|NCT02041533|615744398|FG000|Pre-Treatment Period|Disease Progression|1|||
170384339|NCT02041533|615744399|FG001|Pre-Treatment Period|Disease Progression|1|||
170384340|NCT02041533|615744398|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
170384341|NCT02041533|615744399|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
170384342|NCT02041533|615744398|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
170384343|NCT02041533|615744399|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
170384344|NCT02041533|615744398|FG000|Treatment Period|Disease progression|189|||
170384345|NCT02041533|615744399|FG001|Treatment Period|Disease progression|146|||
170384346|NCT02041533|615744398|FG000|Treatment Period|Study drug toxicity|30|||
170384347|NCT02041533|615744399|FG001|Treatment Period|Study drug toxicity|34|||
170384348|NCT02041533|615744398|FG000|Treatment Period|Death|1|||
170384349|NCT02041533|615744399|FG001|Treatment Period|Death|0|||
170384350|NCT02041533|615744398|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
170384351|NCT02041533|615744399|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
170384352|NCT02041533|615744398|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
170384353|NCT02041533|615744399|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
170384354|NCT02041533|615744398|FG000|Treatment Period|Participant withdrew consent|2|||
170384355|NCT02041533|615744399|FG001|Treatment Period|Participant withdrew consent|2|||
170384356|NCT02041533|615744398|FG000|Treatment Period|Maximum clinical benefit|0|||
170384357|NCT02041533|615744399|FG001|Treatment Period|Maximum clinical benefit|18|||
170384358|NCT02041533|615744398|FG000|Treatment Period|Poor/Non-compliance|1|||
170384359|NCT02041533|615744399|FG001|Treatment Period|Poor/Non-compliance|0|||
170384360|NCT02041533|615744398|FG000|Treatment Period|Administrative reason by sponsor|1|||
170384361|NCT02041533|615744399|FG001|Treatment Period|Administrative reason by sponsor|0|||
170384362|NCT02041533|615744398|FG000|Treatment Period|Other reasons|9|||
170384363|NCT02041533|615744399|FG001|Treatment Period|Other reasons|2|||
170384364|NCT02041533|615744398|FG000|Treatment Period|Not Reported|0|||
170384365|NCT02041533|615744399|FG001|Treatment Period|Not Reported|1|||
170384366|NCT00545740|615744400|FG000|Overall Study|Lack of Efficacy|34|||
170384367|NCT00545740|615744401|FG001|Overall Study|Lack of Efficacy|35|||
170384368|NCT00545740|615744402|FG002|Overall Study|Lack of Efficacy|47|||
170384369|NCT00545740|615744403|FG003|Overall Study|Lack of Efficacy|36|||
170384370|NCT00545740|615744400|FG000|Overall Study|Withdrawal by Subject|17|||
170384371|NCT00545740|615744401|FG001|Overall Study|Withdrawal by Subject|15|||
170384372|NCT00545740|615744402|FG002|Overall Study|Withdrawal by Subject|16|||
170384373|NCT00545740|615744403|FG003|Overall Study|Withdrawal by Subject|18|||
170384374|NCT00545740|615744400|FG000|Overall Study|Adverse Event|10|||
170384375|NCT00545740|615744401|FG001|Overall Study|Adverse Event|18|||
170384376|NCT00545740|615744402|FG002|Overall Study|Adverse Event|19|||
170384377|NCT00545740|615744403|FG003|Overall Study|Adverse Event|9|||
170384378|NCT00545740|615744400|FG000|Overall Study|Lost to Follow-up|7|||
170384379|NCT00545740|615744401|FG001|Overall Study|Lost to Follow-up|5|||
170384380|NCT00545740|615744402|FG002|Overall Study|Lost to Follow-up|5|||
170384381|NCT00545740|615744403|FG003|Overall Study|Lost to Follow-up|6|||
170384382|NCT00545740|615744400|FG000|Overall Study|Protocol Violation|1|||
170384383|NCT00545740|615744401|FG001|Overall Study|Protocol Violation|3|||
170384384|NCT00545740|615744402|FG002|Overall Study|Protocol Violation|1|||
170384385|NCT00545740|615744403|FG003|Overall Study|Protocol Violation|0|||
170384386|NCT00545740|615744400|FG000|Overall Study|Non-compliance|0|||
170384387|NCT00545740|615744401|FG001|Overall Study|Non-compliance|2|||
170384388|NCT00545740|615744402|FG002|Overall Study|Non-compliance|1|||
170384389|NCT00545740|615744403|FG003|Overall Study|Non-compliance|0|||
170384390|NCT00545740|615744400|FG000|Overall Study|Moved|2|||
170384391|NCT00545740|615744401|FG001|Overall Study|Moved|0|||
170384392|NCT00545740|615744402|FG002|Overall Study|Moved|1|||
170384393|NCT00545740|615744403|FG003|Overall Study|Moved|0|||
170384394|NCT00545740|615744400|FG000|Overall Study|Diverticulitis attack|0|||
170384395|NCT00545740|615744401|FG001|Overall Study|Diverticulitis attack|0|||
170384396|NCT00545740|615744402|FG002|Overall Study|Diverticulitis attack|1|||
170384397|NCT00545740|615744403|FG003|Overall Study|Diverticulitis attack|1|||
170384398|NCT00545740|615744400|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
170384399|NCT00545740|615744401|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
170384400|NCT00545740|615744402|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
170384401|NCT00545740|615744403|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
170384402|NCT00545740|615744400|FG000|Overall Study|Site closure|1|||
170384403|NCT00545740|615744401|FG001|Overall Study|Site closure|0|||
170384404|NCT00545740|615744402|FG002|Overall Study|Site closure|0|||
170384405|NCT00545740|615744403|FG003|Overall Study|Site closure|0|||
170384406|NCT00545740|615744400|FG000|Overall Study|Missed visit|1|||
170384407|NCT00545740|615744401|FG001|Overall Study|Missed visit|0|||
170384408|NCT00545740|615744402|FG002|Overall Study|Missed visit|0|||
170384409|NCT00545740|615744403|FG003|Overall Study|Missed visit|0|||
170384410|NCT00545740|615744400|FG000|Overall Study|Physician Decision|0|||
170384411|NCT00545740|615744401|FG001|Overall Study|Physician Decision|0|||
170384412|NCT00545740|615744402|FG002|Overall Study|Physician Decision|3|||
170384413|NCT00545740|615744403|FG003|Overall Study|Physician Decision|0|||
170384414|NCT00545740|615744400|FG000|Overall Study|Accepted only monthly telephone calls|1|||
170384415|NCT00545740|615744401|FG001|Overall Study|Accepted only monthly telephone calls|0|||
170384416|NCT00545740|615744402|FG002|Overall Study|Accepted only monthly telephone calls|0|||
170384417|NCT00545740|615744403|FG003|Overall Study|Accepted only monthly telephone calls|0|||
170384418|NCT00545740|615744400|FG000|Overall Study|Sponsor decision|0|||
170384419|NCT00545740|615744401|FG001|Overall Study|Sponsor decision|1|||
170384420|NCT00545740|615744402|FG002|Overall Study|Sponsor decision|0|||
170384421|NCT00545740|615744403|FG003|Overall Study|Sponsor decision|0|||
170384422|NCT00545740|615744400|FG000|Overall Study|Lack of time|0|||
170384423|NCT00545740|615744401|FG001|Overall Study|Lack of time|1|||
170384424|NCT00545740|615744402|FG002|Overall Study|Lack of time|0|||
170384425|NCT00545740|615744403|FG003|Overall Study|Lack of time|0|||
170384426|NCT00545740|615744400|FG000|Overall Study|Non-adherence to visits|0|||
170384427|NCT00545740|615744401|FG001|Overall Study|Non-adherence to visits|1|||
170384428|NCT00545740|615744402|FG002|Overall Study|Non-adherence to visits|0|||
170384429|NCT00545740|615744403|FG003|Overall Study|Non-adherence to visits|0|||
170384430|NCT00545740|615744400|FG000|Overall Study|Patient difficulties|0|||
170384431|NCT00545740|615744401|FG001|Overall Study|Patient difficulties|1|||
170384432|NCT00545740|615744402|FG002|Overall Study|Patient difficulties|0|||
170384433|NCT00545740|615744403|FG003|Overall Study|Patient difficulties|0|||
170384434|NCT00545740|615744400|FG000|Overall Study|Husband against study|0|||
170384435|NCT00545740|615744401|FG001|Overall Study|Husband against study|0|||
170384436|NCT00545740|615744402|FG002|Overall Study|Husband against study|1|||
170384437|NCT00545740|615744403|FG003|Overall Study|Husband against study|0|||
170384438|NCT02117024|615744404|FG000|Overall Study|Progressive Disease|26|||
170384439|NCT02117024|615744405|FG001|Overall Study|Progressive Disease|9|||
170384440|NCT02117024|615744404|FG000|Overall Study|Significant Clinical Progression|7|||
170384441|NCT02117024|615744405|FG001|Overall Study|Significant Clinical Progression|4|||
170384442|NCT02117024|615744404|FG000|Overall Study|Death|5|||
170384443|NCT02117024|615744405|FG001|Overall Study|Death|0|||
170384444|NCT02117024|615744404|FG000|Overall Study|Withdrawal by Subject|3|||
170384445|NCT02117024|615744405|FG001|Overall Study|Withdrawal by Subject|1|||
170384446|NCT02117024|615744404|FG000|Overall Study|Protocol Violation|1|||
170384447|NCT02117024|615744405|FG001|Overall Study|Protocol Violation|0|||
170384448|NCT02117024|615744404|FG000|Overall Study|Adverse Event|1|||
170384449|NCT02117024|615744405|FG001|Overall Study|Adverse Event|2|||
170384450|NCT02117024|615744404|FG000|Overall Study|Randomized in Error|1|||
170384451|NCT02117024|615744405|FG001|Overall Study|Randomized in Error|0|||
170384452|NCT02117024|615744404|FG000|Overall Study|Patient returned to primary oncologist|0|||
170384453|NCT02117024|615744405|FG001|Overall Study|Patient returned to primary oncologist|1|||
170384454|NCT02117024|615744404|FG000|Overall Study|Patient took treatment break|0|||
170384455|NCT02117024|615744405|FG001|Overall Study|Patient took treatment break|1|||
170384456|NCT02117024|615744404|FG000|Overall Study|Physician Decision|0|||
170384457|NCT02117024|615744405|FG001|Overall Study|Physician Decision|2|||
170384458|NCT02500706|615744408|FG000|Overall Study|Adverse Event|0|||
170384459|NCT02500706|615744409|FG001|Overall Study|Adverse Event|0|||
170384460|NCT02500706|615744410|FG002|Overall Study|Adverse Event|1|||
170384461|NCT02500706|615744408|FG000|Overall Study|Lost to Follow-up|0|||
170384462|NCT02500706|615744409|FG001|Overall Study|Lost to Follow-up|1|||
170384463|NCT02500706|615744410|FG002|Overall Study|Lost to Follow-up|1|||
170384464|NCT02500706|615744408|FG000|Overall Study|Withdrawal by Subject|4|||
170384465|NCT02500706|615744409|FG001|Overall Study|Withdrawal by Subject|6|||
170384466|NCT02500706|615744410|FG002|Overall Study|Withdrawal by Subject|4|||
170384467|NCT02500706|615744408|FG000|Overall Study|Unclassified|0|||
170384468|NCT02500706|615744409|FG001|Overall Study|Unclassified|0|||
170384469|NCT02500706|615744410|FG002|Overall Study|Unclassified|1|||
170384470|NCT01957111|615744416|FG000|Overall Study|Withdrawal by Subject|1|||
170384471|NCT01957111|615744417|FG001|Overall Study|Withdrawal by Subject|1|||
170384472|NCT03961529|615744418|FG000|Overall Study|Adverse Event|13|||
170384473|NCT03961529|615744419|FG001|Overall Study|Adverse Event|5|||
170384474|NCT03961529|615744420|FG002|Overall Study|Adverse Event|2|||
170384475|NCT03961529|615744418|FG000|Overall Study|Withdrawal by Subject|17|||
170384476|NCT03961529|615744419|FG001|Overall Study|Withdrawal by Subject|2|||
170384477|NCT03961529|615744420|FG002|Overall Study|Withdrawal by Subject|1|||
170384478|NCT03961529|615744418|FG000|Overall Study|Withdrawal by parent/guardian|0|||
170384479|NCT03961529|615744419|FG001|Overall Study|Withdrawal by parent/guardian|7|||
170384480|NCT03961529|615744420|FG002|Overall Study|Withdrawal by parent/guardian|0|||
170384481|NCT03961529|615744418|FG000|Overall Study|Physician Decision|2|||
170384482|NCT03961529|615744419|FG001|Overall Study|Physician Decision|1|||
170384483|NCT03961529|615744420|FG002|Overall Study|Physician Decision|1|||
170384484|NCT03961529|615744418|FG000|Overall Study|Lost to Follow-up|2|||
170384485|NCT03961529|615744419|FG001|Overall Study|Lost to Follow-up|1|||
170384486|NCT03961529|615744420|FG002|Overall Study|Lost to Follow-up|0|||
170384487|NCT03961529|615744418|FG000|Overall Study|Lack of Efficacy|2|||
170384488|NCT03961529|615744419|FG001|Overall Study|Lack of Efficacy|0|||
170384489|NCT03961529|615744420|FG002|Overall Study|Lack of Efficacy|1|||
170384490|NCT03961529|615744418|FG000|Overall Study|Other|6|||
170384491|NCT03961529|615744419|FG001|Overall Study|Other|1|||
170384492|NCT03961529|615744420|FG002|Overall Study|Other|0|||
170384493|NCT03644173|615744421|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
170384494|NCT03644173|615744421|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
170384495|NCT03644173|615744421|FG000|Participants at the 1-month Follow up|Death|2|||
170384496|NCT03644173|615744421|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
170384497|NCT03500419|615744422|FG000|Overall Study|Withdrawal by Subject|2|||
170384498|NCT03500419|615744423|FG001|Overall Study|Withdrawal by Subject|25|||
170384499|NCT01497899|615744424|FG000|Double-Blind Phase|Randomized but not Treated|1|||
170384500|NCT01497899|615744425|FG001|Double-Blind Phase|Randomized but not Treated|0|||
170384501|NCT01497899|615744426|FG002|Double-Blind Phase|Randomized but not Treated|0|||
170384502|NCT01497899|615744427|FG003|Double-Blind Phase|Randomized but not Treated|0|||
170384503|NCT01497899|615744424|FG000|Double-Blind Phase|Adverse Event|1|||
170384504|NCT01497899|615744425|FG001|Double-Blind Phase|Adverse Event|0|||
170384505|NCT01497899|615744426|FG002|Double-Blind Phase|Adverse Event|0|||
170384506|NCT01497899|615744427|FG003|Double-Blind Phase|Adverse Event|0|||
170384507|NCT01497899|615744424|FG000|Double-Blind Phase|Lack of Efficacy|0|||
170384508|NCT01497899|615744425|FG001|Double-Blind Phase|Lack of Efficacy|1|||
170384509|NCT01497899|615744426|FG002|Double-Blind Phase|Lack of Efficacy|0|||
170384510|NCT01497899|615744427|FG003|Double-Blind Phase|Lack of Efficacy|0|||
170384511|NCT01497899|615744424|FG000|Double-Blind Phase|Investigator's Discretion|1|||
170384512|NCT01497899|615744425|FG001|Double-Blind Phase|Investigator's Discretion|0|||
170384513|NCT01497899|615744426|FG002|Double-Blind Phase|Investigator's Discretion|0|||
170398857|NCT05004181|615798321|FG009|Overall Study|Lost to Follow-up|6|||
170384514|NCT01497899|615744427|FG003|Double-Blind Phase|Investigator's Discretion|0|||
170384515|NCT01497899|615744424|FG000|Double-Blind Phase|Withdrew Consent|0|||
170384516|NCT01497899|615744425|FG001|Double-Blind Phase|Withdrew Consent|1|||
170384517|NCT01497899|615744426|FG002|Double-Blind Phase|Withdrew Consent|0|||
170384518|NCT01497899|615744427|FG003|Double-Blind Phase|Withdrew Consent|0|||
170384519|NCT01497899|615744424|FG000|Double-Blind Phase|Lost to Follow-up|3|||
170384520|NCT01497899|615744425|FG001|Double-Blind Phase|Lost to Follow-up|2|||
170384521|NCT01497899|615744426|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170384522|NCT01497899|615744427|FG003|Double-Blind Phase|Lost to Follow-up|0|||
170384523|NCT01497899|615744424|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
170384524|NCT01497899|615744425|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
170384525|NCT01497899|615744426|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
170384526|NCT01497899|615744427|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
170384527|NCT01497899|615744424|FG000|Open-Label Extension Phase|Adverse Event|1|||
170384528|NCT01497899|615744425|FG001|Open-Label Extension Phase|Adverse Event|0|||
170384529|NCT01497899|615744426|FG002|Open-Label Extension Phase|Adverse Event|0|||
170384530|NCT01497899|615744427|FG003|Open-Label Extension Phase|Adverse Event|0|||
170384531|NCT01497899|615744424|FG000|Open-Label Extension Phase|Death|1|||
170384532|NCT01497899|615744425|FG001|Open-Label Extension Phase|Death|0|||
170384533|NCT01497899|615744426|FG002|Open-Label Extension Phase|Death|0|||
170384534|NCT01497899|615744427|FG003|Open-Label Extension Phase|Death|0|||
170384535|NCT01497899|615744424|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
170384536|NCT01497899|615744425|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
170384537|NCT01497899|615744426|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
170384538|NCT01497899|615744427|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
170384539|NCT01497899|615744424|FG000|Open-Label Extension Phase|Pregnancy|0|||
170384540|NCT01497899|615744425|FG001|Open-Label Extension Phase|Pregnancy|1|||
170384541|NCT01497899|615744426|FG002|Open-Label Extension Phase|Pregnancy|1|||
170384542|NCT01497899|615744427|FG003|Open-Label Extension Phase|Pregnancy|0|||
170384543|NCT01497899|615744424|FG000|Open-Label Extension Phase|Protocol Violation|0|||
170384544|NCT01497899|615744425|FG001|Open-Label Extension Phase|Protocol Violation|0|||
170384545|NCT01497899|615744426|FG002|Open-Label Extension Phase|Protocol Violation|1|||
170384546|NCT01497899|615744427|FG003|Open-Label Extension Phase|Protocol Violation|0|||
170384547|NCT01497899|615744424|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
170384548|NCT01497899|615744425|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
170384549|NCT01497899|615744426|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
170384550|NCT01497899|615744427|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
170384551|NCT00082628|615744428|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
170384552|NCT00082628|615744429|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
170384553|NCT00082628|615744430|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
170384554|NCT00082628|615744431|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
170384555|NCT00082628|615744432|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
170384556|NCT00082628|615744428|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
170384557|NCT00082628|615744429|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
170384558|NCT00082628|615744430|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
170384559|NCT00082628|615744431|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
170384560|NCT00082628|615744432|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
170384561|NCT00082628|615744428|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
170384562|NCT00082628|615744429|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
170384563|NCT00082628|615744430|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
170384564|NCT00082628|615744431|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
170384565|NCT00082628|615744432|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
170384566|NCT00082628|615744428|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
170384567|NCT00082628|615744429|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
170384568|NCT00082628|615744430|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
170384569|NCT00082628|615744431|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
170384570|NCT00082628|615744432|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
170384571|NCT00082628|615744428|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
170384572|NCT00082628|615744429|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
170384573|NCT00082628|615744430|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
170384574|NCT00082628|615744431|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
170384575|NCT00082628|615744432|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
170384576|NCT00082628|615744428|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
170384577|NCT00082628|615744429|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
170384578|NCT00082628|615744430|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
170384579|NCT00082628|615744431|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
170384580|NCT00082628|615744432|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
170384581|NCT00082628|615744428|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
170384582|NCT00082628|615744429|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
170384583|NCT00082628|615744430|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
170384584|NCT00082628|615744431|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
170384585|NCT00082628|615744432|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
170384586|NCT03481634|615744433|FG000|Overall Study|Withdrawal by Subject|16|||
170384587|NCT03481634|615744434|FG001|Overall Study|Withdrawal by Subject|19|||
170384588|NCT03481634|615744435|FG002|Overall Study|Withdrawal by Subject|14|||
170384589|NCT03481634|615744433|FG000|Overall Study|Protocol Violation|1|||
170384590|NCT03481634|615744434|FG001|Overall Study|Protocol Violation|0|||
170384591|NCT03481634|615744435|FG002|Overall Study|Protocol Violation|1|||
170384592|NCT03481634|615744433|FG000|Overall Study|Progressive disease|0|||
170384593|NCT03481634|615744434|FG001|Overall Study|Progressive disease|1|||
170384594|NCT03481634|615744435|FG002|Overall Study|Progressive disease|0|||
170384595|NCT03481634|615744433|FG000|Overall Study|Physician Decision|3|||
170384596|NCT03481634|615744434|FG001|Overall Study|Physician Decision|0|||
170384597|NCT03481634|615744435|FG002|Overall Study|Physician Decision|1|||
170384598|NCT03481634|615744433|FG000|Overall Study|Lost to Follow-up|3|||
170384599|NCT03481634|615744434|FG001|Overall Study|Lost to Follow-up|4|||
170384600|NCT03481634|615744435|FG002|Overall Study|Lost to Follow-up|4|||
170384601|NCT03481634|615744433|FG000|Overall Study|Death|4|||
170384602|NCT03481634|615744434|FG001|Overall Study|Death|8|||
170384603|NCT03481634|615744435|FG002|Overall Study|Death|7|||
170384604|NCT03481634|615744433|FG000|Overall Study|Adverse Event|6|||
170384605|NCT03481634|615744434|FG001|Overall Study|Adverse Event|3|||
170384606|NCT03481634|615744435|FG002|Overall Study|Adverse Event|7|||
170384607|NCT00352027|615744436|FG000|Overall Study|Progressive disease|3|||
170384608|NCT00636506|615744437|FG000|Overall Study|Lost to Follow-up|8|||
170384609|NCT00636506|615744437|FG000|Overall Study|Explanted|1|||
170384610|NCT00636506|615744437|FG000|Overall Study|Withdrawal by Subject|6|||
170384611|NCT00636506|615744437|FG000|Overall Study|Procedure aborted|1|||
170384612|NCT01624974|615744438|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
170384613|NCT01624974|615744439|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
170384614|NCT01624974|615744438|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
170384615|NCT01624974|615744439|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
170384616|NCT01624974|615744438|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
170384617|NCT01624974|615744439|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
170384618|NCT01624974|615744438|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
170384619|NCT01624974|615744439|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
170384620|NCT01624974|615744438|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
170384621|NCT01624974|615744439|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
170384622|NCT01624974|615744438|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
170384623|NCT01624974|615744439|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
170384624|NCT01624974|615744438|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
170384625|NCT01624974|615744439|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
170384626|NCT01624974|615744438|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
170384627|NCT01624974|615744439|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
170384628|NCT01624974|615744438|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
170384629|NCT01624974|615744439|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
170384630|NCT01624974|615744438|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
170384631|NCT01624974|615744439|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
170384632|NCT01624974|615744438|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
170384633|NCT01624974|615744439|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
170384634|NCT01624974|615744438|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
170384635|NCT01624974|615744439|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
170384636|NCT00715949|615744440|FG000|Overall Study|could not finish first test|4|||
170384637|NCT02607735|615744441|FG000|Primary Study|Randomized but Never Treated|1|||
170384638|NCT02607735|615744442|FG001|Primary Study|Randomized but Never Treated|0|||
170384639|NCT02607735|615744443|FG002|Primary Study|Randomized but Never Treated|0|||
170384640|NCT02607735|615744441|FG000|Primary Study|Lost to Follow-up|4|||
170384641|NCT02607735|615744442|FG001|Primary Study|Lost to Follow-up|0|||
170384642|NCT02607735|615744443|FG002|Primary Study|Lost to Follow-up|0|||
170384643|NCT02607735|615744441|FG000|Primary Study|Withdrew Consent|2|||
170384644|NCT02607735|615744442|FG001|Primary Study|Withdrew Consent|0|||
170384645|NCT02607735|615744443|FG002|Primary Study|Withdrew Consent|0|||
170384646|NCT02607735|615744441|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
170384647|NCT02607735|615744442|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
170384648|NCT02607735|615744443|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
170384649|NCT02607735|615744441|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
170384650|NCT02607735|615744442|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
170384651|NCT02607735|615744443|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
170384652|NCT01376908|615744444|FG000|Overall Study|Protocol Violation|1|||
170384653|NCT01376908|615744445|FG001|Overall Study|Protocol Violation|1|||
170384654|NCT01376908|615744444|FG000|Overall Study|Withdrawal by Subject|1|||
170384655|NCT01376908|615744445|FG001|Overall Study|Withdrawal by Subject|2|||
170384656|NCT00866606|615744454|FG000|Overall Study|Lost to Follow-up|3|||
170384657|NCT00866606|615744454|FG000|Overall Study|Adverse Event|1|||
170384658|NCT01241318|615744455|FG000|Overall Study|Woman: false pregnancies|27|||
170384659|NCT01241318|615744456|FG001|Overall Study|Woman: false pregnancies|15|||
170384660|NCT01241318|615744455|FG000|Overall Study|Woman: miscarriage/abortion|46|||
170384661|NCT01241318|615744456|FG001|Overall Study|Woman: miscarriage/abortion|38|||
170384662|NCT01241318|615744455|FG000|Overall Study|Withdrawal by Subject|175|||
170384663|NCT01241318|615744456|FG001|Overall Study|Withdrawal by Subject|46|||
170384664|NCT01241318|615744455|FG000|Overall Study|Lost to Follow-up|740|||
170384665|NCT01241318|615744456|FG001|Overall Study|Lost to Follow-up|455|||
170384666|NCT01241318|615744455|FG000|Overall Study|Death|2|||
170384667|NCT01241318|615744456|FG001|Overall Study|Death|4|||
170384668|NCT01241318|615744455|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
170384669|NCT01241318|615744456|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
170384670|NCT01241318|615744455|FG000|Overall Study|Woman: Stillborn infant|129|||
170384671|NCT01241318|615744456|FG001|Overall Study|Woman: Stillborn infant|146|||
170384672|NCT00606021|615744457|FG000|Induction Phase|Death|73|||
170384673|NCT00606021|615744458|FG001|Induction Phase|Death|0|||
170384674|NCT00606021|615744459|FG002|Induction Phase|Death|0|||
170384675|NCT00606021|615744457|FG000|Induction Phase|Physician Decision|2|||
170384676|NCT00606021|615744458|FG001|Induction Phase|Physician Decision|0|||
170384677|NCT00606021|615744459|FG002|Induction Phase|Physician Decision|0|||
170384678|NCT00606021|615744457|FG000|Induction Phase|Withdrawal by Subject|2|||
170384679|NCT00606021|615744458|FG001|Induction Phase|Withdrawal by Subject|0|||
170384680|NCT00606021|615744459|FG002|Induction Phase|Withdrawal by Subject|0|||
170384681|NCT00606021|615744457|FG000|Induction Phase|Lost to Follow-up|10|||
170384682|NCT00606021|615744458|FG001|Induction Phase|Lost to Follow-up|0|||
170384683|NCT00606021|615744459|FG002|Induction Phase|Lost to Follow-up|0|||
170384684|NCT00606021|615744457|FG000|Maintenance Phase|Death|0|||
170384685|NCT00606021|615744458|FG001|Maintenance Phase|Death|17|||
170384686|NCT00606021|615744459|FG002|Maintenance Phase|Death|15|||
170384687|NCT00606021|615744457|FG000|Maintenance Phase|Physician Decision|0|||
170384688|NCT00606021|615744458|FG001|Maintenance Phase|Physician Decision|1|||
170384689|NCT00606021|615744459|FG002|Maintenance Phase|Physician Decision|0|||
170384690|NCT00606021|615744457|FG000|Maintenance Phase|Lost to Follow-up|0|||
170384691|NCT00606021|615744458|FG001|Maintenance Phase|Lost to Follow-up|5|||
170384692|NCT00606021|615744459|FG002|Maintenance Phase|Lost to Follow-up|2|||
170384693|NCT02380703|615744460|FG000|Overall Study|Withdrawal by Subject|12|||
170384694|NCT02380703|615744461|FG001|Overall Study|Withdrawal by Subject|9|||
170384695|NCT02380703|615744460|FG000|Overall Study|Lost to Follow-up|12|||
170384696|NCT02380703|615744461|FG001|Overall Study|Lost to Follow-up|12|||
170384697|NCT02380703|615744460|FG000|Overall Study|Caregiver death|1|||
170384698|NCT02380703|615744461|FG001|Overall Study|Caregiver death|0|||
170384699|NCT02380703|615744460|FG000|Overall Study|Person with dementia (PWD) death|7|||
170384700|NCT02380703|615744461|FG001|Overall Study|Person with dementia (PWD) death|8|||
170384701|NCT02380703|615744460|FG000|Overall Study|Entered Long-term Care|4|||
170384702|NCT02380703|615744461|FG001|Overall Study|Entered Long-term Care|7|||
170384703|NCT00806494|615744462|FG000|Overall Study|Adverse Event|29|||
170384704|NCT00806494|615744462|FG000|Overall Study|Lack of Efficacy|6|||
170384705|NCT00806494|615744462|FG000|Overall Study|Lost to Follow-up|10|||
170384706|NCT00806494|615744462|FG000|Overall Study|Other|30|||
170384707|NCT00806494|615744462|FG000|Overall Study|Withdrawal by Subject|5|||
170384708|NCT04815291|615744463|FG000|Overall Study|Lost to Follow-up|1|||
170384709|NCT04815291|615744463|FG000|Overall Study|Physician Decision|4|||
170384710|NCT04815291|615744463|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
170384711|NCT03529162|615744464|FG000|Overall Study|Lost to Follow-up|2|||
170384712|NCT03529162|615744465|FG001|Overall Study|Lost to Follow-up|2|||
170384713|NCT03323385|615745620|FG000|Overall Study|Withdrawal by Subject|1|||
170384714|NCT03323385|615745621|FG001|Overall Study|Withdrawal by Subject|2|||
170384715|NCT03323385|615745620|FG000|Overall Study|Noncompliance|0|||
170384716|NCT03323385|615745621|FG001|Overall Study|Noncompliance|1|||
170384717|NCT01646255|615745623|FG000|Overall Study|Adverse Event|7|||
170384718|NCT01646255|615745624|FG001|Overall Study|Adverse Event|8|||
170384719|NCT01646255|615745623|FG000|Overall Study|Lack of Efficacy|2|||
170384720|NCT01646255|615745624|FG001|Overall Study|Lack of Efficacy|0|||
170384721|NCT01646255|615745623|FG000|Overall Study|Withdrawal by Subject|10|||
170384722|NCT01646255|615745624|FG001|Overall Study|Withdrawal by Subject|6|||
170384723|NCT01646255|615745623|FG000|Overall Study|Compliance is not well|1|||
170384724|NCT01646255|615745624|FG001|Overall Study|Compliance is not well|0|||
170384725|NCT01646255|615745623|FG000|Overall Study|Inclusion Criteria Deviation|1|||
170384726|NCT01646255|615745624|FG001|Overall Study|Inclusion Criteria Deviation|0|||
170384727|NCT00266695|615745631|FG000|Overall Study|Adverse Event|1|||
170384728|NCT00266695|615745631|FG000|Overall Study|Death|9|||
170384729|NCT00266695|615745631|FG000|Overall Study|Physician Decision|1|||
170384730|NCT00266695|615745631|FG000|Overall Study|Lost to Follow-up|3|||
170384731|NCT00266695|615745631|FG000|Overall Study|Withdrawal by Subject|15|||
170384732|NCT03607994|615745635|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
170384733|NCT03607994|615745636|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
170384734|NCT01997333|615745648|FG000|Randomization and Treatment|Disease Progression|70|||
170384735|NCT01997333|615745649|FG001|Randomization and Treatment|Disease Progression|159|||
170384736|NCT01997333|615745648|FG000|Randomization and Treatment|Adverse Event|10|||
170384737|NCT01997333|615745649|FG001|Randomization and Treatment|Adverse Event|32|||
170384738|NCT01997333|615745648|FG000|Randomization and Treatment|Physician Decision|0|||
170384739|NCT01997333|615745649|FG001|Randomization and Treatment|Physician Decision|4|||
170384740|NCT01997333|615745648|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
170384741|NCT01997333|615745649|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
170384742|NCT01997333|615745648|FG000|Randomization and Treatment|Did not receive treatment|17|||
170384743|NCT01997333|615745649|FG001|Randomization and Treatment|Did not receive treatment|5|||
170384744|NCT01997333|615745648|FG000|Survival Follow up|Withdrawal by Subject|15|||
170384745|NCT01997333|615745649|FG001|Survival Follow up|Withdrawal by Subject|6|||
170384746|NCT01997333|615745648|FG000|Survival Follow up|Lost to Follow-up|0|||
170384747|NCT01997333|615745649|FG001|Survival Follow up|Lost to Follow-up|6|||
170384748|NCT01997333|615745648|FG000|Survival Follow up|Various|1|||
170384749|NCT01997333|615745649|FG001|Survival Follow up|Various|2|||
170384750|NCT02269709|615745650|FG000|Time of Enrollment|Withdrawal by Subject|3|||
170384751|NCT02269709|615745650|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
170384752|NCT02269709|615745650|FG000|Six Month Follow-up|Lost to Follow-up|12|||
170384753|NCT04411472|615745651|FG000|Overall Study|Adverse Event|5|||
170384754|NCT04411472|615745652|FG001|Overall Study|Adverse Event|10|||
170384755|NCT04411472|615745653|FG002|Overall Study|Adverse Event|1|||
170384756|NCT04411472|615745654|FG003|Overall Study|Adverse Event|0|||
170384757|NCT04411472|615745655|FG004|Overall Study|Adverse Event|0|||
170384758|NCT04411472|615745656|FG005|Overall Study|Adverse Event|0|||
170384759|NCT04411472|615745651|FG000|Overall Study|Protocol Violation|1|||
170384760|NCT04411472|615745652|FG001|Overall Study|Protocol Violation|0|||
170384761|NCT04411472|615745653|FG002|Overall Study|Protocol Violation|0|||
170384762|NCT04411472|615745654|FG003|Overall Study|Protocol Violation|0|||
170384763|NCT04411472|615745655|FG004|Overall Study|Protocol Violation|0|||
170384764|NCT04411472|615745656|FG005|Overall Study|Protocol Violation|0|||
170384765|NCT04411472|615745651|FG000|Overall Study|Withdrawal by Subject|0|||
170384766|NCT04411472|615745652|FG001|Overall Study|Withdrawal by Subject|1|||
170384767|NCT04411472|615745653|FG002|Overall Study|Withdrawal by Subject|0|||
170384768|NCT04411472|615745654|FG003|Overall Study|Withdrawal by Subject|1|||
170384769|NCT04411472|615745655|FG004|Overall Study|Withdrawal by Subject|0|||
170384770|NCT04411472|615745656|FG005|Overall Study|Withdrawal by Subject|0|||
170384771|NCT04411472|615745651|FG000|Overall Study|Physician Decision|1|||
170384772|NCT04411472|615745652|FG001|Overall Study|Physician Decision|0|||
170384773|NCT04411472|615745653|FG002|Overall Study|Physician Decision|0|||
170384774|NCT04411472|615745654|FG003|Overall Study|Physician Decision|0|||
170384775|NCT04411472|615745655|FG004|Overall Study|Physician Decision|0|||
170384776|NCT04411472|615745656|FG005|Overall Study|Physician Decision|0|||
170384777|NCT04411472|615745651|FG000|Overall Study|Study terminated by sponsor|17|||
170384778|NCT04411472|615745652|FG001|Overall Study|Study terminated by sponsor|20|||
170384779|NCT04411472|615745653|FG002|Overall Study|Study terminated by sponsor|3|||
170384780|NCT04411472|615745654|FG003|Overall Study|Study terminated by sponsor|0|||
170384781|NCT04411472|615745655|FG004|Overall Study|Study terminated by sponsor|0|||
170384782|NCT04411472|615745656|FG005|Overall Study|Study terminated by sponsor|0|||
170384783|NCT00440232|615745659|FG000|Overall Study|Lost to Follow-up|1|||
170384784|NCT00440232|615745660|FG001|Overall Study|Lost to Follow-up|1|||
170384785|NCT00440232|615745659|FG000|Overall Study|Unable to treat within allowed time|0|||
170384786|NCT00440232|615745660|FG001|Overall Study|Unable to treat within allowed time|1|||
170384787|NCT00440232|615745659|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
170384788|NCT00440232|615745660|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
170384789|NCT00362297|615745661|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
170384790|NCT00362297|615745662|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
170384791|NCT00426842|615745663|FG000|Overall Study|Lost to Follow-up|1|||
170384792|NCT00819052|615745664|FG000|Overall Study|Adverse Event|0|||
170384793|NCT00819052|615745665|FG001|Overall Study|Adverse Event|5|||
170384794|NCT00819052|615745664|FG000|Overall Study|Protocol Violation|1|||
170384795|NCT00819052|615745665|FG001|Overall Study|Protocol Violation|2|||
170384796|NCT00819052|615745664|FG000|Overall Study|Lost to Follow-up|1|||
170384797|NCT00819052|615745665|FG001|Overall Study|Lost to Follow-up|2|||
170384798|NCT00819052|615745664|FG000|Overall Study|Withdrawal by Subject|1|||
170384799|NCT00819052|615745665|FG001|Overall Study|Withdrawal by Subject|2|||
170384800|NCT00819052|615745664|FG000|Overall Study|Lack of Efficacy|1|||
170384801|NCT00819052|615745665|FG001|Overall Study|Lack of Efficacy|1|||
170384802|NCT00819052|615745664|FG000|Overall Study|Pregnancy|1|||
170384803|NCT00819052|615745665|FG001|Overall Study|Pregnancy|2|||
170384804|NCT00819052|615745664|FG000|Overall Study|Death or events leading to death|1|||
170384805|NCT00819052|615745665|FG001|Overall Study|Death or events leading to death|0|||
170384806|NCT01747655|615745668|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
170384807|NCT01747655|615745669|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
170384808|NCT01747655|615745668|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
170384809|NCT01747655|615745669|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
170384810|NCT01747655|615745668|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
170384811|NCT01747655|615745669|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
170384812|NCT00982111|615745672|FG000|Overall Study|Adverse Event|1|||
170384813|NCT00982111|615745673|FG001|Overall Study|Adverse Event|1|||
170384814|NCT00982111|615745672|FG000|Overall Study|Progressive Disease|46|||
170384815|NCT00982111|615745673|FG001|Overall Study|Progressive Disease|39|||
170384816|NCT00982111|615745672|FG000|Overall Study|Lost to Follow-up|9|||
170384817|NCT00982111|615745673|FG001|Overall Study|Lost to Follow-up|6|||
170384818|NCT00982111|615745672|FG000|Overall Study|New Anti-Cancer Therapy|5|||
170384819|NCT00982111|615745673|FG001|Overall Study|New Anti-Cancer Therapy|5|||
170384820|NCT00982111|615745672|FG000|Overall Study|Medical Decision|1|||
170384821|NCT00982111|615745673|FG001|Overall Study|Medical Decision|0|||
170384822|NCT00982111|615745672|FG000|Overall Study|Withdrawal by Subject|17|||
170384823|NCT00982111|615745673|FG001|Overall Study|Withdrawal by Subject|19|||
170384824|NCT00982111|615745672|FG000|Overall Study|Global Study End|0|||
170384825|NCT00982111|615745673|FG001|Overall Study|Global Study End|1|||
170384826|NCT00982111|615745672|FG000|Overall Study|Sponsor's Decision|0|||
170384827|NCT00982111|615745673|FG001|Overall Study|Sponsor's Decision|1|||
170384828|NCT03769753|615745674|FG000|Overall Study|Not Treated|6|||
170384829|NCT03769753|615745674|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
170384830|NCT01070381|615745675|FG000|Period 2, 1 Week of Wear|Handling|0|||
170384831|NCT01070381|615745676|FG001|Period 2, 1 Week of Wear|Handling|1|||
170384832|NCT01070381|615745675|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
170384833|NCT01070381|615745676|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
170384834|NCT00684073|615745677|FG000|Selection|Selection/non-selection criteria|3|||
170384835|NCT00684073|615745677|FG000|Selection|Death|1|||
170384836|NCT00684073|615745677|FG000|Selection|noncompliance|1|||
170384837|NCT00684073|615745677|FG000|Selection|Lost to Follow-up|1|||
170384838|NCT00684073|615745677|FG000|Selection|request of the sponsor|1|||
170384839|NCT00684073|615745677|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
170384840|NCT01259388|615745679|FG000|Overall Study|Adverse Event|3|||
170384841|NCT01259388|615745680|FG001|Overall Study|Adverse Event|0|||
170384842|NCT01259388|615745679|FG000|Overall Study|Withdrawal by Subject|1|||
170384843|NCT01259388|615745680|FG001|Overall Study|Withdrawal by Subject|1|||
170384844|NCT01259388|615745679|FG000|Overall Study|Physician Decision|1|||
170384845|NCT01259388|615745680|FG001|Overall Study|Physician Decision|0|||
170384846|NCT00620815|615745681|FG000|Overall Study|Adverse Event|1|||
170384847|NCT00620815|615745682|FG001|Overall Study|Adverse Event|1|||
170384848|NCT00620815|615745683|FG002|Overall Study|Adverse Event|2|||
170384849|NCT00620815|615745681|FG000|Overall Study|Withdrawal by Subject|1|||
170384850|NCT00620815|615745682|FG001|Overall Study|Withdrawal by Subject|2|||
170384851|NCT00620815|615745683|FG002|Overall Study|Withdrawal by Subject|0|||
170384852|NCT00620815|615745681|FG000|Overall Study|Lost to Follow-up|1|||
170384853|NCT00620815|615745682|FG001|Overall Study|Lost to Follow-up|6|||
170384854|NCT00620815|615745683|FG002|Overall Study|Lost to Follow-up|3|||
170384855|NCT00620815|615745681|FG000|Overall Study|Inappropriate enrolment|0|||
170384856|NCT00620815|615745682|FG001|Overall Study|Inappropriate enrolment|0|||
170384857|NCT00620815|615745683|FG002|Overall Study|Inappropriate enrolment|1|||
170384858|NCT00620815|615745681|FG000|Overall Study|Protocol Violation|1|||
170384859|NCT00620815|615745682|FG001|Overall Study|Protocol Violation|2|||
170384860|NCT00620815|615745683|FG002|Overall Study|Protocol Violation|1|||
170384861|NCT01230827|615745684|FG000|Overall Study|Lost to Follow-up|0|||
170384862|NCT01230827|615745685|FG001|Overall Study|Lost to Follow-up|0|||
170384863|NCT01230827|615745686|FG002|Overall Study|Lost to Follow-up|1|||
170384864|NCT01230827|615745687|FG003|Overall Study|Lost to Follow-up|3|||
170384865|NCT01230827|615745684|FG000|Overall Study|Withdrawal by Subject|1|||
170384866|NCT01230827|615745685|FG001|Overall Study|Withdrawal by Subject|0|||
170384867|NCT01230827|615745686|FG002|Overall Study|Withdrawal by Subject|3|||
170384868|NCT01230827|615745687|FG003|Overall Study|Withdrawal by Subject|2|||
170384869|NCT01230827|615745684|FG000|Overall Study|Lack of Efficacy|14|||
170384870|NCT01230827|615745685|FG001|Overall Study|Lack of Efficacy|1|||
170384871|NCT01230827|615745686|FG002|Overall Study|Lack of Efficacy|2|||
170384872|NCT01230827|615745687|FG003|Overall Study|Lack of Efficacy|3|||
170384873|NCT01230827|615745684|FG000|Overall Study|Adverse Event|4|||
170384874|NCT01230827|615745685|FG001|Overall Study|Adverse Event|2|||
170384875|NCT01230827|615745686|FG002|Overall Study|Adverse Event|3|||
170384876|NCT01230827|615745687|FG003|Overall Study|Adverse Event|7|||
170384877|NCT01230827|615745684|FG000|Overall Study|Recovery|0|||
170384878|NCT01230827|615745685|FG001|Overall Study|Recovery|6|||
170384879|NCT01230827|615745686|FG002|Overall Study|Recovery|0|||
170384880|NCT01230827|615745687|FG003|Overall Study|Recovery|0|||
170384881|NCT01230827|615745684|FG000|Overall Study|Study terminated by Sponsor|0|||
170384882|NCT01230827|615745685|FG001|Overall Study|Study terminated by Sponsor|2|||
170384883|NCT01230827|615745686|FG002|Overall Study|Study terminated by Sponsor|56|||
170384884|NCT01230827|615745687|FG003|Overall Study|Study terminated by Sponsor|63|||
170384885|NCT02728804|615745693|FG000|Overall Study|Ineligible|3|||
170384886|NCT02728804|615745693|FG000|Overall Study|Did not complete baseline questionnaire|9|||
170384887|NCT02728804|615745693|FG000|Overall Study|Death|99|||
170384888|NCT01888367|615745694|FG000|Overall Study|Physician Decision|3|||
170384889|NCT01888367|615745695|FG001|Overall Study|Physician Decision|4|||
170384890|NCT01888367|615745696|FG002|Overall Study|Physician Decision|2|||
170384891|NCT01888367|615745694|FG000|Overall Study|Death|2|||
170384892|NCT01888367|615745695|FG001|Overall Study|Death|0|||
170384893|NCT01888367|615745696|FG002|Overall Study|Death|1|||
170384894|NCT01888367|615745694|FG000|Overall Study|Withdrawal by Subject|1|||
170384895|NCT01888367|615745695|FG001|Overall Study|Withdrawal by Subject|0|||
170384896|NCT01888367|615745696|FG002|Overall Study|Withdrawal by Subject|1|||
170384897|NCT01888367|615745694|FG000|Overall Study|Lost to Follow-up|1|||
170384898|NCT01888367|615745695|FG001|Overall Study|Lost to Follow-up|1|||
170384899|NCT01888367|615745696|FG002|Overall Study|Lost to Follow-up|0|||
170384900|NCT01888367|615745694|FG000|Overall Study|Protocol Violation|0|||
170384901|NCT01888367|615745695|FG001|Overall Study|Protocol Violation|0|||
170384902|NCT01888367|615745696|FG002|Overall Study|Protocol Violation|1|||
170384903|NCT01888367|615745694|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
170384904|NCT01888367|615745695|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
170384905|NCT01888367|615745696|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
170384906|NCT01854918|615745697|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
170384907|NCT01854918|615745698|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
170384908|NCT01854918|615745697|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
170384909|NCT01854918|615745698|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
170384910|NCT01854918|615745697|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
170384911|NCT01854918|615745698|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
170384912|NCT01854918|615745697|FG000|SOC-controlled Period (Year 1)|Death|5|||
170384913|NCT01854918|615745698|FG001|SOC-controlled Period (Year 1)|Death|5|||
170384914|NCT01854918|615745697|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
170384915|NCT01854918|615745698|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
170384916|NCT01854918|615745697|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
170384917|NCT01854918|615745698|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
170384918|NCT01854918|615745697|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
170384919|NCT01854918|615745698|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
170384920|NCT01854918|615745697|FG000|All-IP Period (Years 2 and 3)|Death|5|||
170384921|NCT01854918|615745698|FG001|All-IP Period (Years 2 and 3)|Death|16|||
170384922|NCT00489216|615745709|FG000|Overall Study|Adverse Event|1|||
170384923|NCT00422942|615745712|FG000|Overall Study|Study terminated by Sponsor|3|||
170384924|NCT01513460|615745719|FG000|Overall Study|Death|0|||
170384925|NCT01513460|615745720|FG001|Overall Study|Death|0|||
170384926|NCT01513460|615745721|FG002|Overall Study|Death|1|||
170384927|NCT01513460|615745719|FG000|Overall Study|Lost to Follow-up|0|||
170384928|NCT01513460|615745720|FG001|Overall Study|Lost to Follow-up|0|||
170384929|NCT01513460|615745721|FG002|Overall Study|Lost to Follow-up|2|||
170384930|NCT01513460|615745719|FG000|Overall Study|Abnormal laboratory value|1|||
170384931|NCT01513460|615745720|FG001|Overall Study|Abnormal laboratory value|0|||
170384932|NCT01513460|615745721|FG002|Overall Study|Abnormal laboratory value|1|||
170384933|NCT01513460|615745719|FG000|Overall Study|Lack of Efficacy|1|||
170384934|NCT01513460|615745720|FG001|Overall Study|Lack of Efficacy|2|||
170384935|NCT01513460|615745721|FG002|Overall Study|Lack of Efficacy|5|||
170384936|NCT01513460|615745719|FG000|Overall Study|Protocol deviations|3|||
170384937|NCT01513460|615745720|FG001|Overall Study|Protocol deviations|4|||
170384938|NCT01513460|615745721|FG002|Overall Study|Protocol deviations|3|||
170384939|NCT01513460|615745719|FG000|Overall Study|Withdrawal by Subject|7|||
170384940|NCT01513460|615745720|FG001|Overall Study|Withdrawal by Subject|8|||
170384941|NCT01513460|615745721|FG002|Overall Study|Withdrawal by Subject|21|||
170384942|NCT01513460|615745719|FG000|Overall Study|Adverse Event|16|||
170384943|NCT01513460|615745720|FG001|Overall Study|Adverse Event|18|||
170384944|NCT01513460|615745721|FG002|Overall Study|Adverse Event|23|||
170384945|NCT01513460|615745719|FG000|Overall Study|Abnormal test procedure|1|||
170384946|NCT01513460|615745720|FG001|Overall Study|Abnormal test procedure|0|||
170384947|NCT01513460|615745721|FG002|Overall Study|Abnormal test procedure|0|||
170384948|NCT01156012|615745722|FG000|Overall Study|Adverse Event|3|||
170384949|NCT01156012|615745723|FG001|Overall Study|Adverse Event|1|||
170384950|NCT01156012|615745722|FG000|Overall Study|Lost to Follow-up|1|||
170384951|NCT01156012|615745723|FG001|Overall Study|Lost to Follow-up|0|||
170384952|NCT01156012|615745722|FG000|Overall Study|Withdrawal by Subject|1|||
170384953|NCT01156012|615745723|FG001|Overall Study|Withdrawal by Subject|0|||
170384954|NCT01156012|615745722|FG000|Overall Study|use of commercial drug instead of study|0|||
170384955|NCT01156012|615745723|FG001|Overall Study|use of commercial drug instead of study|1|||
170384956|NCT01156012|615745722|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
170384957|NCT01156012|615745723|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
170384958|NCT02475564|615745724|FG000|Overall Study|Withdrawal by Subject|1|||
170384959|NCT02475564|615745725|FG001|Overall Study|Withdrawal by Subject|0|||
170384960|NCT02475564|615745724|FG000|Overall Study|Lost to Follow-up|2|||
170384961|NCT02475564|615745725|FG001|Overall Study|Lost to Follow-up|1|||
170384962|NCT02475564|615745724|FG000|Overall Study|Intense Menstrual bleeding|1|||
170384963|NCT02475564|615745725|FG001|Overall Study|Intense Menstrual bleeding|0|||
170384964|NCT02705755|615745727|FG000|Part A (6 Days)|Adverse Event|1|||
170384965|NCT02705755|615745728|FG001|Part A (6 Days)|Adverse Event|0|||
170384966|NCT02705755|615745729|FG002|Part A (6 Days)|Adverse Event|0|||
170384967|NCT02705755|615745730|FG003|Part A (6 Days)|Adverse Event|0|||
170384968|NCT02705755|615745727|FG000|Part A (6 Days)|Physician Decision|3|||
170384969|NCT02705755|615745728|FG001|Part A (6 Days)|Physician Decision|0|||
170384970|NCT02705755|615745729|FG002|Part A (6 Days)|Physician Decision|0|||
170384971|NCT02705755|615745730|FG003|Part A (6 Days)|Physician Decision|0|||
170384972|NCT02705755|615745727|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
170384973|NCT02705755|615745728|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
170384974|NCT02705755|615745729|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
170384975|NCT02705755|615745730|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
170384976|NCT02705755|615745727|FG000|Part C (20 Weeks)|Physician Decision|0|||
170384977|NCT02705755|615745728|FG001|Part C (20 Weeks)|Physician Decision|0|||
170384978|NCT02705755|615745729|FG002|Part C (20 Weeks)|Physician Decision|0|||
170384979|NCT02705755|615745730|FG003|Part C (20 Weeks)|Physician Decision|2|||
170384980|NCT02705755|615745727|FG000|Part C (20 Weeks)|Adverse Event|0|||
170384981|NCT02705755|615745728|FG001|Part C (20 Weeks)|Adverse Event|0|||
170384982|NCT02705755|615745729|FG002|Part C (20 Weeks)|Adverse Event|0|||
170384983|NCT02705755|615745730|FG003|Part C (20 Weeks)|Adverse Event|6|||
170384984|NCT02705755|615745727|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
170384985|NCT02705755|615745728|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
170384986|NCT02705755|615745729|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
170384987|NCT02705755|615745730|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
170384988|NCT01906489|615745731|FG000|Overall Study|Adverse Event|10|||
170384989|NCT01906489|615745732|FG001|Overall Study|Adverse Event|3|||
170384990|NCT01906489|615745731|FG000|Overall Study|Worsening of CKD|6|||
170384991|NCT01906489|615745732|FG001|Overall Study|Worsening of CKD|4|||
170384992|NCT01906489|615745731|FG000|Overall Study|Withdrawal by Subject|5|||
170384993|NCT01906489|615745732|FG001|Overall Study|Withdrawal by Subject|0|||
170384994|NCT01906489|615745731|FG000|Overall Study|Worsening of Anemia|1|||
170384995|NCT01906489|615745732|FG001|Overall Study|Worsening of Anemia|0|||
170384996|NCT01906489|615745731|FG000|Overall Study|Protocol Violation|0|||
170384997|NCT01906489|615745732|FG001|Overall Study|Protocol Violation|1|||
170384998|NCT01906489|615745731|FG000|Overall Study|Non- Compliance|1|||
170384999|NCT01906489|615745732|FG001|Overall Study|Non- Compliance|0|||
170385000|NCT01906489|615745731|FG000|Overall Study|Sponsor Decision|1|||
170385001|NCT01906489|615745732|FG001|Overall Study|Sponsor Decision|0|||
170385002|NCT01906489|615745731|FG000|Overall Study|Lost to Follow-up|1|||
170385003|NCT01906489|615745732|FG001|Overall Study|Lost to Follow-up|1|||
170385004|NCT01906489|615745731|FG000|Overall Study|Other|1|||
170385005|NCT01906489|615745732|FG001|Overall Study|Other|0|||
170385006|NCT03458234|615745733|FG000|Overall Study|Withdrawal by Subject|1|||
170385007|NCT04823494|615747712|FG000|Overall Study|Programming software malfunction.|1|||
170385008|NCT04823494|615747713|FG001|Overall Study|Programming software malfunction.|0|||
170385009|NCT04823494|615747712|FG000|Overall Study|Withdrawal by Subject|1|||
170385010|NCT04823494|615747713|FG001|Overall Study|Withdrawal by Subject|0|||
170385011|NCT04823494|615747712|FG000|Overall Study|Devices lost|0|||
170385012|NCT04823494|615747713|FG001|Overall Study|Devices lost|1|||
170385013|NCT01233076|615747717|FG000|Period 2, One Week|Lost to Follow-up|1|||
170385014|NCT01233076|615747718|FG001|Period 2, One Week|Lost to Follow-up|0|||
170385015|NCT01336647|615747719|FG000|Overall Study|Lost to Follow-up|4|||
170385016|NCT01336647|615747720|FG001|Overall Study|Lost to Follow-up|1|||
170385017|NCT01336647|615747721|FG002|Overall Study|Lost to Follow-up|3|||
170385018|NCT04563845|615747722|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385019|NCT04563845|615747723|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385020|NCT04563845|615747724|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385021|NCT04563845|615747725|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385022|NCT04563845|615747726|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385023|NCT04563845|615747727|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385024|NCT04563845|615747728|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385025|NCT04563845|615747729|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
170385026|NCT04563845|615747730|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385027|NCT04563845|615747731|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385028|NCT04563845|615747732|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385029|NCT04563845|615747733|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385030|NCT04563845|615747734|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385031|NCT04563845|615747735|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
170385032|NCT04563845|615747722|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385033|NCT04563845|615747723|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385034|NCT04563845|615747724|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385035|NCT04563845|615747725|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385036|NCT04563845|615747726|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
170385037|NCT04563845|615747727|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385038|NCT04563845|615747728|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385039|NCT04563845|615747729|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385040|NCT04563845|615747730|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385041|NCT04563845|615747731|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385042|NCT04563845|615747732|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385043|NCT04563845|615747733|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385044|NCT04563845|615747734|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385045|NCT04563845|615747735|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
170385046|NCT01674010|615747738|FG000|Open Treatment Phase 1|Adverse Event|10|||
170385047|NCT01674010|615747739|FG001|Open Treatment Phase 1|Adverse Event|0|||
170385048|NCT01674010|615747740|FG002|Open Treatment Phase 1|Adverse Event|0|||
170385049|NCT01674010|615747738|FG000|Open Treatment Phase 1|Death|1|||
170385050|NCT01674010|615747739|FG001|Open Treatment Phase 1|Death|0|||
170385051|NCT01674010|615747740|FG002|Open Treatment Phase 1|Death|0|||
170385052|NCT01674010|615747738|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
170385053|NCT01674010|615747739|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
170385054|NCT01674010|615747740|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
170385055|NCT01674010|615747738|FG000|Open Treatment Phase 1|Physician Decision|9|||
170385056|NCT01674010|615747739|FG001|Open Treatment Phase 1|Physician Decision|0|||
170385057|NCT01674010|615747740|FG002|Open Treatment Phase 1|Physician Decision|0|||
170385058|NCT01674010|615747738|FG000|Open Treatment Phase 1|Protocol Violation|7|||
170385059|NCT01674010|615747739|FG001|Open Treatment Phase 1|Protocol Violation|0|||
170385060|NCT01674010|615747740|FG002|Open Treatment Phase 1|Protocol Violation|0|||
170385061|NCT01674010|615747738|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
170385062|NCT01674010|615747739|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
170385063|NCT01674010|615747740|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
170385064|NCT01674010|615747738|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
170385065|NCT01674010|615747739|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
170385066|NCT01674010|615747740|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
170385067|NCT01674010|615747738|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
170385068|NCT01674010|615747739|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
170385069|NCT01674010|615747740|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
170385070|NCT01674010|615747738|FG000|Randomization Phase 2|Adverse Event|0|||
170385071|NCT01674010|615747739|FG001|Randomization Phase 2|Adverse Event|1|||
170385072|NCT01674010|615747740|FG002|Randomization Phase 2|Adverse Event|1|||
170385073|NCT01674010|615747738|FG000|Randomization Phase 2|Lost to Follow-up|0|||
170385074|NCT01674010|615747739|FG001|Randomization Phase 2|Lost to Follow-up|1|||
170385075|NCT01674010|615747740|FG002|Randomization Phase 2|Lost to Follow-up|2|||
170385076|NCT01674010|615747738|FG000|Randomization Phase 2|Mood episode recurrence|0|||
170385077|NCT01674010|615747739|FG001|Randomization Phase 2|Mood episode recurrence|8|||
170385078|NCT01674010|615747740|FG002|Randomization Phase 2|Mood episode recurrence|2|||
170385079|NCT01674010|615747738|FG000|Randomization Phase 2|Physician Decision|0|||
170385080|NCT01674010|615747739|FG001|Randomization Phase 2|Physician Decision|0|||
170385081|NCT01674010|615747740|FG002|Randomization Phase 2|Physician Decision|2|||
170385082|NCT01674010|615747738|FG000|Randomization Phase 2|Pregnancy|0|||
170385083|NCT01674010|615747739|FG001|Randomization Phase 2|Pregnancy|1|||
170385084|NCT01674010|615747740|FG002|Randomization Phase 2|Pregnancy|1|||
170385085|NCT01674010|615747738|FG000|Randomization Phase 2|Protocol Violation|0|||
170385086|NCT01674010|615747739|FG001|Randomization Phase 2|Protocol Violation|1|||
170385087|NCT01674010|615747740|FG002|Randomization Phase 2|Protocol Violation|1|||
170385088|NCT01674010|615747738|FG000|Randomization Phase 2|Sponsor Decision|0|||
170385089|NCT01674010|615747739|FG001|Randomization Phase 2|Sponsor Decision|42|||
170385090|NCT01674010|615747740|FG002|Randomization Phase 2|Sponsor Decision|45|||
170385091|NCT01674010|615747738|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
170385092|NCT01674010|615747739|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
170385093|NCT01674010|615747740|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
170385094|NCT01020812|615747741|FG000|Overall Study|Physician Decision|1|||
170385095|NCT01020812|615747741|FG000|Overall Study|Withdrawal by Subject|1|||
170385096|NCT01020812|615747741|FG000|Overall Study|Protocol Violation|1|||
170385097|NCT01801475|615747742|FG000|Overall Study|Withdrawal by Subject|0|||
170385098|NCT01801475|615747743|FG001|Overall Study|Withdrawal by Subject|0|||
170385099|NCT01801475|615747744|FG002|Overall Study|Withdrawal by Subject|0|||
170385100|NCT01801475|615747745|FG003|Overall Study|Withdrawal by Subject|0|||
170385101|NCT01801475|615747746|FG004|Overall Study|Withdrawal by Subject|1|||
170385102|NCT01786707|615747747|FG000|Overall Study|Lost to Follow-up|1|||
170385103|NCT01786707|615747748|FG001|Overall Study|Lost to Follow-up|1|||
170385104|NCT00421928|615747749|FG000|Overall Study|Adverse Event|61|||
170385105|NCT00421928|615747750|FG001|Overall Study|Adverse Event|140|||
170385106|NCT00421928|615747751|FG002|Overall Study|Adverse Event|22|||
170385107|NCT00421928|615747749|FG000|Overall Study|Lost to Follow-up|5|||
170385108|NCT00421928|615747750|FG001|Overall Study|Lost to Follow-up|0|||
170385109|NCT00421928|615747751|FG002|Overall Study|Lost to Follow-up|3|||
170385110|NCT00421928|615747749|FG000|Overall Study|Withdrawal by Subject|50|||
170385111|NCT00421928|615747750|FG001|Overall Study|Withdrawal by Subject|48|||
170385112|NCT00421928|615747751|FG002|Overall Study|Withdrawal by Subject|43|||
170385113|NCT00421928|615747749|FG000|Overall Study|Lack of Efficacy|15|||
170385114|NCT00421928|615747750|FG001|Overall Study|Lack of Efficacy|7|||
170385115|NCT00421928|615747751|FG002|Overall Study|Lack of Efficacy|35|||
170385116|NCT00421928|615747749|FG000|Overall Study|Study drug non-compliant|6|||
170385117|NCT00421928|615747750|FG001|Overall Study|Study drug non-compliant|7|||
170385118|NCT00421928|615747751|FG002|Overall Study|Study drug non-compliant|4|||
170385119|NCT00421928|615747749|FG000|Overall Study|All other|26|||
170385120|NCT00421928|615747750|FG001|Overall Study|All other|21|||
170385121|NCT00421928|615747751|FG002|Overall Study|All other|27|||
170385122|NCT00421928|615747749|FG000|Overall Study|Death|0|||
170385123|NCT00421928|615747750|FG001|Overall Study|Death|1|||
170385124|NCT00421928|615747751|FG002|Overall Study|Death|0|||
170385125|NCT00346775|615747752|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
170385126|NCT00346775|615747753|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
170385127|NCT00346775|615747752|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
170385128|NCT00346775|615747753|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
170385129|NCT00346775|615747752|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
170385130|NCT00346775|615747753|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
170385131|NCT02946515|615747754|FG000|Overall Study|Lost to Follow-up|2|||
170385132|NCT02946515|615747755|FG001|Overall Study|Lost to Follow-up|1|||
170385133|NCT00965458|615747760|FG000|Overall Study|Adverse Event|1|||
170385134|NCT00965458|615747761|FG001|Overall Study|Adverse Event|0|||
170385135|NCT00965458|615747760|FG000|Overall Study|Lost to Follow-up|1|||
170385136|NCT00965458|615747761|FG001|Overall Study|Lost to Follow-up|3|||
170385137|NCT00965458|615747760|FG000|Overall Study|Withdrawal by Subject|0|||
170385138|NCT00965458|615747761|FG001|Overall Study|Withdrawal by Subject|1|||
170385139|NCT04177862|615747763|FG000|Overall Study|Protocol Violation|2|||
170385140|NCT04177862|615747764|FG001|Overall Study|Protocol Violation|7|||
170385141|NCT05637515|615747765|FG000|Overall Study|Withdrawal by Subject|17|||
170385142|NCT05637515|615747766|FG001|Overall Study|Withdrawal by Subject|17|||
170385143|NCT03233009|615747767|FG000|Overall Study|Lost to Follow-up|1|||
170385144|NCT04516291|615747769|FG000|Treatment Period (24 Weeks)|Other|1|||
170385145|NCT04516291|615747770|FG001|Treatment Period (24 Weeks)|Other|0|||
170385146|NCT04516291|615747771|FG002|Treatment Period (24 Weeks)|Other|0|||
170385147|NCT04516291|615747772|FG003|Treatment Period (24 Weeks)|Other|2|||
170385148|NCT04516291|615747773|FG004|Treatment Period (24 Weeks)|Other|2|||
170385149|NCT04516291|615747774|FG005|Treatment Period (24 Weeks)|Other|4|||
170385150|NCT04516291|615747775|FG006|Treatment Period (24 Weeks)|Other|2|||
170385151|NCT04516291|615747776|FG007|Treatment Period (24 Weeks)|Other|0|||
170385152|NCT04516291|615747769|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170385153|NCT04516291|615747770|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
170385154|NCT04516291|615747771|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
170385155|NCT04516291|615747772|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170385156|NCT04516291|615747773|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
170385157|NCT04516291|615747774|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170385158|NCT04516291|615747775|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170385159|NCT04516291|615747776|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
170385160|NCT04516291|615747769|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
170385161|NCT04516291|615747770|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
170385162|NCT04516291|615747771|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
170385163|NCT04516291|615747772|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
170385164|NCT04516291|615747773|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
170385165|NCT04516291|615747774|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
170385166|NCT04516291|615747775|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
170385167|NCT04516291|615747776|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
170385168|NCT04516291|615747769|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170385169|NCT04516291|615747770|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
170385170|NCT04516291|615747771|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170385171|NCT04516291|615747772|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170385172|NCT04516291|615747773|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170385173|NCT04516291|615747774|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170385174|NCT04516291|615747775|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170385175|NCT04516291|615747776|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
170385176|NCT04516291|615747769|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
170385177|NCT04516291|615747770|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
170385178|NCT04516291|615747771|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
170385179|NCT04516291|615747772|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
170385180|NCT04516291|615747773|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
170385181|NCT04516291|615747774|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
170385182|NCT04516291|615747775|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
170385183|NCT04516291|615747776|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
170385184|NCT04516291|615747769|FG000|Follow-up Period (12 Weeks)|Other|0|||
170385185|NCT04516291|615747770|FG001|Follow-up Period (12 Weeks)|Other|1|||
170385186|NCT04516291|615747771|FG002|Follow-up Period (12 Weeks)|Other|0|||
170385187|NCT04516291|615747772|FG003|Follow-up Period (12 Weeks)|Other|2|||
170385188|NCT04516291|615747773|FG004|Follow-up Period (12 Weeks)|Other|0|||
170385189|NCT04516291|615747774|FG005|Follow-up Period (12 Weeks)|Other|0|||
170385190|NCT04516291|615747775|FG006|Follow-up Period (12 Weeks)|Other|0|||
170385191|NCT04516291|615747776|FG007|Follow-up Period (12 Weeks)|Other|0|||
170385192|NCT04516291|615747769|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170385193|NCT04516291|615747770|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170385194|NCT04516291|615747771|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170385195|NCT04516291|615747772|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170385196|NCT04516291|615747773|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
170385197|NCT04516291|615747774|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170385198|NCT04516291|615747775|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170385199|NCT04516291|615747776|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
170385200|NCT04516291|615747769|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
170385201|NCT04516291|615747770|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
170385202|NCT04516291|615747771|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
170385203|NCT04516291|615747772|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
170385204|NCT04516291|615747773|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
170385205|NCT04516291|615747774|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
170385206|NCT04516291|615747775|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
170385207|NCT04516291|615747776|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
170385208|NCT03868410|615747786|FG000|Overall Study|Physician Decision|0|||
170385209|NCT03868410|615747787|FG001|Overall Study|Physician Decision|1|||
170385210|NCT03824704|615747788|FG000|Overall Study|Study Terminated by Sponsor|1|||
170385211|NCT02155660|615747796|FG000|Overall Study|Other Reason|8|||
170385212|NCT02155660|615747797|FG001|Overall Study|Other Reason|6|||
170385213|NCT02155660|615747798|FG002|Overall Study|Other Reason|10|||
170385214|NCT02155660|615747799|FG003|Overall Study|Other Reason|10|||
170385215|NCT02155660|615747796|FG000|Overall Study|Study-specific withdrawal criteria|0|||
170385216|NCT02155660|615747797|FG001|Overall Study|Study-specific withdrawal criteria|1|||
170385217|NCT02155660|615747798|FG002|Overall Study|Study-specific withdrawal criteria|1|||
170385218|NCT02155660|615747799|FG003|Overall Study|Study-specific withdrawal criteria|1|||
170385219|NCT02155660|615747796|FG000|Overall Study|Severe non-compliance|0|||
170385220|NCT02155660|615747797|FG001|Overall Study|Severe non-compliance|4|||
170385221|NCT02155660|615747798|FG002|Overall Study|Severe non-compliance|0|||
170385222|NCT02155660|615747799|FG003|Overall Study|Severe non-compliance|1|||
170385223|NCT02155660|615747796|FG000|Overall Study|Adverse Event|2|||
170385224|NCT02155660|615747797|FG001|Overall Study|Adverse Event|6|||
170385225|NCT02155660|615747798|FG002|Overall Study|Adverse Event|3|||
170385226|NCT02155660|615747799|FG003|Overall Study|Adverse Event|1|||
170385227|NCT02155660|615747796|FG000|Overall Study|Lost to Follow-up|3|||
170385228|NCT02155660|615747797|FG001|Overall Study|Lost to Follow-up|6|||
170385229|NCT02155660|615747798|FG002|Overall Study|Lost to Follow-up|5|||
170385230|NCT02155660|615747799|FG003|Overall Study|Lost to Follow-up|8|||
170385231|NCT02155660|615747796|FG000|Overall Study|Death|17|||
170385232|NCT02155660|615747797|FG001|Overall Study|Death|19|||
170385233|NCT02155660|615747798|FG002|Overall Study|Death|17|||
170385234|NCT02155660|615747799|FG003|Overall Study|Death|19|||
170385235|NCT02155660|615747796|FG000|Overall Study|Withdrawal by Subject|28|||
170385236|NCT02155660|615747797|FG001|Overall Study|Withdrawal by Subject|31|||
170385237|NCT02155660|615747798|FG002|Overall Study|Withdrawal by Subject|24|||
170385238|NCT02155660|615747799|FG003|Overall Study|Withdrawal by Subject|21|||
170385239|NCT03730987|615747800|FG000|Overall Study|Lost to Follow-up|2|||
170385240|NCT03730987|615747801|FG001|Overall Study|Lost to Follow-up|0|||
170385241|NCT03730987|615747802|FG002|Overall Study|Lost to Follow-up|2|||
170385242|NCT03730987|615747803|FG003|Overall Study|Lost to Follow-up|0|||
170385243|NCT02087085|615747807|FG000|Overall Study|Adverse Event|10|||
170385244|NCT02087085|615747808|FG001|Overall Study|Adverse Event|14|||
170385245|NCT02087085|615747807|FG000|Overall Study|Lack of Efficacy|4|||
170385246|NCT02087085|615747808|FG001|Overall Study|Lack of Efficacy|3|||
170385247|NCT02087085|615747807|FG000|Overall Study|Lost to Follow-up|6|||
170385248|NCT02087085|615747808|FG001|Overall Study|Lost to Follow-up|4|||
170385249|NCT02087085|615747807|FG000|Overall Study|Withdrawal by Subject|9|||
170385250|NCT02087085|615747808|FG001|Overall Study|Withdrawal by Subject|11|||
170385251|NCT02087085|615747807|FG000|Overall Study|Protocol Violation|1|||
170385252|NCT02087085|615747808|FG001|Overall Study|Protocol Violation|0|||
170385253|NCT02087085|615747807|FG000|Overall Study|Study Terminated by Sponsor|87|||
170385254|NCT02087085|615747808|FG001|Overall Study|Study Terminated by Sponsor|80|||
170385255|NCT02087085|615747807|FG000|Overall Study|Other Miscellaneous Reasons|3|||
170385256|NCT02087085|615747808|FG001|Overall Study|Other Miscellaneous Reasons|4|||
170385257|NCT02505945|615747809|FG000|Overall Study|Withdrawal by Subject|13|||
170385258|NCT02505945|615747810|FG001|Overall Study|Withdrawal by Subject|2|||
170385259|NCT02505945|615747809|FG000|Overall Study|Adverse Event|1|||
170385260|NCT02505945|615747810|FG001|Overall Study|Adverse Event|0|||
170385261|NCT02505945|615747809|FG000|Overall Study|Physician Decision|2|||
170385262|NCT02505945|615747810|FG001|Overall Study|Physician Decision|1|||
170385263|NCT02505945|615747809|FG000|Overall Study|Lost to Follow-up|6|||
170385264|NCT02505945|615747810|FG001|Overall Study|Lost to Follow-up|1|||
170385265|NCT00635804|615747811|FG000|Overall Study|Adverse Event|0|||
170385266|NCT00635804|615747812|FG001|Overall Study|Adverse Event|0|||
170385267|NCT00635804|615747813|FG002|Overall Study|Adverse Event|0|||
170385268|NCT00635804|615747814|FG003|Overall Study|Adverse Event|0|||
170385269|NCT00635804|615747815|FG004|Overall Study|Adverse Event|0|||
170385270|NCT00635804|615747816|FG005|Overall Study|Adverse Event|1|||
170385271|NCT00635804|615747817|FG006|Overall Study|Adverse Event|0|||
170385272|NCT00635804|615747818|FG007|Overall Study|Adverse Event|0|||
170385273|NCT00635804|615747811|FG000|Overall Study|Withdrawal by Subject|1|||
170385274|NCT00635804|615747812|FG001|Overall Study|Withdrawal by Subject|0|||
170385275|NCT00635804|615747813|FG002|Overall Study|Withdrawal by Subject|0|||
170385276|NCT00635804|615747814|FG003|Overall Study|Withdrawal by Subject|0|||
170385277|NCT00635804|615747815|FG004|Overall Study|Withdrawal by Subject|0|||
170385278|NCT00635804|615747816|FG005|Overall Study|Withdrawal by Subject|0|||
170385279|NCT00635804|615747817|FG006|Overall Study|Withdrawal by Subject|0|||
170385280|NCT00635804|615747818|FG007|Overall Study|Withdrawal by Subject|0|||
170385281|NCT02681094|615747825|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
170385282|NCT02681094|615747826|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
170385283|NCT02681094|615747827|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
170385284|NCT02681094|615747825|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
170385285|NCT02681094|615747826|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
170385286|NCT02681094|615747827|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
170385287|NCT02681094|615747825|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
170385288|NCT02681094|615747826|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
170385289|NCT02681094|615747827|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
170385290|NCT02681094|615747825|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
170385291|NCT02681094|615747826|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
170385292|NCT02681094|615747827|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
170385293|NCT02681094|615747825|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
170385294|NCT02681094|615747826|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
170385295|NCT02681094|615747827|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
170385296|NCT02681094|615747825|FG000|1 -Modified Enrolled Participants Set|Other|6|||
170385297|NCT02681094|615747826|FG001|1 -Modified Enrolled Participants Set|Other|6|||
170385298|NCT02681094|615747827|FG002|1 -Modified Enrolled Participants Set|Other|7|||
170385299|NCT02681094|615747825|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
170385300|NCT02681094|615747826|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
170385301|NCT02681094|615747827|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
170385302|NCT02681094|615747825|FG000|2 - Enrolled Participants Set|Participant decision|7|||
170385303|NCT02681094|615747826|FG001|2 - Enrolled Participants Set|Participant decision|10|||
170385304|NCT02681094|615747827|FG002|2 - Enrolled Participants Set|Participant decision|9|||
170385305|NCT02681094|615747825|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
170385306|NCT02681094|615747826|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
170385307|NCT02681094|615747827|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
170385308|NCT02681094|615747825|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
170385309|NCT02681094|615747826|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
170385310|NCT02681094|615747827|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
170385311|NCT02681094|615747825|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
170385312|NCT02681094|615747826|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
170385313|NCT02681094|615747827|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
170385314|NCT02681094|615747825|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
170385315|NCT02681094|615747826|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
170385316|NCT02681094|615747827|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
170385317|NCT02681094|615747825|FG000|2 - Enrolled Participants Set|Other|6|||
170385318|NCT02681094|615747826|FG001|2 - Enrolled Participants Set|Other|6|||
170385319|NCT02681094|615747827|FG002|2 - Enrolled Participants Set|Other|7|||
170385320|NCT02681094|615747825|FG000|2 - Enrolled Participants Set|No treatment given|0|||
170385321|NCT02681094|615747826|FG001|2 - Enrolled Participants Set|No treatment given|1|||
170385322|NCT02681094|615747827|FG002|2 - Enrolled Participants Set|No treatment given|1|||
170385323|NCT01072175|615747828|FG000|Part A (Drug-Drug Interaction)|Death|1|||
170385324|NCT01072175|615747829|FG001|Part A (Drug-Drug Interaction)|Death|0|||
170385325|NCT01072175|615747830|FG002|Part A (Drug-Drug Interaction)|Death|0|||
170385326|NCT01072175|615747831|FG003|Part A (Drug-Drug Interaction)|Death|0|||
170385327|NCT01072175|615747832|FG004|Part A (Drug-Drug Interaction)|Death|0|||
170385328|NCT01072175|615747833|FG005|Part A (Drug-Drug Interaction)|Death|0|||
170385329|NCT01072175|615747834|FG006|Part A (Drug-Drug Interaction)|Death|0|||
170385330|NCT01072175|615747835|FG007|Part A (Drug-Drug Interaction)|Death|0|||
170385331|NCT01072175|615747836|FG008|Part A (Drug-Drug Interaction)|Death|0|||
170385332|NCT01072175|615747837|FG009|Part A (Drug-Drug Interaction)|Death|0|||
170385333|NCT01072175|615747838|FG010|Part A (Drug-Drug Interaction)|Death|0|||
170385334|NCT01072175|615747839|FG011|Part A (Drug-Drug Interaction)|Death|0|||
170385335|NCT01072175|615747840|FG012|Part A (Drug-Drug Interaction)|Death|0|||
170385336|NCT01072175|615747828|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
170385337|NCT01072175|615747829|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385338|NCT01072175|615747830|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385339|NCT01072175|615747831|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385340|NCT01072175|615747832|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385341|NCT01072175|615747833|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385342|NCT01072175|615747834|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385343|NCT01072175|615747835|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385344|NCT01072175|615747836|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385345|NCT01072175|615747837|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385346|NCT01072175|615747838|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385347|NCT01072175|615747839|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385348|NCT01072175|615747840|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
170385349|NCT01072175|615747828|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
170385350|NCT01072175|615747829|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385351|NCT01072175|615747830|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385352|NCT01072175|615747831|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385353|NCT01072175|615747832|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385354|NCT01072175|615747833|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385355|NCT01072175|615747834|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385356|NCT01072175|615747835|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385357|NCT01072175|615747836|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385358|NCT01072175|615747837|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385359|NCT01072175|615747838|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385360|NCT01072175|615747839|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385361|NCT01072175|615747840|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
170385362|NCT01072175|615747828|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
170385363|NCT01072175|615747829|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
170385364|NCT01072175|615747830|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
170385365|NCT01072175|615747831|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
170385366|NCT01072175|615747832|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
170385367|NCT01072175|615747833|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
170385368|NCT01072175|615747834|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
170385369|NCT01072175|615747835|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
170385370|NCT01072175|615747836|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
170385371|NCT01072175|615747837|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
170385372|NCT01072175|615747838|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
170385373|NCT01072175|615747839|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
170385374|NCT01072175|615747840|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
170385375|NCT01072175|615747828|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385376|NCT01072175|615747829|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385377|NCT01072175|615747830|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
170385378|NCT01072175|615747831|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385379|NCT01072175|615747832|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
170385380|NCT01072175|615747833|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385381|NCT01072175|615747834|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385382|NCT01072175|615747835|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385383|NCT01072175|615747836|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385384|NCT01072175|615747837|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385385|NCT01072175|615747838|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385386|NCT01072175|615747839|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385387|NCT01072175|615747840|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
170385388|NCT01072175|615747828|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385389|NCT01072175|615747829|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
170385390|NCT01072175|615747830|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385391|NCT01072175|615747831|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
170385392|NCT01072175|615747832|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
170385393|NCT01072175|615747833|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170398858|NCT05004181|615798322|FG010|Overall Study|Lost to Follow-up|6|||
170385394|NCT01072175|615747834|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385395|NCT01072175|615747835|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385396|NCT01072175|615747836|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385397|NCT01072175|615747837|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385398|NCT01072175|615747838|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385399|NCT01072175|615747839|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385400|NCT01072175|615747840|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
170385401|NCT01072175|615747828|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385402|NCT01072175|615747829|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385403|NCT01072175|615747830|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
170385404|NCT01072175|615747831|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
170385405|NCT01072175|615747832|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
170385406|NCT01072175|615747833|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385407|NCT01072175|615747834|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385408|NCT01072175|615747835|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385409|NCT01072175|615747836|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385410|NCT01072175|615747837|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385411|NCT01072175|615747838|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385412|NCT01072175|615747839|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385413|NCT01072175|615747840|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
170385414|NCT01072175|615747828|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385415|NCT01072175|615747829|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
170385416|NCT01072175|615747830|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385417|NCT01072175|615747831|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
170385418|NCT01072175|615747832|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
170385419|NCT01072175|615747833|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385420|NCT01072175|615747834|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385421|NCT01072175|615747835|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385422|NCT01072175|615747836|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385423|NCT01072175|615747837|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385424|NCT01072175|615747838|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385425|NCT01072175|615747839|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385426|NCT01072175|615747840|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
170385427|NCT01072175|615747828|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
170385428|NCT01072175|615747829|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
170385429|NCT01072175|615747830|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
170385430|NCT01072175|615747831|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
170385431|NCT01072175|615747832|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
170385432|NCT01072175|615747833|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
170385433|NCT01072175|615747834|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
170385434|NCT01072175|615747835|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
170385435|NCT01072175|615747836|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
170385436|NCT01072175|615747837|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
170385437|NCT01072175|615747838|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
170385438|NCT01072175|615747839|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
170385439|NCT01072175|615747840|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
170385440|NCT01072175|615747828|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385441|NCT01072175|615747829|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385442|NCT01072175|615747830|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385443|NCT01072175|615747831|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385444|NCT01072175|615747832|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385445|NCT01072175|615747833|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
170385446|NCT01072175|615747834|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
170385447|NCT01072175|615747835|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
170385448|NCT01072175|615747836|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385449|NCT01072175|615747837|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385450|NCT01072175|615747838|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385451|NCT01072175|615747839|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385452|NCT01072175|615747840|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
170385453|NCT01072175|615747828|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385454|NCT01072175|615747829|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385455|NCT01072175|615747830|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385456|NCT01072175|615747831|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385457|NCT01072175|615747832|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385458|NCT01072175|615747833|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170398859|NCT05004181|615798323|FG011|Overall Study|Lost to Follow-up|0|||
170385459|NCT01072175|615747834|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
170385460|NCT01072175|615747835|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
170385461|NCT01072175|615747836|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385462|NCT01072175|615747837|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385463|NCT01072175|615747838|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385464|NCT01072175|615747839|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385465|NCT01072175|615747840|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
170385466|NCT01072175|615747828|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385467|NCT01072175|615747829|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385468|NCT01072175|615747830|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385469|NCT01072175|615747831|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385470|NCT01072175|615747832|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385471|NCT01072175|615747833|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
170385472|NCT01072175|615747834|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
170385473|NCT01072175|615747835|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
170385474|NCT01072175|615747836|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385475|NCT01072175|615747837|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385476|NCT01072175|615747838|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385477|NCT01072175|615747839|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385478|NCT01072175|615747840|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
170385479|NCT01072175|615747828|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385480|NCT01072175|615747829|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385481|NCT01072175|615747830|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385482|NCT01072175|615747831|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385483|NCT01072175|615747832|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385484|NCT01072175|615747833|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
170385485|NCT01072175|615747834|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
170385486|NCT01072175|615747835|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385487|NCT01072175|615747836|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385488|NCT01072175|615747837|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385489|NCT01072175|615747838|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385490|NCT01072175|615747839|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385491|NCT01072175|615747840|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
170385492|NCT01072175|615747828|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385493|NCT01072175|615747829|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385494|NCT01072175|615747830|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385495|NCT01072175|615747831|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385496|NCT01072175|615747832|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385497|NCT01072175|615747833|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385498|NCT01072175|615747834|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385499|NCT01072175|615747835|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385500|NCT01072175|615747836|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
170385501|NCT01072175|615747837|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385502|NCT01072175|615747838|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385503|NCT01072175|615747839|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385504|NCT01072175|615747840|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
170385505|NCT01072175|615747828|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385506|NCT01072175|615747829|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385507|NCT01072175|615747830|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385508|NCT01072175|615747831|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385509|NCT01072175|615747832|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385510|NCT01072175|615747833|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385511|NCT01072175|615747834|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385512|NCT01072175|615747835|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385513|NCT01072175|615747836|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
170385514|NCT01072175|615747837|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385515|NCT01072175|615747838|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385516|NCT01072175|615747839|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385517|NCT01072175|615747840|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
170385518|NCT01072175|615747828|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385519|NCT01072175|615747829|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385520|NCT01072175|615747830|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385521|NCT01072175|615747831|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385522|NCT01072175|615747832|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385523|NCT01072175|615747833|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385524|NCT01072175|615747834|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385525|NCT01072175|615747835|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385526|NCT01072175|615747836|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
170385527|NCT01072175|615747837|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385528|NCT01072175|615747838|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385529|NCT01072175|615747839|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385530|NCT01072175|615747840|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
170385531|NCT01072175|615747828|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385532|NCT01072175|615747829|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385533|NCT01072175|615747830|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385534|NCT01072175|615747831|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385535|NCT01072175|615747832|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385536|NCT01072175|615747833|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385537|NCT01072175|615747834|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385538|NCT01072175|615747835|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385539|NCT01072175|615747836|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
170385540|NCT01072175|615747837|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385541|NCT01072175|615747838|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385542|NCT01072175|615747839|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385543|NCT01072175|615747840|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
170385544|NCT01072175|615747828|FG000|Part D (HPMC Capsules)|Death|0|||
170385545|NCT01072175|615747829|FG001|Part D (HPMC Capsules)|Death|0|||
170385546|NCT01072175|615747830|FG002|Part D (HPMC Capsules)|Death|0|||
170385547|NCT01072175|615747831|FG003|Part D (HPMC Capsules)|Death|0|||
170385548|NCT01072175|615747832|FG004|Part D (HPMC Capsules)|Death|0|||
170385549|NCT01072175|615747833|FG005|Part D (HPMC Capsules)|Death|0|||
170385550|NCT01072175|615747834|FG006|Part D (HPMC Capsules)|Death|0|||
170385551|NCT01072175|615747835|FG007|Part D (HPMC Capsules)|Death|0|||
170385552|NCT01072175|615747836|FG008|Part D (HPMC Capsules)|Death|0|||
170385553|NCT01072175|615747837|FG009|Part D (HPMC Capsules)|Death|10|||
170385554|NCT01072175|615747838|FG010|Part D (HPMC Capsules)|Death|12|||
170385555|NCT01072175|615747839|FG011|Part D (HPMC Capsules)|Death|28|||
170385556|NCT01072175|615747840|FG012|Part D (HPMC Capsules)|Death|26|||
170385557|NCT01072175|615747828|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
170385558|NCT01072175|615747829|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
170385559|NCT01072175|615747830|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
170385560|NCT01072175|615747831|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
170385561|NCT01072175|615747832|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
170385562|NCT01072175|615747833|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
170385563|NCT01072175|615747834|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
170385564|NCT01072175|615747835|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
170385565|NCT01072175|615747836|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
170385566|NCT01072175|615747837|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
170385567|NCT01072175|615747838|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
170385568|NCT01072175|615747839|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
170385569|NCT01072175|615747840|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
170385570|NCT01072175|615747828|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385571|NCT01072175|615747829|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385572|NCT01072175|615747830|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385573|NCT01072175|615747831|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385574|NCT01072175|615747832|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385575|NCT01072175|615747833|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385576|NCT01072175|615747834|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385577|NCT01072175|615747835|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385578|NCT01072175|615747836|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385579|NCT01072175|615747837|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
170385580|NCT01072175|615747838|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
170385581|NCT01072175|615747839|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
170385582|NCT01072175|615747840|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
170385583|NCT01072175|615747828|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385584|NCT01072175|615747829|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385585|NCT01072175|615747830|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385586|NCT01072175|615747831|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385587|NCT01072175|615747832|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385588|NCT01072175|615747833|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385589|NCT01072175|615747834|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385590|NCT01072175|615747835|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385591|NCT01072175|615747836|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
170385592|NCT01072175|615747837|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
170385593|NCT01072175|615747838|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
170385594|NCT01072175|615747839|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
170385595|NCT01072175|615747840|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
170385596|NCT01072175|615747828|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385597|NCT01072175|615747829|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385598|NCT01072175|615747830|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385599|NCT01072175|615747831|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385600|NCT01072175|615747832|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385601|NCT01072175|615747833|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385602|NCT01072175|615747834|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385603|NCT01072175|615747835|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385604|NCT01072175|615747836|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385605|NCT01072175|615747837|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385606|NCT01072175|615747838|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
170385607|NCT01072175|615747839|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
170385608|NCT01072175|615747840|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
170385609|NCT02839330|615747841|FG000|Overall Study|Adverse Event|0|||
170385610|NCT02839330|615747842|FG001|Overall Study|Adverse Event|1|||
170385611|NCT02839330|615747843|FG002|Overall Study|Adverse Event|2|||
170385612|NCT02839330|615747844|FG003|Overall Study|Adverse Event|2|||
170385613|NCT02839330|615747841|FG000|Overall Study|Death|4|||
170385614|NCT02839330|615747842|FG001|Overall Study|Death|6|||
170385615|NCT02839330|615747843|FG002|Overall Study|Death|1|||
170385616|NCT02839330|615747844|FG003|Overall Study|Death|1|||
170385617|NCT02839330|615747841|FG000|Overall Study|Withdrawal by Subject|27|||
170385618|NCT02839330|615747842|FG001|Overall Study|Withdrawal by Subject|19|||
170385619|NCT02839330|615747843|FG002|Overall Study|Withdrawal by Subject|11|||
170385620|NCT02839330|615747844|FG003|Overall Study|Withdrawal by Subject|13|||
170385621|NCT02839330|615747841|FG000|Overall Study|Lost to Follow-up|22|||
170385622|NCT02839330|615747842|FG001|Overall Study|Lost to Follow-up|27|||
170385623|NCT02839330|615747843|FG002|Overall Study|Lost to Follow-up|29|||
170385624|NCT02839330|615747844|FG003|Overall Study|Lost to Follow-up|25|||
170385625|NCT02839330|615747841|FG000|Overall Study|Administrative Reason|0|||
170385626|NCT02839330|615747842|FG001|Overall Study|Administrative Reason|0|||
170385627|NCT02839330|615747843|FG002|Overall Study|Administrative Reason|0|||
170385628|NCT02839330|615747844|FG003|Overall Study|Administrative Reason|1|||
170385629|NCT02839330|615747841|FG000|Overall Study|Protocol Violation|1|||
170385630|NCT02839330|615747842|FG001|Overall Study|Protocol Violation|2|||
170385631|NCT02839330|615747843|FG002|Overall Study|Protocol Violation|2|||
170385632|NCT02839330|615747844|FG003|Overall Study|Protocol Violation|3|||
170385633|NCT02839330|615747841|FG000|Overall Study|Other reason, not specified|4|||
170385634|NCT02839330|615747842|FG001|Overall Study|Other reason, not specified|3|||
170385635|NCT02839330|615747843|FG002|Overall Study|Other reason, not specified|3|||
170385636|NCT02839330|615747844|FG003|Overall Study|Other reason, not specified|6|||
170385637|NCT06104423|615747851|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
170385638|NCT06104423|615747852|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
170385639|NCT06104423|615747853|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
170385640|NCT06104423|615747851|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
170385641|NCT06104423|615747852|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
170385642|NCT06104423|615747853|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
170385643|NCT02708524|615747854|FG000|Overall Study|Adverse Event|0|||
170385644|NCT02708524|615747855|FG001|Overall Study|Adverse Event|1|||
170385645|NCT02708524|615747856|FG002|Overall Study|Adverse Event|0|||
170385646|NCT02708524|615747857|FG003|Overall Study|Adverse Event|0|||
170385647|NCT02708524|615747854|FG000|Overall Study|Lens Discomfort|1|||
170385648|NCT02708524|615747855|FG001|Overall Study|Lens Discomfort|0|||
170385649|NCT02708524|615747856|FG002|Overall Study|Lens Discomfort|1|||
170385650|NCT02708524|615747857|FG003|Overall Study|Lens Discomfort|0|||
170385651|NCT02708524|615747854|FG000|Overall Study|Lost to Follow-up|1|||
170385652|NCT02708524|615747855|FG001|Overall Study|Lost to Follow-up|1|||
170385653|NCT02708524|615747856|FG002|Overall Study|Lost to Follow-up|1|||
170385654|NCT02708524|615747857|FG003|Overall Study|Lost to Follow-up|0|||
170385655|NCT02708524|615747854|FG000|Overall Study|Protocol Violation|0|||
170385656|NCT02708524|615747855|FG001|Overall Study|Protocol Violation|1|||
170385657|NCT02708524|615747856|FG002|Overall Study|Protocol Violation|0|||
170385658|NCT02708524|615747857|FG003|Overall Study|Protocol Violation|0|||
170385659|NCT02708524|615747854|FG000|Overall Study|Withdrawal by Subject|1|||
170385660|NCT02708524|615747855|FG001|Overall Study|Withdrawal by Subject|1|||
170385661|NCT02708524|615747856|FG002|Overall Study|Withdrawal by Subject|0|||
170385662|NCT02708524|615747857|FG003|Overall Study|Withdrawal by Subject|0|||
170385663|NCT02708524|615747854|FG000|Overall Study|Dispensed incorrect study lens|0|||
170385664|NCT02708524|615747855|FG001|Overall Study|Dispensed incorrect study lens|1|||
170385665|NCT02708524|615747856|FG002|Overall Study|Dispensed incorrect study lens|1|||
170385666|NCT02708524|615747857|FG003|Overall Study|Dispensed incorrect study lens|0|||
170385667|NCT02708524|615747854|FG000|Overall Study|Did not wear lens at final visit|0|||
170398860|NCT05004181|615798312|FG000|Overall Study|Death|0|||
170385668|NCT02708524|615747855|FG001|Overall Study|Did not wear lens at final visit|1|||
170385669|NCT02708524|615747856|FG002|Overall Study|Did not wear lens at final visit|0|||
170385670|NCT02708524|615747857|FG003|Overall Study|Did not wear lens at final visit|0|||
170385671|NCT02708524|615747854|FG000|Overall Study|Subject lost study lens|1|||
170385672|NCT02708524|615747855|FG001|Overall Study|Subject lost study lens|0|||
170385673|NCT02708524|615747856|FG002|Overall Study|Subject lost study lens|0|||
170385674|NCT02708524|615747857|FG003|Overall Study|Subject lost study lens|0|||
170385675|NCT00475657|615747859|FG000|Overall Study|Death|1|||
170385676|NCT00475657|615747859|FG000|Overall Study|Sponsor's Decision|3|||
170385677|NCT00408408|615747860|FG000|Overall Study|No follow up data|2|||
170385678|NCT00408408|615747861|FG001|Overall Study|No follow up data|3|||
170385679|NCT00408408|615747862|FG002|Overall Study|No follow up data|0|||
170385680|NCT00408408|615747863|FG003|Overall Study|No follow up data|7|||
170385681|NCT00408408|615747864|FG004|Overall Study|No follow up data|5|||
170385682|NCT00408408|615747865|FG005|Overall Study|No follow up data|3|||
170385683|NCT00535262|615747868|FG000|Overall Study|No funding|3|||
170385684|NCT03802331|615747870|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
170385685|NCT03802331|615747871|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
170385686|NCT00399542|615747872|FG000|Overall Study|Adverse Event|18|||
170385687|NCT00399542|615747873|FG001|Overall Study|Adverse Event|15|||
170385688|NCT00399542|615747872|FG000|Overall Study|Protocol Violation|13|||
170385689|NCT00399542|615747873|FG001|Overall Study|Protocol Violation|3|||
170385690|NCT00399542|615747872|FG000|Overall Study|Withdrawal by Subject|28|||
170385691|NCT00399542|615747873|FG001|Overall Study|Withdrawal by Subject|10|||
170385692|NCT00399542|615747872|FG000|Overall Study|Lack of Efficacy|18|||
170385693|NCT00399542|615747873|FG001|Overall Study|Lack of Efficacy|8|||
170385694|NCT00399542|615747872|FG000|Overall Study|Lost to Follow-up|6|||
170385695|NCT00399542|615747873|FG001|Overall Study|Lost to Follow-up|6|||
170385696|NCT00399542|615747872|FG000|Overall Study|Other|1|||
170385697|NCT00399542|615747873|FG001|Overall Study|Other|0|||
170385698|NCT00399542|615747872|FG000|Overall Study|Physician Decision|0|||
170385699|NCT00399542|615747873|FG001|Overall Study|Physician Decision|1|||
170385700|NCT00917553|615747877|FG000|Overall Study|Lost to Follow-up|2|||
170385701|NCT00917553|615747878|FG001|Overall Study|Lost to Follow-up|1|||
170385702|NCT01616173|615747879|FG000|Overall Study|Lost to Follow-up|0|||
170385703|NCT01616173|615747880|FG001|Overall Study|Lost to Follow-up|2|||
170385704|NCT01616173|615747881|FG002|Overall Study|Lost to Follow-up|0|||
170385705|NCT00504595|615747883|FG000|Overall Study|Lack of Efficacy|1|||
170385706|NCT00504595|615747884|FG001|Overall Study|Lack of Efficacy|0|||
170385707|NCT00504595|615747885|FG002|Overall Study|Lack of Efficacy|0|||
170385708|NCT00504595|615747886|FG003|Overall Study|Lack of Efficacy|0|||
170385709|NCT00504595|615747883|FG000|Overall Study|Other|0|||
170385710|NCT00504595|615747884|FG001|Overall Study|Other|0|||
170385711|NCT00504595|615747885|FG002|Overall Study|Other|2|||
170385712|NCT00504595|615747886|FG003|Overall Study|Other|0|||
170385713|NCT01177943|615747887|FG000|First Intervention|Withdrawal by Subject|2|||
170385714|NCT01177943|615747888|FG001|First Intervention|Withdrawal by Subject|0|||
170385715|NCT01220024|615747892|FG000|Overall Study|Lost to Follow-up|1|||
170385716|NCT01220024|615747893|FG001|Overall Study|Lost to Follow-up|1|||
170385717|NCT04225026|615747894|FG000|Overall Study|Withdrawal by Subject|4|||
170385718|NCT04225026|615747894|FG000|Overall Study|Adverse Event|1|||
170385719|NCT04225026|615747894|FG000|Overall Study|Other|1|||
170385720|NCT04225026|615747894|FG000|Overall Study|Death|11|||
170385721|NCT04225026|615747894|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
170385722|NCT04652245|615747897|FG000|Wash-Out Period|Adverse Event|0|||
170385723|NCT04652245|615747898|FG001|Wash-Out Period|Adverse Event|2|||
170385724|NCT04652245|615747897|FG000|Wash-Out Period|Withdrawal by Subject|0|||
170385725|NCT04652245|615747898|FG001|Wash-Out Period|Withdrawal by Subject|2|||
170385726|NCT02135848|615747901|FG000|Overall Study|Adverse Event|2|||
170385727|NCT02135848|615747902|FG001|Overall Study|Adverse Event|0|||
170385728|NCT02135848|615747901|FG000|Overall Study|Withdrawal by Subject|1|||
170385729|NCT02135848|615747902|FG001|Overall Study|Withdrawal by Subject|1|||
170385730|NCT01724021|615747909|FG000|Overall Study|Adverse Event|11|||
170385731|NCT01724021|615747910|FG001|Overall Study|Adverse Event|6|||
170385732|NCT01724021|615747909|FG000|Overall Study|Death|46|||
170385733|NCT01724021|615747910|FG001|Overall Study|Death|58|||
170385734|NCT01724021|615747909|FG000|Overall Study|Participant request/ Withdrew consent|18|||
170385735|NCT01724021|615747910|FG001|Overall Study|Participant request/ Withdrew consent|14|||
170385736|NCT01724021|615747909|FG000|Overall Study|Lost to Follow-up|15|||
170385737|NCT01724021|615747910|FG001|Overall Study|Lost to Follow-up|15|||
170385738|NCT01724021|615747909|FG000|Overall Study|Reason Not Specified|36|||
170385739|NCT01724021|615747910|FG001|Overall Study|Reason Not Specified|39|||
170385740|NCT01724021|615747909|FG000|Overall Study|Missing|1|||
170385741|NCT01724021|615747910|FG001|Overall Study|Missing|1|||
170385742|NCT01468844|615747911|FG000|Overall Study|Adverse Event|1|||
170385743|NCT01468844|615747912|FG001|Overall Study|Adverse Event|0|||
170385744|NCT01468844|615747911|FG000|Overall Study|Withdrawal by Subject|1|||
170385745|NCT01468844|615747912|FG001|Overall Study|Withdrawal by Subject|0|||
170385746|NCT00701064|615747915|FG000|Overall Study|Protocol Violation|1|||
170385747|NCT00701064|615747916|FG001|Overall Study|Protocol Violation|1|||
170385748|NCT00701064|615747915|FG000|Overall Study|Withdrawal by Subject|1|||
170385749|NCT00701064|615747916|FG001|Overall Study|Withdrawal by Subject|1|||
170385750|NCT00701064|615747915|FG000|Overall Study|initiated other PTSD treatment|2|||
170385751|NCT00701064|615747916|FG001|Overall Study|initiated other PTSD treatment|2|||
170385752|NCT02613910|615747917|FG000|Overall Study|Termination of study|1|||
170385753|NCT02098733|615747918|FG000|Overall Study|Data Not Available|5|||
170385754|NCT02098733|615747918|FG000|Overall Study|Lost to Follow-up|5|||
170385755|NCT03077646|615747919|FG000|Overall Study|Lost to Follow-up|29|||
170385756|NCT03077646|615747920|FG001|Overall Study|Lost to Follow-up|30|||
170385757|NCT03077646|615747921|FG002|Overall Study|Lost to Follow-up|31|||
170385758|NCT00765726|615747922|FG000|Overall Study|Withdrawal by Subject|1|||
170385759|NCT00765726|615747922|FG000|Overall Study|Discontinuation of study by sponsor|8|||
170385760|NCT01682876|615750043|FG000|Overall Study|Administrative reason|4|||
170385761|NCT01682876|615750044|FG001|Overall Study|Administrative reason|4|||
170385762|NCT01682876|615750045|FG002|Overall Study|Administrative reason|0|||
170385763|NCT01682876|615750046|FG003|Overall Study|Administrative reason|3|||
170385764|NCT01682876|615750043|FG000|Overall Study|Adverse Event|0|||
170385765|NCT01682876|615750044|FG001|Overall Study|Adverse Event|0|||
170385766|NCT01682876|615750045|FG002|Overall Study|Adverse Event|0|||
170385767|NCT01682876|615750046|FG003|Overall Study|Adverse Event|1|||
170385768|NCT01682876|615750043|FG000|Overall Study|Lost to Follow-up|11|||
170385769|NCT01682876|615750044|FG001|Overall Study|Lost to Follow-up|15|||
170385770|NCT01682876|615750045|FG002|Overall Study|Lost to Follow-up|9|||
170385771|NCT01682876|615750046|FG003|Overall Study|Lost to Follow-up|11|||
170385772|NCT01682876|615750043|FG000|Overall Study|Protocol Violation|1|||
170385773|NCT01682876|615750044|FG001|Overall Study|Protocol Violation|1|||
170385774|NCT01682876|615750045|FG002|Overall Study|Protocol Violation|1|||
170385775|NCT01682876|615750046|FG003|Overall Study|Protocol Violation|1|||
170385776|NCT01682876|615750043|FG000|Overall Study|Withdrawal by Subject|4|||
170385777|NCT01682876|615750044|FG001|Overall Study|Withdrawal by Subject|0|||
170385778|NCT01682876|615750045|FG002|Overall Study|Withdrawal by Subject|0|||
170385779|NCT01682876|615750046|FG003|Overall Study|Withdrawal by Subject|2|||
170385780|NCT01682876|615750043|FG000|Overall Study|Other|1|||
170385781|NCT01682876|615750044|FG001|Overall Study|Other|0|||
170385782|NCT01682876|615750045|FG002|Overall Study|Other|1|||
170385783|NCT01682876|615750046|FG003|Overall Study|Other|1|||
170385784|NCT01545375|615750051|FG000|Overall Study|Adverse Event|2|||
170385785|NCT01545375|615750052|FG001|Overall Study|Adverse Event|1|||
170385786|NCT01545375|615750051|FG000|Overall Study|Lost to Follow-up|34|||
170385787|NCT01545375|615750052|FG001|Overall Study|Lost to Follow-up|31|||
170385788|NCT01545375|615750051|FG000|Overall Study|Protocol Violation|3|||
170385789|NCT01545375|615750052|FG001|Overall Study|Protocol Violation|3|||
170385790|NCT01545375|615750051|FG000|Overall Study|Withdrawal by Subject|58|||
170385791|NCT01545375|615750052|FG001|Overall Study|Withdrawal by Subject|55|||
170385792|NCT01846039|615750053|FG000|Overall Study|Protocol Violation|1|||
170385793|NCT01846039|615750053|FG000|Overall Study|Subject Withdrew Consent|1|||
170385794|NCT00594958|615750054|FG000|Overall Study|Withdrawal by Subject|1|||
170385795|NCT00594958|615750055|FG001|Overall Study|Withdrawal by Subject|0|||
170385796|NCT00594958|615750056|FG002|Overall Study|Withdrawal by Subject|1|||
170385797|NCT00594958|615750054|FG000|Overall Study|Adverse Event|4|||
170385798|NCT00594958|615750055|FG001|Overall Study|Adverse Event|1|||
170385799|NCT00594958|615750056|FG002|Overall Study|Adverse Event|2|||
170385800|NCT00594958|615750054|FG000|Overall Study|Pregnancy|0|||
170385801|NCT00594958|615750055|FG001|Overall Study|Pregnancy|2|||
170385802|NCT00594958|615750056|FG002|Overall Study|Pregnancy|0|||
170385803|NCT00594958|615750054|FG000|Overall Study|Protocol Violation|1|||
170385804|NCT00594958|615750055|FG001|Overall Study|Protocol Violation|0|||
170385805|NCT00594958|615750056|FG002|Overall Study|Protocol Violation|2|||
170385806|NCT00594958|615750054|FG000|Overall Study|Lost to Follow-up|5|||
170385807|NCT00594958|615750055|FG001|Overall Study|Lost to Follow-up|0|||
170385808|NCT00594958|615750056|FG002|Overall Study|Lost to Follow-up|3|||
170385809|NCT00594958|615750054|FG000|Overall Study|administrative|3|||
170385810|NCT00594958|615750055|FG001|Overall Study|administrative|0|||
170385811|NCT00594958|615750056|FG002|Overall Study|administrative|2|||
170385812|NCT02158949|615750057|FG000|Overall Study|Withdrawal by Subject|1|||
170385813|NCT02158949|615750058|FG001|Overall Study|Withdrawal by Subject|0|||
170385814|NCT02158949|615750057|FG000|Overall Study|Lost to Follow-up|5|||
170385815|NCT02158949|615750058|FG001|Overall Study|Lost to Follow-up|11|||
170385816|NCT02181634|615750059|FG000|Overall Study|Lack of Efficacy|33|||
170385817|NCT02181634|615750059|FG000|Overall Study|Adverse Event|17|||
170385818|NCT02181634|615750059|FG000|Overall Study|Physician Decision|8|||
170385819|NCT02181634|615750059|FG000|Overall Study|Withdrawal by Subject|5|||
170385820|NCT02181634|615750059|FG000|Overall Study|Death|2|||
170385821|NCT02181634|615750059|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
170385822|NCT02181634|615750059|FG000|Overall Study|Ineligible|1|||
170385823|NCT02181634|615750059|FG000|Overall Study|Max number of dose reduction|1|||
170385824|NCT02181634|615750059|FG000|Overall Study|Symptomatic progression|1|||
170385825|NCT02181634|615750059|FG000|Overall Study|Patient opted to proceed to surgery|1|||
170385826|NCT02477215|615750069|FG000|Dose Escalation Phase|Physician Decision|1|||
170385827|NCT02477215|615750070|FG001|Dose Escalation Phase|Physician Decision|2|||
170385828|NCT02477215|615750071|FG002|Dose Escalation Phase|Physician Decision|0|||
170385829|NCT02477215|615750069|FG000|Fixed Dose Phase|Physician Decision|0|||
170385830|NCT02477215|615750070|FG001|Fixed Dose Phase|Physician Decision|7|||
170385831|NCT02477215|615750071|FG002|Fixed Dose Phase|Physician Decision|0|||
170385832|NCT02898662|615750085|FG000|Overall Study|Adverse Event|1|||
170385833|NCT02898662|615750086|FG001|Overall Study|Adverse Event|0|||
170385834|NCT02898662|615750085|FG000|Overall Study|Loss of asthma control|23|||
170385835|NCT02898662|615750086|FG001|Overall Study|Loss of asthma control|24|||
170385836|NCT02898662|615750085|FG000|Overall Study|Withdrawal by Subject|4|||
170385837|NCT02898662|615750086|FG001|Overall Study|Withdrawal by Subject|1|||
170385838|NCT02898662|615750085|FG000|Overall Study|Technical issue|0|||
170385839|NCT02898662|615750086|FG001|Overall Study|Technical issue|1|||
170385840|NCT02898662|615750085|FG000|Overall Study|Randomized in error|0|||
170385841|NCT02898662|615750086|FG001|Overall Study|Randomized in error|1|||
170385842|NCT02898662|615750085|FG000|Overall Study|Subject decision|1|||
170385843|NCT02898662|615750086|FG001|Overall Study|Subject decision|0|||
170385844|NCT02898662|615750085|FG000|Overall Study|Other|0|||
170385845|NCT02898662|615750086|FG001|Overall Study|Other|1|||
170385846|NCT03172026|615750090|FG000|Overall Study|Withdrawal by Subject|1|||
170385847|NCT03172026|615750091|FG001|Overall Study|Withdrawal by Subject|0|||
170385848|NCT03172026|615750090|FG000|Overall Study|COVID restrictions|1|||
170385849|NCT03172026|615750091|FG001|Overall Study|COVID restrictions|0|||
170385850|NCT04382066|615750095|FG000|Overall Study|Adverse Event|1|||
170385851|NCT04382066|615750096|FG001|Overall Study|Adverse Event|0|||
170385852|NCT04382066|615750097|FG002|Overall Study|Adverse Event|0|||
170385853|NCT04382066|615750095|FG000|Overall Study|Death|1|||
170385854|NCT04382066|615750096|FG001|Overall Study|Death|0|||
170385855|NCT04382066|615750097|FG002|Overall Study|Death|1|||
170385856|NCT01430559|615750098|FG000|Overall Study|Adverse Event|7|||
170385857|NCT01430559|615750099|FG001|Overall Study|Adverse Event|3|||
170385858|NCT01430559|615750098|FG000|Overall Study|Entry criteria not met|1|||
170385859|NCT01430559|615750099|FG001|Overall Study|Entry criteria not met|1|||
170385860|NCT01430559|615750098|FG000|Overall Study|Lost to Follow-up|1|||
170385861|NCT01430559|615750099|FG001|Overall Study|Lost to Follow-up|0|||
170385862|NCT01430559|615750098|FG000|Overall Study|Medication error|1|||
170385863|NCT01430559|615750099|FG001|Overall Study|Medication error|0|||
170385864|NCT01430559|615750098|FG000|Overall Study|Withdrawal by Subject|3|||
170385865|NCT01430559|615750099|FG001|Overall Study|Withdrawal by Subject|2|||
170385866|NCT01430559|615750098|FG000|Overall Study|Protocol Violation|1|||
170385867|NCT01430559|615750099|FG001|Overall Study|Protocol Violation|0|||
170385868|NCT01430559|615750098|FG000|Overall Study|Other|3|||
170385869|NCT01430559|615750099|FG001|Overall Study|Other|3|||
170385870|NCT01430559|615750098|FG000|Overall Study|Randomized, Not Treated|3|||
170385871|NCT01430559|615750099|FG001|Overall Study|Randomized, Not Treated|3|||
170385872|NCT01258803|615750100|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
170385873|NCT01258803|615750101|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
170385874|NCT01258803|615750102|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
170385875|NCT01258803|615750103|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
170385876|NCT01258803|615750104|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
170385877|NCT01258803|615750105|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
170385878|NCT01258803|615750100|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
170385879|NCT01258803|615750101|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
170385880|NCT01258803|615750102|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
170385881|NCT01258803|615750103|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
170385882|NCT01258803|615750104|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
170385883|NCT01258803|615750105|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
170385884|NCT01258803|615750100|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
170385885|NCT01258803|615750101|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
170385886|NCT01258803|615750102|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
170385887|NCT01258803|615750103|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
170385888|NCT01258803|615750104|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
170385889|NCT01258803|615750105|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
170385890|NCT00779142|615750106|FG000|Overall Study|Screen Failures|3|||
170385891|NCT01552408|615750109|FG000|Overall Study|Lost to Follow-up|2|||
170385892|NCT01552408|615750110|FG001|Overall Study|Lost to Follow-up|0|||
170385893|NCT01552408|615750109|FG000|Overall Study|Relocation|0|||
170385894|NCT01552408|615750110|FG001|Overall Study|Relocation|1|||
170385895|NCT01552408|615750109|FG000|Overall Study|Withdrawal by Subject|2|||
170385896|NCT01552408|615750110|FG001|Overall Study|Withdrawal by Subject|1|||
170385897|NCT04738123|615750113|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
170385898|NCT04738123|615750114|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
170385899|NCT04738123|615750113|FG000|Overall Study|Progressive Disease|0|||
170385900|NCT04738123|615750114|FG001|Overall Study|Progressive Disease|4|||
170385901|NCT04738123|615750113|FG000|Overall Study|Adverse Event|8|||
170385902|NCT04738123|615750114|FG001|Overall Study|Adverse Event|7|||
170385903|NCT04738123|615750113|FG000|Overall Study|Other Reasons|0|||
170385904|NCT04738123|615750114|FG001|Overall Study|Other Reasons|1|||
170385905|NCT04738123|615750113|FG000|Overall Study|Suicidal or assaultive behavior|0|||
170385906|NCT04738123|615750114|FG001|Overall Study|Suicidal or assaultive behavior|2|||
170385907|NCT04738123|615750113|FG000|Overall Study|Protocol Violation|2|||
170385908|NCT04738123|615750114|FG001|Overall Study|Protocol Violation|2|||
170385909|NCT04738123|615750113|FG000|Overall Study|Consent Withdrawn|35|||
170385910|NCT04738123|615750114|FG001|Overall Study|Consent Withdrawn|22|||
170385911|NCT00787527|615750116|FG000|Overall Study|Toxicity|3|||
170385912|NCT00083616|615750117|FG000|Overall Study|Disease Progression|16|||
170385913|NCT00083616|615750117|FG000|Overall Study|Lost to Follow-up|1|||
170385914|NCT00083616|615750117|FG000|Overall Study|Physician Decision|2|||
170385915|NCT00083616|615750117|FG000|Overall Study|Withdrawal by Subject|3|||
170385916|NCT00083616|615750117|FG000|Overall Study|Ineligibility determined|2|||
170385917|NCT00083616|615750117|FG000|Overall Study|Non-compliance|1|||
170385918|NCT00083616|615750117|FG000|Overall Study|Other|6|||
170385919|NCT00486720|615750118|FG000|Overall Study|Adverse Event|1|||
170385920|NCT00486720|615750119|FG001|Overall Study|Adverse Event|2|||
170385921|NCT00486720|615750118|FG000|Overall Study|Lack of Efficacy|4|||
170385922|NCT00486720|615750119|FG001|Overall Study|Lack of Efficacy|6|||
170385923|NCT00486720|615750118|FG000|Overall Study|Physician Decision|1|||
170385924|NCT00486720|615750119|FG001|Overall Study|Physician Decision|2|||
170385925|NCT00486720|615750118|FG000|Overall Study|Protocol Violation|1|||
170385926|NCT00486720|615750119|FG001|Overall Study|Protocol Violation|0|||
170385927|NCT00486720|615750118|FG000|Overall Study|Withdrawal by Subject|3|||
170385928|NCT00486720|615750119|FG001|Overall Study|Withdrawal by Subject|1|||
170385929|NCT00486720|615750118|FG000|Overall Study|Progressive Disease|0|||
170385930|NCT00486720|615750119|FG001|Overall Study|Progressive Disease|1|||
170385931|NCT02452892|615750120|FG000|Week 1 Initial Randommization|Adverse Event|1|||
170385932|NCT02452892|615750121|FG001|Week 1 Initial Randommization|Adverse Event|0|||
170385933|NCT02452892|615750122|FG002|Week 1 Initial Randommization|Adverse Event|0|||
170385934|NCT02452892|615750123|FG003|Week 1 Initial Randommization|Adverse Event|0|||
170385935|NCT02452892|615750120|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
170385936|NCT02452892|615750121|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
170385937|NCT02452892|615750122|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
170385938|NCT02452892|615750123|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
170385939|NCT02452892|615750120|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
170385940|NCT02452892|615750121|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
170385941|NCT02452892|615750122|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
170385942|NCT02452892|615750123|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
170385943|NCT02452892|615750120|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
170385944|NCT02452892|615750121|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
170385945|NCT02452892|615750122|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
170385946|NCT02452892|615750123|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
170385947|NCT02452892|615750120|FG000|Follow-up|Withdrawal by Subject|0|||
170385948|NCT02452892|615750121|FG001|Follow-up|Withdrawal by Subject|0|||
170385949|NCT02452892|615750122|FG002|Follow-up|Withdrawal by Subject|0|||
170385950|NCT02452892|615750123|FG003|Follow-up|Withdrawal by Subject|1|||
170385951|NCT02452892|615750120|FG000|Follow-up|Subject left town on Day 42|1|||
170385952|NCT02452892|615750121|FG001|Follow-up|Subject left town on Day 42|0|||
170385953|NCT02452892|615750122|FG002|Follow-up|Subject left town on Day 42|0|||
170385954|NCT02452892|615750123|FG003|Follow-up|Subject left town on Day 42|0|||
170385955|NCT00606931|615750128|FG000|Overall Study|Withdrawal by Subject|3|||
170385956|NCT05047601|615750130|FG000|Overall Study|Lost to Follow-up|9|||
170385957|NCT05047601|615750131|FG001|Overall Study|Lost to Follow-up|11|||
170385958|NCT05047601|615750132|FG002|Overall Study|Lost to Follow-up|7|||
170385959|NCT05047601|615750130|FG000|Overall Study|Withdrawal by Subject|25|||
170385960|NCT05047601|615750131|FG001|Overall Study|Withdrawal by Subject|36|||
170385961|NCT05047601|615750132|FG002|Overall Study|Withdrawal by Subject|23|||
170385962|NCT05047601|615750130|FG000|Overall Study|Other|10|||
170385963|NCT05047601|615750131|FG001|Overall Study|Other|6|||
170385964|NCT05047601|615750132|FG002|Overall Study|Other|5|||
170385965|NCT04246996|615750153|FG000|Overall Study|Physician Decision|1|||
170385966|NCT04246996|615750154|FG001|Overall Study|Physician Decision|1|||
170385967|NCT04246996|615750153|FG000|Overall Study|Did not meet eligibility criteria|1|||
170385968|NCT04246996|615750154|FG001|Overall Study|Did not meet eligibility criteria|4|||
170385969|NCT02853318|615750158|FG000|Overall Study|Withdrawal by Subject|1|||
170385970|NCT04490499|615750159|FG000|Overall Study|Withdrawal by Subject|2|||
170385971|NCT01882439|615750160|FG000|Overall Study|Adverse event related to study drug|3|||
170385972|NCT01882439|615750161|FG001|Overall Study|Adverse event related to study drug|8|||
170385973|NCT01882439|615750162|FG002|Overall Study|Adverse event related to study drug|1|||
170385974|NCT01882439|615750163|FG003|Overall Study|Adverse event related to study drug|2|||
170385975|NCT01882439|615750160|FG000|Overall Study|Pregnancy|0|||
170385976|NCT01882439|615750161|FG001|Overall Study|Pregnancy|1|||
170385977|NCT01882439|615750162|FG002|Overall Study|Pregnancy|0|||
170385978|NCT01882439|615750163|FG003|Overall Study|Pregnancy|0|||
170385979|NCT01882439|615750160|FG000|Overall Study|Protocol Violation|2|||
170385980|NCT01882439|615750161|FG001|Overall Study|Protocol Violation|2|||
170385981|NCT01882439|615750162|FG002|Overall Study|Protocol Violation|0|||
170385982|NCT01882439|615750163|FG003|Overall Study|Protocol Violation|1|||
170385983|NCT01882439|615750160|FG000|Overall Study|No longer willing to participate|1|||
170385984|NCT01882439|615750161|FG001|Overall Study|No longer willing to participate|4|||
170385985|NCT01882439|615750162|FG002|Overall Study|No longer willing to participate|2|||
170385986|NCT01882439|615750163|FG003|Overall Study|No longer willing to participate|3|||
170385987|NCT01882439|615750160|FG000|Overall Study|Medication error with no associated AE|0|||
170385988|NCT01882439|615750161|FG001|Overall Study|Medication error with no associated AE|0|||
170385989|NCT01882439|615750162|FG002|Overall Study|Medication error with no associated AE|2|||
170385990|NCT01882439|615750163|FG003|Overall Study|Medication error with no associated AE|0|||
170385991|NCT01882439|615750160|FG000|Overall Study|Insufficient clinical response|1|||
170385992|NCT01882439|615750161|FG001|Overall Study|Insufficient clinical response|4|||
170385993|NCT01882439|615750162|FG002|Overall Study|Insufficient clinical response|4|||
170385994|NCT01882439|615750163|FG003|Overall Study|Insufficient clinical response|2|||
170385995|NCT01882439|615750160|FG000|Overall Study|Adverse event unrelated to study drug|2|||
170385996|NCT01882439|615750161|FG001|Overall Study|Adverse event unrelated to study drug|2|||
170385997|NCT01882439|615750162|FG002|Overall Study|Adverse event unrelated to study drug|1|||
170385998|NCT01882439|615750163|FG003|Overall Study|Adverse event unrelated to study drug|1|||
170385999|NCT03125902|615750166|FG000|Overall Study|Adverse Event|0|||
170386000|NCT03125902|615750167|FG001|Overall Study|Adverse Event|1|||
170386001|NCT03125902|615750166|FG000|Overall Study|Death|119|||
170386002|NCT03125902|615750167|FG001|Overall Study|Death|229|||
170386003|NCT03125902|615750166|FG000|Overall Study|Lost to Follow-up|4|||
170386004|NCT03125902|615750167|FG001|Overall Study|Lost to Follow-up|13|||
170386005|NCT03125902|615750166|FG000|Overall Study|Other|0|||
170386006|NCT03125902|615750167|FG001|Overall Study|Other|4|||
170386007|NCT03125902|615750166|FG000|Overall Study|Physician Decision|2|||
170386008|NCT03125902|615750167|FG001|Overall Study|Physician Decision|1|||
170386009|NCT03125902|615750166|FG000|Overall Study|Progressive Disease|0|||
170386010|NCT03125902|615750167|FG001|Overall Study|Progressive Disease|3|||
170386011|NCT03125902|615750166|FG000|Overall Study|Study Terminated By Sponsor|74|||
170386012|NCT03125902|615750167|FG001|Overall Study|Study Terminated By Sponsor|143|||
170386013|NCT03125902|615750166|FG000|Overall Study|Withdrawal by Subject|21|||
170386014|NCT03125902|615750167|FG001|Overall Study|Withdrawal by Subject|37|||
170386015|NCT00423267|615750168|FG000|Period A|Withdrawal by Subject|0|||
170386016|NCT00423267|615750169|FG001|Period A|Withdrawal by Subject|1|||
170386017|NCT00423267|615750168|FG000|Period A|Non-compliance with protocol|1|||
170386018|NCT00423267|615750169|FG001|Period A|Non-compliance with protocol|0|||
170386019|NCT00423267|615750168|FG000|Period A|Administrative|1|||
170386020|NCT00423267|615750169|FG001|Period A|Administrative|0|||
170386021|NCT00827112|615750170|FG000|Overall Study|Adverse Event|2|||
170386022|NCT00827112|615750171|FG001|Overall Study|Adverse Event|0|||
170386023|NCT00827112|615750170|FG000|Overall Study|Lack of Efficacy|2|||
170386024|NCT00827112|615750171|FG001|Overall Study|Lack of Efficacy|0|||
170386025|NCT00827112|615750170|FG000|Overall Study|Lost to Follow-up|3|||
170386026|NCT00827112|615750171|FG001|Overall Study|Lost to Follow-up|2|||
170386027|NCT00827112|615750170|FG000|Overall Study|Pregnancy|0|||
170386028|NCT00827112|615750171|FG001|Overall Study|Pregnancy|1|||
170386029|NCT00827112|615750170|FG000|Overall Study|Protocol Violation|0|||
170386030|NCT00827112|615750171|FG001|Overall Study|Protocol Violation|2|||
170386031|NCT00827112|615750170|FG000|Overall Study|Withdrawal by Subject|2|||
170386032|NCT00827112|615750171|FG001|Overall Study|Withdrawal by Subject|1|||
170386033|NCT00827112|615750170|FG000|Overall Study|Randomized but not treated|5|||
170386034|NCT00827112|615750171|FG001|Overall Study|Randomized but not treated|3|||
170386035|NCT00827112|615750170|FG000|Overall Study|Other|1|||
170386036|NCT00827112|615750171|FG001|Overall Study|Other|3|||
170386037|NCT01333865|615750172|FG000|Overall Study|Adverse Event|2|||
170386038|NCT03512028|615750173|FG000|Overall Study|Withdrawal by Subject|2|||
170386039|NCT03512028|615750174|FG001|Overall Study|Withdrawal by Subject|0|||
170386040|NCT03512028|615750173|FG000|Overall Study|Protocol Violation|2|||
170386041|NCT03512028|615750174|FG001|Overall Study|Protocol Violation|0|||
170386042|NCT01521494|615750177|FG000|Overall Study|Adverse Event|1|||
170386043|NCT01521494|615750178|FG001|Overall Study|Adverse Event|2|||
170386044|NCT01521494|615750179|FG002|Overall Study|Adverse Event|9|||
170386045|NCT01521494|615750180|FG003|Overall Study|Adverse Event|6|||
170386046|NCT01521494|615750181|FG004|Overall Study|Adverse Event|2|||
170386047|NCT01521494|615750177|FG000|Overall Study|Lack of Efficacy|0|||
170386048|NCT01521494|615750178|FG001|Overall Study|Lack of Efficacy|0|||
170386049|NCT01521494|615750179|FG002|Overall Study|Lack of Efficacy|0|||
170386050|NCT01521494|615750180|FG003|Overall Study|Lack of Efficacy|0|||
170386051|NCT01521494|615750181|FG004|Overall Study|Lack of Efficacy|2|||
170386052|NCT01521494|615750177|FG000|Overall Study|Withdrawal by Subject|1|||
170386053|NCT01521494|615750178|FG001|Overall Study|Withdrawal by Subject|1|||
170386054|NCT01521494|615750179|FG002|Overall Study|Withdrawal by Subject|0|||
170386055|NCT01521494|615750180|FG003|Overall Study|Withdrawal by Subject|2|||
170398861|NCT05004181|615798313|FG001|Overall Study|Death|0|||
170386056|NCT01521494|615750181|FG004|Overall Study|Withdrawal by Subject|0|||
170386057|NCT01521494|615750177|FG000|Overall Study|Decrease in serum phosphate|0|||
170386058|NCT01521494|615750178|FG001|Overall Study|Decrease in serum phosphate|2|||
170386059|NCT01521494|615750179|FG002|Overall Study|Decrease in serum phosphate|3|||
170386060|NCT01521494|615750180|FG003|Overall Study|Decrease in serum phosphate|12|||
170386061|NCT01521494|615750181|FG004|Overall Study|Decrease in serum phosphate|0|||
170386062|NCT01521494|615750177|FG000|Overall Study|Decrease in serum calcium|0|||
170386063|NCT01521494|615750178|FG001|Overall Study|Decrease in serum calcium|0|||
170386064|NCT01521494|615750179|FG002|Overall Study|Decrease in serum calcium|0|||
170386065|NCT01521494|615750180|FG003|Overall Study|Decrease in serum calcium|1|||
170386066|NCT01521494|615750181|FG004|Overall Study|Decrease in serum calcium|1|||
170386067|NCT01521494|615750177|FG000|Overall Study|Physician Decision|0|||
170386068|NCT01521494|615750178|FG001|Overall Study|Physician Decision|0|||
170386069|NCT01521494|615750179|FG002|Overall Study|Physician Decision|0|||
170386070|NCT01521494|615750180|FG003|Overall Study|Physician Decision|0|||
170386071|NCT01521494|615750181|FG004|Overall Study|Physician Decision|2|||
170386072|NCT01140646|615750186|FG000|Overall Study|Adverse Event|4|||
170386073|NCT01140646|615750186|FG000|Overall Study|Refused Further Treatment|5|||
170386074|NCT02146352|615750190|FG000|Overall Study|Death|1|||
170386075|NCT02146352|615750190|FG000|Overall Study|Patient entered hospice care|1|||
170386076|NCT00784836|615750191|FG000|Overall Study|Early Study Termination|3|||
170386077|NCT02918006|615750192|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
170386078|NCT02918006|615750193|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
170386079|NCT02918006|615750194|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
170386080|NCT02918006|615750192|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
170386081|NCT02918006|615750193|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
170386082|NCT02918006|615750194|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
170386083|NCT02918006|615750192|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
170386084|NCT02918006|615750193|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
170386085|NCT02918006|615750194|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
170386086|NCT02918006|615750192|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
170386087|NCT02918006|615750193|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
170386088|NCT02918006|615750194|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
170386089|NCT02918006|615750192|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
170386090|NCT02918006|615750193|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
170386091|NCT02918006|615750194|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
170386092|NCT02918006|615750192|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
170386093|NCT02918006|615750193|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
170386094|NCT02918006|615750194|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
170386095|NCT02918006|615750192|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
170386096|NCT02918006|615750193|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
170386097|NCT02918006|615750194|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
170386098|NCT02918006|615750192|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
170386099|NCT02918006|615750193|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
170386100|NCT02918006|615750194|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
170386101|NCT02918006|615750192|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
170386102|NCT02918006|615750193|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
170386103|NCT02918006|615750194|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
170386104|NCT03969589|615750195|FG000|Overall Study|Lost to Follow-up|3|||
170386105|NCT03969589|615750196|FG001|Overall Study|Lost to Follow-up|2|||
170386106|NCT03969589|615750195|FG000|Overall Study|Declined Follow-Up|0|||
170386107|NCT03969589|615750196|FG001|Overall Study|Declined Follow-Up|1|||
170386108|NCT00517634|615750197|FG000|Second Treatment Period|Withdrawal by Subject|0|||
170386109|NCT00517634|615750198|FG001|Second Treatment Period|Withdrawal by Subject|0|||
170386110|NCT00517634|615750199|FG002|Second Treatment Period|Withdrawal by Subject|0|||
170386111|NCT00517634|615750200|FG003|Second Treatment Period|Withdrawal by Subject|0|||
170386112|NCT00517634|615750201|FG004|Second Treatment Period|Withdrawal by Subject|1|||
170386113|NCT00517634|615750202|FG005|Second Treatment Period|Withdrawal by Subject|0|||
170386114|NCT03091920|615750203|FG000|Overall Study|Adverse Event|0|||
170386115|NCT03091920|615750204|FG001|Overall Study|Adverse Event|1|||
170386116|NCT03091920|615750205|FG002|Overall Study|Adverse Event|0|||
170386117|NCT03143855|615750206|FG000|Overall Study|Withdrawal by Subject|4|||
170386118|NCT03143855|615750207|FG001|Overall Study|Withdrawal by Subject|3|||
170386119|NCT03143855|615750206|FG000|Overall Study|Protocol Violation|1|||
170386120|NCT03143855|615750207|FG001|Overall Study|Protocol Violation|0|||
170386121|NCT03143855|615750206|FG000|Overall Study|Participant experienced withdrawal|0|||
170386122|NCT03143855|615750207|FG001|Overall Study|Participant experienced withdrawal|1|||
170386123|NCT00453349|615750208|FG000|Randomized|Adverse Event|12|||
170386124|NCT00453349|615750209|FG001|Randomized|Adverse Event|11|||
170386125|NCT00453349|615750208|FG000|Randomized|Lack of Efficacy|2|||
170386126|NCT00453349|615750209|FG001|Randomized|Lack of Efficacy|1|||
170386127|NCT00453349|615750208|FG000|Randomized|Lost to Follow-up|7|||
170386128|NCT00453349|615750209|FG001|Randomized|Lost to Follow-up|5|||
170386129|NCT00453349|615750208|FG000|Randomized|Protocol Violation|1|||
170386130|NCT00453349|615750209|FG001|Randomized|Protocol Violation|1|||
170386131|NCT00453349|615750208|FG000|Randomized|Withdrawal by Subject|3|||
170386132|NCT00453349|615750209|FG001|Randomized|Withdrawal by Subject|5|||
170386133|NCT00453349|615750208|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
170386134|NCT00453349|615750209|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
170386135|NCT00453349|615750208|FG000|Completed Study|Adverse Event|12|||
170386136|NCT00453349|615750209|FG001|Completed Study|Adverse Event|11|||
170386137|NCT00453349|615750208|FG000|Completed Study|Lack of Efficacy|2|||
170386138|NCT00453349|615750209|FG001|Completed Study|Lack of Efficacy|1|||
170386139|NCT00453349|615750208|FG000|Completed Study|Lost to Follow-up|7|||
170386140|NCT00453349|615750209|FG001|Completed Study|Lost to Follow-up|5|||
170386141|NCT00453349|615750208|FG000|Completed Study|Protocol Violation|1|||
170386142|NCT00453349|615750209|FG001|Completed Study|Protocol Violation|1|||
170386143|NCT00453349|615750208|FG000|Completed Study|Withdrawal by Subject|3|||
170386144|NCT00453349|615750209|FG001|Completed Study|Withdrawal by Subject|5|||
170386145|NCT00453349|615750208|FG000|Completed Study|Lost to follow up after study treatment|2|||
170386146|NCT00453349|615750209|FG001|Completed Study|Lost to follow up after study treatment|11|||
170386147|NCT00805142|615750210|FG000|Titration Period|Adverse Event|3|||
170386148|NCT00805142|615750211|FG001|Titration Period|Adverse Event|3|||
170386149|NCT00805142|615750210|FG000|Titration Period|Lack of Efficacy|1|||
170386150|NCT00805142|615750211|FG001|Titration Period|Lack of Efficacy|1|||
170386151|NCT00805142|615750210|FG000|Titration Period|Lost to Follow-up|0|||
170386152|NCT00805142|615750211|FG001|Titration Period|Lost to Follow-up|1|||
170386153|NCT00805142|615750210|FG000|Titration Period|Disease Progression|2|||
170386154|NCT00805142|615750211|FG001|Titration Period|Disease Progression|1|||
170386155|NCT00805142|615750210|FG000|Titration Period|Withdrawal of consent|0|||
170386156|NCT00805142|615750211|FG001|Titration Period|Withdrawal of consent|1|||
170386157|NCT00805142|615750210|FG000|Titration Period|Other|0|||
170386158|NCT00805142|615750211|FG001|Titration Period|Other|3|||
170386159|NCT00805142|615750210|FG000|Maintenance Period|Adverse Event|0|||
170386160|NCT00805142|615750211|FG001|Maintenance Period|Adverse Event|1|||
170386161|NCT00805142|615750210|FG000|Maintenance Period|Other|0|||
170386162|NCT00805142|615750211|FG001|Maintenance Period|Other|1|||
170386163|NCT02993731|615750213|FG000|Overall Study|Study Termination|101|||
170386164|NCT02993731|615750214|FG001|Overall Study|Study Termination|105|||
170386165|NCT01078389|615751833|FG000|Overall Study|Adverse Event|10|||
170386166|NCT01078389|615751834|FG001|Overall Study|Adverse Event|6|||
170386167|NCT01078389|615751833|FG000|Overall Study|Major Protocol Deviation|2|||
170386168|NCT01078389|615751834|FG001|Overall Study|Major Protocol Deviation|0|||
170386169|NCT01078389|615751833|FG000|Overall Study|Lost to Follow-up|23|||
170386170|NCT01078389|615751834|FG001|Overall Study|Lost to Follow-up|23|||
170386171|NCT01078389|615751833|FG000|Overall Study|Voluntary Withdrawal|20|||
170386172|NCT01078389|615751834|FG001|Overall Study|Voluntary Withdrawal|36|||
170386173|NCT01078389|615751833|FG000|Overall Study|Other|9|||
170386174|NCT01078389|615751834|FG001|Overall Study|Other|2|||
170386175|NCT02028182|615751840|FG000|Overall Study|Protocol Violation|2|||
170386176|NCT01684930|615751843|FG000|Overall Study|Withdrawal by Subject|3|||
170386177|NCT01684930|615751844|FG001|Overall Study|Withdrawal by Subject|1|||
170386178|NCT01945866|615751847|FG000|Overall Study|Eyes did not complete or were dropped|2|||
170386179|NCT01945866|615751848|FG001|Overall Study|Eyes did not complete or were dropped|0|||
170386180|NCT04398030|615751849|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
170386181|NCT04398030|615751850|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
170386182|NCT04398030|615751849|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
170386183|NCT04398030|615751850|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
170386184|NCT01004822|615751851|FG000|Overall Study|Objective progression or relapse|3|||
170386185|NCT01004822|615751852|FG001|Overall Study|Objective progression or relapse|3|||
170386186|NCT01004822|615751853|FG002|Overall Study|Objective progression or relapse|0|||
170386187|NCT01004822|615751854|FG003|Overall Study|Objective progression or relapse|1|||
170386188|NCT01004822|615751855|FG004|Overall Study|Objective progression or relapse|2|||
170386189|NCT01004822|615751856|FG005|Overall Study|Objective progression or relapse|2|||
170386190|NCT01004822|615751857|FG006|Overall Study|Objective progression or relapse|1|||
170386191|NCT01004822|615751858|FG007|Overall Study|Objective progression or relapse|4|||
170386192|NCT01004822|615751851|FG000|Overall Study|Global deterioration of health status|0|||
170386193|NCT01004822|615751852|FG001|Overall Study|Global deterioration of health status|0|||
170386194|NCT01004822|615751853|FG002|Overall Study|Global deterioration of health status|0|||
170386195|NCT01004822|615751854|FG003|Overall Study|Global deterioration of health status|1|||
170386196|NCT01004822|615751855|FG004|Overall Study|Global deterioration of health status|0|||
170386197|NCT01004822|615751856|FG005|Overall Study|Global deterioration of health status|0|||
170386198|NCT01004822|615751857|FG006|Overall Study|Global deterioration of health status|1|||
170386199|NCT01004822|615751858|FG007|Overall Study|Global deterioration of health status|0|||
170386200|NCT01004822|615751851|FG000|Overall Study|No longer willing to continue|0|||
170386201|NCT01004822|615751852|FG001|Overall Study|No longer willing to continue|0|||
170386202|NCT01004822|615751853|FG002|Overall Study|No longer willing to continue|0|||
170386203|NCT01004822|615751854|FG003|Overall Study|No longer willing to continue|1|||
170386204|NCT01004822|615751855|FG004|Overall Study|No longer willing to continue|2|||
170386205|NCT01004822|615751856|FG005|Overall Study|No longer willing to continue|1|||
170386206|NCT01004822|615751857|FG006|Overall Study|No longer willing to continue|1|||
170386207|NCT01004822|615751858|FG007|Overall Study|No longer willing to continue|0|||
170386208|NCT01004822|615751851|FG000|Overall Study|Adverse Event|0|||
170386209|NCT01004822|615751852|FG001|Overall Study|Adverse Event|0|||
170386210|NCT01004822|615751853|FG002|Overall Study|Adverse Event|0|||
170386211|NCT01004822|615751854|FG003|Overall Study|Adverse Event|0|||
170386212|NCT01004822|615751855|FG004|Overall Study|Adverse Event|0|||
170386213|NCT01004822|615751856|FG005|Overall Study|Adverse Event|0|||
170386214|NCT01004822|615751857|FG006|Overall Study|Adverse Event|1|||
170386215|NCT01004822|615751858|FG007|Overall Study|Adverse Event|1|||
170386216|NCT01004822|615751851|FG000|Overall Study|Other|0|||
170386217|NCT01004822|615751852|FG001|Overall Study|Other|0|||
170386218|NCT01004822|615751853|FG002|Overall Study|Other|4|||
170386219|NCT01004822|615751854|FG003|Overall Study|Other|1|||
170386220|NCT01004822|615751855|FG004|Overall Study|Other|0|||
170386221|NCT01004822|615751856|FG005|Overall Study|Other|1|||
170386222|NCT01004822|615751857|FG006|Overall Study|Other|0|||
170386223|NCT01004822|615751858|FG007|Overall Study|Other|0|||
170386224|NCT01858701|615751859|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
170386225|NCT01858701|615751860|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
170386226|NCT01858701|615751859|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
170386227|NCT01858701|615751860|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
170386228|NCT01858701|615751859|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
170386229|NCT01858701|615751860|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
170386230|NCT01858701|615751859|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
170386231|NCT01858701|615751860|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
170386232|NCT02713490|615751870|FG000|Overall Study|Withdrawal by Subject|2|||
170386233|NCT02713490|615751871|FG001|Overall Study|Withdrawal by Subject|1|||
170386234|NCT02713490|615751870|FG000|Overall Study|Did not receive study drug|1|||
170386235|NCT02713490|615751871|FG001|Overall Study|Did not receive study drug|0|||
170386236|NCT02713490|615751870|FG000|Overall Study|Met exclusion criteria|0|||
170386237|NCT02713490|615751871|FG001|Overall Study|Met exclusion criteria|1|||
170386238|NCT01714726|615751875|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
170386239|NCT01714726|615751876|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
170386240|NCT01714726|615751877|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
170386241|NCT01714726|615751878|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
170386242|NCT01714726|615751875|FG000|Double-Blinded Induction Period|Adverse Event|0|||
170386243|NCT01714726|615751876|FG001|Double-Blinded Induction Period|Adverse Event|1|||
170386244|NCT01714726|615751877|FG002|Double-Blinded Induction Period|Adverse Event|0|||
170386245|NCT01714726|615751878|FG003|Double-Blinded Induction Period|Adverse Event|0|||
170386246|NCT01714726|615751875|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
170386247|NCT01714726|615751876|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
170386248|NCT01714726|615751877|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
170386249|NCT01714726|615751878|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
170386250|NCT01714726|615751875|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
170386251|NCT01714726|615751876|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
170386252|NCT01714726|615751877|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
170386253|NCT01714726|615751878|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
170386254|NCT01714726|615751875|FG000|Open-Label Period|Other|0|||
170386255|NCT01714726|615751876|FG001|Open-Label Period|Other|0|||
170386256|NCT01714726|615751877|FG002|Open-Label Period|Other|1|||
170386257|NCT01714726|615751878|FG003|Open-Label Period|Other|3|||
170386258|NCT01714726|615751875|FG000|Open-Label Period|Adverse Event|0|||
170386259|NCT01714726|615751876|FG001|Open-Label Period|Adverse Event|0|||
170386260|NCT01714726|615751877|FG002|Open-Label Period|Adverse Event|1|||
170386261|NCT01714726|615751878|FG003|Open-Label Period|Adverse Event|0|||
170386262|NCT01714726|615751875|FG000|Open-Label Period|Withdrawal by Subject|0|||
170386263|NCT01714726|615751876|FG001|Open-Label Period|Withdrawal by Subject|0|||
170386264|NCT01714726|615751877|FG002|Open-Label Period|Withdrawal by Subject|9|||
170386265|NCT01714726|615751878|FG003|Open-Label Period|Withdrawal by Subject|19|||
170386266|NCT01714726|615751875|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
170386267|NCT01714726|615751876|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
170386268|NCT01714726|615751877|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
170386269|NCT01714726|615751878|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
170386270|NCT01714726|615751875|FG000|Open-Label Period|Lost to Follow-up|0|||
170386271|NCT01714726|615751876|FG001|Open-Label Period|Lost to Follow-up|0|||
170386272|NCT01714726|615751877|FG002|Open-Label Period|Lost to Follow-up|3|||
170386273|NCT01714726|615751878|FG003|Open-Label Period|Lost to Follow-up|4|||
170386274|NCT01096017|615751884|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
170386275|NCT01096017|615751885|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
170386276|NCT02600559|615751886|FG000|Overall Study|Withdrawal by Subject|3|||
170386277|NCT02600559|615751886|FG000|Overall Study|Lost to Follow-up|20|||
170386278|NCT03628781|615751891|FG000|Overall Study|Lost to Follow-up|16|||
170386279|NCT03628781|615751892|FG001|Overall Study|Lost to Follow-up|8|||
170386280|NCT03628781|615751891|FG000|Overall Study|Withdrawal by Subject|16|||
170386281|NCT03628781|615751892|FG001|Overall Study|Withdrawal by Subject|1|||
170386282|NCT00679042|615751893|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
170386283|NCT00679042|615751893|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
170386284|NCT00679042|615751893|FG000|5-Year Follow Up|Death|1|||
170386285|NCT00679042|615751893|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
170386286|NCT00679042|615751893|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
170386287|NCT02687815|615751894|FG000|Overall Study|Lost to Follow-up|2|||
170386288|NCT02687815|615751895|FG001|Overall Study|Lost to Follow-up|4|||
170386289|NCT02687815|615751894|FG000|Overall Study|Withdrawal by Subject|2|||
170386290|NCT02687815|615751895|FG001|Overall Study|Withdrawal by Subject|4|||
170386291|NCT00682539|615751898|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
170386292|NCT00682539|615751899|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
170386293|NCT00682539|615751900|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
170386294|NCT00682539|615751898|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
170386295|NCT00682539|615751899|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
170386296|NCT00682539|615751900|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
170386297|NCT02624713|615751901|FG000|Overall Study|Lost to Follow-up|14|||
170386298|NCT02624713|615751902|FG001|Overall Study|Lost to Follow-up|0|||
170386299|NCT00883896|615751903|FG000|Overall Study|Lost to Follow-up|0|||
170386300|NCT00883896|615751904|FG001|Overall Study|Lost to Follow-up|0|||
170386301|NCT00883896|615751905|FG002|Overall Study|Lost to Follow-up|0|||
170386302|NCT00883896|615751906|FG003|Overall Study|Lost to Follow-up|2|||
170386303|NCT00883896|615751903|FG000|Overall Study|Withdrawal by Subject|5|||
170386304|NCT00883896|615751904|FG001|Overall Study|Withdrawal by Subject|0|||
170386305|NCT00883896|615751905|FG002|Overall Study|Withdrawal by Subject|1|||
170386306|NCT00883896|615751906|FG003|Overall Study|Withdrawal by Subject|3|||
170386307|NCT00883896|615751903|FG000|Overall Study|Lack of Efficacy|0|||
170386308|NCT00883896|615751904|FG001|Overall Study|Lack of Efficacy|0|||
170386309|NCT00883896|615751905|FG002|Overall Study|Lack of Efficacy|0|||
170386310|NCT00883896|615751906|FG003|Overall Study|Lack of Efficacy|2|||
170386311|NCT00883896|615751903|FG000|Overall Study|Other|1|||
170386312|NCT00883896|615751904|FG001|Overall Study|Other|0|||
170386313|NCT00883896|615751905|FG002|Overall Study|Other|0|||
170386314|NCT00883896|615751906|FG003|Overall Study|Other|0|||
170386315|NCT00310440|615751907|FG000|Overall Study|Lost to Follow-up|17|||
170386316|NCT00310440|615751908|FG001|Overall Study|Lost to Follow-up|8|||
170386317|NCT00310440|615751907|FG000|Overall Study|Withdrawal by Subject|2|||
170386318|NCT00310440|615751908|FG001|Overall Study|Withdrawal by Subject|1|||
170386319|NCT00310440|615751907|FG000|Overall Study|Missed 12 Month Visit|7|||
170386320|NCT00310440|615751908|FG001|Overall Study|Missed 12 Month Visit|4|||
170386321|NCT00148109|615751909|FG000|Overall Study|Lack of Efficacy|10|||
170386322|NCT00148109|615751910|FG001|Overall Study|Lack of Efficacy|18|||
170386323|NCT00148109|615751909|FG000|Overall Study|Adverse Event|0|||
170386324|NCT00148109|615751910|FG001|Overall Study|Adverse Event|2|||
170386325|NCT00148109|615751909|FG000|Overall Study|Withdrawal by Subject|2|||
170386326|NCT00148109|615751910|FG001|Overall Study|Withdrawal by Subject|0|||
170386327|NCT00351611|615751915|FG000|Overall Study|Adverse Event|11|||
170386328|NCT00351611|615751916|FG001|Overall Study|Adverse Event|3|||
170386329|NCT00351611|615751915|FG000|Overall Study|Death|1|||
170386330|NCT00351611|615751916|FG001|Overall Study|Death|0|||
170386331|NCT00351611|615751915|FG000|Overall Study|Lost to Follow-up|1|||
170386332|NCT00351611|615751916|FG001|Overall Study|Lost to Follow-up|0|||
170386333|NCT00351611|615751915|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
170386334|NCT00351611|615751916|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
170386335|NCT00351611|615751915|FG000|Overall Study|Other|1|||
170386336|NCT00351611|615751916|FG001|Overall Study|Other|0|||
170386337|NCT00351611|615751915|FG000|Overall Study|Protocol Violation|0|||
170386338|NCT00351611|615751916|FG001|Overall Study|Protocol Violation|2|||
170386339|NCT01589185|615751917|FG000|Overall Study|Death|1|||
170386340|NCT01589185|615751918|FG001|Overall Study|Death|2|||
170386341|NCT01589185|615751919|FG002|Overall Study|Death|2|||
170386342|NCT01589185|615751920|FG003|Overall Study|Death|0|||
170386343|NCT01589185|615751921|FG004|Overall Study|Death|1|||
170386344|NCT01589185|615751917|FG000|Overall Study|Lost to Follow-up|1|||
170386345|NCT01589185|615751918|FG001|Overall Study|Lost to Follow-up|0|||
170386346|NCT01589185|615751919|FG002|Overall Study|Lost to Follow-up|2|||
170386347|NCT01589185|615751920|FG003|Overall Study|Lost to Follow-up|3|||
170386348|NCT01589185|615751921|FG004|Overall Study|Lost to Follow-up|0|||
170386349|NCT03781167|615751927|FG000|Overall Study|Adverse Event|23|||
170386350|NCT03781167|615751928|FG001|Overall Study|Adverse Event|25|||
170386351|NCT03781167|615751927|FG000|Overall Study|Withdrew consent|16|||
170386352|NCT03781167|615751928|FG001|Overall Study|Withdrew consent|12|||
170386353|NCT03781167|615751927|FG000|Overall Study|Lost to Follow-up|0|||
170386354|NCT03781167|615751928|FG001|Overall Study|Lost to Follow-up|1|||
170386355|NCT03781167|615751927|FG000|Overall Study|Lack of Efficacy|4|||
170386356|NCT03781167|615751928|FG001|Overall Study|Lack of Efficacy|5|||
170386357|NCT03781167|615751927|FG000|Overall Study|Difficulty with drug delivery system|2|||
170386358|NCT03781167|615751928|FG001|Overall Study|Difficulty with drug delivery system|3|||
170386359|NCT03781167|615751927|FG000|Overall Study|Other, not specified|2|||
170386360|NCT03781167|615751928|FG001|Overall Study|Other, not specified|2|||
170386361|NCT00462501|615751929|FG000|Overall Study|Not treated|3|||
170386362|NCT00462501|615751929|FG000|Overall Study|Adverse Event|2|||
170386363|NCT00679354|615751930|FG000|Overall Study|Death|3|||
170386364|NCT00679354|615751930|FG000|Overall Study|Lack of Efficacy|22|||
170386365|NCT00679354|615751930|FG000|Overall Study|Physician Decision|4|||
170386366|NCT00679354|615751930|FG000|Overall Study|Ineligible|1|||
170386367|NCT00174460|615751932|FG000|Overall Study|Withdrawal by Subject|0|||
170386368|NCT00174460|615751933|FG001|Overall Study|Withdrawal by Subject|1|||
170386369|NCT00579059|615751934|FG000|Overall Study|Study Canceled at 1 Year|21|||
170386370|NCT00579059|615751935|FG001|Overall Study|Study Canceled at 1 Year|10|||
170386371|NCT00779506|615751936|FG000|Overall Study|Screening Failed|2|||
170386372|NCT00779506|615751936|FG000|Overall Study|Adverse Event|4|||
170386373|NCT00779506|615751936|FG000|Overall Study|Lack of Efficacy|11|||
170386374|NCT00779506|615751936|FG000|Overall Study|Protocol Violation|5|||
170386375|NCT00779506|615751936|FG000|Overall Study|Withdrawal by Subject|6|||
170386376|NCT00779506|615751936|FG000|Overall Study|Lost to Follow-up|1|||
170386377|NCT03982069|615751937|FG000|Overall Study|Lost to Follow-up|5|||
170386378|NCT03982069|615751938|FG001|Overall Study|Lost to Follow-up|5|||
170386379|NCT03982069|615751939|FG002|Overall Study|Lost to Follow-up|3|||
170386380|NCT03982069|615751940|FG003|Overall Study|Lost to Follow-up|5|||
170386381|NCT03982069|615751937|FG000|Overall Study|Physician Decision|0|||
170386382|NCT03982069|615751938|FG001|Overall Study|Physician Decision|1|||
170386383|NCT03982069|615751939|FG002|Overall Study|Physician Decision|0|||
170386384|NCT03982069|615751940|FG003|Overall Study|Physician Decision|0|||
170386385|NCT03982069|615751937|FG000|Overall Study|Withdrawal by Subject|2|||
170386386|NCT03982069|615751938|FG001|Overall Study|Withdrawal by Subject|1|||
170386387|NCT03982069|615751939|FG002|Overall Study|Withdrawal by Subject|5|||
170386388|NCT03982069|615751940|FG003|Overall Study|Withdrawal by Subject|2|||
170386389|NCT03982069|615751937|FG000|Overall Study|Specimen loss|3|||
170386390|NCT03982069|615751938|FG001|Overall Study|Specimen loss|3|||
170386391|NCT03982069|615751939|FG002|Overall Study|Specimen loss|1|||
170386392|NCT03982069|615751940|FG003|Overall Study|Specimen loss|1|||
170386393|NCT01016912|615751943|FG000|End of Treatment Period|Lack of Efficacy|0|||
170386394|NCT01016912|615751944|FG001|End of Treatment Period|Lack of Efficacy|1|||
170386395|NCT01016912|615751945|FG002|End of Treatment Period|Lack of Efficacy|0|||
170386396|NCT01016912|615751946|FG003|End of Treatment Period|Lack of Efficacy|4|||
170386397|NCT01016912|615751947|FG004|End of Treatment Period|Lack of Efficacy|4|||
170386398|NCT01016912|615751943|FG000|End of Treatment Period|Adverse Event|0|||
170386399|NCT01016912|615751944|FG001|End of Treatment Period|Adverse Event|1|||
170386400|NCT01016912|615751945|FG002|End of Treatment Period|Adverse Event|1|||
170386401|NCT01016912|615751946|FG003|End of Treatment Period|Adverse Event|0|||
170386402|NCT01016912|615751947|FG004|End of Treatment Period|Adverse Event|0|||
170386403|NCT01016912|615751943|FG000|End of Treatment Period|Completed double-blind period only|0|||
170386404|NCT01016912|615751944|FG001|End of Treatment Period|Completed double-blind period only|1|||
170386405|NCT01016912|615751945|FG002|End of Treatment Period|Completed double-blind period only|0|||
170386406|NCT01016912|615751946|FG003|End of Treatment Period|Completed double-blind period only|0|||
170386407|NCT01016912|615751947|FG004|End of Treatment Period|Completed double-blind period only|0|||
170386408|NCT01016912|615751943|FG000|Follow-up Period|Other reason|0|||
170386409|NCT01016912|615751944|FG001|Follow-up Period|Other reason|0|||
170386410|NCT01016912|615751945|FG002|Follow-up Period|Other reason|1|||
170386411|NCT01016912|615751946|FG003|Follow-up Period|Other reason|1|||
170386412|NCT01016912|615751947|FG004|Follow-up Period|Other reason|0|||
170386413|NCT00914940|615751948|FG000|D0 to D100 Post-transplant|Death|2|||
170386414|NCT00914940|615751948|FG000|D101 to 2 Years Post-transplant|Death|8|||
170386415|NCT00914940|615751948|FG000|2 Years to 5 Years Post-transplant|Death|3|||
170386416|NCT01853397|615751951|FG000|Overall Study|Withdrawal by Subject|0|||
170386417|NCT01853397|615751952|FG001|Overall Study|Withdrawal by Subject|0|||
170386418|NCT01853397|615751953|FG002|Overall Study|Withdrawal by Subject|0|||
170386419|NCT01853397|615751954|FG003|Overall Study|Withdrawal by Subject|1|||
170386420|NCT01853397|615751951|FG000|Overall Study|Subject Noncompliance|0|||
170386421|NCT01853397|615751952|FG001|Overall Study|Subject Noncompliance|0|||
170386422|NCT01853397|615751953|FG002|Overall Study|Subject Noncompliance|0|||
170386423|NCT01853397|615751954|FG003|Overall Study|Subject Noncompliance|1|||
170386424|NCT01288911|615751955|FG000|Double-blind Period|Death|11|||
170386425|NCT01288911|615751956|FG001|Double-blind Period|Death|7|||
170386426|NCT01288911|615751955|FG000|Double-blind Period|Lost to Follow-up|0|||
170386427|NCT01288911|615751956|FG001|Double-blind Period|Lost to Follow-up|2|||
170386428|NCT01288911|615751955|FG000|Double-blind Period|Progressive Disease|75|||
170386429|NCT01288911|615751956|FG001|Double-blind Period|Progressive Disease|103|||
170386430|NCT01288911|615751955|FG000|Double-blind Period|Protocol Violation|1|||
170386431|NCT01288911|615751956|FG001|Double-blind Period|Protocol Violation|0|||
170386432|NCT01288911|615751955|FG000|Double-blind Period|Withdrawal by Subject|25|||
170386433|NCT01288911|615751956|FG001|Double-blind Period|Withdrawal by Subject|26|||
170386434|NCT01288911|615751955|FG000|Double-blind Period|Miscellaneous Reason|29|||
170386435|NCT01288911|615751956|FG001|Double-blind Period|Miscellaneous Reason|42|||
170386436|NCT01288911|615751955|FG000|Double-blind Period|Randomized but never received study drug|1|||
170386437|NCT01288911|615751956|FG001|Double-blind Period|Randomized but never received study drug|2|||
170386438|NCT01288911|615751955|FG000|Open-label Period (All Enzalutamide)|Death|0|||
170386439|NCT01288911|615751956|FG001|Open-label Period (All Enzalutamide)|Death|1|||
170386440|NCT01288911|615751955|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
170386441|NCT01288911|615751956|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
170386442|NCT01288911|615751955|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
170386443|NCT01288911|615751956|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
170386444|NCT01288911|615751955|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
170386445|NCT01288911|615751956|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
170386446|NCT01288911|615751955|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
170386447|NCT01288911|615751956|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
170386448|NCT01288911|615751955|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
170386449|NCT01288911|615751956|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
170386450|NCT01632345|615751957|FG000|Treatment: Part I|Adverse Event|1|||
170386451|NCT01632345|615751958|FG001|Treatment: Part I|Adverse Event|4|||
170386452|NCT01632345|615751959|FG002|Treatment: Part I|Adverse Event|2|||
170386453|NCT01632345|615751960|FG003|Treatment: Part I|Adverse Event|1|||
170386454|NCT01632345|615751961|FG004|Treatment: Part I|Adverse Event|3|||
170386455|NCT01632345|615751962|FG005|Treatment: Part I|Adverse Event|0|||
170386456|NCT01632345|615751963|FG006|Treatment: Part I|Adverse Event|0|||
170386457|NCT01632345|615751957|FG000|Treatment: Part I|Lack of Efficacy|0|||
170386458|NCT01632345|615751958|FG001|Treatment: Part I|Lack of Efficacy|1|||
170386459|NCT01632345|615751959|FG002|Treatment: Part I|Lack of Efficacy|0|||
170386460|NCT01632345|615751960|FG003|Treatment: Part I|Lack of Efficacy|1|||
170386461|NCT01632345|615751961|FG004|Treatment: Part I|Lack of Efficacy|1|||
170386462|NCT01632345|615751962|FG005|Treatment: Part I|Lack of Efficacy|0|||
170386463|NCT01632345|615751963|FG006|Treatment: Part I|Lack of Efficacy|0|||
170386464|NCT01632345|615751957|FG000|Treatment: Part I|Lost to Follow-up|3|||
170386465|NCT01632345|615751958|FG001|Treatment: Part I|Lost to Follow-up|2|||
170386466|NCT01632345|615751959|FG002|Treatment: Part I|Lost to Follow-up|1|||
170386467|NCT01632345|615751960|FG003|Treatment: Part I|Lost to Follow-up|3|||
170386468|NCT01632345|615751961|FG004|Treatment: Part I|Lost to Follow-up|4|||
170386469|NCT01632345|615751962|FG005|Treatment: Part I|Lost to Follow-up|0|||
170386470|NCT01632345|615751963|FG006|Treatment: Part I|Lost to Follow-up|0|||
170386471|NCT01632345|615751957|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
170386472|NCT01632345|615751958|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
170386473|NCT01632345|615751959|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
170386474|NCT01632345|615751960|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
170386475|NCT01632345|615751961|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
170386476|NCT01632345|615751962|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
170386477|NCT01632345|615751963|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
170386478|NCT01632345|615751957|FG000|Treatment: Part I|Physician Decision|2|||
170386479|NCT01632345|615751958|FG001|Treatment: Part I|Physician Decision|1|||
170386480|NCT01632345|615751959|FG002|Treatment: Part I|Physician Decision|0|||
170386481|NCT01632345|615751960|FG003|Treatment: Part I|Physician Decision|0|||
170386482|NCT01632345|615751961|FG004|Treatment: Part I|Physician Decision|1|||
170386483|NCT01632345|615751962|FG005|Treatment: Part I|Physician Decision|0|||
170386484|NCT01632345|615751963|FG006|Treatment: Part I|Physician Decision|0|||
170386485|NCT01632345|615751957|FG000|Treatment: Part I|Pregnancy|0|||
170386486|NCT01632345|615751958|FG001|Treatment: Part I|Pregnancy|1|||
170386487|NCT01632345|615751959|FG002|Treatment: Part I|Pregnancy|0|||
170386488|NCT01632345|615751960|FG003|Treatment: Part I|Pregnancy|0|||
170386489|NCT01632345|615751961|FG004|Treatment: Part I|Pregnancy|0|||
170386490|NCT01632345|615751962|FG005|Treatment: Part I|Pregnancy|0|||
170386491|NCT01632345|615751963|FG006|Treatment: Part I|Pregnancy|0|||
170386492|NCT01632345|615751957|FG000|Treatment: Part I|Protocol Deviation|0|||
170386493|NCT01632345|615751958|FG001|Treatment: Part I|Protocol Deviation|0|||
170386494|NCT01632345|615751959|FG002|Treatment: Part I|Protocol Deviation|1|||
170386495|NCT01632345|615751960|FG003|Treatment: Part I|Protocol Deviation|1|||
170386496|NCT01632345|615751961|FG004|Treatment: Part I|Protocol Deviation|0|||
170386497|NCT01632345|615751962|FG005|Treatment: Part I|Protocol Deviation|0|||
170386498|NCT01632345|615751963|FG006|Treatment: Part I|Protocol Deviation|0|||
170386499|NCT01632345|615751957|FG000|Treatment: Part I|Withdrawal by Subject|3|||
170386500|NCT01632345|615751958|FG001|Treatment: Part I|Withdrawal by Subject|4|||
170386501|NCT01632345|615751959|FG002|Treatment: Part I|Withdrawal by Subject|4|||
170386502|NCT01632345|615751960|FG003|Treatment: Part I|Withdrawal by Subject|1|||
170386503|NCT01632345|615751961|FG004|Treatment: Part I|Withdrawal by Subject|4|||
170386504|NCT01632345|615751962|FG005|Treatment: Part I|Withdrawal by Subject|0|||
170386505|NCT01632345|615751963|FG006|Treatment: Part I|Withdrawal by Subject|0|||
170386506|NCT01632345|615751957|FG000|Treatment: Part II|Adverse Event|0|||
170386507|NCT01632345|615751958|FG001|Treatment: Part II|Adverse Event|0|||
170386508|NCT01632345|615751959|FG002|Treatment: Part II|Adverse Event|0|||
170386509|NCT01632345|615751960|FG003|Treatment: Part II|Adverse Event|0|||
170386510|NCT01632345|615751961|FG004|Treatment: Part II|Adverse Event|0|||
170386511|NCT01632345|615751962|FG005|Treatment: Part II|Adverse Event|3|||
170386512|NCT01632345|615751963|FG006|Treatment: Part II|Adverse Event|8|||
170386513|NCT01632345|615751957|FG000|Treatment: Part II|Lost to Follow-up|0|||
170386514|NCT01632345|615751958|FG001|Treatment: Part II|Lost to Follow-up|0|||
170386515|NCT01632345|615751959|FG002|Treatment: Part II|Lost to Follow-up|0|||
170386516|NCT01632345|615751960|FG003|Treatment: Part II|Lost to Follow-up|0|||
170386517|NCT01632345|615751961|FG004|Treatment: Part II|Lost to Follow-up|0|||
170386518|NCT01632345|615751962|FG005|Treatment: Part II|Lost to Follow-up|3|||
170386519|NCT01632345|615751963|FG006|Treatment: Part II|Lost to Follow-up|1|||
170386520|NCT01632345|615751957|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
170386521|NCT01632345|615751958|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
170386522|NCT01632345|615751959|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
170386523|NCT01632345|615751960|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
170386524|NCT01632345|615751961|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
170386525|NCT01632345|615751962|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
170386526|NCT01632345|615751963|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
170386527|NCT01632345|615751957|FG000|Treatment: Part II|Withdrawal by Subject|0|||
170386528|NCT01632345|615751958|FG001|Treatment: Part II|Withdrawal by Subject|0|||
170386529|NCT01632345|615751959|FG002|Treatment: Part II|Withdrawal by Subject|0|||
170386530|NCT01632345|615751960|FG003|Treatment: Part II|Withdrawal by Subject|0|||
170386531|NCT01632345|615751961|FG004|Treatment: Part II|Withdrawal by Subject|0|||
170386532|NCT01632345|615751962|FG005|Treatment: Part II|Withdrawal by Subject|2|||
170386533|NCT01632345|615751963|FG006|Treatment: Part II|Withdrawal by Subject|2|||
170386534|NCT00089505|615751964|FG000|Overall Study|Death|4|||
170386535|NCT00089505|615751965|FG001|Overall Study|Death|1|||
170386536|NCT00089505|615751966|FG002|Overall Study|Death|5|||
170386537|NCT00089505|615751967|FG003|Overall Study|Death|8|||
170386538|NCT00089505|615751964|FG000|Overall Study|Withdrawal by Subject|3|||
170386539|NCT00089505|615751965|FG001|Overall Study|Withdrawal by Subject|0|||
170386540|NCT00089505|615751966|FG002|Overall Study|Withdrawal by Subject|6|||
170386541|NCT00089505|615751967|FG003|Overall Study|Withdrawal by Subject|6|||
170386542|NCT00089505|615751964|FG000|Overall Study|Lost to Follow-up|1|||
170386543|NCT00089505|615751965|FG001|Overall Study|Lost to Follow-up|1|||
170386544|NCT00089505|615751966|FG002|Overall Study|Lost to Follow-up|9|||
170386545|NCT00089505|615751967|FG003|Overall Study|Lost to Follow-up|7|||
170386546|NCT00089505|615751964|FG000|Overall Study|Physician Decision|1|||
170386547|NCT00089505|615751965|FG001|Overall Study|Physician Decision|0|||
170386548|NCT00089505|615751966|FG002|Overall Study|Physician Decision|0|||
170386549|NCT00089505|615751967|FG003|Overall Study|Physician Decision|0|||
170386550|NCT00089505|615751964|FG000|Overall Study|Protocol Violation|0|||
170386551|NCT00089505|615751965|FG001|Overall Study|Protocol Violation|0|||
170386552|NCT00089505|615751966|FG002|Overall Study|Protocol Violation|1|||
170386553|NCT00089505|615751967|FG003|Overall Study|Protocol Violation|0|||
170386554|NCT01005875|615751968|FG000|Overall Study|Death|3|||
170386555|NCT00286234|615751969|FG000|Overall Study|Protocol Violation|1|||
170386556|NCT00286234|615751970|FG001|Overall Study|Protocol Violation|2|||
170386557|NCT00286234|615751971|FG002|Overall Study|Protocol Violation|0|||
170386558|NCT00286234|615751972|FG003|Overall Study|Protocol Violation|1|||
170386559|NCT00286234|615751969|FG000|Overall Study|Physician Decision|1|||
170386560|NCT00286234|615751970|FG001|Overall Study|Physician Decision|0|||
170386561|NCT00286234|615751971|FG002|Overall Study|Physician Decision|0|||
170386562|NCT00286234|615751972|FG003|Overall Study|Physician Decision|1|||
170386563|NCT00286234|615751969|FG000|Overall Study|Adverse Event|0|||
170386564|NCT00286234|615751970|FG001|Overall Study|Adverse Event|0|||
170386565|NCT00286234|615751971|FG002|Overall Study|Adverse Event|0|||
170386566|NCT00286234|615751972|FG003|Overall Study|Adverse Event|1|||
170386567|NCT00286234|615751969|FG000|Overall Study|Adverse Event|0|||
170386568|NCT00286234|615751970|FG001|Overall Study|Adverse Event|0|||
170386569|NCT00286234|615751971|FG002|Overall Study|Adverse Event|0|||
170386570|NCT00286234|615751972|FG003|Overall Study|Adverse Event|1|||
170386571|NCT02924129|615751975|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
170386572|NCT02924129|615751976|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
170386573|NCT02924129|615751975|FG000|Overall Study|Withdrawal by Subject|2|||
170386574|NCT02924129|615751976|FG001|Overall Study|Withdrawal by Subject|2|||
170386575|NCT02924129|615751975|FG000|Overall Study|Physician Decision|1|||
170386576|NCT02924129|615751976|FG001|Overall Study|Physician Decision|0|||
170386577|NCT02924129|615751975|FG000|Overall Study|Missed Visit|0|||
170386578|NCT02924129|615751976|FG001|Overall Study|Missed Visit|1|||
170386579|NCT01348828|615751980|FG000|Overall Study|Death|20|||
170386580|NCT01348828|615751980|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
170386581|NCT01348828|615751980|FG000|Overall Study|Conversion|2|||
170386582|NCT01348828|615751980|FG000|Overall Study|missed visit|1|||
170386583|NCT02442284|615751981|FG000|Overall Study|Adverse Event|1|||
170386584|NCT02442284|615751981|FG000|Overall Study|Withdrew Consent|2|||
170386585|NCT02442284|615751981|FG000|Overall Study|Lost to Follow-up|3|||
170386586|NCT02442284|615751981|FG000|Overall Study|Other|1|||
170386587|NCT00302731|615751982|FG000|Overall Study|Lost to Follow-up|1|||
170386588|NCT00302731|615751983|FG001|Overall Study|Lost to Follow-up|2|||
170386589|NCT00302731|615751984|FG002|Overall Study|Lost to Follow-up|0|||
170386590|NCT00302731|615751985|FG003|Overall Study|Lost to Follow-up|0|||
170386591|NCT00302731|615751982|FG000|Overall Study|Adverse Event|0|||
170386592|NCT00302731|615751983|FG001|Overall Study|Adverse Event|2|||
170386593|NCT00302731|615751984|FG002|Overall Study|Adverse Event|2|||
170386594|NCT00302731|615751985|FG003|Overall Study|Adverse Event|0|||
170386595|NCT00302731|615751982|FG000|Overall Study|Withdrawal by Subject|1|||
170386596|NCT00302731|615751983|FG001|Overall Study|Withdrawal by Subject|1|||
170386597|NCT00302731|615751984|FG002|Overall Study|Withdrawal by Subject|0|||
170386598|NCT00302731|615751985|FG003|Overall Study|Withdrawal by Subject|0|||
170386599|NCT00302731|615751982|FG000|Overall Study|Protocol Violation|1|||
170386600|NCT00302731|615751983|FG001|Overall Study|Protocol Violation|0|||
170386601|NCT00302731|615751984|FG002|Overall Study|Protocol Violation|0|||
170386602|NCT00302731|615751985|FG003|Overall Study|Protocol Violation|0|||
170386603|NCT00302731|615751982|FG000|Overall Study|cancer unrelated to study discovered|1|||
170386604|NCT00302731|615751983|FG001|Overall Study|cancer unrelated to study discovered|0|||
170386605|NCT00302731|615751984|FG002|Overall Study|cancer unrelated to study discovered|1|||
170386606|NCT00302731|615751985|FG003|Overall Study|cancer unrelated to study discovered|0|||
170386607|NCT01000311|615751986|FG000|Overall Study|Adverse Event|2|||
170386608|NCT01000311|615751987|FG001|Overall Study|Adverse Event|5|||
170386609|NCT01000311|615751986|FG000|Overall Study|Withdrawal by Subject|16|||
170386610|NCT01000311|615751987|FG001|Overall Study|Withdrawal by Subject|24|||
170386611|NCT01000311|615751986|FG000|Overall Study|Lost to Follow-up|15|||
170386612|NCT01000311|615751987|FG001|Overall Study|Lost to Follow-up|24|||
170386613|NCT01000311|615751986|FG000|Overall Study|Protocol Violation|1|||
170386614|NCT01000311|615751987|FG001|Overall Study|Protocol Violation|2|||
170386615|NCT01000311|615751986|FG000|Overall Study|Inappropriate enrollment|2|||
170386616|NCT01000311|615751987|FG001|Overall Study|Inappropriate enrollment|0|||
170386617|NCT01000311|615751986|FG000|Overall Study|Administrative reason|9|||
170386618|NCT01000311|615751987|FG001|Overall Study|Administrative reason|15|||
170386619|NCT01002573|615753272|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
170386620|NCT01002573|615753273|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
170386621|NCT00690612|615753274|FG000|Overall Study|Adverse Event|1|||
170386622|NCT00690612|615753274|FG000|Overall Study|Withdrawal by Subject|2|||
170386623|NCT02926833|615753275|FG000|Overall Study|Death|1|||
170386624|NCT02926833|615753276|FG001|Overall Study|Death|1|||
170386625|NCT02926833|615753277|FG002|Overall Study|Death|2|||
170386626|NCT02926833|615753278|FG003|Overall Study|Death|13|||
170386627|NCT02926833|615753275|FG000|Overall Study|Lost to Follow-up|1|||
170386628|NCT02926833|615753276|FG001|Overall Study|Lost to Follow-up|2|||
170386629|NCT02926833|615753277|FG002|Overall Study|Lost to Follow-up|0|||
170386630|NCT02926833|615753278|FG003|Overall Study|Lost to Follow-up|3|||
170386631|NCT02926833|615753275|FG000|Overall Study|Full Consent Withdrawal|0|||
170386632|NCT02926833|615753276|FG001|Overall Study|Full Consent Withdrawal|0|||
170386633|NCT02926833|615753277|FG002|Overall Study|Full Consent Withdrawal|0|||
170386634|NCT02926833|615753278|FG003|Overall Study|Full Consent Withdrawal|2|||
170386635|NCT02926833|615753275|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
170386636|NCT02926833|615753276|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
170386637|NCT02926833|615753277|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
170386638|NCT02926833|615753278|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
170386639|NCT02926833|615753275|FG000|Overall Study|Investigator Decision|0|||
170386640|NCT02926833|615753276|FG001|Overall Study|Investigator Decision|1|||
170386641|NCT02926833|615753277|FG002|Overall Study|Investigator Decision|0|||
170386642|NCT02926833|615753278|FG003|Overall Study|Investigator Decision|0|||
170386643|NCT02926833|615753275|FG000|Overall Study|Adverse Event|0|||
170386644|NCT02926833|615753276|FG001|Overall Study|Adverse Event|0|||
170386645|NCT02926833|615753277|FG002|Overall Study|Adverse Event|1|||
170386646|NCT02926833|615753278|FG003|Overall Study|Adverse Event|0|||
170386647|NCT02926833|615753275|FG000|Overall Study|Partial Withdrawal of Consent|0|||
170386648|NCT02926833|615753276|FG001|Overall Study|Partial Withdrawal of Consent|0|||
170386649|NCT02926833|615753277|FG002|Overall Study|Partial Withdrawal of Consent|0|||
170386650|NCT02926833|615753278|FG003|Overall Study|Partial Withdrawal of Consent|1|||
170386651|NCT03808298|615753279|FG000|Overall Study|Adverse Event|3|||
170386652|NCT03808298|615753279|FG000|Overall Study|Physician Decision|1|||
170386653|NCT03808298|615753279|FG000|Overall Study|Withdrawal by Subject|1|||
170386654|NCT03808298|615753279|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
170386655|NCT01018680|615753280|FG000|Overall Study|Adverse Event|23|||
170386656|NCT01018680|615753281|FG001|Overall Study|Adverse Event|40|||
170386657|NCT01018680|615753280|FG000|Overall Study|Withdrawal by Subject|10|||
170386658|NCT01018680|615753281|FG001|Overall Study|Withdrawal by Subject|10|||
170386659|NCT01018680|615753280|FG000|Overall Study|Protocol Violation|5|||
170386660|NCT01018680|615753281|FG001|Overall Study|Protocol Violation|8|||
170386661|NCT01018680|615753280|FG000|Overall Study|Sponsor Decision|6|||
170386662|NCT01018680|615753281|FG001|Overall Study|Sponsor Decision|7|||
170386663|NCT01018680|615753280|FG000|Overall Study|Lack of Efficacy|8|||
170386664|NCT01018680|615753281|FG001|Overall Study|Lack of Efficacy|2|||
170386665|NCT01018680|615753280|FG000|Overall Study|Lost to Follow-up|5|||
170386666|NCT01018680|615753281|FG001|Overall Study|Lost to Follow-up|3|||
170386667|NCT01018680|615753280|FG000|Overall Study|Entry Criteria Not Met|1|||
170386668|NCT01018680|615753281|FG001|Overall Study|Entry Criteria Not Met|4|||
170386669|NCT01018680|615753280|FG000|Overall Study|Physician Decision|3|||
170386670|NCT01018680|615753281|FG001|Overall Study|Physician Decision|1|||
170386671|NCT02930889|615753282|FG000|Overall Study|Lost to Follow-up|2|||
170386672|NCT02930889|615753282|FG000|Overall Study|Withdrawal by Subject|6|||
170386673|NCT02930889|615753282|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
170386674|NCT05056311|615753291|FG000|Overall Study|Lost to Follow-up|14|||
170386675|NCT05056311|615753291|FG000|Overall Study|Withdrawal by Subject|1|||
170386676|NCT05056311|615753291|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
170386677|NCT00548340|615753296|FG000|Overall Study|Protocol Violation|2|||
170386678|NCT00548340|615753297|FG001|Overall Study|Protocol Violation|3|||
170386679|NCT00548340|615753298|FG002|Overall Study|Protocol Violation|3|||
170386680|NCT00548340|615753296|FG000|Overall Study|Adverse Event|2|||
170386681|NCT00548340|615753297|FG001|Overall Study|Adverse Event|2|||
170386682|NCT00548340|615753298|FG002|Overall Study|Adverse Event|2|||
170386683|NCT00548340|615753296|FG000|Overall Study|Lost to Follow-up|1|||
170386684|NCT00548340|615753297|FG001|Overall Study|Lost to Follow-up|1|||
170386685|NCT00548340|615753298|FG002|Overall Study|Lost to Follow-up|0|||
170386686|NCT00548340|615753296|FG000|Overall Study|Withdrawal by Subject|2|||
170386687|NCT00548340|615753297|FG001|Overall Study|Withdrawal by Subject|4|||
170386688|NCT00548340|615753298|FG002|Overall Study|Withdrawal by Subject|3|||
170386689|NCT00548340|615753296|FG000|Overall Study|Other|1|||
170386690|NCT00548340|615753297|FG001|Overall Study|Other|1|||
170386691|NCT00548340|615753298|FG002|Overall Study|Other|1|||
170386692|NCT00665366|615753299|FG000|Overall Study|Lack of Efficacy|11|||
170386693|NCT00665366|615753300|FG001|Overall Study|Lack of Efficacy|10|||
170386694|NCT00665366|615753299|FG000|Overall Study|Adverse Event|25|||
170386695|NCT00665366|615753300|FG001|Overall Study|Adverse Event|23|||
170386696|NCT00665366|615753299|FG000|Overall Study|Withdrawal by Subject|11|||
170386697|NCT00665366|615753300|FG001|Overall Study|Withdrawal by Subject|14|||
170386698|NCT00665366|615753299|FG000|Overall Study|Lost to Follow-up|3|||
170386699|NCT00665366|615753300|FG001|Overall Study|Lost to Follow-up|5|||
170386700|NCT00665366|615753299|FG000|Overall Study|Poor compliance/noncompliance|3|||
170386701|NCT00665366|615753300|FG001|Overall Study|Poor compliance/noncompliance|5|||
170386702|NCT00665366|615753299|FG000|Overall Study|Pregnancy|1|||
170386703|NCT00665366|615753300|FG001|Overall Study|Pregnancy|0|||
170386704|NCT00665366|615753299|FG000|Overall Study|No longer meets study criteria|0|||
170386705|NCT00665366|615753300|FG001|Overall Study|No longer meets study criteria|1|||
170386706|NCT00665366|615753299|FG000|Overall Study|Other reasons|4|||
170386707|NCT00665366|615753300|FG001|Overall Study|Other reasons|1|||
170386708|NCT00379639|615753305|FG000|Overall Study|Disease Progression|3|||
170386709|NCT00379639|615753306|FG001|Overall Study|Disease Progression|3|||
170386710|NCT00379639|615753307|FG002|Overall Study|Disease Progression|3|||
170386711|NCT00379639|615753308|FG003|Overall Study|Disease Progression|4|||
170386712|NCT00379639|615753309|FG004|Overall Study|Disease Progression|4|||
170386713|NCT00379639|615753305|FG000|Overall Study|Physician Decision|0|||
170386714|NCT00379639|615753306|FG001|Overall Study|Physician Decision|2|||
170386715|NCT00379639|615753307|FG002|Overall Study|Physician Decision|1|||
170386716|NCT00379639|615753308|FG003|Overall Study|Physician Decision|1|||
170386717|NCT00379639|615753309|FG004|Overall Study|Physician Decision|0|||
170386718|NCT00379639|615753305|FG000|Overall Study|Symptomatic Deterioration|0|||
170386719|NCT00379639|615753306|FG001|Overall Study|Symptomatic Deterioration|0|||
170386720|NCT00379639|615753307|FG002|Overall Study|Symptomatic Deterioration|1|||
170386721|NCT00379639|615753308|FG003|Overall Study|Symptomatic Deterioration|0|||
170386722|NCT00379639|615753309|FG004|Overall Study|Symptomatic Deterioration|1|||
170386723|NCT00379639|615753305|FG000|Overall Study|Adverse Event|0|||
170386724|NCT00379639|615753306|FG001|Overall Study|Adverse Event|0|||
170386725|NCT00379639|615753307|FG002|Overall Study|Adverse Event|1|||
170386726|NCT00379639|615753308|FG003|Overall Study|Adverse Event|0|||
170386727|NCT00379639|615753309|FG004|Overall Study|Adverse Event|1|||
170386728|NCT00379639|615753305|FG000|Overall Study|Lost to Follow-up|0|||
170386729|NCT00379639|615753306|FG001|Overall Study|Lost to Follow-up|0|||
170386730|NCT00379639|615753307|FG002|Overall Study|Lost to Follow-up|0|||
170386731|NCT00379639|615753308|FG003|Overall Study|Lost to Follow-up|1|||
170386732|NCT00379639|615753309|FG004|Overall Study|Lost to Follow-up|0|||
170386733|NCT00379639|615753305|FG000|Overall Study|Other|0|||
170386734|NCT00379639|615753306|FG001|Overall Study|Other|0|||
170386735|NCT00379639|615753307|FG002|Overall Study|Other|3|||
170386736|NCT00379639|615753308|FG003|Overall Study|Other|0|||
170386737|NCT00379639|615753309|FG004|Overall Study|Other|0|||
170386738|NCT02322866|615753322|FG000|Overall Study|Adverse Event|6|||
170386739|NCT02322866|615753323|FG001|Overall Study|Adverse Event|11|||
170386740|NCT02322866|615753322|FG000|Overall Study|Withdrawal of Consent|16|||
170386741|NCT02322866|615753323|FG001|Overall Study|Withdrawal of Consent|25|||
170386742|NCT02322866|615753322|FG000|Overall Study|Lost to Follow-up|36|||
170386743|NCT02322866|615753323|FG001|Overall Study|Lost to Follow-up|39|||
170386744|NCT02322866|615753322|FG000|Overall Study|Protocol Violation|1|||
170386745|NCT02322866|615753323|FG001|Overall Study|Protocol Violation|0|||
170386746|NCT02322866|615753322|FG000|Overall Study|Noncompliance with Treatment|3|||
170386747|NCT02322866|615753323|FG001|Overall Study|Noncompliance with Treatment|4|||
170386748|NCT02322866|615753322|FG000|Overall Study|Lack of Efficacy|3|||
170386749|NCT02322866|615753323|FG001|Overall Study|Lack of Efficacy|1|||
170386750|NCT02322866|615753322|FG000|Overall Study|Other Miscellaneous Reasons|6|||
170386751|NCT02322866|615753323|FG001|Overall Study|Other Miscellaneous Reasons|6|||
170386752|NCT03735680|615753326|FG000|Overall Study|Withdrawal by Subject|0|||
170386753|NCT03735680|615753327|FG001|Overall Study|Withdrawal by Subject|1|||
170386754|NCT03735680|615753328|FG002|Overall Study|Withdrawal by Subject|0|||
170386755|NCT03735680|615753329|FG003|Overall Study|Withdrawal by Subject|0|||
170386756|NCT03735680|615753330|FG004|Overall Study|Withdrawal by Subject|0|||
170386757|NCT03735680|615753331|FG005|Overall Study|Withdrawal by Subject|1|||
170386758|NCT03735680|615753326|FG000|Overall Study|Patient unable or unwilling to continue|0|||
170386759|NCT03735680|615753327|FG001|Overall Study|Patient unable or unwilling to continue|0|||
170386760|NCT03735680|615753328|FG002|Overall Study|Patient unable or unwilling to continue|1|||
170386761|NCT03735680|615753329|FG003|Overall Study|Patient unable or unwilling to continue|0|||
170386762|NCT03735680|615753330|FG004|Overall Study|Patient unable or unwilling to continue|0|||
170386763|NCT03735680|615753331|FG005|Overall Study|Patient unable or unwilling to continue|0|||
170386764|NCT01928758|615753341|FG000|Overall Study|Lost to Follow-up|14|||
170386765|NCT01928758|615753342|FG001|Overall Study|Lost to Follow-up|9|||
170386766|NCT01928758|615753341|FG000|Overall Study|Withdrawal by Subject|5|||
170386767|NCT01928758|615753342|FG001|Overall Study|Withdrawal by Subject|2|||
170386768|NCT01928758|615753341|FG000|Overall Study|Adverse Event|3|||
170386769|NCT01928758|615753342|FG001|Overall Study|Adverse Event|5|||
170386770|NCT01928758|615753341|FG000|Overall Study|Protocol Violation|3|||
170386771|NCT01928758|615753342|FG001|Overall Study|Protocol Violation|4|||
170386772|NCT01474291|615753344|FG000|Overall Study|Not Evaluable for Efficacy|26|||
170386773|NCT01474291|615753344|FG000|Overall Study|Lack of Treatment Efficacy|88|||
170386774|NCT01474291|615753344|FG000|Overall Study|Adverse Event|53|||
170386775|NCT01474291|615753344|FG000|Overall Study|Lost to Follow-up|29|||
170386776|NCT01474291|615753344|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
170386777|NCT01474291|615753344|FG000|Overall Study|No Reason Reported|10|||
170386778|NCT01474291|615753344|FG000|Overall Study|Death|2|||
170386779|NCT03471507|615753345|FG000|Overall Study|Lost to Follow-up|1|||
170386780|NCT03471507|615753346|FG001|Overall Study|Lost to Follow-up|3|||
170386781|NCT03471507|615753345|FG000|Overall Study|Physician Decision|0|||
170386782|NCT03471507|615753346|FG001|Overall Study|Physician Decision|1|||
170386783|NCT03471507|615753345|FG000|Overall Study|Withdrawal by Subject|2|||
170386784|NCT03471507|615753346|FG001|Overall Study|Withdrawal by Subject|1|||
170386785|NCT01333501|615753358|FG000|Overall Study|Adverse Event|3|||
170386786|NCT01333501|615753359|FG001|Overall Study|Adverse Event|1|||
170386787|NCT01333501|615753358|FG000|Overall Study|Abnormal laboratory value|2|||
170386788|NCT01333501|615753359|FG001|Overall Study|Abnormal laboratory value|1|||
170386789|NCT01333501|615753358|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
170386790|NCT01333501|615753359|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
170386791|NCT01333501|615753358|FG000|Overall Study|Withdrawn consent|3|||
170386792|NCT01333501|615753359|FG001|Overall Study|Withdrawn consent|12|||
170386793|NCT01303159|615753360|FG000|Overall Study|Death|16|||
170386794|NCT01303159|615753360|FG000|Overall Study|Study Termination|7|||
170386795|NCT02431559|615753361|FG000|Overall Study|Adverse Event|0|||
170386796|NCT02431559|615753362|FG001|Overall Study|Adverse Event|1|||
170386797|NCT02431559|615753363|FG002|Overall Study|Adverse Event|0|||
170386798|NCT02431559|615753364|FG003|Overall Study|Adverse Event|4|||
170386799|NCT02431559|615753361|FG000|Overall Study|Progressive disease|2|||
170386800|NCT02431559|615753362|FG001|Overall Study|Progressive disease|1|||
170386801|NCT02431559|615753363|FG002|Overall Study|Progressive disease|4|||
170386802|NCT02431559|615753364|FG003|Overall Study|Progressive disease|22|||
170386803|NCT02431559|615753361|FG000|Overall Study|Withdrawal by Subject|0|||
170386804|NCT02431559|615753362|FG001|Overall Study|Withdrawal by Subject|1|||
170386805|NCT02431559|615753363|FG002|Overall Study|Withdrawal by Subject|0|||
170386806|NCT02431559|615753364|FG003|Overall Study|Withdrawal by Subject|4|||
170386807|NCT02431559|615753361|FG000|Overall Study|Physician Decision|0|||
170386808|NCT02431559|615753362|FG001|Overall Study|Physician Decision|0|||
170386809|NCT02431559|615753363|FG002|Overall Study|Physician Decision|0|||
170386810|NCT02431559|615753364|FG003|Overall Study|Physician Decision|1|||
170386811|NCT00955682|615753365|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
170386812|NCT00955682|615753366|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
170386813|NCT01610752|615753373|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
170386814|NCT01610752|615753374|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
170386815|NCT01610752|615753375|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
170386816|NCT00283062|615753379|FG000|Overall Study|Did not receive any study medication|5|||
170398862|NCT05004181|615798314|FG002|Overall Study|Death|0|||
170386817|NCT00283062|615753380|FG001|Overall Study|Did not receive any study medication|4|||
170386818|NCT00283062|615753381|FG002|Overall Study|Did not receive any study medication|36|||
170386819|NCT00283062|615753382|FG003|Overall Study|Did not receive any study medication|45|||
170386820|NCT00283062|615753379|FG000|Overall Study|Adverse Event|2|||
170386821|NCT00283062|615753380|FG001|Overall Study|Adverse Event|0|||
170386822|NCT00283062|615753381|FG002|Overall Study|Adverse Event|1|||
170386823|NCT00283062|615753382|FG003|Overall Study|Adverse Event|0|||
170386824|NCT00283062|615753379|FG000|Overall Study|Lost to Follow-up|1|||
170386825|NCT00283062|615753380|FG001|Overall Study|Lost to Follow-up|0|||
170386826|NCT00283062|615753381|FG002|Overall Study|Lost to Follow-up|1|||
170386827|NCT00283062|615753382|FG003|Overall Study|Lost to Follow-up|0|||
170386828|NCT00283062|615753379|FG000|Overall Study|Progressive disease|0|||
170386829|NCT00283062|615753380|FG001|Overall Study|Progressive disease|0|||
170386830|NCT00283062|615753381|FG002|Overall Study|Progressive disease|1|||
170386831|NCT00283062|615753382|FG003|Overall Study|Progressive disease|0|||
170386832|NCT00283062|615753379|FG000|Overall Study|Participant did not wish to continue|3|||
170386833|NCT00283062|615753380|FG001|Overall Study|Participant did not wish to continue|2|||
170386834|NCT00283062|615753381|FG002|Overall Study|Participant did not wish to continue|1|||
170386835|NCT00283062|615753382|FG003|Overall Study|Participant did not wish to continue|0|||
170386836|NCT00283062|615753379|FG000|Overall Study|Undefined|0|||
170386837|NCT00283062|615753380|FG001|Overall Study|Undefined|1|||
170386838|NCT00283062|615753381|FG002|Overall Study|Undefined|1|||
170386839|NCT00283062|615753382|FG003|Overall Study|Undefined|4|||
170386840|NCT00283062|615753379|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
170386841|NCT00283062|615753380|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
170386842|NCT00283062|615753381|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
170386843|NCT00283062|615753382|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
170386844|NCT03742271|615753385|FG000|Overall Study|Unsatisfactory Visual Response|1|||
170386845|NCT03742271|615753385|FG000|Overall Study|Withdrawal by Subject|3|||
170386846|NCT03742271|615753385|FG000|Overall Study|Lost to Follow-up|4|||
170386847|NCT03742271|615753385|FG000|Overall Study|Failed Insertion & removal|3|||
170386848|NCT03742271|615753385|FG000|Overall Study|Protocol Violation|1|||
170386849|NCT00252499|615753390|FG000|Overall Study|Lost to Follow-up|1|||
170386850|NCT00252499|615753391|FG001|Overall Study|Lost to Follow-up|0|||
170386851|NCT00252499|615753392|FG002|Overall Study|Lost to Follow-up|0|||
170386852|NCT03137173|615753393|FG000|Overall Study|Withdrawal by Subject|8|||
170386853|NCT03137173|615753394|FG001|Overall Study|Withdrawal by Subject|13|||
170386854|NCT03137173|615753393|FG000|Overall Study|Death|1|||
170386855|NCT03137173|615753394|FG001|Overall Study|Death|3|||
170386856|NCT03137173|615753393|FG000|Overall Study|Physician Decision|1|||
170386857|NCT03137173|615753394|FG001|Overall Study|Physician Decision|0|||
170386858|NCT03137173|615753393|FG000|Overall Study|Lost to Follow-up|13|||
170386859|NCT03137173|615753394|FG001|Overall Study|Lost to Follow-up|18|||
170386860|NCT03137173|615753393|FG000|Overall Study|Other reasons|3|||
170386861|NCT03137173|615753394|FG001|Overall Study|Other reasons|2|||
170386862|NCT01535638|615753395|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
170386863|NCT01535638|615753396|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
170386864|NCT01535638|615753397|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
170386865|NCT01535638|615753398|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
170386866|NCT01535638|615753399|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
170386867|NCT01535638|615753400|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
170386868|NCT01535638|615753395|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
170386869|NCT01535638|615753396|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
170386870|NCT01535638|615753397|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
170386871|NCT01535638|615753398|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
170386872|NCT01535638|615753399|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
170386873|NCT01535638|615753400|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
170386874|NCT05060003|615753401|FG000|Overall Study|ctDNA negative|7|||
170386875|NCT01365468|615753402|FG000|Overall Study|Physician Decision|1|||
170386876|NCT01365468|615753403|FG001|Overall Study|Physician Decision|0|||
170386877|NCT01365468|615753402|FG000|Overall Study|Disease progression|1|||
170386878|NCT01365468|615753403|FG001|Overall Study|Disease progression|0|||
170386879|NCT01365468|615753402|FG000|Overall Study|Lost to Follow-up|2|||
170386880|NCT01365468|615753403|FG001|Overall Study|Lost to Follow-up|0|||
170386881|NCT03524664|615753404|FG000|Overall Study|Withdrawal by Subject|1|||
170386882|NCT03524664|615753405|FG001|Overall Study|Withdrawal by Subject|2|||
170386883|NCT03524664|615753404|FG000|Overall Study|Lost to Follow-up|4|||
170386884|NCT03524664|615753405|FG001|Overall Study|Lost to Follow-up|13|||
170386885|NCT01482598|615753406|FG000|Overall Study|Death|7|||
170386886|NCT01482598|615753407|FG001|Overall Study|Death|10|||
170386887|NCT01482598|615753406|FG000|Overall Study|Physician Decision|0|||
170386888|NCT01482598|615753407|FG001|Overall Study|Physician Decision|3|||
170386889|NCT01482598|615753406|FG000|Overall Study|Withdrawal by Subject|4|||
170386890|NCT01482598|615753407|FG001|Overall Study|Withdrawal by Subject|5|||
170386891|NCT01482598|615753406|FG000|Overall Study|Lost to Follow-up|5|||
170386892|NCT01482598|615753407|FG001|Overall Study|Lost to Follow-up|4|||
170386893|NCT02694562|615753408|FG000|Overall Study|Death|8|||
170386894|NCT02694562|615753408|FG000|Overall Study|Protocol Violation|4|||
170386895|NCT02694562|615753408|FG000|Overall Study|Lost to Follow-up|3|||
170386896|NCT02694562|615753408|FG000|Overall Study|Screen Failure|2|||
170386897|NCT02694562|615753408|FG000|Overall Study|Physician Decision|1|||
170386898|NCT03702166|615753409|FG000|Overall Study|Lost to Follow-up|1|||
170386899|NCT03702166|615753409|FG000|Overall Study|Withdrawal by Subject|1|||
170386900|NCT00660829|615753416|FG000|Overall Study|Adverse Event|3|||
170386901|NCT00660829|615753417|FG001|Overall Study|Adverse Event|4|||
170386902|NCT00660829|615753416|FG000|Overall Study|Lack of Efficacy|2|||
170386903|NCT00660829|615753417|FG001|Overall Study|Lack of Efficacy|3|||
170386904|NCT00660829|615753416|FG000|Overall Study|Non-Compliance|0|||
170386905|NCT00660829|615753417|FG001|Overall Study|Non-Compliance|4|||
170386906|NCT00660829|615753416|FG000|Overall Study|Withdrawal by Subject|1|||
170386907|NCT00660829|615753417|FG001|Overall Study|Withdrawal by Subject|2|||
170386908|NCT00660829|615753416|FG000|Overall Study|Lost to Follow-up|3|||
170386909|NCT00660829|615753417|FG001|Overall Study|Lost to Follow-up|2|||
170386910|NCT00660829|615753416|FG000|Overall Study|Other|9|||
170386911|NCT00660829|615753417|FG001|Overall Study|Other|4|||
170386912|NCT00495794|615753418|FG000|Overall Study|Pharmacist did not activate patient|522|||
170386913|NCT00495794|615753419|FG001|Overall Study|Pharmacist did not activate patient|0|||
170386914|NCT03053102|615755058|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
170386915|NCT03053102|615755058|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
170386916|NCT01798056|615755059|FG000|Overall Study|Serious Adverse Event|13|||
170386917|NCT01798056|615755060|FG001|Overall Study|Serious Adverse Event|12|||
170386918|NCT01798056|615755059|FG000|Overall Study|Withdrawal by Subject|12|||
170386919|NCT01798056|615755060|FG001|Overall Study|Withdrawal by Subject|9|||
170386920|NCT01798056|615755059|FG000|Overall Study|Migrated/moved from study area|1|||
170386921|NCT01798056|615755060|FG001|Overall Study|Migrated/moved from study area|1|||
170386922|NCT01798056|615755059|FG000|Overall Study|Lost to Follow-up|1|||
170386923|NCT01798056|615755060|FG001|Overall Study|Lost to Follow-up|1|||
170386924|NCT01798056|615755059|FG000|Overall Study|Other|0|||
170386925|NCT01798056|615755060|FG001|Overall Study|Other|2|||
170386926|NCT00151775|615755063|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
170386927|NCT00151775|615755064|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
170386928|NCT00151775|615755065|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386929|NCT00151775|615755066|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386930|NCT00151775|615755067|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386931|NCT00151775|615755068|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386932|NCT00151775|615755069|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386933|NCT00151775|615755070|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386934|NCT00151775|615755071|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386935|NCT00151775|615755072|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386936|NCT00151775|615755073|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386937|NCT00151775|615755074|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
170386938|NCT00151775|615755063|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
170386939|NCT00151775|615755064|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386940|NCT00151775|615755065|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386941|NCT00151775|615755066|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386942|NCT00151775|615755067|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386943|NCT00151775|615755068|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386944|NCT00151775|615755069|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
170386945|NCT00151775|615755070|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386946|NCT00151775|615755071|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386947|NCT00151775|615755072|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386948|NCT00151775|615755073|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
170386949|NCT00151775|615755074|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
170386950|NCT00151775|615755063|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386951|NCT00151775|615755064|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
170386952|NCT00151775|615755065|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386953|NCT00151775|615755066|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386954|NCT00151775|615755067|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386955|NCT00151775|615755068|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386956|NCT00151775|615755069|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386957|NCT00151775|615755070|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386958|NCT00151775|615755071|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386959|NCT00151775|615755072|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386960|NCT00151775|615755073|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386961|NCT00151775|615755074|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
170386962|NCT00151775|615755063|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
170386963|NCT00151775|615755064|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
170386964|NCT00151775|615755065|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
170386965|NCT00151775|615755066|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
170386966|NCT00151775|615755067|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
170386967|NCT00151775|615755068|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
170386968|NCT00151775|615755069|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
170386969|NCT00151775|615755070|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
170386970|NCT00151775|615755071|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
170386971|NCT00151775|615755072|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
170386972|NCT00151775|615755073|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
170386973|NCT00151775|615755074|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
170386974|NCT00151775|615755063|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386975|NCT00151775|615755064|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386976|NCT00151775|615755065|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386977|NCT00151775|615755066|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386978|NCT00151775|615755067|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386979|NCT00151775|615755068|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
170386980|NCT00151775|615755069|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386981|NCT00151775|615755070|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386982|NCT00151775|615755071|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386983|NCT00151775|615755072|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386984|NCT00151775|615755073|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386985|NCT00151775|615755074|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
170386986|NCT00151775|615755063|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386987|NCT00151775|615755064|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386988|NCT00151775|615755065|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386989|NCT00151775|615755066|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386990|NCT00151775|615755067|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386991|NCT00151775|615755068|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
170386992|NCT00151775|615755069|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386993|NCT00151775|615755070|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386994|NCT00151775|615755071|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386995|NCT00151775|615755072|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386996|NCT00151775|615755073|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386997|NCT00151775|615755074|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
170386998|NCT00151775|615755063|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170386999|NCT00151775|615755064|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387000|NCT00151775|615755065|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387001|NCT00151775|615755066|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387002|NCT00151775|615755067|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387003|NCT00151775|615755068|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387004|NCT00151775|615755069|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
170387005|NCT00151775|615755070|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387006|NCT00151775|615755071|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387007|NCT00151775|615755072|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387008|NCT00151775|615755073|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387009|NCT00151775|615755074|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
170387010|NCT00151775|615755063|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387011|NCT00151775|615755064|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387012|NCT00151775|615755065|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387013|NCT00151775|615755066|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387014|NCT00151775|615755067|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387015|NCT00151775|615755068|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
170387016|NCT00151775|615755069|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387017|NCT00151775|615755070|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387018|NCT00151775|615755071|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387019|NCT00151775|615755072|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387020|NCT00151775|615755073|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387021|NCT00151775|615755074|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
170387022|NCT00151775|615755063|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
170387023|NCT00151775|615755064|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
170387024|NCT00151775|615755065|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
170387025|NCT00151775|615755066|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
170387026|NCT00151775|615755067|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
170387027|NCT00151775|615755068|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
170387028|NCT00151775|615755069|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
170387029|NCT00151775|615755070|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
170387030|NCT00151775|615755071|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
170387031|NCT00151775|615755072|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
170387032|NCT00151775|615755073|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
170387033|NCT00151775|615755074|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
170387034|NCT00151775|615755063|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387035|NCT00151775|615755064|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387036|NCT00151775|615755065|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387037|NCT00151775|615755066|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387038|NCT00151775|615755067|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387039|NCT00151775|615755068|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387040|NCT00151775|615755069|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
170387041|NCT00151775|615755070|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387042|NCT00151775|615755071|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387043|NCT00151775|615755072|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387044|NCT00151775|615755073|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387045|NCT00151775|615755074|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
170387046|NCT00151775|615755063|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387047|NCT00151775|615755064|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387048|NCT00151775|615755065|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
170387049|NCT00151775|615755066|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387050|NCT00151775|615755067|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387051|NCT00151775|615755068|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387052|NCT00151775|615755069|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387053|NCT00151775|615755070|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387054|NCT00151775|615755071|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387055|NCT00151775|615755072|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387056|NCT00151775|615755073|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387057|NCT00151775|615755074|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
170387058|NCT00151775|615755063|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387059|NCT00151775|615755064|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387060|NCT00151775|615755065|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
170387061|NCT00151775|615755066|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387062|NCT00151775|615755067|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387063|NCT00151775|615755068|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387064|NCT00151775|615755069|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387065|NCT00151775|615755070|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387066|NCT00151775|615755071|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387067|NCT00151775|615755072|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387068|NCT00151775|615755073|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387069|NCT00151775|615755074|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
170387070|NCT00151775|615755063|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387071|NCT00151775|615755064|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387072|NCT00151775|615755065|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387073|NCT00151775|615755066|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387074|NCT00151775|615755067|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387075|NCT00151775|615755068|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387076|NCT00151775|615755069|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387077|NCT00151775|615755070|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387078|NCT00151775|615755071|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387079|NCT00151775|615755072|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387080|NCT00151775|615755073|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
170387081|NCT00151775|615755074|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
170387082|NCT00151775|615755063|FG000|Period 4: Open Label|Increased blood pressure|0|||
170387083|NCT00151775|615755064|FG001|Period 4: Open Label|Increased blood pressure|0|||
170387084|NCT00151775|615755065|FG002|Period 4: Open Label|Increased blood pressure|0|||
170387085|NCT00151775|615755066|FG003|Period 4: Open Label|Increased blood pressure|0|||
170387086|NCT00151775|615755067|FG004|Period 4: Open Label|Increased blood pressure|1|||
170387087|NCT00151775|615755068|FG005|Period 4: Open Label|Increased blood pressure|0|||
170387088|NCT00151775|615755069|FG006|Period 4: Open Label|Increased blood pressure|0|||
170387089|NCT00151775|615755070|FG007|Period 4: Open Label|Increased blood pressure|0|||
170387090|NCT00151775|615755071|FG008|Period 4: Open Label|Increased blood pressure|0|||
170387091|NCT00151775|615755072|FG009|Period 4: Open Label|Increased blood pressure|1|||
170387092|NCT00151775|615755073|FG010|Period 4: Open Label|Increased blood pressure|0|||
170387093|NCT00151775|615755074|FG011|Period 4: Open Label|Increased blood pressure|0|||
170387094|NCT00151775|615755063|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
170387095|NCT00151775|615755064|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
170387096|NCT00151775|615755065|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
170387097|NCT00151775|615755066|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
170387098|NCT00151775|615755067|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
170387099|NCT00151775|615755068|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
170387100|NCT00151775|615755069|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
170387101|NCT00151775|615755070|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
170387102|NCT00151775|615755071|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
170387103|NCT00151775|615755072|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
170387104|NCT00151775|615755073|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
170387105|NCT00151775|615755074|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
170387106|NCT00151775|615755063|FG000|Period 4: Open Label|Adverse Event|0|||
170387107|NCT00151775|615755064|FG001|Period 4: Open Label|Adverse Event|0|||
170387108|NCT00151775|615755065|FG002|Period 4: Open Label|Adverse Event|0|||
170387109|NCT00151775|615755066|FG003|Period 4: Open Label|Adverse Event|0|||
170387110|NCT00151775|615755067|FG004|Period 4: Open Label|Adverse Event|1|||
170387111|NCT00151775|615755068|FG005|Period 4: Open Label|Adverse Event|0|||
170387112|NCT00151775|615755069|FG006|Period 4: Open Label|Adverse Event|0|||
170387113|NCT00151775|615755070|FG007|Period 4: Open Label|Adverse Event|0|||
170387114|NCT00151775|615755071|FG008|Period 4: Open Label|Adverse Event|0|||
170387115|NCT00151775|615755072|FG009|Period 4: Open Label|Adverse Event|2|||
170387116|NCT00151775|615755073|FG010|Period 4: Open Label|Adverse Event|0|||
170387117|NCT00151775|615755074|FG011|Period 4: Open Label|Adverse Event|0|||
170387118|NCT00151775|615755063|FG000|Period 4: Open Label|Lost to Follow-up|0|||
170387119|NCT00151775|615755064|FG001|Period 4: Open Label|Lost to Follow-up|0|||
170387120|NCT00151775|615755065|FG002|Period 4: Open Label|Lost to Follow-up|0|||
170387121|NCT00151775|615755066|FG003|Period 4: Open Label|Lost to Follow-up|0|||
170387122|NCT00151775|615755067|FG004|Period 4: Open Label|Lost to Follow-up|17|||
170387123|NCT00151775|615755068|FG005|Period 4: Open Label|Lost to Follow-up|0|||
170387124|NCT00151775|615755069|FG006|Period 4: Open Label|Lost to Follow-up|0|||
170387125|NCT00151775|615755070|FG007|Period 4: Open Label|Lost to Follow-up|0|||
170387126|NCT00151775|615755071|FG008|Period 4: Open Label|Lost to Follow-up|0|||
170387127|NCT00151775|615755072|FG009|Period 4: Open Label|Lost to Follow-up|7|||
170387128|NCT00151775|615755073|FG010|Period 4: Open Label|Lost to Follow-up|0|||
170387129|NCT00151775|615755074|FG011|Period 4: Open Label|Lost to Follow-up|0|||
170387130|NCT00151775|615755063|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
170387131|NCT00151775|615755064|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
170387132|NCT00151775|615755065|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
170387133|NCT00151775|615755066|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
170387134|NCT00151775|615755067|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
170387135|NCT00151775|615755068|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
170387136|NCT00151775|615755069|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
170387137|NCT00151775|615755070|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
170387138|NCT00151775|615755071|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
170387139|NCT00151775|615755072|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
170387140|NCT00151775|615755073|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
170387141|NCT00151775|615755074|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
170387142|NCT00151775|615755063|FG000|Period 4: Open Label|Other|0|||
170387143|NCT00151775|615755064|FG001|Period 4: Open Label|Other|0|||
170387144|NCT00151775|615755065|FG002|Period 4: Open Label|Other|0|||
170387145|NCT00151775|615755066|FG003|Period 4: Open Label|Other|0|||
170387146|NCT00151775|615755067|FG004|Period 4: Open Label|Other|1|||
170387147|NCT00151775|615755068|FG005|Period 4: Open Label|Other|0|||
170387148|NCT00151775|615755069|FG006|Period 4: Open Label|Other|0|||
170387149|NCT00151775|615755070|FG007|Period 4: Open Label|Other|0|||
170387150|NCT00151775|615755071|FG008|Period 4: Open Label|Other|0|||
170387151|NCT00151775|615755072|FG009|Period 4: Open Label|Other|3|||
170387152|NCT00151775|615755073|FG010|Period 4: Open Label|Other|0|||
170387153|NCT00151775|615755074|FG011|Period 4: Open Label|Other|0|||
170387154|NCT00151775|615755063|FG000|Period 4: Open Label|Physician Decision|0|||
170387155|NCT00151775|615755064|FG001|Period 4: Open Label|Physician Decision|0|||
170387156|NCT00151775|615755065|FG002|Period 4: Open Label|Physician Decision|0|||
170387157|NCT00151775|615755066|FG003|Period 4: Open Label|Physician Decision|0|||
170387158|NCT00151775|615755067|FG004|Period 4: Open Label|Physician Decision|0|||
170387159|NCT00151775|615755068|FG005|Period 4: Open Label|Physician Decision|0|||
170387160|NCT00151775|615755069|FG006|Period 4: Open Label|Physician Decision|0|||
170387161|NCT00151775|615755070|FG007|Period 4: Open Label|Physician Decision|0|||
170387162|NCT00151775|615755071|FG008|Period 4: Open Label|Physician Decision|0|||
170387163|NCT00151775|615755072|FG009|Period 4: Open Label|Physician Decision|2|||
170387164|NCT00151775|615755073|FG010|Period 4: Open Label|Physician Decision|0|||
170387165|NCT00151775|615755074|FG011|Period 4: Open Label|Physician Decision|0|||
170387166|NCT00151775|615755063|FG000|Period 4: Open Label|Protocol Violation|0|||
170387167|NCT00151775|615755064|FG001|Period 4: Open Label|Protocol Violation|0|||
170387168|NCT00151775|615755065|FG002|Period 4: Open Label|Protocol Violation|0|||
170387169|NCT00151775|615755066|FG003|Period 4: Open Label|Protocol Violation|0|||
170387170|NCT00151775|615755067|FG004|Period 4: Open Label|Protocol Violation|1|||
170387171|NCT00151775|615755068|FG005|Period 4: Open Label|Protocol Violation|0|||
170387172|NCT00151775|615755069|FG006|Period 4: Open Label|Protocol Violation|0|||
170387173|NCT00151775|615755070|FG007|Period 4: Open Label|Protocol Violation|0|||
170387174|NCT00151775|615755071|FG008|Period 4: Open Label|Protocol Violation|0|||
170387175|NCT00151775|615755072|FG009|Period 4: Open Label|Protocol Violation|0|||
170387176|NCT00151775|615755073|FG010|Period 4: Open Label|Protocol Violation|0|||
170387177|NCT00151775|615755074|FG011|Period 4: Open Label|Protocol Violation|0|||
170387178|NCT03323034|615755075|FG000|Overall Study|Lack of Efficacy|5|||
170387179|NCT03323034|615755076|FG001|Overall Study|Lack of Efficacy|5|||
170387180|NCT03323034|615755077|FG002|Overall Study|Lack of Efficacy|6|||
170387181|NCT03323034|615755078|FG003|Overall Study|Lack of Efficacy|5|||
170387182|NCT03323034|615755079|FG004|Overall Study|Lack of Efficacy|5|||
170387183|NCT03323034|615755075|FG000|Overall Study|Physician Decision|0|||
170387184|NCT03323034|615755076|FG001|Overall Study|Physician Decision|0|||
170387185|NCT03323034|615755077|FG002|Overall Study|Physician Decision|0|||
170387186|NCT03323034|615755078|FG003|Overall Study|Physician Decision|0|||
170387187|NCT03323034|615755079|FG004|Overall Study|Physician Decision|1|||
170387188|NCT03323034|615755075|FG000|Overall Study|Withdrawal by Subject|1|||
170387189|NCT03323034|615755076|FG001|Overall Study|Withdrawal by Subject|1|||
170387190|NCT03323034|615755077|FG002|Overall Study|Withdrawal by Subject|0|||
170387191|NCT03323034|615755078|FG003|Overall Study|Withdrawal by Subject|1|||
170387192|NCT03323034|615755079|FG004|Overall Study|Withdrawal by Subject|0|||
170387193|NCT02660489|615755080|FG000|Overall Study|Lost to Follow-up|1|||
170387194|NCT02660489|615755081|FG001|Overall Study|Lost to Follow-up|1|||
170387195|NCT02660489|615755080|FG000|Overall Study|Adverse Event|1|||
170387196|NCT02660489|615755081|FG001|Overall Study|Adverse Event|3|||
170387197|NCT02660489|615755080|FG000|Overall Study|no rhinovirus infection|4|||
170387198|NCT02660489|615755081|FG001|Overall Study|no rhinovirus infection|4|||
170387199|NCT00278473|615755082|FG000|Overall Study|drop out|4|||
170387200|NCT00278473|615755083|FG001|Overall Study|drop out|3|||
170387201|NCT03039686|615755084|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
170387202|NCT03039686|615755085|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
170387203|NCT03039686|615755086|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
170387204|NCT03039686|615755084|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
170387205|NCT03039686|615755085|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
170387206|NCT03039686|615755086|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
170387207|NCT03039686|615755084|FG000|Double-blind Period|Withdrawal by Subject|2|||
170387208|NCT03039686|615755085|FG001|Double-blind Period|Withdrawal by Subject|2|||
170387209|NCT03039686|615755086|FG002|Double-blind Period|Withdrawal by Subject|1|||
170387210|NCT03039686|615755084|FG000|Double-blind Period|Death|0|||
170387211|NCT03039686|615755085|FG001|Double-blind Period|Death|0|||
170387212|NCT03039686|615755086|FG002|Double-blind Period|Death|1|||
170387213|NCT03039686|615755084|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
170387214|NCT03039686|615755085|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
170387215|NCT03039686|615755086|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
170387216|NCT03039686|615755084|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
170387217|NCT03039686|615755085|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
170387218|NCT03039686|615755086|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
170387219|NCT03039686|615755084|FG000|Open Label Period|Withdrawal by Subject|0|||
170387220|NCT03039686|615755085|FG001|Open Label Period|Withdrawal by Subject|3|||
170387221|NCT03039686|615755086|FG002|Open Label Period|Withdrawal by Subject|1|||
170387222|NCT00761761|615755087|FG000|Overall Study|Lost to Follow-up|3|||
170387223|NCT00761761|615755088|FG001|Overall Study|Lost to Follow-up|1|||
170387224|NCT00761761|615755087|FG000|Overall Study|Withdrawal by Subject|3|||
170387225|NCT00761761|615755088|FG001|Overall Study|Withdrawal by Subject|0|||
170387226|NCT01711736|615755090|FG000|Overall Study|Lost to Follow-up|4|||
170387227|NCT01711736|615755091|FG001|Overall Study|Lost to Follow-up|1|||
170387228|NCT01711736|615755090|FG000|Overall Study|Withdrawal by Subject|6|||
170387229|NCT01711736|615755091|FG001|Overall Study|Withdrawal by Subject|6|||
170387230|NCT01711736|615755090|FG000|Overall Study|Migrated/moved from study area|2|||
170387231|NCT01711736|615755091|FG001|Overall Study|Migrated/moved from study area|1|||
170387232|NCT02079077|615755097|FG000|Overall Study|Lost to Follow-up|5|||
170387233|NCT02079077|615755098|FG001|Overall Study|Lost to Follow-up|7|||
170387234|NCT02079077|615755097|FG000|Overall Study|Became STIs Positive|1|||
170387235|NCT02079077|615755098|FG001|Overall Study|Became STIs Positive|2|||
170387236|NCT04963231|615755099|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
170387237|NCT04963231|615755100|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
170387238|NCT04963231|615755101|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
170387239|NCT04963231|615755099|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
170387240|NCT04963231|615755100|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
170387241|NCT04963231|615755101|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
170387242|NCT04963231|615755099|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
170387243|NCT04963231|615755100|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
170387244|NCT04963231|615755101|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
170387245|NCT04963231|615755099|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
170387246|NCT04963231|615755100|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
170387247|NCT04963231|615755101|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
170387248|NCT04963231|615755099|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
170387249|NCT04963231|615755100|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
170387250|NCT04963231|615755101|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
170387251|NCT04963231|615755099|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
170387252|NCT04963231|615755100|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
170387253|NCT04963231|615755101|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
170387254|NCT04963231|615755099|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
170387255|NCT04963231|615755100|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
170387256|NCT04963231|615755101|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
170387257|NCT02957149|615755102|FG000|Overall Study|Withdrawal by Subject|5|||
170387258|NCT02718131|615755103|FG000|Overall Study|Withdrawal by Subject|1|||
170387259|NCT02718131|615755104|FG001|Overall Study|Withdrawal by Subject|0|||
170387260|NCT02718131|615755103|FG000|Overall Study|Adverse Event|1|||
170387261|NCT02718131|615755104|FG001|Overall Study|Adverse Event|0|||
170387262|NCT02718131|615755103|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
170387263|NCT02718131|615755104|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
170387264|NCT00134563|615755105|FG000|Overall Study|Not treated due to protocol violation|0|||
170387265|NCT00134563|615755106|FG001|Overall Study|Not treated due to protocol violation|1|||
170387266|NCT00134563|615755107|FG002|Overall Study|Not treated due to protocol violation|1|||
170387267|NCT00134563|615755105|FG000|Overall Study|Adverse Event|29|||
170387268|NCT00134563|615755106|FG001|Overall Study|Adverse Event|37|||
170387269|NCT00134563|615755107|FG002|Overall Study|Adverse Event|38|||
170387270|NCT00134563|615755105|FG000|Overall Study|Lack of Efficacy|24|||
170387271|NCT00134563|615755106|FG001|Overall Study|Lack of Efficacy|14|||
170387272|NCT00134563|615755107|FG002|Overall Study|Lack of Efficacy|17|||
170387273|NCT00134563|615755105|FG000|Overall Study|Protocol Violation|3|||
170387274|NCT00134563|615755106|FG001|Overall Study|Protocol Violation|2|||
170387275|NCT00134563|615755107|FG002|Overall Study|Protocol Violation|5|||
170387276|NCT00134563|615755105|FG000|Overall Study|Lost to Follow-up|4|||
170387277|NCT00134563|615755106|FG001|Overall Study|Lost to Follow-up|0|||
170387278|NCT00134563|615755107|FG002|Overall Study|Lost to Follow-up|2|||
170387279|NCT00134563|615755105|FG000|Overall Study|progressive disease|11|||
170387280|NCT00134563|615755106|FG001|Overall Study|progressive disease|4|||
170387281|NCT00134563|615755107|FG002|Overall Study|progressive disease|2|||
170387282|NCT00134563|615755105|FG000|Overall Study|did not wish to continue|33|||
170387283|NCT00134563|615755106|FG001|Overall Study|did not wish to continue|32|||
170387284|NCT00134563|615755107|FG002|Overall Study|did not wish to continue|26|||
170387285|NCT00134563|615755105|FG000|Overall Study|Reason other than above|0|||
170387286|NCT00134563|615755106|FG001|Overall Study|Reason other than above|2|||
170387287|NCT00134563|615755107|FG002|Overall Study|Reason other than above|5|||
170387288|NCT03382639|615755108|FG000|Overall Study|Adverse Event|2|||
170387289|NCT03382639|615755109|FG001|Overall Study|Adverse Event|0|||
170387290|NCT03382639|615755110|FG002|Overall Study|Adverse Event|1|||
170387291|NCT03382639|615755111|FG003|Overall Study|Adverse Event|1|||
170387292|NCT03382639|615755108|FG000|Overall Study|Lost to Follow-up|1|||
170387293|NCT03382639|615755109|FG001|Overall Study|Lost to Follow-up|0|||
170387294|NCT03382639|615755110|FG002|Overall Study|Lost to Follow-up|0|||
170387295|NCT03382639|615755111|FG003|Overall Study|Lost to Follow-up|0|||
170387296|NCT03382639|615755108|FG000|Overall Study|Withdrawal by Subject|4|||
170387297|NCT03382639|615755109|FG001|Overall Study|Withdrawal by Subject|3|||
170387298|NCT03382639|615755110|FG002|Overall Study|Withdrawal by Subject|2|||
170387299|NCT03382639|615755111|FG003|Overall Study|Withdrawal by Subject|3|||
170387300|NCT03382639|615755108|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
170387301|NCT03382639|615755109|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
170387302|NCT03382639|615755110|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
170387303|NCT03382639|615755111|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
170387304|NCT03382639|615755108|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
170387305|NCT03382639|615755109|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
170387306|NCT03382639|615755110|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
170387307|NCT03382639|615755111|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
170387308|NCT03382639|615755108|FG000|Overall Study|Other|2|||
170387309|NCT03382639|615755109|FG001|Overall Study|Other|0|||
170387310|NCT03382639|615755110|FG002|Overall Study|Other|0|||
170387311|NCT03382639|615755111|FG003|Overall Study|Other|3|||
170387312|NCT03737812|615755114|FG000|Overall Study|Withdrawal by Subject|1|||
170387313|NCT03737812|615755115|FG001|Overall Study|Withdrawal by Subject|2|||
170387314|NCT03737812|615755116|FG002|Overall Study|Withdrawal by Subject|1|||
170387315|NCT03737812|615755114|FG000|Overall Study|Sponsor Discontinued the Study|4|||
170387316|NCT03737812|615755115|FG001|Overall Study|Sponsor Discontinued the Study|3|||
170387317|NCT03737812|615755116|FG002|Overall Study|Sponsor Discontinued the Study|2|||
170387318|NCT03737812|615755114|FG000|Overall Study|Adverse Event|0|||
170387319|NCT03737812|615755115|FG001|Overall Study|Adverse Event|1|||
170387320|NCT03737812|615755116|FG002|Overall Study|Adverse Event|0|||
170387321|NCT03737812|615755114|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
170387322|NCT03737812|615755115|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
170387323|NCT03737812|615755116|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
170387324|NCT02213666|615755119|FG000|Overall Study|Withdrawal by Subject|1|||
170387325|NCT02557308|615755120|FG000|Overall Study|Withdrawal by Subject|11|||
170387326|NCT02557308|615755121|FG001|Overall Study|Withdrawal by Subject|3|||
170387327|NCT02557308|615755122|FG002|Overall Study|Withdrawal by Subject|2|||
170387328|NCT02557308|615755123|FG003|Overall Study|Withdrawal by Subject|0|||
170387329|NCT02557308|615755124|FG004|Overall Study|Withdrawal by Subject|1|||
170387330|NCT02557308|615755125|FG005|Overall Study|Withdrawal by Subject|0|||
170387331|NCT02557308|615755126|FG006|Overall Study|Withdrawal by Subject|10|||
170387332|NCT02557308|615755127|FG007|Overall Study|Withdrawal by Subject|1|||
170387333|NCT02557308|615755120|FG000|Overall Study|Disease Progression|0|||
170387334|NCT02557308|615755121|FG001|Overall Study|Disease Progression|1|||
170387335|NCT02557308|615755122|FG002|Overall Study|Disease Progression|0|||
170387336|NCT02557308|615755123|FG003|Overall Study|Disease Progression|0|||
170387337|NCT02557308|615755124|FG004|Overall Study|Disease Progression|0|||
170387338|NCT02557308|615755125|FG005|Overall Study|Disease Progression|0|||
170387339|NCT02557308|615755126|FG006|Overall Study|Disease Progression|0|||
170387340|NCT02557308|615755127|FG007|Overall Study|Disease Progression|0|||
170387341|NCT02557308|615755120|FG000|Overall Study|Lack of Efficacy|3|||
170387342|NCT02557308|615755121|FG001|Overall Study|Lack of Efficacy|0|||
170387343|NCT02557308|615755122|FG002|Overall Study|Lack of Efficacy|0|||
170387344|NCT02557308|615755123|FG003|Overall Study|Lack of Efficacy|0|||
170387345|NCT02557308|615755124|FG004|Overall Study|Lack of Efficacy|0|||
170387346|NCT02557308|615755125|FG005|Overall Study|Lack of Efficacy|0|||
170387347|NCT02557308|615755126|FG006|Overall Study|Lack of Efficacy|1|||
170387348|NCT02557308|615755127|FG007|Overall Study|Lack of Efficacy|0|||
170387349|NCT02557308|615755120|FG000|Overall Study|Adverse Event|4|||
170387350|NCT02557308|615755121|FG001|Overall Study|Adverse Event|1|||
170387351|NCT02557308|615755122|FG002|Overall Study|Adverse Event|2|||
170387352|NCT02557308|615755123|FG003|Overall Study|Adverse Event|0|||
170387353|NCT02557308|615755124|FG004|Overall Study|Adverse Event|0|||
170387354|NCT02557308|615755125|FG005|Overall Study|Adverse Event|0|||
170387355|NCT02557308|615755126|FG006|Overall Study|Adverse Event|4|||
170387356|NCT02557308|615755127|FG007|Overall Study|Adverse Event|1|||
170387357|NCT02557308|615755120|FG000|Overall Study|Lost to Follow-up|2|||
170387358|NCT02557308|615755121|FG001|Overall Study|Lost to Follow-up|0|||
170387359|NCT02557308|615755122|FG002|Overall Study|Lost to Follow-up|1|||
170387360|NCT02557308|615755123|FG003|Overall Study|Lost to Follow-up|0|||
170387361|NCT02557308|615755124|FG004|Overall Study|Lost to Follow-up|0|||
170387362|NCT02557308|615755125|FG005|Overall Study|Lost to Follow-up|0|||
170387363|NCT02557308|615755126|FG006|Overall Study|Lost to Follow-up|2|||
170387364|NCT02557308|615755127|FG007|Overall Study|Lost to Follow-up|0|||
170387365|NCT02557308|615755120|FG000|Overall Study|Death|1|||
170387366|NCT02557308|615755121|FG001|Overall Study|Death|0|||
170387367|NCT02557308|615755122|FG002|Overall Study|Death|0|||
170387368|NCT02557308|615755123|FG003|Overall Study|Death|0|||
170387369|NCT02557308|615755124|FG004|Overall Study|Death|0|||
170387370|NCT02557308|615755125|FG005|Overall Study|Death|0|||
170387371|NCT02557308|615755126|FG006|Overall Study|Death|0|||
170387372|NCT02557308|615755127|FG007|Overall Study|Death|0|||
170387373|NCT02557308|615755120|FG000|Overall Study|Study Close|98|||
170387374|NCT02557308|615755121|FG001|Overall Study|Study Close|18|||
170387375|NCT02557308|615755122|FG002|Overall Study|Study Close|5|||
170387376|NCT02557308|615755123|FG003|Overall Study|Study Close|3|||
170387377|NCT02557308|615755124|FG004|Overall Study|Study Close|1|||
170387378|NCT02557308|615755125|FG005|Overall Study|Study Close|0|||
170387379|NCT02557308|615755126|FG006|Overall Study|Study Close|123|||
170387380|NCT02557308|615755127|FG007|Overall Study|Study Close|5|||
170387381|NCT02557308|615755120|FG000|Overall Study|Except for study close|5|||
170387382|NCT02557308|615755121|FG001|Overall Study|Except for study close|0|||
170387383|NCT02557308|615755122|FG002|Overall Study|Except for study close|0|||
170387384|NCT02557308|615755123|FG003|Overall Study|Except for study close|0|||
170387385|NCT02557308|615755124|FG004|Overall Study|Except for study close|3|||
170387386|NCT02557308|615755125|FG005|Overall Study|Except for study close|0|||
170387387|NCT02557308|615755126|FG006|Overall Study|Except for study close|6|||
170387388|NCT02557308|615755127|FG007|Overall Study|Except for study close|10|||
170387389|NCT03911401|615755128|FG000|Overall Study|Adverse Event|1|||
170387390|NCT03911401|615755129|FG001|Overall Study|Adverse Event|2|||
170387391|NCT03911401|615755130|FG002|Overall Study|Adverse Event|5|||
170387392|NCT03911401|615755128|FG000|Overall Study|Lack of Efficacy|1|||
170387393|NCT03911401|615755129|FG001|Overall Study|Lack of Efficacy|1|||
170387394|NCT03911401|615755130|FG002|Overall Study|Lack of Efficacy|8|||
170387395|NCT03911401|615755128|FG000|Overall Study|Physician Decision|0|||
170387396|NCT03911401|615755129|FG001|Overall Study|Physician Decision|0|||
170387397|NCT03911401|615755130|FG002|Overall Study|Physician Decision|1|||
170387398|NCT03911401|615755128|FG000|Overall Study|Withdrawal by Subject|1|||
170398863|NCT05004181|615798315|FG003|Overall Study|Death|0|||
170387399|NCT03911401|615755129|FG001|Overall Study|Withdrawal by Subject|2|||
170387400|NCT03911401|615755130|FG002|Overall Study|Withdrawal by Subject|0|||
170387401|NCT03911401|615755128|FG000|Overall Study|Withdrawal by parent/guardian|4|||
170387402|NCT03911401|615755129|FG001|Overall Study|Withdrawal by parent/guardian|4|||
170387403|NCT03911401|615755130|FG002|Overall Study|Withdrawal by parent/guardian|11|||
170387404|NCT05602818|615755131|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
170387405|NCT05602818|615755132|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
170387406|NCT05602818|615755133|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
170387407|NCT05602818|615755134|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
170387408|NCT05602818|615755135|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
170387409|NCT05602818|615755136|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
170387410|NCT05602818|615755137|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
170387411|NCT05602818|615755138|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
170387412|NCT05602818|615755139|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
170387413|NCT05602818|615755140|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
170387414|NCT05602818|615755141|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
170387415|NCT05602818|615755142|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
170387416|NCT05602818|615755131|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
170387417|NCT05602818|615755132|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
170387418|NCT05602818|615755133|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387419|NCT05602818|615755134|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387420|NCT05602818|615755135|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387421|NCT05602818|615755136|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387422|NCT05602818|615755137|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387423|NCT05602818|615755138|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387424|NCT05602818|615755139|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387425|NCT05602818|615755140|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387426|NCT05602818|615755141|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387427|NCT05602818|615755142|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
170387428|NCT05602818|615755131|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
170387429|NCT05602818|615755132|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387430|NCT05602818|615755133|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387431|NCT05602818|615755134|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387432|NCT05602818|615755135|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387433|NCT05602818|615755136|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387434|NCT05602818|615755137|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387435|NCT05602818|615755138|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387436|NCT05602818|615755139|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387437|NCT05602818|615755140|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387438|NCT05602818|615755141|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387439|NCT05602818|615755142|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
170387440|NCT05602818|615755131|FG000|Qualification Phase (3 Days)|Other|1|||
170387441|NCT05602818|615755132|FG001|Qualification Phase (3 Days)|Other|0|||
170387442|NCT05602818|615755133|FG002|Qualification Phase (3 Days)|Other|0|||
170387443|NCT05602818|615755134|FG003|Qualification Phase (3 Days)|Other|0|||
170387444|NCT05602818|615755135|FG004|Qualification Phase (3 Days)|Other|0|||
170387445|NCT05602818|615755136|FG005|Qualification Phase (3 Days)|Other|0|||
170387446|NCT05602818|615755137|FG006|Qualification Phase (3 Days)|Other|0|||
170387447|NCT05602818|615755138|FG007|Qualification Phase (3 Days)|Other|0|||
170387448|NCT05602818|615755139|FG008|Qualification Phase (3 Days)|Other|0|||
170387449|NCT05602818|615755140|FG009|Qualification Phase (3 Days)|Other|0|||
170387450|NCT05602818|615755141|FG010|Qualification Phase (3 Days)|Other|0|||
170387451|NCT05602818|615755142|FG011|Qualification Phase (3 Days)|Other|0|||
170387452|NCT05602818|615755131|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387453|NCT05602818|615755132|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
170387454|NCT05602818|615755133|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387455|NCT05602818|615755134|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387456|NCT05602818|615755135|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387457|NCT05602818|615755136|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387458|NCT05602818|615755137|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387459|NCT05602818|615755138|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387460|NCT05602818|615755139|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387461|NCT05602818|615755140|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170398864|NCT05004181|615798316|FG004|Overall Study|Death|0|||
170387462|NCT05602818|615755141|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387463|NCT05602818|615755142|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
170387464|NCT05602818|615755131|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
170387465|NCT05602818|615755132|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
170387466|NCT05602818|615755133|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
170387467|NCT05602818|615755134|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
170387468|NCT05602818|615755135|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
170387469|NCT05602818|615755136|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
170387470|NCT05602818|615755137|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
170387471|NCT05602818|615755138|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
170387472|NCT05602818|615755139|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
170387473|NCT05602818|615755140|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
170387474|NCT05602818|615755141|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
170387475|NCT05602818|615755142|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
170387476|NCT05602818|615755131|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387477|NCT05602818|615755132|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387478|NCT05602818|615755133|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387479|NCT05602818|615755134|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387480|NCT05602818|615755135|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387481|NCT05602818|615755136|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387482|NCT05602818|615755137|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387483|NCT05602818|615755138|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387484|NCT05602818|615755139|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387485|NCT05602818|615755140|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
170387486|NCT05602818|615755141|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
170387487|NCT05602818|615755142|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
170387488|NCT05602818|615755131|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
170387489|NCT05602818|615755132|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
170387490|NCT05602818|615755133|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
170387491|NCT05602818|615755134|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
170387492|NCT05602818|615755135|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
170387493|NCT05602818|615755136|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
170387494|NCT05602818|615755137|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
170387495|NCT05602818|615755138|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
170387496|NCT05602818|615755139|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
170387497|NCT05602818|615755140|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
170387498|NCT05602818|615755141|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
170387499|NCT05602818|615755142|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
170387500|NCT03417245|615755144|FG000|Overall Study|Adverse Event|1|||
170387501|NCT03417245|615755145|FG001|Overall Study|Adverse Event|0|||
170387502|NCT03417245|615755144|FG000|Overall Study|Protocol Violation|1|||
170387503|NCT03417245|615755145|FG001|Overall Study|Protocol Violation|0|||
170387504|NCT03417245|615755144|FG000|Overall Study|Withdrawal by Subject|1|||
170387505|NCT03417245|615755145|FG001|Overall Study|Withdrawal by Subject|1|||
170387506|NCT02046993|615755146|FG000|Overall Study|Withdrawal by Subject|2|||
170387507|NCT02046993|615755147|FG001|Overall Study|Withdrawal by Subject|10|||
170387508|NCT02046993|615755146|FG000|Overall Study|Lost to Follow-up|1|||
170387509|NCT02046993|615755147|FG001|Overall Study|Lost to Follow-up|1|||
170387510|NCT02992743|615755154|FG000|Overall Study|Withdrawal by Subject|1|||
170387511|NCT02992743|615755155|FG001|Overall Study|Withdrawal by Subject|1|||
170387512|NCT02992743|615755154|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
170387513|NCT02992743|615755155|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
170387514|NCT02992743|615755154|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
170387515|NCT02992743|615755155|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
170387516|NCT02992743|615755154|FG000|Overall Study|No measurable disease|1|||
170387517|NCT02992743|615755155|FG001|Overall Study|No measurable disease|0|||
170387518|NCT02992743|615755154|FG000|Overall Study|Lost to Follow-up|0|||
170387519|NCT02992743|615755155|FG001|Overall Study|Lost to Follow-up|1|||
170387520|NCT00361504|615755156|FG000|Overall Study|Withdrawal by Subject|94|||
170387521|NCT00361504|615755157|FG001|Overall Study|Withdrawal by Subject|31|||
170387522|NCT00361504|615755156|FG000|Overall Study|Lost to Follow-up|40|||
170387523|NCT00361504|615755157|FG001|Overall Study|Lost to Follow-up|7|||
170387524|NCT00361504|615755156|FG000|Overall Study|Adverse Event|203|||
170387525|NCT00361504|615755157|FG001|Overall Study|Adverse Event|82|||
170387526|NCT00361504|615755156|FG000|Overall Study|Lack of Efficacy|72|||
170387527|NCT00361504|615755157|FG001|Overall Study|Lack of Efficacy|7|||
170387528|NCT00361504|615755156|FG000|Overall Study|Resolution of Pain|2|||
170387529|NCT00361504|615755157|FG001|Overall Study|Resolution of Pain|0|||
170387530|NCT00361504|615755156|FG000|Overall Study|Study medication non compliant|42|||
170387531|NCT00361504|615755157|FG001|Overall Study|Study medication non compliant|15|||
170387532|NCT00361504|615755156|FG000|Overall Study|All other|28|||
170387533|NCT00361504|615755157|FG001|Overall Study|All other|3|||
170387534|NCT02463097|615755158|FG000|Overall Study|Withdrawal by Subject|1|||
170387535|NCT01757821|615755159|FG000|Overall Study|Adverse Event|1|||
170387536|NCT00920582|615755160|FG000|Overall Study|Lost to Follow-up|5|||
170387537|NCT00920582|615755161|FG001|Overall Study|Lost to Follow-up|1|||
170387538|NCT00920582|615755162|FG002|Overall Study|Lost to Follow-up|2|||
170387539|NCT00920582|615755163|FG003|Overall Study|Lost to Follow-up|0|||
170387540|NCT00920582|615755160|FG000|Overall Study|Withdrawal by Subject|5|||
170387541|NCT00920582|615755161|FG001|Overall Study|Withdrawal by Subject|4|||
170387542|NCT00920582|615755162|FG002|Overall Study|Withdrawal by Subject|6|||
170387543|NCT00920582|615755163|FG003|Overall Study|Withdrawal by Subject|3|||
170387544|NCT00920582|615755160|FG000|Overall Study|Protocol Violation|1|||
170387545|NCT00920582|615755161|FG001|Overall Study|Protocol Violation|0|||
170387546|NCT00920582|615755162|FG002|Overall Study|Protocol Violation|0|||
170387547|NCT00920582|615755163|FG003|Overall Study|Protocol Violation|0|||
170387548|NCT00920582|615755160|FG000|Overall Study|Other|2|||
170387549|NCT00920582|615755161|FG001|Overall Study|Other|1|||
170387550|NCT00920582|615755162|FG002|Overall Study|Other|3|||
170387551|NCT00920582|615755163|FG003|Overall Study|Other|2|||
170387552|NCT00851721|615755166|FG000|Overall Study|planned surgery|1|||
170387553|NCT00851721|615755167|FG001|Overall Study|planned surgery|0|||
170387554|NCT00851721|615755166|FG000|Overall Study|Death|1|||
170387555|NCT00851721|615755167|FG001|Overall Study|Death|0|||
170387556|NCT00851721|615755166|FG000|Overall Study|Adverse Event|0|||
170387557|NCT00851721|615755167|FG001|Overall Study|Adverse Event|1|||
170387558|NCT04047472|615755168|FG000|Overall Study|Adverse Event|3|||
170387559|NCT04047472|615755169|FG001|Overall Study|Adverse Event|3|||
170387560|NCT04047472|615755168|FG000|Overall Study|Death|0|||
170387561|NCT04047472|615755169|FG001|Overall Study|Death|1|||
170387562|NCT04047472|615755168|FG000|Overall Study|Lost to Follow-up|1|||
170387563|NCT04047472|615755169|FG001|Overall Study|Lost to Follow-up|0|||
170387564|NCT04047472|615755168|FG000|Overall Study|Physician Decision|1|||
170387565|NCT04047472|615755169|FG001|Overall Study|Physician Decision|2|||
170387566|NCT04047472|615755168|FG000|Overall Study|Protocol Violation|1|||
170387567|NCT04047472|615755169|FG001|Overall Study|Protocol Violation|0|||
170387568|NCT04047472|615755168|FG000|Overall Study|Withdrawal by Subject|10|||
170387569|NCT04047472|615755169|FG001|Overall Study|Withdrawal by Subject|10|||
170387570|NCT03137433|615755173|FG000|Overall Study|Withdrawal by Subject|11|||
170387571|NCT03137433|615755174|FG001|Overall Study|Withdrawal by Subject|11|||
170387572|NCT03137433|615755173|FG000|Overall Study|Lost to Follow-up|5|||
170387573|NCT03137433|615755174|FG001|Overall Study|Lost to Follow-up|6|||
170387574|NCT03137433|615755173|FG000|Overall Study|Physician Decision|2|||
170387575|NCT03137433|615755174|FG001|Overall Study|Physician Decision|0|||
170387576|NCT03137433|615755173|FG000|Overall Study|Moved out of study area|1|||
170387577|NCT03137433|615755174|FG001|Overall Study|Moved out of study area|0|||
170387578|NCT03137433|615755173|FG000|Overall Study|Too far out of window due to COVID|0|||
170387579|NCT03137433|615755174|FG001|Overall Study|Too far out of window due to COVID|1|||
170387580|NCT00496782|615755175|FG000|Overall Study|Protocol Violation|1|||
170387581|NCT00496782|615755176|FG001|Overall Study|Protocol Violation|2|||
170387582|NCT02132312|615755177|FG000|Overall Study|Adverse Event|2|||
170387583|NCT02132312|615755178|FG001|Overall Study|Adverse Event|0|||
170387584|NCT02132312|615755177|FG000|Overall Study|Physician Decision|1|||
170387585|NCT02132312|615755178|FG001|Overall Study|Physician Decision|1|||
170387586|NCT02132312|615755177|FG000|Overall Study|Protocol Violation|0|||
170387587|NCT02132312|615755178|FG001|Overall Study|Protocol Violation|1|||
170387588|NCT02132312|615755177|FG000|Overall Study|Withdrawal by Subject|1|||
170387589|NCT02132312|615755178|FG001|Overall Study|Withdrawal by Subject|0|||
170387590|NCT02132312|615755177|FG000|Overall Study|Lost to Follow-up|2|||
170387591|NCT02132312|615755178|FG001|Overall Study|Lost to Follow-up|1|||
170387592|NCT01843933|615755181|FG000|Overall Study|Data lost|6|||
170387593|NCT01843933|615755182|FG001|Overall Study|Data lost|4|||
170387594|NCT01373294|615755183|FG000|Overall Study|Adverse Event|1|||
170387595|NCT01373294|615755184|FG001|Overall Study|Adverse Event|0|||
170387596|NCT00554229|615755185|FG000|Overall Study|Lost to Follow-up|3|||
170387597|NCT00554229|615755186|FG001|Overall Study|Lost to Follow-up|6|||
170387598|NCT00554229|615755185|FG000|Overall Study|Withdrawal by Subject|29|||
170387599|NCT00554229|615755186|FG001|Overall Study|Withdrawal by Subject|37|||
170387600|NCT00554229|615755185|FG000|Overall Study|Adverse Event|71|||
170387601|NCT00554229|615755186|FG001|Overall Study|Adverse Event|39|||
170387602|NCT00554229|615755185|FG000|Overall Study|Protocol Violation|3|||
170387603|NCT00554229|615755186|FG001|Overall Study|Protocol Violation|3|||
170387604|NCT00554229|615755185|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
170387605|NCT00554229|615755186|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
170387606|NCT00554229|615755185|FG000|Overall Study|Randomised but no treatment received|1|||
170387607|NCT00554229|615755186|FG001|Overall Study|Randomised but no treatment received|0|||
170387608|NCT00842829|615755189|FG000|Dose Titration Period|Adverse Event|11|||
170387609|NCT00842829|615755190|FG001|Dose Titration Period|Adverse Event|10|||
170387610|NCT00842829|615755191|FG002|Dose Titration Period|Adverse Event|0|||
170387611|NCT00842829|615755189|FG000|Dose Titration Period|Lack of Efficacy|4|||
170387612|NCT00842829|615755190|FG001|Dose Titration Period|Lack of Efficacy|1|||
170387613|NCT00842829|615755191|FG002|Dose Titration Period|Lack of Efficacy|0|||
170387614|NCT00842829|615755189|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
170387615|NCT00842829|615755190|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
170387616|NCT00842829|615755191|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
170387617|NCT00842829|615755189|FG000|Dose Titration Period|Withdrawal by Subject|2|||
170387618|NCT00842829|615755190|FG001|Dose Titration Period|Withdrawal by Subject|6|||
170387619|NCT00842829|615755191|FG002|Dose Titration Period|Withdrawal by Subject|0|||
170387620|NCT00842829|615755189|FG000|Dose Titration Period|Other|5|||
170387621|NCT00842829|615755190|FG001|Dose Titration Period|Other|4|||
170387622|NCT00842829|615755191|FG002|Dose Titration Period|Other|0|||
170387623|NCT00842829|615755189|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
170387624|NCT00842829|615755190|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
170387625|NCT00842829|615755191|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
170387626|NCT00842829|615755189|FG000|Dose Titration Period|Non-compliance to study drug|2|||
170387627|NCT00842829|615755190|FG001|Dose Titration Period|Non-compliance to study drug|1|||
170387628|NCT00842829|615755191|FG002|Dose Titration Period|Non-compliance to study drug|0|||
170387629|NCT00842829|615755189|FG000|Treatment Period|Adverse Event|0|||
170387630|NCT00842829|615755190|FG001|Treatment Period|Adverse Event|0|||
170387631|NCT00842829|615755191|FG002|Treatment Period|Adverse Event|15|||
170387632|NCT00842829|615755189|FG000|Treatment Period|Lack of Efficacy|0|||
170387633|NCT00842829|615755190|FG001|Treatment Period|Lack of Efficacy|0|||
170387634|NCT00842829|615755191|FG002|Treatment Period|Lack of Efficacy|6|||
170387635|NCT00842829|615755189|FG000|Treatment Period|Unstable persistent cancer pain|0|||
170387636|NCT00842829|615755190|FG001|Treatment Period|Unstable persistent cancer pain|0|||
170387637|NCT00842829|615755191|FG002|Treatment Period|Unstable persistent cancer pain|5|||
170387638|NCT00842829|615755189|FG000|Treatment Period|Withdrawal by Subject|0|||
170387639|NCT00842829|615755190|FG001|Treatment Period|Withdrawal by Subject|0|||
170387640|NCT00842829|615755191|FG002|Treatment Period|Withdrawal by Subject|11|||
170387641|NCT00842829|615755189|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
170387642|NCT00842829|615755190|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
170387643|NCT00842829|615755191|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
170387644|NCT00842829|615755189|FG000|Treatment Period|Protocol Violation|0|||
170387645|NCT00842829|615755190|FG001|Treatment Period|Protocol Violation|0|||
170387646|NCT00842829|615755191|FG002|Treatment Period|Protocol Violation|2|||
170387647|NCT00842829|615755189|FG000|Treatment Period|Other|0|||
170387648|NCT00842829|615755190|FG001|Treatment Period|Other|0|||
170387649|NCT00842829|615755191|FG002|Treatment Period|Other|18|||
170387650|NCT00842829|615755189|FG000|Treatment Period|Non-compliance to study procedures|0|||
170387651|NCT00842829|615755190|FG001|Treatment Period|Non-compliance to study procedures|0|||
170387652|NCT00842829|615755191|FG002|Treatment Period|Non-compliance to study procedures|4|||
170387653|NCT00842829|615755189|FG000|Treatment Period|Unclear completion status|0|||
170387654|NCT00842829|615755190|FG001|Treatment Period|Unclear completion status|0|||
170387655|NCT00842829|615755191|FG002|Treatment Period|Unclear completion status|1|||
170387656|NCT00842829|615755189|FG000|Continuation Period|Adverse Event|0|||
170387657|NCT00842829|615755190|FG001|Continuation Period|Adverse Event|0|||
170387658|NCT00842829|615755191|FG002|Continuation Period|Adverse Event|32|||
170387659|NCT00842829|615755189|FG000|Continuation Period|Lack of Efficacy|0|||
170387660|NCT00842829|615755190|FG001|Continuation Period|Lack of Efficacy|0|||
170387661|NCT00842829|615755191|FG002|Continuation Period|Lack of Efficacy|6|||
170387662|NCT00842829|615755189|FG000|Continuation Period|Unstable persistent cancer pain|0|||
170387663|NCT00842829|615755190|FG001|Continuation Period|Unstable persistent cancer pain|0|||
170387664|NCT00842829|615755191|FG002|Continuation Period|Unstable persistent cancer pain|3|||
170387665|NCT00842829|615755189|FG000|Continuation Period|Withdrawal by Subject|0|||
170387666|NCT00842829|615755190|FG001|Continuation Period|Withdrawal by Subject|0|||
170387667|NCT00842829|615755191|FG002|Continuation Period|Withdrawal by Subject|10|||
170387668|NCT00842829|615755189|FG000|Continuation Period|Other|0|||
170387669|NCT00842829|615755190|FG001|Continuation Period|Other|0|||
170387670|NCT00842829|615755191|FG002|Continuation Period|Other|7|||
170387671|NCT00842829|615755189|FG000|Continuation Period|Non-compliance to study procedures|0|||
170387672|NCT00842829|615755190|FG001|Continuation Period|Non-compliance to study procedures|0|||
170387673|NCT00842829|615755191|FG002|Continuation Period|Non-compliance to study procedures|2|||
170387674|NCT00842829|615755189|FG000|Continuation Period|Non-compliance to study drug|0|||
170387675|NCT00842829|615755190|FG001|Continuation Period|Non-compliance to study drug|0|||
170387676|NCT00842829|615755191|FG002|Continuation Period|Non-compliance to study drug|1|||
170387677|NCT02127931|615755197|FG000|Overall Study|Glitch in Game|1|||
170387678|NCT03417999|615755198|FG000|Overall Study|Withdrawal by Subject|1|||
170387679|NCT03417999|615755199|FG001|Overall Study|Withdrawal by Subject|0|||
170387680|NCT03417999|615755200|FG002|Overall Study|Withdrawal by Subject|0|||
170387681|NCT03417999|615755198|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
170387682|NCT03417999|615755199|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
170387683|NCT03417999|615755200|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
170387684|NCT03417999|615755198|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
170387685|NCT03417999|615755199|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
170387686|NCT03417999|615755200|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
170387687|NCT03417999|615755198|FG000|Overall Study|Inadequate study staff available to process samples|0|||
170387688|NCT03417999|615755199|FG001|Overall Study|Inadequate study staff available to process samples|0|||
170387689|NCT03417999|615755200|FG002|Overall Study|Inadequate study staff available to process samples|1|||
170387690|NCT02612194|615755204|FG000|Overall Study|Death|5|||
170387691|NCT02612194|615755205|FG001|Overall Study|Death|0|||
170387692|NCT02612194|615755206|FG002|Overall Study|Death|2|||
170387693|NCT02612194|615755204|FG000|Overall Study|Early Study Termination|1|||
170387694|NCT02612194|615755205|FG001|Overall Study|Early Study Termination|0|||
170387695|NCT02612194|615755206|FG002|Overall Study|Early Study Termination|0|||
170387696|NCT02539160|615755207|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
170387697|NCT02539160|615755208|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
170387698|NCT02539160|615755209|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
170387699|NCT02539160|615755210|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
170387700|NCT02539160|615755207|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
170387701|NCT02539160|615755208|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
170387702|NCT02539160|615755209|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
170387703|NCT02539160|615755210|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
170387704|NCT02539160|615755207|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
170387705|NCT02539160|615755208|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
170387706|NCT02539160|615755209|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
170387707|NCT02539160|615755210|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
170387708|NCT01681004|615755211|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
170387709|NCT01681004|615755212|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
170387710|NCT01681004|615755211|FG000|Study Completion|Lost to Follow-up|8|||
170387711|NCT01681004|615755212|FG001|Study Completion|Lost to Follow-up|3|||
170387712|NCT01681004|615755211|FG000|Study Completion|Physician Decision|1|||
170387713|NCT01681004|615755212|FG001|Study Completion|Physician Decision|3|||
170387714|NCT01681004|615755211|FG000|Study Completion|Site Termination|2|||
170387715|NCT01681004|615755212|FG001|Study Completion|Site Termination|1|||
170387716|NCT01681004|615755211|FG000|Study Completion|Death|1|||
170387717|NCT01681004|615755212|FG001|Study Completion|Death|1|||
170387718|NCT00372905|615755213|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
170387719|NCT00372905|615755214|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
170387720|NCT00372905|615755215|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
170387721|NCT00372905|615755216|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
170387722|NCT00372905|615755213|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
170387723|NCT00372905|615755214|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
170387724|NCT00372905|615755215|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
170387725|NCT00372905|615755216|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
170387726|NCT00372905|615755213|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
170387727|NCT00372905|615755214|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
170387728|NCT00372905|615755215|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
170387729|NCT00372905|615755216|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
170387730|NCT00372905|615755213|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
170387731|NCT00372905|615755214|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
170387732|NCT00372905|615755215|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
170387733|NCT00372905|615755216|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
170387734|NCT00372905|615755213|FG000|Follow up Until Relapse or Progression|Study closed|0|||
170387735|NCT00372905|615755214|FG001|Follow up Until Relapse or Progression|Study closed|0|||
170387736|NCT00372905|615755215|FG002|Follow up Until Relapse or Progression|Study closed|0|||
170387737|NCT00372905|615755216|FG003|Follow up Until Relapse or Progression|Study closed|3|||
170387738|NCT00372905|615755213|FG000|Follow up Until Relapse or Progression|Other|0|||
170387739|NCT00372905|615755214|FG001|Follow up Until Relapse or Progression|Other|1|||
170387740|NCT00372905|615755215|FG002|Follow up Until Relapse or Progression|Other|0|||
170387741|NCT00372905|615755216|FG003|Follow up Until Relapse or Progression|Other|0|||
170387742|NCT00689299|615755219|FG000|Overall Study|Adverse Event|2|||
170387743|NCT00689299|615755220|FG001|Overall Study|Adverse Event|1|||
170387744|NCT00689299|615755221|FG002|Overall Study|Adverse Event|1|||
170387745|NCT00689299|615755219|FG000|Overall Study|Lost to Follow-up|0|||
170387746|NCT00689299|615755220|FG001|Overall Study|Lost to Follow-up|1|||
170387747|NCT00689299|615755221|FG002|Overall Study|Lost to Follow-up|1|||
170387748|NCT00689299|615755219|FG000|Overall Study|Withdrawal by Subject|4|||
170387749|NCT00689299|615755220|FG001|Overall Study|Withdrawal by Subject|1|||
170387750|NCT00689299|615755221|FG002|Overall Study|Withdrawal by Subject|3|||
170387751|NCT00689299|615755219|FG000|Overall Study|Protocol Violation|1|||
170387752|NCT00689299|615755220|FG001|Overall Study|Protocol Violation|0|||
170387753|NCT00689299|615755221|FG002|Overall Study|Protocol Violation|0|||
170387754|NCT00695318|615755225|FG000|Overall Study|Lost to Follow-up|1|||
170387755|NCT00695318|615755226|FG001|Overall Study|Lost to Follow-up|0|||
170387756|NCT00695318|615755225|FG000|Overall Study|Withdrawal by Subject|2|||
170387757|NCT00695318|615755226|FG001|Overall Study|Withdrawal by Subject|0|||
170387758|NCT00695318|615755225|FG000|Overall Study|Death|1|||
170387759|NCT00695318|615755226|FG001|Overall Study|Death|1|||
170387760|NCT00695318|615755225|FG000|Overall Study|Study Terminated|1|||
170387761|NCT00695318|615755226|FG001|Overall Study|Study Terminated|0|||
170387762|NCT02058966|615755227|FG000|Open-Label Methamphetamine|Adverse Event|1|||
170387763|NCT02058966|615755227|FG000|First Intervention|Withdrawal by Subject|1|||
170387764|NCT01265511|615755228|FG000|Overall Study|Lack of Efficacy|2|||
170387765|NCT01265511|615755229|FG001|Overall Study|Lack of Efficacy|1|||
170387766|NCT01265511|615755228|FG000|Overall Study|Met stopping rules|0|||
170387767|NCT01265511|615755229|FG001|Overall Study|Met stopping rules|2|||
170387768|NCT00939094|615755235|FG000|Overall Study|Adverse Event|9|||
170387769|NCT00939094|615755236|FG001|Overall Study|Adverse Event|0|||
170387770|NCT00939094|615755235|FG000|Overall Study|Withdrawal by Subject|1|||
170387771|NCT00939094|615755236|FG001|Overall Study|Withdrawal by Subject|6|||
170387772|NCT00939094|615755235|FG000|Overall Study|Lost to Follow-up|1|||
170387773|NCT00939094|615755236|FG001|Overall Study|Lost to Follow-up|1|||
170387774|NCT00939094|615755235|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
170387775|NCT00939094|615755236|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
170387776|NCT00939094|615755235|FG000|Overall Study|Severe non-compliance to protocol|0|||
170387777|NCT00939094|615755236|FG001|Overall Study|Severe non-compliance to protocol|1|||
170387778|NCT00939094|615755235|FG000|Overall Study|Study stopped by sponsor|0|||
170387779|NCT00939094|615755236|FG001|Overall Study|Study stopped by sponsor|2|||
170387780|NCT00939094|615755235|FG000|Overall Study|Abnormal ECG findings|1|||
170387781|NCT00939094|615755236|FG001|Overall Study|Abnormal ECG findings|0|||
170387782|NCT02545504|615755239|FG000|Overall Study|Death|174|||
170387783|NCT02545504|615755240|FG001|Overall Study|Death|168|||
170387784|NCT02545504|615755239|FG000|Overall Study|Unknown reason|30|||
170387785|NCT02545504|615755240|FG001|Overall Study|Unknown reason|32|||
170387786|NCT02545504|615755239|FG000|Overall Study|Withdrew consent|9|||
170387787|NCT02545504|615755240|FG001|Overall Study|Withdrew consent|11|||
170387788|NCT02545504|615755239|FG000|Overall Study|Investigator's discretion|3|||
170387789|NCT02545504|615755240|FG001|Overall Study|Investigator's discretion|1|||
170387790|NCT02545504|615755239|FG000|Overall Study|Lost to Follow-up|2|||
170387791|NCT02545504|615755240|FG001|Overall Study|Lost to Follow-up|2|||
170387792|NCT00434876|615755241|FG000|Overall Study|Lost to Follow-up|1|||
170387793|NCT00434876|615755242|FG001|Overall Study|Lost to Follow-up|1|||
170387794|NCT01846442|615756789|FG000|Overall Study|Adverse Event|2|||
170387795|NCT01846442|615756790|FG001|Overall Study|Adverse Event|4|||
170387796|NCT01846442|615756791|FG002|Overall Study|Adverse Event|2|||
170387797|NCT01846442|615756792|FG003|Overall Study|Adverse Event|1|||
170387798|NCT01846442|615756789|FG000|Overall Study|Lost to Follow-up|0|||
170387799|NCT01846442|615756790|FG001|Overall Study|Lost to Follow-up|0|||
170387800|NCT01846442|615756791|FG002|Overall Study|Lost to Follow-up|1|||
170387801|NCT01846442|615756792|FG003|Overall Study|Lost to Follow-up|0|||
170387802|NCT01846442|615756789|FG000|Overall Study|Withdrawal by Subject|3|||
170387803|NCT01846442|615756790|FG001|Overall Study|Withdrawal by Subject|2|||
170387804|NCT01846442|615756791|FG002|Overall Study|Withdrawal by Subject|0|||
170387805|NCT01846442|615756792|FG003|Overall Study|Withdrawal by Subject|1|||
170387806|NCT01846442|615756789|FG000|Overall Study|Left the city/Lost medication|1|||
170387807|NCT01846442|615756790|FG001|Overall Study|Left the city/Lost medication|0|||
170387808|NCT01846442|615756791|FG002|Overall Study|Left the city/Lost medication|1|||
170387809|NCT01846442|615756792|FG003|Overall Study|Left the city/Lost medication|1|||
170387810|NCT03778021|615756795|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
170387811|NCT03778021|615756796|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
170387812|NCT01342445|615756800|FG000|Overall Study|Experienced side effects|0|||
170387813|NCT01342445|615756801|FG001|Overall Study|Experienced side effects|2|||
170387814|NCT02392078|615756802|FG000|Overall Study|Did not have procedure|32|||
170387815|NCT02392078|615756803|FG001|Overall Study|Did not have procedure|43|||
170387816|NCT02392078|615756804|FG002|Overall Study|Did not have procedure|20|||
170387817|NCT02392078|615756805|FG003|Overall Study|Did not have procedure|1|||
170387818|NCT01059175|615756806|FG000|Overall Study|Death|17|||
170387819|NCT01059175|615756807|FG001|Overall Study|Death|17|||
170387820|NCT01059175|615756806|FG000|Overall Study|Adverse Event|4|||
170387821|NCT01059175|615756807|FG001|Overall Study|Adverse Event|2|||
170387822|NCT01059175|615756806|FG000|Overall Study|Lost to Follow-up|0|||
170387823|NCT01059175|615756807|FG001|Overall Study|Lost to Follow-up|1|||
170387824|NCT02406586|615756811|FG000|Overall Study|Lost to Follow-up|0|||
170387825|NCT02406586|615756812|FG001|Overall Study|Lost to Follow-up|4|||
170387826|NCT02406586|615756813|FG002|Overall Study|Lost to Follow-up|2|||
170387827|NCT02406586|615756811|FG000|Overall Study|Withdrawal by Subject|1|||
170387828|NCT02406586|615756812|FG001|Overall Study|Withdrawal by Subject|0|||
170387829|NCT02406586|615756813|FG002|Overall Study|Withdrawal by Subject|0|||
170387830|NCT03198559|615756814|FG000|Overall Study|Adverse Event|2|||
170387831|NCT00285857|615756815|FG000|Overall Study|Withdrawal by Subject|2|||
170387832|NCT00285857|615756815|FG000|Overall Study|Inadequate initial breast cytology|1|||
170387833|NCT00285857|615756815|FG000|Overall Study|Adverse Event|1|||
170387834|NCT01399619|615756819|FG000|Overall Study|Adverse Event|10|||
170387835|NCT01399619|615756820|FG001|Overall Study|Adverse Event|0|||
170387836|NCT01399619|615756821|FG002|Overall Study|Adverse Event|4|||
170387837|NCT01399619|615756822|FG003|Overall Study|Adverse Event|10|||
170387838|NCT01399619|615756819|FG000|Overall Study|Lack of Efficacy|9|||
170387839|NCT01399619|615756820|FG001|Overall Study|Lack of Efficacy|0|||
170387840|NCT01399619|615756821|FG002|Overall Study|Lack of Efficacy|5|||
170387841|NCT01399619|615756822|FG003|Overall Study|Lack of Efficacy|0|||
170387842|NCT01399619|615756819|FG000|Overall Study|Withdrawal by Subject|6|||
170387843|NCT01399619|615756820|FG001|Overall Study|Withdrawal by Subject|0|||
170387844|NCT01399619|615756821|FG002|Overall Study|Withdrawal by Subject|3|||
170387845|NCT01399619|615756822|FG003|Overall Study|Withdrawal by Subject|4|||
170387846|NCT01399619|615756819|FG000|Overall Study|Protocol Violation|0|||
170387847|NCT01399619|615756820|FG001|Overall Study|Protocol Violation|0|||
170387848|NCT01399619|615756821|FG002|Overall Study|Protocol Violation|0|||
170387849|NCT01399619|615756822|FG003|Overall Study|Protocol Violation|1|||
170387850|NCT01399619|615756819|FG000|Overall Study|Not treated|0|||
170387851|NCT01399619|615756820|FG001|Overall Study|Not treated|0|||
170387852|NCT01399619|615756821|FG002|Overall Study|Not treated|0|||
170387853|NCT01399619|615756822|FG003|Overall Study|Not treated|2|||
170387854|NCT01243762|615756827|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
170387855|NCT01243762|615756828|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
170387856|NCT01243762|615756829|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
170387857|NCT01243762|615756830|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
170387858|NCT01243762|615756831|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
170387859|NCT01243762|615756832|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
170387860|NCT01243762|615756833|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
170387861|NCT01243762|615756827|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
170387862|NCT01243762|615756828|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
170387863|NCT01243762|615756829|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
170387864|NCT01243762|615756830|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
170387865|NCT01243762|615756831|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
170387866|NCT01243762|615756832|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
170387867|NCT01243762|615756833|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
170387868|NCT01243762|615756827|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
170387869|NCT01243762|615756828|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
170387870|NCT01243762|615756829|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
170387871|NCT01243762|615756830|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
170387872|NCT01243762|615756831|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
170387873|NCT01243762|615756832|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
170387874|NCT01243762|615756833|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
170387875|NCT01243762|615756827|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
170387876|NCT01243762|615756828|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
170387877|NCT01243762|615756829|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
170387878|NCT01243762|615756830|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
170387879|NCT01243762|615756831|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
170387880|NCT01243762|615756832|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
170387881|NCT01243762|615756833|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
170387882|NCT01243762|615756827|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
170387883|NCT01243762|615756828|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
170387884|NCT01243762|615756829|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
170387885|NCT01243762|615756830|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
170387886|NCT01243762|615756831|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
170387887|NCT01243762|615756832|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
170387888|NCT01243762|615756833|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
170387889|NCT01243762|615756827|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
170387890|NCT01243762|615756828|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
170387891|NCT01243762|615756829|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
170387892|NCT01243762|615756830|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
170387893|NCT01243762|615756831|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
170387894|NCT01243762|615756832|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
170387895|NCT01243762|615756833|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
170387896|NCT01243762|615756827|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
170387897|NCT01243762|615756828|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
170387898|NCT01243762|615756829|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
170387899|NCT01243762|615756830|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
170387900|NCT01243762|615756831|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
170387901|NCT01243762|615756832|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
170387902|NCT01243762|615756833|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
170387903|NCT01243762|615756827|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
170387904|NCT01243762|615756828|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
170387905|NCT01243762|615756829|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
170387906|NCT01243762|615756830|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
170398865|NCT05004181|615798317|FG005|Overall Study|Death|0|||
170387907|NCT01243762|615756831|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
170387908|NCT01243762|615756832|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
170387909|NCT01243762|615756833|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
170387910|NCT00381680|615756840|FG000|Overall Study|Adverse Event|9|||
170387911|NCT00381680|615756841|FG001|Overall Study|Adverse Event|3|||
170387912|NCT00381680|615756840|FG000|Overall Study|Death|10|||
170387913|NCT00381680|615756841|FG001|Overall Study|Death|7|||
170387914|NCT00381680|615756840|FG000|Overall Study|Lost to Follow-up|3|||
170387915|NCT00381680|615756841|FG001|Overall Study|Lost to Follow-up|2|||
170387916|NCT00381680|615756840|FG000|Overall Study|Physician Decision|25|||
170387917|NCT00381680|615756841|FG001|Overall Study|Physician Decision|6|||
170387918|NCT00381680|615756840|FG000|Overall Study|Withdrawal by Subject|3|||
170387919|NCT00381680|615756841|FG001|Overall Study|Withdrawal by Subject|1|||
170387920|NCT00381680|615756840|FG000|Overall Study|Entry onto another COG Trial|1|||
170387921|NCT00381680|615756841|FG001|Overall Study|Entry onto another COG Trial|2|||
170387922|NCT00381680|615756840|FG000|Overall Study|Alternative Therapy|11|||
170387923|NCT00381680|615756841|FG001|Overall Study|Alternative Therapy|5|||
170387924|NCT00381680|615756840|FG000|Overall Study|Secondary Malignancy|3|||
170387925|NCT00381680|615756841|FG001|Overall Study|Secondary Malignancy|0|||
170387926|NCT00381680|615756840|FG000|Overall Study|Delay initiation|1|||
170387927|NCT00381680|615756841|FG001|Overall Study|Delay initiation|0|||
170387928|NCT00381680|615756840|FG000|Overall Study|Stem Cell Transplant|26|||
170387929|NCT00381680|615756841|FG001|Overall Study|Stem Cell Transplant|10|||
170387930|NCT00381680|615756840|FG000|Overall Study|Relapse|18|||
170387931|NCT00381680|615756841|FG001|Overall Study|Relapse|9|||
170387932|NCT00381680|615756840|FG000|Overall Study|Induction Failure|4|||
170387933|NCT00381680|615756841|FG001|Overall Study|Induction Failure|1|||
170387934|NCT00381680|615756840|FG000|Overall Study|Progression|1|||
170387935|NCT00381680|615756841|FG001|Overall Study|Progression|1|||
170387936|NCT00381680|615756840|FG000|Overall Study|Other not otherwise specified|7|||
170387937|NCT00381680|615756841|FG001|Overall Study|Other not otherwise specified|2|||
170387938|NCT00381680|615756840|FG000|Overall Study|Ineligible|3|||
170387939|NCT00381680|615756841|FG001|Overall Study|Ineligible|1|||
170387940|NCT03764813|615756845|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
170387941|NCT03764813|615756846|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
170387942|NCT03764813|615756847|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
170387943|NCT03764813|615756848|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
170387944|NCT01374516|615756849|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
170387945|NCT01374516|615756850|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
170387946|NCT01374516|615756849|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
170387947|NCT01374516|615756850|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
170387948|NCT01374516|615756849|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
170387949|NCT01374516|615756850|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
170387950|NCT01374516|615756849|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
170387951|NCT01374516|615756850|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
170387952|NCT01374516|615756849|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
170387953|NCT01374516|615756850|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
170387954|NCT01374516|615756849|FG000|Surveillance Expansion Period|Protocol Violation|386|||
170387955|NCT01374516|615756850|FG001|Surveillance Expansion Period|Protocol Violation|217|||
170387956|NCT01374516|615756849|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
170387957|NCT01374516|615756850|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
170387958|NCT01374516|615756849|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
170387959|NCT01374516|615756850|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
170387960|NCT01374516|615756849|FG000|Surveillance Expansion Period|Serious adverse event|20|||
170387961|NCT01374516|615756850|FG001|Surveillance Expansion Period|Serious adverse event|5|||
170387962|NCT03602976|615756854|FG000|Overall Study|Withdrawal by Subject|1|||
170387963|NCT04837807|615756855|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
170387964|NCT04837807|615756856|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
170387965|NCT00267202|615756857|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
170387966|NCT00267202|615756858|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
170387967|NCT00267202|615756857|FG000|Overall Study|Withdrawal by Subject|12|||
170387968|NCT00267202|615756858|FG001|Overall Study|Withdrawal by Subject|15|||
170387969|NCT00267202|615756857|FG000|Overall Study|Adverse Event|13|||
170387970|NCT00267202|615756858|FG001|Overall Study|Adverse Event|7|||
170387971|NCT00267202|615756857|FG000|Overall Study|Protocol Violation|2|||
170387972|NCT00267202|615756858|FG001|Overall Study|Protocol Violation|3|||
170387973|NCT00267202|615756857|FG000|Overall Study|Administrative problems|2|||
170387974|NCT00267202|615756858|FG001|Overall Study|Administrative problems|1|||
170387975|NCT00267202|615756857|FG000|Overall Study|Lost to Follow-up|3|||
170387976|NCT00267202|615756858|FG001|Overall Study|Lost to Follow-up|0|||
170387977|NCT01428882|615756867|FG000|Overall Study|Lack of Efficacy|2|||
170387978|NCT01428882|615756868|FG001|Overall Study|Lack of Efficacy|7|||
170387979|NCT01428882|615756867|FG000|Overall Study|Protocol Violation|4|||
170387980|NCT01428882|615756868|FG001|Overall Study|Protocol Violation|3|||
170387981|NCT03907072|615756873|FG000|Overall Study|Study Terminated by Sponsor|2|||
170387982|NCT03907072|615756874|FG001|Overall Study|Study Terminated by Sponsor|2|||
170387983|NCT03907072|615756875|FG002|Overall Study|Study Terminated by Sponsor|2|||
170387984|NCT00612456|615756876|FG000|Overall Study|Adverse Event|1|||
170387985|NCT00612456|615756877|FG001|Overall Study|Adverse Event|0|||
170387986|NCT00612456|615756878|FG002|Overall Study|Adverse Event|0|||
170387987|NCT00612456|615756876|FG000|Overall Study|Lack of Efficacy|1|||
170387988|NCT00612456|615756877|FG001|Overall Study|Lack of Efficacy|1|||
170387989|NCT00612456|615756878|FG002|Overall Study|Lack of Efficacy|0|||
170387990|NCT00612456|615756876|FG000|Overall Study|Withdrawal by Subject|0|||
170387991|NCT00612456|615756877|FG001|Overall Study|Withdrawal by Subject|1|||
170387992|NCT00612456|615756878|FG002|Overall Study|Withdrawal by Subject|0|||
170387993|NCT00265109|615756881|FG000|Overall Study|Withdrawal by Subject|5|||
170387994|NCT00265109|615756881|FG000|Overall Study|Adverse Event|1|||
170387995|NCT03326323|615756882|FG000|Overall Study|Unable to receive ANH protocol|3|||
170387996|NCT00334893|615756885|FG000|Overall Study|Not Treated|1|||
170387997|NCT00334893|615756886|FG001|Overall Study|Not Treated|0|||
170387998|NCT03604159|615756887|FG000|Overall Study|Lost to Follow-up|6|||
170387999|NCT03604159|615756888|FG001|Overall Study|Lost to Follow-up|7|||
170388000|NCT00665002|615756889|FG000|Overall Study|Progression/relapse during treatment|11|||
170388001|NCT00665002|615756889|FG000|Overall Study|Cytogenetic resistance|1|||
170388002|NCT00697255|615756890|FG000|Stage 1a|Insufficient ovarian response|1|||
170388003|NCT00697255|615756891|FG001|Stage 1a|Insufficient ovarian response|0|||
170388004|NCT00697255|615756890|FG000|Stage 1a|Multifollicular growth|1|||
170388005|NCT00697255|615756891|FG001|Stage 1a|Multifollicular growth|0|||
170388006|NCT00697255|615756890|FG000|Stage 1a|Not growing of dominant follicle|1|||
170388007|NCT00697255|615756891|FG001|Stage 1a|Not growing of dominant follicle|0|||
170388008|NCT00697255|615756890|FG000|Stage 1b|Not growing of dominant follicle|0|||
170388009|NCT00697255|615756891|FG001|Stage 1b|Not growing of dominant follicle|1|||
170388010|NCT00697255|615756890|FG000|Stage 1b|Insufficient ovarian response|0|||
170388011|NCT00697255|615756891|FG001|Stage 1b|Insufficient ovarian response|1|||
170388012|NCT01218477|615756892|FG000|Overall Study|Disease progression|2|||
170388013|NCT01218477|615756893|FG001|Overall Study|Disease progression|3|||
170388014|NCT01218477|615756894|FG002|Overall Study|Disease progression|6|||
170388015|NCT01218477|615756895|FG003|Overall Study|Disease progression|2|||
170388016|NCT01218477|615756892|FG000|Overall Study|Study drug toxicity|0|||
170388017|NCT01218477|615756893|FG001|Overall Study|Study drug toxicity|2|||
170388018|NCT01218477|615756894|FG002|Overall Study|Study drug toxicity|5|||
170388019|NCT01218477|615756895|FG003|Overall Study|Study drug toxicity|0|||
170388020|NCT01218477|615756892|FG000|Overall Study|No longer meets study criteria|1|||
170388021|NCT01218477|615756893|FG001|Overall Study|No longer meets study criteria|0|||
170388022|NCT01218477|615756894|FG002|Overall Study|No longer meets study criteria|0|||
170388023|NCT01218477|615756895|FG003|Overall Study|No longer meets study criteria|0|||
170388024|NCT01218477|615756892|FG000|Overall Study|Withdrawal by Subject|0|||
170388025|NCT01218477|615756893|FG001|Overall Study|Withdrawal by Subject|0|||
170388026|NCT01218477|615756894|FG002|Overall Study|Withdrawal by Subject|1|||
170388027|NCT01218477|615756895|FG003|Overall Study|Withdrawal by Subject|0|||
170388028|NCT01218477|615756892|FG000|Overall Study|Prepared for cell transplantation|0|||
170388029|NCT01218477|615756893|FG001|Overall Study|Prepared for cell transplantation|1|||
170388030|NCT01218477|615756894|FG002|Overall Study|Prepared for cell transplantation|1|||
170388031|NCT01218477|615756895|FG003|Overall Study|Prepared for cell transplantation|0|||
170388032|NCT01218477|615756892|FG000|Overall Study|Administrative reason by sponsor|0|||
170388033|NCT01218477|615756893|FG001|Overall Study|Administrative reason by sponsor|0|||
170388034|NCT01218477|615756894|FG002|Overall Study|Administrative reason by sponsor|1|||
170388035|NCT01218477|615756895|FG003|Overall Study|Administrative reason by sponsor|0|||
170388036|NCT01218477|615756892|FG000|Overall Study|Maximum clinical benefit|0|||
170388037|NCT01218477|615756893|FG001|Overall Study|Maximum clinical benefit|2|||
170388038|NCT01218477|615756894|FG002|Overall Study|Maximum clinical benefit|0|||
170388039|NCT01218477|615756895|FG003|Overall Study|Maximum clinical benefit|0|||
170388040|NCT02543918|615756902|FG000|Overall Study|Never treated|0|||
170388041|NCT02543918|615756903|FG001|Overall Study|Never treated|1|||
170388042|NCT02543918|615756902|FG000|Overall Study|Lost to Follow-up|1|||
170388043|NCT02543918|615756903|FG001|Overall Study|Lost to Follow-up|1|||
170388044|NCT02543918|615756902|FG000|Overall Study|Withdrawal by Subject|1|||
170388045|NCT02543918|615756903|FG001|Overall Study|Withdrawal by Subject|1|||
170388046|NCT02543918|615756902|FG000|Overall Study|Adverse Event|1|||
170388047|NCT02543918|615756903|FG001|Overall Study|Adverse Event|1|||
170388048|NCT04034225|615756906|FG000|Overall Study|Death|3|||
170388049|NCT04034225|615756906|FG000|Overall Study|Withdrawal by Subject|2|||
170388050|NCT04034225|615756906|FG000|Overall Study|Study termination by Sponsor|18|||
170388051|NCT04034225|615756906|FG000|Overall Study|Physician Decision|1|||
170388052|NCT04034225|615756906|FG000|Overall Study|Lack of Efficacy|1|||
170388053|NCT02354599|615756913|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
170388054|NCT02354599|615756914|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
170388055|NCT02354599|615756915|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
170388056|NCT02354599|615756916|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
170388057|NCT02354599|615756917|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
170388058|NCT02354599|615756918|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
170388059|NCT02354599|615756913|FG000|Overall Study|Withdrawal by Subject|1|||
170388060|NCT02354599|615756914|FG001|Overall Study|Withdrawal by Subject|1|||
170388061|NCT02354599|615756915|FG002|Overall Study|Withdrawal by Subject|0|||
170388062|NCT02354599|615756916|FG003|Overall Study|Withdrawal by Subject|0|||
170388063|NCT02354599|615756917|FG004|Overall Study|Withdrawal by Subject|0|||
170388064|NCT02354599|615756918|FG005|Overall Study|Withdrawal by Subject|0|||
170388065|NCT00689728|615756919|FG000|Double-Blind Treatment|Adverse Event|1|||
170388066|NCT00689728|615756920|FG001|Double-Blind Treatment|Adverse Event|0|||
170388067|NCT00689728|615756921|FG002|Double-Blind Treatment|Adverse Event|0|||
170388068|NCT00689728|615756919|FG000|Double-Blind Treatment|Protocol Violation|0|||
170388069|NCT00689728|615756920|FG001|Double-Blind Treatment|Protocol Violation|0|||
170388070|NCT00689728|615756921|FG002|Double-Blind Treatment|Protocol Violation|1|||
170388071|NCT00689728|615756919|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
170388072|NCT00689728|615756920|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
170388073|NCT00689728|615756921|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
170388074|NCT00689728|615756919|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
170388075|NCT00689728|615756920|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
170388076|NCT00689728|615756921|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
170388077|NCT00689728|615756919|FG000|Rescue|Adverse Event|0|||
170388078|NCT00689728|615756920|FG001|Rescue|Adverse Event|1|||
170388079|NCT00689728|615756921|FG002|Rescue|Adverse Event|0|||
170388080|NCT00689728|615756919|FG000|Rescue|Withdrawal by Subject|1|||
170388081|NCT00689728|615756920|FG001|Rescue|Withdrawal by Subject|1|||
170388082|NCT00689728|615756921|FG002|Rescue|Withdrawal by Subject|1|||
170388083|NCT00689728|615756919|FG000|Optional Follow-Up|Adverse Event|1|||
170388084|NCT00689728|615756920|FG001|Optional Follow-Up|Adverse Event|0|||
170388085|NCT00689728|615756921|FG002|Optional Follow-Up|Adverse Event|0|||
170388086|NCT00689728|615756919|FG000|Optional Follow-Up|Lack of Efficacy|0|||
170388087|NCT00689728|615756920|FG001|Optional Follow-Up|Lack of Efficacy|1|||
170388088|NCT00689728|615756921|FG002|Optional Follow-Up|Lack of Efficacy|1|||
170388089|NCT00689728|615756919|FG000|Optional Follow-Up|Lost to Follow-up|0|||
170388090|NCT00689728|615756920|FG001|Optional Follow-Up|Lost to Follow-up|1|||
170388091|NCT00689728|615756921|FG002|Optional Follow-Up|Lost to Follow-up|1|||
170388092|NCT00689728|615756919|FG000|Optional Follow-Up|Protocol Violation|0|||
170388093|NCT00689728|615756920|FG001|Optional Follow-Up|Protocol Violation|0|||
170388094|NCT00689728|615756921|FG002|Optional Follow-Up|Protocol Violation|1|||
170388095|NCT00689728|615756919|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
170388096|NCT00689728|615756920|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
170388097|NCT00689728|615756921|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
170388098|NCT00280059|615756924|FG000|Efficacy Assessment Phase|Death|2|||
170388099|NCT00280059|615756925|FG001|Efficacy Assessment Phase|Death|0|||
170388100|NCT00280059|615756924|FG000|Efficacy Assessment Phase|Adverse Event|33|||
170388101|NCT00280059|615756925|FG001|Efficacy Assessment Phase|Adverse Event|31|||
170388102|NCT00280059|615756924|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
170388103|NCT00280059|615756925|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
170388104|NCT00280059|615756924|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
170388105|NCT00280059|615756925|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
170388106|NCT00280059|615756924|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
170388107|NCT00280059|615756925|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
170388108|NCT00280059|615756924|FG000|Efficacy Assessment Phase|Other|7|||
170388109|NCT00280059|615756925|FG001|Efficacy Assessment Phase|Other|8|||
170388110|NCT00280059|615756924|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
170388111|NCT00280059|615756925|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
170388112|NCT01728454|615756927|FG000|Stage 1 and 2|Pregnancy|1|||
170388113|NCT01728454|615756928|FG001|Stage 1 and 2|Pregnancy|0|||
170388114|NCT01728454|615756929|FG002|Stage 1 and 2|Pregnancy|0|||
170388115|NCT01728454|615756927|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
170388116|NCT01728454|615756928|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
170388117|NCT01728454|615756929|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
170388118|NCT01728454|615756927|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
170388119|NCT01728454|615756928|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
170388120|NCT01728454|615756929|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
170388121|NCT01728454|615756927|FG000|Stage 1 and 2|Lost to Follow-up|1|||
170388122|NCT01728454|615756928|FG001|Stage 1 and 2|Lost to Follow-up|1|||
170388123|NCT01728454|615756929|FG002|Stage 1 and 2|Lost to Follow-up|0|||
170388124|NCT01728454|615756927|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
170388125|NCT01728454|615756928|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
170388126|NCT01728454|615756929|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
170388127|NCT01728454|615756927|FG000|Stage 3|Reason Missing|0|||
170388128|NCT01728454|615756928|FG001|Stage 3|Reason Missing|0|||
170388129|NCT01728454|615756929|FG002|Stage 3|Reason Missing|1|||
170388130|NCT01728454|615756927|FG000|Stage 3|Subject Required Other Treatment|0|||
170388131|NCT01728454|615756928|FG001|Stage 3|Subject Required Other Treatment|1|||
170388132|NCT01728454|615756929|FG002|Stage 3|Subject Required Other Treatment|0|||
170388133|NCT01728454|615756927|FG000|Stage 3|Pregnancy|1|||
170388134|NCT01728454|615756928|FG001|Stage 3|Pregnancy|0|||
170388135|NCT01728454|615756929|FG002|Stage 3|Pregnancy|0|||
170388136|NCT01728454|615756927|FG000|Stage 3|Withdrew Consent|1|||
170388137|NCT01728454|615756928|FG001|Stage 3|Withdrew Consent|0|||
170388138|NCT01728454|615756929|FG002|Stage 3|Withdrew Consent|1|||
170388139|NCT01728454|615756927|FG000|Stage 3|Non-compliance with Protocol|0|||
170388140|NCT01728454|615756928|FG001|Stage 3|Non-compliance with Protocol|0|||
170388141|NCT01728454|615756929|FG002|Stage 3|Non-compliance with Protocol|1|||
170388142|NCT01728454|615756927|FG000|Stage 3|Lost to Follow-up|0|||
170388143|NCT01728454|615756928|FG001|Stage 3|Lost to Follow-up|3|||
170388144|NCT01728454|615756929|FG002|Stage 3|Lost to Follow-up|1|||
170388145|NCT01728454|615756927|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
170388146|NCT01728454|615756928|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
170388147|NCT01728454|615756929|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
170388148|NCT00323479|615756933|FG000|Overall Study|Adverse Event|2|||
170388149|NCT00323479|615756933|FG000|Overall Study|Withdrawal by Subject|2|||
170388150|NCT00323479|615756933|FG000|Overall Study|Protocol Violation|3|||
170388151|NCT00323479|615756933|FG000|Overall Study|house moving|1|||
170388152|NCT01362062|615756934|FG000|Overall Study|Adverse Event|1|||
170388153|NCT01362062|615756935|FG001|Overall Study|Adverse Event|0|||
170388154|NCT01362062|615756934|FG000|Overall Study|Lost to Follow-up|11|||
170388155|NCT01362062|615756935|FG001|Overall Study|Lost to Follow-up|0|||
170388156|NCT01362062|615756934|FG000|Overall Study|Withdrawal by Subject|2|||
170388157|NCT01362062|615756935|FG001|Overall Study|Withdrawal by Subject|0|||
170388158|NCT01362062|615756934|FG000|Overall Study|Non-compliant participant|2|||
170388159|NCT01362062|615756935|FG001|Overall Study|Non-compliant participant|0|||
170388160|NCT01362062|615756934|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
170388161|NCT01362062|615756935|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
170388162|NCT01362062|615756934|FG000|Overall Study|Had significant improvement|9|||
170388163|NCT01362062|615756935|FG001|Overall Study|Had significant improvement|0|||
170388164|NCT00758394|615756936|FG000|2nd Intervention Order|Lost to Follow-up|0|||
170388165|NCT00758394|615756937|FG001|2nd Intervention Order|Lost to Follow-up|1|||
170388166|NCT00758394|615756938|FG002|2nd Intervention Order|Lost to Follow-up|0|||
170388167|NCT00758394|615756939|FG003|2nd Intervention Order|Lost to Follow-up|0|||
170388168|NCT00758394|615756936|FG000|3rd Intervention|Lost to Follow-up|1|||
170388169|NCT00758394|615756937|FG001|3rd Intervention|Lost to Follow-up|0|||
170388170|NCT00758394|615756938|FG002|3rd Intervention|Lost to Follow-up|0|||
170388171|NCT00758394|615756939|FG003|3rd Intervention|Lost to Follow-up|1|||
170388172|NCT03159455|615758833|FG000|Overall Study|Adverse Event|0|||
170388173|NCT03159455|615758834|FG001|Overall Study|Adverse Event|0|||
170388174|NCT03159455|615758835|FG002|Overall Study|Adverse Event|0|||
170388175|NCT03159455|615758836|FG003|Overall Study|Adverse Event|0|||
170388176|NCT03159455|615758837|FG004|Overall Study|Adverse Event|0|||
170388177|NCT03159455|615758838|FG005|Overall Study|Adverse Event|1|||
170388178|NCT01302366|615758839|FG000|Overall Study|patient choice or noncompliance|5|||
170388179|NCT03799198|615758840|FG000|Overall Study|Lost to Follow-up|4|||
170388180|NCT03799198|615758841|FG001|Overall Study|Lost to Follow-up|8|||
170388181|NCT03799198|615758840|FG000|Overall Study|Death|0|||
170388182|NCT03799198|615758841|FG001|Overall Study|Death|1|||
170388183|NCT00960869|615758843|FG000|Overall Study|Adverse Event|17|||
170388184|NCT00960869|615758844|FG001|Overall Study|Adverse Event|26|||
170388185|NCT00960869|615758843|FG000|Overall Study|Withdrawal by Subject|16|||
170388186|NCT00960869|615758844|FG001|Overall Study|Withdrawal by Subject|14|||
170388187|NCT00960869|615758843|FG000|Overall Study|Lost to Follow-up|1|||
170388188|NCT00960869|615758844|FG001|Overall Study|Lost to Follow-up|4|||
170388189|NCT00960869|615758843|FG000|Overall Study|Misc|19|||
170388190|NCT00960869|615758844|FG001|Overall Study|Misc|18|||
170388191|NCT02501642|615758847|FG000|Overall Study|Lost to Follow-up|7|||
170388192|NCT02501642|615758848|FG001|Overall Study|Lost to Follow-up|11|||
170388193|NCT00198107|615758849|FG000|Double-Blind Period|Adverse Event|1|||
170388194|NCT00198107|615758850|FG001|Double-Blind Period|Adverse Event|1|||
170388195|NCT00198107|615758851|FG002|Double-Blind Period|Adverse Event|0|||
170388196|NCT00198107|615758849|FG000|Double-Blind Period|Lack of Efficacy|2|||
170388197|NCT00198107|615758850|FG001|Double-Blind Period|Lack of Efficacy|0|||
170388198|NCT00198107|615758851|FG002|Double-Blind Period|Lack of Efficacy|0|||
170388199|NCT00198107|615758849|FG000|Double-Blind Period|Lost to Follow-up|2|||
170388200|NCT00198107|615758850|FG001|Double-Blind Period|Lost to Follow-up|1|||
170388201|NCT00198107|615758851|FG002|Double-Blind Period|Lost to Follow-up|0|||
170388202|NCT00198107|615758849|FG000|Double-Blind Period|Physician Decision|1|||
170388203|NCT00198107|615758850|FG001|Double-Blind Period|Physician Decision|0|||
170388204|NCT00198107|615758851|FG002|Double-Blind Period|Physician Decision|0|||
170388205|NCT00198107|615758849|FG000|Double-Blind Period|Withdrawal by Subject|0|||
170388206|NCT00198107|615758850|FG001|Double-Blind Period|Withdrawal by Subject|1|||
170388207|NCT00198107|615758851|FG002|Double-Blind Period|Withdrawal by Subject|0|||
170388208|NCT00198107|615758849|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
170388209|NCT00198107|615758850|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
170388210|NCT00198107|615758851|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
170388211|NCT00934661|615758852|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
170388212|NCT00934661|615758853|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
170388213|NCT03996694|615758858|FG000|First Washout (7 Days)|positive urine drug screen|0|||
170388214|NCT03996694|615758859|FG001|First Washout (7 Days)|positive urine drug screen|0|||
170388215|NCT03996694|615758860|FG002|First Washout (7 Days)|positive urine drug screen|1|||
170388216|NCT03996694|615758861|FG003|First Washout (7 Days)|positive urine drug screen|0|||
170388217|NCT03996694|615758862|FG004|First Washout (7 Days)|positive urine drug screen|0|||
170388218|NCT03996694|615758863|FG005|First Washout (7 Days)|positive urine drug screen|0|||
170388219|NCT03996694|615758858|FG000|First Washout (7 Days)|Adverse Event|0|||
170388220|NCT03996694|615758859|FG001|First Washout (7 Days)|Adverse Event|1|||
170388221|NCT03996694|615758860|FG002|First Washout (7 Days)|Adverse Event|0|||
170388222|NCT03996694|615758861|FG003|First Washout (7 Days)|Adverse Event|0|||
170388223|NCT03996694|615758862|FG004|First Washout (7 Days)|Adverse Event|0|||
170388224|NCT03996694|615758863|FG005|First Washout (7 Days)|Adverse Event|0|||
170388225|NCT03996694|615758858|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
170388226|NCT03996694|615758859|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
170388227|NCT03996694|615758860|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
170388228|NCT03996694|615758861|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
170388229|NCT03996694|615758862|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
170388230|NCT03996694|615758863|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
170388231|NCT03996694|615758858|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
170388232|NCT03996694|615758859|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
170388233|NCT03996694|615758860|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
170388234|NCT03996694|615758861|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
170388235|NCT03996694|615758862|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
170388236|NCT03996694|615758863|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
170388237|NCT01153971|615758868|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
170388238|NCT01153971|615758868|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
170388239|NCT01153971|615758868|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
170388240|NCT01153971|615758868|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
170388241|NCT01153971|615758868|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
170388242|NCT01153971|615758868|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
170388243|NCT01153971|615758868|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
170388244|NCT03410693|615758869|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
170388245|NCT03410693|615758870|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
170388246|NCT03410693|615758869|FG000|Overall Study|Disc trt: Lost to follow up|0|||
170388247|NCT03410693|615758870|FG001|Overall Study|Disc trt: Lost to follow up|1|||
170388248|NCT03410693|615758869|FG000|Overall Study|Disc trt: radiological progression|58|||
170388249|NCT03410693|615758870|FG001|Overall Study|Disc trt: radiological progression|50|||
170388250|NCT03410693|615758869|FG000|Overall Study|Disc trt: Other|1|||
170388251|NCT03410693|615758870|FG001|Overall Study|Disc trt: Other|0|||
170388252|NCT03410693|615758869|FG000|Overall Study|Study drug never administered|1|||
170388253|NCT03410693|615758870|FG001|Overall Study|Study drug never administered|6|||
170388254|NCT03410693|615758869|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
170388255|NCT03410693|615758870|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
170388256|NCT03410693|615758869|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
170388257|NCT03410693|615758870|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
170388258|NCT03410693|615758869|FG000|Overall Study|Disc trt: Physician decision|0|||
170388259|NCT03410693|615758870|FG001|Overall Study|Disc trt: Physician decision|5|||
170388260|NCT03410693|615758869|FG000|Overall Study|Disc trt: clinical progression|1|||
170388261|NCT03410693|615758870|FG001|Overall Study|Disc trt: clinical progression|5|||
170388262|NCT03410693|615758869|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
170388263|NCT03410693|615758870|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
170388264|NCT01789476|615758871|FG000|Overall Study|Lack of Efficacy|6|||
170388265|NCT01789476|615758872|FG001|Overall Study|Lack of Efficacy|2|||
170388266|NCT01789476|615758871|FG000|Overall Study|Adverse Event|1|||
170388267|NCT01789476|615758872|FG001|Overall Study|Adverse Event|0|||
170388268|NCT01789476|615758871|FG000|Overall Study|Unable to get IV access|1|||
170388269|NCT01789476|615758872|FG001|Overall Study|Unable to get IV access|0|||
170388270|NCT00953576|615758873|FG000|Overall Study|Adverse Event|0|||
170388271|NCT00953576|615758874|FG001|Overall Study|Adverse Event|1|||
170388272|NCT00953576|615758873|FG000|Overall Study|Ineligible after Consent|2|||
170388273|NCT00953576|615758874|FG001|Overall Study|Ineligible after Consent|0|||
170388274|NCT00501969|615758875|FG000|Overall Study|Major Protocol Violation|4|||
170388275|NCT00501969|615758875|FG000|Overall Study|Lack of Efficacy|29|||
170388276|NCT00501969|615758875|FG000|Overall Study|Adverse Event|76|||
170388277|NCT00501969|615758875|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
170388278|NCT00501969|615758875|FG000|Overall Study|Subject withdrew consent|51|||
170388279|NCT00501969|615758875|FG000|Overall Study|Lost to Follow-up|4|||
170388280|NCT00501969|615758875|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
170388281|NCT00501969|615758875|FG000|Overall Study|Other: Sponsors Request|10|||
170388282|NCT00501969|615758875|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
170388283|NCT00501969|615758875|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
170388284|NCT00501969|615758875|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
170388285|NCT00501969|615758875|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
170388286|NCT00501969|615758875|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
170388287|NCT00501969|615758875|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
170388288|NCT00501969|615758875|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
170388289|NCT00501969|615758875|FG000|Overall Study|Other: As Required by Local EC|2|||
170388290|NCT00501969|615758875|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
170388291|NCT00501969|615758875|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
170388292|NCT02777554|615758876|FG000|Overall Study|Adverse Event|4|||
170388293|NCT02777554|615758877|FG001|Overall Study|Adverse Event|4|||
170388294|NCT02777554|615758878|FG002|Overall Study|Adverse Event|0|||
170388295|NCT02777554|615758879|FG003|Overall Study|Adverse Event|1|||
170388296|NCT02777554|615758880|FG004|Overall Study|Adverse Event|0|||
170388297|NCT02777554|615758881|FG005|Overall Study|Adverse Event|0|||
170388298|NCT02777554|615758876|FG000|Overall Study|Withdrawal by Subject|3|||
170388299|NCT02777554|615758877|FG001|Overall Study|Withdrawal by Subject|1|||
170388300|NCT02777554|615758878|FG002|Overall Study|Withdrawal by Subject|1|||
170388301|NCT02777554|615758879|FG003|Overall Study|Withdrawal by Subject|0|||
170388302|NCT02777554|615758880|FG004|Overall Study|Withdrawal by Subject|0|||
170388303|NCT02777554|615758881|FG005|Overall Study|Withdrawal by Subject|0|||
170388304|NCT02777554|615758876|FG000|Overall Study|Discharged early due to hurricane|22|||
170388305|NCT02777554|615758877|FG001|Overall Study|Discharged early due to hurricane|20|||
170388306|NCT02777554|615758878|FG002|Overall Study|Discharged early due to hurricane|0|||
170388307|NCT02777554|615758879|FG003|Overall Study|Discharged early due to hurricane|0|||
170388308|NCT02777554|615758880|FG004|Overall Study|Discharged early due to hurricane|0|||
170388309|NCT02777554|615758881|FG005|Overall Study|Discharged early due to hurricane|0|||
170388310|NCT02777554|615758876|FG000|Overall Study|Other - Miscellaneous|1|||
170388311|NCT02777554|615758877|FG001|Overall Study|Other - Miscellaneous|0|||
170388312|NCT02777554|615758878|FG002|Overall Study|Other - Miscellaneous|0|||
170388313|NCT02777554|615758879|FG003|Overall Study|Other - Miscellaneous|0|||
170388314|NCT02777554|615758880|FG004|Overall Study|Other - Miscellaneous|0|||
170388315|NCT02777554|615758881|FG005|Overall Study|Other - Miscellaneous|0|||
170388316|NCT01013207|615758884|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
170388317|NCT01541644|615758885|FG000|Overall Study|Withdrawal by Subject|3|||
170388318|NCT01238861|615758886|FG000|Overall Study|Lost to Follow-up|4|||
170388319|NCT01238861|615758887|FG001|Overall Study|Lost to Follow-up|2|||
170388320|NCT01238861|615758888|FG002|Overall Study|Lost to Follow-up|3|||
170388321|NCT01238861|615758889|FG003|Overall Study|Lost to Follow-up|1|||
170388322|NCT01238861|615758890|FG004|Overall Study|Lost to Follow-up|1|||
170388323|NCT01238861|615758891|FG005|Overall Study|Lost to Follow-up|2|||
170388324|NCT01238861|615758886|FG000|Overall Study|Unplanned surgery|1|||
170388325|NCT01238861|615758887|FG001|Overall Study|Unplanned surgery|0|||
170388326|NCT01238861|615758888|FG002|Overall Study|Unplanned surgery|0|||
170388327|NCT01238861|615758889|FG003|Overall Study|Unplanned surgery|0|||
170388328|NCT01238861|615758890|FG004|Overall Study|Unplanned surgery|0|||
170388329|NCT01238861|615758891|FG005|Overall Study|Unplanned surgery|0|||
170388330|NCT01238861|615758886|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
170388331|NCT01238861|615758887|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
170388332|NCT01238861|615758888|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
170388333|NCT01238861|615758889|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
170388334|NCT01238861|615758890|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
170388335|NCT01238861|615758891|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
170388336|NCT01238861|615758886|FG000|Overall Study|Incorrect enrollment/randomization|0|||
170388337|NCT01238861|615758887|FG001|Overall Study|Incorrect enrollment/randomization|0|||
170388338|NCT01238861|615758888|FG002|Overall Study|Incorrect enrollment/randomization|1|||
170388339|NCT01238861|615758889|FG003|Overall Study|Incorrect enrollment/randomization|0|||
170388340|NCT01238861|615758890|FG004|Overall Study|Incorrect enrollment/randomization|1|||
170388341|NCT01238861|615758891|FG005|Overall Study|Incorrect enrollment/randomization|0|||
170388342|NCT01238861|615758886|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
170388343|NCT01238861|615758887|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
170388344|NCT01238861|615758888|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
170388345|NCT01238861|615758889|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
170388346|NCT01238861|615758890|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
170388347|NCT01238861|615758891|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
170388348|NCT01238861|615758886|FG000|Overall Study|Subject moved out of state/area|0|||
170388349|NCT01238861|615758887|FG001|Overall Study|Subject moved out of state/area|0|||
170388350|NCT01238861|615758888|FG002|Overall Study|Subject moved out of state/area|1|||
170388351|NCT01238861|615758889|FG003|Overall Study|Subject moved out of state/area|1|||
170388352|NCT01238861|615758890|FG004|Overall Study|Subject moved out of state/area|0|||
170388353|NCT01238861|615758891|FG005|Overall Study|Subject moved out of state/area|0|||
170388354|NCT01238861|615758886|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
170388355|NCT01238861|615758887|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
170388356|NCT01238861|615758888|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
170388357|NCT01238861|615758889|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
170388358|NCT01238861|615758890|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
170388359|NCT01238861|615758891|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
170388360|NCT01238861|615758886|FG000|Overall Study|Personal problems|0|||
170388361|NCT01238861|615758887|FG001|Overall Study|Personal problems|0|||
170388362|NCT01238861|615758888|FG002|Overall Study|Personal problems|0|||
170388363|NCT01238861|615758889|FG003|Overall Study|Personal problems|1|||
170388364|NCT01238861|615758890|FG004|Overall Study|Personal problems|0|||
170388365|NCT01238861|615758891|FG005|Overall Study|Personal problems|0|||
170388366|NCT01238861|615758886|FG000|Overall Study|Unable to continue visits|0|||
170388367|NCT01238861|615758887|FG001|Overall Study|Unable to continue visits|0|||
170388368|NCT01238861|615758888|FG002|Overall Study|Unable to continue visits|0|||
170388369|NCT01238861|615758889|FG003|Overall Study|Unable to continue visits|1|||
170388370|NCT01238861|615758890|FG004|Overall Study|Unable to continue visits|0|||
170388371|NCT01238861|615758891|FG005|Overall Study|Unable to continue visits|1|||
170388372|NCT01238861|615758886|FG000|Overall Study|Serious adverse event|0|||
170388373|NCT01238861|615758887|FG001|Overall Study|Serious adverse event|0|||
170388374|NCT01238861|615758888|FG002|Overall Study|Serious adverse event|0|||
170388375|NCT01238861|615758889|FG003|Overall Study|Serious adverse event|0|||
170388376|NCT01238861|615758890|FG004|Overall Study|Serious adverse event|0|||
170388377|NCT01238861|615758891|FG005|Overall Study|Serious adverse event|1|||
170388378|NCT01238861|615758886|FG000|Overall Study|Lack of compliance|0|||
170388379|NCT01238861|615758887|FG001|Overall Study|Lack of compliance|0|||
170388380|NCT01238861|615758888|FG002|Overall Study|Lack of compliance|0|||
170388381|NCT01238861|615758889|FG003|Overall Study|Lack of compliance|0|||
170388382|NCT01238861|615758890|FG004|Overall Study|Lack of compliance|0|||
170388383|NCT01238861|615758891|FG005|Overall Study|Lack of compliance|1|||
170388384|NCT01238861|615758886|FG000|Overall Study|Adverse Event|0|||
170388385|NCT01238861|615758887|FG001|Overall Study|Adverse Event|1|||
170388386|NCT01238861|615758888|FG002|Overall Study|Adverse Event|0|||
170388387|NCT01238861|615758889|FG003|Overall Study|Adverse Event|0|||
170388388|NCT01238861|615758890|FG004|Overall Study|Adverse Event|0|||
170388389|NCT01238861|615758891|FG005|Overall Study|Adverse Event|0|||
170388390|NCT01238861|615758886|FG000|Overall Study|Withdrawal by Subject|6|||
170388391|NCT01238861|615758887|FG001|Overall Study|Withdrawal by Subject|5|||
170388392|NCT01238861|615758888|FG002|Overall Study|Withdrawal by Subject|4|||
170388393|NCT01238861|615758889|FG003|Overall Study|Withdrawal by Subject|8|||
170388394|NCT01238861|615758890|FG004|Overall Study|Withdrawal by Subject|10|||
170388395|NCT01238861|615758891|FG005|Overall Study|Withdrawal by Subject|9|||
170388396|NCT01269346|615758892|FG000|Treatment Phase|Disease progression|3|||
170388397|NCT01269346|615758892|FG000|Treatment Phase|Adverse Event|3|||
170388398|NCT01269346|615758892|FG000|Treatment Phase|Withdrawal by Subject|1|||
170388399|NCT01269346|615758892|FG000|Treatment Phase|Other|2|||
170388400|NCT01269346|615758892|FG000|Extension Phase|Adverse Event|6|||
170388401|NCT01269346|615758892|FG000|Extension Phase|Withdrawal by Subject|4|||
170388402|NCT01269346|615758892|FG000|Extension Phase|Disease progression|22|||
170388403|NCT01269346|615758892|FG000|Extension Phase|Physician decision or participant choice|9|||
170388404|NCT01269346|615758892|FG000|Extension Phase|Clinical progression|1|||
170388405|NCT01269346|615758892|FG000|Extension Phase|Started a prohibited con med|1|||
170388406|NCT00247416|615758893|FG000|Overall Study|3 patients were found to be ineligible|1|||
170388407|NCT00247416|615758894|FG001|Overall Study|3 patients were found to be ineligible|2|||
170388408|NCT02646566|615758895|FG000|Overall Study|Lost to Follow-up|5|||
170388409|NCT02646566|615758896|FG001|Overall Study|Lost to Follow-up|4|||
170388410|NCT02646566|615758897|FG002|Overall Study|Lost to Follow-up|5|||
170388411|NCT02646566|615758895|FG000|Overall Study|Treatment failure|1|||
170388412|NCT02646566|615758896|FG001|Overall Study|Treatment failure|0|||
170388413|NCT02646566|615758897|FG002|Overall Study|Treatment failure|0|||
170388414|NCT04001790|615758900|FG000|Overall Study|Withdrawal by Subject|1|||
170388415|NCT04001790|615758901|FG001|Overall Study|Withdrawal by Subject|2|||
170388416|NCT03472586|615758902|FG000|Overall Study|Physician Decision|6|||
170388417|NCT03472586|615758902|FG000|Overall Study|Death|6|||
170388418|NCT03472586|615758902|FG000|Overall Study|Adverse Event|1|||
170388419|NCT05028816|615758904|FG000|Overall Study|Lost to Follow-up|5|||
170388420|NCT05028816|615758905|FG001|Overall Study|Lost to Follow-up|3|||
170388421|NCT05028816|615758904|FG000|Overall Study|Withdrawal by Subject|4|||
170388422|NCT05028816|615758905|FG001|Overall Study|Withdrawal by Subject|1|||
170388423|NCT05028816|615758904|FG000|Overall Study|Physician Decision|1|||
170388424|NCT05028816|615758905|FG001|Overall Study|Physician Decision|0|||
170388425|NCT05064436|615758906|FG000|Overall Study|Other Reasons|1|||
170388426|NCT05064436|615758907|FG001|Overall Study|Other Reasons|0|||
170388427|NCT02652793|615758910|FG000|Overall Study|Adverse Event|1|||
170388428|NCT02652793|615758910|FG000|Overall Study|Lost to Follow-up|2|||
170388429|NCT02652793|615758910|FG000|Overall Study|Withdrawal by Subject|1|||
170388430|NCT01982942|615758919|FG000|Overall Study|Adverse Event|10|||
170388431|NCT01982942|615758920|FG001|Overall Study|Adverse Event|5|||
170388432|NCT01982942|615758919|FG000|Overall Study|Lost to Follow-up|4|||
170388433|NCT01982942|615758920|FG001|Overall Study|Lost to Follow-up|3|||
170388434|NCT01982942|615758919|FG000|Overall Study|Multiple sclerosis progression|3|||
170388435|NCT01982942|615758920|FG001|Overall Study|Multiple sclerosis progression|2|||
170388436|NCT01982942|615758919|FG000|Overall Study|Wanted to try therapy not permitted|1|||
170388437|NCT01982942|615758920|FG001|Overall Study|Wanted to try therapy not permitted|0|||
170388438|NCT01982942|615758919|FG000|Overall Study|Subject declined future visits|0|||
170388439|NCT01982942|615758920|FG001|Overall Study|Subject declined future visits|1|||
170388440|NCT01982942|615758919|FG000|Overall Study|Left geographical area|2|||
170388441|NCT01982942|615758920|FG001|Overall Study|Left geographical area|0|||
170388442|NCT01982942|615758919|FG000|Overall Study|Too many pills|1|||
170388443|NCT01982942|615758920|FG001|Overall Study|Too many pills|0|||
170388444|NCT01982942|615758919|FG000|Overall Study|MS Relapse|0|||
170388445|NCT01982942|615758920|FG001|Overall Study|MS Relapse|1|||
170388446|NCT01982942|615758919|FG000|Overall Study|Chose to join a stem cell trial|0|||
170388447|NCT01982942|615758920|FG001|Overall Study|Chose to join a stem cell trial|1|||
170388448|NCT01982942|615758919|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
170388449|NCT01982942|615758920|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
170388450|NCT01270139|615758921|FG000|Overall Study|Adverse Event|8|||
170388451|NCT01270139|615758922|FG001|Overall Study|Adverse Event|17|||
170388452|NCT01270139|615758923|FG002|Overall Study|Adverse Event|18|||
170388453|NCT01270139|615758921|FG000|Overall Study|Lost to Follow-up|10|||
170388454|NCT01270139|615758922|FG001|Overall Study|Lost to Follow-up|9|||
170388455|NCT01270139|615758923|FG002|Overall Study|Lost to Follow-up|2|||
170388456|NCT00750061|615758929|FG000|Overall Study|Adverse Event|2|||
170388457|NCT00750061|615758930|FG001|Overall Study|Adverse Event|0|||
170388458|NCT00750061|615758929|FG000|Overall Study|Withdrawal by Subject|0|||
170388459|NCT00750061|615758930|FG001|Overall Study|Withdrawal by Subject|1|||
170388460|NCT00750061|615758929|FG000|Overall Study|Physician Decision|0|||
170388461|NCT00750061|615758930|FG001|Overall Study|Physician Decision|1|||
170388462|NCT03814499|615758931|FG000|Overall Study|Lost to Follow-up|3|||
170388463|NCT00598442|615758932|FG000|Overall Study|Adverse Event|3|||
170388464|NCT00598442|615758933|FG001|Overall Study|Adverse Event|0|||
170388465|NCT00598442|615758934|FG002|Overall Study|Adverse Event|0|||
170388466|NCT00598442|615758932|FG000|Overall Study|Death|19|||
170388467|NCT00598442|615758933|FG001|Overall Study|Death|11|||
170388468|NCT00598442|615758934|FG002|Overall Study|Death|11|||
170388469|NCT00598442|615758932|FG000|Overall Study|Lost to Follow-up|4|||
170388470|NCT00598442|615758933|FG001|Overall Study|Lost to Follow-up|3|||
170388471|NCT00598442|615758934|FG002|Overall Study|Lost to Follow-up|3|||
170388472|NCT00598442|615758932|FG000|Overall Study|Physician Decision|2|||
170388473|NCT00598442|615758933|FG001|Overall Study|Physician Decision|1|||
170388474|NCT00598442|615758934|FG002|Overall Study|Physician Decision|1|||
170388475|NCT00598442|615758932|FG000|Overall Study|Withdrawal by Subject|8|||
170388476|NCT00598442|615758933|FG001|Overall Study|Withdrawal by Subject|16|||
170388477|NCT00598442|615758934|FG002|Overall Study|Withdrawal by Subject|6|||
170388478|NCT00598442|615758932|FG000|Overall Study|Noncompliance|0|||
170388479|NCT00598442|615758933|FG001|Overall Study|Noncompliance|2|||
170388480|NCT00598442|615758934|FG002|Overall Study|Noncompliance|1|||
170388481|NCT00598442|615758932|FG000|Overall Study|Relocation|1|||
170388482|NCT00598442|615758933|FG001|Overall Study|Relocation|4|||
170388483|NCT00598442|615758934|FG002|Overall Study|Relocation|0|||
170388484|NCT00598442|615758932|FG000|Overall Study|Renal transplant|0|||
170388485|NCT00598442|615758933|FG001|Overall Study|Renal transplant|0|||
170388486|NCT00598442|615758934|FG002|Overall Study|Renal transplant|1|||
170388487|NCT00598442|615758932|FG000|Overall Study|Site closed by sponsor|5|||
170388488|NCT00598442|615758933|FG001|Overall Study|Site closed by sponsor|2|||
170388489|NCT00598442|615758934|FG002|Overall Study|Site closed by sponsor|1|||
170388490|NCT00598442|615758932|FG000|Overall Study|Started dialysis|1|||
170388491|NCT00598442|615758933|FG001|Overall Study|Started dialysis|0|||
170388492|NCT00598442|615758934|FG002|Overall Study|Started dialysis|0|||
170388493|NCT00761735|615758937|FG000|Overall Study|Lost to Follow-up|6|||
170388494|NCT00761735|615758937|FG000|Overall Study|Withdrawal by Subject|6|||
170388495|NCT00761735|615758937|FG000|Overall Study|Non-compliance with protocol|1|||
170388496|NCT00761735|615758937|FG000|Overall Study|Administrative|1|||
170388497|NCT00450814|615758941|FG000|Overall Study|Failed to complete the initial therapy|0|||
170388498|NCT00450814|615758942|FG001|Overall Study|Failed to complete the initial therapy|0|||
170388499|NCT00450814|615758943|FG002|Overall Study|Failed to complete the initial therapy|0|||
170388500|NCT00450814|615758944|FG003|Overall Study|Failed to complete the initial therapy|1|||
170388501|NCT00450814|615758945|FG004|Overall Study|Failed to complete the initial therapy|1|||
170388502|NCT00450814|615758946|FG005|Overall Study|Failed to complete the initial therapy|1|||
170388503|NCT00450814|615758947|FG006|Overall Study|Failed to complete the initial therapy|0|||
170388504|NCT00450814|615758948|FG007|Overall Study|Failed to complete the initial therapy|0|||
170388505|NCT00450814|615758949|FG008|Overall Study|Failed to complete the initial therapy|0|||
170388506|NCT00450814|615758950|FG009|Overall Study|Failed to complete the initial therapy|0|||
170388507|NCT00450814|615758951|FG010|Overall Study|Failed to complete the initial therapy|0|||
170388508|NCT00450814|615758941|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
170388509|NCT00450814|615758942|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
170388510|NCT00450814|615758943|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
170388511|NCT00450814|615758944|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
170388512|NCT00450814|615758945|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
170388513|NCT00450814|615758946|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
170388514|NCT00450814|615758947|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
170388515|NCT00450814|615758948|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
170388516|NCT00450814|615758949|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
170388517|NCT00450814|615758950|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
170388518|NCT00450814|615758951|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
170388519|NCT02985996|615758954|FG000|Overall Study|Withdrawal by Subject|0|||
170388520|NCT02985996|615758955|FG001|Overall Study|Withdrawal by Subject|0|||
170388521|NCT02985996|615758956|FG002|Overall Study|Withdrawal by Subject|1|||
170388522|NCT02985996|615758957|FG003|Overall Study|Withdrawal by Subject|0|||
170388523|NCT02985996|615758958|FG004|Overall Study|Withdrawal by Subject|0|||
170388524|NCT02985996|615758954|FG000|Overall Study|Protocol Violation|0|||
170388525|NCT02985996|615758955|FG001|Overall Study|Protocol Violation|1|||
170388526|NCT02985996|615758956|FG002|Overall Study|Protocol Violation|0|||
170388527|NCT02985996|615758957|FG003|Overall Study|Protocol Violation|0|||
170388528|NCT02985996|615758958|FG004|Overall Study|Protocol Violation|0|||
170388529|NCT03732534|615758959|FG000|Overall Study|Study terminated by Sponsor|6|||
170388530|NCT03125382|615758960|FG000|Randomization|screening failure|1|||
170388531|NCT03125382|615758961|FG001|Randomization|screening failure|4|||
170388532|NCT03125382|615758962|FG002|Randomization|screening failure|2|||
170388533|NCT03125382|615758963|FG003|Randomization|screening failure|0|||
170388534|NCT03125382|615758960|FG000|Follow-up|Death|1|||
170388535|NCT03125382|615758961|FG001|Follow-up|Death|2|||
170388536|NCT03125382|615758962|FG002|Follow-up|Death|1|||
170388537|NCT03125382|615758963|FG003|Follow-up|Death|2|||
170388538|NCT03125382|615758960|FG000|Follow-up|Lost to Follow-up|1|||
170388539|NCT03125382|615758961|FG001|Follow-up|Lost to Follow-up|4|||
170388540|NCT03125382|615758962|FG002|Follow-up|Lost to Follow-up|3|||
170388541|NCT03125382|615758963|FG003|Follow-up|Lost to Follow-up|1|||
170388542|NCT03556202|615758968|FG000|Extension Treatment Period|Adverse Event|18|||
170388543|NCT03556202|615758969|FG001|Extension Treatment Period|Adverse Event|14|||
170388544|NCT03556202|615758970|FG002|Extension Treatment Period|Adverse Event|9|||
170388545|NCT03556202|615758968|FG000|Extension Treatment Period|Death|2|||
170388546|NCT03556202|615758969|FG001|Extension Treatment Period|Death|6|||
170388547|NCT03556202|615758970|FG002|Extension Treatment Period|Death|0|||
170388548|NCT03556202|615758968|FG000|Extension Treatment Period|Lack of Efficacy|5|||
170388549|NCT03556202|615758969|FG001|Extension Treatment Period|Lack of Efficacy|12|||
170388550|NCT03556202|615758970|FG002|Extension Treatment Period|Lack of Efficacy|18|||
170388551|NCT03556202|615758968|FG000|Extension Treatment Period|Lost to Follow-up|9|||
170388552|NCT03556202|615758969|FG001|Extension Treatment Period|Lost to Follow-up|20|||
170388553|NCT03556202|615758970|FG002|Extension Treatment Period|Lost to Follow-up|2|||
170388554|NCT03556202|615758968|FG000|Extension Treatment Period|Pregnancy|2|||
170388555|NCT03556202|615758969|FG001|Extension Treatment Period|Pregnancy|4|||
170388556|NCT03556202|615758970|FG002|Extension Treatment Period|Pregnancy|3|||
170388557|NCT03556202|615758968|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
170388558|NCT03556202|615758969|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
170388559|NCT03556202|615758970|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
170388560|NCT03556202|615758968|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
170388561|NCT03556202|615758969|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
170388562|NCT03556202|615758970|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
170388563|NCT03556202|615758968|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
170388564|NCT03556202|615758969|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
170388565|NCT03556202|615758970|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
170388566|NCT03556202|615758968|FG000|Extension Treatment Period|Physician Decision|0|||
170388567|NCT03556202|615758969|FG001|Extension Treatment Period|Physician Decision|8|||
170388568|NCT03556202|615758970|FG002|Extension Treatment Period|Physician Decision|2|||
170388569|NCT03556202|615758968|FG000|Extension Treatment Period|Protocol Violation|0|||
170388570|NCT03556202|615758969|FG001|Extension Treatment Period|Protocol Violation|1|||
170388571|NCT03556202|615758970|FG002|Extension Treatment Period|Protocol Violation|1|||
170388572|NCT03556202|615758968|FG000|Extension Treatment Period|Sponsor Decision|0|||
170388573|NCT03556202|615758969|FG001|Extension Treatment Period|Sponsor Decision|1|||
170388574|NCT03556202|615758970|FG002|Extension Treatment Period|Sponsor Decision|0|||
170388575|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
170388576|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
170388577|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
170388578|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Death|1|||
170388579|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Death|0|||
170388580|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Death|0|||
170388581|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
170388582|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
170388583|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
170388584|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
170388585|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
170388586|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
170388587|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
170388588|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
170388589|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
170388590|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
170388591|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
170388592|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
170388593|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
170388594|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
170388595|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
170388596|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
170388597|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
170388598|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
170388599|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
170388600|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
170388601|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
170388602|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
170388603|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
170388604|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
170388605|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
170388606|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
170388607|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
170388608|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
170388609|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
170388610|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
170388611|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
170388612|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
170388613|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
170388614|NCT03556202|615758968|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
170388615|NCT03556202|615758969|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
170388616|NCT03556202|615758970|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
170388617|NCT00678652|615758971|FG000|Overall Study|Protocol Violation|2|||
170388618|NCT00678652|615758972|FG001|Overall Study|Protocol Violation|0|||
170388619|NCT00678652|615758973|FG002|Overall Study|Protocol Violation|0|||
170388620|NCT00678652|615758974|FG003|Overall Study|Protocol Violation|0|||
170388621|NCT00678652|615758971|FG000|Overall Study|Pregnancy|0|||
170388622|NCT00678652|615758972|FG001|Overall Study|Pregnancy|0|||
170388623|NCT00678652|615758973|FG002|Overall Study|Pregnancy|1|||
170388624|NCT00678652|615758974|FG003|Overall Study|Pregnancy|0|||
170388625|NCT00678652|615758971|FG000|Overall Study|Relocation|1|||
170388626|NCT00678652|615758972|FG001|Overall Study|Relocation|0|||
170388627|NCT00678652|615758973|FG002|Overall Study|Relocation|0|||
170388628|NCT00678652|615758974|FG003|Overall Study|Relocation|0|||
170388629|NCT04533204|615758975|FG000|Overall Study|Unable to understand training instructions|1|||
170388630|NCT04533204|615758976|FG001|Overall Study|Unable to understand training instructions|1|||
170388631|NCT03457701|615758984|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
170388632|NCT03457701|615758985|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
170388633|NCT03457701|615758984|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
170388634|NCT03457701|615758985|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
170388635|NCT03329404|615758986|FG000|Overall Study|The study was suspended.|1|||
170388636|NCT03329404|615758987|FG001|Overall Study|The study was suspended.|4|||
170388637|NCT05664672|615758988|FG000|Overall Study|Adverse Event|0|||
170388638|NCT05664672|615758989|FG001|Overall Study|Adverse Event|0|||
170388639|NCT05664672|615758990|FG002|Overall Study|Adverse Event|0|||
170388640|NCT05664672|615758991|FG003|Overall Study|Adverse Event|0|||
170388641|NCT05664672|615758992|FG004|Overall Study|Adverse Event|0|||
170388642|NCT05664672|615758993|FG005|Overall Study|Adverse Event|1|||
170388643|NCT05664672|615758988|FG000|Overall Study|Withdrawal by Subject|0|||
170388644|NCT05664672|615758989|FG001|Overall Study|Withdrawal by Subject|1|||
170388645|NCT05664672|615758990|FG002|Overall Study|Withdrawal by Subject|3|||
170388646|NCT05664672|615758991|FG003|Overall Study|Withdrawal by Subject|0|||
170388647|NCT05664672|615758992|FG004|Overall Study|Withdrawal by Subject|5|||
170388648|NCT05664672|615758993|FG005|Overall Study|Withdrawal by Subject|6|||
170388649|NCT05664672|615758988|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
170388650|NCT05664672|615758989|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
170388651|NCT05664672|615758990|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
170388652|NCT05664672|615758991|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
170388653|NCT05664672|615758992|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
170388654|NCT05664672|615758993|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
170388655|NCT05664672|615758988|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
170388656|NCT05664672|615758989|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
170388657|NCT05664672|615758990|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
170388658|NCT05664672|615758991|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
170388659|NCT05664672|615758992|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
170388660|NCT05664672|615758993|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
170388661|NCT04768881|615758994|FG000|Overall Study|Completed Study Follow-up|0|||
170388662|NCT04768881|615758995|FG001|Overall Study|Completed Study Follow-up|2|||
170388663|NCT04768881|615758994|FG000|Overall Study|Death|3|||
170388664|NCT04768881|615758995|FG001|Overall Study|Death|2|||
170388665|NCT04768881|615758994|FG000|Overall Study|Study Terminated by Sponsor|2|||
170388666|NCT04768881|615758995|FG001|Overall Study|Study Terminated by Sponsor|2|||
170388667|NCT04768881|615758994|FG000|Overall Study|Withdrawal by Subject|2|||
170388668|NCT04768881|615758995|FG001|Overall Study|Withdrawal by Subject|0|||
170388669|NCT04768881|615758994|FG000|Overall Study|Other|2|||
170388670|NCT04768881|615758995|FG001|Overall Study|Other|0|||
170388671|NCT02260791|615758999|FG000|Overall Study|Lost to Follow-up|4|||
170388672|NCT02260791|615759000|FG001|Overall Study|Lost to Follow-up|4|||
170388673|NCT02260791|615758999|FG000|Overall Study|Lack of Efficacy|2|||
170388674|NCT02260791|615759000|FG001|Overall Study|Lack of Efficacy|1|||
170388675|NCT02260791|615758999|FG000|Overall Study|Adverse Event|13|||
170388676|NCT02260791|615759000|FG001|Overall Study|Adverse Event|9|||
170388677|NCT02260791|615758999|FG000|Overall Study|Death|1|||
170388678|NCT02260791|615759000|FG001|Overall Study|Death|0|||
170388679|NCT02260791|615758999|FG000|Overall Study|Withdrawal by Subject|11|||
170388680|NCT02260791|615759000|FG001|Overall Study|Withdrawal by Subject|16|||
170388681|NCT02260791|615758999|FG000|Overall Study|Screen failure|0|||
170388682|NCT02260791|615759000|FG001|Overall Study|Screen failure|1|||
170388683|NCT02260791|615758999|FG000|Overall Study|Protocol deviation|2|||
170388684|NCT02260791|615759000|FG001|Overall Study|Protocol deviation|3|||
170388685|NCT03289676|615759005|FG000|Overall Study|Withdrawal by Subject|2|||
170388686|NCT03289676|615759006|FG001|Overall Study|Withdrawal by Subject|0|||
170388687|NCT03289676|615759005|FG000|Overall Study|Protocol Violation|2|||
170388688|NCT03289676|615759006|FG001|Overall Study|Protocol Violation|0|||
170388689|NCT03289676|615759005|FG000|Overall Study|Lost to Follow-up|0|||
170388690|NCT03289676|615759006|FG001|Overall Study|Lost to Follow-up|1|||
170388691|NCT01314261|615759009|FG000|Overall Study|Adverse Event|1|||
170388692|NCT01314261|615759010|FG001|Overall Study|Adverse Event|0|||
170388693|NCT01314261|615759011|FG002|Overall Study|Adverse Event|0|||
170388694|NCT01314261|615759012|FG003|Overall Study|Adverse Event|0|||
170388695|NCT01314261|615759009|FG000|Overall Study|Withdrawal by Subject|0|||
170388696|NCT01314261|615759010|FG001|Overall Study|Withdrawal by Subject|3|||
170388697|NCT01314261|615759011|FG002|Overall Study|Withdrawal by Subject|1|||
170388698|NCT01314261|615759012|FG003|Overall Study|Withdrawal by Subject|0|||
170388699|NCT01314261|615759009|FG000|Overall Study|Lost to Follow-up|1|||
170388700|NCT01314261|615759010|FG001|Overall Study|Lost to Follow-up|0|||
170388701|NCT01314261|615759011|FG002|Overall Study|Lost to Follow-up|2|||
170388702|NCT01314261|615759012|FG003|Overall Study|Lost to Follow-up|2|||
170388703|NCT01314261|615759009|FG000|Overall Study|Virologic Failure|0|||
170388704|NCT01314261|615759010|FG001|Overall Study|Virologic Failure|1|||
170388705|NCT01314261|615759011|FG002|Overall Study|Virologic Failure|0|||
170388706|NCT01314261|615759012|FG003|Overall Study|Virologic Failure|1|||
170388707|NCT00877929|615759013|FG000|Overall Study|Adverse Event|11|||
170388708|NCT00877929|615759014|FG001|Overall Study|Adverse Event|20|||
170388709|NCT00877929|615759013|FG000|Overall Study|Protocol Violation|3|||
170388710|NCT00877929|615759014|FG001|Overall Study|Protocol Violation|3|||
170388711|NCT00877929|615759013|FG000|Overall Study|Lost to Follow-up|0|||
170388712|NCT00877929|615759014|FG001|Overall Study|Lost to Follow-up|1|||
170388713|NCT00877929|615759013|FG000|Overall Study|Withdrawal by Subject|4|||
170388714|NCT00877929|615759014|FG001|Overall Study|Withdrawal by Subject|4|||
170388715|NCT00877929|615759013|FG000|Overall Study|Lack of Efficacy|0|||
170388716|NCT00877929|615759014|FG001|Overall Study|Lack of Efficacy|1|||
170388717|NCT00877929|615759013|FG000|Overall Study|Other reason (not specified)|2|||
170388718|NCT00877929|615759014|FG001|Overall Study|Other reason (not specified)|6|||
170388719|NCT01231620|615759015|FG000|Overall Study|Physician Decision|3|||
170388720|NCT01231620|615759016|FG001|Overall Study|Physician Decision|5|||
170388721|NCT01231620|615759017|FG002|Overall Study|Physician Decision|10|||
170388722|NCT01231620|615759015|FG000|Overall Study|Death|12|||
170388723|NCT01231620|615759016|FG001|Overall Study|Death|14|||
170388724|NCT01231620|615759017|FG002|Overall Study|Death|11|||
170388725|NCT01231620|615759015|FG000|Overall Study|Adverse Event|2|||
170388726|NCT01231620|615759016|FG001|Overall Study|Adverse Event|2|||
170388727|NCT01231620|615759017|FG002|Overall Study|Adverse Event|1|||
170388728|NCT01231620|615759015|FG000|Overall Study|Withdrawal by Subject|6|||
170388729|NCT01231620|615759016|FG001|Overall Study|Withdrawal by Subject|6|||
170388730|NCT01231620|615759017|FG002|Overall Study|Withdrawal by Subject|8|||
170388731|NCT01231620|615759015|FG000|Overall Study|Lost to Follow-up|3|||
170388732|NCT01231620|615759016|FG001|Overall Study|Lost to Follow-up|4|||
170388733|NCT01231620|615759017|FG002|Overall Study|Lost to Follow-up|9|||
170388734|NCT01097057|615761102|FG000|Overall Study|Physician Decision|3|||
170388735|NCT04576702|615761103|FG000|Overall Study|Death|1|||
170388736|NCT04576702|615761104|FG001|Overall Study|Death|0|||
170388737|NCT04576702|615761105|FG002|Overall Study|Death|0|||
170388738|NCT04576702|615761106|FG003|Overall Study|Death|0|||
170388739|NCT04576702|615761103|FG000|Overall Study|Withdrawal by Subject|0|||
170388740|NCT04576702|615761104|FG001|Overall Study|Withdrawal by Subject|2|||
170388741|NCT04576702|615761105|FG002|Overall Study|Withdrawal by Subject|1|||
170388742|NCT04576702|615761106|FG003|Overall Study|Withdrawal by Subject|0|||
170388743|NCT04576702|615761103|FG000|Overall Study|Lost to Follow-up|3|||
170388744|NCT04576702|615761104|FG001|Overall Study|Lost to Follow-up|3|||
170388745|NCT04576702|615761105|FG002|Overall Study|Lost to Follow-up|3|||
170388746|NCT04576702|615761106|FG003|Overall Study|Lost to Follow-up|4|||
170388747|NCT02452320|615761107|FG000|Overall Study|Adverse Event|0|||
170388748|NCT02452320|615761108|FG001|Overall Study|Adverse Event|1|||
170388749|NCT00229931|615761116|FG000|Overall Study|Death|1|||
170388750|NCT00229931|615761117|FG001|Overall Study|Death|0|||
170388751|NCT00229931|615761116|FG000|Overall Study|Lost to Follow-up|3|||
170388752|NCT00229931|615761117|FG001|Overall Study|Lost to Follow-up|2|||
170388753|NCT03290131|615761118|FG000|Overall Study|Adverse Event|22|||
170388754|NCT03290131|615761119|FG001|Overall Study|Adverse Event|57|||
170388755|NCT03290131|615761120|FG002|Overall Study|Adverse Event|11|||
170388756|NCT03290131|615761118|FG000|Overall Study|Withdrawal by Subject|18|||
170388757|NCT03290131|615761119|FG001|Overall Study|Withdrawal by Subject|13|||
170388758|NCT03290131|615761120|FG002|Overall Study|Withdrawal by Subject|8|||
170388759|NCT03290131|615761118|FG000|Overall Study|MS Relapse|2|||
170388760|NCT03290131|615761119|FG001|Overall Study|MS Relapse|1|||
170388761|NCT03290131|615761120|FG002|Overall Study|MS Relapse|0|||
170388762|NCT03290131|615761118|FG000|Overall Study|Unknown reason|0|||
170388763|NCT03290131|615761119|FG001|Overall Study|Unknown reason|1|||
170388764|NCT03290131|615761120|FG002|Overall Study|Unknown reason|0|||
170388765|NCT00465101|615761121|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
170388766|NCT00465101|615761121|FG000|Overall Study|Change in health precluded follow up|4|||
170388767|NCT00465101|615761121|FG000|Overall Study|Did not meet study criteria|4|||
170388768|NCT00465101|615761121|FG000|Overall Study|Lost to Follow-up|5|||
170388769|NCT00465101|615761121|FG000|Overall Study|Other|6|||
170388770|NCT00465101|615761121|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
170388771|NCT00465101|615761121|FG000|Overall Study|Patient postponed procedure|1|||
170388772|NCT00465101|615761121|FG000|Overall Study|Site closed due to IRB expiration|1|||
170388773|NCT00465101|615761121|FG000|Overall Study|Unable to obtain IRB approval|1|||
170388774|NCT00465101|615761121|FG000|Overall Study|Death|3|||
170388775|NCT00465101|615761121|FG000|Overall Study|Withdrawal by Subject|25|||
170388776|NCT00465101|615761121|FG000|Overall Study|Physician Decision|1|||
170388777|NCT00465101|615761121|FG000|Overall Study|Withdrew consent prior to procedure|3|||
170388778|NCT04629534|615761127|FG000|Overall Study|Physician Decision|1|||
170388779|NCT04629534|615761128|FG001|Overall Study|Physician Decision|0|||
170388780|NCT04629534|615761127|FG000|Overall Study|Protocol Violation|0|||
170388781|NCT04629534|615761128|FG001|Overall Study|Protocol Violation|2|||
170388782|NCT02190604|615761131|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388783|NCT02190604|615761132|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388784|NCT02190604|615761133|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388785|NCT02190604|615761134|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388786|NCT02190604|615761135|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388787|NCT02190604|615761136|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388788|NCT02190604|615761137|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388789|NCT02190604|615761138|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388790|NCT02190604|615761139|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388791|NCT02190604|615761140|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388792|NCT02190604|615761141|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388793|NCT02190604|615761142|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388794|NCT02190604|615761143|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388795|NCT02190604|615761144|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388796|NCT02190604|615761145|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
170388797|NCT02190604|615761146|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388798|NCT02190604|615761147|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388799|NCT02190604|615761148|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388800|NCT02190604|615761149|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
170388801|NCT02190604|615761131|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388802|NCT02190604|615761132|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388803|NCT02190604|615761133|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388804|NCT02190604|615761134|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388805|NCT02190604|615761135|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388806|NCT02190604|615761136|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388807|NCT02190604|615761137|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388808|NCT02190604|615761138|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388809|NCT02190604|615761139|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388810|NCT02190604|615761140|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388811|NCT02190604|615761141|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388812|NCT02190604|615761142|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388813|NCT02190604|615761143|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388814|NCT02190604|615761144|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
170388815|NCT02190604|615761145|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388816|NCT02190604|615761146|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388817|NCT02190604|615761147|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388818|NCT02190604|615761148|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388819|NCT02190604|615761149|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
170388820|NCT02797951|615761150|FG000|Overall Study|Adverse Event|4|||
170388821|NCT02797951|615761150|FG000|Overall Study|Death|1|||
170388822|NCT02797951|615761150|FG000|Overall Study|Lack of Efficacy|19|||
170388823|NCT02797951|615761150|FG000|Overall Study|Lost to Follow-up|4|||
170388824|NCT02797951|615761150|FG000|Overall Study|Physician Decision|6|||
170388825|NCT02797951|615761150|FG000|Overall Study|Withdrawal by Subject|15|||
170388826|NCT00814502|615761151|FG000|Overall Study|Adverse Event|1|||
170388827|NCT00814502|615761152|FG001|Overall Study|Adverse Event|0|||
170388828|NCT00814502|615761151|FG000|Overall Study|Withdrawal by Subject|0|||
170388829|NCT00814502|615761152|FG001|Overall Study|Withdrawal by Subject|2|||
170388830|NCT01901393|615761153|FG000|Overall Study|Adverse Event|1|||
170388831|NCT01901393|615761154|FG001|Overall Study|Adverse Event|0|||
170388832|NCT04626947|615761158|FG000|Overall Study|Study terminated|14|||
170388833|NCT03831282|615761161|FG000|Overall Study|Could not place sensor|1|||
170388834|NCT01694849|615761162|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
170388835|NCT01694849|615761163|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
170388836|NCT01694849|615761164|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
170388837|NCT01694849|615761162|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
170388838|NCT01694849|615761163|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
170388839|NCT01694849|615761164|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
170388840|NCT01694849|615761162|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
170388841|NCT01694849|615761163|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
170388842|NCT01694849|615761164|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
170388843|NCT01694849|615761162|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
170388844|NCT01694849|615761163|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
170388845|NCT01694849|615761164|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
170388846|NCT01694849|615761162|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
170388847|NCT01694849|615761163|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
170388848|NCT01694849|615761164|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
170388849|NCT01694849|615761162|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
170388850|NCT01694849|615761163|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
170388851|NCT01694849|615761164|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
170388852|NCT01694849|615761162|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
170388853|NCT01694849|615761163|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
170388854|NCT01694849|615761164|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
170388855|NCT01694849|615761162|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
170388856|NCT01694849|615761163|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
170388857|NCT01694849|615761164|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
170388858|NCT01012765|615761167|FG000|Treatment Period 1|Adverse Event|1|||
170388859|NCT01012765|615761168|FG001|Treatment Period 1|Adverse Event|0|||
170388860|NCT01012765|615761169|FG002|Treatment Period 1|Adverse Event|1|||
170388861|NCT01012765|615761170|FG003|Treatment Period 1|Adverse Event|0|||
170388862|NCT01012765|615761171|FG004|Treatment Period 1|Adverse Event|0|||
170388863|NCT01012765|615761172|FG005|Treatment Period 1|Adverse Event|0|||
170388864|NCT01012765|615761167|FG000|Treatment Period 1|Withdrawal by Subject|2|||
170388865|NCT01012765|615761168|FG001|Treatment Period 1|Withdrawal by Subject|0|||
170388866|NCT01012765|615761169|FG002|Treatment Period 1|Withdrawal by Subject|0|||
170388867|NCT01012765|615761170|FG003|Treatment Period 1|Withdrawal by Subject|0|||
170388868|NCT01012765|615761171|FG004|Treatment Period 1|Withdrawal by Subject|0|||
170388869|NCT01012765|615761172|FG005|Treatment Period 1|Withdrawal by Subject|0|||
170388870|NCT01012765|615761167|FG000|Treatment Period 1|Administrative problems|0|||
170388871|NCT01012765|615761168|FG001|Treatment Period 1|Administrative problems|0|||
170388872|NCT01012765|615761169|FG002|Treatment Period 1|Administrative problems|1|||
170388873|NCT01012765|615761170|FG003|Treatment Period 1|Administrative problems|1|||
170388874|NCT01012765|615761171|FG004|Treatment Period 1|Administrative problems|1|||
170388875|NCT01012765|615761172|FG005|Treatment Period 1|Administrative problems|0|||
170388876|NCT01012765|615761167|FG000|Treatment Period 1|Protocol Violation|0|||
170388877|NCT01012765|615761168|FG001|Treatment Period 1|Protocol Violation|0|||
170388878|NCT01012765|615761169|FG002|Treatment Period 1|Protocol Violation|0|||
170388879|NCT01012765|615761170|FG003|Treatment Period 1|Protocol Violation|2|||
170388880|NCT01012765|615761171|FG004|Treatment Period 1|Protocol Violation|1|||
170388881|NCT01012765|615761172|FG005|Treatment Period 1|Protocol Violation|0|||
170388882|NCT01012765|615761167|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
170388883|NCT01012765|615761168|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
170388884|NCT01012765|615761169|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
170388885|NCT01012765|615761170|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
170388886|NCT01012765|615761171|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
170388887|NCT01012765|615761172|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
170388888|NCT01012765|615761167|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170388889|NCT01012765|615761168|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170388890|NCT01012765|615761169|FG002|Treatment Period 2|Withdrawal by Subject|1|||
170388891|NCT01012765|615761170|FG003|Treatment Period 2|Withdrawal by Subject|0|||
170388892|NCT01012765|615761171|FG004|Treatment Period 2|Withdrawal by Subject|1|||
170388893|NCT01012765|615761172|FG005|Treatment Period 2|Withdrawal by Subject|0|||
170388894|NCT01012765|615761167|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
170388895|NCT01012765|615761168|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
170388896|NCT01012765|615761169|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
170388897|NCT01012765|615761170|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
170388898|NCT01012765|615761171|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
170388899|NCT01012765|615761172|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
170388900|NCT01012765|615761167|FG000|Treatment Period 2|Adverse Event|0|||
170388901|NCT01012765|615761168|FG001|Treatment Period 2|Adverse Event|1|||
170388902|NCT01012765|615761169|FG002|Treatment Period 2|Adverse Event|1|||
170388903|NCT01012765|615761170|FG003|Treatment Period 2|Adverse Event|0|||
170388904|NCT01012765|615761171|FG004|Treatment Period 2|Adverse Event|0|||
170388905|NCT01012765|615761172|FG005|Treatment Period 2|Adverse Event|0|||
170388906|NCT01012765|615761167|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
170388907|NCT01012765|615761168|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
170388908|NCT01012765|615761169|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
170388909|NCT01012765|615761170|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
170388910|NCT01012765|615761171|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
170388911|NCT01012765|615761172|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
170388912|NCT01326312|615761173|FG000|Overall Study|Adverse Event|11|||
170388913|NCT01326312|615761174|FG001|Overall Study|Adverse Event|11|||
170388914|NCT01326312|615761175|FG002|Overall Study|Adverse Event|1|||
170388915|NCT01326312|615761173|FG000|Overall Study|Withdrawal by Subject|1|||
170388916|NCT01326312|615761174|FG001|Overall Study|Withdrawal by Subject|2|||
170388917|NCT01326312|615761175|FG002|Overall Study|Withdrawal by Subject|1|||
170388918|NCT01326312|615761173|FG000|Overall Study|Protocol Violation|0|||
170388919|NCT01326312|615761174|FG001|Overall Study|Protocol Violation|1|||
170388920|NCT01326312|615761175|FG002|Overall Study|Protocol Violation|0|||
170388921|NCT01326312|615761173|FG000|Overall Study|Lack of Efficacy|13|||
170388922|NCT01326312|615761174|FG001|Overall Study|Lack of Efficacy|7|||
170388923|NCT01326312|615761175|FG002|Overall Study|Lack of Efficacy|1|||
170388924|NCT01326312|615761173|FG000|Overall Study|Death|1|||
170388925|NCT01326312|615761174|FG001|Overall Study|Death|0|||
170388926|NCT01326312|615761175|FG002|Overall Study|Death|1|||
170388927|NCT01326312|615761173|FG000|Overall Study|progressive disease|0|||
170388928|NCT01326312|615761174|FG001|Overall Study|progressive disease|1|||
170388929|NCT01326312|615761175|FG002|Overall Study|progressive disease|1|||
170388930|NCT01326312|615761173|FG000|Overall Study|Study terminated by Sponsor|8|||
170388931|NCT01326312|615761174|FG001|Overall Study|Study terminated by Sponsor|32|||
170388932|NCT01326312|615761175|FG002|Overall Study|Study terminated by Sponsor|46|||
170388933|NCT01326312|615761173|FG000|Overall Study|Treatment arm terminated|19|||
170388934|NCT01326312|615761174|FG001|Overall Study|Treatment arm terminated|0|||
170388935|NCT01326312|615761175|FG002|Overall Study|Treatment arm terminated|0|||
170388936|NCT01326312|615761173|FG000|Overall Study|QTc > 500|0|||
170388937|NCT01326312|615761174|FG001|Overall Study|QTc > 500|1|||
170388938|NCT01326312|615761175|FG002|Overall Study|QTc > 500|0|||
170388939|NCT05146999|615761178|FG000|Overall Study|Withdrew consent|6|||
170388940|NCT05146999|615761179|FG001|Overall Study|Withdrew consent|1|||
170388941|NCT05146999|615761178|FG000|Overall Study|Lost to Follow-up|3|||
170388942|NCT05146999|615761179|FG001|Overall Study|Lost to Follow-up|2|||
170388943|NCT05146999|615761178|FG000|Overall Study|Other|1|||
170388944|NCT05146999|615761179|FG001|Overall Study|Other|3|||
170388945|NCT03319160|615761180|FG000|Overall Study|Data not available.|7|||
170388946|NCT04236986|615761183|FG000|Overall Study|Withdrawal by Subject|3|||
170388947|NCT04236986|615761184|FG001|Overall Study|Withdrawal by Subject|1|||
170388948|NCT01365182|615761187|FG000|Overall Study|Withdrawal by Subject|10|||
170388949|NCT01365182|615761188|FG001|Overall Study|Withdrawal by Subject|13|||
170388950|NCT01365182|615761189|FG002|Overall Study|Withdrawal by Subject|12|||
170388951|NCT00736840|615761190|FG000|Overall Study|Lost to Follow-up|13|||
170388952|NCT01411917|615761191|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
170388953|NCT01411917|615761192|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
170388954|NCT02815670|615761193|FG000|Overall Study|Prematurely discontinued of the trial|1|||
170388955|NCT01728194|615761194|FG000|Overall Study|Lost to Follow-up|4|||
170388956|NCT01728194|615761195|FG001|Overall Study|Lost to Follow-up|3|||
170388957|NCT01728194|615761194|FG000|Overall Study|Physician Decision|4|||
170388958|NCT01728194|615761195|FG001|Overall Study|Physician Decision|0|||
170388959|NCT01728194|615761194|FG000|Overall Study|Withdrawal by Subject|7|||
170388960|NCT01728194|615761195|FG001|Overall Study|Withdrawal by Subject|3|||
170388961|NCT01728194|615761194|FG000|Overall Study|Perceived Medication Side Effects|4|||
170388962|NCT01728194|615761195|FG001|Overall Study|Perceived Medication Side Effects|0|||
170388963|NCT01728194|615761194|FG000|Overall Study|Family Member Request|1|||
170388964|NCT01728194|615761195|FG001|Overall Study|Family Member Request|0|||
170388965|NCT01815099|615761198|FG000|Overall Study|Lack of Efficacy|1|||
170388966|NCT01815099|615761198|FG000|Overall Study|unable to attend study visits|1|||
170388967|NCT01475214|615761199|FG000|Overall Study|Lost to Follow-up|1|||
170388968|NCT01475214|615761200|FG001|Overall Study|Lost to Follow-up|0|||
170388969|NCT01475214|615761201|FG002|Overall Study|Lost to Follow-up|1|||
170388970|NCT01475214|615761199|FG000|Overall Study|Physician Decision|2|||
170388971|NCT01475214|615761200|FG001|Overall Study|Physician Decision|0|||
170388972|NCT01475214|615761201|FG002|Overall Study|Physician Decision|0|||
170388973|NCT01475214|615761199|FG000|Overall Study|Withdrawal by Subject|2|||
170388974|NCT01475214|615761200|FG001|Overall Study|Withdrawal by Subject|4|||
170388975|NCT01475214|615761201|FG002|Overall Study|Withdrawal by Subject|1|||
170388976|NCT00643851|615761202|FG000|Overall Study|Death|0|||
170388977|NCT00643851|615761203|FG001|Overall Study|Death|1|||
170388978|NCT00643851|615761204|FG002|Overall Study|Death|0|||
170388979|NCT00643851|615761202|FG000|Overall Study|Lack of Efficacy|0|||
170388980|NCT00643851|615761203|FG001|Overall Study|Lack of Efficacy|1|||
170388981|NCT00643851|615761204|FG002|Overall Study|Lack of Efficacy|0|||
170388982|NCT00643851|615761202|FG000|Overall Study|Adverse Event|2|||
170388983|NCT00643851|615761203|FG001|Overall Study|Adverse Event|6|||
170388984|NCT00643851|615761204|FG002|Overall Study|Adverse Event|6|||
170388985|NCT00643851|615761202|FG000|Overall Study|Lost to Follow-up|4|||
170388986|NCT00643851|615761203|FG001|Overall Study|Lost to Follow-up|6|||
170388987|NCT00643851|615761204|FG002|Overall Study|Lost to Follow-up|9|||
170388988|NCT00643851|615761202|FG000|Overall Study|Withdrawal by Subject|8|||
170388989|NCT00643851|615761203|FG001|Overall Study|Withdrawal by Subject|15|||
170388990|NCT00643851|615761204|FG002|Overall Study|Withdrawal by Subject|9|||
170388991|NCT00643851|615761202|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
170388992|NCT00643851|615761203|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
170388993|NCT00643851|615761204|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
170388994|NCT02576652|615761208|FG000|Overall Study|Withdrawal by Subject|2|||
170388995|NCT04806334|615761213|FG000|Overall Study|Withdrawal by Subject|1|||
170388996|NCT02811640|615761214|FG000|Overall Study|Technology malfunction|2|||
170388997|NCT03590613|615761225|FG000|Period 2, 4 Days|Physician Decision|0|||
170388998|NCT03590613|615761226|FG001|Period 2, 4 Days|Physician Decision|0|||
170388999|NCT03590613|615761227|FG002|Period 2, 4 Days|Physician Decision|0|||
170389000|NCT03590613|615761228|FG003|Period 2, 4 Days|Physician Decision|1|||
170389001|NCT04369742|615761233|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
170389002|NCT04369742|615761234|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
170389003|NCT04369742|615761233|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
170389004|NCT04369742|615761234|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
170389005|NCT03575975|615761235|FG000|Overall Study|Lost to Follow-up|1|||
170389006|NCT03575975|615761236|FG001|Overall Study|Lost to Follow-up|0|||
170389007|NCT03575975|615761237|FG002|Overall Study|Lost to Follow-up|0|||
170389008|NCT00951912|615761238|FG000|Overall Study|Lack of Efficacy|1|||
170389009|NCT00951912|615761239|FG001|Overall Study|Lack of Efficacy|0|||
170389010|NCT00951912|615761240|FG002|Overall Study|Lack of Efficacy|0|||
170389011|NCT00951912|615761238|FG000|Overall Study|Adverse Event|0|||
170389012|NCT00951912|615761239|FG001|Overall Study|Adverse Event|1|||
170389013|NCT00951912|615761240|FG002|Overall Study|Adverse Event|1|||
170389014|NCT00951912|615761238|FG000|Overall Study|Lost to Follow-up|2|||
170389015|NCT00951912|615761239|FG001|Overall Study|Lost to Follow-up|2|||
170389016|NCT00951912|615761240|FG002|Overall Study|Lost to Follow-up|0|||
170389017|NCT00951912|615761238|FG000|Overall Study|Physician Decision|1|||
170389018|NCT00951912|615761239|FG001|Overall Study|Physician Decision|0|||
170389019|NCT00951912|615761240|FG002|Overall Study|Physician Decision|1|||
170389020|NCT00951912|615761238|FG000|Overall Study|Withdrawal by Subject|1|||
170389021|NCT00951912|615761239|FG001|Overall Study|Withdrawal by Subject|1|||
170389022|NCT00951912|615761240|FG002|Overall Study|Withdrawal by Subject|0|||
170389023|NCT00951912|615761238|FG000|Overall Study|Other:Depression|1|||
170389024|NCT00951912|615761239|FG001|Overall Study|Other:Depression|0|||
170389025|NCT00951912|615761240|FG002|Overall Study|Other:Depression|0|||
170389026|NCT00951912|615761238|FG000|Overall Study|Other: Colon cancer|1|||
170389027|NCT00951912|615761239|FG001|Overall Study|Other: Colon cancer|0|||
170389028|NCT00951912|615761240|FG002|Overall Study|Other: Colon cancer|0|||
170389029|NCT00951912|615761238|FG000|Overall Study|Other: Stroke|0|||
170389030|NCT00951912|615761239|FG001|Overall Study|Other: Stroke|1|||
170389031|NCT00951912|615761240|FG002|Overall Study|Other: Stroke|0|||
170389032|NCT00129220|615761242|FG000|Study Period II|Adverse Event|9|||
170389033|NCT00129220|615761243|FG001|Study Period II|Adverse Event|5|||
170389034|NCT00129220|615761244|FG002|Study Period II|Adverse Event|7|||
170389035|NCT00129220|615761242|FG000|Study Period II|Lack of Efficacy|15|||
170389036|NCT00129220|615761243|FG001|Study Period II|Lack of Efficacy|1|||
170389037|NCT00129220|615761244|FG002|Study Period II|Lack of Efficacy|28|||
170389038|NCT00129220|615761242|FG000|Study Period II|Entry Criteria Not Met|2|||
170389039|NCT00129220|615761243|FG001|Study Period II|Entry Criteria Not Met|0|||
170389040|NCT00129220|615761244|FG002|Study Period II|Entry Criteria Not Met|2|||
170389041|NCT00129220|615761242|FG000|Study Period II|Protocol Violation|4|||
170389042|NCT00129220|615761243|FG001|Study Period II|Protocol Violation|2|||
170389043|NCT00129220|615761244|FG002|Study Period II|Protocol Violation|1|||
170389044|NCT00129220|615761242|FG000|Study Period II|Physician Decision|0|||
170389045|NCT00129220|615761243|FG001|Study Period II|Physician Decision|1|||
170389046|NCT00129220|615761244|FG002|Study Period II|Physician Decision|0|||
170389047|NCT00129220|615761242|FG000|Study Period II|Withdrawal by Subject|1|||
170389048|NCT00129220|615761243|FG001|Study Period II|Withdrawal by Subject|3|||
170389049|NCT00129220|615761244|FG002|Study Period II|Withdrawal by Subject|4|||
170389050|NCT00129220|615761242|FG000|Study Period II|Reason Not Specified|2|||
170389051|NCT00129220|615761243|FG001|Study Period II|Reason Not Specified|0|||
170389052|NCT00129220|615761244|FG002|Study Period II|Reason Not Specified|5|||
170389053|NCT00129220|615761242|FG000|Study Period III|Adverse Event|1|||
170389054|NCT00129220|615761243|FG001|Study Period III|Adverse Event|0|||
170389055|NCT00129220|615761244|FG002|Study Period III|Adverse Event|3|||
170389056|NCT00129220|615761242|FG000|Study Period III|Protocol Violation|1|||
170389057|NCT00129220|615761243|FG001|Study Period III|Protocol Violation|1|||
170389058|NCT00129220|615761244|FG002|Study Period III|Protocol Violation|2|||
170389059|NCT00129220|615761242|FG000|Study Period III|Withdrawal by Subject|1|||
170389060|NCT00129220|615761243|FG001|Study Period III|Withdrawal by Subject|0|||
170389061|NCT00129220|615761244|FG002|Study Period III|Withdrawal by Subject|3|||
170389062|NCT00129220|615761242|FG000|Study Period III|Sponsor Decision|1|||
170389063|NCT00129220|615761243|FG001|Study Period III|Sponsor Decision|0|||
170389064|NCT00129220|615761244|FG002|Study Period III|Sponsor Decision|0|||
170389065|NCT00129220|615761242|FG000|Study Period III|Reason Not Specified|9|||
170389066|NCT00129220|615761243|FG001|Study Period III|Reason Not Specified|0|||
170389067|NCT00129220|615761244|FG002|Study Period III|Reason Not Specified|2|||
170389068|NCT01383317|615761246|FG000|Overall Study|Lost to Follow-up|2|||
170389069|NCT01383317|615761247|FG001|Overall Study|Lost to Follow-up|1|||
170389070|NCT01383317|615761246|FG000|Overall Study|Death|1|||
170389071|NCT01383317|615761247|FG001|Overall Study|Death|0|||
170389072|NCT01383317|615761246|FG000|Overall Study|Adverse Event|0|||
170389073|NCT01383317|615761247|FG001|Overall Study|Adverse Event|1|||
170389074|NCT02173158|615761248|FG000|Efficacy Phase|Adverse Event|1|||
170389075|NCT01377194|615761250|FG000|Overall Study|Adverse Event|3|||
170389076|NCT01377194|615761251|FG001|Overall Study|Adverse Event|12|||
170389077|NCT01377194|615761252|FG002|Overall Study|Adverse Event|19|||
170389078|NCT01377194|615761250|FG000|Overall Study|Lack of Efficacy|3|||
170389079|NCT01377194|615761251|FG001|Overall Study|Lack of Efficacy|3|||
170389080|NCT01377194|615761252|FG002|Overall Study|Lack of Efficacy|3|||
170389081|NCT01377194|615761250|FG000|Overall Study|Protocol Violation|4|||
170389082|NCT01377194|615761251|FG001|Overall Study|Protocol Violation|10|||
170389083|NCT01377194|615761252|FG002|Overall Study|Protocol Violation|6|||
170389084|NCT01377194|615761250|FG000|Overall Study|Withdrawal by Subject|8|||
170389085|NCT01377194|615761251|FG001|Overall Study|Withdrawal by Subject|10|||
170389086|NCT01377194|615761252|FG002|Overall Study|Withdrawal by Subject|7|||
170389087|NCT01377194|615761250|FG000|Overall Study|Lost to Follow-up|14|||
170389088|NCT01377194|615761251|FG001|Overall Study|Lost to Follow-up|8|||
170389089|NCT01377194|615761252|FG002|Overall Study|Lost to Follow-up|11|||
170389090|NCT00422227|615761253|FG000|Overall Study|Adverse Event|3|||
170389091|NCT00422227|615761254|FG001|Overall Study|Adverse Event|8|||
170389092|NCT00422227|615761253|FG000|Overall Study|Lost to Follow-up|1|||
170389093|NCT00422227|615761254|FG001|Overall Study|Lost to Follow-up|3|||
170389094|NCT00422227|615761253|FG000|Overall Study|Withdrawal by Subject|0|||
170389095|NCT00422227|615761254|FG001|Overall Study|Withdrawal by Subject|4|||
170389096|NCT01207427|615761255|FG000|Double-blind Treatment Period|Adverse Event|0|||
170389097|NCT01207427|615761256|FG001|Double-blind Treatment Period|Adverse Event|1|||
170389098|NCT01207427|615761257|FG002|Double-blind Treatment Period|Adverse Event|0|||
170389099|NCT01207427|615761255|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
170389100|NCT01207427|615761256|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
170389101|NCT01207427|615761257|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
170389102|NCT01207427|615761255|FG000|Double-blind Treatment Period|Protocol Violation|2|||
170389103|NCT01207427|615761256|FG001|Double-blind Treatment Period|Protocol Violation|1|||
170389104|NCT01207427|615761257|FG002|Double-blind Treatment Period|Protocol Violation|1|||
170398866|NCT05004181|615798318|FG006|Overall Study|Death|1|||
170389105|NCT01207427|615761255|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
170389106|NCT01207427|615761256|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
170389107|NCT01207427|615761257|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170389108|NCT01190839|615761258|FG000|Overall Study|Adverse Event|32|||
170389109|NCT01190839|615761259|FG001|Overall Study|Adverse Event|41|||
170389110|NCT01190839|615761258|FG000|Overall Study|Protocol Violation|2|||
170389111|NCT01190839|615761259|FG001|Overall Study|Protocol Violation|2|||
170389112|NCT01190839|615761258|FG000|Overall Study|Lost to Follow-up|7|||
170389113|NCT01190839|615761259|FG001|Overall Study|Lost to Follow-up|1|||
170389114|NCT01190839|615761258|FG000|Overall Study|Death|1|||
170389115|NCT01190839|615761259|FG001|Overall Study|Death|0|||
170389116|NCT01190839|615761258|FG000|Overall Study|Trial stopped by Sponsor|71|||
170389117|NCT01190839|615761259|FG001|Overall Study|Trial stopped by Sponsor|68|||
170389118|NCT01190839|615761258|FG000|Overall Study|Undefined|35|||
170389119|NCT01190839|615761259|FG001|Overall Study|Undefined|31|||
170389120|NCT01190839|615761258|FG000|Overall Study|Randomized but not treated|2|||
170389121|NCT01190839|615761259|FG001|Overall Study|Randomized but not treated|4|||
170389122|NCT01977573|615761262|FG000|Overall Study|Adverse Event|7|||
170389123|NCT01977573|615761263|FG001|Overall Study|Adverse Event|0|||
170389124|NCT01977573|615761264|FG002|Overall Study|Adverse Event|2|||
170389125|NCT01977573|615761265|FG003|Overall Study|Adverse Event|1|||
170389126|NCT01977573|615761262|FG000|Overall Study|Lost to Follow-up|1|||
170389127|NCT01977573|615761263|FG001|Overall Study|Lost to Follow-up|0|||
170389128|NCT01977573|615761264|FG002|Overall Study|Lost to Follow-up|0|||
170389129|NCT01977573|615761265|FG003|Overall Study|Lost to Follow-up|1|||
170389130|NCT01977573|615761262|FG000|Overall Study|Physician Decision|1|||
170389131|NCT01977573|615761263|FG001|Overall Study|Physician Decision|0|||
170389132|NCT01977573|615761264|FG002|Overall Study|Physician Decision|0|||
170389133|NCT01977573|615761265|FG003|Overall Study|Physician Decision|0|||
170389134|NCT01977573|615761262|FG000|Overall Study|Protocol Violation|3|||
170389135|NCT01977573|615761263|FG001|Overall Study|Protocol Violation|1|||
170389136|NCT01977573|615761264|FG002|Overall Study|Protocol Violation|0|||
170389137|NCT01977573|615761265|FG003|Overall Study|Protocol Violation|0|||
170389138|NCT01977573|615761262|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
170389139|NCT01977573|615761263|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
170389140|NCT01977573|615761264|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
170389141|NCT01977573|615761265|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
170389142|NCT01977573|615761262|FG000|Overall Study|Withdrawal by Subject|6|||
170389143|NCT01977573|615761263|FG001|Overall Study|Withdrawal by Subject|1|||
170389144|NCT01977573|615761264|FG002|Overall Study|Withdrawal by Subject|1|||
170389145|NCT01977573|615761265|FG003|Overall Study|Withdrawal by Subject|1|||
170389146|NCT03044730|615761268|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
170389147|NCT03044730|615761268|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
170389148|NCT03044730|615761268|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
170389149|NCT03044730|615761268|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
170389150|NCT03044730|615761268|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
170389151|NCT03044730|615761268|FG000|Cycles 4 and Beyond|Adverse Event|1|||
170389152|NCT03044730|615761268|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
170389153|NCT03044730|615761268|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
170389154|NCT03044730|615761268|FG000|On Follow-up for 2 Years|Death|17|||
170389155|NCT00950755|615761272|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
170389156|NCT00950755|615761272|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
170389157|NCT00950755|615761272|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
170389158|NCT00950755|615761272|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
170389159|NCT00950755|615761272|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
170389160|NCT00950755|615761272|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
170389161|NCT00950755|615761272|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
170389162|NCT00950755|615761272|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
170389163|NCT00950755|615761272|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
170389164|NCT00950755|615761272|FG000|Long-Term Follow-Up|Death|8|||
170389165|NCT00508820|615761276|FG000|Overall Study|Adverse Event|6|||
170389166|NCT00508820|615761277|FG001|Overall Study|Adverse Event|10|||
170389167|NCT00508820|615761276|FG000|Overall Study|Death|6|||
170389168|NCT00508820|615761277|FG001|Overall Study|Death|8|||
170389169|NCT00508820|615761276|FG000|Overall Study|Lost to Follow-up|1|||
170389170|NCT00508820|615761277|FG001|Overall Study|Lost to Follow-up|1|||
170389171|NCT00508820|615761276|FG000|Overall Study|Physician Decision|8|||
170389172|NCT00508820|615761277|FG001|Overall Study|Physician Decision|2|||
170389173|NCT00508820|615761276|FG000|Overall Study|Pregnancy|0|||
170389174|NCT00508820|615761277|FG001|Overall Study|Pregnancy|2|||
170389175|NCT00508820|615761276|FG000|Overall Study|Protocol Violation|2|||
170389176|NCT00508820|615761277|FG001|Overall Study|Protocol Violation|0|||
170389177|NCT00508820|615761276|FG000|Overall Study|Withdrawal by Subject|10|||
170389178|NCT00508820|615761277|FG001|Overall Study|Withdrawal by Subject|12|||
170389179|NCT00508820|615761276|FG000|Overall Study|Other|11|||
170389180|NCT00508820|615761277|FG001|Overall Study|Other|2|||
170389181|NCT00508820|615761276|FG000|Overall Study|Noncompliance|1|||
170389182|NCT00508820|615761277|FG001|Overall Study|Noncompliance|0|||
170389183|NCT00508820|615761276|FG000|Overall Study|Requirement for alternative therapy|7|||
170389184|NCT00508820|615761277|FG001|Overall Study|Requirement for alternative therapy|15|||
170389185|NCT00508820|615761276|FG000|Overall Study|Protocol-specified Criteria|3|||
170389186|NCT00508820|615761277|FG001|Overall Study|Protocol-specified Criteria|12|||
170389187|NCT02513732|615762946|FG000|Overall Study|Lost to Follow-up|11|||
170389188|NCT02513732|615762946|FG000|Overall Study|Death|9|||
170389189|NCT02513732|615762946|FG000|Overall Study|Changing hospital|2|||
170389190|NCT00467051|615762947|FG000|Overall Study|Adverse Event|2|||
170389191|NCT03575806|615762953|FG000|Overall Study|Withdrawal by Subject|0|||
170389192|NCT03575806|615762954|FG001|Overall Study|Withdrawal by Subject|2|||
170389193|NCT03575806|615762953|FG000|Overall Study|Protocol Violation|0|||
170389194|NCT03575806|615762954|FG001|Overall Study|Protocol Violation|2|||
170389195|NCT00869362|615762958|FG000|Overall Study|Death|0|||
170389196|NCT00869362|615762959|FG001|Overall Study|Death|2|||
170389197|NCT00869362|615762958|FG000|Overall Study|Lost to Follow-up|1|||
170389198|NCT00869362|615762959|FG001|Overall Study|Lost to Follow-up|3|||
170389199|NCT02147132|615762960|FG000|Overall Study|Lost to Follow-up|1|||
170389200|NCT02147132|615762961|FG001|Overall Study|Lost to Follow-up|0|||
170389201|NCT02147132|615762962|FG002|Overall Study|Lost to Follow-up|0|||
170389202|NCT02147132|615762963|FG003|Overall Study|Lost to Follow-up|0|||
170389203|NCT01548573|615762966|FG000|Overall Study|Death|3|||
170389204|NCT01548573|615762966|FG000|Overall Study|Withdrawal by Subject|2|||
170389205|NCT01366846|615762967|FG000|Overall Study|Withdrawal by Subject|2|||
170389206|NCT01366846|615762968|FG001|Overall Study|Withdrawal by Subject|0|||
170389207|NCT01366846|615762969|FG002|Overall Study|Withdrawal by Subject|0|||
170389208|NCT01366846|615762970|FG003|Overall Study|Withdrawal by Subject|0|||
170389209|NCT01366846|615762967|FG000|Overall Study|Communication Difficulties|1|||
170389210|NCT01366846|615762968|FG001|Overall Study|Communication Difficulties|4|||
170389211|NCT01366846|615762969|FG002|Overall Study|Communication Difficulties|0|||
170389212|NCT01366846|615762970|FG003|Overall Study|Communication Difficulties|1|||
170389213|NCT01366846|615762967|FG000|Overall Study|Scheduling Conflicts|0|||
170389214|NCT01366846|615762968|FG001|Overall Study|Scheduling Conflicts|0|||
170389215|NCT01366846|615762969|FG002|Overall Study|Scheduling Conflicts|1|||
170389216|NCT01366846|615762970|FG003|Overall Study|Scheduling Conflicts|0|||
170389217|NCT00290511|615762971|FG000|Overall Study|Adverse Event|1|||
170389218|NCT00290511|615762971|FG000|Overall Study|Death|1|||
170389219|NCT00290511|615762971|FG000|Overall Study|Physician Decision|1|||
170389220|NCT00290511|615762971|FG000|Overall Study|Withdrawal by Subject|1|||
170389221|NCT04341727|615762976|FG000|Overall Study|Withdrawal by Subject|0|||
170389222|NCT04341727|615762977|FG001|Overall Study|Withdrawal by Subject|0|||
170389223|NCT04341727|615762978|FG002|Overall Study|Withdrawal by Subject|1|||
170389224|NCT04341727|615762979|FG003|Overall Study|Withdrawal by Subject|0|||
170389225|NCT04341727|615762976|FG000|Overall Study|Lost to Follow-up|0|||
170389226|NCT04341727|615762977|FG001|Overall Study|Lost to Follow-up|0|||
170389227|NCT04341727|615762978|FG002|Overall Study|Lost to Follow-up|0|||
170389228|NCT04341727|615762979|FG003|Overall Study|Lost to Follow-up|1|||
170389229|NCT00447265|615762980|FG000|Overall Study|Physician Decision|1|||
170389230|NCT00447265|615762981|FG001|Overall Study|Physician Decision|0|||
170389231|NCT00503035|615762982|FG000|Overall Study|Lost to Follow-up|2|||
170389232|NCT00503035|615762982|FG000|Overall Study|Physician Decision|3|||
170389233|NCT00503035|615762982|FG000|Overall Study|Ineligible|15|||
170389234|NCT04311411|615762985|FG000|Overall Study|Adverse Event|2|||
170389235|NCT04311411|615762986|FG001|Overall Study|Adverse Event|3|||
170389236|NCT04311411|615762987|FG002|Overall Study|Adverse Event|2|||
170389237|NCT04311411|615762985|FG000|Overall Study|Withdrawal by Subject|3|||
170389238|NCT04311411|615762986|FG001|Overall Study|Withdrawal by Subject|3|||
170389239|NCT04311411|615762987|FG002|Overall Study|Withdrawal by Subject|0|||
170389240|NCT02706327|615762991|FG000|Overall Study|Lost to Follow-up|1|||
170389241|NCT02706327|615762992|FG001|Overall Study|Lost to Follow-up|1|||
170389242|NCT02706327|615762993|FG002|Overall Study|Lost to Follow-up|2|||
170389243|NCT03113760|615763001|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
170389244|NCT03113760|615763002|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
170389245|NCT03113760|615763003|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
170389246|NCT03113760|615763004|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
170389247|NCT03113760|615763001|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
170389248|NCT03113760|615763002|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
170389249|NCT03113760|615763003|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
170389250|NCT03113760|615763004|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
170389251|NCT03113760|615763001|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
170389252|NCT03113760|615763002|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
170389253|NCT03113760|615763003|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
170389254|NCT03113760|615763004|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
170389255|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Adverse Event|4|||
170389256|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Adverse Event|3|||
170389257|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Adverse Event|0|||
170389258|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Adverse Event|0|||
170389259|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Death|24|||
170389260|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Death|9|||
170389261|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Death|0|||
170389262|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Death|0|||
170389263|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
170389264|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
170389265|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
170389266|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
170389267|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Physician Decision|4|||
170389268|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Physician Decision|1|||
170389269|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Physician Decision|0|||
170389270|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Physician Decision|0|||
170389271|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Progressive disease|1|||
170389272|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Progressive disease|0|||
170389273|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Progressive disease|0|||
170389274|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Progressive disease|0|||
170389275|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
170389276|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
170389277|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
170389278|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
170389279|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
170389280|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
170389281|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
170389282|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
170389283|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
170389284|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
170389285|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
170389286|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
170389287|NCT04579666|615763005|FG000|RTP (Up to Week 52)|Other|2|||
170389288|NCT04579666|615763006|FG001|RTP (Up to Week 52)|Other|0|||
170389289|NCT04579666|615763007|FG002|RTP (Up to Week 52)|Other|0|||
170389290|NCT04579666|615763008|FG003|RTP (Up to Week 52)|Other|0|||
170389291|NCT04579666|615763005|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
170389292|NCT04579666|615763006|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
170389293|NCT04579666|615763007|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
170389294|NCT04579666|615763008|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
170389295|NCT04579666|615763005|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
170389296|NCT04579666|615763006|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
170389297|NCT04579666|615763007|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
170389298|NCT04579666|615763008|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
170389299|NCT04579666|615763005|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
170389300|NCT04579666|615763006|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
170389301|NCT04579666|615763007|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
170389302|NCT04579666|615763008|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
170389303|NCT04579666|615763005|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
170389304|NCT04579666|615763006|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
170389305|NCT04579666|615763007|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
170389306|NCT04579666|615763008|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
170389307|NCT04579666|615763005|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
170389308|NCT04579666|615763006|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
170389309|NCT04579666|615763007|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
170389310|NCT04579666|615763008|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
170389311|NCT06045026|615763009|FG000|Overall Study|Lost to Follow-up|60|||
170389312|NCT06045026|615763009|FG000|Overall Study|Adverse Event|12|||
170389313|NCT06045026|615763009|FG000|Overall Study|Withdrawal by Subject|3|||
170389314|NCT06045026|615763009|FG000|Overall Study|Enrollment closed|1|||
170389315|NCT05450198|615763010|FG000|Overall Study|Withdrawal by Subject|1|||
170389316|NCT05450198|615763011|FG001|Overall Study|Withdrawal by Subject|1|||
170389317|NCT05450198|615763012|FG002|Overall Study|Withdrawal by Subject|2|||
170389318|NCT05450198|615763013|FG003|Overall Study|Withdrawal by Subject|0|||
170389319|NCT05450198|615763010|FG000|Overall Study|Lost to Follow-up|1|||
170389320|NCT05450198|615763011|FG001|Overall Study|Lost to Follow-up|0|||
170389321|NCT05450198|615763012|FG002|Overall Study|Lost to Follow-up|2|||
170389322|NCT05450198|615763013|FG003|Overall Study|Lost to Follow-up|1|||
170389323|NCT04511533|615763014|FG000|Treatment|Other|2|||
170389324|NCT04511533|615763014|FG000|Treatment|Withdrawal by Subject|11|||
170389325|NCT04511533|615763014|FG000|Treatment|Death|5|||
170389326|NCT04511533|615763014|FG000|Treatment|Physician Decision|1|||
170389327|NCT04511533|615763014|FG000|Treatment|Progressive Disease|61|||
170389328|NCT04511533|615763014|FG000|Follow-Up|Other|7|||
170389329|NCT04511533|615763014|FG000|Follow-Up|Withdrawal by Subject|5|||
170389330|NCT04511533|615763014|FG000|Follow-Up|Lost to Follow-up|2|||
170389331|NCT04511533|615763014|FG000|Follow-Up|Death|4|||
170389332|NCT01224171|615763015|FG000|Overall Study|Adverse Event|8|||
170389333|NCT01224171|615763016|FG001|Overall Study|Adverse Event|4|||
170389334|NCT01224171|615763015|FG000|Overall Study|Protocol Violation|0|||
170389335|NCT01224171|615763016|FG001|Overall Study|Protocol Violation|1|||
170389336|NCT01224171|615763015|FG000|Overall Study|Lack of Efficacy|5|||
170389337|NCT01224171|615763016|FG001|Overall Study|Lack of Efficacy|1|||
170389338|NCT01224171|615763015|FG000|Overall Study|Withdrawal of Consent|2|||
170389339|NCT01224171|615763016|FG001|Overall Study|Withdrawal of Consent|4|||
170389340|NCT01224171|615763015|FG000|Overall Study|Lost to Follow-up|0|||
170389341|NCT01224171|615763016|FG001|Overall Study|Lost to Follow-up|3|||
170389342|NCT01161173|615763017|FG000|Overall Study|Protocol Violation|13|||
170389343|NCT01161173|615763017|FG000|Overall Study|Lost to Follow-up|7|||
170389344|NCT01161173|615763017|FG000|Overall Study|Progressive Disease|82|||
170389345|NCT01161173|615763017|FG000|Overall Study|Withdrawal of Consent|5|||
170389346|NCT01161173|615763017|FG000|Overall Study|Unacceptable Toxicity|21|||
170389347|NCT01161173|615763017|FG000|Overall Study|Death|194|||
170389348|NCT01161173|615763017|FG000|Overall Study|End of Study|2|||
170389349|NCT01161173|615763017|FG000|Overall Study|Reasons Not Specified|23|||
170389350|NCT01911546|615763018|FG000|Overall Study|Lost to Follow-up|1|||
170389351|NCT01911546|615763018|FG000|Overall Study|Everolimus was discontinued|5|||
170389352|NCT01151085|615763020|FG000|Overall Study|Lost to Follow-up|31|||
170389353|NCT01151085|615763020|FG000|Overall Study|Protocol Violation|25|||
170389354|NCT01319422|615763021|FG000|Overall Study|Withdrawal by Subject|1|||
170389355|NCT01319422|615763022|FG001|Overall Study|Withdrawal by Subject|0|||
170389356|NCT02918968|615763025|FG000|1st Line AAT|Progressive disease|9|||
170389357|NCT02918968|615763026|FG001|1st Line AAT|Progressive disease|4|||
170389358|NCT02918968|615763025|FG000|1st Line AAT|Adverse Event|12|||
170389359|NCT02918968|615763026|FG001|1st Line AAT|Adverse Event|3|||
170389360|NCT02918968|615763025|FG000|1st Line AAT|Physician Decision|4|||
170389361|NCT02918968|615763026|FG001|1st Line AAT|Physician Decision|2|||
170389362|NCT02918968|615763025|FG000|1st Line AAT|Withdrawal by Subject|2|||
170389363|NCT02918968|615763026|FG001|1st Line AAT|Withdrawal by Subject|1|||
170389364|NCT02918968|615763025|FG000|1st Line AAT|Lost to Follow-up|0|||
170389365|NCT02918968|615763026|FG001|1st Line AAT|Lost to Follow-up|1|||
170389366|NCT02918968|615763025|FG000|1st Line AAT|Death|1|||
170389367|NCT02918968|615763026|FG001|1st Line AAT|Death|0|||
170389368|NCT02918968|615763025|FG000|1st Line AAT|Miscellaneous|1|||
170389369|NCT02918968|615763026|FG001|1st Line AAT|Miscellaneous|0|||
170389370|NCT02918968|615763025|FG000|2nd Line AAT|Progressive disease|21|||
170389371|NCT02918968|615763026|FG001|2nd Line AAT|Progressive disease|3|||
170389372|NCT02918968|615763025|FG000|2nd Line AAT|Adverse Event|2|||
170389373|NCT02918968|615763026|FG001|2nd Line AAT|Adverse Event|5|||
170389374|NCT02918968|615763025|FG000|2nd Line AAT|Physician Decision|0|||
170389375|NCT02918968|615763026|FG001|2nd Line AAT|Physician Decision|1|||
170389376|NCT02918968|615763025|FG000|2nd Line AAT|Withdrawal by Subject|2|||
170389377|NCT02918968|615763026|FG001|2nd Line AAT|Withdrawal by Subject|2|||
170389378|NCT02918968|615763025|FG000|2nd Line AAT|Death|0|||
170389379|NCT02918968|615763026|FG001|2nd Line AAT|Death|1|||
170389380|NCT00423137|615763031|FG000|Overall Study|Lost to Follow-up|0|||
170389381|NCT00423137|615763032|FG001|Overall Study|Lost to Follow-up|0|||
170389382|NCT00423137|615763033|FG002|Overall Study|Lost to Follow-up|1|||
170389383|NCT00423137|615763034|FG003|Overall Study|Lost to Follow-up|0|||
170389384|NCT00423137|615763031|FG000|Overall Study|Protocol Violation|0|||
170389385|NCT00423137|615763032|FG001|Overall Study|Protocol Violation|0|||
170389386|NCT00423137|615763033|FG002|Overall Study|Protocol Violation|0|||
170389387|NCT00423137|615763034|FG003|Overall Study|Protocol Violation|1|||
170389388|NCT00423137|615763031|FG000|Overall Study|Adverse Event Study disease worse|1|||
170389389|NCT00423137|615763032|FG001|Overall Study|Adverse Event Study disease worse|0|||
170389390|NCT00423137|615763033|FG002|Overall Study|Adverse Event Study disease worse|3|||
170389391|NCT00423137|615763034|FG003|Overall Study|Adverse Event Study disease worse|1|||
170389392|NCT00423137|615763031|FG000|Overall Study|Adverse Event Other|0|||
170389393|NCT00423137|615763032|FG001|Overall Study|Adverse Event Other|0|||
170389394|NCT00423137|615763033|FG002|Overall Study|Adverse Event Other|2|||
170389395|NCT00423137|615763034|FG003|Overall Study|Adverse Event Other|0|||
170389396|NCT00003526|615763035|FG000|Overall Study|Not evaluable|6|||
170389397|NCT02059265|615763036|FG000|Overall Study|Ineligible|4|||
170389398|NCT04196023|615763037|FG000|Overall Study|Withdrawal by Subject|0|||
170389399|NCT04196023|615763038|FG001|Overall Study|Withdrawal by Subject|1|||
170389400|NCT04196023|615763037|FG000|Overall Study|Adverse Event|3|||
170389401|NCT04196023|615763038|FG001|Overall Study|Adverse Event|1|||
170389402|NCT04196023|615763037|FG000|Overall Study|Lost to Follow-up|0|||
170389403|NCT04196023|615763038|FG001|Overall Study|Lost to Follow-up|1|||
170389404|NCT01590628|615763039|FG000|Overall Study|Death|2|||
170389405|NCT01590628|615763040|FG001|Overall Study|Death|0|||
170389406|NCT03099096|615763041|FG000|Overall Study|Adverse Event|1|||
170389407|NCT03099096|615763041|FG000|Overall Study|Physician Decision|1|||
170389408|NCT00998166|615763042|FG000|Overall Study|Early Study Termination|8|||
170389409|NCT00401726|615763044|FG000|Overall Study|Adverse Event|34|||
170389410|NCT00401726|615763045|FG001|Overall Study|Adverse Event|45|||
170389411|NCT00401726|615763044|FG000|Overall Study|Death|0|||
170389412|NCT00401726|615763045|FG001|Overall Study|Death|3|||
170389413|NCT00401726|615763044|FG000|Overall Study|Sponsor Request|0|||
170389414|NCT00401726|615763045|FG001|Overall Study|Sponsor Request|1|||
170389415|NCT00401726|615763044|FG000|Overall Study|Physician Decision|3|||
170389416|NCT00401726|615763045|FG001|Overall Study|Physician Decision|6|||
170389417|NCT00401726|615763044|FG000|Overall Study|Lost to Follow-up|23|||
170389418|NCT00401726|615763045|FG001|Overall Study|Lost to Follow-up|20|||
170389419|NCT00401726|615763044|FG000|Overall Study|Protocol Violation|6|||
170389420|NCT00401726|615763045|FG001|Overall Study|Protocol Violation|3|||
170389421|NCT00401726|615763044|FG000|Overall Study|Withdrawal by Subject|18|||
170389422|NCT00401726|615763045|FG001|Overall Study|Withdrawal by Subject|24|||
170389423|NCT00401726|615763044|FG000|Overall Study|Lack of Efficacy|4|||
170389424|NCT00401726|615763045|FG001|Overall Study|Lack of Efficacy|6|||
170389425|NCT00401726|615763044|FG000|Overall Study|Protocol Deviation|9|||
170389426|NCT00401726|615763045|FG001|Overall Study|Protocol Deviation|4|||
170389427|NCT04366258|615763046|FG000|Baseline Assessments|Screen Failure|21|||
170389428|NCT04366258|615763046|FG000|Baseline Assessments|Early Termination|3|||
170389429|NCT04113746|615763049|FG000|Overall Study|Lost to Follow-up|4|||
170389430|NCT04113746|615763050|FG001|Overall Study|Lost to Follow-up|4|||
170389431|NCT01050998|615763051|FG000|Overall Study|Adverse Event|1|||
170389432|NCT01050998|615763052|FG001|Overall Study|Adverse Event|0|||
170389433|NCT01050998|615763053|FG002|Overall Study|Adverse Event|1|||
170389434|NCT01050998|615763054|FG003|Overall Study|Adverse Event|0|||
170389435|NCT01050998|615763055|FG004|Overall Study|Adverse Event|2|||
170389436|NCT01050998|615763051|FG000|Overall Study|Withdrawal by Subject|0|||
170389437|NCT01050998|615763052|FG001|Overall Study|Withdrawal by Subject|0|||
170389438|NCT01050998|615763053|FG002|Overall Study|Withdrawal by Subject|0|||
170389439|NCT01050998|615763054|FG003|Overall Study|Withdrawal by Subject|1|||
170389440|NCT01050998|615763055|FG004|Overall Study|Withdrawal by Subject|3|||
170389441|NCT01050998|615763051|FG000|Overall Study|Other|3|||
170389442|NCT01050998|615763052|FG001|Overall Study|Other|2|||
170389443|NCT01050998|615763053|FG002|Overall Study|Other|1|||
170389444|NCT01050998|615763054|FG003|Overall Study|Other|1|||
170389445|NCT01050998|615763055|FG004|Overall Study|Other|5|||
170389446|NCT01050998|615763051|FG000|Overall Study|Data integrity issues|0|||
170389447|NCT01050998|615763052|FG001|Overall Study|Data integrity issues|0|||
170389448|NCT01050998|615763053|FG002|Overall Study|Data integrity issues|1|||
170389449|NCT01050998|615763054|FG003|Overall Study|Data integrity issues|1|||
170389450|NCT01050998|615763055|FG004|Overall Study|Data integrity issues|4|||
170389451|NCT00499694|615763068|FG000|Overall Study|Patient never received treatment.|1|||
170389452|NCT00674440|615763069|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
170389453|NCT00674440|615763069|FG000|Overall Study|did not have surgery, so unevaluable|7|||
170389454|NCT00674440|615763069|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
170389455|NCT02221882|615763073|FG000|Overall Study|Withdrawal by Subject|0|||
170389456|NCT02221882|615763074|FG001|Overall Study|Withdrawal by Subject|0|||
170389457|NCT02221882|615763075|FG002|Overall Study|Withdrawal by Subject|4|||
170389458|NCT02221882|615763076|FG003|Overall Study|Withdrawal by Subject|2|||
170389459|NCT02221882|615763077|FG004|Overall Study|Withdrawal by Subject|2|||
170389460|NCT02221882|615763078|FG005|Overall Study|Withdrawal by Subject|2|||
170389461|NCT02221882|615763073|FG000|Overall Study|Death|0|||
170389462|NCT02221882|615763074|FG001|Overall Study|Death|1|||
170389463|NCT02221882|615763075|FG002|Overall Study|Death|0|||
170389464|NCT02221882|615763076|FG003|Overall Study|Death|0|||
170389465|NCT02221882|615763077|FG004|Overall Study|Death|0|||
170389466|NCT02221882|615763078|FG005|Overall Study|Death|0|||
170389467|NCT00796367|615763079|FG000|Overall Study|Adverse Event|6|||
170389468|NCT00796367|615763080|FG001|Overall Study|Adverse Event|4|||
170389469|NCT00796367|615763081|FG002|Overall Study|Adverse Event|7|||
170389470|NCT00796367|615763079|FG000|Overall Study|Lost to Follow-up|5|||
170389471|NCT00796367|615763080|FG001|Overall Study|Lost to Follow-up|4|||
170389472|NCT00796367|615763081|FG002|Overall Study|Lost to Follow-up|21|||
170389473|NCT00796367|615763079|FG000|Overall Study|Withdrawal by Subject|9|||
170389474|NCT00796367|615763080|FG001|Overall Study|Withdrawal by Subject|11|||
170389475|NCT00796367|615763081|FG002|Overall Study|Withdrawal by Subject|12|||
170389476|NCT00796367|615763079|FG000|Overall Study|Lack of Efficacy|2|||
170389477|NCT00796367|615763080|FG001|Overall Study|Lack of Efficacy|1|||
170389478|NCT00796367|615763081|FG002|Overall Study|Lack of Efficacy|0|||
170389479|NCT00796367|615763079|FG000|Overall Study|non compliance|3|||
170389480|NCT00796367|615763080|FG001|Overall Study|non compliance|1|||
170389481|NCT00796367|615763081|FG002|Overall Study|non compliance|1|||
170389482|NCT00796367|615763079|FG000|Overall Study|Pregnancy|1|||
170389483|NCT00796367|615763080|FG001|Overall Study|Pregnancy|0|||
170389484|NCT00796367|615763081|FG002|Overall Study|Pregnancy|1|||
170389485|NCT00796367|615763079|FG000|Overall Study|Requirement for restricted medication|2|||
170389486|NCT00796367|615763080|FG001|Overall Study|Requirement for restricted medication|0|||
170389487|NCT00796367|615763081|FG002|Overall Study|Requirement for restricted medication|2|||
170389488|NCT00796367|615763079|FG000|Overall Study|other|2|||
170389489|NCT00796367|615763080|FG001|Overall Study|other|4|||
170389490|NCT00796367|615763081|FG002|Overall Study|other|3|||
170389491|NCT01463631|615763082|FG000|Overall Study|Withdrawal by Subject|0|||
170389492|NCT01463631|615763083|FG001|Overall Study|Withdrawal by Subject|0|||
170389493|NCT01463631|615763084|FG002|Overall Study|Withdrawal by Subject|0|||
170389494|NCT01463631|615763085|FG003|Overall Study|Withdrawal by Subject|1|||
170389495|NCT01463631|615763082|FG000|Overall Study|Death|0|||
170389496|NCT01463631|615763083|FG001|Overall Study|Death|0|||
170389497|NCT01463631|615763084|FG002|Overall Study|Death|1|||
170389498|NCT01463631|615763085|FG003|Overall Study|Death|0|||
170389499|NCT01463631|615763082|FG000|Overall Study|Progressive Disease|0|||
170389500|NCT01463631|615763083|FG001|Overall Study|Progressive Disease|0|||
170389501|NCT01463631|615763084|FG002|Overall Study|Progressive Disease|0|||
170389502|NCT01463631|615763085|FG003|Overall Study|Progressive Disease|5|||
170389503|NCT01458535|615764919|FG000|Overall Study|Other|0|||
170389504|NCT01458535|615764920|FG001|Overall Study|Other|0|||
170389505|NCT01458535|615764921|FG002|Overall Study|Other|0|||
170389506|NCT01458535|615764922|FG003|Overall Study|Other|0|||
170389507|NCT01458535|615764923|FG004|Overall Study|Other|1|||
170389508|NCT01458535|615764924|FG005|Overall Study|Other|1|||
170389509|NCT01458535|615764919|FG000|Overall Study|Withdrawal by Subject|0|||
170389510|NCT01458535|615764920|FG001|Overall Study|Withdrawal by Subject|0|||
170389511|NCT01458535|615764921|FG002|Overall Study|Withdrawal by Subject|2|||
170389512|NCT01458535|615764922|FG003|Overall Study|Withdrawal by Subject|0|||
170389513|NCT01458535|615764923|FG004|Overall Study|Withdrawal by Subject|1|||
170389514|NCT01458535|615764924|FG005|Overall Study|Withdrawal by Subject|1|||
170389515|NCT01458535|615764919|FG000|Overall Study|Lost to Follow-up|0|||
170389516|NCT01458535|615764920|FG001|Overall Study|Lost to Follow-up|2|||
170389517|NCT01458535|615764921|FG002|Overall Study|Lost to Follow-up|0|||
170389518|NCT01458535|615764922|FG003|Overall Study|Lost to Follow-up|3|||
170389519|NCT01458535|615764923|FG004|Overall Study|Lost to Follow-up|2|||
170389520|NCT01458535|615764924|FG005|Overall Study|Lost to Follow-up|2|||
170389521|NCT01458535|615764919|FG000|Overall Study|Adverse Event|0|||
170389522|NCT01458535|615764920|FG001|Overall Study|Adverse Event|0|||
170389523|NCT01458535|615764921|FG002|Overall Study|Adverse Event|0|||
170389524|NCT01458535|615764922|FG003|Overall Study|Adverse Event|1|||
170389525|NCT01458535|615764923|FG004|Overall Study|Adverse Event|0|||
170389526|NCT01458535|615764924|FG005|Overall Study|Adverse Event|0|||
170389527|NCT02842736|615764925|FG000|Overall Study|Lost to Follow-up|13|||
170389528|NCT02842736|615764925|FG000|Overall Study|Intervention for menstrual bleeding|17|||
170389529|NCT02842736|615764925|FG000|Overall Study|Withdrawal by Subject|4|||
170389530|NCT02842736|615764925|FG000|Overall Study|Pregnancy|3|||
170389531|NCT02842736|615764925|FG000|Overall Study|Hysterectomy for fibroids|2|||
170389532|NCT02842736|615764925|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
170389533|NCT02842736|615764925|FG000|Overall Study|IUD: Mirena|1|||
170389534|NCT02815540|615764936|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
170389535|NCT00474994|615764937|FG000|Overall Study|Patient Not treated|1|||
170389536|NCT00474994|615764937|FG000|Overall Study|Patient evaluable for toxicity only|3|||
170389537|NCT00474994|615764937|FG000|Overall Study|Patient found to be ineligible|1|||
170389538|NCT04887922|615764945|FG000|1st Randomization|Decided not to have surgery|0|||
170389539|NCT04887922|615764946|FG001|1st Randomization|Decided not to have surgery|1|||
170389540|NCT04887922|615764947|FG002|1st Randomization|Decided not to have surgery|0|||
170389541|NCT04887922|615764948|FG003|1st Randomization|Decided not to have surgery|0|||
170389542|NCT04887922|615764949|FG004|1st Randomization|Decided not to have surgery|0|||
170389543|NCT00953017|615764950|FG000|Overall Study|DId not show up for colonoscopy|4|||
170389544|NCT00953017|615764951|FG001|Overall Study|DId not show up for colonoscopy|4|||
170389545|NCT00953017|615764952|FG002|Overall Study|DId not show up for colonoscopy|5|||
170389546|NCT00953017|615764953|FG003|Overall Study|DId not show up for colonoscopy|4|||
170389547|NCT00953017|615764950|FG000|Overall Study|Incomplete data|1|||
170389548|NCT00953017|615764951|FG001|Overall Study|Incomplete data|1|||
170389549|NCT00953017|615764952|FG002|Overall Study|Incomplete data|0|||
170389550|NCT00953017|615764953|FG003|Overall Study|Incomplete data|0|||
170389551|NCT00953017|615764950|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
170389552|NCT00953017|615764951|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
170389553|NCT00953017|615764952|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
170389554|NCT00953017|615764953|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
170389555|NCT00953017|615764950|FG000|Overall Study|Brown stool prior to procedure|0|||
170389556|NCT00953017|615764951|FG001|Overall Study|Brown stool prior to procedure|0|||
170389557|NCT00953017|615764952|FG002|Overall Study|Brown stool prior to procedure|1|||
170389558|NCT00953017|615764953|FG003|Overall Study|Brown stool prior to procedure|0|||
170389559|NCT01473602|615764955|FG000|Overall Study|Adverse Event|1|||
170389560|NCT01473602|615764956|FG001|Overall Study|Adverse Event|2|||
170389561|NCT01473602|615764955|FG000|Overall Study|Death|0|||
170389562|NCT01473602|615764956|FG001|Overall Study|Death|1|||
170389563|NCT01473602|615764955|FG000|Overall Study|Lost to Follow-up|1|||
170389564|NCT01473602|615764956|FG001|Overall Study|Lost to Follow-up|1|||
170389565|NCT01473602|615764955|FG000|Overall Study|Withdrawal by Subject|5|||
170389566|NCT01473602|615764956|FG001|Overall Study|Withdrawal by Subject|4|||
170389567|NCT01473602|615764955|FG000|Overall Study|Physician Decision|1|||
170389568|NCT01473602|615764956|FG001|Overall Study|Physician Decision|0|||
170389569|NCT04854421|615764957|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
170389570|NCT04854421|615764958|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
170389571|NCT00726882|615764960|FG000|Overall Study|Withdrawal by Subject|5|||
170389572|NCT00726882|615764960|FG000|Overall Study|Lost to Follow-up|7|||
170389573|NCT00726882|615764960|FG000|Overall Study|Other|10|||
170389574|NCT00344968|615764961|FG000|Overall Study|Adverse Event|5|||
170389575|NCT00344968|615764962|FG001|Overall Study|Adverse Event|4|||
170389576|NCT00344968|615764963|FG002|Overall Study|Adverse Event|15|||
170389577|NCT00344968|615764961|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
170389578|NCT00344968|615764962|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
170389579|NCT00344968|615764963|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
170389580|NCT00344968|615764961|FG000|Overall Study|Protocol Violation|2|||
170389581|NCT00344968|615764962|FG001|Overall Study|Protocol Violation|2|||
170389582|NCT00344968|615764963|FG002|Overall Study|Protocol Violation|5|||
170389583|NCT00344968|615764961|FG000|Overall Study|Withdrawal by Subject|14|||
170389584|NCT00344968|615764962|FG001|Overall Study|Withdrawal by Subject|31|||
170389585|NCT00344968|615764963|FG002|Overall Study|Withdrawal by Subject|27|||
170389586|NCT00344968|615764961|FG000|Overall Study|Lost to Follow-up|24|||
170389587|NCT00344968|615764962|FG001|Overall Study|Lost to Follow-up|37|||
170389588|NCT00344968|615764963|FG002|Overall Study|Lost to Follow-up|37|||
170389589|NCT00344968|615764961|FG000|Overall Study|Death|11|||
170389590|NCT00344968|615764962|FG001|Overall Study|Death|27|||
170389591|NCT00344968|615764963|FG002|Overall Study|Death|31|||
170389592|NCT00344968|615764961|FG000|Overall Study|Other|0|||
170389593|NCT00344968|615764962|FG001|Overall Study|Other|1|||
170389594|NCT00344968|615764963|FG002|Overall Study|Other|0|||
170389595|NCT00594568|615764964|FG000|Initial Treatment|Adverse Event|51|||
170389596|NCT00594568|615764965|FG001|Initial Treatment|Adverse Event|121|||
170389597|NCT00594568|615764966|FG002|Initial Treatment|Adverse Event|144|||
170389598|NCT00594568|615764964|FG000|Initial Treatment|Death|6|||
170389599|NCT00594568|615764965|FG001|Initial Treatment|Death|11|||
170389600|NCT00594568|615764966|FG002|Initial Treatment|Death|15|||
170389601|NCT00594568|615764964|FG000|Initial Treatment|Lost to Follow-up|4|||
170389602|NCT00594568|615764965|FG001|Initial Treatment|Lost to Follow-up|1|||
170389603|NCT00594568|615764966|FG002|Initial Treatment|Lost to Follow-up|4|||
170389604|NCT00594568|615764964|FG000|Initial Treatment|Physician Decision|3|||
170389605|NCT00594568|615764965|FG001|Initial Treatment|Physician Decision|2|||
170389606|NCT00594568|615764966|FG002|Initial Treatment|Physician Decision|4|||
170389607|NCT00594568|615764964|FG000|Initial Treatment|Protocol Violation|2|||
170389608|NCT00594568|615764965|FG001|Initial Treatment|Protocol Violation|2|||
170389609|NCT00594568|615764966|FG002|Initial Treatment|Protocol Violation|5|||
170389610|NCT00594568|615764964|FG000|Initial Treatment|Withdrawal by Subject|25|||
170389611|NCT00594568|615764965|FG001|Initial Treatment|Withdrawal by Subject|31|||
170389612|NCT00594568|615764966|FG002|Initial Treatment|Withdrawal by Subject|46|||
170389613|NCT00594568|615764964|FG000|Initial Treatment|Sponsor decision|193|||
170389614|NCT00594568|615764965|FG001|Initial Treatment|Sponsor decision|142|||
170389615|NCT00594568|615764966|FG002|Initial Treatment|Sponsor decision|147|||
170389616|NCT00594568|615764964|FG000|Initial Treatment|Caregiver decision|21|||
170389617|NCT00594568|615764965|FG001|Initial Treatment|Caregiver decision|36|||
170389618|NCT00594568|615764966|FG002|Initial Treatment|Caregiver decision|36|||
170389619|NCT00594568|615764964|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
170389620|NCT00594568|615764965|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
170389621|NCT00594568|615764966|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
170389622|NCT00594568|615764964|FG000|Initial Treatment|Entry criteria exclusion|0|||
170389623|NCT00594568|615764965|FG001|Initial Treatment|Entry criteria exclusion|1|||
170389624|NCT00594568|615764966|FG002|Initial Treatment|Entry criteria exclusion|1|||
170389625|NCT00594568|615764964|FG000|Delayed Start|Death|0|||
170389626|NCT00594568|615764965|FG001|Delayed Start|Death|0|||
170389627|NCT00594568|615764966|FG002|Delayed Start|Death|1|||
170389628|NCT00594568|615764964|FG000|Delayed Start|Adverse Event|12|||
170389629|NCT00594568|615764965|FG001|Delayed Start|Adverse Event|2|||
170389630|NCT00594568|615764966|FG002|Delayed Start|Adverse Event|2|||
170389631|NCT00594568|615764964|FG000|Delayed Start|Withdrawal by Subject|4|||
170389632|NCT00594568|615764965|FG001|Delayed Start|Withdrawal by Subject|3|||
170389633|NCT00594568|615764966|FG002|Delayed Start|Withdrawal by Subject|0|||
170389634|NCT00594568|615764964|FG000|Delayed Start|Physician Decision|0|||
170389635|NCT00594568|615764965|FG001|Delayed Start|Physician Decision|0|||
170389636|NCT00594568|615764966|FG002|Delayed Start|Physician Decision|1|||
170389637|NCT00594568|615764964|FG000|Delayed Start|Lost to Follow-up|0|||
170389638|NCT00594568|615764965|FG001|Delayed Start|Lost to Follow-up|0|||
170389639|NCT00594568|615764966|FG002|Delayed Start|Lost to Follow-up|1|||
170389640|NCT00594568|615764964|FG000|Delayed Start|Caregiver Decision|5|||
170389641|NCT00594568|615764965|FG001|Delayed Start|Caregiver Decision|6|||
170389642|NCT00594568|615764966|FG002|Delayed Start|Caregiver Decision|2|||
170389643|NCT00594568|615764964|FG000|Delayed Start|Sponsor Decision|77|||
170389644|NCT00594568|615764965|FG001|Delayed Start|Sponsor Decision|66|||
170389645|NCT00594568|615764966|FG002|Delayed Start|Sponsor Decision|59|||
170389646|NCT00594568|615764964|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
170389647|NCT00594568|615764965|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
170389648|NCT00594568|615764966|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
170389649|NCT00594568|615764964|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
170389650|NCT00594568|615764965|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
170389651|NCT00594568|615764966|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
170389652|NCT00594568|615764964|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
170389653|NCT00594568|615764965|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
170389654|NCT00594568|615764966|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
170389655|NCT00594568|615764964|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
170389656|NCT00594568|615764965|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
170389657|NCT00594568|615764966|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
170389658|NCT00594568|615764964|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
170389659|NCT00594568|615764965|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
170389660|NCT00594568|615764966|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
170389661|NCT00594568|615764964|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
170389662|NCT00594568|615764965|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
170389663|NCT00594568|615764966|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
170389664|NCT01422876|615764967|FG000|Week 24|Lost to Follow-up|1|||
170389665|NCT01422876|615764968|FG001|Week 24|Lost to Follow-up|1|||
170389666|NCT01422876|615764969|FG002|Week 24|Lost to Follow-up|2|||
170389667|NCT01422876|615764970|FG003|Week 24|Lost to Follow-up|4|||
170389668|NCT01422876|615764971|FG004|Week 24|Lost to Follow-up|2|||
170389669|NCT01422876|615764972|FG005|Week 24|Lost to Follow-up|0|||
170389670|NCT01422876|615764973|FG006|Week 24|Lost to Follow-up|1|||
170389671|NCT01422876|615764974|FG007|Week 24|Lost to Follow-up|3|||
170389672|NCT01422876|615764975|FG008|Week 24|Lost to Follow-up|3|||
170389673|NCT01422876|615764976|FG009|Week 24|Lost to Follow-up|4|||
170389674|NCT01422876|615764967|FG000|Week 24|Consent withdrawn|5|||
170389675|NCT01422876|615764968|FG001|Week 24|Consent withdrawn|1|||
170389676|NCT01422876|615764969|FG002|Week 24|Consent withdrawn|3|||
170389677|NCT01422876|615764970|FG003|Week 24|Consent withdrawn|4|||
170389678|NCT01422876|615764971|FG004|Week 24|Consent withdrawn|5|||
170389679|NCT01422876|615764972|FG005|Week 24|Consent withdrawn|6|||
170389680|NCT01422876|615764973|FG006|Week 24|Consent withdrawn|5|||
170389681|NCT01422876|615764974|FG007|Week 24|Consent withdrawn|4|||
170389682|NCT01422876|615764975|FG008|Week 24|Consent withdrawn|3|||
170389683|NCT01422876|615764976|FG009|Week 24|Consent withdrawn|6|||
170389684|NCT01422876|615764967|FG000|Week 24|Death|0|||
170389685|NCT01422876|615764968|FG001|Week 24|Death|1|||
170389686|NCT01422876|615764969|FG002|Week 24|Death|0|||
170389687|NCT01422876|615764970|FG003|Week 24|Death|0|||
170389688|NCT01422876|615764971|FG004|Week 24|Death|0|||
170389689|NCT01422876|615764972|FG005|Week 24|Death|0|||
170389690|NCT01422876|615764973|FG006|Week 24|Death|0|||
170389691|NCT01422876|615764974|FG007|Week 24|Death|0|||
170389692|NCT01422876|615764975|FG008|Week 24|Death|0|||
170389693|NCT01422876|615764976|FG009|Week 24|Death|0|||
170389694|NCT01422876|615764967|FG000|Week 52|Lost to Follow-up|3|||
170389695|NCT01422876|615764968|FG001|Week 52|Lost to Follow-up|5|||
170389696|NCT01422876|615764969|FG002|Week 52|Lost to Follow-up|7|||
170389697|NCT01422876|615764970|FG003|Week 52|Lost to Follow-up|5|||
170389698|NCT01422876|615764971|FG004|Week 52|Lost to Follow-up|8|||
170389699|NCT01422876|615764972|FG005|Week 52|Lost to Follow-up|5|||
170389700|NCT01422876|615764973|FG006|Week 52|Lost to Follow-up|5|||
170389701|NCT01422876|615764974|FG007|Week 52|Lost to Follow-up|8|||
170389702|NCT01422876|615764975|FG008|Week 52|Lost to Follow-up|7|||
170389703|NCT01422876|615764976|FG009|Week 52|Lost to Follow-up|8|||
170389704|NCT01422876|615764967|FG000|Week 52|Consent withdrawn|9|||
170389705|NCT01422876|615764968|FG001|Week 52|Consent withdrawn|4|||
170389706|NCT01422876|615764969|FG002|Week 52|Consent withdrawn|6|||
170389707|NCT01422876|615764970|FG003|Week 52|Consent withdrawn|12|||
170389708|NCT01422876|615764971|FG004|Week 52|Consent withdrawn|7|||
170389709|NCT01422876|615764972|FG005|Week 52|Consent withdrawn|12|||
170389710|NCT01422876|615764973|FG006|Week 52|Consent withdrawn|10|||
170389711|NCT01422876|615764974|FG007|Week 52|Consent withdrawn|12|||
170389712|NCT01422876|615764975|FG008|Week 52|Consent withdrawn|13|||
170389713|NCT01422876|615764976|FG009|Week 52|Consent withdrawn|9|||
170389714|NCT01422876|615764967|FG000|Week 52|Death|0|||
170389715|NCT01422876|615764968|FG001|Week 52|Death|1|||
170389716|NCT01422876|615764969|FG002|Week 52|Death|0|||
170389717|NCT01422876|615764970|FG003|Week 52|Death|1|||
170389718|NCT01422876|615764971|FG004|Week 52|Death|0|||
170389719|NCT01422876|615764972|FG005|Week 52|Death|0|||
170389720|NCT01422876|615764973|FG006|Week 52|Death|1|||
170389721|NCT01422876|615764974|FG007|Week 52|Death|3|||
170389722|NCT01422876|615764975|FG008|Week 52|Death|1|||
170389723|NCT01422876|615764976|FG009|Week 52|Death|0|||
170389724|NCT02526017|615764979|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
170389725|NCT02526017|615764980|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
170389726|NCT02526017|615764981|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
170389727|NCT02526017|615764982|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
170389728|NCT02526017|615764983|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
170389729|NCT02526017|615764984|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
170389730|NCT02526017|615764985|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
170389731|NCT02526017|615764986|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
170389732|NCT02526017|615764987|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
170389733|NCT01976663|615764992|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
170389734|NCT01976663|615764992|FG000|Overall Study|Personal Reasons|6|||
170389735|NCT01976663|615764992|FG000|Overall Study|Withdrawal by Subject|4|||
170389736|NCT01976663|615764992|FG000|Overall Study|Screen Failure|3|||
170389737|NCT01976663|615764992|FG000|Overall Study|Adverse Event|2|||
170389738|NCT01976663|615764992|FG000|Overall Study|Lost to Follow-up|3|||
170389739|NCT00933543|615764994|FG000|Overall Study|Adverse Event|2|||
170389740|NCT00933543|615764995|FG001|Overall Study|Adverse Event|1|||
170389741|NCT00933543|615764994|FG000|Overall Study|Lost to Follow-up|0|||
170389742|NCT00933543|615764995|FG001|Overall Study|Lost to Follow-up|1|||
170389743|NCT00933543|615764994|FG000|Overall Study|Withdrawal by Subject|0|||
170389744|NCT00933543|615764995|FG001|Overall Study|Withdrawal by Subject|1|||
170389745|NCT00933543|615764994|FG000|Overall Study|Lack of Efficacy|0|||
170389746|NCT00933543|615764995|FG001|Overall Study|Lack of Efficacy|3|||
170389747|NCT00933543|615764994|FG000|Overall Study|Other|1|||
170389748|NCT00933543|615764995|FG001|Overall Study|Other|1|||
170389749|NCT04988035|615765001|FG000|Overall Study|Death|19|||
170389750|NCT04988035|615765002|FG001|Overall Study|Death|13|||
170389751|NCT04988035|615765001|FG000|Overall Study|Lost to Follow-up|12|||
170389752|NCT04988035|615765002|FG001|Overall Study|Lost to Follow-up|6|||
170389753|NCT04988035|615765001|FG000|Overall Study|Protocol Violation|0|||
170389754|NCT04988035|615765002|FG001|Overall Study|Protocol Violation|1|||
170389755|NCT04988035|615765001|FG000|Overall Study|Withdrawal by Subject|2|||
170389756|NCT04988035|615765002|FG001|Overall Study|Withdrawal by Subject|4|||
170389757|NCT04988035|615765001|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
170389758|NCT04988035|615765002|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
170389759|NCT03532048|615765003|FG000|Overall Study|Lost to Follow-up|12|||
170389760|NCT03532048|615765004|FG001|Overall Study|Lost to Follow-up|17|||
170389761|NCT03532048|615765003|FG000|Overall Study|Withdrawal by Subject|7|||
170389762|NCT03532048|615765004|FG001|Overall Study|Withdrawal by Subject|0|||
170389763|NCT01023815|615765005|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
170389764|NCT01023815|615765006|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
170389765|NCT01023815|615765007|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
170389766|NCT01023815|615765008|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
170389767|NCT01023815|615765005|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
170389768|NCT01023815|615765006|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
170389769|NCT01023815|615765007|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
170389770|NCT01023815|615765008|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
170389771|NCT01023815|615765005|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
170389772|NCT01023815|615765006|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
170389773|NCT01023815|615765007|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
170389774|NCT01023815|615765008|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
170389775|NCT01023815|615765005|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
170389776|NCT01023815|615765006|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
170389777|NCT01023815|615765007|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
170389778|NCT01023815|615765008|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
170389779|NCT01023815|615765005|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
170389780|NCT01023815|615765006|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
170389781|NCT01023815|615765007|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
170389782|NCT01023815|615765008|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
170389783|NCT03735849|615765015|FG000|Overall Study|Lost to Follow-up|1|||
170389784|NCT03735849|615765016|FG001|Overall Study|Lost to Follow-up|0|||
170389785|NCT03735849|615765017|FG002|Overall Study|Lost to Follow-up|0|||
170389786|NCT03735849|615765015|FG000|Overall Study|Participant unable to adhere to visit|1|||
170389787|NCT03735849|615765016|FG001|Overall Study|Participant unable to adhere to visit|0|||
170389788|NCT03735849|615765017|FG002|Overall Study|Participant unable to adhere to visit|0|||
170389789|NCT03735849|615765015|FG000|Overall Study|Not Randomized|0|||
170389790|NCT03735849|615765016|FG001|Overall Study|Not Randomized|0|||
170389791|NCT03735849|615765017|FG002|Overall Study|Not Randomized|4|||
170389792|NCT01977625|615765018|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
170389793|NCT01977625|615765019|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
170389794|NCT01977625|615765018|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
170389795|NCT01977625|615765019|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
170389796|NCT04585906|615765021|FG000|Overall Study|Lost to Follow-up|8|||
170389797|NCT04585906|615765022|FG001|Overall Study|Lost to Follow-up|5|||
170389798|NCT04246593|615765025|FG000|Overall Study|Withdrawal by Subject|14|||
170389799|NCT04246593|615765026|FG001|Overall Study|Withdrawal by Subject|13|||
170389800|NCT04246593|615765025|FG000|Overall Study|Lost to Follow-up|124|||
170389801|NCT04246593|615765026|FG001|Overall Study|Lost to Follow-up|71|||
170389802|NCT04246593|615765025|FG000|Overall Study|Moved out of area/became ineligible|3|||
170389803|NCT04246593|615765026|FG001|Overall Study|Moved out of area/became ineligible|1|||
170389804|NCT04246593|615765025|FG000|Overall Study|Reason unknown|4|||
170389805|NCT04246593|615765026|FG001|Overall Study|Reason unknown|2|||
170389806|NCT00808665|615765028|FG000|Overall Study|Withdrawal by Subject|1|||
170389807|NCT00808665|615765029|FG001|Overall Study|Withdrawal by Subject|0|||
170389808|NCT00808665|615765028|FG000|Overall Study|only required minimally invasive surgery|1|||
170389809|NCT00808665|615765029|FG001|Overall Study|only required minimally invasive surgery|0|||
170389810|NCT00808665|615765028|FG000|Overall Study|surgery cancelled|1|||
170389811|NCT00808665|615765029|FG001|Overall Study|surgery cancelled|0|||
170389812|NCT00808665|615765028|FG000|Overall Study|required an additional procedure|0|||
170389813|NCT00808665|615765029|FG001|Overall Study|required an additional procedure|1|||
170389814|NCT00808665|615765028|FG000|Overall Study|Physician Decision|3|||
170389815|NCT00808665|615765029|FG001|Overall Study|Physician Decision|1|||
170389816|NCT00808665|615765028|FG000|Overall Study|Medication stopped by resident|0|||
170389817|NCT00808665|615765029|FG001|Overall Study|Medication stopped by resident|1|||
170389818|NCT00634933|615765030|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
170389819|NCT00634933|615765031|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
170389820|NCT00634933|615765032|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
170389821|NCT00634933|615765033|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
170389822|NCT00634933|615765034|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
170389823|NCT00634933|615765030|FG000|Part A: Baseline to Week 24|Death|1|||
170389824|NCT00634933|615765031|FG001|Part A: Baseline to Week 24|Death|0|||
170389825|NCT00634933|615765032|FG002|Part A: Baseline to Week 24|Death|0|||
170389826|NCT00634933|615765033|FG003|Part A: Baseline to Week 24|Death|0|||
170389827|NCT00634933|615765034|FG004|Part A: Baseline to Week 24|Death|0|||
170389828|NCT00634933|615765030|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
170389829|NCT00634933|615765031|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
170389830|NCT00634933|615765032|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
170389831|NCT00634933|615765033|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
170389832|NCT00634933|615765034|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
170389833|NCT00634933|615765030|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
170389834|NCT00634933|615765031|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
170389835|NCT00634933|615765032|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
170389836|NCT00634933|615765033|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
170389837|NCT00634933|615765034|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
170389838|NCT00634933|615765030|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
170389839|NCT00634933|615765031|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
170389840|NCT00634933|615765032|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
170389841|NCT00634933|615765033|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
170389842|NCT00634933|615765034|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
170389843|NCT00634933|615765030|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
170389844|NCT00634933|615765031|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
170389845|NCT00634933|615765032|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
170389846|NCT00634933|615765033|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
170389847|NCT00634933|615765034|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
170389848|NCT00634933|615765030|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
170389849|NCT00634933|615765031|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
170389850|NCT00634933|615765032|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
170389851|NCT00634933|615765033|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
170389852|NCT00634933|615765034|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
170389853|NCT00634933|615765030|FG000|Part A: Baseline to Week 24|Other|1|||
170389854|NCT00634933|615765031|FG001|Part A: Baseline to Week 24|Other|8|||
170389855|NCT00634933|615765032|FG002|Part A: Baseline to Week 24|Other|5|||
170389856|NCT00634933|615765033|FG003|Part A: Baseline to Week 24|Other|0|||
170389857|NCT00634933|615765034|FG004|Part A: Baseline to Week 24|Other|0|||
170389858|NCT00634933|615765030|FG000|Between Part A and Part B|Physician Decision|0|||
170389859|NCT00634933|615765031|FG001|Between Part A and Part B|Physician Decision|1|||
170389860|NCT00634933|615765032|FG002|Between Part A and Part B|Physician Decision|0|||
170389861|NCT00634933|615765033|FG003|Between Part A and Part B|Physician Decision|0|||
170389862|NCT00634933|615765034|FG004|Between Part A and Part B|Physician Decision|0|||
170389863|NCT00634933|615765030|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
170389864|NCT00634933|615765031|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
170389865|NCT00634933|615765032|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
170389866|NCT00634933|615765033|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
170389867|NCT00634933|615765034|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
170389868|NCT00634933|615765030|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
170389869|NCT00634933|615765031|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
170389870|NCT00634933|615765032|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
170389871|NCT00634933|615765033|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
170389872|NCT00634933|615765034|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
170389873|NCT00634933|615765030|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
170389874|NCT00634933|615765031|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
170389875|NCT00634933|615765032|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
170389876|NCT00634933|615765033|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
170389877|NCT00634933|615765034|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
170389878|NCT00634933|615765030|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
170389879|NCT00634933|615765031|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
170389880|NCT00634933|615765032|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
170389881|NCT00634933|615765033|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
170389882|NCT00634933|615765034|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
170389883|NCT00634933|615765030|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
170389884|NCT00634933|615765031|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
170389885|NCT00634933|615765032|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
170389886|NCT00634933|615765033|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
170389887|NCT00634933|615765034|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
170389888|NCT00634933|615765030|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
170389889|NCT00634933|615765031|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
170389890|NCT00634933|615765032|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
170389891|NCT00634933|615765033|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
170389892|NCT00634933|615765034|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
170389893|NCT00634933|615765030|FG000|Part B: Week 24 to Week 52|Other|0|||
170389894|NCT00634933|615765031|FG001|Part B: Week 24 to Week 52|Other|0|||
170389895|NCT00634933|615765032|FG002|Part B: Week 24 to Week 52|Other|5|||
170389896|NCT00634933|615765033|FG003|Part B: Week 24 to Week 52|Other|0|||
170389897|NCT00634933|615765034|FG004|Part B: Week 24 to Week 52|Other|1|||
170389898|NCT00429026|615765035|FG000|Overall Study|Inevaluable for response.|40|||
170389899|NCT00976989|615765036|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
170389900|NCT00976989|615765037|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
170389901|NCT00976989|615765038|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
170389902|NCT00976989|615765036|FG000|Overall Study|Death|5|||
170389903|NCT00976989|615765037|FG001|Overall Study|Death|7|||
170389904|NCT00976989|615765038|FG002|Overall Study|Death|10|||
170389905|NCT00976989|615765036|FG000|Overall Study|Refused Treatment|4|||
170389906|NCT00976989|615765037|FG001|Overall Study|Refused Treatment|3|||
170389907|NCT00976989|615765038|FG002|Overall Study|Refused Treatment|5|||
170389908|NCT00976989|615765036|FG000|Overall Study|Failure to Return|2|||
170389909|NCT00976989|615765037|FG001|Overall Study|Failure to Return|1|||
170389910|NCT00976989|615765038|FG002|Overall Study|Failure to Return|0|||
170389911|NCT00976989|615765036|FG000|Overall Study|Recurrence of Disease|0|||
170389912|NCT00976989|615765037|FG001|Overall Study|Recurrence of Disease|1|||
170389913|NCT00976989|615765038|FG002|Overall Study|Recurrence of Disease|0|||
170389914|NCT00976989|615765036|FG000|Overall Study|Other|1|||
170389915|NCT00976989|615765037|FG001|Overall Study|Other|0|||
170389916|NCT00976989|615765038|FG002|Overall Study|Other|1|||
170389917|NCT00903357|615765039|FG000|First Intervention|Withdrawal by Subject|5|||
170389918|NCT00903357|615765040|FG001|First Intervention|Withdrawal by Subject|3|||
170389919|NCT00903357|615765039|FG000|First Intervention|Flu|0|||
170389920|NCT00903357|615765040|FG001|First Intervention|Flu|1|||
170389921|NCT00903357|615765039|FG000|Wash Out Period of 2 Weeks|Flu|0|||
170389922|NCT00903357|615765040|FG001|Wash Out Period of 2 Weeks|Flu|1|||
170389923|NCT00903357|615765039|FG000|Second Intervention|Lost to Follow-up|1|||
170389924|NCT00903357|615765040|FG001|Second Intervention|Lost to Follow-up|0|||
170389925|NCT02279888|615765042|FG000|Overall Study|Death|326|||
170389926|NCT02279888|615765042|FG000|Overall Study|Withdrawal by Subject|38|||
170389927|NCT02279888|615765042|FG000|Overall Study|Lost to Follow-up|21|||
170389928|NCT02279888|615765042|FG000|Overall Study|Physician Decision|62|||
170389929|NCT02279888|615765042|FG000|Overall Study|Subject Non-compliance|43|||
170389930|NCT02279888|615765042|FG000|Overall Study|Not implanted|14|||
170389931|NCT02279888|615765042|FG000|Overall Study|Visit not performed|26|||
170389932|NCT04668157|615765046|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
170389933|NCT04668157|615765047|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
170389934|NCT04668157|615765046|FG000|Treatment Period (52 Weeks)|Other|0|||
170389935|NCT04668157|615765047|FG001|Treatment Period (52 Weeks)|Other|2|||
170389936|NCT03958045|615765048|FG000|Overall Study|Withdrawal by Subject|1|||
170389937|NCT02283411|615765055|FG000|Overall Study|Withdrawal by Subject|3|||
170389938|NCT02283411|615765055|FG000|Overall Study|Screen Failed|28|||
170389939|NCT00383292|615765056|FG000|Overall Study|Adverse Event|4|||
170389940|NCT00383292|615765057|FG001|Overall Study|Adverse Event|1|||
170389941|NCT00383292|615765058|FG002|Overall Study|Adverse Event|2|||
170389942|NCT00383292|615765056|FG000|Overall Study|Death|3|||
170389943|NCT00383292|615765057|FG001|Overall Study|Death|3|||
170389944|NCT00383292|615765058|FG002|Overall Study|Death|3|||
170389945|NCT00383292|615765056|FG000|Overall Study|Physician Decision|4|||
170389946|NCT00383292|615765057|FG001|Overall Study|Physician Decision|0|||
170389947|NCT00383292|615765058|FG002|Overall Study|Physician Decision|1|||
170389948|NCT00383292|615765056|FG000|Overall Study|Withdrawal by Subject|3|||
170389949|NCT00383292|615765057|FG001|Overall Study|Withdrawal by Subject|2|||
170389950|NCT00383292|615765058|FG002|Overall Study|Withdrawal by Subject|2|||
170389951|NCT00383292|615765056|FG000|Overall Study|Other|1|||
170389952|NCT00383292|615765057|FG001|Overall Study|Other|0|||
170389953|NCT00383292|615765058|FG002|Overall Study|Other|0|||
170389954|NCT05437211|615765059|FG000|Overall Study|Patient's decision|1|||
170389955|NCT05437211|615765060|FG001|Overall Study|Patient's decision|1|||
170389956|NCT03282123|615765062|FG000|Overall Study|Withdrawal by Subject|5|||
170389957|NCT02243306|615765065|FG000|Overall Study|Adverse Event|0|||
170389958|NCT02243306|615765066|FG001|Overall Study|Adverse Event|1|||
170389959|NCT02243306|615765065|FG000|Overall Study|Other: Reached stopping criteria|0|||
170389960|NCT02243306|615765066|FG001|Overall Study|Other: Reached stopping criteria|1|||
170389961|NCT02243306|615765065|FG000|Overall Study|Physician Decision|0|||
170389962|NCT02243306|615765066|FG001|Overall Study|Physician Decision|1|||
170389963|NCT04095039|615765073|FG000|Overall Study|Withdrawal by Subject|2|||
170389964|NCT04095039|615765074|FG001|Overall Study|Withdrawal by Subject|16|||
170389965|NCT04095039|615765073|FG000|Overall Study|Transplanted|21|||
170389966|NCT04095039|615765074|FG001|Overall Study|Transplanted|24|||
170389967|NCT04095039|615765073|FG000|Overall Study|Transferred to Non-study Facility|47|||
170389968|NCT04095039|615765074|FG001|Overall Study|Transferred to Non-study Facility|44|||
170389969|NCT04095039|615765073|FG000|Overall Study|Withdrawal from internvention target|0|||
170389970|NCT04095039|615765074|FG001|Overall Study|Withdrawal from internvention target|2|||
170389971|NCT04095039|615765073|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
170389972|NCT04095039|615765074|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
170389973|NCT04095039|615765073|FG000|Overall Study|Cacliphylaxis|0|||
170389974|NCT04095039|615765074|FG001|Overall Study|Cacliphylaxis|1|||
170389975|NCT04095039|615765073|FG000|Overall Study|Pregnancy|1|||
170389976|NCT04095039|615765074|FG001|Overall Study|Pregnancy|0|||
170389977|NCT02370173|615765078|FG000|Overall Study|Protocol Violation|1|||
170389978|NCT02370173|615765079|FG001|Overall Study|Protocol Violation|1|||
170389979|NCT02370173|615765078|FG000|Overall Study|Withdrawal by Subject|2|||
170389980|NCT02370173|615765079|FG001|Overall Study|Withdrawal by Subject|2|||
170389981|NCT02309372|615765086|FG000|Overall Study|Lost to Follow-up|3|||
170389982|NCT02309372|615765087|FG001|Overall Study|Lost to Follow-up|2|||
170389983|NCT01731600|615765088|FG000|Overall Study|Adverse Event|2|||
170389984|NCT01731600|615765089|FG001|Overall Study|Adverse Event|0|||
170389985|NCT01731600|615765088|FG000|Overall Study|Withdrawal criteria|1|||
170389986|NCT01731600|615765089|FG001|Overall Study|Withdrawal criteria|0|||
170389987|NCT01731600|615765088|FG000|Overall Study|Other reasons|3|||
170389988|NCT01731600|615765089|FG001|Overall Study|Other reasons|0|||
170389989|NCT02441517|615765090|FG000|Overall Study|Lost to Follow-up|1|||
170389990|NCT02441517|615765090|FG000|Overall Study|Withdrawal by Subject|2|||
170389991|NCT02441517|615765090|FG000|Overall Study|Study Terminated by Sponsor|1|||
170389992|NCT01230489|615765091|FG000|Overall Study|Death|2|||
170389993|NCT01230489|615765091|FG000|Overall Study|Adverse Event|2|||
170389994|NCT01230489|615765091|FG000|Overall Study|Treatment modality changed|1|||
170389995|NCT00686894|615765092|FG000|Overall Study|Relapse|2|||
170389996|NCT00686894|615765092|FG000|Overall Study|Protocol Violation|4|||
170389997|NCT02451137|615765093|FG000|Overall Study|Randomized but not treated|19|||
170389998|NCT02451137|615765094|FG001|Overall Study|Randomized but not treated|27|||
170389999|NCT02451137|615765093|FG000|Overall Study|Adverse Event|43|||
170390000|NCT02451137|615765094|FG001|Overall Study|Adverse Event|42|||
170390001|NCT02451137|615765093|FG000|Overall Study|Lack of Efficacy|4|||
170390002|NCT02451137|615765094|FG001|Overall Study|Lack of Efficacy|9|||
170390003|NCT02451137|615765093|FG000|Overall Study|Participant decision:discontinue insulin|41|||
170390004|NCT02451137|615765094|FG001|Overall Study|Participant decision:discontinue insulin|43|||
170390005|NCT02451137|615765093|FG000|Overall Study|Hypoglycemia|2|||
170390006|NCT02451137|615765094|FG001|Overall Study|Hypoglycemia|1|||
170390007|NCT02451137|615765093|FG000|Overall Study|Investigator's decision|23|||
170390008|NCT02451137|615765094|FG001|Overall Study|Investigator's decision|19|||
170390009|NCT02451137|615765093|FG000|Overall Study|Lost to Follow-up|53|||
170390010|NCT02451137|615765094|FG001|Overall Study|Lost to Follow-up|61|||
170390011|NCT02451137|615765093|FG000|Overall Study|Physician Decision|6|||
170390012|NCT02451137|615765094|FG001|Overall Study|Physician Decision|5|||
170390013|NCT02451137|615765093|FG000|Overall Study|Sponsor decision|13|||
170390014|NCT02451137|615765094|FG001|Overall Study|Sponsor decision|25|||
170390015|NCT02451137|615765093|FG000|Overall Study|Withdrawal by Subject|40|||
170390016|NCT02451137|615765094|FG001|Overall Study|Withdrawal by Subject|63|||
170390017|NCT02451137|615765093|FG000|Overall Study|Other than specified above|2|||
170390018|NCT02451137|615765094|FG001|Overall Study|Other than specified above|3|||
170390019|NCT01300741|615766855|FG000|Overall Study|Lens deposits|1|||
170390020|NCT01300741|615766855|FG000|Overall Study|Lost to Follow-up|1|||
170390021|NCT01300741|615766855|FG000|Overall Study|Discomfort|1|||
170390022|NCT00463385|615766857|FG000|Overall Study|Other|4|||
170390023|NCT00463385|615766858|FG001|Overall Study|Other|3|||
170390024|NCT00463385|615766859|FG002|Overall Study|Other|6|||
170390025|NCT00463385|615766860|FG003|Overall Study|Other|4|||
170390026|NCT00463385|615766857|FG000|Overall Study|Adverse Event|5|||
170390027|NCT00463385|615766858|FG001|Overall Study|Adverse Event|8|||
170390028|NCT00463385|615766859|FG002|Overall Study|Adverse Event|4|||
170390029|NCT00463385|615766860|FG003|Overall Study|Adverse Event|2|||
170390030|NCT00463385|615766857|FG000|Overall Study|Lack of Efficacy|6|||
170390031|NCT00463385|615766858|FG001|Overall Study|Lack of Efficacy|6|||
170390032|NCT00463385|615766859|FG002|Overall Study|Lack of Efficacy|7|||
170390033|NCT00463385|615766860|FG003|Overall Study|Lack of Efficacy|9|||
170390034|NCT00463385|615766857|FG000|Overall Study|Withdrawal by Subject|3|||
170390035|NCT00463385|615766858|FG001|Overall Study|Withdrawal by Subject|3|||
170390036|NCT00463385|615766859|FG002|Overall Study|Withdrawal by Subject|3|||
170390037|NCT00463385|615766860|FG003|Overall Study|Withdrawal by Subject|4|||
170390038|NCT00463385|615766857|FG000|Overall Study|Lost to Follow-up|0|||
170390039|NCT00463385|615766858|FG001|Overall Study|Lost to Follow-up|0|||
170390040|NCT00463385|615766859|FG002|Overall Study|Lost to Follow-up|0|||
170390041|NCT00463385|615766860|FG003|Overall Study|Lost to Follow-up|1|||
170390042|NCT00463385|615766857|FG000|Overall Study|Death|2|||
170390043|NCT00463385|615766858|FG001|Overall Study|Death|1|||
170390044|NCT00463385|615766859|FG002|Overall Study|Death|2|||
170390045|NCT00463385|615766860|FG003|Overall Study|Death|0|||
170390046|NCT00463385|615766857|FG000|Overall Study|Missing|2|||
170390047|NCT00463385|615766858|FG001|Overall Study|Missing|0|||
170390048|NCT00463385|615766859|FG002|Overall Study|Missing|0|||
170390049|NCT00463385|615766860|FG003|Overall Study|Missing|2|||
170390050|NCT00463385|615766857|FG000|Overall Study|1 participant received commercial drug|0|||
170390051|NCT00463385|615766858|FG001|Overall Study|1 participant received commercial drug|1|||
170390052|NCT00463385|615766859|FG002|Overall Study|1 participant received commercial drug|0|||
170390053|NCT00463385|615766860|FG003|Overall Study|1 participant received commercial drug|0|||
170390054|NCT00449761|615766861|FG000|Overall Study|Disease progression|12|||
170390055|NCT00449761|615766861|FG000|Overall Study|Death|5|||
170390056|NCT00449761|615766861|FG000|Overall Study|New cancer therapy|1|||
170390057|NCT03246152|615766867|FG000|Overall Study|Lost to Follow-up|2|||
170390058|NCT03246152|615766867|FG000|Overall Study|Protocol Violation|1|||
170390059|NCT04145531|615766869|FG000|Part A|Adverse Event|2|||
170390060|NCT04145531|615766870|FG001|Part A|Adverse Event|12|||
170390061|NCT04145531|615766871|FG002|Part A|Adverse Event|6|||
170390062|NCT04145531|615766872|FG003|Part A|Adverse Event|0|||
170390063|NCT04145531|615766869|FG000|Part A|Death|1|||
170390064|NCT04145531|615766870|FG001|Part A|Death|2|||
170390065|NCT04145531|615766871|FG002|Part A|Death|0|||
170390066|NCT04145531|615766872|FG003|Part A|Death|0|||
170390067|NCT04145531|615766869|FG000|Part A|Physician Decision|2|||
170390068|NCT04145531|615766870|FG001|Part A|Physician Decision|5|||
170390069|NCT04145531|615766871|FG002|Part A|Physician Decision|2|||
170390070|NCT04145531|615766872|FG003|Part A|Physician Decision|0|||
170390071|NCT04145531|615766869|FG000|Part A|Progressive disease|0|||
170390072|NCT04145531|615766870|FG001|Part A|Progressive disease|2|||
170390073|NCT04145531|615766871|FG002|Part A|Progressive disease|1|||
170390074|NCT04145531|615766872|FG003|Part A|Progressive disease|0|||
170390075|NCT04145531|615766869|FG000|Part A|Protocol deviation|0|||
170390076|NCT04145531|615766870|FG001|Part A|Protocol deviation|0|||
170390077|NCT04145531|615766871|FG002|Part A|Protocol deviation|1|||
170390078|NCT04145531|615766872|FG003|Part A|Protocol deviation|0|||
170390079|NCT04145531|615766869|FG000|Part A|Withdrawal by parent or guardian|1|||
170390080|NCT04145531|615766870|FG001|Part A|Withdrawal by parent or guardian|0|||
170390081|NCT04145531|615766871|FG002|Part A|Withdrawal by parent or guardian|0|||
170390082|NCT04145531|615766872|FG003|Part A|Withdrawal by parent or guardian|0|||
170390083|NCT04145531|615766869|FG000|Part A|Withdrawal by participant|0|||
170390084|NCT04145531|615766870|FG001|Part A|Withdrawal by participant|0|||
170390085|NCT04145531|615766871|FG002|Part A|Withdrawal by participant|1|||
170390086|NCT04145531|615766872|FG003|Part A|Withdrawal by participant|0|||
170390087|NCT04145531|615766869|FG000|Part A|Other|0|||
170390088|NCT04145531|615766870|FG001|Part A|Other|0|||
170390089|NCT04145531|615766871|FG002|Part A|Other|1|||
170390090|NCT04145531|615766872|FG003|Part A|Other|0|||
170390091|NCT04145531|615766869|FG000|Part B|Adverse Event|0|||
170390092|NCT04145531|615766870|FG001|Part B|Adverse Event|0|||
170390093|NCT04145531|615766871|FG002|Part B|Adverse Event|0|||
170390094|NCT04145531|615766872|FG003|Part B|Adverse Event|21|||
170390095|NCT04145531|615766869|FG000|Part B|Physician Decision|0|||
170390096|NCT04145531|615766870|FG001|Part B|Physician Decision|0|||
170390097|NCT04145531|615766871|FG002|Part B|Physician Decision|0|||
170390098|NCT04145531|615766872|FG003|Part B|Physician Decision|7|||
170390099|NCT04145531|615766869|FG000|Part B|Progressive disease|0|||
170390100|NCT04145531|615766870|FG001|Part B|Progressive disease|0|||
170390101|NCT04145531|615766871|FG002|Part B|Progressive disease|0|||
170390102|NCT04145531|615766872|FG003|Part B|Progressive disease|1|||
170390103|NCT04145531|615766869|FG000|Part B|Recurrent disease|0|||
170390104|NCT04145531|615766870|FG001|Part B|Recurrent disease|0|||
170390105|NCT04145531|615766871|FG002|Part B|Recurrent disease|0|||
170390106|NCT04145531|615766872|FG003|Part B|Recurrent disease|1|||
170390107|NCT04145531|615766869|FG000|Part B|Withdrawal by parent or guardian|0|||
170390108|NCT04145531|615766870|FG001|Part B|Withdrawal by parent or guardian|0|||
170390109|NCT04145531|615766871|FG002|Part B|Withdrawal by parent or guardian|0|||
170390110|NCT04145531|615766872|FG003|Part B|Withdrawal by parent or guardian|3|||
170390111|NCT04145531|615766869|FG000|Part B|Withdrawal by participant|0|||
170390112|NCT04145531|615766870|FG001|Part B|Withdrawal by participant|0|||
170390113|NCT04145531|615766871|FG002|Part B|Withdrawal by participant|0|||
170390114|NCT04145531|615766872|FG003|Part B|Withdrawal by participant|1|||
170390115|NCT04145531|615766869|FG000|Part B|Other|0|||
170390116|NCT04145531|615766870|FG001|Part B|Other|0|||
170390117|NCT04145531|615766871|FG002|Part B|Other|0|||
170390118|NCT04145531|615766872|FG003|Part B|Other|1|||
170390119|NCT02067728|615766873|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
170390120|NCT02067728|615766874|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
170390121|NCT02067728|615766873|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
170390122|NCT02067728|615766874|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
170390123|NCT02067728|615766873|FG000|6 Month Measurements|Unable to attend|114|||
170390124|NCT02067728|615766874|FG001|6 Month Measurements|Unable to attend|97|||
170390125|NCT04640168|615766876|FG000|Overall Study|Withdrawal by Subject|8|||
170390126|NCT04640168|615766877|FG001|Overall Study|Withdrawal by Subject|7|||
170390127|NCT04640168|615766876|FG000|Overall Study|Lost to Follow-up|1|||
170390128|NCT04640168|615766877|FG001|Overall Study|Lost to Follow-up|0|||
170390129|NCT04640168|615766876|FG000|Overall Study|Enrolled but not treated|12|||
170390130|NCT04640168|615766877|FG001|Overall Study|Enrolled but not treated|12|||
170390131|NCT04338685|615766878|FG000|Overall Study|Death|3|||
170390132|NCT04338685|615766879|FG001|Overall Study|Death|4|||
170390133|NCT04338685|615766880|FG002|Overall Study|Death|2|||
170390134|NCT04338685|615766881|FG003|Overall Study|Death|4|||
170390135|NCT04338685|615766882|FG004|Overall Study|Death|4|||
170390136|NCT04338685|615766883|FG005|Overall Study|Death|8|||
170390137|NCT04338685|615766884|FG006|Overall Study|Death|1|||
170390138|NCT04338685|615766885|FG007|Overall Study|Death|0|||
170390139|NCT04338685|615766886|FG008|Overall Study|Death|0|||
170390140|NCT04338685|615766878|FG000|Overall Study|Study terminated by Sponsor|0|||
170390141|NCT04338685|615766879|FG001|Overall Study|Study terminated by Sponsor|0|||
170390142|NCT04338685|615766880|FG002|Overall Study|Study terminated by Sponsor|1|||
170390143|NCT04338685|615766881|FG003|Overall Study|Study terminated by Sponsor|4|||
170390144|NCT04338685|615766882|FG004|Overall Study|Study terminated by Sponsor|0|||
170390145|NCT04338685|615766883|FG005|Overall Study|Study terminated by Sponsor|5|||
170390146|NCT04338685|615766884|FG006|Overall Study|Study terminated by Sponsor|2|||
170390147|NCT04338685|615766885|FG007|Overall Study|Study terminated by Sponsor|4|||
170390148|NCT04338685|615766886|FG008|Overall Study|Study terminated by Sponsor|1|||
170390149|NCT04338685|615766878|FG000|Overall Study|Withdrawal by Subject|1|||
170390150|NCT04338685|615766879|FG001|Overall Study|Withdrawal by Subject|2|||
170390151|NCT04338685|615766880|FG002|Overall Study|Withdrawal by Subject|0|||
170390152|NCT04338685|615766881|FG003|Overall Study|Withdrawal by Subject|2|||
170390153|NCT04338685|615766882|FG004|Overall Study|Withdrawal by Subject|0|||
170390154|NCT04338685|615766883|FG005|Overall Study|Withdrawal by Subject|5|||
170390155|NCT04338685|615766884|FG006|Overall Study|Withdrawal by Subject|1|||
170390156|NCT04338685|615766885|FG007|Overall Study|Withdrawal by Subject|1|||
170390157|NCT04338685|615766886|FG008|Overall Study|Withdrawal by Subject|0|||
170390158|NCT00234533|615766887|FG000|Overall Study|Withdrawal by Subject|6|||
170390159|NCT00234533|615766887|FG000|Overall Study|Adverse Event|2|||
170390160|NCT00234533|615766887|FG000|Overall Study|Enrolled but not treated|3|||
170390161|NCT00570492|615766888|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
170390162|NCT00570492|615766889|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
170390163|NCT00570492|615766890|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
170390164|NCT00570492|615766888|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
170390165|NCT00570492|615766889|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
170390166|NCT00570492|615766890|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
170390167|NCT00570492|615766888|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
170390168|NCT00570492|615766889|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
170390169|NCT00570492|615766890|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
170390170|NCT00570492|615766888|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
170390171|NCT00570492|615766889|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
170390172|NCT00570492|615766890|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
170390173|NCT00570492|615766888|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
170390174|NCT00570492|615766889|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
170390175|NCT00570492|615766890|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
170390176|NCT00570492|615766888|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
170390177|NCT00570492|615766889|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
170390178|NCT00570492|615766890|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
170390179|NCT00570492|615766888|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
170390180|NCT00570492|615766889|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
170390181|NCT00570492|615766890|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
170390182|NCT00570492|615766888|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
170390183|NCT00570492|615766889|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
170390184|NCT00570492|615766890|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
170390185|NCT00570492|615766888|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
170390186|NCT00570492|615766889|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
170390187|NCT00570492|615766890|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
170390188|NCT00570492|615766888|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
170390189|NCT00570492|615766889|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
170390190|NCT00570492|615766890|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
170390191|NCT00570492|615766888|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
170390192|NCT00570492|615766889|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
170390193|NCT00570492|615766890|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
170390194|NCT00570492|615766888|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
170390195|NCT00570492|615766889|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
170390196|NCT00570492|615766890|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
170390197|NCT00570492|615766888|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
170390198|NCT00570492|615766889|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
170390199|NCT00570492|615766890|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
170390200|NCT00570492|615766888|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
170390201|NCT00570492|615766889|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
170390202|NCT00570492|615766890|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
170390203|NCT00908375|615766891|FG000|Overall Study|Withdrawal by Subject|2|||
170390204|NCT00908375|615766892|FG001|Overall Study|Withdrawal by Subject|4|||
170390205|NCT00908375|615766891|FG000|Overall Study|Lost to Follow-up|8|||
170390206|NCT00908375|615766892|FG001|Overall Study|Lost to Follow-up|6|||
170390207|NCT01484691|615766893|FG000|Overall Study|Withdrawal by Subject|1|||
170390208|NCT01484691|615766894|FG001|Overall Study|Withdrawal by Subject|1|||
170390209|NCT01484691|615766895|FG002|Overall Study|Withdrawal by Subject|1|||
170390210|NCT01484691|615766893|FG000|Overall Study|Physician Decision|0|||
170390211|NCT01484691|615766894|FG001|Overall Study|Physician Decision|2|||
170390212|NCT01484691|615766895|FG002|Overall Study|Physician Decision|1|||
170390213|NCT03522506|615766896|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170390214|NCT03522506|615766897|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170390215|NCT03522506|615766898|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
170390216|NCT03522506|615766899|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
170390217|NCT03522506|615766896|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
170390218|NCT03522506|615766897|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
170390219|NCT03522506|615766898|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
170390220|NCT03522506|615766899|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
170390221|NCT03480243|615766900|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
170390222|NCT03480243|615766900|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
170390223|NCT04365387|615766901|FG000|Overall Study|Adverse Event|4|||
170390224|NCT04365387|615766902|FG001|Overall Study|Adverse Event|2|||
170390225|NCT04365387|615766901|FG000|Overall Study|Participants request|14|||
170390226|NCT04365387|615766902|FG001|Overall Study|Participants request|14|||
170390227|NCT04365387|615766901|FG000|Overall Study|Lost to Follow-up|8|||
170390228|NCT04365387|615766902|FG001|Overall Study|Lost to Follow-up|5|||
170390229|NCT04365387|615766901|FG000|Overall Study|Protocol deviation|3|||
170390230|NCT04365387|615766902|FG001|Overall Study|Protocol deviation|4|||
170390231|NCT04365387|615766901|FG000|Overall Study|Participant compliance with visit schedule|1|||
170390232|NCT04365387|615766902|FG001|Overall Study|Participant compliance with visit schedule|0|||
170390233|NCT04365387|615766901|FG000|Overall Study|Participant incarcerated|1|||
170390234|NCT04365387|615766902|FG001|Overall Study|Participant incarcerated|0|||
170390235|NCT04365387|615766901|FG000|Overall Study|Participant moved out of town (relocated)|0|||
170390236|NCT04365387|615766902|FG001|Overall Study|Participant moved out of town (relocated)|1|||
170390237|NCT04365387|615766901|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
170390238|NCT04365387|615766902|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
170390239|NCT04365387|615766901|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
170390240|NCT04365387|615766902|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
170390241|NCT05770401|615766903|FG000|Overall Study|Lost to Follow-up|5|||
170390242|NCT05770401|615766904|FG001|Overall Study|Lost to Follow-up|4|||
170390243|NCT01683565|615766905|FG000|Overall Study|Lost to Follow-up|2|||
170390244|NCT01683565|615766906|FG001|Overall Study|Lost to Follow-up|0|||
170390245|NCT01683565|615766905|FG000|Overall Study|Discontinued Intervention|1|||
170390246|NCT01683565|615766906|FG001|Overall Study|Discontinued Intervention|1|||
170390247|NCT00764465|615766907|FG000|Overall Study|Adverse Event|2|||
170390248|NCT00764465|615766908|FG001|Overall Study|Adverse Event|0|||
170390249|NCT00764465|615766909|FG002|Overall Study|Adverse Event|0|||
170390250|NCT00764465|615766910|FG003|Overall Study|Adverse Event|1|||
170390251|NCT00764465|615766911|FG004|Overall Study|Adverse Event|1|||
170390252|NCT00764465|615766912|FG005|Overall Study|Adverse Event|1|||
170390253|NCT00764465|615766907|FG000|Overall Study|Withdrawal by Subject|0|||
170390254|NCT00764465|615766908|FG001|Overall Study|Withdrawal by Subject|1|||
170390255|NCT00764465|615766909|FG002|Overall Study|Withdrawal by Subject|1|||
170390256|NCT00764465|615766910|FG003|Overall Study|Withdrawal by Subject|0|||
170390257|NCT00764465|615766911|FG004|Overall Study|Withdrawal by Subject|0|||
170390258|NCT00764465|615766912|FG005|Overall Study|Withdrawal by Subject|0|||
170390259|NCT01195662|615766913|FG000|Double Blind Treatment Period|Adverse Event|4|||
170390260|NCT01195662|615766914|FG001|Double Blind Treatment Period|Adverse Event|1|||
170390261|NCT01195662|615766915|FG002|Double Blind Treatment Period|Adverse Event|2|||
170390262|NCT01195662|615766913|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
170390263|NCT01195662|615766914|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
170390264|NCT01195662|615766915|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
170390265|NCT01195662|615766913|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
170390266|NCT01195662|615766914|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
170390267|NCT01195662|615766915|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
170390268|NCT01195662|615766913|FG000|Double Blind Treatment Period|Administrative reason|2|||
170390269|NCT01195662|615766914|FG001|Double Blind Treatment Period|Administrative reason|1|||
170390270|NCT01195662|615766915|FG002|Double Blind Treatment Period|Administrative reason|1|||
170390271|NCT01195662|615766913|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
170390272|NCT01195662|615766914|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
170390273|NCT01195662|615766915|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
170390274|NCT01195662|615766913|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
170390275|NCT01195662|615766914|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
170390276|NCT01195662|615766915|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
170390277|NCT01195662|615766913|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
170390278|NCT01195662|615766914|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
170390279|NCT01195662|615766915|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
170390280|NCT01195662|615766913|FG000|Double Blind Treatment Period|Non-specified|3|||
170390281|NCT01195662|615766914|FG001|Double Blind Treatment Period|Non-specified|0|||
170390282|NCT01195662|615766915|FG002|Double Blind Treatment Period|Non-specified|0|||
170390283|NCT01195662|615766913|FG000|Double Blind Treatment Period|Missing disposition information|0|||
170390284|NCT01195662|615766914|FG001|Double Blind Treatment Period|Missing disposition information|1|||
170390285|NCT01195662|615766915|FG002|Double Blind Treatment Period|Missing disposition information|1|||
170390286|NCT01195662|615766913|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
170390287|NCT01195662|615766914|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
170390288|NCT01195662|615766915|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
170390289|NCT01195662|615766913|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
170390290|NCT01195662|615766914|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
170390291|NCT01195662|615766915|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
170390292|NCT01298323|615766917|FG000|Overall Study|Adverse Event|2|||
170390293|NCT01298323|615766918|FG001|Overall Study|Adverse Event|4|||
170390294|NCT01298323|615766917|FG000|Overall Study|Death|11|||
170390295|NCT01298323|615766918|FG001|Overall Study|Death|16|||
170390296|NCT01298323|615766917|FG000|Overall Study|Lost to Follow-up|1|||
170390297|NCT01298323|615766918|FG001|Overall Study|Lost to Follow-up|0|||
170390298|NCT01298323|615766917|FG000|Overall Study|Withdrawal by Subject|6|||
170390299|NCT01298323|615766918|FG001|Overall Study|Withdrawal by Subject|3|||
170390300|NCT01298323|615766917|FG000|Overall Study|Protocol Violation|1|||
170390301|NCT01298323|615766918|FG001|Overall Study|Protocol Violation|0|||
170390302|NCT01298323|615766917|FG000|Overall Study|Other|10|||
170390303|NCT01298323|615766918|FG001|Overall Study|Other|9|||
170390304|NCT01298323|615766917|FG000|Overall Study|Ongoing|55|||
170390305|NCT01298323|615766918|FG001|Overall Study|Ongoing|55|||
170390306|NCT01298323|615766917|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
170390307|NCT01298323|615766918|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
170390308|NCT01761565|615766919|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
170390309|NCT02161380|615766920|FG000|Overall Study|Lost to Follow-up|0|||
170390310|NCT02161380|615766921|FG001|Overall Study|Lost to Follow-up|1|||
170390311|NCT02161380|615766922|FG002|Overall Study|Lost to Follow-up|0|||
170390312|NCT02161380|615766923|FG003|Overall Study|Lost to Follow-up|0|||
170390313|NCT04409262|615766925|FG000|Overall Study|Adverse Event|0|||
170390314|NCT04409262|615766926|FG001|Overall Study|Adverse Event|2|||
170390315|NCT04409262|615766925|FG000|Overall Study|Death|55|||
170390316|NCT04409262|615766926|FG001|Overall Study|Death|97|||
170390317|NCT04409262|615766925|FG000|Overall Study|Lost to Follow-up|12|||
170390318|NCT04409262|615766926|FG001|Overall Study|Lost to Follow-up|23|||
170390319|NCT04409262|615766925|FG000|Overall Study|Lack of Staff|0|||
170390320|NCT04409262|615766926|FG001|Overall Study|Lack of Staff|1|||
170390321|NCT04409262|615766925|FG000|Overall Study|Protocol Violation|3|||
170390322|NCT04409262|615766926|FG001|Overall Study|Protocol Violation|1|||
170390323|NCT04409262|615766925|FG000|Overall Study|Withdrawal by Subject|5|||
170390324|NCT04409262|615766926|FG001|Overall Study|Withdrawal by Subject|10|||
170390325|NCT04794491|615766930|FG000|Overall Study|Adverse Event|1|||
170390326|NCT04794491|615766930|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
170390327|NCT04794491|615766930|FG000|Overall Study|Noncompliance With Study Intervention|1|||
170390328|NCT04794491|615766930|FG000|Overall Study|Withdrawal by Subject|2|||
170390329|NCT00307736|615766931|FG000|Overall Study|Adverse Event|0|||
170390330|NCT00307736|615766932|FG001|Overall Study|Adverse Event|0|||
170390331|NCT00307736|615766933|FG002|Overall Study|Adverse Event|1|||
170390332|NCT00307736|615766934|FG003|Overall Study|Adverse Event|3|||
170390333|NCT00307736|615766931|FG000|Overall Study|Withdrawal by Subject|0|||
170390334|NCT00307736|615766932|FG001|Overall Study|Withdrawal by Subject|0|||
170390335|NCT00307736|615766933|FG002|Overall Study|Withdrawal by Subject|2|||
170390336|NCT00307736|615766934|FG003|Overall Study|Withdrawal by Subject|0|||
170390337|NCT00948896|615766939|FG000|Randomization to 24 Months of Age|Death|1|||
170390338|NCT00948896|615766940|FG001|Randomization to 24 Months of Age|Death|0|||
170390339|NCT00948896|615766941|FG002|Randomization to 24 Months of Age|Death|0|||
170390340|NCT00948896|615766942|FG003|Randomization to 24 Months of Age|Death|0|||
170390341|NCT00948896|615766943|FG004|Randomization to 24 Months of Age|Death|2|||
170390342|NCT00948896|615766944|FG005|Randomization to 24 Months of Age|Death|1|||
170390343|NCT00948896|615766945|FG006|Randomization to 24 Months of Age|Death|2|||
170390344|NCT00948896|615766946|FG007|Randomization to 24 Months of Age|Death|1|||
170390345|NCT00948896|615766939|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
170390346|NCT00948896|615766940|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
170390347|NCT00948896|615766941|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
170390348|NCT00948896|615766942|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
170390349|NCT00948896|615766943|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
170390350|NCT00948896|615766944|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
170390351|NCT00948896|615766945|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
170390352|NCT00948896|615766946|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
170390353|NCT00948896|615766939|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
170390354|NCT00948896|615766940|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
170390355|NCT00948896|615766941|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
170390356|NCT00948896|615766942|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
170390357|NCT00948896|615766943|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
170390358|NCT00948896|615766944|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
170390359|NCT00948896|615766945|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
170390360|NCT00948896|615766946|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
170390361|NCT00948896|615766939|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
170390362|NCT00948896|615766940|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
170390363|NCT00948896|615766941|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
170390364|NCT00948896|615766942|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
170390365|NCT00948896|615766943|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
170390366|NCT00948896|615766944|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
170390367|NCT00948896|615766945|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
170390368|NCT00948896|615766946|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
170390369|NCT00948896|615766939|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
170390370|NCT00948896|615766940|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
170390371|NCT00948896|615766941|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
170390372|NCT00948896|615766942|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
170390373|NCT00948896|615766943|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
170390374|NCT00948896|615766944|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
170390375|NCT00948896|615766945|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
170390376|NCT00948896|615766946|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
170390377|NCT00948896|615766939|FG000|24 Months of Age to 36 Months of Age|Death|0|||
170390378|NCT00948896|615766940|FG001|24 Months of Age to 36 Months of Age|Death|2|||
170390379|NCT00948896|615766941|FG002|24 Months of Age to 36 Months of Age|Death|2|||
170390380|NCT00948896|615766942|FG003|24 Months of Age to 36 Months of Age|Death|0|||
170390381|NCT00948896|615766943|FG004|24 Months of Age to 36 Months of Age|Death|0|||
170390382|NCT00948896|615766944|FG005|24 Months of Age to 36 Months of Age|Death|1|||
170390383|NCT00948896|615766945|FG006|24 Months of Age to 36 Months of Age|Death|0|||
170390384|NCT00948896|615766946|FG007|24 Months of Age to 36 Months of Age|Death|0|||
170390385|NCT00948896|615766939|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
170390386|NCT00948896|615766940|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
170390387|NCT00948896|615766941|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
170390388|NCT00948896|615766942|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
170390389|NCT00948896|615766943|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
170390390|NCT00948896|615766944|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
170390391|NCT00948896|615766945|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
170390392|NCT00948896|615766946|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
170390393|NCT00948896|615766939|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
170390394|NCT00948896|615766940|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
170390395|NCT00948896|615766941|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
170390396|NCT00948896|615766942|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
170390397|NCT00948896|615766943|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
170390398|NCT00948896|615766944|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
170390399|NCT00948896|615766945|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
170390400|NCT00948896|615766946|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
170390401|NCT00948896|615766939|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
170390402|NCT00948896|615766940|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
170390403|NCT00948896|615766941|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
170390404|NCT00948896|615766942|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
170390405|NCT00948896|615766943|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
170390406|NCT00948896|615766944|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
170390407|NCT00948896|615766945|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
170390408|NCT00948896|615766946|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
170390409|NCT00948896|615766939|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
170390410|NCT00948896|615766940|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
170390411|NCT00948896|615766941|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
170390412|NCT00948896|615766942|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
170390413|NCT00948896|615766943|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
170390414|NCT00948896|615766944|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
170390415|NCT00948896|615766945|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
170390416|NCT00948896|615766946|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
170390417|NCT00945815|615766947|FG000|Overall Study|Death|3|||
170390418|NCT00945815|615766947|FG000|Overall Study|Not protocol specified|1|||
170390419|NCT00945815|615766947|FG000|Overall Study|Ineligible|3|||
170390420|NCT00945815|615766947|FG000|Overall Study|Did not begin protocol therapy|1|||
170390421|NCT01990339|615766952|FG000|Overall Study|Data Not Available|49|||
170390422|NCT01990339|615766952|FG000|Overall Study|Voluntary Withdrawal|1402|||
170390423|NCT01990339|615766952|FG000|Overall Study|Lost to Follow-up|861|||
170390424|NCT01038609|615766953|FG000|Overall Study|Adverse Event|0|||
170390425|NCT01038609|615766954|FG001|Overall Study|Adverse Event|0|||
170390426|NCT01038609|615766955|FG002|Overall Study|Adverse Event|1|||
170390427|NCT01038609|615766956|FG003|Overall Study|Adverse Event|0|||
170390428|NCT01038609|615766957|FG004|Overall Study|Adverse Event|0|||
170390429|NCT01038609|615766953|FG000|Overall Study|Dosing Error|0|||
170390430|NCT01038609|615766954|FG001|Overall Study|Dosing Error|0|||
170390431|NCT01038609|615766955|FG002|Overall Study|Dosing Error|0|||
170390432|NCT01038609|615766956|FG003|Overall Study|Dosing Error|1|||
170390433|NCT01038609|615766957|FG004|Overall Study|Dosing Error|1|||
170390434|NCT01038609|615766953|FG000|Overall Study|Death in the Family|1|||
170390435|NCT01038609|615766954|FG001|Overall Study|Death in the Family|0|||
170390436|NCT01038609|615766955|FG002|Overall Study|Death in the Family|0|||
170390437|NCT01038609|615766956|FG003|Overall Study|Death in the Family|0|||
170390438|NCT01038609|615766957|FG004|Overall Study|Death in the Family|0|||
170390439|NCT01038609|615766953|FG000|Overall Study|Refusal of Blood Draws|0|||
170390440|NCT01038609|615766954|FG001|Overall Study|Refusal of Blood Draws|1|||
170390441|NCT01038609|615766955|FG002|Overall Study|Refusal of Blood Draws|0|||
170390442|NCT01038609|615766956|FG003|Overall Study|Refusal of Blood Draws|0|||
170390443|NCT01038609|615766957|FG004|Overall Study|Refusal of Blood Draws|0|||
170390444|NCT00242658|615766960|FG000|Overall Study|Lost to Follow-up|22|||
170390445|NCT00242658|615766961|FG001|Overall Study|Lost to Follow-up|19|||
170390446|NCT01590810|615766962|FG000|Overall Study|Physician Decision|0|||
170390447|NCT01590810|615766963|FG001|Overall Study|Physician Decision|1|||
170390448|NCT01590810|615766964|FG002|Overall Study|Physician Decision|1|||
170390449|NCT01590810|615766965|FG003|Overall Study|Physician Decision|0|||
170390450|NCT01590810|615766966|FG004|Overall Study|Physician Decision|0|||
170390451|NCT04604015|615766967|FG000|Overall Study|Incomplete Data Collection|33|||
170390452|NCT02129192|615766970|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
170390453|NCT02129192|615766971|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
170390454|NCT04524507|615766973|FG000|Overall Study|Lost to Follow-up|2|||
170390455|NCT04524507|615766974|FG001|Overall Study|Lost to Follow-up|4|||
170390456|NCT04524507|615766973|FG000|Overall Study|Withdrawal by Subject|2|||
170390457|NCT04524507|615766974|FG001|Overall Study|Withdrawal by Subject|9|||
170390458|NCT04524507|615766973|FG000|Overall Study|Death|2|||
170390459|NCT04524507|615766974|FG001|Overall Study|Death|10|||
170390460|NCT00412360|615766975|FG000|Overall Study|Lost to Follow-up|0|||
170390461|NCT00412360|615766976|FG001|Overall Study|Lost to Follow-up|1|||
170390462|NCT00412360|615766975|FG000|Overall Study|Not Transplanted|1|||
170390463|NCT00412360|615766976|FG001|Overall Study|Not Transplanted|2|||
170390464|NCT03655951|615766979|FG000|Overall Study|Lost to Follow-up|39|||
170390465|NCT03655951|615766980|FG001|Overall Study|Lost to Follow-up|20|||
170390466|NCT03655951|615766979|FG000|Overall Study|Withdrawal by Subject|0|||
170390467|NCT03655951|615766980|FG001|Overall Study|Withdrawal by Subject|1|||
170390468|NCT04557189|615766981|FG000|Overall Study|Adverse Event|0|||
170390469|NCT04557189|615766982|FG001|Overall Study|Adverse Event|1|||
170390470|NCT04557189|615766981|FG000|Overall Study|Lost to Follow-up|1|||
170390471|NCT04557189|615766982|FG001|Overall Study|Lost to Follow-up|1|||
170390472|NCT04557189|615766981|FG000|Overall Study|Withdrawal by Subject|2|||
170390473|NCT04557189|615766982|FG001|Overall Study|Withdrawal by Subject|1|||
170390474|NCT04557189|615766981|FG000|Overall Study|Reason not Specified|3|||
170390475|NCT04557189|615766982|FG001|Overall Study|Reason not Specified|6|||
170390476|NCT01087944|615766994|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
170390477|NCT01087944|615766995|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
170390478|NCT01087944|615766994|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
170390479|NCT01087944|615766995|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
170390480|NCT00553319|615766996|FG000|Overall Study|Lost to Follow-up|10|||
170390481|NCT00553319|615766997|FG001|Overall Study|Lost to Follow-up|9|||
170390482|NCT00553319|615766998|FG002|Overall Study|Lost to Follow-up|5|||
170390483|NCT00553319|615766996|FG000|Overall Study|wanted treatment elsewhere|2|||
170390484|NCT00553319|615766997|FG001|Overall Study|wanted treatment elsewhere|1|||
170390485|NCT00553319|615766998|FG002|Overall Study|wanted treatment elsewhere|1|||
170390486|NCT00553319|615766996|FG000|Overall Study|non-compliance|0|||
170390487|NCT00553319|615766997|FG001|Overall Study|non-compliance|0|||
170390488|NCT00553319|615766998|FG002|Overall Study|non-compliance|2|||
170390489|NCT00553319|615766996|FG000|Overall Study|incarceration|1|||
170390490|NCT00553319|615766997|FG001|Overall Study|incarceration|0|||
170390491|NCT00553319|615766998|FG002|Overall Study|incarceration|0|||
170390492|NCT00553319|615766996|FG000|Overall Study|moved|1|||
170390493|NCT00553319|615766997|FG001|Overall Study|moved|0|||
170390494|NCT00553319|615766998|FG002|Overall Study|moved|1|||
170390495|NCT01636076|615767000|FG000|Overall Study|Terminated by sponsor|1|||
170390496|NCT01636076|615767001|FG001|Overall Study|Terminated by sponsor|1|||
170390497|NCT01636076|615767000|FG000|Overall Study|Lack of Efficacy|0|||
170390498|NCT01636076|615767001|FG001|Overall Study|Lack of Efficacy|1|||
170390499|NCT01636076|615767000|FG000|Overall Study|Lost to Follow-up|1|||
170390500|NCT01636076|615767001|FG001|Overall Study|Lost to Follow-up|0|||
170390501|NCT01636076|615767000|FG000|Overall Study|Physician Decision|1|||
170390502|NCT01636076|615767001|FG001|Overall Study|Physician Decision|1|||
170390503|NCT01636076|615767000|FG000|Overall Study|Non-compliance with study treatment|1|||
170390504|NCT01636076|615767001|FG001|Overall Study|Non-compliance with study treatment|1|||
170390505|NCT01636076|615767000|FG000|Overall Study|Adverse Event|6|||
170390506|NCT01636076|615767001|FG001|Overall Study|Adverse Event|11|||
170390507|NCT01636076|615767000|FG000|Overall Study|Withdrawal by Subject|7|||
170390508|NCT01636076|615767001|FG001|Overall Study|Withdrawal by Subject|10|||
170390509|NCT01130831|615767002|FG000|Overall Study|Withdrawal by Subject|7|||
170390510|NCT01130831|615767002|FG000|Overall Study|Death|4|||
170390511|NCT01130831|615767002|FG000|Overall Study|Information was missing|3|||
170390512|NCT01393444|615767003|FG000|Overall Study|Withdrawal by Subject|1|||
170390513|NCT01393444|615767003|FG000|Overall Study|Determined ineligible during screening.|2|||
170390514|NCT03039699|615767004|FG000|Overall Study|Incorrect inclusion|5|||
170390515|NCT03039699|615767005|FG001|Overall Study|Incorrect inclusion|4|||
170390516|NCT03039699|615767004|FG000|Overall Study|Lack of data to assess study endpoint|5|||
170390517|NCT03039699|615767005|FG001|Overall Study|Lack of data to assess study endpoint|3|||
170390518|NCT03039699|615767004|FG000|Overall Study|Bacterial infection|12|||
170390519|NCT03039699|615767005|FG001|Overall Study|Bacterial infection|28|||
170390520|NCT02911285|615767006|FG000|Overall Study|Lost to Follow-up|8|||
170390521|NCT02911285|615767007|FG001|Overall Study|Lost to Follow-up|5|||
170390522|NCT02911285|615767006|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
170390523|NCT02911285|615767007|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
170390524|NCT00761462|615768546|FG000|Treatment|Subjects never received study medication|23|||
170390525|NCT00761462|615768547|FG001|Treatment|Subjects never received study medication|12|||
170390526|NCT00761462|615768546|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
170390527|NCT00761462|615768547|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
170390528|NCT00761462|615768546|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
170390529|NCT00761462|615768547|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
170390530|NCT00761462|615768546|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
170390531|NCT00761462|615768547|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
170390532|NCT02163759|615768548|FG000|Overall Study|Withdrawal by Subject|1|||
170390533|NCT02163759|615768549|FG001|Overall Study|Withdrawal by Subject|5|||
170390534|NCT02163759|615768550|FG002|Overall Study|Withdrawal by Subject|1|||
170390535|NCT02163759|615768548|FG000|Overall Study|Adverse Event|0|||
170390536|NCT02163759|615768549|FG001|Overall Study|Adverse Event|0|||
170390537|NCT02163759|615768550|FG002|Overall Study|Adverse Event|1|||
170390538|NCT02163759|615768548|FG000|Overall Study|Death|0|||
170390539|NCT02163759|615768549|FG001|Overall Study|Death|0|||
170390540|NCT02163759|615768550|FG002|Overall Study|Death|1|||
170390541|NCT01479777|615768560|FG000|Overall Study|Physician Decision|2|||
170390542|NCT00451191|615768564|FG000|Overall Study|withdrawal or received alternate tx|15|||
170390543|NCT00451191|615768565|FG001|Overall Study|withdrawal or received alternate tx|11|||
170390544|NCT00656669|615768568|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
170390545|NCT00656669|615768568|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
170390546|NCT00656669|615768568|FG000|AC (Cycles 6-9)|Adverse Event|1|||
170390547|NCT00656669|615768568|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
170390548|NCT00219349|615768573|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
170390549|NCT00219349|615768573|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
170390550|NCT00219349|615768573|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
170390551|NCT00219349|615768573|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
170390552|NCT03839693|615768575|FG000|Overall Study|Lost to Follow-up|0|||
170390553|NCT03839693|615768576|FG001|Overall Study|Lost to Follow-up|2|||
170390554|NCT03839693|615768577|FG002|Overall Study|Lost to Follow-up|2|||
170390555|NCT03839693|615768575|FG000|Overall Study|Withdrawal by Subject|1|||
170390556|NCT03839693|615768576|FG001|Overall Study|Withdrawal by Subject|0|||
170390557|NCT03839693|615768577|FG002|Overall Study|Withdrawal by Subject|2|||
170390558|NCT03839693|615768575|FG000|Overall Study|subject moved out of the area|1|||
170390559|NCT03839693|615768576|FG001|Overall Study|subject moved out of the area|0|||
170390560|NCT03839693|615768577|FG002|Overall Study|subject moved out of the area|0|||
170390561|NCT00270205|615768586|FG000|Overall Study|Lost to Follow-up|1|||
170390562|NCT00270205|615768587|FG001|Overall Study|Lost to Follow-up|0|||
170390563|NCT00270205|615768588|FG002|Overall Study|Lost to Follow-up|0|||
170390564|NCT00270205|615768589|FG003|Overall Study|Lost to Follow-up|1|||
170390565|NCT00066573|615768590|FG000|Overall Study|Did not received protocol treatment|28|||
170390566|NCT00066573|615768591|FG001|Overall Study|Did not received protocol treatment|28|||
170390567|NCT01945034|615768592|FG000|Overall Study|Medication Error|0|||
170390568|NCT01945034|615768593|FG001|Overall Study|Medication Error|1|||
170390569|NCT01945034|615768594|FG002|Overall Study|Medication Error|0|||
170390570|NCT01945034|615768592|FG000|Overall Study|Withdrawal by Subject|0|||
170390571|NCT01945034|615768593|FG001|Overall Study|Withdrawal by Subject|3|||
170390572|NCT01945034|615768594|FG002|Overall Study|Withdrawal by Subject|1|||
170390573|NCT01945034|615768592|FG000|Overall Study|Other|0|||
170390574|NCT01945034|615768593|FG001|Overall Study|Other|1|||
170390575|NCT01945034|615768594|FG002|Overall Study|Other|3|||
170390576|NCT01945034|615768592|FG000|Overall Study|Lost to Follow-up|0|||
170390577|NCT01945034|615768593|FG001|Overall Study|Lost to Follow-up|0|||
170390578|NCT01945034|615768594|FG002|Overall Study|Lost to Follow-up|2|||
170390579|NCT01945034|615768592|FG000|Overall Study|Protocol Violation|1|||
170390580|NCT01945034|615768593|FG001|Overall Study|Protocol Violation|0|||
170390581|NCT01945034|615768594|FG002|Overall Study|Protocol Violation|1|||
170390582|NCT00700115|615768597|FG000|Overall Study|Withdrawal by Subject|1|||
170390583|NCT00700115|615768598|FG001|Overall Study|Withdrawal by Subject|0|||
170390584|NCT00700115|615768597|FG000|Overall Study|Lost to Follow-up|0|||
170390585|NCT00700115|615768598|FG001|Overall Study|Lost to Follow-up|1|||
170390586|NCT00706901|615768599|FG000|Overall Study|Lost to Follow-up|2|||
170390587|NCT00706901|615768600|FG001|Overall Study|Lost to Follow-up|3|||
170390588|NCT00706901|615768601|FG002|Overall Study|Lost to Follow-up|2|||
170390589|NCT00706901|615768599|FG000|Overall Study|Withdrawal by Subject|4|||
170390590|NCT00706901|615768600|FG001|Overall Study|Withdrawal by Subject|2|||
170390591|NCT00706901|615768601|FG002|Overall Study|Withdrawal by Subject|5|||
170390592|NCT00706901|615768599|FG000|Overall Study|In Jail|1|||
170390593|NCT00706901|615768600|FG001|Overall Study|In Jail|0|||
170390594|NCT00706901|615768601|FG002|Overall Study|In Jail|1|||
170390595|NCT00706901|615768599|FG000|Overall Study|Death|1|||
170390596|NCT00706901|615768600|FG001|Overall Study|Death|0|||
170390597|NCT00706901|615768601|FG002|Overall Study|Death|0|||
170390598|NCT00718809|615768602|FG000|Overall Study|Disease progression|9|||
170390599|NCT00718809|615768603|FG001|Overall Study|Disease progression|7|||
170390600|NCT00718809|615768602|FG000|Overall Study|Adverse Event|1|||
170390601|NCT00718809|615768603|FG001|Overall Study|Adverse Event|1|||
170390602|NCT00718809|615768602|FG000|Overall Study|Withdrawal by Subject|0|||
170390603|NCT00718809|615768603|FG001|Overall Study|Withdrawal by Subject|1|||
170390604|NCT00718809|615768602|FG000|Overall Study|Lost to Follow-up|1|||
170390605|NCT00718809|615768603|FG001|Overall Study|Lost to Follow-up|0|||
170390606|NCT00718809|615768602|FG000|Overall Study|Noncompliance|1|||
170390607|NCT00718809|615768603|FG001|Overall Study|Noncompliance|0|||
170390608|NCT00798161|615768604|FG000|Overall Study|Adverse Event|3|||
170390609|NCT00798161|615768605|FG001|Overall Study|Adverse Event|4|||
170390610|NCT00798161|615768606|FG002|Overall Study|Adverse Event|6|||
170390611|NCT00798161|615768607|FG003|Overall Study|Adverse Event|6|||
170390612|NCT00798161|615768608|FG004|Overall Study|Adverse Event|5|||
170390613|NCT00798161|615768609|FG005|Overall Study|Adverse Event|2|||
170390614|NCT00798161|615768610|FG006|Overall Study|Adverse Event|4|||
170390615|NCT00798161|615768604|FG000|Overall Study|Protocol Violation|2|||
170390616|NCT00798161|615768605|FG001|Overall Study|Protocol Violation|1|||
170390617|NCT00798161|615768606|FG002|Overall Study|Protocol Violation|3|||
170390618|NCT00798161|615768607|FG003|Overall Study|Protocol Violation|3|||
170390619|NCT00798161|615768608|FG004|Overall Study|Protocol Violation|3|||
170390620|NCT00798161|615768609|FG005|Overall Study|Protocol Violation|2|||
170390621|NCT00798161|615768610|FG006|Overall Study|Protocol Violation|0|||
170390622|NCT00798161|615768604|FG000|Overall Study|Lost to Follow-up|1|||
170390623|NCT00798161|615768605|FG001|Overall Study|Lost to Follow-up|3|||
170390624|NCT00798161|615768606|FG002|Overall Study|Lost to Follow-up|4|||
170390625|NCT00798161|615768607|FG003|Overall Study|Lost to Follow-up|3|||
170390626|NCT00798161|615768608|FG004|Overall Study|Lost to Follow-up|4|||
170390627|NCT00798161|615768609|FG005|Overall Study|Lost to Follow-up|0|||
170390628|NCT00798161|615768610|FG006|Overall Study|Lost to Follow-up|0|||
170390629|NCT00798161|615768604|FG000|Overall Study|Withdrawal by Subject|5|||
170390630|NCT00798161|615768605|FG001|Overall Study|Withdrawal by Subject|4|||
170390631|NCT00798161|615768606|FG002|Overall Study|Withdrawal by Subject|5|||
170390632|NCT00798161|615768607|FG003|Overall Study|Withdrawal by Subject|4|||
170390633|NCT00798161|615768608|FG004|Overall Study|Withdrawal by Subject|2|||
170390634|NCT00798161|615768609|FG005|Overall Study|Withdrawal by Subject|3|||
170390635|NCT00798161|615768610|FG006|Overall Study|Withdrawal by Subject|1|||
170390636|NCT00798161|615768604|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
170390637|NCT00798161|615768605|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
170390638|NCT00798161|615768606|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
170390639|NCT00798161|615768607|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
170390640|NCT00798161|615768608|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
170390641|NCT00798161|615768609|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
170390642|NCT00798161|615768610|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
170390643|NCT00560573|615768611|FG000|Overall Study|Death|4|||
170390644|NCT00560573|615768612|FG001|Overall Study|Death|1|||
170390645|NCT00560573|615768613|FG002|Overall Study|Death|4|||
170390646|NCT00560573|615768614|FG003|Overall Study|Death|5|||
170390647|NCT00560573|615768615|FG004|Overall Study|Death|1|||
170390648|NCT00560573|615768616|FG005|Overall Study|Death|10|||
170390649|NCT00560573|615768611|FG000|Overall Study|Lost to Follow-up|0|||
170390650|NCT00560573|615768612|FG001|Overall Study|Lost to Follow-up|0|||
170390651|NCT00560573|615768613|FG002|Overall Study|Lost to Follow-up|0|||
170390652|NCT00560573|615768614|FG003|Overall Study|Lost to Follow-up|1|||
170390653|NCT00560573|615768615|FG004|Overall Study|Lost to Follow-up|1|||
170390654|NCT00560573|615768616|FG005|Overall Study|Lost to Follow-up|0|||
170390655|NCT00560573|615768611|FG000|Overall Study|Withdrawal by Subject|0|||
170390656|NCT00560573|615768612|FG001|Overall Study|Withdrawal by Subject|0|||
170390657|NCT00560573|615768613|FG002|Overall Study|Withdrawal by Subject|0|||
170390658|NCT00560573|615768614|FG003|Overall Study|Withdrawal by Subject|1|||
170390659|NCT00560573|615768615|FG004|Overall Study|Withdrawal by Subject|1|||
170390660|NCT00560573|615768616|FG005|Overall Study|Withdrawal by Subject|0|||
170390661|NCT00560573|615768611|FG000|Overall Study|Other|2|||
170390662|NCT00560573|615768612|FG001|Overall Study|Other|2|||
170390663|NCT00560573|615768613|FG002|Overall Study|Other|2|||
170390664|NCT00560573|615768614|FG003|Overall Study|Other|3|||
170390665|NCT00560573|615768615|FG004|Overall Study|Other|3|||
170390666|NCT00560573|615768616|FG005|Overall Study|Other|3|||
170390667|NCT00560573|615768611|FG000|Overall Study|Enrolled, not treated|0|||
170390668|NCT00560573|615768612|FG001|Overall Study|Enrolled, not treated|0|||
170390669|NCT00560573|615768613|FG002|Overall Study|Enrolled, not treated|0|||
170390670|NCT00560573|615768614|FG003|Overall Study|Enrolled, not treated|0|||
170390671|NCT00560573|615768615|FG004|Overall Study|Enrolled, not treated|1|||
170390672|NCT00560573|615768616|FG005|Overall Study|Enrolled, not treated|0|||
170390673|NCT00536991|615768621|FG000|Overall Study|Withdrawal by Subject|10|||
170390674|NCT00536991|615768621|FG000|Overall Study|Physician Decision|1|||
170390675|NCT00536991|615768621|FG000|Overall Study|patient ineligible|2|||
170390676|NCT00054639|615768622|FG000|Overall Study|Lack of Efficacy|1|||
170390677|NCT00054639|615768622|FG000|Overall Study|Physician Decision|1|||
170390678|NCT01600755|615768623|FG000|Overall Study|Withdrawal by Subject|6|||
170390679|NCT00938392|615768628|FG000|Overall Study|Adverse Event|0|||
170390680|NCT00938392|615768629|FG001|Overall Study|Adverse Event|1|||
170390681|NCT00938392|615768628|FG000|Overall Study|Withdrawal by Subject|0|||
170390682|NCT00938392|615768629|FG001|Overall Study|Withdrawal by Subject|1|||
170390683|NCT00938392|615768628|FG000|Overall Study|Lost to Follow-up|2|||
170390684|NCT00938392|615768629|FG001|Overall Study|Lost to Follow-up|2|||
170390685|NCT02204449|615768630|FG000|Overall Study|Lost to Follow-up|7|||
170390686|NCT02204449|615768631|FG001|Overall Study|Lost to Follow-up|9|||
170390687|NCT02204449|615768630|FG000|Overall Study|Death|0|||
170390688|NCT02204449|615768631|FG001|Overall Study|Death|1|||
170390689|NCT02204449|615768630|FG000|Overall Study|Withdrawal by Subject|0|||
170390690|NCT02204449|615768631|FG001|Overall Study|Withdrawal by Subject|1|||
170390691|NCT01491737|615768635|FG000|Overall Study|Withdrawal by Subject|20|||
170390692|NCT01491737|615768636|FG001|Overall Study|Withdrawal by Subject|17|||
170390693|NCT01491737|615768635|FG000|Overall Study|Lost to Follow-up|2|||
170390694|NCT01491737|615768636|FG001|Overall Study|Lost to Follow-up|10|||
170390695|NCT01491737|615768635|FG000|Overall Study|Death|63|||
170390696|NCT01491737|615768636|FG001|Overall Study|Death|57|||
170390697|NCT01491737|615768635|FG000|Overall Study|Study Termination by Sponsor|36|||
170390698|NCT01491737|615768636|FG001|Overall Study|Study Termination by Sponsor|36|||
170390699|NCT01491737|615768635|FG000|Overall Study|Reason Not Specified|8|||
170390700|NCT01491737|615768636|FG001|Overall Study|Reason Not Specified|9|||
170390701|NCT04780776|615768637|FG000|Titration Week 1-5|Lost to Follow-up|2|||
170390702|NCT04780776|615768638|FG001|Titration Week 1-5|Lost to Follow-up|8|||
170390703|NCT04780776|615768637|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
170390704|NCT04780776|615768638|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
170390705|NCT04780776|615768637|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
170390706|NCT04780776|615768638|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
170390707|NCT00489411|615768639|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
170390708|NCT00489411|615768640|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
170390709|NCT00489411|615768639|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
170390710|NCT00489411|615768640|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
170390711|NCT00489411|615768639|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
170390712|NCT00489411|615768640|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
170390713|NCT00489411|615768639|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
170390714|NCT00489411|615768640|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
170390715|NCT00489411|615768639|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
170390716|NCT00489411|615768640|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
170390717|NCT01748162|615768641|FG000|Overall Study|no additional croup episodes to evaluate|2|||
170390718|NCT01748162|615768642|FG001|Overall Study|no additional croup episodes to evaluate|2|||
170390719|NCT01748162|615768641|FG000|Overall Study|participant consented but did not begin|0|||
170390720|NCT01748162|615768642|FG001|Overall Study|participant consented but did not begin|1|||
170390721|NCT01748162|615768641|FG000|Overall Study|reasons not available|3|||
170390722|NCT01748162|615768642|FG001|Overall Study|reasons not available|2|||
170390723|NCT01012609|615768643|FG000|Overall Study|Withdrawal by Subject|1|||
170390724|NCT01012609|615768644|FG001|Overall Study|Withdrawal by Subject|1|||
170390725|NCT00779857|615768645|FG000|Overall Study|Death|1|||
170390726|NCT00779857|615768645|FG000|Overall Study|Withdrawal by Subject|3|||
170390727|NCT00779857|615768645|FG000|Overall Study|Missed Visit|2|||
170390728|NCT01453296|615768646|FG000|Treatment Period 1|Adverse Event|0|||
170390729|NCT01453296|615768647|FG001|Treatment Period 1|Adverse Event|1|||
170390730|NCT01453296|615768646|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
170390731|NCT01453296|615768647|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
170390732|NCT01453296|615768646|FG000|Treatment Period 2|Adverse Event|1|||
170390733|NCT01453296|615768647|FG001|Treatment Period 2|Adverse Event|0|||
170390734|NCT01453296|615768646|FG000|Treatment Period 2|Withdrawal by Subject|1|||
170390735|NCT01453296|615768647|FG001|Treatment Period 2|Withdrawal by Subject|0|||
170390736|NCT00442572|615768651|FG000|Overall Study|Relapse|8|||
170390737|NCT00442572|615768652|FG001|Overall Study|Relapse|1|||
170390738|NCT00442572|615768651|FG000|Overall Study|Lost to Follow-up|0|||
170390739|NCT00442572|615768652|FG001|Overall Study|Lost to Follow-up|1|||
170390740|NCT00442572|615768651|FG000|Overall Study|Withdrawal by Subject|0|||
170390741|NCT00442572|615768652|FG001|Overall Study|Withdrawal by Subject|1|||
170390742|NCT00308555|615768654|FG000|Overall Study|Withdrawal by Subject|1|||
170390743|NCT00308555|615768655|FG001|Overall Study|Withdrawal by Subject|0|||
170390744|NCT00308555|615768654|FG000|Overall Study|Physician Decision|2|||
170390745|NCT00308555|615768655|FG001|Overall Study|Physician Decision|0|||
170390746|NCT01078974|615768658|FG000|Overall Study|Adverse Event|3|||
170390747|NCT00465894|615768659|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
170390748|NCT00465894|615768660|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
170390749|NCT00465894|615768659|FG000|Treatment For 12 Weeks|Family Issues|1|||
170390750|NCT00465894|615768660|FG001|Treatment For 12 Weeks|Family Issues|1|||
170390751|NCT00465894|615768659|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
170390752|NCT00465894|615768660|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
170390753|NCT01159665|615768661|FG000|Overall Study|Withdrawal by Subject|0|||
170390754|NCT01159665|615768662|FG001|Overall Study|Withdrawal by Subject|1|||
170390755|NCT01159665|615768663|FG002|Overall Study|Withdrawal by Subject|0|||
170390756|NCT01159665|615768664|FG003|Overall Study|Withdrawal by Subject|0|||
170390757|NCT01159665|615768665|FG004|Overall Study|Withdrawal by Subject|0|||
170390758|NCT01159665|615768666|FG005|Overall Study|Withdrawal by Subject|0|||
170390759|NCT00540228|615768667|FG000|Overall Study|Adverse Event|2|||
170390760|NCT00540228|615768668|FG001|Overall Study|Adverse Event|0|||
170390761|NCT00540228|615768669|FG002|Overall Study|Adverse Event|0|||
170390762|NCT00540228|615768670|FG003|Overall Study|Adverse Event|0|||
170390763|NCT00540228|615768671|FG004|Overall Study|Adverse Event|0|||
170390764|NCT00540228|615768667|FG000|Overall Study|Lost to Follow-up|1|||
170390765|NCT00540228|615768668|FG001|Overall Study|Lost to Follow-up|1|||
170390766|NCT00540228|615768669|FG002|Overall Study|Lost to Follow-up|0|||
170390767|NCT00540228|615768670|FG003|Overall Study|Lost to Follow-up|0|||
170390768|NCT00540228|615768671|FG004|Overall Study|Lost to Follow-up|0|||
170390769|NCT01883362|615768672|FG000|Treatment|Adverse Event|1|||
170390770|NCT01883362|615768673|FG001|Treatment|Adverse Event|8|||
170390771|NCT01883362|615768672|FG000|Treatment|Withdrawal by Subject|6|||
170390772|NCT01883362|615768673|FG001|Treatment|Withdrawal by Subject|2|||
170390773|NCT01883362|615768672|FG000|Treatment|Administrative problems|4|||
170390774|NCT01883362|615768673|FG001|Treatment|Administrative problems|1|||
170390775|NCT01883362|615768672|FG000|Treatment|Relapse|4|||
170390776|NCT01883362|615768673|FG001|Treatment|Relapse|2|||
170390777|NCT01883362|615768672|FG000|Treatment|Randomized, not treated|1|||
170390778|NCT01883362|615768673|FG001|Treatment|Randomized, not treated|1|||
170390779|NCT01883362|615768672|FG000|Post Treatment Follow-up|Protocol Violation|0|||
170390780|NCT01883362|615768673|FG001|Post Treatment Follow-up|Protocol Violation|1|||
170390781|NCT01883362|615768672|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
170390782|NCT01883362|615768673|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
170390783|NCT01883362|615768672|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
170390784|NCT01883362|615768673|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
170390785|NCT01883362|615768672|FG000|Post Treatment Follow-up|Administrative problems|2|||
170390786|NCT01883362|615768673|FG001|Post Treatment Follow-up|Administrative problems|0|||
170390787|NCT01883362|615768672|FG000|Post Treatment Follow-up|Death|8|||
170390788|NCT01883362|615768673|FG001|Post Treatment Follow-up|Death|4|||
170390789|NCT01883362|615768672|FG000|Post Treatment Follow-up|Relapse|1|||
170390790|NCT01883362|615768673|FG001|Post Treatment Follow-up|Relapse|2|||
170390791|NCT02569996|615768674|FG000|Overall Study|Adverse Event|6|||
170390792|NCT02569996|615768674|FG000|Overall Study|Physician Decision|3|||
170390793|NCT02569996|615768674|FG000|Overall Study|Progression of the disease|18|||
170390794|NCT02569996|615768674|FG000|Overall Study|New anti-lymphoma treatment|1|||
170390795|NCT02569996|615768674|FG000|Overall Study|Non-compliance|9|||
170390796|NCT02569996|615768674|FG000|Overall Study|Withdrawal by Subject|5|||
170390797|NCT02569996|615768674|FG000|Overall Study|Lost to Follow-up|5|||
170390798|NCT02569996|615768674|FG000|Overall Study|Complete remission|7|||
170390799|NCT02569996|615768674|FG000|Overall Study|Unknown reason|1|||
170390800|NCT01349816|615768677|FG000|Overall Study|Withdrawal by Subject|4|||
170390801|NCT01349816|615768677|FG000|Overall Study|Physician Decision|1|||
170390802|NCT01349816|615768677|FG000|Overall Study|Adverse Event|14|||
170390803|NCT01349816|615768677|FG000|Overall Study|Lost to Follow-up|2|||
170390804|NCT01349816|615768677|FG000|Overall Study|Protocol Violation|1|||
170390805|NCT01349816|615768677|FG000|Overall Study|Protocol-specified criteria|8|||
170390806|NCT01397409|615768679|FG000|Stage 2|Adverse Event|0|||
170390807|NCT01397409|615768680|FG001|Stage 2|Adverse Event|0|||
170390808|NCT01397409|615768681|FG002|Stage 2|Adverse Event|0|||
170390809|NCT01397409|615768682|FG003|Stage 2|Adverse Event|0|||
170390810|NCT01397409|615768683|FG004|Stage 2|Adverse Event|6|||
170390811|NCT01397409|615768684|FG005|Stage 2|Adverse Event|3|||
170390812|NCT01397409|615768685|FG006|Stage 2|Adverse Event|0|||
170390813|NCT01397409|615768686|FG007|Stage 2|Adverse Event|0|||
170390814|NCT01397409|615768687|FG008|Stage 2|Adverse Event|0|||
170390815|NCT01397409|615768688|FG009|Stage 2|Adverse Event|0|||
170390816|NCT01397409|615768679|FG000|Stage 2|Personal Reasons|0|||
170390817|NCT01397409|615768680|FG001|Stage 2|Personal Reasons|0|||
170390818|NCT01397409|615768681|FG002|Stage 2|Personal Reasons|0|||
170390819|NCT01397409|615768682|FG003|Stage 2|Personal Reasons|0|||
170390820|NCT01397409|615768683|FG004|Stage 2|Personal Reasons|1|||
170390821|NCT01397409|615768684|FG005|Stage 2|Personal Reasons|0|||
170390822|NCT01397409|615768685|FG006|Stage 2|Personal Reasons|0|||
170390823|NCT01397409|615768686|FG007|Stage 2|Personal Reasons|0|||
170390824|NCT01397409|615768687|FG008|Stage 2|Personal Reasons|0|||
170390825|NCT01397409|615768688|FG009|Stage 2|Personal Reasons|0|||
170390826|NCT01397409|615768679|FG000|Stage 2|Other Miscellaneous Reasons|0|||
170390827|NCT01397409|615768680|FG001|Stage 2|Other Miscellaneous Reasons|0|||
170390828|NCT01397409|615768681|FG002|Stage 2|Other Miscellaneous Reasons|0|||
170390829|NCT01397409|615768682|FG003|Stage 2|Other Miscellaneous Reasons|0|||
170390830|NCT01397409|615768683|FG004|Stage 2|Other Miscellaneous Reasons|1|||
170390831|NCT01397409|615768684|FG005|Stage 2|Other Miscellaneous Reasons|1|||
170390832|NCT01397409|615768685|FG006|Stage 2|Other Miscellaneous Reasons|0|||
170390833|NCT01397409|615768686|FG007|Stage 2|Other Miscellaneous Reasons|0|||
170390834|NCT01397409|615768687|FG008|Stage 2|Other Miscellaneous Reasons|0|||
170390835|NCT01397409|615768688|FG009|Stage 2|Other Miscellaneous Reasons|0|||
170390836|NCT01397409|615768679|FG000|Stage 3|Adverse Event|0|||
170390837|NCT01397409|615768680|FG001|Stage 3|Adverse Event|0|||
170390838|NCT01397409|615768681|FG002|Stage 3|Adverse Event|0|||
170390839|NCT01397409|615768682|FG003|Stage 3|Adverse Event|0|||
170390840|NCT01397409|615768683|FG004|Stage 3|Adverse Event|0|||
170390841|NCT01397409|615768684|FG005|Stage 3|Adverse Event|0|||
170390842|NCT01397409|615768685|FG006|Stage 3|Adverse Event|0|||
170390843|NCT01397409|615768686|FG007|Stage 3|Adverse Event|1|||
170390844|NCT01397409|615768687|FG008|Stage 3|Adverse Event|0|||
170390845|NCT01397409|615768688|FG009|Stage 3|Adverse Event|0|||
170390846|NCT01397409|615768679|FG000|Stage 3|Other Miscellaneous Reasons|0|||
170390847|NCT01397409|615768680|FG001|Stage 3|Other Miscellaneous Reasons|0|||
170390848|NCT01397409|615768681|FG002|Stage 3|Other Miscellaneous Reasons|0|||
170390849|NCT01397409|615768682|FG003|Stage 3|Other Miscellaneous Reasons|0|||
170390850|NCT01397409|615768683|FG004|Stage 3|Other Miscellaneous Reasons|0|||
170390851|NCT01397409|615768684|FG005|Stage 3|Other Miscellaneous Reasons|0|||
170390852|NCT01397409|615768685|FG006|Stage 3|Other Miscellaneous Reasons|0|||
170390853|NCT01397409|615768686|FG007|Stage 3|Other Miscellaneous Reasons|1|||
170390854|NCT01397409|615768687|FG008|Stage 3|Other Miscellaneous Reasons|0|||
170390855|NCT01397409|615768688|FG009|Stage 3|Other Miscellaneous Reasons|0|||
170390856|NCT03418727|615768689|FG000|Overall Study|Adverse Event|1|||
170390857|NCT03418727|615768690|FG001|Overall Study|Adverse Event|2|||
170390858|NCT03418727|615768691|FG002|Overall Study|Adverse Event|0|||
170390859|NCT03418727|615768689|FG000|Overall Study|Withdrawal by Subject|0|||
170390860|NCT03418727|615768690|FG001|Overall Study|Withdrawal by Subject|0|||
170390861|NCT03418727|615768691|FG002|Overall Study|Withdrawal by Subject|2|||
170390862|NCT01791543|615768693|FG000|Overall Study|Lost to Follow-up|1|||
170390863|NCT01791543|615768693|FG000|Overall Study|Adverse Event|1|||
170390864|NCT01790633|615768694|FG000|Overall Study|Protocol Violation|1|||
170390865|NCT01790633|615768695|FG001|Overall Study|Protocol Violation|2|||
170390866|NCT01790633|615768694|FG000|Overall Study|Did not have serology performed|47|||
170390867|NCT01790633|615768695|FG001|Overall Study|Did not have serology performed|0|||
170390868|NCT01790633|615768694|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
170390869|NCT01790633|615768695|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
170390870|NCT00967343|615768696|FG000|Overall Study|Study termination by sponsor|12|||
170390871|NCT00967343|615768696|FG000|Overall Study|Death|24|||
170390872|NCT00967343|615768696|FG000|Overall Study|Relapse|1|||
170390873|NCT00967343|615768696|FG000|Overall Study|Lost to Follow-up|1|||
170390874|NCT00509223|615770512|FG000|Overall Study|Lost to Follow-up|1|||
170390875|NCT00509223|615770513|FG001|Overall Study|Lost to Follow-up|1|||
170390876|NCT00509223|615770512|FG000|Overall Study|Adverse Event|1|||
170390877|NCT00509223|615770513|FG001|Overall Study|Adverse Event|1|||
170390878|NCT00509223|615770512|FG000|Overall Study|Withdrawal by Subject|25|||
170390879|NCT00509223|615770513|FG001|Overall Study|Withdrawal by Subject|6|||
170390880|NCT00509223|615770512|FG000|Overall Study|Including: subject change of address|5|||
170390881|NCT00509223|615770513|FG001|Overall Study|Including: subject change of address|2|||
170390882|NCT00509223|615770512|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
170390883|NCT00509223|615770513|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
170390884|NCT01740297|615770514|FG000|Overall Study|Withdrawal by Subject|4|||
170390885|NCT01740297|615770515|FG001|Overall Study|Withdrawal by Subject|16|||
170390886|NCT01740297|615770516|FG002|Overall Study|Withdrawal by Subject|17|||
170390887|NCT01740297|615770514|FG000|Overall Study|Death|8|||
170390888|NCT01740297|615770515|FG001|Overall Study|Death|46|||
170390889|NCT01740297|615770516|FG002|Overall Study|Death|40|||
170390890|NCT01740297|615770514|FG000|Overall Study|Lost to Follow-up|1|||
170390891|NCT01740297|615770515|FG001|Overall Study|Lost to Follow-up|2|||
170390892|NCT01740297|615770516|FG002|Overall Study|Lost to Follow-up|4|||
170390893|NCT00563706|615770521|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
170390894|NCT00563706|615770522|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
170390895|NCT00563706|615770523|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
170390896|NCT00563706|615770524|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
170390897|NCT00563706|615770525|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
170390898|NCT00563706|615770526|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
170390899|NCT00563706|615770527|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
170390900|NCT00563706|615770528|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
170390901|NCT00563706|615770529|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
170390902|NCT00563706|615770521|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
170390903|NCT00563706|615770522|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
170390904|NCT00563706|615770523|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
170390905|NCT00563706|615770524|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
170390906|NCT00563706|615770525|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
170390907|NCT00563706|615770526|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
170390908|NCT00563706|615770527|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
170390909|NCT00563706|615770528|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
170390910|NCT00563706|615770529|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
170390911|NCT00563706|615770521|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
170390912|NCT00563706|615770522|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
170390913|NCT00563706|615770523|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
170390914|NCT00563706|615770524|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
170390915|NCT00563706|615770525|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
170390916|NCT00563706|615770526|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
170390917|NCT00563706|615770527|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
170390918|NCT00563706|615770528|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
170390919|NCT00563706|615770529|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
170390920|NCT00563706|615770521|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
170390921|NCT00563706|615770522|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
170390922|NCT00563706|615770523|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
170390923|NCT00563706|615770524|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
170390924|NCT00563706|615770525|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
170390925|NCT00563706|615770526|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
170390926|NCT00563706|615770527|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
170390927|NCT00563706|615770528|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
170390928|NCT00563706|615770529|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
170390929|NCT00563706|615770521|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
170390930|NCT00563706|615770522|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
170390931|NCT00563706|615770523|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
170390932|NCT00563706|615770524|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
170390933|NCT00563706|615770525|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
170390934|NCT00563706|615770526|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
170390935|NCT00563706|615770527|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
170390936|NCT00563706|615770528|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
170390937|NCT00563706|615770529|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
170390938|NCT03280628|615770532|FG000|Overall Study|Lost to Follow-up|8|||
170390939|NCT03280628|615770533|FG001|Overall Study|Lost to Follow-up|6|||
170390940|NCT03280628|615770534|FG002|Overall Study|Lost to Follow-up|11|||
170390941|NCT02383966|615770542|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
170390942|NCT02383966|615770543|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
170390943|NCT02383966|615770542|FG000|Overall Study|Randomized, but not treated|1|||
170390944|NCT02383966|615770543|FG001|Overall Study|Randomized, but not treated|3|||
170390945|NCT01361308|615770549|FG000|Overall Study|Withdrawal by Subject|9|||
170390946|NCT01361308|615770550|FG001|Overall Study|Withdrawal by Subject|13|||
170390947|NCT01361308|615770549|FG000|Overall Study|Physician Decision|3|||
170390948|NCT01361308|615770550|FG001|Overall Study|Physician Decision|3|||
170390949|NCT01361308|615770549|FG000|Overall Study|Lack of Efficacy|2|||
170390950|NCT01361308|615770550|FG001|Overall Study|Lack of Efficacy|0|||
170390951|NCT01361308|615770549|FG000|Overall Study|Protocol Violation|1|||
170390952|NCT01361308|615770550|FG001|Overall Study|Protocol Violation|0|||
170390953|NCT01361308|615770549|FG000|Overall Study|Lost to Follow-up|5|||
170390954|NCT01361308|615770550|FG001|Overall Study|Lost to Follow-up|4|||
170390955|NCT01361308|615770549|FG000|Overall Study|Adverse Event|8|||
170390956|NCT01361308|615770550|FG001|Overall Study|Adverse Event|4|||
170390957|NCT01361308|615770549|FG000|Overall Study|Eligibility Criteria Not Met|2|||
170390958|NCT01361308|615770550|FG001|Overall Study|Eligibility Criteria Not Met|3|||
170390959|NCT01361308|615770549|FG000|Overall Study|Failed C-SSRS|5|||
170390960|NCT01361308|615770550|FG001|Overall Study|Failed C-SSRS|2|||
170390961|NCT01361308|615770549|FG000|Overall Study|Other|0|||
170390962|NCT01361308|615770550|FG001|Overall Study|Other|1|||
170390963|NCT01241591|615770559|FG000|Overall Study|Lack of Efficacy|5|||
170390964|NCT01241591|615770560|FG001|Overall Study|Lack of Efficacy|2|||
170390965|NCT01241591|615770561|FG002|Overall Study|Lack of Efficacy|2|||
170390966|NCT01241591|615770562|FG003|Overall Study|Lack of Efficacy|3|||
170390967|NCT01241591|615770559|FG000|Overall Study|Protocol Violation|5|||
170390968|NCT01241591|615770560|FG001|Overall Study|Protocol Violation|2|||
170390969|NCT01241591|615770561|FG002|Overall Study|Protocol Violation|3|||
170390970|NCT01241591|615770562|FG003|Overall Study|Protocol Violation|0|||
170390971|NCT01241591|615770559|FG000|Overall Study|Lost to Follow-up|1|||
170390972|NCT01241591|615770560|FG001|Overall Study|Lost to Follow-up|2|||
170390973|NCT01241591|615770561|FG002|Overall Study|Lost to Follow-up|2|||
170390974|NCT01241591|615770562|FG003|Overall Study|Lost to Follow-up|2|||
170390975|NCT01241591|615770559|FG000|Overall Study|Screen Failure|3|||
170390976|NCT01241591|615770560|FG001|Overall Study|Screen Failure|2|||
170390977|NCT01241591|615770561|FG002|Overall Study|Screen Failure|1|||
170390978|NCT01241591|615770562|FG003|Overall Study|Screen Failure|0|||
170390979|NCT01241591|615770559|FG000|Overall Study|Withdrawal by Subject|6|||
170390980|NCT01241591|615770560|FG001|Overall Study|Withdrawal by Subject|4|||
170390981|NCT01241591|615770561|FG002|Overall Study|Withdrawal by Subject|2|||
170390982|NCT01241591|615770562|FG003|Overall Study|Withdrawal by Subject|2|||
170390983|NCT01241591|615770559|FG000|Overall Study|Other|0|||
170390984|NCT01241591|615770560|FG001|Overall Study|Other|1|||
170390985|NCT01241591|615770561|FG002|Overall Study|Other|0|||
170390986|NCT01241591|615770562|FG003|Overall Study|Other|1|||
170390987|NCT01241591|615770559|FG000|Overall Study|Adverse Event|3|||
170390988|NCT01241591|615770560|FG001|Overall Study|Adverse Event|11|||
170390989|NCT01241591|615770561|FG002|Overall Study|Adverse Event|12|||
170390990|NCT01241591|615770562|FG003|Overall Study|Adverse Event|4|||
170390991|NCT02389621|615770564|FG000|Treatment Period|Withdrawal by Subject|1|||
170390992|NCT02389621|615770565|FG001|Treatment Period|Withdrawal by Subject|1|||
170390993|NCT02389621|615770564|FG000|Posttreatment Period|Adverse Event|3|||
170390994|NCT02389621|615770565|FG001|Posttreatment Period|Adverse Event|1|||
170390995|NCT02389621|615770564|FG000|Posttreatment Period|Withdrawal by Subject|3|||
170390996|NCT02389621|615770565|FG001|Posttreatment Period|Withdrawal by Subject|2|||
170390997|NCT02389621|615770564|FG000|Posttreatment Period|Lost to Follow-up|1|||
170390998|NCT02389621|615770565|FG001|Posttreatment Period|Lost to Follow-up|1|||
170390999|NCT02389621|615770564|FG000|Posttreatment Period|Other - Miscellaneous|2|||
170391000|NCT02389621|615770565|FG001|Posttreatment Period|Other - Miscellaneous|0|||
170391001|NCT00437294|615770566|FG000|Overall Study|Adverse Event|5|||
170391002|NCT00437294|615770567|FG001|Overall Study|Adverse Event|4|||
170391003|NCT00437294|615770566|FG000|Overall Study|Death|5|||
170391004|NCT00437294|615770567|FG001|Overall Study|Death|2|||
170391005|NCT00437294|615770566|FG000|Overall Study|Physician Decision|0|||
170391006|NCT00437294|615770567|FG001|Overall Study|Physician Decision|3|||
170391007|NCT00437294|615770566|FG000|Overall Study|Withdrawal by Subject|5|||
170391008|NCT00437294|615770567|FG001|Overall Study|Withdrawal by Subject|0|||
170391009|NCT00437294|615770566|FG000|Overall Study|Progressive Disease|19|||
170391010|NCT00437294|615770567|FG001|Overall Study|Progressive Disease|23|||
170391011|NCT00437294|615770566|FG000|Overall Study|Sponsor Decision|8|||
170391012|NCT00437294|615770567|FG001|Overall Study|Sponsor Decision|9|||
170391013|NCT00437294|615770566|FG000|Overall Study|Protocol Violation|0|||
170391014|NCT00437294|615770567|FG001|Overall Study|Protocol Violation|1|||
170391015|NCT00437294|615770566|FG000|Overall Study|Entry criteria not met|1|||
170391016|NCT00437294|615770567|FG001|Overall Study|Entry criteria not met|1|||
170391017|NCT01339273|615770576|FG000|Overall Study|Lost to Follow-up|8|||
170391018|NCT01339273|615770577|FG001|Overall Study|Lost to Follow-up|8|||
170391019|NCT00124709|615770580|FG000|Overall Study|Randomized but did not take medication|3|||
170391020|NCT00124709|615770581|FG001|Overall Study|Randomized but did not take medication|1|||
170391021|NCT00124709|615770580|FG000|Overall Study|Adverse Event|3|||
170391022|NCT00124709|615770581|FG001|Overall Study|Adverse Event|0|||
170391023|NCT00124709|615770580|FG000|Overall Study|Lack of Efficacy|5|||
170391024|NCT00124709|615770581|FG001|Overall Study|Lack of Efficacy|10|||
170391025|NCT00124709|615770580|FG000|Overall Study|Protocol Violation|3|||
170391026|NCT00124709|615770581|FG001|Overall Study|Protocol Violation|5|||
170391027|NCT00124709|615770580|FG000|Overall Study|Withdrawal by Subject|127|||
170391028|NCT00124709|615770581|FG001|Overall Study|Withdrawal by Subject|136|||
170391029|NCT00124709|615770580|FG000|Overall Study|Lost to Follow-up|114|||
170391030|NCT00124709|615770581|FG001|Overall Study|Lost to Follow-up|120|||
170391031|NCT00122954|615770582|FG000|Overall Study|Withdrawal by Subject|2|||
170391032|NCT00122954|615770583|FG001|Overall Study|Withdrawal by Subject|2|||
170391033|NCT00122954|615770582|FG000|Overall Study|Protocol Violation|0|||
170391034|NCT00122954|615770583|FG001|Overall Study|Protocol Violation|1|||
170391035|NCT00558831|615770584|FG000|Overall Study|Lost to Follow-up|1|||
170391036|NCT03772574|615770587|FG000|Overall Study|Protocol Violation|2|||
170391037|NCT03772574|615770588|FG001|Overall Study|Protocol Violation|0|||
170391038|NCT03772574|615770589|FG002|Overall Study|Protocol Violation|0|||
170391039|NCT03772574|615770587|FG000|Overall Study|Discomfort|0|||
170391040|NCT03772574|615770588|FG001|Overall Study|Discomfort|5|||
170391041|NCT03772574|615770589|FG002|Overall Study|Discomfort|4|||
170391042|NCT03358407|615770599|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391043|NCT03358407|615770600|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391044|NCT03358407|615770601|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
170391045|NCT03358407|615770602|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391046|NCT03358407|615770603|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391047|NCT03358407|615770604|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391048|NCT03358407|615770605|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391049|NCT03358407|615770606|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391050|NCT03358407|615770607|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391051|NCT03358407|615770608|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
170391052|NCT03358407|615770599|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391053|NCT03358407|615770600|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391054|NCT03358407|615770601|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391055|NCT03358407|615770602|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391056|NCT03358407|615770603|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
170391057|NCT03358407|615770604|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391058|NCT03358407|615770605|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391059|NCT03358407|615770606|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391060|NCT03358407|615770607|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391061|NCT03358407|615770608|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391062|NCT03358407|615770599|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
170391063|NCT03358407|615770600|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
170391064|NCT03358407|615770601|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
170391065|NCT03358407|615770602|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
170391066|NCT03358407|615770603|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
170391067|NCT03358407|615770604|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
170391068|NCT03358407|615770605|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
170391069|NCT03358407|615770606|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
170391070|NCT03358407|615770607|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
170391071|NCT03358407|615770608|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
170391072|NCT03358407|615770599|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
170391073|NCT03358407|615770600|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
170391074|NCT03358407|615770601|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
170391075|NCT03358407|615770602|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
170391076|NCT03358407|615770603|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
170391077|NCT03358407|615770604|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
170391078|NCT03358407|615770605|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
170391079|NCT03358407|615770606|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
170391080|NCT03358407|615770607|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
170391081|NCT03358407|615770608|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
170391082|NCT03358407|615770599|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391083|NCT03358407|615770600|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391084|NCT03358407|615770601|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391085|NCT03358407|615770602|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391086|NCT03358407|615770603|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391087|NCT03358407|615770604|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
170391088|NCT03358407|615770605|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
170391089|NCT03358407|615770606|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391090|NCT03358407|615770607|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391091|NCT03358407|615770608|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
170391092|NCT03358407|615770599|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
170391093|NCT03358407|615770600|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
170391094|NCT03358407|615770601|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
170391095|NCT03358407|615770602|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
170391096|NCT03358407|615770603|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
170391097|NCT03358407|615770604|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
170391098|NCT03358407|615770605|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
170391099|NCT03358407|615770606|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
170391100|NCT03358407|615770607|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
170391101|NCT03358407|615770608|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
170391102|NCT00483574|615770609|FG000|Overall Study|Adverse Event|6|||
170391103|NCT00483574|615770610|FG001|Overall Study|Adverse Event|0|||
170391104|NCT00483574|615770609|FG000|Overall Study|Protocol Violation|28|||
170391105|NCT00483574|615770610|FG001|Overall Study|Protocol Violation|9|||
170391106|NCT00483574|615770609|FG000|Overall Study|Lost to Follow-up|16|||
170391107|NCT00483574|615770610|FG001|Overall Study|Lost to Follow-up|4|||
170391108|NCT00483574|615770609|FG000|Overall Study|Withdrawal by Subject|52|||
170391109|NCT00483574|615770610|FG001|Overall Study|Withdrawal by Subject|0|||
170391110|NCT03605758|615770611|FG000|Overall Study|Lost to Follow-up|2|||
170391111|NCT03605758|615770612|FG001|Overall Study|Lost to Follow-up|1|||
170391112|NCT03605758|615770611|FG000|Overall Study|Illness|0|||
170391113|NCT03605758|615770612|FG001|Overall Study|Illness|1|||
170391114|NCT03605758|615770611|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
170391115|NCT03605758|615770612|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
170391116|NCT04753606|615770615|FG000|Overall Study|Adverse Event|1|||
170391117|NCT04753606|615770616|FG001|Overall Study|Adverse Event|0|||
170391118|NCT04753606|615770617|FG002|Overall Study|Adverse Event|0|||
170391119|NCT03841331|615770620|FG000|Overall Study|Withdrawal by Subject|4|||
170391120|NCT03841331|615770621|FG001|Overall Study|Withdrawal by Subject|9|||
170391121|NCT03841331|615770620|FG000|Overall Study|Lost to Follow-up|5|||
170391122|NCT03841331|615770621|FG001|Overall Study|Lost to Follow-up|1|||
170391123|NCT03219372|615770622|FG000|Overall Study|Withdrawal by Subject|1|||
170391124|NCT03219372|615770623|FG001|Overall Study|Withdrawal by Subject|0|||
170391125|NCT02743117|615770624|FG000|Overall Study|Lost to Follow-up|0|||
170391126|NCT02743117|615770625|FG001|Overall Study|Lost to Follow-up|1|||
170391127|NCT02743117|615770624|FG000|Overall Study|Other|1|||
170391128|NCT02743117|615770625|FG001|Overall Study|Other|0|||
170391129|NCT04983589|615770626|FG000|Overall Study|Withdrawal by Subject|0|||
170391130|NCT04983589|615770627|FG001|Overall Study|Withdrawal by Subject|3|||
170391131|NCT04983589|615770626|FG000|Overall Study|COVID-19 Infection|1|||
170391132|NCT04983589|615770627|FG001|Overall Study|COVID-19 Infection|0|||
170391133|NCT04983589|615770626|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
170391134|NCT04983589|615770627|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
170391135|NCT00761969|615770628|FG000|Overall Study|Death|112|||
170391136|NCT00761969|615770629|FG001|Overall Study|Death|47|||
170391137|NCT00761969|615770628|FG000|Overall Study|Lost to Follow-up|88|||
170391138|NCT00761969|615770629|FG001|Overall Study|Lost to Follow-up|93|||
170391139|NCT03557775|615770630|FG000|Overall Study|Withdrawal by Subject|1|||
170391140|NCT03557775|615770631|FG001|Overall Study|Withdrawal by Subject|2|||
170391141|NCT03557775|615770632|FG002|Overall Study|Withdrawal by Subject|4|||
170391142|NCT03557775|615770630|FG000|Overall Study|Physician Decision|0|||
170391143|NCT03557775|615770631|FG001|Overall Study|Physician Decision|1|||
170391144|NCT03557775|615770632|FG002|Overall Study|Physician Decision|0|||
170391145|NCT01725217|615770633|FG000|Overall Study|Withdrawal by Subject|1|||
170391146|NCT01725217|615770634|FG001|Overall Study|Withdrawal by Subject|0|||
170391147|NCT01725217|615770635|FG002|Overall Study|Withdrawal by Subject|0|||
170391148|NCT00276458|615770640|FG000|Overall Study|Adverse Event|0|||
170391149|NCT00276458|615770641|FG001|Overall Study|Adverse Event|2|||
170391150|NCT00276458|615770640|FG000|Overall Study|Lost to Follow-up|2|||
170391151|NCT00276458|615770641|FG001|Overall Study|Lost to Follow-up|2|||
170391152|NCT00276458|615770640|FG000|Overall Study|Protocol Violation|4|||
170391153|NCT00276458|615770641|FG001|Overall Study|Protocol Violation|3|||
170391154|NCT00585468|615770642|FG000|First Intervention|Withdrawal by Subject|1|||
170391155|NCT00585468|615770643|FG001|First Intervention|Withdrawal by Subject|1|||
170391156|NCT02940392|615770650|FG000|Overall Study|Lost to Follow-up|3|||
170391157|NCT02940392|615770650|FG000|Overall Study|Retreatment|3|||
170391158|NCT02940392|615770650|FG000|Overall Study|Death|2|||
170391159|NCT03205046|615770652|FG000|Overall Study|Death|10|||
170391160|NCT03205046|615770653|FG001|Overall Study|Death|6|||
170391161|NCT03205046|615770652|FG000|Overall Study|Withdrawal by Subject|1|||
170391162|NCT03205046|615770653|FG001|Overall Study|Withdrawal by Subject|2|||
170391163|NCT03205046|615770652|FG000|Overall Study|Lost to Follow-up|0|||
170391164|NCT03205046|615770653|FG001|Overall Study|Lost to Follow-up|1|||
170391165|NCT03205046|615770652|FG000|Overall Study|Study terminated by sponsor|2|||
170391166|NCT03205046|615770653|FG001|Overall Study|Study terminated by sponsor|1|||
170391167|NCT00762073|615770656|FG000|Overall Study|Lack of Efficacy|1|||
170391168|NCT00762073|615770657|FG001|Overall Study|Lack of Efficacy|1|||
170391169|NCT00762073|615770658|FG002|Overall Study|Lack of Efficacy|0|||
170391170|NCT00762073|615770659|FG003|Overall Study|Lack of Efficacy|0|||
170391171|NCT00762073|615770656|FG000|Overall Study|Adverse Event|1|||
170391172|NCT00762073|615770657|FG001|Overall Study|Adverse Event|0|||
170391173|NCT00762073|615770658|FG002|Overall Study|Adverse Event|1|||
170391174|NCT00762073|615770659|FG003|Overall Study|Adverse Event|1|||
170391175|NCT00762073|615770656|FG000|Overall Study|Significant Subject Noncompliance|0|||
170391176|NCT00762073|615770657|FG001|Overall Study|Significant Subject Noncompliance|1|||
170391177|NCT00762073|615770658|FG002|Overall Study|Significant Subject Noncompliance|0|||
170391178|NCT00762073|615770659|FG003|Overall Study|Significant Subject Noncompliance|1|||
170391179|NCT00762073|615770656|FG000|Overall Study|Withdrawal by Subject|1|||
170391180|NCT00762073|615770657|FG001|Overall Study|Withdrawal by Subject|2|||
170391181|NCT00762073|615770658|FG002|Overall Study|Withdrawal by Subject|1|||
170391182|NCT00762073|615770659|FG003|Overall Study|Withdrawal by Subject|1|||
170391183|NCT00762073|615770656|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
170391184|NCT00762073|615770657|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
170391185|NCT00762073|615770658|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
170391186|NCT00762073|615770659|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
170391187|NCT02319642|615770660|FG000|Overall Study|Adverse Event|2|||
170391188|NCT02319642|615770661|FG001|Overall Study|Adverse Event|4|||
170391189|NCT02319642|615770660|FG000|Overall Study|Lack of Efficacy|1|||
170391190|NCT02319642|615770661|FG001|Overall Study|Lack of Efficacy|1|||
170391191|NCT02319642|615770660|FG000|Overall Study|Withdrawal by Subject|1|||
170391192|NCT02319642|615770661|FG001|Overall Study|Withdrawal by Subject|1|||
170391193|NCT01265875|615770662|FG000|Overall Study|Uncooperative/unreliable|1|||
170391194|NCT02304484|615770665|FG000|Overall Study|Death|9|||
170391195|NCT02304484|615770665|FG000|Overall Study|Withdrawal by Subject|14|||
170391196|NCT02304484|615770665|FG000|Overall Study|Lost to Follow-up|2|||
170391197|NCT02967055|615770666|FG000|Overall Study|Excluded|40|||
170391198|NCT02967055|615770666|FG000|Overall Study|Screen fail|3|||
170391199|NCT02967055|615770666|FG000|Overall Study|Lost to Follow-up|2|||
170391200|NCT02967055|615770666|FG000|Overall Study|Stopped due to side effects|3|||
170391201|NCT02967055|615770666|FG000|Overall Study|Stopped due to drug cost|1|||
170391202|NCT00752206|615770667|FG000|Overall Study|Disease progression|8|||
170391203|NCT00752206|615770668|FG001|Overall Study|Disease progression|11|||
170391204|NCT00752206|615770667|FG000|Overall Study|Pregnancy|1|||
170391205|NCT00752206|615770668|FG001|Overall Study|Pregnancy|0|||
170391206|NCT01326481|615770681|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
170391207|NCT02400281|615770682|FG000|Overall Study|Adverse Event|0|||
170391208|NCT02400281|615770683|FG001|Overall Study|Adverse Event|0|||
170391209|NCT02400281|615770684|FG002|Overall Study|Adverse Event|1|||
170391210|NCT02400281|615770685|FG003|Overall Study|Adverse Event|0|||
170391211|NCT02400281|615770686|FG004|Overall Study|Adverse Event|1|||
170391212|NCT02400281|615770687|FG005|Overall Study|Adverse Event|0|||
170391213|NCT02400281|615770682|FG000|Overall Study|Physician Decision|0|||
170391214|NCT02400281|615770683|FG001|Overall Study|Physician Decision|0|||
170391215|NCT02400281|615770684|FG002|Overall Study|Physician Decision|1|||
170391216|NCT02400281|615770685|FG003|Overall Study|Physician Decision|0|||
170391217|NCT02400281|615770686|FG004|Overall Study|Physician Decision|0|||
170391218|NCT02400281|615770687|FG005|Overall Study|Physician Decision|0|||
170391219|NCT00157157|615770690|FG000|Overall Study|Withdrawal by Subject|6|||
170391220|NCT00157157|615770690|FG000|Overall Study|Physician Decision|1|||
170391221|NCT00157157|615770690|FG000|Overall Study|Lost to Follow-up|1|||
170391222|NCT00157157|615770690|FG000|Overall Study|Enrolled in another study|1|||
170391223|NCT00157157|615770690|FG000|Overall Study|Met exclusion criteria|1|||
170391224|NCT00157157|615770690|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
170391225|NCT02985541|615772392|FG000|Overall Study|Withdrawal by Subject|33|||
170391226|NCT02985541|615772392|FG000|Overall Study|Lost to Follow-up|26|||
170391227|NCT02985541|615772392|FG000|Overall Study|Adverse Event|27|||
170391228|NCT02985541|615772392|FG000|Overall Study|Physician Decision|2|||
170391229|NCT02985541|615772392|FG000|Overall Study|Pregnancy|2|||
170391230|NCT02985541|615772392|FG000|Overall Study|Wish for pregnancy|44|||
170391231|NCT02985541|615772392|FG000|Overall Study|Other reason|5|||
170391232|NCT02985541|615772392|FG000|Overall Study|Not valid for analysis|2|||
170391233|NCT02983305|615772393|FG000|Overall Study|incomplete data|2|||
170391234|NCT02983305|615772394|FG001|Overall Study|incomplete data|0|||
170391235|NCT02222246|615772399|FG000|Overall Study|No Emergency Department Visits|27|||
170391236|NCT02222246|615772400|FG001|Overall Study|No Emergency Department Visits|26|||
170391237|NCT02222246|615772399|FG000|Overall Study|Physician Decision|0|||
170391238|NCT02222246|615772400|FG001|Overall Study|Physician Decision|1|||
170391239|NCT01646268|615772401|FG000|Overall Study|Adverse Event|6|||
170391240|NCT01646268|615772402|FG001|Overall Study|Adverse Event|7|||
170391241|NCT01646268|615772401|FG000|Overall Study|Lack of Efficacy|1|||
170391242|NCT01646268|615772402|FG001|Overall Study|Lack of Efficacy|3|||
170391243|NCT01646268|615772401|FG000|Overall Study|Protocol Violation|0|||
170391244|NCT01646268|615772402|FG001|Overall Study|Protocol Violation|1|||
170391245|NCT01646268|615772401|FG000|Overall Study|Withdrawal by Subject|2|||
170391246|NCT01646268|615772402|FG001|Overall Study|Withdrawal by Subject|5|||
170391247|NCT01646268|615772401|FG000|Overall Study|Other|2|||
170391248|NCT01646268|615772402|FG001|Overall Study|Other|0|||
170391249|NCT02064231|615772405|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
170391250|NCT02064231|615772406|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
170391251|NCT02064231|615772407|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
170391252|NCT02064231|615772408|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
170391253|NCT02064231|615772405|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
170391254|NCT02064231|615772406|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
170391255|NCT02064231|615772407|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
170391256|NCT02064231|615772408|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
170391257|NCT02064231|615772405|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
170391258|NCT02064231|615772406|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
170391259|NCT02064231|615772407|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
170391260|NCT02064231|615772408|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
170391261|NCT02064231|615772405|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
170391262|NCT02064231|615772406|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
170391263|NCT02064231|615772407|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
170391264|NCT02064231|615772408|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
170391265|NCT00457249|615772409|FG000|Overall Study|Lost to Follow-up|3|||
170391266|NCT00457249|615772410|FG001|Overall Study|Lost to Follow-up|0|||
170391267|NCT00457249|615772409|FG000|Overall Study|Protocol Violation|4|||
170391268|NCT00457249|615772410|FG001|Overall Study|Protocol Violation|1|||
170391269|NCT00457249|615772409|FG000|Overall Study|Withdrawal by Subject|3|||
170391270|NCT00457249|615772410|FG001|Overall Study|Withdrawal by Subject|1|||
170391271|NCT00457249|615772409|FG000|Overall Study|Serious Adverse Events|2|||
170391272|NCT00457249|615772410|FG001|Overall Study|Serious Adverse Events|0|||
170391273|NCT04621227|615772413|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
170391274|NCT04621227|615772413|FG000|Period 3 (29 Days)|Adverse Event|1|||
170391275|NCT04621227|615772413|FG000|Period 8 (2 Days)|Adverse Event|1|||
170391276|NCT02916056|615772414|FG000|Overall Study|Adverse Event|6|||
170391277|NCT02916056|615772414|FG000|Overall Study|Lost to Follow-up|1|||
170391278|NCT02916056|615772414|FG000|Overall Study|Other|12|||
170391279|NCT02916056|615772414|FG000|Overall Study|Protocol Violation|1|||
170391280|NCT02916056|615772414|FG000|Overall Study|Withdrawal by Subject|8|||
170391281|NCT02916056|615772414|FG000|Overall Study|Study Terminated by Sponsor|269|||
170391282|NCT02875340|615772419|FG000|Overall Study|Death|2|||
170391283|NCT02875340|615772419|FG000|Overall Study|Withdrawal by Subject|2|||
170391284|NCT02875340|615772419|FG000|Overall Study|Physician Decision|3|||
170391285|NCT02875340|615772419|FG000|Overall Study|Adverse Event|1|||
170391286|NCT00812968|615772422|FG000|Overall Study|Relapse after erythroid response|6|||
170391287|NCT00812968|615772422|FG000|Overall Study|Disease progression|1|||
170391288|NCT00812968|615772422|FG000|Overall Study|No further treatment required|1|||
170391289|NCT00812968|615772422|FG000|Overall Study|Study closed due to marketing approval|3|||
170391290|NCT02696382|615772423|FG000|Overall Study|Death|7|||
170391291|NCT02696382|615772424|FG001|Overall Study|Death|2|||
170391292|NCT02696382|615772423|FG000|Overall Study|Withdrawal by Subject|5|||
170391293|NCT02696382|615772424|FG001|Overall Study|Withdrawal by Subject|12|||
170391294|NCT02696382|615772423|FG000|Overall Study|Lost to Follow-up|4|||
170391295|NCT02696382|615772424|FG001|Overall Study|Lost to Follow-up|7|||
170391296|NCT00494234|615772425|FG000|Overall Study|Withdrawal by Subject|1|||
170391297|NCT00494234|615772426|FG001|Overall Study|Withdrawal by Subject|0|||
170391298|NCT00494234|615772425|FG000|Overall Study|Disease progression|11|||
170391299|NCT00494234|615772426|FG001|Overall Study|Disease progression|8|||
170391300|NCT00494234|615772425|FG000|Overall Study|Death|2|||
170391301|NCT00494234|615772426|FG001|Overall Study|Death|1|||
170391302|NCT04359758|615772427|FG000|Overall Study|Protocol Violation|3|||
170391303|NCT04359758|615772428|FG001|Overall Study|Protocol Violation|2|||
170391304|NCT00505765|615772432|FG000|Overall Study|Withdrawal by Subject|1|||
170391305|NCT00505765|615772433|FG001|Overall Study|Withdrawal by Subject|0|||
170391306|NCT00505765|615772434|FG002|Overall Study|Withdrawal by Subject|0|||
170391307|NCT00505765|615772432|FG000|Overall Study|Adverse Event|1|||
170391308|NCT00505765|615772433|FG001|Overall Study|Adverse Event|2|||
170391309|NCT00505765|615772434|FG002|Overall Study|Adverse Event|0|||
170391310|NCT00505765|615772432|FG000|Overall Study|Noncompliance|0|||
170391311|NCT00505765|615772433|FG001|Overall Study|Noncompliance|1|||
170391312|NCT00505765|615772434|FG002|Overall Study|Noncompliance|3|||
170391313|NCT00620776|615772436|FG000|Overall Study|Did not receive treatment|3|||
170391314|NCT00620776|615772437|FG001|Overall Study|Did not receive treatment|5|||
170391315|NCT00620776|615772436|FG000|Overall Study|Adverse Event|2|||
170391316|NCT00620776|615772437|FG001|Overall Study|Adverse Event|3|||
170391317|NCT00620776|615772436|FG000|Overall Study|Lack of Efficacy|2|||
170391318|NCT00620776|615772437|FG001|Overall Study|Lack of Efficacy|1|||
170391319|NCT00620776|615772436|FG000|Overall Study|Lost to Follow-up|2|||
170391320|NCT00620776|615772437|FG001|Overall Study|Lost to Follow-up|5|||
170391321|NCT00620776|615772436|FG000|Overall Study|Withdrawal by Subject|3|||
170391322|NCT00620776|615772437|FG001|Overall Study|Withdrawal by Subject|2|||
170391323|NCT01353586|615772439|FG000|Overall Study|Procedure terminated prior to ablation|3|||
170391324|NCT01353586|615772440|FG001|Overall Study|Procedure terminated prior to ablation|0|||
170391325|NCT01353586|615772439|FG000|Overall Study|Never had insertion of study catheter|4|||
170391326|NCT01353586|615772440|FG001|Overall Study|Never had insertion of study catheter|1|||
170391327|NCT01353586|615772439|FG000|Overall Study|Neurological exam not done|0|||
170391328|NCT01353586|615772440|FG001|Overall Study|Neurological exam not done|1|||
170391329|NCT00978120|615772441|FG000|Overall Study|Death|0|||
170391330|NCT00978120|615772442|FG001|Overall Study|Death|0|||
170391331|NCT00978120|615772443|FG002|Overall Study|Death|0|||
170391332|NCT00978120|615772444|FG003|Overall Study|Death|1|||
170391333|NCT00978120|615772441|FG000|Overall Study|Lost to Follow-up|0|||
170391334|NCT00978120|615772442|FG001|Overall Study|Lost to Follow-up|0|||
170391335|NCT00978120|615772443|FG002|Overall Study|Lost to Follow-up|3|||
170391336|NCT00978120|615772444|FG003|Overall Study|Lost to Follow-up|0|||
170391337|NCT00978120|615772441|FG000|Overall Study|Withdrawal by Subject|2|||
170391338|NCT00978120|615772442|FG001|Overall Study|Withdrawal by Subject|0|||
170391339|NCT00978120|615772443|FG002|Overall Study|Withdrawal by Subject|0|||
170391340|NCT00978120|615772444|FG003|Overall Study|Withdrawal by Subject|0|||
170391341|NCT00978120|615772441|FG000|Overall Study|Moved out of state|0|||
170391342|NCT00978120|615772442|FG001|Overall Study|Moved out of state|0|||
170391343|NCT00978120|615772443|FG002|Overall Study|Moved out of state|0|||
170391344|NCT00978120|615772444|FG003|Overall Study|Moved out of state|1|||
170391345|NCT03253809|615772445|FG000|Overall Study|Unable to obtain study related data|14|||
170391346|NCT03992456|615772446|FG000|Overall Study|Withdrawal by Subject|1|||
170391347|NCT03992456|615772447|FG001|Overall Study|Withdrawal by Subject|0|||
170391348|NCT03992456|615772446|FG000|Overall Study|Disease progression|4|||
170391349|NCT03992456|615772447|FG001|Overall Study|Disease progression|5|||
170391350|NCT03992456|615772446|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
170391351|NCT03992456|615772447|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
170391352|NCT01068418|615772448|FG000|Overall Study|Physician Decision|12|||
170391353|NCT01049360|615772450|FG000|Period 1|Adverse Event|0|||
170391354|NCT01049360|615772451|FG001|Period 1|Adverse Event|1|||
170391355|NCT01049360|615772452|FG002|Period 1|Adverse Event|0|||
170391356|NCT01049360|615772453|FG003|Period 1|Adverse Event|1|||
170391357|NCT01049360|615772454|FG004|Period 1|Adverse Event|0|||
170391358|NCT01049360|615772455|FG005|Period 1|Adverse Event|0|||
170391359|NCT01049360|615772456|FG006|Period 1|Adverse Event|0|||
170391360|NCT01049360|615772457|FG007|Period 1|Adverse Event|1|||
170391361|NCT01049360|615772458|FG008|Period 1|Adverse Event|0|||
170391362|NCT01049360|615772459|FG009|Period 1|Adverse Event|0|||
170391363|NCT01049360|615772460|FG010|Period 1|Adverse Event|0|||
170391364|NCT01049360|615772461|FG011|Period 1|Adverse Event|0|||
170391365|NCT01049360|615772462|FG012|Period 1|Adverse Event|1|||
170391366|NCT01049360|615772463|FG013|Period 1|Adverse Event|1|||
170391367|NCT01049360|615772464|FG014|Period 1|Adverse Event|0|||
170391368|NCT01049360|615772465|FG015|Period 1|Adverse Event|0|||
170391369|NCT01049360|615772466|FG016|Period 1|Adverse Event|1|||
170391370|NCT01049360|615772467|FG017|Period 1|Adverse Event|0|||
170391371|NCT01049360|615772468|FG018|Period 1|Adverse Event|1|||
170391372|NCT01049360|615772469|FG019|Period 1|Adverse Event|0|||
170391373|NCT01049360|615772450|FG000|Period 1|Did not meet inc/exc criteria|0|||
170391374|NCT01049360|615772451|FG001|Period 1|Did not meet inc/exc criteria|0|||
170391375|NCT01049360|615772452|FG002|Period 1|Did not meet inc/exc criteria|0|||
170391376|NCT01049360|615772453|FG003|Period 1|Did not meet inc/exc criteria|0|||
170391377|NCT01049360|615772454|FG004|Period 1|Did not meet inc/exc criteria|0|||
170391378|NCT01049360|615772455|FG005|Period 1|Did not meet inc/exc criteria|0|||
170391379|NCT01049360|615772456|FG006|Period 1|Did not meet inc/exc criteria|0|||
170391380|NCT01049360|615772457|FG007|Period 1|Did not meet inc/exc criteria|1|||
170391381|NCT01049360|615772458|FG008|Period 1|Did not meet inc/exc criteria|1|||
170391382|NCT01049360|615772459|FG009|Period 1|Did not meet inc/exc criteria|0|||
170391383|NCT01049360|615772460|FG010|Period 1|Did not meet inc/exc criteria|0|||
170391384|NCT01049360|615772461|FG011|Period 1|Did not meet inc/exc criteria|0|||
170391385|NCT01049360|615772462|FG012|Period 1|Did not meet inc/exc criteria|0|||
170391386|NCT01049360|615772463|FG013|Period 1|Did not meet inc/exc criteria|0|||
170391387|NCT01049360|615772464|FG014|Period 1|Did not meet inc/exc criteria|0|||
170391388|NCT01049360|615772465|FG015|Period 1|Did not meet inc/exc criteria|0|||
170391389|NCT01049360|615772466|FG016|Period 1|Did not meet inc/exc criteria|0|||
170391390|NCT01049360|615772467|FG017|Period 1|Did not meet inc/exc criteria|0|||
170391391|NCT01049360|615772468|FG018|Period 1|Did not meet inc/exc criteria|0|||
170391392|NCT01049360|615772469|FG019|Period 1|Did not meet inc/exc criteria|0|||
170391393|NCT01049360|615772450|FG000|Period 1|Withdrawal by Subject|0|||
170391394|NCT01049360|615772451|FG001|Period 1|Withdrawal by Subject|0|||
170391395|NCT01049360|615772452|FG002|Period 1|Withdrawal by Subject|0|||
170391396|NCT01049360|615772453|FG003|Period 1|Withdrawal by Subject|0|||
170391397|NCT01049360|615772454|FG004|Period 1|Withdrawal by Subject|0|||
170391398|NCT01049360|615772455|FG005|Period 1|Withdrawal by Subject|0|||
170391399|NCT01049360|615772456|FG006|Period 1|Withdrawal by Subject|0|||
170391400|NCT01049360|615772457|FG007|Period 1|Withdrawal by Subject|0|||
170391401|NCT01049360|615772458|FG008|Period 1|Withdrawal by Subject|1|||
170391402|NCT01049360|615772459|FG009|Period 1|Withdrawal by Subject|0|||
170391403|NCT01049360|615772460|FG010|Period 1|Withdrawal by Subject|1|||
170391404|NCT01049360|615772461|FG011|Period 1|Withdrawal by Subject|0|||
170391405|NCT01049360|615772462|FG012|Period 1|Withdrawal by Subject|1|||
170391406|NCT01049360|615772463|FG013|Period 1|Withdrawal by Subject|0|||
170391407|NCT01049360|615772464|FG014|Period 1|Withdrawal by Subject|0|||
170391408|NCT01049360|615772465|FG015|Period 1|Withdrawal by Subject|0|||
170391409|NCT01049360|615772466|FG016|Period 1|Withdrawal by Subject|0|||
170391410|NCT01049360|615772467|FG017|Period 1|Withdrawal by Subject|0|||
170391411|NCT01049360|615772468|FG018|Period 1|Withdrawal by Subject|0|||
170391412|NCT01049360|615772469|FG019|Period 1|Withdrawal by Subject|0|||
170391413|NCT01049360|615772450|FG000|Period 2|Protocol Violation|0|||
170391414|NCT01049360|615772451|FG001|Period 2|Protocol Violation|0|||
170391415|NCT01049360|615772452|FG002|Period 2|Protocol Violation|0|||
170391416|NCT01049360|615772453|FG003|Period 2|Protocol Violation|1|||
170391417|NCT01049360|615772454|FG004|Period 2|Protocol Violation|0|||
170391418|NCT01049360|615772455|FG005|Period 2|Protocol Violation|0|||
170391419|NCT01049360|615772456|FG006|Period 2|Protocol Violation|0|||
170391420|NCT01049360|615772457|FG007|Period 2|Protocol Violation|0|||
170391421|NCT01049360|615772458|FG008|Period 2|Protocol Violation|0|||
170391422|NCT01049360|615772459|FG009|Period 2|Protocol Violation|0|||
170391423|NCT01049360|615772460|FG010|Period 2|Protocol Violation|0|||
170391424|NCT01049360|615772461|FG011|Period 2|Protocol Violation|0|||
170391425|NCT01049360|615772462|FG012|Period 2|Protocol Violation|0|||
170391426|NCT01049360|615772463|FG013|Period 2|Protocol Violation|0|||
170391427|NCT01049360|615772464|FG014|Period 2|Protocol Violation|1|||
170391428|NCT01049360|615772465|FG015|Period 2|Protocol Violation|1|||
170391429|NCT01049360|615772466|FG016|Period 2|Protocol Violation|0|||
170391430|NCT01049360|615772467|FG017|Period 2|Protocol Violation|0|||
170391431|NCT01049360|615772468|FG018|Period 2|Protocol Violation|0|||
170391432|NCT01049360|615772469|FG019|Period 2|Protocol Violation|0|||
170391433|NCT01049360|615772450|FG000|Period 2|Adverse Event|0|||
170391434|NCT01049360|615772451|FG001|Period 2|Adverse Event|1|||
170391435|NCT01049360|615772452|FG002|Period 2|Adverse Event|0|||
170391436|NCT01049360|615772453|FG003|Period 2|Adverse Event|0|||
170391437|NCT01049360|615772454|FG004|Period 2|Adverse Event|0|||
170391438|NCT01049360|615772455|FG005|Period 2|Adverse Event|0|||
170391439|NCT01049360|615772456|FG006|Period 2|Adverse Event|0|||
170391440|NCT01049360|615772457|FG007|Period 2|Adverse Event|0|||
170391441|NCT01049360|615772458|FG008|Period 2|Adverse Event|1|||
170391442|NCT01049360|615772459|FG009|Period 2|Adverse Event|0|||
170391443|NCT01049360|615772460|FG010|Period 2|Adverse Event|0|||
170391444|NCT01049360|615772461|FG011|Period 2|Adverse Event|0|||
170391445|NCT01049360|615772462|FG012|Period 2|Adverse Event|0|||
170391446|NCT01049360|615772463|FG013|Period 2|Adverse Event|0|||
170391447|NCT01049360|615772464|FG014|Period 2|Adverse Event|0|||
170391448|NCT01049360|615772465|FG015|Period 2|Adverse Event|0|||
170391449|NCT01049360|615772466|FG016|Period 2|Adverse Event|0|||
170391450|NCT01049360|615772467|FG017|Period 2|Adverse Event|0|||
170391451|NCT01049360|615772468|FG018|Period 2|Adverse Event|0|||
170391452|NCT01049360|615772469|FG019|Period 2|Adverse Event|1|||
170391453|NCT01049360|615772450|FG000|Period 2|Withdrawal by Subject|0|||
170391454|NCT01049360|615772451|FG001|Period 2|Withdrawal by Subject|0|||
170391455|NCT01049360|615772452|FG002|Period 2|Withdrawal by Subject|0|||
170391456|NCT01049360|615772453|FG003|Period 2|Withdrawal by Subject|1|||
170391457|NCT01049360|615772454|FG004|Period 2|Withdrawal by Subject|0|||
170391458|NCT01049360|615772455|FG005|Period 2|Withdrawal by Subject|0|||
170391459|NCT01049360|615772456|FG006|Period 2|Withdrawal by Subject|0|||
170391460|NCT01049360|615772457|FG007|Period 2|Withdrawal by Subject|0|||
170391461|NCT01049360|615772458|FG008|Period 2|Withdrawal by Subject|0|||
170391462|NCT01049360|615772459|FG009|Period 2|Withdrawal by Subject|0|||
170391463|NCT01049360|615772460|FG010|Period 2|Withdrawal by Subject|0|||
170391464|NCT01049360|615772461|FG011|Period 2|Withdrawal by Subject|0|||
170391465|NCT01049360|615772462|FG012|Period 2|Withdrawal by Subject|0|||
170391466|NCT01049360|615772463|FG013|Period 2|Withdrawal by Subject|0|||
170391467|NCT01049360|615772464|FG014|Period 2|Withdrawal by Subject|1|||
170391468|NCT01049360|615772465|FG015|Period 2|Withdrawal by Subject|0|||
170391469|NCT01049360|615772466|FG016|Period 2|Withdrawal by Subject|0|||
170391470|NCT01049360|615772467|FG017|Period 2|Withdrawal by Subject|0|||
170391471|NCT01049360|615772468|FG018|Period 2|Withdrawal by Subject|0|||
170391472|NCT01049360|615772469|FG019|Period 2|Withdrawal by Subject|1|||
170391473|NCT01049360|615772450|FG000|Period 2|Lack of Efficacy|0|||
170391474|NCT01049360|615772451|FG001|Period 2|Lack of Efficacy|0|||
170391475|NCT01049360|615772452|FG002|Period 2|Lack of Efficacy|0|||
170391476|NCT01049360|615772453|FG003|Period 2|Lack of Efficacy|0|||
170391477|NCT01049360|615772454|FG004|Period 2|Lack of Efficacy|0|||
170391478|NCT01049360|615772455|FG005|Period 2|Lack of Efficacy|1|||
170391479|NCT01049360|615772456|FG006|Period 2|Lack of Efficacy|0|||
170391480|NCT01049360|615772457|FG007|Period 2|Lack of Efficacy|0|||
170391481|NCT01049360|615772458|FG008|Period 2|Lack of Efficacy|0|||
170391482|NCT01049360|615772459|FG009|Period 2|Lack of Efficacy|0|||
170391483|NCT01049360|615772460|FG010|Period 2|Lack of Efficacy|0|||
170391484|NCT01049360|615772461|FG011|Period 2|Lack of Efficacy|0|||
170391485|NCT01049360|615772462|FG012|Period 2|Lack of Efficacy|0|||
170391486|NCT01049360|615772463|FG013|Period 2|Lack of Efficacy|0|||
170391487|NCT01049360|615772464|FG014|Period 2|Lack of Efficacy|0|||
170391488|NCT01049360|615772465|FG015|Period 2|Lack of Efficacy|0|||
170391489|NCT01049360|615772466|FG016|Period 2|Lack of Efficacy|0|||
170391490|NCT01049360|615772467|FG017|Period 2|Lack of Efficacy|0|||
170391491|NCT01049360|615772468|FG018|Period 2|Lack of Efficacy|0|||
170391492|NCT01049360|615772469|FG019|Period 2|Lack of Efficacy|0|||
170391493|NCT01049360|615772450|FG000|Period 4|Protocol Violation|0|||
170391494|NCT01049360|615772451|FG001|Period 4|Protocol Violation|0|||
170391495|NCT01049360|615772452|FG002|Period 4|Protocol Violation|0|||
170391496|NCT01049360|615772453|FG003|Period 4|Protocol Violation|0|||
170391497|NCT01049360|615772454|FG004|Period 4|Protocol Violation|0|||
170391498|NCT01049360|615772455|FG005|Period 4|Protocol Violation|0|||
170391499|NCT01049360|615772456|FG006|Period 4|Protocol Violation|0|||
170391500|NCT01049360|615772457|FG007|Period 4|Protocol Violation|0|||
170391501|NCT01049360|615772458|FG008|Period 4|Protocol Violation|0|||
170391502|NCT01049360|615772459|FG009|Period 4|Protocol Violation|0|||
170391503|NCT01049360|615772460|FG010|Period 4|Protocol Violation|0|||
170391504|NCT01049360|615772461|FG011|Period 4|Protocol Violation|0|||
170391505|NCT01049360|615772462|FG012|Period 4|Protocol Violation|0|||
170391506|NCT01049360|615772463|FG013|Period 4|Protocol Violation|0|||
170391507|NCT01049360|615772464|FG014|Period 4|Protocol Violation|0|||
170391508|NCT01049360|615772465|FG015|Period 4|Protocol Violation|0|||
170391509|NCT01049360|615772466|FG016|Period 4|Protocol Violation|0|||
170391510|NCT01049360|615772467|FG017|Period 4|Protocol Violation|1|||
170391511|NCT01049360|615772468|FG018|Period 4|Protocol Violation|0|||
170391512|NCT01049360|615772469|FG019|Period 4|Protocol Violation|0|||
170391513|NCT01049360|615772450|FG000|Period 4|Withdrawal by Subject|0|||
170391514|NCT01049360|615772451|FG001|Period 4|Withdrawal by Subject|0|||
170391515|NCT01049360|615772452|FG002|Period 4|Withdrawal by Subject|0|||
170391516|NCT01049360|615772453|FG003|Period 4|Withdrawal by Subject|1|||
170391517|NCT01049360|615772454|FG004|Period 4|Withdrawal by Subject|0|||
170391518|NCT01049360|615772455|FG005|Period 4|Withdrawal by Subject|0|||
170391519|NCT01049360|615772456|FG006|Period 4|Withdrawal by Subject|0|||
170391520|NCT01049360|615772457|FG007|Period 4|Withdrawal by Subject|0|||
170391521|NCT01049360|615772458|FG008|Period 4|Withdrawal by Subject|0|||
170391522|NCT01049360|615772459|FG009|Period 4|Withdrawal by Subject|0|||
170391523|NCT01049360|615772460|FG010|Period 4|Withdrawal by Subject|0|||
170391524|NCT01049360|615772461|FG011|Period 4|Withdrawal by Subject|0|||
170391525|NCT01049360|615772462|FG012|Period 4|Withdrawal by Subject|0|||
170391526|NCT01049360|615772463|FG013|Period 4|Withdrawal by Subject|0|||
170391527|NCT01049360|615772464|FG014|Period 4|Withdrawal by Subject|0|||
170391528|NCT01049360|615772465|FG015|Period 4|Withdrawal by Subject|0|||
170391529|NCT01049360|615772466|FG016|Period 4|Withdrawal by Subject|0|||
170391530|NCT01049360|615772467|FG017|Period 4|Withdrawal by Subject|0|||
170391531|NCT01049360|615772468|FG018|Period 4|Withdrawal by Subject|0|||
170391532|NCT01049360|615772469|FG019|Period 4|Withdrawal by Subject|0|||
170391533|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Adverse Event|6|||
170391534|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Adverse Event|6|||
170391535|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Death|14|||
170391536|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Death|11|||
170391537|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
170391538|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
170391539|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
170391540|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
170391541|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
170391542|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
170391543|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Disease Progression|1|||
170391544|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Disease Progression|0|||
170391545|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
170391546|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
170391547|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
170391548|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
170391549|NCT04419558|615772473|FG000|DB Period (48 Weeks)|Participant Decision|4|||
170391550|NCT04419558|615772474|FG001|DB Period (48 Weeks)|Participant Decision|3|||
170391551|NCT04419558|615772473|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
170391552|NCT04419558|615772474|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
170391553|NCT04419558|615772473|FG000|OLE Period (48 Weeks)|Death|4|||
170391554|NCT04419558|615772474|FG001|OLE Period (48 Weeks)|Death|6|||
170391555|NCT04419558|615772473|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
170391556|NCT04419558|615772474|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
170391557|NCT04419558|615772473|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
170391558|NCT04419558|615772474|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
170391559|NCT01539512|615772478|FG000|Overall Study|Adverse Event|9|||
170391560|NCT01539512|615772479|FG001|Overall Study|Adverse Event|7|||
170391561|NCT01539512|615772478|FG000|Overall Study|Physician Decision|1|||
170391562|NCT01539512|615772479|FG001|Overall Study|Physician Decision|1|||
170391563|NCT01539512|615772478|FG000|Overall Study|Withdrawal by Subject|12|||
170391564|NCT01539512|615772479|FG001|Overall Study|Withdrawal by Subject|5|||
170391565|NCT01539512|615772478|FG000|Overall Study|Richter's Transformation|1|||
170391566|NCT01539512|615772479|FG001|Overall Study|Richter's Transformation|0|||
170391567|NCT00262119|615772483|FG000|Overall Study|Lost to Follow-up|38|||
170391568|NCT00262119|615772484|FG001|Overall Study|Lost to Follow-up|51|||
170391569|NCT00262119|615772485|FG002|Overall Study|Lost to Follow-up|42|||
170391570|NCT00262119|615772483|FG000|Overall Study|Death|20|||
170391571|NCT00262119|615772484|FG001|Overall Study|Death|19|||
170391572|NCT00262119|615772485|FG002|Overall Study|Death|16|||
170391573|NCT00859313|615772486|FG000|Overall Study|Lack of Efficacy|2|||
170391574|NCT00859313|615772486|FG000|Overall Study|Adverse Event|1|||
170391575|NCT00859313|615772486|FG000|Overall Study|staff error|1|||
170391576|NCT05261126|615772487|FG000|Overall Study|Death|0|||
170391577|NCT05261126|615772488|FG001|Overall Study|Death|0|||
170391578|NCT05261126|615772489|FG002|Overall Study|Death|1|||
170391579|NCT05261126|615772490|FG003|Overall Study|Death|0|||
170391580|NCT05261126|615772491|FG004|Overall Study|Death|0|||
170391581|NCT05261126|615772487|FG000|Overall Study|Lost to Follow-up|0|||
170391582|NCT05261126|615772488|FG001|Overall Study|Lost to Follow-up|0|||
170391583|NCT05261126|615772489|FG002|Overall Study|Lost to Follow-up|0|||
170391584|NCT05261126|615772490|FG003|Overall Study|Lost to Follow-up|0|||
170391585|NCT05261126|615772491|FG004|Overall Study|Lost to Follow-up|1|||
170391586|NCT05261126|615772487|FG000|Overall Study|Physician Decision|1|||
170391587|NCT05261126|615772488|FG001|Overall Study|Physician Decision|0|||
170391588|NCT05261126|615772489|FG002|Overall Study|Physician Decision|0|||
170391589|NCT05261126|615772490|FG003|Overall Study|Physician Decision|0|||
170391590|NCT05261126|615772491|FG004|Overall Study|Physician Decision|0|||
170391591|NCT05261126|615772487|FG000|Overall Study|Screen Failure|0|||
170391592|NCT05261126|615772488|FG001|Overall Study|Screen Failure|0|||
170391593|NCT05261126|615772489|FG002|Overall Study|Screen Failure|0|||
170391594|NCT05261126|615772490|FG003|Overall Study|Screen Failure|0|||
170391595|NCT05261126|615772491|FG004|Overall Study|Screen Failure|1|||
170391596|NCT05261126|615772487|FG000|Overall Study|Withdrawal by Subject|1|||
170391597|NCT05261126|615772488|FG001|Overall Study|Withdrawal by Subject|0|||
170391598|NCT05261126|615772489|FG002|Overall Study|Withdrawal by Subject|1|||
170391599|NCT05261126|615772490|FG003|Overall Study|Withdrawal by Subject|1|||
170391600|NCT05261126|615772491|FG004|Overall Study|Withdrawal by Subject|0|||
170391601|NCT05261126|615772487|FG000|Overall Study|Not Recorded|0|||
170391602|NCT05261126|615772488|FG001|Overall Study|Not Recorded|0|||
170391603|NCT05261126|615772489|FG002|Overall Study|Not Recorded|0|||
170391604|NCT05261126|615772490|FG003|Overall Study|Not Recorded|1|||
170391605|NCT05261126|615772491|FG004|Overall Study|Not Recorded|0|||
170391606|NCT05116241|615772502|FG000|Study|Withdrawal by Subject|5|||
170391607|NCT05116241|615772503|FG001|Study|Withdrawal by Subject|2|||
170391608|NCT05116241|615772504|FG002|Study|Withdrawal by Subject|1|||
170391609|NCT05116241|615772502|FG000|Study|Lost to Follow-up|0|||
170391610|NCT05116241|615772503|FG001|Study|Lost to Follow-up|2|||
170391611|NCT05116241|615772504|FG002|Study|Lost to Follow-up|2|||
170391612|NCT04410991|615772505|FG000|Overall Study|Poor compliance to protocol|5|||
170391613|NCT04410991|615772506|FG001|Overall Study|Poor compliance to protocol|4|||
170391614|NCT04410991|615772505|FG000|Overall Study|Withdrawal by Subject|59|||
170391615|NCT04410991|615772506|FG001|Overall Study|Withdrawal by Subject|55|||
170391616|NCT04410991|615772505|FG000|Overall Study|Other|10|||
170391617|NCT04410991|615772506|FG001|Overall Study|Other|4|||
170391618|NCT01250418|615772515|FG000|Overall Study|monitor data failure|1|||
170391619|NCT01250418|615772516|FG001|Overall Study|monitor data failure|1|||
170391620|NCT05966129|615772518|FG000|Overall Study|Death|1|||
170391621|NCT05966129|615772519|FG001|Overall Study|Death|2|||
170391622|NCT05966129|615772518|FG000|Overall Study|Lost to Follow-up|63|||
170391623|NCT05966129|615772519|FG001|Overall Study|Lost to Follow-up|66|||
170391624|NCT05966129|615772518|FG000|Overall Study|Protocol Violation|1|||
170391625|NCT05966129|615772519|FG001|Overall Study|Protocol Violation|0|||
170391626|NCT05966129|615772518|FG000|Overall Study|Withdrawal by Subject|26|||
170391627|NCT05966129|615772519|FG001|Overall Study|Withdrawal by Subject|25|||
170391628|NCT05966129|615772518|FG000|Overall Study|Surgery not completed|63|||
170391629|NCT05966129|615772519|FG001|Overall Study|Surgery not completed|69|||
170391630|NCT05966129|615772518|FG000|Overall Study|Surgery logistics issue|2|||
170391631|NCT05966129|615772519|FG001|Overall Study|Surgery logistics issue|1|||
170391632|NCT05182840|615772520|FG000|Run-in Period|Not treated|0|||
170391633|NCT05182840|615772521|FG001|Run-in Period|Not treated|1|||
170391634|NCT05182840|615772522|FG002|Run-in Period|Not treated|0|||
170391635|NCT05182840|615772523|FG003|Run-in Period|Not treated|0|||
170391636|NCT05182840|615772524|FG004|Run-in Period|Not treated|0|||
170391637|NCT05182840|615772525|FG005|Run-in Period|Not treated|0|||
170391638|NCT05182840|615772526|FG006|Run-in Period|Not treated|0|||
170391639|NCT05182840|615772527|FG007|Run-in Period|Not treated|0|||
170391640|NCT05182840|615772528|FG008|Run-in Period|Not treated|0|||
170391641|NCT05182840|615772529|FG009|Run-in Period|Not treated|0|||
170391642|NCT05182840|615772520|FG000|Run-in Period|Other reason but not sponsor termination|14|||
170391643|NCT05182840|615772521|FG001|Run-in Period|Other reason but not sponsor termination|18|||
170391644|NCT05182840|615772522|FG002|Run-in Period|Other reason but not sponsor termination|0|||
170391645|NCT05182840|615772523|FG003|Run-in Period|Other reason but not sponsor termination|0|||
170391646|NCT05182840|615772524|FG004|Run-in Period|Other reason but not sponsor termination|0|||
170391647|NCT05182840|615772525|FG005|Run-in Period|Other reason but not sponsor termination|0|||
170391648|NCT05182840|615772526|FG006|Run-in Period|Other reason but not sponsor termination|0|||
170391649|NCT05182840|615772527|FG007|Run-in Period|Other reason but not sponsor termination|0|||
170391650|NCT05182840|615772528|FG008|Run-in Period|Other reason but not sponsor termination|0|||
170391651|NCT05182840|615772529|FG009|Run-in Period|Other reason but not sponsor termination|0|||
170391652|NCT05182840|615772520|FG000|Run-in Period|No reason available|2|||
170391653|NCT05182840|615772521|FG001|Run-in Period|No reason available|2|||
170391654|NCT05182840|615772522|FG002|Run-in Period|No reason available|0|||
170391655|NCT05182840|615772523|FG003|Run-in Period|No reason available|0|||
170391656|NCT05182840|615772524|FG004|Run-in Period|No reason available|0|||
170391657|NCT05182840|615772525|FG005|Run-in Period|No reason available|0|||
170391658|NCT05182840|615772526|FG006|Run-in Period|No reason available|0|||
170391659|NCT05182840|615772527|FG007|Run-in Period|No reason available|0|||
170391660|NCT05182840|615772528|FG008|Run-in Period|No reason available|0|||
170391661|NCT05182840|615772529|FG009|Run-in Period|No reason available|0|||
170391662|NCT05182840|615772520|FG000|Run-in Period|Burden of study procedures|2|||
170391663|NCT05182840|615772521|FG001|Run-in Period|Burden of study procedures|2|||
170391664|NCT05182840|615772522|FG002|Run-in Period|Burden of study procedures|0|||
170391665|NCT05182840|615772523|FG003|Run-in Period|Burden of study procedures|0|||
170391666|NCT05182840|615772524|FG004|Run-in Period|Burden of study procedures|0|||
170391667|NCT05182840|615772525|FG005|Run-in Period|Burden of study procedures|0|||
170391668|NCT05182840|615772526|FG006|Run-in Period|Burden of study procedures|0|||
170391669|NCT05182840|615772527|FG007|Run-in Period|Burden of study procedures|0|||
170391670|NCT05182840|615772528|FG008|Run-in Period|Burden of study procedures|0|||
170391671|NCT05182840|615772529|FG009|Run-in Period|Burden of study procedures|0|||
170391672|NCT05182840|615772520|FG000|Run-in Period|Change of residence|1|||
170391673|NCT05182840|615772521|FG001|Run-in Period|Change of residence|0|||
170391674|NCT05182840|615772522|FG002|Run-in Period|Change of residence|0|||
170391675|NCT05182840|615772523|FG003|Run-in Period|Change of residence|0|||
170391676|NCT05182840|615772524|FG004|Run-in Period|Change of residence|0|||
170391677|NCT05182840|615772525|FG005|Run-in Period|Change of residence|0|||
170391678|NCT05182840|615772526|FG006|Run-in Period|Change of residence|0|||
170391679|NCT05182840|615772527|FG007|Run-in Period|Change of residence|0|||
170391680|NCT05182840|615772528|FG008|Run-in Period|Change of residence|0|||
170391681|NCT05182840|615772529|FG009|Run-in Period|Change of residence|0|||
170391682|NCT05182840|615772520|FG000|Run-in Period|Adverse Event|5|||
170391683|NCT05182840|615772521|FG001|Run-in Period|Adverse Event|5|||
170391684|NCT05182840|615772522|FG002|Run-in Period|Adverse Event|0|||
170391685|NCT05182840|615772523|FG003|Run-in Period|Adverse Event|0|||
170391686|NCT05182840|615772524|FG004|Run-in Period|Adverse Event|0|||
170391687|NCT05182840|615772525|FG005|Run-in Period|Adverse Event|0|||
170391688|NCT05182840|615772526|FG006|Run-in Period|Adverse Event|0|||
170391689|NCT05182840|615772527|FG007|Run-in Period|Adverse Event|0|||
170391690|NCT05182840|615772528|FG008|Run-in Period|Adverse Event|0|||
170391691|NCT05182840|615772529|FG009|Run-in Period|Adverse Event|0|||
170391692|NCT05182840|615772520|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
170391693|NCT05182840|615772521|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
170391694|NCT05182840|615772522|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
170391695|NCT05182840|615772523|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
170398692|NCT03981614|615798254|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
170391696|NCT05182840|615772524|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
170391697|NCT05182840|615772525|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
170391698|NCT05182840|615772526|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
170391699|NCT05182840|615772527|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
170391700|NCT05182840|615772528|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
170391701|NCT05182840|615772529|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
170391702|NCT05182840|615772520|FG000|Treatment Period|Reason missing|0|||
170391703|NCT05182840|615772521|FG001|Treatment Period|Reason missing|0|||
170391704|NCT05182840|615772522|FG002|Treatment Period|Reason missing|1|||
170391705|NCT05182840|615772523|FG003|Treatment Period|Reason missing|0|||
170391706|NCT05182840|615772524|FG004|Treatment Period|Reason missing|0|||
170391707|NCT05182840|615772525|FG005|Treatment Period|Reason missing|0|||
170391708|NCT05182840|615772526|FG006|Treatment Period|Reason missing|0|||
170391709|NCT05182840|615772527|FG007|Treatment Period|Reason missing|0|||
170391710|NCT05182840|615772528|FG008|Treatment Period|Reason missing|0|||
170391711|NCT05182840|615772529|FG009|Treatment Period|Reason missing|0|||
170391712|NCT05182840|615772520|FG000|Treatment Period|Other but not sponsor termination|0|||
170391713|NCT05182840|615772521|FG001|Treatment Period|Other but not sponsor termination|0|||
170391714|NCT05182840|615772522|FG002|Treatment Period|Other but not sponsor termination|8|||
170391715|NCT05182840|615772523|FG003|Treatment Period|Other but not sponsor termination|6|||
170391716|NCT05182840|615772524|FG004|Treatment Period|Other but not sponsor termination|6|||
170391717|NCT05182840|615772525|FG005|Treatment Period|Other but not sponsor termination|7|||
170391718|NCT05182840|615772526|FG006|Treatment Period|Other but not sponsor termination|5|||
170391719|NCT05182840|615772527|FG007|Treatment Period|Other but not sponsor termination|8|||
170391720|NCT05182840|615772528|FG008|Treatment Period|Other but not sponsor termination|7|||
170391721|NCT05182840|615772529|FG009|Treatment Period|Other but not sponsor termination|2|||
170391722|NCT05182840|615772520|FG000|Treatment Period|Protocol deviation|0|||
170391723|NCT05182840|615772521|FG001|Treatment Period|Protocol deviation|0|||
170391724|NCT05182840|615772522|FG002|Treatment Period|Protocol deviation|0|||
170391725|NCT05182840|615772523|FG003|Treatment Period|Protocol deviation|0|||
170391726|NCT05182840|615772524|FG004|Treatment Period|Protocol deviation|0|||
170391727|NCT05182840|615772525|FG005|Treatment Period|Protocol deviation|0|||
170391728|NCT05182840|615772526|FG006|Treatment Period|Protocol deviation|0|||
170391729|NCT05182840|615772527|FG007|Treatment Period|Protocol deviation|0|||
170391730|NCT05182840|615772528|FG008|Treatment Period|Protocol deviation|1|||
170391731|NCT05182840|615772529|FG009|Treatment Period|Protocol deviation|0|||
170391732|NCT05182840|615772520|FG000|Treatment Period|No reason available|0|||
170391733|NCT05182840|615772521|FG001|Treatment Period|No reason available|0|||
170391734|NCT05182840|615772522|FG002|Treatment Period|No reason available|0|||
170391735|NCT05182840|615772523|FG003|Treatment Period|No reason available|1|||
170391736|NCT05182840|615772524|FG004|Treatment Period|No reason available|0|||
170391737|NCT05182840|615772525|FG005|Treatment Period|No reason available|2|||
170391738|NCT05182840|615772526|FG006|Treatment Period|No reason available|0|||
170391739|NCT05182840|615772527|FG007|Treatment Period|No reason available|1|||
170391740|NCT05182840|615772528|FG008|Treatment Period|No reason available|0|||
170391741|NCT05182840|615772529|FG009|Treatment Period|No reason available|0|||
170391742|NCT05182840|615772520|FG000|Treatment Period|Burden of study procedures|0|||
170391743|NCT05182840|615772521|FG001|Treatment Period|Burden of study procedures|0|||
170391744|NCT05182840|615772522|FG002|Treatment Period|Burden of study procedures|0|||
170391745|NCT05182840|615772523|FG003|Treatment Period|Burden of study procedures|0|||
170391746|NCT05182840|615772524|FG004|Treatment Period|Burden of study procedures|1|||
170391747|NCT05182840|615772525|FG005|Treatment Period|Burden of study procedures|0|||
170391748|NCT05182840|615772526|FG006|Treatment Period|Burden of study procedures|0|||
170391749|NCT05182840|615772527|FG007|Treatment Period|Burden of study procedures|0|||
170391750|NCT05182840|615772528|FG008|Treatment Period|Burden of study procedures|0|||
170391751|NCT05182840|615772529|FG009|Treatment Period|Burden of study procedures|0|||
170391752|NCT05182840|615772520|FG000|Treatment Period|Change of residence|0|||
170391753|NCT05182840|615772521|FG001|Treatment Period|Change of residence|0|||
170391754|NCT05182840|615772522|FG002|Treatment Period|Change of residence|0|||
170391755|NCT05182840|615772523|FG003|Treatment Period|Change of residence|0|||
170391756|NCT05182840|615772524|FG004|Treatment Period|Change of residence|0|||
170391757|NCT05182840|615772525|FG005|Treatment Period|Change of residence|1|||
170391758|NCT05182840|615772526|FG006|Treatment Period|Change of residence|0|||
170391759|NCT05182840|615772527|FG007|Treatment Period|Change of residence|0|||
170391760|NCT05182840|615772528|FG008|Treatment Period|Change of residence|0|||
170391761|NCT05182840|615772529|FG009|Treatment Period|Change of residence|0|||
170391762|NCT05182840|615772520|FG000|Treatment Period|Adverse Event|0|||
170391763|NCT05182840|615772521|FG001|Treatment Period|Adverse Event|0|||
170391764|NCT05182840|615772522|FG002|Treatment Period|Adverse Event|4|||
170391765|NCT05182840|615772523|FG003|Treatment Period|Adverse Event|16|||
170391766|NCT05182840|615772524|FG004|Treatment Period|Adverse Event|12|||
170391767|NCT05182840|615772525|FG005|Treatment Period|Adverse Event|6|||
170391768|NCT05182840|615772526|FG006|Treatment Period|Adverse Event|4|||
170391769|NCT05182840|615772527|FG007|Treatment Period|Adverse Event|8|||
170391770|NCT05182840|615772528|FG008|Treatment Period|Adverse Event|16|||
170391771|NCT05182840|615772529|FG009|Treatment Period|Adverse Event|5|||
170391772|NCT05182840|615772520|FG000|Treatment Period|Not treated with study drug|0|||
170391773|NCT05182840|615772521|FG001|Treatment Period|Not treated with study drug|0|||
170391774|NCT05182840|615772522|FG002|Treatment Period|Not treated with study drug|0|||
170391775|NCT05182840|615772523|FG003|Treatment Period|Not treated with study drug|1|||
170391776|NCT05182840|615772524|FG004|Treatment Period|Not treated with study drug|0|||
170391777|NCT05182840|615772525|FG005|Treatment Period|Not treated with study drug|0|||
170391778|NCT05182840|615772526|FG006|Treatment Period|Not treated with study drug|1|||
170391779|NCT05182840|615772527|FG007|Treatment Period|Not treated with study drug|1|||
170391780|NCT05182840|615772528|FG008|Treatment Period|Not treated with study drug|0|||
170391781|NCT05182840|615772529|FG009|Treatment Period|Not treated with study drug|0|||
170391782|NCT00931515|615772532|FG000|Overall Study|Lost to Follow-up|2|||
170391783|NCT00931515|615772533|FG001|Overall Study|Lost to Follow-up|5|||
170391784|NCT01054443|615772534|FG000|Overall Study|Withdrawal by Subject|0|||
170391785|NCT01054443|615772535|FG001|Overall Study|Withdrawal by Subject|0|||
170391786|NCT01054443|615772536|FG002|Overall Study|Withdrawal by Subject|0|||
170391787|NCT01054443|615772537|FG003|Overall Study|Withdrawal by Subject|1|||
170391788|NCT00828009|615772538|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
170391789|NCT00828009|615772538|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
170391790|NCT00828009|615772538|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
170391791|NCT00828009|615772538|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
170391792|NCT00828009|615772538|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
170391793|NCT00828009|615772538|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
170391794|NCT00828009|615772538|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
170391795|NCT00828009|615772538|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
170391796|NCT00828009|615772538|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
170391797|NCT00828009|615772538|FG000|Step 2 - Maintenance Therapy|Death|1|||
170391798|NCT00828009|615772538|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
170391799|NCT00828009|615772538|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
170391800|NCT00828009|615772538|FG000|Step 2 - Maintenance Therapy|Other|1|||
170391801|NCT03145207|615772542|FG000|Overall Study|volunteer started taking allergy shots|1|||
170391802|NCT03145207|615772542|FG000|Overall Study|baseline blood pressure high|1|||
170391803|NCT01396434|615772548|FG000|Overall Study|Lost to Follow-up|1|||
170391804|NCT01396434|615772549|FG001|Overall Study|Lost to Follow-up|0|||
170391805|NCT01396434|615772550|FG002|Overall Study|Lost to Follow-up|0|||
170391806|NCT01396434|615772548|FG000|Overall Study|Other|10|||
170391807|NCT01396434|615772549|FG001|Overall Study|Other|0|||
170391808|NCT01396434|615772550|FG002|Overall Study|Other|0|||
170391809|NCT02260804|615772556|FG000|Induction Study Period|Protocol Violation|2|||
170391810|NCT02260804|615772557|FG001|Induction Study Period|Protocol Violation|0|||
170391811|NCT02260804|615772556|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
170391812|NCT02260804|615772557|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
170391813|NCT02260804|615772556|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
170391814|NCT02260804|615772557|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
170391815|NCT02260804|615772556|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
170391816|NCT02260804|615772557|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
170391817|NCT02260804|615772556|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
170391818|NCT02260804|615772557|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
170391819|NCT02260804|615772556|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
170391820|NCT02260804|615772557|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
170391821|NCT02260804|615772556|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
170391822|NCT02260804|615772557|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
170391823|NCT02260804|615772556|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
170391824|NCT02260804|615772557|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
170391825|NCT02260804|615772556|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
170391826|NCT02260804|615772557|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
170391827|NCT02260804|615772556|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
170391828|NCT02260804|615772557|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
170391829|NCT02260804|615772556|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
170391830|NCT02260804|615772557|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
170391831|NCT02503215|615773982|FG000|Overall Study|Unable to wear compression stockings|1|||
170391832|NCT02503215|615773982|FG000|Overall Study|Unable to use positive airway pressure|2|||
170391833|NCT00822237|615773987|FG000|Dose 1 Vaccination|Not vaccinated|3|||
170391834|NCT00822237|615773988|FG001|Dose 1 Vaccination|Not vaccinated|0|||
170391835|NCT00822237|615773987|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
170391836|NCT00822237|615773988|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
170391837|NCT00822237|615773987|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
170391838|NCT00822237|615773988|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
170391839|NCT00822237|615773987|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
170391840|NCT00822237|615773988|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
170391841|NCT00822237|615773987|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
170391842|NCT00822237|615773988|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
170391843|NCT03433482|615773989|FG000|Overall Study|Lost to Follow-up|1|||
170391844|NCT03433482|615773990|FG001|Overall Study|Lost to Follow-up|0|||
170391845|NCT03433482|615773991|FG002|Overall Study|Lost to Follow-up|1|||
170391846|NCT03433482|615773992|FG003|Overall Study|Lost to Follow-up|1|||
170391847|NCT03433482|615773989|FG000|Overall Study|Withdrawal by Subject|0|||
170391848|NCT03433482|615773990|FG001|Overall Study|Withdrawal by Subject|0|||
170391849|NCT03433482|615773991|FG002|Overall Study|Withdrawal by Subject|1|||
170391850|NCT03433482|615773992|FG003|Overall Study|Withdrawal by Subject|0|||
170391851|NCT03433482|615773989|FG000|Overall Study|Unknown reason|0|||
170391852|NCT03433482|615773990|FG001|Overall Study|Unknown reason|0|||
170391853|NCT03433482|615773991|FG002|Overall Study|Unknown reason|2|||
170391854|NCT03433482|615773992|FG003|Overall Study|Unknown reason|0|||
170391855|NCT04478994|615773993|FG000|Overall Study|Withdrawal by Subject|1|||
170391856|NCT04478994|615773994|FG001|Overall Study|Withdrawal by Subject|1|||
170391857|NCT00396318|615773998|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
170391858|NCT00326118|615773999|FG000|Active Phase|Withdrawal by Subject|4|||
170391859|NCT00326118|615774000|FG001|Active Phase|Withdrawal by Subject|1|||
170391860|NCT01728376|615774006|FG000|Overall Study|Adverse Event|1|||
170391861|NCT01728376|615774007|FG001|Overall Study|Adverse Event|1|||
170391862|NCT01728376|615774008|FG002|Overall Study|Adverse Event|1|||
170391863|NCT01728376|615774009|FG003|Overall Study|Adverse Event|1|||
170391864|NCT01728376|615774010|FG004|Overall Study|Adverse Event|1|||
170391865|NCT01728376|615774011|FG005|Overall Study|Adverse Event|0|||
170391866|NCT01728376|615774006|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
170391867|NCT01728376|615774007|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
170391868|NCT01728376|615774008|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
170391869|NCT01728376|615774009|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
170391870|NCT01728376|615774010|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
170391871|NCT01728376|615774011|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
170391872|NCT01728376|615774006|FG000|Overall Study|No relevant bacteria|2|||
170391873|NCT01728376|615774007|FG001|Overall Study|No relevant bacteria|0|||
170391874|NCT01728376|615774008|FG002|Overall Study|No relevant bacteria|0|||
170391875|NCT01728376|615774009|FG003|Overall Study|No relevant bacteria|0|||
170391876|NCT01728376|615774010|FG004|Overall Study|No relevant bacteria|1|||
170391877|NCT01728376|615774011|FG005|Overall Study|No relevant bacteria|1|||
170391878|NCT01728376|615774006|FG000|Overall Study|Did not receive treatment|0|||
170391879|NCT01728376|615774007|FG001|Overall Study|Did not receive treatment|1|||
170391880|NCT01728376|615774008|FG002|Overall Study|Did not receive treatment|0|||
170391881|NCT01728376|615774009|FG003|Overall Study|Did not receive treatment|0|||
170391882|NCT01728376|615774010|FG004|Overall Study|Did not receive treatment|0|||
170391883|NCT01728376|615774011|FG005|Overall Study|Did not receive treatment|0|||
170391884|NCT01728376|615774006|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
170391885|NCT01728376|615774007|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
170391886|NCT01728376|615774008|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
170391887|NCT01728376|615774009|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
170391888|NCT01728376|615774010|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
170391889|NCT01728376|615774011|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
170391890|NCT01741259|615774019|FG000|Overall Study|Protocol Violation|6|||
170391891|NCT01741259|615774020|FG001|Overall Study|Protocol Violation|4|||
170391892|NCT01741259|615774019|FG000|Overall Study|Withdrawal by Subject|0|||
170391893|NCT01741259|615774020|FG001|Overall Study|Withdrawal by Subject|2|||
170391894|NCT05604521|615774022|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
170391895|NCT05604521|615774023|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
170391896|NCT05604521|615774022|FG000|Overall Study|Adverse Event|1|||
170391897|NCT05604521|615774023|FG001|Overall Study|Adverse Event|0|||
170391898|NCT02856282|615774024|FG000|Overall Study|Withdrawal by Subject|1|||
170391899|NCT00057330|615774025|FG000|Overall Study|Adverse Event|9|||
170391900|NCT00057330|615774026|FG001|Overall Study|Adverse Event|12|||
170391901|NCT00057330|615774025|FG000|Overall Study|Death|1|||
170391902|NCT00057330|615774026|FG001|Overall Study|Death|0|||
170391903|NCT00057330|615774025|FG000|Overall Study|Protocol Violation|1|||
170391904|NCT00057330|615774026|FG001|Overall Study|Protocol Violation|1|||
170391905|NCT00057330|615774025|FG000|Overall Study|Withdrawal by Subject|115|||
170391906|NCT00057330|615774026|FG001|Overall Study|Withdrawal by Subject|84|||
170391907|NCT00057330|615774025|FG000|Overall Study|Lost to Follow-up|745|||
170391908|NCT00057330|615774026|FG001|Overall Study|Lost to Follow-up|617|||
170391909|NCT00057330|615774025|FG000|Overall Study|Physician Decision|1|||
170391910|NCT00057330|615774026|FG001|Overall Study|Physician Decision|0|||
170391911|NCT00057330|615774025|FG000|Overall Study|Other|260|||
170391912|NCT00057330|615774026|FG001|Overall Study|Other|206|||
170391913|NCT02094573|615774027|FG000|Overall Study|Adverse Event|4|||
170391914|NCT02094573|615774028|FG001|Overall Study|Adverse Event|14|||
170391915|NCT02094573|615774027|FG000|Overall Study|Clinical Progressive Disease|9|||
170391916|NCT02094573|615774028|FG001|Overall Study|Clinical Progressive Disease|13|||
170391917|NCT02094573|615774027|FG000|Overall Study|Death|11|||
170391918|NCT02094573|615774028|FG001|Overall Study|Death|3|||
170391919|NCT02094573|615774027|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
170391920|NCT02094573|615774028|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
170391921|NCT02094573|615774027|FG000|Overall Study|Non-compliance with Study Drug|1|||
170391922|NCT02094573|615774028|FG001|Overall Study|Non-compliance with Study Drug|1|||
170391923|NCT02094573|615774027|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
170391924|NCT02094573|615774028|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
170391925|NCT02094573|615774027|FG000|Overall Study|Physician Decision|4|||
170391926|NCT02094573|615774028|FG001|Overall Study|Physician Decision|4|||
170391927|NCT02094573|615774027|FG000|Overall Study|Site Terminated by Sponsor|10|||
170391928|NCT02094573|615774028|FG001|Overall Study|Site Terminated by Sponsor|17|||
170391929|NCT02094573|615774027|FG000|Overall Study|Withdrawal by Subject|6|||
170391930|NCT02094573|615774028|FG001|Overall Study|Withdrawal by Subject|8|||
170391931|NCT02094573|615774027|FG000|Overall Study|Randomized but not Treated|3|||
170391932|NCT02094573|615774028|FG001|Overall Study|Randomized but not Treated|0|||
170391933|NCT00924313|615774031|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
170391934|NCT01207219|615774034|FG000|Overall Study|changed diagnosis during study period|5|||
170391935|NCT01207219|615774035|FG001|Overall Study|changed diagnosis during study period|3|||
170391936|NCT01207219|615774036|FG002|Overall Study|changed diagnosis during study period|1|||
170391937|NCT01207219|615774034|FG000|Overall Study|Lost to Follow-up|6|||
170391938|NCT01207219|615774035|FG001|Overall Study|Lost to Follow-up|8|||
170391939|NCT01207219|615774036|FG002|Overall Study|Lost to Follow-up|6|||
170391940|NCT00924820|615774037|FG000|Overall Study|Death|2|||
170391941|NCT00924820|615774037|FG000|Overall Study|Ineligible, Screen Failure|5|||
170391942|NCT05027958|615774040|FG000|Overall Study|Lost to Follow-up|1|||
170391943|NCT05027958|615774041|FG001|Overall Study|Lost to Follow-up|1|||
170391944|NCT05027958|615774040|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
170391945|NCT05027958|615774041|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
170391946|NCT05027958|615774040|FG000|Overall Study|Physician Decision|1|||
170391947|NCT05027958|615774041|FG001|Overall Study|Physician Decision|4|||
170391948|NCT05027958|615774040|FG000|Overall Study|Adverse Event|0|||
170391949|NCT05027958|615774041|FG001|Overall Study|Adverse Event|1|||
170391950|NCT03155269|615774042|FG000|Overall Study|Withdrawal by Subject|4|||
170391951|NCT03155269|615774043|FG001|Overall Study|Withdrawal by Subject|5|||
170391952|NCT03155269|615774042|FG000|Overall Study|Lost to Follow-up|1|||
170391953|NCT03155269|615774043|FG001|Overall Study|Lost to Follow-up|2|||
170391954|NCT02594384|615774047|FG000|Overall Study|Disease Progression|3|||
170391955|NCT02594384|615774048|FG001|Overall Study|Disease Progression|7|||
170391956|NCT02594384|615774049|FG002|Overall Study|Disease Progression|0|||
170391957|NCT02594384|615774050|FG003|Overall Study|Disease Progression|2|||
170391958|NCT02594384|615774051|FG004|Overall Study|Disease Progression|2|||
170391959|NCT02594384|615774052|FG005|Overall Study|Disease Progression|12|||
170391960|NCT02594384|615774053|FG006|Overall Study|Disease Progression|5|||
170391961|NCT02594384|615774054|FG007|Overall Study|Disease Progression|5|||
170391962|NCT02594384|615774047|FG000|Overall Study|Adverse Event|0|||
170391963|NCT02594384|615774048|FG001|Overall Study|Adverse Event|1|||
170391964|NCT02594384|615774049|FG002|Overall Study|Adverse Event|4|||
170391965|NCT02594384|615774050|FG003|Overall Study|Adverse Event|1|||
170391966|NCT02594384|615774051|FG004|Overall Study|Adverse Event|0|||
170391967|NCT02594384|615774052|FG005|Overall Study|Adverse Event|6|||
170391968|NCT02594384|615774053|FG006|Overall Study|Adverse Event|1|||
170391969|NCT02594384|615774054|FG007|Overall Study|Adverse Event|1|||
170391970|NCT02594384|615774047|FG000|Overall Study|Withdrawal by Subject|0|||
170391971|NCT02594384|615774048|FG001|Overall Study|Withdrawal by Subject|0|||
170391972|NCT02594384|615774049|FG002|Overall Study|Withdrawal by Subject|0|||
170391973|NCT02594384|615774050|FG003|Overall Study|Withdrawal by Subject|1|||
170391974|NCT02594384|615774051|FG004|Overall Study|Withdrawal by Subject|0|||
170391975|NCT02594384|615774052|FG005|Overall Study|Withdrawal by Subject|0|||
170391976|NCT02594384|615774053|FG006|Overall Study|Withdrawal by Subject|0|||
170391977|NCT02594384|615774054|FG007|Overall Study|Withdrawal by Subject|1|||
170391978|NCT02594384|615774047|FG000|Overall Study|Physician Decision|0|||
170391979|NCT02594384|615774048|FG001|Overall Study|Physician Decision|0|||
170391980|NCT02594384|615774049|FG002|Overall Study|Physician Decision|0|||
170391981|NCT02594384|615774050|FG003|Overall Study|Physician Decision|0|||
170391982|NCT02594384|615774051|FG004|Overall Study|Physician Decision|0|||
170391983|NCT02594384|615774052|FG005|Overall Study|Physician Decision|1|||
170391984|NCT02594384|615774053|FG006|Overall Study|Physician Decision|2|||
170391985|NCT02594384|615774054|FG007|Overall Study|Physician Decision|0|||
170391986|NCT02594384|615774047|FG000|Overall Study|Progressive Leukocytosis|0|||
170391987|NCT02594384|615774048|FG001|Overall Study|Progressive Leukocytosis|0|||
170391988|NCT02594384|615774049|FG002|Overall Study|Progressive Leukocytosis|1|||
170391989|NCT02594384|615774050|FG003|Overall Study|Progressive Leukocytosis|0|||
170391990|NCT02594384|615774051|FG004|Overall Study|Progressive Leukocytosis|0|||
170391991|NCT02594384|615774052|FG005|Overall Study|Progressive Leukocytosis|0|||
170391992|NCT02594384|615774053|FG006|Overall Study|Progressive Leukocytosis|0|||
170391993|NCT02594384|615774054|FG007|Overall Study|Progressive Leukocytosis|0|||
170391994|NCT02594384|615774047|FG000|Overall Study|Lack of Efficacy|0|||
170391995|NCT02594384|615774048|FG001|Overall Study|Lack of Efficacy|0|||
170391996|NCT02594384|615774049|FG002|Overall Study|Lack of Efficacy|0|||
170391997|NCT02594384|615774050|FG003|Overall Study|Lack of Efficacy|0|||
170391998|NCT02594384|615774051|FG004|Overall Study|Lack of Efficacy|1|||
170391999|NCT02594384|615774052|FG005|Overall Study|Lack of Efficacy|0|||
170392000|NCT02594384|615774053|FG006|Overall Study|Lack of Efficacy|0|||
170392001|NCT02594384|615774054|FG007|Overall Study|Lack of Efficacy|0|||
170392002|NCT02594384|615774047|FG000|Overall Study|Substantial noncompliance|0|||
170392003|NCT02594384|615774048|FG001|Overall Study|Substantial noncompliance|0|||
170392004|NCT02594384|615774049|FG002|Overall Study|Substantial noncompliance|0|||
170392005|NCT02594384|615774050|FG003|Overall Study|Substantial noncompliance|0|||
170392006|NCT02594384|615774051|FG004|Overall Study|Substantial noncompliance|0|||
170392007|NCT02594384|615774052|FG005|Overall Study|Substantial noncompliance|0|||
170392008|NCT02594384|615774053|FG006|Overall Study|Substantial noncompliance|1|||
170392009|NCT02594384|615774054|FG007|Overall Study|Substantial noncompliance|0|||
170392010|NCT02686749|615774055|FG000|Overall Study|terminated for poor enrollment|2|||
170392011|NCT02686749|615774056|FG001|Overall Study|terminated for poor enrollment|2|||
170392012|NCT02369874|615774059|FG000|Overall Study|Lost to Follow-up|2|||
170392013|NCT02369874|615774060|FG001|Overall Study|Lost to Follow-up|2|||
170392014|NCT02369874|615774061|FG002|Overall Study|Lost to Follow-up|2|||
170392015|NCT02369874|615774059|FG000|Overall Study|Withdrawal by Subject|7|||
170392016|NCT02369874|615774060|FG001|Overall Study|Withdrawal by Subject|9|||
170392017|NCT02369874|615774061|FG002|Overall Study|Withdrawal by Subject|27|||
170392018|NCT02369874|615774059|FG000|Overall Study|Miscellaneous|1|||
170392019|NCT02369874|615774060|FG001|Overall Study|Miscellaneous|1|||
170392020|NCT02369874|615774061|FG002|Overall Study|Miscellaneous|0|||
170392021|NCT02369874|615774059|FG000|Overall Study|On Treatment/Off Study|34|||
170392022|NCT02369874|615774060|FG001|Overall Study|On Treatment/Off Study|45|||
170392023|NCT02369874|615774061|FG002|Overall Study|On Treatment/Off Study|32|||
170392024|NCT05147311|615774062|FG000|Overall Study|Did not complete survey|2|||
170392025|NCT05147311|615774063|FG001|Overall Study|Did not complete survey|1|||
170392026|NCT05147311|615774062|FG000|Overall Study|Patient too sick|1|||
170392027|NCT05147311|615774063|FG001|Overall Study|Patient too sick|2|||
170392028|NCT05147311|615774062|FG000|Overall Study|Death|0|||
170392029|NCT05147311|615774063|FG001|Overall Study|Death|1|||
170392030|NCT05147311|615774062|FG000|Overall Study|Declined survey|1|||
170392031|NCT05147311|615774063|FG001|Overall Study|Declined survey|0|||
170392032|NCT00145795|615774064|FG000|Overall Study|Adverse Event|1|||
170392033|NCT00145795|615774065|FG001|Overall Study|Adverse Event|0|||
170392034|NCT01015118|615774066|FG000|Overall Study|Protocol Violation|5|||
170392035|NCT01015118|615774067|FG001|Overall Study|Protocol Violation|6|||
170392036|NCT01015118|615774066|FG000|Overall Study|Withdrawal by Subject|103|||
170392037|NCT01015118|615774067|FG001|Overall Study|Withdrawal by Subject|27|||
170392038|NCT01015118|615774066|FG000|Overall Study|Other Adverse Event (AE)|141|||
170392039|NCT01015118|615774067|FG001|Overall Study|Other Adverse Event (AE)|33|||
170392040|NCT01015118|615774066|FG000|Overall Study|Worsening or AE of underlying disease|5|||
170392041|NCT01015118|615774067|FG001|Overall Study|Worsening or AE of underlying disease|4|||
170392042|NCT01015118|615774066|FG000|Overall Study|Progressive disease|364|||
170392043|NCT01015118|615774067|FG001|Overall Study|Progressive disease|229|||
170392044|NCT01015118|615774066|FG000|Overall Study|Not treated|9|||
170392045|NCT01015118|615774067|FG001|Overall Study|Not treated|5|||
170392046|NCT01015118|615774066|FG000|Overall Study|Other than stated above|42|||
170392047|NCT01015118|615774067|FG001|Overall Study|Other than stated above|23|||
170392048|NCT02388906|615774069|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
170392049|NCT02388906|615774070|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
170392050|NCT02388906|615774069|FG000|Treatment Period|Disease progression|121|||
170392051|NCT02388906|615774070|FG001|Treatment Period|Disease progression|100|||
170392052|NCT02388906|615774069|FG000|Treatment Period|Study drug toxicity|41|||
170392053|NCT02388906|615774070|FG001|Treatment Period|Study drug toxicity|208|||
170392054|NCT02388906|615774069|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
170392055|NCT02388906|615774070|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
170392056|NCT02388906|615774069|FG000|Treatment Period|Participant request to stop treatment|5|||
170392057|NCT02388906|615774070|FG001|Treatment Period|Participant request to stop treatment|9|||
170392058|NCT02388906|615774069|FG000|Treatment Period|Participant withdrew consent|2|||
170392059|NCT02388906|615774070|FG001|Treatment Period|Participant withdrew consent|3|||
170392060|NCT02388906|615774069|FG000|Treatment Period|Poor/non-compliance|0|||
170392061|NCT02388906|615774070|FG001|Treatment Period|Poor/non-compliance|1|||
170392062|NCT02388906|615774069|FG000|Treatment Period|Participant no longer meets study criteria|0|||
170392063|NCT02388906|615774070|FG001|Treatment Period|Participant no longer meets study criteria|1|||
170392064|NCT02388906|615774069|FG000|Treatment Period|Other reasons|3|||
170392065|NCT02388906|615774070|FG001|Treatment Period|Other reasons|3|||
170392066|NCT00402298|615774079|FG000|Overall Study|Withdrawal by Subject|1|||
170392067|NCT00402298|615774080|FG001|Overall Study|Withdrawal by Subject|0|||
170392068|NCT00480077|615774081|FG000|Overall Study|Death|19|||
170392069|NCT00480077|615774082|FG001|Overall Study|Death|15|||
170392070|NCT00480077|615774081|FG000|Overall Study|early exit|12|||
170392071|NCT00480077|615774082|FG001|Overall Study|early exit|11|||
170392072|NCT04298229|615774085|FG000|Overall Study|Physician Decision|1|||
170392073|NCT04298229|615774086|FG001|Overall Study|Physician Decision|1|||
170392074|NCT04298229|615774085|FG000|Overall Study|Withdrawal by Subject|1|||
170392075|NCT04298229|615774086|FG001|Overall Study|Withdrawal by Subject|1|||
170392076|NCT04298229|615774085|FG000|Overall Study|Did not receive IV loop diuretics|2|||
170392077|NCT04298229|615774086|FG001|Overall Study|Did not receive IV loop diuretics|0|||
170392078|NCT00071006|615774087|FG000|Overall Study|Lack of Efficacy|7|||
170392079|NCT00071006|615774087|FG000|Overall Study|Adverse Event|1|||
170392080|NCT00071006|615774087|FG000|Overall Study|Withdrawal by Subject|1|||
170392081|NCT00071006|615774087|FG000|Overall Study|Other|3|||
170392082|NCT05939388|615774092|FG000|Overall Study|Lost to Follow-up|1|||
170392083|NCT03901274|615774093|FG000|Overall Study|Lost to Follow-up|120|||
170392084|NCT03901274|615774094|FG001|Overall Study|Lost to Follow-up|124|||
170392085|NCT03901274|615774093|FG000|Overall Study|Withdrawal by Subject|0|||
170392086|NCT03901274|615774094|FG001|Overall Study|Withdrawal by Subject|6|||
170392087|NCT05570604|615774095|FG000|Overall Study|Lost to Follow-up|1|||
170392088|NCT05570604|615774096|FG001|Overall Study|Lost to Follow-up|5|||
170392089|NCT05570604|615774095|FG000|Overall Study|Illness|2|||
170392090|NCT05570604|615774096|FG001|Overall Study|Illness|2|||
170392091|NCT04527380|615774103|FG000|Overall Study|Lack of Efficacy|0|||
170392092|NCT04527380|615774104|FG001|Overall Study|Lack of Efficacy|1|||
170392093|NCT04527380|615774103|FG000|Overall Study|Withdrawal by Subject|1|||
170392094|NCT04527380|615774104|FG001|Overall Study|Withdrawal by Subject|0|||
170392095|NCT00938366|615774105|FG000|Overall Study|Withdrawal by Subject|1|||
170392096|NCT00938366|615774106|FG001|Overall Study|Withdrawal by Subject|0|||
170392097|NCT01215968|615774107|FG000|Overall Study|Adverse Event|0|||
170392098|NCT01215968|615774108|FG001|Overall Study|Adverse Event|2|||
170392099|NCT01215968|615774107|FG000|Overall Study|Protocol Violation|2|||
170392100|NCT01215968|615774108|FG001|Overall Study|Protocol Violation|4|||
170392101|NCT01215968|615774107|FG000|Overall Study|Not received study drug|0|||
170392102|NCT01215968|615774108|FG001|Overall Study|Not received study drug|1|||
170392103|NCT04242498|615774109|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
170392104|NCT04242498|615774110|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
170392105|NCT04242498|615774111|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
170392106|NCT04242498|615774112|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
170392107|NCT04242498|615774113|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
170392108|NCT04242498|615774114|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
170392109|NCT04242498|615774115|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
170392110|NCT04242498|615774109|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
170392111|NCT04242498|615774110|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
170392112|NCT04242498|615774111|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
170392113|NCT04242498|615774112|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
170392114|NCT04242498|615774113|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
170392115|NCT04242498|615774114|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
170392116|NCT04242498|615774115|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
170392117|NCT04242498|615774109|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
170392118|NCT04242498|615774110|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392119|NCT04242498|615774111|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
170392120|NCT04242498|615774112|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392121|NCT04242498|615774113|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392122|NCT04242498|615774114|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392123|NCT04242498|615774115|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392124|NCT04242498|615774109|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
170392125|NCT04242498|615774110|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392126|NCT04242498|615774111|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
170392127|NCT04242498|615774112|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392128|NCT04242498|615774113|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392129|NCT04242498|615774114|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392130|NCT04242498|615774115|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392131|NCT04242498|615774109|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
170392132|NCT04242498|615774110|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
170392133|NCT04242498|615774111|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
170392134|NCT04242498|615774112|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
170392135|NCT04242498|615774113|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
170392136|NCT04242498|615774114|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
170392137|NCT04242498|615774115|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
170392138|NCT04242498|615774109|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
170392139|NCT04242498|615774110|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
170392140|NCT04242498|615774111|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
170392141|NCT04242498|615774112|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
170392142|NCT04242498|615774113|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
170392143|NCT04242498|615774114|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
170392144|NCT04242498|615774115|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
170392145|NCT04242498|615774109|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
170392146|NCT04242498|615774110|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
170392147|NCT04242498|615774111|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
170392148|NCT04242498|615774112|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
170392149|NCT04242498|615774113|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
170392150|NCT04242498|615774114|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
170392151|NCT04242498|615774115|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
170392152|NCT04242498|615774109|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392153|NCT04242498|615774110|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
170392154|NCT04242498|615774111|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
170392155|NCT04242498|615774112|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392156|NCT04242498|615774113|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392157|NCT04242498|615774114|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392158|NCT04242498|615774115|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392159|NCT04242498|615774109|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
170392160|NCT04242498|615774110|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
170392161|NCT04242498|615774111|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
170392162|NCT04242498|615774112|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
170392163|NCT04242498|615774113|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
170392164|NCT04242498|615774114|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
170392165|NCT04242498|615774115|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
170392166|NCT04242498|615774109|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
170392167|NCT04242498|615774110|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
170392168|NCT04242498|615774111|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
170392169|NCT04242498|615774112|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
170392170|NCT04242498|615774113|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
170392171|NCT04242498|615774114|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
170392172|NCT04242498|615774115|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
170392173|NCT04242498|615774109|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
170392174|NCT04242498|615774110|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
170392175|NCT04242498|615774111|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
170392176|NCT04242498|615774112|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
170392177|NCT04242498|615774113|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
170392178|NCT04242498|615774114|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
170392179|NCT04242498|615774115|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
170392180|NCT04242498|615774109|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
170392181|NCT04242498|615774110|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
170392182|NCT04242498|615774111|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
170392183|NCT04242498|615774112|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
170392184|NCT04242498|615774113|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
170392185|NCT04242498|615774114|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
170392186|NCT04242498|615774115|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
170392187|NCT04242498|615774109|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
170392188|NCT04242498|615774110|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
170392189|NCT04242498|615774111|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
170392190|NCT04242498|615774112|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
170392191|NCT04242498|615774113|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
170392192|NCT04242498|615774114|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
170392193|NCT04242498|615774115|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
170392194|NCT04242498|615774109|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
170392195|NCT04242498|615774110|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
170392196|NCT04242498|615774111|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
170392197|NCT04242498|615774112|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
170392198|NCT04242498|615774113|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
170392199|NCT04242498|615774114|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
170392200|NCT04242498|615774115|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
170392201|NCT04242498|615774109|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
170392202|NCT04242498|615774110|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
170392203|NCT04242498|615774111|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
170392204|NCT04242498|615774112|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
170392205|NCT04242498|615774113|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
170392206|NCT04242498|615774114|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
170392207|NCT04242498|615774115|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
170392208|NCT04242498|615774109|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
170392209|NCT04242498|615774110|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
170392210|NCT04242498|615774111|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
170392211|NCT04242498|615774112|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
170392212|NCT04242498|615774113|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
170392213|NCT04242498|615774114|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
170392214|NCT04242498|615774115|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
170392215|NCT02396849|615774117|FG000|Overall Study|Lost to Follow-up|1|||
170392216|NCT02396849|615774118|FG001|Overall Study|Lost to Follow-up|1|||
170392217|NCT02396849|615774117|FG000|Overall Study|Did not tolerate intervention|1|||
170392218|NCT02396849|615774118|FG001|Overall Study|Did not tolerate intervention|1|||
170392219|NCT03328325|615774119|FG000|Overall Study|Lost to Follow-up|4|||
170392220|NCT03328325|615774119|FG000|Overall Study|Physician Decision|1|||
170392221|NCT03328325|615774119|FG000|Overall Study|Withdrawal by Subject|3|||
170392222|NCT03328325|615774119|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
170392223|NCT00985114|615774121|FG000|Overall Study|Adverse Event|1|||
170392224|NCT00985114|615774122|FG001|Overall Study|Adverse Event|0|||
170392225|NCT00985114|615774121|FG000|Overall Study|Withdrawal by Subject|0|||
170392226|NCT00985114|615774122|FG001|Overall Study|Withdrawal by Subject|2|||
170392227|NCT02950831|615774123|FG000|Overall Study|Lost to Follow-up|1|||
170392228|NCT02950831|615774123|FG000|Overall Study|Withdrawal by Subject|3|||
170392229|NCT02950831|615774123|FG000|Overall Study|stimulation trail failure|5|||
170392230|NCT04678557|615774129|FG000|Overall Study|Withdrawal by Subject|1|||
170392231|NCT04678557|615774130|FG001|Overall Study|Withdrawal by Subject|0|||
170392232|NCT04678557|615774129|FG000|Overall Study|Lack of Efficacy|0|||
170392233|NCT04678557|615774130|FG001|Overall Study|Lack of Efficacy|13|||
170392234|NCT04678557|615774129|FG000|Overall Study|Safety Evaluation|0|||
170392235|NCT04678557|615774130|FG001|Overall Study|Safety Evaluation|1|||
170392236|NCT01519635|615776559|FG000|Overall Study|Withdrawal by Subject|0|||
170392237|NCT01519635|615776560|FG001|Overall Study|Withdrawal by Subject|1|||
170392238|NCT01519635|615776559|FG000|Overall Study|No possibility to put a catheter|1|||
170392239|NCT01519635|615776560|FG001|Overall Study|No possibility to put a catheter|2|||
170392240|NCT00347776|615776561|FG000|1.5 Month Follow-up|Death|2|||
170392241|NCT00347776|615776562|FG001|1.5 Month Follow-up|Death|0|||
170392242|NCT00347776|615776563|FG002|1.5 Month Follow-up|Death|0|||
170392243|NCT00347776|615776561|FG000|1.5 Month Follow-up|reached the endpoint|12|||
170392244|NCT00347776|615776562|FG001|1.5 Month Follow-up|reached the endpoint|8|||
170392245|NCT00347776|615776563|FG002|1.5 Month Follow-up|reached the endpoint|12|||
170392246|NCT00347776|615776561|FG000|6 Month Follow-up|Death|2|||
170392247|NCT00347776|615776562|FG001|6 Month Follow-up|Death|1|||
170392248|NCT00347776|615776563|FG002|6 Month Follow-up|Death|3|||
170392249|NCT00347776|615776561|FG000|6 Month Follow-up|reached endpont|20|||
170392250|NCT00347776|615776562|FG001|6 Month Follow-up|reached endpont|12|||
170392251|NCT00347776|615776563|FG002|6 Month Follow-up|reached endpont|15|||
170392252|NCT00347776|615776561|FG000|12 Month Follow-up|Lost to Follow-up|7|||
170392253|NCT00347776|615776562|FG001|12 Month Follow-up|Lost to Follow-up|6|||
170392254|NCT00347776|615776563|FG002|12 Month Follow-up|Lost to Follow-up|6|||
170392255|NCT00347776|615776561|FG000|12 Month Follow-up|Death|3|||
170392256|NCT00347776|615776562|FG001|12 Month Follow-up|Death|4|||
170392257|NCT00347776|615776563|FG002|12 Month Follow-up|Death|4|||
170392258|NCT00347776|615776561|FG000|12 Month Follow-up|Reached endpoint|13|||
170392259|NCT00347776|615776562|FG001|12 Month Follow-up|Reached endpoint|6|||
170392260|NCT00347776|615776563|FG002|12 Month Follow-up|Reached endpoint|9|||
170392261|NCT01100073|615776564|FG000|Overall Study|Lack of Efficacy|4|||
170392262|NCT01100073|615776564|FG000|Overall Study|Insufficient Tolerability|21|||
170392263|NCT01100073|615776564|FG000|Overall Study|Withdrawal by Subject|13|||
170392264|NCT01100073|615776564|FG000|Overall Study|Lost to Follow-up|39|||
170392265|NCT01100073|615776564|FG000|Overall Study|Lack of effect + patient's wish|2|||
170392266|NCT01100073|615776564|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
170392267|NCT01100073|615776564|FG000|Overall Study|Other|8|||
170392268|NCT01100073|615776564|FG000|Overall Study|Missing|5|||
170392269|NCT00299546|615776565|FG000|Overall Study|Death|3|||
170392270|NCT00299546|615776566|FG001|Overall Study|Death|2|||
170392271|NCT00299546|615776567|FG002|Overall Study|Death|0|||
170392272|NCT00299546|615776565|FG000|Overall Study|Lost to Follow-up|2|||
170392273|NCT00299546|615776566|FG001|Overall Study|Lost to Follow-up|2|||
170392274|NCT00299546|615776567|FG002|Overall Study|Lost to Follow-up|5|||
170392275|NCT00299546|615776565|FG000|Overall Study|Adverse Event|37|||
170392276|NCT00299546|615776566|FG001|Overall Study|Adverse Event|22|||
170392277|NCT00299546|615776567|FG002|Overall Study|Adverse Event|27|||
170392278|NCT00299546|615776565|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
170392279|NCT00299546|615776566|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
170392280|NCT00299546|615776567|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
170392281|NCT00299546|615776565|FG000|Overall Study|Other|24|||
170392282|NCT00299546|615776566|FG001|Overall Study|Other|26|||
170392283|NCT00299546|615776567|FG002|Overall Study|Other|19|||
170392284|NCT00299546|615776565|FG000|Overall Study|Not treated|0|||
170392285|NCT00299546|615776566|FG001|Overall Study|Not treated|1|||
170392286|NCT00299546|615776567|FG002|Overall Study|Not treated|1|||
170392287|NCT03099265|615776568|FG000|Overall Study|Adverse Event|1|||
170392288|NCT00518531|615776573|FG000|Treatment Period 1|Adverse Event|5|||
170392289|NCT00518531|615776574|FG001|Treatment Period 1|Adverse Event|0|||
170392290|NCT00518531|615776573|FG000|Treatment Period 1|Lost to Follow-up|5|||
170392291|NCT00518531|615776574|FG001|Treatment Period 1|Lost to Follow-up|3|||
170392292|NCT00518531|615776573|FG000|Treatment Period 1|Physician Decision|1|||
170392293|NCT00518531|615776574|FG001|Treatment Period 1|Physician Decision|0|||
170392294|NCT00518531|615776573|FG000|Treatment Period 1|Protocol Violation|2|||
170392295|NCT00518531|615776574|FG001|Treatment Period 1|Protocol Violation|0|||
170392296|NCT00518531|615776573|FG000|Treatment Period 1|Withdrawal by Subject|4|||
170392297|NCT00518531|615776574|FG001|Treatment Period 1|Withdrawal by Subject|6|||
170392298|NCT00518531|615776573|FG000|Treatment Period 1|Early crossover|1|||
170392299|NCT00518531|615776574|FG001|Treatment Period 1|Early crossover|3|||
170392300|NCT00518531|615776573|FG000|Treatment Period 2|Withdrawal by Subject|0|||
170392301|NCT00518531|615776574|FG001|Treatment Period 2|Withdrawal by Subject|8|||
170392302|NCT00518531|615776573|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
170392303|NCT00518531|615776574|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
170392304|NCT00518531|615776573|FG000|Treatment Period 2|Adverse Event|1|||
170392305|NCT00518531|615776574|FG001|Treatment Period 2|Adverse Event|7|||
170392306|NCT00518531|615776573|FG000|Treatment Period 2|Protocol-specified criteria|0|||
170392307|NCT00518531|615776574|FG001|Treatment Period 2|Protocol-specified criteria|1|||
170392308|NCT00518531|615776573|FG000|Treatment Period 2|Non-compliance|1|||
170392309|NCT00518531|615776574|FG001|Treatment Period 2|Non-compliance|2|||
170392310|NCT01656850|615776575|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
170392311|NCT01656850|615776576|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
170392312|NCT00968539|615776577|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
170392313|NCT00968539|615776578|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
170392314|NCT00602927|615776579|FG000|Period 1: 13 Days|Protocol Violation|2|||
170392315|NCT00602927|615776580|FG001|Period 1: 13 Days|Protocol Violation|4|||
170392316|NCT00602927|615776579|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
170392317|NCT00602927|615776580|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
170392318|NCT00602927|615776579|FG000|Period 1: 13 Days|Time|1|||
170392319|NCT00602927|615776580|FG001|Period 1: 13 Days|Time|0|||
170392320|NCT00602927|615776579|FG000|Period 1: 13 Days|Claustrophobia|0|||
170392321|NCT00602927|615776580|FG001|Period 1: 13 Days|Claustrophobia|1|||
170392322|NCT00602927|615776579|FG000|Period 2: 14 Days|Protocol Violation|0|||
170392323|NCT00602927|615776580|FG001|Period 2: 14 Days|Protocol Violation|2|||
170392324|NCT00602927|615776579|FG000|Period 3: 13 Days|Protocol Violation|0|||
170392325|NCT00602927|615776580|FG001|Period 3: 13 Days|Protocol Violation|1|||
170392326|NCT00602927|615776579|FG000|Period 3: 13 Days|MRI data quality|2|||
170392327|NCT00602927|615776580|FG001|Period 3: 13 Days|MRI data quality|2|||
170392328|NCT02074982|615776583|FG000|Overall Study|Adverse Event|15|||
170392329|NCT02074982|615776584|FG001|Overall Study|Adverse Event|7|||
170392330|NCT02074982|615776583|FG000|Overall Study|Lack of Efficacy|6|||
170392331|NCT02074982|615776584|FG001|Overall Study|Lack of Efficacy|1|||
170392332|NCT02074982|615776583|FG000|Overall Study|Lost to Follow-up|9|||
170392333|NCT02074982|615776584|FG001|Overall Study|Lost to Follow-up|10|||
170392334|NCT02074982|615776583|FG000|Overall Study|Non-compliance with study treatment|0|||
170392335|NCT02074982|615776584|FG001|Overall Study|Non-compliance with study treatment|2|||
170392336|NCT02074982|615776583|FG000|Overall Study|Physician Decision|1|||
170392337|NCT02074982|615776584|FG001|Overall Study|Physician Decision|1|||
170392338|NCT02074982|615776583|FG000|Overall Study|Pregnancy|1|||
170392339|NCT02074982|615776584|FG001|Overall Study|Pregnancy|2|||
170392340|NCT02074982|615776583|FG000|Overall Study|Protocol deviation|4|||
170392341|NCT02074982|615776584|FG001|Overall Study|Protocol deviation|3|||
170392342|NCT02074982|615776583|FG000|Overall Study|Technical problems|0|||
170392343|NCT02074982|615776584|FG001|Overall Study|Technical problems|2|||
170392344|NCT02074982|615776583|FG000|Overall Study|Subject/guardian decision|15|||
170392345|NCT02074982|615776584|FG001|Overall Study|Subject/guardian decision|24|||
170392346|NCT02074982|615776583|FG000|Overall Study|Death|0|||
170392347|NCT02074982|615776584|FG001|Overall Study|Death|2|||
170392348|NCT02525627|615776591|FG000|Overall Study|Revision|1|||
170392349|NCT02525627|615776592|FG001|Overall Study|Revision|1|||
170392350|NCT02525627|615776591|FG000|Overall Study|Withdrawal by Subject|1|||
170392351|NCT02525627|615776592|FG001|Overall Study|Withdrawal by Subject|2|||
170392352|NCT02525627|615776591|FG000|Overall Study|Death|1|||
170392353|NCT02525627|615776592|FG001|Overall Study|Death|0|||
170392354|NCT02525627|615776591|FG000|Overall Study|Site terminated|11|||
170392355|NCT02525627|615776592|FG001|Overall Study|Site terminated|10|||
170392356|NCT01160770|615776593|FG000|Overall Study|Adverse Event|10|||
170392357|NCT01160770|615776593|FG000|Overall Study|Protocol Violation|2|||
170392358|NCT01160770|615776593|FG000|Overall Study|Subject/parent/caregiver request|33|||
170392359|NCT01160770|615776593|FG000|Overall Study|Physician Decision|1|||
170392360|NCT01160770|615776593|FG000|Overall Study|Lost to Follow-up|7|||
170392361|NCT01160770|615776593|FG000|Overall Study|Study termination or sponsor request|1|||
170392362|NCT01160770|615776593|FG000|Overall Study|Death|9|||
170392363|NCT01160770|615776593|FG000|Overall Study|Lack of Efficacy|15|||
170392364|NCT01160770|615776593|FG000|Overall Study|Other Reasons|1|||
170392365|NCT00242567|615776594|FG000|Overall Study|Adverse Event|70|||
170392366|NCT00242567|615776595|FG001|Overall Study|Adverse Event|43|||
170392367|NCT00242567|615776594|FG000|Overall Study|Disease Progression|17|||
170392368|NCT00242567|615776595|FG001|Overall Study|Disease Progression|22|||
170392369|NCT00242567|615776594|FG000|Overall Study|Symptomatic deterioration|9|||
170392370|NCT00242567|615776595|FG001|Overall Study|Symptomatic deterioration|3|||
170392371|NCT00242567|615776594|FG000|Overall Study|Lack of Efficacy|2|||
170392372|NCT00242567|615776595|FG001|Overall Study|Lack of Efficacy|2|||
170392373|NCT00242567|615776594|FG000|Overall Study|Lost to Follow-up|9|||
170392374|NCT00242567|615776595|FG001|Overall Study|Lost to Follow-up|19|||
170392375|NCT00242567|615776594|FG000|Overall Study|Withdrawal by Subject|33|||
170392376|NCT00242567|615776595|FG001|Overall Study|Withdrawal by Subject|28|||
170392377|NCT00242567|615776594|FG000|Overall Study|Protocol Violation|12|||
170392378|NCT00242567|615776595|FG001|Overall Study|Protocol Violation|12|||
170392379|NCT00242567|615776594|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
170392380|NCT00242567|615776595|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
170392381|NCT00242567|615776594|FG000|Overall Study|Other|14|||
170392382|NCT00242567|615776595|FG001|Overall Study|Other|9|||
170392383|NCT00630994|615776596|FG000|Overall Study|Adverse Event|1|||
170392384|NCT00630994|615776596|FG000|Overall Study|Disease Progression|1|||
170392385|NCT00630994|615776596|FG000|Overall Study|Lack of Efficacy|1|||
170392386|NCT00630994|615776596|FG000|Overall Study|Other|1|||
170392387|NCT05553600|615776599|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
170392388|NCT05553600|615776600|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
170392389|NCT05553600|615776601|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
170392390|NCT05553600|615776602|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
170392391|NCT05553600|615776599|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
170392392|NCT05553600|615776600|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
170392393|NCT05553600|615776601|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
170392394|NCT05553600|615776602|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
170392395|NCT05553600|615776599|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
170392396|NCT05553600|615776600|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
170392397|NCT05553600|615776601|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
170392398|NCT05553600|615776602|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
170392399|NCT05553600|615776599|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
170392400|NCT05553600|615776600|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
170392401|NCT05553600|615776601|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
170392402|NCT05553600|615776602|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
170392403|NCT05553600|615776599|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
170392404|NCT05553600|615776600|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
170392405|NCT05553600|615776601|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
170392406|NCT05553600|615776602|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
170392407|NCT05553600|615776599|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
170392408|NCT05553600|615776600|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
170392409|NCT05553600|615776601|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
170392410|NCT05553600|615776602|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
170392411|NCT05553600|615776599|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
170392412|NCT05553600|615776600|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
170392413|NCT05553600|615776601|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
170392414|NCT05553600|615776602|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
170392415|NCT05553600|615776599|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
170392416|NCT05553600|615776600|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
170392417|NCT05553600|615776601|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
170392418|NCT05553600|615776602|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
170392419|NCT05553600|615776599|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
170392420|NCT05553600|615776600|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
170392421|NCT05553600|615776601|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
170392422|NCT05553600|615776602|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
170392423|NCT05553600|615776599|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
170392424|NCT05553600|615776600|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
170392425|NCT05553600|615776601|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
170392426|NCT05553600|615776602|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
170392427|NCT05553600|615776599|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
170392428|NCT05553600|615776600|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
170392429|NCT05553600|615776601|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
170392430|NCT05553600|615776602|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
170392431|NCT05553600|615776599|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
170392432|NCT05553600|615776600|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
170392433|NCT05553600|615776601|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
170392434|NCT05553600|615776602|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
170392435|NCT03443973|615776603|FG000|Double-blind Treatment Period|Adverse Event|5|||
170392436|NCT03443973|615776604|FG001|Double-blind Treatment Period|Adverse Event|19|||
170392437|NCT03443973|615776605|FG002|Double-blind Treatment Period|Adverse Event|0|||
170392438|NCT03443973|615776606|FG003|Double-blind Treatment Period|Adverse Event|0|||
170392439|NCT03443973|615776603|FG000|Double-blind Treatment Period|Death|5|||
170392440|NCT03443973|615776604|FG001|Double-blind Treatment Period|Death|7|||
170392441|NCT03443973|615776605|FG002|Double-blind Treatment Period|Death|0|||
170392442|NCT03443973|615776606|FG003|Double-blind Treatment Period|Death|0|||
170392443|NCT03443973|615776603|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
170392444|NCT03443973|615776604|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
170392445|NCT03443973|615776605|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
170392446|NCT03443973|615776606|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
170392447|NCT03443973|615776603|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
170392448|NCT03443973|615776604|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
170392449|NCT03443973|615776605|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
170392450|NCT03443973|615776606|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
170392451|NCT03443973|615776603|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
170392452|NCT03443973|615776604|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
170392453|NCT03443973|615776605|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
170392454|NCT03443973|615776606|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
170392455|NCT03443973|615776603|FG000|Double-blind Treatment Period|Physician Decision|5|||
170392456|NCT03443973|615776604|FG001|Double-blind Treatment Period|Physician Decision|6|||
170392457|NCT03443973|615776605|FG002|Double-blind Treatment Period|Physician Decision|0|||
170392458|NCT03443973|615776606|FG003|Double-blind Treatment Period|Physician Decision|0|||
170392459|NCT03443973|615776603|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
170392460|NCT03443973|615776604|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
170392461|NCT03443973|615776605|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
170392462|NCT03443973|615776606|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
170392463|NCT03443973|615776603|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
170392464|NCT03443973|615776604|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
170392465|NCT03443973|615776605|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
170392466|NCT03443973|615776606|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
170392467|NCT03443973|615776603|FG000|Open-label Extension Period|Reason Not Specified|0|||
170392468|NCT03443973|615776604|FG001|Open-label Extension Period|Reason Not Specified|0|||
170392469|NCT03443973|615776605|FG002|Open-label Extension Period|Reason Not Specified|3|||
170392470|NCT03443973|615776606|FG003|Open-label Extension Period|Reason Not Specified|0|||
170392471|NCT03443973|615776603|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
170392472|NCT03443973|615776604|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
170392473|NCT03443973|615776605|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
170392474|NCT03443973|615776606|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
170392475|NCT02411110|615776611|FG000|Treatment Period 1|Adverse Event|4|||
170392476|NCT02411110|615776612|FG001|Treatment Period 1|Adverse Event|2|||
170392477|NCT02411110|615776611|FG000|Treatment Period 1|Lost to Follow-up|1|||
170392478|NCT02411110|615776612|FG001|Treatment Period 1|Lost to Follow-up|0|||
170392479|NCT02411110|615776611|FG000|Treatment Period 1|Personal Reasons|2|||
170392480|NCT02411110|615776612|FG001|Treatment Period 1|Personal Reasons|5|||
170392481|NCT02411110|615776611|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
170392482|NCT02411110|615776612|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
170392483|NCT02411110|615776611|FG000|Treatment Period 2|Adverse Event|1|||
170392484|NCT02411110|615776612|FG001|Treatment Period 2|Adverse Event|0|||
170392485|NCT02411110|615776611|FG000|Treatment Period 2|Lost to Follow-up|0|||
170392486|NCT02411110|615776612|FG001|Treatment Period 2|Lost to Follow-up|2|||
170392487|NCT02411110|615776611|FG000|Treatment Period 2|Personal Reasons|0|||
170392488|NCT02411110|615776612|FG001|Treatment Period 2|Personal Reasons|2|||
170392489|NCT04888377|615776613|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
170392490|NCT04888377|615776614|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
170392491|NCT04888377|615776613|FG000|Overall Study|Physician Decision|6|||
170392492|NCT04888377|615776614|FG001|Overall Study|Physician Decision|6|||
170392493|NCT04888377|615776613|FG000|Overall Study|Withdrawal by Subject|7|||
170392494|NCT04888377|615776614|FG001|Overall Study|Withdrawal by Subject|3|||
170392495|NCT00526162|615776615|FG000|Overall Study|Device not implanted|3|||
170392496|NCT05279807|615776616|FG000|Overall Study|Withdrawal by Subject|1|||
170392497|NCT05279807|615776617|FG001|Overall Study|Withdrawal by Subject|0|||
170392498|NCT05279807|615776616|FG000|Overall Study|Adverse Event|0|||
170392499|NCT05279807|615776617|FG001|Overall Study|Adverse Event|1|||
170392500|NCT05279807|615776616|FG000|Overall Study|Laboratory Abnormal Results|1|||
170392501|NCT05279807|615776617|FG001|Overall Study|Laboratory Abnormal Results|0|||
170392502|NCT05299359|615776632|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
170392503|NCT05299359|615776633|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
170392504|NCT05299359|615776632|FG000|Main Part: Day 1 up to Day 366|Other|2|||
170392505|NCT05299359|615776633|FG001|Main Part: Day 1 up to Day 366|Other|0|||
170392506|NCT05299359|615776632|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
170392507|NCT05299359|615776633|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
170392508|NCT05299359|615776632|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
170392509|NCT05299359|615776633|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
170392510|NCT05299359|615776632|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
170392511|NCT05299359|615776633|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
170392512|NCT05299359|615776632|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
170392513|NCT05299359|615776633|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
170392514|NCT05299359|615776632|FG000|Extension Part: Day 1 to Day 366|Other|0|||
170392515|NCT05299359|615776633|FG001|Extension Part: Day 1 to Day 366|Other|1|||
170392516|NCT04242446|615776634|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
170392517|NCT04242446|615776635|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
170392518|NCT04242446|615776636|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
170392519|NCT04242446|615776637|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
170392520|NCT04242446|615776638|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
170392521|NCT04242446|615776639|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
170392522|NCT04242446|615776640|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
170392523|NCT04242446|615776634|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392524|NCT04242446|615776635|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
170392525|NCT04242446|615776636|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
170392526|NCT04242446|615776637|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392527|NCT04242446|615776638|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392528|NCT04242446|615776639|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392529|NCT04242446|615776640|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
170392530|NCT04242446|615776634|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
170392531|NCT04242446|615776635|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
170392532|NCT04242446|615776636|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
170392533|NCT04242446|615776637|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392534|NCT04242446|615776638|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392535|NCT04242446|615776639|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392536|NCT04242446|615776640|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
170392537|NCT04242446|615776634|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
170392538|NCT04242446|615776635|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
170392539|NCT04242446|615776636|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
170392540|NCT04242446|615776637|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
170392541|NCT04242446|615776638|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
170392542|NCT04242446|615776639|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
170392543|NCT04242446|615776640|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
170392544|NCT04242446|615776634|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
170392545|NCT04242446|615776635|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
170392546|NCT04242446|615776636|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
170392547|NCT04242446|615776637|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
170392548|NCT04242446|615776638|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
170392549|NCT04242446|615776639|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
170392550|NCT04242446|615776640|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
170392551|NCT04242446|615776634|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
170392552|NCT04242446|615776635|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
170392553|NCT04242446|615776636|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
170392554|NCT04242446|615776637|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
170392555|NCT04242446|615776638|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
170392556|NCT04242446|615776639|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
170392557|NCT04242446|615776640|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
170392558|NCT04242446|615776634|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
170392559|NCT04242446|615776635|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
170392560|NCT04242446|615776636|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
170392561|NCT04242446|615776637|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
170392562|NCT04242446|615776638|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
170392563|NCT04242446|615776639|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
170392564|NCT04242446|615776640|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
170392565|NCT04242446|615776634|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392566|NCT04242446|615776635|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
170392567|NCT04242446|615776636|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
170392568|NCT04242446|615776637|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392569|NCT04242446|615776638|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392570|NCT04242446|615776639|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392571|NCT04242446|615776640|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
170392572|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
170392573|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
170392574|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
170392575|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
170392576|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
170392577|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
170392578|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
170392579|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
170392580|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
170392581|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
170392582|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
170392583|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
170392584|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
170392585|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
170392586|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
170392587|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
170392588|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
170392589|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
170392590|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
170392591|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
170392592|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
170392593|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
170392594|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
170392595|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
170392596|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
170392597|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
170392598|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
170392599|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
170392600|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
170392601|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
170392602|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
170392603|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
170392604|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
170392605|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
170392606|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
170392607|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
170392608|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
170392609|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
170392610|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
170392611|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
170392612|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
170392613|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
170392614|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
170392615|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
170392616|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
170392617|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
170392618|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
170392619|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
170392620|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
170392621|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
170392622|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
170392623|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
170392624|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
170392625|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
170392626|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
170392627|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
170392628|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
170392629|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
170392630|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
170392631|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
170392632|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
170392633|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
170392634|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
170392635|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
170392636|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
170392637|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
170392638|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
170392639|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
170392640|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
170392641|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
170392642|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
170392643|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
170392644|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
170392645|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
170392646|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
170392647|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
170392648|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
170392649|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
170392650|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
170392651|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
170392652|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
170392653|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
170392654|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
170392655|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
170392656|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
170392657|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
170392658|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
170392659|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
170392660|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
170392661|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
170392662|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
170392663|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
170392664|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
170392665|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
170392666|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
170392667|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
170392668|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
170392669|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
170392670|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
170392671|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
170392672|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
170392673|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
170392674|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
170392675|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
170392676|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
170392677|NCT04242446|615776634|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
170392678|NCT04242446|615776635|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
170392679|NCT04242446|615776636|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
170392680|NCT04242446|615776637|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
170392681|NCT04242446|615776638|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
170392682|NCT04242446|615776639|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
170392683|NCT04242446|615776640|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
170392684|NCT03587116|615776641|FG000|Overall Study|Lost to Follow-up|0|||
170392685|NCT03587116|615776642|FG001|Overall Study|Lost to Follow-up|1|||
170392686|NCT03587116|615776641|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
170392687|NCT03587116|615776642|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
170392688|NCT03587116|615776641|FG000|Overall Study|Withdrawal by Subject|4|||
170392689|NCT03587116|615776642|FG001|Overall Study|Withdrawal by Subject|0|||
170392690|NCT05993299|615776643|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
170392691|NCT05993299|615776643|FG000|Overall Study|Ongoing|4|||
170392692|NCT05644756|615776644|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
170392693|NCT05644756|615776644|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
170392694|NCT03110107|615776645|FG000|Treatment Period|Disease Progression|3|||
170392695|NCT03110107|615776646|FG001|Treatment Period|Disease Progression|9|||
170392696|NCT03110107|615776647|FG002|Treatment Period|Disease Progression|8|||
170392697|NCT03110107|615776648|FG003|Treatment Period|Disease Progression|11|||
170392698|NCT03110107|615776649|FG004|Treatment Period|Disease Progression|8|||
170392699|NCT03110107|615776650|FG005|Treatment Period|Disease Progression|4|||
170392700|NCT03110107|615776651|FG006|Treatment Period|Disease Progression|6|||
170392701|NCT03110107|615776652|FG007|Treatment Period|Disease Progression|7|||
170392702|NCT03110107|615776653|FG008|Treatment Period|Disease Progression|2|||
170392703|NCT03110107|615776654|FG009|Treatment Period|Disease Progression|10|||
170392704|NCT03110107|615776655|FG010|Treatment Period|Disease Progression|5|||
170392705|NCT03110107|615776656|FG011|Treatment Period|Disease Progression|2|||
170392706|NCT03110107|615776657|FG012|Treatment Period|Disease Progression|0|||
170392707|NCT03110107|615776658|FG013|Treatment Period|Disease Progression|5|||
170392708|NCT03110107|615776659|FG014|Treatment Period|Disease Progression|14|||
170392709|NCT03110107|615776660|FG015|Treatment Period|Disease Progression|14|||
170392710|NCT03110107|615776661|FG016|Treatment Period|Disease Progression|4|||
170392711|NCT03110107|615776662|FG017|Treatment Period|Disease Progression|3|||
170392712|NCT03110107|615776663|FG018|Treatment Period|Disease Progression|16|||
170392713|NCT03110107|615776664|FG019|Treatment Period|Disease Progression|14|||
170392714|NCT03110107|615776665|FG020|Treatment Period|Disease Progression|12|||
170392715|NCT03110107|615776666|FG021|Treatment Period|Disease Progression|16|||
170392716|NCT03110107|615776667|FG022|Treatment Period|Disease Progression|18|||
170392717|NCT03110107|615776668|FG023|Treatment Period|Disease Progression|13|||
170392718|NCT03110107|615776669|FG024|Treatment Period|Disease Progression|16|||
170392719|NCT03110107|615776670|FG025|Treatment Period|Disease Progression|31|||
170392720|NCT03110107|615776645|FG000|Treatment Period|Study drug toxicity|1|||
170392721|NCT03110107|615776646|FG001|Treatment Period|Study drug toxicity|0|||
170392722|NCT03110107|615776647|FG002|Treatment Period|Study drug toxicity|1|||
170392723|NCT03110107|615776648|FG003|Treatment Period|Study drug toxicity|2|||
170392724|NCT03110107|615776649|FG004|Treatment Period|Study drug toxicity|0|||
170392725|NCT03110107|615776650|FG005|Treatment Period|Study drug toxicity|3|||
170392726|NCT03110107|615776651|FG006|Treatment Period|Study drug toxicity|1|||
170392727|NCT03110107|615776652|FG007|Treatment Period|Study drug toxicity|1|||
170392728|NCT03110107|615776653|FG008|Treatment Period|Study drug toxicity|3|||
170392729|NCT03110107|615776654|FG009|Treatment Period|Study drug toxicity|2|||
170392730|NCT03110107|615776655|FG010|Treatment Period|Study drug toxicity|0|||
170392731|NCT03110107|615776656|FG011|Treatment Period|Study drug toxicity|2|||
170392732|NCT03110107|615776657|FG012|Treatment Period|Study drug toxicity|0|||
170392733|NCT03110107|615776658|FG013|Treatment Period|Study drug toxicity|0|||
170392734|NCT03110107|615776659|FG014|Treatment Period|Study drug toxicity|2|||
170392735|NCT03110107|615776660|FG015|Treatment Period|Study drug toxicity|3|||
170392736|NCT03110107|615776661|FG016|Treatment Period|Study drug toxicity|3|||
170392737|NCT03110107|615776662|FG017|Treatment Period|Study drug toxicity|3|||
170392738|NCT03110107|615776663|FG018|Treatment Period|Study drug toxicity|1|||
170392739|NCT03110107|615776664|FG019|Treatment Period|Study drug toxicity|2|||
170392740|NCT03110107|615776665|FG020|Treatment Period|Study drug toxicity|2|||
170392741|NCT03110107|615776666|FG021|Treatment Period|Study drug toxicity|0|||
170392742|NCT03110107|615776667|FG022|Treatment Period|Study drug toxicity|2|||
170392743|NCT03110107|615776668|FG023|Treatment Period|Study drug toxicity|6|||
170392744|NCT03110107|615776669|FG024|Treatment Period|Study drug toxicity|7|||
170392745|NCT03110107|615776670|FG025|Treatment Period|Study drug toxicity|6|||
170392746|NCT03110107|615776645|FG000|Treatment Period|Death|0|||
170392747|NCT03110107|615776646|FG001|Treatment Period|Death|0|||
170392748|NCT03110107|615776647|FG002|Treatment Period|Death|0|||
170392749|NCT03110107|615776648|FG003|Treatment Period|Death|0|||
170392750|NCT03110107|615776649|FG004|Treatment Period|Death|0|||
170392751|NCT03110107|615776650|FG005|Treatment Period|Death|0|||
170392752|NCT03110107|615776651|FG006|Treatment Period|Death|0|||
170392753|NCT03110107|615776652|FG007|Treatment Period|Death|0|||
170392754|NCT03110107|615776653|FG008|Treatment Period|Death|0|||
170392755|NCT03110107|615776654|FG009|Treatment Period|Death|0|||
170392756|NCT03110107|615776655|FG010|Treatment Period|Death|0|||
170392757|NCT03110107|615776656|FG011|Treatment Period|Death|0|||
170392758|NCT03110107|615776657|FG012|Treatment Period|Death|1|||
170392759|NCT03110107|615776658|FG013|Treatment Period|Death|0|||
170392760|NCT03110107|615776659|FG014|Treatment Period|Death|0|||
170392761|NCT03110107|615776660|FG015|Treatment Period|Death|0|||
170392762|NCT03110107|615776661|FG016|Treatment Period|Death|0|||
170392763|NCT03110107|615776662|FG017|Treatment Period|Death|0|||
170392764|NCT03110107|615776663|FG018|Treatment Period|Death|0|||
170392765|NCT03110107|615776664|FG019|Treatment Period|Death|0|||
170392766|NCT03110107|615776665|FG020|Treatment Period|Death|0|||
170392767|NCT03110107|615776666|FG021|Treatment Period|Death|0|||
170392768|NCT03110107|615776667|FG022|Treatment Period|Death|0|||
170392769|NCT03110107|615776668|FG023|Treatment Period|Death|0|||
170392770|NCT03110107|615776669|FG024|Treatment Period|Death|0|||
170392771|NCT03110107|615776670|FG025|Treatment Period|Death|0|||
170392772|NCT03110107|615776645|FG000|Treatment Period|Adverse Event|0|||
170392773|NCT03110107|615776646|FG001|Treatment Period|Adverse Event|0|||
170392774|NCT03110107|615776647|FG002|Treatment Period|Adverse Event|1|||
170392775|NCT03110107|615776648|FG003|Treatment Period|Adverse Event|0|||
170392776|NCT03110107|615776649|FG004|Treatment Period|Adverse Event|0|||
170392777|NCT03110107|615776650|FG005|Treatment Period|Adverse Event|2|||
170392778|NCT03110107|615776651|FG006|Treatment Period|Adverse Event|0|||
170392779|NCT03110107|615776652|FG007|Treatment Period|Adverse Event|2|||
170392780|NCT03110107|615776653|FG008|Treatment Period|Adverse Event|0|||
170392781|NCT03110107|615776654|FG009|Treatment Period|Adverse Event|1|||
170392782|NCT03110107|615776655|FG010|Treatment Period|Adverse Event|0|||
170392783|NCT03110107|615776656|FG011|Treatment Period|Adverse Event|0|||
170392784|NCT03110107|615776657|FG012|Treatment Period|Adverse Event|0|||
170392785|NCT03110107|615776658|FG013|Treatment Period|Adverse Event|0|||
170392786|NCT03110107|615776659|FG014|Treatment Period|Adverse Event|0|||
170392787|NCT03110107|615776660|FG015|Treatment Period|Adverse Event|2|||
170392788|NCT03110107|615776661|FG016|Treatment Period|Adverse Event|0|||
170392789|NCT03110107|615776662|FG017|Treatment Period|Adverse Event|1|||
170392790|NCT03110107|615776663|FG018|Treatment Period|Adverse Event|2|||
170392791|NCT03110107|615776664|FG019|Treatment Period|Adverse Event|1|||
170392792|NCT03110107|615776665|FG020|Treatment Period|Adverse Event|4|||
170392793|NCT03110107|615776666|FG021|Treatment Period|Adverse Event|2|||
170392794|NCT03110107|615776667|FG022|Treatment Period|Adverse Event|2|||
170392795|NCT03110107|615776668|FG023|Treatment Period|Adverse Event|2|||
170392796|NCT03110107|615776669|FG024|Treatment Period|Adverse Event|2|||
170392797|NCT03110107|615776670|FG025|Treatment Period|Adverse Event|4|||
170392798|NCT03110107|615776645|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
170392799|NCT03110107|615776646|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
170392800|NCT03110107|615776647|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
170392801|NCT03110107|615776648|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
170392802|NCT03110107|615776649|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
170392803|NCT03110107|615776650|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
170392804|NCT03110107|615776651|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
170392805|NCT03110107|615776652|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
170392806|NCT03110107|615776653|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
170392807|NCT03110107|615776654|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
170392808|NCT03110107|615776655|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
170392809|NCT03110107|615776656|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
170392810|NCT03110107|615776657|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
170392811|NCT03110107|615776658|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
170392812|NCT03110107|615776659|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
170392813|NCT03110107|615776660|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
170392814|NCT03110107|615776661|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
170392815|NCT03110107|615776662|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
170392816|NCT03110107|615776663|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
170392817|NCT03110107|615776664|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
170392818|NCT03110107|615776665|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
170392819|NCT03110107|615776666|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
170392820|NCT03110107|615776667|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
170392821|NCT03110107|615776668|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
170392822|NCT03110107|615776669|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
170392823|NCT03110107|615776670|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
170392824|NCT03110107|615776645|FG000|Treatment Period|Participant withdrew consent|0|||
170392825|NCT03110107|615776646|FG001|Treatment Period|Participant withdrew consent|0|||
170392826|NCT03110107|615776647|FG002|Treatment Period|Participant withdrew consent|1|||
170392827|NCT03110107|615776648|FG003|Treatment Period|Participant withdrew consent|0|||
170392828|NCT03110107|615776649|FG004|Treatment Period|Participant withdrew consent|4|||
170392829|NCT03110107|615776650|FG005|Treatment Period|Participant withdrew consent|3|||
170392830|NCT03110107|615776651|FG006|Treatment Period|Participant withdrew consent|0|||
170392831|NCT03110107|615776652|FG007|Treatment Period|Participant withdrew consent|0|||
170392832|NCT03110107|615776653|FG008|Treatment Period|Participant withdrew consent|0|||
170392833|NCT03110107|615776654|FG009|Treatment Period|Participant withdrew consent|1|||
170392834|NCT03110107|615776655|FG010|Treatment Period|Participant withdrew consent|0|||
170392835|NCT03110107|615776656|FG011|Treatment Period|Participant withdrew consent|0|||
170392836|NCT03110107|615776657|FG012|Treatment Period|Participant withdrew consent|0|||
170392837|NCT03110107|615776658|FG013|Treatment Period|Participant withdrew consent|0|||
170392838|NCT03110107|615776659|FG014|Treatment Period|Participant withdrew consent|0|||
170392839|NCT03110107|615776660|FG015|Treatment Period|Participant withdrew consent|0|||
170392840|NCT03110107|615776661|FG016|Treatment Period|Participant withdrew consent|0|||
170392841|NCT03110107|615776662|FG017|Treatment Period|Participant withdrew consent|0|||
170392842|NCT03110107|615776663|FG018|Treatment Period|Participant withdrew consent|0|||
170392843|NCT03110107|615776664|FG019|Treatment Period|Participant withdrew consent|1|||
170392844|NCT03110107|615776665|FG020|Treatment Period|Participant withdrew consent|0|||
170392845|NCT03110107|615776666|FG021|Treatment Period|Participant withdrew consent|2|||
170392846|NCT03110107|615776667|FG022|Treatment Period|Participant withdrew consent|0|||
170392847|NCT03110107|615776668|FG023|Treatment Period|Participant withdrew consent|0|||
170392848|NCT03110107|615776669|FG024|Treatment Period|Participant withdrew consent|0|||
170392849|NCT03110107|615776670|FG025|Treatment Period|Participant withdrew consent|2|||
170392850|NCT03110107|615776645|FG000|Treatment Period|Participants no longer meets study criteria|0|||
170392851|NCT03110107|615776646|FG001|Treatment Period|Participants no longer meets study criteria|0|||
170392852|NCT03110107|615776647|FG002|Treatment Period|Participants no longer meets study criteria|0|||
170392853|NCT03110107|615776648|FG003|Treatment Period|Participants no longer meets study criteria|0|||
170392854|NCT03110107|615776649|FG004|Treatment Period|Participants no longer meets study criteria|0|||
170392855|NCT03110107|615776650|FG005|Treatment Period|Participants no longer meets study criteria|0|||
170392856|NCT03110107|615776651|FG006|Treatment Period|Participants no longer meets study criteria|0|||
170392857|NCT03110107|615776652|FG007|Treatment Period|Participants no longer meets study criteria|0|||
170392858|NCT03110107|615776653|FG008|Treatment Period|Participants no longer meets study criteria|0|||
170392859|NCT03110107|615776654|FG009|Treatment Period|Participants no longer meets study criteria|0|||
170392860|NCT03110107|615776655|FG010|Treatment Period|Participants no longer meets study criteria|0|||
170392861|NCT03110107|615776656|FG011|Treatment Period|Participants no longer meets study criteria|0|||
170392862|NCT03110107|615776657|FG012|Treatment Period|Participants no longer meets study criteria|0|||
170392863|NCT03110107|615776658|FG013|Treatment Period|Participants no longer meets study criteria|0|||
170392864|NCT03110107|615776659|FG014|Treatment Period|Participants no longer meets study criteria|0|||
170392865|NCT03110107|615776660|FG015|Treatment Period|Participants no longer meets study criteria|0|||
170392866|NCT03110107|615776661|FG016|Treatment Period|Participants no longer meets study criteria|0|||
170392867|NCT03110107|615776662|FG017|Treatment Period|Participants no longer meets study criteria|0|||
170392868|NCT03110107|615776663|FG018|Treatment Period|Participants no longer meets study criteria|0|||
170392869|NCT03110107|615776664|FG019|Treatment Period|Participants no longer meets study criteria|0|||
170392870|NCT03110107|615776665|FG020|Treatment Period|Participants no longer meets study criteria|0|||
170392871|NCT03110107|615776666|FG021|Treatment Period|Participants no longer meets study criteria|0|||
170392872|NCT03110107|615776667|FG022|Treatment Period|Participants no longer meets study criteria|0|||
170392873|NCT03110107|615776668|FG023|Treatment Period|Participants no longer meets study criteria|1|||
170392874|NCT03110107|615776669|FG024|Treatment Period|Participants no longer meets study criteria|0|||
170392875|NCT03110107|615776670|FG025|Treatment Period|Participants no longer meets study criteria|0|||
170392876|NCT03110107|615776645|FG000|Treatment Period|Other Reasons|0|||
170392877|NCT03110107|615776646|FG001|Treatment Period|Other Reasons|0|||
170392878|NCT03110107|615776647|FG002|Treatment Period|Other Reasons|1|||
170392879|NCT03110107|615776648|FG003|Treatment Period|Other Reasons|1|||
170392880|NCT03110107|615776649|FG004|Treatment Period|Other Reasons|0|||
170392881|NCT03110107|615776650|FG005|Treatment Period|Other Reasons|1|||
170392882|NCT03110107|615776651|FG006|Treatment Period|Other Reasons|0|||
170392883|NCT03110107|615776652|FG007|Treatment Period|Other Reasons|0|||
170392884|NCT03110107|615776653|FG008|Treatment Period|Other Reasons|0|||
170392885|NCT03110107|615776654|FG009|Treatment Period|Other Reasons|0|||
170392886|NCT03110107|615776655|FG010|Treatment Period|Other Reasons|0|||
170392887|NCT03110107|615776656|FG011|Treatment Period|Other Reasons|0|||
170392888|NCT03110107|615776657|FG012|Treatment Period|Other Reasons|0|||
170392889|NCT03110107|615776658|FG013|Treatment Period|Other Reasons|0|||
170392890|NCT03110107|615776659|FG014|Treatment Period|Other Reasons|0|||
170392891|NCT03110107|615776660|FG015|Treatment Period|Other Reasons|0|||
170392892|NCT03110107|615776661|FG016|Treatment Period|Other Reasons|0|||
170392893|NCT03110107|615776662|FG017|Treatment Period|Other Reasons|0|||
170392894|NCT03110107|615776663|FG018|Treatment Period|Other Reasons|0|||
170392895|NCT03110107|615776664|FG019|Treatment Period|Other Reasons|0|||
170392896|NCT03110107|615776665|FG020|Treatment Period|Other Reasons|0|||
170392897|NCT03110107|615776666|FG021|Treatment Period|Other Reasons|0|||
170392898|NCT03110107|615776667|FG022|Treatment Period|Other Reasons|0|||
170392899|NCT03110107|615776668|FG023|Treatment Period|Other Reasons|0|||
170392900|NCT03110107|615776669|FG024|Treatment Period|Other Reasons|1|||
170392901|NCT03110107|615776670|FG025|Treatment Period|Other Reasons|0|||
170392902|NCT03985982|615776671|FG000|Double-Blind Phase|Lost to Follow-up|4|||
170392903|NCT03985982|615776672|FG001|Double-Blind Phase|Lost to Follow-up|3|||
170392904|NCT03985982|615776673|FG002|Double-Blind Phase|Lost to Follow-up|0|||
170392905|NCT03985982|615776671|FG000|Double-Blind Phase|Physician Decision|1|||
170392906|NCT03985982|615776672|FG001|Double-Blind Phase|Physician Decision|0|||
170392907|NCT03985982|615776673|FG002|Double-Blind Phase|Physician Decision|0|||
170392908|NCT03985982|615776671|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
170392909|NCT03985982|615776672|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
170392910|NCT03985982|615776673|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
170392911|NCT03985982|615776671|FG000|Double-Blind Phase|COVID-19|1|||
170392912|NCT03985982|615776672|FG001|Double-Blind Phase|COVID-19|0|||
170392913|NCT03985982|615776673|FG002|Double-Blind Phase|COVID-19|0|||
170392914|NCT03985982|615776671|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
170392915|NCT03985982|615776672|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
170392916|NCT03985982|615776673|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
170392917|NCT03985982|615776671|FG000|Open-Label Phase|Lost to Follow-up|0|||
170392918|NCT03985982|615776672|FG001|Open-Label Phase|Lost to Follow-up|0|||
170392919|NCT03985982|615776673|FG002|Open-Label Phase|Lost to Follow-up|13|||
170392920|NCT03985982|615776671|FG000|Open-Label Phase|Physician Decision|0|||
170392921|NCT03985982|615776672|FG001|Open-Label Phase|Physician Decision|0|||
170392922|NCT03985982|615776673|FG002|Open-Label Phase|Physician Decision|2|||
170392923|NCT03985982|615776671|FG000|Open-Label Phase|Withdrawal by Subject|0|||
170392924|NCT03985982|615776672|FG001|Open-Label Phase|Withdrawal by Subject|0|||
170392925|NCT03985982|615776673|FG002|Open-Label Phase|Withdrawal by Subject|11|||
170392926|NCT03526549|615776675|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
170392927|NCT03526549|615776676|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
170392928|NCT03526549|615776675|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
170392929|NCT03526549|615776676|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
170392930|NCT03526549|615776675|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
170392931|NCT03526549|615776676|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
170392932|NCT03526549|615776675|FG000|Open-label Phase|Adverse Event|4|||
170392933|NCT03526549|615776676|FG001|Open-label Phase|Adverse Event|0|||
170392934|NCT03526549|615776675|FG000|Open-label Phase|Withdrawal by Subject|54|||
170392935|NCT03526549|615776676|FG001|Open-label Phase|Withdrawal by Subject|0|||
170392936|NCT03526549|615776675|FG000|Open-label Phase|Lost to Follow-up|35|||
170392937|NCT03526549|615776676|FG001|Open-label Phase|Lost to Follow-up|0|||
170392938|NCT03526549|615776675|FG000|Open-label Phase|Other than Specified|5|||
170392939|NCT03526549|615776676|FG001|Open-label Phase|Other than Specified|0|||
170392940|NCT05981365|615776677|FG000|Period 1|Adverse Event|1|||
170392941|NCT05981365|615776678|FG001|Period 1|Adverse Event|0|||
170392942|NCT03927989|615776681|FG000|Overall Study|Withdrawal by Subject|0|||
170392943|NCT03927989|615776682|FG001|Overall Study|Withdrawal by Subject|1|||
170392944|NCT02593175|615776683|FG000|Overall Study|Adverse Event|5|||
170392945|NCT02593175|615776683|FG000|Overall Study|Disease progression|4|||
170392946|NCT00478933|615776687|FG000|Overall Study|Protocol Violation|22|||
170392947|NCT00478933|615776687|FG000|Overall Study|Informed consent not verified|3|||
170392948|NCT00478933|615776687|FG000|Overall Study|Inadequate data available|53|||
170392949|NCT00643006|615776690|FG000|Overall Study|Lost to Follow-up|5|||
170392950|NCT00643006|615776691|FG001|Overall Study|Lost to Follow-up|4|||
170392951|NCT02506101|615776692|FG000|Overall Study|Transportation issues|1|||
170392952|NCT02506101|615776693|FG001|Overall Study|Transportation issues|0|||
170392953|NCT02506101|615776692|FG000|Overall Study|No enrollment and staff unavailability|1|||
170392954|NCT02506101|615776693|FG001|Overall Study|No enrollment and staff unavailability|0|||
170392955|NCT01308476|615776694|FG000|Overall Study|Lost to Follow-up|2|||
170392956|NCT01308476|615776695|FG001|Overall Study|Lost to Follow-up|2|||
170392957|NCT01308476|615776694|FG000|Overall Study|Other|1|||
170392958|NCT01308476|615776695|FG001|Overall Study|Other|0|||
170392959|NCT03586427|615776699|FG000|Overall Study|Lost to Follow-up|0|||
170392960|NCT03586427|615776700|FG001|Overall Study|Lost to Follow-up|3|||
170392961|NCT03586427|615776701|FG002|Overall Study|Lost to Follow-up|1|||
170392962|NCT03586427|615776702|FG003|Overall Study|Lost to Follow-up|3|||
170392963|NCT03586427|615776703|FG004|Overall Study|Lost to Follow-up|3|||
170392964|NCT03586427|615776699|FG000|Overall Study|Withdrawal by Subject|0|||
170392965|NCT03586427|615776700|FG001|Overall Study|Withdrawal by Subject|1|||
170392966|NCT03586427|615776701|FG002|Overall Study|Withdrawal by Subject|2|||
170392967|NCT03586427|615776702|FG003|Overall Study|Withdrawal by Subject|1|||
170392968|NCT03586427|615776703|FG004|Overall Study|Withdrawal by Subject|1|||
170392969|NCT03586427|615776699|FG000|Overall Study|Adverse Event|0|||
170392970|NCT03586427|615776700|FG001|Overall Study|Adverse Event|0|||
170392971|NCT03586427|615776701|FG002|Overall Study|Adverse Event|1|||
170392972|NCT03586427|615776702|FG003|Overall Study|Adverse Event|0|||
170392973|NCT03586427|615776703|FG004|Overall Study|Adverse Event|0|||
170392974|NCT03586427|615776699|FG000|Overall Study|Protocol Violation|0|||
170392975|NCT03586427|615776700|FG001|Overall Study|Protocol Violation|0|||
170392976|NCT03586427|615776701|FG002|Overall Study|Protocol Violation|1|||
170392977|NCT03586427|615776702|FG003|Overall Study|Protocol Violation|0|||
170392978|NCT03586427|615776703|FG004|Overall Study|Protocol Violation|1|||
170392979|NCT03586427|615776699|FG000|Overall Study|Noncompliance with study drug|0|||
170392980|NCT03586427|615776700|FG001|Overall Study|Noncompliance with study drug|0|||
170392981|NCT03586427|615776701|FG002|Overall Study|Noncompliance with study drug|1|||
170392982|NCT03586427|615776702|FG003|Overall Study|Noncompliance with study drug|0|||
170392983|NCT03586427|615776703|FG004|Overall Study|Noncompliance with study drug|0|||
170392984|NCT03193996|615776708|FG000|Overall Study|Withdrawal by Subject|4|||
170392985|NCT03193996|615776708|FG000|Overall Study|Lost to Follow-up|4|||
170392986|NCT03193996|615776708|FG000|Overall Study|Physician Decision|2|||
170392987|NCT03193996|615776708|FG000|Overall Study|Pregnancy|1|||
170392988|NCT03193996|615776708|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
170392989|NCT03193996|615776708|FG000|Overall Study|Complicating disease|1|||
170392990|NCT02116309|615776709|FG000|Overall Study|Lost to Follow-up|0|||
170392991|NCT02116309|615776710|FG001|Overall Study|Lost to Follow-up|1|||
170392992|NCT03292731|615776711|FG000|Overall Study|Protocol Violation|4|||
170392993|NCT03292731|615776712|FG001|Overall Study|Protocol Violation|11|||
170392994|NCT03292731|615776713|FG002|Overall Study|Protocol Violation|1|||
170392995|NCT00471237|615776720|FG000|Overall Study|Adverse Event|6|||
170392996|NCT00471237|615776721|FG001|Overall Study|Adverse Event|5|||
170392997|NCT00471237|615776722|FG002|Overall Study|Adverse Event|4|||
170392998|NCT00471237|615776723|FG003|Overall Study|Adverse Event|8|||
170392999|NCT00471237|615776724|FG004|Overall Study|Adverse Event|7|||
170393000|NCT00471237|615776725|FG005|Overall Study|Adverse Event|5|||
170393001|NCT00471237|615776726|FG006|Overall Study|Adverse Event|0|||
170393002|NCT00471237|615776720|FG000|Overall Study|Lost to Follow-up|1|||
170393003|NCT00471237|615776721|FG001|Overall Study|Lost to Follow-up|1|||
170393004|NCT00471237|615776722|FG002|Overall Study|Lost to Follow-up|0|||
170393005|NCT00471237|615776723|FG003|Overall Study|Lost to Follow-up|2|||
170393006|NCT00471237|615776724|FG004|Overall Study|Lost to Follow-up|3|||
170393007|NCT00471237|615776725|FG005|Overall Study|Lost to Follow-up|0|||
170393008|NCT00471237|615776726|FG006|Overall Study|Lost to Follow-up|0|||
170393009|NCT00471237|615776720|FG000|Overall Study|Protocol Violation|3|||
170393010|NCT00471237|615776721|FG001|Overall Study|Protocol Violation|6|||
170393011|NCT00471237|615776722|FG002|Overall Study|Protocol Violation|3|||
170393012|NCT00471237|615776723|FG003|Overall Study|Protocol Violation|2|||
170393013|NCT00471237|615776724|FG004|Overall Study|Protocol Violation|2|||
170393014|NCT00471237|615776725|FG005|Overall Study|Protocol Violation|4|||
170393015|NCT00471237|615776726|FG006|Overall Study|Protocol Violation|1|||
170393016|NCT00471237|615776720|FG000|Overall Study|Withdrawal by Subject|8|||
170393017|NCT00471237|615776721|FG001|Overall Study|Withdrawal by Subject|6|||
170393018|NCT00471237|615776722|FG002|Overall Study|Withdrawal by Subject|5|||
170393019|NCT00471237|615776723|FG003|Overall Study|Withdrawal by Subject|8|||
170393020|NCT00471237|615776724|FG004|Overall Study|Withdrawal by Subject|7|||
170393021|NCT00471237|615776725|FG005|Overall Study|Withdrawal by Subject|4|||
170393022|NCT00471237|615776726|FG006|Overall Study|Withdrawal by Subject|2|||
170393023|NCT00471237|615776720|FG000|Overall Study|Sponsor terminated study|20|||
170393024|NCT00471237|615776721|FG001|Overall Study|Sponsor terminated study|23|||
170393025|NCT00471237|615776722|FG002|Overall Study|Sponsor terminated study|19|||
170393026|NCT00471237|615776723|FG003|Overall Study|Sponsor terminated study|22|||
170393027|NCT00471237|615776724|FG004|Overall Study|Sponsor terminated study|18|||
170393028|NCT00471237|615776725|FG005|Overall Study|Sponsor terminated study|24|||
170393029|NCT00471237|615776726|FG006|Overall Study|Sponsor terminated study|0|||
170393030|NCT00471237|615776720|FG000|Overall Study|Non-compliance|0|||
170393031|NCT00471237|615776721|FG001|Overall Study|Non-compliance|1|||
170393032|NCT00471237|615776722|FG002|Overall Study|Non-compliance|0|||
170393033|NCT00471237|615776723|FG003|Overall Study|Non-compliance|1|||
170393034|NCT00471237|615776724|FG004|Overall Study|Non-compliance|0|||
170393035|NCT00471237|615776725|FG005|Overall Study|Non-compliance|0|||
170393036|NCT00471237|615776726|FG006|Overall Study|Non-compliance|0|||
170393037|NCT00471237|615776720|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
170393038|NCT00471237|615776721|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
170393039|NCT00471237|615776722|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
170393040|NCT00471237|615776723|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
170393041|NCT00471237|615776724|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
170393042|NCT00471237|615776725|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
170393043|NCT00471237|615776726|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
170393044|NCT00471237|615776720|FG000|Overall Study|Early stopping due to non-efficacy|1|||
170393045|NCT00471237|615776721|FG001|Overall Study|Early stopping due to non-efficacy|0|||
170393046|NCT00471237|615776722|FG002|Overall Study|Early stopping due to non-efficacy|0|||
170393047|NCT00471237|615776723|FG003|Overall Study|Early stopping due to non-efficacy|0|||
170393048|NCT00471237|615776724|FG004|Overall Study|Early stopping due to non-efficacy|1|||
170393049|NCT00471237|615776725|FG005|Overall Study|Early stopping due to non-efficacy|0|||
170393050|NCT00471237|615776726|FG006|Overall Study|Early stopping due to non-efficacy|0|||
170393051|NCT00471237|615776720|FG000|Overall Study|Participant planned to travel to abraod|1|||
170393052|NCT00471237|615776721|FG001|Overall Study|Participant planned to travel to abraod|0|||
170393053|NCT00471237|615776722|FG002|Overall Study|Participant planned to travel to abraod|0|||
170393054|NCT00471237|615776723|FG003|Overall Study|Participant planned to travel to abraod|0|||
170393055|NCT00471237|615776724|FG004|Overall Study|Participant planned to travel to abraod|0|||
170393056|NCT00471237|615776725|FG005|Overall Study|Participant planned to travel to abraod|1|||
170393057|NCT00471237|615776726|FG006|Overall Study|Participant planned to travel to abraod|0|||
170393058|NCT00471237|615776720|FG000|Overall Study|High parathyroid hormone|0|||
170393059|NCT00471237|615776721|FG001|Overall Study|High parathyroid hormone|0|||
170393060|NCT00471237|615776722|FG002|Overall Study|High parathyroid hormone|1|||
170393061|NCT00471237|615776723|FG003|Overall Study|High parathyroid hormone|0|||
170393062|NCT00471237|615776724|FG004|Overall Study|High parathyroid hormone|0|||
170393063|NCT00471237|615776725|FG005|Overall Study|High parathyroid hormone|0|||
170393064|NCT00471237|615776726|FG006|Overall Study|High parathyroid hormone|0|||
170393065|NCT00471237|615776720|FG000|Overall Study|Participant lost medication|0|||
170393066|NCT00471237|615776721|FG001|Overall Study|Participant lost medication|0|||
170393067|NCT00471237|615776722|FG002|Overall Study|Participant lost medication|0|||
170393068|NCT00471237|615776723|FG003|Overall Study|Participant lost medication|0|||
170393069|NCT00471237|615776724|FG004|Overall Study|Participant lost medication|1|||
170393070|NCT00471237|615776725|FG005|Overall Study|Participant lost medication|0|||
170393071|NCT00471237|615776726|FG006|Overall Study|Participant lost medication|0|||
170393072|NCT00471237|615776720|FG000|Overall Study|Administration of prohibited medicine|0|||
170393073|NCT00471237|615776721|FG001|Overall Study|Administration of prohibited medicine|0|||
170393074|NCT00471237|615776722|FG002|Overall Study|Administration of prohibited medicine|0|||
170393075|NCT00471237|615776723|FG003|Overall Study|Administration of prohibited medicine|0|||
170393076|NCT00471237|615776724|FG004|Overall Study|Administration of prohibited medicine|1|||
170393077|NCT00471237|615776725|FG005|Overall Study|Administration of prohibited medicine|0|||
170393078|NCT00471237|615776726|FG006|Overall Study|Administration of prohibited medicine|0|||
170393079|NCT00471237|615776720|FG000|Overall Study|Participant shifted residence|0|||
170393080|NCT00471237|615776721|FG001|Overall Study|Participant shifted residence|0|||
170393081|NCT00471237|615776722|FG002|Overall Study|Participant shifted residence|0|||
170393082|NCT00471237|615776723|FG003|Overall Study|Participant shifted residence|0|||
170393083|NCT00471237|615776724|FG004|Overall Study|Participant shifted residence|1|||
170393084|NCT00471237|615776725|FG005|Overall Study|Participant shifted residence|0|||
170393085|NCT00471237|615776726|FG006|Overall Study|Participant shifted residence|0|||
170393086|NCT00471237|615776720|FG000|Overall Study|Participant's decision|0|||
170393087|NCT00471237|615776721|FG001|Overall Study|Participant's decision|0|||
170393088|NCT00471237|615776722|FG002|Overall Study|Participant's decision|0|||
170393089|NCT00471237|615776723|FG003|Overall Study|Participant's decision|0|||
170393090|NCT00471237|615776724|FG004|Overall Study|Participant's decision|0|||
170393091|NCT00471237|615776725|FG005|Overall Study|Participant's decision|1|||
170393092|NCT00471237|615776726|FG006|Overall Study|Participant's decision|0|||
170393093|NCT00593385|615776727|FG000|Overall Study|Death|14|||
170393094|NCT00593385|615776727|FG000|Overall Study|Lost to Follow-up|17|||
170393095|NCT00593385|615776727|FG000|Overall Study|Withdrawal by Subject|9|||
170393096|NCT01471197|615776732|FG000|Overall Study|Disease Progression|4|||
170393097|NCT01471197|615776733|FG001|Overall Study|Disease Progression|2|||
170393098|NCT01471197|615776732|FG000|Overall Study|Death|1|||
170393099|NCT01471197|615776733|FG001|Overall Study|Death|0|||
170393100|NCT01471197|615776732|FG000|Overall Study|Study Drug Toxicity|1|||
170393101|NCT01471197|615776733|FG001|Overall Study|Study Drug Toxicity|0|||
170393102|NCT01298362|615776736|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
170393103|NCT01298362|615776737|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
170393104|NCT02871921|615776739|FG000|Overall Study|Withdrawal by Subject|34|||
170393105|NCT02871921|615776740|FG001|Overall Study|Withdrawal by Subject|27|||
170393106|NCT02871921|615776741|FG002|Overall Study|Withdrawal by Subject|27|||
170393107|NCT02871921|615776742|FG003|Overall Study|Withdrawal by Subject|30|||
170393108|NCT00910000|615776743|FG000|Overall Study|Adverse Event|0|||
170393109|NCT00910000|615776744|FG001|Overall Study|Adverse Event|3|||
170393110|NCT00910000|615776745|FG002|Overall Study|Adverse Event|2|||
170393111|NCT00910000|615776746|FG003|Overall Study|Adverse Event|2|||
170393112|NCT00910000|615776747|FG004|Overall Study|Adverse Event|0|||
170393113|NCT00910000|615776748|FG005|Overall Study|Adverse Event|1|||
170393114|NCT00910000|615776743|FG000|Overall Study|Withdrawal by Subject|0|||
170393115|NCT00910000|615776744|FG001|Overall Study|Withdrawal by Subject|0|||
170393116|NCT00910000|615776745|FG002|Overall Study|Withdrawal by Subject|1|||
170393117|NCT00910000|615776746|FG003|Overall Study|Withdrawal by Subject|0|||
170393118|NCT00910000|615776747|FG004|Overall Study|Withdrawal by Subject|1|||
170393119|NCT00910000|615776748|FG005|Overall Study|Withdrawal by Subject|0|||
170393120|NCT00625846|615776753|FG000|Overall Study|Withdrawal by Subject|2|||
170393121|NCT00625846|615776754|FG001|Overall Study|Withdrawal by Subject|0|||
170393122|NCT00625846|615776755|FG002|Overall Study|Withdrawal by Subject|1|||
170393123|NCT00625846|615776756|FG003|Overall Study|Withdrawal by Subject|2|||
170393124|NCT00455923|615776759|FG000|Overall Study|Pregnancy|0|||
170393125|NCT00455923|615776760|FG001|Overall Study|Pregnancy|2|||
170393126|NCT00455923|615776759|FG000|Overall Study|Other|3|||
170393127|NCT00455923|615776760|FG001|Overall Study|Other|1|||
170393128|NCT04465916|615778525|FG000|Overall Study|Withdrawal by Subject|0|||
170393129|NCT04465916|615778526|FG001|Overall Study|Withdrawal by Subject|1|||
170393130|NCT00348348|615778527|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
170393131|NCT00348348|615778528|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
170393132|NCT00348348|615778527|FG000|Overall Study|Lack of Efficacy|1|||
170393133|NCT00348348|615778528|FG001|Overall Study|Lack of Efficacy|1|||
170393134|NCT00348348|615778527|FG000|Overall Study|Lost to Follow-up|8|||
170393135|NCT00348348|615778528|FG001|Overall Study|Lost to Follow-up|10|||
170393136|NCT00348348|615778527|FG000|Overall Study|Withdrawal by Subject|4|||
170393137|NCT00348348|615778528|FG001|Overall Study|Withdrawal by Subject|1|||
170393138|NCT00348348|615778527|FG000|Overall Study|Other|7|||
170393139|NCT00348348|615778528|FG001|Overall Study|Other|4|||
170393140|NCT00348348|615778527|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
170393141|NCT00348348|615778528|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
170393142|NCT00348348|615778527|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
170393143|NCT00348348|615778528|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
170393144|NCT00348348|615778527|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
170393145|NCT00348348|615778528|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
170393146|NCT00348348|615778527|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
170393147|NCT00348348|615778528|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
170393148|NCT00348348|615778527|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
170393149|NCT00348348|615778528|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
170393150|NCT00348348|615778527|FG000|Overall Study|Adverse event probably related to study|1|||
170393151|NCT00348348|615778528|FG001|Overall Study|Adverse event probably related to study|0|||
170393152|NCT03710824|615778529|FG000|Overall Study|Withdrawal by Subject|1|||
170393153|NCT03710824|615778529|FG000|Overall Study|Lost to Follow-up|3|||
170393154|NCT03710824|615778529|FG000|Overall Study|Adverse Event|25|||
170393155|NCT03710824|615778529|FG000|Overall Study|Treatment discontinuation|2|||
170393156|NCT01301625|615778532|FG000|Overall Study|Death|5|||
170393157|NCT01301625|615778532|FG000|Overall Study|Not Due|21|||
170393158|NCT01301625|615778532|FG000|Overall Study|Expected|8|||
170393159|NCT01301625|615778532|FG000|Overall Study|Lost to Follow-up|1|||
170393160|NCT04637815|615778533|FG000|Overall Study|Death|1|||
170393161|NCT04637815|615778534|FG001|Overall Study|Death|0|||
170393162|NCT04637815|615778533|FG000|Overall Study|Lost to Follow-up|5|||
170393163|NCT04637815|615778534|FG001|Overall Study|Lost to Follow-up|2|||
170393164|NCT00337727|615778535|FG000|Overall Study|Adverse Event|5|||
170393165|NCT00337727|615778536|FG001|Overall Study|Adverse Event|3|||
170393166|NCT00337727|615778535|FG000|Overall Study|Lost to Follow-up|5|||
170393167|NCT00337727|615778536|FG001|Overall Study|Lost to Follow-up|4|||
170393168|NCT00337727|615778535|FG000|Overall Study|Physician Decision|1|||
170393169|NCT00337727|615778536|FG001|Overall Study|Physician Decision|0|||
170393170|NCT00337727|615778535|FG000|Overall Study|Protocol Violation|4|||
170393171|NCT00337727|615778536|FG001|Overall Study|Protocol Violation|0|||
170393172|NCT00337727|615778535|FG000|Overall Study|Withdrawal by Subject|3|||
170393173|NCT00337727|615778536|FG001|Overall Study|Withdrawal by Subject|5|||
170393174|NCT02050373|615778537|FG000|Overall Study|Adverse Event|4|||
170393175|NCT02050373|615778538|FG001|Overall Study|Adverse Event|7|||
170393176|NCT02050373|615778537|FG000|Overall Study|Death|3|||
170393177|NCT02050373|615778538|FG001|Overall Study|Death|3|||
170393178|NCT00326625|615778539|FG000|Overall Study|Adverse Event|20|||
170393179|NCT00326625|615778540|FG001|Overall Study|Adverse Event|9|||
170393180|NCT00326625|615778539|FG000|Overall Study|Withdrawal by Subject|15|||
170393181|NCT00326625|615778540|FG001|Overall Study|Withdrawal by Subject|12|||
170393182|NCT00326625|615778539|FG000|Overall Study|Death|18|||
170393183|NCT00326625|615778540|FG001|Overall Study|Death|16|||
170393184|NCT00326625|615778539|FG000|Overall Study|Lost to Follow-up|1|||
170393185|NCT00326625|615778540|FG001|Overall Study|Lost to Follow-up|0|||
170393186|NCT00326625|615778539|FG000|Overall Study|prescheduled medical intervention|0|||
170393187|NCT00326625|615778540|FG001|Overall Study|prescheduled medical intervention|1|||
170393188|NCT06067191|615778545|FG000|Overall Study|Withdrawal by Subject|0|||
170393189|NCT06067191|615778546|FG001|Overall Study|Withdrawal by Subject|1|||
170393190|NCT03919669|615778549|FG000|Overall Study|Withdrawal by Subject|1|||
170393191|NCT03919669|615778550|FG001|Overall Study|Withdrawal by Subject|0|||
170393192|NCT03919669|615778551|FG002|Overall Study|Withdrawal by Subject|0|||
170393193|NCT00807040|615778552|FG000|Overall Study|Death|24|||
170393194|NCT00807040|615778553|FG001|Overall Study|Death|29|||
170393195|NCT00807040|615778552|FG000|Overall Study|Withdrawal by Subject|8|||
170393196|NCT00807040|615778553|FG001|Overall Study|Withdrawal by Subject|6|||
170393197|NCT00807040|615778552|FG000|Overall Study|Lost to Follow-up|4|||
170393198|NCT00807040|615778553|FG001|Overall Study|Lost to Follow-up|6|||
170393199|NCT00890409|615778556|FG000|Overall Study|Lost to Follow-up|20|||
170393200|NCT00890409|615778557|FG001|Overall Study|Lost to Follow-up|21|||
170393201|NCT02353572|615778558|FG000|Overall Study|Withdrawal by Subject|1|||
170393202|NCT02353572|615778558|FG000|Overall Study|Study terminated|2|||
170393203|NCT01569074|615778569|FG000|Overall Study|Study stopped|6|||
170393204|NCT01569074|615778570|FG001|Overall Study|Study stopped|6|||
170393205|NCT01569074|615778571|FG002|Overall Study|Study stopped|8|||
170393206|NCT01569074|615778572|FG003|Overall Study|Study stopped|7|||
170393207|NCT01569074|615778573|FG004|Overall Study|Study stopped|7|||
170393208|NCT01569074|615778569|FG000|Overall Study|Study-specific discontinuation criteria|0|||
170393209|NCT01569074|615778570|FG001|Overall Study|Study-specific discontinuation criteria|1|||
170393210|NCT01569074|615778571|FG002|Overall Study|Study-specific discontinuation criteria|0|||
170393211|NCT01569074|615778572|FG003|Overall Study|Study-specific discontinuation criteria|0|||
170393212|NCT01569074|615778573|FG004|Overall Study|Study-specific discontinuation criteria|0|||
170393213|NCT01569074|615778569|FG000|Overall Study|Severe non-compliance to protocol|0|||
170393214|NCT01569074|615778570|FG001|Overall Study|Severe non-compliance to protocol|0|||
170393215|NCT01569074|615778571|FG002|Overall Study|Severe non-compliance to protocol|1|||
170393216|NCT01569074|615778572|FG003|Overall Study|Severe non-compliance to protocol|0|||
170393217|NCT01569074|615778573|FG004|Overall Study|Severe non-compliance to protocol|0|||
170393218|NCT01569074|615778569|FG000|Overall Study|eg change in circumstances|0|||
170393219|NCT01569074|615778570|FG001|Overall Study|eg change in circumstances|2|||
170393220|NCT01569074|615778571|FG002|Overall Study|eg change in circumstances|0|||
170393221|NCT01569074|615778572|FG003|Overall Study|eg change in circumstances|1|||
170393222|NCT01569074|615778573|FG004|Overall Study|eg change in circumstances|1|||
170393223|NCT01569074|615778569|FG000|Overall Study|Adverse Event|1|||
170393224|NCT01569074|615778570|FG001|Overall Study|Adverse Event|0|||
170393225|NCT01569074|615778571|FG002|Overall Study|Adverse Event|3|||
170393226|NCT01569074|615778572|FG003|Overall Study|Adverse Event|0|||
170393227|NCT01569074|615778573|FG004|Overall Study|Adverse Event|0|||
170393228|NCT01244516|615778575|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
170393229|NCT01244516|615778576|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
170393230|NCT01244516|615778577|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
170393231|NCT01244516|615778575|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
170393232|NCT01244516|615778576|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
170393233|NCT01244516|615778577|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
170393234|NCT01244516|615778575|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
170393235|NCT01244516|615778576|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
170393236|NCT01244516|615778577|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
170393237|NCT01244516|615778575|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
170393238|NCT01244516|615778576|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
170393239|NCT01244516|615778577|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
170393240|NCT01244516|615778575|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
170393241|NCT01244516|615778576|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
170393242|NCT01244516|615778577|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
170393243|NCT01244516|615778575|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
170393244|NCT01244516|615778576|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
170393245|NCT01244516|615778577|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
170393246|NCT01244516|615778575|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
170393247|NCT01244516|615778576|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
170393248|NCT01244516|615778577|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
170393249|NCT04409509|615778581|FG000|Overall Study|Failure to meet randomization requirement|1|||
170393250|NCT04409509|615778582|FG001|Overall Study|Failure to meet randomization requirement|0|||
170393251|NCT04409509|615778581|FG000|Overall Study|Adverse Event|0|||
170393252|NCT04409509|615778582|FG001|Overall Study|Adverse Event|1|||
170393253|NCT04409509|615778581|FG000|Overall Study|Death|11|||
170393254|NCT04409509|615778582|FG001|Overall Study|Death|10|||
170393255|NCT04409509|615778581|FG000|Overall Study|Non-compliance with study drug|0|||
170393256|NCT04409509|615778582|FG001|Overall Study|Non-compliance with study drug|1|||
170393257|NCT04409509|615778581|FG000|Overall Study|Lost to Follow-up|0|||
170393258|NCT04409509|615778582|FG001|Overall Study|Lost to Follow-up|3|||
170393259|NCT04409509|615778581|FG000|Overall Study|Withdrawal by Subject|0|||
170393260|NCT04409509|615778582|FG001|Overall Study|Withdrawal by Subject|3|||
170393261|NCT04409509|615778581|FG000|Overall Study|Randomized by mistake|0|||
170393262|NCT04409509|615778582|FG001|Overall Study|Randomized by mistake|1|||
170393263|NCT04409509|615778581|FG000|Overall Study|Other|1|||
170393264|NCT04409509|615778582|FG001|Overall Study|Other|1|||
170393265|NCT00483119|615778583|FG000|Overall Study|Adverse Event|0|||
170393266|NCT00483119|615778584|FG001|Overall Study|Adverse Event|1|||
170393267|NCT00483119|615778583|FG000|Overall Study|Physician Decision|1|||
170393268|NCT00483119|615778584|FG001|Overall Study|Physician Decision|0|||
170393269|NCT04668066|615778585|FG000|Part 1: Treatment Phase|Adverse Event|0|||
170393270|NCT04668066|615778586|FG001|Part 1: Treatment Phase|Adverse Event|0|||
170393271|NCT04668066|615778587|FG002|Part 1: Treatment Phase|Adverse Event|0|||
170393272|NCT04668066|615778588|FG003|Part 1: Treatment Phase|Adverse Event|0|||
170393273|NCT04668066|615778589|FG004|Part 1: Treatment Phase|Adverse Event|0|||
170393274|NCT04668066|615778590|FG005|Part 1: Treatment Phase|Adverse Event|0|||
170393275|NCT04668066|615778591|FG006|Part 1: Treatment Phase|Adverse Event|0|||
170393276|NCT04668066|615778592|FG007|Part 1: Treatment Phase|Adverse Event|0|||
170393277|NCT04668066|615778593|FG008|Part 1: Treatment Phase|Adverse Event|0|||
170393278|NCT04668066|615778594|FG009|Part 1: Treatment Phase|Adverse Event|0|||
170393279|NCT04668066|615778595|FG010|Part 1: Treatment Phase|Adverse Event|0|||
170393280|NCT04668066|615778596|FG011|Part 1: Treatment Phase|Adverse Event|1|||
170393281|NCT04668066|615778597|FG012|Part 1: Treatment Phase|Adverse Event|1|||
170393282|NCT04668066|615778598|FG013|Part 1: Treatment Phase|Adverse Event|0|||
170393283|NCT04668066|615778599|FG014|Part 1: Treatment Phase|Adverse Event|0|||
170393284|NCT04668066|615778600|FG015|Part 1: Treatment Phase|Adverse Event|0|||
170393285|NCT04668066|615778601|FG016|Part 1: Treatment Phase|Adverse Event|0|||
170393286|NCT04668066|615778602|FG017|Part 1: Treatment Phase|Adverse Event|0|||
170393287|NCT04668066|615778603|FG018|Part 1: Treatment Phase|Adverse Event|0|||
170393288|NCT04668066|615778585|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393289|NCT04668066|615778586|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393290|NCT04668066|615778587|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
170393291|NCT04668066|615778588|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393292|NCT04668066|615778589|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393293|NCT04668066|615778590|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393294|NCT04668066|615778591|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393295|NCT04668066|615778592|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393296|NCT04668066|615778593|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393297|NCT04668066|615778594|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393298|NCT04668066|615778595|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393299|NCT04668066|615778596|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393300|NCT04668066|615778597|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393301|NCT04668066|615778598|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393302|NCT04668066|615778599|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393303|NCT04668066|615778600|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393304|NCT04668066|615778601|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393305|NCT04668066|615778602|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393306|NCT04668066|615778603|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
170393307|NCT04668066|615778585|FG000|Part 1: Treatment Phase|Other|0|||
170393308|NCT04668066|615778586|FG001|Part 1: Treatment Phase|Other|0|||
170393309|NCT04668066|615778587|FG002|Part 1: Treatment Phase|Other|0|||
170393310|NCT04668066|615778588|FG003|Part 1: Treatment Phase|Other|0|||
170393311|NCT04668066|615778589|FG004|Part 1: Treatment Phase|Other|0|||
170393312|NCT04668066|615778590|FG005|Part 1: Treatment Phase|Other|0|||
170393313|NCT04668066|615778591|FG006|Part 1: Treatment Phase|Other|0|||
170393314|NCT04668066|615778592|FG007|Part 1: Treatment Phase|Other|0|||
170393315|NCT04668066|615778593|FG008|Part 1: Treatment Phase|Other|0|||
170393316|NCT04668066|615778594|FG009|Part 1: Treatment Phase|Other|0|||
170393317|NCT04668066|615778595|FG010|Part 1: Treatment Phase|Other|0|||
170393318|NCT04668066|615778596|FG011|Part 1: Treatment Phase|Other|1|||
170393319|NCT04668066|615778597|FG012|Part 1: Treatment Phase|Other|0|||
170393320|NCT04668066|615778598|FG013|Part 1: Treatment Phase|Other|0|||
170393321|NCT04668066|615778599|FG014|Part 1: Treatment Phase|Other|0|||
170393322|NCT04668066|615778600|FG015|Part 1: Treatment Phase|Other|0|||
170393323|NCT04668066|615778601|FG016|Part 1: Treatment Phase|Other|0|||
170393324|NCT04668066|615778602|FG017|Part 1: Treatment Phase|Other|0|||
170393325|NCT04668066|615778603|FG018|Part 1: Treatment Phase|Other|0|||
170393326|NCT04668066|615778585|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393327|NCT04668066|615778586|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393328|NCT04668066|615778587|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393329|NCT04668066|615778588|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393330|NCT04668066|615778589|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393331|NCT04668066|615778590|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393332|NCT04668066|615778591|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393333|NCT04668066|615778592|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393334|NCT04668066|615778593|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393335|NCT04668066|615778594|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393336|NCT04668066|615778595|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393337|NCT04668066|615778596|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393338|NCT04668066|615778597|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
170393339|NCT04668066|615778598|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393340|NCT04668066|615778599|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393341|NCT04668066|615778600|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
170393342|NCT04668066|615778601|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393343|NCT04668066|615778602|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393344|NCT04668066|615778603|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
170393345|NCT04668066|615778585|FG000|Part 1: Follow-Up|Adverse Event|0|||
170393346|NCT04668066|615778586|FG001|Part 1: Follow-Up|Adverse Event|0|||
170393347|NCT04668066|615778587|FG002|Part 1: Follow-Up|Adverse Event|0|||
170393348|NCT04668066|615778588|FG003|Part 1: Follow-Up|Adverse Event|0|||
170393349|NCT04668066|615778589|FG004|Part 1: Follow-Up|Adverse Event|0|||
170393350|NCT04668066|615778590|FG005|Part 1: Follow-Up|Adverse Event|0|||
170393351|NCT04668066|615778591|FG006|Part 1: Follow-Up|Adverse Event|0|||
170393352|NCT04668066|615778592|FG007|Part 1: Follow-Up|Adverse Event|0|||
170393353|NCT04668066|615778593|FG008|Part 1: Follow-Up|Adverse Event|0|||
170393354|NCT04668066|615778594|FG009|Part 1: Follow-Up|Adverse Event|0|||
170393355|NCT04668066|615778595|FG010|Part 1: Follow-Up|Adverse Event|0|||
170393356|NCT04668066|615778596|FG011|Part 1: Follow-Up|Adverse Event|1|||
170393357|NCT04668066|615778597|FG012|Part 1: Follow-Up|Adverse Event|0|||
170393358|NCT04668066|615778598|FG013|Part 1: Follow-Up|Adverse Event|0|||
170393359|NCT04668066|615778599|FG014|Part 1: Follow-Up|Adverse Event|0|||
170393360|NCT04668066|615778600|FG015|Part 1: Follow-Up|Adverse Event|0|||
170393361|NCT04668066|615778601|FG016|Part 1: Follow-Up|Adverse Event|0|||
170393362|NCT04668066|615778602|FG017|Part 1: Follow-Up|Adverse Event|0|||
170393363|NCT04668066|615778603|FG018|Part 1: Follow-Up|Adverse Event|0|||
170393364|NCT04668066|615778585|FG000|Part 1: Follow-Up|Other|0|||
170393365|NCT04668066|615778586|FG001|Part 1: Follow-Up|Other|0|||
170393366|NCT04668066|615778587|FG002|Part 1: Follow-Up|Other|0|||
170393367|NCT04668066|615778588|FG003|Part 1: Follow-Up|Other|0|||
170393368|NCT04668066|615778589|FG004|Part 1: Follow-Up|Other|0|||
170393369|NCT04668066|615778590|FG005|Part 1: Follow-Up|Other|0|||
170393370|NCT04668066|615778591|FG006|Part 1: Follow-Up|Other|0|||
170393371|NCT04668066|615778592|FG007|Part 1: Follow-Up|Other|0|||
170393372|NCT04668066|615778593|FG008|Part 1: Follow-Up|Other|0|||
170393373|NCT04668066|615778594|FG009|Part 1: Follow-Up|Other|0|||
170393374|NCT04668066|615778595|FG010|Part 1: Follow-Up|Other|0|||
170393375|NCT04668066|615778596|FG011|Part 1: Follow-Up|Other|1|||
170393376|NCT04668066|615778597|FG012|Part 1: Follow-Up|Other|1|||
170393377|NCT04668066|615778598|FG013|Part 1: Follow-Up|Other|0|||
170393378|NCT04668066|615778599|FG014|Part 1: Follow-Up|Other|0|||
170393379|NCT04668066|615778600|FG015|Part 1: Follow-Up|Other|0|||
170393380|NCT04668066|615778601|FG016|Part 1: Follow-Up|Other|0|||
170393381|NCT04668066|615778602|FG017|Part 1: Follow-Up|Other|0|||
170393382|NCT04668066|615778603|FG018|Part 1: Follow-Up|Other|0|||
170393383|NCT04668066|615778585|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393384|NCT04668066|615778586|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393385|NCT04668066|615778587|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393386|NCT04668066|615778588|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393387|NCT04668066|615778589|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393388|NCT04668066|615778590|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393389|NCT04668066|615778591|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393390|NCT04668066|615778592|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393391|NCT04668066|615778593|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393392|NCT04668066|615778594|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393393|NCT04668066|615778595|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393394|NCT04668066|615778596|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393395|NCT04668066|615778597|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
170393396|NCT04668066|615778598|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393397|NCT04668066|615778599|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393398|NCT04668066|615778600|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
170393399|NCT04668066|615778601|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393400|NCT04668066|615778602|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393401|NCT04668066|615778603|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
170393402|NCT04668066|615778585|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393403|NCT04668066|615778586|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393404|NCT04668066|615778587|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393405|NCT04668066|615778588|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393406|NCT04668066|615778589|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393407|NCT04668066|615778590|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393408|NCT04668066|615778591|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393409|NCT04668066|615778592|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393410|NCT04668066|615778593|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393411|NCT04668066|615778594|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393412|NCT04668066|615778595|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393413|NCT04668066|615778596|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393414|NCT04668066|615778597|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393415|NCT04668066|615778598|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393416|NCT04668066|615778599|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393417|NCT04668066|615778600|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393418|NCT04668066|615778601|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393419|NCT04668066|615778602|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
170393420|NCT04668066|615778603|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
170393421|NCT04668066|615778585|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393422|NCT04668066|615778586|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393423|NCT04668066|615778587|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393424|NCT04668066|615778588|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393425|NCT04668066|615778589|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393426|NCT04668066|615778590|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393427|NCT04668066|615778591|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393428|NCT04668066|615778592|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393429|NCT04668066|615778593|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393430|NCT04668066|615778594|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393431|NCT04668066|615778595|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393432|NCT04668066|615778596|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393433|NCT04668066|615778597|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393434|NCT04668066|615778598|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393435|NCT04668066|615778599|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393436|NCT04668066|615778600|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393437|NCT04668066|615778601|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393438|NCT04668066|615778602|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
170393439|NCT04668066|615778603|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
170393440|NCT04668066|615778585|FG000|Part 2: Treatment Phase|Other|0|||
170393441|NCT04668066|615778586|FG001|Part 2: Treatment Phase|Other|0|||
170393442|NCT04668066|615778587|FG002|Part 2: Treatment Phase|Other|0|||
170393443|NCT04668066|615778588|FG003|Part 2: Treatment Phase|Other|0|||
170393444|NCT04668066|615778589|FG004|Part 2: Treatment Phase|Other|0|||
170393445|NCT04668066|615778590|FG005|Part 2: Treatment Phase|Other|0|||
170393446|NCT04668066|615778591|FG006|Part 2: Treatment Phase|Other|0|||
170393447|NCT04668066|615778592|FG007|Part 2: Treatment Phase|Other|0|||
170393448|NCT04668066|615778593|FG008|Part 2: Treatment Phase|Other|0|||
170393449|NCT04668066|615778594|FG009|Part 2: Treatment Phase|Other|0|||
170393450|NCT04668066|615778595|FG010|Part 2: Treatment Phase|Other|0|||
170393451|NCT04668066|615778596|FG011|Part 2: Treatment Phase|Other|0|||
170393452|NCT04668066|615778597|FG012|Part 2: Treatment Phase|Other|0|||
170393453|NCT04668066|615778598|FG013|Part 2: Treatment Phase|Other|0|||
170393454|NCT04668066|615778599|FG014|Part 2: Treatment Phase|Other|0|||
170393455|NCT04668066|615778600|FG015|Part 2: Treatment Phase|Other|0|||
170393456|NCT04668066|615778601|FG016|Part 2: Treatment Phase|Other|0|||
170393457|NCT04668066|615778602|FG017|Part 2: Treatment Phase|Other|0|||
170393458|NCT04668066|615778603|FG018|Part 2: Treatment Phase|Other|1|||
170393459|NCT04668066|615778585|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393460|NCT04668066|615778586|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393461|NCT04668066|615778587|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393462|NCT04668066|615778588|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393463|NCT04668066|615778589|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393464|NCT04668066|615778590|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393465|NCT04668066|615778591|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393466|NCT04668066|615778592|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393467|NCT04668066|615778593|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393468|NCT04668066|615778594|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393469|NCT04668066|615778595|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393470|NCT04668066|615778596|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393471|NCT04668066|615778597|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393472|NCT04668066|615778598|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393473|NCT04668066|615778599|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393474|NCT04668066|615778600|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393475|NCT04668066|615778601|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393476|NCT04668066|615778602|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
170393477|NCT04668066|615778603|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
170393478|NCT02058849|615778604|FG000|Overall Study|Hospitalization|1|||
170393479|NCT02058849|615778605|FG001|Overall Study|Hospitalization|1|||
170393480|NCT02058849|615778604|FG000|Overall Study|Death|1|||
170393481|NCT02058849|615778605|FG001|Overall Study|Death|0|||
170393482|NCT02058849|615778604|FG000|Overall Study|Lost to Follow-up|1|||
170393483|NCT02058849|615778605|FG001|Overall Study|Lost to Follow-up|0|||
170393484|NCT02058849|615778604|FG000|Overall Study|Withdrawal by Subject|4|||
170393485|NCT02058849|615778605|FG001|Overall Study|Withdrawal by Subject|0|||
170393486|NCT02331680|615778606|FG000|Overall Study|Adverse Event|3|||
170393487|NCT02331680|615778607|FG001|Overall Study|Adverse Event|0|||
170393488|NCT02331680|615778608|FG002|Overall Study|Adverse Event|2|||
170393489|NCT02331680|615778606|FG000|Overall Study|Physician Decision|1|||
170393490|NCT02331680|615778607|FG001|Overall Study|Physician Decision|1|||
170393491|NCT02331680|615778608|FG002|Overall Study|Physician Decision|2|||
170393492|NCT02331680|615778606|FG000|Overall Study|Withdrawal by Subject|0|||
170393493|NCT02331680|615778607|FG001|Overall Study|Withdrawal by Subject|1|||
170393494|NCT02331680|615778608|FG002|Overall Study|Withdrawal by Subject|2|||
170393495|NCT02331680|615778606|FG000|Overall Study|Met withdrawal criteria|2|||
170393496|NCT02331680|615778607|FG001|Overall Study|Met withdrawal criteria|2|||
170393497|NCT02331680|615778608|FG002|Overall Study|Met withdrawal criteria|5|||
170393498|NCT02331680|615778606|FG000|Overall Study|Non-compliance with study drug|0|||
170393499|NCT02331680|615778607|FG001|Overall Study|Non-compliance with study drug|0|||
170393500|NCT02331680|615778608|FG002|Overall Study|Non-compliance with study drug|1|||
170393501|NCT02331680|615778606|FG000|Overall Study|Protocol Violation|0|||
170393502|NCT02331680|615778607|FG001|Overall Study|Protocol Violation|0|||
170393503|NCT02331680|615778608|FG002|Overall Study|Protocol Violation|3|||
170393504|NCT02219477|615778609|FG000|Overall Study|Adverse Event|0|||
170393505|NCT02219477|615778610|FG001|Overall Study|Adverse Event|1|||
170393506|NCT02219477|615778611|FG002|Overall Study|Adverse Event|1|||
170393507|NCT02219477|615778609|FG000|Overall Study|Withdrawal by Subject|0|||
170393508|NCT02219477|615778610|FG001|Overall Study|Withdrawal by Subject|1|||
170393509|NCT02219477|615778611|FG002|Overall Study|Withdrawal by Subject|0|||
170393510|NCT02242942|615778618|FG000|Overall Study|Death|17|||
170393511|NCT02242942|615778619|FG001|Overall Study|Death|20|||
170393512|NCT02242942|615778620|FG002|Overall Study|Death|2|||
170393513|NCT02242942|615778618|FG000|Overall Study|Physician Decision|1|||
170393514|NCT02242942|615778619|FG001|Overall Study|Physician Decision|0|||
170393515|NCT02242942|615778620|FG002|Overall Study|Physician Decision|0|||
170393516|NCT02242942|615778618|FG000|Overall Study|Withdrawal by Subject|8|||
170393517|NCT02242942|615778619|FG001|Overall Study|Withdrawal by Subject|10|||
170393518|NCT02242942|615778620|FG002|Overall Study|Withdrawal by Subject|0|||
170393519|NCT02242942|615778618|FG000|Overall Study|On-going in Study|190|||
170393520|NCT02242942|615778619|FG001|Overall Study|On-going in Study|186|||
170393521|NCT02242942|615778620|FG002|Overall Study|On-going in Study|11|||
170393522|NCT04784455|615778621|FG000|Overall Study|Death|4|||
170393523|NCT04882085|615778622|FG000|Overall Study|Death|6|||
170393524|NCT04882085|615778623|FG001|Overall Study|Death|9|||
170393525|NCT04882085|615778622|FG000|Overall Study|Withdrawal by Subject|0|||
170393526|NCT04882085|615778623|FG001|Overall Study|Withdrawal by Subject|3|||
170393527|NCT04882085|615778622|FG000|Overall Study|Randomized not treated|1|||
170393528|NCT04882085|615778623|FG001|Overall Study|Randomized not treated|0|||
170393529|NCT04455620|615778624|FG000|Overall Study|Withdrawal by Subject|0|||
170393530|NCT04455620|615778625|FG001|Overall Study|Withdrawal by Subject|0|||
170393531|NCT04455620|615778626|FG002|Overall Study|Withdrawal by Subject|2|||
170393532|NCT04455620|615778627|FG003|Overall Study|Withdrawal by Subject|0|||
170393533|NCT04455620|615778628|FG004|Overall Study|Withdrawal by Subject|1|||
170393534|NCT04455620|615778624|FG000|Overall Study|Lost to Follow-up|0|||
170393535|NCT04455620|615778625|FG001|Overall Study|Lost to Follow-up|0|||
170393536|NCT04455620|615778626|FG002|Overall Study|Lost to Follow-up|1|||
170393537|NCT04455620|615778627|FG003|Overall Study|Lost to Follow-up|1|||
170393538|NCT04455620|615778628|FG004|Overall Study|Lost to Follow-up|0|||
170393539|NCT04455620|615778624|FG000|Overall Study|Death|1|||
170393540|NCT04455620|615778625|FG001|Overall Study|Death|6|||
170393541|NCT04455620|615778626|FG002|Overall Study|Death|20|||
170393542|NCT04455620|615778627|FG003|Overall Study|Death|1|||
170393543|NCT04455620|615778628|FG004|Overall Study|Death|7|||
170393544|NCT04455620|615778624|FG000|Overall Study|Study Termination|0|||
170393545|NCT04455620|615778625|FG001|Overall Study|Study Termination|2|||
170393546|NCT04455620|615778626|FG002|Overall Study|Study Termination|1|||
170393547|NCT04455620|615778627|FG003|Overall Study|Study Termination|0|||
170393548|NCT04455620|615778628|FG004|Overall Study|Study Termination|6|||
170393549|NCT00965562|615778629|FG000|Overall Study|Lost to Follow-up|1|||
170393550|NCT00965562|615778630|FG001|Overall Study|Lost to Follow-up|2|||
170393551|NCT00965562|615778631|FG002|Overall Study|Lost to Follow-up|3|||
170393552|NCT00965562|615778629|FG000|Overall Study|Withdrawal by Subject|2|||
170393553|NCT00965562|615778630|FG001|Overall Study|Withdrawal by Subject|2|||
170393554|NCT00965562|615778631|FG002|Overall Study|Withdrawal by Subject|0|||
170398867|NCT05004181|615798319|FG007|Overall Study|Death|0|||
170393555|NCT03792633|615778632|FG000|Overall Study|Alternative Treatment|17|||
170393556|NCT03792633|615778633|FG001|Overall Study|Alternative Treatment|19|||
170393557|NCT03792633|615778632|FG000|Overall Study|Death|2|||
170393558|NCT03792633|615778633|FG001|Overall Study|Death|0|||
170393559|NCT03792633|615778632|FG000|Overall Study|Disease progression|8|||
170393560|NCT03792633|615778633|FG001|Overall Study|Disease progression|9|||
170393561|NCT03792633|615778632|FG000|Overall Study|Lost to Follow-up|1|||
170393562|NCT03792633|615778633|FG001|Overall Study|Lost to Follow-up|1|||
170393563|NCT03792633|615778632|FG000|Overall Study|Screen fail|1|||
170393564|NCT03792633|615778633|FG001|Overall Study|Screen fail|0|||
170393565|NCT03792633|615778632|FG000|Overall Study|Second malignancy|0|||
170393566|NCT03792633|615778633|FG001|Overall Study|Second malignancy|1|||
170393567|NCT00145119|615778634|FG000|Overall Study|Death|45|||
170393568|NCT04479358|615778635|FG000|Overall Study|Withdrawal by Subject|0|||
170393569|NCT04479358|615778636|FG001|Overall Study|Withdrawal by Subject|0|||
170393570|NCT04479358|615778637|FG002|Overall Study|Withdrawal by Subject|1|||
170393571|NCT04479358|615778638|FG003|Overall Study|Withdrawal by Subject|0|||
170393572|NCT04479358|615778639|FG004|Overall Study|Withdrawal by Subject|0|||
170393573|NCT04479358|615778640|FG005|Overall Study|Withdrawal by Subject|1|||
170393574|NCT05048875|615778641|FG000|Overall Study|Withdrawal by Subject|1|||
170393575|NCT05048875|615778642|FG001|Overall Study|Withdrawal by Subject|0|||
170393576|NCT05048875|615778643|FG002|Overall Study|Withdrawal by Subject|0|||
170393577|NCT05048875|615778644|FG003|Overall Study|Withdrawal by Subject|0|||
170393578|NCT05048875|615778645|FG004|Overall Study|Withdrawal by Subject|0|||
170393579|NCT05048875|615778646|FG005|Overall Study|Withdrawal by Subject|0|||
170393580|NCT05048875|615778647|FG006|Overall Study|Withdrawal by Subject|0|||
170393581|NCT05048875|615778648|FG007|Overall Study|Withdrawal by Subject|0|||
170393582|NCT05048875|615778641|FG000|Overall Study|Adverse Event|0|||
170393583|NCT05048875|615778642|FG001|Overall Study|Adverse Event|0|||
170393584|NCT05048875|615778643|FG002|Overall Study|Adverse Event|0|||
170393585|NCT05048875|615778644|FG003|Overall Study|Adverse Event|1|||
170393586|NCT05048875|615778645|FG004|Overall Study|Adverse Event|0|||
170393587|NCT05048875|615778646|FG005|Overall Study|Adverse Event|0|||
170393588|NCT05048875|615778647|FG006|Overall Study|Adverse Event|0|||
170393589|NCT05048875|615778648|FG007|Overall Study|Adverse Event|0|||
170393590|NCT05681715|615778649|FG000|Training Period (6-weeks)|Adverse Event|3|||
170393591|NCT05681715|615778650|FG001|Training Period (6-weeks)|Adverse Event|0|||
170393592|NCT05681715|615778651|FG002|Training Period (6-weeks)|Adverse Event|0|||
170393593|NCT05681715|615778649|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
170393594|NCT05681715|615778650|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
170393595|NCT05681715|615778651|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
170393596|NCT05681715|615778649|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
170393597|NCT05681715|615778650|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
170393598|NCT05681715|615778651|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
170393599|NCT05681715|615778649|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
170393600|NCT05681715|615778650|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
170393601|NCT05681715|615778651|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
170393602|NCT05681715|615778649|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
170393603|NCT05681715|615778650|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
170393604|NCT05681715|615778651|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
170393605|NCT05681715|615778649|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
170393606|NCT05681715|615778650|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
170393607|NCT05681715|615778651|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
170393608|NCT05681715|615778649|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
170393609|NCT05681715|615778650|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
170393610|NCT05681715|615778651|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
170393611|NCT05681715|615778649|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
170393612|NCT05681715|615778650|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
170393613|NCT05681715|615778651|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
170393614|NCT05204563|615778652|FG000|Overall Study|Other than Specified|2|||
170393615|NCT05204563|615778653|FG001|Overall Study|Other than Specified|1|||
170393616|NCT05204563|615778652|FG000|Overall Study|Death|18|||
170393617|NCT05204563|615778653|FG001|Overall Study|Death|4|||
170393618|NCT05204563|615778652|FG000|Overall Study|Lost to Follow-up|6|||
170393619|NCT05204563|615778653|FG001|Overall Study|Lost to Follow-up|3|||
170393620|NCT05204563|615778652|FG000|Overall Study|Withdrawal by Subject|12|||
170393621|NCT05204563|615778653|FG001|Overall Study|Withdrawal by Subject|3|||
170393622|NCT05204563|615778652|FG000|Overall Study|Enrolled, Not Treated|1|||
170393623|NCT05204563|615778653|FG001|Overall Study|Enrolled, Not Treated|0|||
170393624|NCT01958619|615778662|FG000|Overall Study|Protocol Violation|2|||
170393625|NCT01958619|615778663|FG001|Overall Study|Protocol Violation|0|||
170393626|NCT01958619|615778664|FG002|Overall Study|Protocol Violation|1|||
170393627|NCT01958619|615778665|FG003|Overall Study|Protocol Violation|0|||
170393628|NCT03795233|615778673|FG000|Overall Study|Withdrawal by Subject|2|||
170393629|NCT03795233|615778674|FG001|Overall Study|Withdrawal by Subject|1|||
170393630|NCT03795233|615778673|FG000|Overall Study|Lost to Follow-up|1|||
170393631|NCT03795233|615778674|FG001|Overall Study|Lost to Follow-up|0|||
170393632|NCT03795233|615778673|FG000|Overall Study|Death|1|||
170393633|NCT03795233|615778674|FG001|Overall Study|Death|0|||
170393634|NCT05403502|615778676|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
170393635|NCT05403502|615778676|FG000|Humalog Lead-In Period|Physician Decision|2|||
170393636|NCT05403502|615778676|FG000|Humalog Lead-In Period|Protocol Violation|1|||
170393637|NCT05403502|615778676|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
170393638|NCT05403502|615778676|FG000|Lyumjev Treatment Period|Physician Decision|2|||
170393639|NCT02756182|615778677|FG000|Overall Study|StudyTechnical Difficulties|4|||
170393640|NCT01119118|615778678|FG000|Overall Study|Adverse Event|1|||
170393641|NCT01003691|615778679|FG000|Overall Study|Adverse Event|0|||
170393642|NCT01003691|615778680|FG001|Overall Study|Adverse Event|0|||
170393643|NCT01003691|615778681|FG002|Overall Study|Adverse Event|0|||
170393644|NCT01003691|615778682|FG003|Overall Study|Adverse Event|1|||
170393645|NCT00157820|615778695|FG000|Randomized|Physician Decision|4|||
170393646|NCT00157820|615778696|FG001|Randomized|Physician Decision|2|||
170393647|NCT00157820|615778697|FG002|Randomized|Physician Decision|3|||
170393648|NCT00157820|615778695|FG000|Randomized|Withdrawal by Subject|1|||
170393649|NCT00157820|615778696|FG001|Randomized|Withdrawal by Subject|2|||
170393650|NCT00157820|615778697|FG002|Randomized|Withdrawal by Subject|3|||
170393651|NCT00157820|615778695|FG000|Randomized|Protocol Violation|2|||
170393652|NCT00157820|615778696|FG001|Randomized|Protocol Violation|1|||
170393653|NCT00157820|615778697|FG002|Randomized|Protocol Violation|2|||
170393654|NCT00157820|615778695|FG000|1st 8 Month|Death|7|||
170393655|NCT00157820|615778696|FG001|1st 8 Month|Death|8|||
170393656|NCT00157820|615778697|FG002|1st 8 Month|Death|3|||
170393657|NCT00157820|615778695|FG000|1st 8 Month|Lost to Follow-up|1|||
170393658|NCT00157820|615778696|FG001|1st 8 Month|Lost to Follow-up|2|||
170393659|NCT00157820|615778697|FG002|1st 8 Month|Lost to Follow-up|1|||
170393660|NCT00157820|615778695|FG000|1st 8 Month|Premature cross-over|0|||
170393661|NCT00157820|615778696|FG001|1st 8 Month|Premature cross-over|2|||
170393662|NCT00157820|615778697|FG002|1st 8 Month|Premature cross-over|2|||
170393663|NCT00157820|615778695|FG000|2nd 8 Months|Death|3|||
170393664|NCT00157820|615778696|FG001|2nd 8 Months|Death|1|||
170393665|NCT00157820|615778697|FG002|2nd 8 Months|Death|3|||
170393666|NCT00157820|615778695|FG000|2nd 8 Months|Lost to Follow-up|1|||
170393667|NCT00157820|615778696|FG001|2nd 8 Months|Lost to Follow-up|5|||
170393668|NCT00157820|615778697|FG002|2nd 8 Months|Lost to Follow-up|2|||
170393669|NCT00157820|615778695|FG000|2nd 8 Months|Premature cross-over|1|||
170393670|NCT00157820|615778696|FG001|2nd 8 Months|Premature cross-over|7|||
170393671|NCT00157820|615778697|FG002|2nd 8 Months|Premature cross-over|9|||
170393672|NCT01676818|615778698|FG000|Overall Study|Physician Decision|1|||
170393673|NCT01676818|615778698|FG000|Overall Study|Withdrawal by Subject|1|||
170393674|NCT03505606|615780551|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
170393675|NCT03505606|615780552|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
170393676|NCT03505606|615780553|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
170393677|NCT03505606|615780551|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
170393678|NCT03505606|615780552|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
170393679|NCT03505606|615780553|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
170393680|NCT03505606|615780551|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
170393681|NCT03505606|615780552|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
170393682|NCT03505606|615780553|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
170393683|NCT03505606|615780551|FG000|Overall Study|Poor compliance with refractive correction|0|||
170393684|NCT03505606|615780552|FG001|Overall Study|Poor compliance with refractive correction|0|||
170393685|NCT03505606|615780553|FG002|Overall Study|Poor compliance with refractive correction|1|||
170393686|NCT03505606|615780551|FG000|Overall Study|Insufficient anisometropia|0|||
170393687|NCT03505606|615780552|FG001|Overall Study|Insufficient anisometropia|0|||
170393688|NCT03505606|615780553|FG002|Overall Study|Insufficient anisometropia|2|||
170393689|NCT03505606|615780551|FG000|Overall Study|Ectopia Lentis|0|||
170393690|NCT03505606|615780552|FG001|Overall Study|Ectopia Lentis|0|||
170393691|NCT03505606|615780553|FG002|Overall Study|Ectopia Lentis|1|||
170393692|NCT03505606|615780551|FG000|Overall Study|alternation of amblyopic eye|0|||
170393693|NCT03505606|615780552|FG001|Overall Study|alternation of amblyopic eye|1|||
170393694|NCT03505606|615780553|FG002|Overall Study|alternation of amblyopic eye|0|||
170393695|NCT01340794|615780555|FG000|Overall Study|Withdrawal by Subject|0|||
170393696|NCT01340794|615780556|FG001|Overall Study|Withdrawal by Subject|1|||
170393697|NCT01392469|615780558|FG000|Overall Study|Adverse Event|2|||
170393698|NCT01392469|615780558|FG000|Overall Study|Withdrawal by Subject|1|||
170393699|NCT01392469|615780558|FG000|Overall Study|Protocol Violation|1|||
170393700|NCT03255226|615780559|FG000|Overall Study|Adverse Event|2|||
170393701|NCT03255226|615780559|FG000|Overall Study|Physician Decision|3|||
170393702|NCT03255226|615780559|FG000|Overall Study|Withdrawal by Subject|1|||
170393703|NCT03255226|615780559|FG000|Overall Study|Serum or blood sodium increased|4|||
170393704|NCT03255226|615780559|FG000|Overall Study|Serum or blood potassium increased|4|||
170393705|NCT03387423|615780564|FG000|Overall Study|Lost to Follow-up|16|||
170393706|NCT03387423|615780565|FG001|Overall Study|Lost to Follow-up|12|||
170393707|NCT03387423|615780566|FG002|Overall Study|Lost to Follow-up|1|||
170393708|NCT03387423|615780567|FG003|Overall Study|Lost to Follow-up|0|||
170393709|NCT03387423|615780564|FG000|Overall Study|Other|0|||
170393710|NCT03387423|615780565|FG001|Overall Study|Other|3|||
170393711|NCT03387423|615780566|FG002|Overall Study|Other|0|||
170393712|NCT03387423|615780567|FG003|Overall Study|Other|0|||
170393713|NCT03387423|615780564|FG000|Overall Study|Administrative Reason|166|||
170393714|NCT03387423|615780565|FG001|Overall Study|Administrative Reason|89|||
170393715|NCT03387423|615780566|FG002|Overall Study|Administrative Reason|17|||
170393716|NCT03387423|615780567|FG003|Overall Study|Administrative Reason|19|||
170393717|NCT03387423|615780564|FG000|Overall Study|Revocation Consent|76|||
170393718|NCT03387423|615780565|FG001|Overall Study|Revocation Consent|32|||
170393719|NCT03387423|615780566|FG002|Overall Study|Revocation Consent|3|||
170393720|NCT03387423|615780567|FG003|Overall Study|Revocation Consent|5|||
170393721|NCT00267020|615780570|FG000|Overall Study|Adverse Event|22|||
170393722|NCT00267020|615780571|FG001|Overall Study|Adverse Event|5|||
170393723|NCT00267020|615780570|FG000|Overall Study|Death|2|||
170393724|NCT00267020|615780571|FG001|Overall Study|Death|1|||
170393725|NCT00267020|615780570|FG000|Overall Study|Withdrawal by Subject|17|||
170393726|NCT00267020|615780571|FG001|Overall Study|Withdrawal by Subject|7|||
170393727|NCT00267020|615780570|FG000|Overall Study|Physician Decision|3|||
170393728|NCT00267020|615780571|FG001|Overall Study|Physician Decision|2|||
170393729|NCT00267020|615780570|FG000|Overall Study|Disease Progression|39|||
170393730|NCT00267020|615780571|FG001|Overall Study|Disease Progression|25|||
170393731|NCT00267020|615780570|FG000|Overall Study|Unrelated Complication|1|||
170393732|NCT00267020|615780571|FG001|Overall Study|Unrelated Complication|1|||
170393733|NCT00267020|615780570|FG000|Overall Study|Sponsor Request|1|||
170393734|NCT00267020|615780571|FG001|Overall Study|Sponsor Request|0|||
170393735|NCT00267020|615780570|FG000|Overall Study|Other|1|||
170393736|NCT00267020|615780571|FG001|Overall Study|Other|2|||
170393737|NCT04292171|615780573|FG000|Overall Study|Pharmacy error|2|||
170393738|NCT04292171|615780574|FG001|Overall Study|Pharmacy error|0|||
170393739|NCT04292171|615780573|FG000|Overall Study|Delivered prior to procedure|0|||
170393740|NCT04292171|615780574|FG001|Overall Study|Delivered prior to procedure|1|||
170393741|NCT04633434|615780575|FG000|Overall Study|Lost to Follow-up|32|||
170393742|NCT04633434|615780576|FG001|Overall Study|Lost to Follow-up|32|||
170393743|NCT00848965|615780581|FG000|Overall Study|Adverse Event|1|||
170393744|NCT00848965|615780581|FG000|Overall Study|Withdrawal by Subject|1|||
170393745|NCT01353209|615780582|FG000|Overall Study|Adverse Event|1|||
170393746|NCT01353209|615780583|FG001|Overall Study|Adverse Event|1|||
170393747|NCT02181673|615780598|FG000|Up to Week 24|Adverse Event|2|||
170393748|NCT02181673|615780599|FG001|Up to Week 24|Adverse Event|0|||
170393749|NCT02181673|615780600|FG002|Up to Week 24|Adverse Event|3|||
170393750|NCT02181673|615780598|FG000|Up to Week 24|Death|1|||
170393751|NCT02181673|615780599|FG001|Up to Week 24|Death|0|||
170393752|NCT02181673|615780600|FG002|Up to Week 24|Death|0|||
170393753|NCT02181673|615780598|FG000|Up to Week 24|Lack of Efficacy|1|||
170393754|NCT02181673|615780599|FG001|Up to Week 24|Lack of Efficacy|0|||
170393755|NCT02181673|615780600|FG002|Up to Week 24|Lack of Efficacy|0|||
170393756|NCT02181673|615780598|FG000|Up to Week 24|Lost to Follow-up|1|||
170393757|NCT02181673|615780599|FG001|Up to Week 24|Lost to Follow-up|0|||
170393758|NCT02181673|615780600|FG002|Up to Week 24|Lost to Follow-up|0|||
170393759|NCT02181673|615780598|FG000|Up to Week 24|Physician Decision|0|||
170393760|NCT02181673|615780599|FG001|Up to Week 24|Physician Decision|0|||
170393761|NCT02181673|615780600|FG002|Up to Week 24|Physician Decision|3|||
170393762|NCT02181673|615780598|FG000|Up to Week 24|Withdrawal by Subject|10|||
170393763|NCT02181673|615780599|FG001|Up to Week 24|Withdrawal by Subject|0|||
170393764|NCT02181673|615780600|FG002|Up to Week 24|Withdrawal by Subject|1|||
170393765|NCT02181673|615780598|FG000|Up to Week 24|Other|2|||
170393766|NCT02181673|615780599|FG001|Up to Week 24|Other|0|||
170393767|NCT02181673|615780600|FG002|Up to Week 24|Other|3|||
170393768|NCT02181673|615780598|FG000|Up to Week 24|Randomized not Treated|0|||
170393769|NCT02181673|615780599|FG001|Up to Week 24|Randomized not Treated|0|||
170393770|NCT02181673|615780600|FG002|Up to Week 24|Randomized not Treated|1|||
170393771|NCT02181673|615780598|FG000|Week 24-Week 60|Adverse Event|0|||
170393772|NCT02181673|615780599|FG001|Week 24-Week 60|Adverse Event|4|||
170393773|NCT02181673|615780600|FG002|Week 24-Week 60|Adverse Event|10|||
170393774|NCT02181673|615780598|FG000|Week 24-Week 60|Other|0|||
170393775|NCT02181673|615780599|FG001|Week 24-Week 60|Other|2|||
170393776|NCT02181673|615780600|FG002|Week 24-Week 60|Other|1|||
170393777|NCT02181673|615780598|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
170393778|NCT02181673|615780599|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
170393779|NCT02181673|615780600|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
170393780|NCT02181673|615780598|FG000|Week 24-Week 60|Pregnancy|0|||
170393781|NCT02181673|615780599|FG001|Week 24-Week 60|Pregnancy|0|||
170393782|NCT02181673|615780600|FG002|Week 24-Week 60|Pregnancy|1|||
170393783|NCT02181673|615780598|FG000|Week 24-Week 60|Lack of Efficacy|0|||
170393784|NCT02181673|615780599|FG001|Week 24-Week 60|Lack of Efficacy|0|||
170393785|NCT02181673|615780600|FG002|Week 24-Week 60|Lack of Efficacy|1|||
170393786|NCT02181673|615780598|FG000|Week 24-Week 60|Lost to Follow-up|0|||
170393787|NCT02181673|615780599|FG001|Week 24-Week 60|Lost to Follow-up|0|||
170393788|NCT02181673|615780600|FG002|Week 24-Week 60|Lost to Follow-up|1|||
170393789|NCT02181673|615780598|FG000|Week 24-Week 60|Physician Decision|0|||
170393790|NCT02181673|615780599|FG001|Week 24-Week 60|Physician Decision|0|||
170393791|NCT02181673|615780600|FG002|Week 24-Week 60|Physician Decision|1|||
170393792|NCT00138658|615780601|FG000|Overall Study|Adverse Event|23|||
170393793|NCT00138658|615780601|FG000|Overall Study|Death|1|||
170393794|NCT00138658|615780601|FG000|Overall Study|Disease Progression|21|||
170393795|NCT00138658|615780601|FG000|Overall Study|Physician Decision|11|||
170393796|NCT00138658|615780601|FG000|Overall Study|Withdrawal by Subject|5|||
170393797|NCT03733301|615780606|FG000|Overall Study|Screen Fail|1|||
170393798|NCT03733301|615780607|FG001|Overall Study|Screen Fail|0|||
170393799|NCT03733301|615780608|FG002|Overall Study|Screen Fail|0|||
170393800|NCT03733301|615780606|FG000|Overall Study|Non-compliance|1|||
170393801|NCT03733301|615780607|FG001|Overall Study|Non-compliance|0|||
170393802|NCT03733301|615780608|FG002|Overall Study|Non-compliance|0|||
170393803|NCT03733301|615780606|FG000|Overall Study|Lack of Efficacy|2|||
170393804|NCT03733301|615780607|FG001|Overall Study|Lack of Efficacy|3|||
170393805|NCT03733301|615780608|FG002|Overall Study|Lack of Efficacy|0|||
170393806|NCT03733301|615780606|FG000|Overall Study|Adverse Event|0|||
170393807|NCT03733301|615780607|FG001|Overall Study|Adverse Event|1|||
170393808|NCT03733301|615780608|FG002|Overall Study|Adverse Event|3|||
170393809|NCT03733301|615780606|FG000|Overall Study|Withdrawal by Subject|3|||
170393810|NCT03733301|615780607|FG001|Overall Study|Withdrawal by Subject|5|||
170393811|NCT03733301|615780608|FG002|Overall Study|Withdrawal by Subject|1|||
170393812|NCT00320801|615780609|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
170393813|NCT00320801|615780610|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
170393814|NCT00320801|615780611|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
170393815|NCT00320801|615780612|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
170393816|NCT00320801|615780609|FG000|Open-label Run-in Period|Adverse Event|33|||
170393817|NCT00320801|615780610|FG001|Open-label Run-in Period|Adverse Event|0|||
170393818|NCT00320801|615780611|FG002|Open-label Run-in Period|Adverse Event|0|||
170393819|NCT00320801|615780612|FG003|Open-label Run-in Period|Adverse Event|0|||
170393820|NCT00320801|615780609|FG000|Open-label Run-in Period|Administrative|10|||
170393821|NCT00320801|615780610|FG001|Open-label Run-in Period|Administrative|0|||
170393822|NCT00320801|615780611|FG002|Open-label Run-in Period|Administrative|0|||
170393823|NCT00320801|615780612|FG003|Open-label Run-in Period|Administrative|0|||
170393824|NCT00320801|615780609|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
170393825|NCT00320801|615780610|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
170393826|NCT00320801|615780611|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
170393827|NCT00320801|615780612|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
170393828|NCT00320801|615780609|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
170393829|NCT00320801|615780610|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
170393830|NCT00320801|615780611|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
170393831|NCT00320801|615780612|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
170393832|NCT00320801|615780609|FG000|Open-label Run-in Period|Did not qualify|1|||
170393833|NCT00320801|615780610|FG001|Open-label Run-in Period|Did not qualify|0|||
170393834|NCT00320801|615780611|FG002|Open-label Run-in Period|Did not qualify|0|||
170393835|NCT00320801|615780612|FG003|Open-label Run-in Period|Did not qualify|0|||
170393836|NCT00320801|615780609|FG000|Double-blind Phase|Withdrawal by Subject|0|||
170393837|NCT00320801|615780610|FG001|Double-blind Phase|Withdrawal by Subject|0|||
170393838|NCT00320801|615780611|FG002|Double-blind Phase|Withdrawal by Subject|1|||
170393839|NCT00320801|615780612|FG003|Double-blind Phase|Withdrawal by Subject|0|||
170393840|NCT00320801|615780609|FG000|Double-blind Phase|Adverse Event|0|||
170393841|NCT00320801|615780610|FG001|Double-blind Phase|Adverse Event|2|||
170393842|NCT00320801|615780611|FG002|Double-blind Phase|Adverse Event|8|||
170393843|NCT00320801|615780612|FG003|Double-blind Phase|Adverse Event|0|||
170393844|NCT00320801|615780609|FG000|Double-blind Phase|Administrative|0|||
170393845|NCT00320801|615780610|FG001|Double-blind Phase|Administrative|0|||
170393846|NCT00320801|615780611|FG002|Double-blind Phase|Administrative|4|||
170393847|NCT00320801|615780612|FG003|Double-blind Phase|Administrative|0|||
170393848|NCT00320801|615780609|FG000|Double-blind Phase|Lack of Efficacy|0|||
170393849|NCT00320801|615780610|FG001|Double-blind Phase|Lack of Efficacy|9|||
170393850|NCT00320801|615780611|FG002|Double-blind Phase|Lack of Efficacy|1|||
170393851|NCT00320801|615780612|FG003|Double-blind Phase|Lack of Efficacy|0|||
170393852|NCT00320801|615780609|FG000|Extension Phase|Withdrawal by Subject|0|||
170393853|NCT00320801|615780610|FG001|Extension Phase|Withdrawal by Subject|0|||
170393854|NCT00320801|615780611|FG002|Extension Phase|Withdrawal by Subject|0|||
170393855|NCT00320801|615780612|FG003|Extension Phase|Withdrawal by Subject|6|||
170393856|NCT00320801|615780609|FG000|Extension Phase|Adverse Event|0|||
170393857|NCT00320801|615780610|FG001|Extension Phase|Adverse Event|0|||
170393858|NCT00320801|615780611|FG002|Extension Phase|Adverse Event|0|||
170393859|NCT00320801|615780612|FG003|Extension Phase|Adverse Event|8|||
170393860|NCT00320801|615780609|FG000|Extension Phase|Administrative|0|||
170393861|NCT00320801|615780610|FG001|Extension Phase|Administrative|0|||
170393862|NCT00320801|615780611|FG002|Extension Phase|Administrative|0|||
170393863|NCT00320801|615780612|FG003|Extension Phase|Administrative|29|||
170393864|NCT00320801|615780609|FG000|Extension Phase|Lack of Efficacy|0|||
170393865|NCT00320801|615780610|FG001|Extension Phase|Lack of Efficacy|0|||
170393866|NCT00320801|615780611|FG002|Extension Phase|Lack of Efficacy|0|||
170393867|NCT00320801|615780612|FG003|Extension Phase|Lack of Efficacy|2|||
170393868|NCT00320801|615780609|FG000|Extension Phase|Lost to Follow-up|0|||
170393869|NCT00320801|615780610|FG001|Extension Phase|Lost to Follow-up|0|||
170393870|NCT00320801|615780611|FG002|Extension Phase|Lost to Follow-up|0|||
170393871|NCT00320801|615780612|FG003|Extension Phase|Lost to Follow-up|3|||
170393872|NCT00491322|615780614|FG000|Overall Study|Protocol Violation|1|||
170393873|NCT00491322|615780615|FG001|Overall Study|Protocol Violation|0|||
170393874|NCT00491322|615780614|FG000|Overall Study|Pregnancy|0|||
170393875|NCT00491322|615780615|FG001|Overall Study|Pregnancy|1|||
170393876|NCT00557830|615780625|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
170393877|NCT00557830|615780626|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
170393878|NCT00557830|615780627|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
170393879|NCT00557830|615780625|FG000|Screening Treatment Phase|Adverse Event|2|||
170393880|NCT00557830|615780626|FG001|Screening Treatment Phase|Adverse Event|0|||
170393881|NCT00557830|615780627|FG002|Screening Treatment Phase|Adverse Event|0|||
170393882|NCT00557830|615780625|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
170393883|NCT00557830|615780626|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
170393884|NCT00557830|615780627|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
170393885|NCT01833897|615780631|FG000|Overall Study|Lack of Efficacy|1|||
170393886|NCT00669110|615780632|FG000|Overall Study|Adverse Event|4|||
170393887|NCT00669110|615780633|FG001|Overall Study|Adverse Event|3|||
170393888|NCT00669110|615780632|FG000|Overall Study|Caregiver request|3|||
170393889|NCT00669110|615780633|FG001|Overall Study|Caregiver request|2|||
170393890|NCT00669110|615780632|FG000|Overall Study|Physician Decision|0|||
170393891|NCT00669110|615780633|FG001|Overall Study|Physician Decision|1|||
170393892|NCT00669110|615780632|FG000|Overall Study|Lost to Follow-up|1|||
170393893|NCT00669110|615780633|FG001|Overall Study|Lost to Follow-up|0|||
170393894|NCT00669110|615780632|FG000|Overall Study|Protocol Violation|0|||
170393895|NCT00669110|615780633|FG001|Overall Study|Protocol Violation|5|||
170393896|NCT00669110|615780632|FG000|Overall Study|Withdrawal by Subject|0|||
170393897|NCT00669110|615780633|FG001|Overall Study|Withdrawal by Subject|2|||
170393898|NCT01870921|615780634|FG000|Overall Study|Subject decision|80|||
170393899|NCT01870921|615780634|FG000|Overall Study|Severe non-compliance to protocol|7|||
170393900|NCT01870921|615780634|FG000|Overall Study|Subject Lost to Follow up|2|||
170393901|NCT01870921|615780634|FG000|Overall Study|Other|1|||
170393902|NCT00806416|615780637|FG000|Period 1 - Part I|Adverse Event|0|||
170393903|NCT00806416|615780638|FG001|Period 1 - Part I|Adverse Event|1|||
170393904|NCT00806416|615780639|FG002|Period 1 - Part I|Adverse Event|0|||
170393905|NCT00806416|615780640|FG003|Period 1 - Part I|Adverse Event|0|||
170393906|NCT00806416|615780637|FG000|Period 1 - Part I|Lost to Follow-up|0|||
170393907|NCT00806416|615780638|FG001|Period 1 - Part I|Lost to Follow-up|2|||
170393908|NCT00806416|615780639|FG002|Period 1 - Part I|Lost to Follow-up|0|||
170393909|NCT00806416|615780640|FG003|Period 1 - Part I|Lost to Follow-up|0|||
170393910|NCT00806416|615780637|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
170393911|NCT00806416|615780638|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
170393912|NCT00806416|615780639|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
170393913|NCT00806416|615780640|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
170393914|NCT00806416|615780637|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
170393915|NCT00806416|615780638|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
170393916|NCT00806416|615780639|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
170393917|NCT00806416|615780640|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
170393918|NCT02325739|615780646|FG000|Phase I Part|Adverse Event|1|||
170393919|NCT02325739|615780647|FG001|Phase I Part|Adverse Event|0|||
170393920|NCT02325739|615780648|FG002|Phase I Part|Adverse Event|1|||
170393921|NCT02325739|615780649|FG003|Phase I Part|Adverse Event|2|||
170393922|NCT02325739|615780650|FG004|Phase I Part|Adverse Event|3|||
170393923|NCT02325739|615780651|FG005|Phase I Part|Adverse Event|1|||
170393924|NCT02325739|615780652|FG006|Phase I Part|Adverse Event|0|||
170393925|NCT02325739|615780653|FG007|Phase I Part|Adverse Event|2|||
170393926|NCT02325739|615780654|FG008|Phase I Part|Adverse Event|0|||
170393927|NCT02325739|615780655|FG009|Phase I Part|Adverse Event|0|||
170393928|NCT02325739|615780656|FG010|Phase I Part|Adverse Event|0|||
170393929|NCT02325739|615780646|FG000|Phase I Part|Progressive disease|9|||
170393930|NCT02325739|615780647|FG001|Phase I Part|Progressive disease|6|||
170393931|NCT02325739|615780648|FG002|Phase I Part|Progressive disease|3|||
170393932|NCT02325739|615780649|FG003|Phase I Part|Progressive disease|23|||
170393933|NCT02325739|615780650|FG004|Phase I Part|Progressive disease|14|||
170393934|NCT02325739|615780651|FG005|Phase I Part|Progressive disease|6|||
170393935|NCT02325739|615780652|FG006|Phase I Part|Progressive disease|6|||
170393936|NCT02325739|615780653|FG007|Phase I Part|Progressive disease|3|||
170393937|NCT02325739|615780654|FG008|Phase I Part|Progressive disease|0|||
170393938|NCT02325739|615780655|FG009|Phase I Part|Progressive disease|0|||
170393939|NCT02325739|615780656|FG010|Phase I Part|Progressive disease|0|||
170393940|NCT02325739|615780646|FG000|Phase I Part|Subject/guardian decision|1|||
170393941|NCT02325739|615780647|FG001|Phase I Part|Subject/guardian decision|0|||
170393942|NCT02325739|615780648|FG002|Phase I Part|Subject/guardian decision|1|||
170393943|NCT02325739|615780649|FG003|Phase I Part|Subject/guardian decision|1|||
170393944|NCT02325739|615780650|FG004|Phase I Part|Subject/guardian decision|0|||
170393945|NCT02325739|615780651|FG005|Phase I Part|Subject/guardian decision|0|||
170393946|NCT02325739|615780652|FG006|Phase I Part|Subject/guardian decision|0|||
170393947|NCT02325739|615780653|FG007|Phase I Part|Subject/guardian decision|1|||
170393948|NCT02325739|615780654|FG008|Phase I Part|Subject/guardian decision|0|||
170393949|NCT02325739|615780655|FG009|Phase I Part|Subject/guardian decision|0|||
170393950|NCT02325739|615780656|FG010|Phase I Part|Subject/guardian decision|0|||
170393951|NCT02325739|615780646|FG000|Phase I Part|Death|0|||
170393952|NCT02325739|615780647|FG001|Phase I Part|Death|0|||
170393953|NCT02325739|615780648|FG002|Phase I Part|Death|0|||
170393954|NCT02325739|615780649|FG003|Phase I Part|Death|0|||
170393955|NCT02325739|615780650|FG004|Phase I Part|Death|2|||
170393956|NCT02325739|615780651|FG005|Phase I Part|Death|0|||
170393957|NCT02325739|615780652|FG006|Phase I Part|Death|0|||
170393958|NCT02325739|615780653|FG007|Phase I Part|Death|0|||
170393959|NCT02325739|615780654|FG008|Phase I Part|Death|0|||
170393960|NCT02325739|615780655|FG009|Phase I Part|Death|0|||
170393961|NCT02325739|615780656|FG010|Phase I Part|Death|0|||
170393962|NCT02325739|615780646|FG000|Phase II Part|Adverse Event|0|||
170393963|NCT02325739|615780647|FG001|Phase II Part|Adverse Event|0|||
170393964|NCT02325739|615780648|FG002|Phase II Part|Adverse Event|0|||
170393965|NCT02325739|615780649|FG003|Phase II Part|Adverse Event|0|||
170393966|NCT02325739|615780650|FG004|Phase II Part|Adverse Event|0|||
170393967|NCT02325739|615780651|FG005|Phase II Part|Adverse Event|0|||
170393968|NCT02325739|615780652|FG006|Phase II Part|Adverse Event|0|||
170393969|NCT02325739|615780653|FG007|Phase II Part|Adverse Event|0|||
170393970|NCT02325739|615780654|FG008|Phase II Part|Adverse Event|4|||
170393971|NCT02325739|615780655|FG009|Phase II Part|Adverse Event|5|||
170393972|NCT02325739|615780656|FG010|Phase II Part|Adverse Event|1|||
170393973|NCT02325739|615780646|FG000|Phase II Part|Physician Decision|0|||
170393974|NCT02325739|615780647|FG001|Phase II Part|Physician Decision|0|||
170393975|NCT02325739|615780648|FG002|Phase II Part|Physician Decision|0|||
170393976|NCT02325739|615780649|FG003|Phase II Part|Physician Decision|0|||
170393977|NCT02325739|615780650|FG004|Phase II Part|Physician Decision|0|||
170393978|NCT02325739|615780651|FG005|Phase II Part|Physician Decision|0|||
170393979|NCT02325739|615780652|FG006|Phase II Part|Physician Decision|0|||
170393980|NCT02325739|615780653|FG007|Phase II Part|Physician Decision|0|||
170393981|NCT02325739|615780654|FG008|Phase II Part|Physician Decision|0|||
170393982|NCT02325739|615780655|FG009|Phase II Part|Physician Decision|1|||
170393983|NCT02325739|615780656|FG010|Phase II Part|Physician Decision|0|||
170393984|NCT02325739|615780646|FG000|Phase II Part|Progressive disease|0|||
170393985|NCT02325739|615780647|FG001|Phase II Part|Progressive disease|0|||
170393986|NCT02325739|615780648|FG002|Phase II Part|Progressive disease|0|||
170393987|NCT02325739|615780649|FG003|Phase II Part|Progressive disease|0|||
170393988|NCT02325739|615780650|FG004|Phase II Part|Progressive disease|0|||
170393989|NCT02325739|615780651|FG005|Phase II Part|Progressive disease|0|||
170393990|NCT02325739|615780652|FG006|Phase II Part|Progressive disease|0|||
170393991|NCT02325739|615780653|FG007|Phase II Part|Progressive disease|0|||
170393992|NCT02325739|615780654|FG008|Phase II Part|Progressive disease|22|||
170393993|NCT02325739|615780655|FG009|Phase II Part|Progressive disease|29|||
170393994|NCT02325739|615780656|FG010|Phase II Part|Progressive disease|18|||
170393995|NCT02325739|615780646|FG000|Phase II Part|Subject/guardian decision|0|||
170393996|NCT02325739|615780647|FG001|Phase II Part|Subject/guardian decision|0|||
170393997|NCT02325739|615780648|FG002|Phase II Part|Subject/guardian decision|0|||
170393998|NCT02325739|615780649|FG003|Phase II Part|Subject/guardian decision|0|||
170393999|NCT02325739|615780650|FG004|Phase II Part|Subject/guardian decision|0|||
170394000|NCT02325739|615780651|FG005|Phase II Part|Subject/guardian decision|0|||
170394001|NCT02325739|615780652|FG006|Phase II Part|Subject/guardian decision|0|||
170394002|NCT02325739|615780653|FG007|Phase II Part|Subject/guardian decision|0|||
170394003|NCT02325739|615780654|FG008|Phase II Part|Subject/guardian decision|4|||
170394004|NCT02325739|615780655|FG009|Phase II Part|Subject/guardian decision|1|||
170394005|NCT02325739|615780656|FG010|Phase II Part|Subject/guardian decision|1|||
170394006|NCT00596466|615780657|FG000|Overall Study|Lack of Efficacy|5|||
170394007|NCT00596466|615780657|FG000|Overall Study|Adverse Event|4|||
170394008|NCT00596466|615780657|FG000|Overall Study|Withdrawal by Subject|2|||
170394009|NCT00596466|615780657|FG000|Overall Study|Protocol Violation|2|||
170394010|NCT00596466|615780657|FG000|Overall Study|Unpecified|2|||
170394011|NCT00596466|615780657|FG000|Overall Study|Enrolled, not treated|2|||
170394012|NCT04505592|615780658|FG000|Overall Study|Death|2|||
170394013|NCT04505592|615780659|FG001|Overall Study|Death|1|||
170394014|NCT00227591|615780660|FG000|Overall Study|Withdrawal by Subject|1|||
170394015|NCT01886105|615780661|FG000|Overall Study|Lack of Efficacy|3|||
170394016|NCT01891669|615780663|FG000|Overall Study|Death|0|||
170394017|NCT01891669|615780664|FG001|Overall Study|Death|0|||
170394018|NCT01891669|615780665|FG002|Overall Study|Death|0|||
170394019|NCT01891669|615780666|FG003|Overall Study|Death|0|||
170394020|NCT01891669|615780667|FG004|Overall Study|Death|0|||
170394021|NCT01891669|615780668|FG005|Overall Study|Death|0|||
170394022|NCT01891669|615780669|FG006|Overall Study|Death|0|||
170394023|NCT01891669|615780670|FG007|Overall Study|Death|1|||
170394024|NCT01891669|615780671|FG008|Overall Study|Death|0|||
170394025|NCT01891669|615780672|FG009|Overall Study|Death|1|||
170394026|NCT01891669|615780663|FG000|Overall Study|Withdrawal by Subject|1|||
170394027|NCT01891669|615780664|FG001|Overall Study|Withdrawal by Subject|1|||
170394028|NCT01891669|615780665|FG002|Overall Study|Withdrawal by Subject|0|||
170394029|NCT01891669|615780666|FG003|Overall Study|Withdrawal by Subject|0|||
170394030|NCT01891669|615780667|FG004|Overall Study|Withdrawal by Subject|0|||
170394031|NCT01891669|615780668|FG005|Overall Study|Withdrawal by Subject|0|||
170394032|NCT01891669|615780669|FG006|Overall Study|Withdrawal by Subject|1|||
170394033|NCT01891669|615780670|FG007|Overall Study|Withdrawal by Subject|2|||
170394034|NCT01891669|615780671|FG008|Overall Study|Withdrawal by Subject|1|||
170394035|NCT01891669|615780672|FG009|Overall Study|Withdrawal by Subject|1|||
170394036|NCT01891669|615780663|FG000|Overall Study|Other|1|||
170394037|NCT01891669|615780664|FG001|Overall Study|Other|0|||
170394038|NCT01891669|615780665|FG002|Overall Study|Other|0|||
170394039|NCT01891669|615780666|FG003|Overall Study|Other|0|||
170394040|NCT01891669|615780667|FG004|Overall Study|Other|0|||
170394041|NCT01891669|615780668|FG005|Overall Study|Other|0|||
170394042|NCT01891669|615780669|FG006|Overall Study|Other|0|||
170394043|NCT01891669|615780670|FG007|Overall Study|Other|1|||
170394044|NCT01891669|615780671|FG008|Overall Study|Other|0|||
170394045|NCT01891669|615780672|FG009|Overall Study|Other|0|||
170394046|NCT01360021|615780673|FG000|Overall Study|Eligibility criteria + other|2|||
170394047|NCT01360021|615780674|FG001|Overall Study|Eligibility criteria + other|1|||
170394048|NCT01360021|615780675|FG002|Overall Study|Eligibility criteria + other|1|||
170394049|NCT01360021|615780673|FG000|Overall Study|Protocol Violation|0|||
170394050|NCT01360021|615780674|FG001|Overall Study|Protocol Violation|0|||
170394051|NCT01360021|615780675|FG002|Overall Study|Protocol Violation|1|||
170394052|NCT01360021|615780673|FG000|Overall Study|Withdrawal by Subject|4|||
170394053|NCT01360021|615780674|FG001|Overall Study|Withdrawal by Subject|0|||
170394054|NCT01360021|615780675|FG002|Overall Study|Withdrawal by Subject|2|||
170394055|NCT01360021|615780673|FG000|Overall Study|Adverse Event|2|||
170394056|NCT01360021|615780674|FG001|Overall Study|Adverse Event|3|||
170394057|NCT01360021|615780675|FG002|Overall Study|Adverse Event|3|||
170394058|NCT00650806|615780677|FG000|Overall Study|Adverse Event|0|||
170394059|NCT00650806|615780678|FG001|Overall Study|Adverse Event|5|||
170394060|NCT00650806|615780679|FG002|Overall Study|Adverse Event|3|||
170394061|NCT00650806|615780680|FG003|Overall Study|Adverse Event|4|||
170394062|NCT00650806|615780677|FG000|Overall Study|Lost to Follow-up|7|||
170394063|NCT00650806|615780678|FG001|Overall Study|Lost to Follow-up|6|||
170394064|NCT00650806|615780679|FG002|Overall Study|Lost to Follow-up|11|||
170394065|NCT00650806|615780680|FG003|Overall Study|Lost to Follow-up|10|||
170394066|NCT00650806|615780677|FG000|Overall Study|Protocol Violation|0|||
170394067|NCT00650806|615780678|FG001|Overall Study|Protocol Violation|0|||
170394068|NCT00650806|615780679|FG002|Overall Study|Protocol Violation|0|||
170394069|NCT00650806|615780680|FG003|Overall Study|Protocol Violation|1|||
170394070|NCT00650806|615780677|FG000|Overall Study|Pregnancy|0|||
170394071|NCT00650806|615780678|FG001|Overall Study|Pregnancy|0|||
170394072|NCT00650806|615780679|FG002|Overall Study|Pregnancy|0|||
170394073|NCT00650806|615780680|FG003|Overall Study|Pregnancy|1|||
170394074|NCT00650806|615780677|FG000|Overall Study|Withdrawal by Subject|7|||
170394075|NCT00650806|615780678|FG001|Overall Study|Withdrawal by Subject|5|||
170394076|NCT00650806|615780679|FG002|Overall Study|Withdrawal by Subject|8|||
170394077|NCT00650806|615780680|FG003|Overall Study|Withdrawal by Subject|6|||
170394078|NCT00650806|615780677|FG000|Overall Study|Noncompliance with study drug regimen|1|||
170394079|NCT00650806|615780678|FG001|Overall Study|Noncompliance with study drug regimen|1|||
170394080|NCT00650806|615780679|FG002|Overall Study|Noncompliance with study drug regimen|0|||
170394081|NCT00650806|615780680|FG003|Overall Study|Noncompliance with study drug regimen|0|||
170394082|NCT00650806|615780677|FG000|Overall Study|Study terminated by sponsor|2|||
170394083|NCT00650806|615780678|FG001|Overall Study|Study terminated by sponsor|3|||
170394084|NCT00650806|615780679|FG002|Overall Study|Study terminated by sponsor|5|||
170394085|NCT00650806|615780680|FG003|Overall Study|Study terminated by sponsor|4|||
170394086|NCT00650806|615780677|FG000|Overall Study|Other|1|||
170394087|NCT00650806|615780678|FG001|Overall Study|Other|1|||
170394088|NCT00650806|615780679|FG002|Overall Study|Other|2|||
170394089|NCT00650806|615780680|FG003|Overall Study|Other|0|||
170394090|NCT00530621|615780683|FG000|Overall Study|Adverse Event|11|||
170394091|NCT00530621|615780684|FG001|Overall Study|Adverse Event|8|||
170394092|NCT00530621|615780683|FG000|Overall Study|Physician Decision|2|||
170394093|NCT00530621|615780684|FG001|Overall Study|Physician Decision|4|||
170394094|NCT00530621|615780683|FG000|Overall Study|Progressive Disease (PD)|47|||
170394095|NCT00530621|615780684|FG001|Overall Study|Progressive Disease (PD)|40|||
170394096|NCT00530621|615780683|FG000|Overall Study|Sponsor Decision|12|||
170394097|NCT00530621|615780684|FG001|Overall Study|Sponsor Decision|15|||
170394098|NCT00530621|615780683|FG000|Overall Study|Subject Decision|4|||
170394099|NCT00530621|615780684|FG001|Overall Study|Subject Decision|7|||
170394100|NCT00530621|615780683|FG000|Overall Study|Death|3|||
170394101|NCT00530621|615780684|FG001|Overall Study|Death|6|||
170394102|NCT00530621|615780683|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
170394103|NCT00530621|615780684|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
170394104|NCT04456998|615780687|FG000|Overall Study|Adverse Event|0|||
170394105|NCT04456998|615780688|FG001|Overall Study|Adverse Event|4|||
170394106|NCT04456998|615780687|FG000|Overall Study|Protocol Deviation|0|||
170394107|NCT04456998|615780688|FG001|Overall Study|Protocol Deviation|1|||
170394108|NCT04456998|615780687|FG000|Overall Study|Withdrawal by Subject|0|||
170394109|NCT04456998|615780688|FG001|Overall Study|Withdrawal by Subject|1|||
170394110|NCT05455684|615780689|FG000|Overall Study|Withdrawal by Subject|7|||
170394111|NCT05455684|615780690|FG001|Overall Study|Withdrawal by Subject|4|||
170394112|NCT05455684|615780689|FG000|Overall Study|Lost to Follow-up|3|||
170394113|NCT05455684|615780690|FG001|Overall Study|Lost to Follow-up|3|||
170394114|NCT05455684|615780689|FG000|Overall Study|Adverse Event|2|||
170394115|NCT05455684|615780690|FG001|Overall Study|Adverse Event|3|||
170394116|NCT05455684|615780689|FG000|Overall Study|Protocol Violation|1|||
170394117|NCT05455684|615780690|FG001|Overall Study|Protocol Violation|1|||
170394118|NCT05455684|615780689|FG000|Overall Study|Non-Compliant with study drug|0|||
170394119|NCT05455684|615780690|FG001|Overall Study|Non-Compliant with study drug|1|||
170394120|NCT05455684|615780689|FG000|Overall Study|Other|1|||
170394121|NCT05455684|615780690|FG001|Overall Study|Other|2|||
170394122|NCT05455684|615780689|FG000|Overall Study|Randomized but not treated|1|||
170394123|NCT05455684|615780690|FG001|Overall Study|Randomized but not treated|0|||
170394124|NCT04411641|615780691|FG000|DB Period|Other|7|||
170394125|NCT04411641|615780692|FG001|DB Period|Other|27|||
170394126|NCT04411641|615780693|FG002|DB Period|Other|0|||
170394127|NCT04411641|615780694|FG003|DB Period|Other|0|||
170394128|NCT04411641|615780691|FG000|DB Period|Withdrawal by Subject|67|||
170394129|NCT04411641|615780692|FG001|DB Period|Withdrawal by Subject|122|||
170394130|NCT04411641|615780693|FG002|DB Period|Withdrawal by Subject|0|||
170394131|NCT04411641|615780694|FG003|DB Period|Withdrawal by Subject|0|||
170394132|NCT04411641|615780691|FG000|DB Period|Progressive disease|76|||
170394133|NCT04411641|615780692|FG001|DB Period|Progressive disease|116|||
170394134|NCT04411641|615780693|FG002|DB Period|Progressive disease|0|||
170394135|NCT04411641|615780694|FG003|DB Period|Progressive disease|0|||
170394136|NCT04411641|615780691|FG000|DB Period|Poor compliance to protocol|1|||
170394137|NCT04411641|615780692|FG001|DB Period|Poor compliance to protocol|5|||
170394138|NCT04411641|615780693|FG002|DB Period|Poor compliance to protocol|0|||
170394139|NCT04411641|615780694|FG003|DB Period|Poor compliance to protocol|0|||
170394140|NCT04411641|615780691|FG000|DB Period|Lack of Efficacy|19|||
170394141|NCT04411641|615780692|FG001|DB Period|Lack of Efficacy|19|||
170394142|NCT04411641|615780693|FG002|DB Period|Lack of Efficacy|0|||
170394143|NCT04411641|615780694|FG003|DB Period|Lack of Efficacy|0|||
170394144|NCT04411641|615780691|FG000|DB Period|Adverse Event|13|||
170394145|NCT04411641|615780692|FG001|DB Period|Adverse Event|29|||
170394146|NCT04411641|615780693|FG002|DB Period|Adverse Event|0|||
170394147|NCT04411641|615780694|FG003|DB Period|Adverse Event|0|||
170394148|NCT04411641|615780691|FG000|DB Period|Randomized and not treated|2|||
170394149|NCT04411641|615780692|FG001|DB Period|Randomized and not treated|2|||
170394150|NCT04411641|615780693|FG002|DB Period|Randomized and not treated|0|||
170394151|NCT04411641|615780694|FG003|DB Period|Randomized and not treated|0|||
170394152|NCT04411641|615780691|FG000|OL|Withdrawal by Subject|0|||
170394153|NCT04411641|615780692|FG001|OL|Withdrawal by Subject|0|||
170394154|NCT04411641|615780693|FG002|OL|Withdrawal by Subject|6|||
170394155|NCT04411641|615780694|FG003|OL|Withdrawal by Subject|17|||
170394156|NCT04411641|615780691|FG000|OL|Progressive disease|0|||
170394157|NCT04411641|615780692|FG001|OL|Progressive disease|0|||
170394158|NCT04411641|615780693|FG002|OL|Progressive disease|1|||
170394159|NCT04411641|615780694|FG003|OL|Progressive disease|2|||
170394160|NCT04411641|615780691|FG000|OL|Poor compliance to protocol|0|||
170394161|NCT04411641|615780692|FG001|OL|Poor compliance to protocol|0|||
170394162|NCT04411641|615780693|FG002|OL|Poor compliance to protocol|1|||
170394163|NCT04411641|615780694|FG003|OL|Poor compliance to protocol|0|||
170394164|NCT04411641|615780691|FG000|OL|Adverse Event|0|||
170394165|NCT04411641|615780692|FG001|OL|Adverse Event|0|||
170394166|NCT04411641|615780693|FG002|OL|Adverse Event|1|||
170394167|NCT04411641|615780694|FG003|OL|Adverse Event|0|||
170394168|NCT04411641|615780691|FG000|OL|Other|0|||
170394169|NCT04411641|615780692|FG001|OL|Other|0|||
170394170|NCT04411641|615780693|FG002|OL|Other|0|||
170394171|NCT04411641|615780694|FG003|OL|Other|6|||
170394172|NCT05643573|615780699|FG000|Overall Study|Adverse Event|117|||
170394173|NCT05643573|615780700|FG001|Overall Study|Adverse Event|90|||
170394174|NCT05643573|615780699|FG000|Overall Study|Death|53|||
170394175|NCT05643573|615780700|FG001|Overall Study|Death|57|||
170394176|NCT05643573|615780699|FG000|Overall Study|Lost to Follow-up|6|||
170394177|NCT05643573|615780700|FG001|Overall Study|Lost to Follow-up|3|||
170394178|NCT05643573|615780699|FG000|Overall Study|Other|18|||
170394179|NCT05643573|615780700|FG001|Overall Study|Other|15|||
170394180|NCT05643573|615780699|FG000|Overall Study|Outcome event|64|||
170394181|NCT05643573|615780700|FG001|Overall Study|Outcome event|36|||
170394182|NCT05643573|615780699|FG000|Overall Study|Physician Decision|33|||
170394183|NCT05643573|615780700|FG001|Overall Study|Physician Decision|19|||
170394184|NCT05643573|615780699|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
170394185|NCT05643573|615780700|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
170394186|NCT05643573|615780699|FG000|Overall Study|Site terminated by sponsor|10|||
170394187|NCT05643573|615780700|FG001|Overall Study|Site terminated by sponsor|10|||
170394188|NCT05643573|615780699|FG000|Overall Study|Study terminated by sponsor|1|||
170394189|NCT05643573|615780700|FG001|Overall Study|Study terminated by sponsor|0|||
170394190|NCT05643573|615780699|FG000|Overall Study|Withdrawal by Subject|178|||
170394191|NCT05643573|615780700|FG001|Overall Study|Withdrawal by Subject|130|||
170394192|NCT02268214|615780706|FG000|Overall Study|Subject no longer meets study criteria|0|||
170394193|NCT02268214|615780707|FG001|Overall Study|Subject no longer meets study criteria|2|||
170394194|NCT02268214|615780708|FG002|Overall Study|Subject no longer meets study criteria|0|||
170394195|NCT02268214|615780706|FG000|Overall Study|Pregnancy|2|||
170394196|NCT02268214|615780707|FG001|Overall Study|Pregnancy|2|||
170394197|NCT02268214|615780708|FG002|Overall Study|Pregnancy|1|||
170394198|NCT02268214|615780706|FG000|Overall Study|Lost to Follow-up|3|||
170394199|NCT02268214|615780707|FG001|Overall Study|Lost to Follow-up|3|||
170394200|NCT02268214|615780708|FG002|Overall Study|Lost to Follow-up|4|||
170394201|NCT02268214|615780706|FG000|Overall Study|Lack of Efficacy|1|||
170394202|NCT02268214|615780707|FG001|Overall Study|Lack of Efficacy|0|||
170394203|NCT02268214|615780708|FG002|Overall Study|Lack of Efficacy|2|||
170394204|NCT02268214|615780706|FG000|Overall Study|Adverse Event|11|||
170394205|NCT02268214|615780707|FG001|Overall Study|Adverse Event|14|||
170394206|NCT02268214|615780708|FG002|Overall Study|Adverse Event|9|||
170394207|NCT02268214|615780706|FG000|Overall Study|Withdrawal by Subject|4|||
170394208|NCT02268214|615780707|FG001|Overall Study|Withdrawal by Subject|5|||
170394209|NCT02268214|615780708|FG002|Overall Study|Withdrawal by Subject|10|||
170394210|NCT02268214|615780706|FG000|Overall Study|Subject request to discontinue treatment|10|||
170394211|NCT02268214|615780707|FG001|Overall Study|Subject request to discontinue treatment|8|||
170394212|NCT02268214|615780708|FG002|Overall Study|Subject request to discontinue treatment|6|||
170394213|NCT02268214|615780706|FG000|Overall Study|Poor/non-compliance|2|||
170394214|NCT02268214|615780707|FG001|Overall Study|Poor/non-compliance|1|||
170394215|NCT02268214|615780708|FG002|Overall Study|Poor/non-compliance|2|||
170394216|NCT02268214|615780706|FG000|Overall Study|Other reasons|7|||
170394217|NCT02268214|615780707|FG001|Overall Study|Other reasons|3|||
170394218|NCT02268214|615780708|FG002|Overall Study|Other reasons|3|||
170394219|NCT02268214|615780706|FG000|Overall Study|Not entering long-term period|2|||
170394220|NCT02268214|615780707|FG001|Overall Study|Not entering long-term period|3|||
170394221|NCT02268214|615780708|FG002|Overall Study|Not entering long-term period|5|||
170394222|NCT04342390|615780709|FG000|Overall Study|Lost to Follow-up|3|||
170394223|NCT04342390|615780710|FG001|Overall Study|Lost to Follow-up|0|||
170394224|NCT02951130|615780711|FG000|Overall Study|Protocol Violation|1|||
170394225|NCT02951130|615780712|FG001|Overall Study|Protocol Violation|1|||
170394226|NCT02500732|615780724|FG000|Overall Study|Physician Decision|0|||
170394227|NCT02500732|615780725|FG001|Overall Study|Physician Decision|1|||
170394228|NCT01869959|615780726|FG000|Randomization Period|Physician Decision|0|||
170394229|NCT01869959|615780727|FG001|Randomization Period|Physician Decision|0|||
170394230|NCT01869959|615780728|FG002|Randomization Period|Physician Decision|0|||
170394231|NCT01869959|615780729|FG003|Randomization Period|Physician Decision|0|||
170394232|NCT01869959|615780730|FG004|Randomization Period|Physician Decision|1|||
170394233|NCT01869959|615780726|FG000|Treatment Period|Adverse Event|1|||
170394234|NCT01869959|615780727|FG001|Treatment Period|Adverse Event|0|||
170394235|NCT01869959|615780728|FG002|Treatment Period|Adverse Event|3|||
170394236|NCT01869959|615780729|FG003|Treatment Period|Adverse Event|1|||
170394237|NCT01869959|615780730|FG004|Treatment Period|Adverse Event|0|||
170394238|NCT01869959|615780726|FG000|Treatment Period|Sponsor decision|0|||
170394239|NCT01869959|615780727|FG001|Treatment Period|Sponsor decision|1|||
170394240|NCT01869959|615780728|FG002|Treatment Period|Sponsor decision|0|||
170394241|NCT01869959|615780729|FG003|Treatment Period|Sponsor decision|1|||
170394242|NCT01869959|615780730|FG004|Treatment Period|Sponsor decision|0|||
170394243|NCT01869959|615780726|FG000|Treatment Period|Withdrawal by Subject|0|||
170394244|NCT01869959|615780727|FG001|Treatment Period|Withdrawal by Subject|1|||
170394245|NCT01869959|615780728|FG002|Treatment Period|Withdrawal by Subject|0|||
170394246|NCT01869959|615780729|FG003|Treatment Period|Withdrawal by Subject|0|||
170394247|NCT01869959|615780730|FG004|Treatment Period|Withdrawal by Subject|0|||
170394248|NCT01808508|615782852|FG000|Overall Study|Lost to Follow-up|1|||
170394249|NCT01808508|615782853|FG001|Overall Study|Lost to Follow-up|0|||
170394250|NCT01808508|615782854|FG002|Overall Study|Lost to Follow-up|0|||
170394251|NCT03862807|615782855|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
170394252|NCT01389024|615782856|FG000|Overall Study|Withdrawal by Subject|0|||
170394253|NCT01389024|615782857|FG001|Overall Study|Withdrawal by Subject|1|||
170394254|NCT01389024|615782856|FG000|Overall Study|Lost to Follow-up|1|||
170394255|NCT01389024|615782857|FG001|Overall Study|Lost to Follow-up|0|||
170394256|NCT01005680|615782860|FG000|Overall Study|Lost to Follow-up|4|||
170394257|NCT01005680|615782861|FG001|Overall Study|Lost to Follow-up|6|||
170394258|NCT01005680|615782860|FG000|Overall Study|Withdrawal by Subject|1|||
170394259|NCT01005680|615782861|FG001|Overall Study|Withdrawal by Subject|4|||
170394260|NCT01005680|615782860|FG000|Overall Study|Physician Decision|1|||
170394261|NCT01005680|615782861|FG001|Overall Study|Physician Decision|1|||
170394262|NCT00297882|615782865|FG000|Day 14|Lack of Efficacy|12|||
170394263|NCT00297882|615782866|FG001|Day 14|Lack of Efficacy|49|||
170394264|NCT00297882|615782865|FG000|Day 28|Lost to Follow-up|13|||
170394265|NCT00297882|615782866|FG001|Day 28|Lost to Follow-up|23|||
170394266|NCT00297882|615782865|FG000|Day 28|Lack of Efficacy|3|||
170394267|NCT00297882|615782866|FG001|Day 28|Lack of Efficacy|0|||
170394268|NCT02118896|615782867|FG000|Overall Study|Death|4|||
170394269|NCT02118896|615782868|FG001|Overall Study|Death|0|||
170394270|NCT02118896|615782869|FG002|Overall Study|Death|4|||
170394271|NCT02118896|615782870|FG003|Overall Study|Death|6|||
170394272|NCT02118896|615782871|FG004|Overall Study|Death|3|||
170394273|NCT02118896|615782872|FG005|Overall Study|Death|1|||
170394274|NCT02118896|615782873|FG006|Overall Study|Death|0|||
170394275|NCT02118896|615782874|FG007|Overall Study|Death|0|||
170394276|NCT02118896|615782875|FG008|Overall Study|Death|0|||
170394277|NCT02118896|615782876|FG009|Overall Study|Death|0|||
170394278|NCT02118896|615782867|FG000|Overall Study|Adverse Event|5|||
170394279|NCT02118896|615782868|FG001|Overall Study|Adverse Event|4|||
170394280|NCT02118896|615782869|FG002|Overall Study|Adverse Event|4|||
170394281|NCT02118896|615782870|FG003|Overall Study|Adverse Event|5|||
170394282|NCT02118896|615782871|FG004|Overall Study|Adverse Event|5|||
170394283|NCT02118896|615782872|FG005|Overall Study|Adverse Event|9|||
170394284|NCT02118896|615782873|FG006|Overall Study|Adverse Event|1|||
170394285|NCT02118896|615782874|FG007|Overall Study|Adverse Event|1|||
170394286|NCT02118896|615782875|FG008|Overall Study|Adverse Event|4|||
170394287|NCT02118896|615782876|FG009|Overall Study|Adverse Event|0|||
170394288|NCT02118896|615782867|FG000|Overall Study|Consent withdrawn|2|||
170394289|NCT02118896|615782868|FG001|Overall Study|Consent withdrawn|0|||
170394290|NCT02118896|615782869|FG002|Overall Study|Consent withdrawn|3|||
170394291|NCT02118896|615782870|FG003|Overall Study|Consent withdrawn|4|||
170394292|NCT02118896|615782871|FG004|Overall Study|Consent withdrawn|1|||
170394293|NCT02118896|615782872|FG005|Overall Study|Consent withdrawn|4|||
170394294|NCT02118896|615782873|FG006|Overall Study|Consent withdrawn|0|||
170394295|NCT02118896|615782874|FG007|Overall Study|Consent withdrawn|0|||
170394296|NCT02118896|615782875|FG008|Overall Study|Consent withdrawn|0|||
170394297|NCT02118896|615782876|FG009|Overall Study|Consent withdrawn|0|||
170394298|NCT02118896|615782867|FG000|Overall Study|Non-compliance|2|||
170394299|NCT02118896|615782868|FG001|Overall Study|Non-compliance|1|||
170394300|NCT02118896|615782869|FG002|Overall Study|Non-compliance|1|||
170394301|NCT02118896|615782870|FG003|Overall Study|Non-compliance|5|||
170394302|NCT02118896|615782871|FG004|Overall Study|Non-compliance|0|||
170394303|NCT02118896|615782872|FG005|Overall Study|Non-compliance|1|||
170394304|NCT02118896|615782873|FG006|Overall Study|Non-compliance|0|||
170394305|NCT02118896|615782874|FG007|Overall Study|Non-compliance|1|||
170394306|NCT02118896|615782875|FG008|Overall Study|Non-compliance|0|||
170394307|NCT02118896|615782876|FG009|Overall Study|Non-compliance|0|||
170394308|NCT02118896|615782867|FG000|Overall Study|Pregnancy|1|||
170394309|NCT02118896|615782868|FG001|Overall Study|Pregnancy|1|||
170394310|NCT02118896|615782869|FG002|Overall Study|Pregnancy|0|||
170394311|NCT02118896|615782870|FG003|Overall Study|Pregnancy|0|||
170394312|NCT02118896|615782871|FG004|Overall Study|Pregnancy|1|||
170394313|NCT02118896|615782872|FG005|Overall Study|Pregnancy|3|||
170394314|NCT02118896|615782873|FG006|Overall Study|Pregnancy|1|||
170394315|NCT02118896|615782874|FG007|Overall Study|Pregnancy|0|||
170394316|NCT02118896|615782875|FG008|Overall Study|Pregnancy|0|||
170394317|NCT02118896|615782876|FG009|Overall Study|Pregnancy|0|||
170394318|NCT02118896|615782867|FG000|Overall Study|Lost to Follow-up|1|||
170394319|NCT02118896|615782868|FG001|Overall Study|Lost to Follow-up|2|||
170394320|NCT02118896|615782869|FG002|Overall Study|Lost to Follow-up|1|||
170394321|NCT02118896|615782870|FG003|Overall Study|Lost to Follow-up|0|||
170394322|NCT02118896|615782871|FG004|Overall Study|Lost to Follow-up|2|||
170394323|NCT02118896|615782872|FG005|Overall Study|Lost to Follow-up|1|||
170394324|NCT02118896|615782873|FG006|Overall Study|Lost to Follow-up|0|||
170394325|NCT02118896|615782874|FG007|Overall Study|Lost to Follow-up|0|||
170394326|NCT02118896|615782875|FG008|Overall Study|Lost to Follow-up|0|||
170394327|NCT02118896|615782876|FG009|Overall Study|Lost to Follow-up|0|||
170394328|NCT02118896|615782867|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
170394329|NCT02118896|615782868|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
170394330|NCT02118896|615782869|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
170394331|NCT02118896|615782870|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
170394332|NCT02118896|615782871|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
170394333|NCT02118896|615782872|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
170394334|NCT02118896|615782873|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
170394335|NCT02118896|615782874|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
170394336|NCT02118896|615782875|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
170394337|NCT02118896|615782876|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
170394338|NCT02118896|615782867|FG000|Overall Study|Prohibited medication|0|||
170394339|NCT02118896|615782868|FG001|Overall Study|Prohibited medication|0|||
170394340|NCT02118896|615782869|FG002|Overall Study|Prohibited medication|0|||
170394341|NCT02118896|615782870|FG003|Overall Study|Prohibited medication|0|||
170394342|NCT02118896|615782871|FG004|Overall Study|Prohibited medication|1|||
170394343|NCT02118896|615782872|FG005|Overall Study|Prohibited medication|3|||
170394344|NCT02118896|615782873|FG006|Overall Study|Prohibited medication|0|||
170394345|NCT02118896|615782874|FG007|Overall Study|Prohibited medication|0|||
170394346|NCT02118896|615782875|FG008|Overall Study|Prohibited medication|0|||
170394347|NCT02118896|615782876|FG009|Overall Study|Prohibited medication|0|||
170394348|NCT02118896|615782867|FG000|Overall Study|Miscellaneous|1|||
170394349|NCT02118896|615782868|FG001|Overall Study|Miscellaneous|2|||
170394350|NCT02118896|615782869|FG002|Overall Study|Miscellaneous|0|||
170394351|NCT02118896|615782870|FG003|Overall Study|Miscellaneous|2|||
170394352|NCT02118896|615782871|FG004|Overall Study|Miscellaneous|0|||
170394353|NCT02118896|615782872|FG005|Overall Study|Miscellaneous|4|||
170394354|NCT02118896|615782873|FG006|Overall Study|Miscellaneous|0|||
170394355|NCT02118896|615782874|FG007|Overall Study|Miscellaneous|0|||
170394356|NCT02118896|615782875|FG008|Overall Study|Miscellaneous|0|||
170394357|NCT02118896|615782876|FG009|Overall Study|Miscellaneous|0|||
170394358|NCT04242264|615782878|FG000|Overall Study|Lost to Follow-up|2|||
170394359|NCT04242264|615782879|FG001|Overall Study|Lost to Follow-up|2|||
170394360|NCT04242264|615782880|FG002|Overall Study|Lost to Follow-up|1|||
170394361|NCT04242264|615782881|FG003|Overall Study|Lost to Follow-up|1|||
170394362|NCT04242264|615782878|FG000|Overall Study|Withdrawal by Subject|1|||
170394363|NCT04242264|615782879|FG001|Overall Study|Withdrawal by Subject|0|||
170394364|NCT04242264|615782880|FG002|Overall Study|Withdrawal by Subject|0|||
170394365|NCT04242264|615782881|FG003|Overall Study|Withdrawal by Subject|0|||
170394366|NCT01317199|615782882|FG000|Dose-escalation Phase 1|Physician Decision|5|||
170394367|NCT01317199|615782883|FG001|Dose-escalation Phase 1|Physician Decision|0|||
170394368|NCT01317199|615782884|FG002|Dose-escalation Phase 1|Physician Decision|0|||
170394369|NCT01317199|615782885|FG003|Dose-escalation Phase 1|Physician Decision|0|||
170394370|NCT01317199|615782882|FG000|Dose-escalation Phase 1|Disease progression|1|||
170394371|NCT01317199|615782883|FG001|Dose-escalation Phase 1|Disease progression|0|||
170394372|NCT01317199|615782884|FG002|Dose-escalation Phase 1|Disease progression|0|||
170394373|NCT01317199|615782885|FG003|Dose-escalation Phase 1|Disease progression|0|||
170394374|NCT01317199|615782882|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
170394375|NCT01317199|615782883|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
170394376|NCT01317199|615782884|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
170394377|NCT01317199|615782885|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
170394378|NCT01317199|615782882|FG000|Randomized Phase 2|Disease progression|0|||
170394379|NCT01317199|615782883|FG001|Randomized Phase 2|Disease progression|3|||
170394380|NCT01317199|615782884|FG002|Randomized Phase 2|Disease progression|7|||
170394381|NCT01317199|615782885|FG003|Randomized Phase 2|Disease progression|5|||
170394382|NCT01317199|615782882|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
170394383|NCT01317199|615782883|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
170394384|NCT01317199|615782884|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
170394385|NCT01317199|615782885|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
170394386|NCT01317199|615782882|FG000|Randomized Phase 2|Adverse Event|0|||
170394387|NCT01317199|615782883|FG001|Randomized Phase 2|Adverse Event|0|||
170394388|NCT01317199|615782884|FG002|Randomized Phase 2|Adverse Event|0|||
170394389|NCT01317199|615782885|FG003|Randomized Phase 2|Adverse Event|1|||
170394390|NCT01317199|615782882|FG000|Randomized Phase 2|Comorbidities|0|||
170394391|NCT01317199|615782883|FG001|Randomized Phase 2|Comorbidities|2|||
170394392|NCT01317199|615782884|FG002|Randomized Phase 2|Comorbidities|2|||
170394393|NCT01317199|615782885|FG003|Randomized Phase 2|Comorbidities|2|||
170394394|NCT01317199|615782882|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
170394395|NCT01317199|615782883|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
170394396|NCT01317199|615782884|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
170394397|NCT01317199|615782885|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
170394398|NCT01317199|615782882|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
170394399|NCT01317199|615782883|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
170394400|NCT01317199|615782884|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
170394401|NCT01317199|615782885|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
170394402|NCT01317199|615782882|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
170394403|NCT01317199|615782883|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
170394404|NCT01317199|615782884|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
170394405|NCT01317199|615782885|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
170394406|NCT01317199|615782882|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
170394407|NCT01317199|615782883|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
170394408|NCT01317199|615782884|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
170394409|NCT01317199|615782885|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
170394410|NCT04221373|615782892|FG000|Overall Study|Physician Decision|4|||
170394411|NCT04221373|615782893|FG001|Overall Study|Physician Decision|0|||
170394412|NCT00627094|615782899|FG000|Overall Study|Adverse Event|8|||
170394413|NCT00627094|615782900|FG001|Overall Study|Adverse Event|7|||
170394414|NCT00627094|615782899|FG000|Overall Study|Lost to Follow-up|1|||
170394415|NCT00627094|615782900|FG001|Overall Study|Lost to Follow-up|0|||
170394416|NCT00627094|615782899|FG000|Overall Study|Withdrawal by Subject|1|||
170394417|NCT00627094|615782900|FG001|Overall Study|Withdrawal by Subject|1|||
170394418|NCT00627094|615782899|FG000|Overall Study|ulcer healed|1|||
170394419|NCT00627094|615782900|FG001|Overall Study|ulcer healed|7|||
170394420|NCT00627094|615782899|FG000|Overall Study|Other reason|1|||
170394421|NCT00627094|615782900|FG001|Overall Study|Other reason|0|||
170394422|NCT00183170|615782901|FG000|First Intervention|Did not complete study|1|||
170394423|NCT00183170|615782902|FG001|First Intervention|Did not complete study|0|||
170394424|NCT00183170|615782901|FG000|First Intervention|Did not meet targeted BrAC|1|||
170394425|NCT00183170|615782902|FG001|First Intervention|Did not meet targeted BrAC|0|||
170394426|NCT00183170|615782901|FG000|Washout 1 Week|Did not complete study|6|||
170394427|NCT00183170|615782902|FG001|Washout 1 Week|Did not complete study|8|||
170394428|NCT00183170|615782901|FG000|Second Intervention|Did not complete study|1|||
170394429|NCT00183170|615782902|FG001|Second Intervention|Did not complete study|0|||
170394430|NCT00183170|615782901|FG000|Second Intervention|Did not meet targeted BrAC|0|||
170394431|NCT00183170|615782902|FG001|Second Intervention|Did not meet targeted BrAC|2|||
170394432|NCT01165424|615782903|FG000|Overall Study|Clinical adverse experiences|1|||
170394433|NCT01165424|615782903|FG000|Overall Study|Laboratory adverse experiences|1|||
170394434|NCT01165424|615782903|FG000|Overall Study|Did not meet entry criteria|1|||
170394435|NCT01165424|615782903|FG000|Overall Study|Participant moved (relocated)|1|||
170394436|NCT00577031|615782906|FG000|Overall Study|Adverse Event|52|||
170394437|NCT00577031|615782906|FG000|Overall Study|Progression of disease|93|||
170394438|NCT00577031|615782906|FG000|Overall Study|Protocol Violation|5|||
170394439|NCT00577031|615782906|FG000|Overall Study|Participant withdrew consent|13|||
170394440|NCT00577031|615782906|FG000|Overall Study|Participant non-compliance|5|||
170394441|NCT00577031|615782906|FG000|Overall Study|Need for surgery|17|||
170394442|NCT00577031|615782906|FG000|Overall Study|Medical decision|14|||
170394443|NCT00577031|615782906|FG000|Overall Study|Death|6|||
170394444|NCT00538473|615782907|FG000|Overall Study|Adverse Event|1|||
170394445|NCT00538473|615782908|FG001|Overall Study|Adverse Event|0|||
170394446|NCT01102972|615782909|FG000|Overall Study|Adverse Event|8|||
170394447|NCT01102972|615782910|FG001|Overall Study|Adverse Event|2|||
170394448|NCT01102972|615782909|FG000|Overall Study|Lack of Efficacy|2|||
170394449|NCT01102972|615782910|FG001|Overall Study|Lack of Efficacy|1|||
170394450|NCT01102972|615782909|FG000|Overall Study|Protocol Violation|1|||
170394451|NCT01102972|615782910|FG001|Overall Study|Protocol Violation|0|||
170394452|NCT01102972|615782909|FG000|Overall Study|Lost to Follow-up|10|||
170394453|NCT01102972|615782910|FG001|Overall Study|Lost to Follow-up|5|||
170394454|NCT01102972|615782909|FG000|Overall Study|Investigator Discretion|2|||
170394455|NCT01102972|615782910|FG001|Overall Study|Investigator Discretion|0|||
170394456|NCT01102972|615782909|FG000|Overall Study|Withdrawal by Subject|6|||
170394457|NCT01102972|615782910|FG001|Overall Study|Withdrawal by Subject|6|||
170394458|NCT03664024|615782914|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
170394459|NCT03664024|615782914|FG000|Overall Study|Lost to Follow-up|2|||
170394460|NCT03664024|615782914|FG000|Overall Study|Withdrawal by Subject|2|||
170394461|NCT03664024|615782914|FG000|Overall Study|Death|80|||
170394462|NCT01157065|615782915|FG000|Overall Study|Death|0|||
170394463|NCT01157065|615782916|FG001|Overall Study|Death|1|||
170394464|NCT05275673|615782921|FG000|Overall Study|Study Termination by Sponsor|2|||
170394465|NCT05275673|615782922|FG001|Overall Study|Study Termination by Sponsor|3|||
170394466|NCT05275673|615782921|FG000|Overall Study|Death|1|||
170394467|NCT05275673|615782922|FG001|Overall Study|Death|0|||
170394468|NCT05275673|615782921|FG000|Overall Study|Withdrawal by Subject|1|||
170394469|NCT05275673|615782922|FG001|Overall Study|Withdrawal by Subject|0|||
170394470|NCT02060188|615782923|FG000|Overall Study|Disease Progression|36|||
170394471|NCT02060188|615782924|FG001|Overall Study|Disease Progression|42|||
170394472|NCT02060188|615782925|FG002|Overall Study|Disease Progression|8|||
170394473|NCT02060188|615782926|FG003|Overall Study|Disease Progression|5|||
170394474|NCT02060188|615782927|FG004|Overall Study|Disease Progression|6|||
170394475|NCT02060188|615782928|FG005|Overall Study|Disease Progression|3|||
170394476|NCT02060188|615782929|FG006|Overall Study|Disease Progression|23|||
170394477|NCT02060188|615782930|FG007|Overall Study|Disease Progression|20|||
170394478|NCT02060188|615782931|FG008|Overall Study|Disease Progression|43|||
170394479|NCT02060188|615782923|FG000|Overall Study|Study Drug Toxicity|10|||
170394480|NCT02060188|615782924|FG001|Overall Study|Study Drug Toxicity|18|||
170394481|NCT02060188|615782925|FG002|Overall Study|Study Drug Toxicity|7|||
170394482|NCT02060188|615782926|FG003|Overall Study|Study Drug Toxicity|4|||
170394483|NCT02060188|615782927|FG004|Overall Study|Study Drug Toxicity|3|||
170394484|NCT02060188|615782928|FG005|Overall Study|Study Drug Toxicity|0|||
170394485|NCT02060188|615782929|FG006|Overall Study|Study Drug Toxicity|2|||
170394486|NCT02060188|615782930|FG007|Overall Study|Study Drug Toxicity|5|||
170394487|NCT02060188|615782931|FG008|Overall Study|Study Drug Toxicity|0|||
170394488|NCT02060188|615782923|FG000|Overall Study|Adverse event unrelated to study drug|2|||
170394489|NCT02060188|615782924|FG001|Overall Study|Adverse event unrelated to study drug|5|||
170394490|NCT02060188|615782925|FG002|Overall Study|Adverse event unrelated to study drug|6|||
170398868|NCT05004181|615798320|FG008|Overall Study|Death|2|||
170394491|NCT02060188|615782926|FG003|Overall Study|Adverse event unrelated to study drug|0|||
170394492|NCT02060188|615782927|FG004|Overall Study|Adverse event unrelated to study drug|1|||
170394493|NCT02060188|615782928|FG005|Overall Study|Adverse event unrelated to study drug|0|||
170394494|NCT02060188|615782929|FG006|Overall Study|Adverse event unrelated to study drug|4|||
170394495|NCT02060188|615782930|FG007|Overall Study|Adverse event unrelated to study drug|4|||
170394496|NCT02060188|615782931|FG008|Overall Study|Adverse event unrelated to study drug|1|||
170394497|NCT02060188|615782923|FG000|Overall Study|Participant request to discontinue study treatment|7|||
170394498|NCT02060188|615782924|FG001|Overall Study|Participant request to discontinue study treatment|7|||
170394499|NCT02060188|615782925|FG002|Overall Study|Participant request to discontinue study treatment|4|||
170394500|NCT02060188|615782926|FG003|Overall Study|Participant request to discontinue study treatment|0|||
170394501|NCT02060188|615782927|FG004|Overall Study|Participant request to discontinue study treatment|0|||
170394502|NCT02060188|615782928|FG005|Overall Study|Participant request to discontinue study treatment|0|||
170394503|NCT02060188|615782929|FG006|Overall Study|Participant request to discontinue study treatment|1|||
170394504|NCT02060188|615782930|FG007|Overall Study|Participant request to discontinue study treatment|1|||
170394505|NCT02060188|615782931|FG008|Overall Study|Participant request to discontinue study treatment|0|||
170394506|NCT02060188|615782923|FG000|Overall Study|Participant withdrew consent|3|||
170394507|NCT02060188|615782924|FG001|Overall Study|Participant withdrew consent|0|||
170394508|NCT02060188|615782925|FG002|Overall Study|Participant withdrew consent|0|||
170394509|NCT02060188|615782926|FG003|Overall Study|Participant withdrew consent|0|||
170394510|NCT02060188|615782927|FG004|Overall Study|Participant withdrew consent|0|||
170394511|NCT02060188|615782928|FG005|Overall Study|Participant withdrew consent|0|||
170394512|NCT02060188|615782929|FG006|Overall Study|Participant withdrew consent|0|||
170394513|NCT02060188|615782930|FG007|Overall Study|Participant withdrew consent|0|||
170394514|NCT02060188|615782931|FG008|Overall Study|Participant withdrew consent|0|||
170394515|NCT02060188|615782923|FG000|Overall Study|Maximum clinical benefit|13|||
170394516|NCT02060188|615782924|FG001|Overall Study|Maximum clinical benefit|38|||
170394517|NCT02060188|615782925|FG002|Overall Study|Maximum clinical benefit|19|||
170394518|NCT02060188|615782926|FG003|Overall Study|Maximum clinical benefit|0|||
170394519|NCT02060188|615782927|FG004|Overall Study|Maximum clinical benefit|0|||
170394520|NCT02060188|615782928|FG005|Overall Study|Maximum clinical benefit|0|||
170394521|NCT02060188|615782929|FG006|Overall Study|Maximum clinical benefit|0|||
170394522|NCT02060188|615782930|FG007|Overall Study|Maximum clinical benefit|10|||
170394523|NCT02060188|615782931|FG008|Overall Study|Maximum clinical benefit|0|||
170394524|NCT02060188|615782923|FG000|Overall Study|Other reason|3|||
170394525|NCT02060188|615782924|FG001|Overall Study|Other reason|7|||
170394526|NCT02060188|615782925|FG002|Overall Study|Other reason|0|||
170394527|NCT02060188|615782926|FG003|Overall Study|Other reason|1|||
170394528|NCT02060188|615782927|FG004|Overall Study|Other reason|0|||
170394529|NCT02060188|615782928|FG005|Overall Study|Other reason|0|||
170394530|NCT02060188|615782929|FG006|Overall Study|Other reason|0|||
170394531|NCT02060188|615782930|FG007|Overall Study|Other reason|9|||
170394532|NCT02060188|615782931|FG008|Overall Study|Other reason|0|||
170394533|NCT02060188|615782923|FG000|Overall Study|Death|0|||
170394534|NCT02060188|615782924|FG001|Overall Study|Death|1|||
170394535|NCT02060188|615782925|FG002|Overall Study|Death|0|||
170394536|NCT02060188|615782926|FG003|Overall Study|Death|0|||
170394537|NCT02060188|615782927|FG004|Overall Study|Death|0|||
170394538|NCT02060188|615782928|FG005|Overall Study|Death|0|||
170394539|NCT02060188|615782929|FG006|Overall Study|Death|0|||
170394540|NCT02060188|615782930|FG007|Overall Study|Death|1|||
170394541|NCT02060188|615782931|FG008|Overall Study|Death|0|||
170394542|NCT02060188|615782923|FG000|Overall Study|Administrative reasons by sponsor|0|||
170394543|NCT02060188|615782924|FG001|Overall Study|Administrative reasons by sponsor|1|||
170394544|NCT02060188|615782925|FG002|Overall Study|Administrative reasons by sponsor|0|||
170394545|NCT02060188|615782926|FG003|Overall Study|Administrative reasons by sponsor|0|||
170394546|NCT02060188|615782927|FG004|Overall Study|Administrative reasons by sponsor|0|||
170394547|NCT02060188|615782928|FG005|Overall Study|Administrative reasons by sponsor|0|||
170394548|NCT02060188|615782929|FG006|Overall Study|Administrative reasons by sponsor|0|||
170394549|NCT02060188|615782930|FG007|Overall Study|Administrative reasons by sponsor|0|||
170394550|NCT02060188|615782931|FG008|Overall Study|Administrative reasons by sponsor|0|||
170394551|NCT02060188|615782923|FG000|Overall Study|Lost to Follow-up|0|||
170394552|NCT02060188|615782924|FG001|Overall Study|Lost to Follow-up|0|||
170394553|NCT02060188|615782925|FG002|Overall Study|Lost to Follow-up|1|||
170394554|NCT02060188|615782926|FG003|Overall Study|Lost to Follow-up|0|||
170394555|NCT02060188|615782927|FG004|Overall Study|Lost to Follow-up|0|||
170394556|NCT02060188|615782928|FG005|Overall Study|Lost to Follow-up|0|||
170394557|NCT02060188|615782929|FG006|Overall Study|Lost to Follow-up|0|||
170394558|NCT02060188|615782930|FG007|Overall Study|Lost to Follow-up|0|||
170394559|NCT02060188|615782931|FG008|Overall Study|Lost to Follow-up|0|||
170394560|NCT03426995|615782932|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394561|NCT03426995|615782933|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394562|NCT03426995|615782934|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
170398869|NCT05004181|615798321|FG009|Overall Study|Death|0|||
170394563|NCT03426995|615782935|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394564|NCT03426995|615782936|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394565|NCT03426995|615782937|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394566|NCT03426995|615782938|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394567|NCT03426995|615782939|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394568|NCT03426995|615782940|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394569|NCT03426995|615782941|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394570|NCT03426995|615782942|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394571|NCT03426995|615782943|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394572|NCT03426995|615782944|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394573|NCT03426995|615782945|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394574|NCT03426995|615782946|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394575|NCT03426995|615782947|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394576|NCT03426995|615782948|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394577|NCT03426995|615782949|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394578|NCT03426995|615782950|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
170394579|NCT03426995|615782932|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394580|NCT03426995|615782933|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394581|NCT03426995|615782934|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394582|NCT03426995|615782935|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394583|NCT03426995|615782936|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394584|NCT03426995|615782937|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
170394585|NCT03426995|615782938|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394586|NCT03426995|615782939|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394587|NCT03426995|615782940|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394588|NCT03426995|615782941|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394589|NCT03426995|615782942|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394590|NCT03426995|615782943|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394591|NCT03426995|615782944|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394592|NCT03426995|615782945|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394593|NCT03426995|615782946|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394594|NCT03426995|615782947|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394595|NCT03426995|615782948|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394596|NCT03426995|615782949|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394597|NCT03426995|615782950|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
170394598|NCT03426995|615782932|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394599|NCT03426995|615782933|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394600|NCT03426995|615782934|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394601|NCT03426995|615782935|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394602|NCT03426995|615782936|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
170394603|NCT03426995|615782937|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
170394604|NCT03426995|615782938|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394605|NCT03426995|615782939|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394606|NCT03426995|615782940|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394607|NCT03426995|615782941|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394608|NCT03426995|615782942|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394609|NCT03426995|615782943|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394610|NCT03426995|615782944|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394611|NCT03426995|615782945|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394612|NCT03426995|615782946|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394613|NCT03426995|615782947|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394614|NCT03426995|615782948|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394615|NCT03426995|615782949|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394616|NCT03426995|615782950|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
170394617|NCT03426995|615782932|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394618|NCT03426995|615782933|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394619|NCT03426995|615782934|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394620|NCT03426995|615782935|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394621|NCT03426995|615782936|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394622|NCT03426995|615782937|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394623|NCT03426995|615782938|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394624|NCT03426995|615782939|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394625|NCT03426995|615782940|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394626|NCT03426995|615782941|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394627|NCT03426995|615782942|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
170394628|NCT03426995|615782943|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394629|NCT03426995|615782944|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394630|NCT03426995|615782945|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394631|NCT03426995|615782946|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394632|NCT03426995|615782947|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394633|NCT03426995|615782948|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394634|NCT03426995|615782949|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394635|NCT03426995|615782950|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
170394636|NCT03426995|615782932|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394637|NCT03426995|615782933|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394638|NCT03426995|615782934|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394639|NCT03426995|615782935|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394640|NCT03426995|615782936|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394641|NCT03426995|615782937|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394642|NCT03426995|615782938|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394643|NCT03426995|615782939|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
170394644|NCT03426995|615782940|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394645|NCT03426995|615782941|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394646|NCT03426995|615782942|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394647|NCT03426995|615782943|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394648|NCT03426995|615782944|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394649|NCT03426995|615782945|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394650|NCT03426995|615782946|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394651|NCT03426995|615782947|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394652|NCT03426995|615782948|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394653|NCT03426995|615782949|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394654|NCT03426995|615782950|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
170394655|NCT03426995|615782932|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394656|NCT03426995|615782933|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394657|NCT03426995|615782934|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394658|NCT03426995|615782935|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394659|NCT03426995|615782936|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394660|NCT03426995|615782937|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394661|NCT03426995|615782938|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394662|NCT03426995|615782939|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394663|NCT03426995|615782940|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394664|NCT03426995|615782941|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394665|NCT03426995|615782942|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394666|NCT03426995|615782943|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394667|NCT03426995|615782944|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394668|NCT03426995|615782945|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394669|NCT03426995|615782946|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
170394670|NCT03426995|615782947|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
170394671|NCT03426995|615782948|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394672|NCT03426995|615782949|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394673|NCT03426995|615782950|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
170394674|NCT03426995|615782932|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394675|NCT03426995|615782933|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394676|NCT03426995|615782934|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394677|NCT03426995|615782935|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394678|NCT03426995|615782936|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394679|NCT03426995|615782937|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394680|NCT03426995|615782938|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394681|NCT03426995|615782939|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394682|NCT03426995|615782940|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394683|NCT03426995|615782941|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394684|NCT03426995|615782942|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394685|NCT03426995|615782943|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394686|NCT03426995|615782944|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394687|NCT03426995|615782945|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394688|NCT03426995|615782946|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
170394689|NCT03426995|615782947|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
170394690|NCT03426995|615782948|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394691|NCT03426995|615782949|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394692|NCT03426995|615782950|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
170394693|NCT02335411|615782951|FG000|Overall Study|Death|223|||
170394694|NCT02335411|615782952|FG001|Overall Study|Death|22|||
170394695|NCT02335411|615782953|FG002|Overall Study|Death|26|||
170394696|NCT02335411|615782951|FG000|Overall Study|Physician Decision|3|||
170394697|NCT02335411|615782952|FG001|Overall Study|Physician Decision|0|||
170394698|NCT02335411|615782953|FG002|Overall Study|Physician Decision|0|||
170394699|NCT02335411|615782951|FG000|Overall Study|Protocol Violation|1|||
170394700|NCT02335411|615782952|FG001|Overall Study|Protocol Violation|0|||
170394701|NCT02335411|615782953|FG002|Overall Study|Protocol Violation|0|||
170394702|NCT02335411|615782951|FG000|Overall Study|Withdrawal by Subject|11|||
170394703|NCT02335411|615782952|FG001|Overall Study|Withdrawal by Subject|0|||
170394704|NCT02335411|615782953|FG002|Overall Study|Withdrawal by Subject|3|||
170394705|NCT02335411|615782951|FG000|Overall Study|Sponsor Decision|12|||
170394706|NCT02335411|615782952|FG001|Overall Study|Sponsor Decision|3|||
170394707|NCT02335411|615782953|FG002|Overall Study|Sponsor Decision|2|||
170394708|NCT02335411|615782951|FG000|Overall Study|Adverse Event|9|||
170394709|NCT02335411|615782952|FG001|Overall Study|Adverse Event|0|||
170394710|NCT02335411|615782953|FG002|Overall Study|Adverse Event|0|||
170394711|NCT03075826|615782957|FG000|Overall Study|Withdrawal by Subject|1|||
170394712|NCT03075826|615782957|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
170394713|NCT02596009|615782959|FG000|Overall Study|Administrative problems|0|||
170394714|NCT02596009|615782960|FG001|Overall Study|Administrative problems|1|||
170394715|NCT02596009|615782961|FG002|Overall Study|Administrative problems|0|||
170394716|NCT02596009|615782962|FG003|Overall Study|Administrative problems|0|||
170394717|NCT02596009|615782963|FG004|Overall Study|Administrative problems|0|||
170394718|NCT02596009|615782964|FG005|Overall Study|Administrative problems|0|||
170394719|NCT04611152|615782965|FG000|Overall Study|Adverse Event|9|||
170394720|NCT04611152|615782966|FG001|Overall Study|Adverse Event|8|||
170394721|NCT04611152|615782965|FG000|Overall Study|Non-compliance with study schedule|1|||
170394722|NCT04611152|615782966|FG001|Overall Study|Non-compliance with study schedule|3|||
170394723|NCT04611152|615782965|FG000|Overall Study|Withdrawal by Subject|5|||
170394724|NCT04611152|615782966|FG001|Overall Study|Withdrawal by Subject|6|||
170394725|NCT04611152|615782965|FG000|Overall Study|Lost to Follow-up|11|||
170394726|NCT04611152|615782966|FG001|Overall Study|Lost to Follow-up|2|||
170394727|NCT03707145|615782972|FG000|Overall Study|Lost to Follow-up|0|||
170394728|NCT03707145|615782973|FG001|Overall Study|Lost to Follow-up|1|||
170394729|NCT03707145|615782974|FG002|Overall Study|Lost to Follow-up|1|||
170394730|NCT03707145|615782975|FG003|Overall Study|Lost to Follow-up|0|||
170394731|NCT04228107|615782979|FG000|Overall Study|Protocol Violation|1|||
170394732|NCT04228107|615782980|FG001|Overall Study|Protocol Violation|0|||
170394733|NCT04228107|615782979|FG000|Overall Study|Withdrawal by Subject|6|||
170394734|NCT04228107|615782980|FG001|Overall Study|Withdrawal by Subject|0|||
170394735|NCT04228107|615782979|FG000|Overall Study|Lost to Follow-up|18|||
170394736|NCT04228107|615782980|FG001|Overall Study|Lost to Follow-up|0|||
170394737|NCT04228107|615782979|FG000|Overall Study|No controller use data|1|||
170394738|NCT04228107|615782980|FG001|Overall Study|No controller use data|0|||
170394739|NCT04228107|615782979|FG000|Overall Study|No medication data collected|1|||
170394740|NCT04228107|615782980|FG001|Overall Study|No medication data collected|0|||
170394741|NCT04584294|615782989|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
170394742|NCT04584294|615782990|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
170394743|NCT04584294|615782989|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
170394744|NCT04584294|615782990|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
170394745|NCT04584294|615782989|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
170394746|NCT04584294|615782990|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
170394747|NCT04584294|615782989|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
170394748|NCT04584294|615782990|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
170394749|NCT04584294|615782989|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
170394750|NCT04584294|615782990|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
170394751|NCT04584294|615782989|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
170394752|NCT04584294|615782990|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
170394753|NCT04410978|615782993|FG000|Overall Study|Poor compliance to protocol|2|||
170394754|NCT04410978|615782994|FG001|Overall Study|Poor compliance to protocol|4|||
170394755|NCT04410978|615782993|FG000|Overall Study|Withdrawal by Subject|64|||
170394756|NCT04410978|615782994|FG001|Overall Study|Withdrawal by Subject|66|||
170394757|NCT04410978|615782993|FG000|Overall Study|Other|6|||
170394758|NCT04410978|615782994|FG001|Overall Study|Other|7|||
170394759|NCT04410978|615782993|FG000|Overall Study|Missing study status|1|||
170394760|NCT04410978|615782994|FG001|Overall Study|Missing study status|0|||
170394761|NCT05153629|615782995|FG000|Overall Study|Withdrawal by Subject|0|||
170394762|NCT05153629|615782996|FG001|Overall Study|Withdrawal by Subject|2|||
170394763|NCT04089566|615782999|FG000|Overall Study|Death|0|||
170394764|NCT04089566|615783000|FG001|Overall Study|Death|6|||
170394765|NCT04089566|615783001|FG002|Overall Study|Death|10|||
170394766|NCT04089566|615783002|FG003|Overall Study|Death|0|||
170394767|NCT04089566|615783003|FG004|Overall Study|Death|0|||
170394768|NCT04089566|615783004|FG005|Overall Study|Death|0|||
170394769|NCT04089566|615782999|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
170394770|NCT04089566|615783000|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
170394771|NCT04089566|615783001|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
170394772|NCT04089566|615783002|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
170394773|NCT04089566|615783003|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
170394774|NCT04089566|615783004|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
170394775|NCT04089566|615782999|FG000|Overall Study|Reason not Specified|0|||
170394776|NCT04089566|615783000|FG001|Overall Study|Reason not Specified|4|||
170394777|NCT04089566|615783001|FG002|Overall Study|Reason not Specified|4|||
170394778|NCT04089566|615783002|FG003|Overall Study|Reason not Specified|1|||
170394779|NCT04089566|615783003|FG004|Overall Study|Reason not Specified|0|||
170394780|NCT04089566|615783004|FG005|Overall Study|Reason not Specified|0|||
170394781|NCT03205605|615783005|FG000|Overall Study|Withdrawal by Subject|1|||
170394782|NCT01233284|615783006|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
170394783|NCT01233284|615783007|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
170394784|NCT01233284|615783008|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
170394785|NCT01233284|615783009|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
170394786|NCT01233284|615783010|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
170394787|NCT01233284|615783006|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
170394788|NCT01233284|615783007|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
170394789|NCT01233284|615783008|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
170394790|NCT01233284|615783009|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
170394791|NCT01233284|615783010|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
170394792|NCT01233284|615783006|FG000|Period 1 (4 Weeks)|Other|0|||
170394793|NCT01233284|615783007|FG001|Period 1 (4 Weeks)|Other|0|||
170394794|NCT01233284|615783008|FG002|Period 1 (4 Weeks)|Other|1|||
170394795|NCT01233284|615783009|FG003|Period 1 (4 Weeks)|Other|0|||
170394796|NCT01233284|615783010|FG004|Period 1 (4 Weeks)|Other|0|||
170394797|NCT01233284|615783006|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170394798|NCT01233284|615783007|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170394799|NCT01233284|615783008|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
170394800|NCT01233284|615783009|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170394801|NCT01233284|615783010|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
170394802|NCT01233284|615783006|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
170394803|NCT01233284|615783007|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
170394804|NCT01233284|615783008|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
170394805|NCT01233284|615783009|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
170394806|NCT01233284|615783010|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
170394807|NCT01233284|615783006|FG000|Period 3 (4 Weeks)|Other|0|||
170394808|NCT01233284|615783007|FG001|Period 3 (4 Weeks)|Other|0|||
170394809|NCT01233284|615783008|FG002|Period 3 (4 Weeks)|Other|0|||
170394810|NCT01233284|615783009|FG003|Period 3 (4 Weeks)|Other|1|||
170394811|NCT01233284|615783010|FG004|Period 3 (4 Weeks)|Other|0|||
170394812|NCT01233284|615783006|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
170394813|NCT01233284|615783007|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
170394814|NCT01233284|615783008|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
170394815|NCT01233284|615783009|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
170394816|NCT01233284|615783010|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
170394817|NCT01233284|615783006|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
170394818|NCT01233284|615783007|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
170394819|NCT01233284|615783008|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
170394820|NCT01233284|615783009|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
170394821|NCT01233284|615783010|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
170394822|NCT03759340|615783011|FG000|Overall Study|Adverse Event|2|||
170394823|NCT03759340|615783011|FG000|Overall Study|Lost to Follow-up|1|||
170394824|NCT03759340|615783011|FG000|Overall Study|Withdrawal by Subject|15|||
170394825|NCT03759340|615783011|FG000|Overall Study|Study Terminated by Sponsor|38|||
170394826|NCT01593761|615783014|FG000|Overall Study|Lost to Follow-up|1|||
170394827|NCT01593761|615783014|FG000|Overall Study|culture negative for MRSA at baseline|5|||
170394828|NCT01593761|615783014|FG000|Overall Study|positive for hepatitis C virus|1|||
170394829|NCT01593761|615783014|FG000|Overall Study|secondary cellulitis|1|||
170394830|NCT01965600|615783019|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
170394831|NCT01965600|615783020|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
170394832|NCT01965600|615783021|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
170394833|NCT01965600|615783022|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
170394834|NCT01965600|615783019|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
170394835|NCT01965600|615783020|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
170394836|NCT01965600|615783021|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
170394837|NCT01965600|615783022|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
170394838|NCT01965600|615783019|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
170394839|NCT01965600|615783020|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
170394840|NCT01965600|615783021|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
170394841|NCT01965600|615783022|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
170394842|NCT01965600|615783019|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
170394843|NCT01965600|615783020|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
170394844|NCT01965600|615783021|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
170394845|NCT01965600|615783022|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
170394846|NCT01965600|615783019|FG000|Second Intervention|Study terminated by Sponsor|0|||
170394847|NCT01965600|615783020|FG001|Second Intervention|Study terminated by Sponsor|0|||
170394848|NCT01965600|615783021|FG002|Second Intervention|Study terminated by Sponsor|2|||
170394849|NCT01965600|615783022|FG003|Second Intervention|Study terminated by Sponsor|2|||
170394850|NCT02087865|615784246|FG000|Overall Study|Withdrawal by Subject|6|||
170394851|NCT02087865|615784247|FG001|Overall Study|Withdrawal by Subject|0|||
170394852|NCT02087865|615784248|FG002|Overall Study|Withdrawal by Subject|1|||
170394853|NCT02087865|615784246|FG000|Overall Study|Lost to Follow-up|0|||
170394854|NCT02087865|615784247|FG001|Overall Study|Lost to Follow-up|0|||
170394855|NCT02087865|615784248|FG002|Overall Study|Lost to Follow-up|1|||
170394856|NCT02087865|615784246|FG000|Overall Study|Drug Non-compliance|0|||
170394857|NCT02087865|615784247|FG001|Overall Study|Drug Non-compliance|2|||
170394858|NCT02087865|615784248|FG002|Overall Study|Drug Non-compliance|0|||
170394859|NCT02087865|615784246|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
170394860|NCT02087865|615784247|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
170394861|NCT02087865|615784248|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
170394862|NCT01319994|615784249|FG000|Overall Study|Protocol Violation|7|||
170394863|NCT01319994|615784250|FG001|Overall Study|Protocol Violation|6|||
170394864|NCT01118949|615784257|FG000|Overall Study|Adverse Event|5|||
170394865|NCT01118949|615784257|FG000|Overall Study|Withdrawal by Subject|4|||
170394866|NCT01017731|615784263|FG000|Overall Study|Lost to Follow-up|2|||
170394867|NCT01017731|615784263|FG000|Overall Study|Withdrawal by Subject|3|||
170394868|NCT01017731|615784263|FG000|Overall Study|Physician Decision|2|||
170394869|NCT01017731|615784263|FG000|Overall Study|Adverse Event|1|||
170394870|NCT00798707|615784269|FG000|Overall Study|Adverse Event|6|||
170394871|NCT00798707|615784270|FG001|Overall Study|Adverse Event|8|||
170394872|NCT00798707|615784271|FG002|Overall Study|Adverse Event|8|||
170394873|NCT00798707|615784269|FG000|Overall Study|Failed to return|2|||
170394874|NCT00798707|615784270|FG001|Overall Study|Failed to return|2|||
170394875|NCT00798707|615784271|FG002|Overall Study|Failed to return|0|||
170394876|NCT00798707|615784269|FG000|Overall Study|Investigator|0|||
170394877|NCT00798707|615784270|FG001|Overall Study|Investigator|1|||
170394878|NCT00798707|615784271|FG002|Overall Study|Investigator|2|||
170394879|NCT00798707|615784269|FG000|Overall Study|Lack of Efficacy|2|||
170394880|NCT00798707|615784270|FG001|Overall Study|Lack of Efficacy|2|||
170394881|NCT00798707|615784271|FG002|Overall Study|Lack of Efficacy|1|||
170394882|NCT00798707|615784269|FG000|Overall Study|Lost to Follow-up|5|||
170394883|NCT00798707|615784270|FG001|Overall Study|Lost to Follow-up|6|||
170394884|NCT00798707|615784271|FG002|Overall Study|Lost to Follow-up|6|||
170394885|NCT00798707|615784269|FG000|Overall Study|Other|0|||
170394886|NCT00798707|615784270|FG001|Overall Study|Other|1|||
170394887|NCT00798707|615784271|FG002|Overall Study|Other|0|||
170394888|NCT00798707|615784269|FG000|Overall Study|Protocol Violation|4|||
170394889|NCT00798707|615784270|FG001|Overall Study|Protocol Violation|0|||
170394890|NCT00798707|615784271|FG002|Overall Study|Protocol Violation|2|||
170394891|NCT00798707|615784269|FG000|Overall Study|Withdrawal by Subject|3|||
170394892|NCT00798707|615784270|FG001|Overall Study|Withdrawal by Subject|8|||
170394893|NCT00798707|615784271|FG002|Overall Study|Withdrawal by Subject|2|||
170394894|NCT00798707|615784269|FG000|Overall Study|Randomized not treated|4|||
170394895|NCT00798707|615784270|FG001|Overall Study|Randomized not treated|5|||
170394896|NCT00798707|615784271|FG002|Overall Study|Randomized not treated|1|||
170394897|NCT01473589|615784272|FG000|Overall Study|Adverse Event|1|||
170394898|NCT01473589|615784273|FG001|Overall Study|Adverse Event|1|||
170394899|NCT01473589|615784272|FG000|Overall Study|Death|2|||
170394900|NCT01473589|615784273|FG001|Overall Study|Death|0|||
170394901|NCT01473589|615784272|FG000|Overall Study|Lost to Follow-up|2|||
170394902|NCT01473589|615784273|FG001|Overall Study|Lost to Follow-up|2|||
170394903|NCT01473589|615784272|FG000|Overall Study|Protocol Violation|1|||
170394904|NCT01473589|615784273|FG001|Overall Study|Protocol Violation|0|||
170394905|NCT01473589|615784272|FG000|Overall Study|Withdrawal by Subject|5|||
170394906|NCT01473589|615784273|FG001|Overall Study|Withdrawal by Subject|11|||
170394907|NCT01473589|615784272|FG000|Overall Study|Physician Decision|0|||
170394908|NCT01473589|615784273|FG001|Overall Study|Physician Decision|1|||
170394909|NCT01473589|615784272|FG000|Overall Study|Entry criteria not met|0|||
170394910|NCT01473589|615784273|FG001|Overall Study|Entry criteria not met|1|||
170394911|NCT03722849|615784282|FG000|Overall Study|Withdrawal by Subject|1|||
170394912|NCT03722849|615784283|FG001|Overall Study|Withdrawal by Subject|1|||
170394913|NCT02729545|615784284|FG000|Overall Study|Pregnancy|1|||
170394914|NCT02729545|615784285|FG001|Overall Study|Pregnancy|1|||
170394915|NCT02729545|615784284|FG000|Overall Study|Lost to Follow-up|0|||
170394916|NCT02729545|615784285|FG001|Overall Study|Lost to Follow-up|1|||
170394917|NCT02729545|615784284|FG000|Overall Study|Withdrawal by Subject|2|||
170394918|NCT02729545|615784285|FG001|Overall Study|Withdrawal by Subject|3|||
170394919|NCT03533608|615784286|FG000|Overall Study|Withdrawal by Subject|3|||
170394920|NCT03533608|615784286|FG000|Overall Study|Physician Decision|2|||
170394921|NCT00915473|615784287|FG000|Screening|Withdrawal by Subject|1|||
170394922|NCT00915473|615784288|FG001|Screening|Withdrawal by Subject|0|||
170394923|NCT00915473|615784287|FG000|4-week Follow Up|Lost to Follow-up|1|||
170394924|NCT00915473|615784288|FG001|4-week Follow Up|Lost to Follow-up|5|||
170394925|NCT04930536|615784292|FG000|Overall Study|Adverse Event|1|||
170394926|NCT04930536|615784293|FG001|Overall Study|Adverse Event|0|||
170394927|NCT04930536|615784292|FG000|Overall Study|Disease Progression|2|||
170394928|NCT04930536|615784293|FG001|Overall Study|Disease Progression|0|||
170394929|NCT04930536|615784292|FG000|Overall Study|Patient Decision|4|||
170394930|NCT04930536|615784293|FG001|Overall Study|Patient Decision|2|||
170394931|NCT04930536|615784292|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
170394932|NCT04930536|615784293|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
170394933|NCT01432600|615784294|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
170394934|NCT01432600|615784295|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
170394935|NCT01432600|615784296|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
170394936|NCT00398632|615784297|FG000|Overall Study|Withdrawal by Subject|1|||
170394937|NCT00398632|615784297|FG000|Overall Study|Lack of Efficacy|1|||
170394938|NCT00640614|615784300|FG000|Overall Study|Lost to Follow-up|1|||
170394939|NCT00640614|615784301|FG001|Overall Study|Lost to Follow-up|0|||
170394940|NCT00529802|615784302|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
170394941|NCT00529802|615784302|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
170394942|NCT00529802|615784302|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
170394943|NCT00529802|615784302|FG000|Evaluable for Primary Endpoint|Death|1|||
170394944|NCT00529802|615784302|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
170394945|NCT00529802|615784302|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
170394946|NCT00529802|615784302|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
170394947|NCT02209454|615784305|FG000|Second Period|Adverse Event|1|||
170394948|NCT02209454|615784306|FG001|Second Period|Adverse Event|0|||
170394949|NCT00366678|615784307|FG000|Infant Series|Withdrawal by Subject|8|||
170394950|NCT00366678|615784308|FG001|Infant Series|Withdrawal by Subject|6|||
170394951|NCT00366678|615784309|FG002|Infant Series|Withdrawal by Subject|0|||
170394952|NCT00366678|615784307|FG000|Infant Series|Protocol Violation|4|||
170394953|NCT00366678|615784308|FG001|Infant Series|Protocol Violation|3|||
170394954|NCT00366678|615784309|FG002|Infant Series|Protocol Violation|0|||
170394955|NCT00366678|615784307|FG000|Infant Series|Failed to return|1|||
170394956|NCT00366678|615784308|FG001|Infant Series|Failed to return|1|||
170394957|NCT00366678|615784309|FG002|Infant Series|Failed to return|0|||
170394958|NCT00366678|615784307|FG000|Infant Series|Adverse Event|1|||
170394959|NCT00366678|615784308|FG001|Infant Series|Adverse Event|0|||
170394960|NCT00366678|615784309|FG002|Infant Series|Adverse Event|0|||
170394961|NCT00366678|615784307|FG000|After Infant|Withdrawal by Subject|8|||
170394962|NCT00366678|615784308|FG001|After Infant|Withdrawal by Subject|4|||
170394963|NCT00366678|615784309|FG002|After Infant|Withdrawal by Subject|0|||
170394964|NCT00366678|615784307|FG000|After Infant|Lost to Follow-up|2|||
170394965|NCT00366678|615784308|FG001|After Infant|Lost to Follow-up|1|||
170394966|NCT00366678|615784309|FG002|After Infant|Lost to Follow-up|0|||
170394967|NCT00366678|615784307|FG000|After Infant|Failed to return|5|||
170394968|NCT00366678|615784308|FG001|After Infant|Failed to return|5|||
170394969|NCT00366678|615784309|FG002|After Infant|Failed to return|0|||
170394970|NCT00366678|615784307|FG000|After Infant|Adverse Event|1|||
170394971|NCT00366678|615784308|FG001|After Infant|Adverse Event|0|||
170394972|NCT00366678|615784309|FG002|After Infant|Adverse Event|0|||
170394973|NCT00366678|615784307|FG000|After Infant|Protocol Violation|1|||
170394974|NCT00366678|615784308|FG001|After Infant|Protocol Violation|0|||
170394975|NCT00366678|615784309|FG002|After Infant|Protocol Violation|0|||
170394976|NCT00366678|615784307|FG000|Toddler Dose|Protocol Violation|2|||
170394977|NCT00366678|615784308|FG001|Toddler Dose|Protocol Violation|1|||
170394978|NCT00366678|615784309|FG002|Toddler Dose|Protocol Violation|0|||
170394979|NCT00366678|615784307|FG000|Toddler Dose|Failed to return|1|||
170394980|NCT00366678|615784308|FG001|Toddler Dose|Failed to return|0|||
170394981|NCT00366678|615784309|FG002|Toddler Dose|Failed to return|0|||
170394982|NCT00366678|615784307|FG000|Toddler Dose|Withdrawal by Subject|1|||
170394983|NCT00366678|615784308|FG001|Toddler Dose|Withdrawal by Subject|0|||
170394984|NCT00366678|615784309|FG002|Toddler Dose|Withdrawal by Subject|0|||
170394985|NCT00366678|615784307|FG000|Toddler Dose|protocol deviation|1|||
170394986|NCT00366678|615784308|FG001|Toddler Dose|protocol deviation|0|||
170394987|NCT00366678|615784309|FG002|Toddler Dose|protocol deviation|0|||
170394988|NCT00740480|615784325|FG000|Overall Study|Adverse Event|1|||
170394989|NCT00740480|615784325|FG000|Overall Study|Physician Decision|1|||
170394990|NCT03079869|615784331|FG000|Overall Study|Adverse Event|6|||
170394991|NCT03079869|615784332|FG001|Overall Study|Adverse Event|8|||
170394992|NCT03079869|615784331|FG000|Overall Study|Withdrawal by Subject|4|||
170394993|NCT03079869|615784332|FG001|Overall Study|Withdrawal by Subject|1|||
170394994|NCT03079869|615784331|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
170394995|NCT03079869|615784332|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
170394996|NCT01325701|615784333|FG000|Overall Study|Adverse Event|12|||
170394997|NCT01325701|615784334|FG001|Overall Study|Adverse Event|0|||
170394998|NCT01325701|615784333|FG000|Overall Study|Protocol Violation|1|||
170394999|NCT01325701|615784334|FG001|Overall Study|Protocol Violation|0|||
170395000|NCT01325701|615784333|FG000|Overall Study|Physician Decision|2|||
170395001|NCT01325701|615784334|FG001|Overall Study|Physician Decision|2|||
170395002|NCT01325701|615784333|FG000|Overall Study|Withdrawal by Subject|2|||
170395003|NCT01325701|615784334|FG001|Overall Study|Withdrawal by Subject|1|||
170395004|NCT01325701|615784333|FG000|Overall Study|Rollerover Extension Study|4|||
170395005|NCT01325701|615784334|FG001|Overall Study|Rollerover Extension Study|0|||
170395006|NCT05102162|615784345|FG000|Overall Study|Withdrawal by Subject|3|||
170395007|NCT05102162|615784346|FG001|Overall Study|Withdrawal by Subject|0|||
170395008|NCT05102162|615784345|FG000|Overall Study|Baseline cultures negative|4|||
170395009|NCT05102162|615784346|FG001|Overall Study|Baseline cultures negative|2|||
170395010|NCT05102162|615784345|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
170395011|NCT05102162|615784346|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
170395012|NCT05102162|615784345|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
170395013|NCT05102162|615784346|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
170395014|NCT02255422|615784349|FG000|Overall Study|Withdrawal by Subject|0|||
170395015|NCT02255422|615784350|FG001|Overall Study|Withdrawal by Subject|0|||
170395016|NCT02255422|615784351|FG002|Overall Study|Withdrawal by Subject|0|||
170395017|NCT02255422|615784352|FG003|Overall Study|Withdrawal by Subject|0|||
170395018|NCT02255422|615784353|FG004|Overall Study|Withdrawal by Subject|0|||
170395019|NCT02255422|615784354|FG005|Overall Study|Withdrawal by Subject|0|||
170395020|NCT02255422|615784355|FG006|Overall Study|Withdrawal by Subject|2|||
170395021|NCT02255422|615784349|FG000|Overall Study|Lost to Follow-up|0|||
170395022|NCT02255422|615784350|FG001|Overall Study|Lost to Follow-up|0|||
170395023|NCT02255422|615784351|FG002|Overall Study|Lost to Follow-up|1|||
170395024|NCT02255422|615784352|FG003|Overall Study|Lost to Follow-up|0|||
170395025|NCT02255422|615784353|FG004|Overall Study|Lost to Follow-up|0|||
170395026|NCT02255422|615784354|FG005|Overall Study|Lost to Follow-up|0|||
170395027|NCT02255422|615784355|FG006|Overall Study|Lost to Follow-up|0|||
170395028|NCT03179462|615784359|FG000|Overall Study|screening failure|1|||
170395029|NCT03179462|615784360|FG001|Overall Study|screening failure|2|||
170395030|NCT03179462|615784361|FG002|Overall Study|screening failure|0|||
170395031|NCT02711306|615784364|FG000|Overall Study|Withdrawal by Subject|2|||
170395032|NCT02711306|615784365|FG001|Overall Study|Withdrawal by Subject|2|||
170395033|NCT02576951|615784366|FG000|Overall Study|Lost to Follow-up|0|||
170395034|NCT02576951|615784367|FG001|Overall Study|Lost to Follow-up|0|||
170395035|NCT02576951|615784368|FG002|Overall Study|Lost to Follow-up|2|||
170395036|NCT02576951|615784369|FG003|Overall Study|Lost to Follow-up|2|||
170395037|NCT02576951|615784366|FG000|Overall Study|Withdrawal by Subject|1|||
170395038|NCT02576951|615784367|FG001|Overall Study|Withdrawal by Subject|0|||
170395039|NCT02576951|615784368|FG002|Overall Study|Withdrawal by Subject|0|||
170395040|NCT02576951|615784369|FG003|Overall Study|Withdrawal by Subject|2|||
170395041|NCT02576951|615784366|FG000|Overall Study|Protocol Violation|0|||
170395042|NCT02576951|615784367|FG001|Overall Study|Protocol Violation|0|||
170395043|NCT02576951|615784368|FG002|Overall Study|Protocol Violation|0|||
170395044|NCT02576951|615784369|FG003|Overall Study|Protocol Violation|1|||
170395045|NCT02062385|615784370|FG000|Overall Study|Adverse Event|19|||
170395046|NCT02062385|615784371|FG001|Overall Study|Adverse Event|13|||
170395047|NCT02062385|615784372|FG002|Overall Study|Adverse Event|1|||
170395048|NCT02062385|615784373|FG003|Overall Study|Adverse Event|0|||
170395049|NCT02062385|615784370|FG000|Overall Study|Protocol Violation|1|||
170395050|NCT02062385|615784371|FG001|Overall Study|Protocol Violation|0|||
170395051|NCT02062385|615784372|FG002|Overall Study|Protocol Violation|0|||
170395052|NCT02062385|615784373|FG003|Overall Study|Protocol Violation|0|||
170395053|NCT02062385|615784370|FG000|Overall Study|Incomplete EPI by database lock|2|||
170395054|NCT02062385|615784371|FG001|Overall Study|Incomplete EPI by database lock|0|||
170395055|NCT02062385|615784372|FG002|Overall Study|Incomplete EPI by database lock|0|||
170395056|NCT02062385|615784373|FG003|Overall Study|Incomplete EPI by database lock|0|||
170395057|NCT02062385|615784370|FG000|Overall Study|Moved|10|||
170395058|NCT02062385|615784371|FG001|Overall Study|Moved|11|||
170395059|NCT02062385|615784372|FG002|Overall Study|Moved|1|||
170395060|NCT02062385|615784373|FG003|Overall Study|Moved|0|||
170395061|NCT02062385|615784370|FG000|Overall Study|Withdrawn by parent/guardian|46|||
170395062|NCT02062385|615784371|FG001|Overall Study|Withdrawn by parent/guardian|41|||
170395063|NCT02062385|615784372|FG002|Overall Study|Withdrawn by parent/guardian|9|||
170395064|NCT02062385|615784373|FG003|Overall Study|Withdrawn by parent/guardian|8|||
170395065|NCT02062385|615784370|FG000|Overall Study|Death|0|||
170395066|NCT02062385|615784371|FG001|Overall Study|Death|0|||
170395067|NCT02062385|615784372|FG002|Overall Study|Death|0|||
170395068|NCT02062385|615784373|FG003|Overall Study|Death|1|||
170395069|NCT02062385|615784370|FG000|Overall Study|Lost to Follow-up|0|||
170395070|NCT02062385|615784371|FG001|Overall Study|Lost to Follow-up|0|||
170395071|NCT02062385|615784372|FG002|Overall Study|Lost to Follow-up|1|||
170395072|NCT02062385|615784373|FG003|Overall Study|Lost to Follow-up|0|||
170395073|NCT02207413|615784374|FG000|Overall Study|Withdrawal by Subject|1|||
170395074|NCT02207413|615784375|FG001|Overall Study|Withdrawal by Subject|0|||
170395075|NCT02207413|615784376|FG002|Overall Study|Withdrawal by Subject|0|||
170395076|NCT02207413|615784377|FG003|Overall Study|Withdrawal by Subject|0|||
170395077|NCT02207413|615784378|FG004|Overall Study|Withdrawal by Subject|3|||
170395078|NCT02207413|615784379|FG005|Overall Study|Withdrawal by Subject|7|||
170395079|NCT02207413|615784374|FG000|Overall Study|Lost to Follow-up|0|||
170395080|NCT02207413|615784375|FG001|Overall Study|Lost to Follow-up|0|||
170395081|NCT02207413|615784376|FG002|Overall Study|Lost to Follow-up|0|||
170395082|NCT02207413|615784377|FG003|Overall Study|Lost to Follow-up|1|||
170395083|NCT02207413|615784378|FG004|Overall Study|Lost to Follow-up|1|||
170395084|NCT02207413|615784379|FG005|Overall Study|Lost to Follow-up|5|||
170395085|NCT02207413|615784374|FG000|Overall Study|Adverse Event|0|||
170395086|NCT02207413|615784375|FG001|Overall Study|Adverse Event|0|||
170395087|NCT02207413|615784376|FG002|Overall Study|Adverse Event|0|||
170395088|NCT02207413|615784377|FG003|Overall Study|Adverse Event|0|||
170395089|NCT02207413|615784378|FG004|Overall Study|Adverse Event|2|||
170395090|NCT02207413|615784379|FG005|Overall Study|Adverse Event|1|||
170395091|NCT02207413|615784374|FG000|Overall Study|Migrated/moved from study area|0|||
170395092|NCT02207413|615784375|FG001|Overall Study|Migrated/moved from study area|0|||
170395093|NCT02207413|615784376|FG002|Overall Study|Migrated/moved from study area|0|||
170395094|NCT02207413|615784377|FG003|Overall Study|Migrated/moved from study area|0|||
170395095|NCT02207413|615784378|FG004|Overall Study|Migrated/moved from study area|1|||
170395096|NCT02207413|615784379|FG005|Overall Study|Migrated/moved from study area|0|||
170395097|NCT04075656|615784380|FG000|Overall Study|Withdrawal by Subject|5|||
170395098|NCT04075656|615784381|FG001|Overall Study|Withdrawal by Subject|5|||
170395099|NCT02674568|615786028|FG000|Overall Study|Withdrawal by Subject|5|||
170395100|NCT02674568|615786028|FG000|Overall Study|Death|303|||
170395101|NCT02674568|615786028|FG000|Overall Study|Physician Decision|2|||
170395102|NCT02674568|615786028|FG000|Overall Study|Lost to Follow-up|9|||
170395103|NCT02674568|615786028|FG000|Overall Study|Other, Not Specified|20|||
170395104|NCT00648739|615786029|FG000|Overall Study|Adverse Event|1|||
170395105|NCT00648739|615786030|FG001|Overall Study|Adverse Event|0|||
170395106|NCT00648739|615786031|FG002|Overall Study|Adverse Event|1|||
170395107|NCT00648739|615786032|FG003|Overall Study|Adverse Event|2|||
170395108|NCT00648739|615786033|FG004|Overall Study|Adverse Event|1|||
170395109|NCT00648739|615786034|FG005|Overall Study|Adverse Event|0|||
170395110|NCT00648739|615786035|FG006|Overall Study|Adverse Event|0|||
170395111|NCT00648739|615786029|FG000|Overall Study|Withdrawal by Subject|1|||
170395112|NCT00648739|615786030|FG001|Overall Study|Withdrawal by Subject|0|||
170395113|NCT00648739|615786031|FG002|Overall Study|Withdrawal by Subject|1|||
170395114|NCT00648739|615786032|FG003|Overall Study|Withdrawal by Subject|0|||
170395115|NCT00648739|615786033|FG004|Overall Study|Withdrawal by Subject|0|||
170395116|NCT00648739|615786034|FG005|Overall Study|Withdrawal by Subject|2|||
170395117|NCT00648739|615786035|FG006|Overall Study|Withdrawal by Subject|0|||
170395118|NCT00648739|615786029|FG000|Overall Study|Lack of Efficacy|0|||
170395119|NCT00648739|615786030|FG001|Overall Study|Lack of Efficacy|0|||
170395120|NCT00648739|615786031|FG002|Overall Study|Lack of Efficacy|0|||
170395121|NCT00648739|615786032|FG003|Overall Study|Lack of Efficacy|0|||
170395122|NCT00648739|615786033|FG004|Overall Study|Lack of Efficacy|1|||
170395123|NCT00648739|615786034|FG005|Overall Study|Lack of Efficacy|2|||
170395124|NCT00648739|615786035|FG006|Overall Study|Lack of Efficacy|0|||
170395125|NCT00648739|615786029|FG000|Overall Study|Investigator Considered it Advisable|0|||
170395126|NCT00648739|615786030|FG001|Overall Study|Investigator Considered it Advisable|0|||
170395127|NCT00648739|615786031|FG002|Overall Study|Investigator Considered it Advisable|0|||
170395128|NCT00648739|615786032|FG003|Overall Study|Investigator Considered it Advisable|0|||
170395129|NCT00648739|615786033|FG004|Overall Study|Investigator Considered it Advisable|0|||
170395130|NCT00648739|615786034|FG005|Overall Study|Investigator Considered it Advisable|1|||
170395131|NCT00648739|615786035|FG006|Overall Study|Investigator Considered it Advisable|1|||
170395132|NCT00648739|615786029|FG000|Overall Study|Death|0|||
170395133|NCT00648739|615786030|FG001|Overall Study|Death|1|||
170395134|NCT00648739|615786031|FG002|Overall Study|Death|0|||
170395135|NCT00648739|615786032|FG003|Overall Study|Death|0|||
170395136|NCT00648739|615786033|FG004|Overall Study|Death|0|||
170395137|NCT00648739|615786034|FG005|Overall Study|Death|0|||
170395138|NCT00648739|615786035|FG006|Overall Study|Death|0|||
170395139|NCT00648739|615786029|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
170395140|NCT00648739|615786030|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
170395141|NCT00648739|615786031|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
170395142|NCT00648739|615786032|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
170395143|NCT00648739|615786033|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
170395144|NCT00648739|615786034|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
170395145|NCT00648739|615786035|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
170395146|NCT00648739|615786029|FG000|Overall Study|Follow-up Visits Not Completed|0|||
170395147|NCT00648739|615786030|FG001|Overall Study|Follow-up Visits Not Completed|1|||
170395148|NCT00648739|615786031|FG002|Overall Study|Follow-up Visits Not Completed|0|||
170395149|NCT00648739|615786032|FG003|Overall Study|Follow-up Visits Not Completed|0|||
170395150|NCT00648739|615786033|FG004|Overall Study|Follow-up Visits Not Completed|0|||
170395151|NCT00648739|615786034|FG005|Overall Study|Follow-up Visits Not Completed|0|||
170395152|NCT00648739|615786035|FG006|Overall Study|Follow-up Visits Not Completed|0|||
170395153|NCT00698009|615786039|FG000|Overall Study|Withdrawal by Subject|1|||
170395154|NCT00564486|615786040|FG000|Overall Study|Adverse Event|0|||
170395155|NCT00564486|615786041|FG001|Overall Study|Adverse Event|1|||
170395156|NCT00564486|615786042|FG002|Overall Study|Adverse Event|0|||
170395157|NCT00564486|615786043|FG003|Overall Study|Adverse Event|0|||
170395158|NCT00564486|615786040|FG000|Overall Study|Withdrawal by Subject|4|||
170395159|NCT00564486|615786041|FG001|Overall Study|Withdrawal by Subject|0|||
170395160|NCT00564486|615786042|FG002|Overall Study|Withdrawal by Subject|0|||
170395161|NCT00564486|615786043|FG003|Overall Study|Withdrawal by Subject|5|||
170395162|NCT00564486|615786040|FG000|Overall Study|Subject refused to have blood drawn|0|||
170395163|NCT00564486|615786041|FG001|Overall Study|Subject refused to have blood drawn|0|||
170395164|NCT00564486|615786042|FG002|Overall Study|Subject refused to have blood drawn|1|||
170395165|NCT00564486|615786043|FG003|Overall Study|Subject refused to have blood drawn|0|||
170395166|NCT00564486|615786040|FG000|Overall Study|Lost to Follow-up|3|||
170395167|NCT00564486|615786041|FG001|Overall Study|Lost to Follow-up|0|||
170395168|NCT00564486|615786042|FG002|Overall Study|Lost to Follow-up|2|||
170395169|NCT00564486|615786043|FG003|Overall Study|Lost to Follow-up|2|||
170395170|NCT00684645|615786048|FG000|Overall Study|Death|2|||
170395171|NCT00684645|615786048|FG000|Overall Study|Progressive disease|67|||
170395172|NCT00684645|615786048|FG000|Overall Study|Adverse Event|27|||
170395173|NCT00684645|615786048|FG000|Overall Study|Lost to Follow-up|3|||
170395174|NCT00684645|615786048|FG000|Overall Study|Other|15|||
170395175|NCT01819467|615786057|FG000|Overall Study|Physician Decision|20|||
170395176|NCT01819467|615786058|FG001|Overall Study|Physician Decision|9|||
170395177|NCT01299272|615786060|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
170395178|NCT01299272|615786061|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
170395179|NCT01299272|615786062|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
170395180|NCT01299272|615786063|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
170395181|NCT01299272|615786060|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
170395182|NCT01299272|615786061|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
170395183|NCT01299272|615786062|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
170395184|NCT01299272|615786063|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
170395185|NCT01299272|615786060|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
170395186|NCT01299272|615786061|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
170395187|NCT01299272|615786062|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
170395188|NCT01299272|615786063|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
170395189|NCT01299272|615786060|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
170395190|NCT01299272|615786061|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
170395191|NCT01299272|615786062|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
170395192|NCT01299272|615786063|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
170395193|NCT01299272|615786060|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
170395194|NCT01299272|615786061|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
170395195|NCT01299272|615786062|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
170395196|NCT01299272|615786063|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
170395197|NCT01299272|615786060|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
170395198|NCT01299272|615786061|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
170395199|NCT01299272|615786062|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
170395200|NCT01299272|615786063|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
170395201|NCT01299272|615786060|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
170395202|NCT01299272|615786061|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
170395203|NCT01299272|615786062|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
170395204|NCT01299272|615786063|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
170395205|NCT01299272|615786060|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
170395206|NCT01299272|615786061|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
170395207|NCT01299272|615786062|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
170395208|NCT01299272|615786063|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
170395209|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
170395210|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
170395211|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
170395212|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
170395213|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
170395214|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
170395215|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
170395216|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
170395217|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
170395218|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
170395219|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
170395220|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
170398870|NCT05004181|615798322|FG010|Overall Study|Death|0|||
170395221|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
170395222|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
170395223|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
170395224|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
170395225|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
170395226|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
170395227|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
170395228|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
170395229|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
170395230|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
170395231|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
170395232|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
170395233|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
170395234|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
170395235|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
170395236|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
170395237|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
170395238|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
170395239|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
170395240|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
170395241|NCT01299272|615786060|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
170395242|NCT01299272|615786061|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
170395243|NCT01299272|615786062|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
170395244|NCT01299272|615786063|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
170395245|NCT01299272|615786060|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
170395246|NCT01299272|615786061|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
170395247|NCT01299272|615786062|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
170395248|NCT01299272|615786063|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
170395249|NCT01299272|615786060|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
170395250|NCT01299272|615786061|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
170395251|NCT01299272|615786062|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
170395252|NCT01299272|615786063|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
170395253|NCT01299272|615786060|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
170395254|NCT01299272|615786061|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
170395255|NCT01299272|615786062|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
170395256|NCT01299272|615786063|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
170395257|NCT01299272|615786060|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
170395258|NCT01299272|615786061|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
170395259|NCT01299272|615786062|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
170395260|NCT01299272|615786063|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
170395261|NCT01299272|615786060|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
170395262|NCT01299272|615786061|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
170395263|NCT01299272|615786062|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
170395264|NCT01299272|615786063|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
170395265|NCT01299272|615786060|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
170395266|NCT01299272|615786061|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
170395267|NCT01299272|615786062|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
170395268|NCT01299272|615786063|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
170395269|NCT01299272|615786060|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
170395270|NCT01299272|615786061|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
170395271|NCT01299272|615786062|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
170395272|NCT01299272|615786063|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
170395273|NCT01299272|615786060|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
170395274|NCT01299272|615786061|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
170395275|NCT01299272|615786062|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
170395276|NCT01299272|615786063|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
170395277|NCT03926728|615786064|FG000|Overall Study|Withdrawal by Subject|0|||
170395278|NCT03926728|615786065|FG001|Overall Study|Withdrawal by Subject|1|||
170395279|NCT03926728|615786066|FG002|Overall Study|Withdrawal by Subject|1|||
170395280|NCT03926728|615786067|FG003|Overall Study|Withdrawal by Subject|0|||
170395281|NCT03926728|615786068|FG004|Overall Study|Withdrawal by Subject|0|||
170395282|NCT03926728|615786069|FG005|Overall Study|Withdrawal by Subject|1|||
170395283|NCT03926728|615786070|FG006|Overall Study|Withdrawal by Subject|1|||
170395284|NCT03926728|615786071|FG007|Overall Study|Withdrawal by Subject|0|||
170395285|NCT03926728|615786072|FG008|Overall Study|Withdrawal by Subject|0|||
170395286|NCT03926728|615786073|FG009|Overall Study|Withdrawal by Subject|1|||
170395287|NCT03926728|615786074|FG010|Overall Study|Withdrawal by Subject|0|||
170395288|NCT03926728|615786075|FG011|Overall Study|Withdrawal by Subject|0|||
170395289|NCT03286426|615786076|FG000|Overall Study|Physician Decision|3|||
170395290|NCT01817764|615786077|FG000|Overall Study|Adverse Event|7|||
170395291|NCT01817764|615786078|FG001|Overall Study|Adverse Event|10|||
170395292|NCT01817764|615786077|FG000|Overall Study|Lack of Efficacy|9|||
170395293|NCT01817764|615786078|FG001|Overall Study|Lack of Efficacy|7|||
170395294|NCT01817764|615786077|FG000|Overall Study|Protocol Violation|7|||
170395295|NCT01817764|615786078|FG001|Overall Study|Protocol Violation|5|||
170395296|NCT01817764|615786077|FG000|Overall Study|Lost to Follow-up|1|||
170395297|NCT01817764|615786078|FG001|Overall Study|Lost to Follow-up|4|||
170395298|NCT01817764|615786077|FG000|Overall Study|Withdrawal by Subject|10|||
170395299|NCT01817764|615786078|FG001|Overall Study|Withdrawal by Subject|12|||
170395300|NCT00388674|615786081|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
170395301|NCT00388674|615786082|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
170395302|NCT00388674|615786081|FG000|Initial Treatment|Adverse Event|22|||
170395303|NCT00388674|615786082|FG001|Initial Treatment|Adverse Event|87|||
170395304|NCT00388674|615786081|FG000|Initial Treatment|Death|215|||
170395305|NCT00388674|615786082|FG001|Initial Treatment|Death|216|||
170395306|NCT00388674|615786081|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
170395307|NCT00388674|615786082|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
170395308|NCT00388674|615786081|FG000|Initial Treatment|HCC|12|||
170395309|NCT00388674|615786082|FG001|Initial Treatment|HCC|20|||
170395310|NCT00388674|615786081|FG000|Initial Treatment|Lost to Follow-up|526|||
170395311|NCT00388674|615786082|FG001|Initial Treatment|Lost to Follow-up|624|||
170395312|NCT00388674|615786081|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
170395313|NCT00388674|615786082|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
170395314|NCT00388674|615786081|FG000|Initial Treatment|Never Treated with Study Medication|1|||
170395315|NCT00388674|615786082|FG001|Initial Treatment|Never Treated with Study Medication|7|||
170395316|NCT00388674|615786081|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
170395317|NCT00388674|615786082|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
170395318|NCT00388674|615786081|FG000|Initial Treatment|Not Defined|125|||
170395319|NCT00388674|615786082|FG001|Initial Treatment|Not Defined|172|||
170395320|NCT00388674|615786081|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
170395321|NCT00388674|615786082|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
170395322|NCT00388674|615786081|FG000|Initial Treatment|Pregnancy|26|||
170395323|NCT00388674|615786082|FG001|Initial Treatment|Pregnancy|16|||
170395324|NCT00388674|615786081|FG000|Initial Treatment|Study Drug Toxicity|5|||
170395325|NCT00388674|615786082|FG001|Initial Treatment|Study Drug Toxicity|92|||
170395326|NCT00388674|615786081|FG000|Initial Treatment|Participant Request|501|||
170395327|NCT00388674|615786082|FG001|Initial Treatment|Participant Request|673|||
170395328|NCT00388674|615786081|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
170395329|NCT00388674|615786082|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
170395330|NCT00388674|615786081|FG000|Initial Treatment|Not Reported|10|||
170395331|NCT00388674|615786082|FG001|Initial Treatment|Not Reported|12|||
170395332|NCT00388674|615786081|FG000|End of Study|Administrative Reason By Sponsor|299|||
170395333|NCT00388674|615786082|FG001|End of Study|Administrative Reason By Sponsor|253|||
170395334|NCT00388674|615786081|FG000|End of Study|Death|239|||
170395335|NCT00388674|615786082|FG001|End of Study|Death|262|||
170395336|NCT00388674|615786081|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
170395337|NCT00388674|615786082|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
170395338|NCT00388674|615786081|FG000|End of Study|HCC|8|||
170395339|NCT00388674|615786082|FG001|End of Study|HCC|7|||
170395340|NCT00388674|615786081|FG000|End of Study|Lost to Follow-up|587|||
170395341|NCT00388674|615786082|FG001|End of Study|Lost to Follow-up|715|||
170395342|NCT00388674|615786081|FG000|End of Study|Malignancy (Non-HCC)|1|||
170395343|NCT00388674|615786082|FG001|End of Study|Malignancy (Non-HCC)|1|||
170395344|NCT00388674|615786081|FG000|End of Study|Non-Study Related Comorbidities|3|||
170395345|NCT00388674|615786082|FG001|End of Study|Non-Study Related Comorbidities|4|||
170395346|NCT00388674|615786081|FG000|End of Study|Not Defined|135|||
170395347|NCT00388674|615786082|FG001|End of Study|Not Defined|214|||
170395348|NCT00388674|615786081|FG000|End of Study|Participant Withdrew Consent|437|||
170395349|NCT00388674|615786082|FG001|End of Study|Participant Withdrew Consent|673|||
170395350|NCT00388674|615786081|FG000|End of Study|No Off-Treatment Status Data|22|||
170395351|NCT00388674|615786082|FG001|End of Study|No Off-Treatment Status Data|30|||
170395352|NCT00388674|615786081|FG000|End of Study|Not Reported|0|||
170395353|NCT00388674|615786082|FG001|End of Study|Not Reported|1|||
170395354|NCT04484805|615786087|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
170395355|NCT04484805|615786088|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
170395356|NCT04484805|615786087|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
170395357|NCT04484805|615786088|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
170395358|NCT02329834|615786091|FG000|Overall Study|Physician Decision|1|||
170395359|NCT02329834|615786092|FG001|Overall Study|Physician Decision|0|||
170395360|NCT01605370|615786093|FG000|Overall Study|Adverse Event|1|||
170395361|NCT01605370|615786094|FG001|Overall Study|Adverse Event|0|||
170395362|NCT00578448|615786095|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
170395363|NCT00578448|615786095|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
170395364|NCT00578448|615786095|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
170395365|NCT00578448|615786095|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
170395366|NCT01976104|615786099|FG000|Overall Study|Adverse Event|0|||
170395367|NCT01976104|615786100|FG001|Overall Study|Adverse Event|0|||
170395368|NCT01976104|615786101|FG002|Overall Study|Adverse Event|1|||
170395369|NCT01976104|615786102|FG003|Overall Study|Adverse Event|0|||
170395370|NCT01976104|615786099|FG000|Overall Study|Lost to Follow-up|3|||
170395371|NCT01976104|615786100|FG001|Overall Study|Lost to Follow-up|0|||
170395372|NCT01976104|615786101|FG002|Overall Study|Lost to Follow-up|1|||
170395373|NCT01976104|615786102|FG003|Overall Study|Lost to Follow-up|1|||
170395374|NCT01976104|615786099|FG000|Overall Study|Subject Choice|0|||
170395375|NCT01976104|615786100|FG001|Overall Study|Subject Choice|1|||
170395376|NCT01976104|615786101|FG002|Overall Study|Subject Choice|0|||
170395377|NCT01976104|615786102|FG003|Overall Study|Subject Choice|1|||
170395378|NCT01976104|615786099|FG000|Overall Study|Withdrawal by Subject|3|||
170395379|NCT01976104|615786100|FG001|Overall Study|Withdrawal by Subject|0|||
170395380|NCT01976104|615786101|FG002|Overall Study|Withdrawal by Subject|0|||
170395381|NCT01976104|615786102|FG003|Overall Study|Withdrawal by Subject|1|||
170395382|NCT01976104|615786099|FG000|Overall Study|Other|0|||
170395383|NCT01976104|615786100|FG001|Overall Study|Other|1|||
170395384|NCT01976104|615786101|FG002|Overall Study|Other|0|||
170395385|NCT01976104|615786102|FG003|Overall Study|Other|0|||
170395386|NCT01283009|615786103|FG000|Overall Study|Death|83|||
170395387|NCT01283009|615786104|FG001|Overall Study|Death|78|||
170395388|NCT01283009|615786103|FG000|Overall Study|Study ended early|23|||
170395389|NCT01283009|615786104|FG001|Overall Study|Study ended early|26|||
170395390|NCT01283009|615786103|FG000|Overall Study|Withdrawal by Subject|10|||
170395391|NCT01283009|615786104|FG001|Overall Study|Withdrawal by Subject|8|||
170395392|NCT01283009|615786103|FG000|Overall Study|Physician Decision|1|||
170395393|NCT01283009|615786104|FG001|Overall Study|Physician Decision|1|||
170395394|NCT01283009|615786103|FG000|Overall Study|Lost to Follow-up|1|||
170395395|NCT01283009|615786104|FG001|Overall Study|Lost to Follow-up|0|||
170395396|NCT01283009|615786103|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
170395397|NCT01283009|615786104|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
170395398|NCT03237325|615786105|FG000|Overall Study|Lost to Follow-up|3|||
170395399|NCT03237325|615786106|FG001|Overall Study|Lost to Follow-up|5|||
170395400|NCT03237325|615786105|FG000|Overall Study|Physician Decision|2|||
170395401|NCT03237325|615786106|FG001|Overall Study|Physician Decision|4|||
170395402|NCT03237325|615786105|FG000|Overall Study|Withdrawal by Subject|9|||
170395403|NCT03237325|615786106|FG001|Overall Study|Withdrawal by Subject|12|||
170395404|NCT03237325|615786105|FG000|Overall Study|Noncompliance with Study Procedures|1|||
170395405|NCT03237325|615786106|FG001|Overall Study|Noncompliance with Study Procedures|1|||
170395406|NCT03237325|615786105|FG000|Overall Study|Termination by Sponsor|0|||
170395407|NCT03237325|615786106|FG001|Overall Study|Termination by Sponsor|1|||
170395408|NCT03237325|615786105|FG000|Overall Study|Reason other than described|0|||
170395409|NCT03237325|615786106|FG001|Overall Study|Reason other than described|2|||
170395410|NCT02684370|615786107|FG000|Part A|Adverse Event|2|||
170395411|NCT02684370|615786108|FG001|Part A|Adverse Event|0|||
170395412|NCT02684370|615786109|FG002|Part A|Adverse Event|1|||
170395413|NCT02684370|615786110|FG003|Part A|Adverse Event|0|||
170395414|NCT02684370|615786111|FG004|Part A|Adverse Event|0|||
170395415|NCT02684370|615786112|FG005|Part A|Adverse Event|0|||
170395416|NCT02684370|615786107|FG000|Part A|Lost to Follow-up|1|||
170395417|NCT02684370|615786108|FG001|Part A|Lost to Follow-up|1|||
170395418|NCT02684370|615786109|FG002|Part A|Lost to Follow-up|0|||
170395419|NCT02684370|615786110|FG003|Part A|Lost to Follow-up|0|||
170395420|NCT02684370|615786111|FG004|Part A|Lost to Follow-up|0|||
170395421|NCT02684370|615786112|FG005|Part A|Lost to Follow-up|0|||
170395422|NCT02684370|615786107|FG000|Part A|Subject Withdrawal|1|||
170395423|NCT02684370|615786108|FG001|Part A|Subject Withdrawal|0|||
170395424|NCT02684370|615786109|FG002|Part A|Subject Withdrawal|3|||
170395425|NCT02684370|615786110|FG003|Part A|Subject Withdrawal|0|||
170395426|NCT02684370|615786111|FG004|Part A|Subject Withdrawal|0|||
170395427|NCT02684370|615786112|FG005|Part A|Subject Withdrawal|0|||
170395428|NCT02684370|615786107|FG000|Part A|Other|0|||
170395429|NCT02684370|615786108|FG001|Part A|Other|0|||
170395430|NCT02684370|615786109|FG002|Part A|Other|1|||
170395431|NCT02684370|615786110|FG003|Part A|Other|0|||
170395432|NCT02684370|615786111|FG004|Part A|Other|0|||
170395433|NCT02684370|615786112|FG005|Part A|Other|0|||
170395434|NCT02684370|615786107|FG000|Part B|Adverse Event|0|||
170395435|NCT02684370|615786108|FG001|Part B|Adverse Event|0|||
170395436|NCT02684370|615786109|FG002|Part B|Adverse Event|0|||
170395437|NCT02684370|615786110|FG003|Part B|Adverse Event|0|||
170395438|NCT02684370|615786111|FG004|Part B|Adverse Event|2|||
170395439|NCT02684370|615786112|FG005|Part B|Adverse Event|1|||
170395440|NCT02684370|615786107|FG000|Part B|Lost to Follow-up|0|||
170395441|NCT02684370|615786108|FG001|Part B|Lost to Follow-up|0|||
170395442|NCT02684370|615786109|FG002|Part B|Lost to Follow-up|0|||
170395443|NCT02684370|615786110|FG003|Part B|Lost to Follow-up|1|||
170395444|NCT02684370|615786111|FG004|Part B|Lost to Follow-up|2|||
170395445|NCT02684370|615786112|FG005|Part B|Lost to Follow-up|5|||
170395446|NCT02684370|615786107|FG000|Part B|Subject Withdrawal|0|||
170395447|NCT02684370|615786108|FG001|Part B|Subject Withdrawal|0|||
170395448|NCT02684370|615786109|FG002|Part B|Subject Withdrawal|0|||
170395449|NCT02684370|615786110|FG003|Part B|Subject Withdrawal|1|||
170395450|NCT02684370|615786111|FG004|Part B|Subject Withdrawal|1|||
170395451|NCT02684370|615786112|FG005|Part B|Subject Withdrawal|2|||
170395452|NCT01569594|615786116|FG000|Overall Study|Physician Decision|4|||
170395453|NCT01569594|615786116|FG000|Overall Study|Death|13|||
170395454|NCT01569594|615786116|FG000|Overall Study|Lost to Follow-up|22|||
170395455|NCT01569594|615786116|FG000|Overall Study|Adverse Event|2|||
170395456|NCT01569594|615786116|FG000|Overall Study|Withdrawal by Subject|13|||
170395457|NCT01569594|615786116|FG000|Overall Study|Other|4|||
170395458|NCT01569594|615786116|FG000|Overall Study|No ECM used|9|||
170395459|NCT04139642|615786117|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
170395460|NCT04139642|615786118|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
170395461|NCT00433771|615786121|FG000|Overall Study|screen fail|14|||
170395462|NCT00433771|615786121|FG000|Overall Study|Treated and later found to be ineligible|2|||
170395463|NCT00433771|615786121|FG000|Overall Study|Death|2|||
170395464|NCT00433771|615786121|FG000|Overall Study|Failure to deploy stent|1|||
170395465|NCT03069365|615786125|FG000|Overall Study|Adverse Event|1|||
170395466|NCT00539006|615786126|FG000|Pre-treatment|Other|0|||
170395467|NCT00539006|615786127|FG001|Pre-treatment|Other|1|||
170395468|NCT00539006|615786128|FG002|Pre-treatment|Other|0|||
170395469|NCT00539006|615786129|FG003|Pre-treatment|Other|0|||
170395470|NCT00539006|615786126|FG000|Treatment Period 1|Lost to Follow-up|0|||
170395471|NCT00539006|615786127|FG001|Treatment Period 1|Lost to Follow-up|0|||
170395472|NCT00539006|615786128|FG002|Treatment Period 1|Lost to Follow-up|1|||
170395473|NCT00539006|615786129|FG003|Treatment Period 1|Lost to Follow-up|0|||
170395474|NCT00539006|615786126|FG000|Treatment Period 1|Protocol Violation|0|||
170395475|NCT00539006|615786127|FG001|Treatment Period 1|Protocol Violation|0|||
170395476|NCT00539006|615786128|FG002|Treatment Period 1|Protocol Violation|1|||
170395477|NCT00539006|615786129|FG003|Treatment Period 1|Protocol Violation|0|||
170395478|NCT00539006|615786126|FG000|Treatment Period 1|Lack of Efficacy|0|||
170395479|NCT00539006|615786127|FG001|Treatment Period 1|Lack of Efficacy|0|||
170395480|NCT00539006|615786128|FG002|Treatment Period 1|Lack of Efficacy|0|||
170395481|NCT00539006|615786129|FG003|Treatment Period 1|Lack of Efficacy|1|||
170395482|NCT00539006|615786126|FG000|Washout|Adverse Event|2|||
170395483|NCT00539006|615786127|FG001|Washout|Adverse Event|1|||
170395484|NCT00539006|615786128|FG002|Washout|Adverse Event|0|||
170395485|NCT00539006|615786129|FG003|Washout|Adverse Event|0|||
170395486|NCT00539006|615786126|FG000|Washout|Protocol Violation|1|||
170395487|NCT00539006|615786127|FG001|Washout|Protocol Violation|1|||
170395488|NCT00539006|615786128|FG002|Washout|Protocol Violation|0|||
170395489|NCT00539006|615786129|FG003|Washout|Protocol Violation|0|||
170395490|NCT00539006|615786126|FG000|Washout|Withdrawal by Subject|0|||
170395491|NCT00539006|615786127|FG001|Washout|Withdrawal by Subject|2|||
170395492|NCT00539006|615786128|FG002|Washout|Withdrawal by Subject|0|||
170395493|NCT00539006|615786129|FG003|Washout|Withdrawal by Subject|0|||
170395494|NCT00539006|615786126|FG000|Washout|Failed to meet continuation criteria|16|||
170395495|NCT00539006|615786127|FG001|Washout|Failed to meet continuation criteria|5|||
170395496|NCT00539006|615786128|FG002|Washout|Failed to meet continuation criteria|14|||
170395497|NCT00539006|615786129|FG003|Washout|Failed to meet continuation criteria|6|||
170395498|NCT00539006|615786126|FG000|Washout|Other|1|||
170395499|NCT00539006|615786127|FG001|Washout|Other|1|||
170395500|NCT00539006|615786128|FG002|Washout|Other|2|||
170395501|NCT00539006|615786129|FG003|Washout|Other|3|||
170395502|NCT00539006|615786126|FG000|Treatment Period 2|Protocol Violation|1|||
170395503|NCT00539006|615786127|FG001|Treatment Period 2|Protocol Violation|0|||
170395504|NCT00539006|615786128|FG002|Treatment Period 2|Protocol Violation|0|||
170395505|NCT00539006|615786129|FG003|Treatment Period 2|Protocol Violation|0|||
170395506|NCT00539006|615786126|FG000|Treatment Period 2|Other|0|||
170395507|NCT00539006|615786127|FG001|Treatment Period 2|Other|1|||
170395508|NCT00539006|615786128|FG002|Treatment Period 2|Other|0|||
170395509|NCT00539006|615786129|FG003|Treatment Period 2|Other|0|||
170395510|NCT01965431|615786131|FG000|Overall Study|Adverse Event|0|||
170395511|NCT01965431|615786132|FG001|Overall Study|Adverse Event|1|||
170395512|NCT01965431|615786133|FG002|Overall Study|Adverse Event|0|||
170395513|NCT01965431|615786134|FG003|Overall Study|Adverse Event|0|||
170395514|NCT01965431|615786135|FG004|Overall Study|Adverse Event|0|||
170395515|NCT01965431|615786136|FG005|Overall Study|Adverse Event|0|||
170395516|NCT01965431|615786131|FG000|Overall Study|Other than stated above|6|||
170395517|NCT01965431|615786132|FG001|Overall Study|Other than stated above|5|||
170395518|NCT01965431|615786133|FG002|Overall Study|Other than stated above|6|||
170395519|NCT01965431|615786134|FG003|Overall Study|Other than stated above|6|||
170395520|NCT01965431|615786135|FG004|Overall Study|Other than stated above|6|||
170395521|NCT01965431|615786136|FG005|Overall Study|Other than stated above|6|||
170395522|NCT04635631|615786137|FG000|Overall Study|Adverse Event|1|||
170395523|NCT04635631|615786137|FG000|Overall Study|Progressive disease|13|||
170395524|NCT04635631|615786137|FG000|Overall Study|Withdrawal by Subject|1|||
170395525|NCT01067339|615786138|FG000|Overall Study|Withdrawal by Subject|6|||
170395526|NCT01067339|615786139|FG001|Overall Study|Withdrawal by Subject|5|||
170395527|NCT01179191|615786140|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
170395528|NCT01179191|615786140|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
170395529|NCT01179191|615786140|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
170395530|NCT01179191|615786140|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
170395531|NCT01179191|615786140|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
170395532|NCT01179191|615786140|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
170395533|NCT01179191|615786140|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
170395534|NCT01179191|615786140|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
170395535|NCT01179191|615786140|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
170395536|NCT01179191|615786140|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
170395537|NCT01179191|615786140|FG000|Maintenance Phase (8 Weeks)|Other|66|||
170395538|NCT00572910|615786141|FG000|Overall Study|Adverse Event|1|||
170395539|NCT00572910|615786142|FG001|Overall Study|Adverse Event|2|||
170395540|NCT00572910|615786143|FG002|Overall Study|Adverse Event|0|||
170395541|NCT00572910|615786144|FG003|Overall Study|Adverse Event|2|||
170395542|NCT00572910|615786145|FG004|Overall Study|Adverse Event|0|||
170395543|NCT00572910|615786146|FG005|Overall Study|Adverse Event|0|||
170395544|NCT00572910|615786147|FG006|Overall Study|Adverse Event|4|||
170395545|NCT00572910|615786148|FG007|Overall Study|Adverse Event|2|||
170395546|NCT00572910|615786149|FG008|Overall Study|Adverse Event|1|||
170395547|NCT00572910|615786150|FG009|Overall Study|Adverse Event|3|||
170395548|NCT00572910|615786151|FG010|Overall Study|Adverse Event|2|||
170395549|NCT00572910|615786141|FG000|Overall Study|Lost to Follow-up|0|||
170395550|NCT00572910|615786142|FG001|Overall Study|Lost to Follow-up|1|||
170395551|NCT00572910|615786143|FG002|Overall Study|Lost to Follow-up|1|||
170395552|NCT00572910|615786144|FG003|Overall Study|Lost to Follow-up|2|||
170395553|NCT00572910|615786145|FG004|Overall Study|Lost to Follow-up|1|||
170395554|NCT00572910|615786146|FG005|Overall Study|Lost to Follow-up|0|||
170395555|NCT00572910|615786147|FG006|Overall Study|Lost to Follow-up|0|||
170395556|NCT00572910|615786148|FG007|Overall Study|Lost to Follow-up|0|||
170395557|NCT00572910|615786149|FG008|Overall Study|Lost to Follow-up|0|||
170395558|NCT00572910|615786150|FG009|Overall Study|Lost to Follow-up|1|||
170395559|NCT00572910|615786151|FG010|Overall Study|Lost to Follow-up|0|||
170395560|NCT00572910|615786141|FG000|Overall Study|Withdrawal by Subject|3|||
170395561|NCT00572910|615786142|FG001|Overall Study|Withdrawal by Subject|0|||
170395562|NCT00572910|615786143|FG002|Overall Study|Withdrawal by Subject|1|||
170395563|NCT00572910|615786144|FG003|Overall Study|Withdrawal by Subject|0|||
170395564|NCT00572910|615786145|FG004|Overall Study|Withdrawal by Subject|1|||
170395565|NCT00572910|615786146|FG005|Overall Study|Withdrawal by Subject|3|||
170395566|NCT00572910|615786147|FG006|Overall Study|Withdrawal by Subject|0|||
170395567|NCT00572910|615786148|FG007|Overall Study|Withdrawal by Subject|2|||
170395568|NCT00572910|615786149|FG008|Overall Study|Withdrawal by Subject|2|||
170395569|NCT00572910|615786150|FG009|Overall Study|Withdrawal by Subject|2|||
170395570|NCT00572910|615786151|FG010|Overall Study|Withdrawal by Subject|1|||
170395571|NCT04054011|615786152|FG000|Overall Study|COVID|3|||
170395572|NCT00592007|615786153|FG000|Overall Study|Withdrawal by Subject|1|||
170395573|NCT00592007|615786153|FG000|Overall Study|patient ineligible (out of lab range)|1|||
170395574|NCT00595127|615786154|FG000|Overall Study|Death|6|||
170395575|NCT00595127|615786154|FG000|Overall Study|Relapsed|3|||
170395576|NCT00595127|615786154|FG000|Overall Study|joined another trial|1|||
170395577|NCT01785472|615786155|FG000|Overall Study|Adverse Event|5|||
170395578|NCT01785472|615786156|FG001|Overall Study|Adverse Event|4|||
170395579|NCT01785472|615786157|FG002|Overall Study|Adverse Event|6|||
170395580|NCT01785472|615786155|FG000|Overall Study|Lack of Efficacy|2|||
170395581|NCT01785472|615786156|FG001|Overall Study|Lack of Efficacy|0|||
170395582|NCT01785472|615786157|FG002|Overall Study|Lack of Efficacy|1|||
170395583|NCT01785472|615786155|FG000|Overall Study|Lost to Follow-up|1|||
170395584|NCT01785472|615786156|FG001|Overall Study|Lost to Follow-up|2|||
170395585|NCT01785472|615786157|FG002|Overall Study|Lost to Follow-up|0|||
170395586|NCT01785472|615786155|FG000|Overall Study|Physician Decision|1|||
170395587|NCT01785472|615786156|FG001|Overall Study|Physician Decision|1|||
170395588|NCT01785472|615786157|FG002|Overall Study|Physician Decision|1|||
170395589|NCT01785472|615786155|FG000|Overall Study|Protocol deviation|0|||
170395590|NCT01785472|615786156|FG001|Overall Study|Protocol deviation|2|||
170395591|NCT01785472|615786157|FG002|Overall Study|Protocol deviation|2|||
170395592|NCT01785472|615786155|FG000|Overall Study|Subject/guardian decision|15|||
170395593|NCT01785472|615786156|FG001|Overall Study|Subject/guardian decision|10|||
170395594|NCT01785472|615786157|FG002|Overall Study|Subject/guardian decision|11|||
170395595|NCT01785472|615786155|FG000|Overall Study|Technical problems|0|||
170395596|NCT01785472|615786156|FG001|Overall Study|Technical problems|0|||
170395597|NCT01785472|615786157|FG002|Overall Study|Technical problems|1|||
170395598|NCT01125358|615786162|FG000|Overall Study|Adverse Event|3|||
170395599|NCT01125358|615786163|FG001|Overall Study|Adverse Event|0|||
170395600|NCT01125358|615786164|FG002|Overall Study|Adverse Event|0|||
170395601|NCT01125358|615786165|FG003|Overall Study|Adverse Event|2|||
170395602|NCT01125358|615786162|FG000|Overall Study|Perceived Lack of Efficacy|6|||
170395603|NCT01125358|615786163|FG001|Overall Study|Perceived Lack of Efficacy|3|||
170395604|NCT01125358|615786164|FG002|Overall Study|Perceived Lack of Efficacy|7|||
170395605|NCT01125358|615786165|FG003|Overall Study|Perceived Lack of Efficacy|4|||
170395606|NCT01125358|615786162|FG000|Overall Study|Protocol Violation|1|||
170395607|NCT01125358|615786163|FG001|Overall Study|Protocol Violation|0|||
170395608|NCT01125358|615786164|FG002|Overall Study|Protocol Violation|0|||
170395609|NCT01125358|615786165|FG003|Overall Study|Protocol Violation|0|||
170395610|NCT01125358|615786162|FG000|Overall Study|Sponsor Decision|0|||
170395611|NCT01125358|615786163|FG001|Overall Study|Sponsor Decision|0|||
170395612|NCT01125358|615786164|FG002|Overall Study|Sponsor Decision|1|||
170395613|NCT01125358|615786165|FG003|Overall Study|Sponsor Decision|1|||
170395614|NCT01125358|615786162|FG000|Overall Study|Withdrawal by Subject|2|||
170395615|NCT01125358|615786163|FG001|Overall Study|Withdrawal by Subject|1|||
170395616|NCT01125358|615786164|FG002|Overall Study|Withdrawal by Subject|1|||
170395617|NCT01125358|615786165|FG003|Overall Study|Withdrawal by Subject|1|||
170395618|NCT05168657|615786169|FG000|Overall Study|Adverse Event|0|||
170395619|NCT05168657|615786170|FG001|Overall Study|Adverse Event|0|||
170395620|NCT05168657|615786171|FG002|Overall Study|Adverse Event|1|||
170395621|NCT05168657|615786172|FG003|Overall Study|Adverse Event|0|||
170395622|NCT05168657|615786173|FG004|Overall Study|Adverse Event|0|||
170395623|NCT05168657|615786174|FG005|Overall Study|Adverse Event|0|||
170395624|NCT05168657|615786175|FG006|Overall Study|Adverse Event|0|||
170395625|NCT05168657|615786176|FG007|Overall Study|Adverse Event|0|||
170395626|NCT00962013|615786179|FG000|Overall Study|Did not have surgery|1|||
170395627|NCT00962013|615786179|FG000|Overall Study|Death|8|||
170395628|NCT00962013|615786179|FG000|Overall Study|Lost to Follow-up|12|||
170395629|NCT00962013|615786179|FG000|Overall Study|Unable/Unwilling to return|6|||
170395630|NCT00962013|615786179|FG000|Overall Study|Withdrawal by Subject|8|||
170395631|NCT00962013|615786179|FG000|Overall Study|Removal of study device|3|||
170395632|NCT00962013|615786179|FG000|Overall Study|Site Termination|24|||
170395633|NCT00962013|615786179|FG000|Overall Study|No 5 year evaluation|6|||
170395634|NCT00424632|615786180|FG000|Overall Study|Death|0|||
170395635|NCT00424632|615786181|FG001|Overall Study|Death|0|||
170395636|NCT00424632|615786182|FG002|Overall Study|Death|0|||
170395637|NCT00424632|615786183|FG003|Overall Study|Death|0|||
170395638|NCT00424632|615786184|FG004|Overall Study|Death|0|||
170395639|NCT00424632|615786185|FG005|Overall Study|Death|2|||
170395640|NCT00424632|615786186|FG006|Overall Study|Death|0|||
170395641|NCT00424632|615786187|FG007|Overall Study|Death|0|||
170395642|NCT00424632|615786188|FG008|Overall Study|Death|0|||
170395643|NCT00424632|615786189|FG009|Overall Study|Death|0|||
170395644|NCT00424632|615786180|FG000|Overall Study|Adverse Event|0|||
170395645|NCT00424632|615786181|FG001|Overall Study|Adverse Event|0|||
170395646|NCT00424632|615786182|FG002|Overall Study|Adverse Event|0|||
170395647|NCT00424632|615786183|FG003|Overall Study|Adverse Event|0|||
170395648|NCT00424632|615786184|FG004|Overall Study|Adverse Event|0|||
170395649|NCT00424632|615786185|FG005|Overall Study|Adverse Event|0|||
170395650|NCT00424632|615786186|FG006|Overall Study|Adverse Event|0|||
170395651|NCT00424632|615786187|FG007|Overall Study|Adverse Event|0|||
170395652|NCT00424632|615786188|FG008|Overall Study|Adverse Event|3|||
170395653|NCT00424632|615786189|FG009|Overall Study|Adverse Event|2|||
170395654|NCT00424632|615786180|FG000|Overall Study|Global deterioration of health status|0|||
170395655|NCT00424632|615786181|FG001|Overall Study|Global deterioration of health status|0|||
170395656|NCT00424632|615786182|FG002|Overall Study|Global deterioration of health status|0|||
170395657|NCT00424632|615786183|FG003|Overall Study|Global deterioration of health status|1|||
170395658|NCT00424632|615786184|FG004|Overall Study|Global deterioration of health status|1|||
170395659|NCT00424632|615786185|FG005|Overall Study|Global deterioration of health status|0|||
170395660|NCT00424632|615786186|FG006|Overall Study|Global deterioration of health status|0|||
170395661|NCT00424632|615786187|FG007|Overall Study|Global deterioration of health status|0|||
170395662|NCT00424632|615786188|FG008|Overall Study|Global deterioration of health status|0|||
170395663|NCT00424632|615786189|FG009|Overall Study|Global deterioration of health status|0|||
170395664|NCT00424632|615786180|FG000|Overall Study|Objective progression or relapse|1|||
170395665|NCT00424632|615786181|FG001|Overall Study|Objective progression or relapse|1|||
170395666|NCT00424632|615786182|FG002|Overall Study|Objective progression or relapse|1|||
170395667|NCT00424632|615786183|FG003|Overall Study|Objective progression or relapse|2|||
170395668|NCT00424632|615786184|FG004|Overall Study|Objective progression or relapse|2|||
170395669|NCT00424632|615786185|FG005|Overall Study|Objective progression or relapse|13|||
170395670|NCT00424632|615786186|FG006|Overall Study|Objective progression or relapse|7|||
170395671|NCT00424632|615786187|FG007|Overall Study|Objective progression or relapse|3|||
170395672|NCT00424632|615786188|FG008|Overall Study|Objective progression or relapse|12|||
170395673|NCT00424632|615786189|FG009|Overall Study|Objective progression or relapse|4|||
170395674|NCT00424632|615786180|FG000|Overall Study|Other|0|||
170395675|NCT00424632|615786181|FG001|Overall Study|Other|0|||
170395676|NCT00424632|615786182|FG002|Overall Study|Other|0|||
170395677|NCT00424632|615786183|FG003|Overall Study|Other|1|||
170395678|NCT00424632|615786184|FG004|Overall Study|Other|0|||
170395679|NCT00424632|615786185|FG005|Overall Study|Other|0|||
170395680|NCT00424632|615786186|FG006|Overall Study|Other|0|||
170395681|NCT00424632|615786187|FG007|Overall Study|Other|0|||
170395682|NCT00424632|615786188|FG008|Overall Study|Other|1|||
170395683|NCT00424632|615786189|FG009|Overall Study|Other|0|||
170395684|NCT02628418|615786190|FG000|Overall Study|Lost to Follow-up|1|||
170395685|NCT02628418|615786191|FG001|Overall Study|Lost to Follow-up|2|||
170395686|NCT02072174|615786195|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
170395687|NCT02072174|615786196|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
170395688|NCT02072174|615786195|FG000|Overall Study|Protocol Violation|16|||
170395689|NCT02072174|615786196|FG001|Overall Study|Protocol Violation|23|||
170395690|NCT02072174|615786195|FG000|Overall Study|Physician Decision|0|||
170395691|NCT02072174|615786196|FG001|Overall Study|Physician Decision|1|||
170395692|NCT02072174|615786195|FG000|Overall Study|Non-compliance with protocol requirement|2|||
170395693|NCT02072174|615786196|FG001|Overall Study|Non-compliance with protocol requirement|0|||
170395694|NCT05674721|615786197|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
170395695|NCT05674721|615786198|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
170395696|NCT05674721|615786197|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
170395697|NCT05674721|615786198|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
170395698|NCT01393626|615786211|FG000|Overall Study|Adverse Event|2|||
170395699|NCT01393626|615786212|FG001|Overall Study|Adverse Event|1|||
170395700|NCT01393626|615786213|FG002|Overall Study|Adverse Event|5|||
170395701|NCT01393626|615786214|FG003|Overall Study|Adverse Event|0|||
170395702|NCT01393626|615786211|FG000|Overall Study|Did not meet entrance criteria|1|||
170395703|NCT01393626|615786212|FG001|Overall Study|Did not meet entrance criteria|0|||
170395704|NCT01393626|615786213|FG002|Overall Study|Did not meet entrance criteria|0|||
170395705|NCT01393626|615786214|FG003|Overall Study|Did not meet entrance criteria|0|||
170395706|NCT01393626|615786211|FG000|Overall Study|Lack of Efficacy|6|||
170395707|NCT01393626|615786212|FG001|Overall Study|Lack of Efficacy|6|||
170395708|NCT01393626|615786213|FG002|Overall Study|Lack of Efficacy|4|||
170395709|NCT01393626|615786214|FG003|Overall Study|Lack of Efficacy|1|||
170395710|NCT01393626|615786211|FG000|Overall Study|Lost to Follow-up|1|||
170395711|NCT01393626|615786212|FG001|Overall Study|Lost to Follow-up|1|||
170395712|NCT01393626|615786213|FG002|Overall Study|Lost to Follow-up|1|||
170395713|NCT01393626|615786214|FG003|Overall Study|Lost to Follow-up|0|||
170395714|NCT01393626|615786211|FG000|Overall Study|Withdrawal by Subject|6|||
170395715|NCT01393626|615786212|FG001|Overall Study|Withdrawal by Subject|4|||
170395716|NCT01393626|615786213|FG002|Overall Study|Withdrawal by Subject|0|||
170395717|NCT01393626|615786214|FG003|Overall Study|Withdrawal by Subject|0|||
170395718|NCT01393626|615786211|FG000|Overall Study|Other|1|||
170395719|NCT01393626|615786212|FG001|Overall Study|Other|0|||
170395720|NCT01393626|615786213|FG002|Overall Study|Other|0|||
170395721|NCT01393626|615786214|FG003|Overall Study|Other|0|||
170395722|NCT01393626|615786211|FG000|Overall Study|Protocol Violation|1|||
170395723|NCT01393626|615786212|FG001|Overall Study|Protocol Violation|0|||
170395724|NCT01393626|615786213|FG002|Overall Study|Protocol Violation|2|||
170395725|NCT01393626|615786214|FG003|Overall Study|Protocol Violation|0|||
170395726|NCT02426125|615786215|FG000|Overall Study|Lost to Follow-up|14|||
170395727|NCT02426125|615786216|FG001|Overall Study|Lost to Follow-up|12|||
170395728|NCT02426125|615786215|FG000|Overall Study|Withdrawal by Subject|13|||
170395729|NCT02426125|615786216|FG001|Overall Study|Withdrawal by Subject|14|||
170395730|NCT02426125|615786215|FG000|Overall Study|Death|185|||
170395731|NCT02426125|615786216|FG001|Overall Study|Death|200|||
170395732|NCT02426125|615786215|FG000|Overall Study|Randomized, But Never Treated|5|||
170395733|NCT02426125|615786216|FG001|Overall Study|Randomized, But Never Treated|2|||
170395734|NCT03506425|615786217|FG000|Overall Study|Adverse Event|1|||
170395735|NCT03506425|615786218|FG001|Overall Study|Adverse Event|3|||
170395736|NCT03506425|615786219|FG002|Overall Study|Adverse Event|0|||
170395737|NCT03506425|615786217|FG000|Overall Study|Death|1|||
170395738|NCT03506425|615786218|FG001|Overall Study|Death|0|||
170395739|NCT03506425|615786219|FG002|Overall Study|Death|0|||
170395740|NCT03506425|615786217|FG000|Overall Study|Withdrawal by Subject|0|||
170395741|NCT03506425|615786218|FG001|Overall Study|Withdrawal by Subject|0|||
170395742|NCT03506425|615786219|FG002|Overall Study|Withdrawal by Subject|1|||
170395743|NCT00077766|615786220|FG000|Overall Study|Adverse Event|1|||
170395744|NCT00077766|615786221|FG001|Overall Study|Adverse Event|1|||
170395745|NCT00077766|615786220|FG000|Overall Study|Withdrawal by Subject|4|||
170395746|NCT00077766|615786221|FG001|Overall Study|Withdrawal by Subject|3|||
170395747|NCT00077766|615786220|FG000|Overall Study|Death|12|||
170395748|NCT00077766|615786221|FG001|Overall Study|Death|10|||
170395749|NCT00077766|615786220|FG000|Overall Study|Lost to Follow-up|2|||
170395750|NCT00077766|615786221|FG001|Overall Study|Lost to Follow-up|0|||
170395751|NCT00077766|615786220|FG000|Overall Study|Protocol Violation|1|||
170395752|NCT00077766|615786221|FG001|Overall Study|Protocol Violation|0|||
170395753|NCT00077766|615786220|FG000|Overall Study|Kidney Transplantation|9|||
170395754|NCT00077766|615786221|FG001|Overall Study|Kidney Transplantation|5|||
170395755|NCT00077766|615786220|FG000|Overall Study|Transplantation|5|||
170395756|NCT00077766|615786221|FG001|Overall Study|Transplantation|1|||
170395757|NCT00077766|615786220|FG000|Overall Study|Investigators Discretion|1|||
170395758|NCT00077766|615786221|FG001|Overall Study|Investigators Discretion|0|||
170395759|NCT00077766|615786220|FG000|Overall Study|Participant's decision|1|||
170395760|NCT00077766|615786221|FG001|Overall Study|Participant's decision|0|||
170395761|NCT00077766|615786220|FG000|Overall Study|Dialysis Discontinued|1|||
170395762|NCT00077766|615786221|FG001|Overall Study|Dialysis Discontinued|0|||
170395763|NCT00077766|615786220|FG000|Overall Study|Dialysis|0|||
170395764|NCT00077766|615786221|FG001|Overall Study|Dialysis|1|||
170395765|NCT00077766|615786220|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
170395766|NCT00077766|615786221|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
170395767|NCT00077766|615786220|FG000|Overall Study|Started Nocturnal Dialysis|0|||
170395768|NCT00077766|615786221|FG001|Overall Study|Started Nocturnal Dialysis|1|||
170395769|NCT00077766|615786220|FG000|Overall Study|Stop Dialysis|0|||
170395770|NCT00077766|615786221|FG001|Overall Study|Stop Dialysis|1|||
170395771|NCT00077766|615786220|FG000|Overall Study|Participants Vacation|2|||
170395772|NCT00077766|615786221|FG001|Overall Study|Participants Vacation|1|||
170395773|NCT05378269|615787581|FG000|Overall Study|Protocol Violation|1|||
170395774|NCT05378269|615787582|FG001|Overall Study|Protocol Violation|0|||
170395775|NCT05378269|615787583|FG002|Overall Study|Protocol Violation|2|||
170395776|NCT05378269|615787584|FG003|Overall Study|Protocol Violation|0|||
170395777|NCT05378269|615787585|FG004|Overall Study|Protocol Violation|0|||
170395778|NCT00359073|615787586|FG000|Overall Study|Withdrawal by Subject|1|||
170395779|NCT00359073|615787587|FG001|Overall Study|Withdrawal by Subject|1|||
170395780|NCT00359073|615787586|FG000|Overall Study|Eligibility criteria no longer met|3|||
170395781|NCT00359073|615787587|FG001|Overall Study|Eligibility criteria no longer met|0|||
170395782|NCT00359073|615787586|FG000|Overall Study|developed RV16 antibody|0|||
170395783|NCT00359073|615787587|FG001|Overall Study|developed RV16 antibody|1|||
170395784|NCT00685763|615787588|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
170395785|NCT00685763|615787588|FG000|Overall Study|Protocol Violation|1|||
170395786|NCT04362761|615787592|FG000|Part A (48 Weeks)|Adverse Event|2|||
170395787|NCT04362761|615787592|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
170395788|NCT04362761|615787592|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
170395789|NCT04362761|615787592|FG000|Part A (48 Weeks)|Other|5|||
170395790|NCT04362761|615787592|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
170395791|NCT04362761|615787592|FG000|Part B (86 Weeks)|Other|4|||
170395792|NCT01956123|615787598|FG000|COS Cycle 2|Protocol Violation|8|||
170395793|NCT01956123|615787599|FG001|COS Cycle 2|Protocol Violation|3|||
170395794|NCT01956123|615787600|FG002|COS Cycle 2|Protocol Violation|0|||
170395795|NCT01956123|615787601|FG003|COS Cycle 2|Protocol Violation|0|||
170395796|NCT01956123|615787598|FG000|COS Cycle 2|Adverse Event|3|||
170395797|NCT01956123|615787599|FG001|COS Cycle 2|Adverse Event|4|||
170395798|NCT01956123|615787600|FG002|COS Cycle 2|Adverse Event|0|||
170395799|NCT01956123|615787601|FG003|COS Cycle 2|Adverse Event|0|||
170395800|NCT01956123|615787598|FG000|COS Cycle 2|Personal Reasons|2|||
170395801|NCT01956123|615787599|FG001|COS Cycle 2|Personal Reasons|0|||
170395802|NCT01956123|615787600|FG002|COS Cycle 2|Personal Reasons|0|||
170395803|NCT01956123|615787601|FG003|COS Cycle 2|Personal Reasons|0|||
170395804|NCT01956123|615787598|FG000|COS Cycle 2|Withdrawal by Subject|1|||
170395805|NCT01956123|615787599|FG001|COS Cycle 2|Withdrawal by Subject|0|||
170395806|NCT01956123|615787600|FG002|COS Cycle 2|Withdrawal by Subject|0|||
170395807|NCT01956123|615787601|FG003|COS Cycle 2|Withdrawal by Subject|0|||
170395808|NCT01956123|615787598|FG000|COS Cycle 3|Protocol Violation|0|||
170395809|NCT01956123|615787599|FG001|COS Cycle 3|Protocol Violation|0|||
170395810|NCT01956123|615787600|FG002|COS Cycle 3|Protocol Violation|2|||
170395811|NCT01956123|615787601|FG003|COS Cycle 3|Protocol Violation|1|||
170395812|NCT01956123|615787598|FG000|COS Cycle 3|Adverse Event|0|||
170395813|NCT01956123|615787599|FG001|COS Cycle 3|Adverse Event|0|||
170395814|NCT01956123|615787600|FG002|COS Cycle 3|Adverse Event|3|||
170395815|NCT01956123|615787601|FG003|COS Cycle 3|Adverse Event|0|||
170395816|NCT01956123|615787598|FG000|COS Cycle 3|Personal Reasons|0|||
170395817|NCT01956123|615787599|FG001|COS Cycle 3|Personal Reasons|0|||
170395818|NCT01956123|615787600|FG002|COS Cycle 3|Personal Reasons|1|||
170395819|NCT01956123|615787601|FG003|COS Cycle 3|Personal Reasons|0|||
170395820|NCT01956123|615787598|FG000|COS Cycle 3|Withdrawal by Subject|0|||
170395821|NCT01956123|615787599|FG001|COS Cycle 3|Withdrawal by Subject|0|||
170395822|NCT01956123|615787600|FG002|COS Cycle 3|Withdrawal by Subject|0|||
170395823|NCT01956123|615787601|FG003|COS Cycle 3|Withdrawal by Subject|1|||
170395824|NCT01615822|615787604|FG000|Period 1|Withdrawal by Subject|0|||
170395825|NCT01615822|615787605|FG001|Period 1|Withdrawal by Subject|1|||
170395826|NCT01615822|615787606|FG002|Period 1|Withdrawal by Subject|0|||
170395827|NCT01615822|615787604|FG000|Period 1|Adverse Event|1|||
170395828|NCT01615822|615787605|FG001|Period 1|Adverse Event|1|||
170395829|NCT01615822|615787606|FG002|Period 1|Adverse Event|0|||
170395830|NCT01615822|615787604|FG000|Period 2|Lost to Follow-up|0|||
170395831|NCT01615822|615787605|FG001|Period 2|Lost to Follow-up|1|||
170395832|NCT01615822|615787606|FG002|Period 2|Lost to Follow-up|2|||
170395833|NCT00943826|615787607|FG000|Concurrent Phase|Adverse Event|50|||
170395834|NCT00943826|615787608|FG001|Concurrent Phase|Adverse Event|27|||
170395835|NCT00943826|615787607|FG000|Concurrent Phase|Withdrew consent|3|||
170395836|NCT00943826|615787608|FG001|Concurrent Phase|Withdrew consent|7|||
170395837|NCT00943826|615787607|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
170395838|NCT00943826|615787608|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
170395839|NCT00943826|615787607|FG000|Concurrent Phase|Administrative reasons|2|||
170395840|NCT00943826|615787608|FG001|Concurrent Phase|Administrative reasons|1|||
170395841|NCT00943826|615787607|FG000|Concurrent Phase|Protocol Violation|1|||
170395842|NCT00943826|615787608|FG001|Concurrent Phase|Protocol Violation|0|||
170395843|NCT00943826|615787607|FG000|Maintenance Phase|Adverse Event|31|||
170395844|NCT00943826|615787608|FG001|Maintenance Phase|Adverse Event|30|||
170395845|NCT00943826|615787607|FG000|Maintenance Phase|Withdrew consent|2|||
170395846|NCT00943826|615787608|FG001|Maintenance Phase|Withdrew consent|4|||
170395847|NCT00943826|615787607|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
170395848|NCT00943826|615787608|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
170395849|NCT00943826|615787607|FG000|Maintenance Phase|Administrative reasons|4|||
170395850|NCT00943826|615787608|FG001|Maintenance Phase|Administrative reasons|1|||
170395851|NCT00943826|615787607|FG000|Maintenance Phase|Failure to return|0|||
170395852|NCT00943826|615787608|FG001|Maintenance Phase|Failure to return|1|||
170395853|NCT00943826|615787607|FG000|Monotherapy Phase|Adverse Event|42|||
170395854|NCT00943826|615787608|FG001|Monotherapy Phase|Adverse Event|5|||
170395855|NCT00943826|615787607|FG000|Monotherapy Phase|Administrative reasons|11|||
170395856|NCT00943826|615787608|FG001|Monotherapy Phase|Administrative reasons|5|||
170395857|NCT00943826|615787607|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
170395858|NCT00943826|615787608|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
170395859|NCT00943826|615787607|FG000|Monotherapy Phase|Withdrew Consent|2|||
170395860|NCT00943826|615787608|FG001|Monotherapy Phase|Withdrew Consent|3|||
170395861|NCT00943826|615787607|FG000|Monotherapy Phase|Failure to return|2|||
170395862|NCT00943826|615787608|FG001|Monotherapy Phase|Failure to return|1|||
170395863|NCT00943826|615787607|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
170395864|NCT00943826|615787608|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
170395865|NCT00943826|615787607|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
170395866|NCT00943826|615787608|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
170395867|NCT00943826|615787607|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
170395868|NCT00943826|615787608|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
170395869|NCT00943826|615787607|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
170395870|NCT00943826|615787608|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
170395871|NCT01803464|615787609|FG000|Overall Study|Incomplete data|0|||
170395872|NCT01803464|615787610|FG001|Overall Study|Incomplete data|0|||
170395873|NCT01803464|615787611|FG002|Overall Study|Incomplete data|4|||
170395874|NCT01803464|615787612|FG003|Overall Study|Incomplete data|0|||
170395875|NCT01803464|615787609|FG000|Overall Study|Withdrawal by Subject|1|||
170395876|NCT01803464|615787610|FG001|Overall Study|Withdrawal by Subject|0|||
170395877|NCT01803464|615787611|FG002|Overall Study|Withdrawal by Subject|0|||
170395878|NCT01803464|615787612|FG003|Overall Study|Withdrawal by Subject|0|||
170395879|NCT01036594|615787616|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
170395880|NCT01036594|615787617|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
170395881|NCT01036594|615787616|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
170395882|NCT01036594|615787617|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
170395883|NCT01036594|615787616|FG000|Week 12 Evaluation|Adverse Event|5|||
170395884|NCT01036594|615787617|FG001|Week 12 Evaluation|Adverse Event|0|||
170395885|NCT01036594|615787616|FG000|Week 12 Evaluation|Physician Decision|1|||
170395886|NCT01036594|615787617|FG001|Week 12 Evaluation|Physician Decision|0|||
170395887|NCT01036594|615787616|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
170395888|NCT01036594|615787617|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
170395889|NCT01036594|615787616|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
170395890|NCT01036594|615787617|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
170395891|NCT01036594|615787616|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
170395892|NCT01036594|615787617|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
170395893|NCT01036594|615787616|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
170395894|NCT01036594|615787617|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
170395895|NCT01036594|615787616|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
170395896|NCT01036594|615787617|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
170395897|NCT01612780|615787618|FG000|Overall Study|Treatment not completed|1|||
170395898|NCT01612780|615787618|FG000|Overall Study|Withdrawal by Subject|5|||
170395899|NCT03345485|615787619|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
170395900|NCT03345485|615787620|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
170395901|NCT03345485|615787621|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
170395902|NCT03345485|615787622|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
170395903|NCT03345485|615787623|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
170395904|NCT03345485|615787624|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
170395905|NCT03345485|615787625|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
170395906|NCT03345485|615787626|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
170395907|NCT03345485|615787627|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
170395908|NCT03345485|615787628|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
170395909|NCT03345485|615787629|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
170395910|NCT03345485|615787630|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
170395911|NCT03345485|615787631|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
170395912|NCT02985515|615787632|FG000|Olfaction Testing|Lost to Follow-up|0|||
170395913|NCT02985515|615787633|FG001|Olfaction Testing|Lost to Follow-up|5|||
170395914|NCT02985515|615787632|FG000|Olfaction Testing|Protocol Violation|0|||
170395915|NCT02985515|615787633|FG001|Olfaction Testing|Protocol Violation|3|||
170395916|NCT01610284|615787634|FG000|Randomization Phase|Adverse Event|1|||
170395917|NCT01610284|615787635|FG001|Randomization Phase|Adverse Event|0|||
170395918|NCT01610284|615787634|FG000|Randomization Phase|Physician Decision|1|||
170395919|NCT01610284|615787635|FG001|Randomization Phase|Physician Decision|1|||
170395920|NCT01610284|615787634|FG000|Randomization Phase|Death|0|||
170395921|NCT01610284|615787635|FG001|Randomization Phase|Death|1|||
170395922|NCT01610284|615787634|FG000|Treatment Phase|Adverse Event|80|||
170395923|NCT01610284|615787635|FG001|Treatment Phase|Adverse Event|12|||
170395924|NCT01610284|615787634|FG000|Treatment Phase|Lost to Follow-up|1|||
170395925|NCT01610284|615787635|FG001|Treatment Phase|Lost to Follow-up|0|||
170395926|NCT01610284|615787634|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
170395927|NCT01610284|615787635|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
170395928|NCT01610284|615787634|FG000|Treatment Phase|Physician Decision|27|||
170395929|NCT01610284|615787635|FG001|Treatment Phase|Physician Decision|24|||
170395930|NCT01610284|615787634|FG000|Treatment Phase|Progressive Disease|377|||
170395931|NCT01610284|615787635|FG001|Treatment Phase|Progressive Disease|486|||
170395932|NCT01610284|615787634|FG000|Treatment Phase|Protocol Deviation|2|||
170395933|NCT01610284|615787635|FG001|Treatment Phase|Protocol Deviation|3|||
170395934|NCT01610284|615787634|FG000|Treatment Phase|Study terminated by Sponsor|18|||
170395935|NCT01610284|615787635|FG001|Treatment Phase|Study terminated by Sponsor|15|||
170395936|NCT01610284|615787634|FG000|Treatment Phase|Subject/Guardian Decision|55|||
170395937|NCT01610284|615787635|FG001|Treatment Phase|Subject/Guardian Decision|23|||
170395938|NCT01610284|615787634|FG000|Treatment Phase|Death|6|||
170395939|NCT01610284|615787635|FG001|Treatment Phase|Death|5|||
170395940|NCT01610284|615787634|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
170395941|NCT01610284|615787635|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
170395942|NCT01610284|615787634|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
170395943|NCT01610284|615787635|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
170395944|NCT01610284|615787634|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
170395945|NCT01610284|615787635|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
170395946|NCT01610284|615787634|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
170395947|NCT01610284|615787635|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
170395948|NCT01610284|615787634|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
170395949|NCT01610284|615787635|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
170395950|NCT01610284|615787634|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
170395951|NCT01610284|615787635|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
170395952|NCT03020966|615787636|FG000|Overall Study|Withdrawal by Subject|2|||
170395953|NCT03020966|615787637|FG001|Overall Study|Withdrawal by Subject|0|||
170395954|NCT03159611|615787638|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
170395955|NCT03159611|615787639|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
170395956|NCT03159611|615787638|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
170395957|NCT03159611|615787639|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
170395958|NCT03159611|615787638|FG000|Overall Study|Protocol Violation|7|||
170395959|NCT03159611|615787639|FG001|Overall Study|Protocol Violation|4|||
170395960|NCT03159611|615787638|FG000|Overall Study|Adverse Event|1|||
170395961|NCT03159611|615787639|FG001|Overall Study|Adverse Event|0|||
170395962|NCT03159611|615787638|FG000|Overall Study|Withdrawal by Subject|1|||
170395963|NCT03159611|615787639|FG001|Overall Study|Withdrawal by Subject|1|||
170395964|NCT03159611|615787638|FG000|Overall Study|Non-compliance with protocol requirement|3|||
170395965|NCT03159611|615787639|FG001|Overall Study|Non-compliance with protocol requirement|2|||
170395966|NCT03159611|615787638|FG000|Overall Study|Inability to perform procedures|1|||
170395967|NCT03159611|615787639|FG001|Overall Study|Inability to perform procedures|0|||
170395968|NCT03843775|615787640|FG000|Overall Study|Adverse Event|1|||
170395969|NCT03843775|615787641|FG001|Overall Study|Adverse Event|1|||
170395970|NCT03843775|615787640|FG000|Overall Study|Lack of Efficacy|2|||
170395971|NCT03843775|615787641|FG001|Overall Study|Lack of Efficacy|6|||
170395972|NCT03843775|615787640|FG000|Overall Study|Withdrawal by Subject|0|||
170395973|NCT03843775|615787641|FG001|Overall Study|Withdrawal by Subject|1|||
170395974|NCT02998645|615787642|FG000|Treatment Period 1|Adverse Event|6|||
170395975|NCT02998645|615787642|FG000|Treatment Period 1|Death|5|||
170395976|NCT02998645|615787642|FG000|Treatment Period 1|Technical Problems|4|||
170395977|NCT02998645|615787642|FG000|Treatment Period 1|Lack of Efficacy|2|||
170395978|NCT02998645|615787642|FG000|Treatment Period 1|Progressive disease|1|||
170395979|NCT02998645|615787642|FG000|Treatment Period 1|Subject/guardian decision|1|||
170395980|NCT02998645|615787642|FG000|Treatment Period 2|Lack of Efficacy|5|||
170395981|NCT02998645|615787642|FG000|Treatment Period 2|Adverse Event|2|||
170395982|NCT02998645|615787642|FG000|Treatment Period 2|Progressive disease|2|||
170395983|NCT02998645|615787642|FG000|Treatment Period 2|Physician Decision|1|||
170395984|NCT03930615|615787643|FG000|Overall Study|Death|9|||
170395985|NCT03930615|615787644|FG001|Overall Study|Death|3|||
170395986|NCT03930615|615787643|FG000|Overall Study|Lost to Follow-up|1|||
170395987|NCT03930615|615787644|FG001|Overall Study|Lost to Follow-up|2|||
170395988|NCT03930615|615787643|FG000|Overall Study|Physician Decision|3|||
170395989|NCT03930615|615787644|FG001|Overall Study|Physician Decision|4|||
170395990|NCT03930615|615787643|FG000|Overall Study|Withdrawal by Subject|13|||
170395991|NCT03930615|615787644|FG001|Overall Study|Withdrawal by Subject|2|||
170395992|NCT03930615|615787643|FG000|Overall Study|Not treated|1|||
170395993|NCT03930615|615787644|FG001|Overall Study|Not treated|1|||
170395994|NCT00956813|615787647|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
170395995|NCT00956813|615787648|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
170395996|NCT00956813|615787647|FG000|Flaxseed and Placebo|Ineligible|3|||
170395997|NCT00956813|615787648|FG001|Flaxseed and Placebo|Ineligible|1|||
170395998|NCT02380248|615787652|FG000|Overall Study|Lost to Follow-up|11|||
170395999|NCT02380248|615787652|FG000|Overall Study|Withdrawal by Subject|3|||
170396000|NCT02704130|615787655|FG000|Overall Study|Physician Decision|5|||
170396001|NCT02704130|615787656|FG001|Overall Study|Physician Decision|3|||
170396002|NCT03917654|615787663|FG000|Year 1|Withdrawal by Subject|1|||
170396003|NCT03917654|615787664|FG001|Year 1|Withdrawal by Subject|0|||
170396004|NCT03917654|615787665|FG002|Year 1|Withdrawal by Subject|0|||
170396005|NCT03917654|615787666|FG003|Year 1|Withdrawal by Subject|0|||
170396006|NCT03917654|615787667|FG004|Year 1|Withdrawal by Subject|0|||
170396007|NCT03917654|615787668|FG005|Year 1|Withdrawal by Subject|1|||
170396008|NCT03917654|615787669|FG006|Year 1|Withdrawal by Subject|6|||
170396009|NCT03917654|615787670|FG007|Year 1|Withdrawal by Subject|2|||
170396010|NCT03917654|615787671|FG008|Year 1|Withdrawal by Subject|5|||
170396011|NCT03917654|615787672|FG009|Year 1|Withdrawal by Subject|3|||
170396012|NCT03917654|615787673|FG010|Year 1|Withdrawal by Subject|1|||
170396013|NCT03917654|615787674|FG011|Year 1|Withdrawal by Subject|0|||
170396014|NCT03917654|615787663|FG000|Year 1|Travel|0|||
170396015|NCT03917654|615787664|FG001|Year 1|Travel|1|||
170396016|NCT03917654|615787665|FG002|Year 1|Travel|1|||
170396017|NCT03917654|615787666|FG003|Year 1|Travel|0|||
170396018|NCT03917654|615787667|FG004|Year 1|Travel|4|||
170396019|NCT03917654|615787668|FG005|Year 1|Travel|4|||
170396020|NCT03917654|615787669|FG006|Year 1|Travel|10|||
170396021|NCT03917654|615787670|FG007|Year 1|Travel|8|||
170396022|NCT03917654|615787671|FG008|Year 1|Travel|2|||
170396023|NCT03917654|615787672|FG009|Year 1|Travel|5|||
170396024|NCT03917654|615787673|FG010|Year 1|Travel|3|||
170396025|NCT03917654|615787674|FG011|Year 1|Travel|3|||
170396026|NCT03917654|615787663|FG000|Year 1|Subject moved away from site|0|||
170396027|NCT03917654|615787664|FG001|Year 1|Subject moved away from site|1|||
170396028|NCT03917654|615787665|FG002|Year 1|Subject moved away from site|0|||
170396029|NCT03917654|615787666|FG003|Year 1|Subject moved away from site|0|||
170396030|NCT03917654|615787667|FG004|Year 1|Subject moved away from site|0|||
170396031|NCT03917654|615787668|FG005|Year 1|Subject moved away from site|0|||
170396032|NCT03917654|615787669|FG006|Year 1|Subject moved away from site|1|||
170396033|NCT03917654|615787670|FG007|Year 1|Subject moved away from site|2|||
170396034|NCT03917654|615787671|FG008|Year 1|Subject moved away from site|1|||
170396035|NCT03917654|615787672|FG009|Year 1|Subject moved away from site|0|||
170396036|NCT03917654|615787673|FG010|Year 1|Subject moved away from site|0|||
170396037|NCT03917654|615787674|FG011|Year 1|Subject moved away from site|3|||
170396038|NCT03917654|615787663|FG000|Year 1|Spouse/Family member request|0|||
170396039|NCT03917654|615787664|FG001|Year 1|Spouse/Family member request|0|||
170396040|NCT03917654|615787665|FG002|Year 1|Spouse/Family member request|1|||
170396041|NCT03917654|615787666|FG003|Year 1|Spouse/Family member request|0|||
170396042|NCT03917654|615787667|FG004|Year 1|Spouse/Family member request|1|||
170396043|NCT03917654|615787668|FG005|Year 1|Spouse/Family member request|0|||
170396044|NCT03917654|615787669|FG006|Year 1|Spouse/Family member request|0|||
170396045|NCT03917654|615787670|FG007|Year 1|Spouse/Family member request|2|||
170396046|NCT03917654|615787671|FG008|Year 1|Spouse/Family member request|0|||
170396047|NCT03917654|615787672|FG009|Year 1|Spouse/Family member request|0|||
170396048|NCT03917654|615787673|FG010|Year 1|Spouse/Family member request|0|||
170396049|NCT03917654|615787674|FG011|Year 1|Spouse/Family member request|1|||
170396050|NCT03917654|615787663|FG000|Year 1|Death|0|||
170396051|NCT03917654|615787664|FG001|Year 1|Death|0|||
170396052|NCT03917654|615787665|FG002|Year 1|Death|0|||
170396053|NCT03917654|615787666|FG003|Year 1|Death|0|||
170396054|NCT03917654|615787667|FG004|Year 1|Death|0|||
170396055|NCT03917654|615787668|FG005|Year 1|Death|0|||
170396056|NCT03917654|615787669|FG006|Year 1|Death|0|||
170396057|NCT03917654|615787670|FG007|Year 1|Death|0|||
170396058|NCT03917654|615787671|FG008|Year 1|Death|1|||
170396059|NCT03917654|615787672|FG009|Year 1|Death|1|||
170396060|NCT03917654|615787673|FG010|Year 1|Death|0|||
170396061|NCT03917654|615787674|FG011|Year 1|Death|0|||
170396062|NCT03917654|615787663|FG000|Year 1|Lost to Follow-up|0|||
170396063|NCT03917654|615787664|FG001|Year 1|Lost to Follow-up|0|||
170396064|NCT03917654|615787665|FG002|Year 1|Lost to Follow-up|0|||
170396065|NCT03917654|615787666|FG003|Year 1|Lost to Follow-up|0|||
170396066|NCT03917654|615787667|FG004|Year 1|Lost to Follow-up|0|||
170396067|NCT03917654|615787668|FG005|Year 1|Lost to Follow-up|0|||
170396068|NCT03917654|615787669|FG006|Year 1|Lost to Follow-up|2|||
170396069|NCT03917654|615787670|FG007|Year 1|Lost to Follow-up|0|||
170396070|NCT03917654|615787671|FG008|Year 1|Lost to Follow-up|0|||
170396071|NCT03917654|615787672|FG009|Year 1|Lost to Follow-up|0|||
170396072|NCT03917654|615787673|FG010|Year 1|Lost to Follow-up|0|||
170396073|NCT03917654|615787674|FG011|Year 1|Lost to Follow-up|0|||
170396074|NCT03917654|615787663|FG000|Year 1|Missed visits|0|||
170396075|NCT03917654|615787664|FG001|Year 1|Missed visits|0|||
170396076|NCT03917654|615787665|FG002|Year 1|Missed visits|0|||
170396077|NCT03917654|615787666|FG003|Year 1|Missed visits|0|||
170396078|NCT03917654|615787667|FG004|Year 1|Missed visits|0|||
170396079|NCT03917654|615787668|FG005|Year 1|Missed visits|0|||
170396080|NCT03917654|615787669|FG006|Year 1|Missed visits|0|||
170396081|NCT03917654|615787670|FG007|Year 1|Missed visits|0|||
170396082|NCT03917654|615787671|FG008|Year 1|Missed visits|0|||
170396083|NCT03917654|615787672|FG009|Year 1|Missed visits|0|||
170396084|NCT03917654|615787673|FG010|Year 1|Missed visits|1|||
170396085|NCT03917654|615787674|FG011|Year 1|Missed visits|1|||
170396086|NCT03917654|615787663|FG000|Year 1|Pregnancy|0|||
170396087|NCT03917654|615787664|FG001|Year 1|Pregnancy|0|||
170396088|NCT03917654|615787665|FG002|Year 1|Pregnancy|0|||
170396089|NCT03917654|615787666|FG003|Year 1|Pregnancy|0|||
170396090|NCT03917654|615787667|FG004|Year 1|Pregnancy|0|||
170396091|NCT03917654|615787668|FG005|Year 1|Pregnancy|0|||
170396092|NCT03917654|615787669|FG006|Year 1|Pregnancy|0|||
170396093|NCT03917654|615787670|FG007|Year 1|Pregnancy|1|||
170396094|NCT03917654|615787671|FG008|Year 1|Pregnancy|0|||
170396095|NCT03917654|615787672|FG009|Year 1|Pregnancy|1|||
170396096|NCT03917654|615787673|FG010|Year 1|Pregnancy|0|||
170396097|NCT03917654|615787674|FG011|Year 1|Pregnancy|0|||
170396098|NCT03917654|615787663|FG000|Year 2|Travel|1|||
170396099|NCT03917654|615787664|FG001|Year 2|Travel|0|||
170396100|NCT03917654|615787665|FG002|Year 2|Travel|0|||
170396101|NCT03917654|615787666|FG003|Year 2|Travel|0|||
170396102|NCT03917654|615787667|FG004|Year 2|Travel|1|||
170396103|NCT03917654|615787668|FG005|Year 2|Travel|1|||
170396104|NCT03917654|615787669|FG006|Year 2|Travel|2|||
170396105|NCT03917654|615787670|FG007|Year 2|Travel|1|||
170396106|NCT03917654|615787671|FG008|Year 2|Travel|0|||
170396107|NCT03917654|615787672|FG009|Year 2|Travel|1|||
170396108|NCT03917654|615787673|FG010|Year 2|Travel|0|||
170396109|NCT03917654|615787674|FG011|Year 2|Travel|1|||
170396110|NCT03917654|615787663|FG000|Year 2|Married|1|||
170396111|NCT03917654|615787664|FG001|Year 2|Married|0|||
170396112|NCT03917654|615787665|FG002|Year 2|Married|0|||
170396113|NCT03917654|615787666|FG003|Year 2|Married|0|||
170396114|NCT03917654|615787667|FG004|Year 2|Married|0|||
170396115|NCT03917654|615787668|FG005|Year 2|Married|0|||
170396116|NCT03917654|615787669|FG006|Year 2|Married|1|||
170396117|NCT03917654|615787670|FG007|Year 2|Married|1|||
170396118|NCT03917654|615787671|FG008|Year 2|Married|0|||
170396119|NCT03917654|615787672|FG009|Year 2|Married|0|||
170396120|NCT03917654|615787673|FG010|Year 2|Married|0|||
170396121|NCT03917654|615787674|FG011|Year 2|Married|0|||
170396122|NCT03917654|615787663|FG000|Year 2|Subject moved away from site|1|||
170396123|NCT03917654|615787664|FG001|Year 2|Subject moved away from site|0|||
170396124|NCT03917654|615787665|FG002|Year 2|Subject moved away from site|0|||
170396125|NCT03917654|615787666|FG003|Year 2|Subject moved away from site|0|||
170396126|NCT03917654|615787667|FG004|Year 2|Subject moved away from site|1|||
170396127|NCT03917654|615787668|FG005|Year 2|Subject moved away from site|0|||
170396128|NCT03917654|615787669|FG006|Year 2|Subject moved away from site|2|||
170396129|NCT03917654|615787670|FG007|Year 2|Subject moved away from site|3|||
170396130|NCT03917654|615787671|FG008|Year 2|Subject moved away from site|0|||
170396131|NCT03917654|615787672|FG009|Year 2|Subject moved away from site|2|||
170396132|NCT03917654|615787673|FG010|Year 2|Subject moved away from site|0|||
170396133|NCT03917654|615787674|FG011|Year 2|Subject moved away from site|1|||
170396134|NCT03917654|615787663|FG000|Year 2|Year 2 Screening failure|0|||
170396135|NCT03917654|615787664|FG001|Year 2|Year 2 Screening failure|1|||
170396136|NCT03917654|615787665|FG002|Year 2|Year 2 Screening failure|0|||
170396137|NCT03917654|615787666|FG003|Year 2|Year 2 Screening failure|0|||
170396138|NCT03917654|615787667|FG004|Year 2|Year 2 Screening failure|2|||
170396139|NCT03917654|615787668|FG005|Year 2|Year 2 Screening failure|0|||
170396140|NCT03917654|615787669|FG006|Year 2|Year 2 Screening failure|4|||
170396141|NCT03917654|615787670|FG007|Year 2|Year 2 Screening failure|3|||
170396142|NCT03917654|615787671|FG008|Year 2|Year 2 Screening failure|10|||
170396143|NCT03917654|615787672|FG009|Year 2|Year 2 Screening failure|2|||
170396144|NCT03917654|615787673|FG010|Year 2|Year 2 Screening failure|1|||
170396145|NCT03917654|615787674|FG011|Year 2|Year 2 Screening failure|1|||
170396146|NCT03917654|615787663|FG000|Year 2|Death|0|||
170396147|NCT03917654|615787664|FG001|Year 2|Death|0|||
170396148|NCT03917654|615787665|FG002|Year 2|Death|0|||
170396149|NCT03917654|615787666|FG003|Year 2|Death|0|||
170396150|NCT03917654|615787667|FG004|Year 2|Death|0|||
170396151|NCT03917654|615787668|FG005|Year 2|Death|1|||
170396152|NCT03917654|615787669|FG006|Year 2|Death|0|||
170396153|NCT03917654|615787670|FG007|Year 2|Death|0|||
170396154|NCT03917654|615787671|FG008|Year 2|Death|1|||
170396155|NCT03917654|615787672|FG009|Year 2|Death|1|||
170396156|NCT03917654|615787673|FG010|Year 2|Death|0|||
170396157|NCT03917654|615787674|FG011|Year 2|Death|0|||
170396158|NCT03917654|615787663|FG000|Year 2|Withdrawal by Subject|0|||
170396159|NCT03917654|615787664|FG001|Year 2|Withdrawal by Subject|0|||
170396160|NCT03917654|615787665|FG002|Year 2|Withdrawal by Subject|0|||
170396161|NCT03917654|615787666|FG003|Year 2|Withdrawal by Subject|0|||
170396162|NCT03917654|615787667|FG004|Year 2|Withdrawal by Subject|0|||
170396163|NCT03917654|615787668|FG005|Year 2|Withdrawal by Subject|0|||
170396164|NCT03917654|615787669|FG006|Year 2|Withdrawal by Subject|3|||
170396165|NCT03917654|615787670|FG007|Year 2|Withdrawal by Subject|0|||
170396166|NCT03917654|615787671|FG008|Year 2|Withdrawal by Subject|2|||
170396167|NCT03917654|615787672|FG009|Year 2|Withdrawal by Subject|5|||
170396168|NCT03917654|615787673|FG010|Year 2|Withdrawal by Subject|0|||
170396169|NCT03917654|615787674|FG011|Year 2|Withdrawal by Subject|0|||
170396170|NCT03917654|615787663|FG000|Year 2|Spouse/family member request|0|||
170396171|NCT03917654|615787664|FG001|Year 2|Spouse/family member request|0|||
170396172|NCT03917654|615787665|FG002|Year 2|Spouse/family member request|0|||
170396173|NCT03917654|615787666|FG003|Year 2|Spouse/family member request|0|||
170396174|NCT03917654|615787667|FG004|Year 2|Spouse/family member request|0|||
170396175|NCT03917654|615787668|FG005|Year 2|Spouse/family member request|0|||
170396176|NCT03917654|615787669|FG006|Year 2|Spouse/family member request|1|||
170396177|NCT03917654|615787670|FG007|Year 2|Spouse/family member request|0|||
170396178|NCT03917654|615787671|FG008|Year 2|Spouse/family member request|0|||
170396179|NCT03917654|615787672|FG009|Year 2|Spouse/family member request|0|||
170396180|NCT03917654|615787673|FG010|Year 2|Spouse/family member request|0|||
170396181|NCT03917654|615787674|FG011|Year 2|Spouse/family member request|0|||
170396182|NCT03917654|615787663|FG000|Year 2|Lost to Follow-up|0|||
170396183|NCT03917654|615787664|FG001|Year 2|Lost to Follow-up|0|||
170396184|NCT03917654|615787665|FG002|Year 2|Lost to Follow-up|0|||
170396185|NCT03917654|615787666|FG003|Year 2|Lost to Follow-up|0|||
170396186|NCT03917654|615787667|FG004|Year 2|Lost to Follow-up|0|||
170396187|NCT03917654|615787668|FG005|Year 2|Lost to Follow-up|0|||
170396188|NCT03917654|615787669|FG006|Year 2|Lost to Follow-up|1|||
170396189|NCT03917654|615787670|FG007|Year 2|Lost to Follow-up|0|||
170396190|NCT03917654|615787671|FG008|Year 2|Lost to Follow-up|1|||
170396191|NCT03917654|615787672|FG009|Year 2|Lost to Follow-up|0|||
170396192|NCT03917654|615787673|FG010|Year 2|Lost to Follow-up|0|||
170396193|NCT03917654|615787674|FG011|Year 2|Lost to Follow-up|1|||
170396194|NCT03917654|615787663|FG000|Year 2|Adverse Event|0|||
170396195|NCT03917654|615787664|FG001|Year 2|Adverse Event|0|||
170396196|NCT03917654|615787665|FG002|Year 2|Adverse Event|0|||
170396197|NCT03917654|615787666|FG003|Year 2|Adverse Event|0|||
170396198|NCT03917654|615787667|FG004|Year 2|Adverse Event|0|||
170396199|NCT03917654|615787668|FG005|Year 2|Adverse Event|0|||
170396200|NCT03917654|615787669|FG006|Year 2|Adverse Event|0|||
170396201|NCT03917654|615787670|FG007|Year 2|Adverse Event|0|||
170396202|NCT03917654|615787671|FG008|Year 2|Adverse Event|0|||
170396203|NCT03917654|615787672|FG009|Year 2|Adverse Event|1|||
170396204|NCT03917654|615787673|FG010|Year 2|Adverse Event|0|||
170396205|NCT03917654|615787674|FG011|Year 2|Adverse Event|0|||
170396206|NCT05012943|615787675|FG000|Overall Study|Adverse Event|2|||
170396207|NCT05012943|615787676|FG001|Overall Study|Adverse Event|1|||
170396208|NCT05012943|615787677|FG002|Overall Study|Adverse Event|0|||
170396209|NCT05012943|615787675|FG000|Overall Study|Withdrawal by Subject|1052|||
170396210|NCT05012943|615787676|FG001|Overall Study|Withdrawal by Subject|1006|||
170396211|NCT05012943|615787677|FG002|Overall Study|Withdrawal by Subject|20|||
170396212|NCT05012943|615787675|FG000|Overall Study|Death|25|||
170396213|NCT05012943|615787676|FG001|Overall Study|Death|17|||
170396214|NCT05012943|615787677|FG002|Overall Study|Death|4|||
170396215|NCT05012943|615787675|FG000|Overall Study|Lost to Follow-up|11|||
170396216|NCT05012943|615787676|FG001|Overall Study|Lost to Follow-up|24|||
170396217|NCT05012943|615787677|FG002|Overall Study|Lost to Follow-up|3|||
170396218|NCT05012943|615787675|FG000|Overall Study|Physician Decision|1|||
170396219|NCT05012943|615787676|FG001|Overall Study|Physician Decision|1|||
170396220|NCT05012943|615787677|FG002|Overall Study|Physician Decision|0|||
170396221|NCT05012943|615787675|FG000|Overall Study|Other than Specified|2|||
170396222|NCT05012943|615787676|FG001|Overall Study|Other than Specified|1|||
170396223|NCT05012943|615787677|FG002|Overall Study|Other than Specified|0|||
170396224|NCT00400985|615787678|FG000|Overall Study|Withdrawal by Subject|5|||
170396225|NCT00400985|615787678|FG000|Overall Study|system modification|8|||
170396226|NCT00400985|615787678|FG000|Overall Study|Death|30|||
170396227|NCT00400985|615787678|FG000|Overall Study|Lost to Follow-up|9|||
170396228|NCT04755283|615787681|FG000|Overall Study|Withdrawal by Subject|14|||
170396229|NCT04755283|615787682|FG001|Overall Study|Withdrawal by Subject|3|||
170396230|NCT04755283|615787683|FG002|Overall Study|Withdrawal by Subject|6|||
170396231|NCT04755283|615787681|FG000|Overall Study|Lost to Follow-up|0|||
170396232|NCT04755283|615787682|FG001|Overall Study|Lost to Follow-up|0|||
170396233|NCT04755283|615787683|FG002|Overall Study|Lost to Follow-up|1|||
170396234|NCT04755283|615787681|FG000|Overall Study|Death|31|||
170396235|NCT04755283|615787682|FG001|Overall Study|Death|36|||
170396236|NCT04755283|615787683|FG002|Overall Study|Death|34|||
170396237|NCT03128931|615787684|FG000|Overall Study|Physician Decision|1|||
170396238|NCT03128931|615787684|FG000|Overall Study|Equipment Issues|3|||
170396239|NCT04636437|615787688|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
170396240|NCT04636437|615787689|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
170396241|NCT04636437|615787690|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
170396242|NCT04636437|615787688|FG000|Overall Study|Started weight loss drug/program|2|||
170396243|NCT04636437|615787689|FG001|Overall Study|Started weight loss drug/program|1|||
170396244|NCT04636437|615787690|FG002|Overall Study|Started weight loss drug/program|1|||
170396245|NCT04636437|615787688|FG000|Overall Study|Lost to Follow-up|3|||
170396246|NCT04636437|615787689|FG001|Overall Study|Lost to Follow-up|1|||
170396247|NCT04636437|615787690|FG002|Overall Study|Lost to Follow-up|4|||
170396248|NCT04636437|615787688|FG000|Overall Study|Participant or physician decision|3|||
170396249|NCT04636437|615787689|FG001|Overall Study|Participant or physician decision|1|||
170396250|NCT04636437|615787690|FG002|Overall Study|Participant or physician decision|1|||
170396251|NCT00816166|615787691|FG000|Overall Study|Lost to Follow-up|6|||
170396252|NCT00816166|615787692|FG001|Overall Study|Lost to Follow-up|10|||
170396253|NCT00816166|615787691|FG000|Overall Study|Death|4|||
170396254|NCT00816166|615787692|FG001|Overall Study|Death|2|||
170396255|NCT01071278|615787693|FG000|Overall Study|Premature Discontinuation|254|||
170396256|NCT01071278|615787693|FG000|Overall Study|Completion Status Unknown|459|||
170396257|NCT02851069|615787694|FG000|Overall Study|Failure to Return|3|||
170396258|NCT02851069|615787694|FG000|Overall Study|Other|3|||
170396259|NCT01083121|615787697|FG000|Overall Study|Use of Humira outside the approved label|81|||
170396260|NCT01489865|615787702|FG000|Overall Study|Progression of Disease|4|||
170396261|NCT01489865|615787703|FG001|Overall Study|Progression of Disease|2|||
170396262|NCT01489865|615787704|FG002|Overall Study|Progression of Disease|2|||
170396263|NCT01489865|615787705|FG003|Overall Study|Progression of Disease|3|||
170396264|NCT01489865|615787706|FG004|Overall Study|Progression of Disease|1|||
170396265|NCT01489865|615787707|FG005|Overall Study|Progression of Disease|6|||
170396266|NCT01489865|615787708|FG006|Overall Study|Progression of Disease|3|||
170396267|NCT01489865|615787709|FG007|Overall Study|Progression of Disease|0|||
170396268|NCT01489865|615787710|FG008|Overall Study|Progression of Disease|23|||
170396269|NCT01489865|615787702|FG000|Overall Study|Adverse Event|2|||
170396270|NCT01489865|615787703|FG001|Overall Study|Adverse Event|0|||
170396271|NCT01489865|615787704|FG002|Overall Study|Adverse Event|0|||
170396272|NCT01489865|615787705|FG003|Overall Study|Adverse Event|0|||
170396273|NCT01489865|615787706|FG004|Overall Study|Adverse Event|1|||
170396274|NCT01489865|615787707|FG005|Overall Study|Adverse Event|0|||
170396275|NCT01489865|615787708|FG006|Overall Study|Adverse Event|2|||
170396276|NCT01489865|615787709|FG007|Overall Study|Adverse Event|0|||
170396277|NCT01489865|615787710|FG008|Overall Study|Adverse Event|5|||
170396278|NCT01489865|615787702|FG000|Overall Study|Death|0|||
170396279|NCT01489865|615787703|FG001|Overall Study|Death|1|||
170396280|NCT01489865|615787704|FG002|Overall Study|Death|0|||
170396281|NCT01489865|615787705|FG003|Overall Study|Death|0|||
170396282|NCT01489865|615787706|FG004|Overall Study|Death|1|||
170396283|NCT01489865|615787707|FG005|Overall Study|Death|0|||
170396284|NCT01489865|615787708|FG006|Overall Study|Death|0|||
170396285|NCT01489865|615787709|FG007|Overall Study|Death|0|||
170396286|NCT01489865|615787710|FG008|Overall Study|Death|2|||
170396287|NCT01489865|615787702|FG000|Overall Study|Withdrawal by Subject|0|||
170396288|NCT01489865|615787703|FG001|Overall Study|Withdrawal by Subject|0|||
170396289|NCT01489865|615787704|FG002|Overall Study|Withdrawal by Subject|0|||
170396290|NCT01489865|615787705|FG003|Overall Study|Withdrawal by Subject|0|||
170396291|NCT01489865|615787706|FG004|Overall Study|Withdrawal by Subject|0|||
170396292|NCT01489865|615787707|FG005|Overall Study|Withdrawal by Subject|1|||
170396293|NCT01489865|615787708|FG006|Overall Study|Withdrawal by Subject|1|||
170396294|NCT01489865|615787709|FG007|Overall Study|Withdrawal by Subject|0|||
170396295|NCT01489865|615787710|FG008|Overall Study|Withdrawal by Subject|2|||
170396296|NCT01489865|615787702|FG000|Overall Study|Shifted|0|||
170396297|NCT01489865|615787703|FG001|Overall Study|Shifted|0|||
170396298|NCT01489865|615787704|FG002|Overall Study|Shifted|1|||
170396299|NCT01489865|615787705|FG003|Overall Study|Shifted|0|||
170396300|NCT01489865|615787706|FG004|Overall Study|Shifted|0|||
170396301|NCT01489865|615787707|FG005|Overall Study|Shifted|0|||
170396302|NCT01489865|615787708|FG006|Overall Study|Shifted|0|||
170396303|NCT01489865|615787709|FG007|Overall Study|Shifted|0|||
170396304|NCT01489865|615787710|FG008|Overall Study|Shifted|0|||
170396305|NCT04115488|615787711|FG000|Overall Study|Adverse Event|8|||
170396306|NCT04115488|615787712|FG001|Overall Study|Adverse Event|4|||
170396307|NCT04115488|615787711|FG000|Overall Study|Withdrawal by Subject|3|||
170396308|NCT04115488|615787712|FG001|Overall Study|Withdrawal by Subject|6|||
170396309|NCT04115488|615787711|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
170396310|NCT04115488|615787712|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
170396311|NCT04115488|615787711|FG000|Overall Study|Patient 's location change|1|||
170396312|NCT04115488|615787712|FG001|Overall Study|Patient 's location change|0|||
170398871|NCT05004181|615798323|FG011|Overall Study|Death|0|||
170396313|NCT04115488|615787711|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
170396314|NCT04115488|615787712|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
170396315|NCT00885677|615787713|FG000|Overall Study|Death|40|||
170396316|NCT00885677|615787714|FG001|Overall Study|Death|34|||
170396317|NCT00885677|615787713|FG000|Overall Study|Lost to Follow-up|15|||
170396318|NCT00885677|615787714|FG001|Overall Study|Lost to Follow-up|13|||
170396319|NCT00885677|615787713|FG000|Overall Study|Protocol Violation|54|||
170396320|NCT00885677|615787714|FG001|Overall Study|Protocol Violation|54|||
170396321|NCT00885677|615787713|FG000|Overall Study|premature study closure|41|||
170396322|NCT00885677|615787714|FG001|Overall Study|premature study closure|44|||
170396323|NCT00885677|615787713|FG000|Overall Study|device/lead revision or replacement|7|||
170396324|NCT00885677|615787714|FG001|Overall Study|device/lead revision or replacement|6|||
170396325|NCT00885677|615787713|FG000|Overall Study|Heart transplantation|1|||
170396326|NCT00885677|615787714|FG001|Overall Study|Heart transplantation|0|||
170396327|NCT00885677|615787713|FG000|Overall Study|Inclusion/exclusion not met|25|||
170396328|NCT00885677|615787714|FG001|Overall Study|Inclusion/exclusion not met|27|||
170396329|NCT00972309|615787715|FG000|Overall Study|Switched to alternative treatment|0|||
170396330|NCT00972309|615787716|FG001|Overall Study|Switched to alternative treatment|2|||
170396331|NCT00972309|615787715|FG000|Overall Study|Refused further treatment|0|||
170396332|NCT00972309|615787716|FG001|Overall Study|Refused further treatment|1|||
170396333|NCT00972309|615787715|FG000|Overall Study|Late determination of ineligibility|0|||
170396334|NCT00972309|615787716|FG001|Overall Study|Late determination of ineligibility|1|||
170396335|NCT00972309|615787715|FG000|Overall Study|Second malignancy|1|||
170396336|NCT00972309|615787716|FG001|Overall Study|Second malignancy|1|||
170396337|NCT00972309|615787715|FG000|Overall Study|Visa issues|0|||
170396338|NCT00972309|615787716|FG001|Overall Study|Visa issues|1|||
170396339|NCT00972309|615787715|FG000|Overall Study|Secondary cancer (SCC)|0|||
170396340|NCT00972309|615787716|FG001|Overall Study|Secondary cancer (SCC)|1|||
170396341|NCT00972309|615787715|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
170396342|NCT00972309|615787716|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
170396343|NCT00972309|615787715|FG000|Overall Study|Lost to Follow-up|1|||
170396344|NCT00972309|615787716|FG001|Overall Study|Lost to Follow-up|1|||
170396345|NCT00972309|615787715|FG000|Overall Study|Disease progression on study|10|||
170396346|NCT00972309|615787716|FG001|Overall Study|Disease progression on study|4|||
170396347|NCT00167414|615787728|FG000|Overall Study|Death|10|||
170396348|NCT00795886|615787730|FG000|Overall Study|Death|10|||
170396349|NCT05554471|615787731|FG000|Overall Study|Physician Decision|2|||
170396350|NCT05554471|615787732|FG001|Overall Study|Physician Decision|1|||
170396351|NCT05554471|615787731|FG000|Overall Study|Lost to Follow-up|2|||
170396352|NCT05554471|615787732|FG001|Overall Study|Lost to Follow-up|1|||
170396353|NCT05554471|615787731|FG000|Overall Study|Death|0|||
170396354|NCT05554471|615787732|FG001|Overall Study|Death|1|||
170396355|NCT01875731|615787733|FG000|Overall Study|Fail to obtain lab sample|1|||
170396356|NCT01875731|615787734|FG001|Overall Study|Fail to obtain lab sample|0|||
170396357|NCT03417102|615787735|FG000|Overall Study|Adverse Event|0|||
170396358|NCT03417102|615787736|FG001|Overall Study|Adverse Event|1|||
170396359|NCT03417102|615787735|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
170396360|NCT03417102|615787736|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
170396361|NCT03417102|615787735|FG000|Overall Study|Other|0|||
170396362|NCT03417102|615787736|FG001|Overall Study|Other|1|||
170396363|NCT03188991|615787740|FG000|Overall Study|Withdrawal by Subject|0|||
170396364|NCT03188991|615787741|FG001|Overall Study|Withdrawal by Subject|0|||
170396365|NCT03188991|615787742|FG002|Overall Study|Withdrawal by Subject|0|||
170396366|NCT03188991|615787743|FG003|Overall Study|Withdrawal by Subject|1|||
170396367|NCT00223990|615787746|FG000|Overall Study|Moved from area|2|||
170396368|NCT00223990|615787747|FG001|Overall Study|Moved from area|1|||
170396369|NCT00223990|615787746|FG000|Overall Study|Withdrawal by Subject|4|||
170396370|NCT00223990|615787747|FG001|Overall Study|Withdrawal by Subject|8|||
170396371|NCT00223990|615787746|FG000|Overall Study|Lost to Follow-up|1|||
170396372|NCT00223990|615787747|FG001|Overall Study|Lost to Follow-up|0|||
170396373|NCT01035229|615790551|FG000|Overall Study|Adverse Event|61|||
170396374|NCT01035229|615790552|FG001|Overall Study|Adverse Event|14|||
170396375|NCT01035229|615790551|FG000|Overall Study|Withdrawal by Subject|20|||
170396376|NCT01035229|615790552|FG001|Overall Study|Withdrawal by Subject|7|||
170396377|NCT01035229|615790551|FG000|Overall Study|Lost to Follow-up|1|||
170396378|NCT01035229|615790552|FG001|Overall Study|Lost to Follow-up|0|||
170396379|NCT01035229|615790551|FG000|Overall Study|Administrative problems|1|||
170396380|NCT01035229|615790552|FG001|Overall Study|Administrative problems|1|||
170396381|NCT01035229|615790551|FG000|Overall Study|Death|13|||
170396382|NCT01035229|615790552|FG001|Overall Study|Death|5|||
170396383|NCT01035229|615790551|FG000|Overall Study|New cancer therapy|2|||
170396384|NCT01035229|615790552|FG001|Overall Study|New cancer therapy|0|||
170396385|NCT01035229|615790551|FG000|Overall Study|Protocol Violation|0|||
170396386|NCT01035229|615790552|FG001|Overall Study|Protocol Violation|2|||
170396387|NCT01035229|615790551|FG000|Overall Study|Sponsor's decision to end study|3|||
170396388|NCT01035229|615790552|FG001|Overall Study|Sponsor's decision to end study|3|||
170396389|NCT01035229|615790551|FG000|Overall Study|Disease Progression|261|||
170396390|NCT01035229|615790552|FG001|Overall Study|Disease Progression|152|||
170396391|NCT03256526|615790553|FG000|Overall Study|Adverse Event|1|||
170396392|NCT03256526|615790554|FG001|Overall Study|Adverse Event|0|||
170396393|NCT03256526|615790555|FG002|Overall Study|Adverse Event|1|||
170396394|NCT03256526|615790553|FG000|Overall Study|Lost to Follow-up|1|||
170396395|NCT03256526|615790554|FG001|Overall Study|Lost to Follow-up|0|||
170396396|NCT03256526|615790555|FG002|Overall Study|Lost to Follow-up|2|||
170396397|NCT03457727|615790556|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
170396398|NCT03457727|615790557|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
170396399|NCT03457727|615790558|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
170396400|NCT03457727|615790559|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
170396401|NCT00929201|615790560|FG000|Period 1|Withdrawal by Subject|0|||
170396402|NCT00929201|615790561|FG001|Period 1|Withdrawal by Subject|1|||
170396403|NCT00464308|615790565|FG000|Overall Study|Adverse Event|22|||
170396404|NCT00464308|615790566|FG001|Overall Study|Adverse Event|27|||
170396405|NCT00464308|615790567|FG002|Overall Study|Adverse Event|16|||
170396406|NCT00464308|615790565|FG000|Overall Study|Lost to Follow-up|29|||
170396407|NCT00464308|615790566|FG001|Overall Study|Lost to Follow-up|19|||
170396408|NCT00464308|615790567|FG002|Overall Study|Lost to Follow-up|20|||
170396409|NCT00464308|615790565|FG000|Overall Study|Patient discontinued and other reasons|17|||
170396410|NCT00464308|615790566|FG001|Overall Study|Patient discontinued and other reasons|17|||
170396411|NCT00464308|615790567|FG002|Overall Study|Patient discontinued and other reasons|23|||
170396412|NCT00464308|615790565|FG000|Overall Study|Physician Decision|1|||
170396413|NCT00464308|615790566|FG001|Overall Study|Physician Decision|0|||
170396414|NCT00464308|615790567|FG002|Overall Study|Physician Decision|0|||
170396415|NCT01721200|615790568|FG000|Overall Study|Lost to Follow-up|3|||
170396416|NCT01721200|615790569|FG001|Overall Study|Lost to Follow-up|5|||
170396417|NCT01513759|615790570|FG000|Overall Study|Protocol Violation|4|||
170396418|NCT01513759|615790570|FG000|Overall Study|Death during catheter placement|1|||
170396419|NCT03606109|615790571|FG000|Overall Study|Lost to Follow-up|2|||
170396420|NCT03606109|615790572|FG001|Overall Study|Lost to Follow-up|1|||
170396421|NCT00891527|615790573|FG000|Overall Study|Withdrawal by Subject|2|||
170396422|NCT03669640|615790574|FG000|Overall Study|Study Terminated by Sponsor|0|||
170396423|NCT03669640|615790575|FG001|Overall Study|Study Terminated by Sponsor|0|||
170396424|NCT03669640|615790576|FG002|Overall Study|Study Terminated by Sponsor|0|||
170396425|NCT03669640|615790577|FG003|Overall Study|Study Terminated by Sponsor|0|||
170396426|NCT03669640|615790578|FG004|Overall Study|Study Terminated by Sponsor|1|||
170396427|NCT03669640|615790579|FG005|Overall Study|Study Terminated by Sponsor|0|||
170396428|NCT03669640|615790574|FG000|Overall Study|Lost to Follow-up|0|||
170396429|NCT03669640|615790575|FG001|Overall Study|Lost to Follow-up|0|||
170396430|NCT03669640|615790576|FG002|Overall Study|Lost to Follow-up|2|||
170396431|NCT03669640|615790577|FG003|Overall Study|Lost to Follow-up|0|||
170396432|NCT03669640|615790578|FG004|Overall Study|Lost to Follow-up|0|||
170396433|NCT03669640|615790579|FG005|Overall Study|Lost to Follow-up|0|||
170396434|NCT03669640|615790574|FG000|Overall Study|Death|0|||
170396435|NCT03669640|615790575|FG001|Overall Study|Death|0|||
170396436|NCT03669640|615790576|FG002|Overall Study|Death|1|||
170396437|NCT03669640|615790577|FG003|Overall Study|Death|0|||
170396438|NCT03669640|615790578|FG004|Overall Study|Death|0|||
170396439|NCT03669640|615790579|FG005|Overall Study|Death|0|||
170396440|NCT03669640|615790574|FG000|Overall Study|Withdrawal by Subject|1|||
170396441|NCT03669640|615790575|FG001|Overall Study|Withdrawal by Subject|2|||
170396442|NCT03669640|615790576|FG002|Overall Study|Withdrawal by Subject|1|||
170396443|NCT03669640|615790577|FG003|Overall Study|Withdrawal by Subject|0|||
170396444|NCT03669640|615790578|FG004|Overall Study|Withdrawal by Subject|1|||
170396445|NCT03669640|615790579|FG005|Overall Study|Withdrawal by Subject|3|||
170396446|NCT03669640|615790574|FG000|Overall Study|Protocol Violation|1|||
170396447|NCT03669640|615790575|FG001|Overall Study|Protocol Violation|0|||
170396448|NCT03669640|615790576|FG002|Overall Study|Protocol Violation|0|||
170396449|NCT03669640|615790577|FG003|Overall Study|Protocol Violation|0|||
170396450|NCT03669640|615790578|FG004|Overall Study|Protocol Violation|0|||
170396451|NCT03669640|615790579|FG005|Overall Study|Protocol Violation|0|||
170396452|NCT03669640|615790574|FG000|Overall Study|Physician Decision|0|||
170396453|NCT03669640|615790575|FG001|Overall Study|Physician Decision|2|||
170396454|NCT03669640|615790576|FG002|Overall Study|Physician Decision|0|||
170396455|NCT03669640|615790577|FG003|Overall Study|Physician Decision|0|||
170396456|NCT03669640|615790578|FG004|Overall Study|Physician Decision|0|||
170396457|NCT03669640|615790579|FG005|Overall Study|Physician Decision|0|||
170396458|NCT03669640|615790574|FG000|Overall Study|Disease Relapse|1|||
170396459|NCT03669640|615790575|FG001|Overall Study|Disease Relapse|0|||
170396460|NCT03669640|615790576|FG002|Overall Study|Disease Relapse|0|||
170396461|NCT03669640|615790577|FG003|Overall Study|Disease Relapse|0|||
170396462|NCT03669640|615790578|FG004|Overall Study|Disease Relapse|0|||
170396463|NCT03669640|615790579|FG005|Overall Study|Disease Relapse|0|||
170396464|NCT03669640|615790574|FG000|Overall Study|Adverse Event|2|||
170396465|NCT03669640|615790575|FG001|Overall Study|Adverse Event|1|||
170396466|NCT03669640|615790576|FG002|Overall Study|Adverse Event|0|||
170396467|NCT03669640|615790577|FG003|Overall Study|Adverse Event|0|||
170396468|NCT03669640|615790578|FG004|Overall Study|Adverse Event|1|||
170396469|NCT03669640|615790579|FG005|Overall Study|Adverse Event|0|||
170396470|NCT01186744|615790580|FG000|Overall Study|Lack of Efficacy|156|||
170396471|NCT01186744|615790581|FG001|Overall Study|Lack of Efficacy|99|||
170396472|NCT01186744|615790582|FG002|Overall Study|Lack of Efficacy|0|||
170396473|NCT01186744|615790583|FG003|Overall Study|Lack of Efficacy|2|||
170396474|NCT01186744|615790584|FG004|Overall Study|Lack of Efficacy|2|||
170396475|NCT01186744|615790585|FG005|Overall Study|Lack of Efficacy|5|||
170396476|NCT01186744|615790580|FG000|Overall Study|Protocol Violation|1|||
170396477|NCT01186744|615790581|FG001|Overall Study|Protocol Violation|2|||
170396478|NCT01186744|615790582|FG002|Overall Study|Protocol Violation|0|||
170396479|NCT01186744|615790583|FG003|Overall Study|Protocol Violation|1|||
170396480|NCT01186744|615790584|FG004|Overall Study|Protocol Violation|1|||
170396481|NCT01186744|615790585|FG005|Overall Study|Protocol Violation|2|||
170396482|NCT01186744|615790580|FG000|Overall Study|Lost to Follow-up|15|||
170396483|NCT01186744|615790581|FG001|Overall Study|Lost to Follow-up|16|||
170396484|NCT01186744|615790582|FG002|Overall Study|Lost to Follow-up|2|||
170396485|NCT01186744|615790583|FG003|Overall Study|Lost to Follow-up|1|||
170396486|NCT01186744|615790584|FG004|Overall Study|Lost to Follow-up|1|||
170396487|NCT01186744|615790585|FG005|Overall Study|Lost to Follow-up|4|||
170396488|NCT01186744|615790580|FG000|Overall Study|Screen failure|1|||
170396489|NCT01186744|615790581|FG001|Overall Study|Screen failure|1|||
170396490|NCT01186744|615790582|FG002|Overall Study|Screen failure|0|||
170396491|NCT01186744|615790583|FG003|Overall Study|Screen failure|1|||
170396492|NCT01186744|615790584|FG004|Overall Study|Screen failure|0|||
170396493|NCT01186744|615790585|FG005|Overall Study|Screen failure|0|||
170396494|NCT01186744|615790580|FG000|Overall Study|Withdrawal by Subject|14|||
170396495|NCT01186744|615790581|FG001|Overall Study|Withdrawal by Subject|10|||
170396496|NCT01186744|615790582|FG002|Overall Study|Withdrawal by Subject|2|||
170396497|NCT01186744|615790583|FG003|Overall Study|Withdrawal by Subject|5|||
170396498|NCT01186744|615790584|FG004|Overall Study|Withdrawal by Subject|0|||
170396499|NCT01186744|615790585|FG005|Overall Study|Withdrawal by Subject|6|||
170396500|NCT01186744|615790580|FG000|Overall Study|Study terminated by Sponsor|1|||
170396501|NCT01186744|615790581|FG001|Overall Study|Study terminated by Sponsor|0|||
170396502|NCT01186744|615790582|FG002|Overall Study|Study terminated by Sponsor|0|||
170396503|NCT01186744|615790583|FG003|Overall Study|Study terminated by Sponsor|0|||
170396504|NCT01186744|615790584|FG004|Overall Study|Study terminated by Sponsor|0|||
170396505|NCT01186744|615790585|FG005|Overall Study|Study terminated by Sponsor|0|||
170396506|NCT01186744|615790580|FG000|Overall Study|Other|9|||
170396507|NCT01186744|615790581|FG001|Overall Study|Other|10|||
170396508|NCT01186744|615790582|FG002|Overall Study|Other|1|||
170396509|NCT01186744|615790583|FG003|Overall Study|Other|2|||
170396510|NCT01186744|615790584|FG004|Overall Study|Other|1|||
170396511|NCT01186744|615790585|FG005|Overall Study|Other|5|||
170396512|NCT01186744|615790580|FG000|Overall Study|Adverse Event|10|||
170396513|NCT01186744|615790581|FG001|Overall Study|Adverse Event|14|||
170396514|NCT01186744|615790582|FG002|Overall Study|Adverse Event|1|||
170396515|NCT01186744|615790583|FG003|Overall Study|Adverse Event|0|||
170396516|NCT01186744|615790584|FG004|Overall Study|Adverse Event|1|||
170396517|NCT01186744|615790585|FG005|Overall Study|Adverse Event|4|||
170396518|NCT01186744|615790580|FG000|Overall Study|Death|1|||
170396519|NCT01186744|615790581|FG001|Overall Study|Death|0|||
170396520|NCT01186744|615790582|FG002|Overall Study|Death|0|||
170396521|NCT01186744|615790583|FG003|Overall Study|Death|0|||
170396522|NCT01186744|615790584|FG004|Overall Study|Death|0|||
170396523|NCT01186744|615790585|FG005|Overall Study|Death|0|||
170396524|NCT03993288|615790586|FG000|Overall Study|Lost to Follow-up|2|||
170396525|NCT03993288|615790587|FG001|Overall Study|Lost to Follow-up|1|||
170396526|NCT03993288|615790586|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
170396527|NCT03993288|615790587|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
170396528|NCT03993288|615790586|FG000|Overall Study|wrong randomization|0|||
170396529|NCT03993288|615790587|FG001|Overall Study|wrong randomization|1|||
170396530|NCT03993288|615790586|FG000|Overall Study|improper enrollment|0|||
170396531|NCT03993288|615790587|FG001|Overall Study|improper enrollment|1|||
170396532|NCT03993288|615790586|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
170396533|NCT03993288|615790587|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
170396534|NCT03993288|615790586|FG000|Overall Study|developed SAE|2|||
170396535|NCT03993288|615790587|FG001|Overall Study|developed SAE|0|||
170396536|NCT03993288|615790586|FG000|Overall Study|consent withdrawal|1|||
170396537|NCT03993288|615790587|FG001|Overall Study|consent withdrawal|0|||
170396538|NCT03993288|615790586|FG000|Overall Study|did not follow the treatment schedule|1|||
170396539|NCT03993288|615790587|FG001|Overall Study|did not follow the treatment schedule|0|||
170396540|NCT03993288|615790586|FG000|Overall Study|did not follow the treatment regimen|1|||
170396541|NCT03993288|615790587|FG001|Overall Study|did not follow the treatment regimen|0|||
170396542|NCT03993288|615790586|FG000|Overall Study|Adverse Event|1|||
170396543|NCT03993288|615790587|FG001|Overall Study|Adverse Event|0|||
170396544|NCT03993288|615790586|FG000|Overall Study|Withdrawal by Subject|1|||
170396545|NCT03993288|615790587|FG001|Overall Study|Withdrawal by Subject|1|||
170396546|NCT01964898|615790590|FG000|Overall Study|ineligible post-randomization|1|||
170396547|NCT01964898|615790591|FG001|Overall Study|ineligible post-randomization|1|||
170396548|NCT01964898|615790590|FG000|Overall Study|did not receive the allocated interventi|2|||
170396549|NCT01964898|615790591|FG001|Overall Study|did not receive the allocated interventi|1|||
170396550|NCT01964898|615790590|FG000|Overall Study|Lost to Follow-up|3|||
170396551|NCT01964898|615790591|FG001|Overall Study|Lost to Follow-up|5|||
170396552|NCT01964898|615790590|FG000|Overall Study|Withdrawal by Subject|1|||
170396553|NCT01964898|615790591|FG001|Overall Study|Withdrawal by Subject|0|||
170396554|NCT03514121|615790592|FG000|Overall Study|Withdrawal by Subject|0|||
170396555|NCT03514121|615790593|FG001|Overall Study|Withdrawal by Subject|0|||
170396556|NCT03514121|615790594|FG002|Overall Study|Withdrawal by Subject|0|||
170396557|NCT03514121|615790595|FG003|Overall Study|Withdrawal by Subject|0|||
170396558|NCT03514121|615790596|FG004|Overall Study|Withdrawal by Subject|1|||
170396559|NCT03514121|615790597|FG005|Overall Study|Withdrawal by Subject|2|||
170396560|NCT03514121|615790598|FG006|Overall Study|Withdrawal by Subject|1|||
170396561|NCT03514121|615790599|FG007|Overall Study|Withdrawal by Subject|1|||
170396562|NCT03514121|615790600|FG008|Overall Study|Withdrawal by Subject|7|||
170396563|NCT03514121|615790601|FG009|Overall Study|Withdrawal by Subject|2|||
170396564|NCT03514121|615790592|FG000|Overall Study|Death|0|||
170396565|NCT03514121|615790593|FG001|Overall Study|Death|0|||
170396566|NCT03514121|615790594|FG002|Overall Study|Death|0|||
170396567|NCT03514121|615790595|FG003|Overall Study|Death|0|||
170396568|NCT03514121|615790596|FG004|Overall Study|Death|0|||
170396569|NCT03514121|615790597|FG005|Overall Study|Death|3|||
170396570|NCT03514121|615790598|FG006|Overall Study|Death|2|||
170396571|NCT03514121|615790599|FG007|Overall Study|Death|1|||
170396572|NCT03514121|615790600|FG008|Overall Study|Death|26|||
170396573|NCT03514121|615790601|FG009|Overall Study|Death|3|||
170396574|NCT03514121|615790592|FG000|Overall Study|Lost to Follow-up|0|||
170396575|NCT03514121|615790593|FG001|Overall Study|Lost to Follow-up|0|||
170396576|NCT03514121|615790594|FG002|Overall Study|Lost to Follow-up|1|||
170396577|NCT03514121|615790595|FG003|Overall Study|Lost to Follow-up|0|||
170396578|NCT03514121|615790596|FG004|Overall Study|Lost to Follow-up|0|||
170396579|NCT03514121|615790597|FG005|Overall Study|Lost to Follow-up|0|||
170396580|NCT03514121|615790598|FG006|Overall Study|Lost to Follow-up|0|||
170396581|NCT03514121|615790599|FG007|Overall Study|Lost to Follow-up|0|||
170396582|NCT03514121|615790600|FG008|Overall Study|Lost to Follow-up|1|||
170396583|NCT03514121|615790601|FG009|Overall Study|Lost to Follow-up|0|||
170396584|NCT03514121|615790592|FG000|Overall Study|Adverse Event|0|||
170396585|NCT03514121|615790593|FG001|Overall Study|Adverse Event|0|||
170396586|NCT03514121|615790594|FG002|Overall Study|Adverse Event|0|||
170396587|NCT03514121|615790595|FG003|Overall Study|Adverse Event|0|||
170396588|NCT03514121|615790596|FG004|Overall Study|Adverse Event|0|||
170396589|NCT03514121|615790597|FG005|Overall Study|Adverse Event|0|||
170396590|NCT03514121|615790598|FG006|Overall Study|Adverse Event|1|||
170396591|NCT03514121|615790599|FG007|Overall Study|Adverse Event|0|||
170396592|NCT03514121|615790600|FG008|Overall Study|Adverse Event|0|||
170396593|NCT03514121|615790601|FG009|Overall Study|Adverse Event|0|||
170396594|NCT03514121|615790592|FG000|Overall Study|Other|0|||
170396595|NCT03514121|615790593|FG001|Overall Study|Other|1|||
170396596|NCT03514121|615790594|FG002|Overall Study|Other|1|||
170396597|NCT03514121|615790595|FG003|Overall Study|Other|0|||
170396598|NCT03514121|615790596|FG004|Overall Study|Other|1|||
170396599|NCT03514121|615790597|FG005|Overall Study|Other|2|||
170396600|NCT03514121|615790598|FG006|Overall Study|Other|3|||
170396601|NCT03514121|615790599|FG007|Overall Study|Other|2|||
170396602|NCT03514121|615790600|FG008|Overall Study|Other|7|||
170396603|NCT03514121|615790601|FG009|Overall Study|Other|3|||
170396604|NCT03514121|615790592|FG000|Overall Study|Study termination by Sponsor|0|||
170396605|NCT03514121|615790593|FG001|Overall Study|Study termination by Sponsor|0|||
170396606|NCT03514121|615790594|FG002|Overall Study|Study termination by Sponsor|0|||
170396607|NCT03514121|615790595|FG003|Overall Study|Study termination by Sponsor|0|||
170396608|NCT03514121|615790596|FG004|Overall Study|Study termination by Sponsor|0|||
170396609|NCT03514121|615790597|FG005|Overall Study|Study termination by Sponsor|0|||
170396610|NCT03514121|615790598|FG006|Overall Study|Study termination by Sponsor|0|||
170396611|NCT03514121|615790599|FG007|Overall Study|Study termination by Sponsor|0|||
170396612|NCT03514121|615790600|FG008|Overall Study|Study termination by Sponsor|11|||
170396613|NCT03514121|615790601|FG009|Overall Study|Study termination by Sponsor|3|||
170396614|NCT03514121|615790592|FG000|Overall Study|Investigator decision|0|||
170396615|NCT03514121|615790593|FG001|Overall Study|Investigator decision|0|||
170396616|NCT03514121|615790594|FG002|Overall Study|Investigator decision|0|||
170396617|NCT03514121|615790595|FG003|Overall Study|Investigator decision|0|||
170396618|NCT03514121|615790596|FG004|Overall Study|Investigator decision|0|||
170396619|NCT03514121|615790597|FG005|Overall Study|Investigator decision|0|||
170396620|NCT03514121|615790598|FG006|Overall Study|Investigator decision|0|||
170396621|NCT03514121|615790599|FG007|Overall Study|Investigator decision|0|||
170396622|NCT03514121|615790600|FG008|Overall Study|Investigator decision|1|||
170396623|NCT03514121|615790601|FG009|Overall Study|Investigator decision|0|||
170396624|NCT02545868|615790604|FG000|Overall Study|Lack of Efficacy|1|||
170396625|NCT02545868|615790605|FG001|Overall Study|Lack of Efficacy|1|||
170396626|NCT02545868|615790606|FG002|Overall Study|Lack of Efficacy|0|||
170396627|NCT02545868|615790604|FG000|Overall Study|Lost to Follow-up|1|||
170396628|NCT02545868|615790605|FG001|Overall Study|Lost to Follow-up|5|||
170396629|NCT02545868|615790606|FG002|Overall Study|Lost to Follow-up|1|||
170396630|NCT02545868|615790604|FG000|Overall Study|Non-compliance|1|||
170396631|NCT02545868|615790605|FG001|Overall Study|Non-compliance|1|||
170396632|NCT02545868|615790606|FG002|Overall Study|Non-compliance|1|||
170396633|NCT02545868|615790604|FG000|Overall Study|Treatment change|21|||
170396634|NCT02545868|615790605|FG001|Overall Study|Treatment change|19|||
170396635|NCT02545868|615790606|FG002|Overall Study|Treatment change|22|||
170396636|NCT02545868|615790604|FG000|Overall Study|Physician Decision|1|||
170396637|NCT02545868|615790605|FG001|Overall Study|Physician Decision|1|||
170396638|NCT02545868|615790606|FG002|Overall Study|Physician Decision|1|||
170396639|NCT02545868|615790604|FG000|Overall Study|Withdrawal by Subject|6|||
170396640|NCT02545868|615790605|FG001|Overall Study|Withdrawal by Subject|7|||
170396641|NCT02545868|615790606|FG002|Overall Study|Withdrawal by Subject|9|||
170396642|NCT01777191|615790607|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
170396643|NCT01777191|615790608|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
170396644|NCT01777191|615790607|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
170396645|NCT01777191|615790608|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
170396646|NCT01777191|615790607|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
170396647|NCT01777191|615790608|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
170396648|NCT01777191|615790607|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
170396649|NCT01777191|615790608|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
170396650|NCT01777191|615790607|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
170396651|NCT01777191|615790608|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
170396652|NCT01777191|615790607|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
170396653|NCT01777191|615790608|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
170396654|NCT01777191|615790607|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
170396655|NCT01777191|615790608|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
170396656|NCT01777191|615790607|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
170396657|NCT01777191|615790608|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
170396658|NCT01777191|615790607|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
170396659|NCT01777191|615790608|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
170396660|NCT01777191|615790607|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
170396661|NCT01777191|615790608|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
170396662|NCT01777191|615790607|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
170396663|NCT01777191|615790608|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
170396664|NCT00826176|615790613|FG000|Overall Study|Lost to Follow-up|1|||
170396665|NCT00826176|615790614|FG001|Overall Study|Lost to Follow-up|0|||
170396666|NCT00826176|615790613|FG000|Overall Study|Subject Withdrew Consent|3|||
170396667|NCT00826176|615790614|FG001|Overall Study|Subject Withdrew Consent|0|||
170396668|NCT00826176|615790613|FG000|Overall Study|Administrative|9|||
170396669|NCT00826176|615790614|FG001|Overall Study|Administrative|0|||
170396670|NCT01461369|615790617|FG000|Overall Study|Lack of Efficacy|2|||
170396671|NCT01461369|615790618|FG001|Overall Study|Lack of Efficacy|0|||
170396672|NCT01461369|615790619|FG002|Overall Study|Lack of Efficacy|6|||
170396673|NCT01461369|615790617|FG000|Overall Study|Lost to Follow-up|0|||
170396674|NCT01461369|615790618|FG001|Overall Study|Lost to Follow-up|0|||
170396675|NCT01461369|615790619|FG002|Overall Study|Lost to Follow-up|3|||
170396676|NCT01461369|615790617|FG000|Overall Study|Adverse Event|9|||
170396677|NCT01461369|615790618|FG001|Overall Study|Adverse Event|12|||
170396678|NCT01461369|615790619|FG002|Overall Study|Adverse Event|4|||
170396679|NCT01461369|615790617|FG000|Overall Study|Protocol Violation|1|||
170396680|NCT01461369|615790618|FG001|Overall Study|Protocol Violation|2|||
170396681|NCT01461369|615790619|FG002|Overall Study|Protocol Violation|2|||
170396682|NCT01461369|615790617|FG000|Overall Study|Withdrawal by Subject|1|||
170396683|NCT01461369|615790618|FG001|Overall Study|Withdrawal by Subject|3|||
170396684|NCT01461369|615790619|FG002|Overall Study|Withdrawal by Subject|2|||
170396685|NCT00734617|615790620|FG000|Overall Study|Adverse Event|4|||
170396686|NCT00734617|615790621|FG001|Overall Study|Adverse Event|7|||
170396687|NCT00734617|615790620|FG000|Overall Study|Withdrawal by Subject|103|||
170396688|NCT00734617|615790621|FG001|Overall Study|Withdrawal by Subject|95|||
170396689|NCT01643928|615790624|FG000|Overall Study|Lost to Follow-up|1|||
170396690|NCT01643928|615790625|FG001|Overall Study|Lost to Follow-up|0|||
170396691|NCT01643928|615790626|FG002|Overall Study|Lost to Follow-up|2|||
170396692|NCT01643928|615790627|FG003|Overall Study|Lost to Follow-up|0|||
170396693|NCT01643928|615790628|FG004|Overall Study|Lost to Follow-up|0|||
170396694|NCT01643928|615790624|FG000|Overall Study|Withdrawal by Subject|2|||
170396695|NCT01643928|615790625|FG001|Overall Study|Withdrawal by Subject|0|||
170396696|NCT01643928|615790626|FG002|Overall Study|Withdrawal by Subject|0|||
170396697|NCT01643928|615790627|FG003|Overall Study|Withdrawal by Subject|1|||
170396698|NCT01643928|615790628|FG004|Overall Study|Withdrawal by Subject|0|||
170396699|NCT01643928|615790624|FG000|Overall Study|Pregnancy|0|||
170396700|NCT01643928|615790625|FG001|Overall Study|Pregnancy|0|||
170396701|NCT01643928|615790626|FG002|Overall Study|Pregnancy|0|||
170396702|NCT01643928|615790627|FG003|Overall Study|Pregnancy|1|||
170396703|NCT01643928|615790628|FG004|Overall Study|Pregnancy|0|||
170396704|NCT01643928|615790624|FG000|Overall Study|Other|5|||
170396705|NCT01643928|615790625|FG001|Overall Study|Other|1|||
170396706|NCT01643928|615790626|FG002|Overall Study|Other|1|||
170396707|NCT01643928|615790627|FG003|Overall Study|Other|0|||
170396708|NCT01643928|615790628|FG004|Overall Study|Other|0|||
170396709|NCT01643928|615790624|FG000|Overall Study|Adverse Event|2|||
170396710|NCT01643928|615790625|FG001|Overall Study|Adverse Event|1|||
170396711|NCT01643928|615790626|FG002|Overall Study|Adverse Event|0|||
170396712|NCT01643928|615790627|FG003|Overall Study|Adverse Event|1|||
170396713|NCT01643928|615790628|FG004|Overall Study|Adverse Event|2|||
170396714|NCT00568776|615790630|FG000|Overall Study|Adverse Event|8|||
170396715|NCT00568776|615790631|FG001|Overall Study|Adverse Event|8|||
170396716|NCT00568776|615790632|FG002|Overall Study|Adverse Event|10|||
170396717|NCT00568776|615790633|FG003|Overall Study|Adverse Event|8|||
170396718|NCT00568776|615790630|FG000|Overall Study|Death|0|||
170396719|NCT00568776|615790631|FG001|Overall Study|Death|1|||
170396720|NCT00568776|615790632|FG002|Overall Study|Death|4|||
170396721|NCT00568776|615790633|FG003|Overall Study|Death|3|||
170396722|NCT00568776|615790630|FG000|Overall Study|Physician Decision|0|||
170396723|NCT00568776|615790631|FG001|Overall Study|Physician Decision|2|||
170396724|NCT00568776|615790632|FG002|Overall Study|Physician Decision|0|||
170396725|NCT00568776|615790633|FG003|Overall Study|Physician Decision|0|||
170396726|NCT00568776|615790630|FG000|Overall Study|Lack of Efficacy|2|||
170396727|NCT00568776|615790631|FG001|Overall Study|Lack of Efficacy|2|||
170396728|NCT00568776|615790632|FG002|Overall Study|Lack of Efficacy|2|||
170396729|NCT00568776|615790633|FG003|Overall Study|Lack of Efficacy|4|||
170396730|NCT00568776|615790630|FG000|Overall Study|Lost to Follow-up|1|||
170396731|NCT00568776|615790631|FG001|Overall Study|Lost to Follow-up|1|||
170396732|NCT00568776|615790632|FG002|Overall Study|Lost to Follow-up|1|||
170396733|NCT00568776|615790633|FG003|Overall Study|Lost to Follow-up|1|||
170396734|NCT00568776|615790630|FG000|Overall Study|Protocol Violation|1|||
170396735|NCT00568776|615790631|FG001|Overall Study|Protocol Violation|0|||
170396736|NCT00568776|615790632|FG002|Overall Study|Protocol Violation|1|||
170396737|NCT00568776|615790633|FG003|Overall Study|Protocol Violation|1|||
170396738|NCT00568776|615790630|FG000|Overall Study|Withdrawal by Subject|13|||
170396739|NCT00568776|615790631|FG001|Overall Study|Withdrawal by Subject|15|||
170396740|NCT00568776|615790632|FG002|Overall Study|Withdrawal by Subject|13|||
170396741|NCT00568776|615790633|FG003|Overall Study|Withdrawal by Subject|7|||
170396742|NCT00568776|615790630|FG000|Overall Study|Loss of Caregiver|0|||
170396743|NCT00568776|615790631|FG001|Overall Study|Loss of Caregiver|2|||
170396744|NCT00568776|615790632|FG002|Overall Study|Loss of Caregiver|1|||
170396745|NCT00568776|615790633|FG003|Overall Study|Loss of Caregiver|2|||
170396746|NCT00568776|615790630|FG000|Overall Study|Sponsor Decision|2|||
170396747|NCT00568776|615790631|FG001|Overall Study|Sponsor Decision|2|||
170396748|NCT00568776|615790632|FG002|Overall Study|Sponsor Decision|41|||
170396749|NCT00568776|615790633|FG003|Overall Study|Sponsor Decision|42|||
170396750|NCT00568776|615790630|FG000|Overall Study|Miscellaeneous|3|||
170396751|NCT00568776|615790631|FG001|Overall Study|Miscellaeneous|3|||
170396752|NCT00568776|615790632|FG002|Overall Study|Miscellaeneous|1|||
170396753|NCT00568776|615790633|FG003|Overall Study|Miscellaeneous|4|||
170396754|NCT03692078|615790634|FG000|Overall Study|Adverse Event|0|||
170396755|NCT03692078|615790635|FG001|Overall Study|Adverse Event|0|||
170396756|NCT03692078|615790636|FG002|Overall Study|Adverse Event|0|||
170396757|NCT03692078|615790637|FG003|Overall Study|Adverse Event|0|||
170396758|NCT03692078|615790638|FG004|Overall Study|Adverse Event|0|||
170396759|NCT03692078|615790639|FG005|Overall Study|Adverse Event|1|||
170396760|NCT03692078|615790640|FG006|Overall Study|Adverse Event|0|||
170396761|NCT03692078|615790634|FG000|Overall Study|Enrollment Closed|5|||
170396762|NCT03692078|615790635|FG001|Overall Study|Enrollment Closed|0|||
170396763|NCT03692078|615790636|FG002|Overall Study|Enrollment Closed|0|||
170396764|NCT03692078|615790637|FG003|Overall Study|Enrollment Closed|0|||
170396765|NCT03692078|615790638|FG004|Overall Study|Enrollment Closed|0|||
170396766|NCT03692078|615790639|FG005|Overall Study|Enrollment Closed|0|||
170396767|NCT03692078|615790640|FG006|Overall Study|Enrollment Closed|0|||
170396768|NCT03692078|615790634|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
170396769|NCT03692078|615790635|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
170396770|NCT03692078|615790636|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
170396771|NCT03692078|615790637|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
170396772|NCT03692078|615790638|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
170396773|NCT03692078|615790639|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
170396774|NCT03692078|615790640|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
170396775|NCT03692078|615790634|FG000|Overall Study|Withdrawal by Subject|0|||
170396776|NCT03692078|615790635|FG001|Overall Study|Withdrawal by Subject|2|||
170396777|NCT03692078|615790636|FG002|Overall Study|Withdrawal by Subject|0|||
170396778|NCT03692078|615790637|FG003|Overall Study|Withdrawal by Subject|1|||
170396779|NCT03692078|615790638|FG004|Overall Study|Withdrawal by Subject|5|||
170396780|NCT03692078|615790639|FG005|Overall Study|Withdrawal by Subject|3|||
170396781|NCT03692078|615790640|FG006|Overall Study|Withdrawal by Subject|3|||
170396782|NCT03576131|615790641|FG000|Overall Study|Investigator decision|0|||
170396783|NCT03576131|615790642|FG001|Overall Study|Investigator decision|0|||
170396784|NCT03576131|615790643|FG002|Overall Study|Investigator decision|0|||
170396785|NCT03576131|615790644|FG003|Overall Study|Investigator decision|1|||
170396786|NCT03576131|615790645|FG004|Overall Study|Investigator decision|0|||
170396787|NCT03576131|615790646|FG005|Overall Study|Investigator decision|1|||
170396788|NCT03576131|615790647|FG006|Overall Study|Investigator decision|0|||
170396789|NCT03576131|615790648|FG007|Overall Study|Investigator decision|0|||
170396790|NCT03576131|615790641|FG000|Overall Study|Withdrawal by Subject|1|||
170396791|NCT03576131|615790642|FG001|Overall Study|Withdrawal by Subject|1|||
170396792|NCT03576131|615790643|FG002|Overall Study|Withdrawal by Subject|0|||
170396793|NCT03576131|615790644|FG003|Overall Study|Withdrawal by Subject|1|||
170396794|NCT03576131|615790645|FG004|Overall Study|Withdrawal by Subject|2|||
170396795|NCT03576131|615790646|FG005|Overall Study|Withdrawal by Subject|3|||
170396796|NCT03576131|615790647|FG006|Overall Study|Withdrawal by Subject|1|||
170396797|NCT03576131|615790648|FG007|Overall Study|Withdrawal by Subject|0|||
170396798|NCT03576131|615790641|FG000|Overall Study|Death|3|||
170396799|NCT03576131|615790642|FG001|Overall Study|Death|3|||
170396800|NCT03576131|615790643|FG002|Overall Study|Death|1|||
170396801|NCT03576131|615790644|FG003|Overall Study|Death|5|||
170396802|NCT03576131|615790645|FG004|Overall Study|Death|4|||
170396803|NCT03576131|615790646|FG005|Overall Study|Death|1|||
170396804|NCT03576131|615790647|FG006|Overall Study|Death|0|||
170396805|NCT03576131|615790648|FG007|Overall Study|Death|1|||
170396806|NCT03576131|615790641|FG000|Overall Study|New anti-cancer treatment|5|||
170396807|NCT03576131|615790642|FG001|Overall Study|New anti-cancer treatment|1|||
170396808|NCT03576131|615790643|FG002|Overall Study|New anti-cancer treatment|2|||
170396809|NCT03576131|615790644|FG003|Overall Study|New anti-cancer treatment|3|||
170396810|NCT03576131|615790645|FG004|Overall Study|New anti-cancer treatment|0|||
170396811|NCT03576131|615790646|FG005|Overall Study|New anti-cancer treatment|0|||
170396812|NCT03576131|615790647|FG006|Overall Study|New anti-cancer treatment|0|||
170396813|NCT03576131|615790648|FG007|Overall Study|New anti-cancer treatment|0|||
170396814|NCT03576131|615790641|FG000|Overall Study|Unspecified reason|0|||
170396815|NCT03576131|615790642|FG001|Overall Study|Unspecified reason|0|||
170396816|NCT03576131|615790643|FG002|Overall Study|Unspecified reason|1|||
170396817|NCT03576131|615790644|FG003|Overall Study|Unspecified reason|1|||
170396818|NCT03576131|615790645|FG004|Overall Study|Unspecified reason|1|||
170396819|NCT03576131|615790646|FG005|Overall Study|Unspecified reason|1|||
170396820|NCT03576131|615790647|FG006|Overall Study|Unspecified reason|0|||
170396821|NCT03576131|615790648|FG007|Overall Study|Unspecified reason|0|||
170396822|NCT03576131|615790641|FG000|Overall Study|Subject non-compliance|0|||
170396823|NCT03576131|615790642|FG001|Overall Study|Subject non-compliance|0|||
170396824|NCT03576131|615790643|FG002|Overall Study|Subject non-compliance|0|||
170396825|NCT03576131|615790644|FG003|Overall Study|Subject non-compliance|0|||
170396826|NCT03576131|615790645|FG004|Overall Study|Subject non-compliance|0|||
170396827|NCT03576131|615790646|FG005|Overall Study|Subject non-compliance|1|||
170396828|NCT03576131|615790647|FG006|Overall Study|Subject non-compliance|0|||
170396829|NCT03576131|615790648|FG007|Overall Study|Subject non-compliance|0|||
170396830|NCT00996632|615790653|FG000|Overall Study|Physician Decision|0|||
170396831|NCT00996632|615790654|FG001|Overall Study|Physician Decision|0|||
170396832|NCT01563029|615790656|FG000|Overall Study|Adverse Event|1|||
170396833|NCT01563029|615790657|FG001|Overall Study|Adverse Event|0|||
170396834|NCT01563029|615790658|FG002|Overall Study|Adverse Event|1|||
170396835|NCT01563029|615790659|FG003|Overall Study|Adverse Event|2|||
170396836|NCT01563029|615790660|FG004|Overall Study|Adverse Event|1|||
170396837|NCT01563029|615790656|FG000|Overall Study|Lack of Efficacy|42|||
170396838|NCT01563029|615790657|FG001|Overall Study|Lack of Efficacy|16|||
170396839|NCT01563029|615790658|FG002|Overall Study|Lack of Efficacy|23|||
170396840|NCT01563029|615790659|FG003|Overall Study|Lack of Efficacy|21|||
170396841|NCT01563029|615790660|FG004|Overall Study|Lack of Efficacy|19|||
170396842|NCT01563029|615790656|FG000|Overall Study|Protocol Violation|1|||
170396843|NCT01563029|615790657|FG001|Overall Study|Protocol Violation|2|||
170396844|NCT01563029|615790658|FG002|Overall Study|Protocol Violation|3|||
170396845|NCT01563029|615790659|FG003|Overall Study|Protocol Violation|1|||
170396846|NCT01563029|615790660|FG004|Overall Study|Protocol Violation|3|||
170396847|NCT01563029|615790656|FG000|Overall Study|Protocol defined stopping criteria|1|||
170396848|NCT01563029|615790657|FG001|Overall Study|Protocol defined stopping criteria|0|||
170396849|NCT01563029|615790658|FG002|Overall Study|Protocol defined stopping criteria|0|||
170396850|NCT01563029|615790659|FG003|Overall Study|Protocol defined stopping criteria|0|||
170396851|NCT01563029|615790660|FG004|Overall Study|Protocol defined stopping criteria|0|||
170396852|NCT01563029|615790656|FG000|Overall Study|Lost to Follow-up|1|||
170396853|NCT01563029|615790657|FG001|Overall Study|Lost to Follow-up|0|||
170396854|NCT01563029|615790658|FG002|Overall Study|Lost to Follow-up|1|||
170396855|NCT01563029|615790659|FG003|Overall Study|Lost to Follow-up|1|||
170396856|NCT01563029|615790660|FG004|Overall Study|Lost to Follow-up|1|||
170396857|NCT01563029|615790656|FG000|Overall Study|Physician Decision|3|||
170396858|NCT01563029|615790657|FG001|Overall Study|Physician Decision|5|||
170396859|NCT01563029|615790658|FG002|Overall Study|Physician Decision|2|||
170396860|NCT01563029|615790659|FG003|Overall Study|Physician Decision|4|||
170396861|NCT01563029|615790660|FG004|Overall Study|Physician Decision|2|||
170396862|NCT01563029|615790656|FG000|Overall Study|Withdrawal by Subject|4|||
170396863|NCT01563029|615790657|FG001|Overall Study|Withdrawal by Subject|1|||
170396864|NCT01563029|615790658|FG002|Overall Study|Withdrawal by Subject|3|||
170396865|NCT01563029|615790659|FG003|Overall Study|Withdrawal by Subject|4|||
170396866|NCT01563029|615790660|FG004|Overall Study|Withdrawal by Subject|3|||
170396867|NCT02780115|615790661|FG000|Overall Study|Withdrawal by Subject|0|||
170396868|NCT02780115|615790662|FG001|Overall Study|Withdrawal by Subject|1|||
170396869|NCT02780115|615790663|FG002|Overall Study|Withdrawal by Subject|1|||
170396870|NCT02780115|615790664|FG003|Overall Study|Withdrawal by Subject|0|||
170396871|NCT02780115|615790665|FG004|Overall Study|Withdrawal by Subject|0|||
170396872|NCT02780115|615790661|FG000|Overall Study|Adverse Event|0|||
170396873|NCT02780115|615790662|FG001|Overall Study|Adverse Event|0|||
170396874|NCT02780115|615790663|FG002|Overall Study|Adverse Event|0|||
170396875|NCT02780115|615790664|FG003|Overall Study|Adverse Event|1|||
170396876|NCT02780115|615790665|FG004|Overall Study|Adverse Event|1|||
170396877|NCT02860039|615790671|FG000|Overall Study|Death|4|||
170396878|NCT02860039|615790672|FG001|Overall Study|Death|0|||
170396879|NCT02860039|615790671|FG000|Overall Study|Lost to Follow-up|2|||
170396880|NCT02860039|615790672|FG001|Overall Study|Lost to Follow-up|2|||
170396881|NCT02860039|615790671|FG000|Overall Study|Protocol Violation|3|||
170396882|NCT02860039|615790672|FG001|Overall Study|Protocol Violation|1|||
170396883|NCT02860039|615790671|FG000|Overall Study|Withdrawal by Subject|1|||
170396884|NCT02860039|615790672|FG001|Overall Study|Withdrawal by Subject|0|||
170396885|NCT02860039|615790671|FG000|Overall Study|Not otherwise eligible|1|||
170396886|NCT02860039|615790672|FG001|Overall Study|Not otherwise eligible|1|||
170396887|NCT03466060|615790685|FG000|Period 1|Test Lens Damage|0|||
170396888|NCT03466060|615790686|FG001|Period 1|Test Lens Damage|2|||
170396889|NCT03466060|615790687|FG002|Period 1|Test Lens Damage|0|||
170396890|NCT03466060|615790688|FG003|Period 1|Test Lens Damage|0|||
170396891|NCT03466060|615790689|FG004|Period 1|Test Lens Damage|0|||
170396892|NCT03466060|615790690|FG005|Period 1|Test Lens Damage|0|||
170396893|NCT03466060|615790685|FG000|Period 1|Withdrawal by Subject|0|||
170396894|NCT03466060|615790686|FG001|Period 1|Withdrawal by Subject|0|||
170396895|NCT03466060|615790687|FG002|Period 1|Withdrawal by Subject|2|||
170396896|NCT03466060|615790688|FG003|Period 1|Withdrawal by Subject|0|||
170396897|NCT03466060|615790689|FG004|Period 1|Withdrawal by Subject|0|||
170396898|NCT03466060|615790690|FG005|Period 1|Withdrawal by Subject|0|||
170396899|NCT03466060|615790685|FG000|Period 1|Lost to Follow-up|0|||
170396900|NCT03466060|615790686|FG001|Period 1|Lost to Follow-up|0|||
170396901|NCT03466060|615790687|FG002|Period 1|Lost to Follow-up|0|||
170396902|NCT03466060|615790688|FG003|Period 1|Lost to Follow-up|1|||
170396903|NCT03466060|615790689|FG004|Period 1|Lost to Follow-up|0|||
170396904|NCT03466060|615790690|FG005|Period 1|Lost to Follow-up|0|||
170396905|NCT03466060|615790685|FG000|Period 1|Grade 2 Conjunctivitis|0|||
170396906|NCT03466060|615790686|FG001|Period 1|Grade 2 Conjunctivitis|0|||
170396907|NCT03466060|615790687|FG002|Period 1|Grade 2 Conjunctivitis|1|||
170396908|NCT03466060|615790688|FG003|Period 1|Grade 2 Conjunctivitis|0|||
170396909|NCT03466060|615790689|FG004|Period 1|Grade 2 Conjunctivitis|0|||
170396910|NCT03466060|615790690|FG005|Period 1|Grade 2 Conjunctivitis|0|||
170396911|NCT03466060|615790685|FG000|Period 2|Lens Handling Difficulties|0|||
170396912|NCT03466060|615790686|FG001|Period 2|Lens Handling Difficulties|0|||
170396913|NCT03466060|615790687|FG002|Period 2|Lens Handling Difficulties|1|||
170396914|NCT03466060|615790688|FG003|Period 2|Lens Handling Difficulties|0|||
170396915|NCT03466060|615790689|FG004|Period 2|Lens Handling Difficulties|0|||
170396916|NCT03466060|615790690|FG005|Period 2|Lens Handling Difficulties|0|||
170396917|NCT01856257|615790693|FG000|Overall Study|Death|2|||
170396918|NCT01856257|615790694|FG001|Overall Study|Death|0|||
170396919|NCT01856257|615790695|FG002|Overall Study|Death|0|||
170396920|NCT01856257|615790696|FG003|Overall Study|Death|0|||
170396921|NCT01856257|615790693|FG000|Overall Study|Physician Decision|0|||
170396922|NCT01856257|615790694|FG001|Overall Study|Physician Decision|0|||
170396923|NCT01856257|615790695|FG002|Overall Study|Physician Decision|0|||
170396924|NCT01856257|615790696|FG003|Overall Study|Physician Decision|1|||
170396925|NCT01856257|615790693|FG000|Overall Study|Withdrawal by Subject|1|||
170396926|NCT01856257|615790694|FG001|Overall Study|Withdrawal by Subject|1|||
170396927|NCT01856257|615790695|FG002|Overall Study|Withdrawal by Subject|0|||
170396928|NCT01856257|615790696|FG003|Overall Study|Withdrawal by Subject|0|||
170396929|NCT01856257|615790693|FG000|Overall Study|Donor complication|0|||
170396930|NCT01856257|615790694|FG001|Overall Study|Donor complication|0|||
170396931|NCT01856257|615790695|FG002|Overall Study|Donor complication|0|||
170396932|NCT01856257|615790696|FG003|Overall Study|Donor complication|1|||
170396933|NCT04935931|615790697|FG000|Overall Study|Withdrawal by Subject|1|||
170396934|NCT01418365|615790702|FG000|First Intervention|Withdrawal by Subject|0|||
170396935|NCT01418365|615790703|FG001|First Intervention|Withdrawal by Subject|1|||
170396936|NCT01418365|615790702|FG000|First Intervention|Non-compliance|1|||
170396937|NCT01418365|615790703|FG001|First Intervention|Non-compliance|0|||
170396938|NCT01418365|615790702|FG000|Second Intervention|Withdrawal by Subject|0|||
170396939|NCT01418365|615790703|FG001|Second Intervention|Withdrawal by Subject|1|||
170396940|NCT03644927|615790704|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
170396941|NCT03644927|615790705|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
170396942|NCT04797637|615790706|FG000|Overall Study|Lost to Follow-up|23|||
170396943|NCT04797637|615790707|FG001|Overall Study|Lost to Follow-up|32|||
170396944|NCT04797637|615790706|FG000|Overall Study|Withdrawal by Subject|0|||
170396945|NCT04797637|615790707|FG001|Overall Study|Withdrawal by Subject|1|||
170396946|NCT01275170|615790710|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
170396947|NCT01275170|615790711|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
170396948|NCT01275170|615790712|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
170396949|NCT01275170|615790713|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
170396950|NCT01275170|615790714|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
170396951|NCT01275170|615790715|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
170396952|NCT01275170|615790716|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
170396953|NCT01275170|615790717|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
170396954|NCT05083559|615790718|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
170396955|NCT05083559|615790719|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
170396956|NCT05083559|615790718|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
170396957|NCT05083559|615790719|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
170396958|NCT05083559|615790718|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
170396959|NCT05083559|615790719|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
170396960|NCT00352664|615790720|FG000|Overall Study|Withdrawal by Subject|7|||
170396961|NCT00352664|615790721|FG001|Overall Study|Withdrawal by Subject|0|||
170396962|NCT03743571|615790722|FG000|Overall Study|Withdrawal by Subject|1|||
170396963|NCT03743571|615790723|FG001|Overall Study|Withdrawal by Subject|1|||
170396964|NCT03743571|615790722|FG000|Overall Study|Lost to Follow-up|1|||
170396965|NCT03743571|615790723|FG001|Overall Study|Lost to Follow-up|2|||
170396966|NCT01371006|615791949|FG000|Overall Study|Adverse Event|1|||
170396967|NCT01371006|615791950|FG001|Overall Study|Adverse Event|0|||
170396968|NCT03515837|615791953|FG000|Overall Study|Death|219|||
170396969|NCT03515837|615791954|FG001|Overall Study|Death|227|||
170396970|NCT03515837|615791953|FG000|Overall Study|Lost to Follow-up|0|||
170396971|NCT03515837|615791954|FG001|Overall Study|Lost to Follow-up|1|||
170396972|NCT03515837|615791953|FG000|Overall Study|Withdrawal by Subject|0|||
170396973|NCT03515837|615791954|FG001|Overall Study|Withdrawal by Subject|4|||
170396974|NCT03515837|615791953|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
170396975|NCT03515837|615791954|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
170396976|NCT00391092|615791955|FG000|Overall Study|Death|78|||
170396977|NCT00391092|615791956|FG001|Overall Study|Death|81|||
170396978|NCT00391092|615791955|FG000|Overall Study|Lost to Follow-up|13|||
170396979|NCT00391092|615791956|FG001|Overall Study|Lost to Follow-up|18|||
170396980|NCT00391092|615791955|FG000|Overall Study|Alive on treatment|29|||
170396981|NCT00391092|615791956|FG001|Overall Study|Alive on treatment|33|||
170396982|NCT00391092|615791955|FG000|Overall Study|Alive in follow-up|88|||
170396983|NCT00391092|615791956|FG001|Overall Study|Alive in follow-up|84|||
170396984|NCT01614925|615791957|FG000|Overall Study|Withdrawal by Subject|1|||
170396985|NCT01614925|615791958|FG001|Overall Study|Withdrawal by Subject|0|||
170396986|NCT01614925|615791957|FG000|Overall Study|Protocol Violation|3|||
170396987|NCT01614925|615791958|FG001|Overall Study|Protocol Violation|2|||
170396988|NCT01856686|615791959|FG000|Overall Study|Lost to Follow-up|5|||
170396989|NCT01856686|615791960|FG001|Overall Study|Lost to Follow-up|11|||
170396990|NCT01890109|615791965|FG000|Overall Study|Withdrawal by Subject|0|||
170396991|NCT01890109|615791966|FG001|Overall Study|Withdrawal by Subject|3|||
170396992|NCT01890109|615791965|FG000|Overall Study|Lost to Follow-up|1|||
170396993|NCT01890109|615791966|FG001|Overall Study|Lost to Follow-up|2|||
170396994|NCT05226286|615791967|FG000|Overall Study|Screen failures prior to implant|62|||
170396995|NCT05226286|615791967|FG000|Overall Study|Withdrawal by Subject|13|||
170396996|NCT05226286|615791967|FG000|Overall Study|Lost to Follow-up|3|||
170396997|NCT05226286|615791967|FG000|Overall Study|Physician Decision|1|||
170396998|NCT05226286|615791967|FG000|Overall Study|Adverse Event|1|||
170396999|NCT05226286|615791967|FG000|Overall Study|Death|1|||
170397000|NCT05226286|615791967|FG000|Overall Study|Device explant with no planned replacement|1|||
170397001|NCT05226286|615791967|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
170397002|NCT05226286|615791967|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
170397003|NCT02861534|615791968|FG000|Overall Study|Death|541|||
170397004|NCT02861534|615791969|FG001|Overall Study|Death|552|||
170397005|NCT02861534|615791968|FG000|Overall Study|Lost to Follow-up|14|||
170397006|NCT02861534|615791969|FG001|Overall Study|Lost to Follow-up|14|||
170397007|NCT02861534|615791968|FG000|Overall Study|Site Terminated by Sponsor|4|||
170397008|NCT02861534|615791969|FG001|Overall Study|Site Terminated by Sponsor|3|||
170397009|NCT02861534|615791968|FG000|Overall Study|Withdrawal by Subject|15|||
170397010|NCT02861534|615791969|FG001|Overall Study|Withdrawal by Subject|18|||
170397011|NCT02886494|615791972|FG000|Overall Study|Adverse Event|1|||
170397012|NCT02886494|615791973|FG001|Overall Study|Adverse Event|0|||
170397013|NCT02886494|615791972|FG000|Overall Study|Withdrawal by Subject|12|||
170397014|NCT02886494|615791973|FG001|Overall Study|Withdrawal by Subject|3|||
170397015|NCT02886494|615791972|FG000|Overall Study|Protocol Violation|4|||
170397016|NCT02886494|615791973|FG001|Overall Study|Protocol Violation|1|||
170397017|NCT04764669|615791974|FG000|Overall Study|Adverse Event|1|||
170397018|NCT04764669|615791975|FG001|Overall Study|Adverse Event|0|||
170397019|NCT04764669|615791976|FG002|Overall Study|Adverse Event|1|||
170397020|NCT04764669|615791977|FG003|Overall Study|Adverse Event|0|||
170397021|NCT04764669|615791974|FG000|Overall Study|Subject Choice|0|||
170397022|NCT04764669|615791975|FG001|Overall Study|Subject Choice|0|||
170397023|NCT04764669|615791976|FG002|Overall Study|Subject Choice|1|||
170397024|NCT04764669|615791977|FG003|Overall Study|Subject Choice|0|||
170397025|NCT04764669|615791974|FG000|Overall Study|Withdrawal by Subject|2|||
170397026|NCT04764669|615791975|FG001|Overall Study|Withdrawal by Subject|0|||
170397027|NCT04764669|615791976|FG002|Overall Study|Withdrawal by Subject|0|||
170397028|NCT04764669|615791977|FG003|Overall Study|Withdrawal by Subject|0|||
170397029|NCT00877799|615791983|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
170397030|NCT00877799|615791984|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
170397031|NCT00877799|615791985|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
170397032|NCT00877799|615791986|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
170397033|NCT00877799|615791987|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
170397034|NCT00877799|615791983|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
170397035|NCT00877799|615791984|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
170397036|NCT00877799|615791985|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
170397037|NCT00877799|615791986|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
170397038|NCT00877799|615791987|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
170397039|NCT00877799|615791983|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
170397040|NCT00877799|615791984|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
170397041|NCT00877799|615791985|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
170397042|NCT00877799|615791986|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
170397043|NCT00877799|615791987|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
170397044|NCT00877799|615791983|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
170397045|NCT00877799|615791984|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
170397046|NCT00877799|615791985|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
170397047|NCT00877799|615791986|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
170397048|NCT00877799|615791987|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
170397049|NCT00877799|615791983|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
170397050|NCT00877799|615791984|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
170397051|NCT00877799|615791985|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
170397052|NCT00877799|615791986|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
170397053|NCT00877799|615791987|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
170397054|NCT02086968|615791988|FG000|Overall Study|Adverse Event|1|||
170397055|NCT02086968|615791989|FG001|Overall Study|Adverse Event|5|||
170397056|NCT02086968|615791988|FG000|Overall Study|Lost to Follow-up|2|||
170397057|NCT02086968|615791989|FG001|Overall Study|Lost to Follow-up|3|||
170397058|NCT02086968|615791988|FG000|Overall Study|Study drug received outside protocol|0|||
170397059|NCT02086968|615791989|FG001|Overall Study|Study drug received outside protocol|1|||
170397060|NCT02086968|615791988|FG000|Overall Study|Physician Decision|4|||
170397061|NCT02086968|615791989|FG001|Overall Study|Physician Decision|0|||
170397062|NCT02086968|615791988|FG000|Overall Study|Withdrawal by Subject|1|||
170397063|NCT02086968|615791989|FG001|Overall Study|Withdrawal by Subject|4|||
170397064|NCT01984229|615791992|FG000|Safety Follow-up Period|Adverse Event|1|||
170397065|NCT01984229|615791993|FG001|Safety Follow-up Period|Adverse Event|1|||
170397066|NCT01984229|615791992|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
170397067|NCT01984229|615791993|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
170397068|NCT00938015|615792002|FG000|Overall Study|Death|2|||
170397069|NCT00938015|615792002|FG000|Overall Study|Lost to Follow-up|32|||
170397070|NCT00938015|615792002|FG000|Overall Study|Adverse Event|32|||
170397071|NCT00938015|615792002|FG000|Overall Study|Non-responder|52|||
170397072|NCT00938015|615792002|FG000|Overall Study|Reason not related to Etanercept|29|||
170397073|NCT03186794|615792003|FG000|Overall Study|Physician Decision|2|||
170397074|NCT03186794|615792003|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
170397075|NCT03319368|615792009|FG000|Overall Study|Discharge swabs not collected from resident|57|||
170397076|NCT03319368|615792010|FG001|Overall Study|Discharge swabs not collected from resident|46|||
170397077|NCT04150107|615792013|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
170397078|NCT04150107|615792014|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
170397079|NCT04150107|615792013|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
170397080|NCT04150107|615792014|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
170397081|NCT00440193|615792019|FG000|Treatment Period|Adverse Event|74|||
170397082|NCT00440193|615792020|FG001|Treatment Period|Adverse Event|67|||
170397083|NCT00440193|615792019|FG000|Treatment Period|Death|19|||
170397084|NCT00440193|615792020|FG001|Treatment Period|Death|22|||
170397085|NCT00440193|615792019|FG000|Treatment Period|Lack of Efficacy|0|||
170397086|NCT00440193|615792020|FG001|Treatment Period|Lack of Efficacy|1|||
170397087|NCT00440193|615792019|FG000|Treatment Period|Lost to Follow-up|12|||
170397088|NCT00440193|615792020|FG001|Treatment Period|Lost to Follow-up|18|||
170397089|NCT00440193|615792019|FG000|Treatment Period|Physician Decision|3|||
170397090|NCT00440193|615792020|FG001|Treatment Period|Physician Decision|6|||
170397091|NCT00440193|615792019|FG000|Treatment Period|Protocol Violation|16|||
170397092|NCT00440193|615792020|FG001|Treatment Period|Protocol Violation|19|||
170397093|NCT00440193|615792019|FG000|Treatment Period|Withdrawal by Subject|36|||
170397094|NCT00440193|615792020|FG001|Treatment Period|Withdrawal by Subject|77|||
170397095|NCT00440193|615792019|FG000|Treatment Period|Clinical endpoint reached|28|||
170397096|NCT00440193|615792020|FG001|Treatment Period|Clinical endpoint reached|25|||
170397097|NCT00440193|615792019|FG000|Treatment Period|Study terminated by sponsor|102|||
170397098|NCT00440193|615792020|FG001|Treatment Period|Study terminated by sponsor|94|||
170397099|NCT00440193|615792019|FG000|Treatment Period|Protocol driven decision point|2|||
170397100|NCT00440193|615792020|FG001|Treatment Period|Protocol driven decision point|2|||
170397101|NCT00440193|615792019|FG000|Treatment Period|Switch to commercial drug|0|||
170397102|NCT00440193|615792020|FG001|Treatment Period|Switch to commercial drug|2|||
170397103|NCT00440193|615792019|FG000|Treatment Period|Technical problems|1|||
170397104|NCT00440193|615792020|FG001|Treatment Period|Technical problems|1|||
170397105|NCT00440193|615792019|FG000|Treatment Period|Participant convenience|5|||
170397106|NCT00440193|615792020|FG001|Treatment Period|Participant convenience|2|||
170397107|NCT00440193|615792019|FG000|Treatment Period|Participant did not receive treatment|7|||
170397108|NCT00440193|615792020|FG001|Treatment Period|Participant did not receive treatment|13|||
170397109|NCT00440193|615792019|FG000|Treatment Period|Site closed by investigator|0|||
170397110|NCT00440193|615792020|FG001|Treatment Period|Site closed by investigator|2|||
170397111|NCT00440193|615792019|FG000|Observational Period|Adverse Event|2|||
170397112|NCT00440193|615792020|FG001|Observational Period|Adverse Event|2|||
170397113|NCT00440193|615792019|FG000|Observational Period|Death|15|||
170397114|NCT00440193|615792020|FG001|Observational Period|Death|20|||
170397115|NCT00440193|615792019|FG000|Observational Period|Lost to Follow-up|12|||
170397116|NCT00440193|615792020|FG001|Observational Period|Lost to Follow-up|8|||
170397117|NCT00440193|615792019|FG000|Observational Period|Protocol Violation|1|||
170397118|NCT00440193|615792020|FG001|Observational Period|Protocol Violation|0|||
170397119|NCT00440193|615792019|FG000|Observational Period|Withdrawal by Subject|11|||
170397120|NCT00440193|615792020|FG001|Observational Period|Withdrawal by Subject|8|||
170397121|NCT00440193|615792019|FG000|Observational Period|Physician Decision|1|||
170397122|NCT00440193|615792020|FG001|Observational Period|Physician Decision|0|||
170397123|NCT00440193|615792019|FG000|Observational Period|Clinical endpoint reached|1|||
170397124|NCT00440193|615792020|FG001|Observational Period|Clinical endpoint reached|0|||
170397125|NCT00440193|615792019|FG000|Observational Period|Participant convenience|2|||
170397126|NCT00440193|615792020|FG001|Observational Period|Participant convenience|0|||
170397127|NCT01495793|615792021|FG000|Overall Study|Lost to Follow-up|1|||
170397128|NCT01495793|615792021|FG000|Overall Study|Violation of inclusion criteria|1|||
170397129|NCT00824993|615792022|FG000|Overall Study|Withdrawal by Subject|1|||
170397130|NCT00824993|615792023|FG001|Overall Study|Withdrawal by Subject|1|||
170397131|NCT00824993|615792022|FG000|Overall Study|Malignancy Relapse|9|||
170397132|NCT00824993|615792023|FG001|Overall Study|Malignancy Relapse|10|||
170397133|NCT00824993|615792022|FG000|Overall Study|Rapid Bone Loss|0|||
170397134|NCT00824993|615792023|FG001|Overall Study|Rapid Bone Loss|1|||
170397135|NCT00824993|615792022|FG000|Overall Study|Non-Compliant|2|||
170397136|NCT00824993|615792023|FG001|Overall Study|Non-Compliant|1|||
170397137|NCT00824993|615792022|FG000|Overall Study|Insurance Issue|2|||
170397138|NCT00824993|615792023|FG001|Overall Study|Insurance Issue|1|||
170397139|NCT00824993|615792022|FG000|Overall Study|Death|0|||
170397140|NCT00824993|615792023|FG001|Overall Study|Death|3|||
170397141|NCT00834366|615792024|FG000|Treatment Period 1|Adverse Event|1|||
170397142|NCT00834366|615792025|FG001|Treatment Period 1|Adverse Event|1|||
170397143|NCT00981019|615792028|FG000|Overall Study|Did not respond|65|||
170397144|NCT00981019|615792028|FG000|Overall Study|Did not match target population|94|||
170397145|NCT00981019|615792028|FG000|Overall Study|Inadvertent exclusion|239|||
170397146|NCT00981019|615792028|FG000|Overall Study|Hit the survey after closure|79|||
170397147|NCT00865306|615792029|FG000|Controlled Trial|Lost to Follow-up|1|||
170397148|NCT00865306|615792030|FG001|Controlled Trial|Lost to Follow-up|1|||
170397149|NCT00865306|615792029|FG000|Controlled Trial|Difficulty commuting|2|||
170397150|NCT00865306|615792030|FG001|Controlled Trial|Difficulty commuting|0|||
170397151|NCT00865306|615792029|FG000|Controlled Trial|Improved btw baseline and first session|1|||
170397152|NCT00865306|615792030|FG001|Controlled Trial|Improved btw baseline and first session|0|||
170397153|NCT00865306|615792029|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
170397154|NCT00865306|615792030|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
170397155|NCT00865306|615792029|FG000|Controlled Trial|Withdrawal by Subject|0|||
170397156|NCT00865306|615792030|FG001|Controlled Trial|Withdrawal by Subject|1|||
170397157|NCT03611751|615792031|FG000|Pre-treatment|Randomized but not treated|1|||
170397158|NCT03611751|615792032|FG001|Pre-treatment|Randomized but not treated|1|||
170397159|NCT03611751|615792033|FG002|Pre-treatment|Randomized but not treated|0|||
170397160|NCT03611751|615792031|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
170397161|NCT03611751|615792032|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
170397162|NCT03611751|615792033|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
170397163|NCT03611751|615792031|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
170397164|NCT03611751|615792032|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
170397165|NCT03611751|615792033|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
170397166|NCT03611751|615792031|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
170397167|NCT03611751|615792032|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
170397168|NCT03611751|615792033|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
170397169|NCT03611751|615792031|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
170397170|NCT03611751|615792032|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
170397171|NCT03611751|615792033|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
170397172|NCT03611751|615792031|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
170397173|NCT03611751|615792032|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
170397174|NCT03611751|615792033|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
170397175|NCT03611751|615792031|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
170397176|NCT03611751|615792032|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
170397177|NCT03611751|615792033|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
170397178|NCT03611751|615792031|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
170397179|NCT03611751|615792032|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
170397180|NCT03611751|615792033|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
170397181|NCT03611751|615792031|FG000|Treatment Week 0 - Week 16|Death|0|||
170397182|NCT03611751|615792032|FG001|Treatment Week 0 - Week 16|Death|0|||
170397183|NCT03611751|615792033|FG002|Treatment Week 0 - Week 16|Death|1|||
170397184|NCT03611751|615792031|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
170397185|NCT03611751|615792032|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
170397186|NCT03611751|615792033|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
170397187|NCT03611751|615792031|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
170397188|NCT03611751|615792032|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
170397189|NCT03611751|615792033|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
170397190|NCT03611751|615792031|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
170397191|NCT03611751|615792032|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
170397192|NCT03611751|615792033|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
170397193|NCT03611751|615792031|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
170397194|NCT03611751|615792032|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
170397195|NCT03611751|615792033|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
170397196|NCT03611751|615792031|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
170397197|NCT03611751|615792032|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
170397198|NCT03611751|615792033|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
170397199|NCT03611751|615792031|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
170397200|NCT03611751|615792032|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
170397201|NCT03611751|615792033|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
170397202|NCT03611751|615792031|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
170397203|NCT03611751|615792032|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
170397204|NCT03611751|615792033|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
170397205|NCT03611751|615792031|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
170397206|NCT03611751|615792032|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
170397207|NCT03611751|615792033|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
170397208|NCT03611751|615792031|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
170397209|NCT03611751|615792032|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
170397210|NCT03611751|615792033|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
170397211|NCT03611751|615792031|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
170397212|NCT03611751|615792032|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
170397213|NCT03611751|615792033|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
170397214|NCT03611751|615792031|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
170397215|NCT03611751|615792032|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
170397216|NCT03611751|615792033|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
170397217|NCT03611751|615792031|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
170397218|NCT03611751|615792032|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
170397219|NCT03611751|615792033|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
170397220|NCT03611751|615792031|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
170397221|NCT03611751|615792032|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
170397222|NCT03611751|615792033|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
170397223|NCT03611751|615792031|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
170397224|NCT03611751|615792032|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
170397225|NCT03611751|615792033|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
170397226|NCT01023022|615792037|FG000|Overall Study|Death|5|||
170397227|NCT01023022|615792037|FG000|Overall Study|Lost to Follow-up|7|||
170397228|NCT01023022|615792037|FG000|Overall Study|due to technical issues|2|||
170397229|NCT02684162|615792038|FG000|Overall Study|Physician Decision|0|||
170397230|NCT02684162|615792039|FG001|Overall Study|Physician Decision|1|||
170397231|NCT02684162|615792040|FG002|Overall Study|Physician Decision|0|||
170397232|NCT01058707|615792043|FG000|Overall Study|Disease Progression|15|||
170397233|NCT01058707|615792044|FG001|Overall Study|Disease Progression|20|||
170397234|NCT01058707|615792045|FG002|Overall Study|Disease Progression|20|||
170397235|NCT01058707|615792046|FG003|Overall Study|Disease Progression|15|||
170397236|NCT01058707|615792047|FG004|Overall Study|Disease Progression|23|||
170397237|NCT01058707|615792048|FG005|Overall Study|Disease Progression|10|||
170397238|NCT01058707|615792049|FG006|Overall Study|Disease Progression|12|||
170397239|NCT01058707|615792043|FG000|Overall Study|Adverse Event|11|||
170397240|NCT01058707|615792044|FG001|Overall Study|Adverse Event|4|||
170397241|NCT01058707|615792045|FG002|Overall Study|Adverse Event|7|||
170397242|NCT01058707|615792046|FG003|Overall Study|Adverse Event|6|||
170397243|NCT01058707|615792047|FG004|Overall Study|Adverse Event|7|||
170397244|NCT01058707|615792048|FG005|Overall Study|Adverse Event|3|||
170397245|NCT01058707|615792049|FG006|Overall Study|Adverse Event|1|||
170397246|NCT01058707|615792043|FG000|Overall Study|Subject Decision|5|||
170397247|NCT01058707|615792044|FG001|Overall Study|Subject Decision|3|||
170397248|NCT01058707|615792045|FG002|Overall Study|Subject Decision|3|||
170397249|NCT01058707|615792046|FG003|Overall Study|Subject Decision|1|||
170397250|NCT01058707|615792047|FG004|Overall Study|Subject Decision|2|||
170397251|NCT01058707|615792048|FG005|Overall Study|Subject Decision|3|||
170397252|NCT01058707|615792049|FG006|Overall Study|Subject Decision|6|||
170397253|NCT01058707|615792043|FG000|Overall Study|Lost to Follow-up|0|||
170397254|NCT01058707|615792044|FG001|Overall Study|Lost to Follow-up|0|||
170397255|NCT01058707|615792045|FG002|Overall Study|Lost to Follow-up|1|||
170397256|NCT01058707|615792046|FG003|Overall Study|Lost to Follow-up|0|||
170397257|NCT01058707|615792047|FG004|Overall Study|Lost to Follow-up|0|||
170397258|NCT01058707|615792048|FG005|Overall Study|Lost to Follow-up|0|||
170397259|NCT01058707|615792049|FG006|Overall Study|Lost to Follow-up|0|||
170397260|NCT01058707|615792043|FG000|Overall Study|Reason Not Specified|0|||
170397261|NCT01058707|615792044|FG001|Overall Study|Reason Not Specified|3|||
170397262|NCT01058707|615792045|FG002|Overall Study|Reason Not Specified|2|||
170397263|NCT01058707|615792046|FG003|Overall Study|Reason Not Specified|0|||
170397264|NCT01058707|615792047|FG004|Overall Study|Reason Not Specified|7|||
170397265|NCT01058707|615792048|FG005|Overall Study|Reason Not Specified|1|||
170397266|NCT01058707|615792049|FG006|Overall Study|Reason Not Specified|7|||
170397267|NCT01821391|615792050|FG000|Overall Study|Adverse Event|1|||
170397268|NCT01821391|615792051|FG001|Overall Study|Adverse Event|0|||
170397269|NCT01608321|615792057|FG000|Overall Study|Withdrawal by Subject|1|||
170397270|NCT01608321|615792058|FG001|Overall Study|Withdrawal by Subject|0|||
170397271|NCT03222856|615792059|FG000|Overall Study|Adverse Event|6|||
170397272|NCT03222856|615792059|FG000|Overall Study|Death|1|||
170397273|NCT02325401|615793409|FG000|Overall Study|Withdrawal by Subject|0|||
170397274|NCT02325401|615793410|FG001|Overall Study|Withdrawal by Subject|1|||
170397275|NCT02325401|615793411|FG002|Overall Study|Withdrawal by Subject|1|||
170397276|NCT03286400|615793416|FG000|Overall Study|Death|10|||
170397277|NCT03286400|615793416|FG000|Overall Study|Lost to Follow-up|10|||
170397278|NCT03286400|615793416|FG000|Overall Study|Physician Decision|1|||
170397279|NCT03286400|615793416|FG000|Overall Study|Scheduling difficulty|4|||
170397280|NCT02953262|615793417|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
170397281|NCT02953262|615793418|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
170397282|NCT02953262|615793419|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
170397283|NCT02953262|615793420|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
170397284|NCT00602979|615793421|FG000|Overall Study|Lost to Follow-up|3|||
170397285|NCT00602979|615793422|FG001|Overall Study|Lost to Follow-up|2|||
170397286|NCT00602979|615793423|FG002|Overall Study|Lost to Follow-up|3|||
170397287|NCT00602979|615793424|FG003|Overall Study|Lost to Follow-up|2|||
170397288|NCT00602979|615793425|FG004|Overall Study|Lost to Follow-up|3|||
170397289|NCT00602979|615793421|FG000|Overall Study|Failed Intubation|0|||
170397290|NCT00602979|615793422|FG001|Overall Study|Failed Intubation|1|||
170397291|NCT00602979|615793423|FG002|Overall Study|Failed Intubation|0|||
170397292|NCT00602979|615793424|FG003|Overall Study|Failed Intubation|1|||
170397293|NCT00602979|615793425|FG004|Overall Study|Failed Intubation|0|||
170397294|NCT02406742|615793428|FG000|Overall Study|Progression of Disease|5|||
170397295|NCT02406742|615793429|FG001|Overall Study|Progression of Disease|1|||
170397296|NCT02406742|615793430|FG002|Overall Study|Progression of Disease|6|||
170397297|NCT02406742|615793428|FG000|Overall Study|Adverse Event|3|||
170397298|NCT02406742|615793429|FG001|Overall Study|Adverse Event|0|||
170397299|NCT02406742|615793430|FG002|Overall Study|Adverse Event|2|||
170397300|NCT02406742|615793428|FG000|Overall Study|Death|1|||
170397301|NCT02406742|615793429|FG001|Overall Study|Death|0|||
170397302|NCT02406742|615793430|FG002|Overall Study|Death|0|||
170397303|NCT02406742|615793428|FG000|Overall Study|Lack of Efficacy|0|||
170397304|NCT02406742|615793429|FG001|Overall Study|Lack of Efficacy|0|||
170397305|NCT02406742|615793430|FG002|Overall Study|Lack of Efficacy|1|||
170397306|NCT02406742|615793428|FG000|Overall Study|Withdrawal by Participant|1|||
170397307|NCT02406742|615793429|FG001|Overall Study|Withdrawal by Participant|2|||
170397308|NCT02406742|615793430|FG002|Overall Study|Withdrawal by Participant|0|||
170397309|NCT02406742|615793428|FG000|Overall Study|Physician Decision|1|||
170397310|NCT02406742|615793429|FG001|Overall Study|Physician Decision|2|||
170397311|NCT02406742|615793430|FG002|Overall Study|Physician Decision|1|||
170397312|NCT02406742|615793428|FG000|Overall Study|Transition to other treatment|2|||
170397313|NCT02406742|615793429|FG001|Overall Study|Transition to other treatment|0|||
170397314|NCT02406742|615793430|FG002|Overall Study|Transition to other treatment|1|||
170397315|NCT02406742|615793428|FG000|Overall Study|Other Reasons|1|||
170397316|NCT02406742|615793429|FG001|Overall Study|Other Reasons|11|||
170397317|NCT02406742|615793430|FG002|Overall Study|Other Reasons|5|||
170397318|NCT00765999|615793431|FG000|Overall Study|Adverse Event|203|||
170397319|NCT00765999|615793431|FG000|Overall Study|Insufficient Therapeutic Response|100|||
170397320|NCT00765999|615793431|FG000|Overall Study|Protocol Violation|95|||
170397321|NCT00765999|615793431|FG000|Overall Study|Consent Withdrawn|202|||
170397322|NCT00765999|615793431|FG000|Overall Study|Lost to Follow-up|131|||
170397323|NCT00765999|615793431|FG000|Overall Study|Study Terminated by Sponsor|2|||
170397324|NCT00765999|615793431|FG000|Overall Study|Other Miscellaneous Reasons|51|||
170397325|NCT02367729|615793432|FG000|Overall Study|Organic disorder diagnosed|2|||
170397326|NCT02367729|615793433|FG001|Overall Study|Organic disorder diagnosed|1|||
170397327|NCT02367729|615793432|FG000|Overall Study|Adverse Event|1|||
170397328|NCT02367729|615793433|FG001|Overall Study|Adverse Event|2|||
170397329|NCT02367729|615793432|FG000|Overall Study|Withdrawal by Subject|0|||
170397330|NCT02367729|615793433|FG001|Overall Study|Withdrawal by Subject|5|||
170397331|NCT00759174|615793434|FG000|Overall Study|Other|0|||
170397332|NCT00759174|615793435|FG001|Overall Study|Other|2|||
170397333|NCT05723835|615793436|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
170397334|NCT05723835|615793437|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
170397335|NCT05723835|615793438|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
170397336|NCT05723835|615793439|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
170397337|NCT05723835|615793440|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
170397338|NCT05723835|615793441|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
170397339|NCT05723835|615793442|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
170397340|NCT05723835|615793443|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
170397341|NCT00916617|615793444|FG000|Overall Study|Adverse Event|3|||
170397342|NCT00916617|615793445|FG001|Overall Study|Adverse Event|2|||
170397343|NCT00916617|615793446|FG002|Overall Study|Adverse Event|6|||
170397344|NCT00916617|615793447|FG003|Overall Study|Adverse Event|3|||
170397345|NCT00916617|615793444|FG000|Overall Study|Withdrawal by Subject|3|||
170397346|NCT00916617|615793445|FG001|Overall Study|Withdrawal by Subject|2|||
170397347|NCT00916617|615793446|FG002|Overall Study|Withdrawal by Subject|0|||
170397348|NCT00916617|615793447|FG003|Overall Study|Withdrawal by Subject|1|||
170397349|NCT00916617|615793444|FG000|Overall Study|Caregiver Request|3|||
170397350|NCT00916617|615793445|FG001|Overall Study|Caregiver Request|2|||
170397351|NCT00916617|615793446|FG002|Overall Study|Caregiver Request|1|||
170397352|NCT00916617|615793447|FG003|Overall Study|Caregiver Request|0|||
170397353|NCT00916617|615793444|FG000|Overall Study|Physician Decision|1|||
170397354|NCT00916617|615793445|FG001|Overall Study|Physician Decision|1|||
170397355|NCT00916617|615793446|FG002|Overall Study|Physician Decision|0|||
170397356|NCT00916617|615793447|FG003|Overall Study|Physician Decision|0|||
170397357|NCT00916617|615793444|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
170397358|NCT00916617|615793445|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
170397359|NCT00916617|615793446|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
170397360|NCT00916617|615793447|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
170397361|NCT00916617|615793444|FG000|Overall Study|Lost to Follow-up|2|||
170397362|NCT00916617|615793445|FG001|Overall Study|Lost to Follow-up|1|||
170397363|NCT00916617|615793446|FG002|Overall Study|Lost to Follow-up|0|||
170397364|NCT00916617|615793447|FG003|Overall Study|Lost to Follow-up|0|||
170397365|NCT00916617|615793444|FG000|Overall Study|Lack of Efficacy|1|||
170397366|NCT00916617|615793445|FG001|Overall Study|Lack of Efficacy|0|||
170397367|NCT00916617|615793446|FG002|Overall Study|Lack of Efficacy|0|||
170397368|NCT00916617|615793447|FG003|Overall Study|Lack of Efficacy|0|||
170397369|NCT00916617|615793444|FG000|Overall Study|Other|2|||
170397370|NCT00916617|615793445|FG001|Overall Study|Other|0|||
170397371|NCT00916617|615793446|FG002|Overall Study|Other|0|||
170397372|NCT00916617|615793447|FG003|Overall Study|Other|2|||
170397373|NCT00769132|615793449|FG000|Period 1|Adverse Event|1|||
170397374|NCT00769132|615793450|FG001|Period 1|Adverse Event|0|||
170397375|NCT00769132|615793451|FG002|Period 1|Adverse Event|0|||
170397376|NCT00769132|615793452|FG003|Period 1|Adverse Event|1|||
170397377|NCT00769132|615793449|FG000|Period 2|Withdrawal by Subject|0|||
170397378|NCT00769132|615793450|FG001|Period 2|Withdrawal by Subject|0|||
170397379|NCT00769132|615793451|FG002|Period 2|Withdrawal by Subject|0|||
170397380|NCT00769132|615793452|FG003|Period 2|Withdrawal by Subject|1|||
170397381|NCT00769132|615793449|FG000|Period 3|Withdrawal by Subject|1|||
170397382|NCT00769132|615793450|FG001|Period 3|Withdrawal by Subject|0|||
170397383|NCT00769132|615793451|FG002|Period 3|Withdrawal by Subject|0|||
170397384|NCT00769132|615793452|FG003|Period 3|Withdrawal by Subject|0|||
170397385|NCT00769132|615793449|FG000|Period 4|Withdrawal by Subject|0|||
170397386|NCT00769132|615793450|FG001|Period 4|Withdrawal by Subject|1|||
170397387|NCT00769132|615793451|FG002|Period 4|Withdrawal by Subject|0|||
170397388|NCT00769132|615793452|FG003|Period 4|Withdrawal by Subject|0|||
170397389|NCT00499252|615793453|FG000|Overall Study|Adverse Event|3|||
170397390|NCT00499252|615793453|FG000|Overall Study|Refused further treatment|2|||
170397391|NCT00499252|615793453|FG000|Overall Study|Ineligible|4|||
170397392|NCT00499252|615793453|FG000|Overall Study|<no further label>|3|||
170397393|NCT01988337|615793454|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
170397394|NCT02230332|615793455|FG000|Overall Study|Adverse Event|2|||
170397395|NCT02230332|615793456|FG001|Overall Study|Adverse Event|1|||
170397396|NCT02230332|615793455|FG000|Overall Study|Lost to Follow-up|1|||
170397397|NCT02230332|615793456|FG001|Overall Study|Lost to Follow-up|0|||
170397398|NCT02230332|615793455|FG000|Overall Study|Protocol Violation|1|||
170397399|NCT02230332|615793456|FG001|Overall Study|Protocol Violation|0|||
170397400|NCT01260194|615793458|FG000|Overall Study|Withdrawal of Consent|1|||
170397401|NCT00566631|615793459|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
170397402|NCT00566631|615793459|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
170397403|NCT00566631|615793459|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
170397404|NCT00566631|615793459|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
170397405|NCT00566631|615793459|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
170397406|NCT00566631|615793459|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
170397407|NCT00566631|615793459|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
170397408|NCT00566631|615793459|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
170397409|NCT00566631|615793459|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
170397410|NCT00566631|615793459|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
170397411|NCT00566631|615793459|FG000|Part 2: Extension Phase|Adverse Event|11|||
170397412|NCT00566631|615793459|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
170397413|NCT00566631|615793459|FG000|Part 2: Extension Phase|Death|1|||
170397414|NCT00566631|615793459|FG000|Part 2: Extension Phase|Other|5|||
170397415|NCT00457418|615793460|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
170397416|NCT00457418|615793460|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
170397417|NCT00457418|615793460|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
170397418|NCT00457418|615793460|FG000|Post PK Maintenance|Adverse Event|10|||
170397419|NCT00457418|615793460|FG000|Post PK Maintenance|Progression of Disease|6|||
170397420|NCT00457418|615793460|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
170397421|NCT00457418|615793460|FG000|Post PK Maintenance|Lost to Follow-up|1|||
170397422|NCT02723786|615793466|FG000|Overall Study|Lost to Follow-up|1|||
170397423|NCT00127192|615793475|FG000|Overall Study|Adverse Event|0|||
170397424|NCT00127192|615793476|FG001|Overall Study|Adverse Event|1|||
170397425|NCT00127192|615793477|FG002|Overall Study|Adverse Event|1|||
170397426|NCT00127192|615793478|FG003|Overall Study|Adverse Event|1|||
170397427|NCT00127192|615793479|FG004|Overall Study|Adverse Event|0|||
170397428|NCT00127192|615793475|FG000|Overall Study|Lack of Efficacy|2|||
170397429|NCT00127192|615793476|FG001|Overall Study|Lack of Efficacy|0|||
170397430|NCT00127192|615793477|FG002|Overall Study|Lack of Efficacy|0|||
170397431|NCT00127192|615793478|FG003|Overall Study|Lack of Efficacy|0|||
170397432|NCT00127192|615793479|FG004|Overall Study|Lack of Efficacy|2|||
170397433|NCT00127192|615793475|FG000|Overall Study|Withdrawal by Subject|0|||
170397434|NCT00127192|615793476|FG001|Overall Study|Withdrawal by Subject|0|||
170397435|NCT00127192|615793477|FG002|Overall Study|Withdrawal by Subject|1|||
170397436|NCT00127192|615793478|FG003|Overall Study|Withdrawal by Subject|0|||
170397437|NCT00127192|615793479|FG004|Overall Study|Withdrawal by Subject|3|||
170397438|NCT00127192|615793475|FG000|Overall Study|Adverse event in pre-treatment period|1|||
170397439|NCT00127192|615793476|FG001|Overall Study|Adverse event in pre-treatment period|0|||
170397440|NCT00127192|615793477|FG002|Overall Study|Adverse event in pre-treatment period|0|||
170397441|NCT00127192|615793478|FG003|Overall Study|Adverse event in pre-treatment period|0|||
170397442|NCT00127192|615793479|FG004|Overall Study|Adverse event in pre-treatment period|0|||
170397443|NCT03170271|615793480|FG000|Overall Study|Adverse Event|7|||
170397444|NCT03170271|615793481|FG001|Overall Study|Adverse Event|2|||
170397445|NCT03170271|615793480|FG000|Overall Study|Lost to Follow-up|0|||
170397446|NCT03170271|615793481|FG001|Overall Study|Lost to Follow-up|1|||
170397447|NCT03170271|615793480|FG000|Overall Study|Physician Decision|1|||
170397448|NCT03170271|615793481|FG001|Overall Study|Physician Decision|0|||
170397449|NCT03170271|615793480|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
170397450|NCT03170271|615793481|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
170397451|NCT03170271|615793480|FG000|Overall Study|Withdrawal by Subject|17|||
170397452|NCT03170271|615793481|FG001|Overall Study|Withdrawal by Subject|5|||
170397453|NCT03170271|615793480|FG000|Overall Study|Other|2|||
170397454|NCT03170271|615793481|FG001|Overall Study|Other|2|||
170397455|NCT03170271|615793480|FG000|Overall Study|Randomized in error|4|||
170397456|NCT03170271|615793481|FG001|Overall Study|Randomized in error|0|||
170397457|NCT00203892|615793482|FG000|Overall Study|Physician Decision|1|||
170397458|NCT00203892|615793483|FG001|Overall Study|Physician Decision|2|||
170397459|NCT00203892|615793484|FG002|Overall Study|Physician Decision|0|||
170397460|NCT00203892|615793482|FG000|Overall Study|Death|1|||
170397461|NCT00203892|615793483|FG001|Overall Study|Death|0|||
170397462|NCT00203892|615793484|FG002|Overall Study|Death|0|||
170397463|NCT00556166|615793486|FG000|Overall Study|Withdrawal by Subject|1|||
170397464|NCT00244881|615793487|FG000|Overall Study|Withdrawal by Subject|3|||
170397465|NCT03359473|615793488|FG000|Overall Study|Adverse Event|0|||
170397466|NCT03359473|615793489|FG001|Overall Study|Adverse Event|2|||
170397467|NCT03359473|615793490|FG002|Overall Study|Adverse Event|5|||
170397468|NCT03359473|615793491|FG003|Overall Study|Adverse Event|3|||
170397469|NCT03359473|615793488|FG000|Overall Study|Lost to Follow-up|0|||
170397470|NCT03359473|615793489|FG001|Overall Study|Lost to Follow-up|1|||
170397471|NCT03359473|615793490|FG002|Overall Study|Lost to Follow-up|0|||
170397472|NCT03359473|615793491|FG003|Overall Study|Lost to Follow-up|0|||
170397473|NCT03359473|615793488|FG000|Overall Study|Physician Decision|0|||
170397474|NCT03359473|615793489|FG001|Overall Study|Physician Decision|1|||
170397475|NCT03359473|615793490|FG002|Overall Study|Physician Decision|0|||
170397476|NCT03359473|615793491|FG003|Overall Study|Physician Decision|1|||
170397477|NCT03359473|615793488|FG000|Overall Study|Withdrawal by Subject|1|||
170397478|NCT03359473|615793489|FG001|Overall Study|Withdrawal by Subject|2|||
170397479|NCT03359473|615793490|FG002|Overall Study|Withdrawal by Subject|1|||
170397480|NCT03359473|615793491|FG003|Overall Study|Withdrawal by Subject|0|||
170397481|NCT03359473|615793488|FG000|Overall Study|Protocol-defined stopping criteria|1|||
170397482|NCT03359473|615793489|FG001|Overall Study|Protocol-defined stopping criteria|0|||
170397483|NCT03359473|615793490|FG002|Overall Study|Protocol-defined stopping criteria|0|||
170397484|NCT03359473|615793491|FG003|Overall Study|Protocol-defined stopping criteria|1|||
170397485|NCT01060007|615793495|FG000|Overall Study|Withdrawal by Subject|1|||
170397486|NCT01060007|615793495|FG000|Overall Study|Inevaluable for response at surgery|3|||
170397487|NCT02341482|615793503|FG000|Overall Study|Adverse Event|1|||
170397488|NCT02575807|615793504|FG000|Overall Study|Death|8|||
170397489|NCT02575807|615793505|FG001|Overall Study|Death|3|||
170397490|NCT02575807|615793506|FG002|Overall Study|Death|7|||
170397491|NCT02575807|615793507|FG003|Overall Study|Death|0|||
170397492|NCT02575807|615793508|FG004|Overall Study|Death|1|||
170397493|NCT02575807|615793504|FG000|Overall Study|Study terminated by Sponsor|0|||
170397494|NCT02575807|615793505|FG001|Overall Study|Study terminated by Sponsor|1|||
170397495|NCT02575807|615793506|FG002|Overall Study|Study terminated by Sponsor|7|||
170397496|NCT02575807|615793507|FG003|Overall Study|Study terminated by Sponsor|0|||
170397497|NCT02575807|615793508|FG004|Overall Study|Study terminated by Sponsor|1|||
170397498|NCT02575807|615793504|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
170397499|NCT02575807|615793505|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
170397500|NCT02575807|615793506|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
170397501|NCT02575807|615793507|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
170397502|NCT02575807|615793508|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
170397503|NCT02575807|615793504|FG000|Overall Study|Terminated due to physician decision|0|||
170397504|NCT02575807|615793505|FG001|Overall Study|Terminated due to physician decision|0|||
170397505|NCT02575807|615793506|FG002|Overall Study|Terminated due to physician decision|1|||
170397506|NCT02575807|615793507|FG003|Overall Study|Terminated due to physician decision|0|||
170397507|NCT02575807|615793508|FG004|Overall Study|Terminated due to physician decision|0|||
170397508|NCT02575807|615793504|FG000|Overall Study|Subject ineligible - medical implant|0|||
170397509|NCT02575807|615793505|FG001|Overall Study|Subject ineligible - medical implant|0|||
170397510|NCT02575807|615793506|FG002|Overall Study|Subject ineligible - medical implant|0|||
170397511|NCT02575807|615793507|FG003|Overall Study|Subject ineligible - medical implant|1|||
170397512|NCT02575807|615793508|FG004|Overall Study|Subject ineligible - medical implant|0|||
170397513|NCT02575807|615793504|FG000|Overall Study|Withdrawal by Subject|0|||
170397514|NCT02575807|615793505|FG001|Overall Study|Withdrawal by Subject|0|||
170397515|NCT02575807|615793506|FG002|Overall Study|Withdrawal by Subject|1|||
170397516|NCT02575807|615793507|FG003|Overall Study|Withdrawal by Subject|1|||
170397517|NCT02575807|615793508|FG004|Overall Study|Withdrawal by Subject|2|||
170397518|NCT03000075|615793509|FG000|Part A|Adverse Event|4|||
170397519|NCT03000075|615793510|FG001|Part A|Adverse Event|0|||
170397520|NCT03000075|615793511|FG002|Part A|Adverse Event|0|||
170397521|NCT03000075|615793512|FG003|Part A|Adverse Event|0|||
170397522|NCT03000075|615793513|FG004|Part A|Adverse Event|0|||
170397523|NCT03000075|615793514|FG005|Part A|Adverse Event|0|||
170397524|NCT03000075|615793515|FG006|Part A|Adverse Event|0|||
170397525|NCT03000075|615793509|FG000|Part B|Not dosed due to AE|0|||
170397526|NCT03000075|615793510|FG001|Part B|Not dosed due to AE|0|||
170397527|NCT03000075|615793511|FG002|Part B|Not dosed due to AE|0|||
170397528|NCT03000075|615793512|FG003|Part B|Not dosed due to AE|0|||
170397529|NCT03000075|615793513|FG004|Part B|Not dosed due to AE|0|||
170397530|NCT03000075|615793514|FG005|Part B|Not dosed due to AE|2|||
170397531|NCT03000075|615793515|FG006|Part B|Not dosed due to AE|1|||
170397532|NCT03000075|615793509|FG000|Part B|Adverse Event|0|||
170397533|NCT03000075|615793510|FG001|Part B|Adverse Event|0|||
170397534|NCT03000075|615793511|FG002|Part B|Adverse Event|0|||
170397535|NCT03000075|615793512|FG003|Part B|Adverse Event|0|||
170397536|NCT03000075|615793513|FG004|Part B|Adverse Event|1|||
170397537|NCT03000075|615793514|FG005|Part B|Adverse Event|0|||
170397538|NCT03000075|615793515|FG006|Part B|Adverse Event|0|||
170397539|NCT02180659|615793516|FG000|Overall Study|Adverse Event|1|||
170397540|NCT02180659|615793517|FG001|Overall Study|Adverse Event|0|||
170397541|NCT02180659|615793516|FG000|Overall Study|Lost to Follow-up|4|||
170397542|NCT02180659|615793517|FG001|Overall Study|Lost to Follow-up|2|||
170397543|NCT02180659|615793516|FG000|Overall Study|Subject incarcerated during conduct|1|||
170397544|NCT02180659|615793517|FG001|Overall Study|Subject incarcerated during conduct|0|||
170397545|NCT02180659|615793516|FG000|Overall Study|Withdrawal by Subject|0|||
170397546|NCT02180659|615793517|FG001|Overall Study|Withdrawal by Subject|2|||
170397547|NCT02180659|615793516|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
170397548|NCT02180659|615793517|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
170397549|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
170397550|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
170397551|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Death|5|||
170397552|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Death|2|||
170397553|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
170397554|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
170397555|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
170397556|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
170397557|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
170397558|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
170397559|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Relapse|1|||
170397560|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Relapse|0|||
170397561|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
170397562|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
170397563|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
170397564|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
170397565|NCT00111007|615793518|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
170397566|NCT00111007|615793519|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
170397567|NCT00111007|615793518|FG000|Active Follow-up|Adverse Event|1|||
170397568|NCT00111007|615793519|FG001|Active Follow-up|Adverse Event|0|||
170397569|NCT00111007|615793518|FG000|Active Follow-up|Death|2|||
170397570|NCT00111007|615793519|FG001|Active Follow-up|Death|0|||
170397571|NCT00111007|615793518|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
170397572|NCT00111007|615793519|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
170397573|NCT00111007|615793518|FG000|Long Term Follow-up|Death|34|||
170397574|NCT00111007|615793519|FG001|Long Term Follow-up|Death|39|||
170397575|NCT00111007|615793518|FG000|Long Term Follow-up|Lost to Follow-up|1|||
170397576|NCT00111007|615793519|FG001|Long Term Follow-up|Lost to Follow-up|1|||
170397577|NCT00111007|615793518|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
170397578|NCT00111007|615793519|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
170397579|NCT00111007|615793518|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
170397580|NCT00111007|615793519|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
170397581|NCT00111007|615793518|FG000|Long Term Follow-up|Missing|10|||
170397582|NCT00111007|615793519|FG001|Long Term Follow-up|Missing|3|||
170397583|NCT03014570|615793520|FG000|Overall Study|COVID-19 Restrictions|38|||
170397584|NCT03014570|615793521|FG001|Overall Study|COVID-19 Restrictions|24|||
170397585|NCT03014570|615793520|FG000|Overall Study|Death|70|||
170397586|NCT03014570|615793521|FG001|Overall Study|Death|79|||
170397587|NCT03014570|615793520|FG000|Overall Study|Transfer from facility|11|||
170397588|NCT03014570|615793521|FG001|Overall Study|Transfer from facility|14|||
170397589|NCT03014570|615793520|FG000|Overall Study|Hospitalized|5|||
170397590|NCT03014570|615793521|FG001|Overall Study|Hospitalized|3|||
170397591|NCT03014570|615793520|FG000|Overall Study|Transfer within facility|1|||
170397592|NCT03014570|615793521|FG001|Overall Study|Transfer within facility|0|||
170397593|NCT03014570|615793520|FG000|Overall Study|Site refusal|0|||
170397594|NCT03014570|615793521|FG001|Overall Study|Site refusal|11|||
170397595|NCT01154673|615793522|FG000|Overall Study|Lost to Follow-up|1|||
170397596|NCT01154673|615793523|FG001|Overall Study|Lost to Follow-up|0|||
170397597|NCT01154673|615793522|FG000|Overall Study|moved out of province|1|||
170397598|NCT01154673|615793523|FG001|Overall Study|moved out of province|0|||
170397599|NCT03083639|615793534|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
170397600|NCT03083639|615793535|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
170397601|NCT03083639|615793534|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
170397602|NCT03083639|615793535|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
170397603|NCT00605839|615793536|FG000|Overall Study|Protocol Violation|1|||
170397604|NCT00605839|615793537|FG001|Overall Study|Protocol Violation|0|||
170397605|NCT00605839|615793538|FG002|Overall Study|Protocol Violation|0|||
170397606|NCT02864953|615793542|FG000|Overall Study|Adverse Event|22|||
170397607|NCT02864953|615793543|FG001|Overall Study|Adverse Event|19|||
170397608|NCT02864953|615793542|FG000|Overall Study|Withdrawal by Subject|1|||
170398872|NCT05004181|615798312|FG000|Overall Study|Physician Decision|0|||
170397609|NCT02864953|615793543|FG001|Overall Study|Withdrawal by Subject|0|||
170397610|NCT02864953|615793542|FG000|Overall Study|Physician Decision|4|||
170397611|NCT02864953|615793543|FG001|Overall Study|Physician Decision|2|||
170397612|NCT02864953|615793542|FG000|Overall Study|Death|3|||
170397613|NCT02864953|615793543|FG001|Overall Study|Death|13|||
170397614|NCT02864953|615793542|FG000|Overall Study|Reason not specified|14|||
170397615|NCT02864953|615793543|FG001|Overall Study|Reason not specified|12|||
170397616|NCT02864953|615793542|FG000|Overall Study|Withdrew Prior to Dosing|9|||
170397617|NCT02864953|615793543|FG001|Overall Study|Withdrew Prior to Dosing|8|||
170397618|NCT00358670|615793544|FG000|Overall Study|Adverse Event|26|||
170397619|NCT00358670|615793545|FG001|Overall Study|Adverse Event|29|||
170397620|NCT00358670|615793544|FG000|Overall Study|Lack of Efficacy|20|||
170397621|NCT00358670|615793545|FG001|Overall Study|Lack of Efficacy|23|||
170397622|NCT00358670|615793544|FG000|Overall Study|Protocol Violation|6|||
170397623|NCT00358670|615793545|FG001|Overall Study|Protocol Violation|9|||
170397624|NCT00358670|615793544|FG000|Overall Study|Lost to Follow-up|4|||
170397625|NCT00358670|615793545|FG001|Overall Study|Lost to Follow-up|5|||
170397626|NCT00358670|615793544|FG000|Overall Study|Withdrawal by Subject|13|||
170397627|NCT00358670|615793545|FG001|Overall Study|Withdrawal by Subject|24|||
170397628|NCT00358670|615793544|FG000|Overall Study|Protocol Defined Clinical Event|0|||
170397629|NCT00358670|615793545|FG001|Overall Study|Protocol Defined Clinical Event|1|||
170397630|NCT00358670|615793544|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
170397631|NCT00358670|615793545|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
170397632|NCT00358670|615793544|FG000|Overall Study|Administrative|153|||
170397633|NCT00358670|615793545|FG001|Overall Study|Administrative|125|||
170397634|NCT00960687|615793546|FG000|Washout Period of 7 Days|Adverse Event|3|||
170397635|NCT00960687|615793547|FG001|Washout Period of 7 Days|Adverse Event|2|||
170397636|NCT00960687|615793546|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
170397637|NCT00960687|615793547|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
170397638|NCT02362646|615793548|FG000|Overall Study|Death|15|||
170397639|NCT02362646|615793549|FG001|Overall Study|Death|8|||
170397640|NCT02362646|615793548|FG000|Overall Study|Withdrawal by Subject|2|||
170397641|NCT02362646|615793549|FG001|Overall Study|Withdrawal by Subject|2|||
170397642|NCT02362646|615793548|FG000|Overall Study|received transplant|21|||
170397643|NCT02362646|615793549|FG001|Overall Study|received transplant|14|||
170397644|NCT02666768|615793551|FG000|Overall Study|Withdrawal by Subject|4|||
170397645|NCT00402779|615793553|FG000|Overall Study|Screen Failure|77|||
170397646|NCT00402779|615793554|FG001|Overall Study|Screen Failure|76|||
170397647|NCT02184988|615793555|FG000|Overall Study|Pregnancy|2|||
170397648|NCT02184988|615793555|FG000|Overall Study|Adverse Event|2|||
170397649|NCT02184988|615793555|FG000|Overall Study|moving away/travelling/unable to complet|6|||
170397650|NCT02184988|615793555|FG000|Overall Study|work scheduling issues|4|||
170397651|NCT02184988|615793555|FG000|Overall Study|various other reasons|9|||
170397652|NCT02184988|615793555|FG000|Overall Study|Lost to Follow-up|32|||
170397653|NCT00209560|615793557|FG000|Overall Study|Lack of Efficacy|1|||
170397654|NCT00209560|615793558|FG001|Overall Study|Lack of Efficacy|0|||
170397655|NCT02428231|615795071|FG000|Overall Study|Other|10|||
170397656|NCT02428231|615795072|FG001|Overall Study|Other|16|||
170397657|NCT02428231|615795071|FG000|Overall Study|Required Symptomatic Therapy|0|||
170397658|NCT02428231|615795072|FG001|Overall Study|Required Symptomatic Therapy|1|||
170397659|NCT02428231|615795071|FG000|Overall Study|Adverse Event|3|||
170397660|NCT02428231|615795072|FG001|Overall Study|Adverse Event|0|||
170397661|NCT01652573|615795073|FG000|Overall Study|Adverse Event|0|||
170397662|NCT01652573|615795074|FG001|Overall Study|Adverse Event|1|||
170397663|NCT03284424|615795075|FG000|Overall Study|Death|70|||
170397664|NCT03284424|615795076|FG001|Overall Study|Death|24|||
170397665|NCT03284424|615795075|FG000|Overall Study|Lost to Follow-up|3|||
170397666|NCT03284424|615795076|FG001|Overall Study|Lost to Follow-up|1|||
170397667|NCT03284424|615795075|FG000|Overall Study|Physician Decision|1|||
170397668|NCT03284424|615795076|FG001|Overall Study|Physician Decision|2|||
170397669|NCT03284424|615795075|FG000|Overall Study|Withdrawal by Subject|4|||
170397670|NCT03284424|615795076|FG001|Overall Study|Withdrawal by Subject|5|||
170397671|NCT03284424|615795075|FG000|Overall Study|Sponsor's decision|27|||
170397672|NCT03284424|615795076|FG001|Overall Study|Sponsor's decision|22|||
170397673|NCT01052038|615795077|FG000|Overall Study|Lost to Follow-up|2|||
170397674|NCT01052038|615795078|FG001|Overall Study|Lost to Follow-up|3|||
170397675|NCT01052038|615795079|FG002|Overall Study|Lost to Follow-up|1|||
170397676|NCT01052038|615795077|FG000|Overall Study|Protocol Violation|2|||
170397677|NCT01052038|615795078|FG001|Overall Study|Protocol Violation|3|||
170397678|NCT01052038|615795079|FG002|Overall Study|Protocol Violation|3|||
170397679|NCT03343054|615795082|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
170397680|NCT03343054|615795083|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
170397681|NCT03343054|615795084|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
170397682|NCT03343054|615795082|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
170397683|NCT03343054|615795083|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
170397684|NCT03343054|615795084|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
170398873|NCT05004181|615798313|FG001|Overall Study|Physician Decision|0|||
170397685|NCT03343054|615795082|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
170397686|NCT03343054|615795083|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
170397687|NCT03343054|615795084|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
170397688|NCT03343054|615795082|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
170397689|NCT03343054|615795083|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
170397690|NCT03343054|615795084|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
170397691|NCT00110084|615795096|FG000|Overall Study|Adverse Event|9|||
170397692|NCT00110084|615795096|FG000|Overall Study|Death|1|||
170397693|NCT00110084|615795096|FG000|Overall Study|Patient Refusal|10|||
170397694|NCT00110084|615795096|FG000|Overall Study|Alternate Therapy|5|||
170397695|NCT00110084|615795096|FG000|Overall Study|Intercurrent Illness|1|||
170397696|NCT00110084|615795096|FG000|Overall Study|Other|2|||
170397697|NCT00537056|615795097|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
170397698|NCT04854707|615795098|FG000|Overall Study|Lack of Efficacy|78|||
170397699|NCT04854707|615795099|FG001|Overall Study|Lack of Efficacy|59|||
170397700|NCT04854707|615795100|FG002|Overall Study|Lack of Efficacy|30|||
170397701|NCT01257737|615795102|FG000|Overall Study|Lost to Follow-up|1|||
170397702|NCT01257737|615795103|FG001|Overall Study|Lost to Follow-up|2|||
170397703|NCT01257737|615795102|FG000|Overall Study|Liver transplant|1|||
170397704|NCT01257737|615795103|FG001|Overall Study|Liver transplant|0|||
170397705|NCT01257737|615795102|FG000|Overall Study|Relocation out of the country|0|||
170397706|NCT01257737|615795103|FG001|Overall Study|Relocation out of the country|1|||
170397707|NCT01257737|615795102|FG000|Overall Study|Withdrew from study|0|||
170397708|NCT01257737|615795103|FG001|Overall Study|Withdrew from study|1|||
170397709|NCT01071083|615795110|FG000|Overall Study|Adverse Event|1|||
170397710|NCT01071083|615795111|FG001|Overall Study|Adverse Event|0|||
170397711|NCT01071083|615795112|FG002|Overall Study|Adverse Event|1|||
170397712|NCT01071083|615795113|FG003|Overall Study|Adverse Event|0|||
170397713|NCT01071083|615795114|FG004|Overall Study|Adverse Event|1|||
170397714|NCT01071083|615795110|FG000|Overall Study|Withdrawal by Subject|3|||
170397715|NCT01071083|615795111|FG001|Overall Study|Withdrawal by Subject|0|||
170397716|NCT01071083|615795112|FG002|Overall Study|Withdrawal by Subject|2|||
170397717|NCT01071083|615795113|FG003|Overall Study|Withdrawal by Subject|0|||
170397718|NCT01071083|615795114|FG004|Overall Study|Withdrawal by Subject|3|||
170397719|NCT01071083|615795110|FG000|Overall Study|Physician Decision|1|||
170397720|NCT01071083|615795111|FG001|Overall Study|Physician Decision|0|||
170397721|NCT01071083|615795112|FG002|Overall Study|Physician Decision|0|||
170397722|NCT01071083|615795113|FG003|Overall Study|Physician Decision|1|||
170397723|NCT01071083|615795114|FG004|Overall Study|Physician Decision|1|||
170397724|NCT01071083|615795110|FG000|Overall Study|Early Rescue|1|||
170397725|NCT01071083|615795111|FG001|Overall Study|Early Rescue|0|||
170397726|NCT01071083|615795112|FG002|Overall Study|Early Rescue|0|||
170397727|NCT01071083|615795113|FG003|Overall Study|Early Rescue|0|||
170397728|NCT01071083|615795114|FG004|Overall Study|Early Rescue|1|||
170397729|NCT01071083|615795110|FG000|Overall Study|Subject Moved|0|||
170397730|NCT01071083|615795111|FG001|Overall Study|Subject Moved|1|||
170397731|NCT01071083|615795112|FG002|Overall Study|Subject Moved|0|||
170397732|NCT01071083|615795113|FG003|Overall Study|Subject Moved|0|||
170397733|NCT01071083|615795114|FG004|Overall Study|Subject Moved|0|||
170397734|NCT01071083|615795110|FG000|Overall Study|Images Not Usable (Motion)|0|||
170397735|NCT01071083|615795111|FG001|Overall Study|Images Not Usable (Motion)|1|||
170397736|NCT01071083|615795112|FG002|Overall Study|Images Not Usable (Motion)|0|||
170397737|NCT01071083|615795113|FG003|Overall Study|Images Not Usable (Motion)|0|||
170397738|NCT01071083|615795114|FG004|Overall Study|Images Not Usable (Motion)|0|||
170397739|NCT01071083|615795110|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
170397740|NCT01071083|615795111|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
170397741|NCT01071083|615795112|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
170397742|NCT01071083|615795113|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
170397743|NCT01071083|615795114|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
170397744|NCT01071083|615795110|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
170397745|NCT01071083|615795111|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
170397746|NCT01071083|615795112|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
170397747|NCT01071083|615795113|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
170397748|NCT01071083|615795114|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
170397749|NCT01071083|615795110|FG000|Overall Study|Subject Refused to Continue|1|||
170397750|NCT01071083|615795111|FG001|Overall Study|Subject Refused to Continue|0|||
170397751|NCT01071083|615795112|FG002|Overall Study|Subject Refused to Continue|0|||
170397752|NCT01071083|615795113|FG003|Overall Study|Subject Refused to Continue|0|||
170397753|NCT01071083|615795114|FG004|Overall Study|Subject Refused to Continue|0|||
170397754|NCT02858076|615795116|FG000|Overall Study|Death|6|||
170397755|NCT02858076|615795117|FG001|Overall Study|Death|3|||
170397756|NCT02858076|615795116|FG000|Overall Study|Withdrawal by Subject|1|||
170397757|NCT02858076|615795117|FG001|Overall Study|Withdrawal by Subject|5|||
170397758|NCT02858076|615795116|FG000|Overall Study|Lost to Follow-up|2|||
170397759|NCT02858076|615795117|FG001|Overall Study|Lost to Follow-up|7|||
170397760|NCT02858076|615795116|FG000|Overall Study|Completed Out of Window|1|||
170397761|NCT02858076|615795117|FG001|Overall Study|Completed Out of Window|3|||
170397762|NCT02643394|615795118|FG000|Overall Study|Protocol Violation|4|||
170397763|NCT02643394|615795119|FG001|Overall Study|Protocol Violation|5|||
170397764|NCT03829462|615795120|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
170397765|NCT03829462|615795121|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
170397766|NCT03829462|615795120|FG000|Overall Study|No treatment due to progression disease|0|||
170397767|NCT03829462|615795121|FG001|Overall Study|No treatment due to progression disease|1|||
170397768|NCT02057549|615795123|FG000|Overall Study|Lost to Follow-up|1|||
170397769|NCT02057549|615795124|FG001|Overall Study|Lost to Follow-up|0|||
170397770|NCT02057549|615795123|FG000|Overall Study|Physician Decision|1|||
170397771|NCT02057549|615795124|FG001|Overall Study|Physician Decision|0|||
170397772|NCT02057549|615795123|FG000|Overall Study|Withdrawal by Subject|1|||
170397773|NCT02057549|615795124|FG001|Overall Study|Withdrawal by Subject|0|||
170397774|NCT00518011|615795128|FG000|Overall Study|Death|1|||
170397775|NCT00518011|615795129|FG001|Overall Study|Death|1|||
170397776|NCT00518011|615795128|FG000|Overall Study|Adverse Event|2|||
170397777|NCT00518011|615795129|FG001|Overall Study|Adverse Event|3|||
170397778|NCT00518011|615795128|FG000|Overall Study|Disease Progression|2|||
170397779|NCT00518011|615795129|FG001|Overall Study|Disease Progression|2|||
170397780|NCT00518011|615795128|FG000|Overall Study|Other Reasons|3|||
170397781|NCT00518011|615795129|FG001|Overall Study|Other Reasons|2|||
170397782|NCT00518011|615795128|FG000|Overall Study|Withdrawal by Subject|1|||
170397783|NCT00518011|615795129|FG001|Overall Study|Withdrawal by Subject|0|||
170397784|NCT03409328|615795130|FG000|Overall Study|Lost to Follow-up|6|||
170397785|NCT03409328|615795131|FG001|Overall Study|Lost to Follow-up|3|||
170397786|NCT00090259|615795132|FG000|Overall Study|Lost to Follow-up|30|||
170397787|NCT00090259|615795133|FG001|Overall Study|Lost to Follow-up|26|||
170397788|NCT00090259|615795132|FG000|Overall Study|Withdrawal by Subject|21|||
170397789|NCT00090259|615795133|FG001|Overall Study|Withdrawal by Subject|15|||
170397790|NCT00090259|615795132|FG000|Overall Study|Investigator site closed|11|||
170397791|NCT00090259|615795133|FG001|Overall Study|Investigator site closed|7|||
170397792|NCT03701516|615795134|FG000|Period 1|Lost to Follow-up|0|||
170397793|NCT03701516|615795135|FG001|Period 1|Lost to Follow-up|1|||
170397794|NCT03701516|615795134|FG000|Period 1|Adverse Event|0|||
170397795|NCT03701516|615795135|FG001|Period 1|Adverse Event|2|||
170397796|NCT03701516|615795134|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
170397797|NCT03701516|615795135|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
170397798|NCT03701516|615795134|FG000|Period 1|Non Compliance to Protocol|2|||
170397799|NCT03701516|615795135|FG001|Period 1|Non Compliance to Protocol|1|||
170397800|NCT03701516|615795134|FG000|Period 1|Withdrawal by Subject|0|||
170397801|NCT03701516|615795135|FG001|Period 1|Withdrawal by Subject|1|||
170397802|NCT03701516|615795134|FG000|Period 2|failed to meet all eligibility creiteria|1|||
170397803|NCT03701516|615795135|FG001|Period 2|failed to meet all eligibility creiteria|0|||
170397804|NCT03701516|615795134|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
170397805|NCT03701516|615795135|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
170397806|NCT00478673|615795136|FG000|30-Days Post-Procedure|Death|2|||
170397807|NCT00478673|615795136|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
170397808|NCT00478673|615795136|FG000|30-Days Post-Procedure|Missed Visit|7|||
170397809|NCT00478673|615795136|FG000|12-Months Post-Procedure|Death|23|||
170397810|NCT00478673|615795136|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
170397811|NCT00478673|615795136|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
170397812|NCT00478673|615795136|FG000|12-Months Post-Procedure|Missed Visit|25|||
170397813|NCT00478673|615795136|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
170397814|NCT01216319|615795145|FG000|Overall Study|Lost to Follow-up|2|||
170397815|NCT01216319|615795145|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
170397816|NCT00905437|615795154|FG000|Overall Study|Adverse Event|3|||
170397817|NCT00905437|615795155|FG001|Overall Study|Adverse Event|2|||
170397818|NCT00905437|615795154|FG000|Overall Study|Lost to Follow-up|0|||
170397819|NCT00905437|615795155|FG001|Overall Study|Lost to Follow-up|1|||
170397820|NCT00905437|615795154|FG000|Overall Study|Withdrawal by Subject|0|||
170397821|NCT00905437|615795155|FG001|Overall Study|Withdrawal by Subject|1|||
170397822|NCT00905437|615795154|FG000|Overall Study|Other|5|||
170397823|NCT00905437|615795155|FG001|Overall Study|Other|6|||
170397824|NCT00903409|615795156|FG000|Overall Study|Adverse Event|11|||
170397825|NCT00903409|615795157|FG001|Overall Study|Adverse Event|9|||
170397826|NCT00903409|615795156|FG000|Overall Study|Non-compliance with Protocol|1|||
170397827|NCT00903409|615795157|FG001|Overall Study|Non-compliance with Protocol|1|||
170397828|NCT00903409|615795156|FG000|Overall Study|Laboratory Abnormality|2|||
170397829|NCT00903409|615795157|FG001|Overall Study|Laboratory Abnormality|0|||
170397830|NCT00903409|615795156|FG000|Overall Study|Withdrawal by Subject|8|||
170397831|NCT00903409|615795157|FG001|Overall Study|Withdrawal by Subject|8|||
170397832|NCT00903409|615795156|FG000|Overall Study|Other|2|||
170397833|NCT00903409|615795157|FG001|Overall Study|Other|3|||
170397834|NCT00903409|615795156|FG000|Overall Study|Lost to Follow-up|2|||
170397835|NCT00903409|615795157|FG001|Overall Study|Lost to Follow-up|6|||
170397836|NCT03239340|615795158|FG000|Overall Study|Other|26|||
170398874|NCT05004181|615798314|FG002|Overall Study|Physician Decision|0|||
170397837|NCT03239340|615795158|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
170397838|NCT03239340|615795158|FG000|Overall Study|Death|40|||
170397839|NCT03239340|615795158|FG000|Overall Study|Lost to Follow-up|2|||
170397840|NCT03239340|615795158|FG000|Overall Study|Physician Decision|16|||
170397841|NCT03239340|615795158|FG000|Overall Study|Withdrawal by Subject|27|||
170397842|NCT01907516|615795164|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
170397843|NCT01907516|615795165|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
170397844|NCT01907516|615795164|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
170397845|NCT01907516|615795165|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
170397846|NCT01907516|615795164|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
170397847|NCT01907516|615795165|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
170397848|NCT01907516|615795164|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
170397849|NCT01907516|615795165|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
170397850|NCT03539952|615795166|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
170397851|NCT03539952|615795167|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
170397852|NCT03539952|615795166|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
170397853|NCT03539952|615795167|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
170397854|NCT03539952|615795166|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
170397855|NCT03539952|615795167|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
170397856|NCT03539952|615795166|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
170397857|NCT03539952|615795167|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
170397858|NCT03539952|615795166|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
170397859|NCT03539952|615795167|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
170397860|NCT03539952|615795166|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
170397861|NCT03539952|615795167|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
170397862|NCT03539952|615795166|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
170397863|NCT03539952|615795167|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
170397864|NCT04278872|615795168|FG000|Overall Study|Adverse Event|1|||
170397865|NCT04278872|615795169|FG001|Overall Study|Adverse Event|0|||
170397866|NCT04278872|615795168|FG000|Overall Study|Protocol Violation|0|||
170397867|NCT04278872|615795169|FG001|Overall Study|Protocol Violation|1|||
170397868|NCT04278872|615795168|FG000|Overall Study|Study Termination|2|||
170397869|NCT04278872|615795169|FG001|Overall Study|Study Termination|0|||
170397870|NCT00777920|615795174|FG000|Overall Study|Adverse Event|39|||
170397871|NCT00777920|615795174|FG000|Overall Study|Withdrawal of Consent|4|||
170397872|NCT00777920|615795174|FG000|Overall Study|Lost to Follow-up|1|||
170397873|NCT00777920|615795174|FG000|Overall Study|Investigator's discretion|1|||
170397874|NCT00777920|615795174|FG000|Overall Study|Clinical status did not improve|1|||
170397875|NCT00777920|615795174|FG000|Overall Study|Other, not specified|4|||
170397876|NCT00975000|615795175|FG000|Overall Study|Other|1|||
170397877|NCT00975000|615795176|FG001|Overall Study|Other|0|||
170397878|NCT00975000|615795175|FG000|Overall Study|Adverse Event|1|||
170397879|NCT00975000|615795176|FG001|Overall Study|Adverse Event|1|||
170397880|NCT00975000|615795175|FG000|Overall Study|Withdrawal by Subject|2|||
170397881|NCT00975000|615795176|FG001|Overall Study|Withdrawal by Subject|2|||
170397882|NCT00975000|615795175|FG000|Overall Study|Lost to Follow-up|0|||
170397883|NCT00975000|615795176|FG001|Overall Study|Lost to Follow-up|1|||
170397884|NCT00975000|615795175|FG000|Overall Study|Protocol-specified Criteria|1|||
170397885|NCT00975000|615795176|FG001|Overall Study|Protocol-specified Criteria|0|||
170397886|NCT00975000|615795175|FG000|Overall Study|Non-compliance|0|||
170397887|NCT00975000|615795176|FG001|Overall Study|Non-compliance|1|||
170397888|NCT01126359|615795179|FG000|First Intervention (20-minutes)|Physician Decision|0|||
170397889|NCT01126359|615795180|FG001|First Intervention (20-minutes)|Physician Decision|1|||
170397890|NCT00902486|615795181|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
170397891|NCT00902486|615795182|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
170397892|NCT00902486|615795183|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
170397893|NCT00902486|615795184|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
170397894|NCT00902486|615795185|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
170397895|NCT00902486|615795186|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
170397896|NCT00902486|615795181|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
170397897|NCT00902486|615795182|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
170397898|NCT00902486|615795183|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
170397899|NCT00902486|615795184|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
170397900|NCT00902486|615795185|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
170397901|NCT00902486|615795186|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
170397902|NCT00902486|615795181|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
170397903|NCT00902486|615795182|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
170397904|NCT00902486|615795183|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
170397905|NCT00902486|615795184|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
170397906|NCT00902486|615795185|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
170397907|NCT00902486|615795186|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
170397908|NCT00902486|615795181|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
170397909|NCT00902486|615795182|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
170397910|NCT00902486|615795183|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
170397911|NCT00902486|615795184|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
170397912|NCT00902486|615795185|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
170397913|NCT00902486|615795186|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
170397914|NCT00902486|615795181|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
170397915|NCT00902486|615795182|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
170397916|NCT00902486|615795183|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
170397917|NCT00902486|615795184|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
170397918|NCT00902486|615795185|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
170397919|NCT00902486|615795186|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
170397920|NCT00902486|615795181|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
170397921|NCT00902486|615795182|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
170397922|NCT00902486|615795183|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
170397923|NCT00902486|615795184|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
170397924|NCT00902486|615795185|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
170397925|NCT00902486|615795186|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
170397926|NCT00902486|615795181|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
170397927|NCT00902486|615795182|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
170397928|NCT00902486|615795183|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
170397929|NCT00902486|615795184|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
170397930|NCT00902486|615795185|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
170397931|NCT00902486|615795186|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
170397932|NCT00902486|615795181|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
170397933|NCT00902486|615795182|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
170397934|NCT00902486|615795183|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
170397935|NCT00902486|615795184|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
170397936|NCT00902486|615795185|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
170397937|NCT00902486|615795186|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
170397938|NCT00902486|615795181|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
170397939|NCT00902486|615795182|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
170397940|NCT00902486|615795183|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
170397941|NCT00902486|615795184|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
170397942|NCT00902486|615795185|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
170397943|NCT00902486|615795186|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
170397944|NCT00902486|615795181|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
170397945|NCT00902486|615795182|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
170397946|NCT00902486|615795183|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
170397947|NCT00902486|615795184|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
170397948|NCT00902486|615795185|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
170397949|NCT00902486|615795186|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
170397950|NCT00902486|615795181|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
170397951|NCT00902486|615795182|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
170397952|NCT00902486|615795183|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
170397953|NCT00902486|615795184|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
170397954|NCT00902486|615795185|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
170397955|NCT00902486|615795186|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
170397956|NCT02332655|615795187|FG000|Overall Study|Lack of Efficacy|1|||
170397957|NCT01843660|615795188|FG000|Overall Study|Other|30|||
170397958|NCT01977482|615795189|FG000|Overall Study|Adverse Event|0|||
170397959|NCT01977482|615795190|FG001|Overall Study|Adverse Event|1|||
170397960|NCT01977482|615795191|FG002|Overall Study|Adverse Event|1|||
170397961|NCT01977482|615795192|FG003|Overall Study|Adverse Event|0|||
170397962|NCT01977482|615795193|FG004|Overall Study|Adverse Event|2|||
170397963|NCT01977482|615795194|FG005|Overall Study|Adverse Event|0|||
170397964|NCT01977482|615795189|FG000|Overall Study|Lost to Follow-up|1|||
170397965|NCT01977482|615795190|FG001|Overall Study|Lost to Follow-up|0|||
170397966|NCT01977482|615795191|FG002|Overall Study|Lost to Follow-up|0|||
170397967|NCT01977482|615795192|FG003|Overall Study|Lost to Follow-up|0|||
170397968|NCT01977482|615795193|FG004|Overall Study|Lost to Follow-up|0|||
170397969|NCT01977482|615795194|FG005|Overall Study|Lost to Follow-up|0|||
170397970|NCT01977482|615795189|FG000|Overall Study|Physician Decision|0|||
170397971|NCT01977482|615795190|FG001|Overall Study|Physician Decision|1|||
170397972|NCT01977482|615795191|FG002|Overall Study|Physician Decision|0|||
170397973|NCT01977482|615795192|FG003|Overall Study|Physician Decision|0|||
170397974|NCT01977482|615795193|FG004|Overall Study|Physician Decision|0|||
170397975|NCT01977482|615795194|FG005|Overall Study|Physician Decision|0|||
170397976|NCT01977482|615795189|FG000|Overall Study|Protocol Violation|0|||
170397977|NCT01977482|615795190|FG001|Overall Study|Protocol Violation|0|||
170397978|NCT01977482|615795191|FG002|Overall Study|Protocol Violation|1|||
170397979|NCT01977482|615795192|FG003|Overall Study|Protocol Violation|0|||
170397980|NCT01977482|615795193|FG004|Overall Study|Protocol Violation|0|||
170397981|NCT01977482|615795194|FG005|Overall Study|Protocol Violation|0|||
170397982|NCT01977482|615795189|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
170397983|NCT01977482|615795190|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
170397984|NCT01977482|615795191|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
170397985|NCT01977482|615795192|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
170397986|NCT01977482|615795193|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
170397987|NCT01977482|615795194|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
170397988|NCT01977482|615795189|FG000|Overall Study|Withdrawal by Subject|2|||
170397989|NCT01977482|615795190|FG001|Overall Study|Withdrawal by Subject|4|||
170397990|NCT01977482|615795191|FG002|Overall Study|Withdrawal by Subject|1|||
170397991|NCT01977482|615795192|FG003|Overall Study|Withdrawal by Subject|3|||
170397992|NCT01977482|615795193|FG004|Overall Study|Withdrawal by Subject|1|||
170397993|NCT01977482|615795194|FG005|Overall Study|Withdrawal by Subject|5|||
170397994|NCT04439110|615795195|FG000|Overall Study|Ineligible|2|||
170397995|NCT04439110|615795195|FG000|Overall Study|Adverse Event|4|||
170397996|NCT04439110|615795195|FG000|Overall Study|Death|2|||
170397997|NCT04439110|615795195|FG000|Overall Study|Disease proression|25|||
170397998|NCT04439110|615795195|FG000|Overall Study|Withdrawal by Subject|1|||
170397999|NCT04439110|615795195|FG000|Overall Study|Alternative therapy|1|||
170398000|NCT04439110|615795195|FG000|Overall Study|Other complicating disease|1|||
170398001|NCT04439110|615795195|FG000|Overall Study|Personal reasons|1|||
170398002|NCT04439110|615795195|FG000|Overall Study|Still on treatment|1|||
170398003|NCT01298661|615795202|FG000|Overall Study|Withdrawal by Subject|2|||
170398004|NCT01298661|615795203|FG001|Overall Study|Withdrawal by Subject|0|||
170398005|NCT01298661|615795204|FG002|Overall Study|Withdrawal by Subject|2|||
170398006|NCT01211613|615796369|FG000|Overall Study|Lost to Follow-up|2|||
170398007|NCT01211613|615796370|FG001|Overall Study|Lost to Follow-up|2|||
170398008|NCT01211613|615796371|FG002|Overall Study|Lost to Follow-up|2|||
170398009|NCT01211613|615796369|FG000|Overall Study|Withdrawal by Subject|1|||
170398010|NCT01211613|615796370|FG001|Overall Study|Withdrawal by Subject|0|||
170398011|NCT01211613|615796371|FG002|Overall Study|Withdrawal by Subject|0|||
170398012|NCT03853213|615796372|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
170398013|NCT03853213|615796373|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
170398014|NCT03853213|615796372|FG000|Overall Study|Other (e.g., too busy)|0|||
170398015|NCT03853213|615796373|FG001|Overall Study|Other (e.g., too busy)|2|||
170398016|NCT00981409|615796375|FG000|Overall Study|Adverse Event|4|||
170398017|NCT00981409|615796376|FG001|Overall Study|Adverse Event|0|||
170398018|NCT00981409|615796375|FG000|Overall Study|Protocol Violation|0|||
170398019|NCT00981409|615796376|FG001|Overall Study|Protocol Violation|1|||
170398020|NCT00981409|615796375|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
170398021|NCT00981409|615796376|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
170398022|NCT03869684|615796377|FG000|Overall Study|Adverse Event|0|||
170398023|NCT03869684|615796378|FG001|Overall Study|Adverse Event|3|||
170398024|NCT03869684|615796379|FG002|Overall Study|Adverse Event|1|||
170398025|NCT03869684|615796377|FG000|Overall Study|Withdrawal by Subject|1|||
170398026|NCT03869684|615796378|FG001|Overall Study|Withdrawal by Subject|0|||
170398027|NCT03869684|615796379|FG002|Overall Study|Withdrawal by Subject|0|||
170398028|NCT03869684|615796377|FG000|Overall Study|Lost to Follow-up|1|||
170398029|NCT03869684|615796378|FG001|Overall Study|Lost to Follow-up|0|||
170398030|NCT03869684|615796379|FG002|Overall Study|Lost to Follow-up|0|||
170398031|NCT03869684|615796377|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
170398032|NCT03869684|615796378|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
170398033|NCT03869684|615796379|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
170398034|NCT04056299|615796380|FG000|Overall Study|Sponsor discontinued study|3|||
170398035|NCT04056299|615796381|FG001|Overall Study|Sponsor discontinued study|3|||
170398036|NCT01227954|615796382|FG000|Overall Study|Protocol Violation|6|||
170398037|NCT01227954|615796382|FG000|Overall Study|No protocol treatment|7|||
170398038|NCT01268683|615796384|FG000|Overall Study|Lost to Follow-up|1|||
170398039|NCT01268683|615796384|FG000|Overall Study|Death|1|||
170398040|NCT04256759|615796385|FG000|Overall Study|Physician Decision|1|||
170398041|NCT04256759|615796385|FG000|Overall Study|Lack of Efficacy|1|||
170398042|NCT00602641|615796386|FG000|Overall Study|Never started protocol therapy|6|||
170398043|NCT00602641|615796387|FG001|Overall Study|Never started protocol therapy|2|||
170398044|NCT00602641|615796386|FG000|Overall Study|Still on treatment at time of analysis|8|||
170398045|NCT00602641|615796387|FG001|Overall Study|Still on treatment at time of analysis|15|||
170398046|NCT00602641|615796386|FG000|Overall Study|Adverse Event|62|||
170398047|NCT00602641|615796387|FG001|Overall Study|Adverse Event|53|||
170398048|NCT00602641|615796386|FG000|Overall Study|Disease progression|38|||
170398049|NCT00602641|615796387|FG001|Overall Study|Disease progression|55|||
170398050|NCT00602641|615796386|FG000|Overall Study|Death|6|||
170398051|NCT00602641|615796387|FG001|Overall Study|Death|5|||
170398052|NCT00602641|615796386|FG000|Overall Study|Withdrawal by Subject|15|||
170398053|NCT00602641|615796387|FG001|Overall Study|Withdrawal by Subject|12|||
170398054|NCT00602641|615796386|FG000|Overall Study|Alternative therapy|5|||
170398055|NCT00602641|615796387|FG001|Overall Study|Alternative therapy|2|||
170398056|NCT00602641|615796386|FG000|Overall Study|Other Complicating Disease|5|||
170398057|NCT00602641|615796387|FG001|Overall Study|Other Complicating Disease|2|||
170398058|NCT00602641|615796386|FG000|Overall Study|Physician Decision|5|||
170398059|NCT00602641|615796387|FG001|Overall Study|Physician Decision|4|||
170398060|NCT00602641|615796386|FG000|Overall Study|Administrative Closure|1|||
170398061|NCT00602641|615796387|FG001|Overall Study|Administrative Closure|1|||
170398062|NCT00602641|615796386|FG000|Overall Study|Other|3|||
170398063|NCT00602641|615796387|FG001|Overall Study|Other|1|||
170398064|NCT03901352|615796388|FG000|Double-blind Phase|Adverse Event|6|||
170398065|NCT03901352|615796389|FG001|Double-blind Phase|Adverse Event|4|||
170398066|NCT03901352|615796388|FG000|Double-blind Phase|Death|1|||
170398067|NCT03901352|615796389|FG001|Double-blind Phase|Death|0|||
170398068|NCT03901352|615796388|FG000|Double-blind Phase|Lack of Efficacy|0|||
170398069|NCT03901352|615796389|FG001|Double-blind Phase|Lack of Efficacy|1|||
170398070|NCT03901352|615796388|FG000|Double-blind Phase|Protocol Violation|0|||
170398071|NCT03901352|615796389|FG001|Double-blind Phase|Protocol Violation|1|||
170398072|NCT03901352|615796388|FG000|Double-blind Phase|Withdrawal by Subject|10|||
170398073|NCT03901352|615796389|FG001|Double-blind Phase|Withdrawal by Subject|8|||
170398074|NCT03901352|615796388|FG000|Open-label Extension Phase|Adverse Event|24|||
170398075|NCT03901352|615796389|FG001|Open-label Extension Phase|Adverse Event|0|||
170398076|NCT03901352|615796388|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
170398077|NCT03901352|615796389|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
170398078|NCT03901352|615796388|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
170398079|NCT03901352|615796389|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
170398080|NCT03901352|615796388|FG000|Open-label Extension Phase|Other|1|||
170398081|NCT03901352|615796389|FG001|Open-label Extension Phase|Other|0|||
170398082|NCT01826201|615796390|FG000|Overall Study|Non compliance with protocol|4|||
170398083|NCT03901339|615796391|FG000|Overall Study|Death|220|||
170398084|NCT03901339|615796392|FG001|Overall Study|Death|192|||
170398085|NCT03901339|615796391|FG000|Overall Study|Informed consent withdrawn|13|||
170398086|NCT03901339|615796392|FG001|Overall Study|Informed consent withdrawn|40|||
170398087|NCT03901339|615796391|FG000|Overall Study|Sponsor request|30|||
170398088|NCT03901339|615796392|FG001|Overall Study|Sponsor request|23|||
170398089|NCT03901339|615796391|FG000|Overall Study|Reason not specified|5|||
170398090|NCT03901339|615796392|FG001|Overall Study|Reason not specified|7|||
170398091|NCT03901339|615796391|FG000|Overall Study|Lost to Follow-up|4|||
170398092|NCT03901339|615796392|FG001|Overall Study|Lost to Follow-up|7|||
170398093|NCT03901339|615796391|FG000|Overall Study|Covid19|0|||
170398094|NCT03901339|615796392|FG001|Overall Study|Covid19|2|||
170398095|NCT04701658|615796395|FG000|Overall Study|Lost to Follow-up|6|||
170398096|NCT04101721|615796402|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
170398097|NCT04101721|615796403|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
170398098|NCT04101721|615796402|FG000|Overall Study|Death|0|||
170398099|NCT04101721|615796403|FG001|Overall Study|Death|1|||
170398100|NCT04101721|615796402|FG000|Overall Study|Lost to Follow-up|0|||
170398101|NCT04101721|615796403|FG001|Overall Study|Lost to Follow-up|3|||
170398102|NCT01215955|615796404|FG000|Overall Study|Adverse Event|1|||
170398103|NCT01215955|615796405|FG001|Overall Study|Adverse Event|4|||
170398104|NCT01215955|615796406|FG002|Overall Study|Adverse Event|2|||
170398105|NCT01215955|615796407|FG003|Overall Study|Adverse Event|3|||
170398106|NCT01215955|615796404|FG000|Overall Study|Death|2|||
170398107|NCT01215955|615796405|FG001|Overall Study|Death|0|||
170398108|NCT01215955|615796406|FG002|Overall Study|Death|1|||
170398109|NCT01215955|615796407|FG003|Overall Study|Death|3|||
170398110|NCT01215955|615796404|FG000|Overall Study|Entry Criteria Not Met|1|||
170398111|NCT01215955|615796405|FG001|Overall Study|Entry Criteria Not Met|3|||
170398112|NCT01215955|615796406|FG002|Overall Study|Entry Criteria Not Met|4|||
170398113|NCT01215955|615796407|FG003|Overall Study|Entry Criteria Not Met|7|||
170398114|NCT01215955|615796404|FG000|Overall Study|Lack of Efficacy|1|||
170398115|NCT01215955|615796405|FG001|Overall Study|Lack of Efficacy|2|||
170398116|NCT01215955|615796406|FG002|Overall Study|Lack of Efficacy|1|||
170398117|NCT01215955|615796407|FG003|Overall Study|Lack of Efficacy|0|||
170398118|NCT01215955|615796404|FG000|Overall Study|Lost to Follow-up|4|||
170398119|NCT01215955|615796405|FG001|Overall Study|Lost to Follow-up|4|||
170398120|NCT01215955|615796406|FG002|Overall Study|Lost to Follow-up|8|||
170398121|NCT01215955|615796407|FG003|Overall Study|Lost to Follow-up|9|||
170398122|NCT01215955|615796404|FG000|Overall Study|Physician Decision|4|||
170398123|NCT01215955|615796405|FG001|Overall Study|Physician Decision|10|||
170398124|NCT01215955|615796406|FG002|Overall Study|Physician Decision|8|||
170398125|NCT01215955|615796407|FG003|Overall Study|Physician Decision|11|||
170398126|NCT01215955|615796404|FG000|Overall Study|Protocol Violation|17|||
170398127|NCT01215955|615796405|FG001|Overall Study|Protocol Violation|13|||
170398128|NCT01215955|615796406|FG002|Overall Study|Protocol Violation|8|||
170398129|NCT01215955|615796407|FG003|Overall Study|Protocol Violation|8|||
170398130|NCT01215955|615796404|FG000|Overall Study|Sponsor Decision|1|||
170398131|NCT01215955|615796405|FG001|Overall Study|Sponsor Decision|2|||
170398132|NCT01215955|615796406|FG002|Overall Study|Sponsor Decision|0|||
170398133|NCT01215955|615796407|FG003|Overall Study|Sponsor Decision|1|||
170398134|NCT01215955|615796404|FG000|Overall Study|Withdrawal by Subject|14|||
170398135|NCT01215955|615796405|FG001|Overall Study|Withdrawal by Subject|15|||
170398136|NCT01215955|615796406|FG002|Overall Study|Withdrawal by Subject|13|||
170398137|NCT01215955|615796407|FG003|Overall Study|Withdrawal by Subject|9|||
170398138|NCT01215955|615796404|FG000|Overall Study|Quality Issues|0|||
170398139|NCT01215955|615796405|FG001|Overall Study|Quality Issues|0|||
170398140|NCT01215955|615796406|FG002|Overall Study|Quality Issues|3|||
170398141|NCT01215955|615796407|FG003|Overall Study|Quality Issues|2|||
170398142|NCT00445458|615796408|FG000|Overall Study|Disease Progression|3|||
170398143|NCT00445458|615796409|FG001|Overall Study|Disease Progression|4|||
170398144|NCT00445458|615796410|FG002|Overall Study|Disease Progression|54|||
170398145|NCT00445458|615796411|FG003|Overall Study|Disease Progression|27|||
170398146|NCT00445458|615796408|FG000|Overall Study|Withdrawal by Subject|0|||
170398147|NCT00445458|615796409|FG001|Overall Study|Withdrawal by Subject|0|||
170398148|NCT00445458|615796410|FG002|Overall Study|Withdrawal by Subject|7|||
170398149|NCT00445458|615796411|FG003|Overall Study|Withdrawal by Subject|0|||
170398150|NCT00445458|615796408|FG000|Overall Study|Adverse Event|0|||
170398151|NCT00445458|615796409|FG001|Overall Study|Adverse Event|0|||
170398152|NCT00445458|615796410|FG002|Overall Study|Adverse Event|3|||
170398153|NCT00445458|615796411|FG003|Overall Study|Adverse Event|0|||
170398154|NCT00445458|615796408|FG000|Overall Study|Death|0|||
170398155|NCT00445458|615796409|FG001|Overall Study|Death|1|||
170398156|NCT00445458|615796410|FG002|Overall Study|Death|2|||
170398157|NCT00445458|615796411|FG003|Overall Study|Death|0|||
170398158|NCT00445458|615796408|FG000|Overall Study|Physician Decision|0|||
170398159|NCT00445458|615796409|FG001|Overall Study|Physician Decision|0|||
170398160|NCT00445458|615796410|FG002|Overall Study|Physician Decision|1|||
170398161|NCT00445458|615796411|FG003|Overall Study|Physician Decision|1|||
170398162|NCT00445458|615796408|FG000|Overall Study|Surgery|0|||
170398163|NCT00445458|615796409|FG001|Overall Study|Surgery|0|||
170398164|NCT00445458|615796410|FG002|Overall Study|Surgery|1|||
170398165|NCT00445458|615796411|FG003|Overall Study|Surgery|0|||
170398166|NCT00038467|615796414|FG000|Overall Study|Adverse Event|170|||
170398167|NCT00038467|615796415|FG001|Overall Study|Adverse Event|145|||
170398168|NCT00038467|615796414|FG000|Overall Study|Withdrawal by Subject|150|||
170398169|NCT00038467|615796415|FG001|Overall Study|Withdrawal by Subject|107|||
170398170|NCT00038467|615796414|FG000|Overall Study|Protocol Violation|19|||
170398171|NCT00038467|615796415|FG001|Overall Study|Protocol Violation|22|||
170398172|NCT00038467|615796414|FG000|Overall Study|Death|22|||
170398173|NCT00038467|615796415|FG001|Overall Study|Death|16|||
170398174|NCT00038467|615796414|FG000|Overall Study|Lost to Follow-up|15|||
170398175|NCT00038467|615796415|FG001|Overall Study|Lost to Follow-up|10|||
170398176|NCT00038467|615796414|FG000|Overall Study|Recurrence|109|||
170398177|NCT00038467|615796415|FG001|Overall Study|Recurrence|179|||
170398178|NCT00038467|615796414|FG000|Overall Study|Randomized, but not treated|31|||
170398179|NCT00038467|615796415|FG001|Overall Study|Randomized, but not treated|35|||
170398180|NCT00038467|615796414|FG000|Overall Study|Other|26|||
170398181|NCT00038467|615796415|FG001|Overall Study|Other|28|||
170398182|NCT01523301|615796416|FG000|Overall Study|Adverse Event|25|||
170398183|NCT01523301|615796417|FG001|Overall Study|Adverse Event|16|||
170398184|NCT01523301|615796416|FG000|Overall Study|Lack of Efficacy|0|||
170398185|NCT01523301|615796417|FG001|Overall Study|Lack of Efficacy|2|||
170398186|NCT01523301|615796416|FG000|Overall Study|Protocol Violation|3|||
170398187|NCT01523301|615796417|FG001|Overall Study|Protocol Violation|4|||
170398188|NCT01523301|615796416|FG000|Overall Study|Lost to Follow-up|1|||
170398189|NCT01523301|615796417|FG001|Overall Study|Lost to Follow-up|0|||
170398190|NCT01523301|615796416|FG000|Overall Study|Withdrawal by Subject|6|||
170398191|NCT01523301|615796417|FG001|Overall Study|Withdrawal by Subject|8|||
170398192|NCT01523301|615796416|FG000|Overall Study|Other Reason|0|||
170398193|NCT01523301|615796417|FG001|Overall Study|Other Reason|2|||
170398194|NCT01339000|615796418|FG000|Overall Study|study closed due to lack of drug supply|1|||
170398195|NCT01339000|615796419|FG001|Overall Study|study closed due to lack of drug supply|0|||
170398196|NCT05013749|615796420|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
170398197|NCT05013749|615796421|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
170398198|NCT05013749|615796420|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
170398199|NCT05013749|615796421|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
170398200|NCT05511428|615796422|FG000|Overall Study|Withdrawal by Subject|1|||
170398201|NCT05511428|615796422|FG000|Overall Study|Adverse Event|1|||
170398202|NCT00943384|615796423|FG000|Overall Study|Dispositioned prior to treatment|23|||
170398203|NCT00943384|615796423|FG000|Overall Study|Treated off protocol-protocol violation|5|||
170398204|NCT00943384|615796423|FG000|Overall Study|Lost to Follow-up|16|||
170398205|NCT00943384|615796423|FG000|Overall Study|Withdrawal by Subject|5|||
170398206|NCT00096200|615796424|FG000|Overall Study|Adverse Event|0|||
170398207|NCT00096200|615796425|FG001|Overall Study|Adverse Event|4|||
170398208|NCT00096200|615796426|FG002|Overall Study|Adverse Event|0|||
170398209|NCT00096200|615796424|FG000|Overall Study|Withdrawal by Subject|1|||
170398210|NCT00096200|615796425|FG001|Overall Study|Withdrawal by Subject|2|||
170398211|NCT00096200|615796426|FG002|Overall Study|Withdrawal by Subject|0|||
170398212|NCT00096200|615796424|FG000|Overall Study|Ineligible pathology|0|||
170398213|NCT00096200|615796425|FG001|Overall Study|Ineligible pathology|1|||
170398214|NCT00096200|615796426|FG002|Overall Study|Ineligible pathology|0|||
170398215|NCT03332212|615796429|FG000|Overall Study|Not treated|0|||
170398216|NCT03332212|615796430|FG001|Overall Study|Not treated|1|||
170398217|NCT03332212|615796431|FG002|Overall Study|Not treated|0|||
170398218|NCT03332212|615796432|FG003|Overall Study|Not treated|0|||
170398219|NCT03332212|615796429|FG000|Overall Study|Adverse Event|0|||
170398220|NCT03332212|615796430|FG001|Overall Study|Adverse Event|0|||
170398221|NCT03332212|615796431|FG002|Overall Study|Adverse Event|0|||
170398222|NCT03332212|615796432|FG003|Overall Study|Adverse Event|1|||
170398223|NCT03332212|615796429|FG000|Overall Study|worsening of disease under study|1|||
170398224|NCT03332212|615796430|FG001|Overall Study|worsening of disease under study|1|||
170398225|NCT03332212|615796431|FG002|Overall Study|worsening of disease under study|0|||
170398226|NCT03332212|615796432|FG003|Overall Study|worsening of disease under study|0|||
170398227|NCT00929864|615796433|FG000|Overall Study|Death|1|||
170398228|NCT00929864|615796434|FG001|Overall Study|Death|1|||
170398229|NCT00929864|615796433|FG000|Overall Study|Adverse Event|11|||
170398230|NCT00929864|615796434|FG001|Overall Study|Adverse Event|30|||
170398231|NCT00929864|615796433|FG000|Overall Study|Lack of Efficacy|19|||
170398232|NCT00929864|615796434|FG001|Overall Study|Lack of Efficacy|16|||
170398233|NCT00929864|615796433|FG000|Overall Study|Lost to Follow-up|7|||
170398234|NCT00929864|615796434|FG001|Overall Study|Lost to Follow-up|12|||
170398235|NCT00929864|615796433|FG000|Overall Study|Withdrawal by Subject|20|||
170398236|NCT00929864|615796434|FG001|Overall Study|Withdrawal by Subject|9|||
170398237|NCT00929864|615796433|FG000|Overall Study|No longer met criteria|2|||
170398238|NCT00929864|615796434|FG001|Overall Study|No longer met criteria|1|||
170398239|NCT00929864|615796433|FG000|Overall Study|Poor or non-compliance|3|||
170398240|NCT00929864|615796434|FG001|Overall Study|Poor or non-compliance|3|||
170398241|NCT00929864|615796433|FG000|Overall Study|Pregnancy|0|||
170398242|NCT00929864|615796434|FG001|Overall Study|Pregnancy|3|||
170398243|NCT00929864|615796433|FG000|Overall Study|Administrative reason by Sponsor|1|||
170398244|NCT00929864|615796434|FG001|Overall Study|Administrative reason by Sponsor|1|||
170398245|NCT00929864|615796433|FG000|Overall Study|Non-specified|2|||
170398246|NCT00929864|615796434|FG001|Overall Study|Non-specified|7|||
170398247|NCT03728257|615796435|FG000|Overall Study|Death|3|||
170398248|NCT03728257|615796436|FG001|Overall Study|Death|0|||
170398249|NCT03940742|615796437|FG000|Overall Study|Lost to Follow-up|0|||
170398250|NCT03940742|615796438|FG001|Overall Study|Lost to Follow-up|0|||
170398251|NCT03940742|615796439|FG002|Overall Study|Lost to Follow-up|0|||
170398252|NCT03940742|615796440|FG003|Overall Study|Lost to Follow-up|1|||
170398253|NCT03428217|615796442|FG000|Overall Study|Death|89|||
170398254|NCT03428217|615796443|FG001|Overall Study|Death|93|||
170398255|NCT03428217|615796442|FG000|Overall Study|Withdrawal by Subject|8|||
170398256|NCT03428217|615796443|FG001|Overall Study|Withdrawal by Subject|7|||
170398257|NCT03428217|615796442|FG000|Overall Study|Lost to Follow-up|1|||
170398258|NCT03428217|615796443|FG001|Overall Study|Lost to Follow-up|3|||
170398259|NCT03428217|615796442|FG000|Overall Study|Study terminated by sponsor|124|||
170398260|NCT03428217|615796443|FG001|Overall Study|Study terminated by sponsor|118|||
170398261|NCT03428217|615796442|FG000|Overall Study|Other, Not Specified|1|||
170398262|NCT03428217|615796443|FG001|Overall Study|Other, Not Specified|0|||
170398263|NCT05246111|615796444|FG000|Period 01|NOT ELIGIBLE IC5|1|||
170398264|NCT05246111|615796445|FG001|Period 01|NOT ELIGIBLE IC5|0|||
170398265|NCT02736695|615796446|FG000|Overall Study|Ineligible|6|||
170398266|NCT02736695|615796447|FG001|Overall Study|Ineligible|0|||
170398267|NCT03252015|615796448|FG000|Overall Study|Withdrawal by Subject|0|||
170398268|NCT03252015|615796449|FG001|Overall Study|Withdrawal by Subject|1|||
170398269|NCT03252015|615796450|FG002|Overall Study|Withdrawal by Subject|1|||
170398270|NCT03252015|615796451|FG003|Overall Study|Withdrawal by Subject|0|||
170398271|NCT03252015|615796448|FG000|Overall Study|Adverse Event|1|||
170398272|NCT03252015|615796449|FG001|Overall Study|Adverse Event|0|||
170398273|NCT03252015|615796450|FG002|Overall Study|Adverse Event|0|||
170398274|NCT03252015|615796451|FG003|Overall Study|Adverse Event|1|||
170398275|NCT01329562|615796452|FG000|Overall Study|Protocol Violation|5|||
170398276|NCT01329562|615796453|FG001|Overall Study|Protocol Violation|3|||
170398277|NCT01329562|615796452|FG000|Overall Study|Lost to Follow-up|1|||
170398278|NCT01329562|615796453|FG001|Overall Study|Lost to Follow-up|1|||
170398279|NCT01329562|615796452|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
170398280|NCT01329562|615796453|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
170398281|NCT01329562|615796452|FG000|Overall Study|Physician Decision|0|||
170398282|NCT01329562|615796453|FG001|Overall Study|Physician Decision|1|||
170398283|NCT04993339|615796454|FG000|Overall Study|Lost to Follow-up|0|||
170398284|NCT04993339|615796455|FG001|Overall Study|Lost to Follow-up|1|||
170398285|NCT04993339|615796454|FG000|Overall Study|no MRI scan|3|||
170398286|NCT04993339|615796455|FG001|Overall Study|no MRI scan|1|||
170398287|NCT01381068|615796456|FG000|Overall Study|Death|1|||
170398288|NCT01381068|615796457|FG001|Overall Study|Death|0|||
170398289|NCT03868059|615796465|FG000|Overall Study|Adverse Event|3|||
170398290|NCT03868059|615796465|FG000|Overall Study|Lost to Follow-up|3|||
170398291|NCT03868059|615796465|FG000|Overall Study|Withdrawal by Subject|6|||
170398292|NCT03075215|615796466|FG000|12-Month Primary Endpoint|Death|152|||
170398293|NCT03075215|615796466|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
170398294|NCT03075215|615796466|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
170398295|NCT03075215|615796466|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
170398296|NCT00690573|615796473|FG000|Overall Study|Lack of Efficacy|8|||
170398297|NCT00690573|615796473|FG000|Overall Study|Withdrawal by Subject|1|||
170398298|NCT02146365|615796474|FG000|Overall Study|Lost to Follow-up|2|||
170398299|NCT02146365|615796475|FG001|Overall Study|Lost to Follow-up|1|||
170398300|NCT02146365|615796476|FG002|Overall Study|Lost to Follow-up|3|||
170398301|NCT02146365|615796477|FG003|Overall Study|Lost to Follow-up|3|||
170398302|NCT02146365|615796478|FG004|Overall Study|Lost to Follow-up|1|||
170398303|NCT02146365|615796479|FG005|Overall Study|Lost to Follow-up|1|||
170398304|NCT02146365|615796480|FG006|Overall Study|Lost to Follow-up|0|||
170398305|NCT02146365|615796481|FG007|Overall Study|Lost to Follow-up|1|||
170398306|NCT02146365|615796474|FG000|Overall Study|Withdrawal by Subject|1|||
170398307|NCT02146365|615796475|FG001|Overall Study|Withdrawal by Subject|2|||
170398308|NCT02146365|615796476|FG002|Overall Study|Withdrawal by Subject|1|||
170398309|NCT02146365|615796477|FG003|Overall Study|Withdrawal by Subject|5|||
170398310|NCT02146365|615796478|FG004|Overall Study|Withdrawal by Subject|1|||
170398311|NCT02146365|615796479|FG005|Overall Study|Withdrawal by Subject|0|||
170398312|NCT02146365|615796480|FG006|Overall Study|Withdrawal by Subject|0|||
170398313|NCT02146365|615796481|FG007|Overall Study|Withdrawal by Subject|0|||
170398314|NCT02146365|615796474|FG000|Overall Study|Unable to Comply with Protocol|0|||
170398315|NCT02146365|615796475|FG001|Overall Study|Unable to Comply with Protocol|1|||
170398316|NCT02146365|615796476|FG002|Overall Study|Unable to Comply with Protocol|1|||
170398317|NCT02146365|615796477|FG003|Overall Study|Unable to Comply with Protocol|0|||
170398318|NCT02146365|615796478|FG004|Overall Study|Unable to Comply with Protocol|0|||
170398319|NCT02146365|615796479|FG005|Overall Study|Unable to Comply with Protocol|0|||
170398320|NCT02146365|615796480|FG006|Overall Study|Unable to Comply with Protocol|0|||
170398321|NCT02146365|615796481|FG007|Overall Study|Unable to Comply with Protocol|0|||
170398322|NCT02146365|615796474|FG000|Overall Study|Other|1|||
170398323|NCT02146365|615796475|FG001|Overall Study|Other|0|||
170398324|NCT02146365|615796476|FG002|Overall Study|Other|2|||
170398325|NCT02146365|615796477|FG003|Overall Study|Other|1|||
170398326|NCT02146365|615796478|FG004|Overall Study|Other|0|||
170398327|NCT02146365|615796479|FG005|Overall Study|Other|0|||
170398328|NCT02146365|615796480|FG006|Overall Study|Other|0|||
170398329|NCT02146365|615796481|FG007|Overall Study|Other|0|||
170398330|NCT00526227|615796482|FG000|Overall Study|Device not implanted|1|||
170398331|NCT00526227|615796482|FG000|Overall Study|Death|1|||
170398332|NCT01721369|615796483|FG000|Overall Study|Not initial etiological diagnosis|12|||
170398333|NCT05257109|615796484|FG000|Overall Study|Withdrawal by Subject|1|||
170398334|NCT05257109|615796485|FG001|Overall Study|Withdrawal by Subject|0|||
170398335|NCT05257109|615796486|FG002|Overall Study|Withdrawal by Subject|0|||
170398336|NCT05257109|615796487|FG003|Overall Study|Withdrawal by Subject|0|||
170398337|NCT00819091|615798168|FG000|Overall Study|Adverse Event|3|||
170398338|NCT00819091|615798169|FG001|Overall Study|Adverse Event|5|||
170398339|NCT00819091|615798168|FG000|Overall Study|Protocol Violation|0|||
170398340|NCT00819091|615798169|FG001|Overall Study|Protocol Violation|1|||
170398341|NCT00819091|615798168|FG000|Overall Study|Lost to Follow-up|2|||
170398342|NCT00819091|615798169|FG001|Overall Study|Lost to Follow-up|0|||
170398343|NCT00819091|615798168|FG000|Overall Study|Withdrawal by Subject|1|||
170398344|NCT00819091|615798169|FG001|Overall Study|Withdrawal by Subject|2|||
170398345|NCT00819091|615798168|FG000|Overall Study|Other|1|||
170398346|NCT00819091|615798169|FG001|Overall Study|Other|2|||
170398347|NCT01788163|615798170|FG000|Overall Study|Other|53|||
170398348|NCT01788163|615798171|FG001|Overall Study|Other|0|||
170398349|NCT01788163|615798172|FG002|Overall Study|Other|0|||
170398350|NCT01788163|615798173|FG003|Overall Study|Other|0|||
170398351|NCT01788163|615798174|FG004|Overall Study|Other|0|||
170398352|NCT01788163|615798175|FG005|Overall Study|Other|7|||
170398353|NCT01788163|615798176|FG006|Overall Study|Other|1|||
170398354|NCT01788163|615798177|FG007|Overall Study|Other|48|||
170398355|NCT01788163|615798178|FG008|Overall Study|Other|15|||
170398356|NCT01788163|615798170|FG000|Overall Study|Withdrawal by Subject|2|||
170398357|NCT01788163|615798171|FG001|Overall Study|Withdrawal by Subject|0|||
170398358|NCT01788163|615798172|FG002|Overall Study|Withdrawal by Subject|0|||
170398359|NCT01788163|615798173|FG003|Overall Study|Withdrawal by Subject|0|||
170398360|NCT01788163|615798174|FG004|Overall Study|Withdrawal by Subject|0|||
170398361|NCT01788163|615798175|FG005|Overall Study|Withdrawal by Subject|0|||
170398362|NCT01788163|615798176|FG006|Overall Study|Withdrawal by Subject|0|||
170398363|NCT01788163|615798177|FG007|Overall Study|Withdrawal by Subject|0|||
170398364|NCT01788163|615798178|FG008|Overall Study|Withdrawal by Subject|1|||
170398365|NCT00424515|615798179|FG000|Overall Study|Progressive Disease|10|||
170398366|NCT00424515|615798180|FG001|Overall Study|Progressive Disease|11|||
170398367|NCT00424515|615798179|FG000|Overall Study|Adverse Event|0|||
170398368|NCT00424515|615798180|FG001|Overall Study|Adverse Event|1|||
170398369|NCT00424515|615798179|FG000|Overall Study|Intercurrent Illness|0|||
170398370|NCT00424515|615798180|FG001|Overall Study|Intercurrent Illness|1|||
170398371|NCT00424515|615798179|FG000|Overall Study|Withdrawal by Subject|1|||
170398372|NCT00424515|615798180|FG001|Overall Study|Withdrawal by Subject|0|||
170398373|NCT04071366|615798181|FG000|Part 1: Open-label (29 Days)|Death|4|||
170398374|NCT04071366|615798182|FG001|Part 1: Open-label (29 Days)|Death|2|||
170398375|NCT04071366|615798183|FG002|Part 1: Open-label (29 Days)|Death|8|||
170398376|NCT04071366|615798184|FG003|Part 1: Open-label (29 Days)|Death|0|||
170398377|NCT04071366|615798185|FG004|Part 1: Open-label (29 Days)|Death|0|||
170398378|NCT04071366|615798181|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
170398379|NCT04071366|615798182|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
170398380|NCT04071366|615798183|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
170398381|NCT04071366|615798184|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
170398382|NCT04071366|615798185|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
170398383|NCT04071366|615798181|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
170398384|NCT04071366|615798182|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
170398385|NCT04071366|615798183|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
170398386|NCT04071366|615798184|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
170398387|NCT04071366|615798185|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
170398388|NCT04071366|615798181|FG000|Part 2: Randomized (29 Days)|Death|0|||
170398389|NCT04071366|615798182|FG001|Part 2: Randomized (29 Days)|Death|0|||
170398390|NCT04071366|615798183|FG002|Part 2: Randomized (29 Days)|Death|0|||
170398391|NCT04071366|615798184|FG003|Part 2: Randomized (29 Days)|Death|2|||
170398392|NCT04071366|615798185|FG004|Part 2: Randomized (29 Days)|Death|2|||
170398393|NCT04071366|615798181|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
170398394|NCT04071366|615798182|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
170398395|NCT04071366|615798183|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
170398396|NCT04071366|615798184|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
170398397|NCT04071366|615798185|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
170398398|NCT04071366|615798181|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
170398399|NCT04071366|615798182|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
170398400|NCT04071366|615798183|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
170398401|NCT04071366|615798184|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
170398402|NCT04071366|615798185|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
170398403|NCT04071366|615798181|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
170398404|NCT04071366|615798182|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
170398405|NCT04071366|615798183|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
170398406|NCT04071366|615798184|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
170398407|NCT04071366|615798185|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
170398408|NCT04071366|615798181|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
170398409|NCT04071366|615798182|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
170398410|NCT04071366|615798183|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
170398411|NCT04071366|615798184|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
170398412|NCT04071366|615798185|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
170398413|NCT04071366|615798181|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
170398414|NCT04071366|615798182|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
170398415|NCT04071366|615798183|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
170398416|NCT04071366|615798184|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
170398417|NCT04071366|615798185|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
170398418|NCT04071366|615798181|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
170398419|NCT04071366|615798182|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
170398420|NCT04071366|615798183|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
170398421|NCT04071366|615798184|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
170398422|NCT04071366|615798185|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
170398423|NCT02239692|615798186|FG000|Overall Study|Incomplete colonoscopy|1|||
170398424|NCT02239692|615798187|FG001|Overall Study|Incomplete colonoscopy|2|||
170398425|NCT02239692|615798186|FG000|Overall Study|Adverse Event|0|||
170398426|NCT02239692|615798187|FG001|Overall Study|Adverse Event|1|||
170398427|NCT02239692|615798186|FG000|Overall Study|Physician Decision|0|||
170398428|NCT02239692|615798187|FG001|Overall Study|Physician Decision|1|||
170398429|NCT02239692|615798186|FG000|Overall Study|Lost to Follow-up|1|||
170398430|NCT02239692|615798187|FG001|Overall Study|Lost to Follow-up|4|||
170398431|NCT02239692|615798186|FG000|Overall Study|Withdrawal by Subject|3|||
170398432|NCT02239692|615798187|FG001|Overall Study|Withdrawal by Subject|5|||
170398433|NCT02239692|615798186|FG000|Overall Study|Other reason|1|||
170398434|NCT02239692|615798187|FG001|Overall Study|Other reason|0|||
170398435|NCT04318535|615798188|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
170398436|NCT04318535|615798189|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
170398875|NCT05004181|615798315|FG003|Overall Study|Physician Decision|0|||
170398437|NCT04318535|615798190|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
170398438|NCT00858234|615798191|FG000|Overall Study|Adverse Event|6|||
170398439|NCT00858234|615798191|FG000|Overall Study|Progressive disease|2|||
170398440|NCT00858234|615798191|FG000|Overall Study|Status unknown|1|||
170398441|NCT01678924|615798192|FG000|Overall Study|Adverse Event|1|||
170398442|NCT01678924|615798193|FG001|Overall Study|Adverse Event|1|||
170398443|NCT01678924|615798194|FG002|Overall Study|Adverse Event|0|||
170398444|NCT01678924|615798195|FG003|Overall Study|Adverse Event|1|||
170398445|NCT01678924|615798192|FG000|Overall Study|Lack of Efficacy|7|||
170398446|NCT01678924|615798193|FG001|Overall Study|Lack of Efficacy|2|||
170398447|NCT01678924|615798194|FG002|Overall Study|Lack of Efficacy|0|||
170398448|NCT01678924|615798195|FG003|Overall Study|Lack of Efficacy|5|||
170398449|NCT01678924|615798192|FG000|Overall Study|Lost to Follow-up|0|||
170398450|NCT01678924|615798193|FG001|Overall Study|Lost to Follow-up|4|||
170398451|NCT01678924|615798194|FG002|Overall Study|Lost to Follow-up|0|||
170398452|NCT01678924|615798195|FG003|Overall Study|Lost to Follow-up|2|||
170398453|NCT01678924|615798192|FG000|Overall Study|Personal Reasons|2|||
170398454|NCT01678924|615798193|FG001|Overall Study|Personal Reasons|2|||
170398455|NCT01678924|615798194|FG002|Overall Study|Personal Reasons|2|||
170398456|NCT01678924|615798195|FG003|Overall Study|Personal Reasons|7|||
170398457|NCT01678924|615798192|FG000|Overall Study|Withdrawal by Subject|0|||
170398458|NCT01678924|615798193|FG001|Overall Study|Withdrawal by Subject|3|||
170398459|NCT01678924|615798194|FG002|Overall Study|Withdrawal by Subject|0|||
170398460|NCT01678924|615798195|FG003|Overall Study|Withdrawal by Subject|2|||
170398461|NCT01678924|615798192|FG000|Overall Study|Unable to attend scheduled visits|0|||
170398462|NCT01678924|615798193|FG001|Overall Study|Unable to attend scheduled visits|0|||
170398463|NCT01678924|615798194|FG002|Overall Study|Unable to attend scheduled visits|0|||
170398464|NCT01678924|615798195|FG003|Overall Study|Unable to attend scheduled visits|1|||
170398465|NCT00021229|615798197|FG000|Overall Study|Adverse Event|10|||
170398466|NCT00021229|615798198|FG001|Overall Study|Adverse Event|5|||
170398467|NCT00021229|615798199|FG002|Overall Study|Adverse Event|2|||
170398468|NCT00021229|615798197|FG000|Overall Study|Death|0|||
170398469|NCT00021229|615798198|FG001|Overall Study|Death|1|||
170398470|NCT00021229|615798199|FG002|Overall Study|Death|0|||
170398471|NCT00021229|615798197|FG000|Overall Study|Withdrawal by Subject|7|||
170398472|NCT00021229|615798198|FG001|Overall Study|Withdrawal by Subject|7|||
170398473|NCT00021229|615798199|FG002|Overall Study|Withdrawal by Subject|1|||
170398474|NCT00021229|615798197|FG000|Overall Study|Progressive Disease|15|||
170398475|NCT00021229|615798198|FG001|Overall Study|Progressive Disease|19|||
170398476|NCT00021229|615798199|FG002|Overall Study|Progressive Disease|12|||
170398477|NCT00021229|615798197|FG000|Overall Study|Protocol Violation|1|||
170398478|NCT00021229|615798198|FG001|Overall Study|Protocol Violation|1|||
170398479|NCT00021229|615798199|FG002|Overall Study|Protocol Violation|0|||
170398480|NCT00021229|615798197|FG000|Overall Study|Physician Decision|0|||
170398481|NCT00021229|615798198|FG001|Overall Study|Physician Decision|0|||
170398482|NCT00021229|615798199|FG002|Overall Study|Physician Decision|1|||
170398483|NCT00021229|615798197|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
170398484|NCT00021229|615798198|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
170398485|NCT00021229|615798199|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
170398486|NCT01901146|615798200|FG000|Neoadjuvant Phase|Death|1|||
170398487|NCT01901146|615798201|FG001|Neoadjuvant Phase|Death|2|||
170398488|NCT01901146|615798202|FG002|Neoadjuvant Phase|Death|0|||
170398489|NCT01901146|615798203|FG003|Neoadjuvant Phase|Death|0|||
170398490|NCT01901146|615798204|FG004|Neoadjuvant Phase|Death|0|||
170398491|NCT01901146|615798200|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
170398492|NCT01901146|615798201|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
170398493|NCT01901146|615798202|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
170398876|NCT05004181|615798316|FG004|Overall Study|Physician Decision|0|||
170398494|NCT01901146|615798203|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
170398495|NCT01901146|615798204|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
170398496|NCT01901146|615798200|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
170398497|NCT01901146|615798201|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
170398498|NCT01901146|615798202|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
170398499|NCT01901146|615798203|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
170398500|NCT01901146|615798204|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
170398501|NCT01901146|615798200|FG000|Neoadjuvant Phase|Physician Decision|1|||
170398502|NCT01901146|615798201|FG001|Neoadjuvant Phase|Physician Decision|2|||
170398503|NCT01901146|615798202|FG002|Neoadjuvant Phase|Physician Decision|0|||
170398504|NCT01901146|615798203|FG003|Neoadjuvant Phase|Physician Decision|0|||
170398505|NCT01901146|615798204|FG004|Neoadjuvant Phase|Physician Decision|0|||
170398506|NCT01901146|615798200|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
170398507|NCT01901146|615798201|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
170398508|NCT01901146|615798202|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
170398509|NCT01901146|615798203|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
170398510|NCT01901146|615798204|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
170398511|NCT01901146|615798200|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
170398512|NCT01901146|615798201|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
170398513|NCT01901146|615798202|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
170398514|NCT01901146|615798203|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
170398515|NCT01901146|615798204|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
170398516|NCT01901146|615798200|FG000|Adjuvant Phase|Other|0|||
170398517|NCT01901146|615798201|FG001|Adjuvant Phase|Other|0|||
170398518|NCT01901146|615798202|FG002|Adjuvant Phase|Other|1|||
170398519|NCT01901146|615798203|FG003|Adjuvant Phase|Other|0|||
170398520|NCT01901146|615798204|FG004|Adjuvant Phase|Other|0|||
170398521|NCT01901146|615798200|FG000|Adjuvant Phase|Death|0|||
170398522|NCT01901146|615798201|FG001|Adjuvant Phase|Death|0|||
170398523|NCT01901146|615798202|FG002|Adjuvant Phase|Death|0|||
170398524|NCT01901146|615798203|FG003|Adjuvant Phase|Death|0|||
170398525|NCT01901146|615798204|FG004|Adjuvant Phase|Death|3|||
170398526|NCT01901146|615798200|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
170398527|NCT01901146|615798201|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
170398528|NCT01901146|615798202|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
170398529|NCT01901146|615798203|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
170398530|NCT01901146|615798204|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
170398531|NCT01901146|615798200|FG000|Adjuvant Phase|Physician Decision|0|||
170398532|NCT01901146|615798201|FG001|Adjuvant Phase|Physician Decision|0|||
170398533|NCT01901146|615798202|FG002|Adjuvant Phase|Physician Decision|9|||
170398534|NCT01901146|615798203|FG003|Adjuvant Phase|Physician Decision|2|||
170398535|NCT01901146|615798204|FG004|Adjuvant Phase|Physician Decision|4|||
170398536|NCT01901146|615798200|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
170398537|NCT01901146|615798201|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
170398538|NCT01901146|615798202|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
170398539|NCT01901146|615798203|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
170398540|NCT01901146|615798204|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
170398541|NCT02675426|615798208|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
170398542|NCT02675426|615798209|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
170398543|NCT02675426|615798210|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
170398544|NCT02675426|615798211|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
170398545|NCT02675426|615798208|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
170398546|NCT02675426|615798209|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
170398547|NCT02675426|615798210|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
170398548|NCT02675426|615798211|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
170398549|NCT02675426|615798208|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
170398550|NCT02675426|615798209|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
170398551|NCT02675426|615798210|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
170398552|NCT02675426|615798211|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
170398553|NCT02675426|615798208|FG000|Period 1: Week 1 to Week 12|Other|2|||
170398554|NCT02675426|615798209|FG001|Period 1: Week 1 to Week 12|Other|1|||
170398555|NCT02675426|615798210|FG002|Period 1: Week 1 to Week 12|Other|0|||
170398556|NCT02675426|615798211|FG003|Period 1: Week 1 to Week 12|Other|2|||
170398557|NCT02675426|615798208|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
170398558|NCT02675426|615798209|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
170398559|NCT02675426|615798210|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
170398560|NCT02675426|615798211|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
170398561|NCT02675426|615798208|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
170398562|NCT02675426|615798209|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
170398563|NCT02675426|615798210|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
170398564|NCT02675426|615798211|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
170398565|NCT02675426|615798208|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
170398566|NCT02675426|615798209|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
170398567|NCT02675426|615798210|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
170398568|NCT02675426|615798211|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
170398569|NCT02675426|615798208|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
170398570|NCT02675426|615798209|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
170398571|NCT02675426|615798210|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
170398572|NCT02675426|615798211|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
170398573|NCT02675426|615798208|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
170398574|NCT02675426|615798209|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
170398575|NCT02675426|615798210|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
170398576|NCT02675426|615798211|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
170398577|NCT02675426|615798208|FG000|Period 2: Week 12 to Week 260|Other|8|||
170398578|NCT02675426|615798209|FG001|Period 2: Week 12 to Week 260|Other|12|||
170398579|NCT02675426|615798210|FG002|Period 2: Week 12 to Week 260|Other|23|||
170398580|NCT02675426|615798211|FG003|Period 2: Week 12 to Week 260|Other|15|||
170398581|NCT02156466|615798214|FG000|Overall Study|Adverse Event|0|||
170398582|NCT02156466|615798215|FG001|Overall Study|Adverse Event|0|||
170398583|NCT02156466|615798216|FG002|Overall Study|Adverse Event|1|||
170398584|NCT02156466|615798217|FG003|Overall Study|Adverse Event|1|||
170398585|NCT02156466|615798218|FG004|Overall Study|Adverse Event|0|||
170398586|NCT02156466|615798214|FG000|Overall Study|Quantiferon Positivity|0|||
170398587|NCT02156466|615798215|FG001|Overall Study|Quantiferon Positivity|0|||
170398588|NCT02156466|615798216|FG002|Overall Study|Quantiferon Positivity|0|||
170398589|NCT02156466|615798217|FG003|Overall Study|Quantiferon Positivity|1|||
170398590|NCT02156466|615798218|FG004|Overall Study|Quantiferon Positivity|0|||
170398591|NCT03724968|615798219|FG000|Overall Study|Insurance issues|0|||
170398592|NCT03724968|615798220|FG001|Overall Study|Insurance issues|1|||
170398593|NCT03724968|615798219|FG000|Overall Study|Study closed|0|||
170398594|NCT03724968|615798220|FG001|Overall Study|Study closed|1|||
170398595|NCT01784419|615798223|FG000|Overall Study|Adverse Event|3|||
170398596|NCT01336608|615798224|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
170398597|NCT01336608|615798225|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170398598|NCT01336608|615798226|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170398599|NCT01336608|615798227|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
170398600|NCT01336608|615798224|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
170398601|NCT01336608|615798225|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170398602|NCT01336608|615798226|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170398603|NCT01336608|615798227|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
170398604|NCT01336608|615798224|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
170398605|NCT01336608|615798225|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
170398606|NCT01336608|615798226|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
170398607|NCT01336608|615798227|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
170398608|NCT01336608|615798224|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
170398609|NCT01336608|615798225|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
170398610|NCT01336608|615798226|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
170398611|NCT01336608|615798227|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
170398612|NCT01336608|615798224|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
170398613|NCT01336608|615798225|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170398614|NCT01336608|615798226|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170398615|NCT01336608|615798227|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
170398616|NCT01336608|615798224|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
170398617|NCT01336608|615798225|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
170398618|NCT01336608|615798226|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
170398619|NCT01336608|615798227|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
170398620|NCT01336608|615798224|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170398621|NCT01336608|615798225|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
170398622|NCT01336608|615798226|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170398623|NCT01336608|615798227|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
170398624|NCT01336608|615798224|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
170398625|NCT01336608|615798225|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
170398626|NCT01336608|615798226|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
170398627|NCT01336608|615798227|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
170398628|NCT01336608|615798224|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
170398629|NCT01336608|615798225|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
170398630|NCT01336608|615798226|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
170398631|NCT01336608|615798227|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
170398632|NCT01336608|615798224|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
170398633|NCT01336608|615798225|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
170398634|NCT01336608|615798226|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
170398635|NCT01336608|615798227|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
170398636|NCT01336608|615798224|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170398637|NCT01336608|615798225|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
170398638|NCT01336608|615798226|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170398639|NCT01336608|615798227|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
170398640|NCT01336608|615798224|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
170398641|NCT01336608|615798225|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
170398642|NCT01336608|615798226|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
170398694|NCT03981614|615798256|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
170398695|NCT02742818|615798257|FG000|Overall Study|Adverse Event|0|||
170398696|NCT02742818|615798258|FG001|Overall Study|Adverse Event|1|||
170398697|NCT02742818|615798257|FG000|Overall Study|Protocol Violation|0|||
170398698|NCT02742818|615798258|FG001|Overall Study|Protocol Violation|1|||
170398699|NCT05302414|615798262|FG000|Pretest to Posttest|Lost to Follow-up|12|||
170398700|NCT05302414|615798263|FG001|Pretest to Posttest|Lost to Follow-up|8|||
170398701|NCT05302414|615798264|FG002|Pretest to Posttest|Lost to Follow-up|8|||
170398702|NCT05302414|615798262|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
170398703|NCT05302414|615798263|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
170398704|NCT05302414|615798264|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
170398705|NCT00742859|615798265|FG000|Overall Study|Adverse Event|5|||
170398706|NCT00742859|615798266|FG001|Overall Study|Adverse Event|6|||
170398707|NCT00742859|615798267|FG002|Overall Study|Adverse Event|3|||
170398708|NCT00742859|615798268|FG003|Overall Study|Adverse Event|1|||
170398709|NCT00742859|615798265|FG000|Overall Study|Death|1|||
170398710|NCT00742859|615798266|FG001|Overall Study|Death|0|||
170398711|NCT00742859|615798267|FG002|Overall Study|Death|0|||
170398712|NCT00742859|615798268|FG003|Overall Study|Death|1|||
170398713|NCT00742859|615798265|FG000|Overall Study|Physician Decision|1|||
170398714|NCT00742859|615798266|FG001|Overall Study|Physician Decision|2|||
170398715|NCT00742859|615798267|FG002|Overall Study|Physician Decision|0|||
170398716|NCT00742859|615798268|FG003|Overall Study|Physician Decision|0|||
170398717|NCT00742859|615798265|FG000|Overall Study|Withdrawal by Subject|4|||
170398718|NCT00742859|615798266|FG001|Overall Study|Withdrawal by Subject|2|||
170398719|NCT00742859|615798267|FG002|Overall Study|Withdrawal by Subject|4|||
170398720|NCT00742859|615798268|FG003|Overall Study|Withdrawal by Subject|1|||
170398721|NCT00742859|615798265|FG000|Overall Study|Endpoint|0|||
170398722|NCT00742859|615798266|FG001|Overall Study|Endpoint|1|||
170398723|NCT00742859|615798267|FG002|Overall Study|Endpoint|1|||
170398724|NCT00742859|615798268|FG003|Overall Study|Endpoint|2|||
170398725|NCT00742859|615798265|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
170398726|NCT00742859|615798266|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
170398727|NCT00742859|615798267|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
170398728|NCT00742859|615798268|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
170398729|NCT00742859|615798265|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
170398730|NCT00742859|615798266|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
170398731|NCT00742859|615798267|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
170398732|NCT00742859|615798268|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
170398733|NCT00742859|615798265|FG000|Overall Study|Sponsor request patient out of town|0|||
170398734|NCT00742859|615798266|FG001|Overall Study|Sponsor request patient out of town|0|||
170398735|NCT00742859|615798267|FG002|Overall Study|Sponsor request patient out of town|1|||
170398736|NCT00742859|615798268|FG003|Overall Study|Sponsor request patient out of town|1|||
170398737|NCT00742859|615798265|FG000|Overall Study|Site error|0|||
170398738|NCT00742859|615798266|FG001|Overall Study|Site error|0|||
170398739|NCT00742859|615798267|FG002|Overall Study|Site error|1|||
170398740|NCT00742859|615798268|FG003|Overall Study|Site error|1|||
170398741|NCT01346501|615798270|FG000|Overall Study|Initiated Other Biological Agents|3|||
170398742|NCT01346501|615798271|FG001|Overall Study|Initiated Other Biological Agents|1|||
170398743|NCT01346501|615798270|FG000|Overall Study|Other|8|||
170398744|NCT01346501|615798271|FG001|Overall Study|Other|12|||
170398745|NCT00728988|615798272|FG000|Overall Study|Not Treated|2|||
170398746|NCT00728988|615798273|FG001|Overall Study|Not Treated|2|||
170398747|NCT00728988|615798272|FG000|Overall Study|Death|1|||
170398748|NCT00728988|615798273|FG001|Overall Study|Death|1|||
170398749|NCT00728988|615798272|FG000|Overall Study|Adverse Event|3|||
170398750|NCT00728988|615798273|FG001|Overall Study|Adverse Event|2|||
170398751|NCT00728988|615798272|FG000|Overall Study|Other|85|||
170398752|NCT00728988|615798273|FG001|Overall Study|Other|77|||
170398753|NCT00728988|615798272|FG000|Overall Study|Withdrawal by Subject|2|||
170398754|NCT00728988|615798273|FG001|Overall Study|Withdrawal by Subject|6|||
170398755|NCT02017535|615798274|FG000|Overall Study|Withdrawal by Subject|1|||
170398756|NCT02017535|615798275|FG001|Overall Study|Withdrawal by Subject|0|||
170398757|NCT02017535|615798276|FG002|Overall Study|Withdrawal by Subject|0|||
170398758|NCT02017535|615798277|FG003|Overall Study|Withdrawal by Subject|0|||
170398759|NCT00664066|615798280|FG000|Overall Study|Study terminated|3|||
170398760|NCT00481871|615798281|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
170398761|NCT00481871|615798282|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
170398762|NCT00481871|615798283|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
170398763|NCT00481871|615798284|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
170398764|NCT00481871|615798285|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
170398765|NCT04439149|615798287|FG000|Overall Study|Ineligible|1|||
170398766|NCT04439149|615798287|FG000|Overall Study|Never start protocol therapy|1|||
170398767|NCT04439149|615798287|FG000|Overall Study|Adverse Event|4|||
170398768|NCT04439149|615798287|FG000|Overall Study|Disease Progression|14|||
170398769|NCT04439149|615798287|FG000|Overall Study|Complicating disease|1|||
170398770|NCT04439149|615798287|FG000|Overall Study|Withdrawal by Subject|3|||
170398771|NCT02617446|615798288|FG000|Overall Study|Withdrawal by Subject|0|||
170398772|NCT02617446|615798289|FG001|Overall Study|Withdrawal by Subject|2|||
170398773|NCT02617446|615798290|FG002|Overall Study|Withdrawal by Subject|0|||
170398774|NCT02617446|615798288|FG000|Overall Study|Adverse Event|1|||
170398775|NCT02617446|615798289|FG001|Overall Study|Adverse Event|0|||
170398776|NCT02617446|615798290|FG002|Overall Study|Adverse Event|5|||
170398777|NCT02617446|615798288|FG000|Overall Study|Lost to Follow-up|3|||
170398778|NCT02617446|615798289|FG001|Overall Study|Lost to Follow-up|0|||
170398779|NCT02617446|615798290|FG002|Overall Study|Lost to Follow-up|0|||
170398780|NCT02617446|615798288|FG000|Overall Study|Death|0|||
170398781|NCT02617446|615798289|FG001|Overall Study|Death|0|||
170398782|NCT02617446|615798290|FG002|Overall Study|Death|2|||
170398783|NCT05264506|615798291|FG000|Overall Study|Adverse Event|59|||
170398784|NCT05264506|615798291|FG000|Overall Study|Lost to Follow-up|204|||
170398785|NCT05264506|615798291|FG000|Overall Study|Protocol Violation|185|||
170398786|NCT05264506|615798291|FG000|Overall Study|Pregnancy|60|||
170398787|NCT05264506|615798291|FG000|Overall Study|Physician Decision|6|||
170398788|NCT05264506|615798291|FG000|Overall Study|Non-compliance with Study Drug|29|||
170398789|NCT05264506|615798291|FG000|Overall Study|Study termination|677|||
170398790|NCT05264506|615798291|FG000|Overall Study|Withdrawal by Subject|208|||
170398791|NCT05264506|615798291|FG000|Overall Study|Discontinued prior treatment|89|||
170398792|NCT00621309|615798292|FG000|Overall Study|Withdrawal by Subject|2|||
170398793|NCT00621309|615798293|FG001|Overall Study|Withdrawal by Subject|0|||
170398794|NCT00621309|615798294|FG002|Overall Study|Withdrawal by Subject|1|||
170398795|NCT00621309|615798295|FG003|Overall Study|Withdrawal by Subject|1|||
170398796|NCT00621309|615798296|FG004|Overall Study|Withdrawal by Subject|1|||
170398797|NCT00621309|615798297|FG005|Overall Study|Withdrawal by Subject|1|||
170398798|NCT01306968|615798300|FG000|Overall Study|Lost to Follow-up|1|||
170398799|NCT01306968|615798301|FG001|Overall Study|Lost to Follow-up|1|||
170398800|NCT01306968|615798302|FG002|Overall Study|Lost to Follow-up|0|||
170398801|NCT01306968|615798303|FG003|Overall Study|Lost to Follow-up|0|||
170398802|NCT01306968|615798300|FG000|Overall Study|Physician Decision|0|||
170398803|NCT01306968|615798301|FG001|Overall Study|Physician Decision|1|||
170398804|NCT01306968|615798302|FG002|Overall Study|Physician Decision|0|||
170398805|NCT01306968|615798303|FG003|Overall Study|Physician Decision|0|||
170398806|NCT01306968|615798300|FG000|Overall Study|Relocated and left active duty|0|||
170398807|NCT01306968|615798301|FG001|Overall Study|Relocated and left active duty|1|||
170398808|NCT01306968|615798302|FG002|Overall Study|Relocated and left active duty|1|||
170398809|NCT01306968|615798303|FG003|Overall Study|Relocated and left active duty|1|||
170398810|NCT01306968|615798300|FG000|Overall Study|Withdrew - time commitment|0|||
170398811|NCT01306968|615798301|FG001|Overall Study|Withdrew - time commitment|0|||
170398812|NCT01306968|615798302|FG002|Overall Study|Withdrew - time commitment|0|||
170398813|NCT01306968|615798303|FG003|Overall Study|Withdrew - time commitment|2|||
170398814|NCT01306968|615798300|FG000|Overall Study|Withdrew over privacy concerns|0|||
170398815|NCT01306968|615798301|FG001|Overall Study|Withdrew over privacy concerns|0|||
170398816|NCT01306968|615798302|FG002|Overall Study|Withdrew over privacy concerns|0|||
170398817|NCT01306968|615798303|FG003|Overall Study|Withdrew over privacy concerns|1|||
170398818|NCT00061568|615798306|FG000|Overall Study|Lost to Follow-up|12|||
170398819|NCT00061568|615798307|FG001|Overall Study|Lost to Follow-up|0|||
170398820|NCT00061568|615798306|FG000|Overall Study|Death|6|||
170398821|NCT00061568|615798307|FG001|Overall Study|Death|0|||
170398822|NCT00061568|615798306|FG000|Overall Study|Withdrawal by Subject|1|||
170398823|NCT00061568|615798307|FG001|Overall Study|Withdrawal by Subject|0|||
170398824|NCT00797316|615798308|FG000|Overall Study|Administrative problems|1|||
170398825|NCT00797316|615798309|FG001|Overall Study|Administrative problems|0|||
170398826|NCT00797316|615798308|FG000|Overall Study|Adverse Event|5|||
170398827|NCT00797316|615798309|FG001|Overall Study|Adverse Event|3|||
170398828|NCT00797316|615798308|FG000|Overall Study|Lost to Follow-up|4|||
170398829|NCT00797316|615798309|FG001|Overall Study|Lost to Follow-up|8|||
170398830|NCT00797316|615798308|FG000|Overall Study|Protocol Deviation|1|||
170398831|NCT00797316|615798309|FG001|Overall Study|Protocol Deviation|2|||
170398832|NCT00797316|615798308|FG000|Overall Study|Patient withdrew consent|12|||
170398833|NCT00797316|615798309|FG001|Overall Study|Patient withdrew consent|6|||
170398834|NCT00797316|615798308|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
170398835|NCT00797316|615798309|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
170398836|NCT05004181|615798312|FG000|Overall Study|Withdrawal of consent|0|||
170398837|NCT05004181|615798313|FG001|Overall Study|Withdrawal of consent|0|||
170398838|NCT05004181|615798314|FG002|Overall Study|Withdrawal of consent|1|||
170398839|NCT05004181|615798315|FG003|Overall Study|Withdrawal of consent|3|||
170398840|NCT05004181|615798316|FG004|Overall Study|Withdrawal of consent|3|||
170398841|NCT05004181|615798317|FG005|Overall Study|Withdrawal of consent|0|||
170398842|NCT05004181|615798318|FG006|Overall Study|Withdrawal of consent|30|||
170398843|NCT05004181|615798319|FG007|Overall Study|Withdrawal of consent|9|||
170398844|NCT05004181|615798320|FG008|Overall Study|Withdrawal of consent|3|||
170398845|NCT05004181|615798321|FG009|Overall Study|Withdrawal of consent|2|||
170398846|NCT05004181|615798322|FG010|Overall Study|Withdrawal of consent|5|||
170398847|NCT05004181|615798323|FG011|Overall Study|Withdrawal of consent|1|||
170398884|NCT05004181|615798312|FG000|Overall Study|Withdrawal by Subject|2|||
170398885|NCT05004181|615798313|FG001|Overall Study|Withdrawal by Subject|3|||
170398886|NCT05004181|615798314|FG002|Overall Study|Withdrawal by Subject|2|||
170398887|NCT05004181|615798315|FG003|Overall Study|Withdrawal by Subject|2|||
170398888|NCT05004181|615798316|FG004|Overall Study|Withdrawal by Subject|4|||
170398889|NCT05004181|615798317|FG005|Overall Study|Withdrawal by Subject|2|||
170398890|NCT05004181|615798318|FG006|Overall Study|Withdrawal by Subject|4|||
170398891|NCT05004181|615798319|FG007|Overall Study|Withdrawal by Subject|22|||
170398892|NCT05004181|615798320|FG008|Overall Study|Withdrawal by Subject|8|||
170398893|NCT05004181|615798321|FG009|Overall Study|Withdrawal by Subject|1|||
170398894|NCT05004181|615798322|FG010|Overall Study|Withdrawal by Subject|3|||
170398895|NCT05004181|615798323|FG011|Overall Study|Withdrawal by Subject|2|||
170398896|NCT05004181|615798312|FG000|Overall Study|Protocol Violation|2|||
170398897|NCT05004181|615798313|FG001|Overall Study|Protocol Violation|3|||
170398898|NCT05004181|615798314|FG002|Overall Study|Protocol Violation|0|||
170398899|NCT05004181|615798315|FG003|Overall Study|Protocol Violation|0|||
170398900|NCT05004181|615798316|FG004|Overall Study|Protocol Violation|1|||
170398901|NCT05004181|615798317|FG005|Overall Study|Protocol Violation|0|||
170398902|NCT05004181|615798318|FG006|Overall Study|Protocol Violation|16|||
170398903|NCT05004181|615798319|FG007|Overall Study|Protocol Violation|18|||
170398904|NCT05004181|615798320|FG008|Overall Study|Protocol Violation|2|||
170398905|NCT05004181|615798321|FG009|Overall Study|Protocol Violation|2|||
170398906|NCT05004181|615798322|FG010|Overall Study|Protocol Violation|2|||
170398907|NCT05004181|615798323|FG011|Overall Study|Protocol Violation|1|||
170398908|NCT05004181|615798312|FG000|Overall Study|Not further specified|1|||
170398909|NCT05004181|615798313|FG001|Overall Study|Not further specified|0|||
170398910|NCT05004181|615798314|FG002|Overall Study|Not further specified|0|||
170398911|NCT05004181|615798315|FG003|Overall Study|Not further specified|0|||
170398912|NCT05004181|615798316|FG004|Overall Study|Not further specified|0|||
170398913|NCT05004181|615798317|FG005|Overall Study|Not further specified|0|||
170398914|NCT05004181|615798318|FG006|Overall Study|Not further specified|1|||
170398915|NCT05004181|615798319|FG007|Overall Study|Not further specified|0|||
170398916|NCT05004181|615798320|FG008|Overall Study|Not further specified|2|||
170398917|NCT05004181|615798321|FG009|Overall Study|Not further specified|1|||
170398918|NCT05004181|615798322|FG010|Overall Study|Not further specified|0|||
170398919|NCT05004181|615798323|FG011|Overall Study|Not further specified|1|||
170398920|NCT02949219|615798324|FG000|Overall Study|Withdrawal by Subject|1|||
170398921|NCT01525407|615798325|FG000|Overall Study|Change in recipient treatment plan|2|||
170398922|NCT01525407|615798326|FG001|Overall Study|Change in recipient treatment plan|2|||
170398923|NCT01525407|615798325|FG000|Overall Study|Withdrawal by Subject|0|||
170398924|NCT01525407|615798326|FG001|Overall Study|Withdrawal by Subject|1|||
170398925|NCT01525407|615798325|FG000|Overall Study|Transplant was delayed|0|||
170398926|NCT01525407|615798326|FG001|Overall Study|Transplant was delayed|1|||
170398927|NCT01525407|615798325|FG000|Overall Study|Delay in Transplant|1|||
170398928|NCT01525407|615798326|FG001|Overall Study|Delay in Transplant|0|||
170398929|NCT01607398|615799810|FG000|Overall Study|Adverse Event|0|||
170398930|NCT01607398|615799811|FG001|Overall Study|Adverse Event|2|||
170398931|NCT01607398|615799810|FG000|Overall Study|Severe COPD|2|||
170398932|NCT01607398|615799811|FG001|Overall Study|Severe COPD|0|||
170398933|NCT01020773|615799812|FG000|Overall Study|Withdrawal by Subject|4|||
170398934|NCT01020773|615799813|FG001|Overall Study|Withdrawal by Subject|3|||
170398935|NCT02253654|615799814|FG000|Overall Study|Withdrawal by Subject|12|||
170398936|NCT02253654|615799815|FG001|Overall Study|Withdrawal by Subject|4|||
170398937|NCT02253654|615799814|FG000|Overall Study|Decision by Sponsor|1|||
170398938|NCT02253654|615799815|FG001|Overall Study|Decision by Sponsor|1|||
170398939|NCT02253654|615799814|FG000|Overall Study|Lost to Follow-up|2|||
170398940|NCT02253654|615799815|FG001|Overall Study|Lost to Follow-up|5|||
170398941|NCT02253654|615799814|FG000|Overall Study|Death|4|||
170398942|NCT02253654|615799815|FG001|Overall Study|Death|7|||
170398943|NCT02253654|615799814|FG000|Overall Study|Did Not Receive Study Treatment|4|||
170398944|NCT02253654|615799815|FG001|Overall Study|Did Not Receive Study Treatment|1|||
170398945|NCT02576054|615799820|FG000|Overall Study|Withdrawal by Subject|1|||
170398946|NCT04723173|615799829|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
170398947|NCT02996448|615799830|FG000|Overall Study|Study terminated due to adverse effects|3|||
170398948|NCT02082262|615799831|FG000|Overall Study|Withdrawal by Subject|3|||
170398949|NCT02082262|615799831|FG000|Overall Study|Adverse Event|48|||
170398950|NCT01796860|615799834|FG000|Overall Study|Withdrawal by Subject|3|||
170398951|NCT00791154|615799839|FG000|Overall Study|Noncompliance|0|||
170398952|NCT00791154|615799840|FG001|Overall Study|Noncompliance|1|||
170398953|NCT00791154|615799841|FG002|Overall Study|Noncompliance|0|||
170398954|NCT00791154|615799842|FG003|Overall Study|Noncompliance|0|||
170398955|NCT00791154|615799843|FG004|Overall Study|Noncompliance|1|||
170398956|NCT00791154|615799844|FG005|Overall Study|Noncompliance|1|||
170398957|NCT00791154|615799845|FG006|Overall Study|Noncompliance|1|||
170398958|NCT00791154|615799839|FG000|Overall Study|Adverse Event|0|||
170398959|NCT00791154|615799840|FG001|Overall Study|Adverse Event|0|||
170398960|NCT00791154|615799841|FG002|Overall Study|Adverse Event|0|||
170398965|NCT00791154|615799839|FG000|Overall Study|Full Consent withdrawn|1|||
170398966|NCT00791154|615799840|FG001|Overall Study|Full Consent withdrawn|3|||
170398967|NCT00791154|615799841|FG002|Overall Study|Full Consent withdrawn|0|||
170398968|NCT00791154|615799842|FG003|Overall Study|Full Consent withdrawn|0|||
170398969|NCT00791154|615799843|FG004|Overall Study|Full Consent withdrawn|1|||
170398970|NCT00791154|615799844|FG005|Overall Study|Full Consent withdrawn|3|||
170398971|NCT00791154|615799845|FG006|Overall Study|Full Consent withdrawn|1|||
170398972|NCT00791154|615799839|FG000|Overall Study|Lost to Follow-up|0|||
170398973|NCT00791154|615799840|FG001|Overall Study|Lost to Follow-up|0|||
170398974|NCT00791154|615799841|FG002|Overall Study|Lost to Follow-up|0|||
170398975|NCT00791154|615799842|FG003|Overall Study|Lost to Follow-up|1|||
170398976|NCT00791154|615799843|FG004|Overall Study|Lost to Follow-up|2|||
170398977|NCT00791154|615799844|FG005|Overall Study|Lost to Follow-up|0|||
170398978|NCT00791154|615799845|FG006|Overall Study|Lost to Follow-up|4|||
170398979|NCT00791154|615799839|FG000|Overall Study|Death|5|||
170398980|NCT00791154|615799840|FG001|Overall Study|Death|4|||
170398981|NCT00791154|615799841|FG002|Overall Study|Death|4|||
170398982|NCT00791154|615799842|FG003|Overall Study|Death|7|||
170398983|NCT00791154|615799843|FG004|Overall Study|Death|54|||
170398984|NCT00791154|615799844|FG005|Overall Study|Death|54|||
170398985|NCT00791154|615799845|FG006|Overall Study|Death|52|||
170398986|NCT00791154|615799839|FG000|Overall Study|Other event|0|||
170398987|NCT00791154|615799840|FG001|Overall Study|Other event|0|||
170398988|NCT00791154|615799841|FG002|Overall Study|Other event|2|||
170398989|NCT00791154|615799842|FG003|Overall Study|Other event|0|||
170398990|NCT00791154|615799843|FG004|Overall Study|Other event|2|||
170398991|NCT00791154|615799844|FG005|Overall Study|Other event|4|||
170398992|NCT00791154|615799845|FG006|Overall Study|Other event|2|||
170398993|NCT00953927|615799846|FG000|Overall Study|Lost to Follow-up|61|||
170398994|NCT00953927|615799847|FG001|Overall Study|Lost to Follow-up|65|||
170398995|NCT00953927|615799846|FG000|Overall Study|Withdrawal by Subject|36|||
170398996|NCT00953927|615799847|FG001|Overall Study|Withdrawal by Subject|25|||
170398997|NCT00953927|615799846|FG000|Overall Study|Death|7|||
170398998|NCT00953927|615799847|FG001|Overall Study|Death|4|||
170398999|NCT00953927|615799846|FG000|Overall Study|Other study discontinuation|1|||
170399000|NCT00953927|615799847|FG001|Overall Study|Other study discontinuation|1|||
170399001|NCT00934622|615799848|FG000|Overall Study|Lost to Follow-up|7|||
170399002|NCT00934622|615799848|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
170399003|NCT01396161|615799849|FG000|Overall Study|Withdrawal by Subject|0|||
170399004|NCT01396161|615799850|FG001|Overall Study|Withdrawal by Subject|0|||
170399005|NCT01396161|615799851|FG002|Overall Study|Withdrawal by Subject|0|||
170399006|NCT01396161|615799852|FG003|Overall Study|Withdrawal by Subject|0|||
170399007|NCT01396161|615799853|FG004|Overall Study|Withdrawal by Subject|1|||
170399008|NCT01396161|615799854|FG005|Overall Study|Withdrawal by Subject|0|||
170399009|NCT01396161|615799855|FG006|Overall Study|Withdrawal by Subject|0|||
170399010|NCT01396161|615799849|FG000|Overall Study|Other|0|||
170399011|NCT01396161|615799850|FG001|Overall Study|Other|0|||
170399012|NCT01396161|615799851|FG002|Overall Study|Other|0|||
170399013|NCT01396161|615799852|FG003|Overall Study|Other|0|||
170399014|NCT01396161|615799853|FG004|Overall Study|Other|0|||
170399015|NCT01396161|615799854|FG005|Overall Study|Other|0|||
170399016|NCT01396161|615799855|FG006|Overall Study|Other|1|||
170399017|NCT03976076|615799856|FG000|Overall Study|Withdrawal by Subject|2|||
170399018|NCT00414011|615799857|FG000|Overall Study|Physician Decision|3|||
170399019|NCT00414011|615799857|FG000|Overall Study|Withdrawal by Subject|2|||
170399020|NCT00883740|615799858|FG000|First Intervention|Lost to Follow-up|1|||
170399021|NCT00883740|615799859|FG001|First Intervention|Lost to Follow-up|0|||
170399022|NCT00883740|615799858|FG000|First Intervention|No longer willing to participate|2|||
170399023|NCT00883740|615799859|FG001|First Intervention|No longer willing to participate|0|||
170399024|NCT00883740|615799858|FG000|First Intervention|Protocol Violation|3|||
170399025|NCT00883740|615799859|FG001|First Intervention|Protocol Violation|6|||
170399026|NCT00883740|615799858|FG000|First Intervention|Adverse Event|1|||
170399027|NCT00883740|615799859|FG001|First Intervention|Adverse Event|2|||
170399028|NCT00883740|615799858|FG000|Second Intervention|Protocol Violation|1|||
170399029|NCT00883740|615799859|FG001|Second Intervention|Protocol Violation|0|||
170399030|NCT00883740|615799858|FG000|Second Intervention|No longer willing to participate|0|||
170399031|NCT00883740|615799859|FG001|Second Intervention|No longer willing to participate|1|||
170399032|NCT00450177|615799860|FG000|Overall Study|Adverse Event|7|||
170399033|NCT00450177|615799861|FG001|Overall Study|Adverse Event|4|||
170399034|NCT00450177|615799860|FG000|Overall Study|Withdrawal by Subject|1|||
170399035|NCT00450177|615799861|FG001|Overall Study|Withdrawal by Subject|6|||
170399036|NCT00450177|615799860|FG000|Overall Study|Withdrawal by Primary Team|1|||
170399037|NCT00450177|615799861|FG001|Overall Study|Withdrawal by Primary Team|1|||
170399038|NCT02923115|615799862|FG000|Overall Study|Lost to Follow-up|0|||
170399039|NCT02923115|615799863|FG001|Overall Study|Lost to Follow-up|0|||
170399040|NCT02923115|615799864|FG002|Overall Study|Lost to Follow-up|0|||
170399041|NCT02923115|615799865|FG003|Overall Study|Lost to Follow-up|1|||
170399042|NCT02923115|615799866|FG004|Overall Study|Lost to Follow-up|0|||
170399043|NCT02923115|615799867|FG005|Overall Study|Lost to Follow-up|0|||
170399044|NCT02923115|615799862|FG000|Overall Study|Withdrawal by Subject|0|||
170399045|NCT02923115|615799863|FG001|Overall Study|Withdrawal by Subject|1|||
170399046|NCT02923115|615799864|FG002|Overall Study|Withdrawal by Subject|0|||
170399047|NCT02923115|615799865|FG003|Overall Study|Withdrawal by Subject|0|||
170399048|NCT02923115|615799866|FG004|Overall Study|Withdrawal by Subject|0|||
170399049|NCT02923115|615799867|FG005|Overall Study|Withdrawal by Subject|0|||
170399050|NCT02923115|615799862|FG000|Overall Study|Randomized, but not dosed|0|||
170399051|NCT02923115|615799863|FG001|Overall Study|Randomized, but not dosed|0|||
170399052|NCT02923115|615799864|FG002|Overall Study|Randomized, but not dosed|3|||
170399053|NCT02923115|615799865|FG003|Overall Study|Randomized, but not dosed|1|||
170399054|NCT02923115|615799866|FG004|Overall Study|Randomized, but not dosed|5|||
170399055|NCT02923115|615799867|FG005|Overall Study|Randomized, but not dosed|0|||
170399056|NCT00078312|615799874|FG000|Overall Study|Adverse Event|43|||
170399057|NCT00078312|615799874|FG000|Overall Study|Lack of Efficacy|15|||
170399058|NCT00078312|615799874|FG000|Overall Study|Lost to Follow-up|41|||
170399059|NCT00078312|615799874|FG000|Overall Study|Physician Decision|9|||
170399060|NCT00078312|615799874|FG000|Overall Study|Protocol Violation|3|||
170399061|NCT00078312|615799874|FG000|Overall Study|Withdrawal by Subject|33|||
170399062|NCT00078312|615799874|FG000|Overall Study|Miscellaneous|33|||
170399063|NCT01296152|615799875|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
170399064|NCT01875991|615799876|FG000|Overall Study|Withdrawal by Subject|6|||
170399065|NCT01875991|615799877|FG001|Overall Study|Withdrawal by Subject|6|||
170399066|NCT01875991|615799876|FG000|Overall Study|Sponsor Decision|1|||
170399067|NCT01875991|615799877|FG001|Overall Study|Sponsor Decision|0|||
170399068|NCT03387735|615799880|FG000|Overall Study|Lost to Follow-up|4|||
170399069|NCT03387735|615799881|FG001|Overall Study|Lost to Follow-up|8|||
170399070|NCT03387735|615799880|FG000|Overall Study|Death|4|||
170399071|NCT03387735|615799881|FG001|Overall Study|Death|8|||
170399072|NCT03099161|615799884|FG000|Overall Study|Adverse Event|0|||
170399073|NCT03099161|615799885|FG001|Overall Study|Adverse Event|0|||
170399074|NCT03099161|615799886|FG002|Overall Study|Adverse Event|2|||
170399075|NCT03099161|615799884|FG000|Overall Study|Physician Decision|2|||
170399076|NCT03099161|615799885|FG001|Overall Study|Physician Decision|0|||
170399077|NCT03099161|615799886|FG002|Overall Study|Physician Decision|0|||
170399078|NCT03099161|615799884|FG000|Overall Study|Progressive Disease|1|||
170399079|NCT03099161|615799885|FG001|Overall Study|Progressive Disease|4|||
170399080|NCT03099161|615799886|FG002|Overall Study|Progressive Disease|1|||
170399081|NCT00103259|615799887|FG000|Overall Study|Death|3|||
170399082|NCT00103259|615799888|FG001|Overall Study|Death|2|||
170399083|NCT00103259|615799887|FG000|Overall Study|Withdrawal by Subject|2|||
170399084|NCT00103259|615799888|FG001|Overall Study|Withdrawal by Subject|3|||
170399085|NCT00103259|615799887|FG000|Overall Study|alternative therapy|1|||
170399086|NCT00103259|615799888|FG001|Overall Study|alternative therapy|0|||
170399087|NCT00103259|615799887|FG000|Overall Study|other (reasons were not specified)|2|||
170399088|NCT00103259|615799888|FG001|Overall Study|other (reasons were not specified)|1|||
170399089|NCT00103259|615799887|FG000|Overall Study|ineligible/no protocol therapy|4|||
170399090|NCT00103259|615799888|FG001|Overall Study|ineligible/no protocol therapy|6|||
170399091|NCT02866695|615799889|FG000|Overall Study|Adverse Event|1|||
170399092|NCT02866695|615799889|FG000|Overall Study|Lost to Follow-up|1|||
170399093|NCT03224234|615799890|FG000|Main Study|Lost to Follow-up|5|||
170399094|NCT03224234|615799891|FG001|Main Study|Lost to Follow-up|5|||
170399095|NCT02610842|615799892|FG000|Overall Study|Lost to Follow-up|5|||
170399096|NCT00756652|615799893|FG000|Original Phase|Withdrawal by Subject|864|||
170399097|NCT00756652|615799894|FG001|Original Phase|Withdrawal by Subject|23|||
170399098|NCT00756652|615799893|FG000|Original Phase|Lost to Follow-up|601|||
170399099|NCT00756652|615799894|FG001|Original Phase|Lost to Follow-up|0|||
170399100|NCT00756652|615799893|FG000|Original Phase|Other Discontinuation|797|||
170399101|NCT00756652|615799894|FG001|Original Phase|Other Discontinuation|5|||
170399102|NCT00756652|615799893|FG000|Original Phase|Participant Noncompliance|18622|||
170399103|NCT00756652|615799894|FG001|Original Phase|Participant Noncompliance|424|||
170399104|NCT00756652|615799893|FG000|Original Phase|Unknown Discontinuation Reason|2|||
170399105|NCT00756652|615799894|FG001|Original Phase|Unknown Discontinuation Reason|0|||
170399106|NCT00756652|615799893|FG000|Original Phase|Participants without data|3259|||
170399107|NCT00756652|615799894|FG001|Original Phase|Participants without data|466|||
170399108|NCT00756652|615799893|FG000|Original Phase|Death|168|||
170399109|NCT00756652|615799894|FG001|Original Phase|Death|1|||
170399110|NCT00756652|615799893|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
170399111|NCT00756652|615799894|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
170399112|NCT00756652|615799893|FG000|Re-Op Phase|Withdrawal by Subject|62|||
170399113|NCT00756652|615799894|FG001|Re-Op Phase|Withdrawal by Subject|0|||
170399114|NCT00756652|615799893|FG000|Re-Op Phase|Death|6|||
170399115|NCT00756652|615799894|FG001|Re-Op Phase|Death|0|||
170399116|NCT00756652|615799893|FG000|Re-Op Phase|Lost to Follow-up|340|||
170399117|NCT00756652|615799894|FG001|Re-Op Phase|Lost to Follow-up|0|||
170399118|NCT00756652|615799893|FG000|Re-Op Phase|Site Closed|2454|||
170399119|NCT00756652|615799894|FG001|Re-Op Phase|Site Closed|0|||
170399120|NCT00756652|615799893|FG000|Re-Op Phase|Withdrawn after explant|14|||
170399121|NCT00756652|615799894|FG001|Re-Op Phase|Withdrawn after explant|0|||
170399124|NCT02564952|615799895|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
170399125|NCT02564952|615799895|FG000|Overall Study|Withdrawal by Subject|1|||
170399126|NCT02564952|615799895|FG000|Overall Study|Low Efficacy|1|||
170399127|NCT02564952|615799895|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
170399128|NCT03972709|615799900|FG000|Overall Study|Withdrawal by Subject|18|||
170399129|NCT03972709|615799901|FG001|Overall Study|Withdrawal by Subject|7|||
170399130|NCT03972709|615799902|FG002|Overall Study|Withdrawal by Subject|14|||
170399131|NCT03972709|615799900|FG000|Overall Study|Study Terminated by Sponsor|48|||
170399132|NCT03972709|615799901|FG001|Overall Study|Study Terminated by Sponsor|25|||
170399133|NCT03972709|615799902|FG002|Overall Study|Study Terminated by Sponsor|50|||
170399134|NCT03972709|615799900|FG000|Overall Study|Physician Decision|1|||
170399135|NCT03972709|615799901|FG001|Overall Study|Physician Decision|0|||
170399136|NCT03972709|615799902|FG002|Overall Study|Physician Decision|0|||
170399137|NCT03972709|615799900|FG000|Overall Study|COVID-19|0|||
170399138|NCT03972709|615799901|FG001|Overall Study|COVID-19|1|||
170399139|NCT03972709|615799902|FG002|Overall Study|COVID-19|1|||
170399140|NCT03972709|615799900|FG000|Overall Study|Lost to Follow-up|6|||
170399141|NCT03972709|615799901|FG001|Overall Study|Lost to Follow-up|1|||
170399142|NCT03972709|615799902|FG002|Overall Study|Lost to Follow-up|2|||
170399143|NCT03972709|615799900|FG000|Overall Study|Death|5|||
170399144|NCT03972709|615799901|FG001|Overall Study|Death|1|||
170399145|NCT03972709|615799902|FG002|Overall Study|Death|4|||
170399146|NCT03972709|615799900|FG000|Overall Study|Adverse Event|3|||
170399147|NCT03972709|615799901|FG001|Overall Study|Adverse Event|1|||
170399148|NCT03972709|615799902|FG002|Overall Study|Adverse Event|4|||
170399149|NCT03972709|615799900|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
170399150|NCT03972709|615799901|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
170399151|NCT03972709|615799902|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
170399152|NCT03972709|615799900|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
170399153|NCT03972709|615799901|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
170399154|NCT03972709|615799902|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
170399155|NCT03972709|615799900|FG000|Overall Study|Subject Unable to be Contacted|0|||
170399156|NCT03972709|615799901|FG001|Overall Study|Subject Unable to be Contacted|1|||
170399157|NCT03972709|615799902|FG002|Overall Study|Subject Unable to be Contacted|0|||
170399158|NCT03972709|615799900|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
170399159|NCT03972709|615799901|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
170399160|NCT03972709|615799902|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
170399161|NCT03972709|615799900|FG000|Overall Study|Subject Moved|0|||
170399162|NCT03972709|615799901|FG001|Overall Study|Subject Moved|1|||
170399163|NCT03972709|615799902|FG002|Overall Study|Subject Moved|0|||
170399164|NCT03972709|615799900|FG000|Overall Study|Missed Study Visits|1|||
170399165|NCT03972709|615799901|FG001|Overall Study|Missed Study Visits|0|||
170399166|NCT03972709|615799902|FG002|Overall Study|Missed Study Visits|0|||
170399167|NCT04732728|615799903|FG000|Overall Study|Death|12|||
170399168|NCT04732728|615799903|FG000|Overall Study|Withdrawn|136|||
170399169|NCT02494583|615799908|FG000|Overall Study|Death|224|||
170399170|NCT02494583|615799909|FG001|Overall Study|Death|214|||
170399171|NCT02494583|615799910|FG002|Overall Study|Death|225|||
170399172|NCT02494583|615799908|FG000|Overall Study|Lost to Follow-up|1|||
170399173|NCT02494583|615799909|FG001|Overall Study|Lost to Follow-up|0|||
170399174|NCT02494583|615799910|FG002|Overall Study|Lost to Follow-up|0|||
170399175|NCT02494583|615799908|FG000|Overall Study|Protocol Violation|1|||
170399176|NCT02494583|615799909|FG001|Overall Study|Protocol Violation|2|||
170399177|NCT02494583|615799910|FG002|Overall Study|Protocol Violation|0|||
170399178|NCT02494583|615799908|FG000|Overall Study|Screen Failure|0|||
170399179|NCT02494583|615799909|FG001|Overall Study|Screen Failure|1|||
170399180|NCT02494583|615799910|FG002|Overall Study|Screen Failure|0|||
170399181|NCT02494583|615799908|FG000|Overall Study|Transferred to Extension Study|15|||
170399182|NCT02494583|615799909|FG001|Overall Study|Transferred to Extension Study|15|||
170399183|NCT02494583|615799910|FG002|Overall Study|Transferred to Extension Study|6|||
170399184|NCT02494583|615799908|FG000|Overall Study|Did Not Continue on Extension Study|8|||
170399185|NCT02494583|615799909|FG001|Overall Study|Did Not Continue on Extension Study|10|||
170399186|NCT02494583|615799910|FG002|Overall Study|Did Not Continue on Extension Study|4|||
170399187|NCT02494583|615799908|FG000|Overall Study|Withdrawal by Subject|7|||
170399188|NCT02494583|615799909|FG001|Overall Study|Withdrawal by Subject|15|||
170399189|NCT02494583|615799910|FG002|Overall Study|Withdrawal by Subject|15|||
170399190|NCT00627458|615799911|FG000|Overall Study|Migrated from study area|1|||
170399191|NCT00627458|615799912|FG001|Overall Study|Migrated from study area|0|||
170399192|NCT00627458|615799913|FG002|Overall Study|Migrated from study area|1|||
170399193|NCT00627458|615799911|FG000|Overall Study|Withdrawal by Subject|2|||
170399194|NCT00627458|615799912|FG001|Overall Study|Withdrawal by Subject|6|||
170399195|NCT00627458|615799913|FG002|Overall Study|Withdrawal by Subject|5|||
170399196|NCT00627458|615799911|FG000|Overall Study|Lost to Follow-up|1|||
170399197|NCT00627458|615799912|FG001|Overall Study|Lost to Follow-up|1|||
170399198|NCT00627458|615799913|FG002|Overall Study|Lost to Follow-up|0|||
170399199|NCT05349188|615799914|FG000|Overall Study|Withdrawal by Subject|1|||
170399200|NCT05349188|615799915|FG001|Overall Study|Withdrawal by Subject|0|||
170399201|NCT04088734|615799916|FG000|Overall Study|Other, Not Specified|5|||
170399202|NCT04971226|615799917|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
170399203|NCT04971226|615799918|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
170399204|NCT04971226|615799919|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
170399205|NCT04971226|615799920|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
170399206|NCT04971226|615799917|FG000|Overall Study|Adverse Event|6|||
170399207|NCT04971226|615799918|FG001|Overall Study|Adverse Event|5|||
170399208|NCT04971226|615799919|FG002|Overall Study|Adverse Event|11|||
170399209|NCT04971226|615799920|FG003|Overall Study|Adverse Event|10|||
170399210|NCT04971226|615799917|FG000|Overall Study|Progressive disease|2|||
170399211|NCT04971226|615799918|FG001|Overall Study|Progressive disease|0|||
170399212|NCT04971226|615799919|FG002|Overall Study|Progressive disease|3|||
170399213|NCT04971226|615799920|FG003|Overall Study|Progressive disease|1|||
170399214|NCT04971226|615799917|FG000|Overall Study|Protocol Deviation|1|||
170399215|NCT04971226|615799918|FG001|Overall Study|Protocol Deviation|0|||
170399216|NCT04971226|615799919|FG002|Overall Study|Protocol Deviation|1|||
170399217|NCT04971226|615799920|FG003|Overall Study|Protocol Deviation|1|||
170399218|NCT04971226|615799917|FG000|Overall Study|Subject Decision|0|||
170399219|NCT04971226|615799918|FG001|Overall Study|Subject Decision|1|||
170399220|NCT04971226|615799919|FG002|Overall Study|Subject Decision|1|||
170399221|NCT04971226|615799920|FG003|Overall Study|Subject Decision|1|||
170399222|NCT04971226|615799917|FG000|Overall Study|Pregnancy|0|||
170399223|NCT04971226|615799918|FG001|Overall Study|Pregnancy|0|||
170399224|NCT04971226|615799919|FG002|Overall Study|Pregnancy|0|||
170399225|NCT04971226|615799920|FG003|Overall Study|Pregnancy|1|||
170399226|NCT04971226|615799917|FG000|Overall Study|Participants not treated|1|||
170399227|NCT04971226|615799918|FG001|Overall Study|Participants not treated|0|||
170399228|NCT04971226|615799919|FG002|Overall Study|Participants not treated|2|||
170399229|NCT04971226|615799920|FG003|Overall Study|Participants not treated|1|||
170399230|NCT03151226|615799932|FG000|Overall Study|Withdrawal by Subject|2|||
170399231|NCT03151226|615799932|FG000|Overall Study|not wear device correctly|1|||
170399232|NCT03193190|615799937|FG000|Stage 1|Arm Terminated by Sponsor|0|||
170399233|NCT03193190|615799938|FG001|Stage 1|Arm Terminated by Sponsor|0|||
170399234|NCT03193190|615799939|FG002|Stage 1|Arm Terminated by Sponsor|0|||
170399235|NCT03193190|615799940|FG003|Stage 1|Arm Terminated by Sponsor|1|||
170399236|NCT03193190|615799941|FG004|Stage 1|Arm Terminated by Sponsor|0|||
170399237|NCT03193190|615799942|FG005|Stage 1|Arm Terminated by Sponsor|2|||
170399238|NCT03193190|615799943|FG006|Stage 1|Arm Terminated by Sponsor|0|||
170399239|NCT03193190|615799944|FG007|Stage 1|Arm Terminated by Sponsor|0|||
170399240|NCT03193190|615799945|FG008|Stage 1|Arm Terminated by Sponsor|0|||
170399241|NCT03193190|615799946|FG009|Stage 1|Arm Terminated by Sponsor|0|||
170399242|NCT03193190|615799947|FG010|Stage 1|Arm Terminated by Sponsor|0|||
170399243|NCT03193190|615799948|FG011|Stage 1|Arm Terminated by Sponsor|0|||
170399244|NCT03193190|615799949|FG012|Stage 1|Arm Terminated by Sponsor|0|||
170399245|NCT03193190|615799950|FG013|Stage 1|Arm Terminated by Sponsor|0|||
170399246|NCT03193190|615799951|FG014|Stage 1|Arm Terminated by Sponsor|0|||
170399247|NCT03193190|615799952|FG015|Stage 1|Arm Terminated by Sponsor|0|||
170399248|NCT03193190|615799937|FG000|Stage 1|Death|22|||
170399249|NCT03193190|615799938|FG001|Stage 1|Death|8|||
170399250|NCT03193190|615799939|FG002|Stage 1|Death|23|||
170399251|NCT03193190|615799940|FG003|Stage 1|Death|14|||
170399252|NCT03193190|615799941|FG004|Stage 1|Death|34|||
170399253|NCT03193190|615799942|FG005|Stage 1|Death|28|||
170399254|NCT03193190|615799943|FG006|Stage 1|Death|19|||
170399255|NCT03193190|615799944|FG007|Stage 1|Death|21|||
170399256|NCT03193190|615799945|FG008|Stage 1|Death|14|||
170399257|NCT03193190|615799946|FG009|Stage 1|Death|10|||
170399258|NCT03193190|615799947|FG010|Stage 1|Death|59|||
170399259|NCT03193190|615799948|FG011|Stage 1|Death|14|||
170399260|NCT03193190|615799949|FG012|Stage 1|Death|14|||
170399261|NCT03193190|615799950|FG013|Stage 1|Death|0|||
170399262|NCT03193190|615799951|FG014|Stage 1|Death|0|||
170399263|NCT03193190|615799952|FG015|Stage 1|Death|0|||
170399264|NCT03193190|615799937|FG000|Stage 1|Lost to Follow-up|2|||
170399265|NCT03193190|615799938|FG001|Stage 1|Lost to Follow-up|1|||
170399266|NCT03193190|615799939|FG002|Stage 1|Lost to Follow-up|1|||
170399267|NCT03193190|615799940|FG003|Stage 1|Lost to Follow-up|0|||
170399268|NCT03193190|615799941|FG004|Stage 1|Lost to Follow-up|0|||
170399269|NCT03193190|615799942|FG005|Stage 1|Lost to Follow-up|0|||
170399270|NCT03193190|615799943|FG006|Stage 1|Lost to Follow-up|1|||
170399271|NCT03193190|615799944|FG007|Stage 1|Lost to Follow-up|0|||
170399272|NCT03193190|615799945|FG008|Stage 1|Lost to Follow-up|0|||
170399273|NCT03193190|615799946|FG009|Stage 1|Lost to Follow-up|0|||
170399274|NCT03193190|615799947|FG010|Stage 1|Lost to Follow-up|0|||
170399275|NCT03193190|615799948|FG011|Stage 1|Lost to Follow-up|0|||
170399276|NCT03193190|615799949|FG012|Stage 1|Lost to Follow-up|0|||
170399277|NCT03193190|615799950|FG013|Stage 1|Lost to Follow-up|0|||
170399278|NCT03193190|615799951|FG014|Stage 1|Lost to Follow-up|0|||
170399279|NCT03193190|615799952|FG015|Stage 1|Lost to Follow-up|0|||
170399280|NCT03193190|615799937|FG000|Stage 1|Reason not Specified|1|||
170399281|NCT03193190|615799938|FG001|Stage 1|Reason not Specified|0|||
170399282|NCT03193190|615799939|FG002|Stage 1|Reason not Specified|0|||
170399328|NCT03193190|615799937|FG000|Stage 1|Study Terminated By Sponsor|3|||
170399329|NCT03193190|615799938|FG001|Stage 1|Study Terminated By Sponsor|0|||
170399330|NCT03193190|615799939|FG002|Stage 1|Study Terminated By Sponsor|0|||
170399331|NCT03193190|615799940|FG003|Stage 1|Study Terminated By Sponsor|0|||
170399332|NCT03193190|615799941|FG004|Stage 1|Study Terminated By Sponsor|6|||
170399333|NCT03193190|615799942|FG005|Stage 1|Study Terminated By Sponsor|0|||
170399334|NCT03193190|615799943|FG006|Stage 1|Study Terminated By Sponsor|0|||
170399335|NCT03193190|615799944|FG007|Stage 1|Study Terminated By Sponsor|0|||
170399336|NCT03193190|615799945|FG008|Stage 1|Study Terminated By Sponsor|0|||
170399337|NCT03193190|615799946|FG009|Stage 1|Study Terminated By Sponsor|0|||
170399338|NCT03193190|615799947|FG010|Stage 1|Study Terminated By Sponsor|0|||
170399339|NCT03193190|615799948|FG011|Stage 1|Study Terminated By Sponsor|0|||
170399340|NCT03193190|615799949|FG012|Stage 1|Study Terminated By Sponsor|0|||
170399341|NCT03193190|615799950|FG013|Stage 1|Study Terminated By Sponsor|0|||
170399342|NCT03193190|615799951|FG014|Stage 1|Study Terminated By Sponsor|0|||
170399343|NCT03193190|615799952|FG015|Stage 1|Study Terminated By Sponsor|0|||
170399344|NCT03193190|615799937|FG000|Stage 1|Withdrawal by Subject|6|||
170399345|NCT03193190|615799938|FG001|Stage 1|Withdrawal by Subject|0|||
170399346|NCT03193190|615799939|FG002|Stage 1|Withdrawal by Subject|1|||
170399347|NCT03193190|615799940|FG003|Stage 1|Withdrawal by Subject|0|||
170399348|NCT03193190|615799941|FG004|Stage 1|Withdrawal by Subject|2|||
170399349|NCT03193190|615799942|FG005|Stage 1|Withdrawal by Subject|0|||
170399350|NCT03193190|615799943|FG006|Stage 1|Withdrawal by Subject|3|||
170399351|NCT03193190|615799944|FG007|Stage 1|Withdrawal by Subject|2|||
170399352|NCT03193190|615799945|FG008|Stage 1|Withdrawal by Subject|2|||
170399353|NCT03193190|615799946|FG009|Stage 1|Withdrawal by Subject|4|||
170399354|NCT03193190|615799947|FG010|Stage 1|Withdrawal by Subject|9|||
170399355|NCT03193190|615799948|FG011|Stage 1|Withdrawal by Subject|1|||
170399356|NCT03193190|615799949|FG012|Stage 1|Withdrawal by Subject|0|||
170399357|NCT03193190|615799950|FG013|Stage 1|Withdrawal by Subject|0|||
170399358|NCT03193190|615799951|FG014|Stage 1|Withdrawal by Subject|0|||
170399359|NCT03193190|615799952|FG015|Stage 1|Withdrawal by Subject|0|||
170399360|NCT03193190|615799937|FG000|Stage 2|Death|0|||
170399361|NCT03193190|615799938|FG001|Stage 2|Death|0|||
170399362|NCT03193190|615799939|FG002|Stage 2|Death|0|||
170399363|NCT03193190|615799940|FG003|Stage 2|Death|0|||
170399364|NCT03193190|615799941|FG004|Stage 2|Death|0|||
170399365|NCT03193190|615799942|FG005|Stage 2|Death|0|||
170399366|NCT03193190|615799943|FG006|Stage 2|Death|0|||
170399367|NCT03193190|615799944|FG007|Stage 2|Death|0|||
170399368|NCT03193190|615799945|FG008|Stage 2|Death|0|||
170399369|NCT03193190|615799946|FG009|Stage 2|Death|0|||
170399370|NCT03193190|615799947|FG010|Stage 2|Death|0|||
170399371|NCT03193190|615799948|FG011|Stage 2|Death|0|||
170399372|NCT03193190|615799949|FG012|Stage 2|Death|0|||
170399373|NCT03193190|615799950|FG013|Stage 2|Death|14|||
170399374|NCT03193190|615799951|FG014|Stage 2|Death|4|||
170399375|NCT03193190|615799952|FG015|Stage 2|Death|1|||
170399376|NCT03193190|615799937|FG000|Stage 2|Lost to Follow-up|0|||
170399377|NCT03193190|615799938|FG001|Stage 2|Lost to Follow-up|0|||
170399378|NCT03193190|615799939|FG002|Stage 2|Lost to Follow-up|0|||
170399379|NCT03193190|615799940|FG003|Stage 2|Lost to Follow-up|0|||
170399380|NCT03193190|615799941|FG004|Stage 2|Lost to Follow-up|0|||
170399381|NCT03193190|615799942|FG005|Stage 2|Lost to Follow-up|0|||
170399382|NCT03193190|615799943|FG006|Stage 2|Lost to Follow-up|0|||
170399383|NCT03193190|615799944|FG007|Stage 2|Lost to Follow-up|0|||
170399384|NCT03193190|615799945|FG008|Stage 2|Lost to Follow-up|0|||
170399385|NCT03193190|615799946|FG009|Stage 2|Lost to Follow-up|0|||
170399386|NCT03193190|615799947|FG010|Stage 2|Lost to Follow-up|0|||
170399387|NCT03193190|615799948|FG011|Stage 2|Lost to Follow-up|0|||
170399388|NCT03193190|615799949|FG012|Stage 2|Lost to Follow-up|0|||
170399389|NCT03193190|615799950|FG013|Stage 2|Lost to Follow-up|0|||
170399390|NCT03193190|615799951|FG014|Stage 2|Lost to Follow-up|1|||
170399391|NCT03193190|615799952|FG015|Stage 2|Lost to Follow-up|0|||
170399392|NCT03193190|615799937|FG000|Stage 2|Withdrawal by Subject|0|||
170399393|NCT03193190|615799938|FG001|Stage 2|Withdrawal by Subject|0|||
170399394|NCT03193190|615799939|FG002|Stage 2|Withdrawal by Subject|0|||
170399395|NCT03193190|615799940|FG003|Stage 2|Withdrawal by Subject|0|||
170399396|NCT03193190|615799941|FG004|Stage 2|Withdrawal by Subject|0|||
170399397|NCT03193190|615799942|FG005|Stage 2|Withdrawal by Subject|0|||
170399398|NCT03193190|615799943|FG006|Stage 2|Withdrawal by Subject|0|||
170399399|NCT03193190|615799944|FG007|Stage 2|Withdrawal by Subject|0|||
170399400|NCT03193190|615799945|FG008|Stage 2|Withdrawal by Subject|0|||
170399401|NCT03193190|615799946|FG009|Stage 2|Withdrawal by Subject|0|||
170399402|NCT03193190|615799947|FG010|Stage 2|Withdrawal by Subject|0|||
170399403|NCT03193190|615799948|FG011|Stage 2|Withdrawal by Subject|0|||
170399404|NCT03193190|615799949|FG012|Stage 2|Withdrawal by Subject|0|||
170399405|NCT03193190|615799950|FG013|Stage 2|Withdrawal by Subject|1|||
170399406|NCT03193190|615799951|FG014|Stage 2|Withdrawal by Subject|1|||
170399407|NCT03193190|615799952|FG015|Stage 2|Withdrawal by Subject|0|||
170399408|NCT03532295|615799953|FG000|Overall Study|Did not start treatment|0|||
170399409|NCT03532295|615799954|FG001|Overall Study|Did not start treatment|2|||
170399410|NCT04644237|615799955|FG000|Overall Study|Death|4|||
170399411|NCT04644237|615799956|FG001|Overall Study|Death|2|||
170399416|NCT04644237|615799955|FG000|Overall Study|Clinical Progression|4|||
170399417|NCT04644237|615799956|FG001|Overall Study|Clinical Progression|1|||
170399418|NCT04644237|615799955|FG000|Overall Study|Withdrawal by Subject|4|||
170399419|NCT04644237|615799956|FG001|Overall Study|Withdrawal by Subject|2|||
170399420|NCT04644237|615799955|FG000|Overall Study|Physician Decision|4|||
170399421|NCT04644237|615799956|FG001|Overall Study|Physician Decision|0|||
170399422|NCT04644237|615799955|FG000|Overall Study|Other|6|||
170399423|NCT04644237|615799956|FG001|Overall Study|Other|3|||
170399424|NCT04644237|615799955|FG000|Overall Study|Randomized but not Treated|1|||
170399425|NCT04644237|615799956|FG001|Overall Study|Randomized but not Treated|0|||
170399426|NCT03131817|615799957|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
170399427|NCT03494816|615799959|FG000|Overall Study|Protocol Violation|2|||
170399428|NCT03494816|615799959|FG000|Overall Study|Physician Decision|2|||
170399429|NCT03494816|615799959|FG000|Overall Study|Did not start trial treatment|1|||
170399430|NCT03494816|615799959|FG000|Overall Study|Adverse Event|1|||
